id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
706|NCT03489551|2026|P1|NOT COMPLETED|Overall Study||2
707|NCT03489551|2026|P1|COMPLETED|Overall Study||15
708|NCT03489551|2026|P1|STARTED|Overall Study||17
709|NCT03405818|2030|P1|NOT COMPLETED|Overall Study||8
710|NCT03405818|2030|P1|COMPLETED|Overall Study||47
711|NCT03405818|2030|P1|STARTED|Overall Study||55
712|NCT03363633|2071|P1|NOT COMPLETED|Overall Study||12
713|NCT03363633|2071|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
714|NCT03363633|2071|P1|STARTED|Overall Study||12
715|NCT03350724|2081|P2|NOT COMPLETED|Overall Study||0
716|NCT03350724|2082|P1|NOT COMPLETED|Overall Study||0
717|NCT03350724|2081|P2|COMPLETED|Overall Study||17
718|NCT03350724|2082|P1|COMPLETED|Overall Study||17
719|NCT03350724|2081|P2|STARTED|Overall Study||17
720|NCT03350724|2082|P1|STARTED|Overall Study||17
721|NCT03349099|2138|P2|NOT COMPLETED|Overall Study||4
722|NCT03349099|2139|P1|NOT COMPLETED|Overall Study||4
723|NCT03349099|2138|P2|COMPLETED|Overall Study||43
724|NCT03349099|2139|P1|COMPLETED|Overall Study||44
725|NCT03349099|2138|P2|STARTED|Overall Study||47
726|NCT03349099|2139|P1|STARTED|Overall Study||48
727|NCT03292692|2151|P2|NOT COMPLETED|Overall Study||38
728|NCT03292692|2152|P1|NOT COMPLETED|Overall Study||38
729|NCT03292692|2151|P2|COMPLETED|Overall Study||260
730|NCT03292692|2152|P1|COMPLETED|Overall Study||264
731|NCT03292692|2151|P2|STARTED|Overall Study||298
732|NCT03292692|2152|P1|STARTED|Overall Study||302
733|NCT03271424|2167|P3|NOT COMPLETED|April-May 2016||0
734|NCT03271424|2168|P2|NOT COMPLETED|April-May 2016||0
735|NCT03271424|2169|P1|NOT COMPLETED|April-May 2016||0
736|NCT03271424|2167|P3|COMPLETED|April-May 2016||40
737|NCT03271424|2168|P2|COMPLETED|April-May 2016||0
738|NCT03271424|2169|P1|COMPLETED|April-May 2016||0
739|NCT03271424|2167|P3|STARTED|April-May 2016||40
740|NCT03271424|2168|P2|STARTED|April-May 2016||0
741|NCT03271424|2169|P1|STARTED|April-May 2016||0
742|NCT03271424|2167|P3|NOT COMPLETED|December 2015||0
743|NCT03271424|2168|P2|NOT COMPLETED|December 2015||0
744|NCT03271424|2169|P1|NOT COMPLETED|December 2015||0
745|NCT03271424|2167|P3|COMPLETED|December 2015||0
746|NCT03271424|2168|P2|COMPLETED|December 2015||35
747|NCT03271424|2169|P1|COMPLETED|December 2015||0
748|NCT03271424|2167|P3|STARTED|December 2015||0
749|NCT03271424|2168|P2|STARTED|December 2015||35
750|NCT03271424|2169|P1|STARTED|December 2015||0
751|NCT03271424|2167|P3|NOT COMPLETED|November 2015||0
752|NCT03271424|2168|P2|NOT COMPLETED|November 2015||0
753|NCT03271424|2169|P1|NOT COMPLETED|November 2015||0
754|NCT03271424|2167|P3|COMPLETED|November 2015||0
755|NCT03271424|2168|P2|COMPLETED|November 2015||0
756|NCT03271424|2169|P1|COMPLETED|November 2015||20
757|NCT03271424|2167|P3|STARTED|November 2015||0
758|NCT03271424|2168|P2|STARTED|November 2015||0
759|NCT03271424|2169|P1|STARTED|November 2015||20
760|NCT03256552|2179|P1|NOT COMPLETED|Overall Study||5
761|NCT03256552|2179|P1|COMPLETED|Overall Study||61
762|NCT03256552|2179|P1|Placebo MDI|Overall Study||65
763|NCT03256552|2179|P1|GP MDI 7.2 µg|Overall Study||62
764|NCT03256552|2179|P1|GP MDI 14.4 µg|Overall Study||63
765|NCT03256552|2179|P1|GP MDI 28.8 µg|Overall Study||61
766|NCT03256552|2179|P1|STARTED|Overall Study||66
767|NCT03255733|2201|P1|NOT COMPLETED|Overall Study||4
768|NCT03255733|2201|P1|COMPLETED|Overall Study||25
769|NCT03255733|2201|P1|STARTED|Overall Study||29
770|NCT03255655|2208|P2|NOT COMPLETED|Overall Study||4
771|NCT03255655|2209|P1|NOT COMPLETED|Overall Study||7
772|NCT03255655|2208|P2|COMPLETED|Overall Study||8
773|NCT03255655|2209|P1|COMPLETED|Overall Study||22
774|NCT03255655|2208|P2|STARTED|Overall Study||12
775|NCT03255655|2209|P1|STARTED|Overall Study||29
776|NCT03254602|2217|P1|NOT COMPLETED|Overall Study||4
777|NCT03254602|2217|P1|COMPLETED|Overall Study||29
778|NCT03254602|2217|P1|STARTED|Overall Study||33
779|NCT03247985|2225|P2|NOT COMPLETED|Overall Study||0
780|NCT03247985|2226|P1|NOT COMPLETED|Overall Study||0
781|NCT03247985|2225|P2|COMPLETED|Overall Study||19
782|NCT03247985|2226|P1|COMPLETED|Overall Study||19
783|NCT03247985|2225|P2|STARTED|Overall Study||19
784|NCT03247985|2226|P1|STARTED|Overall Study||19
785|NCT03238924|2242|P2|NOT COMPLETED|Overall Study||2
786|NCT03238924|2243|P1|NOT COMPLETED|Overall Study||2
787|NCT03238924|2242|P2|COMPLETED|Overall Study||7
788|NCT03238924|2243|P1|COMPLETED|Overall Study||6
789|NCT03238924|2242|P2|STARTED|Overall Study||9
790|NCT03238924|2243|P1|STARTED|Overall Study||8
791|NCT03238001|2253|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
792|NCT03238001|2253|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
793|NCT03238001|2253|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
794|NCT03238001|2253|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
795|NCT03238001|2253|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
796|NCT03238001|2253|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
797|NCT03235817|2279|P3|NOT COMPLETED|Overall Study||2
798|NCT03235817|2280|P2|NOT COMPLETED|Overall Study||1
799|NCT03235817|2281|P1|NOT COMPLETED|Overall Study||3
800|NCT03235817|2279|P3|COMPLETED|Overall Study||11
801|NCT03235817|2280|P2|COMPLETED|Overall Study||12
802|NCT03235817|2281|P1|COMPLETED|Overall Study||10
803|NCT03235817|2279|P3|STARTED|Overall Study||13
804|NCT03235817|2280|P2|STARTED|Overall Study||13
805|NCT03235817|2281|P1|STARTED|Overall Study||13
806|NCT03231371|2298|P1|NOT COMPLETED|Overall Study||13
807|NCT03231371|2298|P1|COMPLETED|Overall Study||9
808|NCT03231371|2298|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
809|NCT03231371|2298|P1|STARTED|Overall Study||22
810|NCT03225001|2303|P1|NOT COMPLETED|Overall Study||9
811|NCT03225001|2303|P1|COMPLETED|Overall Study||188
812|NCT03225001|2303|P1|Valve-Implanted|Overall Study||195
813|NCT03225001|2303|P1|STARTED|Overall Study||197
814|NCT03218163|2308|P1|NOT COMPLETED|Overall Study||1
815|NCT03218163|2308|P1|COMPLETED|Overall Study||0
816|NCT03218163|2308|P1|STARTED|Overall Study||1
817|NCT03191552|2315|P3|NOT COMPLETED|Overall Study||0
818|NCT03191552|2316|P2|NOT COMPLETED|Overall Study||1
819|NCT03191552|2317|P1|NOT COMPLETED|Overall Study||1
820|NCT03191552|2315|P3|COMPLETED|Overall Study||8
821|NCT03191552|2316|P2|COMPLETED|Overall Study||8
822|NCT03191552|2317|P1|COMPLETED|Overall Study||8
823|NCT03191552|2315|P3|STARTED|Overall Study||8
824|NCT03191552|2316|P2|STARTED|Overall Study||9
825|NCT03191552|2317|P1|STARTED|Overall Study||9
826|NCT03182582|2368|P2|NOT COMPLETED|Treatment 2||0
827|NCT03182582|2369|P1|NOT COMPLETED|Treatment 2||0
828|NCT03182582|2368|P2|COMPLETED|Treatment 2||10
829|NCT03182582|2369|P1|COMPLETED|Treatment 2||12
830|NCT03182582|2368|P2|STARTED|Treatment 2||10
831|NCT03182582|2369|P1|STARTED|Treatment 2||12
832|NCT03182582|2368|P2|NOT COMPLETED|Treatment 1||0
833|NCT03182582|2369|P1|NOT COMPLETED|Treatment 1||0
834|NCT03182582|2368|P2|COMPLETED|Treatment 1||10
835|NCT03182582|2369|P1|COMPLETED|Treatment 1||12
836|NCT03182582|2368|P2|STARTED|Treatment 1||10
837|NCT03182582|2369|P1|STARTED|Treatment 1||12
838|NCT03163134|2386|P2|NOT COMPLETED|Overall Study||0
839|NCT03163134|2387|P1|NOT COMPLETED|Overall Study||0
840|NCT03163134|2386|P2|COMPLETED|Overall Study||85
841|NCT03163134|2387|P1|COMPLETED|Overall Study||85
842|NCT03163134|2386|P2|STARTED|Overall Study||85
843|NCT03163134|2387|P1|STARTED|Overall Study||85
844|NCT03159143|2395|P1|NOT COMPLETED|Overall Study||0
845|NCT03159143|2395|P1|COMPLETED|Overall Study||22
846|NCT03159143|2395|P1|STARTED|Overall Study||22
847|NCT03157232|2402|P1|NOT COMPLETED|Overall Study||0
848|NCT03157232|2402|P1|COMPLETED|Overall Study||18
849|NCT03157232|2402|P1|STARTED|Overall Study||18
850|NCT03151226|2406|P1|NOT COMPLETED|Overall Study||3
851|NCT03151226|2406|P1|COMPLETED|Overall Study||0
852|NCT03151226|2406|P1|STARTED|Overall Study||3
853|NCT03134326|2410|P1|NOT COMPLETED|Overall Study||0
854|NCT03134326|2410|P1|COMPLETED|Overall Study||21
855|NCT03134326|2410|P1|STARTED|Overall Study||21
856|NCT03134313|2414|P1|NOT COMPLETED|Overall Study||0
857|NCT03134313|2414|P1|COMPLETED|Overall Study||25
858|NCT03134313|2414|P1|STARTED|Overall Study||25
859|NCT03128307|2418|P1|NOT COMPLETED|Overall Study||34
860|NCT03128307|2418|P1|COMPLETED|Overall Study||570
861|NCT03128307|2418|P1|STARTED|Overall Study||604
862|NCT03125031|2423|P2|NOT COMPLETED|Overall Study||0
863|NCT03125031|2424|P1|NOT COMPLETED|Overall Study||0
864|NCT03125031|2423|P2|COMPLETED|Overall Study||44
865|NCT03125031|2424|P1|COMPLETED|Overall Study||44
866|NCT03125031|2423|P2|STARTED|Overall Study||44
867|NCT03125031|2424|P1|STARTED|Overall Study||44
868|NCT03125018|2429|P1|NOT COMPLETED|Overall Study||0
869|NCT03125018|2429|P1|COMPLETED|Overall Study||13
870|NCT03125018|2429|P1|STARTED|Overall Study||13
871|NCT03125005|2433|P1|NOT COMPLETED|Overall Study||0
872|NCT03125005|2433|P1|COMPLETED|Overall Study||51
873|NCT03125005|2433|P1|STARTED|Overall Study||51
874|NCT03124979|2437|P1|NOT COMPLETED|Overall Study||0
875|NCT03124979|2437|P1|COMPLETED|Overall Study||13
876|NCT03124979|2437|P1|STARTED|Overall Study||13
877|NCT03124966|2441|P1|NOT COMPLETED|Overall Study||0
878|NCT03124966|2441|P1|COMPLETED|Overall Study||118
879|NCT03124966|2441|P1|STARTED|Overall Study||118
880|NCT03124927|2445|P1|NOT COMPLETED|Overall Study||0
881|NCT03124927|2445|P1|COMPLETED|Overall Study||25
882|NCT03124927|2445|P1|STARTED|Overall Study||25
883|NCT03124901|2449|P1|NOT COMPLETED|Overall Study||0
884|NCT03124901|2449|P1|COMPLETED|Overall Study||147
885|NCT03124901|2449|P1|STARTED|Overall Study||147
886|NCT03124836|2453|P1|NOT COMPLETED|Overall Study||0
887|NCT03124836|2453|P1|COMPLETED|Overall Study||28
888|NCT03124836|2453|P1|STARTED|Overall Study||28
889|NCT03124823|2457|P1|NOT COMPLETED|Overall Study||0
890|NCT03124823|2457|P1|COMPLETED|Overall Study||11
891|NCT03124823|2457|P1|STARTED|Overall Study||11
892|NCT03124797|2461|P1|NOT COMPLETED|Overall Study||0
893|NCT03124797|2461|P1|COMPLETED|Overall Study||18
894|NCT03124797|2461|P1|STARTED|Overall Study||18
895|NCT03124784|2465|P1|NOT COMPLETED|Overall Study||2
896|NCT03124784|2465|P1|COMPLETED|Overall Study||25
897|NCT03124784|2465|P1|STARTED|Overall Study||27
898|NCT03124771|2469|P1|NOT COMPLETED|Overall Study||0
899|NCT03124771|2469|P1|COMPLETED|Overall Study||132
900|NCT03124771|2469|P1|STARTED|Overall Study||132
901|NCT03124758|2473|P1|NOT COMPLETED|Overall Study||0
902|NCT03124758|2473|P1|COMPLETED|Overall Study||354
903|NCT03124758|2473|P1|STARTED|Overall Study||354
904|NCT03124693|2477|P1|NOT COMPLETED|Overall Study||0
905|NCT03124693|2477|P1|COMPLETED|Overall Study||90
906|NCT03124693|2477|P1|STARTED|Overall Study||90
907|NCT03124199|2481|P1|NOT COMPLETED|Overall Study||4
908|NCT03124199|2481|P1|COMPLETED|Overall Study||36
909|NCT03124199|2481|P1|STARTED|Overall Study||40
910|NCT03119831|2490|P3|NOT COMPLETED|Overall Study||0
911|NCT03119831|2491|P2|NOT COMPLETED|Overall Study||0
912|NCT03119831|2492|P1|NOT COMPLETED|Overall Study||0
913|NCT03119831|2490|P3|COMPLETED|Overall Study||14
914|NCT03119831|2491|P2|COMPLETED|Overall Study||14
915|NCT03119831|2492|P1|COMPLETED|Overall Study||14
916|NCT03119831|2490|P3|STARTED|Overall Study||14
917|NCT03119831|2491|P2|STARTED|Overall Study||14
918|NCT03119831|2492|P1|STARTED|Overall Study||14
919|NCT03115853|2509|P1|NOT COMPLETED|Overall Study||0
920|NCT03115853|2509|P1|COMPLETED|Overall Study||31
921|NCT03115853|2509|P1|STARTED|Overall Study||31
922|NCT03109769|2529|P2|NOT COMPLETED|Overall Study||0
923|NCT03109769|2530|P1|NOT COMPLETED|Overall Study||0
924|NCT03109769|2529|P2|COMPLETED|Overall Study||22
925|NCT03109769|2530|P1|COMPLETED|Overall Study||22
926|NCT03109769|2529|P2|STARTED|Overall Study||22
927|NCT03109769|2530|P1|STARTED|Overall Study||22
928|NCT03106870|2540|P2|NOT COMPLETED|Overall Study||0
929|NCT03106870|2541|P1|NOT COMPLETED|Overall Study||0
930|NCT03106870|2540|P2|COMPLETED|Overall Study||31
931|NCT03106870|2541|P1|COMPLETED|Overall Study||31
932|NCT03106870|2540|P2|STARTED|Overall Study||31
933|NCT03106870|2541|P1|STARTED|Overall Study||31
934|NCT03106337|2551|P1|NOT COMPLETED|Overall Study||0
935|NCT03106337|2551|P1|COMPLETED|Overall Study||35
936|NCT03106337|2551|P1|STARTED|Overall Study||35
937|NCT03105518|2556|P1|NOT COMPLETED|Overall Study||0
938|NCT03105518|2556|P1|COMPLETED|Overall Study||100
939|NCT03105518|2556|P1|STARTED|Overall Study||100
940|NCT03098966|2561|P1|NOT COMPLETED|Overall Study||0
941|NCT03098966|2561|P1|COMPLETED|Overall Study||368
942|NCT03098966|2561|P1|STARTED|Overall Study||368
943|NCT03091751|2567|P1|NOT COMPLETED|Overall Study||0
944|NCT03091751|2567|P1|COMPLETED|Overall Study||22
945|NCT03091751|2567|P1|STARTED|Overall Study||22
946|NCT03073798|2575|P1|NOT COMPLETED|Overall Study||2
947|NCT03073798|2575|P1|COMPLETED|Overall Study||10
948|NCT03073798|2575|P1|STARTED|Overall Study||12
949|NCT03072719|2588|P2|NOT COMPLETED|Overall Study||1
950|NCT03072719|2589|P1|NOT COMPLETED|Overall Study||1
951|NCT03072719|2588|P2|COMPLETED|Overall Study||59
952|NCT03072719|2589|P1|COMPLETED|Overall Study||59
953|NCT03072719|2588|P2|STARTED|Overall Study||60
954|NCT03072719|2589|P1|STARTED|Overall Study||60
955|NCT03070730|2602|P3|NOT COMPLETED|Overall Study||0
956|NCT03070730|2603|P2|NOT COMPLETED|Overall Study||0
957|NCT03070730|2604|P1|NOT COMPLETED|Overall Study||0
958|NCT03070730|2602|P3|COMPLETED|Overall Study||0
959|NCT03070730|2603|P2|COMPLETED|Overall Study||0
960|NCT03070730|2604|P1|COMPLETED|Overall Study||0
961|NCT03070730|2602|P3|STARTED|Overall Study||0
962|NCT03070730|2603|P2|STARTED|Overall Study||0
963|NCT03070730|2604|P1|STARTED|Overall Study||0
964|NCT03069313|2735|P1|NOT COMPLETED|Overall Study||5
965|NCT03069313|2735|P1|COMPLETED|Overall Study||36
966|NCT03069313|2735|P1|STARTED|Overall Study||41
967|NCT03065933|2742|P1|NOT COMPLETED|Overall Study||5
968|NCT03065933|2742|P1|COMPLETED|Overall Study||0
969|NCT03065933|2742|P1|STARTED|Overall Study||5
970|NCT03061513|2748|P2|NOT COMPLETED|Overall Study||1
971|NCT03061513|2749|P1|NOT COMPLETED|Overall Study||0
972|NCT03061513|2748|P2|COMPLETED|Overall Study||4
973|NCT03061513|2749|P1|COMPLETED|Overall Study||6
974|NCT03061513|2748|P2|STARTED|Overall Study||5
975|NCT03061513|2749|P1|STARTED|Overall Study||6
976|NCT03057704|2759|P2|NOT COMPLETED|Overall Study||0
977|NCT03057704|2760|P1|NOT COMPLETED|Overall Study||0
978|NCT03057704|2759|P2|COMPLETED|Overall Study||25
979|NCT03057704|2760|P1|COMPLETED|Overall Study||25
980|NCT03057704|2759|P2|STARTED|Overall Study||25
981|NCT03057704|2760|P1|STARTED|Overall Study||25
982|NCT03055221|2770|P1|NOT COMPLETED|Overall Study||16
983|NCT03055221|2770|P1|COMPLETED|Overall Study||0
984|NCT03055221|2770|P1|STARTED|Overall Study||16
985|NCT03054103|2778|P3|NOT COMPLETED|Overall Study||0
986|NCT03054103|2779|P2|NOT COMPLETED|Overall Study||0
987|NCT03054103|2780|P1|NOT COMPLETED|Overall Study||0
988|NCT03054103|2778|P3|COMPLETED|Overall Study||35
989|NCT03054103|2779|P2|COMPLETED|Overall Study||29
990|NCT03054103|2780|P1|COMPLETED|Overall Study||41
991|NCT03054103|2778|P3|STARTED|Overall Study||35
992|NCT03054103|2779|P2|STARTED|Overall Study||29
993|NCT03054103|2780|P1|STARTED|Overall Study||41
994|NCT03054077|2799|P2|NOT COMPLETED|Overall Study||0
995|NCT03054077|2800|P1|NOT COMPLETED|Overall Study||0
996|NCT03054077|2799|P2|COMPLETED|Overall Study||12
997|NCT03054077|2800|P1|COMPLETED|Overall Study||12
998|NCT03054077|2799|P2|STARTED|Overall Study||12
999|NCT03054077|2800|P1|STARTED|Overall Study||12
1000|NCT03052530|2806|P1|NOT COMPLETED|Overall Study||0
1001|NCT03052530|2806|P1|COMPLETED|Overall Study||61
1002|NCT03052530|2806|P1|STARTED|Overall Study||61
1003|NCT03050775|2815|P2|NOT COMPLETED|Overall Study||0
1004|NCT03050775|2816|P1|NOT COMPLETED|Overall Study||0
1005|NCT03050775|2815|P2|COMPLETED|Overall Study||35
1006|NCT03050775|2816|P1|COMPLETED|Overall Study||35
1007|NCT03050775|2815|P2|STARTED|Overall Study||35
1008|NCT03050775|2816|P1|STARTED|Overall Study||35
1009|NCT03048383|2837|P3|NOT COMPLETED|Overall Study||12
1010|NCT03048383|2838|P2|NOT COMPLETED|Overall Study||8
1011|NCT03048383|2839|P1|NOT COMPLETED|Overall Study||13
1012|NCT03048383|2837|P3|COMPLETED|Overall Study||10
1013|NCT03048383|2838|P2|COMPLETED|Overall Study||13
1014|NCT03048383|2839|P1|COMPLETED|Overall Study||15
1015|NCT03048383|2837|P3|STARTED|Overall Study||22
1016|NCT03048383|2838|P2|STARTED|Overall Study||21
1017|NCT03048383|2839|P1|STARTED|Overall Study||28
1018|NCT03048006|2850|P1|NOT COMPLETED|Overall Study||0
1019|NCT03048006|2850|P1|COMPLETED|Overall Study||44456
1020|NCT03048006|2850|P1|STARTED|Overall Study||44456
1021|NCT03047447|2859|P3|NOT COMPLETED|Overall Study||0
1022|NCT03047447|2860|P2|NOT COMPLETED|Overall Study||0
1023|NCT03047447|2861|P1|NOT COMPLETED|Overall Study||0
1024|NCT03047447|2859|P3|COMPLETED|Overall Study||10
1025|NCT03047447|2860|P2|COMPLETED|Overall Study||10
1026|NCT03047447|2861|P1|COMPLETED|Overall Study||10
1027|NCT03047447|2859|P3|STARTED|Overall Study||10
1028|NCT03047447|2860|P2|STARTED|Overall Study||10
1029|NCT03047447|2861|P1|STARTED|Overall Study||10
1030|NCT03046225|2883|P2|NOT COMPLETED|Overall Study||0
1031|NCT03046225|2884|P1|NOT COMPLETED|Overall Study||0
1032|NCT03046225|2883|P2|COMPLETED|Overall Study||13
1033|NCT03046225|2884|P1|COMPLETED|Overall Study||13
1034|NCT03046225|2883|P2|STARTED|Overall Study||13
1035|NCT03046225|2884|P1|STARTED|Overall Study||13
1036|NCT03046212|2896|P2|NOT COMPLETED|Overall Study||0
1037|NCT03046212|2897|P1|NOT COMPLETED|Overall Study||0
1038|NCT03046212|2896|P2|COMPLETED|Overall Study||15
1039|NCT03046212|2897|P1|COMPLETED|Overall Study||15
1040|NCT03046212|2896|P2|STARTED|Overall Study||15
1041|NCT03046212|2897|P1|STARTED|Overall Study||15
1042|NCT03044431|2907|P1|NOT COMPLETED|Overall Study||59
1043|NCT03044431|2907|P1|COMPLETED|Overall Study||148
1044|NCT03044431|2907|P1|STARTED|Overall Study||207
1045|NCT03043534|2919|P2|NOT COMPLETED|Overall Study||0
1046|NCT03043534|2920|P1|NOT COMPLETED|Overall Study||0
1047|NCT03043534|2919|P2|COMPLETED|Overall Study||14
1048|NCT03043534|2920|P1|COMPLETED|Overall Study||15
1049|NCT03043534|2919|P2|STARTED|Overall Study||14
1050|NCT03043534|2920|P1|STARTED|Overall Study||15
1051|NCT03041298|2928|P1|NOT COMPLETED|Overall Study||0
1052|NCT03041298|2928|P1|COMPLETED|Overall Study||1537
1053|NCT03041298|2928|P1|STARTED|Overall Study||1537
1054|NCT03039543|2938|P2|NOT COMPLETED|Overall Study||3
1055|NCT03039543|2939|P1|NOT COMPLETED|Overall Study||1
1056|NCT03039543|2938|P2|COMPLETED|Overall Study||51
1057|NCT03039543|2939|P1|COMPLETED|Overall Study||53
1058|NCT03039543|2938|P2|STARTED|Overall Study||54
1059|NCT03039543|2939|P1|STARTED|Overall Study||54
1060|NCT03039179|2955|P2|NOT COMPLETED|Overall Study||0
1061|NCT03039179|2956|P1|NOT COMPLETED|Overall Study||0
1062|NCT03039179|2955|P2|COMPLETED|Overall Study||42
1063|NCT03039179|2956|P1|COMPLETED|Overall Study||38
1064|NCT03039179|2955|P2|STARTED|Overall Study||42
1065|NCT03039179|2956|P1|STARTED|Overall Study||38
1066|NCT03037905|2966|P2|NOT COMPLETED|Overall Study||0
1067|NCT03037905|2967|P1|NOT COMPLETED|Overall Study||0
1068|NCT03037905|2966|P2|COMPLETED|Overall Study||50
1069|NCT03037905|2967|P1|COMPLETED|Overall Study||50
1070|NCT03037905|2966|P2|STARTED|Overall Study||50
1071|NCT03037905|2967|P1|STARTED|Overall Study||50
1072|NCT03037541|2981|P2|NOT COMPLETED|Overall Study||0
1073|NCT03037541|2982|P1|NOT COMPLETED|Overall Study||0
1074|NCT03037541|2981|P2|COMPLETED|Overall Study||30
1075|NCT03037541|2982|P1|COMPLETED|Overall Study||30
1076|NCT03037541|2981|P2|STARTED|Overall Study||30
1077|NCT03037541|2982|P1|STARTED|Overall Study||30
1078|NCT03035955|2992|P2|NOT COMPLETED|Overall Study||1
1079|NCT03035955|2993|P1|NOT COMPLETED|Overall Study||1
1080|NCT03035955|2992|P2|COMPLETED|Overall Study||9
1081|NCT03035955|2993|P1|COMPLETED|Overall Study||9
1082|NCT03035955|2992|P2|STARTED|Overall Study||10
1083|NCT03035955|2993|P1|STARTED|Overall Study||10
1084|NCT03035916|3002|P3|NOT COMPLETED|Overall Study||0
1085|NCT03035916|3003|P2|NOT COMPLETED|Overall Study||2
1086|NCT03035916|3004|P1|NOT COMPLETED|Overall Study||0
1087|NCT03035916|3002|P3|COMPLETED|Overall Study||31
1088|NCT03035916|3003|P2|COMPLETED|Overall Study||28
1089|NCT03035916|3004|P1|COMPLETED|Overall Study||30
1090|NCT03035916|3002|P3|STARTED|Overall Study||31
1091|NCT03035916|3003|P2|STARTED|Overall Study||30
1092|NCT03035916|3004|P1|STARTED|Overall Study||30
1093|NCT03032965|3053|P2|NOT COMPLETED|Overall Study||0
1094|NCT03032965|3054|P1|NOT COMPLETED|Overall Study||0
1095|NCT03032965|3053|P2|COMPLETED|Overall Study||68
1096|NCT03032965|3054|P1|COMPLETED|Overall Study||61
1097|NCT03032965|3053|P2|STARTED|Overall Study||68
1098|NCT03032965|3054|P1|STARTED|Overall Study||61
1099|NCT03028987|3078|P2|NOT COMPLETED|Overall Study||0
1100|NCT03028987|3079|P1|NOT COMPLETED|Overall Study||0
1101|NCT03028987|3078|P2|COMPLETED|Overall Study||5
1102|NCT03028987|3079|P1|COMPLETED|Overall Study||5
1103|NCT03028987|3078|P2|STARTED|Overall Study||5
1104|NCT03028987|3079|P1|STARTED|Overall Study||5
1105|NCT03028025|3089|P2|NOT COMPLETED|Overall Study||1
1106|NCT03028025|3090|P1|NOT COMPLETED|Overall Study||3
1107|NCT03028025|3089|P2|COMPLETED|Overall Study||93
1108|NCT03028025|3090|P1|COMPLETED|Overall Study||87
1109|NCT03028025|3089|P2|STARTED|Overall Study||94
1110|NCT03028025|3090|P1|STARTED|Overall Study||90
1111|NCT03026803|3098|P1|NOT COMPLETED|Overall Study||0
1112|NCT03026803|3098|P1|COMPLETED|Overall Study||4
1113|NCT03026803|3098|P1|STARTED|Overall Study||4
1114|NCT03024112|3104|P2|NOT COMPLETED|Overall Study||0
1115|NCT03024112|3105|P1|NOT COMPLETED|Overall Study||7
1116|NCT03024112|3104|P2|COMPLETED|Overall Study||26
1117|NCT03024112|3105|P1|COMPLETED|Overall Study||18
1118|NCT03024112|3104|P2|STARTED|Overall Study||26
1119|NCT03024112|3105|P1|STARTED|Overall Study||25
1120|NCT03023709|3119|P2|NOT COMPLETED|Overall Study||0
1121|NCT03023709|3120|P1|NOT COMPLETED|Overall Study||0
1122|NCT03023709|3119|P2|COMPLETED|Overall Study||0
1123|NCT03023709|3120|P1|COMPLETED|Overall Study||3
1124|NCT03023709|3119|P2|STARTED|Overall Study||0
1125|NCT03023709|3120|P1|STARTED|Overall Study||3
1126|NCT03023683|3130|P2|NOT COMPLETED|Overall Study||1
1127|NCT03023683|3131|P1|NOT COMPLETED|Overall Study||0
1128|NCT03023683|3130|P2|COMPLETED|Overall Study||17
1129|NCT03023683|3131|P1|COMPLETED|Overall Study||0
1130|NCT03023683|3130|P2|STARTED|Overall Study||18
1131|NCT03023683|3131|P1|STARTED|Overall Study||0
1132|NCT03023553|3141|P2|NOT COMPLETED|Overall Study||1
1133|NCT03023553|3142|P1|NOT COMPLETED|Overall Study||0
1134|NCT03023553|3141|P2|COMPLETED|Overall Study||8
1135|NCT03023553|3142|P1|COMPLETED|Overall Study||4
1136|NCT03023553|3141|P2|STARTED|Overall Study||9
1137|NCT03023553|3142|P1|STARTED|Overall Study||4
1138|NCT03023488|3150|P1|NOT COMPLETED|Overall Study||0
1139|NCT03023488|3150|P1|COMPLETED|Overall Study||46
1140|NCT03023488|3150|P1|STARTED|Overall Study||46
1141|NCT03023176|3163|P1|NOT COMPLETED|Overall Study||0
1142|NCT03023176|3163|P1|COMPLETED|Overall Study||20
1143|NCT03023176|3163|P1|STARTED|Overall Study||20
1144|NCT03023137|3170|P2|NOT COMPLETED|Overall Study||9
1145|NCT03023137|3171|P1|NOT COMPLETED|Overall Study||4
1146|NCT03023137|3170|P2|COMPLETED|Overall Study||162
1147|NCT03023137|3171|P1|COMPLETED|Overall Study||174
1148|NCT03023137|3170|P2|STARTED|Overall Study||171
1149|NCT03023137|3171|P1|STARTED|Overall Study||178
1150|NCT03022435|3202|P5|NOT COMPLETED|Overall Study||0
1151|NCT03022435|3203|P4|NOT COMPLETED|Overall Study||0
1152|NCT03022435|3204|P3|NOT COMPLETED|Overall Study||0
1153|NCT03022435|3205|P2|NOT COMPLETED|Overall Study||0
1154|NCT03022435|3206|P1|NOT COMPLETED|Overall Study||0
1155|NCT03022435|3202|P5|COMPLETED|Overall Study||3
1156|NCT03022435|3203|P4|COMPLETED|Overall Study||3
1157|NCT03022435|3204|P3|COMPLETED|Overall Study||6
1158|NCT03022435|3205|P2|COMPLETED|Overall Study||5
1159|NCT03022435|3206|P1|COMPLETED|Overall Study||5
1160|NCT03022435|3202|P5|STARTED|Overall Study||3
1161|NCT03022435|3203|P4|STARTED|Overall Study||3
1162|NCT03022435|3204|P3|STARTED|Overall Study||6
1163|NCT03022435|3205|P2|STARTED|Overall Study||5
1164|NCT03022435|3206|P1|STARTED|Overall Study||5
1165|NCT03022422|3229|P6|NOT COMPLETED|Overall Study||0
1166|NCT03022422|3230|P5|NOT COMPLETED|Overall Study||0
1167|NCT03022422|3231|P4|NOT COMPLETED|Overall Study||0
1168|NCT03022422|3232|P3|NOT COMPLETED|Overall Study||3
1169|NCT03022422|3233|P2|NOT COMPLETED|Overall Study||0
1170|NCT03022422|3234|P1|NOT COMPLETED|Overall Study||0
1171|NCT03022422|3229|P6|COMPLETED|Overall Study||5
1172|NCT03022422|3230|P5|COMPLETED|Overall Study||5
1173|NCT03022422|3231|P4|COMPLETED|Overall Study||12
1174|NCT03022422|3232|P3|COMPLETED|Overall Study||20
1175|NCT03022422|3233|P2|COMPLETED|Overall Study||10
1176|NCT03022422|3234|P1|COMPLETED|Overall Study||8
1177|NCT03022422|3229|P6|STARTED|Overall Study||5
1178|NCT03022422|3230|P5|STARTED|Overall Study||5
1179|NCT03022422|3231|P4|STARTED|Overall Study||12
1180|NCT03022422|3232|P3|STARTED|Overall Study||23
1181|NCT03022422|3233|P2|STARTED|Overall Study||10
1182|NCT03022422|3234|P1|STARTED|Overall Study||8
1183|NCT03022396|3260|P6|NOT COMPLETED|Overall Study||0
1184|NCT03022396|3261|P5|NOT COMPLETED|Overall Study||0
1185|NCT03022396|3262|P4|NOT COMPLETED|Overall Study||0
1186|NCT03022396|3263|P3|NOT COMPLETED|Overall Study||0
1187|NCT03022396|3264|P2|NOT COMPLETED|Overall Study||0
1188|NCT03022396|3265|P1|NOT COMPLETED|Overall Study||0
1189|NCT03022396|3260|P6|COMPLETED|Overall Study||8
1190|NCT03022396|3261|P5|COMPLETED|Overall Study||14
1191|NCT03022396|3262|P4|COMPLETED|Overall Study||20
1192|NCT03022396|3263|P3|COMPLETED|Overall Study||10
1193|NCT03022396|3264|P2|COMPLETED|Overall Study||14
1194|NCT03022396|3265|P1|COMPLETED|Overall Study||16
1195|NCT03022396|3260|P6|STARTED|Overall Study||8
1196|NCT03022396|3261|P5|STARTED|Overall Study||14
1197|NCT03022396|3262|P4|STARTED|Overall Study||20
1198|NCT03022396|3263|P3|STARTED|Overall Study||10
1199|NCT03022396|3264|P2|STARTED|Overall Study||14
1200|NCT03022396|3265|P1|STARTED|Overall Study||16
1201|NCT03021343|3287|P2|NOT COMPLETED|Overall Study||7
1202|NCT03021343|3288|P1|NOT COMPLETED|Overall Study||5
1203|NCT03021343|3287|P2|COMPLETED|Overall Study||174
1204|NCT03021343|3288|P1|COMPLETED|Overall Study||174
1205|NCT03021343|3287|P2|STARTED|Overall Study||181
1206|NCT03021343|3288|P1|STARTED|Overall Study||179
1207|NCT03021304|3296|P1|NOT COMPLETED|Overall Study||1
1208|NCT03021304|3296|P1|COMPLETED|Overall Study||55
1209|NCT03021304|3296|P1|STARTED|Overall Study||56
1210|NCT03020576|3303|P2|NOT COMPLETED|Overall Study||2
1211|NCT03020576|3304|P1|NOT COMPLETED|Overall Study||1
1212|NCT03020576|3303|P2|COMPLETED|Overall Study||14
1213|NCT03020576|3304|P1|COMPLETED|Overall Study||14
1214|NCT03020576|3303|P2|STARTED|Overall Study||16
1215|NCT03020576|3304|P1|STARTED|Overall Study||15
1216|NCT03020537|3326|P2|NOT COMPLETED|Overall Study||0
1217|NCT03020537|3327|P1|NOT COMPLETED|Overall Study||0
1218|NCT03020537|3326|P2|COMPLETED|Overall Study||7
1219|NCT03020537|3327|P1|COMPLETED|Overall Study||1
1220|NCT03020537|3326|P2|STARTED|Overall Study||7
1221|NCT03020537|3327|P1|STARTED|Overall Study||1
1222|NCT03020498|3338|P3|NOT COMPLETED|Overall Study||0
1223|NCT03020498|3339|P2|NOT COMPLETED|Overall Study||3
1224|NCT03020498|3340|P1|NOT COMPLETED|Overall Study||0
1225|NCT03020498|3338|P3|COMPLETED|Overall Study||36
1226|NCT03020498|3339|P2|COMPLETED|Overall Study||38
1227|NCT03020498|3340|P1|COMPLETED|Overall Study||14
1228|NCT03020498|3338|P3|STARTED|Overall Study||36
1229|NCT03020498|3339|P2|STARTED|Overall Study||41
1230|NCT03020498|3340|P1|STARTED|Overall Study||14
1231|NCT03020472|3351|P1|NOT COMPLETED|Overall Study||0
1232|NCT03020472|3351|P1|COMPLETED|Overall Study||6
1233|NCT03020472|3351|P1|STARTED|Overall Study||6
1234|NCT03020004|3357|P1|NOT COMPLETED|Overall Study||1
1235|NCT03020004|3357|P1|COMPLETED|Overall Study||69
1236|NCT03020004|3357|P1|STARTED|Overall Study||70
1237|NCT03019783|3363|P2|NOT COMPLETED|Overall Study||0
1238|NCT03019783|3364|P1|NOT COMPLETED|Overall Study||0
1239|NCT03019783|3363|P2|COMPLETED|Overall Study||31
1240|NCT03019783|3364|P1|COMPLETED|Overall Study||29
1241|NCT03019783|3363|P2|STARTED|Overall Study||31
1242|NCT03019783|3364|P1|STARTED|Overall Study||29
1243|NCT03018106|3374|P2|NOT COMPLETED|Overall Study||1
1244|NCT03018106|3375|P1|NOT COMPLETED|Overall Study||0
1245|NCT03018106|3374|P2|COMPLETED|Overall Study||0
1246|NCT03018106|3375|P1|COMPLETED|Overall Study||0
1247|NCT03018106|3374|P2|STARTED|Overall Study||1
1248|NCT03018106|3375|P1|STARTED|Overall Study||0
1249|NCT03017612|3383|P1|NOT COMPLETED|Overall Study||2
1250|NCT03017612|3383|P1|COMPLETED|Overall Study||11
1251|NCT03017612|3383|P1|STARTED|Overall Study||13
1252|NCT03016078|3391|P1|NOT COMPLETED|Overall Study||2
1253|NCT03016078|3391|P1|COMPLETED|Overall Study||19
1254|NCT03016078|3391|P1|STARTED|Overall Study||21
1255|NCT03011099|3404|P2|NOT COMPLETED|Overall Study||2
1256|NCT03011099|3405|P1|NOT COMPLETED|Overall Study||0
1257|NCT03011099|3404|P2|COMPLETED|Overall Study||3
1258|NCT03011099|3405|P1|COMPLETED|Overall Study||6
1259|NCT03011099|3404|P2|STARTED|Overall Study||5
1260|NCT03011099|3405|P1|STARTED|Overall Study||6
1261|NCT03010800|3431|P2|NOT COMPLETED|Cross Over||0
1262|NCT03010800|3432|P1|NOT COMPLETED|Cross Over||0
1263|NCT03010800|3431|P2|COMPLETED|Cross Over||4
1264|NCT03010800|3432|P1|COMPLETED|Cross Over||4
1265|NCT03010800|3431|P2|STARTED|Cross Over||4
1266|NCT03010800|3432|P1|STARTED|Cross Over||4
1267|NCT03010800|3431|P2|NOT COMPLETED|Initial Assignment||0
1268|NCT03010800|3432|P1|NOT COMPLETED|Initial Assignment||0
1269|NCT03010800|3431|P2|COMPLETED|Initial Assignment||4
1270|NCT03010800|3432|P1|COMPLETED|Initial Assignment||4
1271|NCT03010800|3431|P2|STARTED|Initial Assignment||4
1272|NCT03010800|3432|P1|STARTED|Initial Assignment||4
1273|NCT03005041|3438|P2|NOT COMPLETED|Period 2||0
1274|NCT03005041|3439|P1|NOT COMPLETED|Period 2||0
1275|NCT03005041|3438|P2|COMPLETED|Period 2||27
1276|NCT03005041|3439|P1|COMPLETED|Period 2||28
1277|NCT03005041|3438|P2|STARTED|Period 2||27
1278|NCT03005041|3439|P1|STARTED|Period 2||28
1279|NCT03005041|3438|P2|NOT COMPLETED|Washout Period 1||0
1280|NCT03005041|3439|P1|NOT COMPLETED|Washout Period 1||0
1281|NCT03005041|3438|P2|COMPLETED|Washout Period 1||27
1282|NCT03005041|3439|P1|COMPLETED|Washout Period 1||28
1283|NCT03005041|3438|P2|STARTED|Washout Period 1||27
1284|NCT03005041|3439|P1|STARTED|Washout Period 1||28
1285|NCT03005041|3438|P2|NOT COMPLETED|Period 1||0
1286|NCT03005041|3439|P1|NOT COMPLETED|Period 1||0
1287|NCT03005041|3438|P2|COMPLETED|Period 1||27
1288|NCT03005041|3439|P1|COMPLETED|Period 1||28
1289|NCT03005041|3438|P2|STARTED|Period 1||27
1290|NCT03005041|3439|P1|STARTED|Period 1||28
1291|NCT03002454|3451|P1|NOT COMPLETED|Overall Study||0
1292|NCT03002454|3451|P1|COMPLETED|Overall Study||4
1293|NCT03002454|3451|P1|STARTED|Overall Study||4
1294|NCT03001674|3458|P2|NOT COMPLETED|Overall Study||0
1295|NCT03001674|3459|P1|NOT COMPLETED|Overall Study||0
1296|NCT03001674|3458|P2|COMPLETED|Overall Study||5
1297|NCT03001674|3459|P1|COMPLETED|Overall Study||10
1298|NCT03001674|3458|P2|STARTED|Overall Study||5
1299|NCT03001674|3459|P1|STARTED|Overall Study||10
1300|NCT03001258|3468|P3|NOT COMPLETED|Overall Study||0
1301|NCT03001258|3469|P2|NOT COMPLETED|Overall Study||0
1302|NCT03001258|3470|P1|NOT COMPLETED|Overall Study||0
1303|NCT03001258|3468|P3|COMPLETED|Overall Study||485
1304|NCT03001258|3469|P2|COMPLETED|Overall Study||751
1305|NCT03001258|3470|P1|COMPLETED|Overall Study||765
1306|NCT03001258|3468|P3|STARTED|Overall Study||485
1307|NCT03001258|3469|P2|STARTED|Overall Study||751
1308|NCT03001258|3470|P1|STARTED|Overall Study||765
1309|NCT03000088|3480|P2|NOT COMPLETED|Overall Study||0
1310|NCT03000088|3481|P1|NOT COMPLETED|Overall Study||0
1311|NCT03000088|3480|P2|COMPLETED|Overall Study||70
1312|NCT03000088|3481|P1|COMPLETED|Overall Study||70
1313|NCT03000088|3480|P2|STARTED|Overall Study||70
1314|NCT03000088|3481|P1|STARTED|Overall Study||70
1315|NCT02997904|3489|P2|NOT COMPLETED|Overall Study||0
1316|NCT02997904|3490|P1|NOT COMPLETED|Overall Study||0
1317|NCT02997904|3489|P2|COMPLETED|Overall Study||49
1318|NCT02997904|3490|P1|COMPLETED|Overall Study||51
1319|NCT02997904|3489|P2|STARTED|Overall Study||49
1320|NCT02997904|3490|P1|STARTED|Overall Study||51
1321|NCT02990910|3502|P2|NOT COMPLETED|Overall Study||10
1322|NCT02990910|3503|P1|NOT COMPLETED|Overall Study||6
1323|NCT02990910|3502|P2|COMPLETED|Overall Study||130
1324|NCT02990910|3503|P1|COMPLETED|Overall Study||134
1325|NCT02990910|3502|P2|STARTED|Overall Study||140
1326|NCT02990910|3503|P1|STARTED|Overall Study||140
1327|NCT02988882|3513|P2|NOT COMPLETED|Overall Study||2
1328|NCT02988882|3514|P1|NOT COMPLETED|Overall Study||3
1329|NCT02988882|3513|P2|COMPLETED|Overall Study||40
1330|NCT02988882|3514|P1|COMPLETED|Overall Study||41
1331|NCT02988882|3513|P2|STARTED|Overall Study||42
1332|NCT02988882|3514|P1|STARTED|Overall Study||44
1333|NCT02988622|3524|P1|NOT COMPLETED|Overall Study||17
1334|NCT02988622|3524|P1|COMPLETED|Overall Study||83
1335|NCT02988622|3524|P1|STARTED|Overall Study||100
1336|NCT02988219|3548|P2|NOT COMPLETED|Overall Study||3
1337|NCT02988219|3549|P1|NOT COMPLETED|Overall Study||1
1338|NCT02988219|3548|P2|COMPLETED|Overall Study||22
1339|NCT02988219|3549|P1|COMPLETED|Overall Study||24
1340|NCT02988219|3548|P2|STARTED|Overall Study||25
1341|NCT02988219|3549|P1|STARTED|Overall Study||25
1342|NCT02987868|3557|P2|NOT COMPLETED|Second Intervention||0
1343|NCT02987868|3558|P1|NOT COMPLETED|Second Intervention||0
1344|NCT02987868|3557|P2|COMPLETED|Second Intervention||8
1345|NCT02987868|3558|P1|COMPLETED|Second Intervention||8
1346|NCT02987868|3557|P2|STARTED|Second Intervention||8
1347|NCT02987868|3558|P1|STARTED|Second Intervention||8
1348|NCT02987868|3557|P2|NOT COMPLETED|Wash Out Period 1 Week||0
1349|NCT02987868|3558|P1|NOT COMPLETED|Wash Out Period 1 Week||0
1350|NCT02987868|3557|P2|COMPLETED|Wash Out Period 1 Week||8
1351|NCT02987868|3558|P1|COMPLETED|Wash Out Period 1 Week||8
1352|NCT02987868|3557|P2|STARTED|Wash Out Period 1 Week||8
1353|NCT02987868|3558|P1|STARTED|Wash Out Period 1 Week||8
1354|NCT02987868|3557|P2|NOT COMPLETED|First Intervention||0
1355|NCT02987868|3558|P1|NOT COMPLETED|First Intervention||0
1356|NCT02987868|3557|P2|COMPLETED|First Intervention||8
1357|NCT02987868|3558|P1|COMPLETED|First Intervention||8
1358|NCT02987868|3557|P2|STARTED|First Intervention||8
1359|NCT02987868|3558|P1|STARTED|First Intervention||8
1360|NCT02987374|3564|P1|NOT COMPLETED|Overall Study||0
1361|NCT02987374|3564|P1|COMPLETED|Overall Study||10
1362|NCT02987374|3564|P1|STARTED|Overall Study||10
1363|NCT02987205|3569|P1|NOT COMPLETED|Overall Study||4
1364|NCT02987205|3569|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
1365|NCT02987205|3569|P1|Treated - Bilateral NLF Injection|Overall Study||163
1366|NCT02987205|3569|P1|STARTED|Overall Study||163
1367|NCT02986282|3577|P1|NOT COMPLETED|Overall Study||16
1368|NCT02986282|3577|P1|COMPLETED|Overall Study||99
1369|NCT02986282|3577|P1|STARTED|Overall Study||115
1370|NCT02984878|3584|P2|NOT COMPLETED|Overall Study||0
1371|NCT02984878|3585|P1|NOT COMPLETED|Overall Study||0
1372|NCT02984878|3584|P2|COMPLETED|Overall Study||41
1373|NCT02984878|3585|P1|COMPLETED|Overall Study||30
1374|NCT02984878|3584|P2|STARTED|Overall Study||41
1375|NCT02984878|3585|P1|STARTED|Overall Study||30
1376|NCT02983981|3595|P1|NOT COMPLETED|Overall Study||0
1377|NCT02983981|3595|P1|COMPLETED|Overall Study||20
1378|NCT02983981|3595|P1|STARTED|Overall Study||20
1379|NCT02977572|3604|P2|NOT COMPLETED|Overall Study||2
1380|NCT02977572|3605|P1|NOT COMPLETED|Overall Study||2
1381|NCT02977572|3604|P2|COMPLETED|Overall Study||54
1382|NCT02977572|3605|P1|COMPLETED|Overall Study||56
1383|NCT02977572|3604|P2|STARTED|Overall Study||56
1384|NCT02977572|3605|P1|STARTED|Overall Study||58
1385|NCT02974543|3629|P2|NOT COMPLETED|Overall Study||0
1386|NCT02974543|3630|P1|NOT COMPLETED|Overall Study||1
1387|NCT02974543|3629|P2|COMPLETED|Overall Study||10
1388|NCT02974543|3630|P1|COMPLETED|Overall Study||10
1389|NCT02974543|3629|P2|Began Crossover Assignment|Overall Study||10
1390|NCT02974543|3630|P1|Began Crossover Assignment|Overall Study||10
1391|NCT02974543|3629|P2|Began Washout Period|Overall Study||10
1392|NCT02974543|3630|P1|Began Washout Period|Overall Study||10
1393|NCT02974543|3629|P2|STARTED|Overall Study||10
1394|NCT02974543|3630|P1|STARTED|Overall Study||11
1395|NCT02971670|3654|P4|NOT COMPLETED|Overall Study||2
1396|NCT02971670|3655|P3|NOT COMPLETED|Overall Study||1
1397|NCT02971670|3656|P2|NOT COMPLETED|Overall Study||1
1398|NCT02971670|3657|P1|NOT COMPLETED|Overall Study||4
1399|NCT02971670|3654|P4|COMPLETED|Overall Study||1
1400|NCT02971670|3655|P3|COMPLETED|Overall Study||4
1401|NCT02971670|3656|P2|COMPLETED|Overall Study||1
1402|NCT02971670|3657|P1|COMPLETED|Overall Study||9
1403|NCT02971670|3654|P4|STARTED|Overall Study||3
1404|NCT02971670|3655|P3|STARTED|Overall Study||5
1405|NCT02971670|3656|P2|STARTED|Overall Study||2
1406|NCT02971670|3657|P1|STARTED|Overall Study||13
1407|NCT02968173|3675|P1|NOT COMPLETED|Overall Study||1
1408|NCT02968173|3675|P1|COMPLETED|Overall Study||49
1409|NCT02968173|3675|P1|STARTED|Overall Study||50
1410|NCT02967393|3689|P2|NOT COMPLETED|Overall Study||0
1411|NCT02967393|3690|P1|NOT COMPLETED|Overall Study||0
1412|NCT02967393|3689|P2|COMPLETED|Overall Study||20
1413|NCT02967393|3690|P1|COMPLETED|Overall Study||20
1414|NCT02967393|3689|P2|STARTED|Overall Study||20
1415|NCT02967393|3690|P1|STARTED|Overall Study||20
1416|NCT02967354|3720|P5|NOT COMPLETED|Overall Study||0
1417|NCT02967354|3721|P4|NOT COMPLETED|Overall Study||0
1418|NCT02967354|3722|P3|NOT COMPLETED|Overall Study||0
1419|NCT02967354|3723|P2|NOT COMPLETED|Overall Study||0
1420|NCT02967354|3724|P1|NOT COMPLETED|Overall Study||0
1421|NCT02967354|3720|P5|COMPLETED|Overall Study||8
1422|NCT02967354|3721|P4|COMPLETED|Overall Study||7
1423|NCT02967354|3722|P3|COMPLETED|Overall Study||9
1424|NCT02967354|3723|P2|COMPLETED|Overall Study||7
1425|NCT02967354|3724|P1|COMPLETED|Overall Study||8
1426|NCT02967354|3720|P5|STARTED|Overall Study||8
1427|NCT02967354|3721|P4|STARTED|Overall Study||7
1428|NCT02967354|3722|P3|STARTED|Overall Study||9
1429|NCT02967354|3723|P2|STARTED|Overall Study||7
1430|NCT02967354|3724|P1|STARTED|Overall Study||8
1431|NCT02966509|3758|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
1432|NCT02966509|3759|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
1433|NCT02966509|3758|P2|COMPLETED|End of Life Utilization and Cost 15month||60
1434|NCT02966509|3759|P1|COMPLETED|End of Life Utilization and Cost 15month||60
1435|NCT02966509|3758|P2|STARTED|End of Life Utilization and Cost 15month||108
1436|NCT02966509|3759|P1|STARTED|End of Life Utilization and Cost 15month||105
1437|NCT02966509|3758|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
1438|NCT02966509|3759|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
1439|NCT02966509|3758|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
1440|NCT02966509|3759|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
1441|NCT02966509|3758|P2|STARTED|End of Life Utilization and Cost 6 Month||108
1442|NCT02966509|3759|P1|STARTED|End of Life Utilization and Cost 6 Month||105
1443|NCT02966509|3758|P2|NOT COMPLETED|15-Month Utilization and Cost||0
1444|NCT02966509|3759|P1|NOT COMPLETED|15-Month Utilization and Cost||0
1445|NCT02966509|3758|P2|COMPLETED|15-Month Utilization and Cost||108
1446|NCT02966509|3759|P1|COMPLETED|15-Month Utilization and Cost||105
1447|NCT02966509|3758|P2|STARTED|15-Month Utilization and Cost||108
1448|NCT02966509|3759|P1|STARTED|15-Month Utilization and Cost||105
1449|NCT02966509|3758|P2|NOT COMPLETED|6-Month Utilization and Cost||0
1450|NCT02966509|3759|P1|NOT COMPLETED|6-Month Utilization and Cost||0
1451|NCT02966509|3758|P2|COMPLETED|6-Month Utilization and Cost||108
1452|NCT02966509|3759|P1|COMPLETED|6-Month Utilization and Cost||105
1453|NCT02966509|3758|P2|STARTED|6-Month Utilization and Cost||108
1454|NCT02966509|3759|P1|STARTED|6-Month Utilization and Cost||105
1455|NCT02966509|3758|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
1456|NCT02966509|3759|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
1457|NCT02966509|3758|P2|COMPLETED|6 Month Satisfaction Survey||60
1458|NCT02966509|3759|P1|COMPLETED|6 Month Satisfaction Survey||58
1459|NCT02966509|3758|P2|STARTED|6 Month Satisfaction Survey||108
1460|NCT02966509|3759|P1|STARTED|6 Month Satisfaction Survey||105
1461|NCT02966509|3758|P2|NOT COMPLETED|4-Month Satisfaction Decision Survey||31
1462|NCT02966509|3759|P1|NOT COMPLETED|4-Month Satisfaction Decision Survey||25
1463|NCT02966509|3758|P2|COMPLETED|4-Month Satisfaction Decision Survey||77
1464|NCT02966509|3759|P1|COMPLETED|4-Month Satisfaction Decision Survey||80
1465|NCT02966509|3758|P2|STARTED|4-Month Satisfaction Decision Survey||108
1555|NCT02958345|3922|P2|COMPLETED|Overall Study||13
1466|NCT02966509|3759|P1|STARTED|4-Month Satisfaction Decision Survey||105
1467|NCT02966509|3758|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
1468|NCT02966509|3759|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
1469|NCT02966509|3758|P2|COMPLETED|Baseline Satisfaction Survey||101
1470|NCT02966509|3759|P1|COMPLETED|Baseline Satisfaction Survey||101
1471|NCT02966509|3758|P2|STARTED|Baseline Satisfaction Survey||108
1472|NCT02966509|3759|P1|STARTED|Baseline Satisfaction Survey||105
1473|NCT02966015|3785|P2|NOT COMPLETED|Test Period||0
1474|NCT02966015|3786|P1|NOT COMPLETED|Test Period||0
1475|NCT02966015|3785|P2|COMPLETED|Test Period||55
1476|NCT02966015|3786|P1|COMPLETED|Test Period||87
1477|NCT02966015|3785|P2|STARTED|Test Period||55
1478|NCT02966015|3786|P1|STARTED|Test Period||87
1479|NCT02966015|3785|P2|NOT COMPLETED|Inclusion Visit||3
1480|NCT02966015|3786|P1|NOT COMPLETED|Inclusion Visit||8
1481|NCT02966015|3785|P2|COMPLETED|Inclusion Visit||55
1482|NCT02966015|3786|P1|COMPLETED|Inclusion Visit||87
1483|NCT02966015|3785|P2|STARTED|Inclusion Visit||58
1484|NCT02966015|3786|P1|STARTED|Inclusion Visit||95
1485|NCT02966002|3792|P1|NOT COMPLETED|Overall Study||4
1486|NCT02966002|3792|P1|COMPLETED|Overall Study||5
1487|NCT02966002|3792|P1|STARTED|Overall Study||9
1488|NCT02965833|3799|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
1489|NCT02965833|3800|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
1490|NCT02965833|3799|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
1491|NCT02965833|3800|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
1492|NCT02965833|3799|P2|STARTED|Period 2, Second 30 Days of Wear||52
1493|NCT02965833|3800|P1|STARTED|Period 2, Second 30 Days of Wear||64
1494|NCT02965833|3799|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
1495|NCT02965833|3800|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
1496|NCT02965833|3799|P2|COMPLETED|Period 1, First 30 Days of Wear||52
1497|NCT02965833|3800|P1|COMPLETED|Period 1, First 30 Days of Wear||64
1498|NCT02965833|3799|P2|STARTED|Period 1, First 30 Days of Wear||54
1499|NCT02965833|3800|P1|STARTED|Period 1, First 30 Days of Wear||67
1500|NCT02965820|3806|P2|NOT COMPLETED|Period 2, Second 30 Days||1
1501|NCT02965820|3807|P1|NOT COMPLETED|Period 2, Second 30 Days||1
1502|NCT02965820|3806|P2|COMPLETED|Period 2, Second 30 Days||61
1503|NCT02965820|3807|P1|COMPLETED|Period 2, Second 30 Days||57
1504|NCT02965820|3806|P2|STARTED|Period 2, Second 30 Days||62
1505|NCT02965820|3807|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
1506|NCT02965820|3806|P2|NOT COMPLETED|Period 1, First 30 Days||0
1507|NCT02965820|3807|P1|NOT COMPLETED|Period 1, First 30 Days||0
1508|NCT02965820|3806|P2|COMPLETED|Period 1, First 30 Days||62
1509|NCT02965820|3807|P1|COMPLETED|Period 1, First 30 Days||59
1510|NCT02965820|3806|P2|STARTED|Period 1, First 30 Days||62
1511|NCT02965820|3807|P1|STARTED|Period 1, First 30 Days||59
1512|NCT02964767|3815|P2|NOT COMPLETED|Overall Study||0
1513|NCT02964767|3816|P1|NOT COMPLETED|Overall Study||0
1514|NCT02964767|3815|P2|COMPLETED|Overall Study||48
1515|NCT02964767|3816|P1|COMPLETED|Overall Study||171
1516|NCT02964767|3815|P2|STARTED|Overall Study||48
1517|NCT02964767|3816|P1|STARTED|Overall Study||171
1518|NCT02962882|3823|P1|NOT COMPLETED|Overall Study||36
1519|NCT02962882|3823|P1|COMPLETED|Overall Study||14
1520|NCT02962882|3823|P1|STARTED|Overall Study||50
1521|NCT02961244|3834|P2|NOT COMPLETED|Overall Study||9
1522|NCT02961244|3835|P1|NOT COMPLETED|Overall Study||1
1523|NCT02961244|3834|P2|COMPLETED|Overall Study||55
1524|NCT02961244|3835|P1|COMPLETED|Overall Study||63
1525|NCT02961244|3834|P2|Patients Excluded During Randomization|Overall Study||1
1526|NCT02961244|3835|P1|Patients Excluded During Randomization|Overall Study||0
1527|NCT02961244|3834|P2|STARTED|Overall Study||64
1528|NCT02961244|3835|P1|STARTED|Overall Study||64
1529|NCT02959840|3846|P3|NOT COMPLETED|Overall Study||0
1530|NCT02959840|3847|P2|NOT COMPLETED|Overall Study||0
1531|NCT02959840|3848|P1|NOT COMPLETED|Overall Study||0
1532|NCT02959840|3846|P3|COMPLETED|Overall Study||60
1533|NCT02959840|3847|P2|COMPLETED|Overall Study||60
1534|NCT02959840|3848|P1|COMPLETED|Overall Study||60
1535|NCT02959840|3846|P3|STARTED|Overall Study||60
1536|NCT02959840|3847|P2|STARTED|Overall Study||60
1537|NCT02959840|3848|P1|STARTED|Overall Study||60
1538|NCT02958995|3891|P2|NOT COMPLETED|Overall Study||0
1539|NCT02958995|3892|P1|NOT COMPLETED|Overall Study||0
1540|NCT02958995|3891|P2|COMPLETED|Overall Study||107495
1541|NCT02958995|3892|P1|COMPLETED|Overall Study||2630666
1542|NCT02958995|3891|P2|STARTED|Overall Study||107495
1543|NCT02958995|3892|P1|STARTED|Overall Study||2630666
1544|NCT02958956|3902|P2|NOT COMPLETED|Overall Study||0
1545|NCT02958956|3903|P1|NOT COMPLETED|Overall Study||0
1546|NCT02958956|3902|P2|COMPLETED|Overall Study||198317
1547|NCT02958956|3903|P1|COMPLETED|Overall Study||38190
1548|NCT02958956|3902|P2|STARTED|Overall Study||198317
1549|NCT02958956|3903|P1|STARTED|Overall Study||38190
1550|NCT02958787|3916|P1|NOT COMPLETED|Overall Study||0
1551|NCT02958787|3916|P1|COMPLETED|Overall Study||135
1552|NCT02958787|3916|P1|STARTED|Overall Study||135
1553|NCT02958345|3922|P2|NOT COMPLETED|Overall Study||1
1554|NCT02958345|3923|P1|NOT COMPLETED|Overall Study||1
1556|NCT02958345|3923|P1|COMPLETED|Overall Study||13
1557|NCT02958345|3922|P2|STARTED|Overall Study||14
1558|NCT02958345|3923|P1|STARTED|Overall Study||14
1559|NCT02956460|3933|P2|NOT COMPLETED|Lens 2||0
1560|NCT02956460|3934|P1|NOT COMPLETED|Lens 2||0
1561|NCT02956460|3933|P2|COMPLETED|Lens 2||34
1562|NCT02956460|3934|P1|COMPLETED|Lens 2||29
1563|NCT02956460|3933|P2|STARTED|Lens 2||34
1564|NCT02956460|3934|P1|STARTED|Lens 2||29
1565|NCT02956460|3933|P2|NOT COMPLETED|Lens 1||0
1566|NCT02956460|3934|P1|NOT COMPLETED|Lens 1||1
1567|NCT02956460|3933|P2|COMPLETED|Lens 1||34
1568|NCT02956460|3934|P1|COMPLETED|Lens 1||29
1569|NCT02956460|3933|P2|STARTED|Lens 1||34
1570|NCT02956460|3934|P1|STARTED|Lens 1||30
1571|NCT02951767|3960|P1|NOT COMPLETED|Overall Study||119
1572|NCT02951767|3960|P1|COMPLETED|Overall Study||0
1573|NCT02951767|3960|P1|STARTED|Overall Study||119
1574|NCT02951702|3979|P2|NOT COMPLETED|Overall Study||0
1575|NCT02951702|3980|P1|NOT COMPLETED|Overall Study||0
1576|NCT02951702|3979|P2|COMPLETED|Overall Study||17
1577|NCT02951702|3980|P1|COMPLETED|Overall Study||34
1578|NCT02951702|3979|P2|STARTED|Overall Study||17
1579|NCT02951702|3980|P1|STARTED|Overall Study||34
1580|NCT02951312|3994|P4|NOT COMPLETED|Study Part 2||0
1581|NCT02951312|3995|P3|NOT COMPLETED|Study Part 2||0
1582|NCT02951312|3996|P2|NOT COMPLETED|Study Part 2||0
1583|NCT02951312|3997|P1|NOT COMPLETED|Study Part 2||0
1584|NCT02951312|3994|P4|COMPLETED|Study Part 2||6
1585|NCT02951312|3995|P3|COMPLETED|Study Part 2||6
1586|NCT02951312|3996|P2|COMPLETED|Study Part 2||0
1587|NCT02951312|3997|P1|COMPLETED|Study Part 2||0
1588|NCT02951312|3994|P4|STARTED|Study Part 2||6
1589|NCT02951312|3995|P3|STARTED|Study Part 2||6
1590|NCT02951312|3996|P2|STARTED|Study Part 2||0
1591|NCT02951312|3997|P1|STARTED|Study Part 2||0
1592|NCT02951312|3994|P4|NOT COMPLETED|Study Part 1||0
1593|NCT02951312|3995|P3|NOT COMPLETED|Study Part 1||0
1594|NCT02951312|3996|P2|NOT COMPLETED|Study Part 1||0
1595|NCT02951312|3997|P1|NOT COMPLETED|Study Part 1||0
1596|NCT02951312|3994|P4|COMPLETED|Study Part 1||0
1597|NCT02951312|3995|P3|COMPLETED|Study Part 1||0
1598|NCT02951312|3996|P2|COMPLETED|Study Part 1||6
1599|NCT02951312|3997|P1|COMPLETED|Study Part 1||6
1600|NCT02951312|3994|P4|STARTED|Study Part 1||0
1601|NCT02951312|3995|P3|STARTED|Study Part 1||0
1602|NCT02951312|3996|P2|STARTED|Study Part 1||6
1603|NCT02951312|3997|P1|STARTED|Study Part 1||6
1604|NCT02951273|4117|P1|NOT COMPLETED|Overall Study||3
1605|NCT02951273|4117|P1|COMPLETED|Overall Study||27
1606|NCT02951273|4117|P1|STARTED|Overall Study||30
1607|NCT02949141|4132|P1|NOT COMPLETED|Overall Study||0
1608|NCT02949141|4132|P1|COMPLETED|Overall Study||62
1609|NCT02949141|4132|P1|STARTED|Overall Study||62
1610|NCT02948582|4139|P6|NOT COMPLETED|Wshout Period 6||0
1611|NCT02948582|4140|P5|NOT COMPLETED|Wshout Period 6||0
1612|NCT02948582|4141|P4|NOT COMPLETED|Wshout Period 6||0
1613|NCT02948582|4142|P3|NOT COMPLETED|Wshout Period 6||0
1614|NCT02948582|4143|P2|NOT COMPLETED|Wshout Period 6||0
1615|NCT02948582|4144|P1|NOT COMPLETED|Wshout Period 6||0
1616|NCT02948582|4139|P6|COMPLETED|Wshout Period 6||6
1617|NCT02948582|4140|P5|COMPLETED|Wshout Period 6||7
1618|NCT02948582|4141|P4|COMPLETED|Wshout Period 6||6
1619|NCT02948582|4142|P3|COMPLETED|Wshout Period 6||6
1620|NCT02948582|4143|P2|COMPLETED|Wshout Period 6||4
1621|NCT02948582|4144|P1|COMPLETED|Wshout Period 6||6
1622|NCT02948582|4139|P6|STARTED|Wshout Period 6||6
1623|NCT02948582|4140|P5|STARTED|Wshout Period 6||7
1624|NCT02948582|4141|P4|STARTED|Wshout Period 6||6
1625|NCT02948582|4142|P3|STARTED|Wshout Period 6||6
1626|NCT02948582|4143|P2|STARTED|Wshout Period 6||4
1627|NCT02948582|4144|P1|STARTED|Wshout Period 6||6
1628|NCT02948582|4139|P6|NOT COMPLETED|Treatment Period 6||0
1629|NCT02948582|4140|P5|NOT COMPLETED|Treatment Period 6||0
1630|NCT02948582|4141|P4|NOT COMPLETED|Treatment Period 6||0
1631|NCT02948582|4142|P3|NOT COMPLETED|Treatment Period 6||0
1632|NCT02948582|4143|P2|NOT COMPLETED|Treatment Period 6||0
1633|NCT02948582|4144|P1|NOT COMPLETED|Treatment Period 6||0
1634|NCT02948582|4139|P6|COMPLETED|Treatment Period 6||6
1635|NCT02948582|4140|P5|COMPLETED|Treatment Period 6||7
1636|NCT02948582|4141|P4|COMPLETED|Treatment Period 6||6
1637|NCT02948582|4142|P3|COMPLETED|Treatment Period 6||6
1638|NCT02948582|4143|P2|COMPLETED|Treatment Period 6||4
1639|NCT02948582|4144|P1|COMPLETED|Treatment Period 6||6
1640|NCT02948582|4139|P6|STARTED|Treatment Period 6||6
1641|NCT02948582|4140|P5|STARTED|Treatment Period 6||7
1642|NCT02948582|4141|P4|STARTED|Treatment Period 6||6
1643|NCT02948582|4142|P3|STARTED|Treatment Period 6||6
1644|NCT02948582|4143|P2|STARTED|Treatment Period 6||4
1645|NCT02948582|4144|P1|STARTED|Treatment Period 6||6
1646|NCT02948582|4139|P6|NOT COMPLETED|Washout Period 5||0
1647|NCT02948582|4140|P5|NOT COMPLETED|Washout Period 5||0
1648|NCT02948582|4141|P4|NOT COMPLETED|Washout Period 5||0
1649|NCT02948582|4142|P3|NOT COMPLETED|Washout Period 5||0
1650|NCT02948582|4143|P2|NOT COMPLETED|Washout Period 5||0
1651|NCT02948582|4144|P1|NOT COMPLETED|Washout Period 5||0
1652|NCT02948582|4139|P6|COMPLETED|Washout Period 5||6
1653|NCT02948582|4140|P5|COMPLETED|Washout Period 5||7
1654|NCT02948582|4141|P4|COMPLETED|Washout Period 5||6
1655|NCT02948582|4142|P3|COMPLETED|Washout Period 5||6
1656|NCT02948582|4143|P2|COMPLETED|Washout Period 5||4
1657|NCT02948582|4144|P1|COMPLETED|Washout Period 5||6
1658|NCT02948582|4139|P6|STARTED|Washout Period 5||6
1659|NCT02948582|4140|P5|STARTED|Washout Period 5||7
1660|NCT02948582|4141|P4|STARTED|Washout Period 5||6
1661|NCT02948582|4142|P3|STARTED|Washout Period 5||6
1662|NCT02948582|4143|P2|STARTED|Washout Period 5||4
1663|NCT02948582|4144|P1|STARTED|Washout Period 5||6
1664|NCT02948582|4139|P6|NOT COMPLETED|Treatment Period 5||0
1665|NCT02948582|4140|P5|NOT COMPLETED|Treatment Period 5||0
1666|NCT02948582|4141|P4|NOT COMPLETED|Treatment Period 5||0
1667|NCT02948582|4142|P3|NOT COMPLETED|Treatment Period 5||0
1668|NCT02948582|4143|P2|NOT COMPLETED|Treatment Period 5||0
1669|NCT02948582|4144|P1|NOT COMPLETED|Treatment Period 5||0
1670|NCT02948582|4139|P6|COMPLETED|Treatment Period 5||6
1671|NCT02948582|4140|P5|COMPLETED|Treatment Period 5||7
1672|NCT02948582|4141|P4|COMPLETED|Treatment Period 5||6
1673|NCT02948582|4142|P3|COMPLETED|Treatment Period 5||6
1674|NCT02948582|4143|P2|COMPLETED|Treatment Period 5||4
1675|NCT02948582|4144|P1|COMPLETED|Treatment Period 5||6
1676|NCT02948582|4139|P6|STARTED|Treatment Period 5||6
1677|NCT02948582|4140|P5|STARTED|Treatment Period 5||7
1678|NCT02948582|4141|P4|STARTED|Treatment Period 5||6
1679|NCT02948582|4142|P3|STARTED|Treatment Period 5||6
1680|NCT02948582|4143|P2|STARTED|Treatment Period 5||4
1681|NCT02948582|4144|P1|STARTED|Treatment Period 5||6
1682|NCT02948582|4139|P6|NOT COMPLETED|Washout Period 4||0
1683|NCT02948582|4140|P5|NOT COMPLETED|Washout Period 4||0
1684|NCT02948582|4141|P4|NOT COMPLETED|Washout Period 4||0
1685|NCT02948582|4142|P3|NOT COMPLETED|Washout Period 4||1
1686|NCT02948582|4143|P2|NOT COMPLETED|Washout Period 4||0
1687|NCT02948582|4144|P1|NOT COMPLETED|Washout Period 4||1
1688|NCT02948582|4139|P6|COMPLETED|Washout Period 4||6
1689|NCT02948582|4140|P5|COMPLETED|Washout Period 4||7
1690|NCT02948582|4141|P4|COMPLETED|Washout Period 4||6
1691|NCT02948582|4142|P3|COMPLETED|Washout Period 4||6
1692|NCT02948582|4143|P2|COMPLETED|Washout Period 4||4
1693|NCT02948582|4144|P1|COMPLETED|Washout Period 4||6
1694|NCT02948582|4139|P6|STARTED|Washout Period 4||6
1695|NCT02948582|4140|P5|STARTED|Washout Period 4||7
1696|NCT02948582|4141|P4|STARTED|Washout Period 4||6
1697|NCT02948582|4142|P3|STARTED|Washout Period 4||7
1698|NCT02948582|4143|P2|STARTED|Washout Period 4||4
1699|NCT02948582|4144|P1|STARTED|Washout Period 4||7
1700|NCT02948582|4139|P6|NOT COMPLETED|Treatment Period 4||0
1701|NCT02948582|4140|P5|NOT COMPLETED|Treatment Period 4||0
1702|NCT02948582|4141|P4|NOT COMPLETED|Treatment Period 4||0
1703|NCT02948582|4142|P3|NOT COMPLETED|Treatment Period 4||0
1704|NCT02948582|4143|P2|NOT COMPLETED|Treatment Period 4||0
1705|NCT02948582|4144|P1|NOT COMPLETED|Treatment Period 4||0
1706|NCT02948582|4139|P6|COMPLETED|Treatment Period 4||6
1707|NCT02948582|4140|P5|COMPLETED|Treatment Period 4||7
1708|NCT02948582|4141|P4|COMPLETED|Treatment Period 4||6
1709|NCT02948582|4142|P3|COMPLETED|Treatment Period 4||7
1710|NCT02948582|4143|P2|COMPLETED|Treatment Period 4||4
1711|NCT02948582|4144|P1|COMPLETED|Treatment Period 4||7
1712|NCT02948582|4139|P6|STARTED|Treatment Period 4||6
1713|NCT02948582|4140|P5|STARTED|Treatment Period 4||7
1714|NCT02948582|4141|P4|STARTED|Treatment Period 4||6
1715|NCT02948582|4142|P3|STARTED|Treatment Period 4||7
1716|NCT02948582|4143|P2|STARTED|Treatment Period 4||4
1717|NCT02948582|4144|P1|STARTED|Treatment Period 4||7
1718|NCT02948582|4139|P6|NOT COMPLETED|Washout Period 3||0
1719|NCT02948582|4140|P5|NOT COMPLETED|Washout Period 3||0
1720|NCT02948582|4141|P4|NOT COMPLETED|Washout Period 3||0
1721|NCT02948582|4142|P3|NOT COMPLETED|Washout Period 3||0
1722|NCT02948582|4143|P2|NOT COMPLETED|Washout Period 3||0
1723|NCT02948582|4144|P1|NOT COMPLETED|Washout Period 3||0
1724|NCT02948582|4139|P6|COMPLETED|Washout Period 3||6
1725|NCT02948582|4140|P5|COMPLETED|Washout Period 3||7
1726|NCT02948582|4141|P4|COMPLETED|Washout Period 3||6
1727|NCT02948582|4142|P3|COMPLETED|Washout Period 3||7
1728|NCT02948582|4143|P2|COMPLETED|Washout Period 3||4
1729|NCT02948582|4144|P1|COMPLETED|Washout Period 3||7
1730|NCT02948582|4139|P6|STARTED|Washout Period 3||6
1731|NCT02948582|4140|P5|STARTED|Washout Period 3||7
1732|NCT02948582|4141|P4|STARTED|Washout Period 3||6
1733|NCT02948582|4142|P3|STARTED|Washout Period 3||7
1734|NCT02948582|4143|P2|STARTED|Washout Period 3||4
1735|NCT02948582|4144|P1|STARTED|Washout Period 3||7
1736|NCT02948582|4139|P6|NOT COMPLETED|Treatment Period 3||0
1737|NCT02948582|4140|P5|NOT COMPLETED|Treatment Period 3||0
1738|NCT02948582|4141|P4|NOT COMPLETED|Treatment Period 3||0
1739|NCT02948582|4142|P3|NOT COMPLETED|Treatment Period 3||0
1740|NCT02948582|4143|P2|NOT COMPLETED|Treatment Period 3||0
1741|NCT02948582|4144|P1|NOT COMPLETED|Treatment Period 3||0
1742|NCT02948582|4139|P6|COMPLETED|Treatment Period 3||6
1743|NCT02948582|4140|P5|COMPLETED|Treatment Period 3||7
1744|NCT02948582|4141|P4|COMPLETED|Treatment Period 3||6
1745|NCT02948582|4142|P3|COMPLETED|Treatment Period 3||7
1746|NCT02948582|4143|P2|COMPLETED|Treatment Period 3||4
1747|NCT02948582|4144|P1|COMPLETED|Treatment Period 3||7
1748|NCT02948582|4139|P6|STARTED|Treatment Period 3||6
1749|NCT02948582|4140|P5|STARTED|Treatment Period 3||7
1750|NCT02948582|4141|P4|STARTED|Treatment Period 3||6
1751|NCT02948582|4142|P3|STARTED|Treatment Period 3||7
1752|NCT02948582|4143|P2|STARTED|Treatment Period 3||4
1753|NCT02948582|4144|P1|STARTED|Treatment Period 3||7
1754|NCT02948582|4139|P6|NOT COMPLETED|Washout Period 2||0
1755|NCT02948582|4140|P5|NOT COMPLETED|Washout Period 2||0
1756|NCT02948582|4141|P4|NOT COMPLETED|Washout Period 2||1
1757|NCT02948582|4142|P3|NOT COMPLETED|Washout Period 2||0
1758|NCT02948582|4143|P2|NOT COMPLETED|Washout Period 2||1
1759|NCT02948582|4144|P1|NOT COMPLETED|Washout Period 2||0
1760|NCT02948582|4139|P6|COMPLETED|Washout Period 2||6
1761|NCT02948582|4140|P5|COMPLETED|Washout Period 2||7
1762|NCT02948582|4141|P4|COMPLETED|Washout Period 2||6
1763|NCT02948582|4142|P3|COMPLETED|Washout Period 2||7
1764|NCT02948582|4143|P2|COMPLETED|Washout Period 2||4
1765|NCT02948582|4144|P1|COMPLETED|Washout Period 2||7
1766|NCT02948582|4139|P6|STARTED|Washout Period 2||6
1767|NCT02948582|4140|P5|STARTED|Washout Period 2||7
1768|NCT02948582|4141|P4|STARTED|Washout Period 2||7
1769|NCT02948582|4142|P3|STARTED|Washout Period 2||7
1770|NCT02948582|4143|P2|STARTED|Washout Period 2||5
1771|NCT02948582|4144|P1|STARTED|Washout Period 2||7
1772|NCT02948582|4139|P6|NOT COMPLETED|Treatment Period 2||0
1773|NCT02948582|4140|P5|NOT COMPLETED|Treatment Period 2||0
1774|NCT02948582|4141|P4|NOT COMPLETED|Treatment Period 2||0
1775|NCT02948582|4142|P3|NOT COMPLETED|Treatment Period 2||0
1776|NCT02948582|4143|P2|NOT COMPLETED|Treatment Period 2||0
1777|NCT02948582|4144|P1|NOT COMPLETED|Treatment Period 2||0
1778|NCT02948582|4139|P6|COMPLETED|Treatment Period 2||6
1779|NCT02948582|4140|P5|COMPLETED|Treatment Period 2||7
1780|NCT02948582|4141|P4|COMPLETED|Treatment Period 2||7
1781|NCT02948582|4142|P3|COMPLETED|Treatment Period 2||7
1782|NCT02948582|4143|P2|COMPLETED|Treatment Period 2||5
1783|NCT02948582|4144|P1|COMPLETED|Treatment Period 2||7
1784|NCT02948582|4139|P6|STARTED|Treatment Period 2||6
1785|NCT02948582|4140|P5|STARTED|Treatment Period 2||7
1786|NCT02948582|4141|P4|STARTED|Treatment Period 2||7
1787|NCT02948582|4142|P3|STARTED|Treatment Period 2||7
1788|NCT02948582|4143|P2|STARTED|Treatment Period 2||5
1789|NCT02948582|4144|P1|STARTED|Treatment Period 2||7
1790|NCT02948582|4139|P6|NOT COMPLETED|Washout Period 1||1
1791|NCT02948582|4140|P5|NOT COMPLETED|Washout Period 1||0
1792|NCT02948582|4141|P4|NOT COMPLETED|Washout Period 1||0
1793|NCT02948582|4142|P3|NOT COMPLETED|Washout Period 1||0
1794|NCT02948582|4143|P2|NOT COMPLETED|Washout Period 1||2
1795|NCT02948582|4144|P1|NOT COMPLETED|Washout Period 1||0
1796|NCT02948582|4139|P6|COMPLETED|Washout Period 1||6
1797|NCT02948582|4140|P5|COMPLETED|Washout Period 1||7
1798|NCT02948582|4141|P4|COMPLETED|Washout Period 1||7
1799|NCT02948582|4142|P3|COMPLETED|Washout Period 1||7
1800|NCT02948582|4143|P2|COMPLETED|Washout Period 1||5
1801|NCT02948582|4144|P1|COMPLETED|Washout Period 1||7
1802|NCT02948582|4139|P6|STARTED|Washout Period 1||7
1803|NCT02948582|4140|P5|STARTED|Washout Period 1||7
1804|NCT02948582|4141|P4|STARTED|Washout Period 1||7
1805|NCT02948582|4142|P3|STARTED|Washout Period 1||7
1806|NCT02948582|4143|P2|STARTED|Washout Period 1||7
1807|NCT02948582|4144|P1|STARTED|Washout Period 1||7
1808|NCT02948582|4139|P6|NOT COMPLETED|Treatment Period 1||0
1809|NCT02948582|4140|P5|NOT COMPLETED|Treatment Period 1||0
1810|NCT02948582|4141|P4|NOT COMPLETED|Treatment Period 1||0
1811|NCT02948582|4142|P3|NOT COMPLETED|Treatment Period 1||0
1812|NCT02948582|4143|P2|NOT COMPLETED|Treatment Period 1||0
1813|NCT02948582|4144|P1|NOT COMPLETED|Treatment Period 1||0
1814|NCT02948582|4139|P6|COMPLETED|Treatment Period 1||7
1815|NCT02948582|4140|P5|COMPLETED|Treatment Period 1||7
1816|NCT02948582|4141|P4|COMPLETED|Treatment Period 1||7
1817|NCT02948582|4142|P3|COMPLETED|Treatment Period 1||7
1818|NCT02948582|4143|P2|COMPLETED|Treatment Period 1||7
1819|NCT02948582|4144|P1|COMPLETED|Treatment Period 1||7
1820|NCT02948582|4139|P6|STARTED|Treatment Period 1||7
1821|NCT02948582|4140|P5|STARTED|Treatment Period 1||7
1822|NCT02948582|4141|P4|STARTED|Treatment Period 1||7
1823|NCT02948582|4142|P3|STARTED|Treatment Period 1||7
1824|NCT02948582|4143|P2|STARTED|Treatment Period 1||7
1825|NCT02948582|4144|P1|STARTED|Treatment Period 1||7
1826|NCT02947984|4239|P2|NOT COMPLETED|Overall Study||0
1827|NCT02947984|4240|P1|NOT COMPLETED|Overall Study||0
1828|NCT02947984|4239|P2|COMPLETED|Overall Study||22
1829|NCT02947984|4240|P1|COMPLETED|Overall Study||22
1830|NCT02947984|4239|P2|STARTED|Overall Study||22
1831|NCT02947984|4240|P1|STARTED|Overall Study||22
1832|NCT02947022|4252|P1|NOT COMPLETED|Overall Study||1
1833|NCT02947022|4252|P1|COMPLETED|Overall Study||0
1834|NCT02947022|4252|P1|STARTED|Overall Study||1
1835|NCT02945254|4273|P2|NOT COMPLETED|Overall Study||0
1836|NCT02945254|4274|P1|NOT COMPLETED|Overall Study||2
1837|NCT02945254|4273|P2|COMPLETED|Overall Study||10
1838|NCT02945254|4274|P1|COMPLETED|Overall Study||8
1839|NCT02945254|4273|P2|STARTED|Overall Study||10
1840|NCT02945254|4274|P1|STARTED|Overall Study||10
1841|NCT02943226|4284|P2|NOT COMPLETED|Overall Study||0
1842|NCT02943226|4285|P1|NOT COMPLETED|Overall Study||0
1843|NCT02943226|4284|P2|COMPLETED|Overall Study||30
1844|NCT02943226|4285|P1|COMPLETED|Overall Study||31
1845|NCT02943226|4284|P2|STARTED|Overall Study||30
1846|NCT02943226|4285|P1|STARTED|Overall Study||31
1847|NCT02943213|4301|P1|NOT COMPLETED|Treatment Period 2||0
1848|NCT02943213|4301|P1|COMPLETED|Treatment Period 2||20
1849|NCT02943213|4301|P1|STARTED|Treatment Period 2||20
1850|NCT02943213|4301|P1|NOT COMPLETED|Treatment Period 1||0
1851|NCT02943213|4301|P1|COMPLETED|Treatment Period 1||20
1852|NCT02943213|4301|P1|STARTED|Treatment Period 1||20
1853|NCT02941640|4333|P4|NOT COMPLETED|Overall Study||0
1854|NCT02941640|4334|P3|NOT COMPLETED|Overall Study||0
1855|NCT02941640|4335|P2|NOT COMPLETED|Overall Study||0
1856|NCT02941640|4336|P1|NOT COMPLETED|Overall Study||0
1857|NCT02941640|4333|P4|COMPLETED|Overall Study||30
1858|NCT02941640|4334|P3|COMPLETED|Overall Study||30
1859|NCT02941640|4335|P2|COMPLETED|Overall Study||30
1860|NCT02941640|4336|P1|COMPLETED|Overall Study||30
1861|NCT02941640|4333|P4|STARTED|Overall Study||30
1862|NCT02941640|4334|P3|STARTED|Overall Study||30
1863|NCT02941640|4335|P2|STARTED|Overall Study||30
1864|NCT02941640|4336|P1|STARTED|Overall Study||30
1865|NCT02939170|4368|P2|NOT COMPLETED|Overall Study||0
1866|NCT02939170|4369|P1|NOT COMPLETED|Overall Study||0
1867|NCT02939170|4368|P2|COMPLETED|Overall Study||40
1868|NCT02939170|4369|P1|COMPLETED|Overall Study||40
1869|NCT02939170|4368|P2|STARTED|Overall Study||40
1870|NCT02939170|4369|P1|STARTED|Overall Study||40
1871|NCT02937870|4380|P1|NOT COMPLETED|Overall Study||3
1872|NCT02937870|4380|P1|COMPLETED|Overall Study||20
1873|NCT02937870|4380|P1|Received no Adhesive|Overall Study||20
1874|NCT02937870|4380|P1|Received Positive Control Adhesive|Overall Study||21
1875|NCT02937870|4380|P1|Received Test Adhesive 2|Overall Study||22
1876|NCT02937870|4380|P1|Received Test Adhesive 1|Overall Study||21
1877|NCT02937870|4380|P1|STARTED|Overall Study||23
1878|NCT02937623|4398|P2|NOT COMPLETED|Overall Study||0
1879|NCT02937623|4399|P1|NOT COMPLETED|Overall Study||0
1880|NCT02937623|4398|P2|COMPLETED|Overall Study||60
1881|NCT02937623|4399|P1|COMPLETED|Overall Study||60
1882|NCT02937623|4398|P2|STARTED|Overall Study||60
1883|NCT02937623|4399|P1|STARTED|Overall Study||60
1884|NCT02937506|4413|P2|NOT COMPLETED|Overall Study||0
1885|NCT02937506|4414|P1|NOT COMPLETED|Overall Study||0
1886|NCT02937506|4413|P2|COMPLETED|Overall Study||300
1887|NCT02937506|4414|P1|COMPLETED|Overall Study||300
1888|NCT02937506|4413|P2|STARTED|Overall Study||300
1889|NCT02937506|4414|P1|STARTED|Overall Study||300
1890|NCT02934347|4422|P2|NOT COMPLETED|Overall Study||0
1891|NCT02934347|4423|P1|NOT COMPLETED|Overall Study||0
1892|NCT02934347|4422|P2|COMPLETED|Overall Study||407
1893|NCT02934347|4423|P1|COMPLETED|Overall Study||374
1894|NCT02934347|4422|P2|STARTED|Overall Study||407
1895|NCT02934347|4423|P1|STARTED|Overall Study||374
1896|NCT02933476|4435|P1|NOT COMPLETED|Overall Study||0
1897|NCT02933476|4435|P1|COMPLETED|Overall Study||5
1898|NCT02933476|4435|P1|STARTED|Overall Study||5
1899|NCT02928380|4442|P6|NOT COMPLETED|Period 3||0
1900|NCT02928380|4443|P5|NOT COMPLETED|Period 3||0
1901|NCT02928380|4444|P4|NOT COMPLETED|Period 3||0
1902|NCT02928380|4445|P3|NOT COMPLETED|Period 3||0
1903|NCT02928380|4446|P2|NOT COMPLETED|Period 3||0
1904|NCT02928380|4447|P1|NOT COMPLETED|Period 3||0
1905|NCT02928380|4442|P6|COMPLETED|Period 3||14
1906|NCT02928380|4443|P5|COMPLETED|Period 3||14
1907|NCT02928380|4444|P4|COMPLETED|Period 3||14
1908|NCT02928380|4445|P3|COMPLETED|Period 3||14
1909|NCT02928380|4446|P2|COMPLETED|Period 3||14
1910|NCT02928380|4447|P1|COMPLETED|Period 3||13
1911|NCT02928380|4442|P6|STARTED|Period 3||14
1912|NCT02928380|4443|P5|STARTED|Period 3||14
1913|NCT02928380|4444|P4|STARTED|Period 3||14
1914|NCT02928380|4445|P3|STARTED|Period 3||14
1915|NCT02928380|4446|P2|STARTED|Period 3||14
1916|NCT02928380|4447|P1|STARTED|Period 3||13
1917|NCT02928380|4442|P6|NOT COMPLETED|Wash Out Period 2||0
1918|NCT02928380|4443|P5|NOT COMPLETED|Wash Out Period 2||0
1919|NCT02928380|4444|P4|NOT COMPLETED|Wash Out Period 2||0
1920|NCT02928380|4445|P3|NOT COMPLETED|Wash Out Period 2||0
1921|NCT02928380|4446|P2|NOT COMPLETED|Wash Out Period 2||0
1922|NCT02928380|4447|P1|NOT COMPLETED|Wash Out Period 2||0
1923|NCT02928380|4442|P6|COMPLETED|Wash Out Period 2||14
1924|NCT02928380|4443|P5|COMPLETED|Wash Out Period 2||14
1925|NCT02928380|4444|P4|COMPLETED|Wash Out Period 2||14
1926|NCT02928380|4445|P3|COMPLETED|Wash Out Period 2||14
1927|NCT02928380|4446|P2|COMPLETED|Wash Out Period 2||14
1928|NCT02928380|4447|P1|COMPLETED|Wash Out Period 2||13
1929|NCT02928380|4442|P6|STARTED|Wash Out Period 2||14
1930|NCT02928380|4443|P5|STARTED|Wash Out Period 2||14
1931|NCT02928380|4444|P4|STARTED|Wash Out Period 2||14
1932|NCT02928380|4445|P3|STARTED|Wash Out Period 2||14
1933|NCT02928380|4446|P2|STARTED|Wash Out Period 2||14
1934|NCT02928380|4447|P1|STARTED|Wash Out Period 2||13
1935|NCT02928380|4442|P6|NOT COMPLETED|Period 2||0
1936|NCT02928380|4443|P5|NOT COMPLETED|Period 2||0
1937|NCT02928380|4444|P4|NOT COMPLETED|Period 2||0
1938|NCT02928380|4445|P3|NOT COMPLETED|Period 2||0
1939|NCT02928380|4446|P2|NOT COMPLETED|Period 2||0
1940|NCT02928380|4447|P1|NOT COMPLETED|Period 2||0
1941|NCT02928380|4442|P6|COMPLETED|Period 2||14
1942|NCT02928380|4443|P5|COMPLETED|Period 2||14
1943|NCT02928380|4444|P4|COMPLETED|Period 2||14
1944|NCT02928380|4445|P3|COMPLETED|Period 2||14
1945|NCT02928380|4446|P2|COMPLETED|Period 2||14
1946|NCT02928380|4447|P1|COMPLETED|Period 2||13
1947|NCT02928380|4442|P6|STARTED|Period 2||14
1948|NCT02928380|4443|P5|STARTED|Period 2||14
1949|NCT02928380|4444|P4|STARTED|Period 2||14
1950|NCT02928380|4445|P3|STARTED|Period 2||14
1951|NCT02928380|4446|P2|STARTED|Period 2||14
1952|NCT02928380|4447|P1|STARTED|Period 2||13
1953|NCT02928380|4442|P6|NOT COMPLETED|Wash Out Period 1||0
1954|NCT02928380|4443|P5|NOT COMPLETED|Wash Out Period 1||0
1955|NCT02928380|4444|P4|NOT COMPLETED|Wash Out Period 1||0
1956|NCT02928380|4445|P3|NOT COMPLETED|Wash Out Period 1||0
1957|NCT02928380|4446|P2|NOT COMPLETED|Wash Out Period 1||0
1958|NCT02928380|4447|P1|NOT COMPLETED|Wash Out Period 1||0
1959|NCT02928380|4442|P6|COMPLETED|Wash Out Period 1||14
1960|NCT02928380|4443|P5|COMPLETED|Wash Out Period 1||14
1961|NCT02928380|4444|P4|COMPLETED|Wash Out Period 1||14
1962|NCT02928380|4445|P3|COMPLETED|Wash Out Period 1||14
1963|NCT02928380|4446|P2|COMPLETED|Wash Out Period 1||14
1964|NCT02928380|4447|P1|COMPLETED|Wash Out Period 1||13
1965|NCT02928380|4442|P6|STARTED|Wash Out Period 1||14
1966|NCT02928380|4443|P5|STARTED|Wash Out Period 1||14
1967|NCT02928380|4444|P4|STARTED|Wash Out Period 1||14
1968|NCT02928380|4445|P3|STARTED|Wash Out Period 1||14
1969|NCT02928380|4446|P2|STARTED|Wash Out Period 1||14
1970|NCT02928380|4447|P1|STARTED|Wash Out Period 1||13
1971|NCT02928380|4442|P6|NOT COMPLETED|Period 1||0
1972|NCT02928380|4443|P5|NOT COMPLETED|Period 1||0
1973|NCT02928380|4444|P4|NOT COMPLETED|Period 1||0
1974|NCT02928380|4445|P3|NOT COMPLETED|Period 1||0
1975|NCT02928380|4446|P2|NOT COMPLETED|Period 1||0
1976|NCT02928380|4447|P1|NOT COMPLETED|Period 1||0
1977|NCT02928380|4442|P6|COMPLETED|Period 1||14
1978|NCT02928380|4443|P5|COMPLETED|Period 1||14
1979|NCT02928380|4444|P4|COMPLETED|Period 1||14
1980|NCT02928380|4445|P3|COMPLETED|Period 1||14
1981|NCT02928380|4446|P2|COMPLETED|Period 1||14
1982|NCT02928380|4447|P1|COMPLETED|Period 1||13
1983|NCT02928380|4442|P6|STARTED|Period 1||14
1984|NCT02928380|4443|P5|STARTED|Period 1||14
1985|NCT02928380|4444|P4|STARTED|Period 1||14
1986|NCT02928380|4445|P3|STARTED|Period 1||14
1987|NCT02928380|4446|P2|STARTED|Period 1||14
1988|NCT02928380|4447|P1|STARTED|Period 1||13
1989|NCT02923245|4469|P2|NOT COMPLETED|Overall Study||1
1990|NCT02923245|4470|P1|NOT COMPLETED|Overall Study||2
1991|NCT02923245|4469|P2|COMPLETED|Overall Study||59
1992|NCT02923245|4470|P1|COMPLETED|Overall Study||58
1993|NCT02923245|4469|P2|STARTED|Overall Study||60
1994|NCT02923245|4470|P1|STARTED|Overall Study||60
1995|NCT02922868|4489|P2|NOT COMPLETED|Overall Study||0
1996|NCT02922868|4490|P1|NOT COMPLETED|Overall Study||0
1997|NCT02922868|4489|P2|COMPLETED|Overall Study||30
1998|NCT02922868|4490|P1|COMPLETED|Overall Study||30
1999|NCT02922868|4489|P2|STARTED|Overall Study||30
2000|NCT02922868|4490|P1|STARTED|Overall Study||30
2001|NCT02921412|4508|P1|NOT COMPLETED|Overall Study||0
2002|NCT02921412|4508|P1|COMPLETED|Overall Study||36
2003|NCT02921412|4508|P1|STARTED|Overall Study||36
2004|NCT02921386|4531|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
2005|NCT02921386|4531|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
2006|NCT02921386|4531|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
2007|NCT02921386|4531|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
2008|NCT02921386|4531|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
2009|NCT02921386|4531|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
2010|NCT02921386|4531|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
2011|NCT02921386|4531|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
2012|NCT02921386|4531|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
2013|NCT02921386|4531|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
2014|NCT02921386|4531|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
2015|NCT02921386|4531|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
2016|NCT02921386|4531|P1|NOT COMPLETED|Sequence A: Fasting||0
2017|NCT02921386|4531|P1|COMPLETED|Sequence A: Fasting||18
2018|NCT02921386|4531|P1|STARTED|Sequence A: Fasting||18
2019|NCT02921295|4554|P1|NOT COMPLETED|Conventional Prostheses||0
2020|NCT02921295|4554|P1|COMPLETED|Conventional Prostheses||1
2021|NCT02921295|4554|P1|STARTED|Conventional Prostheses||1
2022|NCT02921295|4554|P1|NOT COMPLETED|Sidekicks||0
2023|NCT02921295|4554|P1|COMPLETED|Sidekicks||1
2024|NCT02921295|4554|P1|STARTED|Sidekicks||1
2025|NCT02920957|4564|P2|NOT COMPLETED|Second Intervention: 1 Month||1
2026|NCT02920957|4565|P1|NOT COMPLETED|Second Intervention: 1 Month||0
2027|NCT02920957|4564|P2|COMPLETED|Second Intervention: 1 Month||40
2028|NCT02920957|4565|P1|COMPLETED|Second Intervention: 1 Month||42
2029|NCT02920957|4564|P2|STARTED|Second Intervention: 1 Month||41
2030|NCT02920957|4565|P1|STARTED|Second Intervention: 1 Month||42
2031|NCT02920957|4564|P2|NOT COMPLETED|First Intervention : 1 Month||0
2032|NCT02920957|4565|P1|NOT COMPLETED|First Intervention : 1 Month||4
2033|NCT02920957|4564|P2|COMPLETED|First Intervention : 1 Month||41
2034|NCT02920957|4565|P1|COMPLETED|First Intervention : 1 Month||42
2035|NCT02920957|4564|P2|STARTED|First Intervention : 1 Month||41
2036|NCT02920957|4565|P1|STARTED|First Intervention : 1 Month||46
2037|NCT02920749|4621|P4|NOT COMPLETED|Overall Study||0
2038|NCT02920749|4622|P3|NOT COMPLETED|Overall Study||0
2039|NCT02920749|4623|P2|NOT COMPLETED|Overall Study||0
2040|NCT02920749|4624|P1|NOT COMPLETED|Overall Study||0
2041|NCT02920749|4621|P4|COMPLETED|Overall Study||30
2042|NCT02920749|4622|P3|COMPLETED|Overall Study||30
2043|NCT02920749|4623|P2|COMPLETED|Overall Study||30
2044|NCT02920749|4624|P1|COMPLETED|Overall Study||30
2045|NCT02920749|4621|P4|STARTED|Overall Study||30
2046|NCT02920749|4622|P3|STARTED|Overall Study||30
2047|NCT02920749|4623|P2|STARTED|Overall Study||30
2048|NCT02920749|4624|P1|STARTED|Overall Study||30
2049|NCT02919657|4638|P2|NOT COMPLETED|Overall Study||0
2050|NCT02919657|4639|P1|NOT COMPLETED|Overall Study||0
2051|NCT02919657|4638|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
2052|NCT02919657|4639|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
2053|NCT02919657|4638|P2|STARTED|Overall Study|10 Participants|10
2054|NCT02919657|4639|P1|STARTED|Overall Study|10 Participants|10
2055|NCT02918396|4648|P3|NOT COMPLETED|Overall Study||0
2056|NCT02918396|4649|P2|NOT COMPLETED|Overall Study||0
2057|NCT02918396|4650|P1|NOT COMPLETED|Overall Study||0
2058|NCT02918396|4648|P3|COMPLETED|Overall Study||2
2059|NCT02918396|4649|P2|COMPLETED|Overall Study||1
2060|NCT02918396|4650|P1|COMPLETED|Overall Study||2
2061|NCT02918396|4648|P3|STARTED|Overall Study||2
2062|NCT02918396|4649|P2|STARTED|Overall Study||1
2063|NCT02918396|4650|P1|STARTED|Overall Study||2
2064|NCT02915978|4661|P3|NOT COMPLETED|Overall Study||0
2065|NCT02915978|4662|P2|NOT COMPLETED|Overall Study||1
2066|NCT02915978|4663|P1|NOT COMPLETED|Overall Study||2
2067|NCT02915978|4661|P3|COMPLETED|Overall Study||15
2068|NCT02915978|4662|P2|COMPLETED|Overall Study||14
2069|NCT02915978|4663|P1|COMPLETED|Overall Study||13
2070|NCT02915978|4661|P3|STARTED|Overall Study||15
2071|NCT02915978|4662|P2|STARTED|Overall Study||15
2072|NCT02915978|4663|P1|STARTED|Overall Study||15
2073|NCT02915302|4715|P2|NOT COMPLETED|Overall Study||78
2074|NCT02915302|4716|P1|NOT COMPLETED|Overall Study||65
2075|NCT02915302|4715|P2|COMPLETED|Overall Study||917
2076|NCT02915302|4716|P1|COMPLETED|Overall Study||890
2077|NCT02915302|4715|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
2078|NCT02915302|4716|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
2079|NCT02915302|4715|P2|STARTED|Overall Study||995
2080|NCT02915302|4716|P1|STARTED|Overall Study||955
2081|NCT02914236|4726|P1|NOT COMPLETED|Overall Study||1
2082|NCT02914236|4726|P1|COMPLETED|Overall Study||49
2083|NCT02914236|4726|P1|26-week Follow-up Visit|Overall Study||49
2084|NCT02914236|4726|P1|12-week Follow-up Visit|Overall Study||50
2085|NCT02914236|4726|P1|4-week Follow-up Visit|Overall Study||50
2086|NCT02914236|4726|P1|STARTED|Overall Study||50
2087|NCT02912650|4738|P4|NOT COMPLETED|Overall Study||5
2088|NCT02912650|4739|P3|NOT COMPLETED|Overall Study||2
2089|NCT02912650|4740|P2|NOT COMPLETED|Overall Study||0
2090|NCT02912650|4741|P1|NOT COMPLETED|Overall Study||1
2091|NCT02912650|4738|P4|COMPLETED|Overall Study||160
2092|NCT02912650|4739|P3|COMPLETED|Overall Study||173
2093|NCT02912650|4740|P2|COMPLETED|Overall Study||172
2094|NCT02912650|4741|P1|COMPLETED|Overall Study||55
2095|NCT02912650|4738|P4|STARTED|Overall Study||165
2096|NCT02912650|4739|P3|STARTED|Overall Study||175
2097|NCT02912650|4740|P2|STARTED|Overall Study||172
2098|NCT02912650|4741|P1|STARTED|Overall Study||56
2099|NCT02910362|4825|P2|NOT COMPLETED|Overall Study||0
2100|NCT02910362|4826|P1|NOT COMPLETED|Overall Study||0
2101|NCT02910362|4825|P2|COMPLETED|Overall Study||7
2102|NCT02910362|4826|P1|COMPLETED|Overall Study||8
2103|NCT02910362|4825|P2|STARTED|Overall Study||7
2104|NCT02910362|4826|P1|STARTED|Overall Study||8
2105|NCT02908269|4835|P3|NOT COMPLETED|Overall Study||0
2106|NCT02908269|4836|P2|NOT COMPLETED|Overall Study||0
2107|NCT02908269|4837|P1|NOT COMPLETED|Overall Study||0
2108|NCT02908269|4835|P3|COMPLETED|Overall Study||60
2109|NCT02908269|4836|P2|COMPLETED|Overall Study||60
2110|NCT02908269|4837|P1|COMPLETED|Overall Study||60
2111|NCT02908269|4835|P3|STARTED|Overall Study||60
2112|NCT02908269|4836|P2|STARTED|Overall Study||60
2113|NCT02908269|4837|P1|STARTED|Overall Study||60
2114|NCT02907268|4853|P2|NOT COMPLETED|Overall Study||0
2115|NCT02907268|4854|P1|NOT COMPLETED|Overall Study||0
2116|NCT02907268|4853|P2|COMPLETED|Overall Study||5
2117|NCT02907268|4854|P1|COMPLETED|Overall Study||5
2118|NCT02907268|4853|P2|STARTED|Overall Study||5
2119|NCT02907268|4854|P1|STARTED|Overall Study||5
2120|NCT02903238|4861|P1|NOT COMPLETED|Overall Study||4
2121|NCT02903238|4861|P1|COMPLETED|Overall Study||17
2122|NCT02903238|4861|P1|STARTED|Overall Study||21
2123|NCT02901054|4870|P1|NOT COMPLETED|Overall Study||4
2124|NCT02901054|4870|P1|COMPLETED|Overall Study||15
2125|NCT02901054|4870|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
2126|NCT02895347|4876|P2|NOT COMPLETED|Overall Study||1
2127|NCT02895347|4877|P1|NOT COMPLETED|Overall Study||3
2128|NCT02895347|4876|P2|COMPLETED|Overall Study||19
2129|NCT02895347|4877|P1|COMPLETED|Overall Study||17
2130|NCT02895347|4876|P2|STARTED|Overall Study||20
2131|NCT02895347|4877|P1|STARTED|Overall Study||20
2132|NCT02891863|4886|P1|NOT COMPLETED|Overall Study||0
2133|NCT02891863|4886|P1|COMPLETED|Overall Study||9
2134|NCT02891863|4886|P1|STARTED|Overall Study||9
2135|NCT02890303|4891|P1|NOT COMPLETED|Overall Study||0
2136|NCT02890303|4891|P1|COMPLETED|Overall Study||100
2137|NCT02890303|4891|P1|STARTED|Overall Study||100
2138|NCT02889289|4895|P1|NOT COMPLETED|Overall Study||0
2139|NCT02889289|4895|P1|COMPLETED|Overall Study||1
2140|NCT02889289|4895|P1|STARTED|Overall Study||1
2141|NCT02886338|4904|P1|NOT COMPLETED|Overall Study||1
2142|NCT02886338|4904|P1|COMPLETED|Overall Study||9
2143|NCT02886338|4904|P1|STARTED|Overall Study||10
2144|NCT02884427|4911|P3|NOT COMPLETED|Overall Study||0
2145|NCT02884427|4912|P2|NOT COMPLETED|Overall Study||0
2146|NCT02884427|4913|P1|NOT COMPLETED|Overall Study||0
2147|NCT02884427|4911|P3|COMPLETED|Overall Study||50
2148|NCT02884427|4912|P2|COMPLETED|Overall Study||52
2149|NCT02884427|4913|P1|COMPLETED|Overall Study||48
2150|NCT02884427|4911|P3|STARTED|Overall Study||50
2151|NCT02884427|4912|P2|STARTED|Overall Study||52
2152|NCT02884427|4913|P1|STARTED|Overall Study||48
2153|NCT02882152|4929|P2|NOT COMPLETED|Overall Study||0
2154|NCT02882152|4930|P1|NOT COMPLETED|Overall Study||1
2155|NCT02882152|4929|P2|COMPLETED|Overall Study||20
2156|NCT02882152|4930|P1|COMPLETED|Overall Study||19
2157|NCT02882152|4929|P2|STARTED|Overall Study||20
2158|NCT02882152|4930|P1|STARTED|Overall Study||20
2159|NCT02881658|4940|P2|NOT COMPLETED|Overall Study||5
2160|NCT02881658|4941|P1|NOT COMPLETED|Overall Study||2
2161|NCT02881658|4940|P2|COMPLETED|Overall Study||96
2162|NCT02881658|4941|P1|COMPLETED|Overall Study||98
2163|NCT02881658|4940|P2|STARTED|Overall Study||101
2164|NCT02881658|4941|P1|STARTED|Overall Study||100
2165|NCT02877732|4977|P2|NOT COMPLETED|Overall Study||6
2166|NCT02877732|4978|P1|NOT COMPLETED|Overall Study||6
2167|NCT02877732|4977|P2|COMPLETED|Overall Study||0
2168|NCT02877732|4978|P1|COMPLETED|Overall Study||0
2169|NCT02877732|4977|P2|STARTED|Overall Study||6
2170|NCT02877732|4978|P1|STARTED|Overall Study||6
2171|NCT02877082|4994|P1|NOT COMPLETED|Overall Study||5
2172|NCT02877082|4994|P1|COMPLETED|Overall Study||0
2173|NCT02877082|4994|P1|STARTED|Overall Study||5
2174|NCT02876757|5004|P2|NOT COMPLETED|Overall Study||0
2175|NCT02876757|5005|P1|NOT COMPLETED|Overall Study||0
2176|NCT02876757|5004|P2|COMPLETED|Overall Study||93197
2177|NCT02876757|5005|P1|COMPLETED|Overall Study||93197
2178|NCT02876757|5004|P2|STARTED|Overall Study||93197
2179|NCT02876757|5005|P1|STARTED|Overall Study||93197
2180|NCT02874846|5017|P2|NOT COMPLETED|Overall Study||0
2181|NCT02874846|5018|P1|NOT COMPLETED|Overall Study||0
2182|NCT02874846|5017|P2|COMPLETED|Overall Study||4
2183|NCT02874846|5018|P1|COMPLETED|Overall Study||8
2184|NCT02874846|5017|P2|STARTED|Overall Study||4
2185|NCT02874846|5018|P1|STARTED|Overall Study||8
2186|NCT02873429|5028|P2|NOT COMPLETED|16 Weeks||2
2187|NCT02873429|5029|P1|NOT COMPLETED|16 Weeks||5
2188|NCT02873429|5028|P2|COMPLETED|16 Weeks||96
2189|NCT02873429|5029|P1|COMPLETED|16 Weeks||100
2190|NCT02873429|5028|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
2191|NCT02873429|5029|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
2192|NCT02873429|5028|P2|NOT COMPLETED|6-8 Weeks||1
2193|NCT02873429|5029|P1|NOT COMPLETED|6-8 Weeks||10
2194|NCT02873429|5028|P2|COMPLETED|6-8 Weeks||97
2195|NCT02873429|5029|P1|COMPLETED|6-8 Weeks||95
2196|NCT02873429|5028|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
2197|NCT02873429|5029|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
2198|NCT02873429|5028|P2|NOT COMPLETED|Baseline||0
2199|NCT02873429|5029|P1|NOT COMPLETED|Baseline||0
2200|NCT02873429|5028|P2|COMPLETED|Baseline||100
2201|NCT02873429|5029|P1|COMPLETED|Baseline||109
2202|NCT02873429|5028|P2|STARTED|Baseline||100
2203|NCT02873429|5029|P1|STARTED|Baseline||109
2204|NCT02873104|5041|P2|NOT COMPLETED|Overall Study||0
2205|NCT02873104|5042|P1|NOT COMPLETED|Overall Study||1
2206|NCT02873104|5041|P2|COMPLETED|Overall Study||23
2207|NCT02873104|5042|P1|COMPLETED|Overall Study||46
2208|NCT02873104|5041|P2|STARTED|Overall Study||23
2209|NCT02873104|5042|P1|STARTED|Overall Study||47
2210|NCT02871375|5054|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
2211|NCT02871375|5055|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
2212|NCT02871375|5054|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
2213|NCT02871375|5055|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
2214|NCT02871375|5054|P2|STARTED|Period 2, Second 14 Days of Wear||76
2215|NCT02871375|5055|P1|STARTED|Period 2, Second 14 Days of Wear||89
2216|NCT02871375|5054|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
2217|NCT02871375|5055|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
2218|NCT02871375|5054|P2|COMPLETED|Period 1, First 14 Days of Wear||76
2219|NCT02871375|5055|P1|COMPLETED|Period 1, First 14 Days of Wear||89
2220|NCT02871375|5054|P2|STARTED|Period 1, First 14 Days of Wear||77
2221|NCT02871375|5055|P1|STARTED|Period 1, First 14 Days of Wear||89
2222|NCT02870205|5068|P4|NOT COMPLETED|Overall Study||7
2223|NCT02870205|5069|P3|NOT COMPLETED|Overall Study||7
2224|NCT02870205|5070|P2|NOT COMPLETED|Overall Study||5
2225|NCT02870205|5071|P1|NOT COMPLETED|Overall Study||10
2226|NCT02870205|5068|P4|COMPLETED|Overall Study||287
2227|NCT02870205|5069|P3|COMPLETED|Overall Study||287
2228|NCT02870205|5070|P2|COMPLETED|Overall Study||289
2229|NCT02870205|5071|P1|COMPLETED|Overall Study||284
2230|NCT02870205|5068|P4|STARTED|Overall Study||294
2231|NCT02870205|5069|P3|STARTED|Overall Study||294
2232|NCT02870205|5070|P2|STARTED|Overall Study||294
2233|NCT02870205|5071|P1|STARTED|Overall Study||294
2234|NCT02869451|5081|P1|NOT COMPLETED|Overall Study||0
2235|NCT02869451|5081|P1|COMPLETED|Overall Study||5
2236|NCT02869451|5081|P1|STARTED|Overall Study||5
2237|NCT02867150|5103|P1|NOT COMPLETED|Overall Study||0
2238|NCT02867150|5103|P1|COMPLETED|Overall Study||58
2239|NCT02867150|5103|P1|STARTED|Overall Study||58
2240|NCT02865083|5109|P2|NOT COMPLETED|Overall Study||1
2241|NCT02865083|5110|P1|NOT COMPLETED|Overall Study||3
2242|NCT02865083|5109|P2|COMPLETED|Overall Study||0
2243|NCT02865083|5110|P1|COMPLETED|Overall Study||0
2244|NCT02865083|5109|P2|STARTED|Overall Study||1
2245|NCT02865083|5110|P1|STARTED|Overall Study||3
2246|NCT02864732|5120|P2|NOT COMPLETED|Overall Study||2
2247|NCT02864732|5121|P1|NOT COMPLETED|Overall Study||2
2248|NCT02864732|5120|P2|COMPLETED|Overall Study||13
2249|NCT02864732|5121|P1|COMPLETED|Overall Study||13
2250|NCT02864732|5120|P2|STARTED|Overall Study||15
2251|NCT02864732|5121|P1|STARTED|Overall Study||15
2252|NCT02863198|5138|P2|NOT COMPLETED|Overall Study||0
2253|NCT02863198|5139|P1|NOT COMPLETED|Overall Study||0
2254|NCT02863198|5138|P2|COMPLETED|Overall Study||60
2255|NCT02863198|5139|P1|COMPLETED|Overall Study||60
2256|NCT02863198|5138|P2|STARTED|Overall Study||60
2257|NCT02863198|5139|P1|STARTED|Overall Study||60
2258|NCT02862730|5155|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2259|NCT02862730|5156|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2260|NCT02862730|5157|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2261|NCT02862730|5158|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2262|NCT02862730|5159|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2263|NCT02862730|5160|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2264|NCT02862730|5161|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2265|NCT02862730|5155|P7|COMPLETED|Fourth Intervention (84 Hours)||1
2266|NCT02862730|5156|P6|COMPLETED|Fourth Intervention (84 Hours)||1
2267|NCT02862730|5157|P5|COMPLETED|Fourth Intervention (84 Hours)||4
2268|NCT02862730|5158|P4|COMPLETED|Fourth Intervention (84 Hours)||4
2269|NCT02862730|5159|P3|COMPLETED|Fourth Intervention (84 Hours)||6
2270|NCT02862730|5160|P2|COMPLETED|Fourth Intervention (84 Hours)||1
2271|NCT02862730|5161|P1|COMPLETED|Fourth Intervention (84 Hours)||3
2272|NCT02862730|5155|P7|STARTED|Fourth Intervention (84 Hours)||1
2273|NCT02862730|5156|P6|STARTED|Fourth Intervention (84 Hours)||1
2274|NCT02862730|5157|P5|STARTED|Fourth Intervention (84 Hours)||4
2275|NCT02862730|5158|P4|STARTED|Fourth Intervention (84 Hours)||4
2276|NCT02862730|5159|P3|STARTED|Fourth Intervention (84 Hours)||6
2277|NCT02862730|5160|P2|STARTED|Fourth Intervention (84 Hours)||1
2278|NCT02862730|5161|P1|STARTED|Fourth Intervention (84 Hours)||3
2279|NCT02862730|5155|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2280|NCT02862730|5156|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2281|NCT02862730|5157|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2282|NCT02862730|5158|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2283|NCT02862730|5159|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2284|NCT02862730|5160|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2285|NCT02862730|5161|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2286|NCT02862730|5155|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
2287|NCT02862730|5156|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
2288|NCT02862730|5157|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
2289|NCT02862730|5158|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
2290|NCT02862730|5159|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
2291|NCT02862730|5160|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
2292|NCT02862730|5161|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
2293|NCT02862730|5155|P7|STARTED|Fourth Rest Period (7-45 Days)||1
2294|NCT02862730|5156|P6|STARTED|Fourth Rest Period (7-45 Days)||1
2295|NCT02862730|5157|P5|STARTED|Fourth Rest Period (7-45 Days)||4
2296|NCT02862730|5158|P4|STARTED|Fourth Rest Period (7-45 Days)||4
2297|NCT02862730|5159|P3|STARTED|Fourth Rest Period (7-45 Days)||6
2298|NCT02862730|5160|P2|STARTED|Fourth Rest Period (7-45 Days)||1
2299|NCT02862730|5161|P1|STARTED|Fourth Rest Period (7-45 Days)||3
2300|NCT02862730|5155|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
2301|NCT02862730|5156|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
2302|NCT02862730|5157|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
2303|NCT02862730|5158|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
2304|NCT02862730|5159|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
2305|NCT02862730|5160|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
2306|NCT02862730|5161|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
2307|NCT02862730|5155|P7|COMPLETED|Third Intervention (84 Hours)||1
2308|NCT02862730|5156|P6|COMPLETED|Third Intervention (84 Hours)||1
2309|NCT02862730|5157|P5|COMPLETED|Third Intervention (84 Hours)||4
2310|NCT02862730|5158|P4|COMPLETED|Third Intervention (84 Hours)||4
2311|NCT02862730|5159|P3|COMPLETED|Third Intervention (84 Hours)||6
2312|NCT02862730|5160|P2|COMPLETED|Third Intervention (84 Hours)||1
2313|NCT02862730|5161|P1|COMPLETED|Third Intervention (84 Hours)||3
2314|NCT02862730|5155|P7|STARTED|Third Intervention (84 Hours)||1
2315|NCT02862730|5156|P6|STARTED|Third Intervention (84 Hours)||1
2316|NCT02862730|5157|P5|STARTED|Third Intervention (84 Hours)||4
2317|NCT02862730|5158|P4|STARTED|Third Intervention (84 Hours)||5
2318|NCT02862730|5159|P3|STARTED|Third Intervention (84 Hours)||6
2319|NCT02862730|5160|P2|STARTED|Third Intervention (84 Hours)||1
2320|NCT02862730|5161|P1|STARTED|Third Intervention (84 Hours)||3
2321|NCT02862730|5155|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2322|NCT02862730|5156|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2323|NCT02862730|5157|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
2324|NCT02862730|5158|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2325|NCT02862730|5159|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
2326|NCT02862730|5160|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2327|NCT02862730|5161|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2328|NCT02862730|5155|P7|COMPLETED|Third Rest Period (7-45 Days)||1
2329|NCT02862730|5156|P6|COMPLETED|Third Rest Period (7-45 Days)||1
2330|NCT02862730|5157|P5|COMPLETED|Third Rest Period (7-45 Days)||4
2331|NCT02862730|5158|P4|COMPLETED|Third Rest Period (7-45 Days)||5
2332|NCT02862730|5159|P3|COMPLETED|Third Rest Period (7-45 Days)||6
2333|NCT02862730|5160|P2|COMPLETED|Third Rest Period (7-45 Days)||1
2334|NCT02862730|5161|P1|COMPLETED|Third Rest Period (7-45 Days)||3
2335|NCT02862730|5155|P7|STARTED|Third Rest Period (7-45 Days)||1
2336|NCT02862730|5156|P6|STARTED|Third Rest Period (7-45 Days)||1
2337|NCT02862730|5157|P5|STARTED|Third Rest Period (7-45 Days)||5
2338|NCT02862730|5158|P4|STARTED|Third Rest Period (7-45 Days)||5
2339|NCT02862730|5159|P3|STARTED|Third Rest Period (7-45 Days)||7
2340|NCT02862730|5160|P2|STARTED|Third Rest Period (7-45 Days)||1
2341|NCT02862730|5161|P1|STARTED|Third Rest Period (7-45 Days)||3
2342|NCT02862730|5155|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
2343|NCT02862730|5156|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
2344|NCT02862730|5157|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
2345|NCT02862730|5158|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
2346|NCT02862730|5159|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
2347|NCT02862730|5160|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
2348|NCT02862730|5161|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
2349|NCT02862730|5155|P7|COMPLETED|Second Intervention (84 Hours)||1
2350|NCT02862730|5156|P6|COMPLETED|Second Intervention (84 Hours)||1
2351|NCT02862730|5157|P5|COMPLETED|Second Intervention (84 Hours)||5
2352|NCT02862730|5158|P4|COMPLETED|Second Intervention (84 Hours)||5
2353|NCT02862730|5159|P3|COMPLETED|Second Intervention (84 Hours)||7
2354|NCT02862730|5160|P2|COMPLETED|Second Intervention (84 Hours)||1
2355|NCT02862730|5161|P1|COMPLETED|Second Intervention (84 Hours)||3
2356|NCT02862730|5155|P7|STARTED|Second Intervention (84 Hours)||1
2357|NCT02862730|5156|P6|STARTED|Second Intervention (84 Hours)||1
2358|NCT02862730|5157|P5|STARTED|Second Intervention (84 Hours)||5
2359|NCT02862730|5158|P4|STARTED|Second Intervention (84 Hours)||5
2360|NCT02862730|5159|P3|STARTED|Second Intervention (84 Hours)||7
2361|NCT02862730|5160|P2|STARTED|Second Intervention (84 Hours)||1
2362|NCT02862730|5161|P1|STARTED|Second Intervention (84 Hours)||4
2363|NCT02862730|5155|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2364|NCT02862730|5156|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2365|NCT02862730|5157|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2366|NCT02862730|5158|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2367|NCT02862730|5159|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2368|NCT02862730|5160|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2369|NCT02862730|5161|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2370|NCT02862730|5155|P7|COMPLETED|Second Rest Period (7-45 Days)||1
2371|NCT02862730|5156|P6|COMPLETED|Second Rest Period (7-45 Days)||1
2372|NCT02862730|5157|P5|COMPLETED|Second Rest Period (7-45 Days)||5
2373|NCT02862730|5158|P4|COMPLETED|Second Rest Period (7-45 Days)||5
2374|NCT02862730|5159|P3|COMPLETED|Second Rest Period (7-45 Days)||7
2375|NCT02862730|5160|P2|COMPLETED|Second Rest Period (7-45 Days)||1
2376|NCT02862730|5161|P1|COMPLETED|Second Rest Period (7-45 Days)||4
2377|NCT02862730|5155|P7|STARTED|Second Rest Period (7-45 Days)||1
2378|NCT02862730|5156|P6|STARTED|Second Rest Period (7-45 Days)||1
2379|NCT02862730|5157|P5|STARTED|Second Rest Period (7-45 Days)||5
2380|NCT02862730|5158|P4|STARTED|Second Rest Period (7-45 Days)||5
2381|NCT02862730|5159|P3|STARTED|Second Rest Period (7-45 Days)||7
2382|NCT02862730|5160|P2|STARTED|Second Rest Period (7-45 Days)||1
2383|NCT02862730|5161|P1|STARTED|Second Rest Period (7-45 Days)||4
2384|NCT02862730|5155|P7|NOT COMPLETED|First Intervention (84 Hours)||0
2385|NCT02862730|5156|P6|NOT COMPLETED|First Intervention (84 Hours)||0
2386|NCT02862730|5157|P5|NOT COMPLETED|First Intervention (84 Hours)||0
2387|NCT02862730|5158|P4|NOT COMPLETED|First Intervention (84 Hours)||0
2388|NCT02862730|5159|P3|NOT COMPLETED|First Intervention (84 Hours)||0
2389|NCT02862730|5160|P2|NOT COMPLETED|First Intervention (84 Hours)||0
2390|NCT02862730|5161|P1|NOT COMPLETED|First Intervention (84 Hours)||0
2391|NCT02862730|5155|P7|COMPLETED|First Intervention (84 Hours)||1
2392|NCT02862730|5156|P6|COMPLETED|First Intervention (84 Hours)||1
2393|NCT02862730|5157|P5|COMPLETED|First Intervention (84 Hours)||5
2394|NCT02862730|5158|P4|COMPLETED|First Intervention (84 Hours)||5
2395|NCT02862730|5159|P3|COMPLETED|First Intervention (84 Hours)||7
2396|NCT02862730|5160|P2|COMPLETED|First Intervention (84 Hours)||1
2397|NCT02862730|5161|P1|COMPLETED|First Intervention (84 Hours)||4
2398|NCT02862730|5155|P7|STARTED|First Intervention (84 Hours)||1
2399|NCT02862730|5156|P6|STARTED|First Intervention (84 Hours)||1
2400|NCT02862730|5157|P5|STARTED|First Intervention (84 Hours)||5
2401|NCT02862730|5158|P4|STARTED|First Intervention (84 Hours)||5
2402|NCT02862730|5159|P3|STARTED|First Intervention (84 Hours)||7
2403|NCT02862730|5160|P2|STARTED|First Intervention (84 Hours)||1
2404|NCT02862730|5161|P1|STARTED|First Intervention (84 Hours)||4
2405|NCT02862730|5155|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2406|NCT02862730|5156|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2407|NCT02862730|5157|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2408|NCT02862730|5158|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2409|NCT02862730|5159|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2410|NCT02862730|5160|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2411|NCT02862730|5161|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2412|NCT02862730|5155|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
2413|NCT02862730|5156|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
2414|NCT02862730|5157|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
2415|NCT02862730|5158|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
2416|NCT02862730|5159|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
2417|NCT02862730|5160|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
2418|NCT02862730|5161|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
2419|NCT02862730|5155|P7|STARTED|First Rest Period (1-12 Weeks)||1
2420|NCT02862730|5156|P6|STARTED|First Rest Period (1-12 Weeks)||1
2421|NCT02862730|5157|P5|STARTED|First Rest Period (1-12 Weeks)||5
2422|NCT02862730|5158|P4|STARTED|First Rest Period (1-12 Weeks)||5
2423|NCT02862730|5159|P3|STARTED|First Rest Period (1-12 Weeks)||7
2424|NCT02862730|5160|P2|STARTED|First Rest Period (1-12 Weeks)||1
2425|NCT02862730|5161|P1|STARTED|First Rest Period (1-12 Weeks)||4
2426|NCT02862730|5155|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2427|NCT02862730|5156|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2428|NCT02862730|5157|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2429|NCT02862730|5158|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2430|NCT02862730|5159|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
2431|NCT02862730|5160|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2432|NCT02862730|5161|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2433|NCT02862730|5155|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
2434|NCT02862730|5156|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
2435|NCT02862730|5157|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
2436|NCT02862730|5158|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
2437|NCT02862730|5159|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
2438|NCT02862730|5160|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
2439|NCT02862730|5161|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
2440|NCT02862730|5155|P7|STARTED|Tslim Training Visit (2 Weeks)||1
2441|NCT02862730|5156|P6|STARTED|Tslim Training Visit (2 Weeks)||1
2442|NCT02862730|5157|P5|STARTED|Tslim Training Visit (2 Weeks)||5
2443|NCT02862730|5158|P4|STARTED|Tslim Training Visit (2 Weeks)||5
2444|NCT02862730|5159|P3|STARTED|Tslim Training Visit (2 Weeks)||8
2445|NCT02862730|5160|P2|STARTED|Tslim Training Visit (2 Weeks)||1
2446|NCT02862730|5161|P1|STARTED|Tslim Training Visit (2 Weeks)||4
2447|NCT02862600|5216|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
2448|NCT02862600|5216|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
2449|NCT02862600|5216|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
2450|NCT02862600|5216|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
2451|NCT02862600|5216|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
2452|NCT02862600|5216|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
2453|NCT02862106|5229|P2|NOT COMPLETED|Overall Study||6
2454|NCT02862106|5230|P1|NOT COMPLETED|Overall Study||38
2455|NCT02862106|5229|P2|COMPLETED|Overall Study||20
2456|NCT02862106|5230|P1|COMPLETED|Overall Study||145
2457|NCT02862106|5229|P2|STARTED|Overall Study||26
2458|NCT02862106|5230|P1|STARTED|Overall Study||183
2459|NCT02856880|5288|P1|NOT COMPLETED|Overall Study||1
2460|NCT02856880|5288|P1|COMPLETED|Overall Study||44
2461|NCT02856880|5288|P1|Received SLS Negative Control|Overall Study||44
2462|NCT02856880|5288|P1|Received Non-SLS Negative Control|Overall Study||44
2463|NCT02856880|5288|P1|Received Positive Control|Overall Study||45
2464|NCT02856880|5288|P1|Received Test Zinc Non-IPMP|Overall Study||44
2465|NCT02856880|5288|P1|Received Test Zinc-IPMP|Overall Study||44
2466|NCT02856880|5288|P1|STARTED|Overall Study||45
2467|NCT02855411|5312|P1|NOT COMPLETED|Overall Study||35
2468|NCT02855411|5312|P1|COMPLETED|Overall Study||0
2469|NCT02855411|5312|P1|Assigned to Study Treatment|Overall Study||0
2470|NCT02855411|5312|P1|STARTED|Overall Study||35
2471|NCT02855086|5334|P2|NOT COMPLETED|Overall Study||0
2472|NCT02855086|5335|P1|NOT COMPLETED|Overall Study||0
2473|NCT02855086|5334|P2|COMPLETED|Overall Study||1
2474|NCT02855086|5335|P1|COMPLETED|Overall Study||2
2475|NCT02855086|5334|P2|STARTED|Overall Study||1
2476|NCT02855086|5335|P1|STARTED|Overall Study||2
2477|NCT02852434|5345|P2|NOT COMPLETED|Overall Study||1
2478|NCT02852434|5346|P1|NOT COMPLETED|Overall Study||2
2479|NCT02852434|5345|P2|COMPLETED|Overall Study||35
2480|NCT02852434|5346|P1|COMPLETED|Overall Study||34
2481|NCT02852434|5345|P2|STARTED|Overall Study||36
2482|NCT02852434|5346|P1|STARTED|Overall Study||36
2483|NCT02851823|5360|P1|NOT COMPLETED|Overall Study||0
2484|NCT02851823|5360|P1|COMPLETED|Overall Study||25
2485|NCT02851823|5360|P1|3 Months|Overall Study||25
2486|NCT02851823|5360|P1|1 Month|Overall Study||25
2487|NCT02851823|5360|P1|STARTED|Overall Study||25
2488|NCT02850159|5370|P2|NOT COMPLETED|Overall Study||0
2489|NCT02850159|5371|P1|NOT COMPLETED|Overall Study||0
2490|NCT02850159|5370|P2|COMPLETED|Overall Study||16
2491|NCT02850159|5371|P1|COMPLETED|Overall Study||16
2492|NCT02850159|5370|P2|STARTED|Overall Study||16
2493|NCT02850159|5371|P1|STARTED|Overall Study||16
2494|NCT02849678|5379|P2|NOT COMPLETED|Overall Study||6
2495|NCT02849678|5380|P1|NOT COMPLETED|Overall Study||3
2496|NCT02849678|5379|P2|COMPLETED|Overall Study||18
2497|NCT02849678|5380|P1|COMPLETED|Overall Study||17
2498|NCT02849678|5379|P2|STARTED|Overall Study||24
2499|NCT02849678|5380|P1|STARTED|Overall Study||20
2500|NCT02848222|5401|P3|NOT COMPLETED|Overall Study||0
2501|NCT02848222|5402|P2|NOT COMPLETED|Overall Study||1
2502|NCT02848222|5403|P1|NOT COMPLETED|Overall Study||7
2503|NCT02848222|5401|P3|COMPLETED|Overall Study||17
2504|NCT02848222|5402|P2|COMPLETED|Overall Study||17
2505|NCT02848222|5403|P1|COMPLETED|Overall Study||18
2506|NCT02848222|5401|P3|STARTED|Overall Study||17
2507|NCT02848222|5402|P2|STARTED|Overall Study||18
2508|NCT02848222|5403|P1|STARTED|Overall Study||25
2509|NCT02847260|5411|P1|NOT COMPLETED|Overall Study||7
2510|NCT02847260|5411|P1|COMPLETED|Overall Study||32
2511|NCT02847260|5411|P1|STARTED|Overall Study||39
2512|NCT02847169|5423|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2513|NCT02847169|5424|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2514|NCT02847169|5423|P2|COMPLETED|Second Intervention (1 Week)||15
2515|NCT02847169|5424|P1|COMPLETED|Second Intervention (1 Week)||15
2516|NCT02847169|5423|P2|STARTED|Second Intervention (1 Week)||15
2517|NCT02847169|5424|P1|STARTED|Second Intervention (1 Week)||15
2518|NCT02847169|5423|P2|NOT COMPLETED|First Intervention (1 Week)||0
2519|NCT02847169|5424|P1|NOT COMPLETED|First Intervention (1 Week)||0
2520|NCT02847169|5423|P2|COMPLETED|First Intervention (1 Week)||15
2521|NCT02847169|5424|P1|COMPLETED|First Intervention (1 Week)||15
2522|NCT02847169|5423|P2|STARTED|First Intervention (1 Week)||15
2523|NCT02847169|5424|P1|STARTED|First Intervention (1 Week)||15
2524|NCT02844998|5461|P3|NOT COMPLETED|Overall Study||4
2525|NCT02844998|5462|P2|NOT COMPLETED|Overall Study||4
2526|NCT02844998|5463|P1|NOT COMPLETED|Overall Study||7
2527|NCT02844998|5461|P3|COMPLETED|Overall Study||35
2528|NCT02844998|5462|P2|COMPLETED|Overall Study||35
2529|NCT02844998|5463|P1|COMPLETED|Overall Study||35
2530|NCT02844998|5461|P3|STARTED|Overall Study||39
2531|NCT02844998|5462|P2|STARTED|Overall Study||39
2532|NCT02844998|5463|P1|STARTED|Overall Study||42
2533|NCT02844543|5474|P1|NOT COMPLETED|Overall Study||5
2534|NCT02844543|5474|P1|COMPLETED|Overall Study||150
2535|NCT02844543|5474|P1|STARTED|Overall Study||155
2536|NCT02840916|5483|P2|NOT COMPLETED|Overall Study||3
2537|NCT02840916|5484|P1|NOT COMPLETED|Overall Study||1
2538|NCT02840916|5483|P2|COMPLETED|Overall Study||30
2539|NCT02840916|5484|P1|COMPLETED|Overall Study||32
2540|NCT02840916|5483|P2|STARTED|Overall Study||33
2541|NCT02840916|5484|P1|STARTED|Overall Study||33
2542|NCT02839772|5496|P2|NOT COMPLETED|Overall Study||0
2543|NCT02839772|5497|P1|NOT COMPLETED|Overall Study||1
2544|NCT02839772|5496|P2|COMPLETED|Overall Study||96
2640|NCT02826551|5730|P1|STARTED|Overall Study||11
2545|NCT02839772|5497|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
2546|NCT02839772|5496|P2|STARTED|Overall Study||96
2547|NCT02839772|5497|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
2548|NCT02838901|5536|P2|NOT COMPLETED|Overall Study||2
2549|NCT02838901|5537|P1|NOT COMPLETED|Overall Study||2
2550|NCT02838901|5536|P2|COMPLETED|Overall Study||7
2551|NCT02838901|5537|P1|COMPLETED|Overall Study||7
2552|NCT02838901|5536|P2|STARTED|Overall Study||9
2553|NCT02838901|5537|P1|STARTED|Overall Study||9
2554|NCT02837952|5567|P2|NOT COMPLETED|Overall Study||6
2555|NCT02837952|5568|P1|NOT COMPLETED|Overall Study||5
2556|NCT02837952|5567|P2|COMPLETED|Overall Study||76
2557|NCT02837952|5568|P1|COMPLETED|Overall Study||36
2558|NCT02837952|5567|P2|STARTED|Overall Study||82
2559|NCT02837952|5568|P1|STARTED|Overall Study||41
2560|NCT02836249|5582|P2|NOT COMPLETED|Overall Study||58
2561|NCT02836249|5583|P1|NOT COMPLETED|Overall Study||123
2562|NCT02836249|5582|P2|COMPLETED|Overall Study||0
2563|NCT02836249|5583|P1|COMPLETED|Overall Study||0
2564|NCT02836249|5582|P2|STARTED|Overall Study||58
2565|NCT02836249|5583|P1|STARTED|Overall Study||123
2566|NCT02836236|5601|P2|NOT COMPLETED|Overall Study||50
2567|NCT02836236|5602|P1|NOT COMPLETED|Overall Study||105
2568|NCT02836236|5601|P2|COMPLETED|Overall Study||0
2569|NCT02836236|5602|P1|COMPLETED|Overall Study||0
2570|NCT02836236|5601|P2|STARTED|Overall Study||50
2571|NCT02836236|5602|P1|STARTED|Overall Study||105
2572|NCT02834624|5618|P2|NOT COMPLETED|Overall Study||0
2573|NCT02834624|5619|P1|NOT COMPLETED|Overall Study||0
2574|NCT02834624|5618|P2|COMPLETED|Overall Study||15
2575|NCT02834624|5619|P1|COMPLETED|Overall Study||15
2576|NCT02834624|5618|P2|STARTED|Overall Study||15
2577|NCT02834624|5619|P1|STARTED|Overall Study||15
2578|NCT02832674|5629|P1|NOT COMPLETED|Overall Study||5
2579|NCT02832674|5629|P1|COMPLETED|Overall Study||67
2580|NCT02832674|5629|P1|STARTED|Overall Study||72
2581|NCT02832375|5640|P2|NOT COMPLETED|Overall Study||0
2582|NCT02832375|5641|P1|NOT COMPLETED|Overall Study||2
2583|NCT02832375|5640|P2|COMPLETED|Overall Study||121
2584|NCT02832375|5641|P1|COMPLETED|Overall Study||119
2585|NCT02832375|5640|P2|STARTED|Overall Study||121
2586|NCT02832375|5641|P1|STARTED|Overall Study||121
2587|NCT02831660|5651|P1|NOT COMPLETED|Overall Study||0
2588|NCT02831660|5651|P1|COMPLETED|Overall Study||1
2589|NCT02831660|5651|P1|STARTED|Overall Study||1
2590|NCT02829996|5660|P5|NOT COMPLETED|Overall Study||0
2591|NCT02829996|5661|P4|NOT COMPLETED|Overall Study||0
2592|NCT02829996|5662|P3|NOT COMPLETED|Overall Study||0
2593|NCT02829996|5663|P2|NOT COMPLETED|Overall Study||0
2594|NCT02829996|5664|P1|NOT COMPLETED|Overall Study||1
2595|NCT02829996|5660|P5|COMPLETED|Overall Study||42
2596|NCT02829996|5661|P4|COMPLETED|Overall Study||41
2597|NCT02829996|5662|P3|COMPLETED|Overall Study||40
2598|NCT02829996|5663|P2|COMPLETED|Overall Study||39
2599|NCT02829996|5664|P1|COMPLETED|Overall Study||38
2600|NCT02829996|5660|P5|STARTED|Overall Study||42
2601|NCT02829996|5661|P4|STARTED|Overall Study||41
2602|NCT02829996|5662|P3|STARTED|Overall Study||40
2603|NCT02829996|5663|P2|STARTED|Overall Study||39
2604|NCT02829996|5664|P1|STARTED|Overall Study||39
2605|NCT02829983|5678|P2|NOT COMPLETED|Overall Study||0
2606|NCT02829983|5679|P1|NOT COMPLETED|Overall Study||0
2607|NCT02829983|5678|P2|COMPLETED|Overall Study||20
2608|NCT02829983|5679|P1|COMPLETED|Overall Study||20
2609|NCT02829983|5678|P2|STARTED|Overall Study||20
2610|NCT02829983|5679|P1|STARTED|Overall Study||20
2611|NCT02829775|5687|P1|NOT COMPLETED|Overall Study||5
2612|NCT02829775|5687|P1|COMPLETED|Overall Study||4
2613|NCT02829775|5687|P1|STARTED|Overall Study||9
2614|NCT02829463|5694|P2|NOT COMPLETED|Overall Study||0
2615|NCT02829463|5695|P1|NOT COMPLETED|Overall Study||0
2616|NCT02829463|5694|P2|COMPLETED|Overall Study||62
2617|NCT02829463|5695|P1|COMPLETED|Overall Study||59
2618|NCT02829463|5694|P2|STARTED|Overall Study||62
2619|NCT02829463|5695|P1|STARTED|Overall Study||59
2620|NCT02829138|5703|P2|NOT COMPLETED|Overall Study||0
2621|NCT02829138|5704|P1|NOT COMPLETED|Overall Study||1
2622|NCT02829138|5703|P2|COMPLETED|Overall Study||28
2623|NCT02829138|5704|P1|COMPLETED|Overall Study||28
2624|NCT02829138|5703|P2|STARTED|Overall Study||28
2625|NCT02829138|5704|P1|STARTED|Overall Study||29
2626|NCT02828137|5717|P3|NOT COMPLETED|Overall Study||0
2627|NCT02828137|5718|P2|NOT COMPLETED|Overall Study||0
2628|NCT02828137|5719|P1|NOT COMPLETED|Overall Study||0
2629|NCT02828137|5717|P3|COMPLETED|Overall Study||41
2630|NCT02828137|5718|P2|COMPLETED|Overall Study||41
2631|NCT02828137|5719|P1|COMPLETED|Overall Study||41
2632|NCT02828137|5717|P3|STARTED|Overall Study||41
2633|NCT02828137|5718|P2|STARTED|Overall Study||41
2634|NCT02828137|5719|P1|STARTED|Overall Study||41
2635|NCT02826551|5729|P2|NOT COMPLETED|Overall Study||0
2636|NCT02826551|5730|P1|NOT COMPLETED|Overall Study||0
2637|NCT02826551|5729|P2|COMPLETED|Overall Study||12
2638|NCT02826551|5730|P1|COMPLETED|Overall Study||11
2639|NCT02826551|5729|P2|STARTED|Overall Study||12
2641|NCT02826421|5740|P4|NOT COMPLETED|Overall Study||2
2642|NCT02826421|5741|P3|NOT COMPLETED|Overall Study||2
2643|NCT02826421|5742|P2|NOT COMPLETED|Overall Study||3
2644|NCT02826421|5743|P1|NOT COMPLETED|Overall Study||3
2645|NCT02826421|5740|P4|COMPLETED|Overall Study||28
2646|NCT02826421|5741|P3|COMPLETED|Overall Study||26
2647|NCT02826421|5742|P2|COMPLETED|Overall Study||26
2648|NCT02826421|5743|P1|COMPLETED|Overall Study||19
2649|NCT02826421|5740|P4|Treated|Overall Study||28
2650|NCT02826421|5741|P3|Treated|Overall Study||26
2651|NCT02826421|5742|P2|Treated|Overall Study||26
2652|NCT02826421|5743|P1|Treated|Overall Study||19
2653|NCT02826421|5740|P4|STARTED|Overall Study||30
2654|NCT02826421|5741|P3|STARTED|Overall Study||28
2655|NCT02826421|5742|P2|STARTED|Overall Study||29
2656|NCT02826421|5743|P1|STARTED|Overall Study||22
2657|NCT02824913|5757|P2|NOT COMPLETED|Second Intervention(1 Day)||0
2658|NCT02824913|5758|P1|NOT COMPLETED|Second Intervention(1 Day)||0
2659|NCT02824913|5757|P2|COMPLETED|Second Intervention(1 Day)||0
2660|NCT02824913|5758|P1|COMPLETED|Second Intervention(1 Day)||1
2661|NCT02824913|5757|P2|STARTED|Second Intervention(1 Day)||0
2662|NCT02824913|5758|P1|STARTED|Second Intervention(1 Day)||1
2663|NCT02824913|5757|P2|NOT COMPLETED|Washout (7-14 Days)||0
2664|NCT02824913|5758|P1|NOT COMPLETED|Washout (7-14 Days)||0
2665|NCT02824913|5757|P2|COMPLETED|Washout (7-14 Days)||0
2666|NCT02824913|5758|P1|COMPLETED|Washout (7-14 Days)||1
2667|NCT02824913|5757|P2|STARTED|Washout (7-14 Days)||0
2668|NCT02824913|5758|P1|STARTED|Washout (7-14 Days)||1
2669|NCT02824913|5757|P2|NOT COMPLETED|First Intervention (1 Day)||0
2670|NCT02824913|5758|P1|NOT COMPLETED|First Intervention (1 Day)||0
2671|NCT02824913|5757|P2|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|0
2672|NCT02824913|5758|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
2673|NCT02824913|5757|P2|STARTED|First Intervention (1 Day)||0
2674|NCT02824913|5758|P1|STARTED|First Intervention (1 Day)||1
2675|NCT02823964|5768|P1|NOT COMPLETED|Overall Study||5
2676|NCT02823964|5768|P1|COMPLETED|Overall Study||20
2677|NCT02823964|5768|P1|STARTED|Overall Study||25
2678|NCT02823080|5774|P2|NOT COMPLETED|Overall Study||0
2679|NCT02823080|5775|P1|NOT COMPLETED|Overall Study||0
2680|NCT02823080|5774|P2|COMPLETED|Overall Study||24
2681|NCT02823080|5775|P1|COMPLETED|Overall Study||24
2682|NCT02823080|5774|P2|STARTED|Overall Study||24
2683|NCT02823080|5775|P1|STARTED|Overall Study||24
2684|NCT02822885|5793|P1|NOT COMPLETED|Overall Study||0
2685|NCT02822885|5793|P1|COMPLETED|Overall Study||70
2686|NCT02822885|5793|P1|STARTED|Overall Study||70
2687|NCT02822287|5801|P1|NOT COMPLETED|Overall Study||0
2688|NCT02822287|5801|P1|COMPLETED|Overall Study||57
2689|NCT02822287|5801|P1|STARTED|Overall Study||57
2690|NCT02821403|5813|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
2691|NCT02821403|5814|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
2692|NCT02821403|5813|P2|COMPLETED|"Third Intervention (1 Month)"||40
2693|NCT02821403|5814|P1|COMPLETED|"Third Intervention (1 Month)"||40
2694|NCT02821403|5813|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
2695|NCT02821403|5814|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
2696|NCT02821403|5813|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
2697|NCT02821403|5814|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
2698|NCT02821403|5813|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
2699|NCT02821403|5814|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
2700|NCT02821403|5813|P2|STARTED|"Third Intervention (1 Month)"||40
2701|NCT02821403|5814|P1|STARTED|"Third Intervention (1 Month)"||40
2702|NCT02821403|5813|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
2703|NCT02821403|5814|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
2704|NCT02821403|5813|P2|COMPLETED|"Second Intervention (1 Month)"||40
2705|NCT02821403|5814|P1|COMPLETED|"Second Intervention (1 Month)"||40
2706|NCT02821403|5813|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
2707|NCT02821403|5814|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
2708|NCT02821403|5813|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
2709|NCT02821403|5814|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
2710|NCT02821403|5813|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
2711|NCT02821403|5814|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
2712|NCT02821403|5813|P2|STARTED|"Second Intervention (1 Month)"||40
2713|NCT02821403|5814|P1|STARTED|"Second Intervention (1 Month)"||40
2714|NCT02821403|5813|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
2715|NCT02821403|5814|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
2716|NCT02821403|5813|P2|COMPLETED|"First Intervention (1 Month)"||40
2717|NCT02821403|5814|P1|COMPLETED|"First Intervention (1 Month)"||40
2718|NCT02821403|5813|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
2719|NCT02821403|5814|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
2720|NCT02821403|5813|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
2721|NCT02821403|5814|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
2722|NCT02821403|5813|P2|Used Clear Lens|"First Intervention (1 Month)"||13
2723|NCT02821403|5814|P1|Used Clear Lens|"First Intervention (1 Month)"||13
2724|NCT02821403|5813|P2|STARTED|"First Intervention (1 Month)"||40
2725|NCT02821403|5814|P1|STARTED|"First Intervention (1 Month)"||40
2726|NCT02818244|5836|P4|NOT COMPLETED|Overall Study||0
2727|NCT02818244|5837|P3|NOT COMPLETED|Overall Study||0
2728|NCT02818244|5838|P2|NOT COMPLETED|Overall Study||0
2729|NCT02818244|5839|P1|NOT COMPLETED|Overall Study||0
2730|NCT02818244|5836|P4|COMPLETED|Overall Study||25
2731|NCT02818244|5837|P3|COMPLETED|Overall Study||25
2732|NCT02818244|5838|P2|COMPLETED|Overall Study||25
2733|NCT02818244|5839|P1|COMPLETED|Overall Study||25
2734|NCT02818244|5836|P4|STARTED|Overall Study||25
2735|NCT02818244|5837|P3|STARTED|Overall Study||25
2736|NCT02818244|5838|P2|STARTED|Overall Study||25
2737|NCT02818244|5839|P1|STARTED|Overall Study||25
2738|NCT02817763|5851|P2|NOT COMPLETED|Overall Study||0
2739|NCT02817763|5852|P1|NOT COMPLETED|Overall Study||0
2740|NCT02817763|5851|P2|COMPLETED|Overall Study||20
2741|NCT02817763|5852|P1|COMPLETED|Overall Study||20
2742|NCT02817763|5851|P2|STARTED|Overall Study||20
2743|NCT02817763|5852|P1|STARTED|Overall Study||20
2744|NCT02815735|5860|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2745|NCT02815735|5861|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
2746|NCT02815735|5860|P2|COMPLETED|Second Intervention (4 Weeks)||37
2747|NCT02815735|5861|P1|COMPLETED|Second Intervention (4 Weeks)||33
2748|NCT02815735|5860|P2|STARTED|Second Intervention (4 Weeks)||37
2749|NCT02815735|5861|P1|STARTED|Second Intervention (4 Weeks)||34
2750|NCT02815735|5860|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
2751|NCT02815735|5861|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
2752|NCT02815735|5860|P2|COMPLETED|First Intervention (4 Weeks)||37
2753|NCT02815735|5861|P1|COMPLETED|First Intervention (4 Weeks)||34
2754|NCT02815735|5860|P2|STARTED|First Intervention (4 Weeks)||38
2755|NCT02815735|5861|P1|STARTED|First Intervention (4 Weeks)||36
2756|NCT02815397|5876|P1|NOT COMPLETED|Overall Study||2
2757|NCT02815397|5876|P1|COMPLETED|Overall Study||0
2758|NCT02815397|5876|P1|STARTED|Overall Study||2
2759|NCT02814643|5885|P2|NOT COMPLETED|Overall Study||3
2760|NCT02814643|5886|P1|NOT COMPLETED|Overall Study||1
2761|NCT02814643|5885|P2|COMPLETED|Overall Study||49
2762|NCT02814643|5886|P1|COMPLETED|Overall Study||50
2763|NCT02814643|5885|P2|STARTED|Overall Study||52
2764|NCT02814643|5886|P1|STARTED|Overall Study||51
2765|NCT02814279|5910|P2|NOT COMPLETED|Overall Study||0
2766|NCT02814279|5911|P1|NOT COMPLETED|Overall Study||0
2767|NCT02814279|5910|P2|COMPLETED|Overall Study||21
2768|NCT02814279|5911|P1|COMPLETED|Overall Study||21
2769|NCT02814279|5910|P2|STARTED|Overall Study||21
2770|NCT02814279|5911|P1|STARTED|Overall Study||21
2771|NCT02814227|5919|P1|NOT COMPLETED|Overall Study||0
2772|NCT02814227|5919|P1|COMPLETED|Overall Study||52
2773|NCT02814227|5919|P1|STARTED|Overall Study||52
2774|NCT02813070|5929|P3|NOT COMPLETED|Overall Study||11
2775|NCT02813070|5930|P2|NOT COMPLETED|Overall Study||3
2776|NCT02813070|5931|P1|NOT COMPLETED|Overall Study||3
2777|NCT02813070|5929|P3|COMPLETED|Overall Study||25
2778|NCT02813070|5930|P2|COMPLETED|Overall Study||20
2779|NCT02813070|5931|P1|COMPLETED|Overall Study||25
2780|NCT02813070|5929|P3|Treated (Safety Population)|Overall Study||25
2781|NCT02813070|5930|P2|Treated (Safety Population)|Overall Study||20
2782|NCT02813070|5931|P1|Treated (Safety Population)|Overall Study||25
2783|NCT02813070|5929|P3|STARTED|Overall Study||36
2784|NCT02813070|5930|P2|STARTED|Overall Study||23
2785|NCT02813070|5931|P1|STARTED|Overall Study||28
2786|NCT02811965|5940|P1|NOT COMPLETED|Overall Study||0
2787|NCT02811965|5940|P1|COMPLETED|Overall Study||21
2788|NCT02811965|5940|P1|STARTED|Overall Study||21
2789|NCT02810873|5965|P2|NOT COMPLETED|Overall Study||0
2790|NCT02810873|5966|P1|NOT COMPLETED|Overall Study||0
2791|NCT02810873|5965|P2|COMPLETED|Overall Study||13
2792|NCT02810873|5966|P1|COMPLETED|Overall Study||6
2793|NCT02810873|5965|P2|STARTED|Overall Study||13
2794|NCT02810873|5966|P1|STARTED|Overall Study||6
2795|NCT02809911|5976|P2|NOT COMPLETED|Overall Study||0
2796|NCT02809911|5977|P1|NOT COMPLETED|Overall Study||0
2797|NCT02809911|5976|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
2798|NCT02809911|5977|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
2799|NCT02809911|5976|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
2800|NCT02809911|5977|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
2801|NCT02809833|5985|P1|NOT COMPLETED|Overall Study||300
2802|NCT02809833|5985|P1|COMPLETED|Overall Study||550
2803|NCT02809833|5985|P1|STARTED|Overall Study||850
2804|NCT02808130|6065|P6|NOT COMPLETED|Overall Study||0
2805|NCT02808130|6066|P5|NOT COMPLETED|Overall Study||0
2806|NCT02808130|6067|P4|NOT COMPLETED|Overall Study||0
2807|NCT02808130|6068|P3|NOT COMPLETED|Overall Study||0
2808|NCT02808130|6069|P2|NOT COMPLETED|Overall Study||0
2809|NCT02808130|6070|P1|NOT COMPLETED|Overall Study||0
2810|NCT02808130|6065|P6|COMPLETED|Overall Study||15
2811|NCT02808130|6066|P5|COMPLETED|Overall Study||15
2812|NCT02808130|6067|P4|COMPLETED|Overall Study||15
2813|NCT02808130|6068|P3|COMPLETED|Overall Study||15
2814|NCT02808130|6069|P2|COMPLETED|Overall Study||15
2815|NCT02808130|6070|P1|COMPLETED|Overall Study||15
2816|NCT02808130|6065|P6|STARTED|Overall Study||15
2817|NCT02808130|6066|P5|STARTED|Overall Study||15
2818|NCT02808130|6067|P4|STARTED|Overall Study||15
2819|NCT02808130|6068|P3|STARTED|Overall Study||15
2820|NCT02808130|6069|P2|STARTED|Overall Study||15
2821|NCT02808130|6070|P1|STARTED|Overall Study||15
2822|NCT02806869|6098|P2|NOT COMPLETED|Second Intervention (1 Day)||2
2823|NCT02806869|6099|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2824|NCT02806869|6098|P2|COMPLETED|Second Intervention (1 Day)||5
2825|NCT02806869|6099|P1|COMPLETED|Second Intervention (1 Day)||7
2826|NCT02806869|6098|P2|STARTED|Second Intervention (1 Day)||7
2827|NCT02806869|6099|P1|STARTED|Second Intervention (1 Day)||7
2828|NCT02806869|6098|P2|NOT COMPLETED|Washout (7 Days)||0
2829|NCT02806869|6099|P1|NOT COMPLETED|Washout (7 Days)||0
2830|NCT02806869|6098|P2|COMPLETED|Washout (7 Days)||7
2831|NCT02806869|6099|P1|COMPLETED|Washout (7 Days)||7
2832|NCT02806869|6098|P2|STARTED|Washout (7 Days)||7
2833|NCT02806869|6099|P1|STARTED|Washout (7 Days)||7
2834|NCT02806869|6098|P2|NOT COMPLETED|First Intervention (1 Day)||12
2835|NCT02806869|6099|P1|NOT COMPLETED|First Intervention (1 Day)||11
2836|NCT02806869|6098|P2|COMPLETED|First Intervention (1 Day)||12
2837|NCT02806869|6099|P1|COMPLETED|First Intervention (1 Day)||13
2838|NCT02806869|6098|P2|STARTED|First Intervention (1 Day)||24
2839|NCT02806869|6099|P1|STARTED|First Intervention (1 Day)||24
2840|NCT02806544|6109|P1|NOT COMPLETED|Overall Study||4
2841|NCT02806544|6109|P1|COMPLETED|Overall Study||31
2842|NCT02806544|6109|P1|STARTED|Overall Study||35
2843|NCT02806505|6120|P2|NOT COMPLETED|Overall Study||11
2844|NCT02806505|6121|P1|NOT COMPLETED|Overall Study||10
2845|NCT02806505|6120|P2|COMPLETED|Overall Study||32
2846|NCT02806505|6121|P1|COMPLETED|Overall Study||28
2847|NCT02806505|6120|P2|STARTED|Overall Study||43
2848|NCT02806505|6121|P1|STARTED|Overall Study||38
2849|NCT02805907|6133|P2|NOT COMPLETED|Overall Study||3
2850|NCT02805907|6134|P1|NOT COMPLETED|Overall Study||3
2851|NCT02805907|6133|P2|COMPLETED|Overall Study||53
2852|NCT02805907|6134|P1|COMPLETED|Overall Study||53
2853|NCT02805907|6133|P2|STARTED|Overall Study||56
2854|NCT02805907|6134|P1|STARTED|Overall Study||56
2855|NCT02802878|6148|P2|NOT COMPLETED|Overall Study||3
2856|NCT02802878|6149|P1|NOT COMPLETED|Overall Study||4
2857|NCT02802878|6148|P2|COMPLETED|Overall Study||18
2858|NCT02802878|6149|P1|COMPLETED|Overall Study||17
2859|NCT02802878|6148|P2|STARTED|Overall Study||21
2860|NCT02802878|6149|P1|STARTED|Overall Study||21
2861|NCT02802592|6163|P1|NOT COMPLETED|Overall Study||4
2862|NCT02802592|6163|P1|COMPLETED|Overall Study||0
2863|NCT02802592|6163|P1|STARTED|Overall Study||4
2864|NCT02802449|6174|P2|NOT COMPLETED|Overall Study||17
2865|NCT02802449|6175|P1|NOT COMPLETED|Overall Study||9
2866|NCT02802449|6174|P2|COMPLETED|Overall Study||202
2867|NCT02802449|6175|P1|COMPLETED|Overall Study||102
2868|NCT02802449|6174|P2|STARTED|Overall Study||219
2869|NCT02802449|6175|P1|STARTED|Overall Study||111
2870|NCT02801396|6191|P6|NOT COMPLETED|Period 3||0
2871|NCT02801396|6192|P5|NOT COMPLETED|Period 3||0
2872|NCT02801396|6193|P4|NOT COMPLETED|Period 3||0
2873|NCT02801396|6194|P3|NOT COMPLETED|Period 3||0
2874|NCT02801396|6195|P2|NOT COMPLETED|Period 3||0
2875|NCT02801396|6196|P1|NOT COMPLETED|Period 3||0
2876|NCT02801396|6191|P6|COMPLETED|Period 3||17
2877|NCT02801396|6192|P5|COMPLETED|Period 3||16
2878|NCT02801396|6193|P4|COMPLETED|Period 3||16
2879|NCT02801396|6194|P3|COMPLETED|Period 3||17
2880|NCT02801396|6195|P2|COMPLETED|Period 3||17
2881|NCT02801396|6196|P1|COMPLETED|Period 3||17
2882|NCT02801396|6191|P6|STARTED|Period 3||17
2883|NCT02801396|6192|P5|STARTED|Period 3||16
2884|NCT02801396|6193|P4|STARTED|Period 3||16
2885|NCT02801396|6194|P3|STARTED|Period 3||17
2886|NCT02801396|6195|P2|STARTED|Period 3||17
2887|NCT02801396|6196|P1|STARTED|Period 3||17
2888|NCT02801396|6191|P6|NOT COMPLETED|Period 2||0
2889|NCT02801396|6192|P5|NOT COMPLETED|Period 2||0
2890|NCT02801396|6193|P4|NOT COMPLETED|Period 2||0
2891|NCT02801396|6194|P3|NOT COMPLETED|Period 2||0
2892|NCT02801396|6195|P2|NOT COMPLETED|Period 2||0
2893|NCT02801396|6196|P1|NOT COMPLETED|Period 2||0
2894|NCT02801396|6191|P6|COMPLETED|Period 2||17
2895|NCT02801396|6192|P5|COMPLETED|Period 2||16
2896|NCT02801396|6193|P4|COMPLETED|Period 2||16
2897|NCT02801396|6194|P3|COMPLETED|Period 2||17
2898|NCT02801396|6195|P2|COMPLETED|Period 2||17
2899|NCT02801396|6196|P1|COMPLETED|Period 2||17
2900|NCT02801396|6191|P6|STARTED|Period 2||17
2901|NCT02801396|6192|P5|STARTED|Period 2||16
2902|NCT02801396|6193|P4|STARTED|Period 2||16
2903|NCT02801396|6194|P3|STARTED|Period 2||17
2904|NCT02801396|6195|P2|STARTED|Period 2||17
2905|NCT02801396|6196|P1|STARTED|Period 2||17
2906|NCT02801396|6191|P6|NOT COMPLETED|Period 1||0
2907|NCT02801396|6192|P5|NOT COMPLETED|Period 1||1
2908|NCT02801396|6193|P4|NOT COMPLETED|Period 1||0
2909|NCT02801396|6194|P3|NOT COMPLETED|Period 1||0
2910|NCT02801396|6195|P2|NOT COMPLETED|Period 1||0
2911|NCT02801396|6196|P1|NOT COMPLETED|Period 1||0
2912|NCT02801396|6191|P6|COMPLETED|Period 1||17
2913|NCT02801396|6192|P5|COMPLETED|Period 1||16
2914|NCT02801396|6193|P4|COMPLETED|Period 1||16
2915|NCT02801396|6194|P3|COMPLETED|Period 1||17
2916|NCT02801396|6195|P2|COMPLETED|Period 1||17
2917|NCT02801396|6196|P1|COMPLETED|Period 1||17
2918|NCT02801396|6191|P6|STARTED|Period 1||17
2919|NCT02801396|6192|P5|STARTED|Period 1||17
2920|NCT02801396|6193|P4|STARTED|Period 1||16
2921|NCT02801396|6194|P3|STARTED|Period 1||17
2922|NCT02801396|6195|P2|STARTED|Period 1||17
2923|NCT02801396|6196|P1|STARTED|Period 1||17
2924|NCT02801006|6213|P2|NOT COMPLETED|Lens 2||0
2925|NCT02801006|6214|P1|NOT COMPLETED|Lens 2||0
2926|NCT02801006|6213|P2|COMPLETED|Lens 2||19
2927|NCT02801006|6214|P1|COMPLETED|Lens 2||22
2928|NCT02801006|6213|P2|STARTED|Lens 2||19
2929|NCT02801006|6214|P1|STARTED|Lens 2||22
2930|NCT02801006|6213|P2|NOT COMPLETED|Lens 1||0
2931|NCT02801006|6214|P1|NOT COMPLETED|Lens 1||0
2932|NCT02801006|6213|P2|COMPLETED|Lens 1||19
2933|NCT02801006|6214|P1|COMPLETED|Lens 1||22
2934|NCT02801006|6213|P2|STARTED|Lens 1||19
2935|NCT02801006|6214|P1|STARTED|Lens 1||22
2936|NCT02800213|6232|P2|NOT COMPLETED|Second Intervention||0
2937|NCT02800213|6233|P1|NOT COMPLETED|Second Intervention||0
2938|NCT02800213|6232|P2|COMPLETED|Second Intervention||35
2939|NCT02800213|6233|P1|COMPLETED|Second Intervention||35
2940|NCT02800213|6232|P2|STARTED|Second Intervention||35
2941|NCT02800213|6233|P1|STARTED|Second Intervention||35
2942|NCT02800213|6232|P2|NOT COMPLETED|First Intervention||0
2943|NCT02800213|6233|P1|NOT COMPLETED|First Intervention||0
2944|NCT02800213|6232|P2|COMPLETED|First Intervention||35
2945|NCT02800213|6233|P1|COMPLETED|First Intervention||35
2946|NCT02800213|6232|P2|STARTED|First Intervention||35
2947|NCT02800213|6233|P1|STARTED|First Intervention||35
2948|NCT02799082|6241|P2|NOT COMPLETED|Overall Study||4
2949|NCT02799082|6242|P1|NOT COMPLETED|Overall Study||4
2950|NCT02799082|6241|P2|COMPLETED|Overall Study||77
2951|NCT02799082|6242|P1|COMPLETED|Overall Study||37
2952|NCT02799082|6241|P2|STARTED|Overall Study||81
2953|NCT02799082|6242|P1|STARTED|Overall Study||41
2954|NCT02799069|6279|P3|NOT COMPLETED|Overall Study||7
2955|NCT02799069|6280|P2|NOT COMPLETED|Overall Study||7
2956|NCT02799069|6281|P1|NOT COMPLETED|Overall Study||8
2957|NCT02799069|6279|P3|COMPLETED|Overall Study||240
2958|NCT02799069|6280|P2|COMPLETED|Overall Study||241
2959|NCT02799069|6281|P1|COMPLETED|Overall Study||68
2960|NCT02799069|6279|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
2961|NCT02799069|6280|P2|ITT/Safety|Overall Study||248
2962|NCT02799069|6281|P1|ITT/Safety|Overall Study||76
2963|NCT02799069|6279|P3|STARTED|Overall Study||247
2964|NCT02799069|6280|P2|STARTED|Overall Study||248
2965|NCT02799069|6281|P1|STARTED|Overall Study||76
2966|NCT02798289|6391|P1|NOT COMPLETED|Overall Study||0
2967|NCT02798289|6391|P1|COMPLETED|Overall Study||55
2968|NCT02798289|6391|P1|STARTED|Overall Study||55
2969|NCT02797080|6395|P1|NOT COMPLETED|Overall Study||2
2970|NCT02797080|6395|P1|COMPLETED|Overall Study||36
2971|NCT02797080|6395|P1|STARTED|Overall Study||38
2972|NCT02796963|6403|P4|NOT COMPLETED|Overall Study||72
2973|NCT02796963|6404|P3|NOT COMPLETED|Overall Study||69
2974|NCT02796963|6405|P2|NOT COMPLETED|Overall Study||76
2975|NCT02796963|6406|P1|NOT COMPLETED|Overall Study||89
2976|NCT02796963|6403|P4|COMPLETED|Overall Study||282
2977|NCT02796963|6404|P3|COMPLETED|Overall Study||247
2978|NCT02796963|6405|P2|COMPLETED|Overall Study||252
2979|NCT02796963|6406|P1|COMPLETED|Overall Study||294
2980|NCT02796963|6403|P4|HIV Sero Converted|Overall Study||19
2981|NCT02796963|6404|P3|HIV Sero Converted|Overall Study||11
2982|NCT02796963|6405|P2|HIV Sero Converted|Overall Study||19
2983|NCT02796963|6406|P1|HIV Sero Converted|Overall Study||19
2984|NCT02796963|6403|P4|Fourth Follow up|Overall Study||263
2985|NCT02796963|6404|P3|Fourth Follow up|Overall Study||236
2986|NCT02796963|6405|P2|Fourth Follow up|Overall Study||233
2987|NCT02796963|6406|P1|Fourth Follow up|Overall Study||275
2988|NCT02796963|6403|P4|Third Follow up|Overall Study||286
2989|NCT02796963|6404|P3|Third Follow up|Overall Study||245
2990|NCT02796963|6405|P2|Third Follow up|Overall Study||237
2991|NCT02796963|6406|P1|Third Follow up|Overall Study||276
2992|NCT02796963|6403|P4|Second Follow up|Overall Study||293
2993|NCT02796963|6404|P3|Second Follow up|Overall Study||255
2994|NCT02796963|6405|P2|Second Follow up|Overall Study||260
2995|NCT02796963|6406|P1|Second Follow up|Overall Study||280
2996|NCT02796963|6403|P4|First Follow up|Overall Study||291
2997|NCT02796963|6404|P3|First Follow up|Overall Study||257
2998|NCT02796963|6405|P2|First Follow up|Overall Study||279
2999|NCT02796963|6406|P1|First Follow up|Overall Study||293
3000|NCT02796963|6403|P4|STARTED|Overall Study||354
3001|NCT02796963|6404|P3|STARTED|Overall Study||316
3002|NCT02796963|6405|P2|STARTED|Overall Study||328
3003|NCT02796963|6406|P1|STARTED|Overall Study||383
3004|NCT02796651|6468|P1|NOT COMPLETED|Overall Study||26
3005|NCT02796651|6468|P1|COMPLETED|Overall Study||106
3006|NCT02796651|6468|P1|Placebo (Lactose Monohydrate)|Overall Study||38
3007|NCT02796651|6468|P1|Perforomist 40 μg|Overall Study||108
3008|NCT02796651|6468|P1|Perforomist 20 μg|Overall Study||118
3009|NCT02796651|6468|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
3010|NCT02796651|6468|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
3011|NCT02796651|6468|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
3012|NCT02796651|6468|P1|STARTED|Overall Study||132
3013|NCT02796352|6497|P1|NOT COMPLETED|Overall Study||0
3014|NCT02796352|6497|P1|COMPLETED|Overall Study||1
3015|NCT02796352|6497|P1|STARTED|Overall Study||1
3016|NCT02796092|6506|P2|NOT COMPLETED|Overall Study||0
3017|NCT02796092|6507|P1|NOT COMPLETED|Overall Study||0
3018|NCT02796092|6506|P2|COMPLETED|Overall Study||50
3019|NCT02796092|6507|P1|COMPLETED|Overall Study||50
3020|NCT02796092|6506|P2|STARTED|Overall Study||50
3021|NCT02796092|6507|P1|STARTED|Overall Study||50
3022|NCT02794844|6539|P1|NOT COMPLETED|Overall Study||5
3023|NCT02794844|6539|P1|COMPLETED|Overall Study||23
3024|NCT02794844|6539|P1|STARTED|Overall Study||28
3025|NCT02794480|6550|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
3026|NCT02794480|6551|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
3027|NCT02794480|6552|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
3028|NCT02794480|6553|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
3029|NCT02794480|6550|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
3030|NCT02794480|6551|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
3031|NCT02794480|6552|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
3032|NCT02794480|6553|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
3033|NCT02794480|6550|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
3034|NCT02794480|6551|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
3035|NCT02794480|6552|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
3036|NCT02794480|6553|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
3037|NCT02794480|6550|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
3038|NCT02794480|6551|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
3039|NCT02794480|6552|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
3040|NCT02794480|6553|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
3041|NCT02794480|6550|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
3042|NCT02794480|6551|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
3043|NCT02794480|6552|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
3044|NCT02794480|6553|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
3045|NCT02794480|6550|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
3046|NCT02794480|6551|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
3047|NCT02794480|6552|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
3048|NCT02794480|6553|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
3049|NCT02793947|6573|P2|NOT COMPLETED|Overall Study||5
3050|NCT02793947|6574|P1|NOT COMPLETED|Overall Study||2
3051|NCT02793947|6573|P2|COMPLETED|Overall Study||50
3052|NCT02793947|6574|P1|COMPLETED|Overall Study||45
3053|NCT02793947|6573|P2|STARTED|Overall Study||55
3054|NCT02793947|6574|P1|STARTED|Overall Study||47
3055|NCT02793154|6587|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3056|NCT02793154|6588|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3057|NCT02793154|6589|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3058|NCT02793154|6587|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3059|NCT02793154|6588|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3060|NCT02793154|6589|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
3061|NCT02793154|6587|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
3062|NCT02793154|6588|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
3063|NCT02793154|6589|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
3064|NCT02793154|6587|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
3065|NCT02793154|6588|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
3066|NCT02793154|6589|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
3067|NCT02793154|6587|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
3068|NCT02793154|6588|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
3069|NCT02793154|6589|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
3070|NCT02793154|6587|P3|STARTED|Part A (Single Group-up to 12 Days)||0
3071|NCT02793154|6588|P2|STARTED|Part A (Single Group-up to 12 Days)||0
3072|NCT02793154|6589|P1|STARTED|Part A (Single Group-up to 12 Days)||4
3073|NCT02792062|6661|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3074|NCT02792062|6662|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3075|NCT02792062|6663|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3076|NCT02792062|6664|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3077|NCT02792062|6665|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3078|NCT02792062|6666|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
3079|NCT02792062|6661|P6|COMPLETED|Intervention Period 3 (6 Days)||2
3080|NCT02792062|6662|P5|COMPLETED|Intervention Period 3 (6 Days)||2
3081|NCT02792062|6663|P4|COMPLETED|Intervention Period 3 (6 Days)||2
3082|NCT02792062|6664|P3|COMPLETED|Intervention Period 3 (6 Days)||2
3083|NCT02792062|6665|P2|COMPLETED|Intervention Period 3 (6 Days)||2
3084|NCT02792062|6666|P1|COMPLETED|Intervention Period 3 (6 Days)||1
3085|NCT02792062|6661|P6|STARTED|Intervention Period 3 (6 Days)||2
3086|NCT02792062|6662|P5|STARTED|Intervention Period 3 (6 Days)||2
3087|NCT02792062|6663|P4|STARTED|Intervention Period 3 (6 Days)||2
3088|NCT02792062|6664|P3|STARTED|Intervention Period 3 (6 Days)||2
3089|NCT02792062|6665|P2|STARTED|Intervention Period 3 (6 Days)||2
3090|NCT02792062|6666|P1|STARTED|Intervention Period 3 (6 Days)||1
3091|NCT02792062|6661|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3092|NCT02792062|6662|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3093|NCT02792062|6663|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3094|NCT02792062|6664|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3095|NCT02792062|6665|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3096|NCT02792062|6666|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
3097|NCT02792062|6661|P6|COMPLETED|Washout Period (at Least 14 Days)||2
3098|NCT02792062|6662|P5|COMPLETED|Washout Period (at Least 14 Days)||2
3099|NCT02792062|6663|P4|COMPLETED|Washout Period (at Least 14 Days)||2
3100|NCT02792062|6664|P3|COMPLETED|Washout Period (at Least 14 Days)||2
3101|NCT02792062|6665|P2|COMPLETED|Washout Period (at Least 14 Days)||2
3102|NCT02792062|6666|P1|COMPLETED|Washout Period (at Least 14 Days)||1
3103|NCT02792062|6661|P6|STARTED|Washout Period (at Least 14 Days)||2
3104|NCT02792062|6662|P5|STARTED|Washout Period (at Least 14 Days)||2
3105|NCT02792062|6663|P4|STARTED|Washout Period (at Least 14 Days)||2
3106|NCT02792062|6664|P3|STARTED|Washout Period (at Least 14 Days)||2
3107|NCT02792062|6665|P2|STARTED|Washout Period (at Least 14 Days)||2
3108|NCT02792062|6666|P1|STARTED|Washout Period (at Least 14 Days)||2
3109|NCT02792062|6661|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3110|NCT02792062|6662|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3111|NCT02792062|6663|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3112|NCT02792062|6664|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3113|NCT02792062|6665|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3114|NCT02792062|6666|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3115|NCT02792062|6661|P6|COMPLETED|Intervention Period 2 (6 Days)||2
3116|NCT02792062|6662|P5|COMPLETED|Intervention Period 2 (6 Days)||2
3117|NCT02792062|6663|P4|COMPLETED|Intervention Period 2 (6 Days)||2
3118|NCT02792062|6664|P3|COMPLETED|Intervention Period 2 (6 Days)||2
3119|NCT02792062|6665|P2|COMPLETED|Intervention Period 2 (6 Days)||2
3120|NCT02792062|6666|P1|COMPLETED|Intervention Period 2 (6 Days)||2
3121|NCT02792062|6661|P6|STARTED|Intervention Period 2 (6 Days)||2
3122|NCT02792062|6662|P5|STARTED|Intervention Period 2 (6 Days)||2
3123|NCT02792062|6663|P4|STARTED|Intervention Period 2 (6 Days)||2
3124|NCT02792062|6664|P3|STARTED|Intervention Period 2 (6 Days)||2
3125|NCT02792062|6665|P2|STARTED|Intervention Period 2 (6 Days)||2
3126|NCT02792062|6666|P1|STARTED|Intervention Period 2 (6 Days)||2
3127|NCT02792062|6661|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3128|NCT02792062|6662|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3129|NCT02792062|6663|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3130|NCT02792062|6664|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3131|NCT02792062|6665|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3132|NCT02792062|6666|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3133|NCT02792062|6661|P6|COMPLETED|Washout Period (at Least 14 Days)||2
3134|NCT02792062|6662|P5|COMPLETED|Washout Period (at Least 14 Days)||2
3135|NCT02792062|6663|P4|COMPLETED|Washout Period (at Least 14 Days)||2
3136|NCT02792062|6664|P3|COMPLETED|Washout Period (at Least 14 Days)||2
3137|NCT02792062|6665|P2|COMPLETED|Washout Period (at Least 14 Days)||2
3138|NCT02792062|6666|P1|COMPLETED|Washout Period (at Least 14 Days)||2
3139|NCT02792062|6661|P6|STARTED|Washout Period (at Least 14 Days)||2
3140|NCT02792062|6662|P5|STARTED|Washout Period (at Least 14 Days)||2
3141|NCT02792062|6663|P4|STARTED|Washout Period (at Least 14 Days)||2
3142|NCT02792062|6664|P3|STARTED|Washout Period (at Least 14 Days)||2
3143|NCT02792062|6665|P2|STARTED|Washout Period (at Least 14 Days)||2
3144|NCT02792062|6666|P1|STARTED|Washout Period (at Least 14 Days)||2
3145|NCT02792062|6661|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3146|NCT02792062|6662|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3147|NCT02792062|6663|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3148|NCT02792062|6664|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3149|NCT02792062|6665|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3150|NCT02792062|6666|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3151|NCT02792062|6661|P6|COMPLETED|Intervention Period 1 (6 Days)||2
3152|NCT02792062|6662|P5|COMPLETED|Intervention Period 1 (6 Days)||2
3153|NCT02792062|6663|P4|COMPLETED|Intervention Period 1 (6 Days)||2
3154|NCT02792062|6664|P3|COMPLETED|Intervention Period 1 (6 Days)||2
3155|NCT02792062|6665|P2|COMPLETED|Intervention Period 1 (6 Days)||2
3156|NCT02792062|6666|P1|COMPLETED|Intervention Period 1 (6 Days)||2
3157|NCT02792062|6661|P6|STARTED|Intervention Period 1 (6 Days)||2
3158|NCT02792062|6662|P5|STARTED|Intervention Period 1 (6 Days)||2
3159|NCT02792062|6663|P4|STARTED|Intervention Period 1 (6 Days)||2
3160|NCT02792062|6664|P3|STARTED|Intervention Period 1 (6 Days)||2
3161|NCT02792062|6665|P2|STARTED|Intervention Period 1 (6 Days)||2
3162|NCT02792062|6666|P1|STARTED|Intervention Period 1 (6 Days)||2
3163|NCT02792049|6700|P2|NOT COMPLETED|Overall Study||0
3164|NCT02792049|6701|P1|NOT COMPLETED|Overall Study||0
3165|NCT02792049|6700|P2|COMPLETED|Overall Study||35
3166|NCT02792049|6701|P1|COMPLETED|Overall Study||35
3167|NCT02792049|6700|P2|STARTED|Overall Study||35
3168|NCT02792049|6701|P1|STARTED|Overall Study||35
3169|NCT02791659|6717|P2|NOT COMPLETED|Overall Study||1
3170|NCT02791659|6718|P1|NOT COMPLETED|Overall Study||0
3171|NCT02791659|6717|P2|COMPLETED|Overall Study||27
3172|NCT02791659|6718|P1|COMPLETED|Overall Study||27
3173|NCT02791659|6717|P2|STARTED|Overall Study||28
3174|NCT02791659|6718|P1|STARTED|Overall Study||27
3175|NCT02791269|6726|P2|NOT COMPLETED|Overall Study||1
3176|NCT02791269|6727|P1|NOT COMPLETED|Overall Study||0
3177|NCT02791269|6726|P2|COMPLETED|Overall Study||19
3178|NCT02791269|6727|P1|COMPLETED|Overall Study||4
3179|NCT02791269|6726|P2|STARTED|Overall Study||20
3180|NCT02791269|6727|P1|STARTED|Overall Study||4
3181|NCT02790281|6741|P1|NOT COMPLETED|Overall Study||0
3182|NCT02790281|6741|P1|COMPLETED|Overall Study||33
3183|NCT02790281|6741|P1|STARTED|Overall Study||33
3184|NCT02788357|6749|P2|NOT COMPLETED|Overall Study||0
3185|NCT02788357|6750|P1|NOT COMPLETED|Overall Study||3
3186|NCT02788357|6749|P2|COMPLETED|Overall Study||6
3187|NCT02788357|6750|P1|COMPLETED|Overall Study||3
3188|NCT02788357|6749|P2|STARTED|Overall Study||6
3189|NCT02788357|6750|P1|STARTED|Overall Study||6
3190|NCT02788097|6764|P2|NOT COMPLETED|Overall Study||0
3191|NCT02788097|6765|P1|NOT COMPLETED|Overall Study||0
3192|NCT02788097|6764|P2|COMPLETED|Overall Study||69
3193|NCT02788097|6765|P1|COMPLETED|Overall Study||61
3194|NCT02788097|6764|P2|STARTED|Overall Study||69
3195|NCT02788097|6765|P1|STARTED|Overall Study||61
3196|NCT02787564|6773|P2|NOT COMPLETED|Overall Study||2
3197|NCT02787564|6774|P1|NOT COMPLETED|Overall Study||7
3198|NCT02787564|6773|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
3199|NCT02787564|6774|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
3200|NCT02787564|6773|P2|STARTED|Overall Study||29
3201|NCT02787564|6774|P1|STARTED|Overall Study||32
3202|NCT02786927|6790|P1|NOT COMPLETED|Overall Study||5
3203|NCT02786927|6790|P1|COMPLETED|Overall Study||207
3204|NCT02786927|6790|P1|STARTED|Overall Study||212
3205|NCT02786810|6797|P1|NOT COMPLETED|Overall Study||0
3206|NCT02786810|6797|P1|COMPLETED|Overall Study||10
3207|NCT02786810|6797|P1|STARTED|Overall Study||10
3208|NCT02786771|6804|P2|NOT COMPLETED|Overall Study||6
3209|NCT02786771|6805|P1|NOT COMPLETED|Overall Study||10
3210|NCT02786771|6804|P2|COMPLETED|Overall Study||56
3211|NCT02786771|6805|P1|COMPLETED|Overall Study||53
3212|NCT02786771|6804|P2|STARTED|Overall Study||62
3213|NCT02786771|6805|P1|STARTED|Overall Study||63
3214|NCT02786004|6813|P2|NOT COMPLETED|Overall Study||14
3215|NCT02786004|6814|P1|NOT COMPLETED|Overall Study||9
3216|NCT02786004|6813|P2|COMPLETED|Overall Study||9
3217|NCT02786004|6814|P1|COMPLETED|Overall Study||14
3218|NCT02786004|6813|P2|STARTED|Overall Study||23
3219|NCT02786004|6814|P1|STARTED|Overall Study||23
3220|NCT02784925|6820|P1|NOT COMPLETED|Overall Study||0
3221|NCT02784925|6820|P1|COMPLETED|Overall Study||30
3222|NCT02784925|6820|P1|STARTED|Overall Study||30
3223|NCT02784106|6826|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
3224|NCT02784106|6827|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
3225|NCT02784106|6828|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
3226|NCT02784106|6829|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
3227|NCT02784106|6826|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
3228|NCT02784106|6827|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
3229|NCT02784106|6828|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
3230|NCT02784106|6829|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
3231|NCT02784106|6826|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
3232|NCT02784106|6827|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
3233|NCT02784106|6828|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
3234|NCT02784106|6829|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
3235|NCT02784106|6826|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3236|NCT02784106|6827|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3237|NCT02784106|6828|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
3238|NCT02784106|6829|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
3239|NCT02784106|6826|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3240|NCT02784106|6827|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
3241|NCT02784106|6828|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
3242|NCT02784106|6829|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
3243|NCT02784106|6826|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
3244|NCT02784106|6827|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
3245|NCT02784106|6828|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
3246|NCT02784106|6829|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
3247|NCT02782676|6890|P2|NOT COMPLETED|Overall Study||1
3248|NCT02782676|6891|P1|NOT COMPLETED|Overall Study||0
3249|NCT02782676|6890|P2|COMPLETED|Overall Study||209
3250|NCT02782676|6891|P1|COMPLETED|Overall Study||211
3251|NCT02782676|6890|P2|STARTED|Overall Study||210
3252|NCT02782676|6891|P1|STARTED|Overall Study||211
3253|NCT02782169|6921|P2|NOT COMPLETED|Overall Study||2
3254|NCT02782169|6922|P1|NOT COMPLETED|Overall Study||1
3255|NCT02782169|6921|P2|COMPLETED|Overall Study||52
3256|NCT02782169|6922|P1|COMPLETED|Overall Study||55
3257|NCT02782169|6921|P2|STARTED|Overall Study||54
3258|NCT02782169|6922|P1|STARTED|Overall Study||56
3259|NCT02781818|6939|P3|NOT COMPLETED|Overall Study||1
3260|NCT02781818|6940|P2|NOT COMPLETED|Overall Study||2
3261|NCT02781818|6941|P1|NOT COMPLETED|Overall Study||4
3262|NCT02781818|6939|P3|COMPLETED|Overall Study||16
3263|NCT02781818|6940|P2|COMPLETED|Overall Study||16
3264|NCT02781818|6941|P1|COMPLETED|Overall Study||16
3265|NCT02781818|6939|P3|STARTED|Overall Study||17
3266|NCT02781818|6940|P2|STARTED|Overall Study||18
3267|NCT02781818|6941|P1|STARTED|Overall Study||20
3268|NCT02781649|6958|P3|NOT COMPLETED|Overall Study||0
3269|NCT02781649|6959|P2|NOT COMPLETED|Overall Study||0
3270|NCT02781649|6960|P1|NOT COMPLETED|Overall Study||0
3271|NCT02781649|6958|P3|COMPLETED|Overall Study||3
3272|NCT02781649|6959|P2|COMPLETED|Overall Study||0
3273|NCT02781649|6960|P1|COMPLETED|Overall Study||7
3274|NCT02781649|6958|P3|STARTED|Overall Study||3
3275|NCT02781649|6959|P2|STARTED|Overall Study||0
3276|NCT02781649|6960|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
3277|NCT02780622|6986|P2|NOT COMPLETED|Treatment Period 2||0
3278|NCT02780622|6987|P1|NOT COMPLETED|Treatment Period 2||0
3279|NCT02780622|6986|P2|COMPLETED|Treatment Period 2||10
3280|NCT02780622|6987|P1|COMPLETED|Treatment Period 2||10
3281|NCT02780622|6986|P2|STARTED|Treatment Period 2||10
3282|NCT02780622|6987|P1|STARTED|Treatment Period 2||10
3283|NCT02780622|6986|P2|NOT COMPLETED|Treatment Period 1||0
3284|NCT02780622|6987|P1|NOT COMPLETED|Treatment Period 1||0
3285|NCT02780622|6986|P2|COMPLETED|Treatment Period 1||10
3286|NCT02780622|6987|P1|COMPLETED|Treatment Period 1||10
3287|NCT02780622|6986|P2|STARTED|Treatment Period 1||10
3288|NCT02780622|6987|P1|STARTED|Treatment Period 1||10
3289|NCT02780349|7025|P1|NOT COMPLETED|Overall Study||2
3290|NCT02780349|7025|P1|COMPLETED|Overall Study||101
3291|NCT02780349|7025|P1|STARTED|Overall Study||103
3292|NCT02780167|7034|P5|NOT COMPLETED|Overall Study||17
3293|NCT02780167|7035|P4|NOT COMPLETED|Overall Study||19
3294|NCT02780167|7036|P3|NOT COMPLETED|Overall Study||24
3295|NCT02780167|7037|P2|NOT COMPLETED|Overall Study||22
3296|NCT02780167|7038|P1|NOT COMPLETED|Overall Study||28
3297|NCT02780167|7034|P5|COMPLETED|Overall Study||38
3298|NCT02780167|7035|P4|COMPLETED|Overall Study||37
3299|NCT02780167|7036|P3|COMPLETED|Overall Study||27
3300|NCT02780167|7037|P2|COMPLETED|Overall Study||27
3301|NCT02780167|7038|P1|COMPLETED|Overall Study||28
3302|NCT02780167|7034|P5|STARTED|Overall Study||55
3303|NCT02780167|7035|P4|STARTED|Overall Study||56
3304|NCT02780167|7036|P3|STARTED|Overall Study||51
3305|NCT02780167|7037|P2|STARTED|Overall Study||49
3306|NCT02780167|7038|P1|STARTED|Overall Study||56
3307|NCT02777931|7172|P2|NOT COMPLETED|Overall Study||13
3308|NCT02777931|7173|P1|NOT COMPLETED|Overall Study||12
3309|NCT02777931|7172|P2|COMPLETED|Overall Study||39
3310|NCT02777931|7173|P1|COMPLETED|Overall Study||37
3311|NCT02777931|7172|P2|Modified Intent to Treat Population|Overall Study||50
3312|NCT02777931|7173|P1|Modified Intent to Treat Population|Overall Study||46
3313|NCT02777931|7172|P2|Safety Population|Overall Study||50
3314|NCT02777931|7173|P1|Safety Population|Overall Study||47
3315|NCT02777931|7172|P2|STARTED|Overall Study||52
3316|NCT02777931|7173|P1|STARTED|Overall Study||49
3317|NCT02777268|7181|P1|NOT COMPLETED|Overall Study||0
3318|NCT02777268|7181|P1|COMPLETED|Overall Study||16
3319|NCT02777268|7181|P1|STARTED|Overall Study||16
3320|NCT02777242|7207|P1|NOT COMPLETED|Overall Study||6
3321|NCT02777242|7207|P1|COMPLETED|Overall Study||59
3322|NCT02777242|7207|P1|STARTED|Overall Study||65
3323|NCT02777125|7213|P2|NOT COMPLETED|Overall Study||47
3324|NCT02777125|7214|P1|NOT COMPLETED|Overall Study||43
3325|NCT02777125|7213|P2|COMPLETED|Overall Study||445
3326|NCT02777125|7214|P1|COMPLETED|Overall Study||445
3327|NCT02777125|7213|P2|STARTED|Overall Study||492
3328|NCT02777125|7214|P1|STARTED|Overall Study||488
3329|NCT02774343|7230|P2|NOT COMPLETED|Overall Study||3
3330|NCT02774343|7231|P1|NOT COMPLETED|Overall Study||6
3331|NCT02774343|7230|P2|COMPLETED|Overall Study||12
3332|NCT02774343|7231|P1|COMPLETED|Overall Study||9
3333|NCT02774343|7230|P2|Received at Least One Capsule|Overall Study||14
3334|NCT02774343|7231|P1|Received at Least One Capsule|Overall Study||12
3335|NCT02774343|7230|P2|STARTED|Overall Study||15
3336|NCT02774343|7231|P1|STARTED|Overall Study||15
3337|NCT02774278|7267|P1|NOT COMPLETED|Overall Study||264
3338|NCT02774278|7267|P1|COMPLETED|Overall Study||0
3339|NCT02774278|7267|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
3340|NCT02774278|7267|P1|STARTED|Overall Study||264
3341|NCT02774148|7277|P2|NOT COMPLETED|Overall Study||0
3342|NCT02774148|7278|P1|NOT COMPLETED|Overall Study||0
3343|NCT02774148|7277|P2|COMPLETED|Overall Study||0
3344|NCT02774148|7278|P1|COMPLETED|Overall Study||0
3345|NCT02774148|7277|P2|STARTED|Overall Study||0
3346|NCT02774148|7278|P1|STARTED|Overall Study||0
3347|NCT02773758|7294|P2|NOT COMPLETED|Overall Study||0
3348|NCT02773758|7295|P1|NOT COMPLETED|Overall Study||0
3349|NCT02773758|7294|P2|COMPLETED|Overall Study||70
3350|NCT02773758|7295|P1|COMPLETED|Overall Study||71
3351|NCT02773758|7294|P2|STARTED|Overall Study||70
3352|NCT02773758|7295|P1|STARTED|Overall Study||71
3353|NCT02772666|7305|P1|NOT COMPLETED|SFT Then O-Glass||0
3354|NCT02772666|7305|P1|COMPLETED|SFT Then O-Glass||44
3355|NCT02772666|7305|P1|STARTED|SFT Then O-Glass||44
3356|NCT02772666|7305|P1|NOT COMPLETED|O-Glas Then SFT||0
3357|NCT02772666|7305|P1|COMPLETED|O-Glas Then SFT||44
3358|NCT02772666|7305|P1|STARTED|O-Glas Then SFT||44
3359|NCT02770625|7310|P1|NOT COMPLETED|Overall Study||0
3360|NCT02770625|7310|P1|COMPLETED|Overall Study||8
3361|NCT02770625|7310|P1|STARTED|Overall Study||8
3362|NCT02770248|7325|P2|NOT COMPLETED|Overall Study||2
3363|NCT02770248|7326|P1|NOT COMPLETED|Overall Study||0
3364|NCT02770248|7325|P2|COMPLETED|Overall Study||61
3365|NCT02770248|7326|P1|COMPLETED|Overall Study||62
3366|NCT02770248|7325|P2|STARTED|Overall Study||63
3367|NCT02770248|7326|P1|STARTED|Overall Study||62
3368|NCT02769858|7338|P1|NOT COMPLETED|Overall Study||2
3369|NCT02769858|7338|P1|COMPLETED|Overall Study||8
3370|NCT02769858|7338|P1|STARTED|Overall Study||10
3371|NCT02768194|7344|P6|NOT COMPLETED|Period 3||0
3372|NCT02768194|7345|P5|NOT COMPLETED|Period 3||0
3373|NCT02768194|7346|P4|NOT COMPLETED|Period 3||0
3374|NCT02768194|7347|P3|NOT COMPLETED|Period 3||0
3375|NCT02768194|7348|P2|NOT COMPLETED|Period 3||1
3376|NCT02768194|7349|P1|NOT COMPLETED|Period 3||0
3377|NCT02768194|7344|P6|COMPLETED|Period 3||4
3378|NCT02768194|7345|P5|COMPLETED|Period 3||4
3379|NCT02768194|7346|P4|COMPLETED|Period 3||3
3380|NCT02768194|7347|P3|COMPLETED|Period 3||4
3381|NCT02768194|7348|P2|COMPLETED|Period 3||3
3382|NCT02768194|7349|P1|COMPLETED|Period 3||3
3383|NCT02768194|7344|P6|STARTED|Period 3||4
3384|NCT02768194|7345|P5|STARTED|Period 3||4
3385|NCT02768194|7346|P4|STARTED|Period 3||3
3386|NCT02768194|7347|P3|STARTED|Period 3||4
3387|NCT02768194|7348|P2|STARTED|Period 3||4
3388|NCT02768194|7349|P1|STARTED|Period 3||3
3389|NCT02768194|7344|P6|NOT COMPLETED|Period 2||0
3390|NCT02768194|7345|P5|NOT COMPLETED|Period 2||0
3391|NCT02768194|7346|P4|NOT COMPLETED|Period 2||0
3392|NCT02768194|7347|P3|NOT COMPLETED|Period 2||0
3393|NCT02768194|7348|P2|NOT COMPLETED|Period 2||0
3394|NCT02768194|7349|P1|NOT COMPLETED|Period 2||1
3395|NCT02768194|7344|P6|COMPLETED|Period 2||4
3396|NCT02768194|7345|P5|COMPLETED|Period 2||4
3397|NCT02768194|7346|P4|COMPLETED|Period 2||3
3398|NCT02768194|7347|P3|COMPLETED|Period 2||4
3399|NCT02768194|7348|P2|COMPLETED|Period 2||4
3400|NCT02768194|7349|P1|COMPLETED|Period 2||3
3401|NCT02768194|7344|P6|STARTED|Period 2||4
3402|NCT02768194|7345|P5|STARTED|Period 2||4
3403|NCT02768194|7346|P4|STARTED|Period 2||3
3404|NCT02768194|7347|P3|STARTED|Period 2||4
3405|NCT02768194|7348|P2|STARTED|Period 2||4
3406|NCT02768194|7349|P1|STARTED|Period 2||4
3407|NCT02768194|7344|P6|NOT COMPLETED|Period 1||0
3408|NCT02768194|7345|P5|NOT COMPLETED|Period 1||0
3409|NCT02768194|7346|P4|NOT COMPLETED|Period 1||1
3410|NCT02768194|7347|P3|NOT COMPLETED|Period 1||0
3411|NCT02768194|7348|P2|NOT COMPLETED|Period 1||0
3412|NCT02768194|7349|P1|NOT COMPLETED|Period 1||0
3413|NCT02768194|7344|P6|COMPLETED|Period 1||4
3414|NCT02768194|7345|P5|COMPLETED|Period 1||4
3415|NCT02768194|7346|P4|COMPLETED|Period 1||3
3416|NCT02768194|7347|P3|COMPLETED|Period 1||4
3417|NCT02768194|7348|P2|COMPLETED|Period 1||4
3418|NCT02768194|7349|P1|COMPLETED|Period 1||4
3419|NCT02768194|7344|P6|STARTED|Period 1||4
3420|NCT02768194|7345|P5|STARTED|Period 1||4
3421|NCT02768194|7346|P4|STARTED|Period 1||4
3422|NCT02768194|7347|P3|STARTED|Period 1||4
3423|NCT02768194|7348|P2|STARTED|Period 1||4
3424|NCT02768194|7349|P1|STARTED|Period 1||4
3425|NCT02767843|7360|P1|NOT COMPLETED|Overall Study||0
3426|NCT02767843|7360|P1|COMPLETED|Overall Study||4
3427|NCT02767843|7360|P1|STARTED|Overall Study||4
3428|NCT02767765|7366|P1|NOT COMPLETED|Overall Study||11
3429|NCT02767765|7366|P1|COMPLETED|Overall Study||50
3430|NCT02767765|7366|P1|STARTED|Overall Study||61
3431|NCT02766400|7377|P2|NOT COMPLETED|Overall Study||2
3432|NCT02766400|7378|P1|NOT COMPLETED|Overall Study||2
3433|NCT02766400|7377|P2|COMPLETED|Overall Study||20
3434|NCT02766400|7378|P1|COMPLETED|Overall Study||19
3435|NCT02766400|7377|P2|STARTED|Overall Study||22
3436|NCT02766400|7378|P1|STARTED|Overall Study||21
3437|NCT02766283|7384|P1|NOT COMPLETED|Overall Study||27
3438|NCT02766283|7384|P1|COMPLETED|Overall Study||816
3439|NCT02766283|7384|P1|STARTED|Overall Study||843
3440|NCT02766244|7408|P1|NOT COMPLETED|Overall Study||0
3441|NCT02766244|7408|P1|COMPLETED|Overall Study||3
3442|NCT02766244|7408|P1|STARTED|Overall Study||3
3443|NCT02765269|7419|P2|NOT COMPLETED|Overall Study||0
3444|NCT02765269|7420|P1|NOT COMPLETED|Overall Study||0
3445|NCT02765269|7419|P2|COMPLETED|Overall Study||21
3446|NCT02765269|7420|P1|COMPLETED|Overall Study||25
3447|NCT02765269|7419|P2|STARTED|Overall Study||21
3448|NCT02765269|7420|P1|STARTED|Overall Study||25
3449|NCT02764970|7434|P2|NOT COMPLETED|Overall Study||0
3450|NCT02764970|7435|P1|NOT COMPLETED|Overall Study||0
3451|NCT02764970|7434|P2|COMPLETED|Overall Study||47
3452|NCT02764970|7435|P1|COMPLETED|Overall Study||65
3453|NCT02764970|7434|P2|STARTED|Overall Study||47
3454|NCT02764970|7435|P1|STARTED|Overall Study||65
3455|NCT02763189|7449|P2|NOT COMPLETED|Overall Study||2
3456|NCT02763189|7450|P1|NOT COMPLETED|Overall Study||0
3457|NCT02763189|7449|P2|COMPLETED|Overall Study||2
3458|NCT02763189|7450|P1|COMPLETED|Overall Study||4
3459|NCT02763189|7449|P2|STARTED|Overall Study||4
3460|NCT02763189|7450|P1|STARTED|Overall Study||4
3461|NCT02762370|7460|P2|NOT COMPLETED|Overall Study||0
3462|NCT02762370|7461|P1|NOT COMPLETED|Overall Study||1
3463|NCT02762370|7460|P2|COMPLETED|Overall Study||15
3464|NCT02762370|7461|P1|COMPLETED|Overall Study||17
3465|NCT02762370|7460|P2|STARTED|Overall Study||15
3466|NCT02762370|7461|P1|STARTED|Overall Study||18
3467|NCT02761733|7483|P4|NOT COMPLETED|Overall Study||15
3468|NCT02761733|7484|P3|NOT COMPLETED|Overall Study||27
3469|NCT02761733|7485|P2|NOT COMPLETED|Overall Study||21
3470|NCT02761733|7486|P1|NOT COMPLETED|Overall Study||30
3471|NCT02761733|7483|P4|COMPLETED|Overall Study||45
3472|NCT02761733|7484|P3|COMPLETED|Overall Study||33
3473|NCT02761733|7485|P2|COMPLETED|Overall Study||39
3474|NCT02761733|7486|P1|COMPLETED|Overall Study||30
3475|NCT02761733|7483|P4|9/30/2015|Overall Study||50
3476|NCT02761733|7484|P3|9/30/2015|Overall Study||33
3477|NCT02761733|7485|P2|9/30/2015|Overall Study||44
3478|NCT02761733|7486|P1|9/30/2015|Overall Study||40
3479|NCT02761733|7483|P4|3/31/2015|Overall Study||50
3480|NCT02761733|7484|P3|3/31/2015|Overall Study||43
3481|NCT02761733|7485|P2|3/31/2015|Overall Study||47
3482|NCT02761733|7486|P1|3/31/2015|Overall Study||48
3483|NCT02761733|7483|P4|9/30/2014|Overall Study||55
3484|NCT02761733|7484|P3|9/30/2014|Overall Study||48
3485|NCT02761733|7485|P2|9/30/2014|Overall Study||56
3486|NCT02761733|7486|P1|9/30/2014|Overall Study||53
3487|NCT02761733|7483|P4|STARTED|Overall Study||60
3488|NCT02761733|7484|P3|STARTED|Overall Study||60
3489|NCT02761733|7485|P2|STARTED|Overall Study||60
3490|NCT02761733|7486|P1|STARTED|Overall Study||60
3491|NCT02761629|7518|P2|NOT COMPLETED|Overall Study||32
3492|NCT02761629|7519|P1|NOT COMPLETED|Overall Study||27
3493|NCT02761629|7518|P2|COMPLETED|Overall Study||58
3494|NCT02761629|7519|P1|COMPLETED|Overall Study||63
3495|NCT02761629|7518|P2|Treated|Overall Study||86
3496|NCT02761629|7519|P1|Treated|Overall Study||82
3497|NCT02761629|7518|P2|STARTED|Overall Study||90
3498|NCT02761629|7519|P1|STARTED|Overall Study||90
3499|NCT02760810|7539|P1|NOT COMPLETED|Overall Study||1
3500|NCT02760810|7539|P1|COMPLETED|Overall Study||29
3501|NCT02760810|7539|P1|STARTED|Overall Study||30
3502|NCT02760654|7547|P2|NOT COMPLETED|Overall Study||6
3503|NCT02760654|7548|P1|NOT COMPLETED|Overall Study||7
3504|NCT02760654|7547|P2|COMPLETED|Overall Study||24
3505|NCT02760654|7548|P1|COMPLETED|Overall Study||23
3506|NCT02760654|7547|P2|STARTED|Overall Study||30
3507|NCT02760654|7548|P1|STARTED|Overall Study||30
3508|NCT02759692|7572|P2|NOT COMPLETED|Period 3||0
3509|NCT02759692|7573|P1|NOT COMPLETED|Period 3||0
3510|NCT02759692|7572|P2|COMPLETED|Period 3||139
3511|NCT02759692|7573|P1|COMPLETED|Period 3||137
3512|NCT02759692|7572|P2|STARTED|Period 3||139
3513|NCT02759692|7573|P1|STARTED|Period 3||137
3514|NCT02759692|7572|P2|NOT COMPLETED|Period 2||1
3515|NCT02759692|7573|P1|NOT COMPLETED|Period 2||1
3516|NCT02759692|7572|P2|COMPLETED|Period 2||139
3517|NCT02759692|7573|P1|COMPLETED|Period 2||137
3518|NCT02759692|7572|P2|STARTED|Period 2||140
3519|NCT02759692|7573|P1|STARTED|Period 2||138
3520|NCT02759692|7572|P2|NOT COMPLETED|Period 1||2
3521|NCT02759692|7573|P1|NOT COMPLETED|Period 1||3
3522|NCT02759692|7572|P2|COMPLETED|Period 1||140
3523|NCT02759692|7573|P1|COMPLETED|Period 1||138
3524|NCT02759692|7572|P2|STARTED|Period 1||142
3525|NCT02759692|7573|P1|STARTED|Period 1||141
3526|NCT02759471|7589|P1|NOT COMPLETED|Overall Study||2
3527|NCT02759471|7589|P1|COMPLETED|Overall Study||52
3528|NCT02759471|7589|P1|STARTED|Overall Study||54
3529|NCT02758613|7603|P4|NOT COMPLETED|Follow-up||0
3530|NCT02758613|7604|P3|NOT COMPLETED|Follow-up||0
3531|NCT02758613|7605|P2|NOT COMPLETED|Follow-up||0
3532|NCT02758613|7606|P1|NOT COMPLETED|Follow-up||0
3533|NCT02758613|7603|P4|COMPLETED|Follow-up||8
3534|NCT02758613|7604|P3|COMPLETED|Follow-up||8
3535|NCT02758613|7605|P2|COMPLETED|Follow-up||8
3536|NCT02758613|7606|P1|COMPLETED|Follow-up||6
3537|NCT02758613|7603|P4|STARTED|Follow-up||8
3538|NCT02758613|7604|P3|STARTED|Follow-up||8
3539|NCT02758613|7605|P2|STARTED|Follow-up||8
3540|NCT02758613|7606|P1|STARTED|Follow-up||6
3541|NCT02758613|7603|P4|NOT COMPLETED|Treatment||0
3542|NCT02758613|7604|P3|NOT COMPLETED|Treatment||1
3543|NCT02758613|7605|P2|NOT COMPLETED|Treatment||0
3544|NCT02758613|7606|P1|NOT COMPLETED|Treatment||2
3545|NCT02758613|7603|P4|COMPLETED|Treatment||8
3546|NCT02758613|7604|P3|COMPLETED|Treatment||8
3547|NCT02758613|7605|P2|COMPLETED|Treatment||8
3548|NCT02758613|7606|P1|COMPLETED|Treatment||6
3549|NCT02758613|7603|P4|Received at Least One Dose of Study Drug|Treatment||8
3550|NCT02758613|7604|P3|Received at Least One Dose of Study Drug|Treatment||9
3551|NCT02758613|7605|P2|Received at Least One Dose of Study Drug|Treatment||8
3552|NCT02758613|7606|P1|Received at Least One Dose of Study Drug|Treatment||8
3553|NCT02758613|7603|P4|STARTED|Treatment||8
3554|NCT02758613|7604|P3|STARTED|Treatment||9
3555|NCT02758613|7605|P2|STARTED|Treatment||8
3556|NCT02758613|7606|P1|STARTED|Treatment||8
3557|NCT02758210|7622|P1|NOT COMPLETED|Overall Study||0
3558|NCT02758210|7622|P1|COMPLETED|Overall Study||20
3559|NCT02758210|7622|P1|STARTED|Overall Study||20
3560|NCT02758171|7633|P2|NOT COMPLETED|Treatment Period 2||0
3561|NCT02758171|7634|P1|NOT COMPLETED|Treatment Period 2||0
3562|NCT02758171|7633|P2|COMPLETED|Treatment Period 2||28
3563|NCT02758171|7634|P1|COMPLETED|Treatment Period 2||26
3564|NCT02758171|7633|P2|STARTED|Treatment Period 2||28
3565|NCT02758171|7634|P1|STARTED|Treatment Period 2||26
3566|NCT02758171|7633|P2|NOT COMPLETED|Wash-out||0
3567|NCT02758171|7634|P1|NOT COMPLETED|Wash-out||2
3568|NCT02758171|7633|P2|COMPLETED|Wash-out||28
3569|NCT02758171|7634|P1|COMPLETED|Wash-out||26
3570|NCT02758171|7633|P2|STARTED|Wash-out||28
3571|NCT02758171|7634|P1|STARTED|Wash-out||28
3572|NCT02758171|7633|P2|NOT COMPLETED|Treatment Period 1||0
3573|NCT02758171|7634|P1|NOT COMPLETED|Treatment Period 1||0
3574|NCT02758171|7633|P2|COMPLETED|Treatment Period 1||28
3575|NCT02758171|7634|P1|COMPLETED|Treatment Period 1||28
3576|NCT02758171|7633|P2|STARTED|Treatment Period 1||28
3577|NCT02758171|7634|P1|STARTED|Treatment Period 1||28
3578|NCT02757053|7652|P2|NOT COMPLETED|Overall Study||5
3579|NCT02757053|7653|P1|NOT COMPLETED|Overall Study||3
3580|NCT02757053|7652|P2|COMPLETED|Overall Study||0
3581|NCT02757053|7653|P1|COMPLETED|Overall Study||0
3582|NCT02757053|7652|P2|STARTED|Overall Study||5
3583|NCT02757053|7653|P1|STARTED|Overall Study||3
3584|NCT02756637|7667|P2|NOT COMPLETED|Overall Study||54
3585|NCT02756637|7668|P1|NOT COMPLETED|Overall Study||87
3586|NCT02756637|7667|P2|COMPLETED|Overall Study||263
3587|NCT02756637|7668|P1|COMPLETED|Overall Study||230
3588|NCT02756637|7667|P2|Completed Curative Treatment|Overall Study||0
3589|NCT02756637|7668|P1|Completed Curative Treatment|Overall Study||230
3590|NCT02756637|7667|P2|Had NLR Value|Overall Study||263
3591|NCT02756637|7668|P1|Had NLR Value|Overall Study||263
3592|NCT02756637|7667|P2|Eligible for SWOG 8710|Overall Study||307
3593|NCT02756637|7668|P1|Eligible for SWOG 8710|Overall Study||307
3594|NCT02756637|7667|P2|STARTED|Overall Study||317
3595|NCT02756637|7668|P1|STARTED|Overall Study||317
3596|NCT02756624|7676|P2|NOT COMPLETED|Overall Study||7
3597|NCT02756624|7677|P1|NOT COMPLETED|Overall Study||16
3598|NCT02756624|7676|P2|COMPLETED|Overall Study||166
3599|NCT02756624|7677|P1|COMPLETED|Overall Study||327
3600|NCT02756624|7676|P2|STARTED|Overall Study||173
3601|NCT02756624|7677|P1|STARTED|Overall Study||343
3602|NCT02756351|7691|P2|NOT COMPLETED|Overall Study||0
3603|NCT02756351|7692|P1|NOT COMPLETED|Overall Study||0
3604|NCT02756351|7691|P2|COMPLETED|Overall Study||24
3605|NCT02756351|7692|P1|COMPLETED|Overall Study||24
3606|NCT02756351|7691|P2|STARTED|Overall Study||24
3607|NCT02756351|7692|P1|STARTED|Overall Study||24
3608|NCT02755935|7700|P1|NOT COMPLETED|Overall Study||2
3609|NCT02755935|7700|P1|COMPLETED|Overall Study||22
3610|NCT02755935|7700|P1|STARTED|Overall Study||24
3611|NCT02755805|7707|P2|NOT COMPLETED|Overall Study||4
3612|NCT02755805|7708|P1|NOT COMPLETED|Overall Study||2
3613|NCT02755805|7707|P2|COMPLETED|Overall Study||11
3614|NCT02755805|7708|P1|COMPLETED|Overall Study||13
3615|NCT02755805|7707|P2|STARTED|Overall Study||15
3616|NCT02755805|7708|P1|STARTED|Overall Study||15
3617|NCT02755090|7722|P2|NOT COMPLETED|Overall Study||0
3618|NCT02755090|7723|P1|NOT COMPLETED|Overall Study||1
3619|NCT02755090|7722|P2|COMPLETED|Overall Study||20
3620|NCT02755090|7723|P1|COMPLETED|Overall Study||18
3621|NCT02755090|7722|P2|STARTED|Overall Study||20
3622|NCT02755090|7723|P1|STARTED|Overall Study||19
3623|NCT02754492|7735|P4|NOT COMPLETED|Overall Study||23
3624|NCT02754492|7736|P3|NOT COMPLETED|Overall Study||2
3625|NCT02754492|7737|P2|NOT COMPLETED|Overall Study||2
3626|NCT02754492|7738|P1|NOT COMPLETED|Overall Study||4
3627|NCT02754492|7735|P4|COMPLETED|Overall Study||0
3628|NCT02754492|7736|P3|COMPLETED|Overall Study||93
3629|NCT02754492|7737|P2|COMPLETED|Overall Study||93
3630|NCT02754492|7738|P1|COMPLETED|Overall Study||93
3631|NCT02754492|7735|P4|STARTED|Overall Study||23
3632|NCT02754492|7736|P3|STARTED|Overall Study||95
3633|NCT02754492|7737|P2|STARTED|Overall Study||95
3634|NCT02754492|7738|P1|STARTED|Overall Study||97
3635|NCT02754440|7754|P4|NOT COMPLETED|Overall Study||35
3636|NCT02754440|7755|P3|NOT COMPLETED|Overall Study||7
3637|NCT02754440|7756|P2|NOT COMPLETED|Overall Study||8
3638|NCT02754440|7757|P1|NOT COMPLETED|Overall Study||6
3639|NCT02754440|7754|P4|COMPLETED|Overall Study||0
3640|NCT02754440|7755|P3|COMPLETED|Overall Study||93
3641|NCT02754440|7756|P2|COMPLETED|Overall Study||93
3642|NCT02754440|7757|P1|COMPLETED|Overall Study||93
3643|NCT02754440|7754|P4|STARTED|Overall Study||35
3644|NCT02754440|7755|P3|STARTED|Overall Study||100
3645|NCT02754440|7756|P2|STARTED|Overall Study||101
3646|NCT02754440|7757|P1|STARTED|Overall Study||99
3647|NCT02753699|7772|P3|NOT COMPLETED|Overall Study||23
3648|NCT02753699|7773|P2|NOT COMPLETED|Overall Study||43
3649|NCT02753699|7774|P1|NOT COMPLETED|Overall Study||14
3650|NCT02753699|7772|P3|COMPLETED|Overall Study||139
3651|NCT02753699|7773|P2|COMPLETED|Overall Study||354
3652|NCT02753699|7774|P1|COMPLETED|Overall Study||150
3653|NCT02753699|7772|P3|STARTED|Overall Study||162
3654|NCT02753699|7773|P2|STARTED|Overall Study||397
3655|NCT02753699|7774|P1|STARTED|Overall Study||164
3656|NCT02753413|7790|P2|NOT COMPLETED|Overall Study||0
3657|NCT02753413|7791|P1|NOT COMPLETED|Overall Study||0
3658|NCT02753413|7790|P2|COMPLETED|Overall Study||51
3659|NCT02753413|7791|P1|COMPLETED|Overall Study||49
3660|NCT02753413|7790|P2|STARTED|Overall Study||51
3661|NCT02753413|7791|P1|STARTED|Overall Study||49
3662|NCT02753075|7826|P3|NOT COMPLETED|Overall Study||3
3663|NCT02753075|7827|P2|NOT COMPLETED|Overall Study||3
3664|NCT02753075|7828|P1|NOT COMPLETED|Overall Study||8
3665|NCT02753075|7826|P3|COMPLETED|Overall Study||78
3666|NCT02753075|7827|P2|COMPLETED|Overall Study||77
3667|NCT02753075|7828|P1|COMPLETED|Overall Study||71
3668|NCT02753075|7826|P3|STARTED|Overall Study||81
3669|NCT02753075|7827|P2|STARTED|Overall Study||80
3670|NCT02753075|7828|P1|STARTED|Overall Study||79
3671|NCT02752802|7855|P2|NOT COMPLETED|Overall Study||0
3672|NCT02752802|7856|P1|NOT COMPLETED|Overall Study||1
3673|NCT02752802|7855|P2|COMPLETED|Overall Study||48
3674|NCT02752802|7856|P1|COMPLETED|Overall Study||47
3675|NCT02752802|7855|P2|STARTED|Overall Study||48
3676|NCT02752802|7856|P1|STARTED|Overall Study||48
3677|NCT02752633|7865|P1|NOT COMPLETED|Overall Study||1
3678|NCT02752633|7865|P1|COMPLETED|Overall Study||8
3679|NCT02752633|7865|P1|STARTED|Overall Study||9
3680|NCT02752490|7871|P2|NOT COMPLETED|Overall Study||0
3681|NCT02752490|7872|P1|NOT COMPLETED|Overall Study||0
3682|NCT02752490|7871|P2|COMPLETED|Overall Study||435
3683|NCT02752490|7872|P1|COMPLETED|Overall Study||409
3684|NCT02752490|7871|P2|STARTED|Overall Study||435
3685|NCT02752490|7872|P1|STARTED|Overall Study||409
3686|NCT02751450|7894|P2|NOT COMPLETED|Overall Study||0
3687|NCT02751450|7895|P1|NOT COMPLETED|Overall Study||1
3688|NCT02751450|7894|P2|COMPLETED|Overall Study||116
3689|NCT02751450|7895|P1|COMPLETED|Overall Study||116
3690|NCT02751450|7894|P2|STARTED|Overall Study||116
3691|NCT02751450|7895|P1|STARTED|Overall Study||117
3692|NCT02751320|7907|P1|NOT COMPLETED|Overall Study||3
3693|NCT02751320|7907|P1|COMPLETED|Overall Study||42
3694|NCT02751320|7907|P1|Received Reference Product 3|Overall Study||28
3695|NCT02751320|7907|P1|Received Reference Product 2|Overall Study||28
3696|NCT02751320|7907|P1|Received Reference Product 1|Overall Study||29
3697|NCT02751320|7907|P1|Received Test Prodcut 3|Overall Study||28
3698|NCT02751320|7907|P1|Received Test Prodcut 2|Overall Study||28
3699|NCT02751320|7907|P1|Received Test Product 1|Overall Study||29
3700|NCT02751320|7907|P1|STARTED|Overall Study||45
3701|NCT02750943|7945|P2|NOT COMPLETED|Overall Study||9
3702|NCT02750943|7946|P1|NOT COMPLETED|Overall Study||6
3703|NCT02750943|7945|P2|COMPLETED|Overall Study||119
3704|NCT02750943|7946|P1|COMPLETED|Overall Study||119
3705|NCT02750943|7945|P2|STARTED|Overall Study||128
3706|NCT02750943|7946|P1|STARTED|Overall Study||125
3707|NCT02750930|7960|P1|NOT COMPLETED|Overall Study||8
3708|NCT02750930|7960|P1|COMPLETED|Overall Study||0
3709|NCT02750930|7960|P1|STARTED|Overall Study||8
3710|NCT02750813|7972|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
3711|NCT02750813|7973|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
3712|NCT02750813|7972|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
3713|NCT02750813|7973|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
3714|NCT02750813|7972|P2|STARTED|Period 2, Second 14 Days of Wear||120
3715|NCT02750813|7973|P1|STARTED|Period 2, Second 14 Days of Wear||124
3716|NCT02750813|7972|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
3717|NCT02750813|7973|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
3718|NCT02750813|7972|P2|COMPLETED|Period 1, First 14 Days of Wear||120
3719|NCT02750813|7973|P1|COMPLETED|Period 1, First 14 Days of Wear||124
3720|NCT02750813|7972|P2|STARTED|Period 1, First 14 Days of Wear||121
3721|NCT02750813|7973|P1|STARTED|Period 1, First 14 Days of Wear||125
3722|NCT02750709|7982|P6|NOT COMPLETED|Treatment Period 3||0
3723|NCT02750709|7983|P5|NOT COMPLETED|Treatment Period 3||0
3724|NCT02750709|7984|P4|NOT COMPLETED|Treatment Period 3||0
3725|NCT02750709|7985|P3|NOT COMPLETED|Treatment Period 3||0
3726|NCT02750709|7986|P2|NOT COMPLETED|Treatment Period 3||0
3727|NCT02750709|7987|P1|NOT COMPLETED|Treatment Period 3||0
3728|NCT02750709|7982|P6|COMPLETED|Treatment Period 3||3
3729|NCT02750709|7983|P5|COMPLETED|Treatment Period 3||4
3730|NCT02750709|7984|P4|COMPLETED|Treatment Period 3||4
3731|NCT02750709|7985|P3|COMPLETED|Treatment Period 3||4
3732|NCT02750709|7986|P2|COMPLETED|Treatment Period 3||4
3733|NCT02750709|7987|P1|COMPLETED|Treatment Period 3||4
3734|NCT02750709|7982|P6|STARTED|Treatment Period 3||3
3735|NCT02750709|7983|P5|STARTED|Treatment Period 3||4
3736|NCT02750709|7984|P4|STARTED|Treatment Period 3||4
3737|NCT02750709|7985|P3|STARTED|Treatment Period 3||4
3738|NCT02750709|7986|P2|STARTED|Treatment Period 3||4
3739|NCT02750709|7987|P1|STARTED|Treatment Period 3||4
3740|NCT02750709|7982|P6|NOT COMPLETED|Treatment Period 2||0
3741|NCT02750709|7983|P5|NOT COMPLETED|Treatment Period 2||0
3742|NCT02750709|7984|P4|NOT COMPLETED|Treatment Period 2||0
3743|NCT02750709|7985|P3|NOT COMPLETED|Treatment Period 2||0
3744|NCT02750709|7986|P2|NOT COMPLETED|Treatment Period 2||0
3745|NCT02750709|7987|P1|NOT COMPLETED|Treatment Period 2||0
3746|NCT02750709|7982|P6|COMPLETED|Treatment Period 2||3
3747|NCT02750709|7983|P5|COMPLETED|Treatment Period 2||4
3748|NCT02750709|7984|P4|COMPLETED|Treatment Period 2||4
3749|NCT02750709|7985|P3|COMPLETED|Treatment Period 2||4
3750|NCT02750709|7986|P2|COMPLETED|Treatment Period 2||4
3751|NCT02750709|7987|P1|COMPLETED|Treatment Period 2||4
3752|NCT02750709|7982|P6|STARTED|Treatment Period 2||3
3753|NCT02750709|7983|P5|STARTED|Treatment Period 2||4
3754|NCT02750709|7984|P4|STARTED|Treatment Period 2||4
3755|NCT02750709|7985|P3|STARTED|Treatment Period 2||4
3756|NCT02750709|7986|P2|STARTED|Treatment Period 2||4
3757|NCT02750709|7987|P1|STARTED|Treatment Period 2||4
3758|NCT02750709|7982|P6|NOT COMPLETED|Treatment Period 1||1
3759|NCT02750709|7983|P5|NOT COMPLETED|Treatment Period 1||0
3760|NCT02750709|7984|P4|NOT COMPLETED|Treatment Period 1||0
3761|NCT02750709|7985|P3|NOT COMPLETED|Treatment Period 1||0
3762|NCT02750709|7986|P2|NOT COMPLETED|Treatment Period 1||0
3763|NCT02750709|7987|P1|NOT COMPLETED|Treatment Period 1||0
3764|NCT02750709|7982|P6|COMPLETED|Treatment Period 1||3
3765|NCT02750709|7983|P5|COMPLETED|Treatment Period 1||4
3766|NCT02750709|7984|P4|COMPLETED|Treatment Period 1||4
3767|NCT02750709|7985|P3|COMPLETED|Treatment Period 1||4
3768|NCT02750709|7986|P2|COMPLETED|Treatment Period 1||4
3769|NCT02750709|7987|P1|COMPLETED|Treatment Period 1||4
3770|NCT02750709|7982|P6|STARTED|Treatment Period 1||4
3771|NCT02750709|7983|P5|STARTED|Treatment Period 1||4
3772|NCT02750709|7984|P4|STARTED|Treatment Period 1||4
3773|NCT02750709|7985|P3|STARTED|Treatment Period 1||4
3774|NCT02750709|7986|P2|STARTED|Treatment Period 1||4
3775|NCT02750709|7987|P1|STARTED|Treatment Period 1||4
3776|NCT02750345|8013|P6|NOT COMPLETED|Intervention 3||0
3777|NCT02750345|8014|P5|NOT COMPLETED|Intervention 3||0
3778|NCT02750345|8015|P4|NOT COMPLETED|Intervention 3||0
3779|NCT02750345|8016|P3|NOT COMPLETED|Intervention 3||0
3780|NCT02750345|8017|P2|NOT COMPLETED|Intervention 3||0
3781|NCT02750345|8018|P1|NOT COMPLETED|Intervention 3||0
3782|NCT02750345|8013|P6|COMPLETED|Intervention 3||4
3783|NCT02750345|8014|P5|COMPLETED|Intervention 3||3
3784|NCT02750345|8015|P4|COMPLETED|Intervention 3||4
3785|NCT02750345|8016|P3|COMPLETED|Intervention 3||4
3786|NCT02750345|8017|P2|COMPLETED|Intervention 3||4
3787|NCT02750345|8018|P1|COMPLETED|Intervention 3||4
3788|NCT02750345|8013|P6|STARTED|Intervention 3||4
3789|NCT02750345|8014|P5|STARTED|Intervention 3||3
3790|NCT02750345|8015|P4|STARTED|Intervention 3||4
3791|NCT02750345|8016|P3|STARTED|Intervention 3||4
3792|NCT02750345|8017|P2|STARTED|Intervention 3||4
3793|NCT02750345|8018|P1|STARTED|Intervention 3||4
3794|NCT02750345|8013|P6|NOT COMPLETED|Intervention 2||0
3795|NCT02750345|8014|P5|NOT COMPLETED|Intervention 2||0
3796|NCT02750345|8015|P4|NOT COMPLETED|Intervention 2||0
3797|NCT02750345|8016|P3|NOT COMPLETED|Intervention 2||0
3798|NCT02750345|8017|P2|NOT COMPLETED|Intervention 2||0
3799|NCT02750345|8018|P1|NOT COMPLETED|Intervention 2||0
3800|NCT02750345|8013|P6|COMPLETED|Intervention 2||4
3801|NCT02750345|8014|P5|COMPLETED|Intervention 2||3
3802|NCT02750345|8015|P4|COMPLETED|Intervention 2||4
3803|NCT02750345|8016|P3|COMPLETED|Intervention 2||4
3804|NCT02750345|8017|P2|COMPLETED|Intervention 2||4
3805|NCT02750345|8018|P1|COMPLETED|Intervention 2||4
3806|NCT02750345|8013|P6|STARTED|Intervention 2||4
3807|NCT02750345|8014|P5|STARTED|Intervention 2||3
3808|NCT02750345|8015|P4|STARTED|Intervention 2||4
3809|NCT02750345|8016|P3|STARTED|Intervention 2||4
3810|NCT02750345|8017|P2|STARTED|Intervention 2||4
3811|NCT02750345|8018|P1|STARTED|Intervention 2||4
3812|NCT02750345|8013|P6|NOT COMPLETED|Intervention 1||0
3813|NCT02750345|8014|P5|NOT COMPLETED|Intervention 1||1
3814|NCT02750345|8015|P4|NOT COMPLETED|Intervention 1||0
3815|NCT02750345|8016|P3|NOT COMPLETED|Intervention 1||0
3816|NCT02750345|8017|P2|NOT COMPLETED|Intervention 1||0
3817|NCT02750345|8018|P1|NOT COMPLETED|Intervention 1||0
3818|NCT02750345|8013|P6|COMPLETED|Intervention 1||4
3819|NCT02750345|8014|P5|COMPLETED|Intervention 1||3
3820|NCT02750345|8015|P4|COMPLETED|Intervention 1||4
3821|NCT02750345|8016|P3|COMPLETED|Intervention 1||4
3822|NCT02750345|8017|P2|COMPLETED|Intervention 1||4
3823|NCT02750345|8018|P1|COMPLETED|Intervention 1||4
3824|NCT02750345|8013|P6|STARTED|Intervention 1||4
3825|NCT02750345|8014|P5|STARTED|Intervention 1||4
3826|NCT02750345|8015|P4|STARTED|Intervention 1||4
3827|NCT02750345|8016|P3|STARTED|Intervention 1||4
3828|NCT02750345|8017|P2|STARTED|Intervention 1||4
3829|NCT02750345|8018|P1|STARTED|Intervention 1||4
3830|NCT02750332|8044|P2|NOT COMPLETED|Treatment Period 2||0
3831|NCT02750332|8045|P1|NOT COMPLETED|Treatment Period 2||0
3832|NCT02750332|8044|P2|COMPLETED|Treatment Period 2||9
3833|NCT02750332|8045|P1|COMPLETED|Treatment Period 2||10
3834|NCT02750332|8044|P2|STARTED|Treatment Period 2||9
3835|NCT02750332|8045|P1|STARTED|Treatment Period 2||10
3836|NCT02750332|8044|P2|NOT COMPLETED|Treatment Period 1||1
3837|NCT02750332|8045|P1|NOT COMPLETED|Treatment Period 1||0
3838|NCT02750332|8044|P2|COMPLETED|Treatment Period 1||9
3839|NCT02750332|8045|P1|COMPLETED|Treatment Period 1||10
3840|NCT02750332|8044|P2|STARTED|Treatment Period 1||10
3841|NCT02750332|8045|P1|STARTED|Treatment Period 1||10
3842|NCT02750267|8065|P2|NOT COMPLETED|Overall Study||0
3843|NCT02750267|8066|P1|NOT COMPLETED|Overall Study||0
3844|NCT02750267|8065|P2|COMPLETED|Overall Study||6
3845|NCT02750267|8066|P1|COMPLETED|Overall Study||6
3846|NCT02750267|8065|P2|STARTED|Overall Study||6
3847|NCT02750267|8066|P1|STARTED|Overall Study||6
3848|NCT02748213|8106|P2|NOT COMPLETED|Overall Study||112
3849|NCT02748213|8107|P1|NOT COMPLETED|Overall Study||113
3850|NCT02748213|8106|P2|COMPLETED|Overall Study||0
3851|NCT02748213|8107|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
3852|NCT02748213|8106|P2|Treated|Overall Study||110
3853|NCT02748213|8107|P1|Treated|Overall Study||112
3854|NCT02748213|8106|P2|STARTED|Overall Study||112
3855|NCT02748213|8107|P1|STARTED|Overall Study||113
3856|NCT02746809|8123|P1|NOT COMPLETED|Baseline-6 Months||5
3857|NCT02746809|8123|P1|COMPLETED|Baseline-6 Months||54
3858|NCT02746809|8123|P1|STARTED|Baseline-6 Months||59
3859|NCT02746809|8123|P1|NOT COMPLETED|Baseline- 30 Days||1
3860|NCT02746809|8123|P1|COMPLETED|Baseline- 30 Days||59
3861|NCT02746809|8123|P1|STARTED|Baseline- 30 Days||60
3862|NCT02746679|8143|P2|NOT COMPLETED|Overall Study||6
3863|NCT02746679|8144|P1|NOT COMPLETED|Overall Study||4
3864|NCT02746679|8143|P2|COMPLETED|Overall Study||75
3865|NCT02746679|8144|P1|COMPLETED|Overall Study||76
3866|NCT02746679|8143|P2|STARTED|Overall Study||81
3867|NCT02746679|8144|P1|STARTED|Overall Study||80
3868|NCT02746406|8174|P1|NOT COMPLETED|Overall Study||0
3869|NCT02746406|8174|P1|COMPLETED|Overall Study||5
3870|NCT02746406|8174|P1|STARTED|Overall Study||5
3871|NCT02746107|8178|P1|NOT COMPLETED|Overall Study||0
3872|NCT02746107|8178|P1|COMPLETED|Overall Study||968
3873|NCT02746107|8178|P1|CHA2DS2-VASC Score = 5|Overall Study||192
3874|NCT02746107|8178|P1|CHA2DS2-VASC Score = 4|Overall Study||197
3875|NCT02746107|8178|P1|CHA2DS2-VASC Score = 3|Overall Study||195
3876|NCT02746107|8178|P1|CHA2DS2-VASC Score = 2|Overall Study||189
3877|NCT02746107|8178|P1|CHA2DS2-VASC Score = 1|Overall Study||195
3878|NCT02746107|8178|P1|Target=Physician|Overall Study||482
3879|NCT02746107|8178|P1|Target=Patient|Overall Study||486
3880|NCT02746107|8178|P1|5year Risk Estimate|Overall Study||485
3881|NCT02746107|8178|P1|1year Risk Estimate|Overall Study||483
3882|NCT02746107|8178|P1|1 Diagram DA|Overall Study||486
3883|NCT02746107|8178|P1|2 Diagrams DA|Overall Study||482
3884|NCT02746107|8178|P1|STARTED|Overall Study||968
3885|NCT02745626|8196|P3|NOT COMPLETED|Overall Study||3
3886|NCT02745626|8197|P2|NOT COMPLETED|Overall Study||6
3887|NCT02745626|8198|P1|NOT COMPLETED|Overall Study||3
3888|NCT02745626|8196|P3|COMPLETED|Overall Study||19
3889|NCT02745626|8197|P2|COMPLETED|Overall Study||16
3890|NCT02745626|8198|P1|COMPLETED|Overall Study||21
3891|NCT02745626|8196|P3|STARTED|Overall Study||22
3892|NCT02745626|8197|P2|STARTED|Overall Study||22
3893|NCT02745626|8198|P1|STARTED|Overall Study||24
3894|NCT02745392|8228|P4|NOT COMPLETED|Overall Study||0
3895|NCT02745392|8229|P3|NOT COMPLETED|Overall Study||0
3896|NCT02745392|8230|P2|NOT COMPLETED|Overall Study||1
3897|NCT02745392|8231|P1|NOT COMPLETED|Overall Study||0
3898|NCT02745392|8228|P4|COMPLETED|Overall Study||92
3899|NCT02745392|8229|P3|COMPLETED|Overall Study||92
3900|NCT02745392|8230|P2|COMPLETED|Overall Study||89
3901|NCT02745392|8231|P1|COMPLETED|Overall Study||91
3902|NCT02745392|8228|P4|STARTED|Overall Study||92
3903|NCT02745392|8229|P3|STARTED|Overall Study||92
3904|NCT02745392|8230|P2|STARTED|Overall Study||90
3905|NCT02745392|8231|P1|STARTED|Overall Study||91
3906|NCT02743962|8247|P2|NOT COMPLETED|Overall Study||0
3907|NCT02743962|8248|P1|NOT COMPLETED|Overall Study||1
3908|NCT02743962|8247|P2|COMPLETED|Overall Study||5
3909|NCT02743962|8248|P1|COMPLETED|Overall Study||4
3910|NCT02743962|8247|P2|STARTED|Overall Study||5
3911|NCT02743962|8248|P1|STARTED|Overall Study||5
3912|NCT02743936|8269|P2|NOT COMPLETED|Overall Study||0
3913|NCT02743936|8270|P1|NOT COMPLETED|Overall Study||0
3914|NCT02743936|8269|P2|COMPLETED|Overall Study||32
3915|NCT02743936|8270|P1|COMPLETED|Overall Study||32
3916|NCT02743936|8269|P2|STARTED|Overall Study||32
3917|NCT02743936|8270|P1|STARTED|Overall Study||32
3918|NCT02743780|8283|P5|NOT COMPLETED|Part 3 (7 Days)||0
3919|NCT02743780|8284|P4|NOT COMPLETED|Part 3 (7 Days)||0
3920|NCT02743780|8285|P3|NOT COMPLETED|Part 3 (7 Days)||1
3921|NCT02743780|8286|P2|NOT COMPLETED|Part 3 (7 Days)||0
3922|NCT02743780|8287|P1|NOT COMPLETED|Part 3 (7 Days)||0
3923|NCT02743780|8283|P5|COMPLETED|Part 3 (7 Days)||25
3924|NCT02743780|8284|P4|COMPLETED|Part 3 (7 Days)||0
3925|NCT02743780|8285|P3|COMPLETED|Part 3 (7 Days)||24
3926|NCT02743780|8286|P2|COMPLETED|Part 3 (7 Days)||0
3927|NCT02743780|8287|P1|COMPLETED|Part 3 (7 Days)||0
3928|NCT02743780|8283|P5|STARTED|Part 3 (7 Days)||25
3929|NCT02743780|8284|P4|STARTED|Part 3 (7 Days)||0
3930|NCT02743780|8285|P3|STARTED|Part 3 (7 Days)||25
3931|NCT02743780|8286|P2|STARTED|Part 3 (7 Days)||0
3932|NCT02743780|8287|P1|STARTED|Part 3 (7 Days)||0
3933|NCT02743780|8283|P5|NOT COMPLETED|Part 2 (8 Days)||0
3934|NCT02743780|8284|P4|NOT COMPLETED|Part 2 (8 Days)||0
3935|NCT02743780|8285|P3|NOT COMPLETED|Part 2 (8 Days)||0
3936|NCT02743780|8286|P2|NOT COMPLETED|Part 2 (8 Days)||0
3937|NCT02743780|8287|P1|NOT COMPLETED|Part 2 (8 Days)||0
3938|NCT02743780|8283|P5|COMPLETED|Part 2 (8 Days)||4
3939|NCT02743780|8284|P4|COMPLETED|Part 2 (8 Days)||0
3940|NCT02743780|8285|P3|COMPLETED|Part 2 (8 Days)||6
3941|NCT02743780|8286|P2|COMPLETED|Part 2 (8 Days)||6
3942|NCT02743780|8287|P1|COMPLETED|Part 2 (8 Days)||0
3943|NCT02743780|8283|P5|STARTED|Part 2 (8 Days)||4
3944|NCT02743780|8284|P4|STARTED|Part 2 (8 Days)||0
3945|NCT02743780|8285|P3|STARTED|Part 2 (8 Days)||6
3946|NCT02743780|8286|P2|STARTED|Part 2 (8 Days)||6
3947|NCT02743780|8287|P1|STARTED|Part 2 (8 Days)||0
3948|NCT02743780|8283|P5|NOT COMPLETED|Part 1 (3 Days)||0
3949|NCT02743780|8284|P4|NOT COMPLETED|Part 1 (3 Days)||0
3950|NCT02743780|8285|P3|NOT COMPLETED|Part 1 (3 Days)||0
3951|NCT02743780|8286|P2|NOT COMPLETED|Part 1 (3 Days)||0
3952|NCT02743780|8287|P1|NOT COMPLETED|Part 1 (3 Days)||0
3953|NCT02743780|8283|P5|COMPLETED|Part 1 (3 Days)||8
3954|NCT02743780|8284|P4|COMPLETED|Part 1 (3 Days)||6
3955|NCT02743780|8285|P3|COMPLETED|Part 1 (3 Days)||6
3956|NCT02743780|8286|P2|COMPLETED|Part 1 (3 Days)||6
3957|NCT02743780|8287|P1|COMPLETED|Part 1 (3 Days)||6
3958|NCT02743780|8283|P5|STARTED|Part 1 (3 Days)||8
3959|NCT02743780|8284|P4|STARTED|Part 1 (3 Days)||6
3960|NCT02743780|8285|P3|STARTED|Part 1 (3 Days)||6
3961|NCT02743780|8286|P2|STARTED|Part 1 (3 Days)||6
3962|NCT02743780|8287|P1|STARTED|Part 1 (3 Days)||6
3963|NCT02743702|8334|P2|NOT COMPLETED|Overall Study||0
3964|NCT02743702|8335|P1|NOT COMPLETED|Overall Study||0
3965|NCT02743702|8334|P2|COMPLETED|Overall Study||10
3966|NCT02743702|8335|P1|COMPLETED|Overall Study||11
3967|NCT02743702|8334|P2|STARTED|Overall Study||10
3968|NCT02743702|8335|P1|STARTED|Overall Study||11
3969|NCT02743117|8343|P2|NOT COMPLETED|Overall Study||1
3970|NCT02743117|8344|P1|NOT COMPLETED|Overall Study||1
3971|NCT02743117|8343|P2|COMPLETED|Overall Study||240
3972|NCT02743117|8344|P1|COMPLETED|Overall Study||59
3973|NCT02743117|8343|P2|Treated|Overall Study||241
3974|NCT02743117|8344|P1|Treated|Overall Study||59
3975|NCT02743117|8343|P2|STARTED|Overall Study||241
3976|NCT02743117|8344|P1|STARTED|Overall Study||60
3977|NCT02742987|8360|P2|NOT COMPLETED|Overall Study||0
3978|NCT02742987|8361|P1|NOT COMPLETED|Overall Study||0
3979|NCT02742987|8360|P2|COMPLETED|Overall Study||21
3980|NCT02742987|8361|P1|COMPLETED|Overall Study||21
3981|NCT02742987|8360|P2|STARTED|Overall Study||21
3982|NCT02742987|8361|P1|STARTED|Overall Study||21
3983|NCT02742818|8369|P2|NOT COMPLETED|Overall Study||2
3984|NCT02742818|8370|P1|NOT COMPLETED|Overall Study||0
3985|NCT02742818|8369|P2|COMPLETED|Overall Study||23
3986|NCT02742818|8370|P1|COMPLETED|Overall Study||25
3987|NCT02742818|8369|P2|STARTED|Overall Study||25
3988|NCT02742818|8370|P1|STARTED|Overall Study||25
3989|NCT02741245|8389|P5|NOT COMPLETED|Overall Study||2
3990|NCT02741245|8390|P4|NOT COMPLETED|Overall Study||4
3991|NCT02741245|8391|P3|NOT COMPLETED|Overall Study||0
3992|NCT02741245|8392|P2|NOT COMPLETED|Overall Study||1
3993|NCT02741245|8393|P1|NOT COMPLETED|Overall Study||0
3994|NCT02741245|8389|P5|COMPLETED|Overall Study||70
3995|NCT02741245|8390|P4|COMPLETED|Overall Study||67
3996|NCT02741245|8391|P3|COMPLETED|Overall Study||71
3997|NCT02741245|8392|P2|COMPLETED|Overall Study||71
3998|NCT02741245|8393|P1|COMPLETED|Overall Study||35
3999|NCT02741245|8389|P5|STARTED|Overall Study||72
4000|NCT02741245|8390|P4|STARTED|Overall Study||71
4001|NCT02741245|8391|P3|STARTED|Overall Study||71
4002|NCT02741245|8392|P2|STARTED|Overall Study||72
4003|NCT02741245|8393|P1|STARTED|Overall Study||35
4004|NCT02739698|8497|P2|NOT COMPLETED|Overall Study||5
4005|NCT02739698|8498|P1|NOT COMPLETED|Overall Study||6
4006|NCT02739698|8497|P2|COMPLETED|Overall Study||16
4007|NCT02739698|8498|P1|COMPLETED|Overall Study||16
4008|NCT02739698|8497|P2|STARTED|Overall Study||21
4009|NCT02739698|8498|P1|STARTED|Overall Study||22
4010|NCT02739594|8506|P2|NOT COMPLETED|Overall Study||28
4011|NCT02739594|8507|P1|NOT COMPLETED|Overall Study||25
4012|NCT02739594|8506|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
4013|NCT02739594|8507|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
4014|NCT02739594|8506|P2|Completed at Week 96|Overall Study||10
4015|NCT02739594|8507|P1|Completed at Week 96|Overall Study||10
4016|NCT02739594|8506|P2|Completed at Week 44|Overall Study||5
4017|NCT02739594|8507|P1|Completed at Week 44|Overall Study||11
4018|NCT02739594|8506|P2|STARTED|Overall Study||43
4019|NCT02739594|8507|P1|STARTED|Overall Study||46
4020|NCT02739321|8539|P2|NOT COMPLETED|Overall Study||4
4021|NCT02739321|8540|P1|NOT COMPLETED|Overall Study||3
4022|NCT02739321|8539|P2|COMPLETED|Overall Study||18
4023|NCT02739321|8540|P1|COMPLETED|Overall Study||20
4024|NCT02739321|8539|P2|STARTED|Overall Study||22
4025|NCT02739321|8540|P1|STARTED|Overall Study||23
4026|NCT02738853|8584|P1|NOT COMPLETED|30 Days- 6 Months||2
4027|NCT02738853|8584|P1|COMPLETED|30 Days- 6 Months||57
4028|NCT02738853|8584|P1|STARTED|30 Days- 6 Months||59
4029|NCT02738853|8584|P1|NOT COMPLETED|Baseline -30 Days||1
4030|NCT02738853|8584|P1|COMPLETED|Baseline -30 Days||59
4031|NCT02738853|8584|P1|STARTED|Baseline -30 Days||60
4032|NCT02738333|8603|P3|NOT COMPLETED|Overall Study||0
4033|NCT02738333|8604|P2|NOT COMPLETED|Overall Study||0
4034|NCT02738333|8605|P1|NOT COMPLETED|Overall Study||2
4035|NCT02738333|8603|P3|COMPLETED|Overall Study||25
4036|NCT02738333|8604|P2|COMPLETED|Overall Study||108
4037|NCT02738333|8605|P1|COMPLETED|Overall Study||104
4038|NCT02738333|8603|P3|STARTED|Overall Study||25
4039|NCT02738333|8604|P2|STARTED|Overall Study||108
4040|NCT02738333|8605|P1|STARTED|Overall Study||106
4041|NCT02738138|8681|P2|NOT COMPLETED|Overall Study||1
4042|NCT02738138|8682|P1|NOT COMPLETED|Overall Study||3
4043|NCT02738138|8681|P2|COMPLETED|Overall Study||15
4044|NCT02738138|8682|P1|COMPLETED|Overall Study||134
4045|NCT02738138|8681|P2|STARTED|Overall Study||16
4046|NCT02738138|8682|P1|STARTED|Overall Study||137
4047|NCT02737852|8689|P1|NOT COMPLETED|Overall Study||2
4048|NCT02737852|8689|P1|COMPLETED|Overall Study||30
4049|NCT02737852|8689|P1|STARTED|Overall Study||32
4050|NCT02737631|8694|P1|NOT COMPLETED|Overall Study||0
4051|NCT02737631|8694|P1|COMPLETED|Overall Study||222
4052|NCT02737631|8694|P1|STARTED|Overall Study||222
4053|NCT02737618|8699|P1|NOT COMPLETED|Overall Study||9
4054|NCT02737618|8699|P1|COMPLETED|Overall Study||34
4055|NCT02737618|8699|P1|STARTED|Overall Study||43
4056|NCT02737592|8704|P1|NOT COMPLETED|Overall Study||1
4057|NCT02737592|8704|P1|COMPLETED|Overall Study||33
4058|NCT02737592|8704|P1|STARTED|Overall Study||34
4059|NCT02736721|8709|P1|NOT COMPLETED|Overall Study||16
4060|NCT02736721|8709|P1|COMPLETED|Overall Study||25
4061|NCT02736721|8709|P1|STARTED|Overall Study||41
4062|NCT02736175|8720|P2|NOT COMPLETED|Overall Study||1
4063|NCT02736175|8721|P1|NOT COMPLETED|Overall Study||2
4064|NCT02736175|8720|P2|COMPLETED|Overall Study||221
4065|NCT02736175|8721|P1|COMPLETED|Overall Study||214
4066|NCT02736175|8720|P2|STARTED|Overall Study||222
4067|NCT02736175|8721|P1|STARTED|Overall Study||216
4068|NCT02735200|8731|P2|NOT COMPLETED|Overall Study||5
4069|NCT02735200|8732|P1|NOT COMPLETED|Overall Study||8
4070|NCT02735200|8731|P2|COMPLETED|Overall Study||345
4071|NCT02735200|8732|P1|COMPLETED|Overall Study||192
4072|NCT02735200|8731|P2|STARTED|Overall Study||350
4073|NCT02735200|8732|P1|STARTED|Overall Study||200
4074|NCT02734940|8740|P2|NOT COMPLETED|Overall Study||0
4075|NCT02734940|8741|P1|NOT COMPLETED|Overall Study||0
4076|NCT02734940|8740|P2|COMPLETED|Overall Study||0
4077|NCT02734940|8741|P1|COMPLETED|Overall Study||0
4078|NCT02734940|8740|P2|STARTED|Overall Study||0
4079|NCT02734940|8741|P1|STARTED|Overall Study||0
4080|NCT02734810|8765|P2|NOT COMPLETED|Overall Study||0
4081|NCT02734810|8766|P1|NOT COMPLETED|Overall Study||2
4082|NCT02734810|8765|P2|COMPLETED|Overall Study||0
4083|NCT02734810|8766|P1|COMPLETED|Overall Study||13
4084|NCT02734810|8765|P2|STARTED|Overall Study||0
4085|NCT02734810|8766|P1|STARTED|Overall Study||15
4086|NCT02734355|8774|P2|NOT COMPLETED|Overall Study||0
4087|NCT02734355|8775|P1|NOT COMPLETED|Overall Study||0
4088|NCT02734355|8774|P2|COMPLETED|Overall Study||30
4089|NCT02734355|8775|P1|COMPLETED|Overall Study||34
4090|NCT02734355|8774|P2|STARTED|Overall Study||30
4091|NCT02734355|8775|P1|STARTED|Overall Study||34
4092|NCT02734212|8807|P2|NOT COMPLETED|Overall Study||10
4093|NCT02734212|8808|P1|NOT COMPLETED|Overall Study||5
4094|NCT02734212|8807|P2|COMPLETED|Overall Study||18
4095|NCT02734212|8808|P1|COMPLETED|Overall Study||24
4096|NCT02734212|8807|P2|STARTED|Overall Study||28
4097|NCT02734212|8808|P1|STARTED|Overall Study||29
4098|NCT02734056|8820|P2|NOT COMPLETED|Overall Study||1
4099|NCT02734056|8821|P1|NOT COMPLETED|Overall Study||0
4100|NCT02734056|8820|P2|COMPLETED|Overall Study||49
4101|NCT02734056|8821|P1|COMPLETED|Overall Study||50
4102|NCT02734056|8820|P2|STARTED|Overall Study||50
4103|NCT02734056|8821|P1|STARTED|Overall Study||50
4104|NCT02732899|8829|P2|NOT COMPLETED|Overall Study||0
4105|NCT02732899|8830|P1|NOT COMPLETED|Overall Study||0
4106|NCT02732899|8829|P2|COMPLETED|Overall Study||10
4107|NCT02732899|8830|P1|COMPLETED|Overall Study||10
4108|NCT02732899|8829|P2|STARTED|Overall Study||10
4109|NCT02732899|8830|P1|STARTED|Overall Study||10
4110|NCT02732639|8838|P1|NOT COMPLETED|Overall Study||1
4111|NCT02732639|8838|P1|COMPLETED|Overall Study||30
4112|NCT02732639|8838|P1|STARTED|Overall Study||31
4113|NCT02732561|8851|P2|NOT COMPLETED|Overall Study||1
4114|NCT02732561|8852|P1|NOT COMPLETED|Overall Study||2
4115|NCT02732561|8851|P2|COMPLETED|Overall Study||4
4116|NCT02732561|8852|P1|COMPLETED|Overall Study||3
4117|NCT02732561|8851|P2|STARTED|Overall Study||5
4118|NCT02732561|8852|P1|STARTED|Overall Study||5
4119|NCT02732327|8862|P2|NOT COMPLETED|Overall Study||1
4120|NCT02732327|8863|P1|NOT COMPLETED|Overall Study||0
4121|NCT02732327|8862|P2|COMPLETED|Overall Study||1
4122|NCT02732327|8863|P1|COMPLETED|Overall Study||0
4123|NCT02732327|8862|P2|STARTED|Overall Study||2
4124|NCT02732327|8863|P1|STARTED|Overall Study||0
4125|NCT02732210|8871|P2|NOT COMPLETED|Overall Study||294
4126|NCT02732210|8872|P1|NOT COMPLETED|Overall Study||85
4127|NCT02732210|8871|P2|COMPLETED|Overall Study||338
4128|NCT02732210|8872|P1|COMPLETED|Overall Study||218
4129|NCT02732210|8871|P2|STARTED|Overall Study||632
4130|NCT02732210|8872|P1|STARTED|Overall Study||303
4131|NCT02731833|8890|P2|NOT COMPLETED|Overall Study||0
4132|NCT02731833|8891|P1|NOT COMPLETED|Overall Study||0
4133|NCT02731833|8890|P2|COMPLETED|Overall Study||111
4134|NCT02731833|8891|P1|COMPLETED|Overall Study||111
4135|NCT02731833|8890|P2|STARTED|Overall Study||111
4136|NCT02731833|8891|P1|STARTED|Overall Study||111
4137|NCT02731313|8903|P1|NOT COMPLETED|Overall Study||0
4138|NCT02731313|8903|P1|COMPLETED|Overall Study||367
4139|NCT02731313|8903|P1|STARTED|Overall Study||367
4140|NCT02731300|8913|P2|NOT COMPLETED|Overall Study||0
4141|NCT02731300|8914|P1|NOT COMPLETED|Overall Study||0
4142|NCT02731300|8913|P2|COMPLETED|Overall Study||7
4143|NCT02731300|8914|P1|COMPLETED|Overall Study||15
4144|NCT02731300|8913|P2|STARTED|Overall Study||7
4145|NCT02731300|8914|P1|STARTED|Overall Study||15
4146|NCT02731131|8924|P2|NOT COMPLETED|Overall Study||2
4147|NCT02731131|8925|P1|NOT COMPLETED|Overall Study||0
4148|NCT02731131|8924|P2|COMPLETED|Overall Study||4
4149|NCT02731131|8925|P1|COMPLETED|Overall Study||6
4150|NCT02731131|8924|P2|STARTED|Overall Study||6
4151|NCT02731131|8925|P1|STARTED|Overall Study||6
4152|NCT02730819|8941|P1|NOT COMPLETED|Overall Study||9
4153|NCT02730819|8941|P1|COMPLETED|Overall Study||10
4154|NCT02730819|8941|P1|Follow-up Week 20|Overall Study||10
4155|NCT02730819|8941|P1|Follow-up Week 16|Overall Study||11
4156|NCT02730819|8941|P1|Follow-up Week 12|Overall Study||11
4157|NCT02730819|8941|P1|Follow-up Week 8|Overall Study||14
4158|NCT02730819|8941|P1|Follow-up Week 4|Overall Study||16
4159|NCT02730819|8941|P1|Follow-up Week 2|Overall Study||15
4160|NCT02730819|8941|P1|STARTED|Overall Study||19
4161|NCT02730351|8947|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
4162|NCT02730351|8948|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
4163|NCT02730351|8947|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
4164|NCT02730351|8948|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
4165|NCT02730351|8947|P2|STARTED|Treatment Period 2 (2 Weeks)||36
4166|NCT02730351|8948|P1|STARTED|Treatment Period 2 (2 Weeks)||35
4167|NCT02730351|8947|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
4168|NCT02730351|8948|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
4169|NCT02730351|8947|P2|COMPLETED|Wash-out Period (2 Weeks)||36
4170|NCT02730351|8948|P1|COMPLETED|Wash-out Period (2 Weeks)||35
4171|NCT02730351|8947|P2|STARTED|Wash-out Period (2 Weeks)||37
4172|NCT02730351|8948|P1|STARTED|Wash-out Period (2 Weeks)||36
4173|NCT02730351|8947|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
4174|NCT02730351|8948|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
4175|NCT02730351|8947|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
4176|NCT02730351|8948|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
4177|NCT02730351|8947|P2|STARTED|Treatment Period 1 (2 Weeks)||37
4178|NCT02730351|8948|P1|STARTED|Treatment Period 1 (2 Weeks)||37
4179|NCT02730260|8962|P2|NOT COMPLETED|Overall Study||75
4180|NCT02730260|8963|P1|NOT COMPLETED|Overall Study||82
4181|NCT02730260|8962|P2|COMPLETED|Overall Study||185
4182|NCT02730260|8963|P1|COMPLETED|Overall Study||176
4183|NCT02730260|8962|P2|STARTED|Overall Study||260
4184|NCT02730260|8963|P1|STARTED|Overall Study||258
4185|NCT02727816|8969|P1|NOT COMPLETED|Overall Study||0
4186|NCT02727816|8969|P1|COMPLETED|Overall Study||35
4187|NCT02727816|8969|P1|STARTED|Overall Study||35
4188|NCT02726971|9018|P2|NOT COMPLETED|Overall Study||9
4189|NCT02726971|9019|P1|NOT COMPLETED|Overall Study||11
4190|NCT02726971|9018|P2|COMPLETED|Overall Study||62
4191|NCT02726971|9019|P1|COMPLETED|Overall Study||59
4192|NCT02726971|9018|P2|STARTED|Overall Study||71
4193|NCT02726971|9019|P1|STARTED|Overall Study||70
4194|NCT02726178|9031|P2|NOT COMPLETED|Overall Study||0
4195|NCT02726178|9032|P1|NOT COMPLETED|Overall Study||0
4196|NCT02726178|9031|P2|COMPLETED|Overall Study||28
4197|NCT02726178|9032|P1|COMPLETED|Overall Study||28
4198|NCT02726178|9031|P2|STARTED|Overall Study||28
4199|NCT02726178|9032|P1|STARTED|Overall Study||28
4200|NCT02726022|9040|P1|NOT COMPLETED|Overall Study||36
4201|NCT02726022|9040|P1|COMPLETED|Overall Study||78
4202|NCT02726022|9040|P1|STARTED|Overall Study||114
4203|NCT02725788|9051|P2|NOT COMPLETED|Overall Study||2
4204|NCT02725788|9052|P1|NOT COMPLETED|Overall Study||1
4205|NCT02725788|9051|P2|COMPLETED|Overall Study||122
4206|NCT02725788|9052|P1|COMPLETED|Overall Study||122
4207|NCT02725788|9051|P2|STARTED|Overall Study||124
4208|NCT02725788|9052|P1|STARTED|Overall Study||123
4209|NCT02724644|9060|P2|NOT COMPLETED|Overall Study||4
4210|NCT02724644|9061|P1|NOT COMPLETED|Overall Study||21
4211|NCT02724644|9060|P2|COMPLETED|Overall Study||182
4212|NCT02724644|9061|P1|COMPLETED|Overall Study||168
4213|NCT02724644|9060|P2|STARTED|Overall Study||186
4214|NCT02724644|9061|P1|STARTED|Overall Study||189
4215|NCT02724449|9089|P1|NOT COMPLETED|Overall Study||0
4216|NCT02724449|9089|P1|COMPLETED|Overall Study||16
4217|NCT02724449|9089|P1|STARTED|Overall Study||16
4218|NCT02724111|9095|P2|NOT COMPLETED|Overall Study||5
4219|NCT02724111|9096|P1|NOT COMPLETED|Overall Study||2
4220|NCT02724111|9095|P2|COMPLETED|Overall Study||40
4221|NCT02724111|9096|P1|COMPLETED|Overall Study||43
4222|NCT02724111|9095|P2|STARTED|Overall Study||45
4223|NCT02724111|9096|P1|STARTED|Overall Study||45
4224|NCT02723201|9119|P3|NOT COMPLETED|Fourth Intervention Period||0
4225|NCT02723201|9120|P2|NOT COMPLETED|Fourth Intervention Period||0
4226|NCT02723201|9121|P1|NOT COMPLETED|Fourth Intervention Period||0
4227|NCT02723201|9119|P3|COMPLETED|Fourth Intervention Period||0
4228|NCT02723201|9120|P2|COMPLETED|Fourth Intervention Period||0
4229|NCT02723201|9121|P1|COMPLETED|Fourth Intervention Period||9
4230|NCT02723201|9119|P3|STARTED|Fourth Intervention Period||0
4231|NCT02723201|9120|P2|STARTED|Fourth Intervention Period||0
4232|NCT02723201|9121|P1|STARTED|Fourth Intervention Period||9
4233|NCT02723201|9119|P3|NOT COMPLETED|Washout Period 3||0
4234|NCT02723201|9120|P2|NOT COMPLETED|Washout Period 3||0
4235|NCT02723201|9121|P1|NOT COMPLETED|Washout Period 3||0
4236|NCT02723201|9119|P3|COMPLETED|Washout Period 3||0
4237|NCT02723201|9120|P2|COMPLETED|Washout Period 3||0
4238|NCT02723201|9121|P1|COMPLETED|Washout Period 3||9
4239|NCT02723201|9119|P3|STARTED|Washout Period 3||0
4240|NCT02723201|9120|P2|STARTED|Washout Period 3||0
4241|NCT02723201|9121|P1|STARTED|Washout Period 3||9
4242|NCT02723201|9119|P3|NOT COMPLETED|Third Intervention Period||0
4243|NCT02723201|9120|P2|NOT COMPLETED|Third Intervention Period||0
4244|NCT02723201|9121|P1|NOT COMPLETED|Third Intervention Period||0
4245|NCT02723201|9119|P3|COMPLETED|Third Intervention Period||0
4246|NCT02723201|9120|P2|COMPLETED|Third Intervention Period||0
4247|NCT02723201|9121|P1|COMPLETED|Third Intervention Period||9
4248|NCT02723201|9119|P3|STARTED|Third Intervention Period||0
4249|NCT02723201|9120|P2|STARTED|Third Intervention Period||0
4250|NCT02723201|9121|P1|STARTED|Third Intervention Period||9
4251|NCT02723201|9119|P3|NOT COMPLETED|Washout Period 2||0
4252|NCT02723201|9120|P2|NOT COMPLETED|Washout Period 2||0
4253|NCT02723201|9121|P1|NOT COMPLETED|Washout Period 2||0
4254|NCT02723201|9119|P3|COMPLETED|Washout Period 2||0
4255|NCT02723201|9120|P2|COMPLETED|Washout Period 2||0
4256|NCT02723201|9121|P1|COMPLETED|Washout Period 2||9
4257|NCT02723201|9119|P3|STARTED|Washout Period 2||0
4258|NCT02723201|9120|P2|STARTED|Washout Period 2||0
4259|NCT02723201|9121|P1|STARTED|Washout Period 2||9
4260|NCT02723201|9119|P3|NOT COMPLETED|Second Intervention Period||0
4261|NCT02723201|9120|P2|NOT COMPLETED|Second Intervention Period||0
4262|NCT02723201|9121|P1|NOT COMPLETED|Second Intervention Period||2
4263|NCT02723201|9119|P3|COMPLETED|Second Intervention Period||7
4264|NCT02723201|9120|P2|COMPLETED|Second Intervention Period||7
4265|NCT02723201|9121|P1|COMPLETED|Second Intervention Period||9
4266|NCT02723201|9119|P3|STARTED|Second Intervention Period||7
4267|NCT02723201|9120|P2|STARTED|Second Intervention Period||7
4268|NCT02723201|9121|P1|STARTED|Second Intervention Period||11
4269|NCT02723201|9119|P3|NOT COMPLETED|Washout Period 1||0
4270|NCT02723201|9120|P2|NOT COMPLETED|Washout Period 1||0
4271|NCT02723201|9121|P1|NOT COMPLETED|Washout Period 1||0
4272|NCT02723201|9119|P3|COMPLETED|Washout Period 1||7
4273|NCT02723201|9120|P2|COMPLETED|Washout Period 1||7
4274|NCT02723201|9121|P1|COMPLETED|Washout Period 1||11
4275|NCT02723201|9119|P3|STARTED|Washout Period 1||7
4276|NCT02723201|9120|P2|STARTED|Washout Period 1||7
4277|NCT02723201|9121|P1|STARTED|Washout Period 1||11
4278|NCT02723201|9119|P3|NOT COMPLETED|First Intervention Period||0
4279|NCT02723201|9120|P2|NOT COMPLETED|First Intervention Period||0
4280|NCT02723201|9121|P1|NOT COMPLETED|First Intervention Period||0
4281|NCT02723201|9119|P3|COMPLETED|First Intervention Period||7
4282|NCT02723201|9120|P2|COMPLETED|First Intervention Period||7
4283|NCT02723201|9121|P1|COMPLETED|First Intervention Period||11
4284|NCT02723201|9119|P3|STARTED|First Intervention Period||7
4285|NCT02723201|9120|P2|STARTED|First Intervention Period||7
4286|NCT02723201|9121|P1|STARTED|First Intervention Period||11
4287|NCT02723188|9180|P3|NOT COMPLETED|Overall Study||0
4288|NCT02723188|9181|P2|NOT COMPLETED|Overall Study||0
4289|NCT02723188|9182|P1|NOT COMPLETED|Overall Study||1
4290|NCT02723188|9180|P3|COMPLETED|Overall Study||15
4291|NCT02723188|9181|P2|COMPLETED|Overall Study||15
4292|NCT02723188|9182|P1|COMPLETED|Overall Study||14
4293|NCT02723188|9180|P3|STARTED|Overall Study||15
4294|NCT02723188|9181|P2|STARTED|Overall Study||15
4295|NCT02723188|9182|P1|STARTED|Overall Study||15
4296|NCT02722967|9196|P3|NOT COMPLETED|Overall Study||4
4297|NCT02722967|9197|P2|NOT COMPLETED|Overall Study||2
4298|NCT02722967|9198|P1|NOT COMPLETED|Overall Study||5
4299|NCT02722967|9196|P3|COMPLETED|Overall Study||11
4300|NCT02722967|9197|P2|COMPLETED|Overall Study||10
4301|NCT02722967|9198|P1|COMPLETED|Overall Study||17
4302|NCT02722967|9196|P3|STARTED|Overall Study||15
4303|NCT02722967|9197|P2|STARTED|Overall Study||12
4304|NCT02722967|9198|P1|STARTED|Overall Study||22
4305|NCT02722564|9206|P1|NOT COMPLETED|Overall Study||0
4306|NCT02722564|9206|P1|COMPLETED|Overall Study||55
4307|NCT02722564|9206|P1|STARTED|Overall Study||55
4308|NCT02722278|9212|P2|NOT COMPLETED|Overall Study||7
4309|NCT02722278|9213|P1|NOT COMPLETED|Overall Study||12
4310|NCT02722278|9212|P2|COMPLETED|Overall Study||49
4311|NCT02722278|9213|P1|COMPLETED|Overall Study||154
4312|NCT02722278|9212|P2|STARTED|Overall Study||56
4313|NCT02722278|9213|P1|STARTED|Overall Study||166
4314|NCT02722239|9223|P2|NOT COMPLETED|Overall Study||0
4315|NCT02722239|9224|P1|NOT COMPLETED|Overall Study||0
4316|NCT02722239|9223|P2|COMPLETED|Overall Study||20
4317|NCT02722239|9224|P1|COMPLETED|Overall Study||20
4318|NCT02722239|9223|P2|Second Intervention (1 Day)|Overall Study||20
4319|NCT02722239|9224|P1|Second Intervention (1 Day)|Overall Study||20
4320|NCT02722239|9223|P2|Washout (7 Days)|Overall Study||20
4321|NCT02722239|9224|P1|Washout (7 Days)|Overall Study||20
4322|NCT02722239|9223|P2|First Intervention (1 Day)|Overall Study||20
4323|NCT02722239|9224|P1|First Intervention (1 Day)|Overall Study||20
4324|NCT02722239|9223|P2|STARTED|Overall Study||20
4325|NCT02722239|9224|P1|STARTED|Overall Study||20
4326|NCT02722044|9237|P1|NOT COMPLETED|Overall Study||5
4327|NCT02722044|9237|P1|COMPLETED|Overall Study||28
4328|NCT02722044|9237|P1|STARTED|Overall Study||33
4329|NCT02721641|9264|P1|NOT COMPLETED|Overall Study||0
4330|NCT02721641|9264|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
4331|NCT02721641|9264|P1|STARTED|Overall Study||69
4332|NCT02721277|9270|P1|NOT COMPLETED|Overall Study||0
4333|NCT02721277|9270|P1|COMPLETED|Overall Study||2
4334|NCT02721277|9270|P1|STARTED|Overall Study||2
4335|NCT02720952|9299|P1|NOT COMPLETED|Overall Study||0
4336|NCT02720952|9299|P1|COMPLETED|Overall Study||24
4337|NCT02720952|9299|P1|STARTED|Overall Study||24
4338|NCT02718898|9310|P2|NOT COMPLETED|Overall Study||1
4339|NCT02718898|9311|P1|NOT COMPLETED|Overall Study||9
4340|NCT02718898|9310|P2|COMPLETED|Overall Study||74
4341|NCT02718898|9311|P1|COMPLETED|Overall Study||65
4342|NCT02718898|9310|P2|STARTED|Overall Study||75
4343|NCT02718898|9311|P1|STARTED|Overall Study||74
4344|NCT02717754|9345|P6|NOT COMPLETED|Overall Study||20
4345|NCT02717754|9346|P5|NOT COMPLETED|Overall Study||20
4346|NCT02717754|9347|P4|NOT COMPLETED|Overall Study||10
4347|NCT02717754|9348|P3|NOT COMPLETED|Overall Study||0
4348|NCT02717754|9349|P2|NOT COMPLETED|Overall Study||0
4349|NCT02717754|9350|P1|NOT COMPLETED|Overall Study||0
4350|NCT02717754|9345|P6|COMPLETED|Overall Study||0
4351|NCT02717754|9346|P5|COMPLETED|Overall Study||0
4352|NCT02717754|9347|P4|COMPLETED|Overall Study||0
4353|NCT02717754|9348|P3|COMPLETED|Overall Study||20
4354|NCT02717754|9349|P2|COMPLETED|Overall Study||19
4355|NCT02717754|9350|P1|COMPLETED|Overall Study||10
4356|NCT02717754|9345|P6|STARTED|Overall Study||20
4357|NCT02717754|9346|P5|STARTED|Overall Study||20
4358|NCT02717754|9347|P4|STARTED|Overall Study||10
4359|NCT02717754|9348|P3|STARTED|Overall Study||20
4360|NCT02717754|9349|P2|STARTED|Overall Study||19
4361|NCT02717754|9350|P1|STARTED|Overall Study||10
4362|NCT02716779|9381|P3|NOT COMPLETED|Combination Therapy||1
4363|NCT02716779|9382|P2|NOT COMPLETED|Combination Therapy||2
4364|NCT02716779|9383|P1|NOT COMPLETED|Combination Therapy||0
4365|NCT02716779|9381|P3|COMPLETED|Combination Therapy||25
4366|NCT02716779|9382|P2|COMPLETED|Combination Therapy||23
4367|NCT02716779|9383|P1|COMPLETED|Combination Therapy||14
4368|NCT02716779|9381|P3|STARTED|Combination Therapy||26
4369|NCT02716779|9382|P2|STARTED|Combination Therapy||25
4370|NCT02716779|9383|P1|STARTED|Combination Therapy||14
4371|NCT02716779|9381|P3|NOT COMPLETED|Monotherapy||1
4372|NCT02716779|9382|P2|NOT COMPLETED|Monotherapy||1
4373|NCT02716779|9383|P1|NOT COMPLETED|Monotherapy||0
4374|NCT02716779|9381|P3|COMPLETED|Monotherapy||26
4375|NCT02716779|9382|P2|COMPLETED|Monotherapy||25
4376|NCT02716779|9383|P1|COMPLETED|Monotherapy||14
4377|NCT02716779|9381|P3|STARTED|Monotherapy||27
4378|NCT02716779|9382|P2|STARTED|Monotherapy||26
4379|NCT02716779|9383|P1|STARTED|Monotherapy||14
4380|NCT02716714|9429|P2|NOT COMPLETED|Overall Study||2
4381|NCT02716714|9430|P1|NOT COMPLETED|Overall Study||12
4382|NCT02716714|9429|P2|COMPLETED|Overall Study||8
4383|NCT02716714|9430|P1|COMPLETED|Overall Study||55
4384|NCT02716714|9429|P2|STARTED|Overall Study||10
4385|NCT02716714|9430|P1|STARTED|Overall Study||67
4386|NCT02716298|9456|P2|NOT COMPLETED|Second Intervention (1 Month)||0
4387|NCT02716298|9457|P1|NOT COMPLETED|Second Intervention (1 Month)||0
4388|NCT02716298|9456|P2|COMPLETED|Second Intervention (1 Month)||23
4389|NCT02716298|9457|P1|COMPLETED|Second Intervention (1 Month)||24
4390|NCT02716298|9456|P2|STARTED|Second Intervention (1 Month)||23
4391|NCT02716298|9457|P1|STARTED|Second Intervention (1 Month)||24
4392|NCT02716298|9456|P2|NOT COMPLETED|First Intervention (1 Month)||1
4393|NCT02716298|9457|P1|NOT COMPLETED|First Intervention (1 Month)||1
4394|NCT02716298|9456|P2|COMPLETED|First Intervention (1 Month)||23
4395|NCT02716298|9457|P1|COMPLETED|First Intervention (1 Month)||24
4396|NCT02716298|9456|P2|STARTED|First Intervention (1 Month)||24
4397|NCT02716298|9457|P1|STARTED|First Intervention (1 Month)||25
4398|NCT02714062|9475|P3|NOT COMPLETED|Overall Study||3
4399|NCT02714062|9476|P2|NOT COMPLETED|Overall Study||1
4400|NCT02714062|9477|P1|NOT COMPLETED|Overall Study||1
4401|NCT02714062|9475|P3|COMPLETED|Overall Study||10
4402|NCT02714062|9476|P2|COMPLETED|Overall Study||14
4403|NCT02714062|9477|P1|COMPLETED|Overall Study||13
4404|NCT02714062|9475|P3|STARTED|Overall Study||13
4405|NCT02714062|9476|P2|STARTED|Overall Study||15
4406|NCT02714062|9477|P1|STARTED|Overall Study||14
4407|NCT02713594|9523|P2|NOT COMPLETED|Overall Study||396
4408|NCT02713594|9524|P1|NOT COMPLETED|Overall Study||390
4409|NCT02713594|9523|P2|COMPLETED|Overall Study||552
4410|NCT02713594|9524|P1|COMPLETED|Overall Study||562
4411|NCT02713594|9523|P2|STARTED|Overall Study||948
4412|NCT02713594|9524|P1|STARTED|Overall Study||952
4413|NCT02713256|9534|P1|NOT COMPLETED|Overall Study||0
4414|NCT02713256|9534|P1|COMPLETED|Overall Study||15
4415|NCT02713256|9534|P1|STARTED|Overall Study||15
4416|NCT02712333|9542|P2|NOT COMPLETED|Second Period||0
4417|NCT02712333|9543|P1|NOT COMPLETED|Second Period||0
4418|NCT02712333|9542|P2|COMPLETED|Second Period||24
4419|NCT02712333|9543|P1|COMPLETED|Second Period||31
4420|NCT02712333|9542|P2|STARTED|Second Period||24
4421|NCT02712333|9543|P1|STARTED|Second Period||31
4422|NCT02712333|9542|P2|NOT COMPLETED|First Period||2
4423|NCT02712333|9543|P1|NOT COMPLETED|First Period||3
4424|NCT02712333|9542|P2|COMPLETED|First Period||24
4425|NCT02712333|9543|P1|COMPLETED|First Period||31
4426|NCT02712333|9542|P2|STARTED|First Period||26
4427|NCT02712333|9543|P1|STARTED|First Period||34
4428|NCT02712099|9563|P2|NOT COMPLETED|Overall Study||0
4429|NCT02712099|9564|P1|NOT COMPLETED|Overall Study||0
4430|NCT02712099|9563|P2|COMPLETED|Overall Study||20
4431|NCT02712099|9564|P1|COMPLETED|Overall Study||30
4432|NCT02712099|9563|P2|STARTED|Overall Study||20
4433|NCT02712099|9564|P1|STARTED|Overall Study||30
4434|NCT02711995|9580|P1|NOT COMPLETED|Second Intervention (30 Days)||0
4435|NCT02711995|9580|P1|COMPLETED|Second Intervention (30 Days)||7
4436|NCT02711995|9580|P1|STARTED|Second Intervention (30 Days)||7
4437|NCT02711995|9580|P1|NOT COMPLETED|Washout (90 Days)||1
4438|NCT02711995|9580|P1|COMPLETED|Washout (90 Days)||7
4439|NCT02711995|9580|P1|STARTED|Washout (90 Days)||8
4440|NCT02711995|9580|P1|NOT COMPLETED|First Intervention (30 Days)||0
4441|NCT02711995|9580|P1|COMPLETED|First Intervention (30 Days)||8
4442|NCT02711995|9580|P1|STARTED|First Intervention (30 Days)||8
4443|NCT02710630|9607|P5|NOT COMPLETED|Period 6||0
4444|NCT02710630|9608|P4|NOT COMPLETED|Period 6||0
4445|NCT02710630|9609|P3|NOT COMPLETED|Period 6||0
4446|NCT02710630|9610|P2|NOT COMPLETED|Period 6||0
4447|NCT02710630|9611|P1|NOT COMPLETED|Period 6||0
4448|NCT02710630|9607|P5|COMPLETED|Period 6||7
4449|NCT02710630|9608|P4|COMPLETED|Period 6||7
4450|NCT02710630|9609|P3|COMPLETED|Period 6||7
4451|NCT02710630|9610|P2|COMPLETED|Period 6||7
4452|NCT02710630|9611|P1|COMPLETED|Period 6||7
4453|NCT02710630|9607|P5|STARTED|Period 6||7
4454|NCT02710630|9608|P4|STARTED|Period 6||7
4455|NCT02710630|9609|P3|STARTED|Period 6||7
4456|NCT02710630|9610|P2|STARTED|Period 6||7
4457|NCT02710630|9611|P1|STARTED|Period 6||7
4458|NCT02710630|9607|P5|NOT COMPLETED|Period 5||0
4459|NCT02710630|9608|P4|NOT COMPLETED|Period 5||0
4460|NCT02710630|9609|P3|NOT COMPLETED|Period 5||0
4461|NCT02710630|9610|P2|NOT COMPLETED|Period 5||0
4462|NCT02710630|9611|P1|NOT COMPLETED|Period 5||0
4463|NCT02710630|9607|P5|COMPLETED|Period 5||7
4464|NCT02710630|9608|P4|COMPLETED|Period 5||7
4465|NCT02710630|9609|P3|COMPLETED|Period 5||7
4466|NCT02710630|9610|P2|COMPLETED|Period 5||7
4467|NCT02710630|9611|P1|COMPLETED|Period 5||7
4468|NCT02710630|9607|P5|STARTED|Period 5||7
4469|NCT02710630|9608|P4|STARTED|Period 5||7
4470|NCT02710630|9609|P3|STARTED|Period 5||7
4471|NCT02710630|9610|P2|STARTED|Period 5||7
4472|NCT02710630|9611|P1|STARTED|Period 5||7
4473|NCT02710630|9607|P5|NOT COMPLETED|Period 4||0
4474|NCT02710630|9608|P4|NOT COMPLETED|Period 4||0
4475|NCT02710630|9609|P3|NOT COMPLETED|Period 4||0
4476|NCT02710630|9610|P2|NOT COMPLETED|Period 4||0
4477|NCT02710630|9611|P1|NOT COMPLETED|Period 4||0
4478|NCT02710630|9607|P5|COMPLETED|Period 4||7
4479|NCT02710630|9608|P4|COMPLETED|Period 4||7
4480|NCT02710630|9609|P3|COMPLETED|Period 4||7
4481|NCT02710630|9610|P2|COMPLETED|Period 4||7
4482|NCT02710630|9611|P1|COMPLETED|Period 4||7
4483|NCT02710630|9607|P5|STARTED|Period 4||7
4484|NCT02710630|9608|P4|STARTED|Period 4||7
4485|NCT02710630|9609|P3|STARTED|Period 4||7
4486|NCT02710630|9610|P2|STARTED|Period 4||7
4487|NCT02710630|9611|P1|STARTED|Period 4||7
4488|NCT02710630|9607|P5|NOT COMPLETED|Period 3||0
4489|NCT02710630|9608|P4|NOT COMPLETED|Period 3||0
4490|NCT02710630|9609|P3|NOT COMPLETED|Period 3||0
4491|NCT02710630|9610|P2|NOT COMPLETED|Period 3||0
4492|NCT02710630|9611|P1|NOT COMPLETED|Period 3||0
4493|NCT02710630|9607|P5|COMPLETED|Period 3||7
4494|NCT02710630|9608|P4|COMPLETED|Period 3||7
4495|NCT02710630|9609|P3|COMPLETED|Period 3||7
4496|NCT02710630|9610|P2|COMPLETED|Period 3||7
4497|NCT02710630|9611|P1|COMPLETED|Period 3||7
4498|NCT02710630|9607|P5|STARTED|Period 3||7
4499|NCT02710630|9608|P4|STARTED|Period 3||7
4500|NCT02710630|9609|P3|STARTED|Period 3||7
4501|NCT02710630|9610|P2|STARTED|Period 3||7
4502|NCT02710630|9611|P1|STARTED|Period 3||7
4503|NCT02710630|9607|P5|NOT COMPLETED|Period 2||0
4504|NCT02710630|9608|P4|NOT COMPLETED|Period 2||0
4505|NCT02710630|9609|P3|NOT COMPLETED|Period 2||0
4506|NCT02710630|9610|P2|NOT COMPLETED|Period 2||0
4507|NCT02710630|9611|P1|NOT COMPLETED|Period 2||0
4508|NCT02710630|9607|P5|COMPLETED|Period 2||7
4509|NCT02710630|9608|P4|COMPLETED|Period 2||7
4510|NCT02710630|9609|P3|COMPLETED|Period 2||7
4511|NCT02710630|9610|P2|COMPLETED|Period 2||7
4512|NCT02710630|9611|P1|COMPLETED|Period 2||7
4513|NCT02710630|9607|P5|Not Treated|Period 2||0
4514|NCT02710630|9608|P4|Not Treated|Period 2||0
4515|NCT02710630|9609|P3|Not Treated|Period 2||0
4516|NCT02710630|9610|P2|Not Treated|Period 2||0
4517|NCT02710630|9611|P1|Not Treated|Period 2||1
4518|NCT02710630|9607|P5|STARTED|Period 2||7
4519|NCT02710630|9608|P4|STARTED|Period 2||7
4520|NCT02710630|9609|P3|STARTED|Period 2||7
4521|NCT02710630|9610|P2|STARTED|Period 2||7
4522|NCT02710630|9611|P1|STARTED|Period 2||7
4523|NCT02710630|9607|P5|NOT COMPLETED|Period 1||0
4524|NCT02710630|9608|P4|NOT COMPLETED|Period 1||0
4525|NCT02710630|9609|P3|NOT COMPLETED|Period 1||0
4526|NCT02710630|9610|P2|NOT COMPLETED|Period 1||0
4527|NCT02710630|9611|P1|NOT COMPLETED|Period 1||0
4528|NCT02710630|9607|P5|COMPLETED|Period 1||7
4529|NCT02710630|9608|P4|COMPLETED|Period 1||7
4530|NCT02710630|9609|P3|COMPLETED|Period 1||7
4531|NCT02710630|9610|P2|COMPLETED|Period 1||7
4532|NCT02710630|9611|P1|COMPLETED|Period 1||7
4533|NCT02710630|9607|P5|STARTED|Period 1||7
4534|NCT02710630|9608|P4|STARTED|Period 1||7
4535|NCT02710630|9609|P3|STARTED|Period 1||7
4536|NCT02710630|9610|P2|STARTED|Period 1||7
4537|NCT02710630|9611|P1|STARTED|Period 1||7
4538|NCT02710292|9655|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
4539|NCT02710292|9656|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
4540|NCT02710292|9655|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
4541|NCT02710292|9656|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
4542|NCT02710292|9655|P2|STARTED|Period 2, Second 10 Days of Wear||49
4543|NCT02710292|9656|P1|STARTED|Period 2, Second 10 Days of Wear||46
4544|NCT02710292|9655|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
4545|NCT02710292|9656|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
4546|NCT02710292|9655|P2|COMPLETED|Period 1, First 10 Days of Wear||49
4547|NCT02710292|9656|P1|COMPLETED|Period 1, First 10 Days of Wear||46
4548|NCT02710292|9655|P2|STARTED|Period 1, First 10 Days of Wear||52
4549|NCT02710292|9656|P1|STARTED|Period 1, First 10 Days of Wear||47
4550|NCT02709577|9665|P4|NOT COMPLETED|Overall Study||0
4551|NCT02709577|9666|P3|NOT COMPLETED|Overall Study||2
4552|NCT02709577|9667|P2|NOT COMPLETED|Overall Study||5
4553|NCT02709577|9668|P1|NOT COMPLETED|Overall Study||2
4554|NCT02709577|9665|P4|COMPLETED|Overall Study||5
4555|NCT02709577|9666|P3|COMPLETED|Overall Study||4
4556|NCT02709577|9667|P2|COMPLETED|Overall Study||8
4557|NCT02709577|9668|P1|COMPLETED|Overall Study||10
4558|NCT02709577|9665|P4|STARTED|Overall Study||5
4559|NCT02709577|9666|P3|STARTED|Overall Study||6
4560|NCT02709577|9667|P2|STARTED|Overall Study||13
4561|NCT02709577|9668|P1|STARTED|Overall Study||12
4562|NCT02709096|9682|P2|NOT COMPLETED|Overall Study||1
4563|NCT02709096|9683|P1|NOT COMPLETED|Overall Study||1
4564|NCT02709096|9682|P2|COMPLETED|Overall Study||10
4565|NCT02709096|9683|P1|COMPLETED|Overall Study||21
4566|NCT02709096|9682|P2|STARTED|Overall Study||11
4567|NCT02709096|9683|P1|STARTED|Overall Study||22
4568|NCT02708524|9693|P4|NOT COMPLETED|Overall Study||0
4569|NCT02708524|9694|P3|NOT COMPLETED|Overall Study||3
4570|NCT02708524|9695|P2|NOT COMPLETED|Overall Study||6
4571|NCT02708524|9696|P1|NOT COMPLETED|Overall Study||4
4572|NCT02708524|9693|P4|COMPLETED|Overall Study||136
4573|NCT02708524|9694|P3|COMPLETED|Overall Study||134
4574|NCT02708524|9695|P2|COMPLETED|Overall Study||130
4575|NCT02708524|9696|P1|COMPLETED|Overall Study||135
4576|NCT02708524|9693|P4|STARTED|Overall Study||136
4577|NCT02708524|9694|P3|STARTED|Overall Study||137
4578|NCT02708524|9695|P2|STARTED|Overall Study||136
4579|NCT02708524|9696|P1|STARTED|Overall Study||139
4580|NCT02708355|9745|P3|NOT COMPLETED|Overall Study||0
4581|NCT02708355|9746|P2|NOT COMPLETED|Overall Study||0
4582|NCT02708355|9747|P1|NOT COMPLETED|Overall Study||1
4583|NCT02708355|9745|P3|COMPLETED|Overall Study||12
4584|NCT02708355|9746|P2|COMPLETED|Overall Study||22
4585|NCT02708355|9747|P1|COMPLETED|Overall Study||20
4586|NCT02708355|9745|P3|STARTED|Overall Study||12
4587|NCT02708355|9746|P2|STARTED|Overall Study||22
4588|NCT02708355|9747|P1|STARTED|Overall Study||21
4589|NCT02708277|9760|P2|NOT COMPLETED|Overall Study||4
4590|NCT02708277|9761|P1|NOT COMPLETED|Overall Study||7
4591|NCT02708277|9760|P2|COMPLETED|Overall Study||39
4592|NCT02708277|9761|P1|COMPLETED|Overall Study||43
4593|NCT02708277|9760|P2|STARTED|Overall Study||43
4594|NCT02708277|9761|P1|STARTED|Overall Study||50
4595|NCT02708238|9776|P3|NOT COMPLETED|Overall Study||3
4596|NCT02708238|9777|P2|NOT COMPLETED|Overall Study||1
4597|NCT02708238|9778|P1|NOT COMPLETED|Overall Study||0
4598|NCT02708238|9776|P3|COMPLETED|Overall Study||57
4599|NCT02708238|9777|P2|COMPLETED|Overall Study||59
4600|NCT02708238|9778|P1|COMPLETED|Overall Study||60
4601|NCT02708238|9776|P3|STARTED|Overall Study||60
4602|NCT02708238|9777|P2|STARTED|Overall Study||60
4603|NCT02708238|9778|P1|STARTED|Overall Study||60
4604|NCT02708212|9791|P2|NOT COMPLETED|Overall Study||0
4605|NCT02708212|9792|P1|NOT COMPLETED|Overall Study||0
4606|NCT02708212|9791|P2|COMPLETED|Overall Study||60
4607|NCT02708212|9792|P1|COMPLETED|Overall Study||60
4608|NCT02708212|9791|P2|STARTED|Overall Study||60
4609|NCT02708212|9792|P1|STARTED|Overall Study||60
4610|NCT02707640|9804|P2|NOT COMPLETED|Overall Study||7
4611|NCT02707640|9805|P1|NOT COMPLETED|Overall Study||9
4612|NCT02707640|9804|P2|COMPLETED|Overall Study||55
4613|NCT02707640|9805|P1|COMPLETED|Overall Study||52
4614|NCT02707640|9804|P2|STARTED|Overall Study||62
4615|NCT02707640|9805|P1|STARTED|Overall Study||61
4616|NCT02707172|9823|P1|NOT COMPLETED|2nd Set of Experiment||0
4617|NCT02707172|9823|P1|COMPLETED|2nd Set of Experiment||28
4618|NCT02707172|9823|P1|STARTED|2nd Set of Experiment||28
4619|NCT02707172|9823|P1|NOT COMPLETED|Wash Out||0
4620|NCT02707172|9823|P1|COMPLETED|Wash Out||28
4621|NCT02707172|9823|P1|STARTED|Wash Out||28
4622|NCT02707172|9823|P1|NOT COMPLETED|1st Set of Experiment||0
4623|NCT02707172|9823|P1|COMPLETED|1st Set of Experiment||28
4624|NCT02707172|9823|P1|STARTED|1st Set of Experiment||28
4625|NCT02706327|9831|P3|NOT COMPLETED|Overall Study||2
4626|NCT02706327|9832|P2|NOT COMPLETED|Overall Study||1
4627|NCT02706327|9833|P1|NOT COMPLETED|Overall Study||1
4628|NCT02706327|9831|P3|COMPLETED|Overall Study||21
4629|NCT02706327|9832|P2|COMPLETED|Overall Study||21
4630|NCT02706327|9833|P1|COMPLETED|Overall Study||21
4631|NCT02706327|9831|P3|STARTED|Overall Study||23
4632|NCT02706327|9832|P2|STARTED|Overall Study||22
4633|NCT02706327|9833|P1|STARTED|Overall Study||22
4634|NCT02705807|9853|P1|NOT COMPLETED|Overall Study||0
4635|NCT02705807|9853|P1|COMPLETED|Overall Study||10
4636|NCT02705807|9853|P1|STARTED|Overall Study||10
4637|NCT02705716|9885|P2|NOT COMPLETED|Overall Study||2
4638|NCT02705716|9886|P1|NOT COMPLETED|Overall Study||4
4639|NCT02705716|9885|P2|COMPLETED|Overall Study||68
4640|NCT02705716|9886|P1|COMPLETED|Overall Study||68
4641|NCT02705716|9885|P2|STARTED|Overall Study||70
4642|NCT02705716|9886|P1|STARTED|Overall Study||72
4643|NCT02705365|9898|P2|NOT COMPLETED|Overall Study||0
4644|NCT02705365|9899|P1|NOT COMPLETED|Overall Study||0
4645|NCT02705365|9898|P2|COMPLETED|Overall Study||800
4646|NCT02705365|9899|P1|COMPLETED|Overall Study||400
4647|NCT02705365|9898|P2|STARTED|Overall Study||800
4648|NCT02705365|9899|P1|STARTED|Overall Study||400
4649|NCT02704689|9907|P1|NOT COMPLETED|Overall Study||3
4650|NCT02704689|9907|P1|COMPLETED|Overall Study||6
4651|NCT02704689|9907|P1|STARTED|Overall Study||9
4652|NCT02703948|9924|P1|NOT COMPLETED|Overall Study||3
4653|NCT02703948|9924|P1|COMPLETED|Overall Study||57
4654|NCT02703948|9924|P1|STARTED|Overall Study||60
4655|NCT02702011|9932|P4|NOT COMPLETED|Overall Study||0
4656|NCT02702011|9933|P3|NOT COMPLETED|Overall Study||0
4657|NCT02702011|9934|P2|NOT COMPLETED|Overall Study||1
4658|NCT02702011|9935|P1|NOT COMPLETED|Overall Study||0
4659|NCT02702011|9932|P4|COMPLETED|Overall Study||12
4660|NCT02702011|9933|P3|COMPLETED|Overall Study||12
4661|NCT02702011|9934|P2|COMPLETED|Overall Study||12
4662|NCT02702011|9935|P1|COMPLETED|Overall Study||11
4663|NCT02702011|9932|P4|STARTED|Overall Study|Started are the treated patients.|12
4664|NCT02702011|9933|P3|STARTED|Overall Study|Started are the treated patients.|12
4665|NCT02702011|9934|P2|STARTED|Overall Study|Started are the treated patients.|13
4666|NCT02702011|9935|P1|STARTED|Overall Study|Started are the treated patients.|11
4667|NCT02701556|9947|P2|NOT COMPLETED|Overall Study||20
4668|NCT02701556|9948|P1|NOT COMPLETED|Overall Study||23
4669|NCT02701556|9947|P2|COMPLETED|Overall Study||178
4670|NCT02701556|9948|P1|COMPLETED|Overall Study||175
4671|NCT02701556|9947|P2|STARTED|Overall Study||198
4672|NCT02701556|9948|P1|STARTED|Overall Study||198
4673|NCT02701387|9954|P1|NOT COMPLETED|Overall Study||0
4674|NCT02701387|9954|P1|COMPLETED|Overall Study||7
4675|NCT02701387|9954|P1|STARTED|Overall Study||7
4676|NCT02701361|9962|P3|NOT COMPLETED|Overall Study||2
4677|NCT02701361|9963|P2|NOT COMPLETED|Overall Study||3
4678|NCT02701361|9964|P1|NOT COMPLETED|Overall Study||9
4679|NCT02701361|9962|P3|COMPLETED|Overall Study||16
4680|NCT02701361|9963|P2|COMPLETED|Overall Study||28
4681|NCT02701361|9964|P1|COMPLETED|Overall Study||22
4682|NCT02701361|9962|P3|STARTED|Overall Study||18
4683|NCT02701361|9963|P2|STARTED|Overall Study||31
4684|NCT02701361|9964|P1|STARTED|Overall Study||31
4685|NCT02701296|10005|P2|NOT COMPLETED|Overall Study||2
4686|NCT02701296|10006|P1|NOT COMPLETED|Overall Study||0
4687|NCT02701296|10005|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
4688|NCT02701296|10006|P1|COMPLETED|Overall Study||42
4689|NCT02701296|10005|P2|STARTED|Overall Study||38
4690|NCT02701296|10006|P1|STARTED|Overall Study||42
4691|NCT02701270|10022|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
4692|NCT02701270|10023|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
4693|NCT02701270|10024|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
4694|NCT02701270|10025|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
4695|NCT02701270|10022|P4|COMPLETED|Fourth Intervention at Visit 4||3
4696|NCT02701270|10023|P3|COMPLETED|Fourth Intervention at Visit 4||3
4697|NCT02701270|10024|P2|COMPLETED|Fourth Intervention at Visit 4||3
4698|NCT02701270|10025|P1|COMPLETED|Fourth Intervention at Visit 4||2
4699|NCT02701270|10022|P4|STARTED|Fourth Intervention at Visit 4||3
4700|NCT02701270|10023|P3|STARTED|Fourth Intervention at Visit 4||3
4701|NCT02701270|10024|P2|STARTED|Fourth Intervention at Visit 4||3
4702|NCT02701270|10025|P1|STARTED|Fourth Intervention at Visit 4||2
4703|NCT02701270|10022|P4|NOT COMPLETED|Third Intervention at Visit 3||0
4704|NCT02701270|10023|P3|NOT COMPLETED|Third Intervention at Visit 3||0
4705|NCT02701270|10024|P2|NOT COMPLETED|Third Intervention at Visit 3||0
4706|NCT02701270|10025|P1|NOT COMPLETED|Third Intervention at Visit 3||0
4707|NCT02701270|10022|P4|COMPLETED|Third Intervention at Visit 3||3
4708|NCT02701270|10023|P3|COMPLETED|Third Intervention at Visit 3||3
4709|NCT02701270|10024|P2|COMPLETED|Third Intervention at Visit 3||3
4710|NCT02701270|10025|P1|COMPLETED|Third Intervention at Visit 3||2
4711|NCT02701270|10022|P4|STARTED|Third Intervention at Visit 3||3
4712|NCT02701270|10023|P3|STARTED|Third Intervention at Visit 3||3
4713|NCT02701270|10024|P2|STARTED|Third Intervention at Visit 3||3
4714|NCT02701270|10025|P1|STARTED|Third Intervention at Visit 3||2
4715|NCT02701270|10022|P4|NOT COMPLETED|Second Intervention at Visit 2||0
4716|NCT02701270|10023|P3|NOT COMPLETED|Second Intervention at Visit 2||0
4717|NCT02701270|10024|P2|NOT COMPLETED|Second Intervention at Visit 2||0
4718|NCT02701270|10025|P1|NOT COMPLETED|Second Intervention at Visit 2||0
4719|NCT02701270|10022|P4|COMPLETED|Second Intervention at Visit 2||3
4720|NCT02701270|10023|P3|COMPLETED|Second Intervention at Visit 2||3
4721|NCT02701270|10024|P2|COMPLETED|Second Intervention at Visit 2||3
4722|NCT02701270|10025|P1|COMPLETED|Second Intervention at Visit 2||2
4723|NCT02701270|10022|P4|STARTED|Second Intervention at Visit 2||3
4724|NCT02701270|10023|P3|STARTED|Second Intervention at Visit 2||3
4725|NCT02701270|10024|P2|STARTED|Second Intervention at Visit 2||3
4726|NCT02701270|10025|P1|STARTED|Second Intervention at Visit 2||2
4727|NCT02701270|10022|P4|NOT COMPLETED|First Intervention at Visit 1||0
4728|NCT02701270|10023|P3|NOT COMPLETED|First Intervention at Visit 1||0
4729|NCT02701270|10024|P2|NOT COMPLETED|First Intervention at Visit 1||0
4730|NCT02701270|10025|P1|NOT COMPLETED|First Intervention at Visit 1||0
4731|NCT02701270|10022|P4|COMPLETED|First Intervention at Visit 1||3
4732|NCT02701270|10023|P3|COMPLETED|First Intervention at Visit 1||3
4733|NCT02701270|10024|P2|COMPLETED|First Intervention at Visit 1||3
4734|NCT02701270|10025|P1|COMPLETED|First Intervention at Visit 1||2
4735|NCT02701270|10022|P4|STARTED|First Intervention at Visit 1||3
4736|NCT02701270|10023|P3|STARTED|First Intervention at Visit 1||3
4737|NCT02701270|10024|P2|STARTED|First Intervention at Visit 1||3
4738|NCT02701270|10025|P1|STARTED|First Intervention at Visit 1||2
4739|NCT02699892|10039|P1|NOT COMPLETED|Overall Study||36
4740|NCT02699892|10039|P1|COMPLETED|Overall Study||94
4741|NCT02699892|10039|P1|STARTED|Overall Study||130
4742|NCT02699684|10044|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
4743|NCT02699684|10045|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
4744|NCT02699684|10044|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
4745|NCT02699684|10045|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
4746|NCT02699684|10044|P2|STARTED|Period 2, Second 30 Days of Wear||38
4747|NCT02699684|10045|P1|STARTED|Period 2, Second 30 Days of Wear||37
4748|NCT02699684|10044|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
4749|NCT02699684|10045|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
4750|NCT02699684|10044|P2|COMPLETED|Period 1, First 30 Days of Wear||38
4751|NCT02699684|10045|P1|COMPLETED|Period 1, First 30 Days of Wear||37
4752|NCT02699684|10044|P2|STARTED|Period 1, First 30 Days of Wear||38
4753|NCT02699684|10045|P1|STARTED|Period 1, First 30 Days of Wear||37
4754|NCT02699632|10055|P1|NOT COMPLETED|Overall Study||2
4755|NCT02699632|10055|P1|COMPLETED|Overall Study||358
4756|NCT02699632|10055|P1|STARTED|Overall Study||360
4757|NCT02699593|10062|P2|NOT COMPLETED|Period 2||2
4758|NCT02699593|10063|P1|NOT COMPLETED|Period 2||2
4759|NCT02699593|10062|P2|COMPLETED|Period 2||60
4760|NCT02699593|10063|P1|COMPLETED|Period 2||65
4761|NCT02699593|10062|P2|STARTED|Period 2||62
4762|NCT02699593|10063|P1|STARTED|Period 2||67
4763|NCT02699593|10062|P2|NOT COMPLETED|Period 1||7
4764|NCT02699593|10063|P1|NOT COMPLETED|Period 1||5
4765|NCT02699593|10062|P2|COMPLETED|Period 1||62
4766|NCT02699593|10063|P1|COMPLETED|Period 1||67
4767|NCT02699593|10062|P2|STARTED|Period 1||69
4768|NCT02699593|10063|P1|STARTED|Period 1||72
4769|NCT02698566|10071|P2|NOT COMPLETED|Overall Study||0
4770|NCT02698566|10072|P1|NOT COMPLETED|Overall Study||0
4771|NCT02698566|10071|P2|COMPLETED|Overall Study||3
4772|NCT02698566|10072|P1|COMPLETED|Overall Study||35
4773|NCT02698566|10071|P2|STARTED|Overall Study||3
4774|NCT02698566|10072|P1|STARTED|Overall Study||35
4775|NCT02698436|10080|P2|NOT COMPLETED|Overall Study||7
4776|NCT02698436|10081|P1|NOT COMPLETED|Overall Study||7
4777|NCT02698436|10080|P2|COMPLETED|Overall Study||51
4778|NCT02698436|10081|P1|COMPLETED|Overall Study||52
4779|NCT02698436|10080|P2|STARTED|Overall Study||58
4780|NCT02698436|10081|P1|STARTED|Overall Study||59
4781|NCT02698423|10121|P2|NOT COMPLETED|Overall Study||24
4782|NCT02698423|10122|P1|NOT COMPLETED|Overall Study||19
4783|NCT02698423|10121|P2|COMPLETED|Overall Study||307
4784|NCT02698423|10122|P1|COMPLETED|Overall Study||317
4785|NCT02698423|10121|P2|STARTED|Overall Study||331
4786|NCT02698423|10122|P1|STARTED|Overall Study||336
4787|NCT02697890|10130|P2|NOT COMPLETED|Overall Study||0
4788|NCT02697890|10131|P1|NOT COMPLETED|Overall Study||0
4789|NCT02697890|10130|P2|COMPLETED|Overall Study||14
4790|NCT02697890|10131|P1|COMPLETED|Overall Study||14
4791|NCT02697890|10130|P2|STARTED|Overall Study||14
4792|NCT02697890|10131|P1|STARTED|Overall Study||14
4793|NCT02696317|10143|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
4794|NCT02696317|10144|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
4795|NCT02696317|10143|P2|COMPLETED|Period 2, 10 Days of Wear||36
4796|NCT02696317|10144|P1|COMPLETED|Period 2, 10 Days of Wear||39
4797|NCT02696317|10143|P2|STARTED|Period 2, 10 Days of Wear||36
4798|NCT02696317|10144|P1|STARTED|Period 2, 10 Days of Wear||40
4799|NCT02696317|10143|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
4800|NCT02696317|10144|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
4801|NCT02696317|10143|P2|COMPLETED|Period 1, 10 Days of Wear||36
4802|NCT02696317|10144|P1|COMPLETED|Period 1, 10 Days of Wear||40
4803|NCT02696317|10143|P2|STARTED|Period 1, 10 Days of Wear||36
4804|NCT02696317|10144|P1|STARTED|Period 1, 10 Days of Wear||40
4805|NCT02696317|10143|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
4806|NCT02696317|10144|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
4807|NCT02696317|10143|P2|COMPLETED|Habitual, 10 Days of Wear||36
4808|NCT02696317|10144|P1|COMPLETED|Habitual, 10 Days of Wear||40
4809|NCT02696317|10143|P2|STARTED|Habitual, 10 Days of Wear||40
4810|NCT02696317|10144|P1|STARTED|Habitual, 10 Days of Wear||42
4811|NCT02696291|10160|P2|NOT COMPLETED|Overall Study||0
4812|NCT02696291|10161|P1|NOT COMPLETED|Overall Study||0
4813|NCT02696291|10160|P2|COMPLETED|Overall Study||2
4814|NCT02696291|10161|P1|COMPLETED|Overall Study||5
4815|NCT02696291|10160|P2|STARTED|Overall Study||2
4816|NCT02696291|10161|P1|STARTED|Overall Study||5
4817|NCT02696226|10188|P4|NOT COMPLETED|Overall Study||0
4818|NCT02696226|10189|P3|NOT COMPLETED|Overall Study||2
4819|NCT02696226|10190|P2|NOT COMPLETED|Overall Study||0
4820|NCT02696226|10191|P1|NOT COMPLETED|Overall Study||1
4821|NCT02696226|10188|P4|COMPLETED|Overall Study||0
4822|NCT02696226|10189|P3|COMPLETED|Overall Study||0
4823|NCT02696226|10190|P2|COMPLETED|Overall Study||0
4824|NCT02696226|10191|P1|COMPLETED|Overall Study||0
4825|NCT02696226|10188|P4|STARTED|Overall Study||0
4826|NCT02696226|10189|P3|STARTED|Overall Study||2
4827|NCT02696226|10190|P2|STARTED|Overall Study||0
4828|NCT02696226|10191|P1|STARTED|Overall Study||1
4829|NCT02696083|10201|P1|NOT COMPLETED|Overall Study||6
4830|NCT02696083|10201|P1|COMPLETED|Overall Study||13
4831|NCT02696083|10201|P1|STARTED|Overall Study||19
4832|NCT02696070|10212|P2|NOT COMPLETED|Overall Study||2
4833|NCT02696070|10213|P1|NOT COMPLETED|Overall Study||1
4834|NCT02696070|10212|P2|COMPLETED|Overall Study||12
4835|NCT02696070|10213|P1|COMPLETED|Overall Study||7
4836|NCT02696070|10212|P2|STARTED|Overall Study||14
4837|NCT02696070|10213|P1|STARTED|Overall Study||8
4838|NCT02695446|10219|P1|NOT COMPLETED|Overall Study||0
4839|NCT02695446|10219|P1|COMPLETED|Overall Study||12
4840|NCT02695446|10219|P1|STARTED|Overall Study||12
4841|NCT02695290|10224|P1|NOT COMPLETED|Overall Study||0
4842|NCT02695290|10224|P1|COMPLETED|Overall Study||1
4843|NCT02695290|10224|P1|STARTED|Overall Study||1
4844|NCT02694744|10232|P2|NOT COMPLETED|Overall Study||5
4845|NCT02694744|10233|P1|NOT COMPLETED|Overall Study||6
4846|NCT02694744|10232|P2|COMPLETED|Overall Study||52
4847|NCT02694744|10233|P1|COMPLETED|Overall Study||51
4848|NCT02694744|10232|P2|ITT|Overall Study||55
4849|NCT02694744|10233|P1|ITT|Overall Study||57
4850|NCT02694744|10232|P2|Safety Population|Overall Study||56
4851|NCT02694744|10233|P1|Safety Population|Overall Study||57
4852|NCT02694744|10232|P2|STARTED|Overall Study||57
4853|NCT02694744|10233|P1|STARTED|Overall Study||57
4854|NCT02694718|10241|P1|NOT COMPLETED|Overall Study||2
4855|NCT02694718|10241|P1|COMPLETED|Overall Study||58
4856|NCT02694718|10241|P1|STARTED|Overall Study||60
4857|NCT02694536|10251|P1|NOT COMPLETED|Overall Study||80
4858|NCT02694536|10251|P1|COMPLETED|Overall Study||0
4859|NCT02694536|10251|P1|STARTED|Overall Study||80
4860|NCT02694315|10260|P1|NOT COMPLETED|Overall Study||0
4861|NCT02694315|10260|P1|COMPLETED|Overall Study||200
4862|NCT02694315|10260|P1|STARTED|Overall Study||200
4863|NCT02694198|10265|P1|NOT COMPLETED|Overall Study||0
4864|NCT02694198|10265|P1|COMPLETED|Overall Study||135
4865|NCT02694198|10265|P1|STARTED|Overall Study||135
4866|NCT02693704|10274|P4|NOT COMPLETED|Overall Study||0
4867|NCT02693704|10275|P3|NOT COMPLETED|Overall Study||0
4868|NCT02693704|10276|P2|NOT COMPLETED|Overall Study||0
4869|NCT02693704|10277|P1|NOT COMPLETED|Overall Study||0
4870|NCT02693704|10274|P4|COMPLETED|Overall Study||10
4871|NCT02693704|10275|P3|COMPLETED|Overall Study||10
4872|NCT02693704|10276|P2|COMPLETED|Overall Study||10
4873|NCT02693704|10277|P1|COMPLETED|Overall Study||10
4874|NCT02693704|10274|P4|STARTED|Overall Study||10
4875|NCT02693704|10275|P3|STARTED|Overall Study||10
4876|NCT02693704|10276|P2|STARTED|Overall Study||10
4877|NCT02693704|10277|P1|STARTED|Overall Study||10
4878|NCT02692859|10297|P2|NOT COMPLETED|Overall Study||95
4879|NCT02692859|10298|P1|NOT COMPLETED|Overall Study||84
4880|NCT02692859|10297|P2|COMPLETED|Overall Study||901
4881|NCT02692859|10298|P1|COMPLETED|Overall Study||912
4882|NCT02692859|10297|P2|STARTED|Overall Study||996
4883|NCT02692859|10298|P1|STARTED|Overall Study||996
4884|NCT02692703|10304|P1|NOT COMPLETED|Overall Study||2
4885|NCT02692703|10304|P1|COMPLETED|Overall Study||98
4886|NCT02692703|10304|P1|STARTED|Overall Study||100
4887|NCT02692560|10312|P2|NOT COMPLETED|Overall Study||6
4888|NCT02692560|10313|P1|NOT COMPLETED|Overall Study||0
4889|NCT02692560|10312|P2|COMPLETED|Overall Study||25
4890|NCT02692560|10313|P1|COMPLETED|Overall Study||29
4891|NCT02692560|10312|P2|STARTED|Overall Study||31
4892|NCT02692560|10313|P1|STARTED|Overall Study||29
4893|NCT02692495|10335|P2|NOT COMPLETED|Overall Study||0
4894|NCT02692495|10336|P1|NOT COMPLETED|Overall Study||0
4895|NCT02692495|10335|P2|COMPLETED|Overall Study||4
4896|NCT02692495|10336|P1|COMPLETED|Overall Study||12
4897|NCT02692495|10335|P2|STARTED|Overall Study||4
4898|NCT02692495|10336|P1|STARTED|Overall Study||12
4899|NCT02691507|10353|P2|NOT COMPLETED|Overall Study||1
4900|NCT02691507|10354|P1|NOT COMPLETED|Overall Study||0
4901|NCT02691507|10353|P2|COMPLETED|Overall Study||12
4902|NCT02691507|10354|P1|COMPLETED|Overall Study||40
4903|NCT02691507|10353|P2|STARTED|Overall Study||13
4904|NCT02691507|10354|P1|STARTED|Overall Study||40
4905|NCT02691416|10486|P2|NOT COMPLETED|Overall Study||0
4906|NCT02691416|10487|P1|NOT COMPLETED|Overall Study||0
4907|NCT02691416|10486|P2|COMPLETED|Overall Study||30
4908|NCT02691416|10487|P1|COMPLETED|Overall Study||30
4909|NCT02691416|10486|P2|STARTED|Overall Study||30
4910|NCT02691416|10487|P1|STARTED|Overall Study||30
4911|NCT02691143|10509|P2|NOT COMPLETED|Overall Study||0
4912|NCT02691143|10510|P1|NOT COMPLETED|Overall Study||0
4913|NCT02691143|10509|P2|COMPLETED|Overall Study||23
4914|NCT02691143|10510|P1|COMPLETED|Overall Study||27
4915|NCT02691143|10509|P2|STARTED|Overall Study||23
4916|NCT02691143|10510|P1|STARTED|Overall Study||27
4917|NCT02690935|10520|P2|NOT COMPLETED|Overall Study||0
4918|NCT02690935|10521|P1|NOT COMPLETED|Overall Study||0
4919|NCT02690935|10520|P2|COMPLETED|Overall Study|Count of participants|51
4920|NCT02690935|10521|P1|COMPLETED|Overall Study|Count of participants|51
4921|NCT02690935|10520|P2|STARTED|Overall Study|Count of participants|51
4922|NCT02690935|10521|P1|STARTED|Overall Study|Count of participants|51
4923|NCT02690727|10529|P2|NOT COMPLETED|Overall Study||2
4924|NCT02690727|10530|P1|NOT COMPLETED|Overall Study||2
4925|NCT02690727|10529|P2|COMPLETED|Overall Study||7
4926|NCT02690727|10530|P1|COMPLETED|Overall Study||7
4927|NCT02690727|10529|P2|STARTED|Overall Study||9
4928|NCT02690727|10530|P1|STARTED|Overall Study||9
4929|NCT02689804|10542|P2|NOT COMPLETED|Overall Study||0
4930|NCT02689804|10543|P1|NOT COMPLETED|Overall Study||2
4931|NCT02689804|10542|P2|COMPLETED|Overall Study||16
4932|NCT02689804|10543|P1|COMPLETED|Overall Study||16
4933|NCT02689804|10542|P2|STARTED|Overall Study||16
4934|NCT02689804|10543|P1|STARTED|Overall Study||18
4935|NCT02689206|10574|P5|NOT COMPLETED|Overall Study||8
4936|NCT02689206|10575|P4|NOT COMPLETED|Overall Study||4
4937|NCT02689206|10576|P3|NOT COMPLETED|Overall Study||4
4938|NCT02689206|10577|P2|NOT COMPLETED|Overall Study||1
4939|NCT02689206|10578|P1|NOT COMPLETED|Overall Study||3
4940|NCT02689206|10574|P5|COMPLETED|Overall Study||14
4941|NCT02689206|10575|P4|COMPLETED|Overall Study||17
4942|NCT02689206|10576|P3|COMPLETED|Overall Study||16
4943|NCT02689206|10577|P2|COMPLETED|Overall Study||19
4944|NCT02689206|10578|P1|COMPLETED|Overall Study||17
4945|NCT02689206|10574|P5|STARTED|Overall Study||22
4946|NCT02689206|10575|P4|STARTED|Overall Study||21
4947|NCT02689206|10576|P3|STARTED|Overall Study||20
4948|NCT02689206|10577|P2|STARTED|Overall Study||20
4949|NCT02689206|10578|P1|STARTED|Overall Study||20
4950|NCT02687217|10784|P2|NOT COMPLETED|Overall Study||0
4951|NCT02687217|10785|P1|NOT COMPLETED|Overall Study||0
4952|NCT02687217|10784|P2|COMPLETED|Overall Study||30
4953|NCT02687217|10785|P1|COMPLETED|Overall Study||30
4954|NCT02687217|10784|P2|STARTED|Overall Study||30
4955|NCT02687217|10785|P1|STARTED|Overall Study||30
4956|NCT02687126|10795|P1|NOT COMPLETED|Data Analysis||0
4957|NCT02687126|10795|P1|COMPLETED|Data Analysis||106
4958|NCT02687126|10795|P1|STARTED|Data Analysis||106
4959|NCT02687126|10795|P1|NOT COMPLETED|Data Collection||0
4960|NCT02687126|10795|P1|COMPLETED|Data Collection||106
4961|NCT02687126|10795|P1|STARTED|Data Collection||106
4962|NCT02686437|10804|P2|NOT COMPLETED|Overall Study||8
4963|NCT02686437|10805|P1|NOT COMPLETED|Overall Study||3
4964|NCT02686437|10804|P2|COMPLETED|Overall Study||12
4965|NCT02686437|10805|P1|COMPLETED|Overall Study||13
4966|NCT02686437|10804|P2|STARTED|Overall Study||20
4967|NCT02686437|10805|P1|STARTED|Overall Study||16
4968|NCT02685488|10815|P2|NOT COMPLETED|Overall Study||1
4969|NCT02685488|10816|P1|NOT COMPLETED|Overall Study||0
4970|NCT02685488|10815|P2|COMPLETED|Overall Study||13
4971|NCT02685488|10816|P1|COMPLETED|Overall Study||12
4972|NCT02685488|10815|P2|STARTED|Overall Study||14
4973|NCT02685488|10816|P1|STARTED|Overall Study||12
4974|NCT02685202|10830|P1|NOT COMPLETED|Overall Study||9
4975|NCT02685202|10830|P1|COMPLETED|Overall Study||0
4976|NCT02685202|10830|P1|STARTED|Overall Study||9
4977|NCT02684942|10836|P6|NOT COMPLETED|Overall Study||0
4978|NCT02684942|10837|P5|NOT COMPLETED|Overall Study||0
4979|NCT02684942|10838|P4|NOT COMPLETED|Overall Study||0
4980|NCT02684942|10839|P3|NOT COMPLETED|Overall Study||0
4981|NCT02684942|10840|P2|NOT COMPLETED|Overall Study||0
4982|NCT02684942|10841|P1|NOT COMPLETED|Overall Study||0
4983|NCT02684942|10836|P6|COMPLETED|Overall Study||6
4984|NCT02684942|10837|P5|COMPLETED|Overall Study||6
4985|NCT02684942|10838|P4|COMPLETED|Overall Study||7
4986|NCT02684942|10839|P3|COMPLETED|Overall Study||7
4987|NCT02684942|10840|P2|COMPLETED|Overall Study||7
4988|NCT02684942|10841|P1|COMPLETED|Overall Study||7
4989|NCT02684942|10836|P6|STARTED|Overall Study||6
4990|NCT02684942|10837|P5|STARTED|Overall Study||6
4991|NCT02684942|10838|P4|STARTED|Overall Study||7
4992|NCT02684942|10839|P3|STARTED|Overall Study||7
4993|NCT02684942|10840|P2|STARTED|Overall Study||7
4994|NCT02684942|10841|P1|STARTED|Overall Study||7
4995|NCT02684630|10857|P2|NOT COMPLETED|Overall Study||3
4996|NCT02684630|10858|P1|NOT COMPLETED|Overall Study||5
4997|NCT02684630|10857|P2|COMPLETED|Overall Study||60
4998|NCT02684630|10858|P1|COMPLETED|Overall Study||60
4999|NCT02684630|10857|P2|STARTED|Overall Study||63
5000|NCT02684630|10858|P1|STARTED|Overall Study||65
5001|NCT02684604|10868|P2|NOT COMPLETED|Overall Study||0
5002|NCT02684604|10869|P1|NOT COMPLETED|Overall Study||0
5003|NCT02684604|10868|P2|COMPLETED|Overall Study||44
5004|NCT02684604|10869|P1|COMPLETED|Overall Study||44
5005|NCT02684604|10868|P2|STARTED|Overall Study||44
5006|NCT02684604|10869|P1|STARTED|Overall Study||44
5007|NCT02684396|10881|P6|NOT COMPLETED|Overall Study||0
5008|NCT02684396|10882|P5|NOT COMPLETED|Overall Study||0
5009|NCT02684396|10883|P4|NOT COMPLETED|Overall Study||0
5010|NCT02684396|10884|P3|NOT COMPLETED|Overall Study||0
5011|NCT02684396|10885|P2|NOT COMPLETED|Overall Study||0
5012|NCT02684396|10886|P1|NOT COMPLETED|Overall Study||0
5013|NCT02684396|10881|P6|COMPLETED|Overall Study||10
5014|NCT02684396|10882|P5|COMPLETED|Overall Study||5
5015|NCT02684396|10883|P4|COMPLETED|Overall Study||6
5016|NCT02684396|10884|P3|COMPLETED|Overall Study||6
5017|NCT02684396|10885|P2|COMPLETED|Overall Study||6
5018|NCT02684396|10886|P1|COMPLETED|Overall Study||6
5019|NCT02684396|10881|P6|STARTED|Overall Study||10
5020|NCT02684396|10882|P5|STARTED|Overall Study||5
5021|NCT02684396|10883|P4|STARTED|Overall Study||6
5022|NCT02684396|10884|P3|STARTED|Overall Study||6
5023|NCT02684396|10885|P2|STARTED|Overall Study||6
5024|NCT02684396|10886|P1|STARTED|Overall Study||6
5025|NCT02684188|10940|P2|NOT COMPLETED|Overall Study||3
5026|NCT02684188|10941|P1|NOT COMPLETED|Overall Study||2
5027|NCT02684188|10940|P2|COMPLETED|Overall Study||47
5028|NCT02684188|10941|P1|COMPLETED|Overall Study||75
5029|NCT02684188|10940|P2|STARTED|Overall Study||50
5030|NCT02684188|10941|P1|STARTED|Overall Study||77
5031|NCT02683954|10967|P2|NOT COMPLETED|Overall Study||0
5032|NCT02683954|10968|P1|NOT COMPLETED|Overall Study||0
5033|NCT02683954|10967|P2|COMPLETED|Overall Study||30
5034|NCT02683954|10968|P1|COMPLETED|Overall Study||30
5035|NCT02683954|10967|P2|STARTED|Overall Study||30
5036|NCT02683954|10968|P1|STARTED|Overall Study||30
5037|NCT02683746|10976|P2|NOT COMPLETED|Overall Study||14
5038|NCT02683746|10977|P1|NOT COMPLETED|Overall Study||16
5039|NCT02683746|10976|P2|COMPLETED|Overall Study||140
5040|NCT02683746|10977|P1|COMPLETED|Overall Study||138
5041|NCT02683746|10976|P2|STARTED|Overall Study||154
5042|NCT02683746|10977|P1|STARTED|Overall Study||154
5043|NCT02683707|11007|P2|NOT COMPLETED|Overall Study||0
5044|NCT02683707|11008|P1|NOT COMPLETED|Overall Study||0
5045|NCT02683707|11007|P2|COMPLETED|Overall Study||107
5046|NCT02683707|11008|P1|COMPLETED|Overall Study||105
5047|NCT02683707|11007|P2|STARTED|Overall Study||107
5048|NCT02683707|11008|P1|STARTED|Overall Study||105
5049|NCT02683577|11023|P3|NOT COMPLETED|Overall Study||0
5050|NCT02683577|11024|P2|NOT COMPLETED|Overall Study||0
5051|NCT02683577|11025|P1|NOT COMPLETED|Overall Study||0
5052|NCT02683577|11023|P3|COMPLETED|Overall Study||8
5053|NCT02683577|11024|P2|COMPLETED|Overall Study||8
5054|NCT02683577|11025|P1|COMPLETED|Overall Study||8
5055|NCT02683577|11023|P3|STARTED|Overall Study||8
5056|NCT02683577|11024|P2|STARTED|Overall Study||8
5057|NCT02683577|11025|P1|STARTED|Overall Study||8
5058|NCT02682498|11073|P2|NOT COMPLETED|Overall Study||0
5059|NCT02682498|11074|P1|NOT COMPLETED|Overall Study||0
5060|NCT02682498|11073|P2|COMPLETED|Overall Study||20
5061|NCT02682498|11074|P1|COMPLETED|Overall Study||18
5062|NCT02682498|11073|P2|STARTED|Overall Study||20
5063|NCT02682498|11074|P1|STARTED|Overall Study||18
5064|NCT02681510|11088|P1|NOT COMPLETED|Overall Study||10
5065|NCT02681510|11088|P1|COMPLETED|Overall Study||26
5066|NCT02681510|11088|P1|STARTED|Overall Study||36
5067|NCT02681458|11097|P2|NOT COMPLETED|Overall Study||656
5068|NCT02681458|11098|P1|NOT COMPLETED|Overall Study||645
5069|NCT02681458|11097|P2|COMPLETED|Overall Study||62
5070|NCT02681458|11098|P1|COMPLETED|Overall Study||73
5071|NCT02681458|11097|P2|STARTED|Overall Study||718
5072|NCT02681458|11098|P1|STARTED|Overall Study||718
5073|NCT02679976|11104|P1|NOT COMPLETED|Overall Study||0
5074|NCT02679976|11104|P1|COMPLETED|Overall Study||30
5075|NCT02679976|11104|P1|Myopes|Overall Study||14
5076|NCT02679976|11104|P1|Hyperopes|Overall Study||16
5077|NCT02679976|11104|P1|STARTED|Overall Study||30
5078|NCT02679469|11113|P1|NOT COMPLETED|Overall Study||0
5079|NCT02679469|11113|P1|COMPLETED|Overall Study||7
5080|NCT02679469|11113|P1|STARTED|Overall Study||7
5081|NCT02678923|11121|P2|NOT COMPLETED|Overall Study||5
5082|NCT02678923|11122|P1|NOT COMPLETED|Overall Study||6
5083|NCT02678923|11121|P2|COMPLETED|Overall Study||62
5084|NCT02678923|11122|P1|COMPLETED|Overall Study||53
5085|NCT02678923|11121|P2|mITT Population|Overall Study||61
5086|NCT02678923|11122|P1|mITT Population|Overall Study||52
5087|NCT02678923|11121|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
5088|NCT02678923|11122|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
5089|NCT02678923|11121|P2|STARTED|Overall Study||67
5090|NCT02678923|11122|P1|STARTED|Overall Study||59
5091|NCT02678676|11138|P2|NOT COMPLETED|Overall Study||872
5092|NCT02678676|11139|P1|NOT COMPLETED|Overall Study||888
5093|NCT02678676|11138|P2|COMPLETED|Overall Study||907
5094|NCT02678676|11139|P1|COMPLETED|Overall Study||932
5095|NCT02678676|11138|P2|STARTED|Overall Study||1779
5096|NCT02678676|11139|P1|STARTED|Overall Study||1820
5097|NCT02678286|11149|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
5098|NCT02678286|11150|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
5099|NCT02678286|11149|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
5100|NCT02678286|11150|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
5101|NCT02678286|11149|P2|STARTED|Study Overall (28 Day Follow-Up)||109
5102|NCT02678286|11150|P1|STARTED|Study Overall (28 Day Follow-Up)||110
5103|NCT02678286|11149|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
5104|NCT02678286|11150|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
5105|NCT02678286|11149|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
5106|NCT02678286|11150|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
5107|NCT02678286|11149|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
5108|NCT02678286|11150|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
5109|NCT02678039|11182|P2|NOT COMPLETED|Overall Study||0
5110|NCT02678039|11183|P1|NOT COMPLETED|Overall Study||0
5111|NCT02678039|11182|P2|COMPLETED|Overall Study||47
5112|NCT02678039|11183|P1|COMPLETED|Overall Study||53
5113|NCT02678039|11182|P2|STARTED|Overall Study||47
5114|NCT02678039|11183|P1|STARTED|Overall Study||53
5115|NCT02677779|11199|P2|NOT COMPLETED|Overall Study||0
5116|NCT02677779|11200|P1|NOT COMPLETED|Overall Study||0
5117|NCT02677779|11199|P2|COMPLETED|Overall Study||10
5118|NCT02677779|11200|P1|COMPLETED|Overall Study||10
5119|NCT02677779|11199|P2|STARTED|Overall Study||10
5120|NCT02677779|11200|P1|STARTED|Overall Study||10
5121|NCT02677493|11217|P3|NOT COMPLETED|Overall Study||3
5122|NCT02677493|11218|P2|NOT COMPLETED|Overall Study||2
5123|NCT02677493|11219|P1|NOT COMPLETED|Overall Study||11
5124|NCT02677493|11217|P3|COMPLETED|Overall Study||296
5125|NCT02677493|11218|P2|COMPLETED|Overall Study||296
5126|NCT02677493|11219|P1|COMPLETED|Overall Study||1186
5127|NCT02677493|11217|P3|STARTED|Overall Study||299
5128|NCT02677493|11218|P2|STARTED|Overall Study||298
5129|NCT02677493|11219|P1|STARTED|Overall Study||1197
5130|NCT02675907|11232|P2|NOT COMPLETED|Study Overall||4
5131|NCT02675907|11233|P1|NOT COMPLETED|Study Overall||3
5132|NCT02675907|11232|P2|COMPLETED|Study Overall||97
5133|NCT02675907|11233|P1|COMPLETED|Study Overall||97
5134|NCT02675907|11232|P2|STARTED|Study Overall||101
5135|NCT02675907|11233|P1|STARTED|Study Overall||100
5136|NCT02675907|11232|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
5137|NCT02675907|11233|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
5138|NCT02675907|11232|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
5139|NCT02675907|11233|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
5140|NCT02675907|11232|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
5141|NCT02675907|11233|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
5142|NCT02675634|11263|P6|NOT COMPLETED|Test Period 3||0
5143|NCT02675634|11264|P5|NOT COMPLETED|Test Period 3||0
5144|NCT02675634|11265|P4|NOT COMPLETED|Test Period 3||0
5145|NCT02675634|11266|P3|NOT COMPLETED|Test Period 3||0
5146|NCT02675634|11267|P2|NOT COMPLETED|Test Period 3||0
5147|NCT02675634|11268|P1|NOT COMPLETED|Test Period 3||0
5148|NCT02675634|11263|P6|COMPLETED|Test Period 3||8
5149|NCT02675634|11264|P5|COMPLETED|Test Period 3||10
5150|NCT02675634|11265|P4|COMPLETED|Test Period 3||8
5151|NCT02675634|11266|P3|COMPLETED|Test Period 3||8
5152|NCT02675634|11267|P2|COMPLETED|Test Period 3||7
5153|NCT02675634|11268|P1|COMPLETED|Test Period 3||9
5154|NCT02675634|11263|P6|STARTED|Test Period 3||8
5155|NCT02675634|11264|P5|STARTED|Test Period 3||10
5156|NCT02675634|11265|P4|STARTED|Test Period 3||8
5157|NCT02675634|11266|P3|STARTED|Test Period 3||8
5158|NCT02675634|11267|P2|STARTED|Test Period 3||7
5159|NCT02675634|11268|P1|STARTED|Test Period 3||9
5160|NCT02675634|11263|P6|NOT COMPLETED|Test Period 2||1
5161|NCT02675634|11264|P5|NOT COMPLETED|Test Period 2||0
5162|NCT02675634|11265|P4|NOT COMPLETED|Test Period 2||0
5163|NCT02675634|11266|P3|NOT COMPLETED|Test Period 2||0
5164|NCT02675634|11267|P2|NOT COMPLETED|Test Period 2||0
5165|NCT02675634|11268|P1|NOT COMPLETED|Test Period 2||1
5166|NCT02675634|11263|P6|COMPLETED|Test Period 2||8
5167|NCT02675634|11264|P5|COMPLETED|Test Period 2||10
5168|NCT02675634|11265|P4|COMPLETED|Test Period 2||8
5169|NCT02675634|11266|P3|COMPLETED|Test Period 2||8
5170|NCT02675634|11267|P2|COMPLETED|Test Period 2||7
5171|NCT02675634|11268|P1|COMPLETED|Test Period 2||9
5172|NCT02675634|11263|P6|STARTED|Test Period 2||9
5173|NCT02675634|11264|P5|STARTED|Test Period 2||10
5174|NCT02675634|11265|P4|STARTED|Test Period 2||8
5175|NCT02675634|11266|P3|STARTED|Test Period 2||8
5176|NCT02675634|11267|P2|STARTED|Test Period 2||7
5177|NCT02675634|11268|P1|STARTED|Test Period 2||10
5178|NCT02675634|11263|P6|NOT COMPLETED|Test Period 1||0
5179|NCT02675634|11264|P5|NOT COMPLETED|Test Period 1||0
5180|NCT02675634|11265|P4|NOT COMPLETED|Test Period 1||1
5181|NCT02675634|11266|P3|NOT COMPLETED|Test Period 1||1
5182|NCT02675634|11267|P2|NOT COMPLETED|Test Period 1||1
5183|NCT02675634|11268|P1|NOT COMPLETED|Test Period 1||0
5184|NCT02675634|11263|P6|COMPLETED|Test Period 1||9
5185|NCT02675634|11264|P5|COMPLETED|Test Period 1||10
5186|NCT02675634|11265|P4|COMPLETED|Test Period 1||8
5187|NCT02675634|11266|P3|COMPLETED|Test Period 1||8
5188|NCT02675634|11267|P2|COMPLETED|Test Period 1||7
5189|NCT02675634|11268|P1|COMPLETED|Test Period 1||10
5190|NCT02675634|11263|P6|STARTED|Test Period 1||9
5191|NCT02675634|11264|P5|STARTED|Test Period 1||10
5192|NCT02675634|11265|P4|STARTED|Test Period 1||9
5193|NCT02675634|11266|P3|STARTED|Test Period 1||9
5194|NCT02675634|11267|P2|STARTED|Test Period 1||8
5195|NCT02675634|11268|P1|STARTED|Test Period 1||10
5196|NCT02675543|11278|P2|NOT COMPLETED|Overall Study||0
5197|NCT02675543|11279|P1|NOT COMPLETED|Overall Study||0
5198|NCT02675543|11278|P2|COMPLETED|Overall Study||20
5199|NCT02675543|11279|P1|COMPLETED|Overall Study||15
5200|NCT02675543|11278|P2|STARTED|Overall Study||20
5201|NCT02675543|11279|P1|STARTED|Overall Study||15
5202|NCT02674334|11287|P2|NOT COMPLETED|Overall Study||3
5203|NCT02674334|11288|P1|NOT COMPLETED|Overall Study||7
5204|NCT02674334|11287|P2|COMPLETED|Overall Study||40
5205|NCT02674334|11288|P1|COMPLETED|Overall Study||40
5206|NCT02674334|11287|P2|STARTED|Overall Study||43
5207|NCT02674334|11288|P1|STARTED|Overall Study||47
5208|NCT02673944|11296|P1|NOT COMPLETED|Overall Study||0
5209|NCT02673944|11296|P1|COMPLETED|Overall Study||10
5210|NCT02673944|11296|P1|STARTED|Overall Study||10
5211|NCT02673619|11305|P4|NOT COMPLETED|Overall Study||0
5212|NCT02673619|11306|P3|NOT COMPLETED|Overall Study||3
5213|NCT02673619|11307|P2|NOT COMPLETED|Overall Study||1
5214|NCT02673619|11308|P1|NOT COMPLETED|Overall Study||2
5215|NCT02673619|11305|P4|COMPLETED|Overall Study||7
5216|NCT02673619|11306|P3|COMPLETED|Overall Study||23
5217|NCT02673619|11307|P2|COMPLETED|Overall Study||4
5218|NCT02673619|11308|P1|COMPLETED|Overall Study||18
5219|NCT02673619|11305|P4|STARTED|Overall Study||7
5220|NCT02673619|11306|P3|STARTED|Overall Study||26
5221|NCT02673619|11307|P2|STARTED|Overall Study||5
5222|NCT02673619|11308|P1|STARTED|Overall Study||20
5223|NCT02673489|11400|P2|NOT COMPLETED|Follow Up Period||2
5224|NCT02673489|11401|P1|NOT COMPLETED|Follow Up Period||0
5225|NCT02673489|11400|P2|COMPLETED|Follow Up Period||21
5226|NCT02673489|11401|P1|COMPLETED|Follow Up Period||50
5227|NCT02673489|11400|P2|STARTED|Follow Up Period||23
5228|NCT02673489|11401|P1|STARTED|Follow Up Period||50
5229|NCT02673489|11400|P2|NOT COMPLETED|Treatment Period||3
5230|NCT02673489|11401|P1|NOT COMPLETED|Treatment Period||5
5231|NCT02673489|11400|P2|COMPLETED|Treatment Period||21
5232|NCT02673489|11401|P1|COMPLETED|Treatment Period||49
5233|NCT02673489|11400|P2|STARTED|Treatment Period||24
5234|NCT02673489|11401|P1|STARTED|Treatment Period||54
5235|NCT02672514|11416|P2|NOT COMPLETED|Overall Study||0
5236|NCT02672514|11417|P1|NOT COMPLETED|Overall Study||0
5237|NCT02672514|11416|P2|COMPLETED|Overall Study||51
5238|NCT02672514|11417|P1|COMPLETED|Overall Study||53
5239|NCT02672514|11416|P2|STARTED|Overall Study||51
5240|NCT02672514|11417|P1|STARTED|Overall Study||53
5241|NCT02671760|11423|P3|NOT COMPLETED|Overall Study||0
5242|NCT02671760|11424|P2|NOT COMPLETED|Overall Study||1
5243|NCT02671760|11425|P1|NOT COMPLETED|Overall Study||0
5244|NCT02671760|11423|P3|COMPLETED|Overall Study||13
5245|NCT02671760|11424|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
5246|NCT02671760|11425|P1|COMPLETED|Overall Study||13
5247|NCT02671760|11423|P3|STARTED|Overall Study||13
5248|NCT02671760|11424|P2|STARTED|Overall Study||13
5249|NCT02671760|11425|P1|STARTED|Overall Study||13
5250|NCT02670811|11453|P2|NOT COMPLETED|Overall Study||0
5251|NCT02670811|11454|P1|NOT COMPLETED|Overall Study||1
5252|NCT02670811|11453|P2|COMPLETED|Overall Study||18
5253|NCT02670811|11454|P1|COMPLETED|Overall Study||17
5254|NCT02670811|11453|P2|STARTED|Overall Study||18
5255|NCT02670811|11454|P1|STARTED|Overall Study||18
5256|NCT02670473|11470|P1|NOT COMPLETED|Overall Study||1
5257|NCT02670473|11470|P1|COMPLETED|Overall Study||34
5258|NCT02670473|11470|P1|STARTED|Overall Study||35
5259|NCT02670343|11523|P1|NOT COMPLETED|Overall Study||0
5260|NCT02670343|11523|P1|COMPLETED|Overall Study||8
5261|NCT02670343|11523|P1|STARTED|Overall Study||8
5262|NCT02669095|11529|P2|NOT COMPLETED|Overall Study||3
5263|NCT02669095|11530|P1|NOT COMPLETED|Overall Study||1
5264|NCT02669095|11529|P2|COMPLETED|Overall Study||72
5265|NCT02669095|11530|P1|COMPLETED|Overall Study||74
5266|NCT02669095|11529|P2|STARTED|Overall Study||75
5267|NCT02669095|11530|P1|STARTED|Overall Study||75
5268|NCT02669043|11538|P1|NOT COMPLETED|Overall Study||4
5269|NCT02669043|11538|P1|COMPLETED|Overall Study||4
5270|NCT02669043|11538|P1|STARTED|Overall Study||8
5271|NCT02668952|11544|P2|NOT COMPLETED|Overall Study||0
5272|NCT02668952|11545|P1|NOT COMPLETED|Overall Study||0
5273|NCT02668952|11544|P2|COMPLETED|Overall Study||14
5274|NCT02668952|11545|P1|COMPLETED|Overall Study||16
5275|NCT02668952|11544|P2|STARTED|Overall Study||14
5276|NCT02668952|11545|P1|STARTED|Overall Study||16
5277|NCT02668822|11565|P2|NOT COMPLETED|Overall Study||9
5278|NCT02668822|11566|P1|NOT COMPLETED|Overall Study||9
5279|NCT02668822|11565|P2|COMPLETED|Overall Study||0
5280|NCT02668822|11566|P1|COMPLETED|Overall Study||0
5281|NCT02668822|11565|P2|STARTED|Overall Study||9
5282|NCT02668822|11566|P1|STARTED|Overall Study||9
5283|NCT02668783|11588|P2|NOT COMPLETED|Overall Study||12
5284|NCT02668783|11589|P1|NOT COMPLETED|Overall Study||13
5285|NCT02668783|11588|P2|COMPLETED|Overall Study||0
5286|NCT02668783|11589|P1|COMPLETED|Overall Study||0
5287|NCT02668783|11588|P2|Treated|Overall Study||11
5288|NCT02668783|11589|P1|Treated|Overall Study||13
5289|NCT02668783|11588|P2|STARTED|Overall Study||12
5290|NCT02668783|11589|P1|STARTED|Overall Study||13
5291|NCT02667821|11609|P1|NOT COMPLETED|Overall Study||0
5292|NCT02667821|11609|P1|COMPLETED|Overall Study||20
5293|NCT02667821|11609|P1|STARTED|Overall Study||20
5294|NCT02667704|11615|P1|NOT COMPLETED|Treatment Period 2||0
5295|NCT02667704|11615|P1|COMPLETED|Treatment Period 2||13
5296|NCT02667704|11615|P1|STARTED|Treatment Period 2||13
5297|NCT02667704|11615|P1|NOT COMPLETED|Treatment Period 1||0
5298|NCT02667704|11615|P1|COMPLETED|Treatment Period 1||13
5299|NCT02667704|11615|P1|STARTED|Treatment Period 1||13
5300|NCT02667288|11626|P1|NOT COMPLETED|Overall Study||13
5301|NCT02667288|11626|P1|COMPLETED|Overall Study||134
5302|NCT02667288|11626|P1|STARTED|Overall Study||147
5303|NCT02667275|11633|P2|NOT COMPLETED|Overall Study||15
5304|NCT02667275|11634|P1|NOT COMPLETED|Overall Study||11
5305|NCT02667275|11633|P2|COMPLETED|Overall Study||228
5306|NCT02667275|11634|P1|COMPLETED|Overall Study||233
5307|NCT02667275|11633|P2|STARTED|Overall Study||243
5308|NCT02667275|11634|P1|STARTED|Overall Study||244
5309|NCT02667236|11644|P2|NOT COMPLETED|Overall Study||1
5310|NCT02667236|11645|P1|NOT COMPLETED|Overall Study||3
5311|NCT02667236|11644|P2|COMPLETED|Overall Study||226
5312|NCT02667236|11645|P1|COMPLETED|Overall Study||220
5313|NCT02667236|11644|P2|STARTED|Overall Study||227
5314|NCT02667236|11645|P1|STARTED|Overall Study||223
5315|NCT02666560|11653|P2|NOT COMPLETED|Condition 2 (1 Day)||0
5316|NCT02666560|11654|P1|NOT COMPLETED|Condition 2 (1 Day)||0
5317|NCT02666560|11653|P2|COMPLETED|Condition 2 (1 Day)||11
5318|NCT02666560|11654|P1|COMPLETED|Condition 2 (1 Day)||8
5319|NCT02666560|11653|P2|STARTED|Condition 2 (1 Day)||11
5320|NCT02666560|11654|P1|STARTED|Condition 2 (1 Day)||8
5321|NCT02666560|11653|P2|NOT COMPLETED|Condition 1 (1 Day)||0
5322|NCT02666560|11654|P1|NOT COMPLETED|Condition 1 (1 Day)||0
5323|NCT02666560|11653|P2|COMPLETED|Condition 1 (1 Day)||11
5324|NCT02666560|11654|P1|COMPLETED|Condition 1 (1 Day)||8
5325|NCT02666560|11653|P2|STARTED|Condition 1 (1 Day)||11
5326|NCT02666560|11654|P1|STARTED|Condition 1 (1 Day)||8
5327|NCT02666222|11670|P1|NOT COMPLETED|Overall Study||2
5328|NCT02666222|11670|P1|COMPLETED|Overall Study||49
5329|NCT02666222|11670|P1|STARTED|Overall Study||51
5330|NCT02665455|11678|P1|NOT COMPLETED|Overall Study||9
5331|NCT02665455|11678|P1|COMPLETED|Overall Study||74
5332|NCT02665455|11678|P1|STARTED|Overall Study||83
5333|NCT02665260|11686|P4|NOT COMPLETED|Overall Study||1
5334|NCT02665260|11687|P3|NOT COMPLETED|Overall Study||4
5335|NCT02665260|11688|P2|NOT COMPLETED|Overall Study||1
5336|NCT02665260|11689|P1|NOT COMPLETED|Overall Study||2
5337|NCT02665260|11686|P4|COMPLETED|Overall Study||21
5338|NCT02665260|11687|P3|COMPLETED|Overall Study||21
5339|NCT02665260|11688|P2|COMPLETED|Overall Study||22
5340|NCT02665260|11689|P1|COMPLETED|Overall Study||22
5341|NCT02665260|11686|P4|STARTED|Overall Study||22
5342|NCT02665260|11687|P3|STARTED|Overall Study||25
5343|NCT02665260|11688|P2|STARTED|Overall Study||23
5344|NCT02665260|11689|P1|STARTED|Overall Study||24
5345|NCT02665221|11705|P2|NOT COMPLETED|Overall Study||15
5346|NCT02665221|11706|P1|NOT COMPLETED|Overall Study||15
5347|NCT02665221|11705|P2|COMPLETED|Overall Study||0
5348|NCT02665221|11706|P1|COMPLETED|Overall Study||0
5349|NCT02665221|11705|P2|STARTED|Overall Study||15
5350|NCT02665221|11706|P1|STARTED|Overall Study||15
5351|NCT02664987|11718|P1|NOT COMPLETED|Overall Study||0
5352|NCT02664987|11718|P1|COMPLETED|Overall Study||462
5353|NCT02664987|11718|P1|STARTED|Overall Study||462
5354|NCT02664610|11729|P2|NOT COMPLETED|Overall Study||7
5355|NCT02664610|11730|P1|NOT COMPLETED|Overall Study||14
5356|NCT02664610|11729|P2|COMPLETED|Overall Study||41
5357|NCT02664610|11730|P1|COMPLETED|Overall Study||32
5358|NCT02664610|11729|P2|STARTED|Overall Study||48
5359|NCT02664610|11730|P1|STARTED|Overall Study||46
5360|NCT02664532|11740|P2|NOT COMPLETED|Overall Study||0
5361|NCT02664532|11741|P1|NOT COMPLETED|Overall Study||0
5362|NCT02664532|11740|P2|COMPLETED|Overall Study||75
5363|NCT02664532|11741|P1|COMPLETED|Overall Study||75
5364|NCT02664532|11740|P2|STARTED|Overall Study||75
5365|NCT02664532|11741|P1|STARTED|Overall Study||75
5366|NCT02664311|11755|P2|NOT COMPLETED|Overall Study||0
5367|NCT02664311|11756|P1|NOT COMPLETED|Overall Study||0
5368|NCT02664311|11755|P2|COMPLETED|Overall Study||3
5369|NCT02664311|11756|P1|COMPLETED|Overall Study||6
5370|NCT02664311|11755|P2|STARTED|Overall Study||3
5371|NCT02664311|11756|P1|STARTED|Overall Study||6
5372|NCT02663453|11768|P2|NOT COMPLETED|Overall Study||4
5373|NCT02663453|11769|P1|NOT COMPLETED|Overall Study||5
5374|NCT02663453|11768|P2|COMPLETED|Overall Study||18
5375|NCT02663453|11769|P1|COMPLETED|Overall Study||17
5376|NCT02663453|11768|P2|STARTED|Overall Study||22
5377|NCT02663453|11769|P1|STARTED|Overall Study||22
5378|NCT02663232|11791|P1|NOT COMPLETED|Overall Study||0
5379|NCT02663232|11791|P1|COMPLETED|Overall Study||264
5380|NCT02663232|11791|P1|STARTED|Overall Study||264
5381|NCT02662608|11812|P1|NOT COMPLETED|Overall Study||0
5382|NCT02662608|11812|P1|COMPLETED|Overall Study||1
5383|NCT02662608|11812|P1|STARTED|Overall Study||1
5384|NCT02662556|11816|P1|NOT COMPLETED|Overall Study||8
5385|NCT02662556|11816|P1|COMPLETED|Overall Study||132
5386|NCT02662556|11816|P1|STARTED|Overall Study||140
5387|NCT02662387|11825|P2|NOT COMPLETED|Overall Study||0
5388|NCT02662387|11826|P1|NOT COMPLETED|Overall Study||0
5389|NCT02662387|11825|P2|COMPLETED|Overall Study||28
5390|NCT02662387|11826|P1|COMPLETED|Overall Study||27
5391|NCT02662387|11825|P2|STARTED|Overall Study||28
5392|NCT02662387|11826|P1|STARTED|Overall Study||27
5393|NCT02661594|11838|P4|NOT COMPLETED|Overall Study||0
5394|NCT02661594|11839|P3|NOT COMPLETED|Overall Study||1
5395|NCT02661594|11840|P2|NOT COMPLETED|Overall Study||0
5396|NCT02661594|11841|P1|NOT COMPLETED|Overall Study||1
5397|NCT02661594|11838|P4|COMPLETED|Overall Study||9
5398|NCT02661594|11839|P3|COMPLETED|Overall Study||9
5399|NCT02661594|11840|P2|COMPLETED|Overall Study||11
5400|NCT02661594|11841|P1|COMPLETED|Overall Study||9
5401|NCT02661594|11838|P4|STARTED|Overall Study||9
5402|NCT02661594|11839|P3|STARTED|Overall Study||10
5403|NCT02661594|11840|P2|STARTED|Overall Study||11
5404|NCT02661594|11841|P1|STARTED|Overall Study||10
5405|NCT02658461|11854|P3|NOT COMPLETED|Overall Study||0
5406|NCT02658461|11855|P2|NOT COMPLETED|Overall Study||0
5407|NCT02658461|11856|P1|NOT COMPLETED|Overall Study||0
5408|NCT02658461|11854|P3|COMPLETED|Overall Study||12
5409|NCT02658461|11855|P2|COMPLETED|Overall Study||12
5410|NCT02658461|11856|P1|COMPLETED|Overall Study||12
5411|NCT02658461|11854|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
5412|NCT02658461|11855|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
5413|NCT02658461|11856|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
5414|NCT02658149|11884|P2|NOT COMPLETED|Overall Study||0
5415|NCT02658149|11885|P1|NOT COMPLETED|Overall Study||1
5416|NCT02658149|11884|P2|COMPLETED|Overall Study||50
5417|NCT02658149|11885|P1|COMPLETED|Overall Study||49
5418|NCT02658149|11884|P2|STARTED|Overall Study||50
5419|NCT02658149|11885|P1|STARTED|Overall Study||50
5420|NCT02657629|11901|P2|NOT COMPLETED|Overall Study||0
5421|NCT02657629|11902|P1|NOT COMPLETED|Overall Study||2
5422|NCT02657629|11901|P2|COMPLETED|Overall Study||14
5423|NCT02657629|11902|P1|COMPLETED|Overall Study||12
5424|NCT02657629|11901|P2|STARTED|Overall Study||14
5425|NCT02657629|11902|P1|STARTED|Overall Study||14
5426|NCT02657538|11908|P1|NOT COMPLETED|Overall Study||4
5427|NCT02657538|11908|P1|COMPLETED|Overall Study||31
5428|NCT02657538|11908|P1|Received Visual Caries Detection + Bite|Overall Study||35
5429|NCT02657538|11908|P1|Received Near Infrared Transillumination|Overall Study||35
5430|NCT02657538|11908|P1|STARTED|Overall Study||35
5431|NCT02657252|11917|P2|NOT COMPLETED|Overall Study||7
5432|NCT02657252|11918|P1|NOT COMPLETED|Overall Study||10
5433|NCT02657252|11917|P2|COMPLETED|Overall Study||51
5434|NCT02657252|11918|P1|COMPLETED|Overall Study||47
5435|NCT02657252|11917|P2|STARTED|Overall Study||58
5436|NCT02657252|11918|P1|STARTED|Overall Study||57
5437|NCT02657031|11930|P2|NOT COMPLETED|Overall Study||2
5438|NCT02657031|11931|P1|NOT COMPLETED|Overall Study||1
5439|NCT02657031|11930|P2|COMPLETED|Overall Study||23
5440|NCT02657031|11931|P1|COMPLETED|Overall Study||28
5441|NCT02657031|11930|P2|STARTED|Overall Study||25
5442|NCT02657031|11931|P1|STARTED|Overall Study||29
5443|NCT02656485|11949|P4|NOT COMPLETED|Overall Study||2
5444|NCT02656485|11950|P3|NOT COMPLETED|Overall Study||2
5445|NCT02656485|11951|P2|NOT COMPLETED|Overall Study||3
5446|NCT02656485|11952|P1|NOT COMPLETED|Overall Study||2
5447|NCT02656485|11949|P4|COMPLETED|Overall Study||7
5448|NCT02656485|11950|P3|COMPLETED|Overall Study||7
5449|NCT02656485|11951|P2|COMPLETED|Overall Study||6
5450|NCT02656485|11952|P1|COMPLETED|Overall Study||7
5451|NCT02656485|11949|P4|STARTED|Overall Study||9
5452|NCT02656485|11950|P3|STARTED|Overall Study||9
5453|NCT02656485|11951|P2|STARTED|Overall Study||9
5454|NCT02656485|11952|P1|STARTED|Overall Study||9
5455|NCT02656160|11964|P2|NOT COMPLETED|Second Study Night||0
5456|NCT02656160|11965|P1|NOT COMPLETED|Second Study Night||0
5457|NCT02656160|11964|P2|COMPLETED|Second Study Night||6
5458|NCT02656160|11965|P1|COMPLETED|Second Study Night||4
5459|NCT02656160|11964|P2|STARTED|Second Study Night||6
5460|NCT02656160|11965|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
5461|NCT02656160|11964|P2|NOT COMPLETED|First Study Night||0
5462|NCT02656160|11965|P1|NOT COMPLETED|First Study Night||0
5463|NCT02656160|11964|P2|COMPLETED|First Study Night||6
5464|NCT02656160|11965|P1|COMPLETED|First Study Night||7
5465|NCT02656160|11964|P2|STARTED|First Study Night||6
5466|NCT02656160|11965|P1|STARTED|First Study Night||7
5467|NCT02654145|11973|P1|NOT COMPLETED|Overall Study||7
5468|NCT02654145|11973|P1|COMPLETED|Overall Study||138
5469|NCT02654145|11973|P1|STARTED|Overall Study||145
5470|NCT02653872|11980|P1|NOT COMPLETED|Overall Study||0
5471|NCT02653872|11980|P1|COMPLETED|Overall Study||15
5472|NCT02653872|11980|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
5473|NCT02653872|11980|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
5474|NCT02653872|11980|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
5475|NCT02653872|11980|P1|STARTED|Overall Study||15
5476|NCT02653560|12015|P4|NOT COMPLETED|Placebo Phase||0
5477|NCT02653560|12016|P3|NOT COMPLETED|Placebo Phase||0
5478|NCT02653560|12017|P2|NOT COMPLETED|Placebo Phase||0
5479|NCT02653560|12018|P1|NOT COMPLETED|Placebo Phase||0
5480|NCT02653560|12015|P4|COMPLETED|Placebo Phase||30
5481|NCT02653560|12016|P3|COMPLETED|Placebo Phase||0
5482|NCT02653560|12017|P2|COMPLETED|Placebo Phase||0
5483|NCT02653560|12018|P1|COMPLETED|Placebo Phase||0
5484|NCT02653560|12015|P4|STARTED|Placebo Phase||30
5485|NCT02653560|12016|P3|STARTED|Placebo Phase||0
5486|NCT02653560|12017|P2|STARTED|Placebo Phase||0
5487|NCT02653560|12018|P1|STARTED|Placebo Phase||0
5488|NCT02653560|12015|P4|NOT COMPLETED|KCl Phase||0
5489|NCT02653560|12016|P3|NOT COMPLETED|KCl Phase||0
5490|NCT02653560|12017|P2|NOT COMPLETED|KCl Phase||0
5491|NCT02653560|12018|P1|NOT COMPLETED|KCl Phase||0
5492|NCT02653560|12015|P4|COMPLETED|KCl Phase||0
5493|NCT02653560|12016|P3|COMPLETED|KCl Phase||30
5494|NCT02653560|12017|P2|COMPLETED|KCl Phase||0
5495|NCT02653560|12018|P1|COMPLETED|KCl Phase||0
5496|NCT02653560|12015|P4|STARTED|KCl Phase||0
5497|NCT02653560|12016|P3|STARTED|KCl Phase||30
5498|NCT02653560|12017|P2|STARTED|KCl Phase||0
5499|NCT02653560|12018|P1|STARTED|KCl Phase||0
5500|NCT02653560|12015|P4|NOT COMPLETED|K Citrate Phase||0
5501|NCT02653560|12016|P3|NOT COMPLETED|K Citrate Phase||0
5502|NCT02653560|12017|P2|NOT COMPLETED|K Citrate Phase||0
5503|NCT02653560|12018|P1|NOT COMPLETED|K Citrate Phase||0
5504|NCT02653560|12015|P4|COMPLETED|K Citrate Phase||0
5505|NCT02653560|12016|P3|COMPLETED|K Citrate Phase||0
5506|NCT02653560|12017|P2|COMPLETED|K Citrate Phase||30
5507|NCT02653560|12018|P1|COMPLETED|K Citrate Phase||0
5508|NCT02653560|12015|P4|STARTED|K Citrate Phase||0
5509|NCT02653560|12016|P3|STARTED|K Citrate Phase||0
5510|NCT02653560|12017|P2|STARTED|K Citrate Phase||30
5511|NCT02653560|12018|P1|STARTED|K Citrate Phase||0
5512|NCT02653560|12015|P4|NOT COMPLETED|KMgCit Phase||0
5513|NCT02653560|12016|P3|NOT COMPLETED|KMgCit Phase||0
5514|NCT02653560|12017|P2|NOT COMPLETED|KMgCit Phase||0
5515|NCT02653560|12018|P1|NOT COMPLETED|KMgCit Phase||0
5516|NCT02653560|12015|P4|COMPLETED|KMgCit Phase||0
5517|NCT02653560|12016|P3|COMPLETED|KMgCit Phase||0
5518|NCT02653560|12017|P2|COMPLETED|KMgCit Phase||0
5519|NCT02653560|12018|P1|COMPLETED|KMgCit Phase||30
5520|NCT02653560|12015|P4|STARTED|KMgCit Phase||0
5521|NCT02653560|12016|P3|STARTED|KMgCit Phase||0
5522|NCT02653560|12017|P2|STARTED|KMgCit Phase||0
5523|NCT02653560|12018|P1|STARTED|KMgCit Phase||30
5524|NCT02653495|12030|P2|NOT COMPLETED|Overall Study||0
5525|NCT02653495|12031|P1|NOT COMPLETED|Overall Study||12
5526|NCT02653495|12030|P2|COMPLETED|Overall Study||2
5527|NCT02653495|12031|P1|COMPLETED|Overall Study||3
5528|NCT02653495|12030|P2|STARTED|Overall Study||2
5529|NCT02653495|12031|P1|STARTED|Overall Study||15
5530|NCT02652221|12045|P1|NOT COMPLETED|Overall Study||0
5531|NCT02652221|12045|P1|COMPLETED|Overall Study||55
5532|NCT02652221|12045|P1|STARTED|Overall Study||55
5533|NCT02652208|12054|P2|NOT COMPLETED|Overall Study||2
5534|NCT02652208|12055|P1|NOT COMPLETED|Overall Study||4
5535|NCT02652208|12054|P2|COMPLETED|Overall Study||15
5536|NCT02652208|12055|P1|COMPLETED|Overall Study||13
5537|NCT02652208|12054|P2|STARTED|Overall Study||17
5538|NCT02652208|12055|P1|STARTED|Overall Study||17
5539|NCT02651922|12065|P1|NOT COMPLETED|Overall Study||2
5540|NCT02651922|12065|P1|COMPLETED|Overall Study||154
5541|NCT02651922|12065|P1|STARTED|Overall Study||156
5542|NCT02651467|12085|P3|NOT COMPLETED|Overall Study||4
5543|NCT02651467|12086|P2|NOT COMPLETED|Overall Study||0
5544|NCT02651467|12087|P1|NOT COMPLETED|Overall Study||1
5545|NCT02651467|12085|P3|COMPLETED|Overall Study||69
5546|NCT02651467|12086|P2|COMPLETED|Overall Study||74
5547|NCT02651467|12087|P1|COMPLETED|Overall Study||73
5548|NCT02651467|12085|P3|STARTED|Overall Study||73
5549|NCT02651467|12086|P2|STARTED|Overall Study||74
5550|NCT02651467|12087|P1|STARTED|Overall Study||74
5551|NCT02651194|12106|P1|NOT COMPLETED|Overall Study||5
5552|NCT02651194|12106|P1|COMPLETED|Overall Study||99
5553|NCT02651194|12106|P1|STARTED|Overall Study||104
5554|NCT02650440|12114|P2|NOT COMPLETED|Overall Study||2
5555|NCT02650440|12115|P1|NOT COMPLETED|Overall Study||0
5556|NCT02650440|12114|P2|COMPLETED|Overall Study||8
5557|NCT02650440|12115|P1|COMPLETED|Overall Study||10
5558|NCT02650440|12114|P2|STARTED|Overall Study||10
5559|NCT02650440|12115|P1|STARTED|Overall Study||10
5560|NCT02650219|12133|P2|NOT COMPLETED|Overall Study||0
5561|NCT02650219|12134|P1|NOT COMPLETED|Overall Study||0
5562|NCT02650219|12133|P2|COMPLETED|Overall Study||20
5563|NCT02650219|12134|P1|COMPLETED|Overall Study||40
5564|NCT02650219|12133|P2|STARTED|Overall Study||20
5565|NCT02650219|12134|P1|STARTED|Overall Study||40
5566|NCT02649634|12146|P2|NOT COMPLETED|Overall Study||6
5567|NCT02649634|12147|P1|NOT COMPLETED|Overall Study||3
5568|NCT02649634|12146|P2|COMPLETED|Overall Study||60
5569|NCT02649634|12147|P1|COMPLETED|Overall Study||66
5570|NCT02649634|12146|P2|STARTED|Overall Study||66
5571|NCT02649634|12147|P1|STARTED|Overall Study||69
5572|NCT02648438|12206|P3|NOT COMPLETED|Overall Study||0
5573|NCT02648438|12207|P2|NOT COMPLETED|Overall Study||3
5574|NCT02648438|12208|P1|NOT COMPLETED|Overall Study||3
5575|NCT02648438|12206|P3|COMPLETED|Overall Study||6
5576|NCT02648438|12207|P2|COMPLETED|Overall Study||9
5577|NCT02648438|12208|P1|COMPLETED|Overall Study||9
5578|NCT02648438|12206|P3|STARTED|Overall Study||6
5579|NCT02648438|12207|P2|STARTED|Overall Study||12
5580|NCT02648438|12208|P1|STARTED|Overall Study||12
5581|NCT02648204|12252|P4|NOT COMPLETED|Overall Study||16
5582|NCT02648204|12253|P3|NOT COMPLETED|Overall Study||13
5583|NCT02648204|12254|P2|NOT COMPLETED|Overall Study||21
5584|NCT02648204|12255|P1|NOT COMPLETED|Overall Study||22
5585|NCT02648204|12252|P4|COMPLETED|Overall Study||284
5586|NCT02648204|12253|P3|COMPLETED|Overall Study||287
5587|NCT02648204|12254|P2|COMPLETED|Overall Study||279
5588|NCT02648204|12255|P1|COMPLETED|Overall Study||279
5589|NCT02648204|12252|P4|Exposed|Overall Study||299
5590|NCT02648204|12253|P3|Exposed|Overall Study||299
5591|NCT02648204|12254|P2|Exposed|Overall Study||300
5592|NCT02648204|12255|P1|Exposed|Overall Study||301
5593|NCT02648204|12252|P4|STARTED|Overall Study||300
5594|NCT02648204|12253|P3|STARTED|Overall Study||300
5595|NCT02648204|12254|P2|STARTED|Overall Study||300
5596|NCT02648204|12255|P1|STARTED|Overall Study||301
5597|NCT02648022|12375|P2|NOT COMPLETED|Overall Study||0
5598|NCT02648022|12376|P1|NOT COMPLETED|Overall Study||0
5599|NCT02648022|12375|P2|COMPLETED|Overall Study||39
5600|NCT02648022|12376|P1|COMPLETED|Overall Study||40
5601|NCT02648022|12375|P2|STARTED|Overall Study||39
5602|NCT02648022|12376|P1|STARTED|Overall Study||40
5603|NCT02647944|12388|P2|NOT COMPLETED|Overall Study||3
5604|NCT02647944|12389|P1|NOT COMPLETED|Overall Study||2
5605|NCT02647944|12388|P2|COMPLETED|Overall Study||18
5606|NCT02647944|12389|P1|COMPLETED|Overall Study||17
5607|NCT02647944|12388|P2|STARTED|Overall Study||21
5608|NCT02647944|12389|P1|STARTED|Overall Study||19
5609|NCT02647320|12418|P5|NOT COMPLETED|Overall Study||17
5610|NCT02647320|12419|P4|NOT COMPLETED|Overall Study||10
5611|NCT02647320|12420|P3|NOT COMPLETED|Overall Study||15
5612|NCT02647320|12421|P2|NOT COMPLETED|Overall Study||11
5613|NCT02647320|12422|P1|NOT COMPLETED|Overall Study||12
5614|NCT02647320|12418|P5|COMPLETED|Overall Study||52
5615|NCT02647320|12419|P4|COMPLETED|Overall Study||58
5616|NCT02647320|12420|P3|COMPLETED|Overall Study||54
5617|NCT02647320|12421|P2|COMPLETED|Overall Study||35
5618|NCT02647320|12422|P1|COMPLETED|Overall Study||34
5619|NCT02647320|12418|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
5620|NCT02647320|12419|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
5621|NCT02647320|12420|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
5622|NCT02647320|12421|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
5623|NCT02647320|12422|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
5624|NCT02647320|12418|P5|Safety Set|Overall Study||69
5625|NCT02647320|12419|P4|Safety Set|Overall Study||68
5626|NCT02647320|12420|P3|Safety Set|Overall Study||68
5627|NCT02647320|12421|P2|Safety Set|Overall Study||44
5628|NCT02647320|12422|P1|Safety Set|Overall Study||43
5629|NCT02647320|12418|P5|Inadvertently Randomized|Overall Study||0
5630|NCT02647320|12419|P4|Inadvertently Randomized|Overall Study||1
5631|NCT02647320|12420|P3|Inadvertently Randomized|Overall Study||0
5632|NCT02647320|12421|P2|Inadvertently Randomized|Overall Study||0
5633|NCT02647320|12422|P1|Inadvertently Randomized|Overall Study||0
5634|NCT02647320|12418|P5|STARTED|Overall Study||69
5635|NCT02647320|12419|P4|STARTED|Overall Study||68
5636|NCT02647320|12420|P3|STARTED|Overall Study||69
5637|NCT02647320|12421|P2|STARTED|Overall Study||46
5638|NCT02647320|12422|P1|STARTED|Overall Study||46
5639|NCT02646449|12506|P2|NOT COMPLETED|Overall Study||0
5640|NCT02646449|12507|P1|NOT COMPLETED|Overall Study||0
5641|NCT02646449|12506|P2|COMPLETED|Overall Study||3
5642|NCT02646449|12507|P1|COMPLETED|Overall Study||4
5643|NCT02646449|12506|P2|STARTED|Overall Study||3
5644|NCT02646449|12507|P1|STARTED|Overall Study||4
5645|NCT02645760|12517|P2|NOT COMPLETED|Overall Study||0
5646|NCT02645760|12518|P1|NOT COMPLETED|Overall Study||0
5647|NCT02645760|12517|P2|COMPLETED|Overall Study||19
5648|NCT02645760|12518|P1|COMPLETED|Overall Study||19
5649|NCT02645760|12517|P2|STARTED|Overall Study||19
5650|NCT02645760|12518|P1|STARTED|Overall Study||19
5651|NCT02645253|12534|P4|NOT COMPLETED|Overall Study||0
5652|NCT02645253|12535|P3|NOT COMPLETED|Overall Study||0
5653|NCT02645253|12536|P2|NOT COMPLETED|Overall Study||0
5654|NCT02645253|12537|P1|NOT COMPLETED|Overall Study||0
5655|NCT02645253|12534|P4|COMPLETED|Overall Study||6
5656|NCT02645253|12535|P3|COMPLETED|Overall Study||7
5657|NCT02645253|12536|P2|COMPLETED|Overall Study||7
5658|NCT02645253|12537|P1|COMPLETED|Overall Study||7
5659|NCT02645253|12534|P4|STARTED|Overall Study||6
5660|NCT02645253|12535|P3|STARTED|Overall Study||7
5661|NCT02645253|12536|P2|STARTED|Overall Study||7
5662|NCT02645253|12537|P1|STARTED|Overall Study||7
5663|NCT02645123|12659|P3|NOT COMPLETED|Overall Study||0
5664|NCT02645123|12660|P2|NOT COMPLETED|Overall Study||0
5665|NCT02645123|12661|P1|NOT COMPLETED|Overall Study||0
5666|NCT02645123|12659|P3|COMPLETED|Overall Study||25
5667|NCT02645123|12660|P2|COMPLETED|Overall Study||25
5668|NCT02645123|12661|P1|COMPLETED|Overall Study||25
5669|NCT02645123|12659|P3|STARTED|Overall Study||25
5670|NCT02645123|12660|P2|STARTED|Overall Study||25
5671|NCT02645123|12661|P1|STARTED|Overall Study||25
5672|NCT02644356|12678|P1|NOT COMPLETED|Overall Study||2
5673|NCT02644356|12678|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
5674|NCT02644356|12678|P1|STARTED|Overall Study||51
5675|NCT02644109|12690|P2|NOT COMPLETED|Overall Study||4
5676|NCT02644109|12691|P1|NOT COMPLETED|Overall Study||0
5677|NCT02644109|12690|P2|COMPLETED|Overall Study||24
5678|NCT02644109|12691|P1|COMPLETED|Overall Study||24
5679|NCT02644109|12690|P2|STARTED|Overall Study||28
5680|NCT02644109|12691|P1|STARTED|Overall Study||24
5681|NCT02644096|12699|P2|NOT COMPLETED|Overall Study||25
5682|NCT02644096|12700|P1|NOT COMPLETED|Overall Study||28
5683|NCT02644096|12699|P2|COMPLETED|Overall Study||57
5684|NCT02644096|12700|P1|COMPLETED|Overall Study||65
5685|NCT02644096|12699|P2|9 Month SF-36 Questionnaire|Overall Study||57
5686|NCT02644096|12700|P1|9 Month SF-36 Questionnaire|Overall Study||65
5687|NCT02644096|12699|P2|12 Week SF-36 Questionnaire|Overall Study||59
5688|NCT02644096|12700|P1|12 Week SF-36 Questionnaire|Overall Study||68
5689|NCT02644096|12699|P2|10 Week Interview|Overall Study||59
5690|NCT02644096|12700|P1|10 Week Interview|Overall Study|Not done in control group|0
5691|NCT02644096|12699|P2|2 Week Interview|Overall Study||68
5692|NCT02644096|12700|P1|2 Week Interview|Overall Study|Not done in control group|0
5693|NCT02644096|12699|P2|STARTED|Overall Study||82
5694|NCT02644096|12700|P1|STARTED|Overall Study||93
5695|NCT02643862|12708|P2|NOT COMPLETED|Overall Study||0
5696|NCT02643862|12709|P1|NOT COMPLETED|Overall Study||0
5697|NCT02643862|12708|P2|COMPLETED|Overall Study||12
5698|NCT02643862|12709|P1|COMPLETED|Overall Study||36
5699|NCT02643862|12708|P2|STARTED|Overall Study||12
5700|NCT02643862|12709|P1|STARTED|Overall Study||36
5701|NCT02643615|12719|P2|NOT COMPLETED|Overall Study||0
5702|NCT02643615|12720|P1|NOT COMPLETED|Overall Study||0
5703|NCT02643615|12719|P2|COMPLETED|Overall Study||11
5704|NCT02643615|12720|P1|COMPLETED|Overall Study||9
5705|NCT02643615|12719|P2|STARTED|Overall Study||11
5706|NCT02643615|12720|P1|STARTED|Overall Study||9
5707|NCT02643394|12734|P2|NOT COMPLETED|Overall Study||5
5708|NCT02643394|12735|P1|NOT COMPLETED|Overall Study||4
5709|NCT02643394|12734|P2|COMPLETED|Overall Study||50
5710|NCT02643394|12735|P1|COMPLETED|Overall Study||51
5711|NCT02643394|12734|P2|STARTED|Overall Study||55
5712|NCT02643394|12735|P1|STARTED|Overall Study||55
5713|NCT02643251|12745|P2|NOT COMPLETED|Overall Study||2
5714|NCT02643251|12746|P1|NOT COMPLETED|Overall Study||11
5715|NCT02643251|12745|P2|COMPLETED|Overall Study||67
5716|NCT02643251|12746|P1|COMPLETED|Overall Study||58
5717|NCT02643251|12745|P2|STARTED|Overall Study||69
5718|NCT02643251|12746|P1|STARTED|Overall Study||69
5719|NCT02643225|12756|P2|NOT COMPLETED|Overall Study||0
5720|NCT02643225|12757|P1|NOT COMPLETED|Overall Study||0
5721|NCT02643225|12756|P2|COMPLETED|Overall Study||40
5722|NCT02643225|12757|P1|COMPLETED|Overall Study||40
5723|NCT02643225|12756|P2|STARTED|Overall Study||40
5724|NCT02643225|12757|P1|STARTED|Overall Study||40
5725|NCT02643199|12769|P1|NOT COMPLETED|Overall Study||0
5726|NCT02643199|12769|P1|COMPLETED|Overall Study||90
5727|NCT02643199|12769|P1|STARTED|Overall Study||90
5728|NCT02643004|12774|P2|NOT COMPLETED|Second Intervention (One Week)||0
5729|NCT02643004|12775|P1|NOT COMPLETED|Second Intervention (One Week)||0
5730|NCT02643004|12774|P2|COMPLETED|Second Intervention (One Week)||35
5731|NCT02643004|12775|P1|COMPLETED|Second Intervention (One Week)||35
5732|NCT02643004|12774|P2|STARTED|Second Intervention (One Week)||35
5733|NCT02643004|12775|P1|STARTED|Second Intervention (One Week)||35
5734|NCT02643004|12774|P2|NOT COMPLETED|First Intervention (One Week)||0
5735|NCT02643004|12775|P1|NOT COMPLETED|First Intervention (One Week)||0
5736|NCT02643004|12774|P2|COMPLETED|First Intervention (One Week)||35
5737|NCT02643004|12775|P1|COMPLETED|First Intervention (One Week)||35
5738|NCT02643004|12774|P2|STARTED|First Intervention (One Week)||35
5739|NCT02643004|12775|P1|STARTED|First Intervention (One Week)||35
5740|NCT02642835|12815|P1|NOT COMPLETED|Overall Study||0
5741|NCT02642835|12815|P1|COMPLETED|Overall Study||48
5742|NCT02642835|12815|P1|STARTED|Overall Study||48
5743|NCT02642679|12828|P1|NOT COMPLETED|Overall Study||3
5744|NCT02642679|12828|P1|COMPLETED|Overall Study||16
5745|NCT02642679|12828|P1|STARTED|Overall Study||19
5746|NCT02642575|12834|P1|NOT COMPLETED|Overall Study||0
5747|NCT02642575|12834|P1|COMPLETED|Overall Study||67
5748|NCT02642575|12834|P1|STARTED|Overall Study||67
5749|NCT02642536|12842|P2|NOT COMPLETED|Overall Study||5
5750|NCT02642536|12843|P1|NOT COMPLETED|Overall Study||2
5751|NCT02642536|12842|P2|COMPLETED|Overall Study||18
5752|NCT02642536|12843|P1|COMPLETED|Overall Study||19
5753|NCT02642536|12842|P2|STARTED|Overall Study||23
5754|NCT02642536|12843|P1|STARTED|Overall Study||21
5755|NCT02642432|12869|P1|NOT COMPLETED|Overall Study||8
5756|NCT02642432|12869|P1|COMPLETED|Overall Study||138
5757|NCT02642432|12869|P1|STARTED|Overall Study||146
5758|NCT02642159|12877|P2|NOT COMPLETED|Overall Study||8
5759|NCT02642159|12878|P1|NOT COMPLETED|Overall Study||31
5760|NCT02642159|12877|P2|COMPLETED|Overall Study||129
5761|NCT02642159|12878|P1|COMPLETED|Overall Study||245
5762|NCT02642159|12877|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
5763|NCT02642159|12878|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|47
5764|NCT02642159|12877|P2|ITT Population|Overall Study||136
5765|NCT02642159|12878|P1|ITT Population|Overall Study||273
5766|NCT02642159|12877|P2|Treated (Safety Population)|Overall Study||137
5767|NCT02642159|12878|P1|Treated (Safety Population)|Overall Study||275
5768|NCT02642159|12877|P2|STARTED|Overall Study|Randomized|137
5769|NCT02642159|12878|P1|STARTED|Overall Study|Randomized|276
5770|NCT02641912|12930|P2|NOT COMPLETED|Overall Study||0
5771|NCT02641912|12931|P1|NOT COMPLETED|Overall Study||0
5772|NCT02641912|12930|P2|COMPLETED|Overall Study||47
5773|NCT02641912|12931|P1|COMPLETED|Overall Study||53
5774|NCT02641912|12930|P2|STARTED|Overall Study||47
5775|NCT02641912|12931|P1|STARTED|Overall Study||53
5776|NCT02641561|13003|P4|NOT COMPLETED|Overall Study||0
5777|NCT02641561|13004|P3|NOT COMPLETED|Overall Study||0
5778|NCT02641561|13005|P2|NOT COMPLETED|Overall Study||0
5779|NCT02641561|13006|P1|NOT COMPLETED|Overall Study||0
5780|NCT02641561|13003|P4|COMPLETED|Overall Study||48
5781|NCT02641561|13004|P3|COMPLETED|Overall Study||48
5782|NCT02641561|13005|P2|COMPLETED|Overall Study||48
5783|NCT02641561|13006|P1|COMPLETED|Overall Study||48
5784|NCT02641561|13003|P4|STARTED|Overall Study||48
5785|NCT02641561|13004|P3|STARTED|Overall Study||48
5786|NCT02641561|13005|P2|STARTED|Overall Study||48
5787|NCT02641561|13006|P1|STARTED|Overall Study||48
5788|NCT02641379|13103|P11|NOT COMPLETED|Overall Study||8
5789|NCT02641379|13104|P10|NOT COMPLETED|Overall Study||9
5790|NCT02641379|13105|P9|NOT COMPLETED|Overall Study||6
5791|NCT02641379|13106|P8|NOT COMPLETED|Overall Study||19
5792|NCT02641379|13107|P7|NOT COMPLETED|Overall Study||13
5793|NCT02641379|13108|P6|NOT COMPLETED|Overall Study||16
5794|NCT02641379|13109|P5|NOT COMPLETED|Overall Study||17
5795|NCT02641379|13110|P4|NOT COMPLETED|Overall Study||17
5796|NCT02641379|13111|P3|NOT COMPLETED|Overall Study||71
5797|NCT02641379|13112|P2|NOT COMPLETED|Overall Study||51
5798|NCT02641379|13113|P1|NOT COMPLETED|Overall Study||35
5799|NCT02641379|13103|P11|COMPLETED|Overall Study||0
5800|NCT02641379|13104|P10|COMPLETED|Overall Study||36
5801|NCT02641379|13105|P9|COMPLETED|Overall Study||36
5802|NCT02641379|13106|P8|COMPLETED|Overall Study||1
5803|NCT02641379|13107|P7|COMPLETED|Overall Study||12
5804|NCT02641379|13108|P6|COMPLETED|Overall Study||20
5805|NCT02641379|13109|P5|COMPLETED|Overall Study||0
5806|NCT02641379|13110|P4|COMPLETED|Overall Study||139
5807|NCT02641379|13111|P3|COMPLETED|Overall Study||7
5808|NCT02641379|13112|P2|COMPLETED|Overall Study||101
5809|NCT02641379|13113|P1|COMPLETED|Overall Study||107
5810|NCT02641379|13103|P11|STARTED|Overall Study||8
5811|NCT02641379|13104|P10|STARTED|Overall Study||45
5812|NCT02641379|13105|P9|STARTED|Overall Study||42
5813|NCT02641379|13106|P8|STARTED|Overall Study||20
5814|NCT02641379|13107|P7|STARTED|Overall Study||25
5815|NCT02641379|13108|P6|STARTED|Overall Study||36
5816|NCT02641379|13109|P5|STARTED|Overall Study||17
5817|NCT02641379|13110|P4|STARTED|Overall Study||156
5818|NCT02641379|13111|P3|STARTED|Overall Study||78
5819|NCT02641379|13112|P2|STARTED|Overall Study||152
5820|NCT02641379|13113|P1|STARTED|Overall Study||142
5821|NCT02641249|13178|P1|NOT COMPLETED|Overall Study||4
5822|NCT02641249|13178|P1|COMPLETED|Overall Study||15
5823|NCT02641249|13178|P1|STARTED|Overall Study||19
5824|NCT02640482|13189|P2|NOT COMPLETED|Overall Study||0
5825|NCT02640482|13190|P1|NOT COMPLETED|Overall Study||3
5826|NCT02640482|13189|P2|COMPLETED|Overall Study||100
5827|NCT02640482|13190|P1|COMPLETED|Overall Study||199
5828|NCT02640482|13189|P2|STARTED|Overall Study||100
5829|NCT02640482|13190|P1|STARTED|Overall Study||202
5830|NCT02640404|13202|P2|NOT COMPLETED|Overall Study||0
5831|NCT02640404|13203|P1|NOT COMPLETED|Overall Study||2
5832|NCT02640404|13202|P2|COMPLETED|Overall Study||112
5833|NCT02640404|13203|P1|COMPLETED|Overall Study||110
5834|NCT02640404|13202|P2|STARTED|Overall Study||112
5835|NCT02640404|13203|P1|STARTED|Overall Study||112
5836|NCT02640157|13214|P3|NOT COMPLETED|Overall Study||10
5837|NCT02640157|13215|P2|NOT COMPLETED|Overall Study||5
5838|NCT02640157|13216|P1|NOT COMPLETED|Overall Study||13
5839|NCT02640157|13214|P3|COMPLETED|Overall Study||147
5840|NCT02640157|13215|P2|COMPLETED|Overall Study||111
5841|NCT02640157|13216|P1|COMPLETED|Overall Study||220
5842|NCT02640157|13214|P3|Discontinued Study Drug|Overall Study||3
5843|NCT02640157|13215|P2|Discontinued Study Drug|Overall Study||3
5844|NCT02640157|13216|P1|Discontinued Study Drug|Overall Study||8
5845|NCT02640157|13214|P3|Completed Study Drug|Overall Study||154
5846|NCT02640157|13215|P2|Completed Study Drug|Overall Study||112
5847|NCT02640157|13216|P1|Completed Study Drug|Overall Study||225
5848|NCT02640157|13214|P3|Received Study Drug|Overall Study||157
5849|NCT02640157|13215|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
5850|NCT02640157|13216|P1|Received Study Drug|Overall Study||233
5851|NCT02640157|13214|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
5852|NCT02640157|13215|P2|STARTED|Overall Study||116
5853|NCT02640157|13216|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
5854|NCT02639338|13235|P2|NOT COMPLETED|Overall Study||5
5855|NCT02639338|13236|P1|NOT COMPLETED|Overall Study||4
5856|NCT02639338|13235|P2|COMPLETED|Overall Study||105
5857|NCT02639338|13236|P1|COMPLETED|Overall Study||106
5858|NCT02639338|13235|P2|STARTED|Overall Study||110
5859|NCT02639338|13236|P1|STARTED|Overall Study||110
5860|NCT02639247|13254|P2|NOT COMPLETED|Overall Study||2
5861|NCT02639247|13255|P1|NOT COMPLETED|Overall Study||5
5862|NCT02639247|13254|P2|COMPLETED|Overall Study||149
5863|NCT02639247|13255|P1|COMPLETED|Overall Study||177
5864|NCT02639247|13254|P2|STARTED|Overall Study||151
5865|NCT02639247|13255|P1|STARTED|Overall Study||182
5866|NCT02639052|13271|P1|NOT COMPLETED|Overall Study||1
5867|NCT02639052|13271|P1|COMPLETED|Overall Study||34
5868|NCT02639052|13271|P1|Visit 4 (3-month Follow-up)|Overall Study||34
5869|NCT02639052|13271|P1|Visit 3 (1-month Follow-up)|Overall Study||35
5870|NCT02639052|13271|P1|Visit 2 (1-week Follow-up)|Overall Study||35
5871|NCT02639052|13271|P1|Visit 1 (Baseline)|Overall Study||35
5872|NCT02639052|13271|P1|STARTED|Overall Study||35
5873|NCT02638493|13288|P3|NOT COMPLETED|Overall Study||0
5874|NCT02638493|13289|P2|NOT COMPLETED|Overall Study||0
5875|NCT02638493|13290|P1|NOT COMPLETED|Overall Study||2
5876|NCT02638493|13288|P3|COMPLETED|Overall Study||8
5877|NCT02638493|13289|P2|COMPLETED|Overall Study||8
5878|NCT02638493|13290|P1|COMPLETED|Overall Study||8
5879|NCT02638493|13288|P3|STARTED|Overall Study||8
5880|NCT02638493|13289|P2|STARTED|Overall Study||8
5969|NCT02635425|13637|P2|NOT COMPLETED|Overall Study||0
5881|NCT02638493|13290|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
5882|NCT02638259|13321|P2|NOT COMPLETED|Treatment Period 2||11
5883|NCT02638259|13322|P1|NOT COMPLETED|Treatment Period 2||6
5884|NCT02638259|13321|P2|COMPLETED|Treatment Period 2||155
5885|NCT02638259|13322|P1|COMPLETED|Treatment Period 2||169
5886|NCT02638259|13321|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
5887|NCT02638259|13322|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
5888|NCT02638259|13321|P2|NOT COMPLETED|Treatment Period 1||18
5889|NCT02638259|13322|P1|NOT COMPLETED|Treatment Period 1||5
5890|NCT02638259|13321|P2|COMPLETED|Treatment Period 1||172
5891|NCT02638259|13322|P1|COMPLETED|Treatment Period 1||181
5892|NCT02638259|13321|P2|STARTED|Treatment Period 1||190
5893|NCT02638259|13322|P1|STARTED|Treatment Period 1||186
5894|NCT02638129|13334|P2|NOT COMPLETED|Overall Study||30
5895|NCT02638129|13335|P1|NOT COMPLETED|Overall Study||28
5896|NCT02638129|13334|P2|COMPLETED|Overall Study||0
5897|NCT02638129|13335|P1|COMPLETED|Overall Study||0
5898|NCT02638129|13334|P2|STARTED|Overall Study||30
5899|NCT02638129|13335|P1|STARTED|Overall Study||28
5900|NCT02638051|13349|P2|NOT COMPLETED|Overall Study||0
5901|NCT02638051|13350|P1|NOT COMPLETED|Overall Study||0
5902|NCT02638051|13349|P2|COMPLETED|Overall Study||130
5903|NCT02638051|13350|P1|COMPLETED|Overall Study||130
5904|NCT02638051|13349|P2|STARTED|Overall Study||130
5905|NCT02638051|13350|P1|STARTED|Overall Study||130
5906|NCT02637999|13363|P3|NOT COMPLETED|Overall Study||2
5907|NCT02637999|13364|P2|NOT COMPLETED|Overall Study||2
5908|NCT02637999|13365|P1|NOT COMPLETED|Overall Study||1
5909|NCT02637999|13363|P3|COMPLETED|Overall Study||6
5910|NCT02637999|13364|P2|COMPLETED|Overall Study||6
5911|NCT02637999|13365|P1|COMPLETED|Overall Study||7
5912|NCT02637999|13363|P3|STARTED|Overall Study||8
5913|NCT02637999|13364|P2|STARTED|Overall Study||8
5914|NCT02637999|13365|P1|STARTED|Overall Study||8
5915|NCT02637804|13399|P4|NOT COMPLETED|Second Intervention (1 Week)||0
5916|NCT02637804|13400|P3|NOT COMPLETED|Second Intervention (1 Week)||0
5917|NCT02637804|13401|P2|NOT COMPLETED|Second Intervention (1 Week)||0
5918|NCT02637804|13402|P1|NOT COMPLETED|Second Intervention (1 Week)||0
5919|NCT02637804|13399|P4|COMPLETED|Second Intervention (1 Week)||26
5920|NCT02637804|13400|P3|COMPLETED|Second Intervention (1 Week)||25
5921|NCT02637804|13401|P2|COMPLETED|Second Intervention (1 Week)||28
5922|NCT02637804|13402|P1|COMPLETED|Second Intervention (1 Week)||27
5923|NCT02637804|13399|P4|STARTED|Second Intervention (1 Week)||26
5924|NCT02637804|13400|P3|STARTED|Second Intervention (1 Week)||25
5925|NCT02637804|13401|P2|STARTED|Second Intervention (1 Week)||28
5926|NCT02637804|13402|P1|STARTED|Second Intervention (1 Week)||27
5927|NCT02637804|13399|P4|NOT COMPLETED|First Intervention (1 Week)||0
5928|NCT02637804|13400|P3|NOT COMPLETED|First Intervention (1 Week)||0
5929|NCT02637804|13401|P2|NOT COMPLETED|First Intervention (1 Week)||0
5930|NCT02637804|13402|P1|NOT COMPLETED|First Intervention (1 Week)||0
5931|NCT02637804|13399|P4|COMPLETED|First Intervention (1 Week)||26
5932|NCT02637804|13400|P3|COMPLETED|First Intervention (1 Week)||25
5933|NCT02637804|13401|P2|COMPLETED|First Intervention (1 Week)||28
5934|NCT02637804|13402|P1|COMPLETED|First Intervention (1 Week)||27
5935|NCT02637804|13399|P4|STARTED|First Intervention (1 Week)||26
5936|NCT02637804|13400|P3|STARTED|First Intervention (1 Week)||25
5937|NCT02637804|13401|P2|STARTED|First Intervention (1 Week)||28
5938|NCT02637804|13402|P1|STARTED|First Intervention (1 Week)||27
5939|NCT02637323|13508|P2|NOT COMPLETED|Overall Study||1
5940|NCT02637323|13509|P1|NOT COMPLETED|Overall Study||2
5941|NCT02637323|13508|P2|COMPLETED|Overall Study||17
5942|NCT02637323|13509|P1|COMPLETED|Overall Study||61
5943|NCT02637323|13508|P2|STARTED|Overall Study||18
5944|NCT02637323|13509|P1|STARTED|Overall Study||63
5945|NCT02637063|13520|P3|NOT COMPLETED|Overall Study||6
5946|NCT02637063|13521|P2|NOT COMPLETED|Overall Study||4
5947|NCT02637063|13522|P1|NOT COMPLETED|Overall Study||5
5948|NCT02637063|13520|P3|COMPLETED|Overall Study||62
5949|NCT02637063|13521|P2|COMPLETED|Overall Study||64
5950|NCT02637063|13522|P1|COMPLETED|Overall Study||62
5951|NCT02637063|13520|P3|STARTED|Overall Study||68
5952|NCT02637063|13521|P2|STARTED|Overall Study||68
5953|NCT02637063|13522|P1|STARTED|Overall Study||67
5954|NCT02637037|13550|P2|NOT COMPLETED|Overall Study||1
5955|NCT02637037|13551|P1|NOT COMPLETED|Overall Study||4
5956|NCT02637037|13550|P2|COMPLETED|Overall Study||39
5957|NCT02637037|13551|P1|COMPLETED|Overall Study||36
5958|NCT02637037|13550|P2|STARTED|Overall Study||40
5959|NCT02637037|13551|P1|STARTED|Overall Study||40
5960|NCT02636907|13617|P1|NOT COMPLETED|Overall Study||4
5961|NCT02636907|13617|P1|COMPLETED|Overall Study|Completed autoinjector assessment period (Day 50).|73
5962|NCT02636907|13617|P1|STARTED|Overall Study|Assigned to treatment.|77
5963|NCT02636595|13624|P1|NOT COMPLETED|Overall Study||2
5964|NCT02636595|13624|P1|COMPLETED|Overall Study||119
5965|NCT02636595|13624|P1|STARTED|Overall Study||121
5966|NCT02635828|13630|P1|NOT COMPLETED|Overall Study||14
5967|NCT02635828|13630|P1|COMPLETED|Overall Study||40
5968|NCT02635828|13630|P1|STARTED|Overall Study||54
5970|NCT02635425|13638|P1|NOT COMPLETED|Overall Study||0
5971|NCT02635425|13637|P2|COMPLETED|Overall Study||15
5972|NCT02635425|13638|P1|COMPLETED|Overall Study||15
5973|NCT02635425|13637|P2|STARTED|Overall Study||15
5974|NCT02635425|13638|P1|STARTED|Overall Study||15
5975|NCT02635204|13646|P2|NOT COMPLETED|Overall Study||1
5976|NCT02635204|13647|P1|NOT COMPLETED|Overall Study||2
5977|NCT02635204|13646|P2|COMPLETED|Overall Study||88
5978|NCT02635204|13647|P1|COMPLETED|Overall Study||176
5979|NCT02635204|13646|P2|STARTED|Overall Study||89
5980|NCT02635204|13647|P1|STARTED|Overall Study||178
5981|NCT02634788|13661|P4|NOT COMPLETED|Overall Study||5
5982|NCT02634788|13662|P3|NOT COMPLETED|Overall Study||5
5983|NCT02634788|13663|P2|NOT COMPLETED|Overall Study||10
5984|NCT02634788|13664|P1|NOT COMPLETED|Overall Study||4
5985|NCT02634788|13661|P4|COMPLETED|Overall Study||77
5986|NCT02634788|13662|P3|COMPLETED|Overall Study||75
5987|NCT02634788|13663|P2|COMPLETED|Overall Study||71
5988|NCT02634788|13664|P1|COMPLETED|Overall Study||75
5989|NCT02634788|13661|P4|STARTED|Overall Study||82
5990|NCT02634788|13662|P3|STARTED|Overall Study||80
5991|NCT02634788|13663|P2|STARTED|Overall Study||81
5992|NCT02634788|13664|P1|STARTED|Overall Study||79
5993|NCT02634073|13730|P4|NOT COMPLETED|Overall Study||0
5994|NCT02634073|13731|P3|NOT COMPLETED|Overall Study||0
5995|NCT02634073|13732|P2|NOT COMPLETED|Overall Study||0
5996|NCT02634073|13733|P1|NOT COMPLETED|Overall Study||0
5997|NCT02634073|13730|P4|COMPLETED|Overall Study||4
5998|NCT02634073|13731|P3|COMPLETED|Overall Study||4
5999|NCT02634073|13732|P2|COMPLETED|Overall Study||4
6000|NCT02634073|13733|P1|COMPLETED|Overall Study||4
6001|NCT02634073|13730|P4|STARTED|Overall Study||4
6002|NCT02634073|13731|P3|STARTED|Overall Study||4
6003|NCT02634073|13732|P2|STARTED|Overall Study||4
6004|NCT02634073|13733|P1|STARTED|Overall Study||4
6005|NCT02633787|13819|P1|NOT COMPLETED|Overall Study||1
6006|NCT02633787|13819|P1|COMPLETED|Overall Study||109
6007|NCT02633787|13819|P1|STARTED|Overall Study||110
6008|NCT02633215|13827|P2|NOT COMPLETED|Overall Study||3
6009|NCT02633215|13828|P1|NOT COMPLETED|Overall Study||2
6010|NCT02633215|13827|P2|COMPLETED|Overall Study||15
6011|NCT02633215|13828|P1|COMPLETED|Overall Study||16
6012|NCT02633215|13827|P2|STARTED|Overall Study||18
6013|NCT02633215|13828|P1|STARTED|Overall Study||18
6014|NCT02632812|13840|P2|NOT COMPLETED|Overall Study||0
6015|NCT02632812|13841|P1|NOT COMPLETED|Overall Study||0
6016|NCT02632812|13840|P2|COMPLETED|Overall Study||12
6017|NCT02632812|13841|P1|COMPLETED|Overall Study||12
6018|NCT02632812|13840|P2|STARTED|Overall Study||12
6019|NCT02632812|13841|P1|STARTED|Overall Study||12
6020|NCT02632110|13864|P10|NOT COMPLETED|Overall Study||1
6021|NCT02632110|13865|P9|NOT COMPLETED|Overall Study||1
6022|NCT02632110|13866|P8|NOT COMPLETED|Overall Study||3
6023|NCT02632110|13867|P7|NOT COMPLETED|Overall Study||3
6024|NCT02632110|13868|P6|NOT COMPLETED|Overall Study||1
6025|NCT02632110|13869|P5|NOT COMPLETED|Overall Study||1
6026|NCT02632110|13870|P4|NOT COMPLETED|Overall Study||0
6027|NCT02632110|13871|P3|NOT COMPLETED|Overall Study||0
6028|NCT02632110|13872|P2|NOT COMPLETED|Overall Study||1
6029|NCT02632110|13873|P1|NOT COMPLETED|Overall Study||1
6030|NCT02632110|13864|P10|COMPLETED|Overall Study||29
6031|NCT02632110|13865|P9|COMPLETED|Overall Study||29
6032|NCT02632110|13866|P8|COMPLETED|Overall Study||23
6033|NCT02632110|13867|P7|COMPLETED|Overall Study||23
6034|NCT02632110|13868|P6|COMPLETED|Overall Study||28
6035|NCT02632110|13869|P5|COMPLETED|Overall Study||28
6036|NCT02632110|13870|P4|COMPLETED|Overall Study||27
6037|NCT02632110|13871|P3|COMPLETED|Overall Study||27
6038|NCT02632110|13872|P2|COMPLETED|Overall Study||24
6039|NCT02632110|13873|P1|COMPLETED|Overall Study||24
6040|NCT02632110|13864|P10|STARTED|Overall Study||30
6041|NCT02632110|13865|P9|STARTED|Overall Study||30
6042|NCT02632110|13866|P8|STARTED|Overall Study||26
6043|NCT02632110|13867|P7|STARTED|Overall Study||26
6044|NCT02632110|13868|P6|STARTED|Overall Study||29
6045|NCT02632110|13869|P5|STARTED|Overall Study||29
6046|NCT02632110|13870|P4|STARTED|Overall Study||27
6047|NCT02632110|13871|P3|STARTED|Overall Study||27
6048|NCT02632110|13872|P2|STARTED|Overall Study||25
6049|NCT02632110|13873|P1|STARTED|Overall Study||25
6050|NCT02631057|14342|P2|NOT COMPLETED|Overall Study||0
6051|NCT02631057|14343|P1|NOT COMPLETED|Overall Study||0
6052|NCT02631057|14342|P2|COMPLETED|Overall Study||3414
6053|NCT02631057|14343|P1|COMPLETED|Overall Study||899
6054|NCT02631057|14342|P2|STARTED|Overall Study||3414
6055|NCT02631057|14343|P1|STARTED|Overall Study||899
6056|NCT02630992|14349|P1|NOT COMPLETED|Overall Study||13
6057|NCT02630992|14349|P1|COMPLETED|Overall Study||99
6058|NCT02630992|14349|P1|STARTED|Overall Study||112
6059|NCT02630563|14366|P1|NOT COMPLETED|Overall Study||1
6060|NCT02630563|14366|P1|COMPLETED|Overall Study||8
6061|NCT02630563|14366|P1|STARTED|Overall Study||9
6062|NCT02629354|14377|P2|NOT COMPLETED|Follow-up||0
6063|NCT02629354|14378|P1|NOT COMPLETED|Follow-up||0
6064|NCT02629354|14377|P2|COMPLETED|Follow-up||18
6065|NCT02629354|14378|P1|COMPLETED|Follow-up||18
6066|NCT02629354|14377|P2|STARTED|Follow-up||18
6067|NCT02629354|14378|P1|STARTED|Follow-up||18
6068|NCT02629354|14377|P2|NOT COMPLETED|Period 2||0
6069|NCT02629354|14378|P1|NOT COMPLETED|Period 2||0
6070|NCT02629354|14377|P2|COMPLETED|Period 2||18
6071|NCT02629354|14378|P1|COMPLETED|Period 2||18
6072|NCT02629354|14377|P2|STARTED|Period 2||18
6073|NCT02629354|14378|P1|STARTED|Period 2||18
6074|NCT02629354|14377|P2|NOT COMPLETED|Washout Period||0
6075|NCT02629354|14378|P1|NOT COMPLETED|Washout Period||0
6076|NCT02629354|14377|P2|COMPLETED|Washout Period||18
6077|NCT02629354|14378|P1|COMPLETED|Washout Period||18
6078|NCT02629354|14377|P2|STARTED|Washout Period||18
6079|NCT02629354|14378|P1|STARTED|Washout Period||18
6080|NCT02629354|14377|P2|NOT COMPLETED|Period 1||0
6081|NCT02629354|14378|P1|NOT COMPLETED|Period 1||0
6082|NCT02629354|14377|P2|COMPLETED|Period 1||18
6083|NCT02629354|14378|P1|COMPLETED|Period 1||18
6084|NCT02629354|14377|P2|STARTED|Period 1||18
6085|NCT02629354|14378|P1|STARTED|Period 1||18
6086|NCT02628938|14403|P3|NOT COMPLETED|Overall Study||4
6087|NCT02628938|14404|P2|NOT COMPLETED|Overall Study||2
6088|NCT02628938|14405|P1|NOT COMPLETED|Overall Study||5
6089|NCT02628938|14403|P3|COMPLETED|Overall Study||11
6090|NCT02628938|14404|P2|COMPLETED|Overall Study||13
6091|NCT02628938|14405|P1|COMPLETED|Overall Study||10
6092|NCT02628938|14403|P3|STARTED|Overall Study||15
6093|NCT02628938|14404|P2|STARTED|Overall Study||15
6094|NCT02628938|14405|P1|STARTED|Overall Study||15
6095|NCT02628418|14421|P2|NOT COMPLETED|Overall Study||2
6096|NCT02628418|14422|P1|NOT COMPLETED|Overall Study||1
6097|NCT02628418|14421|P2|COMPLETED|Overall Study||13
6098|NCT02628418|14422|P1|COMPLETED|Overall Study||14
6099|NCT02628418|14421|P2|STARTED|Overall Study||15
6100|NCT02628418|14422|P1|STARTED|Overall Study||15
6101|NCT02628236|14443|P1|NOT COMPLETED|Overall Study||0
6102|NCT02628236|14443|P1|COMPLETED|Overall Study||14
6103|NCT02628236|14443|P1|STARTED|Overall Study||14
6104|NCT02628106|14480|P1|NOT COMPLETED|Overall Study||0
6105|NCT02628106|14480|P1|COMPLETED|Overall Study||21
6106|NCT02628106|14480|P1|STARTED|Overall Study||21
6107|NCT02627794|14484|P1|NOT COMPLETED|Overall Study||0
6108|NCT02627794|14484|P1|COMPLETED|Overall Study||3
6109|NCT02627794|14484|P1|STARTED|Overall Study||3
6110|NCT02627144|14497|P1|NOT COMPLETED|Overall Study||365
6111|NCT02627144|14497|P1|COMPLETED|Overall Study||0
6112|NCT02627144|14497|P1|Treated|Overall Study||359
6113|NCT02627144|14497|P1|STARTED|Overall Study||365
6114|NCT02627001|14507|P2|NOT COMPLETED|Overall Study||0
6115|NCT02627001|14508|P1|NOT COMPLETED|Overall Study||0
6116|NCT02627001|14507|P2|COMPLETED|Overall Study||14
6117|NCT02627001|14508|P1|COMPLETED|Overall Study||13
6118|NCT02627001|14507|P2|STARTED|Overall Study||14
6119|NCT02627001|14508|P1|STARTED|Overall Study||13
6120|NCT02626910|14518|P4|NOT COMPLETED|Overall Study||0
6121|NCT02626910|14519|P3|NOT COMPLETED|Overall Study||0
6122|NCT02626910|14520|P2|NOT COMPLETED|Overall Study||0
6123|NCT02626910|14521|P1|NOT COMPLETED|Overall Study||0
6124|NCT02626910|14518|P4|COMPLETED|Overall Study||10
6125|NCT02626910|14519|P3|COMPLETED|Overall Study||6
6126|NCT02626910|14520|P2|COMPLETED|Overall Study||10
6127|NCT02626910|14521|P1|COMPLETED|Overall Study||23
6128|NCT02626910|14518|P4|STARTED|Overall Study||10
6129|NCT02626910|14519|P3|STARTED|Overall Study||6
6130|NCT02626910|14520|P2|STARTED|Overall Study||10
6131|NCT02626910|14521|P1|STARTED|Overall Study||23
6132|NCT02626611|14534|P3|NOT COMPLETED|Overall Study||3
6133|NCT02626611|14535|P2|NOT COMPLETED|Overall Study||1
6134|NCT02626611|14536|P1|NOT COMPLETED|Overall Study||4
6135|NCT02626611|14534|P3|COMPLETED|Overall Study||16
6136|NCT02626611|14535|P2|COMPLETED|Overall Study||20
6137|NCT02626611|14536|P1|COMPLETED|Overall Study||16
6138|NCT02626611|14534|P3|STARTED|Overall Study||19
6139|NCT02626611|14535|P2|STARTED|Overall Study||21
6140|NCT02626611|14536|P1|STARTED|Overall Study||20
6141|NCT02625844|14557|P1|NOT COMPLETED|Overall Study||0
6142|NCT02625844|14557|P1|COMPLETED|Overall Study||110
6143|NCT02625844|14557|P1|STARTED|Overall Study||110
6144|NCT02625402|14563|P2|NOT COMPLETED|Overall Study||12
6145|NCT02625402|14564|P1|NOT COMPLETED|Overall Study||9
6146|NCT02625402|14563|P2|COMPLETED|Overall Study||25
6147|NCT02625402|14564|P1|COMPLETED|Overall Study||33
6148|NCT02625402|14563|P2|STARTED|Overall Study||37
6149|NCT02625402|14564|P1|STARTED|Overall Study||42
6150|NCT02625298|14576|P2|NOT COMPLETED|Overall Study||0
6151|NCT02625298|14577|P1|NOT COMPLETED|Overall Study||1
6152|NCT02625298|14576|P2|COMPLETED|Overall Study||13
6153|NCT02625298|14577|P1|COMPLETED|Overall Study||10
6154|NCT02625298|14576|P2|STARTED|Overall Study||13
6155|NCT02625298|14577|P1|STARTED|Overall Study||11
6156|NCT02625259|14590|P5|NOT COMPLETED|Second Intervention (Day 15)||0
6157|NCT02625259|14591|P4|NOT COMPLETED|Second Intervention (Day 15)||0
6158|NCT02625259|14592|P3|NOT COMPLETED|Second Intervention (Day 15)||0
6159|NCT02625259|14593|P2|NOT COMPLETED|Second Intervention (Day 15)||0
6160|NCT02625259|14594|P1|NOT COMPLETED|Second Intervention (Day 15)||0
6161|NCT02625259|14590|P5|COMPLETED|Second Intervention (Day 15)||0
6162|NCT02625259|14591|P4|COMPLETED|Second Intervention (Day 15)||9
6163|NCT02625259|14592|P3|COMPLETED|Second Intervention (Day 15)||7
6164|NCT02625259|14593|P2|COMPLETED|Second Intervention (Day 15)||8
6165|NCT02625259|14594|P1|COMPLETED|Second Intervention (Day 15)||9
6166|NCT02625259|14590|P5|STARTED|Second Intervention (Day 15)||0
6167|NCT02625259|14591|P4|STARTED|Second Intervention (Day 15)||9
6168|NCT02625259|14592|P3|STARTED|Second Intervention (Day 15)||7
6169|NCT02625259|14593|P2|STARTED|Second Intervention (Day 15)||8
6170|NCT02625259|14594|P1|STARTED|Second Intervention (Day 15)||9
6171|NCT02625259|14590|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6172|NCT02625259|14591|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6173|NCT02625259|14592|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6174|NCT02625259|14593|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6175|NCT02625259|14594|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6176|NCT02625259|14590|P5|COMPLETED|Washout (Day 2 to Day 14)||0
6177|NCT02625259|14591|P4|COMPLETED|Washout (Day 2 to Day 14)||9
6178|NCT02625259|14592|P3|COMPLETED|Washout (Day 2 to Day 14)||7
6179|NCT02625259|14593|P2|COMPLETED|Washout (Day 2 to Day 14)||8
6180|NCT02625259|14594|P1|COMPLETED|Washout (Day 2 to Day 14)||9
6181|NCT02625259|14590|P5|STARTED|Washout (Day 2 to Day 14)||0
6182|NCT02625259|14591|P4|STARTED|Washout (Day 2 to Day 14)||9
6183|NCT02625259|14592|P3|STARTED|Washout (Day 2 to Day 14)||7
6184|NCT02625259|14593|P2|STARTED|Washout (Day 2 to Day 14)||8
6185|NCT02625259|14594|P1|STARTED|Washout (Day 2 to Day 14)||9
6186|NCT02625259|14590|P5|NOT COMPLETED|First Intervention (Day 1)||0
6187|NCT02625259|14591|P4|NOT COMPLETED|First Intervention (Day 1)||1
6188|NCT02625259|14592|P3|NOT COMPLETED|First Intervention (Day 1)||1
6189|NCT02625259|14593|P2|NOT COMPLETED|First Intervention (Day 1)||1
6190|NCT02625259|14594|P1|NOT COMPLETED|First Intervention (Day 1)||2
6191|NCT02625259|14590|P5|COMPLETED|First Intervention (Day 1)||16
6192|NCT02625259|14591|P4|COMPLETED|First Intervention (Day 1)||9
6193|NCT02625259|14592|P3|COMPLETED|First Intervention (Day 1)||7
6194|NCT02625259|14593|P2|COMPLETED|First Intervention (Day 1)||8
6195|NCT02625259|14594|P1|COMPLETED|First Intervention (Day 1)||9
6196|NCT02625259|14590|P5|STARTED|First Intervention (Day 1)||16
6197|NCT02625259|14591|P4|STARTED|First Intervention (Day 1)||10
6198|NCT02625259|14592|P3|STARTED|First Intervention (Day 1)||8
6199|NCT02625259|14593|P2|STARTED|First Intervention (Day 1)||9
6200|NCT02625259|14594|P1|STARTED|First Intervention (Day 1)||11
6201|NCT02625233|14631|P2|NOT COMPLETED|Overall Study||0
6202|NCT02625233|14632|P1|NOT COMPLETED|Overall Study||2
6203|NCT02625233|14631|P2|COMPLETED|Overall Study||56
6204|NCT02625233|14632|P1|COMPLETED|Overall Study||47
6205|NCT02625233|14631|P2|STARTED|Overall Study||56
6206|NCT02625233|14632|P1|STARTED|Overall Study||49
6207|NCT02625220|14640|P1|NOT COMPLETED|Overall Study||7
6208|NCT02625220|14640|P1|COMPLETED|Overall Study||163
6209|NCT02625220|14640|P1|STARTED|Overall Study||170
6210|NCT02625207|14651|P4|NOT COMPLETED|Part 2 (11 Days)||0
6211|NCT02625207|14652|P3|NOT COMPLETED|Part 2 (11 Days)||0
6212|NCT02625207|14653|P2|NOT COMPLETED|Part 2 (11 Days)||0
6213|NCT02625207|14654|P1|NOT COMPLETED|Part 2 (11 Days)||0
6214|NCT02625207|14651|P4|COMPLETED|Part 2 (11 Days)||0
6215|NCT02625207|14652|P3|COMPLETED|Part 2 (11 Days)||12
6216|NCT02625207|14653|P2|COMPLETED|Part 2 (11 Days)||0
6217|NCT02625207|14654|P1|COMPLETED|Part 2 (11 Days)||11
6218|NCT02625207|14651|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
6219|NCT02625207|14652|P3|STARTED|Part 2 (11 Days)||12
6220|NCT02625207|14653|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
6221|NCT02625207|14654|P1|STARTED|Part 2 (11 Days)||11
6222|NCT02625207|14651|P4|NOT COMPLETED|Part 1 (6 Days)||0
6223|NCT02625207|14652|P3|NOT COMPLETED|Part 1 (6 Days)||0
6224|NCT02625207|14653|P2|NOT COMPLETED|Part 1 (6 Days)||0
6225|NCT02625207|14654|P1|NOT COMPLETED|Part 1 (6 Days)||0
6226|NCT02625207|14651|P4|COMPLETED|Part 1 (6 Days)||12
6227|NCT02625207|14652|P3|COMPLETED|Part 1 (6 Days)||12
6228|NCT02625207|14653|P2|COMPLETED|Part 1 (6 Days)||12
6229|NCT02625207|14654|P1|COMPLETED|Part 1 (6 Days)||11
6230|NCT02625207|14651|P4|STARTED|Part 1 (6 Days)||12
6231|NCT02625207|14652|P3|STARTED|Part 1 (6 Days)||12
6232|NCT02625207|14653|P2|STARTED|Part 1 (6 Days)||12
6233|NCT02625207|14654|P1|STARTED|Part 1 (6 Days)||11
6234|NCT02624791|14740|P6|NOT COMPLETED|Overall Study||0
6235|NCT02624791|14741|P5|NOT COMPLETED|Overall Study||0
6236|NCT02624791|14742|P4|NOT COMPLETED|Overall Study||0
6237|NCT02624791|14743|P3|NOT COMPLETED|Overall Study||0
6238|NCT02624791|14744|P2|NOT COMPLETED|Overall Study||0
6239|NCT02624791|14745|P1|NOT COMPLETED|Overall Study||2
6240|NCT02624791|14740|P6|COMPLETED|Overall Study||2
6241|NCT02624791|14741|P5|COMPLETED|Overall Study||2
6242|NCT02624791|14742|P4|COMPLETED|Overall Study||2
6243|NCT02624791|14743|P3|COMPLETED|Overall Study||2
6244|NCT02624791|14744|P2|COMPLETED|Overall Study||1
6245|NCT02624791|14745|P1|COMPLETED|Overall Study||0
6246|NCT02624791|14740|P6|STARTED|Overall Study||2
6247|NCT02624791|14741|P5|STARTED|Overall Study||2
6248|NCT02624791|14742|P4|STARTED|Overall Study||2
6249|NCT02624791|14743|P3|STARTED|Overall Study||2
6250|NCT02624791|14744|P2|STARTED|Overall Study||1
6251|NCT02624791|14745|P1|STARTED|Overall Study||2
6252|NCT02622568|14752|P2|NOT COMPLETED|Overall Study||5
6253|NCT02622568|14753|P1|NOT COMPLETED|Overall Study||5
6254|NCT02622568|14752|P2|COMPLETED|Overall Study||9
6255|NCT02622568|14753|P1|COMPLETED|Overall Study||9
6256|NCT02622568|14752|P2|STARTED|Overall Study||14
6257|NCT02622568|14753|P1|STARTED|Overall Study||14
6258|NCT02622321|14763|P4|NOT COMPLETED|Overall Study||7
6259|NCT02622321|14764|P3|NOT COMPLETED|Overall Study||49
6260|NCT02622321|14765|P2|NOT COMPLETED|Overall Study||18
6261|NCT02622321|14766|P1|NOT COMPLETED|Overall Study||35
6262|NCT02622321|14763|P4|COMPLETED|Overall Study||0
6263|NCT02622321|14764|P3|COMPLETED|Overall Study||0
6264|NCT02622321|14765|P2|COMPLETED|Overall Study||0
6265|NCT02622321|14766|P1|COMPLETED|Overall Study||0
6266|NCT02622321|14763|P4|Treated|Overall Study||7
6267|NCT02622321|14764|P3|Treated|Overall Study||49
6268|NCT02622321|14765|P2|Treated|Overall Study||18
6269|NCT02622321|14766|P1|Treated|Overall Study||34
6270|NCT02622321|14763|P4|STARTED|Overall Study||7
6271|NCT02622321|14764|P3|STARTED|Overall Study||49
6272|NCT02622321|14765|P2|STARTED|Overall Study||18
6273|NCT02622321|14766|P1|STARTED|Overall Study||35
6274|NCT02621034|14812|P3|NOT COMPLETED|Overall Study||5
6275|NCT02621034|14813|P2|NOT COMPLETED|Overall Study||2
6276|NCT02621034|14814|P1|NOT COMPLETED|Overall Study||3
6277|NCT02621034|14812|P3|COMPLETED|Overall Study||50
6278|NCT02621034|14813|P2|COMPLETED|Overall Study||50
6279|NCT02621034|14814|P1|COMPLETED|Overall Study||50
6280|NCT02621034|14812|P3|STARTED|Overall Study||55
6281|NCT02621034|14813|P2|STARTED|Overall Study||52
6282|NCT02621034|14814|P1|STARTED|Overall Study||53
6283|NCT02620683|14827|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
6284|NCT02620683|14828|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
6285|NCT02620683|14827|P2|COMPLETED|Second Intervention (Visit 2)||11
6286|NCT02620683|14828|P1|COMPLETED|Second Intervention (Visit 2)||12
6287|NCT02620683|14827|P2|STARTED|Second Intervention (Visit 2)||11
6288|NCT02620683|14828|P1|STARTED|Second Intervention (Visit 2)||12
6289|NCT02620683|14827|P2|NOT COMPLETED|Washout (2 Weeks)||0
6290|NCT02620683|14828|P1|NOT COMPLETED|Washout (2 Weeks)||0
6291|NCT02620683|14827|P2|COMPLETED|Washout (2 Weeks)||11
6292|NCT02620683|14828|P1|COMPLETED|Washout (2 Weeks)||12
6293|NCT02620683|14827|P2|STARTED|Washout (2 Weeks)||11
6294|NCT02620683|14828|P1|STARTED|Washout (2 Weeks)||12
6295|NCT02620683|14827|P2|NOT COMPLETED|First Intervention (Visit 1)||0
6296|NCT02620683|14828|P1|NOT COMPLETED|First Intervention (Visit 1)||0
6297|NCT02620683|14827|P2|COMPLETED|First Intervention (Visit 1)||11
6298|NCT02620683|14828|P1|COMPLETED|First Intervention (Visit 1)||12
6299|NCT02620683|14827|P2|STARTED|First Intervention (Visit 1)||11
6300|NCT02620683|14828|P1|STARTED|First Intervention (Visit 1)||12
6301|NCT02619812|14840|P4|NOT COMPLETED|Overall Study||2
6302|NCT02619812|14841|P3|NOT COMPLETED|Overall Study||1
6303|NCT02619812|14842|P2|NOT COMPLETED|Overall Study||0
6304|NCT02619812|14843|P1|NOT COMPLETED|Overall Study||0
6305|NCT02619812|14840|P4|COMPLETED|Overall Study||0
6306|NCT02619812|14841|P3|COMPLETED|Overall Study||0
6307|NCT02619812|14842|P2|COMPLETED|Overall Study||0
6308|NCT02619812|14843|P1|COMPLETED|Overall Study||0
6309|NCT02619812|14840|P4|STARTED|Overall Study||2
6310|NCT02619812|14841|P3|STARTED|Overall Study||1
6311|NCT02619812|14842|P2|STARTED|Overall Study||0
6312|NCT02619812|14843|P1|STARTED|Overall Study||0
6313|NCT02619799|14859|P2|NOT COMPLETED|Overall Study||0
6314|NCT02619799|14860|P1|NOT COMPLETED|Overall Study||0
6315|NCT02619799|14859|P2|COMPLETED|Overall Study||25
6316|NCT02619799|14860|P1|COMPLETED|Overall Study||25
6317|NCT02619799|14859|P2|STARTED|Overall Study||25
6318|NCT02619799|14860|P1|STARTED|Overall Study||25
6319|NCT02619591|14878|P2|NOT COMPLETED|Overall Study||121
6320|NCT02619591|14879|P1|NOT COMPLETED|Overall Study||139
6321|NCT02619591|14878|P2|COMPLETED|Overall Study||0
6322|NCT02619591|14879|P1|COMPLETED|Overall Study||0
6323|NCT02619591|14878|P2|STARTED|Overall Study||121
6324|NCT02619591|14879|P1|STARTED|Overall Study||139
6325|NCT02618772|14887|P2|NOT COMPLETED|Overall Study||0
6326|NCT02618772|14888|P1|NOT COMPLETED|Overall Study||1
6327|NCT02618772|14887|P2|COMPLETED|Overall Study||40
6328|NCT02618772|14888|P1|COMPLETED|Overall Study||38
6329|NCT02618772|14887|P2|Withdrawal by Subject|Overall Study||0
6330|NCT02618772|14888|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
6331|NCT02618772|14887|P2|STARTED|Overall Study||40
6332|NCT02618772|14888|P1|STARTED|Overall Study||39
6333|NCT02618512|14920|P1|NOT COMPLETED|Overall Study||0
6334|NCT02618512|14920|P1|COMPLETED|Overall Study||3
6335|NCT02618512|14920|P1|STARTED|Overall Study||3
6336|NCT02617901|14924|P1|NOT COMPLETED|Overall Study||0
6337|NCT02617901|14924|P1|COMPLETED|Overall Study||20
6338|NCT02617901|14924|P1|STARTED|Overall Study||20
6339|NCT02617888|14931|P3|NOT COMPLETED|Overall Study||0
6340|NCT02617888|14932|P2|NOT COMPLETED|Overall Study||7
6341|NCT02617888|14933|P1|NOT COMPLETED|Overall Study||1
6342|NCT02617888|14931|P3|COMPLETED|Overall Study||127
6435|NCT02613403|15240|P2|COMPLETED|Overall Study||35
6343|NCT02617888|14932|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
6344|NCT02617888|14933|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
6345|NCT02617888|14931|P3|STARTED|Overall Study||127
6346|NCT02617888|14932|P2|STARTED|Overall Study||51
6347|NCT02617888|14933|P1|STARTED|Overall Study||50
6348|NCT02617784|14942|P2|NOT COMPLETED|Overall Study||0
6349|NCT02617784|14943|P1|NOT COMPLETED|Overall Study||0
6350|NCT02617784|14942|P2|COMPLETED|Overall Study||12
6351|NCT02617784|14943|P1|COMPLETED|Overall Study||12
6352|NCT02617784|14942|P2|Second Dose Assessment Period|Overall Study||12
6353|NCT02617784|14943|P1|Second Dose Assessment Period|Overall Study||11
6354|NCT02617784|14942|P2|First Dose Assessment Period|Overall Study||12
6355|NCT02617784|14943|P1|First Dose Assessment Period|Overall Study||12
6356|NCT02617784|14942|P2|STARTED|Overall Study||12
6357|NCT02617784|14943|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
6358|NCT02616523|14993|P3|NOT COMPLETED|Overall Study||0
6359|NCT02616523|14994|P2|NOT COMPLETED|Overall Study||0
6360|NCT02616523|14995|P1|NOT COMPLETED|Overall Study||1
6361|NCT02616523|14993|P3|COMPLETED|Overall Study|April 2015|20
6362|NCT02616523|14994|P2|COMPLETED|Overall Study|April 2015|20
6363|NCT02616523|14995|P1|COMPLETED|Overall Study|April 2015|19
6364|NCT02616523|14993|P3|STARTED|Overall Study|June 2014|20
6365|NCT02616523|14994|P2|STARTED|Overall Study|June 2014|20
6366|NCT02616523|14995|P1|STARTED|Overall Study|June 2014|20
6367|NCT02616250|15011|P2|NOT COMPLETED|Overall Study||9
6368|NCT02616250|15012|P1|NOT COMPLETED|Overall Study||10
6369|NCT02616250|15011|P2|COMPLETED|Overall Study||86
6370|NCT02616250|15012|P1|COMPLETED|Overall Study||85
6371|NCT02616250|15011|P2|STARTED|Overall Study||95
6372|NCT02616250|15012|P1|STARTED|Overall Study||95
6373|NCT02615990|15020|P2|NOT COMPLETED|Overall Study||1
6374|NCT02615990|15021|P1|NOT COMPLETED|Overall Study||1
6375|NCT02615990|15020|P2|COMPLETED|Overall Study||0
6376|NCT02615990|15021|P1|COMPLETED|Overall Study||0
6377|NCT02615990|15020|P2|STARTED|Overall Study||1
6378|NCT02615990|15021|P1|STARTED|Overall Study||1
6379|NCT02615743|15067|P2|NOT COMPLETED|Overall Study||3
6380|NCT02615743|15068|P1|NOT COMPLETED|Overall Study||6
6381|NCT02615743|15067|P2|COMPLETED|Overall Study||17
6382|NCT02615743|15068|P1|COMPLETED|Overall Study||15
6383|NCT02615743|15067|P2|STARTED|Overall Study||20
6384|NCT02615743|15068|P1|STARTED|Overall Study||21
6385|NCT02615717|15082|P2|NOT COMPLETED|Overall Study||0
6386|NCT02615717|15083|P1|NOT COMPLETED|Overall Study||0
6387|NCT02615717|15082|P2|COMPLETED|Overall Study||3
6388|NCT02615717|15083|P1|COMPLETED|Overall Study||3
6389|NCT02615717|15082|P2|STARTED|Overall Study||3
6390|NCT02615717|15083|P1|STARTED|Overall Study||3
6391|NCT02614924|15097|P2|NOT COMPLETED|Overall Study||0
6392|NCT02614924|15098|P1|NOT COMPLETED|Overall Study||0
6393|NCT02614924|15097|P2|COMPLETED|Overall Study||20
6394|NCT02614924|15098|P1|COMPLETED|Overall Study||20
6395|NCT02614924|15097|P2|STARTED|Overall Study||20
6396|NCT02614924|15098|P1|STARTED|Overall Study||20
6397|NCT02614586|15106|P1|NOT COMPLETED|Overall Study||0
6398|NCT02614586|15106|P1|COMPLETED|Overall Study||11
6399|NCT02614586|15106|P1|STARTED|Overall Study||11
6400|NCT02614469|15113|P2|NOT COMPLETED|Period 2||0
6401|NCT02614469|15114|P1|NOT COMPLETED|Period 2||0
6402|NCT02614469|15113|P2|COMPLETED|Period 2||9
6403|NCT02614469|15114|P1|COMPLETED|Period 2||9
6404|NCT02614469|15113|P2|STARTED|Period 2||9
6405|NCT02614469|15114|P1|STARTED|Period 2||9
6406|NCT02614469|15113|P2|NOT COMPLETED|Period 1||0
6407|NCT02614469|15114|P1|NOT COMPLETED|Period 1||0
6408|NCT02614469|15113|P2|COMPLETED|Period 1||9
6409|NCT02614469|15114|P1|COMPLETED|Period 1||9
6410|NCT02614469|15113|P2|STARTED|Period 1||9
6411|NCT02614469|15114|P1|STARTED|Period 1||9
6412|NCT02614222|15144|P2|NOT COMPLETED|Overall Study||0
6413|NCT02614222|15145|P1|NOT COMPLETED|Overall Study||0
6414|NCT02614222|15144|P2|COMPLETED|Overall Study||14
6415|NCT02614222|15145|P1|COMPLETED|Overall Study||13
6416|NCT02614222|15144|P2|STARTED|Overall Study||14
6417|NCT02614222|15145|P1|STARTED|Overall Study||13
6418|NCT02614079|15165|P1|NOT COMPLETED|Overall Study||1
6419|NCT02614079|15165|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
6420|NCT02614079|15165|P1|STARTED|Overall Study||6
6421|NCT02613910|15169|P1|NOT COMPLETED|Overall Study||1
6422|NCT02613910|15169|P1|COMPLETED|Overall Study||0
6423|NCT02613910|15169|P1|STARTED|Overall Study||1
6424|NCT02613871|15218|P1|NOT COMPLETED|Overall Study||111
6425|NCT02613871|15218|P1|COMPLETED|Overall Study||0
6426|NCT02613871|15218|P1|STARTED|Overall Study||111
6427|NCT02613403|15237|P5|NOT COMPLETED|Overall Study||0
6428|NCT02613403|15238|P4|NOT COMPLETED|Overall Study||0
6429|NCT02613403|15239|P3|NOT COMPLETED|Overall Study||0
6430|NCT02613403|15240|P2|NOT COMPLETED|Overall Study||1
6431|NCT02613403|15241|P1|NOT COMPLETED|Overall Study||2
6432|NCT02613403|15237|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6433|NCT02613403|15238|P4|COMPLETED|Overall Study||13
6434|NCT02613403|15239|P3|COMPLETED|Overall Study||9
6436|NCT02613403|15241|P1|COMPLETED|Overall Study||34
6437|NCT02613403|15237|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6438|NCT02613403|15238|P4|Treated|Overall Study||13
6439|NCT02613403|15239|P3|Treated|Overall Study||9
6440|NCT02613403|15240|P2|Treated|Overall Study||36
6441|NCT02613403|15241|P1|Treated|Overall Study||35
6442|NCT02613403|15237|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6443|NCT02613403|15238|P4|STARTED|Overall Study||13
6444|NCT02613403|15239|P3|STARTED|Overall Study||9
6445|NCT02613403|15240|P2|STARTED|Overall Study||36
6446|NCT02613403|15241|P1|STARTED|Overall Study||36
6447|NCT02612610|15287|P4|NOT COMPLETED|Overall Study||13
6448|NCT02612610|15288|P3|NOT COMPLETED|Overall Study||5
6449|NCT02612610|15289|P2|NOT COMPLETED|Overall Study||8
6450|NCT02612610|15290|P1|NOT COMPLETED|Overall Study||5
6451|NCT02612610|15287|P4|COMPLETED|Overall Study||50
6452|NCT02612610|15288|P3|COMPLETED|Overall Study||58
6453|NCT02612610|15289|P2|COMPLETED|Overall Study||56
6454|NCT02612610|15290|P1|COMPLETED|Overall Study||58
6455|NCT02612610|15287|P4|Treated|Overall Study||63
6456|NCT02612610|15288|P3|Treated|Overall Study||63
6457|NCT02612610|15289|P2|Treated|Overall Study||63
6458|NCT02612610|15290|P1|Treated|Overall Study||63
6459|NCT02612610|15287|P4|STARTED|Overall Study||63
6460|NCT02612610|15288|P3|STARTED|Overall Study||63
6461|NCT02612610|15289|P2|STARTED|Overall Study||64
6462|NCT02612610|15290|P1|STARTED|Overall Study||63
6463|NCT02612077|15532|P1|NOT COMPLETED|Overall Study||466
6464|NCT02612077|15532|P1|COMPLETED|Overall Study||299
6465|NCT02612077|15532|P1|Efficacy Analysis Set|Overall Study||737
6466|NCT02612077|15532|P1|Safety Analysis Set|Overall Study||760
6467|NCT02612077|15532|P1|Did Not Receive Study Product|Overall Study||5
6468|NCT02612077|15532|P1|STARTED|Overall Study||765
6469|NCT02612064|15544|P2|NOT COMPLETED|Overall Study||3
6470|NCT02612064|15545|P1|NOT COMPLETED|Overall Study||1
6471|NCT02612064|15544|P2|COMPLETED|Overall Study||112
6472|NCT02612064|15545|P1|COMPLETED|Overall Study||114
6473|NCT02612064|15544|P2|STARTED|Overall Study||115
6474|NCT02612064|15545|P1|STARTED|Overall Study||115
6475|NCT02611765|15557|P2|NOT COMPLETED|Overall Study||6
6476|NCT02611765|15558|P1|NOT COMPLETED|Overall Study||2
6477|NCT02611765|15557|P2|COMPLETED|Overall Study||29
6478|NCT02611765|15558|P1|COMPLETED|Overall Study||27
6479|NCT02611765|15557|P2|STARTED|Overall Study||35
6480|NCT02611765|15558|P1|STARTED|Overall Study||29
6481|NCT02611154|15564|P1|NOT COMPLETED|Overall Study||0
6482|NCT02611154|15564|P1|COMPLETED|Overall Study||5
6483|NCT02611154|15564|P1|STARTED|Overall Study||5
6484|NCT02610634|15585|P2|NOT COMPLETED|Overall Study||0
6485|NCT02610634|15586|P1|NOT COMPLETED|Overall Study||0
6486|NCT02610634|15585|P2|COMPLETED|Overall Study||40
6487|NCT02610634|15586|P1|COMPLETED|Overall Study||60
6488|NCT02610634|15585|P2|STARTED|Overall Study||40
6489|NCT02610634|15586|P1|STARTED|Overall Study||60
6490|NCT02609841|15594|P1|NOT COMPLETED|Overall Study||28
6491|NCT02609841|15594|P1|COMPLETED|Overall Study||212
6492|NCT02609841|15594|P1|STARTED|Overall Study||240
6493|NCT02609672|15602|P2|NOT COMPLETED|Overall Study||1
6494|NCT02609672|15603|P1|NOT COMPLETED|Overall Study||3
6495|NCT02609672|15602|P2|COMPLETED|Overall Study||11
6496|NCT02609672|15603|P1|COMPLETED|Overall Study||9
6497|NCT02609672|15602|P2|STARTED|Overall Study||12
6498|NCT02609672|15603|P1|STARTED|Overall Study||12
6499|NCT02609659|15637|P1|NOT COMPLETED|Overall Study||8
6500|NCT02609659|15637|P1|COMPLETED|Overall Study||97
6501|NCT02609659|15637|P1|STARTED|Overall Study||105
6502|NCT02609633|15647|P2|NOT COMPLETED|Overall Study||2
6503|NCT02609633|15648|P1|NOT COMPLETED|Overall Study||5
6504|NCT02609633|15647|P2|COMPLETED|Overall Study||54
6505|NCT02609633|15648|P1|COMPLETED|Overall Study||37
6506|NCT02609633|15647|P2|Full Analysis Set (FAS)|Overall Study||46
6507|NCT02609633|15648|P1|Full Analysis Set (FAS)|Overall Study||32
6508|NCT02609633|15647|P2|STARTED|Overall Study||56
6509|NCT02609633|15648|P1|STARTED|Overall Study||42
6510|NCT02609178|15673|P6|NOT COMPLETED|Third Crown||0
6511|NCT02609178|15674|P5|NOT COMPLETED|Third Crown||0
6512|NCT02609178|15675|P4|NOT COMPLETED|Third Crown||0
6513|NCT02609178|15676|P3|NOT COMPLETED|Third Crown||0
6514|NCT02609178|15677|P2|NOT COMPLETED|Third Crown||0
6515|NCT02609178|15678|P1|NOT COMPLETED|Third Crown||0
6516|NCT02609178|15673|P6|COMPLETED|Third Crown||2
6517|NCT02609178|15674|P5|COMPLETED|Third Crown||0
6518|NCT02609178|15675|P4|COMPLETED|Third Crown||2
6519|NCT02609178|15676|P3|COMPLETED|Third Crown||5
6520|NCT02609178|15677|P2|COMPLETED|Third Crown||1
6521|NCT02609178|15678|P1|COMPLETED|Third Crown||0
6522|NCT02609178|15673|P6|STARTED|Third Crown||2
6523|NCT02609178|15674|P5|STARTED|Third Crown||0
6524|NCT02609178|15675|P4|STARTED|Third Crown||2
6525|NCT02609178|15676|P3|STARTED|Third Crown||5
6526|NCT02609178|15677|P2|STARTED|Third Crown||1
6527|NCT02609178|15678|P1|STARTED|Third Crown||0
6528|NCT02609178|15673|P6|NOT COMPLETED|5-minute Washout Time||0
6529|NCT02609178|15674|P5|NOT COMPLETED|5-minute Washout Time||0
6530|NCT02609178|15675|P4|NOT COMPLETED|5-minute Washout Time||0
6531|NCT02609178|15676|P3|NOT COMPLETED|5-minute Washout Time||0
6532|NCT02609178|15677|P2|NOT COMPLETED|5-minute Washout Time||0
6533|NCT02609178|15678|P1|NOT COMPLETED|5-minute Washout Time||0
6534|NCT02609178|15673|P6|COMPLETED|5-minute Washout Time||2
6535|NCT02609178|15674|P5|COMPLETED|5-minute Washout Time||0
6536|NCT02609178|15675|P4|COMPLETED|5-minute Washout Time||2
6537|NCT02609178|15676|P3|COMPLETED|5-minute Washout Time||5
6538|NCT02609178|15677|P2|COMPLETED|5-minute Washout Time||1
6539|NCT02609178|15678|P1|COMPLETED|5-minute Washout Time||0
6540|NCT02609178|15673|P6|STARTED|5-minute Washout Time||2
6541|NCT02609178|15674|P5|STARTED|5-minute Washout Time||0
6542|NCT02609178|15675|P4|STARTED|5-minute Washout Time||2
6543|NCT02609178|15676|P3|STARTED|5-minute Washout Time||5
6544|NCT02609178|15677|P2|STARTED|5-minute Washout Time||1
6545|NCT02609178|15678|P1|STARTED|5-minute Washout Time||0
6546|NCT02609178|15673|P6|NOT COMPLETED|Second Crown||0
6547|NCT02609178|15674|P5|NOT COMPLETED|Second Crown||0
6548|NCT02609178|15675|P4|NOT COMPLETED|Second Crown||0
6549|NCT02609178|15676|P3|NOT COMPLETED|Second Crown||0
6550|NCT02609178|15677|P2|NOT COMPLETED|Second Crown||0
6551|NCT02609178|15678|P1|NOT COMPLETED|Second Crown||0
6552|NCT02609178|15673|P6|COMPLETED|Second Crown||2
6553|NCT02609178|15674|P5|COMPLETED|Second Crown||0
6554|NCT02609178|15675|P4|COMPLETED|Second Crown||2
6555|NCT02609178|15676|P3|COMPLETED|Second Crown||5
6556|NCT02609178|15677|P2|COMPLETED|Second Crown||1
6557|NCT02609178|15678|P1|COMPLETED|Second Crown||0
6558|NCT02609178|15673|P6|STARTED|Second Crown||2
6559|NCT02609178|15674|P5|STARTED|Second Crown||0
6560|NCT02609178|15675|P4|STARTED|Second Crown||2
6561|NCT02609178|15676|P3|STARTED|Second Crown||5
6562|NCT02609178|15677|P2|STARTED|Second Crown||1
6563|NCT02609178|15678|P1|STARTED|Second Crown||0
6564|NCT02609178|15673|P6|NOT COMPLETED|5-minute Washout Time||0
6565|NCT02609178|15674|P5|NOT COMPLETED|5-minute Washout Time||0
6566|NCT02609178|15675|P4|NOT COMPLETED|5-minute Washout Time||0
6567|NCT02609178|15676|P3|NOT COMPLETED|5-minute Washout Time||0
6568|NCT02609178|15677|P2|NOT COMPLETED|5-minute Washout Time||0
6569|NCT02609178|15678|P1|NOT COMPLETED|5-minute Washout Time||0
6570|NCT02609178|15673|P6|COMPLETED|5-minute Washout Time||2
6571|NCT02609178|15674|P5|COMPLETED|5-minute Washout Time||0
6572|NCT02609178|15675|P4|COMPLETED|5-minute Washout Time||2
6573|NCT02609178|15676|P3|COMPLETED|5-minute Washout Time||5
6574|NCT02609178|15677|P2|COMPLETED|5-minute Washout Time||1
6575|NCT02609178|15678|P1|COMPLETED|5-minute Washout Time||0
6576|NCT02609178|15673|P6|STARTED|5-minute Washout Time||2
6577|NCT02609178|15674|P5|STARTED|5-minute Washout Time||0
6578|NCT02609178|15675|P4|STARTED|5-minute Washout Time||2
6579|NCT02609178|15676|P3|STARTED|5-minute Washout Time||5
6580|NCT02609178|15677|P2|STARTED|5-minute Washout Time||1
6581|NCT02609178|15678|P1|STARTED|5-minute Washout Time||0
6582|NCT02609178|15673|P6|NOT COMPLETED|First Crown||0
6583|NCT02609178|15674|P5|NOT COMPLETED|First Crown||0
6584|NCT02609178|15675|P4|NOT COMPLETED|First Crown||1
6585|NCT02609178|15676|P3|NOT COMPLETED|First Crown||1
6586|NCT02609178|15677|P2|NOT COMPLETED|First Crown||0
6587|NCT02609178|15678|P1|NOT COMPLETED|First Crown||0
6588|NCT02609178|15673|P6|COMPLETED|First Crown||2
6589|NCT02609178|15674|P5|COMPLETED|First Crown||0
6590|NCT02609178|15675|P4|COMPLETED|First Crown||2
6591|NCT02609178|15676|P3|COMPLETED|First Crown||5
6592|NCT02609178|15677|P2|COMPLETED|First Crown||1
6593|NCT02609178|15678|P1|COMPLETED|First Crown||0
6594|NCT02609178|15673|P6|STARTED|First Crown||2
6595|NCT02609178|15674|P5|STARTED|First Crown||0
6596|NCT02609178|15675|P4|STARTED|First Crown||3
6597|NCT02609178|15676|P3|STARTED|First Crown||6
6598|NCT02609178|15677|P2|STARTED|First Crown||1
6599|NCT02609178|15678|P1|STARTED|First Crown||0
6600|NCT02609113|15695|P2|NOT COMPLETED|Overall Study||2
6601|NCT02609113|15696|P1|NOT COMPLETED|Overall Study||2
6602|NCT02609113|15695|P2|COMPLETED|Overall Study||9
6603|NCT02609113|15696|P1|COMPLETED|Overall Study||9
6604|NCT02609113|15695|P2|STARTED|Overall Study||11
6605|NCT02609113|15696|P1|STARTED|Overall Study||11
6606|NCT02608489|15710|P2|NOT COMPLETED|Overall Study||10
6607|NCT02608489|15711|P1|NOT COMPLETED|Overall Study||13
6608|NCT02608489|15710|P2|COMPLETED|Overall Study||33
6609|NCT02608489|15711|P1|COMPLETED|Overall Study||30
6610|NCT02608489|15710|P2|STARTED|Overall Study||43
6611|NCT02608489|15711|P1|STARTED|Overall Study||43
6612|NCT02607800|15733|P2|NOT COMPLETED|Overall Study||11
6613|NCT02607800|15734|P1|NOT COMPLETED|Overall Study||10
6614|NCT02607800|15733|P2|COMPLETED|Overall Study||430
6615|NCT02607800|15734|P1|COMPLETED|Overall Study||492
6616|NCT02607800|15733|P2|STARTED|Overall Study||441
6617|NCT02607800|15734|P1|STARTED|Overall Study||502
6618|NCT02607735|15752|P2|NOT COMPLETED|Overall Study||0
6619|NCT02607735|15753|P1|NOT COMPLETED|Overall Study||7
6620|NCT02607735|15752|P2|COMPLETED|Overall Study||152
6621|NCT02607735|15753|P1|COMPLETED|Overall Study||257
6622|NCT02607735|15752|P2|STARTED|Overall Study||152
6623|NCT02607735|15753|P1|STARTED|Overall Study||264
6624|NCT02606838|15767|P1|NOT COMPLETED|Overall Study||0
6625|NCT02606838|15767|P1|COMPLETED|Overall Study||119
6626|NCT02606838|15767|P1|STARTED|Overall Study||119
6627|NCT02606734|15775|P1|NOT COMPLETED|Overall Study||0
6628|NCT02606734|15775|P1|COMPLETED|Overall Study||44
6629|NCT02606734|15775|P1|STARTED|Overall Study||44
6630|NCT02606279|15781|P2|NOT COMPLETED|Overall Study||1
6631|NCT02606279|15782|P1|NOT COMPLETED|Overall Study||0
6632|NCT02606279|15781|P2|COMPLETED|Overall Study||0
6633|NCT02606279|15782|P1|COMPLETED|Overall Study||0
6634|NCT02606279|15781|P2|STARTED|Overall Study||1
6635|NCT02606279|15782|P1|STARTED|Overall Study||0
6636|NCT02605928|15794|P1|NOT COMPLETED|Overall Study||33
6637|NCT02605928|15794|P1|COMPLETED|Overall Study||46
6638|NCT02605928|15794|P1|Pivotal Phase, Statistical Phase|Overall Study||51
6639|NCT02605928|15794|P1|STARTED|Overall Study||79
6640|NCT02605863|15800|P2|NOT COMPLETED|Overall Study||0
6641|NCT02605863|15801|P1|NOT COMPLETED|Overall Study||0
6642|NCT02605863|15800|P2|COMPLETED|Overall Study||0
6643|NCT02605863|15801|P1|COMPLETED|Overall Study||1
6644|NCT02605863|15800|P2|STARTED|Overall Study||0
6645|NCT02605863|15801|P1|STARTED|Overall Study||1
6646|NCT02605304|15809|P2|NOT COMPLETED|Overall Study||0
6647|NCT02605304|15810|P1|NOT COMPLETED|Overall Study||0
6648|NCT02605304|15809|P2|COMPLETED|Overall Study||3
6649|NCT02605304|15810|P1|COMPLETED|Overall Study||4
6650|NCT02605304|15809|P2|STARTED|Overall Study||3
6651|NCT02605304|15810|P1|STARTED|Overall Study||4
6652|NCT02604589|15833|P3|NOT COMPLETED|Overall Study||1
6653|NCT02604589|15834|P2|NOT COMPLETED|Overall Study||0
6654|NCT02604589|15835|P1|NOT COMPLETED|Overall Study||0
6655|NCT02604589|15833|P3|COMPLETED|Overall Study||1
6656|NCT02604589|15834|P2|COMPLETED|Overall Study||5
6657|NCT02604589|15835|P1|COMPLETED|Overall Study||3
6658|NCT02604589|15833|P3|STARTED|Overall Study||2
6659|NCT02604589|15834|P2|STARTED|Overall Study||5
6660|NCT02604589|15835|P1|STARTED|Overall Study||3
6661|NCT02604550|15863|P2|NOT COMPLETED|Overall Study||26
6662|NCT02604550|15864|P1|NOT COMPLETED|Overall Study||25
6663|NCT02604550|15863|P2|COMPLETED|Overall Study||33
6664|NCT02604550|15864|P1|COMPLETED|Overall Study||31
6665|NCT02604550|15863|P2|STARTED|Overall Study||59
6666|NCT02604550|15864|P1|STARTED|Overall Study||56
6667|NCT02604407|15891|P3|NOT COMPLETED|Overall Study||16
6668|NCT02604407|15892|P2|NOT COMPLETED|Overall Study||12
6669|NCT02604407|15893|P1|NOT COMPLETED|Overall Study||11
6670|NCT02604407|15891|P3|COMPLETED|Overall Study||76
6671|NCT02604407|15892|P2|COMPLETED|Overall Study||80
6672|NCT02604407|15893|P1|COMPLETED|Overall Study||80
6673|NCT02604407|15891|P3|TREATED|Overall Study||90
6674|NCT02604407|15892|P2|TREATED|Overall Study||92
6675|NCT02604407|15893|P1|TREATED|Overall Study||89
6676|NCT02604407|15891|P3|STARTED|Overall Study||92
6677|NCT02604407|15892|P2|STARTED|Overall Study||92
6678|NCT02604407|15893|P1|STARTED|Overall Study||91
6679|NCT02604342|15906|P2|NOT COMPLETED|Overall Study||35
6680|NCT02604342|15907|P1|NOT COMPLETED|Overall Study||72
6681|NCT02604342|15906|P2|COMPLETED|Overall Study||0
6682|NCT02604342|15907|P1|COMPLETED|Overall Study||0
6683|NCT02604342|15906|P2|STARTED|Overall Study||35
6684|NCT02604342|15907|P1|STARTED|Overall Study||72
6685|NCT02604264|15959|P2|NOT COMPLETED|Overall Study||242
6686|NCT02604264|15960|P1|NOT COMPLETED|Overall Study||200
6687|NCT02604264|15959|P2|COMPLETED|Overall Study||1225
6688|NCT02604264|15960|P1|COMPLETED|Overall Study||1245
6689|NCT02604264|15959|P2|STARTED|Overall Study||1467
6690|NCT02604264|15960|P1|STARTED|Overall Study||1445
6691|NCT02604173|15969|P3|NOT COMPLETED|Overall Study||0
6692|NCT02604173|15970|P2|NOT COMPLETED|Overall Study||0
6693|NCT02604173|15971|P1|NOT COMPLETED|Overall Study||0
6694|NCT02604173|15969|P3|COMPLETED|Overall Study||35
6695|NCT02604173|15970|P2|COMPLETED|Overall Study||35
6696|NCT02604173|15971|P1|COMPLETED|Overall Study||33
6697|NCT02604173|15969|P3|STARTED|Overall Study||35
6698|NCT02604173|15970|P2|STARTED|Overall Study||35
6699|NCT02604173|15971|P1|STARTED|Overall Study||33
6700|NCT02604017|15987|P2|NOT COMPLETED|Overall Study||8
6701|NCT02604017|15988|P1|NOT COMPLETED|Overall Study||6
6702|NCT02604017|15987|P2|COMPLETED|Overall Study||343
6703|NCT02604017|15988|P1|COMPLETED|Overall Study||346
6704|NCT02604017|15987|P2|STARTED|Overall Study||351
6705|NCT02604017|15988|P1|STARTED|Overall Study||352
6706|NCT02603666|16013|P1|NOT COMPLETED|Overall Study||0
6707|NCT02603666|16013|P1|COMPLETED|Overall Study||130
6708|NCT02603666|16013|P1|STARTED|Overall Study||130
6709|NCT02602223|16017|P1|NOT COMPLETED|Overall Study||0
6710|NCT02602223|16017|P1|COMPLETED|Overall Study||9
6711|NCT02602223|16017|P1|STARTED|Overall Study||9
6712|NCT02601573|16038|P5|NOT COMPLETED|Overall Study||2
6713|NCT02601573|16039|P4|NOT COMPLETED|Overall Study||1
6714|NCT02601573|16040|P3|NOT COMPLETED|Overall Study||1
6715|NCT02601573|16041|P2|NOT COMPLETED|Overall Study||4
6716|NCT02601573|16042|P1|NOT COMPLETED|Overall Study||0
6717|NCT02601573|16038|P5|COMPLETED|Overall Study||16
6718|NCT02601573|16039|P4|COMPLETED|Overall Study||17
6719|NCT02601573|16040|P3|COMPLETED|Overall Study||16
6720|NCT02601573|16041|P2|COMPLETED|Overall Study||20
6721|NCT02601573|16042|P1|COMPLETED|Overall Study||23
6722|NCT02601573|16038|P5|STARTED|Overall Study|Number randomized and treated.|18
6723|NCT02601573|16039|P4|STARTED|Overall Study|Number randomized and treated.|18
6724|NCT02601573|16040|P3|STARTED|Overall Study|Number randomized and treated.|17
6725|NCT02601573|16041|P2|STARTED|Overall Study|Number randomized and treated.|24
6726|NCT02601573|16042|P1|STARTED|Overall Study|Number randomized and treated.|23
6727|NCT02601560|16077|P8|NOT COMPLETED|Overall Study||0
6728|NCT02601560|16078|P7|NOT COMPLETED|Overall Study||1
6729|NCT02601560|16079|P6|NOT COMPLETED|Overall Study||0
6730|NCT02601560|16080|P5|NOT COMPLETED|Overall Study||0
6731|NCT02601560|16081|P4|NOT COMPLETED|Overall Study||0
6732|NCT02601560|16082|P3|NOT COMPLETED|Overall Study||0
6733|NCT02601560|16083|P2|NOT COMPLETED|Overall Study||0
6734|NCT02601560|16084|P1|NOT COMPLETED|Overall Study||0
6735|NCT02601560|16077|P8|COMPLETED|Overall Study||6
6736|NCT02601560|16078|P7|COMPLETED|Overall Study||5
6737|NCT02601560|16079|P6|COMPLETED|Overall Study||4
6738|NCT02601560|16080|P5|COMPLETED|Overall Study||6
6739|NCT02601560|16081|P4|COMPLETED|Overall Study||6
6740|NCT02601560|16082|P3|COMPLETED|Overall Study||6
6741|NCT02601560|16083|P2|COMPLETED|Overall Study||6
6742|NCT02601560|16084|P1|COMPLETED|Overall Study||8
6743|NCT02601560|16077|P8|STARTED|Overall Study||6
6744|NCT02601560|16078|P7|STARTED|Overall Study||6
6745|NCT02601560|16079|P6|STARTED|Overall Study||4
6746|NCT02601560|16080|P5|STARTED|Overall Study||6
6747|NCT02601560|16081|P4|STARTED|Overall Study||6
6748|NCT02601560|16082|P3|STARTED|Overall Study||6
6749|NCT02601560|16083|P2|STARTED|Overall Study||6
6750|NCT02601560|16084|P1|STARTED|Overall Study||8
6751|NCT02600871|16268|P2|NOT COMPLETED|Overall Study||10
6752|NCT02600871|16269|P1|NOT COMPLETED|Overall Study||13
6753|NCT02600871|16268|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
6754|NCT02600871|16269|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
6755|NCT02600871|16268|P2|STARTED|Overall Study||49
6756|NCT02600871|16269|P1|STARTED|Overall Study||52
6757|NCT02600845|16279|P1|NOT COMPLETED|Overall Study||18
6758|NCT02600845|16279|P1|COMPLETED|Overall Study||104
6759|NCT02600845|16279|P1|STARTED|Overall Study||122
6760|NCT02600767|16294|P1|NOT COMPLETED|Overall Study||5
6761|NCT02600767|16294|P1|COMPLETED|Overall Study||74
6762|NCT02600767|16294|P1|STARTED|Overall Study||79
6763|NCT02600403|16301|P3|NOT COMPLETED|Overall Study||0
6764|NCT02600403|16302|P2|NOT COMPLETED|Overall Study||0
6765|NCT02600403|16303|P1|NOT COMPLETED|Overall Study||0
6766|NCT02600403|16301|P3|COMPLETED|Overall Study||11
6767|NCT02600403|16302|P2|COMPLETED|Overall Study||6
6768|NCT02600403|16303|P1|COMPLETED|Overall Study||44
6769|NCT02600403|16301|P3|STARTED|Overall Study||11
6770|NCT02600403|16302|P2|STARTED|Overall Study||6
6771|NCT02600403|16303|P1|STARTED|Overall Study||44
6772|NCT02600351|16330|P4|NOT COMPLETED|Overall Study||5
6773|NCT02600351|16331|P3|NOT COMPLETED|Overall Study||6
6774|NCT02600351|16332|P2|NOT COMPLETED|Overall Study||0
6775|NCT02600351|16333|P1|NOT COMPLETED|Overall Study||5
6776|NCT02600351|16330|P4|COMPLETED|Overall Study||22
6777|NCT02600351|16331|P3|COMPLETED|Overall Study||20
6778|NCT02600351|16332|P2|COMPLETED|Overall Study||17
6779|NCT02600351|16333|P1|COMPLETED|Overall Study||12
6780|NCT02600351|16330|P4|STARTED|Overall Study||27
6781|NCT02600351|16331|P3|STARTED|Overall Study||26
6782|NCT02600351|16332|P2|STARTED|Overall Study||17
6783|NCT02600351|16333|P1|STARTED|Overall Study||17
6784|NCT02599129|16365|P2|NOT COMPLETED|Overall Study||3
6785|NCT02599129|16366|P1|NOT COMPLETED|Overall Study||5
6786|NCT02599129|16365|P2|COMPLETED|Overall Study||1
6787|NCT02599129|16366|P1|COMPLETED|Overall Study||2
6788|NCT02599129|16365|P2|STARTED|Overall Study||4
6789|NCT02599129|16366|P1|STARTED|Overall Study||7
6790|NCT02598934|16382|P2|NOT COMPLETED|Overall Study||22
6791|NCT02598934|16383|P1|NOT COMPLETED|Overall Study||19
6792|NCT02598934|16382|P2|COMPLETED|Overall Study||132
6793|NCT02598934|16383|P1|COMPLETED|Overall Study||135
6794|NCT02598934|16382|P2|STARTED|Overall Study||154
6795|NCT02598934|16383|P1|STARTED|Overall Study||154
6796|NCT02598622|16395|P2|NOT COMPLETED|Overall Study||0
6797|NCT02598622|16396|P1|NOT COMPLETED|Overall Study||6
6798|NCT02598622|16395|P2|COMPLETED|Overall Study||0
6799|NCT02598622|16396|P1|COMPLETED|Overall Study||2
6800|NCT02598622|16395|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
6801|NCT02598622|16396|P1|STARTED|Overall Study||8
6802|NCT02598583|16404|P2|NOT COMPLETED|Overall Study||0
6803|NCT02598583|16405|P1|NOT COMPLETED|Overall Study||0
6804|NCT02598583|16404|P2|COMPLETED|Overall Study||7
6805|NCT02598583|16405|P1|COMPLETED|Overall Study||6
6806|NCT02598583|16404|P2|STARTED|Overall Study||7
6807|NCT02598583|16405|P1|STARTED|Overall Study||6
6808|NCT02598128|16423|P4|NOT COMPLETED|Period C: Days 12 to 20||0
6809|NCT02598128|16424|P3|NOT COMPLETED|Period C: Days 12 to 20||0
6810|NCT02598128|16425|P2|NOT COMPLETED|Period C: Days 12 to 20||0
6811|NCT02598128|16426|P1|NOT COMPLETED|Period C: Days 12 to 20||0
6812|NCT02598128|16423|P4|COMPLETED|Period C: Days 12 to 20||33
6813|NCT02598128|16424|P3|COMPLETED|Period C: Days 12 to 20||0
6814|NCT02598128|16425|P2|COMPLETED|Period C: Days 12 to 20||0
6815|NCT02598128|16426|P1|COMPLETED|Period C: Days 12 to 20||0
6816|NCT02598128|16423|P4|STARTED|Period C: Days 12 to 20||33
6817|NCT02598128|16424|P3|STARTED|Period C: Days 12 to 20||0
6818|NCT02598128|16425|P2|STARTED|Period C: Days 12 to 20||0
6819|NCT02598128|16426|P1|STARTED|Period C: Days 12 to 20||0
6820|NCT02598128|16423|P4|NOT COMPLETED|Period B: Days 1 to 11||0
6821|NCT02598128|16424|P3|NOT COMPLETED|Period B: Days 1 to 11||0
6822|NCT02598128|16425|P2|NOT COMPLETED|Period B: Days 1 to 11||0
6823|NCT02598128|16426|P1|NOT COMPLETED|Period B: Days 1 to 11||0
6824|NCT02598128|16423|P4|COMPLETED|Period B: Days 1 to 11||0
6825|NCT02598128|16424|P3|COMPLETED|Period B: Days 1 to 11||16
6826|NCT02598128|16425|P2|COMPLETED|Period B: Days 1 to 11||17
6827|NCT02598128|16426|P1|COMPLETED|Period B: Days 1 to 11||0
6828|NCT02598128|16423|P4|STARTED|Period B: Days 1 to 11||0
6829|NCT02598128|16424|P3|STARTED|Period B: Days 1 to 11||16
6830|NCT02598128|16425|P2|STARTED|Period B: Days 1 to 11||17
6831|NCT02598128|16426|P1|STARTED|Period B: Days 1 to 11||0
6832|NCT02598128|16423|P4|NOT COMPLETED|Period A: Days -7 to -1||0
6833|NCT02598128|16424|P3|NOT COMPLETED|Period A: Days -7 to -1||0
6834|NCT02598128|16425|P2|NOT COMPLETED|Period A: Days -7 to -1||0
6835|NCT02598128|16426|P1|NOT COMPLETED|Period A: Days -7 to -1||1
6836|NCT02598128|16423|P4|COMPLETED|Period A: Days -7 to -1||0
6837|NCT02598128|16424|P3|COMPLETED|Period A: Days -7 to -1||0
6838|NCT02598128|16425|P2|COMPLETED|Period A: Days -7 to -1||0
6839|NCT02598128|16426|P1|COMPLETED|Period A: Days -7 to -1||33
6840|NCT02598128|16423|P4|STARTED|Period A: Days -7 to -1||0
6841|NCT02598128|16424|P3|STARTED|Period A: Days -7 to -1||0
6842|NCT02598128|16425|P2|STARTED|Period A: Days -7 to -1||0
6843|NCT02598128|16426|P1|STARTED|Period A: Days -7 to -1||34
6844|NCT02597907|16440|P2|NOT COMPLETED|Overall Study||0
6845|NCT02597907|16441|P1|NOT COMPLETED|Overall Study||0
6846|NCT02597907|16440|P2|COMPLETED|Overall Study||44
6847|NCT02597907|16441|P1|COMPLETED|Overall Study||44
6848|NCT02597907|16440|P2|STARTED|Overall Study||44
6849|NCT02597907|16441|P1|STARTED|Overall Study||44
6850|NCT02597855|16449|P2|NOT COMPLETED|Overall Study||1
6851|NCT02597855|16450|P1|NOT COMPLETED|Overall Study||2
6852|NCT02597855|16449|P2|COMPLETED|Overall Study||13
6853|NCT02597855|16450|P1|COMPLETED|Overall Study||16
6854|NCT02597855|16449|P2|STARTED|Overall Study||14
6855|NCT02597855|16450|P1|STARTED|Overall Study||18
6856|NCT02597582|16460|P2|NOT COMPLETED|Overall Study||0
6857|NCT02597582|16461|P1|NOT COMPLETED|Overall Study||0
6858|NCT02597582|16460|P2|COMPLETED|Overall Study||20
6859|NCT02597582|16461|P1|COMPLETED|Overall Study||21
6860|NCT02597582|16460|P2|STARTED|Overall Study||20
6861|NCT02597582|16461|P1|STARTED|Overall Study||21
6862|NCT02597543|16479|P2|NOT COMPLETED|Overall Study||0
6863|NCT02597543|16480|P1|NOT COMPLETED|Overall Study||0
6864|NCT02597543|16479|P2|COMPLETED|Overall Study||8
6865|NCT02597543|16480|P1|COMPLETED|Overall Study||6
6866|NCT02597543|16479|P2|STARTED|Overall Study||8
6867|NCT02597543|16480|P1|STARTED|Overall Study||6
6868|NCT02597049|16499|P3|NOT COMPLETED|Overall Study||3
6869|NCT02597049|16500|P2|NOT COMPLETED|Overall Study||5
6870|NCT02597049|16501|P1|NOT COMPLETED|Overall Study||7
6871|NCT02597049|16499|P3|COMPLETED|Overall Study||137
6872|NCT02597049|16500|P2|COMPLETED|Overall Study||137
6873|NCT02597049|16501|P1|COMPLETED|Overall Study||135
6874|NCT02597049|16499|P3|Received at Least One Dose of Study Drug|Overall Study||140
6875|NCT02597049|16500|P2|Received at Least One Dose of Study Drug|Overall Study||141
6876|NCT02597049|16501|P1|Received at Least One Dose of Study Drug|Overall Study||142
6877|NCT02597049|16499|P3|STARTED|Overall Study||140
6878|NCT02597049|16500|P2|STARTED|Overall Study||142
6879|NCT02597049|16501|P1|STARTED|Overall Study||142
6880|NCT02596958|16539|P1|NOT COMPLETED|Overall Study||996
6881|NCT02596958|16539|P1|COMPLETED|Overall Study||0
6882|NCT02596958|16539|P1|STARTED|Overall Study||996
6883|NCT02596945|16551|P1|NOT COMPLETED|Overall Study||56
6884|NCT02596945|16551|P1|COMPLETED|Overall Study||167
6885|NCT02596945|16551|P1|Treated|Overall Study||220
6886|NCT02596945|16551|P1|STARTED|Overall Study||223
6887|NCT02596867|16557|P1|NOT COMPLETED|Overall Study||0
6888|NCT02596867|16557|P1|COMPLETED|Overall Study||2
6889|NCT02596867|16557|P1|2 Patients Prospectively Recruited|Overall Study||2
6890|NCT02596867|16557|P1|STARTED|Overall Study||2
6891|NCT02596854|16562|P1|NOT COMPLETED|Overall Study||8
6892|NCT02596854|16562|P1|COMPLETED|Overall Study||109
6893|NCT02596854|16562|P1|STARTED|Overall Study||117
6894|NCT02596620|16568|P2|NOT COMPLETED|Overall Study||1
6895|NCT02596620|16569|P1|NOT COMPLETED|Overall Study||1
6896|NCT02596620|16568|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
6897|NCT02596620|16569|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
6898|NCT02596620|16568|P2|STARTED|Overall Study|Started from 1st October 2013|82
6899|NCT02596620|16569|P1|STARTED|Overall Study|Started from 1st October 2013|82
6900|NCT02596451|16578|P3|NOT COMPLETED|Overall Study||14
6901|NCT02596451|16579|P2|NOT COMPLETED|Overall Study||18
6902|NCT02596451|16580|P1|NOT COMPLETED|Overall Study||4
6903|NCT02596451|16578|P3|COMPLETED|Overall Study||373
6904|NCT02596451|16579|P2|COMPLETED|Overall Study||374
6905|NCT02596451|16580|P1|COMPLETED|Overall Study||381
6906|NCT02596451|16578|P3|STARTED|Overall Study||387
6907|NCT02596451|16579|P2|STARTED|Overall Study||392
6908|NCT02596451|16580|P1|STARTED|Overall Study||385
6909|NCT02596321|16589|P2|NOT COMPLETED|Overall Study||0
6910|NCT02596321|16590|P1|NOT COMPLETED|Overall Study||3
6911|NCT02596321|16589|P2|COMPLETED|Overall Study||56
6912|NCT02596321|16590|P1|COMPLETED|Overall Study||53
6913|NCT02596321|16589|P2|STARTED|Overall Study||56
6914|NCT02596321|16590|P1|STARTED|Overall Study||56
6915|NCT02596022|16604|P2|NOT COMPLETED|Overall Study||0
6916|NCT02596022|16605|P1|NOT COMPLETED|Overall Study||0
6917|NCT02596022|16604|P2|COMPLETED|Overall Study||8
6918|NCT02596022|16605|P1|COMPLETED|Overall Study||10
6919|NCT02596022|16604|P2|STARTED|Overall Study||8
6920|NCT02596022|16605|P1|STARTED|Overall Study||10
6921|NCT02595567|16611|P1|NOT COMPLETED|Overall Study||0
6922|NCT02595567|16611|P1|COMPLETED|Overall Study||25
6923|NCT02595567|16611|P1|STARTED|Overall Study||25
6924|NCT02595502|16615|P2|NOT COMPLETED|Period 3||2
6925|NCT02595502|16616|P1|NOT COMPLETED|Period 3||1
6926|NCT02595502|16615|P2|COMPLETED|Period 3||136
6927|NCT02595502|16616|P1|COMPLETED|Period 3||140
6928|NCT02595502|16615|P2|STARTED|Period 3||138
6929|NCT02595502|16616|P1|STARTED|Period 3||141
6930|NCT02595502|16615|P2|NOT COMPLETED|Period 2||2
6931|NCT02595502|16616|P1|NOT COMPLETED|Period 2||1
6932|NCT02595502|16615|P2|COMPLETED|Period 2||138
6933|NCT02595502|16616|P1|COMPLETED|Period 2||141
6934|NCT02595502|16615|P2|STARTED|Period 2||140
6935|NCT02595502|16616|P1|STARTED|Period 2||142
6936|NCT02595502|16615|P2|NOT COMPLETED|Period 1||2
6937|NCT02595502|16616|P1|NOT COMPLETED|Period 1||1
6938|NCT02595502|16615|P2|COMPLETED|Period 1||140
6939|NCT02595502|16616|P1|COMPLETED|Period 1||142
6940|NCT02595502|16615|P2|STARTED|Period 1||142
6941|NCT02595502|16616|P1|STARTED|Period 1||143
6942|NCT02595450|16622|P1|NOT COMPLETED|Overall Study||81
6943|NCT02595450|16622|P1|COMPLETED|Overall Study||218
6944|NCT02595450|16622|P1|Treated|Overall Study||291
6945|NCT02595450|16622|P1|STARTED|Overall Study||299
6946|NCT02594826|16630|P2|NOT COMPLETED|Overall Study||60
6947|NCT02594826|16631|P1|NOT COMPLETED|Overall Study||57
6948|NCT02594826|16630|P2|COMPLETED|Overall Study||298
6949|NCT02594826|16631|P1|COMPLETED|Overall Study||290
6950|NCT02594826|16630|P2|STARTED|Overall Study||358
6951|NCT02594826|16631|P1|STARTED|Overall Study||347
6952|NCT02593773|16637|P1|NOT COMPLETED|Overall Study||35
6953|NCT02593773|16637|P1|COMPLETED|Overall Study||51
6954|NCT02593773|16637|P1|STARTED|Overall Study||86
6955|NCT02592655|16649|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
6956|NCT02592655|16649|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
6957|NCT02592655|16649|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
6958|NCT02592655|16649|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
6959|NCT02592655|16649|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
6960|NCT02592655|16649|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
6961|NCT02592655|16649|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
6962|NCT02592655|16649|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
6963|NCT02592655|16649|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
6964|NCT02592655|16649|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
6965|NCT02592655|16649|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
6966|NCT02592655|16649|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
6967|NCT02592655|16649|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
6968|NCT02592655|16649|P1|STARTED|Third Tourniquet, Left Thigh.||19
6969|NCT02592655|16649|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
6970|NCT02592655|16649|P1|COMPLETED|Second Tourniquet Right Thigh.||19
6971|NCT02592655|16649|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
6972|NCT02592655|16649|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
6973|NCT02592655|16649|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
6974|NCT02592655|16649|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
6975|NCT02592655|16649|P1|STARTED|Second Tourniquet Right Thigh.||19
6976|NCT02592655|16649|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
6977|NCT02592655|16649|P1|COMPLETED|First Tourniquet, Left Thigh.||19
6978|NCT02592655|16649|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
6979|NCT02592655|16649|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
6980|NCT02592655|16649|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
6981|NCT02592655|16649|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
6982|NCT02592655|16649|P1|STARTED|First Tourniquet, Left Thigh.||19
6983|NCT02591537|16666|P2|NOT COMPLETED|Overall Study||0
6984|NCT02591537|16667|P1|NOT COMPLETED|Overall Study||0
6985|NCT02591537|16666|P2|COMPLETED|Overall Study||8
6986|NCT02591537|16667|P1|COMPLETED|Overall Study||8
6987|NCT02591537|16666|P2|STARTED|Overall Study||8
6988|NCT02591537|16667|P1|STARTED|Overall Study||8
6989|NCT02591290|16687|P1|NOT COMPLETED|Overall Study||2
6990|NCT02591290|16687|P1|COMPLETED|Overall Study||58
6991|NCT02591290|16687|P1|Vaccinated Dose 2|Overall Study||58
6992|NCT02591290|16687|P1|Vaccinated Dose 1|Overall Study||60
6993|NCT02591290|16687|P1|STARTED|Overall Study||60
6994|NCT02591238|16697|P4|NOT COMPLETED|Overall Study||3
6995|NCT02591238|16698|P3|NOT COMPLETED|Overall Study||0
6996|NCT02591238|16699|P2|NOT COMPLETED|Overall Study||1
6997|NCT02591238|16700|P1|NOT COMPLETED|Overall Study||1
6998|NCT02591238|16697|P4|COMPLETED|Overall Study||15
6999|NCT02591238|16698|P3|COMPLETED|Overall Study||17
7000|NCT02591238|16699|P2|COMPLETED|Overall Study||16
7001|NCT02591238|16700|P1|COMPLETED|Overall Study||15
7002|NCT02591238|16697|P4|STARTED|Overall Study||18
7003|NCT02591238|16698|P3|STARTED|Overall Study||17
7004|NCT02591238|16699|P2|STARTED|Overall Study||17
7005|NCT02591238|16700|P1|STARTED|Overall Study||16
7006|NCT02591056|16730|P1|NOT COMPLETED|Overall Study||0
7007|NCT02591056|16730|P1|COMPLETED|Overall Study||27
7008|NCT02591056|16730|P1|STARTED|Overall Study||27
7009|NCT02590939|16736|P2|NOT COMPLETED|Overall Study||2
7010|NCT02590939|16737|P1|NOT COMPLETED|Overall Study||5
7011|NCT02590939|16736|P2|COMPLETED|Overall Study||52
7012|NCT02590939|16737|P1|COMPLETED|Overall Study||47
7013|NCT02590939|16736|P2|STARTED|Overall Study||54
7014|NCT02590939|16737|P1|STARTED|Overall Study||52
7015|NCT02590588|16757|P1|NOT COMPLETED|Overall Study||1
7016|NCT02590588|16757|P1|COMPLETED|Overall Study||0
7017|NCT02590588|16757|P1|STARTED|Overall Study||1
7018|NCT02590562|16765|P1|NOT COMPLETED|Overall Study||6
7019|NCT02590562|16765|P1|COMPLETED|Overall Study||802
7020|NCT02590562|16765|P1|STARTED|Overall Study||808
7021|NCT02590003|16824|P2|NOT COMPLETED|Overall Study||2
7022|NCT02590003|16825|P1|NOT COMPLETED|Overall Study||1
7023|NCT02590003|16824|P2|COMPLETED|Overall Study||0
7024|NCT02590003|16825|P1|COMPLETED|Overall Study||0
7025|NCT02590003|16824|P2|STARTED|Overall Study||2
7026|NCT02590003|16825|P1|STARTED|Overall Study||1
7027|NCT02588976|16845|P1|NOT COMPLETED|Overall Study||0
7028|NCT02588976|16845|P1|COMPLETED|Overall Study||30
7029|NCT02588976|16845|P1|STARTED|Overall Study||30
7030|NCT02588872|16852|P2|NOT COMPLETED|Overall Study||0
7031|NCT02588872|16853|P1|NOT COMPLETED|Overall Study||0
7032|NCT02588872|16852|P2|COMPLETED|Overall Study||52
7033|NCT02588872|16853|P1|COMPLETED|Overall Study||59
7034|NCT02588872|16852|P2|STARTED|Overall Study||52
7035|NCT02588872|16853|P1|STARTED|Overall Study||59
7036|NCT02588599|16867|P1|NOT COMPLETED|Overall Study||0
7037|NCT02588599|16867|P1|COMPLETED|Overall Study||54
7038|NCT02588599|16867|P1|STARTED|Overall Study||54
7039|NCT02587819|16872|P1|NOT COMPLETED|Overall Study||2
7040|NCT02587819|16872|P1|COMPLETED|Overall Study||19
7041|NCT02587819|16872|P1|Exposed|Overall Study||21
7042|NCT02587819|16872|P1|STARTED|Overall Study||21
7043|NCT02587234|16881|P2|NOT COMPLETED|Overall Study||3
7044|NCT02587234|16882|P1|NOT COMPLETED|Overall Study||1
7045|NCT02587234|16881|P2|COMPLETED|Overall Study||7
7046|NCT02587234|16882|P1|COMPLETED|Overall Study||10
7047|NCT02587234|16881|P2|STARTED|Overall Study||10
7048|NCT02587234|16882|P1|STARTED|Overall Study||11
7049|NCT02587117|16894|P2|NOT COMPLETED|Overall Study||0
7050|NCT02587117|16895|P1|NOT COMPLETED|Overall Study||0
7051|NCT02587117|16894|P2|COMPLETED|Overall Study||15
7052|NCT02587117|16895|P1|COMPLETED|Overall Study||13
7053|NCT02587117|16894|P2|STARTED|Overall Study||15
7054|NCT02587117|16895|P1|STARTED|Overall Study||13
7055|NCT02586805|16907|P4|NOT COMPLETED|Overall Study||2
7056|NCT02586805|16908|P3|NOT COMPLETED|Overall Study||3
7057|NCT02586805|16909|P2|NOT COMPLETED|Overall Study||1
7058|NCT02586805|16910|P1|NOT COMPLETED|Overall Study||6
7059|NCT02586805|16907|P4|COMPLETED|Overall Study||25
7060|NCT02586805|16908|P3|COMPLETED|Overall Study||26
7061|NCT02586805|16909|P2|COMPLETED|Overall Study||27
7062|NCT02586805|16910|P1|COMPLETED|Overall Study||35
7063|NCT02586805|16907|P4|STARTED|Overall Study||27
7064|NCT02586805|16908|P3|STARTED|Overall Study||29
7065|NCT02586805|16909|P2|STARTED|Overall Study||28
7066|NCT02586805|16910|P1|STARTED|Overall Study||41
7067|NCT02586506|16932|P1|NOT COMPLETED|Overall Study||9
7068|NCT02586506|16932|P1|COMPLETED|Overall Study||250
7069|NCT02586506|16932|P1|STARTED|Overall Study||259
7070|NCT02586493|16938|P1|NOT COMPLETED|Overall Study||12
7071|NCT02586493|16938|P1|COMPLETED|Overall Study||266
7072|NCT02586493|16938|P1|STARTED|Overall Study||278
7073|NCT02585999|16944|P1|NOT COMPLETED|Overall Study||2
7074|NCT02585999|16944|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
7075|NCT02585999|16944|P1|STARTED|Overall Study||28
7076|NCT02585895|16951|P2|NOT COMPLETED|Post-primary Period||0
7077|NCT02585895|16952|P1|NOT COMPLETED|Post-primary Period||0
7078|NCT02585895|16951|P2|COMPLETED|Post-primary Period||19
7079|NCT02585895|16952|P1|COMPLETED|Post-primary Period||20
7080|NCT02585895|16951|P2|STARTED|Post-primary Period||19
7081|NCT02585895|16952|P1|STARTED|Post-primary Period||20
7082|NCT02585895|16951|P2|NOT COMPLETED|Primary Period||0
7083|NCT02585895|16952|P1|NOT COMPLETED|Primary Period||0
7084|NCT02585895|16951|P2|COMPLETED|Primary Period||19
7085|NCT02585895|16952|P1|COMPLETED|Primary Period||20
7086|NCT02585895|16951|P2|STARTED|Primary Period||19
7087|NCT02585895|16952|P1|STARTED|Primary Period||20
7088|NCT02585778|16971|P2|NOT COMPLETED|Overall Study||15
7089|NCT02585778|16972|P1|NOT COMPLETED|Overall Study||33
7090|NCT02585778|16971|P2|COMPLETED|Overall Study||157
7091|NCT02585778|16972|P1|COMPLETED|Overall Study||312
7092|NCT02585778|16971|P2|T2DM Participants|Overall Study||147
7093|NCT02585778|16972|P1|T2DM Participants|Overall Study||294
7094|NCT02585778|16971|P2|T1DM Participants|Overall Study||25
7095|NCT02585778|16972|P1|T1DM Participants|Overall Study||51
7096|NCT02585778|16971|P2|mITT Population|Overall Study||164
7097|NCT02585778|16972|P1|mITT Population|Overall Study||333
7098|NCT02585778|16971|P2|ITT Population|Overall Study||167
7099|NCT02585778|16972|P1|ITT Population|Overall Study||336
7100|NCT02585778|16971|P2|Treated (Safety Population)|Overall Study||170
7101|NCT02585778|16972|P1|Treated (Safety Population)|Overall Study||344
7102|NCT02585778|16971|P2|STARTED|Overall Study|Randomized|172
7103|NCT02585778|16972|P1|STARTED|Overall Study|Randomized|345
7104|NCT02585245|17086|P1|NOT COMPLETED|Overall Study||13
7105|NCT02585245|17086|P1|COMPLETED|Overall Study||594
7106|NCT02585245|17086|P1|STARTED|Overall Study||607
7107|NCT02584790|17091|P1|NOT COMPLETED|Overall Study||15
7108|NCT02584790|17091|P1|COMPLETED|Overall Study||40
7109|NCT02584790|17091|P1|STARTED|Overall Study||55
7110|NCT02584686|17099|P2|NOT COMPLETED|Overall Study||0
7111|NCT02584686|17100|P1|NOT COMPLETED|Overall Study||0
7112|NCT02584686|17099|P2|COMPLETED|Overall Study||12
7113|NCT02584686|17100|P1|COMPLETED|Overall Study||12
7114|NCT02584686|17099|P2|STARTED|Overall Study||12
7115|NCT02584686|17100|P1|STARTED|Overall Study||12
7116|NCT02584673|17128|P2|NOT COMPLETED|Overall Study||0
7117|NCT02584673|17129|P1|NOT COMPLETED|Overall Study||0
7118|NCT02584673|17128|P2|COMPLETED|Overall Study||15
7119|NCT02584673|17129|P1|COMPLETED|Overall Study||15
7120|NCT02584673|17128|P2|STARTED|Overall Study||15
7121|NCT02584673|17129|P1|STARTED|Overall Study||15
7122|NCT02584660|17143|P2|NOT COMPLETED|Overall Study||8
7123|NCT02584660|17144|P1|NOT COMPLETED|Overall Study||7
7124|NCT02584660|17143|P2|COMPLETED|Overall Study||55
7125|NCT02584660|17144|P1|COMPLETED|Overall Study||44
7126|NCT02584660|17143|P2|Treated|Overall Study||63
7127|NCT02584660|17144|P1|Treated|Overall Study||49
7128|NCT02584660|17143|P2|STARTED|Overall Study||63
7129|NCT02584660|17144|P1|STARTED|Overall Study||51
7130|NCT02584504|17163|P3|NOT COMPLETED|Open-label Treatment||55
7131|NCT02584504|17164|P2|NOT COMPLETED|Open-label Treatment||51
7132|NCT02584504|17165|P1|NOT COMPLETED|Open-label Treatment||54
7133|NCT02584504|17163|P3|COMPLETED|Open-label Treatment||0
7134|NCT02584504|17164|P2|COMPLETED|Open-label Treatment||0
7135|NCT02584504|17165|P1|COMPLETED|Open-label Treatment||0
7136|NCT02584504|17163|P3|Completed 12 Week Treatment|Open-label Treatment||52
7137|NCT02584504|17164|P2|Completed 12 Week Treatment|Open-label Treatment||49
7138|NCT02584504|17165|P1|Completed 12 Week Treatment|Open-label Treatment||54
7139|NCT02584504|17163|P3|Treated|Open-label Treatment||54
7140|NCT02584504|17164|P2|Treated|Open-label Treatment||50
7141|NCT02584504|17165|P1|Treated|Open-label Treatment||54
7142|NCT02584504|17163|P3|STARTED|Open-label Treatment||55
7143|NCT02584504|17164|P2|STARTED|Open-label Treatment||51
7144|NCT02584504|17165|P1|STARTED|Open-label Treatment||54
7145|NCT02584504|17163|P3|NOT COMPLETED|Double-blind Treatment||1
7146|NCT02584504|17164|P2|NOT COMPLETED|Double-blind Treatment||2
7147|NCT02584504|17165|P1|NOT COMPLETED|Double-blind Treatment||0
7148|NCT02584504|17163|P3|COMPLETED|Double-blind Treatment||55
7149|NCT02584504|17164|P2|COMPLETED|Double-blind Treatment||51
7150|NCT02584504|17165|P1|COMPLETED|Double-blind Treatment||54
7151|NCT02584504|17163|P3|Safety Population|Double-blind Treatment||56
7152|NCT02584504|17164|P2|Safety Population|Double-blind Treatment||53
7153|NCT02584504|17165|P1|Safety Population|Double-blind Treatment||54
7154|NCT02584504|17163|P3|mITT Population|Double-blind Treatment||56
7155|NCT02584504|17164|P2|mITT Population|Double-blind Treatment||53
7156|NCT02584504|17165|P1|mITT Population|Double-blind Treatment||54
7157|NCT02584504|17163|P3|ITT Population|Double-blind Treatment||56
7158|NCT02584504|17164|P2|ITT Population|Double-blind Treatment||53
7159|NCT02584504|17165|P1|ITT Population|Double-blind Treatment||54
7160|NCT02584504|17163|P3|STARTED|Double-blind Treatment|Randomized|56
7161|NCT02584504|17164|P2|STARTED|Double-blind Treatment|Randomized|53
7162|NCT02584504|17165|P1|STARTED|Double-blind Treatment|Randomized|54
7163|NCT02583425|17216|P1|NOT COMPLETED|Treatment Period||1
7164|NCT02583425|17216|P1|COMPLETED|Treatment Period||9
7165|NCT02583425|17216|P1|STARTED|Treatment Period||10
7166|NCT02583425|17216|P1|NOT COMPLETED|Baseline||5
7167|NCT02583425|17216|P1|COMPLETED|Baseline||10
7168|NCT02583425|17216|P1|STARTED|Baseline||15
7169|NCT02583425|17216|P1|NOT COMPLETED|Screening||12
7170|NCT02583425|17216|P1|COMPLETED|Screening||15
7171|NCT02583425|17216|P1|STARTED|Screening||27
7172|NCT02582983|17221|P1|NOT COMPLETED|Overall Study||6
7173|NCT02582983|17221|P1|COMPLETED|Overall Study||17
7174|NCT02582983|17221|P1|STARTED|Overall Study||23
7175|NCT02582970|17226|P1|NOT COMPLETED|Overall Study||0
7176|NCT02582970|17226|P1|COMPLETED|Overall Study||40
7177|NCT02582970|17226|P1|STARTED|Overall Study||40
7178|NCT02582684|17236|P1|NOT COMPLETED|Overall Study||17
7179|NCT02582684|17236|P1|COMPLETED|Overall Study||105
7180|NCT02582684|17236|P1|STARTED|Overall Study||122
7181|NCT02582632|17255|P1|NOT COMPLETED|Overall Study||1
7182|NCT02582632|17255|P1|COMPLETED|Overall Study||165
7183|NCT02582632|17255|P1|STARTED|Overall Study||166
7184|NCT02582242|17270|P2|NOT COMPLETED|Overall Study||17
7185|NCT02582242|17271|P1|NOT COMPLETED|Overall Study||20
7186|NCT02582242|17270|P2|COMPLETED|Overall Study||200
7187|NCT02582242|17271|P1|COMPLETED|Overall Study||200
7188|NCT02582242|17270|P2|STARTED|Overall Study||217
7189|NCT02582242|17271|P1|STARTED|Overall Study||220
7190|NCT02581475|17313|P2|NOT COMPLETED|Overall Study||15
7191|NCT02581475|17314|P1|NOT COMPLETED|Overall Study||11
7192|NCT02581475|17313|P2|COMPLETED|Overall Study||178
7193|NCT02581475|17314|P1|COMPLETED|Overall Study||182
7194|NCT02581475|17313|P2|STARTED|Overall Study||193
7195|NCT02581475|17314|P1|STARTED|Overall Study||193
7196|NCT02581410|17328|P2|NOT COMPLETED|Overall Study||3
7197|NCT02581410|17329|P1|NOT COMPLETED|Overall Study||2
7198|NCT02581410|17328|P2|COMPLETED|Overall Study||212
7199|NCT02581410|17329|P1|COMPLETED|Overall Study||213
7200|NCT02581410|17328|P2|STARTED|Overall Study||215
7201|NCT02581410|17329|P1|STARTED|Overall Study||215
7202|NCT02580799|17349|P1|NOT COMPLETED|Overall Study||0
7203|NCT02580799|17349|P1|COMPLETED|Overall Study||30
7204|NCT02580799|17349|P1|STARTED|Overall Study||30
7205|NCT02580357|17374|P3|NOT COMPLETED|Overall Study||0
7206|NCT02580357|17375|P2|NOT COMPLETED|Overall Study||0
7207|NCT02580357|17376|P1|NOT COMPLETED|Overall Study||3
7208|NCT02580357|17374|P3|COMPLETED|Overall Study||18
7209|NCT02580357|17375|P2|COMPLETED|Overall Study||18
7210|NCT02580357|17376|P1|COMPLETED|Overall Study||15
7211|NCT02580357|17374|P3|STARTED|Overall Study||18
7212|NCT02580357|17375|P2|STARTED|Overall Study||18
7213|NCT02580357|17376|P1|STARTED|Overall Study||18
7214|NCT02580318|17387|P1|NOT COMPLETED|Overall Study||0
7215|NCT02580318|17387|P1|COMPLETED|Overall Study||54
7216|NCT02580318|17387|P1|Drinking Water (5 Minutes)|Overall Study||54
7217|NCT02580318|17387|P1|Drinking Water (Immediate)|Overall Study||51
7218|NCT02580318|17387|P1|Hyperventilation (10 Minutes)|Overall Study||54
7219|NCT02580318|17387|P1|Hyperventilation (5 Minutes)|Overall Study||54
7220|NCT02580318|17387|P1|Hyperventilation (Immediate)|Overall Study||54
7221|NCT02580318|17387|P1|Poor Effort|Overall Study||53
7222|NCT02580318|17387|P1|STARTED|Overall Study||54
7223|NCT02580240|17393|P2|NOT COMPLETED|Overall Study||0
7224|NCT02580240|17394|P1|NOT COMPLETED|Overall Study||2
7225|NCT02580240|17393|P2|COMPLETED|Overall Study||58
7226|NCT02580240|17394|P1|COMPLETED|Overall Study||60
7227|NCT02580240|17393|P2|STARTED|Overall Study||58
7228|NCT02580240|17394|P1|STARTED|Overall Study||62
7229|NCT02579603|17404|P2|NOT COMPLETED|Overall Study||2
7230|NCT02579603|17405|P1|NOT COMPLETED|Overall Study||4
7231|NCT02579603|17404|P2|COMPLETED|Overall Study||51
7232|NCT02579603|17405|P1|COMPLETED|Overall Study||48
7233|NCT02579603|17404|P2|Number of Patients Treated|Overall Study||53
7234|NCT02579603|17405|P1|Number of Patients Treated|Overall Study||51
7235|NCT02579603|17404|P2|STARTED|Overall Study|Started are the randomised patients|53
7236|NCT02579603|17405|P1|STARTED|Overall Study|Started are the randomised patients|52
7237|NCT02579057|17416|P2|NOT COMPLETED|Overall Study||0
7238|NCT02579057|17417|P1|NOT COMPLETED|Overall Study||0
7239|NCT02579057|17416|P2|COMPLETED|Overall Study||21
7240|NCT02579057|17417|P1|COMPLETED|Overall Study||19
7241|NCT02579057|17416|P2|STARTED|Overall Study||21
7242|NCT02579057|17417|P1|STARTED|Overall Study||19
7243|NCT02578992|17431|P2|NOT COMPLETED|Overall Study||3
7244|NCT02578992|17432|P1|NOT COMPLETED|Overall Study||3
7245|NCT02578992|17431|P2|COMPLETED|Overall Study|October 2015|62
7246|NCT02578992|17432|P1|COMPLETED|Overall Study|October 2015|62
7247|NCT02578992|17431|P2|STARTED|Overall Study|November 2014|65
7248|NCT02578992|17432|P1|STARTED|Overall Study|November 2014|65
7249|NCT02578706|17447|P3|NOT COMPLETED|Overall Study||0
7250|NCT02578706|17448|P2|NOT COMPLETED|Overall Study||5
7251|NCT02578706|17449|P1|NOT COMPLETED|Overall Study||1
7252|NCT02578706|17447|P3|COMPLETED|Overall Study||8
7253|NCT02578706|17448|P2|COMPLETED|Overall Study||5
7254|NCT02578706|17449|P1|COMPLETED|Overall Study||8
7255|NCT02578706|17447|P3|STARTED|Overall Study||8
7256|NCT02578706|17448|P2|STARTED|Overall Study||10
7257|NCT02578706|17449|P1|STARTED|Overall Study||9
7258|NCT02578316|17526|P1|NOT COMPLETED|Extension Phase||6
7259|NCT02578316|17526|P1|COMPLETED|Extension Phase||0
7260|NCT02578316|17526|P1|STARTED|Extension Phase||6
7261|NCT02578316|17526|P1|NOT COMPLETED|Study Phase||0
7262|NCT02578316|17526|P1|COMPLETED|Study Phase||6
7263|NCT02578316|17526|P1|STARTED|Study Phase||6
7264|NCT02578199|17550|P1|NOT COMPLETED|Overall Study||4
7265|NCT02578199|17550|P1|COMPLETED|Overall Study||27
7266|NCT02578199|17550|P1|STARTED|Overall Study||31
7267|NCT02578186|17555|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
7268|NCT02578186|17556|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
7269|NCT02578186|17555|P2|COMPLETED|Period 2 (Second of Crossover)||13
7270|NCT02578186|17556|P1|COMPLETED|Period 2 (Second of Crossover)||12
7271|NCT02578186|17555|P2|STARTED|Period 2 (Second of Crossover)||13
7272|NCT02578186|17556|P1|STARTED|Period 2 (Second of Crossover)||12
7273|NCT02578186|17555|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
7274|NCT02578186|17556|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
7275|NCT02578186|17555|P2|COMPLETED|Period 1 (First of Crossover)||13
7276|NCT02578186|17556|P1|COMPLETED|Period 1 (First of Crossover)||12
7277|NCT02578186|17555|P2|STARTED|Period 1 (First of Crossover)||18
7278|NCT02578186|17556|P1|STARTED|Period 1 (First of Crossover)||17
7279|NCT02577718|17562|P1|NOT COMPLETED|Overall Study||8
7280|NCT02577718|17562|P1|COMPLETED|Overall Study||52
7281|NCT02577718|17562|P1|STARTED|Overall Study||60
7282|NCT02577510|17568|P2|NOT COMPLETED|Overall Study||0
7283|NCT02577510|17569|P1|NOT COMPLETED|Overall Study||0
7284|NCT02577510|17568|P2|COMPLETED|Overall Study||21
7285|NCT02577510|17569|P1|COMPLETED|Overall Study||21
7286|NCT02577510|17568|P2|STARTED|Overall Study||21
7287|NCT02577510|17569|P1|STARTED|Overall Study||21
7288|NCT02577445|17583|P2|NOT COMPLETED|Overall Study||17
7289|NCT02577445|17584|P1|NOT COMPLETED|Overall Study||14
7290|NCT02577445|17583|P2|COMPLETED|Overall Study|study terminated prematurely|0
7291|NCT02577445|17584|P1|COMPLETED|Overall Study|study terminated prematurely|0
7292|NCT02577445|17583|P2|STARTED|Overall Study||17
7293|NCT02577445|17584|P1|STARTED|Overall Study||14
7294|NCT02577315|17597|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7295|NCT02577315|17598|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7296|NCT02577315|17597|P2|COMPLETED|Treatment Period 2 (4 Days)||12
7297|NCT02577315|17598|P1|COMPLETED|Treatment Period 2 (4 Days)||12
7298|NCT02577315|17597|P2|STARTED|Treatment Period 2 (4 Days)||12
7299|NCT02577315|17598|P1|STARTED|Treatment Period 2 (4 Days)||12
7300|NCT02577315|17597|P2|NOT COMPLETED|Washout Period (5 Days)||0
7301|NCT02577315|17598|P1|NOT COMPLETED|Washout Period (5 Days)||0
7302|NCT02577315|17597|P2|COMPLETED|Washout Period (5 Days)||12
7303|NCT02577315|17598|P1|COMPLETED|Washout Period (5 Days)||12
7304|NCT02577315|17597|P2|STARTED|Washout Period (5 Days)||12
7305|NCT02577315|17598|P1|STARTED|Washout Period (5 Days)||12
7306|NCT02577315|17597|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
7307|NCT02577315|17598|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7308|NCT02577315|17597|P2|COMPLETED|Treatment Period 1 (4 Days)||12
7309|NCT02577315|17598|P1|COMPLETED|Treatment Period 1 (4 Days)||12
7310|NCT02577315|17597|P2|STARTED|Treatment Period 1 (4 Days)||13
7311|NCT02577315|17598|P1|STARTED|Treatment Period 1 (4 Days)||12
7312|NCT02577107|17616|P2|NOT COMPLETED|Overall Study||1
7313|NCT02577107|17617|P1|NOT COMPLETED|Overall Study||0
7314|NCT02577107|17616|P2|COMPLETED|Overall Study||5
7315|NCT02577107|17617|P1|COMPLETED|Overall Study||6
7316|NCT02577107|17616|P2|STARTED|Overall Study||6
7317|NCT02577107|17617|P1|STARTED|Overall Study||6
7318|NCT02577016|17631|P2|NOT COMPLETED|Overall Study||2
7319|NCT02577016|17632|P1|NOT COMPLETED|Overall Study||2
7320|NCT02577016|17631|P2|COMPLETED|Overall Study||69
7321|NCT02577016|17632|P1|COMPLETED|Overall Study||68
7322|NCT02577016|17631|P2|STARTED|Overall Study||71
7323|NCT02577016|17632|P1|STARTED|Overall Study||70
7324|NCT02577003|17650|P2|NOT COMPLETED|Overall Study||5
7325|NCT02577003|17651|P1|NOT COMPLETED|Overall Study||2
7326|NCT02577003|17650|P2|COMPLETED|Overall Study||65
7327|NCT02577003|17651|P1|COMPLETED|Overall Study||71
7328|NCT02577003|17650|P2|STARTED|Overall Study||70
7329|NCT02577003|17651|P1|STARTED|Overall Study||73
7330|NCT02576938|17672|P3|NOT COMPLETED|Overall Study||12
7331|NCT02576938|17673|P2|NOT COMPLETED|Overall Study||12
7332|NCT02576938|17674|P1|NOT COMPLETED|Overall Study||20
7333|NCT02576938|17672|P3|COMPLETED|Overall Study||26
7334|NCT02576938|17673|P2|COMPLETED|Overall Study||25
7335|NCT02576938|17674|P1|COMPLETED|Overall Study||29
7336|NCT02576938|17672|P3|Received at Least One Dose of Study Drug|Overall Study||38
7337|NCT02576938|17673|P2|Received at Least One Dose of Study Drug|Overall Study||37
7338|NCT02576938|17674|P1|Received at Least One Dose of Study Drug|Overall Study||49
7339|NCT02576938|17672|P3|STARTED|Overall Study||38
7340|NCT02576938|17673|P2|STARTED|Overall Study||37
7341|NCT02576938|17674|P1|STARTED|Overall Study||49
7342|NCT02576639|17707|P5|NOT COMPLETED|Overall Study||4
7343|NCT02576639|17708|P4|NOT COMPLETED|Overall Study||1
7344|NCT02576639|17709|P3|NOT COMPLETED|Overall Study||2
7345|NCT02576639|17710|P2|NOT COMPLETED|Overall Study||2
7346|NCT02576639|17711|P1|NOT COMPLETED|Overall Study||2
7347|NCT02576639|17707|P5|COMPLETED|Overall Study||20
7348|NCT02576639|17708|P4|COMPLETED|Overall Study||25
7349|NCT02576639|17709|P3|COMPLETED|Overall Study||23
7350|NCT02576639|17710|P2|COMPLETED|Overall Study||23
7351|NCT02576639|17711|P1|COMPLETED|Overall Study||22
7352|NCT02576639|17707|P5|Safety Analysis Set|Overall Study||24
7353|NCT02576639|17708|P4|Safety Analysis Set|Overall Study||26
7354|NCT02576639|17709|P3|Safety Analysis Set|Overall Study||25
7355|NCT02576639|17710|P2|Safety Analysis Set|Overall Study||25
7356|NCT02576639|17711|P1|Safety Analysis Set|Overall Study||24
7357|NCT02576639|17707|P5|Pharmacokinetic Analysis Set|Overall Study||24
7358|NCT02576639|17708|P4|Pharmacokinetic Analysis Set|Overall Study||26
7359|NCT02576639|17709|P3|Pharmacokinetic Analysis Set|Overall Study||25
7360|NCT02576639|17710|P2|Pharmacokinetic Analysis Set|Overall Study||25
7361|NCT02576639|17711|P1|Pharmacokinetic Analysis Set|Overall Study||0
7362|NCT02576639|17707|P5|Pharmacodynamic Analysis Set|Overall Study||25
7363|NCT02576639|17708|P4|Pharmacodynamic Analysis Set|Overall Study||25
7364|NCT02576639|17709|P3|Pharmacodynamic Analysis Set|Overall Study||25
7365|NCT02576639|17710|P2|Pharmacodynamic Analysis Set|Overall Study||24
7366|NCT02576639|17711|P1|Pharmacodynamic Analysis Set|Overall Study||24
7367|NCT02576639|17707|P5|STARTED|Overall Study||24
7368|NCT02576639|17708|P4|STARTED|Overall Study||26
7369|NCT02576639|17709|P3|STARTED|Overall Study||25
7370|NCT02576639|17710|P2|STARTED|Overall Study||25
7371|NCT02576639|17711|P1|STARTED|Overall Study||24
7372|NCT02576535|17768|P1|NOT COMPLETED|Overall Study||2
7373|NCT02576535|17768|P1|COMPLETED|Overall Study||16
7374|NCT02576535|17768|P1|STARTED|Overall Study||18
7375|NCT02576249|17779|P2|NOT COMPLETED|Overall Study||0
7376|NCT02576249|17780|P1|NOT COMPLETED|Overall Study||0
7377|NCT02576249|17779|P2|COMPLETED|Overall Study||14
7378|NCT02576249|17780|P1|COMPLETED|Overall Study||15
7379|NCT02576249|17779|P2|STARTED|Overall Study||14
7380|NCT02576249|17780|P1|STARTED|Overall Study||15
7381|NCT02576145|17792|P2|NOT COMPLETED|Overall Study||1
7382|NCT02576145|17793|P1|NOT COMPLETED|Overall Study||3
7383|NCT02576145|17792|P2|COMPLETED|Overall Study||4
7384|NCT02576145|17793|P1|COMPLETED|Overall Study||3
7385|NCT02576145|17792|P2|STARTED|Overall Study||5
7386|NCT02576145|17793|P1|STARTED|Overall Study||6
7387|NCT02576041|17829|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
7388|NCT02576041|17829|P1|COMPLETED|Bilastine (Active Treatement)||18
7389|NCT02576041|17829|P1|STARTED|Bilastine (Active Treatement)||18
7390|NCT02576041|17829|P1|NOT COMPLETED|Placebo (run-in)||0
7391|NCT02576041|17829|P1|COMPLETED|Placebo (run-in)||18
7392|NCT02576041|17829|P1|STARTED|Placebo (run-in)||18
7393|NCT02575911|17835|P1|NOT COMPLETED|Overall Study||1
7394|NCT02575911|17835|P1|COMPLETED|Overall Study||29
7395|NCT02575911|17835|P1|STARTED|Overall Study||30
7396|NCT02574858|17853|P1|NOT COMPLETED|Overall Study||0
7397|NCT02574858|17853|P1|COMPLETED|Overall Study||25
7398|NCT02574858|17853|P1|STARTED|Overall Study||25
7399|NCT02574845|17864|P6|NOT COMPLETED|Overall Study||1
7400|NCT02574845|17865|P5|NOT COMPLETED|Overall Study||1
7401|NCT02574845|17866|P4|NOT COMPLETED|Overall Study||0
7402|NCT02574845|17867|P3|NOT COMPLETED|Overall Study||0
7403|NCT02574845|17868|P2|NOT COMPLETED|Overall Study||1
7404|NCT02574845|17869|P1|NOT COMPLETED|Overall Study||0
7405|NCT02574845|17864|P6|COMPLETED|Overall Study||2
7406|NCT02574845|17865|P5|COMPLETED|Overall Study||2
7407|NCT02574845|17866|P4|COMPLETED|Overall Study||3
7408|NCT02574845|17867|P3|COMPLETED|Overall Study||3
7409|NCT02574845|17868|P2|COMPLETED|Overall Study||2
7410|NCT02574845|17869|P1|COMPLETED|Overall Study||3
7411|NCT02574845|17864|P6|Received R|Overall Study||3
7412|NCT02574845|17865|P5|Received R|Overall Study||2
7413|NCT02574845|17866|P4|Received R|Overall Study||3
7414|NCT02574845|17867|P3|Received R|Overall Study||3
7415|NCT02574845|17868|P2|Received R|Overall Study||2
7416|NCT02574845|17869|P1|Received R|Overall Study||3
7417|NCT02574845|17864|P6|Received T5|Overall Study||2
7418|NCT02574845|17865|P5|Received T5|Overall Study||3
7419|NCT02574845|17866|P4|Received T5|Overall Study||3
7420|NCT02574845|17867|P3|Received T5|Overall Study||3
7421|NCT02574845|17868|P2|Received T5|Overall Study||2
7422|NCT02574845|17869|P1|Received T5|Overall Study||3
7423|NCT02574845|17864|P6|Received T4|Overall Study||2
7424|NCT02574845|17865|P5|Received T4|Overall Study||2
7425|NCT02574845|17866|P4|Received T4|Overall Study||3
7426|NCT02574845|17867|P3|Received T4|Overall Study||3
7427|NCT02574845|17868|P2|Received T4|Overall Study||2
7428|NCT02574845|17869|P1|Received T4|Overall Study||3
7429|NCT02574845|17864|P6|Received T3|Overall Study||3
7430|NCT02574845|17865|P5|Received T3|Overall Study||2
7431|NCT02574845|17866|P4|Received T3|Overall Study||3
7432|NCT02574845|17867|P3|Received T3|Overall Study||3
7433|NCT02574845|17868|P2|Received T3|Overall Study||2
7434|NCT02574845|17869|P1|Received T3|Overall Study|one subject missed treatment period 2|2
7435|NCT02574845|17864|P6|Received T2|Overall Study||3
7436|NCT02574845|17865|P5|Received T2|Overall Study||2
7437|NCT02574845|17866|P4|Received T2|Overall Study||3
7438|NCT02574845|17867|P3|Received T2|Overall Study||3
7439|NCT02574845|17868|P2|Received T2|Overall Study||3
7440|NCT02574845|17869|P1|Received T2|Overall Study||3
7441|NCT02574845|17864|P6|Received T1|Overall Study|one subject missed treatment period 2|2
7442|NCT02574845|17865|P5|Received T1|Overall Study||2
7443|NCT02574845|17866|P4|Received T1|Overall Study||3
7444|NCT02574845|17867|P3|Received T1|Overall Study||3
7445|NCT02574845|17868|P2|Received T1|Overall Study||2
7446|NCT02574845|17869|P1|Received T1|Overall Study||3
7447|NCT02574845|17864|P6|STARTED|Overall Study||3
7448|NCT02574845|17865|P5|STARTED|Overall Study||3
7449|NCT02574845|17866|P4|STARTED|Overall Study||3
7450|NCT02574845|17867|P3|STARTED|Overall Study||3
7451|NCT02574845|17868|P2|STARTED|Overall Study||3
7452|NCT02574845|17869|P1|STARTED|Overall Study||3
7453|NCT02574832|17895|P1|NOT COMPLETED|Overall Study||0
7454|NCT02574832|17895|P1|COMPLETED|Overall Study||2
7455|NCT02574832|17895|P1|STARTED|Overall Study||2
7456|NCT02574260|17899|P1|NOT COMPLETED|Overall Study||1
7457|NCT02574260|17899|P1|COMPLETED|Overall Study||2
7458|NCT02574260|17899|P1|STARTED|Overall Study||3
7459|NCT02574247|17908|P3|NOT COMPLETED|Overall Study||5
7460|NCT02574247|17909|P2|NOT COMPLETED|Overall Study||3
7461|NCT02574247|17910|P1|NOT COMPLETED|Overall Study||5
7462|NCT02574247|17908|P3|COMPLETED|Overall Study||5
7463|NCT02574247|17909|P2|COMPLETED|Overall Study||5
7464|NCT02574247|17910|P1|COMPLETED|Overall Study||5
7465|NCT02574247|17908|P3|STARTED|Overall Study||10
7466|NCT02574247|17909|P2|STARTED|Overall Study||8
7467|NCT02574247|17910|P1|STARTED|Overall Study||10
7468|NCT02573870|17924|P2|NOT COMPLETED|Overall Study||7
7469|NCT02573870|17925|P1|NOT COMPLETED|Overall Study||0
7470|NCT02573870|17924|P2|COMPLETED|Overall Study||35
7471|NCT02573870|17925|P1|COMPLETED|Overall Study||20
7472|NCT02573870|17924|P2|STARTED|Overall Study||42
7473|NCT02573870|17925|P1|STARTED|Overall Study||20
7474|NCT02573467|17935|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
7475|NCT02573467|17936|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
7476|NCT02573467|17937|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
7477|NCT02573467|17938|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
7478|NCT02573467|17935|P4|COMPLETED|Post-treatment Follow up Epoch||44
7479|NCT02573467|17936|P3|COMPLETED|Post-treatment Follow up Epoch||34
7480|NCT02573467|17937|P2|COMPLETED|Post-treatment Follow up Epoch||41
7481|NCT02573467|17938|P1|COMPLETED|Post-treatment Follow up Epoch||35
7482|NCT02573467|17935|P4|STARTED|Post-treatment Follow up Epoch||47
7483|NCT02573467|17936|P3|STARTED|Post-treatment Follow up Epoch||44
7484|NCT02573467|17937|P2|STARTED|Post-treatment Follow up Epoch||46
7485|NCT02573467|17938|P1|STARTED|Post-treatment Follow up Epoch||41
7486|NCT02573467|17935|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
7487|NCT02573467|17936|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
7488|NCT02573467|17937|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
7489|NCT02573467|17938|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
7490|NCT02573467|17935|P4|COMPLETED|Double-blind Treatment Epoch||0
7491|NCT02573467|17936|P3|COMPLETED|Double-blind Treatment Epoch||0
7492|NCT02573467|17937|P2|COMPLETED|Double-blind Treatment Epoch||0
7493|NCT02573467|17938|P1|COMPLETED|Double-blind Treatment Epoch||0
7494|NCT02573467|17935|P4|Full Analysis Set|Double-blind Treatment Epoch||55
7495|NCT02573467|17936|P3|Full Analysis Set|Double-blind Treatment Epoch||51
7496|NCT02573467|17937|P2|Full Analysis Set|Double-blind Treatment Epoch||52
7497|NCT02573467|17938|P1|Full Analysis Set|Double-blind Treatment Epoch||53
7498|NCT02573467|17935|P4|STARTED|Double-blind Treatment Epoch||55
7499|NCT02573467|17936|P3|STARTED|Double-blind Treatment Epoch||51
7500|NCT02573467|17937|P2|STARTED|Double-blind Treatment Epoch||52
7501|NCT02573467|17938|P1|STARTED|Double-blind Treatment Epoch||53
7502|NCT02572752|17980|P3|NOT COMPLETED|Period 3 Including Washout||0
7503|NCT02572752|17981|P2|NOT COMPLETED|Period 3 Including Washout||0
7504|NCT02572752|17982|P1|NOT COMPLETED|Period 3 Including Washout||0
7505|NCT02572752|17980|P3|COMPLETED|Period 3 Including Washout||24
7506|NCT02572752|17981|P2|COMPLETED|Period 3 Including Washout||23
7507|NCT02572752|17982|P1|COMPLETED|Period 3 Including Washout||23
7508|NCT02572752|17980|P3|STARTED|Period 3 Including Washout||24
7509|NCT02572752|17981|P2|STARTED|Period 3 Including Washout||23
7510|NCT02572752|17982|P1|STARTED|Period 3 Including Washout||23
7511|NCT02572752|17980|P3|NOT COMPLETED|Period 2 Including Washout||0
7512|NCT02572752|17981|P2|NOT COMPLETED|Period 2 Including Washout||0
7513|NCT02572752|17982|P1|NOT COMPLETED|Period 2 Including Washout||0
7514|NCT02572752|17980|P3|COMPLETED|Period 2 Including Washout||24
7515|NCT02572752|17981|P2|COMPLETED|Period 2 Including Washout||23
7516|NCT02572752|17982|P1|COMPLETED|Period 2 Including Washout||23
7517|NCT02572752|17980|P3|STARTED|Period 2 Including Washout||24
7518|NCT02572752|17981|P2|STARTED|Period 2 Including Washout||23
7519|NCT02572752|17982|P1|STARTED|Period 2 Including Washout||23
7520|NCT02572752|17980|P3|NOT COMPLETED|Period 1 Including Washout||0
7521|NCT02572752|17981|P2|NOT COMPLETED|Period 1 Including Washout||0
7522|NCT02572752|17982|P1|NOT COMPLETED|Period 1 Including Washout||0
7523|NCT02572752|17980|P3|COMPLETED|Period 1 Including Washout||24
7524|NCT02572752|17981|P2|COMPLETED|Period 1 Including Washout||23
7525|NCT02572752|17982|P1|COMPLETED|Period 1 Including Washout||23
7526|NCT02572752|17980|P3|STARTED|Period 1 Including Washout||24
7527|NCT02572752|17981|P2|STARTED|Period 1 Including Washout||23
7528|NCT02572752|17982|P1|STARTED|Period 1 Including Washout||23
7529|NCT02572609|17997|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
7530|NCT02572609|17998|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
7531|NCT02572609|17997|P2|COMPLETED|Period 2: Treatment Period 2||18
7532|NCT02572609|17998|P1|COMPLETED|Period 2: Treatment Period 2||18
7533|NCT02572609|17997|P2|STARTED|Period 2: Treatment Period 2||18
7534|NCT02572609|17998|P1|STARTED|Period 2: Treatment Period 2||18
7535|NCT02572609|17997|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
7536|NCT02572609|17998|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
7537|NCT02572609|17997|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
7538|NCT02572609|17998|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
7539|NCT02572609|17997|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
7540|NCT02572609|17998|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
7541|NCT02572427|18008|P2|NOT COMPLETED|Overall Study||9
7542|NCT02572427|18009|P1|NOT COMPLETED|Overall Study||6
7543|NCT02572427|18008|P2|COMPLETED|Overall Study||36
7544|NCT02572427|18009|P1|COMPLETED|Overall Study||31
7545|NCT02572427|18008|P2|STARTED|Overall Study||45
7546|NCT02572427|18009|P1|STARTED|Overall Study||37
7547|NCT02571634|18017|P1|NOT COMPLETED|Overall Study||0
7548|NCT02571634|18017|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
7549|NCT02571634|18017|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
7550|NCT02571153|18028|P3|NOT COMPLETED|Overall Study||2
7551|NCT02571153|18029|P2|NOT COMPLETED|Overall Study||8
7552|NCT02571153|18030|P1|NOT COMPLETED|Overall Study||6
7553|NCT02571153|18028|P3|COMPLETED|Overall Study||43
7554|NCT02571153|18029|P2|COMPLETED|Overall Study||37
7555|NCT02571153|18030|P1|COMPLETED|Overall Study||39
7556|NCT02571153|18028|P3|STARTED|Overall Study||45
7557|NCT02571153|18029|P2|STARTED|Overall Study||45
7558|NCT02571153|18030|P1|STARTED|Overall Study||45
7559|NCT02570425|18058|P2|NOT COMPLETED|Visit 3||0
7560|NCT02570425|18059|P1|NOT COMPLETED|Visit 3||0
7561|NCT02570425|18058|P2|COMPLETED|Visit 3||231
7562|NCT02570425|18059|P1|COMPLETED|Visit 3||229
7563|NCT02570425|18058|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
7564|NCT02570425|18059|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
7565|NCT02570425|18058|P2|NOT COMPLETED|Visit 2||0
7566|NCT02570425|18059|P1|NOT COMPLETED|Visit 2||0
7567|NCT02570425|18058|P2|COMPLETED|Visit 2||247
7568|NCT02570425|18059|P1|COMPLETED|Visit 2||251
7569|NCT02570425|18058|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
7570|NCT02570425|18059|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
7571|NCT02570425|18058|P2|NOT COMPLETED|Visit 1||0
7572|NCT02570425|18059|P1|NOT COMPLETED|Visit 1||0
7573|NCT02570425|18058|P2|COMPLETED|Visit 1||242
7574|NCT02570425|18059|P1|COMPLETED|Visit 1||274
7575|NCT02570425|18058|P2|STARTED|Visit 1||242
7576|NCT02570425|18059|P1|STARTED|Visit 1||274
7577|NCT02570295|18108|P2|NOT COMPLETED|Overall Study||58
7578|NCT02570295|18109|P1|NOT COMPLETED|Overall Study||11
7579|NCT02570295|18108|P2|COMPLETED|Overall Study||289
7580|NCT02570295|18109|P1|COMPLETED|Overall Study||364
7581|NCT02570295|18108|P2|STARTED|Overall Study||347
7582|NCT02570295|18109|P1|STARTED|Overall Study||375
7583|NCT02570165|18138|P7|NOT COMPLETED|Overall Study||0
7584|NCT02570165|18139|P6|NOT COMPLETED|Overall Study||2
7585|NCT02570165|18140|P5|NOT COMPLETED|Overall Study||6
7586|NCT02570165|18141|P4|NOT COMPLETED|Overall Study||5
7587|NCT02570165|18142|P3|NOT COMPLETED|Overall Study||5
7588|NCT02570165|18143|P2|NOT COMPLETED|Overall Study||3
7589|NCT02570165|18144|P1|NOT COMPLETED|Overall Study||2
7590|NCT02570165|18138|P7|COMPLETED|Overall Study||47
7591|NCT02570165|18139|P6|COMPLETED|Overall Study||44
7592|NCT02570165|18140|P5|COMPLETED|Overall Study||41
7593|NCT02570165|18141|P4|COMPLETED|Overall Study||40
7594|NCT02570165|18142|P3|COMPLETED|Overall Study||41
7595|NCT02570165|18143|P2|COMPLETED|Overall Study||43
7596|NCT02570165|18144|P1|COMPLETED|Overall Study||44
7597|NCT02570165|18138|P7|STARTED|Overall Study||47
7598|NCT02570165|18139|P6|STARTED|Overall Study||46
7599|NCT02570165|18140|P5|STARTED|Overall Study||47
7600|NCT02570165|18141|P4|STARTED|Overall Study||45
7601|NCT02570165|18142|P3|STARTED|Overall Study||46
7602|NCT02570165|18143|P2|STARTED|Overall Study||46
7603|NCT02570165|18144|P1|STARTED|Overall Study||46
7604|NCT02570126|18169|P2|NOT COMPLETED|Overall Study||9
7605|NCT02570126|18170|P1|NOT COMPLETED|Overall Study||6
7606|NCT02570126|18169|P2|COMPLETED|Overall Study||607
7607|NCT02570126|18170|P1|COMPLETED|Overall Study||609
7608|NCT02570126|18169|P2|STARTED|Overall Study||616
7609|NCT02570126|18170|P1|STARTED|Overall Study||615
7610|NCT02570022|18196|P2|NOT COMPLETED|Overall Study||0
7611|NCT02570022|18197|P1|NOT COMPLETED|Overall Study||0
7612|NCT02570022|18196|P2|COMPLETED|Overall Study||31
7613|NCT02570022|18197|P1|COMPLETED|Overall Study||26
7614|NCT02570022|18196|P2|STARTED|Overall Study||31
7615|NCT02570022|18197|P1|STARTED|Overall Study||26
7616|NCT02569996|18205|P1|NOT COMPLETED|Overall Study||55
7617|NCT02569996|18205|P1|COMPLETED|Overall Study||69
7618|NCT02569996|18205|P1|STARTED|Overall Study||124
7619|NCT02569957|18217|P2|NOT COMPLETED|Overall Study||1
7620|NCT02569957|18218|P1|NOT COMPLETED|Overall Study||0
7621|NCT02569957|18217|P2|COMPLETED|Overall Study||0
7622|NCT02569957|18218|P1|COMPLETED|Overall Study||0
7623|NCT02569957|18217|P2|STARTED|Overall Study||1
7624|NCT02569957|18218|P1|STARTED|Overall Study||0
7625|NCT02569658|18250|P2|NOT COMPLETED|Overall Study||1
7626|NCT02569658|18251|P1|NOT COMPLETED|Overall Study||1
7627|NCT02569658|18250|P2|COMPLETED|Overall Study||56
7628|NCT02569658|18251|P1|COMPLETED|Overall Study||52
7629|NCT02569658|18250|P2|STARTED|Overall Study||57
7630|NCT02569658|18251|P1|STARTED|Overall Study||53
7631|NCT02569437|18269|P2|NOT COMPLETED|Overall Study||14
7632|NCT02569437|18270|P1|NOT COMPLETED|Overall Study||12
7633|NCT02569437|18269|P2|COMPLETED|Overall Study||11
7634|NCT02569437|18270|P1|COMPLETED|Overall Study||12
7635|NCT02569437|18269|P2|STARTED|Overall Study||25
7636|NCT02569437|18270|P1|STARTED|Overall Study||24
7637|NCT02569086|18284|P1|NOT COMPLETED|Overall Study||0
7638|NCT02569086|18284|P1|COMPLETED|Overall Study||22
7639|NCT02569086|18284|P1|STARTED|Overall Study||22
7640|NCT02568852|18291|P2|NOT COMPLETED|Overall Study||0
7641|NCT02568852|18292|P1|NOT COMPLETED|Overall Study||0
7642|NCT02568852|18291|P2|COMPLETED|Overall Study||25
7643|NCT02568852|18292|P1|COMPLETED|Overall Study||25
7644|NCT02568852|18291|P2|STARTED|Overall Study||25
7645|NCT02568852|18292|P1|STARTED|Overall Study||25
7646|NCT02568384|18328|P1|NOT COMPLETED|Overall Study||2
7647|NCT02568384|18328|P1|COMPLETED|Overall Study||43
7648|NCT02568384|18328|P1|STARTED|Overall Study||45
7649|NCT02568345|18338|P1|NOT COMPLETED|Overall Study||0
7650|NCT02568345|18338|P1|COMPLETED|Overall Study||31
7651|NCT02568345|18338|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
7652|NCT02568345|18338|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
7653|NCT02568345|18338|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
7654|NCT02568345|18338|P1|STARTED|Overall Study||31
7655|NCT02568254|18342|P6|NOT COMPLETED|Period 3||0
7656|NCT02568254|18343|P5|NOT COMPLETED|Period 3||1
7657|NCT02568254|18344|P4|NOT COMPLETED|Period 3||0
7658|NCT02568254|18345|P3|NOT COMPLETED|Period 3||0
7659|NCT02568254|18346|P2|NOT COMPLETED|Period 3||0
7660|NCT02568254|18347|P1|NOT COMPLETED|Period 3||0
7661|NCT02568254|18342|P6|COMPLETED|Period 3||12
7662|NCT02568254|18343|P5|COMPLETED|Period 3||11
7663|NCT02568254|18344|P4|COMPLETED|Period 3||12
7664|NCT02568254|18345|P3|COMPLETED|Period 3||12
7665|NCT02568254|18346|P2|COMPLETED|Period 3||12
7666|NCT02568254|18347|P1|COMPLETED|Period 3||13
7667|NCT02568254|18342|P6|STARTED|Period 3||12
7668|NCT02568254|18343|P5|STARTED|Period 3||12
7669|NCT02568254|18344|P4|STARTED|Period 3||12
7670|NCT02568254|18345|P3|STARTED|Period 3||12
7671|NCT02568254|18346|P2|STARTED|Period 3||12
7672|NCT02568254|18347|P1|STARTED|Period 3||13
7673|NCT02568254|18342|P6|NOT COMPLETED|Period 2||0
7674|NCT02568254|18343|P5|NOT COMPLETED|Period 2||0
7675|NCT02568254|18344|P4|NOT COMPLETED|Period 2||0
7676|NCT02568254|18345|P3|NOT COMPLETED|Period 2||1
7677|NCT02568254|18346|P2|NOT COMPLETED|Period 2||0
7678|NCT02568254|18347|P1|NOT COMPLETED|Period 2||0
7679|NCT02568254|18342|P6|COMPLETED|Period 2||12
7680|NCT02568254|18343|P5|COMPLETED|Period 2||12
7681|NCT02568254|18344|P4|COMPLETED|Period 2||12
7682|NCT02568254|18345|P3|COMPLETED|Period 2||12
7683|NCT02568254|18346|P2|COMPLETED|Period 2||12
7684|NCT02568254|18347|P1|COMPLETED|Period 2||13
7685|NCT02568254|18342|P6|STARTED|Period 2||12
7686|NCT02568254|18343|P5|STARTED|Period 2||12
7687|NCT02568254|18344|P4|STARTED|Period 2||12
7688|NCT02568254|18345|P3|STARTED|Period 2||13
7689|NCT02568254|18346|P2|STARTED|Period 2||12
7690|NCT02568254|18347|P1|STARTED|Period 2||13
7691|NCT02568254|18342|P6|NOT COMPLETED|Period 1||0
7692|NCT02568254|18343|P5|NOT COMPLETED|Period 1||0
7693|NCT02568254|18344|P4|NOT COMPLETED|Period 1||0
7694|NCT02568254|18345|P3|NOT COMPLETED|Period 1||0
7695|NCT02568254|18346|P2|NOT COMPLETED|Period 1||0
7696|NCT02568254|18347|P1|NOT COMPLETED|Period 1||0
7697|NCT02568254|18342|P6|COMPLETED|Period 1||12
7698|NCT02568254|18343|P5|COMPLETED|Period 1||12
7699|NCT02568254|18344|P4|COMPLETED|Period 1||12
7700|NCT02568254|18345|P3|COMPLETED|Period 1||13
7701|NCT02568254|18346|P2|COMPLETED|Period 1||12
7702|NCT02568254|18347|P1|COMPLETED|Period 1||13
7703|NCT02568254|18342|P6|STARTED|Period 1||12
7704|NCT02568254|18343|P5|STARTED|Period 1||12
7705|NCT02568254|18344|P4|STARTED|Period 1||12
7706|NCT02568254|18345|P3|STARTED|Period 1||13
7707|NCT02568254|18346|P2|STARTED|Period 1||12
7708|NCT02568254|18347|P1|STARTED|Period 1||13
7709|NCT02567552|18357|P2|NOT COMPLETED|Overall Study||1
7710|NCT02567552|18358|P1|NOT COMPLETED|Overall Study||0
7711|NCT02567552|18357|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
7712|NCT02567552|18358|P1|COMPLETED|Overall Study||12
7713|NCT02567552|18357|P2|STARTED|Overall Study||12
7714|NCT02567552|18358|P1|STARTED|Overall Study||12
7715|NCT02567188|18388|P1|NOT COMPLETED|Overall Study||35
7716|NCT02567188|18388|P1|COMPLETED|Overall Study||109
7717|NCT02567188|18388|P1|STARTED|Overall Study||144
7718|NCT02566759|18434|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7719|NCT02566759|18435|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7720|NCT02566759|18436|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7721|NCT02566759|18437|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7722|NCT02566759|18438|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7723|NCT02566759|18439|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7724|NCT02566759|18440|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7725|NCT02566759|18441|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7726|NCT02566759|18442|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8041|NCT02563899|19242|P1|NOT COMPLETED|Overall Study||1
7727|NCT02566759|18443|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7728|NCT02566759|18444|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7729|NCT02566759|18445|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7730|NCT02566759|18446|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7731|NCT02566759|18447|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7732|NCT02566759|18448|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7733|NCT02566759|18449|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7734|NCT02566759|18450|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7735|NCT02566759|18434|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
7736|NCT02566759|18435|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7737|NCT02566759|18436|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7738|NCT02566759|18437|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7739|NCT02566759|18438|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7740|NCT02566759|18439|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7741|NCT02566759|18440|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7742|NCT02566759|18441|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7743|NCT02566759|18442|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7744|NCT02566759|18443|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7745|NCT02566759|18444|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7746|NCT02566759|18445|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7747|NCT02566759|18446|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7748|NCT02566759|18447|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7749|NCT02566759|18448|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7750|NCT02566759|18449|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7751|NCT02566759|18450|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7752|NCT02566759|18434|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
7753|NCT02566759|18435|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7754|NCT02566759|18436|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7755|NCT02566759|18437|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7756|NCT02566759|18438|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7757|NCT02566759|18439|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7758|NCT02566759|18440|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7759|NCT02566759|18441|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7760|NCT02566759|18442|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7761|NCT02566759|18443|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7762|NCT02566759|18444|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7763|NCT02566759|18445|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7764|NCT02566759|18446|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7765|NCT02566759|18447|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7766|NCT02566759|18448|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7767|NCT02566759|18449|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7768|NCT02566759|18450|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7769|NCT02566759|18434|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7770|NCT02566759|18435|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7771|NCT02566759|18436|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7772|NCT02566759|18437|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7773|NCT02566759|18438|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7774|NCT02566759|18439|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7775|NCT02566759|18440|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7776|NCT02566759|18441|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7777|NCT02566759|18442|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7778|NCT02566759|18443|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7779|NCT02566759|18444|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7780|NCT02566759|18445|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7781|NCT02566759|18446|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7782|NCT02566759|18447|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7783|NCT02566759|18448|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7784|NCT02566759|18449|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7785|NCT02566759|18450|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7786|NCT02566759|18434|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
7787|NCT02566759|18435|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7788|NCT02566759|18436|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7789|NCT02566759|18437|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7790|NCT02566759|18438|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7791|NCT02566759|18439|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7792|NCT02566759|18440|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7793|NCT02566759|18441|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7794|NCT02566759|18442|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7795|NCT02566759|18443|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7796|NCT02566759|18444|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7797|NCT02566759|18445|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7798|NCT02566759|18446|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7799|NCT02566759|18447|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7800|NCT02566759|18448|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7801|NCT02566759|18449|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7802|NCT02566759|18450|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7803|NCT02566759|18434|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
7804|NCT02566759|18435|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7805|NCT02566759|18436|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7806|NCT02566759|18437|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7807|NCT02566759|18438|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7808|NCT02566759|18439|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7809|NCT02566759|18440|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7810|NCT02566759|18441|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7811|NCT02566759|18442|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7812|NCT02566759|18443|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7813|NCT02566759|18444|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7814|NCT02566759|18445|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7815|NCT02566759|18446|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7816|NCT02566759|18447|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7817|NCT02566759|18448|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7818|NCT02566759|18449|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7819|NCT02566759|18450|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7820|NCT02566759|18434|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
7821|NCT02566759|18435|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7822|NCT02566759|18436|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7823|NCT02566759|18437|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7824|NCT02566759|18438|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7825|NCT02566759|18439|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7826|NCT02566759|18440|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7827|NCT02566759|18441|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7828|NCT02566759|18442|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7829|NCT02566759|18443|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7830|NCT02566759|18444|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7831|NCT02566759|18445|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7832|NCT02566759|18446|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7833|NCT02566759|18447|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7834|NCT02566759|18448|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7835|NCT02566759|18449|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7836|NCT02566759|18450|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7837|NCT02566759|18434|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
7838|NCT02566759|18435|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7839|NCT02566759|18436|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7840|NCT02566759|18437|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7841|NCT02566759|18438|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7842|NCT02566759|18439|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7843|NCT02566759|18440|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7844|NCT02566759|18441|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7845|NCT02566759|18442|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7846|NCT02566759|18443|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7847|NCT02566759|18444|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7848|NCT02566759|18445|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7849|NCT02566759|18446|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7850|NCT02566759|18447|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7851|NCT02566759|18448|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7852|NCT02566759|18449|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7853|NCT02566759|18450|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7854|NCT02566759|18434|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7855|NCT02566759|18435|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7856|NCT02566759|18436|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7857|NCT02566759|18437|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7858|NCT02566759|18438|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7859|NCT02566759|18439|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7860|NCT02566759|18440|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7861|NCT02566759|18441|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7862|NCT02566759|18442|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7863|NCT02566759|18443|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7864|NCT02566759|18444|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7865|NCT02566759|18445|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7866|NCT02566759|18446|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7867|NCT02566759|18447|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7868|NCT02566759|18448|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7869|NCT02566759|18449|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7870|NCT02566759|18450|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7871|NCT02566759|18434|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7872|NCT02566759|18435|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7873|NCT02566759|18436|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7874|NCT02566759|18437|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7875|NCT02566759|18438|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7876|NCT02566759|18439|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7877|NCT02566759|18440|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7878|NCT02566759|18441|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7879|NCT02566759|18442|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7880|NCT02566759|18443|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7881|NCT02566759|18444|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7882|NCT02566759|18445|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7883|NCT02566759|18446|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7884|NCT02566759|18447|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7885|NCT02566759|18448|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7886|NCT02566759|18449|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7887|NCT02566759|18450|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7888|NCT02566759|18434|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7889|NCT02566759|18435|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7890|NCT02566759|18436|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7891|NCT02566759|18437|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7892|NCT02566759|18438|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7893|NCT02566759|18439|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7894|NCT02566759|18440|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7895|NCT02566759|18441|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7896|NCT02566759|18442|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7897|NCT02566759|18443|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7898|NCT02566759|18444|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7899|NCT02566759|18445|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7900|NCT02566759|18446|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7901|NCT02566759|18447|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7902|NCT02566759|18448|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7903|NCT02566759|18449|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7904|NCT02566759|18450|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7905|NCT02566759|18434|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7906|NCT02566759|18435|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7907|NCT02566759|18436|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7908|NCT02566759|18437|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7909|NCT02566759|18438|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7910|NCT02566759|18439|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7911|NCT02566759|18440|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7912|NCT02566759|18441|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7913|NCT02566759|18442|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7914|NCT02566759|18443|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7915|NCT02566759|18444|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7916|NCT02566759|18445|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7917|NCT02566759|18446|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7918|NCT02566759|18447|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7919|NCT02566759|18448|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7920|NCT02566759|18449|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7921|NCT02566759|18450|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7922|NCT02566759|18434|P17|NOT COMPLETED|All Parts||0
7923|NCT02566759|18435|P16|NOT COMPLETED|All Parts||0
7924|NCT02566759|18436|P15|NOT COMPLETED|All Parts||0
7925|NCT02566759|18437|P14|NOT COMPLETED|All Parts||5
7926|NCT02566759|18438|P13|NOT COMPLETED|All Parts||1
7927|NCT02566759|18439|P12|NOT COMPLETED|All Parts||0
7928|NCT02566759|18440|P11|NOT COMPLETED|All Parts||0
7929|NCT02566759|18441|P10|NOT COMPLETED|All Parts||0
7930|NCT02566759|18442|P9|NOT COMPLETED|All Parts||0
7931|NCT02566759|18443|P8|NOT COMPLETED|All Parts||0
7932|NCT02566759|18444|P7|NOT COMPLETED|All Parts||0
7933|NCT02566759|18445|P6|NOT COMPLETED|All Parts||0
7934|NCT02566759|18446|P5|NOT COMPLETED|All Parts||0
7935|NCT02566759|18447|P4|NOT COMPLETED|All Parts||0
7936|NCT02566759|18448|P3|NOT COMPLETED|All Parts||0
7937|NCT02566759|18449|P2|NOT COMPLETED|All Parts||1
7938|NCT02566759|18450|P1|NOT COMPLETED|All Parts||0
7939|NCT02566759|18434|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
7940|NCT02566759|18435|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
7941|NCT02566759|18436|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
7942|NCT02566759|18437|P14|COMPLETED|All Parts||0
7943|NCT02566759|18438|P13|COMPLETED|All Parts||0
7944|NCT02566759|18439|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7945|NCT02566759|18440|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7946|NCT02566759|18441|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7947|NCT02566759|18442|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7948|NCT02566759|18443|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
7949|NCT02566759|18444|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8042|NCT02563899|19239|P4|COMPLETED|Overall Study||6
7950|NCT02566759|18445|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7951|NCT02566759|18446|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7952|NCT02566759|18447|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7953|NCT02566759|18448|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7954|NCT02566759|18449|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
7955|NCT02566759|18450|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
7956|NCT02566759|18434|P17|STARTED|All Parts||8
7957|NCT02566759|18435|P16|STARTED|All Parts||8
7958|NCT02566759|18436|P15|STARTED|All Parts||8
7959|NCT02566759|18437|P14|STARTED|All Parts||5
7960|NCT02566759|18438|P13|STARTED|All Parts||1
7961|NCT02566759|18439|P12|STARTED|All Parts||6
7962|NCT02566759|18440|P11|STARTED|All Parts||6
7963|NCT02566759|18441|P10|STARTED|All Parts||6
7964|NCT02566759|18442|P9|STARTED|All Parts||6
7965|NCT02566759|18443|P8|STARTED|All Parts||8
7966|NCT02566759|18444|P7|STARTED|All Parts||6
7967|NCT02566759|18445|P6|STARTED|All Parts||6
7968|NCT02566759|18446|P5|STARTED|All Parts||6
7969|NCT02566759|18447|P4|STARTED|All Parts||6
7970|NCT02566759|18448|P3|STARTED|All Parts||6
7971|NCT02566759|18449|P2|STARTED|All Parts||6
7972|NCT02566759|18450|P1|STARTED|All Parts||12
7973|NCT02566005|18603|P2|NOT COMPLETED|Overall Study||6
7974|NCT02566005|18604|P1|NOT COMPLETED|Overall Study||8
7975|NCT02566005|18603|P2|COMPLETED|Overall Study||94
7976|NCT02566005|18604|P1|COMPLETED|Overall Study||92
7977|NCT02566005|18603|P2|STARTED|Overall Study||100
7978|NCT02566005|18604|P1|STARTED|Overall Study||100
7979|NCT02565628|18634|P2|NOT COMPLETED|Overall Study||0
7980|NCT02565628|18635|P1|NOT COMPLETED|Overall Study||0
7981|NCT02565628|18634|P2|COMPLETED|Overall Study||9
7982|NCT02565628|18635|P1|COMPLETED|Overall Study||10
7983|NCT02565628|18634|P2|Received Treatment|Overall Study||9
7984|NCT02565628|18635|P1|Received Treatment|Overall Study||10
7985|NCT02565628|18634|P2|STARTED|Overall Study||9
7986|NCT02565628|18635|P1|STARTED|Overall Study||10
7987|NCT02565381|18666|P3|NOT COMPLETED|Overall Study||1
7988|NCT02565381|18667|P2|NOT COMPLETED|Overall Study||0
7989|NCT02565381|18668|P1|NOT COMPLETED|Overall Study||1
7990|NCT02565381|18666|P3|COMPLETED|Overall Study||24
7991|NCT02565381|18667|P2|COMPLETED|Overall Study||25
7992|NCT02565381|18668|P1|COMPLETED|Overall Study||24
7993|NCT02565381|18666|P3|STARTED|Overall Study||25
7994|NCT02565381|18667|P2|STARTED|Overall Study||25
7995|NCT02565381|18668|P1|STARTED|Overall Study||25
7996|NCT02564211|18706|P1|NOT COMPLETED|Overall Study||4
7997|NCT02564211|18706|P1|COMPLETED|Overall Study||73
7998|NCT02564211|18706|P1|STARTED|Overall Study||77
7999|NCT02564055|18718|P6|NOT COMPLETED|Overall Study||12
8000|NCT02564055|18719|P5|NOT COMPLETED|Overall Study||15
8001|NCT02564055|18720|P4|NOT COMPLETED|Overall Study||6
8002|NCT02564055|18721|P3|NOT COMPLETED|Overall Study||12
8003|NCT02564055|18722|P2|NOT COMPLETED|Overall Study||5
8004|NCT02564055|18723|P1|NOT COMPLETED|Overall Study||6
8005|NCT02564055|18718|P6|COMPLETED|Overall Study||28
8006|NCT02564055|18719|P5|COMPLETED|Overall Study||27
8007|NCT02564055|18720|P4|COMPLETED|Overall Study||35
8008|NCT02564055|18721|P3|COMPLETED|Overall Study||31
8009|NCT02564055|18722|P2|COMPLETED|Overall Study||36
8010|NCT02564055|18723|P1|COMPLETED|Overall Study||34
8011|NCT02564055|18718|P6|STARTED|Overall Study||40
8012|NCT02564055|18719|P5|STARTED|Overall Study||42
8013|NCT02564055|18720|P4|STARTED|Overall Study||41
8014|NCT02564055|18721|P3|STARTED|Overall Study||43
8015|NCT02564055|18722|P2|STARTED|Overall Study||41
8016|NCT02564055|18723|P1|STARTED|Overall Study||40
8017|NCT02564042|18977|P6|NOT COMPLETED|Overall Study||14
8018|NCT02564042|18978|P5|NOT COMPLETED|Overall Study||11
8019|NCT02564042|18979|P4|NOT COMPLETED|Overall Study||3
8020|NCT02564042|18980|P3|NOT COMPLETED|Overall Study||6
8021|NCT02564042|18981|P2|NOT COMPLETED|Overall Study||8
8022|NCT02564042|18982|P1|NOT COMPLETED|Overall Study||11
8023|NCT02564042|18977|P6|COMPLETED|Overall Study||24
8024|NCT02564042|18978|P5|COMPLETED|Overall Study||26
8025|NCT02564042|18979|P4|COMPLETED|Overall Study||35
8026|NCT02564042|18980|P3|COMPLETED|Overall Study||32
8027|NCT02564042|18981|P2|COMPLETED|Overall Study||30
8028|NCT02564042|18982|P1|COMPLETED|Overall Study||27
8029|NCT02564042|18977|P6|STARTED|Overall Study||38
8030|NCT02564042|18978|P5|STARTED|Overall Study||37
8031|NCT02564042|18979|P4|STARTED|Overall Study||38
8032|NCT02564042|18980|P3|STARTED|Overall Study||38
8033|NCT02564042|18981|P2|STARTED|Overall Study||38
8034|NCT02564042|18982|P1|STARTED|Overall Study||38
8035|NCT02564029|19194|P1|NOT COMPLETED|Overall Study||0
8036|NCT02564029|19194|P1|COMPLETED|Overall Study||7
8037|NCT02564029|19194|P1|STARTED|Overall Study||7
8038|NCT02563899|19239|P4|NOT COMPLETED|Overall Study||0
8039|NCT02563899|19240|P3|NOT COMPLETED|Overall Study||1
8040|NCT02563899|19241|P2|NOT COMPLETED|Overall Study||0
8043|NCT02563899|19240|P3|COMPLETED|Overall Study||9
8044|NCT02563899|19241|P2|COMPLETED|Overall Study||5
8045|NCT02563899|19242|P1|COMPLETED|Overall Study||17
8046|NCT02563899|19239|P4|STARTED|Overall Study||6
8047|NCT02563899|19240|P3|STARTED|Overall Study||10
8048|NCT02563899|19241|P2|STARTED|Overall Study||5
8049|NCT02563899|19242|P1|STARTED|Overall Study||18
8050|NCT02563834|19285|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8051|NCT02563834|19286|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8052|NCT02563834|19285|P2|COMPLETED|Insulin Infusion (*Day 2)||8
8053|NCT02563834|19286|P1|COMPLETED|Insulin Infusion (*Day 2)||10
8054|NCT02563834|19285|P2|STARTED|Insulin Infusion (*Day 2)||8
8055|NCT02563834|19286|P1|STARTED|Insulin Infusion (*Day 2)||10
8056|NCT02563834|19285|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8057|NCT02563834|19286|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8058|NCT02563834|19285|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
8059|NCT02563834|19286|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
8060|NCT02563834|19285|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
8061|NCT02563834|19286|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
8062|NCT02563106|19304|P2|NOT COMPLETED|Overall Study||28
8063|NCT02563106|19305|P1|NOT COMPLETED|Overall Study||34
8064|NCT02563106|19304|P2|COMPLETED|Overall Study||178
8065|NCT02563106|19305|P1|COMPLETED|Overall Study||172
8066|NCT02563106|19304|P2|STARTED|Overall Study|207 subjects were randomized to the placebo group, however only 206 subjects received study drug.|206
8067|NCT02563106|19305|P1|STARTED|Overall Study||206
8068|NCT02563093|19315|P4|NOT COMPLETED|Overall Study||0
8069|NCT02563093|19316|P3|NOT COMPLETED|Overall Study||0
8070|NCT02563093|19317|P2|NOT COMPLETED|Overall Study||0
8071|NCT02563093|19318|P1|NOT COMPLETED|Overall Study||0
8072|NCT02563093|19315|P4|COMPLETED|Overall Study||51
8073|NCT02563093|19316|P3|COMPLETED|Overall Study||53
8074|NCT02563093|19317|P2|COMPLETED|Overall Study||52
8075|NCT02563093|19318|P1|COMPLETED|Overall Study||52
8076|NCT02563093|19315|P4|STARTED|Overall Study||51
8077|NCT02563093|19316|P3|STARTED|Overall Study||53
8078|NCT02563093|19317|P2|STARTED|Overall Study||52
8079|NCT02563093|19318|P1|STARTED|Overall Study||52
8080|NCT02562521|19346|P2|NOT COMPLETED|Overall Study||0
8081|NCT02562521|19347|P1|NOT COMPLETED|Overall Study||0
8082|NCT02562521|19346|P2|COMPLETED|Overall Study||7
8083|NCT02562521|19347|P1|COMPLETED|Overall Study||18
8084|NCT02562521|19346|P2|STARTED|Overall Study||7
8085|NCT02562521|19347|P1|STARTED|Overall Study||18
8086|NCT02561806|19363|P2|NOT COMPLETED|Overall Study||4
8087|NCT02561806|19364|P1|NOT COMPLETED|Overall Study||1
8088|NCT02561806|19363|P2|COMPLETED|Overall Study||132
8089|NCT02561806|19364|P1|COMPLETED|Overall Study||165
8090|NCT02561806|19363|P2|Received At Least One Dose of Study Drug|Overall Study||135
8091|NCT02561806|19364|P1|Received At Least One Dose of Study Drug|Overall Study||166
8092|NCT02561806|19363|P2|STARTED|Overall Study||136
8093|NCT02561806|19364|P1|STARTED|Overall Study||166
8094|NCT02561702|19416|P2|NOT COMPLETED|Second Intervention||0
8095|NCT02561702|19417|P1|NOT COMPLETED|Second Intervention||0
8096|NCT02561702|19416|P2|COMPLETED|Second Intervention||2
8097|NCT02561702|19417|P1|COMPLETED|Second Intervention||2
8098|NCT02561702|19416|P2|STARTED|Second Intervention||2
8099|NCT02561702|19417|P1|STARTED|Second Intervention||2
8100|NCT02561702|19416|P2|NOT COMPLETED|Washout||0
8101|NCT02561702|19417|P1|NOT COMPLETED|Washout||0
8102|NCT02561702|19416|P2|COMPLETED|Washout||2
8103|NCT02561702|19417|P1|COMPLETED|Washout||2
8104|NCT02561702|19416|P2|STARTED|Washout||2
8105|NCT02561702|19417|P1|STARTED|Washout||2
8106|NCT02561702|19416|P2|NOT COMPLETED|First Intervention||0
8107|NCT02561702|19417|P1|NOT COMPLETED|First Intervention||0
8108|NCT02561702|19416|P2|COMPLETED|First Intervention||2
8109|NCT02561702|19417|P1|COMPLETED|First Intervention||2
8110|NCT02561702|19416|P2|STARTED|First Intervention||2
8111|NCT02561702|19417|P1|STARTED|First Intervention||2
8112|NCT02561572|19427|P2|NOT COMPLETED|Overall Study||2
8113|NCT02561572|19428|P1|NOT COMPLETED|Overall Study||2
8114|NCT02561572|19427|P2|COMPLETED|Overall Study||62
8115|NCT02561572|19428|P1|COMPLETED|Overall Study||62
8116|NCT02561572|19427|P2|STARTED|Overall Study||64
8117|NCT02561572|19428|P1|STARTED|Overall Study||64
8118|NCT02561195|19450|P6|NOT COMPLETED|Overall Study||10
8119|NCT02561195|19451|P5|NOT COMPLETED|Overall Study||28
8120|NCT02561195|19452|P4|NOT COMPLETED|Overall Study||26
8121|NCT02561195|19453|P3|NOT COMPLETED|Overall Study||6
8122|NCT02561195|19454|P2|NOT COMPLETED|Overall Study||22
8123|NCT02561195|19455|P1|NOT COMPLETED|Overall Study||23
8124|NCT02561195|19450|P6|COMPLETED|Overall Study||51
8125|NCT02561195|19451|P5|COMPLETED|Overall Study||155
8126|NCT02561195|19452|P4|COMPLETED|Overall Study||157
8127|NCT02561195|19453|P3|COMPLETED|Overall Study||55
8128|NCT02561195|19454|P2|COMPLETED|Overall Study||162
8129|NCT02561195|19455|P1|COMPLETED|Overall Study||160
8130|NCT02561195|19450|P6|Treated|Overall Study||61
8131|NCT02561195|19451|P5|Treated|Overall Study||183
8132|NCT02561195|19452|P4|Treated|Overall Study||183
8133|NCT02561195|19453|P3|Treated|Overall Study||61
8134|NCT02561195|19454|P2|Treated|Overall Study||184
8135|NCT02561195|19455|P1|Treated|Overall Study||182
8136|NCT02561195|19450|P6|STARTED|Overall Study||61
8137|NCT02561195|19451|P5|STARTED|Overall Study||183
8138|NCT02561195|19452|P4|STARTED|Overall Study||183
8139|NCT02561195|19453|P3|STARTED|Overall Study||61
8140|NCT02561195|19454|P2|STARTED|Overall Study||184
8141|NCT02561195|19455|P1|STARTED|Overall Study||183
8142|NCT02559622|19607|P4|NOT COMPLETED|Overall Study||3
8143|NCT02559622|19608|P3|NOT COMPLETED|Overall Study||2
8144|NCT02559622|19609|P2|NOT COMPLETED|Overall Study||5
8145|NCT02559622|19610|P1|NOT COMPLETED|Overall Study||1
8146|NCT02559622|19607|P4|COMPLETED|Overall Study||20
8147|NCT02559622|19608|P3|COMPLETED|Overall Study||24
8148|NCT02559622|19609|P2|COMPLETED|Overall Study||49
8149|NCT02559622|19610|P1|COMPLETED|Overall Study||47
8150|NCT02559622|19607|P4|STARTED|Overall Study||23
8151|NCT02559622|19608|P3|STARTED|Overall Study||26
8152|NCT02559622|19609|P2|STARTED|Overall Study||54
8153|NCT02559622|19610|P1|STARTED|Overall Study||48
8154|NCT02559414|19692|P3|NOT COMPLETED|Overall Study||2
8155|NCT02559414|19693|P2|NOT COMPLETED|Overall Study||2
8156|NCT02559414|19694|P1|NOT COMPLETED|Overall Study||1
8157|NCT02559414|19692|P3|COMPLETED|Overall Study||20
8158|NCT02559414|19693|P2|COMPLETED|Overall Study||20
8159|NCT02559414|19694|P1|COMPLETED|Overall Study||10
8160|NCT02559414|19692|P3|STARTED|Overall Study||22
8161|NCT02559414|19693|P2|STARTED|Overall Study||22
8162|NCT02559414|19694|P1|STARTED|Overall Study||11
8163|NCT02558829|19718|P8|NOT COMPLETED|Overall Study||3
8164|NCT02558829|19719|P7|NOT COMPLETED|Overall Study||1
8165|NCT02558829|19720|P6|NOT COMPLETED|Overall Study||2
8166|NCT02558829|19721|P5|NOT COMPLETED|Overall Study||2
8167|NCT02558829|19722|P4|NOT COMPLETED|Overall Study||2
8168|NCT02558829|19723|P3|NOT COMPLETED|Overall Study||3
8169|NCT02558829|19724|P2|NOT COMPLETED|Overall Study||3
8170|NCT02558829|19725|P1|NOT COMPLETED|Overall Study||1
8171|NCT02558829|19718|P8|COMPLETED|Overall Study||8
8172|NCT02558829|19719|P7|COMPLETED|Overall Study||17
8173|NCT02558829|19720|P6|COMPLETED|Overall Study||24
8174|NCT02558829|19721|P5|COMPLETED|Overall Study||16
8175|NCT02558829|19722|P4|COMPLETED|Overall Study||16
8176|NCT02558829|19723|P3|COMPLETED|Overall Study||21
8177|NCT02558829|19724|P2|COMPLETED|Overall Study||18
8178|NCT02558829|19725|P1|COMPLETED|Overall Study||20
8179|NCT02558829|19718|P8|STARTED|Overall Study||11
8180|NCT02558829|19719|P7|STARTED|Overall Study||18
8181|NCT02558829|19720|P6|STARTED|Overall Study||26
8182|NCT02558829|19721|P5|STARTED|Overall Study||18
8183|NCT02558829|19722|P4|STARTED|Overall Study||18
8184|NCT02558829|19723|P3|STARTED|Overall Study||24
8185|NCT02558829|19724|P2|STARTED|Overall Study||21
8186|NCT02558829|19725|P1|STARTED|Overall Study||21
8187|NCT02558790|19751|P1|NOT COMPLETED|Overall Study||7
8188|NCT02558790|19751|P1|COMPLETED|Overall Study||13
8189|NCT02558790|19751|P1|Treated|Overall Study||15
8190|NCT02558790|19751|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
8191|NCT02558374|19757|P2|NOT COMPLETED|Overall Study||43
8192|NCT02558374|19758|P1|NOT COMPLETED|Overall Study||108
8193|NCT02558374|19757|P2|COMPLETED|Overall Study||314
8194|NCT02558374|19758|P1|COMPLETED|Overall Study||243
8195|NCT02558374|19757|P2|STARTED|Overall Study||357
8196|NCT02558374|19758|P1|STARTED|Overall Study||351
8197|NCT02557698|19768|P2|NOT COMPLETED|Overall Study||0
8198|NCT02557698|19769|P1|NOT COMPLETED|Overall Study||0
8199|NCT02557698|19768|P2|COMPLETED|Overall Study||30
8200|NCT02557698|19769|P1|COMPLETED|Overall Study||30
8201|NCT02557698|19768|P2|STARTED|Overall Study||30
8202|NCT02557698|19769|P1|STARTED|Overall Study||30
8203|NCT02557646|19833|P1|NOT COMPLETED|Overall Study||276
8204|NCT02557646|19833|P1|COMPLETED|Overall Study||417
8205|NCT02557646|19833|P1|STARTED|Overall Study||693
8206|NCT02557555|19851|P1|NOT COMPLETED|Overall Study||0
8207|NCT02557555|19851|P1|COMPLETED|Overall Study||100
8208|NCT02557555|19851|P1|STARTED|Overall Study||100
8209|NCT02557399|19858|P2|NOT COMPLETED|Overall Study||8
8210|NCT02557399|19859|P1|NOT COMPLETED|Overall Study||7
8211|NCT02557399|19858|P2|COMPLETED|Overall Study||169
8212|NCT02557399|19859|P1|COMPLETED|Overall Study||165
8213|NCT02557399|19858|P2|STARTED|Overall Study||177
8214|NCT02557399|19859|P1|STARTED|Overall Study||172
8215|NCT02556632|19894|P3|NOT COMPLETED|Overall Study||9
8216|NCT02556632|19895|P2|NOT COMPLETED|Overall Study||6
8217|NCT02556632|19896|P1|NOT COMPLETED|Overall Study||5
8218|NCT02556632|19894|P3|COMPLETED|Overall Study||53
8219|NCT02556632|19895|P2|COMPLETED|Overall Study||59
8220|NCT02556632|19896|P1|COMPLETED|Overall Study||59
8221|NCT02556632|19894|P3|STARTED|Overall Study||62
8222|NCT02556632|19895|P2|STARTED|Overall Study||65
8223|NCT02556632|19896|P1|STARTED|Overall Study||64
8224|NCT02556333|19910|P1|NOT COMPLETED|Overall Study||0
8225|NCT02556333|19910|P1|COMPLETED|Overall Study||1
8226|NCT02556333|19910|P1|STARTED|Overall Study||1
8227|NCT02556307|19914|P1|NOT COMPLETED|Overall Study||53
8228|NCT02556307|19914|P1|COMPLETED|Overall Study||217
8229|NCT02556307|19914|P1|Treated|Overall Study||268
8230|NCT02556307|19914|P1|STARTED|Overall Study||270
8231|NCT02556138|19924|P1|NOT COMPLETED|Overall Study||1
8232|NCT02556138|19924|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
8233|NCT02556138|19924|P1|STARTED|Overall Study||8
8234|NCT02555722|19932|P2|NOT COMPLETED|Month 3||0
8235|NCT02555722|19933|P1|NOT COMPLETED|Month 3||0
8236|NCT02555722|19932|P2|COMPLETED|Month 3||29
8237|NCT02555722|19933|P1|COMPLETED|Month 3||53
8238|NCT02555722|19932|P2|STARTED|Month 3||29
8239|NCT02555722|19933|P1|STARTED|Month 3||53
8240|NCT02555722|19932|P2|NOT COMPLETED|Month 2||0
8241|NCT02555722|19933|P1|NOT COMPLETED|Month 2||3
8242|NCT02555722|19932|P2|COMPLETED|Month 2||29
8243|NCT02555722|19933|P1|COMPLETED|Month 2||53
8244|NCT02555722|19932|P2|STARTED|Month 2||29
8245|NCT02555722|19933|P1|STARTED|Month 2||56
8246|NCT02555722|19932|P2|NOT COMPLETED|Month 1||0
8247|NCT02555722|19933|P1|NOT COMPLETED|Month 1||2
8248|NCT02555722|19932|P2|COMPLETED|Month 1||29
8249|NCT02555722|19933|P1|COMPLETED|Month 1||56
8250|NCT02555722|19932|P2|STARTED|Month 1||29
8251|NCT02555722|19933|P1|STARTED|Month 1||58
8252|NCT02555722|19932|P2|NOT COMPLETED|Week 2||1
8253|NCT02555722|19933|P1|NOT COMPLETED|Week 2||0
8254|NCT02555722|19932|P2|COMPLETED|Week 2||29
8255|NCT02555722|19933|P1|COMPLETED|Week 2||58
8256|NCT02555722|19932|P2|STARTED|Week 2||30
8257|NCT02555722|19933|P1|STARTED|Week 2||58
8258|NCT02555722|19932|P2|NOT COMPLETED|Week 1||0
8259|NCT02555722|19933|P1|NOT COMPLETED|Week 1||1
8260|NCT02555722|19932|P2|COMPLETED|Week 1||30
8261|NCT02555722|19933|P1|COMPLETED|Week 1||58
8262|NCT02555722|19932|P2|STARTED|Week 1||30
8263|NCT02555722|19933|P1|STARTED|Week 1||59
8264|NCT02555722|19932|P2|NOT COMPLETED|Lens Dispensed||0
8265|NCT02555722|19933|P1|NOT COMPLETED|Lens Dispensed||0
8266|NCT02555722|19932|P2|COMPLETED|Lens Dispensed||30
8267|NCT02555722|19933|P1|COMPLETED|Lens Dispensed||59
8268|NCT02555722|19932|P2|STARTED|Lens Dispensed||30
8269|NCT02555722|19933|P1|STARTED|Lens Dispensed||59
8270|NCT02555618|20093|P2|NOT COMPLETED|Overall Study||0
8271|NCT02555618|20094|P1|NOT COMPLETED|Overall Study||1
8272|NCT02555618|20093|P2|COMPLETED|Overall Study||200
8273|NCT02555618|20094|P1|COMPLETED|Overall Study||199
8274|NCT02555618|20093|P2|STARTED|Overall Study||200
8275|NCT02555618|20094|P1|STARTED|Overall Study||200
8276|NCT02555228|20138|P2|NOT COMPLETED|Overall Study||0
8277|NCT02555228|20139|P1|NOT COMPLETED|Overall Study||0
8278|NCT02555228|20138|P2|COMPLETED|Overall Study|29th October 2015|27
8279|NCT02555228|20139|P1|COMPLETED|Overall Study|19th November 2015|27
8280|NCT02555228|20138|P2|STARTED|Overall Study|14th August 2015|27
8281|NCT02555228|20139|P1|STARTED|Overall Study|20th August 2015|27
8282|NCT02554981|20151|P1|NOT COMPLETED|Overall Study||5
8283|NCT02554981|20151|P1|COMPLETED|Overall Study||46
8284|NCT02554981|20151|P1|STARTED|Overall Study||51
8285|NCT02554877|20179|P4|NOT COMPLETED|Overall Study||7
8286|NCT02554877|20180|P3|NOT COMPLETED|Overall Study||6
8287|NCT02554877|20181|P2|NOT COMPLETED|Overall Study||7
8288|NCT02554877|20182|P1|NOT COMPLETED|Overall Study||12
8289|NCT02554877|20179|P4|COMPLETED|Overall Study||45
8290|NCT02554877|20180|P3|COMPLETED|Overall Study||46
8291|NCT02554877|20181|P2|COMPLETED|Overall Study||44
8292|NCT02554877|20182|P1|COMPLETED|Overall Study||39
8293|NCT02554877|20179|P4|STARTED|Overall Study||52
8294|NCT02554877|20180|P3|STARTED|Overall Study||52
8295|NCT02554877|20181|P2|STARTED|Overall Study||51
8296|NCT02554877|20182|P1|STARTED|Overall Study||51
8297|NCT02554279|20246|P2|NOT COMPLETED|Overall Study||18
8298|NCT02554279|20247|P1|NOT COMPLETED|Overall Study||32
8299|NCT02554279|20246|P2|COMPLETED|Overall Study||291
8300|NCT02554279|20247|P1|COMPLETED|Overall Study||279
8301|NCT02554279|20246|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
8302|NCT02554279|20247|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
8303|NCT02554279|20246|P2|Completed Oocyte Retrieval|Overall Study||306
8304|NCT02554279|20247|P1|Completed Oocyte Retrieval|Overall Study||292
8305|NCT02554279|20246|P2|Received Trigger|Overall Study||307
8306|NCT02554279|20247|P1|Received Trigger|Overall Study||293
8307|NCT02554279|20246|P2|Completed Day 6 of Stimulation|Overall Study||309
8308|NCT02554279|20247|P1|Completed Day 6 of Stimulation|Overall Study||308
8309|NCT02554279|20246|P2|Treated|Overall Study||309
8310|NCT02554279|20247|P1|Treated|Overall Study||310
8311|NCT02554279|20246|P2|STARTED|Overall Study||309
8312|NCT02554279|20247|P1|STARTED|Overall Study||311
8313|NCT02553772|20281|P2|NOT COMPLETED|Overall Study||6
8314|NCT02553772|20282|P1|NOT COMPLETED|Overall Study||6
8315|NCT02553772|20281|P2|COMPLETED|Overall Study||116
8316|NCT02553772|20282|P1|COMPLETED|Overall Study||114
8317|NCT02553772|20281|P2|STARTED|Overall Study||122
8318|NCT02553772|20282|P1|STARTED|Overall Study||120
8319|NCT02553629|20298|P2|NOT COMPLETED|Overall Study||6
8320|NCT02553629|20299|P1|NOT COMPLETED|Overall Study||3
8321|NCT02553629|20298|P2|COMPLETED|Overall Study||50
8322|NCT02553629|20299|P1|COMPLETED|Overall Study||50
8323|NCT02553629|20298|P2|STARTED|Overall Study||56
8324|NCT02553629|20299|P1|STARTED|Overall Study||53
8325|NCT02553538|20315|P2|NOT COMPLETED|Overall Study||56
8326|NCT02553538|20316|P1|NOT COMPLETED|Overall Study||187
8327|NCT02553538|20315|P2|COMPLETED|Overall Study||764
8328|NCT02553538|20316|P1|COMPLETED|Overall Study||605
8329|NCT02553538|20315|P2|STARTED|Overall Study||820
8330|NCT02553538|20316|P1|STARTED|Overall Study||792
8331|NCT02553512|20328|P1|NOT COMPLETED|Overall Study||23
8332|NCT02553512|20328|P1|COMPLETED|Overall Study||144
8333|NCT02553512|20328|P1|STARTED|Overall Study||167
8334|NCT02553421|20338|P2|NOT COMPLETED|Overall Study||1
8335|NCT02553421|20339|P1|NOT COMPLETED|Overall Study||29
8336|NCT02553421|20338|P2|COMPLETED|Overall Study||57
8337|NCT02553421|20339|P1|COMPLETED|Overall Study||156
8338|NCT02553421|20338|P2|STARTED|Overall Study||58
8339|NCT02553421|20339|P1|STARTED|Overall Study||185
8340|NCT02552810|20349|P2|NOT COMPLETED|Overall Study||0
8341|NCT02552810|20350|P1|NOT COMPLETED|Overall Study||0
8342|NCT02552810|20349|P2|COMPLETED|Overall Study||15
8343|NCT02552810|20350|P1|COMPLETED|Overall Study||15
8344|NCT02552810|20349|P2|STARTED|Overall Study||15
8345|NCT02552810|20350|P1|STARTED|Overall Study||15
8346|NCT02552303|20370|P4|NOT COMPLETED|Follow-Up||0
8347|NCT02552303|20371|P3|NOT COMPLETED|Follow-Up||1
8348|NCT02552303|20372|P2|NOT COMPLETED|Follow-Up||2
8349|NCT02552303|20373|P1|NOT COMPLETED|Follow-Up||0
8350|NCT02552303|20370|P4|COMPLETED|Follow-Up||10
8351|NCT02552303|20371|P3|COMPLETED|Follow-Up||6
8352|NCT02552303|20372|P2|COMPLETED|Follow-Up||6
8353|NCT02552303|20373|P1|COMPLETED|Follow-Up||7
8354|NCT02552303|20370|P4|STARTED|Follow-Up||10
8355|NCT02552303|20371|P3|STARTED|Follow-Up||7
8356|NCT02552303|20372|P2|STARTED|Follow-Up||8
8357|NCT02552303|20373|P1|STARTED|Follow-Up||7
8358|NCT02552303|20370|P4|NOT COMPLETED|Allocation||1
8359|NCT02552303|20371|P3|NOT COMPLETED|Allocation||1
8360|NCT02552303|20372|P2|NOT COMPLETED|Allocation||2
8361|NCT02552303|20373|P1|NOT COMPLETED|Allocation||3
8362|NCT02552303|20370|P4|COMPLETED|Allocation||10
8363|NCT02552303|20371|P3|COMPLETED|Allocation||7
8364|NCT02552303|20372|P2|COMPLETED|Allocation||8
8365|NCT02552303|20373|P1|COMPLETED|Allocation||7
8366|NCT02552303|20370|P4|STARTED|Allocation||11
8367|NCT02552303|20371|P3|STARTED|Allocation||8
8368|NCT02552303|20372|P2|STARTED|Allocation||10
8369|NCT02552303|20373|P1|STARTED|Allocation||10
8370|NCT02551887|20390|P3|NOT COMPLETED|Overall Study||0
8371|NCT02551887|20391|P2|NOT COMPLETED|Overall Study||0
8372|NCT02551887|20392|P1|NOT COMPLETED|Overall Study||0
8373|NCT02551887|20390|P3|COMPLETED|Overall Study||222
8374|NCT02551887|20391|P2|COMPLETED|Overall Study||124
8375|NCT02551887|20392|P1|COMPLETED|Overall Study||301
8376|NCT02551887|20390|P3|STARTED|Overall Study||222
8377|NCT02551887|20391|P2|STARTED|Overall Study||124
8378|NCT02551887|20392|P1|STARTED|Overall Study||301
8379|NCT02551822|20405|P2|NOT COMPLETED|Overall Study||2
8380|NCT02551822|20406|P1|NOT COMPLETED|Overall Study||2
8381|NCT02551822|20405|P2|COMPLETED|Overall Study||10
8382|NCT02551822|20406|P1|COMPLETED|Overall Study||9
8383|NCT02551822|20405|P2|STARTED|Overall Study||12
8384|NCT02551822|20406|P1|STARTED|Overall Study||11
8385|NCT02551224|20416|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
8386|NCT02551224|20417|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
8387|NCT02551224|20416|P2|COMPLETED|Second Intervention (5 Min After First )||50
8388|NCT02551224|20417|P1|COMPLETED|Second Intervention (5 Min After First )||50
8389|NCT02551224|20416|P2|STARTED|Second Intervention (5 Min After First )||50
8390|NCT02551224|20417|P1|STARTED|Second Intervention (5 Min After First )||50
8391|NCT02551224|20416|P2|NOT COMPLETED|First Intervention||0
8392|NCT02551224|20417|P1|NOT COMPLETED|First Intervention||0
8393|NCT02551224|20416|P2|COMPLETED|First Intervention||50
8394|NCT02551224|20417|P1|COMPLETED|First Intervention||50
8395|NCT02551224|20416|P2|STARTED|First Intervention||50
8396|NCT02551224|20417|P1|STARTED|First Intervention||50
8397|NCT02550288|20430|P5|NOT COMPLETED|Overall Study||3
8398|NCT02550288|20431|P4|NOT COMPLETED|Overall Study||3
8399|NCT02550288|20432|P3|NOT COMPLETED|Overall Study||1
8400|NCT02550288|20433|P2|NOT COMPLETED|Overall Study||3
8401|NCT02550288|20434|P1|NOT COMPLETED|Overall Study||2
8402|NCT02550288|20430|P5|COMPLETED|Overall Study||66
8403|NCT02550288|20431|P4|COMPLETED|Overall Study||65
8404|NCT02550288|20432|P3|COMPLETED|Overall Study||68
8405|NCT02550288|20433|P2|COMPLETED|Overall Study||65
8406|NCT02550288|20434|P1|COMPLETED|Overall Study||33
8407|NCT02550288|20430|P5|STARTED|Overall Study||69
8408|NCT02550288|20431|P4|STARTED|Overall Study||68
8409|NCT02550288|20432|P3|STARTED|Overall Study||69
8410|NCT02550288|20433|P2|STARTED|Overall Study||68
8411|NCT02550288|20434|P1|STARTED|Overall Study||35
8412|NCT02550197|20533|P2|NOT COMPLETED|Overall Study||0
8413|NCT02550197|20534|P1|NOT COMPLETED|Overall Study||0
8414|NCT02550197|20533|P2|COMPLETED|Overall Study||100
8415|NCT02550197|20534|P1|COMPLETED|Overall Study||200
8416|NCT02550197|20533|P2|STARTED|Overall Study||100
8417|NCT02550197|20534|P1|STARTED|Overall Study||200
8418|NCT02550132|20552|P1|NOT COMPLETED|Overall Study||0
8419|NCT02550132|20552|P1|COMPLETED|Overall Study||25
8420|NCT02550132|20552|P1|STARTED|Overall Study||25
8421|NCT02549755|20583|P1|NOT COMPLETED|Overall Study||1
8422|NCT02549755|20583|P1|COMPLETED|Overall Study||0
8423|NCT02549755|20583|P1|STARTED|Overall Study||1
8424|NCT02549573|20589|P2|NOT COMPLETED|Overall Study||3
8425|NCT02549573|20590|P1|NOT COMPLETED|Overall Study||0
8426|NCT02549573|20589|P2|COMPLETED|Overall Study||4
8427|NCT02549573|20590|P1|COMPLETED|Overall Study||6
8428|NCT02549573|20589|P2|STARTED|Overall Study||7
8429|NCT02549573|20590|P1|STARTED|Overall Study||6
8430|NCT02549027|20632|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8431|NCT02549027|20633|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
8432|NCT02549027|20634|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8433|NCT02549027|20635|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8434|NCT02549027|20636|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8435|NCT02549027|20637|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8436|NCT02549027|20632|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
8437|NCT02549027|20633|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
8438|NCT02549027|20634|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
8439|NCT02549027|20635|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
8440|NCT02549027|20636|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
8441|NCT02549027|20637|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
8442|NCT02549027|20632|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
8443|NCT02549027|20633|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
8444|NCT02549027|20634|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8445|NCT02549027|20635|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8446|NCT02549027|20636|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8447|NCT02549027|20637|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
8448|NCT02549027|20632|P6|NOT COMPLETED|Washout After Period 4||0
8449|NCT02549027|20633|P5|NOT COMPLETED|Washout After Period 4||0
8450|NCT02549027|20634|P4|NOT COMPLETED|Washout After Period 4||1
8451|NCT02549027|20635|P3|NOT COMPLETED|Washout After Period 4||1
8452|NCT02549027|20636|P2|NOT COMPLETED|Washout After Period 4||1
8453|NCT02549027|20637|P1|NOT COMPLETED|Washout After Period 4||0
8454|NCT02549027|20632|P6|COMPLETED|Washout After Period 4||0
8455|NCT02549027|20633|P5|COMPLETED|Washout After Period 4||0
8456|NCT02549027|20634|P4|COMPLETED|Washout After Period 4||4
8457|NCT02549027|20635|P3|COMPLETED|Washout After Period 4||4
8458|NCT02549027|20636|P2|COMPLETED|Washout After Period 4||4
8459|NCT02549027|20637|P1|COMPLETED|Washout After Period 4||5
8460|NCT02549027|20632|P6|STARTED|Washout After Period 4||0
8461|NCT02549027|20633|P5|STARTED|Washout After Period 4||0
8462|NCT02549027|20634|P4|STARTED|Washout After Period 4||5
8463|NCT02549027|20635|P3|STARTED|Washout After Period 4||5
8464|NCT02549027|20636|P2|STARTED|Washout After Period 4||5
8465|NCT02549027|20637|P1|STARTED|Washout After Period 4||5
8466|NCT02549027|20632|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8467|NCT02549027|20633|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8468|NCT02549027|20634|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8469|NCT02549027|20635|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8470|NCT02549027|20636|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8471|NCT02549027|20637|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8472|NCT02549027|20632|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
8473|NCT02549027|20633|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
8474|NCT02549027|20634|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
8475|NCT02549027|20635|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
8476|NCT02549027|20636|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
8477|NCT02549027|20637|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
8478|NCT02549027|20632|P6|STARTED|Period 4 - MK-1064 or Placebo||0
8479|NCT02549027|20633|P5|STARTED|Period 4 - MK-1064 or Placebo||0
8480|NCT02549027|20634|P4|STARTED|Period 4 - MK-1064 or Placebo||5
8481|NCT02549027|20635|P3|STARTED|Period 4 - MK-1064 or Placebo||5
8482|NCT02549027|20636|P2|STARTED|Period 4 - MK-1064 or Placebo||5
8483|NCT02549027|20637|P1|STARTED|Period 4 - MK-1064 or Placebo||5
8484|NCT02549027|20632|P6|NOT COMPLETED|Washout After Period 3||0
8485|NCT02549027|20633|P5|NOT COMPLETED|Washout After Period 3||0
8486|NCT02549027|20634|P4|NOT COMPLETED|Washout After Period 3||0
8487|NCT02549027|20635|P3|NOT COMPLETED|Washout After Period 3||0
8488|NCT02549027|20636|P2|NOT COMPLETED|Washout After Period 3||0
8489|NCT02549027|20637|P1|NOT COMPLETED|Washout After Period 3||0
8490|NCT02549027|20632|P6|COMPLETED|Washout After Period 3||0
8491|NCT02549027|20633|P5|COMPLETED|Washout After Period 3||0
8492|NCT02549027|20634|P4|COMPLETED|Washout After Period 3||5
8493|NCT02549027|20635|P3|COMPLETED|Washout After Period 3||5
8494|NCT02549027|20636|P2|COMPLETED|Washout After Period 3||5
8495|NCT02549027|20637|P1|COMPLETED|Washout After Period 3||5
8496|NCT02549027|20632|P6|STARTED|Washout After Period 3||0
8497|NCT02549027|20633|P5|STARTED|Washout After Period 3||0
8498|NCT02549027|20634|P4|STARTED|Washout After Period 3||5
8499|NCT02549027|20635|P3|STARTED|Washout After Period 3||5
8500|NCT02549027|20636|P2|STARTED|Washout After Period 3||5
8501|NCT02549027|20637|P1|STARTED|Washout After Period 3||5
8502|NCT02549027|20632|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8503|NCT02549027|20633|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8504|NCT02549027|20634|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8505|NCT02549027|20635|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8506|NCT02549027|20636|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8507|NCT02549027|20637|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8508|NCT02549027|20632|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
8509|NCT02549027|20633|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
8510|NCT02549027|20634|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
8511|NCT02549027|20635|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
8512|NCT02549027|20636|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
8513|NCT02549027|20637|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
8514|NCT02549027|20632|P6|STARTED|Period 3 - MK-1064 or Placebo||0
8515|NCT02549027|20633|P5|STARTED|Period 3 - MK-1064 or Placebo||0
8516|NCT02549027|20634|P4|STARTED|Period 3 - MK-1064 or Placebo||5
8517|NCT02549027|20635|P3|STARTED|Period 3 - MK-1064 or Placebo||5
8518|NCT02549027|20636|P2|STARTED|Period 3 - MK-1064 or Placebo||5
8519|NCT02549027|20637|P1|STARTED|Period 3 - MK-1064 or Placebo||5
8520|NCT02549027|20632|P6|NOT COMPLETED|Washout After Period 2||0
8521|NCT02549027|20633|P5|NOT COMPLETED|Washout After Period 2||0
8522|NCT02549027|20634|P4|NOT COMPLETED|Washout After Period 2||0
8523|NCT02549027|20635|P3|NOT COMPLETED|Washout After Period 2||0
8524|NCT02549027|20636|P2|NOT COMPLETED|Washout After Period 2||0
8525|NCT02549027|20637|P1|NOT COMPLETED|Washout After Period 2||0
8526|NCT02549027|20632|P6|COMPLETED|Washout After Period 2||0
8527|NCT02549027|20633|P5|COMPLETED|Washout After Period 2||0
8528|NCT02549027|20634|P4|COMPLETED|Washout After Period 2||5
8529|NCT02549027|20635|P3|COMPLETED|Washout After Period 2||5
8530|NCT02549027|20636|P2|COMPLETED|Washout After Period 2||5
8531|NCT02549027|20637|P1|COMPLETED|Washout After Period 2||5
8532|NCT02549027|20632|P6|STARTED|Washout After Period 2||0
8533|NCT02549027|20633|P5|STARTED|Washout After Period 2||0
8534|NCT02549027|20634|P4|STARTED|Washout After Period 2||5
8535|NCT02549027|20635|P3|STARTED|Washout After Period 2||5
8536|NCT02549027|20636|P2|STARTED|Washout After Period 2||5
8537|NCT02549027|20637|P1|STARTED|Washout After Period 2||5
8538|NCT02549027|20632|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8539|NCT02549027|20633|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8540|NCT02549027|20634|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8541|NCT02549027|20635|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8542|NCT02549027|20636|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8543|NCT02549027|20637|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8544|NCT02549027|20632|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
8545|NCT02549027|20633|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
8546|NCT02549027|20634|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
8547|NCT02549027|20635|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
8548|NCT02549027|20636|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
8549|NCT02549027|20637|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
8550|NCT02549027|20632|P6|STARTED|Period 2 - MK-1064 or Placebo||0
8551|NCT02549027|20633|P5|STARTED|Period 2 - MK-1064 or Placebo||0
8552|NCT02549027|20634|P4|STARTED|Period 2 - MK-1064 or Placebo||5
8553|NCT02549027|20635|P3|STARTED|Period 2 - MK-1064 or Placebo||5
8554|NCT02549027|20636|P2|STARTED|Period 2 - MK-1064 or Placebo||5
8555|NCT02549027|20637|P1|STARTED|Period 2 - MK-1064 or Placebo||5
8556|NCT02549027|20632|P6|NOT COMPLETED|Washout After Period 1||0
8557|NCT02549027|20633|P5|NOT COMPLETED|Washout After Period 1||0
8558|NCT02549027|20634|P4|NOT COMPLETED|Washout After Period 1||0
8559|NCT02549027|20635|P3|NOT COMPLETED|Washout After Period 1||0
8560|NCT02549027|20636|P2|NOT COMPLETED|Washout After Period 1||0
8561|NCT02549027|20637|P1|NOT COMPLETED|Washout After Period 1||0
8562|NCT02549027|20632|P6|COMPLETED|Washout After Period 1||0
8563|NCT02549027|20633|P5|COMPLETED|Washout After Period 1||0
8564|NCT02549027|20634|P4|COMPLETED|Washout After Period 1||5
8565|NCT02549027|20635|P3|COMPLETED|Washout After Period 1||5
8566|NCT02549027|20636|P2|COMPLETED|Washout After Period 1||5
8567|NCT02549027|20637|P1|COMPLETED|Washout After Period 1||5
8568|NCT02549027|20632|P6|STARTED|Washout After Period 1||0
8569|NCT02549027|20633|P5|STARTED|Washout After Period 1||0
8570|NCT02549027|20634|P4|STARTED|Washout After Period 1||5
8571|NCT02549027|20635|P3|STARTED|Washout After Period 1||5
8572|NCT02549027|20636|P2|STARTED|Washout After Period 1||5
8573|NCT02549027|20637|P1|STARTED|Washout After Period 1||5
8574|NCT02549027|20632|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8575|NCT02549027|20633|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8576|NCT02549027|20634|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8577|NCT02549027|20635|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8578|NCT02549027|20636|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8579|NCT02549027|20637|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8580|NCT02549027|20632|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
8581|NCT02549027|20633|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
8582|NCT02549027|20634|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
8583|NCT02549027|20635|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
8584|NCT02549027|20636|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
8585|NCT02549027|20637|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
8586|NCT02549027|20632|P6|STARTED|Period 1 - MK-1064 or Placebo||0
8587|NCT02549027|20633|P5|STARTED|Period 1 - MK-1064 or Placebo||0
8588|NCT02549027|20634|P4|STARTED|Period 1 - MK-1064 or Placebo||5
8589|NCT02549027|20635|P3|STARTED|Period 1 - MK-1064 or Placebo||5
8590|NCT02549027|20636|P2|STARTED|Period 1 - MK-1064 or Placebo||5
8591|NCT02549027|20637|P1|STARTED|Period 1 - MK-1064 or Placebo||5
8592|NCT02549014|20674|P2|NOT COMPLETED|Overall Study||0
8593|NCT02549014|20675|P1|NOT COMPLETED|Overall Study||0
8594|NCT02549014|20674|P2|COMPLETED|Overall Study||8
8595|NCT02549014|20675|P1|COMPLETED|Overall Study||8
8596|NCT02549014|20674|P2|STARTED|Overall Study||8
8597|NCT02549014|20675|P1|STARTED|Overall Study||8
8598|NCT02548455|20765|P1|NOT COMPLETED|Overall Study||240
8599|NCT02548455|20765|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
8600|NCT02548455|20765|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
8601|NCT02548455|20765|P1|Completed 6-Month Follow-up|Overall Study||259
8602|NCT02548455|20765|P1|Completed Pre-Discharge|Overall Study||484
8603|NCT02548455|20765|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
8604|NCT02548156|20769|P6|NOT COMPLETED|Period 3||0
8605|NCT02548156|20770|P5|NOT COMPLETED|Period 3||0
8606|NCT02548156|20771|P4|NOT COMPLETED|Period 3||0
8607|NCT02548156|20772|P3|NOT COMPLETED|Period 3||0
8608|NCT02548156|20773|P2|NOT COMPLETED|Period 3||0
8609|NCT02548156|20774|P1|NOT COMPLETED|Period 3||0
8610|NCT02548156|20769|P6|COMPLETED|Period 3||5
8611|NCT02548156|20770|P5|COMPLETED|Period 3||4
8612|NCT02548156|20771|P4|COMPLETED|Period 3||5
8613|NCT02548156|20772|P3|COMPLETED|Period 3||4
8614|NCT02548156|20773|P2|COMPLETED|Period 3||5
8615|NCT02548156|20774|P1|COMPLETED|Period 3||5
8616|NCT02548156|20769|P6|STARTED|Period 3||5
8617|NCT02548156|20770|P5|STARTED|Period 3||4
8618|NCT02548156|20771|P4|STARTED|Period 3||5
8619|NCT02548156|20772|P3|STARTED|Period 3||4
8620|NCT02548156|20773|P2|STARTED|Period 3||5
8621|NCT02548156|20774|P1|STARTED|Period 3||5
8622|NCT02548156|20769|P6|NOT COMPLETED|Washout Period 2||0
8623|NCT02548156|20770|P5|NOT COMPLETED|Washout Period 2||0
8624|NCT02548156|20771|P4|NOT COMPLETED|Washout Period 2||0
8625|NCT02548156|20772|P3|NOT COMPLETED|Washout Period 2||0
8626|NCT02548156|20773|P2|NOT COMPLETED|Washout Period 2||0
8627|NCT02548156|20774|P1|NOT COMPLETED|Washout Period 2||0
8628|NCT02548156|20769|P6|COMPLETED|Washout Period 2||5
8629|NCT02548156|20770|P5|COMPLETED|Washout Period 2||4
8630|NCT02548156|20771|P4|COMPLETED|Washout Period 2||5
8631|NCT02548156|20772|P3|COMPLETED|Washout Period 2||4
8632|NCT02548156|20773|P2|COMPLETED|Washout Period 2||5
8633|NCT02548156|20774|P1|COMPLETED|Washout Period 2||5
8634|NCT02548156|20769|P6|STARTED|Washout Period 2||5
8635|NCT02548156|20770|P5|STARTED|Washout Period 2||4
8636|NCT02548156|20771|P4|STARTED|Washout Period 2||5
8637|NCT02548156|20772|P3|STARTED|Washout Period 2||4
8638|NCT02548156|20773|P2|STARTED|Washout Period 2||5
8639|NCT02548156|20774|P1|STARTED|Washout Period 2||5
8640|NCT02548156|20769|P6|NOT COMPLETED|Period 2||0
8641|NCT02548156|20770|P5|NOT COMPLETED|Period 2||0
8642|NCT02548156|20771|P4|NOT COMPLETED|Period 2||0
8643|NCT02548156|20772|P3|NOT COMPLETED|Period 2||0
8644|NCT02548156|20773|P2|NOT COMPLETED|Period 2||0
8645|NCT02548156|20774|P1|NOT COMPLETED|Period 2||0
8646|NCT02548156|20769|P6|COMPLETED|Period 2||5
8647|NCT02548156|20770|P5|COMPLETED|Period 2||4
8648|NCT02548156|20771|P4|COMPLETED|Period 2||5
8649|NCT02548156|20772|P3|COMPLETED|Period 2||4
8650|NCT02548156|20773|P2|COMPLETED|Period 2||5
8651|NCT02548156|20774|P1|COMPLETED|Period 2||5
8652|NCT02548156|20769|P6|STARTED|Period 2||5
8653|NCT02548156|20770|P5|STARTED|Period 2||4
8654|NCT02548156|20771|P4|STARTED|Period 2||5
8655|NCT02548156|20772|P3|STARTED|Period 2||4
8656|NCT02548156|20773|P2|STARTED|Period 2||5
8657|NCT02548156|20774|P1|STARTED|Period 2||5
8658|NCT02548156|20769|P6|NOT COMPLETED|Washout Period 1||0
8659|NCT02548156|20770|P5|NOT COMPLETED|Washout Period 1||1
8660|NCT02548156|20771|P4|NOT COMPLETED|Washout Period 1||0
8661|NCT02548156|20772|P3|NOT COMPLETED|Washout Period 1||0
8662|NCT02548156|20773|P2|NOT COMPLETED|Washout Period 1||0
8663|NCT02548156|20774|P1|NOT COMPLETED|Washout Period 1||0
8664|NCT02548156|20769|P6|COMPLETED|Washout Period 1||5
8665|NCT02548156|20770|P5|COMPLETED|Washout Period 1||4
8666|NCT02548156|20771|P4|COMPLETED|Washout Period 1||5
8667|NCT02548156|20772|P3|COMPLETED|Washout Period 1||4
8668|NCT02548156|20773|P2|COMPLETED|Washout Period 1||5
8669|NCT02548156|20774|P1|COMPLETED|Washout Period 1||5
8670|NCT02548156|20769|P6|STARTED|Washout Period 1||5
8671|NCT02548156|20770|P5|STARTED|Washout Period 1||5
8672|NCT02548156|20771|P4|STARTED|Washout Period 1||5
8673|NCT02548156|20772|P3|STARTED|Washout Period 1||4
8674|NCT02548156|20773|P2|STARTED|Washout Period 1||5
8675|NCT02548156|20774|P1|STARTED|Washout Period 1||5
8676|NCT02548156|20769|P6|NOT COMPLETED|Period 1||0
8677|NCT02548156|20770|P5|NOT COMPLETED|Period 1||0
8678|NCT02548156|20771|P4|NOT COMPLETED|Period 1||0
8679|NCT02548156|20772|P3|NOT COMPLETED|Period 1||0
8680|NCT02548156|20773|P2|NOT COMPLETED|Period 1||0
8681|NCT02548156|20774|P1|NOT COMPLETED|Period 1||0
8682|NCT02548156|20769|P6|COMPLETED|Period 1||5
8683|NCT02548156|20770|P5|COMPLETED|Period 1||5
8684|NCT02548156|20771|P4|COMPLETED|Period 1||5
8685|NCT02548156|20772|P3|COMPLETED|Period 1||4
8686|NCT02548156|20773|P2|COMPLETED|Period 1||5
8687|NCT02548156|20774|P1|COMPLETED|Period 1||5
8688|NCT02548156|20769|P6|STARTED|Period 1||5
8689|NCT02548156|20770|P5|STARTED|Period 1||5
8690|NCT02548156|20771|P4|STARTED|Period 1||5
8691|NCT02548156|20772|P3|STARTED|Period 1||4
8692|NCT02548156|20773|P2|STARTED|Period 1||5
8693|NCT02548156|20774|P1|STARTED|Period 1||5
8694|NCT02548078|20793|P2|NOT COMPLETED|Overall Study||6
8695|NCT02548078|20794|P1|NOT COMPLETED|Overall Study||5
8696|NCT02548078|20793|P2|COMPLETED|Overall Study||294
8697|NCT02548078|20794|P1|COMPLETED|Overall Study||295
8698|NCT02548078|20793|P2|STARTED|Overall Study||300
8699|NCT02548078|20794|P1|STARTED|Overall Study||300
8700|NCT02547714|20982|P1|NOT COMPLETED|Overall Study||0
8701|NCT02547714|20982|P1|COMPLETED|Overall Study||34
8702|NCT02547714|20982|P1|STARTED|Overall Study||34
8703|NCT02547454|20992|P1|NOT COMPLETED|Overall Study||172
8704|NCT02547454|20992|P1|COMPLETED|Overall Study||221
8705|NCT02547454|20992|P1|STARTED|Overall Study||393
8706|NCT02547064|21022|P2|NOT COMPLETED|Overall Study||2
8707|NCT02547064|21023|P1|NOT COMPLETED|Overall Study||3
8708|NCT02547064|21022|P2|COMPLETED|Overall Study||79
8709|NCT02547064|21023|P1|COMPLETED|Overall Study||78
8710|NCT02547064|21022|P2|STARTED|Overall Study||81
8711|NCT02547064|21023|P1|STARTED|Overall Study||81
8712|NCT02546986|21051|P2|NOT COMPLETED|Survival Follow-Up Phase||35
8713|NCT02546986|21052|P1|NOT COMPLETED|Survival Follow-Up Phase||36
8714|NCT02546986|21051|P2|COMPLETED|Survival Follow-Up Phase||0
8715|NCT02546986|21052|P1|COMPLETED|Survival Follow-Up Phase||0
8716|NCT02546986|21051|P2|STARTED|Survival Follow-Up Phase||35
8717|NCT02546986|21052|P1|STARTED|Survival Follow-Up Phase||36
8718|NCT02546986|21051|P2|NOT COMPLETED|Treatment Period||49
8719|NCT02546986|21052|P1|NOT COMPLETED|Treatment Period||51
8720|NCT02546986|21051|P2|COMPLETED|Treatment Period||0
8721|NCT02546986|21052|P1|COMPLETED|Treatment Period||0
8722|NCT02546986|21051|P2|STARTED|Treatment Period||49
8723|NCT02546986|21052|P1|STARTED|Treatment Period||51
8724|NCT02546609|21078|P3|NOT COMPLETED|Overall Study||7
8725|NCT02546609|21079|P2|NOT COMPLETED|Overall Study||11
8726|NCT02546609|21080|P1|NOT COMPLETED|Overall Study||2
8727|NCT02546609|21078|P3|COMPLETED|Overall Study||25
8728|NCT02546609|21079|P2|COMPLETED|Overall Study||24
8729|NCT02546609|21080|P1|COMPLETED|Overall Study||22
8730|NCT02546609|21078|P3|STARTED|Overall Study||32
8731|NCT02546609|21079|P2|STARTED|Overall Study||35
8732|NCT02546609|21080|P1|STARTED|Overall Study||24
8733|NCT02545543|21123|P2|NOT COMPLETED|Overall Study||34
8734|NCT02545543|21124|P1|NOT COMPLETED|Overall Study||81
8735|NCT02545543|21123|P2|COMPLETED|Overall Study||535
8736|NCT02545543|21124|P1|COMPLETED|Overall Study||1628
8737|NCT02545543|21123|P2|STARTED|Overall Study||569
8738|NCT02545543|21124|P1|STARTED|Overall Study||1709
8739|NCT02545322|21148|P1|NOT COMPLETED|Overall Study||3
8740|NCT02545322|21148|P1|COMPLETED|Overall Study||15
8741|NCT02545322|21148|P1|STARTED|Overall Study||18
8742|NCT02545101|21153|P1|NOT COMPLETED|Overall Study||0
8743|NCT02545101|21153|P1|COMPLETED|Overall Study||100
8744|NCT02545101|21153|P1|STARTED|Overall Study||100
8745|NCT02544074|21191|P21|NOT COMPLETED|Overall Study||0
8746|NCT02544074|21192|P20|NOT COMPLETED|Overall Study||0
8747|NCT02544074|21193|P19|NOT COMPLETED|Overall Study||0
8748|NCT02544074|21194|P18|NOT COMPLETED|Overall Study||0
8749|NCT02544074|21195|P17|NOT COMPLETED|Overall Study||0
8750|NCT02544074|21196|P16|NOT COMPLETED|Overall Study||0
8751|NCT02544074|21197|P15|NOT COMPLETED|Overall Study||0
8752|NCT02544074|21198|P14|NOT COMPLETED|Overall Study||0
8753|NCT02544074|21199|P13|NOT COMPLETED|Overall Study||0
8754|NCT02544074|21200|P12|NOT COMPLETED|Overall Study||0
8755|NCT02544074|21201|P11|NOT COMPLETED|Overall Study||0
8756|NCT02544074|21202|P10|NOT COMPLETED|Overall Study||1
8757|NCT02544074|21203|P9|NOT COMPLETED|Overall Study||0
8758|NCT02544074|21204|P8|NOT COMPLETED|Overall Study||0
8759|NCT02544074|21205|P7|NOT COMPLETED|Overall Study||0
8760|NCT02544074|21206|P6|NOT COMPLETED|Overall Study||1
8761|NCT02544074|21207|P5|NOT COMPLETED|Overall Study||0
8762|NCT02544074|21208|P4|NOT COMPLETED|Overall Study||0
8763|NCT02544074|21209|P3|NOT COMPLETED|Overall Study||0
8764|NCT02544074|21210|P2|NOT COMPLETED|Overall Study||1
8765|NCT02544074|21211|P1|NOT COMPLETED|Overall Study||0
8766|NCT02544074|21191|P21|COMPLETED|Overall Study||3
8767|NCT02544074|21192|P20|COMPLETED|Overall Study||3
8768|NCT02544074|21193|P19|COMPLETED|Overall Study||4
8769|NCT02544074|21194|P18|COMPLETED|Overall Study||3
8770|NCT02544074|21195|P17|COMPLETED|Overall Study||6
8771|NCT02544074|21196|P16|COMPLETED|Overall Study||8
8772|NCT02544074|21197|P15|COMPLETED|Overall Study||5
8773|NCT02544074|21198|P14|COMPLETED|Overall Study||5
8774|NCT02544074|21199|P13|COMPLETED|Overall Study||4
8775|NCT02544074|21200|P12|COMPLETED|Overall Study||3
8776|NCT02544074|21201|P11|COMPLETED|Overall Study||2
8777|NCT02544074|21202|P10|COMPLETED|Overall Study||1
8778|NCT02544074|21203|P9|COMPLETED|Overall Study||6
8779|NCT02544074|21204|P8|COMPLETED|Overall Study||4
8780|NCT02544074|21205|P7|COMPLETED|Overall Study||2
8781|NCT02544074|21206|P6|COMPLETED|Overall Study||0
8782|NCT02544074|21207|P5|COMPLETED|Overall Study||4
8783|NCT02544074|21208|P4|COMPLETED|Overall Study||1
8784|NCT02544074|21209|P3|COMPLETED|Overall Study||1
8785|NCT02544074|21210|P2|COMPLETED|Overall Study||0
8786|NCT02544074|21211|P1|COMPLETED|Overall Study||1
8787|NCT02544074|21191|P21|STARTED|Overall Study||3
8788|NCT02544074|21192|P20|STARTED|Overall Study||3
8789|NCT02544074|21193|P19|STARTED|Overall Study||4
8790|NCT02544074|21194|P18|STARTED|Overall Study||3
8791|NCT02544074|21195|P17|STARTED|Overall Study||6
8792|NCT02544074|21196|P16|STARTED|Overall Study||8
8793|NCT02544074|21197|P15|STARTED|Overall Study||5
8794|NCT02544074|21198|P14|STARTED|Overall Study||5
8795|NCT02544074|21199|P13|STARTED|Overall Study||4
8796|NCT02544074|21200|P12|STARTED|Overall Study||3
8797|NCT02544074|21201|P11|STARTED|Overall Study||2
8798|NCT02544074|21202|P10|STARTED|Overall Study||2
8799|NCT02544074|21203|P9|STARTED|Overall Study||6
8800|NCT02544074|21204|P8|STARTED|Overall Study||4
8801|NCT02544074|21205|P7|STARTED|Overall Study||2
8802|NCT02544074|21206|P6|STARTED|Overall Study||1
8803|NCT02544074|21207|P5|STARTED|Overall Study||4
8804|NCT02544074|21208|P4|STARTED|Overall Study||1
8805|NCT02544074|21209|P3|STARTED|Overall Study||1
8806|NCT02544074|21210|P2|STARTED|Overall Study||1
8807|NCT02544074|21211|P1|STARTED|Overall Study||1
8808|NCT02543918|21247|P2|NOT COMPLETED|Overall Study||4
8809|NCT02543918|21248|P1|NOT COMPLETED|Overall Study||3
8810|NCT02543918|21247|P2|COMPLETED|Overall Study||39
8811|NCT02543918|21248|P1|COMPLETED|Overall Study||38
8812|NCT02543918|21247|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
8813|NCT02543918|21248|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
8814|NCT02543918|21247|P2|STARTED|Overall Study||43
8815|NCT02543918|21248|P1|STARTED|Overall Study||41
8816|NCT02543528|21254|P5|NOT COMPLETED|Extended Wear Period||0
8817|NCT02543528|21255|P4|NOT COMPLETED|Extended Wear Period||12
8818|NCT02543528|21256|P3|NOT COMPLETED|Extended Wear Period||28
8819|NCT02543528|21257|P2|NOT COMPLETED|Extended Wear Period||21
8820|NCT02543528|21258|P1|NOT COMPLETED|Extended Wear Period||23
8821|NCT02543528|21254|P5|COMPLETED|Extended Wear Period||0
8822|NCT02543528|21255|P4|COMPLETED|Extended Wear Period||23
8823|NCT02543528|21256|P3|COMPLETED|Extended Wear Period||8
8824|NCT02543528|21257|P2|COMPLETED|Extended Wear Period||14
8825|NCT02543528|21258|P1|COMPLETED|Extended Wear Period||13
8826|NCT02543528|21254|P5|STARTED|Extended Wear Period||0
8827|NCT02543528|21255|P4|STARTED|Extended Wear Period||35
8828|NCT02543528|21256|P3|STARTED|Extended Wear Period||36
8829|NCT02543528|21257|P2|STARTED|Extended Wear Period||35
8830|NCT02543528|21258|P1|STARTED|Extended Wear Period||36
8831|NCT02543528|21254|P5|NOT COMPLETED|Adaptation Period||26
8832|NCT02543528|21255|P4|NOT COMPLETED|Adaptation Period||0
8833|NCT02543528|21256|P3|NOT COMPLETED|Adaptation Period||0
8834|NCT02543528|21257|P2|NOT COMPLETED|Adaptation Period||0
8835|NCT02543528|21258|P1|NOT COMPLETED|Adaptation Period||0
8836|NCT02543528|21254|P5|COMPLETED|Adaptation Period||142
8837|NCT02543528|21255|P4|COMPLETED|Adaptation Period||0
8838|NCT02543528|21256|P3|COMPLETED|Adaptation Period||0
8839|NCT02543528|21257|P2|COMPLETED|Adaptation Period||0
8840|NCT02543528|21258|P1|COMPLETED|Adaptation Period||0
8841|NCT02543528|21254|P5|STARTED|Adaptation Period||168
8842|NCT02543528|21255|P4|STARTED|Adaptation Period||0
8843|NCT02543528|21256|P3|STARTED|Adaptation Period||0
8844|NCT02543528|21257|P2|STARTED|Adaptation Period||0
8845|NCT02543528|21258|P1|STARTED|Adaptation Period||0
8846|NCT02543437|21277|P1|NOT COMPLETED|Overall Study||0
8847|NCT02543437|21277|P1|COMPLETED|Overall Study||117
8848|NCT02543437|21277|P1|STARTED|Overall Study||117
8849|NCT02543398|21284|P2|NOT COMPLETED|Overall Study||0
8850|NCT02543398|21285|P1|NOT COMPLETED|Overall Study||0
8851|NCT02543398|21284|P2|COMPLETED|Overall Study||20
8852|NCT02543398|21285|P1|COMPLETED|Overall Study||20
8853|NCT02543398|21284|P2|STARTED|Overall Study||20
8854|NCT02543398|21285|P1|STARTED|Overall Study||20
8855|NCT02542943|21294|P3|NOT COMPLETED|Overall Study||0
8856|NCT02542943|21295|P2|NOT COMPLETED|Overall Study||1
8857|NCT02542943|21296|P1|NOT COMPLETED|Overall Study||1
8858|NCT02542943|21294|P3|COMPLETED|Overall Study||81
8859|NCT02542943|21295|P2|COMPLETED|Overall Study||79
8860|NCT02542943|21296|P1|COMPLETED|Overall Study||78
8861|NCT02542943|21294|P3|STARTED|Overall Study||81
8862|NCT02542943|21295|P2|STARTED|Overall Study||80
8863|NCT02542943|21296|P1|STARTED|Overall Study||79
8864|NCT02542761|21321|P2|NOT COMPLETED|Second Intervention||0
8865|NCT02542761|21322|P1|NOT COMPLETED|Second Intervention||0
8866|NCT02542761|21321|P2|COMPLETED|Second Intervention||5
8867|NCT02542761|21322|P1|COMPLETED|Second Intervention||5
8868|NCT02542761|21321|P2|STARTED|Second Intervention||5
8869|NCT02542761|21322|P1|STARTED|Second Intervention||5
8870|NCT02542761|21321|P2|NOT COMPLETED|Acclimation Period 2||0
8871|NCT02542761|21322|P1|NOT COMPLETED|Acclimation Period 2||0
8872|NCT02542761|21321|P2|COMPLETED|Acclimation Period 2||5
8873|NCT02542761|21322|P1|COMPLETED|Acclimation Period 2||5
8874|NCT02542761|21321|P2|STARTED|Acclimation Period 2||5
8875|NCT02542761|21322|P1|STARTED|Acclimation Period 2||5
8876|NCT02542761|21321|P2|NOT COMPLETED|First Intervention||0
8877|NCT02542761|21322|P1|NOT COMPLETED|First Intervention||0
8878|NCT02542761|21321|P2|COMPLETED|First Intervention||5
8879|NCT02542761|21322|P1|COMPLETED|First Intervention||5
8880|NCT02542761|21321|P2|STARTED|First Intervention||5
8881|NCT02542761|21322|P1|STARTED|First Intervention||5
8882|NCT02542761|21321|P2|NOT COMPLETED|Acclimation Period 1||0
8883|NCT02542761|21322|P1|NOT COMPLETED|Acclimation Period 1||0
8884|NCT02542761|21321|P2|COMPLETED|Acclimation Period 1||5
8885|NCT02542761|21322|P1|COMPLETED|Acclimation Period 1||5
8886|NCT02542761|21321|P2|STARTED|Acclimation Period 1||5
8887|NCT02542761|21322|P1|STARTED|Acclimation Period 1||5
8888|NCT02542280|21340|P2|NOT COMPLETED|Overall Study||8
8889|NCT02542280|21341|P1|NOT COMPLETED|Overall Study||12
8890|NCT02542280|21340|P2|COMPLETED|Overall Study||167
8891|NCT02542280|21341|P1|COMPLETED|Overall Study||162
8892|NCT02542280|21340|P2|STARTED|Overall Study||175
8893|NCT02542280|21341|P1|STARTED|Overall Study||174
8894|NCT02542072|21351|P2|NOT COMPLETED|Second Intervention (1 Month)||0
8895|NCT02542072|21352|P1|NOT COMPLETED|Second Intervention (1 Month)||2
8896|NCT02542072|21351|P2|COMPLETED|Second Intervention (1 Month)||43
8897|NCT02542072|21352|P1|COMPLETED|Second Intervention (1 Month)||37
8898|NCT02542072|21351|P2|STARTED|Second Intervention (1 Month)||43
8899|NCT02542072|21352|P1|STARTED|Second Intervention (1 Month)||39
8900|NCT02542072|21351|P2|NOT COMPLETED|First Intervention (1 Month)||3
8901|NCT02542072|21352|P1|NOT COMPLETED|First Intervention (1 Month)||5
8902|NCT02542072|21351|P2|COMPLETED|First Intervention (1 Month)||43
8903|NCT02542072|21352|P1|COMPLETED|First Intervention (1 Month)||39
8904|NCT02542072|21351|P2|STARTED|First Intervention (1 Month)||46
8905|NCT02542072|21352|P1|STARTED|First Intervention (1 Month)||44
8906|NCT02541864|21454|P2|NOT COMPLETED|Overall Study||0
8907|NCT02541864|21455|P1|NOT COMPLETED|Overall Study||0
8908|NCT02541864|21454|P2|COMPLETED|Overall Study||166
8909|NCT02541864|21455|P1|COMPLETED|Overall Study||164
8910|NCT02541864|21454|P2|STARTED|Overall Study||166
8911|NCT02541864|21455|P1|STARTED|Overall Study||164
8912|NCT02541422|21461|P2|NOT COMPLETED|Second Intervention||0
8913|NCT02541422|21462|P1|NOT COMPLETED|Second Intervention||0
8914|NCT02541422|21461|P2|COMPLETED|Second Intervention||26
8915|NCT02541422|21462|P1|COMPLETED|Second Intervention||23
8916|NCT02541422|21461|P2|STARTED|Second Intervention||26
8917|NCT02541422|21462|P1|STARTED|Second Intervention||23
8918|NCT02541422|21461|P2|NOT COMPLETED|First Intervention||0
8919|NCT02541422|21462|P1|NOT COMPLETED|First Intervention||0
8920|NCT02541422|21461|P2|COMPLETED|First Intervention||26
8921|NCT02541422|21462|P1|COMPLETED|First Intervention||23
8922|NCT02541422|21461|P2|STARTED|First Intervention||26
8923|NCT02541422|21462|P1|STARTED|First Intervention||23
8924|NCT02540850|21471|P3|NOT COMPLETED|Overall Study||34
8925|NCT02540850|21472|P2|NOT COMPLETED|Overall Study||66
8926|NCT02540850|21473|P1|NOT COMPLETED|Overall Study||69
8927|NCT02540850|21471|P3|COMPLETED|Overall Study||410
8928|NCT02540850|21472|P2|COMPLETED|Overall Study||330
8929|NCT02540850|21473|P1|COMPLETED|Overall Study||291
8930|NCT02540850|21471|P3|STARTED|Overall Study||444
8931|NCT02540850|21472|P2|STARTED|Overall Study||396
8932|NCT02540850|21473|P1|STARTED|Overall Study||360
8933|NCT02540772|21501|P2|NOT COMPLETED|Overall Study||0
8934|NCT02540772|21502|P1|NOT COMPLETED|Overall Study||0
8935|NCT02540772|21501|P2|COMPLETED|Overall Study||10
8936|NCT02540772|21502|P1|COMPLETED|Overall Study||10
8937|NCT02540772|21501|P2|STARTED|Overall Study||10
8938|NCT02540772|21502|P1|STARTED|Overall Study||10
8939|NCT02540447|21516|P2|NOT COMPLETED|Overall Study||0
8940|NCT02540447|21517|P1|NOT COMPLETED|Overall Study||0
8941|NCT02540447|21516|P2|COMPLETED|Overall Study||40
8942|NCT02540447|21517|P1|COMPLETED|Overall Study||40
8943|NCT02540447|21516|P2|STARTED|Overall Study||40
8944|NCT02540447|21517|P1|STARTED|Overall Study||40
8945|NCT02540434|21533|P2|NOT COMPLETED|Overall Study||0
8946|NCT02540434|21534|P1|NOT COMPLETED|Overall Study||0
8947|NCT02540434|21533|P2|COMPLETED|Overall Study||1
8948|NCT02540434|21534|P1|COMPLETED|Overall Study||0
8949|NCT02540434|21533|P2|STARTED|Overall Study||1
8950|NCT02540434|21534|P1|STARTED|Overall Study||0
8951|NCT02540356|21544|P2|NOT COMPLETED|Overall Study||0
8952|NCT02540356|21545|P1|NOT COMPLETED|Overall Study||1
8953|NCT02540356|21544|P2|COMPLETED|Overall Study||0
8954|NCT02540356|21545|P1|COMPLETED|Overall Study||0
8955|NCT02540356|21544|P2|STARTED|Overall Study||0
8956|NCT02540356|21545|P1|STARTED|Overall Study||1
8957|NCT02540265|21579|P3|NOT COMPLETED|Overall Study||1
8958|NCT02540265|21580|P2|NOT COMPLETED|Overall Study||0
8959|NCT02540265|21581|P1|NOT COMPLETED|Overall Study||0
8960|NCT02540265|21579|P3|COMPLETED|Overall Study||18
8961|NCT02540265|21580|P2|COMPLETED|Overall Study||20
8962|NCT02540265|21581|P1|COMPLETED|Overall Study||20
8963|NCT02540265|21579|P3|Treatment Completion|Overall Study||18
8964|NCT02540265|21580|P2|Treatment Completion|Overall Study||19
8965|NCT02540265|21581|P1|Treatment Completion|Overall Study||20
8966|NCT02540265|21579|P3|STARTED|Overall Study||19
8967|NCT02540265|21580|P2|STARTED|Overall Study||20
8968|NCT02540265|21581|P1|STARTED|Overall Study||20
8969|NCT02540213|21601|P1|NOT COMPLETED|Overall Study||39
8970|NCT02540213|21601|P1|COMPLETED|Overall Study||201
8971|NCT02540213|21601|P1|STARTED|Overall Study||240
8972|NCT02539992|21625|P3|NOT COMPLETED|Overall Study||4
8973|NCT02539992|21626|P2|NOT COMPLETED|Overall Study||4
8974|NCT02539992|21627|P1|NOT COMPLETED|Overall Study||0
8975|NCT02539992|21625|P3|COMPLETED|Overall Study||14
8976|NCT02539992|21626|P2|COMPLETED|Overall Study||7
8977|NCT02539992|21627|P1|COMPLETED|Overall Study||15
8978|NCT02539992|21625|P3|STARTED|Overall Study||18
8979|NCT02539992|21626|P2|STARTED|Overall Study||11
8980|NCT02539992|21627|P1|STARTED|Overall Study||15
8981|NCT02539797|21653|P3|NOT COMPLETED|Overall Study||0
8982|NCT02539797|21654|P2|NOT COMPLETED|Overall Study||1
8983|NCT02539797|21655|P1|NOT COMPLETED|Overall Study||0
8984|NCT02539797|21653|P3|COMPLETED|Overall Study||13
8985|NCT02539797|21654|P2|COMPLETED|Overall Study||12
8986|NCT02539797|21655|P1|COMPLETED|Overall Study||12
8987|NCT02539797|21653|P3|STARTED|Overall Study||13
8988|NCT02539797|21654|P2|STARTED|Overall Study||13
8989|NCT02539797|21655|P1|STARTED|Overall Study||12
8990|NCT02539134|21672|P6|NOT COMPLETED|Overall Study||0
8991|NCT02539134|21673|P5|NOT COMPLETED|Overall Study||0
8992|NCT02539134|21674|P4|NOT COMPLETED|Overall Study||0
8993|NCT02539134|21675|P3|NOT COMPLETED|Overall Study||0
8994|NCT02539134|21676|P2|NOT COMPLETED|Overall Study||0
8995|NCT02539134|21677|P1|NOT COMPLETED|Overall Study||1
8996|NCT02539134|21672|P6|COMPLETED|Overall Study||6
8997|NCT02539134|21673|P5|COMPLETED|Overall Study||6
8998|NCT02539134|21674|P4|COMPLETED|Overall Study||6
8999|NCT02539134|21675|P3|COMPLETED|Overall Study||6
9000|NCT02539134|21676|P2|COMPLETED|Overall Study||6
9001|NCT02539134|21677|P1|COMPLETED|Overall Study||9
9002|NCT02539134|21672|P6|STARTED|Overall Study||6
9003|NCT02539134|21673|P5|STARTED|Overall Study||6
9004|NCT02539134|21674|P4|STARTED|Overall Study||6
9005|NCT02539134|21675|P3|STARTED|Overall Study||6
9006|NCT02539134|21676|P2|STARTED|Overall Study||6
9007|NCT02539134|21677|P1|STARTED|Overall Study||10
9008|NCT02539108|21731|P2|NOT COMPLETED|Overall Study||0
9009|NCT02539108|21732|P1|NOT COMPLETED|Overall Study||0
9010|NCT02539108|21731|P2|COMPLETED|Overall Study||30
9011|NCT02539108|21732|P1|COMPLETED|Overall Study||30
9012|NCT02539108|21731|P2|STARTED|Overall Study||30
9013|NCT02539108|21732|P1|STARTED|Overall Study||30
9014|NCT02538679|21749|P3|NOT COMPLETED|Overall Study||8
9015|NCT02538679|21750|P2|NOT COMPLETED|Overall Study||9
9016|NCT02538679|21751|P1|NOT COMPLETED|Overall Study||3
9017|NCT02538679|21749|P3|COMPLETED|Overall Study||41
9018|NCT02538679|21750|P2|COMPLETED|Overall Study||45
9019|NCT02538679|21751|P1|COMPLETED|Overall Study||21
9020|NCT02538679|21749|P3|STARTED|Overall Study||49
9021|NCT02538679|21750|P2|STARTED|Overall Study||54
9022|NCT02538679|21751|P1|STARTED|Overall Study||24
9023|NCT02538107|21759|P1|NOT COMPLETED|Overall Study||110
9024|NCT02538107|21759|P1|COMPLETED|Overall Study||180
9025|NCT02538107|21759|P1|STARTED|Overall Study||290
9026|NCT02537730|21779|P2|NOT COMPLETED|Second Intervention (7 Days)||0
9027|NCT02537730|21780|P1|NOT COMPLETED|Second Intervention (7 Days)||0
9028|NCT02537730|21779|P2|COMPLETED|Second Intervention (7 Days)||16
9029|NCT02537730|21780|P1|COMPLETED|Second Intervention (7 Days)||17
9030|NCT02537730|21779|P2|STARTED|Second Intervention (7 Days)||16
9031|NCT02537730|21780|P1|STARTED|Second Intervention (7 Days)||17
9032|NCT02537730|21779|P2|NOT COMPLETED|First Intervention (7 Days)||0
9033|NCT02537730|21780|P1|NOT COMPLETED|First Intervention (7 Days)||0
9034|NCT02537730|21779|P2|COMPLETED|First Intervention (7 Days)||16
9035|NCT02537730|21780|P1|COMPLETED|First Intervention (7 Days)||17
9036|NCT02537730|21779|P2|STARTED|First Intervention (7 Days)||16
9037|NCT02537730|21780|P1|STARTED|First Intervention (7 Days)||17
9038|NCT02537522|21792|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
9039|NCT02537522|21793|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
9040|NCT02537522|21794|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
9041|NCT02537522|21795|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
9042|NCT02537522|21792|P4|COMPLETED|Phase II - Period 2 Bilateral||22
9043|NCT02537522|21793|P3|COMPLETED|Phase II - Period 2 Bilateral||23
9044|NCT02537522|21794|P2|COMPLETED|Phase II - Period 2 Bilateral||0
9045|NCT02537522|21795|P1|COMPLETED|Phase II - Period 2 Bilateral||0
9046|NCT02537522|21792|P4|STARTED|Phase II - Period 2 Bilateral||22
9047|NCT02537522|21793|P3|STARTED|Phase II - Period 2 Bilateral||23
9048|NCT02537522|21794|P2|STARTED|Phase II - Period 2 Bilateral||0
9049|NCT02537522|21795|P1|STARTED|Phase II - Period 2 Bilateral||0
9050|NCT02537522|21792|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
9051|NCT02537522|21793|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
9052|NCT02537522|21794|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
9053|NCT02537522|21795|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
9054|NCT02537522|21792|P4|COMPLETED|Phase II - Period 1 Bilateral||22
9055|NCT02537522|21793|P3|COMPLETED|Phase II - Period 1 Bilateral||23
9056|NCT02537522|21794|P2|COMPLETED|Phase II - Period 1 Bilateral||0
9057|NCT02537522|21795|P1|COMPLETED|Phase II - Period 1 Bilateral||0
9058|NCT02537522|21792|P4|STARTED|Phase II - Period 1 Bilateral||23
9059|NCT02537522|21793|P3|STARTED|Phase II - Period 1 Bilateral||23
9060|NCT02537522|21794|P2|STARTED|Phase II - Period 1 Bilateral||0
9061|NCT02537522|21795|P1|STARTED|Phase II - Period 1 Bilateral||0
9062|NCT02537522|21792|P4|NOT COMPLETED|Phase I - Contralateral||0
9063|NCT02537522|21793|P3|NOT COMPLETED|Phase I - Contralateral||0
9064|NCT02537522|21794|P2|NOT COMPLETED|Phase I - Contralateral||10
9065|NCT02537522|21795|P1|NOT COMPLETED|Phase I - Contralateral||15
9066|NCT02537522|21792|P4|COMPLETED|Phase I - Contralateral||0
9067|NCT02537522|21793|P3|COMPLETED|Phase I - Contralateral||0
9068|NCT02537522|21794|P2|COMPLETED|Phase I - Contralateral||27
9069|NCT02537522|21795|P1|COMPLETED|Phase I - Contralateral||19
9070|NCT02537522|21792|P4|STARTED|Phase I - Contralateral||0
9071|NCT02537522|21793|P3|STARTED|Phase I - Contralateral||0
9072|NCT02537522|21794|P2|STARTED|Phase I - Contralateral||37
9073|NCT02537522|21795|P1|STARTED|Phase I - Contralateral||34
9074|NCT02536781|21805|P2|NOT COMPLETED|Overall Study||0
9075|NCT02536781|21806|P1|NOT COMPLETED|Overall Study||2
9076|NCT02536781|21805|P2|COMPLETED|Overall Study||34
9077|NCT02536781|21806|P1|COMPLETED|Overall Study||34
9078|NCT02536781|21805|P2|STARTED|Overall Study||34
9079|NCT02536781|21806|P1|STARTED|Overall Study||36
9080|NCT02536664|21816|P2|NOT COMPLETED|Overall Study||80
9081|NCT02536664|21817|P1|NOT COMPLETED|Overall Study||107
9082|NCT02536664|21816|P2|COMPLETED|Overall Study||97
9083|NCT02536664|21817|P1|COMPLETED|Overall Study||205
9084|NCT02536664|21816|P2|STARTED|Overall Study||177
9085|NCT02536664|21817|P1|STARTED|Overall Study||312
9086|NCT02536313|21837|P2|NOT COMPLETED|Overall Study||1
9087|NCT02536313|21838|P1|NOT COMPLETED|Overall Study||0
9088|NCT02536313|21837|P2|COMPLETED|Overall Study||24
9089|NCT02536313|21838|P1|COMPLETED|Overall Study||24
9090|NCT02536313|21837|P2|STARTED|Overall Study||25
9091|NCT02536313|21838|P1|STARTED|Overall Study||24
9092|NCT02535741|21854|P1|NOT COMPLETED|Overall Study||32
9093|NCT02535741|21854|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
9094|NCT02535741|21854|P1|STARTED|Overall Study||168
9095|NCT02535416|21871|P9|NOT COMPLETED|Overall Study||0
9096|NCT02535416|21872|P8|NOT COMPLETED|Overall Study||0
9097|NCT02535416|21873|P7|NOT COMPLETED|Overall Study||0
9098|NCT02535416|21874|P6|NOT COMPLETED|Overall Study||0
9099|NCT02535416|21875|P5|NOT COMPLETED|Overall Study||0
9100|NCT02535416|21876|P4|NOT COMPLETED|Overall Study||0
9101|NCT02535416|21877|P3|NOT COMPLETED|Overall Study||0
9102|NCT02535416|21878|P2|NOT COMPLETED|Overall Study||0
9103|NCT02535416|21879|P1|NOT COMPLETED|Overall Study||1
9104|NCT02535416|21871|P9|COMPLETED|Overall Study||6
9105|NCT02535416|21872|P8|COMPLETED|Overall Study||6
9106|NCT02535416|21873|P7|COMPLETED|Overall Study||6
9107|NCT02535416|21874|P6|COMPLETED|Overall Study||4
9108|NCT02535416|21875|P5|COMPLETED|Overall Study||4
9109|NCT02535416|21876|P4|COMPLETED|Overall Study||4
9110|NCT02535416|21877|P3|COMPLETED|Overall Study||4
9111|NCT02535416|21878|P2|COMPLETED|Overall Study||2
9112|NCT02535416|21879|P1|COMPLETED|Overall Study||3
9113|NCT02535416|21871|P9|STARTED|Overall Study||6
9114|NCT02535416|21872|P8|STARTED|Overall Study||6
9115|NCT02535416|21873|P7|STARTED|Overall Study||6
9116|NCT02535416|21874|P6|STARTED|Overall Study||4
9117|NCT02535416|21875|P5|STARTED|Overall Study||4
9118|NCT02535416|21876|P4|STARTED|Overall Study||4
9119|NCT02535416|21877|P3|STARTED|Overall Study||4
9120|NCT02535416|21878|P2|STARTED|Overall Study||2
9121|NCT02535416|21879|P1|STARTED|Overall Study||4
9122|NCT02535026|21931|P1|NOT COMPLETED|Overall Study||0
9123|NCT02535026|21931|P1|COMPLETED|Overall Study||580
9124|NCT02535026|21931|P1|STARTED|Overall Study||580
9125|NCT02534935|21986|P3|NOT COMPLETED|Overall Study||5
9126|NCT02534935|21987|P2|NOT COMPLETED|Overall Study||10
9127|NCT02534935|21988|P1|NOT COMPLETED|Overall Study||0
9128|NCT02534935|21986|P3|COMPLETED|Overall Study||127
9129|NCT02534935|21987|P2|COMPLETED|Overall Study||210
9130|NCT02534935|21988|P1|COMPLETED|Overall Study||44
9131|NCT02534935|21986|P3|STARTED|Overall Study||132
9132|NCT02534935|21987|P2|STARTED|Overall Study||220
9133|NCT02534935|21988|P1|STARTED|Overall Study||44
9134|NCT02534493|22146|P1|NOT COMPLETED|Overall Study||2
9135|NCT02534493|22146|P1|COMPLETED|Overall Study||11
9136|NCT02534493|22146|P1|STARTED|Overall Study||13
9137|NCT02534324|22157|P2|NOT COMPLETED|Overall Study||8
9138|NCT02534324|22158|P1|NOT COMPLETED|Overall Study||25
9139|NCT02534324|22157|P2|COMPLETED|Overall Study||40
9140|NCT02534324|22158|P1|COMPLETED|Overall Study||73
9141|NCT02534324|22157|P2|STARTED|Overall Study||48
9142|NCT02534324|22158|P1|STARTED|Overall Study||98
9143|NCT02534129|22168|P2|NOT COMPLETED|Overall Study||0
9144|NCT02534129|22169|P1|NOT COMPLETED|Overall Study||0
9145|NCT02534129|22168|P2|COMPLETED|Overall Study||13
9146|NCT02534129|22169|P1|COMPLETED|Overall Study||13
9147|NCT02534129|22168|P2|STARTED|Overall Study||13
9148|NCT02534129|22169|P1|STARTED|Overall Study||13
9149|NCT02533999|22177|P2|NOT COMPLETED|Overall Study||7
9150|NCT02533999|22178|P1|NOT COMPLETED|Overall Study||6
9151|NCT02533999|22177|P2|COMPLETED|Overall Study||30
9152|NCT02533999|22178|P1|COMPLETED|Overall Study||32
9153|NCT02533999|22177|P2|STARTED|Overall Study||37
9154|NCT02533999|22178|P1|STARTED|Overall Study||38
9155|NCT02533726|22198|P2|NOT COMPLETED|Treatment||0
9156|NCT02533726|22199|P1|NOT COMPLETED|Treatment||0
9157|NCT02533726|22198|P2|COMPLETED|Treatment||603
9158|NCT02533726|22199|P1|COMPLETED|Treatment||709
9159|NCT02533726|22198|P2|Per Protocol Population|Treatment||555
9160|NCT02533726|22199|P1|Per Protocol Population|Treatment||671
9161|NCT02533726|22198|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
9162|NCT02533726|22199|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
9163|NCT02533726|22198|P2|NOT COMPLETED|Initial Allocation||0
9164|NCT02533726|22199|P1|NOT COMPLETED|Initial Allocation||0
9165|NCT02533726|22198|P2|COMPLETED|Initial Allocation||653
9166|NCT02533726|22199|P1|COMPLETED|Initial Allocation||659
9167|NCT02533726|22198|P2|STARTED|Initial Allocation||653
9168|NCT02533726|22199|P1|STARTED|Initial Allocation||659
9169|NCT02533531|22207|P1|NOT COMPLETED|Overall Study||1
9170|NCT02533531|22207|P1|COMPLETED|Overall Study||0
9171|NCT02533531|22207|P1|STARTED|Overall Study||1
9172|NCT02533466|22214|P2|NOT COMPLETED|Overall Study||0
9173|NCT02533466|22215|P1|NOT COMPLETED|Overall Study||0
9174|NCT02533466|22214|P2|COMPLETED|Overall Study||14
9175|NCT02533466|22215|P1|COMPLETED|Overall Study||16
9176|NCT02533466|22214|P2|STARTED|Overall Study||14
9177|NCT02533466|22215|P1|STARTED|Overall Study||16
9178|NCT02533401|22239|P1|NOT COMPLETED|Overall Study||11
9179|NCT02533401|22239|P1|COMPLETED|Overall Study||23
9180|NCT02533401|22239|P1|STARTED|Overall Study||34
9181|NCT02533258|22247|P1|NOT COMPLETED|Overall Study||8
9182|NCT02533258|22247|P1|COMPLETED|Overall Study||5
9183|NCT02533258|22247|P1|STARTED|Overall Study||13
9184|NCT02532998|22259|P1|NOT COMPLETED|Overall Study||0
9185|NCT02532998|22259|P1|COMPLETED|Overall Study||23
9186|NCT02532998|22259|P1|STARTED|Overall Study||23
9187|NCT02532374|22341|P1|NOT COMPLETED|Overall Study||2
9188|NCT02532374|22341|P1|COMPLETED|Overall Study||14
9189|NCT02532374|22341|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
9190|NCT02532374|22341|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
9191|NCT02532374|22341|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
9192|NCT02532374|22341|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
9193|NCT02532374|22341|P1|STARTED|Overall Study||16
9194|NCT02532179|22365|P1|NOT COMPLETED|Overall Study||3
9195|NCT02532179|22365|P1|COMPLETED|Overall Study||9
9196|NCT02532179|22365|P1|STARTED|Overall Study||12
9197|NCT02531867|22374|P1|NOT COMPLETED|Overall Study||0
9198|NCT02531867|22374|P1|COMPLETED|Overall Study||13
9199|NCT02531867|22374|P1|STARTED|Overall Study||13
9200|NCT02531698|22380|P2|NOT COMPLETED|Overall Study||2
9201|NCT02531698|22381|P1|NOT COMPLETED|Overall Study||11
9202|NCT02531698|22380|P2|COMPLETED|Overall Study||104
9203|NCT02531698|22381|P1|COMPLETED|Overall Study||283
9204|NCT02531698|22380|P2|STARTED|Overall Study||106
9205|NCT02531698|22381|P1|STARTED|Overall Study||294
9206|NCT02531646|22628|P3|NOT COMPLETED|Overall Study||0
9207|NCT02531646|22629|P2|NOT COMPLETED|Overall Study||1
9208|NCT02531646|22630|P1|NOT COMPLETED|Overall Study||5
9209|NCT02531646|22628|P3|COMPLETED|Overall Study||11
9210|NCT02531646|22629|P2|COMPLETED|Overall Study||17
9211|NCT02531646|22630|P1|COMPLETED|Overall Study||32
9212|NCT02531646|22628|P3|STARTED|Overall Study||11
9213|NCT02531646|22629|P2|STARTED|Overall Study||18
9214|NCT02531646|22630|P1|STARTED|Overall Study||37
9215|NCT02531373|22653|P9|NOT COMPLETED|Overall Study||9
9216|NCT02531373|22654|P8|NOT COMPLETED|Overall Study||9
9217|NCT02531373|22655|P7|NOT COMPLETED|Overall Study||11
9218|NCT02531373|22656|P6|NOT COMPLETED|Overall Study||9
9219|NCT02531373|22657|P5|NOT COMPLETED|Overall Study||8
9220|NCT02531373|22658|P4|NOT COMPLETED|Overall Study||0
9221|NCT02531373|22659|P3|NOT COMPLETED|Overall Study||0
9222|NCT02531373|22660|P2|NOT COMPLETED|Overall Study||0
9223|NCT02531373|22661|P1|NOT COMPLETED|Overall Study||0
9224|NCT02531373|22653|P9|COMPLETED|Overall Study||43
9225|NCT02531373|22654|P8|COMPLETED|Overall Study||43
9226|NCT02531373|22655|P7|COMPLETED|Overall Study||41
9227|NCT02531373|22656|P6|COMPLETED|Overall Study||42
9228|NCT02531373|22657|P5|COMPLETED|Overall Study||43
9229|NCT02531373|22658|P4|COMPLETED|Overall Study||20
9230|NCT02531373|22659|P3|COMPLETED|Overall Study||20
9231|NCT02531373|22660|P2|COMPLETED|Overall Study||20
9232|NCT02531373|22661|P1|COMPLETED|Overall Study||20
9233|NCT02531373|22653|P9|Vaccination 4|Overall Study||43
9234|NCT02531373|22654|P8|Vaccination 4|Overall Study||43
9235|NCT02531373|22655|P7|Vaccination 4|Overall Study||43
9236|NCT02531373|22656|P6|Vaccination 4|Overall Study||43
9237|NCT02531373|22657|P5|Vaccination 4|Overall Study||44
9238|NCT02531373|22658|P4|Vaccination 4|Overall Study||0
9239|NCT02531373|22659|P3|Vaccination 4|Overall Study||0
9240|NCT02531373|22660|P2|Vaccination 4|Overall Study||0
9241|NCT02531373|22661|P1|Vaccination 4|Overall Study||0
9242|NCT02531373|22653|P9|Vaccination 3|Overall Study||49
9243|NCT02531373|22654|P8|Vaccination 3|Overall Study||51
9244|NCT02531373|22655|P7|Vaccination 3|Overall Study||49
9245|NCT02531373|22656|P6|Vaccination 3|Overall Study||47
9246|NCT02531373|22657|P5|Vaccination 3|Overall Study||48
9247|NCT02531373|22658|P4|Vaccination 3|Overall Study||0
9248|NCT02531373|22659|P3|Vaccination 3|Overall Study||0
9249|NCT02531373|22660|P2|Vaccination 3|Overall Study||0
9250|NCT02531373|22661|P1|Vaccination 3|Overall Study||0
9251|NCT02531373|22653|P9|Vaccination 2|Overall Study||51
9252|NCT02531373|22654|P8|Vaccination 2|Overall Study||51
9253|NCT02531373|22655|P7|Vaccination 2|Overall Study||50
9254|NCT02531373|22656|P6|Vaccination 2|Overall Study||48
9255|NCT02531373|22657|P5|Vaccination 2|Overall Study||49
9256|NCT02531373|22658|P4|Vaccination 2|Overall Study||0
9257|NCT02531373|22659|P3|Vaccination 2|Overall Study||0
9258|NCT02531373|22660|P2|Vaccination 2|Overall Study||0
9259|NCT02531373|22661|P1|Vaccination 2|Overall Study||0
9260|NCT02531373|22653|P9|Vaccination 1|Overall Study||52
9261|NCT02531373|22654|P8|Vaccination 1|Overall Study||52
9262|NCT02531373|22655|P7|Vaccination 1|Overall Study||52
9263|NCT02531373|22656|P6|Vaccination 1|Overall Study||50
9264|NCT02531373|22657|P5|Vaccination 1|Overall Study||50
9265|NCT02531373|22658|P4|Vaccination 1|Overall Study||20
9266|NCT02531373|22659|P3|Vaccination 1|Overall Study||20
9267|NCT02531373|22660|P2|Vaccination 1|Overall Study||20
9268|NCT02531373|22661|P1|Vaccination 1|Overall Study||20
9269|NCT02531373|22653|P9|STARTED|Overall Study||52
9270|NCT02531373|22654|P8|STARTED|Overall Study||52
9271|NCT02531373|22655|P7|STARTED|Overall Study||52
9272|NCT02531373|22656|P6|STARTED|Overall Study||51
9273|NCT02531373|22657|P5|STARTED|Overall Study||51
9274|NCT02531373|22658|P4|STARTED|Overall Study||20
9275|NCT02531373|22659|P3|STARTED|Overall Study||20
9276|NCT02531373|22660|P2|STARTED|Overall Study||20
9277|NCT02531373|22661|P1|STARTED|Overall Study||20
9278|NCT02531308|22718|P1|NOT COMPLETED|Overall Study||3
9279|NCT02531308|22718|P1|COMPLETED|Overall Study||2
9280|NCT02531308|22718|P1|STARTED|Overall Study||5
9281|NCT02530671|22724|P2|NOT COMPLETED|Overall Study||0
9282|NCT02530671|22725|P1|NOT COMPLETED|Overall Study||3
9283|NCT02530671|22724|P2|COMPLETED|Overall Study||55
9284|NCT02530671|22725|P1|COMPLETED|Overall Study||52
9285|NCT02530671|22724|P2|STARTED|Overall Study||55
9286|NCT02530671|22725|P1|STARTED|Overall Study||55
9287|NCT02530450|22743|P2|NOT COMPLETED|Overall Study||5
9288|NCT02530450|22744|P1|NOT COMPLETED|Overall Study||6
9289|NCT02530450|22743|P2|COMPLETED|Overall Study||9
9290|NCT02530450|22744|P1|COMPLETED|Overall Study||10
9291|NCT02530450|22743|P2|STARTED|Overall Study||14
9292|NCT02530450|22744|P1|STARTED|Overall Study||16
9293|NCT02530125|22750|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
9294|NCT02530125|22750|P1|COMPLETED|Followed for Survival for 2 Years||0
9295|NCT02530125|22750|P1|STARTED|Followed for Survival for 2 Years||3
9296|NCT02530125|22750|P1|NOT COMPLETED|Completed Treatment||1
9297|NCT02530125|22750|P1|COMPLETED|Completed Treatment||3
9298|NCT02530125|22750|P1|STARTED|Completed Treatment||4
9299|NCT02529995|22764|P2|NOT COMPLETED|Part B||12
9300|NCT02529995|22765|P1|NOT COMPLETED|Part B||6
9301|NCT02529995|22764|P2|COMPLETED|Part B||4
9302|NCT02529995|22765|P1|COMPLETED|Part B||9
9303|NCT02529995|22764|P2|STARTED|Part B||16
9304|NCT02529995|22765|P1|STARTED|Part B||15
9305|NCT02529995|22764|P2|NOT COMPLETED|Part A||16
9306|NCT02529995|22765|P1|NOT COMPLETED|Part A||15
9307|NCT02529995|22764|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
9308|NCT02529995|22765|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
9309|NCT02529995|22764|P2|STARTED|Part A||16
9310|NCT02529995|22765|P1|STARTED|Part A||15
9311|NCT02529488|22799|P1|NOT COMPLETED|Overall Study||4
9312|NCT02529488|22799|P1|COMPLETED|Overall Study||145
9313|NCT02529488|22799|P1|STARTED|Overall Study||149
9314|NCT02528786|22807|P1|NOT COMPLETED|Overall Study||0
9315|NCT02528786|22807|P1|COMPLETED|Overall Study||8
9316|NCT02528786|22807|P1|STARTED|Overall Study||8
9317|NCT02528721|22813|P2|NOT COMPLETED|Overall Study||3
9318|NCT02528721|22814|P1|NOT COMPLETED|Overall Study||7
9319|NCT02528721|22813|P2|COMPLETED|Overall Study||76
9320|NCT02528721|22814|P1|COMPLETED|Overall Study||196
9321|NCT02528721|22813|P2|STARTED|Overall Study||79
9322|NCT02528721|22814|P1|STARTED|Overall Study||203
9323|NCT02528331|22824|P1|NOT COMPLETED|Overall Study||2
9324|NCT02528331|22824|P1|COMPLETED|Overall Study||0
9325|NCT02528331|22824|P1|STARTED|Overall Study||2
9326|NCT02528305|22831|P1|NOT COMPLETED|Overall Study||3
9327|NCT02528305|22831|P1|COMPLETED|Overall Study||9
9328|NCT02528305|22831|P1|End of Intervention Period Assessment|Overall Study||9
9329|NCT02528305|22831|P1|End of Control Period Assessment|Overall Study||11
9330|NCT02528305|22831|P1|STARTED|Overall Study||12
9331|NCT02528097|22875|P2|NOT COMPLETED|Overall Study||0
9332|NCT02528097|22876|P1|NOT COMPLETED|Overall Study||0
9333|NCT02528097|22875|P2|COMPLETED|Overall Study||1
9334|NCT02528097|22876|P1|COMPLETED|Overall Study||1
9335|NCT02528097|22875|P2|STARTED|Overall Study||1
9336|NCT02528097|22876|P1|STARTED|Overall Study||1
9337|NCT02527161|22884|P1|NOT COMPLETED|Overall Study||62
9338|NCT02527161|22884|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
9339|NCT02527161|22884|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
9340|NCT02527148|22903|P2|NOT COMPLETED|Overall Study||0
9341|NCT02527148|22904|P1|NOT COMPLETED|Overall Study||1
9342|NCT02527148|22903|P2|COMPLETED|Overall Study||50
9343|NCT02527148|22904|P1|COMPLETED|Overall Study||49
9344|NCT02527148|22903|P2|STARTED|Overall Study||50
9345|NCT02527148|22904|P1|STARTED|Overall Study||50
9346|NCT02526550|22922|P1|NOT COMPLETED|Overall Study||1
9347|NCT02526550|22922|P1|COMPLETED|Overall Study||49
9348|NCT02526550|22922|P1|STARTED|Overall Study||50
9349|NCT02526524|22934|P6|NOT COMPLETED|Overall Study||21
9350|NCT02526524|22935|P5|NOT COMPLETED|Overall Study||24
9351|NCT02526524|22936|P4|NOT COMPLETED|Overall Study||7
9352|NCT02526524|22937|P3|NOT COMPLETED|Overall Study||26
9353|NCT02526524|22938|P2|NOT COMPLETED|Overall Study||9
9354|NCT02526524|22939|P1|NOT COMPLETED|Overall Study||12
9355|NCT02526524|22934|P6|COMPLETED|Overall Study||73
9356|NCT02526524|22935|P5|COMPLETED|Overall Study||72
9357|NCT02526524|22936|P4|COMPLETED|Overall Study||89
9358|NCT02526524|22937|P3|COMPLETED|Overall Study||70
9359|NCT02526524|22938|P2|COMPLETED|Overall Study||86
9360|NCT02526524|22939|P1|COMPLETED|Overall Study||82
9361|NCT02526524|22934|P6|STARTED|Overall Study||94
9362|NCT02526524|22935|P5|STARTED|Overall Study||96
9363|NCT02526524|22936|P4|STARTED|Overall Study||96
9364|NCT02526524|22937|P3|STARTED|Overall Study||96
9365|NCT02526524|22938|P2|STARTED|Overall Study||95
9366|NCT02526524|22939|P1|STARTED|Overall Study||94
9367|NCT02526290|22953|P1|NOT COMPLETED|Overall Study||8
9368|NCT02526290|22953|P1|COMPLETED|Overall Study||89
9369|NCT02526290|22953|P1|STARTED|Overall Study||97
9370|NCT02525536|22963|P3|NOT COMPLETED|Overall Study||0
9371|NCT02525536|22964|P2|NOT COMPLETED|Overall Study||0
9372|NCT02525536|22965|P1|NOT COMPLETED|Overall Study||0
9373|NCT02525536|22963|P3|COMPLETED|Overall Study||6
9374|NCT02525536|22964|P2|COMPLETED|Overall Study||6
9375|NCT02525536|22965|P1|COMPLETED|Overall Study||6
9376|NCT02525536|22963|P3|STARTED|Overall Study||6
9377|NCT02525536|22964|P2|STARTED|Overall Study||6
9378|NCT02525536|22965|P1|STARTED|Overall Study||6
9379|NCT02525094|23038|P2|NOT COMPLETED|Overall Study||8
9380|NCT02525094|23039|P1|NOT COMPLETED|Overall Study||8
9381|NCT02525094|23038|P2|COMPLETED|Overall Study||48
9382|NCT02525094|23039|P1|COMPLETED|Overall Study||49
9383|NCT02525094|23038|P2|Treated|Overall Study||55
9384|NCT02525094|23039|P1|Treated|Overall Study||56
9385|NCT02525094|23038|P2|STARTED|Overall Study||56
9386|NCT02525094|23039|P1|STARTED|Overall Study||57
9387|NCT02524665|23066|P1|NOT COMPLETED|Overall Study||1
9388|NCT02524665|23066|P1|COMPLETED|Overall Study||19
9389|NCT02524665|23066|P1|STARTED|Overall Study||20
9390|NCT02524561|23084|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
9391|NCT02524561|23085|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
9392|NCT02524561|23086|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
9393|NCT02524561|23084|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
9394|NCT02524561|23085|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
9395|NCT02524561|23086|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
9396|NCT02524561|23084|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
9397|NCT02524561|23085|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
9398|NCT02524561|23086|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
9399|NCT02524561|23084|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
9400|NCT02524561|23085|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
9401|NCT02524561|23086|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
9402|NCT02524561|23084|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
9403|NCT02524561|23085|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
9404|NCT02524561|23086|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
9405|NCT02524561|23084|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
9406|NCT02524561|23085|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
9407|NCT02524561|23086|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
9408|NCT02524561|23084|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
9409|NCT02524561|23085|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
9410|NCT02524561|23086|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
9411|NCT02524561|23084|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
9412|NCT02524561|23085|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
9413|NCT02524561|23086|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
9414|NCT02524561|23084|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
9415|NCT02524561|23085|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
9416|NCT02524561|23086|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
9417|NCT02524561|23084|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
9418|NCT02524561|23085|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
9419|NCT02524561|23086|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
9420|NCT02524561|23084|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
9421|NCT02524561|23085|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
9422|NCT02524561|23086|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
9423|NCT02524561|23084|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
9424|NCT02524561|23085|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
9425|NCT02524561|23086|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
9426|NCT02524418|23103|P1|NOT COMPLETED|Overall Study||13
9427|NCT02524418|23103|P1|COMPLETED|Overall Study||75
9428|NCT02524418|23103|P1|STARTED|Overall Study||88
9429|NCT02524288|23117|P1|NOT COMPLETED|Overall Study||1941
9430|NCT02524288|23117|P1|COMPLETED|Overall Study||0
9431|NCT02524288|23117|P1|Treated|Overall Study||1936
9432|NCT02524288|23117|P1|STARTED|Overall Study||1941
9433|NCT02524158|23127|P2|NOT COMPLETED|6-month Assessment||21
9434|NCT02524158|23128|P1|NOT COMPLETED|6-month Assessment||22
9435|NCT02524158|23127|P2|COMPLETED|6-month Assessment||55
9436|NCT02524158|23128|P1|COMPLETED|6-month Assessment||54
9437|NCT02524158|23127|P2|STARTED|6-month Assessment||76
9438|NCT02524158|23128|P1|STARTED|6-month Assessment||76
9439|NCT02524158|23127|P2|NOT COMPLETED|12-weeks Assessment||13
9440|NCT02524158|23128|P1|NOT COMPLETED|12-weeks Assessment||19
9441|NCT02524158|23127|P2|COMPLETED|12-weeks Assessment||63
9442|NCT02524158|23128|P1|COMPLETED|12-weeks Assessment||57
9443|NCT02524158|23127|P2|STARTED|12-weeks Assessment||76
9444|NCT02524158|23128|P1|STARTED|12-weeks Assessment||76
9445|NCT02524054|23142|P3|NOT COMPLETED|Overall Study||0
9446|NCT02524054|23143|P2|NOT COMPLETED|Overall Study||0
9447|NCT02524054|23144|P1|NOT COMPLETED|Overall Study||0
9448|NCT02524054|23142|P3|COMPLETED|Overall Study||8
9449|NCT02524054|23143|P2|COMPLETED|Overall Study||9
9450|NCT02524054|23144|P1|COMPLETED|Overall Study||7
9451|NCT02524054|23142|P3|STARTED|Overall Study||8
9452|NCT02524054|23143|P2|STARTED|Overall Study||9
9453|NCT02524054|23144|P1|STARTED|Overall Study||7
9454|NCT02522624|23157|P2|NOT COMPLETED|Overall Study||0
9455|NCT02522624|23158|P1|NOT COMPLETED|Overall Study||1
9456|NCT02522624|23157|P2|COMPLETED|Overall Study||163
9457|NCT02522624|23158|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
9458|NCT02522624|23157|P2|STARTED|Overall Study||163
9459|NCT02522624|23158|P1|STARTED|Overall Study||165
9460|NCT02520726|23176|P2|NOT COMPLETED|Overall Study||2
9461|NCT02520726|23177|P1|NOT COMPLETED|Overall Study||3
9462|NCT02520726|23176|P2|COMPLETED|Overall Study||0
9463|NCT02520726|23177|P1|COMPLETED|Overall Study||0
9464|NCT02520726|23176|P2|STARTED|Overall Study||2
9465|NCT02520726|23177|P1|STARTED|Overall Study||3
9466|NCT02520414|23185|P1|NOT COMPLETED|Overall Study||0
9467|NCT02520414|23185|P1|COMPLETED|Overall Study||10
9468|NCT02520414|23185|P1|STARTED|Overall Study||10
9469|NCT02519855|23191|P2|NOT COMPLETED|Overall Study||4
9470|NCT02519855|23192|P1|NOT COMPLETED|Overall Study||3
9471|NCT02519855|23191|P2|COMPLETED|Overall Study||437
9472|NCT02519855|23192|P1|COMPLETED|Overall Study||438
9473|NCT02519855|23191|P2|Vaccinated at Week 4|Overall Study||424
9474|NCT02519855|23192|P1|Vaccinated at Week 4|Overall Study||432
9475|NCT02519855|23191|P2|Vaccinated on Day 1|Overall Study||441
9476|NCT02519855|23192|P1|Vaccinated on Day 1|Overall Study||440
9477|NCT02519855|23191|P2|STARTED|Overall Study|Participants are included as treated|441
9478|NCT02519855|23192|P1|STARTED|Overall Study|Participants are included as treated|441
9479|NCT02519842|23210|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
9480|NCT02519842|23211|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
9481|NCT02519842|23212|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
9482|NCT02519842|23210|P3|COMPLETED|Optional Extension: Cycles 2-6||26
9483|NCT02519842|23211|P2|COMPLETED|Optional Extension: Cycles 2-6||0
9484|NCT02519842|23212|P1|COMPLETED|Optional Extension: Cycles 2-6||0
9485|NCT02519842|23210|P3|Treated|Optional Extension: Cycles 2-6||55
9486|NCT02519842|23211|P2|Treated|Optional Extension: Cycles 2-6||0
9487|NCT02519842|23212|P1|Treated|Optional Extension: Cycles 2-6||0
9488|NCT02519842|23210|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
9489|NCT02519842|23211|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
9490|NCT02519842|23212|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
9491|NCT02519842|23210|P3|NOT COMPLETED|Base Study: Cycle 1||0
9492|NCT02519842|23211|P2|NOT COMPLETED|Base Study: Cycle 1||3
9493|NCT02519842|23212|P1|NOT COMPLETED|Base Study: Cycle 1||2
9494|NCT02519842|23210|P3|COMPLETED|Base Study: Cycle 1||0
9495|NCT02519842|23211|P2|COMPLETED|Base Study: Cycle 1||34
9496|NCT02519842|23212|P1|COMPLETED|Base Study: Cycle 1||36
9497|NCT02519842|23210|P3|Treated|Base Study: Cycle 1||0
9498|NCT02519842|23211|P2|Treated|Base Study: Cycle 1||34
9499|NCT02519842|23212|P1|Treated|Base Study: Cycle 1||37
9500|NCT02519842|23210|P3|STARTED|Base Study: Cycle 1||0
9501|NCT02519842|23211|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
9502|NCT02519842|23212|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
9503|NCT02519712|23231|P1|NOT COMPLETED|Overall Study||4
9504|NCT02519712|23231|P1|COMPLETED|Overall Study||0
9505|NCT02519712|23231|P1|STARTED|Overall Study||4
9506|NCT02519595|23238|P3|NOT COMPLETED|Overall Study||16
9507|NCT02519595|23239|P2|NOT COMPLETED|Overall Study||22
9508|NCT02519595|23240|P1|NOT COMPLETED|Overall Study||8
9509|NCT02519595|23238|P3|COMPLETED|Overall Study||40
9510|NCT02519595|23239|P2|COMPLETED|Overall Study||35
9511|NCT02519595|23240|P1|COMPLETED|Overall Study||50
9512|NCT02519595|23238|P3|STARTED|Overall Study||56
9513|NCT02519595|23239|P2|STARTED|Overall Study||57
9514|NCT02519595|23240|P1|STARTED|Overall Study||58
9515|NCT02519387|23263|P1|NOT COMPLETED|Overall Study||22
9516|NCT02519387|23263|P1|COMPLETED|Overall Study||56
9517|NCT02519387|23263|P1|STARTED|Overall Study||78
9518|NCT02518048|23271|P1|NOT COMPLETED|Overall Study||1
9519|NCT02518048|23271|P1|COMPLETED|Overall Study||34
9520|NCT02518048|23271|P1|STARTED|Overall Study||35
9521|NCT02517580|23282|P1|NOT COMPLETED|Overall Study||4
9522|NCT02517580|23282|P1|COMPLETED|Overall Study||56
9523|NCT02517580|23282|P1|STARTED|Overall Study||60
9524|NCT02517567|23286|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
9525|NCT02517567|23287|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
9526|NCT02517567|23288|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
9527|NCT02517567|23289|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
9528|NCT02517567|23286|P4|COMPLETED|Fourth Exposure (8 Hours)||8
9529|NCT02517567|23287|P3|COMPLETED|Fourth Exposure (8 Hours)||6
9530|NCT02517567|23288|P2|COMPLETED|Fourth Exposure (8 Hours)||8
9531|NCT02517567|23289|P1|COMPLETED|Fourth Exposure (8 Hours)||6
9532|NCT02517567|23286|P4|STARTED|Fourth Exposure (8 Hours)||8
9533|NCT02517567|23287|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
9534|NCT02517567|23288|P2|STARTED|Fourth Exposure (8 Hours)||8
9535|NCT02517567|23289|P1|STARTED|Fourth Exposure (8 Hours)||6
9536|NCT02517567|23286|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
9537|NCT02517567|23287|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
9538|NCT02517567|23288|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
9539|NCT02517567|23289|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
9540|NCT02517567|23286|P4|COMPLETED|Third Exposure (8 Hours)||8
9541|NCT02517567|23287|P3|COMPLETED|Third Exposure (8 Hours)||7
9542|NCT02517567|23288|P2|COMPLETED|Third Exposure (8 Hours)||8
9543|NCT02517567|23289|P1|COMPLETED|Third Exposure (8 Hours)||6
9544|NCT02517567|23286|P4|STARTED|Third Exposure (8 Hours)||8
9545|NCT02517567|23287|P3|STARTED|Third Exposure (8 Hours)||7
9546|NCT02517567|23288|P2|STARTED|Third Exposure (8 Hours)||8
9547|NCT02517567|23289|P1|STARTED|Third Exposure (8 Hours)||6
9548|NCT02517567|23286|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
9549|NCT02517567|23287|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
9550|NCT02517567|23288|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
9551|NCT02517567|23289|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
9552|NCT02517567|23286|P4|COMPLETED|Second Exposure (8 Hours)||8
9553|NCT02517567|23287|P3|COMPLETED|Second Exposure (8 Hours)||7
9554|NCT02517567|23288|P2|COMPLETED|Second Exposure (8 Hours)||8
9555|NCT02517567|23289|P1|COMPLETED|Second Exposure (8 Hours)||6
9556|NCT02517567|23286|P4|STARTED|Second Exposure (8 Hours)||8
9557|NCT02517567|23287|P3|STARTED|Second Exposure (8 Hours)||7
9558|NCT02517567|23288|P2|STARTED|Second Exposure (8 Hours)||8
9559|NCT02517567|23289|P1|STARTED|Second Exposure (8 Hours)||6
9560|NCT02517567|23286|P4|NOT COMPLETED|First Exposure (8 Hours)||0
9561|NCT02517567|23287|P3|NOT COMPLETED|First Exposure (8 Hours)||0
9562|NCT02517567|23288|P2|NOT COMPLETED|First Exposure (8 Hours)||0
9563|NCT02517567|23289|P1|NOT COMPLETED|First Exposure (8 Hours)||0
9564|NCT02517567|23286|P4|COMPLETED|First Exposure (8 Hours)||8
9565|NCT02517567|23287|P3|COMPLETED|First Exposure (8 Hours)||7
9566|NCT02517567|23288|P2|COMPLETED|First Exposure (8 Hours)||8
9567|NCT02517567|23289|P1|COMPLETED|First Exposure (8 Hours)||6
9568|NCT02517567|23286|P4|STARTED|First Exposure (8 Hours)||8
9569|NCT02517567|23287|P3|STARTED|First Exposure (8 Hours)||7
9570|NCT02517567|23288|P2|STARTED|First Exposure (8 Hours)||8
9571|NCT02517567|23289|P1|STARTED|First Exposure (8 Hours)||6
9572|NCT02517515|23300|P2|NOT COMPLETED|Overall Study||2
9573|NCT02517515|23301|P1|NOT COMPLETED|Overall Study||2
9574|NCT02517515|23300|P2|COMPLETED|Overall Study||323
9575|NCT02517515|23301|P1|COMPLETED|Overall Study||323
9576|NCT02517515|23300|P2|STARTED|Overall Study||325
9577|NCT02517515|23301|P1|STARTED|Overall Study||325
9578|NCT02517047|23316|P1|NOT COMPLETED|Overall Study||2
9579|NCT02517047|23316|P1|COMPLETED|Overall Study||24
9580|NCT02517047|23316|P1|STARTED|Overall Study||26
9581|NCT02516306|23325|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
9582|NCT02516306|23326|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
9583|NCT02516306|23325|P2|COMPLETED|Period 2: Day 8 - 91||23
9584|NCT02516306|23326|P1|COMPLETED|Period 2: Day 8 - 91||49
9585|NCT02516306|23325|P2|STARTED|Period 2: Day 8 - 91||25
9586|NCT02516306|23326|P1|STARTED|Period 2: Day 8 - 91||50
9587|NCT02516306|23325|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
9588|NCT02516306|23326|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
9589|NCT02516306|23325|P2|COMPLETED|Period 1: Day 1 - 7||25
9590|NCT02516306|23326|P1|COMPLETED|Period 1: Day 1 - 7||50
9591|NCT02516306|23325|P2|STARTED|Period 1: Day 1 - 7||25
9592|NCT02516306|23326|P1|STARTED|Period 1: Day 1 - 7||50
9593|NCT02516163|23332|P1|NOT COMPLETED|Overall Study||28
9594|NCT02516163|23332|P1|COMPLETED|Overall Study||24
9595|NCT02516163|23332|P1|STARTED|Overall Study||52
9596|NCT02516150|23336|P1|NOT COMPLETED|Overall Study||0
9597|NCT02516150|23336|P1|COMPLETED|Overall Study||15
9598|NCT02516150|23336|P1|STARTED|Overall Study||15
9599|NCT02516098|23346|P2|NOT COMPLETED|Washout After Period 2||0
9600|NCT02516098|23347|P1|NOT COMPLETED|Washout After Period 2||0
9601|NCT02516098|23346|P2|COMPLETED|Washout After Period 2||26
9602|NCT02516098|23347|P1|COMPLETED|Washout After Period 2||27
9603|NCT02516098|23346|P2|STARTED|Washout After Period 2||26
9604|NCT02516098|23347|P1|STARTED|Washout After Period 2||27
9605|NCT02516098|23346|P2|NOT COMPLETED|Period 2||1
9606|NCT02516098|23347|P1|NOT COMPLETED|Period 2||0
9607|NCT02516098|23346|P2|COMPLETED|Period 2||26
9608|NCT02516098|23347|P1|COMPLETED|Period 2||27
9609|NCT02516098|23346|P2|STARTED|Period 2||27
9610|NCT02516098|23347|P1|STARTED|Period 2||27
9611|NCT02516098|23346|P2|NOT COMPLETED|Washout After Period 1||1
9612|NCT02516098|23347|P1|NOT COMPLETED|Washout After Period 1||0
9613|NCT02516098|23346|P2|COMPLETED|Washout After Period 1||27
9614|NCT02516098|23347|P1|COMPLETED|Washout After Period 1||27
9615|NCT02516098|23346|P2|STARTED|Washout After Period 1||28
9616|NCT02516098|23347|P1|STARTED|Washout After Period 1||27
9617|NCT02516098|23346|P2|NOT COMPLETED|Period 1||0
9618|NCT02516098|23347|P1|NOT COMPLETED|Period 1||1
9619|NCT02516098|23346|P2|COMPLETED|Period 1||28
9620|NCT02516098|23347|P1|COMPLETED|Period 1||27
9621|NCT02516098|23346|P2|STARTED|Period 1||28
9622|NCT02516098|23347|P1|STARTED|Period 1||28
9623|NCT02515994|23361|P2|NOT COMPLETED|Overall Study||7
9624|NCT02515994|23362|P1|NOT COMPLETED|Overall Study||10
9625|NCT02515994|23361|P2|COMPLETED|Overall Study||105
9626|NCT02515994|23362|P1|COMPLETED|Overall Study||99
9627|NCT02515994|23361|P2|STARTED|Overall Study||112
9628|NCT02515994|23362|P1|STARTED|Overall Study||109
9629|NCT02515851|23376|P2|NOT COMPLETED|Overall Study||0
9630|NCT02515851|23377|P1|NOT COMPLETED|Overall Study||0
9631|NCT02515851|23376|P2|COMPLETED|Overall Study||15
9632|NCT02515851|23377|P1|COMPLETED|Overall Study||15
9633|NCT02515851|23376|P2|STARTED|Overall Study||15
9634|NCT02515851|23377|P1|STARTED|Overall Study||15
9635|NCT02515279|23389|P1|NOT COMPLETED|Overall Study||104
9636|NCT02515279|23389|P1|COMPLETED|Overall Study||359
9637|NCT02515279|23389|P1|STARTED|Overall Study||463
9638|NCT02515058|23397|P2|NOT COMPLETED|Overall Study||2
9639|NCT02515058|23398|P1|NOT COMPLETED|Overall Study||3
9640|NCT02515058|23397|P2|COMPLETED|Overall Study||20
9641|NCT02515058|23398|P1|COMPLETED|Overall Study||18
9642|NCT02515058|23397|P2|STARTED|Overall Study||22
9643|NCT02515058|23398|P1|STARTED|Overall Study||21
9644|NCT02515045|23408|P3|NOT COMPLETED|Overall Study||4
9645|NCT02515045|23409|P2|NOT COMPLETED|Overall Study||4
9646|NCT02515045|23410|P1|NOT COMPLETED|Overall Study||0
9647|NCT02515045|23408|P3|COMPLETED|Overall Study||55
9648|NCT02515045|23409|P2|COMPLETED|Overall Study||26
9649|NCT02515045|23410|P1|COMPLETED|Overall Study||29
9650|NCT02515045|23408|P3|STARTED|Overall Study||59
9651|NCT02515045|23409|P2|STARTED|Overall Study||30
9652|NCT02515045|23410|P1|STARTED|Overall Study||29
9653|NCT02514889|23426|P2|NOT COMPLETED|Follow-up Assessment Participation||12
9654|NCT02514889|23427|P1|NOT COMPLETED|Follow-up Assessment Participation||10
9655|NCT02514889|23426|P2|COMPLETED|Follow-up Assessment Participation||86
9656|NCT02514889|23427|P1|COMPLETED|Follow-up Assessment Participation||92
9657|NCT02514889|23426|P2|STARTED|Follow-up Assessment Participation||98
9658|NCT02514889|23427|P1|STARTED|Follow-up Assessment Participation||102
9659|NCT02514889|23426|P2|NOT COMPLETED|Intervention Participation||8
9660|NCT02514889|23427|P1|NOT COMPLETED|Intervention Participation||9
9661|NCT02514889|23426|P2|COMPLETED|Intervention Participation||98
9662|NCT02514889|23427|P1|COMPLETED|Intervention Participation||102
9663|NCT02514889|23426|P2|STARTED|Intervention Participation||106
9664|NCT02514889|23427|P1|STARTED|Intervention Participation||111
9665|NCT02514889|23426|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
9666|NCT02514889|23427|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
9667|NCT02514889|23426|P2|COMPLETED|Randomization/Allocation to Condition||106
9668|NCT02514889|23427|P1|COMPLETED|Randomization/Allocation to Condition||111
9669|NCT02514889|23426|P2|STARTED|Randomization/Allocation to Condition||130
9670|NCT02514889|23427|P1|STARTED|Randomization/Allocation to Condition||131
9671|NCT02514772|23447|P2|NOT COMPLETED|Overall Study||2
9672|NCT02514772|23448|P1|NOT COMPLETED|Overall Study||3
9673|NCT02514772|23447|P2|COMPLETED|Overall Study||52
9674|NCT02514772|23448|P1|COMPLETED|Overall Study||50
9675|NCT02514772|23447|P2|STARTED|Overall Study||54
9676|NCT02514772|23448|P1|STARTED|Overall Study||53
9677|NCT02514473|23462|P2|NOT COMPLETED|Overall Study||5
9678|NCT02514473|23463|P1|NOT COMPLETED|Overall Study||3
9679|NCT02514473|23462|P2|COMPLETED|Overall Study||98
9680|NCT02514473|23463|P1|COMPLETED|Overall Study||98
9681|NCT02514473|23462|P2|STARTED|Overall Study||103
9682|NCT02514473|23463|P1|STARTED|Overall Study||101
9683|NCT02513771|23506|P2|NOT COMPLETED|Overall Study||1
9684|NCT02513771|23507|P1|NOT COMPLETED|Overall Study||2
9685|NCT02513771|23506|P2|COMPLETED|Overall Study||44
9686|NCT02513771|23507|P1|COMPLETED|Overall Study||43
9687|NCT02513771|23506|P2|STARTED|Overall Study||45
9688|NCT02513771|23507|P1|STARTED|Overall Study||45
9689|NCT02513550|23536|P3|NOT COMPLETED|Overall Study||74
9690|NCT02513550|23537|P2|NOT COMPLETED|Overall Study||38
9691|NCT02513550|23538|P1|NOT COMPLETED|Overall Study||36
9692|NCT02513550|23536|P3|COMPLETED|Overall Study||537
9693|NCT02513550|23537|P2|COMPLETED|Overall Study||268
9694|NCT02513550|23538|P1|COMPLETED|Overall Study||274
9695|NCT02513550|23536|P3|Received at Least One Dose of Study Drug|Overall Study||609
9696|NCT02513550|23537|P2|Received at Least One Dose of Study Drug|Overall Study||306
9697|NCT02513550|23538|P1|Received at Least One Dose of Study Drug|Overall Study||310
9698|NCT02513550|23536|P3|STARTED|Overall Study||611
9699|NCT02513550|23537|P2|STARTED|Overall Study||306
9700|NCT02513550|23538|P1|STARTED|Overall Study||310
9701|NCT02513160|23605|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
9702|NCT02513160|23606|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
9703|NCT02513160|23607|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
9704|NCT02513160|23608|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
9705|NCT02513160|23605|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
9706|NCT02513160|23606|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
9707|NCT02513160|23607|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
9708|NCT02513160|23608|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
9709|NCT02513160|23605|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
9710|NCT02513160|23606|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
9711|NCT02513160|23607|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
9712|NCT02513160|23608|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
9713|NCT02513160|23605|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
9714|NCT02513160|23606|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
9715|NCT02513160|23607|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
9716|NCT02513160|23608|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
9717|NCT02513160|23605|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
9718|NCT02513160|23606|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
9719|NCT02513160|23607|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
9720|NCT02513160|23608|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
9721|NCT02513160|23605|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
9722|NCT02513160|23606|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
9723|NCT02513160|23607|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
9724|NCT02513160|23608|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
9725|NCT02513095|23645|P2|NOT COMPLETED|Overall Study||16
9726|NCT02513095|23646|P1|NOT COMPLETED|Overall Study||14
9727|NCT02513095|23645|P2|COMPLETED|Overall Study||1
9728|NCT02513095|23646|P1|COMPLETED|Overall Study||3
9729|NCT02513095|23645|P2|STARTED|Overall Study||17
9730|NCT02513095|23646|P1|STARTED|Overall Study||17
9731|NCT02512900|23654|P2|NOT COMPLETED|Overall Study||0
9732|NCT02512900|23655|P1|NOT COMPLETED|Overall Study||0
9733|NCT02512900|23654|P2|COMPLETED|Overall Study||10
9734|NCT02512900|23655|P1|COMPLETED|Overall Study||11
9735|NCT02512900|23654|P2|STARTED|Overall Study||10
9736|NCT02512900|23655|P1|STARTED|Overall Study||11
9737|NCT02512783|23688|P2|NOT COMPLETED|Overall Study||0
9738|NCT02512783|23689|P1|NOT COMPLETED|Overall Study||0
9739|NCT02512783|23688|P2|COMPLETED|Overall Study||75
9740|NCT02512783|23689|P1|COMPLETED|Overall Study||96
9741|NCT02512783|23688|P2|STARTED|Overall Study||75
9742|NCT02512783|23689|P1|STARTED|Overall Study||96
9743|NCT02512679|23697|P2|NOT COMPLETED|Overall Study||0
9744|NCT02512679|23698|P1|NOT COMPLETED|Overall Study||0
9745|NCT02512679|23697|P2|COMPLETED|Overall Study||0
9746|NCT02512679|23698|P1|COMPLETED|Overall Study||20
9747|NCT02512679|23697|P2|STARTED|Overall Study||0
9748|NCT02512679|23698|P1|STARTED|Overall Study||20
9749|NCT02512393|23708|P2|NOT COMPLETED|Overall Study||0
9750|NCT02512393|23709|P1|NOT COMPLETED|Overall Study||1
9751|NCT02512393|23708|P2|COMPLETED|Overall Study||20
9752|NCT02512393|23709|P1|COMPLETED|Overall Study||20
9753|NCT02512393|23708|P2|STARTED|Overall Study||20
9754|NCT02512393|23709|P1|STARTED|Overall Study||21
9755|NCT02512224|23791|P2|NOT COMPLETED|Overall Study||0
9756|NCT02512224|23792|P1|NOT COMPLETED|Overall Study||0
9757|NCT02512224|23791|P2|COMPLETED|Overall Study||2912
9758|NCT02512224|23792|P1|COMPLETED|Overall Study||2912
9759|NCT02512224|23791|P2|STARTED|Overall Study||2912
9760|NCT02512224|23792|P1|STARTED|Overall Study||2912
9761|NCT02512094|23808|P1|NOT COMPLETED|Overall Study||0
9762|NCT02512094|23808|P1|COMPLETED|Overall Study||53
9763|NCT02512094|23808|P1|STARTED|Overall Study||53
9764|NCT02511782|23815|P3|NOT COMPLETED|Overall Study||0
9765|NCT02511782|23816|P2|NOT COMPLETED|Overall Study||0
9766|NCT02511782|23817|P1|NOT COMPLETED|Overall Study||1
9767|NCT02511782|23815|P3|COMPLETED|Overall Study||10
9768|NCT02511782|23816|P2|COMPLETED|Overall Study||2
9769|NCT02511782|23817|P1|COMPLETED|Overall Study||50
9770|NCT02511782|23815|P3|STARTED|Overall Study||10
9771|NCT02511782|23816|P2|STARTED|Overall Study||2
9772|NCT02511782|23817|P1|STARTED|Overall Study||51
9773|NCT02511587|23829|P2|NOT COMPLETED|Overall Study||0
9774|NCT02511587|23830|P1|NOT COMPLETED|Overall Study||0
9775|NCT02511587|23829|P2|COMPLETED|Overall Study||58
9776|NCT02511587|23830|P1|COMPLETED|Overall Study||58
9777|NCT02511587|23829|P2|STARTED|Overall Study||58
9778|NCT02511587|23830|P1|STARTED|Overall Study||58
9779|NCT02511431|23846|P6|NOT COMPLETED|Post-treatment Follow-up||0
9780|NCT02511431|23847|P5|NOT COMPLETED|Post-treatment Follow-up||0
9781|NCT02511431|23848|P4|NOT COMPLETED|Post-treatment Follow-up||0
9782|NCT02511431|23849|P3|NOT COMPLETED|Post-treatment Follow-up||0
9783|NCT02511431|23850|P2|NOT COMPLETED|Post-treatment Follow-up||0
9784|NCT02511431|23851|P1|NOT COMPLETED|Post-treatment Follow-up||0
9785|NCT02511431|23846|P6|COMPLETED|Post-treatment Follow-up||2
9786|NCT02511431|23847|P5|COMPLETED|Post-treatment Follow-up||3
9787|NCT02511431|23848|P4|COMPLETED|Post-treatment Follow-up||3
9788|NCT02511431|23849|P3|COMPLETED|Post-treatment Follow-up||3
9789|NCT02511431|23850|P2|COMPLETED|Post-treatment Follow-up||4
9790|NCT02511431|23851|P1|COMPLETED|Post-treatment Follow-up||4
9791|NCT02511431|23846|P6|STARTED|Post-treatment Follow-up||2
9792|NCT02511431|23847|P5|STARTED|Post-treatment Follow-up||3
9793|NCT02511431|23848|P4|STARTED|Post-treatment Follow-up||3
9794|NCT02511431|23849|P3|STARTED|Post-treatment Follow-up||3
9795|NCT02511431|23850|P2|STARTED|Post-treatment Follow-up||4
9796|NCT02511431|23851|P1|STARTED|Post-treatment Follow-up||4
9797|NCT02511431|23846|P6|NOT COMPLETED|Treatment||1
9798|NCT02511431|23847|P5|NOT COMPLETED|Treatment||0
9799|NCT02511431|23848|P4|NOT COMPLETED|Treatment||0
9800|NCT02511431|23849|P3|NOT COMPLETED|Treatment||1
9801|NCT02511431|23850|P2|NOT COMPLETED|Treatment||0
9802|NCT02511431|23851|P1|NOT COMPLETED|Treatment||0
9803|NCT02511431|23846|P6|COMPLETED|Treatment||2
9804|NCT02511431|23847|P5|COMPLETED|Treatment||3
9805|NCT02511431|23848|P4|COMPLETED|Treatment||3
9806|NCT02511431|23849|P3|COMPLETED|Treatment||3
9807|NCT02511431|23850|P2|COMPLETED|Treatment||4
9808|NCT02511431|23851|P1|COMPLETED|Treatment||4
9809|NCT02511431|23846|P6|STARTED|Treatment||3
9810|NCT02511431|23847|P5|STARTED|Treatment||3
9811|NCT02511431|23848|P4|STARTED|Treatment||3
9812|NCT02511431|23849|P3|STARTED|Treatment||4
9813|NCT02511431|23850|P2|STARTED|Treatment||4
9814|NCT02511431|23851|P1|STARTED|Treatment||4
9815|NCT02510820|23871|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
9816|NCT02510820|23872|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
9817|NCT02510820|23871|P2|COMPLETED|Second Intervention (4 Weeks)||26
9818|NCT02510820|23872|P1|COMPLETED|Second Intervention (4 Weeks)||20
9819|NCT02510820|23871|P2|STARTED|Second Intervention (4 Weeks)||26
9820|NCT02510820|23872|P1|STARTED|Second Intervention (4 Weeks)||21
9821|NCT02510820|23871|P2|NOT COMPLETED|Washout (1 Week)||0
9822|NCT02510820|23872|P1|NOT COMPLETED|Washout (1 Week)||0
9823|NCT02510820|23871|P2|COMPLETED|Washout (1 Week)||26
9824|NCT02510820|23872|P1|COMPLETED|Washout (1 Week)||21
9825|NCT02510820|23871|P2|STARTED|Washout (1 Week)||26
9826|NCT02510820|23872|P1|STARTED|Washout (1 Week)||21
9827|NCT02510820|23871|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
9828|NCT02510820|23872|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
9829|NCT02510820|23871|P2|COMPLETED|First Intervention (4 Weeks)||26
9830|NCT02510820|23872|P1|COMPLETED|First Intervention (4 Weeks)||21
9831|NCT02510820|23871|P2|STARTED|First Intervention (4 Weeks)||27
9832|NCT02510820|23872|P1|STARTED|First Intervention (4 Weeks)||21
9833|NCT02510014|23912|P2|NOT COMPLETED|Treatment Period||57
9834|NCT02510014|23913|P1|NOT COMPLETED|Treatment Period||206
9835|NCT02510014|23912|P2|COMPLETED|Treatment Period||200
9836|NCT02510014|23913|P1|COMPLETED|Treatment Period||206
9837|NCT02510014|23912|P2|STARTED|Treatment Period||257
9838|NCT02510014|23913|P1|STARTED|Treatment Period||412
9839|NCT02510014|23912|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
9840|NCT02510014|23913|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
9841|NCT02510014|23912|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
9842|NCT02510014|23913|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
9843|NCT02510014|23912|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
9844|NCT02510014|23913|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
9845|NCT02508194|23935|P2|NOT COMPLETED|Overall Study||44
9846|NCT02508194|23936|P1|NOT COMPLETED|Overall Study||52
9847|NCT02508194|23935|P2|COMPLETED|Overall Study||907
9848|NCT02508194|23936|P1|COMPLETED|Overall Study||897
9849|NCT02508194|23935|P2|STARTED|Overall Study||951
9850|NCT02508194|23936|P1|STARTED|Overall Study||949
9851|NCT02508103|23976|P2|NOT COMPLETED|Overall Study||0
9852|NCT02508103|23977|P1|NOT COMPLETED|Overall Study||0
9853|NCT02508103|23976|P2|COMPLETED|Overall Study||5
9854|NCT02508103|23977|P1|COMPLETED|Overall Study||5
9855|NCT02508103|23976|P2|STARTED|Overall Study||5
9856|NCT02508103|23977|P1|STARTED|Overall Study||5
9857|NCT02507752|23985|P1|NOT COMPLETED|Overall Study||17
9858|NCT02507752|23985|P1|COMPLETED|Overall Study||55
9859|NCT02507752|23985|P1|STARTED|Overall Study||72
9860|NCT02507388|24005|P2|NOT COMPLETED|Overall Study||0
9861|NCT02507388|24006|P1|NOT COMPLETED|Overall Study||0
9862|NCT02507388|24005|P2|COMPLETED|Overall Study||25
9863|NCT02507388|24006|P1|COMPLETED|Overall Study||25
9864|NCT02507388|24005|P2|STARTED|Overall Study||25
9865|NCT02507388|24006|P1|STARTED|Overall Study||25
9866|NCT02507375|24029|P2|NOT COMPLETED|Overall Study||8
9867|NCT02507375|24030|P1|NOT COMPLETED|Overall Study||4
9868|NCT02507375|24029|P2|COMPLETED|Overall Study||1
9869|NCT02507375|24030|P1|COMPLETED|Overall Study||2
9870|NCT02507375|24029|P2|Extension Period|Overall Study||1
9871|NCT02507375|24030|P1|Extension Period|Overall Study||2
9872|NCT02507375|24029|P2|Cycle 6|Overall Study||1
9873|NCT02507375|24030|P1|Cycle 6|Overall Study||3
9874|NCT02507375|24029|P2|Cycle 5|Overall Study||1
9875|NCT02507375|24030|P1|Cycle 5|Overall Study||3
9876|NCT02507375|24029|P2|Cycle 4|Overall Study||2
9877|NCT02507375|24030|P1|Cycle 4|Overall Study||4
9878|NCT02507375|24029|P2|Cycle 3|Overall Study||5
9879|NCT02507375|24030|P1|Cycle 3|Overall Study||4
9880|NCT02507375|24029|P2|Cycle 2|Overall Study||5
9881|NCT02507375|24030|P1|Cycle 2|Overall Study||5
9882|NCT02507375|24029|P2|Received Pertuzumab|Overall Study||6
9883|NCT02507375|24030|P1|Received Pertuzumab|Overall Study||6
9884|NCT02507375|24029|P2|Cycle 1|Overall Study||9
9885|NCT02507375|24030|P1|Cycle 1|Overall Study||6
9886|NCT02507375|24029|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
9887|NCT02507375|24030|P1|STARTED|Overall Study||6
9888|NCT02507219|24047|P6|NOT COMPLETED|Overall Study||0
9889|NCT02507219|24048|P5|NOT COMPLETED|Overall Study||1
9890|NCT02507219|24049|P4|NOT COMPLETED|Overall Study||0
9891|NCT02507219|24050|P3|NOT COMPLETED|Overall Study||0
9892|NCT02507219|24051|P2|NOT COMPLETED|Overall Study||0
9893|NCT02507219|24052|P1|NOT COMPLETED|Overall Study||1
9894|NCT02507219|24047|P6|COMPLETED|Overall Study||3
9895|NCT02507219|24048|P5|COMPLETED|Overall Study||3
9896|NCT02507219|24049|P4|COMPLETED|Overall Study||3
9897|NCT02507219|24050|P3|COMPLETED|Overall Study||3
9898|NCT02507219|24051|P2|COMPLETED|Overall Study||4
9899|NCT02507219|24052|P1|COMPLETED|Overall Study||4
9900|NCT02507219|24047|P6|STARTED|Overall Study||3
9901|NCT02507219|24048|P5|STARTED|Overall Study||4
9902|NCT02507219|24049|P4|STARTED|Overall Study||3
9903|NCT02507219|24050|P3|STARTED|Overall Study||3
9904|NCT02507219|24051|P2|STARTED|Overall Study||4
9905|NCT02507219|24052|P1|STARTED|Overall Study||5
9906|NCT02506881|24064|P4|NOT COMPLETED|Second Intervention (Day 1)||0
9907|NCT02506881|24065|P3|NOT COMPLETED|Second Intervention (Day 1)||0
9908|NCT02506881|24066|P2|NOT COMPLETED|Second Intervention (Day 1)||0
9909|NCT02506881|24067|P1|NOT COMPLETED|Second Intervention (Day 1)||0
9910|NCT02506881|24064|P4|COMPLETED|Second Intervention (Day 1)||12
9911|NCT02506881|24065|P3|COMPLETED|Second Intervention (Day 1)||12
9912|NCT02506881|24066|P2|COMPLETED|Second Intervention (Day 1)||12
9913|NCT02506881|24067|P1|COMPLETED|Second Intervention (Day 1)||12
9914|NCT02506881|24064|P4|STARTED|Second Intervention (Day 1)||12
9915|NCT02506881|24065|P3|STARTED|Second Intervention (Day 1)||12
9916|NCT02506881|24066|P2|STARTED|Second Intervention (Day 1)||12
9917|NCT02506881|24067|P1|STARTED|Second Intervention (Day 1)||12
9918|NCT02506881|24064|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
9919|NCT02506881|24065|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
9920|NCT02506881|24066|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
9921|NCT02506881|24067|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
9922|NCT02506881|24064|P4|COMPLETED|Washout (at Least 25 Days)||12
9923|NCT02506881|24065|P3|COMPLETED|Washout (at Least 25 Days)||12
9924|NCT02506881|24066|P2|COMPLETED|Washout (at Least 25 Days)||12
9925|NCT02506881|24067|P1|COMPLETED|Washout (at Least 25 Days)||12
9926|NCT02506881|24064|P4|STARTED|Washout (at Least 25 Days)||12
9927|NCT02506881|24065|P3|STARTED|Washout (at Least 25 Days)||12
9928|NCT02506881|24066|P2|STARTED|Washout (at Least 25 Days)||12
9929|NCT02506881|24067|P1|STARTED|Washout (at Least 25 Days)||12
9930|NCT02506881|24064|P4|NOT COMPLETED|First Intervention (Day 1)||12
9931|NCT02506881|24065|P3|NOT COMPLETED|First Intervention (Day 1)||13
9932|NCT02506881|24066|P2|NOT COMPLETED|First Intervention (Day 1)||0
9933|NCT02506881|24067|P1|NOT COMPLETED|First Intervention (Day 1)||1
9934|NCT02506881|24064|P4|COMPLETED|First Intervention (Day 1)||12
9935|NCT02506881|24065|P3|COMPLETED|First Intervention (Day 1)||12
9936|NCT02506881|24066|P2|COMPLETED|First Intervention (Day 1)||12
9937|NCT02506881|24067|P1|COMPLETED|First Intervention (Day 1)||12
9938|NCT02506881|24064|P4|STARTED|First Intervention (Day 1)||24
9939|NCT02506881|24065|P3|STARTED|First Intervention (Day 1)||25
9940|NCT02506881|24066|P2|STARTED|First Intervention (Day 1)||12
9941|NCT02506881|24067|P1|STARTED|First Intervention (Day 1)||13
9942|NCT02506309|24103|P2|NOT COMPLETED|Overall Study||1
9943|NCT02506309|24104|P1|NOT COMPLETED|Overall Study||2
9944|NCT02506309|24103|P2|COMPLETED|Overall Study||44
9945|NCT02506309|24104|P1|COMPLETED|Overall Study||46
9946|NCT02506309|24103|P2|STARTED|Overall Study||45
9947|NCT02506309|24104|P1|STARTED|Overall Study||48
9948|NCT02506257|24120|P4|NOT COMPLETED|Overall Study||0
9949|NCT02506257|24121|P3|NOT COMPLETED|Overall Study||4
9950|NCT02506257|24122|P2|NOT COMPLETED|Overall Study||2
9951|NCT02506257|24123|P1|NOT COMPLETED|Overall Study||0
9952|NCT02506257|24120|P4|COMPLETED|Overall Study||9
9953|NCT02506257|24121|P3|COMPLETED|Overall Study||23
9954|NCT02506257|24122|P2|COMPLETED|Overall Study||26
9955|NCT02506257|24123|P1|COMPLETED|Overall Study||26
9956|NCT02506257|24120|P4|STARTED|Overall Study||9
9957|NCT02506257|24121|P3|STARTED|Overall Study||27
9958|NCT02506257|24122|P2|STARTED|Overall Study||28
9959|NCT02506257|24123|P1|STARTED|Overall Study||26
9960|NCT02506101|24155|P2|NOT COMPLETED|Overall Study||0
9961|NCT02506101|24156|P1|NOT COMPLETED|Overall Study||2
9962|NCT02506101|24155|P2|COMPLETED|Overall Study||0
9963|NCT02506101|24156|P1|COMPLETED|Overall Study||0
9964|NCT02506101|24155|P2|STARTED|Overall Study||0
9965|NCT02506101|24156|P1|STARTED|Overall Study||2
9966|NCT02504931|24172|P2|NOT COMPLETED|Overall Study||10
9967|NCT02504931|24173|P1|NOT COMPLETED|Overall Study||12
9968|NCT02504931|24172|P2|COMPLETED|Overall Study||13
9969|NCT02504931|24173|P1|COMPLETED|Overall Study||14
9970|NCT02504931|24172|P2|STARTED|Overall Study||23
9971|NCT02504931|24173|P1|STARTED|Overall Study||26
9972|NCT02504775|24181|P2|NOT COMPLETED|Period 2||0
9973|NCT02504775|24182|P1|NOT COMPLETED|Period 2||0
9974|NCT02504775|24181|P2|COMPLETED|Period 2||14
9975|NCT02504775|24182|P1|COMPLETED|Period 2||14
9976|NCT02504775|24181|P2|STARTED|Period 2||14
9977|NCT02504775|24182|P1|STARTED|Period 2||14
9978|NCT02504775|24181|P2|NOT COMPLETED|Washout||0
9979|NCT02504775|24182|P1|NOT COMPLETED|Washout||0
9980|NCT02504775|24181|P2|COMPLETED|Washout||14
9981|NCT02504775|24182|P1|COMPLETED|Washout||14
9982|NCT02504775|24181|P2|STARTED|Washout||14
9983|NCT02504775|24182|P1|STARTED|Washout||14
9984|NCT02504775|24181|P2|NOT COMPLETED|Period 1||0
9985|NCT02504775|24182|P1|NOT COMPLETED|Period 1||0
9986|NCT02504775|24181|P2|COMPLETED|Period 1||14
9987|NCT02504775|24182|P1|COMPLETED|Period 1||14
9988|NCT02504775|24181|P2|STARTED|Period 1||14
9989|NCT02504775|24182|P1|STARTED|Period 1||14
9990|NCT02504723|24196|P2|NOT COMPLETED|Overall Study||0
9991|NCT02504723|24197|P1|NOT COMPLETED|Overall Study||0
9992|NCT02504723|24196|P2|COMPLETED|Overall Study||61
9993|NCT02504723|24197|P1|COMPLETED|Overall Study||60
9994|NCT02504723|24196|P2|STARTED|Overall Study||61
9995|NCT02504723|24197|P1|STARTED|Overall Study||60
9996|NCT02504541|24209|P1|NOT COMPLETED|Overall Study||20
9997|NCT02504541|24209|P1|COMPLETED|Overall Study||113
9998|NCT02504541|24209|P1|STARTED|Overall Study||133
9999|NCT02504502|24215|P2|NOT COMPLETED|Crossover to Enhanced Report||0
10000|NCT02504502|24216|P1|NOT COMPLETED|Crossover to Enhanced Report||5
10001|NCT02504502|24215|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
10002|NCT02504502|24216|P1|COMPLETED|Crossover to Enhanced Report||15
10003|NCT02504502|24215|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
10004|NCT02504502|24216|P1|STARTED|Crossover to Enhanced Report||20
10005|NCT02504502|24215|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
10006|NCT02504502|24216|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
10007|NCT02504502|24215|P2|COMPLETED|Routine Care vs. Enhanced Report||21
10008|NCT02504502|24216|P1|COMPLETED|Routine Care vs. Enhanced Report||20
10009|NCT02504502|24215|P2|STARTED|Routine Care vs. Enhanced Report||28
10010|NCT02504502|24216|P1|STARTED|Routine Care vs. Enhanced Report||24
10011|NCT02504320|24226|P4|NOT COMPLETED|Treatment Period 4||0
10012|NCT02504320|24227|P3|NOT COMPLETED|Treatment Period 4||0
10013|NCT02504320|24228|P2|NOT COMPLETED|Treatment Period 4||0
10014|NCT02504320|24229|P1|NOT COMPLETED|Treatment Period 4||0
10015|NCT02504320|24226|P4|COMPLETED|Treatment Period 4||19
10016|NCT02504320|24227|P3|COMPLETED|Treatment Period 4||18
10017|NCT02504320|24228|P2|COMPLETED|Treatment Period 4||18
10018|NCT02504320|24229|P1|COMPLETED|Treatment Period 4||19
10019|NCT02504320|24226|P4|STARTED|Treatment Period 4||19
10020|NCT02504320|24227|P3|STARTED|Treatment Period 4||18
10021|NCT02504320|24228|P2|STARTED|Treatment Period 4||18
10022|NCT02504320|24229|P1|STARTED|Treatment Period 4||19
10023|NCT02504320|24226|P4|NOT COMPLETED|Treatment Period 3||1
10024|NCT02504320|24227|P3|NOT COMPLETED|Treatment Period 3||1
10025|NCT02504320|24228|P2|NOT COMPLETED|Treatment Period 3||0
10026|NCT02504320|24229|P1|NOT COMPLETED|Treatment Period 3||0
10027|NCT02504320|24226|P4|COMPLETED|Treatment Period 3||19
10028|NCT02504320|24227|P3|COMPLETED|Treatment Period 3||18
10029|NCT02504320|24228|P2|COMPLETED|Treatment Period 3||18
10030|NCT02504320|24229|P1|COMPLETED|Treatment Period 3||19
10031|NCT02504320|24226|P4|STARTED|Treatment Period 3||20
10032|NCT02504320|24227|P3|STARTED|Treatment Period 3||19
10033|NCT02504320|24228|P2|STARTED|Treatment Period 3||18
10034|NCT02504320|24229|P1|STARTED|Treatment Period 3||19
10035|NCT02504320|24226|P4|NOT COMPLETED|Treatment Period 2||0
10036|NCT02504320|24227|P3|NOT COMPLETED|Treatment Period 2||0
10037|NCT02504320|24228|P2|NOT COMPLETED|Treatment Period 2||1
10038|NCT02504320|24229|P1|NOT COMPLETED|Treatment Period 2||0
10039|NCT02504320|24226|P4|COMPLETED|Treatment Period 2||20
10040|NCT02504320|24227|P3|COMPLETED|Treatment Period 2||19
10041|NCT02504320|24228|P2|COMPLETED|Treatment Period 2||18
10042|NCT02504320|24229|P1|COMPLETED|Treatment Period 2||19
10043|NCT02504320|24226|P4|STARTED|Treatment Period 2||20
10044|NCT02504320|24227|P3|STARTED|Treatment Period 2||19
10045|NCT02504320|24228|P2|STARTED|Treatment Period 2||19
10046|NCT02504320|24229|P1|STARTED|Treatment Period 2||19
10047|NCT02504320|24226|P4|NOT COMPLETED|Treatment Period 1||0
10048|NCT02504320|24227|P3|NOT COMPLETED|Treatment Period 1||1
10049|NCT02504320|24228|P2|NOT COMPLETED|Treatment Period 1||0
10050|NCT02504320|24229|P1|NOT COMPLETED|Treatment Period 1||0
10051|NCT02504320|24226|P4|COMPLETED|Treatment Period 1||20
10052|NCT02504320|24227|P3|COMPLETED|Treatment Period 1||19
10053|NCT02504320|24228|P2|COMPLETED|Treatment Period 1||19
10054|NCT02504320|24229|P1|COMPLETED|Treatment Period 1||19
10055|NCT02504320|24226|P4|STARTED|Treatment Period 1||20
10056|NCT02504320|24227|P3|STARTED|Treatment Period 1||20
10057|NCT02504320|24228|P2|STARTED|Treatment Period 1||19
10058|NCT02504320|24229|P1|STARTED|Treatment Period 1||19
10059|NCT02504099|24247|P1|NOT COMPLETED|Overall Study||0
10060|NCT02504099|24247|P1|COMPLETED|Overall Study||3
10061|NCT02504099|24247|P1|STARTED|Overall Study||3
10062|NCT02504073|24255|P1|NOT COMPLETED|Overall Study||0
10063|NCT02504073|24255|P1|COMPLETED|Overall Study||54
10064|NCT02504073|24255|P1|STARTED|Overall Study||54
10065|NCT02503982|24261|P1|NOT COMPLETED|Overall Study||0
10066|NCT02503982|24261|P1|COMPLETED|Overall Study||13
10067|NCT02503982|24261|P1|STARTED|Overall Study||13
10068|NCT02503865|24268|P3|NOT COMPLETED|Overall Study||2
10069|NCT02503865|24269|P2|NOT COMPLETED|Overall Study||47
10070|NCT02503865|24270|P1|NOT COMPLETED|Overall Study||5
10071|NCT02503865|24268|P3|COMPLETED|Overall Study||64
10072|NCT02503865|24269|P2|COMPLETED|Overall Study||222
10073|NCT02503865|24270|P1|COMPLETED|Overall Study||65
10074|NCT02503865|24268|P3|STARTED|Overall Study||66
10075|NCT02503865|24269|P2|STARTED|Overall Study||269
10076|NCT02503865|24270|P1|STARTED|Overall Study||70
10077|NCT02503787|24290|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
10078|NCT02503787|24290|P1|COMPLETED|Implant to 3 Month Endpoint||29
10079|NCT02503787|24290|P1|STARTED|Implant to 3 Month Endpoint||32
10080|NCT02503787|24290|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
10081|NCT02503787|24290|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
10082|NCT02503787|24290|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
10083|NCT02503787|24290|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
10084|NCT02503787|24290|P1|COMPLETED|Device Trial (HD Programming Trial)||37
10085|NCT02503787|24290|P1|STARTED|Device Trial (HD Programming Trial)||44
10086|NCT02503787|24290|P1|NOT COMPLETED|Enrollment||20
10087|NCT02503787|24290|P1|COMPLETED|Enrollment||44
10088|NCT02503787|24290|P1|STARTED|Enrollment||64
10089|NCT02503254|24299|P2|NOT COMPLETED|Overall Study||0
10090|NCT02503254|24300|P1|NOT COMPLETED|Overall Study||0
10091|NCT02503254|24299|P2|COMPLETED|Overall Study||39
10092|NCT02503254|24300|P1|COMPLETED|Overall Study||41
10093|NCT02503254|24299|P2|STARTED|Overall Study||39
10094|NCT02503254|24300|P1|STARTED|Overall Study||41
10095|NCT02503215|24313|P1|NOT COMPLETED|Overall Study||3
10096|NCT02503215|24313|P1|COMPLETED|Overall Study||14
10097|NCT02503215|24313|P1|STARTED|Overall Study||17
10098|NCT02503085|24319|P4|NOT COMPLETED|Period 4||0
10099|NCT02503085|24320|P3|NOT COMPLETED|Period 4||0
10100|NCT02503085|24321|P2|NOT COMPLETED|Period 4||0
10101|NCT02503085|24322|P1|NOT COMPLETED|Period 4||0
10102|NCT02503085|24319|P4|COMPLETED|Period 4||7
10103|NCT02503085|24320|P3|COMPLETED|Period 4||6
10104|NCT02503085|24321|P2|COMPLETED|Period 4||7
10105|NCT02503085|24322|P1|COMPLETED|Period 4||6
10106|NCT02503085|24319|P4|STARTED|Period 4||7
10107|NCT02503085|24320|P3|STARTED|Period 4||6
10108|NCT02503085|24321|P2|STARTED|Period 4||7
10109|NCT02503085|24322|P1|STARTED|Period 4||6
10110|NCT02503085|24319|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10111|NCT02503085|24320|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10112|NCT02503085|24321|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10113|NCT02503085|24322|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10114|NCT02503085|24319|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
10115|NCT02503085|24320|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10116|NCT02503085|24321|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
10117|NCT02503085|24322|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10118|NCT02503085|24319|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
10119|NCT02503085|24320|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
10120|NCT02503085|24321|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
10121|NCT02503085|24322|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
10122|NCT02503085|24319|P4|NOT COMPLETED|Period 3||0
10123|NCT02503085|24320|P3|NOT COMPLETED|Period 3||0
10124|NCT02503085|24321|P2|NOT COMPLETED|Period 3||0
10125|NCT02503085|24322|P1|NOT COMPLETED|Period 3||0
10126|NCT02503085|24319|P4|COMPLETED|Period 3||7
10127|NCT02503085|24320|P3|COMPLETED|Period 3||6
10128|NCT02503085|24321|P2|COMPLETED|Period 3||7
10129|NCT02503085|24322|P1|COMPLETED|Period 3||6
10130|NCT02503085|24319|P4|STARTED|Period 3||7
10131|NCT02503085|24320|P3|STARTED|Period 3||6
10132|NCT02503085|24321|P2|STARTED|Period 3||7
10133|NCT02503085|24322|P1|STARTED|Period 3||6
10134|NCT02503085|24319|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10135|NCT02503085|24320|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
10136|NCT02503085|24321|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10137|NCT02503085|24322|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
10138|NCT02503085|24319|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
10139|NCT02503085|24320|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10140|NCT02503085|24321|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
10141|NCT02503085|24322|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10142|NCT02503085|24319|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
10143|NCT02503085|24320|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
10144|NCT02503085|24321|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
10145|NCT02503085|24322|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
10146|NCT02503085|24319|P4|NOT COMPLETED|Period 2||0
10147|NCT02503085|24320|P3|NOT COMPLETED|Period 2||0
10148|NCT02503085|24321|P2|NOT COMPLETED|Period 2||0
10149|NCT02503085|24322|P1|NOT COMPLETED|Period 2||0
10150|NCT02503085|24319|P4|COMPLETED|Period 2||7
10151|NCT02503085|24320|P3|COMPLETED|Period 2||7
10152|NCT02503085|24321|P2|COMPLETED|Period 2||7
10153|NCT02503085|24322|P1|COMPLETED|Period 2||7
10154|NCT02503085|24319|P4|STARTED|Period 2||7
10155|NCT02503085|24320|P3|STARTED|Period 2||7
10156|NCT02503085|24321|P2|STARTED|Period 2||7
10157|NCT02503085|24322|P1|STARTED|Period 2||7
10158|NCT02503085|24319|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10159|NCT02503085|24320|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10160|NCT02503085|24321|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10161|NCT02503085|24322|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10162|NCT02503085|24319|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10163|NCT02503085|24320|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10164|NCT02503085|24321|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10165|NCT02503085|24322|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10166|NCT02503085|24319|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
10167|NCT02503085|24320|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
10168|NCT02503085|24321|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
10169|NCT02503085|24322|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
10170|NCT02503085|24319|P4|NOT COMPLETED|Period 1||0
10171|NCT02503085|24320|P3|NOT COMPLETED|Period 1||0
10172|NCT02503085|24321|P2|NOT COMPLETED|Period 1||0
10173|NCT02503085|24322|P1|NOT COMPLETED|Period 1||0
10174|NCT02503085|24319|P4|COMPLETED|Period 1||7
10175|NCT02503085|24320|P3|COMPLETED|Period 1||7
10176|NCT02503085|24321|P2|COMPLETED|Period 1||7
10177|NCT02503085|24322|P1|COMPLETED|Period 1||7
10178|NCT02503085|24319|P4|STARTED|Period 1||7
10179|NCT02503085|24320|P3|STARTED|Period 1||7
10180|NCT02503085|24321|P2|STARTED|Period 1||7
10181|NCT02503085|24322|P1|STARTED|Period 1||7
10182|NCT02502734|24361|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
10183|NCT02502734|24362|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
10184|NCT02502734|24361|P2|COMPLETED|Double-blind Treatment Period 2||30
10185|NCT02502734|24362|P1|COMPLETED|Double-blind Treatment Period 2||28
10186|NCT02502734|24361|P2|STARTED|Double-blind Treatment Period 2||30
10187|NCT02502734|24362|P1|STARTED|Double-blind Treatment Period 2||28
10188|NCT02502734|24361|P2|NOT COMPLETED|Washout Period||0
10189|NCT02502734|24362|P1|NOT COMPLETED|Washout Period||1
10190|NCT02502734|24361|P2|COMPLETED|Washout Period||30
10191|NCT02502734|24362|P1|COMPLETED|Washout Period||28
10192|NCT02502734|24361|P2|STARTED|Washout Period||30
10193|NCT02502734|24362|P1|STARTED|Washout Period||29
10194|NCT02502734|24361|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
10195|NCT02502734|24362|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
10196|NCT02502734|24361|P2|COMPLETED|Double-blind Treatment Period 1||30
10197|NCT02502734|24362|P1|COMPLETED|Double-blind Treatment Period 1||29
10198|NCT02502734|24361|P2|STARTED|Double-blind Treatment Period 1||30
10199|NCT02502734|24362|P1|STARTED|Double-blind Treatment Period 1||30
10200|NCT02502526|24373|P3|NOT COMPLETED|Overall Study||6
10201|NCT02502526|24374|P2|NOT COMPLETED|Overall Study||4
10202|NCT02502526|24375|P1|NOT COMPLETED|Overall Study||6
10203|NCT02502526|24373|P3|COMPLETED|Overall Study||55
10204|NCT02502526|24374|P2|COMPLETED|Overall Study||55
10205|NCT02502526|24375|P1|COMPLETED|Overall Study||56
10206|NCT02502526|24373|P3|Intent-to-Treat (ITT)|Overall Study||59
10207|NCT02502526|24374|P2|Intent-to-Treat (ITT)|Overall Study||57
10208|NCT02502526|24375|P1|Intent-to-Treat (ITT)|Overall Study||57
10209|NCT02502526|24373|P3|STARTED|Overall Study||61
10210|NCT02502526|24374|P2|STARTED|Overall Study||59
10211|NCT02502526|24375|P1|STARTED|Overall Study||62
10212|NCT02502487|24391|P3|NOT COMPLETED|Overall Study||0
10213|NCT02502487|24392|P2|NOT COMPLETED|Overall Study||0
10214|NCT02502487|24393|P1|NOT COMPLETED|Overall Study||0
10215|NCT02502487|24391|P3|COMPLETED|Overall Study||86
10216|NCT02502487|24392|P2|COMPLETED|Overall Study||86
10217|NCT02502487|24393|P1|COMPLETED|Overall Study||86
10218|NCT02502487|24391|P3|STARTED|Overall Study||86
10219|NCT02502487|24392|P2|STARTED|Overall Study||86
10220|NCT02502487|24393|P1|STARTED|Overall Study||86
10221|NCT02502149|24461|P5|NOT COMPLETED|Treatment Period||0
10222|NCT02502149|24462|P4|NOT COMPLETED|Treatment Period||0
10223|NCT02502149|24463|P3|NOT COMPLETED|Treatment Period||0
10224|NCT02502149|24464|P2|NOT COMPLETED|Treatment Period||0
10225|NCT02502149|24465|P1|NOT COMPLETED|Treatment Period||0
10226|NCT02502149|24461|P5|COMPLETED|Treatment Period||12
10227|NCT02502149|24462|P4|COMPLETED|Treatment Period||11
10228|NCT02502149|24463|P3|COMPLETED|Treatment Period||0
10229|NCT02502149|24464|P2|COMPLETED|Treatment Period||0
10230|NCT02502149|24465|P1|COMPLETED|Treatment Period||0
10231|NCT02502149|24461|P5|STARTED|Treatment Period||12
10232|NCT02502149|24462|P4|STARTED|Treatment Period||11
10233|NCT02502149|24463|P3|STARTED|Treatment Period||0
10234|NCT02502149|24464|P2|STARTED|Treatment Period||0
10235|NCT02502149|24465|P1|STARTED|Treatment Period||0
10236|NCT02502149|24461|P5|NOT COMPLETED|PK2 Assessment Period||0
10237|NCT02502149|24462|P4|NOT COMPLETED|PK2 Assessment Period||0
10238|NCT02502149|24463|P3|NOT COMPLETED|PK2 Assessment Period||0
10239|NCT02502149|24464|P2|NOT COMPLETED|PK2 Assessment Period||0
10240|NCT02502149|24465|P1|NOT COMPLETED|PK2 Assessment Period||0
10241|NCT02502149|24461|P5|COMPLETED|PK2 Assessment Period||0
10242|NCT02502149|24462|P4|COMPLETED|PK2 Assessment Period||0
10243|NCT02502149|24463|P3|COMPLETED|PK2 Assessment Period||12
10244|NCT02502149|24464|P2|COMPLETED|PK2 Assessment Period||11
10245|NCT02502149|24465|P1|COMPLETED|PK2 Assessment Period||0
10246|NCT02502149|24461|P5|STARTED|PK2 Assessment Period||0
10247|NCT02502149|24462|P4|STARTED|PK2 Assessment Period||0
10248|NCT02502149|24463|P3|STARTED|PK2 Assessment Period||12
10249|NCT02502149|24464|P2|STARTED|PK2 Assessment Period||11
10250|NCT02502149|24465|P1|STARTED|PK2 Assessment Period||0
10251|NCT02502149|24461|P5|NOT COMPLETED|Intermediate||0
10252|NCT02502149|24462|P4|NOT COMPLETED|Intermediate||0
10253|NCT02502149|24463|P3|NOT COMPLETED|Intermediate||0
10254|NCT02502149|24464|P2|NOT COMPLETED|Intermediate||0
10255|NCT02502149|24465|P1|NOT COMPLETED|Intermediate||1
10256|NCT02502149|24461|P5|COMPLETED|Intermediate||0
10257|NCT02502149|24462|P4|COMPLETED|Intermediate||0
10258|NCT02502149|24463|P3|COMPLETED|Intermediate||0
10259|NCT02502149|24464|P2|COMPLETED|Intermediate||0
10260|NCT02502149|24465|P1|COMPLETED|Intermediate||23
10261|NCT02502149|24461|P5|STARTED|Intermediate||0
10262|NCT02502149|24462|P4|STARTED|Intermediate||0
10263|NCT02502149|24463|P3|STARTED|Intermediate||0
10264|NCT02502149|24464|P2|STARTED|Intermediate||0
10265|NCT02502149|24465|P1|STARTED|Intermediate||24
10266|NCT02502149|24461|P5|NOT COMPLETED|PK1 Assessment Period||0
10267|NCT02502149|24462|P4|NOT COMPLETED|PK1 Assessment Period||0
10268|NCT02502149|24463|P3|NOT COMPLETED|PK1 Assessment Period||0
10269|NCT02502149|24464|P2|NOT COMPLETED|PK1 Assessment Period||0
10270|NCT02502149|24465|P1|NOT COMPLETED|PK1 Assessment Period||0
10271|NCT02502149|24461|P5|COMPLETED|PK1 Assessment Period||0
10272|NCT02502149|24462|P4|COMPLETED|PK1 Assessment Period||0
10273|NCT02502149|24463|P3|COMPLETED|PK1 Assessment Period||0
10274|NCT02502149|24464|P2|COMPLETED|PK1 Assessment Period||0
10275|NCT02502149|24465|P1|COMPLETED|PK1 Assessment Period||24
10276|NCT02502149|24461|P5|STARTED|PK1 Assessment Period||0
10277|NCT02502149|24462|P4|STARTED|PK1 Assessment Period||0
10278|NCT02502149|24463|P3|STARTED|PK1 Assessment Period||0
10279|NCT02502149|24464|P2|STARTED|PK1 Assessment Period||0
10280|NCT02502149|24465|P1|STARTED|PK1 Assessment Period||24
10281|NCT02501590|24586|P2|NOT COMPLETED|Overall Study||0
10282|NCT02501590|24587|P1|NOT COMPLETED|Overall Study||0
10283|NCT02501590|24586|P2|COMPLETED|Overall Study||35
10284|NCT02501590|24587|P1|COMPLETED|Overall Study||13
10285|NCT02501590|24586|P2|STARTED|Overall Study||35
10286|NCT02501590|24587|P1|STARTED|Overall Study||13
10287|NCT02500836|24596|P3|NOT COMPLETED|Overall Study||1
10288|NCT02500836|24597|P2|NOT COMPLETED|Overall Study||5
10289|NCT02500836|24598|P1|NOT COMPLETED|Overall Study||3
10290|NCT02500836|24596|P3|COMPLETED|Overall Study||127
10291|NCT02500836|24597|P2|COMPLETED|Overall Study||254
10292|NCT02500836|24598|P1|COMPLETED|Overall Study||256
10293|NCT02500836|24596|P3|STARTED|Overall Study||128
10294|NCT02500836|24597|P2|STARTED|Overall Study||259
10295|NCT02500836|24598|P1|STARTED|Overall Study||259
10296|NCT02500758|24609|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
10297|NCT02500758|24610|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
10298|NCT02500758|24609|P2|COMPLETED|Second Intervention (2 Minutes)||10
10299|NCT02500758|24610|P1|COMPLETED|Second Intervention (2 Minutes)||10
10300|NCT02500758|24609|P2|STARTED|Second Intervention (2 Minutes)||12
10301|NCT02500758|24610|P1|STARTED|Second Intervention (2 Minutes)||13
10302|NCT02500758|24609|P2|NOT COMPLETED|Washout (1 Week)||2
10303|NCT02500758|24610|P1|NOT COMPLETED|Washout (1 Week)||2
10304|NCT02500758|24609|P2|COMPLETED|Washout (1 Week)||12
10305|NCT02500758|24610|P1|COMPLETED|Washout (1 Week)||13
10306|NCT02500758|24609|P2|STARTED|Washout (1 Week)||14
10307|NCT02500758|24610|P1|STARTED|Washout (1 Week)||15
10308|NCT02500758|24609|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
10309|NCT02500758|24610|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
10310|NCT02500758|24609|P2|COMPLETED|First Intervention (2 Minutes)||14
10311|NCT02500758|24610|P1|COMPLETED|First Intervention (2 Minutes)||15
10312|NCT02500758|24609|P2|STARTED|First Intervention (2 Minutes)||15
10313|NCT02500758|24610|P1|STARTED|First Intervention (2 Minutes)||15
10314|NCT02500628|24620|P2|NOT COMPLETED|Overall Study||0
10315|NCT02500628|24621|P1|NOT COMPLETED|Overall Study||0
10316|NCT02500628|24620|P2|COMPLETED|Overall Study||23
10317|NCT02500628|24621|P1|COMPLETED|Overall Study||38
10318|NCT02500628|24620|P2|STARTED|Overall Study||23
10319|NCT02500628|24621|P1|STARTED|Overall Study||38
10320|NCT02500537|24633|P2|NOT COMPLETED|Overall Study||1
10321|NCT02500537|24634|P1|NOT COMPLETED|Overall Study||3
10322|NCT02500537|24633|P2|COMPLETED|Overall Study||39
10323|NCT02500537|24634|P1|COMPLETED|Overall Study||57
10324|NCT02500537|24633|P2|STARTED|Overall Study||40
10325|NCT02500537|24634|P1|STARTED|Overall Study||60
10326|NCT02500368|24652|P2|NOT COMPLETED|Second Intervention (1 Week)||0
10327|NCT02500368|24653|P1|NOT COMPLETED|Second Intervention (1 Week)||0
10328|NCT02500368|24652|P2|COMPLETED|Second Intervention (1 Week)||20
10329|NCT02500368|24653|P1|COMPLETED|Second Intervention (1 Week)||20
10330|NCT02500368|24652|P2|STARTED|Second Intervention (1 Week)||20
10331|NCT02500368|24653|P1|STARTED|Second Intervention (1 Week)||20
10332|NCT02500368|24652|P2|NOT COMPLETED|First Intervention (1 Week)||0
10333|NCT02500368|24653|P1|NOT COMPLETED|First Intervention (1 Week)||0
10334|NCT02500368|24652|P2|COMPLETED|First Intervention (1 Week)||20
10335|NCT02500368|24653|P1|COMPLETED|First Intervention (1 Week)||20
10336|NCT02500368|24652|P2|STARTED|First Intervention (1 Week)||20
10337|NCT02500368|24653|P1|STARTED|First Intervention (1 Week)||20
10338|NCT02500056|24703|P2|NOT COMPLETED|Overall Study||8
10339|NCT02500056|24704|P1|NOT COMPLETED|Overall Study||7
10340|NCT02500056|24703|P2|COMPLETED|Overall Study||65
10341|NCT02500056|24704|P1|COMPLETED|Overall Study||63
10342|NCT02500056|24703|P2|STARTED|Overall Study||73
10343|NCT02500056|24704|P1|STARTED|Overall Study||70
10344|NCT02499952|24714|P1|NOT COMPLETED|Overall Study||10
10345|NCT02499952|24714|P1|COMPLETED|Overall Study||2
10346|NCT02499952|24714|P1|STARTED|Overall Study||12
10347|NCT02499692|24721|P1|NOT COMPLETED|Overall Study||0
10348|NCT02499692|24721|P1|COMPLETED|Overall Study||103
10349|NCT02499692|24721|P1|STARTED|Overall Study||103
10350|NCT02499575|24732|P2|NOT COMPLETED|Overall Study||1
10351|NCT02499575|24733|P1|NOT COMPLETED|Overall Study||0
10352|NCT02499575|24732|P2|COMPLETED|Overall Study||0
10353|NCT02499575|24733|P1|COMPLETED|Overall Study||1
10354|NCT02499575|24732|P2|STARTED|Overall Study||1
10355|NCT02499575|24733|P1|STARTED|Overall Study||1
10356|NCT02498821|24745|P2|NOT COMPLETED|Overall Study||5
10357|NCT02498821|24746|P1|NOT COMPLETED|Overall Study||3
10358|NCT02498821|24745|P2|COMPLETED|Overall Study||60
10359|NCT02498821|24746|P1|COMPLETED|Overall Study||60
10360|NCT02498821|24745|P2|STARTED|Overall Study||65
10361|NCT02498821|24746|P1|STARTED|Overall Study||63
10362|NCT02498678|24775|P2|NOT COMPLETED|Overall Study||2
10363|NCT02498678|24776|P1|NOT COMPLETED|Overall Study||0
10364|NCT02498678|24775|P2|COMPLETED|Overall Study||23
10365|NCT02498678|24776|P1|COMPLETED|Overall Study||25
10366|NCT02498678|24775|P2|STARTED|Overall Study||25
10367|NCT02498678|24776|P1|STARTED|Overall Study||25
10368|NCT02498652|24792|P2|NOT COMPLETED|Overall Study||1
10369|NCT02498652|24793|P1|NOT COMPLETED|Overall Study||0
10370|NCT02498652|24792|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
10371|NCT02498652|24793|P1|COMPLETED|Overall Study||20
10372|NCT02498652|24792|P2|STARTED|Overall Study||21
10373|NCT02498652|24793|P1|STARTED|Overall Study||20
10374|NCT02498522|24894|P2|NOT COMPLETED|Overall Study||2
10375|NCT02498522|24895|P1|NOT COMPLETED|Overall Study||2
10376|NCT02498522|24894|P2|COMPLETED|Overall Study||83
10377|NCT02498522|24895|P1|COMPLETED|Overall Study||83
10378|NCT02498522|24894|P2|STARTED|Overall Study||85
10379|NCT02498522|24895|P1|STARTED|Overall Study||85
10380|NCT02497976|24903|P2|NOT COMPLETED|Overall Study||1
10381|NCT02497976|24904|P1|NOT COMPLETED|Overall Study||2
10382|NCT02497976|24903|P2|COMPLETED|Overall Study||13
10383|NCT02497976|24904|P1|COMPLETED|Overall Study||26
10384|NCT02497976|24903|P2|STARTED|Overall Study||14
10385|NCT02497976|24904|P1|STARTED|Overall Study||28
10386|NCT02497781|24922|P2|NOT COMPLETED|Overall Study||3
10387|NCT02497781|24923|P1|NOT COMPLETED|Overall Study||4
10388|NCT02497781|24922|P2|COMPLETED|Overall Study||26
10389|NCT02497781|24923|P1|COMPLETED|Overall Study||64
10390|NCT02497781|24922|P2|Treated|Overall Study||28
10391|NCT02497781|24923|P1|Treated|Overall Study||67
10392|NCT02497781|24922|P2|STARTED|Overall Study||29
10393|NCT02497781|24923|P1|STARTED|Overall Study||68
10394|NCT02497755|24986|P2|NOT COMPLETED|Overall Study||0
10395|NCT02497755|24987|P1|NOT COMPLETED|Overall Study||1
10396|NCT02497755|24986|P2|COMPLETED|Overall Study||1
10397|NCT02497755|24987|P1|COMPLETED|Overall Study||17
10398|NCT02497755|24986|P2|STARTED|Overall Study||1
10399|NCT02497755|24987|P1|STARTED|Overall Study||18
10400|NCT02497235|25005|P5|NOT COMPLETED|Overall Study||0
10401|NCT02497235|25006|P4|NOT COMPLETED|Overall Study||0
10402|NCT02497235|25007|P3|NOT COMPLETED|Overall Study||0
10403|NCT02497235|25008|P2|NOT COMPLETED|Overall Study||0
10404|NCT02497235|25009|P1|NOT COMPLETED|Overall Study||0
10405|NCT02497235|25005|P5|COMPLETED|Overall Study||3
10406|NCT02497235|25006|P4|COMPLETED|Overall Study||2
10407|NCT02497235|25007|P3|COMPLETED|Overall Study||2
10408|NCT02497235|25008|P2|COMPLETED|Overall Study||2
10409|NCT02497235|25009|P1|COMPLETED|Overall Study||2
10410|NCT02497235|25005|P5|STARTED|Overall Study||3
10411|NCT02497235|25006|P4|STARTED|Overall Study||2
10412|NCT02497235|25007|P3|STARTED|Overall Study||2
10413|NCT02497235|25008|P2|STARTED|Overall Study||2
10414|NCT02497235|25009|P1|STARTED|Overall Study||2
10415|NCT02497040|25042|P3|NOT COMPLETED|Overall Study||0
10416|NCT02497040|25043|P2|NOT COMPLETED|Overall Study||0
10417|NCT02497040|25044|P1|NOT COMPLETED|Overall Study||0
10418|NCT02497040|25042|P3|COMPLETED|Overall Study||30
10419|NCT02497040|25043|P2|COMPLETED|Overall Study||30
10420|NCT02497040|25044|P1|COMPLETED|Overall Study||30
10421|NCT02497040|25042|P3|STARTED|Overall Study||30
10422|NCT02497040|25043|P2|STARTED|Overall Study||30
10423|NCT02497040|25044|P1|STARTED|Overall Study||30
10424|NCT02496533|25054|P2|NOT COMPLETED|Overall Study||6
10425|NCT02496533|25055|P1|NOT COMPLETED|Overall Study||3
10426|NCT02496533|25054|P2|COMPLETED|Overall Study||106
10427|NCT02496533|25055|P1|COMPLETED|Overall Study||102
10428|NCT02496533|25054|P2|STARTED|Overall Study||112
10429|NCT02496533|25055|P1|STARTED|Overall Study||105
10430|NCT02496221|25067|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
10431|NCT02496221|25068|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
10432|NCT02496221|25067|P2|COMPLETED|Treatment Period 2 - 4 Days||9
10433|NCT02496221|25068|P1|COMPLETED|Treatment Period 2 - 4 Days||8
10434|NCT02496221|25067|P2|STARTED|Treatment Period 2 - 4 Days||10
10435|NCT02496221|25068|P1|STARTED|Treatment Period 2 - 4 Days||10
10436|NCT02496221|25067|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
10437|NCT02496221|25068|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
10438|NCT02496221|25067|P2|COMPLETED|Treatment Period 1 - 4 Days||10
10439|NCT02496221|25068|P1|COMPLETED|Treatment Period 1 - 4 Days||10
10440|NCT02496221|25067|P2|STARTED|Treatment Period 1 - 4 Days||10
10441|NCT02496221|25068|P1|STARTED|Treatment Period 1 - 4 Days||10
10442|NCT02496039|25102|P1|NOT COMPLETED|Overall Study||4
10443|NCT02496039|25102|P1|COMPLETED|Overall Study||1
10444|NCT02496039|25102|P1|STARTED|Overall Study||5
10445|NCT02496000|25117|P3|NOT COMPLETED|Overall Study||2
10446|NCT02496000|25118|P2|NOT COMPLETED|Overall Study||5
10447|NCT02496000|25119|P1|NOT COMPLETED|Overall Study||2
10448|NCT02496000|25117|P3|COMPLETED|Overall Study||61
10449|NCT02496000|25118|P2|COMPLETED|Overall Study||56
10450|NCT02496000|25119|P1|COMPLETED|Overall Study||62
10451|NCT02496000|25117|P3|STARTED|Overall Study||63
10452|NCT02496000|25118|P2|STARTED|Overall Study||61
10453|NCT02496000|25119|P1|STARTED|Overall Study||64
10454|NCT02495948|25128|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10455|NCT02495948|25129|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10456|NCT02495948|25128|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
10457|NCT02495948|25129|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
10458|NCT02495948|25128|P2|STARTED|Period 2, Second 30 Days of Wear||83
10459|NCT02495948|25129|P1|STARTED|Period 2, Second 30 Days of Wear||83
10460|NCT02495948|25128|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
10461|NCT02495948|25129|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10462|NCT02495948|25128|P2|COMPLETED|Period 1, First 30 Days of Wear||83
10463|NCT02495948|25129|P1|COMPLETED|Period 1, First 30 Days of Wear||83
10464|NCT02495948|25128|P2|STARTED|Period 1, First 30 Days of Wear||84
10465|NCT02495948|25129|P1|STARTED|Period 1, First 30 Days of Wear||83
10466|NCT02495831|25136|P2|NOT COMPLETED|Second Intervention||0
10467|NCT02495831|25137|P1|NOT COMPLETED|Second Intervention||0
10468|NCT02495831|25136|P2|COMPLETED|Second Intervention||10
10469|NCT02495831|25137|P1|COMPLETED|Second Intervention||12
10470|NCT02495831|25136|P2|STARTED|Second Intervention||10
10471|NCT02495831|25137|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
10472|NCT02495831|25136|P2|NOT COMPLETED|First Intervention||0
10473|NCT02495831|25137|P1|NOT COMPLETED|First Intervention||0
10474|NCT02495831|25136|P2|COMPLETED|First Intervention||10
10475|NCT02495831|25137|P1|COMPLETED|First Intervention||13
10476|NCT02495831|25136|P2|STARTED|First Intervention||10
10477|NCT02495831|25137|P1|STARTED|First Intervention||13
10478|NCT02495623|25154|P3|NOT COMPLETED|Overall Study||8
10479|NCT02495623|25155|P2|NOT COMPLETED|Overall Study||9
10480|NCT02495623|25156|P1|NOT COMPLETED|Overall Study||5
10481|NCT02495623|25154|P3|COMPLETED|Overall Study||20
10482|NCT02495623|25155|P2|COMPLETED|Overall Study||17
10483|NCT02495623|25156|P1|COMPLETED|Overall Study||20
10484|NCT02495623|25154|P3|Dosed|Overall Study||22
10485|NCT02495623|25155|P2|Dosed|Overall Study||19
10486|NCT02495623|25156|P1|Dosed|Overall Study||22
10487|NCT02495623|25154|P3|STARTED|Overall Study||28
10488|NCT02495623|25155|P2|STARTED|Overall Study||26
10489|NCT02495623|25156|P1|STARTED|Overall Study||25
10490|NCT02495038|25167|P3|NOT COMPLETED|Overall Study||0
10491|NCT02495038|25168|P2|NOT COMPLETED|Overall Study||0
10492|NCT02495038|25169|P1|NOT COMPLETED|Overall Study||0
10493|NCT02495038|25167|P3|COMPLETED|Overall Study||27
10494|NCT02495038|25168|P2|COMPLETED|Overall Study||27
10495|NCT02495038|25169|P1|COMPLETED|Overall Study||27
10496|NCT02495038|25167|P3|STARTED|Overall Study||27
10497|NCT02495038|25168|P2|STARTED|Overall Study||27
10498|NCT02495038|25169|P1|STARTED|Overall Study||27
10499|NCT02494596|25204|P3|NOT COMPLETED|Overall Study||1
10500|NCT02494596|25205|P2|NOT COMPLETED|Overall Study||5
10501|NCT02494596|25206|P1|NOT COMPLETED|Overall Study||3
10502|NCT02494596|25204|P3|COMPLETED|Overall Study||6
10503|NCT02494596|25205|P2|COMPLETED|Overall Study||2
10504|NCT02494596|25206|P1|COMPLETED|Overall Study||2
10505|NCT02494596|25204|P3|STARTED|Overall Study||7
10506|NCT02494596|25205|P2|STARTED|Overall Study||7
10507|NCT02494596|25206|P1|STARTED|Overall Study||5
10508|NCT02494440|25231|P1|NOT COMPLETED|Overall Study||0
10509|NCT02494440|25231|P1|COMPLETED|Overall Study||90
10510|NCT02494440|25231|P1|STARTED|Overall Study||90
10511|NCT02494323|25237|P1|NOT COMPLETED|Overall Study||0
10512|NCT02494323|25237|P1|COMPLETED|Overall Study||70
10513|NCT02494323|25237|P1|STARTED|Overall Study||70
10514|NCT02494076|25244|P2|NOT COMPLETED|Overall Study||0
10515|NCT02494076|25245|P1|NOT COMPLETED|Overall Study||0
10516|NCT02494076|25244|P2|COMPLETED|Overall Study||26
10517|NCT02494076|25245|P1|COMPLETED|Overall Study||26
10518|NCT02494076|25244|P2|STARTED|Overall Study||26
10519|NCT02494076|25245|P1|STARTED|Overall Study||26
10520|NCT02493855|25258|P3|NOT COMPLETED|Overall Study||0
10521|NCT02493855|25259|P2|NOT COMPLETED|Overall Study||1
10522|NCT02493855|25260|P1|NOT COMPLETED|Overall Study||2
10523|NCT02493855|25258|P3|COMPLETED|Overall Study||6
10524|NCT02493855|25259|P2|COMPLETED|Overall Study||18
10525|NCT02493855|25260|P1|COMPLETED|Overall Study||19
10526|NCT02493855|25258|P3|STARTED|Overall Study||6
10527|NCT02493855|25259|P2|STARTED|Overall Study||19
10528|NCT02493855|25260|P1|STARTED|Overall Study||21
10529|NCT02493127|25270|P2|NOT COMPLETED|Overall Study||1
10530|NCT02493127|25271|P1|NOT COMPLETED|Overall Study||1
10531|NCT02493127|25270|P2|COMPLETED|Overall Study||60
10532|NCT02493127|25271|P1|COMPLETED|Overall Study||60
10533|NCT02493127|25270|P2|STARTED|Overall Study||61
10534|NCT02493127|25271|P1|STARTED|Overall Study||61
10535|NCT02493088|25283|P1|NOT COMPLETED|Overall Study||0
10536|NCT02493088|25283|P1|COMPLETED|Overall Study||11
10537|NCT02493088|25283|P1|STARTED|Overall Study||11
10538|NCT02493036|25292|P3|NOT COMPLETED|Overall Study||2
10539|NCT02493036|25293|P2|NOT COMPLETED|Overall Study||2
10540|NCT02493036|25294|P1|NOT COMPLETED|Overall Study||1
10541|NCT02493036|25292|P3|COMPLETED|Overall Study||15
10542|NCT02493036|25293|P2|COMPLETED|Overall Study||18
10543|NCT02493036|25294|P1|COMPLETED|Overall Study||16
10544|NCT02493036|25292|P3|STARTED|Overall Study||17
10545|NCT02493036|25293|P2|STARTED|Overall Study||20
10546|NCT02493036|25294|P1|STARTED|Overall Study||17
10547|NCT02492984|25304|P2|NOT COMPLETED|Overall Study||0
10548|NCT02492984|25305|P1|NOT COMPLETED|Overall Study||3
10549|NCT02492984|25304|P2|COMPLETED|Overall Study||14
10550|NCT02492984|25305|P1|COMPLETED|Overall Study||70
10551|NCT02492984|25304|P2|STARTED|Overall Study||14
10552|NCT02492984|25305|P1|STARTED|Overall Study||73
10553|NCT02492841|25328|P3|NOT COMPLETED|Overall Study||35
10554|NCT02492841|25329|P2|NOT COMPLETED|Overall Study||31
10555|NCT02492841|25330|P1|NOT COMPLETED|Overall Study||34
10556|NCT02492841|25328|P3|COMPLETED|Overall Study||25
10557|NCT02492841|25329|P2|COMPLETED|Overall Study||22
10558|NCT02492841|25330|P1|COMPLETED|Overall Study||22
10559|NCT02492841|25328|P3|STARTED|Overall Study||60
10560|NCT02492841|25329|P2|STARTED|Overall Study||53
10561|NCT02492841|25330|P1|STARTED|Overall Study||56
10562|NCT02492763|25345|P4|NOT COMPLETED|Overall Study||13
10563|NCT02492763|25346|P3|NOT COMPLETED|Overall Study||10
10564|NCT02492763|25347|P2|NOT COMPLETED|Overall Study||15
10565|NCT02492763|25348|P1|NOT COMPLETED|Overall Study||16
10566|NCT02492763|25345|P4|COMPLETED|Overall Study||30
10567|NCT02492763|25346|P3|COMPLETED|Overall Study||33
10568|NCT02492763|25347|P2|COMPLETED|Overall Study||29
10569|NCT02492763|25348|P1|COMPLETED|Overall Study||30
10570|NCT02492763|25345|P4|Treated|Overall Study||42
10571|NCT02492763|25346|P3|Treated|Overall Study||43
10572|NCT02492763|25347|P2|Treated|Overall Study||44
10573|NCT02492763|25348|P1|Treated|Overall Study||46
10574|NCT02492763|25345|P4|STARTED|Overall Study||43
10575|NCT02492763|25346|P3|STARTED|Overall Study||43
10576|NCT02492763|25347|P2|STARTED|Overall Study||44
10577|NCT02492763|25348|P1|STARTED|Overall Study||46
10578|NCT02492451|25405|P3|NOT COMPLETED|Overall Study||0
10579|NCT02492451|25406|P2|NOT COMPLETED|Overall Study||0
10580|NCT02492451|25407|P1|NOT COMPLETED|Overall Study||0
10581|NCT02492451|25405|P3|COMPLETED|Overall Study||39
10582|NCT02492451|25406|P2|COMPLETED|Overall Study||39
10583|NCT02492451|25407|P1|COMPLETED|Overall Study||40
10584|NCT02492451|25405|P3|STARTED|Overall Study||39
10585|NCT02492451|25406|P2|STARTED|Overall Study||39
10586|NCT02492451|25407|P1|STARTED|Overall Study||40
10587|NCT02492165|25419|P4|NOT COMPLETED|Overall Study||0
10588|NCT02492165|25420|P3|NOT COMPLETED|Overall Study||0
10589|NCT02492165|25421|P2|NOT COMPLETED|Overall Study||1
10590|NCT02492165|25422|P1|NOT COMPLETED|Overall Study||0
10591|NCT02492165|25419|P4|COMPLETED|Overall Study||30
10592|NCT02492165|25420|P3|COMPLETED|Overall Study||60
10593|NCT02492165|25421|P2|COMPLETED|Overall Study||59
10594|NCT02492165|25422|P1|COMPLETED|Overall Study||100
10595|NCT02492165|25419|P4|STARTED|Overall Study||30
10596|NCT02492165|25420|P3|STARTED|Overall Study||60
10597|NCT02492165|25421|P2|STARTED|Overall Study||60
10598|NCT02492165|25422|P1|STARTED|Overall Study||100
10599|NCT02491944|25444|P1|NOT COMPLETED|Overall Study||0
10600|NCT02491944|25444|P1|COMPLETED|Overall Study||10
10601|NCT02491944|25444|P1|STARTED|Overall Study||10
10602|NCT02491892|25466|P2|NOT COMPLETED|Overall Study||38
10603|NCT02491892|25467|P1|NOT COMPLETED|Overall Study||41
10604|NCT02491892|25466|P2|COMPLETED|Overall Study||0
10605|NCT02491892|25467|P1|COMPLETED|Overall Study||0
10606|NCT02491892|25466|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
10607|NCT02491892|25467|P1|Treated|Overall Study||41
10608|NCT02491892|25466|P2|STARTED|Overall Study||38
10609|NCT02491892|25467|P1|STARTED|Overall Study||41
10610|NCT02491073|25513|P2|NOT COMPLETED|Overall Study||0
10611|NCT02491073|25514|P1|NOT COMPLETED|Overall Study||1
10612|NCT02491073|25513|P2|COMPLETED|Overall Study||34
10613|NCT02491073|25514|P1|COMPLETED|Overall Study||36
10614|NCT02491073|25513|P2|STARTED|Overall Study||34
10615|NCT02491073|25514|P1|STARTED|Overall Study||37
10616|NCT02490670|25542|P2|NOT COMPLETED|Period 2 (19 Days)||0
10617|NCT02490670|25543|P1|NOT COMPLETED|Period 2 (19 Days)||0
10618|NCT02490670|25542|P2|COMPLETED|Period 2 (19 Days)||14
10619|NCT02490670|25543|P1|COMPLETED|Period 2 (19 Days)||14
10620|NCT02490670|25542|P2|STARTED|Period 2 (19 Days)||14
10621|NCT02490670|25543|P1|STARTED|Period 2 (19 Days)||14
10622|NCT02490670|25542|P2|NOT COMPLETED|Washout Period (7 Days)||0
10623|NCT02490670|25543|P1|NOT COMPLETED|Washout Period (7 Days)||0
10624|NCT02490670|25542|P2|COMPLETED|Washout Period (7 Days)||14
10625|NCT02490670|25543|P1|COMPLETED|Washout Period (7 Days)||14
10626|NCT02490670|25542|P2|STARTED|Washout Period (7 Days)||14
10627|NCT02490670|25543|P1|STARTED|Washout Period (7 Days)||14
10628|NCT02490670|25542|P2|NOT COMPLETED|Period 1 (19 Days)||0
10629|NCT02490670|25543|P1|NOT COMPLETED|Period 1 (19 Days)||0
10630|NCT02490670|25542|P2|COMPLETED|Period 1 (19 Days)||14
10631|NCT02490670|25543|P1|COMPLETED|Period 1 (19 Days)||14
10632|NCT02490670|25542|P2|STARTED|Period 1 (19 Days)||14
10633|NCT02490670|25543|P1|STARTED|Period 1 (19 Days)||14
10634|NCT02490475|25555|P4|NOT COMPLETED|Period 2: Extension Phase||1
10635|NCT02490475|25556|P3|NOT COMPLETED|Period 2: Extension Phase||3
10636|NCT02490475|25557|P2|NOT COMPLETED|Period 2: Extension Phase||0
10637|NCT02490475|25558|P1|NOT COMPLETED|Period 2: Extension Phase||1
10638|NCT02490475|25555|P4|COMPLETED|Period 2: Extension Phase||0
10639|NCT02490475|25556|P3|COMPLETED|Period 2: Extension Phase||0
10640|NCT02490475|25557|P2|COMPLETED|Period 2: Extension Phase||0
10641|NCT02490475|25558|P1|COMPLETED|Period 2: Extension Phase||0
10642|NCT02490475|25555|P4|STARTED|Period 2: Extension Phase||1
10643|NCT02490475|25556|P3|STARTED|Period 2: Extension Phase||3
10644|NCT02490475|25557|P2|STARTED|Period 2: Extension Phase||0
10645|NCT02490475|25558|P1|STARTED|Period 2: Extension Phase||1
10646|NCT02490475|25555|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
10647|NCT02490475|25556|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
10648|NCT02490475|25557|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
10649|NCT02490475|25558|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
10650|NCT02490475|25555|P4|COMPLETED|Period 1: First 6 Cycles||0
10651|NCT02490475|25556|P3|COMPLETED|Period 1: First 6 Cycles||0
10652|NCT02490475|25557|P2|COMPLETED|Period 1: First 6 Cycles||0
10653|NCT02490475|25558|P1|COMPLETED|Period 1: First 6 Cycles||0
10654|NCT02490475|25555|P4|STARTED|Period 1: First 6 Cycles||5
10655|NCT02490475|25556|P3|STARTED|Period 1: First 6 Cycles||6
10656|NCT02490475|25557|P2|STARTED|Period 1: First 6 Cycles||2
10657|NCT02490475|25558|P1|STARTED|Period 1: First 6 Cycles||6
10658|NCT02490293|25636|P2|NOT COMPLETED|Overall Study||3
10659|NCT02490293|25637|P1|NOT COMPLETED|Overall Study||2
10660|NCT02490293|25636|P2|COMPLETED|Overall Study||99
10661|NCT02490293|25637|P1|COMPLETED|Overall Study||94
10662|NCT02490293|25636|P2|STARTED|Overall Study||102
10663|NCT02490293|25637|P1|STARTED|Overall Study||96
10664|NCT02489799|25647|P2|NOT COMPLETED|Overall Study||9
10665|NCT02489799|25648|P1|NOT COMPLETED|Overall Study||9
10666|NCT02489799|25647|P2|COMPLETED|Overall Study||38
10667|NCT02489799|25648|P1|COMPLETED|Overall Study||36
10668|NCT02489799|25647|P2|Postsurgical One Week Visit (V3)|Overall Study||39
10669|NCT02489799|25648|P1|Postsurgical One Week Visit (V3)|Overall Study||40
10670|NCT02489799|25647|P2|Presurgical Consent Visit (V2)|Overall Study||39
10671|NCT02489799|25648|P1|Presurgical Consent Visit (V2)|Overall Study||40
10672|NCT02489799|25647|P2|STARTED|Overall Study||47
10673|NCT02489799|25648|P1|STARTED|Overall Study||45
10674|NCT02488980|25675|P3|NOT COMPLETED|Overall Study||2
10675|NCT02488980|25676|P2|NOT COMPLETED|Overall Study||2
10676|NCT02488980|25677|P1|NOT COMPLETED|Overall Study||2
10677|NCT02488980|25675|P3|COMPLETED|Overall Study||99
10678|NCT02488980|25676|P2|COMPLETED|Overall Study||99
10679|NCT02488980|25677|P1|COMPLETED|Overall Study||102
10680|NCT02488980|25675|P3|STARTED|Overall Study||101
10681|NCT02488980|25676|P2|STARTED|Overall Study||101
10682|NCT02488980|25677|P1|STARTED|Overall Study||104
10683|NCT02488681|25694|P1|NOT COMPLETED|Overall Study||7
10684|NCT02488681|25694|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
10685|NCT02488681|25694|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
10686|NCT02488317|25700|P2|NOT COMPLETED|Overall Study||47
10687|NCT02488317|25701|P1|NOT COMPLETED|Overall Study||54
10688|NCT02488317|25700|P2|COMPLETED|Overall Study||70
10689|NCT02488317|25701|P1|COMPLETED|Overall Study||63
10690|NCT02488317|25700|P2|STARTED|Overall Study||117
10691|NCT02488317|25701|P1|STARTED|Overall Study||117
10692|NCT02488070|25715|P1|NOT COMPLETED|Overall Study||0
10693|NCT02488070|25715|P1|COMPLETED|Overall Study||10
10694|NCT02488070|25715|P1|STARTED|Overall Study||10
10695|NCT02488018|25723|P1|NOT COMPLETED|Overall Study||0
10696|NCT02488018|25723|P1|COMPLETED|Overall Study||10
10697|NCT02488018|25723|P1|STARTED|Overall Study||10
10698|NCT02487771|25729|P2|NOT COMPLETED|Overall Study||14
10699|NCT02487771|25730|P1|NOT COMPLETED|Overall Study||10
10700|NCT02487771|25729|P2|COMPLETED|Overall Study||85
10701|NCT02487771|25730|P1|COMPLETED|Overall Study||81
10702|NCT02487771|25729|P2|STARTED|Overall Study||99
10703|NCT02487771|25730|P1|STARTED|Overall Study||91
10704|NCT02487498|25880|P2|NOT COMPLETED|Period: Period 2||5
10705|NCT02487498|25881|P1|NOT COMPLETED|Period: Period 2||6
10706|NCT02487498|25880|P2|COMPLETED|Period: Period 2||154
10707|NCT02487498|25881|P1|COMPLETED|Period: Period 2||164
10708|NCT02487498|25880|P2|STARTED|Period: Period 2||159
10709|NCT02487498|25881|P1|STARTED|Period: Period 2||170
10710|NCT02487498|25880|P2|NOT COMPLETED|Period: Washout||7
10711|NCT02487498|25881|P1|NOT COMPLETED|Period: Washout||2
10712|NCT02487498|25880|P2|COMPLETED|Period: Washout||159
10713|NCT02487498|25881|P1|COMPLETED|Period: Washout||170
10714|NCT02487498|25880|P2|STARTED|Period: Washout||166
10715|NCT02487498|25881|P1|STARTED|Period: Washout||172
10716|NCT02487498|25880|P2|NOT COMPLETED|Period: Period 1||11
10717|NCT02487498|25881|P1|NOT COMPLETED|Period: Period 1||6
10718|NCT02487498|25880|P2|COMPLETED|Period: Period 1||166
10719|NCT02487498|25881|P1|COMPLETED|Period: Period 1||172
10720|NCT02487498|25880|P2|STARTED|Period: Period 1||177
10721|NCT02487498|25881|P1|STARTED|Period: Period 1||178
10722|NCT02487446|25904|P2|NOT COMPLETED|Period 2||5
10723|NCT02487446|25905|P1|NOT COMPLETED|Period 2||8
10724|NCT02487446|25904|P2|COMPLETED|Period 2||158
10725|NCT02487446|25905|P1|COMPLETED|Period 2||154
10726|NCT02487446|25904|P2|STARTED|Period 2||163
10727|NCT02487446|25905|P1|STARTED|Period 2||162
10728|NCT02487446|25904|P2|NOT COMPLETED|Washout||8
10729|NCT02487446|25905|P1|NOT COMPLETED|Washout||3
10730|NCT02487446|25904|P2|COMPLETED|Washout||163
10731|NCT02487446|25905|P1|COMPLETED|Washout||162
10732|NCT02487446|25904|P2|STARTED|Washout||171
10733|NCT02487446|25905|P1|STARTED|Washout||165
10734|NCT02487446|25904|P2|NOT COMPLETED|Period 1||8
10735|NCT02487446|25905|P1|NOT COMPLETED|Period 1||13
10736|NCT02487446|25904|P2|COMPLETED|Period 1||171
10737|NCT02487446|25905|P1|COMPLETED|Period 1||165
10738|NCT02487446|25904|P2|STARTED|Period 1||179
10739|NCT02487446|25905|P1|STARTED|Period 1||178
10740|NCT02487199|25930|P2|NOT COMPLETED|Overall Study||1
10741|NCT02487199|25931|P1|NOT COMPLETED|Overall Study||0
10742|NCT02487199|25930|P2|COMPLETED|Overall Study||4
10743|NCT02487199|25931|P1|COMPLETED|Overall Study||13
10744|NCT02487199|25930|P2|STARTED|Overall Study||5
10745|NCT02487199|25931|P1|STARTED|Overall Study||13
10746|NCT02487030|25950|P7|NOT COMPLETED|Overall Study||0
10747|NCT02487030|25951|P6|NOT COMPLETED|Overall Study||1
10748|NCT02487030|25952|P5|NOT COMPLETED|Overall Study||2
10749|NCT02487030|25953|P4|NOT COMPLETED|Overall Study||2
10750|NCT02487030|25954|P3|NOT COMPLETED|Overall Study||2
10751|NCT02487030|25955|P2|NOT COMPLETED|Overall Study||4
10752|NCT02487030|25956|P1|NOT COMPLETED|Overall Study||2
10753|NCT02487030|25950|P7|COMPLETED|Overall Study||11
10754|NCT02487030|25951|P6|COMPLETED|Overall Study||37
10755|NCT02487030|25952|P5|COMPLETED|Overall Study||34
10756|NCT02487030|25953|P4|COMPLETED|Overall Study||40
10757|NCT02487030|25954|P3|COMPLETED|Overall Study||41
10758|NCT02487030|25955|P2|COMPLETED|Overall Study||38
10759|NCT02487030|25956|P1|COMPLETED|Overall Study||41
10760|NCT02487030|25950|P7|STARTED|Overall Study||11
10761|NCT02487030|25951|P6|STARTED|Overall Study||38
10762|NCT02487030|25952|P5|STARTED|Overall Study||36
10763|NCT02487030|25953|P4|STARTED|Overall Study||42
10764|NCT02487030|25954|P3|STARTED|Overall Study||43
10765|NCT02487030|25955|P2|STARTED|Overall Study||42
10766|NCT02487030|25956|P1|STARTED|Overall Study||43
10767|NCT02486952|25987|P1|NOT COMPLETED|Overall Study||50
10768|NCT02486952|25987|P1|COMPLETED|Overall Study||104
10769|NCT02486952|25987|P1|Started Induction Therapy|Overall Study||151
10770|NCT02486952|25987|P1|STARTED|Overall Study||154
10771|NCT02485483|25994|P2|NOT COMPLETED|Overall Study||0
10772|NCT02485483|25995|P1|NOT COMPLETED|Overall Study||54
10773|NCT02485483|25994|P2|COMPLETED|Overall Study||1015
10774|NCT02485483|25995|P1|COMPLETED|Overall Study||223
10775|NCT02485483|25994|P2|STARTED|Overall Study||1015
10776|NCT02485483|25995|P1|STARTED|Overall Study||277
10777|NCT02485353|26010|P1|NOT COMPLETED|Overall Study||2
10778|NCT02485353|26010|P1|COMPLETED|Overall Study||0
10779|NCT02485353|26010|P1|STARTED|Overall Study||2
10780|NCT02485301|26017|P2|NOT COMPLETED|Overall Study||49
10781|NCT02485301|26018|P1|NOT COMPLETED|Overall Study||38
10782|NCT02485301|26017|P2|COMPLETED|Overall Study||1455
10783|NCT02485301|26018|P1|COMPLETED|Overall Study||1471
10784|NCT02485301|26017|P2|STARTED|Overall Study||1504
10785|NCT02485301|26018|P1|STARTED|Overall Study||1509
10786|NCT02485158|26068|P1|NOT COMPLETED|Overall Study||4
10787|NCT02485158|26068|P1|COMPLETED|Overall Study||24
10788|NCT02485158|26068|P1|STARTED|Overall Study||28
10789|NCT02484911|26157|P2|NOT COMPLETED|Overall Study||2
10790|NCT02484911|26158|P1|NOT COMPLETED|Overall Study||4
10791|NCT02484911|26157|P2|COMPLETED|Overall Study||58
10792|NCT02484911|26158|P1|COMPLETED|Overall Study||56
10793|NCT02484911|26157|P2|STARTED|Overall Study||60
10794|NCT02484911|26158|P1|STARTED|Overall Study||60
10795|NCT02484898|26186|P1|NOT COMPLETED|Overall Study||18
10796|NCT02484898|26186|P1|COMPLETED|Overall Study||182
10797|NCT02484898|26186|P1|STARTED|Overall Study||200
10798|NCT02484729|26200|P10|NOT COMPLETED|Overall Study||1
10799|NCT02484729|26201|P9|NOT COMPLETED|Overall Study||0
10800|NCT02484729|26202|P8|NOT COMPLETED|Overall Study||0
10801|NCT02484729|26203|P7|NOT COMPLETED|Overall Study||0
10802|NCT02484729|26204|P6|NOT COMPLETED|Overall Study||0
10803|NCT02484729|26205|P5|NOT COMPLETED|Overall Study||0
10804|NCT02484729|26206|P4|NOT COMPLETED|Overall Study||0
10805|NCT02484729|26207|P3|NOT COMPLETED|Overall Study||0
10806|NCT02484729|26208|P2|NOT COMPLETED|Overall Study||0
10807|NCT02484729|26209|P1|NOT COMPLETED|Overall Study||0
10808|NCT02484729|26200|P10|COMPLETED|Overall Study||7
10809|NCT02484729|26201|P9|COMPLETED|Overall Study||6
10810|NCT02484729|26202|P8|COMPLETED|Overall Study||6
10811|NCT02484729|26203|P7|COMPLETED|Overall Study||5
10812|NCT02484729|26204|P6|COMPLETED|Overall Study||6
10813|NCT02484729|26205|P5|COMPLETED|Overall Study||5
10814|NCT02484729|26206|P4|COMPLETED|Overall Study||6
10815|NCT02484729|26207|P3|COMPLETED|Overall Study||6
10816|NCT02484729|26208|P2|COMPLETED|Overall Study||6
10817|NCT02484729|26209|P1|COMPLETED|Overall Study||16
10818|NCT02484729|26200|P10|STARTED|Overall Study||8
10819|NCT02484729|26201|P9|STARTED|Overall Study||6
10820|NCT02484729|26202|P8|STARTED|Overall Study||6
10821|NCT02484729|26203|P7|STARTED|Overall Study||5
10822|NCT02484729|26204|P6|STARTED|Overall Study||6
10823|NCT02484729|26205|P5|STARTED|Overall Study||5
10824|NCT02484729|26206|P4|STARTED|Overall Study||6
10825|NCT02484729|26207|P3|STARTED|Overall Study||6
10826|NCT02484729|26208|P2|STARTED|Overall Study||6
10827|NCT02484729|26209|P1|STARTED|Overall Study||16
10828|NCT02483975|26407|P2|NOT COMPLETED|Overall Study||2
10829|NCT02483975|26408|P1|NOT COMPLETED|Overall Study||2
10830|NCT02483975|26407|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
10831|NCT02483975|26408|P1|COMPLETED|Overall Study||54
10832|NCT02483975|26407|P2|STARTED|Overall Study||55
10833|NCT02483975|26408|P1|STARTED|Overall Study||56
10834|NCT02483611|26425|P3|NOT COMPLETED|Overall Study||1
10835|NCT02483611|26426|P2|NOT COMPLETED|Overall Study||0
10836|NCT02483611|26427|P1|NOT COMPLETED|Overall Study||0
10837|NCT02483611|26425|P3|COMPLETED|Overall Study|One patient required decurarization|15
10838|NCT02483611|26426|P2|COMPLETED|Overall Study||16
10839|NCT02483611|26427|P1|COMPLETED|Overall Study||16
10840|NCT02483611|26425|P3|STARTED|Overall Study||16
10841|NCT02483611|26426|P2|STARTED|Overall Study||16
10842|NCT02483611|26427|P1|STARTED|Overall Study||16
10843|NCT02482870|26522|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
10844|NCT02482870|26523|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
10845|NCT02482870|26522|P2|COMPLETED|Period 2 - Rest of the Study||202
10846|NCT02482870|26523|P1|COMPLETED|Period 2 - Rest of the Study||186
10847|NCT02482870|26522|P2|STARTED|Period 2 - Rest of the Study||202
10848|NCT02482870|26523|P1|STARTED|Period 2 - Rest of the Study||186
10849|NCT02482870|26522|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
10850|NCT02482870|26523|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
10851|NCT02482870|26522|P2|COMPLETED|Period 1 - First 60 Patients||30
10852|NCT02482870|26523|P1|COMPLETED|Period 1 - First 60 Patients||30
10853|NCT02482870|26522|P2|STARTED|Period 1 - First 60 Patients||30
10854|NCT02482870|26523|P1|STARTED|Period 1 - First 60 Patients||30
10855|NCT02482805|26540|P3|NOT COMPLETED|Overall Study||0
10856|NCT02482805|26541|P2|NOT COMPLETED|Overall Study||4
10857|NCT02482805|26542|P1|NOT COMPLETED|Overall Study||4
10858|NCT02482805|26540|P3|COMPLETED|Overall Study||20
10859|NCT02482805|26541|P2|COMPLETED|Overall Study||23
10860|NCT02482805|26542|P1|COMPLETED|Overall Study||22
10861|NCT02482805|26540|P3|STARTED|Overall Study||20
10862|NCT02482805|26541|P2|STARTED|Overall Study||27
10863|NCT02482805|26542|P1|STARTED|Overall Study||26
10864|NCT02482571|26556|P1|NOT COMPLETED|Overall Study||8
10865|NCT02482571|26556|P1|COMPLETED|Overall Study||17
10866|NCT02482571|26556|P1|STARTED|Overall Study||25
10867|NCT02482428|26568|P5|NOT COMPLETED|Overall Study||7
10868|NCT02482428|26569|P4|NOT COMPLETED|Overall Study||2
10869|NCT02482428|26570|P3|NOT COMPLETED|Overall Study||1
10870|NCT02482428|26571|P2|NOT COMPLETED|Overall Study||12
10871|NCT02482428|26572|P1|NOT COMPLETED|Overall Study||9
10872|NCT02482428|26568|P5|COMPLETED|Overall Study||15
10873|NCT02482428|26569|P4|COMPLETED|Overall Study||8
10874|NCT02482428|26570|P3|COMPLETED|Overall Study||9
10875|NCT02482428|26571|P2|COMPLETED|Overall Study||10
10876|NCT02482428|26572|P1|COMPLETED|Overall Study||15
10877|NCT02482428|26568|P5|STARTED|Overall Study||22
10878|NCT02482428|26569|P4|STARTED|Overall Study||10
10879|NCT02482428|26570|P3|STARTED|Overall Study||10
10880|NCT02482428|26571|P2|STARTED|Overall Study||22
10881|NCT02482428|26572|P1|STARTED|Overall Study||24
10882|NCT02482298|26595|P3|NOT COMPLETED|Overall Study||3
10883|NCT02482298|26596|P2|NOT COMPLETED|Overall Study||3
10884|NCT02482298|26597|P1|NOT COMPLETED|Overall Study||2
10885|NCT02482298|26595|P3|COMPLETED|Overall Study||27
10886|NCT02482298|26596|P2|COMPLETED|Overall Study||24
10887|NCT02482298|26597|P1|COMPLETED|Overall Study||28
10888|NCT02482298|26595|P3|STARTED|Overall Study||30
10889|NCT02482298|26596|P2|STARTED|Overall Study||27
10890|NCT02482298|26597|P1|STARTED|Overall Study||30
10891|NCT02482129|26619|P2|NOT COMPLETED|Overall Study||2
10892|NCT02482129|26620|P1|NOT COMPLETED|Overall Study||6
10893|NCT02482129|26619|P2|COMPLETED|Overall Study||9
10894|NCT02482129|26620|P1|COMPLETED|Overall Study||26
10895|NCT02482129|26619|P2|Treated, as Randomized|Overall Study||9
10896|NCT02482129|26620|P1|Treated, as Randomized|Overall Study||30
10897|NCT02482129|26619|P2|STARTED|Overall Study||11
10898|NCT02482129|26620|P1|STARTED|Overall Study||32
10899|NCT02481934|26647|P1|NOT COMPLETED|Overall Study||2
10900|NCT02481934|26647|P1|COMPLETED|Overall Study||3
10901|NCT02481934|26647|P1|STARTED|Overall Study||5
10902|NCT02481219|26654|P2|NOT COMPLETED|Overall Study||1
10903|NCT02481219|26655|P1|NOT COMPLETED|Overall Study||2
10904|NCT02481219|26654|P2|COMPLETED|Overall Study||61
10905|NCT02481219|26655|P1|COMPLETED|Overall Study||58
10906|NCT02481219|26654|P2|STARTED|Overall Study||62
10907|NCT02481219|26655|P1|STARTED|Overall Study||60
10908|NCT02481141|26673|P2|NOT COMPLETED|Overall Study||5
10909|NCT02481141|26674|P1|NOT COMPLETED|Overall Study||9
10910|NCT02481141|26673|P2|COMPLETED|Overall Study||13
10911|NCT02481141|26674|P1|COMPLETED|Overall Study||26
10912|NCT02481141|26673|P2|STARTED|Overall Study||18
10913|NCT02481141|26674|P1|STARTED|Overall Study||35
10914|NCT02480712|26726|P1|NOT COMPLETED|Overall Study||11
10915|NCT02480712|26726|P1|COMPLETED|Overall Study||96
10916|NCT02480712|26726|P1|STARTED|Overall Study||107
10917|NCT02480621|26745|P2|NOT COMPLETED|Follow Up||2
10918|NCT02480621|26746|P1|NOT COMPLETED|Follow Up||4
10919|NCT02480621|26745|P2|COMPLETED|Follow Up||37
10920|NCT02480621|26746|P1|COMPLETED|Follow Up||39
10921|NCT02480621|26745|P2|STARTED|Follow Up||39
10922|NCT02480621|26746|P1|STARTED|Follow Up||43
10923|NCT02480621|26745|P2|NOT COMPLETED|Randomization||1
10924|NCT02480621|26746|P1|NOT COMPLETED|Randomization||1
10925|NCT02480621|26745|P2|COMPLETED|Randomization||39
10926|NCT02480621|26746|P1|COMPLETED|Randomization||43
10927|NCT02480621|26745|P2|STARTED|Randomization||40
10928|NCT02480621|26746|P1|STARTED|Randomization||44
10929|NCT02480582|26752|P6|NOT COMPLETED|Overall Study||0
10930|NCT02480582|26753|P5|NOT COMPLETED|Overall Study||0
10931|NCT02480582|26754|P4|NOT COMPLETED|Overall Study||0
10932|NCT02480582|26755|P3|NOT COMPLETED|Overall Study||0
10933|NCT02480582|26756|P2|NOT COMPLETED|Overall Study||0
10934|NCT02480582|26757|P1|NOT COMPLETED|Overall Study||0
10935|NCT02480582|26752|P6|COMPLETED|Overall Study||7
10936|NCT02480582|26753|P5|COMPLETED|Overall Study||7
10937|NCT02480582|26754|P4|COMPLETED|Overall Study||7
10938|NCT02480582|26755|P3|COMPLETED|Overall Study||7
10939|NCT02480582|26756|P2|COMPLETED|Overall Study||7
10940|NCT02480582|26757|P1|COMPLETED|Overall Study||7
10941|NCT02480582|26752|P6|STARTED|Overall Study||7
10942|NCT02480582|26753|P5|STARTED|Overall Study||7
10943|NCT02480582|26754|P4|STARTED|Overall Study||7
10944|NCT02480582|26755|P3|STARTED|Overall Study||7
10945|NCT02480582|26756|P2|STARTED|Overall Study||7
10946|NCT02480582|26757|P1|STARTED|Overall Study||7
10947|NCT02480439|26780|P3|NOT COMPLETED|Treatment Period 3||0
10948|NCT02480439|26781|P2|NOT COMPLETED|Treatment Period 3||0
10949|NCT02480439|26782|P1|NOT COMPLETED|Treatment Period 3||0
10950|NCT02480439|26780|P3|COMPLETED|Treatment Period 3||7
10951|NCT02480439|26781|P2|COMPLETED|Treatment Period 3||7
10952|NCT02480439|26782|P1|COMPLETED|Treatment Period 3||8
10953|NCT02480439|26780|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
10954|NCT02480439|26781|P2|STARTED|Treatment Period 3||7
10955|NCT02480439|26782|P1|STARTED|Treatment Period 3||8
10956|NCT02480439|26780|P3|NOT COMPLETED|Treatment Period 2||0
10957|NCT02480439|26781|P2|NOT COMPLETED|Treatment Period 2||0
10958|NCT02480439|26782|P1|NOT COMPLETED|Treatment Period 2||0
10959|NCT02480439|26780|P3|COMPLETED|Treatment Period 2||8
10960|NCT02480439|26781|P2|COMPLETED|Treatment Period 2||7
10961|NCT02480439|26782|P1|COMPLETED|Treatment Period 2||8
10962|NCT02480439|26780|P3|STARTED|Treatment Period 2||8
10963|NCT02480439|26781|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
10964|NCT02480439|26782|P1|STARTED|Treatment Period 2||8
10965|NCT02480439|26780|P3|NOT COMPLETED|Treatment Period 1||0
10966|NCT02480439|26781|P2|NOT COMPLETED|Treatment Period 1||0
10967|NCT02480439|26782|P1|NOT COMPLETED|Treatment Period 1||0
10968|NCT02480439|26780|P3|COMPLETED|Treatment Period 1||8
10969|NCT02480439|26781|P2|COMPLETED|Treatment Period 1||8
10970|NCT02480439|26782|P1|COMPLETED|Treatment Period 1||8
10971|NCT02480439|26780|P3|STARTED|Treatment Period 1||8
10972|NCT02480439|26781|P2|STARTED|Treatment Period 1||8
10973|NCT02480439|26782|P1|STARTED|Treatment Period 1||8
10974|NCT02480166|26808|P3|NOT COMPLETED|Overall Study||0
10975|NCT02480166|26809|P2|NOT COMPLETED|Overall Study||0
10976|NCT02480166|26810|P1|NOT COMPLETED|Overall Study||0
10977|NCT02480166|26808|P3|COMPLETED|Overall Study||4
10978|NCT02480166|26809|P2|COMPLETED|Overall Study||36
10979|NCT02480166|26810|P1|COMPLETED|Overall Study||20
10980|NCT02480166|26808|P3|STARTED|Overall Study||4
10981|NCT02480166|26809|P2|STARTED|Overall Study||36
10982|NCT02480166|26810|P1|STARTED|Overall Study||20
10983|NCT02480153|26823|P2|NOT COMPLETED|Overall Study||27
10984|NCT02480153|26824|P1|NOT COMPLETED|Overall Study||11
10985|NCT02480153|26823|P2|COMPLETED|Overall Study||273
10986|NCT02480153|26824|P1|COMPLETED|Overall Study||286
10987|NCT02480153|26823|P2|Received Treatment|Overall Study||299
10988|NCT02480153|26824|P1|Received Treatment|Overall Study||297
10989|NCT02480153|26823|P2|STARTED|Overall Study||300
10990|NCT02480153|26824|P1|STARTED|Overall Study||297
10991|NCT02480010|26832|P2|NOT COMPLETED|Overall Study||33
10992|NCT02480010|26833|P1|NOT COMPLETED|Overall Study||35
10993|NCT02480010|26832|P2|COMPLETED|Overall Study||0
10994|NCT02480010|26833|P1|COMPLETED|Overall Study||0
10995|NCT02480010|26832|P2|STARTED|Overall Study||33
10996|NCT02480010|26833|P1|STARTED|Overall Study||35
10997|NCT02479763|26879|P2|NOT COMPLETED|Overall Study||3
10998|NCT02479763|26880|P1|NOT COMPLETED|Overall Study||3
10999|NCT02479763|26879|P2|COMPLETED|Overall Study||50
11000|NCT02479763|26880|P1|COMPLETED|Overall Study||50
11001|NCT02479763|26879|P2|STARTED|Overall Study||53
11002|NCT02479763|26880|P1|STARTED|Overall Study||53
11003|NCT02479412|26895|P9|NOT COMPLETED|Overall Study||1
11004|NCT02479412|26896|P8|NOT COMPLETED|Overall Study||1
11005|NCT02479412|26897|P7|NOT COMPLETED|Overall Study||0
11006|NCT02479412|26898|P6|NOT COMPLETED|Overall Study||0
11007|NCT02479412|26899|P5|NOT COMPLETED|Overall Study||1
11008|NCT02479412|26900|P4|NOT COMPLETED|Overall Study||1
11009|NCT02479412|26901|P3|NOT COMPLETED|Overall Study||2
11010|NCT02479412|26902|P2|NOT COMPLETED|Overall Study||0
11011|NCT02479412|26903|P1|NOT COMPLETED|Overall Study||0
11012|NCT02479412|26895|P9|COMPLETED|Overall Study||6
11013|NCT02479412|26896|P8|COMPLETED|Overall Study||4
11014|NCT02479412|26897|P7|COMPLETED|Overall Study||6
11015|NCT02479412|26898|P6|COMPLETED|Overall Study||5
11016|NCT02479412|26899|P5|COMPLETED|Overall Study||5
11017|NCT02479412|26900|P4|COMPLETED|Overall Study||6
11018|NCT02479412|26901|P3|COMPLETED|Overall Study||4
11019|NCT02479412|26902|P2|COMPLETED|Overall Study||6
11020|NCT02479412|26903|P1|COMPLETED|Overall Study||6
11021|NCT02479412|26895|P9|STARTED|Overall Study||7
11022|NCT02479412|26896|P8|STARTED|Overall Study||5
11023|NCT02479412|26897|P7|STARTED|Overall Study||6
11024|NCT02479412|26898|P6|STARTED|Overall Study||5
11025|NCT02479412|26899|P5|STARTED|Overall Study||6
11026|NCT02479412|26900|P4|STARTED|Overall Study||7
11027|NCT02479412|26901|P3|STARTED|Overall Study||6
11028|NCT02479412|26902|P2|STARTED|Overall Study||6
11029|NCT02479412|26903|P1|STARTED|Overall Study||6
11030|NCT02479139|26980|P6|NOT COMPLETED|Overall Study||6
11031|NCT02479139|26981|P5|NOT COMPLETED|Overall Study||5
11032|NCT02479139|26982|P4|NOT COMPLETED|Overall Study||7
11033|NCT02479139|26983|P3|NOT COMPLETED|Overall Study||7
11034|NCT02479139|26984|P2|NOT COMPLETED|Overall Study||10
11035|NCT02479139|26985|P1|NOT COMPLETED|Overall Study||8
11036|NCT02479139|26980|P6|COMPLETED|Overall Study||19
11037|NCT02479139|26981|P5|COMPLETED|Overall Study||17
11038|NCT02479139|26982|P4|COMPLETED|Overall Study||14
11039|NCT02479139|26983|P3|COMPLETED|Overall Study||21
11040|NCT02479139|26984|P2|COMPLETED|Overall Study||12
11041|NCT02479139|26985|P1|COMPLETED|Overall Study||19
11042|NCT02479139|26980|P6|STARTED|Overall Study||25
11043|NCT02479139|26981|P5|STARTED|Overall Study||22
11044|NCT02479139|26982|P4|STARTED|Overall Study||21
11045|NCT02479139|26983|P3|STARTED|Overall Study||28
11046|NCT02479139|26984|P2|STARTED|Overall Study||22
11047|NCT02479139|26985|P1|STARTED|Overall Study||27
11048|NCT02478671|27011|P1|NOT COMPLETED|Overall Study||0
11049|NCT02478671|27011|P1|COMPLETED|Overall Study||4
11050|NCT02478671|27011|P1|STARTED|Overall Study||4
11051|NCT02478632|27018|P2|NOT COMPLETED|Overall Study||5
11052|NCT02478632|27019|P1|NOT COMPLETED|Overall Study||4
11053|NCT02478632|27018|P2|COMPLETED|Overall Study||44
11054|NCT02478632|27019|P1|COMPLETED|Overall Study||49
11055|NCT02478632|27018|P2|STARTED|Overall Study||49
11056|NCT02478632|27019|P1|STARTED|Overall Study||53
11057|NCT02478580|27035|P2|NOT COMPLETED|Overall Study||0
11058|NCT02478580|27036|P1|NOT COMPLETED|Overall Study||0
11059|NCT02478580|27035|P2|COMPLETED|Overall Study||33
11060|NCT02478580|27036|P1|COMPLETED|Overall Study||34
11061|NCT02478580|27035|P2|STARTED|Overall Study||33
11062|NCT02478580|27036|P1|STARTED|Overall Study||34
11063|NCT02478372|27046|P2|NOT COMPLETED|Overall Study||14
11064|NCT02478372|27047|P1|NOT COMPLETED|Overall Study||13
11065|NCT02478372|27046|P2|COMPLETED|Overall Study||107
11066|NCT02478372|27047|P1|COMPLETED|Overall Study||108
11067|NCT02478372|27046|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
11068|NCT02478372|27047|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
11069|NCT02478372|27046|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
11070|NCT02478372|27047|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
11071|NCT02478372|27046|P2|Recieved Allocation Intervention|Overall Study||113
11072|NCT02478372|27047|P1|Recieved Allocation Intervention|Overall Study||109
11073|NCT02478372|27046|P2|STARTED|Overall Study||121
11074|NCT02478372|27047|P1|STARTED|Overall Study||121
11075|NCT02478164|27069|P1|NOT COMPLETED|Overall Study||15
11076|NCT02478164|27069|P1|COMPLETED|Overall Study||0
11077|NCT02478164|27069|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
11078|NCT02477709|27076|P1|NOT COMPLETED|Overall Study||0
11079|NCT02477709|27076|P1|COMPLETED|Overall Study||6
11080|NCT02477709|27076|P1|STARTED|Overall Study||6
11081|NCT02477605|27082|P2|NOT COMPLETED|Overall Study||4
11082|NCT02477605|27083|P1|NOT COMPLETED|Overall Study||1
11083|NCT02477605|27082|P2|COMPLETED|Overall Study||64
11084|NCT02477605|27083|P1|COMPLETED|Overall Study||67
11085|NCT02477605|27082|P2|Randomized and Treated|Overall Study||68
11086|NCT02477605|27083|P1|Randomized and Treated|Overall Study||67
11087|NCT02477605|27082|P2|STARTED|Overall Study||68
11088|NCT02477605|27083|P1|STARTED|Overall Study||68
11089|NCT02477527|27097|P1|NOT COMPLETED|Overall Study||6
11090|NCT02477527|27097|P1|COMPLETED|Overall Study||21
11091|NCT02477527|27097|P1|STARTED|Overall Study||27
11092|NCT02477020|27107|P2|NOT COMPLETED|Overall Study||28
11093|NCT02477020|27108|P1|NOT COMPLETED|Overall Study||30
11094|NCT02477020|27107|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
11095|NCT02477020|27108|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
11096|NCT02477020|27107|P2|STARTED|Overall Study||83
11097|NCT02477020|27108|P1|STARTED|Overall Study||81
11098|NCT02476994|27138|P2|NOT COMPLETED|Overall Study||0
11099|NCT02476994|27139|P1|NOT COMPLETED|Overall Study||1
11100|NCT02476994|27138|P2|COMPLETED|Overall Study||0
11101|NCT02476994|27139|P1|COMPLETED|Overall Study||0
11102|NCT02476994|27138|P2|STARTED|Overall Study||0
11103|NCT02476994|27139|P1|STARTED|Overall Study||1
11104|NCT02476890|27169|P4|NOT COMPLETED|Overall Study||0
11105|NCT02476890|27170|P3|NOT COMPLETED|Overall Study||0
11106|NCT02476890|27171|P2|NOT COMPLETED|Overall Study||0
11107|NCT02476890|27172|P1|NOT COMPLETED|Overall Study||0
11108|NCT02476890|27169|P4|COMPLETED|Overall Study||12
11109|NCT02476890|27170|P3|COMPLETED|Overall Study||12
11110|NCT02476890|27171|P2|COMPLETED|Overall Study||6
11111|NCT02476890|27172|P1|COMPLETED|Overall Study||6
11112|NCT02476890|27169|P4|Washout|Overall Study||12
11113|NCT02476890|27170|P3|Washout|Overall Study||12
11114|NCT02476890|27171|P2|Washout|Overall Study||6
11115|NCT02476890|27172|P1|Washout|Overall Study||6
11116|NCT02476890|27169|P4|STARTED|Overall Study|Crossover study|12
11117|NCT02476890|27170|P3|STARTED|Overall Study|Crossover study|12
11118|NCT02476890|27171|P2|STARTED|Overall Study|Crossover study|6
11119|NCT02476890|27172|P1|STARTED|Overall Study|Crossover study|6
11120|NCT02476617|27208|P1|NOT COMPLETED|Overall Study||2
11121|NCT02476617|27208|P1|COMPLETED|Overall Study||23
11122|NCT02476617|27208|P1|STARTED|Overall Study||25
11123|NCT02476565|27214|P2|NOT COMPLETED|Overall Study||0
11124|NCT02476565|27215|P1|NOT COMPLETED|Overall Study||0
11125|NCT02476565|27214|P2|COMPLETED|Overall Study||19
11126|NCT02476565|27215|P1|COMPLETED|Overall Study||20
11127|NCT02476565|27214|P2|STARTED|Overall Study||19
11128|NCT02476565|27215|P1|STARTED|Overall Study||20
11129|NCT02476422|27237|P2|NOT COMPLETED|Overall Study||1
11130|NCT02476422|27238|P1|NOT COMPLETED|Overall Study||0
11131|NCT02476422|27237|P2|COMPLETED|Overall Study||161
11132|NCT02476422|27238|P1|COMPLETED|Overall Study||166
11133|NCT02476422|27237|P2|STARTED|Overall Study||162
11134|NCT02476422|27238|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
11135|NCT02476175|27268|P1|NOT COMPLETED|Overall Study||2
11136|NCT02476175|27268|P1|COMPLETED|Overall Study||33
11137|NCT02476175|27268|P1|STARTED|Overall Study||35
11138|NCT02476032|27279|P3|NOT COMPLETED|Overall Study||1
11139|NCT02476032|27280|P2|NOT COMPLETED|Overall Study||1
11140|NCT02476032|27281|P1|NOT COMPLETED|Overall Study||0
11141|NCT02476032|27279|P3|COMPLETED|Overall Study||19
11142|NCT02476032|27280|P2|COMPLETED|Overall Study||19
11143|NCT02476032|27281|P1|COMPLETED|Overall Study||20
11144|NCT02476032|27279|P3|STARTED|Overall Study||20
11145|NCT02476032|27280|P2|STARTED|Overall Study||20
11146|NCT02476032|27281|P1|STARTED|Overall Study||20
11147|NCT02475980|27292|P1|NOT COMPLETED|Overall Study||5
11148|NCT02475980|27292|P1|COMPLETED|Overall Study||8
11149|NCT02475980|27292|P1|STARTED|Overall Study||13
11150|NCT02475564|27303|P2|NOT COMPLETED|Overall Study||1
11151|NCT02475564|27304|P1|NOT COMPLETED|Overall Study||4
11152|NCT02475564|27303|P2|COMPLETED|Overall Study||21
11153|NCT02475564|27304|P1|COMPLETED|Overall Study||18
11154|NCT02475564|27303|P2|STARTED|Overall Study||22
11155|NCT02475564|27304|P1|STARTED|Overall Study||22
11156|NCT02475395|27316|P2|NOT COMPLETED|Overall Study||3
11157|NCT02475395|27317|P1|NOT COMPLETED|Overall Study||30
11158|NCT02475395|27316|P2|COMPLETED|Overall Study||11
11159|NCT02475395|27317|P1|COMPLETED|Overall Study||228
11160|NCT02475395|27316|P2|STARTED|Overall Study||14
11161|NCT02475395|27317|P1|STARTED|Overall Study||258
11162|NCT02475278|27327|P1|NOT COMPLETED|Overall Study||2
11163|NCT02475278|27327|P1|COMPLETED|Overall Study||48
11164|NCT02475278|27327|P1|STARTED|Overall Study||50
11165|NCT02475031|27340|P2|NOT COMPLETED|Overall Study||0
11166|NCT02475031|27341|P1|NOT COMPLETED|Overall Study||0
11167|NCT02475031|27340|P2|COMPLETED|Overall Study||35
11168|NCT02475031|27341|P1|COMPLETED|Overall Study||35
11169|NCT02475031|27340|P2|STARTED|Overall Study||35
11170|NCT02475031|27341|P1|STARTED|Overall Study||35
11171|NCT02474901|27357|P2|NOT COMPLETED|Overall Study||0
11172|NCT02474901|27358|P1|NOT COMPLETED|Overall Study||1
11173|NCT02474901|27357|P2|COMPLETED|Overall Study||56
11174|NCT02474901|27358|P1|COMPLETED|Overall Study||44
11175|NCT02474901|27357|P2|STARTED|Overall Study||56
11176|NCT02474901|27358|P1|STARTED|Overall Study||45
11177|NCT02474589|27374|P2|NOT COMPLETED|Overall Study||5
11178|NCT02474589|27375|P1|NOT COMPLETED|Overall Study||25
11179|NCT02474589|27374|P2|COMPLETED|Overall Study||85
11180|NCT02474589|27375|P1|COMPLETED|Overall Study||334
11181|NCT02474589|27374|P2|STARTED|Overall Study||90
11182|NCT02474589|27375|P1|STARTED|Overall Study||359
11183|NCT02474498|27384|P3|NOT COMPLETED|Overall Study||0
11184|NCT02474498|27385|P2|NOT COMPLETED|Overall Study||0
11185|NCT02474498|27386|P1|NOT COMPLETED|Overall Study||0
11186|NCT02474498|27384|P3|COMPLETED|Overall Study||14
11187|NCT02474498|27385|P2|COMPLETED|Overall Study||14
11188|NCT02474498|27386|P1|COMPLETED|Overall Study||13
11189|NCT02474498|27384|P3|STARTED|Overall Study||14
11190|NCT02474498|27385|P2|STARTED|Overall Study||14
11191|NCT02474498|27386|P1|STARTED|Overall Study||13
11192|NCT02474082|27405|P2|NOT COMPLETED|Overall Study||54
11193|NCT02474082|27406|P1|NOT COMPLETED|Overall Study||6
11194|NCT02474082|27405|P2|COMPLETED|Overall Study||43
11195|NCT02474082|27406|P1|COMPLETED|Overall Study||99
11196|NCT02474082|27405|P2|Full Analysis Set (FAS)|Overall Study||95
11197|NCT02474082|27406|P1|Full Analysis Set (FAS)|Overall Study||105
11198|NCT02474082|27405|P2|STARTED|Overall Study||97
11199|NCT02474082|27406|P1|STARTED|Overall Study||105
11200|NCT02473991|27440|P1|NOT COMPLETED|Overall Study||0
11201|NCT02473991|27440|P1|COMPLETED|Overall Study||395
11202|NCT02473991|27440|P1|STARTED|Overall Study||395
11203|NCT02473783|27448|P2|NOT COMPLETED|Overall Study||0
11204|NCT02473783|27449|P1|NOT COMPLETED|Overall Study||0
11205|NCT02473783|27448|P2|COMPLETED|Overall Study||17
11206|NCT02473783|27449|P1|COMPLETED|Overall Study||20
11207|NCT02473783|27448|P2|STARTED|Overall Study||17
11208|NCT02473783|27449|P1|STARTED|Overall Study||20
11209|NCT02473718|27459|P2|NOT COMPLETED|Overall Study||0
11210|NCT02473718|27460|P1|NOT COMPLETED|Overall Study||0
11211|NCT02473718|27459|P2|COMPLETED|Overall Study||41
11212|NCT02473718|27460|P1|COMPLETED|Overall Study||41
11213|NCT02473718|27459|P2|STARTED|Overall Study||41
11214|NCT02473718|27460|P1|STARTED|Overall Study||41
11215|NCT02473640|27480|P1|NOT COMPLETED|Treatment Period 2||0
11216|NCT02473640|27480|P1|COMPLETED|Treatment Period 2||14
11217|NCT02473640|27480|P1|STARTED|Treatment Period 2||14
11218|NCT02473640|27480|P1|NOT COMPLETED|Run-in Phase||0
11219|NCT02473640|27480|P1|COMPLETED|Run-in Phase||14
11220|NCT02473640|27480|P1|STARTED|Run-in Phase||14
11221|NCT02473640|27480|P1|NOT COMPLETED|Treatment Period 1||1
11222|NCT02473640|27480|P1|COMPLETED|Treatment Period 1||14
11223|NCT02473640|27480|P1|STARTED|Treatment Period 1||15
11224|NCT02473523|27489|P1|NOT COMPLETED|Overall Study||2
11225|NCT02473523|27489|P1|COMPLETED|Overall Study||0
11226|NCT02473523|27489|P1|STARTED|Overall Study||2
11227|NCT02473510|27510|P2|NOT COMPLETED|Overall Study||2
11228|NCT02473510|27511|P1|NOT COMPLETED|Overall Study||1
11229|NCT02473510|27510|P2|COMPLETED|Overall Study||238
11230|NCT02473510|27511|P1|COMPLETED|Overall Study||59
11231|NCT02473510|27510|P2|STARTED|Overall Study||240
11232|NCT02473510|27511|P1|STARTED|Overall Study||60
11233|NCT02473471|27525|P1|NOT COMPLETED|Overall Study||3
11234|NCT02473471|27525|P1|COMPLETED|Overall Study||32
11235|NCT02473471|27525|P1|Randomized Not Treated|Overall Study||2
11236|NCT02473471|27525|P1|Received Allocated Intervention|Overall Study||33
11237|NCT02473471|27525|P1|STARTED|Overall Study||35
11238|NCT02473445|27556|P1|NOT COMPLETED|Overall Study||22
11239|NCT02473445|27556|P1|COMPLETED|Overall Study||0
11240|NCT02473445|27556|P1|STARTED|Overall Study||22
11241|NCT02473367|27562|P1|NOT COMPLETED|Period 4||1
11242|NCT02473367|27562|P1|COMPLETED|Period 4||18
11243|NCT02473367|27562|P1|STARTED|Period 4||19
11244|NCT02473367|27562|P1|NOT COMPLETED|Wait 3||0
11245|NCT02473367|27562|P1|COMPLETED|Wait 3||19
11246|NCT02473367|27562|P1|STARTED|Wait 3||19
11247|NCT02473367|27562|P1|NOT COMPLETED|Period 3||0
11248|NCT02473367|27562|P1|COMPLETED|Period 3||19
11249|NCT02473367|27562|P1|STARTED|Period 3||19
11250|NCT02473367|27562|P1|NOT COMPLETED|Wait 2||0
11251|NCT02473367|27562|P1|COMPLETED|Wait 2||19
11252|NCT02473367|27562|P1|STARTED|Wait 2||19
11253|NCT02473367|27562|P1|NOT COMPLETED|Period 2||0
11254|NCT02473367|27562|P1|COMPLETED|Period 2||19
11255|NCT02473367|27562|P1|STARTED|Period 2||19
11256|NCT02473367|27562|P1|NOT COMPLETED|Wait 1||1
11257|NCT02473367|27562|P1|COMPLETED|Wait 1||19
11258|NCT02473367|27562|P1|STARTED|Wait 1||20
11259|NCT02473367|27562|P1|NOT COMPLETED|Period 1||0
11260|NCT02473367|27562|P1|COMPLETED|Period 1||20
11261|NCT02473367|27562|P1|STARTED|Period 1||20
11262|NCT02472977|27583|P3|NOT COMPLETED|Overall Study||8
11263|NCT02472977|27584|P2|NOT COMPLETED|Overall Study||27
11264|NCT02472977|27585|P1|NOT COMPLETED|Overall Study||6
11265|NCT02472977|27583|P3|COMPLETED|Overall Study||0
11266|NCT02472977|27584|P2|COMPLETED|Overall Study||0
11267|NCT02472977|27585|P1|COMPLETED|Overall Study||0
11268|NCT02472977|27583|P3|STARTED|Overall Study||8
11269|NCT02472977|27584|P2|STARTED|Overall Study||27
11270|NCT02472977|27585|P1|STARTED|Overall Study||6
11271|NCT02472886|27611|P3|NOT COMPLETED|Overall Study||1
11272|NCT02472886|27612|P2|NOT COMPLETED|Overall Study||2
11273|NCT02472886|27613|P1|NOT COMPLETED|Overall Study||0
11274|NCT02472886|27611|P3|COMPLETED|Overall Study||26
11275|NCT02472886|27612|P2|COMPLETED|Overall Study||57
11276|NCT02472886|27613|P1|COMPLETED|Overall Study||67
11277|NCT02472886|27611|P3|STARTED|Overall Study||27
11278|NCT02472886|27612|P2|STARTED|Overall Study||59
11279|NCT02472886|27613|P1|STARTED|Overall Study||67
11280|NCT02472847|27641|P2|NOT COMPLETED|Overall Study||5
11281|NCT02472847|27642|P1|NOT COMPLETED|Overall Study||1
11282|NCT02472847|27641|P2|COMPLETED|Overall Study||21
11283|NCT02472847|27642|P1|COMPLETED|Overall Study||23
11284|NCT02472847|27641|P2|STARTED|Overall Study||26
11285|NCT02472847|27642|P1|STARTED|Overall Study||24
11286|NCT02472756|27648|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
11287|NCT02472756|27648|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
11288|NCT02472756|27648|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
11289|NCT02472756|27648|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
11290|NCT02472756|27648|P1|COMPLETED|Induction (Approximately 6 Months)||39
11291|NCT02472756|27648|P1|Treated|Induction (Approximately 6 Months)||40
11292|NCT02472756|27648|P1|STARTED|Induction (Approximately 6 Months)||41
11293|NCT02472639|27656|P2|NOT COMPLETED|Overall Study||3
11294|NCT02472639|27657|P1|NOT COMPLETED|Overall Study||4
11295|NCT02472639|27656|P2|COMPLETED|Overall Study||0
11296|NCT02472639|27657|P1|COMPLETED|Overall Study||0
11297|NCT02472639|27656|P2|STARTED|Overall Study||3
11298|NCT02472639|27657|P1|STARTED|Overall Study||4
11299|NCT02472522|27673|P2|NOT COMPLETED|Overall Study||0
11300|NCT02472522|27674|P1|NOT COMPLETED|Overall Study||0
11301|NCT02472522|27673|P2|COMPLETED|Overall Study||50
11302|NCT02472522|27674|P1|COMPLETED|Overall Study||50
11303|NCT02472522|27673|P2|STARTED|Overall Study||50
11304|NCT02472522|27674|P1|STARTED|Overall Study||50
11305|NCT02472366|27706|P2|NOT COMPLETED|Overall Study||0
11306|NCT02472366|27707|P1|NOT COMPLETED|Overall Study||1
11307|NCT02472366|27706|P2|COMPLETED|Overall Study||10
11308|NCT02472366|27707|P1|COMPLETED|Overall Study||5
11309|NCT02472366|27706|P2|STARTED|Overall Study||10
11310|NCT02472366|27707|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
11311|NCT02471755|27723|P2|NOT COMPLETED|Overall Study||1
11312|NCT02471755|27724|P1|NOT COMPLETED|Overall Study||1
11313|NCT02471755|27723|P2|COMPLETED|Overall Study||44
11314|NCT02471755|27724|P1|COMPLETED|Overall Study||44
11315|NCT02471755|27723|P2|STARTED|Overall Study||45
11316|NCT02471755|27724|P1|STARTED|Overall Study||45
11317|NCT02471612|27740|P1|NOT COMPLETED|Overall Study||2
11318|NCT02471612|27740|P1|COMPLETED|Overall Study||157
11319|NCT02471612|27740|P1|STARTED|Overall Study||159
11320|NCT02471326|27757|P1|NOT COMPLETED|Overall Study||1
11321|NCT02471326|27757|P1|COMPLETED|Overall Study||9
11322|NCT02471326|27757|P1|STARTED|Overall Study||10
11323|NCT02471183|27762|P1|NOT COMPLETED|Extended Treatment Period||1
11324|NCT02471183|27762|P1|COMPLETED|Extended Treatment Period||31
11325|NCT02471183|27762|P1|STARTED|Extended Treatment Period||32
11326|NCT02471183|27762|P1|NOT COMPLETED|Main Treatment Period||2
11327|NCT02471183|27762|P1|COMPLETED|Main Treatment Period||32
11328|NCT02471183|27762|P1|STARTED|Main Treatment Period||34
11329|NCT02470949|27777|P2|NOT COMPLETED|Second Intervention||0
11330|NCT02470949|27778|P1|NOT COMPLETED|Second Intervention||0
11331|NCT02470949|27777|P2|COMPLETED|Second Intervention||2
11332|NCT02470949|27778|P1|COMPLETED|Second Intervention||4
11333|NCT02470949|27777|P2|STARTED|Second Intervention||2
11334|NCT02470949|27778|P1|STARTED|Second Intervention||4
11335|NCT02470949|27777|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
11336|NCT02470949|27778|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
11337|NCT02470949|27777|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
11338|NCT02470949|27778|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
11339|NCT02470949|27777|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
11340|NCT02470949|27778|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
11341|NCT02470949|27777|P2|NOT COMPLETED|First Intervention||0
11342|NCT02470949|27778|P1|NOT COMPLETED|First Intervention||0
11343|NCT02470949|27777|P2|COMPLETED|First Intervention||5
11344|NCT02470949|27778|P1|COMPLETED|First Intervention||4
11345|NCT02470949|27777|P2|STARTED|First Intervention||5
11346|NCT02470949|27778|P1|STARTED|First Intervention||4
11347|NCT02470494|27788|P1|NOT COMPLETED|Overall Study||5
11348|NCT02470494|27788|P1|COMPLETED|Overall Study||41
11349|NCT02470494|27788|P1|STARTED|Overall Study||46
11350|NCT02470429|27798|P2|NOT COMPLETED|Overall Study||0
11351|NCT02470429|27799|P1|NOT COMPLETED|Overall Study||2
11352|NCT02470429|27798|P2|COMPLETED|Overall Study||49
11353|NCT02470429|27799|P1|COMPLETED|Overall Study||48
11354|NCT02470429|27798|P2|STARTED|Overall Study||49
11355|NCT02470429|27799|P1|STARTED|Overall Study||50
11356|NCT02470403|27817|P5|NOT COMPLETED|Overall Study||0
11357|NCT02470403|27818|P4|NOT COMPLETED|Overall Study||4
11358|NCT02470403|27819|P3|NOT COMPLETED|Overall Study||0
11359|NCT02470403|27820|P2|NOT COMPLETED|Overall Study||1
11360|NCT02470403|27821|P1|NOT COMPLETED|Overall Study||2
11361|NCT02470403|27817|P5|COMPLETED|Overall Study||10
11362|NCT02470403|27818|P4|COMPLETED|Overall Study||39
11363|NCT02470403|27819|P3|COMPLETED|Overall Study||40
11364|NCT02470403|27820|P2|COMPLETED|Overall Study||43
11365|NCT02470403|27821|P1|COMPLETED|Overall Study||42
11366|NCT02470403|27817|P5|Normoglycemic|Overall Study||5
11367|NCT02470403|27818|P4|Normoglycemic|Overall Study||23
11368|NCT02470403|27819|P3|Normoglycemic|Overall Study||20
11369|NCT02470403|27820|P2|Normoglycemic|Overall Study||20
11370|NCT02470403|27821|P1|Normoglycemic|Overall Study||20
11371|NCT02470403|27817|P5|Dysglycemic|Overall Study||5
11372|NCT02470403|27818|P4|Dysglycemic|Overall Study||20
11373|NCT02470403|27819|P3|Dysglycemic|Overall Study||20
11374|NCT02470403|27820|P2|Dysglycemic|Overall Study||24
11375|NCT02470403|27821|P1|Dysglycemic|Overall Study||24
11376|NCT02470403|27817|P5|STARTED|Overall Study||10
11377|NCT02470403|27818|P4|STARTED|Overall Study||43
11378|NCT02470403|27819|P3|STARTED|Overall Study||40
11379|NCT02470403|27820|P2|STARTED|Overall Study||44
11380|NCT02470403|27821|P1|STARTED|Overall Study||44
11381|NCT02470390|27861|P2|NOT COMPLETED|Overall Study||1
11382|NCT02470390|27862|P1|NOT COMPLETED|Overall Study||0
11383|NCT02470390|27861|P2|COMPLETED|Overall Study||6
11384|NCT02470390|27862|P1|COMPLETED|Overall Study||6
11385|NCT02470390|27861|P2|STARTED|Overall Study||7
11386|NCT02470390|27862|P1|STARTED|Overall Study||6
11387|NCT02469961|27890|P2|NOT COMPLETED|Overall Study||1
11388|NCT02469961|27891|P1|NOT COMPLETED|Overall Study||4
11389|NCT02469961|27890|P2|COMPLETED|Overall Study||24
11390|NCT02469961|27891|P1|COMPLETED|Overall Study||21
11391|NCT02469961|27890|P2|STARTED|Overall Study||25
11392|NCT02469961|27891|P1|STARTED|Overall Study||25
11393|NCT02469701|27903|P1|NOT COMPLETED|Overall Study||0
11394|NCT02469701|27903|P1|COMPLETED|Overall Study||10
11395|NCT02469701|27903|P1|STARTED|Overall Study||10
11396|NCT02469597|27909|P2|NOT COMPLETED|Overall Study||0
11397|NCT02469597|27910|P1|NOT COMPLETED|Overall Study||0
11398|NCT02469597|27909|P2|COMPLETED|Overall Study||24
11399|NCT02469597|27910|P1|COMPLETED|Overall Study||22
11400|NCT02469597|27909|P2|STARTED|Overall Study||24
11401|NCT02469597|27910|P1|STARTED|Overall Study||22
11402|NCT02469415|27926|P1|NOT COMPLETED|Overall Study||3
11403|NCT02469415|27926|P1|COMPLETED|Overall Study||0
11404|NCT02469415|27926|P1|STARTED|Overall Study||3
11405|NCT02469298|27934|P4|NOT COMPLETED|Overall Study||2
11406|NCT02469298|27935|P3|NOT COMPLETED|Overall Study||2
11407|NCT02469298|27936|P2|NOT COMPLETED|Overall Study||1
11408|NCT02469298|27937|P1|NOT COMPLETED|Overall Study||1
11409|NCT02469298|27934|P4|COMPLETED|Overall Study||5
11410|NCT02469298|27935|P3|COMPLETED|Overall Study||14
11411|NCT02469298|27936|P2|COMPLETED|Overall Study||6
11412|NCT02469298|27937|P1|COMPLETED|Overall Study||14
11413|NCT02469298|27934|P4|STARTED|Overall Study||7
11414|NCT02469298|27935|P3|STARTED|Overall Study||16
11415|NCT02469298|27936|P2|STARTED|Overall Study||7
11416|NCT02469298|27937|P1|STARTED|Overall Study||15
11417|NCT02469168|28077|P2|NOT COMPLETED|Overall Study||0
11418|NCT02469168|28078|P1|NOT COMPLETED|Overall Study||1
11419|NCT02469168|28077|P2|COMPLETED|Overall Study||0
11420|NCT02469168|28078|P1|COMPLETED|Overall Study||0
11421|NCT02469168|28077|P2|STARTED|Overall Study||0
11422|NCT02469168|28078|P1|STARTED|Overall Study||1
11423|NCT02469116|28086|P1|NOT COMPLETED|Overall Study||0
11424|NCT02469116|28086|P1|COMPLETED|Overall Study||18
11425|NCT02469116|28086|P1|STARTED|Overall Study||18
11426|NCT02468700|28098|P2|NOT COMPLETED|Overall Study||2
11427|NCT02468700|28099|P1|NOT COMPLETED|Overall Study||2
11428|NCT02468700|28098|P2|COMPLETED|Overall Study||19
11429|NCT02468700|28099|P1|COMPLETED|Overall Study||20
11430|NCT02468700|28098|P2|STARTED|Overall Study||21
11431|NCT02468700|28099|P1|STARTED|Overall Study||22
11432|NCT02468583|28113|P2|NOT COMPLETED|Overall Study||0
11433|NCT02468583|28114|P1|NOT COMPLETED|Overall Study||0
11434|NCT02468583|28113|P2|COMPLETED|Overall Study||3
11435|NCT02468583|28114|P1|COMPLETED|Overall Study||3
11436|NCT02468583|28113|P2|STARTED|Overall Study||3
11437|NCT02468583|28114|P1|STARTED|Overall Study||3
11438|NCT02468414|28122|P2|NOT COMPLETED|Overall Study||0
11439|NCT02468414|28123|P1|NOT COMPLETED|Overall Study||3
11440|NCT02468414|28122|P2|COMPLETED|Overall Study||0
11441|NCT02468414|28123|P1|COMPLETED|Overall Study||0
11442|NCT02468414|28122|P2|Safety Follow-up|Overall Study||0
11443|NCT02468414|28123|P1|Safety Follow-up|Overall Study||0
11444|NCT02468414|28122|P2|Implantation|Overall Study||0
11445|NCT02468414|28123|P1|Implantation|Overall Study||1
11446|NCT02468414|28122|P2|Harvesting|Overall Study||0
11447|NCT02468414|28123|P1|Harvesting|Overall Study||1
11448|NCT02468414|28122|P2|Successfully Screened|Overall Study||0
11449|NCT02468414|28123|P1|Successfully Screened|Overall Study||2
11450|NCT02468414|28122|P2|STARTED|Overall Study||0
11451|NCT02468414|28123|P1|STARTED|Overall Study||3
11452|NCT02468154|28131|P2|NOT COMPLETED|Overall Study||0
11453|NCT02468154|28132|P1|NOT COMPLETED|Overall Study||0
11454|NCT02468154|28131|P2|COMPLETED|Overall Study||28
11455|NCT02468154|28132|P1|COMPLETED|Overall Study||29
11456|NCT02468154|28131|P2|STARTED|Overall Study||28
11457|NCT02468154|28132|P1|STARTED|Overall Study||29
11458|NCT02467777|28146|P2|NOT COMPLETED|Overall Study||0
11459|NCT02467777|28147|P1|NOT COMPLETED|Overall Study||0
11460|NCT02467777|28146|P2|COMPLETED|Overall Study||27
11461|NCT02467777|28147|P1|COMPLETED|Overall Study||23
11462|NCT02467777|28146|P2|STARTED|Overall Study||27
11463|NCT02467777|28147|P1|STARTED|Overall Study||23
11464|NCT02467491|28153|P1|NOT COMPLETED|Overall Study||0
11465|NCT02467491|28153|P1|COMPLETED|Overall Study||12
11466|NCT02467491|28153|P1|STARTED|Overall Study||12
11467|NCT02467075|28164|P2|NOT COMPLETED|30 Day Follow-up||0
11468|NCT02467075|28165|P1|NOT COMPLETED|30 Day Follow-up||0
11469|NCT02467075|28164|P2|COMPLETED|30 Day Follow-up||1
11470|NCT02467075|28165|P1|COMPLETED|30 Day Follow-up||0
11471|NCT02467075|28164|P2|STARTED|30 Day Follow-up||1
11472|NCT02467075|28165|P1|STARTED|30 Day Follow-up||0
11473|NCT02467075|28164|P2|NOT COMPLETED|72 Hour Follow-up||0
11474|NCT02467075|28165|P1|NOT COMPLETED|72 Hour Follow-up||0
11475|NCT02467075|28164|P2|COMPLETED|72 Hour Follow-up||1
11476|NCT02467075|28165|P1|COMPLETED|72 Hour Follow-up||0
11477|NCT02467075|28164|P2|STARTED|72 Hour Follow-up||1
11478|NCT02467075|28165|P1|STARTED|72 Hour Follow-up||0
11479|NCT02467075|28164|P2|NOT COMPLETED|48 Hour Follow-up||0
11480|NCT02467075|28165|P1|NOT COMPLETED|48 Hour Follow-up||0
11481|NCT02467075|28164|P2|COMPLETED|48 Hour Follow-up||1
11482|NCT02467075|28165|P1|COMPLETED|48 Hour Follow-up||0
11483|NCT02467075|28164|P2|STARTED|48 Hour Follow-up||1
11484|NCT02467075|28165|P1|STARTED|48 Hour Follow-up||0
11485|NCT02467075|28164|P2|NOT COMPLETED|Initial CT Scan||0
11486|NCT02467075|28165|P1|NOT COMPLETED|Initial CT Scan||0
11487|NCT02467075|28164|P2|COMPLETED|Initial CT Scan||1
11488|NCT02467075|28165|P1|COMPLETED|Initial CT Scan||0
11489|NCT02467075|28164|P2|STARTED|Initial CT Scan||1
11490|NCT02467075|28165|P1|STARTED|Initial CT Scan||0
11491|NCT02466659|28183|P2|NOT COMPLETED|Overall Study||2
11492|NCT02466659|28184|P1|NOT COMPLETED|Overall Study||5
11493|NCT02466659|28183|P2|COMPLETED|Overall Study||1
11494|NCT02466659|28184|P1|COMPLETED|Overall Study||0
11495|NCT02466659|28183|P2|STARTED|Overall Study||3
11496|NCT02466659|28184|P1|STARTED|Overall Study||5
11497|NCT02466425|28194|P2|NOT COMPLETED|Overall Study||16
11498|NCT02466425|28195|P1|NOT COMPLETED|Overall Study||14
11499|NCT02466425|28194|P2|COMPLETED|Overall Study||116
11500|NCT02466425|28195|P1|COMPLETED|Overall Study||118
11501|NCT02466425|28194|P2|Treated|Overall Study||132
11502|NCT02466425|28195|P1|Treated|Overall Study||131
11503|NCT02466425|28194|P2|STARTED|Overall Study||132
11504|NCT02466425|28195|P1|STARTED|Overall Study||132
11505|NCT02466412|28205|P2|NOT COMPLETED|Second Intervention (Day 3)||0
11506|NCT02466412|28206|P1|NOT COMPLETED|Second Intervention (Day 3)||0
11507|NCT02466412|28205|P2|COMPLETED|Second Intervention (Day 3)||24
11508|NCT02466412|28206|P1|COMPLETED|Second Intervention (Day 3)||24
11509|NCT02466412|28205|P2|STARTED|Second Intervention (Day 3)||24
11510|NCT02466412|28206|P1|STARTED|Second Intervention (Day 3)||24
11511|NCT02466412|28205|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11512|NCT02466412|28206|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11513|NCT02466412|28205|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
11514|NCT02466412|28206|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
11515|NCT02466412|28205|P2|STARTED|Washout Period of 1 Day (Day 2)||24
11516|NCT02466412|28206|P1|STARTED|Washout Period of 1 Day (Day 2)||24
11517|NCT02466412|28205|P2|NOT COMPLETED|First Intervention (Day 1)||0
11518|NCT02466412|28206|P1|NOT COMPLETED|First Intervention (Day 1)||0
11519|NCT02466412|28205|P2|COMPLETED|First Intervention (Day 1)||24
11520|NCT02466412|28206|P1|COMPLETED|First Intervention (Day 1)||24
11521|NCT02466412|28205|P2|STARTED|First Intervention (Day 1)||24
11522|NCT02466412|28206|P1|STARTED|First Intervention (Day 1)||24
11523|NCT02466412|28205|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
11524|NCT02466412|28206|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
11525|NCT02466412|28205|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
11526|NCT02466412|28206|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
11527|NCT02466412|28205|P2|STARTED|Washout Period of 1 Day (Day -1)||24
11528|NCT02466412|28206|P1|STARTED|Washout Period of 1 Day (Day -1)||24
11529|NCT02465866|28215|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
11530|NCT02465866|28216|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
11531|NCT02465866|28217|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
11532|NCT02465866|28218|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
11533|NCT02465866|28215|P4|COMPLETED|Period 4: Washout (14 Days)||5
11534|NCT02465866|28216|P3|COMPLETED|Period 4: Washout (14 Days)||5
11535|NCT02465866|28217|P2|COMPLETED|Period 4: Washout (14 Days)||4
11536|NCT02465866|28218|P1|COMPLETED|Period 4: Washout (14 Days)||5
11537|NCT02465866|28215|P4|STARTED|Period 4: Washout (14 Days)||5
11538|NCT02465866|28216|P3|STARTED|Period 4: Washout (14 Days)||5
11539|NCT02465866|28217|P2|STARTED|Period 4: Washout (14 Days)||4
11540|NCT02465866|28218|P1|STARTED|Period 4: Washout (14 Days)||5
11541|NCT02465866|28215|P4|NOT COMPLETED|Period 4||0
11542|NCT02465866|28216|P3|NOT COMPLETED|Period 4||0
11543|NCT02465866|28217|P2|NOT COMPLETED|Period 4||0
11544|NCT02465866|28218|P1|NOT COMPLETED|Period 4||0
11545|NCT02465866|28215|P4|COMPLETED|Period 4||5
11546|NCT02465866|28216|P3|COMPLETED|Period 4||5
11547|NCT02465866|28217|P2|COMPLETED|Period 4||4
11548|NCT02465866|28218|P1|COMPLETED|Period 4||5
11549|NCT02465866|28215|P4|STARTED|Period 4||5
11550|NCT02465866|28216|P3|STARTED|Period 4||5
11551|NCT02465866|28217|P2|STARTED|Period 4||4
11552|NCT02465866|28218|P1|STARTED|Period 4||5
11553|NCT02465866|28215|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
11554|NCT02465866|28216|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
11555|NCT02465866|28217|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
11556|NCT02465866|28218|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
11557|NCT02465866|28215|P4|COMPLETED|Period 3: Washout (14 Days)||5
11558|NCT02465866|28216|P3|COMPLETED|Period 3: Washout (14 Days)||5
11559|NCT02465866|28217|P2|COMPLETED|Period 3: Washout (14 Days)||4
11560|NCT02465866|28218|P1|COMPLETED|Period 3: Washout (14 Days)||5
11561|NCT02465866|28215|P4|STARTED|Period 3: Washout (14 Days)||5
11562|NCT02465866|28216|P3|STARTED|Period 3: Washout (14 Days)||5
11563|NCT02465866|28217|P2|STARTED|Period 3: Washout (14 Days)||4
11564|NCT02465866|28218|P1|STARTED|Period 3: Washout (14 Days)||5
11565|NCT02465866|28215|P4|NOT COMPLETED|Period 3||0
11566|NCT02465866|28216|P3|NOT COMPLETED|Period 3||0
11567|NCT02465866|28217|P2|NOT COMPLETED|Period 3||1
11568|NCT02465866|28218|P1|NOT COMPLETED|Period 3||0
11569|NCT02465866|28215|P4|COMPLETED|Period 3||5
11570|NCT02465866|28216|P3|COMPLETED|Period 3||5
11571|NCT02465866|28217|P2|COMPLETED|Period 3||4
11572|NCT02465866|28218|P1|COMPLETED|Period 3||5
11573|NCT02465866|28215|P4|STARTED|Period 3||5
11574|NCT02465866|28216|P3|STARTED|Period 3||5
11575|NCT02465866|28217|P2|STARTED|Period 3||5
11576|NCT02465866|28218|P1|STARTED|Period 3||5
11577|NCT02465866|28215|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
11578|NCT02465866|28216|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
11579|NCT02465866|28217|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
11580|NCT02465866|28218|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
11581|NCT02465866|28215|P4|COMPLETED|Period 2: Washout (14 Days)||5
11582|NCT02465866|28216|P3|COMPLETED|Period 2: Washout (14 Days)||5
11583|NCT02465866|28217|P2|COMPLETED|Period 2: Washout (14 Days)||5
11584|NCT02465866|28218|P1|COMPLETED|Period 2: Washout (14 Days)||5
11585|NCT02465866|28215|P4|STARTED|Period 2: Washout (14 Days)||5
11586|NCT02465866|28216|P3|STARTED|Period 2: Washout (14 Days)||5
11587|NCT02465866|28217|P2|STARTED|Period 2: Washout (14 Days)||5
11588|NCT02465866|28218|P1|STARTED|Period 2: Washout (14 Days)||5
11589|NCT02465866|28215|P4|NOT COMPLETED|Period 2||0
11590|NCT02465866|28216|P3|NOT COMPLETED|Period 2||0
11591|NCT02465866|28217|P2|NOT COMPLETED|Period 2||0
11592|NCT02465866|28218|P1|NOT COMPLETED|Period 2||0
11593|NCT02465866|28215|P4|COMPLETED|Period 2||5
11594|NCT02465866|28216|P3|COMPLETED|Period 2||5
11595|NCT02465866|28217|P2|COMPLETED|Period 2||5
11596|NCT02465866|28218|P1|COMPLETED|Period 2||5
11597|NCT02465866|28215|P4|STARTED|Period 2||5
11598|NCT02465866|28216|P3|STARTED|Period 2||5
11599|NCT02465866|28217|P2|STARTED|Period 2||5
11600|NCT02465866|28218|P1|STARTED|Period 2||5
11601|NCT02465866|28215|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
11602|NCT02465866|28216|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
11603|NCT02465866|28217|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
11604|NCT02465866|28218|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
11605|NCT02465866|28215|P4|COMPLETED|Period 1: Washout (14 Days)||5
11606|NCT02465866|28216|P3|COMPLETED|Period 1: Washout (14 Days)||5
11607|NCT02465866|28217|P2|COMPLETED|Period 1: Washout (14 Days)||5
11608|NCT02465866|28218|P1|COMPLETED|Period 1: Washout (14 Days)||5
11609|NCT02465866|28215|P4|STARTED|Period 1: Washout (14 Days)||5
11610|NCT02465866|28216|P3|STARTED|Period 1: Washout (14 Days)||5
11611|NCT02465866|28217|P2|STARTED|Period 1: Washout (14 Days)||5
11612|NCT02465866|28218|P1|STARTED|Period 1: Washout (14 Days)||5
11613|NCT02465866|28215|P4|NOT COMPLETED|Period 1||0
11614|NCT02465866|28216|P3|NOT COMPLETED|Period 1||0
11615|NCT02465866|28217|P2|NOT COMPLETED|Period 1||0
11616|NCT02465866|28218|P1|NOT COMPLETED|Period 1||0
11617|NCT02465866|28215|P4|COMPLETED|Period 1||5
11618|NCT02465866|28216|P3|COMPLETED|Period 1||5
11619|NCT02465866|28217|P2|COMPLETED|Period 1||5
11620|NCT02465866|28218|P1|COMPLETED|Period 1||5
11621|NCT02465866|28215|P4|STARTED|Period 1||5
11622|NCT02465866|28216|P3|STARTED|Period 1||5
11623|NCT02465866|28217|P2|STARTED|Period 1||5
11624|NCT02465866|28218|P1|STARTED|Period 1||5
11625|NCT02465632|28291|P3|NOT COMPLETED|Overall Study||17
11626|NCT02465632|28292|P2|NOT COMPLETED|Overall Study||23
11627|NCT02465632|28293|P1|NOT COMPLETED|Overall Study||31
11628|NCT02465632|28291|P3|COMPLETED|Overall Study||203
11629|NCT02465632|28292|P2|COMPLETED|Overall Study||417
11630|NCT02465632|28293|P1|COMPLETED|Overall Study||409
11631|NCT02465632|28291|P3|STARTED|Overall Study||220
11632|NCT02465632|28292|P2|STARTED|Overall Study||440
11633|NCT02465632|28293|P1|STARTED|Overall Study||440
11634|NCT02465489|28304|P1|NOT COMPLETED|Overall Study||5
11635|NCT02465489|28304|P1|COMPLETED|Overall Study||15
11636|NCT02465489|28304|P1|STARTED|Overall Study||20
11637|NCT02465463|28333|P2|NOT COMPLETED|Overall Study||1
11638|NCT02465463|28334|P1|NOT COMPLETED|Overall Study||4
11639|NCT02465463|28333|P2|COMPLETED|Overall Study||4
11640|NCT02465463|28334|P1|COMPLETED|Overall Study||4
11641|NCT02465463|28333|P2|STARTED|Overall Study||5
11642|NCT02465463|28334|P1|STARTED|Overall Study||8
11643|NCT02465450|28353|P6|NOT COMPLETED|Treatment Period 2||0
11644|NCT02465450|28354|P5|NOT COMPLETED|Treatment Period 2||4
11645|NCT02465450|28355|P4|NOT COMPLETED|Treatment Period 2||3
11646|NCT02465450|28356|P3|NOT COMPLETED|Treatment Period 2||0
11647|NCT02465450|28357|P2|NOT COMPLETED|Treatment Period 2||0
11648|NCT02465450|28358|P1|NOT COMPLETED|Treatment Period 2||0
11649|NCT02465450|28353|P6|COMPLETED|Treatment Period 2||23
11650|NCT02465450|28354|P5|COMPLETED|Treatment Period 2||24
11651|NCT02465450|28355|P4|COMPLETED|Treatment Period 2||27
11652|NCT02465450|28356|P3|COMPLETED|Treatment Period 2||0
11653|NCT02465450|28357|P2|COMPLETED|Treatment Period 2||0
11654|NCT02465450|28358|P1|COMPLETED|Treatment Period 2||0
11655|NCT02465450|28353|P6|STARTED|Treatment Period 2||23
11656|NCT02465450|28354|P5|STARTED|Treatment Period 2||28
11657|NCT02465450|28355|P4|STARTED|Treatment Period 2||30
11658|NCT02465450|28356|P3|STARTED|Treatment Period 2||0
11659|NCT02465450|28357|P2|STARTED|Treatment Period 2||0
11660|NCT02465450|28358|P1|STARTED|Treatment Period 2||0
11661|NCT02465450|28353|P6|NOT COMPLETED|Treatment Period 1||0
11662|NCT02465450|28354|P5|NOT COMPLETED|Treatment Period 1||0
11663|NCT02465450|28355|P4|NOT COMPLETED|Treatment Period 1||0
11664|NCT02465450|28356|P3|NOT COMPLETED|Treatment Period 1||1
11665|NCT02465450|28357|P2|NOT COMPLETED|Treatment Period 1||1
11666|NCT02465450|28358|P1|NOT COMPLETED|Treatment Period 1||2
11667|NCT02465450|28353|P6|COMPLETED|Treatment Period 1||0
11668|NCT02465450|28354|P5|COMPLETED|Treatment Period 1||0
11669|NCT02465450|28355|P4|COMPLETED|Treatment Period 1||0
11670|NCT02465450|28356|P3|COMPLETED|Treatment Period 1||34
11671|NCT02465450|28357|P2|COMPLETED|Treatment Period 1||23
11672|NCT02465450|28358|P1|COMPLETED|Treatment Period 1||24
11673|NCT02465450|28353|P6|STARTED|Treatment Period 1||0
11674|NCT02465450|28354|P5|STARTED|Treatment Period 1||0
11675|NCT02465450|28355|P4|STARTED|Treatment Period 1||0
11676|NCT02465450|28356|P3|STARTED|Treatment Period 1||35
11677|NCT02465450|28357|P2|STARTED|Treatment Period 1||24
11678|NCT02465450|28358|P1|STARTED|Treatment Period 1||26
11679|NCT02465203|28381|P3|NOT COMPLETED|Overall Study||13
11680|NCT02465203|28382|P2|NOT COMPLETED|Overall Study||36
11681|NCT02465203|28383|P1|NOT COMPLETED|Overall Study||56
11682|NCT02465203|28381|P3|COMPLETED|Overall Study||0
11683|NCT02465203|28382|P2|COMPLETED|Overall Study||0
11684|NCT02465203|28383|P1|COMPLETED|Overall Study||0
11685|NCT02465203|28381|P3|STARTED|Overall Study||13
11686|NCT02465203|28382|P2|STARTED|Overall Study||36
11687|NCT02465203|28383|P1|STARTED|Overall Study||56
11688|NCT02465099|28396|P2|NOT COMPLETED|Overall Study||0
11689|NCT02465099|28397|P1|NOT COMPLETED|Overall Study||0
11690|NCT02465099|28396|P2|COMPLETED|Overall Study||19
11691|NCT02465099|28397|P1|COMPLETED|Overall Study||45
11692|NCT02465099|28396|P2|STARTED|Overall Study||19
11693|NCT02465099|28397|P1|STARTED|Overall Study||45
11694|NCT02465073|28406|P3|NOT COMPLETED|Overall Study||1
11695|NCT02465073|28407|P2|NOT COMPLETED|Overall Study||1
11696|NCT02465073|28408|P1|NOT COMPLETED|Overall Study||2
11697|NCT02465073|28406|P3|COMPLETED|Overall Study||15
11698|NCT02465073|28407|P2|COMPLETED|Overall Study||15
11699|NCT02465073|28408|P1|COMPLETED|Overall Study||15
11700|NCT02465073|28406|P3|STARTED|Overall Study||16
11701|NCT02465073|28407|P2|STARTED|Overall Study||16
11702|NCT02465073|28408|P1|STARTED|Overall Study||17
11703|NCT02464176|28419|P3|NOT COMPLETED|Overall Study||0
11704|NCT02464176|28420|P2|NOT COMPLETED|Overall Study||0
11705|NCT02464176|28421|P1|NOT COMPLETED|Overall Study||0
11706|NCT02464176|28419|P3|COMPLETED|Overall Study||15
11707|NCT02464176|28420|P2|COMPLETED|Overall Study||50
11708|NCT02464176|28421|P1|COMPLETED|Overall Study||50
11709|NCT02464176|28419|P3|STARTED|Overall Study||15
11710|NCT02464176|28420|P2|STARTED|Overall Study||50
11711|NCT02464176|28421|P1|STARTED|Overall Study||50
11712|NCT02464163|28442|P4|NOT COMPLETED|Overall Study||5
11713|NCT02464163|28443|P3|NOT COMPLETED|Overall Study||5
11714|NCT02464163|28444|P2|NOT COMPLETED|Overall Study||8
11715|NCT02464163|28445|P1|NOT COMPLETED|Overall Study||3
11716|NCT02464163|28442|P4|COMPLETED|Overall Study||96
11717|NCT02464163|28443|P3|COMPLETED|Overall Study||97
11718|NCT02464163|28444|P2|COMPLETED|Overall Study||94
11719|NCT02464163|28445|P1|COMPLETED|Overall Study||99
11720|NCT02464163|28442|P4|STARTED|Overall Study||101
11721|NCT02464163|28443|P3|STARTED|Overall Study||102
11722|NCT02464163|28444|P2|STARTED|Overall Study||102
11723|NCT02464163|28445|P1|STARTED|Overall Study||102
11724|NCT02463981|28469|P2|NOT COMPLETED|Overall Study||2
11725|NCT02463981|28470|P1|NOT COMPLETED|Overall Study||3
11726|NCT02463981|28469|P2|COMPLETED|Overall Study||14
11727|NCT02463981|28470|P1|COMPLETED|Overall Study||18
11728|NCT02463981|28469|P2|STARTED|Overall Study||16
11729|NCT02463981|28470|P1|STARTED|Overall Study||21
11730|NCT02463409|28478|P1|NOT COMPLETED|Overall Study||2
11731|NCT02463409|28478|P1|COMPLETED|Overall Study||4
11732|NCT02463409|28478|P1|STARTED|Overall Study||6
11733|NCT02463331|28486|P2|NOT COMPLETED|Overall Study||6
11734|NCT02463331|28487|P1|NOT COMPLETED|Overall Study||16
11735|NCT02463331|28486|P2|COMPLETED|Overall Study||25
11736|NCT02463331|28487|P1|COMPLETED|Overall Study||10
11737|NCT02463331|28486|P2|STARTED|Overall Study||31
11738|NCT02463331|28487|P1|STARTED|Overall Study||26
11739|NCT02463227|28495|P1|NOT COMPLETED|Overall Study||0
11740|NCT02463227|28495|P1|COMPLETED|Overall Study||14
11741|NCT02463227|28495|P1|STARTED|Overall Study||14
11742|NCT02463097|28503|P1|NOT COMPLETED|Overall Study||1
11743|NCT02463097|28503|P1|COMPLETED|Overall Study||123
11744|NCT02463097|28503|P1|STARTED|Overall Study||124
11745|NCT02462720|28509|P2|NOT COMPLETED|Part 2||1
11746|NCT02462720|28510|P1|NOT COMPLETED|Part 2||1
11747|NCT02462720|28509|P2|COMPLETED|Part 2||16
11748|NCT02462720|28510|P1|COMPLETED|Part 2||17
11749|NCT02462720|28509|P2|STARTED|Part 2||17
11750|NCT02462720|28510|P1|STARTED|Part 2||18
11751|NCT02462720|28509|P2|NOT COMPLETED|Part 1||0
11752|NCT02462720|28510|P1|NOT COMPLETED|Part 1||0
11753|NCT02462720|28509|P2|COMPLETED|Part 1||17
11754|NCT02462720|28510|P1|COMPLETED|Part 1||18
11755|NCT02462720|28509|P2|STARTED|Part 1||17
11756|NCT02462720|28510|P1|STARTED|Part 1||18
11757|NCT02462473|28520|P1|NOT COMPLETED|Overall Study||4
11758|NCT02462473|28520|P1|COMPLETED|Overall Study||5
11759|NCT02462473|28520|P1|STARTED|Overall Study||9
11760|NCT02462291|28533|P2|NOT COMPLETED|Overall Study||6
11761|NCT02462291|28534|P1|NOT COMPLETED|Overall Study||5
11762|NCT02462291|28533|P2|COMPLETED|Overall Study||75
11763|NCT02462291|28534|P1|COMPLETED|Overall Study||77
11764|NCT02462291|28533|P2|STARTED|Overall Study||81
11765|NCT02462291|28534|P1|STARTED|Overall Study||82
11766|NCT02461992|28572|P1|NOT COMPLETED|Overall Study||0
11767|NCT02461992|28572|P1|COMPLETED|Overall Study||13
11768|NCT02461992|28572|P1|STARTED|Overall Study||13
11769|NCT02461966|28592|P3|NOT COMPLETED|Overall Study||0
11770|NCT02461966|28593|P2|NOT COMPLETED|Overall Study||0
11771|NCT02461966|28594|P1|NOT COMPLETED|Overall Study||0
11772|NCT02461966|28592|P3|COMPLETED|Overall Study||60
11773|NCT02461966|28593|P2|COMPLETED|Overall Study||80
11774|NCT02461966|28594|P1|COMPLETED|Overall Study||160
11775|NCT02461966|28592|P3|STARTED|Overall Study||60
11776|NCT02461966|28593|P2|STARTED|Overall Study||80
11777|NCT02461966|28594|P1|STARTED|Overall Study||160
11778|NCT02461693|28604|P2|NOT COMPLETED|Overall Study||0
11779|NCT02461693|28605|P1|NOT COMPLETED|Overall Study||0
11780|NCT02461693|28604|P2|COMPLETED|Overall Study||102
11781|NCT02461693|28605|P1|COMPLETED|Overall Study||103
11782|NCT02461693|28604|P2|STARTED|Overall Study||102
11783|NCT02461693|28605|P1|STARTED|Overall Study||103
11784|NCT02461589|28627|P10|NOT COMPLETED|Overall Study||5
11785|NCT02461589|28628|P9|NOT COMPLETED|Overall Study||6
11786|NCT02461589|28629|P8|NOT COMPLETED|Overall Study||5
11787|NCT02461589|28630|P7|NOT COMPLETED|Overall Study||6
11788|NCT02461589|28631|P6|NOT COMPLETED|Overall Study||3
11789|NCT02461589|28632|P5|NOT COMPLETED|Overall Study||2
11790|NCT02461589|28633|P4|NOT COMPLETED|Overall Study||5
11791|NCT02461589|28634|P3|NOT COMPLETED|Overall Study||5
11792|NCT02461589|28635|P2|NOT COMPLETED|Overall Study||2
11793|NCT02461589|28636|P1|NOT COMPLETED|Overall Study||6
11794|NCT02461589|28627|P10|COMPLETED|Overall Study||60
11795|NCT02461589|28628|P9|COMPLETED|Overall Study||123
11796|NCT02461589|28629|P8|COMPLETED|Overall Study||60
11797|NCT02461589|28630|P7|COMPLETED|Overall Study||58
11798|NCT02461589|28631|P6|COMPLETED|Overall Study||61
11799|NCT02461589|28632|P5|COMPLETED|Overall Study||62
11800|NCT02461589|28633|P4|COMPLETED|Overall Study||58
11801|NCT02461589|28634|P3|COMPLETED|Overall Study||60
11802|NCT02461589|28635|P2|COMPLETED|Overall Study||61
11803|NCT02461589|28636|P1|COMPLETED|Overall Study||58
11804|NCT02461589|28627|P10|Exposed|Overall Study||64
11805|NCT02461589|28628|P9|Exposed|Overall Study||129
11806|NCT02461589|28629|P8|Exposed|Overall Study||65
11807|NCT02461589|28630|P7|Exposed|Overall Study||64
11808|NCT02461589|28631|P6|Exposed|Overall Study||64
11809|NCT02461589|28632|P5|Exposed|Overall Study||64
11810|NCT02461589|28633|P4|Exposed|Overall Study||63
11811|NCT02461589|28634|P3|Exposed|Overall Study||65
11812|NCT02461589|28635|P2|Exposed|Overall Study||63
11813|NCT02461589|28636|P1|Exposed|Overall Study||64
11814|NCT02461589|28627|P10|STARTED|Overall Study||65
11815|NCT02461589|28628|P9|STARTED|Overall Study||129
11816|NCT02461589|28629|P8|STARTED|Overall Study||65
11817|NCT02461589|28630|P7|STARTED|Overall Study||64
11818|NCT02461589|28631|P6|STARTED|Overall Study||64
11819|NCT02461589|28632|P5|STARTED|Overall Study||64
11820|NCT02461589|28633|P4|STARTED|Overall Study||63
11821|NCT02461589|28634|P3|STARTED|Overall Study||65
11822|NCT02461589|28635|P2|STARTED|Overall Study||63
11823|NCT02461589|28636|P1|STARTED|Overall Study||64
11824|NCT02461550|28688|P1|NOT COMPLETED|Overall Study||0
11825|NCT02461550|28688|P1|COMPLETED|Overall Study||2
11826|NCT02461550|28688|P1|STARTED|Overall Study||2
11827|NCT02461433|28694|P2|NOT COMPLETED|Overall Study||0
11828|NCT02461433|28695|P1|NOT COMPLETED|Overall Study||0
11829|NCT02461433|28694|P2|COMPLETED|Overall Study||1
11830|NCT02461433|28695|P1|COMPLETED|Overall Study||1
11831|NCT02461433|28694|P2|STARTED|Overall Study||1
11832|NCT02461433|28695|P1|STARTED|Overall Study||1
11833|NCT02461290|28721|P1|NOT COMPLETED|Overall Study||10
11834|NCT02461290|28721|P1|COMPLETED|Overall Study||89
11835|NCT02461290|28721|P1|STARTED|Overall Study||99
11836|NCT02461134|28728|P1|NOT COMPLETED|Overall Study||1
11837|NCT02461134|28728|P1|COMPLETED|Overall Study||0
11838|NCT02461134|28728|P1|STARTED|Overall Study||1
11839|NCT02460991|28736|P2|NOT COMPLETED|Overall Study||2
11840|NCT02460991|28737|P1|NOT COMPLETED|Overall Study||0
11841|NCT02460991|28736|P2|COMPLETED|Overall Study||0
11842|NCT02460991|28737|P1|COMPLETED|Overall Study||0
11843|NCT02460991|28736|P2|STARTED|Overall Study||2
11844|NCT02460991|28737|P1|STARTED|Overall Study||0
11845|NCT02460822|28743|P1|NOT COMPLETED|Overall Study||1
11846|NCT02460822|28743|P1|COMPLETED|Overall Study||15
11847|NCT02460822|28743|P1|STARTED|Overall Study||16
11848|NCT02460458|28752|P1|NOT COMPLETED|Prospective Phase||0
11849|NCT02460458|28752|P1|COMPLETED|Prospective Phase|Information not yet available.|0
11850|NCT02460458|28752|P1|STARTED|Prospective Phase|Information not yet available.|0
11851|NCT02460458|28752|P1|NOT COMPLETED|Confirmatory Phase||266
11852|NCT02460458|28752|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
11853|NCT02460458|28752|P1|STARTED|Confirmatory Phase||266
11854|NCT02460458|28752|P1|NOT COMPLETED|Retrospective Phase||0
11855|NCT02460458|28752|P1|COMPLETED|Retrospective Phase||266
11856|NCT02460458|28752|P1|STARTED|Retrospective Phase||266
11857|NCT02460159|28760|P2|NOT COMPLETED|Overall Study||1
11858|NCT02460159|28761|P1|NOT COMPLETED|Overall Study||6
11859|NCT02460159|28760|P2|COMPLETED|Overall Study||17
11860|NCT02460159|28761|P1|COMPLETED|Overall Study||111
11861|NCT02460159|28760|P2|STARTED|Overall Study||18
11862|NCT02460159|28761|P1|STARTED|Overall Study||117
11863|NCT02459418|28791|P2|NOT COMPLETED|Overall Study||6
11864|NCT02459418|28792|P1|NOT COMPLETED|Overall Study||8
11865|NCT02459418|28791|P2|COMPLETED|Overall Study||15
11866|NCT02459418|28792|P1|COMPLETED|Overall Study||13
11867|NCT02459418|28791|P2|Received Second Treatment|Overall Study||15
11868|NCT02459418|28792|P1|Received Second Treatment|Overall Study||13
11869|NCT02459418|28791|P2|Received First Treatment|Overall Study||21
11870|NCT02459418|28792|P1|Received First Treatment|Overall Study||21
11871|NCT02459418|28791|P2|STARTED|Overall Study||21
11872|NCT02459418|28792|P1|STARTED|Overall Study||21
11873|NCT02458768|28814|P2|NOT COMPLETED|Overall Study||5
11874|NCT02458768|28815|P1|NOT COMPLETED|Overall Study||7
11875|NCT02458768|28814|P2|COMPLETED|Overall Study||50
11876|NCT02458768|28815|P1|COMPLETED|Overall Study||50
11877|NCT02458768|28814|P2|STARTED|Overall Study||55
11878|NCT02458768|28815|P1|STARTED|Overall Study||57
11879|NCT02458365|28823|P2|NOT COMPLETED|Overall Study||294
11880|NCT02458365|28824|P1|NOT COMPLETED|Overall Study||277
11881|NCT02458365|28823|P2|COMPLETED|Overall Study||1607
11882|NCT02458365|28824|P1|COMPLETED|Overall Study||1723
11883|NCT02458365|28823|P2|STARTED|Overall Study||1901
11884|NCT02458365|28824|P1|STARTED|Overall Study||2000
11885|NCT02458287|28848|P4|NOT COMPLETED|Overall Study||3
11886|NCT02458287|28849|P3|NOT COMPLETED|Overall Study||3
11887|NCT02458287|28850|P2|NOT COMPLETED|Overall Study||4
11888|NCT02458287|28851|P1|NOT COMPLETED|Overall Study||0
11889|NCT02458287|28848|P4|COMPLETED|Overall Study||97
11890|NCT02458287|28849|P3|COMPLETED|Overall Study||46
11891|NCT02458287|28850|P2|COMPLETED|Overall Study||96
11892|NCT02458287|28851|P1|COMPLETED|Overall Study||50
11893|NCT02458287|28848|P4|STARTED|Overall Study||100
11894|NCT02458287|28849|P3|STARTED|Overall Study||49
11895|NCT02458287|28850|P2|STARTED|Overall Study||100
11896|NCT02458287|28851|P1|STARTED|Overall Study||50
11897|NCT02457728|28896|P1|NOT COMPLETED|Overall Study||0
11898|NCT02457728|28896|P1|COMPLETED|Overall Study||34
11899|NCT02457728|28896|P1|STARTED|Overall Study||34
11900|NCT02457611|28900|P1|NOT COMPLETED|Overall Study||3
11901|NCT02457611|28900|P1|COMPLETED|Overall Study||23
11902|NCT02457611|28900|P1|STARTED|Overall Study||26
11903|NCT02457247|28916|P4|NOT COMPLETED|Period 2||0
11904|NCT02457247|28917|P3|NOT COMPLETED|Period 2||0
11905|NCT02457247|28918|P2|NOT COMPLETED|Period 2||3
11906|NCT02457247|28919|P1|NOT COMPLETED|Period 2||2
11907|NCT02457247|28916|P4|COMPLETED|Period 2||70
11908|NCT02457247|28917|P3|COMPLETED|Period 2||68
11909|NCT02457247|28918|P2|COMPLETED|Period 2||65
11910|NCT02457247|28919|P1|COMPLETED|Period 2||64
11911|NCT02457247|28916|P4|STARTED|Period 2||70
11912|NCT02457247|28917|P3|STARTED|Period 2||68
11913|NCT02457247|28918|P2|STARTED|Period 2||68
11914|NCT02457247|28919|P1|STARTED|Period 2||66
11915|NCT02457247|28916|P4|NOT COMPLETED|Period 1||0
11916|NCT02457247|28917|P3|NOT COMPLETED|Period 1||0
11917|NCT02457247|28918|P2|NOT COMPLETED|Period 1||2
11918|NCT02457247|28919|P1|NOT COMPLETED|Period 1||2
11919|NCT02457247|28916|P4|COMPLETED|Period 1||70
11920|NCT02457247|28917|P3|COMPLETED|Period 1||68
11921|NCT02457247|28918|P2|COMPLETED|Period 1||68
11922|NCT02457247|28919|P1|COMPLETED|Period 1||66
11923|NCT02457247|28916|P4|STARTED|Period 1||70
11924|NCT02457247|28917|P3|STARTED|Period 1||68
11925|NCT02457247|28918|P2|STARTED|Period 1||70
11926|NCT02457247|28919|P1|STARTED|Period 1||68
11927|NCT02455518|28943|P4|NOT COMPLETED|Overall Study||3
11928|NCT02455518|28944|P3|NOT COMPLETED|Overall Study||1
11929|NCT02455518|28945|P2|NOT COMPLETED|Overall Study||1
11930|NCT02455518|28946|P1|NOT COMPLETED|Overall Study||0
11931|NCT02455518|28943|P4|COMPLETED|Overall Study||101
11932|NCT02455518|28944|P3|COMPLETED|Overall Study||103
11933|NCT02455518|28945|P2|COMPLETED|Overall Study||103
11934|NCT02455518|28946|P1|COMPLETED|Overall Study||104
11935|NCT02455518|28943|P4|STARTED|Overall Study||104
11936|NCT02455518|28944|P3|STARTED|Overall Study||104
11937|NCT02455518|28945|P2|STARTED|Overall Study||104
11938|NCT02455518|28946|P1|STARTED|Overall Study||104
11939|NCT02455050|28964|P4|NOT COMPLETED|Treatment Period 2||1
11940|NCT02455050|28965|P3|NOT COMPLETED|Treatment Period 2||2
11941|NCT02455050|28966|P2|NOT COMPLETED|Treatment Period 2||0
11942|NCT02455050|28967|P1|NOT COMPLETED|Treatment Period 2||1
11943|NCT02455050|28964|P4|COMPLETED|Treatment Period 2||17
11944|NCT02455050|28965|P3|COMPLETED|Treatment Period 2||17
11945|NCT02455050|28966|P2|COMPLETED|Treatment Period 2||18
11946|NCT02455050|28967|P1|COMPLETED|Treatment Period 2||18
11947|NCT02455050|28964|P4|STARTED|Treatment Period 2||18
11948|NCT02455050|28965|P3|STARTED|Treatment Period 2||19
11949|NCT02455050|28966|P2|STARTED|Treatment Period 2||18
11950|NCT02455050|28967|P1|STARTED|Treatment Period 2||19
11951|NCT02455050|28964|P4|NOT COMPLETED|Treatment Period 1||2
11952|NCT02455050|28965|P3|NOT COMPLETED|Treatment Period 1||1
11953|NCT02455050|28966|P2|NOT COMPLETED|Treatment Period 1||1
11954|NCT02455050|28967|P1|NOT COMPLETED|Treatment Period 1||1
11955|NCT02455050|28964|P4|COMPLETED|Treatment Period 1||18
11956|NCT02455050|28965|P3|COMPLETED|Treatment Period 1||19
11957|NCT02455050|28966|P2|COMPLETED|Treatment Period 1||18
11958|NCT02455050|28967|P1|COMPLETED|Treatment Period 1||19
11959|NCT02455050|28964|P4|STARTED|Treatment Period 1||20
11960|NCT02455050|28965|P3|STARTED|Treatment Period 1||20
11961|NCT02455050|28966|P2|STARTED|Treatment Period 1||19
11962|NCT02455050|28967|P1|STARTED|Treatment Period 1||20
11963|NCT02454959|29031|P1|NOT COMPLETED|Overall Study||9
11964|NCT02454959|29031|P1|COMPLETED|Overall Study||70
11965|NCT02454959|29031|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
11966|NCT02454959|29031|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
11967|NCT02454959|29031|P1|STARTED|Overall Study||79
11968|NCT02454608|29051|P2|NOT COMPLETED|Overall Study||2
11969|NCT02454608|29052|P1|NOT COMPLETED|Overall Study||0
11970|NCT02454608|29051|P2|COMPLETED|Overall Study||8
11971|NCT02454608|29052|P1|COMPLETED|Overall Study||10
11972|NCT02454608|29051|P2|STARTED|Overall Study||10
11973|NCT02454608|29052|P1|STARTED|Overall Study||10
11974|NCT02454296|29072|P2|NOT COMPLETED|Overall Study||0
11975|NCT02454296|29073|P1|NOT COMPLETED|Overall Study||0
11976|NCT02454296|29072|P2|COMPLETED|Overall Study||21
11977|NCT02454296|29073|P1|COMPLETED|Overall Study||20
11978|NCT02454296|29072|P2|STARTED|Overall Study||21
11979|NCT02454296|29073|P1|STARTED|Overall Study||20
11980|NCT02454283|29085|P2|NOT COMPLETED|Overall Study||0
11981|NCT02454283|29086|P1|NOT COMPLETED|Overall Study||0
11982|NCT02454283|29085|P2|COMPLETED|Overall Study||15
11983|NCT02454283|29086|P1|COMPLETED|Overall Study||26
11984|NCT02454283|29085|P2|STARTED|Overall Study||15
11985|NCT02454283|29086|P1|STARTED|Overall Study||26
11986|NCT02454127|29098|P4|NOT COMPLETED|Overall Study||20
11987|NCT02454127|29099|P3|NOT COMPLETED|Overall Study||14
11988|NCT02454127|29100|P2|NOT COMPLETED|Overall Study||14
11989|NCT02454127|29101|P1|NOT COMPLETED|Overall Study||19
11990|NCT02454127|29098|P4|COMPLETED|Overall Study||20
11991|NCT02454127|29099|P3|COMPLETED|Overall Study||26
11992|NCT02454127|29100|P2|COMPLETED|Overall Study||26
11993|NCT02454127|29101|P1|COMPLETED|Overall Study||21
11994|NCT02454127|29098|P4|STARTED|Overall Study||40
11995|NCT02454127|29099|P3|STARTED|Overall Study||40
11996|NCT02454127|29100|P2|STARTED|Overall Study||40
11997|NCT02454127|29101|P1|STARTED|Overall Study||40
11998|NCT02454101|29141|P2|NOT COMPLETED|Overall Study||7
11999|NCT02454101|29142|P1|NOT COMPLETED|Overall Study||5
12000|NCT02454101|29141|P2|COMPLETED|Overall Study||143
12001|NCT02454101|29142|P1|COMPLETED|Overall Study||145
12002|NCT02454101|29141|P2|STARTED|Overall Study||150
12003|NCT02454101|29142|P1|STARTED|Overall Study||150
12004|NCT02453581|29164|P3|NOT COMPLETED|Overall Study||0
12005|NCT02453581|29165|P2|NOT COMPLETED|Overall Study||0
12006|NCT02453581|29166|P1|NOT COMPLETED|Overall Study||0
12007|NCT02453581|29164|P3|COMPLETED|Overall Study||8
12008|NCT02453581|29165|P2|COMPLETED|Overall Study||8
12009|NCT02453581|29166|P1|COMPLETED|Overall Study||8
12010|NCT02453581|29164|P3|STARTED|Overall Study||8
12011|NCT02453581|29165|P2|STARTED|Overall Study||8
12012|NCT02453581|29166|P1|STARTED|Overall Study||8
12013|NCT02453347|29186|P1|NOT COMPLETED|Overall Study||0
12014|NCT02453347|29186|P1|COMPLETED|Overall Study||6
12015|NCT02453347|29186|P1|STARTED|Overall Study||6
12016|NCT02453321|29202|P3|NOT COMPLETED|Overall Study||2
12017|NCT02453321|29203|P2|NOT COMPLETED|Overall Study||2
12018|NCT02453321|29204|P1|NOT COMPLETED|Overall Study||1
12019|NCT02453321|29202|P3|COMPLETED|Overall Study||19
12020|NCT02453321|29203|P2|COMPLETED|Overall Study||19
12021|NCT02453321|29204|P1|COMPLETED|Overall Study||19
12022|NCT02453321|29202|P3|STARTED|Overall Study||21
12023|NCT02453321|29203|P2|STARTED|Overall Study||21
12024|NCT02453321|29204|P1|STARTED|Overall Study||20
12025|NCT02452944|29223|P2|NOT COMPLETED|Overall Study||0
12026|NCT02452944|29224|P1|NOT COMPLETED|Overall Study||0
12027|NCT02452944|29223|P2|COMPLETED|Overall Study||31
12028|NCT02452944|29224|P1|COMPLETED|Overall Study||31
12029|NCT02452944|29223|P2|STARTED|Overall Study||31
12030|NCT02452944|29224|P1|STARTED|Overall Study||31
12031|NCT02452892|29236|P4|NOT COMPLETED|Follow-up||1
12032|NCT02452892|29237|P3|NOT COMPLETED|Follow-up||0
12033|NCT02452892|29238|P2|NOT COMPLETED|Follow-up||0
12034|NCT02452892|29239|P1|NOT COMPLETED|Follow-up||1
12035|NCT02452892|29236|P4|COMPLETED|Follow-up||38
12036|NCT02452892|29237|P3|COMPLETED|Follow-up||7
12037|NCT02452892|29238|P2|COMPLETED|Follow-up||7
12038|NCT02452892|29239|P1|COMPLETED|Follow-up||62
12039|NCT02452892|29236|P4|STARTED|Follow-up||39
12040|NCT02452892|29237|P3|STARTED|Follow-up||7
12041|NCT02452892|29238|P2|STARTED|Follow-up||7
12042|NCT02452892|29239|P1|STARTED|Follow-up||63
12043|NCT02452892|29236|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
12044|NCT02452892|29237|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
12045|NCT02452892|29238|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
12046|NCT02452892|29239|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
12047|NCT02452892|29236|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
12048|NCT02452892|29237|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
12049|NCT02452892|29238|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
12050|NCT02452892|29239|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
12051|NCT02452892|29236|P4|Responders|Week 2 Stratification & Re-Randomization||0
12052|NCT02452892|29237|P3|Responders|Week 2 Stratification & Re-Randomization||7
12053|NCT02452892|29238|P2|Responders|Week 2 Stratification & Re-Randomization||7
12054|NCT02452892|29239|P1|Responders|Week 2 Stratification & Re-Randomization||27
12055|NCT02452892|29236|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
12056|NCT02452892|29237|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
12057|NCT02452892|29238|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
12058|NCT02452892|29239|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
12059|NCT02452892|29236|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
12060|NCT02452892|29237|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
12061|NCT02452892|29238|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
12062|NCT02452892|29239|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
12063|NCT02452892|29236|P4|NOT COMPLETED|Week 1 Initial Randommization||0
12064|NCT02452892|29237|P3|NOT COMPLETED|Week 1 Initial Randommization||1
12065|NCT02452892|29238|P2|NOT COMPLETED|Week 1 Initial Randommization||0
12066|NCT02452892|29239|P1|NOT COMPLETED|Week 1 Initial Randommization||1
12067|NCT02452892|29236|P4|COMPLETED|Week 1 Initial Randommization||0
12068|NCT02452892|29237|P3|COMPLETED|Week 1 Initial Randommization||40
12069|NCT02452892|29238|P2|COMPLETED|Week 1 Initial Randommization||40
12070|NCT02452892|29239|P1|COMPLETED|Week 1 Initial Randommization||40
12071|NCT02452892|29236|P4|STARTED|Week 1 Initial Randommization||0
12072|NCT02452892|29237|P3|STARTED|Week 1 Initial Randommization||41
12073|NCT02452892|29238|P2|STARTED|Week 1 Initial Randommization||40
12074|NCT02452892|29239|P1|STARTED|Week 1 Initial Randommization||41
12075|NCT02452528|29270|P2|NOT COMPLETED|Overall Study||1
12076|NCT02452528|29271|P1|NOT COMPLETED|Overall Study||1
12077|NCT02452528|29270|P2|COMPLETED|Overall Study||1
12078|NCT02452528|29271|P1|COMPLETED|Overall Study||1
12079|NCT02452528|29270|P2|STARTED|Overall Study||2
12080|NCT02452528|29271|P1|STARTED|Overall Study||2
12081|NCT02452320|29305|P2|NOT COMPLETED|Overall Study||1
12082|NCT02452320|29306|P1|NOT COMPLETED|Overall Study||0
12083|NCT02452320|29305|P2|COMPLETED|Overall Study||63
12084|NCT02452320|29306|P1|COMPLETED|Overall Study||64
12085|NCT02452320|29305|P2|STARTED|Overall Study||64
12086|NCT02452320|29306|P1|STARTED|Overall Study||64
12087|NCT02451917|29318|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
12088|NCT02451917|29319|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
12089|NCT02451917|29318|P2|COMPLETED|Second Intervention (24 Weeks)||15
12090|NCT02451917|29319|P1|COMPLETED|Second Intervention (24 Weeks)||14
12091|NCT02451917|29318|P2|STARTED|Second Intervention (24 Weeks)||15
12092|NCT02451917|29319|P1|STARTED|Second Intervention (24 Weeks)||14
12093|NCT02451917|29318|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
12094|NCT02451917|29319|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
12095|NCT02451917|29318|P2|COMPLETED|First Intervention (24 Weeks)||15
12096|NCT02451917|29319|P1|COMPLETED|First Intervention (24 Weeks)||14
12097|NCT02451917|29318|P2|STARTED|First Intervention (24 Weeks)||18
12098|NCT02451917|29319|P1|STARTED|First Intervention (24 Weeks)||16
12099|NCT02451358|29341|P4|NOT COMPLETED|Overall Study||0
12100|NCT02451358|29342|P3|NOT COMPLETED|Overall Study||1
12101|NCT02451358|29343|P2|NOT COMPLETED|Overall Study||2
12102|NCT02451358|29344|P1|NOT COMPLETED|Overall Study||1
12103|NCT02451358|29341|P4|COMPLETED|Overall Study||100
12104|NCT02451358|29342|P3|COMPLETED|Overall Study||99
12105|NCT02451358|29343|P2|COMPLETED|Overall Study||98
12106|NCT02451358|29344|P1|COMPLETED|Overall Study||99
12107|NCT02451358|29341|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
12108|NCT02451358|29342|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
12109|NCT02451358|29343|P2|Vaccinated at Day 28|Overall Study||98
12110|NCT02451358|29344|P1|Vaccinated at Day 28|Overall Study||99
12111|NCT02451358|29341|P4|Vaccinated at Day 0|Overall Study||100
12112|NCT02451358|29342|P3|Vaccinated at Day 0|Overall Study||100
12113|NCT02451358|29343|P2|Vaccinated at Day 0|Overall Study||100
12114|NCT02451358|29344|P1|Vaccinated at Day 0|Overall Study||100
12115|NCT02451358|29341|P4|STARTED|Overall Study||100
12116|NCT02451358|29342|P3|STARTED|Overall Study||100
12117|NCT02451358|29343|P2|STARTED|Overall Study||100
12118|NCT02451358|29344|P1|STARTED|Overall Study||100
12119|NCT02451150|29368|P2|NOT COMPLETED|Overall Study||0
12120|NCT02451150|29369|P1|NOT COMPLETED|Overall Study||0
12121|NCT02451150|29368|P2|COMPLETED|Overall Study||3
12122|NCT02451150|29369|P1|COMPLETED|Overall Study||3
12123|NCT02451150|29368|P2|STARTED|Overall Study||3
12124|NCT02451150|29369|P1|STARTED|Overall Study||3
12125|NCT02450799|29422|P3|NOT COMPLETED|Overall Study||0
12126|NCT02450799|29423|P2|NOT COMPLETED|Overall Study||0
12127|NCT02450799|29424|P1|NOT COMPLETED|Overall Study||0
12128|NCT02450799|29422|P3|COMPLETED|Overall Study||30
12129|NCT02450799|29423|P2|COMPLETED|Overall Study||37
12130|NCT02450799|29424|P1|COMPLETED|Overall Study||31
12131|NCT02450799|29422|P3|STARTED|Overall Study||30
12132|NCT02450799|29423|P2|STARTED|Overall Study||37
12133|NCT02450799|29424|P1|STARTED|Overall Study||31
12134|NCT02450747|29435|P1|NOT COMPLETED|Overall Study||0
12135|NCT02450747|29435|P1|COMPLETED|Overall Study||39
12136|NCT02450747|29435|P1|STARTED|Overall Study||39
12137|NCT02450591|29444|P1|NOT COMPLETED|Overall Study||0
12138|NCT02450591|29444|P1|COMPLETED|Overall Study||4
12139|NCT02450591|29444|P1|STARTED|Overall Study||4
12140|NCT02450383|29450|P2|NOT COMPLETED|Overall Study||0
12141|NCT02450383|29451|P1|NOT COMPLETED|Overall Study||0
12142|NCT02450383|29450|P2|COMPLETED|Overall Study||10
12143|NCT02450383|29451|P1|COMPLETED|Overall Study||10
12144|NCT02450383|29450|P2|STARTED|Overall Study||10
12145|NCT02450383|29451|P1|STARTED|Overall Study||10
12146|NCT02449915|29465|P2|NOT COMPLETED|Overall Study||4
12147|NCT02449915|29466|P1|NOT COMPLETED|Overall Study||2
12148|NCT02449915|29465|P2|COMPLETED|Overall Study||31
12149|NCT02449915|29466|P1|COMPLETED|Overall Study||33
12150|NCT02449915|29465|P2|STARTED|Overall Study||35
12151|NCT02449915|29466|P1|STARTED|Overall Study||35
12152|NCT02449902|29474|P2|NOT COMPLETED|Overall Study||2
12153|NCT02449902|29475|P1|NOT COMPLETED|Overall Study||0
12154|NCT02449902|29474|P2|COMPLETED|Overall Study||24
12155|NCT02449902|29475|P1|COMPLETED|Overall Study||24
12156|NCT02449902|29474|P2|STARTED|Overall Study||26
12157|NCT02449902|29475|P1|STARTED|Overall Study||24
12158|NCT02449798|29499|P1|NOT COMPLETED|Overall Study||0
12159|NCT02449798|29499|P1|COMPLETED|Overall Study||120
12160|NCT02449798|29499|P1|STARTED|Overall Study||120
12161|NCT02449356|29513|P2|NOT COMPLETED|Overall Study||0
12162|NCT02449356|29514|P1|NOT COMPLETED|Overall Study||0
12163|NCT02449356|29513|P2|COMPLETED|Overall Study||30
12164|NCT02449356|29514|P1|COMPLETED|Overall Study||30
12165|NCT02449356|29513|P2|STARTED|Overall Study||30
12166|NCT02449356|29514|P1|STARTED|Overall Study||30
12167|NCT02449044|29530|P1|NOT COMPLETED|Overall Study||64
12168|NCT02449044|29530|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
12169|NCT02449044|29530|P1|STARTED|Overall Study||111
12170|NCT02449018|29551|P2|NOT COMPLETED|Overall Study||2
12171|NCT02449018|29552|P1|NOT COMPLETED|Overall Study||12
12172|NCT02449018|29551|P2|COMPLETED|Overall Study||26
12173|NCT02449018|29552|P1|COMPLETED|Overall Study||52
12174|NCT02449018|29551|P2|STARTED|Overall Study||28
12175|NCT02449018|29552|P1|STARTED|Overall Study||64
12176|NCT02448914|29579|P2|NOT COMPLETED|Second Intervention (1 Day)||0
12177|NCT02448914|29580|P1|NOT COMPLETED|Second Intervention (1 Day)||0
12178|NCT02448914|29579|P2|COMPLETED|Second Intervention (1 Day)||5
12179|NCT02448914|29580|P1|COMPLETED|Second Intervention (1 Day)||6
12180|NCT02448914|29579|P2|STARTED|Second Intervention (1 Day)||5
12181|NCT02448914|29580|P1|STARTED|Second Intervention (1 Day)||6
12182|NCT02448914|29579|P2|NOT COMPLETED|First Intervention (1 Day)||0
12183|NCT02448914|29580|P1|NOT COMPLETED|First Intervention (1 Day)||0
12184|NCT02448914|29579|P2|COMPLETED|First Intervention (1 Day)||5
12185|NCT02448914|29580|P1|COMPLETED|First Intervention (1 Day)||6
12186|NCT02448914|29579|P2|STARTED|First Intervention (1 Day)||5
12187|NCT02448914|29580|P1|STARTED|First Intervention (1 Day)||6
12188|NCT02448862|29598|P2|NOT COMPLETED|Overall Study||0
12189|NCT02448862|29599|P1|NOT COMPLETED|Overall Study||0
12190|NCT02448862|29598|P2|COMPLETED|Overall Study||6050
12191|NCT02448862|29599|P1|COMPLETED|Overall Study||4525
12192|NCT02448862|29598|P2|STARTED|Overall Study||6050
12193|NCT02448862|29599|P1|STARTED|Overall Study||4525
12194|NCT02448810|29621|P8|NOT COMPLETED|Overall Study||8
12195|NCT02448810|29622|P7|NOT COMPLETED|Overall Study||18
12196|NCT02448810|29623|P6|NOT COMPLETED|Overall Study||16
12197|NCT02448810|29624|P5|NOT COMPLETED|Overall Study||31
12198|NCT02448810|29625|P4|NOT COMPLETED|Overall Study||3
12199|NCT02448810|29626|P3|NOT COMPLETED|Overall Study||3
12200|NCT02448810|29627|P2|NOT COMPLETED|Overall Study||3
12201|NCT02448810|29628|P1|NOT COMPLETED|Overall Study||3
12202|NCT02448810|29621|P8|COMPLETED|Overall Study||0
12203|NCT02448810|29622|P7|COMPLETED|Overall Study||0
12204|NCT02448810|29623|P6|COMPLETED|Overall Study||0
12205|NCT02448810|29624|P5|COMPLETED|Overall Study||0
12206|NCT02448810|29625|P4|COMPLETED|Overall Study||0
12207|NCT02448810|29626|P3|COMPLETED|Overall Study||0
12208|NCT02448810|29627|P2|COMPLETED|Overall Study||0
12209|NCT02448810|29628|P1|COMPLETED|Overall Study||0
12210|NCT02448810|29621|P8|Treated|Overall Study||7
12211|NCT02448810|29622|P7|Treated|Overall Study||18
12212|NCT02448810|29623|P6|Treated|Overall Study||13
12213|NCT02448810|29624|P5|Treated|Overall Study||29
12214|NCT02448810|29625|P4|Treated|Overall Study||3
12215|NCT02448810|29626|P3|Treated|Overall Study||3
12216|NCT02448810|29627|P2|Treated|Overall Study||3
12217|NCT02448810|29628|P1|Treated|Overall Study||3
12218|NCT02448810|29621|P8|STARTED|Overall Study||8
12219|NCT02448810|29622|P7|STARTED|Overall Study||18
12220|NCT02448810|29623|P6|STARTED|Overall Study||16
12221|NCT02448810|29624|P5|STARTED|Overall Study||31
12222|NCT02448810|29625|P4|STARTED|Overall Study||3
12223|NCT02448810|29626|P3|STARTED|Overall Study||3
12224|NCT02448810|29627|P2|STARTED|Overall Study||3
12225|NCT02448810|29628|P1|STARTED|Overall Study||3
12226|NCT02448563|29698|P2|NOT COMPLETED|Overall Study||11
12227|NCT02448563|29699|P1|NOT COMPLETED|Overall Study||16
12228|NCT02448563|29698|P2|COMPLETED|Overall Study||19
12229|NCT02448563|29699|P1|COMPLETED|Overall Study||16
12230|NCT02448563|29698|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
12231|NCT02448563|29699|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
12232|NCT02448537|29721|P3|NOT COMPLETED|Overall Study||1
12233|NCT02448537|29722|P2|NOT COMPLETED|Overall Study||1
12234|NCT02448537|29723|P1|NOT COMPLETED|Overall Study||1
12235|NCT02448537|29721|P3|COMPLETED|Overall Study||11
12236|NCT02448537|29722|P2|COMPLETED|Overall Study||9
12237|NCT02448537|29723|P1|COMPLETED|Overall Study||19
12238|NCT02448537|29721|P3|STARTED|Overall Study||12
12239|NCT02448537|29722|P2|STARTED|Overall Study||10
12240|NCT02448537|29723|P1|STARTED|Overall Study||20
12241|NCT02447848|29737|P1|NOT COMPLETED|Overall Study||11
12242|NCT02447848|29737|P1|COMPLETED|Overall Study||65
12243|NCT02447848|29737|P1|STARTED|Overall Study||76
12244|NCT02447458|29749|P6|NOT COMPLETED|Overall Study||0
12245|NCT02447458|29750|P5|NOT COMPLETED|Overall Study||0
12246|NCT02447458|29751|P4|NOT COMPLETED|Overall Study||0
12247|NCT02447458|29752|P3|NOT COMPLETED|Overall Study||1
12248|NCT02447458|29753|P2|NOT COMPLETED|Overall Study||0
12249|NCT02447458|29754|P1|NOT COMPLETED|Overall Study||0
12250|NCT02447458|29749|P6|COMPLETED|Overall Study||10
12251|NCT02447458|29750|P5|COMPLETED|Overall Study||6
12252|NCT02447458|29751|P4|COMPLETED|Overall Study||6
12253|NCT02447458|29752|P3|COMPLETED|Overall Study||5
12254|NCT02447458|29753|P2|COMPLETED|Overall Study||6
12255|NCT02447458|29754|P1|COMPLETED|Overall Study||5
12256|NCT02447458|29749|P6|STARTED|Overall Study||10
12257|NCT02447458|29750|P5|STARTED|Overall Study||6
12258|NCT02447458|29751|P4|STARTED|Overall Study||6
12259|NCT02447458|29752|P3|STARTED|Overall Study||6
12260|NCT02447458|29753|P2|STARTED|Overall Study||6
12261|NCT02447458|29754|P1|STARTED|Overall Study||5
12262|NCT02447432|29852|P2|NOT COMPLETED|Epoch 002||0
12263|NCT02447432|29853|P1|NOT COMPLETED|Epoch 002||0
12264|NCT02447432|29852|P2|COMPLETED|Epoch 002||145
12265|NCT02447432|29853|P1|COMPLETED|Epoch 002||152
12266|NCT02447432|29852|P2|STARTED|Epoch 002||145
12267|NCT02447432|29853|P1|STARTED|Epoch 002||152
12268|NCT02447432|29852|P2|NOT COMPLETED|Epoch 001||13
12269|NCT02447432|29853|P1|NOT COMPLETED|Epoch 001||5
12270|NCT02447432|29852|P2|COMPLETED|Epoch 001||147
12271|NCT02447432|29853|P1|COMPLETED|Epoch 001||155
12272|NCT02447432|29852|P2|STARTED|Epoch 001||160
12273|NCT02447432|29853|P1|STARTED|Epoch 001||160
12274|NCT02447328|29885|P1|NOT COMPLETED|Overall Study||1
12275|NCT02447328|29885|P1|COMPLETED|Overall Study||82
12276|NCT02447328|29885|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
12277|NCT02447133|29889|P1|NOT COMPLETED|Overall Study||0
12278|NCT02447133|29889|P1|COMPLETED|Overall Study||12
12279|NCT02447133|29889|P1|STARTED|Overall Study||12
12280|NCT02447029|29897|P2|NOT COMPLETED|Overall Study||2
12281|NCT02447029|29898|P1|NOT COMPLETED|Overall Study||3
12282|NCT02447029|29897|P2|COMPLETED|Overall Study||68
12283|NCT02447029|29898|P1|COMPLETED|Overall Study||69
12284|NCT02447029|29897|P2|Treated|Overall Study||68
12285|NCT02447029|29898|P1|Treated|Overall Study||69
12286|NCT02447029|29897|P2|STARTED|Overall Study||70
12287|NCT02447029|29898|P1|STARTED|Overall Study||72
12288|NCT02446990|29918|P2|NOT COMPLETED|Overall Study||658
12289|NCT02446990|29919|P1|NOT COMPLETED|Overall Study||720
12290|NCT02446990|29918|P2|COMPLETED|Overall Study||8894
12291|NCT02446990|29919|P1|COMPLETED|Overall Study||8830
12292|NCT02446990|29918|P2|STARTED|Overall Study||9552
12293|NCT02446990|29919|P1|STARTED|Overall Study||9550
12294|NCT02446743|29953|P2|NOT COMPLETED|Overall Study||5
12295|NCT02446743|29954|P1|NOT COMPLETED|Overall Study||5
12296|NCT02446743|29953|P2|COMPLETED|Overall Study||250
12297|NCT02446743|29954|P1|COMPLETED|Overall Study||271
12298|NCT02446743|29953|P2|STARTED|Overall Study||255
12299|NCT02446743|29954|P1|STARTED|Overall Study||276
12300|NCT02446717|30086|P5|NOT COMPLETED|Overall Study||1
12301|NCT02446717|30087|P4|NOT COMPLETED|Overall Study||1
12302|NCT02446717|30088|P3|NOT COMPLETED|Overall Study||2
12303|NCT02446717|30089|P2|NOT COMPLETED|Overall Study||1
12304|NCT02446717|30090|P1|NOT COMPLETED|Overall Study||0
12305|NCT02446717|30086|P5|COMPLETED|Overall Study||46
12306|NCT02446717|30087|P4|COMPLETED|Overall Study||43
12307|NCT02446717|30088|P3|COMPLETED|Overall Study||20
12308|NCT02446717|30089|P2|COMPLETED|Overall Study||21
12309|NCT02446717|30090|P1|COMPLETED|Overall Study||6
12310|NCT02446717|30086|P5|STARTED|Overall Study||47
12311|NCT02446717|30087|P4|STARTED|Overall Study||44
12312|NCT02446717|30088|P3|STARTED|Overall Study||22
12313|NCT02446717|30089|P2|STARTED|Overall Study||22
12314|NCT02446717|30090|P1|STARTED|Overall Study||6
12315|NCT02446613|30119|P2|NOT COMPLETED|Overall Study||0
12316|NCT02446613|30120|P1|NOT COMPLETED|Overall Study||0
12317|NCT02446613|30119|P2|COMPLETED|Overall Study||10
12318|NCT02446613|30120|P1|COMPLETED|Overall Study||6
12319|NCT02446613|30119|P2|STARTED|Overall Study||10
12320|NCT02446613|30120|P1|STARTED|Overall Study||6
12321|NCT02446496|30142|P1|NOT COMPLETED|Overall Study||0
12322|NCT02446496|30142|P1|COMPLETED|Overall Study||24
12323|NCT02446496|30142|P1|STARTED|Overall Study||24
12324|NCT02446483|30154|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
12325|NCT02446483|30155|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
12326|NCT02446483|30154|P2|COMPLETED|Period 3: Intervention Period 2||30
12327|NCT02446483|30155|P1|COMPLETED|Period 3: Intervention Period 2||30
12328|NCT02446483|30154|P2|STARTED|Period 3: Intervention Period 2||30
12329|NCT02446483|30155|P1|STARTED|Period 3: Intervention Period 2||30
12330|NCT02446483|30154|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
12331|NCT02446483|30155|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
12332|NCT02446483|30154|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
12333|NCT02446483|30155|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
12334|NCT02446483|30154|P2|STARTED|Period 2: Washout Period (7 Days)||30
12335|NCT02446483|30155|P1|STARTED|Period 2: Washout Period (7 Days)||30
12336|NCT02446483|30154|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
12337|NCT02446483|30155|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
12338|NCT02446483|30154|P2|COMPLETED|Period 1: Intervention Period 1||30
12339|NCT02446483|30155|P1|COMPLETED|Period 1: Intervention Period 1||30
12340|NCT02446483|30154|P2|STARTED|Period 1: Intervention Period 1||30
12341|NCT02446483|30155|P1|STARTED|Period 1: Intervention Period 1||30
12342|NCT02446171|30171|P4|NOT COMPLETED|Overall Study||0
12343|NCT02446171|30172|P3|NOT COMPLETED|Overall Study||2
12344|NCT02446171|30173|P2|NOT COMPLETED|Overall Study||0
12345|NCT02446171|30174|P1|NOT COMPLETED|Overall Study||0
12346|NCT02446171|30171|P4|COMPLETED|Overall Study||11
12347|NCT02446171|30172|P3|COMPLETED|Overall Study||9
12348|NCT02446171|30173|P2|COMPLETED|Overall Study||11
12349|NCT02446171|30174|P1|COMPLETED|Overall Study||11
12350|NCT02446171|30171|P4|STARTED|Overall Study||11
12351|NCT02446171|30172|P3|STARTED|Overall Study||11
12352|NCT02446171|30173|P2|STARTED|Overall Study||11
12353|NCT02446171|30174|P1|STARTED|Overall Study||11
12354|NCT02446015|30245|P2|NOT COMPLETED|Overall Study||1
12355|NCT02446015|30246|P1|NOT COMPLETED|Overall Study||1
12356|NCT02446015|30245|P2|COMPLETED|Overall Study||62
12357|NCT02446015|30246|P1|COMPLETED|Overall Study||33
12358|NCT02446015|30245|P2|STARTED|Overall Study||63
12359|NCT02446015|30246|P1|STARTED|Overall Study||34
12360|NCT02445807|30259|P2|NOT COMPLETED|Overall Study||0
12361|NCT02445807|30260|P1|NOT COMPLETED|Overall Study||0
12362|NCT02445807|30259|P2|COMPLETED|Overall Study||89
12363|NCT02445807|30260|P1|COMPLETED|Overall Study||176
12364|NCT02445807|30259|P2|STARTED|Overall Study||89
12365|NCT02445807|30260|P1|STARTED|Overall Study||176
12366|NCT02445755|30270|P1|NOT COMPLETED|Overall Study||13
12367|NCT02445755|30270|P1|COMPLETED|Overall Study||100
12368|NCT02445755|30270|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
12369|NCT02445573|30279|P2|NOT COMPLETED|Overall Study||2
12370|NCT02445573|30280|P1|NOT COMPLETED|Overall Study||1
12371|NCT02445573|30279|P2|COMPLETED|Overall Study||38
12372|NCT02445573|30280|P1|COMPLETED|Overall Study||39
12373|NCT02445573|30279|P2|STARTED|Overall Study||40
12374|NCT02445573|30280|P1|STARTED|Overall Study||40
12375|NCT02445326|30296|P2|NOT COMPLETED|Overall Study||1
12376|NCT02445326|30297|P1|NOT COMPLETED|Overall Study||2
12377|NCT02445326|30296|P2|COMPLETED|Overall Study||37
12378|NCT02445326|30297|P1|COMPLETED|Overall Study||33
12379|NCT02445326|30296|P2|STARTED|Overall Study||38
12380|NCT02445326|30297|P1|STARTED|Overall Study||35
12381|NCT02445287|30315|P2|NOT COMPLETED|Overall Study||0
12382|NCT02445287|30316|P1|NOT COMPLETED|Overall Study||0
12383|NCT02445287|30315|P2|COMPLETED|Overall Study||13
12384|NCT02445287|30316|P1|COMPLETED|Overall Study||35
12385|NCT02445287|30315|P2|STARTED|Overall Study||13
12386|NCT02445287|30316|P1|STARTED|Overall Study||35
12387|NCT02445196|30331|P2|NOT COMPLETED|Overall Study||6
12388|NCT02445196|30332|P1|NOT COMPLETED|Overall Study||11
12389|NCT02445196|30331|P2|COMPLETED|Overall Study||52
12390|NCT02445196|30332|P1|COMPLETED|Overall Study||51
12391|NCT02445196|30331|P2|STARTED|Overall Study||58
12392|NCT02445196|30332|P1|STARTED|Overall Study||62
12393|NCT02444936|30347|P2|NOT COMPLETED|Overall Study||0
12394|NCT02444936|30348|P1|NOT COMPLETED|Overall Study||0
12395|NCT02444936|30347|P2|COMPLETED|Overall Study||12
12396|NCT02444936|30348|P1|COMPLETED|Overall Study||10
12397|NCT02444936|30347|P2|STARTED|Overall Study||12
12398|NCT02444936|30348|P1|STARTED|Overall Study||10
12399|NCT02444715|30356|P2|NOT COMPLETED|Overall Study||16
12400|NCT02444715|30357|P1|NOT COMPLETED|Overall Study||10
12401|NCT02444715|30356|P2|COMPLETED|Overall Study||32
12402|NCT02444715|30357|P1|COMPLETED|Overall Study||36
12403|NCT02444715|30356|P2|STARTED|Overall Study||48
12404|NCT02444715|30357|P1|STARTED|Overall Study||46
12405|NCT02444533|30388|P2|NOT COMPLETED|Overall Study||4
12406|NCT02444533|30389|P1|NOT COMPLETED|Overall Study||2
12407|NCT02444533|30388|P2|COMPLETED|Overall Study||18
12408|NCT02444533|30389|P1|COMPLETED|Overall Study||15
12409|NCT02444533|30388|P2|STARTED|Overall Study||22
12410|NCT02444533|30389|P1|STARTED|Overall Study||17
12411|NCT02444182|30405|P2|NOT COMPLETED|Overall Study||5
12412|NCT02444182|30406|P1|NOT COMPLETED|Overall Study||2
12413|NCT02444182|30405|P2|COMPLETED|Overall Study||49
12414|NCT02444182|30406|P1|COMPLETED|Overall Study||52
12415|NCT02444182|30405|P2|STARTED|Overall Study||54
12416|NCT02444182|30406|P1|STARTED|Overall Study||54
12417|NCT02443883|30418|P4|NOT COMPLETED|Overall Study||7
12418|NCT02443883|30419|P3|NOT COMPLETED|Overall Study||4
12419|NCT02443883|30420|P2|NOT COMPLETED|Overall Study||5
12420|NCT02443883|30421|P1|NOT COMPLETED|Overall Study||6
12421|NCT02443883|30418|P4|COMPLETED|Overall Study||34
12422|NCT02443883|30419|P3|COMPLETED|Overall Study||37
12423|NCT02443883|30420|P2|COMPLETED|Overall Study||37
12424|NCT02443883|30421|P1|COMPLETED|Overall Study||34
12425|NCT02443883|30418|P4|Received at Least One Dose of Study Drug|Overall Study||40
12426|NCT02443883|30419|P3|Received at Least One Dose of Study Drug|Overall Study||41
12427|NCT02443883|30420|P2|Received at Least One Dose of Study Drug|Overall Study||42
12428|NCT02443883|30421|P1|Received at Least One Dose of Study Drug|Overall Study||38
12429|NCT02443883|30418|P4|STARTED|Overall Study||41
12430|NCT02443883|30419|P3|STARTED|Overall Study||41
12431|NCT02443883|30420|P2|STARTED|Overall Study||42
12432|NCT02443883|30421|P1|STARTED|Overall Study||40
12433|NCT02443792|30441|P2|NOT COMPLETED|Overall Study||2
12434|NCT02443792|30442|P1|NOT COMPLETED|Overall Study||7
12435|NCT02443792|30441|P2|COMPLETED|Overall Study||23
12436|NCT02443792|30442|P1|COMPLETED|Overall Study||43
12437|NCT02443792|30441|P2|STARTED|Overall Study||25
12438|NCT02443792|30442|P1|STARTED|Overall Study||50
12439|NCT02443740|30460|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12440|NCT02443740|30461|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12441|NCT02443740|30462|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12442|NCT02443740|30463|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12443|NCT02443740|30464|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12444|NCT02443740|30465|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12445|NCT02443740|30466|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12446|NCT02443740|30467|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12447|NCT02443740|30468|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12448|NCT02443740|30469|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12449|NCT02443740|30470|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
12450|NCT02443740|30460|P11|COMPLETED|Intervention Period 4 (3 Days)||0
12451|NCT02443740|30461|P10|COMPLETED|Intervention Period 4 (3 Days)||0
12452|NCT02443740|30462|P9|COMPLETED|Intervention Period 4 (3 Days)||0
12453|NCT02443740|30463|P8|COMPLETED|Intervention Period 4 (3 Days)||2
12454|NCT02443740|30464|P7|COMPLETED|Intervention Period 4 (3 Days)||2
12455|NCT02443740|30465|P6|COMPLETED|Intervention Period 4 (3 Days)||2
12456|NCT02443740|30466|P5|COMPLETED|Intervention Period 4 (3 Days)||2
12457|NCT02443740|30467|P4|COMPLETED|Intervention Period 4 (3 Days)||3
12458|NCT02443740|30468|P3|COMPLETED|Intervention Period 4 (3 Days)||2
12459|NCT02443740|30469|P2|COMPLETED|Intervention Period 4 (3 Days)||2
12460|NCT02443740|30470|P1|COMPLETED|Intervention Period 4 (3 Days)||1
12461|NCT02443740|30460|P11|STARTED|Intervention Period 4 (3 Days)||0
12462|NCT02443740|30461|P10|STARTED|Intervention Period 4 (3 Days)||0
12463|NCT02443740|30462|P9|STARTED|Intervention Period 4 (3 Days)||0
12464|NCT02443740|30463|P8|STARTED|Intervention Period 4 (3 Days)||2
12465|NCT02443740|30464|P7|STARTED|Intervention Period 4 (3 Days)||2
12466|NCT02443740|30465|P6|STARTED|Intervention Period 4 (3 Days)||2
12467|NCT02443740|30466|P5|STARTED|Intervention Period 4 (3 Days)||2
12468|NCT02443740|30467|P4|STARTED|Intervention Period 4 (3 Days)||3
12469|NCT02443740|30468|P3|STARTED|Intervention Period 4 (3 Days)||2
12470|NCT02443740|30469|P2|STARTED|Intervention Period 4 (3 Days)||2
12471|NCT02443740|30470|P1|STARTED|Intervention Period 4 (3 Days)||1
12472|NCT02443740|30460|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
12473|NCT02443740|30461|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
12474|NCT02443740|30462|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
12475|NCT02443740|30463|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
12476|NCT02443740|30464|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
12477|NCT02443740|30465|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
12478|NCT02443740|30466|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
12479|NCT02443740|30467|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
12480|NCT02443740|30468|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
12481|NCT02443740|30469|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
12482|NCT02443740|30470|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
12483|NCT02443740|30460|P11|COMPLETED|Washout Period 3 (7 Days)||0
12484|NCT02443740|30461|P10|COMPLETED|Washout Period 3 (7 Days)||0
12485|NCT02443740|30462|P9|COMPLETED|Washout Period 3 (7 Days)||0
12486|NCT02443740|30463|P8|COMPLETED|Washout Period 3 (7 Days)||2
12487|NCT02443740|30464|P7|COMPLETED|Washout Period 3 (7 Days)||2
12488|NCT02443740|30465|P6|COMPLETED|Washout Period 3 (7 Days)||2
12489|NCT02443740|30466|P5|COMPLETED|Washout Period 3 (7 Days)||2
12490|NCT02443740|30467|P4|COMPLETED|Washout Period 3 (7 Days)||3
12491|NCT02443740|30468|P3|COMPLETED|Washout Period 3 (7 Days)||2
12492|NCT02443740|30469|P2|COMPLETED|Washout Period 3 (7 Days)||2
12493|NCT02443740|30470|P1|COMPLETED|Washout Period 3 (7 Days)||1
12494|NCT02443740|30460|P11|STARTED|Washout Period 3 (7 Days)||0
12495|NCT02443740|30461|P10|STARTED|Washout Period 3 (7 Days)||0
12496|NCT02443740|30462|P9|STARTED|Washout Period 3 (7 Days)||0
12497|NCT02443740|30463|P8|STARTED|Washout Period 3 (7 Days)||2
12498|NCT02443740|30464|P7|STARTED|Washout Period 3 (7 Days)||2
12499|NCT02443740|30465|P6|STARTED|Washout Period 3 (7 Days)||2
12500|NCT02443740|30466|P5|STARTED|Washout Period 3 (7 Days)||2
12501|NCT02443740|30467|P4|STARTED|Washout Period 3 (7 Days)||3
12502|NCT02443740|30468|P3|STARTED|Washout Period 3 (7 Days)||2
12503|NCT02443740|30469|P2|STARTED|Washout Period 3 (7 Days)||2
12504|NCT02443740|30470|P1|STARTED|Washout Period 3 (7 Days)||1
12505|NCT02443740|30460|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12506|NCT02443740|30461|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12507|NCT02443740|30462|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12508|NCT02443740|30463|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12509|NCT02443740|30464|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12510|NCT02443740|30465|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12511|NCT02443740|30466|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12512|NCT02443740|30467|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12513|NCT02443740|30468|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12514|NCT02443740|30469|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12515|NCT02443740|30470|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
12516|NCT02443740|30460|P11|COMPLETED|Intervention Period 3 (3 Days)||0
12517|NCT02443740|30461|P10|COMPLETED|Intervention Period 3 (3 Days)||0
12518|NCT02443740|30462|P9|COMPLETED|Intervention Period 3 (3 Days)||0
12519|NCT02443740|30463|P8|COMPLETED|Intervention Period 3 (3 Days)||2
12520|NCT02443740|30464|P7|COMPLETED|Intervention Period 3 (3 Days)||2
12521|NCT02443740|30465|P6|COMPLETED|Intervention Period 3 (3 Days)||2
12522|NCT02443740|30466|P5|COMPLETED|Intervention Period 3 (3 Days)||2
12523|NCT02443740|30467|P4|COMPLETED|Intervention Period 3 (3 Days)||3
12524|NCT02443740|30468|P3|COMPLETED|Intervention Period 3 (3 Days)||2
12525|NCT02443740|30469|P2|COMPLETED|Intervention Period 3 (3 Days)||2
12526|NCT02443740|30470|P1|COMPLETED|Intervention Period 3 (3 Days)||1
12527|NCT02443740|30460|P11|STARTED|Intervention Period 3 (3 Days)||0
12528|NCT02443740|30461|P10|STARTED|Intervention Period 3 (3 Days)||0
12529|NCT02443740|30462|P9|STARTED|Intervention Period 3 (3 Days)||0
12530|NCT02443740|30463|P8|STARTED|Intervention Period 3 (3 Days)||2
12531|NCT02443740|30464|P7|STARTED|Intervention Period 3 (3 Days)||2
12532|NCT02443740|30465|P6|STARTED|Intervention Period 3 (3 Days)||2
12533|NCT02443740|30466|P5|STARTED|Intervention Period 3 (3 Days)||2
12534|NCT02443740|30467|P4|STARTED|Intervention Period 3 (3 Days)||3
12535|NCT02443740|30468|P3|STARTED|Intervention Period 3 (3 Days)||2
12536|NCT02443740|30469|P2|STARTED|Intervention Period 3 (3 Days)||2
12537|NCT02443740|30470|P1|STARTED|Intervention Period 3 (3 Days)||1
12538|NCT02443740|30460|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
12539|NCT02443740|30461|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
12540|NCT02443740|30462|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
12541|NCT02443740|30463|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
12542|NCT02443740|30464|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
12543|NCT02443740|30465|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
12544|NCT02443740|30466|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
12545|NCT02443740|30467|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
12546|NCT02443740|30468|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
12547|NCT02443740|30469|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
12548|NCT02443740|30470|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
12549|NCT02443740|30460|P11|COMPLETED|Washout Period 2 (7 Days)||0
12550|NCT02443740|30461|P10|COMPLETED|Washout Period 2 (7 Days)||0
12551|NCT02443740|30462|P9|COMPLETED|Washout Period 2 (7 Days)||0
12552|NCT02443740|30463|P8|COMPLETED|Washout Period 2 (7 Days)||2
12553|NCT02443740|30464|P7|COMPLETED|Washout Period 2 (7 Days)||2
12554|NCT02443740|30465|P6|COMPLETED|Washout Period 2 (7 Days)||2
12555|NCT02443740|30466|P5|COMPLETED|Washout Period 2 (7 Days)||2
12556|NCT02443740|30467|P4|COMPLETED|Washout Period 2 (7 Days)||3
12557|NCT02443740|30468|P3|COMPLETED|Washout Period 2 (7 Days)||2
12558|NCT02443740|30469|P2|COMPLETED|Washout Period 2 (7 Days)||2
12559|NCT02443740|30470|P1|COMPLETED|Washout Period 2 (7 Days)||1
12560|NCT02443740|30460|P11|STARTED|Washout Period 2 (7 Days)||0
12561|NCT02443740|30461|P10|STARTED|Washout Period 2 (7 Days)||0
12562|NCT02443740|30462|P9|STARTED|Washout Period 2 (7 Days)||0
12563|NCT02443740|30463|P8|STARTED|Washout Period 2 (7 Days)||2
12564|NCT02443740|30464|P7|STARTED|Washout Period 2 (7 Days)||2
12565|NCT02443740|30465|P6|STARTED|Washout Period 2 (7 Days)||2
12566|NCT02443740|30466|P5|STARTED|Washout Period 2 (7 Days)||2
12567|NCT02443740|30467|P4|STARTED|Washout Period 2 (7 Days)||3
12568|NCT02443740|30468|P3|STARTED|Washout Period 2 (7 Days)||2
12569|NCT02443740|30469|P2|STARTED|Washout Period 2 (7 Days)||2
12570|NCT02443740|30470|P1|STARTED|Washout Period 2 (7 Days)||1
12571|NCT02443740|30460|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12572|NCT02443740|30461|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12573|NCT02443740|30462|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12574|NCT02443740|30463|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12575|NCT02443740|30464|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12576|NCT02443740|30465|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12577|NCT02443740|30466|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12578|NCT02443740|30467|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12579|NCT02443740|30468|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12580|NCT02443740|30469|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12581|NCT02443740|30470|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
12582|NCT02443740|30460|P11|COMPLETED|Intervention Period 2 (3 Days)||3
12583|NCT02443740|30461|P10|COMPLETED|Intervention Period 2 (3 Days)||3
12584|NCT02443740|30462|P9|COMPLETED|Intervention Period 2 (3 Days)||0
12585|NCT02443740|30463|P8|COMPLETED|Intervention Period 2 (3 Days)||2
12586|NCT02443740|30464|P7|COMPLETED|Intervention Period 2 (3 Days)||2
12587|NCT02443740|30465|P6|COMPLETED|Intervention Period 2 (3 Days)||2
12588|NCT02443740|30466|P5|COMPLETED|Intervention Period 2 (3 Days)||2
12589|NCT02443740|30467|P4|COMPLETED|Intervention Period 2 (3 Days)||3
12590|NCT02443740|30468|P3|COMPLETED|Intervention Period 2 (3 Days)||2
12591|NCT02443740|30469|P2|COMPLETED|Intervention Period 2 (3 Days)||2
12592|NCT02443740|30470|P1|COMPLETED|Intervention Period 2 (3 Days)||1
12593|NCT02443740|30460|P11|STARTED|Intervention Period 2 (3 Days)||3
12594|NCT02443740|30461|P10|STARTED|Intervention Period 2 (3 Days)||3
12595|NCT02443740|30462|P9|STARTED|Intervention Period 2 (3 Days)||0
12596|NCT02443740|30463|P8|STARTED|Intervention Period 2 (3 Days)||2
12597|NCT02443740|30464|P7|STARTED|Intervention Period 2 (3 Days)||2
12598|NCT02443740|30465|P6|STARTED|Intervention Period 2 (3 Days)||2
12599|NCT02443740|30466|P5|STARTED|Intervention Period 2 (3 Days)||2
12600|NCT02443740|30467|P4|STARTED|Intervention Period 2 (3 Days)||3
12601|NCT02443740|30468|P3|STARTED|Intervention Period 2 (3 Days)||2
12602|NCT02443740|30469|P2|STARTED|Intervention Period 2 (3 Days)||2
12603|NCT02443740|30470|P1|STARTED|Intervention Period 2 (3 Days)||1
12604|NCT02443740|30460|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
12605|NCT02443740|30461|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
12606|NCT02443740|30462|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
12607|NCT02443740|30463|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
12608|NCT02443740|30464|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
12609|NCT02443740|30465|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
12610|NCT02443740|30466|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
12611|NCT02443740|30467|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
12612|NCT02443740|30468|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
12613|NCT02443740|30469|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
12614|NCT02443740|30470|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
12615|NCT02443740|30460|P11|COMPLETED|Washout Period 1 (7 Days)||3
12616|NCT02443740|30461|P10|COMPLETED|Washout Period 1 (7 Days)||3
12617|NCT02443740|30462|P9|COMPLETED|Washout Period 1 (7 Days)||0
12618|NCT02443740|30463|P8|COMPLETED|Washout Period 1 (7 Days)||2
12619|NCT02443740|30464|P7|COMPLETED|Washout Period 1 (7 Days)||2
12620|NCT02443740|30465|P6|COMPLETED|Washout Period 1 (7 Days)||2
12621|NCT02443740|30466|P5|COMPLETED|Washout Period 1 (7 Days)||2
12622|NCT02443740|30467|P4|COMPLETED|Washout Period 1 (7 Days)||3
12623|NCT02443740|30468|P3|COMPLETED|Washout Period 1 (7 Days)||2
12624|NCT02443740|30469|P2|COMPLETED|Washout Period 1 (7 Days)||2
12625|NCT02443740|30470|P1|COMPLETED|Washout Period 1 (7 Days)||1
12626|NCT02443740|30460|P11|STARTED|Washout Period 1 (7 Days)||3
12627|NCT02443740|30461|P10|STARTED|Washout Period 1 (7 Days)||3
12628|NCT02443740|30462|P9|STARTED|Washout Period 1 (7 Days)||0
12629|NCT02443740|30463|P8|STARTED|Washout Period 1 (7 Days)||2
12630|NCT02443740|30464|P7|STARTED|Washout Period 1 (7 Days)||2
12631|NCT02443740|30465|P6|STARTED|Washout Period 1 (7 Days)||2
12632|NCT02443740|30466|P5|STARTED|Washout Period 1 (7 Days)||2
12633|NCT02443740|30467|P4|STARTED|Washout Period 1 (7 Days)||3
12634|NCT02443740|30468|P3|STARTED|Washout Period 1 (7 Days)||2
12635|NCT02443740|30469|P2|STARTED|Washout Period 1 (7 Days)||2
12636|NCT02443740|30470|P1|STARTED|Washout Period 1 (7 Days)||1
12637|NCT02443740|30460|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12638|NCT02443740|30461|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12639|NCT02443740|30462|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12640|NCT02443740|30463|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12641|NCT02443740|30464|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
12642|NCT02443740|30465|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
12643|NCT02443740|30466|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12644|NCT02443740|30467|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12645|NCT02443740|30468|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12646|NCT02443740|30469|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
12647|NCT02443740|30470|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
12648|NCT02443740|30460|P11|COMPLETED|Intervention Period 1 (3 Days)||3
12649|NCT02443740|30461|P10|COMPLETED|Intervention Period 1 (3 Days)||3
12650|NCT02443740|30462|P9|COMPLETED|Intervention Period 1 (3 Days)||6
12651|NCT02443740|30463|P8|COMPLETED|Intervention Period 1 (3 Days)||2
12652|NCT02443740|30464|P7|COMPLETED|Intervention Period 1 (3 Days)||2
12653|NCT02443740|30465|P6|COMPLETED|Intervention Period 1 (3 Days)||2
12654|NCT02443740|30466|P5|COMPLETED|Intervention Period 1 (3 Days)||2
12655|NCT02443740|30467|P4|COMPLETED|Intervention Period 1 (3 Days)||3
12656|NCT02443740|30468|P3|COMPLETED|Intervention Period 1 (3 Days)||2
12657|NCT02443740|30469|P2|COMPLETED|Intervention Period 1 (3 Days)||2
12658|NCT02443740|30470|P1|COMPLETED|Intervention Period 1 (3 Days)||1
12659|NCT02443740|30460|P11|STARTED|Intervention Period 1 (3 Days)||3
12660|NCT02443740|30461|P10|STARTED|Intervention Period 1 (3 Days)||3
12661|NCT02443740|30462|P9|STARTED|Intervention Period 1 (3 Days)||6
12662|NCT02443740|30463|P8|STARTED|Intervention Period 1 (3 Days)||2
12663|NCT02443740|30464|P7|STARTED|Intervention Period 1 (3 Days)||3
12664|NCT02443740|30465|P6|STARTED|Intervention Period 1 (3 Days)||4
12665|NCT02443740|30466|P5|STARTED|Intervention Period 1 (3 Days)||2
12666|NCT02443740|30467|P4|STARTED|Intervention Period 1 (3 Days)||3
12667|NCT02443740|30468|P3|STARTED|Intervention Period 1 (3 Days)||2
12668|NCT02443740|30469|P2|STARTED|Intervention Period 1 (3 Days)||2
12669|NCT02443740|30470|P1|STARTED|Intervention Period 1 (3 Days)||2
12670|NCT02443402|30651|P2|NOT COMPLETED|Overall Study||3
12671|NCT02443402|30652|P1|NOT COMPLETED|Overall Study||4
12672|NCT02443402|30651|P2|COMPLETED|Overall Study||28
12673|NCT02443402|30652|P1|COMPLETED|Overall Study||32
12674|NCT02443402|30651|P2|STARTED|Overall Study||31
12675|NCT02443402|30652|P1|STARTED|Overall Study||36
12676|NCT02443103|30712|P1|NOT COMPLETED|Overall Study||3
12677|NCT02443103|30712|P1|COMPLETED|Overall Study||1
12678|NCT02443103|30712|P1|STARTED|Overall Study||4
12679|NCT02442804|30719|P2|NOT COMPLETED|Overall Study||1
12680|NCT02442804|30720|P1|NOT COMPLETED|Overall Study||1
12681|NCT02442804|30719|P2|COMPLETED|Overall Study||7
12682|NCT02442804|30720|P1|COMPLETED|Overall Study||7
12683|NCT02442804|30719|P2|STARTED|Overall Study||8
12684|NCT02442804|30720|P1|STARTED|Overall Study||8
12685|NCT02442700|30750|P2|NOT COMPLETED|Later 12 Weeks||0
12686|NCT02442700|30751|P1|NOT COMPLETED|Later 12 Weeks||0
12687|NCT02442700|30750|P2|COMPLETED|Later 12 Weeks||12
12688|NCT02442700|30751|P1|COMPLETED|Later 12 Weeks||12
12689|NCT02442700|30750|P2|STARTED|Later 12 Weeks||12
12690|NCT02442700|30751|P1|STARTED|Later 12 Weeks||12
12691|NCT02442700|30750|P2|NOT COMPLETED|First 12 Weeks||0
12692|NCT02442700|30751|P1|NOT COMPLETED|First 12 Weeks||0
12693|NCT02442700|30750|P2|COMPLETED|First 12 Weeks||12
12694|NCT02442700|30751|P1|COMPLETED|First 12 Weeks||12
12695|NCT02442700|30750|P2|STARTED|First 12 Weeks||12
12696|NCT02442700|30751|P1|STARTED|First 12 Weeks||12
12697|NCT02442349|30759|P1|NOT COMPLETED|Overall Study||171
12698|NCT02442349|30759|P1|COMPLETED|Overall Study||0
12699|NCT02442349|30759|P1|STARTED|Overall Study||171
12700|NCT02442310|30764|P1|NOT COMPLETED|Overall Study||3
12701|NCT02442310|30764|P1|COMPLETED|Overall Study||17
12702|NCT02442310|30764|P1|STARTED|Overall Study||20
12703|NCT02442284|30786|P1|NOT COMPLETED|Overall Study||7
12704|NCT02442284|30786|P1|COMPLETED|Overall Study||92
12705|NCT02442284|30786|P1|STARTED|Overall Study||99
12706|NCT02442271|30793|P1|NOT COMPLETED|Overall Study||4
12707|NCT02442271|30793|P1|COMPLETED|Overall Study||218
12708|NCT02442271|30793|P1|STARTED|Overall Study||222
12709|NCT02441946|30820|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
12710|NCT02441946|30821|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
12711|NCT02441946|30822|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
12712|NCT02441946|30820|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
12713|NCT02441946|30821|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
12714|NCT02441946|30822|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
12715|NCT02441946|30820|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
12716|NCT02441946|30821|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
12717|NCT02441946|30822|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||214
12718|NCT02441946|30820|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
12719|NCT02441946|30821|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
12720|NCT02441946|30822|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
12721|NCT02441946|30820|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
12722|NCT02441946|30821|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
12723|NCT02441946|30822|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
12724|NCT02441946|30820|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
12725|NCT02441946|30821|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
12726|NCT02441946|30822|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
12727|NCT02441946|30820|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
12728|NCT02441946|30821|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
12729|NCT02441946|30822|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
12730|NCT02441946|30820|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
12731|NCT02441946|30821|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
12732|NCT02441946|30822|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
12733|NCT02441517|30834|P1|NOT COMPLETED|Overall Study||4
12734|NCT02441517|30834|P1|COMPLETED|Overall Study||0
12735|NCT02441517|30834|P1|Received Treatment|Overall Study||4
12736|NCT02441517|30834|P1|STARTED|Overall Study||4
12737|NCT02441218|30846|P2|NOT COMPLETED|Overall Study||612
12738|NCT02441218|30847|P1|NOT COMPLETED|Overall Study||578
12739|NCT02441218|30846|P2|COMPLETED|Overall Study||2652
12740|NCT02441218|30847|P1|COMPLETED|Overall Study||2663
12741|NCT02441218|30846|P2|STARTED|Overall Study||3264
12742|NCT02441218|30847|P1|STARTED|Overall Study||3241
12743|NCT02441179|30873|P2|NOT COMPLETED|Overall Study||1
12744|NCT02441179|30874|P1|NOT COMPLETED|Overall Study||1
12745|NCT02441179|30873|P2|COMPLETED|Overall Study||16
12746|NCT02441179|30874|P1|COMPLETED|Overall Study||17
12747|NCT02441179|30873|P2|STARTED|Overall Study||17
12748|NCT02441179|30874|P1|STARTED|Overall Study||18
12749|NCT02441114|30892|P1|NOT COMPLETED|Period3||0
12750|NCT02441114|30892|P1|COMPLETED|Period3||6
12751|NCT02441114|30892|P1|STARTED|Period3||6
12752|NCT02441114|30892|P1|NOT COMPLETED|Washout2||4
12753|NCT02441114|30892|P1|COMPLETED|Washout2||6
12754|NCT02441114|30892|P1|STARTED|Washout2||10
12755|NCT02441114|30892|P1|NOT COMPLETED|Period2||0
12756|NCT02441114|30892|P1|COMPLETED|Period2||10
12757|NCT02441114|30892|P1|STARTED|Period2||10
12758|NCT02441114|30892|P1|NOT COMPLETED|Washout1||0
12759|NCT02441114|30892|P1|COMPLETED|Washout1||10
12760|NCT02441114|30892|P1|STARTED|Washout1||10
12761|NCT02441114|30892|P1|NOT COMPLETED|Period1||0
12762|NCT02441114|30892|P1|COMPLETED|Period1||10
12763|NCT02441114|30892|P1|STARTED|Period1||10
12764|NCT02440659|30900|P2|NOT COMPLETED|Overall Study||335
12765|NCT02440659|30901|P1|NOT COMPLETED|Overall Study||651
12766|NCT02440659|30900|P2|COMPLETED|Overall Study||614
12767|NCT02440659|30901|P1|COMPLETED|Overall Study||1346
12768|NCT02440659|30900|P2|STARTED|Overall Study||949
12769|NCT02440659|30901|P1|STARTED|Overall Study||1997
12770|NCT02440633|30907|P1|NOT COMPLETED|Overall Study||0
12771|NCT02440633|30907|P1|COMPLETED|Overall Study||8
12772|NCT02440633|30907|P1|STARTED|Overall Study||8
12773|NCT02440308|30916|P1|NOT COMPLETED|Overall Study||0
12774|NCT02440308|30916|P1|COMPLETED|Overall Study||10
12775|NCT02440308|30916|P1|STARTED|Overall Study||10
12776|NCT02439879|30923|P2|NOT COMPLETED|Overall Study||0
12777|NCT02439879|30924|P1|NOT COMPLETED|Overall Study||0
12778|NCT02439879|30923|P2|COMPLETED|Overall Study||17
12779|NCT02439879|30924|P1|COMPLETED|Overall Study||16
12780|NCT02439879|30923|P2|STARTED|Overall Study||17
12781|NCT02439879|30924|P1|STARTED|Overall Study||16
12782|NCT02439164|30932|P2|NOT COMPLETED|Overall Study||0
12783|NCT02439164|30933|P1|NOT COMPLETED|Overall Study||0
12784|NCT02439164|30932|P2|COMPLETED|Overall Study||18
12785|NCT02439164|30933|P1|COMPLETED|Overall Study||18
12786|NCT02439164|30932|P2|STARTED|Overall Study||18
12787|NCT02439164|30933|P1|STARTED|Overall Study||18
12788|NCT02439138|30946|P1|NOT COMPLETED|Overall Study||3
12789|NCT02439138|30946|P1|COMPLETED|Overall Study||2
12790|NCT02439138|30946|P1|STARTED|Overall Study||5
12791|NCT02438540|30959|P2|NOT COMPLETED|Overall Study||0
12792|NCT02438540|30960|P1|NOT COMPLETED|Overall Study||0
12793|NCT02438540|30959|P2|COMPLETED|Overall Study||20
12794|NCT02438540|30960|P1|COMPLETED|Overall Study||19
12795|NCT02438540|30959|P2|STARTED|Overall Study||20
12796|NCT02438540|30960|P1|STARTED|Overall Study||19
12797|NCT02438137|31002|P2|NOT COMPLETED|Overall Study||6
12798|NCT02438137|31003|P1|NOT COMPLETED|Overall Study||8
12799|NCT02438137|31002|P2|COMPLETED|Overall Study||15
12800|NCT02438137|31003|P1|COMPLETED|Overall Study||36
12801|NCT02438137|31002|P2|STARTED|Overall Study||21
12802|NCT02438137|31003|P1|STARTED|Overall Study||44
12803|NCT02437903|31011|P1|NOT COMPLETED|Overall Study||5
12804|NCT02437903|31011|P1|COMPLETED|Overall Study||25
12805|NCT02437903|31011|P1|STARTED|Overall Study||30
12806|NCT02437513|31019|P1|NOT COMPLETED|Overall Study||2
12807|NCT02437513|31019|P1|COMPLETED|Overall Study||0
12808|NCT02437513|31019|P1|STARTED|Overall Study||2
12809|NCT02437409|31027|P1|NOT COMPLETED|Overall Study||15
12810|NCT02437409|31027|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
12811|NCT02437409|31027|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
12812|NCT02437344|31036|P1|NOT COMPLETED|Overall Study||1
12813|NCT02437344|31036|P1|COMPLETED|Overall Study||15
12814|NCT02437344|31036|P1|STARTED|Overall Study||16
12815|NCT02437305|31042|P2|NOT COMPLETED|Overall Study||12
12816|NCT02437305|31043|P1|NOT COMPLETED|Overall Study||18
12817|NCT02437305|31042|P2|COMPLETED|Overall Study||38
12818|NCT02437305|31043|P1|COMPLETED|Overall Study||32
12819|NCT02437305|31042|P2|STARTED|Overall Study||50
12820|NCT02437305|31043|P1|STARTED|Overall Study||50
12821|NCT02437253|31053|P2|NOT COMPLETED|Overall Study||0
12822|NCT02437253|31054|P1|NOT COMPLETED|Overall Study||0
12823|NCT02437253|31053|P2|COMPLETED|Overall Study||1
12824|NCT02437253|31054|P1|COMPLETED|Overall Study||1
12825|NCT02437253|31053|P2|STARTED|Overall Study||1
12826|NCT02437253|31054|P1|STARTED|Overall Study||1
12827|NCT02437162|31071|P3|NOT COMPLETED|Overall Study||1
12828|NCT02437162|31072|P2|NOT COMPLETED|Overall Study||1
12829|NCT02437162|31073|P1|NOT COMPLETED|Overall Study||3
12830|NCT02437162|31071|P3|COMPLETED|Overall Study||114
12831|NCT02437162|31072|P2|COMPLETED|Overall Study||115
12832|NCT02437162|31073|P1|COMPLETED|Overall Study||113
12833|NCT02437162|31071|P3|Randomized and Treated|Overall Study||114
12834|NCT02437162|31072|P2|Randomized and Treated|Overall Study||116
12835|NCT02437162|31073|P1|Randomized and Treated|Overall Study||116
12836|NCT02437162|31071|P3|STARTED|Overall Study||115
12837|NCT02437162|31072|P2|STARTED|Overall Study||116
12838|NCT02437162|31073|P1|STARTED|Overall Study||116
12839|NCT02436811|31084|P3|NOT COMPLETED|Overall Study||7
12840|NCT02436811|31085|P2|NOT COMPLETED|Overall Study||9
12841|NCT02436811|31086|P1|NOT COMPLETED|Overall Study||2
12842|NCT02436811|31084|P3|COMPLETED|Overall Study||53
12843|NCT02436811|31085|P2|COMPLETED|Overall Study||51
12844|NCT02436811|31086|P1|COMPLETED|Overall Study||58
12845|NCT02436811|31084|P3|STARTED|Overall Study||60
12846|NCT02436811|31085|P2|STARTED|Overall Study||60
12847|NCT02436811|31086|P1|STARTED|Overall Study||60
12848|NCT02436577|31100|P6|NOT COMPLETED|Overall Study||0
12849|NCT02436577|31101|P5|NOT COMPLETED|Overall Study||0
12850|NCT02436577|31102|P4|NOT COMPLETED|Overall Study||0
12851|NCT02436577|31103|P3|NOT COMPLETED|Overall Study||0
12852|NCT02436577|31104|P2|NOT COMPLETED|Overall Study||1
12853|NCT02436577|31105|P1|NOT COMPLETED|Overall Study||0
12854|NCT02436577|31100|P6|COMPLETED|Overall Study||7
12855|NCT02436577|31101|P5|COMPLETED|Overall Study||7
12856|NCT02436577|31102|P4|COMPLETED|Overall Study||7
12857|NCT02436577|31103|P3|COMPLETED|Overall Study||7
12858|NCT02436577|31104|P2|COMPLETED|Overall Study||6
12859|NCT02436577|31105|P1|COMPLETED|Overall Study||7
12860|NCT02436577|31100|P6|STARTED|Overall Study||7
12861|NCT02436577|31101|P5|STARTED|Overall Study||7
12862|NCT02436577|31102|P4|STARTED|Overall Study||7
12863|NCT02436577|31103|P3|STARTED|Overall Study||7
12864|NCT02436577|31104|P2|STARTED|Overall Study||7
12865|NCT02436577|31105|P1|STARTED|Overall Study||7
12866|NCT02436330|31160|P2|NOT COMPLETED|Cohort 6||1
12867|NCT02436330|31161|P1|NOT COMPLETED|Cohort 6||3
12868|NCT02436330|31160|P2|COMPLETED|Cohort 6||4
12869|NCT02436330|31161|P1|COMPLETED|Cohort 6||1
12870|NCT02436330|31160|P2|STARTED|Cohort 6||5
12871|NCT02436330|31161|P1|STARTED|Cohort 6||4
12872|NCT02436330|31160|P2|NOT COMPLETED|Cohort 5||4
12873|NCT02436330|31161|P1|NOT COMPLETED|Cohort 5||6
12874|NCT02436330|31160|P2|COMPLETED|Cohort 5||1
12875|NCT02436330|31161|P1|COMPLETED|Cohort 5||4
12876|NCT02436330|31160|P2|STARTED|Cohort 5||5
12877|NCT02436330|31161|P1|STARTED|Cohort 5||10
12878|NCT02436330|31160|P2|NOT COMPLETED|Cohort 4||0
12879|NCT02436330|31161|P1|NOT COMPLETED|Cohort 4||2
12880|NCT02436330|31160|P2|COMPLETED|Cohort 4||0
12881|NCT02436330|31161|P1|COMPLETED|Cohort 4||4
12882|NCT02436330|31160|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
12883|NCT02436330|31161|P1|STARTED|Cohort 4||6
12884|NCT02436330|31160|P2|NOT COMPLETED|Cohort 3||0
12885|NCT02436330|31161|P1|NOT COMPLETED|Cohort 3||5
12886|NCT02436330|31160|P2|COMPLETED|Cohort 3||0
12887|NCT02436330|31161|P1|COMPLETED|Cohort 3||7
12888|NCT02436330|31160|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
12889|NCT02436330|31161|P1|STARTED|Cohort 3||12
12890|NCT02436330|31160|P2|NOT COMPLETED|Cohort 2||3
12891|NCT02436330|31161|P1|NOT COMPLETED|Cohort 2||4
12892|NCT02436330|31160|P2|COMPLETED|Cohort 2||7
12893|NCT02436330|31161|P1|COMPLETED|Cohort 2||10
12894|NCT02436330|31160|P2|STARTED|Cohort 2||10
12895|NCT02436330|31161|P1|STARTED|Cohort 2||14
12896|NCT02436330|31160|P2|NOT COMPLETED|Cohort 1||3
12897|NCT02436330|31161|P1|NOT COMPLETED|Cohort 1||5
12898|NCT02436330|31160|P2|COMPLETED|Cohort 1||1
12899|NCT02436330|31161|P1|COMPLETED|Cohort 1||9
12900|NCT02436330|31160|P2|STARTED|Cohort 1||4
12901|NCT02436330|31161|P1|STARTED|Cohort 1||14
12902|NCT02436304|31206|P3|NOT COMPLETED|Overall Study||1
12903|NCT02436304|31207|P2|NOT COMPLETED|Overall Study||2
12904|NCT02436304|31208|P1|NOT COMPLETED|Overall Study||0
12905|NCT02436304|31206|P3|COMPLETED|Overall Study||100
12906|NCT02436304|31207|P2|COMPLETED|Overall Study||100
12907|NCT02436304|31208|P1|COMPLETED|Overall Study||153
12908|NCT02436304|31206|P3|STARTED|Overall Study||101
12909|NCT02436304|31207|P2|STARTED|Overall Study||102
12910|NCT02436304|31208|P1|STARTED|Overall Study||153
12911|NCT02436031|31223|P2|NOT COMPLETED|Second Study Night||0
12912|NCT02436031|31224|P1|NOT COMPLETED|Second Study Night||0
12913|NCT02436031|31223|P2|COMPLETED|Second Study Night||8
12914|NCT02436031|31224|P1|COMPLETED|Second Study Night||7
12915|NCT02436031|31223|P2|STARTED|Second Study Night||8
12916|NCT02436031|31224|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
12917|NCT02436031|31223|P2|NOT COMPLETED|First Study Night||0
12918|NCT02436031|31224|P1|NOT COMPLETED|First Study Night||0
12919|NCT02436031|31223|P2|COMPLETED|First Study Night||8
12920|NCT02436031|31224|P1|COMPLETED|First Study Night||8
12921|NCT02436031|31223|P2|STARTED|First Study Night||8
12922|NCT02436031|31224|P1|STARTED|First Study Night||8
12923|NCT02435966|31237|P3|NOT COMPLETED|Overall Study||0
12924|NCT02435966|31238|P2|NOT COMPLETED|Overall Study||1
12925|NCT02435966|31239|P1|NOT COMPLETED|Overall Study||0
12926|NCT02435966|31237|P3|COMPLETED|Overall Study||30
12927|NCT02435966|31238|P2|COMPLETED|Overall Study||53
12928|NCT02435966|31239|P1|COMPLETED|Overall Study||47
12929|NCT02435966|31237|P3|Follow-up|Overall Study||30
12930|NCT02435966|31238|P2|Follow-up|Overall Study||53
12931|NCT02435966|31239|P1|Follow-up|Overall Study||47
12932|NCT02435966|31237|P3|Second Intervention|Overall Study||30
12933|NCT02435966|31238|P2|Second Intervention|Overall Study||53
12934|NCT02435966|31239|P1|Second Intervention|Overall Study||47
12935|NCT02435966|31237|P3|First Intervention|Overall Study||30
12936|NCT02435966|31238|P2|First Intervention|Overall Study||54
12937|NCT02435966|31239|P1|First Intervention|Overall Study||47
12938|NCT02435966|31237|P3|STARTED|Overall Study||30
12939|NCT02435966|31238|P2|STARTED|Overall Study||54
12940|NCT02435966|31239|P1|STARTED|Overall Study||47
12941|NCT02435836|31247|P1|NOT COMPLETED|Overall Study||631
12942|NCT02435836|31247|P1|COMPLETED|Overall Study||0
12943|NCT02435836|31247|P1|STARTED|Overall Study||631
12944|NCT02435277|31267|P4|NOT COMPLETED|Overall Study||0
12945|NCT02435277|31268|P3|NOT COMPLETED|Overall Study||0
12946|NCT02435277|31269|P2|NOT COMPLETED|Overall Study||1
12947|NCT02435277|31270|P1|NOT COMPLETED|Overall Study||2
12948|NCT02435277|31267|P4|COMPLETED|Overall Study||11
12949|NCT02435277|31268|P3|COMPLETED|Overall Study||11
12950|NCT02435277|31269|P2|COMPLETED|Overall Study||15
12951|NCT02435277|31270|P1|COMPLETED|Overall Study||10
12952|NCT02435277|31267|P4|STARTED|Overall Study||11
12953|NCT02435277|31268|P3|STARTED|Overall Study||11
12954|NCT02435277|31269|P2|STARTED|Overall Study||16
12955|NCT02435277|31270|P1|STARTED|Overall Study||12
12956|NCT02434939|31286|P2|NOT COMPLETED|Overall Study||49
12957|NCT02434939|31287|P1|NOT COMPLETED|Overall Study||37
12958|NCT02434939|31286|P2|COMPLETED|Overall Study||71
12959|NCT02434939|31287|P1|COMPLETED|Overall Study||83
12960|NCT02434939|31286|P2|STARTED|Overall Study||120
12961|NCT02434939|31287|P1|STARTED|Overall Study||120
12962|NCT02434523|31301|P2|NOT COMPLETED|Overall Study||6
12963|NCT02434523|31302|P1|NOT COMPLETED|Overall Study||5
12964|NCT02434523|31301|P2|COMPLETED|Overall Study||9
12965|NCT02434523|31302|P1|COMPLETED|Overall Study||10
12966|NCT02434523|31301|P2|STARTED|Overall Study||15
12967|NCT02434523|31302|P1|STARTED|Overall Study||15
12968|NCT02434497|31314|P1|NOT COMPLETED|Overall Study||5
12969|NCT02434497|31314|P1|COMPLETED|Overall Study||4
12970|NCT02434497|31314|P1|STARTED|Overall Study||9
12971|NCT02434471|31414|P1|NOT COMPLETED|Overall Study||9
12972|NCT02434471|31414|P1|COMPLETED|Overall Study||25
12973|NCT02434471|31414|P1|STARTED|Overall Study||34
12974|NCT02434146|31421|P1|NOT COMPLETED|Overall Study||0
12975|NCT02434146|31421|P1|COMPLETED|Overall Study||3
12976|NCT02434146|31421|P1|STARTED|Overall Study||3
12977|NCT02433834|31433|P1|NOT COMPLETED|Overall Study||37
12978|NCT02433834|31433|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
12979|NCT02433834|31433|P1|SAL 50 µg|Overall Study||167
12980|NCT02433834|31433|P1|Placebo MDI|Overall Study||174
12981|NCT02433834|31433|P1|GP MDI 1.9 µg|Overall Study||107
12982|NCT02433834|31433|P1|GP MDI 3.6 µg|Overall Study||118
12983|NCT02433834|31433|P1|GP MDI 7.2 µg|Overall Study||228
12984|NCT02433834|31433|P1|GP MDI 14.4 µg|Overall Study||230
12985|NCT02433834|31433|P1|GP MDI 28.8 µg|Overall Study||112
12986|NCT02433834|31433|P1|STARTED|Overall Study||248
12987|NCT02433483|31491|P1|NOT COMPLETED|Overall Study||2
12988|NCT02433483|31491|P1|COMPLETED|Overall Study||0
12989|NCT02433483|31491|P1|STARTED|Overall Study||2
12990|NCT02433366|31505|P2|NOT COMPLETED|Overall Study||0
12991|NCT02433366|31506|P1|NOT COMPLETED|Overall Study||0
12992|NCT02433366|31505|P2|COMPLETED|Overall Study||802
12993|NCT02433366|31506|P1|COMPLETED|Overall Study||411
12994|NCT02433366|31505|P2|STARTED|Overall Study||802
12995|NCT02433366|31506|P1|STARTED|Overall Study||411
12996|NCT02433340|31518|P4|NOT COMPLETED|Overall Study||2
12997|NCT02433340|31519|P3|NOT COMPLETED|Overall Study||2
12998|NCT02433340|31520|P2|NOT COMPLETED|Overall Study||2
12999|NCT02433340|31521|P1|NOT COMPLETED|Overall Study||2
13000|NCT02433340|31518|P4|COMPLETED|Overall Study||38
13001|NCT02433340|31519|P3|COMPLETED|Overall Study||37
13002|NCT02433340|31520|P2|COMPLETED|Overall Study||35
13003|NCT02433340|31521|P1|COMPLETED|Overall Study||40
13004|NCT02433340|31518|P4|STARTED|Overall Study||40
13005|NCT02433340|31519|P3|STARTED|Overall Study||39
13006|NCT02433340|31520|P2|STARTED|Overall Study||37
13007|NCT02433340|31521|P1|STARTED|Overall Study||42
13008|NCT02432300|32413|P1|NOT COMPLETED|Overall Study||4
13009|NCT02432300|32413|P1|COMPLETED|Overall Study||13
13010|NCT02432300|32413|P1|STARTED|Overall Study||17
13011|NCT02432287|32422|P2|NOT COMPLETED|Second Intervention||0
13012|NCT02432287|32423|P1|NOT COMPLETED|Second Intervention||0
13013|NCT02432287|32422|P2|COMPLETED|Second Intervention||7
13014|NCT02432287|32423|P1|COMPLETED|Second Intervention||7
13015|NCT02432287|32422|P2|STARTED|Second Intervention||7
13016|NCT02432287|32423|P1|STARTED|Second Intervention||7
13017|NCT02432287|32422|P2|NOT COMPLETED|Washout Period||0
13018|NCT02432287|32423|P1|NOT COMPLETED|Washout Period||0
13019|NCT02432287|32422|P2|COMPLETED|Washout Period||7
13020|NCT02432287|32423|P1|COMPLETED|Washout Period||7
13021|NCT02432287|32422|P2|STARTED|Washout Period||7
13022|NCT02432287|32423|P1|STARTED|Washout Period||7
13023|NCT02432287|32422|P2|NOT COMPLETED|First Intervention||1
13024|NCT02432287|32423|P1|NOT COMPLETED|First Intervention||0
13025|NCT02432287|32422|P2|COMPLETED|First Intervention||7
13026|NCT02432287|32423|P1|COMPLETED|First Intervention||8
13027|NCT02432287|32422|P2|STARTED|First Intervention||8
13028|NCT02432287|32423|P1|STARTED|First Intervention||8
13029|NCT02432105|32434|P3|NOT COMPLETED|Overall Study||3
13030|NCT02432105|32435|P2|NOT COMPLETED|Overall Study||2
13031|NCT02432105|32436|P1|NOT COMPLETED|Overall Study||2
13032|NCT02432105|32434|P3|COMPLETED|Overall Study||108
13033|NCT02432105|32435|P2|COMPLETED|Overall Study||108
13034|NCT02432105|32436|P1|COMPLETED|Overall Study||162
13035|NCT02432105|32434|P3|STARTED|Overall Study||111
13036|NCT02432105|32435|P2|STARTED|Overall Study||110
13037|NCT02432105|32436|P1|STARTED|Overall Study||164
13038|NCT02432040|32453|P2|NOT COMPLETED|Overall Study||6
13039|NCT02432040|32454|P1|NOT COMPLETED|Overall Study||8
13040|NCT02432040|32453|P2|COMPLETED|Overall Study||8
13041|NCT02432040|32454|P1|COMPLETED|Overall Study||6
13042|NCT02432040|32453|P2|STARTED|Overall Study||14
13043|NCT02432040|32454|P1|STARTED|Overall Study||14
13044|NCT02431754|32476|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
13045|NCT02431754|32477|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
13046|NCT02431754|32476|P2|COMPLETED|Period 2 (8 Weeks)||78
13047|NCT02431754|32477|P1|COMPLETED|Period 2 (8 Weeks)||74
13048|NCT02431754|32476|P2|STARTED|Period 2 (8 Weeks)||82
13049|NCT02431754|32477|P1|STARTED|Period 2 (8 Weeks)||75
13050|NCT02431754|32476|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
13051|NCT02431754|32477|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
13052|NCT02431754|32476|P2|COMPLETED|Wash-out Period (4 Weeks)||82
13053|NCT02431754|32477|P1|COMPLETED|Wash-out Period (4 Weeks)||75
13054|NCT02431754|32476|P2|STARTED|Wash-out Period (4 Weeks)||82
13055|NCT02431754|32477|P1|STARTED|Wash-out Period (4 Weeks)||79
13056|NCT02431754|32476|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
13057|NCT02431754|32477|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
13058|NCT02431754|32476|P2|COMPLETED|Period 1 (8 Weeks)||82
13059|NCT02431754|32477|P1|COMPLETED|Period 1 (8 Weeks)||79
13060|NCT02431754|32476|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
13061|NCT02431754|32477|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
13062|NCT02431754|32476|P2|STARTED|Period 1 (8 Weeks)||86
13063|NCT02431754|32477|P1|STARTED|Period 1 (8 Weeks)||85
13064|NCT02431741|32495|P1|NOT COMPLETED|Overall Study||0
13065|NCT02431741|32495|P1|COMPLETED|Overall Study||14
13066|NCT02431741|32495|P1|STARTED|Overall Study||14
13067|NCT02431598|32499|P6|NOT COMPLETED|Overall Study||0
13068|NCT02431598|32500|P5|NOT COMPLETED|Overall Study||0
13069|NCT02431598|32501|P4|NOT COMPLETED|Overall Study||0
13070|NCT02431598|32502|P3|NOT COMPLETED|Overall Study||0
13071|NCT02431598|32503|P2|NOT COMPLETED|Overall Study||0
13072|NCT02431598|32504|P1|NOT COMPLETED|Overall Study||0
13073|NCT02431598|32499|P6|COMPLETED|Overall Study||6
13074|NCT02431598|32500|P5|COMPLETED|Overall Study||7
13075|NCT02431598|32501|P4|COMPLETED|Overall Study||7
13076|NCT02431598|32502|P3|COMPLETED|Overall Study||9
13077|NCT02431598|32503|P2|COMPLETED|Overall Study||9
13078|NCT02431598|32504|P1|COMPLETED|Overall Study||6
13079|NCT02431598|32499|P6|STARTED|Overall Study||6
13080|NCT02431598|32500|P5|STARTED|Overall Study||7
13081|NCT02431598|32501|P4|STARTED|Overall Study||7
13082|NCT02431598|32502|P3|STARTED|Overall Study||9
13083|NCT02431598|32503|P2|STARTED|Overall Study||9
13084|NCT02431598|32504|P1|STARTED|Overall Study||6
13085|NCT02431455|32530|P2|NOT COMPLETED|Overall Study||0
13086|NCT02431455|32531|P1|NOT COMPLETED|Overall Study||0
13087|NCT02431455|32530|P2|COMPLETED|Overall Study||112
13088|NCT02431455|32531|P1|COMPLETED|Overall Study||112
13089|NCT02431455|32530|P2|STARTED|Overall Study||112
13090|NCT02431455|32531|P1|STARTED|Overall Study||112
13091|NCT02431299|32545|P2|NOT COMPLETED|Overall Study||1
13092|NCT02431299|32546|P1|NOT COMPLETED|Overall Study||53
13093|NCT02431299|32545|P2|COMPLETED|Overall Study||62
13094|NCT02431299|32546|P1|COMPLETED|Overall Study||183
13095|NCT02431299|32545|P2|STARTED|Overall Study||63
13096|NCT02431299|32546|P1|STARTED|Overall Study||236
13097|NCT02430870|32567|P8|NOT COMPLETED|Part 2||1
13098|NCT02430870|32568|P7|NOT COMPLETED|Part 2||1
13099|NCT02430870|32569|P6|NOT COMPLETED|Part 2||0
13100|NCT02430870|32570|P5|NOT COMPLETED|Part 2||0
13101|NCT02430870|32571|P4|NOT COMPLETED|Part 2||0
13102|NCT02430870|32572|P3|NOT COMPLETED|Part 2||0
13103|NCT02430870|32573|P2|NOT COMPLETED|Part 2||0
13104|NCT02430870|32574|P1|NOT COMPLETED|Part 2||0
13105|NCT02430870|32567|P8|COMPLETED|Part 2||7
13106|NCT02430870|32568|P7|COMPLETED|Part 2||5
13107|NCT02430870|32569|P6|COMPLETED|Part 2||6
13108|NCT02430870|32570|P5|COMPLETED|Part 2||6
13109|NCT02430870|32571|P4|COMPLETED|Part 2||6
13110|NCT02430870|32572|P3|COMPLETED|Part 2||0
13111|NCT02430870|32573|P2|COMPLETED|Part 2||0
13112|NCT02430870|32574|P1|COMPLETED|Part 2||0
13113|NCT02430870|32567|P8|STARTED|Part 2||8
13114|NCT02430870|32568|P7|STARTED|Part 2||6
13115|NCT02430870|32569|P6|STARTED|Part 2||6
13116|NCT02430870|32570|P5|STARTED|Part 2||6
13117|NCT02430870|32571|P4|STARTED|Part 2||6
13118|NCT02430870|32572|P3|STARTED|Part 2||0
13119|NCT02430870|32573|P2|STARTED|Part 2||0
13120|NCT02430870|32574|P1|STARTED|Part 2||0
13121|NCT02430870|32567|P8|NOT COMPLETED|Part 1||0
13122|NCT02430870|32568|P7|NOT COMPLETED|Part 1||0
13123|NCT02430870|32569|P6|NOT COMPLETED|Part 1||0
13124|NCT02430870|32570|P5|NOT COMPLETED|Part 1||0
13125|NCT02430870|32571|P4|NOT COMPLETED|Part 1||0
13126|NCT02430870|32572|P3|NOT COMPLETED|Part 1||0
13127|NCT02430870|32573|P2|NOT COMPLETED|Part 1||0
13128|NCT02430870|32574|P1|NOT COMPLETED|Part 1||0
13129|NCT02430870|32567|P8|COMPLETED|Part 1||0
13130|NCT02430870|32568|P7|COMPLETED|Part 1||0
13131|NCT02430870|32569|P6|COMPLETED|Part 1||0
13132|NCT02430870|32570|P5|COMPLETED|Part 1||0
13133|NCT02430870|32571|P4|COMPLETED|Part 1||0
13134|NCT02430870|32572|P3|COMPLETED|Part 1||4
13135|NCT02430870|32573|P2|COMPLETED|Part 1||6
13136|NCT02430870|32574|P1|COMPLETED|Part 1||6
13137|NCT02430870|32567|P8|STARTED|Part 1||0
13138|NCT02430870|32568|P7|STARTED|Part 1||0
13139|NCT02430870|32569|P6|STARTED|Part 1||0
13140|NCT02430870|32570|P5|STARTED|Part 1||0
13141|NCT02430870|32571|P4|STARTED|Part 1||0
13142|NCT02430870|32572|P3|STARTED|Part 1||4
13143|NCT02430870|32573|P2|STARTED|Part 1||6
13144|NCT02430870|32574|P1|STARTED|Part 1||6
13145|NCT02430532|32648|P2|NOT COMPLETED|Overall Study||28
13146|NCT02430532|32649|P1|NOT COMPLETED|Overall Study||30
13147|NCT02430532|32648|P2|COMPLETED|Overall Study||0
13148|NCT02430532|32649|P1|COMPLETED|Overall Study||0
13149|NCT02430532|32648|P2|STARTED|Overall Study||28
13150|NCT02430532|32649|P1|STARTED|Overall Study||30
13151|NCT02430389|32665|P2|NOT COMPLETED|Overall Study||0
13152|NCT02430389|32666|P1|NOT COMPLETED|Overall Study||0
13153|NCT02430389|32665|P2|COMPLETED|Overall Study||10
13154|NCT02430389|32666|P1|COMPLETED|Overall Study||10
13155|NCT02430389|32665|P2|STARTED|Overall Study||10
13156|NCT02430389|32666|P1|STARTED|Overall Study||10
13157|NCT02430090|32677|P3|NOT COMPLETED|Overall Study||0
13158|NCT02430090|32678|P2|NOT COMPLETED|Overall Study||0
13159|NCT02430090|32679|P1|NOT COMPLETED|Overall Study||0
13160|NCT02430090|32677|P3|COMPLETED|Overall Study||15
13161|NCT02430090|32678|P2|COMPLETED|Overall Study||15
13162|NCT02430090|32679|P1|COMPLETED|Overall Study||15
13163|NCT02430090|32677|P3|STARTED|Overall Study||15
13164|NCT02430090|32678|P2|STARTED|Overall Study||15
13165|NCT02430090|32679|P1|STARTED|Overall Study||15
13166|NCT02429791|32689|P2|NOT COMPLETED|Overall Study||18
13167|NCT02429791|32690|P1|NOT COMPLETED|Overall Study||13
13168|NCT02429791|32689|P2|COMPLETED|Overall Study||238
13169|NCT02429791|32690|P1|COMPLETED|Overall Study||239
13170|NCT02429791|32689|P2|STARTED|Overall Study||256
13171|NCT02429791|32690|P1|STARTED|Overall Study||252
13172|NCT02429258|32762|P2|NOT COMPLETED|Overall Study||1
13173|NCT02429258|32763|P1|NOT COMPLETED|Overall Study||2
13174|NCT02429258|32762|P2|COMPLETED|Overall Study||49
13175|NCT02429258|32763|P1|COMPLETED|Overall Study||48
13176|NCT02429258|32762|P2|STARTED|Overall Study||50
13177|NCT02429258|32763|P1|STARTED|Overall Study||50
13178|NCT02428478|32789|P2|NOT COMPLETED|Second Study Night||0
13179|NCT02428478|32790|P1|NOT COMPLETED|Second Study Night||0
13180|NCT02428478|32789|P2|COMPLETED|Second Study Night||6
13181|NCT02428478|32790|P1|COMPLETED|Second Study Night||8
13182|NCT02428478|32789|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
13183|NCT02428478|32790|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
13184|NCT02428478|32789|P2|NOT COMPLETED|First Study Night||0
13185|NCT02428478|32790|P1|NOT COMPLETED|First Study Night||0
13186|NCT02428478|32789|P2|COMPLETED|First Study Night||8
13187|NCT02428478|32790|P1|COMPLETED|First Study Night||9
13188|NCT02428478|32789|P2|STARTED|First Study Night||8
13189|NCT02428478|32790|P1|STARTED|First Study Night||9
13190|NCT02428413|32800|P2|NOT COMPLETED|Overall Study||9
13191|NCT02428413|32801|P1|NOT COMPLETED|Overall Study||8
13192|NCT02428413|32800|P2|COMPLETED|Overall Study||52
13193|NCT02428413|32801|P1|COMPLETED|Overall Study||56
13194|NCT02428413|32800|P2|STARTED|Overall Study||61
13195|NCT02428413|32801|P1|STARTED|Overall Study||64
13196|NCT02428231|32815|P2|NOT COMPLETED|Overall Study||17
13197|NCT02428231|32816|P1|NOT COMPLETED|Overall Study||13
13198|NCT02428231|32815|P2|COMPLETED|Overall Study||15
13199|NCT02428231|32816|P1|COMPLETED|Overall Study||17
13200|NCT02428231|32815|P2|STARTED|Overall Study||32
13201|NCT02428231|32816|P1|STARTED|Overall Study||30
13202|NCT02427984|32833|P3|NOT COMPLETED|Overall Study||18
13203|NCT02427984|32834|P2|NOT COMPLETED|Overall Study||5
13204|NCT02427984|32835|P1|NOT COMPLETED|Overall Study||13
13205|NCT02427984|32833|P3|COMPLETED|Overall Study||32
13206|NCT02427984|32834|P2|COMPLETED|Overall Study||40
13207|NCT02427984|32835|P1|COMPLETED|Overall Study||40
13208|NCT02427984|32833|P3|STARTED|Overall Study||50
13209|NCT02427984|32834|P2|STARTED|Overall Study||45
13210|NCT02427984|32835|P1|STARTED|Overall Study||53
13211|NCT02427750|32851|P2|NOT COMPLETED|Overall Study||0
13212|NCT02427750|32852|P1|NOT COMPLETED|Overall Study||0
13213|NCT02427750|32851|P2|COMPLETED|Overall Study||63
13214|NCT02427750|32852|P1|COMPLETED|Overall Study||63
13215|NCT02427750|32851|P2|STARTED|Overall Study||63
13216|NCT02427750|32852|P1|STARTED|Overall Study||63
13217|NCT02427477|32877|P2|NOT COMPLETED|Period 3||0
13218|NCT02427477|32878|P1|NOT COMPLETED|Period 3||0
13219|NCT02427477|32877|P2|COMPLETED|Period 3||60
13220|NCT02427477|32878|P1|COMPLETED|Period 3||59
13221|NCT02427477|32877|P2|STARTED|Period 3||60
13222|NCT02427477|32878|P1|STARTED|Period 3||59
13223|NCT02427477|32877|P2|NOT COMPLETED|Period 2||0
13224|NCT02427477|32878|P1|NOT COMPLETED|Period 2||0
13225|NCT02427477|32877|P2|COMPLETED|Period 2||60
13226|NCT02427477|32878|P1|COMPLETED|Period 2||59
13227|NCT02427477|32877|P2|STARTED|Period 2||60
13228|NCT02427477|32878|P1|STARTED|Period 2||59
13229|NCT02427477|32877|P2|NOT COMPLETED|Period 1||0
13230|NCT02427477|32878|P1|NOT COMPLETED|Period 1||1
13231|NCT02427477|32877|P2|COMPLETED|Period 1||60
13232|NCT02427477|32878|P1|COMPLETED|Period 1||59
13233|NCT02427477|32877|P2|STARTED|Period 1||60
13234|NCT02427477|32878|P1|STARTED|Period 1||60
13235|NCT02427399|32891|P5|NOT COMPLETED|Overall Study||15
13236|NCT02427399|32892|P4|NOT COMPLETED|Overall Study||18
13237|NCT02427399|32893|P3|NOT COMPLETED|Overall Study||12
13238|NCT02427399|32894|P2|NOT COMPLETED|Overall Study||16
13239|NCT02427399|32895|P1|NOT COMPLETED|Overall Study||14
13240|NCT02427399|32891|P5|COMPLETED|Overall Study||205
13241|NCT02427399|32892|P4|COMPLETED|Overall Study||202
13242|NCT02427399|32893|P3|COMPLETED|Overall Study||208
13243|NCT02427399|32894|P2|COMPLETED|Overall Study||204
13244|NCT02427399|32895|P1|COMPLETED|Overall Study||206
13245|NCT02427399|32891|P5|STARTED|Overall Study||220
13246|NCT02427399|32892|P4|STARTED|Overall Study||220
13247|NCT02427399|32893|P3|STARTED|Overall Study||220
13248|NCT02427399|32894|P2|STARTED|Overall Study||220
13249|NCT02427399|32895|P1|STARTED|Overall Study||220
13250|NCT02426541|32919|P2|NOT COMPLETED|Overall Study||0
13251|NCT02426541|32920|P1|NOT COMPLETED|Overall Study||1
13252|NCT02426541|32919|P2|COMPLETED|Overall Study||16
13253|NCT02426541|32920|P1|COMPLETED|Overall Study||15
13254|NCT02426541|32919|P2|STARTED|Overall Study||16
13255|NCT02426541|32920|P1|STARTED|Overall Study||16
13256|NCT02425956|32930|P1|NOT COMPLETED|Overall Study||0
13257|NCT02425956|32930|P1|COMPLETED|Overall Study||21
13258|NCT02425956|32930|P1|STARTED|Overall Study||21
13259|NCT02425826|32937|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
13260|NCT02425826|32938|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
13261|NCT02425826|32939|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
13262|NCT02425826|32937|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
13263|NCT02425826|32938|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
13264|NCT02425826|32939|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
13265|NCT02425826|32937|P3|STARTED|Post-Treatment Observational Follow-Up||49
13266|NCT02425826|32938|P2|STARTED|Post-Treatment Observational Follow-Up||0
13267|NCT02425826|32939|P1|STARTED|Post-Treatment Observational Follow-Up||81
13268|NCT02425826|32937|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
13269|NCT02425826|32938|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
13270|NCT02425826|32939|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
13271|NCT02425826|32937|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
13272|NCT02425826|32938|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
13273|NCT02425826|32939|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
13274|NCT02425826|32937|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
13275|NCT02425826|32938|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
13276|NCT02425826|32939|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
13277|NCT02425826|32937|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
13278|NCT02425826|32938|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
13279|NCT02425826|32939|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
13280|NCT02425826|32937|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
13281|NCT02425826|32938|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
13282|NCT02425826|32939|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
13283|NCT02425826|32937|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
13284|NCT02425826|32938|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
13285|NCT02425826|32939|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
13286|NCT02425826|32937|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
13287|NCT02425826|32938|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
13288|NCT02425826|32939|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
13289|NCT02425826|32937|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
13290|NCT02425826|32938|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
13291|NCT02425826|32939|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
13292|NCT02425449|32977|P5|NOT COMPLETED|Overall Study||0
13293|NCT02425449|32978|P4|NOT COMPLETED|Overall Study||0
13294|NCT02425449|32979|P3|NOT COMPLETED|Overall Study||0
13295|NCT02425449|32980|P2|NOT COMPLETED|Overall Study||0
13296|NCT02425449|32981|P1|NOT COMPLETED|Overall Study||0
13297|NCT02425449|32977|P5|COMPLETED|Overall Study||5
13298|NCT02425449|32978|P4|COMPLETED|Overall Study||5
13299|NCT02425449|32979|P3|COMPLETED|Overall Study||5
13300|NCT02425449|32980|P2|COMPLETED|Overall Study||4
13301|NCT02425449|32981|P1|COMPLETED|Overall Study||0
13302|NCT02425449|32977|P5|STARTED|Overall Study||5
13303|NCT02425449|32978|P4|STARTED|Overall Study||5
13304|NCT02425449|32979|P3|STARTED|Overall Study||5
13305|NCT02425449|32980|P2|STARTED|Overall Study||4
13306|NCT02425449|32981|P1|STARTED|Overall Study||0
13307|NCT02424591|32995|P2|NOT COMPLETED|Overall Study||3
13308|NCT02424591|32996|P1|NOT COMPLETED|Overall Study||2
13309|NCT02424591|32995|P2|COMPLETED|Overall Study||20
13310|NCT02424591|32996|P1|COMPLETED|Overall Study||20
13311|NCT02424591|32995|P2|STARTED|Overall Study||23
13312|NCT02424591|32996|P1|STARTED|Overall Study||22
13313|NCT02424578|33008|P2|NOT COMPLETED|Overall Study||1
13314|NCT02424578|33009|P1|NOT COMPLETED|Overall Study||0
13315|NCT02424578|33008|P2|COMPLETED|Overall Study||14
13316|NCT02424578|33009|P1|COMPLETED|Overall Study||15
13317|NCT02424578|33008|P2|STARTED|Overall Study||15
13318|NCT02424578|33009|P1|STARTED|Overall Study||15
13319|NCT02424565|33015|P2|NOT COMPLETED|Period 2 (D3)||0
13320|NCT02424565|33016|P1|NOT COMPLETED|Period 2 (D3)||0
13321|NCT02424565|33015|P2|COMPLETED|Period 2 (D3)||6
13322|NCT02424565|33016|P1|COMPLETED|Period 2 (D3)||8
13323|NCT02424565|33015|P2|STARTED|Period 2 (D3)||6
13324|NCT02424565|33016|P1|STARTED|Period 2 (D3)||8
13325|NCT02424565|33015|P2|NOT COMPLETED|Washout Period||0
13326|NCT02424565|33016|P1|NOT COMPLETED|Washout Period||0
13327|NCT02424565|33015|P2|COMPLETED|Washout Period||6
13328|NCT02424565|33016|P1|COMPLETED|Washout Period||8
13329|NCT02424565|33015|P2|STARTED|Washout Period||6
13330|NCT02424565|33016|P1|STARTED|Washout Period||8
13331|NCT02424565|33015|P2|NOT COMPLETED|Period 1 (D0)||1
13332|NCT02424565|33016|P1|NOT COMPLETED|Period 1 (D0)||0
13333|NCT02424565|33015|P2|COMPLETED|Period 1 (D0)||6
13334|NCT02424565|33016|P1|COMPLETED|Period 1 (D0)||8
13335|NCT02424565|33015|P2|STARTED|Period 1 (D0)||7
13336|NCT02424565|33016|P1|STARTED|Period 1 (D0)||8
13337|NCT02424357|33024|P2|NOT COMPLETED|Overall Study||0
13338|NCT02424357|33025|P1|NOT COMPLETED|Overall Study||0
13339|NCT02424357|33024|P2|COMPLETED|Overall Study||30
13340|NCT02424357|33025|P1|COMPLETED|Overall Study||35
13341|NCT02424357|33024|P2|STARTED|Overall Study||30
13342|NCT02424357|33025|P1|STARTED|Overall Study||35
13343|NCT02424149|33035|P2|NOT COMPLETED|Overall Study||1
13344|NCT02424149|33036|P1|NOT COMPLETED|Overall Study||2
13345|NCT02424149|33035|P2|COMPLETED|Overall Study||52
13346|NCT02424149|33036|P1|COMPLETED|Overall Study||52
13347|NCT02424149|33035|P2|STARTED|Overall Study||53
13348|NCT02424149|33036|P1|STARTED|Overall Study||54
13349|NCT02423993|33054|P4|NOT COMPLETED|Overall Study||0
13350|NCT02423993|33055|P3|NOT COMPLETED|Overall Study||0
13351|NCT02423993|33056|P2|NOT COMPLETED|Overall Study||0
13352|NCT02423993|33057|P1|NOT COMPLETED|Overall Study||0
13353|NCT02423993|33054|P4|COMPLETED|Overall Study||19
13354|NCT02423993|33055|P3|COMPLETED|Overall Study||23
13355|NCT02423993|33056|P2|COMPLETED|Overall Study||16
13356|NCT02423993|33057|P1|COMPLETED|Overall Study||19
13357|NCT02423993|33054|P4|STARTED|Overall Study||19
13358|NCT02423993|33055|P3|STARTED|Overall Study||23
13359|NCT02423993|33056|P2|STARTED|Overall Study||16
13360|NCT02423993|33057|P1|STARTED|Overall Study||19
13361|NCT02423980|33087|P1|NOT COMPLETED|Overall Study||0
13362|NCT02423980|33087|P1|COMPLETED|Overall Study||7
13363|NCT02423980|33087|P1|STARTED|Overall Study||7
13364|NCT02423798|33097|P1|NOT COMPLETED|Overall Study||3
13365|NCT02423798|33097|P1|COMPLETED|Overall Study||21
13366|NCT02423798|33097|P1|STARTED|Overall Study||24
13367|NCT02423577|33105|P2|NOT COMPLETED|Overall Study||0
13368|NCT02423577|33106|P1|NOT COMPLETED|Overall Study||0
13369|NCT02423577|33105|P2|COMPLETED|Overall Study||26
13370|NCT02423577|33106|P1|COMPLETED|Overall Study||53
13371|NCT02423577|33105|P2|STARTED|Overall Study||26
13372|NCT02423577|33106|P1|STARTED|Overall Study||53
13373|NCT02423447|33112|P2|NOT COMPLETED|Overall Study||0
13374|NCT02423447|33113|P1|NOT COMPLETED|Overall Study||0
13375|NCT02423447|33112|P2|COMPLETED|Overall Study||12
13376|NCT02423447|33113|P1|COMPLETED|Overall Study||13
13377|NCT02423447|33112|P2|STARTED|Overall Study||12
13378|NCT02423447|33113|P1|STARTED|Overall Study||13
13379|NCT02423408|33129|P2|NOT COMPLETED|Overall Study||2
13380|NCT02423408|33130|P1|NOT COMPLETED|Overall Study||1
13381|NCT02423408|33129|P2|COMPLETED|Overall Study||80
13382|NCT02423408|33130|P1|COMPLETED|Overall Study||82
13383|NCT02423408|33129|P2|STARTED|Overall Study||82
13384|NCT02423408|33130|P1|STARTED|Overall Study||83
13385|NCT02423317|33144|P2|NOT COMPLETED|Overall Study||0
13386|NCT02423317|33145|P1|NOT COMPLETED|Overall Study||0
13387|NCT02423317|33144|P2|COMPLETED|Overall Study||30
13388|NCT02423317|33145|P1|COMPLETED|Overall Study||30
13389|NCT02423317|33144|P2|STARTED|Overall Study||30
13390|NCT02423317|33145|P1|STARTED|Overall Study||30
13391|NCT02423291|33163|P1|NOT COMPLETED|Overall Study||15
13392|NCT02423291|33163|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
13393|NCT02423291|33163|P1|STARTED|Overall Study|Patients enrolled|15
13394|NCT02423200|33169|P2|NOT COMPLETED|Overall Study||0
13395|NCT02423200|33170|P1|NOT COMPLETED|Overall Study||1
13396|NCT02423200|33169|P2|COMPLETED|Overall Study||1
13397|NCT02423200|33170|P1|COMPLETED|Overall Study||7
13398|NCT02423200|33169|P2|STARTED|Overall Study||1
13399|NCT02423200|33170|P1|STARTED|Overall Study||8
13400|NCT02423109|33178|P2|NOT COMPLETED|Lens 2||0
13401|NCT02423109|33179|P1|NOT COMPLETED|Lens 2||0
13402|NCT02423109|33178|P2|COMPLETED|Lens 2||14
13403|NCT02423109|33179|P1|COMPLETED|Lens 2||18
13404|NCT02423109|33178|P2|STARTED|Lens 2||14
13405|NCT02423109|33179|P1|STARTED|Lens 2||18
13406|NCT02423109|33178|P2|NOT COMPLETED|Lens 1||0
13407|NCT02423109|33179|P1|NOT COMPLETED|Lens 1||1
13408|NCT02423109|33178|P2|COMPLETED|Lens 1||14
13409|NCT02423109|33179|P1|COMPLETED|Lens 1||18
13410|NCT02423109|33178|P2|STARTED|Lens 1||14
13411|NCT02423109|33179|P1|STARTED|Lens 1||19
13412|NCT02422797|33189|P2|NOT COMPLETED|Overall Study||16
13413|NCT02422797|33190|P1|NOT COMPLETED|Overall Study||16
13414|NCT02422797|33189|P2|COMPLETED|Overall Study||239
13415|NCT02422797|33190|P1|COMPLETED|Overall Study||245
13416|NCT02422797|33189|P2|STARTED|Overall Study||255
13417|NCT02422797|33190|P1|STARTED|Overall Study||261
13418|NCT02422303|33262|P2|NOT COMPLETED|Overall Study||1
13419|NCT02422303|33263|P1|NOT COMPLETED|Overall Study||1
13420|NCT02422303|33262|P2|COMPLETED|Overall Study||5
13421|NCT02422303|33263|P1|COMPLETED|Overall Study||5
13422|NCT02422303|33262|P2|STARTED|Overall Study||6
13423|NCT02422303|33263|P1|STARTED|Overall Study||6
13424|NCT02421419|33272|P3|NOT COMPLETED|Overall Study||1
13425|NCT02421419|33273|P2|NOT COMPLETED|Overall Study||0
13426|NCT02421419|33274|P1|NOT COMPLETED|Overall Study||0
13427|NCT02421419|33272|P3|COMPLETED|Overall Study||8
13428|NCT02421419|33273|P2|COMPLETED|Overall Study||11
13429|NCT02421419|33274|P1|COMPLETED|Overall Study||6
13430|NCT02421419|33272|P3|STARTED|Overall Study||9
13431|NCT02421419|33273|P2|STARTED|Overall Study||11
13432|NCT02421419|33274|P1|STARTED|Overall Study||6
13433|NCT02421211|33293|P2|NOT COMPLETED|Overall Study||0
13434|NCT02421211|33294|P1|NOT COMPLETED|Overall Study||0
13435|NCT02421211|33293|P2|COMPLETED|Overall Study||20
13436|NCT02421211|33294|P1|COMPLETED|Overall Study||20
13437|NCT02421211|33293|P2|STARTED|Overall Study||20
13438|NCT02421211|33294|P1|STARTED|Overall Study||20
13439|NCT02421146|33342|P4|NOT COMPLETED|Overall Study||0
13440|NCT02421146|33343|P3|NOT COMPLETED|Overall Study||0
13441|NCT02421146|33344|P2|NOT COMPLETED|Overall Study||0
13442|NCT02421146|33345|P1|NOT COMPLETED|Overall Study||0
13443|NCT02421146|33342|P4|COMPLETED|Overall Study||3
13444|NCT02421146|33343|P3|COMPLETED|Overall Study||3
13445|NCT02421146|33344|P2|COMPLETED|Overall Study||4
13446|NCT02421146|33345|P1|COMPLETED|Overall Study||2
13447|NCT02421146|33342|P4|STARTED|Overall Study||3
13448|NCT02421146|33343|P3|STARTED|Overall Study||3
13449|NCT02421146|33344|P2|STARTED|Overall Study||4
13450|NCT02421146|33345|P1|STARTED|Overall Study||2
13451|NCT02421120|33359|P1|NOT COMPLETED|Overall Study||1
13452|NCT02421120|33359|P1|COMPLETED|Overall Study||20
13453|NCT02421120|33359|P1|STARTED|Overall Study||21
13454|NCT02420951|33369|P2|NOT COMPLETED|Overall Study||0
13455|NCT02420951|33370|P1|NOT COMPLETED|Overall Study||0
13456|NCT02420951|33369|P2|COMPLETED|Overall Study||25
13457|NCT02420951|33370|P1|COMPLETED|Overall Study||25
13458|NCT02420951|33369|P2|STARTED|Overall Study||25
13459|NCT02420951|33370|P1|STARTED|Overall Study||25
13460|NCT02420262|33388|P2|NOT COMPLETED|Overall Study||5
13461|NCT02420262|33389|P1|NOT COMPLETED|Overall Study||2
13462|NCT02420262|33388|P2|COMPLETED|Overall Study||249
13463|NCT02420262|33389|P1|COMPLETED|Overall Study||250
13464|NCT02420262|33388|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
13465|NCT02420262|33389|P1|Exposed|Overall Study||252
13466|NCT02420262|33388|P2|STARTED|Overall Study||254
13467|NCT02420262|33389|P1|STARTED|Overall Study||252
13468|NCT02420210|33403|P1|NOT COMPLETED|Overall Study||0
13469|NCT02420210|33403|P1|COMPLETED|Overall Study||2
13470|NCT02420210|33403|P1|STARTED|Overall Study||2
13471|NCT02420093|33415|P2|NOT COMPLETED|Overall Study||1
13472|NCT02420093|33416|P1|NOT COMPLETED|Overall Study||1
13473|NCT02420093|33415|P2|COMPLETED|Overall Study||7
13474|NCT02420093|33416|P1|COMPLETED|Overall Study||8
13475|NCT02420093|33415|P2|STARTED|Overall Study||8
13476|NCT02420093|33416|P1|STARTED|Overall Study||9
13477|NCT02420041|33432|P2|NOT COMPLETED|Overall Study||0
13478|NCT02420041|33433|P1|NOT COMPLETED|Overall Study||0
13479|NCT02420041|33432|P2|COMPLETED|Overall Study||14
13480|NCT02420041|33433|P1|COMPLETED|Overall Study||14
13481|NCT02420041|33432|P2|STARTED|Overall Study||14
13482|NCT02420041|33433|P1|STARTED|Overall Study||14
13483|NCT02419937|33459|P2|NOT COMPLETED|Overall Study||0
13484|NCT02419937|33460|P1|NOT COMPLETED|Overall Study||1
13485|NCT02419937|33459|P2|COMPLETED|Overall Study||16
13486|NCT02419937|33460|P1|COMPLETED|Overall Study||11
13487|NCT02419937|33459|P2|STARTED|Overall Study||16
13488|NCT02419937|33460|P1|STARTED|Overall Study||12
13489|NCT02419755|33468|P2|NOT COMPLETED|Overall Study||4
13490|NCT02419755|33469|P1|NOT COMPLETED|Overall Study||3
13491|NCT02419755|33468|P2|COMPLETED|Overall Study||2
13492|NCT02419755|33469|P1|COMPLETED|Overall Study||3
13493|NCT02419755|33468|P2|STARTED|Overall Study||6
13494|NCT02419755|33469|P1|STARTED|Overall Study||6
13495|NCT02419521|33493|P1|NOT COMPLETED|Overall Study||1
13496|NCT02419521|33493|P1|COMPLETED|Overall Study||74
13497|NCT02419521|33493|P1|STARTED|Overall Study||75
13498|NCT02419313|33505|P2|NOT COMPLETED|Second Intervention||0
13499|NCT02419313|33506|P1|NOT COMPLETED|Second Intervention||1
13500|NCT02419313|33505|P2|COMPLETED|Second Intervention||15
13501|NCT02419313|33506|P1|COMPLETED|Second Intervention||15
13502|NCT02419313|33505|P2|STARTED|Second Intervention||15
13503|NCT02419313|33506|P1|STARTED|Second Intervention||16
13504|NCT02419313|33505|P2|NOT COMPLETED|First Intervention||0
13505|NCT02419313|33506|P1|NOT COMPLETED|First Intervention||2
13506|NCT02419313|33505|P2|COMPLETED|First Intervention||15
13507|NCT02419313|33506|P1|COMPLETED|First Intervention||16
13508|NCT02419313|33505|P2|STARTED|First Intervention||15
13509|NCT02419313|33506|P1|STARTED|First Intervention||18
13510|NCT02419001|33518|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
13511|NCT02419001|33519|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
13512|NCT02419001|33518|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
13513|NCT02419001|33519|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
13514|NCT02419001|33518|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
13515|NCT02419001|33519|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
13516|NCT02419001|33518|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
13517|NCT02419001|33519|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
13518|NCT02419001|33518|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
13519|NCT02419001|33519|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
13520|NCT02419001|33518|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
13521|NCT02419001|33519|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
13522|NCT02418676|33532|P3|NOT COMPLETED|Overall Study||0
13523|NCT02418676|33533|P2|NOT COMPLETED|Overall Study||0
13524|NCT02418676|33534|P1|NOT COMPLETED|Overall Study||0
13525|NCT02418676|33532|P3|COMPLETED|Overall Study||5
13526|NCT02418676|33533|P2|COMPLETED|Overall Study||5
13527|NCT02418676|33534|P1|COMPLETED|Overall Study||5
13528|NCT02418676|33532|P3|STARTED|Overall Study||5
13529|NCT02418676|33533|P2|STARTED|Overall Study||5
13530|NCT02418676|33534|P1|STARTED|Overall Study||5
13531|NCT02418468|33547|P2|NOT COMPLETED|Overall Study||1
13532|NCT02418468|33548|P1|NOT COMPLETED|Overall Study||2
13533|NCT02418468|33547|P2|COMPLETED|Overall Study||10
13534|NCT02418468|33548|P1|COMPLETED|Overall Study||11
13535|NCT02418468|33547|P2|STARTED|Overall Study||11
13536|NCT02418468|33548|P1|STARTED|Overall Study||13
13537|NCT02418234|33554|P1|NOT COMPLETED|Overall Study||0
13538|NCT02418234|33554|P1|COMPLETED|Overall Study||314
13539|NCT02418234|33554|P1|STARTED|Overall Study||314
13540|NCT02418026|33567|P2|NOT COMPLETED|Overall Study||0
13541|NCT02418026|33568|P1|NOT COMPLETED|Overall Study||0
13542|NCT02418026|33567|P2|COMPLETED|Overall Study||35
13543|NCT02418026|33568|P1|COMPLETED|Overall Study||44
13544|NCT02418026|33567|P2|STARTED|Overall Study||35
13545|NCT02418026|33568|P1|STARTED|Overall Study||44
13546|NCT02417961|33598|P1|NOT COMPLETED|Overall Study||4
13547|NCT02417961|33598|P1|COMPLETED|Overall Study||112
13548|NCT02417961|33598|P1|STARTED|Overall Study||116
13549|NCT02417753|33608|P1|NOT COMPLETED|Overall Study||1
13550|NCT02417753|33608|P1|COMPLETED|Overall Study||0
13551|NCT02417753|33608|P1|STARTED|Overall Study||1
13552|NCT02417532|33618|P1|NOT COMPLETED|Overall Study||4
13553|NCT02417532|33618|P1|COMPLETED|Overall Study||52
13554|NCT02417532|33618|P1|STARTED|Overall Study||56
13555|NCT02417376|33631|P2|NOT COMPLETED|Overall Study||10
13556|NCT02417376|33632|P1|NOT COMPLETED|Overall Study||5
13557|NCT02417376|33631|P2|COMPLETED|Overall Study||25
13558|NCT02417376|33632|P1|COMPLETED|Overall Study||30
13559|NCT02417376|33631|P2|STARTED|Overall Study||35
13560|NCT02417376|33632|P1|STARTED|Overall Study||35
13561|NCT02417129|33676|P2|NOT COMPLETED|Overall Study||0
13562|NCT02417129|33677|P1|NOT COMPLETED|Overall Study||0
13563|NCT02417129|33676|P2|COMPLETED|Overall Study||0
13564|NCT02417129|33677|P1|COMPLETED|Overall Study||2
13565|NCT02417129|33676|P2|STARTED|Overall Study||0
13566|NCT02417129|33677|P1|STARTED|Overall Study||2
13567|NCT02416973|33690|P3|NOT COMPLETED|Overall Study||1
13568|NCT02416973|33691|P2|NOT COMPLETED|Overall Study||3
13569|NCT02416973|33692|P1|NOT COMPLETED|Overall Study||1
13570|NCT02416973|33690|P3|COMPLETED|Overall Study||13
13571|NCT02416973|33691|P2|COMPLETED|Overall Study||10
13572|NCT02416973|33692|P1|COMPLETED|Overall Study||13
13573|NCT02416973|33690|P3|STARTED|Overall Study||14
13574|NCT02416973|33691|P2|STARTED|Overall Study||13
13575|NCT02416973|33692|P1|STARTED|Overall Study||14
13576|NCT02416934|33702|P2|NOT COMPLETED|Overall Study||7
13577|NCT02416934|33703|P1|NOT COMPLETED|Overall Study||3
13578|NCT02416934|33702|P2|COMPLETED|Overall Study||31
13579|NCT02416934|33703|P1|COMPLETED|Overall Study||33
13580|NCT02416934|33702|P2|Last Participant Completed 1 yr|Overall Study||31
13581|NCT02416934|33703|P1|Last Participant Completed 1 yr|Overall Study||33
13582|NCT02416934|33702|P2|Double Blind (0-52 Weeks)|Overall Study||38
13583|NCT02416934|33703|P1|Double Blind (0-52 Weeks)|Overall Study||36
13584|NCT02416934|33702|P2|STARTED|Overall Study||38
13585|NCT02416934|33703|P1|STARTED|Overall Study||36
13586|NCT02416180|33713|P1|NOT COMPLETED|Overall Study||1
13587|NCT02416180|33713|P1|COMPLETED|Overall Study||110
13588|NCT02416180|33713|P1|STARTED|Overall Study||111
13589|NCT02415959|33725|P5|NOT COMPLETED|Overall Study||0
13590|NCT02415959|33726|P4|NOT COMPLETED|Overall Study||1
13591|NCT02415959|33727|P3|NOT COMPLETED|Overall Study||0
13592|NCT02415959|33728|P2|NOT COMPLETED|Overall Study||1
13593|NCT02415959|33729|P1|NOT COMPLETED|Overall Study||0
13594|NCT02415959|33725|P5|COMPLETED|Overall Study||14
13595|NCT02415959|33726|P4|COMPLETED|Overall Study||13
13596|NCT02415959|33727|P3|COMPLETED|Overall Study||14
13597|NCT02415959|33728|P2|COMPLETED|Overall Study||13
13598|NCT02415959|33729|P1|COMPLETED|Overall Study||14
13599|NCT02415959|33725|P5|STARTED|Overall Study||14
13600|NCT02415959|33726|P4|STARTED|Overall Study||14
13601|NCT02415959|33727|P3|STARTED|Overall Study||14
13602|NCT02415959|33728|P2|STARTED|Overall Study||14
13603|NCT02415959|33729|P1|STARTED|Overall Study||14
13604|NCT02415439|33774|P13|NOT COMPLETED|Overall Study||0
13605|NCT02415439|33775|P12|NOT COMPLETED|Overall Study||0
13606|NCT02415439|33776|P11|NOT COMPLETED|Overall Study||0
13607|NCT02415439|33777|P10|NOT COMPLETED|Overall Study||0
13608|NCT02415439|33778|P9|NOT COMPLETED|Overall Study||1
13609|NCT02415439|33779|P8|NOT COMPLETED|Overall Study||0
13610|NCT02415439|33780|P7|NOT COMPLETED|Overall Study||0
13611|NCT02415439|33781|P6|NOT COMPLETED|Overall Study||0
13612|NCT02415439|33782|P5|NOT COMPLETED|Overall Study||0
13613|NCT02415439|33783|P4|NOT COMPLETED|Overall Study||0
13614|NCT02415439|33784|P3|NOT COMPLETED|Overall Study||0
13615|NCT02415439|33785|P2|NOT COMPLETED|Overall Study||0
13616|NCT02415439|33786|P1|NOT COMPLETED|Overall Study||0
13617|NCT02415439|33774|P13|COMPLETED|Overall Study||8
13618|NCT02415439|33775|P12|COMPLETED|Overall Study||6
13619|NCT02415439|33776|P11|COMPLETED|Overall Study||6
13620|NCT02415439|33777|P10|COMPLETED|Overall Study||6
13621|NCT02415439|33778|P9|COMPLETED|Overall Study||5
13622|NCT02415439|33779|P8|COMPLETED|Overall Study||12
13623|NCT02415439|33780|P7|COMPLETED|Overall Study||6
13624|NCT02415439|33781|P6|COMPLETED|Overall Study||6
13625|NCT02415439|33782|P5|COMPLETED|Overall Study||6
13626|NCT02415439|33783|P4|COMPLETED|Overall Study||6
13627|NCT02415439|33784|P3|COMPLETED|Overall Study||6
13628|NCT02415439|33785|P2|COMPLETED|Overall Study||6
13629|NCT02415439|33786|P1|COMPLETED|Overall Study||6
13630|NCT02415439|33774|P13|STARTED|Overall Study||8
13631|NCT02415439|33775|P12|STARTED|Overall Study||6
13632|NCT02415439|33776|P11|STARTED|Overall Study||6
13633|NCT02415439|33777|P10|STARTED|Overall Study||6
13634|NCT02415439|33778|P9|STARTED|Overall Study||6
13635|NCT02415439|33779|P8|STARTED|Overall Study||12
13636|NCT02415439|33780|P7|STARTED|Overall Study||6
13637|NCT02415439|33781|P6|STARTED|Overall Study||6
13638|NCT02415439|33782|P5|STARTED|Overall Study||6
13639|NCT02415439|33783|P4|STARTED|Overall Study||6
13640|NCT02415439|33784|P3|STARTED|Overall Study||6
13641|NCT02415439|33785|P2|STARTED|Overall Study||6
13642|NCT02415439|33786|P1|STARTED|Overall Study||6
13643|NCT02415166|33844|P4|NOT COMPLETED|Overall Study||0
13644|NCT02415166|33845|P3|NOT COMPLETED|Overall Study||0
13645|NCT02415166|33846|P2|NOT COMPLETED|Overall Study||0
13646|NCT02415166|33847|P1|NOT COMPLETED|Overall Study||0
13647|NCT02415166|33844|P4|COMPLETED|Overall Study||0
13648|NCT02415166|33845|P3|COMPLETED|Overall Study||0
13649|NCT02415166|33846|P2|COMPLETED|Overall Study||0
13650|NCT02415166|33847|P1|COMPLETED|Overall Study||6
13651|NCT02415166|33844|P4|STARTED|Overall Study||0
13652|NCT02415166|33845|P3|STARTED|Overall Study||0
13653|NCT02415166|33846|P2|STARTED|Overall Study||0
13654|NCT02415166|33847|P1|STARTED|Overall Study||6
13655|NCT02415127|33875|P2|NOT COMPLETED|Overall Study||0
13656|NCT02415127|33876|P1|NOT COMPLETED|Overall Study||1
13657|NCT02415127|33875|P2|COMPLETED|Overall Study||45
13658|NCT02415127|33876|P1|COMPLETED|Overall Study||46
13659|NCT02415127|33875|P2|STARTED|Overall Study||45
13660|NCT02415127|33876|P1|STARTED|Overall Study||47
13661|NCT02414828|33894|P4|NOT COMPLETED|Overall Study||2
13662|NCT02414828|33895|P3|NOT COMPLETED|Overall Study||1
13663|NCT02414828|33896|P2|NOT COMPLETED|Overall Study||1
13664|NCT02414828|33897|P1|NOT COMPLETED|Overall Study||0
13665|NCT02414828|33894|P4|COMPLETED|Overall Study||29
13666|NCT02414828|33895|P3|COMPLETED|Overall Study||19
13667|NCT02414828|33896|P2|COMPLETED|Overall Study||9
13668|NCT02414828|33897|P1|COMPLETED|Overall Study||11
13669|NCT02414828|33894|P4|STARTED|Overall Study||31
13670|NCT02414828|33895|P3|STARTED|Overall Study||20
13671|NCT02414828|33896|P2|STARTED|Overall Study||10
13672|NCT02414828|33897|P1|STARTED|Overall Study||11
13673|NCT02414152|33935|P1|NOT COMPLETED|Overall Study||2
13674|NCT02414152|33935|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
13675|NCT02414152|33935|P1|STARTED|Overall Study||2
13676|NCT02413918|33939|P1|NOT COMPLETED|Overall Study||25
13677|NCT02413918|33939|P1|COMPLETED|Overall Study||16
13678|NCT02413918|33939|P1|STARTED|Overall Study||41
13679|NCT02413879|33946|P1|NOT COMPLETED|Overall Study||0
13680|NCT02413879|33946|P1|COMPLETED|Overall Study||86
13681|NCT02413879|33946|P1|STARTED|Overall Study||86
13682|NCT02413593|33952|P1|NOT COMPLETED|Overall Study||4
13683|NCT02413593|33952|P1|COMPLETED|Overall Study||107
13684|NCT02413593|33952|P1|STARTED|Overall Study||111
13685|NCT02413346|33963|P2|NOT COMPLETED|Overall Study||70
13686|NCT02413346|33964|P1|NOT COMPLETED|Overall Study||59
13687|NCT02413346|33963|P2|COMPLETED|Overall Study||177
13688|NCT02413346|33964|P1|COMPLETED|Overall Study||177
13689|NCT02413346|33963|P2|STARTED|Overall Study||247
13690|NCT02413346|33964|P1|STARTED|Overall Study||236
13691|NCT02413333|33974|P2|NOT COMPLETED|Period 2||0
13692|NCT02413333|33975|P1|NOT COMPLETED|Period 2||1
13693|NCT02413333|33974|P2|COMPLETED|Period 2||65
13694|NCT02413333|33975|P1|COMPLETED|Period 2||64
13695|NCT02413333|33974|P2|STARTED|Period 2||65
13696|NCT02413333|33975|P1|STARTED|Period 2||65
13697|NCT02413333|33974|P2|NOT COMPLETED|Period 1||1
13698|NCT02413333|33975|P1|NOT COMPLETED|Period 1||1
13699|NCT02413333|33974|P2|COMPLETED|Period 1||65
13700|NCT02413333|33975|P1|COMPLETED|Period 1||65
13701|NCT02413333|33974|P2|Randomized and Treated|Period 1||66
13702|NCT02413333|33975|P1|Randomized and Treated|Period 1||66
13703|NCT02413333|33974|P2|STARTED|Period 1||66
13704|NCT02413333|33975|P1|STARTED|Period 1||66
13705|NCT02413294|33983|P1|NOT COMPLETED|Overall Study||1
13706|NCT02413294|33983|P1|COMPLETED|Overall Study||11
13707|NCT02413294|33983|P1|STARTED|Overall Study||12
13708|NCT02413203|34003|P2|NOT COMPLETED|Overall Study||0
13709|NCT02413203|34004|P1|NOT COMPLETED|Overall Study||0
13710|NCT02413203|34003|P2|COMPLETED|Overall Study||10
13711|NCT02413203|34004|P1|COMPLETED|Overall Study||10
13712|NCT02413203|34003|P2|STARTED|Overall Study||10
13713|NCT02413203|34004|P1|STARTED|Overall Study||10
13714|NCT02413034|34026|P2|NOT COMPLETED|Overall Study||0
13715|NCT02413034|34027|P1|NOT COMPLETED|Overall Study||0
13716|NCT02413034|34026|P2|COMPLETED|Overall Study||14
13717|NCT02413034|34027|P1|COMPLETED|Overall Study||14
13718|NCT02413034|34026|P2|STARTED|Overall Study||14
13719|NCT02413034|34027|P1|STARTED|Overall Study||14
13720|NCT02412657|34038|P3|NOT COMPLETED|Overall Study||3
13721|NCT02412657|34039|P2|NOT COMPLETED|Overall Study||2
13722|NCT02412657|34040|P1|NOT COMPLETED|Overall Study||1
13723|NCT02412657|34038|P3|COMPLETED|Overall Study||22
13724|NCT02412657|34039|P2|COMPLETED|Overall Study||23
13725|NCT02412657|34040|P1|COMPLETED|Overall Study||24
13726|NCT02412657|34038|P3|STARTED|Overall Study||25
13727|NCT02412657|34039|P2|STARTED|Overall Study||25
13728|NCT02412657|34040|P1|STARTED|Overall Study||25
13729|NCT02412501|34048|P1|NOT COMPLETED|Overall Study||1
13730|NCT02412501|34048|P1|COMPLETED|Overall Study||100
13731|NCT02412501|34048|P1|STARTED|Overall Study||101
13732|NCT02411929|34057|P1|NOT COMPLETED|Period 2||0
13733|NCT02411929|34057|P1|COMPLETED|Period 2||8
13734|NCT02411929|34057|P1|STARTED|Period 2||8
13735|NCT02411929|34057|P1|NOT COMPLETED|Washout Period||0
13736|NCT02411929|34057|P1|COMPLETED|Washout Period||8
13737|NCT02411929|34057|P1|STARTED|Washout Period||8
13738|NCT02411929|34057|P1|NOT COMPLETED|Period 1||0
13739|NCT02411929|34057|P1|COMPLETED|Period 1||8
13740|NCT02411929|34057|P1|STARTED|Period 1||8
13741|NCT02411747|34089|P2|NOT COMPLETED|Overall Study||4
13742|NCT02411747|34090|P1|NOT COMPLETED|Overall Study||3
13743|NCT02411747|34089|P2|COMPLETED|Overall Study||12
13744|NCT02411747|34090|P1|COMPLETED|Overall Study||13
13745|NCT02411747|34089|P2|Simulation Training Completed|Overall Study||16
13746|NCT02411747|34090|P1|Simulation Training Completed|Overall Study||16
13747|NCT02411747|34089|P2|STARTED|Overall Study||16
13748|NCT02411747|34090|P1|STARTED|Overall Study||16
13749|NCT02411578|34098|P2|NOT COMPLETED|Extension Phase||0
13750|NCT02411578|34099|P1|NOT COMPLETED|Extension Phase||0
13751|NCT02411578|34098|P2|COMPLETED|Extension Phase||9
13752|NCT02411578|34099|P1|COMPLETED|Extension Phase||8
13753|NCT02411578|34098|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
13754|NCT02411578|34099|P1|STARTED|Extension Phase||8
13755|NCT02411578|34098|P2|NOT COMPLETED|Crossover Trial Phase||1
13756|NCT02411578|34099|P1|NOT COMPLETED|Crossover Trial Phase||0
13757|NCT02411578|34098|P2|COMPLETED|Crossover Trial Phase||11
13758|NCT02411578|34099|P1|COMPLETED|Crossover Trial Phase||8
13759|NCT02411578|34098|P2|STARTED|Crossover Trial Phase||12
13760|NCT02411578|34099|P1|STARTED|Crossover Trial Phase||8
13761|NCT02411539|34141|P2|NOT COMPLETED|Overall Study||1
13762|NCT02411539|34142|P1|NOT COMPLETED|Overall Study||2
13763|NCT02411539|34141|P2|COMPLETED|Overall Study||19
13764|NCT02411539|34142|P1|COMPLETED|Overall Study||18
13765|NCT02411539|34141|P2|STARTED|Overall Study||20
13766|NCT02411539|34142|P1|STARTED|Overall Study||20
13767|NCT02411292|34217|P1|NOT COMPLETED|Overall Study||21
13768|NCT02411292|34217|P1|COMPLETED|Overall Study||89
13769|NCT02411292|34217|P1|STARTED|Overall Study||110
13770|NCT02411201|34223|P1|NOT COMPLETED|Overall Study||6
13771|NCT02411201|34223|P1|COMPLETED|Overall Study||45
13772|NCT02411201|34223|P1|STARTED|Overall Study||51
13773|NCT02411110|34236|P2|NOT COMPLETED|Treatment Period 2||4
13774|NCT02411110|34237|P1|NOT COMPLETED|Treatment Period 2||1
13775|NCT02411110|34236|P2|COMPLETED|Treatment Period 2||44
13776|NCT02411110|34237|P1|COMPLETED|Treatment Period 2||49
13777|NCT02411110|34236|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
13778|NCT02411110|34237|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
13779|NCT02411110|34236|P2|NOT COMPLETED|Treatment Period 1||7
13780|NCT02411110|34237|P1|NOT COMPLETED|Treatment Period 1||9
13781|NCT02411110|34236|P2|COMPLETED|Treatment Period 1||59
13782|NCT02411110|34237|P1|COMPLETED|Treatment Period 1||56
13783|NCT02411110|34236|P2|STARTED|Treatment Period 1||66
13784|NCT02411110|34237|P1|STARTED|Treatment Period 1||65
13785|NCT02410824|34245|P2|NOT COMPLETED|Second Intervention (One Week)||0
13786|NCT02410824|34246|P1|NOT COMPLETED|Second Intervention (One Week)||0
13787|NCT02410824|34245|P2|COMPLETED|Second Intervention (One Week)||22
13788|NCT02410824|34246|P1|COMPLETED|Second Intervention (One Week)||22
13789|NCT02410824|34245|P2|STARTED|Second Intervention (One Week)||22
13790|NCT02410824|34246|P1|STARTED|Second Intervention (One Week)||22
13791|NCT02410824|34245|P2|NOT COMPLETED|First Intervention (One Week)||1
13792|NCT02410824|34246|P1|NOT COMPLETED|First Intervention (One Week)||0
13793|NCT02410824|34245|P2|COMPLETED|First Intervention (One Week)||22
13794|NCT02410824|34246|P1|COMPLETED|First Intervention (One Week)||22
13795|NCT02410824|34245|P2|STARTED|First Intervention (One Week)||23
13796|NCT02410824|34246|P1|STARTED|First Intervention (One Week)||22
13797|NCT02410291|34280|P2|NOT COMPLETED|Overall Study||0
13798|NCT02410291|34281|P1|NOT COMPLETED|Overall Study||0
13799|NCT02410291|34280|P2|COMPLETED|Overall Study||29
13800|NCT02410291|34281|P1|COMPLETED|Overall Study||29
13801|NCT02410291|34280|P2|STARTED|Overall Study||29
13802|NCT02410291|34281|P1|STARTED|Overall Study||29
13803|NCT02410213|34287|P2|NOT COMPLETED|Overall Study||0
13804|NCT02410213|34288|P1|NOT COMPLETED|Overall Study||0
13805|NCT02410213|34287|P2|COMPLETED|Overall Study||19
13806|NCT02410213|34288|P1|COMPLETED|Overall Study||16
13807|NCT02410213|34287|P2|STARTED|Overall Study||19
13808|NCT02410213|34288|P1|STARTED|Overall Study||16
13809|NCT02410200|34294|P1|NOT COMPLETED|Overall Study||2
13810|NCT02410200|34294|P1|COMPLETED|Overall Study||20
13811|NCT02410200|34294|P1|STARTED|Overall Study||22
13812|NCT02409784|34305|P1|NOT COMPLETED|Overall Study||0
13813|NCT02409784|34305|P1|COMPLETED|Overall Study||10
13814|NCT02409784|34305|P1|STARTED|Overall Study||10
13815|NCT02409459|34315|P2|NOT COMPLETED|Overall Study||1
13816|NCT02409459|34316|P1|NOT COMPLETED|Overall Study||1
13817|NCT02409459|34315|P2|COMPLETED|Overall Study||39
13818|NCT02409459|34316|P1|COMPLETED|Overall Study||40
13819|NCT02409459|34315|P2|STARTED|Overall Study||40
13820|NCT02409459|34316|P1|STARTED|Overall Study||41
13821|NCT02408692|34337|P3|NOT COMPLETED|Overall Study||0
13822|NCT02408692|34338|P2|NOT COMPLETED|Overall Study||0
13823|NCT02408692|34339|P1|NOT COMPLETED|Overall Study||0
13824|NCT02408692|34337|P3|COMPLETED|Overall Study||5
13825|NCT02408692|34338|P2|COMPLETED|Overall Study||5
13826|NCT02408692|34339|P1|COMPLETED|Overall Study||5
13827|NCT02408692|34337|P3|STARTED|Overall Study||5
13828|NCT02408692|34338|P2|STARTED|Overall Study||5
13829|NCT02408692|34339|P1|STARTED|Overall Study||5
13830|NCT02408263|34350|P1|NOT COMPLETED|Overall Study||0
13831|NCT02408263|34350|P1|COMPLETED|Overall Study||50
13832|NCT02408263|34350|P1|STARTED|Overall Study||50
13833|NCT02408068|34356|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
13834|NCT02408068|34357|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
13835|NCT02408068|34358|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
13836|NCT02408068|34359|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
13837|NCT02408068|34360|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
13838|NCT02408068|34361|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
13839|NCT02408068|34356|P6|COMPLETED|Treatment 3 (1.5 Days)||3
13840|NCT02408068|34357|P5|COMPLETED|Treatment 3 (1.5 Days)||3
13841|NCT02408068|34358|P4|COMPLETED|Treatment 3 (1.5 Days)||3
13842|NCT02408068|34359|P3|COMPLETED|Treatment 3 (1.5 Days)||2
13843|NCT02408068|34360|P2|COMPLETED|Treatment 3 (1.5 Days)||3
13844|NCT02408068|34361|P1|COMPLETED|Treatment 3 (1.5 Days)||3
13845|NCT02408068|34356|P6|STARTED|Treatment 3 (1.5 Days)||3
13846|NCT02408068|34357|P5|STARTED|Treatment 3 (1.5 Days)||3
13847|NCT02408068|34358|P4|STARTED|Treatment 3 (1.5 Days)||3
13848|NCT02408068|34359|P3|STARTED|Treatment 3 (1.5 Days)||3
13849|NCT02408068|34360|P2|STARTED|Treatment 3 (1.5 Days)||3
13850|NCT02408068|34361|P1|STARTED|Treatment 3 (1.5 Days)||3
13851|NCT02408068|34356|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
13852|NCT02408068|34357|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
13853|NCT02408068|34358|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
13854|NCT02408068|34359|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
13855|NCT02408068|34360|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
13856|NCT02408068|34361|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
13857|NCT02408068|34356|P6|COMPLETED|Washout Period 2 (7 Days)||3
13858|NCT02408068|34357|P5|COMPLETED|Washout Period 2 (7 Days)||3
13859|NCT02408068|34358|P4|COMPLETED|Washout Period 2 (7 Days)||3
13860|NCT02408068|34359|P3|COMPLETED|Washout Period 2 (7 Days)||3
13861|NCT02408068|34360|P2|COMPLETED|Washout Period 2 (7 Days)||3
13862|NCT02408068|34361|P1|COMPLETED|Washout Period 2 (7 Days)||3
13863|NCT02408068|34356|P6|STARTED|Washout Period 2 (7 Days)||3
13864|NCT02408068|34357|P5|STARTED|Washout Period 2 (7 Days)||3
13865|NCT02408068|34358|P4|STARTED|Washout Period 2 (7 Days)||3
13866|NCT02408068|34359|P3|STARTED|Washout Period 2 (7 Days)||3
13867|NCT02408068|34360|P2|STARTED|Washout Period 2 (7 Days)||3
13868|NCT02408068|34361|P1|STARTED|Washout Period 2 (7 Days)||3
13869|NCT02408068|34356|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
13870|NCT02408068|34357|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
13871|NCT02408068|34358|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
13872|NCT02408068|34359|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
13873|NCT02408068|34360|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
13874|NCT02408068|34361|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
13875|NCT02408068|34356|P6|COMPLETED|Treatment 2 (1.5 Days)||3
13876|NCT02408068|34357|P5|COMPLETED|Treatment 2 (1.5 Days)||3
13877|NCT02408068|34358|P4|COMPLETED|Treatment 2 (1.5 Days)||3
13878|NCT02408068|34359|P3|COMPLETED|Treatment 2 (1.5 Days)||3
13879|NCT02408068|34360|P2|COMPLETED|Treatment 2 (1.5 Days)||3
13880|NCT02408068|34361|P1|COMPLETED|Treatment 2 (1.5 Days)||3
13881|NCT02408068|34356|P6|STARTED|Treatment 2 (1.5 Days)||3
13882|NCT02408068|34357|P5|STARTED|Treatment 2 (1.5 Days)||3
13883|NCT02408068|34358|P4|STARTED|Treatment 2 (1.5 Days)||3
13884|NCT02408068|34359|P3|STARTED|Treatment 2 (1.5 Days)||3
13885|NCT02408068|34360|P2|STARTED|Treatment 2 (1.5 Days)||3
13886|NCT02408068|34361|P1|STARTED|Treatment 2 (1.5 Days)||3
13887|NCT02408068|34356|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
13888|NCT02408068|34357|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
13889|NCT02408068|34358|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
13890|NCT02408068|34359|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
13891|NCT02408068|34360|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
13892|NCT02408068|34361|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
13893|NCT02408068|34356|P6|COMPLETED|Washout Period 1 (7 Days)||3
13894|NCT02408068|34357|P5|COMPLETED|Washout Period 1 (7 Days)||3
13895|NCT02408068|34358|P4|COMPLETED|Washout Period 1 (7 Days)||3
13896|NCT02408068|34359|P3|COMPLETED|Washout Period 1 (7 Days)||3
13897|NCT02408068|34360|P2|COMPLETED|Washout Period 1 (7 Days)||3
13898|NCT02408068|34361|P1|COMPLETED|Washout Period 1 (7 Days)||3
13899|NCT02408068|34356|P6|STARTED|Washout Period 1 (7 Days)||3
13900|NCT02408068|34357|P5|STARTED|Washout Period 1 (7 Days)||3
13901|NCT02408068|34358|P4|STARTED|Washout Period 1 (7 Days)||3
13902|NCT02408068|34359|P3|STARTED|Washout Period 1 (7 Days)||3
13903|NCT02408068|34360|P2|STARTED|Washout Period 1 (7 Days)||3
13904|NCT02408068|34361|P1|STARTED|Washout Period 1 (7 Days)||3
13905|NCT02408068|34356|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
13906|NCT02408068|34357|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
13907|NCT02408068|34358|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
13908|NCT02408068|34359|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
13909|NCT02408068|34360|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
13910|NCT02408068|34361|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
13911|NCT02408068|34356|P6|COMPLETED|Treatment 1 (1.5 Days)||3
13912|NCT02408068|34357|P5|COMPLETED|Treatment 1 (1.5 Days)||3
13913|NCT02408068|34358|P4|COMPLETED|Treatment 1 (1.5 Days)||3
13914|NCT02408068|34359|P3|COMPLETED|Treatment 1 (1.5 Days)||3
13915|NCT02408068|34360|P2|COMPLETED|Treatment 1 (1.5 Days)||3
13916|NCT02408068|34361|P1|COMPLETED|Treatment 1 (1.5 Days)||3
13917|NCT02408068|34356|P6|STARTED|Treatment 1 (1.5 Days)||3
13918|NCT02408068|34357|P5|STARTED|Treatment 1 (1.5 Days)||3
13919|NCT02408068|34358|P4|STARTED|Treatment 1 (1.5 Days)||3
13920|NCT02408068|34359|P3|STARTED|Treatment 1 (1.5 Days)||3
13921|NCT02408068|34360|P2|STARTED|Treatment 1 (1.5 Days)||3
13922|NCT02408068|34361|P1|STARTED|Treatment 1 (1.5 Days)||3
13923|NCT02407704|34388|P4|NOT COMPLETED|Overall Study||3
13924|NCT02407704|34389|P3|NOT COMPLETED|Overall Study||1
13925|NCT02407704|34390|P2|NOT COMPLETED|Overall Study||0
13926|NCT02407704|34391|P1|NOT COMPLETED|Overall Study||0
13927|NCT02407704|34388|P4|COMPLETED|Overall Study||2
13928|NCT02407704|34389|P3|COMPLETED|Overall Study||4
13929|NCT02407704|34390|P2|COMPLETED|Overall Study||3
13930|NCT02407704|34391|P1|COMPLETED|Overall Study||2
13931|NCT02407704|34388|P4|STARTED|Overall Study||5
13932|NCT02407704|34389|P3|STARTED|Overall Study||5
13933|NCT02407704|34390|P2|STARTED|Overall Study||3
13934|NCT02407704|34391|P1|STARTED|Overall Study||2
13935|NCT02406937|34428|P3|NOT COMPLETED|Overall Study||2
13936|NCT02406937|34429|P2|NOT COMPLETED|Overall Study||1
13937|NCT02406937|34430|P1|NOT COMPLETED|Overall Study||1
13938|NCT02406937|34428|P3|COMPLETED|Overall Study||58
13939|NCT02406937|34429|P2|COMPLETED|Overall Study||59
13940|NCT02406937|34430|P1|COMPLETED|Overall Study||59
13941|NCT02406937|34428|P3|STARTED|Overall Study||60
13942|NCT02406937|34429|P2|STARTED|Overall Study||60
13943|NCT02406937|34430|P1|STARTED|Overall Study||60
13944|NCT02406586|34489|P3|NOT COMPLETED|Overall Study||2
13945|NCT02406586|34490|P2|NOT COMPLETED|Overall Study||4
13946|NCT02406586|34491|P1|NOT COMPLETED|Overall Study||1
13947|NCT02406586|34489|P3|COMPLETED|Overall Study||10
13948|NCT02406586|34490|P2|COMPLETED|Overall Study||8
13949|NCT02406586|34491|P1|COMPLETED|Overall Study||11
13950|NCT02406586|34489|P3|STARTED|Overall Study||12
13951|NCT02406586|34490|P2|STARTED|Overall Study||12
13952|NCT02406586|34491|P1|STARTED|Overall Study||12
13953|NCT02406495|34544|P1|NOT COMPLETED|Overall Study||0
13954|NCT02406495|34544|P1|COMPLETED|Overall Study||40
13955|NCT02406495|34544|P1|STARTED|Overall Study||40
13956|NCT02406443|34585|P2|NOT COMPLETED|Overall Study||2
13957|NCT02406443|34586|P1|NOT COMPLETED|Overall Study||2
13958|NCT02406443|34585|P2|COMPLETED|Overall Study||16
13959|NCT02406443|34586|P1|COMPLETED|Overall Study||16
13960|NCT02406443|34585|P2|STARTED|Overall Study||18
13961|NCT02406443|34586|P1|STARTED|Overall Study||18
13962|NCT02405429|34604|P1|NOT COMPLETED|Overall Study||0
13963|NCT02405429|34604|P1|COMPLETED|Overall Study||49
13964|NCT02405429|34604|P1|STARTED|Overall Study||49
13965|NCT02405390|34614|P2|NOT COMPLETED|Overall Study||0
13966|NCT02405390|34615|P1|NOT COMPLETED|Overall Study||0
13967|NCT02405390|34614|P2|COMPLETED|Overall Study||46
13968|NCT02405390|34615|P1|COMPLETED|Overall Study||46
13969|NCT02405390|34614|P2|STARTED|Overall Study||46
13970|NCT02405390|34615|P1|STARTED|Overall Study||46
13971|NCT02404649|34625|P2|NOT COMPLETED|Overall Study||2
13972|NCT02404649|34626|P1|NOT COMPLETED|Overall Study||1
13973|NCT02404649|34625|P2|COMPLETED|Overall Study||14
13974|NCT02404649|34626|P1|COMPLETED|Overall Study||16
13975|NCT02404649|34625|P2|STARTED|Overall Study||16
13976|NCT02404649|34626|P1|STARTED|Overall Study||17
13977|NCT02404545|34634|P2|NOT COMPLETED|Overall Study||6
13978|NCT02404545|34635|P1|NOT COMPLETED|Overall Study||6
13979|NCT02404545|34634|P2|COMPLETED|Overall Study||0
13980|NCT02404545|34635|P1|COMPLETED|Overall Study||0
13981|NCT02404545|34634|P2|STARTED|Overall Study||6
13982|NCT02404545|34635|P1|STARTED|Overall Study||6
13983|NCT02404493|34644|P2|NOT COMPLETED|Overall Study||1
13984|NCT02404493|34645|P1|NOT COMPLETED|Overall Study||1
13985|NCT02404493|34644|P2|COMPLETED|Overall Study||5
13986|NCT02404493|34645|P1|COMPLETED|Overall Study||16
13987|NCT02404493|34644|P2|STARTED|Overall Study||6
13988|NCT02404493|34645|P1|STARTED|Overall Study||17
13989|NCT02404389|34890|P5|NOT COMPLETED|Overall Study||3
13990|NCT02404389|34891|P4|NOT COMPLETED|Overall Study||1
13991|NCT02404389|34892|P3|NOT COMPLETED|Overall Study||1
13992|NCT02404389|34893|P2|NOT COMPLETED|Overall Study||0
13993|NCT02404389|34894|P1|NOT COMPLETED|Overall Study||2
13994|NCT02404389|34890|P5|COMPLETED|Overall Study||18
13995|NCT02404389|34891|P4|COMPLETED|Overall Study||9
13996|NCT02404389|34892|P3|COMPLETED|Overall Study||10
13997|NCT02404389|34893|P2|COMPLETED|Overall Study||20
13998|NCT02404389|34894|P1|COMPLETED|Overall Study||18
13999|NCT02404389|34890|P5|STARTED|Overall Study||21
14000|NCT02404389|34891|P4|STARTED|Overall Study||10
14001|NCT02404389|34892|P3|STARTED|Overall Study||11
14002|NCT02404389|34893|P2|STARTED|Overall Study||20
14003|NCT02404389|34894|P1|STARTED|Overall Study||20
14004|NCT02404103|34932|P2|NOT COMPLETED|Overall Study||3
14005|NCT02404103|34933|P1|NOT COMPLETED|Overall Study||4
14006|NCT02404103|34932|P2|COMPLETED|Overall Study||9
14007|NCT02404103|34933|P1|COMPLETED|Overall Study||10
14008|NCT02404103|34932|P2|STARTED|Overall Study||12
14009|NCT02404103|34933|P1|STARTED|Overall Study||14
14010|NCT02403830|34953|P2|NOT COMPLETED|Visit 2||0
14011|NCT02403830|34954|P1|NOT COMPLETED|Visit 2||0
14012|NCT02403830|34953|P2|COMPLETED|Visit 2||15
14013|NCT02403830|34954|P1|COMPLETED|Visit 2||14
14014|NCT02403830|34953|P2|STARTED|Visit 2||15
14015|NCT02403830|34954|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
14016|NCT02403830|34953|P2|NOT COMPLETED|Visit 1||0
14017|NCT02403830|34954|P1|NOT COMPLETED|Visit 1||0
14018|NCT02403830|34953|P2|COMPLETED|Visit 1||15
14019|NCT02403830|34954|P1|COMPLETED|Visit 1||15
14020|NCT02403830|34953|P2|STARTED|Visit 1||15
14021|NCT02403830|34954|P1|STARTED|Visit 1||15
14022|NCT02403674|34966|P2|NOT COMPLETED|Overall Study||63
14023|NCT02403674|34967|P1|NOT COMPLETED|Overall Study||55
14024|NCT02403674|34966|P2|COMPLETED|Overall Study||303
14025|NCT02403674|34967|P1|COMPLETED|Overall Study||313
14026|NCT02403674|34966|P2|Treated|Overall Study||364
14027|NCT02403674|34967|P1|Treated|Overall Study||364
14028|NCT02403674|34966|P2|STARTED|Overall Study||366
14029|NCT02403674|34967|P1|STARTED|Overall Study||368
14030|NCT02403206|35008|P2|NOT COMPLETED|Overall Study||10
14031|NCT02403206|35009|P1|NOT COMPLETED|Overall Study||11
14032|NCT02403206|35008|P2|COMPLETED|Overall Study||186
14033|NCT02403206|35009|P1|COMPLETED|Overall Study||183
14034|NCT02403206|35008|P2|Randomized and Treated|Overall Study||190
14035|NCT02403206|35009|P1|Randomized and Treated|Overall Study||188
14036|NCT02403206|35008|P2|Treated Prior to Randomization|Overall Study||1
14037|NCT02403206|35009|P1|Treated Prior to Randomization|Overall Study||0
14038|NCT02403206|35008|P2|STARTED|Overall Study||196
14039|NCT02403206|35009|P1|STARTED|Overall Study||194
14040|NCT02403180|35020|P2|NOT COMPLETED|Period 2 (5 Days)||1
14041|NCT02403180|35021|P1|NOT COMPLETED|Period 2 (5 Days)||0
14042|NCT02403180|35020|P2|COMPLETED|Period 2 (5 Days)||32
14043|NCT02403180|35021|P1|COMPLETED|Period 2 (5 Days)||36
14044|NCT02403180|35020|P2|STARTED|Period 2 (5 Days)||33
14045|NCT02403180|35021|P1|STARTED|Period 2 (5 Days)||36
14046|NCT02403180|35020|P2|NOT COMPLETED|Period 1 (5 Days)||0
14047|NCT02403180|35021|P1|NOT COMPLETED|Period 1 (5 Days)||0
14048|NCT02403180|35020|P2|COMPLETED|Period 1 (5 Days)||33
14049|NCT02403180|35021|P1|COMPLETED|Period 1 (5 Days)||36
14050|NCT02403180|35020|P2|Randomized|Period 1 (5 Days)||33
14051|NCT02403180|35021|P1|Randomized|Period 1 (5 Days)||36
14052|NCT02403180|35020|P2|STARTED|Period 1 (5 Days)||33
14053|NCT02403180|35021|P1|STARTED|Period 1 (5 Days)||36
14054|NCT02403180|35020|P2|NOT COMPLETED|Pre-Treatment Period||1
14055|NCT02403180|35021|P1|NOT COMPLETED|Pre-Treatment Period||0
14056|NCT02403180|35020|P2|COMPLETED|Pre-Treatment Period||33
14057|NCT02403180|35021|P1|COMPLETED|Pre-Treatment Period||36
14058|NCT02403180|35020|P2|STARTED|Pre-Treatment Period||34
14059|NCT02403180|35021|P1|STARTED|Pre-Treatment Period||36
14060|NCT02403154|35033|P4|NOT COMPLETED|Overall Study||1
14061|NCT02403154|35034|P3|NOT COMPLETED|Overall Study||1
14062|NCT02403154|35035|P2|NOT COMPLETED|Overall Study||0
14063|NCT02403154|35036|P1|NOT COMPLETED|Overall Study||2
14064|NCT02403154|35033|P4|COMPLETED|Overall Study||0
14065|NCT02403154|35034|P3|COMPLETED|Overall Study||0
14066|NCT02403154|35035|P2|COMPLETED|Overall Study||0
14067|NCT02403154|35036|P1|COMPLETED|Overall Study||0
14068|NCT02403154|35033|P4|STARTED|Overall Study||1
14069|NCT02403154|35034|P3|STARTED|Overall Study||1
14070|NCT02403154|35035|P2|STARTED|Overall Study||0
14071|NCT02403154|35036|P1|STARTED|Overall Study||2
14072|NCT02402933|35050|P1|NOT COMPLETED|Overall Study||14
14073|NCT02402933|35050|P1|COMPLETED|Overall Study||12
14074|NCT02402933|35050|P1|Received at Least One Dose of Study Drug|Overall Study||22
14075|NCT02402933|35050|P1|STARTED|Overall Study||26
14076|NCT02402764|35057|P1|NOT COMPLETED|Overall Study||0
14077|NCT02402764|35057|P1|COMPLETED|Overall Study||10
14078|NCT02402764|35057|P1|STARTED|Overall Study||10
14079|NCT02402322|35068|P3|NOT COMPLETED|Follow-up||24
14080|NCT02402322|35069|P2|NOT COMPLETED|Follow-up||3
14081|NCT02402322|35070|P1|NOT COMPLETED|Follow-up||6
14082|NCT02402322|35068|P3|COMPLETED|Follow-up||0
14083|NCT02402322|35069|P2|COMPLETED|Follow-up||21
14084|NCT02402322|35070|P1|COMPLETED|Follow-up||18
14085|NCT02402322|35068|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
14086|NCT02402322|35069|P2|STARTED|Follow-up||24
14087|NCT02402322|35070|P1|STARTED|Follow-up||24
14088|NCT02402322|35068|P3|NOT COMPLETED|Pretreatment||1
14089|NCT02402322|35069|P2|NOT COMPLETED|Pretreatment||1
14090|NCT02402322|35070|P1|NOT COMPLETED|Pretreatment||3
14091|NCT02402322|35068|P3|COMPLETED|Pretreatment||24
14092|NCT02402322|35069|P2|COMPLETED|Pretreatment||24
14093|NCT02402322|35070|P1|COMPLETED|Pretreatment||24
14094|NCT02402322|35068|P3|Posttreatment Measures|Pretreatment||24
14095|NCT02402322|35069|P2|Posttreatment Measures|Pretreatment||24
14096|NCT02402322|35070|P1|Posttreatment Measures|Pretreatment||24
14097|NCT02402322|35068|P3|STARTED|Pretreatment||25
14098|NCT02402322|35069|P2|STARTED|Pretreatment||25
14099|NCT02402322|35070|P1|STARTED|Pretreatment||27
14100|NCT02402296|35104|P2|NOT COMPLETED|Overall Study||0
14101|NCT02402296|35105|P1|NOT COMPLETED|Overall Study||0
14102|NCT02402296|35104|P2|COMPLETED|Overall Study||15
14103|NCT02402296|35105|P1|COMPLETED|Overall Study||15
14104|NCT02402296|35104|P2|STARTED|Overall Study||15
14105|NCT02402296|35105|P1|STARTED|Overall Study||15
14106|NCT02402127|35123|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
14107|NCT02402127|35124|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
14108|NCT02402127|35125|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
14109|NCT02402127|35126|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
14110|NCT02402127|35127|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
14111|NCT02402127|35128|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
14112|NCT02402127|35123|P6|COMPLETED|Third Wear Period (1 Day)||4
14113|NCT02402127|35124|P5|COMPLETED|Third Wear Period (1 Day)||4
14114|NCT02402127|35125|P4|COMPLETED|Third Wear Period (1 Day)||4
14115|NCT02402127|35126|P3|COMPLETED|Third Wear Period (1 Day)||4
14116|NCT02402127|35127|P2|COMPLETED|Third Wear Period (1 Day)||4
14117|NCT02402127|35128|P1|COMPLETED|Third Wear Period (1 Day)||4
14118|NCT02402127|35123|P6|STARTED|Third Wear Period (1 Day)||4
14119|NCT02402127|35124|P5|STARTED|Third Wear Period (1 Day)||4
14120|NCT02402127|35125|P4|STARTED|Third Wear Period (1 Day)||4
14121|NCT02402127|35126|P3|STARTED|Third Wear Period (1 Day)||4
14122|NCT02402127|35127|P2|STARTED|Third Wear Period (1 Day)||4
14123|NCT02402127|35128|P1|STARTED|Third Wear Period (1 Day)||4
14124|NCT02402127|35123|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
14125|NCT02402127|35124|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
14126|NCT02402127|35125|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
14127|NCT02402127|35126|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
14128|NCT02402127|35127|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
14129|NCT02402127|35128|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
14130|NCT02402127|35123|P6|COMPLETED|Second Wear Period (1 Day)||4
14131|NCT02402127|35124|P5|COMPLETED|Second Wear Period (1 Day)||4
14132|NCT02402127|35125|P4|COMPLETED|Second Wear Period (1 Day)||4
14133|NCT02402127|35126|P3|COMPLETED|Second Wear Period (1 Day)||4
14134|NCT02402127|35127|P2|COMPLETED|Second Wear Period (1 Day)||4
14135|NCT02402127|35128|P1|COMPLETED|Second Wear Period (1 Day)||4
14136|NCT02402127|35123|P6|STARTED|Second Wear Period (1 Day)||4
14137|NCT02402127|35124|P5|STARTED|Second Wear Period (1 Day)||4
14138|NCT02402127|35125|P4|STARTED|Second Wear Period (1 Day)||4
14139|NCT02402127|35126|P3|STARTED|Second Wear Period (1 Day)||4
14140|NCT02402127|35127|P2|STARTED|Second Wear Period (1 Day)||4
14141|NCT02402127|35128|P1|STARTED|Second Wear Period (1 Day)||4
14142|NCT02402127|35123|P6|NOT COMPLETED|First Wear Period (1 Day)||0
14143|NCT02402127|35124|P5|NOT COMPLETED|First Wear Period (1 Day)||0
14144|NCT02402127|35125|P4|NOT COMPLETED|First Wear Period (1 Day)||0
14145|NCT02402127|35126|P3|NOT COMPLETED|First Wear Period (1 Day)||0
14146|NCT02402127|35127|P2|NOT COMPLETED|First Wear Period (1 Day)||0
14147|NCT02402127|35128|P1|NOT COMPLETED|First Wear Period (1 Day)||0
14148|NCT02402127|35123|P6|COMPLETED|First Wear Period (1 Day)||4
14149|NCT02402127|35124|P5|COMPLETED|First Wear Period (1 Day)||4
14150|NCT02402127|35125|P4|COMPLETED|First Wear Period (1 Day)||4
14151|NCT02402127|35126|P3|COMPLETED|First Wear Period (1 Day)||4
14152|NCT02402127|35127|P2|COMPLETED|First Wear Period (1 Day)||4
14153|NCT02402127|35128|P1|COMPLETED|First Wear Period (1 Day)||4
14154|NCT02402127|35123|P6|Randomized and Treated|First Wear Period (1 Day)||4
14155|NCT02402127|35124|P5|Randomized and Treated|First Wear Period (1 Day)||4
14156|NCT02402127|35125|P4|Randomized and Treated|First Wear Period (1 Day)||4
14157|NCT02402127|35126|P3|Randomized and Treated|First Wear Period (1 Day)||4
14158|NCT02402127|35127|P2|Randomized and Treated|First Wear Period (1 Day)||4
14159|NCT02402127|35128|P1|Randomized and Treated|First Wear Period (1 Day)||4
14160|NCT02402127|35123|P6|STARTED|First Wear Period (1 Day)||4
14161|NCT02402127|35124|P5|STARTED|First Wear Period (1 Day)||4
14162|NCT02402127|35125|P4|STARTED|First Wear Period (1 Day)||4
14163|NCT02402127|35126|P3|STARTED|First Wear Period (1 Day)||4
14164|NCT02402127|35127|P2|STARTED|First Wear Period (1 Day)||4
14165|NCT02402127|35128|P1|STARTED|First Wear Period (1 Day)||4
14166|NCT02401867|35139|P1|NOT COMPLETED|Analysis||9
14167|NCT02401867|35139|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
14168|NCT02401867|35139|P1|STARTED|Analysis||140
14169|NCT02401867|35139|P1|NOT COMPLETED|Specimen Collection||10
14170|NCT02401867|35139|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
14171|NCT02401867|35139|P1|STARTED|Specimen Collection||150
14172|NCT02401867|35139|P1|NOT COMPLETED|Enrolled||0
14173|NCT02401867|35139|P1|COMPLETED|Enrolled||150
14174|NCT02401867|35139|P1|STARTED|Enrolled||150
14175|NCT02401555|35147|P3|NOT COMPLETED|Overall Study||0
14176|NCT02401555|35148|P2|NOT COMPLETED|Overall Study||0
14177|NCT02401555|35149|P1|NOT COMPLETED|Overall Study||0
14178|NCT02401555|35147|P3|COMPLETED|Overall Study||120
14179|NCT02401555|35148|P2|COMPLETED|Overall Study||212
14180|NCT02401555|35149|P1|COMPLETED|Overall Study||87
14181|NCT02401555|35147|P3|STARTED|Overall Study||120
14182|NCT02401555|35148|P2|STARTED|Overall Study||212
14183|NCT02401555|35149|P1|STARTED|Overall Study||87
14184|NCT02401529|35159|P2|NOT COMPLETED|Overall Study||7
14185|NCT02401529|35160|P1|NOT COMPLETED|Overall Study||9
14186|NCT02401529|35159|P2|COMPLETED|Overall Study||50
14187|NCT02401529|35160|P1|COMPLETED|Overall Study||50
14188|NCT02401529|35159|P2|STARTED|Overall Study||57
14189|NCT02401529|35160|P1|STARTED|Overall Study||59
14190|NCT02401464|35188|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
14191|NCT02401464|35189|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
14192|NCT02401464|35190|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
14193|NCT02401464|35191|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
14194|NCT02401464|35188|P4|COMPLETED|Intervention Period 2 (6 Days)||13
14195|NCT02401464|35189|P3|COMPLETED|Intervention Period 2 (6 Days)||13
14196|NCT02401464|35190|P2|COMPLETED|Intervention Period 2 (6 Days)||13
14197|NCT02401464|35191|P1|COMPLETED|Intervention Period 2 (6 Days)||13
14198|NCT02401464|35188|P4|STARTED|Intervention Period 2 (6 Days)||13
14199|NCT02401464|35189|P3|STARTED|Intervention Period 2 (6 Days)||13
14200|NCT02401464|35190|P2|STARTED|Intervention Period 2 (6 Days)||13
14201|NCT02401464|35191|P1|STARTED|Intervention Period 2 (6 Days)||13
14202|NCT02401464|35188|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
14203|NCT02401464|35189|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
14204|NCT02401464|35190|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
14205|NCT02401464|35191|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
14206|NCT02401464|35188|P4|COMPLETED|Washout Period (At Least 6 Days)||13
14207|NCT02401464|35189|P3|COMPLETED|Washout Period (At Least 6 Days)||13
14208|NCT02401464|35190|P2|COMPLETED|Washout Period (At Least 6 Days)||13
14209|NCT02401464|35191|P1|COMPLETED|Washout Period (At Least 6 Days)||13
14210|NCT02401464|35188|P4|STARTED|Washout Period (At Least 6 Days)||13
14211|NCT02401464|35189|P3|STARTED|Washout Period (At Least 6 Days)||13
14212|NCT02401464|35190|P2|STARTED|Washout Period (At Least 6 Days)||13
14213|NCT02401464|35191|P1|STARTED|Washout Period (At Least 6 Days)||13
14214|NCT02401464|35188|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
14215|NCT02401464|35189|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
14216|NCT02401464|35190|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
14217|NCT02401464|35191|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
14218|NCT02401464|35188|P4|COMPLETED|Intervention Period 1 (6 Days)||13
14219|NCT02401464|35189|P3|COMPLETED|Intervention Period 1 (6 Days)||13
14220|NCT02401464|35190|P2|COMPLETED|Intervention Period 1 (6 Days)||13
14221|NCT02401464|35191|P1|COMPLETED|Intervention Period 1 (6 Days)||13
14222|NCT02401464|35188|P4|STARTED|Intervention Period 1 (6 Days)||13
14223|NCT02401464|35189|P3|STARTED|Intervention Period 1 (6 Days)||13
14224|NCT02401464|35190|P2|STARTED|Intervention Period 1 (6 Days)||13
14225|NCT02401464|35191|P1|STARTED|Intervention Period 1 (6 Days)||13
14226|NCT02401256|35225|P1|NOT COMPLETED|Overall Study||17
14227|NCT02401256|35225|P1|COMPLETED|Overall Study||53
14228|NCT02401256|35225|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
14229|NCT02401256|35225|P1|Finished Phase 3|Overall Study||53
14230|NCT02401256|35225|P1|Finished Phase 2|Overall Study||58
14231|NCT02401256|35225|P1|Finished Phase 1|Overall Study||64
14232|NCT02401256|35225|P1|STARTED|Overall Study||70
14233|NCT02401230|35234|P3|NOT COMPLETED|Overall Study||4
14234|NCT02401230|35235|P2|NOT COMPLETED|Overall Study||6
14235|NCT02401230|35236|P1|NOT COMPLETED|Overall Study||6
14236|NCT02401230|35234|P3|COMPLETED|Overall Study||21
14237|NCT02401230|35235|P2|COMPLETED|Overall Study||19
14238|NCT02401230|35236|P1|COMPLETED|Overall Study||20
14239|NCT02401230|35234|P3|STARTED|Overall Study||25
14240|NCT02401230|35235|P2|STARTED|Overall Study||25
14241|NCT02401230|35236|P1|STARTED|Overall Study||26
14242|NCT02401022|35271|P2|NOT COMPLETED|Overall Study||20
14243|NCT02401022|35272|P1|NOT COMPLETED|Overall Study||15
14244|NCT02401022|35271|P2|COMPLETED|Overall Study||90
14245|NCT02401022|35272|P1|COMPLETED|Overall Study||89
14246|NCT02401022|35271|P2|STARTED|Overall Study||110
14247|NCT02401022|35272|P1|STARTED|Overall Study||104
14248|NCT02400996|35278|P1|NOT COMPLETED|Overall Study||0
14249|NCT02400996|35278|P1|COMPLETED|Overall Study||40
14250|NCT02400996|35278|P1|STARTED|Overall Study||40
14251|NCT02400710|35284|P2|NOT COMPLETED|Overall Study||0
14252|NCT02400710|35285|P1|NOT COMPLETED|Overall Study||0
14253|NCT02400710|35284|P2|COMPLETED|Overall Study||10
14254|NCT02400710|35285|P1|COMPLETED|Overall Study||10
14255|NCT02400710|35284|P2|STARTED|Overall Study||10
14256|NCT02400710|35285|P1|STARTED|Overall Study||10
14257|NCT02400580|35295|P2|NOT COMPLETED|Overall Study||1
14258|NCT02400580|35296|P1|NOT COMPLETED|Overall Study||2
14259|NCT02400580|35295|P2|COMPLETED|Overall Study||91
14260|NCT02400580|35296|P1|COMPLETED|Overall Study||89
14261|NCT02400580|35295|P2|STARTED|Overall Study||92
14262|NCT02400580|35296|P1|STARTED|Overall Study||91
14263|NCT02400346|35306|P1|NOT COMPLETED|Overall Study||44
14264|NCT02400346|35306|P1|COMPLETED|Overall Study||88
14265|NCT02400346|35306|P1|STARTED|Overall Study||132
14266|NCT02400333|35314|P4|NOT COMPLETED|Overall Study||2
14267|NCT02400333|35315|P3|NOT COMPLETED|Overall Study||2
14268|NCT02400333|35316|P2|NOT COMPLETED|Overall Study||1
14269|NCT02400333|35317|P1|NOT COMPLETED|Overall Study||1
14270|NCT02400333|35314|P4|COMPLETED|Overall Study||7
14271|NCT02400333|35315|P3|COMPLETED|Overall Study||7
14272|NCT02400333|35316|P2|COMPLETED|Overall Study||8
14273|NCT02400333|35317|P1|COMPLETED|Overall Study||8
14274|NCT02400333|35314|P4|STARTED|Overall Study||9
14275|NCT02400333|35315|P3|STARTED|Overall Study||9
14276|NCT02400333|35316|P2|STARTED|Overall Study||9
14277|NCT02400333|35317|P1|STARTED|Overall Study||9
14278|NCT02399345|35375|P1|NOT COMPLETED|Overall Study||0
14279|NCT02399345|35375|P1|COMPLETED|Overall Study||10
14280|NCT02399345|35375|P1|STARTED|Overall Study||10
14281|NCT02399163|35381|P1|NOT COMPLETED|Overall Study||9
14282|NCT02399163|35381|P1|COMPLETED|Overall Study||53
14283|NCT02399163|35381|P1|STARTED|Overall Study||62
14284|NCT02399111|35409|P4|NOT COMPLETED|Overall Study||0
14285|NCT02399111|35410|P3|NOT COMPLETED|Overall Study||0
14286|NCT02399111|35411|P2|NOT COMPLETED|Overall Study||0
14287|NCT02399111|35412|P1|NOT COMPLETED|Overall Study||0
14288|NCT02399111|35409|P4|COMPLETED|Overall Study||0
14289|NCT02399111|35410|P3|COMPLETED|Overall Study||4
14290|NCT02399111|35411|P2|COMPLETED|Overall Study||1
14291|NCT02399111|35412|P1|COMPLETED|Overall Study||4
14292|NCT02399111|35409|P4|STARTED|Overall Study||0
14293|NCT02399111|35410|P3|STARTED|Overall Study||4
14294|NCT02399111|35411|P2|STARTED|Overall Study||1
14295|NCT02399111|35412|P1|STARTED|Overall Study||4
14296|NCT02397915|35426|P4|NOT COMPLETED|Period 2||0
14297|NCT02397915|35427|P3|NOT COMPLETED|Period 2||0
14298|NCT02397915|35428|P2|NOT COMPLETED|Period 2||0
14299|NCT02397915|35429|P1|NOT COMPLETED|Period 2||0
14300|NCT02397915|35426|P4|COMPLETED|Period 2||149
14301|NCT02397915|35427|P3|COMPLETED|Period 2||149
14302|NCT02397915|35428|P2|COMPLETED|Period 2||0
14303|NCT02397915|35429|P1|COMPLETED|Period 2||0
14304|NCT02397915|35426|P4|STARTED|Period 2||149
14305|NCT02397915|35427|P3|STARTED|Period 2||149
14306|NCT02397915|35428|P2|STARTED|Period 2||0
14307|NCT02397915|35429|P1|STARTED|Period 2||0
14308|NCT02397915|35426|P4|NOT COMPLETED|Period 1||0
14309|NCT02397915|35427|P3|NOT COMPLETED|Period 1||0
14310|NCT02397915|35428|P2|NOT COMPLETED|Period 1||1
14311|NCT02397915|35429|P1|NOT COMPLETED|Period 1||1
14312|NCT02397915|35426|P4|COMPLETED|Period 1||0
14313|NCT02397915|35427|P3|COMPLETED|Period 1||0
14314|NCT02397915|35428|P2|COMPLETED|Period 1||149
14315|NCT02397915|35429|P1|COMPLETED|Period 1||149
14316|NCT02397915|35426|P4|STARTED|Period 1||0
14317|NCT02397915|35427|P3|STARTED|Period 1||0
14318|NCT02397915|35428|P2|STARTED|Period 1||150
14319|NCT02397915|35429|P1|STARTED|Period 1||150
14320|NCT02397785|35481|P2|NOT COMPLETED|Overall Study||9
14321|NCT02397785|35482|P1|NOT COMPLETED|Overall Study||2
14322|NCT02397785|35481|P2|COMPLETED|Overall Study||25
14323|NCT02397785|35482|P1|COMPLETED|Overall Study||22
14324|NCT02397785|35481|P2|STARTED|Overall Study||34
14325|NCT02397785|35482|P1|STARTED|Overall Study||24
14326|NCT02397694|35528|P2|NOT COMPLETED|Open Label Extension Phase||30
14327|NCT02397694|35529|P1|NOT COMPLETED|Open Label Extension Phase||62
14328|NCT02397694|35528|P2|COMPLETED|Open Label Extension Phase||0
14329|NCT02397694|35529|P1|COMPLETED|Open Label Extension Phase||0
14330|NCT02397694|35528|P2|STARTED|Open Label Extension Phase||30
14331|NCT02397694|35529|P1|STARTED|Open Label Extension Phase||62
14332|NCT02397694|35528|P2|NOT COMPLETED|Double-Blinded Phase||3
14333|NCT02397694|35529|P1|NOT COMPLETED|Double-Blinded Phase||3
14334|NCT02397694|35528|P2|COMPLETED|Double-Blinded Phase||30
14335|NCT02397694|35529|P1|COMPLETED|Double-Blinded Phase||62
14336|NCT02397694|35528|P2|STARTED|Double-Blinded Phase||33
14337|NCT02397694|35529|P1|STARTED|Double-Blinded Phase||65
14338|NCT02397655|35567|P1|NOT COMPLETED|Overall Study||1301
14339|NCT02397655|35567|P1|COMPLETED|Overall Study||10711
14340|NCT02397655|35567|P1|STARTED|Overall Study||12012
14341|NCT02397564|35571|P1|NOT COMPLETED|Overall Study||4
14342|NCT02397564|35571|P1|COMPLETED|Overall Study||16
14343|NCT02397564|35571|P1|STARTED|Overall Study||20
14344|NCT02397122|35578|P2|NOT COMPLETED|Overall Study||0
14345|NCT02397122|35579|P1|NOT COMPLETED|Overall Study||0
14346|NCT02397122|35578|P2|COMPLETED|Overall Study||20
14347|NCT02397122|35579|P1|COMPLETED|Overall Study||20
14348|NCT02397122|35578|P2|STARTED|Overall Study||20
14349|NCT02397122|35579|P1|STARTED|Overall Study||20
14350|NCT02396537|35597|P2|NOT COMPLETED|Overall Study||1
14351|NCT02396537|35598|P1|NOT COMPLETED|Overall Study||0
14352|NCT02396537|35597|P2|COMPLETED|Overall Study||36
14353|NCT02396537|35598|P1|COMPLETED|Overall Study||40
14354|NCT02396537|35597|P2|STARTED|Overall Study||37
14355|NCT02396537|35598|P1|STARTED|Overall Study||40
14356|NCT02396316|35606|P2|NOT COMPLETED|Overall Study||5
14357|NCT02396316|35607|P1|NOT COMPLETED|Overall Study||7
14358|NCT02396316|35606|P2|COMPLETED|Overall Study||22
14359|NCT02396316|35607|P1|COMPLETED|Overall Study||20
14360|NCT02396316|35606|P2|Received Active Injection at Week 9|Overall Study||1
14361|NCT02396316|35607|P1|Received Active Injection at Week 9|Overall Study||2
14362|NCT02396316|35606|P2|Received Active Injection at Week 5|Overall Study||4
14363|NCT02396316|35607|P1|Received Active Injection at Week 5|Overall Study||4
14364|NCT02396316|35606|P2|Received AFL Injection at Week 1|Overall Study||22
14365|NCT02396316|35607|P1|Received AFL Injection at Week 1|Overall Study||0
14366|NCT02396316|35606|P2|Received Sham Injection at Week 1|Overall Study||0
14367|NCT02396316|35607|P1|Received Sham Injection at Week 1|Overall Study||10
14368|NCT02396316|35606|P2|Treated|Overall Study||27
14369|NCT02396316|35607|P1|Treated|Overall Study||27
14370|NCT02396316|35606|P2|STARTED|Overall Study||27
14371|NCT02396316|35607|P1|STARTED|Overall Study||27
14372|NCT02396160|35619|P2|NOT COMPLETED|Overall Study||2
14373|NCT02396160|35620|P1|NOT COMPLETED|Overall Study||6
14374|NCT02396160|35619|P2|COMPLETED|Overall Study||73
14375|NCT02396160|35620|P1|COMPLETED|Overall Study||69
14376|NCT02396160|35619|P2|STARTED|Overall Study||75
14377|NCT02396160|35620|P1|STARTED|Overall Study||75
14378|NCT02396147|35636|P2|NOT COMPLETED|Period 3||0
14379|NCT02396147|35637|P1|NOT COMPLETED|Period 3||0
14380|NCT02396147|35636|P2|COMPLETED|Period 3||27
14381|NCT02396147|35637|P1|COMPLETED|Period 3||27
14382|NCT02396147|35636|P2|STARTED|Period 3||27
14383|NCT02396147|35637|P1|STARTED|Period 3||27
14384|NCT02396147|35636|P2|NOT COMPLETED|Period 2||0
14385|NCT02396147|35637|P1|NOT COMPLETED|Period 2||0
14386|NCT02396147|35636|P2|COMPLETED|Period 2||27
14387|NCT02396147|35637|P1|COMPLETED|Period 2||27
14388|NCT02396147|35636|P2|STARTED|Period 2||27
14389|NCT02396147|35637|P1|STARTED|Period 2||27
14390|NCT02396147|35636|P2|NOT COMPLETED|Period 1||0
14391|NCT02396147|35637|P1|NOT COMPLETED|Period 1||0
14392|NCT02396147|35636|P2|COMPLETED|Period 1||27
14393|NCT02396147|35637|P1|COMPLETED|Period 1||27
14394|NCT02396147|35636|P2|STARTED|Period 1||27
14395|NCT02396147|35637|P1|STARTED|Period 1||27
14396|NCT02395822|35705|P1|NOT COMPLETED|Overall Study||2
14397|NCT02395822|35705|P1|COMPLETED|Overall Study||15
14398|NCT02395822|35705|P1|STARTED|Overall Study||17
14399|NCT02395653|35713|P1|NOT COMPLETED|Overall Study||12
14400|NCT02395653|35713|P1|COMPLETED|Overall Study||59
14401|NCT02395653|35713|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
14402|NCT02395653|35713|P1|STARTED|Overall Study||71
14403|NCT02395536|35722|P2|NOT COMPLETED|Overall Study||30
14404|NCT02395536|35723|P1|NOT COMPLETED|Overall Study||20
14405|NCT02395536|35722|P2|COMPLETED|Overall Study||227
14406|NCT02395536|35723|P1|COMPLETED|Overall Study||244
14407|NCT02395536|35722|P2|REVEAL LINQ Insertion|Overall Study||231
14408|NCT02395536|35723|P1|REVEAL LINQ Insertion|Overall Study||251
14409|NCT02395536|35722|P2|STARTED|Overall Study||257
14410|NCT02395536|35723|P1|STARTED|Overall Study||264
14411|NCT02395302|35729|P1|NOT COMPLETED|Overall Study||14
14412|NCT02395302|35729|P1|COMPLETED|Overall Study||14
14413|NCT02395302|35729|P1|STARTED|Overall Study||28
14414|NCT02395185|35733|P1|NOT COMPLETED|Overall Study||0
14415|NCT02395185|35733|P1|COMPLETED|Overall Study||33
14416|NCT02395185|35733|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
14417|NCT02395185|35733|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
14418|NCT02395185|35733|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
14419|NCT02395185|35733|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
14420|NCT02395185|35733|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
14421|NCT02395185|35733|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
14422|NCT02395185|35733|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
14423|NCT02395185|35733|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
14424|NCT02395185|35733|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
14425|NCT02395185|35733|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
14426|NCT02395185|35733|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
14427|NCT02395185|35733|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
14428|NCT02395185|35733|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
14429|NCT02395185|35733|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
14430|NCT02395185|35733|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
14431|NCT02395185|35733|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
14432|NCT02395185|35733|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
14433|NCT02395185|35733|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
14434|NCT02395185|35733|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
14435|NCT02395055|35749|P2|NOT COMPLETED|Overall Study||3
14436|NCT02395055|35750|P1|NOT COMPLETED|Overall Study||7
14437|NCT02395055|35749|P2|COMPLETED|Overall Study||44
14438|NCT02395055|35750|P1|COMPLETED|Overall Study||40
14439|NCT02395055|35749|P2|STARTED|Overall Study||47
14440|NCT02395055|35750|P1|STARTED|Overall Study||47
14441|NCT02394925|35760|P1|NOT COMPLETED|Overall Study||29
14442|NCT02394925|35760|P1|COMPLETED|Overall Study||79
14443|NCT02394925|35760|P1|STARTED|Overall Study||108
14444|NCT02394808|35764|P2|NOT COMPLETED|Period 2||0
14445|NCT02394808|35765|P1|NOT COMPLETED|Period 2||1
14446|NCT02394808|35764|P2|COMPLETED|Period 2||28
14447|NCT02394808|35765|P1|COMPLETED|Period 2||24
14448|NCT02394808|35764|P2|STARTED|Period 2||28
14449|NCT02394808|35765|P1|STARTED|Period 2||25
14450|NCT02394808|35764|P2|NOT COMPLETED|Period 1||1
14451|NCT02394808|35765|P1|NOT COMPLETED|Period 1||0
14452|NCT02394808|35764|P2|COMPLETED|Period 1||28
14453|NCT02394808|35765|P1|COMPLETED|Period 1||25
14454|NCT02394808|35764|P2|STARTED|Period 1||29
14455|NCT02394808|35765|P1|STARTED|Period 1||25
14456|NCT02394756|35773|P6|NOT COMPLETED|Period 3||0
14457|NCT02394756|35774|P5|NOT COMPLETED|Period 3||0
14458|NCT02394756|35775|P4|NOT COMPLETED|Period 3||0
14459|NCT02394756|35776|P3|NOT COMPLETED|Period 3||0
14460|NCT02394756|35777|P2|NOT COMPLETED|Period 3||0
14461|NCT02394756|35778|P1|NOT COMPLETED|Period 3||0
14462|NCT02394756|35773|P6|COMPLETED|Period 3||6
14463|NCT02394756|35774|P5|COMPLETED|Period 3||6
14464|NCT02394756|35775|P4|COMPLETED|Period 3||6
14465|NCT02394756|35776|P3|COMPLETED|Period 3||6
14466|NCT02394756|35777|P2|COMPLETED|Period 3||6
14467|NCT02394756|35778|P1|COMPLETED|Period 3||7
14468|NCT02394756|35773|P6|STARTED|Period 3||6
14469|NCT02394756|35774|P5|STARTED|Period 3||6
14470|NCT02394756|35775|P4|STARTED|Period 3||6
14471|NCT02394756|35776|P3|STARTED|Period 3||6
14472|NCT02394756|35777|P2|STARTED|Period 3||6
14473|NCT02394756|35778|P1|STARTED|Period 3||7
14474|NCT02394756|35773|P6|NOT COMPLETED|Period 2||0
14475|NCT02394756|35774|P5|NOT COMPLETED|Period 2||1
14476|NCT02394756|35775|P4|NOT COMPLETED|Period 2||0
14477|NCT02394756|35776|P3|NOT COMPLETED|Period 2||0
14478|NCT02394756|35777|P2|NOT COMPLETED|Period 2||0
14479|NCT02394756|35778|P1|NOT COMPLETED|Period 2||0
14480|NCT02394756|35773|P6|COMPLETED|Period 2||6
14481|NCT02394756|35774|P5|COMPLETED|Period 2||6
14482|NCT02394756|35775|P4|COMPLETED|Period 2||6
14483|NCT02394756|35776|P3|COMPLETED|Period 2||6
14484|NCT02394756|35777|P2|COMPLETED|Period 2||6
14485|NCT02394756|35778|P1|COMPLETED|Period 2||7
14486|NCT02394756|35773|P6|STARTED|Period 2||6
14487|NCT02394756|35774|P5|STARTED|Period 2||7
14488|NCT02394756|35775|P4|STARTED|Period 2||6
14489|NCT02394756|35776|P3|STARTED|Period 2||6
14490|NCT02394756|35777|P2|STARTED|Period 2||6
14491|NCT02394756|35778|P1|STARTED|Period 2||7
14492|NCT02394756|35773|P6|NOT COMPLETED|Period 1||1
14493|NCT02394756|35774|P5|NOT COMPLETED|Period 1||0
14494|NCT02394756|35775|P4|NOT COMPLETED|Period 1||1
14495|NCT02394756|35776|P3|NOT COMPLETED|Period 1||1
14496|NCT02394756|35777|P2|NOT COMPLETED|Period 1||1
14497|NCT02394756|35778|P1|NOT COMPLETED|Period 1||0
14498|NCT02394756|35773|P6|COMPLETED|Period 1||6
14499|NCT02394756|35774|P5|COMPLETED|Period 1||7
14500|NCT02394756|35775|P4|COMPLETED|Period 1||6
14501|NCT02394756|35776|P3|COMPLETED|Period 1||6
14502|NCT02394756|35777|P2|COMPLETED|Period 1||6
14503|NCT02394756|35778|P1|COMPLETED|Period 1||7
14504|NCT02394756|35773|P6|STARTED|Period 1||7
14505|NCT02394756|35774|P5|STARTED|Period 1||7
14506|NCT02394756|35775|P4|STARTED|Period 1||7
14507|NCT02394756|35776|P3|STARTED|Period 1||7
14508|NCT02394756|35777|P2|STARTED|Period 1||7
14509|NCT02394756|35778|P1|STARTED|Period 1||7
14510|NCT02394665|35792|P3|NOT COMPLETED|Overall Study||0
14511|NCT02394665|35793|P2|NOT COMPLETED|Overall Study||0
14512|NCT02394665|35794|P1|NOT COMPLETED|Overall Study||1
14513|NCT02394665|35792|P3|COMPLETED|Overall Study||0
14514|NCT02394665|35793|P2|COMPLETED|Overall Study||0
14515|NCT02394665|35794|P1|COMPLETED|Overall Study||0
14516|NCT02394665|35792|P3|STARTED|Overall Study||0
14517|NCT02394665|35793|P2|STARTED|Overall Study||0
14518|NCT02394665|35794|P1|STARTED|Overall Study||1
14519|NCT02394600|35816|P2|NOT COMPLETED|Overall Study||2
14520|NCT02394600|35817|P1|NOT COMPLETED|Overall Study||4
14521|NCT02394600|35816|P2|COMPLETED|Overall Study||44
14522|NCT02394600|35817|P1|COMPLETED|Overall Study||43
14523|NCT02394600|35816|P2|STARTED|Overall Study||46
14524|NCT02394600|35817|P1|STARTED|Overall Study||47
14525|NCT02394457|35827|P2|NOT COMPLETED|Overall Study||0
14526|NCT02394457|35828|P1|NOT COMPLETED|Overall Study||0
14527|NCT02394457|35827|P2|COMPLETED|Overall Study||13
14528|NCT02394457|35828|P1|COMPLETED|Overall Study||15
14529|NCT02394457|35827|P2|STARTED|Overall Study||13
14530|NCT02394457|35828|P1|STARTED|Overall Study||15
14531|NCT02393950|35846|P2|NOT COMPLETED|Overall Study||1
14532|NCT02393950|35847|P1|NOT COMPLETED|Overall Study||1
14533|NCT02393950|35846|P2|COMPLETED|Overall Study||8
14534|NCT02393950|35847|P1|COMPLETED|Overall Study||8
14535|NCT02393950|35846|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
14536|NCT02393950|35847|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
14537|NCT02393950|35846|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
14538|NCT02393950|35847|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
14539|NCT02393950|35846|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
14540|NCT02393950|35847|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
14541|NCT02393950|35846|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
14542|NCT02393950|35847|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
14543|NCT02393950|35846|P2|STARTED|Overall Study||9
14544|NCT02393950|35847|P1|STARTED|Overall Study||9
14545|NCT02393677|35914|P2|NOT COMPLETED|Overall Study||0
14546|NCT02393677|35915|P1|NOT COMPLETED|Overall Study||0
14547|NCT02393677|35914|P2|COMPLETED|Overall Study||40
14548|NCT02393677|35915|P1|COMPLETED|Overall Study||40
14549|NCT02393677|35914|P2|STARTED|Overall Study||40
14550|NCT02393677|35915|P1|STARTED|Overall Study||40
14551|NCT02393547|35921|P1|NOT COMPLETED|Overall Study||6
14552|NCT02393547|35921|P1|COMPLETED|Overall Study||14
14553|NCT02393547|35921|P1|STARTED|Overall Study||20
14554|NCT02393209|35930|P4|NOT COMPLETED|Overall Study||0
14555|NCT02393209|35931|P3|NOT COMPLETED|Overall Study||0
14556|NCT02393209|35932|P2|NOT COMPLETED|Overall Study||8
14557|NCT02393209|35933|P1|NOT COMPLETED|Overall Study||6
14558|NCT02393209|35930|P4|COMPLETED|Overall Study||0
14559|NCT02393209|35931|P3|COMPLETED|Overall Study||0
14560|NCT02393209|35932|P2|COMPLETED|Overall Study||0
14561|NCT02393209|35933|P1|COMPLETED|Overall Study||0
14562|NCT02393209|35930|P4|STARTED|Overall Study||0
14563|NCT02393209|35931|P3|STARTED|Overall Study||0
14564|NCT02393209|35932|P2|STARTED|Overall Study||8
14565|NCT02393209|35933|P1|STARTED|Overall Study||6
14566|NCT02392806|35991|P2|NOT COMPLETED|Overall Study||0
14567|NCT02392806|35992|P1|NOT COMPLETED|Overall Study||0
14568|NCT02392806|35991|P2|COMPLETED|Overall Study||21
14569|NCT02392806|35992|P1|COMPLETED|Overall Study||22
14570|NCT02392806|35991|P2|STARTED|Overall Study||21
14571|NCT02392806|35992|P1|STARTED|Overall Study||22
14572|NCT02392767|36002|P2|NOT COMPLETED|Overall Study||0
14573|NCT02392767|36003|P1|NOT COMPLETED|Overall Study||0
14574|NCT02392767|36002|P2|COMPLETED|Overall Study||13
14575|NCT02392767|36003|P1|COMPLETED|Overall Study||12
14576|NCT02392767|36002|P2|STARTED|Overall Study||13
14577|NCT02392767|36003|P1|STARTED|Overall Study||12
14578|NCT02392624|36022|P3|NOT COMPLETED|Overall Study||13
14579|NCT02392624|36023|P2|NOT COMPLETED|Overall Study||15
14580|NCT02392624|36024|P1|NOT COMPLETED|Overall Study||71
14581|NCT02392624|36022|P3|COMPLETED|Overall Study||40
14582|NCT02392624|36023|P2|COMPLETED|Overall Study||66
14583|NCT02392624|36024|P1|COMPLETED|Overall Study||0
14584|NCT02392624|36022|P3|STARTED|Overall Study||53
14585|NCT02392624|36023|P2|STARTED|Overall Study||81
14586|NCT02392624|36024|P1|STARTED|Overall Study||71
14587|NCT02392377|36039|P2|NOT COMPLETED|Overall Study||1
14588|NCT02392377|36040|P1|NOT COMPLETED|Overall Study||0
14589|NCT02392377|36039|P2|COMPLETED|Overall Study||0
14590|NCT02392377|36040|P1|COMPLETED|Overall Study||0
14591|NCT02392377|36039|P2|STARTED|Overall Study||1
14592|NCT02392377|36040|P1|STARTED|Overall Study||0
14593|NCT02392247|36064|P1|NOT COMPLETED|Overall Study||2
14594|NCT02392247|36064|P1|COMPLETED|Overall Study||50
14595|NCT02392247|36064|P1|STARTED|Overall Study||52
14596|NCT02392208|36069|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
14597|NCT02392208|36069|P1|COMPLETED|Telavancin After Hemodialysis||8
14598|NCT02392208|36069|P1|STARTED|Telavancin After Hemodialysis||8
14599|NCT02392208|36069|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
14600|NCT02392208|36069|P1|COMPLETED|Telavancin Before Hemodialysis||8
14601|NCT02392208|36069|P1|STARTED|Telavancin Before Hemodialysis||8
14602|NCT02392000|36079|P1|NOT COMPLETED|Overall Study||27
14603|NCT02392000|36079|P1|COMPLETED|Overall Study||11
14604|NCT02392000|36079|P1|STARTED|Overall Study||38
14605|NCT02391714|36089|P2|NOT COMPLETED|Overall Study||0
14606|NCT02391714|36090|P1|NOT COMPLETED|Overall Study||0
14607|NCT02391714|36089|P2|COMPLETED|Overall Study||40
14608|NCT02391714|36090|P1|COMPLETED|Overall Study||40
14609|NCT02391714|36089|P2|STARTED|Overall Study||40
14610|NCT02391714|36090|P1|STARTED|Overall Study||40
14611|NCT02391311|36102|P2|NOT COMPLETED|Overall Study||2
14612|NCT02391311|36103|P1|NOT COMPLETED|Overall Study||3
14613|NCT02391311|36102|P2|COMPLETED|Overall Study||19
14614|NCT02391311|36103|P1|COMPLETED|Overall Study||18
14615|NCT02391311|36102|P2|STARTED|Overall Study||21
14616|NCT02391311|36103|P1|STARTED|Overall Study||21
14617|NCT02391116|36111|P1|NOT COMPLETED|Survival Follow-up||14
14618|NCT02391116|36111|P1|COMPLETED|Survival Follow-up|Reason for completion in this period was death.|31
14619|NCT02391116|36111|P1|STARTED|Survival Follow-up|21 patients discontinued from treatment didn't enter due to withdrawal by subject(3) and death(18)|45
14620|NCT02391116|36111|P1|NOT COMPLETED|Active Follow-up||3
14621|NCT02391116|36111|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD.|7
14622|NCT02391116|36111|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological assessments|10
14623|NCT02391116|36111|P1|NOT COMPLETED|Safety Follow-up||13
14624|NCT02391116|36111|P1|COMPLETED|Safety Follow-up|14 subjects were considered completed due to death.|41
14625|NCT02391116|36111|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 10 subjects entering active follow-up|54
14626|NCT02391116|36111|P1|NOT COMPLETED|Treatment||15
14627|NCT02391116|36111|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD and lack of efficacy (1).|52
14628|NCT02391116|36111|P1|Included in Per Protocol Set|Treatment||40
14629|NCT02391116|36111|P1|STARTED|Treatment||67
14630|NCT02391038|36164|P3|NOT COMPLETED|Overall Study||6
14631|NCT02391038|36165|P2|NOT COMPLETED|Overall Study||3
14632|NCT02391038|36166|P1|NOT COMPLETED|Overall Study||3
14633|NCT02391038|36164|P3|COMPLETED|Overall Study||0
14634|NCT02391038|36165|P2|COMPLETED|Overall Study||0
14635|NCT02391038|36166|P1|COMPLETED|Overall Study||0
14636|NCT02391038|36164|P3|STARTED|Overall Study||6
14637|NCT02391038|36165|P2|STARTED|Overall Study||3
14638|NCT02391038|36166|P1|STARTED|Overall Study||3
14639|NCT02390219|36280|P1|NOT COMPLETED|Overall Study||13
14640|NCT02390219|36280|P1|COMPLETED|Overall Study||33
14641|NCT02390219|36280|P1|STARTED|Overall Study||46
14642|NCT02390167|36290|P1|NOT COMPLETED|Overall Study||1
14643|NCT02390167|36290|P1|COMPLETED|Overall Study||375
14644|NCT02390167|36290|P1|Without Diabetes|Overall Study||43
14645|NCT02390167|36290|P1|With Diabetes|Overall Study||333
14646|NCT02390167|36290|P1|STARTED|Overall Study||376
14647|NCT02389881|36316|P7|NOT COMPLETED|Overall Study||0
14648|NCT02389881|36317|P6|NOT COMPLETED|Overall Study||0
14649|NCT02389881|36318|P5|NOT COMPLETED|Overall Study||0
14650|NCT02389881|36319|P4|NOT COMPLETED|Overall Study||0
14651|NCT02389881|36320|P3|NOT COMPLETED|Overall Study||0
14652|NCT02389881|36321|P2|NOT COMPLETED|Overall Study||0
14653|NCT02389881|36322|P1|NOT COMPLETED|Overall Study||0
14654|NCT02389881|36316|P7|COMPLETED|Overall Study||2
14655|NCT02389881|36317|P6|COMPLETED|Overall Study||8
14656|NCT02389881|36318|P5|COMPLETED|Overall Study||6
14657|NCT02389881|36319|P4|COMPLETED|Overall Study||6
14658|NCT02389881|36320|P3|COMPLETED|Overall Study||6
14659|NCT02389881|36321|P2|COMPLETED|Overall Study||6
14660|NCT02389881|36322|P1|COMPLETED|Overall Study||6
14661|NCT02389881|36316|P7|STARTED|Overall Study||2
14662|NCT02389881|36317|P6|STARTED|Overall Study||8
14663|NCT02389881|36318|P5|STARTED|Overall Study||6
14664|NCT02389881|36319|P4|STARTED|Overall Study||6
14665|NCT02389881|36320|P3|STARTED|Overall Study||6
14666|NCT02389881|36321|P2|STARTED|Overall Study||6
14667|NCT02389881|36322|P1|STARTED|Overall Study||6
14668|NCT02389452|36371|P1|NOT COMPLETED|Overall Study||25
14669|NCT02389452|36371|P1|COMPLETED|Overall Study||369
14670|NCT02389452|36371|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
14671|NCT02389452|36371|P1|STARTED|Overall Study||394
14672|NCT02389374|36392|P3|NOT COMPLETED|Overall Study||1
14673|NCT02389374|36393|P2|NOT COMPLETED|Overall Study||28
14674|NCT02389374|36394|P1|NOT COMPLETED|Overall Study||9
14675|NCT02389374|36392|P3|COMPLETED|Overall Study||10
14676|NCT02389374|36393|P2|COMPLETED|Overall Study||87
14677|NCT02389374|36394|P1|COMPLETED|Overall Study||46
14678|NCT02389374|36392|P3|STARTED|Overall Study||11
14679|NCT02389374|36393|P2|STARTED|Overall Study||115
14680|NCT02389374|36394|P1|STARTED|Overall Study||55
14681|NCT02389361|36426|P2|NOT COMPLETED|Overall Study||0
14682|NCT02389361|36427|P1|NOT COMPLETED|Overall Study||0
14683|NCT02389361|36426|P2|COMPLETED|Overall Study||27
14684|NCT02389361|36427|P1|COMPLETED|Overall Study||24
14685|NCT02389361|36426|P2|STARTED|Overall Study||27
14686|NCT02389361|36427|P1|STARTED|Overall Study||24
14687|NCT02389088|36433|P1|NOT COMPLETED|Phase II - All Study Participants||0
14688|NCT02389088|36433|P1|COMPLETED|Phase II - All Study Participants||9
14689|NCT02389088|36433|P1|STARTED|Phase II - All Study Participants||9
14690|NCT02389088|36433|P1|NOT COMPLETED|Overall Study - Phase I||0
14691|NCT02389088|36433|P1|COMPLETED|Overall Study - Phase I||9
14692|NCT02389088|36433|P1|STARTED|Overall Study - Phase I||9
14693|NCT02388815|36477|P1|NOT COMPLETED|Overall Study||4
14694|NCT02388815|36477|P1|COMPLETED|Overall Study||85
14695|NCT02388815|36477|P1|STARTED|Overall Study||89
14696|NCT02388776|36481|P1|NOT COMPLETED|Overall Study||2
14697|NCT02388776|36481|P1|COMPLETED|Overall Study||0
14698|NCT02388776|36481|P1|STARTED|Overall Study||2
14699|NCT02388763|36486|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
14700|NCT02388763|36487|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
14701|NCT02388763|36486|P2|COMPLETED|Period 2, 10 Days of Wear||30
14702|NCT02388763|36487|P1|COMPLETED|Period 2, 10 Days of Wear||30
14703|NCT02388763|36486|P2|STARTED|Period 2, 10 Days of Wear||30
14704|NCT02388763|36487|P1|STARTED|Period 2, 10 Days of Wear||30
14705|NCT02388763|36486|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
14706|NCT02388763|36487|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
14707|NCT02388763|36486|P2|COMPLETED|Period 1, 10 Days of Wear||30
14708|NCT02388763|36487|P1|COMPLETED|Period 1, 10 Days of Wear||30
14709|NCT02388763|36486|P2|STARTED|Period 1, 10 Days of Wear||31
14710|NCT02388763|36487|P1|STARTED|Period 1, 10 Days of Wear||31
14711|NCT02388763|36486|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
14712|NCT02388763|36487|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
14713|NCT02388763|36486|P2|COMPLETED|Habitual, 10 Days of Wear||31
14714|NCT02388763|36487|P1|COMPLETED|Habitual, 10 Days of Wear||31
14715|NCT02388763|36486|P2|STARTED|Habitual, 10 Days of Wear||32
14716|NCT02388763|36487|P1|STARTED|Habitual, 10 Days of Wear||32
14717|NCT02388347|36503|P5|NOT COMPLETED|Overall Study||0
14718|NCT02388347|36504|P4|NOT COMPLETED|Overall Study||0
14719|NCT02388347|36505|P3|NOT COMPLETED|Overall Study||1
14720|NCT02388347|36506|P2|NOT COMPLETED|Overall Study||0
14721|NCT02388347|36507|P1|NOT COMPLETED|Overall Study||0
14722|NCT02388347|36503|P5|COMPLETED|Overall Study||6
14723|NCT02388347|36504|P4|COMPLETED|Overall Study||6
14724|NCT02388347|36505|P3|COMPLETED|Overall Study||5
14725|NCT02388347|36506|P2|COMPLETED|Overall Study||6
14726|NCT02388347|36507|P1|COMPLETED|Overall Study||8
14727|NCT02388347|36503|P5|STARTED|Overall Study||6
14728|NCT02388347|36504|P4|STARTED|Overall Study||6
14729|NCT02388347|36505|P3|STARTED|Overall Study||6
14730|NCT02388347|36506|P2|STARTED|Overall Study||6
14731|NCT02388347|36507|P1|STARTED|Overall Study||8
14732|NCT02388321|36574|P2|NOT COMPLETED|Overall Study||0
14733|NCT02388321|36575|P1|NOT COMPLETED|Overall Study||0
14734|NCT02388321|36574|P2|COMPLETED|Overall Study||11
14735|NCT02388321|36575|P1|COMPLETED|Overall Study||11
14736|NCT02388321|36574|P2|STARTED|Overall Study||11
14737|NCT02388321|36575|P1|STARTED|Overall Study||11
14738|NCT02388295|36586|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
14739|NCT02388295|36587|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
14740|NCT02388295|36588|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
14741|NCT02388295|36586|P3|COMPLETED|Treatment Weeks 3 to 12||17
14742|NCT02388295|36587|P2|COMPLETED|Treatment Weeks 3 to 12||13
14743|NCT02388295|36588|P1|COMPLETED|Treatment Weeks 3 to 12||15
14744|NCT02388295|36586|P3|STARTED|Treatment Weeks 3 to 12||17
14745|NCT02388295|36587|P2|STARTED|Treatment Weeks 3 to 12||14
14746|NCT02388295|36588|P1|STARTED|Treatment Weeks 3 to 12||16
14747|NCT02388295|36586|P3|NOT COMPLETED|Dose Escalation Week 2||1
14748|NCT02388295|36587|P2|NOT COMPLETED|Dose Escalation Week 2||2
14749|NCT02388295|36588|P1|NOT COMPLETED|Dose Escalation Week 2||1
14750|NCT02388295|36586|P3|COMPLETED|Dose Escalation Week 2||17
14751|NCT02388295|36587|P2|COMPLETED|Dose Escalation Week 2||14
14752|NCT02388295|36588|P1|COMPLETED|Dose Escalation Week 2||16
14753|NCT02388295|36586|P3|STARTED|Dose Escalation Week 2||18
14754|NCT02388295|36587|P2|STARTED|Dose Escalation Week 2||16
14755|NCT02388295|36588|P1|STARTED|Dose Escalation Week 2||17
14756|NCT02388295|36586|P3|NOT COMPLETED|Dose Escalation Week 1||2
14757|NCT02388295|36587|P2|NOT COMPLETED|Dose Escalation Week 1||3
14758|NCT02388295|36588|P1|NOT COMPLETED|Dose Escalation Week 1||2
14759|NCT02388295|36586|P3|COMPLETED|Dose Escalation Week 1||18
14760|NCT02388295|36587|P2|COMPLETED|Dose Escalation Week 1||16
14761|NCT02388295|36588|P1|COMPLETED|Dose Escalation Week 1||17
14762|NCT02388295|36586|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
14763|NCT02388295|36587|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
14764|NCT02388295|36588|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
14765|NCT02388269|36606|P3|NOT COMPLETED|Overall Study||10
14766|NCT02388269|36607|P2|NOT COMPLETED|Overall Study||2
14767|NCT02388269|36608|P1|NOT COMPLETED|Overall Study||9
14768|NCT02388269|36606|P3|COMPLETED|Overall Study||0
14769|NCT02388269|36607|P2|COMPLETED|Overall Study||38
14770|NCT02388269|36608|P1|COMPLETED|Overall Study||32
14771|NCT02388269|36606|P3|Open Label|Overall Study||0
14772|NCT02388269|36607|P2|Open Label|Overall Study||38
14773|NCT02388269|36608|P1|Open Label|Overall Study||37
14774|NCT02388269|36606|P3|Randomised Period|Overall Study||0
14775|NCT02388269|36607|P2|Randomised Period|Overall Study||40
14776|NCT02388269|36608|P1|Randomised Period|Overall Study||41
14777|NCT02388269|36606|P3|STARTED|Overall Study||10
14778|NCT02388269|36607|P2|STARTED|Overall Study||40
14779|NCT02388269|36608|P1|STARTED|Overall Study||41
14780|NCT02388191|36640|P2|NOT COMPLETED|Overall Study||0
14781|NCT02388191|36641|P1|NOT COMPLETED|Overall Study||1
14782|NCT02388191|36640|P2|COMPLETED|Overall Study||60
14783|NCT02388191|36641|P1|COMPLETED|Overall Study||58
14784|NCT02388191|36640|P2|STARTED|Overall Study||60
14785|NCT02388191|36641|P1|STARTED|Overall Study||59
14786|NCT02388074|36655|P1|NOT COMPLETED|Overall Study||3
14787|NCT02388074|36655|P1|COMPLETED|Overall Study||22
14788|NCT02388074|36655|P1|STARTED|Overall Study||25
14789|NCT02387996|36659|P1|NOT COMPLETED|Overall Study||204
14790|NCT02387996|36659|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
14791|NCT02387996|36659|P1|STARTED|Overall Study||270
14792|NCT02387983|36670|P1|NOT COMPLETED|Overall Study||7
14793|NCT02387983|36670|P1|COMPLETED|Overall Study||58
14794|NCT02387983|36670|P1|STARTED|Overall Study||65
14795|NCT02387801|36684|P2|NOT COMPLETED|Post-Treatment Follow-up||0
14796|NCT02387801|36685|P1|NOT COMPLETED|Post-Treatment Follow-up||0
14797|NCT02387801|36684|P2|COMPLETED|Post-Treatment Follow-up||12
14798|NCT02387801|36685|P1|COMPLETED|Post-Treatment Follow-up||0
14799|NCT02387801|36684|P2|STARTED|Post-Treatment Follow-up||12
14800|NCT02387801|36685|P1|STARTED|Post-Treatment Follow-up||0
14801|NCT02387801|36684|P2|NOT COMPLETED|Maintenance Dosing Period||0
14802|NCT02387801|36685|P1|NOT COMPLETED|Maintenance Dosing Period||0
14803|NCT02387801|36684|P2|COMPLETED|Maintenance Dosing Period||12
14804|NCT02387801|36685|P1|COMPLETED|Maintenance Dosing Period||0
14805|NCT02387801|36684|P2|STARTED|Maintenance Dosing Period||12
14806|NCT02387801|36685|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
14807|NCT02387801|36684|P2|NOT COMPLETED|Induction Dosing Period||0
14808|NCT02387801|36685|P1|NOT COMPLETED|Induction Dosing Period||0
14809|NCT02387801|36684|P2|COMPLETED|Induction Dosing Period||6
14810|NCT02387801|36685|P1|COMPLETED|Induction Dosing Period||6
14811|NCT02387801|36684|P2|STARTED|Induction Dosing Period||6
14812|NCT02387801|36685|P1|STARTED|Induction Dosing Period||6
14813|NCT02387749|36703|P1|NOT COMPLETED|Overall Study||0
14814|NCT02387749|36703|P1|COMPLETED|Overall Study||10
14815|NCT02387749|36703|P1|STARTED|Overall Study||10
14816|NCT02387710|36712|P2|NOT COMPLETED|Second Study Night||0
14817|NCT02387710|36713|P1|NOT COMPLETED|Second Study Night||0
14818|NCT02387710|36712|P2|COMPLETED|Second Study Night||7
14819|NCT02387710|36713|P1|COMPLETED|Second Study Night||9
14820|NCT02387710|36712|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
14821|NCT02387710|36713|P1|STARTED|Second Study Night||9
14822|NCT02387710|36712|P2|NOT COMPLETED|First Study Night||0
14823|NCT02387710|36713|P1|NOT COMPLETED|First Study Night||0
14824|NCT02387710|36712|P2|COMPLETED|First Study Night||9
14825|NCT02387710|36713|P1|COMPLETED|First Study Night||9
14826|NCT02387710|36712|P2|STARTED|First Study Night||9
14827|NCT02387710|36713|P1|STARTED|First Study Night||9
14828|NCT02387580|36729|P6|NOT COMPLETED|Overall Study||0
14829|NCT02387580|36730|P5|NOT COMPLETED|Overall Study||0
14830|NCT02387580|36731|P4|NOT COMPLETED|Overall Study||1
14831|NCT02387580|36732|P3|NOT COMPLETED|Overall Study||0
14832|NCT02387580|36733|P2|NOT COMPLETED|Overall Study||0
14833|NCT02387580|36734|P1|NOT COMPLETED|Overall Study||0
14834|NCT02387580|36729|P6|COMPLETED|Overall Study||8
14835|NCT02387580|36730|P5|COMPLETED|Overall Study||8
14836|NCT02387580|36731|P4|COMPLETED|Overall Study||7
14837|NCT02387580|36732|P3|COMPLETED|Overall Study||8
14838|NCT02387580|36733|P2|COMPLETED|Overall Study||8
14839|NCT02387580|36734|P1|COMPLETED|Overall Study||8
14840|NCT02387580|36729|P6|STARTED|Overall Study||8
14841|NCT02387580|36730|P5|STARTED|Overall Study||8
14842|NCT02387580|36731|P4|STARTED|Overall Study||8
14843|NCT02387580|36732|P3|STARTED|Overall Study||8
14844|NCT02387580|36733|P2|STARTED|Overall Study||8
14845|NCT02387580|36734|P1|STARTED|Overall Study||8
14846|NCT02387554|36770|P4|NOT COMPLETED|Overall Study||2
14847|NCT02387554|36771|P3|NOT COMPLETED|Overall Study||2
14848|NCT02387554|36772|P2|NOT COMPLETED|Overall Study||0
14849|NCT02387554|36773|P1|NOT COMPLETED|Overall Study||3
14850|NCT02387554|36770|P4|COMPLETED|Overall Study||6
14851|NCT02387554|36771|P3|COMPLETED|Overall Study||6
14852|NCT02387554|36772|P2|COMPLETED|Overall Study||7
14853|NCT02387554|36773|P1|COMPLETED|Overall Study||7
14854|NCT02387554|36770|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
14855|NCT02387554|36771|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
14856|NCT02387554|36772|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
14857|NCT02387554|36773|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
14858|NCT02387502|36786|P3|NOT COMPLETED|Overall Study||0
14859|NCT02387502|36787|P2|NOT COMPLETED|Overall Study||0
14860|NCT02387502|36788|P1|NOT COMPLETED|Overall Study||0
14861|NCT02387502|36786|P3|COMPLETED|Overall Study||40
14862|NCT02387502|36787|P2|COMPLETED|Overall Study||40
14863|NCT02387502|36788|P1|COMPLETED|Overall Study||40
14864|NCT02387502|36786|P3|STARTED|Overall Study||40
14865|NCT02387502|36787|P2|STARTED|Overall Study||40
14866|NCT02387502|36788|P1|STARTED|Overall Study||40
14867|NCT02387476|36798|P2|NOT COMPLETED|Overall Study||5
14868|NCT02387476|36799|P1|NOT COMPLETED|Overall Study||6
14869|NCT02387476|36798|P2|COMPLETED|Overall Study||17
14870|NCT02387476|36799|P1|COMPLETED|Overall Study||19
14871|NCT02387476|36798|P2|STARTED|Overall Study||22
14872|NCT02387476|36799|P1|STARTED|Overall Study||25
14873|NCT02387268|36825|P1|NOT COMPLETED|Overall Study||1
14874|NCT02387268|36825|P1|COMPLETED|Overall Study||9
14875|NCT02387268|36825|P1|STARTED|Overall Study||10
14876|NCT02384538|36832|P2|NOT COMPLETED|Overall Study||15
14877|NCT02384538|36833|P1|NOT COMPLETED|Overall Study||6
14878|NCT02384538|36832|P2|COMPLETED|Overall Study||49
14879|NCT02384538|36833|P1|COMPLETED|Overall Study||61
14880|NCT02384538|36832|P2|STARTED|Overall Study||64
14881|NCT02384538|36833|P1|STARTED|Overall Study||67
14882|NCT02384070|36854|P3|NOT COMPLETED|Overall Study||0
14883|NCT02384070|36855|P2|NOT COMPLETED|Overall Study||0
14884|NCT02384070|36856|P1|NOT COMPLETED|Overall Study||0
14885|NCT02384070|36854|P3|COMPLETED|Overall Study||100
14886|NCT02384070|36855|P2|COMPLETED|Overall Study||100
14887|NCT02384070|36856|P1|COMPLETED|Overall Study||100
14888|NCT02384070|36854|P3|STARTED|Overall Study||100
14889|NCT02384070|36855|P2|STARTED|Overall Study||100
14890|NCT02384070|36856|P1|STARTED|Overall Study||100
14891|NCT02383862|36872|P2|NOT COMPLETED|3 Month Follow up||21
14892|NCT02383862|36873|P1|NOT COMPLETED|3 Month Follow up||23
14893|NCT02383862|36872|P2|COMPLETED|3 Month Follow up||128
14894|NCT02383862|36873|P1|COMPLETED|3 Month Follow up||128
14895|NCT02383862|36872|P2|STARTED|3 Month Follow up||149
14896|NCT02383862|36873|P1|STARTED|3 Month Follow up||151
14897|NCT02383862|36872|P2|NOT COMPLETED|Baseline||0
14898|NCT02383862|36873|P1|NOT COMPLETED|Baseline||0
14899|NCT02383862|36872|P2|COMPLETED|Baseline||149
14900|NCT02383862|36873|P1|COMPLETED|Baseline||151
14901|NCT02383862|36872|P2|STARTED|Baseline||149
14902|NCT02383862|36873|P1|STARTED|Baseline||151
14903|NCT02383758|36906|P2|NOT COMPLETED|Overall Study||2
14904|NCT02383758|36907|P1|NOT COMPLETED|Overall Study||0
14905|NCT02383758|36906|P2|COMPLETED|Overall Study||8
14906|NCT02383758|36907|P1|COMPLETED|Overall Study||10
14907|NCT02383758|36906|P2|STARTED|Overall Study||10
14908|NCT02383758|36907|P1|STARTED|Overall Study||10
14909|NCT02383719|36919|P1|NOT COMPLETED|Overall Study||0
14910|NCT02383719|36919|P1|COMPLETED|Overall Study||18
14911|NCT02383719|36919|P1|STARTED|Overall Study||18
14912|NCT02383576|36925|P2|NOT COMPLETED|Overall Study||45
14913|NCT02383576|36926|P1|NOT COMPLETED|Overall Study||63
14914|NCT02383576|36925|P2|COMPLETED|Overall Study||46
14915|NCT02383576|36926|P1|COMPLETED|Overall Study||31
14916|NCT02383576|36925|P2|STARTED|Overall Study||91
14917|NCT02383576|36926|P1|STARTED|Overall Study||94
14918|NCT02383420|36943|P3|NOT COMPLETED|Overall Study||0
14919|NCT02383420|36944|P2|NOT COMPLETED|Overall Study||0
14920|NCT02383420|36945|P1|NOT COMPLETED|Overall Study||2
14921|NCT02383420|36943|P3|COMPLETED|Overall Study||3
14922|NCT02383420|36944|P2|COMPLETED|Overall Study||10
14923|NCT02383420|36945|P1|COMPLETED|Overall Study||8
14924|NCT02383420|36943|P3|STARTED|Overall Study||3
14925|NCT02383420|36944|P2|STARTED|Overall Study||10
14926|NCT02383420|36945|P1|STARTED|Overall Study||10
14927|NCT02382913|36963|P10|NOT COMPLETED|Overall Study||0
14928|NCT02382913|36964|P9|NOT COMPLETED|Overall Study||0
14929|NCT02382913|36965|P8|NOT COMPLETED|Overall Study||0
14930|NCT02382913|36966|P7|NOT COMPLETED|Overall Study||0
14931|NCT02382913|36967|P6|NOT COMPLETED|Overall Study||0
14932|NCT02382913|36968|P5|NOT COMPLETED|Overall Study||0
14933|NCT02382913|36969|P4|NOT COMPLETED|Overall Study||0
14934|NCT02382913|36970|P3|NOT COMPLETED|Overall Study||0
14935|NCT02382913|36971|P2|NOT COMPLETED|Overall Study||0
14936|NCT02382913|36972|P1|NOT COMPLETED|Overall Study||0
14937|NCT02382913|36963|P10|COMPLETED|Overall Study||33
14938|NCT02382913|36964|P9|COMPLETED|Overall Study||30
14939|NCT02382913|36965|P8|COMPLETED|Overall Study||30
14940|NCT02382913|36966|P7|COMPLETED|Overall Study||37
14941|NCT02382913|36967|P6|COMPLETED|Overall Study||30
14942|NCT02382913|36968|P5|COMPLETED|Overall Study||33
14943|NCT02382913|36969|P4|COMPLETED|Overall Study||27
14944|NCT02382913|36970|P3|COMPLETED|Overall Study||32
14945|NCT02382913|36971|P2|COMPLETED|Overall Study||36
14946|NCT02382913|36972|P1|COMPLETED|Overall Study||27
14947|NCT02382913|36963|P10|STARTED|Overall Study||33
14948|NCT02382913|36964|P9|STARTED|Overall Study||30
14949|NCT02382913|36965|P8|STARTED|Overall Study||30
14950|NCT02382913|36966|P7|STARTED|Overall Study||37
14951|NCT02382913|36967|P6|STARTED|Overall Study||30
14952|NCT02382913|36968|P5|STARTED|Overall Study||33
14953|NCT02382913|36969|P4|STARTED|Overall Study||27
14954|NCT02382913|36970|P3|STARTED|Overall Study||32
14955|NCT02382913|36971|P2|STARTED|Overall Study||36
14956|NCT02382913|36972|P1|STARTED|Overall Study||27
14957|NCT02382744|37010|P2|NOT COMPLETED|Overall Study||0
14958|NCT02382744|37011|P1|NOT COMPLETED|Overall Study||0
14959|NCT02382744|37010|P2|COMPLETED|Overall Study||40
14960|NCT02382744|37011|P1|COMPLETED|Overall Study||40
14961|NCT02382744|37010|P2|Analyzed|Overall Study||40
14962|NCT02382744|37011|P1|Analyzed|Overall Study||40
14963|NCT02382744|37010|P2|Allocated|Overall Study||40
14964|NCT02382744|37011|P1|Allocated|Overall Study||40
14965|NCT02382744|37010|P2|STARTED|Overall Study||40
14966|NCT02382744|37011|P1|STARTED|Overall Study||40
14967|NCT02382640|37046|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
14968|NCT02382640|37047|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
14969|NCT02382640|37048|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
14970|NCT02382640|37049|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
14971|NCT02382640|37046|P4|COMPLETED|Intervention Period 4 (3 Days)||9
14972|NCT02382640|37047|P3|COMPLETED|Intervention Period 4 (3 Days)||9
14973|NCT02382640|37048|P2|COMPLETED|Intervention Period 4 (3 Days)||9
14974|NCT02382640|37049|P1|COMPLETED|Intervention Period 4 (3 Days)||8
14975|NCT02382640|37046|P4|STARTED|Intervention Period 4 (3 Days)||9
14976|NCT02382640|37047|P3|STARTED|Intervention Period 4 (3 Days)||9
14977|NCT02382640|37048|P2|STARTED|Intervention Period 4 (3 Days)||9
14978|NCT02382640|37049|P1|STARTED|Intervention Period 4 (3 Days)||9
14979|NCT02382640|37046|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
14980|NCT02382640|37047|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
14981|NCT02382640|37048|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
14982|NCT02382640|37049|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
14983|NCT02382640|37046|P4|COMPLETED|Washout Period 3 (7 Days)||9
14984|NCT02382640|37047|P3|COMPLETED|Washout Period 3 (7 Days)||9
14985|NCT02382640|37048|P2|COMPLETED|Washout Period 3 (7 Days)||9
14986|NCT02382640|37049|P1|COMPLETED|Washout Period 3 (7 Days)||9
14987|NCT02382640|37046|P4|STARTED|Washout Period 3 (7 Days)||9
14988|NCT02382640|37047|P3|STARTED|Washout Period 3 (7 Days)||9
14989|NCT02382640|37048|P2|STARTED|Washout Period 3 (7 Days)||9
14990|NCT02382640|37049|P1|STARTED|Washout Period 3 (7 Days)||9
14991|NCT02382640|37046|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
14992|NCT02382640|37047|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
14993|NCT02382640|37048|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
14994|NCT02382640|37049|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
14995|NCT02382640|37046|P4|COMPLETED|Intervention Period 3 (3 Days)||9
14996|NCT02382640|37047|P3|COMPLETED|Intervention Period 3 (3 Days)||9
14997|NCT02382640|37048|P2|COMPLETED|Intervention Period 3 (3 Days)||9
14998|NCT02382640|37049|P1|COMPLETED|Intervention Period 3 (3 Days)||9
14999|NCT02382640|37046|P4|STARTED|Intervention Period 3 (3 Days)||9
15000|NCT02382640|37047|P3|STARTED|Intervention Period 3 (3 Days)||9
15001|NCT02382640|37048|P2|STARTED|Intervention Period 3 (3 Days)||9
15002|NCT02382640|37049|P1|STARTED|Intervention Period 3 (3 Days)||9
15003|NCT02382640|37046|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
15004|NCT02382640|37047|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
15005|NCT02382640|37048|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
15006|NCT02382640|37049|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
15007|NCT02382640|37046|P4|COMPLETED|Washout Period 2 (7 Days)||9
15008|NCT02382640|37047|P3|COMPLETED|Washout Period 2 (7 Days)||9
15009|NCT02382640|37048|P2|COMPLETED|Washout Period 2 (7 Days)||9
15010|NCT02382640|37049|P1|COMPLETED|Washout Period 2 (7 Days)||9
15011|NCT02382640|37046|P4|STARTED|Washout Period 2 (7 Days)||9
15012|NCT02382640|37047|P3|STARTED|Washout Period 2 (7 Days)||9
15013|NCT02382640|37048|P2|STARTED|Washout Period 2 (7 Days)||9
15014|NCT02382640|37049|P1|STARTED|Washout Period 2 (7 Days)||9
15015|NCT02382640|37046|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
15016|NCT02382640|37047|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
15017|NCT02382640|37048|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
15018|NCT02382640|37049|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
15019|NCT02382640|37046|P4|COMPLETED|Intervention Period 2 (3 Days)||9
15020|NCT02382640|37047|P3|COMPLETED|Intervention Period 2 (3 Days)||9
15021|NCT02382640|37048|P2|COMPLETED|Intervention Period 2 (3 Days)||9
15022|NCT02382640|37049|P1|COMPLETED|Intervention Period 2 (3 Days)||9
15023|NCT02382640|37046|P4|STARTED|Intervention Period 2 (3 Days)||9
15024|NCT02382640|37047|P3|STARTED|Intervention Period 2 (3 Days)||9
15025|NCT02382640|37048|P2|STARTED|Intervention Period 2 (3 Days)||9
15026|NCT02382640|37049|P1|STARTED|Intervention Period 2 (3 Days)||9
15027|NCT02382640|37046|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
15028|NCT02382640|37047|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
15029|NCT02382640|37048|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
15030|NCT02382640|37049|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
15031|NCT02382640|37046|P4|COMPLETED|Washout Period 1 (7 Days)||9
15032|NCT02382640|37047|P3|COMPLETED|Washout Period 1 (7 Days)||9
15033|NCT02382640|37048|P2|COMPLETED|Washout Period 1 (7 Days)||9
15034|NCT02382640|37049|P1|COMPLETED|Washout Period 1 (7 Days)||9
15035|NCT02382640|37046|P4|STARTED|Washout Period 1 (7 Days)||9
15036|NCT02382640|37047|P3|STARTED|Washout Period 1 (7 Days)||9
15037|NCT02382640|37048|P2|STARTED|Washout Period 1 (7 Days)||9
15038|NCT02382640|37049|P1|STARTED|Washout Period 1 (7 Days)||9
15039|NCT02382640|37046|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
15040|NCT02382640|37047|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
15041|NCT02382640|37048|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
15042|NCT02382640|37049|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
15043|NCT02382640|37046|P4|COMPLETED|Intervention Period 1 (3 Days)||9
15044|NCT02382640|37047|P3|COMPLETED|Intervention Period 1 (3 Days)||9
15045|NCT02382640|37048|P2|COMPLETED|Intervention Period 1 (3 Days)||9
15046|NCT02382640|37049|P1|COMPLETED|Intervention Period 1 (3 Days)||9
15047|NCT02382640|37046|P4|STARTED|Intervention Period 1 (3 Days)||9
15048|NCT02382640|37047|P3|STARTED|Intervention Period 1 (3 Days)||9
15049|NCT02382640|37048|P2|STARTED|Intervention Period 1 (3 Days)||9
15050|NCT02382640|37049|P1|STARTED|Intervention Period 1 (3 Days)||9
15051|NCT02382133|37087|P1|NOT COMPLETED|Overall Study||33
15052|NCT02382133|37087|P1|COMPLETED|Overall Study||10
15053|NCT02382133|37087|P1|STARTED|Overall Study||43
15054|NCT02381795|37092|P1|NOT COMPLETED|Overall Study||3
15055|NCT02381795|37092|P1|COMPLETED|Overall Study||7
15056|NCT02381795|37092|P1|STARTED|Overall Study||10
15057|NCT02381678|37096|P3|NOT COMPLETED|Overall Study||0
15058|NCT02381678|37097|P2|NOT COMPLETED|Overall Study||0
15059|NCT02381678|37098|P1|NOT COMPLETED|Overall Study||0
15060|NCT02381678|37096|P3|COMPLETED|Overall Study||32
15061|NCT02381678|37097|P2|COMPLETED|Overall Study||139
15062|NCT02381678|37098|P1|COMPLETED|Overall Study||54
15063|NCT02381678|37096|P3|STARTED|Overall Study||32
15064|NCT02381678|37097|P2|STARTED|Overall Study||139
15065|NCT02381678|37098|P1|STARTED|Overall Study||54
15066|NCT02381418|37104|P1|NOT COMPLETED|Overall Study||0
15067|NCT02381418|37104|P1|COMPLETED|Overall Study||120
15068|NCT02381418|37104|P1|STARTED|Overall Study||120
15069|NCT02381392|37112|P2|NOT COMPLETED|Overall Study||0
15070|NCT02381392|37113|P1|NOT COMPLETED|Overall Study||0
15071|NCT02381392|37112|P2|COMPLETED|Overall Study||12
15072|NCT02381392|37113|P1|COMPLETED|Overall Study||11
15073|NCT02381392|37112|P2|STARTED|Overall Study||12
15074|NCT02381392|37113|P1|STARTED|Overall Study||11
15075|NCT02381288|37131|P4|NOT COMPLETED|Overall Study||0
15076|NCT02381288|37132|P3|NOT COMPLETED|Overall Study||0
15077|NCT02381288|37133|P2|NOT COMPLETED|Overall Study||0
15078|NCT02381288|37134|P1|NOT COMPLETED|Overall Study||0
15079|NCT02381288|37131|P4|COMPLETED|Overall Study||5
15080|NCT02381288|37132|P3|COMPLETED|Overall Study||5
15081|NCT02381288|37133|P2|COMPLETED|Overall Study||2
15082|NCT02381288|37134|P1|COMPLETED|Overall Study||5
15083|NCT02381288|37131|P4|STARTED|Overall Study||5
15084|NCT02381288|37132|P3|STARTED|Overall Study||5
15085|NCT02381288|37133|P2|STARTED|Overall Study||2
15086|NCT02381288|37134|P1|STARTED|Overall Study||5
15087|NCT02380742|37163|P2|NOT COMPLETED|Overall Study||0
15088|NCT02380742|37164|P1|NOT COMPLETED|Overall Study||1
15089|NCT02380742|37163|P2|COMPLETED|Overall Study||26
15090|NCT02380742|37164|P1|COMPLETED|Overall Study||27
15091|NCT02380742|37163|P2|STARTED|Overall Study||26
15092|NCT02380742|37164|P1|STARTED|Overall Study||28
15093|NCT02380287|37184|P8|NOT COMPLETED|Overall Study||0
15094|NCT02380287|37185|P7|NOT COMPLETED|Overall Study||0
15095|NCT02380287|37186|P6|NOT COMPLETED|Overall Study||0
15096|NCT02380287|37187|P5|NOT COMPLETED|Overall Study||0
15097|NCT02380287|37188|P4|NOT COMPLETED|Overall Study||0
15098|NCT02380287|37189|P3|NOT COMPLETED|Overall Study||1
15099|NCT02380287|37190|P2|NOT COMPLETED|Overall Study||0
15100|NCT02380287|37191|P1|NOT COMPLETED|Overall Study||0
15101|NCT02380287|37184|P8|COMPLETED|Overall Study||3
15102|NCT02380287|37185|P7|COMPLETED|Overall Study||3
15103|NCT02380287|37186|P6|COMPLETED|Overall Study||3
15104|NCT02380287|37187|P5|COMPLETED|Overall Study||3
15105|NCT02380287|37188|P4|COMPLETED|Overall Study||3
15106|NCT02380287|37189|P3|COMPLETED|Overall Study||2
15107|NCT02380287|37190|P2|COMPLETED|Overall Study||3
15108|NCT02380287|37191|P1|COMPLETED|Overall Study||1
15109|NCT02380287|37184|P8|STARTED|Overall Study||3
15110|NCT02380287|37185|P7|STARTED|Overall Study||3
15111|NCT02380287|37186|P6|STARTED|Overall Study||3
15112|NCT02380287|37187|P5|STARTED|Overall Study||3
15113|NCT02380287|37188|P4|STARTED|Overall Study||3
15114|NCT02380287|37189|P3|STARTED|Overall Study||3
15115|NCT02380287|37190|P2|STARTED|Overall Study||3
15116|NCT02380287|37191|P1|STARTED|Overall Study||1
15117|NCT02380261|37202|P1|NOT COMPLETED|Overall Study||0
15118|NCT02380261|37202|P1|COMPLETED|Overall Study||35
15119|NCT02380261|37202|P1|STARTED|Overall Study||35
15120|NCT02380248|37207|P1|NOT COMPLETED|Overall Study||14
15121|NCT02380248|37207|P1|COMPLETED|Overall Study||186
15122|NCT02380248|37207|P1|STARTED|Overall Study||200
15123|NCT02379637|37214|P2|NOT COMPLETED|Overall Study||1
15124|NCT02379637|37215|P1|NOT COMPLETED|Overall Study||2
15125|NCT02379637|37214|P2|COMPLETED|Overall Study||34
15126|NCT02379637|37215|P1|COMPLETED|Overall Study||33
15127|NCT02379637|37214|P2|STARTED|Overall Study||35
15128|NCT02379637|37215|P1|STARTED|Overall Study||35
15129|NCT02379585|37225|P2|NOT COMPLETED|Overall Study||5
15130|NCT02379585|37226|P1|NOT COMPLETED|Overall Study||3
15131|NCT02379585|37225|P2|COMPLETED|Overall Study||0
15132|NCT02379585|37226|P1|COMPLETED|Overall Study||0
15133|NCT02379585|37225|P2|STARTED|Overall Study||5
15134|NCT02379585|37226|P1|STARTED|Overall Study||3
15135|NCT02378961|37252|P4|NOT COMPLETED|Overall Study||1
15136|NCT02378961|37253|P3|NOT COMPLETED|Overall Study||1
15137|NCT02378961|37254|P2|NOT COMPLETED|Overall Study||2
15138|NCT02378961|37255|P1|NOT COMPLETED|Overall Study||4
15139|NCT02378961|37252|P4|COMPLETED|Overall Study||28
15140|NCT02378961|37253|P3|COMPLETED|Overall Study||35
15141|NCT02378961|37254|P2|COMPLETED|Overall Study||28
15142|NCT02378961|37255|P1|COMPLETED|Overall Study||29
15143|NCT02378961|37252|P4|STARTED|Overall Study||29
15144|NCT02378961|37253|P3|STARTED|Overall Study||36
15145|NCT02378961|37254|P2|STARTED|Overall Study||30
15146|NCT02378961|37255|P1|STARTED|Overall Study||33
15147|NCT02378935|37292|P7|NOT COMPLETED|Overall Study||0
15148|NCT02378935|37293|P6|NOT COMPLETED|Overall Study||0
15149|NCT02378935|37294|P5|NOT COMPLETED|Overall Study||0
15150|NCT02378935|37295|P4|NOT COMPLETED|Overall Study||6
15151|NCT02378935|37296|P3|NOT COMPLETED|Overall Study||3
15152|NCT02378935|37297|P2|NOT COMPLETED|Overall Study||0
15153|NCT02378935|37298|P1|NOT COMPLETED|Overall Study||10
15154|NCT02378935|37292|P7|COMPLETED|Overall Study||8
15155|NCT02378935|37293|P6|COMPLETED|Overall Study||32
15156|NCT02378935|37294|P5|COMPLETED|Overall Study||31
15157|NCT02378935|37295|P4|COMPLETED|Overall Study||25
15158|NCT02378935|37296|P3|COMPLETED|Overall Study||30
15159|NCT02378935|37297|P2|COMPLETED|Overall Study||36
15160|NCT02378935|37298|P1|COMPLETED|Overall Study||24
15161|NCT02378935|37292|P7|STARTED|Overall Study||8
15162|NCT02378935|37293|P6|STARTED|Overall Study||32
15163|NCT02378935|37294|P5|STARTED|Overall Study||31
15164|NCT02378935|37295|P4|STARTED|Overall Study||31
15165|NCT02378935|37296|P3|STARTED|Overall Study||33
15166|NCT02378935|37297|P2|STARTED|Overall Study||36
15167|NCT02378935|37298|P1|STARTED|Overall Study||34
15168|NCT02378753|37351|P2|NOT COMPLETED|Overall Study||695
15169|NCT02378753|37352|P1|NOT COMPLETED|Overall Study||218
15170|NCT02378753|37351|P2|COMPLETED|Overall Study||3637
15171|NCT02378753|37352|P1|COMPLETED|Overall Study||4101
15172|NCT02378753|37351|P2|STARTED|Overall Study||4332
15173|NCT02378753|37352|P1|STARTED|Overall Study||4319
15174|NCT02378506|37370|P1|NOT COMPLETED|Overall Study||25
15175|NCT02378506|37370|P1|COMPLETED|Overall Study||163
15176|NCT02378506|37370|P1|Treated|Overall Study||187
15177|NCT02378506|37370|P1|STARTED|Overall Study||188
15178|NCT02377427|37389|P2|NOT COMPLETED|Overall Study||0
15179|NCT02377427|37390|P1|NOT COMPLETED|Overall Study||4
15180|NCT02377427|37389|P2|COMPLETED|Overall Study||10
15181|NCT02377427|37390|P1|COMPLETED|Overall Study||22
15182|NCT02377427|37389|P2|STARTED|Overall Study||10
15183|NCT02377427|37390|P1|STARTED|Overall Study||26
15184|NCT02376998|37421|P1|NOT COMPLETED|Overall Study||9
15185|NCT02376998|37421|P1|COMPLETED|Overall Study||11
15186|NCT02376998|37421|P1|STARTED|Overall Study||20
15187|NCT02376530|37429|P4|NOT COMPLETED|Overall Study||0
15188|NCT02376530|37430|P3|NOT COMPLETED|Overall Study||0
15189|NCT02376530|37431|P2|NOT COMPLETED|Overall Study||0
15190|NCT02376530|37432|P1|NOT COMPLETED|Overall Study||0
15191|NCT02376530|37429|P4|COMPLETED|Overall Study||197
15192|NCT02376530|37430|P3|COMPLETED|Overall Study||197
15193|NCT02376530|37431|P2|COMPLETED|Overall Study||198
15194|NCT02376530|37432|P1|COMPLETED|Overall Study||196
15195|NCT02376530|37429|P4|STARTED|Overall Study||197
15196|NCT02376530|37430|P3|STARTED|Overall Study||197
15197|NCT02376530|37431|P2|STARTED|Overall Study||198
15198|NCT02376530|37432|P1|STARTED|Overall Study||196
15199|NCT02376166|37442|P1|NOT COMPLETED|Overall Study||3
15200|NCT02376166|37442|P1|COMPLETED|Overall Study||12
15201|NCT02376166|37442|P1|STARTED|Overall Study||15
15202|NCT02375724|37469|P2|NOT COMPLETED|Overall Study||6
15203|NCT02375724|37470|P1|NOT COMPLETED|Overall Study||6
15204|NCT02375724|37469|P2|COMPLETED|Overall Study||128
15205|NCT02375724|37470|P1|COMPLETED|Overall Study||129
15206|NCT02375724|37469|P2|STARTED|Overall Study||134
15207|NCT02375724|37470|P1|STARTED|Overall Study||135
15208|NCT02375373|37480|P1|NOT COMPLETED|Overall Study||11
15209|NCT02375373|37480|P1|COMPLETED|Overall Study||1
15210|NCT02375373|37480|P1|STARTED|Overall Study||12
15211|NCT02375347|37484|P1|NOT COMPLETED|Overall Study||1
15212|NCT02375347|37484|P1|COMPLETED|Overall Study||12
15213|NCT02375347|37484|P1|STARTED|Overall Study||13
15214|NCT02374593|37490|P2|NOT COMPLETED|Overall Study||0
15215|NCT02374593|37491|P1|NOT COMPLETED|Overall Study||2
15216|NCT02374593|37490|P2|COMPLETED|Overall Study||44
15217|NCT02374593|37491|P1|COMPLETED|Overall Study||22
15218|NCT02374593|37490|P2|STARTED|Overall Study||44
15219|NCT02374593|37491|P1|STARTED|Overall Study||24
15220|NCT02374398|37505|P4|NOT COMPLETED|Overall Study||0
15221|NCT02374398|37506|P3|NOT COMPLETED|Overall Study||3
15222|NCT02374398|37507|P2|NOT COMPLETED|Overall Study||1
15223|NCT02374398|37508|P1|NOT COMPLETED|Overall Study||2
15224|NCT02374398|37505|P4|COMPLETED|Overall Study||32
15225|NCT02374398|37506|P3|COMPLETED|Overall Study||29
15226|NCT02374398|37507|P2|COMPLETED|Overall Study||31
15227|NCT02374398|37508|P1|COMPLETED|Overall Study||29
15228|NCT02374398|37505|P4|STARTED|Overall Study||32
15229|NCT02374398|37506|P3|STARTED|Overall Study||32
15230|NCT02374398|37507|P2|STARTED|Overall Study||32
15231|NCT02374398|37508|P1|STARTED|Overall Study||31
15232|NCT02374346|37534|P1|NOT COMPLETED|Overall Study||48
15233|NCT02374346|37534|P1|COMPLETED|Overall Study||446
15234|NCT02374346|37534|P1|STARTED|Overall Study||494
15235|NCT02374164|37543|P3|NOT COMPLETED|Treatment Period 3||0
15236|NCT02374164|37544|P2|NOT COMPLETED|Treatment Period 3||0
15237|NCT02374164|37545|P1|NOT COMPLETED|Treatment Period 3||0
15238|NCT02374164|37543|P3|COMPLETED|Treatment Period 3||12
15239|NCT02374164|37544|P2|COMPLETED|Treatment Period 3||11
15240|NCT02374164|37545|P1|COMPLETED|Treatment Period 3||12
15241|NCT02374164|37543|P3|STARTED|Treatment Period 3||12
15242|NCT02374164|37544|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
15243|NCT02374164|37545|P1|STARTED|Treatment Period 3||12
15244|NCT02374164|37543|P3|NOT COMPLETED|Treatment Period 2||0
15245|NCT02374164|37544|P2|NOT COMPLETED|Treatment Period 2||0
15246|NCT02374164|37545|P1|NOT COMPLETED|Treatment Period 2||0
15247|NCT02374164|37543|P3|COMPLETED|Treatment Period 2||12
15248|NCT02374164|37544|P2|COMPLETED|Treatment Period 2||12
15249|NCT02374164|37545|P1|COMPLETED|Treatment Period 2||12
15250|NCT02374164|37543|P3|STARTED|Treatment Period 2||12
15251|NCT02374164|37544|P2|STARTED|Treatment Period 2||12
15252|NCT02374164|37545|P1|STARTED|Treatment Period 2||12
15253|NCT02374164|37543|P3|NOT COMPLETED|Treatment Period 1||0
15254|NCT02374164|37544|P2|NOT COMPLETED|Treatment Period 1||0
15255|NCT02374164|37545|P1|NOT COMPLETED|Treatment Period 1||0
15256|NCT02374164|37543|P3|COMPLETED|Treatment Period 1||12
15257|NCT02374164|37544|P2|COMPLETED|Treatment Period 1||12
15258|NCT02374164|37545|P1|COMPLETED|Treatment Period 1||12
15259|NCT02374164|37543|P3|STARTED|Treatment Period 1||12
15260|NCT02374164|37544|P2|STARTED|Treatment Period 1||12
15261|NCT02374164|37545|P1|STARTED|Treatment Period 1||12
15262|NCT02373202|37566|P4|NOT COMPLETED|Overall Study||1
15263|NCT02373202|37567|P3|NOT COMPLETED|Overall Study||3
15264|NCT02373202|37568|P2|NOT COMPLETED|Overall Study||6
15265|NCT02373202|37569|P1|NOT COMPLETED|Overall Study||2
15266|NCT02373202|37566|P4|COMPLETED|Overall Study||30
15267|NCT02373202|37567|P3|COMPLETED|Overall Study||27
15268|NCT02373202|37568|P2|COMPLETED|Overall Study||9
15269|NCT02373202|37569|P1|COMPLETED|Overall Study||13
15270|NCT02373202|37566|P4|STARTED|Overall Study||31
15271|NCT02373202|37567|P3|STARTED|Overall Study||30
15272|NCT02373202|37568|P2|STARTED|Overall Study||15
15273|NCT02373202|37569|P1|STARTED|Overall Study||15
15274|NCT02372344|37619|P3|NOT COMPLETED|Period 3 (Visit 4)||0
15275|NCT02372344|37620|P2|NOT COMPLETED|Period 3 (Visit 4)||0
15276|NCT02372344|37621|P1|NOT COMPLETED|Period 3 (Visit 4)||0
15277|NCT02372344|37619|P3|COMPLETED|Period 3 (Visit 4)||14
15278|NCT02372344|37620|P2|COMPLETED|Period 3 (Visit 4)||14
15279|NCT02372344|37621|P1|COMPLETED|Period 3 (Visit 4)||14
15280|NCT02372344|37619|P3|STARTED|Period 3 (Visit 4)||14
15281|NCT02372344|37620|P2|STARTED|Period 3 (Visit 4)||14
15282|NCT02372344|37621|P1|STARTED|Period 3 (Visit 4)||14
15283|NCT02372344|37619|P3|NOT COMPLETED|Period 2 (Visit 3)||0
15284|NCT02372344|37620|P2|NOT COMPLETED|Period 2 (Visit 3)||0
15285|NCT02372344|37621|P1|NOT COMPLETED|Period 2 (Visit 3)||0
15286|NCT02372344|37619|P3|COMPLETED|Period 2 (Visit 3)||14
15287|NCT02372344|37620|P2|COMPLETED|Period 2 (Visit 3)||14
15288|NCT02372344|37621|P1|COMPLETED|Period 2 (Visit 3)||14
15289|NCT02372344|37619|P3|STARTED|Period 2 (Visit 3)||14
15290|NCT02372344|37620|P2|STARTED|Period 2 (Visit 3)||14
15291|NCT02372344|37621|P1|STARTED|Period 2 (Visit 3)||14
15292|NCT02372344|37619|P3|NOT COMPLETED|Period 1 (Visit 2)||0
15293|NCT02372344|37620|P2|NOT COMPLETED|Period 1 (Visit 2)||0
15294|NCT02372344|37621|P1|NOT COMPLETED|Period 1 (Visit 2)||0
15295|NCT02372344|37619|P3|COMPLETED|Period 1 (Visit 2)||14
15296|NCT02372344|37620|P2|COMPLETED|Period 1 (Visit 2)||14
15297|NCT02372344|37621|P1|COMPLETED|Period 1 (Visit 2)||14
15298|NCT02372344|37619|P3|STARTED|Period 1 (Visit 2)||14
15299|NCT02372344|37620|P2|STARTED|Period 1 (Visit 2)||14
15300|NCT02372344|37621|P1|STARTED|Period 1 (Visit 2)||14
15301|NCT02372097|37637|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
15302|NCT02372097|37638|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
15303|NCT02372097|37637|P2|COMPLETED|Second Intervention Period (8 Days)||12
15304|NCT02372097|37638|P1|COMPLETED|Second Intervention Period (8 Days)||12
15305|NCT02372097|37637|P2|STARTED|Second Intervention Period (8 Days)||12
15306|NCT02372097|37638|P1|STARTED|Second Intervention Period (8 Days)||12
15307|NCT02372097|37637|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
15308|NCT02372097|37638|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
15309|NCT02372097|37637|P2|COMPLETED|Wash Out Period (13 Days)||12
15310|NCT02372097|37638|P1|COMPLETED|Wash Out Period (13 Days)||12
15311|NCT02372097|37637|P2|STARTED|Wash Out Period (13 Days)||12
15312|NCT02372097|37638|P1|STARTED|Wash Out Period (13 Days)||12
15313|NCT02372097|37637|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
15314|NCT02372097|37638|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
15315|NCT02372097|37637|P2|COMPLETED|First Intervention Period (8 Days)||12
15316|NCT02372097|37638|P1|COMPLETED|First Intervention Period (8 Days)||12
15317|NCT02372097|37637|P2|STARTED|First Intervention Period (8 Days)||12
15318|NCT02372097|37638|P1|STARTED|First Intervention Period (8 Days)||12
15319|NCT02372071|37664|P1|NOT COMPLETED|Overall Study||18
15320|NCT02372071|37664|P1|COMPLETED|Overall Study||93
15321|NCT02372071|37664|P1|STARTED|Overall Study||111
15322|NCT02372058|37669|P1|NOT COMPLETED|Overall Study||3
15323|NCT02372058|37669|P1|COMPLETED|Overall Study||100
15324|NCT02372058|37669|P1|STARTED|Overall Study||103
15325|NCT02371876|37675|P1|NOT COMPLETED|Overall Study||0
15326|NCT02371876|37675|P1|COMPLETED|Overall Study||134
15327|NCT02371876|37675|P1|STARTED|Overall Study||134
15328|NCT02371850|37685|P1|NOT COMPLETED|Overall Study||0
15329|NCT02371850|37685|P1|COMPLETED|Overall Study||10
15330|NCT02371850|37685|P1|STARTED|Overall Study||10
15331|NCT02371759|37698|P8|NOT COMPLETED|Overall Study||4
15332|NCT02371759|37699|P7|NOT COMPLETED|Overall Study||0
15333|NCT02371759|37700|P6|NOT COMPLETED|Overall Study||1
15334|NCT02371759|37701|P5|NOT COMPLETED|Overall Study||3
15335|NCT02371759|37702|P4|NOT COMPLETED|Overall Study||0
15336|NCT02371759|37703|P3|NOT COMPLETED|Overall Study||1
15337|NCT02371759|37704|P2|NOT COMPLETED|Overall Study||1
15338|NCT02371759|37705|P1|NOT COMPLETED|Overall Study||3
15339|NCT02371759|37698|P8|COMPLETED|Overall Study||24
15340|NCT02371759|37699|P7|COMPLETED|Overall Study||25
15341|NCT02371759|37700|P6|COMPLETED|Overall Study||25
15342|NCT02371759|37701|P5|COMPLETED|Overall Study||24
15343|NCT02371759|37702|P4|COMPLETED|Overall Study||31
15344|NCT02371759|37703|P3|COMPLETED|Overall Study||32
15345|NCT02371759|37704|P2|COMPLETED|Overall Study||30
15346|NCT02371759|37705|P1|COMPLETED|Overall Study||29
15347|NCT02371759|37698|P8|STARTED|Overall Study||28
15348|NCT02371759|37699|P7|STARTED|Overall Study||25
15349|NCT02371759|37700|P6|STARTED|Overall Study||26
15350|NCT02371759|37701|P5|STARTED|Overall Study||27
15351|NCT02371759|37702|P4|STARTED|Overall Study||31
15352|NCT02371759|37703|P3|STARTED|Overall Study||33
15353|NCT02371759|37704|P2|STARTED|Overall Study||31
15354|NCT02371759|37705|P1|STARTED|Overall Study||32
15355|NCT02371616|37917|P2|NOT COMPLETED|Overall Study||7
15356|NCT02371616|37918|P1|NOT COMPLETED|Overall Study||4
15357|NCT02371616|37917|P2|COMPLETED|Overall Study||147
15358|NCT02371616|37918|P1|COMPLETED|Overall Study||146
15359|NCT02371616|37917|P2|STARTED|Overall Study||154
15360|NCT02371616|37918|P1|STARTED|Overall Study||150
15361|NCT02370914|37930|P1|NOT COMPLETED|Overall Study||2
15362|NCT02370914|37930|P1|COMPLETED|Overall Study||82
15363|NCT02370914|37930|P1|STARTED|Overall Study||84
15364|NCT02370667|37937|P3|NOT COMPLETED|Overall Study||0
15365|NCT02370667|37938|P2|NOT COMPLETED|Overall Study||1
15366|NCT02370667|37939|P1|NOT COMPLETED|Overall Study||0
15367|NCT02370667|37937|P3|COMPLETED|Overall Study||10
15368|NCT02370667|37938|P2|COMPLETED|Overall Study||10
15369|NCT02370667|37939|P1|COMPLETED|Overall Study||10
15370|NCT02370667|37937|P3|STARTED|Overall Study||10
15371|NCT02370667|37938|P2|STARTED|Overall Study||11
15372|NCT02370667|37939|P1|STARTED|Overall Study||10
15373|NCT02370615|38003|P2|NOT COMPLETED|Overall Study||0
15374|NCT02370615|38004|P1|NOT COMPLETED|Overall Study||1
15375|NCT02370615|38003|P2|COMPLETED|Overall Study||18
15376|NCT02370615|38004|P1|COMPLETED|Overall Study||15
15377|NCT02370615|38003|P2|STARTED|Overall Study||18
15378|NCT02370615|38004|P1|STARTED|Overall Study||16
15379|NCT02370602|38047|P6|NOT COMPLETED|Overall Study||0
15380|NCT02370602|38048|P5|NOT COMPLETED|Overall Study||0
15381|NCT02370602|38049|P4|NOT COMPLETED|Overall Study||0
15382|NCT02370602|38050|P3|NOT COMPLETED|Overall Study||0
15383|NCT02370602|38051|P2|NOT COMPLETED|Overall Study||0
15384|NCT02370602|38052|P1|NOT COMPLETED|Overall Study||1
15385|NCT02370602|38047|P6|COMPLETED|Overall Study||2
15386|NCT02370602|38048|P5|COMPLETED|Overall Study||3
15387|NCT02370602|38049|P4|COMPLETED|Overall Study||3
15388|NCT02370602|38050|P3|COMPLETED|Overall Study||2
15389|NCT02370602|38051|P2|COMPLETED|Overall Study||2
15390|NCT02370602|38052|P1|COMPLETED|Overall Study||0
15391|NCT02370602|38047|P6|STARTED|Overall Study||2
15392|NCT02370602|38048|P5|STARTED|Overall Study||3
15393|NCT02370602|38049|P4|STARTED|Overall Study||3
15394|NCT02370602|38050|P3|STARTED|Overall Study||2
15395|NCT02370602|38051|P2|STARTED|Overall Study||2
15396|NCT02370602|38052|P1|STARTED|Overall Study||1
15397|NCT02370537|38146|P3|NOT COMPLETED|Part B||259
15398|NCT02370537|38147|P2|NOT COMPLETED|Part B||3
15399|NCT02370537|38148|P1|NOT COMPLETED|Part B||1
15400|NCT02370537|38146|P3|COMPLETED|Part B||23
15401|NCT02370537|38147|P2|COMPLETED|Part B||12
15402|NCT02370537|38148|P1|COMPLETED|Part B||15
15403|NCT02370537|38146|P3|Period 2 Sequence BA|Part B||12
15404|NCT02370537|38147|P2|Period 2 Sequence BA|Part B||7
15405|NCT02370537|38148|P1|Period 2 Sequence BA|Part B||7
15406|NCT02370537|38146|P3|Period 2 Sequence AB|Part B||11
15407|NCT02370537|38147|P2|Period 2 Sequence AB|Part B||5
15408|NCT02370537|38148|P1|Period 2 Sequence AB|Part B||8
15409|NCT02370537|38146|P3|Period 1 Sequence BA|Part B||12
15410|NCT02370537|38147|P2|Period 1 Sequence BA|Part B||7
15411|NCT02370537|38148|P1|Period 1 Sequence BA|Part B||7
15412|NCT02370537|38146|P3|Period 1 Sequence AB|Part B||11
15413|NCT02370537|38147|P2|Period 1 Sequence AB|Part B||6
15414|NCT02370537|38148|P1|Period 1 Sequence AB|Part B||8
15415|NCT02370537|38146|P3|Eligible for Randomisation|Part B||23
15416|NCT02370537|38147|P2|Eligible for Randomisation|Part B||13
15417|NCT02370537|38148|P1|Eligible for Randomisation|Part B||15
15418|NCT02370537|38146|P3|STARTED|Part B||282
15419|NCT02370537|38147|P2|STARTED|Part B||15
15420|NCT02370537|38148|P1|STARTED|Part B||16
15421|NCT02370537|38146|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
15422|NCT02370537|38147|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
15423|NCT02370537|38148|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
15424|NCT02370537|38146|P3|COMPLETED|Part A (Open-label Recruitment)||282
15425|NCT02370537|38147|P2|COMPLETED|Part A (Open-label Recruitment)||15
15426|NCT02370537|38148|P1|COMPLETED|Part A (Open-label Recruitment)||16
15427|NCT02370537|38146|P3|STARTED|Part A (Open-label Recruitment)||283
15428|NCT02370537|38147|P2|STARTED|Part A (Open-label Recruitment)||16
15429|NCT02370537|38148|P1|STARTED|Part A (Open-label Recruitment)||16
15430|NCT02370420|38197|P2|NOT COMPLETED|Overall Study||12
15431|NCT02370420|38198|P1|NOT COMPLETED|Overall Study||14
15432|NCT02370420|38197|P2|COMPLETED|Overall Study||15
15433|NCT02370420|38198|P1|COMPLETED|Overall Study||15
15434|NCT02370420|38197|P2|STARTED|Overall Study||27
15435|NCT02370420|38198|P1|STARTED|Overall Study||29
15436|NCT02370407|38210|P2|NOT COMPLETED|Overall Study||0
15437|NCT02370407|38211|P1|NOT COMPLETED|Overall Study||0
15438|NCT02370407|38210|P2|COMPLETED|Overall Study||20
15439|NCT02370407|38211|P1|COMPLETED|Overall Study||20
15440|NCT02370407|38210|P2|STARTED|Overall Study||20
15441|NCT02370407|38211|P1|STARTED|Overall Study||20
15442|NCT02370394|38235|P2|NOT COMPLETED|Overall Study||2
15443|NCT02370394|38236|P1|NOT COMPLETED|Overall Study||2
15444|NCT02370394|38235|P2|COMPLETED|Overall Study||23
15445|NCT02370394|38236|P1|COMPLETED|Overall Study||26
15446|NCT02370394|38235|P2|STARTED|Overall Study||25
15447|NCT02370394|38236|P1|STARTED|Overall Study||28
15448|NCT02370121|38252|P2|NOT COMPLETED|Overall Study||1
15449|NCT02370121|38253|P1|NOT COMPLETED|Overall Study||1
15450|NCT02370121|38252|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
15451|NCT02370121|38253|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
15452|NCT02370121|38252|P2|STARTED|Overall Study||12
15453|NCT02370121|38253|P1|STARTED|Overall Study||12
15454|NCT02369848|38291|P1|NOT COMPLETED|Overall Study||4
15455|NCT02369848|38291|P1|COMPLETED|Overall Study||56
15456|NCT02369848|38291|P1|12 Month Primary Endpoint|Overall Study||30
15457|NCT02369848|38291|P1|30 Day Primary Safety Endpoint|Overall Study||58
15458|NCT02369848|38291|P1|STARTED|Overall Study||60
15459|NCT02369796|38310|P5|NOT COMPLETED|Overall Study||0
15460|NCT02369796|38311|P4|NOT COMPLETED|Overall Study||0
15461|NCT02369796|38312|P3|NOT COMPLETED|Overall Study||0
15462|NCT02369796|38313|P2|NOT COMPLETED|Overall Study||0
15463|NCT02369796|38314|P1|NOT COMPLETED|Overall Study||0
15464|NCT02369796|38310|P5|COMPLETED|Overall Study||3
15465|NCT02369796|38311|P4|COMPLETED|Overall Study||3
15466|NCT02369796|38312|P3|COMPLETED|Overall Study||3
15467|NCT02369796|38313|P2|COMPLETED|Overall Study||3
15468|NCT02369796|38314|P1|COMPLETED|Overall Study||3
15469|NCT02369796|38310|P5|STARTED|Overall Study||3
15470|NCT02369796|38311|P4|STARTED|Overall Study||3
15471|NCT02369796|38312|P3|STARTED|Overall Study||3
15472|NCT02369796|38313|P2|STARTED|Overall Study||3
15473|NCT02369796|38314|P1|STARTED|Overall Study||3
15474|NCT02369510|38356|P3|NOT COMPLETED|Overall Study||6
15475|NCT02369510|38357|P2|NOT COMPLETED|Overall Study||3
15476|NCT02369510|38358|P1|NOT COMPLETED|Overall Study||2
15477|NCT02369510|38356|P3|COMPLETED|Overall Study||17
15478|NCT02369510|38357|P2|COMPLETED|Overall Study||19
15479|NCT02369510|38358|P1|COMPLETED|Overall Study||21
15480|NCT02369510|38356|P3|STARTED|Overall Study||23
15481|NCT02369510|38357|P2|STARTED|Overall Study||22
15482|NCT02369510|38358|P1|STARTED|Overall Study||23
15483|NCT02369341|38389|P2|NOT COMPLETED|Overall Study||0
15484|NCT02369341|38390|P1|NOT COMPLETED|Overall Study||1
15485|NCT02369341|38389|P2|COMPLETED|Overall Study||57
15486|NCT02369341|38390|P1|COMPLETED|Overall Study||62
15487|NCT02369341|38389|P2|STARTED|Overall Study||57
15488|NCT02369341|38390|P1|STARTED|Overall Study||63
15489|NCT02368457|38446|P2|NOT COMPLETED|Overall Study||0
15490|NCT02368457|38447|P1|NOT COMPLETED|Overall Study||0
15491|NCT02368457|38446|P2|COMPLETED|Overall Study||12
15492|NCT02368457|38447|P1|COMPLETED|Overall Study||12
15493|NCT02368457|38446|P2|STARTED|Overall Study||12
15494|NCT02368457|38447|P1|STARTED|Overall Study||12
15495|NCT02368314|38457|P2|NOT COMPLETED|Overall Study||3
15496|NCT02368314|38458|P1|NOT COMPLETED|Overall Study||3
15497|NCT02368314|38457|P2|COMPLETED|Overall Study||57
15498|NCT02368314|38458|P1|COMPLETED|Overall Study||61
15499|NCT02368314|38457|P2|STARTED|Overall Study||60
15500|NCT02368314|38458|P1|STARTED|Overall Study||64
15501|NCT02368093|38470|P2|NOT COMPLETED|Overall Study||0
15502|NCT02368093|38471|P1|NOT COMPLETED|Overall Study||0
15503|NCT02368093|38470|P2|COMPLETED|Overall Study||24
15504|NCT02368093|38471|P1|COMPLETED|Overall Study||24
15505|NCT02368093|38470|P2|STARTED|Overall Study||24
15506|NCT02368093|38471|P1|STARTED|Overall Study||24
15507|NCT02367885|38480|P3|NOT COMPLETED|Overall Study||0
15508|NCT02367885|38481|P2|NOT COMPLETED|Overall Study||0
15509|NCT02367885|38482|P1|NOT COMPLETED|Overall Study||2
15510|NCT02367885|38480|P3|COMPLETED|Overall Study||33
15511|NCT02367885|38481|P2|COMPLETED|Overall Study||33
15512|NCT02367885|38482|P1|COMPLETED|Overall Study||31
15513|NCT02367885|38480|P3|STARTED|Overall Study||33
15514|NCT02367885|38481|P2|STARTED|Overall Study||33
15515|NCT02367885|38482|P1|STARTED|Overall Study||33
15516|NCT02367872|38555|P8|NOT COMPLETED|Overall Study||0
15517|NCT02367872|38556|P7|NOT COMPLETED|Overall Study||0
15518|NCT02367872|38557|P6|NOT COMPLETED|Overall Study||0
15519|NCT02367872|38558|P5|NOT COMPLETED|Overall Study||0
15520|NCT02367872|38559|P4|NOT COMPLETED|Overall Study||0
15521|NCT02367872|38560|P3|NOT COMPLETED|Overall Study||0
15522|NCT02367872|38561|P2|NOT COMPLETED|Overall Study||0
15523|NCT02367872|38562|P1|NOT COMPLETED|Overall Study||0
15524|NCT02367872|38555|P8|COMPLETED|Overall Study||6
15525|NCT02367872|38556|P7|COMPLETED|Overall Study||6
15526|NCT02367872|38557|P6|COMPLETED|Overall Study||6
15527|NCT02367872|38558|P5|COMPLETED|Overall Study||6
15528|NCT02367872|38559|P4|COMPLETED|Overall Study||6
15529|NCT02367872|38560|P3|COMPLETED|Overall Study||6
15530|NCT02367872|38561|P2|COMPLETED|Overall Study||6
15531|NCT02367872|38562|P1|COMPLETED|Overall Study||6
15532|NCT02367872|38555|P8|STARTED|Overall Study||6
15533|NCT02367872|38556|P7|STARTED|Overall Study||6
15534|NCT02367872|38557|P6|STARTED|Overall Study||6
15535|NCT02367872|38558|P5|STARTED|Overall Study||6
15536|NCT02367872|38559|P4|STARTED|Overall Study||6
15537|NCT02367872|38560|P3|STARTED|Overall Study||6
15538|NCT02367872|38561|P2|STARTED|Overall Study||6
15539|NCT02367872|38562|P1|STARTED|Overall Study||6
15540|NCT02367391|38717|P2|NOT COMPLETED|Overall Study||0
15541|NCT02367391|38718|P1|NOT COMPLETED|Overall Study||2
15542|NCT02367391|38717|P2|COMPLETED|Overall Study||76
15543|NCT02367391|38718|P1|COMPLETED|Overall Study||74
15544|NCT02367391|38717|P2|STARTED|Overall Study||76
15545|NCT02367391|38718|P1|STARTED|Overall Study||76
15546|NCT02367170|38738|P2|NOT COMPLETED|Overall Study||0
15547|NCT02367170|38739|P1|NOT COMPLETED|Overall Study||0
15548|NCT02367170|38738|P2|COMPLETED|Overall Study||0
15549|NCT02367170|38739|P1|COMPLETED|Overall Study||1
15550|NCT02367170|38738|P2|STARTED|Overall Study||0
15551|NCT02367170|38739|P1|STARTED|Overall Study||1
15552|NCT02367066|38751|P2|NOT COMPLETED|Overall Study||0
15553|NCT02367066|38752|P1|NOT COMPLETED|Overall Study||0
15554|NCT02367066|38751|P2|COMPLETED|Overall Study||10
15555|NCT02367066|38752|P1|COMPLETED|Overall Study||10
15556|NCT02367066|38751|P2|STARTED|Overall Study||10
15557|NCT02367066|38752|P1|STARTED|Overall Study||10
15558|NCT02366936|38810|P1|NOT COMPLETED|Overall Study||8
15559|NCT02366936|38810|P1|COMPLETED|Overall Study||24
15560|NCT02366936|38810|P1|STARTED|Overall Study||32
15561|NCT02366923|38815|P1|NOT COMPLETED|Overall Study||6
15562|NCT02366923|38815|P1|COMPLETED|Overall Study||22
15563|NCT02366923|38815|P1|STARTED|Overall Study||28
15564|NCT02366910|38828|P1|NOT COMPLETED|Overall Study||5
15565|NCT02366910|38828|P1|COMPLETED|Overall Study||21
15566|NCT02366910|38828|P1|STARTED|Overall Study||26
15567|NCT02366767|38842|P2|NOT COMPLETED|Overall Study||0
15568|NCT02366767|38843|P1|NOT COMPLETED|Overall Study||1
15569|NCT02366767|38842|P2|COMPLETED|Overall Study||10
15570|NCT02366767|38843|P1|COMPLETED|Overall Study||10
15571|NCT02366767|38842|P2|STARTED|Overall Study||10
15572|NCT02366767|38843|P1|STARTED|Overall Study||11
15573|NCT02366689|38856|P3|NOT COMPLETED|Overall Study||2
15574|NCT02366689|38857|P2|NOT COMPLETED|Overall Study||3
15575|NCT02366689|38858|P1|NOT COMPLETED|Overall Study||4
15576|NCT02366689|38856|P3|COMPLETED|Overall Study||59
15577|NCT02366689|38857|P2|COMPLETED|Overall Study||55
15578|NCT02366689|38858|P1|COMPLETED|Overall Study||56
15579|NCT02366689|38856|P3|STARTED|Overall Study||61
15580|NCT02366689|38857|P2|STARTED|Overall Study||58
15581|NCT02366689|38858|P1|STARTED|Overall Study||60
15582|NCT02366663|38883|P2|NOT COMPLETED|Overall Study||0
15583|NCT02366663|38884|P1|NOT COMPLETED|Overall Study||0
15584|NCT02366663|38883|P2|COMPLETED|Overall Study||1
15585|NCT02366663|38884|P1|COMPLETED|Overall Study||2
15586|NCT02366663|38883|P2|STARTED|Overall Study||1
15587|NCT02366663|38884|P1|STARTED|Overall Study||2
15588|NCT02366637|38910|P2|NOT COMPLETED|Second Intervention Period||1
15589|NCT02366637|38911|P1|NOT COMPLETED|Second Intervention Period||1
15590|NCT02366637|38910|P2|COMPLETED|Second Intervention Period||0
15591|NCT02366637|38911|P1|COMPLETED|Second Intervention Period||0
15592|NCT02366637|38910|P2|STARTED|Second Intervention Period||1
15593|NCT02366637|38911|P1|STARTED|Second Intervention Period||1
15594|NCT02366637|38910|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
15595|NCT02366637|38911|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
15596|NCT02366637|38910|P2|COMPLETED|Washout Period 28 to 49 Days||1
15597|NCT02366637|38911|P1|COMPLETED|Washout Period 28 to 49 Days||1
15598|NCT02366637|38910|P2|STARTED|Washout Period 28 to 49 Days||1
15599|NCT02366637|38911|P1|STARTED|Washout Period 28 to 49 Days||1
15600|NCT02366637|38910|P2|NOT COMPLETED|First Intervention Period||5
15601|NCT02366637|38911|P1|NOT COMPLETED|First Intervention Period||6
15602|NCT02366637|38910|P2|COMPLETED|First Intervention Period||1
15603|NCT02366637|38911|P1|COMPLETED|First Intervention Period||1
15604|NCT02366637|38910|P2|STARTED|First Intervention Period||6
15605|NCT02366637|38911|P1|STARTED|First Intervention Period||7
15606|NCT02366338|38938|P3|NOT COMPLETED|Overall Study||0
15607|NCT02366338|38939|P2|NOT COMPLETED|Overall Study||0
15608|NCT02366338|38940|P1|NOT COMPLETED|Overall Study||0
15609|NCT02366338|38938|P3|COMPLETED|Overall Study||36
15610|NCT02366338|38939|P2|COMPLETED|Overall Study||39
15611|NCT02366338|38940|P1|COMPLETED|Overall Study||73
15612|NCT02366338|38938|P3|STARTED|Overall Study||36
15613|NCT02366338|38939|P2|STARTED|Overall Study||39
15614|NCT02366338|38940|P1|STARTED|Overall Study||73
15615|NCT02365714|38948|P1|NOT COMPLETED|Overall Study||0
15616|NCT02365714|38948|P1|COMPLETED|Overall Study||2
15617|NCT02365714|38948|P1|STARTED|Overall Study||2
15618|NCT02365688|38954|P1|NOT COMPLETED|Overall Study||0
15619|NCT02365688|38954|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
15620|NCT02365688|38954|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
15621|NCT02365519|38960|P3|NOT COMPLETED|Randomized and Treated||1
15622|NCT02365519|38961|P2|NOT COMPLETED|Randomized and Treated||2
15623|NCT02365519|38962|P1|NOT COMPLETED|Randomized and Treated||0
15624|NCT02365519|38960|P3|COMPLETED|Randomized and Treated||64
15625|NCT02365519|38961|P2|COMPLETED|Randomized and Treated||67
15626|NCT02365519|38962|P1|COMPLETED|Randomized and Treated||0
15627|NCT02365519|38960|P3|STARTED|Randomized and Treated||65
15628|NCT02365519|38961|P2|STARTED|Randomized and Treated||69
15629|NCT02365519|38962|P1|STARTED|Randomized and Treated||0
15630|NCT02365519|38960|P3|NOT COMPLETED|Vehicle Run-In||0
15631|NCT02365519|38961|P2|NOT COMPLETED|Vehicle Run-In||0
15632|NCT02365519|38962|P1|NOT COMPLETED|Vehicle Run-In||79
15633|NCT02365519|38960|P3|COMPLETED|Vehicle Run-In||0
15634|NCT02365519|38961|P2|COMPLETED|Vehicle Run-In||0
15635|NCT02365519|38962|P1|COMPLETED|Vehicle Run-In||134
15636|NCT02365519|38960|P3|STARTED|Vehicle Run-In||0
15637|NCT02365519|38961|P2|STARTED|Vehicle Run-In||0
15638|NCT02365519|38962|P1|STARTED|Vehicle Run-In||213
15639|NCT02365298|38983|P2|NOT COMPLETED|Period 2||2
15640|NCT02365298|38984|P1|NOT COMPLETED|Period 2||2
15641|NCT02365298|38983|P2|COMPLETED|Period 2||12
15642|NCT02365298|38984|P1|COMPLETED|Period 2||12
15643|NCT02365298|38983|P2|STARTED|Period 2||14
15644|NCT02365298|38984|P1|STARTED|Period 2||14
15645|NCT02365298|38983|P2|NOT COMPLETED|Period 1||0
15646|NCT02365298|38984|P1|NOT COMPLETED|Period 1||0
15647|NCT02365298|38983|P2|COMPLETED|Period 1||14
15648|NCT02365298|38984|P1|COMPLETED|Period 1||14
15649|NCT02365298|38983|P2|STARTED|Period 1||14
15650|NCT02365298|38984|P1|STARTED|Period 1||14
15651|NCT02364778|39002|P1|NOT COMPLETED|Overall Study||0
15652|NCT02364778|39002|P1|COMPLETED|Overall Study||30
15653|NCT02364778|39002|P1|STARTED|Overall Study||30
15654|NCT02364700|39014|P1|NOT COMPLETED|Overall Study||0
15655|NCT02364700|39014|P1|COMPLETED|Overall Study||12
15656|NCT02364700|39014|P1|STARTED|Overall Study||12
15657|NCT02364180|39023|P1|NOT COMPLETED|Overall Study||1
15658|NCT02364180|39023|P1|COMPLETED|Overall Study||10
15659|NCT02364180|39023|P1|STARTED|Overall Study||11
15660|NCT02363933|39027|P1|NOT COMPLETED|Overall Study||6
15661|NCT02363933|39027|P1|COMPLETED|Overall Study||2
15662|NCT02363933|39027|P1|STARTED|Overall Study||8
15663|NCT02363907|39032|P1|NOT COMPLETED|Overall Study||0
15664|NCT02363907|39032|P1|COMPLETED|Overall Study||30
15665|NCT02363907|39032|P1|STARTED|Overall Study||30
15666|NCT02363478|39036|P1|NOT COMPLETED|Overall Study||8
15667|NCT02363478|39036|P1|COMPLETED|Overall Study||22
15668|NCT02363478|39036|P1|STARTED|Overall Study||30
15669|NCT02363439|39043|P1|NOT COMPLETED|Overall Study||4
15670|NCT02363439|39043|P1|COMPLETED|Overall Study||1
15671|NCT02363439|39043|P1|STARTED|Overall Study||5
15672|NCT02363270|39049|P2|NOT COMPLETED|Overall Study||0
15673|NCT02363270|39050|P1|NOT COMPLETED|Overall Study||0
15674|NCT02363270|39049|P2|COMPLETED|Overall Study||24
15675|NCT02363270|39050|P1|COMPLETED|Overall Study||24
15676|NCT02363270|39049|P2|STARTED|Overall Study||24
15677|NCT02363270|39050|P1|STARTED|Overall Study||24
15678|NCT02362412|39056|P2|NOT COMPLETED|Treatment Period III||1
15679|NCT02362412|39057|P1|NOT COMPLETED|Treatment Period III||0
15680|NCT02362412|39056|P2|COMPLETED|Treatment Period III||10
15681|NCT02362412|39057|P1|COMPLETED|Treatment Period III||9
15682|NCT02362412|39056|P2|TREATED|Treatment Period III||11
15683|NCT02362412|39057|P1|TREATED|Treatment Period III||9
15684|NCT02362412|39056|P2|STARTED|Treatment Period III||11
15685|NCT02362412|39057|P1|STARTED|Treatment Period III||9
15686|NCT02362412|39056|P2|NOT COMPLETED|Treatment Period II||0
15687|NCT02362412|39057|P1|NOT COMPLETED|Treatment Period II||0
15688|NCT02362412|39056|P2|COMPLETED|Treatment Period II||11
15689|NCT02362412|39057|P1|COMPLETED|Treatment Period II||9
15690|NCT02362412|39056|P2|TREATED|Treatment Period II||11
15691|NCT02362412|39057|P1|TREATED|Treatment Period II||9
15692|NCT02362412|39056|P2|STARTED|Treatment Period II||11
15693|NCT02362412|39057|P1|STARTED|Treatment Period II||9
15694|NCT02362373|39083|P1|NOT COMPLETED|Overall Study||0
15695|NCT02362373|39083|P1|COMPLETED|Overall Study||20
15696|NCT02362373|39083|P1|STARTED|Overall Study||20
15697|NCT02362360|39091|P2|NOT COMPLETED|Period 2||0
15698|NCT02362360|39092|P1|NOT COMPLETED|Period 2||0
15699|NCT02362360|39091|P2|COMPLETED|Period 2||25
15700|NCT02362360|39092|P1|COMPLETED|Period 2||23
15701|NCT02362360|39091|P2|STARTED|Period 2||25
15702|NCT02362360|39092|P1|STARTED|Period 2||23
15703|NCT02362360|39091|P2|NOT COMPLETED|Period 1||1
15704|NCT02362360|39092|P1|NOT COMPLETED|Period 1||3
15705|NCT02362360|39091|P2|COMPLETED|Period 1||25
15706|NCT02362360|39092|P1|COMPLETED|Period 1||23
15707|NCT02362360|39091|P2|STARTED|Period 1||26
15708|NCT02362360|39092|P1|STARTED|Period 1||26
15709|NCT02362321|39100|P2|NOT COMPLETED|Overall Study||0
15710|NCT02362321|39101|P1|NOT COMPLETED|Overall Study||4
15711|NCT02362321|39100|P2|COMPLETED|Overall Study||10
15712|NCT02362321|39101|P1|COMPLETED|Overall Study||6
15713|NCT02362321|39100|P2|STARTED|Overall Study||10
15714|NCT02362321|39101|P1|STARTED|Overall Study||10
15715|NCT02361736|39109|P2|NOT COMPLETED|Overall Study||1
15716|NCT02361736|39110|P1|NOT COMPLETED|Overall Study||1
15717|NCT02361736|39109|P2|COMPLETED|Overall Study||59
15718|NCT02361736|39110|P1|COMPLETED|Overall Study||59
15719|NCT02361736|39109|P2|STARTED|Overall Study||60
15720|NCT02361736|39110|P1|STARTED|Overall Study||60
15721|NCT02361580|39130|P2|NOT COMPLETED|Overall Study||3
15722|NCT02361580|39131|P1|NOT COMPLETED|Overall Study||6
15723|NCT02361580|39130|P2|COMPLETED|Overall Study||0
15724|NCT02361580|39131|P1|COMPLETED|Overall Study||0
15725|NCT02361580|39130|P2|STARTED|Overall Study||3
15726|NCT02361580|39131|P1|STARTED|Overall Study||6
15727|NCT02360995|39144|P3|NOT COMPLETED|Overall Study||2
15728|NCT02360995|39145|P2|NOT COMPLETED|Overall Study||1
15729|NCT02360995|39146|P1|NOT COMPLETED|Overall Study||2
15730|NCT02360995|39144|P3|COMPLETED|Overall Study||41
15731|NCT02360995|39145|P2|COMPLETED|Overall Study||42
15732|NCT02360995|39146|P1|COMPLETED|Overall Study||41
15733|NCT02360995|39144|P3|STARTED|Overall Study||43
15734|NCT02360995|39145|P2|STARTED|Overall Study||43
15735|NCT02360995|39146|P1|STARTED|Overall Study||43
15736|NCT02360475|39173|P4|NOT COMPLETED|Overall Study||5
15737|NCT02360475|39174|P3|NOT COMPLETED|Overall Study||8
15738|NCT02360475|39175|P2|NOT COMPLETED|Overall Study||13
15739|NCT02360475|39176|P1|NOT COMPLETED|Overall Study||4
15740|NCT02360475|39173|P4|COMPLETED|Overall Study||120
15741|NCT02360475|39174|P3|COMPLETED|Overall Study||117
15742|NCT02360475|39175|P2|COMPLETED|Overall Study||111
15743|NCT02360475|39176|P1|COMPLETED|Overall Study||122
15744|NCT02360475|39173|P4|STARTED|Overall Study||125
15745|NCT02360475|39174|P3|STARTED|Overall Study||125
15746|NCT02360475|39175|P2|STARTED|Overall Study||124
15747|NCT02360475|39176|P1|STARTED|Overall Study||126
15748|NCT02360228|39237|P3|NOT COMPLETED|Overall Study||1
15749|NCT02360228|39238|P2|NOT COMPLETED|Overall Study||1
15750|NCT02360228|39239|P1|NOT COMPLETED|Overall Study||1
15751|NCT02360228|39237|P3|COMPLETED|Overall Study||7
15752|NCT02360228|39238|P2|COMPLETED|Overall Study||7
15753|NCT02360228|39239|P1|COMPLETED|Overall Study||8
15754|NCT02360228|39237|P3|STARTED|Overall Study||8
15755|NCT02360228|39238|P2|STARTED|Overall Study||8
15756|NCT02360228|39239|P1|STARTED|Overall Study||9
15757|NCT02360124|39268|P3|NOT COMPLETED|Overall Study||26
15758|NCT02360124|39269|P2|NOT COMPLETED|Overall Study||12
15759|NCT02360124|39270|P1|NOT COMPLETED|Overall Study||28
15760|NCT02360124|39268|P3|COMPLETED|Overall Study||82
15761|NCT02360124|39269|P2|COMPLETED|Overall Study||95
15762|NCT02360124|39270|P1|COMPLETED|Overall Study||80
15763|NCT02360124|39268|P3|STARTED|Overall Study||108
15764|NCT02360124|39269|P2|STARTED|Overall Study||107
15765|NCT02360124|39270|P1|STARTED|Overall Study||108
15766|NCT02360059|39283|P2|NOT COMPLETED|Overall Study||0
15767|NCT02360059|39284|P1|NOT COMPLETED|Overall Study||0
15768|NCT02360059|39283|P2|COMPLETED|Overall Study||0
15769|NCT02360059|39284|P1|COMPLETED|Overall Study||1
15770|NCT02360059|39283|P2|STARTED|Overall Study||0
15771|NCT02360059|39284|P1|STARTED|Overall Study||1
15772|NCT02359955|39292|P2|NOT COMPLETED|Overall Study||0
15773|NCT02359955|39293|P1|NOT COMPLETED|Overall Study||0
15774|NCT02359955|39292|P2|COMPLETED|Overall Study||10
15775|NCT02359955|39293|P1|COMPLETED|Overall Study||10
15776|NCT02359955|39292|P2|STARTED|Overall Study||10
15777|NCT02359955|39293|P1|STARTED|Overall Study||10
15778|NCT02359916|39316|P7|NOT COMPLETED|Overall Study||0
15779|NCT02359916|39317|P6|NOT COMPLETED|Overall Study||0
15780|NCT02359916|39318|P5|NOT COMPLETED|Overall Study||0
15781|NCT02359916|39319|P4|NOT COMPLETED|Overall Study||0
15782|NCT02359916|39320|P3|NOT COMPLETED|Overall Study||0
15783|NCT02359916|39321|P2|NOT COMPLETED|Overall Study||0
15784|NCT02359916|39322|P1|NOT COMPLETED|Overall Study||0
15785|NCT02359916|39316|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
15786|NCT02359916|39317|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
15787|NCT02359916|39318|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
15788|NCT02359916|39319|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
15789|NCT02359916|39320|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
15790|NCT02359916|39321|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
15791|NCT02359916|39322|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
15792|NCT02359916|39316|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
15793|NCT02359916|39317|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
15794|NCT02359916|39318|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
15795|NCT02359916|39319|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
15796|NCT02359916|39320|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
15797|NCT02359916|39321|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
15798|NCT02359916|39322|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
15799|NCT02359903|39344|P2|NOT COMPLETED|Overall Study||2
15800|NCT02359903|39345|P1|NOT COMPLETED|Overall Study||0
15801|NCT02359903|39344|P2|COMPLETED|Overall Study||43
15802|NCT02359903|39345|P1|COMPLETED|Overall Study||45
15803|NCT02359903|39344|P2|STARTED|Overall Study||45
15804|NCT02359903|39345|P1|STARTED|Overall Study||45
15805|NCT02359890|39353|P1|NOT COMPLETED|Overall Study||10
15806|NCT02359890|39353|P1|COMPLETED|Overall Study||155
15807|NCT02359890|39353|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
15808|NCT02359890|39353|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
15809|NCT02359890|39353|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
15810|NCT02359890|39353|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
15811|NCT02359877|39363|P4|NOT COMPLETED|Overall Study||3
15812|NCT02359877|39364|P3|NOT COMPLETED|Overall Study||0
15813|NCT02359877|39365|P2|NOT COMPLETED|Overall Study||0
15814|NCT02359877|39366|P1|NOT COMPLETED|Overall Study||1
15815|NCT02359877|39363|P4|COMPLETED|Overall Study||11
15816|NCT02359877|39364|P3|COMPLETED|Overall Study||6
15817|NCT02359877|39365|P2|COMPLETED|Overall Study||6
15818|NCT02359877|39366|P1|COMPLETED|Overall Study||33
15819|NCT02359877|39363|P4|STARTED|Overall Study||14
15820|NCT02359877|39364|P3|STARTED|Overall Study||6
15821|NCT02359877|39365|P2|STARTED|Overall Study||6
15822|NCT02359877|39366|P1|STARTED|Overall Study||34
15823|NCT02359851|39416|P1|NOT COMPLETED|Overall Study||2
15824|NCT02359851|39416|P1|COMPLETED|Overall Study||3
15825|NCT02359851|39416|P1|STARTED|Overall Study||5
15826|NCT02359435|39426|P2|NOT COMPLETED|Overall Study||4
15827|NCT02359435|39427|P1|NOT COMPLETED|Overall Study||4
15828|NCT02359435|39426|P2|COMPLETED|Overall Study||216
15829|NCT02359435|39427|P1|COMPLETED|Overall Study||216
15830|NCT02359435|39426|P2|STARTED|Overall Study||220
15831|NCT02359435|39427|P1|STARTED|Overall Study||220
15832|NCT02359305|39435|P2|NOT COMPLETED|Overall Study||0
15833|NCT02359305|39436|P1|NOT COMPLETED|Overall Study||0
15834|NCT02359305|39435|P2|COMPLETED|Overall Study||34
15835|NCT02359305|39436|P1|COMPLETED|Overall Study||34
15836|NCT02359305|39435|P2|STARTED|Overall Study||34
15837|NCT02359305|39436|P1|STARTED|Overall Study||34
15838|NCT02359110|39448|P2|NOT COMPLETED|Overall Study||0
15839|NCT02359110|39449|P1|NOT COMPLETED|Overall Study||0
15840|NCT02359110|39448|P2|COMPLETED|Overall Study||54
15841|NCT02359110|39449|P1|COMPLETED|Overall Study||55
15842|NCT02359110|39448|P2|STARTED|Overall Study||54
15843|NCT02359110|39449|P1|STARTED|Overall Study||55
15844|NCT02359058|39462|P3|NOT COMPLETED|Overall Study||0
15845|NCT02359058|39463|P2|NOT COMPLETED|Overall Study||0
15846|NCT02359058|39464|P1|NOT COMPLETED|Overall Study||0
15847|NCT02359058|39462|P3|COMPLETED|Overall Study||6
15848|NCT02359058|39463|P2|COMPLETED|Overall Study||6
15849|NCT02359058|39464|P1|COMPLETED|Overall Study||6
15850|NCT02359058|39462|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
15851|NCT02359058|39463|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
15852|NCT02359058|39464|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
15853|NCT02359058|39462|P3|STARTED|Overall Study||6
15854|NCT02359058|39463|P2|STARTED|Overall Study||6
15855|NCT02359058|39464|P1|STARTED|Overall Study||6
15856|NCT02359045|39487|P2|NOT COMPLETED|Overall Study||3
15857|NCT02359045|39488|P1|NOT COMPLETED|Overall Study||4
15858|NCT02359045|39487|P2|COMPLETED|Overall Study||39
15859|NCT02359045|39488|P1|COMPLETED|Overall Study||36
15860|NCT02359045|39487|P2|STARTED|Overall Study||42
15861|NCT02359045|39488|P1|STARTED|Overall Study||40
15862|NCT02358876|39721|P1|NOT COMPLETED|Overall Study||2
15863|NCT02358876|39721|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
15864|NCT02358876|39721|P1|STARTED|Overall Study||32
15865|NCT02358668|39728|P3|NOT COMPLETED|Overall Study||0
15866|NCT02358668|39729|P2|NOT COMPLETED|Overall Study||1
15867|NCT02358668|39730|P1|NOT COMPLETED|Overall Study||2
15868|NCT02358668|39728|P3|COMPLETED|Overall Study||12
15869|NCT02358668|39729|P2|COMPLETED|Overall Study||23
15870|NCT02358668|39730|P1|COMPLETED|Overall Study||22
15871|NCT02358668|39728|P3|STARTED|Overall Study||12
15872|NCT02358668|39729|P2|STARTED|Overall Study||24
15873|NCT02358668|39730|P1|STARTED|Overall Study||24
15874|NCT02358044|39872|P2|NOT COMPLETED|Overall Study||7
15875|NCT02358044|39873|P1|NOT COMPLETED|Overall Study||2
15876|NCT02358044|39872|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
15877|NCT02358044|39873|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
15878|NCT02358044|39872|P2|Treated|Overall Study||126
15879|NCT02358044|39873|P1|Treated|Overall Study||129
15880|NCT02358044|39872|P2|STARTED|Overall Study||128
15881|NCT02358044|39873|P1|STARTED|Overall Study||129
15882|NCT02357940|39891|P2|NOT COMPLETED|Overall Study||2
15883|NCT02357940|39892|P1|NOT COMPLETED|Overall Study||0
15884|NCT02357940|39891|P2|COMPLETED|Overall Study||30
15885|NCT02357940|39892|P1|COMPLETED|Overall Study||9
15886|NCT02357940|39891|P2|STARTED|Overall Study||32
15887|NCT02357940|39892|P1|STARTED|Overall Study||9
15888|NCT02357901|40019|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
15889|NCT02357901|40020|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
15890|NCT02357901|40021|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
15891|NCT02357901|40022|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
15892|NCT02357901|40019|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
15893|NCT02357901|40020|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
15894|NCT02357901|40021|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
15895|NCT02357901|40022|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
15896|NCT02357901|40019|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
15897|NCT02357901|40020|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
15898|NCT02357901|40021|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
15899|NCT02357901|40022|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
15900|NCT02357901|40019|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
15901|NCT02357901|40020|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
15902|NCT02357901|40021|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
15903|NCT02357901|40022|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
15904|NCT02357901|40019|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
15905|NCT02357901|40020|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
15906|NCT02357901|40021|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
15907|NCT02357901|40022|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
15908|NCT02357901|40019|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
15909|NCT02357901|40020|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
15910|NCT02357901|40021|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
15911|NCT02357901|40022|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
15912|NCT02357901|40019|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
15913|NCT02357901|40020|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
15914|NCT02357901|40021|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
15915|NCT02357901|40022|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
15916|NCT02357901|40019|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
15917|NCT02357901|40020|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
15918|NCT02357901|40021|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
15919|NCT02357901|40022|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
15920|NCT02357485|40072|P1|NOT COMPLETED|Overall Study||0
15921|NCT02357485|40072|P1|COMPLETED|Overall Study||6
15922|NCT02357485|40072|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
15923|NCT02357459|40083|P3|NOT COMPLETED|Overall Study||12
15924|NCT02357459|40084|P2|NOT COMPLETED|Overall Study||14
15925|NCT02357459|40085|P1|NOT COMPLETED|Overall Study||17
15926|NCT02357459|40083|P3|COMPLETED|Overall Study||150
15927|NCT02357459|40084|P2|COMPLETED|Overall Study||149
15928|NCT02357459|40085|P1|COMPLETED|Overall Study||144
15929|NCT02357459|40083|P3|STARTED|Overall Study||162
15930|NCT02357459|40084|P2|STARTED|Overall Study||163
15931|NCT02357459|40085|P1|STARTED|Overall Study||161
15932|NCT02357342|40129|P2|NOT COMPLETED|Extension Study||0
15933|NCT02357342|40130|P1|NOT COMPLETED|Extension Study||0
15934|NCT02357342|40129|P2|COMPLETED|Extension Study||9
15935|NCT02357342|40130|P1|COMPLETED|Extension Study||4
15936|NCT02357342|40129|P2|STARTED|Extension Study||9
15937|NCT02357342|40130|P1|STARTED|Extension Study||4
15938|NCT02357342|40129|P2|NOT COMPLETED|First 6 Months||0
15939|NCT02357342|40130|P1|NOT COMPLETED|First 6 Months||2
15940|NCT02357342|40129|P2|COMPLETED|First 6 Months||20
15941|NCT02357342|40130|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
15942|NCT02357342|40129|P2|STARTED|First 6 Months||20
15943|NCT02357342|40130|P1|STARTED|First 6 Months||20
15944|NCT02357264|40142|P2|NOT COMPLETED|Overall Study||0
15945|NCT02357264|40143|P1|NOT COMPLETED|Overall Study||0
15946|NCT02357264|40142|P2|COMPLETED|Overall Study||130
15947|NCT02357264|40143|P1|COMPLETED|Overall Study||56
15948|NCT02357264|40142|P2|STARTED|Overall Study||130
15949|NCT02357264|40143|P1|STARTED|Overall Study||56
15950|NCT02357173|40152|P3|NOT COMPLETED|Overall Study||6
15951|NCT02357173|40153|P2|NOT COMPLETED|Overall Study||6
15952|NCT02357173|40154|P1|NOT COMPLETED|Overall Study||6
15953|NCT02357173|40152|P3|COMPLETED|Overall Study||16
15954|NCT02357173|40153|P2|COMPLETED|Overall Study||15
15955|NCT02357173|40154|P1|COMPLETED|Overall Study||19
15956|NCT02357173|40152|P3|STARTED|Overall Study||22
15957|NCT02357173|40153|P2|STARTED|Overall Study||21
15958|NCT02357173|40154|P1|STARTED|Overall Study||25
15959|NCT02356900|40173|P2|NOT COMPLETED|Overall Study||0
15960|NCT02356900|40174|P1|NOT COMPLETED|Overall Study||0
15961|NCT02356900|40173|P2|COMPLETED|Overall Study||10
15962|NCT02356900|40174|P1|COMPLETED|Overall Study||11
15963|NCT02356900|40173|P2|STARTED|Overall Study||10
15964|NCT02356900|40174|P1|STARTED|Overall Study||11
15965|NCT02356783|40194|P2|NOT COMPLETED|Overall Study||3
15966|NCT02356783|40195|P1|NOT COMPLETED|Overall Study||1
15967|NCT02356783|40194|P2|COMPLETED|Overall Study||14
15968|NCT02356783|40195|P1|COMPLETED|Overall Study||15
15969|NCT02356783|40194|P2|STARTED|Overall Study||17
15970|NCT02356783|40195|P1|STARTED|Overall Study||16
15971|NCT02356588|40205|P2|NOT COMPLETED|Overall Study||13
15972|NCT02356588|40206|P1|NOT COMPLETED|Overall Study||5
15973|NCT02356588|40205|P2|COMPLETED|Overall Study||41
15974|NCT02356588|40206|P1|COMPLETED|Overall Study||102
15975|NCT02356588|40205|P2|STARTED|Overall Study||54
15976|NCT02356588|40206|P1|STARTED|Overall Study||107
15977|NCT02356562|40240|P2|NOT COMPLETED|Overall Study||1
15978|NCT02356562|40241|P1|NOT COMPLETED|Overall Study||2
15979|NCT02356562|40240|P2|COMPLETED|Overall Study||6
15980|NCT02356562|40241|P1|COMPLETED|Overall Study||20
15981|NCT02356562|40240|P2|STARTED|Overall Study||7
15982|NCT02356562|40241|P1|STARTED|Overall Study||22
15983|NCT02356107|40251|P1|NOT COMPLETED|Overall Study||3
15984|NCT02356107|40251|P1|COMPLETED|Overall Study||12
15985|NCT02356107|40251|P1|STARTED|Overall Study||15
15986|NCT02355977|40258|P3|NOT COMPLETED|Overall Study||0
15987|NCT02355977|40259|P2|NOT COMPLETED|Overall Study||0
15988|NCT02355977|40260|P1|NOT COMPLETED|Overall Study||0
15989|NCT02355977|40258|P3|COMPLETED|Overall Study||23
15990|NCT02355977|40259|P2|COMPLETED|Overall Study||26
15991|NCT02355977|40260|P1|COMPLETED|Overall Study||21
15992|NCT02355977|40258|P3|STARTED|Overall Study||23
15993|NCT02355977|40259|P2|STARTED|Overall Study||26
15994|NCT02355977|40260|P1|STARTED|Overall Study||21
15995|NCT02355743|40274|P1|NOT COMPLETED|Overall Study||2
15996|NCT02355743|40274|P1|COMPLETED|Overall Study||6
15997|NCT02355743|40274|P1|STARTED|Overall Study||8
15998|NCT02355691|40282|P2|NOT COMPLETED|Overall Study||9
15999|NCT02355691|40283|P1|NOT COMPLETED|Overall Study||7
16000|NCT02355691|40282|P2|COMPLETED|Overall Study||0
16001|NCT02355691|40283|P1|COMPLETED|Overall Study||0
16002|NCT02355691|40282|P2|2nd Postop Visit|Overall Study||9
16003|NCT02355691|40283|P1|2nd Postop Visit|Overall Study||7
16004|NCT02355691|40282|P2|1st Postop Visit|Overall Study||9
16005|NCT02355691|40283|P1|1st Postop Visit|Overall Study||7
16006|NCT02355691|40282|P2|STARTED|Overall Study||9
16007|NCT02355691|40283|P1|STARTED|Overall Study||7
16008|NCT02355275|40291|P1|NOT COMPLETED|Overall Study||8
16009|NCT02355275|40291|P1|COMPLETED|Overall Study||14
16010|NCT02355275|40291|P1|STARTED|Overall Study||22
16011|NCT02355158|40296|P1|NOT COMPLETED|Overall Study||150
16012|NCT02355158|40296|P1|COMPLETED|Overall Study||47
16013|NCT02355158|40296|P1|STARTED|Overall Study||197
16014|NCT02355028|40302|P2|NOT COMPLETED|Overall Study||5
16015|NCT02355028|40303|P1|NOT COMPLETED|Overall Study||11
16016|NCT02355028|40302|P2|COMPLETED|Overall Study||41
16017|NCT02355028|40303|P1|COMPLETED|Overall Study||36
16018|NCT02355028|40302|P2|Treated|Overall Study||45
16019|NCT02355028|40303|P1|Treated|Overall Study||46
16020|NCT02355028|40302|P2|STARTED|Overall Study||46
16021|NCT02355028|40303|P1|STARTED|Overall Study||47
16022|NCT02354924|40338|P2|NOT COMPLETED|Overall Study||0
16023|NCT02354924|40339|P1|NOT COMPLETED|Overall Study||0
16024|NCT02354924|40338|P2|COMPLETED|Overall Study||20
16025|NCT02354924|40339|P1|COMPLETED|Overall Study||40
16026|NCT02354924|40338|P2|STARTED|Overall Study||20
16027|NCT02354924|40339|P1|STARTED|Overall Study||40
16028|NCT02354833|40351|P2|NOT COMPLETED|Overall Study||0
16029|NCT02354833|40352|P1|NOT COMPLETED|Overall Study||0
16030|NCT02354833|40351|P2|COMPLETED|Overall Study||43
16031|NCT02354833|40352|P1|COMPLETED|Overall Study||38
16032|NCT02354833|40351|P2|STARTED|Overall Study||43
16033|NCT02354833|40352|P1|STARTED|Overall Study||38
16034|NCT02354599|40370|P6|NOT COMPLETED|Overall Study||1
16035|NCT02354599|40371|P5|NOT COMPLETED|Overall Study||0
16036|NCT02354599|40372|P4|NOT COMPLETED|Overall Study||0
16037|NCT02354599|40373|P3|NOT COMPLETED|Overall Study||0
16038|NCT02354599|40374|P2|NOT COMPLETED|Overall Study||1
16039|NCT02354599|40375|P1|NOT COMPLETED|Overall Study||1
16040|NCT02354599|40370|P6|COMPLETED|Overall Study||5
16041|NCT02354599|40371|P5|COMPLETED|Overall Study||2
16042|NCT02354599|40372|P4|COMPLETED|Overall Study||6
16043|NCT02354599|40373|P3|COMPLETED|Overall Study||6
16044|NCT02354599|40374|P2|COMPLETED|Overall Study||5
16045|NCT02354599|40375|P1|COMPLETED|Overall Study||5
16046|NCT02354599|40370|P6|STARTED|Overall Study||6
16047|NCT02354599|40371|P5|STARTED|Overall Study||2
16048|NCT02354599|40372|P4|STARTED|Overall Study||6
16049|NCT02354599|40373|P3|STARTED|Overall Study||6
16050|NCT02354599|40374|P2|STARTED|Overall Study||6
16051|NCT02354599|40375|P1|STARTED|Overall Study||6
16052|NCT02353871|40447|P2|NOT COMPLETED|Overall Study||9
16053|NCT02353871|40448|P1|NOT COMPLETED|Overall Study||3
16054|NCT02353871|40447|P2|COMPLETED|Overall Study||51
16055|NCT02353871|40448|P1|COMPLETED|Overall Study||122
16056|NCT02353871|40447|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
16057|NCT02353871|40448|P1|STARTED|Overall Study|Randomised.|125
16058|NCT02353754|40470|P2|NOT COMPLETED|Overall Study||0
16059|NCT02353754|40471|P1|NOT COMPLETED|Overall Study||2
16060|NCT02353754|40470|P2|COMPLETED|Overall Study||0
16061|NCT02353754|40471|P1|COMPLETED|Overall Study||10
16062|NCT02353754|40470|P2|STARTED|Overall Study||0
16063|NCT02353754|40471|P1|STARTED|Overall Study||12
16064|NCT02353572|40481|P1|NOT COMPLETED|Overall Study||3
16065|NCT02353572|40481|P1|COMPLETED|Overall Study||0
16066|NCT02353572|40481|P1|STARTED|Overall Study||3
16067|NCT02353468|40485|P1|NOT COMPLETED|Overall Study||3
16068|NCT02353468|40485|P1|COMPLETED|Overall Study||0
16069|NCT02353468|40485|P1|STARTED|Overall Study||3
16070|NCT02353442|40491|P2|NOT COMPLETED|Overall Study||4
16071|NCT02353442|40492|P1|NOT COMPLETED|Overall Study||3
16072|NCT02353442|40491|P2|COMPLETED|Overall Study||27
16073|NCT02353442|40492|P1|COMPLETED|Overall Study||25
16074|NCT02353442|40491|P2|STARTED|Overall Study||31
16075|NCT02353442|40492|P1|STARTED|Overall Study||28
16076|NCT02353299|40506|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
16077|NCT02353299|40507|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
16078|NCT02353299|40508|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
16079|NCT02353299|40509|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
16080|NCT02353299|40506|P4|COMPLETED|Fourth Intervention (1 Night)||13
16081|NCT02353299|40507|P3|COMPLETED|Fourth Intervention (1 Night)||13
16082|NCT02353299|40508|P2|COMPLETED|Fourth Intervention (1 Night)||12
16083|NCT02353299|40509|P1|COMPLETED|Fourth Intervention (1 Night)||13
16084|NCT02353299|40506|P4|STARTED|Fourth Intervention (1 Night)||13
16085|NCT02353299|40507|P3|STARTED|Fourth Intervention (1 Night)||13
16086|NCT02353299|40508|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
16087|NCT02353299|40509|P1|STARTED|Fourth Intervention (1 Night)||13
16088|NCT02353299|40506|P4|NOT COMPLETED|Third Intervention (1 Night)||0
16089|NCT02353299|40507|P3|NOT COMPLETED|Third Intervention (1 Night)||0
16090|NCT02353299|40508|P2|NOT COMPLETED|Third Intervention (1 Night)||0
16091|NCT02353299|40509|P1|NOT COMPLETED|Third Intervention (1 Night)||0
16092|NCT02353299|40506|P4|COMPLETED|Third Intervention (1 Night)||13
16093|NCT02353299|40507|P3|COMPLETED|Third Intervention (1 Night)||13
16094|NCT02353299|40508|P2|COMPLETED|Third Intervention (1 Night)||13
16095|NCT02353299|40509|P1|COMPLETED|Third Intervention (1 Night)||13
16096|NCT02353299|40506|P4|STARTED|Third Intervention (1 Night)||13
16097|NCT02353299|40507|P3|STARTED|Third Intervention (1 Night)||13
16098|NCT02353299|40508|P2|STARTED|Third Intervention (1 Night)||13
16099|NCT02353299|40509|P1|STARTED|Third Intervention (1 Night)||13
16100|NCT02353299|40506|P4|NOT COMPLETED|Second Intervention (1 Night)||0
16101|NCT02353299|40507|P3|NOT COMPLETED|Second Intervention (1 Night)||0
16102|NCT02353299|40508|P2|NOT COMPLETED|Second Intervention (1 Night)||0
16103|NCT02353299|40509|P1|NOT COMPLETED|Second Intervention (1 Night)||0
16104|NCT02353299|40506|P4|COMPLETED|Second Intervention (1 Night)||13
16105|NCT02353299|40507|P3|COMPLETED|Second Intervention (1 Night)||13
16106|NCT02353299|40508|P2|COMPLETED|Second Intervention (1 Night)||13
16107|NCT02353299|40509|P1|COMPLETED|Second Intervention (1 Night)||13
16108|NCT02353299|40506|P4|STARTED|Second Intervention (1 Night)||13
16109|NCT02353299|40507|P3|STARTED|Second Intervention (1 Night)||13
16110|NCT02353299|40508|P2|STARTED|Second Intervention (1 Night)||13
16111|NCT02353299|40509|P1|STARTED|Second Intervention (1 Night)||13
16112|NCT02353299|40506|P4|NOT COMPLETED|First Intervention (1 Night)||0
16113|NCT02353299|40507|P3|NOT COMPLETED|First Intervention (1 Night)||0
16114|NCT02353299|40508|P2|NOT COMPLETED|First Intervention (1 Night)||0
16115|NCT02353299|40509|P1|NOT COMPLETED|First Intervention (1 Night)||0
16116|NCT02353299|40506|P4|COMPLETED|First Intervention (1 Night)||13
16117|NCT02353299|40507|P3|COMPLETED|First Intervention (1 Night)||13
16118|NCT02353299|40508|P2|COMPLETED|First Intervention (1 Night)||13
16119|NCT02353299|40509|P1|COMPLETED|First Intervention (1 Night)||13
16120|NCT02353299|40506|P4|STARTED|First Intervention (1 Night)||13
16121|NCT02353299|40507|P3|STARTED|First Intervention (1 Night)||13
16122|NCT02353299|40508|P2|STARTED|First Intervention (1 Night)||13
16123|NCT02353299|40509|P1|STARTED|First Intervention (1 Night)||13
16124|NCT02352779|40546|P3|NOT COMPLETED|Overall Study||2
16125|NCT02352779|40547|P2|NOT COMPLETED|Overall Study||1
16126|NCT02352779|40548|P1|NOT COMPLETED|Overall Study||8
16127|NCT02352779|40546|P3|COMPLETED|Overall Study||33
16128|NCT02352779|40547|P2|COMPLETED|Overall Study||35
16129|NCT02352779|40548|P1|COMPLETED|Overall Study||29
16130|NCT02352779|40546|P3|STARTED|Overall Study||35
16131|NCT02352779|40547|P2|STARTED|Overall Study||36
16132|NCT02352779|40548|P1|STARTED|Overall Study||37
16133|NCT02352298|40556|P1|NOT COMPLETED|Overall Study||0
16134|NCT02352298|40556|P1|COMPLETED|Overall Study||52
16135|NCT02352298|40556|P1|STARTED|Overall Study||52
16136|NCT02351960|40563|P2|NOT COMPLETED|Overall Study||12
16137|NCT02351960|40564|P1|NOT COMPLETED|Overall Study||11
16138|NCT02351960|40563|P2|COMPLETED|Overall Study||76
16139|NCT02351960|40564|P1|COMPLETED|Overall Study||197
16140|NCT02351960|40563|P2|STARTED|Overall Study||88
16141|NCT02351960|40564|P1|STARTED|Overall Study||208
16142|NCT02351934|40585|P2|NOT COMPLETED|Follow-Up||10
16143|NCT02351934|40586|P1|NOT COMPLETED|Follow-Up||12
16144|NCT02351934|40585|P2|COMPLETED|Follow-Up||51
16145|NCT02351934|40586|P1|COMPLETED|Follow-Up||44
16146|NCT02351934|40585|P2|STARTED|Follow-Up||61
16147|NCT02351934|40586|P1|STARTED|Follow-Up||56
16148|NCT02351934|40585|P2|NOT COMPLETED|Allocation||0
16149|NCT02351934|40586|P1|NOT COMPLETED|Allocation||6
16150|NCT02351934|40585|P2|COMPLETED|Allocation||61
16151|NCT02351934|40586|P1|COMPLETED|Allocation||56
16152|NCT02351934|40585|P2|Received Allocation|Allocation||61
16153|NCT02351934|40586|P1|Received Allocation|Allocation||56
16154|NCT02351934|40585|P2|STARTED|Allocation||61
16155|NCT02351934|40586|P1|STARTED|Allocation||62
16156|NCT02351817|40602|P2|NOT COMPLETED|Period 2||2
16157|NCT02351817|40603|P1|NOT COMPLETED|Period 2||1
16158|NCT02351817|40602|P2|COMPLETED|Period 2||3
16159|NCT02351817|40603|P1|COMPLETED|Period 2||4
16160|NCT02351817|40602|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
16161|NCT02351817|40603|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
16162|NCT02351817|40602|P2|NOT COMPLETED|Period 1||3
16163|NCT02351817|40603|P1|NOT COMPLETED|Period 1||1
16164|NCT02351817|40602|P2|COMPLETED|Period 1||2
16165|NCT02351817|40603|P1|COMPLETED|Period 1||4
16166|NCT02351817|40602|P2|STARTED|Period 1||5
16167|NCT02351817|40603|P1|STARTED|Period 1||5
16168|NCT02351817|40602|P2|NOT COMPLETED|Baseline Period||0
16169|NCT02351817|40603|P1|NOT COMPLETED|Baseline Period||0
16170|NCT02351817|40602|P2|COMPLETED|Baseline Period||5
16171|NCT02351817|40603|P1|COMPLETED|Baseline Period||5
16172|NCT02351817|40602|P2|STARTED|Baseline Period||5
16173|NCT02351817|40603|P1|STARTED|Baseline Period||5
16174|NCT02351505|40610|P1|NOT COMPLETED|Overall Study||0
16175|NCT02351505|40610|P1|COMPLETED|Overall Study||1
16176|NCT02351505|40610|P1|STARTED|Overall Study||1
16177|NCT02350881|40621|P1|NOT COMPLETED|Overall Study||0
16178|NCT02350881|40621|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
16179|NCT02350881|40621|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
16180|NCT02350569|40649|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
16181|NCT02350569|40649|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
16182|NCT02350569|40649|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
16183|NCT02350569|40649|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
16184|NCT02350569|40649|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
16185|NCT02350569|40649|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
16186|NCT02349711|40661|P2|NOT COMPLETED|Overall Study||2
16187|NCT02349711|40662|P1|NOT COMPLETED|Overall Study||3
16188|NCT02349711|40661|P2|COMPLETED|Overall Study||84
16189|NCT02349711|40662|P1|COMPLETED|Overall Study||84
16190|NCT02349711|40661|P2|STARTED|Overall Study||86
16191|NCT02349711|40662|P1|STARTED|Overall Study||87
16192|NCT02349685|40677|P3|NOT COMPLETED|Overall Study||4
16193|NCT02349685|40678|P2|NOT COMPLETED|Overall Study||2
16194|NCT02349685|40679|P1|NOT COMPLETED|Overall Study||5
16195|NCT02349685|40677|P3|COMPLETED|Overall Study||37
16196|NCT02349685|40678|P2|COMPLETED|Overall Study||87
16197|NCT02349685|40679|P1|COMPLETED|Overall Study||84
16198|NCT02349685|40677|P3|STARTED|Overall Study||41
16199|NCT02349685|40678|P2|STARTED|Overall Study||89
16200|NCT02349685|40679|P1|STARTED|Overall Study||89
16201|NCT02349542|40690|P1|NOT COMPLETED|Overall Study||5
16202|NCT02349542|40690|P1|COMPLETED|Overall Study||15
16203|NCT02349542|40690|P1|STARTED|Overall Study||20
16204|NCT02349451|40699|P4|NOT COMPLETED|Overall Study||1
16205|NCT02349451|40700|P3|NOT COMPLETED|Overall Study||2
16206|NCT02349451|40701|P2|NOT COMPLETED|Overall Study||1
16207|NCT02349451|40702|P1|NOT COMPLETED|Overall Study||0
16208|NCT02349451|40699|P4|COMPLETED|Overall Study||72
16209|NCT02349451|40700|P3|COMPLETED|Overall Study||69
16210|NCT02349451|40701|P2|COMPLETED|Overall Study||71
16211|NCT02349451|40702|P1|COMPLETED|Overall Study||24
16212|NCT02349451|40699|P4|STARTED|Overall Study||73
16213|NCT02349451|40700|P3|STARTED|Overall Study||71
16214|NCT02349451|40701|P2|STARTED|Overall Study||72
16215|NCT02349451|40702|P1|STARTED|Overall Study||24
16216|NCT02349438|40738|P2|NOT COMPLETED|Period 2||0
16217|NCT02349438|40739|P1|NOT COMPLETED|Period 2||0
16218|NCT02349438|40738|P2|COMPLETED|Period 2||10
16219|NCT02349438|40739|P1|COMPLETED|Period 2||11
16220|NCT02349438|40738|P2|STARTED|Period 2||10
16221|NCT02349438|40739|P1|STARTED|Period 2||11
16222|NCT02349438|40738|P2|NOT COMPLETED|Period 1||0
16223|NCT02349438|40739|P1|NOT COMPLETED|Period 1||0
16224|NCT02349438|40738|P2|COMPLETED|Period 1||10
16225|NCT02349438|40739|P1|COMPLETED|Period 1||11
16226|NCT02349438|40738|P2|STARTED|Period 1||10
16227|NCT02349438|40739|P1|STARTED|Period 1||11
16228|NCT02349360|40751|P2|NOT COMPLETED|Overall Study||1
16229|NCT02349360|40752|P1|NOT COMPLETED|Overall Study||0
16230|NCT02349360|40751|P2|COMPLETED|Overall Study||20
16231|NCT02349360|40752|P1|COMPLETED|Overall Study||21
16232|NCT02349360|40751|P2|STARTED|Overall Study||21
16233|NCT02349360|40752|P1|STARTED|Overall Study||21
16234|NCT02349295|40763|P5|NOT COMPLETED|IR (Week 16-24)||1
16235|NCT02349295|40764|P4|NOT COMPLETED|IR (Week 16-24)||0
16236|NCT02349295|40765|P3|NOT COMPLETED|IR (Week 16-24)||0
16237|NCT02349295|40766|P2|NOT COMPLETED|IR (Week 16-24)||0
16238|NCT02349295|40767|P1|NOT COMPLETED|IR (Week 16-24)||0
16239|NCT02349295|40763|P5|COMPLETED|IR (Week 16-24)||32
16240|NCT02349295|40764|P4|COMPLETED|IR (Week 16-24)||31
16241|NCT02349295|40765|P3|COMPLETED|IR (Week 16-24)||0
16242|NCT02349295|40766|P2|COMPLETED|IR (Week 16-24)||0
16243|NCT02349295|40767|P1|COMPLETED|IR (Week 16-24)||0
16244|NCT02349295|40763|P5|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W and IR from ixekizumab 80 mg Q2W.|33
16245|NCT02349295|40764|P4|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W and IR from ixekizumab 80 mg Q4W.|31
16246|NCT02349295|40765|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
16247|NCT02349295|40766|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
16248|NCT02349295|40767|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
16249|NCT02349295|40763|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
16250|NCT02349295|40764|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
16251|NCT02349295|40765|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
16252|NCT02349295|40766|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
16253|NCT02349295|40767|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
16254|NCT02349295|40763|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
16255|NCT02349295|40764|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
16256|NCT02349295|40765|P3|COMPLETED|Double Blind Treatment (Week 0-24)||109
16257|NCT02349295|40766|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
16258|NCT02349295|40767|P1|COMPLETED|Double Blind Treatment (Week 0-24)||94
16259|NCT02349295|40763|P5|STARTED|Double Blind Treatment (Week 0-24)||0
16260|NCT02349295|40764|P4|STARTED|Double Blind Treatment (Week 0-24)||0
16261|NCT02349295|40765|P3|STARTED|Double Blind Treatment (Week 0-24)||123
16262|NCT02349295|40766|P2|STARTED|Double Blind Treatment (Week 0-24)||122
16263|NCT02349295|40767|P1|STARTED|Double Blind Treatment (Week 0-24)||118
16264|NCT02349152|40843|P2|NOT COMPLETED|Overall Study||4
16265|NCT02349152|40844|P1|NOT COMPLETED|Overall Study||6
16266|NCT02349152|40843|P2|COMPLETED|Overall Study||52
16267|NCT02349152|40844|P1|COMPLETED|Overall Study||54
16268|NCT02349152|40843|P2|STARTED|Overall Study||56
16269|NCT02349152|40844|P1|STARTED|Overall Study||60
16270|NCT02349048|40870|P2|NOT COMPLETED|Overall Study||0
16271|NCT02349048|40871|P1|NOT COMPLETED|Overall Study||5
16272|NCT02349048|40870|P2|COMPLETED|Overall Study||9
16273|NCT02349048|40871|P1|COMPLETED|Overall Study||54
16274|NCT02349048|40870|P2|STARTED|Overall Study||9
16275|NCT02349048|40871|P1|STARTED|Overall Study||59
16276|NCT02348723|40893|P2|NOT COMPLETED|Overall Study||26
16277|NCT02348723|40894|P1|NOT COMPLETED|Overall Study||28
16278|NCT02348723|40893|P2|COMPLETED|Overall Study||312
16279|NCT02348723|40894|P1|COMPLETED|Overall Study||310
16280|NCT02348723|40893|P2|STARTED|Overall Study||338
16281|NCT02348723|40894|P1|STARTED|Overall Study||338
16282|NCT02348658|40906|P2|NOT COMPLETED|Period 2 (7 Days)||0
16283|NCT02348658|40907|P1|NOT COMPLETED|Period 2 (7 Days)||0
16284|NCT02348658|40906|P2|COMPLETED|Period 2 (7 Days)||6
16285|NCT02348658|40907|P1|COMPLETED|Period 2 (7 Days)||6
16286|NCT02348658|40906|P2|STARTED|Period 2 (7 Days)||6
16287|NCT02348658|40907|P1|STARTED|Period 2 (7 Days)||6
16288|NCT02348658|40906|P2|NOT COMPLETED|Washout Period (22 Days)||0
16289|NCT02348658|40907|P1|NOT COMPLETED|Washout Period (22 Days)||0
16290|NCT02348658|40906|P2|COMPLETED|Washout Period (22 Days)||6
16291|NCT02348658|40907|P1|COMPLETED|Washout Period (22 Days)||6
16292|NCT02348658|40906|P2|STARTED|Washout Period (22 Days)||6
16293|NCT02348658|40907|P1|STARTED|Washout Period (22 Days)||6
16294|NCT02348658|40906|P2|NOT COMPLETED|Period 1 (7 Days)||0
16295|NCT02348658|40907|P1|NOT COMPLETED|Period 1 (7 Days)||0
16296|NCT02348658|40906|P2|COMPLETED|Period 1 (7 Days)||6
16297|NCT02348658|40907|P1|COMPLETED|Period 1 (7 Days)||6
16298|NCT02348658|40906|P2|STARTED|Period 1 (7 Days)||6
16299|NCT02348658|40907|P1|STARTED|Period 1 (7 Days)||6
16300|NCT02347774|40944|P3|NOT COMPLETED|On Study Treatment||36
16301|NCT02347774|40945|P2|NOT COMPLETED|On Study Treatment||31
16302|NCT02347774|40946|P1|NOT COMPLETED|On Study Treatment||24
16303|NCT02347774|40944|P3|COMPLETED|On Study Treatment||177
16304|NCT02347774|40945|P2|COMPLETED|On Study Treatment||183
16305|NCT02347774|40946|P1|COMPLETED|On Study Treatment||190
16306|NCT02347774|40944|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
16307|NCT02347774|40945|P2|STARTED|On Study Treatment||214
16308|NCT02347774|40946|P1|STARTED|On Study Treatment||214
16309|NCT02347774|40944|P3|NOT COMPLETED|Study Participation||25
16310|NCT02347774|40945|P2|NOT COMPLETED|Study Participation||21
16311|NCT02347774|40946|P1|NOT COMPLETED|Study Participation||15
16312|NCT02347774|40944|P3|COMPLETED|Study Participation||188
16313|NCT02347774|40945|P2|COMPLETED|Study Participation||193
16314|NCT02347774|40946|P1|COMPLETED|Study Participation||199
16315|NCT02347774|40944|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
16316|NCT02347774|40945|P2|STARTED|Study Participation||214
16317|NCT02347774|40946|P1|STARTED|Study Participation||214
16318|NCT02347761|41002|P3|NOT COMPLETED|On Study Treatment||42
16319|NCT02347761|41003|P2|NOT COMPLETED|On Study Treatment||23
16320|NCT02347761|41004|P1|NOT COMPLETED|On Study Treatment||27
16321|NCT02347761|41002|P3|COMPLETED|On Study Treatment||176
16322|NCT02347761|41003|P2|COMPLETED|On Study Treatment||194
16323|NCT02347761|41004|P1|COMPLETED|On Study Treatment||191
16324|NCT02347761|41002|P3|STARTED|On Study Treatment||218
16325|NCT02347761|41003|P2|STARTED|On Study Treatment||217
16326|NCT02347761|41004|P1|STARTED|On Study Treatment||218
16327|NCT02347761|41002|P3|NOT COMPLETED|All Collected||27
16328|NCT02347761|41003|P2|NOT COMPLETED|All Collected||14
16329|NCT02347761|41004|P1|NOT COMPLETED|All Collected||17
16330|NCT02347761|41002|P3|COMPLETED|All Collected||191
16331|NCT02347761|41003|P2|COMPLETED|All Collected||203
16332|NCT02347761|41004|P1|COMPLETED|All Collected||201
16333|NCT02347761|41002|P3|STARTED|All Collected||218
16334|NCT02347761|41003|P2|STARTED|All Collected||217
16335|NCT02347761|41004|P1|STARTED|All Collected||218
16336|NCT02347605|41069|P6|NOT COMPLETED|Overall Study||2
16337|NCT02347605|41070|P5|NOT COMPLETED|Overall Study||3
16338|NCT02347605|41071|P4|NOT COMPLETED|Overall Study||4
16339|NCT02347605|41072|P3|NOT COMPLETED|Overall Study||1
16340|NCT02347605|41073|P2|NOT COMPLETED|Overall Study||3
16341|NCT02347605|41074|P1|NOT COMPLETED|Overall Study||3
16342|NCT02347605|41069|P6|COMPLETED|Overall Study||7
16343|NCT02347605|41070|P5|COMPLETED|Overall Study||6
16344|NCT02347605|41071|P4|COMPLETED|Overall Study||6
16345|NCT02347605|41072|P3|COMPLETED|Overall Study||7
16346|NCT02347605|41073|P2|COMPLETED|Overall Study||7
16347|NCT02347605|41074|P1|COMPLETED|Overall Study||7
16348|NCT02347605|41069|P6|Completed Lab 2|Overall Study||8
16349|NCT02347605|41070|P5|Completed Lab 2|Overall Study||6
16350|NCT02347605|41071|P4|Completed Lab 2|Overall Study||7
16351|NCT02347605|41072|P3|Completed Lab 2|Overall Study||7
16352|NCT02347605|41073|P2|Completed Lab 2|Overall Study||7
16353|NCT02347605|41074|P1|Completed Lab 2|Overall Study||7
16354|NCT02347605|41069|P6|Completed Lab 1|Overall Study||9
16355|NCT02347605|41070|P5|Completed Lab 1|Overall Study||8
16356|NCT02347605|41071|P4|Completed Lab 1|Overall Study||10
16357|NCT02347605|41072|P3|Completed Lab 1|Overall Study||8
16358|NCT02347605|41073|P2|Completed Lab 1|Overall Study||10
16359|NCT02347605|41074|P1|Completed Lab 1|Overall Study||10
16360|NCT02347605|41069|P6|STARTED|Overall Study||9
16361|NCT02347605|41070|P5|STARTED|Overall Study||9
16362|NCT02347605|41071|P4|STARTED|Overall Study||10
16363|NCT02347605|41072|P3|STARTED|Overall Study||8
16364|NCT02347605|41073|P2|STARTED|Overall Study||10
16365|NCT02347605|41074|P1|STARTED|Overall Study||10
16366|NCT02347488|41085|P1|NOT COMPLETED|Overall Study||0
16367|NCT02347488|41085|P1|COMPLETED|Overall Study||30
16368|NCT02347488|41085|P1|STARTED|Overall Study||30
16369|NCT02347189|41095|P1|NOT COMPLETED|Overall Study||11
16370|NCT02347189|41095|P1|COMPLETED|Overall Study||28
16371|NCT02347189|41095|P1|Implanted > 24 Hours|Overall Study||30
16372|NCT02347189|41095|P1|Implanted|Overall Study||30
16373|NCT02347189|41095|P1|Catheterized|Overall Study||39
16374|NCT02347189|41095|P1|STARTED|Overall Study||39
16375|NCT02347176|41103|P4|NOT COMPLETED|Overall Study||4
16376|NCT02347176|41104|P3|NOT COMPLETED|Overall Study||8
16377|NCT02347176|41105|P2|NOT COMPLETED|Overall Study||10
16378|NCT02347176|41106|P1|NOT COMPLETED|Overall Study||12
16379|NCT02347176|41103|P4|COMPLETED|Overall Study||48
16380|NCT02347176|41104|P3|COMPLETED|Overall Study||43
16381|NCT02347176|41105|P2|COMPLETED|Overall Study||40
16382|NCT02347176|41106|P1|COMPLETED|Overall Study||39
16383|NCT02347176|41103|P4|STARTED|Overall Study||52
16384|NCT02347176|41104|P3|STARTED|Overall Study||51
16385|NCT02347176|41105|P2|STARTED|Overall Study||50
16386|NCT02347176|41106|P1|STARTED|Overall Study||51
16387|NCT02347124|41154|P2|NOT COMPLETED|Overall Study||99
16388|NCT02347124|41155|P1|NOT COMPLETED|Overall Study||93
16389|NCT02347124|41154|P2|COMPLETED|Overall Study||259
16390|NCT02347124|41155|P1|COMPLETED|Overall Study||267
16391|NCT02347124|41154|P2|2 Month Follow-up|Overall Study||275
16392|NCT02347124|41155|P1|2 Month Follow-up|Overall Study||298
16393|NCT02347124|41154|P2|STARTED|Overall Study||358
16394|NCT02347124|41155|P1|STARTED|Overall Study||360
16395|NCT02347085|41189|P1|NOT COMPLETED|Overall Study||10
16396|NCT02347085|41189|P1|COMPLETED|Overall Study||33
16397|NCT02347085|41189|P1|Placebo MDI|Overall Study||40
16398|NCT02347085|41189|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
16399|NCT02347085|41189|P1|STARTED|Overall Study||43
16400|NCT02347072|41211|P1|NOT COMPLETED|Overall Study||18
16401|NCT02347072|41211|P1|COMPLETED|Overall Study||62
16402|NCT02347072|41211|P1|Spiriva Respimat 5 µg|Overall Study||73
16403|NCT02347072|41211|P1|Placebo MDI|Overall Study||72
16404|NCT02347072|41211|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
16405|NCT02347072|41211|P1|STARTED|Overall Study||80
16406|NCT02346877|41245|P2|NOT COMPLETED|Overall Study||0
16407|NCT02346877|41246|P1|NOT COMPLETED|Overall Study||19
16408|NCT02346877|41245|P2|COMPLETED|Overall Study||0
16409|NCT02346877|41246|P1|COMPLETED|Overall Study||0
16410|NCT02346877|41245|P2|STARTED|Overall Study||0
16411|NCT02346877|41246|P1|STARTED|Overall Study||19
16412|NCT02346721|41256|P1|NOT COMPLETED|Overall Study||4
16413|NCT02346721|41256|P1|COMPLETED|Overall Study||107
16414|NCT02346721|41256|P1|STARTED|Overall Study||111
16415|NCT02346643|41265|P1|NOT COMPLETED|Overall Study||35
16416|NCT02346643|41265|P1|COMPLETED|Overall Study||6
16417|NCT02346643|41265|P1|Received Permanent System|Overall Study||31
16418|NCT02346643|41265|P1|Received Trial System|Overall Study||29
16419|NCT02346643|41265|P1|STARTED|Overall Study||41
16420|NCT02345772|41270|P1|NOT COMPLETED|Overall Study||4
16421|NCT02345772|41270|P1|COMPLETED|Overall Study||0
16422|NCT02345772|41270|P1|STARTED|Overall Study||4
16423|NCT02345720|41276|P1|NOT COMPLETED|Overall Study||0
16424|NCT02345720|41276|P1|COMPLETED|Overall Study||20
16425|NCT02345720|41276|P1|STARTED|Overall Study||20
16426|NCT02345642|41284|P2|NOT COMPLETED|Overall Study||0
16427|NCT02345642|41285|P1|NOT COMPLETED|Overall Study||0
16428|NCT02345642|41284|P2|COMPLETED|Overall Study||10
16429|NCT02345642|41285|P1|COMPLETED|Overall Study||10
16430|NCT02345642|41284|P2|STARTED|Overall Study||10
16431|NCT02345642|41285|P1|STARTED|Overall Study||10
16432|NCT02345330|41291|P1|NOT COMPLETED|Overall Study||3
16433|NCT02345330|41291|P1|COMPLETED|Overall Study||1
16434|NCT02345330|41291|P1|STARTED|Overall Study||4
16435|NCT02345252|41303|P2|NOT COMPLETED|Overall Study||316
16436|NCT02345252|41304|P1|NOT COMPLETED|Overall Study||316
16437|NCT02345252|41303|P2|COMPLETED|Overall Study||0
16438|NCT02345252|41304|P1|COMPLETED|Overall Study||0
16439|NCT02345252|41303|P2|STARTED|Overall Study||316
16440|NCT02345252|41304|P1|STARTED|Overall Study||316
16441|NCT02345226|41320|P2|NOT COMPLETED|Overall Study||441
16442|NCT02345226|41321|P1|NOT COMPLETED|Overall Study||440
16443|NCT02345226|41320|P2|COMPLETED|Overall Study||0
16444|NCT02345226|41321|P1|COMPLETED|Overall Study||0
16445|NCT02345226|41320|P2|STARTED|Overall Study||441
16446|NCT02345226|41321|P1|STARTED|Overall Study||440
16447|NCT02345031|41339|P2|NOT COMPLETED|Overall Study||1
16448|NCT02345031|41340|P1|NOT COMPLETED|Overall Study||1
16449|NCT02345031|41339|P2|COMPLETED|Overall Study||39
16450|NCT02345031|41340|P1|COMPLETED|Overall Study||37
16451|NCT02345031|41339|P2|STARTED|Overall Study||40
16452|NCT02345031|41340|P1|STARTED|Overall Study||38
16453|NCT02344745|41354|P2|NOT COMPLETED|Overall Study||0
16454|NCT02344745|41355|P1|NOT COMPLETED|Overall Study||2
16455|NCT02344745|41354|P2|COMPLETED|Overall Study||40
16456|NCT02344745|41355|P1|COMPLETED|Overall Study||38
16457|NCT02344745|41354|P2|STARTED|Overall Study||40
16458|NCT02344745|41355|P1|STARTED|Overall Study||40
16459|NCT02344407|41370|P3|NOT COMPLETED|Overall Study||6
16460|NCT02344407|41371|P2|NOT COMPLETED|Overall Study||9
16461|NCT02344407|41372|P1|NOT COMPLETED|Overall Study||8
16462|NCT02344407|41370|P3|COMPLETED|Overall Study||494
16463|NCT02344407|41371|P2|COMPLETED|Overall Study||491
16464|NCT02344407|41372|P1|COMPLETED|Overall Study||492
16465|NCT02344407|41370|P3|STARTED|Overall Study||500
16466|NCT02344407|41371|P2|STARTED|Overall Study||500
16467|NCT02344407|41372|P1|STARTED|Overall Study||500
16468|NCT02344342|41387|P4|NOT COMPLETED|Overall Study||10
16469|NCT02344342|41388|P3|NOT COMPLETED|Overall Study||14
16470|NCT02344342|41389|P2|NOT COMPLETED|Overall Study||9
16471|NCT02344342|41390|P1|NOT COMPLETED|Overall Study||11
16472|NCT02344342|41387|P4|COMPLETED|Overall Study||3
16473|NCT02344342|41388|P3|COMPLETED|Overall Study||0
16474|NCT02344342|41389|P2|COMPLETED|Overall Study||2
16475|NCT02344342|41390|P1|COMPLETED|Overall Study||2
16476|NCT02344342|41387|P4|STARTED|Overall Study||13
16477|NCT02344342|41388|P3|STARTED|Overall Study||14
16478|NCT02344342|41389|P2|STARTED|Overall Study||11
16479|NCT02344342|41390|P1|STARTED|Overall Study||13
16480|NCT02344251|41414|P2|NOT COMPLETED|Overall Study||0
16481|NCT02344251|41415|P1|NOT COMPLETED|Overall Study||0
16482|NCT02344251|41414|P2|COMPLETED|Overall Study||20
16483|NCT02344251|41415|P1|COMPLETED|Overall Study||20
16484|NCT02344251|41414|P2|STARTED|Overall Study||20
16485|NCT02344251|41415|P1|STARTED|Overall Study||20
16486|NCT02343380|41425|P2|NOT COMPLETED|Overall Study||0
16487|NCT02343380|41426|P1|NOT COMPLETED|Overall Study||0
16488|NCT02343380|41425|P2|COMPLETED|Overall Study|Morning test (second week)|10
16489|NCT02343380|41426|P1|COMPLETED|Overall Study|Evening test (second week)|10
16490|NCT02343380|41425|P2|STARTED|Overall Study|Evening test (first week)|10
16491|NCT02343380|41426|P1|STARTED|Overall Study|Morning test (first week)|10
16492|NCT02343159|41445|P3|NOT COMPLETED|Overall Study||30
16493|NCT02343159|41446|P2|NOT COMPLETED|Overall Study||26
16494|NCT02343159|41447|P1|NOT COMPLETED|Overall Study||26
16495|NCT02343159|41445|P3|COMPLETED|Overall Study||0
16496|NCT02343159|41446|P2|COMPLETED|Overall Study||1
16497|NCT02343159|41447|P1|COMPLETED|Overall Study||1
16498|NCT02343159|41445|P3|STARTED|Overall Study||30
16499|NCT02343159|41446|P2|STARTED|Overall Study||27
16500|NCT02343159|41447|P1|STARTED|Overall Study||27
16501|NCT02343081|41474|P2|NOT COMPLETED|Second Intervention (Day 4)||0
16502|NCT02343081|41475|P1|NOT COMPLETED|Second Intervention (Day 4)||0
16503|NCT02343081|41474|P2|COMPLETED|Second Intervention (Day 4)||8
16504|NCT02343081|41475|P1|COMPLETED|Second Intervention (Day 4)||8
16505|NCT02343081|41474|P2|Received Intervention|Second Intervention (Day 4)||8
16506|NCT02343081|41475|P1|Received Intervention|Second Intervention (Day 4)||8
16507|NCT02343081|41474|P2|STARTED|Second Intervention (Day 4)||8
16508|NCT02343081|41475|P1|STARTED|Second Intervention (Day 4)||8
16509|NCT02343081|41474|P2|NOT COMPLETED|Washout (10 Hours)||0
16510|NCT02343081|41475|P1|NOT COMPLETED|Washout (10 Hours)||0
16511|NCT02343081|41474|P2|COMPLETED|Washout (10 Hours)||8
16512|NCT02343081|41475|P1|COMPLETED|Washout (10 Hours)||8
16513|NCT02343081|41474|P2|STARTED|Washout (10 Hours)||8
16514|NCT02343081|41475|P1|STARTED|Washout (10 Hours)||8
16515|NCT02343081|41474|P2|NOT COMPLETED|First Intervention (Day 3)||0
16516|NCT02343081|41475|P1|NOT COMPLETED|First Intervention (Day 3)||0
16517|NCT02343081|41474|P2|COMPLETED|First Intervention (Day 3)||8
16518|NCT02343081|41475|P1|COMPLETED|First Intervention (Day 3)||8
16519|NCT02343081|41474|P2|Received Intervention|First Intervention (Day 3)||8
16520|NCT02343081|41475|P1|Received Intervention|First Intervention (Day 3)||8
16521|NCT02343081|41474|P2|STARTED|First Intervention (Day 3)||8
16522|NCT02343081|41475|P1|STARTED|First Intervention (Day 3)||8
16523|NCT02343003|41491|P2|NOT COMPLETED|Overall Study||7
16524|NCT02343003|41492|P1|NOT COMPLETED|Overall Study||18
16525|NCT02343003|41491|P2|COMPLETED|Overall Study||68
16526|NCT02343003|41492|P1|COMPLETED|Overall Study||58
16527|NCT02343003|41491|P2|STARTED|Overall Study||75
16528|NCT02343003|41492|P1|STARTED|Overall Study||76
16529|NCT02342704|41510|P2|NOT COMPLETED|Overall Study||51
16530|NCT02342704|41511|P1|NOT COMPLETED|Overall Study||53
16531|NCT02342704|41510|P2|COMPLETED|Overall Study||3
16532|NCT02342704|41511|P1|COMPLETED|Overall Study||1
16533|NCT02342704|41510|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
16534|NCT02342704|41511|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
16535|NCT02342561|41537|P1|NOT COMPLETED|Overall Study||0
16536|NCT02342561|41537|P1|COMPLETED|Overall Study||20
16537|NCT02342561|41537|P1|STARTED|Overall Study||20
16538|NCT02342548|41548|P3|NOT COMPLETED|Overall Study||43
16539|NCT02342548|41549|P2|NOT COMPLETED|Overall Study||62
16540|NCT02342548|41550|P1|NOT COMPLETED|Overall Study||34
16541|NCT02342548|41548|P3|COMPLETED|Overall Study||23
16542|NCT02342548|41549|P2|COMPLETED|Overall Study||9
16543|NCT02342548|41550|P1|COMPLETED|Overall Study||17
16544|NCT02342548|41548|P3|STARTED|Overall Study||66
16545|NCT02342548|41549|P2|STARTED|Overall Study||71
16546|NCT02342548|41550|P1|STARTED|Overall Study||51
16547|NCT02342535|41588|P1|NOT COMPLETED|Overall Study||0
16548|NCT02342535|41588|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
16549|NCT02342535|41588|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
16550|NCT02342418|41594|P2|NOT COMPLETED|Overall Study||1
16551|NCT02342418|41595|P1|NOT COMPLETED|Overall Study||0
16552|NCT02342418|41594|P2|COMPLETED|Overall Study||9
16553|NCT02342418|41595|P1|COMPLETED|Overall Study||9
16554|NCT02342418|41594|P2|STARTED|Overall Study||10
16555|NCT02342418|41595|P1|STARTED|Overall Study||9
16556|NCT02342288|41605|P2|NOT COMPLETED|Overall Study||6
16557|NCT02342288|41606|P1|NOT COMPLETED|Overall Study||5
16558|NCT02342288|41605|P2|COMPLETED|Overall Study||27
16559|NCT02342288|41606|P1|COMPLETED|Overall Study||25
16560|NCT02342288|41605|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
16561|NCT02342288|41606|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
16562|NCT02342223|41612|P1|NOT COMPLETED|Overall Study||1
16563|NCT02342223|41612|P1|COMPLETED|Overall Study||19
16564|NCT02342223|41612|P1|STARTED|Overall Study||20
16565|NCT02342197|41623|P2|NOT COMPLETED|Overall Study||2
16566|NCT02342197|41624|P1|NOT COMPLETED|Overall Study||3
16567|NCT02342197|41623|P2|COMPLETED|Overall Study||28
16568|NCT02342197|41624|P1|COMPLETED|Overall Study||27
16569|NCT02342197|41623|P2|STARTED|Overall Study||30
16570|NCT02342197|41624|P1|STARTED|Overall Study||30
16571|NCT02341859|41630|P2|NOT COMPLETED|Second Intervention (1 Day)||0
16572|NCT02341859|41631|P1|NOT COMPLETED|Second Intervention (1 Day)||0
16573|NCT02341859|41630|P2|COMPLETED|Second Intervention (1 Day)||9
16574|NCT02341859|41631|P1|COMPLETED|Second Intervention (1 Day)||10
16575|NCT02341859|41630|P2|STARTED|Second Intervention (1 Day)||9
16576|NCT02341859|41631|P1|STARTED|Second Intervention (1 Day)||10
16577|NCT02341859|41630|P2|NOT COMPLETED|First Intervention (1 Day)||0
16578|NCT02341859|41631|P1|NOT COMPLETED|First Intervention (1 Day)||0
16579|NCT02341859|41630|P2|COMPLETED|First Intervention (1 Day)||9
16580|NCT02341859|41631|P1|COMPLETED|First Intervention (1 Day)||10
16581|NCT02341859|41630|P2|STARTED|First Intervention (1 Day)||9
16582|NCT02341859|41631|P1|STARTED|First Intervention (1 Day)||10
16583|NCT02341482|41784|P1|NOT COMPLETED|Overall Study||1
16584|NCT02341482|41784|P1|COMPLETED|Overall Study||12
16585|NCT02341482|41784|P1|STARTED|Overall Study||13
16586|NCT02341417|41813|P3|NOT COMPLETED|Overall Study||1
16587|NCT02341417|41814|P2|NOT COMPLETED|Overall Study||2
16588|NCT02341417|41815|P1|NOT COMPLETED|Overall Study||2
16589|NCT02341417|41813|P3|COMPLETED|Overall Study||0
16590|NCT02341417|41814|P2|COMPLETED|Overall Study||12
16591|NCT02341417|41815|P1|COMPLETED|Overall Study||11
16592|NCT02341417|41813|P3|STARTED|Overall Study||1
16593|NCT02341417|41814|P2|STARTED|Overall Study||14
16594|NCT02341417|41815|P1|STARTED|Overall Study||13
16595|NCT02341144|41859|P2|NOT COMPLETED|Overall Study||1
16596|NCT02341144|41860|P1|NOT COMPLETED|Overall Study||2
16597|NCT02341144|41859|P2|COMPLETED|Overall Study||30
16598|NCT02341144|41860|P1|COMPLETED|Overall Study||28
16599|NCT02341144|41859|P2|STARTED|Overall Study||31
16600|NCT02341144|41860|P1|STARTED|Overall Study||30
16601|NCT02340715|41874|P1|NOT COMPLETED|Overall Study||0
16602|NCT02340715|41874|P1|COMPLETED|Overall Study|158|158
16603|NCT02340715|41874|P1|STARTED|Overall Study|158|158
16604|NCT02340338|41885|P7|NOT COMPLETED|Overall Study||0
16605|NCT02340338|41886|P6|NOT COMPLETED|Overall Study||0
16606|NCT02340338|41887|P5|NOT COMPLETED|Overall Study||0
16607|NCT02340338|41888|P4|NOT COMPLETED|Overall Study||0
16608|NCT02340338|41889|P3|NOT COMPLETED|Overall Study||0
16609|NCT02340338|41890|P2|NOT COMPLETED|Overall Study||0
16610|NCT02340338|41891|P1|NOT COMPLETED|Overall Study||0
16611|NCT02340338|41885|P7|COMPLETED|Overall Study||12
16612|NCT02340338|41886|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
16613|NCT02340338|41887|P5|COMPLETED|Overall Study||9
16614|NCT02340338|41888|P4|COMPLETED|Overall Study||9
16615|NCT02340338|41889|P3|COMPLETED|Overall Study||3
16616|NCT02340338|41890|P2|COMPLETED|Overall Study||2
16617|NCT02340338|41891|P1|COMPLETED|Overall Study||2
16618|NCT02340338|41885|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
16619|NCT02340338|41886|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
16620|NCT02340338|41887|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
16621|NCT02340338|41888|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
16622|NCT02340338|41889|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
16623|NCT02340338|41890|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
16624|NCT02340338|41891|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
16625|NCT02340104|41914|P1|NOT COMPLETED|Overall Study||0
16626|NCT02340104|41914|P1|COMPLETED|Overall Study||8
16627|NCT02340104|41914|P1|STARTED|Overall Study||8
16628|NCT02340000|41921|P2|NOT COMPLETED|Time Period 2||15
16629|NCT02340000|41922|P1|NOT COMPLETED|Time Period 2||19
16630|NCT02340000|41921|P2|COMPLETED|Time Period 2||52
16631|NCT02340000|41922|P1|COMPLETED|Time Period 2||50
16632|NCT02340000|41921|P2|STARTED|Time Period 2||67
16633|NCT02340000|41922|P1|STARTED|Time Period 2||69
16634|NCT02340000|41921|P2|NOT COMPLETED|Time Period 1||15
16635|NCT02340000|41922|P1|NOT COMPLETED|Time Period 1||12
16636|NCT02340000|41921|P2|COMPLETED|Time Period 1||74
16637|NCT02340000|41922|P1|COMPLETED|Time Period 1||78
16638|NCT02340000|41921|P2|STARTED|Time Period 1||89
16639|NCT02340000|41922|P1|STARTED|Time Period 1||90
16640|NCT02339831|41951|P2|NOT COMPLETED|Overall Study||7
16641|NCT02339831|41952|P1|NOT COMPLETED|Overall Study||20
16642|NCT02339831|41951|P2|COMPLETED|Overall Study||45
16643|NCT02339831|41952|P1|COMPLETED|Overall Study||38
16644|NCT02339831|41951|P2|Lost to Follow Up|Overall Study||7
16645|NCT02339831|41952|P1|Lost to Follow Up|Overall Study||20
16646|NCT02339831|41951|P2|STARTED|Overall Study||52
16647|NCT02339831|41952|P1|STARTED|Overall Study||58
16648|NCT02339584|41976|P2|NOT COMPLETED|Overall Study||15
16649|NCT02339584|41977|P1|NOT COMPLETED|Overall Study||15
16650|NCT02339584|41976|P2|COMPLETED|Overall Study||176
16651|NCT02339584|41977|P1|COMPLETED|Overall Study||173
16652|NCT02339584|41976|P2|STARTED|Overall Study||191
16653|NCT02339584|41977|P1|STARTED|Overall Study||188
16654|NCT02339506|41983|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
16655|NCT02339506|41984|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
16656|NCT02339506|41983|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
16657|NCT02339506|41984|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
16658|NCT02339506|41983|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
16659|NCT02339506|41984|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
16660|NCT02339506|41983|P2|NOT COMPLETED|Washout (Period 2)||0
16661|NCT02339506|41984|P1|NOT COMPLETED|Washout (Period 2)||2
16662|NCT02339506|41983|P2|COMPLETED|Washout (Period 2)||10
16663|NCT02339506|41984|P1|COMPLETED|Washout (Period 2)||10
16664|NCT02339506|41983|P2|STARTED|Washout (Period 2)||10
16665|NCT02339506|41984|P1|STARTED|Washout (Period 2)||12
16666|NCT02339506|41983|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
16667|NCT02339506|41984|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
16668|NCT02339506|41983|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
16669|NCT02339506|41984|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
16670|NCT02339506|41983|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
16671|NCT02339506|41984|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
16672|NCT02339389|41990|P1|NOT COMPLETED|Overall Study||16
16673|NCT02339389|41990|P1|COMPLETED|Overall Study||41
16674|NCT02339389|41990|P1|STARTED|Overall Study||57
16675|NCT02339246|41997|P3|NOT COMPLETED|Third Period (7 Days)||0
16676|NCT02339246|41998|P2|NOT COMPLETED|Third Period (7 Days)||0
16677|NCT02339246|41999|P1|NOT COMPLETED|Third Period (7 Days)||0
16678|NCT02339246|41997|P3|COMPLETED|Third Period (7 Days)||0
16679|NCT02339246|41998|P2|COMPLETED|Third Period (7 Days)||16
16680|NCT02339246|41999|P1|COMPLETED|Third Period (7 Days)||15
16681|NCT02339246|41997|P3|STARTED|Third Period (7 Days)||0
16682|NCT02339246|41998|P2|STARTED|Third Period (7 Days)||16
16683|NCT02339246|41999|P1|STARTED|Third Period (7 Days)||15
16684|NCT02339246|41997|P3|NOT COMPLETED|Second Intervention (7 Days)||0
16685|NCT02339246|41998|P2|NOT COMPLETED|Second Intervention (7 Days)||0
16686|NCT02339246|41999|P1|NOT COMPLETED|Second Intervention (7 Days)||0
16687|NCT02339246|41997|P3|COMPLETED|Second Intervention (7 Days)||0
16688|NCT02339246|41998|P2|COMPLETED|Second Intervention (7 Days)||15
16689|NCT02339246|41999|P1|COMPLETED|Second Intervention (7 Days)||16
16690|NCT02339246|41997|P3|STARTED|Second Intervention (7 Days)||0
16691|NCT02339246|41998|P2|STARTED|Second Intervention (7 Days)||15
16692|NCT02339246|41999|P1|STARTED|Second Intervention (7 Days)||16
16693|NCT02339246|41997|P3|NOT COMPLETED|First Intervention (7 Days)||0
16694|NCT02339246|41998|P2|NOT COMPLETED|First Intervention (7 Days)||0
16695|NCT02339246|41999|P1|NOT COMPLETED|First Intervention (7 Days)||0
16696|NCT02339246|41997|P3|COMPLETED|First Intervention (7 Days)||31
16697|NCT02339246|41998|P2|COMPLETED|First Intervention (7 Days)||0
16698|NCT02339246|41999|P1|COMPLETED|First Intervention (7 Days)||0
16699|NCT02339246|41997|P3|STARTED|First Intervention (7 Days)||31
16700|NCT02339246|41998|P2|STARTED|First Intervention (7 Days)||0
16701|NCT02339246|41999|P1|STARTED|First Intervention (7 Days)||0
16702|NCT02339155|42015|P2|NOT COMPLETED|Overall Study||21
16703|NCT02339155|42016|P1|NOT COMPLETED|Overall Study||15
16704|NCT02339155|42015|P2|COMPLETED|Overall Study||266
16705|NCT02339155|42016|P1|COMPLETED|Overall Study||271
16706|NCT02339155|42015|P2|Received Study Treatment|Overall Study||281
16707|NCT02339155|42016|P1|Received Study Treatment|Overall Study||285
16708|NCT02339155|42015|P2|STARTED|Overall Study||287
16709|NCT02339155|42016|P1|STARTED|Overall Study||286
16710|NCT02339038|42042|P1|NOT COMPLETED|Overall Study||600
16711|NCT02339038|42042|P1|COMPLETED|Overall Study||0
16712|NCT02339038|42042|P1|STARTED|Overall Study||600
16713|NCT02338843|42048|P2|NOT COMPLETED|Overall Study||58
16714|NCT02338843|42049|P1|NOT COMPLETED|Overall Study||44
16715|NCT02338843|42048|P2|COMPLETED|Overall Study||100
16716|NCT02338843|42049|P1|COMPLETED|Overall Study||119
16717|NCT02338843|42048|P2|STARTED|Overall Study||158
16718|NCT02338843|42049|P1|STARTED|Overall Study||163
16719|NCT02338713|42055|P1|NOT COMPLETED|Overall Study||0
16720|NCT02338713|42055|P1|COMPLETED|Overall Study||27
16721|NCT02338713|42055|P1|STARTED|Overall Study||27
16722|NCT02338492|42077|P1|NOT COMPLETED|Overall Study||45
16723|NCT02338492|42077|P1|COMPLETED|Overall Study||36
16724|NCT02338492|42077|P1|Treatment Failure|Overall Study||2
16725|NCT02338492|42077|P1|Device Implanted|Overall Study||79
16726|NCT02338492|42077|P1|Enrolled|Overall Study||81
16727|NCT02338492|42077|P1|STARTED|Overall Study||81
16728|NCT02338336|42093|P4|NOT COMPLETED|Overall Study||0
16729|NCT02338336|42094|P3|NOT COMPLETED|Overall Study||0
16730|NCT02338336|42095|P2|NOT COMPLETED|Overall Study||0
16731|NCT02338336|42096|P1|NOT COMPLETED|Overall Study||2
16732|NCT02338336|42093|P4|COMPLETED|Overall Study||4
16733|NCT02338336|42094|P3|COMPLETED|Overall Study||7
16734|NCT02338336|42095|P2|COMPLETED|Overall Study||17
16735|NCT02338336|42096|P1|COMPLETED|Overall Study||24
16736|NCT02338336|42093|P4|STARTED|Overall Study||4
16737|NCT02338336|42094|P3|STARTED|Overall Study||7
16738|NCT02338336|42095|P2|STARTED|Overall Study||17
16739|NCT02338336|42096|P1|STARTED|Overall Study||26
16740|NCT02338076|42104|P1|NOT COMPLETED|Overall Study||0
16741|NCT02338076|42104|P1|COMPLETED|Overall Study||20
16742|NCT02338076|42104|P1|STARTED|Overall Study||20
16743|NCT02337959|42122|P3|NOT COMPLETED|Overall Study||0
16744|NCT02337959|42123|P2|NOT COMPLETED|Overall Study||3
16745|NCT02337959|42124|P1|NOT COMPLETED|Overall Study||0
16746|NCT02337959|42122|P3|COMPLETED|Overall Study||7
16747|NCT02337959|42123|P2|COMPLETED|Overall Study||7
16748|NCT02337959|42124|P1|COMPLETED|Overall Study||10
16749|NCT02337959|42122|P3|STARTED|Overall Study||7
16750|NCT02337959|42123|P2|STARTED|Overall Study||10
16751|NCT02337959|42124|P1|STARTED|Overall Study||10
16752|NCT02337491|42134|P2|NOT COMPLETED|Overall Study||30
16753|NCT02337491|42135|P1|NOT COMPLETED|Overall Study||50
16754|NCT02337491|42134|P2|COMPLETED|Overall Study||0
16755|NCT02337491|42135|P1|COMPLETED|Overall Study||0
16756|NCT02337491|42134|P2|STARTED|Overall Study||30
16757|NCT02337491|42135|P1|STARTED|Overall Study||50
16758|NCT02337062|42151|P2|NOT COMPLETED|Overall Study||19
16759|NCT02337062|42152|P1|NOT COMPLETED|Overall Study||17
16760|NCT02337062|42151|P2|COMPLETED|Overall Study||556
16761|NCT02337062|42152|P1|COMPLETED|Overall Study||555
16762|NCT02337062|42151|P2|STARTED|Overall Study||575
16763|NCT02337062|42152|P1|STARTED|Overall Study||572
16764|NCT02336958|42160|P2|NOT COMPLETED|Overall Study||0
16765|NCT02336958|42161|P1|NOT COMPLETED|Overall Study||0
16766|NCT02336958|42160|P2|COMPLETED|Overall Study||20
16767|NCT02336958|42161|P1|COMPLETED|Overall Study||20
16768|NCT02336958|42160|P2|STARTED|Overall Study||20
16769|NCT02336958|42161|P1|STARTED|Overall Study||20
16770|NCT02336763|42169|P1|NOT COMPLETED|Overall Study||0
16771|NCT02336763|42169|P1|COMPLETED|Overall Study||2
16772|NCT02336763|42169|P1|STARTED|Overall Study||2
16773|NCT02336607|42183|P4|NOT COMPLETED|Overall Study||87
16774|NCT02336607|42184|P3|NOT COMPLETED|Overall Study||6
16775|NCT02336607|42185|P2|NOT COMPLETED|Overall Study||10
16776|NCT02336607|42186|P1|NOT COMPLETED|Overall Study||4
16777|NCT02336607|42183|P4|COMPLETED|Overall Study||180
16778|NCT02336607|42184|P3|COMPLETED|Overall Study||86
16779|NCT02336607|42185|P2|COMPLETED|Overall Study||75
16780|NCT02336607|42186|P1|COMPLETED|Overall Study||81
16781|NCT02336607|42183|P4|Patients Included in Safety Population|Overall Study||260
16782|NCT02336607|42184|P3|Patients Included in Safety Population|Overall Study||92
16783|NCT02336607|42185|P2|Patients Included in Safety Population|Overall Study||85
16784|NCT02336607|42186|P1|Patients Included in Safety Population|Overall Study||85
16785|NCT02336607|42183|P4|Patients Included in PP Population|Overall Study||162
16786|NCT02336607|42184|P3|Patients Included in PP Population|Overall Study||75
16787|NCT02336607|42185|P2|Patients Included in PP Population|Overall Study||75
16788|NCT02336607|42186|P1|Patients Included in PP Population|Overall Study||78
16789|NCT02336607|42183|P4|Patients Included in ITT Population|Overall Study||222
16790|NCT02336607|42184|P3|Patients Included in ITT Population|Overall Study||91
16791|NCT02336607|42185|P2|Patients Included in ITT Population|Overall Study||84
16792|NCT02336607|42186|P1|Patients Included in ITT Population|Overall Study||84
16793|NCT02336607|42183|P4|STARTED|Overall Study||267
16794|NCT02336607|42184|P3|STARTED|Overall Study||92
16795|NCT02336607|42185|P2|STARTED|Overall Study||85
16796|NCT02336607|42186|P1|STARTED|Overall Study||85
16797|NCT02336594|42244|P4|NOT COMPLETED|Overall Study||0
16798|NCT02336594|42245|P3|NOT COMPLETED|Overall Study||0
16799|NCT02336594|42246|P2|NOT COMPLETED|Overall Study||0
16800|NCT02336594|42247|P1|NOT COMPLETED|Overall Study||0
16801|NCT02336594|42244|P4|COMPLETED|Overall Study||4
16802|NCT02336594|42245|P3|COMPLETED|Overall Study||4
16803|NCT02336594|42246|P2|COMPLETED|Overall Study||4
16804|NCT02336594|42247|P1|COMPLETED|Overall Study||3
16805|NCT02336594|42244|P4|STARTED|Overall Study||4
16806|NCT02336594|42245|P3|STARTED|Overall Study||4
16807|NCT02336594|42246|P2|STARTED|Overall Study||4
16808|NCT02336594|42247|P1|STARTED|Overall Study||3
16809|NCT02336438|42287|P1|NOT COMPLETED|Overall Study||1
16810|NCT02336438|42287|P1|COMPLETED|Overall Study||10
16811|NCT02336438|42287|P1|STARTED|Overall Study||11
16812|NCT02336425|42300|P4|NOT COMPLETED|Overall Study||3
16813|NCT02336425|42301|P3|NOT COMPLETED|Overall Study||3
16814|NCT02336425|42302|P2|NOT COMPLETED|Overall Study||2
16815|NCT02336425|42303|P1|NOT COMPLETED|Overall Study||2
16816|NCT02336425|42300|P4|COMPLETED|Overall Study||0
16817|NCT02336425|42301|P3|COMPLETED|Overall Study||0
16818|NCT02336425|42302|P2|COMPLETED|Overall Study||0
16819|NCT02336425|42303|P1|COMPLETED|Overall Study||0
16820|NCT02336425|42300|P4|STARTED|Overall Study||3
16821|NCT02336425|42301|P3|STARTED|Overall Study||3
16822|NCT02336425|42302|P2|STARTED|Overall Study||2
16823|NCT02336425|42303|P1|STARTED|Overall Study||2
16824|NCT02336178|42353|P1|NOT COMPLETED|Overall Study||4
16825|NCT02336178|42353|P1|COMPLETED|Overall Study||66
16826|NCT02336178|42353|P1|STARTED|Overall Study||70
16827|NCT02335710|42441|P2|NOT COMPLETED|Overall Study||0
16828|NCT02335710|42442|P1|NOT COMPLETED|Overall Study||0
16829|NCT02335710|42441|P2|COMPLETED|Overall Study||10
16830|NCT02335710|42442|P1|COMPLETED|Overall Study||40
16831|NCT02335710|42441|P2|STARTED|Overall Study||10
16832|NCT02335710|42442|P1|STARTED|Overall Study||40
16833|NCT02335502|42462|P1|NOT COMPLETED|Overall Study||17
16834|NCT02335502|42462|P1|COMPLETED|Overall Study||49
16835|NCT02335502|42462|P1|Receiving Permanent System|Overall Study||56
16836|NCT02335502|42462|P1|Received Trial System|Overall Study||65
16837|NCT02335502|42462|P1|STARTED|Overall Study||66
16838|NCT02335489|42467|P1|NOT COMPLETED|Overall Study||10
16839|NCT02335489|42467|P1|COMPLETED|Overall Study||0
16840|NCT02335489|42467|P1|Receiving Permanent System|Overall Study||8
16841|NCT02335489|42467|P1|Received Trial System|Overall Study||9
16842|NCT02335489|42467|P1|STARTED|Overall Study||10
16843|NCT02335346|42471|P1|NOT COMPLETED|Overall Study||12
16844|NCT02335346|42471|P1|COMPLETED|Overall Study||81
16845|NCT02335346|42471|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
16846|NCT02335346|42471|P1|STARTED|Overall Study||93
16847|NCT02335216|42483|P1|NOT COMPLETED|Overall Study||13
16848|NCT02335216|42483|P1|COMPLETED|Overall Study||9
16849|NCT02335216|42483|P1|Received Permanent System|Overall Study||13
16850|NCT02335216|42483|P1|Received Trial System|Overall Study||16
16851|NCT02335216|42483|P1|STARTED|Overall Study||22
16852|NCT02334982|42495|P7|NOT COMPLETED|Overall Study||0
16853|NCT02334982|42496|P6|NOT COMPLETED|Overall Study||0
16854|NCT02334982|42497|P5|NOT COMPLETED|Overall Study||0
16855|NCT02334982|42498|P4|NOT COMPLETED|Overall Study||0
16856|NCT02334982|42499|P3|NOT COMPLETED|Overall Study||0
16857|NCT02334982|42500|P2|NOT COMPLETED|Overall Study||0
16858|NCT02334982|42501|P1|NOT COMPLETED|Overall Study||0
16859|NCT02334982|42495|P7|COMPLETED|Overall Study||12
16860|NCT02334982|42496|P6|COMPLETED|Overall Study||6
16861|NCT02334982|42497|P5|COMPLETED|Overall Study||6
16862|NCT02334982|42498|P4|COMPLETED|Overall Study||6
16863|NCT02334982|42499|P3|COMPLETED|Overall Study||6
16864|NCT02334982|42500|P2|COMPLETED|Overall Study||5
16865|NCT02334982|42501|P1|COMPLETED|Overall Study||6
16866|NCT02334982|42495|P7|STARTED|Overall Study||12
16867|NCT02334982|42496|P6|STARTED|Overall Study||6
16868|NCT02334982|42497|P5|STARTED|Overall Study||6
16869|NCT02334982|42498|P4|STARTED|Overall Study||6
16870|NCT02334982|42499|P3|STARTED|Overall Study||6
16871|NCT02334982|42500|P2|STARTED|Overall Study||5
16872|NCT02334982|42501|P1|STARTED|Overall Study||6
16873|NCT02334813|42607|P2|NOT COMPLETED|Overall Study||1
16874|NCT02334813|42608|P1|NOT COMPLETED|Overall Study||3
16875|NCT02334813|42607|P2|COMPLETED|Overall Study||13
16876|NCT02334813|42608|P1|COMPLETED|Overall Study||9
16877|NCT02334813|42607|P2|STARTED|Overall Study||14
16878|NCT02334813|42608|P1|STARTED|Overall Study||12
16879|NCT02334800|42618|P4|NOT COMPLETED|Overall Study||0
16880|NCT02334800|42619|P3|NOT COMPLETED|Overall Study||0
16881|NCT02334800|42620|P2|NOT COMPLETED|Overall Study||0
16882|NCT02334800|42621|P1|NOT COMPLETED|Overall Study||0
16883|NCT02334800|42618|P4|COMPLETED|Overall Study||7
16884|NCT02334800|42619|P3|COMPLETED|Overall Study||7
16885|NCT02334800|42620|P2|COMPLETED|Overall Study||7
16886|NCT02334800|42621|P1|COMPLETED|Overall Study||7
16887|NCT02334800|42618|P4|Received Treatment|Overall Study||7
16888|NCT02334800|42619|P3|Received Treatment|Overall Study||7
16889|NCT02334800|42620|P2|Received Treatment|Overall Study||7
16890|NCT02334800|42621|P1|Received Treatment|Overall Study||7
16891|NCT02334800|42618|P4|STARTED|Overall Study||7
16892|NCT02334800|42619|P3|STARTED|Overall Study||7
16893|NCT02334800|42620|P2|STARTED|Overall Study||7
16894|NCT02334800|42621|P1|STARTED|Overall Study||7
16895|NCT02334787|42715|P4|NOT COMPLETED|Overall Study||0
16896|NCT02334787|42716|P3|NOT COMPLETED|Overall Study||0
16897|NCT02334787|42717|P2|NOT COMPLETED|Overall Study||0
16898|NCT02334787|42718|P1|NOT COMPLETED|Overall Study||0
16899|NCT02334787|42715|P4|COMPLETED|Overall Study||8
16900|NCT02334787|42716|P3|COMPLETED|Overall Study||8
16901|NCT02334787|42717|P2|COMPLETED|Overall Study||8
16902|NCT02334787|42718|P1|COMPLETED|Overall Study||8
16903|NCT02334787|42715|P4|STARTED|Overall Study||8
16904|NCT02334787|42716|P3|STARTED|Overall Study||8
16905|NCT02334787|42717|P2|STARTED|Overall Study||8
16906|NCT02334787|42718|P1|STARTED|Overall Study||8
16907|NCT02334527|42740|P1|NOT COMPLETED|Overall Study||0
16908|NCT02334527|42740|P1|COMPLETED|Overall Study||12
16909|NCT02334527|42740|P1|STARTED|Overall Study||12
16910|NCT02334267|42751|P2|NOT COMPLETED|Overall Study||0
16911|NCT02334267|42752|P1|NOT COMPLETED|Overall Study||1
16912|NCT02334267|42751|P2|COMPLETED|Overall Study||5
16913|NCT02334267|42752|P1|COMPLETED|Overall Study||5
16914|NCT02334267|42751|P2|STARTED|Overall Study||5
16915|NCT02334267|42752|P1|STARTED|Overall Study||6
16916|NCT02333045|42766|P2|NOT COMPLETED|Overall Study||0
16917|NCT02333045|42767|P1|NOT COMPLETED|Overall Study||0
16918|NCT02333045|42766|P2|COMPLETED|Overall Study||3
16919|NCT02333045|42767|P1|COMPLETED|Overall Study||1
16920|NCT02333045|42766|P2|STARTED|Overall Study||3
16921|NCT02333045|42767|P1|STARTED|Overall Study||1
16922|NCT02332902|42777|P1|NOT COMPLETED|Overall Study||7
16923|NCT02332902|42777|P1|COMPLETED|Overall Study||17
16924|NCT02332902|42777|P1|STARTED|Overall Study||24
16925|NCT02332889|42782|P1|NOT COMPLETED|Overall Study||1
16926|NCT02332889|42782|P1|COMPLETED|Overall Study||0
16927|NCT02332889|42782|P1|STARTED|Overall Study||1
16928|NCT02332798|42789|P3|NOT COMPLETED|Overall Study||1
16929|NCT02332798|42790|P2|NOT COMPLETED|Overall Study||2
16930|NCT02332798|42791|P1|NOT COMPLETED|Overall Study||1
16931|NCT02332798|42789|P3|COMPLETED|Overall Study||11
16932|NCT02332798|42790|P2|COMPLETED|Overall Study||12
16933|NCT02332798|42791|P1|COMPLETED|Overall Study||12
16934|NCT02332798|42789|P3|STARTED|Overall Study||12
16935|NCT02332798|42790|P2|STARTED|Overall Study||14
16936|NCT02332798|42791|P1|STARTED|Overall Study||13
16937|NCT02332707|42859|P18|NOT COMPLETED|Overall Study||0
16938|NCT02332707|42860|P17|NOT COMPLETED|Overall Study||0
16939|NCT02332707|42861|P16|NOT COMPLETED|Overall Study||0
16940|NCT02332707|42862|P15|NOT COMPLETED|Overall Study||0
16941|NCT02332707|42863|P14|NOT COMPLETED|Overall Study||0
16942|NCT02332707|42864|P13|NOT COMPLETED|Overall Study||5
16943|NCT02332707|42865|P12|NOT COMPLETED|Overall Study||0
16944|NCT02332707|42866|P11|NOT COMPLETED|Overall Study||2
16945|NCT02332707|42867|P10|NOT COMPLETED|Overall Study||3
16946|NCT02332707|42868|P9|NOT COMPLETED|Overall Study||0
16947|NCT02332707|42869|P8|NOT COMPLETED|Overall Study||0
16948|NCT02332707|42870|P7|NOT COMPLETED|Overall Study||0
16949|NCT02332707|42871|P6|NOT COMPLETED|Overall Study||1
16950|NCT02332707|42872|P5|NOT COMPLETED|Overall Study||0
16951|NCT02332707|42873|P4|NOT COMPLETED|Overall Study||1
16952|NCT02332707|42874|P3|NOT COMPLETED|Overall Study||1
16953|NCT02332707|42875|P2|NOT COMPLETED|Overall Study||0
16954|NCT02332707|42876|P1|NOT COMPLETED|Overall Study||0
16955|NCT02332707|42859|P18|COMPLETED|Overall Study||16
16956|NCT02332707|42860|P17|COMPLETED|Overall Study||30
16957|NCT02332707|42861|P16|COMPLETED|Overall Study||26
16958|NCT02332707|42862|P15|COMPLETED|Overall Study||16
16959|NCT02332707|42863|P14|COMPLETED|Overall Study||15
16960|NCT02332707|42864|P13|COMPLETED|Overall Study||35
16961|NCT02332707|42865|P12|COMPLETED|Overall Study||35
16962|NCT02332707|42866|P11|COMPLETED|Overall Study||29
16963|NCT02332707|42867|P10|COMPLETED|Overall Study||28
16964|NCT02332707|42868|P9|COMPLETED|Overall Study||48
16965|NCT02332707|42869|P8|COMPLETED|Overall Study||16
16966|NCT02332707|42870|P7|COMPLETED|Overall Study||15
16967|NCT02332707|42871|P6|COMPLETED|Overall Study||22
16968|NCT02332707|42872|P5|COMPLETED|Overall Study||23
16969|NCT02332707|42873|P4|COMPLETED|Overall Study||13
16970|NCT02332707|42874|P3|COMPLETED|Overall Study||15
16971|NCT02332707|42875|P2|COMPLETED|Overall Study||24
16972|NCT02332707|42876|P1|COMPLETED|Overall Study||23
16973|NCT02332707|42859|P18|STARTED|Overall Study||16
16974|NCT02332707|42860|P17|STARTED|Overall Study||30
16975|NCT02332707|42861|P16|STARTED|Overall Study||26
16976|NCT02332707|42862|P15|STARTED|Overall Study||16
16977|NCT02332707|42863|P14|STARTED|Overall Study||15
16978|NCT02332707|42864|P13|STARTED|Overall Study||40
16979|NCT02332707|42865|P12|STARTED|Overall Study||35
16980|NCT02332707|42866|P11|STARTED|Overall Study||31
16981|NCT02332707|42867|P10|STARTED|Overall Study||31
16982|NCT02332707|42868|P9|STARTED|Overall Study||48
16983|NCT02332707|42869|P8|STARTED|Overall Study||16
16984|NCT02332707|42870|P7|STARTED|Overall Study||15
16985|NCT02332707|42871|P6|STARTED|Overall Study||23
16986|NCT02332707|42872|P5|STARTED|Overall Study||23
16987|NCT02332707|42873|P4|STARTED|Overall Study||14
16988|NCT02332707|42874|P3|STARTED|Overall Study||16
16989|NCT02332707|42875|P2|STARTED|Overall Study||24
16990|NCT02332707|42876|P1|STARTED|Overall Study||23
16991|NCT02332590|42970|P2|NOT COMPLETED|Overall Study||19
16992|NCT02332590|42971|P1|NOT COMPLETED|Overall Study||29
16993|NCT02332590|42970|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
16994|NCT02332590|42971|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
16995|NCT02332590|42970|P2|Treated|Overall Study||184
16996|NCT02332590|42971|P1|Treated|Overall Study||184
16997|NCT02332590|42970|P2|STARTED|Overall Study||184
16998|NCT02332590|42971|P1|STARTED|Overall Study||185
16999|NCT02332239|43035|P2|NOT COMPLETED|Overall Study||6
17000|NCT02332239|43036|P1|NOT COMPLETED|Overall Study||4
17001|NCT02332239|43035|P2|COMPLETED|Overall Study||52
17002|NCT02332239|43036|P1|COMPLETED|Overall Study||54
17003|NCT02332239|43035|P2|STARTED|Overall Study||58
17004|NCT02332239|43036|P1|STARTED|Overall Study||58
17005|NCT02331940|43051|P2|NOT COMPLETED|Overall Study||5
17006|NCT02331940|43052|P1|NOT COMPLETED|Overall Study||7
17007|NCT02331940|43051|P2|COMPLETED|Overall Study||95
17008|NCT02331940|43052|P1|COMPLETED|Overall Study||93
17009|NCT02331940|43051|P2|STARTED|Overall Study||100
17010|NCT02331940|43052|P1|STARTED|Overall Study||100
17011|NCT02331589|43066|P2|NOT COMPLETED|Overall Study||5
17012|NCT02331589|43067|P1|NOT COMPLETED|Overall Study||5
17013|NCT02331589|43066|P2|COMPLETED|Overall Study||31
17014|NCT02331589|43067|P1|COMPLETED|Overall Study||34
17015|NCT02331589|43066|P2|STARTED|Overall Study||36
17016|NCT02331589|43067|P1|STARTED|Overall Study||39
17017|NCT02331446|43083|P4|NOT COMPLETED|Overall Study||3
17018|NCT02331446|43084|P3|NOT COMPLETED|Overall Study||3
17019|NCT02331446|43085|P2|NOT COMPLETED|Overall Study||5
17020|NCT02331446|43086|P1|NOT COMPLETED|Overall Study||4
17021|NCT02331446|43083|P4|COMPLETED|Overall Study||8
17022|NCT02331446|43084|P3|COMPLETED|Overall Study||8
17023|NCT02331446|43085|P2|COMPLETED|Overall Study||6
17024|NCT02331446|43086|P1|COMPLETED|Overall Study||5
17025|NCT02331446|43083|P4|STARTED|Overall Study||11
17026|NCT02331446|43084|P3|STARTED|Overall Study||11
17027|NCT02331446|43085|P2|STARTED|Overall Study||11
17028|NCT02331446|43086|P1|STARTED|Overall Study||9
17029|NCT02331108|43162|P6|NOT COMPLETED|Overall Study||2
17030|NCT02331108|43163|P5|NOT COMPLETED|Overall Study||2
17031|NCT02331108|43164|P4|NOT COMPLETED|Overall Study||1
17032|NCT02331108|43165|P3|NOT COMPLETED|Overall Study||1
17033|NCT02331108|43166|P2|NOT COMPLETED|Overall Study||2
17034|NCT02331108|43167|P1|NOT COMPLETED|Overall Study||1
17035|NCT02331108|43162|P6|COMPLETED|Overall Study||50
17036|NCT02331108|43163|P5|COMPLETED|Overall Study||50
17037|NCT02331108|43164|P4|COMPLETED|Overall Study||50
17038|NCT02331108|43165|P3|COMPLETED|Overall Study||50
17039|NCT02331108|43166|P2|COMPLETED|Overall Study||50
17040|NCT02331108|43167|P1|COMPLETED|Overall Study||50
17041|NCT02331108|43162|P6|STARTED|Overall Study||52
17042|NCT02331108|43163|P5|STARTED|Overall Study||52
17043|NCT02331108|43164|P4|STARTED|Overall Study||51
17044|NCT02331108|43165|P3|STARTED|Overall Study||51
17045|NCT02331108|43166|P2|STARTED|Overall Study||52
17046|NCT02331108|43167|P1|STARTED|Overall Study||51
17047|NCT02330588|43194|P5|NOT COMPLETED|Overall Study||19
17048|NCT02330588|43195|P4|NOT COMPLETED|Overall Study||22
17049|NCT02330588|43196|P3|NOT COMPLETED|Overall Study||15
17050|NCT02330588|43197|P2|NOT COMPLETED|Overall Study||18
17051|NCT02330588|43198|P1|NOT COMPLETED|Overall Study||16
17052|NCT02330588|43194|P5|COMPLETED|Overall Study||28
17053|NCT02330588|43195|P4|COMPLETED|Overall Study||24
17054|NCT02330588|43196|P3|COMPLETED|Overall Study||31
17055|NCT02330588|43197|P2|COMPLETED|Overall Study||25
17056|NCT02330588|43198|P1|COMPLETED|Overall Study||28
17057|NCT02330588|43194|P5|STARTED|Overall Study||47
17058|NCT02330588|43195|P4|STARTED|Overall Study||46
17059|NCT02330588|43196|P3|STARTED|Overall Study||46
17060|NCT02330588|43197|P2|STARTED|Overall Study||43
17061|NCT02330588|43198|P1|STARTED|Overall Study||44
17062|NCT02330523|43225|P2|NOT COMPLETED|Overall Study||0
17063|NCT02330523|43226|P1|NOT COMPLETED|Overall Study||0
17064|NCT02330523|43225|P2|COMPLETED|Overall Study||19
17065|NCT02330523|43226|P1|COMPLETED|Overall Study||21
17066|NCT02330523|43225|P2|STARTED|Overall Study||19
17067|NCT02330523|43226|P1|STARTED|Overall Study||21
17068|NCT02330276|43239|P3|NOT COMPLETED|Overall Study||0
17069|NCT02330276|43240|P2|NOT COMPLETED|Overall Study||0
17070|NCT02330276|43241|P1|NOT COMPLETED|Overall Study||0
17071|NCT02330276|43239|P3|COMPLETED|Overall Study||4
17072|NCT02330276|43240|P2|COMPLETED|Overall Study||4
17073|NCT02330276|43241|P1|COMPLETED|Overall Study||4
17074|NCT02330276|43239|P3|STARTED|Overall Study||4
17075|NCT02330276|43240|P2|STARTED|Overall Study||4
17076|NCT02330276|43241|P1|STARTED|Overall Study||4
17077|NCT02330172|43263|P2|NOT COMPLETED|Overall Study||1
17078|NCT02330172|43264|P1|NOT COMPLETED|Overall Study||3
17079|NCT02330172|43263|P2|COMPLETED|Overall Study||21
17080|NCT02330172|43264|P1|COMPLETED|Overall Study||19
17081|NCT02330172|43263|P2|STARTED|Overall Study||22
17082|NCT02330172|43264|P1|STARTED|Overall Study||22
17083|NCT02330055|43274|P2|NOT COMPLETED|Overall Study||9
17084|NCT02330055|43275|P1|NOT COMPLETED|Overall Study||10
17085|NCT02330055|43274|P2|COMPLETED|Overall Study||40
17086|NCT02330055|43275|P1|COMPLETED|Overall Study||40
17087|NCT02330055|43274|P2|STARTED|Overall Study||49
17088|NCT02330055|43275|P1|STARTED|Overall Study||50
17089|NCT02329964|43295|P2|NOT COMPLETED|Overall Study||0
17090|NCT02329964|43296|P1|NOT COMPLETED|Overall Study||0
17091|NCT02329964|43295|P2|COMPLETED|Overall Study||40
17092|NCT02329964|43296|P1|COMPLETED|Overall Study||40
17093|NCT02329964|43295|P2|STARTED|Overall Study||40
17094|NCT02329964|43296|P1|STARTED|Overall Study||40
17095|NCT02329730|43322|P12|NOT COMPLETED|Overall Study||0
17096|NCT02329730|43323|P11|NOT COMPLETED|Overall Study||0
17097|NCT02329730|43324|P10|NOT COMPLETED|Overall Study||1
17098|NCT02329730|43325|P9|NOT COMPLETED|Overall Study||1
17099|NCT02329730|43326|P8|NOT COMPLETED|Overall Study||1
17100|NCT02329730|43327|P7|NOT COMPLETED|Overall Study||1
17101|NCT02329730|43328|P6|NOT COMPLETED|Overall Study||2
17102|NCT02329730|43329|P5|NOT COMPLETED|Overall Study||3
17103|NCT02329730|43330|P4|NOT COMPLETED|Overall Study||0
17104|NCT02329730|43331|P3|NOT COMPLETED|Overall Study||0
17105|NCT02329730|43332|P2|NOT COMPLETED|Overall Study||0
17106|NCT02329730|43333|P1|NOT COMPLETED|Overall Study||0
17107|NCT02329730|43322|P12|COMPLETED|Overall Study||8
17108|NCT02329730|43323|P11|COMPLETED|Overall Study||8
17109|NCT02329730|43324|P10|COMPLETED|Overall Study||7
17110|NCT02329730|43325|P9|COMPLETED|Overall Study||7
17111|NCT02329730|43326|P8|COMPLETED|Overall Study||13
17112|NCT02329730|43327|P7|COMPLETED|Overall Study||13
17113|NCT02329730|43328|P6|COMPLETED|Overall Study||12
17114|NCT02329730|43329|P5|COMPLETED|Overall Study||11
17115|NCT02329730|43330|P4|COMPLETED|Overall Study||14
17116|NCT02329730|43331|P3|COMPLETED|Overall Study||14
17117|NCT02329730|43332|P2|COMPLETED|Overall Study||14
17118|NCT02329730|43333|P1|COMPLETED|Overall Study||14
17119|NCT02329730|43322|P12|STARTED|Overall Study||8
17120|NCT02329730|43323|P11|STARTED|Overall Study||8
17121|NCT02329730|43324|P10|STARTED|Overall Study||8
17122|NCT02329730|43325|P9|STARTED|Overall Study||8
17123|NCT02329730|43326|P8|STARTED|Overall Study||14
17124|NCT02329730|43327|P7|STARTED|Overall Study||14
17125|NCT02329730|43328|P6|STARTED|Overall Study||14
17126|NCT02329730|43329|P5|STARTED|Overall Study||14
17127|NCT02329730|43330|P4|STARTED|Overall Study||14
17128|NCT02329730|43331|P3|STARTED|Overall Study||14
17129|NCT02329730|43332|P2|STARTED|Overall Study||14
17130|NCT02329730|43333|P1|STARTED|Overall Study||14
17131|NCT02329600|43410|P3|NOT COMPLETED|Overall Study||0
17132|NCT02329600|43411|P2|NOT COMPLETED|Overall Study||0
17133|NCT02329600|43412|P1|NOT COMPLETED|Overall Study||0
17134|NCT02329600|43410|P3|COMPLETED|Overall Study||15
17135|NCT02329600|43411|P2|COMPLETED|Overall Study||15
17136|NCT02329600|43412|P1|COMPLETED|Overall Study||10
17137|NCT02329600|43410|P3|STARTED|Overall Study||15
17138|NCT02329600|43411|P2|STARTED|Overall Study||15
17139|NCT02329600|43412|P1|STARTED|Overall Study||10
17140|NCT02329587|43425|P2|NOT COMPLETED|1-month Follow-up||1
17141|NCT02329587|43426|P1|NOT COMPLETED|1-month Follow-up||0
17142|NCT02329587|43425|P2|COMPLETED|1-month Follow-up||5
17143|NCT02329587|43426|P1|COMPLETED|1-month Follow-up||4
17144|NCT02329587|43425|P2|STARTED|1-month Follow-up||6
17145|NCT02329587|43426|P1|STARTED|1-month Follow-up||4
17146|NCT02329587|43425|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
17147|NCT02329587|43426|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
17148|NCT02329587|43425|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
17149|NCT02329587|43426|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
17150|NCT02329587|43425|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
17151|NCT02329587|43426|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
17152|NCT02329587|43425|P2|STARTED|Baseline Thru Post-treatment Assessment||7
17153|NCT02329587|43426|P1|STARTED|Baseline Thru Post-treatment Assessment||5
17154|NCT02329431|43444|P2|NOT COMPLETED|Overall Study||13
17155|NCT02329431|43445|P1|NOT COMPLETED|Overall Study||20
17156|NCT02329431|43444|P2|COMPLETED|Overall Study||76
17157|NCT02329431|43445|P1|COMPLETED|Overall Study||72
17158|NCT02329431|43444|P2|Baseline Interview|Overall Study||85
17159|NCT02329431|43445|P1|Baseline Interview|Overall Study||87
17160|NCT02329431|43444|P2|STARTED|Overall Study||89
17161|NCT02329431|43445|P1|STARTED|Overall Study||92
17162|NCT02329223|43464|P3|NOT COMPLETED|Overall Study||6
17163|NCT02329223|43465|P2|NOT COMPLETED|Overall Study||3
17164|NCT02329223|43466|P1|NOT COMPLETED|Overall Study||1
17165|NCT02329223|43464|P3|COMPLETED|Overall Study||68
17166|NCT02329223|43465|P2|COMPLETED|Overall Study||68
17167|NCT02329223|43466|P1|COMPLETED|Overall Study||72
17168|NCT02329223|43464|P3|Safety Set|Overall Study||74
17169|NCT02329223|43465|P2|Safety Set|Overall Study||71
17170|NCT02329223|43466|P1|Safety Set|Overall Study||73
17171|NCT02329223|43464|P3|Full Analysis Set|Overall Study||74
17172|NCT02329223|43465|P2|Full Analysis Set|Overall Study||70
17173|NCT02329223|43466|P1|Full Analysis Set|Overall Study||73
17174|NCT02329223|43464|P3|STARTED|Overall Study||74
17175|NCT02329223|43465|P2|STARTED|Overall Study||71
17176|NCT02329223|43466|P1|STARTED|Overall Study||73
17177|NCT02329015|43499|P2|NOT COMPLETED|Overall Study||0
17178|NCT02329015|43500|P1|NOT COMPLETED|Overall Study||0
17179|NCT02329015|43499|P2|COMPLETED|Overall Study||64
17180|NCT02329015|43500|P1|COMPLETED|Overall Study||48
17181|NCT02329015|43499|P2|STARTED|Overall Study||64
17182|NCT02329015|43500|P1|STARTED|Overall Study||48
17183|NCT02328937|43516|P6|NOT COMPLETED|Period 3||0
17184|NCT02328937|43517|P5|NOT COMPLETED|Period 3||0
17185|NCT02328937|43518|P4|NOT COMPLETED|Period 3||0
17186|NCT02328937|43519|P3|NOT COMPLETED|Period 3||0
17187|NCT02328937|43520|P2|NOT COMPLETED|Period 3||0
17188|NCT02328937|43521|P1|NOT COMPLETED|Period 3||0
17189|NCT02328937|43516|P6|COMPLETED|Period 3||6
17190|NCT02328937|43517|P5|COMPLETED|Period 3||6
17191|NCT02328937|43518|P4|COMPLETED|Period 3||5
17192|NCT02328937|43519|P3|COMPLETED|Period 3||6
17193|NCT02328937|43520|P2|COMPLETED|Period 3||6
17194|NCT02328937|43521|P1|COMPLETED|Period 3||7
17195|NCT02328937|43516|P6|STARTED|Period 3||6
17196|NCT02328937|43517|P5|STARTED|Period 3||6
17197|NCT02328937|43518|P4|STARTED|Period 3||5
17198|NCT02328937|43519|P3|STARTED|Period 3||6
17199|NCT02328937|43520|P2|STARTED|Period 3||6
17200|NCT02328937|43521|P1|STARTED|Period 3||7
17201|NCT02328937|43516|P6|NOT COMPLETED|Period 2||0
17202|NCT02328937|43517|P5|NOT COMPLETED|Period 2||0
17203|NCT02328937|43518|P4|NOT COMPLETED|Period 2||0
17204|NCT02328937|43519|P3|NOT COMPLETED|Period 2||1
17205|NCT02328937|43520|P2|NOT COMPLETED|Period 2||0
17206|NCT02328937|43521|P1|NOT COMPLETED|Period 2||0
17207|NCT02328937|43516|P6|COMPLETED|Period 2||6
17208|NCT02328937|43517|P5|COMPLETED|Period 2||6
17209|NCT02328937|43518|P4|COMPLETED|Period 2||5
17210|NCT02328937|43519|P3|COMPLETED|Period 2||6
17211|NCT02328937|43520|P2|COMPLETED|Period 2||6
17212|NCT02328937|43521|P1|COMPLETED|Period 2||7
17213|NCT02328937|43516|P6|STARTED|Period 2||6
17214|NCT02328937|43517|P5|STARTED|Period 2||6
17215|NCT02328937|43518|P4|STARTED|Period 2||5
17216|NCT02328937|43519|P3|STARTED|Period 2||7
17217|NCT02328937|43520|P2|STARTED|Period 2||6
17218|NCT02328937|43521|P1|STARTED|Period 2||7
17219|NCT02328937|43516|P6|NOT COMPLETED|Period 1||0
17220|NCT02328937|43517|P5|NOT COMPLETED|Period 1||0
17221|NCT02328937|43518|P4|NOT COMPLETED|Period 1||1
17222|NCT02328937|43519|P3|NOT COMPLETED|Period 1||0
17223|NCT02328937|43520|P2|NOT COMPLETED|Period 1||0
17224|NCT02328937|43521|P1|NOT COMPLETED|Period 1||0
17225|NCT02328937|43516|P6|COMPLETED|Period 1||6
17226|NCT02328937|43517|P5|COMPLETED|Period 1||6
17227|NCT02328937|43518|P4|COMPLETED|Period 1||5
17228|NCT02328937|43519|P3|COMPLETED|Period 1||7
17229|NCT02328937|43520|P2|COMPLETED|Period 1||6
17230|NCT02328937|43521|P1|COMPLETED|Period 1||7
17231|NCT02328937|43516|P6|STARTED|Period 1||6
17232|NCT02328937|43517|P5|STARTED|Period 1||6
17233|NCT02328937|43518|P4|STARTED|Period 1||6
17234|NCT02328937|43519|P3|STARTED|Period 1||7
17235|NCT02328937|43520|P2|STARTED|Period 1||6
17236|NCT02328937|43521|P1|STARTED|Period 1||7
17237|NCT02328404|43534|P2|NOT COMPLETED|Overall Study||1
17238|NCT02328404|43535|P1|NOT COMPLETED|Overall Study||1
17239|NCT02328404|43534|P2|COMPLETED|Overall Study||29
17240|NCT02328404|43535|P1|COMPLETED|Overall Study||29
17241|NCT02328404|43534|P2|STARTED|Overall Study||30
17242|NCT02328404|43535|P1|STARTED|Overall Study||30
17243|NCT02327429|43569|P1|NOT COMPLETED|Overall Study||2
17244|NCT02327429|43569|P1|COMPLETED|Overall Study||17
17245|NCT02327429|43569|P1|STARTED|Overall Study||19
17246|NCT02327117|43591|P2|NOT COMPLETED|Overall Study||0
17247|NCT02327117|43592|P1|NOT COMPLETED|Overall Study||0
17248|NCT02327117|43591|P2|COMPLETED|Overall Study||45
17249|NCT02327117|43592|P1|COMPLETED|Overall Study||45
17250|NCT02327117|43591|P2|STARTED|Overall Study||45
17251|NCT02327117|43592|P1|STARTED|Overall Study||45
17252|NCT02327013|43601|P5|NOT COMPLETED|Overall Study||4
17253|NCT02327013|43602|P4|NOT COMPLETED|Overall Study||1
17254|NCT02327013|43603|P3|NOT COMPLETED|Overall Study||42
17255|NCT02327013|43604|P2|NOT COMPLETED|Overall Study||16
17256|NCT02327013|43605|P1|NOT COMPLETED|Overall Study||13
17257|NCT02327013|43601|P5|COMPLETED|Overall Study||12
17258|NCT02327013|43602|P4|COMPLETED|Overall Study||20
17259|NCT02327013|43603|P3|COMPLETED|Overall Study||54
17260|NCT02327013|43604|P2|COMPLETED|Overall Study||29
17261|NCT02327013|43605|P1|COMPLETED|Overall Study||36
17262|NCT02327013|43601|P5|STARTED|Overall Study||16
17263|NCT02327013|43602|P4|STARTED|Overall Study||21
17264|NCT02327013|43603|P3|STARTED|Overall Study||96
17265|NCT02327013|43604|P2|STARTED|Overall Study||45
17266|NCT02327013|43605|P1|STARTED|Overall Study||49
17267|NCT02326844|43778|P1|NOT COMPLETED|Overall Study||0
17268|NCT02326844|43778|P1|COMPLETED|Overall Study||3
17269|NCT02326844|43778|P1|STARTED|Overall Study||3
17270|NCT02326649|43785|P1|NOT COMPLETED|Overall Study||12
17271|NCT02326649|43785|P1|COMPLETED|Overall Study||21
17272|NCT02326649|43785|P1|STARTED|Overall Study||33
17273|NCT02325856|43791|P2|NOT COMPLETED|Overall Study||27
17274|NCT02325856|43792|P1|NOT COMPLETED|Overall Study||20
17275|NCT02325856|43791|P2|COMPLETED|Overall Study||123
17276|NCT02325856|43792|P1|COMPLETED|Overall Study||128
17277|NCT02325856|43791|P2|STARTED|Overall Study||150
17278|NCT02325856|43792|P1|STARTED|Overall Study||148
17279|NCT02325713|43816|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17280|NCT02325713|43817|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17281|NCT02325713|43818|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17282|NCT02325713|43819|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17283|NCT02325713|43820|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17284|NCT02325713|43821|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17285|NCT02325713|43822|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17286|NCT02325713|43823|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17287|NCT02325713|43824|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17288|NCT02325713|43825|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17289|NCT02325713|43826|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17290|NCT02325713|43827|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17291|NCT02325713|43828|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17292|NCT02325713|43829|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17293|NCT02325713|43830|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17294|NCT02325713|43831|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
17295|NCT02325713|43816|P16|COMPLETED|Intervention Period 4 (2 Days)||2
17296|NCT02325713|43817|P15|COMPLETED|Intervention Period 4 (2 Days)||2
17297|NCT02325713|43818|P14|COMPLETED|Intervention Period 4 (2 Days)||2
17298|NCT02325713|43819|P13|COMPLETED|Intervention Period 4 (2 Days)||2
17299|NCT02325713|43820|P12|COMPLETED|Intervention Period 4 (2 Days)||2
17300|NCT02325713|43821|P11|COMPLETED|Intervention Period 4 (2 Days)||1
17301|NCT02325713|43822|P10|COMPLETED|Intervention Period 4 (2 Days)||1
17302|NCT02325713|43823|P9|COMPLETED|Intervention Period 4 (2 Days)||2
17303|NCT02325713|43824|P8|COMPLETED|Intervention Period 4 (2 Days)||2
17304|NCT02325713|43825|P7|COMPLETED|Intervention Period 4 (2 Days)||2
17305|NCT02325713|43826|P6|COMPLETED|Intervention Period 4 (2 Days)||2
17306|NCT02325713|43827|P5|COMPLETED|Intervention Period 4 (2 Days)||2
17307|NCT02325713|43828|P4|COMPLETED|Intervention Period 4 (2 Days)||2
17308|NCT02325713|43829|P3|COMPLETED|Intervention Period 4 (2 Days)||2
17309|NCT02325713|43830|P2|COMPLETED|Intervention Period 4 (2 Days)||2
17310|NCT02325713|43831|P1|COMPLETED|Intervention Period 4 (2 Days)||1
17311|NCT02325713|43816|P16|STARTED|Intervention Period 4 (2 Days)||2
17312|NCT02325713|43817|P15|STARTED|Intervention Period 4 (2 Days)||2
17313|NCT02325713|43818|P14|STARTED|Intervention Period 4 (2 Days)||2
17314|NCT02325713|43819|P13|STARTED|Intervention Period 4 (2 Days)||2
17315|NCT02325713|43820|P12|STARTED|Intervention Period 4 (2 Days)||2
17316|NCT02325713|43821|P11|STARTED|Intervention Period 4 (2 Days)||1
17317|NCT02325713|43822|P10|STARTED|Intervention Period 4 (2 Days)||1
17318|NCT02325713|43823|P9|STARTED|Intervention Period 4 (2 Days)||2
17319|NCT02325713|43824|P8|STARTED|Intervention Period 4 (2 Days)||2
17320|NCT02325713|43825|P7|STARTED|Intervention Period 4 (2 Days)||2
17321|NCT02325713|43826|P6|STARTED|Intervention Period 4 (2 Days)||2
17322|NCT02325713|43827|P5|STARTED|Intervention Period 4 (2 Days)||2
17323|NCT02325713|43828|P4|STARTED|Intervention Period 4 (2 Days)||2
17324|NCT02325713|43829|P3|STARTED|Intervention Period 4 (2 Days)||2
17325|NCT02325713|43830|P2|STARTED|Intervention Period 4 (2 Days)||2
17326|NCT02325713|43831|P1|STARTED|Intervention Period 4 (2 Days)||1
17327|NCT02325713|43816|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17328|NCT02325713|43817|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17329|NCT02325713|43818|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17330|NCT02325713|43819|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17331|NCT02325713|43820|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17332|NCT02325713|43821|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17333|NCT02325713|43822|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
17334|NCT02325713|43823|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17335|NCT02325713|43824|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17336|NCT02325713|43825|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17337|NCT02325713|43826|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17338|NCT02325713|43827|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17339|NCT02325713|43828|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17340|NCT02325713|43829|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17341|NCT02325713|43830|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17342|NCT02325713|43831|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
17343|NCT02325713|43816|P16|COMPLETED|Intervention Period 3 (2 Days)||2
17344|NCT02325713|43817|P15|COMPLETED|Intervention Period 3 (2 Days)||2
17345|NCT02325713|43818|P14|COMPLETED|Intervention Period 3 (2 Days)||2
17346|NCT02325713|43819|P13|COMPLETED|Intervention Period 3 (2 Days)||2
17347|NCT02325713|43820|P12|COMPLETED|Intervention Period 3 (2 Days)||2
17348|NCT02325713|43821|P11|COMPLETED|Intervention Period 3 (2 Days)||1
17349|NCT02325713|43822|P10|COMPLETED|Intervention Period 3 (2 Days)||1
17350|NCT02325713|43823|P9|COMPLETED|Intervention Period 3 (2 Days)||2
17351|NCT02325713|43824|P8|COMPLETED|Intervention Period 3 (2 Days)||2
17352|NCT02325713|43825|P7|COMPLETED|Intervention Period 3 (2 Days)||2
17353|NCT02325713|43826|P6|COMPLETED|Intervention Period 3 (2 Days)||2
17354|NCT02325713|43827|P5|COMPLETED|Intervention Period 3 (2 Days)||2
17355|NCT02325713|43828|P4|COMPLETED|Intervention Period 3 (2 Days)||2
17356|NCT02325713|43829|P3|COMPLETED|Intervention Period 3 (2 Days)||2
17357|NCT02325713|43830|P2|COMPLETED|Intervention Period 3 (2 Days)||2
17358|NCT02325713|43831|P1|COMPLETED|Intervention Period 3 (2 Days)||1
17359|NCT02325713|43816|P16|STARTED|Intervention Period 3 (2 Days)||2
17360|NCT02325713|43817|P15|STARTED|Intervention Period 3 (2 Days)||2
17361|NCT02325713|43818|P14|STARTED|Intervention Period 3 (2 Days)||2
17362|NCT02325713|43819|P13|STARTED|Intervention Period 3 (2 Days)||2
17363|NCT02325713|43820|P12|STARTED|Intervention Period 3 (2 Days)||2
17364|NCT02325713|43821|P11|STARTED|Intervention Period 3 (2 Days)||1
17365|NCT02325713|43822|P10|STARTED|Intervention Period 3 (2 Days)||2
17366|NCT02325713|43823|P9|STARTED|Intervention Period 3 (2 Days)||2
17367|NCT02325713|43824|P8|STARTED|Intervention Period 3 (2 Days)||2
17368|NCT02325713|43825|P7|STARTED|Intervention Period 3 (2 Days)||2
17369|NCT02325713|43826|P6|STARTED|Intervention Period 3 (2 Days)||2
17370|NCT02325713|43827|P5|STARTED|Intervention Period 3 (2 Days)||2
17371|NCT02325713|43828|P4|STARTED|Intervention Period 3 (2 Days)||2
17372|NCT02325713|43829|P3|STARTED|Intervention Period 3 (2 Days)||2
17373|NCT02325713|43830|P2|STARTED|Intervention Period 3 (2 Days)||2
17374|NCT02325713|43831|P1|STARTED|Intervention Period 3 (2 Days)||1
17375|NCT02325713|43816|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17376|NCT02325713|43817|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17377|NCT02325713|43818|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17378|NCT02325713|43819|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17379|NCT02325713|43820|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17380|NCT02325713|43821|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17381|NCT02325713|43822|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17382|NCT02325713|43823|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17383|NCT02325713|43824|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17384|NCT02325713|43825|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17385|NCT02325713|43826|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17386|NCT02325713|43827|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17387|NCT02325713|43828|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17388|NCT02325713|43829|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17389|NCT02325713|43830|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
17390|NCT02325713|43831|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
17391|NCT02325713|43816|P16|COMPLETED|Intervention Period 2 (2 Days)||2
17392|NCT02325713|43817|P15|COMPLETED|Intervention Period 2 (2 Days)||2
17393|NCT02325713|43818|P14|COMPLETED|Intervention Period 2 (2 Days)||2
17394|NCT02325713|43819|P13|COMPLETED|Intervention Period 2 (2 Days)||2
17395|NCT02325713|43820|P12|COMPLETED|Intervention Period 2 (2 Days)||2
17396|NCT02325713|43821|P11|COMPLETED|Intervention Period 2 (2 Days)||1
17397|NCT02325713|43822|P10|COMPLETED|Intervention Period 2 (2 Days)||2
17398|NCT02325713|43823|P9|COMPLETED|Intervention Period 2 (2 Days)||2
17399|NCT02325713|43824|P8|COMPLETED|Intervention Period 2 (2 Days)||2
17400|NCT02325713|43825|P7|COMPLETED|Intervention Period 2 (2 Days)||2
17401|NCT02325713|43826|P6|COMPLETED|Intervention Period 2 (2 Days)||2
17402|NCT02325713|43827|P5|COMPLETED|Intervention Period 2 (2 Days)||2
17403|NCT02325713|43828|P4|COMPLETED|Intervention Period 2 (2 Days)||2
17404|NCT02325713|43829|P3|COMPLETED|Intervention Period 2 (2 Days)||2
17405|NCT02325713|43830|P2|COMPLETED|Intervention Period 2 (2 Days)||2
17406|NCT02325713|43831|P1|COMPLETED|Intervention Period 2 (2 Days)||1
17407|NCT02325713|43816|P16|STARTED|Intervention Period 2 (2 Days)||2
17408|NCT02325713|43817|P15|STARTED|Intervention Period 2 (2 Days)||2
17409|NCT02325713|43818|P14|STARTED|Intervention Period 2 (2 Days)||2
17410|NCT02325713|43819|P13|STARTED|Intervention Period 2 (2 Days)||2
17411|NCT02325713|43820|P12|STARTED|Intervention Period 2 (2 Days)||2
17412|NCT02325713|43821|P11|STARTED|Intervention Period 2 (2 Days)||1
17413|NCT02325713|43822|P10|STARTED|Intervention Period 2 (2 Days)||2
17414|NCT02325713|43823|P9|STARTED|Intervention Period 2 (2 Days)||2
17415|NCT02325713|43824|P8|STARTED|Intervention Period 2 (2 Days)||2
17416|NCT02325713|43825|P7|STARTED|Intervention Period 2 (2 Days)||2
17417|NCT02325713|43826|P6|STARTED|Intervention Period 2 (2 Days)||2
17418|NCT02325713|43827|P5|STARTED|Intervention Period 2 (2 Days)||2
17419|NCT02325713|43828|P4|STARTED|Intervention Period 2 (2 Days)||2
17420|NCT02325713|43829|P3|STARTED|Intervention Period 2 (2 Days)||2
17421|NCT02325713|43830|P2|STARTED|Intervention Period 2 (2 Days)||2
17422|NCT02325713|43831|P1|STARTED|Intervention Period 2 (2 Days)||2
17423|NCT02325713|43816|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17424|NCT02325713|43817|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17425|NCT02325713|43818|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17426|NCT02325713|43819|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17427|NCT02325713|43820|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17428|NCT02325713|43821|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
17429|NCT02325713|43822|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17430|NCT02325713|43823|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17431|NCT02325713|43824|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17432|NCT02325713|43825|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17433|NCT02325713|43826|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17434|NCT02325713|43827|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17435|NCT02325713|43828|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17436|NCT02325713|43829|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17437|NCT02325713|43830|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17438|NCT02325713|43831|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
17439|NCT02325713|43816|P16|COMPLETED|Intervention Period 1 (2 Days)||2
17440|NCT02325713|43817|P15|COMPLETED|Intervention Period 1 (2 Days)||2
17441|NCT02325713|43818|P14|COMPLETED|Intervention Period 1 (2 Days)||2
17442|NCT02325713|43819|P13|COMPLETED|Intervention Period 1 (2 Days)||2
17443|NCT02325713|43820|P12|COMPLETED|Intervention Period 1 (2 Days)||2
17444|NCT02325713|43821|P11|COMPLETED|Intervention Period 1 (2 Days)||1
17445|NCT02325713|43822|P10|COMPLETED|Intervention Period 1 (2 Days)||2
17446|NCT02325713|43823|P9|COMPLETED|Intervention Period 1 (2 Days)||2
17447|NCT02325713|43824|P8|COMPLETED|Intervention Period 1 (2 Days)||2
17448|NCT02325713|43825|P7|COMPLETED|Intervention Period 1 (2 Days)||2
17449|NCT02325713|43826|P6|COMPLETED|Intervention Period 1 (2 Days)||2
17450|NCT02325713|43827|P5|COMPLETED|Intervention Period 1 (2 Days)||2
17451|NCT02325713|43828|P4|COMPLETED|Intervention Period 1 (2 Days)||2
17452|NCT02325713|43829|P3|COMPLETED|Intervention Period 1 (2 Days)||2
17453|NCT02325713|43830|P2|COMPLETED|Intervention Period 1 (2 Days)||2
17454|NCT02325713|43831|P1|COMPLETED|Intervention Period 1 (2 Days)||2
17455|NCT02325713|43816|P16|STARTED|Intervention Period 1 (2 Days)||2
17456|NCT02325713|43817|P15|STARTED|Intervention Period 1 (2 Days)||2
17457|NCT02325713|43818|P14|STARTED|Intervention Period 1 (2 Days)||2
17458|NCT02325713|43819|P13|STARTED|Intervention Period 1 (2 Days)||2
17459|NCT02325713|43820|P12|STARTED|Intervention Period 1 (2 Days)||2
17460|NCT02325713|43821|P11|STARTED|Intervention Period 1 (2 Days)||2
17461|NCT02325713|43822|P10|STARTED|Intervention Period 1 (2 Days)||2
17462|NCT02325713|43823|P9|STARTED|Intervention Period 1 (2 Days)||2
17463|NCT02325713|43824|P8|STARTED|Intervention Period 1 (2 Days)||2
17464|NCT02325713|43825|P7|STARTED|Intervention Period 1 (2 Days)||2
17465|NCT02325713|43826|P6|STARTED|Intervention Period 1 (2 Days)||2
17466|NCT02325713|43827|P5|STARTED|Intervention Period 1 (2 Days)||2
17467|NCT02325713|43828|P4|STARTED|Intervention Period 1 (2 Days)||2
17468|NCT02325713|43829|P3|STARTED|Intervention Period 1 (2 Days)||2
17469|NCT02325713|43830|P2|STARTED|Intervention Period 1 (2 Days)||2
17470|NCT02325713|43831|P1|STARTED|Intervention Period 1 (2 Days)||2
17471|NCT02325518|43926|P2|NOT COMPLETED|Overall Study||3
17472|NCT02325518|43927|P1|NOT COMPLETED|Overall Study||4
17473|NCT02325518|43926|P2|COMPLETED|Overall Study||100
17474|NCT02325518|43927|P1|COMPLETED|Overall Study||94
17475|NCT02325518|43926|P2|Per Protocol Set (PPS)|Overall Study||97
17476|NCT02325518|43927|P1|Per Protocol Set (PPS)|Overall Study||92
17477|NCT02325518|43926|P2|Full Analysis Set (FAS)|Overall Study||101
17478|NCT02325518|43927|P1|Full Analysis Set (FAS)|Overall Study||98
17479|NCT02325518|43926|P2|Safety Set|Overall Study||103
17480|NCT02325518|43927|P1|Safety Set|Overall Study||98
17481|NCT02325518|43926|P2|STARTED|Overall Study||103
17482|NCT02325518|43927|P1|STARTED|Overall Study||98
17483|NCT02324673|43939|P3|NOT COMPLETED|Overall Study||0
17484|NCT02324673|43940|P2|NOT COMPLETED|Overall Study||0
17485|NCT02324673|43941|P1|NOT COMPLETED|Overall Study||0
17486|NCT02324673|43939|P3|COMPLETED|Overall Study||21
17487|NCT02324673|43940|P2|COMPLETED|Overall Study||20
17488|NCT02324673|43941|P1|COMPLETED|Overall Study||20
17489|NCT02324673|43939|P3|STARTED|Overall Study||21
17490|NCT02324673|43940|P2|STARTED|Overall Study||20
17491|NCT02324673|43941|P1|STARTED|Overall Study||20
17492|NCT02324660|44042|P1|NOT COMPLETED|Overall Study||32
17493|NCT02324660|44042|P1|COMPLETED|Overall Study||137
17494|NCT02324660|44042|P1|STARTED|Overall Study||169
17495|NCT02324504|44047|P1|NOT COMPLETED|Overall Study||0
17496|NCT02324504|44047|P1|COMPLETED|Overall Study||60
17497|NCT02324504|44047|P1|STARTED|Overall Study||60
17498|NCT02323854|44054|P1|NOT COMPLETED|Overall Study||0
17499|NCT02323854|44054|P1|COMPLETED|Overall Study||15
17500|NCT02323854|44054|P1|STARTED|Overall Study||15
17501|NCT02322892|44062|P2|NOT COMPLETED|Overall Study||3
17502|NCT02322892|44063|P1|NOT COMPLETED|Overall Study||2
17503|NCT02322892|44062|P2|COMPLETED|Overall Study|Received thiamine|31
17504|NCT02322892|44063|P1|COMPLETED|Overall Study|Received placebo|33
17505|NCT02322892|44062|P2|STARTED|Overall Study|Number randomized|34
17506|NCT02322892|44063|P1|STARTED|Overall Study|Number randomized|35
17507|NCT02322879|44079|P2|NOT COMPLETED|Second Intervention||0
17508|NCT02322879|44080|P1|NOT COMPLETED|Second Intervention||0
17509|NCT02322879|44079|P2|COMPLETED|Second Intervention||10
17510|NCT02322879|44080|P1|COMPLETED|Second Intervention||10
17511|NCT02322879|44079|P2|STARTED|Second Intervention||10
17512|NCT02322879|44080|P1|STARTED|Second Intervention||10
17513|NCT02322879|44079|P2|NOT COMPLETED|Washout||0
17514|NCT02322879|44080|P1|NOT COMPLETED|Washout||0
17515|NCT02322879|44079|P2|COMPLETED|Washout||10
17516|NCT02322879|44080|P1|COMPLETED|Washout||10
17517|NCT02322879|44079|P2|STARTED|Washout||10
17518|NCT02322879|44080|P1|STARTED|Washout||10
17519|NCT02322879|44079|P2|NOT COMPLETED|First Intervention||0
17520|NCT02322879|44080|P1|NOT COMPLETED|First Intervention||1
17521|NCT02322879|44079|P2|COMPLETED|First Intervention||10
17522|NCT02322879|44080|P1|COMPLETED|First Intervention||10
17523|NCT02322879|44079|P2|STARTED|First Intervention||10
17524|NCT02322879|44080|P1|STARTED|First Intervention||11
17525|NCT02322866|44088|P2|NOT COMPLETED|Overall Study||86
17526|NCT02322866|44089|P1|NOT COMPLETED|Overall Study||71
17527|NCT02322866|44088|P2|COMPLETED|Overall Study||433
17528|NCT02322866|44089|P1|COMPLETED|Overall Study||444
17529|NCT02322866|44088|P2|STARTED|Overall Study||519
17530|NCT02322866|44089|P1|STARTED|Overall Study||515
17531|NCT02322788|44111|P4|NOT COMPLETED|Visit 6||0
17532|NCT02322788|44112|P3|NOT COMPLETED|Visit 6||0
17533|NCT02322788|44113|P2|NOT COMPLETED|Visit 6||0
17534|NCT02322788|44114|P1|NOT COMPLETED|Visit 6||0
17535|NCT02322788|44111|P4|COMPLETED|Visit 6||15
17536|NCT02322788|44112|P3|COMPLETED|Visit 6||15
17537|NCT02322788|44113|P2|COMPLETED|Visit 6||16
17538|NCT02322788|44114|P1|COMPLETED|Visit 6||14
17539|NCT02322788|44111|P4|STARTED|Visit 6||15
17540|NCT02322788|44112|P3|STARTED|Visit 6||15
17541|NCT02322788|44113|P2|STARTED|Visit 6||16
17542|NCT02322788|44114|P1|STARTED|Visit 6||14
17543|NCT02322788|44111|P4|NOT COMPLETED|Visit 5||0
17544|NCT02322788|44112|P3|NOT COMPLETED|Visit 5||0
17545|NCT02322788|44113|P2|NOT COMPLETED|Visit 5||0
17546|NCT02322788|44114|P1|NOT COMPLETED|Visit 5||0
17547|NCT02322788|44111|P4|COMPLETED|Visit 5||14
17548|NCT02322788|44112|P3|COMPLETED|Visit 5||15
17549|NCT02322788|44113|P2|COMPLETED|Visit 5||15
17550|NCT02322788|44114|P1|COMPLETED|Visit 5||16
17551|NCT02322788|44111|P4|STARTED|Visit 5||14
17552|NCT02322788|44112|P3|STARTED|Visit 5||15
17553|NCT02322788|44113|P2|STARTED|Visit 5||15
17554|NCT02322788|44114|P1|STARTED|Visit 5||16
17555|NCT02322788|44111|P4|NOT COMPLETED|Visit 4||0
17556|NCT02322788|44112|P3|NOT COMPLETED|Visit 4||0
17557|NCT02322788|44113|P2|NOT COMPLETED|Visit 4||0
17558|NCT02322788|44114|P1|NOT COMPLETED|Visit 4||0
17559|NCT02322788|44111|P4|COMPLETED|Visit 4||15
17560|NCT02322788|44112|P3|COMPLETED|Visit 4||16
17561|NCT02322788|44113|P2|COMPLETED|Visit 4||14
17562|NCT02322788|44114|P1|COMPLETED|Visit 4||15
17563|NCT02322788|44111|P4|STARTED|Visit 4||15
17564|NCT02322788|44112|P3|STARTED|Visit 4||16
17565|NCT02322788|44113|P2|STARTED|Visit 4||14
17566|NCT02322788|44114|P1|STARTED|Visit 4||15
17567|NCT02322788|44111|P4|NOT COMPLETED|Visit 3||0
17568|NCT02322788|44112|P3|NOT COMPLETED|Visit 3||0
17569|NCT02322788|44113|P2|NOT COMPLETED|Visit 3||0
17570|NCT02322788|44114|P1|NOT COMPLETED|Visit 3||0
17571|NCT02322788|44111|P4|COMPLETED|Visit 3||16
17572|NCT02322788|44112|P3|COMPLETED|Visit 3||14
17573|NCT02322788|44113|P2|COMPLETED|Visit 3||15
17574|NCT02322788|44114|P1|COMPLETED|Visit 3||15
17575|NCT02322788|44111|P4|STARTED|Visit 3||16
17576|NCT02322788|44112|P3|STARTED|Visit 3||14
17577|NCT02322788|44113|P2|STARTED|Visit 3||15
17578|NCT02322788|44114|P1|STARTED|Visit 3||15
17579|NCT02322775|44126|P2|NOT COMPLETED|Overall Study||6
17580|NCT02322775|44127|P1|NOT COMPLETED|Overall Study||5
17581|NCT02322775|44126|P2|COMPLETED|Overall Study||99
17582|NCT02322775|44127|P1|COMPLETED|Overall Study||101
17583|NCT02322775|44126|P2|STARTED|Overall Study||105
17584|NCT02322775|44127|P1|STARTED|Overall Study||106
17585|NCT02322749|44153|P6|NOT COMPLETED|Period 3||0
17586|NCT02322749|44154|P5|NOT COMPLETED|Period 3||0
17587|NCT02322749|44155|P4|NOT COMPLETED|Period 3||0
17588|NCT02322749|44156|P3|NOT COMPLETED|Period 3||1
17589|NCT02322749|44157|P2|NOT COMPLETED|Period 3||0
17590|NCT02322749|44158|P1|NOT COMPLETED|Period 3||0
17591|NCT02322749|44153|P6|COMPLETED|Period 3||8
17592|NCT02322749|44154|P5|COMPLETED|Period 3||8
17593|NCT02322749|44155|P4|COMPLETED|Period 3||6
17594|NCT02322749|44156|P3|COMPLETED|Period 3||7
17595|NCT02322749|44157|P2|COMPLETED|Period 3||8
17596|NCT02322749|44158|P1|COMPLETED|Period 3||8
17597|NCT02322749|44153|P6|STARTED|Period 3||8
17598|NCT02322749|44154|P5|STARTED|Period 3||8
17599|NCT02322749|44155|P4|STARTED|Period 3||6
17600|NCT02322749|44156|P3|STARTED|Period 3||8
17601|NCT02322749|44157|P2|STARTED|Period 3||8
17602|NCT02322749|44158|P1|STARTED|Period 3||8
17603|NCT02322749|44153|P6|NOT COMPLETED|Period 2||0
17604|NCT02322749|44154|P5|NOT COMPLETED|Period 2||0
17605|NCT02322749|44155|P4|NOT COMPLETED|Period 2||2
17606|NCT02322749|44156|P3|NOT COMPLETED|Period 2||0
17607|NCT02322749|44157|P2|NOT COMPLETED|Period 2||0
17608|NCT02322749|44158|P1|NOT COMPLETED|Period 2||0
17609|NCT02322749|44153|P6|COMPLETED|Period 2||8
17610|NCT02322749|44154|P5|COMPLETED|Period 2||8
17611|NCT02322749|44155|P4|COMPLETED|Period 2||6
17612|NCT02322749|44156|P3|COMPLETED|Period 2||8
17613|NCT02322749|44157|P2|COMPLETED|Period 2||8
17614|NCT02322749|44158|P1|COMPLETED|Period 2||8
17615|NCT02322749|44153|P6|STARTED|Period 2||8
17616|NCT02322749|44154|P5|STARTED|Period 2||8
17617|NCT02322749|44155|P4|STARTED|Period 2||8
17618|NCT02322749|44156|P3|STARTED|Period 2||8
17619|NCT02322749|44157|P2|STARTED|Period 2||8
17620|NCT02322749|44158|P1|STARTED|Period 2||8
17621|NCT02322749|44153|P6|NOT COMPLETED|Period 1||0
17622|NCT02322749|44154|P5|NOT COMPLETED|Period 1||0
17623|NCT02322749|44155|P4|NOT COMPLETED|Period 1||0
17624|NCT02322749|44156|P3|NOT COMPLETED|Period 1||0
17625|NCT02322749|44157|P2|NOT COMPLETED|Period 1||0
17626|NCT02322749|44158|P1|NOT COMPLETED|Period 1||0
17627|NCT02322749|44153|P6|COMPLETED|Period 1||8
17628|NCT02322749|44154|P5|COMPLETED|Period 1||8
17629|NCT02322749|44155|P4|COMPLETED|Period 1||8
17630|NCT02322749|44156|P3|COMPLETED|Period 1||8
17631|NCT02322749|44157|P2|COMPLETED|Period 1||8
17632|NCT02322749|44158|P1|COMPLETED|Period 1||8
17633|NCT02322749|44153|P6|STARTED|Period 1||8
17634|NCT02322749|44154|P5|STARTED|Period 1||8
17635|NCT02322749|44155|P4|STARTED|Period 1||8
17636|NCT02322749|44156|P3|STARTED|Period 1||8
17637|NCT02322749|44157|P2|STARTED|Period 1||8
17638|NCT02322749|44158|P1|STARTED|Period 1||8
17639|NCT02322528|44181|P1|NOT COMPLETED|Overall Study||0
17640|NCT02322528|44181|P1|COMPLETED|Overall Study||10
17641|NCT02322528|44181|P1|STARTED|Overall Study||10
17642|NCT02322216|44188|P2|NOT COMPLETED|Overall Study||4
17643|NCT02322216|44189|P1|NOT COMPLETED|Overall Study||2
17644|NCT02322216|44188|P2|COMPLETED|Overall Study||123
17645|NCT02322216|44189|P1|COMPLETED|Overall Study||124
17646|NCT02322216|44188|P2|Per Protocol Set (PPS)|Overall Study||122
17647|NCT02322216|44189|P1|Per Protocol Set (PPS)|Overall Study||123
17648|NCT02322216|44188|P2|Treated (Safety Set)|Overall Study||126
17649|NCT02322216|44189|P1|Treated (Safety Set)|Overall Study||126
17650|NCT02322216|44188|P2|STARTED|Overall Study||127
17651|NCT02322216|44189|P1|STARTED|Overall Study||126
17652|NCT02321527|44196|P1|NOT COMPLETED|Overall Study||1
17653|NCT02321527|44196|P1|COMPLETED|Overall Study||20
17654|NCT02321527|44196|P1|STARTED|Overall Study||21
17655|NCT02321436|44202|P2|NOT COMPLETED|Overall Study||1
17656|NCT02321436|44203|P1|NOT COMPLETED|Overall Study||1
17657|NCT02321436|44202|P2|COMPLETED|Overall Study||13
17658|NCT02321436|44203|P1|COMPLETED|Overall Study||27
17659|NCT02321436|44202|P2|STARTED|Overall Study||14
17660|NCT02321436|44203|P1|STARTED|Overall Study||28
17661|NCT02320903|44222|P3|NOT COMPLETED|Overall Study||16
17662|NCT02320903|44223|P2|NOT COMPLETED|Overall Study||16
17663|NCT02320903|44224|P1|NOT COMPLETED|Overall Study||8
17664|NCT02320903|44222|P3|COMPLETED|Overall Study||16
17665|NCT02320903|44223|P2|COMPLETED|Overall Study||16
17666|NCT02320903|44224|P1|COMPLETED|Overall Study||16
17667|NCT02320903|44222|P3|STARTED|Overall Study||32
17668|NCT02320903|44223|P2|STARTED|Overall Study||32
17669|NCT02320903|44224|P1|STARTED|Overall Study||24
17670|NCT02320838|44257|P5|NOT COMPLETED|Third Intervention (1 Day)||0
17671|NCT02320838|44258|P4|NOT COMPLETED|Third Intervention (1 Day)||0
17672|NCT02320838|44259|P3|NOT COMPLETED|Third Intervention (1 Day)||0
17673|NCT02320838|44260|P2|NOT COMPLETED|Third Intervention (1 Day)||0
17674|NCT02320838|44261|P1|NOT COMPLETED|Third Intervention (1 Day)||0
17675|NCT02320838|44257|P5|COMPLETED|Third Intervention (1 Day)||7
17676|NCT02320838|44258|P4|COMPLETED|Third Intervention (1 Day)||7
17677|NCT02320838|44259|P3|COMPLETED|Third Intervention (1 Day)||8
17678|NCT02320838|44260|P2|COMPLETED|Third Intervention (1 Day)||8
17679|NCT02320838|44261|P1|COMPLETED|Third Intervention (1 Day)||8
17680|NCT02320838|44257|P5|STARTED|Third Intervention (1 Day)||7
17681|NCT02320838|44258|P4|STARTED|Third Intervention (1 Day)||7
17682|NCT02320838|44259|P3|STARTED|Third Intervention (1 Day)||8
17683|NCT02320838|44260|P2|STARTED|Third Intervention (1 Day)||8
17684|NCT02320838|44261|P1|STARTED|Third Intervention (1 Day)||8
17685|NCT02320838|44257|P5|NOT COMPLETED|Washout (1 Day)||0
17686|NCT02320838|44258|P4|NOT COMPLETED|Washout (1 Day)||0
17687|NCT02320838|44259|P3|NOT COMPLETED|Washout (1 Day)||0
17688|NCT02320838|44260|P2|NOT COMPLETED|Washout (1 Day)||0
17689|NCT02320838|44261|P1|NOT COMPLETED|Washout (1 Day)||0
17690|NCT02320838|44257|P5|COMPLETED|Washout (1 Day)||7
17691|NCT02320838|44258|P4|COMPLETED|Washout (1 Day)||7
17692|NCT02320838|44259|P3|COMPLETED|Washout (1 Day)||8
17693|NCT02320838|44260|P2|COMPLETED|Washout (1 Day)||8
17694|NCT02320838|44261|P1|COMPLETED|Washout (1 Day)||8
17695|NCT02320838|44257|P5|STARTED|Washout (1 Day)||7
17696|NCT02320838|44258|P4|STARTED|Washout (1 Day)||7
17697|NCT02320838|44259|P3|STARTED|Washout (1 Day)||8
17698|NCT02320838|44260|P2|STARTED|Washout (1 Day)||8
17699|NCT02320838|44261|P1|STARTED|Washout (1 Day)||8
17700|NCT02320838|44257|P5|NOT COMPLETED|Second Intervention (1 Day)||0
17701|NCT02320838|44258|P4|NOT COMPLETED|Second Intervention (1 Day)||0
17702|NCT02320838|44259|P3|NOT COMPLETED|Second Intervention (1 Day)||0
17703|NCT02320838|44260|P2|NOT COMPLETED|Second Intervention (1 Day)||0
17704|NCT02320838|44261|P1|NOT COMPLETED|Second Intervention (1 Day)||0
17705|NCT02320838|44257|P5|COMPLETED|Second Intervention (1 Day)||7
17706|NCT02320838|44258|P4|COMPLETED|Second Intervention (1 Day)||7
17707|NCT02320838|44259|P3|COMPLETED|Second Intervention (1 Day)||8
17708|NCT02320838|44260|P2|COMPLETED|Second Intervention (1 Day)||8
17709|NCT02320838|44261|P1|COMPLETED|Second Intervention (1 Day)||8
17710|NCT02320838|44257|P5|STARTED|Second Intervention (1 Day)||7
17711|NCT02320838|44258|P4|STARTED|Second Intervention (1 Day)||7
17712|NCT02320838|44259|P3|STARTED|Second Intervention (1 Day)||8
17713|NCT02320838|44260|P2|STARTED|Second Intervention (1 Day)||8
17714|NCT02320838|44261|P1|STARTED|Second Intervention (1 Day)||8
17715|NCT02320838|44257|P5|NOT COMPLETED|Washout (1 Day)||0
17716|NCT02320838|44258|P4|NOT COMPLETED|Washout (1 Day)||0
17717|NCT02320838|44259|P3|NOT COMPLETED|Washout (1 Day)||0
17718|NCT02320838|44260|P2|NOT COMPLETED|Washout (1 Day)||0
17719|NCT02320838|44261|P1|NOT COMPLETED|Washout (1 Day)||0
17720|NCT02320838|44257|P5|COMPLETED|Washout (1 Day)||7
17721|NCT02320838|44258|P4|COMPLETED|Washout (1 Day)||7
17722|NCT02320838|44259|P3|COMPLETED|Washout (1 Day)||8
17723|NCT02320838|44260|P2|COMPLETED|Washout (1 Day)||8
17724|NCT02320838|44261|P1|COMPLETED|Washout (1 Day)||8
17725|NCT02320838|44257|P5|STARTED|Washout (1 Day)||7
17726|NCT02320838|44258|P4|STARTED|Washout (1 Day)||7
17727|NCT02320838|44259|P3|STARTED|Washout (1 Day)||8
17728|NCT02320838|44260|P2|STARTED|Washout (1 Day)||8
17729|NCT02320838|44261|P1|STARTED|Washout (1 Day)||8
17730|NCT02320838|44257|P5|NOT COMPLETED|First Intervention (1 Day)||0
17731|NCT02320838|44258|P4|NOT COMPLETED|First Intervention (1 Day)||0
17732|NCT02320838|44259|P3|NOT COMPLETED|First Intervention (1 Day)||0
17733|NCT02320838|44260|P2|NOT COMPLETED|First Intervention (1 Day)||0
17734|NCT02320838|44261|P1|NOT COMPLETED|First Intervention (1 Day)||0
17735|NCT02320838|44257|P5|COMPLETED|First Intervention (1 Day)||7
17736|NCT02320838|44258|P4|COMPLETED|First Intervention (1 Day)||7
17737|NCT02320838|44259|P3|COMPLETED|First Intervention (1 Day)||8
17738|NCT02320838|44260|P2|COMPLETED|First Intervention (1 Day)||8
17739|NCT02320838|44261|P1|COMPLETED|First Intervention (1 Day)||8
17740|NCT02320838|44257|P5|STARTED|First Intervention (1 Day)||7
17741|NCT02320838|44258|P4|STARTED|First Intervention (1 Day)||7
17742|NCT02320838|44259|P3|STARTED|First Intervention (1 Day)||8
17743|NCT02320838|44260|P2|STARTED|First Intervention (1 Day)||8
17744|NCT02320838|44261|P1|STARTED|First Intervention (1 Day)||8
17745|NCT02320721|44328|P2|NOT COMPLETED|Overall Study||34
17746|NCT02320721|44329|P1|NOT COMPLETED|Overall Study||27
17747|NCT02320721|44328|P2|COMPLETED|Overall Study||472
17748|NCT02320721|44329|P1|COMPLETED|Overall Study||481
17749|NCT02320721|44328|P2|Treated (Safety Population)|Overall Study||505
17750|NCT02320721|44329|P1|Treated (Safety Population)|Overall Study||508
17751|NCT02320721|44328|P2|STARTED|Overall Study||506
17752|NCT02320721|44329|P1|STARTED|Overall Study||508
17753|NCT02320695|44357|P1|NOT COMPLETED|Overall Study||0
17754|NCT02320695|44357|P1|COMPLETED|Overall Study||60
17755|NCT02320695|44357|P1|Pain Relief Ointment|Overall Study||60
17756|NCT02320695|44357|P1|Original Ointment|Overall Study||60
17757|NCT02320695|44357|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
17758|NCT02320695|44357|P1|Pain Relieving Cream|Overall Study||59
17759|NCT02320695|44357|P1|Alcohol|Overall Study||60
17760|NCT02320695|44357|P1|Saline|Overall Study||60
17761|NCT02320695|44357|P1|STARTED|Overall Study||60
17762|NCT02320487|44384|P1|NOT COMPLETED|Overall Study||21
17763|NCT02320487|44384|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
17764|NCT02320487|44384|P1|STARTED|Overall Study||102
17765|NCT02320396|44404|P2|NOT COMPLETED|Overall Study||4
17766|NCT02320396|44405|P1|NOT COMPLETED|Overall Study||4
17767|NCT02320396|44404|P2|COMPLETED|Overall Study||221
17768|NCT02320396|44405|P1|COMPLETED|Overall Study||220
17769|NCT02320396|44404|P2|Treated (Full Analysis Set)|Overall Study||225
17770|NCT02320396|44405|P1|Treated (Full Analysis Set)|Overall Study||223
17771|NCT02320396|44404|P2|STARTED|Overall Study||225
17772|NCT02320396|44405|P1|STARTED|Overall Study||224
17773|NCT02320227|44435|P1|NOT COMPLETED|Overall Study||0
17774|NCT02320227|44435|P1|COMPLETED|Overall Study||30
17775|NCT02320227|44435|P1|STARTED|Overall Study||30
17776|NCT02320214|44440|P1|NOT COMPLETED|Overall Study||0
17777|NCT02320214|44440|P1|COMPLETED|Overall Study||30
17778|NCT02320214|44440|P1|STARTED|Overall Study||30
17779|NCT02320149|44447|P2|NOT COMPLETED|Overall Study||80
17780|NCT02320149|44448|P1|NOT COMPLETED|Overall Study||63
17781|NCT02320149|44447|P2|COMPLETED|Overall Study||405
17782|NCT02320149|44448|P1|COMPLETED|Overall Study||420
17783|NCT02320149|44447|P2|STARTED|Overall Study||485
17784|NCT02320149|44448|P1|STARTED|Overall Study||483
17785|NCT02319824|44486|P1|NOT COMPLETED|Overall Study||0
17786|NCT02319824|44486|P1|COMPLETED|Overall Study||2
17787|NCT02319824|44486|P1|STARTED|Overall Study||2
17788|NCT02319668|44494|P2|NOT COMPLETED|Overall Study||2
17789|NCT02319668|44495|P1|NOT COMPLETED|Overall Study||0
17790|NCT02319668|44494|P2|COMPLETED|Overall Study||17
17791|NCT02319668|44495|P1|COMPLETED|Overall Study||19
17792|NCT02319668|44494|P2|STARTED|Overall Study||19
17793|NCT02319668|44495|P1|STARTED|Overall Study||19
17794|NCT02319525|44509|P2|NOT COMPLETED|Overall Study||1
17795|NCT02319525|44510|P1|NOT COMPLETED|Overall Study||2
17796|NCT02319525|44509|P2|COMPLETED|Overall Study||147
17797|NCT02319525|44510|P1|COMPLETED|Overall Study||151
17798|NCT02319525|44509|P2|Primary Research Completion|Overall Study||147
17799|NCT02319525|44510|P1|Primary Research Completion|Overall Study||151
17800|NCT02319525|44509|P2|STARTED|Overall Study||148
17801|NCT02319525|44510|P1|STARTED|Overall Study||153
17802|NCT02319486|44528|P1|NOT COMPLETED|Overall Study||0
17803|NCT02319486|44528|P1|COMPLETED|Overall Study||26
17804|NCT02319486|44528|P1|STARTED|Overall Study||26
17805|NCT02319317|44536|P2|NOT COMPLETED|Overall Study||0
17806|NCT02319317|44537|P1|NOT COMPLETED|Overall Study||0
17807|NCT02319317|44536|P2|COMPLETED|Overall Study||29
17808|NCT02319317|44537|P1|COMPLETED|Overall Study||31
17809|NCT02319317|44536|P2|STARTED|Overall Study||29
17810|NCT02319317|44537|P1|STARTED|Overall Study||31
17811|NCT02319148|44546|P4|NOT COMPLETED|Second Intervention Period||2
17812|NCT02319148|44547|P3|NOT COMPLETED|Second Intervention Period||1
17813|NCT02319148|44548|P2|NOT COMPLETED|Second Intervention Period||1
17814|NCT02319148|44549|P1|NOT COMPLETED|Second Intervention Period||0
17815|NCT02319148|44546|P4|COMPLETED|Second Intervention Period||6
17816|NCT02319148|44547|P3|COMPLETED|Second Intervention Period||6
17817|NCT02319148|44548|P2|COMPLETED|Second Intervention Period||6
17818|NCT02319148|44549|P1|COMPLETED|Second Intervention Period||0
17819|NCT02319148|44546|P4|STARTED|Second Intervention Period||8
17820|NCT02319148|44547|P3|STARTED|Second Intervention Period||7
17821|NCT02319148|44548|P2|STARTED|Second Intervention Period||7
17822|NCT02319148|44549|P1|STARTED|Second Intervention Period||0
17823|NCT02319148|44546|P4|NOT COMPLETED|Washout Period 4 Days||0
17824|NCT02319148|44547|P3|NOT COMPLETED|Washout Period 4 Days||0
17825|NCT02319148|44548|P2|NOT COMPLETED|Washout Period 4 Days||0
17826|NCT02319148|44549|P1|NOT COMPLETED|Washout Period 4 Days||0
17827|NCT02319148|44546|P4|COMPLETED|Washout Period 4 Days||0
17828|NCT02319148|44547|P3|COMPLETED|Washout Period 4 Days||0
17829|NCT02319148|44548|P2|COMPLETED|Washout Period 4 Days||0
17830|NCT02319148|44549|P1|COMPLETED|Washout Period 4 Days||22
17831|NCT02319148|44546|P4|STARTED|Washout Period 4 Days||0
17832|NCT02319148|44547|P3|STARTED|Washout Period 4 Days||0
17833|NCT02319148|44548|P2|STARTED|Washout Period 4 Days||0
17834|NCT02319148|44549|P1|STARTED|Washout Period 4 Days||22
17835|NCT02319148|44546|P4|NOT COMPLETED|First Intervention Period||0
17836|NCT02319148|44547|P3|NOT COMPLETED|First Intervention Period||0
17837|NCT02319148|44548|P2|NOT COMPLETED|First Intervention Period||0
17838|NCT02319148|44549|P1|NOT COMPLETED|First Intervention Period||0
17839|NCT02319148|44546|P4|COMPLETED|First Intervention Period||0
17840|NCT02319148|44547|P3|COMPLETED|First Intervention Period||0
17841|NCT02319148|44548|P2|COMPLETED|First Intervention Period||0
17842|NCT02319148|44549|P1|COMPLETED|First Intervention Period||22
17843|NCT02319148|44546|P4|STARTED|First Intervention Period||0
17844|NCT02319148|44547|P3|STARTED|First Intervention Period||0
17845|NCT02319148|44548|P2|STARTED|First Intervention Period||0
17846|NCT02319148|44549|P1|STARTED|First Intervention Period||22
17847|NCT02319031|44611|P2|NOT COMPLETED|Follow-Up Period||0
17848|NCT02319031|44612|P1|NOT COMPLETED|Follow-Up Period||0
17849|NCT02319031|44611|P2|COMPLETED|Follow-Up Period||26
17850|NCT02319031|44612|P1|COMPLETED|Follow-Up Period||23
17851|NCT02319031|44611|P2|STARTED|Follow-Up Period||26
17852|NCT02319031|44612|P1|STARTED|Follow-Up Period||23
17853|NCT02319031|44611|P2|NOT COMPLETED|Treatment Period||0
17854|NCT02319031|44612|P1|NOT COMPLETED|Treatment Period||1
17855|NCT02319031|44611|P2|COMPLETED|Treatment Period||26
17856|NCT02319031|44612|P1|COMPLETED|Treatment Period||23
17857|NCT02319031|44611|P2|STARTED|Treatment Period||26
17858|NCT02319031|44612|P1|STARTED|Treatment Period||24
17859|NCT02318940|44624|P2|NOT COMPLETED|Overall Study||0
17860|NCT02318940|44625|P1|NOT COMPLETED|Overall Study||1
17861|NCT02318940|44624|P2|COMPLETED|Overall Study||50
17862|NCT02318940|44625|P1|COMPLETED|Overall Study||49
17863|NCT02318940|44624|P2|STARTED|Overall Study||50
17864|NCT02318940|44625|P1|STARTED|Overall Study|in the last patient we lost the record.|50
17865|NCT02318797|44639|P2|NOT COMPLETED|Overall Study||102
17866|NCT02318797|44640|P1|NOT COMPLETED|Overall Study||88
17867|NCT02318797|44639|P2|COMPLETED|Overall Study||611
17868|NCT02318797|44640|P1|COMPLETED|Overall Study||428
17869|NCT02318797|44639|P2|STARTED|Overall Study||713
17870|NCT02318797|44640|P1|STARTED|Overall Study||516
17871|NCT02318693|44680|P2|NOT COMPLETED|Overall Study||1
17872|NCT02318693|44681|P1|NOT COMPLETED|Overall Study||0
17873|NCT02318693|44680|P2|COMPLETED|Overall Study||26
17874|NCT02318693|44681|P1|COMPLETED|Overall Study||26
17875|NCT02318693|44680|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
17876|NCT02318693|44681|P1|Treated|Overall Study||26
17877|NCT02318693|44680|P2|STARTED|Overall Study||27
17878|NCT02318693|44681|P1|STARTED|Overall Study||26
17879|NCT02318303|44702|P7|NOT COMPLETED|Overall Study||2
17880|NCT02318303|44703|P6|NOT COMPLETED|Overall Study||6
17881|NCT02318303|44704|P5|NOT COMPLETED|Overall Study||5
17882|NCT02318303|44705|P4|NOT COMPLETED|Overall Study||3
17883|NCT02318303|44706|P3|NOT COMPLETED|Overall Study||3
17884|NCT02318303|44707|P2|NOT COMPLETED|Overall Study||3
17885|NCT02318303|44708|P1|NOT COMPLETED|Overall Study||4
17886|NCT02318303|44702|P7|COMPLETED|Overall Study||158
17887|NCT02318303|44703|P6|COMPLETED|Overall Study||153
17888|NCT02318303|44704|P5|COMPLETED|Overall Study||152
17889|NCT02318303|44705|P4|COMPLETED|Overall Study||155
17890|NCT02318303|44706|P3|COMPLETED|Overall Study||157
17891|NCT02318303|44707|P2|COMPLETED|Overall Study||155
17892|NCT02318303|44708|P1|COMPLETED|Overall Study||155
17893|NCT02318303|44702|P7|STARTED|Overall Study||160
17894|NCT02318303|44703|P6|STARTED|Overall Study||159
17895|NCT02318303|44704|P5|STARTED|Overall Study||157
17896|NCT02318303|44705|P4|STARTED|Overall Study||158
17897|NCT02318303|44706|P3|STARTED|Overall Study||160
17898|NCT02318303|44707|P2|STARTED|Overall Study||158
17899|NCT02318303|44708|P1|STARTED|Overall Study||159
17900|NCT02317809|44724|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
17901|NCT02317809|44725|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
17902|NCT02317809|44724|P2|COMPLETED|Second Intervention Period (8 Days)||17
17903|NCT02317809|44725|P1|COMPLETED|Second Intervention Period (8 Days)||14
17904|NCT02317809|44724|P2|STARTED|Second Intervention Period (8 Days)||17
17905|NCT02317809|44725|P1|STARTED|Second Intervention Period (8 Days)||14
17906|NCT02317809|44724|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
17907|NCT02317809|44725|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
17908|NCT02317809|44724|P2|COMPLETED|First Intervention Period (8 Days)||17
17909|NCT02317809|44725|P1|COMPLETED|First Intervention Period (8 Days)||14
17910|NCT02317809|44724|P2|STARTED|First Intervention Period (8 Days)||17
17911|NCT02317809|44725|P1|STARTED|First Intervention Period (8 Days)||17
17912|NCT02317744|44769|P2|NOT COMPLETED|Overall Study||2
17913|NCT02317744|44770|P1|NOT COMPLETED|Overall Study||1
17914|NCT02317744|44769|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
17915|NCT02317744|44770|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
17916|NCT02317744|44769|P2|Completed Treatment|Overall Study||7
17917|NCT02317744|44770|P1|Completed Treatment|Overall Study||10
17918|NCT02317744|44769|P2|STARTED|Overall Study||10
17919|NCT02317744|44770|P1|STARTED|Overall Study||12
17920|NCT02317692|44784|P2|NOT COMPLETED|Overall Study||0
17921|NCT02317692|44785|P1|NOT COMPLETED|Overall Study||6
17922|NCT02317692|44784|P2|COMPLETED|Overall Study||77
17923|NCT02317692|44785|P1|COMPLETED|Overall Study||63
17924|NCT02317692|44784|P2|STARTED|Overall Study||77
17925|NCT02317692|44785|P1|STARTED|Overall Study||69
17926|NCT02317549|44805|P2|NOT COMPLETED|Overall Study||0
17927|NCT02317549|44806|P1|NOT COMPLETED|Overall Study||0
17928|NCT02317549|44805|P2|COMPLETED|Overall Study||3
17929|NCT02317549|44806|P1|COMPLETED|Overall Study||5
17930|NCT02317549|44805|P2|STARTED|Overall Study||3
17931|NCT02317549|44806|P1|STARTED|Overall Study||5
17932|NCT02317510|44814|P2|NOT COMPLETED|Overall Study||1
17933|NCT02317510|44815|P1|NOT COMPLETED|Overall Study||0
17934|NCT02317510|44814|P2|COMPLETED|Overall Study||24
17935|NCT02317510|44815|P1|COMPLETED|Overall Study||25
17936|NCT02317510|44814|P2|STARTED|Overall Study||25
17937|NCT02317510|44815|P1|STARTED|Overall Study||25
17938|NCT02317016|44843|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
17939|NCT02317016|44843|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
17940|NCT02317016|44843|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
17941|NCT02317016|44843|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
17942|NCT02317016|44843|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
17943|NCT02317016|44843|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
17944|NCT02317016|44843|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
17945|NCT02317016|44843|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
17946|NCT02317016|44843|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
17947|NCT02317016|44843|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
17948|NCT02317016|44843|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
17949|NCT02317016|44843|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
17950|NCT02316769|44871|P2|NOT COMPLETED|Overall Study||0
17951|NCT02316769|44872|P1|NOT COMPLETED|Overall Study||2
17952|NCT02316769|44871|P2|COMPLETED|Overall Study||33
17953|NCT02316769|44872|P1|COMPLETED|Overall Study||31
17954|NCT02316769|44871|P2|STARTED|Overall Study||33
17955|NCT02316769|44872|P1|STARTED|Overall Study||33
17956|NCT02316678|44882|P2|NOT COMPLETED|Overall Study||0
17957|NCT02316678|44883|P1|NOT COMPLETED|Overall Study||0
17958|NCT02316678|44882|P2|COMPLETED|Overall Study||7694
17959|NCT02316678|44883|P1|COMPLETED|Overall Study||1879
17960|NCT02316678|44882|P2|STARTED|Overall Study||7694
17961|NCT02316678|44883|P1|STARTED|Overall Study||1879
17962|NCT02316613|44889|P1|NOT COMPLETED|Overall Study||104
17963|NCT02316613|44889|P1|COMPLETED|Overall Study||156
17964|NCT02316613|44889|P1|Overall Population|Overall Study||241
17965|NCT02316613|44889|P1|Safety Population|Overall Study||255
17966|NCT02316613|44889|P1|STARTED|Overall Study||260
17967|NCT02316548|44928|P2|NOT COMPLETED|Overall Study||1
17968|NCT02316548|44929|P1|NOT COMPLETED|Overall Study||0
17969|NCT02316548|44928|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
17970|NCT02316548|44929|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
17971|NCT02316548|44928|P2|Eligible With Adverse Event Data|Overall Study||2
17972|NCT02316548|44929|P1|Eligible With Adverse Event Data|Overall Study||4
17973|NCT02316548|44928|P2|Eligible With Disease Assessment|Overall Study||1
17974|NCT02316548|44929|P1|Eligible With Disease Assessment|Overall Study||4
17975|NCT02316548|44928|P2|Eligible Population|Overall Study||6
17976|NCT02316548|44929|P1|Eligible Population|Overall Study||6
17977|NCT02316548|44928|P2|STARTED|Overall Study|Randomized|7
17978|NCT02316548|44929|P1|STARTED|Overall Study|Randomized|6
17979|NCT02316470|44943|P4|NOT COMPLETED|Overall Study||2
17980|NCT02316470|44944|P3|NOT COMPLETED|Overall Study||5
17981|NCT02316470|44945|P2|NOT COMPLETED|Overall Study||6
17982|NCT02316470|44946|P1|NOT COMPLETED|Overall Study||5
17983|NCT02316470|44943|P4|COMPLETED|Overall Study||46
17984|NCT02316470|44944|P3|COMPLETED|Overall Study||147
17985|NCT02316470|44945|P2|COMPLETED|Overall Study||146
17986|NCT02316470|44946|P1|COMPLETED|Overall Study||143
17987|NCT02316470|44943|P4|STARTED|Overall Study||48
17988|NCT02316470|44944|P3|STARTED|Overall Study||152
17989|NCT02316470|44945|P2|STARTED|Overall Study||152
17990|NCT02316470|44946|P1|STARTED|Overall Study||148
17991|NCT02316366|45042|P2|NOT COMPLETED|Overall Study||0
17992|NCT02316366|45043|P1|NOT COMPLETED|Overall Study||0
17993|NCT02316366|45042|P2|COMPLETED|Overall Study||40
17994|NCT02316366|45043|P1|COMPLETED|Overall Study||40
17995|NCT02316366|45042|P2|STARTED|Overall Study||40
17996|NCT02316366|45043|P1|STARTED|Overall Study||40
17997|NCT02315989|45053|P1|NOT COMPLETED|Overall Study||0
17998|NCT02315989|45053|P1|COMPLETED|Overall Study||6
17999|NCT02315989|45053|P1|STARTED|Overall Study||6
18000|NCT02315352|45063|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
18001|NCT02315352|45064|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
18002|NCT02315352|45065|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
18003|NCT02315352|45066|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
18004|NCT02315352|45067|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
18005|NCT02315352|45068|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
18006|NCT02315352|45069|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
18007|NCT02315352|45070|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
18008|NCT02315352|45063|P8|COMPLETED|Fifth Intervention (Day 2)||8
18009|NCT02315352|45064|P7|COMPLETED|Fifth Intervention (Day 2)||9
18010|NCT02315352|45065|P6|COMPLETED|Fifth Intervention (Day 2)||7
18011|NCT02315352|45066|P5|COMPLETED|Fifth Intervention (Day 2)||8
18012|NCT02315352|45067|P4|COMPLETED|Fifth Intervention (Day 2)||8
18013|NCT02315352|45068|P3|COMPLETED|Fifth Intervention (Day 2)||7
18014|NCT02315352|45069|P2|COMPLETED|Fifth Intervention (Day 2)||0
18015|NCT02315352|45070|P1|COMPLETED|Fifth Intervention (Day 2)||0
18016|NCT02315352|45063|P8|STARTED|Fifth Intervention (Day 2)||8
18017|NCT02315352|45064|P7|STARTED|Fifth Intervention (Day 2)||9
18018|NCT02315352|45065|P6|STARTED|Fifth Intervention (Day 2)||7
18019|NCT02315352|45066|P5|STARTED|Fifth Intervention (Day 2)||8
18020|NCT02315352|45067|P4|STARTED|Fifth Intervention (Day 2)||8
18021|NCT02315352|45068|P3|STARTED|Fifth Intervention (Day 2)||7
18022|NCT02315352|45069|P2|STARTED|Fifth Intervention (Day 2)||0
18023|NCT02315352|45070|P1|STARTED|Fifth Intervention (Day 2)||0
18024|NCT02315352|45063|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
18025|NCT02315352|45064|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
18026|NCT02315352|45065|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
18027|NCT02315352|45066|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
18028|NCT02315352|45067|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
18029|NCT02315352|45068|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
18030|NCT02315352|45069|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
18031|NCT02315352|45070|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
18032|NCT02315352|45063|P8|COMPLETED|Fourth Intervention (Day 2)||8
18033|NCT02315352|45064|P7|COMPLETED|Fourth Intervention (Day 2)||9
18034|NCT02315352|45065|P6|COMPLETED|Fourth Intervention (Day 2)||7
18035|NCT02315352|45066|P5|COMPLETED|Fourth Intervention (Day 2)||8
18036|NCT02315352|45067|P4|COMPLETED|Fourth Intervention (Day 2)||8
18037|NCT02315352|45068|P3|COMPLETED|Fourth Intervention (Day 2)||7
18038|NCT02315352|45069|P2|COMPLETED|Fourth Intervention (Day 2)||0
18039|NCT02315352|45070|P1|COMPLETED|Fourth Intervention (Day 2)||0
18040|NCT02315352|45063|P8|STARTED|Fourth Intervention (Day 2)||8
18041|NCT02315352|45064|P7|STARTED|Fourth Intervention (Day 2)||9
18042|NCT02315352|45065|P6|STARTED|Fourth Intervention (Day 2)||7
18043|NCT02315352|45066|P5|STARTED|Fourth Intervention (Day 2)||8
18044|NCT02315352|45067|P4|STARTED|Fourth Intervention (Day 2)||8
18045|NCT02315352|45068|P3|STARTED|Fourth Intervention (Day 2)||7
18046|NCT02315352|45069|P2|STARTED|Fourth Intervention (Day 2)||0
18047|NCT02315352|45070|P1|STARTED|Fourth Intervention (Day 2)||0
18048|NCT02315352|45063|P8|NOT COMPLETED|Third Intervention (Day 2)||0
18049|NCT02315352|45064|P7|NOT COMPLETED|Third Intervention (Day 2)||0
18050|NCT02315352|45065|P6|NOT COMPLETED|Third Intervention (Day 2)||0
18051|NCT02315352|45066|P5|NOT COMPLETED|Third Intervention (Day 2)||0
18052|NCT02315352|45067|P4|NOT COMPLETED|Third Intervention (Day 2)||0
18053|NCT02315352|45068|P3|NOT COMPLETED|Third Intervention (Day 2)||0
18054|NCT02315352|45069|P2|NOT COMPLETED|Third Intervention (Day 2)||0
18055|NCT02315352|45070|P1|NOT COMPLETED|Third Intervention (Day 2)||0
18056|NCT02315352|45063|P8|COMPLETED|Third Intervention (Day 2)||8
18057|NCT02315352|45064|P7|COMPLETED|Third Intervention (Day 2)||9
18058|NCT02315352|45065|P6|COMPLETED|Third Intervention (Day 2)||7
18059|NCT02315352|45066|P5|COMPLETED|Third Intervention (Day 2)||8
18060|NCT02315352|45067|P4|COMPLETED|Third Intervention (Day 2)||8
18061|NCT02315352|45068|P3|COMPLETED|Third Intervention (Day 2)||7
18062|NCT02315352|45069|P2|COMPLETED|Third Intervention (Day 2)||0
18063|NCT02315352|45070|P1|COMPLETED|Third Intervention (Day 2)||0
18064|NCT02315352|45063|P8|STARTED|Third Intervention (Day 2)||8
18065|NCT02315352|45064|P7|STARTED|Third Intervention (Day 2)||9
18066|NCT02315352|45065|P6|STARTED|Third Intervention (Day 2)||7
18067|NCT02315352|45066|P5|STARTED|Third Intervention (Day 2)||8
18068|NCT02315352|45067|P4|STARTED|Third Intervention (Day 2)||8
18069|NCT02315352|45068|P3|STARTED|Third Intervention (Day 2)||7
18070|NCT02315352|45069|P2|STARTED|Third Intervention (Day 2)||0
18071|NCT02315352|45070|P1|STARTED|Third Intervention (Day 2)||0
18072|NCT02315352|45063|P8|NOT COMPLETED|Second Intervention (Day 1)||0
18073|NCT02315352|45064|P7|NOT COMPLETED|Second Intervention (Day 1)||0
18074|NCT02315352|45065|P6|NOT COMPLETED|Second Intervention (Day 1)||0
18075|NCT02315352|45066|P5|NOT COMPLETED|Second Intervention (Day 1)||0
18076|NCT02315352|45067|P4|NOT COMPLETED|Second Intervention (Day 1)||0
18077|NCT02315352|45068|P3|NOT COMPLETED|Second Intervention (Day 1)||0
18078|NCT02315352|45069|P2|NOT COMPLETED|Second Intervention (Day 1)||0
18079|NCT02315352|45070|P1|NOT COMPLETED|Second Intervention (Day 1)||0
18080|NCT02315352|45063|P8|COMPLETED|Second Intervention (Day 1)||0
18081|NCT02315352|45064|P7|COMPLETED|Second Intervention (Day 1)||0
18082|NCT02315352|45065|P6|COMPLETED|Second Intervention (Day 1)||0
18083|NCT02315352|45066|P5|COMPLETED|Second Intervention (Day 1)||0
18084|NCT02315352|45067|P4|COMPLETED|Second Intervention (Day 1)||0
18085|NCT02315352|45068|P3|COMPLETED|Second Intervention (Day 1)||0
18086|NCT02315352|45069|P2|COMPLETED|Second Intervention (Day 1)||24
18087|NCT02315352|45070|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
18088|NCT02315352|45063|P8|STARTED|Second Intervention (Day 1)||0
18089|NCT02315352|45064|P7|STARTED|Second Intervention (Day 1)||0
18090|NCT02315352|45065|P6|STARTED|Second Intervention (Day 1)||0
18091|NCT02315352|45066|P5|STARTED|Second Intervention (Day 1)||0
18092|NCT02315352|45067|P4|STARTED|Second Intervention (Day 1)||0
18093|NCT02315352|45068|P3|STARTED|Second Intervention (Day 1)||0
18094|NCT02315352|45069|P2|STARTED|Second Intervention (Day 1)||24
18095|NCT02315352|45070|P1|STARTED|Second Intervention (Day 1)||24
18096|NCT02315352|45063|P8|NOT COMPLETED|First Intervention (Day 1)||0
18097|NCT02315352|45064|P7|NOT COMPLETED|First Intervention (Day 1)||0
18098|NCT02315352|45065|P6|NOT COMPLETED|First Intervention (Day 1)||0
18099|NCT02315352|45066|P5|NOT COMPLETED|First Intervention (Day 1)||0
18100|NCT02315352|45067|P4|NOT COMPLETED|First Intervention (Day 1)||0
18101|NCT02315352|45068|P3|NOT COMPLETED|First Intervention (Day 1)||0
18102|NCT02315352|45069|P2|NOT COMPLETED|First Intervention (Day 1)||0
18103|NCT02315352|45070|P1|NOT COMPLETED|First Intervention (Day 1)||0
18104|NCT02315352|45063|P8|COMPLETED|First Intervention (Day 1)||0
18105|NCT02315352|45064|P7|COMPLETED|First Intervention (Day 1)||0
18106|NCT02315352|45065|P6|COMPLETED|First Intervention (Day 1)||0
18107|NCT02315352|45066|P5|COMPLETED|First Intervention (Day 1)||0
18108|NCT02315352|45067|P4|COMPLETED|First Intervention (Day 1)||0
18109|NCT02315352|45068|P3|COMPLETED|First Intervention (Day 1)||0
18110|NCT02315352|45069|P2|COMPLETED|First Intervention (Day 1)||24
18111|NCT02315352|45070|P1|COMPLETED|First Intervention (Day 1)||24
18112|NCT02315352|45063|P8|STARTED|First Intervention (Day 1)||0
18113|NCT02315352|45064|P7|STARTED|First Intervention (Day 1)||0
18114|NCT02315352|45065|P6|STARTED|First Intervention (Day 1)||0
18115|NCT02315352|45066|P5|STARTED|First Intervention (Day 1)||0
18116|NCT02315352|45067|P4|STARTED|First Intervention (Day 1)||0
18117|NCT02315352|45068|P3|STARTED|First Intervention (Day 1)||0
18118|NCT02315352|45069|P2|STARTED|First Intervention (Day 1)||24
18119|NCT02315352|45070|P1|STARTED|First Intervention (Day 1)||24
18120|NCT02314689|45097|P1|NOT COMPLETED|Overall Study||0
18121|NCT02314689|45097|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
18122|NCT02314689|45097|P1|STARTED|Overall Study||4
18123|NCT02314637|45103|P2|NOT COMPLETED|Overall Study||14
18124|NCT02314637|45104|P1|NOT COMPLETED|Overall Study||16
18125|NCT02314637|45103|P2|COMPLETED|Overall Study||75
18126|NCT02314637|45104|P1|COMPLETED|Overall Study||135
18127|NCT02314637|45103|P2|STARTED|Overall Study||89
18128|NCT02314637|45104|P1|STARTED|Overall Study||151
18129|NCT02314546|45117|P3|NOT COMPLETED|Overall Study||0
18130|NCT02314546|45118|P2|NOT COMPLETED|Overall Study||0
18131|NCT02314546|45119|P1|NOT COMPLETED|Overall Study||0
18132|NCT02314546|45117|P3|COMPLETED|Overall Study||5
18133|NCT02314546|45118|P2|COMPLETED|Overall Study||5
18134|NCT02314546|45119|P1|COMPLETED|Overall Study||5
18135|NCT02314546|45117|P3|STARTED|Overall Study||5
18136|NCT02314546|45118|P2|STARTED|Overall Study||5
18137|NCT02314546|45119|P1|STARTED|Overall Study||5
18138|NCT02314520|45147|P2|NOT COMPLETED|Overall Study||0
18139|NCT02314520|45148|P1|NOT COMPLETED|Overall Study||0
18140|NCT02314520|45147|P2|COMPLETED|Overall Study||80
18141|NCT02314520|45148|P1|COMPLETED|Overall Study||72
18142|NCT02314520|45147|P2|STARTED|Overall Study||80
18143|NCT02314520|45148|P1|STARTED|Overall Study||72
18144|NCT02314260|45160|P1|NOT COMPLETED|Overall Study||0
18145|NCT02314260|45160|P1|COMPLETED|Overall Study||80
18146|NCT02314260|45160|P1|STARTED|Overall Study||80
18147|NCT02314117|45169|P2|NOT COMPLETED|Overall Study||38
18148|NCT02314117|45170|P1|NOT COMPLETED|Overall Study||41
18149|NCT02314117|45169|P2|COMPLETED|Overall Study||281
18150|NCT02314117|45170|P1|COMPLETED|Overall Study||285
18151|NCT02314117|45169|P2|Alive But Off Treatment|Overall Study||50
18152|NCT02314117|45170|P1|Alive But Off Treatment|Overall Study||46
18153|NCT02314117|45169|P2|Death|Overall Study||231
18154|NCT02314117|45170|P1|Death|Overall Study||239
18155|NCT02314117|45169|P2|Received at Least One Dose of Study Drug|Overall Study||315
18156|NCT02314117|45170|P1|Received at Least One Dose of Study Drug|Overall Study||323
18157|NCT02314117|45169|P2|STARTED|Overall Study||319
18158|NCT02314117|45170|P1|STARTED|Overall Study||326
18159|NCT02314104|45201|P3|NOT COMPLETED|Overall Study||18
18160|NCT02314104|45202|P2|NOT COMPLETED|Overall Study||20
18161|NCT02314104|45203|P1|NOT COMPLETED|Overall Study||14
18162|NCT02314104|45201|P3|COMPLETED|Overall Study||53
18163|NCT02314104|45202|P2|COMPLETED|Overall Study||58
18164|NCT02314104|45203|P1|COMPLETED|Overall Study||57
18165|NCT02314104|45201|P3|STARTED|Overall Study||71
18166|NCT02314104|45202|P2|STARTED|Overall Study||78
18167|NCT02314104|45203|P1|STARTED|Overall Study||71
18168|NCT02313766|45226|P3|NOT COMPLETED|Overall Study||0
18169|NCT02313766|45227|P2|NOT COMPLETED|Overall Study||3
18170|NCT02313766|45228|P1|NOT COMPLETED|Overall Study||1
18171|NCT02313766|45226|P3|COMPLETED|Overall Study||50
18172|NCT02313766|45227|P2|COMPLETED|Overall Study||47
18173|NCT02313766|45228|P1|COMPLETED|Overall Study||49
18174|NCT02313766|45226|P3|STARTED|Overall Study||50
18175|NCT02313766|45227|P2|STARTED|Overall Study||50
18176|NCT02313766|45228|P1|STARTED|Overall Study||50
18177|NCT02313675|45246|P4|NOT COMPLETED|Overall Study||0
18178|NCT02313675|45247|P3|NOT COMPLETED|Overall Study||0
18179|NCT02313675|45248|P2|NOT COMPLETED|Overall Study||0
18180|NCT02313675|45249|P1|NOT COMPLETED|Overall Study||0
18181|NCT02313675|45246|P4|COMPLETED|Overall Study||11
18182|NCT02313675|45247|P3|COMPLETED|Overall Study||11
18183|NCT02313675|45248|P2|COMPLETED|Overall Study||11
18184|NCT02313675|45249|P1|COMPLETED|Overall Study||11
18185|NCT02313675|45246|P4|STARTED|Overall Study||11
18186|NCT02313675|45247|P3|STARTED|Overall Study||11
18187|NCT02313675|45248|P2|STARTED|Overall Study||11
18188|NCT02313675|45249|P1|STARTED|Overall Study||11
18189|NCT02313558|45265|P2|NOT COMPLETED|Overall Study||4
18190|NCT02313558|45266|P1|NOT COMPLETED|Overall Study||6
18191|NCT02313558|45265|P2|COMPLETED|Overall Study||46
18192|NCT02313558|45266|P1|COMPLETED|Overall Study||44
18193|NCT02313558|45265|P2|STARTED|Overall Study||50
18194|NCT02313558|45266|P1|STARTED|Overall Study||50
18195|NCT02313233|45280|P2|NOT COMPLETED|Overall Study||3
18196|NCT02313233|45281|P1|NOT COMPLETED|Overall Study||2
18197|NCT02313233|45280|P2|COMPLETED|Overall Study||18
18198|NCT02313233|45281|P1|COMPLETED|Overall Study||18
18199|NCT02313233|45280|P2|STARTED|Overall Study||21
18200|NCT02313233|45281|P1|STARTED|Overall Study||20
18201|NCT02313155|45303|P2|NOT COMPLETED|Overall Study||1
18202|NCT02313155|45304|P1|NOT COMPLETED|Overall Study||0
18203|NCT02313155|45303|P2|COMPLETED|Overall Study||54
18204|NCT02313155|45304|P1|COMPLETED|Overall Study||55
18205|NCT02313155|45303|P2|STARTED|Overall Study||55
18206|NCT02313155|45304|P1|STARTED|Overall Study||55
18207|NCT02312882|45352|P1|NOT COMPLETED|Overall Study||4
18208|NCT02312882|45352|P1|COMPLETED|Overall Study||36
18209|NCT02312882|45352|P1|STARTED|Overall Study||40
18210|NCT02312739|45358|P2|NOT COMPLETED|Overall Study||2
18211|NCT02312739|45359|P1|NOT COMPLETED|Overall Study||6
18212|NCT02312739|45358|P2|COMPLETED|Overall Study||34
18213|NCT02312739|45359|P1|COMPLETED|Overall Study||30
18214|NCT02312739|45358|P2|Withdrawn Prior to Procedure|Overall Study||2
18215|NCT02312739|45359|P1|Withdrawn Prior to Procedure|Overall Study||6
18216|NCT02312739|45358|P2|STARTED|Overall Study||36
18217|NCT02312739|45359|P1|STARTED|Overall Study||36
18218|NCT02312726|45373|P3|NOT COMPLETED|Overall Study||67
18219|NCT02312726|45374|P2|NOT COMPLETED|Overall Study||0
18220|NCT02312726|45375|P1|NOT COMPLETED|Overall Study||0
18221|NCT02312726|45373|P3|COMPLETED|Overall Study||0
18222|NCT02312726|45374|P2|COMPLETED|Overall Study||30
18223|NCT02312726|45375|P1|COMPLETED|Overall Study||38
18224|NCT02312726|45373|P3|STARTED|Overall Study||67
18225|NCT02312726|45374|P2|STARTED|Overall Study||30
18226|NCT02312726|45375|P1|STARTED|Overall Study||38
18227|NCT02312713|45390|P3|NOT COMPLETED|Overall Study||5
18228|NCT02312713|45391|P2|NOT COMPLETED|Overall Study||30
18229|NCT02312713|45392|P1|NOT COMPLETED|Overall Study||11
18230|NCT02312713|45390|P3|COMPLETED|Overall Study||63
18231|NCT02312713|45391|P2|COMPLETED|Overall Study||112
18232|NCT02312713|45392|P1|COMPLETED|Overall Study||129
18233|NCT02312713|45390|P3|STARTED|Overall Study||68
18234|NCT02312713|45391|P2|STARTED|Overall Study||142
18235|NCT02312713|45392|P1|STARTED|Overall Study||140
18236|NCT02312154|45436|P1|NOT COMPLETED|Overall Study||1
18237|NCT02312154|45436|P1|COMPLETED|Overall Study||24
18238|NCT02312154|45436|P1|STARTED|Overall Study||25
18239|NCT02311972|45453|P2|NOT COMPLETED|Overall Study||0
18240|NCT02311972|45454|P1|NOT COMPLETED|Overall Study||0
18241|NCT02311972|45453|P2|COMPLETED|Overall Study||8
18242|NCT02311972|45454|P1|COMPLETED|Overall Study||12
18243|NCT02311972|45453|P2|STARTED|Overall Study||8
18244|NCT02311972|45454|P1|STARTED|Overall Study||12
18245|NCT02311907|45473|P2|NOT COMPLETED|Overall Study||0
18246|NCT02311907|45474|P1|NOT COMPLETED|Overall Study||0
18247|NCT02311907|45473|P2|COMPLETED|Overall Study||91
18248|NCT02311907|45474|P1|COMPLETED|Overall Study||94
18249|NCT02311907|45473|P2|STARTED|Overall Study||91
18250|NCT02311907|45474|P1|STARTED|Overall Study||94
18251|NCT02311881|45499|P3|NOT COMPLETED|Overall Study||41
18252|NCT02311881|45500|P2|NOT COMPLETED|Overall Study||43
18253|NCT02311881|45501|P1|NOT COMPLETED|Overall Study||35
18254|NCT02311881|45499|P3|COMPLETED|Overall Study||196
18255|NCT02311881|45500|P2|COMPLETED|Overall Study||193
18256|NCT02311881|45501|P1|COMPLETED|Overall Study||200
18257|NCT02311881|45499|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
18258|NCT02311881|45500|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
18259|NCT02311881|45501|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
18260|NCT02311881|45499|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
18261|NCT02311881|45500|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
18262|NCT02311881|45501|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
18263|NCT02311309|45539|P3|NOT COMPLETED|Overall Study||0
18264|NCT02311309|45540|P2|NOT COMPLETED|Overall Study||0
18265|NCT02311309|45541|P1|NOT COMPLETED|Overall Study||0
18266|NCT02311309|45539|P3|COMPLETED|Overall Study||863
18267|NCT02311309|45540|P2|COMPLETED|Overall Study||35
18268|NCT02311309|45541|P1|COMPLETED|Overall Study||541
18269|NCT02311309|45539|P3|STARTED|Overall Study||863
18270|NCT02311309|45540|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
18271|NCT02311309|45541|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
18272|NCT02310789|45552|P1|NOT COMPLETED|Overall Study||1
18273|NCT02310789|45552|P1|COMPLETED|Overall Study||7
18274|NCT02310789|45552|P1|STARTED|Overall Study||8
18275|NCT02310776|45557|P1|NOT COMPLETED|Overall Study||0
18276|NCT02310776|45557|P1|COMPLETED|Overall Study||501
18277|NCT02310776|45557|P1|STARTED|Overall Study||501
18278|NCT02310750|45572|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
18279|NCT02310750|45573|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
18280|NCT02310750|45574|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
18281|NCT02310750|45575|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
18282|NCT02310750|45576|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
18283|NCT02310750|45577|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
18284|NCT02310750|45578|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
18285|NCT02310750|45579|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
18286|NCT02310750|45580|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
18287|NCT02310750|45581|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
18288|NCT02310750|45582|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
18289|NCT02310750|45583|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
18290|NCT02310750|45584|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
18291|NCT02310750|45585|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
18292|NCT02310750|45586|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
18293|NCT02310750|45587|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
18294|NCT02310750|45572|P16|COMPLETED|HP MAD and Fasted/Fed||2
18295|NCT02310750|45573|P15|COMPLETED|HP MAD and Fasted/Fed||2
18296|NCT02310750|45574|P14|COMPLETED|HP MAD and Fasted/Fed||2
18297|NCT02310750|45575|P13|COMPLETED|HP MAD and Fasted/Fed||2
18298|NCT02310750|45576|P12|COMPLETED|HP MAD and Fasted/Fed||2
18299|NCT02310750|45577|P11|COMPLETED|HP MAD and Fasted/Fed||2
18300|NCT02310750|45578|P10|COMPLETED|HP MAD and Fasted/Fed||0
18301|NCT02310750|45579|P9|COMPLETED|HP MAD and Fasted/Fed||0
18302|NCT02310750|45580|P8|COMPLETED|HP MAD and Fasted/Fed||0
18303|NCT02310750|45581|P7|COMPLETED|HP MAD and Fasted/Fed||2
18304|NCT02310750|45582|P6|COMPLETED|HP MAD and Fasted/Fed||0
18305|NCT02310750|45583|P5|COMPLETED|HP MAD and Fasted/Fed||4
18306|NCT02310750|45584|P4|COMPLETED|HP MAD and Fasted/Fed||0
18307|NCT02310750|45585|P3|COMPLETED|HP MAD and Fasted/Fed||0
18308|NCT02310750|45586|P2|COMPLETED|HP MAD and Fasted/Fed||0
18309|NCT02310750|45587|P1|COMPLETED|HP MAD and Fasted/Fed||0
18310|NCT02310750|45572|P16|STARTED|HP MAD and Fasted/Fed||2
18311|NCT02310750|45573|P15|STARTED|HP MAD and Fasted/Fed||2
18312|NCT02310750|45574|P14|STARTED|HP MAD and Fasted/Fed||2
18313|NCT02310750|45575|P13|STARTED|HP MAD and Fasted/Fed||2
18314|NCT02310750|45576|P12|STARTED|HP MAD and Fasted/Fed||2
18315|NCT02310750|45577|P11|STARTED|HP MAD and Fasted/Fed||2
18316|NCT02310750|45578|P10|STARTED|HP MAD and Fasted/Fed||0
18317|NCT02310750|45579|P9|STARTED|HP MAD and Fasted/Fed||0
18318|NCT02310750|45580|P8|STARTED|HP MAD and Fasted/Fed||0
18319|NCT02310750|45581|P7|STARTED|HP MAD and Fasted/Fed||2
18320|NCT02310750|45582|P6|STARTED|HP MAD and Fasted/Fed||0
18321|NCT02310750|45583|P5|STARTED|HP MAD and Fasted/Fed||5
18322|NCT02310750|45584|P4|STARTED|HP MAD and Fasted/Fed||0
18323|NCT02310750|45585|P3|STARTED|HP MAD and Fasted/Fed||0
18324|NCT02310750|45586|P2|STARTED|HP MAD and Fasted/Fed||0
18325|NCT02310750|45587|P1|STARTED|HP MAD and Fasted/Fed||0
18326|NCT02310750|45572|P16|NOT COMPLETED|HP Washout 2||0
18327|NCT02310750|45573|P15|NOT COMPLETED|HP Washout 2||0
18328|NCT02310750|45574|P14|NOT COMPLETED|HP Washout 2||0
18329|NCT02310750|45575|P13|NOT COMPLETED|HP Washout 2||0
18330|NCT02310750|45576|P12|NOT COMPLETED|HP Washout 2||0
18331|NCT02310750|45577|P11|NOT COMPLETED|HP Washout 2||0
18332|NCT02310750|45578|P10|NOT COMPLETED|HP Washout 2||0
18333|NCT02310750|45579|P9|NOT COMPLETED|HP Washout 2||0
18334|NCT02310750|45580|P8|NOT COMPLETED|HP Washout 2||0
18335|NCT02310750|45581|P7|NOT COMPLETED|HP Washout 2||7
18336|NCT02310750|45582|P6|NOT COMPLETED|HP Washout 2||0
18337|NCT02310750|45583|P5|NOT COMPLETED|HP Washout 2||1
18338|NCT02310750|45584|P4|NOT COMPLETED|HP Washout 2||0
18339|NCT02310750|45585|P3|NOT COMPLETED|HP Washout 2||0
18340|NCT02310750|45586|P2|NOT COMPLETED|HP Washout 2||0
18341|NCT02310750|45587|P1|NOT COMPLETED|HP Washout 2||0
18342|NCT02310750|45572|P16|COMPLETED|HP Washout 2||2
18343|NCT02310750|45573|P15|COMPLETED|HP Washout 2||2
18344|NCT02310750|45574|P14|COMPLETED|HP Washout 2||2
18345|NCT02310750|45575|P13|COMPLETED|HP Washout 2||2
18346|NCT02310750|45576|P12|COMPLETED|HP Washout 2||2
18347|NCT02310750|45577|P11|COMPLETED|HP Washout 2||2
18348|NCT02310750|45578|P10|COMPLETED|HP Washout 2||0
18349|NCT02310750|45579|P9|COMPLETED|HP Washout 2||0
18350|NCT02310750|45580|P8|COMPLETED|HP Washout 2||0
18351|NCT02310750|45581|P7|COMPLETED|HP Washout 2||2
18352|NCT02310750|45582|P6|COMPLETED|HP Washout 2||0
18353|NCT02310750|45583|P5|COMPLETED|HP Washout 2||5
18354|NCT02310750|45584|P4|COMPLETED|HP Washout 2||0
18355|NCT02310750|45585|P3|COMPLETED|HP Washout 2||0
18356|NCT02310750|45586|P2|COMPLETED|HP Washout 2||0
18357|NCT02310750|45587|P1|COMPLETED|HP Washout 2||0
18358|NCT02310750|45572|P16|STARTED|HP Washout 2||2
18359|NCT02310750|45573|P15|STARTED|HP Washout 2||2
18360|NCT02310750|45574|P14|STARTED|HP Washout 2||2
18361|NCT02310750|45575|P13|STARTED|HP Washout 2||2
18362|NCT02310750|45576|P12|STARTED|HP Washout 2||2
18363|NCT02310750|45577|P11|STARTED|HP Washout 2||2
18364|NCT02310750|45578|P10|STARTED|HP Washout 2||0
18365|NCT02310750|45579|P9|STARTED|HP Washout 2||0
18366|NCT02310750|45580|P8|STARTED|HP Washout 2||0
18367|NCT02310750|45581|P7|STARTED|HP Washout 2||9
18368|NCT02310750|45582|P6|STARTED|HP Washout 2||0
18369|NCT02310750|45583|P5|STARTED|HP Washout 2||6
18370|NCT02310750|45584|P4|STARTED|HP Washout 2||0
18371|NCT02310750|45585|P3|STARTED|HP Washout 2||0
18372|NCT02310750|45586|P2|STARTED|HP Washout 2||0
18373|NCT02310750|45587|P1|STARTED|HP Washout 2||0
18374|NCT02310750|45572|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18375|NCT02310750|45573|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18376|NCT02310750|45574|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18377|NCT02310750|45575|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18378|NCT02310750|45576|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18379|NCT02310750|45577|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18380|NCT02310750|45578|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
18381|NCT02310750|45579|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
18382|NCT02310750|45580|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18383|NCT02310750|45581|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18384|NCT02310750|45582|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18385|NCT02310750|45583|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18386|NCT02310750|45584|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
18387|NCT02310750|45585|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18388|NCT02310750|45586|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18389|NCT02310750|45587|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18390|NCT02310750|45572|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18391|NCT02310750|45573|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18392|NCT02310750|45574|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18393|NCT02310750|45575|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18394|NCT02310750|45576|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18395|NCT02310750|45577|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18396|NCT02310750|45578|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
18397|NCT02310750|45579|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
18398|NCT02310750|45580|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
18399|NCT02310750|45581|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
18400|NCT02310750|45582|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
18401|NCT02310750|45583|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
18402|NCT02310750|45584|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
18403|NCT02310750|45585|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
18404|NCT02310750|45586|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18405|NCT02310750|45587|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18406|NCT02310750|45572|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18407|NCT02310750|45573|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18408|NCT02310750|45574|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18409|NCT02310750|45575|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18410|NCT02310750|45576|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18411|NCT02310750|45577|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
18412|NCT02310750|45578|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
18413|NCT02310750|45579|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
18414|NCT02310750|45580|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
18415|NCT02310750|45581|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
18416|NCT02310750|45582|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
18417|NCT02310750|45583|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
18418|NCT02310750|45584|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
18419|NCT02310750|45585|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
18420|NCT02310750|45586|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18421|NCT02310750|45587|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
18422|NCT02310750|45572|P16|NOT COMPLETED|HP Washout 1||0
18423|NCT02310750|45573|P15|NOT COMPLETED|HP Washout 1||0
18424|NCT02310750|45574|P14|NOT COMPLETED|HP Washout 1||0
18425|NCT02310750|45575|P13|NOT COMPLETED|HP Washout 1||0
18426|NCT02310750|45576|P12|NOT COMPLETED|HP Washout 1||0
18427|NCT02310750|45577|P11|NOT COMPLETED|HP Washout 1||0
18428|NCT02310750|45578|P10|NOT COMPLETED|HP Washout 1||0
18429|NCT02310750|45579|P9|NOT COMPLETED|HP Washout 1||0
18430|NCT02310750|45580|P8|NOT COMPLETED|HP Washout 1||0
18431|NCT02310750|45581|P7|NOT COMPLETED|HP Washout 1||3
18432|NCT02310750|45582|P6|NOT COMPLETED|HP Washout 1||2
18433|NCT02310750|45583|P5|NOT COMPLETED|HP Washout 1||2
18434|NCT02310750|45584|P4|NOT COMPLETED|HP Washout 1||1
18435|NCT02310750|45585|P3|NOT COMPLETED|HP Washout 1||1
18436|NCT02310750|45586|P2|NOT COMPLETED|HP Washout 1||0
18437|NCT02310750|45587|P1|NOT COMPLETED|HP Washout 1||0
18438|NCT02310750|45572|P16|COMPLETED|HP Washout 1||2
18439|NCT02310750|45573|P15|COMPLETED|HP Washout 1||2
18440|NCT02310750|45574|P14|COMPLETED|HP Washout 1||2
18441|NCT02310750|45575|P13|COMPLETED|HP Washout 1||2
18442|NCT02310750|45576|P12|COMPLETED|HP Washout 1||2
18443|NCT02310750|45577|P11|COMPLETED|HP Washout 1||2
18444|NCT02310750|45578|P10|COMPLETED|HP Washout 1||0
18445|NCT02310750|45579|P9|COMPLETED|HP Washout 1||0
18446|NCT02310750|45580|P8|COMPLETED|HP Washout 1||0
18447|NCT02310750|45581|P7|COMPLETED|HP Washout 1||9
18448|NCT02310750|45582|P6|COMPLETED|HP Washout 1||6
18449|NCT02310750|45583|P5|COMPLETED|HP Washout 1||6
18450|NCT02310750|45584|P4|COMPLETED|HP Washout 1||4
18451|NCT02310750|45585|P3|COMPLETED|HP Washout 1||5
18452|NCT02310750|45586|P2|COMPLETED|HP Washout 1||0
18453|NCT02310750|45587|P1|COMPLETED|HP Washout 1||0
18454|NCT02310750|45572|P16|STARTED|HP Washout 1||2
18455|NCT02310750|45573|P15|STARTED|HP Washout 1||2
18456|NCT02310750|45574|P14|STARTED|HP Washout 1||2
18457|NCT02310750|45575|P13|STARTED|HP Washout 1||2
18458|NCT02310750|45576|P12|STARTED|HP Washout 1||2
18459|NCT02310750|45577|P11|STARTED|HP Washout 1||2
18460|NCT02310750|45578|P10|STARTED|HP Washout 1||0
18461|NCT02310750|45579|P9|STARTED|HP Washout 1||0
18462|NCT02310750|45580|P8|STARTED|HP Washout 1||0
18463|NCT02310750|45581|P7|STARTED|HP Washout 1||12
18464|NCT02310750|45582|P6|STARTED|HP Washout 1||8
18465|NCT02310750|45583|P5|STARTED|HP Washout 1||8
18466|NCT02310750|45584|P4|STARTED|HP Washout 1||5
18467|NCT02310750|45585|P3|STARTED|HP Washout 1||6
18468|NCT02310750|45586|P2|STARTED|HP Washout 1||0
18469|NCT02310750|45587|P1|STARTED|HP Washout 1||0
18470|NCT02310750|45572|P16|NOT COMPLETED|HP Period 1||0
18471|NCT02310750|45573|P15|NOT COMPLETED|HP Period 1||0
18472|NCT02310750|45574|P14|NOT COMPLETED|HP Period 1||0
18473|NCT02310750|45575|P13|NOT COMPLETED|HP Period 1||0
18474|NCT02310750|45576|P12|NOT COMPLETED|HP Period 1||0
18475|NCT02310750|45577|P11|NOT COMPLETED|HP Period 1||0
18476|NCT02310750|45578|P10|NOT COMPLETED|HP Period 1||0
18477|NCT02310750|45579|P9|NOT COMPLETED|HP Period 1||0
18478|NCT02310750|45580|P8|NOT COMPLETED|HP Period 1||0
18479|NCT02310750|45581|P7|NOT COMPLETED|HP Period 1||1
18480|NCT02310750|45582|P6|NOT COMPLETED|HP Period 1||0
18481|NCT02310750|45583|P5|NOT COMPLETED|HP Period 1||0
18482|NCT02310750|45584|P4|NOT COMPLETED|HP Period 1||1
18483|NCT02310750|45585|P3|NOT COMPLETED|HP Period 1||0
18484|NCT02310750|45586|P2|NOT COMPLETED|HP Period 1||0
18485|NCT02310750|45587|P1|NOT COMPLETED|HP Period 1||1
18486|NCT02310750|45572|P16|COMPLETED|HP Period 1||2
18487|NCT02310750|45573|P15|COMPLETED|HP Period 1||2
18488|NCT02310750|45574|P14|COMPLETED|HP Period 1||2
18489|NCT02310750|45575|P13|COMPLETED|HP Period 1||2
18490|NCT02310750|45576|P12|COMPLETED|HP Period 1||2
18491|NCT02310750|45577|P11|COMPLETED|HP Period 1||2
18492|NCT02310750|45578|P10|COMPLETED|HP Period 1||0
18493|NCT02310750|45579|P9|COMPLETED|HP Period 1||0
18494|NCT02310750|45580|P8|COMPLETED|HP Period 1||0
18495|NCT02310750|45581|P7|COMPLETED|HP Period 1||12
18496|NCT02310750|45582|P6|COMPLETED|HP Period 1||8
18497|NCT02310750|45583|P5|COMPLETED|HP Period 1||8
18498|NCT02310750|45584|P4|COMPLETED|HP Period 1||5
18499|NCT02310750|45585|P3|COMPLETED|HP Period 1||6
18500|NCT02310750|45586|P2|COMPLETED|HP Period 1||6
18501|NCT02310750|45587|P1|COMPLETED|HP Period 1||6
18502|NCT02310750|45572|P16|STARTED|HP Period 1||2
18503|NCT02310750|45573|P15|STARTED|HP Period 1||2
18504|NCT02310750|45574|P14|STARTED|HP Period 1||2
18505|NCT02310750|45575|P13|STARTED|HP Period 1||2
18506|NCT02310750|45576|P12|STARTED|HP Period 1||2
18507|NCT02310750|45577|P11|STARTED|HP Period 1||2
18508|NCT02310750|45578|P10|STARTED|HP Period 1||0
18509|NCT02310750|45579|P9|STARTED|HP Period 1||0
18510|NCT02310750|45580|P8|STARTED|HP Period 1||0
18511|NCT02310750|45581|P7|STARTED|HP Period 1||13
18512|NCT02310750|45582|P6|STARTED|HP Period 1||8
18513|NCT02310750|45583|P5|STARTED|HP Period 1||8
18514|NCT02310750|45584|P4|STARTED|HP Period 1||6
18515|NCT02310750|45585|P3|STARTED|HP Period 1||6
18516|NCT02310750|45586|P2|STARTED|HP Period 1||6
18517|NCT02310750|45587|P1|STARTED|HP Period 1||7
18518|NCT02310646|46028|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
18519|NCT02310646|46029|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
18520|NCT02310646|46028|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
18521|NCT02310646|46029|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
18522|NCT02310646|46028|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
18523|NCT02310646|46029|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
18524|NCT02310646|46028|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
18525|NCT02310646|46029|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
18526|NCT02310646|46028|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
18527|NCT02310646|46029|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
18528|NCT02310646|46028|P2|STARTED|First Intervention (Day 1 - Day 7)||104
18529|NCT02310646|46029|P1|STARTED|First Intervention (Day 1 - Day 7)||109
18530|NCT02310581|46057|P4|NOT COMPLETED|Overall Study||1
18531|NCT02310581|46058|P3|NOT COMPLETED|Overall Study||1
18532|NCT02310581|46059|P2|NOT COMPLETED|Overall Study||2
18533|NCT02310581|46060|P1|NOT COMPLETED|Overall Study||3
18534|NCT02310581|46057|P4|COMPLETED|Overall Study||9
18535|NCT02310581|46058|P3|COMPLETED|Overall Study||9
18536|NCT02310581|46059|P2|COMPLETED|Overall Study||9
18537|NCT02310581|46060|P1|COMPLETED|Overall Study||6
18538|NCT02310581|46057|P4|STARTED|Overall Study||10
18539|NCT02310581|46058|P3|STARTED|Overall Study||10
18540|NCT02310581|46059|P2|STARTED|Overall Study||11
18541|NCT02310581|46060|P1|STARTED|Overall Study||9
18542|NCT02310568|46099|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
18543|NCT02310568|46100|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
18544|NCT02310568|46101|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
18545|NCT02310568|46102|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
18546|NCT02310568|46103|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
18547|NCT02310568|46099|P5|COMPLETED|Stage 2 (4 Weeks)||19
18548|NCT02310568|46100|P4|COMPLETED|Stage 2 (4 Weeks)||17
18549|NCT02310568|46101|P3|COMPLETED|Stage 2 (4 Weeks)||13
18550|NCT02310568|46102|P2|COMPLETED|Stage 2 (4 Weeks)||12
18551|NCT02310568|46103|P1|COMPLETED|Stage 2 (4 Weeks)||11
18552|NCT02310568|46099|P5|STARTED|Stage 2 (4 Weeks)||20
18553|NCT02310568|46100|P4|STARTED|Stage 2 (4 Weeks)||22
18554|NCT02310568|46101|P3|STARTED|Stage 2 (4 Weeks)||14
18555|NCT02310568|46102|P2|STARTED|Stage 2 (4 Weeks)||13
18556|NCT02310568|46103|P1|STARTED|Stage 2 (4 Weeks)||12
18557|NCT02310568|46099|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
18558|NCT02310568|46100|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
18559|NCT02310568|46101|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
18560|NCT02310568|46102|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
18561|NCT02310568|46103|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
18562|NCT02310568|46099|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
18563|NCT02310568|46100|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
18564|NCT02310568|46101|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
18565|NCT02310568|46102|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
18566|NCT02310568|46103|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
18567|NCT02310568|46099|P5|STARTED|Stage 1 ( 4 Weeks)||21
18568|NCT02310568|46100|P4|STARTED|Stage 1 ( 4 Weeks)||24
18569|NCT02310568|46101|P3|STARTED|Stage 1 ( 4 Weeks)||15
18570|NCT02310568|46102|P2|STARTED|Stage 1 ( 4 Weeks)||15
18571|NCT02310568|46103|P1|STARTED|Stage 1 ( 4 Weeks)||15
18572|NCT02310126|46183|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
18573|NCT02310126|46184|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
18574|NCT02310126|46183|P2|COMPLETED|Period 2 (15 Minutes)||95
18575|NCT02310126|46184|P1|COMPLETED|Period 2 (15 Minutes)||94
18576|NCT02310126|46183|P2|Myopes|Period 2 (15 Minutes)||63
18577|NCT02310126|46184|P1|Myopes|Period 2 (15 Minutes)||56
18578|NCT02310126|46183|P2|Hyperopes|Period 2 (15 Minutes)||32
18579|NCT02310126|46184|P1|Hyperopes|Period 2 (15 Minutes)||38
18580|NCT02310126|46183|P2|STARTED|Period 2 (15 Minutes)||95
18581|NCT02310126|46184|P1|STARTED|Period 2 (15 Minutes)||94
18582|NCT02310126|46183|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
18583|NCT02310126|46184|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
18584|NCT02310126|46183|P2|COMPLETED|Period 1 (15 Minutes)||95
18585|NCT02310126|46184|P1|COMPLETED|Period 1 (15 Minutes)||94
18586|NCT02310126|46183|P2|Myopes|Period 1 (15 Minutes)||64
18587|NCT02310126|46184|P1|Myopes|Period 1 (15 Minutes)||56
18588|NCT02310126|46183|P2|Hyperopes|Period 1 (15 Minutes)||33
18589|NCT02310126|46184|P1|Hyperopes|Period 1 (15 Minutes)||38
18590|NCT02310126|46183|P2|STARTED|Period 1 (15 Minutes)||97
18591|NCT02310126|46184|P1|STARTED|Period 1 (15 Minutes)||94
18592|NCT02309723|46193|P3|NOT COMPLETED|Overall Study||24
18593|NCT02309723|46194|P2|NOT COMPLETED|Overall Study||23
18594|NCT02309723|46195|P1|NOT COMPLETED|Overall Study||24
18595|NCT02309723|46193|P3|COMPLETED|Overall Study||105
18596|NCT02309723|46194|P2|COMPLETED|Overall Study||105
18597|NCT02309723|46195|P1|COMPLETED|Overall Study||105
18598|NCT02309723|46193|P3|STARTED|Overall Study||129
18599|NCT02309723|46194|P2|STARTED|Overall Study||128
18600|NCT02309723|46195|P1|STARTED|Overall Study||129
18601|NCT02309294|46209|P1|NOT COMPLETED|Overall Study||2
18602|NCT02309294|46209|P1|COMPLETED|Overall Study||41
18603|NCT02309294|46209|P1|STARTED|Overall Study||43
18604|NCT02309112|46216|P3|NOT COMPLETED|Overall Study||1
18605|NCT02309112|46217|P2|NOT COMPLETED|Overall Study||1
18606|NCT02309112|46218|P1|NOT COMPLETED|Overall Study||1
18607|NCT02309112|46216|P3|COMPLETED|Overall Study||4
18608|NCT02309112|46217|P2|COMPLETED|Overall Study||4
18609|NCT02309112|46218|P1|COMPLETED|Overall Study||4
18610|NCT02309112|46216|P3|Completed Yoga Intervention|Overall Study||4
18611|NCT02309112|46217|P2|Completed Yoga Intervention|Overall Study||5
18612|NCT02309112|46218|P1|Completed Yoga Intervention|Overall Study||4
18613|NCT02309112|46216|P3|STARTED|Overall Study||5
18614|NCT02309112|46217|P2|STARTED|Overall Study||5
18615|NCT02309112|46218|P1|STARTED|Overall Study||5
18616|NCT02308787|46239|P1|NOT COMPLETED|Overall Study||0
18617|NCT02308787|46239|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
18618|NCT02308787|46239|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
18619|NCT02308748|46254|P10|NOT COMPLETED|Period 5||0
18620|NCT02308748|46255|P9|NOT COMPLETED|Period 5||1
18621|NCT02308748|46256|P8|NOT COMPLETED|Period 5||0
18622|NCT02308748|46257|P7|NOT COMPLETED|Period 5||0
18623|NCT02308748|46258|P6|NOT COMPLETED|Period 5||0
18624|NCT02308748|46259|P5|NOT COMPLETED|Period 5||0
18625|NCT02308748|46260|P4|NOT COMPLETED|Period 5||0
18626|NCT02308748|46261|P3|NOT COMPLETED|Period 5||0
18627|NCT02308748|46262|P2|NOT COMPLETED|Period 5||0
18628|NCT02308748|46263|P1|NOT COMPLETED|Period 5||1
18629|NCT02308748|46254|P10|COMPLETED|Period 5||2
18630|NCT02308748|46255|P9|COMPLETED|Period 5||1
18631|NCT02308748|46256|P8|COMPLETED|Period 5||1
18632|NCT02308748|46257|P7|COMPLETED|Period 5||2
18633|NCT02308748|46258|P6|COMPLETED|Period 5||3
18634|NCT02308748|46259|P5|COMPLETED|Period 5||2
18635|NCT02308748|46260|P4|COMPLETED|Period 5||2
18636|NCT02308748|46261|P3|COMPLETED|Period 5||1
18637|NCT02308748|46262|P2|COMPLETED|Period 5||2
18638|NCT02308748|46263|P1|COMPLETED|Period 5||1
18639|NCT02308748|46254|P10|STARTED|Period 5||2
18640|NCT02308748|46255|P9|STARTED|Period 5||2
18641|NCT02308748|46256|P8|STARTED|Period 5||1
18642|NCT02308748|46257|P7|STARTED|Period 5||2
18643|NCT02308748|46258|P6|STARTED|Period 5||3
18644|NCT02308748|46259|P5|STARTED|Period 5||2
18645|NCT02308748|46260|P4|STARTED|Period 5||2
18646|NCT02308748|46261|P3|STARTED|Period 5||1
18647|NCT02308748|46262|P2|STARTED|Period 5||2
18648|NCT02308748|46263|P1|STARTED|Period 5||2
18649|NCT02308748|46254|P10|NOT COMPLETED|Period 4||0
18650|NCT02308748|46255|P9|NOT COMPLETED|Period 4||0
18651|NCT02308748|46256|P8|NOT COMPLETED|Period 4||0
18652|NCT02308748|46257|P7|NOT COMPLETED|Period 4||0
18653|NCT02308748|46258|P6|NOT COMPLETED|Period 4||0
18654|NCT02308748|46259|P5|NOT COMPLETED|Period 4||0
18655|NCT02308748|46260|P4|NOT COMPLETED|Period 4||0
18656|NCT02308748|46261|P3|NOT COMPLETED|Period 4||0
18657|NCT02308748|46262|P2|NOT COMPLETED|Period 4||0
18658|NCT02308748|46263|P1|NOT COMPLETED|Period 4||0
18659|NCT02308748|46254|P10|COMPLETED|Period 4||2
18660|NCT02308748|46255|P9|COMPLETED|Period 4||2
18661|NCT02308748|46256|P8|COMPLETED|Period 4||1
18662|NCT02308748|46257|P7|COMPLETED|Period 4||2
18663|NCT02308748|46258|P6|COMPLETED|Period 4||3
18664|NCT02308748|46259|P5|COMPLETED|Period 4||2
18665|NCT02308748|46260|P4|COMPLETED|Period 4||2
18666|NCT02308748|46261|P3|COMPLETED|Period 4||1
18667|NCT02308748|46262|P2|COMPLETED|Period 4||2
18668|NCT02308748|46263|P1|COMPLETED|Period 4||2
18669|NCT02308748|46254|P10|STARTED|Period 4||2
18670|NCT02308748|46255|P9|STARTED|Period 4||2
18671|NCT02308748|46256|P8|STARTED|Period 4||1
18672|NCT02308748|46257|P7|STARTED|Period 4||2
18673|NCT02308748|46258|P6|STARTED|Period 4||3
18674|NCT02308748|46259|P5|STARTED|Period 4||2
18675|NCT02308748|46260|P4|STARTED|Period 4||2
18676|NCT02308748|46261|P3|STARTED|Period 4||1
18677|NCT02308748|46262|P2|STARTED|Period 4||2
18678|NCT02308748|46263|P1|STARTED|Period 4||2
18679|NCT02308748|46254|P10|NOT COMPLETED|Period 3||1
18680|NCT02308748|46255|P9|NOT COMPLETED|Period 3||0
18681|NCT02308748|46256|P8|NOT COMPLETED|Period 3||0
18682|NCT02308748|46257|P7|NOT COMPLETED|Period 3||0
18683|NCT02308748|46258|P6|NOT COMPLETED|Period 3||0
18684|NCT02308748|46259|P5|NOT COMPLETED|Period 3||0
18685|NCT02308748|46260|P4|NOT COMPLETED|Period 3||0
18686|NCT02308748|46261|P3|NOT COMPLETED|Period 3||0
18687|NCT02308748|46262|P2|NOT COMPLETED|Period 3||0
18688|NCT02308748|46263|P1|NOT COMPLETED|Period 3||0
18689|NCT02308748|46254|P10|COMPLETED|Period 3||2
18690|NCT02308748|46255|P9|COMPLETED|Period 3||2
18691|NCT02308748|46256|P8|COMPLETED|Period 3||1
18692|NCT02308748|46257|P7|COMPLETED|Period 3||2
18693|NCT02308748|46258|P6|COMPLETED|Period 3||3
18694|NCT02308748|46259|P5|COMPLETED|Period 3||2
18695|NCT02308748|46260|P4|COMPLETED|Period 3||2
18696|NCT02308748|46261|P3|COMPLETED|Period 3||1
18697|NCT02308748|46262|P2|COMPLETED|Period 3||2
18698|NCT02308748|46263|P1|COMPLETED|Period 3||2
18699|NCT02308748|46254|P10|STARTED|Period 3||3
18700|NCT02308748|46255|P9|STARTED|Period 3||2
18701|NCT02308748|46256|P8|STARTED|Period 3||1
18702|NCT02308748|46257|P7|STARTED|Period 3||2
18703|NCT02308748|46258|P6|STARTED|Period 3||3
18704|NCT02308748|46259|P5|STARTED|Period 3||2
18705|NCT02308748|46260|P4|STARTED|Period 3||2
18706|NCT02308748|46261|P3|STARTED|Period 3||1
18707|NCT02308748|46262|P2|STARTED|Period 3||2
18708|NCT02308748|46263|P1|STARTED|Period 3||2
18709|NCT02308748|46254|P10|NOT COMPLETED|Period 2||0
18710|NCT02308748|46255|P9|NOT COMPLETED|Period 2||0
18711|NCT02308748|46256|P8|NOT COMPLETED|Period 2||1
18712|NCT02308748|46257|P7|NOT COMPLETED|Period 2||0
18713|NCT02308748|46258|P6|NOT COMPLETED|Period 2||0
18714|NCT02308748|46259|P5|NOT COMPLETED|Period 2||0
18715|NCT02308748|46260|P4|NOT COMPLETED|Period 2||0
18716|NCT02308748|46261|P3|NOT COMPLETED|Period 2||0
18717|NCT02308748|46262|P2|NOT COMPLETED|Period 2||0
18718|NCT02308748|46263|P1|NOT COMPLETED|Period 2||0
18719|NCT02308748|46254|P10|COMPLETED|Period 2||3
18720|NCT02308748|46255|P9|COMPLETED|Period 2||2
18721|NCT02308748|46256|P8|COMPLETED|Period 2||1
18722|NCT02308748|46257|P7|COMPLETED|Period 2||2
18723|NCT02308748|46258|P6|COMPLETED|Period 2||3
18724|NCT02308748|46259|P5|COMPLETED|Period 2||2
18725|NCT02308748|46260|P4|COMPLETED|Period 2||2
18726|NCT02308748|46261|P3|COMPLETED|Period 2||1
18727|NCT02308748|46262|P2|COMPLETED|Period 2||2
18728|NCT02308748|46263|P1|COMPLETED|Period 2||2
18729|NCT02308748|46254|P10|STARTED|Period 2||3
18730|NCT02308748|46255|P9|STARTED|Period 2||2
18731|NCT02308748|46256|P8|STARTED|Period 2||2
18732|NCT02308748|46257|P7|STARTED|Period 2||2
18733|NCT02308748|46258|P6|STARTED|Period 2||3
18734|NCT02308748|46259|P5|STARTED|Period 2||2
18735|NCT02308748|46260|P4|STARTED|Period 2||2
18736|NCT02308748|46261|P3|STARTED|Period 2||1
18737|NCT02308748|46262|P2|STARTED|Period 2||2
18738|NCT02308748|46263|P1|STARTED|Period 2||2
18739|NCT02308748|46254|P10|NOT COMPLETED|Period 1||0
18740|NCT02308748|46255|P9|NOT COMPLETED|Period 1||0
18741|NCT02308748|46256|P8|NOT COMPLETED|Period 1||0
18742|NCT02308748|46257|P7|NOT COMPLETED|Period 1||0
18743|NCT02308748|46258|P6|NOT COMPLETED|Period 1||0
18744|NCT02308748|46259|P5|NOT COMPLETED|Period 1||0
18745|NCT02308748|46260|P4|NOT COMPLETED|Period 1||0
18746|NCT02308748|46261|P3|NOT COMPLETED|Period 1||1
18747|NCT02308748|46262|P2|NOT COMPLETED|Period 1||0
18748|NCT02308748|46263|P1|NOT COMPLETED|Period 1||0
18749|NCT02308748|46254|P10|COMPLETED|Period 1||3
18750|NCT02308748|46255|P9|COMPLETED|Period 1||2
18751|NCT02308748|46256|P8|COMPLETED|Period 1||2
18752|NCT02308748|46257|P7|COMPLETED|Period 1||2
18753|NCT02308748|46258|P6|COMPLETED|Period 1||3
18754|NCT02308748|46259|P5|COMPLETED|Period 1||2
18755|NCT02308748|46260|P4|COMPLETED|Period 1||2
18756|NCT02308748|46261|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
18757|NCT02308748|46262|P2|COMPLETED|Period 1||2
18758|NCT02308748|46263|P1|COMPLETED|Period 1||2
18759|NCT02308748|46254|P10|STARTED|Period 1||3
18760|NCT02308748|46255|P9|STARTED|Period 1||2
18761|NCT02308748|46256|P8|STARTED|Period 1||2
18762|NCT02308748|46257|P7|STARTED|Period 1||2
18763|NCT02308748|46258|P6|STARTED|Period 1||3
18764|NCT02308748|46259|P5|STARTED|Period 1||2
18765|NCT02308748|46260|P4|STARTED|Period 1||2
18766|NCT02308748|46261|P3|STARTED|Period 1||2
18767|NCT02308748|46262|P2|STARTED|Period 1||2
18768|NCT02308748|46263|P1|STARTED|Period 1||2
18769|NCT02308371|46277|P2|NOT COMPLETED|Overall Study||0
18770|NCT02308371|46278|P1|NOT COMPLETED|Overall Study||0
18771|NCT02308371|46277|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
18772|NCT02308371|46278|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
18773|NCT02308371|46277|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
18774|NCT02308371|46278|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
18775|NCT02308124|46295|P3|NOT COMPLETED|Overall Study||8
18776|NCT02308124|46296|P2|NOT COMPLETED|Overall Study||8
18777|NCT02308124|46297|P1|NOT COMPLETED|Overall Study||6
18778|NCT02308124|46295|P3|COMPLETED|Overall Study||21
18779|NCT02308124|46296|P2|COMPLETED|Overall Study||21
18780|NCT02308124|46297|P1|COMPLETED|Overall Study||23
18781|NCT02308124|46295|P3|STARTED|Overall Study||29
18782|NCT02308124|46296|P2|STARTED|Overall Study||29
18783|NCT02308124|46297|P1|STARTED|Overall Study||29
18784|NCT02307838|46320|P3|NOT COMPLETED|Overall Study||0
18785|NCT02307838|46321|P2|NOT COMPLETED|Overall Study||0
18786|NCT02307838|46322|P1|NOT COMPLETED|Overall Study||0
18787|NCT02307838|46320|P3|COMPLETED|Overall Study||55
18788|NCT02307838|46321|P2|COMPLETED|Overall Study||64
18789|NCT02307838|46322|P1|COMPLETED|Overall Study||56
18790|NCT02307838|46320|P3|STARTED|Overall Study||55
18791|NCT02307838|46321|P2|STARTED|Overall Study||64
18792|NCT02307838|46322|P1|STARTED|Overall Study||56
18793|NCT02307552|46365|P1|NOT COMPLETED|Overall Study||0
18794|NCT02307552|46365|P1|COMPLETED|Overall Study||1
18795|NCT02307552|46365|P1|STARTED|Overall Study||1
18796|NCT02307526|46369|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
18797|NCT02307526|46369|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
18798|NCT02307526|46369|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
18799|NCT02307526|46369|P1|NOT COMPLETED|Day 1 - No Drug||0
18800|NCT02307526|46369|P1|COMPLETED|Day 1 - No Drug||10
18801|NCT02307526|46369|P1|STARTED|Day 1 - No Drug||10
18802|NCT02307318|46379|P1|NOT COMPLETED|Overall Study||0
18803|NCT02307318|46379|P1|COMPLETED|Overall Study||51
18804|NCT02307318|46379|P1|STARTED|Overall Study||51
18805|NCT02307266|46389|P3|NOT COMPLETED|Overall Study||6
18806|NCT02307266|46390|P2|NOT COMPLETED|Overall Study||1
18807|NCT02307266|46391|P1|NOT COMPLETED|Overall Study||8
18808|NCT02307266|46389|P3|COMPLETED|Overall Study||25
18809|NCT02307266|46390|P2|COMPLETED|Overall Study||32
18810|NCT02307266|46391|P1|COMPLETED|Overall Study||25
18811|NCT02307266|46389|P3|STARTED|Overall Study||31
18812|NCT02307266|46390|P2|STARTED|Overall Study||33
18813|NCT02307266|46391|P1|STARTED|Overall Study||33
18814|NCT02307188|46399|P1|NOT COMPLETED|Overall Study||4
18815|NCT02307188|46399|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
18816|NCT02307188|46399|P1|STARTED|Overall Study||5
18817|NCT02307123|46403|P1|NOT COMPLETED|Overall Study||0
18818|NCT02307123|46403|P1|COMPLETED|Overall Study||483
18819|NCT02307123|46403|P1|STARTED|Overall Study||483
18820|NCT02306928|46408|P1|NOT COMPLETED|Overall Study||0
18821|NCT02306928|46408|P1|COMPLETED|Overall Study||15
18822|NCT02306928|46408|P1|STARTED|Overall Study||15
18823|NCT02306759|46418|P2|NOT COMPLETED|Overall Study||0
18824|NCT02306759|46419|P1|NOT COMPLETED|Overall Study||0
18825|NCT02306759|46418|P2|COMPLETED|Overall Study||30
18826|NCT02306759|46419|P1|COMPLETED|Overall Study||30
18827|NCT02306759|46418|P2|STARTED|Overall Study||30
18828|NCT02306759|46419|P1|STARTED|Overall Study||30
18829|NCT02305446|46433|P1|NOT COMPLETED|Overall Study||1
18830|NCT02305446|46433|P1|COMPLETED|Overall Study||54
18831|NCT02305446|46433|P1|STARTED|Overall Study||55
18832|NCT02305381|46441|P3|NOT COMPLETED|Overall Study||7
18833|NCT02305381|46442|P2|NOT COMPLETED|Overall Study||5
18834|NCT02305381|46443|P1|NOT COMPLETED|Overall Study||5
18835|NCT02305381|46441|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
18836|NCT02305381|46442|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
18837|NCT02305381|46443|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
18838|NCT02305381|46441|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
18839|NCT02305381|46442|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
18840|NCT02305381|46443|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
18841|NCT02305381|46441|P3|Exposed|Overall Study||133
18842|NCT02305381|46442|P2|Exposed|Overall Study||131
18843|NCT02305381|46443|P1|Exposed|Overall Study||132
18844|NCT02305381|46441|P3|STARTED|Overall Study||133
18845|NCT02305381|46442|P2|STARTED|Overall Study||132
18846|NCT02305381|46443|P1|STARTED|Overall Study||132
18847|NCT02305329|46476|P4|NOT COMPLETED|Overall Study||0
18848|NCT02305329|46477|P3|NOT COMPLETED|Overall Study||0
18849|NCT02305329|46478|P2|NOT COMPLETED|Overall Study||1
18850|NCT02305329|46479|P1|NOT COMPLETED|Overall Study||0
18851|NCT02305329|46476|P4|COMPLETED|Overall Study||14
18852|NCT02305329|46477|P3|COMPLETED|Overall Study||14
18853|NCT02305329|46478|P2|COMPLETED|Overall Study||13
18854|NCT02305329|46479|P1|COMPLETED|Overall Study||14
18855|NCT02305329|46476|P4|Period 2|Overall Study||14
18856|NCT02305329|46477|P3|Period 2|Overall Study||14
18857|NCT02305329|46478|P2|Period 2|Overall Study||13
18858|NCT02305329|46479|P1|Period 2|Overall Study||14
18859|NCT02305329|46476|P4|Period 1|Overall Study||14
18860|NCT02305329|46477|P3|Period 1|Overall Study||14
18861|NCT02305329|46478|P2|Period 1|Overall Study||14
18862|NCT02305329|46479|P1|Period 1|Overall Study||14
18863|NCT02305329|46476|P4|STARTED|Overall Study||14
18864|NCT02305329|46477|P3|STARTED|Overall Study||14
18865|NCT02305329|46478|P2|STARTED|Overall Study||14
18866|NCT02305329|46479|P1|STARTED|Overall Study||14
18867|NCT02305316|46503|P2|NOT COMPLETED|Overall Study||0
18868|NCT02305316|46504|P1|NOT COMPLETED|Overall Study||0
18869|NCT02305316|46503|P2|COMPLETED|Overall Study||14
18870|NCT02305316|46504|P1|COMPLETED|Overall Study||14
18871|NCT02305316|46503|P2|STARTED|Overall Study||14
18872|NCT02305316|46504|P1|STARTED|Overall Study||14
18873|NCT02305277|46522|P6|NOT COMPLETED|Overall Study||0
18874|NCT02305277|46523|P5|NOT COMPLETED|Overall Study||1
18875|NCT02305277|46524|P4|NOT COMPLETED|Overall Study||0
18876|NCT02305277|46525|P3|NOT COMPLETED|Overall Study||0
18877|NCT02305277|46526|P2|NOT COMPLETED|Overall Study||0
18878|NCT02305277|46527|P1|NOT COMPLETED|Overall Study||1
18879|NCT02305277|46522|P6|COMPLETED|Overall Study||14
18880|NCT02305277|46523|P5|COMPLETED|Overall Study||13
18881|NCT02305277|46524|P4|COMPLETED|Overall Study||14
18882|NCT02305277|46525|P3|COMPLETED|Overall Study||14
18883|NCT02305277|46526|P2|COMPLETED|Overall Study||14
18884|NCT02305277|46527|P1|COMPLETED|Overall Study||14
18885|NCT02305277|46522|P6|Received TBM|Overall Study||14
18886|NCT02305277|46523|P5|Received TBM|Overall Study||14
18887|NCT02305277|46524|P4|Received TBM|Overall Study||14
18888|NCT02305277|46525|P3|Received TBM|Overall Study||14
18889|NCT02305277|46526|P2|Received TBM|Overall Study||14
18890|NCT02305277|46527|P1|Received TBM|Overall Study||15
18891|NCT02305277|46522|P6|Received CM|Overall Study||14
18892|NCT02305277|46523|P5|Received CM|Overall Study||14
18893|NCT02305277|46524|P4|Received CM|Overall Study||14
18894|NCT02305277|46525|P3|Received CM|Overall Study||14
18895|NCT02305277|46526|P2|Received CM|Overall Study||14
18896|NCT02305277|46527|P1|Received CM|Overall Study||15
18897|NCT02305277|46522|P6|STARTED|Overall Study||14
18898|NCT02305277|46523|P5|STARTED|Overall Study||14
18899|NCT02305277|46524|P4|STARTED|Overall Study||14
18900|NCT02305277|46525|P3|STARTED|Overall Study||14
18901|NCT02305277|46526|P2|STARTED|Overall Study||14
18902|NCT02305277|46527|P1|STARTED|Overall Study||15
18903|NCT02305238|46556|P3|NOT COMPLETED|Overall Study||8
18904|NCT02305238|46557|P2|NOT COMPLETED|Overall Study||7
18905|NCT02305238|46558|P1|NOT COMPLETED|Overall Study||13
18906|NCT02305238|46556|P3|COMPLETED|Overall Study||0
18907|NCT02305238|46557|P2|COMPLETED|Overall Study||116
18908|NCT02305238|46558|P1|COMPLETED|Overall Study||111
18909|NCT02305238|46556|P3|BCVA Post-randomization Assessment|Overall Study||0
18910|NCT02305238|46557|P2|BCVA Post-randomization Assessment|Overall Study||123
18911|NCT02305238|46558|P1|BCVA Post-randomization Assessment|Overall Study||123
18912|NCT02305238|46556|P3|Randomized|Overall Study||0
18913|NCT02305238|46557|P2|Randomized|Overall Study||123
18914|NCT02305238|46558|P1|Randomized|Overall Study||124
18915|NCT02305238|46556|P3|Treated|Overall Study||7
18916|NCT02305238|46557|P2|Treated|Overall Study||123
18917|NCT02305238|46558|P1|Treated|Overall Study||124
18918|NCT02305238|46556|P3|STARTED|Overall Study||8
18919|NCT02305238|46557|P2|STARTED|Overall Study||123
18920|NCT02305238|46558|P1|STARTED|Overall Study||124
18921|NCT02305017|46575|P2|NOT COMPLETED|Overall Study||0
18922|NCT02305017|46576|P1|NOT COMPLETED|Overall Study||0
18923|NCT02305017|46575|P2|COMPLETED|Overall Study||14
18924|NCT02305017|46576|P1|COMPLETED|Overall Study||14
18925|NCT02305017|46575|P2|STARTED|Overall Study||14
18926|NCT02305017|46576|P1|STARTED|Overall Study||14
18927|NCT02304926|46590|P2|NOT COMPLETED|Overall Study||1
18928|NCT02304926|46591|P1|NOT COMPLETED|Overall Study||2
18929|NCT02304926|46590|P2|COMPLETED|Overall Study||19
18930|NCT02304926|46591|P1|COMPLETED|Overall Study||20
18931|NCT02304926|46590|P2|STARTED|Overall Study||20
18932|NCT02304926|46591|P1|STARTED|Overall Study||22
18933|NCT02304432|46635|P4|NOT COMPLETED|Second Open Label DCS||0
18934|NCT02304432|46636|P3|NOT COMPLETED|Second Open Label DCS||0
18935|NCT02304432|46637|P2|NOT COMPLETED|Second Open Label DCS||0
18936|NCT02304432|46638|P1|NOT COMPLETED|Second Open Label DCS||0
18937|NCT02304432|46635|P4|COMPLETED|Second Open Label DCS||2
18938|NCT02304432|46636|P3|COMPLETED|Second Open Label DCS||0
18939|NCT02304432|46637|P2|COMPLETED|Second Open Label DCS||0
18940|NCT02304432|46638|P1|COMPLETED|Second Open Label DCS||0
18941|NCT02304432|46635|P4|STARTED|Second Open Label DCS||2
18942|NCT02304432|46636|P3|STARTED|Second Open Label DCS||0
18943|NCT02304432|46637|P2|STARTED|Second Open Label DCS||0
18944|NCT02304432|46638|P1|STARTED|Second Open Label DCS||0
18945|NCT02304432|46635|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
18946|NCT02304432|46636|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
18947|NCT02304432|46637|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
18948|NCT02304432|46638|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
18949|NCT02304432|46635|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
18950|NCT02304432|46636|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
18951|NCT02304432|46637|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
18952|NCT02304432|46638|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
18953|NCT02304432|46635|P4|STARTED|Double-Blind DCS Placebo Crossover||0
18954|NCT02304432|46636|P3|STARTED|Double-Blind DCS Placebo Crossover||1
18955|NCT02304432|46637|P2|STARTED|Double-Blind DCS Placebo Crossover||1
18956|NCT02304432|46638|P1|STARTED|Double-Blind DCS Placebo Crossover||0
18957|NCT02304432|46635|P4|NOT COMPLETED|Open Label DCS||0
18958|NCT02304432|46636|P3|NOT COMPLETED|Open Label DCS||0
18959|NCT02304432|46637|P2|NOT COMPLETED|Open Label DCS||0
18960|NCT02304432|46638|P1|NOT COMPLETED|Open Label DCS||0
18961|NCT02304432|46635|P4|COMPLETED|Open Label DCS||0
18962|NCT02304432|46636|P3|COMPLETED|Open Label DCS||0
18963|NCT02304432|46637|P2|COMPLETED|Open Label DCS||0
18964|NCT02304432|46638|P1|COMPLETED|Open Label DCS||2
18965|NCT02304432|46635|P4|STARTED|Open Label DCS||0
18966|NCT02304432|46636|P3|STARTED|Open Label DCS||0
18967|NCT02304432|46637|P2|STARTED|Open Label DCS||0
18968|NCT02304432|46638|P1|STARTED|Open Label DCS||2
18969|NCT02303743|46672|P2|NOT COMPLETED|Overall Study||0
18970|NCT02303743|46673|P1|NOT COMPLETED|Overall Study||0
18971|NCT02303743|46672|P2|COMPLETED|Overall Study||152
18972|NCT02303743|46673|P1|COMPLETED|Overall Study||108
18973|NCT02303743|46672|P2|STARTED|Overall Study||152
18974|NCT02303743|46673|P1|STARTED|Overall Study||108
18975|NCT02303704|46683|P2|NOT COMPLETED|Overall Study||9
18976|NCT02303704|46684|P1|NOT COMPLETED|Overall Study||5
18977|NCT02303704|46683|P2|COMPLETED|Overall Study||219
18978|NCT02303704|46684|P1|COMPLETED|Overall Study||215
18979|NCT02303704|46683|P2|STARTED|Overall Study||228
18980|NCT02303704|46684|P1|STARTED|Overall Study||220
18981|NCT02302807|46702|P2|NOT COMPLETED|Overall Study||334
18982|NCT02302807|46703|P1|NOT COMPLETED|Overall Study||375
18983|NCT02302807|46702|P2|COMPLETED|Overall Study||133
18984|NCT02302807|46703|P1|COMPLETED|Overall Study||89
18985|NCT02302807|46702|P2|Received Treatment|Overall Study||459
18986|NCT02302807|46703|P1|Received Treatment|Overall Study||443
18987|NCT02302807|46702|P2|STARTED|Overall Study||467
18988|NCT02302807|46703|P1|STARTED|Overall Study||464
18989|NCT02302716|46750|P2|NOT COMPLETED|Overall Study||19
18990|NCT02302716|46751|P1|NOT COMPLETED|Overall Study||19
18991|NCT02302716|46750|P2|COMPLETED|Overall Study||225
18992|NCT02302716|46751|P1|COMPLETED|Overall Study||230
18993|NCT02302716|46750|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
18994|NCT02302716|46751|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
18995|NCT02302716|46750|P2|STARTED|Overall Study||244
18996|NCT02302716|46751|P1|STARTED|Overall Study||249
18997|NCT02302365|46777|P1|NOT COMPLETED|Overall Study||2
18998|NCT02302365|46777|P1|COMPLETED|Overall Study|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
18999|NCT02302365|46777|P1|STARTED|Overall Study|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
19000|NCT02302092|46795|P2|NOT COMPLETED|Overall Study||0
19001|NCT02302092|46796|P1|NOT COMPLETED|Overall Study||0
19002|NCT02302092|46795|P2|COMPLETED|Overall Study||7
19003|NCT02302092|46796|P1|COMPLETED|Overall Study||6
19004|NCT02302092|46795|P2|STARTED|Overall Study||7
19005|NCT02302092|46796|P1|STARTED|Overall Study||6
19006|NCT02301975|46825|P3|NOT COMPLETED|Overall Study||22
19007|NCT02301975|46826|P2|NOT COMPLETED|Overall Study||25
19008|NCT02301975|46827|P1|NOT COMPLETED|Overall Study||31
19009|NCT02301975|46825|P3|COMPLETED|Overall Study||477
19010|NCT02301975|46826|P2|COMPLETED|Overall Study||476
19011|NCT02301975|46827|P1|COMPLETED|Overall Study||473
19012|NCT02301975|46825|P3|STARTED|Overall Study||499
19013|NCT02301975|46826|P2|STARTED|Overall Study||501
19014|NCT02301975|46827|P1|STARTED|Overall Study||504
19015|NCT02301936|46855|P2|NOT COMPLETED|Overall Study||0
19016|NCT02301936|46856|P1|NOT COMPLETED|Overall Study||1
19017|NCT02301936|46855|P2|COMPLETED|Overall Study||1
19018|NCT02301936|46856|P1|COMPLETED|Overall Study||8
19019|NCT02301936|46855|P2|STARTED|Overall Study||1
19020|NCT02301936|46856|P1|STARTED|Overall Study||9
19021|NCT02301429|46878|P1|NOT COMPLETED|Overall Study||3
19022|NCT02301429|46878|P1|COMPLETED|Overall Study||13
19023|NCT02301429|46878|P1|STARTED|Overall Study||16
19024|NCT02301377|46884|P2|NOT COMPLETED|Overall Study||0
19025|NCT02301377|46885|P1|NOT COMPLETED|Overall Study||0
19026|NCT02301377|46884|P2|COMPLETED|Overall Study||2
19027|NCT02301377|46885|P1|COMPLETED|Overall Study||3
19028|NCT02301377|46884|P2|STARTED|Overall Study||2
19029|NCT02301377|46885|P1|STARTED|Overall Study||3
19030|NCT02301364|46895|P1|NOT COMPLETED|Overall Study||0
19031|NCT02301364|46895|P1|COMPLETED|Overall Study||4
19032|NCT02301364|46895|P1|STARTED|Overall Study||4
19033|NCT02301169|46904|P2|NOT COMPLETED|Overall Study||0
19034|NCT02301169|46905|P1|NOT COMPLETED|Overall Study||1
19035|NCT02301169|46904|P2|COMPLETED|Overall Study||21
19036|NCT02301169|46905|P1|COMPLETED|Overall Study||20
19037|NCT02301169|46904|P2|STARTED|Overall Study||21
19038|NCT02301169|46905|P1|STARTED|Overall Study||21
19039|NCT02300558|46919|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
19040|NCT02300558|46919|P1|COMPLETED|Open-Label (OL) Extension Phase||0
19041|NCT02300558|46919|P1|STARTED|Open-Label (OL) Extension Phase||32
19042|NCT02300558|46919|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
19043|NCT02300558|46919|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
19044|NCT02300558|46919|P1|STARTED|Single Blind Phase (24 Weeks)||41
19045|NCT02300311|46932|P2|NOT COMPLETED|Overall Study||0
19046|NCT02300311|46933|P1|NOT COMPLETED|Overall Study||19
19047|NCT02300311|46932|P2|COMPLETED|Overall Study||69
19048|NCT02300311|46933|P1|COMPLETED|Overall Study||50
19049|NCT02300311|46932|P2|STARTED|Overall Study||69
19050|NCT02300311|46933|P1|STARTED|Overall Study||69
19051|NCT02300129|46945|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
19052|NCT02300129|46946|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
19053|NCT02300129|46947|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
19054|NCT02300129|46948|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
19055|NCT02300129|46945|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
19056|NCT02300129|46946|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
19057|NCT02300129|46947|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
19058|NCT02300129|46948|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
19059|NCT02300129|46945|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
19060|NCT02300129|46946|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
19061|NCT02300129|46947|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
19062|NCT02300129|46948|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
19063|NCT02300129|46945|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
19064|NCT02300129|46946|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
19065|NCT02300129|46947|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
19066|NCT02300129|46948|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
19067|NCT02300129|46945|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
19068|NCT02300129|46946|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
19069|NCT02300129|46947|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
19070|NCT02300129|46948|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
19071|NCT02300129|46945|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
19072|NCT02300129|46946|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
19073|NCT02300129|46947|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
19074|NCT02300129|46948|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
19075|NCT02300129|46945|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
19076|NCT02300129|46946|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
19077|NCT02300129|46947|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
19078|NCT02300129|46948|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
19079|NCT02300129|46945|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
19080|NCT02300129|46946|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
19081|NCT02300129|46947|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
19082|NCT02300129|46948|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
19083|NCT02300129|46945|P4|STARTED|Period 1 Session 3 (Day 5)||11
19084|NCT02300129|46946|P3|STARTED|Period 1 Session 3 (Day 5)||7
19085|NCT02300129|46947|P2|STARTED|Period 1 Session 3 (Day 5)||4
19086|NCT02300129|46948|P1|STARTED|Period 1 Session 3 (Day 5)||11
19087|NCT02300129|46945|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
19088|NCT02300129|46946|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
19089|NCT02300129|46947|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
19090|NCT02300129|46948|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
19091|NCT02300129|46945|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
19092|NCT02300129|46946|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
19093|NCT02300129|46947|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
19094|NCT02300129|46948|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
19095|NCT02300129|46945|P4|STARTED|Period 1 Session 2 (Day 3)||11
19096|NCT02300129|46946|P3|STARTED|Period 1 Session 2 (Day 3)||7
19284|NCT02296099|47416|P1|STARTED|Overall Study||57
19097|NCT02300129|46947|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
19098|NCT02300129|46948|P1|STARTED|Period 1 Session 2 (Day 3)||11
19099|NCT02300129|46945|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
19100|NCT02300129|46946|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
19101|NCT02300129|46947|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
19102|NCT02300129|46948|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
19103|NCT02300129|46945|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
19104|NCT02300129|46946|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
19105|NCT02300129|46947|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
19106|NCT02300129|46948|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
19107|NCT02300129|46945|P4|STARTED|Period 1 Session 1 (Day 1)||11
19108|NCT02300129|46946|P3|STARTED|Period 1 Session 1 (Day 1)||7
19109|NCT02300129|46947|P2|STARTED|Period 1 Session 1 (Day 1)||5
19110|NCT02300129|46948|P1|STARTED|Period 1 Session 1 (Day 1)||11
19111|NCT02300103|46958|P1|NOT COMPLETED|Overall Study||6
19112|NCT02300103|46958|P1|COMPLETED|Overall Study||63
19113|NCT02300103|46958|P1|STARTED|Overall Study||69
19114|NCT02300025|46971|P4|NOT COMPLETED|Overall Study||0
19115|NCT02300025|46972|P3|NOT COMPLETED|Overall Study||0
19116|NCT02300025|46973|P2|NOT COMPLETED|Overall Study||0
19117|NCT02300025|46974|P1|NOT COMPLETED|Overall Study||0
19118|NCT02300025|46971|P4|COMPLETED|Overall Study||6
19119|NCT02300025|46972|P3|COMPLETED|Overall Study||6
19120|NCT02300025|46973|P2|COMPLETED|Overall Study||6
19121|NCT02300025|46974|P1|COMPLETED|Overall Study||10
19122|NCT02300025|46971|P4|STARTED|Overall Study||6
19123|NCT02300025|46972|P3|STARTED|Overall Study||6
19124|NCT02300025|46973|P2|STARTED|Overall Study||6
19125|NCT02300025|46974|P1|STARTED|Overall Study||10
19126|NCT02299869|47020|P4|NOT COMPLETED|Overall Study||0
19127|NCT02299869|47021|P3|NOT COMPLETED|Overall Study||0
19128|NCT02299869|47022|P2|NOT COMPLETED|Overall Study||0
19129|NCT02299869|47023|P1|NOT COMPLETED|Overall Study||0
19130|NCT02299869|47020|P4|COMPLETED|Overall Study||10
19131|NCT02299869|47021|P3|COMPLETED|Overall Study||10
19132|NCT02299869|47022|P2|COMPLETED|Overall Study||10
19133|NCT02299869|47023|P1|COMPLETED|Overall Study||10
19134|NCT02299869|47020|P4|STARTED|Overall Study||10
19135|NCT02299869|47021|P3|STARTED|Overall Study||10
19136|NCT02299869|47022|P2|STARTED|Overall Study||10
19137|NCT02299869|47023|P1|STARTED|Overall Study||10
19138|NCT02299791|47048|P2|NOT COMPLETED|Overall Study||0
19139|NCT02299791|47049|P1|NOT COMPLETED|Overall Study||0
19140|NCT02299791|47048|P2|COMPLETED|Overall Study||2803
19141|NCT02299791|47049|P1|COMPLETED|Overall Study||2053
19142|NCT02299791|47048|P2|STARTED|Overall Study||2803
19143|NCT02299791|47049|P1|STARTED|Overall Study||2053
19144|NCT02299635|47055|P1|NOT COMPLETED|Overall Study||19
19145|NCT02299635|47055|P1|COMPLETED|Overall Study||0
19146|NCT02299635|47055|P1|STARTED|Overall Study||19
19147|NCT02299427|47076|P2|NOT COMPLETED|Overall Study||3
19148|NCT02299427|47077|P1|NOT COMPLETED|Overall Study||23
19149|NCT02299427|47076|P2|COMPLETED|Overall Study||31
19150|NCT02299427|47077|P1|COMPLETED|Overall Study||12
19151|NCT02299427|47076|P2|STARTED|Overall Study||34
19152|NCT02299427|47077|P1|STARTED|Overall Study||35
19153|NCT02299349|47087|P2|NOT COMPLETED|Overall Study||0
19154|NCT02299349|47088|P1|NOT COMPLETED|Overall Study||0
19155|NCT02299349|47087|P2|COMPLETED|Overall Study||35
19156|NCT02299349|47088|P1|COMPLETED|Overall Study||35
19157|NCT02299349|47087|P2|STARTED|Overall Study||35
19158|NCT02299349|47088|P1|STARTED|Overall Study||35
19159|NCT02299258|47098|P2|NOT COMPLETED|Overall Study||1
19160|NCT02299258|47099|P1|NOT COMPLETED|Overall Study||1
19161|NCT02299258|47098|P2|COMPLETED|Overall Study||30
19162|NCT02299258|47099|P1|COMPLETED|Overall Study||31
19163|NCT02299258|47098|P2|STARTED|Overall Study||31
19164|NCT02299258|47099|P1|STARTED|Overall Study||32
19165|NCT02299206|47107|P1|NOT COMPLETED|Overall Study||2
19166|NCT02299206|47107|P1|COMPLETED|Overall Study||2
19167|NCT02299206|47107|P1|STARTED|Overall Study||4
19168|NCT02299089|47119|P4|NOT COMPLETED|Overall Study||0
19169|NCT02299089|47120|P3|NOT COMPLETED|Overall Study||0
19170|NCT02299089|47121|P2|NOT COMPLETED|Overall Study||0
19171|NCT02299089|47122|P1|NOT COMPLETED|Overall Study||0
19172|NCT02299089|47119|P4|COMPLETED|Overall Study||4
19173|NCT02299089|47120|P3|COMPLETED|Overall Study||1
19174|NCT02299089|47121|P2|COMPLETED|Overall Study||4
19175|NCT02299089|47122|P1|COMPLETED|Overall Study||3
19176|NCT02299089|47119|P4|STARTED|Overall Study||4
19177|NCT02299089|47120|P3|STARTED|Overall Study||1
19178|NCT02299089|47121|P2|STARTED|Overall Study||4
19179|NCT02299089|47122|P1|STARTED|Overall Study||3
19180|NCT02299076|47168|P2|NOT COMPLETED|Overall Study||14
19181|NCT02299076|47169|P1|NOT COMPLETED|Overall Study||20
19182|NCT02299076|47168|P2|COMPLETED|Overall Study||212
19183|NCT02299076|47169|P1|COMPLETED|Overall Study||210
19184|NCT02299076|47168|P2|STARTED|Overall Study||226
19185|NCT02299076|47169|P1|STARTED|Overall Study||230
19186|NCT02298868|47177|P1|NOT COMPLETED|Overall Study||3
19187|NCT02298868|47177|P1|COMPLETED|Overall Study||7
19188|NCT02298868|47177|P1|STARTED|Overall Study||10
19189|NCT02298842|47191|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
19285|NCT02295774|47440|P1|NOT COMPLETED|Overall Study||3
19190|NCT02298842|47192|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
19191|NCT02298842|47191|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
19192|NCT02298842|47192|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
19193|NCT02298842|47191|P2|STARTED|Second Platelet Donation (Day 6-8)||36
19194|NCT02298842|47192|P1|STARTED|Second Platelet Donation (Day 6-8)||38
19195|NCT02298842|47191|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
19196|NCT02298842|47192|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
19197|NCT02298842|47191|P2|COMPLETED|First Platelet Donation (Day 0)||36
19198|NCT02298842|47192|P1|COMPLETED|First Platelet Donation (Day 0)||38
19199|NCT02298842|47191|P2|STARTED|First Platelet Donation (Day 0)||41
19200|NCT02298842|47192|P1|STARTED|First Platelet Donation (Day 0)||44
19201|NCT02298803|47218|P1|NOT COMPLETED|Overall Study||0
19202|NCT02298803|47218|P1|COMPLETED|Overall Study||30
19203|NCT02298803|47218|P1|STARTED|Overall Study||30
19204|NCT02298361|47230|P3|NOT COMPLETED|Overall Study||0
19205|NCT02298361|47231|P2|NOT COMPLETED|Overall Study||0
19206|NCT02298361|47232|P1|NOT COMPLETED|Overall Study||0
19207|NCT02298361|47230|P3|COMPLETED|Overall Study||12227
19208|NCT02298361|47231|P2|COMPLETED|Overall Study||12784
19209|NCT02298361|47232|P1|COMPLETED|Overall Study||2240
19210|NCT02298361|47230|P3|STARTED|Overall Study||12227
19211|NCT02298361|47231|P2|STARTED|Overall Study||12784
19212|NCT02298361|47232|P1|STARTED|Overall Study||2240
19213|NCT02298192|47248|P2|NOT COMPLETED|Overall Study||6
19214|NCT02298192|47249|P1|NOT COMPLETED|Overall Study||19
19215|NCT02298192|47248|P2|COMPLETED|Overall Study||204
19216|NCT02298192|47249|P1|COMPLETED|Overall Study||191
19217|NCT02298192|47248|P2|STARTED|Overall Study||210
19218|NCT02298192|47249|P1|STARTED|Overall Study||210
19219|NCT02297841|47261|P1|NOT COMPLETED|Overall Study||8
19220|NCT02297841|47261|P1|COMPLETED|Overall Study||201
19221|NCT02297841|47261|P1|Challenge Phase|Overall Study||201
19222|NCT02297841|47261|P1|Induction Phase|Overall Study||209
19223|NCT02297841|47261|P1|STARTED|Overall Study||209
19224|NCT02297815|47267|P2|NOT COMPLETED|Overall Study||140
19225|NCT02297815|47268|P1|NOT COMPLETED|Overall Study||236
19226|NCT02297815|47267|P2|COMPLETED|Overall Study||728
19227|NCT02297815|47268|P1|COMPLETED|Overall Study||1368
19228|NCT02297815|47267|P2|14-20 Day Interview|Overall Study||728
19229|NCT02297815|47268|P1|14-20 Day Interview|Overall Study||1368
19230|NCT02297815|47267|P2|5-10 Day Interview|Overall Study||868
19231|NCT02297815|47268|P1|5-10 Day Interview|Overall Study||1604
19232|NCT02297815|47267|P2|STARTED|Overall Study||868
19233|NCT02297815|47268|P1|STARTED|Overall Study||1604
19234|NCT02297308|47282|P1|NOT COMPLETED|Overall Study||0
19235|NCT02297308|47282|P1|COMPLETED|Overall Study||90
19236|NCT02297308|47282|P1|STARTED|Overall Study||90
19237|NCT02297230|47291|P4|NOT COMPLETED|Overall Study||0
19238|NCT02297230|47292|P3|NOT COMPLETED|Overall Study||0
19239|NCT02297230|47293|P2|NOT COMPLETED|Overall Study||0
19240|NCT02297230|47294|P1|NOT COMPLETED|Overall Study||0
19241|NCT02297230|47291|P4|COMPLETED|Overall Study||11
19242|NCT02297230|47292|P3|COMPLETED|Overall Study||11
19243|NCT02297230|47293|P2|COMPLETED|Overall Study||11
19244|NCT02297230|47294|P1|COMPLETED|Overall Study||11
19245|NCT02297230|47291|P4|STARTED|Overall Study||11
19246|NCT02297230|47292|P3|STARTED|Overall Study||11
19247|NCT02297230|47293|P2|STARTED|Overall Study||11
19248|NCT02297230|47294|P1|STARTED|Overall Study||11
19249|NCT02297100|47318|P2|NOT COMPLETED|Overall Study||0
19250|NCT02297100|47319|P1|NOT COMPLETED|Overall Study||0
19251|NCT02297100|47318|P2|COMPLETED|Overall Study||14
19252|NCT02297100|47319|P1|COMPLETED|Overall Study||13
19253|NCT02297100|47318|P2|STARTED|Overall Study||14
19254|NCT02297100|47319|P1|STARTED|Overall Study||13
19255|NCT02296931|47333|P2|NOT COMPLETED|Overall Study||2
19256|NCT02296931|47334|P1|NOT COMPLETED|Overall Study||0
19257|NCT02296931|47333|P2|COMPLETED|Overall Study||22
19258|NCT02296931|47334|P1|COMPLETED|Overall Study||10
19259|NCT02296931|47333|P2|STARTED|Overall Study||24
19260|NCT02296931|47334|P1|STARTED|Overall Study||10
19261|NCT02296840|47342|P2|NOT COMPLETED|Overall Study||19
19262|NCT02296840|47343|P1|NOT COMPLETED|Overall Study||9
19263|NCT02296840|47342|P2|COMPLETED|Overall Study||8
19264|NCT02296840|47343|P1|COMPLETED|Overall Study||9
19265|NCT02296840|47342|P2|STARTED|Overall Study||27
19266|NCT02296840|47343|P1|STARTED|Overall Study||18
19267|NCT02296606|47351|P1|NOT COMPLETED|Overall Study||0
19268|NCT02296606|47351|P1|COMPLETED|Overall Study||127
19269|NCT02296606|47351|P1|STARTED|Overall Study||127
19270|NCT02296476|47358|P3|NOT COMPLETED|Overall Study||2
19271|NCT02296476|47359|P2|NOT COMPLETED|Overall Study||4
19272|NCT02296476|47360|P1|NOT COMPLETED|Overall Study||6
19273|NCT02296476|47358|P3|COMPLETED|Overall Study||0
19274|NCT02296476|47359|P2|COMPLETED|Overall Study||0
19275|NCT02296476|47360|P1|COMPLETED|Overall Study||0
19276|NCT02296476|47358|P3|STARTED|Overall Study||2
19277|NCT02296476|47359|P2|STARTED|Overall Study||4
19278|NCT02296476|47360|P1|STARTED|Overall Study||6
19279|NCT02296099|47415|P2|NOT COMPLETED|Overall Study||2
19280|NCT02296099|47416|P1|NOT COMPLETED|Overall Study||3
19281|NCT02296099|47415|P2|COMPLETED|Overall Study||55
19282|NCT02296099|47416|P1|COMPLETED|Overall Study||54
19283|NCT02296099|47415|P2|STARTED|Overall Study||57
19286|NCT02295774|47440|P1|COMPLETED|Overall Study||10
19287|NCT02295774|47440|P1|STARTED|Overall Study||13
19288|NCT02295644|47448|P4|NOT COMPLETED|Overall Study||2
19289|NCT02295644|47449|P3|NOT COMPLETED|Overall Study||1
19290|NCT02295644|47450|P2|NOT COMPLETED|Overall Study||0
19291|NCT02295644|47451|P1|NOT COMPLETED|Overall Study||0
19292|NCT02295644|47448|P4|COMPLETED|Overall Study|Two subjects did not meet inclusion criterion of pain intensity of ≥4 on the Diagnostic Criteria|5
19293|NCT02295644|47449|P3|COMPLETED|Overall Study|One subject did not meet inclusion criterion of pain intensity of ≥4 on Diagnostic Criteria for TMD|6
19294|NCT02295644|47450|P2|COMPLETED|Overall Study||7
19295|NCT02295644|47451|P1|COMPLETED|Overall Study||7
19296|NCT02295644|47448|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
19297|NCT02295644|47449|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
19298|NCT02295644|47450|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
19299|NCT02295644|47451|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
19300|NCT02295280|47471|P2|NOT COMPLETED|Overall Study||1
19301|NCT02295280|47472|P1|NOT COMPLETED|Overall Study||0
19302|NCT02295280|47471|P2|COMPLETED|Overall Study||34
19303|NCT02295280|47472|P1|COMPLETED|Overall Study||35
19304|NCT02295280|47471|P2|STARTED|Overall Study||35
19305|NCT02295280|47472|P1|STARTED|Overall Study||35
19306|NCT02295020|47480|P2|NOT COMPLETED|Overall Study||3
19307|NCT02295020|47481|P1|NOT COMPLETED|Overall Study||3
19308|NCT02295020|47480|P2|COMPLETED|Overall Study||17
19309|NCT02295020|47481|P1|COMPLETED|Overall Study||17
19310|NCT02295020|47480|P2|STARTED|Overall Study||20
19311|NCT02295020|47481|P1|STARTED|Overall Study||20
19312|NCT02294773|47513|P2|NOT COMPLETED|Overall Study||2
19313|NCT02294773|47514|P1|NOT COMPLETED|Overall Study||0
19314|NCT02294773|47513|P2|COMPLETED|Overall Study||4
19315|NCT02294773|47514|P1|COMPLETED|Overall Study||7
19316|NCT02294773|47513|P2|STARTED|Overall Study||6
19317|NCT02294773|47514|P1|STARTED|Overall Study||7
19318|NCT02294734|47530|P2|NOT COMPLETED|Overall Study||8
19319|NCT02294734|47531|P1|NOT COMPLETED|Overall Study||14
19320|NCT02294734|47530|P2|COMPLETED|Overall Study||55
19321|NCT02294734|47531|P1|COMPLETED|Overall Study||49
19322|NCT02294734|47530|P2|STARTED|Overall Study||63
19323|NCT02294734|47531|P1|STARTED|Overall Study||63
19324|NCT02294682|47583|P2|NOT COMPLETED|Overall Study||0
19325|NCT02294682|47584|P1|NOT COMPLETED|Overall Study||1
19326|NCT02294682|47583|P2|COMPLETED|Overall Study||53
19327|NCT02294682|47584|P1|COMPLETED|Overall Study||52
19328|NCT02294682|47583|P2|STARTED|Overall Study||53
19329|NCT02294682|47584|P1|STARTED|Overall Study||53
19330|NCT02294604|47627|P3|NOT COMPLETED|Overall Study||0
19331|NCT02294604|47628|P2|NOT COMPLETED|Overall Study||3
19332|NCT02294604|47629|P1|NOT COMPLETED|Overall Study||1
19333|NCT02294604|47627|P3|COMPLETED|Overall Study||80
19334|NCT02294604|47628|P2|COMPLETED|Overall Study||77
19335|NCT02294604|47629|P1|COMPLETED|Overall Study||79
19336|NCT02294604|47627|P3|STARTED|Overall Study||80
19337|NCT02294604|47628|P2|STARTED|Overall Study||80
19338|NCT02294604|47629|P1|STARTED|Overall Study||80
19339|NCT02294474|47648|P2|NOT COMPLETED|Overall Study||22
19340|NCT02294474|47649|P1|NOT COMPLETED|Overall Study||25
19341|NCT02294474|47648|P2|COMPLETED|Overall Study||230
19342|NCT02294474|47649|P1|COMPLETED|Overall Study||228
19343|NCT02294474|47648|P2|STARTED|Overall Study||252
19344|NCT02294474|47649|P1|STARTED|Overall Study||253
19345|NCT02294461|47673|P2|NOT COMPLETED|Overall Study||131
19346|NCT02294461|47674|P1|NOT COMPLETED|Overall Study||62
19347|NCT02294461|47673|P2|COMPLETED|Overall Study||59
19348|NCT02294461|47674|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
19349|NCT02294461|47673|P2|Treated/Received Study Drug|Overall Study||190
19350|NCT02294461|47674|P1|Treated/Received Study Drug|Overall Study||198
19351|NCT02294461|47673|P2|STARTED|Overall Study||190
19352|NCT02294461|47674|P1|STARTED|Overall Study||198
19353|NCT02294019|47726|P1|NOT COMPLETED|Overall Study||103
19354|NCT02294019|47726|P1|COMPLETED|Overall Study||635
19355|NCT02294019|47726|P1|STARTED|Overall Study||738
19356|NCT02293902|47734|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
19357|NCT02293902|47735|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
19358|NCT02293902|47736|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
19359|NCT02293902|47737|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
19360|NCT02293902|47738|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
19361|NCT02293902|47734|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
19362|NCT02293902|47735|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
19363|NCT02293902|47736|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
19364|NCT02293902|47737|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
19365|NCT02293902|47738|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
19366|NCT02293902|47734|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
19446|NCT02292433|47876|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
19367|NCT02293902|47735|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
19368|NCT02293902|47736|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
19369|NCT02293902|47737|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
19370|NCT02293902|47738|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
19371|NCT02293902|47734|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
19372|NCT02293902|47735|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
19373|NCT02293902|47736|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
19374|NCT02293902|47737|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
19375|NCT02293902|47738|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
19376|NCT02293902|47734|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
19377|NCT02293902|47735|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
19378|NCT02293902|47736|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
19379|NCT02293902|47737|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
19380|NCT02293902|47738|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
19381|NCT02293902|47734|P5|Rescued|Double-Blind Period (Up to Week 24)||0
19382|NCT02293902|47735|P4|Rescued|Double-Blind Period (Up to Week 24)||0
19383|NCT02293902|47736|P3|Rescued|Double-Blind Period (Up to Week 24)||8
19384|NCT02293902|47737|P2|Rescued|Double-Blind Period (Up to Week 24)||6
19385|NCT02293902|47738|P1|Rescued|Double-Blind Period (Up to Week 24)||44
19386|NCT02293902|47734|P5|Treated|Double-Blind Period (Up to Week 24)||0
19387|NCT02293902|47735|P4|Treated|Double-Blind Period (Up to Week 24)||0
19388|NCT02293902|47736|P3|Treated|Double-Blind Period (Up to Week 24)||80
19389|NCT02293902|47737|P2|Treated|Double-Blind Period (Up to Week 24)||81
19390|NCT02293902|47738|P1|Treated|Double-Blind Period (Up to Week 24)||81
19391|NCT02293902|47734|P5|STARTED|Double-Blind Period (Up to Week 24)||0
19392|NCT02293902|47735|P4|STARTED|Double-Blind Period (Up to Week 24)||0
19393|NCT02293902|47736|P3|STARTED|Double-Blind Period (Up to Week 24)||80
19394|NCT02293902|47737|P2|STARTED|Double-Blind Period (Up to Week 24)||81
19395|NCT02293902|47738|P1|STARTED|Double-Blind Period (Up to Week 24)||82
19396|NCT02293538|47799|P2|NOT COMPLETED|Overall Study||2
19397|NCT02293538|47800|P1|NOT COMPLETED|Overall Study||1
19398|NCT02293538|47799|P2|COMPLETED|Overall Study||69
19399|NCT02293538|47800|P1|COMPLETED|Overall Study||72
19400|NCT02293538|47799|P2|STARTED|Overall Study||71
19401|NCT02293538|47800|P1|STARTED|Overall Study||73
19402|NCT02293395|47815|P2|NOT COMPLETED|Overall Study||7
19403|NCT02293395|47816|P1|NOT COMPLETED|Overall Study||9
19404|NCT02293395|47815|P2|COMPLETED|Overall Study||1511
19405|NCT02293395|47816|P1|COMPLETED|Overall Study||1510
19406|NCT02293395|47815|P2|Treated|Overall Study||1506
19407|NCT02293395|47816|P1|Treated|Overall Study||1510
19408|NCT02293395|47815|P2|STARTED|Overall Study||1518
19409|NCT02293395|47816|P1|STARTED|Overall Study||1519
19410|NCT02292849|47825|P3|NOT COMPLETED|Overall Study||2
19411|NCT02292849|47826|P2|NOT COMPLETED|Overall Study||2
19412|NCT02292849|47827|P1|NOT COMPLETED|Overall Study||4
19413|NCT02292849|47825|P3|COMPLETED|Overall Study||8
19414|NCT02292849|47826|P2|COMPLETED|Overall Study||6
19415|NCT02292849|47827|P1|COMPLETED|Overall Study||7
19416|NCT02292849|47825|P3|STARTED|Overall Study||10
19417|NCT02292849|47826|P2|STARTED|Overall Study||8
19418|NCT02292849|47827|P1|STARTED|Overall Study||11
19419|NCT02292537|47837|P2|NOT COMPLETED|Overall Study||0
19420|NCT02292537|47838|P1|NOT COMPLETED|Overall Study||0
19421|NCT02292537|47837|P2|COMPLETED|Overall Study||84
19422|NCT02292537|47838|P1|COMPLETED|Overall Study||42
19423|NCT02292537|47837|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
19424|NCT02292537|47838|P1|Completed Treatment|Overall Study||42
19425|NCT02292537|47837|P2|STARTED|Overall Study||84
19426|NCT02292537|47838|P1|STARTED|Overall Study||42
19427|NCT02292433|47875|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
19428|NCT02292433|47876|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
19429|NCT02292433|47877|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
19430|NCT02292433|47875|P3|COMPLETED|Third Intervention Period (7 Days)||4
19431|NCT02292433|47876|P2|COMPLETED|Third Intervention Period (7 Days)||4
19432|NCT02292433|47877|P1|COMPLETED|Third Intervention Period (7 Days)||4
19433|NCT02292433|47875|P3|STARTED|Third Intervention Period (7 Days)||4
19434|NCT02292433|47876|P2|STARTED|Third Intervention Period (7 Days)||4
19435|NCT02292433|47877|P1|STARTED|Third Intervention Period (7 Days)||4
19436|NCT02292433|47875|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
19437|NCT02292433|47876|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
19438|NCT02292433|47877|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
19439|NCT02292433|47875|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
19440|NCT02292433|47876|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
19441|NCT02292433|47877|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
19442|NCT02292433|47875|P3|STARTED|Second Washout Period (7 to 14 Days)||4
19443|NCT02292433|47876|P2|STARTED|Second Washout Period (7 to 14 Days)||4
19444|NCT02292433|47877|P1|STARTED|Second Washout Period (7 to 14 Days)||4
19445|NCT02292433|47875|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
19447|NCT02292433|47877|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
19448|NCT02292433|47875|P3|COMPLETED|Second Intervention Period (7 Days)||4
19449|NCT02292433|47876|P2|COMPLETED|Second Intervention Period (7 Days)||4
19450|NCT02292433|47877|P1|COMPLETED|Second Intervention Period (7 Days)||4
19451|NCT02292433|47875|P3|STARTED|Second Intervention Period (7 Days)||4
19452|NCT02292433|47876|P2|STARTED|Second Intervention Period (7 Days)||4
19453|NCT02292433|47877|P1|STARTED|Second Intervention Period (7 Days)||4
19454|NCT02292433|47875|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
19455|NCT02292433|47876|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
19456|NCT02292433|47877|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
19457|NCT02292433|47875|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
19458|NCT02292433|47876|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
19459|NCT02292433|47877|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
19460|NCT02292433|47875|P3|STARTED|First Washout Period (7 to 14 Days)||4
19461|NCT02292433|47876|P2|STARTED|First Washout Period (7 to 14 Days)||4
19462|NCT02292433|47877|P1|STARTED|First Washout Period (7 to 14 Days)||4
19463|NCT02292433|47875|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
19464|NCT02292433|47876|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
19465|NCT02292433|47877|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
19466|NCT02292433|47875|P3|COMPLETED|First Intervention Period (7 Days)||4
19467|NCT02292433|47876|P2|COMPLETED|First Intervention Period (7 Days)||4
19468|NCT02292433|47877|P1|COMPLETED|First Intervention Period (7 Days)||4
19469|NCT02292433|47875|P3|STARTED|First Intervention Period (7 Days)||4
19470|NCT02292433|47876|P2|STARTED|First Intervention Period (7 Days)||4
19471|NCT02292433|47877|P1|STARTED|First Intervention Period (7 Days)||4
19472|NCT02292212|47948|P1|NOT COMPLETED|Post-ViE Phase||0
19473|NCT02292212|47948|P1|COMPLETED|Post-ViE Phase||14
19474|NCT02292212|47948|P1|STARTED|Post-ViE Phase||14
19475|NCT02292212|47948|P1|NOT COMPLETED|ViE Phase||3
19476|NCT02292212|47948|P1|COMPLETED|ViE Phase||14
19477|NCT02292212|47948|P1|STARTED|ViE Phase||17
19478|NCT02292212|47948|P1|NOT COMPLETED|Pre-ViE Phase||0
19479|NCT02292212|47948|P1|COMPLETED|Pre-ViE Phase||17
19480|NCT02292212|47948|P1|STARTED|Pre-ViE Phase||17
19481|NCT02291861|47984|P4|NOT COMPLETED|Overall Study||10
19482|NCT02291861|47985|P3|NOT COMPLETED|Overall Study||9
19483|NCT02291861|47986|P2|NOT COMPLETED|Overall Study||8
19484|NCT02291861|47987|P1|NOT COMPLETED|Overall Study||7
19485|NCT02291861|47984|P4|COMPLETED|Overall Study||65
19486|NCT02291861|47985|P3|COMPLETED|Overall Study||65
19487|NCT02291861|47986|P2|COMPLETED|Overall Study||67
19488|NCT02291861|47987|P1|COMPLETED|Overall Study||67
19489|NCT02291861|47984|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
19490|NCT02291861|47985|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
19491|NCT02291861|47986|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
19492|NCT02291861|47987|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
19493|NCT02291861|47984|P4|Safety Population|Overall Study||74
19494|NCT02291861|47985|P3|Safety Population|Overall Study||73
19495|NCT02291861|47986|P2|Safety Population|Overall Study||74
19496|NCT02291861|47987|P1|Safety Population|Overall Study||72
19497|NCT02291861|47984|P4|STARTED|Overall Study||75
19498|NCT02291861|47985|P3|STARTED|Overall Study||74
19499|NCT02291861|47986|P2|STARTED|Overall Study||75
19500|NCT02291861|47987|P1|STARTED|Overall Study||74
19501|NCT02291718|48028|P3|NOT COMPLETED|Overall Study||0
19502|NCT02291718|48029|P2|NOT COMPLETED|Overall Study||0
19503|NCT02291718|48030|P1|NOT COMPLETED|Overall Study||0
19504|NCT02291718|48028|P3|COMPLETED|Overall Study||50
19505|NCT02291718|48029|P2|COMPLETED|Overall Study||50
19506|NCT02291718|48030|P1|COMPLETED|Overall Study||50
19507|NCT02291718|48028|P3|STARTED|Overall Study||50
19508|NCT02291718|48029|P2|STARTED|Overall Study||50
19509|NCT02291718|48030|P1|STARTED|Overall Study||50
19510|NCT02291679|48050|P3|NOT COMPLETED|Overall Study||59
19511|NCT02291679|48051|P2|NOT COMPLETED|Overall Study||42
19512|NCT02291679|48052|P1|NOT COMPLETED|Overall Study||44
19513|NCT02291679|48050|P3|COMPLETED|Overall Study||352
19514|NCT02291679|48051|P2|COMPLETED|Overall Study||369
19515|NCT02291679|48052|P1|COMPLETED|Overall Study||357
19516|NCT02291679|48050|P3|STARTED|Overall Study||411
19517|NCT02291679|48051|P2|STARTED|Overall Study||411
19518|NCT02291679|48052|P1|STARTED|Overall Study||401
19519|NCT02291510|48085|P4|NOT COMPLETED|Overall Study||1
19520|NCT02291510|48086|P3|NOT COMPLETED|Overall Study||0
19521|NCT02291510|48087|P2|NOT COMPLETED|Overall Study||0
19522|NCT02291510|48088|P1|NOT COMPLETED|Overall Study||0
19523|NCT02291510|48085|P4|COMPLETED|Overall Study||4
19524|NCT02291510|48086|P3|COMPLETED|Overall Study||5
19525|NCT02291510|48087|P2|COMPLETED|Overall Study||5
19526|NCT02291510|48088|P1|COMPLETED|Overall Study||5
19527|NCT02291510|48085|P4|Completed Treatment D|Overall Study||5
19528|NCT02291510|48086|P3|Completed Treatment D|Overall Study||5
19529|NCT02291510|48087|P2|Completed Treatment D|Overall Study||5
19530|NCT02291510|48088|P1|Completed Treatment D|Overall Study||5
19531|NCT02291510|48085|P4|Completed Treatment C|Overall Study||4
19532|NCT02291510|48086|P3|Completed Treatment C|Overall Study||5
19533|NCT02291510|48087|P2|Completed Treatment C|Overall Study||5
19534|NCT02291510|48088|P1|Completed Treatment C|Overall Study||5
19535|NCT02291510|48085|P4|Completed Treatment B|Overall Study||4
19536|NCT02291510|48086|P3|Completed Treatment B|Overall Study||5
19537|NCT02291510|48087|P2|Completed Treatment B|Overall Study||5
19538|NCT02291510|48088|P1|Completed Treatment B|Overall Study||5
19539|NCT02291510|48085|P4|Completed Treatment A|Overall Study||5
19540|NCT02291510|48086|P3|Completed Treatment A|Overall Study||5
19541|NCT02291510|48087|P2|Completed Treatment A|Overall Study||5
19542|NCT02291510|48088|P1|Completed Treatment A|Overall Study||5
19543|NCT02291510|48085|P4|STARTED|Overall Study||5
19544|NCT02291510|48086|P3|STARTED|Overall Study||5
19545|NCT02291510|48087|P2|STARTED|Overall Study||5
19546|NCT02291510|48088|P1|STARTED|Overall Study||5
19547|NCT02291419|48104|P2|NOT COMPLETED|Overall Study||5
19548|NCT02291419|48105|P1|NOT COMPLETED|Overall Study||1
19549|NCT02291419|48104|P2|COMPLETED|Overall Study||0
19550|NCT02291419|48105|P1|COMPLETED|Overall Study||0
19551|NCT02291419|48104|P2|STARTED|Overall Study||5
19552|NCT02291419|48105|P1|STARTED|Overall Study||1
19553|NCT02291237|48123|P2|NOT COMPLETED|Overall Study||86
19554|NCT02291237|48124|P1|NOT COMPLETED|Overall Study||86
19555|NCT02291237|48123|P2|COMPLETED|Overall Study||0
19556|NCT02291237|48124|P1|COMPLETED|Overall Study||0
19557|NCT02291237|48123|P2|STARTED|Overall Study||86
19558|NCT02291237|48124|P1|STARTED|Overall Study||86
19559|NCT02290821|48142|P2|NOT COMPLETED|Overall Study||3
19560|NCT02290821|48143|P1|NOT COMPLETED|Overall Study||6
19561|NCT02290821|48142|P2|COMPLETED|Overall Study||103
19562|NCT02290821|48143|P1|COMPLETED|Overall Study||103
19563|NCT02290821|48142|P2|STARTED|Overall Study||106
19564|NCT02290821|48143|P1|STARTED|Overall Study||109
19565|NCT02290691|48151|P2|NOT COMPLETED|Overall Study||9
19566|NCT02290691|48152|P1|NOT COMPLETED|Overall Study||8
19567|NCT02290691|48151|P2|COMPLETED|Overall Study||479
19568|NCT02290691|48152|P1|COMPLETED|Overall Study||488
19569|NCT02290691|48151|P2|STARTED|Overall Study||488
19570|NCT02290691|48152|P1|STARTED|Overall Study||496
19571|NCT02290509|48168|P2|NOT COMPLETED|Overall Study||14
19572|NCT02290509|48169|P1|NOT COMPLETED|Overall Study||49
19573|NCT02290509|48168|P2|COMPLETED|Overall Study||325
19574|NCT02290509|48169|P1|COMPLETED|Overall Study||962
19575|NCT02290509|48168|P2|STARTED|Overall Study||339
19576|NCT02290509|48169|P1|STARTED|Overall Study||1011
19577|NCT02289989|48183|P2|NOT COMPLETED|Overall Study||0
19578|NCT02289989|48184|P1|NOT COMPLETED|Overall Study||0
19579|NCT02289989|48183|P2|COMPLETED|Overall Study||1
19580|NCT02289989|48184|P1|COMPLETED|Overall Study||0
19581|NCT02289989|48183|P2|STARTED|Overall Study||1
19582|NCT02289989|48184|P1|STARTED|Overall Study||0
19583|NCT02289963|48202|P2|NOT COMPLETED|Overall Study||10
19584|NCT02289963|48203|P1|NOT COMPLETED|Overall Study||5
19585|NCT02289963|48202|P2|COMPLETED|Overall Study||87
19586|NCT02289963|48203|P1|COMPLETED|Overall Study||97
19587|NCT02289963|48202|P2|Treated|Overall Study||97
19588|NCT02289963|48203|P1|Treated|Overall Study||102
19589|NCT02289963|48202|P2|STARTED|Overall Study|Randomized|97
19590|NCT02289963|48203|P1|STARTED|Overall Study|Randomized|102
19591|NCT02289833|48253|P2|NOT COMPLETED|Overall Study||20
19592|NCT02289833|48254|P1|NOT COMPLETED|Overall Study||29
19593|NCT02289833|48253|P2|COMPLETED|Overall Study||0
19594|NCT02289833|48254|P1|COMPLETED|Overall Study||0
19595|NCT02289833|48253|P2|STARTED|Overall Study||20
19596|NCT02289833|48254|P1|STARTED|Overall Study||29
19597|NCT02289820|48292|P7|NOT COMPLETED|Overall Study||2
19598|NCT02289820|48293|P6|NOT COMPLETED|Overall Study||1
19599|NCT02289820|48294|P5|NOT COMPLETED|Overall Study||0
19600|NCT02289820|48295|P4|NOT COMPLETED|Overall Study||2
19601|NCT02289820|48296|P3|NOT COMPLETED|Overall Study||6
19602|NCT02289820|48297|P2|NOT COMPLETED|Overall Study||2
19603|NCT02289820|48298|P1|NOT COMPLETED|Overall Study||2
19604|NCT02289820|48292|P7|COMPLETED|Overall Study||37
19605|NCT02289820|48293|P6|COMPLETED|Overall Study||39
19606|NCT02289820|48294|P5|COMPLETED|Overall Study||40
19607|NCT02289820|48295|P4|COMPLETED|Overall Study||37
19608|NCT02289820|48296|P3|COMPLETED|Overall Study||38
19609|NCT02289820|48297|P2|COMPLETED|Overall Study||18
19610|NCT02289820|48298|P1|COMPLETED|Overall Study||37
19611|NCT02289820|48292|P7|STARTED|Overall Study||39
19612|NCT02289820|48293|P6|STARTED|Overall Study||40
19613|NCT02289820|48294|P5|STARTED|Overall Study||40
19614|NCT02289820|48295|P4|STARTED|Overall Study||39
19615|NCT02289820|48296|P3|STARTED|Overall Study||44
19616|NCT02289820|48297|P2|STARTED|Overall Study||20
19617|NCT02289820|48298|P1|STARTED|Overall Study||39
19618|NCT02289755|48409|P1|NOT COMPLETED|Follow up Period [4 Days]||0
19619|NCT02289755|48409|P1|COMPLETED|Follow up Period [4 Days]||16
19620|NCT02289755|48409|P1|STARTED|Follow up Period [4 Days]||16
19621|NCT02289755|48409|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
19622|NCT02289755|48409|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
19623|NCT02289755|48409|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
19624|NCT02289755|48409|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
19625|NCT02289755|48409|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
19626|NCT02289755|48409|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
19627|NCT02289742|48416|P4|NOT COMPLETED|Third Wear Period||1
19628|NCT02289742|48417|P3|NOT COMPLETED|Third Wear Period||0
19629|NCT02289742|48418|P2|NOT COMPLETED|Third Wear Period||1
19630|NCT02289742|48419|P1|NOT COMPLETED|Third Wear Period||0
19631|NCT02289742|48416|P4|COMPLETED|Third Wear Period||8
19632|NCT02289742|48417|P3|COMPLETED|Third Wear Period||11
19633|NCT02289742|48418|P2|COMPLETED|Third Wear Period||10
19634|NCT02289742|48419|P1|COMPLETED|Third Wear Period||11
19635|NCT02289742|48416|P4|STARTED|Third Wear Period||9
19636|NCT02289742|48417|P3|STARTED|Third Wear Period||11
19637|NCT02289742|48418|P2|STARTED|Third Wear Period||11
19638|NCT02289742|48419|P1|STARTED|Third Wear Period||11
19639|NCT02289742|48416|P4|NOT COMPLETED|Second Wear Period||0
19640|NCT02289742|48417|P3|NOT COMPLETED|Second Wear Period||0
19641|NCT02289742|48418|P2|NOT COMPLETED|Second Wear Period||0
19642|NCT02289742|48419|P1|NOT COMPLETED|Second Wear Period||0
19643|NCT02289742|48416|P4|COMPLETED|Second Wear Period||9
19644|NCT02289742|48417|P3|COMPLETED|Second Wear Period||11
19645|NCT02289742|48418|P2|COMPLETED|Second Wear Period||11
19646|NCT02289742|48419|P1|COMPLETED|Second Wear Period||11
19647|NCT02289742|48416|P4|STARTED|Second Wear Period||9
19648|NCT02289742|48417|P3|STARTED|Second Wear Period||11
19649|NCT02289742|48418|P2|STARTED|Second Wear Period||11
19650|NCT02289742|48419|P1|STARTED|Second Wear Period||11
19651|NCT02289742|48416|P4|NOT COMPLETED|First Wear Period||1
19652|NCT02289742|48417|P3|NOT COMPLETED|First Wear Period||1
19653|NCT02289742|48418|P2|NOT COMPLETED|First Wear Period||1
19654|NCT02289742|48419|P1|NOT COMPLETED|First Wear Period||0
19655|NCT02289742|48416|P4|COMPLETED|First Wear Period||9
19656|NCT02289742|48417|P3|COMPLETED|First Wear Period||11
19657|NCT02289742|48418|P2|COMPLETED|First Wear Period||11
19658|NCT02289742|48419|P1|COMPLETED|First Wear Period||11
19659|NCT02289742|48416|P4|Treated|First Wear Period||9
19660|NCT02289742|48417|P3|Treated|First Wear Period||12
19661|NCT02289742|48418|P2|Treated|First Wear Period||11
19662|NCT02289742|48419|P1|Treated|First Wear Period||11
19663|NCT02289742|48416|P4|STARTED|First Wear Period||10
19664|NCT02289742|48417|P3|STARTED|First Wear Period||12
19665|NCT02289742|48418|P2|STARTED|First Wear Period||12
19666|NCT02289742|48419|P1|STARTED|First Wear Period||11
19667|NCT02289469|48438|P2|NOT COMPLETED|Overall Study||0
19668|NCT02289469|48439|P1|NOT COMPLETED|Overall Study||6
19669|NCT02289469|48438|P2|COMPLETED|Overall Study||244
19670|NCT02289469|48439|P1|COMPLETED|Overall Study||244
19671|NCT02289469|48438|P2|STARTED|Overall Study||244
19672|NCT02289469|48439|P1|STARTED|Overall Study||250
19673|NCT02289456|48447|P1|NOT COMPLETED|Monotherapy Period||16
19674|NCT02289456|48447|P1|COMPLETED|Monotherapy Period||0
19675|NCT02289456|48447|P1|STARTED|Monotherapy Period||16
19676|NCT02289456|48447|P1|NOT COMPLETED|Induction Period||24
19677|NCT02289456|48447|P1|COMPLETED|Induction Period||16
19678|NCT02289456|48447|P1|Treated Population|Induction Period||40
19679|NCT02289456|48447|P1|STARTED|Induction Period||40
19680|NCT02289105|48469|P2|NOT COMPLETED|Overall Study||0
19681|NCT02289105|48470|P1|NOT COMPLETED|Overall Study||0
19682|NCT02289105|48469|P2|COMPLETED|Overall Study||637
19683|NCT02289105|48470|P1|COMPLETED|Overall Study||642
19684|NCT02289105|48469|P2|STARTED|Overall Study||637
19685|NCT02289105|48470|P1|STARTED|Overall Study||642
19686|NCT02289079|48482|P2|NOT COMPLETED|Overall Study||1
19687|NCT02289079|48483|P1|NOT COMPLETED|Overall Study||2
19688|NCT02289079|48482|P2|COMPLETED|Overall Study||29
19689|NCT02289079|48483|P1|COMPLETED|Overall Study||28
19690|NCT02289079|48482|P2|STARTED|Overall Study||30
19691|NCT02289079|48483|P1|STARTED|Overall Study||30
19692|NCT02288364|48497|P2|NOT COMPLETED|Overall Study||0
19693|NCT02288364|48498|P1|NOT COMPLETED|Overall Study||0
19694|NCT02288364|48497|P2|COMPLETED|Overall Study||44
19695|NCT02288364|48498|P1|COMPLETED|Overall Study||42
19696|NCT02288364|48497|P2|STARTED|Overall Study||44
19697|NCT02288364|48498|P1|STARTED|Overall Study||42
19698|NCT02288312|48525|P3|NOT COMPLETED|Overall Study||0
19699|NCT02288312|48526|P2|NOT COMPLETED|Overall Study||0
19700|NCT02288312|48527|P1|NOT COMPLETED|Overall Study||1
19701|NCT02288312|48525|P3|COMPLETED|Overall Study||6
19702|NCT02288312|48526|P2|COMPLETED|Overall Study||6
19703|NCT02288312|48527|P1|COMPLETED|Overall Study||5
19704|NCT02288312|48525|P3|STARTED|Overall Study||6
19705|NCT02288312|48526|P2|STARTED|Overall Study||6
19706|NCT02288312|48527|P1|STARTED|Overall Study||6
19707|NCT02288273|48546|P2|NOT COMPLETED|Overall Study||8
19708|NCT02288273|48547|P1|NOT COMPLETED|Overall Study||8
19709|NCT02288273|48546|P2|COMPLETED|Overall Study||48
19710|NCT02288273|48547|P1|COMPLETED|Overall Study||53
19711|NCT02288273|48546|P2|STARTED|Overall Study||56
19712|NCT02288273|48547|P1|STARTED|Overall Study||61
19713|NCT02288091|48565|P1|NOT COMPLETED|Overall Study||8
19714|NCT02288091|48565|P1|COMPLETED|Overall Study||24
19715|NCT02288091|48565|P1|Randomized/Treated|Overall Study||25
19716|NCT02288091|48565|P1|STARTED|Overall Study||32
19717|NCT02287883|48575|P2|NOT COMPLETED|Overall Study||426
19718|NCT02287883|48576|P1|NOT COMPLETED|Overall Study||459
19719|NCT02287883|48575|P2|COMPLETED|Overall Study||669
19720|NCT02287883|48576|P1|COMPLETED|Overall Study||622
19721|NCT02287883|48575|P2|One-year Follow-up Survey|Overall Study||669
19722|NCT02287883|48576|P1|One-year Follow-up Survey|Overall Study||622
19723|NCT02287883|48575|P2|STARTED|Overall Study||1095
19724|NCT02287883|48576|P1|STARTED|Overall Study||1081
19725|NCT02287779|48594|P8|NOT COMPLETED|Overall Study||0
19726|NCT02287779|48595|P7|NOT COMPLETED|Overall Study||0
19727|NCT02287779|48596|P6|NOT COMPLETED|Overall Study||0
19728|NCT02287779|48597|P5|NOT COMPLETED|Overall Study||0
19729|NCT02287779|48598|P4|NOT COMPLETED|Overall Study||0
19730|NCT02287779|48599|P3|NOT COMPLETED|Overall Study||0
19731|NCT02287779|48600|P2|NOT COMPLETED|Overall Study||0
19732|NCT02287779|48601|P1|NOT COMPLETED|Overall Study||0
19733|NCT02287779|48594|P8|COMPLETED|Overall Study||9
19734|NCT02287779|48595|P7|COMPLETED|Overall Study||9
19735|NCT02287779|48596|P6|COMPLETED|Overall Study||9
19736|NCT02287779|48597|P5|COMPLETED|Overall Study||9
19737|NCT02287779|48598|P4|COMPLETED|Overall Study||9
19738|NCT02287779|48599|P3|COMPLETED|Overall Study||9
19739|NCT02287779|48600|P2|COMPLETED|Overall Study||9
19740|NCT02287779|48601|P1|COMPLETED|Overall Study||21
19741|NCT02287779|48594|P8|STARTED|Overall Study||9
19742|NCT02287779|48595|P7|STARTED|Overall Study||9
19743|NCT02287779|48596|P6|STARTED|Overall Study||9
19744|NCT02287779|48597|P5|STARTED|Overall Study||9
19745|NCT02287779|48598|P4|STARTED|Overall Study||9
19746|NCT02287779|48599|P3|STARTED|Overall Study||9
19747|NCT02287779|48600|P2|STARTED|Overall Study||9
19748|NCT02287779|48601|P1|STARTED|Overall Study||21
19749|NCT02287623|48741|P2|NOT COMPLETED|Overall Study||1
19750|NCT02287623|48742|P1|NOT COMPLETED|Overall Study||0
19751|NCT02287623|48741|P2|COMPLETED|Overall Study||29
19752|NCT02287623|48742|P1|COMPLETED|Overall Study||30
19753|NCT02287623|48741|P2|STARTED|Overall Study||30
19754|NCT02287623|48742|P1|STARTED|Overall Study||30
19755|NCT02287610|48758|P1|NOT COMPLETED|Overall Study||16
19756|NCT02287610|48758|P1|COMPLETED|Overall Study||48
19757|NCT02287610|48758|P1|Per Protocol Follow-Up|Overall Study||56
19758|NCT02287610|48758|P1|STARTED|Overall Study||64
19759|NCT02287415|48791|P1|NOT COMPLETED|Overall Study||0
19760|NCT02287415|48791|P1|COMPLETED|Overall Study||13
19761|NCT02287415|48791|P1|STARTED|Overall Study||13
19762|NCT02287402|48797|P1|NOT COMPLETED|Follow-up||3
19763|NCT02287402|48797|P1|COMPLETED|Follow-up||103
19764|NCT02287402|48797|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
19765|NCT02287402|48797|P1|NOT COMPLETED|Treatment Period||27
19766|NCT02287402|48797|P1|COMPLETED|Treatment Period||170
19767|NCT02287402|48797|P1|STARTED|Treatment Period||197
19768|NCT02287376|48812|P1|NOT COMPLETED|Overall Study||0
19769|NCT02287376|48812|P1|COMPLETED|Overall Study||25
19770|NCT02287376|48812|P1|STARTED|Overall Study||25
19771|NCT02287350|48855|P1|NOT COMPLETED|Overall Study||3
19772|NCT02287350|48855|P1|COMPLETED|Overall Study||48
19773|NCT02287350|48855|P1|STARTED|Overall Study||51
19774|NCT02287025|48902|P2|NOT COMPLETED|Overall Study||9
19775|NCT02287025|48903|P1|NOT COMPLETED|Overall Study||10
19776|NCT02287025|48902|P2|COMPLETED|Overall Study||2
19777|NCT02287025|48903|P1|COMPLETED|Overall Study||2
19778|NCT02287025|48902|P2|STARTED|Overall Study||11
19779|NCT02287025|48903|P1|STARTED|Overall Study||12
19780|NCT02286518|48926|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19781|NCT02286518|48927|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19782|NCT02286518|48928|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19783|NCT02286518|48929|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19784|NCT02286518|48930|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19785|NCT02286518|48931|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19786|NCT02286518|48932|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19787|NCT02286518|48933|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19788|NCT02286518|48934|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19789|NCT02286518|48935|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19790|NCT02286518|48936|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19791|NCT02286518|48937|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19792|NCT02286518|48938|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19793|NCT02286518|48939|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19794|NCT02286518|48926|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19795|NCT02286518|48927|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19796|NCT02286518|48928|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19797|NCT02286518|48929|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19798|NCT02286518|48930|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19799|NCT02286518|48931|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
19800|NCT02286518|48932|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
19801|NCT02286518|48933|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19802|NCT02286518|48934|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19803|NCT02286518|48935|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19804|NCT02286518|48936|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19805|NCT02286518|48937|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19806|NCT02286518|48938|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19807|NCT02286518|48939|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
19808|NCT02286518|48926|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19809|NCT02286518|48927|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19810|NCT02286518|48928|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19811|NCT02286518|48929|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19812|NCT02286518|48930|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19813|NCT02286518|48931|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
19814|NCT02286518|48932|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
19815|NCT02286518|48933|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19816|NCT02286518|48934|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19817|NCT02286518|48935|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19818|NCT02286518|48936|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19819|NCT02286518|48937|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19820|NCT02286518|48938|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19821|NCT02286518|48939|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
19822|NCT02286518|48926|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19823|NCT02286518|48927|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19824|NCT02286518|48928|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19825|NCT02286518|48929|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19826|NCT02286518|48930|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19827|NCT02286518|48931|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19828|NCT02286518|48932|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19829|NCT02286518|48933|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19830|NCT02286518|48934|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19831|NCT02286518|48935|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19832|NCT02286518|48936|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19833|NCT02286518|48937|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19834|NCT02286518|48938|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19835|NCT02286518|48939|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19836|NCT02286518|48926|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19837|NCT02286518|48927|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19838|NCT02286518|48928|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19839|NCT02286518|48929|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19840|NCT02286518|48930|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19841|NCT02286518|48931|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
19842|NCT02286518|48932|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
19843|NCT02286518|48933|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19844|NCT02286518|48934|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19845|NCT02286518|48935|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19846|NCT02286518|48936|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19847|NCT02286518|48937|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19848|NCT02286518|48938|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19849|NCT02286518|48939|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
19850|NCT02286518|48926|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19851|NCT02286518|48927|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19852|NCT02286518|48928|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19853|NCT02286518|48929|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19854|NCT02286518|48930|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19855|NCT02286518|48931|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
19856|NCT02286518|48932|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
19857|NCT02286518|48933|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19858|NCT02286518|48934|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19859|NCT02286518|48935|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19860|NCT02286518|48936|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19861|NCT02286518|48937|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19862|NCT02286518|48938|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19863|NCT02286518|48939|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
19864|NCT02286518|48926|P14|NOT COMPLETED|All Parts (16 Days)||0
19865|NCT02286518|48927|P13|NOT COMPLETED|All Parts (16 Days)||0
19866|NCT02286518|48928|P12|NOT COMPLETED|All Parts (16 Days)||0
19867|NCT02286518|48929|P11|NOT COMPLETED|All Parts (16 Days)||0
19868|NCT02286518|48930|P10|NOT COMPLETED|All Parts (16 Days)||0
19869|NCT02286518|48931|P9|NOT COMPLETED|All Parts (16 Days)||0
19870|NCT02286518|48932|P8|NOT COMPLETED|All Parts (16 Days)||0
19871|NCT02286518|48933|P7|NOT COMPLETED|All Parts (16 Days)||0
19872|NCT02286518|48934|P6|NOT COMPLETED|All Parts (16 Days)||0
19873|NCT02286518|48935|P5|NOT COMPLETED|All Parts (16 Days)||0
19874|NCT02286518|48936|P4|NOT COMPLETED|All Parts (16 Days)||0
19875|NCT02286518|48937|P3|NOT COMPLETED|All Parts (16 Days)||0
19876|NCT02286518|48938|P2|NOT COMPLETED|All Parts (16 Days)||0
19877|NCT02286518|48939|P1|NOT COMPLETED|All Parts (16 Days)||0
19878|NCT02286518|48926|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19879|NCT02286518|48927|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19880|NCT02286518|48928|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19881|NCT02286518|48929|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19882|NCT02286518|48930|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
19967|NCT02284854|49223|P2|NOT COMPLETED|Overall Study||0
19883|NCT02286518|48931|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
19884|NCT02286518|48932|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
19885|NCT02286518|48933|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19886|NCT02286518|48934|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19887|NCT02286518|48935|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19888|NCT02286518|48936|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19889|NCT02286518|48937|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19890|NCT02286518|48938|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19891|NCT02286518|48939|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
19892|NCT02286518|48926|P14|STARTED|All Parts (16 Days)||6
19893|NCT02286518|48927|P13|STARTED|All Parts (16 Days)||6
19894|NCT02286518|48928|P12|STARTED|All Parts (16 Days)||6
19895|NCT02286518|48929|P11|STARTED|All Parts (16 Days)||6
19896|NCT02286518|48930|P10|STARTED|All Parts (16 Days)||4
19897|NCT02286518|48931|P9|STARTED|All Parts (16 Days)||6
19898|NCT02286518|48932|P8|STARTED|All Parts (16 Days)||6
19899|NCT02286518|48933|P7|STARTED|All Parts (16 Days)||6
19900|NCT02286518|48934|P6|STARTED|All Parts (16 Days)||6
19901|NCT02286518|48935|P5|STARTED|All Parts (16 Days)||6
19902|NCT02286518|48936|P4|STARTED|All Parts (16 Days)||6
19903|NCT02286518|48937|P3|STARTED|All Parts (16 Days)||6
19904|NCT02286518|48938|P2|STARTED|All Parts (16 Days)||6
19905|NCT02286518|48939|P1|STARTED|All Parts (16 Days)||6
19906|NCT02286193|49079|P1|NOT COMPLETED|Overall Study||204
19907|NCT02286193|49079|P1|COMPLETED|Overall Study||418
19908|NCT02286193|49079|P1|STARTED|Overall Study||622
19909|NCT02286102|49086|P2|NOT COMPLETED|Overall Study||1
19910|NCT02286102|49087|P1|NOT COMPLETED|Overall Study||1
19911|NCT02286102|49086|P2|COMPLETED|Overall Study||33
19912|NCT02286102|49087|P1|COMPLETED|Overall Study||35
19913|NCT02286102|49086|P2|STARTED|Overall Study||34
19914|NCT02286102|49087|P1|STARTED|Overall Study||36
19915|NCT02285998|49099|P2|NOT COMPLETED|Overall Study||253
19916|NCT02285998|49100|P1|NOT COMPLETED|Overall Study||246
19917|NCT02285998|49099|P2|COMPLETED|Overall Study||4236
19918|NCT02285998|49100|P1|COMPLETED|Overall Study||4228
19919|NCT02285998|49099|P2|STARTED|Overall Study||4489
19920|NCT02285998|49100|P1|STARTED|Overall Study||4474
19921|NCT02285907|49124|P1|NOT COMPLETED|Overall Study||0
19922|NCT02285907|49124|P1|COMPLETED|Overall Study||21
19923|NCT02285907|49124|P1|Began 4th Intervention|Overall Study||21
19924|NCT02285907|49124|P1|Began 3rd Intervention|Overall Study||21
19925|NCT02285907|49124|P1|Began 2nd Intervention|Overall Study||21
19926|NCT02285907|49124|P1|Began 1st Intervention|Overall Study||21
19927|NCT02285907|49124|P1|STARTED|Overall Study||21
19928|NCT02285777|49152|P2|NOT COMPLETED|Overall Study||3
19929|NCT02285777|49153|P1|NOT COMPLETED|Overall Study||5
19930|NCT02285777|49152|P2|COMPLETED|Overall Study||91
19931|NCT02285777|49153|P1|COMPLETED|Overall Study||90
19932|NCT02285777|49152|P2|STARTED|Overall Study||94
19933|NCT02285777|49153|P1|STARTED|Overall Study||95
19934|NCT02285270|49185|P1|NOT COMPLETED|Overall Study||5
19935|NCT02285270|49185|P1|COMPLETED|Overall Study||5
19936|NCT02285270|49185|P1|STARTED|Overall Study||10
19937|NCT02284880|49193|P4|NOT COMPLETED|Overall Study||0
19938|NCT02284880|49194|P3|NOT COMPLETED|Overall Study||2
19939|NCT02284880|49195|P2|NOT COMPLETED|Overall Study||0
19940|NCT02284880|49196|P1|NOT COMPLETED|Overall Study||0
19941|NCT02284880|49193|P4|COMPLETED|Overall Study||10
19942|NCT02284880|49194|P3|COMPLETED|Overall Study||8
19943|NCT02284880|49195|P2|COMPLETED|Overall Study||9
19944|NCT02284880|49196|P1|COMPLETED|Overall Study||11
19945|NCT02284880|49193|P4|Second Period (4 Days)|Overall Study||10
19946|NCT02284880|49194|P3|Second Period (4 Days)|Overall Study||8
19947|NCT02284880|49195|P2|Second Period (4 Days)|Overall Study||9
19948|NCT02284880|49196|P1|Second Period (4 Days)|Overall Study||11
19949|NCT02284880|49193|P4|Wash-out Period (7 Days)|Overall Study||10
19950|NCT02284880|49194|P3|Wash-out Period (7 Days)|Overall Study||10
19951|NCT02284880|49195|P2|Wash-out Period (7 Days)|Overall Study||9
19952|NCT02284880|49196|P1|Wash-out Period (7 Days)|Overall Study||11
19953|NCT02284880|49193|P4|First Period (4 Days)|Overall Study||10
19954|NCT02284880|49194|P3|First Period (4 Days)|Overall Study||10
19955|NCT02284880|49195|P2|First Period (4 Days)|Overall Study||9
19956|NCT02284880|49196|P1|First Period (4 Days)|Overall Study||11
19957|NCT02284880|49193|P4|STARTED|Overall Study||10
19958|NCT02284880|49194|P3|STARTED|Overall Study||10
19959|NCT02284880|49195|P2|STARTED|Overall Study||9
19960|NCT02284880|49196|P1|STARTED|Overall Study||11
19961|NCT02284867|49212|P2|NOT COMPLETED|Overall Study||0
19962|NCT02284867|49213|P1|NOT COMPLETED|Overall Study||0
19963|NCT02284867|49212|P2|COMPLETED|Overall Study||30
19964|NCT02284867|49213|P1|COMPLETED|Overall Study||30
19965|NCT02284867|49212|P2|STARTED|Overall Study||30
19966|NCT02284867|49213|P1|STARTED|Overall Study||30
19968|NCT02284854|49224|P1|NOT COMPLETED|Overall Study||5
19969|NCT02284854|49223|P2|COMPLETED|Overall Study||20
19970|NCT02284854|49224|P1|COMPLETED|Overall Study||18
19971|NCT02284854|49223|P2|STARTED|Overall Study||20
19972|NCT02284854|49224|P1|STARTED|Overall Study||23
19973|NCT02284828|49241|P1|NOT COMPLETED|Overall Study||4
19974|NCT02284828|49241|P1|COMPLETED|Overall Study||22
19975|NCT02284828|49241|P1|STARTED|Overall Study||26
19976|NCT02284555|49253|P1|NOT COMPLETED|Overall Study||0
19977|NCT02284555|49253|P1|COMPLETED|Overall Study||12
19978|NCT02284555|49253|P1|STARTED|Overall Study||12
19979|NCT02284516|49260|P2|NOT COMPLETED|Overall Study||36
19980|NCT02284516|49261|P1|NOT COMPLETED|Overall Study||38
19981|NCT02284516|49260|P2|COMPLETED|Overall Study||319
19982|NCT02284516|49261|P1|COMPLETED|Overall Study||318
19983|NCT02284516|49260|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
19984|NCT02284516|49261|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
19985|NCT02284516|49260|P2|STARTED|Overall Study||355
19986|NCT02284516|49261|P1|STARTED|Overall Study||356
19987|NCT02284386|49269|P1|NOT COMPLETED|Overall Study||0
19988|NCT02284386|49269|P1|COMPLETED|Overall Study||15
19989|NCT02284386|49269|P1|STARTED|Overall Study||15
19990|NCT02284347|49278|P1|NOT COMPLETED|Overall Study||3
19991|NCT02284347|49278|P1|COMPLETED|Overall Study||48
19992|NCT02284347|49278|P1|STARTED|Overall Study||51
19993|NCT02284243|49286|P2|NOT COMPLETED|Overall Study||3
19994|NCT02284243|49287|P1|NOT COMPLETED|Overall Study||4
19995|NCT02284243|49286|P2|COMPLETED|Overall Study||81
19996|NCT02284243|49287|P1|COMPLETED|Overall Study||80
19997|NCT02284243|49286|P2|STARTED|Overall Study||84
19998|NCT02284243|49287|P1|STARTED|Overall Study||84
19999|NCT02284165|49308|P3|NOT COMPLETED|Overall Study||0
20000|NCT02284165|49309|P2|NOT COMPLETED|Overall Study||0
20001|NCT02284165|49310|P1|NOT COMPLETED|Overall Study||0
20002|NCT02284165|49308|P3|COMPLETED|Overall Study||70996
20003|NCT02284165|49309|P2|COMPLETED|Overall Study||40272
20004|NCT02284165|49310|P1|COMPLETED|Overall Study||36448
20005|NCT02284165|49308|P3|STARTED|Overall Study||70996
20006|NCT02284165|49309|P2|STARTED|Overall Study||40272
20007|NCT02284165|49310|P1|STARTED|Overall Study||36448
20008|NCT02283840|49329|P3|NOT COMPLETED|Overall Study||0
20009|NCT02283840|49330|P2|NOT COMPLETED|Overall Study||1
20010|NCT02283840|49331|P1|NOT COMPLETED|Overall Study||0
20011|NCT02283840|49329|P3|COMPLETED|Overall Study||20
20012|NCT02283840|49330|P2|COMPLETED|Overall Study||19
20013|NCT02283840|49331|P1|COMPLETED|Overall Study||20
20014|NCT02283840|49329|P3|STARTED|Overall Study||20
20015|NCT02283840|49330|P2|STARTED|Overall Study||20
20016|NCT02283840|49331|P1|STARTED|Overall Study||20
20017|NCT02283827|49350|P2|NOT COMPLETED|Overall Study||3
20018|NCT02283827|49351|P1|NOT COMPLETED|Overall Study||1
20019|NCT02283827|49350|P2|COMPLETED|Overall Study||13
20020|NCT02283827|49351|P1|COMPLETED|Overall Study||15
20021|NCT02283827|49350|P2|STARTED|Overall Study||16
20022|NCT02283827|49351|P1|STARTED|Overall Study||16
20023|NCT02283814|49368|P2|NOT COMPLETED|Overall Study||2
20024|NCT02283814|49369|P1|NOT COMPLETED|Overall Study||3
20025|NCT02283814|49368|P2|COMPLETED|Overall Study||14
20026|NCT02283814|49369|P1|COMPLETED|Overall Study||13
20027|NCT02283814|49368|P2|STARTED|Overall Study||16
20028|NCT02283814|49369|P1|STARTED|Overall Study||16
20029|NCT02283788|49383|P4|NOT COMPLETED|Overall Study||2
20030|NCT02283788|49384|P3|NOT COMPLETED|Overall Study||5
20031|NCT02283788|49385|P2|NOT COMPLETED|Overall Study||4
20032|NCT02283788|49386|P1|NOT COMPLETED|Overall Study||1
20033|NCT02283788|49383|P4|COMPLETED|Overall Study||14
20034|NCT02283788|49384|P3|COMPLETED|Overall Study||12
20035|NCT02283788|49385|P2|COMPLETED|Overall Study||13
20036|NCT02283788|49386|P1|COMPLETED|Overall Study||16
20037|NCT02283788|49383|P4|STARTED|Overall Study||16
20038|NCT02283788|49384|P3|STARTED|Overall Study||17
20039|NCT02283788|49385|P2|STARTED|Overall Study||17
20040|NCT02283788|49386|P1|STARTED|Overall Study||17
20041|NCT02283411|49396|P1|NOT COMPLETED|Overall Study||31
20042|NCT02283411|49396|P1|COMPLETED|Overall Study||125
20043|NCT02283411|49396|P1|STARTED|Overall Study||156
20044|NCT02283268|49404|P1|NOT COMPLETED|Overall Study||1
20045|NCT02283268|49404|P1|COMPLETED|Overall Study||14
20046|NCT02283268|49404|P1|STARTED|Overall Study||15
20047|NCT02282982|49465|P1|NOT COMPLETED|Overall Study||206
20048|NCT02282982|49465|P1|COMPLETED|Overall Study||153
20049|NCT02282982|49465|P1|Attended Follow-up Visit|Overall Study||349
20050|NCT02282982|49465|P1|Attended Visit 5|Overall Study||83
20051|NCT02282982|49465|P1|Attended Visit 4|Overall Study||194
20052|NCT02282982|49465|P1|Attended Visit 3|Overall Study||298
20053|NCT02282982|49465|P1|Attended Visit 2|Overall Study||341
20054|NCT02282982|49465|P1|Attended Visit 1|Overall Study||359
20055|NCT02282982|49465|P1|STARTED|Overall Study||359
20056|NCT02282813|49483|P3|NOT COMPLETED|Overall Study||3
20057|NCT02282813|49484|P2|NOT COMPLETED|Overall Study||23
20058|NCT02282813|49485|P1|NOT COMPLETED|Overall Study||12
20059|NCT02282813|49483|P3|COMPLETED|Overall Study||39
20060|NCT02282813|49484|P2|COMPLETED|Overall Study||130
20061|NCT02282813|49485|P1|COMPLETED|Overall Study||91
20062|NCT02282813|49483|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
20063|NCT02282813|49484|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
20064|NCT02282813|49485|P1|STARTED|Overall Study|ITT Population|103
20065|NCT02282722|49504|P2|NOT COMPLETED|Overall Study||19
20066|NCT02282722|49505|P1|NOT COMPLETED|Overall Study||23
20067|NCT02282722|49504|P2|COMPLETED|Overall Study||73
20068|NCT02282722|49505|P1|COMPLETED|Overall Study||71
20069|NCT02282722|49504|P2|3-month Assessment|Overall Study||73
20070|NCT02282722|49505|P1|3-month Assessment|Overall Study||71
20071|NCT02282722|49504|P2|2-week Assessment|Overall Study||75
20072|NCT02282722|49505|P1|2-week Assessment|Overall Study||79
20073|NCT02282722|49504|P2|STARTED|Overall Study||92
20074|NCT02282722|49505|P1|STARTED|Overall Study||94
20075|NCT02282631|49531|P2|NOT COMPLETED|Overall Study||0
20076|NCT02282631|49532|P1|NOT COMPLETED|Overall Study||2
20077|NCT02282631|49531|P2|COMPLETED|Overall Study||15
20078|NCT02282631|49532|P1|COMPLETED|Overall Study||12
20079|NCT02282631|49531|P2|STARTED|Overall Study||15
20080|NCT02282631|49532|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
20081|NCT02282605|49573|P3|NOT COMPLETED|Overall Study||0
20082|NCT02282605|49574|P2|NOT COMPLETED|Overall Study||0
20083|NCT02282605|49575|P1|NOT COMPLETED|Overall Study||3
20084|NCT02282605|49573|P3|COMPLETED|Overall Study||24
20085|NCT02282605|49574|P2|COMPLETED|Overall Study||12
20086|NCT02282605|49575|P1|COMPLETED|Overall Study||24
20087|NCT02282605|49573|P3|STARTED|Overall Study||24
20088|NCT02282605|49574|P2|STARTED|Overall Study||12
20089|NCT02282605|49575|P1|STARTED|Overall Study||27
20090|NCT02282527|49597|P2|NOT COMPLETED|Overall Study||1
20091|NCT02282527|49598|P1|NOT COMPLETED|Overall Study||1
20092|NCT02282527|49597|P2|COMPLETED|Overall Study||15
20093|NCT02282527|49598|P1|COMPLETED|Overall Study||15
20094|NCT02282527|49597|P2|STARTED|Overall Study||16
20095|NCT02282527|49598|P1|STARTED|Overall Study||16
20096|NCT02281773|49613|P5|NOT COMPLETED|Overall Study||30
20097|NCT02281773|49614|P4|NOT COMPLETED|Overall Study||21
20098|NCT02281773|49615|P3|NOT COMPLETED|Overall Study||18
20099|NCT02281773|49616|P2|NOT COMPLETED|Overall Study||15
20100|NCT02281773|49617|P1|NOT COMPLETED|Overall Study||11
20101|NCT02281773|49613|P5|COMPLETED|Overall Study||143
20102|NCT02281773|49614|P4|COMPLETED|Overall Study||65
20103|NCT02281773|49615|P3|COMPLETED|Overall Study||67
20104|NCT02281773|49616|P2|COMPLETED|Overall Study||70
20105|NCT02281773|49617|P1|COMPLETED|Overall Study||76
20106|NCT02281773|49613|P5|STARTED|Overall Study|Started are the treated patients|173
20107|NCT02281773|49614|P4|STARTED|Overall Study||86
20108|NCT02281773|49615|P3|STARTED|Overall Study||85
20109|NCT02281773|49616|P2|STARTED|Overall Study|Started are the treated patients|85
20110|NCT02281773|49617|P1|STARTED|Overall Study||87
20111|NCT02281591|49678|P4|NOT COMPLETED|Overall Study||0
20112|NCT02281591|49679|P3|NOT COMPLETED|Overall Study||0
20113|NCT02281591|49680|P2|NOT COMPLETED|Overall Study||0
20114|NCT02281591|49681|P1|NOT COMPLETED|Overall Study||0
20115|NCT02281591|49678|P4|COMPLETED|Overall Study||8
20116|NCT02281591|49679|P3|COMPLETED|Overall Study||8
20117|NCT02281591|49680|P2|COMPLETED|Overall Study||8
20118|NCT02281591|49681|P1|COMPLETED|Overall Study||8
20119|NCT02281591|49678|P4|STARTED|Overall Study||8
20120|NCT02281591|49679|P3|STARTED|Overall Study||8
20121|NCT02281591|49680|P2|STARTED|Overall Study||8
20122|NCT02281591|49681|P1|STARTED|Overall Study||8
20123|NCT02281526|49705|P2|NOT COMPLETED|Overall Study||0
20124|NCT02281526|49706|P1|NOT COMPLETED|Overall Study||1
20125|NCT02281526|49705|P2|COMPLETED|Overall Study||8
20126|NCT02281526|49706|P1|COMPLETED|Overall Study||8
20127|NCT02281526|49705|P2|STARTED|Overall Study||8
20128|NCT02281526|49706|P1|STARTED|Overall Study||9
20129|NCT02281448|49716|P2|NOT COMPLETED|Overall Study||1
20130|NCT02281448|49717|P1|NOT COMPLETED|Overall Study||2
20131|NCT02281448|49716|P2|COMPLETED|Overall Study||9
20132|NCT02281448|49717|P1|COMPLETED|Overall Study||8
20133|NCT02281448|49716|P2|STARTED|Overall Study||10
20134|NCT02281448|49717|P1|STARTED|Overall Study||10
20135|NCT02281422|49730|P5|NOT COMPLETED|Overall Study||0
20136|NCT02281422|49731|P4|NOT COMPLETED|Overall Study||0
20137|NCT02281422|49732|P3|NOT COMPLETED|Overall Study||0
20138|NCT02281422|49733|P2|NOT COMPLETED|Overall Study||0
20139|NCT02281422|49734|P1|NOT COMPLETED|Overall Study||0
20140|NCT02281422|49730|P5|COMPLETED|Overall Study||8
20141|NCT02281422|49731|P4|COMPLETED|Overall Study||8
20142|NCT02281422|49732|P3|COMPLETED|Overall Study||8
20143|NCT02281422|49733|P2|COMPLETED|Overall Study||8
20144|NCT02281422|49734|P1|COMPLETED|Overall Study||8
20145|NCT02281422|49730|P5|STARTED|Overall Study||8
20146|NCT02281422|49731|P4|STARTED|Overall Study||8
20147|NCT02281422|49732|P3|STARTED|Overall Study||8
20148|NCT02281422|49733|P2|STARTED|Overall Study||8
20149|NCT02281422|49734|P1|STARTED|Overall Study||8
20150|NCT02281357|49758|P2|NOT COMPLETED|Overall Study||4
20151|NCT02281357|49759|P1|NOT COMPLETED|Overall Study||7
20152|NCT02281357|49758|P2|COMPLETED|Overall Study||66
20153|NCT02281357|49759|P1|COMPLETED|Overall Study||63
20154|NCT02281357|49758|P2|STARTED|Overall Study||70
20155|NCT02281357|49759|P1|STARTED|Overall Study||70
20156|NCT02281318|49773|P2|NOT COMPLETED|Overall Study||5
20157|NCT02281318|49774|P1|NOT COMPLETED|Overall Study||14
20158|NCT02281318|49773|P2|COMPLETED|Overall Study||269
20159|NCT02281318|49774|P1|COMPLETED|Overall Study||263
20160|NCT02281318|49773|P2|STARTED|Overall Study||274
20161|NCT02281318|49774|P1|STARTED|Overall Study||277
20162|NCT02281136|49786|P1|NOT COMPLETED|Overall Study||0
20163|NCT02281136|49786|P1|COMPLETED|Overall Study||29
20164|NCT02281136|49786|P1|STARTED|Overall Study||29
20165|NCT02280811|49823|P5|NOT COMPLETED|Retreated at the MTD||0
20166|NCT02280811|49824|P4|NOT COMPLETED|Retreated at the MTD||0
20167|NCT02280811|49825|P3|NOT COMPLETED|Retreated at the MTD||0
20168|NCT02280811|49826|P2|NOT COMPLETED|Retreated at the MTD||0
20169|NCT02280811|49827|P1|NOT COMPLETED|Retreated at the MTD||0
20170|NCT02280811|49823|P5|COMPLETED|Retreated at the MTD||1
20171|NCT02280811|49824|P4|COMPLETED|Retreated at the MTD||0
20172|NCT02280811|49825|P3|COMPLETED|Retreated at the MTD||0
20173|NCT02280811|49826|P2|COMPLETED|Retreated at the MTD||0
20174|NCT02280811|49827|P1|COMPLETED|Retreated at the MTD||0
20175|NCT02280811|49823|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
20176|NCT02280811|49824|P4|STARTED|Retreated at the MTD||0
20177|NCT02280811|49825|P3|STARTED|Retreated at the MTD||0
20178|NCT02280811|49826|P2|STARTED|Retreated at the MTD||0
20179|NCT02280811|49827|P1|STARTED|Retreated at the MTD||0
20180|NCT02280811|49823|P5|NOT COMPLETED|Drug Administration||0
20181|NCT02280811|49824|P4|NOT COMPLETED|Drug Administration||0
20182|NCT02280811|49825|P3|NOT COMPLETED|Drug Administration||0
20183|NCT02280811|49826|P2|NOT COMPLETED|Drug Administration||0
20184|NCT02280811|49827|P1|NOT COMPLETED|Drug Administration||0
20185|NCT02280811|49823|P5|COMPLETED|Drug Administration||2
20186|NCT02280811|49824|P4|COMPLETED|Drug Administration||6
20187|NCT02280811|49825|P3|COMPLETED|Drug Administration||1
20188|NCT02280811|49826|P2|COMPLETED|Drug Administration||2
20189|NCT02280811|49827|P1|COMPLETED|Drug Administration||1
20190|NCT02280811|49823|P5|STARTED|Drug Administration||2
20191|NCT02280811|49824|P4|STARTED|Drug Administration||6
20192|NCT02280811|49825|P3|STARTED|Drug Administration||1
20193|NCT02280811|49826|P2|STARTED|Drug Administration||2
20194|NCT02280811|49827|P1|STARTED|Drug Administration||1
20195|NCT02280655|49868|P2|NOT COMPLETED|Overall Study||0
20196|NCT02280655|49869|P1|NOT COMPLETED|Overall Study||0
20197|NCT02280655|49868|P2|COMPLETED|Overall Study||18
20198|NCT02280655|49869|P1|COMPLETED|Overall Study||25
20199|NCT02280655|49868|P2|STARTED|Overall Study||18
20200|NCT02280655|49869|P1|STARTED|Overall Study||25
20201|NCT02280499|49877|P1|NOT COMPLETED|Overall Study||61
20202|NCT02280499|49877|P1|COMPLETED|Overall Study||26
20203|NCT02280499|49877|P1|STARTED|Overall Study||87
20204|NCT02280473|49885|P2|NOT COMPLETED|Overall Study||3
20205|NCT02280473|49886|P1|NOT COMPLETED|Overall Study||1
20206|NCT02280473|49885|P2|COMPLETED|Overall Study||91
20207|NCT02280473|49886|P1|COMPLETED|Overall Study||93
20208|NCT02280473|49885|P2|STARTED|Overall Study||94
20209|NCT02280473|49886|P1|STARTED|Overall Study||94
20210|NCT02280226|49900|P1|NOT COMPLETED|Overall Study||0
20211|NCT02280226|49900|P1|COMPLETED|Overall Study||17
20212|NCT02280226|49900|P1|STARTED|Overall Study||17
20213|NCT02280187|49905|P1|NOT COMPLETED|Overall Study||218
20214|NCT02280187|49905|P1|COMPLETED|Overall Study||182
20215|NCT02280187|49905|P1|STARTED|Overall Study||400
20216|NCT02280122|49923|P3|NOT COMPLETED|Overall Study||0
20217|NCT02280122|49924|P2|NOT COMPLETED|Overall Study||0
20218|NCT02280122|49925|P1|NOT COMPLETED|Overall Study||0
20219|NCT02280122|49923|P3|COMPLETED|Overall Study||30
20220|NCT02280122|49924|P2|COMPLETED|Overall Study||15
20221|NCT02280122|49925|P1|COMPLETED|Overall Study||15
20222|NCT02280122|49923|P3|STARTED|Overall Study||30
20223|NCT02280122|49924|P2|STARTED|Overall Study||15
20224|NCT02280122|49925|P1|STARTED|Overall Study||15
20225|NCT02279667|49934|P3|NOT COMPLETED|Overall Study||0
20226|NCT02279667|49935|P2|NOT COMPLETED|Overall Study||0
20227|NCT02279667|49936|P1|NOT COMPLETED|Overall Study||0
20228|NCT02279667|49934|P3|COMPLETED|Overall Study||6
20229|NCT02279667|49935|P2|COMPLETED|Overall Study||6
20230|NCT02279667|49936|P1|COMPLETED|Overall Study||6
20231|NCT02279667|49934|P3|STARTED|Overall Study||6
20232|NCT02279667|49935|P2|STARTED|Overall Study||6
20233|NCT02279667|49936|P1|STARTED|Overall Study||6
20234|NCT02279641|49956|P2|NOT COMPLETED|Overall Study||0
20235|NCT02279641|49957|P1|NOT COMPLETED|Overall Study||0
20236|NCT02279641|49956|P2|COMPLETED|Overall Study||6
20237|NCT02279641|49957|P1|COMPLETED|Overall Study||6
20238|NCT02279641|49956|P2|STARTED|Overall Study||6
20239|NCT02279641|49957|P1|STARTED|Overall Study||6
20240|NCT02279420|50011|P1|NOT COMPLETED|Overall Study||23
20241|NCT02279420|50011|P1|COMPLETED|Overall Study||50
20242|NCT02279420|50011|P1|STARTED|Overall Study||73
20243|NCT02279407|50019|P4|NOT COMPLETED|Overall Study||1
20244|NCT02279407|50020|P3|NOT COMPLETED|Overall Study||5
20245|NCT02279407|50021|P2|NOT COMPLETED|Overall Study||1
20246|NCT02279407|50022|P1|NOT COMPLETED|Overall Study||2
20247|NCT02279407|50019|P4|COMPLETED|Overall Study||20
20248|NCT02279407|50020|P3|COMPLETED|Overall Study||15
20249|NCT02279407|50021|P2|COMPLETED|Overall Study||20
20250|NCT02279407|50022|P1|COMPLETED|Overall Study||20
20251|NCT02279407|50019|P4|STARTED|Overall Study||21
20252|NCT02279407|50020|P3|STARTED|Overall Study||20
20253|NCT02279407|50021|P2|STARTED|Overall Study||21
20254|NCT02279407|50022|P1|STARTED|Overall Study||22
20255|NCT02279108|50035|P2|NOT COMPLETED|Overall Study||1
20256|NCT02279108|50036|P1|NOT COMPLETED|Overall Study||0
20257|NCT02279108|50035|P2|COMPLETED|Overall Study||49
20258|NCT02279108|50036|P1|COMPLETED|Overall Study||50
20259|NCT02279108|50035|P2|STARTED|Overall Study||50
20260|NCT02279108|50036|P1|STARTED|Overall Study||50
20261|NCT02279082|50058|P1|NOT COMPLETED|Overall Study||33
20262|NCT02279082|50058|P1|COMPLETED|Overall Study||134
20263|NCT02279082|50058|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
20264|NCT02278783|50062|P1|NOT COMPLETED|Overall Study||0
20265|NCT02278783|50062|P1|COMPLETED|Overall Study||1
20266|NCT02278783|50062|P1|STARTED|Overall Study||1
20267|NCT02278640|50069|P1|NOT COMPLETED|Overall Study||0
20268|NCT02278640|50069|P1|COMPLETED|Overall Study||40
20269|NCT02278640|50069|P1|STARTED|Overall Study||40
20270|NCT02278614|50078|P2|NOT COMPLETED|Overall Study||5
20271|NCT02278614|50079|P1|NOT COMPLETED|Overall Study||5
20272|NCT02278614|50078|P2|COMPLETED|Overall Study||110
20273|NCT02278614|50079|P1|COMPLETED|Overall Study||122
20274|NCT02278614|50078|P2|STARTED|Overall Study||115
20275|NCT02278614|50079|P1|STARTED|Overall Study||127
20276|NCT02278562|50088|P3|NOT COMPLETED|Overall Study||0
20277|NCT02278562|50089|P2|NOT COMPLETED|Overall Study||0
20278|NCT02278562|50090|P1|NOT COMPLETED|Overall Study||0
20279|NCT02278562|50088|P3|COMPLETED|Overall Study||8
20280|NCT02278562|50089|P2|COMPLETED|Overall Study||7
20281|NCT02278562|50090|P1|COMPLETED|Overall Study||9
20282|NCT02278562|50088|P3|STARTED|Overall Study||8
20283|NCT02278562|50089|P2|STARTED|Overall Study||7
20284|NCT02278562|50090|P1|STARTED|Overall Study||9
20285|NCT02278484|50104|P1|NOT COMPLETED|Overall Study||0
20286|NCT02278484|50104|P1|COMPLETED|Overall Study||50
20287|NCT02278484|50104|P1|STARTED|Overall Study||50
20288|NCT02278146|50113|P2|NOT COMPLETED|Overall Study||2
20289|NCT02278146|50114|P1|NOT COMPLETED|Overall Study||0
20290|NCT02278146|50113|P2|COMPLETED|Overall Study||8
20291|NCT02278146|50114|P1|COMPLETED|Overall Study||6
20292|NCT02278146|50113|P2|STARTED|Overall Study||10
20293|NCT02278146|50114|P1|STARTED|Overall Study||6
20294|NCT02278003|50126|P2|NOT COMPLETED|Overall Study||0
20295|NCT02278003|50127|P1|NOT COMPLETED|Overall Study||19
20296|NCT02278003|50126|P2|COMPLETED|Overall Study||20
20297|NCT02278003|50127|P1|COMPLETED|Overall Study||30
20298|NCT02278003|50126|P2|STARTED|Overall Study||20
20299|NCT02278003|50127|P1|STARTED|Overall Study||49
20300|NCT02277769|50138|P3|NOT COMPLETED|Overall Study||18
20301|NCT02277769|50139|P2|NOT COMPLETED|Overall Study||13
20302|NCT02277769|50140|P1|NOT COMPLETED|Overall Study||46
20303|NCT02277769|50138|P3|COMPLETED|Overall Study||221
20304|NCT02277769|50139|P2|COMPLETED|Overall Study||220
20305|NCT02277769|50140|P1|COMPLETED|Overall Study||190
20306|NCT02277769|50138|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
20307|NCT02277769|50139|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
20308|NCT02277769|50140|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
20309|NCT02277769|50138|P3|Treated|Overall Study||239
20310|NCT02277769|50139|P2|Treated|Overall Study||233
20311|NCT02277769|50140|P1|Treated|Overall Study||235
20312|NCT02277769|50138|P3|STARTED|Overall Study||239
20313|NCT02277769|50139|P2|STARTED|Overall Study||233
20314|NCT02277769|50140|P1|STARTED|Overall Study||236
20315|NCT02277743|50211|P3|NOT COMPLETED|Overall Study||26
20316|NCT02277743|50212|P2|NOT COMPLETED|Overall Study||16
20317|NCT02277743|50213|P1|NOT COMPLETED|Overall Study||40
20318|NCT02277743|50211|P3|COMPLETED|Overall Study||197
20319|NCT02277743|50212|P2|COMPLETED|Overall Study||208
20320|NCT02277743|50213|P1|COMPLETED|Overall Study||184
20321|NCT02277743|50211|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
20322|NCT02277743|50212|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
20323|NCT02277743|50213|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
20324|NCT02277743|50211|P3|Treated|Overall Study||223
20325|NCT02277743|50212|P2|Treated|Overall Study||223
20326|NCT02277743|50213|P1|Treated|Overall Study||223
20327|NCT02277743|50211|P3|STARTED|Overall Study||223
20328|NCT02277743|50212|P2|STARTED|Overall Study||224
20329|NCT02277743|50213|P1|STARTED|Overall Study||224
20330|NCT02277691|50281|P1|NOT COMPLETED|Overall Study||46
20331|NCT02277691|50281|P1|COMPLETED|Overall Study||295
20332|NCT02277691|50281|P1|STARTED|Overall Study||341
20333|NCT02277639|50293|P2|NOT COMPLETED|Overall Study||0
20334|NCT02277639|50294|P1|NOT COMPLETED|Overall Study||0
20335|NCT02277639|50293|P2|COMPLETED|Overall Study||2
20336|NCT02277639|50294|P1|COMPLETED|Overall Study||0
20337|NCT02277639|50293|P2|STARTED|Overall Study||2
20338|NCT02277639|50294|P1|STARTED|Overall Study||0
20339|NCT02277626|50300|P2|NOT COMPLETED|Overall Study||0
20340|NCT02277626|50301|P1|NOT COMPLETED|Overall Study||0
20341|NCT02277626|50300|P2|COMPLETED|Overall Study||9
20342|NCT02277626|50301|P1|COMPLETED|Overall Study||6
20343|NCT02277626|50300|P2|STARTED|Overall Study||9
20344|NCT02277626|50301|P1|STARTED|Overall Study||6
20345|NCT02277249|50317|P2|NOT COMPLETED|Overall Study||0
20346|NCT02277249|50318|P1|NOT COMPLETED|Overall Study||0
20347|NCT02277249|50317|P2|COMPLETED|Overall Study||30
20348|NCT02277249|50318|P1|COMPLETED|Overall Study||30
20349|NCT02277249|50317|P2|STARTED|Overall Study||30
20350|NCT02277249|50318|P1|STARTED|Overall Study||30
20351|NCT02277119|50327|P3|NOT COMPLETED|Overall Study||8
20352|NCT02277119|50328|P2|NOT COMPLETED|Overall Study||4
20353|NCT02277119|50329|P1|NOT COMPLETED|Overall Study||3
20354|NCT02277119|50327|P3|COMPLETED|Overall Study||19
20355|NCT02277119|50328|P2|COMPLETED|Overall Study||20
20356|NCT02277119|50329|P1|COMPLETED|Overall Study||55
20357|NCT02277119|50327|P3|STARTED|Overall Study||27
20358|NCT02277119|50328|P2|STARTED|Overall Study||24
20359|NCT02277119|50329|P1|STARTED|Overall Study||58
20360|NCT02277093|50346|P1|NOT COMPLETED|Overall Study||0
20361|NCT02277093|50346|P1|COMPLETED|Overall Study||11
20362|NCT02277093|50346|P1|STARTED|Overall Study||11
20363|NCT02276612|50356|P2|NOT COMPLETED|Overall Study||0
20364|NCT02276612|50357|P1|NOT COMPLETED|Overall Study||4
20365|NCT02276612|50356|P2|COMPLETED|Overall Study||10
20366|NCT02276612|50357|P1|COMPLETED|Overall Study||46
20367|NCT02276612|50356|P2|STARTED|Overall Study||10
20368|NCT02276612|50357|P1|STARTED|Overall Study||50
20369|NCT02276560|50380|P3|NOT COMPLETED|Overall Study||0
20370|NCT02276560|50381|P2|NOT COMPLETED|Overall Study||0
20371|NCT02276560|50382|P1|NOT COMPLETED|Overall Study||1
20372|NCT02276560|50380|P3|COMPLETED|Overall Study||0
20373|NCT02276560|50381|P2|COMPLETED|Overall Study||0
20374|NCT02276560|50382|P1|COMPLETED|Overall Study||0
20375|NCT02276560|50380|P3|STARTED|Overall Study||0
20376|NCT02276560|50381|P2|STARTED|Overall Study||0
20377|NCT02276560|50382|P1|STARTED|Overall Study||1
20378|NCT02276274|50392|P2|NOT COMPLETED|Second Intervention Period||0
20379|NCT02276274|50393|P1|NOT COMPLETED|Second Intervention Period||0
20380|NCT02276274|50392|P2|COMPLETED|Second Intervention Period||6
20381|NCT02276274|50393|P1|COMPLETED|Second Intervention Period||6
20382|NCT02276274|50392|P2|STARTED|Second Intervention Period||6
20383|NCT02276274|50393|P1|STARTED|Second Intervention Period||6
20384|NCT02276274|50392|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
20385|NCT02276274|50393|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
20386|NCT02276274|50392|P2|COMPLETED|Washout Period (at Least 15 Days)||6
20387|NCT02276274|50393|P1|COMPLETED|Washout Period (at Least 15 Days)||6
20388|NCT02276274|50392|P2|STARTED|Washout Period (at Least 15 Days)||6
20389|NCT02276274|50393|P1|STARTED|Washout Period (at Least 15 Days)||6
20390|NCT02276274|50392|P2|NOT COMPLETED|First Intervention Period||0
20391|NCT02276274|50393|P1|NOT COMPLETED|First Intervention Period||0
20392|NCT02276274|50392|P2|COMPLETED|First Intervention Period||6
20393|NCT02276274|50393|P1|COMPLETED|First Intervention Period||6
20394|NCT02276274|50392|P2|STARTED|First Intervention Period||6
20395|NCT02276274|50393|P1|STARTED|First Intervention Period||6
20396|NCT02276222|50503|P2|NOT COMPLETED|Overall Study||64
20397|NCT02276222|50504|P1|NOT COMPLETED|Overall Study||185
20398|NCT02276222|50503|P2|COMPLETED|Overall Study||402
20399|NCT02276222|50504|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
20400|NCT02276222|50503|P2|STARTED|Overall Study||466
20401|NCT02276222|50504|P1|STARTED|Overall Study||621
20402|NCT02276040|50528|P1|NOT COMPLETED|Overall Study||15
20403|NCT02276040|50528|P1|COMPLETED|Overall Study||11
20404|NCT02276040|50528|P1|STARTED|Overall Study||26
20405|NCT02275767|50535|P3|NOT COMPLETED|Overall Study||3
20406|NCT02275767|50536|P2|NOT COMPLETED|Overall Study||4
20407|NCT02275767|50537|P1|NOT COMPLETED|Overall Study||2
20408|NCT02275767|50535|P3|COMPLETED|Overall Study||19
20409|NCT02275767|50536|P2|COMPLETED|Overall Study||18
20410|NCT02275767|50537|P1|COMPLETED|Overall Study||20
20411|NCT02275767|50535|P3|STARTED|Overall Study||22
20412|NCT02275767|50536|P2|STARTED|Overall Study||22
20413|NCT02275767|50537|P1|STARTED|Overall Study||22
20414|NCT02275611|50552|P4|NOT COMPLETED|Outpatient Drinking||0
20415|NCT02275611|50553|P3|NOT COMPLETED|Outpatient Drinking||0
20416|NCT02275611|50554|P2|NOT COMPLETED|Outpatient Drinking||0
20417|NCT02275611|50555|P1|NOT COMPLETED|Outpatient Drinking||0
20418|NCT02275611|50552|P4|COMPLETED|Outpatient Drinking||3
20419|NCT02275611|50553|P3|COMPLETED|Outpatient Drinking||6
20420|NCT02275611|50554|P2|COMPLETED|Outpatient Drinking||0
20421|NCT02275611|50555|P1|COMPLETED|Outpatient Drinking||0
20422|NCT02275611|50552|P4|STARTED|Outpatient Drinking||3
20423|NCT02275611|50553|P3|STARTED|Outpatient Drinking||6
20424|NCT02275611|50554|P2|STARTED|Outpatient Drinking||0
20425|NCT02275611|50555|P1|STARTED|Outpatient Drinking||0
20426|NCT02275611|50552|P4|NOT COMPLETED|Inpatient Withdrawal||0
20427|NCT02275611|50553|P3|NOT COMPLETED|Inpatient Withdrawal||0
20428|NCT02275611|50554|P2|NOT COMPLETED|Inpatient Withdrawal||0
20429|NCT02275611|50555|P1|NOT COMPLETED|Inpatient Withdrawal||1
20430|NCT02275611|50552|P4|COMPLETED|Inpatient Withdrawal||0
20431|NCT02275611|50553|P3|COMPLETED|Inpatient Withdrawal||0
20432|NCT02275611|50554|P2|COMPLETED|Inpatient Withdrawal||4
20433|NCT02275611|50555|P1|COMPLETED|Inpatient Withdrawal||4
20434|NCT02275611|50552|P4|STARTED|Inpatient Withdrawal||0
20435|NCT02275611|50553|P3|STARTED|Inpatient Withdrawal||0
20436|NCT02275611|50554|P2|STARTED|Inpatient Withdrawal||4
20437|NCT02275611|50555|P1|STARTED|Inpatient Withdrawal||5
20438|NCT02275546|50567|P2|NOT COMPLETED|Treatment Period 2||2
20439|NCT02275546|50568|P1|NOT COMPLETED|Treatment Period 2||2
20440|NCT02275546|50567|P2|COMPLETED|Treatment Period 2||81
20441|NCT02275546|50568|P1|COMPLETED|Treatment Period 2||79
20442|NCT02275546|50567|P2|STARTED|Treatment Period 2||83
20443|NCT02275546|50568|P1|STARTED|Treatment Period 2||81
20444|NCT02275546|50567|P2|NOT COMPLETED|Treatment Period 1||0
20445|NCT02275546|50568|P1|NOT COMPLETED|Treatment Period 1||0
20446|NCT02275546|50567|P2|COMPLETED|Treatment Period 1||83
20447|NCT02275546|50568|P1|COMPLETED|Treatment Period 1||81
20448|NCT02275546|50567|P2|STARTED|Treatment Period 1||83
20449|NCT02275546|50568|P1|STARTED|Treatment Period 1||81
20450|NCT02275481|50578|P2|NOT COMPLETED|Overall Study||3
20451|NCT02275481|50579|P1|NOT COMPLETED|Overall Study||9
20452|NCT02275481|50578|P2|COMPLETED|Overall Study||31
20453|NCT02275481|50579|P1|COMPLETED|Overall Study||23
20454|NCT02275481|50578|P2|STARTED|Overall Study||34
20455|NCT02275481|50579|P1|STARTED|Overall Study||32
20456|NCT02275364|50585|P2|NOT COMPLETED|Period 4||0
20457|NCT02275364|50586|P1|NOT COMPLETED|Period 4||0
20458|NCT02275364|50585|P2|COMPLETED|Period 4||14
20459|NCT02275364|50586|P1|COMPLETED|Period 4||12
20460|NCT02275364|50585|P2|STARTED|Period 4||14
20461|NCT02275364|50586|P1|STARTED|Period 4||12
20462|NCT02275364|50585|P2|NOT COMPLETED|Period 3||0
20463|NCT02275364|50586|P1|NOT COMPLETED|Period 3||0
20464|NCT02275364|50585|P2|COMPLETED|Period 3||14
20465|NCT02275364|50586|P1|COMPLETED|Period 3||12
20466|NCT02275364|50585|P2|STARTED|Period 3||14
20467|NCT02275364|50586|P1|STARTED|Period 3||12
20468|NCT02275364|50585|P2|NOT COMPLETED|Washout Period 2||0
20469|NCT02275364|50586|P1|NOT COMPLETED|Washout Period 2||0
20470|NCT02275364|50585|P2|COMPLETED|Washout Period 2||14
20471|NCT02275364|50586|P1|COMPLETED|Washout Period 2||12
20472|NCT02275364|50585|P2|STARTED|Washout Period 2||14
20473|NCT02275364|50586|P1|STARTED|Washout Period 2||12
20474|NCT02275364|50585|P2|NOT COMPLETED|Period 2||0
20475|NCT02275364|50586|P1|NOT COMPLETED|Period 2||0
20476|NCT02275364|50585|P2|COMPLETED|Period 2||14
20477|NCT02275364|50586|P1|COMPLETED|Period 2||12
20478|NCT02275364|50585|P2|STARTED|Period 2||14
20479|NCT02275364|50586|P1|STARTED|Period 2||12
20480|NCT02275364|50585|P2|NOT COMPLETED|Washout Period 1||0
20481|NCT02275364|50586|P1|NOT COMPLETED|Washout Period 1||0
20482|NCT02275364|50585|P2|COMPLETED|Washout Period 1||14
20483|NCT02275364|50586|P1|COMPLETED|Washout Period 1||12
20484|NCT02275364|50585|P2|STARTED|Washout Period 1||14
20485|NCT02275364|50586|P1|STARTED|Washout Period 1||12
20486|NCT02275364|50585|P2|NOT COMPLETED|Period 1||0
20487|NCT02275364|50586|P1|NOT COMPLETED|Period 1||2
20488|NCT02275364|50585|P2|COMPLETED|Period 1||14
20489|NCT02275364|50586|P1|COMPLETED|Period 1||12
20490|NCT02275364|50585|P2|STARTED|Period 1||14
20491|NCT02275364|50586|P1|STARTED|Period 1||14
20492|NCT02275156|50618|P3|NOT COMPLETED|Overall Study||0
20493|NCT02275156|50619|P2|NOT COMPLETED|Overall Study||0
20494|NCT02275156|50620|P1|NOT COMPLETED|Overall Study||0
20495|NCT02275156|50618|P3|COMPLETED|Overall Study||6
20496|NCT02275156|50619|P2|COMPLETED|Overall Study||6
20497|NCT02275156|50620|P1|COMPLETED|Overall Study||6
20498|NCT02275156|50618|P3|STARTED|Overall Study||6
20499|NCT02275156|50619|P2|STARTED|Overall Study||6
20500|NCT02275156|50620|P1|STARTED|Overall Study||6
20501|NCT02275052|50647|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
20502|NCT02275052|50648|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
20503|NCT02275052|50649|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
20504|NCT02275052|50650|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
20505|NCT02275052|50647|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
20506|NCT02275052|50648|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
20507|NCT02275052|50649|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
20508|NCT02275052|50650|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
20509|NCT02275052|50647|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
20510|NCT02275052|50648|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
20511|NCT02275052|50649|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
20512|NCT02275052|50650|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
20513|NCT02275052|50647|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
20514|NCT02275052|50648|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
20515|NCT02275052|50649|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
20516|NCT02275052|50650|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
20517|NCT02275052|50647|P4|COMPLETED|Washout Period (12-17 Days)||0
20518|NCT02275052|50648|P3|COMPLETED|Washout Period (12-17 Days)||0
20519|NCT02275052|50649|P2|COMPLETED|Washout Period (12-17 Days)||93
20520|NCT02275052|50650|P1|COMPLETED|Washout Period (12-17 Days)||86
20521|NCT02275052|50647|P4|STARTED|Washout Period (12-17 Days)||0
20522|NCT02275052|50648|P3|STARTED|Washout Period (12-17 Days)||0
20523|NCT02275052|50649|P2|STARTED|Washout Period (12-17 Days)||93
20524|NCT02275052|50650|P1|STARTED|Washout Period (12-17 Days)||90
20525|NCT02275052|50647|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
20526|NCT02275052|50648|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
20527|NCT02275052|50649|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
20528|NCT02275052|50650|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
20529|NCT02275052|50647|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
20530|NCT02275052|50648|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
20531|NCT02275052|50649|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
20532|NCT02275052|50650|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
20533|NCT02275052|50647|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
20534|NCT02275052|50648|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
20535|NCT02275052|50649|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
20536|NCT02275052|50650|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
20537|NCT02274948|50664|P2|NOT COMPLETED|Overall Study||91
20538|NCT02274948|50665|P1|NOT COMPLETED|Overall Study||98
20539|NCT02274948|50664|P2|COMPLETED|Overall Study||82
20540|NCT02274948|50665|P1|COMPLETED|Overall Study||68
20541|NCT02274948|50664|P2|STARTED|Overall Study||173
20542|NCT02274948|50665|P1|STARTED|Overall Study||166
20543|NCT02274792|50679|P1|NOT COMPLETED|Overall Study||25
20544|NCT02274792|50679|P1|COMPLETED|Overall Study||107
20545|NCT02274792|50679|P1|Received Treatment|Overall Study||131
20546|NCT02274792|50679|P1|STARTED|Overall Study||132
20547|NCT02274766|50689|P2|NOT COMPLETED|Overall Study||9
20548|NCT02274766|50690|P1|NOT COMPLETED|Overall Study||4
20549|NCT02274766|50689|P2|COMPLETED|Overall Study||29
20550|NCT02274766|50690|P1|COMPLETED|Overall Study||35
20551|NCT02274766|50689|P2|Received Study Drug|Overall Study||37
20552|NCT02274766|50690|P1|Received Study Drug|Overall Study||38
20553|NCT02274766|50689|P2|STARTED|Overall Study||38
20554|NCT02274766|50690|P1|STARTED|Overall Study||39
20555|NCT02274688|50700|P2|NOT COMPLETED|Overall Study||13
20556|NCT02274688|50701|P1|NOT COMPLETED|Overall Study||14
20557|NCT02274688|50700|P2|COMPLETED|Overall Study||72
20558|NCT02274688|50701|P1|COMPLETED|Overall Study||72
20559|NCT02274688|50700|P2|STARTED|Overall Study||85
20560|NCT02274688|50701|P1|STARTED|Overall Study||86
20561|NCT02274675|50723|P1|NOT COMPLETED|Overall Study||0
20562|NCT02274675|50723|P1|COMPLETED|Overall Study||7
20563|NCT02274675|50723|P1|STARTED|Overall Study||7
20564|NCT02274558|50736|P3|NOT COMPLETED|Overall Study||9
20565|NCT02274558|50737|P2|NOT COMPLETED|Overall Study||13
20566|NCT02274558|50738|P1|NOT COMPLETED|Overall Study||7
20567|NCT02274558|50736|P3|COMPLETED|Overall Study||71
20568|NCT02274558|50737|P2|COMPLETED|Overall Study||63
20569|NCT02274558|50738|P1|COMPLETED|Overall Study||71
20570|NCT02274558|50736|P3|Included in the Safety Analysis Set|Overall Study||79
20571|NCT02274558|50737|P2|Included in the Safety Analysis Set|Overall Study||72
20572|NCT02274558|50738|P1|Included in the Safety Analysis Set|Overall Study||76
20573|NCT02274558|50736|P3|STARTED|Overall Study||80
20574|NCT02274558|50737|P2|STARTED|Overall Study||76
20575|NCT02274558|50738|P1|STARTED|Overall Study||78
20576|NCT02273973|50754|P2|NOT COMPLETED|Overall Study||8
20577|NCT02273973|50755|P1|NOT COMPLETED|Overall Study||9
20578|NCT02273973|50754|P2|COMPLETED|Overall Study||160
20579|NCT02273973|50755|P1|COMPLETED|Overall Study||157
20580|NCT02273973|50754|P2|STARTED|Overall Study||168
20581|NCT02273973|50755|P1|STARTED|Overall Study||166
20582|NCT02273908|50797|P2|NOT COMPLETED|Overall Study||5
20583|NCT02273908|50798|P1|NOT COMPLETED|Overall Study||33
20584|NCT02273908|50797|P2|COMPLETED|Overall Study||169
20585|NCT02273908|50798|P1|COMPLETED|Overall Study||124
20586|NCT02273908|50797|P2|STARTED|Overall Study||174
20587|NCT02273908|50798|P1|STARTED|Overall Study||157
20588|NCT02273752|50820|P1|NOT COMPLETED|Overall Study||2
20589|NCT02273752|50820|P1|COMPLETED|Overall Study||0
20590|NCT02273752|50820|P1|STARTED|Overall Study||2
20591|NCT02273323|50831|P2|NOT COMPLETED|Overall Study||0
20592|NCT02273323|50832|P1|NOT COMPLETED|Overall Study||0
20593|NCT02273323|50831|P2|COMPLETED|Overall Study||15
20594|NCT02273323|50832|P1|COMPLETED|Overall Study||15
20595|NCT02273323|50831|P2|STARTED|Overall Study||15
20596|NCT02273323|50832|P1|STARTED|Overall Study||15
20597|NCT02273310|50850|P2|NOT COMPLETED|Overall Study||3
20598|NCT02273310|50851|P1|NOT COMPLETED|Overall Study||18
20599|NCT02273310|50850|P2|COMPLETED|Overall Study||38
20600|NCT02273310|50851|P1|COMPLETED|Overall Study||24
20601|NCT02273310|50850|P2|STARTED|Overall Study||41
20602|NCT02273310|50851|P1|STARTED|Overall Study||42
20603|NCT02273180|50864|P2|NOT COMPLETED|Overall Study||19
20604|NCT02273180|50865|P1|NOT COMPLETED|Overall Study||27
20605|NCT02273180|50864|P2|COMPLETED|Overall Study||235
20606|NCT02273180|50865|P1|COMPLETED|Overall Study||226
20607|NCT02273180|50864|P2|Treated|Overall Study||254
20608|NCT02273180|50865|P1|Treated|Overall Study||252
20609|NCT02273180|50864|P2|STARTED|Overall Study||254
20610|NCT02273180|50865|P1|STARTED|Overall Study||253
20611|NCT02273167|50890|P3|NOT COMPLETED|Overall Study||21
20612|NCT02273167|50891|P2|NOT COMPLETED|Overall Study||23
20613|NCT02273167|50892|P1|NOT COMPLETED|Overall Study||24
20614|NCT02273167|50890|P3|COMPLETED|Overall Study||262
20615|NCT02273167|50891|P2|COMPLETED|Overall Study||260
20616|NCT02273167|50892|P1|COMPLETED|Overall Study||259
20617|NCT02273167|50890|P3|STARTED|Overall Study||283
20618|NCT02273167|50891|P2|STARTED|Overall Study||283
20619|NCT02273167|50892|P1|STARTED|Overall Study||283
20620|NCT02273141|50917|P2|NOT COMPLETED|Overall Study||25
20621|NCT02273141|50918|P1|NOT COMPLETED|Overall Study||17
20622|NCT02273141|50917|P2|COMPLETED|Overall Study||233
20623|NCT02273141|50918|P1|COMPLETED|Overall Study||240
20624|NCT02273141|50917|P2|STARTED|Overall Study||258
20625|NCT02273141|50918|P1|STARTED|Overall Study||257
20626|NCT02273115|50938|P4|NOT COMPLETED|Overall Study||1
20627|NCT02273115|50939|P3|NOT COMPLETED|Overall Study||0
20628|NCT02273115|50940|P2|NOT COMPLETED|Overall Study||0
20629|NCT02273115|50941|P1|NOT COMPLETED|Overall Study||0
20630|NCT02273115|50938|P4|COMPLETED|Overall Study||71
20631|NCT02273115|50939|P3|COMPLETED|Overall Study||67
20632|NCT02273115|50940|P2|COMPLETED|Overall Study||90
20633|NCT02273115|50941|P1|COMPLETED|Overall Study||94
20634|NCT02273115|50938|P4|STARTED|Overall Study||72
20635|NCT02273115|50939|P3|STARTED|Overall Study||67
20636|NCT02273115|50940|P2|STARTED|Overall Study||90
20637|NCT02273115|50941|P1|STARTED|Overall Study||94
20638|NCT02273050|50986|P3|NOT COMPLETED|Overall Study||29
20639|NCT02273050|50987|P2|NOT COMPLETED|Overall Study||22
20640|NCT02273050|50988|P1|NOT COMPLETED|Overall Study||24
20641|NCT02273050|50986|P3|COMPLETED|Overall Study||185
20642|NCT02273050|50987|P2|COMPLETED|Overall Study||194
20643|NCT02273050|50988|P1|COMPLETED|Overall Study||186
20644|NCT02273050|50986|P3|STARTED|Overall Study||214
20645|NCT02273050|50987|P2|STARTED|Overall Study||216
20646|NCT02273050|50988|P1|STARTED|Overall Study||210
20647|NCT02272803|51016|P2|NOT COMPLETED|Overall Study||17
20648|NCT02272803|51017|P1|NOT COMPLETED|Overall Study||9
20649|NCT02272803|51016|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
20650|NCT02272803|51017|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
20651|NCT02272803|51016|P2|STARTED|Overall Study||42
20652|NCT02272803|51017|P1|STARTED|Overall Study||40
20653|NCT02272725|51030|P2|NOT COMPLETED|Overall Study||0
20654|NCT02272725|51031|P1|NOT COMPLETED|Overall Study||2
20655|NCT02272725|51030|P2|COMPLETED|Overall Study||42
20656|NCT02272725|51031|P1|COMPLETED|Overall Study||47
20657|NCT02272725|51030|P2|STARTED|Overall Study||42
20658|NCT02272725|51031|P1|STARTED|Overall Study||49
20659|NCT02271984|51041|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20660|NCT02271984|51042|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20661|NCT02271984|51043|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20662|NCT02271984|51044|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20663|NCT02271984|51045|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20664|NCT02271984|51046|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20665|NCT02271984|51047|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20666|NCT02271984|51048|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20667|NCT02271984|51049|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20668|NCT02271984|51050|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20669|NCT02271984|51051|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20670|NCT02271984|51052|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
20671|NCT02271984|51041|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
20672|NCT02271984|51042|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
20673|NCT02271984|51043|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
20674|NCT02271984|51044|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
20675|NCT02271984|51045|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
20676|NCT02271984|51046|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
20677|NCT02271984|51047|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
20678|NCT02271984|51048|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
20679|NCT02271984|51049|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
20680|NCT02271984|51050|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
20681|NCT02271984|51051|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
20682|NCT02271984|51052|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
20683|NCT02271984|51041|P12|STARTED|Fifth Intervention Period (1 Day)||3
20684|NCT02271984|51042|P11|STARTED|Fifth Intervention Period (1 Day)||3
20685|NCT02271984|51043|P10|STARTED|Fifth Intervention Period (1 Day)||3
20686|NCT02271984|51044|P9|STARTED|Fifth Intervention Period (1 Day)||3
20687|NCT02271984|51045|P8|STARTED|Fifth Intervention Period (1 Day)||2
20688|NCT02271984|51046|P7|STARTED|Fifth Intervention Period (1 Day)||3
20689|NCT02271984|51047|P6|STARTED|Fifth Intervention Period (1 Day)||2
20690|NCT02271984|51048|P5|STARTED|Fifth Intervention Period (1 Day)||3
20691|NCT02271984|51049|P4|STARTED|Fifth Intervention Period (1 Day)||3
20692|NCT02271984|51050|P3|STARTED|Fifth Intervention Period (1 Day)||3
20693|NCT02271984|51051|P2|STARTED|Fifth Intervention Period (1 Day)||3
20694|NCT02271984|51052|P1|STARTED|Fifth Intervention Period (1 Day)||3
20695|NCT02271984|51041|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
20696|NCT02271984|51042|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
20697|NCT02271984|51043|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
20698|NCT02271984|51044|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
20699|NCT02271984|51045|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
20700|NCT02271984|51046|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
20701|NCT02271984|51047|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
20702|NCT02271984|51048|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
20703|NCT02271984|51049|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
20704|NCT02271984|51050|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
20705|NCT02271984|51051|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
20706|NCT02271984|51052|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
20707|NCT02271984|51041|P12|COMPLETED|Washout Period 4 (7 Days)||3
20708|NCT02271984|51042|P11|COMPLETED|Washout Period 4 (7 Days)||3
20709|NCT02271984|51043|P10|COMPLETED|Washout Period 4 (7 Days)||3
20710|NCT02271984|51044|P9|COMPLETED|Washout Period 4 (7 Days)||3
20711|NCT02271984|51045|P8|COMPLETED|Washout Period 4 (7 Days)||2
20712|NCT02271984|51046|P7|COMPLETED|Washout Period 4 (7 Days)||3
20713|NCT02271984|51047|P6|COMPLETED|Washout Period 4 (7 Days)||2
20714|NCT02271984|51048|P5|COMPLETED|Washout Period 4 (7 Days)||3
20715|NCT02271984|51049|P4|COMPLETED|Washout Period 4 (7 Days)||3
20716|NCT02271984|51050|P3|COMPLETED|Washout Period 4 (7 Days)||3
20717|NCT02271984|51051|P2|COMPLETED|Washout Period 4 (7 Days)||3
20718|NCT02271984|51052|P1|COMPLETED|Washout Period 4 (7 Days)||3
20719|NCT02271984|51041|P12|STARTED|Washout Period 4 (7 Days)||3
20720|NCT02271984|51042|P11|STARTED|Washout Period 4 (7 Days)||3
20721|NCT02271984|51043|P10|STARTED|Washout Period 4 (7 Days)||3
20722|NCT02271984|51044|P9|STARTED|Washout Period 4 (7 Days)||3
20723|NCT02271984|51045|P8|STARTED|Washout Period 4 (7 Days)||3
20724|NCT02271984|51046|P7|STARTED|Washout Period 4 (7 Days)||3
20725|NCT02271984|51047|P6|STARTED|Washout Period 4 (7 Days)||3
20726|NCT02271984|51048|P5|STARTED|Washout Period 4 (7 Days)||3
20727|NCT02271984|51049|P4|STARTED|Washout Period 4 (7 Days)||3
20728|NCT02271984|51050|P3|STARTED|Washout Period 4 (7 Days)||3
20729|NCT02271984|51051|P2|STARTED|Washout Period 4 (7 Days)||3
20730|NCT02271984|51052|P1|STARTED|Washout Period 4 (7 Days)||3
20731|NCT02271984|51041|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20732|NCT02271984|51042|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20733|NCT02271984|51043|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20734|NCT02271984|51044|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20735|NCT02271984|51045|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20736|NCT02271984|51046|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20737|NCT02271984|51047|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20738|NCT02271984|51048|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20739|NCT02271984|51049|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20740|NCT02271984|51050|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20741|NCT02271984|51051|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20742|NCT02271984|51052|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
20743|NCT02271984|51041|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
20744|NCT02271984|51042|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
20745|NCT02271984|51043|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
20746|NCT02271984|51044|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
20747|NCT02271984|51045|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
20748|NCT02271984|51046|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
20749|NCT02271984|51047|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
20750|NCT02271984|51048|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
20751|NCT02271984|51049|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
20752|NCT02271984|51050|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
20753|NCT02271984|51051|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
20754|NCT02271984|51052|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
20755|NCT02271984|51041|P12|STARTED|Fourth Intervention Period (Day 1)||3
20756|NCT02271984|51042|P11|STARTED|Fourth Intervention Period (Day 1)||3
20757|NCT02271984|51043|P10|STARTED|Fourth Intervention Period (Day 1)||3
20758|NCT02271984|51044|P9|STARTED|Fourth Intervention Period (Day 1)||3
20759|NCT02271984|51045|P8|STARTED|Fourth Intervention Period (Day 1)||3
20760|NCT02271984|51046|P7|STARTED|Fourth Intervention Period (Day 1)||3
20761|NCT02271984|51047|P6|STARTED|Fourth Intervention Period (Day 1)||3
20762|NCT02271984|51048|P5|STARTED|Fourth Intervention Period (Day 1)||3
20763|NCT02271984|51049|P4|STARTED|Fourth Intervention Period (Day 1)||3
20764|NCT02271984|51050|P3|STARTED|Fourth Intervention Period (Day 1)||3
20765|NCT02271984|51051|P2|STARTED|Fourth Intervention Period (Day 1)||3
20766|NCT02271984|51052|P1|STARTED|Fourth Intervention Period (Day 1)||3
20767|NCT02271984|51041|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
20768|NCT02271984|51042|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
20769|NCT02271984|51043|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
20770|NCT02271984|51044|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
20771|NCT02271984|51045|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
20772|NCT02271984|51046|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
20773|NCT02271984|51047|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
20774|NCT02271984|51048|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
20775|NCT02271984|51049|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
20776|NCT02271984|51050|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
20777|NCT02271984|51051|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
20778|NCT02271984|51052|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
20779|NCT02271984|51041|P12|COMPLETED|Washout Period 3 (7 Days)||3
20780|NCT02271984|51042|P11|COMPLETED|Washout Period 3 (7 Days)||3
20781|NCT02271984|51043|P10|COMPLETED|Washout Period 3 (7 Days)||3
20782|NCT02271984|51044|P9|COMPLETED|Washout Period 3 (7 Days)||3
20783|NCT02271984|51045|P8|COMPLETED|Washout Period 3 (7 Days)||3
20784|NCT02271984|51046|P7|COMPLETED|Washout Period 3 (7 Days)||3
20785|NCT02271984|51047|P6|COMPLETED|Washout Period 3 (7 Days)||3
20786|NCT02271984|51048|P5|COMPLETED|Washout Period 3 (7 Days)||3
20787|NCT02271984|51049|P4|COMPLETED|Washout Period 3 (7 Days)||3
20788|NCT02271984|51050|P3|COMPLETED|Washout Period 3 (7 Days)||3
20789|NCT02271984|51051|P2|COMPLETED|Washout Period 3 (7 Days)||3
20790|NCT02271984|51052|P1|COMPLETED|Washout Period 3 (7 Days)||3
20791|NCT02271984|51041|P12|STARTED|Washout Period 3 (7 Days)||3
20792|NCT02271984|51042|P11|STARTED|Washout Period 3 (7 Days)||3
20793|NCT02271984|51043|P10|STARTED|Washout Period 3 (7 Days)||3
20794|NCT02271984|51044|P9|STARTED|Washout Period 3 (7 Days)||3
20795|NCT02271984|51045|P8|STARTED|Washout Period 3 (7 Days)||3
20796|NCT02271984|51046|P7|STARTED|Washout Period 3 (7 Days)||3
20797|NCT02271984|51047|P6|STARTED|Washout Period 3 (7 Days)||3
20798|NCT02271984|51048|P5|STARTED|Washout Period 3 (7 Days)||3
20799|NCT02271984|51049|P4|STARTED|Washout Period 3 (7 Days)||3
20800|NCT02271984|51050|P3|STARTED|Washout Period 3 (7 Days)||3
20801|NCT02271984|51051|P2|STARTED|Washout Period 3 (7 Days)||3
20802|NCT02271984|51052|P1|STARTED|Washout Period 3 (7 Days)||3
20803|NCT02271984|51041|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
20804|NCT02271984|51042|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
20805|NCT02271984|51043|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
20806|NCT02271984|51044|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
20807|NCT02271984|51045|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
20808|NCT02271984|51046|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
20809|NCT02271984|51047|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
20810|NCT02271984|51048|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
20811|NCT02271984|51049|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
20812|NCT02271984|51050|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
20813|NCT02271984|51051|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
20814|NCT02271984|51052|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
20815|NCT02271984|51041|P12|COMPLETED|Third Intervention Period (1 Day)||3
20816|NCT02271984|51042|P11|COMPLETED|Third Intervention Period (1 Day)||3
20817|NCT02271984|51043|P10|COMPLETED|Third Intervention Period (1 Day)||3
20818|NCT02271984|51044|P9|COMPLETED|Third Intervention Period (1 Day)||3
20819|NCT02271984|51045|P8|COMPLETED|Third Intervention Period (1 Day)||3
20820|NCT02271984|51046|P7|COMPLETED|Third Intervention Period (1 Day)||3
20821|NCT02271984|51047|P6|COMPLETED|Third Intervention Period (1 Day)||3
20822|NCT02271984|51048|P5|COMPLETED|Third Intervention Period (1 Day)||3
20823|NCT02271984|51049|P4|COMPLETED|Third Intervention Period (1 Day)||3
20824|NCT02271984|51050|P3|COMPLETED|Third Intervention Period (1 Day)||3
20825|NCT02271984|51051|P2|COMPLETED|Third Intervention Period (1 Day)||3
20826|NCT02271984|51052|P1|COMPLETED|Third Intervention Period (1 Day)||3
20827|NCT02271984|51041|P12|STARTED|Third Intervention Period (1 Day)||3
20828|NCT02271984|51042|P11|STARTED|Third Intervention Period (1 Day)||3
20829|NCT02271984|51043|P10|STARTED|Third Intervention Period (1 Day)||3
20830|NCT02271984|51044|P9|STARTED|Third Intervention Period (1 Day)||3
20831|NCT02271984|51045|P8|STARTED|Third Intervention Period (1 Day)||3
20832|NCT02271984|51046|P7|STARTED|Third Intervention Period (1 Day)||3
20833|NCT02271984|51047|P6|STARTED|Third Intervention Period (1 Day)||3
20834|NCT02271984|51048|P5|STARTED|Third Intervention Period (1 Day)||3
20835|NCT02271984|51049|P4|STARTED|Third Intervention Period (1 Day)||3
20836|NCT02271984|51050|P3|STARTED|Third Intervention Period (1 Day)||3
20837|NCT02271984|51051|P2|STARTED|Third Intervention Period (1 Day)||3
20838|NCT02271984|51052|P1|STARTED|Third Intervention Period (1 Day)||3
20839|NCT02271984|51041|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
20840|NCT02271984|51042|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
20841|NCT02271984|51043|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
20842|NCT02271984|51044|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
20843|NCT02271984|51045|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
20844|NCT02271984|51046|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
20845|NCT02271984|51047|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
20846|NCT02271984|51048|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
20847|NCT02271984|51049|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
20848|NCT02271984|51050|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
20849|NCT02271984|51051|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
20850|NCT02271984|51052|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
20851|NCT02271984|51041|P12|COMPLETED|Washout Period 2 (7 Days)||3
20852|NCT02271984|51042|P11|COMPLETED|Washout Period 2 (7 Days)||3
20853|NCT02271984|51043|P10|COMPLETED|Washout Period 2 (7 Days)||3
20854|NCT02271984|51044|P9|COMPLETED|Washout Period 2 (7 Days)||3
20855|NCT02271984|51045|P8|COMPLETED|Washout Period 2 (7 Days)||3
20856|NCT02271984|51046|P7|COMPLETED|Washout Period 2 (7 Days)||3
20857|NCT02271984|51047|P6|COMPLETED|Washout Period 2 (7 Days)||3
20858|NCT02271984|51048|P5|COMPLETED|Washout Period 2 (7 Days)||3
20859|NCT02271984|51049|P4|COMPLETED|Washout Period 2 (7 Days)||3
20860|NCT02271984|51050|P3|COMPLETED|Washout Period 2 (7 Days)||3
20861|NCT02271984|51051|P2|COMPLETED|Washout Period 2 (7 Days)||3
20862|NCT02271984|51052|P1|COMPLETED|Washout Period 2 (7 Days)||3
20863|NCT02271984|51041|P12|STARTED|Washout Period 2 (7 Days)||3
20864|NCT02271984|51042|P11|STARTED|Washout Period 2 (7 Days)||3
20865|NCT02271984|51043|P10|STARTED|Washout Period 2 (7 Days)||3
20866|NCT02271984|51044|P9|STARTED|Washout Period 2 (7 Days)||3
20867|NCT02271984|51045|P8|STARTED|Washout Period 2 (7 Days)||3
20868|NCT02271984|51046|P7|STARTED|Washout Period 2 (7 Days)||3
20869|NCT02271984|51047|P6|STARTED|Washout Period 2 (7 Days)||3
20870|NCT02271984|51048|P5|STARTED|Washout Period 2 (7 Days)||3
20871|NCT02271984|51049|P4|STARTED|Washout Period 2 (7 Days)||3
20872|NCT02271984|51050|P3|STARTED|Washout Period 2 (7 Days)||3
20873|NCT02271984|51051|P2|STARTED|Washout Period 2 (7 Days)||3
20874|NCT02271984|51052|P1|STARTED|Washout Period 2 (7 Days)||3
20875|NCT02271984|51041|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
20876|NCT02271984|51042|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
20877|NCT02271984|51043|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
20878|NCT02271984|51044|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
20879|NCT02271984|51045|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
20880|NCT02271984|51046|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
20881|NCT02271984|51047|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
20882|NCT02271984|51048|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
20883|NCT02271984|51049|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
20884|NCT02271984|51050|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
20885|NCT02271984|51051|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
20886|NCT02271984|51052|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
20887|NCT02271984|51041|P12|COMPLETED|Second Intervention Period (1 Day)||3
20888|NCT02271984|51042|P11|COMPLETED|Second Intervention Period (1 Day)||3
20889|NCT02271984|51043|P10|COMPLETED|Second Intervention Period (1 Day)||3
20890|NCT02271984|51044|P9|COMPLETED|Second Intervention Period (1 Day)||3
20891|NCT02271984|51045|P8|COMPLETED|Second Intervention Period (1 Day)||3
20892|NCT02271984|51046|P7|COMPLETED|Second Intervention Period (1 Day)||3
20893|NCT02271984|51047|P6|COMPLETED|Second Intervention Period (1 Day)||3
20894|NCT02271984|51048|P5|COMPLETED|Second Intervention Period (1 Day)||3
20895|NCT02271984|51049|P4|COMPLETED|Second Intervention Period (1 Day)||3
20896|NCT02271984|51050|P3|COMPLETED|Second Intervention Period (1 Day)||3
20897|NCT02271984|51051|P2|COMPLETED|Second Intervention Period (1 Day)||3
20898|NCT02271984|51052|P1|COMPLETED|Second Intervention Period (1 Day)||3
20899|NCT02271984|51041|P12|STARTED|Second Intervention Period (1 Day)||3
20900|NCT02271984|51042|P11|STARTED|Second Intervention Period (1 Day)||3
20901|NCT02271984|51043|P10|STARTED|Second Intervention Period (1 Day)||3
20902|NCT02271984|51044|P9|STARTED|Second Intervention Period (1 Day)||3
20903|NCT02271984|51045|P8|STARTED|Second Intervention Period (1 Day)||3
20904|NCT02271984|51046|P7|STARTED|Second Intervention Period (1 Day)||3
20905|NCT02271984|51047|P6|STARTED|Second Intervention Period (1 Day)||3
20906|NCT02271984|51048|P5|STARTED|Second Intervention Period (1 Day)||3
20907|NCT02271984|51049|P4|STARTED|Second Intervention Period (1 Day)||3
20908|NCT02271984|51050|P3|STARTED|Second Intervention Period (1 Day)||3
20909|NCT02271984|51051|P2|STARTED|Second Intervention Period (1 Day)||3
20910|NCT02271984|51052|P1|STARTED|Second Intervention Period (1 Day)||3
20911|NCT02271984|51041|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
20912|NCT02271984|51042|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
20913|NCT02271984|51043|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
20914|NCT02271984|51044|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
20915|NCT02271984|51045|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
20916|NCT02271984|51046|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
20917|NCT02271984|51047|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
20918|NCT02271984|51048|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
20919|NCT02271984|51049|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
20920|NCT02271984|51050|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
20921|NCT02271984|51051|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
20922|NCT02271984|51052|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
20923|NCT02271984|51041|P12|COMPLETED|Washout Period 1 (7 Days)||3
20924|NCT02271984|51042|P11|COMPLETED|Washout Period 1 (7 Days)||3
20925|NCT02271984|51043|P10|COMPLETED|Washout Period 1 (7 Days)||3
20926|NCT02271984|51044|P9|COMPLETED|Washout Period 1 (7 Days)||3
20927|NCT02271984|51045|P8|COMPLETED|Washout Period 1 (7 Days)||3
20928|NCT02271984|51046|P7|COMPLETED|Washout Period 1 (7 Days)||3
20929|NCT02271984|51047|P6|COMPLETED|Washout Period 1 (7 Days)||3
20930|NCT02271984|51048|P5|COMPLETED|Washout Period 1 (7 Days)||3
20931|NCT02271984|51049|P4|COMPLETED|Washout Period 1 (7 Days)||3
20932|NCT02271984|51050|P3|COMPLETED|Washout Period 1 (7 Days)||3
20933|NCT02271984|51051|P2|COMPLETED|Washout Period 1 (7 Days)||3
20934|NCT02271984|51052|P1|COMPLETED|Washout Period 1 (7 Days)||3
20935|NCT02271984|51041|P12|STARTED|Washout Period 1 (7 Days)||3
20936|NCT02271984|51042|P11|STARTED|Washout Period 1 (7 Days)||3
20937|NCT02271984|51043|P10|STARTED|Washout Period 1 (7 Days)||3
20938|NCT02271984|51044|P9|STARTED|Washout Period 1 (7 Days)||3
20939|NCT02271984|51045|P8|STARTED|Washout Period 1 (7 Days)||3
20940|NCT02271984|51046|P7|STARTED|Washout Period 1 (7 Days)||3
20941|NCT02271984|51047|P6|STARTED|Washout Period 1 (7 Days)||3
20942|NCT02271984|51048|P5|STARTED|Washout Period 1 (7 Days)||3
20943|NCT02271984|51049|P4|STARTED|Washout Period 1 (7 Days)||3
20944|NCT02271984|51050|P3|STARTED|Washout Period 1 (7 Days)||3
20945|NCT02271984|51051|P2|STARTED|Washout Period 1 (7 Days)||3
20946|NCT02271984|51052|P1|STARTED|Washout Period 1 (7 Days)||3
20947|NCT02271984|51041|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
20948|NCT02271984|51042|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
20949|NCT02271984|51043|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
20950|NCT02271984|51044|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
20951|NCT02271984|51045|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
20952|NCT02271984|51046|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
20953|NCT02271984|51047|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
20954|NCT02271984|51048|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
20955|NCT02271984|51049|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
20956|NCT02271984|51050|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
20957|NCT02271984|51051|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
20958|NCT02271984|51052|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
20959|NCT02271984|51041|P12|COMPLETED|First Intervention Period (1 Day)||3
20960|NCT02271984|51042|P11|COMPLETED|First Intervention Period (1 Day)||3
20961|NCT02271984|51043|P10|COMPLETED|First Intervention Period (1 Day)||3
20962|NCT02271984|51044|P9|COMPLETED|First Intervention Period (1 Day)||3
20963|NCT02271984|51045|P8|COMPLETED|First Intervention Period (1 Day)||3
20964|NCT02271984|51046|P7|COMPLETED|First Intervention Period (1 Day)||3
20965|NCT02271984|51047|P6|COMPLETED|First Intervention Period (1 Day)||3
20966|NCT02271984|51048|P5|COMPLETED|First Intervention Period (1 Day)||3
20967|NCT02271984|51049|P4|COMPLETED|First Intervention Period (1 Day)||3
20968|NCT02271984|51050|P3|COMPLETED|First Intervention Period (1 Day)||3
20969|NCT02271984|51051|P2|COMPLETED|First Intervention Period (1 Day)||3
20970|NCT02271984|51052|P1|COMPLETED|First Intervention Period (1 Day)||3
20971|NCT02271984|51041|P12|STARTED|First Intervention Period (1 Day)||3
20972|NCT02271984|51042|P11|STARTED|First Intervention Period (1 Day)||3
20973|NCT02271984|51043|P10|STARTED|First Intervention Period (1 Day)||3
20974|NCT02271984|51044|P9|STARTED|First Intervention Period (1 Day)||3
20975|NCT02271984|51045|P8|STARTED|First Intervention Period (1 Day)||3
20976|NCT02271984|51046|P7|STARTED|First Intervention Period (1 Day)||3
20977|NCT02271984|51047|P6|STARTED|First Intervention Period (1 Day)||3
20978|NCT02271984|51048|P5|STARTED|First Intervention Period (1 Day)||3
20979|NCT02271984|51049|P4|STARTED|First Intervention Period (1 Day)||3
20980|NCT02271984|51050|P3|STARTED|First Intervention Period (1 Day)||3
20981|NCT02271984|51051|P2|STARTED|First Intervention Period (1 Day)||3
20982|NCT02271984|51052|P1|STARTED|First Intervention Period (1 Day)||3
20983|NCT02271945|51141|P2|NOT COMPLETED|Overall Study||5
20984|NCT02271945|51142|P1|NOT COMPLETED|Overall Study||5
20985|NCT02271945|51141|P2|COMPLETED|Overall Study||0
20986|NCT02271945|51142|P1|COMPLETED|Overall Study||0
20987|NCT02271945|51141|P2|STARTED|Overall Study||5
20988|NCT02271945|51142|P1|STARTED|Overall Study||5
20989|NCT02271880|51180|P2|NOT COMPLETED|Overall Study||4
20990|NCT02271880|51181|P1|NOT COMPLETED|Overall Study||3
20991|NCT02271880|51180|P2|COMPLETED|Overall Study||0
20992|NCT02271880|51181|P1|COMPLETED|Overall Study||0
20993|NCT02271880|51180|P2|STARTED|Overall Study||4
20994|NCT02271880|51181|P1|STARTED|Overall Study||3
20995|NCT02271854|51187|P1|NOT COMPLETED|Overall Study||4
20996|NCT02271854|51187|P1|COMPLETED|Overall Study||98
20997|NCT02271854|51187|P1|STARTED|Overall Study||102
20998|NCT02271698|51198|P4|NOT COMPLETED|Overall Study||0
20999|NCT02271698|51199|P3|NOT COMPLETED|Overall Study||0
21000|NCT02271698|51200|P2|NOT COMPLETED|Overall Study||0
21001|NCT02271698|51201|P1|NOT COMPLETED|Overall Study||0
21002|NCT02271698|51198|P4|COMPLETED|Overall Study||11
21003|NCT02271698|51199|P3|COMPLETED|Overall Study||10
21004|NCT02271698|51200|P2|COMPLETED|Overall Study||10
21005|NCT02271698|51201|P1|COMPLETED|Overall Study||11
21006|NCT02271698|51198|P4|STARTED|Overall Study||11
21007|NCT02271698|51199|P3|STARTED|Overall Study||10
21008|NCT02271698|51200|P2|STARTED|Overall Study||10
21009|NCT02271698|51201|P1|STARTED|Overall Study||11
21010|NCT02271529|51227|P1|NOT COMPLETED|Overall Study||1
21011|NCT02271529|51227|P1|COMPLETED|Overall Study||39
21012|NCT02271529|51227|P1|STARTED|Overall Study||40
21013|NCT02271477|51233|P2|NOT COMPLETED|Overall Study||0
21014|NCT02271477|51234|P1|NOT COMPLETED|Overall Study||0
21015|NCT02271477|51233|P2|COMPLETED|Overall Study||80
21016|NCT02271477|51234|P1|COMPLETED|Overall Study||80
21017|NCT02271477|51233|P2|STARTED|Overall Study||80
21018|NCT02271477|51234|P1|STARTED|Overall Study||80
21019|NCT02271217|51249|P3|NOT COMPLETED|Overall Study||12
21020|NCT02271217|51250|P2|NOT COMPLETED|Overall Study||13
21021|NCT02271217|51251|P1|NOT COMPLETED|Overall Study||11
21022|NCT02271217|51249|P3|COMPLETED|Overall Study||113
21023|NCT02271217|51250|P2|COMPLETED|Overall Study||113
21024|NCT02271217|51251|P1|COMPLETED|Overall Study||115
21025|NCT02271217|51249|P3|STARTED|Overall Study||125
21026|NCT02271217|51250|P2|STARTED|Overall Study||126
21027|NCT02271217|51251|P1|STARTED|Overall Study||126
21028|NCT02270944|51264|P2|NOT COMPLETED|Overall Study||5
21029|NCT02270944|51265|P1|NOT COMPLETED|Overall Study||11
21030|NCT02270944|51264|P2|COMPLETED|Overall Study||516
21031|NCT02270944|51265|P1|COMPLETED|Overall Study||518
21032|NCT02270944|51264|P2|STARTED|Overall Study||521
21033|NCT02270944|51265|P1|STARTED|Overall Study||529
21034|NCT02270684|51281|P2|NOT COMPLETED|Overall Study||3
21035|NCT02270684|51282|P1|NOT COMPLETED|Overall Study||1
21036|NCT02270684|51281|P2|COMPLETED|Overall Study||0
21037|NCT02270684|51282|P1|COMPLETED|Overall Study||0
21038|NCT02270684|51281|P2|STARTED|Overall Study||3
21039|NCT02270684|51282|P1|STARTED|Overall Study||1
21040|NCT02270515|51288|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
21041|NCT02270515|51288|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
21042|NCT02270515|51288|P1|STARTED|Intervention Period 3: 12-18 Months||127
21043|NCT02270515|51288|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
21044|NCT02270515|51288|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
21045|NCT02270515|51288|P1|STARTED|Intervention Period 2: 6-12 Months||159
21046|NCT02270515|51288|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
21047|NCT02270515|51288|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
21048|NCT02270515|51288|P1|STARTED|Intervention Period 1: 0-6 Months||175
21049|NCT02269709|51303|P1|NOT COMPLETED|Six Month Follow-up||12
21050|NCT02269709|51303|P1|COMPLETED|Six Month Follow-up||5
21051|NCT02269709|51303|P1|STARTED|Six Month Follow-up||17
21052|NCT02269709|51303|P1|NOT COMPLETED|Prior to Hospital Discharge||0
21053|NCT02269709|51303|P1|COMPLETED|Prior to Hospital Discharge||17
21054|NCT02269709|51303|P1|STARTED|Prior to Hospital Discharge||17
21055|NCT02269709|51303|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
21056|NCT02269709|51303|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
21057|NCT02269709|51303|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
21058|NCT02269709|51303|P1|NOT COMPLETED|Time of Enrollment||3
21059|NCT02269709|51303|P1|COMPLETED|Time of Enrollment||18
21060|NCT02269709|51303|P1|STARTED|Time of Enrollment||21
21061|NCT02269657|51308|P1|NOT COMPLETED|Overall Study||3
21062|NCT02269657|51308|P1|COMPLETED|Overall Study||37
21063|NCT02269657|51308|P1|STARTED|Overall Study||40
21064|NCT02269488|51322|P1|NOT COMPLETED|Overall Study||0
21065|NCT02269488|51322|P1|COMPLETED|Overall Study||100
21066|NCT02269488|51322|P1|STARTED|Overall Study||100
21067|NCT02269475|51328|P2|NOT COMPLETED|Overall Study||1
21068|NCT02269475|51329|P1|NOT COMPLETED|Overall Study||3
21069|NCT02269475|51328|P2|COMPLETED|Overall Study||432
21070|NCT02269475|51329|P1|COMPLETED|Overall Study||865
21071|NCT02269475|51328|P2|Per Protocol Population|Overall Study||430
21072|NCT02269475|51329|P1|Per Protocol Population|Overall Study||849
21073|NCT02269475|51328|P2|Received IP (Safety Population)|Overall Study||433
21074|NCT02269475|51329|P1|Received IP (Safety Population)|Overall Study||868
21075|NCT02269475|51328|P2|STARTED|Overall Study||433
21076|NCT02269475|51329|P1|STARTED|Overall Study||868
21077|NCT02269098|51342|P2|NOT COMPLETED|Overall Study||9
21078|NCT02269098|51343|P1|NOT COMPLETED|Overall Study||14
21079|NCT02269098|51342|P2|COMPLETED|Overall Study||41
21080|NCT02269098|51343|P1|COMPLETED|Overall Study||37
21081|NCT02269098|51342|P2|STARTED|Overall Study||50
21082|NCT02269098|51343|P1|STARTED|Overall Study||51
21083|NCT02268994|51359|P2|NOT COMPLETED|Overall Study||35
21084|NCT02268994|51360|P1|NOT COMPLETED|Overall Study||31
21085|NCT02268994|51359|P2|COMPLETED|Overall Study||81
21086|NCT02268994|51360|P1|COMPLETED|Overall Study||86
21087|NCT02268994|51359|P2|STARTED|Overall Study||116
21088|NCT02268994|51360|P1|STARTED|Overall Study||117
21089|NCT02268877|51378|P2|NOT COMPLETED|Overall Study||5
21090|NCT02268877|51379|P1|NOT COMPLETED|Overall Study||4
21091|NCT02268877|51378|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
21092|NCT02268877|51379|P1|COMPLETED|Overall Study||118
21093|NCT02268877|51378|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
21094|NCT02268877|51379|P1|STARTED|Overall Study||122
21095|NCT02268864|51390|P3|NOT COMPLETED|Overall Study||0
21096|NCT02268864|51391|P2|NOT COMPLETED|Overall Study||1
21097|NCT02268864|51392|P1|NOT COMPLETED|Overall Study||2
21098|NCT02268864|51390|P3|COMPLETED|Overall Study||64
21099|NCT02268864|51391|P2|COMPLETED|Overall Study||24
21100|NCT02268864|51392|P1|COMPLETED|Overall Study||15
21101|NCT02268864|51390|P3|STARTED|Overall Study||64
21102|NCT02268864|51391|P2|STARTED|Overall Study||25
21103|NCT02268864|51392|P1|STARTED|Overall Study||17
21104|NCT02268526|51417|P3|NOT COMPLETED|Overall Study||5
21105|NCT02268526|51418|P2|NOT COMPLETED|Overall Study||21
21106|NCT02268526|51419|P1|NOT COMPLETED|Overall Study||1
21107|NCT02268526|51417|P3|COMPLETED|Overall Study||16
21108|NCT02268526|51418|P2|COMPLETED|Overall Study||38
21109|NCT02268526|51419|P1|COMPLETED|Overall Study||5
21110|NCT02268526|51417|P3|PD Analysis Set (Cohort 2)|Overall Study||17
21111|NCT02268526|51418|P2|PD Analysis Set (Cohort 2)|Overall Study||42
21112|NCT02268526|51419|P1|PD Analysis Set (Cohort 2)|Overall Study||0
21113|NCT02268526|51417|P3|STARTED|Overall Study||21
21114|NCT02268526|51418|P2|STARTED|Overall Study||59
21115|NCT02268526|51419|P1|STARTED|Overall Study||6
21116|NCT02268396|51440|P1|NOT COMPLETED|Overall Study||12
21117|NCT02268396|51440|P1|COMPLETED|Overall Study||126
21118|NCT02268396|51440|P1|STARTED|Overall Study||138
21119|NCT02268214|51452|P3|NOT COMPLETED|Overall Study||28
21120|NCT02268214|51453|P2|NOT COMPLETED|Overall Study||23
21121|NCT02268214|51454|P1|NOT COMPLETED|Overall Study||24
21122|NCT02268214|51452|P3|COMPLETED|Overall Study||232
21123|NCT02268214|51453|P2|COMPLETED|Overall Study||273
21124|NCT02268214|51454|P1|COMPLETED|Overall Study||253
21125|NCT02268214|51452|P3|STARTED|Overall Study||260
21126|NCT02268214|51453|P2|STARTED|Overall Study||296
21127|NCT02268214|51454|P1|STARTED|Overall Study||277
21128|NCT02268058|51484|P4|NOT COMPLETED|Overall Study||0
21129|NCT02268058|51485|P3|NOT COMPLETED|Overall Study||0
21130|NCT02268058|51486|P2|NOT COMPLETED|Overall Study||0
21131|NCT02268058|51487|P1|NOT COMPLETED|Overall Study||1
21132|NCT02268058|51484|P4|COMPLETED|Overall Study||20
21133|NCT02268058|51485|P3|COMPLETED|Overall Study||20
21134|NCT02268058|51486|P2|COMPLETED|Overall Study||20
21135|NCT02268058|51487|P1|COMPLETED|Overall Study||19
21136|NCT02268058|51484|P4|STARTED|Overall Study||20
21137|NCT02268058|51485|P3|STARTED|Overall Study||20
21138|NCT02268058|51486|P2|STARTED|Overall Study||20
21139|NCT02268058|51487|P1|STARTED|Overall Study||20
21140|NCT02267850|51511|P2|NOT COMPLETED|Overall Study||2
21141|NCT02267850|51512|P1|NOT COMPLETED|Overall Study||1
21142|NCT02267850|51511|P2|COMPLETED|Overall Study||12
21143|NCT02267850|51512|P1|COMPLETED|Overall Study||14
21144|NCT02267850|51511|P2|STARTED|Overall Study||14
21145|NCT02267850|51512|P1|STARTED|Overall Study||15
21146|NCT02267837|51520|P2|NOT COMPLETED|Overall Study||0
21147|NCT02267837|51521|P1|NOT COMPLETED|Overall Study||0
21148|NCT02267837|51520|P2|COMPLETED|Overall Study||9
21149|NCT02267837|51521|P1|COMPLETED|Overall Study||11
21150|NCT02267837|51520|P2|STARTED|Overall Study||9
21151|NCT02267837|51521|P1|STARTED|Overall Study||11
21152|NCT02267824|51529|P2|NOT COMPLETED|Overall Study||1
21153|NCT02267824|51530|P1|NOT COMPLETED|Overall Study||10
21154|NCT02267824|51529|P2|COMPLETED|Overall Study||17
21155|NCT02267824|51530|P1|COMPLETED|Overall Study||73
21156|NCT02267824|51529|P2|STARTED|Overall Study||18
21157|NCT02267824|51530|P1|STARTED|Overall Study||83
21158|NCT02267629|51536|P1|NOT COMPLETED|Overall Study||0
21159|NCT02267629|51536|P1|COMPLETED|Overall Study||7
21160|NCT02267629|51536|P1|STARTED|Overall Study||7
21161|NCT02267538|51543|P2|NOT COMPLETED|Overall Study||0
21162|NCT02267538|51544|P1|NOT COMPLETED|Overall Study||0
21163|NCT02267538|51543|P2|COMPLETED|Overall Study||143
21164|NCT02267538|51544|P1|COMPLETED|Overall Study||142
21165|NCT02267538|51543|P2|STARTED|Overall Study||143
21166|NCT02267538|51544|P1|STARTED|Overall Study||142
21167|NCT02267447|51564|P2|NOT COMPLETED|Overall Study||0
21168|NCT02267447|51565|P1|NOT COMPLETED|Overall Study||0
21169|NCT02267447|51564|P2|COMPLETED|Overall Study||26968
21170|NCT02267447|51565|P1|COMPLETED|Overall Study||77251
21171|NCT02267447|51564|P2|STARTED|Overall Study||26968
21172|NCT02267447|51565|P1|STARTED|Overall Study||77251
21173|NCT02267187|51573|P1|NOT COMPLETED|Overall Study||2
21174|NCT02267187|51573|P1|COMPLETED|Overall Study||10
21175|NCT02267187|51573|P1|STARTED|Overall Study||12
21176|NCT02267135|51581|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
21177|NCT02267135|51582|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
21178|NCT02267135|51581|P2|COMPLETED|Period 2 (Randomized Set)||46
21179|NCT02267135|51582|P1|COMPLETED|Period 2 (Randomized Set)||46
21180|NCT02267135|51581|P2|STARTED|Period 2 (Randomized Set)||47
21181|NCT02267135|51582|P1|STARTED|Period 2 (Randomized Set)||50
21182|NCT02267135|51581|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
21183|NCT02267135|51582|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
21184|NCT02267135|51581|P2|COMPLETED|Period 1 (Randomized Set)||47
21185|NCT02267135|51582|P1|COMPLETED|Period 1 (Randomized Set)||50
21186|NCT02267135|51581|P2|STARTED|Period 1 (Randomized Set)||51
21187|NCT02267135|51582|P1|STARTED|Period 1 (Randomized Set)||51
21188|NCT02267083|51613|P1|NOT COMPLETED|Overall Study||19
21189|NCT02267083|51613|P1|COMPLETED|Overall Study||3
21190|NCT02267083|51613|P1|STARTED|Overall Study||22
21191|NCT02266875|51622|P2|NOT COMPLETED|Overall Study||0
21192|NCT02266875|51623|P1|NOT COMPLETED|Overall Study||11
21193|NCT02266875|51622|P2|COMPLETED|Overall Study||30
21194|NCT02266875|51623|P1|COMPLETED|Overall Study||29
21195|NCT02266875|51622|P2|STARTED|Overall Study||30
21196|NCT02266875|51623|P1|STARTED|Overall Study||40
21197|NCT02266810|51635|P2|NOT COMPLETED|Overall Study||1
21198|NCT02266810|51636|P1|NOT COMPLETED|Overall Study||1
21199|NCT02266810|51635|P2|COMPLETED|Overall Study|sinus sides|79
21200|NCT02266810|51636|P1|COMPLETED|Overall Study|sinus sides|79
21201|NCT02266810|51635|P2|STARTED|Overall Study|sinus sides|80
21202|NCT02266810|51636|P1|STARTED|Overall Study|sinus sides|80
21203|NCT02266797|51662|P2|NOT COMPLETED|Overall Study||1
21204|NCT02266797|51663|P1|NOT COMPLETED|Overall Study||0
21205|NCT02266797|51662|P2|COMPLETED|Overall Study||2
21206|NCT02266797|51663|P1|COMPLETED|Overall Study||1
21207|NCT02266797|51662|P2|STARTED|Overall Study||3
21208|NCT02266797|51663|P1|STARTED|Overall Study||1
21209|NCT02266472|51681|P2|NOT COMPLETED|Period 2+ Washout||0
21210|NCT02266472|51682|P1|NOT COMPLETED|Period 2+ Washout||0
21211|NCT02266472|51681|P2|COMPLETED|Period 2+ Washout||15
21212|NCT02266472|51682|P1|COMPLETED|Period 2+ Washout||15
21213|NCT02266472|51681|P2|STARTED|Period 2+ Washout||15
21214|NCT02266472|51682|P1|STARTED|Period 2+ Washout||15
21215|NCT02266472|51681|P2|NOT COMPLETED|Period 1+ Washout||0
21216|NCT02266472|51682|P1|NOT COMPLETED|Period 1+ Washout||0
21217|NCT02266472|51681|P2|COMPLETED|Period 1+ Washout||15
21218|NCT02266472|51682|P1|COMPLETED|Period 1+ Washout||15
21219|NCT02266472|51681|P2|STARTED|Period 1+ Washout||15
21220|NCT02266472|51682|P1|STARTED|Period 1+ Washout||15
21221|NCT02266381|51701|P3|NOT COMPLETED|Overall Study||4
21222|NCT02266381|51702|P2|NOT COMPLETED|Overall Study||5
21223|NCT02266381|51703|P1|NOT COMPLETED|Overall Study||3
21224|NCT02266381|51701|P3|COMPLETED|Overall Study||146
21225|NCT02266381|51702|P2|COMPLETED|Overall Study||145
21226|NCT02266381|51703|P1|COMPLETED|Overall Study||147
21227|NCT02266381|51701|P3|STARTED|Overall Study||150
21228|NCT02266381|51702|P2|STARTED|Overall Study||150
21229|NCT02266381|51703|P1|STARTED|Overall Study||150
21230|NCT02266277|51726|P6|NOT COMPLETED|Overall Study||0
21231|NCT02266277|51727|P5|NOT COMPLETED|Overall Study||0
21232|NCT02266277|51728|P4|NOT COMPLETED|Overall Study||0
21233|NCT02266277|51729|P3|NOT COMPLETED|Overall Study||0
21234|NCT02266277|51730|P2|NOT COMPLETED|Overall Study||0
21235|NCT02266277|51731|P1|NOT COMPLETED|Overall Study||0
21236|NCT02266277|51726|P6|COMPLETED|Overall Study||5000
21237|NCT02266277|51727|P5|COMPLETED|Overall Study||5000
21238|NCT02266277|51728|P4|COMPLETED|Overall Study||5000
21239|NCT02266277|51729|P3|COMPLETED|Overall Study||5000
21240|NCT02266277|51730|P2|COMPLETED|Overall Study||5000
21241|NCT02266277|51731|P1|COMPLETED|Overall Study||5000
21242|NCT02266277|51726|P6|STARTED|Overall Study||5000
21243|NCT02266277|51727|P5|STARTED|Overall Study||5000
21244|NCT02266277|51728|P4|STARTED|Overall Study||5000
21245|NCT02266277|51729|P3|STARTED|Overall Study||5000
21246|NCT02266277|51730|P2|STARTED|Overall Study||5000
21247|NCT02266277|51731|P1|STARTED|Overall Study||5000
21248|NCT02265848|51755|P2|NOT COMPLETED|Overall Study||0
21249|NCT02265848|51756|P1|NOT COMPLETED|Overall Study||0
21250|NCT02265848|51755|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
21251|NCT02265848|51756|P1|COMPLETED|Overall Study||11
21252|NCT02265848|51755|P2|STARTED|Overall Study||11
21253|NCT02265848|51756|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
21254|NCT02265796|51770|P2|NOT COMPLETED|Overall Study||1
21255|NCT02265796|51771|P1|NOT COMPLETED|Overall Study||3
21256|NCT02265796|51770|P2|COMPLETED|Overall Study||24
21257|NCT02265796|51771|P1|COMPLETED|Overall Study||22
21258|NCT02265796|51770|P2|STARTED|Overall Study||25
21259|NCT02265796|51771|P1|STARTED|Overall Study||25
21260|NCT02265783|51781|P1|NOT COMPLETED|Overall Study||0
21261|NCT02265783|51781|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
21262|NCT02265783|51781|P1|STARTED|Overall Study||20
21263|NCT02265237|51789|P4|NOT COMPLETED|As Treated (Overall Study)||1
21264|NCT02265237|51790|P3|NOT COMPLETED|As Treated (Overall Study)||10
21265|NCT02265237|51791|P2|NOT COMPLETED|As Treated (Overall Study)||3
21266|NCT02265237|51792|P1|NOT COMPLETED|As Treated (Overall Study)||5
21267|NCT02265237|51789|P4|COMPLETED|As Treated (Overall Study)||2
21268|NCT02265237|51790|P3|COMPLETED|As Treated (Overall Study)||51
21269|NCT02265237|51791|P2|COMPLETED|As Treated (Overall Study)||57
21270|NCT02265237|51792|P1|COMPLETED|As Treated (Overall Study)||55
21271|NCT02265237|51789|P4|STARTED|As Treated (Overall Study)||3
21272|NCT02265237|51790|P3|STARTED|As Treated (Overall Study)||61
21273|NCT02265237|51791|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
21274|NCT02265237|51792|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
21275|NCT02265237|51789|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
21276|NCT02265237|51790|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
21277|NCT02265237|51791|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
21278|NCT02265237|51792|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
21279|NCT02265237|51789|P4|COMPLETED|As Enrolled (Overall Study)||2
21280|NCT02265237|51790|P3|COMPLETED|As Enrolled (Overall Study)||51
21281|NCT02265237|51791|P2|COMPLETED|As Enrolled (Overall Study)||58
21282|NCT02265237|51792|P1|COMPLETED|As Enrolled (Overall Study)||54
21283|NCT02265237|51789|P4|STARTED|As Enrolled (Overall Study)||3
21284|NCT02265237|51790|P3|STARTED|As Enrolled (Overall Study)||61
21285|NCT02265237|51791|P2|STARTED|As Enrolled (Overall Study)||61
21286|NCT02265237|51792|P1|STARTED|As Enrolled (Overall Study)||59
21287|NCT02264977|51811|P1|NOT COMPLETED|Overall Study||7
21288|NCT02264977|51811|P1|COMPLETED|Overall Study||2
21289|NCT02264977|51811|P1|STARTED|Overall Study||9
21290|NCT02264821|51822|P3|NOT COMPLETED|Overall Study||6
21291|NCT02264821|51823|P2|NOT COMPLETED|Overall Study||3
21292|NCT02264821|51824|P1|NOT COMPLETED|Overall Study||1
21293|NCT02264821|51822|P3|COMPLETED|Overall Study||58
21294|NCT02264821|51823|P2|COMPLETED|Overall Study||61
21295|NCT02264821|51824|P1|COMPLETED|Overall Study||63
21296|NCT02264821|51822|P3|STARTED|Overall Study|Double Blind|64
21297|NCT02264821|51823|P2|STARTED|Overall Study|Double Blind|64
21298|NCT02264821|51824|P1|STARTED|Overall Study|Double Blind|64
21299|NCT02264249|51838|P3|NOT COMPLETED|Overall Study||0
21300|NCT02264249|51839|P2|NOT COMPLETED|Overall Study||0
21301|NCT02264249|51840|P1|NOT COMPLETED|Overall Study||0
21302|NCT02264249|51838|P3|COMPLETED|Overall Study||241
21303|NCT02264249|51839|P2|COMPLETED|Overall Study||187
21304|NCT02264249|51840|P1|COMPLETED|Overall Study||21
21305|NCT02264249|51838|P3|STARTED|Overall Study||241
21306|NCT02264249|51839|P2|STARTED|Overall Study||187
21307|NCT02264249|51840|P1|STARTED|Overall Study||21
21308|NCT02263911|51854|P4|NOT COMPLETED|Period 5||0
21309|NCT02263911|51855|P3|NOT COMPLETED|Period 5||0
21310|NCT02263911|51856|P2|NOT COMPLETED|Period 5||0
21311|NCT02263911|51857|P1|NOT COMPLETED|Period 5||0
21312|NCT02263911|51854|P4|COMPLETED|Period 5||4
21313|NCT02263911|51855|P3|COMPLETED|Period 5||4
21314|NCT02263911|51856|P2|COMPLETED|Period 5||4
21315|NCT02263911|51857|P1|COMPLETED|Period 5||4
21316|NCT02263911|51854|P4|STARTED|Period 5||4
21317|NCT02263911|51855|P3|STARTED|Period 5||4
21318|NCT02263911|51856|P2|STARTED|Period 5||4
21319|NCT02263911|51857|P1|STARTED|Period 5||4
21320|NCT02263911|51854|P4|NOT COMPLETED|Period 4 Washout||0
21321|NCT02263911|51855|P3|NOT COMPLETED|Period 4 Washout||0
21322|NCT02263911|51856|P2|NOT COMPLETED|Period 4 Washout||0
21323|NCT02263911|51857|P1|NOT COMPLETED|Period 4 Washout||0
21324|NCT02263911|51854|P4|COMPLETED|Period 4 Washout||4
21325|NCT02263911|51855|P3|COMPLETED|Period 4 Washout||4
21326|NCT02263911|51856|P2|COMPLETED|Period 4 Washout||4
21327|NCT02263911|51857|P1|COMPLETED|Period 4 Washout||4
21328|NCT02263911|51854|P4|STARTED|Period 4 Washout||4
21329|NCT02263911|51855|P3|STARTED|Period 4 Washout||4
21330|NCT02263911|51856|P2|STARTED|Period 4 Washout||4
21331|NCT02263911|51857|P1|STARTED|Period 4 Washout||4
21332|NCT02263911|51854|P4|NOT COMPLETED|Period 4||0
21333|NCT02263911|51855|P3|NOT COMPLETED|Period 4||0
21334|NCT02263911|51856|P2|NOT COMPLETED|Period 4||0
21335|NCT02263911|51857|P1|NOT COMPLETED|Period 4||0
21336|NCT02263911|51854|P4|COMPLETED|Period 4||4
21337|NCT02263911|51855|P3|COMPLETED|Period 4||4
21338|NCT02263911|51856|P2|COMPLETED|Period 4||4
21339|NCT02263911|51857|P1|COMPLETED|Period 4||4
21340|NCT02263911|51854|P4|STARTED|Period 4||4
21341|NCT02263911|51855|P3|STARTED|Period 4||4
21342|NCT02263911|51856|P2|STARTED|Period 4||4
21343|NCT02263911|51857|P1|STARTED|Period 4||4
21344|NCT02263911|51854|P4|NOT COMPLETED|Period 3 Washout||0
21345|NCT02263911|51855|P3|NOT COMPLETED|Period 3 Washout||0
21346|NCT02263911|51856|P2|NOT COMPLETED|Period 3 Washout||0
21347|NCT02263911|51857|P1|NOT COMPLETED|Period 3 Washout||0
21348|NCT02263911|51854|P4|COMPLETED|Period 3 Washout||4
21349|NCT02263911|51855|P3|COMPLETED|Period 3 Washout||4
21350|NCT02263911|51856|P2|COMPLETED|Period 3 Washout||4
21351|NCT02263911|51857|P1|COMPLETED|Period 3 Washout||4
21352|NCT02263911|51854|P4|STARTED|Period 3 Washout||4
21353|NCT02263911|51855|P3|STARTED|Period 3 Washout||4
21354|NCT02263911|51856|P2|STARTED|Period 3 Washout||4
21355|NCT02263911|51857|P1|STARTED|Period 3 Washout||4
21356|NCT02263911|51854|P4|NOT COMPLETED|Period 3||0
21357|NCT02263911|51855|P3|NOT COMPLETED|Period 3||0
21358|NCT02263911|51856|P2|NOT COMPLETED|Period 3||0
21359|NCT02263911|51857|P1|NOT COMPLETED|Period 3||0
21360|NCT02263911|51854|P4|COMPLETED|Period 3||4
21361|NCT02263911|51855|P3|COMPLETED|Period 3||4
21362|NCT02263911|51856|P2|COMPLETED|Period 3||4
21363|NCT02263911|51857|P1|COMPLETED|Period 3||4
21364|NCT02263911|51854|P4|STARTED|Period 3||4
21365|NCT02263911|51855|P3|STARTED|Period 3||4
21366|NCT02263911|51856|P2|STARTED|Period 3||4
21367|NCT02263911|51857|P1|STARTED|Period 3||4
21368|NCT02263911|51854|P4|NOT COMPLETED|Period 2 Washout||0
21369|NCT02263911|51855|P3|NOT COMPLETED|Period 2 Washout||0
21370|NCT02263911|51856|P2|NOT COMPLETED|Period 2 Washout||0
21371|NCT02263911|51857|P1|NOT COMPLETED|Period 2 Washout||0
21372|NCT02263911|51854|P4|COMPLETED|Period 2 Washout||4
21373|NCT02263911|51855|P3|COMPLETED|Period 2 Washout||4
21374|NCT02263911|51856|P2|COMPLETED|Period 2 Washout||4
21375|NCT02263911|51857|P1|COMPLETED|Period 2 Washout||4
21376|NCT02263911|51854|P4|STARTED|Period 2 Washout||4
21377|NCT02263911|51855|P3|STARTED|Period 2 Washout||4
21378|NCT02263911|51856|P2|STARTED|Period 2 Washout||4
21379|NCT02263911|51857|P1|STARTED|Period 2 Washout||4
21380|NCT02263911|51854|P4|NOT COMPLETED|Period 2||0
21381|NCT02263911|51855|P3|NOT COMPLETED|Period 2||0
21382|NCT02263911|51856|P2|NOT COMPLETED|Period 2||0
21383|NCT02263911|51857|P1|NOT COMPLETED|Period 2||0
21384|NCT02263911|51854|P4|COMPLETED|Period 2||4
21385|NCT02263911|51855|P3|COMPLETED|Period 2||4
21386|NCT02263911|51856|P2|COMPLETED|Period 2||4
21387|NCT02263911|51857|P1|COMPLETED|Period 2||4
21388|NCT02263911|51854|P4|STARTED|Period 2||4
21389|NCT02263911|51855|P3|STARTED|Period 2||4
21390|NCT02263911|51856|P2|STARTED|Period 2||4
21391|NCT02263911|51857|P1|STARTED|Period 2||4
21392|NCT02263911|51854|P4|NOT COMPLETED|Period 1 Washout||0
21393|NCT02263911|51855|P3|NOT COMPLETED|Period 1 Washout||0
21394|NCT02263911|51856|P2|NOT COMPLETED|Period 1 Washout||0
21395|NCT02263911|51857|P1|NOT COMPLETED|Period 1 Washout||0
21396|NCT02263911|51854|P4|COMPLETED|Period 1 Washout||4
21397|NCT02263911|51855|P3|COMPLETED|Period 1 Washout||4
21398|NCT02263911|51856|P2|COMPLETED|Period 1 Washout||4
21399|NCT02263911|51857|P1|COMPLETED|Period 1 Washout||4
21400|NCT02263911|51854|P4|STARTED|Period 1 Washout||4
21401|NCT02263911|51855|P3|STARTED|Period 1 Washout||4
21402|NCT02263911|51856|P2|STARTED|Period 1 Washout||4
21403|NCT02263911|51857|P1|STARTED|Period 1 Washout||4
21404|NCT02263911|51854|P4|NOT COMPLETED|Period 1||0
21405|NCT02263911|51855|P3|NOT COMPLETED|Period 1||0
21406|NCT02263911|51856|P2|NOT COMPLETED|Period 1||0
21407|NCT02263911|51857|P1|NOT COMPLETED|Period 1||0
21408|NCT02263911|51854|P4|COMPLETED|Period 1||4
21409|NCT02263911|51855|P3|COMPLETED|Period 1||4
21410|NCT02263911|51856|P2|COMPLETED|Period 1||4
21411|NCT02263911|51857|P1|COMPLETED|Period 1||4
21412|NCT02263911|51854|P4|STARTED|Period 1||4
21413|NCT02263911|51855|P3|STARTED|Period 1||4
21414|NCT02263911|51856|P2|STARTED|Period 1||4
21415|NCT02263911|51857|P1|STARTED|Period 1||4
21416|NCT02263833|51879|P1|NOT COMPLETED|Overall Study||0
21417|NCT02263833|51879|P1|COMPLETED|Overall Study||742
21418|NCT02263833|51879|P1|STARTED|Overall Study||742
21419|NCT02263365|51886|P2|NOT COMPLETED|Overall Study||18
21420|NCT02263365|51887|P1|NOT COMPLETED|Overall Study||22
21421|NCT02263365|51886|P2|COMPLETED|Overall Study||0
21422|NCT02263365|51887|P1|COMPLETED|Overall Study||0
21423|NCT02263365|51886|P2|STARTED|Overall Study||18
21424|NCT02263365|51887|P1|STARTED|Overall Study||22
21425|NCT02263131|51901|P2|NOT COMPLETED|Overall Study||1
21426|NCT02263131|51902|P1|NOT COMPLETED|Overall Study||10
21427|NCT02263131|51901|P2|COMPLETED|Overall Study||68
21428|NCT02263131|51902|P1|COMPLETED|Overall Study||337
21429|NCT02263131|51901|P2|STARTED|Overall Study||69
21430|NCT02263131|51902|P1|STARTED|Overall Study||347
21431|NCT02263118|51914|P4|NOT COMPLETED|Overall Study||2
21432|NCT02263118|51915|P3|NOT COMPLETED|Overall Study||8
21433|NCT02263118|51916|P2|NOT COMPLETED|Overall Study||8
21434|NCT02263118|51917|P1|NOT COMPLETED|Overall Study||4
21435|NCT02263118|51914|P4|COMPLETED|Overall Study||12
21436|NCT02263118|51915|P3|COMPLETED|Overall Study||22
21437|NCT02263118|51916|P2|COMPLETED|Overall Study||24
21438|NCT02263118|51917|P1|COMPLETED|Overall Study||20
21439|NCT02263118|51914|P4|STARTED|Overall Study||14
21440|NCT02263118|51915|P3|STARTED|Overall Study||30
21441|NCT02263118|51916|P2|STARTED|Overall Study||32
21442|NCT02263118|51917|P1|STARTED|Overall Study||24
21443|NCT02262754|51942|P3|NOT COMPLETED|Overall Study||9
21444|NCT02262754|51943|P2|NOT COMPLETED|Overall Study||9
21445|NCT02262754|51944|P1|NOT COMPLETED|Overall Study||16
21446|NCT02262754|51942|P3|COMPLETED|Overall Study||65
21447|NCT02262754|51943|P2|COMPLETED|Overall Study||65
21448|NCT02262754|51944|P1|COMPLETED|Overall Study||58
21449|NCT02262754|51942|P3|STARTED|Overall Study||74
21450|NCT02262754|51943|P2|STARTED|Overall Study||74
21451|NCT02262754|51944|P1|STARTED|Overall Study||74
21452|NCT02262728|52019|P2|NOT COMPLETED|Overall Study||0
21453|NCT02262728|52020|P1|NOT COMPLETED|Overall Study||0
21454|NCT02262728|52019|P2|COMPLETED|Overall Study||21
21455|NCT02262728|52020|P1|COMPLETED|Overall Study||19
21456|NCT02262728|52019|P2|STARTED|Overall Study||21
21457|NCT02262728|52020|P1|STARTED|Overall Study||19
21458|NCT02262078|52050|P2|NOT COMPLETED|Overall Study||0
21459|NCT02262078|52051|P1|NOT COMPLETED|Overall Study||0
21460|NCT02262078|52050|P2|COMPLETED|Overall Study||13
21461|NCT02262078|52051|P1|COMPLETED|Overall Study||13
21462|NCT02262078|52050|P2|STARTED|Overall Study||13
21463|NCT02262078|52051|P1|STARTED|Overall Study||13
21464|NCT02262039|52059|P2|NOT COMPLETED|Overall Study||0
21465|NCT02262039|52060|P1|NOT COMPLETED|Overall Study||0
21466|NCT02262039|52059|P2|COMPLETED|Overall Study||27
21467|NCT02262039|52060|P1|COMPLETED|Overall Study||14
21468|NCT02262039|52059|P2|STARTED|Overall Study||27
21469|NCT02262039|52060|P1|STARTED|Overall Study||14
21470|NCT02261974|52080|P2|NOT COMPLETED|Overall Study||7
21471|NCT02261974|52081|P1|NOT COMPLETED|Overall Study||15
21472|NCT02261974|52080|P2|COMPLETED|Overall Study||56
21473|NCT02261974|52081|P1|COMPLETED|Overall Study||108
21474|NCT02261974|52080|P2|Treated|Overall Study||57
21475|NCT02261974|52081|P1|Treated|Overall Study||117
21476|NCT02261974|52080|P2|STARTED|Overall Study||63
21477|NCT02261974|52081|P1|STARTED|Overall Study||123
21478|NCT02261948|52097|P2|NOT COMPLETED|Overall Study||0
21479|NCT02261948|52098|P1|NOT COMPLETED|Overall Study||0
21480|NCT02261948|52097|P2|COMPLETED|Overall Study||19
21481|NCT02261948|52098|P1|COMPLETED|Overall Study||23
21482|NCT02261948|52097|P2|STARTED|Overall Study||19
21483|NCT02261948|52098|P1|STARTED|Overall Study||23
21484|NCT02261818|52108|P1|NOT COMPLETED|Overall Study||3
21485|NCT02261818|52108|P1|COMPLETED|Overall Study||27
21486|NCT02261818|52108|P1|STARTED|Overall Study||30
21487|NCT02261805|52112|P3|NOT COMPLETED|Overall Study||0
21488|NCT02261805|52113|P2|NOT COMPLETED|Overall Study||0
21489|NCT02261805|52114|P1|NOT COMPLETED|Overall Study||0
21490|NCT02261805|52112|P3|COMPLETED|Overall Study||2
21491|NCT02261805|52113|P2|COMPLETED|Overall Study||6
21492|NCT02261805|52114|P1|COMPLETED|Overall Study||3
21493|NCT02261805|52112|P3|STARTED|Overall Study||2
21494|NCT02261805|52113|P2|STARTED|Overall Study||6
21495|NCT02261805|52114|P1|STARTED|Overall Study||3
21496|NCT02261493|52125|P3|NOT COMPLETED|Overall Study||26
21497|NCT02261493|52126|P2|NOT COMPLETED|Overall Study||47
21498|NCT02261493|52127|P1|NOT COMPLETED|Overall Study||30
21499|NCT02261493|52125|P3|COMPLETED|Overall Study||287
21500|NCT02261493|52126|P2|COMPLETED|Overall Study||271
21501|NCT02261493|52127|P1|COMPLETED|Overall Study||126
21502|NCT02261493|52125|P3|STARTED|Overall Study||313
21503|NCT02261493|52126|P2|STARTED|Overall Study||318
21504|NCT02261493|52127|P1|STARTED|Overall Study||156
21505|NCT02261467|52155|P2|NOT COMPLETED|Overall Study||37
21506|NCT02261467|52156|P1|NOT COMPLETED|Overall Study||21
21507|NCT02261467|52155|P2|COMPLETED|Overall Study||253
21508|NCT02261467|52156|P1|COMPLETED|Overall Study||80
21509|NCT02261467|52155|P2|STARTED|Overall Study||290
21510|NCT02261467|52156|P1|STARTED|Overall Study||101
21511|NCT02261428|52176|P2|NOT COMPLETED|Overall Study||0
21512|NCT02261428|52177|P1|NOT COMPLETED|Overall Study||0
21513|NCT02261428|52176|P2|COMPLETED|Overall Study||10
21514|NCT02261428|52177|P1|COMPLETED|Overall Study||10
21515|NCT02261428|52176|P2|STARTED|Overall Study|Washout (30 minutes)|10
21516|NCT02261428|52177|P1|STARTED|Overall Study|Washout (30 minutes)|10
21517|NCT02260986|52198|P3|NOT COMPLETED|Overall Study||41
21518|NCT02260986|52199|P2|NOT COMPLETED|Overall Study||13
21519|NCT02260986|52200|P1|NOT COMPLETED|Overall Study||90
21520|NCT02260986|52198|P3|COMPLETED|Overall Study||278
21521|NCT02260986|52199|P2|COMPLETED|Overall Study||93
21522|NCT02260986|52200|P1|COMPLETED|Overall Study||225
21523|NCT02260986|52198|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
21524|NCT02260986|52199|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
21525|NCT02260986|52200|P1|Safety Population|Overall Study||315
21526|NCT02260986|52198|P3|STARTED|Overall Study||319
21527|NCT02260986|52199|P2|STARTED|Overall Study||106
21528|NCT02260986|52200|P1|STARTED|Overall Study||315
21529|NCT02260882|52318|P2|NOT COMPLETED|Overall Study||1
21530|NCT02260882|52319|P1|NOT COMPLETED|Overall Study||0
21531|NCT02260882|52318|P2|COMPLETED|Overall Study||81
21532|NCT02260882|52319|P1|COMPLETED|Overall Study||161
21533|NCT02260882|52318|P2|STARTED|Overall Study||82
21534|NCT02260882|52319|P1|STARTED|Overall Study||161
21535|NCT02260791|52343|P2|NOT COMPLETED|Overall Study||34
21536|NCT02260791|52344|P1|NOT COMPLETED|Overall Study||33
21537|NCT02260791|52343|P2|COMPLETED|Overall Study||328
21538|NCT02260791|52344|P1|COMPLETED|Overall Study||333
21539|NCT02260791|52343|P2|STARTED|Overall Study||362
21540|NCT02260791|52344|P1|STARTED|Overall Study||366
21541|NCT02260492|52383|P3|NOT COMPLETED|Overall Study||5
21542|NCT02260492|52384|P2|NOT COMPLETED|Overall Study||13
21543|NCT02260492|52385|P1|NOT COMPLETED|Overall Study||23
21544|NCT02260492|52383|P3|COMPLETED|Overall Study||37
21545|NCT02260492|52384|P2|COMPLETED|Overall Study||406
21546|NCT02260492|52385|P1|COMPLETED|Overall Study||395
21547|NCT02260492|52383|P3|Completed Day 1|Overall Study||42
21548|NCT02260492|52384|P2|Completed Day 1|Overall Study||419
21549|NCT02260492|52385|P1|Completed Day 1|Overall Study||418
21550|NCT02260492|52383|P3|STARTED|Overall Study||42
21551|NCT02260492|52384|P2|STARTED|Overall Study||419
21552|NCT02260492|52385|P1|STARTED|Overall Study||418
21553|NCT02260440|52399|P1|NOT COMPLETED|Overall Study||0
21554|NCT02260440|52399|P1|COMPLETED|Overall Study||31
21555|NCT02260440|52399|P1|STARTED|Overall Study||31
21556|NCT02260401|52407|P2|NOT COMPLETED|Overall Study||12
21557|NCT02260401|52408|P1|NOT COMPLETED|Overall Study||5
21558|NCT02260401|52407|P2|COMPLETED|Overall Study||73
21559|NCT02260401|52408|P1|COMPLETED|Overall Study||75
21560|NCT02260401|52407|P2|STARTED|Overall Study||85
21561|NCT02260401|52408|P1|STARTED|Overall Study||80
21562|NCT02259608|52414|P1|NOT COMPLETED|Overall Study||0
21563|NCT02259608|52414|P1|COMPLETED|Overall Study||15
21564|NCT02259608|52414|P1|STARTED|Overall Study||15
21565|NCT02259400|52421|P2|NOT COMPLETED|Overall Study||2
21566|NCT02259400|52422|P1|NOT COMPLETED|Overall Study||0
21567|NCT02259400|52421|P2|COMPLETED|Overall Study||60
21568|NCT02259400|52422|P1|COMPLETED|Overall Study||62
21569|NCT02259400|52421|P2|STARTED|Overall Study||62
21570|NCT02259400|52422|P1|STARTED|Overall Study||62
21571|NCT02259348|52454|P1|NOT COMPLETED|Overall Study||10
21572|NCT02259348|52454|P1|COMPLETED|Overall Study||2
21573|NCT02259348|52454|P1|One Year Post-transplant|Overall Study||2
21574|NCT02259348|52454|P1|STARTED|Overall Study||12
21575|NCT02258529|52466|P1|NOT COMPLETED|Overall Study||10
21576|NCT02258529|52466|P1|COMPLETED|Overall Study||0
21577|NCT02258529|52466|P1|STARTED|Overall Study||10
21578|NCT02258477|52478|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
21579|NCT02258477|52479|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
21580|NCT02258477|52480|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
21581|NCT02258477|52481|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
21582|NCT02258477|52478|P4|COMPLETED|Fourth Intervention (1 Week)||8
21583|NCT02258477|52479|P3|COMPLETED|Fourth Intervention (1 Week)||8
21584|NCT02258477|52480|P2|COMPLETED|Fourth Intervention (1 Week)||8
21585|NCT02258477|52481|P1|COMPLETED|Fourth Intervention (1 Week)||9
21586|NCT02258477|52478|P4|STARTED|Fourth Intervention (1 Week)||8
21587|NCT02258477|52479|P3|STARTED|Fourth Intervention (1 Week)||8
21588|NCT02258477|52480|P2|STARTED|Fourth Intervention (1 Week)||8
21589|NCT02258477|52481|P1|STARTED|Fourth Intervention (1 Week)||9
21590|NCT02258477|52478|P4|NOT COMPLETED|Third Intervention (1 Week)||0
21591|NCT02258477|52479|P3|NOT COMPLETED|Third Intervention (1 Week)||0
21592|NCT02258477|52480|P2|NOT COMPLETED|Third Intervention (1 Week)||0
21593|NCT02258477|52481|P1|NOT COMPLETED|Third Intervention (1 Week)||0
21594|NCT02258477|52478|P4|COMPLETED|Third Intervention (1 Week)||8
21595|NCT02258477|52479|P3|COMPLETED|Third Intervention (1 Week)||8
21596|NCT02258477|52480|P2|COMPLETED|Third Intervention (1 Week)||8
21597|NCT02258477|52481|P1|COMPLETED|Third Intervention (1 Week)||9
21598|NCT02258477|52478|P4|STARTED|Third Intervention (1 Week)||8
21599|NCT02258477|52479|P3|STARTED|Third Intervention (1 Week)||8
21600|NCT02258477|52480|P2|STARTED|Third Intervention (1 Week)||8
21601|NCT02258477|52481|P1|STARTED|Third Intervention (1 Week)||9
21602|NCT02258477|52478|P4|NOT COMPLETED|Second Intervention (1 Week)||1
21603|NCT02258477|52479|P3|NOT COMPLETED|Second Intervention (1 Week)||1
21604|NCT02258477|52480|P2|NOT COMPLETED|Second Intervention (1 Week)||0
21605|NCT02258477|52481|P1|NOT COMPLETED|Second Intervention (1 Week)||0
21606|NCT02258477|52478|P4|COMPLETED|Second Intervention (1 Week)||8
21607|NCT02258477|52479|P3|COMPLETED|Second Intervention (1 Week)||8
21608|NCT02258477|52480|P2|COMPLETED|Second Intervention (1 Week)||8
21609|NCT02258477|52481|P1|COMPLETED|Second Intervention (1 Week)||9
21610|NCT02258477|52478|P4|STARTED|Second Intervention (1 Week)||9
21611|NCT02258477|52479|P3|STARTED|Second Intervention (1 Week)||9
21612|NCT02258477|52480|P2|STARTED|Second Intervention (1 Week)||8
21613|NCT02258477|52481|P1|STARTED|Second Intervention (1 Week)||9
21614|NCT02258477|52478|P4|NOT COMPLETED|First Intervention (1 Week)||0
21615|NCT02258477|52479|P3|NOT COMPLETED|First Intervention (1 Week)||0
21616|NCT02258477|52480|P2|NOT COMPLETED|First Intervention (1 Week)||1
21617|NCT02258477|52481|P1|NOT COMPLETED|First Intervention (1 Week)||1
21618|NCT02258477|52478|P4|COMPLETED|First Intervention (1 Week)||9
21619|NCT02258477|52479|P3|COMPLETED|First Intervention (1 Week)||9
21620|NCT02258477|52480|P2|COMPLETED|First Intervention (1 Week)||8
21621|NCT02258477|52481|P1|COMPLETED|First Intervention (1 Week)||9
21622|NCT02258477|52478|P4|STARTED|First Intervention (1 Week)||9
21623|NCT02258477|52479|P3|STARTED|First Intervention (1 Week)||9
21624|NCT02258477|52480|P2|STARTED|First Intervention (1 Week)||9
21625|NCT02258477|52481|P1|STARTED|First Intervention (1 Week)||10
21626|NCT02258412|52499|P3|NOT COMPLETED|Overall Study||0
21627|NCT02258412|52500|P2|NOT COMPLETED|Overall Study||0
21628|NCT02258412|52501|P1|NOT COMPLETED|Overall Study||0
21629|NCT02258412|52499|P3|COMPLETED|Overall Study||61
21630|NCT02258412|52500|P2|COMPLETED|Overall Study||25
21631|NCT02258412|52501|P1|COMPLETED|Overall Study||26
21632|NCT02258412|52499|P3|STARTED|Overall Study||61
21633|NCT02258412|52500|P2|STARTED|Overall Study||25
21634|NCT02258412|52501|P1|STARTED|Overall Study||26
21635|NCT02258334|52512|P4|NOT COMPLETED|Overall Study||0
21636|NCT02258334|52513|P3|NOT COMPLETED|Overall Study||0
21637|NCT02258334|52514|P2|NOT COMPLETED|Overall Study||0
21638|NCT02258334|52515|P1|NOT COMPLETED|Overall Study||1
21639|NCT02258334|52512|P4|COMPLETED|Overall Study||52
21640|NCT02258334|52513|P3|COMPLETED|Overall Study||52
21641|NCT02258334|52514|P2|COMPLETED|Overall Study||54
21642|NCT02258334|52515|P1|COMPLETED|Overall Study||49
21643|NCT02258334|52512|P4|STARTED|Overall Study||52
21644|NCT02258334|52513|P3|STARTED|Overall Study||52
21645|NCT02258334|52514|P2|STARTED|Overall Study||54
21646|NCT02258334|52515|P1|STARTED|Overall Study||50
21647|NCT02257918|52544|P3|NOT COMPLETED|Overall Study||2
21648|NCT02257918|52545|P2|NOT COMPLETED|Overall Study||1
21649|NCT02257918|52546|P1|NOT COMPLETED|Overall Study||4
21650|NCT02257918|52544|P3|COMPLETED|Overall Study||39
21651|NCT02257918|52545|P2|COMPLETED|Overall Study||66
21652|NCT02257918|52546|P1|COMPLETED|Overall Study||68
21653|NCT02257918|52544|P3|Test of Cure Visit|Overall Study||40
21654|NCT02257918|52545|P2|Test of Cure Visit|Overall Study||67
21655|NCT02257918|52546|P1|Test of Cure Visit|Overall Study||72
21656|NCT02257918|52544|P3|STARTED|Overall Study||41
21657|NCT02257918|52545|P2|STARTED|Overall Study||67
21658|NCT02257918|52546|P1|STARTED|Overall Study||72
21659|NCT02257684|52596|P1|NOT COMPLETED|Overall Study||4
21660|NCT02257684|52596|P1|COMPLETED|Overall Study||0
21661|NCT02257684|52596|P1|STARTED|Overall Study||4
21662|NCT02257385|52606|P2|NOT COMPLETED|Overall Study||22
21663|NCT02257385|52607|P1|NOT COMPLETED|Overall Study||22
21664|NCT02257385|52606|P2|COMPLETED|Overall Study||457
21665|NCT02257385|52607|P1|COMPLETED|Overall Study||460
21666|NCT02257385|52606|P2|STARTED|Overall Study||479
21667|NCT02257385|52607|P1|STARTED|Overall Study||482
21668|NCT02257372|52617|P2|NOT COMPLETED|Overall Study||10
21669|NCT02257372|52618|P1|NOT COMPLETED|Overall Study||7
21670|NCT02257372|52617|P2|COMPLETED|Overall Study||109
21671|NCT02257372|52618|P1|COMPLETED|Overall Study||110
21672|NCT02257372|52617|P2|STARTED|Overall Study||119
21673|NCT02257372|52618|P1|STARTED|Overall Study||117
21674|NCT02256982|52628|P2|NOT COMPLETED|Overall Study||1
21675|NCT02256982|52629|P1|NOT COMPLETED|Overall Study||0
21676|NCT02256982|52628|P2|COMPLETED|Overall Study||1
21677|NCT02256982|52629|P1|COMPLETED|Overall Study||1
21678|NCT02256982|52628|P2|STARTED|Overall Study||2
21679|NCT02256982|52629|P1|STARTED|Overall Study||1
21680|NCT02256969|52638|P3|NOT COMPLETED|Overall Study||1
21681|NCT02256969|52639|P2|NOT COMPLETED|Overall Study||1
21682|NCT02256969|52640|P1|NOT COMPLETED|Overall Study||2
21683|NCT02256969|52638|P3|COMPLETED|Overall Study||14
21684|NCT02256969|52639|P2|COMPLETED|Overall Study||14
21685|NCT02256969|52640|P1|COMPLETED|Overall Study||13
21686|NCT02256969|52638|P3|STARTED|Overall Study||15
21687|NCT02256969|52639|P2|STARTED|Overall Study||15
21688|NCT02256969|52640|P1|STARTED|Overall Study||15
21689|NCT02256891|52659|P2|NOT COMPLETED|Overall Study||13
21690|NCT02256891|52660|P1|NOT COMPLETED|Overall Study||12
21691|NCT02256891|52659|P2|COMPLETED|Overall Study||29
21692|NCT02256891|52660|P1|COMPLETED|Overall Study||43
21693|NCT02256891|52659|P2|STARTED|Overall Study||42
21694|NCT02256891|52660|P1|STARTED|Overall Study||55
21695|NCT02256553|52684|P1|NOT COMPLETED|Period III||3
21696|NCT02256553|52684|P1|COMPLETED|Period III||91
21697|NCT02256553|52684|P1|STARTED|Period III||94
21698|NCT02256553|52684|P1|NOT COMPLETED|Period II||2
21699|NCT02256553|52684|P1|COMPLETED|Period II||94
21700|NCT02256553|52684|P1|STARTED|Period II||96
21701|NCT02256553|52684|P1|NOT COMPLETED|Period I||6
21702|NCT02256553|52684|P1|COMPLETED|Period I||96
21703|NCT02256553|52684|P1|STARTED|Period I||102
21704|NCT02256488|52697|P4|NOT COMPLETED|Overall Study||6
21705|NCT02256488|52698|P3|NOT COMPLETED|Overall Study||10
21706|NCT02256488|52699|P2|NOT COMPLETED|Overall Study||6
21707|NCT02256488|52700|P1|NOT COMPLETED|Overall Study||8
21708|NCT02256488|52697|P4|COMPLETED|Overall Study||384
21709|NCT02256488|52698|P3|COMPLETED|Overall Study||382
21710|NCT02256488|52699|P2|COMPLETED|Overall Study||386
21711|NCT02256488|52700|P1|COMPLETED|Overall Study||379
21712|NCT02256488|52697|P4|STARTED|Overall Study||390
21713|NCT02256488|52698|P3|STARTED|Overall Study||392
21714|NCT02256488|52699|P2|STARTED|Overall Study||392
21715|NCT02256488|52700|P1|STARTED|Overall Study||387
21716|NCT02256436|52716|P2|NOT COMPLETED|Overall Study||272
21717|NCT02256436|52717|P1|NOT COMPLETED|Overall Study||270
21718|NCT02256436|52716|P2|COMPLETED|Overall Study||0
21719|NCT02256436|52717|P1|COMPLETED|Overall Study||0
21720|NCT02256436|52716|P2|Treated|Overall Study||255
21721|NCT02256436|52717|P1|Treated|Overall Study||266
21722|NCT02256436|52716|P2|STARTED|Overall Study||272
21723|NCT02256436|52717|P1|STARTED|Overall Study||270
21724|NCT02256358|52755|P2|NOT COMPLETED|Overall Study||1
21725|NCT02256358|52756|P1|NOT COMPLETED|Overall Study||0
21726|NCT02256358|52755|P2|COMPLETED|Overall Study||33
21727|NCT02256358|52756|P1|COMPLETED|Overall Study||34
21728|NCT02256358|52755|P2|STARTED|Overall Study||34
21729|NCT02256358|52756|P1|STARTED|Overall Study||34
21730|NCT02256345|52764|P2|NOT COMPLETED|Overall Study||0
21731|NCT02256345|52765|P1|NOT COMPLETED|Overall Study||0
21732|NCT02256345|52764|P2|COMPLETED|Overall Study||3
21733|NCT02256345|52765|P1|COMPLETED|Overall Study||9
21734|NCT02256345|52764|P2|STARTED|Overall Study||3
21735|NCT02256345|52765|P1|STARTED|Overall Study||9
21736|NCT02256072|52779|P2|NOT COMPLETED|Overall Study||29
21737|NCT02256072|52780|P1|NOT COMPLETED|Overall Study||42
21738|NCT02256072|52779|P2|COMPLETED|Overall Study||162
21739|NCT02256072|52780|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
21740|NCT02256072|52779|P2|Completed 1 Month Follow-Up|Overall Study||179
21741|NCT02256072|52780|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
21742|NCT02256072|52779|P2|STARTED|Overall Study||191
21743|NCT02256072|52780|P1|STARTED|Overall Study||194
21744|NCT02255565|52797|P3|NOT COMPLETED|Overall Study||0
21745|NCT02255565|52798|P2|NOT COMPLETED|Overall Study||1
21746|NCT02255565|52799|P1|NOT COMPLETED|Overall Study||0
21747|NCT02255565|52797|P3|COMPLETED|Overall Study||9
21748|NCT02255565|52798|P2|COMPLETED|Overall Study||8
21749|NCT02255565|52799|P1|COMPLETED|Overall Study||9
21750|NCT02255565|52797|P3|STARTED|Overall Study||9
21751|NCT02255565|52798|P2|STARTED|Overall Study||9
21752|NCT02255565|52799|P1|STARTED|Overall Study||9
21753|NCT02255279|52860|P2|NOT COMPLETED|Overall Study||9
21754|NCT02255279|52861|P1|NOT COMPLETED|Overall Study||5
21755|NCT02255279|52860|P2|COMPLETED|Overall Study||134
21756|NCT02255279|52861|P1|COMPLETED|Overall Study||139
21757|NCT02255279|52860|P2|STARTED|Overall Study||143
21758|NCT02255279|52861|P1|STARTED|Overall Study||144
21759|NCT02255149|52887|P1|NOT COMPLETED|Overall Study||5
21760|NCT02255149|52887|P1|COMPLETED|Overall Study||5
21761|NCT02255149|52887|P1|STARTED|Overall Study||10
21762|NCT02255097|52891|P1|NOT COMPLETED|Overall Study||172
21763|NCT02255097|52891|P1|COMPLETED|Overall Study||0
21764|NCT02255097|52891|P1|Treated|Overall Study||171
21765|NCT02255097|52891|P1|STARTED|Overall Study||172
21766|NCT02254772|52912|P1|NOT COMPLETED|Overall Study||2
21767|NCT02254772|52912|P1|COMPLETED|Overall Study||7
21768|NCT02254772|52912|P1|STARTED|Overall Study||9
21769|NCT02254551|52918|P1|NOT COMPLETED|Maintenance||0
21770|NCT02254551|52918|P1|COMPLETED|Maintenance||0
21771|NCT02254551|52918|P1|STARTED|Maintenance||0
21772|NCT02254551|52918|P1|NOT COMPLETED|Expansion||0
21773|NCT02254551|52918|P1|COMPLETED|Expansion||0
21774|NCT02254551|52918|P1|STARTED|Expansion||0
21775|NCT02254551|52918|P1|NOT COMPLETED|Dose Escalation||3
21776|NCT02254551|52918|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
21777|NCT02254551|52918|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
21778|NCT02254551|52918|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
21779|NCT02254551|52918|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
21780|NCT02254551|52918|P1|STARTED|Dose Escalation||7
21781|NCT02254486|52928|P2|NOT COMPLETED|Overall Study||55
21782|NCT02254486|52929|P1|NOT COMPLETED|Overall Study||50
21783|NCT02254486|52928|P2|COMPLETED|Overall Study||255
21784|NCT02254486|52929|P1|COMPLETED|Overall Study||261
21785|NCT02254486|52928|P2|STARTED|Overall Study||310
21786|NCT02254486|52929|P1|STARTED|Overall Study||311
21787|NCT02254460|52945|P2|NOT COMPLETED|Overall Study||0
21788|NCT02254460|52946|P1|NOT COMPLETED|Overall Study||1
21789|NCT02254460|52945|P2|COMPLETED|Overall Study||12
21790|NCT02254460|52946|P1|COMPLETED|Overall Study||12
21791|NCT02254460|52945|P2|STARTED|Overall Study||12
21792|NCT02254460|52946|P1|STARTED|Overall Study||13
21793|NCT02254421|52954|P2|NOT COMPLETED|Overall Study||3
21794|NCT02254421|52955|P1|NOT COMPLETED|Overall Study||2
21795|NCT02254421|52954|P2|COMPLETED|Overall Study||26
21796|NCT02254421|52955|P1|COMPLETED|Overall Study||29
21797|NCT02254421|52954|P2|STARTED|Overall Study||29
21798|NCT02254421|52955|P1|STARTED|Overall Study||31
21799|NCT02254304|52969|P2|NOT COMPLETED|Overall Study||4
21800|NCT02254304|52970|P1|NOT COMPLETED|Overall Study||14
21801|NCT02254304|52969|P2|COMPLETED|Overall Study||13
21802|NCT02254304|52970|P1|COMPLETED|Overall Study||75
21803|NCT02254304|52969|P2|STARTED|Overall Study||17
21804|NCT02254304|52970|P1|STARTED|Overall Study||89
21805|NCT02254252|53029|P2|NOT COMPLETED|Overall Study||2
21806|NCT02254252|53030|P1|NOT COMPLETED|Overall Study||3
21807|NCT02254252|53029|P2|COMPLETED|Overall Study||25
21808|NCT02254252|53030|P1|COMPLETED|Overall Study||24
21809|NCT02254252|53029|P2|STARTED|Overall Study||27
21810|NCT02254252|53030|P1|STARTED|Overall Study||27
21811|NCT02253654|53042|P2|NOT COMPLETED|Overall Study||18
21812|NCT02253654|53043|P1|NOT COMPLETED|Overall Study||23
21813|NCT02253654|53042|P2|COMPLETED|Overall Study||90
21814|NCT02253654|53043|P1|COMPLETED|Overall Study||85
21815|NCT02253654|53042|P2|Received Treatment|Overall Study||107
21816|NCT02253654|53043|P1|Received Treatment|Overall Study||104
21817|NCT02253654|53042|P2|STARTED|Overall Study||108
21818|NCT02253654|53043|P1|STARTED|Overall Study||108
21819|NCT02253173|53067|P4|NOT COMPLETED|Overall Study||14
21820|NCT02253173|53068|P3|NOT COMPLETED|Overall Study||13
21821|NCT02253173|53069|P2|NOT COMPLETED|Overall Study||17
21822|NCT02253173|53070|P1|NOT COMPLETED|Overall Study||16
21823|NCT02253173|53067|P4|COMPLETED|Overall Study||178
21824|NCT02253173|53068|P3|COMPLETED|Overall Study||177
21825|NCT02253173|53069|P2|COMPLETED|Overall Study||174
21826|NCT02253173|53070|P1|COMPLETED|Overall Study||175
21827|NCT02253173|53067|P4|STARTED|Overall Study||192
21828|NCT02253173|53068|P3|STARTED|Overall Study||190
21829|NCT02253173|53069|P2|STARTED|Overall Study||191
21830|NCT02253173|53070|P1|STARTED|Overall Study||191
21831|NCT02253160|53267|P3|NOT COMPLETED|Overall Study||0
21832|NCT02253160|53268|P2|NOT COMPLETED|Overall Study||0
21833|NCT02253160|53269|P1|NOT COMPLETED|Overall Study||0
21834|NCT02253160|53267|P3|COMPLETED|Overall Study||10
21835|NCT02253160|53268|P2|COMPLETED|Overall Study||12
21836|NCT02253160|53269|P1|COMPLETED|Overall Study||1
21837|NCT02253160|53267|P3|STARTED|Overall Study||10
21838|NCT02253160|53268|P2|STARTED|Overall Study||12
21839|NCT02253160|53269|P1|STARTED|Overall Study||1
21840|NCT02253147|53305|P1|NOT COMPLETED|Overall Study||47
21841|NCT02253147|53305|P1|COMPLETED|Overall Study||71
21842|NCT02253147|53305|P1|N Patients at W52|Overall Study||84
21843|NCT02253147|53305|P1|N Patients at W36|Overall Study||86
21844|NCT02253147|53305|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
21845|NCT02253147|53305|P1|STARTED|Overall Study||118
21846|NCT02252965|53339|P2|NOT COMPLETED|Overall Study||43
21847|NCT02252965|53340|P1|NOT COMPLETED|Overall Study||40
21848|NCT02252965|53339|P2|COMPLETED|Overall Study||222
21849|NCT02252965|53340|P1|COMPLETED|Overall Study||227
21850|NCT02252965|53339|P2|Safety Population|Overall Study||264
21851|NCT02252965|53340|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
21852|NCT02252965|53339|P2|STARTED|Overall Study||265
21853|NCT02252965|53340|P1|STARTED|Overall Study||267
21854|NCT02252939|53367|P1|NOT COMPLETED|Overall Study||3
21855|NCT02252939|53367|P1|COMPLETED|Overall Study||59
21856|NCT02252939|53367|P1|STARTED|Overall Study||62
21857|NCT02252744|53371|P1|NOT COMPLETED|Overall Study||0
21858|NCT02252744|53371|P1|COMPLETED|Overall Study||286
21859|NCT02252744|53371|P1|STARTED|Overall Study||286
21860|NCT02252718|53375|P1|NOT COMPLETED|Overall Study||0
21861|NCT02252718|53375|P1|COMPLETED|Overall Study||100
21862|NCT02252718|53375|P1|STARTED|Overall Study||100
21863|NCT02252445|53381|P2|NOT COMPLETED|Overall Study||0
21864|NCT02252445|53382|P1|NOT COMPLETED|Overall Study||0
21865|NCT02252445|53381|P2|COMPLETED|Overall Study||41
21866|NCT02252445|53382|P1|COMPLETED|Overall Study||41
21867|NCT02252445|53381|P2|STARTED|Overall Study||41
21868|NCT02252445|53382|P1|STARTED|Overall Study||41
21869|NCT02252354|53408|P2|NOT COMPLETED|Overall Study||0
21870|NCT02252354|53409|P1|NOT COMPLETED|Overall Study||0
21871|NCT02252354|53408|P2|COMPLETED|Overall Study||6
21872|NCT02252354|53409|P1|COMPLETED|Overall Study||6
21873|NCT02252354|53408|P2|STARTED|Overall Study||6
21874|NCT02252354|53409|P1|STARTED|Overall Study||6
21875|NCT02252146|53454|P1|NOT COMPLETED|Overall Study||6
21876|NCT02252146|53454|P1|COMPLETED|Overall Study||0
21877|NCT02252146|53454|P1|STARTED|Overall Study||6
21878|NCT02252133|53458|P2|NOT COMPLETED|Period 2||0
21879|NCT02252133|53459|P1|NOT COMPLETED|Period 2||0
21880|NCT02252133|53458|P2|COMPLETED|Period 2||24
21881|NCT02252133|53459|P1|COMPLETED|Period 2||23
21882|NCT02252133|53458|P2|STARTED|Period 2||24
21883|NCT02252133|53459|P1|STARTED|Period 2||23
21884|NCT02252133|53458|P2|NOT COMPLETED|Period 1||0
21885|NCT02252133|53459|P1|NOT COMPLETED|Period 1||0
21886|NCT02252133|53458|P2|COMPLETED|Period 1||24
21887|NCT02252133|53459|P1|COMPLETED|Period 1||23
21888|NCT02252133|53458|P2|STARTED|Period 1||24
21889|NCT02252133|53459|P1|STARTED|Period 1||23
21890|NCT02252016|53467|P2|NOT COMPLETED|Overall Study||3
21891|NCT02252016|53468|P1|NOT COMPLETED|Overall Study||3
21892|NCT02252016|53467|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
21893|NCT02252016|53468|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
21894|NCT02252016|53467|P2|STARTED|Overall Study||52
21895|NCT02252016|53468|P1|STARTED|Overall Study||107
21896|NCT02251990|53482|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
21897|NCT02251990|53483|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
21898|NCT02251990|53482|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
21899|NCT02251990|53483|P1|COMPLETED|Period 3 (DTG Follow-up)||0
21900|NCT02251990|53482|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
21901|NCT02251990|53483|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
21902|NCT02251990|53482|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
21903|NCT02251990|53483|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
21904|NCT02251990|53482|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
21905|NCT02251990|53483|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
21906|NCT02251990|53482|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
21907|NCT02251990|53483|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
21908|NCT02251990|53482|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
21909|NCT02251990|53483|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
21910|NCT02251990|53482|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
21911|NCT02251990|53483|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
21912|NCT02251990|53482|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
21913|NCT02251990|53483|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
21914|NCT02251990|53482|P2|STARTED|Period 1 (Double-blind [DB])||123
21915|NCT02251990|53483|P1|STARTED|Period 1 (Double-blind [DB])||366
21916|NCT02251912|53500|P2|NOT COMPLETED|Overall Study||5
21917|NCT02251912|53501|P1|NOT COMPLETED|Overall Study||2
21918|NCT02251912|53500|P2|COMPLETED|Overall Study||5
21919|NCT02251912|53501|P1|COMPLETED|Overall Study||10
21920|NCT02251912|53500|P2|STARTED|Overall Study||10
21921|NCT02251912|53501|P1|STARTED|Overall Study||12
21922|NCT02251886|53515|P4|NOT COMPLETED|Overall Study||0
21923|NCT02251886|53516|P3|NOT COMPLETED|Overall Study||0
21924|NCT02251886|53517|P2|NOT COMPLETED|Overall Study||0
21925|NCT02251886|53518|P1|NOT COMPLETED|Overall Study||0
21926|NCT02251886|53515|P4|COMPLETED|Overall Study||54
21927|NCT02251886|53516|P3|COMPLETED|Overall Study||44
21928|NCT02251886|53517|P2|COMPLETED|Overall Study||54
21929|NCT02251886|53518|P1|COMPLETED|Overall Study||48
21930|NCT02251886|53515|P4|STARTED|Overall Study||54
21931|NCT02251886|53516|P3|STARTED|Overall Study||44
21932|NCT02251886|53517|P2|STARTED|Overall Study||54
21933|NCT02251886|53518|P1|STARTED|Overall Study||48
21934|NCT02251717|53530|P2|NOT COMPLETED|Overall Study||1
21935|NCT02251717|53531|P1|NOT COMPLETED|Overall Study||1
21936|NCT02251717|53530|P2|COMPLETED|Overall Study||56
21937|NCT02251717|53531|P1|COMPLETED|Overall Study||56
21938|NCT02251717|53530|P2|STARTED|Overall Study||57
21939|NCT02251717|53531|P1|STARTED|Overall Study||57
21940|NCT02251652|53543|P1|NOT COMPLETED|Overall Study||1
21941|NCT02251652|53543|P1|COMPLETED|Overall Study||16
21942|NCT02251652|53543|P1|STARTED|Overall Study||17
21943|NCT02251613|53553|P1|NOT COMPLETED|Overall Study||0
21944|NCT02251613|53553|P1|COMPLETED|Overall Study||50
21945|NCT02251613|53553|P1|STARTED|Overall Study||50
21946|NCT02251561|53561|P1|NOT COMPLETED|Overall Study||0
21947|NCT02251561|53561|P1|COMPLETED|Overall Study||28
21948|NCT02251561|53561|P1|STARTED|Overall Study||28
21949|NCT02250807|53569|P1|NOT COMPLETED|Overall Study||0
21950|NCT02250807|53569|P1|COMPLETED|Overall Study||40
21951|NCT02250807|53569|P1|STARTED|Overall Study||40
21952|NCT02250703|53581|P2|NOT COMPLETED|Overall Study||1
21953|NCT02250703|53582|P1|NOT COMPLETED|Overall Study||1
21954|NCT02250703|53581|P2|COMPLETED|Overall Study||36
21955|NCT02250703|53582|P1|COMPLETED|Overall Study||37
21956|NCT02250703|53581|P2|STARTED|Overall Study||37
21957|NCT02250703|53582|P1|STARTED|Overall Study||38
21958|NCT02250443|53594|P1|NOT COMPLETED|Overall Study||10
21959|NCT02250443|53594|P1|COMPLETED|Overall Study||0
21960|NCT02250443|53594|P1|STARTED|Overall Study||10
21961|NCT02250274|53609|P2|NOT COMPLETED|Overall Study||6
21962|NCT02250274|53610|P1|NOT COMPLETED|Overall Study||7
21963|NCT02250274|53609|P2|COMPLETED|Overall Study||40
21964|NCT02250274|53610|P1|COMPLETED|Overall Study||78
21965|NCT02250274|53609|P2|STARTED|Overall Study||46
21966|NCT02250274|53610|P1|STARTED|Overall Study||85
21967|NCT02249819|53626|P2|NOT COMPLETED|Overall Study||0
21968|NCT02249819|53627|P1|NOT COMPLETED|Overall Study||0
21969|NCT02249819|53626|P2|COMPLETED|Overall Study||7
21970|NCT02249819|53627|P1|COMPLETED|Overall Study||8
21971|NCT02249819|53626|P2|STARTED|Overall Study||7
21972|NCT02249819|53627|P1|STARTED|Overall Study||8
21973|NCT02249728|53633|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
21974|NCT02249728|53633|P1|COMPLETED|Part Two (up to 6 Days)||6
21975|NCT02249728|53633|P1|STARTED|Part Two (up to 6 Days)||6
21976|NCT02249728|53633|P1|NOT COMPLETED|Part One (4 Days)||0
21977|NCT02249728|53633|P1|COMPLETED|Part One (4 Days)||6
21978|NCT02249728|53633|P1|STARTED|Part One (4 Days)||6
21979|NCT02249104|53643|P1|NOT COMPLETED|Overall Study||3
21980|NCT02249104|53643|P1|COMPLETED|Overall Study||25
21981|NCT02249104|53643|P1|STARTED|Overall Study||28
21982|NCT02249065|53652|P1|NOT COMPLETED|Overall Study||29
21983|NCT02249065|53652|P1|COMPLETED|Overall Study||176
21984|NCT02249065|53652|P1|Treated|Overall Study||181
21985|NCT02249065|53652|P1|STARTED|Overall Study||205
21986|NCT02249052|53660|P1|NOT COMPLETED|Overall Study||0
21987|NCT02249052|53660|P1|COMPLETED|Overall Study||19
21988|NCT02249052|53660|P1|STARTED|Overall Study||19
21989|NCT02248818|53684|P9|NOT COMPLETED|Randomised Study||0
21990|NCT02248818|53685|P8|NOT COMPLETED|Randomised Study||0
21991|NCT02248818|53686|P7|NOT COMPLETED|Randomised Study||0
21992|NCT02248818|53687|P6|NOT COMPLETED|Randomised Study||8
21993|NCT02248818|53688|P5|NOT COMPLETED|Randomised Study||0
21994|NCT02248818|53689|P4|NOT COMPLETED|Randomised Study||0
21995|NCT02248818|53690|P3|NOT COMPLETED|Randomised Study||0
21996|NCT02248818|53691|P2|NOT COMPLETED|Randomised Study||0
21997|NCT02248818|53692|P1|NOT COMPLETED|Randomised Study||0
21998|NCT02248818|53684|P9|COMPLETED|Randomised Study||0
21999|NCT02248818|53685|P8|COMPLETED|Randomised Study||4
22000|NCT02248818|53686|P7|COMPLETED|Randomised Study||6
22001|NCT02248818|53687|P6|COMPLETED|Randomised Study||0
22002|NCT02248818|53688|P5|COMPLETED|Randomised Study||6
22003|NCT02248818|53689|P4|COMPLETED|Randomised Study||6
22004|NCT02248818|53690|P3|COMPLETED|Randomised Study||6
22005|NCT02248818|53691|P2|COMPLETED|Randomised Study||6
22006|NCT02248818|53692|P1|COMPLETED|Randomised Study||6
22007|NCT02248818|53684|P9|STARTED|Randomised Study||0
22008|NCT02248818|53685|P8|STARTED|Randomised Study||4
22009|NCT02248818|53686|P7|STARTED|Randomised Study||6
22010|NCT02248818|53687|P6|STARTED|Randomised Study||8
22011|NCT02248818|53688|P5|STARTED|Randomised Study||6
22012|NCT02248818|53689|P4|STARTED|Randomised Study||6
22013|NCT02248818|53690|P3|STARTED|Randomised Study||6
22014|NCT02248818|53691|P2|STARTED|Randomised Study||6
22015|NCT02248818|53692|P1|STARTED|Randomised Study||6
22016|NCT02248818|53684|P9|NOT COMPLETED|Screening||107
22017|NCT02248818|53685|P8|NOT COMPLETED|Screening||0
22018|NCT02248818|53686|P7|NOT COMPLETED|Screening||0
22019|NCT02248818|53687|P6|NOT COMPLETED|Screening||0
22020|NCT02248818|53688|P5|NOT COMPLETED|Screening||0
22021|NCT02248818|53689|P4|NOT COMPLETED|Screening||0
22022|NCT02248818|53690|P3|NOT COMPLETED|Screening||0
22023|NCT02248818|53691|P2|NOT COMPLETED|Screening||0
22024|NCT02248818|53692|P1|NOT COMPLETED|Screening||0
22025|NCT02248818|53684|P9|COMPLETED|Screening||48
22026|NCT02248818|53685|P8|COMPLETED|Screening||0
22027|NCT02248818|53686|P7|COMPLETED|Screening||0
22028|NCT02248818|53687|P6|COMPLETED|Screening||0
22029|NCT02248818|53688|P5|COMPLETED|Screening||0
22030|NCT02248818|53689|P4|COMPLETED|Screening||0
22031|NCT02248818|53690|P3|COMPLETED|Screening||0
22032|NCT02248818|53691|P2|COMPLETED|Screening||0
22033|NCT02248818|53692|P1|COMPLETED|Screening||0
22034|NCT02248818|53684|P9|STARTED|Screening||155
22035|NCT02248818|53685|P8|STARTED|Screening||0
22036|NCT02248818|53686|P7|STARTED|Screening||0
22037|NCT02248818|53687|P6|STARTED|Screening||0
22038|NCT02248818|53688|P5|STARTED|Screening||0
22039|NCT02248818|53689|P4|STARTED|Screening||0
22040|NCT02248818|53690|P3|STARTED|Screening||0
22041|NCT02248818|53691|P2|STARTED|Screening||0
22042|NCT02248818|53692|P1|STARTED|Screening||0
22043|NCT02248766|53830|P1|NOT COMPLETED|Overall Study||0
22044|NCT02248766|53830|P1|COMPLETED|Overall Study||30
22045|NCT02248766|53830|P1|STARTED|Overall Study||30
22046|NCT02248727|53842|P1|NOT COMPLETED|Overall Study||0
22047|NCT02248727|53842|P1|COMPLETED|Overall Study||30
22048|NCT02248727|53842|P1|STARTED|Overall Study||30
22049|NCT02248675|53855|P2|NOT COMPLETED|Overall Study||1
22050|NCT02248675|53856|P1|NOT COMPLETED|Overall Study||3
22051|NCT02248675|53855|P2|COMPLETED|Overall Study||27
22052|NCT02248675|53856|P1|COMPLETED|Overall Study||23
22053|NCT02248675|53855|P2|STARTED|Overall Study||28
22054|NCT02248675|53856|P1|STARTED|Overall Study||26
22055|NCT02248558|53870|P2|NOT COMPLETED|Overall Study||45
22056|NCT02248558|53871|P1|NOT COMPLETED|Overall Study||52
22057|NCT02248558|53870|P2|COMPLETED|Overall Study||307
22058|NCT02248558|53871|P1|COMPLETED|Overall Study||317
22059|NCT02248558|53870|P2|STARTED|Overall Study||352
22060|NCT02248558|53871|P1|STARTED|Overall Study||369
22061|NCT02248480|53883|P2|NOT COMPLETED|Overall Study||14
22062|NCT02248480|53884|P1|NOT COMPLETED|Overall Study||17
22063|NCT02248480|53883|P2|COMPLETED|Overall Study||162
22064|NCT02248480|53884|P1|COMPLETED|Overall Study||161
22065|NCT02248480|53883|P2|Efficacy Population|Overall Study||176
22066|NCT02248480|53884|P1|Efficacy Population|Overall Study||177
22067|NCT02248480|53883|P2|STARTED|Overall Study||176
22068|NCT02248480|53884|P1|STARTED|Overall Study||178
22069|NCT02248285|53924|P2|NOT COMPLETED|Overall Study||287
22070|NCT02248285|53925|P1|NOT COMPLETED|Overall Study||101
22071|NCT02248285|53924|P2|COMPLETED|Overall Study||571
22072|NCT02248285|53925|P1|COMPLETED|Overall Study||586
22073|NCT02248285|53924|P2|STARTED|Overall Study||858
22074|NCT02248285|53925|P1|STARTED|Overall Study||687
22075|NCT02248246|53931|P1|NOT COMPLETED|Overall Study||0
22076|NCT02248246|53931|P1|COMPLETED|Overall Study||40
22077|NCT02248246|53931|P1|STARTED|Overall Study||40
22078|NCT02248103|53938|P2|NOT COMPLETED|Overall Study||0
22079|NCT02248103|53939|P1|NOT COMPLETED|Overall Study||0
22080|NCT02248103|53938|P2|COMPLETED|Overall Study||10
22081|NCT02248103|53939|P1|COMPLETED|Overall Study||10
22082|NCT02248103|53938|P2|STARTED|Overall Study||10
22083|NCT02248103|53939|P1|STARTED|Overall Study||10
22084|NCT02247960|53951|P2|NOT COMPLETED|Catheter Removed||10
22085|NCT02247960|53952|P1|NOT COMPLETED|Catheter Removed||7
22086|NCT02247960|53951|P2|COMPLETED|Catheter Removed||74
22087|NCT02247960|53952|P1|COMPLETED|Catheter Removed||76
22088|NCT02247960|53951|P2|STARTED|Catheter Removed||84
22089|NCT02247960|53952|P1|STARTED|Catheter Removed||83
22090|NCT02247960|53951|P2|NOT COMPLETED|Patient Consent and Randomization||6
22091|NCT02247960|53952|P1|NOT COMPLETED|Patient Consent and Randomization||2
22092|NCT02247960|53951|P2|COMPLETED|Patient Consent and Randomization||84
22093|NCT02247960|53952|P1|COMPLETED|Patient Consent and Randomization||83
22094|NCT02247960|53951|P2|STARTED|Patient Consent and Randomization||90
22095|NCT02247960|53952|P1|STARTED|Patient Consent and Randomization||85
22096|NCT02247765|53962|P1|NOT COMPLETED|Overall Study||0
22097|NCT02247765|53962|P1|COMPLETED|Overall Study||18
22098|NCT02247765|53962|P1|STARTED|Overall Study||18
22099|NCT02247739|53967|P6|NOT COMPLETED|Overall Study||1
22100|NCT02247739|53968|P5|NOT COMPLETED|Overall Study||1
22101|NCT02247739|53969|P4|NOT COMPLETED|Overall Study||0
22102|NCT02247739|53970|P3|NOT COMPLETED|Overall Study||1
22103|NCT02247739|53971|P2|NOT COMPLETED|Overall Study||3
22104|NCT02247739|53972|P1|NOT COMPLETED|Overall Study||0
22105|NCT02247739|53967|P6|COMPLETED|Overall Study||4
22106|NCT02247739|53968|P5|COMPLETED|Overall Study||5
22107|NCT02247739|53969|P4|COMPLETED|Overall Study||5
22108|NCT02247739|53970|P3|COMPLETED|Overall Study||4
22109|NCT02247739|53971|P2|COMPLETED|Overall Study||3
22110|NCT02247739|53972|P1|COMPLETED|Overall Study||5
22111|NCT02247739|53967|P6|STARTED|Overall Study||5
22112|NCT02247739|53968|P5|STARTED|Overall Study||6
22113|NCT02247739|53969|P4|STARTED|Overall Study||5
22114|NCT02247739|53970|P3|STARTED|Overall Study||5
22115|NCT02247739|53971|P2|STARTED|Overall Study||6
22116|NCT02247739|53972|P1|STARTED|Overall Study||5
22117|NCT02247401|53991|P3|NOT COMPLETED|Overall Study||2
22118|NCT02247401|53992|P2|NOT COMPLETED|Overall Study||2
22119|NCT02247401|53993|P1|NOT COMPLETED|Overall Study||6
22120|NCT02247401|53991|P3|COMPLETED|Overall Study||27
22121|NCT02247401|53992|P2|COMPLETED|Overall Study||29
22122|NCT02247401|53993|P1|COMPLETED|Overall Study||94
22123|NCT02247401|53991|P3|STARTED|Overall Study||29
22124|NCT02247401|53992|P2|STARTED|Overall Study||31
22125|NCT02247401|53993|P1|STARTED|Overall Study||100
22126|NCT02247063|54012|P2|NOT COMPLETED|Overall Study||0
22127|NCT02247063|54013|P1|NOT COMPLETED|Overall Study||0
22128|NCT02247063|54012|P2|COMPLETED|Overall Study||12
22129|NCT02247063|54013|P1|COMPLETED|Overall Study||12
22130|NCT02247063|54012|P2|STARTED|Overall Study||12
22131|NCT02247063|54013|P1|STARTED|Overall Study||12
22132|NCT02247011|54023|P1|NOT COMPLETED|Overall Study||125
22133|NCT02247011|54023|P1|COMPLETED|Overall Study||975
22134|NCT02247011|54023|P1|STARTED|Overall Study||1100
22135|NCT02246998|54044|P4|NOT COMPLETED|Overall Study||2
22136|NCT02246998|54045|P3|NOT COMPLETED|Overall Study||3
22137|NCT02246998|54046|P2|NOT COMPLETED|Overall Study||3
22138|NCT02246998|54047|P1|NOT COMPLETED|Overall Study||2
22139|NCT02246998|54044|P4|COMPLETED|Overall Study||16
22140|NCT02246998|54045|P3|COMPLETED|Overall Study||15
22141|NCT02246998|54046|P2|COMPLETED|Overall Study||15
22142|NCT02246998|54047|P1|COMPLETED|Overall Study||16
22143|NCT02246998|54044|P4|STARTED|Overall Study||18
22144|NCT02246998|54045|P3|STARTED|Overall Study||18
22145|NCT02246998|54046|P2|STARTED|Overall Study||18
22146|NCT02246998|54047|P1|STARTED|Overall Study||18
22147|NCT02246764|54160|P3|NOT COMPLETED|Overall Study||4
22148|NCT02246764|54161|P2|NOT COMPLETED|Overall Study||32
22149|NCT02246764|54162|P1|NOT COMPLETED|Overall Study||18
22150|NCT02246764|54160|P3|COMPLETED|Overall Study||19
22151|NCT02246764|54161|P2|COMPLETED|Overall Study||4
22152|NCT02246764|54162|P1|COMPLETED|Overall Study||16
22153|NCT02246764|54160|P3|STARTED|Overall Study||23
22154|NCT02246764|54161|P2|STARTED|Overall Study||36
22155|NCT02246764|54162|P1|STARTED|Overall Study||34
22156|NCT02246673|54175|P5|NOT COMPLETED|Overall Study||1
22157|NCT02246673|54176|P4|NOT COMPLETED|Overall Study||2
22158|NCT02246673|54177|P3|NOT COMPLETED|Overall Study||0
22159|NCT02246673|54178|P2|NOT COMPLETED|Overall Study||0
22160|NCT02246673|54179|P1|NOT COMPLETED|Overall Study||1
22161|NCT02246673|54175|P5|COMPLETED|Overall Study||11
22162|NCT02246673|54176|P4|COMPLETED|Overall Study||12
22163|NCT02246673|54177|P3|COMPLETED|Overall Study||12
22164|NCT02246673|54178|P2|COMPLETED|Overall Study||12
22165|NCT02246673|54179|P1|COMPLETED|Overall Study||13
22166|NCT02246673|54175|P5|STARTED|Overall Study||12
22167|NCT02246673|54176|P4|STARTED|Overall Study||14
22168|NCT02246673|54177|P3|STARTED|Overall Study||12
22169|NCT02246673|54178|P2|STARTED|Overall Study||12
22170|NCT02246673|54179|P1|STARTED|Overall Study||14
22171|NCT02246660|54287|P3|NOT COMPLETED|Overall Study||1
22172|NCT02246660|54288|P2|NOT COMPLETED|Overall Study||1
22173|NCT02246660|54289|P1|NOT COMPLETED|Overall Study||0
22174|NCT02246660|54287|P3|COMPLETED|Overall Study||21
22175|NCT02246660|54288|P2|COMPLETED|Overall Study||20
22176|NCT02246660|54289|P1|COMPLETED|Overall Study||23
22177|NCT02246660|54287|P3|STARTED|Overall Study||22
22178|NCT02246660|54288|P2|STARTED|Overall Study||21
22179|NCT02246660|54289|P1|STARTED|Overall Study||23
22180|NCT02246621|54299|P2|NOT COMPLETED|Overall Study||148
22181|NCT02246621|54300|P1|NOT COMPLETED|Overall Study||296
22182|NCT02246621|54299|P2|COMPLETED|Overall Study||17
22183|NCT02246621|54300|P1|COMPLETED|Overall Study||32
22184|NCT02246621|54299|P2|Received At Least One Dose of Study Drug|Overall Study||162
22185|NCT02246621|54300|P1|Received At Least One Dose of Study Drug|Overall Study||326
22186|NCT02246621|54299|P2|STARTED|Overall Study||165
22187|NCT02246621|54300|P1|STARTED|Overall Study||328
22188|NCT02246582|54326|P2|NOT COMPLETED|Overall Study||4
22189|NCT02246582|54327|P1|NOT COMPLETED|Overall Study||3
22190|NCT02246582|54326|P2|COMPLETED|Overall Study||41
22191|NCT02246582|54327|P1|COMPLETED|Overall Study||41
22192|NCT02246582|54326|P2|STARTED|Overall Study||45
22193|NCT02246582|54327|P1|STARTED|Overall Study||44
22194|NCT02246309|54335|P2|NOT COMPLETED|Overall Study||0
22195|NCT02246309|54336|P1|NOT COMPLETED|Overall Study||0
22196|NCT02246309|54335|P2|COMPLETED|Overall Study||15
22197|NCT02246309|54336|P1|COMPLETED|Overall Study||16
22198|NCT02246309|54335|P2|STARTED|Overall Study||15
22199|NCT02246309|54336|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
22200|NCT02246166|54348|P2|NOT COMPLETED|Overall Study||0
22201|NCT02246166|54349|P1|NOT COMPLETED|Overall Study||1
22202|NCT02246166|54348|P2|COMPLETED|Overall Study||27
22203|NCT02246166|54349|P1|COMPLETED|Overall Study||25
22204|NCT02246166|54348|P2|STARTED|Overall Study||27
22205|NCT02246166|54349|P1|STARTED|Overall Study||26
22206|NCT02246114|54385|P2|NOT COMPLETED|Overall Study||0
22207|NCT02246114|54386|P1|NOT COMPLETED|Overall Study||1
22208|NCT02246114|54385|P2|COMPLETED|Overall Study||0
22209|NCT02246114|54386|P1|COMPLETED|Overall Study||0
22210|NCT02246114|54385|P2|STARTED|Overall Study||0
22211|NCT02246114|54386|P1|STARTED|Overall Study||1
22212|NCT02246062|54396|P4|NOT COMPLETED|Overall Study||0
22213|NCT02246062|54397|P3|NOT COMPLETED|Overall Study||0
22214|NCT02246062|54398|P2|NOT COMPLETED|Overall Study||0
22215|NCT02246062|54399|P1|NOT COMPLETED|Overall Study||0
22216|NCT02246062|54396|P4|COMPLETED|Overall Study||21
22217|NCT02246062|54397|P3|COMPLETED|Overall Study||21
22218|NCT02246062|54398|P2|COMPLETED|Overall Study||21
22219|NCT02246062|54399|P1|COMPLETED|Overall Study||21
22220|NCT02246062|54396|P4|STARTED|Overall Study||21
22221|NCT02246062|54397|P3|STARTED|Overall Study||21
22222|NCT02246062|54398|P2|STARTED|Overall Study||21
22223|NCT02246062|54399|P1|STARTED|Overall Study||21
22224|NCT02245412|54420|P3|NOT COMPLETED|Overall Study||0
22225|NCT02245412|54421|P2|NOT COMPLETED|Overall Study||3
22226|NCT02245412|54422|P1|NOT COMPLETED|Overall Study||5
22227|NCT02245412|54420|P3|COMPLETED|Overall Study||2
22228|NCT02245412|54421|P2|COMPLETED|Overall Study||3
22229|NCT02245412|54422|P1|COMPLETED|Overall Study||12
22230|NCT02245412|54420|P3|STARTED|Overall Study||2
22231|NCT02245412|54421|P2|STARTED|Overall Study||6
22232|NCT02245412|54422|P1|STARTED|Overall Study||17
22233|NCT02245360|54441|P2|NOT COMPLETED|Overall Study||2
22234|NCT02245360|54442|P1|NOT COMPLETED|Overall Study||5
22235|NCT02245360|54441|P2|COMPLETED|Overall Study||52
22236|NCT02245360|54442|P1|COMPLETED|Overall Study||48
22237|NCT02245360|54441|P2|STARTED|Overall Study||54
22238|NCT02245360|54442|P1|STARTED|Overall Study||53
22239|NCT02245217|54450|P1|NOT COMPLETED|Overall Study||2
22240|NCT02245217|54450|P1|COMPLETED|Overall Study||7
22241|NCT02245217|54450|P1|STARTED|Overall Study||9
22242|NCT02244944|54456|P1|NOT COMPLETED|Overall Study||2
22243|NCT02244944|54456|P1|COMPLETED|Overall Study||0
22244|NCT02244944|54456|P1|STARTED|Overall Study||2
22245|NCT02244840|54462|P1|NOT COMPLETED|Overall Study||0
22246|NCT02244840|54462|P1|COMPLETED|Overall Study||40
22247|NCT02244840|54462|P1|STARTED|Overall Study||40
22248|NCT02244619|54468|P2|NOT COMPLETED|Overall Study||21
22249|NCT02244619|54469|P1|NOT COMPLETED|Overall Study||8
22250|NCT02244619|54468|P2|COMPLETED|Overall Study||245
22251|NCT02244619|54469|P1|COMPLETED|Overall Study||241
22252|NCT02244619|54468|P2|STARTED|Overall Study||266
22253|NCT02244619|54469|P1|STARTED|Overall Study||249
22254|NCT02244580|54487|P1|NOT COMPLETED|Overall Study||241
22255|NCT02244580|54487|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
22256|NCT02244580|54487|P1|STARTED|Overall Study||1010
22257|NCT02243943|54497|P2|NOT COMPLETED|Overall Study||0
22258|NCT02243943|54498|P1|NOT COMPLETED|Overall Study||0
22259|NCT02243943|54497|P2|COMPLETED|Overall Study||50
22260|NCT02243943|54498|P1|COMPLETED|Overall Study||50
22261|NCT02243943|54497|P2|STARTED|Overall Study||50
22262|NCT02243943|54498|P1|STARTED|Overall Study||50
22263|NCT02243293|54525|P22|NOT COMPLETED|Overall Study||3
22264|NCT02243293|54526|P21|NOT COMPLETED|Overall Study||2
22265|NCT02243293|54527|P20|NOT COMPLETED|Overall Study||1
22266|NCT02243293|54528|P19|NOT COMPLETED|Overall Study||0
22267|NCT02243293|54529|P18|NOT COMPLETED|Overall Study||1
22268|NCT02243293|54530|P17|NOT COMPLETED|Overall Study||3
22269|NCT02243293|54531|P16|NOT COMPLETED|Overall Study||1
22270|NCT02243293|54532|P15|NOT COMPLETED|Overall Study||1
22271|NCT02243293|54533|P14|NOT COMPLETED|Overall Study||0
22272|NCT02243293|54534|P13|NOT COMPLETED|Overall Study||0
22273|NCT02243293|54535|P12|NOT COMPLETED|Overall Study||3
22274|NCT02243293|54536|P11|NOT COMPLETED|Overall Study||0
22275|NCT02243293|54537|P10|NOT COMPLETED|Overall Study||2
22276|NCT02243293|54538|P9|NOT COMPLETED|Overall Study||0
22277|NCT02243293|54539|P8|NOT COMPLETED|Overall Study||0
22278|NCT02243293|54540|P7|NOT COMPLETED|Overall Study||3
22279|NCT02243293|54541|P6|NOT COMPLETED|Overall Study||0
22280|NCT02243293|54542|P5|NOT COMPLETED|Overall Study||1
22281|NCT02243293|54543|P4|NOT COMPLETED|Overall Study||1
22282|NCT02243293|54544|P3|NOT COMPLETED|Overall Study||1
22283|NCT02243293|54545|P2|NOT COMPLETED|Overall Study||1
22284|NCT02243293|54546|P1|NOT COMPLETED|Overall Study||2
22285|NCT02243293|54525|P22|COMPLETED|Overall Study||55
22286|NCT02243293|54526|P21|COMPLETED|Overall Study||143
22287|NCT02243293|54527|P20|COMPLETED|Overall Study||47
22288|NCT02243293|54528|P19|COMPLETED|Overall Study||22
22289|NCT02243293|54529|P18|COMPLETED|Overall Study||21
22290|NCT02243293|54530|P17|COMPLETED|Overall Study||37
22291|NCT02243293|54531|P16|COMPLETED|Overall Study||26
22292|NCT02243293|54532|P15|COMPLETED|Overall Study||27
22293|NCT02243293|54533|P14|COMPLETED|Overall Study||0
22294|NCT02243293|54534|P13|COMPLETED|Overall Study||0
22295|NCT02243293|54535|P12|COMPLETED|Overall Study||50
22296|NCT02243293|54536|P11|COMPLETED|Overall Study||0
22297|NCT02243293|54537|P10|COMPLETED|Overall Study||53
22298|NCT02243293|54538|P9|COMPLETED|Overall Study||0
22299|NCT02243293|54539|P8|COMPLETED|Overall Study||0
22300|NCT02243293|54540|P7|COMPLETED|Overall Study||27
22301|NCT02243293|54541|P6|COMPLETED|Overall Study||31
22302|NCT02243293|54542|P5|COMPLETED|Overall Study||30
22303|NCT02243293|54543|P4|COMPLETED|Overall Study||29
22304|NCT02243293|54544|P3|COMPLETED|Overall Study||24
22305|NCT02243293|54545|P2|COMPLETED|Overall Study||23
22306|NCT02243293|54546|P1|COMPLETED|Overall Study||23
22307|NCT02243293|54525|P22|STARTED|Overall Study||58
22308|NCT02243293|54526|P21|STARTED|Overall Study||145
22309|NCT02243293|54527|P20|STARTED|Overall Study||48
22310|NCT02243293|54528|P19|STARTED|Overall Study||22
22311|NCT02243293|54529|P18|STARTED|Overall Study||22
22312|NCT02243293|54530|P17|STARTED|Overall Study||40
22313|NCT02243293|54531|P16|STARTED|Overall Study||27
22314|NCT02243293|54532|P15|STARTED|Overall Study||28
22315|NCT02243293|54533|P14|STARTED|Overall Study||0
22316|NCT02243293|54534|P13|STARTED|Overall Study||0
22317|NCT02243293|54535|P12|STARTED|Overall Study||53
22318|NCT02243293|54536|P11|STARTED|Overall Study||0
22319|NCT02243293|54537|P10|STARTED|Overall Study||55
22320|NCT02243293|54538|P9|STARTED|Overall Study||0
22321|NCT02243293|54539|P8|STARTED|Overall Study||0
22322|NCT02243293|54540|P7|STARTED|Overall Study||30
22323|NCT02243293|54541|P6|STARTED|Overall Study||31
22324|NCT02243293|54542|P5|STARTED|Overall Study||31
22325|NCT02243293|54543|P4|STARTED|Overall Study||30
22326|NCT02243293|54544|P3|STARTED|Overall Study||25
22327|NCT02243293|54545|P2|STARTED|Overall Study||24
22328|NCT02243293|54546|P1|STARTED|Overall Study||25
22329|NCT02243280|54645|P11|NOT COMPLETED|Treated||3
22330|NCT02243280|54646|P10|NOT COMPLETED|Treated||0
22331|NCT02243280|54647|P9|NOT COMPLETED|Treated||1
22332|NCT02243280|54648|P8|NOT COMPLETED|Treated||0
22333|NCT02243280|54649|P7|NOT COMPLETED|Treated||0
22334|NCT02243280|54650|P6|NOT COMPLETED|Treated||0
22335|NCT02243280|54651|P5|NOT COMPLETED|Treated||0
22336|NCT02243280|54652|P4|NOT COMPLETED|Treated||0
22337|NCT02243280|54653|P3|NOT COMPLETED|Treated||0
22338|NCT02243280|54654|P2|NOT COMPLETED|Treated||0
22339|NCT02243280|54655|P1|NOT COMPLETED|Treated||1
22340|NCT02243280|54645|P11|COMPLETED|Treated||31
22341|NCT02243280|54646|P10|COMPLETED|Treated||0
22342|NCT02243280|54647|P9|COMPLETED|Treated||31
22343|NCT02243280|54648|P8|COMPLETED|Treated||0
22344|NCT02243280|54649|P7|COMPLETED|Treated||0
22345|NCT02243280|54650|P6|COMPLETED|Treated||27
22346|NCT02243280|54651|P5|COMPLETED|Treated||0
22347|NCT02243280|54652|P4|COMPLETED|Treated||0
22348|NCT02243280|54653|P3|COMPLETED|Treated||0
22349|NCT02243280|54654|P2|COMPLETED|Treated||39
22350|NCT02243280|54655|P1|COMPLETED|Treated||41
22351|NCT02243280|54645|P11|Completed Treatment|Treated||33
22352|NCT02243280|54646|P10|Completed Treatment|Treated||0
22353|NCT02243280|54647|P9|Completed Treatment|Treated||32
22354|NCT02243280|54648|P8|Completed Treatment|Treated||0
22355|NCT02243280|54649|P7|Completed Treatment|Treated||0
22356|NCT02243280|54650|P6|Completed Treatment|Treated||27
22357|NCT02243280|54651|P5|Completed Treatment|Treated||0
22358|NCT02243280|54652|P4|Completed Treatment|Treated||0
22359|NCT02243280|54653|P3|Completed Treatment|Treated||0
22360|NCT02243280|54654|P2|Completed Treatment|Treated||38
22361|NCT02243280|54655|P1|Completed Treatment|Treated||42
22362|NCT02243280|54645|P11|STARTED|Treated||34
22363|NCT02243280|54646|P10|STARTED|Treated||0
22364|NCT02243280|54647|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
22365|NCT02243280|54648|P8|STARTED|Treated||0
22366|NCT02243280|54649|P7|STARTED|Treated||0
22367|NCT02243280|54650|P6|STARTED|Treated||27
22368|NCT02243280|54651|P5|STARTED|Treated||0
22369|NCT02243280|54652|P4|STARTED|Treated||0
22370|NCT02243280|54653|P3|STARTED|Treated||0
22371|NCT02243280|54654|P2|STARTED|Treated||39
22372|NCT02243280|54655|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
22373|NCT02243280|54645|P11|NOT COMPLETED|Enrolled||0
22374|NCT02243280|54646|P10|NOT COMPLETED|Enrolled||0
22375|NCT02243280|54647|P9|NOT COMPLETED|Enrolled||0
22376|NCT02243280|54648|P8|NOT COMPLETED|Enrolled||0
22377|NCT02243280|54649|P7|NOT COMPLETED|Enrolled||0
22378|NCT02243280|54650|P6|NOT COMPLETED|Enrolled||0
22379|NCT02243280|54651|P5|NOT COMPLETED|Enrolled||0
22380|NCT02243280|54652|P4|NOT COMPLETED|Enrolled||0
22381|NCT02243280|54653|P3|NOT COMPLETED|Enrolled||0
22382|NCT02243280|54654|P2|NOT COMPLETED|Enrolled||0
22383|NCT02243280|54655|P1|NOT COMPLETED|Enrolled||0
22384|NCT02243280|54645|P11|COMPLETED|Enrolled||34
22385|NCT02243280|54646|P10|COMPLETED|Enrolled||0
22386|NCT02243280|54647|P9|COMPLETED|Enrolled||34
22387|NCT02243280|54648|P8|COMPLETED|Enrolled||0
22388|NCT02243280|54649|P7|COMPLETED|Enrolled||0
22389|NCT02243280|54650|P6|COMPLETED|Enrolled||27
22390|NCT02243280|54651|P5|COMPLETED|Enrolled||0
22391|NCT02243280|54652|P4|COMPLETED|Enrolled||0
22392|NCT02243280|54653|P3|COMPLETED|Enrolled||0
22393|NCT02243280|54654|P2|COMPLETED|Enrolled||39
22394|NCT02243280|54655|P1|COMPLETED|Enrolled||40
22395|NCT02243280|54645|P11|STARTED|Enrolled||34
22396|NCT02243280|54646|P10|STARTED|Enrolled||0
22397|NCT02243280|54647|P9|STARTED|Enrolled||34
22398|NCT02243280|54648|P8|STARTED|Enrolled||0
22399|NCT02243280|54649|P7|STARTED|Enrolled||0
22400|NCT02243280|54650|P6|STARTED|Enrolled||27
22401|NCT02243280|54651|P5|STARTED|Enrolled||0
22402|NCT02243280|54652|P4|STARTED|Enrolled||0
22403|NCT02243280|54653|P3|STARTED|Enrolled||0
22404|NCT02243280|54654|P2|STARTED|Enrolled||39
22405|NCT02243280|54655|P1|STARTED|Enrolled||40
22406|NCT02243202|54710|P4|NOT COMPLETED|Overall Study||23
22407|NCT02243202|54711|P3|NOT COMPLETED|Overall Study||31
22408|NCT02243202|54712|P2|NOT COMPLETED|Overall Study||25
22409|NCT02243202|54713|P1|NOT COMPLETED|Overall Study||25
22410|NCT02243202|54710|P4|COMPLETED|Overall Study||61
22411|NCT02243202|54711|P3|COMPLETED|Overall Study||53
22412|NCT02243202|54712|P2|COMPLETED|Overall Study||60
22413|NCT02243202|54713|P1|COMPLETED|Overall Study||57
22414|NCT02243202|54710|P4|Treated|Overall Study||83
22415|NCT02243202|54711|P3|Treated|Overall Study||84
22416|NCT02243202|54712|P2|Treated|Overall Study||85
22417|NCT02243202|54713|P1|Treated|Overall Study||82
22418|NCT02243202|54710|P4|STARTED|Overall Study||84
22419|NCT02243202|54711|P3|STARTED|Overall Study||84
22420|NCT02243202|54712|P2|STARTED|Overall Study||85
22421|NCT02243202|54713|P1|STARTED|Overall Study||82
22422|NCT02243176|54749|P2|NOT COMPLETED|Overall Study||15
22423|NCT02243176|54750|P1|NOT COMPLETED|Overall Study||14
22424|NCT02243176|54749|P2|COMPLETED|Overall Study||229
22425|NCT02243176|54750|P1|COMPLETED|Overall Study||230
22426|NCT02243176|54749|P2|STARTED|Overall Study||244
22427|NCT02243176|54750|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
22428|NCT02243046|54775|P3|NOT COMPLETED|Overall Study||4
22429|NCT02243046|54776|P2|NOT COMPLETED|Overall Study||1
22430|NCT02243046|54777|P1|NOT COMPLETED|Overall Study||1
22431|NCT02243046|54775|P3|COMPLETED|Overall Study||49
22432|NCT02243046|54776|P2|COMPLETED|Overall Study||53
22433|NCT02243046|54777|P1|COMPLETED|Overall Study||54
22434|NCT02243046|54775|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
22435|NCT02243046|54776|P2|6 Month|Overall Study||53
22436|NCT02243046|54777|P1|6 Month|Overall Study||54
22437|NCT02243046|54775|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
22438|NCT02243046|54776|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
22439|NCT02243046|54777|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
22440|NCT02243046|54775|P3|STARTED|Overall Study||53
22441|NCT02243046|54776|P2|STARTED|Overall Study||54
22442|NCT02243046|54777|P1|STARTED|Overall Study||55
22443|NCT02243007|54802|P2|NOT COMPLETED|Overall Study||0
22444|NCT02243007|54803|P1|NOT COMPLETED|Overall Study||0
22445|NCT02243007|54802|P2|COMPLETED|Overall Study||3
22446|NCT02243007|54803|P1|COMPLETED|Overall Study||4
22447|NCT02243007|54802|P2|STARTED|Overall Study||3
22448|NCT02243007|54803|P1|STARTED|Overall Study||4
22449|NCT02242994|54825|P1|NOT COMPLETED|Overall Study||0
22450|NCT02242994|54825|P1|COMPLETED|Overall Study||5
22451|NCT02242994|54825|P1|STARTED|Overall Study||5
22452|NCT02242643|54832|P2|NOT COMPLETED|Overall Study||78
22453|NCT02242643|54833|P1|NOT COMPLETED|Overall Study||75
22454|NCT02242643|54832|P2|COMPLETED|Overall Study||1139
22455|NCT02242643|54833|P1|COMPLETED|Overall Study||1132
22456|NCT02242643|54832|P2|STARTED|Overall Study||1217
22457|NCT02242643|54833|P1|STARTED|Overall Study||1207
22458|NCT02242630|54869|P4|NOT COMPLETED|Overall Study||0
22459|NCT02242630|54870|P3|NOT COMPLETED|Overall Study||0
22460|NCT02242630|54871|P2|NOT COMPLETED|Overall Study||0
22461|NCT02242630|54872|P1|NOT COMPLETED|Overall Study||0
22462|NCT02242630|54869|P4|COMPLETED|Overall Study||16
22463|NCT02242630|54870|P3|COMPLETED|Overall Study||15
22464|NCT02242630|54871|P2|COMPLETED|Overall Study||15
22465|NCT02242630|54872|P1|COMPLETED|Overall Study||15
22466|NCT02242630|54869|P4|STARTED|Overall Study||16
22467|NCT02242630|54870|P3|STARTED|Overall Study||15
22468|NCT02242630|54871|P2|STARTED|Overall Study||15
22469|NCT02242630|54872|P1|STARTED|Overall Study||15
22470|NCT02242305|54888|P2|NOT COMPLETED|Overall Study||10
22471|NCT02242305|54889|P1|NOT COMPLETED|Overall Study||6
22472|NCT02242305|54888|P2|COMPLETED|Overall Study||141
22473|NCT02242305|54889|P1|COMPLETED|Overall Study||145
22474|NCT02242305|54888|P2|STARTED|Overall Study||151
22475|NCT02242305|54889|P1|STARTED|Overall Study||151
22476|NCT02242201|54910|P3|NOT COMPLETED|Overall Study||1
22477|NCT02242201|54911|P2|NOT COMPLETED|Overall Study||1
22478|NCT02242201|54912|P1|NOT COMPLETED|Overall Study||4
22479|NCT02242201|54910|P3|COMPLETED|Overall Study||54
22480|NCT02242201|54911|P2|COMPLETED|Overall Study||54
22481|NCT02242201|54912|P1|COMPLETED|Overall Study||51
22482|NCT02242201|54910|P3|STARTED|Overall Study||55
22483|NCT02242201|54911|P2|STARTED|Overall Study||55
22484|NCT02242201|54912|P1|STARTED|Overall Study||55
22485|NCT02242019|54944|P1|NOT COMPLETED|Overall Study||0
22486|NCT02242019|54944|P1|COMPLETED|Overall Study||109
22487|NCT02242019|54944|P1|STARTED|Overall Study||109
22488|NCT02241889|54950|P6|NOT COMPLETED|Overall Study||1
22489|NCT02241889|54951|P5|NOT COMPLETED|Overall Study||0
22490|NCT02241889|54952|P4|NOT COMPLETED|Overall Study||0
22491|NCT02241889|54953|P3|NOT COMPLETED|Overall Study||1
22492|NCT02241889|54954|P2|NOT COMPLETED|Overall Study||0
22493|NCT02241889|54955|P1|NOT COMPLETED|Overall Study||0
22494|NCT02241889|54950|P6|COMPLETED|Overall Study||3
22495|NCT02241889|54951|P5|COMPLETED|Overall Study||5
22496|NCT02241889|54952|P4|COMPLETED|Overall Study||3
22497|NCT02241889|54953|P3|COMPLETED|Overall Study||2
22498|NCT02241889|54954|P2|COMPLETED|Overall Study||4
22499|NCT02241889|54955|P1|COMPLETED|Overall Study||4
22500|NCT02241889|54950|P6|STARTED|Overall Study||4
22501|NCT02241889|54951|P5|STARTED|Overall Study||5
22502|NCT02241889|54952|P4|STARTED|Overall Study||3
22503|NCT02241889|54953|P3|STARTED|Overall Study||3
22504|NCT02241889|54954|P2|STARTED|Overall Study||4
22505|NCT02241889|54955|P1|STARTED|Overall Study||4
22506|NCT02241785|54990|P1|NOT COMPLETED|Overall Study||47
22507|NCT02241785|54990|P1|COMPLETED|Overall Study||0
22508|NCT02241785|54990|P1|STARTED|Overall Study||47
22509|NCT02241720|54998|P1|NOT COMPLETED|Overall Study||4
22510|NCT02241720|54998|P1|COMPLETED|Overall Study||1
22511|NCT02241720|54998|P1|STARTED|Overall Study||5
22512|NCT02241486|55002|P1|NOT COMPLETED|Overall Study||0
22513|NCT02241486|55002|P1|COMPLETED|Overall Study||2
22514|NCT02241486|55002|P1|STARTED|Overall Study||2
22515|NCT02241187|55006|P1|NOT COMPLETED|Overall Study||2
22516|NCT02241187|55006|P1|COMPLETED|Overall Study||0
22517|NCT02241187|55006|P1|STARTED|Overall Study||2
22518|NCT02240654|55016|P5|NOT COMPLETED|Overall Study||0
22519|NCT02240654|55017|P4|NOT COMPLETED|Overall Study||0
22520|NCT02240654|55018|P3|NOT COMPLETED|Overall Study||0
22521|NCT02240654|55019|P2|NOT COMPLETED|Overall Study||0
22522|NCT02240654|55020|P1|NOT COMPLETED|Overall Study||0
22523|NCT02240654|55016|P5|COMPLETED|Overall Study||1285
22524|NCT02240654|55017|P4|COMPLETED|Overall Study||2150
22525|NCT02240654|55018|P3|COMPLETED|Overall Study||28619
22526|NCT02240654|55019|P2|COMPLETED|Overall Study||2813
22527|NCT02240654|55020|P1|COMPLETED|Overall Study||1706
22528|NCT02240654|55016|P5|STARTED|Overall Study||1285
22529|NCT02240654|55017|P4|STARTED|Overall Study||2150
22530|NCT02240654|55018|P3|STARTED|Overall Study||28619
22531|NCT02240654|55019|P2|STARTED|Overall Study||2813
22532|NCT02240654|55020|P1|STARTED|Overall Study||1706
22533|NCT02240628|55034|P2|NOT COMPLETED|Overall Study||5
22534|NCT02240628|55035|P1|NOT COMPLETED|Overall Study||6
22535|NCT02240628|55034|P2|COMPLETED|Overall Study||33
22536|NCT02240628|55035|P1|COMPLETED|Overall Study||32
22537|NCT02240628|55034|P2|STARTED|Overall Study||38
22538|NCT02240628|55035|P1|STARTED|Overall Study||38
22539|NCT02240589|55045|P2|NOT COMPLETED|Overall Study||2
22540|NCT02240589|55046|P1|NOT COMPLETED|Overall Study||2
22541|NCT02240589|55045|P2|COMPLETED|Overall Study||4
22542|NCT02240589|55046|P1|COMPLETED|Overall Study||3
22543|NCT02240589|55045|P2|STARTED|Overall Study||6
22544|NCT02240589|55046|P1|STARTED|Overall Study||5
22545|NCT02240368|55069|P3|NOT COMPLETED|Overall Study||1
22546|NCT02240368|55070|P2|NOT COMPLETED|Overall Study||0
22547|NCT02240368|55071|P1|NOT COMPLETED|Overall Study||1
22548|NCT02240368|55069|P3|COMPLETED|Overall Study||18
22549|NCT02240368|55070|P2|COMPLETED|Overall Study||22
22550|NCT02240368|55071|P1|COMPLETED|Overall Study||8
22551|NCT02240368|55069|P3|STARTED|Overall Study||19
22552|NCT02240368|55070|P2|STARTED|Overall Study||22
22553|NCT02240368|55071|P1|STARTED|Overall Study||9
22554|NCT02240329|55088|P1|NOT COMPLETED|Overall Study||0
22555|NCT02240329|55088|P1|COMPLETED|Overall Study||4
22556|NCT02240329|55088|P1|Determination of Urge to Cough|Overall Study||4
22557|NCT02240329|55088|P1|STARTED|Overall Study||4
22558|NCT02240030|55096|P3|NOT COMPLETED|Overall Study||15
22559|NCT02240030|55097|P2|NOT COMPLETED|Overall Study||17
22560|NCT02240030|55098|P1|NOT COMPLETED|Overall Study||17
22561|NCT02240030|55096|P3|COMPLETED|Overall Study||97
22562|NCT02240030|55097|P2|COMPLETED|Overall Study||97
22563|NCT02240030|55098|P1|COMPLETED|Overall Study||96
22564|NCT02240030|55096|P3|STARTED|Overall Study||112
22565|NCT02240030|55097|P2|STARTED|Overall Study||114
22566|NCT02240030|55098|P1|STARTED|Overall Study||113
22567|NCT02239978|55122|P2|NOT COMPLETED|Overall Study||0
22568|NCT02239978|55123|P1|NOT COMPLETED|Overall Study||2
22569|NCT02239978|55122|P2|COMPLETED|Overall Study||12
22570|NCT02239978|55123|P1|COMPLETED|Overall Study||28
22571|NCT02239978|55122|P2|STARTED|Overall Study||12
22572|NCT02239978|55123|P1|STARTED|Overall Study||30
22573|NCT02239939|55140|P2|NOT COMPLETED|Overall Study||2
22574|NCT02239939|55141|P1|NOT COMPLETED|Overall Study||2
22575|NCT02239939|55140|P2|COMPLETED|Overall Study||15
22576|NCT02239939|55141|P1|COMPLETED|Overall Study||18
22577|NCT02239939|55140|P2|STARTED|Overall Study||17
22578|NCT02239939|55141|P1|STARTED|Overall Study||20
22579|NCT02239926|55157|P2|NOT COMPLETED|Overall Study||1
22580|NCT02239926|55158|P1|NOT COMPLETED|Overall Study||0
22581|NCT02239926|55157|P2|COMPLETED|Overall Study||1
22582|NCT02239926|55158|P1|COMPLETED|Overall Study||0
22583|NCT02239926|55157|P2|STARTED|Overall Study||2
22584|NCT02239926|55158|P1|STARTED|Overall Study||0
22585|NCT02239744|55168|P2|NOT COMPLETED|Period 2||0
22586|NCT02239744|55169|P1|NOT COMPLETED|Period 2||0
22587|NCT02239744|55168|P2|COMPLETED|Period 2||18
22588|NCT02239744|55169|P1|COMPLETED|Period 2||17
22589|NCT02239744|55168|P2|STARTED|Period 2||18
22590|NCT02239744|55169|P1|STARTED|Period 2||17
22591|NCT02239744|55168|P2|NOT COMPLETED|Period 1||0
22592|NCT02239744|55169|P1|NOT COMPLETED|Period 1||0
22593|NCT02239744|55168|P2|COMPLETED|Period 1||18
22594|NCT02239744|55169|P1|COMPLETED|Period 1||17
22595|NCT02239744|55168|P2|STARTED|Period 1||18
22596|NCT02239744|55169|P1|STARTED|Period 1||17
22597|NCT02239692|55183|P2|NOT COMPLETED|Overall Study||13
22598|NCT02239692|55184|P1|NOT COMPLETED|Overall Study||6
22599|NCT02239692|55183|P2|COMPLETED|Overall Study||118
22600|NCT02239692|55184|P1|COMPLETED|Overall Study||67
22601|NCT02239692|55183|P2|Safety Analysis Set|Overall Study||125
22602|NCT02239692|55184|P1|Safety Analysis Set|Overall Study||70
22603|NCT02239692|55183|P2|Per-protocol Analysis Set|Overall Study||120
22604|NCT02239692|55184|P1|Per-protocol Analysis Set|Overall Study||66
22605|NCT02239692|55183|P2|Intention-to-treat Analysis Set|Overall Study||131
22606|NCT02239692|55184|P1|Intention-to-treat Analysis Set|Overall Study||73
22607|NCT02239692|55183|P2|STARTED|Overall Study||131
22608|NCT02239692|55184|P1|STARTED|Overall Study||73
22609|NCT02239679|55203|P3|NOT COMPLETED|Overall Study||1
22610|NCT02239679|55204|P2|NOT COMPLETED|Overall Study||3
22611|NCT02239679|55205|P1|NOT COMPLETED|Overall Study||3
22612|NCT02239679|55203|P3|COMPLETED|Overall Study||53
22613|NCT02239679|55204|P2|COMPLETED|Overall Study||56
22614|NCT02239679|55205|P1|COMPLETED|Overall Study||50
22615|NCT02239679|55203|P3|STARTED|Overall Study||54
22616|NCT02239679|55204|P2|STARTED|Overall Study||59
22617|NCT02239679|55205|P1|STARTED|Overall Study||53
22618|NCT02239289|55417|P1|NOT COMPLETED|Overall Study||0
22619|NCT02239289|55417|P1|COMPLETED|Overall Study||21
22620|NCT02239289|55417|P1|STARTED|Overall Study||21
22621|NCT02239094|55436|P1|NOT COMPLETED|Overall Study||2
22622|NCT02239094|55436|P1|COMPLETED|Overall Study||18
22623|NCT02239094|55436|P1|STARTED|Overall Study||20
22624|NCT02238925|55441|P1|NOT COMPLETED|Overall Study||25
22625|NCT02238925|55441|P1|COMPLETED|Overall Study||1
22626|NCT02238925|55441|P1|STARTED|Overall Study||26
22627|NCT02238782|55449|P1|NOT COMPLETED|Overall Study||0
22628|NCT02238782|55449|P1|COMPLETED|Overall Study||12
22629|NCT02238782|55449|P1|Subjects Treated|Overall Study||12
22630|NCT02238782|55449|P1|STARTED|Overall Study||12
22631|NCT02238483|55455|P2|NOT COMPLETED|Overall Study||14
22632|NCT02238483|55456|P1|NOT COMPLETED|Overall Study||15
22633|NCT02238483|55455|P2|COMPLETED|Overall Study||91
22634|NCT02238483|55456|P1|COMPLETED|Overall Study||93
22635|NCT02238483|55455|P2|STARTED|Overall Study||105
22636|NCT02238483|55456|P1|STARTED|Overall Study||108
22637|NCT02238379|55494|P2|NOT COMPLETED|Overall Study||0
22638|NCT02238379|55495|P1|NOT COMPLETED|Overall Study||1
22639|NCT02238379|55494|P2|COMPLETED|Overall Study||14
22640|NCT02238379|55495|P1|COMPLETED|Overall Study||11
22641|NCT02238379|55494|P2|STARTED|Overall Study||14
22642|NCT02238379|55495|P1|STARTED|Overall Study||12
22643|NCT02238080|55521|P1|NOT COMPLETED|Overall Study||25
22644|NCT02238080|55521|P1|COMPLETED|Overall Study||172
22645|NCT02238080|55521|P1|STARTED|Overall Study||197
22646|NCT02238067|55535|P1|NOT COMPLETED|Overall Study||45
22647|NCT02238067|55535|P1|COMPLETED|Overall Study||151
22648|NCT02238067|55535|P1|STARTED|Overall Study||196
22649|NCT02238028|55558|P2|NOT COMPLETED|Overall Study||2
22650|NCT02238028|55559|P1|NOT COMPLETED|Overall Study||2
22651|NCT02238028|55558|P2|COMPLETED|Overall Study||12
22652|NCT02238028|55559|P1|COMPLETED|Overall Study||12
22653|NCT02238028|55558|P2|STARTED|Overall Study||14
22654|NCT02238028|55559|P1|STARTED|Overall Study||14
22655|NCT02237118|55580|P2|NOT COMPLETED|Overall Study||1
22656|NCT02237118|55581|P1|NOT COMPLETED|Overall Study||1
22657|NCT02237118|55580|P2|COMPLETED|Overall Study||62
22658|NCT02237118|55581|P1|COMPLETED|Overall Study||59
22659|NCT02237118|55580|P2|STARTED|Overall Study||63
22660|NCT02237118|55581|P1|STARTED|Overall Study||60
22661|NCT02237092|55595|P1|NOT COMPLETED|Overall Study||0
22662|NCT02237092|55595|P1|COMPLETED|Overall Study||196
22663|NCT02237092|55595|P1|STARTED|Overall Study||196
22664|NCT02236767|55612|P1|NOT COMPLETED|Overall Study||0
22665|NCT02236767|55612|P1|COMPLETED|Overall Study||1
22666|NCT02236767|55612|P1|STARTED|Overall Study||1
22667|NCT02236611|55618|P2|NOT COMPLETED|Overall Study||34
22668|NCT02236611|55619|P1|NOT COMPLETED|Overall Study||26
22669|NCT02236611|55618|P2|COMPLETED|Overall Study||484
22670|NCT02236611|55619|P1|COMPLETED|Overall Study||490
22671|NCT02236611|55618|P2|STARTED|Overall Study||518
22672|NCT02236611|55619|P1|STARTED|Overall Study||516
22673|NCT02236598|55627|P2|NOT COMPLETED|Overall Study||2
22674|NCT02236598|55628|P1|NOT COMPLETED|Overall Study||0
22675|NCT02236598|55627|P2|COMPLETED|Overall Study||12
22676|NCT02236598|55628|P1|COMPLETED|Overall Study||15
22677|NCT02236598|55627|P2|STARTED|Overall Study||14
22678|NCT02236598|55628|P1|STARTED|Overall Study||15
22679|NCT02236546|55640|P1|NOT COMPLETED|Overall Study||0
22680|NCT02236546|55640|P1|COMPLETED|Overall Study||3
22681|NCT02236546|55640|P1|STARTED|Overall Study||3
22682|NCT02236338|55649|P2|NOT COMPLETED|Overall Study||0
22683|NCT02236338|55650|P1|NOT COMPLETED|Overall Study||0
22684|NCT02236338|55649|P2|COMPLETED|Overall Study||100
22685|NCT02236338|55650|P1|COMPLETED|Overall Study||100
22686|NCT02236338|55649|P2|STARTED|Overall Study||100
22687|NCT02236338|55650|P1|STARTED|Overall Study||100
22688|NCT02236130|55664|P2|NOT COMPLETED|Overall Study||12
22689|NCT02236130|55665|P1|NOT COMPLETED|Overall Study||7
22690|NCT02236130|55664|P2|COMPLETED|Overall Study||15
22691|NCT02236130|55665|P1|COMPLETED|Overall Study||15
22692|NCT02236130|55664|P2|STARTED|Overall Study||27
22693|NCT02236130|55665|P1|STARTED|Overall Study||22
22694|NCT02235987|55673|P1|NOT COMPLETED|Overall Study||1
22695|NCT02235987|55673|P1|COMPLETED|Overall Study||19
22696|NCT02235987|55673|P1|Received 1800 µg DG3173|Overall Study||19
22697|NCT02235987|55673|P1|Received 900 µg DG3173|Overall Study||19
22698|NCT02235987|55673|P1|Received 300 µg DG3173|Overall Study||20
22699|NCT02235987|55673|P1|Received 100 µg DG3173|Overall Study||20
22700|NCT02235987|55673|P1|Received Octreotide|Overall Study||20
22701|NCT02235987|55673|P1|STARTED|Overall Study||20
22702|NCT02235870|55688|P2|NOT COMPLETED|Overall Study||61
22703|NCT02235870|55689|P1|NOT COMPLETED|Overall Study||38
22704|NCT02235870|55688|P2|COMPLETED|Overall Study||128
22705|NCT02235870|55689|P1|COMPLETED|Overall Study||160
22706|NCT02235870|55688|P2|Crossover (Week 24)|Overall Study||138
22707|NCT02235870|55689|P1|Crossover (Week 24)|Overall Study||170
22708|NCT02235870|55688|P2|Completed Phase I (Week 24)|Overall Study||179
22709|NCT02235870|55689|P1|Completed Phase I (Week 24)|Overall Study||182
22710|NCT02235870|55688|P2|STARTED|Overall Study||189
22711|NCT02235870|55689|P1|STARTED|Overall Study||198
22712|NCT02235831|55698|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
22713|NCT02235831|55699|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
22714|NCT02235831|55700|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
22715|NCT02235831|55701|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
22716|NCT02235831|55702|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
22717|NCT02235831|55703|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
22718|NCT02235831|55698|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
22719|NCT02235831|55699|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
22720|NCT02235831|55700|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
22721|NCT02235831|55701|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
22722|NCT02235831|55702|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
22723|NCT02235831|55703|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
22724|NCT02235831|55698|P6|STARTED|Period 3, Third 5 Days of Wear||4
22725|NCT02235831|55699|P5|STARTED|Period 3, Third 5 Days of Wear||4
22726|NCT02235831|55700|P4|STARTED|Period 3, Third 5 Days of Wear||4
22727|NCT02235831|55701|P3|STARTED|Period 3, Third 5 Days of Wear||4
22728|NCT02235831|55702|P2|STARTED|Period 3, Third 5 Days of Wear||4
22729|NCT02235831|55703|P1|STARTED|Period 3, Third 5 Days of Wear||4
22730|NCT02235831|55698|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
22731|NCT02235831|55699|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
22732|NCT02235831|55700|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
22733|NCT02235831|55701|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
22734|NCT02235831|55702|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
22735|NCT02235831|55703|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
22736|NCT02235831|55698|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
22737|NCT02235831|55699|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
22738|NCT02235831|55700|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
22739|NCT02235831|55701|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
22740|NCT02235831|55702|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
22741|NCT02235831|55703|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
22742|NCT02235831|55698|P6|STARTED|Period 2, Second 5 Days of Wear||4
22743|NCT02235831|55699|P5|STARTED|Period 2, Second 5 Days of Wear||4
22744|NCT02235831|55700|P4|STARTED|Period 2, Second 5 Days of Wear||4
22745|NCT02235831|55701|P3|STARTED|Period 2, Second 5 Days of Wear||4
22746|NCT02235831|55702|P2|STARTED|Period 2, Second 5 Days of Wear||4
22747|NCT02235831|55703|P1|STARTED|Period 2, Second 5 Days of Wear||4
22748|NCT02235831|55698|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
22749|NCT02235831|55699|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
22750|NCT02235831|55700|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
22751|NCT02235831|55701|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
22752|NCT02235831|55702|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
22753|NCT02235831|55703|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
22754|NCT02235831|55698|P6|COMPLETED|Period 1, First 5 Days of Wear||4
22755|NCT02235831|55699|P5|COMPLETED|Period 1, First 5 Days of Wear||4
22756|NCT02235831|55700|P4|COMPLETED|Period 1, First 5 Days of Wear||4
22757|NCT02235831|55701|P3|COMPLETED|Period 1, First 5 Days of Wear||4
22758|NCT02235831|55702|P2|COMPLETED|Period 1, First 5 Days of Wear||4
22759|NCT02235831|55703|P1|COMPLETED|Period 1, First 5 Days of Wear||4
22760|NCT02235831|55698|P6|STARTED|Period 1, First 5 Days of Wear||4
22761|NCT02235831|55699|P5|STARTED|Period 1, First 5 Days of Wear||4
22762|NCT02235831|55700|P4|STARTED|Period 1, First 5 Days of Wear||4
22763|NCT02235831|55701|P3|STARTED|Period 1, First 5 Days of Wear||4
22764|NCT02235831|55702|P2|STARTED|Period 1, First 5 Days of Wear||4
22765|NCT02235831|55703|P1|STARTED|Period 1, First 5 Days of Wear||4
22766|NCT02235493|55710|P1|NOT COMPLETED|Overall Study||0
22767|NCT02235493|55710|P1|COMPLETED|Overall Study||6
22768|NCT02235493|55710|P1|STARTED|Overall Study||6
22769|NCT02235454|55715|P1|NOT COMPLETED|Overall Study||2
22770|NCT02235454|55715|P1|COMPLETED|Overall Study||55
22771|NCT02235454|55715|P1|STARTED|Overall Study||57
22772|NCT02235311|55721|P2|NOT COMPLETED|Overall Study||2
22773|NCT02235311|55722|P1|NOT COMPLETED|Overall Study||0
22774|NCT02235311|55721|P2|COMPLETED|Overall Study||0
22775|NCT02235311|55722|P1|COMPLETED|Overall Study||1
22776|NCT02235311|55721|P2|STARTED|Overall Study||2
22777|NCT02235311|55722|P1|STARTED|Overall Study||1
22778|NCT02235285|55734|P1|NOT COMPLETED|Overall Study||13
22779|NCT02235285|55734|P1|COMPLETED|Overall Study||149
22780|NCT02235285|55734|P1|STARTED|Overall Study||162
22781|NCT02235077|55740|P2|NOT COMPLETED|Overall Study||19
22782|NCT02235077|55741|P1|NOT COMPLETED|Overall Study||18
22783|NCT02235077|55740|P2|COMPLETED|Overall Study||159
22784|NCT02235077|55741|P1|COMPLETED|Overall Study||164
22785|NCT02235077|55740|P2|STARTED|Overall Study||178
22786|NCT02235077|55741|P1|STARTED|Overall Study||182
22787|NCT02235064|55769|P2|NOT COMPLETED|Overall Study||0
22788|NCT02235064|55770|P1|NOT COMPLETED|Overall Study||0
22789|NCT02235064|55769|P2|COMPLETED|Overall Study||1
22790|NCT02235064|55770|P1|COMPLETED|Overall Study||1
22791|NCT02235064|55769|P2|STARTED|Overall Study||1
22792|NCT02235064|55770|P1|STARTED|Overall Study||1
22793|NCT02234752|55796|P1|NOT COMPLETED|Overall Study||1
22794|NCT02234752|55796|P1|COMPLETED|Overall Study||2
22795|NCT02234752|55796|P1|STARTED|Overall Study||3
22796|NCT02234479|55809|P2|NOT COMPLETED|Overall Study||3
22797|NCT02234479|55810|P1|NOT COMPLETED|Overall Study||1
22798|NCT02234479|55809|P2|COMPLETED|Overall Study||15
22799|NCT02234479|55810|P1|COMPLETED|Overall Study||15
22800|NCT02234479|55809|P2|STARTED|Overall Study||18
22801|NCT02234479|55810|P1|STARTED|Overall Study||16
22802|NCT02234427|55816|P1|NOT COMPLETED|Overall Study||1
22803|NCT02234427|55816|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
22804|NCT02234427|55816|P1|STARTED|Overall Study||34
22805|NCT02234362|55820|P1|NOT COMPLETED|Overall Study||26
22806|NCT02234362|55820|P1|COMPLETED|Overall Study||21
22807|NCT02234362|55820|P1|Received at Least One Dose of Medication|Overall Study||27
22808|NCT02234362|55820|P1|STARTED|Overall Study||47
22809|NCT02234115|55837|P1|NOT COMPLETED|Overall Study||15
22810|NCT02234115|55837|P1|COMPLETED|Overall Study||122
22811|NCT02234115|55837|P1|PK Subgroup|Overall Study||31
22812|NCT02234115|55837|P1|PP|Overall Study||124
22813|NCT02234115|55837|P1|ITT|Overall Study||137
22814|NCT02234115|55837|P1|STARTED|Overall Study||137
22815|NCT02234011|55842|P1|NOT COMPLETED|Overall Study||0
22816|NCT02234011|55842|P1|COMPLETED|Overall Study||0
22817|NCT02234011|55842|P1|STARTED|Overall Study||0
22818|NCT02233998|55849|P3|NOT COMPLETED|Overall Study||0
22819|NCT02233998|55850|P2|NOT COMPLETED|Overall Study||0
22820|NCT02233998|55851|P1|NOT COMPLETED|Overall Study||0
22821|NCT02233998|55849|P3|COMPLETED|Overall Study||53
22822|NCT02233998|55850|P2|COMPLETED|Overall Study||52
22823|NCT02233998|55851|P1|COMPLETED|Overall Study||53
22824|NCT02233998|55849|P3|STARTED|Overall Study||53
22825|NCT02233998|55850|P2|STARTED|Overall Study||52
22826|NCT02233998|55851|P1|STARTED|Overall Study||53
22827|NCT02233985|55885|P2|NOT COMPLETED|Overall Study||0
22828|NCT02233985|55886|P1|NOT COMPLETED|Overall Study||0
22829|NCT02233985|55885|P2|COMPLETED|Overall Study||31
22830|NCT02233985|55886|P1|COMPLETED|Overall Study||33
22831|NCT02233985|55885|P2|STARTED|Overall Study||31
22832|NCT02233985|55886|P1|STARTED|Overall Study||33
22833|NCT02233842|55894|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
22834|NCT02233842|55894|P1|COMPLETED|Questionnaire 3 Version 2||5
22835|NCT02233842|55894|P1|STARTED|Questionnaire 3 Version 2||5
22836|NCT02233842|55894|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
22837|NCT02233842|55894|P1|COMPLETED|Questionnaire 3 Version 1||5
22838|NCT02233842|55894|P1|STARTED|Questionnaire 3 Version 1||5
22839|NCT02233842|55894|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
22840|NCT02233842|55894|P1|COMPLETED|Questionnaire 2 Version 2||5
22841|NCT02233842|55894|P1|STARTED|Questionnaire 2 Version 2||5
22842|NCT02233842|55894|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
22843|NCT02233842|55894|P1|COMPLETED|Questionnaire 2 Version 1||5
22844|NCT02233842|55894|P1|STARTED|Questionnaire 2 Version 1||5
22845|NCT02233842|55894|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
22846|NCT02233842|55894|P1|COMPLETED|Questionnaire 1 Version 2||5
22847|NCT02233842|55894|P1|STARTED|Questionnaire 1 Version 2||5
22848|NCT02233842|55894|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
22849|NCT02233842|55894|P1|COMPLETED|Questionnaire 1 Version 1||5
22850|NCT02233842|55894|P1|STARTED|Questionnaire 1 Version 1||5
22851|NCT02233803|55901|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
22852|NCT02233803|55902|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
22853|NCT02233803|55901|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
22854|NCT02233803|55902|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
22855|NCT02233803|55901|P2|STARTED|Treatment Period 2 (4-Wks)||93
22856|NCT02233803|55902|P1|STARTED|Treatment Period 2 (4-Wks)||95
22857|NCT02233803|55901|P2|NOT COMPLETED|Washout Period (4-Wks)||2
22858|NCT02233803|55902|P1|NOT COMPLETED|Washout Period (4-Wks)||2
22859|NCT02233803|55901|P2|COMPLETED|Washout Period (4-Wks)||93
22860|NCT02233803|55902|P1|COMPLETED|Washout Period (4-Wks)||95
22861|NCT02233803|55901|P2|STARTED|Washout Period (4-Wks)||95
22862|NCT02233803|55902|P1|STARTED|Washout Period (4-Wks)||97
22863|NCT02233803|55901|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
22864|NCT02233803|55902|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
22865|NCT02233803|55901|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
22866|NCT02233803|55902|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
22867|NCT02233803|55901|P2|STARTED|Treatment Period 1 (4-Wks)||99
22868|NCT02233803|55902|P1|STARTED|Treatment Period 1 (4-Wks)||100
22869|NCT02233647|55912|P1|NOT COMPLETED|Overall Study||1
22870|NCT02233647|55912|P1|COMPLETED|Overall Study||10
22871|NCT02233647|55912|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
22872|NCT02233647|55912|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
22873|NCT02233647|55912|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
22874|NCT02233647|55912|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
22875|NCT02233647|55912|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
22876|NCT02233647|55912|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
22877|NCT02233647|55912|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
22878|NCT02233647|55912|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
22879|NCT02233647|55912|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
22880|NCT02233647|55912|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
22881|NCT02233647|55912|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
22882|NCT02233647|55912|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
22883|NCT02233647|55912|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
22884|NCT02233647|55912|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
22885|NCT02233647|55912|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
22886|NCT02233647|55912|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
22887|NCT02233647|55912|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
22888|NCT02233647|55912|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
22889|NCT02233647|55912|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
22890|NCT02233647|55912|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
22891|NCT02233647|55912|P1|STARTED|Overall Study||11
22892|NCT02233309|55941|P1|NOT COMPLETED|Overall Study||5
22893|NCT02233309|55941|P1|COMPLETED|Overall Study||31
22894|NCT02233309|55941|P1|STARTED|Overall Study||36
22895|NCT02233296|55947|P2|NOT COMPLETED|Overall Study||0
22896|NCT02233296|55948|P1|NOT COMPLETED|Overall Study||0
22897|NCT02233296|55947|P2|COMPLETED|Overall Study||14
22898|NCT02233296|55948|P1|COMPLETED|Overall Study||16
22899|NCT02233296|55947|P2|STARTED|Overall Study||14
22900|NCT02233296|55948|P1|STARTED|Overall Study||16
22901|NCT02233101|55966|P2|NOT COMPLETED|Overall Study||1
22902|NCT02233101|55967|P1|NOT COMPLETED|Overall Study||12
22903|NCT02233101|55966|P2|COMPLETED|Overall Study||80
22904|NCT02233101|55967|P1|COMPLETED|Overall Study||74
22905|NCT02233101|55966|P2|STARTED|Overall Study||81
22906|NCT02233101|55967|P1|STARTED|Overall Study||86
22907|NCT02232880|55975|P1|NOT COMPLETED|Overall Study||1
22908|NCT02232880|55975|P1|COMPLETED|Overall Study||0
22909|NCT02232880|55975|P1|STARTED|Overall Study||1
22910|NCT02232698|55984|P2|NOT COMPLETED|Overall Study||20
22911|NCT02232698|55985|P1|NOT COMPLETED|Overall Study||10
22912|NCT02232698|55984|P2|COMPLETED|Overall Study||101
22913|NCT02232698|55985|P1|COMPLETED|Overall Study||110
22914|NCT02232698|55984|P2|STARTED|Overall Study||121
22915|NCT02232698|55985|P1|STARTED|Overall Study||120
22916|NCT02232126|56008|P2|NOT COMPLETED|Overall Study||0
22917|NCT02232126|56009|P1|NOT COMPLETED|Overall Study||0
22918|NCT02232126|56008|P2|COMPLETED|Overall Study||90
22919|NCT02232126|56009|P1|COMPLETED|Overall Study||91
22920|NCT02232126|56008|P2|STARTED|Overall Study||90
22921|NCT02232126|56009|P1|STARTED|Overall Study||91
22922|NCT02231918|56020|P3|NOT COMPLETED|Overall Study||1
22923|NCT02231918|56021|P2|NOT COMPLETED|Overall Study||1
22924|NCT02231918|56022|P1|NOT COMPLETED|Overall Study||0
22925|NCT02231918|56020|P3|COMPLETED|Overall Study||1
22926|NCT02231918|56021|P2|COMPLETED|Overall Study||14
22927|NCT02231918|56022|P1|COMPLETED|Overall Study||9
22928|NCT02231918|56020|P3|STARTED|Overall Study||2
22929|NCT02231918|56021|P2|STARTED|Overall Study||15
22930|NCT02231918|56022|P1|STARTED|Overall Study||9
22931|NCT02231580|56086|P2|NOT COMPLETED|Overall Study||0
22932|NCT02231580|56087|P1|NOT COMPLETED|Overall Study||5
22933|NCT02231580|56086|P2|COMPLETED|Overall Study||3
22934|NCT02231580|56087|P1|COMPLETED|Overall Study||9
22935|NCT02231580|56086|P2|Cohort 2|Overall Study||1
22936|NCT02231580|56087|P1|Cohort 2|Overall Study||6
22937|NCT02231580|56086|P2|Cohort 1|Overall Study||2
22938|NCT02231580|56087|P1|Cohort 1|Overall Study||8
22939|NCT02231580|56086|P2|STARTED|Overall Study||3
22940|NCT02231580|56087|P1|STARTED|Overall Study||14
22941|NCT02231177|56143|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
22942|NCT02231177|56144|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
22943|NCT02231177|56145|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
22944|NCT02231177|56146|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
22945|NCT02231177|56147|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
22946|NCT02231177|56148|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
22947|NCT02231177|56143|P6|COMPLETED|Treatment Period 3 (21 Days)||9
22948|NCT02231177|56144|P5|COMPLETED|Treatment Period 3 (21 Days)||8
22949|NCT02231177|56145|P4|COMPLETED|Treatment Period 3 (21 Days)||7
22950|NCT02231177|56146|P3|COMPLETED|Treatment Period 3 (21 Days)||8
22951|NCT02231177|56147|P2|COMPLETED|Treatment Period 3 (21 Days)||7
22952|NCT02231177|56148|P1|COMPLETED|Treatment Period 3 (21 Days)||8
22953|NCT02231177|56143|P6|STARTED|Treatment Period 3 (21 Days)||9
22954|NCT02231177|56144|P5|STARTED|Treatment Period 3 (21 Days)||8
22955|NCT02231177|56145|P4|STARTED|Treatment Period 3 (21 Days)||7
22956|NCT02231177|56146|P3|STARTED|Treatment Period 3 (21 Days)||8
22957|NCT02231177|56147|P2|STARTED|Treatment Period 3 (21 Days)||7
22958|NCT02231177|56148|P1|STARTED|Treatment Period 3 (21 Days)||8
22959|NCT02231177|56143|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
22960|NCT02231177|56144|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
22961|NCT02231177|56145|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
22962|NCT02231177|56146|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
22963|NCT02231177|56147|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
22964|NCT02231177|56148|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
22965|NCT02231177|56143|P6|COMPLETED|Treatment Period 2 (21 Days)||9
22966|NCT02231177|56144|P5|COMPLETED|Treatment Period 2 (21 Days)||8
22967|NCT02231177|56145|P4|COMPLETED|Treatment Period 2 (21 Days)||7
22968|NCT02231177|56146|P3|COMPLETED|Treatment Period 2 (21 Days)||8
22969|NCT02231177|56147|P2|COMPLETED|Treatment Period 2 (21 Days)||7
22970|NCT02231177|56148|P1|COMPLETED|Treatment Period 2 (21 Days)||8
22971|NCT02231177|56143|P6|STARTED|Treatment Period 2 (21 Days)||9
22972|NCT02231177|56144|P5|STARTED|Treatment Period 2 (21 Days)||8
22973|NCT02231177|56145|P4|STARTED|Treatment Period 2 (21 Days)||7
22974|NCT02231177|56146|P3|STARTED|Treatment Period 2 (21 Days)||8
22975|NCT02231177|56147|P2|STARTED|Treatment Period 2 (21 Days)||7
22976|NCT02231177|56148|P1|STARTED|Treatment Period 2 (21 Days)||8
22977|NCT02231177|56143|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
22978|NCT02231177|56144|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
22979|NCT02231177|56145|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
22980|NCT02231177|56146|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
22981|NCT02231177|56147|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
22982|NCT02231177|56148|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
22983|NCT02231177|56143|P6|COMPLETED|Treatment Period 1 (21 Days)||9
22984|NCT02231177|56144|P5|COMPLETED|Treatment Period 1 (21 Days)||8
22985|NCT02231177|56145|P4|COMPLETED|Treatment Period 1 (21 Days)||7
22986|NCT02231177|56146|P3|COMPLETED|Treatment Period 1 (21 Days)||8
22987|NCT02231177|56147|P2|COMPLETED|Treatment Period 1 (21 Days)||7
22988|NCT02231177|56148|P1|COMPLETED|Treatment Period 1 (21 Days)||8
22989|NCT02231177|56143|P6|STARTED|Treatment Period 1 (21 Days)||9
22990|NCT02231177|56144|P5|STARTED|Treatment Period 1 (21 Days)||8
22991|NCT02231177|56145|P4|STARTED|Treatment Period 1 (21 Days)||7
22992|NCT02231177|56146|P3|STARTED|Treatment Period 1 (21 Days)||8
22993|NCT02231177|56147|P2|STARTED|Treatment Period 1 (21 Days)||7
22994|NCT02231177|56148|P1|STARTED|Treatment Period 1 (21 Days)||8
22995|NCT02231164|56204|P2|NOT COMPLETED|Overall Study||6
22996|NCT02231164|56205|P1|NOT COMPLETED|Overall Study||6
22997|NCT02231164|56204|P2|COMPLETED|Overall Study||0
22998|NCT02231164|56205|P1|COMPLETED|Overall Study||0
22999|NCT02231164|56204|P2|STARTED|Overall Study||6
23000|NCT02231164|56205|P1|STARTED|Overall Study||6
23001|NCT02230995|56213|P2|NOT COMPLETED|Period 2 + Washout||0
23002|NCT02230995|56214|P1|NOT COMPLETED|Period 2 + Washout||0
23003|NCT02230995|56213|P2|COMPLETED|Period 2 + Washout||15
23004|NCT02230995|56214|P1|COMPLETED|Period 2 + Washout||15
23005|NCT02230995|56213|P2|STARTED|Period 2 + Washout||15
23006|NCT02230995|56214|P1|STARTED|Period 2 + Washout||15
23007|NCT02230995|56213|P2|NOT COMPLETED|Period 1 + Washout||0
23008|NCT02230995|56214|P1|NOT COMPLETED|Period 1 + Washout||0
23009|NCT02230995|56213|P2|COMPLETED|Period 1 + Washout||15
23010|NCT02230995|56214|P1|COMPLETED|Period 1 + Washout||15
23011|NCT02230995|56213|P2|STARTED|Period 1 + Washout||15
23012|NCT02230995|56214|P1|STARTED|Period 1 + Washout||15
23013|NCT02230956|56233|P3|NOT COMPLETED|Overall Study||7
23014|NCT02230956|56234|P2|NOT COMPLETED|Overall Study||6
23015|NCT02230956|56235|P1|NOT COMPLETED|Overall Study||5
23016|NCT02230956|56233|P3|COMPLETED|Overall Study||82
23017|NCT02230956|56234|P2|COMPLETED|Overall Study||37
23018|NCT02230956|56235|P1|COMPLETED|Overall Study||39
23019|NCT02230956|56233|P3|STARTED|Overall Study||89
23020|NCT02230956|56234|P2|STARTED|Overall Study||43
23021|NCT02230956|56235|P1|STARTED|Overall Study||44
23022|NCT02230904|56257|P2|NOT COMPLETED|Overall Study||1
23023|NCT02230904|56258|P1|NOT COMPLETED|Overall Study||0
23024|NCT02230904|56257|P2|COMPLETED|Overall Study||27
23025|NCT02230904|56258|P1|COMPLETED|Overall Study||29
23026|NCT02230904|56257|P2|STARTED|Overall Study||28
23027|NCT02230904|56258|P1|STARTED|Overall Study||29
23028|NCT02230761|56280|P2|NOT COMPLETED|Overall Study||1
23029|NCT02230761|56281|P1|NOT COMPLETED|Overall Study||0
23030|NCT02230761|56280|P2|COMPLETED|Overall Study||29
23031|NCT02230761|56281|P1|COMPLETED|Overall Study||60
23032|NCT02230761|56280|P2|STARTED|Overall Study||30
23033|NCT02230761|56281|P1|STARTED|Overall Study||60
23034|NCT02230683|56291|P1|NOT COMPLETED|Overall Study||1
23035|NCT02230683|56291|P1|COMPLETED|Overall Study||22
23036|NCT02230683|56291|P1|STARTED|Overall Study||23
23037|NCT02230670|56308|P2|NOT COMPLETED|Overall Study||8
23038|NCT02230670|56309|P1|NOT COMPLETED|Overall Study||4
23039|NCT02230670|56308|P2|COMPLETED|Overall Study||34
23040|NCT02230670|56309|P1|COMPLETED|Overall Study||40
23041|NCT02230670|56308|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
23042|NCT02230670|56309|P1|STARTED|Overall Study||44
23043|NCT02230566|56323|P4|NOT COMPLETED|Overall Study||0
23044|NCT02230566|56324|P3|NOT COMPLETED|Overall Study||0
23045|NCT02230566|56325|P2|NOT COMPLETED|Overall Study||0
23046|NCT02230566|56326|P1|NOT COMPLETED|Overall Study||0
23047|NCT02230566|56323|P4|COMPLETED|Overall Study||3
23048|NCT02230566|56324|P3|COMPLETED|Overall Study||3
23049|NCT02230566|56325|P2|COMPLETED|Overall Study||3
23050|NCT02230566|56326|P1|COMPLETED|Overall Study||3
23051|NCT02230566|56323|P4|STARTED|Overall Study||3
23052|NCT02230566|56324|P3|STARTED|Overall Study||3
23053|NCT02230566|56325|P2|STARTED|Overall Study||3
23054|NCT02230566|56326|P1|STARTED|Overall Study||3
23055|NCT02230540|56341|P2|NOT COMPLETED|Overall Study||0
23056|NCT02230540|56342|P1|NOT COMPLETED|Overall Study||0
23057|NCT02230540|56341|P2|COMPLETED|Overall Study||0
23058|NCT02230540|56342|P1|COMPLETED|Overall Study||8
23059|NCT02230540|56341|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
23060|NCT02230540|56342|P1|STARTED|Overall Study||8
23061|NCT02230384|56348|P2|NOT COMPLETED|Phase 2 Wash Out||0
23062|NCT02230384|56349|P1|NOT COMPLETED|Phase 2 Wash Out||0
23063|NCT02230384|56348|P2|COMPLETED|Phase 2 Wash Out||30
23064|NCT02230384|56349|P1|COMPLETED|Phase 2 Wash Out||26
23065|NCT02230384|56348|P2|STARTED|Phase 2 Wash Out||30
23066|NCT02230384|56349|P1|STARTED|Phase 2 Wash Out||26
23067|NCT02230384|56348|P2|NOT COMPLETED|Phase 2 - Switch||1
23068|NCT02230384|56349|P1|NOT COMPLETED|Phase 2 - Switch||3
23069|NCT02230384|56348|P2|COMPLETED|Phase 2 - Switch||30
23070|NCT02230384|56349|P1|COMPLETED|Phase 2 - Switch||26
23071|NCT02230384|56348|P2|STARTED|Phase 2 - Switch||31
23072|NCT02230384|56349|P1|STARTED|Phase 2 - Switch||29
23073|NCT02230384|56348|P2|NOT COMPLETED|Phase 1 Wash Out||0
23074|NCT02230384|56349|P1|NOT COMPLETED|Phase 1 Wash Out||0
23075|NCT02230384|56348|P2|COMPLETED|Phase 1 Wash Out||31
23076|NCT02230384|56349|P1|COMPLETED|Phase 1 Wash Out||29
23077|NCT02230384|56348|P2|STARTED|Phase 1 Wash Out|Cross over study|31
23078|NCT02230384|56349|P1|STARTED|Phase 1 Wash Out||29
23079|NCT02230384|56348|P2|NOT COMPLETED|Phase 1||1
23080|NCT02230384|56349|P1|NOT COMPLETED|Phase 1||1
23081|NCT02230384|56348|P2|COMPLETED|Phase 1||31
23082|NCT02230384|56349|P1|COMPLETED|Phase 1||29
23083|NCT02230384|56348|P2|STARTED|Phase 1||32
23084|NCT02230384|56349|P1|STARTED|Phase 1||30
23085|NCT02230332|56357|P2|NOT COMPLETED|Overall Study||1
23086|NCT02230332|56358|P1|NOT COMPLETED|Overall Study||4
23087|NCT02230332|56357|P2|COMPLETED|Overall Study||39
23088|NCT02230332|56358|P1|COMPLETED|Overall Study||34
23089|NCT02230332|56357|P2|STARTED|Overall Study||40
23090|NCT02230332|56358|P1|STARTED|Overall Study||38
23091|NCT02230306|56374|P1|NOT COMPLETED|Overall Study||1
23092|NCT02230306|56374|P1|COMPLETED|Overall Study||4
23093|NCT02230306|56374|P1|STARTED|Overall Study||5
23094|NCT02230085|56385|P1|NOT COMPLETED|Overall Study||4
23095|NCT02230085|56385|P1|COMPLETED|Overall Study||106
23096|NCT02230085|56385|P1|STARTED|Overall Study||110
23097|NCT02229864|56389|P1|NOT COMPLETED|3 - Year Visit||2
23098|NCT02229864|56389|P1|COMPLETED|3 - Year Visit||10
23099|NCT02229864|56389|P1|STARTED|3 - Year Visit|The missed visit participant in the 2nd year has joined the study for 3rd year follow-up.|12
23100|NCT02229864|56389|P1|NOT COMPLETED|2 - Year Visit||1
23101|NCT02229864|56389|P1|COMPLETED|2 - Year Visit||11
23102|NCT02229864|56389|P1|STARTED|2 - Year Visit||12
23103|NCT02229864|56389|P1|NOT COMPLETED|1 - Year Visit||0
23104|NCT02229864|56389|P1|COMPLETED|1 - Year Visit||12
23105|NCT02229864|56389|P1|STARTED|1 - Year Visit||12
23106|NCT02229864|56389|P1|NOT COMPLETED|6 - Month Visit||0
23107|NCT02229864|56389|P1|COMPLETED|6 - Month Visit||12
23108|NCT02229864|56389|P1|STARTED|6 - Month Visit||12
23109|NCT02229864|56389|P1|NOT COMPLETED|1 - Month Visit||0
23110|NCT02229864|56389|P1|COMPLETED|1 - Month Visit||12
23111|NCT02229864|56389|P1|STARTED|1 - Month Visit||12
23112|NCT02229539|56444|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
23113|NCT02229539|56445|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
23114|NCT02229539|56446|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
23115|NCT02229539|56444|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
23116|NCT02229539|56445|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
23117|NCT02229539|56446|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
23118|NCT02229539|56444|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
23119|NCT02229539|56445|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
23120|NCT02229539|56446|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
23121|NCT02229539|56444|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
23122|NCT02229539|56445|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
23123|NCT02229539|56446|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
23124|NCT02229539|56444|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
23125|NCT02229539|56445|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
23126|NCT02229539|56446|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
23127|NCT02229539|56444|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
23128|NCT02229539|56445|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
23129|NCT02229539|56446|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
23130|NCT02229513|56456|P2|NOT COMPLETED|Overall Study||0
23131|NCT02229513|56457|P1|NOT COMPLETED|Overall Study||0
23132|NCT02229513|56456|P2|COMPLETED|Overall Study||100
23133|NCT02229513|56457|P1|COMPLETED|Overall Study||100
23134|NCT02229513|56456|P2|STARTED|Overall Study||100
23135|NCT02229513|56457|P1|STARTED|Overall Study||100
23136|NCT02229487|56493|P2|NOT COMPLETED|Overall Study||0
23137|NCT02229487|56494|P1|NOT COMPLETED|Overall Study||0
23138|NCT02229487|56493|P2|COMPLETED|Overall Study||27
23139|NCT02229487|56494|P1|COMPLETED|Overall Study||24
23140|NCT02229487|56493|P2|STARTED|Overall Study||27
23141|NCT02229487|56494|P1|STARTED|Overall Study||24
23142|NCT02229474|56502|P2|NOT COMPLETED|Overall Study||3
23143|NCT02229474|56503|P1|NOT COMPLETED|Overall Study||0
23144|NCT02229474|56502|P2|COMPLETED|Overall Study||15
23145|NCT02229474|56503|P1|COMPLETED|Overall Study||16
23146|NCT02229474|56502|P2|STARTED|Overall Study||18
23147|NCT02229474|56503|P1|STARTED|Overall Study||16
23148|NCT02229461|56536|P6|NOT COMPLETED|Overall Study||0
23149|NCT02229461|56537|P5|NOT COMPLETED|Overall Study||0
23150|NCT02229461|56538|P4|NOT COMPLETED|Overall Study||0
23151|NCT02229461|56539|P3|NOT COMPLETED|Overall Study||0
23152|NCT02229461|56540|P2|NOT COMPLETED|Overall Study||0
23153|NCT02229461|56541|P1|NOT COMPLETED|Overall Study||0
23154|NCT02229461|56536|P6|COMPLETED|Overall Study||17
23155|NCT02229461|56537|P5|COMPLETED|Overall Study||17
23156|NCT02229461|56538|P4|COMPLETED|Overall Study||17
23157|NCT02229461|56539|P3|COMPLETED|Overall Study||17
23158|NCT02229461|56540|P2|COMPLETED|Overall Study||17
23159|NCT02229461|56541|P1|COMPLETED|Overall Study||17
23160|NCT02229461|56536|P6|STARTED|Overall Study|Randomized and received treatment|17
23161|NCT02229461|56537|P5|STARTED|Overall Study|Randomized and received treatment|17
23162|NCT02229461|56538|P4|STARTED|Overall Study|Randomized and received treatment|17
23163|NCT02229461|56539|P3|STARTED|Overall Study|Randomized and received treatment|17
23164|NCT02229461|56540|P2|STARTED|Overall Study|Randomized and received treatment|17
23165|NCT02229461|56541|P1|STARTED|Overall Study|Randomized and received treatment|17
23166|NCT02229396|56577|P3|NOT COMPLETED|Overall Study||38
23167|NCT02229396|56578|P2|NOT COMPLETED|Overall Study||29
23168|NCT02229396|56579|P1|NOT COMPLETED|Overall Study||25
23169|NCT02229396|56577|P3|COMPLETED|Overall Study||193
23170|NCT02229396|56578|P2|COMPLETED|Overall Study||202
23171|NCT02229396|56579|P1|COMPLETED|Overall Study||208
23172|NCT02229396|56577|P3|ITT Analysis Set|Overall Study||227
23173|NCT02229396|56578|P2|ITT Analysis Set|Overall Study||228
23174|NCT02229396|56579|P1|ITT Analysis Set|Overall Study||230
23175|NCT02229396|56577|P3|Safety Analysis Set|Overall Study||230
23176|NCT02229396|56578|P2|Safety Analysis Set|Overall Study||231
23177|NCT02229396|56579|P1|Safety Analysis Set|Overall Study||233
23178|NCT02229396|56577|P3|RANDOMIZATION CODE ALLOCATED|Overall Study||231
23179|NCT02229396|56578|P2|RANDOMIZATION CODE ALLOCATED|Overall Study||231
23180|NCT02229396|56579|P1|RANDOMIZATION CODE ALLOCATED|Overall Study||233
23181|NCT02229396|56577|P3|STARTED|Overall Study||231
23182|NCT02229396|56578|P2|STARTED|Overall Study||231
23183|NCT02229396|56579|P1|STARTED|Overall Study||233
23184|NCT02229383|56610|P2|NOT COMPLETED|Overall Study||24
23185|NCT02229383|56611|P1|NOT COMPLETED|Overall Study||22
23186|NCT02229383|56610|P2|COMPLETED|Overall Study||207
23187|NCT02229383|56611|P1|COMPLETED|Overall Study||211
23188|NCT02229383|56610|P2|ITT Analysis Set|Overall Study||230
23189|NCT02229383|56611|P1|ITT Analysis Set|Overall Study||231
23190|NCT02229383|56610|P2|Safety Analysis Set|Overall Study||231
23191|NCT02229383|56611|P1|Safety Analysis Set|Overall Study||232
23192|NCT02229383|56610|P2|Received Treatment|Overall Study||231
23193|NCT02229383|56611|P1|Received Treatment|Overall Study||232
23194|NCT02229383|56610|P2|STARTED|Overall Study||231
23195|NCT02229383|56611|P1|STARTED|Overall Study||233
23196|NCT02229318|56629|P1|NOT COMPLETED|Overall Study||0
23197|NCT02229318|56629|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
23198|NCT02229318|56629|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
23199|NCT02229214|56636|P2|NOT COMPLETED|Overall Study||0
23200|NCT02229214|56637|P1|NOT COMPLETED|Overall Study||6
23201|NCT02229214|56636|P2|COMPLETED|Overall Study||10
23202|NCT02229214|56637|P1|COMPLETED|Overall Study||35
23203|NCT02229214|56636|P2|STARTED|Overall Study||10
23204|NCT02229214|56637|P1|STARTED|Overall Study||41
23205|NCT02228980|56661|P4|NOT COMPLETED|Overall Study||3
23206|NCT02228980|56662|P3|NOT COMPLETED|Overall Study||2
23207|NCT02228980|56663|P2|NOT COMPLETED|Overall Study||3
23208|NCT02228980|56664|P1|NOT COMPLETED|Overall Study||24
23209|NCT02228980|56661|P4|COMPLETED|Overall Study||148
23210|NCT02228980|56662|P3|COMPLETED|Overall Study||149
23211|NCT02228980|56663|P2|COMPLETED|Overall Study||147
23212|NCT02228980|56664|P1|COMPLETED|Overall Study||126
23213|NCT02228980|56661|P4|STARTED|Overall Study||151
23214|NCT02228980|56662|P3|STARTED|Overall Study||151
23215|NCT02228980|56663|P2|STARTED|Overall Study||150
23216|NCT02228980|56664|P1|STARTED|Overall Study||150
23217|NCT02228720|56686|P1|NOT COMPLETED|Open Label - Day 90||0
23218|NCT02228720|56686|P1|COMPLETED|Open Label - Day 90||14
23219|NCT02228720|56686|P1|STARTED|Open Label - Day 90||14
23220|NCT02228720|56686|P1|NOT COMPLETED|Open Label - Day 30||1
23221|NCT02228720|56686|P1|COMPLETED|Open Label - Day 30||14
23222|NCT02228720|56686|P1|STARTED|Open Label - Day 30||15
23223|NCT02228720|56686|P1|NOT COMPLETED|Open Label - Baseline||0
23224|NCT02228720|56686|P1|COMPLETED|Open Label - Baseline||15
23225|NCT02228720|56686|P1|STARTED|Open Label - Baseline||15
23226|NCT02228395|56694|P3|NOT COMPLETED|Third Intervention Period||0
23227|NCT02228395|56695|P2|NOT COMPLETED|Third Intervention Period||0
23228|NCT02228395|56696|P1|NOT COMPLETED|Third Intervention Period||0
23229|NCT02228395|56694|P3|COMPLETED|Third Intervention Period||3
23230|NCT02228395|56695|P2|COMPLETED|Third Intervention Period||3
23231|NCT02228395|56696|P1|COMPLETED|Third Intervention Period||3
23232|NCT02228395|56694|P3|STARTED|Third Intervention Period||3
23233|NCT02228395|56695|P2|STARTED|Third Intervention Period||3
23234|NCT02228395|56696|P1|STARTED|Third Intervention Period||3
23235|NCT02228395|56694|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
23236|NCT02228395|56695|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
23237|NCT02228395|56696|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
23238|NCT02228395|56694|P3|COMPLETED|Washout Period (at Least 10 Days)||3
23239|NCT02228395|56695|P2|COMPLETED|Washout Period (at Least 10 Days)||3
23240|NCT02228395|56696|P1|COMPLETED|Washout Period (at Least 10 Days)||3
23241|NCT02228395|56694|P3|STARTED|Washout Period (at Least 10 Days)||3
23242|NCT02228395|56695|P2|STARTED|Washout Period (at Least 10 Days)||3
23243|NCT02228395|56696|P1|STARTED|Washout Period (at Least 10 Days)||3
23244|NCT02228395|56694|P3|NOT COMPLETED|Second Intervention Period||0
23245|NCT02228395|56695|P2|NOT COMPLETED|Second Intervention Period||0
23246|NCT02228395|56696|P1|NOT COMPLETED|Second Intervention Period||0
23247|NCT02228395|56694|P3|COMPLETED|Second Intervention Period||3
23248|NCT02228395|56695|P2|COMPLETED|Second Intervention Period||3
23249|NCT02228395|56696|P1|COMPLETED|Second Intervention Period||3
23250|NCT02228395|56694|P3|STARTED|Second Intervention Period||3
23251|NCT02228395|56695|P2|STARTED|Second Intervention Period||3
23252|NCT02228395|56696|P1|STARTED|Second Intervention Period||3
23253|NCT02228395|56694|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
23254|NCT02228395|56695|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
23255|NCT02228395|56696|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
23256|NCT02228395|56694|P3|COMPLETED|Washout Period (at Least 10 Days)||3
23257|NCT02228395|56695|P2|COMPLETED|Washout Period (at Least 10 Days)||3
23258|NCT02228395|56696|P1|COMPLETED|Washout Period (at Least 10 Days)||3
23259|NCT02228395|56694|P3|STARTED|Washout Period (at Least 10 Days)||3
23260|NCT02228395|56695|P2|STARTED|Washout Period (at Least 10 Days)||3
23261|NCT02228395|56696|P1|STARTED|Washout Period (at Least 10 Days)||3
23262|NCT02228395|56694|P3|NOT COMPLETED|First Intervention Period||1
23263|NCT02228395|56695|P2|NOT COMPLETED|First Intervention Period||1
23264|NCT02228395|56696|P1|NOT COMPLETED|First Intervention Period||1
23265|NCT02228395|56694|P3|COMPLETED|First Intervention Period||2
23266|NCT02228395|56695|P2|COMPLETED|First Intervention Period||2
23267|NCT02228395|56696|P1|COMPLETED|First Intervention Period||2
23268|NCT02228395|56694|P3|STARTED|First Intervention Period||3
23269|NCT02228395|56695|P2|STARTED|First Intervention Period||3
23270|NCT02228395|56696|P1|STARTED|First Intervention Period||3
23271|NCT02227810|56762|P2|NOT COMPLETED|Overall Study||5
23272|NCT02227810|56763|P1|NOT COMPLETED|Overall Study||2
23273|NCT02227810|56762|P2|COMPLETED|Overall Study||29
23274|NCT02227810|56763|P1|COMPLETED|Overall Study||17
23275|NCT02227810|56762|P2|STARTED|Overall Study||34
23276|NCT02227810|56763|P1|STARTED|Overall Study||19
23277|NCT02227784|56779|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
23278|NCT02227784|56780|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
23279|NCT02227784|56781|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
23280|NCT02227784|56782|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
23281|NCT02227784|56783|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
23282|NCT02227784|56779|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
23283|NCT02227784|56780|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
23284|NCT02227784|56781|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
23285|NCT02227784|56782|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
23286|NCT02227784|56783|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
23287|NCT02227784|56779|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
23288|NCT02227784|56780|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
23289|NCT02227784|56781|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
23290|NCT02227784|56782|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
23291|NCT02227784|56783|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
23292|NCT02227784|56779|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
23293|NCT02227784|56780|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
23294|NCT02227784|56781|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
23295|NCT02227784|56782|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
23296|NCT02227784|56783|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
23297|NCT02227784|56779|P5|NOT COMPLETED|Double-Blind Phase||0
23298|NCT02227784|56780|P4|NOT COMPLETED|Double-Blind Phase||39
23299|NCT02227784|56781|P3|NOT COMPLETED|Double-Blind Phase||21
23300|NCT02227784|56782|P2|NOT COMPLETED|Double-Blind Phase||18
23301|NCT02227784|56783|P1|NOT COMPLETED|Double-Blind Phase||40
23302|NCT02227784|56779|P5|COMPLETED|Double-Blind Phase||0
23303|NCT02227784|56780|P4|COMPLETED|Double-Blind Phase||88
23304|NCT02227784|56781|P3|COMPLETED|Double-Blind Phase||41
23305|NCT02227784|56782|P2|COMPLETED|Double-Blind Phase||36
23306|NCT02227784|56783|P1|COMPLETED|Double-Blind Phase||83
23307|NCT02227784|56779|P5|STARTED|Double-Blind Phase||0
23308|NCT02227784|56780|P4|STARTED|Double-Blind Phase||127
23309|NCT02227784|56781|P3|STARTED|Double-Blind Phase||62
23310|NCT02227784|56782|P2|STARTED|Double-Blind Phase||54
23311|NCT02227784|56783|P1|STARTED|Double-Blind Phase||123
23312|NCT02227485|56820|P2|NOT COMPLETED|Second Follow-up||2
23313|NCT02227485|56821|P1|NOT COMPLETED|Second Follow-up||2
23314|NCT02227485|56820|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
23315|NCT02227485|56821|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
23316|NCT02227485|56820|P2|STARTED|Second Follow-up||38
23317|NCT02227485|56821|P1|STARTED|Second Follow-up||36
23318|NCT02227485|56820|P2|NOT COMPLETED|First Follow-up||2
23319|NCT02227485|56821|P1|NOT COMPLETED|First Follow-up||4
23320|NCT02227485|56820|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
23321|NCT02227485|56821|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
23322|NCT02227485|56820|P2|STARTED|First Follow-up||40
23323|NCT02227485|56821|P1|STARTED|First Follow-up||40
23324|NCT02227368|56839|P2|NOT COMPLETED|Overall Study||4
23325|NCT02227368|56840|P1|NOT COMPLETED|Overall Study||2
23326|NCT02227368|56839|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
23327|NCT02227368|56840|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
23328|NCT02227368|56839|P2|Sujects Who Completed Treatment|Overall Study||17
23329|NCT02227368|56840|P1|Sujects Who Completed Treatment|Overall Study||10
23330|NCT02227368|56839|P2|Sujects Who Received Treatment|Overall Study||24
23331|NCT02227368|56840|P1|Sujects Who Received Treatment|Overall Study||16
23332|NCT02227368|56839|P2|STARTED|Overall Study||24
23333|NCT02227368|56840|P1|STARTED|Overall Study||16
23334|NCT02227329|56850|P2|NOT COMPLETED|Overall Study||0
23335|NCT02227329|56851|P1|NOT COMPLETED|Overall Study||0
23336|NCT02227329|56850|P2|COMPLETED|Overall Study||20
23337|NCT02227329|56851|P1|COMPLETED|Overall Study||18
23338|NCT02227329|56850|P2|STARTED|Overall Study||20
23339|NCT02227329|56851|P1|STARTED|Overall Study||18
23340|NCT02227121|56857|P1|NOT COMPLETED|Overall Study||0
23341|NCT02227121|56857|P1|COMPLETED|Overall Study||16
23342|NCT02227121|56857|P1|STARTED|Overall Study||16
23343|NCT02227108|56861|P1|NOT COMPLETED|Overall Study||31
23344|NCT02227108|56861|P1|COMPLETED|Overall Study||1
23345|NCT02227108|56861|P1|Treated|Overall Study||30
23346|NCT02227108|56861|P1|STARTED|Overall Study||32
23347|NCT02226562|56890|P2|NOT COMPLETED|Overall Study||1
23348|NCT02226562|56891|P1|NOT COMPLETED|Overall Study||0
23349|NCT02226562|56890|P2|COMPLETED|Overall Study|Lost to follow up|95
23350|NCT02226562|56891|P1|COMPLETED|Overall Study||95
23351|NCT02226562|56890|P2|STARTED|Overall Study||96
23352|NCT02226562|56891|P1|STARTED|Overall Study||95
23353|NCT02226549|56909|P2|NOT COMPLETED|Overall Study||1
23354|NCT02226549|56910|P1|NOT COMPLETED|Overall Study||1
23355|NCT02226549|56909|P2|COMPLETED|Overall Study||23
23356|NCT02226549|56910|P1|COMPLETED|Overall Study||22
23357|NCT02226549|56909|P2|STARTED|Overall Study||24
23358|NCT02226549|56910|P1|STARTED|Overall Study||23
23359|NCT02226198|56920|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
23360|NCT02226198|56921|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
23361|NCT02226198|56922|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
23362|NCT02226198|56920|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
23363|NCT02226198|56921|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
23364|NCT02226198|56922|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
23365|NCT02226198|56920|P3|STARTED|Maintenance Phase (12 Weeks)||0
23366|NCT02226198|56921|P2|STARTED|Maintenance Phase (12 Weeks)||0
23367|NCT02226198|56922|P1|STARTED|Maintenance Phase (12 Weeks)||13
23368|NCT02226198|56920|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
23369|NCT02226198|56921|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
23370|NCT02226198|56922|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
23371|NCT02226198|56920|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
23372|NCT02226198|56921|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
23373|NCT02226198|56922|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
23374|NCT02226198|56920|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
23375|NCT02226198|56921|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
23376|NCT02226198|56922|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
23377|NCT02226198|56920|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
23378|NCT02226198|56921|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
23379|NCT02226198|56922|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
23380|NCT02226198|56920|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
23381|NCT02226198|56921|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
23382|NCT02226198|56922|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
23383|NCT02226198|56920|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
23384|NCT02226198|56921|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
23385|NCT02226198|56922|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
23386|NCT02226198|56920|P3|NOT COMPLETED|Lead-in Phase||0
23387|NCT02226198|56921|P2|NOT COMPLETED|Lead-in Phase||0
23388|NCT02226198|56922|P1|NOT COMPLETED|Lead-in Phase||1
23389|NCT02226198|56920|P3|COMPLETED|Lead-in Phase||0
23390|NCT02226198|56921|P2|COMPLETED|Lead-in Phase||0
23391|NCT02226198|56922|P1|COMPLETED|Lead-in Phase||10
23392|NCT02226198|56920|P3|STARTED|Lead-in Phase||0
23393|NCT02226198|56921|P2|STARTED|Lead-in Phase||0
23394|NCT02226198|56922|P1|STARTED|Lead-in Phase||11
23395|NCT02226172|56995|P1|NOT COMPLETED|Overall Study||13
23396|NCT02226172|56995|P1|COMPLETED|Overall Study||8
23397|NCT02226172|56995|P1|STARTED|Overall Study||21
23398|NCT02226003|57017|P3|NOT COMPLETED|Overall Study||6
23399|NCT02226003|57018|P2|NOT COMPLETED|Overall Study||1
23400|NCT02226003|57019|P1|NOT COMPLETED|Overall Study||2
23401|NCT02226003|57017|P3|COMPLETED|Overall Study||91
23402|NCT02226003|57018|P2|COMPLETED|Overall Study||95
23403|NCT02226003|57019|P1|COMPLETED|Overall Study||96
23404|NCT02226003|57017|P3|STARTED|Overall Study||97
23405|NCT02226003|57018|P2|STARTED|Overall Study||96
23406|NCT02226003|57019|P1|STARTED|Overall Study||98
23407|NCT02225860|57053|P2|NOT COMPLETED|Overall Study||0
23408|NCT02225860|57054|P1|NOT COMPLETED|Overall Study||1
23409|NCT02225860|57053|P2|COMPLETED|Overall Study||17
23410|NCT02225860|57054|P1|COMPLETED|Overall Study||16
23411|NCT02225860|57053|P2|STARTED|Overall Study||17
23412|NCT02225860|57054|P1|STARTED|Overall Study||17
23413|NCT02224846|57066|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||357
23414|NCT02224846|57067|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||173
23415|NCT02224846|57066|P2|COMPLETED|Period 2 (Month 12 to Month 24)||0
23416|NCT02224846|57067|P1|COMPLETED|Period 2 (Month 12 to Month 24)||0
23417|NCT02224846|57066|P2|STARTED|Period 2 (Month 12 to Month 24)||357
23418|NCT02224846|57067|P1|STARTED|Period 2 (Month 12 to Month 24)||173
23419|NCT02224846|57066|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
23420|NCT02224846|57067|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
23421|NCT02224846|57066|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
23422|NCT02224846|57067|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
23423|NCT02224846|57066|P2|STARTED|Period 2 (Month 3 to Month 12)||388
23424|NCT02224846|57067|P1|STARTED|Period 2 (Month 3 to Month 12)||192
23425|NCT02224846|57066|P2|NOT COMPLETED|Period 1 (Month 3)||36
23426|NCT02224846|57067|P1|NOT COMPLETED|Period 1 (Month 3)||19
23427|NCT02224846|57066|P2|COMPLETED|Period 1 (Month 3)||388
23428|NCT02224846|57067|P1|COMPLETED|Period 1 (Month 3)||192
23429|NCT02224846|57066|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
23430|NCT02224846|57067|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
23431|NCT02224846|57066|P2|STARTED|Period 1 (Month 3)||424
23432|NCT02224846|57067|P1|STARTED|Period 1 (Month 3)||211
23433|NCT02224820|57084|P1|NOT COMPLETED|Overall Study||0
23434|NCT02224820|57084|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
23435|NCT02224820|57084|P1|STARTED|Overall Study||8
23436|NCT02224664|57092|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
23437|NCT02224664|57093|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
23438|NCT02224664|57094|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
23439|NCT02224664|57095|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
23440|NCT02224664|57096|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
23441|NCT02224664|57092|P5|COMPLETED|Dose Escalation Period (21 Days)||8
23442|NCT02224664|57093|P4|COMPLETED|Dose Escalation Period (21 Days)||3
23443|NCT02224664|57094|P3|COMPLETED|Dose Escalation Period (21 Days)||9
23444|NCT02224664|57095|P2|COMPLETED|Dose Escalation Period (21 Days)||9
23445|NCT02224664|57096|P1|COMPLETED|Dose Escalation Period (21 Days)||0
23446|NCT02224664|57092|P5|STARTED|Dose Escalation Period (21 Days)||19
23447|NCT02224664|57093|P4|STARTED|Dose Escalation Period (21 Days)||6
23448|NCT02224664|57094|P3|STARTED|Dose Escalation Period (21 Days)||11
23449|NCT02224664|57095|P2|STARTED|Dose Escalation Period (21 Days)||9
23450|NCT02224664|57096|P1|STARTED|Dose Escalation Period (21 Days)||0
23451|NCT02224664|57092|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
23452|NCT02224664|57093|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
23453|NCT02224664|57094|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
23454|NCT02224664|57095|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
23455|NCT02224664|57096|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
23456|NCT02224664|57092|P5|COMPLETED|Lead-in Period (3 Days)||0
23457|NCT02224664|57093|P4|COMPLETED|Lead-in Period (3 Days)||0
23458|NCT02224664|57094|P3|COMPLETED|Lead-in Period (3 Days)||0
23459|NCT02224664|57095|P2|COMPLETED|Lead-in Period (3 Days)||0
23460|NCT02224664|57096|P1|COMPLETED|Lead-in Period (3 Days)||45
23461|NCT02224664|57092|P5|STARTED|Lead-in Period (3 Days)||0
23462|NCT02224664|57093|P4|STARTED|Lead-in Period (3 Days)||0
23463|NCT02224664|57094|P3|STARTED|Lead-in Period (3 Days)||0
23464|NCT02224664|57095|P2|STARTED|Lead-in Period (3 Days)||0
23465|NCT02224664|57096|P1|STARTED|Lead-in Period (3 Days)||50
23466|NCT02224625|57176|P1|NOT COMPLETED|Sensitization||55
23467|NCT02224625|57176|P1|COMPLETED|Sensitization||194
23468|NCT02224625|57176|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
23469|NCT02224625|57176|P1|NOT COMPLETED|Irritation||6
23470|NCT02224625|57176|P1|COMPLETED|Irritation||33
23471|NCT02224625|57176|P1|STARTED|Irritation||39
23472|NCT02224508|57190|P2|NOT COMPLETED|Overall Study||0
23473|NCT02224508|57191|P1|NOT COMPLETED|Overall Study||0
23474|NCT02224508|57190|P2|COMPLETED|Overall Study||653
23475|NCT02224508|57191|P1|COMPLETED|Overall Study||935
23476|NCT02224508|57190|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
23477|NCT02224508|57191|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
23478|NCT02224404|57201|P1|NOT COMPLETED|Overall Study||0
23479|NCT02224404|57201|P1|COMPLETED|Overall Study||21
23480|NCT02224404|57201|P1|STARTED|Overall Study||21
23481|NCT02224053|57206|P1|NOT COMPLETED|AZD9291 Alone||0
23482|NCT02224053|57206|P1|COMPLETED|AZD9291 Alone||47
23483|NCT02224053|57206|P1|STARTED|AZD9291 Alone||47
23484|NCT02224053|57206|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
23485|NCT02224053|57206|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
23486|NCT02224053|57206|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
23487|NCT02223871|57238|P1|NOT COMPLETED|Overall Study||0
23488|NCT02223871|57238|P1|COMPLETED|Overall Study||8
23489|NCT02223871|57238|P1|STARTED|Overall Study||8
23490|NCT02223754|57252|P2|NOT COMPLETED|Period 2||3
23491|NCT02223754|57253|P1|NOT COMPLETED|Period 2||3
23492|NCT02223754|57252|P2|COMPLETED|Period 2||141
23493|NCT02223754|57253|P1|COMPLETED|Period 2||156
23494|NCT02223754|57252|P2|STARTED|Period 2||144
23495|NCT02223754|57253|P1|STARTED|Period 2||159
23496|NCT02223754|57252|P2|NOT COMPLETED|Period 1||15
23497|NCT02223754|57253|P1|NOT COMPLETED|Period 1||4
23498|NCT02223754|57252|P2|COMPLETED|Period 1||144
23499|NCT02223754|57253|P1|COMPLETED|Period 1||159
23500|NCT02223754|57252|P2|STARTED|Period 1||159
23501|NCT02223754|57253|P1|STARTED|Period 1||163
23502|NCT02223715|57273|P1|NOT COMPLETED|Overall Study||104
23503|NCT02223715|57273|P1|COMPLETED|Overall Study||496
23504|NCT02223715|57273|P1|STARTED|Overall Study||600
23505|NCT02223650|57282|P2|NOT COMPLETED|Overall Study||0
23506|NCT02223650|57283|P1|NOT COMPLETED|Overall Study||0
23507|NCT02223650|57282|P2|COMPLETED|Overall Study||31
23508|NCT02223650|57283|P1|COMPLETED|Overall Study||27
23509|NCT02223650|57282|P2|STARTED|Overall Study||31
23510|NCT02223650|57283|P1|STARTED|Overall Study||27
23511|NCT02223429|57317|P4|NOT COMPLETED|Overall Study||0
23512|NCT02223429|57318|P3|NOT COMPLETED|Overall Study||0
23513|NCT02223429|57319|P2|NOT COMPLETED|Overall Study||0
23514|NCT02223429|57320|P1|NOT COMPLETED|Overall Study||1
23515|NCT02223429|57317|P4|COMPLETED|Overall Study||8
23516|NCT02223429|57318|P3|COMPLETED|Overall Study||8
23517|NCT02223429|57319|P2|COMPLETED|Overall Study||8
23518|NCT02223429|57320|P1|COMPLETED|Overall Study||7
23519|NCT02223429|57317|P4|STARTED|Overall Study||8
23520|NCT02223429|57318|P3|STARTED|Overall Study||8
23521|NCT02223429|57319|P2|STARTED|Overall Study||8
23522|NCT02223429|57320|P1|STARTED|Overall Study||8
23523|NCT02223364|57351|P3|NOT COMPLETED|Overall Study||3
23524|NCT02223364|57352|P2|NOT COMPLETED|Overall Study||0
23525|NCT02223364|57353|P1|NOT COMPLETED|Overall Study||5
23526|NCT02223364|57351|P3|COMPLETED|Overall Study||52
23527|NCT02223364|57352|P2|COMPLETED|Overall Study||55
23528|NCT02223364|57353|P1|COMPLETED|Overall Study||50
23529|NCT02223364|57351|P3|STARTED|Overall Study||55
23530|NCT02223364|57352|P2|STARTED|Overall Study||55
23531|NCT02223364|57353|P1|STARTED|Overall Study||55
23532|NCT02223338|57405|P2|NOT COMPLETED|Overall Study||0
23533|NCT02223338|57406|P1|NOT COMPLETED|Overall Study||0
23534|NCT02223338|57405|P2|COMPLETED|Overall Study||60
23535|NCT02223338|57406|P1|COMPLETED|Overall Study||60
23536|NCT02223338|57405|P2|STARTED|Overall Study||60
23537|NCT02223338|57406|P1|STARTED|Overall Study||60
23538|NCT02223260|57414|P1|NOT COMPLETED|Overall Study||0
23539|NCT02223260|57414|P1|COMPLETED|Overall Study||8
23540|NCT02223260|57414|P1|STARTED|Overall Study||8
23541|NCT02223065|57432|P2|NOT COMPLETED|Overall Study||0
23542|NCT02223065|57433|P1|NOT COMPLETED|Overall Study||0
23543|NCT02223065|57432|P2|COMPLETED|Overall Study||18
23544|NCT02223065|57433|P1|COMPLETED|Overall Study||18
23545|NCT02223065|57432|P2|STARTED|Overall Study||18
23546|NCT02223065|57433|P1|STARTED|Overall Study||18
23547|NCT02222870|57451|P2|NOT COMPLETED|Overall Study||0
23548|NCT02222870|57452|P1|NOT COMPLETED|Overall Study||0
23549|NCT02222870|57451|P2|COMPLETED|Overall Study||30
23550|NCT02222870|57452|P1|COMPLETED|Overall Study||30
23551|NCT02222870|57451|P2|STARTED|Overall Study||30
23552|NCT02222870|57452|P1|STARTED|Overall Study||30
23553|NCT02222818|57468|P2|NOT COMPLETED|Period 2||0
23554|NCT02222818|57469|P1|NOT COMPLETED|Period 2||0
23555|NCT02222818|57468|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
23556|NCT02222818|57469|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
23557|NCT02222818|57468|P2|STARTED|Period 2|Start of CAFR evaluation period|30
23558|NCT02222818|57469|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
23559|NCT02222818|57468|P2|NOT COMPLETED|Period 1||3
23560|NCT02222818|57469|P1|NOT COMPLETED|Period 1||0
23561|NCT02222818|57468|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
23562|NCT02222818|57469|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
23563|NCT02222818|57468|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
23564|NCT02222818|57469|P1|STARTED|Period 1|Start of CAFR evaluation period|33
23565|NCT02222558|57476|P6|NOT COMPLETED|Period 3||1
23566|NCT02222558|57477|P5|NOT COMPLETED|Period 3||0
23567|NCT02222558|57478|P4|NOT COMPLETED|Period 3||0
23568|NCT02222558|57479|P3|NOT COMPLETED|Period 3||0
23569|NCT02222558|57480|P2|NOT COMPLETED|Period 3||0
23570|NCT02222558|57481|P1|NOT COMPLETED|Period 3||0
23571|NCT02222558|57476|P6|COMPLETED|Period 3||7
23572|NCT02222558|57477|P5|COMPLETED|Period 3||8
23573|NCT02222558|57478|P4|COMPLETED|Period 3||1
23574|NCT02222558|57479|P3|COMPLETED|Period 3||4
23575|NCT02222558|57480|P2|COMPLETED|Period 3||0
23576|NCT02222558|57481|P1|COMPLETED|Period 3||0
23577|NCT02222558|57476|P6|STARTED|Period 3||8
23578|NCT02222558|57477|P5|STARTED|Period 3||8
23579|NCT02222558|57478|P4|STARTED|Period 3||1
23580|NCT02222558|57479|P3|STARTED|Period 3||4
23581|NCT02222558|57480|P2|STARTED|Period 3||0
23582|NCT02222558|57481|P1|STARTED|Period 3||0
23583|NCT02222558|57476|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23584|NCT02222558|57477|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23585|NCT02222558|57478|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23586|NCT02222558|57479|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23587|NCT02222558|57480|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23588|NCT02222558|57481|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23589|NCT02222558|57476|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23590|NCT02222558|57477|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23591|NCT02222558|57478|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23592|NCT02222558|57479|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23593|NCT02222558|57480|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
23594|NCT02222558|57481|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
23595|NCT02222558|57476|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
23596|NCT02222558|57477|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
23597|NCT02222558|57478|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
23598|NCT02222558|57479|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
23599|NCT02222558|57480|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
23600|NCT02222558|57481|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
23601|NCT02222558|57476|P6|NOT COMPLETED|Period 1: Single Dose||0
23602|NCT02222558|57477|P5|NOT COMPLETED|Period 1: Single Dose||0
23603|NCT02222558|57478|P4|NOT COMPLETED|Period 1: Single Dose||0
23604|NCT02222558|57479|P3|NOT COMPLETED|Period 1: Single Dose||0
23605|NCT02222558|57480|P2|NOT COMPLETED|Period 1: Single Dose||0
23606|NCT02222558|57481|P1|NOT COMPLETED|Period 1: Single Dose||4
23607|NCT02222558|57476|P6|COMPLETED|Period 1: Single Dose||0
23608|NCT02222558|57477|P5|COMPLETED|Period 1: Single Dose||0
23609|NCT02222558|57478|P4|COMPLETED|Period 1: Single Dose||0
23610|NCT02222558|57479|P3|COMPLETED|Period 1: Single Dose||0
23611|NCT02222558|57480|P2|COMPLETED|Period 1: Single Dose||0
23612|NCT02222558|57481|P1|COMPLETED|Period 1: Single Dose||21
23613|NCT02222558|57476|P6|STARTED|Period 1: Single Dose||0
23614|NCT02222558|57477|P5|STARTED|Period 1: Single Dose||0
23615|NCT02222558|57478|P4|STARTED|Period 1: Single Dose||0
23616|NCT02222558|57479|P3|STARTED|Period 1: Single Dose||0
23617|NCT02222558|57480|P2|STARTED|Period 1: Single Dose||0
23618|NCT02222558|57481|P1|STARTED|Period 1: Single Dose||25
23619|NCT02222493|57497|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
23620|NCT02222493|57498|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
23621|NCT02222493|57497|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
23622|NCT02222493|57498|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
23623|NCT02222493|57497|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
23624|NCT02222493|57498|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
23625|NCT02222493|57497|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
23626|NCT02222493|57498|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
23627|NCT02222493|57497|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
23628|NCT02222493|57498|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
23629|NCT02222493|57497|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
23630|NCT02222493|57498|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
23631|NCT02222493|57497|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
23632|NCT02222493|57498|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
23633|NCT02222493|57497|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
23634|NCT02222493|57498|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
23635|NCT02222493|57497|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
23636|NCT02222493|57498|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
23637|NCT02222493|57497|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
23638|NCT02222493|57498|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
23639|NCT02222246|57616|P2|NOT COMPLETED|Overall Study||27
23640|NCT02222246|57617|P1|NOT COMPLETED|Overall Study||27
23641|NCT02222246|57616|P2|COMPLETED|Overall Study||26
23642|NCT02222246|57617|P1|COMPLETED|Overall Study||26
23643|NCT02222246|57616|P2|STARTED|Overall Study||53
23644|NCT02222246|57617|P1|STARTED|Overall Study||53
23645|NCT02222207|57645|P1|NOT COMPLETED|Overall Study||4
23646|NCT02222207|57645|P1|COMPLETED|Overall Study||48
23647|NCT02222207|57645|P1|Treated and Valid for Full Analysis Set|Overall Study||51
23648|NCT02222207|57645|P1|STARTED|Overall Study||52
23649|NCT02222181|57652|P1|NOT COMPLETED|Overall Study||108
23650|NCT02222181|57652|P1|COMPLETED|Overall Study||55
23651|NCT02222181|57652|P1|STARTED|Overall Study||163
23652|NCT02222129|57664|P2|NOT COMPLETED|Overall Study||0
23653|NCT02222129|57665|P1|NOT COMPLETED|Overall Study||0
23654|NCT02222129|57664|P2|COMPLETED|Overall Study||106
23655|NCT02222129|57665|P1|COMPLETED|Overall Study||100
23656|NCT02222129|57664|P2|STARTED|Overall Study||106
23657|NCT02222129|57665|P1|STARTED|Overall Study||100
23658|NCT02221947|57673|P2|NOT COMPLETED|Overall Study||0
23659|NCT02221947|57674|P1|NOT COMPLETED|Overall Study||0
23660|NCT02221947|57673|P2|COMPLETED|Overall Study||3
23661|NCT02221947|57674|P1|COMPLETED|Overall Study||6
23662|NCT02221947|57673|P2|STARTED|Overall Study||3
23663|NCT02221947|57674|P1|STARTED|Overall Study||6
23664|NCT02221674|57689|P3|NOT COMPLETED|Overall Study||0
23665|NCT02221674|57690|P2|NOT COMPLETED|Overall Study||0
23666|NCT02221674|57691|P1|NOT COMPLETED|Overall Study||1
23667|NCT02221674|57689|P3|COMPLETED|Overall Study||5
23668|NCT02221674|57690|P2|COMPLETED|Overall Study||6
23669|NCT02221674|57691|P1|COMPLETED|Overall Study||7
23670|NCT02221674|57689|P3|STARTED|Overall Study||5
23671|NCT02221674|57690|P2|STARTED|Overall Study||6
23672|NCT02221674|57691|P1|STARTED|Overall Study||8
23673|NCT02221648|57707|P2|NOT COMPLETED|Overall Study||3
23674|NCT02221648|57708|P1|NOT COMPLETED|Overall Study||3
23675|NCT02221648|57707|P2|COMPLETED|Overall Study||18
23676|NCT02221648|57708|P1|COMPLETED|Overall Study||19
23677|NCT02221648|57707|P2|STARTED|Overall Study||21
23678|NCT02221648|57708|P1|STARTED|Overall Study||22
23679|NCT02221557|57718|P1|NOT COMPLETED|Overall Study||3
23680|NCT02221557|57718|P1|COMPLETED|Overall Study||5
23681|NCT02221557|57718|P1|STARTED|Overall Study||8
23682|NCT02220998|57724|P2|NOT COMPLETED|Overall Study||11
23683|NCT02220998|57725|P1|NOT COMPLETED|Overall Study||7
23684|NCT02220998|57724|P2|COMPLETED|Overall Study||123
23685|NCT02220998|57725|P1|COMPLETED|Overall Study||128
23686|NCT02220998|57724|P2|STARTED|Overall Study||134
23687|NCT02220998|57725|P1|STARTED|Overall Study||135
23688|NCT02220920|57743|P2|NOT COMPLETED|Overall Study||3
23689|NCT02220920|57744|P1|NOT COMPLETED|Overall Study||3
23690|NCT02220920|57743|P2|COMPLETED|Overall Study||67
23691|NCT02220920|57744|P1|COMPLETED|Overall Study||73
23692|NCT02220920|57743|P2|STARTED|Overall Study||70
23693|NCT02220920|57744|P1|STARTED|Overall Study||76
23694|NCT02220764|57760|P2|NOT COMPLETED|Overall Study||1
23695|NCT02220764|57761|P1|NOT COMPLETED|Overall Study||4
23696|NCT02220764|57760|P2|COMPLETED|Overall Study||7
23697|NCT02220764|57761|P1|COMPLETED|Overall Study||20
23698|NCT02220764|57760|P2|STARTED|Overall Study||8
23699|NCT02220764|57761|P1|STARTED|Overall Study||24
23700|NCT02220205|57773|P2|NOT COMPLETED|Overall Study||0
23701|NCT02220205|57774|P1|NOT COMPLETED|Overall Study||1
23702|NCT02220205|57773|P2|COMPLETED|Overall Study||30
23703|NCT02220205|57774|P1|COMPLETED|Overall Study||29
23704|NCT02220205|57773|P2|STARTED|Overall Study||30
23705|NCT02220205|57774|P1|STARTED|Overall Study||30
23706|NCT02219997|57784|P3|NOT COMPLETED|Second Filter||0
23707|NCT02219997|57785|P2|NOT COMPLETED|Second Filter||0
23708|NCT02219997|57786|P1|NOT COMPLETED|Second Filter||0
23709|NCT02219997|57784|P3|COMPLETED|Second Filter||18
23710|NCT02219997|57785|P2|COMPLETED|Second Filter||17
23711|NCT02219997|57786|P1|COMPLETED|Second Filter||0
23712|NCT02219997|57784|P3|STARTED|Second Filter||18
23713|NCT02219997|57785|P2|STARTED|Second Filter||17
23714|NCT02219997|57786|P1|STARTED|Second Filter||0
23715|NCT02219997|57784|P3|NOT COMPLETED|First Filter||0
23716|NCT02219997|57785|P2|NOT COMPLETED|First Filter||0
23717|NCT02219997|57786|P1|NOT COMPLETED|First Filter||0
23718|NCT02219997|57784|P3|COMPLETED|First Filter||18
23719|NCT02219997|57785|P2|COMPLETED|First Filter||17
23720|NCT02219997|57786|P1|COMPLETED|First Filter||33
23721|NCT02219997|57784|P3|STARTED|First Filter||18
23722|NCT02219997|57785|P2|STARTED|First Filter||17
23723|NCT02219997|57786|P1|STARTED|First Filter||33
23724|NCT02219932|57799|P2|NOT COMPLETED|Overall Study||51
23725|NCT02219932|57800|P1|NOT COMPLETED|Overall Study||65
23726|NCT02219932|57799|P2|COMPLETED|Overall Study||266
23727|NCT02219932|57800|P1|COMPLETED|Overall Study||254
23728|NCT02219932|57799|P2|Randomized, Not Treated|Overall Study||1
23729|NCT02219932|57800|P1|Randomized, Not Treated|Overall Study||0
23730|NCT02219932|57799|P2|STARTED|Overall Study||317
23731|NCT02219932|57800|P1|STARTED|Overall Study||319
23732|NCT02219685|57816|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
23733|NCT02219685|57817|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
23734|NCT02219685|57816|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
23735|NCT02219685|57817|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
23736|NCT02219685|57816|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
23737|NCT02219685|57817|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
23738|NCT02219685|57816|P2|NOT COMPLETED|Blinded Treatment Phase||0
23739|NCT02219685|57817|P1|NOT COMPLETED|Blinded Treatment Phase||2
23740|NCT02219685|57816|P2|COMPLETED|Blinded Treatment Phase||14
23741|NCT02219685|57817|P1|COMPLETED|Blinded Treatment Phase||24
23742|NCT02219685|57816|P2|STARTED|Blinded Treatment Phase||14
23743|NCT02219685|57817|P1|STARTED|Blinded Treatment Phase||26
23744|NCT02219516|57865|P4|NOT COMPLETED|Overall Study||0
23745|NCT02219516|57866|P3|NOT COMPLETED|Overall Study||0
23746|NCT02219516|57867|P2|NOT COMPLETED|Overall Study||0
23747|NCT02219516|57868|P1|NOT COMPLETED|Overall Study||0
23748|NCT02219516|57865|P4|COMPLETED|Overall Study||8
23749|NCT02219516|57866|P3|COMPLETED|Overall Study||7
23750|NCT02219516|57867|P2|COMPLETED|Overall Study||8
23751|NCT02219516|57868|P1|COMPLETED|Overall Study||8
23752|NCT02219516|57865|P4|STARTED|Overall Study||8
23753|NCT02219516|57866|P3|STARTED|Overall Study||7
23754|NCT02219516|57867|P2|STARTED|Overall Study||8
23755|NCT02219516|57868|P1|STARTED|Overall Study||8
23756|NCT02219503|57914|P1|NOT COMPLETED|Overall Study||0
23757|NCT02219503|57914|P1|COMPLETED|Overall Study||60
23758|NCT02219503|57914|P1|STARTED|Overall Study||60
23759|NCT02219477|57923|P3|NOT COMPLETED|Overall Study||1
23760|NCT02219477|57924|P2|NOT COMPLETED|Overall Study||2
23761|NCT02219477|57925|P1|NOT COMPLETED|Overall Study||0
23762|NCT02219477|57923|P3|COMPLETED|Overall Study||2
23763|NCT02219477|57924|P2|COMPLETED|Overall Study||22
23764|NCT02219477|57925|P1|COMPLETED|Overall Study||9
23765|NCT02219477|57923|P3|STARTED|Overall Study||3
23766|NCT02219477|57924|P2|STARTED|Overall Study||24
23767|NCT02219477|57925|P1|STARTED|Overall Study||9
23768|NCT02219464|57953|P2|NOT COMPLETED|Overall Study||0
23769|NCT02219464|57954|P1|NOT COMPLETED|Overall Study||3
23770|NCT02219464|57953|P2|COMPLETED|Overall Study||30
23771|NCT02219464|57954|P1|COMPLETED|Overall Study||27
23772|NCT02219464|57953|P2|STARTED|Overall Study||30
23773|NCT02219464|57954|P1|STARTED|Overall Study||30
23774|NCT02219282|57964|P2|NOT COMPLETED|Overall Study||1
23775|NCT02219282|57965|P1|NOT COMPLETED|Overall Study||1
23776|NCT02219282|57964|P2|COMPLETED|Overall Study||32
23777|NCT02219282|57965|P1|COMPLETED|Overall Study||32
23778|NCT02219282|57964|P2|STARTED|Overall Study||33
23779|NCT02219282|57965|P1|STARTED|Overall Study||33
23780|NCT02219256|57991|P12|NOT COMPLETED|Overall Study||0
23781|NCT02219256|57992|P11|NOT COMPLETED|Overall Study||0
23782|NCT02219256|57993|P10|NOT COMPLETED|Overall Study||0
23783|NCT02219256|57994|P9|NOT COMPLETED|Overall Study||0
23784|NCT02219256|57995|P8|NOT COMPLETED|Overall Study||0
23785|NCT02219256|57996|P7|NOT COMPLETED|Overall Study||0
23786|NCT02219256|57997|P6|NOT COMPLETED|Overall Study||0
23787|NCT02219256|57998|P5|NOT COMPLETED|Overall Study||0
23788|NCT02219256|57999|P4|NOT COMPLETED|Overall Study||0
23789|NCT02219256|58000|P3|NOT COMPLETED|Overall Study||0
23790|NCT02219256|58001|P2|NOT COMPLETED|Overall Study||0
23791|NCT02219256|58002|P1|NOT COMPLETED|Overall Study||0
23792|NCT02219256|57991|P12|COMPLETED|Overall Study||6
23793|NCT02219256|57992|P11|COMPLETED|Overall Study||6
23794|NCT02219256|57993|P10|COMPLETED|Overall Study||6
23795|NCT02219256|57994|P9|COMPLETED|Overall Study||6
23796|NCT02219256|57995|P8|COMPLETED|Overall Study||8
23797|NCT02219256|57996|P7|COMPLETED|Overall Study||6
23798|NCT02219256|57997|P6|COMPLETED|Overall Study||6
23799|NCT02219256|57998|P5|COMPLETED|Overall Study||6
23800|NCT02219256|57999|P4|COMPLETED|Overall Study||4
23801|NCT02219256|58000|P3|COMPLETED|Overall Study||4
23802|NCT02219256|58001|P2|COMPLETED|Overall Study||4
23803|NCT02219256|58002|P1|COMPLETED|Overall Study||12
23804|NCT02219256|57991|P12|STARTED|Overall Study||6
23805|NCT02219256|57992|P11|STARTED|Overall Study||6
23806|NCT02219256|57993|P10|STARTED|Overall Study||6
23807|NCT02219256|57994|P9|STARTED|Overall Study||6
23808|NCT02219256|57995|P8|STARTED|Overall Study||8
23809|NCT02219256|57996|P7|STARTED|Overall Study||6
23810|NCT02219256|57997|P6|STARTED|Overall Study||6
23811|NCT02219256|57998|P5|STARTED|Overall Study||6
23812|NCT02219256|57999|P4|STARTED|Overall Study||4
23813|NCT02219256|58000|P3|STARTED|Overall Study||4
23814|NCT02219256|58001|P2|STARTED|Overall Study||4
23815|NCT02219256|58002|P1|STARTED|Overall Study||12
23816|NCT02219087|58114|P2|NOT COMPLETED|Overall Study||1
23817|NCT02219087|58115|P1|NOT COMPLETED|Overall Study||0
23818|NCT02219087|58114|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
23819|NCT02219087|58115|P1|COMPLETED|Overall Study||30
23820|NCT02219087|58114|P2|STARTED|Overall Study||30
23821|NCT02219087|58115|P1|STARTED|Overall Study||30
23822|NCT02218697|58135|P2|NOT COMPLETED|Overall Study||6
23823|NCT02218697|58136|P1|NOT COMPLETED|Overall Study||2
23824|NCT02218697|58135|P2|COMPLETED|Overall Study||171
23825|NCT02218697|58136|P1|COMPLETED|Overall Study||177
23826|NCT02218697|58135|P2|STARTED|Overall Study||177
23827|NCT02218697|58136|P1|STARTED|Overall Study||179
23828|NCT02218307|58176|P2|NOT COMPLETED|Overall Study||1
23829|NCT02218307|58177|P1|NOT COMPLETED|Overall Study||9
23830|NCT02218307|58176|P2|COMPLETED|Overall Study||33
23831|NCT02218307|58177|P1|COMPLETED|Overall Study||25
23832|NCT02218307|58176|P2|STARTED|Overall Study||34
23833|NCT02218307|58177|P1|STARTED|Overall Study||34
23834|NCT02218268|58185|P2|NOT COMPLETED|Final Phase (2 Hours)||0
23835|NCT02218268|58186|P1|NOT COMPLETED|Final Phase (2 Hours)||0
23836|NCT02218268|58185|P2|COMPLETED|Final Phase (2 Hours)||21
23837|NCT02218268|58186|P1|COMPLETED|Final Phase (2 Hours)||19
23838|NCT02218268|58185|P2|STARTED|Final Phase (2 Hours)||21
23839|NCT02218268|58186|P1|STARTED|Final Phase (2 Hours)||19
23840|NCT02218268|58185|P2|NOT COMPLETED|24 Hour Washout||9
23841|NCT02218268|58186|P1|NOT COMPLETED|24 Hour Washout||11
23842|NCT02218268|58185|P2|COMPLETED|24 Hour Washout||21
23843|NCT02218268|58186|P1|COMPLETED|24 Hour Washout||19
23844|NCT02218268|58185|P2|STARTED|24 Hour Washout||30
23845|NCT02218268|58186|P1|STARTED|24 Hour Washout||30
23846|NCT02218268|58185|P2|NOT COMPLETED|First Phase (2 Hours)||0
23847|NCT02218268|58186|P1|NOT COMPLETED|First Phase (2 Hours)||0
23848|NCT02218268|58185|P2|COMPLETED|First Phase (2 Hours)||30
23849|NCT02218268|58186|P1|COMPLETED|First Phase (2 Hours)||30
23850|NCT02218268|58185|P2|STARTED|First Phase (2 Hours)||30
23851|NCT02218268|58186|P1|STARTED|First Phase (2 Hours)||30
23852|NCT02218216|58194|P3|NOT COMPLETED|Overall Study||0
23853|NCT02218216|58195|P2|NOT COMPLETED|Overall Study||0
23854|NCT02218216|58196|P1|NOT COMPLETED|Overall Study||6
23855|NCT02218216|58194|P3|COMPLETED|Overall Study||3
23856|NCT02218216|58195|P2|COMPLETED|Overall Study||2
23857|NCT02218216|58196|P1|COMPLETED|Overall Study||8
23858|NCT02218216|58194|P3|STARTED|Overall Study||3
23859|NCT02218216|58195|P2|STARTED|Overall Study||2
23860|NCT02218216|58196|P1|STARTED|Overall Study||14
23861|NCT02218203|58204|P1|NOT COMPLETED|Overall Study||0
23862|NCT02218203|58204|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
23863|NCT02218203|58204|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
23864|NCT02218203|58204|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
23865|NCT02218203|58204|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
23866|NCT02218203|58204|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
23867|NCT02218203|58204|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
23868|NCT02218203|58204|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
23869|NCT02218203|58204|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
23870|NCT02218203|58204|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
23871|NCT02218203|58204|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
23872|NCT02218203|58204|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
23873|NCT02218203|58204|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
23874|NCT02218203|58204|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
23875|NCT02218203|58204|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
23876|NCT02218203|58204|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
23877|NCT02218203|58204|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
23878|NCT02218203|58204|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
23879|NCT02218203|58204|P1|STARTED|Overall Study||26
23880|NCT02217982|58228|P2|NOT COMPLETED|Overall Study||1
23881|NCT02217982|58229|P1|NOT COMPLETED|Overall Study||1
23882|NCT02217982|58228|P2|COMPLETED|Overall Study||3
23883|NCT02217982|58229|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
23884|NCT02217982|58228|P2|STARTED|Overall Study||4
23885|NCT02217982|58229|P1|STARTED|Overall Study||1
23886|NCT02217878|58239|P2|NOT COMPLETED|Overall Study||2
23887|NCT02217878|58240|P1|NOT COMPLETED|Overall Study||2
23888|NCT02217878|58239|P2|COMPLETED|Overall Study||35
23889|NCT02217878|58240|P1|COMPLETED|Overall Study||35
23890|NCT02217878|58239|P2|STARTED|Overall Study||37
23891|NCT02217878|58240|P1|STARTED|Overall Study||37
23892|NCT02217800|58320|P1|NOT COMPLETED|Overall Study||0
23893|NCT02217800|58320|P1|COMPLETED|Overall Study||8
23894|NCT02217800|58320|P1|STARTED|Overall Study||8
23895|NCT02217280|58332|P1|NOT COMPLETED|Overall Study||4
23896|NCT02217280|58332|P1|COMPLETED|Overall Study||16
23897|NCT02217280|58332|P1|STARTED|Overall Study||20
23898|NCT02216695|58337|P1|NOT COMPLETED|Overall Study||0
23899|NCT02216695|58337|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
23900|NCT02216695|58337|P1|STARTED|Overall Study||64882
23901|NCT02216591|58348|P2|NOT COMPLETED|Overall Study||1
23902|NCT02216591|58349|P1|NOT COMPLETED|Overall Study||0
23903|NCT02216591|58348|P2|COMPLETED|Overall Study||9
23904|NCT02216591|58349|P1|COMPLETED|Overall Study||11
23905|NCT02216591|58348|P2|STARTED|Overall Study||10
23906|NCT02216591|58349|P1|STARTED|Overall Study||11
23907|NCT02216526|58362|P3|NOT COMPLETED|Overall Study||8
23908|NCT02216526|58363|P2|NOT COMPLETED|Overall Study||3
23909|NCT02216526|58364|P1|NOT COMPLETED|Overall Study||5
23910|NCT02216526|58362|P3|COMPLETED|Overall Study||36
23911|NCT02216526|58363|P2|COMPLETED|Overall Study||41
23912|NCT02216526|58364|P1|COMPLETED|Overall Study||40
23913|NCT02216526|58362|P3|STARTED|Overall Study||44
23914|NCT02216526|58363|P2|STARTED|Overall Study||44
23915|NCT02216526|58364|P1|STARTED|Overall Study||45
23916|NCT02216422|58474|P1|NOT COMPLETED|Overall Study||0
23917|NCT02216422|58474|P1|COMPLETED|Overall Study||36
23918|NCT02216422|58474|P1|STARTED|Overall Study||36
23919|NCT02216357|58482|P2|NOT COMPLETED|Overall Study||1
23920|NCT02216357|58483|P1|NOT COMPLETED|Overall Study||2
23921|NCT02216357|58482|P2|COMPLETED|Overall Study||4
23922|NCT02216357|58483|P1|COMPLETED|Overall Study||12
23923|NCT02216357|58482|P2|STARTED|Overall Study||5
23924|NCT02216357|58483|P1|STARTED|Overall Study||14
23925|NCT02216123|58509|P2|NOT COMPLETED|Overall Study||2
23926|NCT02216123|58510|P1|NOT COMPLETED|Overall Study||6
23927|NCT02216123|58509|P2|COMPLETED|Overall Study||83
23928|NCT02216123|58510|P1|COMPLETED|Overall Study||160
23929|NCT02216123|58509|P2|STARTED|Overall Study||85
23930|NCT02216123|58510|P1|STARTED|Overall Study||166
23931|NCT02216097|58576|P2|NOT COMPLETED|Overall Study||0
23932|NCT02216097|58577|P1|NOT COMPLETED|Overall Study||0
23933|NCT02216097|58576|P2|COMPLETED|Overall Study||6
23934|NCT02216097|58577|P1|COMPLETED|Overall Study||8
23935|NCT02216097|58576|P2|STARTED|Overall Study||6
23936|NCT02216097|58577|P1|STARTED|Overall Study||8
23937|NCT02215954|58602|P3|NOT COMPLETED|Overall Study||6
23938|NCT02215954|58603|P2|NOT COMPLETED|Overall Study||1
23939|NCT02215954|58604|P1|NOT COMPLETED|Overall Study||1
23940|NCT02215954|58602|P3|COMPLETED|Overall Study||205
23941|NCT02215954|58603|P2|COMPLETED|Overall Study||211
23942|NCT02215954|58604|P1|COMPLETED|Overall Study||213
23943|NCT02215954|58602|P3|Safety Analysis Set|Overall Study||208
23944|NCT02215954|58603|P2|Safety Analysis Set|Overall Study||211
23945|NCT02215954|58604|P1|Safety Analysis Set|Overall Study||213
23946|NCT02215954|58602|P3|Per Protocol (PP) Analysis Set|Overall Study||205
23947|NCT02215954|58603|P2|Per Protocol (PP) Analysis Set|Overall Study||208
23948|NCT02215954|58604|P1|Per Protocol (PP) Analysis Set|Overall Study||212
23949|NCT02215954|58602|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
23950|NCT02215954|58603|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
23951|NCT02215954|58604|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
23952|NCT02215954|58602|P3|STARTED|Overall Study||211
23953|NCT02215954|58603|P2|STARTED|Overall Study||212
23954|NCT02215954|58604|P1|STARTED|Overall Study||214
23955|NCT02215252|58627|P3|NOT COMPLETED|Overall Study||4
23956|NCT02215252|58628|P2|NOT COMPLETED|Overall Study||8
23957|NCT02215252|58629|P1|NOT COMPLETED|Overall Study||2
23958|NCT02215252|58627|P3|COMPLETED|Overall Study||41
23959|NCT02215252|58628|P2|COMPLETED|Overall Study||38
23960|NCT02215252|58629|P1|COMPLETED|Overall Study||42
23961|NCT02215252|58627|P3|STARTED|Overall Study||45
23962|NCT02215252|58628|P2|STARTED|Overall Study||46
23963|NCT02215252|58629|P1|STARTED|Overall Study||44
23964|NCT02214615|58688|P2|NOT COMPLETED|Second Intervention||0
23965|NCT02214615|58689|P1|NOT COMPLETED|Second Intervention||0
23966|NCT02214615|58688|P2|COMPLETED|Second Intervention||1
23967|NCT02214615|58689|P1|COMPLETED|Second Intervention||1
23968|NCT02214615|58688|P2|STARTED|Second Intervention||1
23969|NCT02214615|58689|P1|STARTED|Second Intervention||1
23970|NCT02214615|58688|P2|NOT COMPLETED|Washout||0
23971|NCT02214615|58689|P1|NOT COMPLETED|Washout||0
23972|NCT02214615|58688|P2|COMPLETED|Washout||1
23973|NCT02214615|58689|P1|COMPLETED|Washout||1
23974|NCT02214615|58688|P2|STARTED|Washout||1
23975|NCT02214615|58689|P1|STARTED|Washout||1
23976|NCT02214615|58688|P2|NOT COMPLETED|First Intervention||0
23977|NCT02214615|58689|P1|NOT COMPLETED|First Intervention||0
23978|NCT02214615|58688|P2|COMPLETED|First Intervention||1
23979|NCT02214615|58689|P1|COMPLETED|First Intervention||1
23980|NCT02214615|58688|P2|STARTED|First Intervention||1
23981|NCT02214615|58689|P1|STARTED|First Intervention||1
23982|NCT02214420|58699|P2|NOT COMPLETED|Overall Study||0
23983|NCT02214420|58700|P1|NOT COMPLETED|Overall Study||1
23984|NCT02214420|58699|P2|COMPLETED|Overall Study||10
23985|NCT02214420|58700|P1|COMPLETED|Overall Study||13
23986|NCT02214420|58699|P2|STARTED|Overall Study||10
23987|NCT02214420|58700|P1|STARTED|Overall Study||14
23988|NCT02214277|58709|P3|NOT COMPLETED|Overall Study||34
23989|NCT02214277|58710|P2|NOT COMPLETED|Overall Study||25
23990|NCT02214277|58711|P1|NOT COMPLETED|Overall Study||19
23991|NCT02214277|58709|P3|COMPLETED|Overall Study||85
23992|NCT02214277|58710|P2|COMPLETED|Overall Study||96
23993|NCT02214277|58711|P1|COMPLETED|Overall Study||104
23994|NCT02214277|58709|P3|STARTED|Overall Study||119
23995|NCT02214277|58710|P2|STARTED|Overall Study||121
23996|NCT02214277|58711|P1|STARTED|Overall Study||123
23997|NCT02214238|58721|P2|NOT COMPLETED|Overall Study||6
23998|NCT02214238|58722|P1|NOT COMPLETED|Overall Study||6
23999|NCT02214238|58721|P2|COMPLETED|Overall Study||17
24000|NCT02214238|58722|P1|COMPLETED|Overall Study||20
24001|NCT02214238|58721|P2|STARTED|Overall Study||23
24002|NCT02214238|58722|P1|STARTED|Overall Study||26
24003|NCT02214225|58735|P3|NOT COMPLETED|Overall Study||22
24004|NCT02214225|58736|P2|NOT COMPLETED|Overall Study||19
24005|NCT02214225|58737|P1|NOT COMPLETED|Overall Study||55
24006|NCT02214225|58735|P3|COMPLETED|Overall Study||850
24007|NCT02214225|58736|P2|COMPLETED|Overall Study||852
24008|NCT02214225|58737|P1|COMPLETED|Overall Study||1686
24009|NCT02214225|58735|P3|STARTED|Overall Study||872
24010|NCT02214225|58736|P2|STARTED|Overall Study||871
24011|NCT02214225|58737|P1|STARTED|Overall Study||1741
24012|NCT02214186|58796|P2|NOT COMPLETED|Overall Study||2
24013|NCT02214186|58797|P1|NOT COMPLETED|Overall Study||2
24014|NCT02214186|58796|P2|COMPLETED|Overall Study||21
24015|NCT02214186|58797|P1|COMPLETED|Overall Study||21
24016|NCT02214186|58796|P2|STARTED|Overall Study||23
24017|NCT02214186|58797|P1|STARTED|Overall Study||23
24018|NCT02214121|58822|P3|NOT COMPLETED|Part B||1
24019|NCT02214121|58823|P2|NOT COMPLETED|Part B||3
24020|NCT02214121|58824|P1|NOT COMPLETED|Part B||0
24021|NCT02214121|58822|P3|COMPLETED|Part B||7
24022|NCT02214121|58823|P2|COMPLETED|Part B||14
24023|NCT02214121|58824|P1|COMPLETED|Part B||0
24024|NCT02214121|58822|P3|STARTED|Part B||8
24025|NCT02214121|58823|P2|STARTED|Part B||17
24026|NCT02214121|58824|P1|STARTED|Part B||0
24027|NCT02214121|58822|P3|NOT COMPLETED|Part A||0
24028|NCT02214121|58823|P2|NOT COMPLETED|Part A||0
24029|NCT02214121|58824|P1|NOT COMPLETED|Part A||7
24030|NCT02214121|58822|P3|COMPLETED|Part A||0
24031|NCT02214121|58823|P2|COMPLETED|Part A||0
24032|NCT02214121|58824|P1|COMPLETED|Part A||39
24033|NCT02214121|58822|P3|STARTED|Part A||0
24034|NCT02214121|58823|P2|STARTED|Part A||0
24035|NCT02214121|58824|P1|STARTED|Part A||46
24036|NCT02213900|58903|P2|NOT COMPLETED|Overall Study||0
24037|NCT02213900|58904|P1|NOT COMPLETED|Overall Study||0
24038|NCT02213900|58903|P2|COMPLETED|Overall Study||67
24039|NCT02213900|58904|P1|COMPLETED|Overall Study||68
24040|NCT02213900|58903|P2|STARTED|Overall Study||67
24041|NCT02213900|58904|P1|STARTED|Overall Study||68
24042|NCT02213666|58916|P1|NOT COMPLETED|Overall Study||1
24043|NCT02213666|58916|P1|COMPLETED|Overall Study||71
24044|NCT02213666|58916|P1|STARTED|Overall Study||72
24045|NCT02213510|58922|P2|NOT COMPLETED|Overall Study||1
24046|NCT02213510|58923|P1|NOT COMPLETED|Overall Study||1
24047|NCT02213510|58922|P2|COMPLETED|Overall Study||18
24048|NCT02213510|58923|P1|COMPLETED|Overall Study||20
24049|NCT02213510|58922|P2|STARTED|Overall Study||19
24050|NCT02213510|58923|P1|STARTED|Overall Study||21
24051|NCT02213250|58949|P2|NOT COMPLETED|Overall Study||0
24052|NCT02213250|58950|P1|NOT COMPLETED|Overall Study||0
24053|NCT02213250|58949|P2|COMPLETED|Overall Study||8
24054|NCT02213250|58950|P1|COMPLETED|Overall Study||4
24055|NCT02213250|58949|P2|STARTED|Overall Study||8
24056|NCT02213250|58950|P1|STARTED|Overall Study||4
24057|NCT02213198|58981|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
24058|NCT02213198|58982|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
24059|NCT02213198|58981|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
24060|NCT02213198|58982|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
24061|NCT02213198|58981|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
24062|NCT02213198|58982|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
24063|NCT02213198|58981|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
24064|NCT02213198|58982|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
24065|NCT02213198|58981|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
24066|NCT02213198|58982|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
24067|NCT02213198|58981|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
24068|NCT02213198|58982|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
24069|NCT02213198|58981|P2|NOT COMPLETED|Baseline||51
24070|NCT02213198|58982|P1|NOT COMPLETED|Baseline||88
24071|NCT02213198|58981|P2|COMPLETED|Baseline||108
24072|NCT02213198|58982|P1|COMPLETED|Baseline||218
24073|NCT02213198|58981|P2|STARTED|Baseline||159
24074|NCT02213198|58982|P1|STARTED|Baseline||306
24075|NCT02213055|58992|P2|NOT COMPLETED|Overall Study||0
24076|NCT02213055|58993|P1|NOT COMPLETED|Overall Study||39
24077|NCT02213055|58992|P2|COMPLETED|Overall Study||0
24078|NCT02213055|58993|P1|COMPLETED|Overall Study||58
24079|NCT02213055|58992|P2|STARTED|Overall Study||0
24080|NCT02213055|58993|P1|STARTED|Overall Study||97
24081|NCT02212977|59001|P2|NOT COMPLETED|Overall Study||6
24082|NCT02212977|59002|P1|NOT COMPLETED|Overall Study||5
24083|NCT02212977|59001|P2|COMPLETED|Overall Study||48
24084|NCT02212977|59002|P1|COMPLETED|Overall Study||50
24085|NCT02212977|59001|P2|STARTED|Overall Study||54
24086|NCT02212977|59002|P1|STARTED|Overall Study||55
24087|NCT02212834|59018|P2|NOT COMPLETED|Overall Study||0
24088|NCT02212834|59019|P1|NOT COMPLETED|Overall Study||0
24089|NCT02212834|59018|P2|COMPLETED|Overall Study||2506
24090|NCT02212834|59019|P1|COMPLETED|Overall Study||33938
24091|NCT02212834|59018|P2|STARTED|Overall Study||2506
24092|NCT02212834|59019|P1|STARTED|Overall Study||33938
24093|NCT02212457|59031|P6|NOT COMPLETED|Overall Study||13
24094|NCT02212457|59032|P5|NOT COMPLETED|Overall Study||15
24095|NCT02212457|59033|P4|NOT COMPLETED|Overall Study||11
24096|NCT02212457|59034|P3|NOT COMPLETED|Overall Study||16
24097|NCT02212457|59035|P2|NOT COMPLETED|Overall Study||21
24098|NCT02212457|59036|P1|NOT COMPLETED|Overall Study||19
24099|NCT02212457|59031|P6|COMPLETED|Overall Study||147
24100|NCT02212457|59032|P5|COMPLETED|Overall Study||137
24101|NCT02212457|59033|P4|COMPLETED|Overall Study||123
24102|NCT02212457|59034|P3|COMPLETED|Overall Study||141
24103|NCT02212457|59035|P2|COMPLETED|Overall Study||211
24104|NCT02212457|59036|P1|COMPLETED|Overall Study||209
24105|NCT02212457|59031|P6|STARTED|Overall Study||160
24106|NCT02212457|59032|P5|STARTED|Overall Study||152
24107|NCT02212457|59033|P4|STARTED|Overall Study||134
24108|NCT02212457|59034|P3|STARTED|Overall Study||157
24109|NCT02212457|59035|P2|STARTED|Overall Study||232
24110|NCT02212457|59036|P1|STARTED|Overall Study||228
24111|NCT02212301|59074|P2|NOT COMPLETED|Period 2||0
24112|NCT02212301|59075|P1|NOT COMPLETED|Period 2||0
24113|NCT02212301|59074|P2|COMPLETED|Period 2||21
24114|NCT02212301|59075|P1|COMPLETED|Period 2||21
24115|NCT02212301|59074|P2|STARTED|Period 2||21
24116|NCT02212301|59075|P1|STARTED|Period 2||21
24117|NCT02212301|59074|P2|NOT COMPLETED|Period 1||1
24118|NCT02212301|59075|P1|NOT COMPLETED|Period 1||0
24119|NCT02212301|59074|P2|COMPLETED|Period 1||21
24120|NCT02212301|59075|P1|COMPLETED|Period 1||21
24121|NCT02212301|59074|P2|STARTED|Period 1||22
24122|NCT02212301|59075|P1|STARTED|Period 1||21
24123|NCT02212197|59086|P3|NOT COMPLETED|Overall Study||0
24124|NCT02212197|59087|P2|NOT COMPLETED|Overall Study||0
24125|NCT02212197|59088|P1|NOT COMPLETED|Overall Study||1
24126|NCT02212197|59086|P3|COMPLETED|Overall Study||17
24127|NCT02212197|59087|P2|COMPLETED|Overall Study||15
24128|NCT02212197|59088|P1|COMPLETED|Overall Study||18
24129|NCT02212197|59086|P3|STARTED|Overall Study||17
24130|NCT02212197|59087|P2|STARTED|Overall Study||15
24131|NCT02212197|59088|P1|STARTED|Overall Study||19
24132|NCT02212106|59113|P2|NOT COMPLETED|Overall Study||4
24133|NCT02212106|59114|P1|NOT COMPLETED|Overall Study||10
24134|NCT02212106|59113|P2|COMPLETED|Overall Study||96
24135|NCT02212106|59114|P1|COMPLETED|Overall Study||292
24136|NCT02212106|59113|P2|STARTED|Overall Study||100
24137|NCT02212106|59114|P1|STARTED|Overall Study||302
24138|NCT02212028|59132|P2|NOT COMPLETED|Overall Study||0
24139|NCT02212028|59133|P1|NOT COMPLETED|Overall Study||0
24140|NCT02212028|59132|P2|COMPLETED|Overall Study||26
24141|NCT02212028|59133|P1|COMPLETED|Overall Study||26
24142|NCT02212028|59132|P2|STARTED|Overall Study||26
24143|NCT02212028|59133|P1|STARTED|Overall Study||26
24144|NCT02211534|59143|P2|NOT COMPLETED|Overall Study||5
24145|NCT02211534|59144|P1|NOT COMPLETED|Overall Study||13
24146|NCT02211534|59143|P2|COMPLETED|Overall Study||6
24147|NCT02211534|59144|P1|COMPLETED|Overall Study||11
24148|NCT02211534|59143|P2|STARTED|Overall Study||11
24149|NCT02211534|59144|P1|STARTED|Overall Study||24
24150|NCT02210208|59164|P1|NOT COMPLETED|Period B (Donor Site)||7
24151|NCT02210208|59164|P1|COMPLETED|Period B (Donor Site)||12
24152|NCT02210208|59164|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
24153|NCT02210208|59164|P1|NOT COMPLETED|Period A (Graft Site)||2
24154|NCT02210208|59164|P1|COMPLETED|Period A (Graft Site)||23
24155|NCT02210208|59164|P1|STARTED|Period A (Graft Site)||25
24156|NCT02210195|59173|P2|NOT COMPLETED|Overall Study||0
24157|NCT02210195|59174|P1|NOT COMPLETED|Overall Study||4
24158|NCT02210195|59173|P2|COMPLETED|Overall Study||10
24159|NCT02210195|59174|P1|COMPLETED|Overall Study||6
24160|NCT02210195|59173|P2|STARTED|Overall Study||10
24161|NCT02210195|59174|P1|STARTED|Overall Study||10
24162|NCT02210091|59184|P2|NOT COMPLETED|Overall Study||2
24163|NCT02210091|59185|P1|NOT COMPLETED|Overall Study||0
24164|NCT02210091|59184|P2|COMPLETED|Overall Study||32
24165|NCT02210091|59185|P1|COMPLETED|Overall Study||32
24166|NCT02210091|59184|P2|STARTED|Overall Study||34
24167|NCT02210091|59185|P1|STARTED|Overall Study||32
24168|NCT02210052|59257|P1|NOT COMPLETED|Overall Study||0
24169|NCT02210052|59257|P1|COMPLETED|Overall Study||6
24170|NCT02210052|59257|P1|STARTED|Overall Study||6
24171|NCT02210000|59263|P2|NOT COMPLETED|Overall Study||21
24172|NCT02210000|59264|P1|NOT COMPLETED|Overall Study||19
24173|NCT02210000|59263|P2|COMPLETED|Overall Study||36
24174|NCT02210000|59264|P1|COMPLETED|Overall Study||38
24175|NCT02210000|59263|P2|STARTED|Overall Study||57
24176|NCT02210000|59264|P1|STARTED|Overall Study||57
24177|NCT02209766|59290|P5|NOT COMPLETED|Overall Study||0
24178|NCT02209766|59291|P4|NOT COMPLETED|Overall Study||1
24179|NCT02209766|59292|P3|NOT COMPLETED|Overall Study||0
24180|NCT02209766|59293|P2|NOT COMPLETED|Overall Study||0
24181|NCT02209766|59294|P1|NOT COMPLETED|Overall Study||0
24182|NCT02209766|59290|P5|COMPLETED|Overall Study||6
24183|NCT02209766|59291|P4|COMPLETED|Overall Study||2
24184|NCT02209766|59292|P3|COMPLETED|Overall Study||6
24185|NCT02209766|59293|P2|COMPLETED|Overall Study||3
24186|NCT02209766|59294|P1|COMPLETED|Overall Study||6
24187|NCT02209766|59290|P5|STARTED|Overall Study||6
24188|NCT02209766|59291|P4|STARTED|Overall Study||3
24189|NCT02209766|59292|P3|STARTED|Overall Study||6
24190|NCT02209766|59293|P2|STARTED|Overall Study||3
24191|NCT02209766|59294|P1|STARTED|Overall Study||6
24192|NCT02209506|59345|P5|NOT COMPLETED|Overall Study||1
24193|NCT02209506|59346|P4|NOT COMPLETED|Overall Study||0
24194|NCT02209506|59347|P3|NOT COMPLETED|Overall Study||0
24195|NCT02209506|59348|P2|NOT COMPLETED|Overall Study||0
24196|NCT02209506|59349|P1|NOT COMPLETED|Overall Study||0
24197|NCT02209506|59345|P5|COMPLETED|Overall Study||5
24198|NCT02209506|59346|P4|COMPLETED|Overall Study||2
24199|NCT02209506|59347|P3|COMPLETED|Overall Study||6
24200|NCT02209506|59348|P2|COMPLETED|Overall Study||6
24201|NCT02209506|59349|P1|COMPLETED|Overall Study||3
24202|NCT02209506|59345|P5|STARTED|Overall Study||6
24203|NCT02209506|59346|P4|STARTED|Overall Study||2
24204|NCT02209506|59347|P3|STARTED|Overall Study||6
24205|NCT02209506|59348|P2|STARTED|Overall Study||6
24206|NCT02209506|59349|P1|STARTED|Overall Study||3
24207|NCT02209454|59424|P2|NOT COMPLETED|Second Period||0
24208|NCT02209454|59425|P1|NOT COMPLETED|Second Period||1
24209|NCT02209454|59424|P2|COMPLETED|Second Period||13
24210|NCT02209454|59425|P1|COMPLETED|Second Period||12
24211|NCT02209454|59424|P2|STARTED|Second Period||13
24212|NCT02209454|59425|P1|STARTED|Second Period||13
24213|NCT02209454|59424|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
24214|NCT02209454|59425|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
24215|NCT02209454|59424|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
24216|NCT02209454|59425|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
24217|NCT02209454|59424|P2|STARTED|Washout Period a Minimum of a 7 Day||13
24218|NCT02209454|59425|P1|STARTED|Washout Period a Minimum of a 7 Day||13
24219|NCT02209454|59424|P2|NOT COMPLETED|First Period||0
24220|NCT02209454|59425|P1|NOT COMPLETED|First Period||0
24221|NCT02209454|59424|P2|COMPLETED|First Period||13
24222|NCT02209454|59425|P1|COMPLETED|First Period||13
24223|NCT02209454|59424|P2|STARTED|First Period||13
24224|NCT02209454|59425|P1|STARTED|First Period||13
24225|NCT02209259|59442|P3|NOT COMPLETED|Overall Study||0
24226|NCT02209259|59443|P2|NOT COMPLETED|Overall Study||0
24227|NCT02209259|59444|P1|NOT COMPLETED|Overall Study||0
24228|NCT02209259|59442|P3|COMPLETED|Overall Study||56
24229|NCT02209259|59443|P2|COMPLETED|Overall Study||56
24230|NCT02209259|59444|P1|COMPLETED|Overall Study||56
24231|NCT02209259|59442|P3|STARTED|Overall Study||56
24232|NCT02209259|59443|P2|STARTED|Overall Study||56
24233|NCT02209259|59444|P1|STARTED|Overall Study||56
24234|NCT02209181|59462|P4|NOT COMPLETED|Overall Study||0
24235|NCT02209181|59463|P3|NOT COMPLETED|Overall Study||1
24236|NCT02209181|59464|P2|NOT COMPLETED|Overall Study||1
24237|NCT02209181|59465|P1|NOT COMPLETED|Overall Study||1
24238|NCT02209181|59462|P4|COMPLETED|Overall Study||66
24239|NCT02209181|59463|P3|COMPLETED|Overall Study||68
24240|NCT02209181|59464|P2|COMPLETED|Overall Study||66
24241|NCT02209181|59465|P1|COMPLETED|Overall Study||66
24242|NCT02209181|59462|P4|STARTED|Overall Study||66
24243|NCT02209181|59463|P3|STARTED|Overall Study||69
24244|NCT02209181|59464|P2|STARTED|Overall Study||67
24245|NCT02209181|59465|P1|STARTED|Overall Study||67
24246|NCT02209064|59627|P1|NOT COMPLETED|Overall Study||0
24247|NCT02209064|59627|P1|COMPLETED|Overall Study||25
24248|NCT02209064|59627|P1|STARTED|Overall Study||25
24249|NCT02208310|59636|P2|NOT COMPLETED|Overall Study||5
24250|NCT02208310|59637|P1|NOT COMPLETED|Overall Study||6
24251|NCT02208310|59636|P2|COMPLETED|Overall Study||0
24252|NCT02208310|59637|P1|COMPLETED|Overall Study||0
24253|NCT02208310|59636|P2|Day 180|Overall Study||1
24254|NCT02208310|59637|P1|Day 180|Overall Study||0
24255|NCT02208310|59636|P2|STARTED|Overall Study||5
24256|NCT02208310|59637|P1|STARTED|Overall Study||6
24257|NCT02207972|59669|P2|NOT COMPLETED|Overall Study||0
24258|NCT02207972|59670|P1|NOT COMPLETED|Overall Study||0
24259|NCT02207972|59669|P2|COMPLETED|Overall Study||24
24260|NCT02207972|59670|P1|COMPLETED|Overall Study||22
24261|NCT02207972|59669|P2|STARTED|Overall Study||24
24262|NCT02207972|59670|P1|STARTED|Overall Study||22
24263|NCT02207907|59682|P2|NOT COMPLETED|Overall Study||8
24264|NCT02207907|59683|P1|NOT COMPLETED|Overall Study||11
24265|NCT02207907|59682|P2|COMPLETED|Overall Study||115
24266|NCT02207907|59683|P1|COMPLETED|Overall Study||113
24267|NCT02207907|59682|P2|STARTED|Overall Study||123
24268|NCT02207907|59683|P1|STARTED|Overall Study||124
24269|NCT02207829|59701|P2|NOT COMPLETED|Overall Study||34
24270|NCT02207829|59702|P1|NOT COMPLETED|Overall Study||42
24271|NCT02207829|59701|P2|COMPLETED|Overall Study||474
24272|NCT02207829|59702|P1|COMPLETED|Overall Study||467
24273|NCT02207829|59701|P2|STARTED|Overall Study||508
24274|NCT02207829|59702|P1|STARTED|Overall Study||509
24275|NCT02207803|59710|P2|NOT COMPLETED|Overall Study||17
24276|NCT02207803|59711|P1|NOT COMPLETED|Overall Study||15
24277|NCT02207803|59710|P2|COMPLETED|Overall Study||108
24278|NCT02207803|59711|P1|COMPLETED|Overall Study||110
24279|NCT02207803|59710|P2|STARTED|Overall Study||125
24280|NCT02207803|59711|P1|STARTED|Overall Study||125
24281|NCT02207634|59721|P2|NOT COMPLETED|Overall Study||31
24282|NCT02207634|59722|P1|NOT COMPLETED|Overall Study||22
24283|NCT02207634|59721|P2|COMPLETED|Overall Study||953
24284|NCT02207634|59722|P1|COMPLETED|Overall Study||968
24285|NCT02207634|59721|P2|Received Treatment|Overall Study||983
24286|NCT02207634|59722|P1|Received Treatment|Overall Study||990
24287|NCT02207634|59721|P2|STARTED|Overall Study||984
24288|NCT02207634|59722|P1|STARTED|Overall Study||990
24289|NCT02207621|59737|P3|NOT COMPLETED|Overall Study||168
24290|NCT02207621|59738|P2|NOT COMPLETED|Overall Study||47
24291|NCT02207621|59739|P1|NOT COMPLETED|Overall Study||105
24292|NCT02207621|59737|P3|COMPLETED|Overall Study||86
24293|NCT02207621|59738|P2|COMPLETED|Overall Study||204
24294|NCT02207621|59739|P1|COMPLETED|Overall Study||146
24295|NCT02207621|59737|P3|STARTED|Overall Study||254
24296|NCT02207621|59738|P2|STARTED|Overall Study||251
24297|NCT02207621|59739|P1|STARTED|Overall Study||251
24298|NCT02207608|59752|P2|NOT COMPLETED|Overall Study||0
24299|NCT02207608|59753|P1|NOT COMPLETED|Overall Study||1
24300|NCT02207608|59752|P2|COMPLETED|Overall Study||15
24301|NCT02207608|59753|P1|COMPLETED|Overall Study||14
24302|NCT02207608|59752|P2|STARTED|Overall Study||15
24303|NCT02207608|59753|P1|STARTED|Overall Study||15
24304|NCT02207569|59759|P1|NOT COMPLETED|6 Months - 1 Year||9
24305|NCT02207569|59759|P1|COMPLETED|6 Months - 1 Year||213
24306|NCT02207569|59759|P1|STARTED|6 Months - 1 Year||222
24307|NCT02207569|59759|P1|NOT COMPLETED|30 Days to 6 Months||11
24308|NCT02207569|59759|P1|COMPLETED|30 Days to 6 Months||222
24309|NCT02207569|59759|P1|STARTED|30 Days to 6 Months||233
24310|NCT02207569|59759|P1|NOT COMPLETED|Implant to 30 Days||4
24311|NCT02207569|59759|P1|COMPLETED|Implant to 30 Days||233
24312|NCT02207569|59759|P1|STARTED|Implant to 30 Days||237
24313|NCT02207569|59759|P1|NOT COMPLETED|Enrolled to Implant||4
24314|NCT02207569|59759|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
24315|NCT02207569|59759|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
24316|NCT02207491|59779|P2|NOT COMPLETED|Overall Study||13
24317|NCT02207491|59780|P1|NOT COMPLETED|Overall Study||31
24318|NCT02207491|59779|P2|COMPLETED|Overall Study||196
24319|NCT02207491|59780|P1|COMPLETED|Overall Study||171
24320|NCT02207491|59779|P2|STARTED|Overall Study||209
24321|NCT02207491|59780|P1|STARTED|Overall Study||202
24322|NCT02207478|59790|P2|NOT COMPLETED|Overall Study||0
24323|NCT02207478|59791|P1|NOT COMPLETED|Overall Study||0
24324|NCT02207478|59790|P2|COMPLETED|Overall Study||46
24325|NCT02207478|59791|P1|COMPLETED|Overall Study||40
24326|NCT02207478|59790|P2|STARTED|Overall Study||46
24327|NCT02207478|59791|P1|STARTED|Overall Study||40
24328|NCT02207413|59805|P6|NOT COMPLETED|Overall Study||13
24329|NCT02207413|59806|P5|NOT COMPLETED|Overall Study||7
24330|NCT02207413|59807|P4|NOT COMPLETED|Overall Study||1
24331|NCT02207413|59808|P3|NOT COMPLETED|Overall Study||0
24332|NCT02207413|59809|P2|NOT COMPLETED|Overall Study||0
24333|NCT02207413|59810|P1|NOT COMPLETED|Overall Study||1
24334|NCT02207413|59805|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
24335|NCT02207413|59806|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
24336|NCT02207413|59807|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
24337|NCT02207413|59808|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
24338|NCT02207413|59809|P2|COMPLETED|Overall Study||60
24339|NCT02207413|59810|P1|COMPLETED|Overall Study||59
24340|NCT02207413|59805|P6|STARTED|Overall Study||474
24341|NCT02207413|59806|P5|STARTED|Overall Study||466
24342|NCT02207413|59807|P4|STARTED|Overall Study||411
24343|NCT02207413|59808|P3|STARTED|Overall Study||410
24344|NCT02207413|59809|P2|STARTED|Overall Study||60
24345|NCT02207413|59810|P1|STARTED|Overall Study||60
24346|NCT02207400|59906|P2|NOT COMPLETED|Overall Study||14
24347|NCT02207400|59907|P1|NOT COMPLETED|Overall Study||16
24348|NCT02207400|59906|P2|COMPLETED|Overall Study||109
24349|NCT02207400|59907|P1|COMPLETED|Overall Study||107
24350|NCT02207400|59906|P2|STARTED|Overall Study||123
24351|NCT02207400|59907|P1|STARTED|Overall Study||123
24352|NCT02207244|59928|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
24353|NCT02207244|59929|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
24354|NCT02207244|59930|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
24355|NCT02207244|59931|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24356|NCT02207244|59932|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24357|NCT02207244|59933|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24358|NCT02207244|59934|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24359|NCT02207244|59935|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24360|NCT02207244|59936|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24361|NCT02207244|59928|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
24362|NCT02207244|59929|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
24363|NCT02207244|59930|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
24364|NCT02207244|59931|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24365|NCT02207244|59932|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24366|NCT02207244|59933|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24367|NCT02207244|59934|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24368|NCT02207244|59935|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24369|NCT02207244|59936|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
24370|NCT02207244|59928|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
24371|NCT02207244|59929|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
24372|NCT02207244|59930|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
24373|NCT02207244|59931|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
24374|NCT02207244|59932|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
24375|NCT02207244|59933|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
24376|NCT02207244|59934|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
24377|NCT02207244|59935|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
24378|NCT02207244|59936|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
24379|NCT02207244|59928|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24380|NCT02207244|59929|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
24381|NCT02207244|59930|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24382|NCT02207244|59931|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24383|NCT02207244|59932|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24384|NCT02207244|59933|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24385|NCT02207244|59934|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24386|NCT02207244|59935|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24387|NCT02207244|59936|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24388|NCT02207244|59928|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
24389|NCT02207244|59929|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
24390|NCT02207244|59930|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
24391|NCT02207244|59931|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24392|NCT02207244|59932|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24393|NCT02207244|59933|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24394|NCT02207244|59934|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24395|NCT02207244|59935|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24396|NCT02207244|59936|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
24550|NCT02206607|60028|P3|STARTED|Third Intervention Period||9
24397|NCT02207244|59928|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
24398|NCT02207244|59929|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
24399|NCT02207244|59930|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
24400|NCT02207244|59931|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
24401|NCT02207244|59932|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
24402|NCT02207244|59933|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
24403|NCT02207244|59934|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
24404|NCT02207244|59935|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
24405|NCT02207244|59936|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
24406|NCT02207244|59928|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
24407|NCT02207244|59929|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
24408|NCT02207244|59930|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
24409|NCT02207244|59931|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
24410|NCT02207244|59932|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
24411|NCT02207244|59933|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
24412|NCT02207244|59934|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
24413|NCT02207244|59935|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
24414|NCT02207244|59936|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
24415|NCT02207244|59928|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24416|NCT02207244|59929|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24417|NCT02207244|59930|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24418|NCT02207244|59931|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
24419|NCT02207244|59932|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
24420|NCT02207244|59933|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
24421|NCT02207244|59934|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24422|NCT02207244|59935|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24423|NCT02207244|59936|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24424|NCT02207244|59928|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24425|NCT02207244|59929|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24426|NCT02207244|59930|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24427|NCT02207244|59931|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
24428|NCT02207244|59932|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
24429|NCT02207244|59933|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
24430|NCT02207244|59934|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24431|NCT02207244|59935|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24432|NCT02207244|59936|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
24433|NCT02207244|59928|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
24434|NCT02207244|59929|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
24435|NCT02207244|59930|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
24436|NCT02207244|59931|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
24437|NCT02207244|59932|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
24438|NCT02207244|59933|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
24439|NCT02207244|59934|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
24440|NCT02207244|59935|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
24441|NCT02207244|59936|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
24442|NCT02207244|59928|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24443|NCT02207244|59929|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24444|NCT02207244|59930|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24445|NCT02207244|59931|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24446|NCT02207244|59932|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24447|NCT02207244|59933|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24448|NCT02207244|59934|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
24449|NCT02207244|59935|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
24450|NCT02207244|59936|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
24451|NCT02207244|59928|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24452|NCT02207244|59929|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24453|NCT02207244|59930|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24454|NCT02207244|59931|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24455|NCT02207244|59932|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24456|NCT02207244|59933|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
24457|NCT02207244|59934|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
24458|NCT02207244|59935|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
24459|NCT02207244|59936|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
24460|NCT02207244|59928|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
24461|NCT02207244|59929|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
24462|NCT02207244|59930|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
24463|NCT02207244|59931|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
24464|NCT02207244|59932|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
24465|NCT02207244|59933|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
24466|NCT02207244|59934|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
24467|NCT02207244|59935|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
24468|NCT02207244|59936|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
24469|NCT02207244|59928|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
24470|NCT02207244|59929|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
24471|NCT02207244|59930|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
24472|NCT02207244|59931|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
24473|NCT02207244|59932|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
24474|NCT02207244|59933|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
24475|NCT02207244|59934|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
24476|NCT02207244|59935|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
24477|NCT02207244|59936|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
24478|NCT02207231|59977|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
24479|NCT02207231|59978|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
24480|NCT02207231|59979|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
24481|NCT02207231|59977|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
24482|NCT02207231|59978|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
24483|NCT02207231|59979|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
24484|NCT02207231|59977|P3|STARTED|Active Controlled Period: Week 16 - 48||324
24485|NCT02207231|59978|P2|STARTED|Active Controlled Period: Week 16 - 48||322
24486|NCT02207231|59979|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
24487|NCT02207231|59977|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
24488|NCT02207231|59978|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
24489|NCT02207231|59979|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
24490|NCT02207231|59977|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
24491|NCT02207231|59978|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
24492|NCT02207231|59979|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
24493|NCT02207231|59977|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
24494|NCT02207231|59978|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
24495|NCT02207231|59979|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
24496|NCT02207231|59977|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
24497|NCT02207231|59978|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
24498|NCT02207231|59979|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
24499|NCT02207088|60011|P1|NOT COMPLETED|Overall Study||2
24500|NCT02207088|60011|P1|COMPLETED|Overall Study||66
24501|NCT02207088|60011|P1|STARTED|Overall Study||68
24502|NCT02206776|60019|P2|NOT COMPLETED|Overall Study||0
24503|NCT02206776|60020|P1|NOT COMPLETED|Overall Study||0
24504|NCT02206776|60019|P2|COMPLETED|Overall Study||1
24505|NCT02206776|60020|P1|COMPLETED|Overall Study||1
24506|NCT02206776|60019|P2|STARTED|Overall Study||1
24507|NCT02206776|60020|P1|STARTED|Overall Study||1
24508|NCT02206607|60026|P5|NOT COMPLETED|Fourth Intervention Period||0
24509|NCT02206607|60027|P4|NOT COMPLETED|Fourth Intervention Period||0
24510|NCT02206607|60028|P3|NOT COMPLETED|Fourth Intervention Period||0
24511|NCT02206607|60029|P2|NOT COMPLETED|Fourth Intervention Period||0
24512|NCT02206607|60030|P1|NOT COMPLETED|Fourth Intervention Period||0
24513|NCT02206607|60026|P5|COMPLETED|Fourth Intervention Period||10
24514|NCT02206607|60027|P4|COMPLETED|Fourth Intervention Period||10
24515|NCT02206607|60028|P3|COMPLETED|Fourth Intervention Period||9
24516|NCT02206607|60029|P2|COMPLETED|Fourth Intervention Period||9
24517|NCT02206607|60030|P1|COMPLETED|Fourth Intervention Period||0
24518|NCT02206607|60026|P5|STARTED|Fourth Intervention Period||10
24519|NCT02206607|60027|P4|STARTED|Fourth Intervention Period||10
24520|NCT02206607|60028|P3|STARTED|Fourth Intervention Period||9
24521|NCT02206607|60029|P2|STARTED|Fourth Intervention Period||9
24522|NCT02206607|60030|P1|STARTED|Fourth Intervention Period||0
24523|NCT02206607|60026|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
24524|NCT02206607|60027|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
24525|NCT02206607|60028|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
24526|NCT02206607|60029|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
24527|NCT02206607|60030|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
24528|NCT02206607|60026|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
24529|NCT02206607|60027|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
24530|NCT02206607|60028|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
24531|NCT02206607|60029|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
24532|NCT02206607|60030|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
24533|NCT02206607|60026|P5|STARTED|Third Washout Period 5 to 10 Days||10
24534|NCT02206607|60027|P4|STARTED|Third Washout Period 5 to 10 Days||10
24535|NCT02206607|60028|P3|STARTED|Third Washout Period 5 to 10 Days||9
24536|NCT02206607|60029|P2|STARTED|Third Washout Period 5 to 10 Days||9
24537|NCT02206607|60030|P1|STARTED|Third Washout Period 5 to 10 Days||0
24538|NCT02206607|60026|P5|NOT COMPLETED|Third Intervention Period||0
24539|NCT02206607|60027|P4|NOT COMPLETED|Third Intervention Period||0
24540|NCT02206607|60028|P3|NOT COMPLETED|Third Intervention Period||0
24541|NCT02206607|60029|P2|NOT COMPLETED|Third Intervention Period||0
24542|NCT02206607|60030|P1|NOT COMPLETED|Third Intervention Period||0
24543|NCT02206607|60026|P5|COMPLETED|Third Intervention Period||10
24544|NCT02206607|60027|P4|COMPLETED|Third Intervention Period||10
24545|NCT02206607|60028|P3|COMPLETED|Third Intervention Period||9
24546|NCT02206607|60029|P2|COMPLETED|Third Intervention Period||9
24547|NCT02206607|60030|P1|COMPLETED|Third Intervention Period||0
24548|NCT02206607|60026|P5|STARTED|Third Intervention Period||10
24549|NCT02206607|60027|P4|STARTED|Third Intervention Period||10
24551|NCT02206607|60029|P2|STARTED|Third Intervention Period||9
24552|NCT02206607|60030|P1|STARTED|Third Intervention Period||0
24553|NCT02206607|60026|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
24554|NCT02206607|60027|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
24555|NCT02206607|60028|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
24556|NCT02206607|60029|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
24557|NCT02206607|60030|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
24558|NCT02206607|60026|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
24559|NCT02206607|60027|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
24560|NCT02206607|60028|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
24561|NCT02206607|60029|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
24562|NCT02206607|60030|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
24563|NCT02206607|60026|P5|STARTED|Second Washout Period 5 to 10 Days||10
24564|NCT02206607|60027|P4|STARTED|Second Washout Period 5 to 10 Days||10
24565|NCT02206607|60028|P3|STARTED|Second Washout Period 5 to 10 Days||9
24566|NCT02206607|60029|P2|STARTED|Second Washout Period 5 to 10 Days||9
24567|NCT02206607|60030|P1|STARTED|Second Washout Period 5 to 10 Days||0
24568|NCT02206607|60026|P5|NOT COMPLETED|Second Intervention Period||0
24569|NCT02206607|60027|P4|NOT COMPLETED|Second Intervention Period||1
24570|NCT02206607|60028|P3|NOT COMPLETED|Second Intervention Period||0
24571|NCT02206607|60029|P2|NOT COMPLETED|Second Intervention Period||0
24572|NCT02206607|60030|P1|NOT COMPLETED|Second Intervention Period||0
24573|NCT02206607|60026|P5|COMPLETED|Second Intervention Period||10
24574|NCT02206607|60027|P4|COMPLETED|Second Intervention Period||10
24575|NCT02206607|60028|P3|COMPLETED|Second Intervention Period||9
24576|NCT02206607|60029|P2|COMPLETED|Second Intervention Period||9
24577|NCT02206607|60030|P1|COMPLETED|Second Intervention Period||0
24578|NCT02206607|60026|P5|STARTED|Second Intervention Period||10
24579|NCT02206607|60027|P4|STARTED|Second Intervention Period||11
24580|NCT02206607|60028|P3|STARTED|Second Intervention Period||9
24581|NCT02206607|60029|P2|STARTED|Second Intervention Period||9
24582|NCT02206607|60030|P1|STARTED|Second Intervention Period||0
24583|NCT02206607|60026|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
24584|NCT02206607|60027|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
24585|NCT02206607|60028|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
24586|NCT02206607|60029|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
24587|NCT02206607|60030|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
24588|NCT02206607|60026|P5|COMPLETED|First Washout Period 5 to 10 Days||10
24589|NCT02206607|60027|P4|COMPLETED|First Washout Period 5 to 10 Days||11
24590|NCT02206607|60028|P3|COMPLETED|First Washout Period 5 to 10 Days||9
24591|NCT02206607|60029|P2|COMPLETED|First Washout Period 5 to 10 Days||9
24592|NCT02206607|60030|P1|COMPLETED|First Washout Period 5 to 10 Days||0
24593|NCT02206607|60026|P5|STARTED|First Washout Period 5 to 10 Days||10
24594|NCT02206607|60027|P4|STARTED|First Washout Period 5 to 10 Days||11
24595|NCT02206607|60028|P3|STARTED|First Washout Period 5 to 10 Days||9
24596|NCT02206607|60029|P2|STARTED|First Washout Period 5 to 10 Days||9
24597|NCT02206607|60030|P1|STARTED|First Washout Period 5 to 10 Days||0
24598|NCT02206607|60026|P5|NOT COMPLETED|First Intervention Period||0
24599|NCT02206607|60027|P4|NOT COMPLETED|First Intervention Period||0
24600|NCT02206607|60028|P3|NOT COMPLETED|First Intervention Period||0
24601|NCT02206607|60029|P2|NOT COMPLETED|First Intervention Period||0
24602|NCT02206607|60030|P1|NOT COMPLETED|First Intervention Period||0
24603|NCT02206607|60026|P5|COMPLETED|First Intervention Period||10
24604|NCT02206607|60027|P4|COMPLETED|First Intervention Period||11
24605|NCT02206607|60028|P3|COMPLETED|First Intervention Period||9
24606|NCT02206607|60029|P2|COMPLETED|First Intervention Period||9
24607|NCT02206607|60030|P1|COMPLETED|First Intervention Period||0
24608|NCT02206607|60026|P5|STARTED|First Intervention Period||10
24609|NCT02206607|60027|P4|STARTED|First Intervention Period||11
24610|NCT02206607|60028|P3|STARTED|First Intervention Period||9
24611|NCT02206607|60029|P2|STARTED|First Intervention Period||9
24612|NCT02206607|60030|P1|STARTED|First Intervention Period||0
24613|NCT02206607|60026|P5|NOT COMPLETED|Open-Label Run-In||0
24614|NCT02206607|60027|P4|NOT COMPLETED|Open-Label Run-In||0
24615|NCT02206607|60028|P3|NOT COMPLETED|Open-Label Run-In||0
24616|NCT02206607|60029|P2|NOT COMPLETED|Open-Label Run-In||0
24617|NCT02206607|60030|P1|NOT COMPLETED|Open-Label Run-In||3
24618|NCT02206607|60026|P5|COMPLETED|Open-Label Run-In||0
24619|NCT02206607|60027|P4|COMPLETED|Open-Label Run-In||0
24620|NCT02206607|60028|P3|COMPLETED|Open-Label Run-In||0
24621|NCT02206607|60029|P2|COMPLETED|Open-Label Run-In||0
24622|NCT02206607|60030|P1|COMPLETED|Open-Label Run-In||39
24623|NCT02206607|60026|P5|STARTED|Open-Label Run-In||0
24624|NCT02206607|60027|P4|STARTED|Open-Label Run-In||0
24625|NCT02206607|60028|P3|STARTED|Open-Label Run-In||0
24626|NCT02206607|60029|P2|STARTED|Open-Label Run-In||0
24627|NCT02206607|60030|P1|STARTED|Open-Label Run-In||42
24628|NCT02205814|60086|P4|NOT COMPLETED|Overall Study||4
24629|NCT02205814|60087|P3|NOT COMPLETED|Overall Study||5
24630|NCT02205814|60088|P2|NOT COMPLETED|Overall Study||1
24631|NCT02205814|60089|P1|NOT COMPLETED|Overall Study||2
24632|NCT02205814|60086|P4|COMPLETED|Overall Study||104
24633|NCT02205814|60087|P3|COMPLETED|Overall Study||103
24634|NCT02205814|60088|P2|COMPLETED|Overall Study||109
24635|NCT02205814|60089|P1|COMPLETED|Overall Study||108
24636|NCT02205814|60086|P4|STARTED|Overall Study||108
24637|NCT02205814|60087|P3|STARTED|Overall Study||108
24638|NCT02205814|60088|P2|STARTED|Overall Study||110
24639|NCT02205814|60089|P1|STARTED|Overall Study||110
24640|NCT02205801|60115|P4|NOT COMPLETED|Overall Study||0
24641|NCT02205801|60116|P3|NOT COMPLETED|Overall Study||0
24642|NCT02205801|60117|P2|NOT COMPLETED|Overall Study||0
24643|NCT02205801|60118|P1|NOT COMPLETED|Overall Study||0
24644|NCT02205801|60115|P4|COMPLETED|Overall Study||8
24645|NCT02205801|60116|P3|COMPLETED|Overall Study||9
24646|NCT02205801|60117|P2|COMPLETED|Overall Study||8
24647|NCT02205801|60118|P1|COMPLETED|Overall Study||11
24648|NCT02205801|60115|P4|STARTED|Overall Study||8
24649|NCT02205801|60116|P3|STARTED|Overall Study||9
24650|NCT02205801|60117|P2|STARTED|Overall Study||8
24651|NCT02205801|60118|P1|STARTED|Overall Study||11
24652|NCT02205476|60142|P2|NOT COMPLETED|Overall Study||3
24653|NCT02205476|60143|P1|NOT COMPLETED|Overall Study||7
24654|NCT02205476|60142|P2|COMPLETED|Overall Study||0
24655|NCT02205476|60143|P1|COMPLETED|Overall Study||0
24656|NCT02205476|60142|P2|STARTED|Overall Study||3
24657|NCT02205476|60143|P1|STARTED|Overall Study||7
24658|NCT02205333|60182|P9|NOT COMPLETED|Overall Study||0
24659|NCT02205333|60183|P8|NOT COMPLETED|Overall Study||2
24660|NCT02205333|60184|P7|NOT COMPLETED|Overall Study||5
24661|NCT02205333|60185|P6|NOT COMPLETED|Overall Study||3
24662|NCT02205333|60186|P5|NOT COMPLETED|Overall Study||5
24663|NCT02205333|60187|P4|NOT COMPLETED|Overall Study||7
24664|NCT02205333|60188|P3|NOT COMPLETED|Overall Study||2
24665|NCT02205333|60189|P2|NOT COMPLETED|Overall Study||6
24666|NCT02205333|60190|P1|NOT COMPLETED|Overall Study||6
24667|NCT02205333|60182|P9|COMPLETED|Overall Study||1
24668|NCT02205333|60183|P8|COMPLETED|Overall Study||1
24669|NCT02205333|60184|P7|COMPLETED|Overall Study||2
24670|NCT02205333|60185|P6|COMPLETED|Overall Study||4
24671|NCT02205333|60186|P5|COMPLETED|Overall Study||1
24672|NCT02205333|60187|P4|COMPLETED|Overall Study||0
24673|NCT02205333|60188|P3|COMPLETED|Overall Study||1
24674|NCT02205333|60189|P2|COMPLETED|Overall Study||0
24675|NCT02205333|60190|P1|COMPLETED|Overall Study||2
24676|NCT02205333|60182|P9|STARTED|Overall Study||1
24677|NCT02205333|60183|P8|STARTED|Overall Study||3
24678|NCT02205333|60184|P7|STARTED|Overall Study||7
24679|NCT02205333|60185|P6|STARTED|Overall Study||7
24680|NCT02205333|60186|P5|STARTED|Overall Study||6
24681|NCT02205333|60187|P4|STARTED|Overall Study||7
24682|NCT02205333|60188|P3|STARTED|Overall Study||3
24683|NCT02205333|60189|P2|STARTED|Overall Study||6
24684|NCT02205333|60190|P1|STARTED|Overall Study||8
24685|NCT02204748|60363|P1|NOT COMPLETED|Overall Study||0
24686|NCT02204748|60363|P1|COMPLETED|Overall Study||5
24687|NCT02204748|60363|P1|STARTED|Overall Study||5
24688|NCT02204657|60377|P2|NOT COMPLETED|Overall Study||0
24689|NCT02204657|60378|P1|NOT COMPLETED|Overall Study||7
24690|NCT02204657|60377|P2|COMPLETED|Overall Study||25
24691|NCT02204657|60378|P1|COMPLETED|Overall Study||25
24692|NCT02204657|60377|P2|STARTED|Overall Study||25
24693|NCT02204657|60378|P1|STARTED|Overall Study||32
24694|NCT02204579|60386|P1|NOT COMPLETED|Overall Study||2
24695|NCT02204579|60386|P1|COMPLETED|Overall Study||5
24696|NCT02204579|60386|P1|Treated|Overall Study||5
24697|NCT02204579|60386|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
24698|NCT02204579|60386|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
24699|NCT02204579|60386|P1|STARTED|Overall Study||7
24700|NCT02204449|60440|P2|NOT COMPLETED|Overall Study||11
24701|NCT02204449|60441|P1|NOT COMPLETED|Overall Study||7
24702|NCT02204449|60440|P2|COMPLETED|Overall Study||37
24703|NCT02204449|60441|P1|COMPLETED|Overall Study||39
24704|NCT02204449|60440|P2|STARTED|Overall Study||48
24705|NCT02204449|60441|P1|STARTED|Overall Study||46
24706|NCT02204410|60451|P1|NOT COMPLETED|Overall Study||11
24707|NCT02204410|60451|P1|COMPLETED|Overall Study||10
24708|NCT02204410|60451|P1|STARTED|Overall Study||21
24709|NCT02204371|60456|P1|NOT COMPLETED|Overall Study||1
24710|NCT02204371|60456|P1|COMPLETED|Overall Study||6
24711|NCT02204371|60456|P1|STARTED|Overall Study||7
24712|NCT02204319|60479|P1|NOT COMPLETED|Overall Study||3
24713|NCT02204319|60479|P1|COMPLETED|Overall Study|3 did not complete study.|7
24714|NCT02204319|60479|P1|STARTED|Overall Study||10
24715|NCT02204007|60487|P2|NOT COMPLETED|Overall Study||1
24716|NCT02204007|60488|P1|NOT COMPLETED|Overall Study||1
24717|NCT02204007|60487|P2|COMPLETED|Overall Study||17
24718|NCT02204007|60488|P1|COMPLETED|Overall Study||17
24719|NCT02204007|60487|P2|STARTED|Overall Study||18
24720|NCT02204007|60488|P1|STARTED|Overall Study||18
24721|NCT02203916|60499|P3|NOT COMPLETED|Overall Study||11
24722|NCT02203916|60500|P2|NOT COMPLETED|Overall Study||10
24723|NCT02203916|60501|P1|NOT COMPLETED|Overall Study||8
24724|NCT02203916|60499|P3|COMPLETED|Overall Study||120
24725|NCT02203916|60500|P2|COMPLETED|Overall Study||122
24726|NCT02203916|60501|P1|COMPLETED|Overall Study||57
24727|NCT02203916|60499|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
24728|NCT02203916|60500|P2|Safety Analysis Set (SAS)|Overall Study||132
24729|NCT02203916|60501|P1|Safety Analysis Set (SAS)|Overall Study||65
24730|NCT02203916|60499|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
24731|NCT02203916|60500|P2|Full Analysis Set (FAS)|Overall Study||132
24732|NCT02203916|60501|P1|Full Analysis Set (FAS)|Overall Study||65
24733|NCT02203916|60499|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
24734|NCT02203916|60500|P2|STARTED|Overall Study||132
24735|NCT02203916|60501|P1|STARTED|Overall Study||65
24736|NCT02203786|60525|P4|NOT COMPLETED|Overall Study||0
24737|NCT02203786|60526|P3|NOT COMPLETED|Overall Study||2
24738|NCT02203786|60527|P2|NOT COMPLETED|Overall Study||0
24739|NCT02203786|60528|P1|NOT COMPLETED|Overall Study||0
24740|NCT02203786|60525|P4|COMPLETED|Overall Study||15
24741|NCT02203786|60526|P3|COMPLETED|Overall Study||15
24742|NCT02203786|60527|P2|COMPLETED|Overall Study||15
24743|NCT02203786|60528|P1|COMPLETED|Overall Study||15
24744|NCT02203786|60525|P4|STARTED|Overall Study||15
24745|NCT02203786|60526|P3|STARTED|Overall Study||17
24746|NCT02203786|60527|P2|STARTED|Overall Study||15
24747|NCT02203786|60528|P1|STARTED|Overall Study||15
24748|NCT02203747|60560|P2|NOT COMPLETED|Overall Study||0
24749|NCT02203747|60561|P1|NOT COMPLETED|Overall Study||0
24750|NCT02203747|60560|P2|COMPLETED|Overall Study||34
24751|NCT02203747|60561|P1|COMPLETED|Overall Study||45
24752|NCT02203747|60560|P2|STARTED|Overall Study||34
24753|NCT02203747|60561|P1|STARTED|Overall Study||45
24754|NCT02203721|60571|P2|NOT COMPLETED|Overall Study||3
24755|NCT02203721|60572|P1|NOT COMPLETED|Overall Study||1
24756|NCT02203721|60571|P2|COMPLETED|Overall Study||148
24757|NCT02203721|60572|P1|COMPLETED|Overall Study||147
24758|NCT02203721|60571|P2|STARTED|Overall Study||151
24759|NCT02203721|60572|P1|STARTED|Overall Study||148
24760|NCT02203578|60580|P1|NOT COMPLETED|Overall Study||0
24761|NCT02203578|60580|P1|COMPLETED|Overall Study||1
24762|NCT02203578|60580|P1|STARTED|Overall Study||1
24763|NCT02203565|60592|P1|NOT COMPLETED|Overall Study||1
24764|NCT02203565|60592|P1|COMPLETED|Overall Study||19
24765|NCT02203565|60592|P1|STARTED|Overall Study||20
24766|NCT02203331|60602|P6|NOT COMPLETED|Overall Study||7
24767|NCT02203331|60603|P5|NOT COMPLETED|Overall Study||7
24768|NCT02203331|60604|P4|NOT COMPLETED|Overall Study||7
24769|NCT02203331|60605|P3|NOT COMPLETED|Overall Study||5
24770|NCT02203331|60606|P2|NOT COMPLETED|Overall Study||14
24771|NCT02203331|60607|P1|NOT COMPLETED|Overall Study||7
24772|NCT02203331|60602|P6|COMPLETED|Overall Study||46
24773|NCT02203331|60603|P5|COMPLETED|Overall Study||46
24774|NCT02203331|60604|P4|COMPLETED|Overall Study||46
24775|NCT02203331|60605|P3|COMPLETED|Overall Study||50
24776|NCT02203331|60606|P2|COMPLETED|Overall Study||39
24777|NCT02203331|60607|P1|COMPLETED|Overall Study||45
24778|NCT02203331|60602|P6|Treated|Overall Study||53
24779|NCT02203331|60603|P5|Treated|Overall Study||50
24780|NCT02203331|60604|P4|Treated|Overall Study||49
24781|NCT02203331|60605|P3|Treated|Overall Study||54
24782|NCT02203331|60606|P2|Treated|Overall Study||50
24783|NCT02203331|60607|P1|Treated|Overall Study||49
24784|NCT02203331|60602|P6|STARTED|Overall Study||53
24785|NCT02203331|60603|P5|STARTED|Overall Study||53
24786|NCT02203331|60604|P4|STARTED|Overall Study||53
24787|NCT02203331|60605|P3|STARTED|Overall Study||55
24788|NCT02203331|60606|P2|STARTED|Overall Study||53
24789|NCT02203331|60607|P1|STARTED|Overall Study||52
24790|NCT02203162|60657|P1|NOT COMPLETED|Overall Study||0
24791|NCT02203162|60657|P1|COMPLETED|Overall Study||30
24792|NCT02203162|60657|P1|STARTED|Overall Study||30
24793|NCT02203149|60666|P5|NOT COMPLETED|Part 2||1
24794|NCT02203149|60667|P4|NOT COMPLETED|Part 2||3
24795|NCT02203149|60668|P3|NOT COMPLETED|Part 2||1
24796|NCT02203149|60669|P2|NOT COMPLETED|Part 2||0
24797|NCT02203149|60670|P1|NOT COMPLETED|Part 2||0
24798|NCT02203149|60666|P5|COMPLETED|Part 2||34
24799|NCT02203149|60667|P4|COMPLETED|Part 2||71
24800|NCT02203149|60668|P3|COMPLETED|Part 2||226
24801|NCT02203149|60669|P2|COMPLETED|Part 2||0
24802|NCT02203149|60670|P1|COMPLETED|Part 2||0
24803|NCT02203149|60666|P5|Started Deferred Active Treatment|Part 2||0
24804|NCT02203149|60667|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
24805|NCT02203149|60668|P3|Started Deferred Active Treatment|Part 2||0
24806|NCT02203149|60669|P2|Started Deferred Active Treatment|Part 2||0
24807|NCT02203149|60670|P1|Started Deferred Active Treatment|Part 2||0
24808|NCT02203149|60666|P5|STARTED|Part 2||35
24809|NCT02203149|60667|P4|STARTED|Part 2||74
24810|NCT02203149|60668|P3|STARTED|Part 2||227
24811|NCT02203149|60669|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
24812|NCT02203149|60670|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
24813|NCT02203149|60666|P5|NOT COMPLETED|Part 1||0
24814|NCT02203149|60667|P4|NOT COMPLETED|Part 1||0
24815|NCT02203149|60668|P3|NOT COMPLETED|Part 1||0
24816|NCT02203149|60669|P2|NOT COMPLETED|Part 1||1
24817|NCT02203149|60670|P1|NOT COMPLETED|Part 1||0
24818|NCT02203149|60666|P5|COMPLETED|Part 1||0
24819|NCT02203149|60667|P4|COMPLETED|Part 1||0
24820|NCT02203149|60668|P3|COMPLETED|Part 1||0
24821|NCT02203149|60669|P2|COMPLETED|Part 1||31
24822|NCT02203149|60670|P1|COMPLETED|Part 1||31
24823|NCT02203149|60666|P5|STARTED|Part 1||0
24824|NCT02203149|60667|P4|STARTED|Part 1||0
24825|NCT02203149|60668|P3|STARTED|Part 1||0
24826|NCT02203149|60669|P2|STARTED|Part 1||32
24827|NCT02203149|60670|P1|STARTED|Part 1||31
24828|NCT02203032|60703|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
24829|NCT02203032|60704|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
24830|NCT02203032|60705|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
24831|NCT02203032|60706|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
24832|NCT02203032|60703|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
24833|NCT02203032|60704|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
24834|NCT02203032|60705|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
24835|NCT02203032|60706|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
24836|NCT02203032|60703|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
24837|NCT02203032|60704|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
24838|NCT02203032|60705|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
24839|NCT02203032|60706|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
24840|NCT02203032|60703|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
24841|NCT02203032|60704|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
24842|NCT02203032|60705|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
24843|NCT02203032|60706|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
24844|NCT02203032|60703|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
24845|NCT02203032|60704|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
24846|NCT02203032|60705|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
24847|NCT02203032|60706|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
24848|NCT02203032|60703|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
24849|NCT02203032|60704|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
24850|NCT02203032|60705|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
24851|NCT02203032|60706|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
24852|NCT02203032|60703|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
24853|NCT02203032|60704|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
24854|NCT02203032|60705|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
24855|NCT02203032|60706|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
24856|NCT02202980|60734|P14|NOT COMPLETED|Overall Study||0
24857|NCT02202980|60735|P13|NOT COMPLETED|Overall Study||11
24858|NCT02202980|60736|P12|NOT COMPLETED|Overall Study||3
24859|NCT02202980|60737|P11|NOT COMPLETED|Overall Study||0
24860|NCT02202980|60738|P10|NOT COMPLETED|Overall Study||0
24861|NCT02202980|60739|P9|NOT COMPLETED|Overall Study||4
24862|NCT02202980|60740|P8|NOT COMPLETED|Overall Study||3
24863|NCT02202980|60741|P7|NOT COMPLETED|Overall Study||11
24864|NCT02202980|60742|P6|NOT COMPLETED|Overall Study||1
24865|NCT02202980|60743|P5|NOT COMPLETED|Overall Study||6
24866|NCT02202980|60744|P4|NOT COMPLETED|Overall Study||4
24867|NCT02202980|60745|P3|NOT COMPLETED|Overall Study||10
24868|NCT02202980|60746|P2|NOT COMPLETED|Overall Study||2
24869|NCT02202980|60747|P1|NOT COMPLETED|Overall Study||1
24870|NCT02202980|60734|P14|COMPLETED|Overall Study||4
24871|NCT02202980|60735|P13|COMPLETED|Overall Study||19
24872|NCT02202980|60736|P12|COMPLETED|Overall Study||25
24873|NCT02202980|60737|P11|COMPLETED|Overall Study||19
24874|NCT02202980|60738|P10|COMPLETED|Overall Study||17
24875|NCT02202980|60739|P9|COMPLETED|Overall Study||14
24876|NCT02202980|60740|P8|COMPLETED|Overall Study||12
24877|NCT02202980|60741|P7|COMPLETED|Overall Study||4
24878|NCT02202980|60742|P6|COMPLETED|Overall Study||14
24879|NCT02202980|60743|P5|COMPLETED|Overall Study||7
24880|NCT02202980|60744|P4|COMPLETED|Overall Study||28
24881|NCT02202980|60745|P3|COMPLETED|Overall Study||17
24882|NCT02202980|60746|P2|COMPLETED|Overall Study||24
24883|NCT02202980|60747|P1|COMPLETED|Overall Study||13
24884|NCT02202980|60734|P14|STARTED|Overall Study||4
24885|NCT02202980|60735|P13|STARTED|Overall Study||30
24886|NCT02202980|60736|P12|STARTED|Overall Study||28
24887|NCT02202980|60737|P11|STARTED|Overall Study||19
24888|NCT02202980|60738|P10|STARTED|Overall Study||17
24889|NCT02202980|60739|P9|STARTED|Overall Study||18
24890|NCT02202980|60740|P8|STARTED|Overall Study||15
24891|NCT02202980|60741|P7|STARTED|Overall Study||15
24892|NCT02202980|60742|P6|STARTED|Overall Study||15
24893|NCT02202980|60743|P5|STARTED|Overall Study||13
24894|NCT02202980|60744|P4|STARTED|Overall Study||32
24895|NCT02202980|60745|P3|STARTED|Overall Study||27
24896|NCT02202980|60746|P2|STARTED|Overall Study||26
24897|NCT02202980|60747|P1|STARTED|Overall Study||14
24898|NCT02202785|60836|P3|NOT COMPLETED|Overall Study||17
24899|NCT02202785|60837|P2|NOT COMPLETED|Overall Study||15
24900|NCT02202785|60838|P1|NOT COMPLETED|Overall Study||11
24901|NCT02202785|60836|P3|COMPLETED|Overall Study||0
24902|NCT02202785|60837|P2|COMPLETED|Overall Study||0
24903|NCT02202785|60838|P1|COMPLETED|Overall Study||0
24904|NCT02202785|60836|P3|STARTED|Overall Study||17
24905|NCT02202785|60837|P2|STARTED|Overall Study||15
24906|NCT02202785|60838|P1|STARTED|Overall Study||11
24907|NCT02202759|60875|P3|NOT COMPLETED|Overall Study||14
24908|NCT02202759|60876|P2|NOT COMPLETED|Overall Study||15
24909|NCT02202759|60877|P1|NOT COMPLETED|Overall Study||9
24910|NCT02202759|60875|P3|COMPLETED|Overall Study||0
24911|NCT02202759|60876|P2|COMPLETED|Overall Study||0
24912|NCT02202759|60877|P1|COMPLETED|Overall Study||0
24913|NCT02202759|60875|P3|STARTED|Overall Study||14
24914|NCT02202759|60876|P2|STARTED|Overall Study||15
24915|NCT02202759|60877|P1|STARTED|Overall Study||9
24916|NCT02202538|60911|P1|NOT COMPLETED|Overall Study||8
24917|NCT02202538|60911|P1|COMPLETED|Overall Study||45
24918|NCT02202538|60911|P1|Screen Failure|Overall Study||2
24919|NCT02202538|60911|P1|STARTED|Overall Study||53
24920|NCT02202317|60922|P1|NOT COMPLETED|Overall Study||1
24921|NCT02202317|60922|P1|COMPLETED|Overall Study||8
24922|NCT02202317|60922|P1|STARTED|Overall Study||9
24923|NCT02202252|60930|P2|NOT COMPLETED|Overall Study||0
24924|NCT02202252|60931|P1|NOT COMPLETED|Overall Study||0
24925|NCT02202252|60930|P2|COMPLETED|Overall Study||30
24926|NCT02202252|60931|P1|COMPLETED|Overall Study||30
24927|NCT02202252|60930|P2|STARTED|Overall Study||30
24928|NCT02202252|60931|P1|STARTED|Overall Study||30
24929|NCT02202161|60949|P8|NOT COMPLETED|Overall Study||6
24930|NCT02202161|60950|P7|NOT COMPLETED|Overall Study||0
24931|NCT02202161|60951|P6|NOT COMPLETED|Overall Study||1
24932|NCT02202161|60952|P5|NOT COMPLETED|Overall Study||1
24933|NCT02202161|60953|P4|NOT COMPLETED|Overall Study||0
24934|NCT02202161|60954|P3|NOT COMPLETED|Overall Study||0
24935|NCT02202161|60955|P2|NOT COMPLETED|Overall Study||1
24936|NCT02202161|60956|P1|NOT COMPLETED|Overall Study||1
24937|NCT02202161|60949|P8|COMPLETED|Overall Study||0
24938|NCT02202161|60950|P7|COMPLETED|Overall Study||13
24939|NCT02202161|60951|P6|COMPLETED|Overall Study||9
24940|NCT02202161|60952|P5|COMPLETED|Overall Study||8
24941|NCT02202161|60953|P4|COMPLETED|Overall Study||9
24942|NCT02202161|60954|P3|COMPLETED|Overall Study||5
24943|NCT02202161|60955|P2|COMPLETED|Overall Study||4
24944|NCT02202161|60956|P1|COMPLETED|Overall Study||12
24945|NCT02202161|60949|P8|STARTED|Overall Study||6
24946|NCT02202161|60950|P7|STARTED|Overall Study||13
24947|NCT02202161|60951|P6|STARTED|Overall Study||10
24948|NCT02202161|60952|P5|STARTED|Overall Study||9
24949|NCT02202161|60953|P4|STARTED|Overall Study||9
24950|NCT02202161|60954|P3|STARTED|Overall Study||5
24951|NCT02202161|60955|P2|STARTED|Overall Study||5
24952|NCT02202161|60956|P1|STARTED|Overall Study||13
24953|NCT02202135|61110|P1|NOT COMPLETED|Overall Study||0
24954|NCT02202135|61110|P1|COMPLETED|Overall Study||4
24955|NCT02202135|61110|P1|STARTED|Overall Study||4
24956|NCT02201953|61116|P2|NOT COMPLETED|Overall Study||56
24957|NCT02201953|61117|P1|NOT COMPLETED|Overall Study||20
24958|NCT02201953|61116|P2|COMPLETED|Overall Study||224
24959|NCT02201953|61117|P1|COMPLETED|Overall Study||258
24960|NCT02201953|61116|P2|STARTED|Overall Study||280
24961|NCT02201953|61117|P1|STARTED|Overall Study||278
24962|NCT02201940|61135|P2|NOT COMPLETED|Overall Study||116
24963|NCT02201940|61136|P1|NOT COMPLETED|Overall Study||12
24964|NCT02201940|61135|P2|COMPLETED|Overall Study||0
24965|NCT02201940|61136|P1|COMPLETED|Overall Study||613
24966|NCT02201940|61135|P2|STARTED|Overall Study||116
24967|NCT02201940|61136|P1|STARTED|Overall Study||625
24968|NCT02201901|61155|P3|NOT COMPLETED|Overall Study||13
24969|NCT02201901|61156|P2|NOT COMPLETED|Overall Study||9
24970|NCT02201901|61157|P1|NOT COMPLETED|Overall Study||15
24971|NCT02201901|61155|P3|COMPLETED|Overall Study||77
24972|NCT02201901|61156|P2|COMPLETED|Overall Study||79
24973|NCT02201901|61157|P1|COMPLETED|Overall Study||75
24974|NCT02201901|61155|P3|STARTED|Overall Study||90
24975|NCT02201901|61156|P2|STARTED|Overall Study||88
24976|NCT02201901|61157|P1|STARTED|Overall Study||90
24977|NCT02201784|61188|P2|NOT COMPLETED|Overall Study||0
24978|NCT02201784|61189|P1|NOT COMPLETED|Overall Study||2
24979|NCT02201784|61188|P2|COMPLETED|Overall Study||30
24980|NCT02201784|61189|P1|COMPLETED|Overall Study||28
24981|NCT02201784|61188|P2|STARTED|Overall Study||30
24982|NCT02201784|61189|P1|STARTED|Overall Study||30
24983|NCT02201524|61207|P4|NOT COMPLETED|Overall Study||4
24984|NCT02201524|61208|P3|NOT COMPLETED|Overall Study||4
24985|NCT02201524|61209|P2|NOT COMPLETED|Overall Study||3
24986|NCT02201524|61210|P1|NOT COMPLETED|Overall Study||2
24987|NCT02201524|61207|P4|COMPLETED|Overall Study||10
24988|NCT02201524|61208|P3|COMPLETED|Overall Study||12
24989|NCT02201524|61209|P2|COMPLETED|Overall Study||12
24990|NCT02201524|61210|P1|COMPLETED|Overall Study||12
24991|NCT02201524|61207|P4|STARTED|Overall Study||14
24992|NCT02201524|61208|P3|STARTED|Overall Study||16
24993|NCT02201524|61209|P2|STARTED|Overall Study||15
24994|NCT02201524|61210|P1|STARTED|Overall Study||14
24995|NCT02201446|61294|P2|NOT COMPLETED|Overall Study||0
24996|NCT02201446|61295|P1|NOT COMPLETED|Overall Study||0
24997|NCT02201446|61294|P2|COMPLETED|Overall Study||58
24998|NCT02201446|61295|P1|COMPLETED|Overall Study||81
24999|NCT02201446|61294|P2|STARTED|Overall Study||58
25000|NCT02201446|61295|P1|STARTED|Overall Study||81
25001|NCT02201420|61323|P1|NOT COMPLETED|Overall Study||0
25002|NCT02201420|61323|P1|COMPLETED|Overall Study||5
25003|NCT02201420|61323|P1|STARTED|Overall Study||5
25004|NCT02201394|61328|P1|NOT COMPLETED|Maintenance Dose||0
25005|NCT02201394|61328|P1|COMPLETED|Maintenance Dose||20
25006|NCT02201394|61328|P1|STARTED|Maintenance Dose||20
25007|NCT02201394|61328|P1|NOT COMPLETED|Loading Dose||0
25008|NCT02201394|61328|P1|COMPLETED|Loading Dose||20
25009|NCT02201394|61328|P1|STARTED|Loading Dose||20
25010|NCT02201056|61342|P7|NOT COMPLETED|Overall Study||0
25011|NCT02201056|61343|P6|NOT COMPLETED|Overall Study||0
25012|NCT02201056|61344|P5|NOT COMPLETED|Overall Study||0
25013|NCT02201056|61345|P4|NOT COMPLETED|Overall Study||0
25014|NCT02201056|61346|P3|NOT COMPLETED|Overall Study||0
25015|NCT02201056|61347|P2|NOT COMPLETED|Overall Study||0
25016|NCT02201056|61348|P1|NOT COMPLETED|Overall Study||0
25017|NCT02201056|61342|P7|COMPLETED|Overall Study||6
25018|NCT02201056|61343|P6|COMPLETED|Overall Study||6
25019|NCT02201056|61344|P5|COMPLETED|Overall Study||6
25020|NCT02201056|61345|P4|COMPLETED|Overall Study||6
25021|NCT02201056|61346|P3|COMPLETED|Overall Study||6
25022|NCT02201056|61347|P2|COMPLETED|Overall Study||6
25023|NCT02201056|61348|P1|COMPLETED|Overall Study||12
25024|NCT02201056|61342|P7|STARTED|Overall Study||6
25025|NCT02201056|61343|P6|STARTED|Overall Study||6
25026|NCT02201056|61344|P5|STARTED|Overall Study||6
25027|NCT02201056|61345|P4|STARTED|Overall Study||6
25028|NCT02201056|61346|P3|STARTED|Overall Study||6
25029|NCT02201056|61347|P2|STARTED|Overall Study||6
25030|NCT02201056|61348|P1|STARTED|Overall Study||12
25031|NCT02200536|61406|P3|NOT COMPLETED|Overall Study||0
25032|NCT02200536|61407|P2|NOT COMPLETED|Overall Study||0
25033|NCT02200536|61408|P1|NOT COMPLETED|Overall Study||0
25034|NCT02200536|61406|P3|COMPLETED|Overall Study||30
25035|NCT02200536|61407|P2|COMPLETED|Overall Study||30
25036|NCT02200536|61408|P1|COMPLETED|Overall Study||32
25037|NCT02200536|61406|P3|STARTED|Overall Study||30
25038|NCT02200536|61407|P2|STARTED|Overall Study||30
25039|NCT02200536|61408|P1|STARTED|Overall Study||32
25040|NCT02200458|61419|P1|NOT COMPLETED|Overall Study||0
25041|NCT02200458|61419|P1|COMPLETED|Overall Study||62
25042|NCT02200458|61419|P1|STARTED|Overall Study||62
25043|NCT02200328|61425|P2|NOT COMPLETED|Overall Study||33
25044|NCT02200328|61426|P1|NOT COMPLETED|Overall Study||43
25045|NCT02200328|61425|P2|COMPLETED|Overall Study||0
25046|NCT02200328|61426|P1|COMPLETED|Overall Study||0
25047|NCT02200328|61425|P2|STARTED|Overall Study||33
25048|NCT02200328|61426|P1|STARTED|Overall Study||43
25049|NCT02199795|61436|P2|NOT COMPLETED|Overall Study||0
25050|NCT02199795|61437|P1|NOT COMPLETED|Overall Study||2
25051|NCT02199795|61436|P2|COMPLETED|Overall Study||3
25052|NCT02199795|61437|P1|COMPLETED|Overall Study||2
25053|NCT02199795|61436|P2|STARTED|Overall Study||3
25054|NCT02199795|61437|P1|STARTED|Overall Study||4
25055|NCT02199717|61449|P1|NOT COMPLETED|Overall Study||0
25056|NCT02199717|61449|P1|COMPLETED|Overall Study||66
25057|NCT02199717|61449|P1|STARTED|Overall Study||66
25058|NCT02199574|61456|P1|NOT COMPLETED|Overall Study||0
25059|NCT02199574|61456|P1|COMPLETED|Overall Study||12
25060|NCT02199574|61456|P1|STARTED|Overall Study||12
25061|NCT02199509|61465|P2|NOT COMPLETED|Overall Study||1
25062|NCT02199509|61466|P1|NOT COMPLETED|Overall Study||1
25063|NCT02199509|61465|P2|COMPLETED|Overall Study||3
25064|NCT02199509|61466|P1|COMPLETED|Overall Study||2
25065|NCT02199509|61465|P2|STARTED|Overall Study||4
25066|NCT02199509|61466|P1|STARTED|Overall Study||3
25067|NCT02199041|61478|P1|NOT COMPLETED|Overall Study||0
25068|NCT02199041|61478|P1|COMPLETED|Overall Study||12
25069|NCT02199041|61478|P1|STARTED|Overall Study||12
25070|NCT02198963|61491|P1|NOT COMPLETED|Overall Study||7
25071|NCT02198963|61491|P1|COMPLETED|Overall Study||36
25072|NCT02198963|61491|P1|STARTED|Overall Study||43
25073|NCT02198833|61502|P2|NOT COMPLETED|Overall Study||0
25074|NCT02198833|61503|P1|NOT COMPLETED|Overall Study||0
25075|NCT02198833|61502|P2|COMPLETED|Overall Study||1
25076|NCT02198833|61503|P1|COMPLETED|Overall Study||1
25077|NCT02198833|61502|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
25078|NCT02198833|61503|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
25079|NCT02198430|61517|P2|NOT COMPLETED|Overall Study||0
25080|NCT02198430|61518|P1|NOT COMPLETED|Overall Study||0
25081|NCT02198430|61517|P2|COMPLETED|Overall Study||51
25082|NCT02198430|61518|P1|COMPLETED|Overall Study||53
25083|NCT02198430|61517|P2|STARTED|Overall Study||51
25084|NCT02198430|61518|P1|STARTED|Overall Study||53
25085|NCT02198235|61533|P3|NOT COMPLETED|Overall Study||2
25086|NCT02198235|61534|P2|NOT COMPLETED|Overall Study||2
25087|NCT02198235|61535|P1|NOT COMPLETED|Overall Study||3
25088|NCT02198235|61533|P3|COMPLETED|Overall Study||28
25089|NCT02198235|61534|P2|COMPLETED|Overall Study||28
25090|NCT02198235|61535|P1|COMPLETED|Overall Study||27
25091|NCT02198235|61533|P3|STARTED|Overall Study||30
25092|NCT02198235|61534|P2|STARTED|Overall Study||30
25093|NCT02198235|61535|P1|STARTED|Overall Study||30
25094|NCT02198040|61555|P3|NOT COMPLETED|Overall Study||1
25095|NCT02198040|61556|P2|NOT COMPLETED|Overall Study||1
25096|NCT02198040|61557|P1|NOT COMPLETED|Overall Study||0
25097|NCT02198040|61555|P3|COMPLETED|Overall Study||8
25098|NCT02198040|61556|P2|COMPLETED|Overall Study||8
25099|NCT02198040|61557|P1|COMPLETED|Overall Study||9
25100|NCT02198040|61555|P3|STARTED|Overall Study||9
25101|NCT02198040|61556|P2|STARTED|Overall Study||9
25102|NCT02198040|61557|P1|STARTED|Overall Study||9
25103|NCT02197806|61587|P4|NOT COMPLETED|Overall Study||1
25104|NCT02197806|61588|P3|NOT COMPLETED|Overall Study||0
25105|NCT02197806|61589|P2|NOT COMPLETED|Overall Study||1
25106|NCT02197806|61590|P1|NOT COMPLETED|Overall Study||0
25107|NCT02197806|61587|P4|COMPLETED|Overall Study||16
25108|NCT02197806|61588|P3|COMPLETED|Overall Study||16
25109|NCT02197806|61589|P2|COMPLETED|Overall Study||16
25110|NCT02197806|61590|P1|COMPLETED|Overall Study||15
25111|NCT02197806|61587|P4|STARTED|Overall Study||17
25112|NCT02197806|61588|P3|STARTED|Overall Study||16
25113|NCT02197806|61589|P2|STARTED|Overall Study||17
25114|NCT02197806|61590|P1|STARTED|Overall Study||15
25115|NCT02197481|61602|P2|NOT COMPLETED|Overall Study||0
25116|NCT02197481|61603|P1|NOT COMPLETED|Overall Study||0
25117|NCT02197481|61602|P2|COMPLETED|Overall Study||43
25118|NCT02197481|61603|P1|COMPLETED|Overall Study|February 2016|43
25119|NCT02197481|61602|P2|STARTED|Overall Study||43
25120|NCT02197481|61603|P1|STARTED|Overall Study|October 2014|43
25121|NCT02197455|61623|P1|NOT COMPLETED|Overall Study||0
25122|NCT02197455|61623|P1|COMPLETED|Overall Study||30
25123|NCT02197455|61623|P1|STARTED|Overall Study||30
25124|NCT02197273|61630|P2|NOT COMPLETED|Overall Study||0
25125|NCT02197273|61631|P1|NOT COMPLETED|Overall Study||0
25126|NCT02197273|61630|P2|COMPLETED|Overall Study||104
25127|NCT02197273|61631|P1|COMPLETED|Overall Study||107
25128|NCT02197273|61630|P2|STARTED|Overall Study||104
25129|NCT02197273|61631|P1|STARTED|Overall Study||107
25130|NCT02197247|61641|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
25131|NCT02197247|61641|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
25132|NCT02197247|61641|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
25133|NCT02197247|61641|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
25134|NCT02197247|61641|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
25135|NCT02197247|61641|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
25136|NCT02197247|61641|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
25137|NCT02197247|61641|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
25138|NCT02197247|61641|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
25139|NCT02197247|61641|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
25140|NCT02197247|61641|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
25141|NCT02197247|61641|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
25142|NCT02197234|61686|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
25143|NCT02197234|61686|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
25144|NCT02197234|61686|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
25145|NCT02197234|61686|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
25146|NCT02197234|61686|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
25147|NCT02197234|61686|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
25148|NCT02197234|61686|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
25149|NCT02197234|61686|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
25150|NCT02197234|61686|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
25151|NCT02197234|61686|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
25152|NCT02197234|61686|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
25153|NCT02197234|61686|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
25154|NCT02197130|61708|P3|NOT COMPLETED|Overall Study||32
25155|NCT02197130|61709|P2|NOT COMPLETED|Overall Study||8
25156|NCT02197130|61710|P1|NOT COMPLETED|Overall Study||16
25157|NCT02197130|61708|P3|COMPLETED|Overall Study||56
25158|NCT02197130|61709|P2|COMPLETED|Overall Study||81
25159|NCT02197130|61710|P1|COMPLETED|Overall Study||79
25160|NCT02197130|61708|P3|Received Treatment|Overall Study||87
25161|NCT02197130|61709|P2|Received Treatment|Overall Study||88
25162|NCT02197130|61710|P1|Received Treatment|Overall Study||95
25163|NCT02197130|61708|P3|STARTED|Overall Study||88
25164|NCT02197130|61709|P2|STARTED|Overall Study||89
25165|NCT02197130|61710|P1|STARTED|Overall Study||95
25166|NCT02197065|61762|P2|NOT COMPLETED|Overall Study||0
25167|NCT02197065|61763|P1|NOT COMPLETED|Overall Study||0
25168|NCT02197065|61762|P2|COMPLETED|Overall Study||10
25169|NCT02197065|61763|P1|COMPLETED|Overall Study||10
25170|NCT02197065|61762|P2|STARTED|Overall Study||10
25171|NCT02197065|61763|P1|STARTED|Overall Study||10
25172|NCT02196922|61774|P2|NOT COMPLETED|Overall Study||0
25173|NCT02196922|61775|P1|NOT COMPLETED|Overall Study||0
25174|NCT02196922|61774|P2|COMPLETED|Overall Study||46
25175|NCT02196922|61775|P1|COMPLETED|Overall Study||58
25176|NCT02196922|61774|P2|STARTED|Overall Study||46
25177|NCT02196922|61775|P1|STARTED|Overall Study||58
25178|NCT02196766|61785|P2|NOT COMPLETED|Second Intervention (7 Days)||0
25179|NCT02196766|61786|P1|NOT COMPLETED|Second Intervention (7 Days)||0
25180|NCT02196766|61785|P2|COMPLETED|Second Intervention (7 Days)||15
25181|NCT02196766|61786|P1|COMPLETED|Second Intervention (7 Days)||15
25182|NCT02196766|61785|P2|STARTED|Second Intervention (7 Days)||15
25183|NCT02196766|61786|P1|STARTED|Second Intervention (7 Days)||15
25184|NCT02196766|61785|P2|NOT COMPLETED|First Intervention (7 Days)||0
25185|NCT02196766|61786|P1|NOT COMPLETED|First Intervention (7 Days)||0
25186|NCT02196766|61785|P2|COMPLETED|First Intervention (7 Days)||15
25187|NCT02196766|61786|P1|COMPLETED|First Intervention (7 Days)||15
25188|NCT02196766|61785|P2|STARTED|First Intervention (7 Days)||15
25189|NCT02196766|61786|P1|STARTED|First Intervention (7 Days)||15
25190|NCT02196714|61802|P4|NOT COMPLETED|Overall Study||0
25191|NCT02196714|61803|P3|NOT COMPLETED|Overall Study||1
25192|NCT02196714|61804|P2|NOT COMPLETED|Overall Study||0
25193|NCT02196714|61805|P1|NOT COMPLETED|Overall Study||0
25194|NCT02196714|61802|P4|COMPLETED|Overall Study||24
25195|NCT02196714|61803|P3|COMPLETED|Overall Study||23
25196|NCT02196714|61804|P2|COMPLETED|Overall Study||23
25197|NCT02196714|61805|P1|COMPLETED|Overall Study||24
25198|NCT02196714|61802|P4|STARTED|Overall Study||24
25199|NCT02196714|61803|P3|STARTED|Overall Study||24
25200|NCT02196714|61804|P2|STARTED|Overall Study||23
25201|NCT02196714|61805|P1|STARTED|Overall Study||24
25202|NCT02196701|61927|P1|NOT COMPLETED|Overall Study||3
25203|NCT02196701|61927|P1|COMPLETED|Overall Study||43
25204|NCT02196701|61927|P1|STARTED|Overall Study||46
25205|NCT02196675|61986|P3|NOT COMPLETED|Overall Study||1
25206|NCT02196675|61987|P2|NOT COMPLETED|Overall Study||2
25207|NCT02196675|61988|P1|NOT COMPLETED|Overall Study||2
25208|NCT02196675|61986|P3|COMPLETED|Overall Study||7
25209|NCT02196675|61987|P2|COMPLETED|Overall Study||68
25210|NCT02196675|61988|P1|COMPLETED|Overall Study||25
25211|NCT02196675|61986|P3|STARTED|Overall Study||8
25212|NCT02196675|61987|P2|STARTED|Overall Study||70
25213|NCT02196675|61988|P1|STARTED|Overall Study||27
25214|NCT02196259|62011|P3|NOT COMPLETED|Overall Study||1
25215|NCT02196259|62012|P2|NOT COMPLETED|Overall Study||3
25216|NCT02196259|62013|P1|NOT COMPLETED|Overall Study||0
25217|NCT02196259|62011|P3|COMPLETED|Overall Study||2
25218|NCT02196259|62012|P2|COMPLETED|Overall Study||4
25219|NCT02196259|62013|P1|COMPLETED|Overall Study||3
25220|NCT02196259|62011|P3|STARTED|Overall Study||3
25221|NCT02196259|62012|P2|STARTED|Overall Study||7
25222|NCT02196259|62013|P1|STARTED|Overall Study||3
25223|NCT02196168|62022|P2|NOT COMPLETED|Overall Study||0
25224|NCT02196168|62023|P1|NOT COMPLETED|Overall Study||0
25225|NCT02196168|62022|P2|COMPLETED|Overall Study||0
25226|NCT02196168|62023|P1|COMPLETED|Overall Study||6
25227|NCT02196168|62022|P2|STARTED|Overall Study||0
25228|NCT02196168|62023|P1|STARTED|Overall Study||6
25229|NCT02196077|62041|P1|NOT COMPLETED|Overall Study||47
25230|NCT02196077|62041|P1|COMPLETED|Overall Study||133
25231|NCT02196077|62041|P1|FF MDI 9.6 μg|Overall Study||157
25232|NCT02196077|62041|P1|BD MDI 320 μg|Overall Study||108
25233|NCT02196077|62041|P1|BFF MDI 80/9.6 μg|Overall Study||103
25234|NCT02196077|62041|P1|BFF MDI 160/9.6 μg|Overall Study||106
25235|NCT02196077|62041|P1|BFF MDI 320/9.6 μg|Overall Study||155
25236|NCT02196077|62041|P1|STARTED|Overall Study||180
25237|NCT02195986|62091|P3|NOT COMPLETED|Overall Study||2
25238|NCT02195986|62092|P2|NOT COMPLETED|Overall Study||5
25239|NCT02195986|62093|P1|NOT COMPLETED|Overall Study||3
25240|NCT02195986|62091|P3|COMPLETED|Overall Study||71
25241|NCT02195986|62092|P2|COMPLETED|Overall Study||142
25242|NCT02195986|62093|P1|COMPLETED|Overall Study||143
25243|NCT02195986|62091|P3|STARTED|Overall Study||73
25244|NCT02195986|62092|P2|STARTED|Overall Study||147
25245|NCT02195986|62093|P1|STARTED|Overall Study||146
25246|NCT02195713|62110|P2|NOT COMPLETED|Overall Study||0
25247|NCT02195713|62111|P1|NOT COMPLETED|Overall Study||0
25248|NCT02195713|62110|P2|COMPLETED|Overall Study||10
25249|NCT02195713|62111|P1|COMPLETED|Overall Study||10
25250|NCT02195713|62110|P2|STARTED|Overall Study||10
25251|NCT02195713|62111|P1|STARTED|Overall Study||10
25252|NCT02195700|62119|P2|NOT COMPLETED|Overall Study||7
25253|NCT02195700|62120|P1|NOT COMPLETED|Overall Study||6
25254|NCT02195700|62119|P2|COMPLETED|Overall Study||52
25255|NCT02195700|62120|P1|COMPLETED|Overall Study||52
25256|NCT02195700|62119|P2|Maintenance Period|Overall Study||54
25257|NCT02195700|62120|P1|Maintenance Period|Overall Study||53
25258|NCT02195700|62119|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
25259|NCT02195700|62120|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
25260|NCT02195700|62119|P2|Safety and ITT Populations|Overall Study||59
25261|NCT02195700|62120|P1|Safety and ITT Populations|Overall Study||58
25262|NCT02195700|62119|P2|STARTED|Overall Study||59
25263|NCT02195700|62120|P1|STARTED|Overall Study||58
25264|NCT02195687|62142|P2|NOT COMPLETED|Overall Study||2
25265|NCT02195687|62143|P1|NOT COMPLETED|Overall Study||5
25266|NCT02195687|62142|P2|COMPLETED|Overall Study||99
25267|NCT02195687|62143|P1|COMPLETED|Overall Study||311
25268|NCT02195687|62142|P2|STARTED|Overall Study||101
25269|NCT02195687|62143|P1|STARTED|Overall Study||316
25270|NCT02195583|62159|P1|NOT COMPLETED|Overall Study||9
25271|NCT02195583|62159|P1|COMPLETED|Overall Study||53
25272|NCT02195583|62159|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
25273|NCT02195583|62159|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
25274|NCT02195583|62159|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
25362|NCT02193165|62553|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
25275|NCT02195583|62159|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
25276|NCT02195583|62159|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
25277|NCT02195583|62159|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
25278|NCT02195583|62159|P1|STARTED|Overall Study||62
25279|NCT02195427|62193|P2|NOT COMPLETED|Overall Study||27
25280|NCT02195427|62194|P1|NOT COMPLETED|Overall Study||26
25281|NCT02195427|62193|P2|COMPLETED|Overall Study||47
25282|NCT02195427|62194|P1|COMPLETED|Overall Study||47
25283|NCT02195427|62193|P2|N Patients at W52|Overall Study||56
25284|NCT02195427|62194|P1|N Patients at W52|Overall Study||63
25285|NCT02195427|62193|P2|N Patients at W36|Overall Study||59
25286|NCT02195427|62194|P1|N Patients at W36|Overall Study||65
25287|NCT02195427|62193|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
25288|NCT02195427|62194|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
25289|NCT02195427|62193|P2|STARTED|Overall Study||74
25290|NCT02195427|62194|P1|STARTED|Overall Study||73
25291|NCT02195414|62256|P1|NOT COMPLETED|Overall Study||0
25292|NCT02195414|62256|P1|COMPLETED|Overall Study||31
25293|NCT02195414|62256|P1|Primary Endpoint|Overall Study||31
25294|NCT02195414|62256|P1|STARTED|Overall Study||31
25295|NCT02194699|62265|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
25296|NCT02194699|62266|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
25297|NCT02194699|62265|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
25298|NCT02194699|62266|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
25299|NCT02194699|62265|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
25300|NCT02194699|62266|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
25301|NCT02194699|62265|P2|NOT COMPLETED|Randomised||11
25302|NCT02194699|62266|P1|NOT COMPLETED|Randomised||8
25303|NCT02194699|62265|P2|COMPLETED|Randomised||417
25304|NCT02194699|62266|P1|COMPLETED|Randomised||420
25305|NCT02194699|62265|P2|STARTED|Randomised||428
25306|NCT02194699|62266|P1|STARTED|Randomised||428
25307|NCT02194621|62374|P3|NOT COMPLETED|Overall Study||9
25308|NCT02194621|62375|P2|NOT COMPLETED|Overall Study||6
25309|NCT02194621|62376|P1|NOT COMPLETED|Overall Study||6
25310|NCT02194621|62374|P3|COMPLETED|Overall Study||34
25311|NCT02194621|62375|P2|COMPLETED|Overall Study||36
25312|NCT02194621|62376|P1|COMPLETED|Overall Study||37
25313|NCT02194621|62374|P3|STARTED|Overall Study||43
25314|NCT02194621|62375|P2|STARTED|Overall Study||42
25315|NCT02194621|62376|P1|STARTED|Overall Study||43
25316|NCT02194088|62395|P2|NOT COMPLETED|Overall Study||0
25317|NCT02194088|62396|P1|NOT COMPLETED|Overall Study||0
25318|NCT02194088|62395|P2|COMPLETED|Overall Study||25
25319|NCT02194088|62396|P1|COMPLETED|Overall Study||75
25320|NCT02194088|62395|P2|STARTED|Overall Study||25
25321|NCT02194088|62396|P1|STARTED|Overall Study||75
25322|NCT02194062|62409|P3|NOT COMPLETED|Overall Study||5
25323|NCT02194062|62410|P2|NOT COMPLETED|Overall Study||2
25324|NCT02194062|62411|P1|NOT COMPLETED|Overall Study||2
25325|NCT02194062|62409|P3|COMPLETED|Overall Study||7
25326|NCT02194062|62410|P2|COMPLETED|Overall Study||8
25327|NCT02194062|62411|P1|COMPLETED|Overall Study||8
25328|NCT02194062|62409|P3|STARTED|Overall Study||12
25329|NCT02194062|62410|P2|STARTED|Overall Study||10
25330|NCT02194062|62411|P1|STARTED|Overall Study||10
25331|NCT02193828|62426|P4|NOT COMPLETED|Overall Study||1
25332|NCT02193828|62427|P3|NOT COMPLETED|Overall Study||1
25333|NCT02193828|62428|P2|NOT COMPLETED|Overall Study||0
25334|NCT02193828|62429|P1|NOT COMPLETED|Overall Study||0
25335|NCT02193828|62426|P4|COMPLETED|Overall Study||16
25336|NCT02193828|62427|P3|COMPLETED|Overall Study||22
25337|NCT02193828|62428|P2|COMPLETED|Overall Study||18
25338|NCT02193828|62429|P1|COMPLETED|Overall Study||18
25339|NCT02193828|62426|P4|STARTED|Overall Study||17
25340|NCT02193828|62427|P3|STARTED|Overall Study||23
25341|NCT02193828|62428|P2|STARTED|Overall Study||18
25342|NCT02193828|62429|P1|STARTED|Overall Study||18
25343|NCT02193815|62467|P1|NOT COMPLETED|Overall Study||0
25344|NCT02193815|62467|P1|COMPLETED|Overall Study||15
25345|NCT02193815|62467|P1|STARTED|Overall Study||15
25346|NCT02193178|62502|P1|NOT COMPLETED|Overall Study||2
25347|NCT02193178|62502|P1|COMPLETED|Overall Study||13
25348|NCT02193178|62502|P1|STARTED|Overall Study||15
25349|NCT02193165|62552|P3|NOT COMPLETED|6 Week Product Use||0
25350|NCT02193165|62553|P2|NOT COMPLETED|6 Week Product Use||1
25351|NCT02193165|62554|P1|NOT COMPLETED|6 Week Product Use||0
25352|NCT02193165|62552|P3|COMPLETED|6 Week Product Use||39
25353|NCT02193165|62553|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
25354|NCT02193165|62554|P1|COMPLETED|6 Week Product Use||39
25355|NCT02193165|62552|P3|STARTED|6 Week Product Use||39
25356|NCT02193165|62553|P2|STARTED|6 Week Product Use||39
25357|NCT02193165|62554|P1|STARTED|6 Week Product Use||39
25358|NCT02193165|62552|P3|NOT COMPLETED|4 Week Product Use||1
25359|NCT02193165|62553|P2|NOT COMPLETED|4 Week Product Use||1
25360|NCT02193165|62554|P1|NOT COMPLETED|4 Week Product Use||1
25361|NCT02193165|62552|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
25363|NCT02193165|62554|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
25364|NCT02193165|62552|P3|STARTED|4 Week Product Use||40
25365|NCT02193165|62553|P2|STARTED|4 Week Product Use||40
25366|NCT02193165|62554|P1|STARTED|4 Week Product Use||40
25367|NCT02193087|62581|P4|NOT COMPLETED|Overall Study||79
25368|NCT02193087|62582|P3|NOT COMPLETED|Overall Study||7
25369|NCT02193087|62583|P2|NOT COMPLETED|Overall Study||14
25370|NCT02193087|62584|P1|NOT COMPLETED|Overall Study||37
25371|NCT02193087|62581|P4|COMPLETED|Overall Study||524
25372|NCT02193087|62582|P3|COMPLETED|Overall Study||93
25373|NCT02193087|62583|P2|COMPLETED|Overall Study||86
25374|NCT02193087|62584|P1|COMPLETED|Overall Study||162
25375|NCT02193087|62581|P4|Received Vaccination|Overall Study||602
25376|NCT02193087|62582|P3|Received Vaccination|Overall Study||100
25377|NCT02193087|62583|P2|Received Vaccination|Overall Study||97
25378|NCT02193087|62584|P1|Received Vaccination|Overall Study||197
25379|NCT02193087|62581|P4|STARTED|Overall Study||603
25380|NCT02193087|62582|P3|STARTED|Overall Study||100
25381|NCT02193087|62583|P2|STARTED|Overall Study||100
25382|NCT02193087|62584|P1|STARTED|Overall Study||199
25383|NCT02193074|62629|P2|NOT COMPLETED|Overall Study||15
25384|NCT02193074|62630|P1|NOT COMPLETED|Overall Study||17
25385|NCT02193074|62629|P2|COMPLETED|Overall Study||65
25386|NCT02193074|62630|P1|COMPLETED|Overall Study||24
25387|NCT02193074|62629|P2|Completed Due to Early Study Termination|Overall Study||39
25388|NCT02193074|62630|P1|Completed Due to Early Study Termination|Overall Study||13
25389|NCT02193074|62629|P2|Completed During Follow-Up Period|Overall Study||26
25390|NCT02193074|62630|P1|Completed During Follow-Up Period|Overall Study||11
25391|NCT02193074|62629|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
25392|NCT02193074|62630|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
25393|NCT02192905|62662|P1|NOT COMPLETED|Overall Study||1
25394|NCT02192905|62662|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
25395|NCT02192905|62662|P1|STARTED|Overall Study||43
25396|NCT02192879|62676|P3|NOT COMPLETED|Overall Study||0
25397|NCT02192879|62677|P2|NOT COMPLETED|Overall Study||0
25398|NCT02192879|62678|P1|NOT COMPLETED|Overall Study||0
25399|NCT02192879|62676|P3|COMPLETED|Overall Study||3
25400|NCT02192879|62677|P2|COMPLETED|Overall Study||4
25401|NCT02192879|62678|P1|COMPLETED|Overall Study||3
25402|NCT02192879|62676|P3|STARTED|Overall Study||3
25403|NCT02192879|62677|P2|STARTED|Overall Study||4
25404|NCT02192879|62678|P1|STARTED|Overall Study||3
25405|NCT02192814|62704|P1|NOT COMPLETED|Overall Study||0
25406|NCT02192814|62704|P1|COMPLETED|Overall Study||9
25407|NCT02192814|62704|P1|STARTED|Overall Study||9
25408|NCT02192684|62717|P2|NOT COMPLETED|Overall Study||0
25409|NCT02192684|62718|P1|NOT COMPLETED|Overall Study||0
25410|NCT02192684|62717|P2|COMPLETED|Overall Study||15
25411|NCT02192684|62718|P1|COMPLETED|Overall Study||30
25412|NCT02192684|62717|P2|STARTED|Overall Study||15
25413|NCT02192684|62718|P1|STARTED|Overall Study||30
25414|NCT02192606|62726|P2|NOT COMPLETED|Overall Study||4
25415|NCT02192606|62727|P1|NOT COMPLETED|Overall Study||2
25416|NCT02192606|62726|P2|COMPLETED|Overall Study||24
25417|NCT02192606|62727|P1|COMPLETED|Overall Study||27
25418|NCT02192606|62726|P2|STARTED|Overall Study||28
25419|NCT02192606|62727|P1|STARTED|Overall Study||29
25420|NCT02192541|62737|P2|NOT COMPLETED|Overall Study||0
25421|NCT02192541|62738|P1|NOT COMPLETED|Overall Study||0
25422|NCT02192541|62737|P2|COMPLETED|Overall Study||3
25423|NCT02192541|62738|P1|COMPLETED|Overall Study||2
25424|NCT02192541|62737|P2|Evaluable for Response|Overall Study||3
25425|NCT02192541|62738|P1|Evaluable for Response|Overall Study||1
25426|NCT02192541|62737|P2|Treated|Overall Study||3
25427|NCT02192541|62738|P1|Treated|Overall Study||2
25428|NCT02192541|62737|P2|STARTED|Overall Study||3
25429|NCT02192541|62738|P1|STARTED|Overall Study||2
25430|NCT02192164|62758|P1|NOT COMPLETED|Overall Study||14
25431|NCT02192164|62758|P1|COMPLETED|Overall Study||112
25432|NCT02192164|62758|P1|Etanercept Treated Population|Overall Study||112
25433|NCT02192164|62758|P1|STARTED|Overall Study||126
25434|NCT02191865|62777|P3|NOT COMPLETED|Overall Study||0
25435|NCT02191865|62778|P2|NOT COMPLETED|Overall Study||0
25436|NCT02191865|62779|P1|NOT COMPLETED|Overall Study||0
25437|NCT02191865|62777|P3|COMPLETED|Overall Study||17
25438|NCT02191865|62778|P2|COMPLETED|Overall Study||8
25439|NCT02191865|62779|P1|COMPLETED|Overall Study||8
25440|NCT02191865|62777|P3|STARTED|Overall Study||17
25441|NCT02191865|62778|P2|STARTED|Overall Study||8
25442|NCT02191865|62779|P1|STARTED|Overall Study||8
25443|NCT02191267|62802|P3|NOT COMPLETED|Overall Study||0
25444|NCT02191267|62803|P2|NOT COMPLETED|Overall Study||0
25445|NCT02191267|62804|P1|NOT COMPLETED|Overall Study||1
25446|NCT02191267|62802|P3|COMPLETED|Overall Study||4
25447|NCT02191267|62803|P2|COMPLETED|Overall Study||6
25448|NCT02191267|62804|P1|COMPLETED|Overall Study||19
25449|NCT02191267|62802|P3|STARTED|Overall Study||4
25450|NCT02191267|62803|P2|STARTED|Overall Study||6
25451|NCT02191267|62804|P1|STARTED|Overall Study||20
25452|NCT02191137|62815|P1|NOT COMPLETED|Follow-up||5
25453|NCT02191137|62815|P1|COMPLETED|Follow-up||60
25454|NCT02191137|62815|P1|STARTED|Follow-up||65
25455|NCT02191137|62815|P1|NOT COMPLETED|Treatment||10
25456|NCT02191137|62815|P1|COMPLETED|Treatment||65
25457|NCT02191137|62815|P1|STARTED|Treatment||75
25458|NCT02191046|62845|P2|NOT COMPLETED|Overall Study||1
25459|NCT02191046|62846|P1|NOT COMPLETED|Overall Study||5
25460|NCT02191046|62845|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
25461|NCT02191046|62846|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
25462|NCT02191046|62845|P2|STARTED|Overall Study||39
25463|NCT02191046|62846|P1|STARTED|Overall Study||41
25464|NCT02191033|62854|P2|NOT COMPLETED|Overall Study||1
25465|NCT02191033|62855|P1|NOT COMPLETED|Overall Study||2
25466|NCT02191033|62854|P2|COMPLETED|Overall Study||19
25467|NCT02191033|62855|P1|COMPLETED|Overall Study||18
25468|NCT02191033|62854|P2|STARTED|Overall Study||20
25469|NCT02191033|62855|P1|STARTED|Overall Study||20
25470|NCT02190604|62884|P19|NOT COMPLETED|Part 3 (Patients)||0
25471|NCT02190604|62885|P18|NOT COMPLETED|Part 3 (Patients)||0
25472|NCT02190604|62886|P17|NOT COMPLETED|Part 3 (Patients)||0
25473|NCT02190604|62887|P16|NOT COMPLETED|Part 3 (Patients)||0
25474|NCT02190604|62888|P15|NOT COMPLETED|Part 3 (Patients)||0
25475|NCT02190604|62889|P14|NOT COMPLETED|Part 3 (Patients)||0
25476|NCT02190604|62890|P13|NOT COMPLETED|Part 3 (Patients)||0
25477|NCT02190604|62891|P12|NOT COMPLETED|Part 3 (Patients)||0
25478|NCT02190604|62892|P11|NOT COMPLETED|Part 3 (Patients)||0
25479|NCT02190604|62893|P10|NOT COMPLETED|Part 3 (Patients)||0
25480|NCT02190604|62894|P9|NOT COMPLETED|Part 3 (Patients)||0
25481|NCT02190604|62895|P8|NOT COMPLETED|Part 3 (Patients)||0
25482|NCT02190604|62896|P7|NOT COMPLETED|Part 3 (Patients)||0
25483|NCT02190604|62897|P6|NOT COMPLETED|Part 3 (Patients)||0
25484|NCT02190604|62898|P5|NOT COMPLETED|Part 3 (Patients)||0
25485|NCT02190604|62899|P4|NOT COMPLETED|Part 3 (Patients)||0
25486|NCT02190604|62900|P3|NOT COMPLETED|Part 3 (Patients)||0
25487|NCT02190604|62901|P2|NOT COMPLETED|Part 3 (Patients)||0
25488|NCT02190604|62902|P1|NOT COMPLETED|Part 3 (Patients)||0
25489|NCT02190604|62884|P19|COMPLETED|Part 3 (Patients)||12
25490|NCT02190604|62885|P18|COMPLETED|Part 3 (Patients)||19
25491|NCT02190604|62886|P17|COMPLETED|Part 3 (Patients)||12
25492|NCT02190604|62887|P16|COMPLETED|Part 3 (Patients)||6
25493|NCT02190604|62888|P15|COMPLETED|Part 3 (Patients)||0
25494|NCT02190604|62889|P14|COMPLETED|Part 3 (Patients)||0
25495|NCT02190604|62890|P13|COMPLETED|Part 3 (Patients)||0
25496|NCT02190604|62891|P12|COMPLETED|Part 3 (Patients)||0
25497|NCT02190604|62892|P11|COMPLETED|Part 3 (Patients)||0
25498|NCT02190604|62893|P10|COMPLETED|Part 3 (Patients)||0
25499|NCT02190604|62894|P9|COMPLETED|Part 3 (Patients)||0
25500|NCT02190604|62895|P8|COMPLETED|Part 3 (Patients)||0
25501|NCT02190604|62896|P7|COMPLETED|Part 3 (Patients)||0
25502|NCT02190604|62897|P6|COMPLETED|Part 3 (Patients)||0
25503|NCT02190604|62898|P5|COMPLETED|Part 3 (Patients)||0
25504|NCT02190604|62899|P4|COMPLETED|Part 3 (Patients)||0
25505|NCT02190604|62900|P3|COMPLETED|Part 3 (Patients)||0
25506|NCT02190604|62901|P2|COMPLETED|Part 3 (Patients)||0
25507|NCT02190604|62902|P1|COMPLETED|Part 3 (Patients)||0
25508|NCT02190604|62884|P19|STARTED|Part 3 (Patients)||12
25509|NCT02190604|62885|P18|STARTED|Part 3 (Patients)||19
25510|NCT02190604|62886|P17|STARTED|Part 3 (Patients)||12
25511|NCT02190604|62887|P16|STARTED|Part 3 (Patients)||6
25512|NCT02190604|62888|P15|STARTED|Part 3 (Patients)||0
25513|NCT02190604|62889|P14|STARTED|Part 3 (Patients)||0
25514|NCT02190604|62890|P13|STARTED|Part 3 (Patients)||0
25515|NCT02190604|62891|P12|STARTED|Part 3 (Patients)||0
25516|NCT02190604|62892|P11|STARTED|Part 3 (Patients)||0
25517|NCT02190604|62893|P10|STARTED|Part 3 (Patients)||0
25518|NCT02190604|62894|P9|STARTED|Part 3 (Patients)||0
25519|NCT02190604|62895|P8|STARTED|Part 3 (Patients)||0
25520|NCT02190604|62896|P7|STARTED|Part 3 (Patients)||0
25521|NCT02190604|62897|P6|STARTED|Part 3 (Patients)||0
25522|NCT02190604|62898|P5|STARTED|Part 3 (Patients)||0
25523|NCT02190604|62899|P4|STARTED|Part 3 (Patients)||0
25524|NCT02190604|62900|P3|STARTED|Part 3 (Patients)||0
25525|NCT02190604|62901|P2|STARTED|Part 3 (Patients)||0
25526|NCT02190604|62902|P1|STARTED|Part 3 (Patients)||0
25527|NCT02190604|62884|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25528|NCT02190604|62885|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25529|NCT02190604|62886|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25530|NCT02190604|62887|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25531|NCT02190604|62888|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
25532|NCT02190604|62889|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
25533|NCT02190604|62890|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25534|NCT02190604|62891|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25535|NCT02190604|62892|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25536|NCT02190604|62893|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25537|NCT02190604|62894|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25538|NCT02190604|62895|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25539|NCT02190604|62896|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25540|NCT02190604|62897|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25541|NCT02190604|62898|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25542|NCT02190604|62899|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25543|NCT02190604|62900|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25544|NCT02190604|62901|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25545|NCT02190604|62902|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25546|NCT02190604|62884|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25547|NCT02190604|62885|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25548|NCT02190604|62886|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25549|NCT02190604|62887|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
25550|NCT02190604|62888|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
25551|NCT02190604|62889|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
25552|NCT02190604|62890|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25553|NCT02190604|62891|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25554|NCT02190604|62892|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25555|NCT02190604|62893|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25556|NCT02190604|62894|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
25557|NCT02190604|62895|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25558|NCT02190604|62896|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25559|NCT02190604|62897|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25560|NCT02190604|62898|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25561|NCT02190604|62899|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25562|NCT02190604|62900|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25563|NCT02190604|62901|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25564|NCT02190604|62902|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
25565|NCT02190604|62884|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
25566|NCT02190604|62885|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
25567|NCT02190604|62886|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
25568|NCT02190604|62887|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
25569|NCT02190604|62888|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
25570|NCT02190604|62889|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25571|NCT02190604|62890|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25572|NCT02190604|62891|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25573|NCT02190604|62892|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25574|NCT02190604|62893|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25575|NCT02190604|62894|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
25576|NCT02190604|62895|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25577|NCT02190604|62896|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25578|NCT02190604|62897|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25579|NCT02190604|62898|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25580|NCT02190604|62899|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25581|NCT02190604|62900|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25582|NCT02190604|62901|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25583|NCT02190604|62902|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
25584|NCT02190591|63093|P2|NOT COMPLETED|Overall Study||11
25585|NCT02190591|63094|P1|NOT COMPLETED|Overall Study||2
25586|NCT02190591|63093|P2|COMPLETED|Overall Study||91
25587|NCT02190591|63094|P1|COMPLETED|Overall Study||100
25588|NCT02190591|63093|P2|STARTED|Overall Study||102
25589|NCT02190591|63094|P1|STARTED|Overall Study||102
25590|NCT02190435|63106|P2|NOT COMPLETED|Overall Study||0
25591|NCT02190435|63107|P1|NOT COMPLETED|Overall Study||15
25592|NCT02190435|63106|P2|COMPLETED|Overall Study||24
25593|NCT02190435|63107|P1|COMPLETED|Overall Study||26
25594|NCT02190435|63106|P2|STARTED|Overall Study||24
25595|NCT02190435|63107|P1|STARTED|Overall Study||41
25596|NCT02189954|63117|P2|NOT COMPLETED|Overall Study||0
25597|NCT02189954|63118|P1|NOT COMPLETED|Overall Study||0
25598|NCT02189954|63117|P2|COMPLETED|Overall Study||45
25599|NCT02189954|63118|P1|COMPLETED|Overall Study||45
25600|NCT02189954|63117|P2|STARTED|Overall Study||45
25601|NCT02189954|63118|P1|STARTED|Overall Study||45
25602|NCT02189941|63126|P3|NOT COMPLETED|Overall Study||1
25603|NCT02189941|63127|P2|NOT COMPLETED|Overall Study||0
25604|NCT02189941|63128|P1|NOT COMPLETED|Overall Study||0
25605|NCT02189941|63126|P3|COMPLETED|Overall Study||2
25606|NCT02189941|63127|P2|COMPLETED|Overall Study||4
25607|NCT02189941|63128|P1|COMPLETED|Overall Study||4
25608|NCT02189941|63126|P3|STARTED|Overall Study||3
25609|NCT02189941|63127|P2|STARTED|Overall Study||4
25610|NCT02189941|63128|P1|STARTED|Overall Study||4
25611|NCT02189915|63151|P1|NOT COMPLETED|Overall Study||3
25612|NCT02189915|63151|P1|COMPLETED|Overall Study||11
25613|NCT02189915|63151|P1|STARTED|Overall Study||14
25614|NCT02189863|63156|P2|NOT COMPLETED|Second 2 Weeks||0
25615|NCT02189863|63157|P1|NOT COMPLETED|Second 2 Weeks||0
25616|NCT02189863|63156|P2|COMPLETED|Second 2 Weeks||13
25617|NCT02189863|63157|P1|COMPLETED|Second 2 Weeks||8
25618|NCT02189863|63156|P2|STARTED|Second 2 Weeks||13
25619|NCT02189863|63157|P1|STARTED|Second 2 Weeks||8
25620|NCT02189863|63156|P2|NOT COMPLETED|First 2 Weeks||2
25621|NCT02189863|63157|P1|NOT COMPLETED|First 2 Weeks||4
25622|NCT02189863|63156|P2|COMPLETED|First 2 Weeks||13
25623|NCT02189863|63157|P1|COMPLETED|First 2 Weeks||8
25624|NCT02189863|63156|P2|STARTED|First 2 Weeks||15
25625|NCT02189863|63157|P1|STARTED|First 2 Weeks||12
25626|NCT02189837|63172|P4|NOT COMPLETED|Overall Study||2
25627|NCT02189837|63173|P3|NOT COMPLETED|Overall Study||3
25628|NCT02189837|63174|P2|NOT COMPLETED|Overall Study||1
25629|NCT02189837|63175|P1|NOT COMPLETED|Overall Study||2
25630|NCT02189837|63172|P4|COMPLETED|Overall Study||19
25631|NCT02189837|63173|P3|COMPLETED|Overall Study||20
25632|NCT02189837|63174|P2|COMPLETED|Overall Study||22
25633|NCT02189837|63175|P1|COMPLETED|Overall Study||20
25634|NCT02189837|63172|P4|Received Treatment|Overall Study||20
25635|NCT02189837|63173|P3|Received Treatment|Overall Study||22
25636|NCT02189837|63174|P2|Received Treatment|Overall Study||22
25637|NCT02189837|63175|P1|Received Treatment|Overall Study||21
25638|NCT02189837|63172|P4|STARTED|Overall Study||21
25639|NCT02189837|63173|P3|STARTED|Overall Study||23
25640|NCT02189837|63174|P2|STARTED|Overall Study||23
25641|NCT02189837|63175|P1|STARTED|Overall Study||22
25642|NCT02189759|63205|P4|NOT COMPLETED|Overall Study||5
25643|NCT02189759|63206|P3|NOT COMPLETED|Overall Study||2
25644|NCT02189759|63207|P2|NOT COMPLETED|Overall Study||0
25645|NCT02189759|63208|P1|NOT COMPLETED|Overall Study||0
25646|NCT02189759|63205|P4|COMPLETED|Overall Study||84
25647|NCT02189759|63206|P3|COMPLETED|Overall Study||81
25648|NCT02189759|63207|P2|COMPLETED|Overall Study||101
25649|NCT02189759|63208|P1|COMPLETED|Overall Study||102
25650|NCT02189759|63205|P4|STARTED|Overall Study||89
25651|NCT02189759|63206|P3|STARTED|Overall Study||83
25652|NCT02189759|63207|P2|STARTED|Overall Study||101
25653|NCT02189759|63208|P1|STARTED|Overall Study||102
25654|NCT02189668|63228|P2|NOT COMPLETED|Overall Study||0
25655|NCT02189668|63229|P1|NOT COMPLETED|Overall Study||0
25656|NCT02189668|63228|P2|COMPLETED|Overall Study||9
25657|NCT02189668|63229|P1|COMPLETED|Overall Study||5
25658|NCT02189668|63228|P2|STARTED|Overall Study||9
25659|NCT02189668|63229|P1|STARTED|Overall Study||5
25660|NCT02189317|63239|P2|NOT COMPLETED|Overall Study||0
25661|NCT02189317|63240|P1|NOT COMPLETED|Overall Study||0
25662|NCT02189317|63239|P2|COMPLETED|Overall Study||16
25663|NCT02189317|63240|P1|COMPLETED|Overall Study||16
25664|NCT02189317|63239|P2|STARTED|Overall Study||16
25665|NCT02189317|63240|P1|STARTED|Overall Study||16
25666|NCT02189252|63254|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
25667|NCT02189252|63255|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
25668|NCT02189252|63256|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
25669|NCT02189252|63257|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
25670|NCT02189252|63254|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
25671|NCT02189252|63255|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
25672|NCT02189252|63256|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
25673|NCT02189252|63257|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
25674|NCT02189252|63254|P4|STARTED|Period 2 (Visit6b, Week 12)||4
25675|NCT02189252|63255|P3|STARTED|Period 2 (Visit6b, Week 12)||3
25676|NCT02189252|63256|P2|STARTED|Period 2 (Visit6b, Week 12)||2
25677|NCT02189252|63257|P1|STARTED|Period 2 (Visit6b, Week 12)||4
25678|NCT02189252|63254|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
25679|NCT02189252|63255|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
25680|NCT02189252|63256|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
25681|NCT02189252|63257|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
25682|NCT02189252|63254|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
25683|NCT02189252|63255|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
25684|NCT02189252|63256|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
25685|NCT02189252|63257|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
25686|NCT02189252|63254|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
25687|NCT02189252|63255|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
25688|NCT02189252|63256|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
25689|NCT02189252|63257|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
25690|NCT02189161|63289|P1|NOT COMPLETED|Overall Study||0
25691|NCT02189161|63289|P1|COMPLETED|Overall Study||10
25692|NCT02189161|63289|P1|STARTED|Overall Study||10
25693|NCT02189122|63297|P2|NOT COMPLETED|Overall Study||0
25694|NCT02189122|63298|P1|NOT COMPLETED|Overall Study||0
25695|NCT02189122|63297|P2|COMPLETED|Overall Study||18
25696|NCT02189122|63298|P1|COMPLETED|Overall Study||18
25697|NCT02189122|63297|P2|STARTED|Overall Study||18
25698|NCT02189122|63298|P1|STARTED|Overall Study||18
25699|NCT02188849|63316|P2|NOT COMPLETED|Overall Study||8
25700|NCT02188849|63317|P1|NOT COMPLETED|Overall Study||3
25701|NCT02188849|63316|P2|COMPLETED|Overall Study||17
25702|NCT02188849|63317|P1|COMPLETED|Overall Study||22
25703|NCT02188849|63316|P2|STARTED|Overall Study||25
25704|NCT02188849|63317|P1|STARTED|Overall Study||25
25705|NCT02188784|63331|P2|NOT COMPLETED|Overall Study||13
25706|NCT02188784|63332|P1|NOT COMPLETED|Overall Study||9
25707|NCT02188784|63331|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
25708|NCT02188784|63332|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
25709|NCT02188784|63331|P2|STARTED|Overall Study||114
25710|NCT02188784|63332|P1|STARTED|Overall Study||111
25711|NCT02188589|63348|P1|NOT COMPLETED|Overall Study||0
25712|NCT02188589|63348|P1|COMPLETED|Overall Study||30
25713|NCT02188589|63348|P1|STARTED|Overall Study||30
25714|NCT02187887|63355|P2|NOT COMPLETED|Overall Study||4
25715|NCT02187887|63356|P1|NOT COMPLETED|Overall Study||5
25716|NCT02187887|63355|P2|COMPLETED|Overall Study||396
25717|NCT02187887|63356|P1|COMPLETED|Overall Study||388
25718|NCT02187887|63355|P2|STARTED|Overall Study||400
25719|NCT02187887|63356|P1|STARTED|Overall Study||393
25720|NCT02187861|63368|P4|NOT COMPLETED|Overall Study||51
25721|NCT02187861|63369|P3|NOT COMPLETED|Overall Study||51
25722|NCT02187861|63370|P2|NOT COMPLETED|Overall Study||53
25723|NCT02187861|63371|P1|NOT COMPLETED|Overall Study||9
25724|NCT02187861|63368|P4|COMPLETED|Overall Study||0
25725|NCT02187861|63369|P3|COMPLETED|Overall Study||0
25726|NCT02187861|63370|P2|COMPLETED|Overall Study||0
25727|NCT02187861|63371|P1|COMPLETED|Overall Study||0
25728|NCT02187861|63368|P4|Treated|Overall Study||50
25729|NCT02187861|63369|P3|Treated|Overall Study||49
25730|NCT02187861|63370|P2|Treated|Overall Study||52
25731|NCT02187861|63371|P1|Treated|Overall Study||9
25732|NCT02187861|63368|P4|STARTED|Overall Study||51
25733|NCT02187861|63369|P3|STARTED|Overall Study||51
25734|NCT02187861|63370|P2|STARTED|Overall Study||53
25735|NCT02187861|63371|P1|STARTED|Overall Study||9
25736|NCT02187809|63467|P1|NOT COMPLETED|Overall Study||3
25737|NCT02187809|63467|P1|COMPLETED|Overall Study||0
25738|NCT02187809|63467|P1|Treated|Overall Study||1
25739|NCT02187809|63467|P1|STARTED|Overall Study||3
25740|NCT02187744|63479|P2|NOT COMPLETED|Treatment||5
25741|NCT02187744|63480|P1|NOT COMPLETED|Treatment||4
25742|NCT02187744|63479|P2|COMPLETED|Treatment||107
25743|NCT02187744|63480|P1|COMPLETED|Treatment||109
25744|NCT02187744|63479|P2|STARTED|Treatment||112
25745|NCT02187744|63480|P1|STARTED|Treatment||113
25746|NCT02187744|63479|P2|NOT COMPLETED|Study||6
25747|NCT02187744|63480|P1|NOT COMPLETED|Study||4
25748|NCT02187744|63479|P2|COMPLETED|Study||106
25749|NCT02187744|63480|P1|COMPLETED|Study||109
25750|NCT02187744|63479|P2|STARTED|Study|Received treatment|112
25751|NCT02187744|63480|P1|STARTED|Study|Received treatment|113
25752|NCT02187029|63500|P4|NOT COMPLETED|Overall Study||3
25753|NCT02187029|63501|P3|NOT COMPLETED|Overall Study||11
25754|NCT02187029|63502|P2|NOT COMPLETED|Overall Study||1
25755|NCT02187029|63503|P1|NOT COMPLETED|Overall Study||1
25756|NCT02187029|63500|P4|COMPLETED|Overall Study||6
25757|NCT02187029|63501|P3|COMPLETED|Overall Study||0
25758|NCT02187029|63502|P2|COMPLETED|Overall Study||2
25759|NCT02187029|63503|P1|COMPLETED|Overall Study||6
25760|NCT02187029|63500|P4|STARTED|Overall Study||9
25761|NCT02187029|63501|P3|STARTED|Overall Study||11
25762|NCT02187029|63502|P2|STARTED|Overall Study||3
25763|NCT02187029|63503|P1|STARTED|Overall Study||7
25764|NCT02187016|63579|P4|NOT COMPLETED|Overall Study||0
25765|NCT02187016|63580|P3|NOT COMPLETED|Overall Study||1
25766|NCT02187016|63581|P2|NOT COMPLETED|Overall Study||2
25767|NCT02187016|63582|P1|NOT COMPLETED|Overall Study||1
25768|NCT02187016|63579|P4|COMPLETED|Overall Study||51
25769|NCT02187016|63580|P3|COMPLETED|Overall Study||78
25770|NCT02187016|63581|P2|COMPLETED|Overall Study||78
25771|NCT02187016|63582|P1|COMPLETED|Overall Study||79
25772|NCT02187016|63579|P4|STARTED|Overall Study||51
25773|NCT02187016|63580|P3|STARTED|Overall Study||79
25774|NCT02187016|63581|P2|STARTED|Overall Study||80
25775|NCT02187016|63582|P1|STARTED|Overall Study||80
25776|NCT02186873|63614|P2|NOT COMPLETED|Overall Study||8
25777|NCT02186873|63615|P1|NOT COMPLETED|Overall Study||9
25778|NCT02186873|63614|P2|COMPLETED|Overall Study||97
25779|NCT02186873|63615|P1|COMPLETED|Overall Study||94
25780|NCT02186873|63614|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
25781|NCT02186873|63615|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
25782|NCT02186873|63614|P2|STARTED|Overall Study||105
25783|NCT02186873|63615|P1|STARTED|Overall Study||103
25784|NCT02186808|63638|P1|NOT COMPLETED|Overall Study||13
25785|NCT02186808|63638|P1|COMPLETED|Overall Study||67
25786|NCT02186808|63638|P1|STARTED|Overall Study||80
25787|NCT02186665|63645|P2|NOT COMPLETED|Overall Study||1
25788|NCT02186665|63646|P1|NOT COMPLETED|Overall Study||0
25789|NCT02186665|63645|P2|COMPLETED|Overall Study||10
25790|NCT02186665|63646|P1|COMPLETED|Overall Study||8
25791|NCT02186665|63645|P2|STARTED|Overall Study||11
25792|NCT02186665|63646|P1|STARTED|Overall Study||8
25793|NCT02186587|63654|P2|NOT COMPLETED|Overall Study||0
25794|NCT02186587|63655|P1|NOT COMPLETED|Overall Study||5
25795|NCT02186587|63654|P2|COMPLETED|Overall Study||0
25796|NCT02186587|63655|P1|COMPLETED|Overall Study||23
25797|NCT02186587|63654|P2|STARTED|Overall Study||0
25798|NCT02186587|63655|P1|STARTED|Overall Study||28
25799|NCT02186223|63660|P1|NOT COMPLETED|Overall Study||21
25800|NCT02186223|63660|P1|COMPLETED|Overall Study||151
25801|NCT02186223|63660|P1|Device Placed|Overall Study||163
25802|NCT02186223|63660|P1|STARTED|Overall Study||172
25803|NCT02185729|63669|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
25804|NCT02185729|63669|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
25805|NCT02185729|63669|P1|STARTED|24 Hours Into Dextrose Infusion||12
25806|NCT02185729|63669|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
25807|NCT02185729|63669|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
25808|NCT02185729|63669|P1|STARTED|4 Hours Into Dextrose Infusion||12
25809|NCT02185729|63669|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
25810|NCT02185729|63669|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
25811|NCT02185729|63669|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
25812|NCT02185729|63669|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
25813|NCT02185729|63669|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
25814|NCT02185729|63669|P1|STARTED|24 Hours Into ClinOleic Infusion||12
25815|NCT02185729|63669|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
25816|NCT02185729|63669|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
25817|NCT02185729|63669|P1|STARTED|4 Hours Into ClinOleic Infusion||12
25818|NCT02185729|63669|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
25819|NCT02185729|63669|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
25820|NCT02185729|63669|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
25821|NCT02185729|63669|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
25822|NCT02185729|63669|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
25823|NCT02185729|63669|P1|STARTED|24 Hours Into Intralipid Infusion||12
25824|NCT02185729|63669|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
25825|NCT02185729|63669|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
25826|NCT02185729|63669|P1|STARTED|4 Hours Into Intralipid Infusion||12
25827|NCT02185729|63669|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
25828|NCT02185729|63669|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
25829|NCT02185729|63669|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
25830|NCT02185729|63669|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
25831|NCT02185729|63669|P1|COMPLETED|24 Hours Into Saline Infusion||12
25832|NCT02185729|63669|P1|STARTED|24 Hours Into Saline Infusion||12
25833|NCT02185729|63669|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
25834|NCT02185729|63669|P1|COMPLETED|4 Hours Into Saline Infusion||12
25835|NCT02185729|63669|P1|STARTED|4 Hours Into Saline Infusion||12
25836|NCT02185729|63669|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
25837|NCT02185729|63669|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
25838|NCT02185729|63669|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
25839|NCT02185534|63690|P6|NOT COMPLETED|Third Period||0
25840|NCT02185534|63691|P5|NOT COMPLETED|Third Period||0
25841|NCT02185534|63692|P4|NOT COMPLETED|Third Period||0
25842|NCT02185534|63693|P3|NOT COMPLETED|Third Period||0
25843|NCT02185534|63694|P2|NOT COMPLETED|Third Period||0
25844|NCT02185534|63695|P1|NOT COMPLETED|Third Period||0
25845|NCT02185534|63690|P6|COMPLETED|Third Period||13
25846|NCT02185534|63691|P5|COMPLETED|Third Period||13
25847|NCT02185534|63692|P4|COMPLETED|Third Period||13
25848|NCT02185534|63693|P3|COMPLETED|Third Period||14
25849|NCT02185534|63694|P2|COMPLETED|Third Period||14
25850|NCT02185534|63695|P1|COMPLETED|Third Period||13
25851|NCT02185534|63690|P6|STARTED|Third Period||13
25852|NCT02185534|63691|P5|STARTED|Third Period||13
25853|NCT02185534|63692|P4|STARTED|Third Period||13
25854|NCT02185534|63693|P3|STARTED|Third Period||14
25855|NCT02185534|63694|P2|STARTED|Third Period||14
25856|NCT02185534|63695|P1|STARTED|Third Period||13
25857|NCT02185534|63690|P6|NOT COMPLETED|Second Washout Period||0
25858|NCT02185534|63691|P5|NOT COMPLETED|Second Washout Period||0
25859|NCT02185534|63692|P4|NOT COMPLETED|Second Washout Period||0
25860|NCT02185534|63693|P3|NOT COMPLETED|Second Washout Period||0
25861|NCT02185534|63694|P2|NOT COMPLETED|Second Washout Period||0
25862|NCT02185534|63695|P1|NOT COMPLETED|Second Washout Period||0
25863|NCT02185534|63690|P6|COMPLETED|Second Washout Period||13
25864|NCT02185534|63691|P5|COMPLETED|Second Washout Period||13
25865|NCT02185534|63692|P4|COMPLETED|Second Washout Period||13
25866|NCT02185534|63693|P3|COMPLETED|Second Washout Period||14
25867|NCT02185534|63694|P2|COMPLETED|Second Washout Period||14
25868|NCT02185534|63695|P1|COMPLETED|Second Washout Period||13
25869|NCT02185534|63690|P6|STARTED|Second Washout Period||13
25870|NCT02185534|63691|P5|STARTED|Second Washout Period||13
25871|NCT02185534|63692|P4|STARTED|Second Washout Period||13
25872|NCT02185534|63693|P3|STARTED|Second Washout Period||14
25873|NCT02185534|63694|P2|STARTED|Second Washout Period||14
25874|NCT02185534|63695|P1|STARTED|Second Washout Period||13
25875|NCT02185534|63690|P6|NOT COMPLETED|Second Period||0
25876|NCT02185534|63691|P5|NOT COMPLETED|Second Period||0
25877|NCT02185534|63692|P4|NOT COMPLETED|Second Period||0
25878|NCT02185534|63693|P3|NOT COMPLETED|Second Period||0
25879|NCT02185534|63694|P2|NOT COMPLETED|Second Period||0
25880|NCT02185534|63695|P1|NOT COMPLETED|Second Period||0
25881|NCT02185534|63690|P6|COMPLETED|Second Period||13
25882|NCT02185534|63691|P5|COMPLETED|Second Period||13
25883|NCT02185534|63692|P4|COMPLETED|Second Period||13
25884|NCT02185534|63693|P3|COMPLETED|Second Period||14
25885|NCT02185534|63694|P2|COMPLETED|Second Period||14
25886|NCT02185534|63695|P1|COMPLETED|Second Period||13
25887|NCT02185534|63690|P6|STARTED|Second Period||13
25888|NCT02185534|63691|P5|STARTED|Second Period||13
25889|NCT02185534|63692|P4|STARTED|Second Period||13
25890|NCT02185534|63693|P3|STARTED|Second Period||14
25891|NCT02185534|63694|P2|STARTED|Second Period||14
25892|NCT02185534|63695|P1|STARTED|Second Period||13
25893|NCT02185534|63690|P6|NOT COMPLETED|First Washout Period||1
25894|NCT02185534|63691|P5|NOT COMPLETED|First Washout Period||1
25895|NCT02185534|63692|P4|NOT COMPLETED|First Washout Period||0
25896|NCT02185534|63693|P3|NOT COMPLETED|First Washout Period||0
25897|NCT02185534|63694|P2|NOT COMPLETED|First Washout Period||0
25898|NCT02185534|63695|P1|NOT COMPLETED|First Washout Period||1
25899|NCT02185534|63690|P6|COMPLETED|First Washout Period||13
25900|NCT02185534|63691|P5|COMPLETED|First Washout Period||13
25901|NCT02185534|63692|P4|COMPLETED|First Washout Period||13
25902|NCT02185534|63693|P3|COMPLETED|First Washout Period||14
25903|NCT02185534|63694|P2|COMPLETED|First Washout Period||14
25904|NCT02185534|63695|P1|COMPLETED|First Washout Period||13
25905|NCT02185534|63690|P6|STARTED|First Washout Period||14
25906|NCT02185534|63691|P5|STARTED|First Washout Period||14
25907|NCT02185534|63692|P4|STARTED|First Washout Period||13
25908|NCT02185534|63693|P3|STARTED|First Washout Period||14
25909|NCT02185534|63694|P2|STARTED|First Washout Period||14
25910|NCT02185534|63695|P1|STARTED|First Washout Period||14
25911|NCT02185534|63690|P6|NOT COMPLETED|First Period||0
25912|NCT02185534|63691|P5|NOT COMPLETED|First Period||0
25913|NCT02185534|63692|P4|NOT COMPLETED|First Period||1
25914|NCT02185534|63693|P3|NOT COMPLETED|First Period||0
25915|NCT02185534|63694|P2|NOT COMPLETED|First Period||0
25916|NCT02185534|63695|P1|NOT COMPLETED|First Period||0
25917|NCT02185534|63690|P6|COMPLETED|First Period||14
25918|NCT02185534|63691|P5|COMPLETED|First Period||14
25919|NCT02185534|63692|P4|COMPLETED|First Period||13
25920|NCT02185534|63693|P3|COMPLETED|First Period||14
25921|NCT02185534|63694|P2|COMPLETED|First Period||14
25922|NCT02185534|63695|P1|COMPLETED|First Period||14
25923|NCT02185534|63690|P6|STARTED|First Period||14
25924|NCT02185534|63691|P5|STARTED|First Period||14
25925|NCT02185534|63692|P4|STARTED|First Period||14
25926|NCT02185534|63693|P3|STARTED|First Period||14
25927|NCT02185534|63694|P2|STARTED|First Period||14
25928|NCT02185534|63695|P1|STARTED|First Period||14
25929|NCT02185339|63712|P2|NOT COMPLETED|Overall Study||1
25930|NCT02185339|63713|P1|NOT COMPLETED|Overall Study||0
25931|NCT02185339|63712|P2|COMPLETED|Overall Study||30
25932|NCT02185339|63713|P1|COMPLETED|Overall Study||30
25933|NCT02185339|63712|P2|STARTED|Overall Study||31
25934|NCT02185339|63713|P1|STARTED|Overall Study||30
25935|NCT02185183|63735|P1|NOT COMPLETED|Overall Study||0
25936|NCT02185183|63735|P1|COMPLETED|Overall Study||14
25937|NCT02185183|63735|P1|STARTED|Overall Study||14
25938|NCT02185131|63741|P2|NOT COMPLETED|Overall Study||1
25939|NCT02185131|63742|P1|NOT COMPLETED|Overall Study||1
25940|NCT02185131|63741|P2|COMPLETED|Overall Study||8
25941|NCT02185131|63742|P1|COMPLETED|Overall Study||6
25942|NCT02185131|63741|P2|STARTED|Overall Study||9
25943|NCT02185131|63742|P1|STARTED|Overall Study||7
25944|NCT02185105|63750|P1|NOT COMPLETED|Overall Study||0
25945|NCT02185105|63750|P1|COMPLETED|Overall Study||30
25946|NCT02185105|63750|P1|STARTED|Overall Study||30
25947|NCT02184624|63798|P5|NOT COMPLETED|Overall Study||0
25948|NCT02184624|63799|P4|NOT COMPLETED|Overall Study||0
25949|NCT02184624|63800|P3|NOT COMPLETED|Overall Study||0
25950|NCT02184624|63801|P2|NOT COMPLETED|Overall Study||0
25951|NCT02184624|63802|P1|NOT COMPLETED|Overall Study||0
25952|NCT02184624|63798|P5|COMPLETED|Overall Study||98
25953|NCT02184624|63799|P4|COMPLETED|Overall Study||118
25954|NCT02184624|63800|P3|COMPLETED|Overall Study||100
25955|NCT02184624|63801|P2|COMPLETED|Overall Study||80
25956|NCT02184624|63802|P1|COMPLETED|Overall Study||171
25957|NCT02184624|63798|P5|STARTED|Overall Study||98
25958|NCT02184624|63799|P4|STARTED|Overall Study||118
25959|NCT02184624|63800|P3|STARTED|Overall Study||100
25960|NCT02184624|63801|P2|STARTED|Overall Study||80
25961|NCT02184624|63802|P1|STARTED|Overall Study||171
25962|NCT02184494|63847|P3|NOT COMPLETED|Overall Study||0
25963|NCT02184494|63848|P2|NOT COMPLETED|Overall Study||2
25964|NCT02184494|63849|P1|NOT COMPLETED|Overall Study||1
25965|NCT02184494|63847|P3|COMPLETED|Overall Study||8
25966|NCT02184494|63848|P2|COMPLETED|Overall Study||11
25967|NCT02184494|63849|P1|COMPLETED|Overall Study||12
25968|NCT02184494|63847|P3|STARTED|Overall Study||8
25969|NCT02184494|63848|P2|STARTED|Overall Study||13
25970|NCT02184494|63849|P1|STARTED|Overall Study||13
25971|NCT02184208|63869|P1|NOT COMPLETED|Overall Study||56
25972|NCT02184208|63869|P1|COMPLETED|Overall Study||222
25973|NCT02184208|63869|P1|STARTED|Overall Study||278
25974|NCT02183675|63881|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
25975|NCT02183675|63882|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
25976|NCT02183675|63883|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
25977|NCT02183675|63884|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
25978|NCT02183675|63885|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
25979|NCT02183675|63886|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
25980|NCT02183675|63881|P6|COMPLETED|Treatment Period 3 (10 Days)||4
25981|NCT02183675|63882|P5|COMPLETED|Treatment Period 3 (10 Days)||6
25982|NCT02183675|63883|P4|COMPLETED|Treatment Period 3 (10 Days)||6
25983|NCT02183675|63884|P3|COMPLETED|Treatment Period 3 (10 Days)||6
25984|NCT02183675|63885|P2|COMPLETED|Treatment Period 3 (10 Days)||6
25985|NCT02183675|63886|P1|COMPLETED|Treatment Period 3 (10 Days)||6
25986|NCT02183675|63881|P6|STARTED|Treatment Period 3 (10 Days)||4
25987|NCT02183675|63882|P5|STARTED|Treatment Period 3 (10 Days)||6
25988|NCT02183675|63883|P4|STARTED|Treatment Period 3 (10 Days)||6
25989|NCT02183675|63884|P3|STARTED|Treatment Period 3 (10 Days)||6
25990|NCT02183675|63885|P2|STARTED|Treatment Period 3 (10 Days)||6
25991|NCT02183675|63886|P1|STARTED|Treatment Period 3 (10 Days)||6
25992|NCT02183675|63881|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
25993|NCT02183675|63882|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
25994|NCT02183675|63883|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
25995|NCT02183675|63884|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
25996|NCT02183675|63885|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
25997|NCT02183675|63886|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
25998|NCT02183675|63881|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
25999|NCT02183675|63882|P5|COMPLETED|Treatment Period 2 (10 Days)||6
26000|NCT02183675|63883|P4|COMPLETED|Treatment Period 2 (10 Days)||6
26001|NCT02183675|63884|P3|COMPLETED|Treatment Period 2 (10 Days)||6
26002|NCT02183675|63885|P2|COMPLETED|Treatment Period 2 (10 Days)||6
26003|NCT02183675|63886|P1|COMPLETED|Treatment Period 2 (10 Days)||6
26004|NCT02183675|63881|P6|STARTED|Treatment Period 2 (10 Days)||6
26005|NCT02183675|63882|P5|STARTED|Treatment Period 2 (10 Days)||6
26006|NCT02183675|63883|P4|STARTED|Treatment Period 2 (10 Days)||6
26007|NCT02183675|63884|P3|STARTED|Treatment Period 2 (10 Days)||6
26008|NCT02183675|63885|P2|STARTED|Treatment Period 2 (10 Days)||6
26009|NCT02183675|63886|P1|STARTED|Treatment Period 2 (10 Days)||6
26010|NCT02183675|63881|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
26011|NCT02183675|63882|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
26012|NCT02183675|63883|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
26013|NCT02183675|63884|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
26014|NCT02183675|63885|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
26015|NCT02183675|63886|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
26016|NCT02183675|63881|P6|COMPLETED|Treatment Period 1 (10 Days)||6
26017|NCT02183675|63882|P5|COMPLETED|Treatment Period 1 (10 Days)||6
26018|NCT02183675|63883|P4|COMPLETED|Treatment Period 1 (10 Days)||6
26019|NCT02183675|63884|P3|COMPLETED|Treatment Period 1 (10 Days)||6
26020|NCT02183675|63885|P2|COMPLETED|Treatment Period 1 (10 Days)||6
26021|NCT02183675|63886|P1|COMPLETED|Treatment Period 1 (10 Days)||6
26022|NCT02183675|63881|P6|STARTED|Treatment Period 1 (10 Days)||6
26023|NCT02183675|63882|P5|STARTED|Treatment Period 1 (10 Days)||6
26024|NCT02183675|63883|P4|STARTED|Treatment Period 1 (10 Days)||6
26025|NCT02183675|63884|P3|STARTED|Treatment Period 1 (10 Days)||6
26026|NCT02183675|63885|P2|STARTED|Treatment Period 1 (10 Days)||6
26027|NCT02183675|63886|P1|STARTED|Treatment Period 1 (10 Days)||6
26028|NCT02183519|63910|P2|NOT COMPLETED|Overall Study||3
26029|NCT02183519|63911|P1|NOT COMPLETED|Overall Study||3
26030|NCT02183519|63910|P2|COMPLETED|Overall Study||13
26031|NCT02183519|63911|P1|COMPLETED|Overall Study||25
26032|NCT02183519|63910|P2|STARTED|Overall Study||16
26033|NCT02183519|63911|P1|STARTED|Overall Study||28
26034|NCT02182895|63919|P2|NOT COMPLETED|Overall Study||4
26035|NCT02182895|63920|P1|NOT COMPLETED|Overall Study||2
26036|NCT02182895|63919|P2|COMPLETED|Overall Study||33
26037|NCT02182895|63920|P1|COMPLETED|Overall Study||33
26038|NCT02182895|63919|P2|STARTED|Overall Study||37
26039|NCT02182895|63920|P1|STARTED|Overall Study||35
26040|NCT02182115|63942|P2|NOT COMPLETED|Overall Study||0
26041|NCT02182115|63943|P1|NOT COMPLETED|Overall Study||0
26042|NCT02182115|63942|P2|COMPLETED|Overall Study||57
26043|NCT02182115|63943|P1|COMPLETED|Overall Study||53
26044|NCT02182115|63942|P2|STARTED|Overall Study||57
26045|NCT02182115|63943|P1|STARTED|Overall Study||53
26046|NCT02181790|63951|P2|NOT COMPLETED|Overall Study||0
26047|NCT02181790|63952|P1|NOT COMPLETED|Overall Study||2
26048|NCT02181790|63951|P2|COMPLETED|Overall Study||0
26049|NCT02181790|63952|P1|COMPLETED|Overall Study||0
26050|NCT02181790|63951|P2|STARTED|Overall Study||0
26051|NCT02181790|63952|P1|STARTED|Overall Study||2
26052|NCT02181673|63962|P3|NOT COMPLETED|Week 24-Week 60||17
26053|NCT02181673|63963|P2|NOT COMPLETED|Week 24-Week 60||8
26054|NCT02181673|63964|P1|NOT COMPLETED|Week 24-Week 60||0
26055|NCT02181673|63962|P3|COMPLETED|Week 24-Week 60||213
26056|NCT02181673|63963|P2|COMPLETED|Week 24-Week 60||214
26057|NCT02181673|63964|P1|COMPLETED|Week 24-Week 60||0
26058|NCT02181673|63962|P3|Treated|Week 24-Week 60||230
26059|NCT02181673|63963|P2|Treated|Week 24-Week 60||220
26060|NCT02181673|63964|P1|Treated|Week 24-Week 60||0
26061|NCT02181673|63962|P3|STARTED|Week 24-Week 60||230
26062|NCT02181673|63963|P2|STARTED|Week 24-Week 60||222
26063|NCT02181673|63964|P1|STARTED|Week 24-Week 60||0
26064|NCT02181673|63962|P3|NOT COMPLETED|Up to Week 24||11
26065|NCT02181673|63963|P2|NOT COMPLETED|Up to Week 24||0
26066|NCT02181673|63964|P1|NOT COMPLETED|Up to Week 24||17
26067|NCT02181673|63962|P3|COMPLETED|Up to Week 24||230
26068|NCT02181673|63963|P2|COMPLETED|Up to Week 24||0
26069|NCT02181673|63964|P1|COMPLETED|Up to Week 24||222
26070|NCT02181673|63962|P3|Treated|Up to Week 24||240
26071|NCT02181673|63963|P2|Treated|Up to Week 24||0
26072|NCT02181673|63964|P1|Treated|Up to Week 24||239
26073|NCT02181673|63962|P3|STARTED|Up to Week 24||241
26074|NCT02181673|63963|P2|STARTED|Up to Week 24||0
26075|NCT02181673|63964|P1|STARTED|Up to Week 24||239
26076|NCT02181634|63991|P1|NOT COMPLETED|Overall Study||72
26077|NCT02181634|63991|P1|COMPLETED|Overall Study||2
26078|NCT02181634|63991|P1|Eligible and Treated|Overall Study||73
26079|NCT02181634|63991|P1|STARTED|Overall Study||74
26080|NCT02181530|64002|P1|NOT COMPLETED|Overall Study||0
26081|NCT02181530|64002|P1|COMPLETED|Overall Study||43
26082|NCT02181530|64002|P1|STARTED|Overall Study||43
26083|NCT02181517|64015|P3|NOT COMPLETED|Overall Study||0
26084|NCT02181517|64016|P2|NOT COMPLETED|Overall Study||0
26085|NCT02181517|64017|P1|NOT COMPLETED|Overall Study||0
26086|NCT02181517|64015|P3|COMPLETED|Overall Study||5
26087|NCT02181517|64016|P2|COMPLETED|Overall Study||10
26088|NCT02181517|64017|P1|COMPLETED|Overall Study||10
26089|NCT02181517|64015|P3|STARTED|Overall Study||5
26090|NCT02181517|64016|P2|STARTED|Overall Study||10
26091|NCT02181517|64017|P1|STARTED|Overall Study||10
26092|NCT02181504|64040|P3|NOT COMPLETED|Overall Study||1
26093|NCT02181504|64041|P2|NOT COMPLETED|Overall Study||1
26094|NCT02181504|64042|P1|NOT COMPLETED|Overall Study||1
26095|NCT02181504|64040|P3|COMPLETED|Overall Study||4
26096|NCT02181504|64041|P2|COMPLETED|Overall Study||9
26097|NCT02181504|64042|P1|COMPLETED|Overall Study||9
26098|NCT02181504|64040|P3|STARTED|Overall Study||5
26099|NCT02181504|64041|P2|STARTED|Overall Study||10
26100|NCT02181504|64042|P1|STARTED|Overall Study||10
26101|NCT02181387|64064|P2|NOT COMPLETED|Overall Study||4
26102|NCT02181387|64065|P1|NOT COMPLETED|Overall Study||2
26103|NCT02181387|64064|P2|COMPLETED|Overall Study||15
26104|NCT02181387|64065|P1|COMPLETED|Overall Study||12
26105|NCT02181387|64064|P2|STARTED|Overall Study||19
26106|NCT02181387|64065|P1|STARTED|Overall Study||14
26107|NCT02181140|64071|P1|NOT COMPLETED|Overall Study||0
26108|NCT02181140|64071|P1|COMPLETED|Overall Study||56
26109|NCT02181140|64071|P1|STARTED|Overall Study||56
26110|NCT02181127|64077|P1|NOT COMPLETED|Overall Study||0
26111|NCT02181127|64077|P1|COMPLETED|Overall Study||22
26112|NCT02181127|64077|P1|STARTED|Overall Study||22
26113|NCT02180893|64084|P2|NOT COMPLETED|Overall Study||7
26114|NCT02180893|64085|P1|NOT COMPLETED|Overall Study||3
26115|NCT02180893|64084|P2|COMPLETED|Overall Study||23
26116|NCT02180893|64085|P1|COMPLETED|Overall Study||27
26117|NCT02180893|64084|P2|STARTED|Overall Study||30
26118|NCT02180893|64085|P1|STARTED|Overall Study||30
26119|NCT02180828|64099|P2|NOT COMPLETED|Overall Study||7
26120|NCT02180828|64100|P1|NOT COMPLETED|Overall Study||5
26121|NCT02180828|64099|P2|COMPLETED|Overall Study||113
26122|NCT02180828|64100|P1|COMPLETED|Overall Study||115
26123|NCT02180828|64099|P2|STARTED|Overall Study||120
26124|NCT02180828|64100|P1|STARTED|Overall Study||120
26125|NCT02180646|64124|P2|NOT COMPLETED|Second Intervention (7 Days)||0
26126|NCT02180646|64125|P1|NOT COMPLETED|Second Intervention (7 Days)||0
26127|NCT02180646|64124|P2|COMPLETED|Second Intervention (7 Days)||6
26128|NCT02180646|64125|P1|COMPLETED|Second Intervention (7 Days)||6
26129|NCT02180646|64124|P2|STARTED|Second Intervention (7 Days)||6
26130|NCT02180646|64125|P1|STARTED|Second Intervention (7 Days)||6
26131|NCT02180646|64124|P2|NOT COMPLETED|Washout (7 Days)||0
26132|NCT02180646|64125|P1|NOT COMPLETED|Washout (7 Days)||0
26133|NCT02180646|64124|P2|COMPLETED|Washout (7 Days)||6
26134|NCT02180646|64125|P1|COMPLETED|Washout (7 Days)||6
26135|NCT02180646|64124|P2|STARTED|Washout (7 Days)||6
26136|NCT02180646|64125|P1|STARTED|Washout (7 Days)||6
26137|NCT02180646|64124|P2|NOT COMPLETED|First Intervention (7 Days)||0
26138|NCT02180646|64125|P1|NOT COMPLETED|First Intervention (7 Days)||0
26139|NCT02180646|64124|P2|COMPLETED|First Intervention (7 Days)||6
26140|NCT02180646|64125|P1|COMPLETED|First Intervention (7 Days)||6
26141|NCT02180646|64124|P2|STARTED|First Intervention (7 Days)||6
26142|NCT02180646|64125|P1|STARTED|First Intervention (7 Days)||6
26143|NCT02180438|64135|P1|NOT COMPLETED|Overall Study||1
26144|NCT02180438|64135|P1|COMPLETED|Overall Study||29
26145|NCT02180438|64135|P1|STARTED|Overall Study||30
26146|NCT02180230|64146|P1|NOT COMPLETED|Overall Study||7
26147|NCT02180230|64146|P1|COMPLETED|Overall Study||31
26148|NCT02180230|64146|P1|STARTED|Overall Study||38
26149|NCT02180061|64153|P2|NOT COMPLETED|Overall Study||8
26150|NCT02180061|64154|P1|NOT COMPLETED|Overall Study||34
26151|NCT02180061|64153|P2|COMPLETED|Overall Study||0
26152|NCT02180061|64154|P1|COMPLETED|Overall Study||0
26153|NCT02180061|64153|P2|STARTED|Overall Study||8
26154|NCT02180061|64154|P1|STARTED|Overall Study||34
26155|NCT02179892|64170|P2|NOT COMPLETED|Overall Study||0
26156|NCT02179892|64171|P1|NOT COMPLETED|Overall Study||0
26157|NCT02179892|64170|P2|COMPLETED|Overall Study||4
26158|NCT02179892|64171|P1|COMPLETED|Overall Study||5
26159|NCT02179892|64170|P2|STARTED|Overall Study||4
26160|NCT02179892|64171|P1|STARTED|Overall Study||5
26161|NCT02179424|64187|P4|NOT COMPLETED|Overall Study||0
26162|NCT02179424|64188|P3|NOT COMPLETED|Overall Study||0
26163|NCT02179424|64189|P2|NOT COMPLETED|Overall Study||0
26164|NCT02179424|64190|P1|NOT COMPLETED|Overall Study||0
26165|NCT02179424|64187|P4|COMPLETED|Overall Study||39
26166|NCT02179424|64188|P3|COMPLETED|Overall Study||516
26167|NCT02179424|64189|P2|COMPLETED|Overall Study||11
26168|NCT02179424|64190|P1|COMPLETED|Overall Study||76
26169|NCT02179424|64187|P4|STARTED|Overall Study||39
26170|NCT02179424|64188|P3|STARTED|Overall Study||516
26171|NCT02179424|64189|P2|STARTED|Overall Study||11
26172|NCT02179424|64190|P1|STARTED|Overall Study||76
26173|NCT02179398|64207|P2|NOT COMPLETED|Overall Study||4
26174|NCT02179398|64208|P1|NOT COMPLETED|Overall Study||3
26175|NCT02179398|64207|P2|COMPLETED|Overall Study||140
26176|NCT02179398|64208|P1|COMPLETED|Overall Study||131
26177|NCT02179398|64207|P2|STARTED|Overall Study||144
26178|NCT02179398|64208|P1|STARTED|Overall Study||134
26179|NCT02178995|64228|P9|NOT COMPLETED|Open Label||0
26180|NCT02178995|64229|P8|NOT COMPLETED|Open Label||0
26181|NCT02178995|64230|P7|NOT COMPLETED|Open Label||0
26182|NCT02178995|64231|P6|NOT COMPLETED|Open Label||0
26183|NCT02178995|64232|P5|NOT COMPLETED|Open Label||0
26184|NCT02178995|64233|P4|NOT COMPLETED|Open Label||0
26185|NCT02178995|64234|P3|NOT COMPLETED|Open Label||0
26186|NCT02178995|64235|P2|NOT COMPLETED|Open Label||0
26187|NCT02178995|64236|P1|NOT COMPLETED|Open Label||2
26188|NCT02178995|64228|P9|COMPLETED|Open Label||0
26189|NCT02178995|64229|P8|COMPLETED|Open Label||0
26190|NCT02178995|64230|P7|COMPLETED|Open Label||0
26191|NCT02178995|64231|P6|COMPLETED|Open Label||0
26192|NCT02178995|64232|P5|COMPLETED|Open Label||0
26193|NCT02178995|64233|P4|COMPLETED|Open Label||0
26194|NCT02178995|64234|P3|COMPLETED|Open Label||0
26195|NCT02178995|64235|P2|COMPLETED|Open Label||14
26196|NCT02178995|64236|P1|COMPLETED|Open Label||28
26197|NCT02178995|64228|P9|STARTED|Open Label||0
26198|NCT02178995|64229|P8|STARTED|Open Label||0
26199|NCT02178995|64230|P7|STARTED|Open Label||0
26200|NCT02178995|64231|P6|STARTED|Open Label||0
26201|NCT02178995|64232|P5|STARTED|Open Label||0
26202|NCT02178995|64233|P4|STARTED|Open Label||0
26203|NCT02178995|64234|P3|STARTED|Open Label||0
26204|NCT02178995|64235|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
26205|NCT02178995|64236|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
26206|NCT02178995|64228|P9|NOT COMPLETED|Double Blind||1
26207|NCT02178995|64229|P8|NOT COMPLETED|Double Blind||2
26208|NCT02178995|64230|P7|NOT COMPLETED|Double Blind||0
26209|NCT02178995|64231|P6|NOT COMPLETED|Double Blind||1
26210|NCT02178995|64232|P5|NOT COMPLETED|Double Blind||0
26211|NCT02178995|64233|P4|NOT COMPLETED|Double Blind||0
26212|NCT02178995|64234|P3|NOT COMPLETED|Double Blind||0
26213|NCT02178995|64235|P2|NOT COMPLETED|Double Blind||1
26214|NCT02178995|64236|P1|NOT COMPLETED|Double Blind||0
26215|NCT02178995|64228|P9|COMPLETED|Double Blind||0
26216|NCT02178995|64229|P8|COMPLETED|Double Blind||4
26217|NCT02178995|64230|P7|COMPLETED|Double Blind||5
26218|NCT02178995|64231|P6|COMPLETED|Double Blind||5
26219|NCT02178995|64232|P5|COMPLETED|Double Blind||6
26220|NCT02178995|64233|P4|COMPLETED|Double Blind||6
26221|NCT02178995|64234|P3|COMPLETED|Double Blind||5
26222|NCT02178995|64235|P2|COMPLETED|Double Blind||15
26223|NCT02178995|64236|P1|COMPLETED|Double Blind||0
26224|NCT02178995|64228|P9|STARTED|Double Blind||1
26225|NCT02178995|64229|P8|STARTED|Double Blind||6
26226|NCT02178995|64230|P7|STARTED|Double Blind||5
26227|NCT02178995|64231|P6|STARTED|Double Blind||6
26228|NCT02178995|64232|P5|STARTED|Double Blind||6
26229|NCT02178995|64233|P4|STARTED|Double Blind||6
26230|NCT02178995|64234|P3|STARTED|Double Blind||5
26231|NCT02178995|64235|P2|STARTED|Double Blind||16
26232|NCT02178995|64236|P1|STARTED|Double Blind||0
26233|NCT02178787|64309|P2|NOT COMPLETED|Overall Study||9
26234|NCT02178787|64310|P1|NOT COMPLETED|Overall Study||5
26235|NCT02178787|64309|P2|COMPLETED|Overall Study||30
26236|NCT02178787|64310|P1|COMPLETED|Overall Study||30
26237|NCT02178787|64309|P2|STARTED|Overall Study||39
26238|NCT02178787|64310|P1|STARTED|Overall Study||35
26239|NCT02178696|64318|P2|NOT COMPLETED|Open-label Antidepressant||7
26240|NCT02178696|64319|P1|NOT COMPLETED|Open-label Antidepressant||6
26241|NCT02178696|64318|P2|COMPLETED|Open-label Antidepressant||13
26242|NCT02178696|64319|P1|COMPLETED|Open-label Antidepressant||14
26243|NCT02178696|64318|P2|STARTED|Open-label Antidepressant||20
26244|NCT02178696|64319|P1|STARTED|Open-label Antidepressant||20
26245|NCT02178696|64318|P2|NOT COMPLETED|Second Assignment After Crossover||0
26246|NCT02178696|64319|P1|NOT COMPLETED|Second Assignment After Crossover||0
26247|NCT02178696|64318|P2|COMPLETED|Second Assignment After Crossover||20
26248|NCT02178696|64319|P1|COMPLETED|Second Assignment After Crossover||20
26249|NCT02178696|64318|P2|STARTED|Second Assignment After Crossover||20
26250|NCT02178696|64319|P1|STARTED|Second Assignment After Crossover||20
26251|NCT02178696|64318|P2|NOT COMPLETED|First Assignment and Washout||0
26252|NCT02178696|64319|P1|NOT COMPLETED|First Assignment and Washout||0
26253|NCT02178696|64318|P2|COMPLETED|First Assignment and Washout||20
26254|NCT02178696|64319|P1|COMPLETED|First Assignment and Washout||20
26255|NCT02178696|64318|P2|STARTED|First Assignment and Washout||20
26256|NCT02178696|64319|P1|STARTED|First Assignment and Washout||20
26257|NCT02178540|64332|P1|NOT COMPLETED|Overall Study||0
26258|NCT02178540|64332|P1|COMPLETED|Overall Study||45
26259|NCT02178540|64332|P1|STARTED|Overall Study||45
26260|NCT02178059|64339|P2|NOT COMPLETED|Second Intervention||0
26261|NCT02178059|64340|P1|NOT COMPLETED|Second Intervention||0
26262|NCT02178059|64339|P2|COMPLETED|Second Intervention||17
26263|NCT02178059|64340|P1|COMPLETED|Second Intervention||16
26264|NCT02178059|64339|P2|STARTED|Second Intervention||17
26265|NCT02178059|64340|P1|STARTED|Second Intervention||16
26266|NCT02178059|64339|P2|NOT COMPLETED|Washout||0
26267|NCT02178059|64340|P1|NOT COMPLETED|Washout||1
26268|NCT02178059|64339|P2|COMPLETED|Washout||17
26269|NCT02178059|64340|P1|COMPLETED|Washout||16
26270|NCT02178059|64339|P2|STARTED|Washout||17
26271|NCT02178059|64340|P1|STARTED|Washout||17
26272|NCT02178059|64339|P2|NOT COMPLETED|First Intervention||0
26273|NCT02178059|64340|P1|NOT COMPLETED|First Intervention||0
26274|NCT02178059|64339|P2|COMPLETED|First Intervention||17
26275|NCT02178059|64340|P1|COMPLETED|First Intervention||17
26276|NCT02178059|64339|P2|STARTED|First Intervention||17
26277|NCT02178059|64340|P1|STARTED|First Intervention||17
26278|NCT02177266|64358|P2|NOT COMPLETED|Overall Study||1
26279|NCT02177266|64359|P1|NOT COMPLETED|Overall Study||1
26280|NCT02177266|64358|P2|COMPLETED|Overall Study||0
26281|NCT02177266|64359|P1|COMPLETED|Overall Study||0
26282|NCT02177266|64358|P2|STARTED|Overall Study||1
26283|NCT02177266|64359|P1|STARTED|Overall Study||1
26284|NCT02177201|64371|P2|NOT COMPLETED|Overall Study||3
26285|NCT02177201|64372|P1|NOT COMPLETED|Overall Study||3
26286|NCT02177201|64371|P2|COMPLETED|Overall Study||77
26287|NCT02177201|64372|P1|COMPLETED|Overall Study||77
26288|NCT02177201|64371|P2|STARTED|Overall Study||80
26289|NCT02177201|64372|P1|STARTED|Overall Study||80
26290|NCT02177136|64381|P3|NOT COMPLETED|Overall Study||4
26291|NCT02177136|64382|P2|NOT COMPLETED|Overall Study||5
26292|NCT02177136|64383|P1|NOT COMPLETED|Overall Study||6
26293|NCT02177136|64381|P3|COMPLETED|Overall Study||21
26294|NCT02177136|64382|P2|COMPLETED|Overall Study||21
26295|NCT02177136|64383|P1|COMPLETED|Overall Study||19
26296|NCT02177136|64381|P3|STARTED|Overall Study||25
26297|NCT02177136|64382|P2|STARTED|Overall Study||26
26298|NCT02177136|64383|P1|STARTED|Overall Study||25
26299|NCT02177032|64416|P4|NOT COMPLETED|Overall Study||0
26300|NCT02177032|64417|P3|NOT COMPLETED|Overall Study||3
26301|NCT02177032|64418|P2|NOT COMPLETED|Overall Study||2
26302|NCT02177032|64419|P1|NOT COMPLETED|Overall Study||5
26303|NCT02177032|64416|P4|COMPLETED|Overall Study||88
26304|NCT02177032|64417|P3|COMPLETED|Overall Study||351
26305|NCT02177032|64418|P2|COMPLETED|Overall Study||86
26306|NCT02177032|64419|P1|COMPLETED|Overall Study||350
26307|NCT02177032|64416|P4|STARTED|Overall Study||88
26308|NCT02177032|64417|P3|STARTED|Overall Study||354
26309|NCT02177032|64418|P2|STARTED|Overall Study||88
26310|NCT02177032|64419|P1|STARTED|Overall Study||355
26311|NCT02176837|64453|P1|NOT COMPLETED|Overall Study||6
26312|NCT02176837|64453|P1|COMPLETED|Overall Study||0
26313|NCT02176837|64453|P1|STARTED|Overall Study||6
26314|NCT02176655|64457|P1|NOT COMPLETED|Overall Study||6
26315|NCT02176655|64457|P1|COMPLETED|Overall Study||25
26316|NCT02176655|64457|P1|STARTED|Overall Study||31
26317|NCT02176642|64480|P2|NOT COMPLETED|Overall Study||1
26318|NCT02176642|64481|P1|NOT COMPLETED|Overall Study||0
26319|NCT02176642|64480|P2|COMPLETED|Overall Study||16
26320|NCT02176642|64481|P1|COMPLETED|Overall Study||18
26321|NCT02176642|64480|P2|STARTED|Overall Study||17
26322|NCT02176642|64481|P1|STARTED|Overall Study||18
26323|NCT02176525|64511|P8|NOT COMPLETED|Overall Study||0
26324|NCT02176525|64512|P7|NOT COMPLETED|Overall Study||1
26325|NCT02176525|64513|P6|NOT COMPLETED|Overall Study||1
26326|NCT02176525|64514|P5|NOT COMPLETED|Overall Study||1
26327|NCT02176525|64515|P4|NOT COMPLETED|Overall Study||1
26328|NCT02176525|64516|P3|NOT COMPLETED|Overall Study||0
26329|NCT02176525|64517|P2|NOT COMPLETED|Overall Study||0
26330|NCT02176525|64518|P1|NOT COMPLETED|Overall Study||1
26331|NCT02176525|64511|P8|COMPLETED|Overall Study||10
26332|NCT02176525|64512|P7|COMPLETED|Overall Study||8
26333|NCT02176525|64513|P6|COMPLETED|Overall Study||5
26334|NCT02176525|64514|P5|COMPLETED|Overall Study||7
26335|NCT02176525|64515|P4|COMPLETED|Overall Study||8
26336|NCT02176525|64516|P3|COMPLETED|Overall Study||9
26337|NCT02176525|64517|P2|COMPLETED|Overall Study||9
26338|NCT02176525|64518|P1|COMPLETED|Overall Study||14
26339|NCT02176525|64511|P8|STARTED|Overall Study||10
26340|NCT02176525|64512|P7|STARTED|Overall Study||9
26341|NCT02176525|64513|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
26342|NCT02176525|64514|P5|STARTED|Overall Study||8
26343|NCT02176525|64515|P4|STARTED|Overall Study||9
26344|NCT02176525|64516|P3|STARTED|Overall Study||9
26345|NCT02176525|64517|P2|STARTED|Overall Study||9
26346|NCT02176525|64518|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
26347|NCT02176421|64695|P1|NOT COMPLETED|Overall Study||5
26348|NCT02176421|64695|P1|COMPLETED|Overall Study||75
26349|NCT02176421|64695|P1|STARTED|Overall Study||80
26350|NCT02176356|64704|P1|NOT COMPLETED|Overall Study||23
26351|NCT02176356|64704|P1|COMPLETED|Overall Study||93
26352|NCT02176356|64704|P1|Eligible and Received Treatment|Overall Study||100
26353|NCT02176356|64704|P1|STARTED|Overall Study||116
26354|NCT02176343|64721|P1|NOT COMPLETED|Overall Study||0
26355|NCT02176343|64721|P1|COMPLETED|Overall Study||31
26356|NCT02176343|64721|P1|STARTED|Overall Study||31
26357|NCT02176018|64734|P2|NOT COMPLETED|Overall Study||6
26358|NCT02176018|64735|P1|NOT COMPLETED|Overall Study||5
26359|NCT02176018|64734|P2|COMPLETED|Overall Study||17
26360|NCT02176018|64735|P1|COMPLETED|Overall Study||17
26361|NCT02176018|64734|P2|STARTED|Overall Study||23
26362|NCT02176018|64735|P1|STARTED|Overall Study||22
26363|NCT02175771|64767|P9|NOT COMPLETED|Treatment Period||6
26364|NCT02175771|64768|P8|NOT COMPLETED|Treatment Period||17
26365|NCT02175771|64769|P7|NOT COMPLETED|Treatment Period||5
26366|NCT02175771|64770|P6|NOT COMPLETED|Treatment Period||10
26367|NCT02175771|64771|P5|NOT COMPLETED|Treatment Period||5
26368|NCT02175771|64772|P4|NOT COMPLETED|Treatment Period||13
26369|NCT02175771|64773|P3|NOT COMPLETED|Treatment Period||7
26370|NCT02175771|64774|P2|NOT COMPLETED|Treatment Period||16
26371|NCT02175771|64775|P1|NOT COMPLETED|Treatment Period||0
26372|NCT02175771|64767|P9|COMPLETED|Treatment Period||38
26373|NCT02175771|64768|P8|COMPLETED|Treatment Period||116
26374|NCT02175771|64769|P7|COMPLETED|Treatment Period||36
26375|NCT02175771|64770|P6|COMPLETED|Treatment Period||110
26376|NCT02175771|64771|P5|COMPLETED|Treatment Period||36
26377|NCT02175771|64772|P4|COMPLETED|Treatment Period||113
26378|NCT02175771|64773|P3|COMPLETED|Treatment Period||35
26379|NCT02175771|64774|P2|COMPLETED|Treatment Period||111
26380|NCT02175771|64775|P1|COMPLETED|Treatment Period||0
26381|NCT02175771|64767|P9|STARTED|Treatment Period||44
26382|NCT02175771|64768|P8|STARTED|Treatment Period||133
26383|NCT02175771|64769|P7|STARTED|Treatment Period||41
26384|NCT02175771|64770|P6|STARTED|Treatment Period||120
26385|NCT02175771|64771|P5|STARTED|Treatment Period||41
26386|NCT02175771|64772|P4|STARTED|Treatment Period||126
26387|NCT02175771|64773|P3|STARTED|Treatment Period||42
26388|NCT02175771|64774|P2|STARTED|Treatment Period||127
26389|NCT02175771|64775|P1|STARTED|Treatment Period||0
26390|NCT02175771|64767|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26391|NCT02175771|64768|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26392|NCT02175771|64769|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26393|NCT02175771|64770|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26394|NCT02175771|64771|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26395|NCT02175771|64772|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26396|NCT02175771|64773|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26397|NCT02175771|64774|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
26398|NCT02175771|64775|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
26399|NCT02175771|64767|P9|COMPLETED|Run-In Period (Pre-assignment)||0
26400|NCT02175771|64768|P8|COMPLETED|Run-In Period (Pre-assignment)||0
26401|NCT02175771|64769|P7|COMPLETED|Run-In Period (Pre-assignment)||0
26402|NCT02175771|64770|P6|COMPLETED|Run-In Period (Pre-assignment)||0
26403|NCT02175771|64771|P5|COMPLETED|Run-In Period (Pre-assignment)||0
26404|NCT02175771|64772|P4|COMPLETED|Run-In Period (Pre-assignment)||0
26405|NCT02175771|64773|P3|COMPLETED|Run-In Period (Pre-assignment)||0
26406|NCT02175771|64774|P2|COMPLETED|Run-In Period (Pre-assignment)||0
26407|NCT02175771|64775|P1|COMPLETED|Run-In Period (Pre-assignment)||674
26408|NCT02175771|64767|P9|STARTED|Run-In Period (Pre-assignment)||0
26409|NCT02175771|64768|P8|STARTED|Run-In Period (Pre-assignment)||0
26410|NCT02175771|64769|P7|STARTED|Run-In Period (Pre-assignment)||0
26411|NCT02175771|64770|P6|STARTED|Run-In Period (Pre-assignment)||0
26412|NCT02175771|64771|P5|STARTED|Run-In Period (Pre-assignment)||0
26413|NCT02175771|64772|P4|STARTED|Run-In Period (Pre-assignment)||0
26414|NCT02175771|64773|P3|STARTED|Run-In Period (Pre-assignment)||0
26415|NCT02175771|64774|P2|STARTED|Run-In Period (Pre-assignment)||0
26416|NCT02175771|64775|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
26417|NCT02175745|64833|P1|NOT COMPLETED|Overall Study||1
26418|NCT02175745|64833|P1|COMPLETED|Overall Study||1
26419|NCT02175745|64833|P1|STARTED|Overall Study||2
26420|NCT02175368|64838|P1|NOT COMPLETED|Overall Study||1
26421|NCT02175368|64838|P1|COMPLETED|Overall Study||27
26422|NCT02175368|64838|P1|STARTED|Overall Study||28
26423|NCT02175212|64844|P2|NOT COMPLETED|Overall Study||147
26424|NCT02175212|64845|P1|NOT COMPLETED|Overall Study||163
26425|NCT02175212|64844|P2|COMPLETED|Overall Study||31
26426|NCT02175212|64845|P1|COMPLETED|Overall Study||14
26427|NCT02175212|64844|P2|STARTED|Overall Study||178
26428|NCT02175212|64845|P1|STARTED|Overall Study||177
26429|NCT02175199|64861|P2|NOT COMPLETED|Overall Study||5
26430|NCT02175199|64862|P1|NOT COMPLETED|Overall Study||3
26431|NCT02175199|64861|P2|COMPLETED|Overall Study||71
26432|NCT02175199|64862|P1|COMPLETED|Overall Study||71
26433|NCT02175199|64861|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
26434|NCT02175199|64862|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
26435|NCT02175199|64861|P2|STARTED|Overall Study||76
26436|NCT02175199|64862|P1|STARTED|Overall Study||74
26437|NCT02175121|64876|P5|NOT COMPLETED|Overall Study||1
26438|NCT02175121|64877|P4|NOT COMPLETED|Overall Study||1
26439|NCT02175121|64878|P3|NOT COMPLETED|Overall Study||2
26440|NCT02175121|64879|P2|NOT COMPLETED|Overall Study||1
26441|NCT02175121|64880|P1|NOT COMPLETED|Overall Study||1
26442|NCT02175121|64876|P5|COMPLETED|Overall Study||33
26443|NCT02175121|64877|P4|COMPLETED|Overall Study||34
26444|NCT02175121|64878|P3|COMPLETED|Overall Study||32
26445|NCT02175121|64879|P2|COMPLETED|Overall Study||34
26446|NCT02175121|64880|P1|COMPLETED|Overall Study||33
26447|NCT02175121|64876|P5|STARTED|Overall Study||34
26448|NCT02175121|64877|P4|STARTED|Overall Study||35
26449|NCT02175121|64878|P3|STARTED|Overall Study||34
26450|NCT02175121|64879|P2|STARTED|Overall Study||35
26451|NCT02175121|64880|P1|STARTED|Overall Study||34
26452|NCT02173769|65007|P1|NOT COMPLETED|Overall Study||4
26453|NCT02173769|65007|P1|COMPLETED|Overall Study||1854
26454|NCT02173769|65007|P1|STARTED|Overall Study||1858
26455|NCT02173535|65038|P20|NOT COMPLETED|Period 5||0
26456|NCT02173535|65039|P19|NOT COMPLETED|Period 5||0
26457|NCT02173535|65040|P18|NOT COMPLETED|Period 5||0
26458|NCT02173535|65041|P17|NOT COMPLETED|Period 5||0
26459|NCT02173535|65042|P16|NOT COMPLETED|Period 5||0
26460|NCT02173535|65043|P15|NOT COMPLETED|Period 5||0
26461|NCT02173535|65044|P14|NOT COMPLETED|Period 5||0
26462|NCT02173535|65045|P13|NOT COMPLETED|Period 5||0
26463|NCT02173535|65046|P12|NOT COMPLETED|Period 5||0
26464|NCT02173535|65047|P11|NOT COMPLETED|Period 5||0
26465|NCT02173535|65048|P10|NOT COMPLETED|Period 5||0
26466|NCT02173535|65049|P9|NOT COMPLETED|Period 5||0
26467|NCT02173535|65050|P8|NOT COMPLETED|Period 5||0
26468|NCT02173535|65051|P7|NOT COMPLETED|Period 5||0
26469|NCT02173535|65052|P6|NOT COMPLETED|Period 5||0
26470|NCT02173535|65053|P5|NOT COMPLETED|Period 5||0
26471|NCT02173535|65054|P4|NOT COMPLETED|Period 5||0
26472|NCT02173535|65055|P3|NOT COMPLETED|Period 5||0
26473|NCT02173535|65056|P2|NOT COMPLETED|Period 5||0
26474|NCT02173535|65057|P1|NOT COMPLETED|Period 5||0
26475|NCT02173535|65038|P20|COMPLETED|Period 5||12
26476|NCT02173535|65039|P19|COMPLETED|Period 5||12
26477|NCT02173535|65040|P18|COMPLETED|Period 5||12
26478|NCT02173535|65041|P17|COMPLETED|Period 5||12
26479|NCT02173535|65042|P16|COMPLETED|Period 5||12
26480|NCT02173535|65043|P15|COMPLETED|Period 5||12
26481|NCT02173535|65044|P14|COMPLETED|Period 5||12
26482|NCT02173535|65045|P13|COMPLETED|Period 5||12
26483|NCT02173535|65046|P12|COMPLETED|Period 5||12
26484|NCT02173535|65047|P11|COMPLETED|Period 5||12
26485|NCT02173535|65048|P10|COMPLETED|Period 5||12
26486|NCT02173535|65049|P9|COMPLETED|Period 5||12
26487|NCT02173535|65050|P8|COMPLETED|Period 5||12
26488|NCT02173535|65051|P7|COMPLETED|Period 5||12
26489|NCT02173535|65052|P6|COMPLETED|Period 5||12
26490|NCT02173535|65053|P5|COMPLETED|Period 5||12
26491|NCT02173535|65054|P4|COMPLETED|Period 5||12
26492|NCT02173535|65055|P3|COMPLETED|Period 5||12
26493|NCT02173535|65056|P2|COMPLETED|Period 5||12
26494|NCT02173535|65057|P1|COMPLETED|Period 5||12
26495|NCT02173535|65038|P20|STARTED|Period 5||12
26496|NCT02173535|65039|P19|STARTED|Period 5||12
26497|NCT02173535|65040|P18|STARTED|Period 5||12
26498|NCT02173535|65041|P17|STARTED|Period 5||12
26499|NCT02173535|65042|P16|STARTED|Period 5||12
26500|NCT02173535|65043|P15|STARTED|Period 5||12
26501|NCT02173535|65044|P14|STARTED|Period 5||12
26502|NCT02173535|65045|P13|STARTED|Period 5||12
26503|NCT02173535|65046|P12|STARTED|Period 5||12
26504|NCT02173535|65047|P11|STARTED|Period 5||12
26505|NCT02173535|65048|P10|STARTED|Period 5||12
26506|NCT02173535|65049|P9|STARTED|Period 5||12
26507|NCT02173535|65050|P8|STARTED|Period 5||12
26508|NCT02173535|65051|P7|STARTED|Period 5||12
26509|NCT02173535|65052|P6|STARTED|Period 5||12
26510|NCT02173535|65053|P5|STARTED|Period 5||12
26511|NCT02173535|65054|P4|STARTED|Period 5||12
26512|NCT02173535|65055|P3|STARTED|Period 5||12
26513|NCT02173535|65056|P2|STARTED|Period 5||12
26514|NCT02173535|65057|P1|STARTED|Period 5||12
26515|NCT02173535|65038|P20|NOT COMPLETED|Period 4||0
26516|NCT02173535|65039|P19|NOT COMPLETED|Period 4||0
26517|NCT02173535|65040|P18|NOT COMPLETED|Period 4||0
26518|NCT02173535|65041|P17|NOT COMPLETED|Period 4||0
26519|NCT02173535|65042|P16|NOT COMPLETED|Period 4||0
26520|NCT02173535|65043|P15|NOT COMPLETED|Period 4||0
26521|NCT02173535|65044|P14|NOT COMPLETED|Period 4||0
26522|NCT02173535|65045|P13|NOT COMPLETED|Period 4||0
26523|NCT02173535|65046|P12|NOT COMPLETED|Period 4||0
26524|NCT02173535|65047|P11|NOT COMPLETED|Period 4||0
26525|NCT02173535|65048|P10|NOT COMPLETED|Period 4||0
26526|NCT02173535|65049|P9|NOT COMPLETED|Period 4||0
26527|NCT02173535|65050|P8|NOT COMPLETED|Period 4||0
26528|NCT02173535|65051|P7|NOT COMPLETED|Period 4||0
26529|NCT02173535|65052|P6|NOT COMPLETED|Period 4||0
26530|NCT02173535|65053|P5|NOT COMPLETED|Period 4||0
26531|NCT02173535|65054|P4|NOT COMPLETED|Period 4||0
26532|NCT02173535|65055|P3|NOT COMPLETED|Period 4||0
26533|NCT02173535|65056|P2|NOT COMPLETED|Period 4||0
26534|NCT02173535|65057|P1|NOT COMPLETED|Period 4||0
26535|NCT02173535|65038|P20|COMPLETED|Period 4||12
26536|NCT02173535|65039|P19|COMPLETED|Period 4||12
26537|NCT02173535|65040|P18|COMPLETED|Period 4||12
26538|NCT02173535|65041|P17|COMPLETED|Period 4||12
26539|NCT02173535|65042|P16|COMPLETED|Period 4||12
26540|NCT02173535|65043|P15|COMPLETED|Period 4||12
26541|NCT02173535|65044|P14|COMPLETED|Period 4||12
26542|NCT02173535|65045|P13|COMPLETED|Period 4||12
26543|NCT02173535|65046|P12|COMPLETED|Period 4||12
26544|NCT02173535|65047|P11|COMPLETED|Period 4||12
26545|NCT02173535|65048|P10|COMPLETED|Period 4||12
26546|NCT02173535|65049|P9|COMPLETED|Period 4||12
26547|NCT02173535|65050|P8|COMPLETED|Period 4||12
26548|NCT02173535|65051|P7|COMPLETED|Period 4||12
26549|NCT02173535|65052|P6|COMPLETED|Period 4||12
26550|NCT02173535|65053|P5|COMPLETED|Period 4||12
26551|NCT02173535|65054|P4|COMPLETED|Period 4||12
26552|NCT02173535|65055|P3|COMPLETED|Period 4||12
26553|NCT02173535|65056|P2|COMPLETED|Period 4||12
26554|NCT02173535|65057|P1|COMPLETED|Period 4||12
26555|NCT02173535|65038|P20|STARTED|Period 4||12
26556|NCT02173535|65039|P19|STARTED|Period 4||12
26557|NCT02173535|65040|P18|STARTED|Period 4||12
26558|NCT02173535|65041|P17|STARTED|Period 4||12
26559|NCT02173535|65042|P16|STARTED|Period 4||12
26560|NCT02173535|65043|P15|STARTED|Period 4||12
26561|NCT02173535|65044|P14|STARTED|Period 4||12
26562|NCT02173535|65045|P13|STARTED|Period 4||12
26563|NCT02173535|65046|P12|STARTED|Period 4||12
26564|NCT02173535|65047|P11|STARTED|Period 4||12
26565|NCT02173535|65048|P10|STARTED|Period 4||12
26566|NCT02173535|65049|P9|STARTED|Period 4||12
26567|NCT02173535|65050|P8|STARTED|Period 4||12
26568|NCT02173535|65051|P7|STARTED|Period 4||12
26569|NCT02173535|65052|P6|STARTED|Period 4||12
26570|NCT02173535|65053|P5|STARTED|Period 4||12
26571|NCT02173535|65054|P4|STARTED|Period 4||12
26572|NCT02173535|65055|P3|STARTED|Period 4||12
26573|NCT02173535|65056|P2|STARTED|Period 4||12
26574|NCT02173535|65057|P1|STARTED|Period 4||12
26575|NCT02173535|65038|P20|NOT COMPLETED|Period 3||0
26576|NCT02173535|65039|P19|NOT COMPLETED|Period 3||0
26577|NCT02173535|65040|P18|NOT COMPLETED|Period 3||0
26578|NCT02173535|65041|P17|NOT COMPLETED|Period 3||0
26579|NCT02173535|65042|P16|NOT COMPLETED|Period 3||0
26580|NCT02173535|65043|P15|NOT COMPLETED|Period 3||0
26581|NCT02173535|65044|P14|NOT COMPLETED|Period 3||0
26582|NCT02173535|65045|P13|NOT COMPLETED|Period 3||0
26583|NCT02173535|65046|P12|NOT COMPLETED|Period 3||0
26584|NCT02173535|65047|P11|NOT COMPLETED|Period 3||0
26585|NCT02173535|65048|P10|NOT COMPLETED|Period 3||0
26586|NCT02173535|65049|P9|NOT COMPLETED|Period 3||0
26587|NCT02173535|65050|P8|NOT COMPLETED|Period 3||0
26588|NCT02173535|65051|P7|NOT COMPLETED|Period 3||0
26589|NCT02173535|65052|P6|NOT COMPLETED|Period 3||0
26590|NCT02173535|65053|P5|NOT COMPLETED|Period 3||0
26591|NCT02173535|65054|P4|NOT COMPLETED|Period 3||0
26592|NCT02173535|65055|P3|NOT COMPLETED|Period 3||0
26593|NCT02173535|65056|P2|NOT COMPLETED|Period 3||0
26594|NCT02173535|65057|P1|NOT COMPLETED|Period 3||0
26595|NCT02173535|65038|P20|COMPLETED|Period 3||12
26596|NCT02173535|65039|P19|COMPLETED|Period 3||12
26597|NCT02173535|65040|P18|COMPLETED|Period 3||12
26598|NCT02173535|65041|P17|COMPLETED|Period 3||12
26599|NCT02173535|65042|P16|COMPLETED|Period 3||12
26600|NCT02173535|65043|P15|COMPLETED|Period 3||12
26601|NCT02173535|65044|P14|COMPLETED|Period 3||12
26602|NCT02173535|65045|P13|COMPLETED|Period 3||12
26603|NCT02173535|65046|P12|COMPLETED|Period 3||12
26604|NCT02173535|65047|P11|COMPLETED|Period 3||12
26605|NCT02173535|65048|P10|COMPLETED|Period 3||12
26606|NCT02173535|65049|P9|COMPLETED|Period 3||12
26607|NCT02173535|65050|P8|COMPLETED|Period 3||12
26608|NCT02173535|65051|P7|COMPLETED|Period 3||12
26609|NCT02173535|65052|P6|COMPLETED|Period 3||12
26610|NCT02173535|65053|P5|COMPLETED|Period 3||12
26611|NCT02173535|65054|P4|COMPLETED|Period 3||12
26612|NCT02173535|65055|P3|COMPLETED|Period 3||12
26613|NCT02173535|65056|P2|COMPLETED|Period 3||12
26614|NCT02173535|65057|P1|COMPLETED|Period 3||12
26615|NCT02173535|65038|P20|STARTED|Period 3||12
26616|NCT02173535|65039|P19|STARTED|Period 3||12
26617|NCT02173535|65040|P18|STARTED|Period 3||12
26618|NCT02173535|65041|P17|STARTED|Period 3||12
26619|NCT02173535|65042|P16|STARTED|Period 3||12
26620|NCT02173535|65043|P15|STARTED|Period 3||12
26621|NCT02173535|65044|P14|STARTED|Period 3||12
26622|NCT02173535|65045|P13|STARTED|Period 3||12
26623|NCT02173535|65046|P12|STARTED|Period 3||12
26624|NCT02173535|65047|P11|STARTED|Period 3||12
26625|NCT02173535|65048|P10|STARTED|Period 3||12
26626|NCT02173535|65049|P9|STARTED|Period 3||12
26627|NCT02173535|65050|P8|STARTED|Period 3||12
26628|NCT02173535|65051|P7|STARTED|Period 3||12
26629|NCT02173535|65052|P6|STARTED|Period 3||12
26630|NCT02173535|65053|P5|STARTED|Period 3||12
26631|NCT02173535|65054|P4|STARTED|Period 3||12
26632|NCT02173535|65055|P3|STARTED|Period 3||12
26633|NCT02173535|65056|P2|STARTED|Period 3||12
26634|NCT02173535|65057|P1|STARTED|Period 3||12
26635|NCT02173535|65038|P20|NOT COMPLETED|Period 2||0
26636|NCT02173535|65039|P19|NOT COMPLETED|Period 2||0
26637|NCT02173535|65040|P18|NOT COMPLETED|Period 2||0
26638|NCT02173535|65041|P17|NOT COMPLETED|Period 2||0
26639|NCT02173535|65042|P16|NOT COMPLETED|Period 2||0
26640|NCT02173535|65043|P15|NOT COMPLETED|Period 2||0
26641|NCT02173535|65044|P14|NOT COMPLETED|Period 2||0
26642|NCT02173535|65045|P13|NOT COMPLETED|Period 2||0
26643|NCT02173535|65046|P12|NOT COMPLETED|Period 2||0
26644|NCT02173535|65047|P11|NOT COMPLETED|Period 2||0
26645|NCT02173535|65048|P10|NOT COMPLETED|Period 2||0
26646|NCT02173535|65049|P9|NOT COMPLETED|Period 2||0
26647|NCT02173535|65050|P8|NOT COMPLETED|Period 2||0
26648|NCT02173535|65051|P7|NOT COMPLETED|Period 2||0
26649|NCT02173535|65052|P6|NOT COMPLETED|Period 2||0
26650|NCT02173535|65053|P5|NOT COMPLETED|Period 2||0
26651|NCT02173535|65054|P4|NOT COMPLETED|Period 2||0
26652|NCT02173535|65055|P3|NOT COMPLETED|Period 2||0
26653|NCT02173535|65056|P2|NOT COMPLETED|Period 2||0
26654|NCT02173535|65057|P1|NOT COMPLETED|Period 2||0
26655|NCT02173535|65038|P20|COMPLETED|Period 2||12
26656|NCT02173535|65039|P19|COMPLETED|Period 2||12
26657|NCT02173535|65040|P18|COMPLETED|Period 2||12
26658|NCT02173535|65041|P17|COMPLETED|Period 2||12
26659|NCT02173535|65042|P16|COMPLETED|Period 2||12
26660|NCT02173535|65043|P15|COMPLETED|Period 2||12
26661|NCT02173535|65044|P14|COMPLETED|Period 2||12
26662|NCT02173535|65045|P13|COMPLETED|Period 2||12
26663|NCT02173535|65046|P12|COMPLETED|Period 2||12
26664|NCT02173535|65047|P11|COMPLETED|Period 2||12
26665|NCT02173535|65048|P10|COMPLETED|Period 2||12
26666|NCT02173535|65049|P9|COMPLETED|Period 2||12
26667|NCT02173535|65050|P8|COMPLETED|Period 2||12
26668|NCT02173535|65051|P7|COMPLETED|Period 2||12
26669|NCT02173535|65052|P6|COMPLETED|Period 2||12
26670|NCT02173535|65053|P5|COMPLETED|Period 2||12
26671|NCT02173535|65054|P4|COMPLETED|Period 2||12
26672|NCT02173535|65055|P3|COMPLETED|Period 2||12
26673|NCT02173535|65056|P2|COMPLETED|Period 2||12
26674|NCT02173535|65057|P1|COMPLETED|Period 2||12
26675|NCT02173535|65038|P20|STARTED|Period 2||12
26676|NCT02173535|65039|P19|STARTED|Period 2||12
26677|NCT02173535|65040|P18|STARTED|Period 2||12
26678|NCT02173535|65041|P17|STARTED|Period 2||12
26679|NCT02173535|65042|P16|STARTED|Period 2||12
26680|NCT02173535|65043|P15|STARTED|Period 2||12
26681|NCT02173535|65044|P14|STARTED|Period 2||12
26682|NCT02173535|65045|P13|STARTED|Period 2||12
26683|NCT02173535|65046|P12|STARTED|Period 2||12
26684|NCT02173535|65047|P11|STARTED|Period 2||12
26685|NCT02173535|65048|P10|STARTED|Period 2||12
26686|NCT02173535|65049|P9|STARTED|Period 2||12
26687|NCT02173535|65050|P8|STARTED|Period 2||12
26688|NCT02173535|65051|P7|STARTED|Period 2||12
26689|NCT02173535|65052|P6|STARTED|Period 2||12
26690|NCT02173535|65053|P5|STARTED|Period 2||12
26691|NCT02173535|65054|P4|STARTED|Period 2||12
26692|NCT02173535|65055|P3|STARTED|Period 2||12
26693|NCT02173535|65056|P2|STARTED|Period 2||12
26694|NCT02173535|65057|P1|STARTED|Period 2||12
26695|NCT02173535|65038|P20|NOT COMPLETED|Period 1||0
26696|NCT02173535|65039|P19|NOT COMPLETED|Period 1||0
26697|NCT02173535|65040|P18|NOT COMPLETED|Period 1||0
26698|NCT02173535|65041|P17|NOT COMPLETED|Period 1||0
26699|NCT02173535|65042|P16|NOT COMPLETED|Period 1||0
26700|NCT02173535|65043|P15|NOT COMPLETED|Period 1||0
26701|NCT02173535|65044|P14|NOT COMPLETED|Period 1||0
26702|NCT02173535|65045|P13|NOT COMPLETED|Period 1||0
26703|NCT02173535|65046|P12|NOT COMPLETED|Period 1||0
26704|NCT02173535|65047|P11|NOT COMPLETED|Period 1||0
26705|NCT02173535|65048|P10|NOT COMPLETED|Period 1||0
26706|NCT02173535|65049|P9|NOT COMPLETED|Period 1||0
26707|NCT02173535|65050|P8|NOT COMPLETED|Period 1||0
26708|NCT02173535|65051|P7|NOT COMPLETED|Period 1||0
26709|NCT02173535|65052|P6|NOT COMPLETED|Period 1||0
26710|NCT02173535|65053|P5|NOT COMPLETED|Period 1||0
26711|NCT02173535|65054|P4|NOT COMPLETED|Period 1||0
26712|NCT02173535|65055|P3|NOT COMPLETED|Period 1||0
26713|NCT02173535|65056|P2|NOT COMPLETED|Period 1||0
26714|NCT02173535|65057|P1|NOT COMPLETED|Period 1||0
26715|NCT02173535|65038|P20|COMPLETED|Period 1||12
26716|NCT02173535|65039|P19|COMPLETED|Period 1||12
26717|NCT02173535|65040|P18|COMPLETED|Period 1||12
26718|NCT02173535|65041|P17|COMPLETED|Period 1||12
26719|NCT02173535|65042|P16|COMPLETED|Period 1||12
26720|NCT02173535|65043|P15|COMPLETED|Period 1||12
26721|NCT02173535|65044|P14|COMPLETED|Period 1||12
26722|NCT02173535|65045|P13|COMPLETED|Period 1||12
26723|NCT02173535|65046|P12|COMPLETED|Period 1||12
26724|NCT02173535|65047|P11|COMPLETED|Period 1||12
26725|NCT02173535|65048|P10|COMPLETED|Period 1||12
26726|NCT02173535|65049|P9|COMPLETED|Period 1||12
26727|NCT02173535|65050|P8|COMPLETED|Period 1||12
26728|NCT02173535|65051|P7|COMPLETED|Period 1||12
26729|NCT02173535|65052|P6|COMPLETED|Period 1||12
26730|NCT02173535|65053|P5|COMPLETED|Period 1||12
26731|NCT02173535|65054|P4|COMPLETED|Period 1||12
26732|NCT02173535|65055|P3|COMPLETED|Period 1||12
26733|NCT02173535|65056|P2|COMPLETED|Period 1||12
26734|NCT02173535|65057|P1|COMPLETED|Period 1||12
26735|NCT02173535|65038|P20|STARTED|Period 1||12
26736|NCT02173535|65039|P19|STARTED|Period 1||12
26737|NCT02173535|65040|P18|STARTED|Period 1||12
26738|NCT02173535|65041|P17|STARTED|Period 1||12
26739|NCT02173535|65042|P16|STARTED|Period 1||12
26740|NCT02173535|65043|P15|STARTED|Period 1||12
26741|NCT02173535|65044|P14|STARTED|Period 1||12
26742|NCT02173535|65045|P13|STARTED|Period 1||12
26743|NCT02173535|65046|P12|STARTED|Period 1||12
26744|NCT02173535|65047|P11|STARTED|Period 1||12
26745|NCT02173535|65048|P10|STARTED|Period 1||12
26746|NCT02173535|65049|P9|STARTED|Period 1||12
26747|NCT02173535|65050|P8|STARTED|Period 1||12
26748|NCT02173535|65051|P7|STARTED|Period 1||12
26749|NCT02173535|65052|P6|STARTED|Period 1||12
26750|NCT02173535|65053|P5|STARTED|Period 1||12
26751|NCT02173535|65054|P4|STARTED|Period 1||12
26752|NCT02173535|65055|P3|STARTED|Period 1||12
26753|NCT02173535|65056|P2|STARTED|Period 1||12
26754|NCT02173535|65057|P1|STARTED|Period 1||12
26755|NCT02173392|65096|P2|NOT COMPLETED|Overall Study||4
26756|NCT02173392|65097|P1|NOT COMPLETED|Overall Study||14
26757|NCT02173392|65096|P2|COMPLETED|Overall Study||68
26758|NCT02173392|65097|P1|COMPLETED|Overall Study||59
26759|NCT02173392|65096|P2|STARTED|Overall Study||72
26760|NCT02173392|65097|P1|STARTED|Overall Study||73
26761|NCT02173054|65110|P3|NOT COMPLETED|Overall Study||1
26762|NCT02173054|65111|P2|NOT COMPLETED|Overall Study||0
26763|NCT02173054|65112|P1|NOT COMPLETED|Overall Study||1
26764|NCT02173054|65110|P3|COMPLETED|Overall Study||39
26765|NCT02173054|65111|P2|COMPLETED|Overall Study||40
26766|NCT02173054|65112|P1|COMPLETED|Overall Study||39
26767|NCT02173054|65110|P3|STARTED|Overall Study||40
26768|NCT02173054|65111|P2|STARTED|Overall Study||40
26769|NCT02173054|65112|P1|STARTED|Overall Study||40
26770|NCT02172755|65134|P2|NOT COMPLETED|Overall Study||4
26771|NCT02172755|65135|P1|NOT COMPLETED|Overall Study||2
26772|NCT02172755|65134|P2|COMPLETED|Overall Study||12
26773|NCT02172755|65135|P1|COMPLETED|Overall Study||12
26774|NCT02172755|65134|P2|STARTED|Overall Study||16
26775|NCT02172755|65135|P1|STARTED|Overall Study||14
26776|NCT02172742|65147|P2|NOT COMPLETED|Overall Study||0
26777|NCT02172742|65148|P1|NOT COMPLETED|Overall Study||1
26778|NCT02172742|65147|P2|COMPLETED|Overall Study||6
26779|NCT02172742|65148|P1|COMPLETED|Overall Study||6
26780|NCT02172742|65147|P2|STARTED|Overall Study||6
26781|NCT02172742|65148|P1|STARTED|Overall Study||7
26782|NCT02172625|65157|P2|NOT COMPLETED|Overall Study||3
26783|NCT02172625|65158|P1|NOT COMPLETED|Overall Study||0
26784|NCT02172625|65157|P2|COMPLETED|Overall Study||16
26785|NCT02172625|65158|P1|COMPLETED|Overall Study||19
26786|NCT02172625|65157|P2|STARTED|Overall Study||19
26787|NCT02172625|65158|P1|STARTED|Overall Study||19
26788|NCT02172040|65180|P4|NOT COMPLETED|Overall Study||1
26789|NCT02172040|65181|P3|NOT COMPLETED|Overall Study||2
26790|NCT02172040|65182|P2|NOT COMPLETED|Overall Study||3
26791|NCT02172040|65183|P1|NOT COMPLETED|Overall Study||0
26792|NCT02172040|65180|P4|COMPLETED|Overall Study||26
26793|NCT02172040|65181|P3|COMPLETED|Overall Study||29
26794|NCT02172040|65182|P2|COMPLETED|Overall Study||42
26795|NCT02172040|65183|P1|COMPLETED|Overall Study||49
26796|NCT02172040|65180|P4|STARTED|Overall Study||27
26797|NCT02172040|65181|P3|STARTED|Overall Study||31
26798|NCT02172040|65182|P2|STARTED|Overall Study||45
26799|NCT02172040|65183|P1|STARTED|Overall Study||49
26800|NCT02171611|65229|P6|NOT COMPLETED|Overall Study||0
26801|NCT02171611|65230|P5|NOT COMPLETED|Overall Study||0
26802|NCT02171611|65231|P4|NOT COMPLETED|Overall Study||0
26803|NCT02171611|65232|P3|NOT COMPLETED|Overall Study||0
26804|NCT02171611|65233|P2|NOT COMPLETED|Overall Study||0
26805|NCT02171611|65234|P1|NOT COMPLETED|Overall Study||0
26806|NCT02171611|65229|P6|COMPLETED|Overall Study||5
26807|NCT02171611|65230|P5|COMPLETED|Overall Study||5
26808|NCT02171611|65231|P4|COMPLETED|Overall Study||5
26809|NCT02171611|65232|P3|COMPLETED|Overall Study||5
26810|NCT02171611|65233|P2|COMPLETED|Overall Study||5
26811|NCT02171611|65234|P1|COMPLETED|Overall Study||5
26812|NCT02171611|65229|P6|STARTED|Overall Study||5
26813|NCT02171611|65230|P5|STARTED|Overall Study||5
26814|NCT02171611|65231|P4|STARTED|Overall Study||5
26815|NCT02171611|65232|P3|STARTED|Overall Study||5
26816|NCT02171611|65233|P2|STARTED|Overall Study||5
26817|NCT02171611|65234|P1|STARTED|Overall Study||5
26818|NCT02171247|65304|P2|NOT COMPLETED|Overall Study||0
26819|NCT02171247|65305|P1|NOT COMPLETED|Overall Study||0
26820|NCT02171247|65304|P2|COMPLETED|Overall Study||17
26821|NCT02171247|65305|P1|COMPLETED|Overall Study||16
26822|NCT02171247|65304|P2|STARTED|Overall Study||17
26823|NCT02171247|65305|P1|STARTED|Overall Study||16
26824|NCT02171234|65322|P5|NOT COMPLETED|Overall Study||0
26825|NCT02171234|65323|P4|NOT COMPLETED|Overall Study||0
26826|NCT02171234|65324|P3|NOT COMPLETED|Overall Study||0
26827|NCT02171234|65325|P2|NOT COMPLETED|Overall Study||0
26828|NCT02171234|65326|P1|NOT COMPLETED|Overall Study||0
26829|NCT02171234|65322|P5|COMPLETED|Overall Study||6
26830|NCT02171234|65323|P4|COMPLETED|Overall Study||6
26831|NCT02171234|65324|P3|COMPLETED|Overall Study||6
26832|NCT02171234|65325|P2|COMPLETED|Overall Study||6
26833|NCT02171234|65326|P1|COMPLETED|Overall Study||8
26834|NCT02171234|65322|P5|STARTED|Overall Study||6
26835|NCT02171234|65323|P4|STARTED|Overall Study||6
26836|NCT02171234|65324|P3|STARTED|Overall Study||6
26837|NCT02171234|65325|P2|STARTED|Overall Study||6
26838|NCT02171234|65326|P1|STARTED|Overall Study||8
26839|NCT02171195|65355|P9|NOT COMPLETED|Overall Study||0
26840|NCT02171195|65356|P8|NOT COMPLETED|Overall Study||0
26841|NCT02171195|65357|P7|NOT COMPLETED|Overall Study||0
26842|NCT02171195|65358|P6|NOT COMPLETED|Overall Study||0
26843|NCT02171195|65359|P5|NOT COMPLETED|Overall Study||0
26844|NCT02171195|65360|P4|NOT COMPLETED|Overall Study||0
26845|NCT02171195|65361|P3|NOT COMPLETED|Overall Study||0
26846|NCT02171195|65362|P2|NOT COMPLETED|Overall Study||0
26847|NCT02171195|65363|P1|NOT COMPLETED|Overall Study||0
26848|NCT02171195|65355|P9|COMPLETED|Overall Study||6
26849|NCT02171195|65356|P8|COMPLETED|Overall Study||6
26850|NCT02171195|65357|P7|COMPLETED|Overall Study||6
26851|NCT02171195|65358|P6|COMPLETED|Overall Study||6
26852|NCT02171195|65359|P5|COMPLETED|Overall Study||6
26853|NCT02171195|65360|P4|COMPLETED|Overall Study||6
26854|NCT02171195|65361|P3|COMPLETED|Overall Study||6
26855|NCT02171195|65362|P2|COMPLETED|Overall Study||6
26856|NCT02171195|65363|P1|COMPLETED|Overall Study||16
26857|NCT02171195|65355|P9|STARTED|Overall Study||6
26858|NCT02171195|65356|P8|STARTED|Overall Study||6
26859|NCT02171195|65357|P7|STARTED|Overall Study||6
26860|NCT02171195|65358|P6|STARTED|Overall Study||6
26861|NCT02171195|65359|P5|STARTED|Overall Study||6
26862|NCT02171195|65360|P4|STARTED|Overall Study||6
26863|NCT02171195|65361|P3|STARTED|Overall Study||6
26864|NCT02171195|65362|P2|STARTED|Overall Study||6
26865|NCT02171195|65363|P1|STARTED|Overall Study||16
26866|NCT02170779|65385|P2|NOT COMPLETED|Overall Study||1
26867|NCT02170779|65386|P1|NOT COMPLETED|Overall Study||1
26868|NCT02170779|65385|P2|COMPLETED|Overall Study||19
26869|NCT02170779|65386|P1|COMPLETED|Overall Study||19
26870|NCT02170779|65385|P2|STARTED|Overall Study||20
26871|NCT02170779|65386|P1|STARTED|Overall Study||20
26872|NCT02170688|65413|P5|NOT COMPLETED|Overall Study||0
26873|NCT02170688|65414|P4|NOT COMPLETED|Overall Study||2
26874|NCT02170688|65415|P3|NOT COMPLETED|Overall Study||4
26875|NCT02170688|65416|P2|NOT COMPLETED|Overall Study||3
26876|NCT02170688|65417|P1|NOT COMPLETED|Overall Study||4
26877|NCT02170688|65413|P5|COMPLETED|Overall Study||25
26878|NCT02170688|65414|P4|COMPLETED|Overall Study||25
26879|NCT02170688|65415|P3|COMPLETED|Overall Study||25
26880|NCT02170688|65416|P2|COMPLETED|Overall Study||26
26881|NCT02170688|65417|P1|COMPLETED|Overall Study||25
26882|NCT02170688|65413|P5|STARTED|Overall Study||25
26883|NCT02170688|65414|P4|STARTED|Overall Study||27
26884|NCT02170688|65415|P3|STARTED|Overall Study||29
26885|NCT02170688|65416|P2|STARTED|Overall Study||29
26886|NCT02170688|65417|P1|STARTED|Overall Study||29
26887|NCT02170662|65436|P2|NOT COMPLETED|Overall Study||0
26888|NCT02170662|65437|P1|NOT COMPLETED|Overall Study||0
26889|NCT02170662|65436|P2|COMPLETED|Overall Study||6
26890|NCT02170662|65437|P1|COMPLETED|Overall Study||3
26891|NCT02170662|65436|P2|STARTED|Overall Study||6
26892|NCT02170662|65437|P1|STARTED|Overall Study||3
26893|NCT02170649|65449|P1|NOT COMPLETED|Fed Period||0
26894|NCT02170649|65449|P1|COMPLETED|Fed Period||12
26895|NCT02170649|65449|P1|STARTED|Fed Period||12
26896|NCT02170649|65449|P1|NOT COMPLETED|Fasting Period||0
26897|NCT02170649|65449|P1|COMPLETED|Fasting Period||12
26898|NCT02170649|65449|P1|STARTED|Fasting Period||12
26899|NCT02170532|65456|P1|NOT COMPLETED|Overall Study||0
26900|NCT02170532|65456|P1|COMPLETED|Overall Study||10
26901|NCT02170532|65456|P1|STARTED|Overall Study||10
26902|NCT02170519|65486|P2|NOT COMPLETED|Overall Study||0
26903|NCT02170519|65487|P1|NOT COMPLETED|Overall Study||0
26904|NCT02170519|65486|P2|COMPLETED|Overall Study||5
26905|NCT02170519|65487|P1|COMPLETED|Overall Study||22
26906|NCT02170519|65486|P2|STARTED|Overall Study||5
26907|NCT02170519|65487|P1|STARTED|Overall Study||22
26908|NCT02170376|65508|P5|NOT COMPLETED|Overall Study||0
26909|NCT02170376|65509|P4|NOT COMPLETED|Overall Study||0
26910|NCT02170376|65510|P3|NOT COMPLETED|Overall Study||0
26911|NCT02170376|65511|P2|NOT COMPLETED|Overall Study||1
26912|NCT02170376|65512|P1|NOT COMPLETED|Overall Study||0
26913|NCT02170376|65508|P5|COMPLETED|Overall Study||16
26914|NCT02170376|65509|P4|COMPLETED|Overall Study||16
26915|NCT02170376|65510|P3|COMPLETED|Overall Study||16
26916|NCT02170376|65511|P2|COMPLETED|Overall Study||15
26917|NCT02170376|65512|P1|COMPLETED|Overall Study||16
26918|NCT02170376|65508|P5|Pharmacokinetic Population|Overall Study||16
26919|NCT02170376|65509|P4|Pharmacokinetic Population|Overall Study||16
26920|NCT02170376|65510|P3|Pharmacokinetic Population|Overall Study||16
26921|NCT02170376|65511|P2|Pharmacokinetic Population|Overall Study||15
26922|NCT02170376|65512|P1|Pharmacokinetic Population|Overall Study||16
26923|NCT02170376|65508|P5|STARTED|Overall Study||16
26924|NCT02170376|65509|P4|STARTED|Overall Study||16
26925|NCT02170376|65510|P3|STARTED|Overall Study||16
26926|NCT02170376|65511|P2|STARTED|Overall Study||16
26927|NCT02170376|65512|P1|STARTED|Overall Study||16
26928|NCT02170363|65549|P1|NOT COMPLETED|Overall Study||0
26929|NCT02170363|65549|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
26930|NCT02170363|65549|P1|STARTED|Overall Study||50
26931|NCT02170220|65563|P2|NOT COMPLETED|Overall Study||0
26932|NCT02170220|65564|P1|NOT COMPLETED|Overall Study||0
26933|NCT02170220|65563|P2|COMPLETED|Overall Study||6
26934|NCT02170220|65564|P1|COMPLETED|Overall Study||6
26935|NCT02170220|65563|P2|STARTED|Overall Study||6
26936|NCT02170220|65564|P1|STARTED|Overall Study||6
26937|NCT02170207|65590|P1|NOT COMPLETED|Overall Study||5
26938|NCT02170207|65590|P1|COMPLETED|Overall Study||58
26939|NCT02170207|65590|P1|STARTED|Overall Study||63
26940|NCT02170077|65601|P3|NOT COMPLETED|Overall Study||12
26941|NCT02170077|65602|P2|NOT COMPLETED|Overall Study||13
26942|NCT02170077|65603|P1|NOT COMPLETED|Overall Study||9
26943|NCT02170077|65601|P3|COMPLETED|Overall Study||35
26944|NCT02170077|65602|P2|COMPLETED|Overall Study||34
26945|NCT02170077|65603|P1|COMPLETED|Overall Study||41
26946|NCT02170077|65601|P3|Intent to Treat (ITT) Population|Overall Study||47
26947|NCT02170077|65602|P2|Intent to Treat (ITT) Population|Overall Study||46
26948|NCT02170077|65603|P1|Intent to Treat (ITT) Population|Overall Study||50
26949|NCT02170077|65601|P3|STARTED|Overall Study||47
26950|NCT02170077|65602|P2|STARTED|Overall Study||47
26951|NCT02170077|65603|P1|STARTED|Overall Study||50
26952|NCT02170064|65614|P3|NOT COMPLETED|Overall Study||1
26953|NCT02170064|65615|P2|NOT COMPLETED|Overall Study||2
26954|NCT02170064|65616|P1|NOT COMPLETED|Overall Study||6
26955|NCT02170064|65614|P3|COMPLETED|Overall Study||10
26956|NCT02170064|65615|P2|COMPLETED|Overall Study||7
26957|NCT02170064|65616|P1|COMPLETED|Overall Study||9
26958|NCT02170064|65614|P3|Efficacy Population (EP)|Overall Study||10
26959|NCT02170064|65615|P2|Efficacy Population (EP)|Overall Study||8
26960|NCT02170064|65616|P1|Efficacy Population (EP)|Overall Study||11
26961|NCT02170064|65614|P3|Pharmacokinetic Population (PKP)|Overall Study||10
26962|NCT02170064|65615|P2|Pharmacokinetic Population (PKP)|Overall Study||8
26963|NCT02170064|65616|P1|Pharmacokinetic Population (PKP)|Overall Study||11
26964|NCT02170064|65614|P3|Safety Population (SP)|Overall Study||11
26965|NCT02170064|65615|P2|Safety Population (SP)|Overall Study||8
26966|NCT02170064|65616|P1|Safety Population (SP)|Overall Study||12
26967|NCT02170064|65614|P3|STARTED|Overall Study||11
26968|NCT02170064|65615|P2|STARTED|Overall Study||9
26969|NCT02170064|65616|P1|STARTED|Overall Study||15
26970|NCT02170025|65632|P2|NOT COMPLETED|Overall Study||0
26971|NCT02170025|65633|P1|NOT COMPLETED|Overall Study||2
26972|NCT02170025|65632|P2|COMPLETED|Overall Study||7
26973|NCT02170025|65633|P1|COMPLETED|Overall Study||12
26974|NCT02170025|65632|P2|STARTED|Overall Study||7
26975|NCT02170025|65633|P1|STARTED|Overall Study||14
26976|NCT02169895|65643|P4|NOT COMPLETED|Overall Study||2
26977|NCT02169895|65644|P3|NOT COMPLETED|Overall Study||0
26978|NCT02169895|65645|P2|NOT COMPLETED|Overall Study||0
26979|NCT02169895|65646|P1|NOT COMPLETED|Overall Study||0
26980|NCT02169895|65643|P4|COMPLETED|Overall Study||2
26981|NCT02169895|65644|P3|COMPLETED|Overall Study||4
26982|NCT02169895|65645|P2|COMPLETED|Overall Study||4
26983|NCT02169895|65646|P1|COMPLETED|Overall Study||4
26984|NCT02169895|65643|P4|Placebo|Overall Study||4
26985|NCT02169895|65644|P3|Placebo|Overall Study||4
26986|NCT02169895|65645|P2|Placebo|Overall Study||4
26987|NCT02169895|65646|P1|Placebo|Overall Study||4
26988|NCT02169895|65643|P4|100 mg BIA 9-1067|Overall Study||2
26989|NCT02169895|65644|P3|100 mg BIA 9-1067|Overall Study||4
26990|NCT02169895|65645|P2|100 mg BIA 9-1067|Overall Study||4
26991|NCT02169895|65646|P1|100 mg BIA 9-1067|Overall Study||4
26992|NCT02169895|65643|P4|50 mg BIA 9-1067|Overall Study||4
26993|NCT02169895|65644|P3|50 mg BIA 9-1067|Overall Study||4
26994|NCT02169895|65645|P2|50 mg BIA 9-1067|Overall Study||4
26995|NCT02169895|65646|P1|50 mg BIA 9-1067|Overall Study||4
26996|NCT02169895|65643|P4|25 mg BIA 9-1067|Overall Study||4
26997|NCT02169895|65644|P3|25 mg BIA 9-1067|Overall Study||4
26998|NCT02169895|65645|P2|25 mg BIA 9-1067|Overall Study||4
26999|NCT02169895|65646|P1|25 mg BIA 9-1067|Overall Study||4
27000|NCT02169895|65643|P4|STARTED|Overall Study||4
27001|NCT02169895|65644|P3|STARTED|Overall Study||4
27002|NCT02169895|65645|P2|STARTED|Overall Study||4
27003|NCT02169895|65646|P1|STARTED|Overall Study||4
27004|NCT02169479|65668|P4|NOT COMPLETED|Overall Study||0
27005|NCT02169479|65669|P3|NOT COMPLETED|Overall Study||0
27006|NCT02169479|65670|P2|NOT COMPLETED|Overall Study||1
27007|NCT02169479|65671|P1|NOT COMPLETED|Overall Study||1
27008|NCT02169479|65668|P4|COMPLETED|Overall Study||4
27009|NCT02169479|65669|P3|COMPLETED|Overall Study||4
27010|NCT02169479|65670|P2|COMPLETED|Overall Study||3
27011|NCT02169479|65671|P1|COMPLETED|Overall Study||3
27012|NCT02169479|65668|P4|Placebo|Overall Study||4
27013|NCT02169479|65669|P3|Placebo|Overall Study||4
27014|NCT02169479|65670|P2|Placebo|Overall Study||3
27015|NCT02169479|65671|P1|Placebo|Overall Study||3
27016|NCT02169479|65668|P4|100 mg BIA 9-1067|Overall Study||4
27017|NCT02169479|65669|P3|100 mg BIA 9-1067|Overall Study||4
27018|NCT02169479|65670|P2|100 mg BIA 9-1067|Overall Study||4
27019|NCT02169479|65671|P1|100 mg BIA 9-1067|Overall Study||3
27020|NCT02169479|65668|P4|50 mg BIA 9-1067|Overall Study||4
27021|NCT02169479|65669|P3|50 mg BIA 9-1067|Overall Study||4
27022|NCT02169479|65670|P2|50 mg BIA 9-1067|Overall Study||4
27023|NCT02169479|65671|P1|50 mg BIA 9-1067|Overall Study||4
27024|NCT02169479|65668|P4|25 mg BIA 9-1067|Overall Study||4
27025|NCT02169479|65669|P3|25 mg BIA 9-1067|Overall Study||4
27026|NCT02169479|65670|P2|25 mg BIA 9-1067|Overall Study||3
27027|NCT02169479|65671|P1|25 mg BIA 9-1067|Overall Study||4
27028|NCT02169479|65668|P4|STARTED|Overall Study||4
27029|NCT02169479|65669|P3|STARTED|Overall Study||4
27030|NCT02169479|65670|P2|STARTED|Overall Study||4
27031|NCT02169479|65671|P1|STARTED|Overall Study||4
27032|NCT02169466|65693|P4|NOT COMPLETED|Overall Study||0
27033|NCT02169466|65694|P3|NOT COMPLETED|Overall Study||0
27034|NCT02169466|65695|P2|NOT COMPLETED|Overall Study||1
27035|NCT02169466|65696|P1|NOT COMPLETED|Overall Study||1
27036|NCT02169466|65693|P4|COMPLETED|Overall Study||5
27037|NCT02169466|65694|P3|COMPLETED|Overall Study||5
27038|NCT02169466|65695|P2|COMPLETED|Overall Study||5
27039|NCT02169466|65696|P1|COMPLETED|Overall Study||5
27040|NCT02169466|65693|P4|Placebo|Overall Study||5
27041|NCT02169466|65694|P3|Placebo|Overall Study||5
27042|NCT02169466|65695|P2|Placebo|Overall Study||6
27043|NCT02169466|65696|P1|Placebo|Overall Study||5
27044|NCT02169466|65693|P4|100 mg BIA 9-1067|Overall Study||5
27045|NCT02169466|65694|P3|100 mg BIA 9-1067|Overall Study||5
27046|NCT02169466|65695|P2|100 mg BIA 9-1067|Overall Study||6
27047|NCT02169466|65696|P1|100 mg BIA 9-1067|Overall Study||6
27048|NCT02169466|65693|P4|50 mg BIA 9-1067|Overall Study||5
27049|NCT02169466|65694|P3|50 mg BIA 9-1067|Overall Study||5
27050|NCT02169466|65695|P2|50 mg BIA 9-1067|Overall Study||6
27051|NCT02169466|65696|P1|50 mg BIA 9-1067|Overall Study||6
27052|NCT02169466|65693|P4|25 mg BIA 9-1067|Overall Study||5
27053|NCT02169466|65694|P3|25 mg BIA 9-1067|Overall Study||5
27054|NCT02169466|65695|P2|25 mg BIA 9-1067|Overall Study||5
27055|NCT02169466|65696|P1|25 mg BIA 9-1067|Overall Study||6
27056|NCT02169466|65693|P4|STARTED|Overall Study||5
27057|NCT02169466|65694|P3|STARTED|Overall Study||5
27058|NCT02169466|65695|P2|STARTED|Overall Study||6
27059|NCT02169466|65696|P1|STARTED|Overall Study||6
27060|NCT02169453|65722|P4|NOT COMPLETED|Overall Study||0
27061|NCT02169453|65723|P3|NOT COMPLETED|Overall Study||1
27062|NCT02169453|65724|P2|NOT COMPLETED|Overall Study||0
27063|NCT02169453|65725|P1|NOT COMPLETED|Overall Study||0
27064|NCT02169453|65722|P4|COMPLETED|Overall Study||3
27065|NCT02169453|65723|P3|COMPLETED|Overall Study||2
27066|NCT02169453|65724|P2|COMPLETED|Overall Study||3
27067|NCT02169453|65725|P1|COMPLETED|Overall Study||3
27068|NCT02169453|65722|P4|Placebo|Overall Study||3
27069|NCT02169453|65723|P3|Placebo|Overall Study||3
27070|NCT02169453|65724|P2|Placebo|Overall Study||3
27071|NCT02169453|65725|P1|Placebo|Overall Study||3
27072|NCT02169453|65722|P4|100 mg BIA 9-1067|Overall Study||3
27073|NCT02169453|65723|P3|100 mg BIA 9-1067|Overall Study||3
27074|NCT02169453|65724|P2|100 mg BIA 9-1067|Overall Study||3
27075|NCT02169453|65725|P1|100 mg BIA 9-1067|Overall Study||3
27076|NCT02169453|65722|P4|50 mg BIA 9-1067|Overall Study||3
27077|NCT02169453|65723|P3|50 mg BIA 9-1067|Overall Study||2
27078|NCT02169453|65724|P2|50 mg BIA 9-1067|Overall Study||3
27079|NCT02169453|65725|P1|50 mg BIA 9-1067|Overall Study||3
27080|NCT02169453|65722|P4|25 mg BIA 9-1067|Overall Study||3
27081|NCT02169453|65723|P3|25 mg BIA 9-1067|Overall Study||3
27082|NCT02169453|65724|P2|25 mg BIA 9-1067|Overall Study||3
27083|NCT02169453|65725|P1|25 mg BIA 9-1067|Overall Study||3
27084|NCT02169453|65722|P4|STARTED|Overall Study||3
27085|NCT02169453|65723|P3|STARTED|Overall Study||3
27086|NCT02169453|65724|P2|STARTED|Overall Study||3
27087|NCT02169453|65725|P1|STARTED|Overall Study||3
27088|NCT02169440|65757|P2|NOT COMPLETED|Overall Study||0
27089|NCT02169440|65758|P1|NOT COMPLETED|Overall Study||0
27090|NCT02169440|65757|P2|COMPLETED|Overall Study||10
27091|NCT02169440|65758|P1|COMPLETED|Overall Study||10
27092|NCT02169440|65757|P2|STARTED|Overall Study||10
27093|NCT02169440|65758|P1|STARTED|Overall Study||10
27094|NCT02169427|65771|P1|NOT COMPLETED|Overall Study||0
27095|NCT02169427|65771|P1|COMPLETED|Overall Study||6
27096|NCT02169427|65771|P1|STARTED|Overall Study||6
27097|NCT02169414|65781|P4|NOT COMPLETED|Overall Study||0
27098|NCT02169414|65782|P3|NOT COMPLETED|Overall Study||0
27099|NCT02169414|65783|P2|NOT COMPLETED|Overall Study||1
27100|NCT02169414|65784|P1|NOT COMPLETED|Overall Study||1
27101|NCT02169414|65781|P4|COMPLETED|Overall Study||18
27102|NCT02169414|65782|P3|COMPLETED|Overall Study||18
27103|NCT02169414|65783|P2|COMPLETED|Overall Study||18
27104|NCT02169414|65784|P1|COMPLETED|Overall Study||18
27105|NCT02169414|65781|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
27106|NCT02169414|65782|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
27107|NCT02169414|65783|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
27108|NCT02169414|65784|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
27109|NCT02169414|65781|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
27110|NCT02169414|65782|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
27111|NCT02169414|65783|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
27112|NCT02169414|65784|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
27113|NCT02169414|65781|P4|STARTED|Overall Study||18
27114|NCT02169414|65782|P3|STARTED|Overall Study||18
27115|NCT02169414|65783|P2|STARTED|Overall Study||19
27116|NCT02169414|65784|P1|STARTED|Overall Study||19
27117|NCT02169336|65825|P3|NOT COMPLETED|Overall Study||3
27118|NCT02169336|65826|P2|NOT COMPLETED|Overall Study||4
27119|NCT02169336|65827|P1|NOT COMPLETED|Overall Study||4
27120|NCT02169336|65825|P3|COMPLETED|Overall Study||29
27121|NCT02169336|65826|P2|COMPLETED|Overall Study||28
27122|NCT02169336|65827|P1|COMPLETED|Overall Study||27
27123|NCT02169336|65825|P3|STARTED|Overall Study||32
27124|NCT02169336|65826|P2|STARTED|Overall Study||32
27125|NCT02169336|65827|P1|STARTED|Overall Study||31
27126|NCT02169115|65838|P3|NOT COMPLETED|Overall Study||0
27127|NCT02169115|65839|P2|NOT COMPLETED|Overall Study||0
27128|NCT02169115|65840|P1|NOT COMPLETED|Overall Study||0
27129|NCT02169115|65838|P3|COMPLETED|Overall Study||21
27130|NCT02169115|65839|P2|COMPLETED|Overall Study||21
27131|NCT02169115|65840|P1|COMPLETED|Overall Study||19
27132|NCT02169115|65838|P3|STARTED|Overall Study||21
27133|NCT02169115|65839|P2|STARTED|Overall Study||21
27134|NCT02169115|65840|P1|STARTED|Overall Study||19
27135|NCT02168777|65851|P3|NOT COMPLETED|Overall Study||11
27136|NCT02168777|65852|P2|NOT COMPLETED|Overall Study||7
27137|NCT02168777|65853|P1|NOT COMPLETED|Overall Study||2
27138|NCT02168777|65851|P3|COMPLETED|Overall Study||0
27139|NCT02168777|65852|P2|COMPLETED|Overall Study||0
27140|NCT02168777|65853|P1|COMPLETED|Overall Study||0
27141|NCT02168777|65851|P3|STARTED|Overall Study||11
27142|NCT02168777|65852|P2|STARTED|Overall Study||7
27143|NCT02168777|65853|P1|STARTED|Overall Study||2
27144|NCT02168491|65930|P1|NOT COMPLETED|Overall Study||1
27145|NCT02168491|65930|P1|COMPLETED|Overall Study||8
27146|NCT02168491|65930|P1|STARTED|Overall Study||9
27147|NCT02168478|65936|P1|NOT COMPLETED|Overall Study||4
27148|NCT02168478|65936|P1|COMPLETED|Overall Study||202
27149|NCT02168478|65936|P1|STARTED|Overall Study||206
27150|NCT02168439|65942|P2|NOT COMPLETED|Overall Study||2
27151|NCT02168439|65943|P1|NOT COMPLETED|Overall Study||0
27152|NCT02168439|65942|P2|COMPLETED|Overall Study||18
27153|NCT02168439|65943|P1|COMPLETED|Overall Study||20
27154|NCT02168439|65942|P2|STARTED|Overall Study||20
27155|NCT02168439|65943|P1|STARTED|Overall Study||20
27156|NCT02168387|65961|P2|NOT COMPLETED|Overall Study||3
27157|NCT02168387|65962|P1|NOT COMPLETED|Overall Study||7
27158|NCT02168387|65961|P2|COMPLETED|Overall Study||16
27159|NCT02168387|65962|P1|COMPLETED|Overall Study||13
27160|NCT02168387|65961|P2|STARTED|Overall Study||19
27161|NCT02168387|65962|P1|STARTED|Overall Study||20
27162|NCT02168361|65974|P2|NOT COMPLETED|Overall Study||10
27163|NCT02168361|65975|P1|NOT COMPLETED|Overall Study||5
27164|NCT02168361|65974|P2|COMPLETED|Overall Study||21
27165|NCT02168361|65975|P1|COMPLETED|Overall Study||57
27166|NCT02168361|65974|P2|STARTED|Overall Study||31
27167|NCT02168361|65975|P1|STARTED|Overall Study||62
27168|NCT02168309|65985|P2|NOT COMPLETED|Overall Study||0
27169|NCT02168309|65986|P1|NOT COMPLETED|Overall Study||0
27170|NCT02168309|65985|P2|COMPLETED|Overall Study||25
27171|NCT02168309|65986|P1|COMPLETED|Overall Study||25
27172|NCT02168309|65985|P2|STARTED|Overall Study||25
27173|NCT02168309|65986|P1|STARTED|Overall Study||25
27174|NCT02168270|65994|P1|NOT COMPLETED|Overall Study||4
27175|NCT02168270|65994|P1|COMPLETED|Overall Study||0
27176|NCT02168270|65994|P1|STARTED|Overall Study||4
27177|NCT02167893|66001|P1|NOT COMPLETED|Overall Study||163
27178|NCT02167893|66001|P1|COMPLETED|Overall Study||11125
27179|NCT02167893|66001|P1|STARTED|Overall Study||11288
27180|NCT02167867|66012|P2|NOT COMPLETED|Overall Study||0
27181|NCT02167867|66013|P1|NOT COMPLETED|Overall Study||0
27182|NCT02167867|66012|P2|COMPLETED|Overall Study||22
27183|NCT02167867|66013|P1|COMPLETED|Overall Study||22
27184|NCT02167867|66012|P2|STARTED|Overall Study||22
27185|NCT02167867|66013|P1|STARTED|Overall Study||22
27186|NCT02167815|66021|P2|NOT COMPLETED|Overall Study||0
27187|NCT02167815|66022|P1|NOT COMPLETED|Overall Study||0
27188|NCT02167815|66021|P2|COMPLETED|Overall Study||21
27189|NCT02167815|66022|P1|COMPLETED|Overall Study||9
27190|NCT02167815|66021|P2|STARTED|Overall Study||21
27191|NCT02167815|66022|P1|STARTED|Overall Study||9
27192|NCT02167217|66033|P1|NOT COMPLETED|Overall Study||2
27193|NCT02167217|66033|P1|COMPLETED|Overall Study||23
27194|NCT02167217|66033|P1|STARTED|Overall Study||25
27195|NCT02167139|66039|P4|NOT COMPLETED|Transition-extension||5
27196|NCT02167139|66040|P3|NOT COMPLETED|Transition-extension||8
27197|NCT02167139|66041|P2|NOT COMPLETED|Transition-extension||0
27198|NCT02167139|66042|P1|NOT COMPLETED|Transition-extension||6
27199|NCT02167139|66039|P4|COMPLETED|Transition-extension||124
27200|NCT02167139|66040|P3|COMPLETED|Transition-extension||117
27201|NCT02167139|66041|P2|COMPLETED|Transition-extension||0
27202|NCT02167139|66042|P1|COMPLETED|Transition-extension||248
27203|NCT02167139|66039|P4|STARTED|Transition-extension||129
27204|NCT02167139|66040|P3|STARTED|Transition-extension||125
27205|NCT02167139|66041|P2|STARTED|Transition-extension||0
27206|NCT02167139|66042|P1|STARTED|Transition-extension||254
27207|NCT02167139|66039|P4|NOT COMPLETED|Randomised, Double-blind||0
27208|NCT02167139|66040|P3|NOT COMPLETED|Randomised, Double-blind||0
27209|NCT02167139|66041|P2|NOT COMPLETED|Randomised, Double-blind||19
27210|NCT02167139|66042|P1|NOT COMPLETED|Randomised, Double-blind||17
27211|NCT02167139|66039|P4|COMPLETED|Randomised, Double-blind||0
27212|NCT02167139|66040|P3|COMPLETED|Randomised, Double-blind||0
27213|NCT02167139|66041|P2|COMPLETED|Randomised, Double-blind||254
27214|NCT02167139|66042|P1|COMPLETED|Randomised, Double-blind||254
27215|NCT02167139|66039|P4|STARTED|Randomised, Double-blind||0
27216|NCT02167139|66040|P3|STARTED|Randomised, Double-blind||0
27217|NCT02167139|66041|P2|STARTED|Randomised, Double-blind||273
27218|NCT02167139|66042|P1|STARTED|Randomised, Double-blind||271
27219|NCT02166697|66056|P1|NOT COMPLETED|Overall Study||347
27220|NCT02166697|66056|P1|COMPLETED|Overall Study||13804
27221|NCT02166697|66056|P1|STARTED|Overall Study||14151
27222|NCT02166476|66067|P2|NOT COMPLETED|Overall Study||23
27223|NCT02166476|66068|P1|NOT COMPLETED|Overall Study||14
27224|NCT02166476|66067|P2|COMPLETED|Overall Study||250
27225|NCT02166476|66068|P1|COMPLETED|Overall Study||258
27226|NCT02166476|66067|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
27313|NCT02164539|66298|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
27227|NCT02166476|66068|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
27228|NCT02166476|66067|P2|STARTED|Overall Study||273
27229|NCT02166476|66068|P1|STARTED|Overall Study||272
27230|NCT02166346|66101|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
27231|NCT02166346|66102|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
27232|NCT02166346|66101|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
27233|NCT02166346|66102|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
27234|NCT02166346|66101|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
27235|NCT02166346|66102|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
27236|NCT02166346|66101|P2|NOT COMPLETED|Intervention - Phase 1||2
27237|NCT02166346|66102|P1|NOT COMPLETED|Intervention - Phase 1||0
27238|NCT02166346|66101|P2|COMPLETED|Intervention - Phase 1||6
27239|NCT02166346|66102|P1|COMPLETED|Intervention - Phase 1||8
27240|NCT02166346|66101|P2|STARTED|Intervention - Phase 1||8
27241|NCT02166346|66102|P1|STARTED|Intervention - Phase 1||8
27242|NCT02166346|66101|P2|NOT COMPLETED|Screening and Randomization||4
27243|NCT02166346|66102|P1|NOT COMPLETED|Screening and Randomization||4
27244|NCT02166346|66101|P2|COMPLETED|Screening and Randomization||8
27245|NCT02166346|66102|P1|COMPLETED|Screening and Randomization||8
27246|NCT02166346|66101|P2|STARTED|Screening and Randomization||12
27247|NCT02166346|66102|P1|STARTED|Screening and Randomization||12
27248|NCT02165826|66113|P3|NOT COMPLETED|Down-Titration Period||7
27249|NCT02165826|66114|P2|NOT COMPLETED|Down-Titration Period||11
27250|NCT02165826|66115|P1|NOT COMPLETED|Down-Titration Period||7
27251|NCT02165826|66113|P3|COMPLETED|Down-Titration Period||31
27252|NCT02165826|66114|P2|COMPLETED|Down-Titration Period||28
27253|NCT02165826|66115|P1|COMPLETED|Down-Titration Period||20
27254|NCT02165826|66113|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
27255|NCT02165826|66114|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
27256|NCT02165826|66115|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
27257|NCT02165826|66113|P3|STARTED|Down-Titration Period||38
27258|NCT02165826|66114|P2|STARTED|Down-Titration Period||39
27259|NCT02165826|66115|P1|STARTED|Down-Titration Period||27
27260|NCT02165826|66113|P3|NOT COMPLETED|Main Treatment Period||109
27261|NCT02165826|66114|P2|NOT COMPLETED|Main Treatment Period||90
27262|NCT02165826|66115|P1|NOT COMPLETED|Main Treatment Period||81
27263|NCT02165826|66113|P3|COMPLETED|Main Treatment Period||334
27264|NCT02165826|66114|P2|COMPLETED|Main Treatment Period||349
27265|NCT02165826|66115|P1|COMPLETED|Main Treatment Period||360
27266|NCT02165826|66113|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
27267|NCT02165826|66114|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
27268|NCT02165826|66115|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
27269|NCT02165826|66113|P3|STARTED|Main Treatment Period||443
27270|NCT02165826|66114|P2|STARTED|Main Treatment Period||439
27271|NCT02165826|66115|P1|STARTED|Main Treatment Period||441
27272|NCT02165761|66174|P2|NOT COMPLETED|Overall Study||14
27273|NCT02165761|66175|P1|NOT COMPLETED|Overall Study||19
27274|NCT02165761|66174|P2|COMPLETED|Overall Study||5
27275|NCT02165761|66175|P1|COMPLETED|Overall Study||4
27276|NCT02165761|66174|P2|STARTED|Overall Study||19
27277|NCT02165761|66175|P1|STARTED|Overall Study||23
27278|NCT02165462|66181|P1|NOT COMPLETED|Overall Study||0
27279|NCT02165462|66181|P1|COMPLETED|Overall Study||17
27280|NCT02165462|66181|P1|STARTED|Overall Study||17
27281|NCT02165111|66200|P2|NOT COMPLETED|Overall Study||0
27282|NCT02165111|66201|P1|NOT COMPLETED|Overall Study||0
27283|NCT02165111|66200|P2|COMPLETED|Overall Study||40
27284|NCT02165111|66201|P1|COMPLETED|Overall Study||40
27285|NCT02165111|66200|P2|STARTED|Overall Study||40
27286|NCT02165111|66201|P1|STARTED|Overall Study||40
27287|NCT02165072|66217|P1|NOT COMPLETED|Overall Study||0
27288|NCT02165072|66217|P1|COMPLETED|Overall Study||30
27289|NCT02165072|66217|P1|STARTED|Overall Study||30
27290|NCT02164929|66226|P4|NOT COMPLETED|Overall Study||2
27291|NCT02164929|66227|P3|NOT COMPLETED|Overall Study||1
27292|NCT02164929|66228|P2|NOT COMPLETED|Overall Study||0
27293|NCT02164929|66229|P1|NOT COMPLETED|Overall Study||1
27294|NCT02164929|66226|P4|COMPLETED|Overall Study||2
27295|NCT02164929|66227|P3|COMPLETED|Overall Study||4
27296|NCT02164929|66228|P2|COMPLETED|Overall Study||3
27297|NCT02164929|66229|P1|COMPLETED|Overall Study||3
27298|NCT02164929|66226|P4|STARTED|Overall Study||4
27299|NCT02164929|66227|P3|STARTED|Overall Study||5
27300|NCT02164929|66228|P2|STARTED|Overall Study||3
27301|NCT02164929|66229|P1|STARTED|Overall Study||4
27302|NCT02164916|66273|P2|NOT COMPLETED|Overall Study||54
27303|NCT02164916|66274|P1|NOT COMPLETED|Overall Study||52
27304|NCT02164916|66273|P2|COMPLETED|Overall Study||0
27305|NCT02164916|66274|P1|COMPLETED|Overall Study||0
27306|NCT02164916|66273|P2|Cross-over to Arm II|Overall Study||0
27307|NCT02164916|66274|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
27308|NCT02164916|66273|P2|Eligible|Overall Study||49
27309|NCT02164916|66274|P1|Eligible|Overall Study||50
27310|NCT02164916|66273|P2|STARTED|Overall Study||54
27311|NCT02164916|66274|P1|STARTED|Overall Study||52
27312|NCT02164539|66297|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
27314|NCT02164539|66299|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
27315|NCT02164539|66300|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
27316|NCT02164539|66301|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
27317|NCT02164539|66302|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
27318|NCT02164539|66303|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
27319|NCT02164539|66297|P7|COMPLETED|Treatment Phase C (1 Week)||78
27320|NCT02164539|66298|P6|COMPLETED|Treatment Phase C (1 Week)||82
27321|NCT02164539|66299|P5|COMPLETED|Treatment Phase C (1 Week)||84
27322|NCT02164539|66300|P4|COMPLETED|Treatment Phase C (1 Week)||0
27323|NCT02164539|66301|P3|COMPLETED|Treatment Phase C (1 Week)||0
27324|NCT02164539|66302|P2|COMPLETED|Treatment Phase C (1 Week)||0
27325|NCT02164539|66303|P1|COMPLETED|Treatment Phase C (1 Week)||78
27326|NCT02164539|66297|P7|STARTED|Treatment Phase C (1 Week)||80
27327|NCT02164539|66298|P6|STARTED|Treatment Phase C (1 Week)||82
27328|NCT02164539|66299|P5|STARTED|Treatment Phase C (1 Week)||84
27329|NCT02164539|66300|P4|STARTED|Treatment Phase C (1 Week)||0
27330|NCT02164539|66301|P3|STARTED|Treatment Phase C (1 Week)||0
27331|NCT02164539|66302|P2|STARTED|Treatment Phase C (1 Week)||0
27332|NCT02164539|66303|P1|STARTED|Treatment Phase C (1 Week)||79
27333|NCT02164539|66297|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
27334|NCT02164539|66298|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
27335|NCT02164539|66299|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
27336|NCT02164539|66300|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
27337|NCT02164539|66301|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
27338|NCT02164539|66302|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
27339|NCT02164539|66303|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
27340|NCT02164539|66297|P7|COMPLETED|Treatment Phase B (1 Week)||162
27341|NCT02164539|66298|P6|COMPLETED|Treatment Phase B (1 Week)||0
27342|NCT02164539|66299|P5|COMPLETED|Treatment Phase B (1 Week)||163
27343|NCT02164539|66300|P4|COMPLETED|Treatment Phase B (1 Week)||0
27344|NCT02164539|66301|P3|COMPLETED|Treatment Phase B (1 Week)||0
27345|NCT02164539|66302|P2|COMPLETED|Treatment Phase B (1 Week)||0
27346|NCT02164539|66303|P1|COMPLETED|Treatment Phase B (1 Week)||0
27347|NCT02164539|66297|P7|STARTED|Treatment Phase B (1 Week)||163
27348|NCT02164539|66298|P6|STARTED|Treatment Phase B (1 Week)||0
27349|NCT02164539|66299|P5|STARTED|Treatment Phase B (1 Week)||166
27350|NCT02164539|66300|P4|STARTED|Treatment Phase B (1 Week)||0
27351|NCT02164539|66301|P3|STARTED|Treatment Phase B (1 Week)||0
27352|NCT02164539|66302|P2|STARTED|Treatment Phase B (1 Week)||0
27353|NCT02164539|66303|P1|STARTED|Treatment Phase B (1 Week)||0
27354|NCT02164539|66297|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
27355|NCT02164539|66298|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
27356|NCT02164539|66299|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
27357|NCT02164539|66300|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
27358|NCT02164539|66301|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
27359|NCT02164539|66302|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
27360|NCT02164539|66303|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
27361|NCT02164539|66297|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
27362|NCT02164539|66298|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
27363|NCT02164539|66299|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
27364|NCT02164539|66300|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
27365|NCT02164539|66301|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
27366|NCT02164539|66302|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
27367|NCT02164539|66303|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
27368|NCT02164539|66297|P7|STARTED|Treatment Phase A (4 Weeks)||0
27369|NCT02164539|66298|P6|STARTED|Treatment Phase A (4 Weeks)||84
27370|NCT02164539|66299|P5|STARTED|Treatment Phase A (4 Weeks)||85
27371|NCT02164539|66300|P4|STARTED|Treatment Phase A (4 Weeks)||46
27372|NCT02164539|66301|P3|STARTED|Treatment Phase A (4 Weeks)||40
27373|NCT02164539|66302|P2|STARTED|Treatment Phase A (4 Weeks)||42
27374|NCT02164539|66303|P1|STARTED|Treatment Phase A (4 Weeks)||41
27375|NCT02164396|66351|P3|NOT COMPLETED|Overall Study||0
27376|NCT02164396|66352|P2|NOT COMPLETED|Overall Study||0
27377|NCT02164396|66353|P1|NOT COMPLETED|Overall Study||0
27378|NCT02164396|66351|P3|COMPLETED|Overall Study||10
27379|NCT02164396|66352|P2|COMPLETED|Overall Study||10
27380|NCT02164396|66353|P1|COMPLETED|Overall Study||10
27381|NCT02164396|66351|P3|STARTED|Overall Study||10
27382|NCT02164396|66352|P2|STARTED|Overall Study||10
27383|NCT02164396|66353|P1|STARTED|Overall Study||10
27384|NCT02164318|66365|P4|NOT COMPLETED|Overall Study||1
27385|NCT02164318|66366|P3|NOT COMPLETED|Overall Study||0
27386|NCT02164318|66367|P2|NOT COMPLETED|Overall Study||1
27387|NCT02164318|66368|P1|NOT COMPLETED|Overall Study||0
27388|NCT02164318|66365|P4|COMPLETED|Overall Study||2
27389|NCT02164318|66366|P3|COMPLETED|Overall Study||1
27390|NCT02164318|66367|P2|COMPLETED|Overall Study||2
27391|NCT02164318|66368|P1|COMPLETED|Overall Study||4
27392|NCT02164318|66365|P4|STARTED|Overall Study||3
27393|NCT02164318|66366|P3|STARTED|Overall Study||1
27394|NCT02164318|66367|P2|STARTED|Overall Study||3
27395|NCT02164318|66368|P1|STARTED|Overall Study||4
27396|NCT02163915|66391|P5|NOT COMPLETED|Overall Study||4
27397|NCT02163915|66392|P4|NOT COMPLETED|Overall Study||3
27398|NCT02163915|66393|P3|NOT COMPLETED|Overall Study||2
27399|NCT02163915|66394|P2|NOT COMPLETED|Overall Study||0
27400|NCT02163915|66395|P1|NOT COMPLETED|Overall Study||3
27401|NCT02163915|66391|P5|COMPLETED|Overall Study||6
27402|NCT02163915|66392|P4|COMPLETED|Overall Study||6
27403|NCT02163915|66393|P3|COMPLETED|Overall Study||8
27404|NCT02163915|66394|P2|COMPLETED|Overall Study||8
27405|NCT02163915|66395|P1|COMPLETED|Overall Study||7
27406|NCT02163915|66391|P5|STARTED|Overall Study||10
27407|NCT02163915|66392|P4|STARTED|Overall Study||9
27408|NCT02163915|66393|P3|STARTED|Overall Study||10
27409|NCT02163915|66394|P2|STARTED|Overall Study||8
27410|NCT02163915|66395|P1|STARTED|Overall Study||10
27411|NCT02163733|66450|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
27412|NCT02163733|66451|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
27413|NCT02163733|66452|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
27414|NCT02163733|66450|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
27415|NCT02163733|66451|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
27416|NCT02163733|66452|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
27417|NCT02163733|66450|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
27418|NCT02163733|66451|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
27419|NCT02163733|66452|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
27420|NCT02163733|66450|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
27421|NCT02163733|66451|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
27422|NCT02163733|66452|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
27423|NCT02163733|66450|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
27424|NCT02163733|66451|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
27425|NCT02163733|66452|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
27426|NCT02163733|66450|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
27427|NCT02163733|66451|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
27428|NCT02163733|66452|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
27429|NCT02163733|66450|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
27430|NCT02163733|66451|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
27431|NCT02163733|66452|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
27432|NCT02163733|66450|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
27433|NCT02163733|66451|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
27434|NCT02163733|66452|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
27435|NCT02163733|66450|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
27436|NCT02163733|66451|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
27437|NCT02163733|66452|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
27438|NCT02163538|66489|P2|NOT COMPLETED|Overall Study||1
27439|NCT02163538|66490|P1|NOT COMPLETED|Overall Study||1
27440|NCT02163538|66489|P2|COMPLETED|Overall Study||70
27441|NCT02163538|66490|P1|COMPLETED|Overall Study||70
27442|NCT02163538|66489|P2|STARTED|Overall Study||71
27443|NCT02163538|66490|P1|STARTED|Overall Study||71
27444|NCT02163421|66510|P4|NOT COMPLETED|Overall Study||0
27445|NCT02163421|66511|P3|NOT COMPLETED|Overall Study||0
27446|NCT02163421|66512|P2|NOT COMPLETED|Overall Study||0
27447|NCT02163421|66513|P1|NOT COMPLETED|Overall Study||0
27448|NCT02163421|66510|P4|COMPLETED|Overall Study||12
27449|NCT02163421|66511|P3|COMPLETED|Overall Study||12
27450|NCT02163421|66512|P2|COMPLETED|Overall Study||12
27451|NCT02163421|66513|P1|COMPLETED|Overall Study||12
27452|NCT02163421|66510|P4|STARTED|Overall Study||12
27453|NCT02163421|66511|P3|STARTED|Overall Study||12
27454|NCT02163421|66512|P2|STARTED|Overall Study||12
27455|NCT02163421|66513|P1|STARTED|Overall Study||12
27456|NCT02163395|66520|P1|NOT COMPLETED|Overall Study||5
27457|NCT02163395|66520|P1|COMPLETED|Overall Study||39
27458|NCT02163395|66520|P1|STARTED|Overall Study||44
27459|NCT02163187|66529|P2|NOT COMPLETED|Overall Study||0
27460|NCT02163187|66530|P1|NOT COMPLETED|Overall Study||2
27461|NCT02163187|66529|P2|COMPLETED|Overall Study||0
27462|NCT02163187|66530|P1|COMPLETED|Overall Study||2
27463|NCT02163187|66529|P2|Treatment|Overall Study||0
27464|NCT02163187|66530|P1|Treatment|Overall Study||2
27465|NCT02163187|66529|P2|STARTED|Overall Study||0
27466|NCT02163187|66530|P1|STARTED|Overall Study||4
27467|NCT02162979|66540|P2|NOT COMPLETED|Overall Study||0
27468|NCT02162979|66541|P1|NOT COMPLETED|Overall Study||0
27469|NCT02162979|66540|P2|COMPLETED|Overall Study||0
27470|NCT02162979|66541|P1|COMPLETED|Overall Study||0
27471|NCT02162979|66540|P2|STARTED|Overall Study||0
27472|NCT02162979|66541|P1|STARTED|Overall Study||0
27473|NCT02162862|66554|P3|NOT COMPLETED|Overall Study||4
27474|NCT02162862|66555|P2|NOT COMPLETED|Overall Study||11
27475|NCT02162862|66556|P1|NOT COMPLETED|Overall Study||0
27476|NCT02162862|66554|P3|COMPLETED|Overall Study||29
27477|NCT02162862|66555|P2|COMPLETED|Overall Study||24
27478|NCT02162862|66556|P1|COMPLETED|Overall Study||31
27479|NCT02162862|66554|P3|STARTED|Overall Study||33
27480|NCT02162862|66555|P2|STARTED|Overall Study||35
27481|NCT02162862|66556|P1|STARTED|Overall Study||31
27482|NCT02162758|66569|P2|NOT COMPLETED|Overall Study||1
27483|NCT02162758|66570|P1|NOT COMPLETED|Overall Study||0
27484|NCT02162758|66569|P2|COMPLETED|Overall Study||2
27485|NCT02162758|66570|P1|COMPLETED|Overall Study||3
27486|NCT02162758|66569|P2|STARTED|Overall Study||3
27487|NCT02162758|66570|P1|STARTED|Overall Study||3
27488|NCT02162680|66585|P3|NOT COMPLETED|Overall Study||0
27489|NCT02162680|66586|P2|NOT COMPLETED|Overall Study||0
27490|NCT02162680|66587|P1|NOT COMPLETED|Overall Study||0
27491|NCT02162680|66585|P3|COMPLETED|Overall Study||32
27492|NCT02162680|66586|P2|COMPLETED|Overall Study||33
27493|NCT02162680|66587|P1|COMPLETED|Overall Study||33
27494|NCT02162680|66585|P3|STARTED|Overall Study||32
27495|NCT02162680|66586|P2|STARTED|Overall Study||33
27496|NCT02162680|66587|P1|STARTED|Overall Study||33
27497|NCT02162576|66595|P1|NOT COMPLETED|Overall Study||0
27498|NCT02162576|66595|P1|COMPLETED|Overall Study||95
27499|NCT02162576|66595|P1|STARTED|Overall Study||95
27500|NCT02161757|66604|P3|NOT COMPLETED|Treatment Through Study Completion||40
27501|NCT02161757|66605|P2|NOT COMPLETED|Treatment Through Study Completion||49
27502|NCT02161757|66606|P1|NOT COMPLETED|Treatment Through Study Completion||66
27503|NCT02161757|66604|P3|COMPLETED|Treatment Through Study Completion||360
27504|NCT02161757|66605|P2|COMPLETED|Treatment Through Study Completion||355
27505|NCT02161757|66606|P1|COMPLETED|Treatment Through Study Completion||332
27506|NCT02161757|66604|P3|STARTED|Treatment Through Study Completion||400
27507|NCT02161757|66605|P2|STARTED|Treatment Through Study Completion||404
27508|NCT02161757|66606|P1|STARTED|Treatment Through Study Completion||398
27509|NCT02161757|66604|P3|NOT COMPLETED|Randomised Through Start Treatment||0
27510|NCT02161757|66605|P2|NOT COMPLETED|Randomised Through Start Treatment||2
27511|NCT02161757|66606|P1|NOT COMPLETED|Randomised Through Start Treatment||3
27512|NCT02161757|66604|P3|COMPLETED|Randomised Through Start Treatment||400
27513|NCT02161757|66605|P2|COMPLETED|Randomised Through Start Treatment||404
27514|NCT02161757|66606|P1|COMPLETED|Randomised Through Start Treatment||398
27515|NCT02161757|66604|P3|STARTED|Randomised Through Start Treatment||400
27516|NCT02161757|66605|P2|STARTED|Randomised Through Start Treatment||406
27517|NCT02161757|66606|P1|STARTED|Randomised Through Start Treatment||401
27518|NCT02161549|66663|P2|NOT COMPLETED|Overall Study||2
27519|NCT02161549|66664|P1|NOT COMPLETED|Overall Study||6
27520|NCT02161549|66663|P2|COMPLETED|Overall Study||29
27521|NCT02161549|66664|P1|COMPLETED|Overall Study||34
27522|NCT02161549|66663|P2|STARTED|Overall Study||31
27523|NCT02161549|66664|P1|STARTED|Overall Study||40
27524|NCT02161484|66672|P2|NOT COMPLETED|Overall Study||3
27525|NCT02161484|66673|P1|NOT COMPLETED|Overall Study||4
27526|NCT02161484|66672|P2|COMPLETED|Overall Study||2
27527|NCT02161484|66673|P1|COMPLETED|Overall Study||1
27528|NCT02161484|66672|P2|STARTED|Overall Study||5
27529|NCT02161484|66673|P1|STARTED|Overall Study||5
27530|NCT02161146|66700|P5|NOT COMPLETED|Overall Study||1
27531|NCT02161146|66701|P4|NOT COMPLETED|Overall Study||3
27532|NCT02161146|66702|P3|NOT COMPLETED|Overall Study||0
27533|NCT02161146|66703|P2|NOT COMPLETED|Overall Study||4
27534|NCT02161146|66704|P1|NOT COMPLETED|Overall Study||1
27535|NCT02161146|66700|P5|COMPLETED|Overall Study||48
27536|NCT02161146|66701|P4|COMPLETED|Overall Study||45
27537|NCT02161146|66702|P3|COMPLETED|Overall Study||49
27538|NCT02161146|66703|P2|COMPLETED|Overall Study||43
27539|NCT02161146|66704|P1|COMPLETED|Overall Study||46
27540|NCT02161146|66700|P5|STARTED|Overall Study||49
27541|NCT02161146|66701|P4|STARTED|Overall Study||48
27542|NCT02161146|66702|P3|STARTED|Overall Study||49
27543|NCT02161146|66703|P2|STARTED|Overall Study||47
27544|NCT02161146|66704|P1|STARTED|Overall Study||47
27545|NCT02161016|66717|P1|NOT COMPLETED|Overall Study||1
27546|NCT02161016|66717|P1|COMPLETED|Overall Study||0
27547|NCT02161016|66717|P1|STARTED|Overall Study||1
27548|NCT02160990|66727|P2|NOT COMPLETED|Overall Study||0
27549|NCT02160990|66728|P1|NOT COMPLETED|Overall Study||0
27550|NCT02160990|66727|P2|COMPLETED|Overall Study||10
27551|NCT02160990|66728|P1|COMPLETED|Overall Study||10
27552|NCT02160990|66727|P2|STARTED|Overall Study||10
27553|NCT02160990|66728|P1|STARTED|Overall Study||10
27554|NCT02160977|66748|P2|NOT COMPLETED|Six Months After Surgery||1
27555|NCT02160977|66749|P1|NOT COMPLETED|Six Months After Surgery||2
27556|NCT02160977|66748|P2|COMPLETED|Six Months After Surgery||42
27557|NCT02160977|66749|P1|COMPLETED|Six Months After Surgery||42
27558|NCT02160977|66748|P2|STARTED|Six Months After Surgery||43
27559|NCT02160977|66749|P1|STARTED|Six Months After Surgery||44
27560|NCT02160977|66748|P2|NOT COMPLETED|Three Months After Surgery||2
27561|NCT02160977|66749|P1|NOT COMPLETED|Three Months After Surgery||0
27562|NCT02160977|66748|P2|COMPLETED|Three Months After Surgery||43
27563|NCT02160977|66749|P1|COMPLETED|Three Months After Surgery||44
27564|NCT02160977|66748|P2|STARTED|Three Months After Surgery||45
27565|NCT02160977|66749|P1|STARTED|Three Months After Surgery||44
27566|NCT02160977|66748|P2|NOT COMPLETED|Six Weeks After Surgery||0
27567|NCT02160977|66749|P1|NOT COMPLETED|Six Weeks After Surgery||1
27568|NCT02160977|66748|P2|COMPLETED|Six Weeks After Surgery||45
27569|NCT02160977|66749|P1|COMPLETED|Six Weeks After Surgery||44
27570|NCT02160977|66748|P2|STARTED|Six Weeks After Surgery||45
27571|NCT02160977|66749|P1|STARTED|Six Weeks After Surgery||45
27572|NCT02160977|66748|P2|NOT COMPLETED|One Week After Surgery||0
27573|NCT02160977|66749|P1|NOT COMPLETED|One Week After Surgery||0
27574|NCT02160977|66748|P2|COMPLETED|One Week After Surgery||45
27575|NCT02160977|66749|P1|COMPLETED|One Week After Surgery||45
27576|NCT02160977|66748|P2|STARTED|One Week After Surgery||45
27577|NCT02160977|66749|P1|STARTED|One Week After Surgery||45
27578|NCT02160873|66761|P2|NOT COMPLETED|Overall Study||0
27579|NCT02160873|66762|P1|NOT COMPLETED|Overall Study||0
27580|NCT02160873|66761|P2|COMPLETED|Overall Study||6
27581|NCT02160873|66762|P1|COMPLETED|Overall Study||6
27582|NCT02160873|66761|P2|STARTED|Overall Study||6
27583|NCT02160873|66762|P1|STARTED|Overall Study||6
27584|NCT02160314|66776|P2|NOT COMPLETED|Overall Study||13
27585|NCT02160314|66777|P1|NOT COMPLETED|Overall Study||1
27586|NCT02160314|66776|P2|COMPLETED|Overall Study||59
27587|NCT02160314|66777|P1|COMPLETED|Overall Study||72
27588|NCT02160314|66776|P2|STARTED|Overall Study||72
27589|NCT02160314|66777|P1|STARTED|Overall Study||73
27590|NCT02160002|66785|P2|NOT COMPLETED|Overall Study||1
27591|NCT02160002|66786|P1|NOT COMPLETED|Overall Study||2
27592|NCT02160002|66785|P2|COMPLETED|Overall Study||178
27593|NCT02160002|66786|P1|COMPLETED|Overall Study||185
27594|NCT02160002|66785|P2|Primary Outcome|Overall Study||178
27595|NCT02160002|66786|P1|Primary Outcome|Overall Study||185
27596|NCT02160002|66785|P2|STARTED|Overall Study||179
27597|NCT02160002|66786|P1|STARTED|Overall Study||187
27598|NCT02159950|66818|P2|NOT COMPLETED|Overall Study||2
27599|NCT02159950|66819|P1|NOT COMPLETED|Overall Study||0
27600|NCT02159950|66818|P2|COMPLETED|Overall Study||0
27601|NCT02159950|66819|P1|COMPLETED|Overall Study||0
27602|NCT02159950|66818|P2|STARTED|Overall Study||2
27603|NCT02159950|66819|P1|STARTED|Overall Study||0
27604|NCT02159859|66851|P1|NOT COMPLETED|Overall Study||0
27605|NCT02159859|66851|P1|COMPLETED|Overall Study||7
27606|NCT02159859|66851|P1|STARTED|Overall Study||7
27607|NCT02159768|66864|P1|NOT COMPLETED|Overall Study||0
27608|NCT02159768|66864|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
27609|NCT02159768|66864|P1|STARTED|Overall Study|Started 16 July 2014|30
27610|NCT02159547|66871|P2|NOT COMPLETED|Overall Study||0
27611|NCT02159547|66872|P1|NOT COMPLETED|Overall Study||0
27612|NCT02159547|66871|P2|COMPLETED|Overall Study||112
27613|NCT02159547|66872|P1|COMPLETED|Overall Study||112
27614|NCT02159547|66871|P2|STARTED|Overall Study||112
27615|NCT02159547|66872|P1|STARTED|Overall Study||112
27616|NCT02159482|66880|P1|NOT COMPLETED|Overall Study||5
27617|NCT02159482|66880|P1|COMPLETED|Overall Study||6
27618|NCT02159482|66880|P1|STARTED|Overall Study||11
27619|NCT02159469|66885|P1|NOT COMPLETED|Overall Study||53
27620|NCT02159469|66885|P1|COMPLETED|Overall Study||97
27621|NCT02159469|66885|P1|Completed 12 Week|Overall Study||137
27622|NCT02159469|66885|P1|STARTED|Overall Study||150
27623|NCT02159365|66890|P1|NOT COMPLETED|Overall Study||22
27624|NCT02159365|66890|P1|COMPLETED|Overall Study|Completed = Still on Treatment|48
27625|NCT02159365|66890|P1|STARTED|Overall Study||70
27626|NCT02159352|66896|P2|NOT COMPLETED|Overall Study||2
27627|NCT02159352|66897|P1|NOT COMPLETED|Overall Study||3
27628|NCT02159352|66896|P2|COMPLETED|Overall Study||12
27629|NCT02159352|66897|P1|COMPLETED|Overall Study||11
27630|NCT02159352|66896|P2|Phase 2 (Day 5-14)|Overall Study||12
27631|NCT02159352|66897|P1|Phase 2 (Day 5-14)|Overall Study||11
27632|NCT02159352|66896|P2|Phase 1 (Day 1- 4)|Overall Study||14
27633|NCT02159352|66897|P1|Phase 1 (Day 1- 4)|Overall Study||14
27634|NCT02159352|66896|P2|STARTED|Overall Study||14
27635|NCT02159352|66897|P1|STARTED|Overall Study||14
27636|NCT02159118|66949|P2|NOT COMPLETED|Overall Study||0
27637|NCT02159118|66950|P1|NOT COMPLETED|Overall Study||0
27638|NCT02159118|66949|P2|COMPLETED|Overall Study||22
27639|NCT02159118|66950|P1|COMPLETED|Overall Study||22
27640|NCT02159118|66949|P2|STARTED|Overall Study||22
27641|NCT02159118|66950|P1|STARTED|Overall Study||22
27642|NCT02159040|66972|P1|NOT COMPLETED|Overall Study||1
27643|NCT02159040|66972|P1|COMPLETED|Overall Study||0
27644|NCT02159040|66972|P1|STARTED|Overall Study||1
27645|NCT02158975|66985|P1|NOT COMPLETED|Overall Study||1
27646|NCT02158975|66985|P1|COMPLETED|Overall Study||12
27647|NCT02158975|66985|P1|STARTED|Overall Study||13
27648|NCT02158936|66995|P2|NOT COMPLETED|Overall Study||177
27649|NCT02158936|66996|P1|NOT COMPLETED|Overall Study||179
27650|NCT02158936|66995|P2|COMPLETED|Overall Study||0
27651|NCT02158936|66996|P1|COMPLETED|Overall Study||0
27652|NCT02158936|66995|P2|Untreated|Overall Study||0
27653|NCT02158936|66996|P1|Untreated|Overall Study||2
27654|NCT02158936|66995|P2|Treated|Overall Study||177
27655|NCT02158936|66996|P1|Treated|Overall Study||177
27656|NCT02158936|66995|P2|STARTED|Overall Study||177
27657|NCT02158936|66996|P1|STARTED|Overall Study||179
27658|NCT02158728|67038|P1|NOT COMPLETED|Overall Study||27
27659|NCT02158728|67038|P1|COMPLETED|Overall Study||53
27660|NCT02158728|67038|P1|STARTED|Overall Study||80
27661|NCT02158572|67042|P1|NOT COMPLETED|Overall Study||1043
27662|NCT02158572|67042|P1|COMPLETED|Overall Study||989
27663|NCT02158572|67042|P1|STARTED|Overall Study||2032
27664|NCT02158442|67055|P2|NOT COMPLETED|Overall Study||0
27665|NCT02158442|67056|P1|NOT COMPLETED|Overall Study||2
27666|NCT02158442|67055|P2|COMPLETED|Overall Study||7
27667|NCT02158442|67056|P1|COMPLETED|Overall Study||6
27668|NCT02158442|67055|P2|STARTED|Overall Study||7
27669|NCT02158442|67056|P1|STARTED|Overall Study||8
27670|NCT02158364|67062|P1|NOT COMPLETED|Overall Study||60
27671|NCT02158364|67062|P1|COMPLETED|Overall Study||3271
27672|NCT02158364|67062|P1|STARTED|Overall Study||3331
27673|NCT02158273|67069|P2|NOT COMPLETED|Overall Study||3
27674|NCT02158273|67070|P1|NOT COMPLETED|Overall Study||3
27675|NCT02158273|67069|P2|COMPLETED|Overall Study||22
27676|NCT02158273|67070|P1|COMPLETED|Overall Study||22
27677|NCT02158273|67069|P2|STARTED|Overall Study||25
27678|NCT02158273|67070|P1|STARTED|Overall Study||25
27679|NCT02158247|67080|P1|NOT COMPLETED|Overall Study||5
27680|NCT02158247|67080|P1|COMPLETED|Overall Study||176
27681|NCT02158247|67080|P1|STARTED|Overall Study||181
27682|NCT02158039|67096|P1|NOT COMPLETED|Overall Study||10
27683|NCT02158039|67096|P1|COMPLETED|Overall Study||23
27684|NCT02158039|67096|P1|STARTED|Overall Study||33
27685|NCT02157948|67103|P2|NOT COMPLETED|Overall Study||9
27686|NCT02157948|67104|P1|NOT COMPLETED|Overall Study||9
27687|NCT02157948|67103|P2|COMPLETED|Overall Study||188
27688|NCT02157948|67104|P1|COMPLETED|Overall Study||188
27689|NCT02157948|67103|P2|Received Treatment|Overall Study||196
27690|NCT02157948|67104|P1|Received Treatment|Overall Study||196
27691|NCT02157948|67103|P2|STARTED|Overall Study||197
27692|NCT02157948|67104|P1|STARTED|Overall Study||197
27693|NCT02157935|67116|P2|NOT COMPLETED|Overall Study||65
27694|NCT02157935|67117|P1|NOT COMPLETED|Overall Study||39
27695|NCT02157935|67116|P2|COMPLETED|Overall Study||548
27696|NCT02157935|67117|P1|COMPLETED|Overall Study||567
27697|NCT02157935|67116|P2|STARTED|Overall Study||613
27698|NCT02157935|67117|P1|STARTED|Overall Study||606
27699|NCT02157909|67135|P2|NOT COMPLETED|Overall Study||0
27700|NCT02157909|67136|P1|NOT COMPLETED|Overall Study||0
27701|NCT02157909|67135|P2|COMPLETED|Overall Study||66
27702|NCT02157909|67136|P1|COMPLETED|Overall Study||66
27703|NCT02157909|67135|P2|STARTED|Overall Study||66
27704|NCT02157909|67136|P1|STARTED|Overall Study||66
27705|NCT02157883|67143|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
27706|NCT02157883|67143|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
27707|NCT02157883|67143|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
27708|NCT02157883|67143|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
27709|NCT02157883|67143|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
27710|NCT02157883|67143|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
27711|NCT02157883|67143|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
27712|NCT02157883|67143|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
27713|NCT02157883|67143|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
27714|NCT02157623|67174|P2|NOT COMPLETED|Overall Study||3
27715|NCT02157623|67175|P1|NOT COMPLETED|Overall Study||4
27716|NCT02157623|67174|P2|COMPLETED|Overall Study||0
27717|NCT02157623|67175|P1|COMPLETED|Overall Study||0
27718|NCT02157623|67174|P2|STARTED|Overall Study||3
27719|NCT02157623|67175|P1|STARTED|Overall Study||4
27720|NCT02157376|67183|P2|NOT COMPLETED|Overall Study||18
27721|NCT02157376|67184|P1|NOT COMPLETED|Overall Study||22
27722|NCT02157376|67183|P2|COMPLETED|Overall Study||138
27723|NCT02157376|67184|P1|COMPLETED|Overall Study||133
27724|NCT02157376|67183|P2|STARTED|Overall Study||156
27725|NCT02157376|67184|P1|STARTED|Overall Study||155
27726|NCT02157298|67194|P2|NOT COMPLETED|Overall Study||2
27727|NCT02157298|67195|P1|NOT COMPLETED|Overall Study||4
27728|NCT02157298|67194|P2|COMPLETED|Overall Study||58
27729|NCT02157298|67195|P1|COMPLETED|Overall Study||119
27730|NCT02157298|67194|P2|STARTED|Overall Study||60
27731|NCT02157298|67195|P1|STARTED|Overall Study||123
27732|NCT02157168|67212|P3|NOT COMPLETED|Overall Study||0
27733|NCT02157168|67213|P2|NOT COMPLETED|Overall Study||0
27734|NCT02157168|67214|P1|NOT COMPLETED|Overall Study||0
27735|NCT02157168|67212|P3|COMPLETED|Overall Study||1362
27736|NCT02157168|67213|P2|COMPLETED|Overall Study||159
27737|NCT02157168|67214|P1|COMPLETED|Overall Study||746
27738|NCT02157168|67212|P3|STARTED|Overall Study||1362
27739|NCT02157168|67213|P2|STARTED|Overall Study||159
27740|NCT02157168|67214|P1|STARTED|Overall Study||746
27741|NCT02157116|67234|P1|NOT COMPLETED|Overall Study||9
27742|NCT02157116|67234|P1|COMPLETED|Overall Study||4
27743|NCT02157116|67234|P1|STARTED|Overall Study|signed consent form|13
27744|NCT02157103|67243|P1|NOT COMPLETED|Overall Study||0
27745|NCT02157103|67243|P1|COMPLETED|Overall Study||3
27746|NCT02157103|67243|P1|STARTED|Overall Study||3
27747|NCT02156466|67254|P5|NOT COMPLETED|Overall Study||0
27748|NCT02156466|67255|P4|NOT COMPLETED|Overall Study||2
27749|NCT02156466|67256|P3|NOT COMPLETED|Overall Study||1
27750|NCT02156466|67257|P2|NOT COMPLETED|Overall Study||0
27751|NCT02156466|67258|P1|NOT COMPLETED|Overall Study||0
27752|NCT02156466|67254|P5|COMPLETED|Overall Study||8
27753|NCT02156466|67255|P4|COMPLETED|Overall Study||7
27754|NCT02156466|67256|P3|COMPLETED|Overall Study||7
27755|NCT02156466|67257|P2|COMPLETED|Overall Study||8
27756|NCT02156466|67258|P1|COMPLETED|Overall Study||8
27757|NCT02156466|67254|P5|STARTED|Overall Study||8
27758|NCT02156466|67255|P4|STARTED|Overall Study||9
27759|NCT02156466|67256|P3|STARTED|Overall Study||8
27760|NCT02156466|67257|P2|STARTED|Overall Study||8
27761|NCT02156466|67258|P1|STARTED|Overall Study||8
27762|NCT02156271|67439|P2|NOT COMPLETED|Overall Study||3
27763|NCT02156271|67440|P1|NOT COMPLETED|Overall Study||4
27764|NCT02156271|67439|P2|COMPLETED|Overall Study||10
27765|NCT02156271|67440|P1|COMPLETED|Overall Study||22
27766|NCT02156271|67439|P2|STARTED|Overall Study||13
27767|NCT02156271|67440|P1|STARTED|Overall Study||26
27768|NCT02156167|67472|P1|NOT COMPLETED|Overall Study||0
27769|NCT02156167|67472|P1|COMPLETED|Overall Study||15
27770|NCT02156167|67472|P1|STARTED|Overall Study||15
27771|NCT02155985|67479|P3|NOT COMPLETED|Overall Study||1
27772|NCT02155985|67480|P2|NOT COMPLETED|Overall Study||0
27773|NCT02155985|67481|P1|NOT COMPLETED|Overall Study||1
27774|NCT02155985|67479|P3|COMPLETED|Overall Study||39
27775|NCT02155985|67480|P2|COMPLETED|Overall Study||41
27776|NCT02155985|67481|P1|COMPLETED|Overall Study||39
27777|NCT02155985|67479|P3|STARTED|Overall Study||40
27778|NCT02155985|67480|P2|STARTED|Overall Study||41
27779|NCT02155985|67481|P1|STARTED|Overall Study||40
27780|NCT02155881|67548|P2|NOT COMPLETED|Overall Study||4
27781|NCT02155881|67549|P1|NOT COMPLETED|Overall Study||2
27782|NCT02155881|67548|P2|COMPLETED|Overall Study||36
27783|NCT02155881|67549|P1|COMPLETED|Overall Study||38
27784|NCT02155881|67548|P2|STARTED|Overall Study||40
27785|NCT02155881|67549|P1|STARTED|Overall Study||40
27786|NCT02155543|67576|P7|NOT COMPLETED|Overall Study||0
27787|NCT02155543|67577|P6|NOT COMPLETED|Overall Study||0
27788|NCT02155543|67578|P5|NOT COMPLETED|Overall Study||0
27789|NCT02155543|67579|P4|NOT COMPLETED|Overall Study||0
27790|NCT02155543|67580|P3|NOT COMPLETED|Overall Study||0
27791|NCT02155543|67581|P2|NOT COMPLETED|Overall Study||0
27792|NCT02155543|67582|P1|NOT COMPLETED|Overall Study||0
27793|NCT02155543|67576|P7|COMPLETED|Overall Study||9
27794|NCT02155543|67577|P6|COMPLETED|Overall Study||3
27795|NCT02155543|67578|P5|COMPLETED|Overall Study||3
27796|NCT02155543|67579|P4|COMPLETED|Overall Study||9
27797|NCT02155543|67580|P3|COMPLETED|Overall Study||9
27798|NCT02155543|67581|P2|COMPLETED|Overall Study||9
27799|NCT02155543|67582|P1|COMPLETED|Overall Study||9
27800|NCT02155543|67576|P7|STARTED|Overall Study||9
27801|NCT02155543|67577|P6|STARTED|Overall Study||3
27802|NCT02155543|67578|P5|STARTED|Overall Study||3
27803|NCT02155543|67579|P4|STARTED|Overall Study||9
27804|NCT02155543|67580|P3|STARTED|Overall Study||9
27805|NCT02155543|67581|P2|STARTED|Overall Study||9
27806|NCT02155543|67582|P1|STARTED|Overall Study||9
27807|NCT02155335|67595|P2|NOT COMPLETED|Period 2||0
27808|NCT02155335|67596|P1|NOT COMPLETED|Period 2||0
27809|NCT02155335|67595|P2|COMPLETED|Period 2||49
27810|NCT02155335|67596|P1|COMPLETED|Period 2||50
27811|NCT02155335|67595|P2|STARTED|Period 2||49
27812|NCT02155335|67596|P1|STARTED|Period 2||50
27813|NCT02155335|67595|P2|NOT COMPLETED|Period 1||1
27814|NCT02155335|67596|P1|NOT COMPLETED|Period 1||0
27815|NCT02155335|67595|P2|COMPLETED|Period 1||49
27816|NCT02155335|67596|P1|COMPLETED|Period 1||50
27817|NCT02155335|67595|P2|Treated|Period 1||49
27818|NCT02155335|67596|P1|Treated|Period 1||50
27819|NCT02155335|67595|P2|STARTED|Period 1||50
27820|NCT02155335|67596|P1|STARTED|Period 1||50
27821|NCT02155322|67601|P1|NOT COMPLETED|Overall Study||14
27822|NCT02155322|67601|P1|COMPLETED|Overall Study||19
27823|NCT02155322|67601|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
27824|NCT02155322|67601|P1|STARTED|Overall Study||33
27825|NCT02155309|67608|P3|NOT COMPLETED|Overall Study||1
27826|NCT02155309|67609|P2|NOT COMPLETED|Overall Study||0
27827|NCT02155309|67610|P1|NOT COMPLETED|Overall Study||0
27828|NCT02155309|67608|P3|COMPLETED|Overall Study||12
27829|NCT02155309|67609|P2|COMPLETED|Overall Study||10
27830|NCT02155309|67610|P1|COMPLETED|Overall Study||13
27831|NCT02155309|67608|P3|STARTED|Overall Study||13
27832|NCT02155309|67609|P2|STARTED|Overall Study||10
27833|NCT02155309|67610|P1|STARTED|Overall Study||13
27834|NCT02155283|67617|P1|NOT COMPLETED|Overall Study||7
27835|NCT02155283|67617|P1|COMPLETED|Overall Study||9
27836|NCT02155283|67617|P1|STARTED|Overall Study||16
27837|NCT02155010|67624|P2|NOT COMPLETED|Overall Study||6
27838|NCT02155010|67625|P1|NOT COMPLETED|Overall Study||6
27839|NCT02155010|67624|P2|COMPLETED|Overall Study||31
27840|NCT02155010|67625|P1|COMPLETED|Overall Study||31
27841|NCT02155010|67624|P2|STARTED|Overall Study||37
27842|NCT02155010|67625|P1|STARTED|Overall Study||37
27843|NCT02154906|67635|P2|NOT COMPLETED|Overall Study||3
27844|NCT02154906|67636|P1|NOT COMPLETED|Overall Study||2
27845|NCT02154906|67635|P2|COMPLETED|Overall Study||17
27846|NCT02154906|67636|P1|COMPLETED|Overall Study||19
27847|NCT02154906|67635|P2|STARTED|Overall Study||20
27848|NCT02154906|67636|P1|STARTED|Overall Study||21
27849|NCT02154425|67644|P1|NOT COMPLETED|Sampling Period||0
27850|NCT02154425|67644|P1|COMPLETED|Sampling Period||17
27851|NCT02154425|67644|P1|STARTED|Sampling Period||17
27852|NCT02154425|67644|P1|NOT COMPLETED|Screening Period||1
27853|NCT02154425|67644|P1|COMPLETED|Screening Period||17
27854|NCT02154425|67644|P1|STARTED|Screening Period||18
27855|NCT02154386|67676|P2|NOT COMPLETED|Overall Study||2
27856|NCT02154386|67677|P1|NOT COMPLETED|Overall Study||1
27857|NCT02154386|67676|P2|COMPLETED|Overall Study||21
27858|NCT02154386|67677|P1|COMPLETED|Overall Study||22
27859|NCT02154386|67676|P2|STARTED|Overall Study||23
27860|NCT02154386|67677|P1|STARTED|Overall Study||23
27861|NCT02154243|67690|P3|NOT COMPLETED|Overall Study||0
27862|NCT02154243|67691|P2|NOT COMPLETED|Overall Study||0
27863|NCT02154243|67692|P1|NOT COMPLETED|Overall Study||0
27864|NCT02154243|67690|P3|COMPLETED|Overall Study||4
27865|NCT02154243|67691|P2|COMPLETED|Overall Study||4
27866|NCT02154243|67692|P1|COMPLETED|Overall Study||5
27867|NCT02154243|67690|P3|STARTED|Overall Study||4
27868|NCT02154243|67691|P2|STARTED|Overall Study||4
27869|NCT02154243|67692|P1|STARTED|Overall Study||5
27870|NCT02154139|67703|P1|NOT COMPLETED|Overall Study||7
27871|NCT02154139|67703|P1|COMPLETED|Overall Study||644
27872|NCT02154139|67703|P1|STARTED|Overall Study||651
27873|NCT02154087|67711|P1|NOT COMPLETED|Overall Study||1
27874|NCT02154087|67711|P1|COMPLETED|Overall Study||0
27875|NCT02154087|67711|P1|STARTED|Overall Study||1
27876|NCT02154048|67718|P3|NOT COMPLETED|Overall Study||0
27877|NCT02154048|67719|P2|NOT COMPLETED|Overall Study||0
27878|NCT02154048|67720|P1|NOT COMPLETED|Overall Study||0
27879|NCT02154048|67718|P3|COMPLETED|Overall Study||1
27880|NCT02154048|67719|P2|COMPLETED|Overall Study||2
27881|NCT02154048|67720|P1|COMPLETED|Overall Study||2
27882|NCT02154048|67718|P3|STARTED|Overall Study||1
27883|NCT02154048|67719|P2|STARTED|Overall Study||2
27884|NCT02154048|67720|P1|STARTED|Overall Study||2
27885|NCT02153827|67730|P2|NOT COMPLETED|Overall Study||9
27886|NCT02153827|67731|P1|NOT COMPLETED|Overall Study||3
27887|NCT02153827|67730|P2|COMPLETED|Overall Study||14
27888|NCT02153827|67731|P1|COMPLETED|Overall Study||22
27889|NCT02153827|67730|P2|STARTED|Overall Study||23
27890|NCT02153827|67731|P1|STARTED|Overall Study||25
27891|NCT02153788|67747|P2|NOT COMPLETED|Overall Study||1
27892|NCT02153788|67748|P1|NOT COMPLETED|Overall Study||2
27893|NCT02153788|67747|P2|COMPLETED|Overall Study||18
27894|NCT02153788|67748|P1|COMPLETED|Overall Study||23
27895|NCT02153788|67747|P2|STARTED|Overall Study||19
27896|NCT02153788|67748|P1|STARTED|Overall Study||25
27897|NCT02153736|67768|P2|NOT COMPLETED|Overall Study||2
27898|NCT02153736|67769|P1|NOT COMPLETED|Overall Study||2
27899|NCT02153736|67768|P2|COMPLETED|Overall Study||5
27900|NCT02153736|67769|P1|COMPLETED|Overall Study||5
27901|NCT02153736|67768|P2|STARTED|Overall Study||7
27902|NCT02153736|67769|P1|STARTED|Overall Study||7
27903|NCT02153489|67785|P2|NOT COMPLETED|Period 2||0
27904|NCT02153489|67786|P1|NOT COMPLETED|Period 2||0
27905|NCT02153489|67785|P2|COMPLETED|Period 2||15
27906|NCT02153489|67786|P1|COMPLETED|Period 2||15
27907|NCT02153489|67785|P2|STARTED|Period 2||15
27908|NCT02153489|67786|P1|STARTED|Period 2||15
27909|NCT02153489|67785|P2|NOT COMPLETED|Period 1||0
27910|NCT02153489|67786|P1|NOT COMPLETED|Period 1||0
27911|NCT02153489|67785|P2|COMPLETED|Period 1||15
27912|NCT02153489|67786|P1|COMPLETED|Period 1||15
27913|NCT02153489|67785|P2|STARTED|Period 1||15
27914|NCT02153489|67786|P1|STARTED|Period 1||15
27915|NCT02153398|67829|P5|NOT COMPLETED|Overall Study||0
27916|NCT02153398|67830|P4|NOT COMPLETED|Overall Study||1
27917|NCT02153398|67831|P3|NOT COMPLETED|Overall Study||1
27918|NCT02153398|67832|P2|NOT COMPLETED|Overall Study||0
27919|NCT02153398|67833|P1|NOT COMPLETED|Overall Study||1
27920|NCT02153398|67829|P5|COMPLETED|Overall Study||10
27921|NCT02153398|67830|P4|COMPLETED|Overall Study||9
27922|NCT02153398|67831|P3|COMPLETED|Overall Study||9
27923|NCT02153398|67832|P2|COMPLETED|Overall Study||10
27924|NCT02153398|67833|P1|COMPLETED|Overall Study||9
27925|NCT02153398|67829|P5|STARTED|Overall Study||10
27926|NCT02153398|67830|P4|STARTED|Overall Study||10
27927|NCT02153398|67831|P3|STARTED|Overall Study||10
27928|NCT02153398|67832|P2|STARTED|Overall Study||10
27929|NCT02153398|67833|P1|STARTED|Overall Study||10
27930|NCT02153346|67955|P1|NOT COMPLETED|Overall Study||11
27931|NCT02153346|67955|P1|COMPLETED|Overall Study||90
27932|NCT02153346|67955|P1|STARTED|Overall Study||101
27933|NCT02153099|67969|P7|NOT COMPLETED|Overall Study||0
27934|NCT02153099|67970|P6|NOT COMPLETED|Overall Study||0
27935|NCT02153099|67971|P5|NOT COMPLETED|Overall Study||0
27936|NCT02153099|67972|P4|NOT COMPLETED|Overall Study||0
27937|NCT02153099|67973|P3|NOT COMPLETED|Overall Study||0
27938|NCT02153099|67974|P2|NOT COMPLETED|Overall Study||0
27939|NCT02153099|67975|P1|NOT COMPLETED|Overall Study||0
27940|NCT02153099|67969|P7|COMPLETED|Overall Study||12
27941|NCT02153099|67970|P6|COMPLETED|Overall Study||6
27942|NCT02153099|67971|P5|COMPLETED|Overall Study||6
27943|NCT02153099|67972|P4|COMPLETED|Overall Study||6
27944|NCT02153099|67973|P3|COMPLETED|Overall Study||6
27945|NCT02153099|67974|P2|COMPLETED|Overall Study||6
27946|NCT02153099|67975|P1|COMPLETED|Overall Study||6
27947|NCT02153099|67969|P7|STARTED|Overall Study||12
27948|NCT02153099|67970|P6|STARTED|Overall Study||6
27949|NCT02153099|67971|P5|STARTED|Overall Study||6
27950|NCT02153099|67972|P4|STARTED|Overall Study||6
27951|NCT02153099|67973|P3|STARTED|Overall Study||6
27952|NCT02153099|67974|P2|STARTED|Overall Study||6
27953|NCT02153099|67975|P1|STARTED|Overall Study||6
27954|NCT02153086|68029|P1|NOT COMPLETED|Overall Study||4
27955|NCT02153086|68029|P1|COMPLETED|Overall Study||232
27956|NCT02153086|68029|P1|STARTED|Overall Study||236
27957|NCT02152605|68045|P2|NOT COMPLETED|Overall Study||18
27958|NCT02152605|68046|P1|NOT COMPLETED|Overall Study||19
27959|NCT02152605|68045|P2|COMPLETED|Overall Study||230
27960|NCT02152605|68046|P1|COMPLETED|Overall Study||229
27961|NCT02152605|68045|P2|STARTED|Overall Study||248
27962|NCT02152605|68046|P1|STARTED|Overall Study||248
27963|NCT02152566|68056|P1|NOT COMPLETED|Overall Study||3
27964|NCT02152566|68056|P1|COMPLETED|Overall Study||3
27965|NCT02152566|68056|P1|STARTED|Overall Study||6
27966|NCT02152371|68062|P2|NOT COMPLETED|Overall Study||16
27967|NCT02152371|68063|P1|NOT COMPLETED|Overall Study||12
27968|NCT02152371|68062|P2|COMPLETED|Overall Study||134
27969|NCT02152371|68063|P1|COMPLETED|Overall Study||138
27970|NCT02152371|68062|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
27971|NCT02152371|68063|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
27972|NCT02152371|68062|P2|STARTED|Overall Study||150
27973|NCT02152371|68063|P1|STARTED|Overall Study||150
27974|NCT02152007|68099|P1|NOT COMPLETED|Overall Study||1
27975|NCT02152007|68099|P1|COMPLETED|Overall Study||14
27976|NCT02152007|68099|P1|STARTED|Overall Study||15
27977|NCT02151994|68108|P13|NOT COMPLETED|Food Effect (FE): Fed||0
27978|NCT02151994|68109|P12|NOT COMPLETED|Food Effect (FE): Fed||0
27979|NCT02151994|68110|P11|NOT COMPLETED|Food Effect (FE): Fed||0
27980|NCT02151994|68111|P10|NOT COMPLETED|Food Effect (FE): Fed||0
27981|NCT02151994|68112|P9|NOT COMPLETED|Food Effect (FE): Fed||0
27982|NCT02151994|68113|P8|NOT COMPLETED|Food Effect (FE): Fed||0
27983|NCT02151994|68114|P7|NOT COMPLETED|Food Effect (FE): Fed||0
27984|NCT02151994|68115|P6|NOT COMPLETED|Food Effect (FE): Fed||0
27985|NCT02151994|68116|P5|NOT COMPLETED|Food Effect (FE): Fed||0
27986|NCT02151994|68117|P4|NOT COMPLETED|Food Effect (FE): Fed||0
27987|NCT02151994|68118|P3|NOT COMPLETED|Food Effect (FE): Fed||0
27988|NCT02151994|68119|P2|NOT COMPLETED|Food Effect (FE): Fed||0
27989|NCT02151994|68120|P1|NOT COMPLETED|Food Effect (FE): Fed||0
27990|NCT02151994|68108|P13|COMPLETED|Food Effect (FE): Fed||12
27991|NCT02151994|68109|P12|COMPLETED|Food Effect (FE): Fed||0
27992|NCT02151994|68110|P11|COMPLETED|Food Effect (FE): Fed||0
27993|NCT02151994|68111|P10|COMPLETED|Food Effect (FE): Fed||0
27994|NCT02151994|68112|P9|COMPLETED|Food Effect (FE): Fed||0
27995|NCT02151994|68113|P8|COMPLETED|Food Effect (FE): Fed||0
27996|NCT02151994|68114|P7|COMPLETED|Food Effect (FE): Fed||0
27997|NCT02151994|68115|P6|COMPLETED|Food Effect (FE): Fed||0
27998|NCT02151994|68116|P5|COMPLETED|Food Effect (FE): Fed||0
27999|NCT02151994|68117|P4|COMPLETED|Food Effect (FE): Fed||0
28000|NCT02151994|68118|P3|COMPLETED|Food Effect (FE): Fed||0
28001|NCT02151994|68119|P2|COMPLETED|Food Effect (FE): Fed||0
28002|NCT02151994|68120|P1|COMPLETED|Food Effect (FE): Fed||0
28003|NCT02151994|68108|P13|STARTED|Food Effect (FE): Fed||12
28004|NCT02151994|68109|P12|STARTED|Food Effect (FE): Fed||0
28005|NCT02151994|68110|P11|STARTED|Food Effect (FE): Fed||0
28006|NCT02151994|68111|P10|STARTED|Food Effect (FE): Fed||0
28007|NCT02151994|68112|P9|STARTED|Food Effect (FE): Fed||0
28008|NCT02151994|68113|P8|STARTED|Food Effect (FE): Fed||0
28009|NCT02151994|68114|P7|STARTED|Food Effect (FE): Fed||0
28010|NCT02151994|68115|P6|STARTED|Food Effect (FE): Fed||0
28011|NCT02151994|68116|P5|STARTED|Food Effect (FE): Fed||0
28012|NCT02151994|68117|P4|STARTED|Food Effect (FE): Fed||0
28013|NCT02151994|68118|P3|STARTED|Food Effect (FE): Fed||0
28014|NCT02151994|68119|P2|STARTED|Food Effect (FE): Fed||0
28015|NCT02151994|68120|P1|STARTED|Food Effect (FE): Fed||0
28016|NCT02151994|68108|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
28017|NCT02151994|68109|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
28018|NCT02151994|68110|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
28019|NCT02151994|68111|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
28020|NCT02151994|68112|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
28021|NCT02151994|68113|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
28022|NCT02151994|68114|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
28023|NCT02151994|68115|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
28024|NCT02151994|68116|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
28025|NCT02151994|68117|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
28026|NCT02151994|68118|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
28027|NCT02151994|68119|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
28028|NCT02151994|68120|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
28029|NCT02151994|68108|P13|COMPLETED|Food Effect (FE): Fasted||0
28030|NCT02151994|68109|P12|COMPLETED|Food Effect (FE): Fasted||12
28031|NCT02151994|68110|P11|COMPLETED|Food Effect (FE): Fasted||0
28032|NCT02151994|68111|P10|COMPLETED|Food Effect (FE): Fasted||0
28033|NCT02151994|68112|P9|COMPLETED|Food Effect (FE): Fasted||0
28034|NCT02151994|68113|P8|COMPLETED|Food Effect (FE): Fasted||0
28035|NCT02151994|68114|P7|COMPLETED|Food Effect (FE): Fasted||0
28036|NCT02151994|68115|P6|COMPLETED|Food Effect (FE): Fasted||0
28037|NCT02151994|68116|P5|COMPLETED|Food Effect (FE): Fasted||0
28038|NCT02151994|68117|P4|COMPLETED|Food Effect (FE): Fasted||0
28039|NCT02151994|68118|P3|COMPLETED|Food Effect (FE): Fasted||0
28040|NCT02151994|68119|P2|COMPLETED|Food Effect (FE): Fasted||0
28041|NCT02151994|68120|P1|COMPLETED|Food Effect (FE): Fasted||0
28042|NCT02151994|68108|P13|STARTED|Food Effect (FE): Fasted||0
28043|NCT02151994|68109|P12|STARTED|Food Effect (FE): Fasted||12
28044|NCT02151994|68110|P11|STARTED|Food Effect (FE): Fasted||0
28045|NCT02151994|68111|P10|STARTED|Food Effect (FE): Fasted||0
28046|NCT02151994|68112|P9|STARTED|Food Effect (FE): Fasted||0
28047|NCT02151994|68113|P8|STARTED|Food Effect (FE): Fasted||0
28048|NCT02151994|68114|P7|STARTED|Food Effect (FE): Fasted||0
28049|NCT02151994|68115|P6|STARTED|Food Effect (FE): Fasted||0
28050|NCT02151994|68116|P5|STARTED|Food Effect (FE): Fasted||0
28051|NCT02151994|68117|P4|STARTED|Food Effect (FE): Fasted||0
28052|NCT02151994|68118|P3|STARTED|Food Effect (FE): Fasted||0
28053|NCT02151994|68119|P2|STARTED|Food Effect (FE): Fasted||0
28054|NCT02151994|68120|P1|STARTED|Food Effect (FE): Fasted||0
28055|NCT02151994|68108|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28056|NCT02151994|68109|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28057|NCT02151994|68110|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28058|NCT02151994|68111|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28059|NCT02151994|68112|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28060|NCT02151994|68113|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28061|NCT02151994|68114|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28062|NCT02151994|68115|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28063|NCT02151994|68116|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28064|NCT02151994|68117|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28065|NCT02151994|68118|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28066|NCT02151994|68119|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28067|NCT02151994|68120|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
28068|NCT02151994|68108|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
28069|NCT02151994|68109|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
28070|NCT02151994|68110|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
28071|NCT02151994|68111|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
28072|NCT02151994|68112|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
28073|NCT02151994|68113|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
28074|NCT02151994|68114|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
28075|NCT02151994|68115|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
28076|NCT02151994|68116|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
28077|NCT02151994|68117|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
28078|NCT02151994|68118|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
28079|NCT02151994|68119|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
28080|NCT02151994|68120|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
28081|NCT02151994|68108|P13|STARTED|Multiple Ascending Dose (MAD)||0
28082|NCT02151994|68109|P12|STARTED|Multiple Ascending Dose (MAD)||0
28083|NCT02151994|68110|P11|STARTED|Multiple Ascending Dose (MAD)||0
28084|NCT02151994|68111|P10|STARTED|Multiple Ascending Dose (MAD)||0
28085|NCT02151994|68112|P9|STARTED|Multiple Ascending Dose (MAD)||6
28086|NCT02151994|68113|P8|STARTED|Multiple Ascending Dose (MAD)||0
28087|NCT02151994|68114|P7|STARTED|Multiple Ascending Dose (MAD)||6
28088|NCT02151994|68115|P6|STARTED|Multiple Ascending Dose (MAD)||6
28089|NCT02151994|68116|P5|STARTED|Multiple Ascending Dose (MAD)||6
28090|NCT02151994|68117|P4|STARTED|Multiple Ascending Dose (MAD)||6
28091|NCT02151994|68118|P3|STARTED|Multiple Ascending Dose (MAD)||0
28092|NCT02151994|68119|P2|STARTED|Multiple Ascending Dose (MAD)||0
28093|NCT02151994|68120|P1|STARTED|Multiple Ascending Dose (MAD)||10
28094|NCT02151994|68108|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
28095|NCT02151994|68109|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
28096|NCT02151994|68110|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
28097|NCT02151994|68111|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
28098|NCT02151994|68112|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
28099|NCT02151994|68113|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
28100|NCT02151994|68114|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
28101|NCT02151994|68115|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
28102|NCT02151994|68116|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
28103|NCT02151994|68117|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
28104|NCT02151994|68118|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
28105|NCT02151994|68119|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
28106|NCT02151994|68120|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
28107|NCT02151994|68108|P13|COMPLETED|Single Ascending Dose (SAD)||0
28108|NCT02151994|68109|P12|COMPLETED|Single Ascending Dose (SAD)||0
28109|NCT02151994|68110|P11|COMPLETED|Single Ascending Dose (SAD)||6
28110|NCT02151994|68111|P10|COMPLETED|Single Ascending Dose (SAD)||6
28111|NCT02151994|68112|P9|COMPLETED|Single Ascending Dose (SAD)||0
28112|NCT02151994|68113|P8|COMPLETED|Single Ascending Dose (SAD)||6
28113|NCT02151994|68114|P7|COMPLETED|Single Ascending Dose (SAD)||6
28114|NCT02151994|68115|P6|COMPLETED|Single Ascending Dose (SAD)||6
28115|NCT02151994|68116|P5|COMPLETED|Single Ascending Dose (SAD)||6
28116|NCT02151994|68117|P4|COMPLETED|Single Ascending Dose (SAD)||6
28117|NCT02151994|68118|P3|COMPLETED|Single Ascending Dose (SAD)||6
28118|NCT02151994|68119|P2|COMPLETED|Single Ascending Dose (SAD)||6
28119|NCT02151994|68120|P1|COMPLETED|Single Ascending Dose (SAD)||18
28120|NCT02151994|68108|P13|STARTED|Single Ascending Dose (SAD)||0
28121|NCT02151994|68109|P12|STARTED|Single Ascending Dose (SAD)||0
28122|NCT02151994|68110|P11|STARTED|Single Ascending Dose (SAD)||6
28123|NCT02151994|68111|P10|STARTED|Single Ascending Dose (SAD)||6
28124|NCT02151994|68112|P9|STARTED|Single Ascending Dose (SAD)||0
28125|NCT02151994|68113|P8|STARTED|Single Ascending Dose (SAD)||6
28126|NCT02151994|68114|P7|STARTED|Single Ascending Dose (SAD)||6
28127|NCT02151994|68115|P6|STARTED|Single Ascending Dose (SAD)||6
28128|NCT02151994|68116|P5|STARTED|Single Ascending Dose (SAD)||6
28129|NCT02151994|68117|P4|STARTED|Single Ascending Dose (SAD)||6
28130|NCT02151994|68118|P3|STARTED|Single Ascending Dose (SAD)||6
28131|NCT02151994|68119|P2|STARTED|Single Ascending Dose (SAD)||6
28132|NCT02151994|68120|P1|STARTED|Single Ascending Dose (SAD)||18
28133|NCT02151981|68160|P2|NOT COMPLETED|Overall Study||140
28134|NCT02151981|68161|P1|NOT COMPLETED|Overall Study||279
28135|NCT02151981|68160|P2|COMPLETED|Overall Study||0
28136|NCT02151981|68161|P1|COMPLETED|Overall Study||0
28137|NCT02151981|68160|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
28138|NCT02151981|68161|P1|Crossed Over AZD9291|Overall Study||0
28139|NCT02151981|68160|P2|Did Not Receive Treatment|Overall Study||4
28140|NCT02151981|68161|P1|Did Not Receive Treatment|Overall Study||0
28141|NCT02151981|68160|P2|Received Randomised Treatment Only|Overall Study||54
28142|NCT02151981|68161|P1|Received Randomised Treatment Only|Overall Study||279
28143|NCT02151981|68160|P2|STARTED|Overall Study||140
28144|NCT02151981|68161|P1|STARTED|Overall Study||279
28145|NCT02151851|68179|P2|NOT COMPLETED|Overall Study||130
28146|NCT02151851|68180|P1|NOT COMPLETED|Overall Study||76
28147|NCT02151851|68179|P2|COMPLETED|Overall Study||186
28148|NCT02151851|68180|P1|COMPLETED|Overall Study||38
28149|NCT02151851|68179|P2|STARTED|Overall Study||316
28150|NCT02151851|68180|P1|STARTED|Overall Study||114
28151|NCT02151786|68192|P1|NOT COMPLETED|Overall Study||36
28152|NCT02151786|68192|P1|COMPLETED|Overall Study||1084
28153|NCT02151786|68192|P1|STARTED|Overall Study||1120
28154|NCT02151773|68203|P1|NOT COMPLETED|Overall Study||64
28155|NCT02151773|68203|P1|COMPLETED|Overall Study||3429
28156|NCT02151773|68203|P1|STARTED|Overall Study||3493
28157|NCT02151643|68213|P5|NOT COMPLETED|Overall Study||3
28158|NCT02151643|68214|P4|NOT COMPLETED|Overall Study||7
28159|NCT02151643|68215|P3|NOT COMPLETED|Overall Study||4
28160|NCT02151643|68216|P2|NOT COMPLETED|Overall Study||4
28161|NCT02151643|68217|P1|NOT COMPLETED|Overall Study||6
28162|NCT02151643|68213|P5|COMPLETED|Overall Study||35
28163|NCT02151643|68214|P4|COMPLETED|Overall Study||32
28164|NCT02151643|68215|P3|COMPLETED|Overall Study||21
28165|NCT02151643|68216|P2|COMPLETED|Overall Study||21
28166|NCT02151643|68217|P1|COMPLETED|Overall Study||20
28167|NCT02151643|68213|P5|STARTED|Overall Study||38
28168|NCT02151643|68214|P4|STARTED|Overall Study||39
28169|NCT02151643|68215|P3|STARTED|Overall Study||25
28170|NCT02151643|68216|P2|STARTED|Overall Study||25
28171|NCT02151643|68217|P1|STARTED|Overall Study||26
28172|NCT02151461|68258|P4|NOT COMPLETED|Overall Study||4
28173|NCT02151461|68259|P3|NOT COMPLETED|Overall Study||3
28174|NCT02151461|68260|P2|NOT COMPLETED|Overall Study||1
28175|NCT02151461|68261|P1|NOT COMPLETED|Overall Study||6
28176|NCT02151461|68258|P4|COMPLETED|Overall Study||19
28177|NCT02151461|68259|P3|COMPLETED|Overall Study||21
28178|NCT02151461|68260|P2|COMPLETED|Overall Study||24
28179|NCT02151461|68261|P1|COMPLETED|Overall Study||18
28180|NCT02151461|68258|P4|STARTED|Overall Study||23
28181|NCT02151461|68259|P3|STARTED|Overall Study||24
28182|NCT02151461|68260|P2|STARTED|Overall Study||25
28183|NCT02151461|68261|P1|STARTED|Overall Study||24
28184|NCT02151253|68299|P2|NOT COMPLETED|Overall Study||0
28185|NCT02151253|68300|P1|NOT COMPLETED|Overall Study||0
28186|NCT02151253|68299|P2|COMPLETED|Overall Study||15
28187|NCT02151253|68300|P1|COMPLETED|Overall Study||13
28188|NCT02151253|68299|P2|STARTED|Overall Study||15
28189|NCT02151253|68300|P1|STARTED|Overall Study||13
28190|NCT02151058|68317|P3|NOT COMPLETED|Overall Study||5
28191|NCT02151058|68318|P2|NOT COMPLETED|Overall Study||1
28192|NCT02151058|68319|P1|NOT COMPLETED|Overall Study||2
28193|NCT02151058|68317|P3|COMPLETED|Overall Study||86
28194|NCT02151058|68318|P2|COMPLETED|Overall Study||90
28195|NCT02151058|68319|P1|COMPLETED|Overall Study||43
28196|NCT02151058|68317|P3|STARTED|Overall Study||91
28197|NCT02151058|68318|P2|STARTED|Overall Study||91
28198|NCT02151058|68319|P1|STARTED|Overall Study||45
28199|NCT02150954|68353|P2|NOT COMPLETED|Overall Study||0
28200|NCT02150954|68354|P1|NOT COMPLETED|Overall Study||1
28201|NCT02150954|68353|P2|COMPLETED|Overall Study||59
28202|NCT02150954|68354|P1|COMPLETED|Overall Study||57
28203|NCT02150954|68353|P2|STARTED|Overall Study||59
28204|NCT02150954|68354|P1|STARTED|Overall Study||58
28205|NCT02150499|68378|P2|NOT COMPLETED|Overall Study||0
28206|NCT02150499|68379|P1|NOT COMPLETED|Overall Study||0
28207|NCT02150499|68378|P2|COMPLETED|Overall Study||9
28208|NCT02150499|68379|P1|COMPLETED|Overall Study||9
28209|NCT02150499|68378|P2|STARTED|Overall Study||9
28210|NCT02150499|68379|P1|STARTED|Overall Study||9
28211|NCT02150460|68401|P2|NOT COMPLETED|Overall Study||0
28212|NCT02150460|68402|P1|NOT COMPLETED|Overall Study||0
28213|NCT02150460|68401|P2|COMPLETED|Overall Study||50
28214|NCT02150460|68402|P1|COMPLETED|Overall Study||50
28215|NCT02150460|68401|P2|STARTED|Overall Study||50
28216|NCT02150460|68402|P1|STARTED|Overall Study||50
28217|NCT02150213|68426|P1|NOT COMPLETED|Overall Study||2
28218|NCT02150213|68426|P1|COMPLETED|Overall Study||57
28219|NCT02150213|68426|P1|STARTED|Overall Study||59
28220|NCT02150109|68431|P1|NOT COMPLETED|Overall Study||0
28221|NCT02150109|68431|P1|COMPLETED|Overall Study||372
28222|NCT02150109|68431|P1|STARTED|Overall Study||372
28223|NCT02150044|68443|P1|NOT COMPLETED|Overall Study||0
28224|NCT02150044|68443|P1|COMPLETED|Overall Study||29
28225|NCT02150044|68443|P1|Study Cohort|Overall Study||13
28226|NCT02150044|68443|P1|Lead-In Subjects|Overall Study||16
28227|NCT02150044|68443|P1|STARTED|Overall Study||29
28228|NCT02149875|68452|P3|NOT COMPLETED|Overall Study||9
28229|NCT02149875|68453|P2|NOT COMPLETED|Overall Study||8
28230|NCT02149875|68454|P1|NOT COMPLETED|Overall Study||7
28231|NCT02149875|68452|P3|COMPLETED|Overall Study||20
28232|NCT02149875|68453|P2|COMPLETED|Overall Study||20
28233|NCT02149875|68454|P1|COMPLETED|Overall Study||20
28234|NCT02149875|68452|P3|STARTED|Overall Study||29
28235|NCT02149875|68453|P2|STARTED|Overall Study||28
28236|NCT02149875|68454|P1|STARTED|Overall Study||27
28237|NCT02149342|68465|P1|NOT COMPLETED|Overall Study||0
28238|NCT02149342|68465|P1|COMPLETED|Overall Study|14 patients|14
28239|NCT02149342|68465|P1|STARTED|Overall Study|14 patients|14
28240|NCT02149303|68477|P1|NOT COMPLETED|Overall Study||0
28241|NCT02149303|68477|P1|COMPLETED|Overall Study||191
28242|NCT02149303|68477|P1|STARTED|Overall Study||191
28243|NCT02149264|68483|P1|NOT COMPLETED|Overall Study||20
28244|NCT02149264|68483|P1|COMPLETED|Overall Study||139
28245|NCT02149264|68483|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
28246|NCT02149108|68498|P2|NOT COMPLETED|Overall Study||383
28247|NCT02149108|68499|P1|NOT COMPLETED|Overall Study||380
28248|NCT02149108|68498|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
28249|NCT02149108|68499|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
28250|NCT02149108|68498|P2|STARTED|Overall Study|Randomised patients.|386
28251|NCT02149108|68499|P1|STARTED|Overall Study|Randomised patients.|382
28252|NCT02148809|68511|P1|NOT COMPLETED|Overall Study||0
28253|NCT02148809|68511|P1|COMPLETED|Overall Study||14
28254|NCT02148809|68511|P1|STARTED|Overall Study||14
28255|NCT02148718|68516|P1|NOT COMPLETED|Overall Study||31
28256|NCT02148718|68516|P1|COMPLETED|Overall Study||55
28257|NCT02148718|68516|P1|STARTED|Overall Study||86
28258|NCT02148588|68537|P1|NOT COMPLETED|Overall Study||0
28259|NCT02148588|68537|P1|COMPLETED|Overall Study||8
28260|NCT02148588|68537|P1|STARTED|Overall Study||8
28261|NCT02148523|68549|P3|NOT COMPLETED|Overall Study||0
28262|NCT02148523|68550|P2|NOT COMPLETED|Overall Study||0
28263|NCT02148523|68551|P1|NOT COMPLETED|Overall Study||0
28264|NCT02148523|68549|P3|COMPLETED|Overall Study||67
28265|NCT02148523|68550|P2|COMPLETED|Overall Study||67
28266|NCT02148523|68551|P1|COMPLETED|Overall Study||67
28267|NCT02148523|68549|P3|STARTED|Overall Study||67
28268|NCT02148523|68550|P2|STARTED|Overall Study||67
28269|NCT02148523|68551|P1|STARTED|Overall Study||67
28270|NCT02148445|68564|P2|NOT COMPLETED|Overall Study||3
28271|NCT02148445|68565|P1|NOT COMPLETED|Overall Study||1
28272|NCT02148445|68564|P2|COMPLETED|Overall Study||197
28273|NCT02148445|68565|P1|COMPLETED|Overall Study||197
28274|NCT02148445|68564|P2|STARTED|Overall Study||200
28275|NCT02148445|68565|P1|STARTED|Overall Study||198
28276|NCT02148107|68604|P3|NOT COMPLETED|Overall Study||0
28277|NCT02148107|68605|P2|NOT COMPLETED|Overall Study||0
28278|NCT02148107|68606|P1|NOT COMPLETED|Overall Study||0
28279|NCT02148107|68604|P3|COMPLETED|Overall Study||3
28280|NCT02148107|68605|P2|COMPLETED|Overall Study||7
28281|NCT02148107|68606|P1|COMPLETED|Overall Study||8
28282|NCT02148107|68604|P3|STARTED|Overall Study||3
28283|NCT02148107|68605|P2|STARTED|Overall Study||7
28284|NCT02148107|68606|P1|STARTED|Overall Study||8
28285|NCT02147899|68625|P3|NOT COMPLETED|Overall Study||0
28286|NCT02147899|68626|P2|NOT COMPLETED|Overall Study||0
28287|NCT02147899|68627|P1|NOT COMPLETED|Overall Study||0
28288|NCT02147899|68625|P3|COMPLETED|Overall Study||72
28289|NCT02147899|68626|P2|COMPLETED|Overall Study||72
28290|NCT02147899|68627|P1|COMPLETED|Overall Study||71
28291|NCT02147899|68625|P3|STARTED|Overall Study||72
28292|NCT02147899|68626|P2|STARTED|Overall Study||72
28293|NCT02147899|68627|P1|STARTED|Overall Study||71
28294|NCT02147691|68640|P2|NOT COMPLETED|Overall Study||1
28295|NCT02147691|68641|P1|NOT COMPLETED|Overall Study||4
28296|NCT02147691|68640|P2|COMPLETED|Overall Study||11
28297|NCT02147691|68641|P1|COMPLETED|Overall Study||6
28298|NCT02147691|68640|P2|STARTED|Overall Study||12
28299|NCT02147691|68641|P1|STARTED|Overall Study||10
28300|NCT02147587|68687|P2|NOT COMPLETED|Overall Study||5
28301|NCT02147587|68688|P1|NOT COMPLETED|Overall Study||11
28302|NCT02147587|68687|P2|COMPLETED|Overall Study||50
28303|NCT02147587|68688|P1|COMPLETED|Overall Study||46
28304|NCT02147587|68687|P2|STARTED|Overall Study||55
28305|NCT02147587|68688|P1|STARTED|Overall Study||57
28306|NCT02147561|68708|P1|NOT COMPLETED|Overall Study||4
28307|NCT02147561|68708|P1|COMPLETED|Overall Study||276
28308|NCT02147561|68708|P1|STARTED|Overall Study||280
28309|NCT02147522|68716|P2|NOT COMPLETED|Overall Study||48
28310|NCT02147522|68717|P1|NOT COMPLETED|Overall Study||56
28311|NCT02147522|68716|P2|COMPLETED|Overall Study||122
28312|NCT02147522|68717|P1|COMPLETED|Overall Study||122
28313|NCT02147522|68716|P2|STARTED|Overall Study||170
28314|NCT02147522|68717|P1|STARTED|Overall Study||178
28315|NCT02147288|68729|P10|NOT COMPLETED|Overall Study||0
28316|NCT02147288|68730|P9|NOT COMPLETED|Overall Study||0
28317|NCT02147288|68731|P8|NOT COMPLETED|Overall Study||0
28318|NCT02147288|68732|P7|NOT COMPLETED|Overall Study||0
28319|NCT02147288|68733|P6|NOT COMPLETED|Overall Study||0
28320|NCT02147288|68734|P5|NOT COMPLETED|Overall Study||0
28321|NCT02147288|68735|P4|NOT COMPLETED|Overall Study||0
28322|NCT02147288|68736|P3|NOT COMPLETED|Overall Study||0
28323|NCT02147288|68737|P2|NOT COMPLETED|Overall Study||2
28324|NCT02147288|68738|P1|NOT COMPLETED|Overall Study||1
28325|NCT02147288|68729|P10|COMPLETED|Overall Study||0
28326|NCT02147288|68730|P9|COMPLETED|Overall Study||0
28327|NCT02147288|68731|P8|COMPLETED|Overall Study||0
28328|NCT02147288|68732|P7|COMPLETED|Overall Study||0
28329|NCT02147288|68733|P6|COMPLETED|Overall Study||0
28330|NCT02147288|68734|P5|COMPLETED|Overall Study||0
28331|NCT02147288|68735|P4|COMPLETED|Overall Study||0
28332|NCT02147288|68736|P3|COMPLETED|Overall Study||0
28333|NCT02147288|68737|P2|COMPLETED|Overall Study||22
28334|NCT02147288|68738|P1|COMPLETED|Overall Study||21
28335|NCT02147288|68729|P10|STARTED|Overall Study||0
28336|NCT02147288|68730|P9|STARTED|Overall Study||0
28337|NCT02147288|68731|P8|STARTED|Overall Study||0
28338|NCT02147288|68732|P7|STARTED|Overall Study||0
28339|NCT02147288|68733|P6|STARTED|Overall Study||0
28340|NCT02147288|68734|P5|STARTED|Overall Study||0
28341|NCT02147288|68735|P4|STARTED|Overall Study||0
28342|NCT02147288|68736|P3|STARTED|Overall Study||0
28343|NCT02147288|68737|P2|STARTED|Overall Study||24
28344|NCT02147288|68738|P1|STARTED|Overall Study||22
28345|NCT02147184|68746|P2|NOT COMPLETED|Overall Study||27
28346|NCT02147184|68747|P1|NOT COMPLETED|Overall Study||49
28347|NCT02147184|68746|P2|COMPLETED|Overall Study||110
28348|NCT02147184|68747|P1|COMPLETED|Overall Study||78
28349|NCT02147184|68746|P2|STARTED|Overall Study||137
28350|NCT02147184|68747|P1|STARTED|Overall Study||127
28351|NCT02147093|68767|P2|NOT COMPLETED|Period 2||0
28352|NCT02147093|68768|P1|NOT COMPLETED|Period 2||2
28353|NCT02147093|68767|P2|COMPLETED|Period 2||19
28354|NCT02147093|68768|P1|COMPLETED|Period 2||18
28355|NCT02147093|68767|P2|STARTED|Period 2||19
28356|NCT02147093|68768|P1|STARTED|Period 2||20
28357|NCT02147093|68767|P2|NOT COMPLETED|Period 1||1
28358|NCT02147093|68768|P1|NOT COMPLETED|Period 1||0
28359|NCT02147093|68767|P2|COMPLETED|Period 1||19
28360|NCT02147093|68768|P1|COMPLETED|Period 1||20
28361|NCT02147093|68767|P2|STARTED|Period 1||20
28362|NCT02147093|68768|P1|STARTED|Period 1||20
28363|NCT02146599|68776|P1|NOT COMPLETED|Overall Study||5
28364|NCT02146599|68776|P1|COMPLETED|Overall Study||296
28365|NCT02146599|68776|P1|STARTED|Overall Study||301
28366|NCT02146482|68782|P2|NOT COMPLETED|Overall Study||0
28367|NCT02146482|68783|P1|NOT COMPLETED|Overall Study||0
28368|NCT02146482|68782|P2|COMPLETED|Overall Study||25
28369|NCT02146482|68783|P1|COMPLETED|Overall Study||21
28370|NCT02146482|68782|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
28371|NCT02146482|68783|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
28372|NCT02146352|68789|P1|NOT COMPLETED|Overall Study||2
28373|NCT02146352|68789|P1|COMPLETED|Overall Study||28
28374|NCT02146352|68789|P1|7 Days Post-stent Removal|Overall Study||28
28375|NCT02146352|68789|P1|30 or 60 Days Post-procedure|Overall Study||30
28376|NCT02146352|68789|P1|STARTED|Overall Study||30
28377|NCT02146326|68807|P4|NOT COMPLETED|Overall Study||48
28378|NCT02146326|68808|P3|NOT COMPLETED|Overall Study||43
28379|NCT02146326|68809|P2|NOT COMPLETED|Overall Study||37
28380|NCT02146326|68810|P1|NOT COMPLETED|Overall Study||28
28381|NCT02146326|68807|P4|COMPLETED|Overall Study||210
28382|NCT02146326|68808|P3|COMPLETED|Overall Study||168
28383|NCT02146326|68809|P2|COMPLETED|Overall Study||66
28384|NCT02146326|68810|P1|COMPLETED|Overall Study||61
28385|NCT02146326|68807|P4|12 Months|Overall Study||210
28386|NCT02146326|68808|P3|12 Months|Overall Study||168
28387|NCT02146326|68809|P2|12 Months|Overall Study||66
28388|NCT02146326|68810|P1|12 Months|Overall Study||61
28389|NCT02146326|68807|P4|6 Months|Overall Study||235
28390|NCT02146326|68808|P3|6 Months|Overall Study||186
28391|NCT02146326|68809|P2|6 Months|Overall Study||71
28392|NCT02146326|68810|P1|6 Months|Overall Study||71
28393|NCT02146326|68807|P4|3 Months|Overall Study||0
28394|NCT02146326|68808|P3|3 Months|Overall Study||0
28395|NCT02146326|68809|P2|3 Months|Overall Study||83
28396|NCT02146326|68810|P1|3 Months|Overall Study||71
28397|NCT02146326|68807|P4|Baseline|Overall Study||258
28398|NCT02146326|68808|P3|Baseline|Overall Study||211
28399|NCT02146326|68809|P2|Baseline|Overall Study||103
28400|NCT02146326|68810|P1|Baseline|Overall Study||89
28401|NCT02146326|68807|P4|STARTED|Overall Study||258
28402|NCT02146326|68808|P3|STARTED|Overall Study||211
28403|NCT02146326|68809|P2|STARTED|Overall Study||103
28404|NCT02146326|68810|P1|STARTED|Overall Study||89
28405|NCT02146248|68972|P1|NOT COMPLETED|Overall Study||2
28406|NCT02146248|68972|P1|COMPLETED|Overall Study||9
28407|NCT02146248|68972|P1|HSG 5|Overall Study||1
28408|NCT02146248|68972|P1|HSG 4|Overall Study||7
28409|NCT02146248|68972|P1|HSG 3|Overall Study||9
28410|NCT02146248|68972|P1|HSG 2|Overall Study||10
28411|NCT02146248|68972|P1|HSG 1|Overall Study||10
28503|NCT02144220|69206|P1|COMPLETED|Overall Study||258
28412|NCT02146248|68972|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
28413|NCT02146248|68972|P1|Enrolled|Overall Study||11
28414|NCT02146248|68972|P1|STARTED|Overall Study||11
28415|NCT02146105|68980|P1|NOT COMPLETED|Overall Study||6
28416|NCT02146105|68980|P1|COMPLETED|Overall Study||39
28417|NCT02146105|68980|P1|STARTED|Overall Study||45
28418|NCT02146001|68986|P2|NOT COMPLETED|Overall Study||0
28419|NCT02146001|68987|P1|NOT COMPLETED|Overall Study||0
28420|NCT02146001|68986|P2|COMPLETED|Overall Study||19
28421|NCT02146001|68987|P1|COMPLETED|Overall Study||19
28422|NCT02146001|68986|P2|STARTED|Overall Study||19
28423|NCT02146001|68987|P1|STARTED|Overall Study||19
28424|NCT02145754|68997|P1|NOT COMPLETED|Overall Study||0
28425|NCT02145754|68997|P1|COMPLETED|Overall Study||235
28426|NCT02145754|68997|P1|STARTED|Overall Study||235
28427|NCT02145676|69004|P3|NOT COMPLETED|Overall Study||0
28428|NCT02145676|69005|P2|NOT COMPLETED|Overall Study||0
28429|NCT02145676|69006|P1|NOT COMPLETED|Overall Study||0
28430|NCT02145676|69004|P3|COMPLETED|Overall Study||18
28431|NCT02145676|69005|P2|COMPLETED|Overall Study||18
28432|NCT02145676|69006|P1|COMPLETED|Overall Study||17
28433|NCT02145676|69004|P3|STARTED|Overall Study||18
28434|NCT02145676|69005|P2|STARTED|Overall Study||18
28435|NCT02145676|69006|P1|STARTED|Overall Study||17
28436|NCT02145468|69031|P2|NOT COMPLETED|Overall Study||8
28437|NCT02145468|69032|P1|NOT COMPLETED|Overall Study||5
28438|NCT02145468|69031|P2|COMPLETED|Overall Study||1723
28439|NCT02145468|69032|P1|COMPLETED|Overall Study||1753
28440|NCT02145468|69031|P2|STARTED|Overall Study||1731
28441|NCT02145468|69032|P1|STARTED|Overall Study||1758
28442|NCT02145299|69090|P2|NOT COMPLETED|Overall Study||0
28443|NCT02145299|69091|P1|NOT COMPLETED|Overall Study||0
28444|NCT02145299|69090|P2|COMPLETED|Overall Study||2
28445|NCT02145299|69091|P1|COMPLETED|Overall Study||6
28446|NCT02145299|69090|P2|STARTED|Overall Study||2
28447|NCT02145299|69091|P1|STARTED|Overall Study||6
28448|NCT02145156|69120|P3|NOT COMPLETED|Overall Study||41
28449|NCT02145156|69121|P2|NOT COMPLETED|Overall Study||52
28450|NCT02145156|69122|P1|NOT COMPLETED|Overall Study||60
28451|NCT02145156|69120|P3|COMPLETED|Overall Study||398
28452|NCT02145156|69121|P2|COMPLETED|Overall Study||373
28453|NCT02145156|69122|P1|COMPLETED|Overall Study||370
28454|NCT02145156|69120|P3|STARTED|Overall Study||439
28455|NCT02145156|69121|P2|STARTED|Overall Study||425
28456|NCT02145156|69122|P1|STARTED|Overall Study||430
28457|NCT02144519|69165|P2|NOT COMPLETED|Year 3||0
28458|NCT02144519|69166|P1|NOT COMPLETED|Year 3||0
28459|NCT02144519|69165|P2|COMPLETED|Year 3||760
28460|NCT02144519|69166|P1|COMPLETED|Year 3||894
28461|NCT02144519|69165|P2|STARTED|Year 3||760
28462|NCT02144519|69166|P1|STARTED|Year 3||894
28463|NCT02144519|69165|P2|NOT COMPLETED|Year 2||0
28464|NCT02144519|69166|P1|NOT COMPLETED|Year 2||0
28465|NCT02144519|69165|P2|COMPLETED|Year 2||864
28466|NCT02144519|69166|P1|COMPLETED|Year 2||763
28467|NCT02144519|69165|P2|STARTED|Year 2||864
28468|NCT02144519|69166|P1|STARTED|Year 2||763
28469|NCT02144519|69165|P2|NOT COMPLETED|Year 1||0
28470|NCT02144519|69166|P1|NOT COMPLETED|Year 1||0
28471|NCT02144519|69165|P2|COMPLETED|Year 1||870
28472|NCT02144519|69166|P1|COMPLETED|Year 1||895
28473|NCT02144519|69165|P2|STARTED|Year 1||870
28474|NCT02144519|69166|P1|STARTED|Year 1||895
28475|NCT02144337|69176|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
28476|NCT02144337|69177|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
28477|NCT02144337|69176|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
28478|NCT02144337|69177|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
28479|NCT02144337|69176|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
28480|NCT02144337|69177|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
28481|NCT02144337|69176|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
28482|NCT02144337|69177|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
28483|NCT02144337|69176|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
28484|NCT02144337|69177|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
28485|NCT02144337|69176|P2|STARTED|T2 Follow-up (Post-intervention)||5
28486|NCT02144337|69177|P1|STARTED|T2 Follow-up (Post-intervention)||8
28487|NCT02144337|69176|P2|NOT COMPLETED|Baseline 0 Months||0
28488|NCT02144337|69177|P1|NOT COMPLETED|Baseline 0 Months||0
28489|NCT02144337|69176|P2|COMPLETED|Baseline 0 Months||5
28490|NCT02144337|69177|P1|COMPLETED|Baseline 0 Months||8
28491|NCT02144337|69176|P2|STARTED|Baseline 0 Months||5
28492|NCT02144337|69177|P1|STARTED|Baseline 0 Months||8
28493|NCT02144259|69190|P3|NOT COMPLETED|Overall Study||18
28494|NCT02144259|69191|P2|NOT COMPLETED|Overall Study||5
28495|NCT02144259|69192|P1|NOT COMPLETED|Overall Study||10
28496|NCT02144259|69190|P3|COMPLETED|Overall Study||16
28497|NCT02144259|69191|P2|COMPLETED|Overall Study||28
28498|NCT02144259|69192|P1|COMPLETED|Overall Study||23
28499|NCT02144259|69190|P3|STARTED|Overall Study||34
28500|NCT02144259|69191|P2|STARTED|Overall Study||33
28501|NCT02144259|69192|P1|STARTED|Overall Study||33
28502|NCT02144220|69206|P1|NOT COMPLETED|Overall Study||19
28504|NCT02144220|69206|P1|STARTED|Overall Study||277
28505|NCT02144012|69216|P2|NOT COMPLETED|Overall Study||15
28506|NCT02144012|69217|P1|NOT COMPLETED|Overall Study||34
28507|NCT02144012|69216|P2|COMPLETED|Overall Study||0
28508|NCT02144012|69217|P1|COMPLETED|Overall Study||0
28509|NCT02144012|69216|P2|STARTED|Overall Study||15
28510|NCT02144012|69217|P1|STARTED|Overall Study||34
28511|NCT02143947|69254|P2|NOT COMPLETED|Overall Study||2
28512|NCT02143947|69255|P1|NOT COMPLETED|Overall Study||4
28513|NCT02143947|69254|P2|COMPLETED|Overall Study||42
28514|NCT02143947|69255|P1|COMPLETED|Overall Study||32
28515|NCT02143947|69254|P2|STARTED|Overall Study||44
28516|NCT02143947|69255|P1|STARTED|Overall Study||36
28517|NCT02143583|69270|P3|NOT COMPLETED|Overall Study||2
28518|NCT02143583|69271|P2|NOT COMPLETED|Overall Study||0
28519|NCT02143583|69272|P1|NOT COMPLETED|Overall Study||1
28520|NCT02143583|69270|P3|COMPLETED|Overall Study||66
28521|NCT02143583|69271|P2|COMPLETED|Overall Study||66
28522|NCT02143583|69272|P1|COMPLETED|Overall Study||61
28523|NCT02143583|69270|P3|STARTED|Overall Study||68
28524|NCT02143583|69271|P2|STARTED|Overall Study||66
28525|NCT02143583|69272|P1|STARTED|Overall Study||62
28526|NCT02143141|69285|P2|NOT COMPLETED|Overall Study||0
28527|NCT02143141|69286|P1|NOT COMPLETED|Overall Study||1
28528|NCT02143141|69285|P2|COMPLETED|Overall Study||6
28529|NCT02143141|69286|P1|COMPLETED|Overall Study||6
28530|NCT02143141|69285|P2|STARTED|Overall Study||6
28531|NCT02143141|69286|P1|STARTED|Overall Study||7
28532|NCT02142738|69298|P2|NOT COMPLETED|Overall Study||151
28533|NCT02142738|69299|P1|NOT COMPLETED|Overall Study||154
28534|NCT02142738|69298|P2|COMPLETED|Overall Study||0
28535|NCT02142738|69299|P1|COMPLETED|Overall Study||0
28536|NCT02142738|69298|P2|Treated|Overall Study||150
28537|NCT02142738|69299|P1|Treated|Overall Study||154
28538|NCT02142738|69298|P2|STARTED|Overall Study||151
28539|NCT02142738|69299|P1|STARTED|Overall Study||154
28540|NCT02142712|69312|P4|NOT COMPLETED|Overall Study||0
28541|NCT02142712|69313|P3|NOT COMPLETED|Overall Study||1
28542|NCT02142712|69314|P2|NOT COMPLETED|Overall Study||1
28543|NCT02142712|69315|P1|NOT COMPLETED|Overall Study||1
28544|NCT02142712|69312|P4|COMPLETED|Overall Study||0
28545|NCT02142712|69313|P3|COMPLETED|Overall Study||0
28546|NCT02142712|69314|P2|COMPLETED|Overall Study||0
28547|NCT02142712|69315|P1|COMPLETED|Overall Study||0
28548|NCT02142712|69312|P4|STARTED|Overall Study||0
28549|NCT02142712|69313|P3|STARTED|Overall Study||1
28550|NCT02142712|69314|P2|STARTED|Overall Study||1
28551|NCT02142712|69315|P1|STARTED|Overall Study||1
28552|NCT02142504|69338|P3|NOT COMPLETED|Overall Study||43
28553|NCT02142504|69339|P2|NOT COMPLETED|Overall Study||42
28554|NCT02142504|69340|P1|NOT COMPLETED|Overall Study||31
28555|NCT02142504|69338|P3|COMPLETED|Overall Study||111
28556|NCT02142504|69339|P2|COMPLETED|Overall Study||105
28557|NCT02142504|69340|P1|COMPLETED|Overall Study||122
28558|NCT02142504|69338|P3|Received Booster (Second Vaccination)|Overall Study||116
28559|NCT02142504|69339|P2|Received Booster (Second Vaccination)|Overall Study||109
28560|NCT02142504|69340|P1|Received Booster (Second Vaccination)|Overall Study||126
28561|NCT02142504|69338|P3|Randomized and Received Treatment|Overall Study||154
28562|NCT02142504|69339|P2|Randomized and Received Treatment|Overall Study||145
28563|NCT02142504|69340|P1|Randomized and Received Treatment|Overall Study||153
28564|NCT02142504|69338|P3|STARTED|Overall Study||154
28565|NCT02142504|69339|P2|STARTED|Overall Study||147
28566|NCT02142504|69340|P1|STARTED|Overall Study||153
28567|NCT02142361|69426|P3|NOT COMPLETED|Overall Study||0
28568|NCT02142361|69427|P2|NOT COMPLETED|Overall Study||0
28569|NCT02142361|69428|P1|NOT COMPLETED|Overall Study||0
28570|NCT02142361|69426|P3|COMPLETED|Overall Study||20
28571|NCT02142361|69427|P2|COMPLETED|Overall Study||20
28572|NCT02142361|69428|P1|COMPLETED|Overall Study||20
28573|NCT02142361|69426|P3|STARTED|Overall Study||20
28574|NCT02142361|69427|P2|STARTED|Overall Study||20
28575|NCT02142361|69428|P1|STARTED|Overall Study||20
28576|NCT02142153|69537|P10|NOT COMPLETED|Overall Study||0
28577|NCT02142153|69538|P9|NOT COMPLETED|Overall Study||0
28578|NCT02142153|69539|P8|NOT COMPLETED|Overall Study||0
28579|NCT02142153|69540|P7|NOT COMPLETED|Overall Study||0
28580|NCT02142153|69541|P6|NOT COMPLETED|Overall Study||0
28581|NCT02142153|69542|P5|NOT COMPLETED|Overall Study||0
28582|NCT02142153|69543|P4|NOT COMPLETED|Overall Study||0
28583|NCT02142153|69544|P3|NOT COMPLETED|Overall Study||0
28584|NCT02142153|69545|P2|NOT COMPLETED|Overall Study||0
28585|NCT02142153|69546|P1|NOT COMPLETED|Overall Study||0
28586|NCT02142153|69537|P10|COMPLETED|Overall Study||2
28587|NCT02142153|69538|P9|COMPLETED|Overall Study||6
28588|NCT02142153|69539|P8|COMPLETED|Overall Study||2
28589|NCT02142153|69540|P7|COMPLETED|Overall Study||6
28590|NCT02142153|69541|P6|COMPLETED|Overall Study||2
28591|NCT02142153|69542|P5|COMPLETED|Overall Study||6
28592|NCT02142153|69543|P4|COMPLETED|Overall Study||2
28593|NCT02142153|69544|P3|COMPLETED|Overall Study||6
28594|NCT02142153|69545|P2|COMPLETED|Overall Study||2
28595|NCT02142153|69546|P1|COMPLETED|Overall Study||6
28596|NCT02142153|69537|P10|STARTED|Overall Study||2
28597|NCT02142153|69538|P9|STARTED|Overall Study||6
28598|NCT02142153|69539|P8|STARTED|Overall Study||2
28599|NCT02142153|69540|P7|STARTED|Overall Study||6
28600|NCT02142153|69541|P6|STARTED|Overall Study||2
28601|NCT02142153|69542|P5|STARTED|Overall Study||6
28602|NCT02142153|69543|P4|STARTED|Overall Study||2
28603|NCT02142153|69544|P3|STARTED|Overall Study||6
28604|NCT02142153|69545|P2|STARTED|Overall Study||2
28605|NCT02142153|69546|P1|STARTED|Overall Study||6
28606|NCT02141997|69582|P4|NOT COMPLETED|Overall Study||1
28607|NCT02141997|69583|P3|NOT COMPLETED|Overall Study||3
28608|NCT02141997|69584|P2|NOT COMPLETED|Overall Study||6
28609|NCT02141997|69585|P1|NOT COMPLETED|Overall Study||3
28610|NCT02141997|69582|P4|COMPLETED|Overall Study||54
28611|NCT02141997|69583|P3|COMPLETED|Overall Study||53
28612|NCT02141997|69584|P2|COMPLETED|Overall Study||49
28613|NCT02141997|69585|P1|COMPLETED|Overall Study||53
28614|NCT02141997|69582|P4|STARTED|Overall Study||55
28615|NCT02141997|69583|P3|STARTED|Overall Study||56
28616|NCT02141997|69584|P2|STARTED|Overall Study||55
28617|NCT02141997|69585|P1|STARTED|Overall Study||56
28618|NCT02141984|69623|P1|NOT COMPLETED|Overall Study||2
28619|NCT02141984|69623|P1|COMPLETED|Overall Study||26
28620|NCT02141984|69623|P1|STARTED|Overall Study||28
28621|NCT02141867|69630|P1|NOT COMPLETED|Overall Study||94
28622|NCT02141867|69630|P1|COMPLETED|Overall Study||3927
28623|NCT02141867|69630|P1|STARTED|Overall Study||4021
28624|NCT02141854|69642|P6|NOT COMPLETED|Treatment Period||38
28625|NCT02141854|69643|P5|NOT COMPLETED|Treatment Period||10
28626|NCT02141854|69644|P4|NOT COMPLETED|Treatment Period||11
28627|NCT02141854|69645|P3|NOT COMPLETED|Treatment Period||9
28628|NCT02141854|69646|P2|NOT COMPLETED|Treatment Period||10
28629|NCT02141854|69647|P1|NOT COMPLETED|Treatment Period||0
28630|NCT02141854|69642|P6|COMPLETED|Treatment Period||107
28631|NCT02141854|69643|P5|COMPLETED|Treatment Period||136
28632|NCT02141854|69644|P4|COMPLETED|Treatment Period||135
28633|NCT02141854|69645|P3|COMPLETED|Treatment Period||136
28634|NCT02141854|69646|P2|COMPLETED|Treatment Period||136
28635|NCT02141854|69647|P1|COMPLETED|Treatment Period||0
28636|NCT02141854|69642|P6|Full Analysis Set|Treatment Period||143
28637|NCT02141854|69643|P5|Full Analysis Set|Treatment Period||145
28638|NCT02141854|69644|P4|Full Analysis Set|Treatment Period||146
28639|NCT02141854|69645|P3|Full Analysis Set|Treatment Period||141
28640|NCT02141854|69646|P2|Full Analysis Set|Treatment Period||145
28641|NCT02141854|69647|P1|Full Analysis Set|Treatment Period||0
28642|NCT02141854|69642|P6|Safety Population|Treatment Period||144
28643|NCT02141854|69643|P5|Safety Population|Treatment Period||145
28644|NCT02141854|69644|P4|Safety Population|Treatment Period||146
28645|NCT02141854|69645|P3|Safety Population|Treatment Period||143
28646|NCT02141854|69646|P2|Safety Population|Treatment Period||145
28647|NCT02141854|69647|P1|Safety Population|Treatment Period||0
28648|NCT02141854|69642|P6|Intent to Treat Population|Treatment Period||145
28649|NCT02141854|69643|P5|Intent to Treat Population|Treatment Period||146
28650|NCT02141854|69644|P4|Intent to Treat Population|Treatment Period||146
28651|NCT02141854|69645|P3|Intent to Treat Population|Treatment Period||145
28652|NCT02141854|69646|P2|Intent to Treat Population|Treatment Period||146
28653|NCT02141854|69647|P1|Intent to Treat Population|Treatment Period||0
28654|NCT02141854|69642|P6|STARTED|Treatment Period||145
28655|NCT02141854|69643|P5|STARTED|Treatment Period||146
28656|NCT02141854|69644|P4|STARTED|Treatment Period||146
28657|NCT02141854|69645|P3|STARTED|Treatment Period||145
28658|NCT02141854|69646|P2|STARTED|Treatment Period||146
28659|NCT02141854|69647|P1|STARTED|Treatment Period||0
28660|NCT02141854|69642|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28661|NCT02141854|69643|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28662|NCT02141854|69644|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28663|NCT02141854|69645|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28664|NCT02141854|69646|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28665|NCT02141854|69647|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
28666|NCT02141854|69642|P6|COMPLETED|Run-In Period (Pre-assignment)||0
28667|NCT02141854|69643|P5|COMPLETED|Run-In Period (Pre-assignment)||0
28668|NCT02141854|69644|P4|COMPLETED|Run-In Period (Pre-assignment)||0
28669|NCT02141854|69645|P3|COMPLETED|Run-In Period (Pre-assignment)||0
28670|NCT02141854|69646|P2|COMPLETED|Run-In Period (Pre-assignment)||0
28671|NCT02141854|69647|P1|COMPLETED|Run-In Period (Pre-assignment)||728
28672|NCT02141854|69642|P6|STARTED|Run-In Period (Pre-assignment)||0
28673|NCT02141854|69643|P5|STARTED|Run-In Period (Pre-assignment)||0
28674|NCT02141854|69644|P4|STARTED|Run-In Period (Pre-assignment)||0
28675|NCT02141854|69645|P3|STARTED|Run-In Period (Pre-assignment)||0
28676|NCT02141854|69646|P2|STARTED|Run-In Period (Pre-assignment)||0
28677|NCT02141854|69647|P1|STARTED|Run-In Period (Pre-assignment)||882
28678|NCT02141633|69701|P2|NOT COMPLETED|Overall Study||0
28679|NCT02141633|69702|P1|NOT COMPLETED|Overall Study||1
28680|NCT02141633|69701|P2|COMPLETED|Overall Study||15
28681|NCT02141633|69702|P1|COMPLETED|Overall Study||15
28682|NCT02141633|69701|P2|STARTED|Overall Study||15
28683|NCT02141633|69702|P1|STARTED|Overall Study||16
28684|NCT02141620|69710|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
28685|NCT02141620|69711|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
28686|NCT02141620|69710|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
28687|NCT02141620|69711|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
28688|NCT02141620|69710|P2|STARTED|Treatment Condition 2 (7 Days)||7
28689|NCT02141620|69711|P1|STARTED|Treatment Condition 2 (7 Days)||7
28690|NCT02141620|69710|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
28691|NCT02141620|69711|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
28692|NCT02141620|69710|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
28693|NCT02141620|69711|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
28694|NCT02141620|69710|P2|STARTED|Treatment Condition 1 (7 Days)||7
28695|NCT02141620|69711|P1|STARTED|Treatment Condition 1 (7 Days)||8
28696|NCT02141581|69772|P3|NOT COMPLETED|Overall Study||0
28697|NCT02141581|69773|P2|NOT COMPLETED|Overall Study||0
28698|NCT02141581|69774|P1|NOT COMPLETED|Overall Study||0
28699|NCT02141581|69772|P3|COMPLETED|Overall Study||25
28700|NCT02141581|69773|P2|COMPLETED|Overall Study||19
28701|NCT02141581|69774|P1|COMPLETED|Overall Study||42
28702|NCT02141581|69772|P3|STARTED|Overall Study||25
28703|NCT02141581|69773|P2|STARTED|Overall Study||19
28704|NCT02141581|69774|P1|STARTED|Overall Study||42
28705|NCT02141516|69788|P3|NOT COMPLETED|Overall Study||0
28706|NCT02141516|69789|P2|NOT COMPLETED|Overall Study||5
28707|NCT02141516|69790|P1|NOT COMPLETED|Overall Study||0
28708|NCT02141516|69788|P3|COMPLETED|Overall Study||87
28709|NCT02141516|69789|P2|COMPLETED|Overall Study||107
28710|NCT02141516|69790|P1|COMPLETED|Overall Study||40
28711|NCT02141516|69788|P3|STARTED|Overall Study||87
28712|NCT02141516|69789|P2|STARTED|Overall Study||112
28713|NCT02141516|69790|P1|STARTED|Overall Study||40
28714|NCT02141360|69840|P3|NOT COMPLETED|Overall Study||0
28715|NCT02141360|69841|P2|NOT COMPLETED|Overall Study||0
28716|NCT02141360|69842|P1|NOT COMPLETED|Overall Study||7
28717|NCT02141360|69840|P3|COMPLETED|Overall Study||6
28718|NCT02141360|69841|P2|COMPLETED|Overall Study||6
28719|NCT02141360|69842|P1|COMPLETED|Overall Study||4
28720|NCT02141360|69840|P3|STARTED|Overall Study||6
28721|NCT02141360|69841|P2|STARTED|Overall Study||6
28722|NCT02141360|69842|P1|STARTED|Overall Study||11
28723|NCT02141217|69852|P2|NOT COMPLETED|Overall Study||8
28724|NCT02141217|69853|P1|NOT COMPLETED|Overall Study||11
28725|NCT02141217|69852|P2|COMPLETED|Overall Study||229
28726|NCT02141217|69853|P1|COMPLETED|Overall Study||223
28727|NCT02141217|69852|P2|ITT Population-Actual Treatment Received|Overall Study||235
28728|NCT02141217|69853|P1|ITT Population-Actual Treatment Received|Overall Study||236
28729|NCT02141217|69852|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
28730|NCT02141217|69853|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
28731|NCT02141217|69852|P2|STARTED|Overall Study||237
28732|NCT02141217|69853|P1|STARTED|Overall Study||234
28733|NCT02140957|69873|P2|NOT COMPLETED|Overall Study||23
28734|NCT02140957|69874|P1|NOT COMPLETED|Overall Study||27
28735|NCT02140957|69873|P2|COMPLETED|Overall Study||99
28736|NCT02140957|69874|P1|COMPLETED|Overall Study||102
28737|NCT02140957|69873|P2|STARTED|Overall Study||122
28738|NCT02140957|69874|P1|STARTED|Overall Study||129
28739|NCT02140788|69884|P4|NOT COMPLETED|Overall Study||0
28740|NCT02140788|69885|P3|NOT COMPLETED|Overall Study||0
28741|NCT02140788|69886|P2|NOT COMPLETED|Overall Study||0
28742|NCT02140788|69887|P1|NOT COMPLETED|Overall Study||0
28743|NCT02140788|69884|P4|COMPLETED|Overall Study||0
28744|NCT02140788|69885|P3|COMPLETED|Overall Study||0
28745|NCT02140788|69886|P2|COMPLETED|Overall Study||0
28746|NCT02140788|69887|P1|COMPLETED|Overall Study||0
28747|NCT02140788|69884|P4|STARTED|Overall Study||0
28748|NCT02140788|69885|P3|STARTED|Overall Study||0
28749|NCT02140788|69886|P2|STARTED|Overall Study||0
28750|NCT02140788|69887|P1|STARTED|Overall Study||0
28751|NCT02140645|69919|P6|NOT COMPLETED|Overall Study||70896
28752|NCT02140645|69920|P5|NOT COMPLETED|Overall Study||3286
28753|NCT02140645|69921|P4|NOT COMPLETED|Overall Study||13833
28754|NCT02140645|69922|P3|NOT COMPLETED|Overall Study||4236
28755|NCT02140645|69923|P2|NOT COMPLETED|Overall Study||61654
28756|NCT02140645|69924|P1|NOT COMPLETED|Overall Study||5489
28757|NCT02140645|69919|P6|COMPLETED|Overall Study||3050
28758|NCT02140645|69920|P5|COMPLETED|Overall Study||150
28759|NCT02140645|69921|P4|COMPLETED|Overall Study||530
28760|NCT02140645|69922|P3|COMPLETED|Overall Study||205
28761|NCT02140645|69923|P2|COMPLETED|Overall Study||3041
28762|NCT02140645|69924|P1|COMPLETED|Overall Study||243
28763|NCT02140645|69919|P6|STARTED|Overall Study||73946
28764|NCT02140645|69920|P5|STARTED|Overall Study||3436
28765|NCT02140645|69921|P4|STARTED|Overall Study||14363
28766|NCT02140645|69922|P3|STARTED|Overall Study||4441
28767|NCT02140645|69923|P2|STARTED|Overall Study||64695
28768|NCT02140645|69924|P1|STARTED|Overall Study||5732
28769|NCT02140593|70013|P2|NOT COMPLETED|Overall Study||0
28770|NCT02140593|70014|P1|NOT COMPLETED|Overall Study||0
28771|NCT02140593|70013|P2|COMPLETED|Overall Study||65
28772|NCT02140593|70014|P1|COMPLETED|Overall Study||63
28773|NCT02140593|70013|P2|STARTED|Overall Study||65
28774|NCT02140593|70014|P1|STARTED|Overall Study||63
28775|NCT02140372|70022|P1|NOT COMPLETED|Overall Study||0
28776|NCT02140372|70022|P1|COMPLETED|Overall Study||10
28777|NCT02140372|70022|P1|STARTED|Overall Study||10
28778|NCT02140164|70033|P1|NOT COMPLETED|Overall Study||2
28779|NCT02140164|70033|P1|COMPLETED|Overall Study||5
28780|NCT02140164|70033|P1|STARTED|Overall Study||7
28781|NCT02140060|70054|P6|NOT COMPLETED|Overall Study||1
28782|NCT02140060|70055|P5|NOT COMPLETED|Overall Study||1
28783|NCT02140060|70056|P4|NOT COMPLETED|Overall Study||2
28784|NCT02140060|70057|P3|NOT COMPLETED|Overall Study||0
28785|NCT02140060|70058|P2|NOT COMPLETED|Overall Study||0
28786|NCT02140060|70059|P1|NOT COMPLETED|Overall Study||0
28787|NCT02140060|70054|P6|COMPLETED|Overall Study||43
28788|NCT02140060|70055|P5|COMPLETED|Overall Study||44
28789|NCT02140060|70056|P4|COMPLETED|Overall Study||43
28790|NCT02140060|70057|P3|COMPLETED|Overall Study||44
28791|NCT02140060|70058|P2|COMPLETED|Overall Study||44
28792|NCT02140060|70059|P1|COMPLETED|Overall Study||44
28793|NCT02140060|70054|P6|STARTED|Overall Study||44
28794|NCT02140060|70055|P5|STARTED|Overall Study||45
28795|NCT02140060|70056|P4|STARTED|Overall Study||45
28796|NCT02140060|70057|P3|STARTED|Overall Study||44
28797|NCT02140060|70058|P2|STARTED|Overall Study||44
28798|NCT02140060|70059|P1|STARTED|Overall Study||44
28799|NCT02139982|70084|P10|NOT COMPLETED|Overall Study||0
28800|NCT02139982|70085|P9|NOT COMPLETED|Overall Study||0
28801|NCT02139982|70086|P8|NOT COMPLETED|Overall Study||0
28802|NCT02139982|70087|P7|NOT COMPLETED|Overall Study||0
28803|NCT02139982|70088|P6|NOT COMPLETED|Overall Study||0
28804|NCT02139982|70089|P5|NOT COMPLETED|Overall Study||0
28805|NCT02139982|70090|P4|NOT COMPLETED|Overall Study||1
28806|NCT02139982|70091|P3|NOT COMPLETED|Overall Study||0
28807|NCT02139982|70092|P2|NOT COMPLETED|Overall Study||1
28808|NCT02139982|70093|P1|NOT COMPLETED|Overall Study||0
28809|NCT02139982|70084|P10|COMPLETED|Overall Study||13
28810|NCT02139982|70085|P9|COMPLETED|Overall Study||13
28811|NCT02139982|70086|P8|COMPLETED|Overall Study||13
28812|NCT02139982|70087|P7|COMPLETED|Overall Study||13
28813|NCT02139982|70088|P6|COMPLETED|Overall Study||13
28814|NCT02139982|70089|P5|COMPLETED|Overall Study||13
28815|NCT02139982|70090|P4|COMPLETED|Overall Study||7
28816|NCT02139982|70091|P3|COMPLETED|Overall Study||8
28817|NCT02139982|70092|P2|COMPLETED|Overall Study||7
28818|NCT02139982|70093|P1|COMPLETED|Overall Study||8
28819|NCT02139982|70084|P10|STARTED|Overall Study||13
28820|NCT02139982|70085|P9|STARTED|Overall Study||13
28821|NCT02139982|70086|P8|STARTED|Overall Study||13
28822|NCT02139982|70087|P7|STARTED|Overall Study||13
28823|NCT02139982|70088|P6|STARTED|Overall Study||13
28824|NCT02139982|70089|P5|STARTED|Overall Study||13
28825|NCT02139982|70090|P4|STARTED|Overall Study||8
28826|NCT02139982|70091|P3|STARTED|Overall Study||8
28827|NCT02139982|70092|P2|STARTED|Overall Study||8
28828|NCT02139982|70093|P1|STARTED|Overall Study||8
28829|NCT02139943|70138|P3|NOT COMPLETED|Overall Study||7
28830|NCT02139943|70139|P2|NOT COMPLETED|Overall Study||6
28831|NCT02139943|70140|P1|NOT COMPLETED|Overall Study||10
28832|NCT02139943|70138|P3|COMPLETED|Overall Study||110
28833|NCT02139943|70139|P2|COMPLETED|Overall Study||111
28834|NCT02139943|70140|P1|COMPLETED|Overall Study||107
28835|NCT02139943|70138|P3|STARTED|Overall Study||117
28836|NCT02139943|70139|P2|STARTED|Overall Study||117
28837|NCT02139943|70140|P1|STARTED|Overall Study||117
28838|NCT02139878|70151|P2|NOT COMPLETED|Second Intervention (7 Days)||0
28839|NCT02139878|70152|P1|NOT COMPLETED|Second Intervention (7 Days)||0
28840|NCT02139878|70151|P2|COMPLETED|Second Intervention (7 Days)||10
28841|NCT02139878|70152|P1|COMPLETED|Second Intervention (7 Days)||9
28842|NCT02139878|70151|P2|STARTED|Second Intervention (7 Days)||10
28843|NCT02139878|70152|P1|STARTED|Second Intervention (7 Days)||9
28844|NCT02139878|70151|P2|NOT COMPLETED|Washout Period (8 Days)||0
28845|NCT02139878|70152|P1|NOT COMPLETED|Washout Period (8 Days)||0
28846|NCT02139878|70151|P2|COMPLETED|Washout Period (8 Days)||10
28847|NCT02139878|70152|P1|COMPLETED|Washout Period (8 Days)||9
28848|NCT02139878|70151|P2|STARTED|Washout Period (8 Days)||10
28849|NCT02139878|70152|P1|STARTED|Washout Period (8 Days)||9
28850|NCT02139878|70151|P2|NOT COMPLETED|First Intervention (7 Days)||0
28851|NCT02139878|70152|P1|NOT COMPLETED|First Intervention (7 Days)||1
28852|NCT02139878|70151|P2|COMPLETED|First Intervention (7 Days)||10
28853|NCT02139878|70152|P1|COMPLETED|First Intervention (7 Days)||9
28854|NCT02139878|70151|P2|STARTED|First Intervention (7 Days)||10
28855|NCT02139878|70152|P1|STARTED|First Intervention (7 Days)||10
28856|NCT02139644|70165|P6|NOT COMPLETED|Treatment Period||17
28857|NCT02139644|70166|P5|NOT COMPLETED|Treatment Period||8
28858|NCT02139644|70167|P4|NOT COMPLETED|Treatment Period||9
28859|NCT02139644|70168|P3|NOT COMPLETED|Treatment Period||8
28860|NCT02139644|70169|P2|NOT COMPLETED|Treatment Period||3
28861|NCT02139644|70170|P1|NOT COMPLETED|Treatment Period||0
28862|NCT02139644|70165|P6|COMPLETED|Treatment Period||113
28863|NCT02139644|70166|P5|COMPLETED|Treatment Period||121
28864|NCT02139644|70167|P4|COMPLETED|Treatment Period||121
28865|NCT02139644|70168|P3|COMPLETED|Treatment Period||121
28866|NCT02139644|70169|P2|COMPLETED|Treatment Period||126
28867|NCT02139644|70170|P1|COMPLETED|Treatment Period||0
28868|NCT02139644|70165|P6|STARTED|Treatment Period|Randomized|130
28869|NCT02139644|70166|P5|STARTED|Treatment Period|Randomized|129
28870|NCT02139644|70167|P4|STARTED|Treatment Period|Randomized|130
28871|NCT02139644|70168|P3|STARTED|Treatment Period|Randomized|129
28872|NCT02139644|70169|P2|STARTED|Treatment Period|Randomized|129
28873|NCT02139644|70170|P1|STARTED|Treatment Period||0
28874|NCT02139644|70165|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28875|NCT02139644|70166|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28876|NCT02139644|70167|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28877|NCT02139644|70168|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28878|NCT02139644|70169|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
28879|NCT02139644|70170|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
28880|NCT02139644|70165|P6|COMPLETED|Run-In Period (Pre-assignment)||0
28881|NCT02139644|70166|P5|COMPLETED|Run-In Period (Pre-assignment)||0
28882|NCT02139644|70167|P4|COMPLETED|Run-In Period (Pre-assignment)||0
28883|NCT02139644|70168|P3|COMPLETED|Run-In Period (Pre-assignment)||0
28884|NCT02139644|70169|P2|COMPLETED|Run-In Period (Pre-assignment)||0
28885|NCT02139644|70170|P1|COMPLETED|Run-In Period (Pre-assignment)||647
28886|NCT02139644|70165|P6|STARTED|Run-In Period (Pre-assignment)||0
28887|NCT02139644|70166|P5|STARTED|Run-In Period (Pre-assignment)||0
28888|NCT02139644|70167|P4|STARTED|Run-In Period (Pre-assignment)||0
28889|NCT02139644|70168|P3|STARTED|Run-In Period (Pre-assignment)||0
28890|NCT02139644|70169|P2|STARTED|Run-In Period (Pre-assignment)||0
28891|NCT02139644|70170|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
28892|NCT02139228|70224|P2|NOT COMPLETED|Overall Study||0
28893|NCT02139228|70225|P1|NOT COMPLETED|Overall Study||0
28894|NCT02139228|70224|P2|COMPLETED|Overall Study||211
28895|NCT02139228|70225|P1|COMPLETED|Overall Study||215
28896|NCT02139228|70224|P2|STARTED|Overall Study||211
28897|NCT02139228|70225|P1|STARTED|Overall Study||215
28898|NCT02139176|70235|P2|NOT COMPLETED|Overall Study||0
28899|NCT02139176|70236|P1|NOT COMPLETED|Overall Study||0
28900|NCT02139176|70235|P2|COMPLETED|Overall Study||100
28901|NCT02139176|70236|P1|COMPLETED|Overall Study||100
28902|NCT02139176|70235|P2|STARTED|Overall Study||100
28903|NCT02139176|70236|P1|STARTED|Overall Study||100
28904|NCT02139137|70248|P2|NOT COMPLETED|Overall Study||10
28905|NCT02139137|70249|P1|NOT COMPLETED|Overall Study||7
28906|NCT02139137|70248|P2|COMPLETED|Overall Study||10
28907|NCT02139137|70249|P1|COMPLETED|Overall Study||15
28908|NCT02139137|70248|P2|STARTED|Overall Study||20
28909|NCT02139137|70249|P1|STARTED|Overall Study||22
28910|NCT02139046|70268|P5|NOT COMPLETED|Overall Study||57
28911|NCT02139046|70269|P4|NOT COMPLETED|Overall Study||68
28912|NCT02139046|70270|P3|NOT COMPLETED|Overall Study||59
28913|NCT02139046|70271|P2|NOT COMPLETED|Overall Study||54
28914|NCT02139046|70272|P1|NOT COMPLETED|Overall Study||62
28915|NCT02139046|70268|P5|COMPLETED|Overall Study||301
28916|NCT02139046|70269|P4|COMPLETED|Overall Study||290
28917|NCT02139046|70270|P3|COMPLETED|Overall Study||298
28918|NCT02139046|70271|P2|COMPLETED|Overall Study||305
28919|NCT02139046|70272|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
28920|NCT02139046|70268|P5|Full Analysis Set|Overall Study||357
28921|NCT02139046|70269|P4|Full Analysis Set|Overall Study||357
28922|NCT02139046|70270|P3|Full Analysis Set|Overall Study||355
28923|NCT02139046|70271|P2|Full Analysis Set|Overall Study||357
28924|NCT02139046|70272|P1|Full Analysis Set|Overall Study||357
28925|NCT02139046|70268|P5|Safety Analysis Set|Overall Study||357
28926|NCT02139046|70269|P4|Safety Analysis Set|Overall Study||357
28927|NCT02139046|70270|P3|Safety Analysis Set|Overall Study||355
28928|NCT02139046|70271|P2|Safety Analysis Set|Overall Study||358
28929|NCT02139046|70272|P1|Safety Analysis Set|Overall Study||356
28930|NCT02139046|70268|P5|STARTED|Overall Study||358
28931|NCT02139046|70269|P4|STARTED|Overall Study||358
28932|NCT02139046|70270|P3|STARTED|Overall Study||357
28933|NCT02139046|70271|P2|STARTED|Overall Study||359
28934|NCT02139046|70272|P1|STARTED|Overall Study||358
28935|NCT02139007|70296|P2|NOT COMPLETED|Patient Participant Recruitment||1
28936|NCT02139007|70297|P1|NOT COMPLETED|Patient Participant Recruitment||2
28937|NCT02139007|70296|P2|COMPLETED|Patient Participant Recruitment||13
28938|NCT02139007|70297|P1|COMPLETED|Patient Participant Recruitment||11
28939|NCT02139007|70296|P2|STARTED|Patient Participant Recruitment||14
28940|NCT02139007|70297|P1|STARTED|Patient Participant Recruitment||13
28941|NCT02139007|70296|P2|NOT COMPLETED|Study Site Recruitment||4
28942|NCT02139007|70297|P1|NOT COMPLETED|Study Site Recruitment||3
28943|NCT02139007|70296|P2|COMPLETED|Study Site Recruitment||1
28944|NCT02139007|70297|P1|COMPLETED|Study Site Recruitment||1
28945|NCT02139007|70296|P2|STARTED|Study Site Recruitment||5
28946|NCT02139007|70297|P1|STARTED|Study Site Recruitment||4
28947|NCT02138838|70312|P2|NOT COMPLETED|Overall Study||11
28948|NCT02138838|70313|P1|NOT COMPLETED|Overall Study||8
28949|NCT02138838|70312|P2|COMPLETED|Overall Study||16
28950|NCT02138838|70313|P1|COMPLETED|Overall Study||20
28951|NCT02138838|70312|P2|Received Study Drug|Overall Study||25
28952|NCT02138838|70313|P1|Received Study Drug|Overall Study||28
28953|NCT02138838|70312|P2|STARTED|Overall Study||27
28954|NCT02138838|70313|P1|STARTED|Overall Study||28
28955|NCT02138825|70331|P2|NOT COMPLETED|Safety Follow-up||17
28956|NCT02138825|70332|P1|NOT COMPLETED|Safety Follow-up||22
28957|NCT02138825|70331|P2|COMPLETED|Safety Follow-up||47
28958|NCT02138825|70332|P1|COMPLETED|Safety Follow-up||50
28959|NCT02138825|70331|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
29048|NCT02137603|70817|P2|STARTED|Overall Study||18
28960|NCT02138825|70332|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
28961|NCT02138825|70331|P2|NOT COMPLETED|Long-term Extension||38
28962|NCT02138825|70332|P1|NOT COMPLETED|Long-term Extension||32
28963|NCT02138825|70331|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
28964|NCT02138825|70332|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
28965|NCT02138825|70331|P2|STARTED|Long-term Extension||38
28966|NCT02138825|70332|P1|STARTED|Long-term Extension||32
28967|NCT02138825|70331|P2|NOT COMPLETED|Main Study Treatment||35
28968|NCT02138825|70332|P1|NOT COMPLETED|Main Study Treatment||40
28969|NCT02138825|70331|P2|COMPLETED|Main Study Treatment||39
28970|NCT02138825|70332|P1|COMPLETED|Main Study Treatment||33
28971|NCT02138825|70331|P2|STARTED|Main Study Treatment|safety population|74
28972|NCT02138825|70332|P1|STARTED|Main Study Treatment|safety population|73
28973|NCT02138747|70350|P4|NOT COMPLETED|Treatment Period 2||3
28974|NCT02138747|70351|P3|NOT COMPLETED|Treatment Period 2||2
28975|NCT02138747|70352|P2|NOT COMPLETED|Treatment Period 2||7
28976|NCT02138747|70353|P1|NOT COMPLETED|Treatment Period 2||17
28977|NCT02138747|70350|P4|COMPLETED|Treatment Period 2||24
28978|NCT02138747|70351|P3|COMPLETED|Treatment Period 2||24
28979|NCT02138747|70352|P2|COMPLETED|Treatment Period 2||125
28980|NCT02138747|70353|P1|COMPLETED|Treatment Period 2||121
28981|NCT02138747|70350|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
28982|NCT02138747|70351|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
28983|NCT02138747|70352|P2|STARTED|Treatment Period 2||132
28984|NCT02138747|70353|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
28985|NCT02138747|70350|P4|NOT COMPLETED|Treatment Period 1||4
28986|NCT02138747|70351|P3|NOT COMPLETED|Treatment Period 1||4
28987|NCT02138747|70352|P2|NOT COMPLETED|Treatment Period 1||25
28988|NCT02138747|70353|P1|NOT COMPLETED|Treatment Period 1||20
28989|NCT02138747|70350|P4|COMPLETED|Treatment Period 1||28
28990|NCT02138747|70351|P3|COMPLETED|Treatment Period 1||27
28991|NCT02138747|70352|P2|COMPLETED|Treatment Period 1||132
28992|NCT02138747|70353|P1|COMPLETED|Treatment Period 1||136
28993|NCT02138747|70350|P4|STARTED|Treatment Period 1||32
28994|NCT02138747|70351|P3|STARTED|Treatment Period 1||31
28995|NCT02138747|70352|P2|STARTED|Treatment Period 1||157
28996|NCT02138747|70353|P1|STARTED|Treatment Period 1||156
28997|NCT02138578|70388|P3|NOT COMPLETED|Overall Study||0
28998|NCT02138578|70389|P2|NOT COMPLETED|Overall Study||0
28999|NCT02138578|70390|P1|NOT COMPLETED|Overall Study||0
29000|NCT02138578|70388|P3|COMPLETED|Overall Study||3
29001|NCT02138578|70389|P2|COMPLETED|Overall Study||0
29002|NCT02138578|70390|P1|COMPLETED|Overall Study||1
29003|NCT02138578|70388|P3|STARTED|Overall Study||3
29004|NCT02138578|70389|P2|STARTED|Overall Study||0
29005|NCT02138578|70390|P1|STARTED|Overall Study||1
29006|NCT02138461|70418|P2|NOT COMPLETED|Overall Study||0
29007|NCT02138461|70419|P1|NOT COMPLETED|Overall Study||0
29008|NCT02138461|70418|P2|COMPLETED|Overall Study||110
29009|NCT02138461|70419|P1|COMPLETED|Overall Study||101
29010|NCT02138461|70418|P2|STARTED|Overall Study||110
29011|NCT02138461|70419|P1|STARTED|Overall Study||101
29012|NCT02138227|70427|P2|NOT COMPLETED|Overall Study||0
29013|NCT02138227|70428|P1|NOT COMPLETED|Overall Study||0
29014|NCT02138227|70427|P2|COMPLETED|Overall Study||218
29015|NCT02138227|70428|P1|COMPLETED|Overall Study||55
29016|NCT02138227|70427|P2|STARTED|Overall Study||218
29017|NCT02138227|70428|P1|STARTED|Overall Study||55
29018|NCT02138097|70477|P2|NOT COMPLETED|Overall Study||0
29019|NCT02138097|70478|P1|NOT COMPLETED|Overall Study||0
29020|NCT02138097|70477|P2|COMPLETED|Overall Study||459722
29021|NCT02138097|70478|P1|COMPLETED|Overall Study||155345
29022|NCT02138097|70477|P2|STARTED|Overall Study||459722
29023|NCT02138097|70478|P1|STARTED|Overall Study||155345
29024|NCT02138006|70670|P2|NOT COMPLETED|Overall Study||0
29025|NCT02138006|70671|P1|NOT COMPLETED|Overall Study||0
29026|NCT02138006|70670|P2|COMPLETED|Overall Study||54
29027|NCT02138006|70671|P1|COMPLETED|Overall Study||48
29028|NCT02138006|70670|P2|STARTED|Overall Study||54
29029|NCT02138006|70671|P1|STARTED|Overall Study||48
29030|NCT02137785|70681|P2|NOT COMPLETED|Overall Study||4
29031|NCT02137785|70682|P1|NOT COMPLETED|Overall Study||3
29032|NCT02137785|70681|P2|COMPLETED|Overall Study||130
29033|NCT02137785|70682|P1|COMPLETED|Overall Study||132
29034|NCT02137785|70681|P2|STARTED|Overall Study||134
29035|NCT02137785|70682|P1|STARTED|Overall Study||135
29036|NCT02137772|70790|P2|NOT COMPLETED|Overall Study||75
29037|NCT02137772|70791|P1|NOT COMPLETED|Overall Study||132
29038|NCT02137772|70790|P2|COMPLETED|Overall Study||119
29039|NCT02137772|70791|P1|COMPLETED|Overall Study||244
29040|NCT02137772|70790|P2|Treated Participants|Overall Study||192
29041|NCT02137772|70791|P1|Treated Participants|Overall Study||373
29042|NCT02137772|70790|P2|STARTED|Overall Study|Randomized participants|194
29043|NCT02137772|70791|P1|STARTED|Overall Study|Randomized participants|376
29044|NCT02137603|70817|P2|NOT COMPLETED|Overall Study||0
29045|NCT02137603|70818|P1|NOT COMPLETED|Overall Study||2
29046|NCT02137603|70817|P2|COMPLETED|Overall Study||18
29047|NCT02137603|70818|P1|COMPLETED|Overall Study||16
29049|NCT02137603|70818|P1|STARTED|Overall Study||18
29050|NCT02137512|70826|P1|NOT COMPLETED|Overall Study||0
29051|NCT02137512|70826|P1|COMPLETED|Overall Study||30
29052|NCT02137512|70826|P1|STARTED|Overall Study||30
29053|NCT02137447|70842|P1|NOT COMPLETED|Overall Study||0
29054|NCT02137447|70842|P1|COMPLETED|Overall Study||10
29055|NCT02137447|70842|P1|STARTED|Overall Study||10
29056|NCT02137382|70847|P2|NOT COMPLETED|Cross-over Period 2||0
29057|NCT02137382|70848|P1|NOT COMPLETED|Cross-over Period 2||0
29058|NCT02137382|70847|P2|COMPLETED|Cross-over Period 2||21
29059|NCT02137382|70848|P1|COMPLETED|Cross-over Period 2||18
29060|NCT02137382|70847|P2|STARTED|Cross-over Period 2||21
29061|NCT02137382|70848|P1|STARTED|Cross-over Period 2||18
29062|NCT02137382|70847|P2|NOT COMPLETED|Wash Out||0
29063|NCT02137382|70848|P1|NOT COMPLETED|Wash Out||0
29064|NCT02137382|70847|P2|COMPLETED|Wash Out||21
29065|NCT02137382|70848|P1|COMPLETED|Wash Out||18
29066|NCT02137382|70847|P2|STARTED|Wash Out||21
29067|NCT02137382|70848|P1|STARTED|Wash Out||18
29068|NCT02137382|70847|P2|NOT COMPLETED|Cross-over Period 1||0
29069|NCT02137382|70848|P1|NOT COMPLETED|Cross-over Period 1||2
29070|NCT02137382|70847|P2|COMPLETED|Cross-over Period 1||21
29071|NCT02137382|70848|P1|COMPLETED|Cross-over Period 1||18
29072|NCT02137382|70847|P2|STARTED|Cross-over Period 1||21
29073|NCT02137382|70848|P1|STARTED|Cross-over Period 1||20
29074|NCT02137226|70868|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
29075|NCT02137226|70869|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
29076|NCT02137226|70870|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
29077|NCT02137226|70871|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
29078|NCT02137226|70872|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
29079|NCT02137226|70868|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
29080|NCT02137226|70869|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
29081|NCT02137226|70870|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
29082|NCT02137226|70871|P2|COMPLETED|Period 2 (Re - Randomization)||0
29083|NCT02137226|70872|P1|COMPLETED|Period 2 (Re - Randomization)||0
29084|NCT02137226|70868|P5|STARTED|Period 2 (Re - Randomization)||147
29085|NCT02137226|70869|P4|STARTED|Period 2 (Re - Randomization)||148
29086|NCT02137226|70870|P3|STARTED|Period 2 (Re - Randomization)||298
29087|NCT02137226|70871|P2|STARTED|Period 2 (Re - Randomization)||0
29088|NCT02137226|70872|P1|STARTED|Period 2 (Re - Randomization)||0
29089|NCT02137226|70868|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
29090|NCT02137226|70869|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
29091|NCT02137226|70870|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
29092|NCT02137226|70871|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
29093|NCT02137226|70872|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
29094|NCT02137226|70868|P5|COMPLETED|Period 1 (Initial Randomization)||0
29095|NCT02137226|70869|P4|COMPLETED|Period 1 (Initial Randomization)||0
29096|NCT02137226|70870|P3|COMPLETED|Period 1 (Initial Randomization)||0
29097|NCT02137226|70871|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
29098|NCT02137226|70872|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
29099|NCT02137226|70868|P5|STARTED|Period 1 (Initial Randomization)||0
29100|NCT02137226|70869|P4|STARTED|Period 1 (Initial Randomization)||0
29101|NCT02137226|70870|P3|STARTED|Period 1 (Initial Randomization)||0
29102|NCT02137226|70871|P2|STARTED|Period 1 (Initial Randomization)||321
29103|NCT02137226|70872|P1|STARTED|Period 1 (Initial Randomization)||324
29104|NCT02136914|70886|P2|NOT COMPLETED|Overall Study||21
29105|NCT02136914|70887|P1|NOT COMPLETED|Overall Study||21
29106|NCT02136914|70886|P2|COMPLETED|Overall Study||42
29107|NCT02136914|70887|P1|COMPLETED|Overall Study||42
29108|NCT02136914|70886|P2|Received Study Drug|Overall Study||63
29109|NCT02136914|70887|P1|Received Study Drug|Overall Study||60
29110|NCT02136914|70886|P2|STARTED|Overall Study||63
29111|NCT02136914|70887|P1|STARTED|Overall Study||63
29112|NCT02136498|70903|P2|NOT COMPLETED|Overall Study||0
29113|NCT02136498|70904|P1|NOT COMPLETED|Overall Study||0
29114|NCT02136498|70903|P2|COMPLETED|Overall Study||33
29115|NCT02136498|70904|P1|COMPLETED|Overall Study||33
29116|NCT02136498|70903|P2|STARTED|Overall Study||33
29117|NCT02136498|70904|P1|STARTED|Overall Study||33
29118|NCT02136420|70916|P10|NOT COMPLETED|Overall Study||0
29119|NCT02136420|70917|P9|NOT COMPLETED|Overall Study||0
29120|NCT02136420|70918|P8|NOT COMPLETED|Overall Study||0
29121|NCT02136420|70919|P7|NOT COMPLETED|Overall Study||0
29122|NCT02136420|70920|P6|NOT COMPLETED|Overall Study||0
29123|NCT02136420|70921|P5|NOT COMPLETED|Overall Study||0
29124|NCT02136420|70922|P4|NOT COMPLETED|Overall Study||0
29125|NCT02136420|70923|P3|NOT COMPLETED|Overall Study||0
29126|NCT02136420|70924|P2|NOT COMPLETED|Overall Study||0
29127|NCT02136420|70925|P1|NOT COMPLETED|Overall Study||1
29128|NCT02136420|70916|P10|COMPLETED|Overall Study||5
29129|NCT02136420|70917|P9|COMPLETED|Overall Study||5
29130|NCT02136420|70918|P8|COMPLETED|Overall Study||0
29131|NCT02136420|70919|P7|COMPLETED|Overall Study||0
29132|NCT02136420|70920|P6|COMPLETED|Overall Study||0
29133|NCT02136420|70921|P5|COMPLETED|Overall Study||10
29134|NCT02136420|70922|P4|COMPLETED|Overall Study||0
29135|NCT02136420|70923|P3|COMPLETED|Overall Study||0
29136|NCT02136420|70924|P2|COMPLETED|Overall Study||0
29137|NCT02136420|70925|P1|COMPLETED|Overall Study||9
29138|NCT02136420|70916|P10|STARTED|Overall Study||5
29139|NCT02136420|70917|P9|STARTED|Overall Study||5
29140|NCT02136420|70918|P8|STARTED|Overall Study||0
29141|NCT02136420|70919|P7|STARTED|Overall Study||0
29142|NCT02136420|70920|P6|STARTED|Overall Study||0
29143|NCT02136420|70921|P5|STARTED|Overall Study||10
29144|NCT02136420|70922|P4|STARTED|Overall Study||0
29145|NCT02136420|70923|P3|STARTED|Overall Study||0
29146|NCT02136420|70924|P2|STARTED|Overall Study||0
29147|NCT02136420|70925|P1|STARTED|Overall Study||10
29148|NCT02136238|70947|P3|NOT COMPLETED|Overall Study||0
29149|NCT02136238|70948|P2|NOT COMPLETED|Overall Study||0
29150|NCT02136238|70949|P1|NOT COMPLETED|Overall Study||0
29151|NCT02136238|70947|P3|COMPLETED|Overall Study||10
29152|NCT02136238|70948|P2|COMPLETED|Overall Study||4
29153|NCT02136238|70949|P1|COMPLETED|Overall Study||4
29154|NCT02136238|70947|P3|STARTED|Overall Study||10
29155|NCT02136238|70948|P2|STARTED|Overall Study||4
29156|NCT02136238|70949|P1|STARTED|Overall Study||4
29157|NCT02136134|70962|P2|NOT COMPLETED|Overall Study||251
29158|NCT02136134|70963|P1|NOT COMPLETED|Overall Study||247
29159|NCT02136134|70962|P2|COMPLETED|Overall Study||0
29160|NCT02136134|70963|P1|COMPLETED|Overall Study||0
29161|NCT02136134|70962|P2|Treated|Overall Study||243
29162|NCT02136134|70963|P1|Treated|Overall Study||237
29163|NCT02136134|70962|P2|STARTED|Overall Study||251
29164|NCT02136134|70963|P1|STARTED|Overall Study||247
29165|NCT02136004|70981|P1|NOT COMPLETED|Overall Study||1
29166|NCT02136004|70981|P1|COMPLETED|Overall Study||219
29167|NCT02136004|70981|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
29168|NCT02135900|70992|P1|NOT COMPLETED|Overall Study||0
29169|NCT02135900|70992|P1|COMPLETED|Overall Study||32
29170|NCT02135900|70992|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
29171|NCT02135848|71001|P2|NOT COMPLETED|Overall Study||1
29172|NCT02135848|71002|P1|NOT COMPLETED|Overall Study||3
29173|NCT02135848|71001|P2|COMPLETED|Overall Study||19
29174|NCT02135848|71002|P1|COMPLETED|Overall Study||23
29175|NCT02135848|71001|P2|STARTED|Overall Study||20
29176|NCT02135848|71002|P1|STARTED|Overall Study||26
29177|NCT02135692|71060|P1|NOT COMPLETED|Overall Study||339
29178|NCT02135692|71060|P1|COMPLETED|Overall Study||0
29179|NCT02135692|71060|P1|STARTED|Overall Study||339
29180|NCT02135614|71079|P2|NOT COMPLETED|Overall Study||5
29181|NCT02135614|71080|P1|NOT COMPLETED|Overall Study||8
29182|NCT02135614|71079|P2|COMPLETED|Overall Study||90
29183|NCT02135614|71080|P1|COMPLETED|Overall Study||86
29184|NCT02135614|71079|P2|STARTED|Overall Study||95
29185|NCT02135614|71080|P1|STARTED|Overall Study||94
29186|NCT02135445|71094|P2|NOT COMPLETED|Overall Study||0
29187|NCT02135445|71095|P1|NOT COMPLETED|Overall Study||2
29188|NCT02135445|71094|P2|COMPLETED|Overall Study||38
29189|NCT02135445|71095|P1|COMPLETED|Overall Study||63
29190|NCT02135445|71094|P2|STARTED|Overall Study||38
29191|NCT02135445|71095|P1|STARTED|Overall Study||65
29192|NCT02135432|71146|P2|NOT COMPLETED|Overall Study||0
29193|NCT02135432|71147|P1|NOT COMPLETED|Overall Study||0
29194|NCT02135432|71146|P2|COMPLETED|Overall Study||4
29195|NCT02135432|71147|P1|COMPLETED|Overall Study||8
29196|NCT02135432|71146|P2|STARTED|Overall Study||4
29197|NCT02135432|71147|P1|STARTED|Overall Study||8
29198|NCT02135029|71162|P3|NOT COMPLETED|Overall Study||3
29199|NCT02135029|71163|P2|NOT COMPLETED|Overall Study||5
29200|NCT02135029|71164|P1|NOT COMPLETED|Overall Study||4
29201|NCT02135029|71162|P3|COMPLETED|Overall Study||34
29202|NCT02135029|71163|P2|COMPLETED|Overall Study||69
29203|NCT02135029|71164|P1|COMPLETED|Overall Study||69
29204|NCT02135029|71162|P3|Treated|Overall Study||36
29205|NCT02135029|71163|P2|Treated|Overall Study||74
29206|NCT02135029|71164|P1|Treated|Overall Study||73
29207|NCT02135029|71162|P3|STARTED|Overall Study||37
29208|NCT02135029|71163|P2|STARTED|Overall Study||74
29209|NCT02135029|71164|P1|STARTED|Overall Study||73
29210|NCT02135016|71247|P3|NOT COMPLETED|Overall Study||0
29211|NCT02135016|71248|P2|NOT COMPLETED|Overall Study||0
29212|NCT02135016|71249|P1|NOT COMPLETED|Overall Study||0
29213|NCT02135016|71247|P3|COMPLETED|Overall Study||15
29214|NCT02135016|71248|P2|COMPLETED|Overall Study||15
29215|NCT02135016|71249|P1|COMPLETED|Overall Study||15
29216|NCT02135016|71247|P3|STARTED|Overall Study||15
29217|NCT02135016|71248|P2|STARTED|Overall Study||15
29218|NCT02135016|71249|P1|STARTED|Overall Study||15
29219|NCT02134977|71269|P1|NOT COMPLETED|Overall Study||102
29220|NCT02134977|71269|P1|COMPLETED|Overall Study||2714
29221|NCT02134977|71269|P1|STARTED|Overall Study||2816
29222|NCT02134951|71292|P2|NOT COMPLETED|Overall Study||0
29223|NCT02134951|71293|P1|NOT COMPLETED|Overall Study||0
29224|NCT02134951|71292|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
29225|NCT02134951|71293|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
29226|NCT02134951|71292|P2|STARTED|Overall Study||20
29227|NCT02134951|71293|P1|STARTED|Overall Study||39
29228|NCT02134925|71303|P2|NOT COMPLETED|Overall Study||6
29229|NCT02134925|71304|P1|NOT COMPLETED|Overall Study||2
29230|NCT02134925|71303|P2|COMPLETED|Overall Study||50
29231|NCT02134925|71304|P1|COMPLETED|Overall Study||52
29232|NCT02134925|71303|P2|STARTED|Overall Study||56
29233|NCT02134925|71304|P1|STARTED|Overall Study||54
29234|NCT02134717|71312|P1|NOT COMPLETED|Overall Study||0
29235|NCT02134717|71312|P1|COMPLETED|Overall Study||3
29236|NCT02134717|71312|P1|STARTED|Overall Study||3
29237|NCT02134587|71318|P1|NOT COMPLETED|Overall Study||30
29238|NCT02134587|71318|P1|COMPLETED|Overall Study||173
29239|NCT02134587|71318|P1|STARTED|Overall Study||203
29240|NCT02134184|71330|P3|NOT COMPLETED|Overall Study||0
29241|NCT02134184|71331|P2|NOT COMPLETED|Overall Study||0
29242|NCT02134184|71332|P1|NOT COMPLETED|Overall Study||0
29243|NCT02134184|71330|P3|COMPLETED|Overall Study||8
29244|NCT02134184|71331|P2|COMPLETED|Overall Study||37
29245|NCT02134184|71332|P1|COMPLETED|Overall Study||33
29246|NCT02134184|71330|P3|STARTED|Overall Study||8
29247|NCT02134184|71331|P2|STARTED|Overall Study||37
29248|NCT02134184|71332|P1|STARTED|Overall Study||33
29249|NCT02134119|71345|P2|NOT COMPLETED|Overall Study||0
29250|NCT02134119|71346|P1|NOT COMPLETED|Overall Study||0
29251|NCT02134119|71345|P2|COMPLETED|Overall Study||15
29252|NCT02134119|71346|P1|COMPLETED|Overall Study||30
29253|NCT02134119|71345|P2|STARTED|Overall Study||15
29254|NCT02134119|71346|P1|STARTED|Overall Study||30
29255|NCT02134015|71386|P2|NOT COMPLETED|Overall Study||74
29256|NCT02134015|71387|P1|NOT COMPLETED|Overall Study||71
29257|NCT02134015|71386|P2|COMPLETED|Overall Study||0
29258|NCT02134015|71387|P1|COMPLETED|Overall Study||0
29259|NCT02134015|71386|P2|STARTED|Overall Study||74
29260|NCT02134015|71387|P1|STARTED|Overall Study||71
29261|NCT02133781|71410|P3|NOT COMPLETED|Overall Study||0
29262|NCT02133781|71411|P2|NOT COMPLETED|Overall Study||0
29263|NCT02133781|71412|P1|NOT COMPLETED|Overall Study||0
29264|NCT02133781|71410|P3|COMPLETED|Overall Study||21
29265|NCT02133781|71411|P2|COMPLETED|Overall Study||24
29266|NCT02133781|71412|P1|COMPLETED|Overall Study||6
29267|NCT02133781|71410|P3|STARTED|Overall Study||21
29268|NCT02133781|71411|P2|STARTED|Overall Study||24
29269|NCT02133781|71412|P1|STARTED|Overall Study||6
29270|NCT02133664|71425|P2|NOT COMPLETED|Overall Study||7
29271|NCT02133664|71426|P1|NOT COMPLETED|Overall Study||5
29272|NCT02133664|71425|P2|COMPLETED|Overall Study||21
29273|NCT02133664|71426|P1|COMPLETED|Overall Study||21
29274|NCT02133664|71425|P2|STARTED|Overall Study||28
29275|NCT02133664|71426|P1|STARTED|Overall Study||26
29276|NCT02133534|71438|P1|NOT COMPLETED|Overall Study||0
29277|NCT02133534|71438|P1|COMPLETED|Overall Study||1
29278|NCT02133534|71438|P1|STARTED|Overall Study||1
29279|NCT02133508|71442|P1|NOT COMPLETED|Overall Study||15
29280|NCT02133508|71442|P1|COMPLETED|Overall Study||141
29281|NCT02133508|71442|P1|STARTED|Overall Study||156
29282|NCT02133352|71450|P1|NOT COMPLETED|Longer Term Extension||6
29283|NCT02133352|71450|P1|COMPLETED|Longer Term Extension||4
29284|NCT02133352|71450|P1|STARTED|Longer Term Extension||10
29285|NCT02133352|71450|P1|NOT COMPLETED|Main Study (180 Day)||0
29286|NCT02133352|71450|P1|COMPLETED|Main Study (180 Day)||10
29287|NCT02133352|71450|P1|STARTED|Main Study (180 Day)||10
29288|NCT02133235|71461|P2|NOT COMPLETED|Overall Study||0
29289|NCT02133235|71462|P1|NOT COMPLETED|Overall Study||0
29290|NCT02133235|71461|P2|COMPLETED|Overall Study||57
29291|NCT02133235|71462|P1|COMPLETED|Overall Study||55
29292|NCT02133235|71461|P2|STARTED|Overall Study||57
29293|NCT02133235|71462|P1|STARTED|Overall Study||55
29294|NCT02133131|71481|P7|NOT COMPLETED|Overall Study||12
29295|NCT02133131|71482|P6|NOT COMPLETED|Overall Study||14
29296|NCT02133131|71483|P5|NOT COMPLETED|Overall Study||15
29297|NCT02133131|71484|P4|NOT COMPLETED|Overall Study||6
29298|NCT02133131|71485|P3|NOT COMPLETED|Overall Study||1
29299|NCT02133131|71486|P2|NOT COMPLETED|Overall Study||5
29300|NCT02133131|71487|P1|NOT COMPLETED|Overall Study||5
29301|NCT02133131|71481|P7|COMPLETED|Overall Study||0
29302|NCT02133131|71482|P6|COMPLETED|Overall Study||0
29303|NCT02133131|71483|P5|COMPLETED|Overall Study||0
29304|NCT02133131|71484|P4|COMPLETED|Overall Study||15
29305|NCT02133131|71485|P3|COMPLETED|Overall Study||19
29306|NCT02133131|71486|P2|COMPLETED|Overall Study||25
29307|NCT02133131|71487|P1|COMPLETED|Overall Study||26
29308|NCT02133131|71481|P7|STARTED|Overall Study||12
29309|NCT02133131|71482|P6|STARTED|Overall Study||14
29310|NCT02133131|71483|P5|STARTED|Overall Study||15
29311|NCT02133131|71484|P4|STARTED|Overall Study||21
29312|NCT02133131|71485|P3|STARTED|Overall Study||20
29313|NCT02133131|71486|P2|STARTED|Overall Study||30
29314|NCT02133131|71487|P1|STARTED|Overall Study||31
29315|NCT02133066|71526|P2|NOT COMPLETED|Overall Study||0
29316|NCT02133066|71527|P1|NOT COMPLETED|Overall Study||0
29317|NCT02133066|71526|P2|COMPLETED|Overall Study||64
29318|NCT02133066|71527|P1|COMPLETED|Overall Study||64
29319|NCT02133066|71526|P2|STARTED|Overall Study||64
29320|NCT02133066|71527|P1|STARTED|Overall Study||64
29321|NCT02132949|71541|P2|NOT COMPLETED|Adjuvant Treatment Period||167
29322|NCT02132949|71542|P1|NOT COMPLETED|Adjuvant Treatment Period||149
29323|NCT02132949|71541|P2|COMPLETED|Adjuvant Treatment Period||23
29324|NCT02132949|71542|P1|COMPLETED|Adjuvant Treatment Period||29
29415|NCT02131662|71757|P1|COMPLETED|Overall Study||54
29416|NCT02131662|71753|P5|Completed Follow-up|Overall Study||44
29325|NCT02132949|71541|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
29326|NCT02132949|71542|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
29327|NCT02132949|71541|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
29328|NCT02132949|71542|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
29329|NCT02132949|71541|P2|COMPLETED|Neoadjuvant Treatment Period||189
29330|NCT02132949|71542|P1|COMPLETED|Neoadjuvant Treatment Period||182
29331|NCT02132949|71541|P2|No Treatment|Neoadjuvant Treatment Period||3
29332|NCT02132949|71542|P1|No Treatment|Neoadjuvant Treatment Period||1
29333|NCT02132949|71541|P2|STARTED|Neoadjuvant Treatment Period||201
29334|NCT02132949|71542|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
29335|NCT02132936|71574|P4|NOT COMPLETED|Overall Study||14
29336|NCT02132936|71575|P3|NOT COMPLETED|Overall Study||14
29337|NCT02132936|71576|P2|NOT COMPLETED|Overall Study||9
29338|NCT02132936|71577|P1|NOT COMPLETED|Overall Study||10
29339|NCT02132936|71574|P4|COMPLETED|Overall Study||29
29340|NCT02132936|71575|P3|COMPLETED|Overall Study||174
29341|NCT02132936|71576|P2|COMPLETED|Overall Study||38
29342|NCT02132936|71577|P1|COMPLETED|Overall Study||175
29343|NCT02132936|71574|P4|STARTED|Overall Study||43
29344|NCT02132936|71575|P3|STARTED|Overall Study||188
29345|NCT02132936|71576|P2|STARTED|Overall Study||47
29346|NCT02132936|71577|P1|STARTED|Overall Study||185
29347|NCT02132884|71595|P2|NOT COMPLETED|Overall Study||0
29348|NCT02132884|71596|P1|NOT COMPLETED|Overall Study||0
29349|NCT02132884|71595|P2|COMPLETED|Overall Study||0
29350|NCT02132884|71596|P1|COMPLETED|Overall Study||0
29351|NCT02132884|71595|P2|STARTED|Overall Study||0
29352|NCT02132884|71596|P1|STARTED|Overall Study||0
29353|NCT02132832|71604|P2|NOT COMPLETED|Overall Study||7
29354|NCT02132832|71605|P1|NOT COMPLETED|Overall Study||3
29355|NCT02132832|71604|P2|COMPLETED|Overall Study||16
29356|NCT02132832|71605|P1|COMPLETED|Overall Study||16
29357|NCT02132832|71604|P2|STARTED|Overall Study||23
29358|NCT02132832|71605|P1|STARTED|Overall Study||19
29359|NCT02132767|71635|P2|NOT COMPLETED|Overall Study||15
29360|NCT02132767|71636|P1|NOT COMPLETED|Overall Study||17
29361|NCT02132767|71635|P2|COMPLETED|Overall Study||246
29362|NCT02132767|71636|P1|COMPLETED|Overall Study||245
29363|NCT02132767|71635|P2|STARTED|Overall Study||261
29364|NCT02132767|71636|P1|STARTED|Overall Study||262
29365|NCT02132637|71658|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
29366|NCT02132637|71659|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
29367|NCT02132637|71658|P2|COMPLETED|Study Period 2 (Crossover)||29
29368|NCT02132637|71659|P1|COMPLETED|Study Period 2 (Crossover)||31
29369|NCT02132637|71658|P2|STARTED|Study Period 2 (Crossover)||30
29370|NCT02132637|71659|P1|STARTED|Study Period 2 (Crossover)||33
29371|NCT02132637|71658|P2|NOT COMPLETED|Study Period 1||4
29372|NCT02132637|71659|P1|NOT COMPLETED|Study Period 1||1
29373|NCT02132637|71658|P2|COMPLETED|Study Period 1||30
29374|NCT02132637|71659|P1|COMPLETED|Study Period 1||33
29375|NCT02132637|71658|P2|Received at Least One Dose of Study Drug|Study Period 1||34
29376|NCT02132637|71659|P1|Received at Least One Dose of Study Drug|Study Period 1||34
29377|NCT02132637|71658|P2|STARTED|Study Period 1||34
29378|NCT02132637|71659|P1|STARTED|Study Period 1||34
29379|NCT02132611|71683|P1|NOT COMPLETED|Overall Study||2
29380|NCT02132611|71683|P1|COMPLETED|Overall Study||98
29381|NCT02132611|71683|P1|STARTED|Overall Study||100
29382|NCT02132572|71688|P1|NOT COMPLETED|Overall Study||0
29383|NCT02132572|71688|P1|COMPLETED|Overall Study||201
29384|NCT02132572|71688|P1|STARTED|Overall Study||201
29385|NCT02132468|71692|P1|NOT COMPLETED|Overall Study||7
29386|NCT02132468|71692|P1|COMPLETED|Overall Study||11
29387|NCT02132468|71692|P1|STARTED|Overall Study||18
29388|NCT02132247|71701|P2|NOT COMPLETED|Overall Study||0
29389|NCT02132247|71702|P1|NOT COMPLETED|Overall Study||1
29390|NCT02132247|71701|P2|COMPLETED|Overall Study||52
29391|NCT02132247|71702|P1|COMPLETED|Overall Study||51
29392|NCT02132247|71701|P2|STARTED|Overall Study||52
29393|NCT02132247|71702|P1|STARTED|Overall Study||52
29394|NCT02132169|71716|P2|NOT COMPLETED|Overall Study||9
29395|NCT02132169|71717|P1|NOT COMPLETED|Overall Study||15
29396|NCT02132169|71716|P2|COMPLETED|Overall Study||162
29397|NCT02132169|71717|P1|COMPLETED|Overall Study||326
29398|NCT02132169|71716|P2|STARTED|Overall Study||171
29399|NCT02132169|71717|P1|STARTED|Overall Study||341
29400|NCT02132117|71731|P2|NOT COMPLETED|Overall Study||5
29401|NCT02132117|71732|P1|NOT COMPLETED|Overall Study||11
29402|NCT02132117|71731|P2|COMPLETED|Overall Study||216
29403|NCT02132117|71732|P1|COMPLETED|Overall Study||213
29404|NCT02132117|71731|P2|STARTED|Overall Study||221
29405|NCT02132117|71732|P1|STARTED|Overall Study||224
29406|NCT02131662|71753|P5|NOT COMPLETED|Overall Study||18
29407|NCT02131662|71754|P4|NOT COMPLETED|Overall Study||21
29408|NCT02131662|71755|P3|NOT COMPLETED|Overall Study||7
29409|NCT02131662|71756|P2|NOT COMPLETED|Overall Study||14
29410|NCT02131662|71757|P1|NOT COMPLETED|Overall Study||8
29411|NCT02131662|71753|P5|COMPLETED|Overall Study||43
29412|NCT02131662|71754|P4|COMPLETED|Overall Study||41
29413|NCT02131662|71755|P3|COMPLETED|Overall Study||56
29414|NCT02131662|71756|P2|COMPLETED|Overall Study||47
29417|NCT02131662|71754|P4|Completed Follow-up|Overall Study||42
29418|NCT02131662|71755|P3|Completed Follow-up|Overall Study||56
29419|NCT02131662|71756|P2|Completed Follow-up|Overall Study||47
29420|NCT02131662|71757|P1|Completed Follow-up|Overall Study||54
29421|NCT02131662|71753|P5|Completed Treatment|Overall Study||52
29422|NCT02131662|71754|P4|Completed Treatment|Overall Study||56
29423|NCT02131662|71755|P3|Completed Treatment|Overall Study||61
29424|NCT02131662|71756|P2|Completed Treatment|Overall Study||60
29425|NCT02131662|71757|P1|Completed Treatment|Overall Study||57
29426|NCT02131662|71753|P5|Treated|Overall Study||58
29427|NCT02131662|71754|P4|Treated|Overall Study||60
29428|NCT02131662|71755|P3|Treated|Overall Study||61
29429|NCT02131662|71756|P2|Treated|Overall Study||61
29430|NCT02131662|71757|P1|Treated|Overall Study||60
29431|NCT02131662|71753|P5|STARTED|Overall Study||61
29432|NCT02131662|71754|P4|STARTED|Overall Study||62
29433|NCT02131662|71755|P3|STARTED|Overall Study||63
29434|NCT02131662|71756|P2|STARTED|Overall Study||61
29435|NCT02131662|71757|P1|STARTED|Overall Study||62
29436|NCT02131636|71803|P2|NOT COMPLETED|Overall Study||5
29437|NCT02131636|71804|P1|NOT COMPLETED|Overall Study||12
29438|NCT02131636|71803|P2|COMPLETED|Overall Study||213
29439|NCT02131636|71804|P1|COMPLETED|Overall Study||210
29440|NCT02131636|71803|P2|STARTED|Overall Study||218
29441|NCT02131636|71804|P1|STARTED|Overall Study||222
29442|NCT02131532|71820|P1|NOT COMPLETED|Overall Study||4
29443|NCT02131532|71820|P1|COMPLETED|Overall Study||8
29444|NCT02131532|71820|P1|STARTED|Overall Study||12
29445|NCT02131402|71839|P1|NOT COMPLETED|Overall Study||0
29446|NCT02131402|71839|P1|COMPLETED|Overall Study||60
29447|NCT02131402|71839|P1|STARTED|Overall Study||60
29448|NCT02131324|71912|P2|NOT COMPLETED|Overall Study||3
29449|NCT02131324|71913|P1|NOT COMPLETED|Overall Study||2
29450|NCT02131324|71912|P2|COMPLETED|Overall Study||23
29451|NCT02131324|71913|P1|COMPLETED|Overall Study||22
29452|NCT02131324|71912|P2|Analyzed|Overall Study||24
29453|NCT02131324|71913|P1|Analyzed|Overall Study||22
29454|NCT02131324|71912|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
29455|NCT02131324|71913|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
29456|NCT02131311|71919|P1|NOT COMPLETED|Overall Study||4
29457|NCT02131311|71919|P1|COMPLETED|Overall Study||86
29458|NCT02131311|71919|P1|STARTED|Overall Study||90
29459|NCT02131272|71931|P2|NOT COMPLETED|Overall Study||2
29460|NCT02131272|71932|P1|NOT COMPLETED|Overall Study||1
29461|NCT02131272|71931|P2|COMPLETED|Overall Study||20
29462|NCT02131272|71932|P1|COMPLETED|Overall Study||19
29463|NCT02131272|71931|P2|STARTED|Overall Study||22
29464|NCT02131272|71932|P1|STARTED|Overall Study||20
29465|NCT02131233|71952|P2|NOT COMPLETED|Overall Study||42
29466|NCT02131233|71953|P1|NOT COMPLETED|Overall Study||66
29467|NCT02131233|71952|P2|COMPLETED|Overall Study|Completed to Week 96|227
29468|NCT02131233|71953|P1|COMPLETED|Overall Study|Completed to Week 96|467
29469|NCT02131233|71952|P2|Treated|Overall Study||266
29470|NCT02131233|71953|P1|Treated|Overall Study||531
29471|NCT02131233|71952|P2|STARTED|Overall Study|Enrolled participants|269
29472|NCT02131233|71953|P1|STARTED|Overall Study|Enrolled participants|533
29473|NCT02131064|71987|P2|NOT COMPLETED|Overall Study||223
29474|NCT02131064|71988|P1|NOT COMPLETED|Overall Study||221
29475|NCT02131064|71987|P2|COMPLETED|Overall Study||0
29476|NCT02131064|71988|P1|COMPLETED|Overall Study||0
29477|NCT02131064|71987|P2|STARTED|Overall Study||223
29478|NCT02131064|71988|P1|STARTED|Overall Study||221
29479|NCT02130999|72020|P2|NOT COMPLETED|Overall Study||0
29480|NCT02130999|72021|P1|NOT COMPLETED|Overall Study||0
29481|NCT02130999|72020|P2|COMPLETED|Overall Study||8
29482|NCT02130999|72021|P1|COMPLETED|Overall Study||6
29483|NCT02130999|72020|P2|STARTED|Overall Study||8
29484|NCT02130999|72021|P1|STARTED|Overall Study||6
29485|NCT02130635|72056|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
29486|NCT02130635|72057|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
29487|NCT02130635|72058|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
29488|NCT02130635|72059|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
29489|NCT02130635|72060|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
29490|NCT02130635|72061|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
29491|NCT02130635|72062|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
29492|NCT02130635|72063|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
29493|NCT02130635|72064|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
29494|NCT02130635|72056|P9|COMPLETED|Part B-Dose-Response Relationship||5
29495|NCT02130635|72057|P8|COMPLETED|Part B-Dose-Response Relationship||5
29496|NCT02130635|72058|P7|COMPLETED|Part B-Dose-Response Relationship||6
29497|NCT02130635|72059|P6|COMPLETED|Part B-Dose-Response Relationship||5
29498|NCT02130635|72060|P5|COMPLETED|Part B-Dose-Response Relationship||5
29499|NCT02130635|72061|P4|COMPLETED|Part B-Dose-Response Relationship||5
29500|NCT02130635|72062|P3|COMPLETED|Part B-Dose-Response Relationship||5
29501|NCT02130635|72063|P2|COMPLETED|Part B-Dose-Response Relationship||0
29502|NCT02130635|72064|P1|COMPLETED|Part B-Dose-Response Relationship||0
29503|NCT02130635|72056|P9|STARTED|Part B-Dose-Response Relationship||5
29504|NCT02130635|72057|P8|STARTED|Part B-Dose-Response Relationship||5
29505|NCT02130635|72058|P7|STARTED|Part B-Dose-Response Relationship||6
29506|NCT02130635|72059|P6|STARTED|Part B-Dose-Response Relationship||5
29507|NCT02130635|72060|P5|STARTED|Part B-Dose-Response Relationship||5
29508|NCT02130635|72061|P4|STARTED|Part B-Dose-Response Relationship||5
29509|NCT02130635|72062|P3|STARTED|Part B-Dose-Response Relationship||5
29510|NCT02130635|72063|P2|STARTED|Part B-Dose-Response Relationship||0
29511|NCT02130635|72064|P1|STARTED|Part B-Dose-Response Relationship||0
29512|NCT02130635|72056|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
29513|NCT02130635|72057|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
29514|NCT02130635|72058|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
29515|NCT02130635|72059|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
29516|NCT02130635|72060|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
29517|NCT02130635|72061|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
29518|NCT02130635|72062|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
29519|NCT02130635|72063|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
29520|NCT02130635|72064|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
29521|NCT02130635|72056|P9|COMPLETED|Part A-Safety and Tolerability||0
29522|NCT02130635|72057|P8|COMPLETED|Part A-Safety and Tolerability||0
29523|NCT02130635|72058|P7|COMPLETED|Part A-Safety and Tolerability||0
29524|NCT02130635|72059|P6|COMPLETED|Part A-Safety and Tolerability||0
29525|NCT02130635|72060|P5|COMPLETED|Part A-Safety and Tolerability||0
29526|NCT02130635|72061|P4|COMPLETED|Part A-Safety and Tolerability||0
29527|NCT02130635|72062|P3|COMPLETED|Part A-Safety and Tolerability||0
29528|NCT02130635|72063|P2|COMPLETED|Part A-Safety and Tolerability||21
29529|NCT02130635|72064|P1|COMPLETED|Part A-Safety and Tolerability||7
29530|NCT02130635|72056|P9|STARTED|Part A-Safety and Tolerability||0
29531|NCT02130635|72057|P8|STARTED|Part A-Safety and Tolerability||0
29532|NCT02130635|72058|P7|STARTED|Part A-Safety and Tolerability||0
29533|NCT02130635|72059|P6|STARTED|Part A-Safety and Tolerability||0
29534|NCT02130635|72060|P5|STARTED|Part A-Safety and Tolerability||0
29535|NCT02130635|72061|P4|STARTED|Part A-Safety and Tolerability||0
29536|NCT02130635|72062|P3|STARTED|Part A-Safety and Tolerability||0
29537|NCT02130635|72063|P2|STARTED|Part A-Safety and Tolerability||21
29538|NCT02130635|72064|P1|STARTED|Part A-Safety and Tolerability||7
29539|NCT02130622|72238|P2|NOT COMPLETED|Overall Study||0
29540|NCT02130622|72239|P1|NOT COMPLETED|Overall Study||0
29541|NCT02130622|72238|P2|COMPLETED|Overall Study||1
29542|NCT02130622|72239|P1|COMPLETED|Overall Study||2
29543|NCT02130622|72238|P2|STARTED|Overall Study||1
29544|NCT02130622|72239|P1|STARTED|Overall Study||2
29545|NCT02130284|72251|P1|NOT COMPLETED|Overall Study||9
29546|NCT02130284|72251|P1|COMPLETED|Overall Study||71
29547|NCT02130284|72251|P1|STARTED|Overall Study||80
29548|NCT02130258|72264|P2|NOT COMPLETED|Overall Study||0
29549|NCT02130258|72265|P1|NOT COMPLETED|Overall Study||0
29550|NCT02130258|72264|P2|COMPLETED|Overall Study||11
29551|NCT02130258|72265|P1|COMPLETED|Overall Study||9
29552|NCT02130258|72264|P2|STARTED|Overall Study||11
29553|NCT02130258|72265|P1|STARTED|Overall Study||9
29554|NCT02130193|72277|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
29555|NCT02130193|72278|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
29556|NCT02130193|72279|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
29557|NCT02130193|72277|P3|COMPLETED|Part B: 52-week Double-blind Period||37
29558|NCT02130193|72278|P2|COMPLETED|Part B: 52-week Double-blind Period||38
29559|NCT02130193|72279|P1|COMPLETED|Part B: 52-week Double-blind Period||0
29560|NCT02130193|72277|P3|STARTED|Part B: 52-week Double-blind Period||45
29561|NCT02130193|72278|P2|STARTED|Part B: 52-week Double-blind Period||48
29562|NCT02130193|72279|P1|STARTED|Part B: 52-week Double-blind Period||0
29563|NCT02130193|72277|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
29564|NCT02130193|72278|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
29565|NCT02130193|72279|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
29566|NCT02130193|72277|P3|COMPLETED|Part A: 4-week Open-label Period||0
29567|NCT02130193|72278|P2|COMPLETED|Part A: 4-week Open-label Period||0
29568|NCT02130193|72279|P1|COMPLETED|Part A: 4-week Open-label Period||9
29569|NCT02130193|72277|P3|STARTED|Part A: 4-week Open-label Period||0
29570|NCT02130193|72278|P2|STARTED|Part A: 4-week Open-label Period||0
29571|NCT02130193|72279|P1|STARTED|Part A: 4-week Open-label Period||9
29572|NCT02130063|72345|P2|NOT COMPLETED|Overall Study||17
29573|NCT02130063|72346|P1|NOT COMPLETED|Overall Study||25
29574|NCT02130063|72345|P2|COMPLETED|Overall Study||152
29575|NCT02130063|72346|P1|COMPLETED|Overall Study||317
29576|NCT02130063|72345|P2|STARTED|Overall Study||169
29577|NCT02130063|72346|P1|STARTED|Overall Study||342
29578|NCT02129777|72363|P7|NOT COMPLETED|Open-Label Period||48
29579|NCT02129777|72364|P6|NOT COMPLETED|Open-Label Period||12
29580|NCT02129777|72365|P5|NOT COMPLETED|Open-Label Period||0
29581|NCT02129777|72366|P4|NOT COMPLETED|Open-Label Period||0
29582|NCT02129777|72367|P3|NOT COMPLETED|Open-Label Period||0
29583|NCT02129777|72368|P2|NOT COMPLETED|Open-Label Period||0
29584|NCT02129777|72369|P1|NOT COMPLETED|Open-Label Period||0
29585|NCT02129777|72363|P7|COMPLETED|Open-Label Period||0
29586|NCT02129777|72364|P6|COMPLETED|Open-Label Period||0
29587|NCT02129777|72365|P5|COMPLETED|Open-Label Period||0
29588|NCT02129777|72366|P4|COMPLETED|Open-Label Period||0
29589|NCT02129777|72367|P3|COMPLETED|Open-Label Period||0
29590|NCT02129777|72368|P2|COMPLETED|Open-Label Period||0
29591|NCT02129777|72369|P1|COMPLETED|Open-Label Period||0
29592|NCT02129777|72363|P7|STARTED|Open-Label Period||48
29593|NCT02129777|72364|P6|STARTED|Open-Label Period||12
29594|NCT02129777|72365|P5|STARTED|Open-Label Period||0
29595|NCT02129777|72366|P4|STARTED|Open-Label Period||0
29596|NCT02129777|72367|P3|STARTED|Open-Label Period||0
29597|NCT02129777|72368|P2|STARTED|Open-Label Period||0
29598|NCT02129777|72369|P1|STARTED|Open-Label Period||0
29599|NCT02129777|72363|P7|NOT COMPLETED|Double-Blind Period||0
29600|NCT02129777|72364|P6|NOT COMPLETED|Double-Blind Period||0
29601|NCT02129777|72365|P5|NOT COMPLETED|Double-Blind Period||7
29602|NCT02129777|72366|P4|NOT COMPLETED|Double-Blind Period||7
29603|NCT02129777|72367|P3|NOT COMPLETED|Double-Blind Period||4
29604|NCT02129777|72368|P2|NOT COMPLETED|Double-Blind Period||8
29605|NCT02129777|72369|P1|NOT COMPLETED|Double-Blind Period||7
29606|NCT02129777|72363|P7|COMPLETED|Double-Blind Period||0
29607|NCT02129777|72364|P6|COMPLETED|Double-Blind Period||0
29608|NCT02129777|72365|P5|COMPLETED|Double-Blind Period||18
29609|NCT02129777|72366|P4|COMPLETED|Double-Blind Period||18
29610|NCT02129777|72367|P3|COMPLETED|Double-Blind Period||20
29611|NCT02129777|72368|P2|COMPLETED|Double-Blind Period||16
29612|NCT02129777|72369|P1|COMPLETED|Double-Blind Period||17
29613|NCT02129777|72363|P7|STARTED|Double-Blind Period||0
29614|NCT02129777|72364|P6|STARTED|Double-Blind Period||0
29615|NCT02129777|72365|P5|STARTED|Double-Blind Period||25
29616|NCT02129777|72366|P4|STARTED|Double-Blind Period||25
29617|NCT02129777|72367|P3|STARTED|Double-Blind Period||24
29618|NCT02129777|72368|P2|STARTED|Double-Blind Period||24
29619|NCT02129777|72369|P1|STARTED|Double-Blind Period||24
29620|NCT02129725|72475|P2|NOT COMPLETED|Overall Study||3
29621|NCT02129725|72476|P1|NOT COMPLETED|Overall Study||2
29622|NCT02129725|72475|P2|COMPLETED|Overall Study||4
29623|NCT02129725|72476|P1|COMPLETED|Overall Study||6
29624|NCT02129725|72475|P2|STARTED|Overall Study||7
29625|NCT02129725|72476|P1|STARTED|Overall Study||8
29626|NCT02129608|72485|P3|NOT COMPLETED|Overall Study||3
29627|NCT02129608|72486|P2|NOT COMPLETED|Overall Study||1
29628|NCT02129608|72487|P1|NOT COMPLETED|Overall Study||0
29629|NCT02129608|72485|P3|COMPLETED|Overall Study||12
29630|NCT02129608|72486|P2|COMPLETED|Overall Study||13
29631|NCT02129608|72487|P1|COMPLETED|Overall Study||15
29632|NCT02129608|72485|P3|End of Treatment|Overall Study||12
29633|NCT02129608|72486|P2|End of Treatment|Overall Study||13
29634|NCT02129608|72487|P1|End of Treatment|Overall Study||15
29635|NCT02129608|72485|P3|STARTED|Overall Study||15
29636|NCT02129608|72486|P2|STARTED|Overall Study||14
29637|NCT02129608|72487|P1|STARTED|Overall Study||15
29638|NCT02129192|72500|P2|NOT COMPLETED|Period 5||0
29639|NCT02129192|72501|P1|NOT COMPLETED|Period 5||0
29640|NCT02129192|72500|P2|COMPLETED|Period 5||0
29641|NCT02129192|72501|P1|COMPLETED|Period 5||36
29642|NCT02129192|72500|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
29643|NCT02129192|72501|P1|STARTED|Period 5||36
29644|NCT02129192|72500|P2|NOT COMPLETED|Period 4 Including Washout Period||0
29645|NCT02129192|72501|P1|NOT COMPLETED|Period 4 Including Washout Period||0
29646|NCT02129192|72500|P2|COMPLETED|Period 4 Including Washout Period||35
29647|NCT02129192|72501|P1|COMPLETED|Period 4 Including Washout Period||36
29648|NCT02129192|72500|P2|STARTED|Period 4 Including Washout Period||35
29649|NCT02129192|72501|P1|STARTED|Period 4 Including Washout Period||36
29650|NCT02129192|72500|P2|NOT COMPLETED|Period 3 Including Washout Period||0
29651|NCT02129192|72501|P1|NOT COMPLETED|Period 3 Including Washout Period||0
29652|NCT02129192|72500|P2|COMPLETED|Period 3 Including Washout Period||35
29653|NCT02129192|72501|P1|COMPLETED|Period 3 Including Washout Period||36
29654|NCT02129192|72500|P2|STARTED|Period 3 Including Washout Period||35
29655|NCT02129192|72501|P1|STARTED|Period 3 Including Washout Period||36
29656|NCT02129192|72500|P2|NOT COMPLETED|Period 2 Including Washout Period||0
29657|NCT02129192|72501|P1|NOT COMPLETED|Period 2 Including Washout Period||0
29658|NCT02129192|72500|P2|COMPLETED|Period 2 Including Washout Period||35
29659|NCT02129192|72501|P1|COMPLETED|Period 2 Including Washout Period||36
29660|NCT02129192|72500|P2|STARTED|Period 2 Including Washout Period||35
29661|NCT02129192|72501|P1|STARTED|Period 2 Including Washout Period||36
29662|NCT02129192|72500|P2|NOT COMPLETED|Period 1 Including Washout Period||1
29663|NCT02129192|72501|P1|NOT COMPLETED|Period 1 Including Washout Period||0
29664|NCT02129192|72500|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
29665|NCT02129192|72501|P1|COMPLETED|Period 1 Including Washout Period||36
29666|NCT02129192|72500|P2|STARTED|Period 1 Including Washout Period||36
29667|NCT02129192|72501|P1|STARTED|Period 1 Including Washout Period||36
29668|NCT02129062|72518|P1|NOT COMPLETED|Overall Study||3
29669|NCT02129062|72518|P1|COMPLETED|Overall Study||0
29670|NCT02129062|72518|P1|STARTED|Overall Study||3
29671|NCT02128997|72525|P2|NOT COMPLETED|Overall Study||11
29672|NCT02128997|72526|P1|NOT COMPLETED|Overall Study||6
29673|NCT02128997|72525|P2|COMPLETED|Overall Study||58
29674|NCT02128997|72526|P1|COMPLETED|Overall Study||61
29675|NCT02128997|72525|P2|STARTED|Overall Study||69
29676|NCT02128997|72526|P1|STARTED|Overall Study||67
29677|NCT02128932|72541|P3|NOT COMPLETED|Overall Study||18
29678|NCT02128932|72542|P2|NOT COMPLETED|Overall Study||19
29679|NCT02128932|72543|P1|NOT COMPLETED|Overall Study||27
29680|NCT02128932|72541|P3|COMPLETED|Overall Study||342
29681|NCT02128932|72542|P2|COMPLETED|Overall Study||341
29682|NCT02128932|72543|P1|COMPLETED|Overall Study||335
29683|NCT02128932|72541|P3|STARTED|Overall Study||360
29684|NCT02128932|72542|P2|STARTED|Overall Study||360
29685|NCT02128932|72543|P1|STARTED|Overall Study||362
29686|NCT02128919|72574|P2|NOT COMPLETED|Overall Study||1
29687|NCT02128919|72575|P1|NOT COMPLETED|Overall Study||3
29688|NCT02128919|72574|P2|COMPLETED|Overall Study||15
29689|NCT02128919|72575|P1|COMPLETED|Overall Study||14
29690|NCT02128919|72574|P2|STARTED|Overall Study||16
29691|NCT02128919|72575|P1|STARTED|Overall Study||17
29692|NCT02128867|72588|P3|NOT COMPLETED|Overall Study||4
29693|NCT02128867|72589|P2|NOT COMPLETED|Overall Study||2
29694|NCT02128867|72590|P1|NOT COMPLETED|Overall Study||3
29695|NCT02128867|72588|P3|COMPLETED|Overall Study||50
29696|NCT02128867|72589|P2|COMPLETED|Overall Study||50
29697|NCT02128867|72590|P1|COMPLETED|Overall Study||50
29698|NCT02128867|72588|P3|STARTED|Overall Study||54
29699|NCT02128867|72589|P2|STARTED|Overall Study||52
29700|NCT02128867|72590|P1|STARTED|Overall Study||53
29701|NCT02128542|72600|P2|NOT COMPLETED|Overall Study||0
29702|NCT02128542|72601|P1|NOT COMPLETED|Overall Study||4
29703|NCT02128542|72600|P2|COMPLETED|Overall Study||19
29704|NCT02128542|72601|P1|COMPLETED|Overall Study||43
29705|NCT02128542|72600|P2|STARTED|Overall Study||19
29706|NCT02128542|72601|P1|STARTED|Overall Study||47
29707|NCT02128490|72619|P5|NOT COMPLETED|Overall Study||7
29708|NCT02128490|72620|P4|NOT COMPLETED|Overall Study||6
29709|NCT02128490|72621|P3|NOT COMPLETED|Overall Study||5
29710|NCT02128490|72622|P2|NOT COMPLETED|Overall Study||6
29711|NCT02128490|72623|P1|NOT COMPLETED|Overall Study||5
29712|NCT02128490|72619|P5|COMPLETED|Overall Study||31
29713|NCT02128490|72620|P4|COMPLETED|Overall Study||31
29714|NCT02128490|72621|P3|COMPLETED|Overall Study||34
29715|NCT02128490|72622|P2|COMPLETED|Overall Study||31
29716|NCT02128490|72623|P1|COMPLETED|Overall Study||33
29717|NCT02128490|72619|P5|STARTED|Overall Study||38
29718|NCT02128490|72620|P4|STARTED|Overall Study||37
29719|NCT02128490|72621|P3|STARTED|Overall Study||39
29720|NCT02128490|72622|P2|STARTED|Overall Study||37
29721|NCT02128490|72623|P1|STARTED|Overall Study||38
29722|NCT02128269|72645|P1|NOT COMPLETED|Follow-up||0
29723|NCT02128269|72645|P1|COMPLETED|Follow-up||9
29724|NCT02128269|72645|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
29725|NCT02128269|72645|P1|NOT COMPLETED|Treatment Period||2
29726|NCT02128269|72645|P1|COMPLETED|Treatment Period||7
29727|NCT02128269|72645|P1|STARTED|Treatment Period||9
29728|NCT02128217|72651|P2|NOT COMPLETED|Overall Study||1
29729|NCT02128217|72652|P1|NOT COMPLETED|Overall Study||0
29730|NCT02128217|72651|P2|COMPLETED|Overall Study||26
29731|NCT02128217|72652|P1|COMPLETED|Overall Study||17
29732|NCT02128217|72651|P2|STARTED|Overall Study||27
29733|NCT02128217|72652|P1|STARTED|Overall Study||17
29734|NCT02127892|72698|P4|NOT COMPLETED|Overall Study||0
29735|NCT02127892|72699|P3|NOT COMPLETED|Overall Study||0
29736|NCT02127892|72700|P2|NOT COMPLETED|Overall Study||1
29737|NCT02127892|72701|P1|NOT COMPLETED|Overall Study||1
29738|NCT02127892|72698|P4|COMPLETED|Overall Study||0
29739|NCT02127892|72699|P3|COMPLETED|Overall Study||0
29740|NCT02127892|72700|P2|COMPLETED|Overall Study||1
29741|NCT02127892|72701|P1|COMPLETED|Overall Study||6
29742|NCT02127892|72698|P4|STARTED|Overall Study||0
29743|NCT02127892|72699|P3|STARTED|Overall Study||0
29744|NCT02127892|72700|P2|STARTED|Overall Study||2
29745|NCT02127892|72701|P1|STARTED|Overall Study||7
29746|NCT02127710|72730|P3|NOT COMPLETED|Overall Study||0
29747|NCT02127710|72731|P2|NOT COMPLETED|Overall Study||0
29748|NCT02127710|72732|P1|NOT COMPLETED|Overall Study||0
29749|NCT02127710|72730|P3|COMPLETED|Overall Study||19
29750|NCT02127710|72731|P2|COMPLETED|Overall Study||46
29751|NCT02127710|72732|P1|COMPLETED|Overall Study||44
29752|NCT02127710|72730|P3|STARTED|Overall Study||19
29753|NCT02127710|72731|P2|STARTED|Overall Study||46
29754|NCT02127710|72732|P1|STARTED|Overall Study||44
29755|NCT02127632|72755|P2|NOT COMPLETED|Overall Study||0
29756|NCT02127632|72756|P1|NOT COMPLETED|Overall Study||0
29757|NCT02127632|72755|P2|COMPLETED|Overall Study||50
29758|NCT02127632|72756|P1|COMPLETED|Overall Study||50
29759|NCT02127632|72755|P2|STARTED|Overall Study||50
29760|NCT02127632|72756|P1|STARTED|Overall Study||50
29761|NCT02127567|72766|P1|NOT COMPLETED|Overall Study||0
29762|NCT02127567|72766|P1|COMPLETED|Overall Study||41
29763|NCT02127567|72766|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
29764|NCT02127372|72788|P2|NOT COMPLETED|Overall Study||0
29765|NCT02127372|72789|P1|NOT COMPLETED|Overall Study||1
29766|NCT02127372|72788|P2|COMPLETED|Overall Study||28
29767|NCT02127372|72789|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
29768|NCT02127372|72788|P2|Started Study Treatment|Overall Study||28
29769|NCT02127372|72789|P1|Started Study Treatment|Overall Study||15
29770|NCT02127372|72788|P2|STARTED|Overall Study|Signed Consent|28
29771|NCT02127372|72789|P1|STARTED|Overall Study|Signed Consent|15
29772|NCT02127307|72799|P1|NOT COMPLETED|Overall Study||308
29773|NCT02127307|72799|P1|COMPLETED|Overall Study||656
29774|NCT02127307|72799|P1|STARTED|Overall Study||964
29775|NCT02127281|72805|P2|NOT COMPLETED|Overall Study||0
29776|NCT02127281|72806|P1|NOT COMPLETED|Overall Study||1
29777|NCT02127281|72805|P2|COMPLETED|Overall Study||80
29778|NCT02127281|72806|P1|COMPLETED|Overall Study||79
29779|NCT02127281|72805|P2|STARTED|Overall Study||80
29780|NCT02127281|72806|P1|STARTED|Overall Study||80
29781|NCT02126839|72834|P2|NOT COMPLETED|Overall Study||14
29782|NCT02126839|72835|P1|NOT COMPLETED|Overall Study||10
29783|NCT02126839|72834|P2|COMPLETED|Overall Study||80
29784|NCT02126839|72835|P1|COMPLETED|Overall Study||82
29785|NCT02126839|72834|P2|Full Analysis Set|Overall Study||92
29786|NCT02126839|72835|P1|Full Analysis Set|Overall Study||92
29787|NCT02126839|72834|P2|Safety Population|Overall Study||93
29788|NCT02126839|72835|P1|Safety Population|Overall Study||92
29789|NCT02126839|72834|P2|STARTED|Overall Study||94
29790|NCT02126839|72835|P1|STARTED|Overall Study||92
29791|NCT02126748|72848|P3|NOT COMPLETED|Overall Study||5
29792|NCT02126748|72849|P2|NOT COMPLETED|Overall Study||3
29793|NCT02126748|72850|P1|NOT COMPLETED|Overall Study||2
29794|NCT02126748|72848|P3|COMPLETED|Overall Study||31
29795|NCT02126748|72849|P2|COMPLETED|Overall Study||31
29796|NCT02126748|72850|P1|COMPLETED|Overall Study||31
29797|NCT02126748|72848|P3|STARTED|Overall Study||36
29798|NCT02126748|72849|P2|STARTED|Overall Study||34
29799|NCT02126748|72850|P1|STARTED|Overall Study||33
29800|NCT02126670|72862|P4|NOT COMPLETED|Overall Study||1
29801|NCT02126670|72863|P3|NOT COMPLETED|Overall Study||0
29802|NCT02126670|72864|P2|NOT COMPLETED|Overall Study||0
29803|NCT02126670|72865|P1|NOT COMPLETED|Overall Study||1
29804|NCT02126670|72862|P4|COMPLETED|Overall Study||24
29805|NCT02126670|72863|P3|COMPLETED|Overall Study||25
29806|NCT02126670|72864|P2|COMPLETED|Overall Study||24
29807|NCT02126670|72865|P1|COMPLETED|Overall Study||25
29808|NCT02126670|72862|P4|STARTED|Overall Study||25
29809|NCT02126670|72863|P3|STARTED|Overall Study||25
29810|NCT02126670|72864|P2|STARTED|Overall Study||24
29811|NCT02126670|72865|P1|STARTED|Overall Study||26
29812|NCT02126319|72881|P2|NOT COMPLETED|Overall Study||24
29813|NCT02126319|72882|P1|NOT COMPLETED|Overall Study||21
29814|NCT02126319|72881|P2|COMPLETED|Overall Study||43
29815|NCT02126319|72882|P1|COMPLETED|Overall Study||40
29816|NCT02126319|72881|P2|STARTED|Overall Study||67
29817|NCT02126319|72882|P1|STARTED|Overall Study||61
29818|NCT02126306|72908|P2|NOT COMPLETED|Overall Study||0
29819|NCT02126306|72909|P1|NOT COMPLETED|Overall Study||0
29820|NCT02126306|72908|P2|COMPLETED|Overall Study||13
29821|NCT02126306|72909|P1|COMPLETED|Overall Study||10
29822|NCT02126306|72908|P2|STARTED|Overall Study||13
29823|NCT02126306|72909|P1|STARTED|Overall Study||10
29824|NCT02125877|72917|P2|NOT COMPLETED|Overall Study||10
29825|NCT02125877|72918|P1|NOT COMPLETED|Overall Study||13
29826|NCT02125877|72917|P2|COMPLETED|Overall Study||77
29827|NCT02125877|72918|P1|COMPLETED|Overall Study||73
29828|NCT02125877|72917|P2|Safety Set|Overall Study||87
29829|NCT02125877|72918|P1|Safety Set|Overall Study||86
29830|NCT02125877|72917|P2|Pharmacokinetic Subset A|Overall Study||15
29831|NCT02125877|72918|P1|Pharmacokinetic Subset A|Overall Study||16
29832|NCT02125877|72917|P2|Pharmacokinetic Analysis Set|Overall Study||83
29833|NCT02125877|72918|P1|Pharmacokinetic Analysis Set|Overall Study||83
29834|NCT02125877|72917|P2|STARTED|Overall Study||87
29835|NCT02125877|72918|P1|STARTED|Overall Study||86
29836|NCT02125838|72948|P2|NOT COMPLETED|Overall Study||4
29837|NCT02125838|72949|P1|NOT COMPLETED|Overall Study||4
29838|NCT02125838|72948|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
29839|NCT02125838|72949|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
29840|NCT02125838|72948|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
29841|NCT02125838|72949|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
29842|NCT02125734|72967|P2|NOT COMPLETED|Period 2||1
29843|NCT02125734|72968|P1|NOT COMPLETED|Period 2||0
29844|NCT02125734|72967|P2|COMPLETED|Period 2||47
29845|NCT02125734|72968|P1|COMPLETED|Period 2||40
29846|NCT02125734|72967|P2|STARTED|Period 2||48
29847|NCT02125734|72968|P1|STARTED|Period 2||40
29848|NCT02125734|72967|P2|NOT COMPLETED|Period 1||0
29849|NCT02125734|72968|P1|NOT COMPLETED|Period 1||0
29850|NCT02125734|72967|P2|COMPLETED|Period 1||48
29851|NCT02125734|72968|P1|COMPLETED|Period 1||40
29852|NCT02125734|72967|P2|STARTED|Period 1||48
29853|NCT02125734|72968|P1|STARTED|Period 1||40
29854|NCT02125604|72978|P1|NOT COMPLETED|Overall Study||31
29855|NCT02125604|72978|P1|COMPLETED|Overall Study||180
29856|NCT02125604|72978|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
29857|NCT02125292|72992|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
29858|NCT02125292|72993|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
29859|NCT02125292|72994|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
29860|NCT02125292|72995|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
29861|NCT02125292|72996|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
29862|NCT02125292|72997|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
29863|NCT02125292|72992|P6|COMPLETED|Third Intervention (1 Hour)||3
29864|NCT02125292|72993|P5|COMPLETED|Third Intervention (1 Hour)||3
29865|NCT02125292|72994|P4|COMPLETED|Third Intervention (1 Hour)||3
29866|NCT02125292|72995|P3|COMPLETED|Third Intervention (1 Hour)||3
29867|NCT02125292|72996|P2|COMPLETED|Third Intervention (1 Hour)||3
29868|NCT02125292|72997|P1|COMPLETED|Third Intervention (1 Hour)||3
29869|NCT02125292|72992|P6|STARTED|Third Intervention (1 Hour)||3
29870|NCT02125292|72993|P5|STARTED|Third Intervention (1 Hour)||3
29871|NCT02125292|72994|P4|STARTED|Third Intervention (1 Hour)||3
29872|NCT02125292|72995|P3|STARTED|Third Intervention (1 Hour)||3
29873|NCT02125292|72996|P2|STARTED|Third Intervention (1 Hour)||3
29874|NCT02125292|72997|P1|STARTED|Third Intervention (1 Hour)||3
29875|NCT02125292|72992|P6|NOT COMPLETED|Washout (2 Hours)||0
29876|NCT02125292|72993|P5|NOT COMPLETED|Washout (2 Hours)||0
29877|NCT02125292|72994|P4|NOT COMPLETED|Washout (2 Hours)||0
29878|NCT02125292|72995|P3|NOT COMPLETED|Washout (2 Hours)||0
29879|NCT02125292|72996|P2|NOT COMPLETED|Washout (2 Hours)||0
29880|NCT02125292|72997|P1|NOT COMPLETED|Washout (2 Hours)||0
29881|NCT02125292|72992|P6|COMPLETED|Washout (2 Hours)||3
29882|NCT02125292|72993|P5|COMPLETED|Washout (2 Hours)||3
29883|NCT02125292|72994|P4|COMPLETED|Washout (2 Hours)||3
29884|NCT02125292|72995|P3|COMPLETED|Washout (2 Hours)||3
29885|NCT02125292|72996|P2|COMPLETED|Washout (2 Hours)||3
29886|NCT02125292|72997|P1|COMPLETED|Washout (2 Hours)||3
29887|NCT02125292|72992|P6|STARTED|Washout (2 Hours)||3
29888|NCT02125292|72993|P5|STARTED|Washout (2 Hours)||3
29889|NCT02125292|72994|P4|STARTED|Washout (2 Hours)||3
29890|NCT02125292|72995|P3|STARTED|Washout (2 Hours)||3
29891|NCT02125292|72996|P2|STARTED|Washout (2 Hours)||3
29892|NCT02125292|72997|P1|STARTED|Washout (2 Hours)||3
29893|NCT02125292|72992|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
29894|NCT02125292|72993|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
29895|NCT02125292|72994|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
29896|NCT02125292|72995|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
29897|NCT02125292|72996|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
29898|NCT02125292|72997|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
29899|NCT02125292|72992|P6|COMPLETED|Second Intervention (1 Hour)||3
29900|NCT02125292|72993|P5|COMPLETED|Second Intervention (1 Hour)||3
29901|NCT02125292|72994|P4|COMPLETED|Second Intervention (1 Hour)||3
29902|NCT02125292|72995|P3|COMPLETED|Second Intervention (1 Hour)||3
29903|NCT02125292|72996|P2|COMPLETED|Second Intervention (1 Hour)||3
29904|NCT02125292|72997|P1|COMPLETED|Second Intervention (1 Hour)||3
29905|NCT02125292|72992|P6|STARTED|Second Intervention (1 Hour)||3
29906|NCT02125292|72993|P5|STARTED|Second Intervention (1 Hour)||3
29907|NCT02125292|72994|P4|STARTED|Second Intervention (1 Hour)||3
29908|NCT02125292|72995|P3|STARTED|Second Intervention (1 Hour)||3
29909|NCT02125292|72996|P2|STARTED|Second Intervention (1 Hour)||3
29910|NCT02125292|72997|P1|STARTED|Second Intervention (1 Hour)||3
29911|NCT02125292|72992|P6|NOT COMPLETED|Washout (2 Hours)||0
29912|NCT02125292|72993|P5|NOT COMPLETED|Washout (2 Hours)||0
29913|NCT02125292|72994|P4|NOT COMPLETED|Washout (2 Hours)||0
29914|NCT02125292|72995|P3|NOT COMPLETED|Washout (2 Hours)||0
29915|NCT02125292|72996|P2|NOT COMPLETED|Washout (2 Hours)||0
29916|NCT02125292|72997|P1|NOT COMPLETED|Washout (2 Hours)||0
29917|NCT02125292|72992|P6|COMPLETED|Washout (2 Hours)||3
29918|NCT02125292|72993|P5|COMPLETED|Washout (2 Hours)||3
29919|NCT02125292|72994|P4|COMPLETED|Washout (2 Hours)||3
29920|NCT02125292|72995|P3|COMPLETED|Washout (2 Hours)||3
29921|NCT02125292|72996|P2|COMPLETED|Washout (2 Hours)||3
29922|NCT02125292|72997|P1|COMPLETED|Washout (2 Hours)||3
29923|NCT02125292|72992|P6|STARTED|Washout (2 Hours)||3
29924|NCT02125292|72993|P5|STARTED|Washout (2 Hours)||3
29925|NCT02125292|72994|P4|STARTED|Washout (2 Hours)||3
29926|NCT02125292|72995|P3|STARTED|Washout (2 Hours)||3
29927|NCT02125292|72996|P2|STARTED|Washout (2 Hours)||3
29928|NCT02125292|72997|P1|STARTED|Washout (2 Hours)||3
29929|NCT02125292|72992|P6|NOT COMPLETED|First Intervention (1 Hour)||0
29930|NCT02125292|72993|P5|NOT COMPLETED|First Intervention (1 Hour)||0
29931|NCT02125292|72994|P4|NOT COMPLETED|First Intervention (1 Hour)||0
29932|NCT02125292|72995|P3|NOT COMPLETED|First Intervention (1 Hour)||0
29933|NCT02125292|72996|P2|NOT COMPLETED|First Intervention (1 Hour)||0
29934|NCT02125292|72997|P1|NOT COMPLETED|First Intervention (1 Hour)||0
29935|NCT02125292|72992|P6|COMPLETED|First Intervention (1 Hour)||3
29936|NCT02125292|72993|P5|COMPLETED|First Intervention (1 Hour)||3
29937|NCT02125292|72994|P4|COMPLETED|First Intervention (1 Hour)||3
29938|NCT02125292|72995|P3|COMPLETED|First Intervention (1 Hour)||3
29939|NCT02125292|72996|P2|COMPLETED|First Intervention (1 Hour)||3
29940|NCT02125292|72997|P1|COMPLETED|First Intervention (1 Hour)||3
29941|NCT02125292|72992|P6|STARTED|First Intervention (1 Hour)||3
29942|NCT02125292|72993|P5|STARTED|First Intervention (1 Hour)||3
29943|NCT02125292|72994|P4|STARTED|First Intervention (1 Hour)||3
29944|NCT02125292|72995|P3|STARTED|First Intervention (1 Hour)||3
29945|NCT02125292|72996|P2|STARTED|First Intervention (1 Hour)||3
29946|NCT02125292|72997|P1|STARTED|First Intervention (1 Hour)||3
29947|NCT02124863|73018|P1|NOT COMPLETED|Overall Study||17
29948|NCT02124863|73018|P1|COMPLETED|Overall Study||50
29949|NCT02124863|73018|P1|STARTED|Overall Study||67
29950|NCT02124798|73024|P1|NOT COMPLETED|Overall Study||4
29951|NCT02124798|73024|P1|COMPLETED|Overall Study||91
29952|NCT02124798|73024|P1|STARTED|Overall Study||95
29953|NCT02124603|73030|P1|NOT COMPLETED|Overall Study||0
29954|NCT02124603|73030|P1|COMPLETED|Overall Study||120
29955|NCT02124603|73030|P1|STARTED|Overall Study||120
29956|NCT02124460|73038|P2|NOT COMPLETED|Overall Study||24
29957|NCT02124460|73039|P1|NOT COMPLETED|Overall Study||33
29958|NCT02124460|73038|P2|COMPLETED|Overall Study||336
29959|NCT02124460|73039|P1|COMPLETED|Overall Study||328
29960|NCT02124460|73038|P2|STARTED|Overall Study||360
29961|NCT02124460|73039|P1|STARTED|Overall Study||361
29962|NCT02124304|73071|P2|NOT COMPLETED|Overall Study||0
29963|NCT02124304|73072|P1|NOT COMPLETED|Overall Study||0
29964|NCT02124304|73071|P2|COMPLETED|Overall Study||15
29965|NCT02124304|73072|P1|COMPLETED|Overall Study||15
29966|NCT02124304|73071|P2|STARTED|Overall Study||15
29967|NCT02124304|73072|P1|STARTED|Overall Study||15
29968|NCT02124161|73082|P2|NOT COMPLETED|Overall Study||15
29969|NCT02124161|73083|P1|NOT COMPLETED|Overall Study||16
29970|NCT02124161|73082|P2|COMPLETED|Overall Study||426
29971|NCT02124161|73083|P1|COMPLETED|Overall Study||425
29972|NCT02124161|73082|P2|Vaccination 2|Overall Study||432
29973|NCT02124161|73083|P1|Vaccination 2|Overall Study||431
29974|NCT02124161|73082|P2|Vaccination 1|Overall Study||437
29975|NCT02124161|73083|P1|Vaccination 1|Overall Study||439
29976|NCT02124161|73082|P2|STARTED|Overall Study||441
29977|NCT02124161|73083|P1|STARTED|Overall Study||441
29978|NCT02124122|73115|P2|NOT COMPLETED|Overall Study||0
29979|NCT02124122|73116|P1|NOT COMPLETED|Overall Study||0
29980|NCT02124122|73115|P2|COMPLETED|Overall Study||19
29981|NCT02124122|73116|P1|COMPLETED|Overall Study||41
29982|NCT02124122|73115|P2|STARTED|Overall Study||19
29983|NCT02124122|73116|P1|STARTED|Overall Study||41
29984|NCT02124083|73124|P1|NOT COMPLETED|Overall Study||1
29985|NCT02124083|73124|P1|COMPLETED|Overall Study||11
29986|NCT02124083|73124|P1|STARTED|Overall Study||12
29987|NCT02124044|73135|P2|NOT COMPLETED|Overall Study||1
29988|NCT02124044|73136|P1|NOT COMPLETED|Overall Study||0
29989|NCT02124044|73135|P2|COMPLETED|Overall Study||9
29990|NCT02124044|73136|P1|COMPLETED|Overall Study||20
29991|NCT02124044|73135|P2|STARTED|Overall Study||10
29992|NCT02124044|73136|P1|STARTED|Overall Study||20
29993|NCT02123745|73142|P1|NOT COMPLETED|Overall Study||0
29994|NCT02123745|73142|P1|COMPLETED|Overall Study||71
29995|NCT02123745|73142|P1|STARTED|Overall Study||71
29996|NCT02123472|73150|P2|NOT COMPLETED|Period 2 (7 Days)||1
29997|NCT02123472|73151|P1|NOT COMPLETED|Period 2 (7 Days)||0
29998|NCT02123472|73150|P2|COMPLETED|Period 2 (7 Days)||13
29999|NCT02123472|73151|P1|COMPLETED|Period 2 (7 Days)||14
30000|NCT02123472|73150|P2|STARTED|Period 2 (7 Days)||14
30001|NCT02123472|73151|P1|STARTED|Period 2 (7 Days)||14
30002|NCT02123472|73150|P2|NOT COMPLETED|Washout Period (1 Day)||0
30003|NCT02123472|73151|P1|NOT COMPLETED|Washout Period (1 Day)||0
30004|NCT02123472|73150|P2|COMPLETED|Washout Period (1 Day)||14
30005|NCT02123472|73151|P1|COMPLETED|Washout Period (1 Day)||14
30006|NCT02123472|73150|P2|STARTED|Washout Period (1 Day)||14
30007|NCT02123472|73151|P1|STARTED|Washout Period (1 Day)||14
30008|NCT02123472|73150|P2|NOT COMPLETED|Period 1 (7 Days)||0
30009|NCT02123472|73151|P1|NOT COMPLETED|Period 1 (7 Days)||0
30010|NCT02123472|73150|P2|COMPLETED|Period 1 (7 Days)||14
30011|NCT02123472|73151|P1|COMPLETED|Period 1 (7 Days)||14
30012|NCT02123472|73150|P2|STARTED|Period 1 (7 Days)||14
30013|NCT02123472|73151|P1|STARTED|Period 1 (7 Days)||14
30014|NCT02123459|73161|P2|NOT COMPLETED|Period 2 (7 Days)||0
30015|NCT02123459|73162|P1|NOT COMPLETED|Period 2 (7 Days)||0
30016|NCT02123459|73161|P2|COMPLETED|Period 2 (7 Days)||14
30017|NCT02123459|73162|P1|COMPLETED|Period 2 (7 Days)||13
30018|NCT02123459|73161|P2|STARTED|Period 2 (7 Days)||14
30019|NCT02123459|73162|P1|STARTED|Period 2 (7 Days)||13
30020|NCT02123459|73161|P2|NOT COMPLETED|Washout Period (1 Day)||0
30021|NCT02123459|73162|P1|NOT COMPLETED|Washout Period (1 Day)||1
30022|NCT02123459|73161|P2|COMPLETED|Washout Period (1 Day)||14
30023|NCT02123459|73162|P1|COMPLETED|Washout Period (1 Day)||13
30024|NCT02123459|73161|P2|STARTED|Washout Period (1 Day)||14
30025|NCT02123459|73162|P1|STARTED|Washout Period (1 Day)||14
30026|NCT02123459|73161|P2|NOT COMPLETED|Period 1 (7 Days)||0
30027|NCT02123459|73162|P1|NOT COMPLETED|Period 1 (7 Days)||0
30028|NCT02123459|73161|P2|COMPLETED|Period 1 (7 Days)||14
30029|NCT02123459|73162|P1|COMPLETED|Period 1 (7 Days)||14
30030|NCT02123459|73161|P2|STARTED|Period 1 (7 Days)||14
30031|NCT02123459|73162|P1|STARTED|Period 1 (7 Days)||14
30032|NCT02123446|73172|P2|NOT COMPLETED|Period 2 (7 Days)||0
30033|NCT02123446|73173|P1|NOT COMPLETED|Period 2 (7 Days)||0
30034|NCT02123446|73172|P2|COMPLETED|Period 2 (7 Days)||14
30035|NCT02123446|73173|P1|COMPLETED|Period 2 (7 Days)||13
30036|NCT02123446|73172|P2|STARTED|Period 2 (7 Days)||14
30037|NCT02123446|73173|P1|STARTED|Period 2 (7 Days)||13
30038|NCT02123446|73172|P2|NOT COMPLETED|Washout Period (1 Day)||0
30039|NCT02123446|73173|P1|NOT COMPLETED|Washout Period (1 Day)||1
30040|NCT02123446|73172|P2|COMPLETED|Washout Period (1 Day)||14
30041|NCT02123446|73173|P1|COMPLETED|Washout Period (1 Day)||13
30042|NCT02123446|73172|P2|STARTED|Washout Period (1 Day)||14
30043|NCT02123446|73173|P1|STARTED|Washout Period (1 Day)||14
30044|NCT02123446|73172|P2|NOT COMPLETED|Period 1 (7 Days)||0
30045|NCT02123446|73173|P1|NOT COMPLETED|Period 1 (7 Days)||0
30046|NCT02123446|73172|P2|COMPLETED|Period 1 (7 Days)||14
30047|NCT02123446|73173|P1|COMPLETED|Period 1 (7 Days)||14
30048|NCT02123446|73172|P2|STARTED|Period 1 (7 Days)||14
30049|NCT02123446|73173|P1|STARTED|Period 1 (7 Days)||14
30050|NCT02123329|73185|P2|NOT COMPLETED|12 Month Outcome Measure||79
30051|NCT02123329|73186|P1|NOT COMPLETED|12 Month Outcome Measure||64
30052|NCT02123329|73185|P2|COMPLETED|12 Month Outcome Measure||88
30053|NCT02123329|73186|P1|COMPLETED|12 Month Outcome Measure||83
30054|NCT02123329|73185|P2|STARTED|12 Month Outcome Measure||167
30055|NCT02123329|73186|P1|STARTED|12 Month Outcome Measure||147
30056|NCT02123329|73185|P2|NOT COMPLETED|6 Month Outcome Measure||67
30057|NCT02123329|73186|P1|NOT COMPLETED|6 Month Outcome Measure||48
30058|NCT02123329|73185|P2|COMPLETED|6 Month Outcome Measure||100
30059|NCT02123329|73186|P1|COMPLETED|6 Month Outcome Measure||99
30060|NCT02123329|73185|P2|STARTED|6 Month Outcome Measure||167
30061|NCT02123329|73186|P1|STARTED|6 Month Outcome Measure||147
30062|NCT02123329|73185|P2|NOT COMPLETED|3 Month Outcome Measure||66
30063|NCT02123329|73186|P1|NOT COMPLETED|3 Month Outcome Measure||49
30064|NCT02123329|73185|P2|COMPLETED|3 Month Outcome Measure||101
30065|NCT02123329|73186|P1|COMPLETED|3 Month Outcome Measure||98
30066|NCT02123329|73185|P2|STARTED|3 Month Outcome Measure||167
30067|NCT02123329|73186|P1|STARTED|3 Month Outcome Measure||147
30068|NCT02123017|73215|P3|NOT COMPLETED|Overall Study||0
30069|NCT02123017|73216|P2|NOT COMPLETED|Overall Study||0
30070|NCT02123017|73217|P1|NOT COMPLETED|Overall Study||0
30071|NCT02123017|73215|P3|COMPLETED|Overall Study||12
30072|NCT02123017|73216|P2|COMPLETED|Overall Study||12
30073|NCT02123017|73217|P1|COMPLETED|Overall Study||8
30074|NCT02123017|73215|P3|STARTED|Overall Study||12
30075|NCT02123017|73216|P2|STARTED|Overall Study||12
30076|NCT02123017|73217|P1|STARTED|Overall Study||8
30077|NCT02122796|73236|P2|NOT COMPLETED|Visit 2||1
30078|NCT02122796|73237|P1|NOT COMPLETED|Visit 2||3
30079|NCT02122796|73236|P2|COMPLETED|Visit 2||14
30080|NCT02122796|73237|P1|COMPLETED|Visit 2||12
30081|NCT02122796|73236|P2|STARTED|Visit 2||15
30082|NCT02122796|73237|P1|STARTED|Visit 2||15
30083|NCT02122796|73236|P2|NOT COMPLETED|Visit 1||0
30084|NCT02122796|73237|P1|NOT COMPLETED|Visit 1||0
30085|NCT02122796|73236|P2|COMPLETED|Visit 1||15
30086|NCT02122796|73237|P1|COMPLETED|Visit 1||15
30087|NCT02122796|73236|P2|STARTED|Visit 1||15
30088|NCT02122796|73237|P1|STARTED|Visit 1||15
30089|NCT02122549|73250|P1|NOT COMPLETED|Overall Study||0
30090|NCT02122549|73250|P1|COMPLETED|Overall Study||59
30091|NCT02122549|73250|P1|STARTED|Overall Study||59
30092|NCT02122445|73254|P1|NOT COMPLETED|Overall Study||0
30093|NCT02122445|73254|P1|COMPLETED|Overall Study||20
30094|NCT02122445|73254|P1|STARTED|Overall Study||20
30095|NCT02122406|73259|P1|NOT COMPLETED|Overall Study||0
30096|NCT02122406|73259|P1|COMPLETED|Overall Study||200
30097|NCT02122406|73259|P1|STARTED|Overall Study||200
30098|NCT02122146|73271|P8|NOT COMPLETED|Part 3: Expansion||0
30099|NCT02122146|73272|P7|NOT COMPLETED|Part 3: Expansion||0
30100|NCT02122146|73273|P6|NOT COMPLETED|Part 3: Expansion||0
30101|NCT02122146|73274|P5|NOT COMPLETED|Part 3: Expansion||0
30102|NCT02122146|73275|P4|NOT COMPLETED|Part 3: Expansion||0
30103|NCT02122146|73276|P3|NOT COMPLETED|Part 3: Expansion||0
30104|NCT02122146|73277|P2|NOT COMPLETED|Part 3: Expansion||0
30105|NCT02122146|73278|P1|NOT COMPLETED|Part 3: Expansion||0
30106|NCT02122146|73271|P8|COMPLETED|Part 3: Expansion||0
30107|NCT02122146|73272|P7|COMPLETED|Part 3: Expansion||0
30108|NCT02122146|73273|P6|COMPLETED|Part 3: Expansion||0
30109|NCT02122146|73274|P5|COMPLETED|Part 3: Expansion||0
30110|NCT02122146|73275|P4|COMPLETED|Part 3: Expansion||0
30111|NCT02122146|73276|P3|COMPLETED|Part 3: Expansion||0
30112|NCT02122146|73277|P2|COMPLETED|Part 3: Expansion||0
30113|NCT02122146|73278|P1|COMPLETED|Part 3: Expansion||0
30114|NCT02122146|73271|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30115|NCT02122146|73272|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30116|NCT02122146|73273|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30117|NCT02122146|73274|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30118|NCT02122146|73275|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30119|NCT02122146|73276|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30120|NCT02122146|73277|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30121|NCT02122146|73278|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
30122|NCT02122146|73271|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30123|NCT02122146|73272|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30124|NCT02122146|73273|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30125|NCT02122146|73274|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30126|NCT02122146|73275|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30127|NCT02122146|73276|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30128|NCT02122146|73277|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30129|NCT02122146|73278|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
30130|NCT02122146|73271|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
30131|NCT02122146|73272|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
30132|NCT02122146|73273|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
30133|NCT02122146|73274|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
30134|NCT02122146|73275|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
30135|NCT02122146|73276|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
30136|NCT02122146|73277|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
30137|NCT02122146|73278|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
30138|NCT02122146|73271|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30139|NCT02122146|73272|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30140|NCT02122146|73273|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30141|NCT02122146|73274|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30142|NCT02122146|73275|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30143|NCT02122146|73276|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30144|NCT02122146|73277|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30145|NCT02122146|73278|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
30146|NCT02122146|73271|P8|NOT COMPLETED|Part 1: Dose Escalation||2
30147|NCT02122146|73272|P7|NOT COMPLETED|Part 1: Dose Escalation||1
30148|NCT02122146|73273|P6|NOT COMPLETED|Part 1: Dose Escalation||1
30149|NCT02122146|73274|P5|NOT COMPLETED|Part 1: Dose Escalation||1
30150|NCT02122146|73275|P4|NOT COMPLETED|Part 1: Dose Escalation||1
30151|NCT02122146|73276|P3|NOT COMPLETED|Part 1: Dose Escalation||2
30152|NCT02122146|73277|P2|NOT COMPLETED|Part 1: Dose Escalation||1
30153|NCT02122146|73278|P1|NOT COMPLETED|Part 1: Dose Escalation||1
30154|NCT02122146|73271|P8|COMPLETED|Part 1: Dose Escalation||6
30155|NCT02122146|73272|P7|COMPLETED|Part 1: Dose Escalation||0
30156|NCT02122146|73273|P6|COMPLETED|Part 1: Dose Escalation||5
30157|NCT02122146|73274|P5|COMPLETED|Part 1: Dose Escalation||3
30158|NCT02122146|73275|P4|COMPLETED|Part 1: Dose Escalation||3
30159|NCT02122146|73276|P3|COMPLETED|Part 1: Dose Escalation||2
30160|NCT02122146|73277|P2|COMPLETED|Part 1: Dose Escalation||1
30161|NCT02122146|73278|P1|COMPLETED|Part 1: Dose Escalation||1
30162|NCT02122146|73271|P8|STARTED|Part 1: Dose Escalation||8
30163|NCT02122146|73272|P7|STARTED|Part 1: Dose Escalation||1
30164|NCT02122146|73273|P6|STARTED|Part 1: Dose Escalation||6
30165|NCT02122146|73274|P5|STARTED|Part 1: Dose Escalation||4
30166|NCT02122146|73275|P4|STARTED|Part 1: Dose Escalation||4
30167|NCT02122146|73276|P3|STARTED|Part 1: Dose Escalation||4
30168|NCT02122146|73277|P2|STARTED|Part 1: Dose Escalation||2
30169|NCT02122146|73278|P1|STARTED|Part 1: Dose Escalation||2
30170|NCT02121860|73517|P4|NOT COMPLETED|Overall Study||0
30171|NCT02121860|73518|P3|NOT COMPLETED|Overall Study||0
30172|NCT02121860|73519|P2|NOT COMPLETED|Overall Study||0
30173|NCT02121860|73520|P1|NOT COMPLETED|Overall Study||0
30174|NCT02121860|73517|P4|COMPLETED|Overall Study||8
30175|NCT02121860|73518|P3|COMPLETED|Overall Study||8
30176|NCT02121860|73519|P2|COMPLETED|Overall Study||12
30177|NCT02121860|73520|P1|COMPLETED|Overall Study||8
30178|NCT02121860|73517|P4|STARTED|Overall Study||8
30179|NCT02121860|73518|P3|STARTED|Overall Study||8
30180|NCT02121860|73519|P2|STARTED|Overall Study||12
30181|NCT02121860|73520|P1|STARTED|Overall Study||8
30182|NCT02121847|73539|P1|NOT COMPLETED|Overall Study||3
30183|NCT02121847|73539|P1|COMPLETED|Overall Study||37
30184|NCT02121847|73539|P1|STARTED|Overall Study||40
30185|NCT02121808|73558|P1|NOT COMPLETED|Overall Study||3
30186|NCT02121808|73558|P1|COMPLETED|Overall Study||17
30187|NCT02121808|73558|P1|STARTED|Overall Study||20
30188|NCT02121795|73569|P2|NOT COMPLETED|Overall Study||334
30189|NCT02121795|73570|P1|NOT COMPLETED|Overall Study||334
30190|NCT02121795|73569|P2|COMPLETED|Overall Study||0
30191|NCT02121795|73570|P1|COMPLETED|Overall Study||0
30192|NCT02121795|73569|P2|STARTED|Overall Study||334
30193|NCT02121795|73570|P1|STARTED|Overall Study||334
30194|NCT02121535|73586|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
30195|NCT02121535|73587|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
30196|NCT02121535|73586|P2|COMPLETED|Period 4 (8 Trial Days)||35
30197|NCT02121535|73587|P1|COMPLETED|Period 4 (8 Trial Days)||35
30198|NCT02121535|73586|P2|STARTED|Period 4 (8 Trial Days)||35
30199|NCT02121535|73587|P1|STARTED|Period 4 (8 Trial Days)||35
30200|NCT02121535|73586|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
30201|NCT02121535|73587|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
30202|NCT02121535|73586|P2|COMPLETED|Period 3 (8 Trial Days)||35
30203|NCT02121535|73587|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
30204|NCT02121535|73586|P2|STARTED|Period 3 (8 Trial Days)||35
30205|NCT02121535|73587|P1|STARTED|Period 3 (8 Trial Days)||36
30206|NCT02121535|73586|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
30207|NCT02121535|73587|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
30208|NCT02121535|73586|P2|COMPLETED|Period 2 (8 Trial Days)||35
30209|NCT02121535|73587|P1|COMPLETED|Period 2 (8 Trial Days)||36
30210|NCT02121535|73586|P2|STARTED|Period 2 (8 Trial Days)||35
30211|NCT02121535|73587|P1|STARTED|Period 2 (8 Trial Days)||36
30212|NCT02121535|73586|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
30213|NCT02121535|73587|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
30214|NCT02121535|73586|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
30215|NCT02121535|73587|P1|COMPLETED|Period 1 (8 Trial Days)||36
30216|NCT02121535|73586|P2|STARTED|Period 1 (8 Trial Days)||36
30217|NCT02121535|73587|P1|STARTED|Period 1 (8 Trial Days)||36
30218|NCT02121522|73610|P1|NOT COMPLETED|Overall Study||1
30219|NCT02121522|73610|P1|COMPLETED|Overall Study||13
30220|NCT02121522|73610|P1|STARTED|Overall Study||14
30221|NCT02121509|73617|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
30222|NCT02121509|73618|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
30223|NCT02121509|73619|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
30224|NCT02121509|73620|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
30225|NCT02121509|73617|P4|COMPLETED|Treatment Period-2 (4 Days)||8
30226|NCT02121509|73618|P3|COMPLETED|Treatment Period-2 (4 Days)||8
30227|NCT02121509|73619|P2|COMPLETED|Treatment Period-2 (4 Days)||24
30228|NCT02121509|73620|P1|COMPLETED|Treatment Period-2 (4 Days)||28
30229|NCT02121509|73617|P4|STARTED|Treatment Period-2 (4 Days)||8
30230|NCT02121509|73618|P3|STARTED|Treatment Period-2 (4 Days)||8
30231|NCT02121509|73619|P2|STARTED|Treatment Period-2 (4 Days)||24
30232|NCT02121509|73620|P1|STARTED|Treatment Period-2 (4 Days)||28
30233|NCT02121509|73617|P4|NOT COMPLETED|Washout Period (35 Days)||0
30234|NCT02121509|73618|P3|NOT COMPLETED|Washout Period (35 Days)||0
30235|NCT02121509|73619|P2|NOT COMPLETED|Washout Period (35 Days)||4
30236|NCT02121509|73620|P1|NOT COMPLETED|Washout Period (35 Days)||2
30237|NCT02121509|73617|P4|COMPLETED|Washout Period (35 Days)||8
30238|NCT02121509|73618|P3|COMPLETED|Washout Period (35 Days)||8
30239|NCT02121509|73619|P2|COMPLETED|Washout Period (35 Days)||24
30240|NCT02121509|73620|P1|COMPLETED|Washout Period (35 Days)||28
30241|NCT02121509|73617|P4|STARTED|Washout Period (35 Days)||8
30242|NCT02121509|73618|P3|STARTED|Washout Period (35 Days)||8
30243|NCT02121509|73619|P2|STARTED|Washout Period (35 Days)||28
30244|NCT02121509|73620|P1|STARTED|Washout Period (35 Days)||30
30245|NCT02121509|73617|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
30246|NCT02121509|73618|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
30247|NCT02121509|73619|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
30248|NCT02121509|73620|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
30249|NCT02121509|73617|P4|COMPLETED|Treatment Period-1 (4 Days)||8
30250|NCT02121509|73618|P3|COMPLETED|Treatment Period-1 (4 Days)||8
30251|NCT02121509|73619|P2|COMPLETED|Treatment Period-1 (4 Days)||28
30252|NCT02121509|73620|P1|COMPLETED|Treatment Period-1 (4 Days)||30
30253|NCT02121509|73617|P4|STARTED|Treatment Period-1 (4 Days)||8
30254|NCT02121509|73618|P3|STARTED|Treatment Period-1 (4 Days)||8
30255|NCT02121509|73619|P2|STARTED|Treatment Period-1 (4 Days)||28
30256|NCT02121509|73620|P1|STARTED|Treatment Period-1 (4 Days)||30
30257|NCT02121483|73653|P3|NOT COMPLETED|Overall Study||0
30258|NCT02121483|73654|P2|NOT COMPLETED|Overall Study||0
30259|NCT02121483|73655|P1|NOT COMPLETED|Overall Study||0
30260|NCT02121483|73653|P3|COMPLETED|Overall Study||10
30261|NCT02121483|73654|P2|COMPLETED|Overall Study||8
30262|NCT02121483|73655|P1|COMPLETED|Overall Study||9
30263|NCT02121483|73653|P3|STARTED|Overall Study||10
30264|NCT02121483|73654|P2|STARTED|Overall Study||8
30265|NCT02121483|73655|P1|STARTED|Overall Study||9
30266|NCT02121418|73684|P1|NOT COMPLETED|Overall Study||0
30267|NCT02121418|73684|P1|COMPLETED|Overall Study||12
30268|NCT02121418|73684|P1|STARTED|Overall Study||12
30269|NCT02121210|73691|P2|NOT COMPLETED|Overall Study||9
30270|NCT02121210|73692|P1|NOT COMPLETED|Overall Study||7
30271|NCT02121210|73691|P2|COMPLETED|Overall Study||58
30272|NCT02121210|73692|P1|COMPLETED|Overall Study||58
30273|NCT02121210|73691|P2|STARTED|Overall Study||67
30274|NCT02121210|73692|P1|STARTED|Overall Study||65
30275|NCT02121067|73700|P1|NOT COMPLETED|Overall Study||0
30276|NCT02121067|73700|P1|COMPLETED|Overall Study||50
30277|NCT02121067|73700|P1|STARTED|Overall Study||50
30278|NCT02121041|73708|P2|NOT COMPLETED|Overall Study||6
30279|NCT02121041|73709|P1|NOT COMPLETED|Overall Study||1
30280|NCT02121041|73708|P2|COMPLETED|Overall Study||8
30281|NCT02121041|73709|P1|COMPLETED|Overall Study||13
30282|NCT02121041|73708|P2|STARTED|Overall Study||14
30283|NCT02121041|73709|P1|STARTED|Overall Study||14
30284|NCT02120833|73717|P2|NOT COMPLETED|Overall Study||1
30285|NCT02120833|73718|P1|NOT COMPLETED|Overall Study||4
30286|NCT02120833|73717|P2|COMPLETED|Overall Study||11
30287|NCT02120833|73718|P1|COMPLETED|Overall Study||35
30288|NCT02120833|73717|P2|STARTED|Overall Study||12
30289|NCT02120833|73718|P1|STARTED|Overall Study||39
30290|NCT02120664|73877|P5|NOT COMPLETED|Overall Study||0
30291|NCT02120664|73878|P4|NOT COMPLETED|Overall Study||1
30292|NCT02120664|73879|P3|NOT COMPLETED|Overall Study||0
30293|NCT02120664|73880|P2|NOT COMPLETED|Overall Study||0
30294|NCT02120664|73881|P1|NOT COMPLETED|Overall Study||0
30295|NCT02120664|73877|P5|COMPLETED|Overall Study||10
30296|NCT02120664|73878|P4|COMPLETED|Overall Study||3
30297|NCT02120664|73879|P3|COMPLETED|Overall Study||7
30298|NCT02120664|73880|P2|COMPLETED|Overall Study||4
30299|NCT02120664|73881|P1|COMPLETED|Overall Study||10
30300|NCT02120664|73877|P5|STARTED|Overall Study||10
30301|NCT02120664|73878|P4|STARTED|Overall Study||4
30302|NCT02120664|73879|P3|STARTED|Overall Study||7
30303|NCT02120664|73880|P2|STARTED|Overall Study||4
30304|NCT02120664|73881|P1|STARTED|Overall Study||10
30305|NCT02120625|73899|P1|NOT COMPLETED|Overall Study||2
30306|NCT02120625|73899|P1|COMPLETED|Overall Study||6
30307|NCT02120625|73899|P1|STARTED|Overall Study||8
30308|NCT02120443|73906|P1|NOT COMPLETED|Overall Study||0
30309|NCT02120443|73906|P1|COMPLETED|Overall Study||43
30310|NCT02120443|73906|P1|STARTED|Overall Study||43
30311|NCT02120417|73914|P2|NOT COMPLETED|Overall Study||68
30312|NCT02120417|73915|P1|NOT COMPLETED|Overall Study||60
30313|NCT02120417|73914|P2|COMPLETED|Overall Study||5
30314|NCT02120417|73915|P1|COMPLETED|Overall Study||16
30315|NCT02120417|73914|P2|STARTED|Overall Study||73
30316|NCT02120417|73915|P1|STARTED|Overall Study||76
30317|NCT02120300|73937|P4|NOT COMPLETED|Overall Study||1
30318|NCT02120300|73938|P3|NOT COMPLETED|Overall Study||0
30319|NCT02120300|73939|P2|NOT COMPLETED|Overall Study||0
30320|NCT02120300|73940|P1|NOT COMPLETED|Overall Study||3
30321|NCT02120300|73937|P4|COMPLETED|Overall Study||5
30322|NCT02120300|73938|P3|COMPLETED|Overall Study||10
30323|NCT02120300|73939|P2|COMPLETED|Overall Study||5
30324|NCT02120300|73940|P1|COMPLETED|Overall Study||98
30325|NCT02120300|73937|P4|STARTED|Overall Study||6
30326|NCT02120300|73938|P3|STARTED|Overall Study||10
30327|NCT02120300|73939|P2|STARTED|Overall Study||5
30328|NCT02120300|73940|P1|STARTED|Overall Study||101
30329|NCT02120027|73978|P2|NOT COMPLETED|Overall Study||119
30330|NCT02120027|73979|P1|NOT COMPLETED|Overall Study||116
30331|NCT02120027|73978|P2|COMPLETED|Overall Study||160
30332|NCT02120027|73979|P1|COMPLETED|Overall Study||161
30333|NCT02120027|73978|P2|STARTED|Overall Study||279
30334|NCT02120027|73979|P1|STARTED|Overall Study||277
30335|NCT02120001|73995|P2|NOT COMPLETED|Overall Study||0
30336|NCT02120001|73996|P1|NOT COMPLETED|Overall Study||0
30337|NCT02120001|73995|P2|COMPLETED|Overall Study||19
30338|NCT02120001|73996|P1|COMPLETED|Overall Study||17
30339|NCT02120001|73995|P2|STARTED|Overall Study||19
30340|NCT02120001|73996|P1|STARTED|Overall Study||17
30341|NCT02119936|74004|P1|NOT COMPLETED|Overall Study||10
30342|NCT02119936|74004|P1|COMPLETED|Overall Study||0
30343|NCT02119936|74004|P1|STARTED|Overall Study||10
30344|NCT02119871|74015|P2|NOT COMPLETED|Overall Study||0
30345|NCT02119871|74016|P1|NOT COMPLETED|Overall Study||0
30346|NCT02119871|74015|P2|COMPLETED|Overall Study||10
30347|NCT02119871|74016|P1|COMPLETED|Overall Study||10
30348|NCT02119871|74015|P2|STARTED|Overall Study||10
30349|NCT02119871|74016|P1|STARTED|Overall Study||10
30350|NCT02119676|74038|P4|NOT COMPLETED|Overall Study||101
30351|NCT02119676|74039|P3|NOT COMPLETED|Overall Study||97
30352|NCT02119676|74040|P2|NOT COMPLETED|Overall Study||86
30353|NCT02119676|74041|P1|NOT COMPLETED|Overall Study||83
30354|NCT02119676|74038|P4|COMPLETED|Overall Study||10
30355|NCT02119676|74039|P3|COMPLETED|Overall Study||13
30356|NCT02119676|74040|P2|COMPLETED|Overall Study||2
30357|NCT02119676|74041|P1|COMPLETED|Overall Study||4
30358|NCT02119676|74038|P4|Treated Patients|Overall Study||106
30359|NCT02119676|74039|P3|Treated Patients|Overall Study||106
30360|NCT02119676|74040|P2|Treated Patients|Overall Study||86
30361|NCT02119676|74041|P1|Treated Patients|Overall Study||85
30362|NCT02119676|74038|P4|STARTED|Overall Study||111
30363|NCT02119676|74039|P3|STARTED|Overall Study||110
30364|NCT02119676|74040|P2|STARTED|Overall Study||88
30365|NCT02119676|74041|P1|STARTED|Overall Study||87
30366|NCT02119663|74073|P2|NOT COMPLETED|Overall Study||41
30367|NCT02119663|74074|P1|NOT COMPLETED|Overall Study||40
30368|NCT02119663|74073|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
30369|NCT02119663|74074|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
30370|NCT02119663|74073|P2|STARTED|Overall Study||43
30371|NCT02119663|74074|P1|STARTED|Overall Study||43
30372|NCT02119650|74092|P2|NOT COMPLETED|Overall Study||26
30373|NCT02119650|74093|P1|NOT COMPLETED|Overall Study||25
30374|NCT02119650|74092|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
30375|NCT02119650|74093|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
30376|NCT02119650|74092|P2|STARTED|Overall Study||37
30377|NCT02119650|74093|P1|STARTED|Overall Study||39
30378|NCT02119325|74107|P2|NOT COMPLETED|Period 2||0
30379|NCT02119325|74108|P1|NOT COMPLETED|Period 2||0
30380|NCT02119325|74107|P2|COMPLETED|Period 2||47
30381|NCT02119325|74108|P1|COMPLETED|Period 2||48
30382|NCT02119325|74107|P2|STARTED|Period 2||47
30383|NCT02119325|74108|P1|STARTED|Period 2||48
30384|NCT02119325|74107|P2|NOT COMPLETED|Washout Period 1||1
30385|NCT02119325|74108|P1|NOT COMPLETED|Washout Period 1||0
30386|NCT02119325|74107|P2|COMPLETED|Washout Period 1||47
30387|NCT02119325|74108|P1|COMPLETED|Washout Period 1||48
30388|NCT02119325|74107|P2|STARTED|Washout Period 1||48
30389|NCT02119325|74108|P1|STARTED|Washout Period 1||48
30390|NCT02119325|74107|P2|NOT COMPLETED|Period 1||0
30391|NCT02119325|74108|P1|NOT COMPLETED|Period 1||0
30392|NCT02119325|74107|P2|COMPLETED|Period 1||48
30393|NCT02119325|74108|P1|COMPLETED|Period 1||48
30394|NCT02119325|74107|P2|STARTED|Period 1||48
30395|NCT02119325|74108|P1|STARTED|Period 1||48
30396|NCT02119299|74152|P1|NOT COMPLETED|Overall Study||9
30397|NCT02119299|74152|P1|COMPLETED|Overall Study||67
30398|NCT02119299|74152|P1|STARTED|Overall Study||76
30399|NCT02119286|74166|P3|NOT COMPLETED|Overall Study||7
30400|NCT02119286|74167|P2|NOT COMPLETED|Overall Study||11
30401|NCT02119286|74168|P1|NOT COMPLETED|Overall Study||26
30402|NCT02119286|74166|P3|COMPLETED|Overall Study||200
30403|NCT02119286|74167|P2|COMPLETED|Overall Study||195
30404|NCT02119286|74168|P1|COMPLETED|Overall Study||180
30405|NCT02119286|74166|P3|STARTED|Overall Study||207
30406|NCT02119286|74167|P2|STARTED|Overall Study||206
30407|NCT02119286|74168|P1|STARTED|Overall Study||206
30408|NCT02119104|74179|P1|NOT COMPLETED|Overall Study||16
30409|NCT02119104|74179|P1|COMPLETED|Overall Study||1071
30410|NCT02119104|74179|P1|STARTED|Overall Study||1087
30411|NCT02118961|74185|P2|NOT COMPLETED|Overall Study||0
30412|NCT02118961|74186|P1|NOT COMPLETED|Overall Study||1
30413|NCT02118961|74185|P2|COMPLETED|Overall Study||222
30414|NCT02118961|74186|P1|COMPLETED|Overall Study||223
30415|NCT02118961|74185|P2|STARTED|Overall Study||222
30416|NCT02118961|74186|P1|STARTED|Overall Study||224
30417|NCT02118896|74214|P10|NOT COMPLETED|Overall Study||2
30418|NCT02118896|74215|P9|NOT COMPLETED|Overall Study||4
30419|NCT02118896|74216|P8|NOT COMPLETED|Overall Study||2
30420|NCT02118896|74217|P7|NOT COMPLETED|Overall Study||2
30421|NCT02118896|74218|P6|NOT COMPLETED|Overall Study||28
30422|NCT02118896|74219|P5|NOT COMPLETED|Overall Study||17
30423|NCT02118896|74220|P4|NOT COMPLETED|Overall Study||24
30424|NCT02118896|74221|P3|NOT COMPLETED|Overall Study||14
30425|NCT02118896|74222|P2|NOT COMPLETED|Overall Study||15
30426|NCT02118896|74223|P1|NOT COMPLETED|Overall Study||17
30427|NCT02118896|74214|P10|COMPLETED|Overall Study||7
30428|NCT02118896|74215|P9|COMPLETED|Overall Study||84
30429|NCT02118896|74216|P8|COMPLETED|Overall Study||105
30430|NCT02118896|74217|P7|COMPLETED|Overall Study||83
30431|NCT02118896|74218|P6|COMPLETED|Overall Study||163
30432|NCT02118896|74219|P5|COMPLETED|Overall Study||113
30433|NCT02118896|74220|P4|COMPLETED|Overall Study||55
30434|NCT02118896|74221|P3|COMPLETED|Overall Study||53
30435|NCT02118896|74222|P2|COMPLETED|Overall Study||32
30436|NCT02118896|74223|P1|COMPLETED|Overall Study||30
30437|NCT02118896|74214|P10|STARTED|Overall Study||9
30438|NCT02118896|74215|P9|STARTED|Overall Study||88
30439|NCT02118896|74216|P8|STARTED|Overall Study||107
30440|NCT02118896|74217|P7|STARTED|Overall Study||85
30441|NCT02118896|74218|P6|STARTED|Overall Study||191
30442|NCT02118896|74219|P5|STARTED|Overall Study||130
30443|NCT02118896|74220|P4|STARTED|Overall Study||79
30444|NCT02118896|74221|P3|STARTED|Overall Study||67
30445|NCT02118896|74222|P2|STARTED|Overall Study||47
30446|NCT02118896|74223|P1|STARTED|Overall Study||47
30447|NCT02118831|74298|P3|NOT COMPLETED|Overall Study||0
30448|NCT02118831|74299|P2|NOT COMPLETED|Overall Study||0
30449|NCT02118831|74300|P1|NOT COMPLETED|Overall Study||0
30450|NCT02118831|74298|P3|COMPLETED|Overall Study||20
30451|NCT02118831|74299|P2|COMPLETED|Overall Study||15
30452|NCT02118831|74300|P1|COMPLETED|Overall Study||21
30453|NCT02118831|74298|P3|STARTED|Overall Study||20
30454|NCT02118831|74299|P2|STARTED|Overall Study||15
30455|NCT02118831|74300|P1|STARTED|Overall Study||21
30456|NCT02118792|74313|P2|NOT COMPLETED|Overall Study||37
30457|NCT02118792|74314|P1|NOT COMPLETED|Overall Study||31
30458|NCT02118792|74313|P2|COMPLETED|Overall Study||213
30459|NCT02118792|74314|P1|COMPLETED|Overall Study||483
30460|NCT02118792|74313|P2|Treated|Overall Study||250
30461|NCT02118792|74314|P1|Treated|Overall Study||513
30462|NCT02118792|74313|P2|STARTED|Overall Study||250
30463|NCT02118792|74314|P1|STARTED|Overall Study||514
30464|NCT02118766|74356|P2|NOT COMPLETED|Overall Study||31
30465|NCT02118766|74357|P1|NOT COMPLETED|Overall Study||30
30466|NCT02118766|74356|P2|COMPLETED|Overall Study||225
30467|NCT02118766|74357|P1|COMPLETED|Overall Study||477
30468|NCT02118766|74356|P2|Treated|Overall Study||256
30469|NCT02118766|74357|P1|Treated|Overall Study||503
30470|NCT02118766|74356|P2|STARTED|Overall Study||256
30471|NCT02118766|74357|P1|STARTED|Overall Study||507
30472|NCT02118597|74379|P1|NOT COMPLETED|Overall Study||16
30473|NCT02118597|74379|P1|COMPLETED|Overall Study||3
30474|NCT02118597|74379|P1|STARTED|Overall Study||19
30475|NCT02118441|74395|P2|NOT COMPLETED|Overall Study||1
30476|NCT02118441|74396|P1|NOT COMPLETED|Overall Study||3
30477|NCT02118441|74395|P2|COMPLETED|Overall Study||63
30478|NCT02118441|74396|P1|COMPLETED|Overall Study||62
30479|NCT02118441|74395|P2|STARTED|Overall Study||64
30480|NCT02118441|74396|P1|STARTED|Overall Study||65
30481|NCT02117934|74410|P2|NOT COMPLETED|Overall Study||215
30482|NCT02117934|74411|P1|NOT COMPLETED|Overall Study||500
30483|NCT02117934|74410|P2|COMPLETED|Overall Study||2567
30484|NCT02117934|74411|P1|COMPLETED|Overall Study||5092
30485|NCT02117934|74410|P2|STARTED|Overall Study||2782
30486|NCT02117934|74411|P1|STARTED|Overall Study||5592
30487|NCT02117687|74421|P2|NOT COMPLETED|Overall Study||4
30488|NCT02117687|74422|P1|NOT COMPLETED|Overall Study||1
30489|NCT02117687|74421|P2|COMPLETED|Overall Study||36
30490|NCT02117687|74422|P1|COMPLETED|Overall Study||39
30491|NCT02117687|74421|P2|STARTED|Overall Study||40
30492|NCT02117687|74422|P1|STARTED|Overall Study||40
30493|NCT02117570|74457|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
30494|NCT02117570|74458|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
30495|NCT02117570|74459|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
30496|NCT02117570|74457|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
30497|NCT02117570|74458|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
30498|NCT02117570|74459|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
30499|NCT02117570|74457|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
30500|NCT02117570|74458|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
30501|NCT02117570|74459|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
30502|NCT02117570|74457|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
30503|NCT02117570|74458|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
30504|NCT02117570|74459|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
30505|NCT02117570|74457|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
30506|NCT02117570|74458|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
30507|NCT02117570|74459|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
30508|NCT02117570|74457|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
30509|NCT02117570|74458|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
30510|NCT02117570|74459|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
30511|NCT02117570|74457|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
30512|NCT02117570|74458|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
30513|NCT02117570|74459|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
30514|NCT02117570|74457|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
30515|NCT02117570|74458|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
30516|NCT02117570|74459|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
30517|NCT02117570|74457|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
30518|NCT02117570|74458|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
30519|NCT02117570|74459|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
30520|NCT02117570|74457|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
30521|NCT02117570|74458|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
30522|NCT02117570|74459|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
30523|NCT02117570|74457|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
30524|NCT02117570|74458|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
30525|NCT02117570|74459|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
30526|NCT02117570|74457|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
30527|NCT02117570|74458|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
30528|NCT02117570|74459|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
30529|NCT02117544|74509|P2|NOT COMPLETED|Period 2||0
30530|NCT02117544|74510|P1|NOT COMPLETED|Period 2||0
30531|NCT02117544|74509|P2|COMPLETED|Period 2||55
30532|NCT02117544|74510|P1|COMPLETED|Period 2||52
30533|NCT02117544|74509|P2|STARTED|Period 2||55
30534|NCT02117544|74510|P1|STARTED|Period 2||52
30535|NCT02117544|74509|P2|NOT COMPLETED|Period 1||0
30536|NCT02117544|74510|P1|NOT COMPLETED|Period 1||2
30537|NCT02117544|74509|P2|COMPLETED|Period 1||55
30538|NCT02117544|74510|P1|COMPLETED|Period 1||52
30539|NCT02117544|74509|P2|Treated|Period 1||55
30540|NCT02117544|74510|P1|Treated|Period 1||52
30541|NCT02117544|74509|P2|STARTED|Period 1||55
30542|NCT02117544|74510|P1|STARTED|Period 1||54
30543|NCT02117479|74525|P2|NOT COMPLETED|Overall Study||156
30544|NCT02117479|74526|P1|NOT COMPLETED|Overall Study||156
30545|NCT02117479|74525|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
30546|NCT02117479|74526|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
30547|NCT02117479|74525|P2|STARTED|Overall Study||160
30548|NCT02117479|74526|P1|STARTED|Overall Study||161
30549|NCT02117414|74544|P2|NOT COMPLETED|Overall Study||6
30550|NCT02117414|74545|P1|NOT COMPLETED|Overall Study||15
30551|NCT02117414|74544|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
30552|NCT02117414|74545|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
30553|NCT02117414|74544|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
30554|NCT02117414|74545|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
30555|NCT02117310|74563|P1|NOT COMPLETED|Overall Study||0
30556|NCT02117310|74563|P1|COMPLETED|Overall Study||5
30557|NCT02117310|74563|P1|STARTED|Overall Study||5
30558|NCT02117193|74567|P1|NOT COMPLETED|Overall Study||0
30559|NCT02117193|74567|P1|COMPLETED|Overall Study||10
30560|NCT02117193|74567|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
30561|NCT02117193|74567|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
30562|NCT02117193|74567|P1|Placebo Intake + Normal Sleep|Overall Study||10
30563|NCT02117193|74567|P1|Alcohol Intake + Normal Sleep|Overall Study||10
30564|NCT02117193|74567|P1|STARTED|Overall Study||10
30565|NCT02117050|74589|P1|NOT COMPLETED|Overall Study||1
30566|NCT02117050|74589|P1|COMPLETED|Overall Study||0
30567|NCT02117050|74589|P1|STARTED|Overall Study||1
30568|NCT02116972|74604|P3|NOT COMPLETED|Overall Study||19
30569|NCT02116972|74605|P2|NOT COMPLETED|Overall Study||17
30570|NCT02116972|74606|P1|NOT COMPLETED|Overall Study||19
30571|NCT02116972|74604|P3|COMPLETED|Overall Study||85
30572|NCT02116972|74605|P2|COMPLETED|Overall Study||87
30573|NCT02116972|74606|P1|COMPLETED|Overall Study||83
30574|NCT02116972|74604|P3|STARTED|Overall Study||104
30575|NCT02116972|74605|P2|STARTED|Overall Study||104
30576|NCT02116972|74606|P1|STARTED|Overall Study||102
30577|NCT02116803|74638|P2|NOT COMPLETED|Overall Study||2
30578|NCT02116803|74639|P1|NOT COMPLETED|Overall Study||10
30579|NCT02116803|74638|P2|COMPLETED|Overall Study||0
30580|NCT02116803|74639|P1|COMPLETED|Overall Study||0
30581|NCT02116803|74638|P2|STARTED|Overall Study||2
30582|NCT02116803|74639|P1|STARTED|Overall Study||10
30583|NCT02116621|74647|P2|NOT COMPLETED|Twelve Month Follow-up||12
30584|NCT02116621|74648|P1|NOT COMPLETED|Twelve Month Follow-up||16
30585|NCT02116621|74647|P2|COMPLETED|Twelve Month Follow-up||86
30586|NCT02116621|74648|P1|COMPLETED|Twelve Month Follow-up||84
30587|NCT02116621|74647|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
30588|NCT02116621|74648|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
30589|NCT02116621|74647|P2|NOT COMPLETED|Six Month Follow-up||3
30590|NCT02116621|74648|P1|NOT COMPLETED|Six Month Follow-up||4
30591|NCT02116621|74647|P2|COMPLETED|Six Month Follow-up||97
30592|NCT02116621|74648|P1|COMPLETED|Six Month Follow-up||99
30593|NCT02116621|74647|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
30594|NCT02116621|74648|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
30595|NCT02116621|74647|P2|NOT COMPLETED|Three Month Follow-up||7
30596|NCT02116621|74648|P1|NOT COMPLETED|Three Month Follow-up||19
30597|NCT02116621|74647|P2|COMPLETED|Three Month Follow-up||96
30598|NCT02116621|74648|P1|COMPLETED|Three Month Follow-up||89
30599|NCT02116621|74647|P2|STARTED|Three Month Follow-up||103
30600|NCT02116621|74648|P1|STARTED|Three Month Follow-up||108
30601|NCT02116621|74647|P2|NOT COMPLETED|Baseline||4
30602|NCT02116621|74648|P1|NOT COMPLETED|Baseline||0
30603|NCT02116621|74647|P2|COMPLETED|Baseline||103
30604|NCT02116621|74648|P1|COMPLETED|Baseline||108
30605|NCT02116621|74647|P2|Completed Intervention Period|Baseline||103
30606|NCT02116621|74648|P1|Completed Intervention Period|Baseline||95
30607|NCT02116621|74647|P2|Completed Baseline Visit|Baseline||103
30608|NCT02116621|74648|P1|Completed Baseline Visit|Baseline||108
30609|NCT02116621|74647|P2|STARTED|Baseline||107
30610|NCT02116621|74648|P1|STARTED|Baseline||108
30611|NCT02116582|74736|P1|NOT COMPLETED|Overall Study||185
30612|NCT02116582|74736|P1|COMPLETED|Overall Study|Completed indicates participants were still on study drug at the time of the data cut-off.|30
30613|NCT02116582|74736|P1|Treated|Overall Study||214
30614|NCT02116582|74736|P1|STARTED|Overall Study||215
30615|NCT02116530|74746|P2|NOT COMPLETED|Overall Study||4
30616|NCT02116530|74747|P1|NOT COMPLETED|Overall Study||9
30617|NCT02116530|74746|P2|COMPLETED|Overall Study||184
30618|NCT02116530|74747|P1|COMPLETED|Overall Study||183
30619|NCT02116530|74746|P2|STARTED|Overall Study||188
30620|NCT02116530|74747|P1|STARTED|Overall Study||192
30621|NCT02116361|74765|P4|NOT COMPLETED|Overall Study||31
30622|NCT02116361|74766|P3|NOT COMPLETED|Overall Study||26
30623|NCT02116361|74767|P2|NOT COMPLETED|Overall Study||31
30624|NCT02116361|74768|P1|NOT COMPLETED|Overall Study||31
30625|NCT02116361|74765|P4|COMPLETED|Overall Study||34
30626|NCT02116361|74766|P3|COMPLETED|Overall Study||33
30627|NCT02116361|74767|P2|COMPLETED|Overall Study||34
30628|NCT02116361|74768|P1|COMPLETED|Overall Study||38
30629|NCT02116361|74765|P4|STARTED|Overall Study||65
30630|NCT02116361|74766|P3|STARTED|Overall Study||59
30631|NCT02116361|74767|P2|STARTED|Overall Study||65
30632|NCT02116361|74768|P1|STARTED|Overall Study||69
30633|NCT02116322|74798|P1|NOT COMPLETED|Overall Study||0
30634|NCT02116322|74798|P1|COMPLETED|Overall Study||1
30635|NCT02116322|74798|P1|STARTED|Overall Study||1
30636|NCT02116309|74805|P2|NOT COMPLETED|Overall Study||1
30637|NCT02116309|74806|P1|NOT COMPLETED|Overall Study||0
30638|NCT02116309|74805|P2|COMPLETED|Overall Study||477
30639|NCT02116309|74806|P1|COMPLETED|Overall Study||482
30640|NCT02116309|74805|P2|STARTED|Overall Study||478
30641|NCT02116309|74806|P1|STARTED|Overall Study||482
30642|NCT02115984|74816|P2|NOT COMPLETED|Overall Study||7
30643|NCT02115984|74817|P1|NOT COMPLETED|Overall Study||6
30644|NCT02115984|74816|P2|COMPLETED|Overall Study||16
30645|NCT02115984|74817|P1|COMPLETED|Overall Study||51
30646|NCT02115984|74816|P2|STARTED|Overall Study||23
30647|NCT02115984|74817|P1|STARTED|Overall Study||57
30648|NCT02115815|74830|P7|NOT COMPLETED|Overall Study||0
30649|NCT02115815|74831|P6|NOT COMPLETED|Overall Study||2
30650|NCT02115815|74832|P5|NOT COMPLETED|Overall Study||0
30651|NCT02115815|74833|P4|NOT COMPLETED|Overall Study||0
30652|NCT02115815|74834|P3|NOT COMPLETED|Overall Study||0
30653|NCT02115815|74835|P2|NOT COMPLETED|Overall Study||0
30654|NCT02115815|74836|P1|NOT COMPLETED|Overall Study||2
30655|NCT02115815|74830|P7|COMPLETED|Overall Study||20
30656|NCT02115815|74831|P6|COMPLETED|Overall Study||20
30657|NCT02115815|74832|P5|COMPLETED|Overall Study||20
30658|NCT02115815|74833|P4|COMPLETED|Overall Study||20
30659|NCT02115815|74834|P3|COMPLETED|Overall Study||20
30660|NCT02115815|74835|P2|COMPLETED|Overall Study||20
30661|NCT02115815|74836|P1|COMPLETED|Overall Study||22
30662|NCT02115815|74830|P7|STARTED|Overall Study||20
30663|NCT02115815|74831|P6|STARTED|Overall Study||22
30664|NCT02115815|74832|P5|STARTED|Overall Study||20
30665|NCT02115815|74833|P4|STARTED|Overall Study||20
30666|NCT02115815|74834|P3|STARTED|Overall Study||20
30667|NCT02115815|74835|P2|STARTED|Overall Study||20
30668|NCT02115815|74836|P1|STARTED|Overall Study||24
30669|NCT02115646|74929|P1|NOT COMPLETED|Overall Study||7
30670|NCT02115646|74929|P1|COMPLETED|Overall Study||22
30671|NCT02115646|74929|P1|STARTED|Overall Study||29
30672|NCT02115581|74944|P2|NOT COMPLETED|Overall Study||0
30673|NCT02115581|74945|P1|NOT COMPLETED|Overall Study||0
30674|NCT02115581|74944|P2|COMPLETED|Overall Study||21
30675|NCT02115581|74945|P1|COMPLETED|Overall Study||17
30676|NCT02115581|74944|P2|STARTED|Overall Study||21
30677|NCT02115581|74945|P1|STARTED|Overall Study||17
30678|NCT02115321|74957|P2|NOT COMPLETED|Overall Study||0
30679|NCT02115321|74958|P1|NOT COMPLETED|Overall Study||1
30680|NCT02115321|74957|P2|COMPLETED|Overall Study||10
30681|NCT02115321|74958|P1|COMPLETED|Overall Study||29
30682|NCT02115321|74957|P2|STARTED|Overall Study||10
30683|NCT02115321|74958|P1|STARTED|Overall Study||30
30684|NCT02115269|74978|P1|NOT COMPLETED|Overall Study||57
30685|NCT02115269|74978|P1|COMPLETED|Overall Study||702
30686|NCT02115269|74978|P1|STARTED|Overall Study||759
30687|NCT02115256|74998|P2|NOT COMPLETED|Overall Study||1
30688|NCT02115256|74999|P1|NOT COMPLETED|Overall Study||0
30689|NCT02115256|74998|P2|COMPLETED|Overall Study||2
30690|NCT02115256|74999|P1|COMPLETED|Overall Study||3
30691|NCT02115256|74998|P2|STARTED|Overall Study||3
30692|NCT02115256|74999|P1|STARTED|Overall Study||3
30693|NCT02114931|75013|P2|NOT COMPLETED|Overall Study||30
30694|NCT02114931|75014|P1|NOT COMPLETED|Overall Study||25
30695|NCT02114931|75013|P2|COMPLETED|Overall Study||207
30696|NCT02114931|75014|P1|COMPLETED|Overall Study||205
30697|NCT02114931|75013|P2|Received Treatment|Overall Study||237
30698|NCT02114931|75014|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
30699|NCT02114931|75013|P2|STARTED|Overall Study||237
30700|NCT02114931|75014|P1|STARTED|Overall Study||230
30701|NCT02114892|75030|P2|NOT COMPLETED|Overall Study||2
30702|NCT02114892|75031|P1|NOT COMPLETED|Overall Study||1
30703|NCT02114892|75030|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
30704|NCT02114892|75031|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
30705|NCT02114892|75030|P2|STARTED|Overall Study||12
30706|NCT02114892|75031|P1|STARTED|Overall Study||12
30707|NCT02114268|75071|P6|NOT COMPLETED|Overall Study||3
30708|NCT02114268|75072|P5|NOT COMPLETED|Overall Study||0
30709|NCT02114268|75073|P4|NOT COMPLETED|Overall Study||0
30710|NCT02114268|75074|P3|NOT COMPLETED|Overall Study||1
30711|NCT02114268|75075|P2|NOT COMPLETED|Overall Study||1
30712|NCT02114268|75076|P1|NOT COMPLETED|Overall Study||6
30713|NCT02114268|75071|P6|COMPLETED|Overall Study||75
30714|NCT02114268|75072|P5|COMPLETED|Overall Study||6
30715|NCT02114268|75073|P4|COMPLETED|Overall Study||6
30716|NCT02114268|75074|P3|COMPLETED|Overall Study||5
30717|NCT02114268|75075|P2|COMPLETED|Overall Study||5
30718|NCT02114268|75076|P1|COMPLETED|Overall Study||28
30719|NCT02114268|75071|P6|STARTED|Overall Study||78
30720|NCT02114268|75072|P5|STARTED|Overall Study||6
30721|NCT02114268|75073|P4|STARTED|Overall Study||6
30722|NCT02114268|75074|P3|STARTED|Overall Study||6
30723|NCT02114268|75075|P2|STARTED|Overall Study||6
30724|NCT02114268|75076|P1|STARTED|Overall Study||34
30725|NCT02114216|75129|P3|NOT COMPLETED|Overall Study||0
30726|NCT02114216|75130|P2|NOT COMPLETED|Overall Study||0
30727|NCT02114216|75131|P1|NOT COMPLETED|Overall Study||0
30728|NCT02114216|75129|P3|COMPLETED|Overall Study||14
30729|NCT02114216|75130|P2|COMPLETED|Overall Study||45
30730|NCT02114216|75131|P1|COMPLETED|Overall Study||16
30731|NCT02114216|75129|P3|STARTED|Overall Study||14
30732|NCT02114216|75130|P2|STARTED|Overall Study||45
30733|NCT02114216|75131|P1|STARTED|Overall Study||16
30734|NCT02114203|75145|P3|NOT COMPLETED|Overall Study||0
30735|NCT02114203|75146|P2|NOT COMPLETED|Overall Study||2
30736|NCT02114203|75147|P1|NOT COMPLETED|Overall Study||0
30737|NCT02114203|75145|P3|COMPLETED|Overall Study||7
30738|NCT02114203|75146|P2|COMPLETED|Overall Study||14
30739|NCT02114203|75147|P1|COMPLETED|Overall Study||7
30740|NCT02114203|75145|P3|STARTED|Overall Study||7
30741|NCT02114203|75146|P2|STARTED|Overall Study||16
30742|NCT02114203|75147|P1|STARTED|Overall Study||7
30743|NCT02114177|75181|P2|NOT COMPLETED|Overall Study||4
30744|NCT02114177|75182|P1|NOT COMPLETED|Overall Study||9
30745|NCT02114177|75181|P2|COMPLETED|Overall Study||151
30746|NCT02114177|75182|P1|COMPLETED|Overall Study||146
30747|NCT02114177|75181|P2|STARTED|Overall Study||155
30748|NCT02114177|75182|P1|STARTED|Overall Study||155
30749|NCT02114151|75206|P1|NOT COMPLETED|Overall Study||7
30750|NCT02114151|75206|P1|COMPLETED|Overall Study||96
30751|NCT02114151|75206|P1|STARTED|Overall Study||103
30752|NCT02113579|75223|P2|NOT COMPLETED|Overall Study||4
30753|NCT02113579|75224|P1|NOT COMPLETED|Overall Study||10
30754|NCT02113579|75223|P2|COMPLETED|Overall Study||185
30755|NCT02113579|75224|P1|COMPLETED|Overall Study||176
30756|NCT02113579|75223|P2|STARTED|Overall Study||189
30757|NCT02113579|75224|P1|STARTED|Overall Study||186
30758|NCT02113449|75248|P1|NOT COMPLETED|Overall Study||4
30759|NCT02113449|75248|P1|COMPLETED|Overall Study||143
30760|NCT02113449|75248|P1|STARTED|Overall Study||147
30761|NCT02113436|75264|P4|NOT COMPLETED|Period 2: 16 Weeks||11
30762|NCT02113436|75265|P3|NOT COMPLETED|Period 2: 16 Weeks||9
30763|NCT02113436|75266|P2|NOT COMPLETED|Period 2: 16 Weeks||0
30764|NCT02113436|75267|P1|NOT COMPLETED|Period 2: 16 Weeks||0
30765|NCT02113436|75264|P4|COMPLETED|Period 2: 16 Weeks||136
30766|NCT02113436|75265|P3|COMPLETED|Period 2: 16 Weeks||132
30767|NCT02113436|75266|P2|COMPLETED|Period 2: 16 Weeks||0
30768|NCT02113436|75267|P1|COMPLETED|Period 2: 16 Weeks||0
30769|NCT02113436|75264|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
30770|NCT02113436|75265|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
30771|NCT02113436|75266|P2|STARTED|Period 2: 16 Weeks||0
30772|NCT02113436|75267|P1|STARTED|Period 2: 16 Weeks||0
30773|NCT02113436|75264|P4|NOT COMPLETED|Period 1: 8 Weeks||0
30774|NCT02113436|75265|P3|NOT COMPLETED|Period 1: 8 Weeks||0
30775|NCT02113436|75266|P2|NOT COMPLETED|Period 1: 8 Weeks||2
30776|NCT02113436|75267|P1|NOT COMPLETED|Period 1: 8 Weeks||8
30777|NCT02113436|75264|P4|COMPLETED|Period 1: 8 Weeks||0
30778|NCT02113436|75265|P3|COMPLETED|Period 1: 8 Weeks||0
30779|NCT02113436|75266|P2|COMPLETED|Period 1: 8 Weeks||148
30780|NCT02113436|75267|P1|COMPLETED|Period 1: 8 Weeks||142
30781|NCT02113436|75264|P4|STARTED|Period 1: 8 Weeks||0
30782|NCT02113436|75265|P3|STARTED|Period 1: 8 Weeks||0
30783|NCT02113436|75266|P2|STARTED|Period 1: 8 Weeks||150
30784|NCT02113436|75267|P1|STARTED|Period 1: 8 Weeks||150
30785|NCT02113124|75290|P2|NOT COMPLETED|Overall Study||1
30786|NCT02113124|75291|P1|NOT COMPLETED|Overall Study||1
30787|NCT02113124|75290|P2|COMPLETED|Overall Study||24
30788|NCT02113124|75291|P1|COMPLETED|Overall Study||17
30789|NCT02113124|75290|P2|STARTED|Overall Study||25
30790|NCT02113124|75291|P1|STARTED|Overall Study||18
30791|NCT02113007|75297|P1|NOT COMPLETED|Overall Study||2
30792|NCT02113007|75297|P1|COMPLETED|Overall Study||0
30793|NCT02113007|75297|P1|STARTED|Overall Study||2
30794|NCT02112448|75305|P2|NOT COMPLETED|Overall Study||10
30795|NCT02112448|75306|P1|NOT COMPLETED|Overall Study||8
30796|NCT02112448|75305|P2|COMPLETED|Overall Study||30
30797|NCT02112448|75306|P1|COMPLETED|Overall Study||30
30798|NCT02112448|75305|P2|STARTED|Overall Study||40
30799|NCT02112448|75306|P1|STARTED|Overall Study||38
30800|NCT02112370|75316|P2|NOT COMPLETED|Overall Study||0
30801|NCT02112370|75317|P1|NOT COMPLETED|Overall Study||0
30802|NCT02112370|75316|P2|COMPLETED|Overall Study||74
30803|NCT02112370|75317|P1|COMPLETED|Overall Study||74
30804|NCT02112370|75316|P2|STARTED|Overall Study||74
30805|NCT02112370|75317|P1|STARTED|Overall Study||74
30806|NCT02111863|75337|P1|NOT COMPLETED|Overall Study||0
30807|NCT02111863|75337|P1|COMPLETED|Overall Study||6
30808|NCT02111863|75337|P1|STARTED|Overall Study||6
30809|NCT02111772|75345|P2|NOT COMPLETED|Overall Study||0
30810|NCT02111772|75346|P1|NOT COMPLETED|Overall Study||0
30811|NCT02111772|75345|P2|COMPLETED|Overall Study||14
30812|NCT02111772|75346|P1|COMPLETED|Overall Study||12
30813|NCT02111772|75345|P2|STARTED|Overall Study||14
30814|NCT02111772|75346|P1|STARTED|Overall Study||12
30815|NCT02111603|75354|P1|NOT COMPLETED|Overall Study||1
30816|NCT02111603|75354|P1|COMPLETED|Overall Study||12
30817|NCT02111603|75354|P1|STARTED|Overall Study||13
30818|NCT02111369|75363|P1|NOT COMPLETED|Overall Study||3
30819|NCT02111369|75363|P1|COMPLETED|Overall Study||15
30820|NCT02111369|75363|P1|STARTED|Overall Study||18
30821|NCT02111252|75371|P1|NOT COMPLETED|Overall Study||0
30822|NCT02111252|75371|P1|COMPLETED|Overall Study||55
30823|NCT02111252|75371|P1|STARTED|Overall Study||55
30824|NCT02111200|75389|P4|NOT COMPLETED|Overall Study||0
30825|NCT02111200|75390|P3|NOT COMPLETED|Overall Study||0
30826|NCT02111200|75391|P2|NOT COMPLETED|Overall Study||0
30827|NCT02111200|75392|P1|NOT COMPLETED|Overall Study||0
30828|NCT02111200|75389|P4|COMPLETED|Overall Study||1
30829|NCT02111200|75390|P3|COMPLETED|Overall Study||1
30830|NCT02111200|75391|P2|COMPLETED|Overall Study||2
30831|NCT02111200|75392|P1|COMPLETED|Overall Study||3
30832|NCT02111200|75389|P4|STARTED|Overall Study||1
30833|NCT02111200|75390|P3|STARTED|Overall Study||1
30834|NCT02111200|75391|P2|STARTED|Overall Study||2
30835|NCT02111200|75392|P1|STARTED|Overall Study||3
30836|NCT02111096|75409|P3|NOT COMPLETED|Overall Study||66
30837|NCT02111096|75410|P2|NOT COMPLETED|Overall Study||41
30838|NCT02111096|75411|P1|NOT COMPLETED|Overall Study||64
30839|NCT02111096|75409|P3|COMPLETED|Overall Study||2
30840|NCT02111096|75410|P2|COMPLETED|Overall Study||0
30841|NCT02111096|75411|P1|COMPLETED|Overall Study||1
30842|NCT02111096|75409|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
30843|NCT02111096|75410|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
30844|NCT02111096|75411|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
30845|NCT02111096|75409|P3|STARTED|Overall Study||68
30846|NCT02111096|75410|P2|STARTED|Overall Study||41
30847|NCT02111096|75411|P1|STARTED|Overall Study||65
30848|NCT02111083|75459|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
30849|NCT02111083|75460|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
30850|NCT02111083|75459|P2|COMPLETED|Fourth Intervention (1 Day)||18
30851|NCT02111083|75460|P1|COMPLETED|Fourth Intervention (1 Day)||18
30852|NCT02111083|75459|P2|STARTED|Fourth Intervention (1 Day)||18
30853|NCT02111083|75460|P1|STARTED|Fourth Intervention (1 Day)||18
30854|NCT02111083|75459|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
30855|NCT02111083|75460|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
30856|NCT02111083|75459|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
30857|NCT02111083|75460|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
30858|NCT02111083|75459|P2|STARTED|Interval Between Dosing (7-8 Days)||19
30859|NCT02111083|75460|P1|STARTED|Interval Between Dosing (7-8 Days)||19
30860|NCT02111083|75459|P2|NOT COMPLETED|Third Intervention (1 Day)||0
30861|NCT02111083|75460|P1|NOT COMPLETED|Third Intervention (1 Day)||0
30862|NCT02111083|75459|P2|COMPLETED|Third Intervention (1 Day)||19
30863|NCT02111083|75460|P1|COMPLETED|Third Intervention (1 Day)||19
30864|NCT02111083|75459|P2|STARTED|Third Intervention (1 Day)||19
30865|NCT02111083|75460|P1|STARTED|Third Intervention (1 Day)||19
30866|NCT02111083|75459|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
30867|NCT02111083|75460|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
30868|NCT02111083|75459|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
30869|NCT02111083|75460|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
30870|NCT02111083|75459|P2|STARTED|Interval Between Dosing (7-8 Days)||19
30871|NCT02111083|75460|P1|STARTED|Interval Between Dosing (7-8 Days)||19
30872|NCT02111083|75459|P2|NOT COMPLETED|Second Intervention (1 Day)||0
30873|NCT02111083|75460|P1|NOT COMPLETED|Second Intervention (1 Day)||0
30874|NCT02111083|75459|P2|COMPLETED|Second Intervention (1 Day)||19
30875|NCT02111083|75460|P1|COMPLETED|Second Intervention (1 Day)||19
30876|NCT02111083|75459|P2|STARTED|Second Intervention (1 Day)||19
30877|NCT02111083|75460|P1|STARTED|Second Intervention (1 Day)||19
30878|NCT02111083|75459|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
30879|NCT02111083|75460|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
30880|NCT02111083|75459|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
30881|NCT02111083|75460|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
30882|NCT02111083|75459|P2|STARTED|Interval Between Dosing (7-8 Days)||19
30883|NCT02111083|75460|P1|STARTED|Interval Between Dosing (7-8 Days)||19
30884|NCT02111083|75459|P2|NOT COMPLETED|First Intervention (1 Day)||0
30885|NCT02111083|75460|P1|NOT COMPLETED|First Intervention (1 Day)||0
30886|NCT02111083|75459|P2|COMPLETED|First Intervention (1 Day)||19
30887|NCT02111083|75460|P1|COMPLETED|First Intervention (1 Day)||19
30888|NCT02111083|75459|P2|STARTED|First Intervention (1 Day)||19
30889|NCT02111083|75460|P1|STARTED|First Intervention (1 Day)||19
30890|NCT02110693|75478|P2|NOT COMPLETED|Overall Study||29
30891|NCT02110693|75479|P1|NOT COMPLETED|Overall Study||28
30892|NCT02110693|75478|P2|COMPLETED|Overall Study||1002
30893|NCT02110693|75479|P1|COMPLETED|Overall Study||998
30894|NCT02110693|75478|P2|STARTED|Overall Study||1031
30895|NCT02110693|75479|P1|STARTED|Overall Study||1026
30896|NCT02110381|75506|P2|NOT COMPLETED|Dual Modality||1
30897|NCT02110381|75507|P1|NOT COMPLETED|Dual Modality||2
30898|NCT02110381|75506|P2|COMPLETED|Dual Modality||7
30899|NCT02110381|75507|P1|COMPLETED|Dual Modality||5
30900|NCT02110381|75506|P2|Began Active Treatment|Dual Modality||7
30901|NCT02110381|75507|P1|Began Active Treatment|Dual Modality||7
30902|NCT02110381|75506|P2|STARTED|Dual Modality||8
30903|NCT02110381|75507|P1|STARTED|Dual Modality||7
30904|NCT02110381|75506|P2|NOT COMPLETED|Single Modality||1
30905|NCT02110381|75507|P1|NOT COMPLETED|Single Modality||2
30906|NCT02110381|75506|P2|COMPLETED|Single Modality||8
30907|NCT02110381|75507|P1|COMPLETED|Single Modality||7
30908|NCT02110381|75506|P2|STARTED|Single Modality||9
30909|NCT02110381|75507|P1|STARTED|Single Modality||9
30910|NCT02110277|75518|P1|NOT COMPLETED|Overall Study||2
30911|NCT02110277|75518|P1|COMPLETED|Overall Study||0
30912|NCT02110277|75518|P1|STARTED|Overall Study||2
30913|NCT02110238|75525|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
30914|NCT02110238|75526|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
30915|NCT02110238|75525|P2|COMPLETED|14 Week Blinded Extension Phase||188
30916|NCT02110238|75526|P1|COMPLETED|14 Week Blinded Extension Phase||190
30917|NCT02110238|75525|P2|STARTED|14 Week Blinded Extension Phase||200
30918|NCT02110238|75526|P1|STARTED|14 Week Blinded Extension Phase||202
30919|NCT02110238|75525|P2|NOT COMPLETED|12 Week Pivotal Phase||9
30920|NCT02110238|75526|P1|NOT COMPLETED|12 Week Pivotal Phase||10
30921|NCT02110238|75525|P2|COMPLETED|12 Week Pivotal Phase||200
30922|NCT02110238|75526|P1|COMPLETED|12 Week Pivotal Phase||202
30923|NCT02110238|75525|P2|STARTED|12 Week Pivotal Phase||209
30924|NCT02110238|75526|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
30925|NCT02110147|75532|P1|NOT COMPLETED|Overall Study||0
30926|NCT02110147|75532|P1|COMPLETED|Overall Study||4
30927|NCT02110147|75532|P1|STARTED|Overall Study||4
30928|NCT02109731|75538|P1|NOT COMPLETED|Overall Study||0
30929|NCT02109731|75538|P1|COMPLETED|Overall Study||15
30930|NCT02109731|75538|P1|STARTED|Overall Study||15
30931|NCT02109640|75544|P2|NOT COMPLETED|Overall Study||0
30932|NCT02109640|75545|P1|NOT COMPLETED|Overall Study||0
30933|NCT02109640|75544|P2|COMPLETED|Overall Study||23
30934|NCT02109640|75545|P1|COMPLETED|Overall Study||27
30935|NCT02109640|75544|P2|STARTED|Overall Study||23
30936|NCT02109640|75545|P1|STARTED|Overall Study||27
30937|NCT02109497|75555|P1|NOT COMPLETED|Overall Study||1
30938|NCT02109497|75555|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
30939|NCT02109497|75555|P1|STARTED|Overall Study||18
30940|NCT02109484|75568|P8|NOT COMPLETED|Overall Study||3
30941|NCT02109484|75569|P7|NOT COMPLETED|Overall Study||3
30942|NCT02109484|75570|P6|NOT COMPLETED|Overall Study||1
30943|NCT02109484|75571|P5|NOT COMPLETED|Overall Study||4
30944|NCT02109484|75572|P4|NOT COMPLETED|Overall Study||1
30945|NCT02109484|75573|P3|NOT COMPLETED|Overall Study||0
30946|NCT02109484|75574|P2|NOT COMPLETED|Overall Study||0
30947|NCT02109484|75575|P1|NOT COMPLETED|Overall Study||0
30948|NCT02109484|75568|P8|COMPLETED|Overall Study||47
30949|NCT02109484|75569|P7|COMPLETED|Overall Study||47
30950|NCT02109484|75570|P6|COMPLETED|Overall Study||11
30951|NCT02109484|75571|P5|COMPLETED|Overall Study||46
30952|NCT02109484|75572|P4|COMPLETED|Overall Study||11
30953|NCT02109484|75573|P3|COMPLETED|Overall Study||12
30954|NCT02109484|75574|P2|COMPLETED|Overall Study||13
30955|NCT02109484|75575|P1|COMPLETED|Overall Study||5
30956|NCT02109484|75568|P8|STARTED|Overall Study||50
30957|NCT02109484|75569|P7|STARTED|Overall Study||50
30958|NCT02109484|75570|P6|STARTED|Overall Study||12
30959|NCT02109484|75571|P5|STARTED|Overall Study||50
30960|NCT02109484|75572|P4|STARTED|Overall Study||12
30961|NCT02109484|75573|P3|STARTED|Overall Study||12
30962|NCT02109484|75574|P2|STARTED|Overall Study||13
30963|NCT02109484|75575|P1|STARTED|Overall Study||5
30964|NCT02109458|75624|P1|NOT COMPLETED|Overall Study||0
30965|NCT02109458|75624|P1|COMPLETED|Overall Study||24
30966|NCT02109458|75624|P1|STARTED|Overall Study||24
30967|NCT02109445|75631|P1|NOT COMPLETED|Overall Study||3
30968|NCT02109445|75631|P1|COMPLETED|Overall Study||0
30969|NCT02109445|75631|P1|STARTED|Overall Study||3
30970|NCT02109172|75664|P6|NOT COMPLETED|Overall Study||1
30971|NCT02109172|75665|P5|NOT COMPLETED|Overall Study||1
30972|NCT02109172|75666|P4|NOT COMPLETED|Overall Study||1
30973|NCT02109172|75667|P3|NOT COMPLETED|Overall Study||1
30974|NCT02109172|75668|P2|NOT COMPLETED|Overall Study||0
30975|NCT02109172|75669|P1|NOT COMPLETED|Overall Study||1
30976|NCT02109172|75664|P6|COMPLETED|Overall Study||10
30977|NCT02109172|75665|P5|COMPLETED|Overall Study||9
30978|NCT02109172|75666|P4|COMPLETED|Overall Study||10
30979|NCT02109172|75667|P3|COMPLETED|Overall Study||9
30980|NCT02109172|75668|P2|COMPLETED|Overall Study||11
30981|NCT02109172|75669|P1|COMPLETED|Overall Study||10
30982|NCT02109172|75664|P6|STARTED|Overall Study||11
30983|NCT02109172|75665|P5|STARTED|Overall Study||10
30984|NCT02109172|75666|P4|STARTED|Overall Study||11
30985|NCT02109172|75667|P3|STARTED|Overall Study||10
30986|NCT02109172|75668|P2|STARTED|Overall Study||11
30987|NCT02109172|75669|P1|STARTED|Overall Study||11
30988|NCT02109159|75679|P2|NOT COMPLETED|Overall Study||0
30989|NCT02109159|75680|P1|NOT COMPLETED|Overall Study||0
30990|NCT02109159|75679|P2|COMPLETED|Overall Study||4175
30991|NCT02109159|75680|P1|COMPLETED|Overall Study||4178
30992|NCT02109159|75679|P2|STARTED|Overall Study||4175
30993|NCT02109159|75680|P1|STARTED|Overall Study||4178
30994|NCT02109133|75690|P2|NOT COMPLETED|Overall Study||0
30995|NCT02109133|75691|P1|NOT COMPLETED|Overall Study||1
30996|NCT02109133|75690|P2|COMPLETED|Overall Study||34
30997|NCT02109133|75691|P1|COMPLETED|Overall Study||32
30998|NCT02109133|75690|P2|STARTED|Overall Study||34
30999|NCT02109133|75691|P1|STARTED|Overall Study||33
31000|NCT02109107|75703|P1|NOT COMPLETED|Overall Study||2
31001|NCT02109107|75703|P1|COMPLETED|Overall Study||52
31002|NCT02109107|75703|P1|STARTED|Overall Study||54
31003|NCT02108977|75712|P2|NOT COMPLETED|Overall Study||1
31004|NCT02108977|75713|P1|NOT COMPLETED|Overall Study||10
31005|NCT02108977|75712|P2|COMPLETED|Overall Study||19
31006|NCT02108977|75713|P1|COMPLETED|Overall Study||8
31007|NCT02108977|75712|P2|STARTED|Overall Study||20
31008|NCT02108977|75713|P1|STARTED|Overall Study||18
31009|NCT02108951|75725|P1|NOT COMPLETED|Overall Study||16
31010|NCT02108951|75725|P1|COMPLETED|Overall Study||4
31011|NCT02108951|75725|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
31012|NCT02108691|75744|P2|NOT COMPLETED|Overall Study||9
31013|NCT02108691|75745|P1|NOT COMPLETED|Overall Study||8
31014|NCT02108691|75744|P2|COMPLETED|Overall Study||31
31015|NCT02108691|75745|P1|COMPLETED|Overall Study||32
31016|NCT02108691|75744|P2|STARTED|Overall Study||40
31017|NCT02108691|75745|P1|STARTED|Overall Study||40
31018|NCT02108652|75763|P1|NOT COMPLETED|Overall Study||310
31019|NCT02108652|75763|P1|COMPLETED|Overall Study||0
31020|NCT02108652|75763|P1|STARTED|Overall Study||310
31021|NCT02108288|75787|P3|NOT COMPLETED|Overall Study||0
31022|NCT02108288|75788|P2|NOT COMPLETED|Overall Study||0
31023|NCT02108288|75789|P1|NOT COMPLETED|Overall Study||0
31024|NCT02108288|75787|P3|COMPLETED|Overall Study||10
31025|NCT02108288|75788|P2|COMPLETED|Overall Study||10
31026|NCT02108288|75789|P1|COMPLETED|Overall Study||10
31027|NCT02108288|75787|P3|STARTED|Overall Study||10
31028|NCT02108288|75788|P2|STARTED|Overall Study||10
31029|NCT02108288|75789|P1|STARTED|Overall Study||10
31030|NCT02108223|75805|P3|NOT COMPLETED|Overall Study||0
31031|NCT02108223|75806|P2|NOT COMPLETED|Overall Study||0
31032|NCT02108223|75807|P1|NOT COMPLETED|Overall Study||0
31033|NCT02108223|75805|P3|COMPLETED|Overall Study||35
31034|NCT02108223|75806|P2|COMPLETED|Overall Study||50
31035|NCT02108223|75807|P1|COMPLETED|Overall Study||52
31036|NCT02108223|75805|P3|STARTED|Overall Study||35
31037|NCT02108223|75806|P2|STARTED|Overall Study||50
31038|NCT02108223|75807|P1|STARTED|Overall Study||52
31039|NCT02108171|75829|P2|NOT COMPLETED|Overall Study||0
31040|NCT02108171|75830|P1|NOT COMPLETED|Overall Study||0
31041|NCT02108171|75829|P2|COMPLETED|Overall Study||41
31042|NCT02108171|75830|P1|COMPLETED|Overall Study||40
31043|NCT02108171|75829|P2|STARTED|Overall Study||41
31044|NCT02108171|75830|P1|STARTED|Overall Study||40
31045|NCT02107898|75932|P2|NOT COMPLETED|Overall Study||12
31046|NCT02107898|75933|P1|NOT COMPLETED|Overall Study||6
31047|NCT02107898|75932|P2|COMPLETED|Overall Study||132
31048|NCT02107898|75933|P1|COMPLETED|Overall Study||66
31049|NCT02107898|75932|P2|Treated|Overall Study||143
31050|NCT02107898|75933|P1|Treated|Overall Study||72
31051|NCT02107898|75932|P2|STARTED|Overall Study|Randomized|144
31052|NCT02107898|75933|P1|STARTED|Overall Study|Randomized|72
31053|NCT02107703|75987|P2|NOT COMPLETED|Overall Study||175
31054|NCT02107703|75988|P1|NOT COMPLETED|Overall Study||361
31055|NCT02107703|75987|P2|COMPLETED|Overall Study||48
31056|NCT02107703|75988|P1|COMPLETED|Overall Study||85
31057|NCT02107703|75987|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
31058|NCT02107703|75988|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
31059|NCT02107703|75987|P2|STARTED|Overall Study||223
31060|NCT02107703|75988|P1|STARTED|Overall Study||446
31061|NCT02107599|76013|P1|NOT COMPLETED|Overall Study||0
31062|NCT02107599|76013|P1|COMPLETED|Overall Study||96
31063|NCT02107599|76013|P1|STARTED|Overall Study||96
31064|NCT02107482|76020|P1|NOT COMPLETED|Overall Study||4
31065|NCT02107482|76020|P1|COMPLETED|Overall Study||17
31066|NCT02107482|76020|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
31067|NCT02107339|76028|P2|NOT COMPLETED|Overall Study||4
31068|NCT02107339|76029|P1|NOT COMPLETED|Overall Study||1
31069|NCT02107339|76028|P2|COMPLETED|Overall Study||53
31070|NCT02107339|76029|P1|COMPLETED|Overall Study||62
31071|NCT02107339|76028|P2|STARTED|Overall Study||57
31072|NCT02107339|76029|P1|STARTED|Overall Study||63
31073|NCT02107313|76057|P2|NOT COMPLETED|Overall Study||1
31074|NCT02107313|76058|P1|NOT COMPLETED|Overall Study||0
31075|NCT02107313|76057|P2|COMPLETED|Overall Study||8
31076|NCT02107313|76058|P1|COMPLETED|Overall Study||9
31077|NCT02107313|76057|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
31078|NCT02107313|76058|P1|STARTED|Overall Study||9
31079|NCT02107274|76068|P2|NOT COMPLETED|Control Phase||2
31080|NCT02107274|76069|P1|NOT COMPLETED|Control Phase||3
31081|NCT02107274|76068|P2|COMPLETED|Control Phase||35
31082|NCT02107274|76069|P1|COMPLETED|Control Phase||33
31083|NCT02107274|76068|P2|STARTED|Control Phase||37
31084|NCT02107274|76069|P1|STARTED|Control Phase||36
31085|NCT02107274|76068|P2|NOT COMPLETED|Treatment vs. Placebo||2
31086|NCT02107274|76069|P1|NOT COMPLETED|Treatment vs. Placebo||3
31087|NCT02107274|76068|P2|COMPLETED|Treatment vs. Placebo||37
31088|NCT02107274|76069|P1|COMPLETED|Treatment vs. Placebo||36
31089|NCT02107274|76068|P2|STARTED|Treatment vs. Placebo||39
31090|NCT02107274|76069|P1|STARTED|Treatment vs. Placebo||39
31091|NCT02107196|76083|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
31092|NCT02107196|76084|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
31093|NCT02107196|76083|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
31094|NCT02107196|76084|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
31095|NCT02107196|76083|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
31096|NCT02107196|76084|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
31097|NCT02107196|76083|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
31098|NCT02107196|76084|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
31099|NCT02107196|76083|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
31100|NCT02107196|76084|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
31101|NCT02107196|76083|P2|NOT COMPLETED|12-week Treatment Period||39
31102|NCT02107196|76084|P1|NOT COMPLETED|12-week Treatment Period||44
31103|NCT02107196|76083|P2|COMPLETED|12-week Treatment Period||225
31104|NCT02107196|76084|P1|COMPLETED|12-week Treatment Period||227
31105|NCT02107196|76083|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
31106|NCT02107196|76084|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
31107|NCT02107196|76083|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
31108|NCT02107196|76084|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
31109|NCT02107196|76083|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
31110|NCT02107196|76084|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
31111|NCT02107014|76097|P1|NOT COMPLETED|Overall Study||1
31112|NCT02107014|76097|P1|COMPLETED|Overall Study||8
31113|NCT02107014|76097|P1|STARTED|Overall Study||9
31114|NCT02106962|76167|P2|NOT COMPLETED|Overall Study||0
31115|NCT02106962|76168|P1|NOT COMPLETED|Overall Study||0
31116|NCT02106962|76167|P2|COMPLETED|Overall Study||9
31117|NCT02106962|76168|P1|COMPLETED|Overall Study||8
31118|NCT02106962|76167|P2|STARTED|Overall Study||9
31119|NCT02106962|76168|P1|STARTED|Overall Study||8
31120|NCT02106923|76179|P6|NOT COMPLETED|Overall Study||1
31121|NCT02106923|76180|P5|NOT COMPLETED|Overall Study||0
31122|NCT02106923|76181|P4|NOT COMPLETED|Overall Study||0
31123|NCT02106923|76182|P3|NOT COMPLETED|Overall Study||0
31124|NCT02106923|76183|P2|NOT COMPLETED|Overall Study||0
31125|NCT02106923|76184|P1|NOT COMPLETED|Overall Study||0
31126|NCT02106923|76179|P6|COMPLETED|Overall Study||11
31127|NCT02106923|76180|P5|COMPLETED|Overall Study||12
31128|NCT02106923|76181|P4|COMPLETED|Overall Study||12
31129|NCT02106923|76182|P3|COMPLETED|Overall Study||12
31130|NCT02106923|76183|P2|COMPLETED|Overall Study||12
31131|NCT02106923|76184|P1|COMPLETED|Overall Study||12
31132|NCT02106923|76179|P6|STARTED|Overall Study||12
31133|NCT02106923|76180|P5|STARTED|Overall Study||12
31134|NCT02106923|76181|P4|STARTED|Overall Study||12
31135|NCT02106923|76182|P3|STARTED|Overall Study||12
31136|NCT02106923|76183|P2|STARTED|Overall Study||12
31137|NCT02106923|76184|P1|STARTED|Overall Study||12
31138|NCT02106832|76232|P4|NOT COMPLETED|Overall Study||15
31139|NCT02106832|76233|P3|NOT COMPLETED|Overall Study||16
31140|NCT02106832|76234|P2|NOT COMPLETED|Overall Study||25
31141|NCT02106832|76235|P1|NOT COMPLETED|Overall Study||23
31142|NCT02106832|76232|P4|COMPLETED|Overall Study||73
31143|NCT02106832|76233|P3|COMPLETED|Overall Study||70
31144|NCT02106832|76234|P2|COMPLETED|Overall Study||151
31145|NCT02106832|76235|P1|COMPLETED|Overall Study||148
31146|NCT02106832|76232|P4|Participants Received Treatment|Overall Study||88
31147|NCT02106832|76233|P3|Participants Received Treatment|Overall Study||86
31148|NCT02106832|76234|P2|Participants Received Treatment|Overall Study||174
31149|NCT02106832|76235|P1|Participants Received Treatment|Overall Study||171
31150|NCT02106832|76232|P4|STARTED|Overall Study||88
31151|NCT02106832|76233|P3|STARTED|Overall Study||86
31152|NCT02106832|76234|P2|STARTED|Overall Study||176
31153|NCT02106832|76235|P1|STARTED|Overall Study||171
31154|NCT02106728|76270|P2|NOT COMPLETED|Overall Study||0
31155|NCT02106728|76271|P1|NOT COMPLETED|Overall Study||0
31156|NCT02106728|76270|P2|COMPLETED|Overall Study||47
31157|NCT02106728|76271|P1|COMPLETED|Overall Study||70
31158|NCT02106728|76270|P2|STARTED|Overall Study||47
31159|NCT02106728|76271|P1|STARTED|Overall Study||70
31160|NCT02106494|76287|P2|NOT COMPLETED|Overall Study||25
31161|NCT02106494|76288|P1|NOT COMPLETED|Overall Study||26
31162|NCT02106494|76287|P2|COMPLETED|Overall Study||446
31163|NCT02106494|76288|P1|COMPLETED|Overall Study||445
31164|NCT02106494|76287|P2|Efficacy Population|Overall Study||452
31165|NCT02106494|76288|P1|Efficacy Population|Overall Study||450
31166|NCT02106494|76287|P2|Safety Population|Overall Study||459
31167|NCT02106494|76288|P1|Safety Population|Overall Study||456
31168|NCT02106494|76287|P2|STARTED|Overall Study||471
31169|NCT02106494|76288|P1|STARTED|Overall Study||471
31170|NCT02106403|76302|P6|NOT COMPLETED|Follow-Up Visit 3||1
31171|NCT02106403|76303|P5|NOT COMPLETED|Follow-Up Visit 3||0
31172|NCT02106403|76304|P4|NOT COMPLETED|Follow-Up Visit 3||0
31173|NCT02106403|76305|P3|NOT COMPLETED|Follow-Up Visit 3||0
31174|NCT02106403|76306|P2|NOT COMPLETED|Follow-Up Visit 3||0
31175|NCT02106403|76307|P1|NOT COMPLETED|Follow-Up Visit 3||0
31176|NCT02106403|76302|P6|COMPLETED|Follow-Up Visit 3||8
31177|NCT02106403|76303|P5|COMPLETED|Follow-Up Visit 3||8
31178|NCT02106403|76304|P4|COMPLETED|Follow-Up Visit 3||8
31179|NCT02106403|76305|P3|COMPLETED|Follow-Up Visit 3||9
31180|NCT02106403|76306|P2|COMPLETED|Follow-Up Visit 3||8
31181|NCT02106403|76307|P1|COMPLETED|Follow-Up Visit 3||8
31182|NCT02106403|76302|P6|STARTED|Follow-Up Visit 3||9
31183|NCT02106403|76303|P5|STARTED|Follow-Up Visit 3||8
31184|NCT02106403|76304|P4|STARTED|Follow-Up Visit 3||8
31185|NCT02106403|76305|P3|STARTED|Follow-Up Visit 3||9
31186|NCT02106403|76306|P2|STARTED|Follow-Up Visit 3||8
31187|NCT02106403|76307|P1|STARTED|Follow-Up Visit 3||8
31188|NCT02106403|76302|P6|NOT COMPLETED|Follow-Up Visit 2||0
31189|NCT02106403|76303|P5|NOT COMPLETED|Follow-Up Visit 2||0
31190|NCT02106403|76304|P4|NOT COMPLETED|Follow-Up Visit 2||0
31191|NCT02106403|76305|P3|NOT COMPLETED|Follow-Up Visit 2||0
31192|NCT02106403|76306|P2|NOT COMPLETED|Follow-Up Visit 2||0
31193|NCT02106403|76307|P1|NOT COMPLETED|Follow-Up Visit 2||0
31194|NCT02106403|76302|P6|COMPLETED|Follow-Up Visit 2||9
31195|NCT02106403|76303|P5|COMPLETED|Follow-Up Visit 2||8
31196|NCT02106403|76304|P4|COMPLETED|Follow-Up Visit 2||8
31197|NCT02106403|76305|P3|COMPLETED|Follow-Up Visit 2||9
31198|NCT02106403|76306|P2|COMPLETED|Follow-Up Visit 2||8
31199|NCT02106403|76307|P1|COMPLETED|Follow-Up Visit 2||8
31200|NCT02106403|76302|P6|STARTED|Follow-Up Visit 2||9
31201|NCT02106403|76303|P5|STARTED|Follow-Up Visit 2||8
31202|NCT02106403|76304|P4|STARTED|Follow-Up Visit 2||8
31203|NCT02106403|76305|P3|STARTED|Follow-Up Visit 2||9
31204|NCT02106403|76306|P2|STARTED|Follow-Up Visit 2||8
31205|NCT02106403|76307|P1|STARTED|Follow-Up Visit 2||8
31206|NCT02106403|76302|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
31207|NCT02106403|76303|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
31208|NCT02106403|76304|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
31209|NCT02106403|76305|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
31210|NCT02106403|76306|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
31211|NCT02106403|76307|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
31212|NCT02106403|76302|P6|COMPLETED|Visit 1, Treatment Period 3||9
31213|NCT02106403|76303|P5|COMPLETED|Visit 1, Treatment Period 3||8
31214|NCT02106403|76304|P4|COMPLETED|Visit 1, Treatment Period 3||8
31215|NCT02106403|76305|P3|COMPLETED|Visit 1, Treatment Period 3||9
31216|NCT02106403|76306|P2|COMPLETED|Visit 1, Treatment Period 3||8
31217|NCT02106403|76307|P1|COMPLETED|Visit 1, Treatment Period 3||8
31218|NCT02106403|76302|P6|STARTED|Visit 1, Treatment Period 3||9
31219|NCT02106403|76303|P5|STARTED|Visit 1, Treatment Period 3||8
31220|NCT02106403|76304|P4|STARTED|Visit 1, Treatment Period 3||8
31221|NCT02106403|76305|P3|STARTED|Visit 1, Treatment Period 3||9
31222|NCT02106403|76306|P2|STARTED|Visit 1, Treatment Period 3||8
31223|NCT02106403|76307|P1|STARTED|Visit 1, Treatment Period 3||8
31224|NCT02106403|76302|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
31225|NCT02106403|76303|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
31226|NCT02106403|76304|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
31227|NCT02106403|76305|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
31228|NCT02106403|76306|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
31229|NCT02106403|76307|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
31230|NCT02106403|76302|P6|COMPLETED|Visit 1, Treatment Period 2||9
31231|NCT02106403|76303|P5|COMPLETED|Visit 1, Treatment Period 2||8
31232|NCT02106403|76304|P4|COMPLETED|Visit 1, Treatment Period 2||8
31233|NCT02106403|76305|P3|COMPLETED|Visit 1, Treatment Period 2||9
31234|NCT02106403|76306|P2|COMPLETED|Visit 1, Treatment Period 2||8
31235|NCT02106403|76307|P1|COMPLETED|Visit 1, Treatment Period 2||8
31236|NCT02106403|76302|P6|STARTED|Visit 1, Treatment Period 2||9
31237|NCT02106403|76303|P5|STARTED|Visit 1, Treatment Period 2||8
31238|NCT02106403|76304|P4|STARTED|Visit 1, Treatment Period 2||8
31239|NCT02106403|76305|P3|STARTED|Visit 1, Treatment Period 2||9
31240|NCT02106403|76306|P2|STARTED|Visit 1, Treatment Period 2||8
31241|NCT02106403|76307|P1|STARTED|Visit 1, Treatment Period 2||8
31242|NCT02106403|76302|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
31243|NCT02106403|76303|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
31244|NCT02106403|76304|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
31245|NCT02106403|76305|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
31246|NCT02106403|76306|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
31247|NCT02106403|76307|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
31248|NCT02106403|76302|P6|COMPLETED|Visit 1, Treatment Period 1||9
31249|NCT02106403|76303|P5|COMPLETED|Visit 1, Treatment Period 1||8
31250|NCT02106403|76304|P4|COMPLETED|Visit 1, Treatment Period 1||8
31251|NCT02106403|76305|P3|COMPLETED|Visit 1, Treatment Period 1||9
31252|NCT02106403|76306|P2|COMPLETED|Visit 1, Treatment Period 1||8
31253|NCT02106403|76307|P1|COMPLETED|Visit 1, Treatment Period 1||8
31254|NCT02106403|76302|P6|STARTED|Visit 1, Treatment Period 1||9
31255|NCT02106403|76303|P5|STARTED|Visit 1, Treatment Period 1||8
31256|NCT02106403|76304|P4|STARTED|Visit 1, Treatment Period 1||8
31257|NCT02106403|76305|P3|STARTED|Visit 1, Treatment Period 1||9
31258|NCT02106403|76306|P2|STARTED|Visit 1, Treatment Period 1||8
31259|NCT02106403|76307|P1|STARTED|Visit 1, Treatment Period 1||8
31260|NCT02106156|76330|P3|NOT COMPLETED|Overall Study||0
31261|NCT02106156|76331|P2|NOT COMPLETED|Overall Study||40
31262|NCT02106156|76332|P1|NOT COMPLETED|Overall Study||2549
31263|NCT02106156|76330|P3|COMPLETED|Overall Study||518
31264|NCT02106156|76331|P2|COMPLETED|Overall Study||50
31265|NCT02106156|76332|P1|COMPLETED|Overall Study||7071
31266|NCT02106156|76330|P3|STARTED|Overall Study||518
31267|NCT02106156|76331|P2|STARTED|Overall Study||90
31268|NCT02106156|76332|P1|STARTED|Overall Study||9620
31269|NCT02105987|76356|P6|NOT COMPLETED|Continuation Phase||0
31270|NCT02105987|76357|P5|NOT COMPLETED|Continuation Phase||1
31271|NCT02105987|76358|P4|NOT COMPLETED|Continuation Phase||0
31272|NCT02105987|76359|P3|NOT COMPLETED|Continuation Phase||0
31273|NCT02105987|76360|P2|NOT COMPLETED|Continuation Phase||0
31274|NCT02105987|76361|P1|NOT COMPLETED|Continuation Phase||0
31275|NCT02105987|76356|P6|COMPLETED|Continuation Phase||23
31276|NCT02105987|76357|P5|COMPLETED|Continuation Phase||13
31277|NCT02105987|76358|P4|COMPLETED|Continuation Phase||0
31278|NCT02105987|76359|P3|COMPLETED|Continuation Phase||0
31279|NCT02105987|76360|P2|COMPLETED|Continuation Phase||0
31280|NCT02105987|76361|P1|COMPLETED|Continuation Phase||0
31281|NCT02105987|76356|P6|STARTED|Continuation Phase||23
31282|NCT02105987|76357|P5|STARTED|Continuation Phase||14
31283|NCT02105987|76358|P4|STARTED|Continuation Phase||0
31284|NCT02105987|76359|P3|STARTED|Continuation Phase||0
31285|NCT02105987|76360|P2|STARTED|Continuation Phase||0
31286|NCT02105987|76361|P1|STARTED|Continuation Phase||0
31287|NCT02105987|76356|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
31288|NCT02105987|76357|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
31289|NCT02105987|76358|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
31290|NCT02105987|76359|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
31291|NCT02105987|76360|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
31292|NCT02105987|76361|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
31293|NCT02105987|76356|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
31294|NCT02105987|76357|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
31295|NCT02105987|76358|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
31296|NCT02105987|76359|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
31297|NCT02105987|76360|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
31298|NCT02105987|76361|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
31299|NCT02105987|76356|P6|STARTED|Late Switch Phase (24 Weeks)||0
31300|NCT02105987|76357|P5|STARTED|Late Switch Phase (24 Weeks)||0
31301|NCT02105987|76358|P4|STARTED|Late Switch Phase (24 Weeks)||244
31302|NCT02105987|76359|P3|STARTED|Late Switch Phase (24 Weeks)||275
31303|NCT02105987|76360|P2|STARTED|Late Switch Phase (24 Weeks)||0
31304|NCT02105987|76361|P1|STARTED|Late Switch Phase (24 Weeks)||0
31305|NCT02105987|76356|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
31306|NCT02105987|76357|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
31307|NCT02105987|76358|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
31308|NCT02105987|76359|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
31309|NCT02105987|76360|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
31310|NCT02105987|76361|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
31311|NCT02105987|76356|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
31312|NCT02105987|76357|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
31313|NCT02105987|76358|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
31314|NCT02105987|76359|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
31315|NCT02105987|76360|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
31316|NCT02105987|76361|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
31317|NCT02105987|76356|P6|STARTED|Early Switch Phase (24 Weeks)||0
31318|NCT02105987|76357|P5|STARTED|Early Switch Phase (24 Weeks)||0
31319|NCT02105987|76358|P4|STARTED|Early Switch Phase (24 Weeks)||0
31320|NCT02105987|76359|P3|STARTED|Early Switch Phase (24 Weeks)||0
31321|NCT02105987|76360|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
31322|NCT02105987|76361|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
31323|NCT02105974|76415|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
31324|NCT02105974|76416|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
31325|NCT02105974|76417|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
31326|NCT02105974|76415|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
31327|NCT02105974|76416|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
31328|NCT02105974|76417|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
31329|NCT02105974|76415|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
31330|NCT02105974|76416|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
31331|NCT02105974|76417|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
31332|NCT02105974|76415|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
31333|NCT02105974|76416|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
31334|NCT02105974|76417|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
31335|NCT02105974|76415|P3|NOT COMPLETED|2 Week Run-in Period||0
31336|NCT02105974|76416|P2|NOT COMPLETED|2 Week Run-in Period||0
31337|NCT02105974|76417|P1|NOT COMPLETED|2 Week Run-in Period||801
31338|NCT02105974|76415|P3|COMPLETED|2 Week Run-in Period||0
31339|NCT02105974|76416|P2|COMPLETED|2 Week Run-in Period||0
31340|NCT02105974|76417|P1|COMPLETED|2 Week Run-in Period||1622
31341|NCT02105974|76415|P3|STARTED|2 Week Run-in Period||0
31342|NCT02105974|76416|P2|STARTED|2 Week Run-in Period||0
31343|NCT02105974|76417|P1|STARTED|2 Week Run-in Period||2423
31344|NCT02105961|76430|P3|NOT COMPLETED|Overall Study||30
31345|NCT02105961|76431|P2|NOT COMPLETED|Overall Study||17
31346|NCT02105961|76432|P1|NOT COMPLETED|Overall Study||41
31347|NCT02105961|76430|P3|COMPLETED|Overall Study||195
31348|NCT02105961|76431|P2|COMPLETED|Overall Study||206
31349|NCT02105961|76432|P1|COMPLETED|Overall Study||185
31350|NCT02105961|76430|P3|Withdrew IP Due to: Site Closed|Overall Study||1
31351|NCT02105961|76431|P2|Withdrew IP Due to: Site Closed|Overall Study||0
31352|NCT02105961|76432|P1|Withdrew IP Due to: Site Closed|Overall Study||1
31353|NCT02105961|76430|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
31354|NCT02105961|76431|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
31355|NCT02105961|76432|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
31356|NCT02105961|76430|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
31357|NCT02105961|76431|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
31358|NCT02105961|76432|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
31359|NCT02105961|76430|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
31360|NCT02105961|76431|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
31361|NCT02105961|76432|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
31362|NCT02105961|76430|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
31363|NCT02105961|76431|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
31364|NCT02105961|76432|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
31365|NCT02105961|76430|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
31366|NCT02105961|76431|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
31367|NCT02105961|76432|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
31368|NCT02105961|76430|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
31369|NCT02105961|76431|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
31370|NCT02105961|76432|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
31371|NCT02105961|76430|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
31372|NCT02105961|76431|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
31373|NCT02105961|76432|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
31374|NCT02105961|76430|P3|Not Completed IP|Overall Study||42
31375|NCT02105961|76431|P2|Not Completed IP|Overall Study||27
31376|NCT02105961|76432|P1|Not Completed IP|Overall Study||56
31377|NCT02105961|76430|P3|Completed Investigational Product (IP)|Overall Study||183
31378|NCT02105961|76431|P2|Completed Investigational Product (IP)|Overall Study||196
31379|NCT02105961|76432|P1|Completed Investigational Product (IP)|Overall Study||170
31380|NCT02105961|76430|P3|STARTED|Overall Study||225
31381|NCT02105961|76431|P2|STARTED|Overall Study||223
31382|NCT02105961|76432|P1|STARTED|Overall Study||226
31383|NCT02105948|76456|P4|NOT COMPLETED|Overall Study||27
31384|NCT02105948|76457|P3|NOT COMPLETED|Overall Study||28
31385|NCT02105948|76458|P2|NOT COMPLETED|Overall Study||20
31386|NCT02105948|76459|P1|NOT COMPLETED|Overall Study||27
31387|NCT02105948|76456|P4|COMPLETED|Overall Study||157
31388|NCT02105948|76457|P3|COMPLETED|Overall Study||162
31389|NCT02105948|76458|P2|COMPLETED|Overall Study||213
31390|NCT02105948|76459|P1|COMPLETED|Overall Study||202
31391|NCT02105948|76456|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
31392|NCT02105948|76457|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
31393|NCT02105948|76458|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
31394|NCT02105948|76459|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
31395|NCT02105948|76456|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
31396|NCT02105948|76457|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
31397|NCT02105948|76458|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
31398|NCT02105948|76459|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
31399|NCT02105948|76456|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
31400|NCT02105948|76457|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
31401|NCT02105948|76458|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
31402|NCT02105948|76459|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
31403|NCT02105948|76456|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
31404|NCT02105948|76457|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
31405|NCT02105948|76458|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
31406|NCT02105948|76459|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
31407|NCT02105948|76456|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
31408|NCT02105948|76457|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
31409|NCT02105948|76458|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
31410|NCT02105948|76459|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
31411|NCT02105948|76456|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
31412|NCT02105948|76457|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
31413|NCT02105948|76458|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
31414|NCT02105948|76459|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
31415|NCT02105948|76456|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
31416|NCT02105948|76457|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
31417|NCT02105948|76458|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
31418|NCT02105948|76459|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
31419|NCT02105948|76456|P4|Not Completed IP|Overall Study||35
31420|NCT02105948|76457|P3|Not Completed IP|Overall Study||42
31421|NCT02105948|76458|P2|Not Completed IP|Overall Study||30
31422|NCT02105948|76459|P1|Not Completed IP|Overall Study||44
31423|NCT02105948|76456|P4|Completed Investigational Product (IP)|Overall Study||149
31424|NCT02105948|76457|P3|Completed Investigational Product (IP)|Overall Study||148
31425|NCT02105948|76458|P2|Completed Investigational Product (IP)|Overall Study||203
31426|NCT02105948|76459|P1|Completed Investigational Product (IP)|Overall Study||185
31427|NCT02105948|76456|P4|STARTED|Overall Study||184
31428|NCT02105948|76457|P3|STARTED|Overall Study||190
31429|NCT02105948|76458|P2|STARTED|Overall Study||233
31430|NCT02105948|76459|P1|STARTED|Overall Study||229
31431|NCT02105740|76487|P2|NOT COMPLETED|Overall Study||1
31432|NCT02105740|76488|P1|NOT COMPLETED|Overall Study||0
31433|NCT02105740|76487|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
31434|NCT02105740|76488|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
31435|NCT02105740|76487|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
31436|NCT02105740|76488|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
31437|NCT02105740|76487|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
31438|NCT02105740|76488|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
31439|NCT02105701|76500|P4|NOT COMPLETED|Overall Study||2
31440|NCT02105701|76501|P3|NOT COMPLETED|Overall Study||3
31441|NCT02105701|76502|P2|NOT COMPLETED|Overall Study||1
31442|NCT02105701|76503|P1|NOT COMPLETED|Overall Study||4
31443|NCT02105701|76500|P4|COMPLETED|Overall Study||104
31444|NCT02105701|76501|P3|COMPLETED|Overall Study||102
31445|NCT02105701|76502|P2|COMPLETED|Overall Study||103
31446|NCT02105701|76503|P1|COMPLETED|Overall Study||101
31447|NCT02105701|76500|P4|STARTED|Overall Study||106
31448|NCT02105701|76501|P3|STARTED|Overall Study||105
31449|NCT02105701|76502|P2|STARTED|Overall Study||104
31450|NCT02105701|76503|P1|STARTED|Overall Study||105
31451|NCT02105688|76527|P2|NOT COMPLETED|Overall Study||99
31452|NCT02105688|76528|P1|NOT COMPLETED|Overall Study||26
31453|NCT02105688|76527|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
31454|NCT02105688|76528|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
31455|NCT02105688|76527|P2|Not Reached FU Week 12 Visit|Overall Study||15
31456|NCT02105688|76528|P1|Not Reached FU Week 12 Visit|Overall Study||2
31457|NCT02105688|76527|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
31458|NCT02105688|76528|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
31459|NCT02105688|76527|P2|STARTED|Overall Study||100
31460|NCT02105688|76528|P1|STARTED|Overall Study||201
31461|NCT02105662|76538|P1|NOT COMPLETED|Overall Study||6
31462|NCT02105662|76538|P1|COMPLETED|Overall Study||212
31463|NCT02105662|76538|P1|STARTED|Overall Study||218
31464|NCT02105636|76547|P2|NOT COMPLETED|Overall Study||108
31465|NCT02105636|76548|P1|NOT COMPLETED|Overall Study||195
31466|NCT02105636|76547|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
31467|NCT02105636|76548|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
31468|NCT02105636|76547|P2|STARTED|Overall Study||111
31469|NCT02105636|76548|P1|STARTED|Overall Study||236
31470|NCT02105467|76560|P2|NOT COMPLETED|Period 3||1
31471|NCT02105467|76561|P1|NOT COMPLETED|Period 3||0
31472|NCT02105467|76560|P2|COMPLETED|Period 3||102
31473|NCT02105467|76561|P1|COMPLETED|Period 3||0
31474|NCT02105467|76560|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
31475|NCT02105467|76561|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
31476|NCT02105467|76560|P2|NOT COMPLETED|Period 2||2
31477|NCT02105467|76561|P1|NOT COMPLETED|Period 2||2
31478|NCT02105467|76560|P2|COMPLETED|Period 2||102
31479|NCT02105467|76561|P1|COMPLETED|Period 2||312
31480|NCT02105467|76560|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
31481|NCT02105467|76561|P1|STARTED|Period 2||314
31482|NCT02105467|76560|P2|NOT COMPLETED|Period 1||0
31483|NCT02105467|76561|P1|NOT COMPLETED|Period 1||2
31484|NCT02105467|76560|P2|COMPLETED|Period 1||105
31485|NCT02105467|76561|P1|COMPLETED|Period 1||314
31486|NCT02105467|76560|P2|STARTED|Period 1||105
31487|NCT02105467|76561|P1|STARTED|Period 1||316
31488|NCT02105454|76573|P1|NOT COMPLETED|Overall Study||1
31489|NCT02105454|76573|P1|COMPLETED|Overall Study||78
31490|NCT02105454|76573|P1|STARTED|Overall Study||79
31491|NCT02105324|76580|P2|NOT COMPLETED|Period 2||0
31492|NCT02105324|76581|P1|NOT COMPLETED|Period 2||0
31493|NCT02105324|76580|P2|COMPLETED|Period 2||10
31494|NCT02105324|76581|P1|COMPLETED|Period 2||9
31495|NCT02105324|76580|P2|STARTED|Period 2||10
31496|NCT02105324|76581|P1|STARTED|Period 2||9
31497|NCT02105324|76580|P2|NOT COMPLETED|Period 1||0
31498|NCT02105324|76581|P1|NOT COMPLETED|Period 1||0
31499|NCT02105324|76580|P2|COMPLETED|Period 1||10
31500|NCT02105324|76581|P1|COMPLETED|Period 1||9
31501|NCT02105324|76580|P2|STARTED|Period 1||10
31502|NCT02105324|76581|P1|STARTED|Period 1||9
31503|NCT02105285|76660|P3|NOT COMPLETED|Overall Study||0
31504|NCT02105285|76661|P2|NOT COMPLETED|Overall Study||2
31505|NCT02105285|76662|P1|NOT COMPLETED|Overall Study||2
31506|NCT02105285|76660|P3|COMPLETED|Overall Study||37
31507|NCT02105285|76661|P2|COMPLETED|Overall Study||76
31508|NCT02105285|76662|P1|COMPLETED|Overall Study||76
31509|NCT02105285|76660|P3|STARTED|Overall Study||37
31510|NCT02105285|76661|P2|STARTED|Overall Study||78
31511|NCT02105285|76662|P1|STARTED|Overall Study||78
31512|NCT02105272|76681|P2|NOT COMPLETED|Overall Study||3
31513|NCT02105272|76682|P1|NOT COMPLETED|Overall Study||5
31514|NCT02105272|76681|P2|COMPLETED|Overall Study||116
31515|NCT02105272|76682|P1|COMPLETED|Overall Study||113
31516|NCT02105272|76681|P2|STARTED|Overall Study||119
31517|NCT02105272|76682|P1|STARTED|Overall Study||118
31518|NCT02105012|76698|P1|NOT COMPLETED|Overall Study||33
31519|NCT02105012|76698|P1|COMPLETED|Overall Study||114
31520|NCT02105012|76698|P1|Placebo MDI|Overall Study||127
31521|NCT02105012|76698|P1|BD MDI 40 µg|Overall Study||63
31522|NCT02105012|76698|P1|BD MDI 80 µg|Overall Study||64
31523|NCT02105012|76698|P1|BD MDI 160 µg|Overall Study||132
31524|NCT02105012|76698|P1|BD MDI 320 µg|Overall Study||124
31525|NCT02105012|76698|P1|STARTED|Overall Study||147
31526|NCT02104947|76732|P2|NOT COMPLETED|Overall Study||56
31527|NCT02104947|76733|P1|NOT COMPLETED|Overall Study||79
31528|NCT02104947|76732|P2|COMPLETED|Overall Study||146
31529|NCT02104947|76733|P1|COMPLETED|Overall Study||222
31530|NCT02104947|76732|P2|STARTED|Overall Study||202
31531|NCT02104947|76733|P1|STARTED|Overall Study||301
31532|NCT02104895|76751|P2|NOT COMPLETED|Overall Study||14
31533|NCT02104895|76752|P1|NOT COMPLETED|Overall Study||0
31534|NCT02104895|76751|P2|COMPLETED|Overall Study||246
31535|NCT02104895|76752|P1|COMPLETED|Overall Study||260
31536|NCT02104895|76751|P2|STARTED|Overall Study||260
31537|NCT02104895|76752|P1|STARTED|Overall Study||260
31538|NCT02104830|76765|P3|NOT COMPLETED|Overall Study||7
31539|NCT02104830|76766|P2|NOT COMPLETED|Overall Study||7
31540|NCT02104830|76767|P1|NOT COMPLETED|Overall Study||4
31541|NCT02104830|76765|P3|COMPLETED|Overall Study||36
31542|NCT02104830|76766|P2|COMPLETED|Overall Study||36
31543|NCT02104830|76767|P1|COMPLETED|Overall Study||38
31544|NCT02104830|76765|P3|STARTED|Overall Study||43
31545|NCT02104830|76766|P2|STARTED|Overall Study||43
31546|NCT02104830|76767|P1|STARTED|Overall Study||42
31547|NCT02104804|76792|P2|NOT COMPLETED|Overall Study||19
31548|NCT02104804|76793|P1|NOT COMPLETED|Overall Study||16
31549|NCT02104804|76792|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
31550|NCT02104804|76793|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
31551|NCT02104804|76792|P2|STARTED|Overall Study|Number of patients who were randomized|232
31552|NCT02104804|76793|P1|STARTED|Overall Study|Number of patients who were randomized|234
31553|NCT02104505|76811|P2|NOT COMPLETED|Second Intervention (14 Days)||1
31554|NCT02104505|76812|P1|NOT COMPLETED|Second Intervention (14 Days)||2
31555|NCT02104505|76811|P2|COMPLETED|Second Intervention (14 Days)||7
31556|NCT02104505|76812|P1|COMPLETED|Second Intervention (14 Days)||8
31557|NCT02104505|76811|P2|STARTED|Second Intervention (14 Days)||8
31558|NCT02104505|76812|P1|STARTED|Second Intervention (14 Days)||10
31559|NCT02104505|76811|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
31560|NCT02104505|76812|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
31561|NCT02104505|76811|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
31562|NCT02104505|76812|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
31563|NCT02104505|76811|P2|STARTED|Washout (Minimum 3 Weeks)||8
31564|NCT02104505|76812|P1|STARTED|Washout (Minimum 3 Weeks)||10
31565|NCT02104505|76811|P2|NOT COMPLETED|First Intervention (14 Days)||3
31566|NCT02104505|76812|P1|NOT COMPLETED|First Intervention (14 Days)||2
31567|NCT02104505|76811|P2|COMPLETED|First Intervention (14 Days)||8
31568|NCT02104505|76812|P1|COMPLETED|First Intervention (14 Days)||10
31569|NCT02104505|76811|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
31570|NCT02104505|76812|P1|STARTED|First Intervention (14 Days)||12
31571|NCT02104427|76824|P1|NOT COMPLETED|Overall Study||0
31572|NCT02104427|76824|P1|COMPLETED|Overall Study||12
31573|NCT02104427|76824|P1|STARTED|Overall Study||12
31574|NCT02104219|76847|P1|NOT COMPLETED|Overall Study||0
31575|NCT02104219|76847|P1|COMPLETED|Overall Study||32
31576|NCT02104219|76847|P1|STARTED|Overall Study||32
31577|NCT02103855|76854|P1|NOT COMPLETED|Overall Study||2
31578|NCT02103855|76854|P1|COMPLETED|Overall Study||4
31579|NCT02103855|76854|P1|STARTED|Overall Study||6
31580|NCT02103439|76864|P2|NOT COMPLETED|Overall Study||3
31581|NCT02103439|76865|P1|NOT COMPLETED|Overall Study||3
31582|NCT02103439|76864|P2|COMPLETED|Overall Study||67
31583|NCT02103439|76865|P1|COMPLETED|Overall Study||67
31584|NCT02103439|76864|P2|STARTED|Overall Study||70
31585|NCT02103439|76865|P1|STARTED|Overall Study||70
31586|NCT02103309|76885|P2|NOT COMPLETED|Overall Study||0
31587|NCT02103309|76886|P1|NOT COMPLETED|Overall Study||0
31588|NCT02103309|76885|P2|COMPLETED|Overall Study||22
31589|NCT02103309|76886|P1|COMPLETED|Overall Study||20
31590|NCT02103309|76885|P2|STARTED|Overall Study||22
31591|NCT02103309|76886|P1|STARTED|Overall Study||20
31592|NCT02103114|76900|P2|NOT COMPLETED|Overall Study||1
31593|NCT02103114|76901|P1|NOT COMPLETED|Overall Study||0
31594|NCT02103114|76900|P2|COMPLETED|Overall Study||19
31595|NCT02103114|76901|P1|COMPLETED|Overall Study||20
31596|NCT02103114|76900|P2|STARTED|Overall Study||20
31597|NCT02103114|76901|P1|STARTED|Overall Study||20
31598|NCT02103062|76957|P2|NOT COMPLETED|Overall Study||23
31599|NCT02103062|76958|P1|NOT COMPLETED|Overall Study||18
31600|NCT02103062|76957|P2|COMPLETED|Overall Study||0
31601|NCT02103062|76958|P1|COMPLETED|Overall Study||0
31602|NCT02103062|76957|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
31603|NCT02103062|76958|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
31604|NCT02103062|76957|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
31605|NCT02103062|76958|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
31606|NCT02103062|76957|P2|STARTED|Overall Study||23
31607|NCT02103062|76958|P1|STARTED|Overall Study||18
31608|NCT02102932|76984|P8|NOT COMPLETED|Overall Study||0
31609|NCT02102932|76985|P7|NOT COMPLETED|Overall Study||0
31610|NCT02102932|76986|P6|NOT COMPLETED|Overall Study||0
31611|NCT02102932|76987|P5|NOT COMPLETED|Overall Study||0
31612|NCT02102932|76988|P4|NOT COMPLETED|Overall Study||0
31613|NCT02102932|76989|P3|NOT COMPLETED|Overall Study||0
31614|NCT02102932|76990|P2|NOT COMPLETED|Overall Study||0
31615|NCT02102932|76991|P1|NOT COMPLETED|Overall Study||0
31616|NCT02102932|76984|P8|COMPLETED|Overall Study||12
31617|NCT02102932|76985|P7|COMPLETED|Overall Study||12
31618|NCT02102932|76986|P6|COMPLETED|Overall Study||12
31619|NCT02102932|76987|P5|COMPLETED|Overall Study||12
31620|NCT02102932|76988|P4|COMPLETED|Overall Study||12
31621|NCT02102932|76989|P3|COMPLETED|Overall Study||12
31622|NCT02102932|76990|P2|COMPLETED|Overall Study||12
31623|NCT02102932|76991|P1|COMPLETED|Overall Study||12
31624|NCT02102932|76984|P8|STARTED|Overall Study||12
31625|NCT02102932|76985|P7|STARTED|Overall Study||12
31626|NCT02102932|76986|P6|STARTED|Overall Study||12
31627|NCT02102932|76987|P5|STARTED|Overall Study||12
31628|NCT02102932|76988|P4|STARTED|Overall Study||12
31629|NCT02102932|76989|P3|STARTED|Overall Study||12
31630|NCT02102932|76990|P2|STARTED|Overall Study||12
31631|NCT02102932|76991|P1|STARTED|Overall Study||12
31632|NCT02102490|77049|P1|NOT COMPLETED|Overall Study||9
31633|NCT02102490|77049|P1|COMPLETED|Overall Study||123
31634|NCT02102490|77049|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
31635|NCT02102490|77049|P1|STARTED|Overall Study||132
31636|NCT02102464|77063|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
31637|NCT02102464|77064|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
31638|NCT02102464|77065|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
31639|NCT02102464|77063|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
31640|NCT02102464|77064|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
31641|NCT02102464|77065|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
31642|NCT02102464|77063|P3|STARTED|Crossover LipiFlow Treatment of Control||25
31643|NCT02102464|77064|P2|STARTED|Crossover LipiFlow Treatment of Control||0
31644|NCT02102464|77065|P1|STARTED|Crossover LipiFlow Treatment of Control||0
31645|NCT02102464|77063|P3|NOT COMPLETED|Randomized Study||0
31646|NCT02102464|77064|P2|NOT COMPLETED|Randomized Study||1
31647|NCT02102464|77065|P1|NOT COMPLETED|Randomized Study||0
31648|NCT02102464|77063|P3|COMPLETED|Randomized Study||0
31649|NCT02102464|77064|P2|COMPLETED|Randomized Study||25
31650|NCT02102464|77065|P1|COMPLETED|Randomized Study||29
31651|NCT02102464|77063|P3|STARTED|Randomized Study||0
31652|NCT02102464|77064|P2|STARTED|Randomized Study||26
31653|NCT02102464|77065|P1|STARTED|Randomized Study||29
31654|NCT02102399|77084|P2|NOT COMPLETED|Overall Study||4
31655|NCT02102399|77085|P1|NOT COMPLETED|Overall Study||6
31656|NCT02102399|77084|P2|COMPLETED|Overall Study||17
31657|NCT02102399|77085|P1|COMPLETED|Overall Study||14
31658|NCT02102399|77084|P2|STARTED|Overall Study||21
31659|NCT02102399|77085|P1|STARTED|Overall Study||20
31660|NCT02102204|77133|P1|NOT COMPLETED|Overall Study||304
31661|NCT02102204|77133|P1|COMPLETED|Overall Study||598
31662|NCT02102204|77133|P1|Received Etelcalcetide|Overall Study||884
31663|NCT02102204|77133|P1|STARTED|Overall Study||902
31664|NCT02101359|77144|P2|NOT COMPLETED|Overall Study||19
31665|NCT02101359|77145|P1|NOT COMPLETED|Overall Study||29
31666|NCT02101359|77144|P2|COMPLETED|Overall Study||277
31667|NCT02101359|77145|P1|COMPLETED|Overall Study||266
31668|NCT02101359|77144|P2|STARTED|Overall Study||296
31669|NCT02101359|77145|P1|STARTED|Overall Study||295
31670|NCT02101294|77151|P1|NOT COMPLETED|Overall Study||11
31671|NCT02101294|77151|P1|COMPLETED|Overall Study||20
31672|NCT02101294|77151|P1|STARTED|Overall Study||31
31673|NCT02101190|77160|P2|NOT COMPLETED|Overall Study||0
31674|NCT02101190|77161|P1|NOT COMPLETED|Overall Study||0
31675|NCT02101190|77160|P2|COMPLETED|Overall Study||8
31676|NCT02101190|77161|P1|COMPLETED|Overall Study||8
31677|NCT02101190|77160|P2|STARTED|Overall Study||8
31678|NCT02101190|77161|P1|STARTED|Overall Study||8
31679|NCT02101112|77171|P6|NOT COMPLETED|Overall Study||0
31680|NCT02101112|77172|P5|NOT COMPLETED|Overall Study||1
31681|NCT02101112|77173|P4|NOT COMPLETED|Overall Study||0
31682|NCT02101112|77174|P3|NOT COMPLETED|Overall Study||1
31683|NCT02101112|77175|P2|NOT COMPLETED|Overall Study||0
31684|NCT02101112|77176|P1|NOT COMPLETED|Overall Study||0
31685|NCT02101112|77171|P6|COMPLETED|Overall Study||5
31686|NCT02101112|77172|P5|COMPLETED|Overall Study||5
31687|NCT02101112|77173|P4|COMPLETED|Overall Study||5
31688|NCT02101112|77174|P3|COMPLETED|Overall Study||5
31689|NCT02101112|77175|P2|COMPLETED|Overall Study||5
31690|NCT02101112|77176|P1|COMPLETED|Overall Study||6
31691|NCT02101112|77171|P6|STARTED|Overall Study||5
31692|NCT02101112|77172|P5|STARTED|Overall Study||6
31693|NCT02101112|77173|P4|STARTED|Overall Study||5
31694|NCT02101112|77174|P3|STARTED|Overall Study||6
31695|NCT02101112|77175|P2|STARTED|Overall Study||5
31696|NCT02101112|77176|P1|STARTED|Overall Study||6
31697|NCT02101021|77206|P5|NOT COMPLETED|Overall Study||4
31698|NCT02101021|77207|P4|NOT COMPLETED|Overall Study||3
31699|NCT02101021|77208|P3|NOT COMPLETED|Overall Study||7
31700|NCT02101021|77209|P2|NOT COMPLETED|Overall Study||4
31701|NCT02101021|77210|P1|NOT COMPLETED|Overall Study||7
31702|NCT02101021|77206|P5|COMPLETED|Overall Study||0
31703|NCT02101021|77207|P4|COMPLETED|Overall Study||0
31704|NCT02101021|77208|P3|COMPLETED|Overall Study||0
31705|NCT02101021|77209|P2|COMPLETED|Overall Study||0
31706|NCT02101021|77210|P1|COMPLETED|Overall Study||0
31707|NCT02101021|77206|P5|STARTED|Overall Study||4
31708|NCT02101021|77207|P4|STARTED|Overall Study||3
31709|NCT02101021|77208|P3|STARTED|Overall Study||7
31710|NCT02101021|77209|P2|STARTED|Overall Study||4
31711|NCT02101021|77210|P1|STARTED|Overall Study||7
31712|NCT02101008|77252|P1|NOT COMPLETED|Overall Study||0
31713|NCT02101008|77252|P1|COMPLETED|Overall Study||12
31714|NCT02101008|77252|P1|STARTED|Overall Study||12
31715|NCT02100839|77259|P2|NOT COMPLETED|Multiple Ascending Dose||0
31716|NCT02100839|77260|P1|NOT COMPLETED|Multiple Ascending Dose||4
31717|NCT02100839|77259|P2|COMPLETED|Multiple Ascending Dose||3
31718|NCT02100839|77260|P1|COMPLETED|Multiple Ascending Dose||9
31719|NCT02100839|77259|P2|STARTED|Multiple Ascending Dose||3
31720|NCT02100839|77260|P1|STARTED|Multiple Ascending Dose||13
31721|NCT02100839|77259|P2|NOT COMPLETED|Single Ascending Dose||0
31722|NCT02100839|77260|P1|NOT COMPLETED|Single Ascending Dose||0
31723|NCT02100839|77259|P2|COMPLETED|Single Ascending Dose||12
31724|NCT02100839|77260|P1|COMPLETED|Single Ascending Dose||24
31725|NCT02100839|77259|P2|STARTED|Single Ascending Dose||12
31726|NCT02100839|77260|P1|STARTED|Single Ascending Dose||24
31727|NCT02100826|77272|P2|NOT COMPLETED|Period 2 (7 Days)||0
31728|NCT02100826|77273|P1|NOT COMPLETED|Period 2 (7 Days)||0
31729|NCT02100826|77272|P2|COMPLETED|Period 2 (7 Days)||14
31730|NCT02100826|77273|P1|COMPLETED|Period 2 (7 Days)||14
31731|NCT02100826|77272|P2|STARTED|Period 2 (7 Days)||14
31732|NCT02100826|77273|P1|STARTED|Period 2 (7 Days)||14
31733|NCT02100826|77272|P2|NOT COMPLETED|Washout Period (1 Day)||0
31734|NCT02100826|77273|P1|NOT COMPLETED|Washout Period (1 Day)||0
31735|NCT02100826|77272|P2|COMPLETED|Washout Period (1 Day)||14
31736|NCT02100826|77273|P1|COMPLETED|Washout Period (1 Day)||14
31737|NCT02100826|77272|P2|STARTED|Washout Period (1 Day)||14
31738|NCT02100826|77273|P1|STARTED|Washout Period (1 Day)||14
31739|NCT02100826|77272|P2|NOT COMPLETED|Period 1 (7 Days)||0
31740|NCT02100826|77273|P1|NOT COMPLETED|Period 1 (7 Days)||0
31741|NCT02100826|77272|P2|COMPLETED|Period 1 (7 Days)||14
31742|NCT02100826|77273|P1|COMPLETED|Period 1 (7 Days)||14
31743|NCT02100826|77272|P2|STARTED|Period 1 (7 Days)||14
31744|NCT02100826|77273|P1|STARTED|Period 1 (7 Days)||14
31745|NCT02100670|77287|P4|NOT COMPLETED|Overall Study||1
31746|NCT02100670|77288|P3|NOT COMPLETED|Overall Study||4
31747|NCT02100670|77289|P2|NOT COMPLETED|Overall Study||7
31748|NCT02100670|77290|P1|NOT COMPLETED|Overall Study||13
31749|NCT02100670|77287|P4|COMPLETED|Overall Study||75
31750|NCT02100670|77288|P3|COMPLETED|Overall Study||74
31751|NCT02100670|77289|P2|COMPLETED|Overall Study||106
31752|NCT02100670|77290|P1|COMPLETED|Overall Study||105
31753|NCT02100670|77287|P4|STARTED|Overall Study||76
31754|NCT02100670|77288|P3|STARTED|Overall Study||78
31755|NCT02100670|77289|P2|STARTED|Overall Study||113
31756|NCT02100670|77290|P1|STARTED|Overall Study||118
31757|NCT02100644|77350|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
31758|NCT02100644|77351|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
31759|NCT02100644|77352|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
31760|NCT02100644|77350|P3|COMPLETED|LTG and VPA Maintenance Phase||20
31761|NCT02100644|77351|P2|COMPLETED|LTG and VPA Maintenance Phase||0
31762|NCT02100644|77352|P1|COMPLETED|LTG and VPA Maintenance Phase||0
31763|NCT02100644|77350|P3|STARTED|LTG and VPA Maintenance Phase||20
31764|NCT02100644|77351|P2|STARTED|LTG and VPA Maintenance Phase||0
31765|NCT02100644|77352|P1|STARTED|LTG and VPA Maintenance Phase||0
31766|NCT02100644|77350|P3|NOT COMPLETED|VPA Reduction Phase||0
31767|NCT02100644|77351|P2|NOT COMPLETED|VPA Reduction Phase||0
31768|NCT02100644|77352|P1|NOT COMPLETED|VPA Reduction Phase||0
31769|NCT02100644|77350|P3|COMPLETED|VPA Reduction Phase||0
31770|NCT02100644|77351|P2|COMPLETED|VPA Reduction Phase||20
31771|NCT02100644|77352|P1|COMPLETED|VPA Reduction Phase||0
31772|NCT02100644|77350|P3|STARTED|VPA Reduction Phase||0
31773|NCT02100644|77351|P2|STARTED|VPA Reduction Phase||20
31774|NCT02100644|77352|P1|STARTED|VPA Reduction Phase||0
31775|NCT02100644|77350|P3|NOT COMPLETED|LTG Escalation Phase||0
31776|NCT02100644|77351|P2|NOT COMPLETED|LTG Escalation Phase||0
31777|NCT02100644|77352|P1|NOT COMPLETED|LTG Escalation Phase||13
31778|NCT02100644|77350|P3|COMPLETED|LTG Escalation Phase||0
31779|NCT02100644|77351|P2|COMPLETED|LTG Escalation Phase||0
31780|NCT02100644|77352|P1|COMPLETED|LTG Escalation Phase||20
31781|NCT02100644|77350|P3|STARTED|LTG Escalation Phase||0
31782|NCT02100644|77351|P2|STARTED|LTG Escalation Phase||0
31783|NCT02100644|77352|P1|STARTED|LTG Escalation Phase||33
31784|NCT02100579|77364|P2|NOT COMPLETED|Overall Study||0
31785|NCT02100579|77365|P1|NOT COMPLETED|Overall Study||0
31786|NCT02100579|77364|P2|COMPLETED|Overall Study||20
31787|NCT02100579|77365|P1|COMPLETED|Overall Study||20
31788|NCT02100579|77364|P2|STARTED|Overall Study||20
31789|NCT02100579|77365|P1|STARTED|Overall Study||20
31790|NCT02100514|77377|P2|NOT COMPLETED|Overall Study||74
31791|NCT02100514|77378|P1|NOT COMPLETED|Overall Study||29
31792|NCT02100514|77377|P2|COMPLETED|Overall Study||425
31793|NCT02100514|77378|P1|COMPLETED|Overall Study||218
31794|NCT02100514|77377|P2|STARTED|Overall Study||499
31795|NCT02100514|77378|P1|STARTED|Overall Study||247
31796|NCT02100475|77438|P2|NOT COMPLETED|Overall Study||2
31797|NCT02100475|77439|P1|NOT COMPLETED|Overall Study||2
31798|NCT02100475|77438|P2|COMPLETED|Overall Study||13
31799|NCT02100475|77439|P1|COMPLETED|Overall Study||14
31800|NCT02100475|77438|P2|STARTED|Overall Study||15
31801|NCT02100475|77439|P1|STARTED|Overall Study||16
31802|NCT02100410|77449|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
31803|NCT02100410|77450|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
31804|NCT02100410|77451|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
31805|NCT02100410|77452|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
31806|NCT02100410|77453|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
31807|NCT02100410|77454|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
31808|NCT02100410|77449|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
31809|NCT02100410|77450|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
31810|NCT02100410|77451|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
31811|NCT02100410|77452|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
31812|NCT02100410|77453|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
31813|NCT02100410|77454|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
31814|NCT02100410|77449|P6|STARTED|Exposure Pair 3, 30 Minutes||9
31815|NCT02100410|77450|P5|STARTED|Exposure Pair 3, 30 Minutes||8
31816|NCT02100410|77451|P4|STARTED|Exposure Pair 3, 30 Minutes||8
31817|NCT02100410|77452|P3|STARTED|Exposure Pair 3, 30 Minutes||8
31818|NCT02100410|77453|P2|STARTED|Exposure Pair 3, 30 Minutes||8
31819|NCT02100410|77454|P1|STARTED|Exposure Pair 3, 30 Minutes||8
31820|NCT02100410|77449|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
31821|NCT02100410|77450|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
31822|NCT02100410|77451|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
31823|NCT02100410|77452|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
31824|NCT02100410|77453|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
31825|NCT02100410|77454|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
31826|NCT02100410|77449|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
31827|NCT02100410|77450|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
31828|NCT02100410|77451|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
31829|NCT02100410|77452|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
31830|NCT02100410|77453|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
31831|NCT02100410|77454|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
31832|NCT02100410|77449|P6|STARTED|Exposure Pair 2, 30 Minutes||9
31833|NCT02100410|77450|P5|STARTED|Exposure Pair 2, 30 Minutes||8
31834|NCT02100410|77451|P4|STARTED|Exposure Pair 2, 30 Minutes||8
31835|NCT02100410|77452|P3|STARTED|Exposure Pair 2, 30 Minutes||8
31836|NCT02100410|77453|P2|STARTED|Exposure Pair 2, 30 Minutes||8
31837|NCT02100410|77454|P1|STARTED|Exposure Pair 2, 30 Minutes||8
31838|NCT02100410|77449|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
31839|NCT02100410|77450|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
31840|NCT02100410|77451|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
31841|NCT02100410|77452|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
31842|NCT02100410|77453|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
31843|NCT02100410|77454|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
31844|NCT02100410|77449|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
31845|NCT02100410|77450|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
31846|NCT02100410|77451|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
31847|NCT02100410|77452|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
31848|NCT02100410|77453|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
31849|NCT02100410|77454|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
31850|NCT02100410|77449|P6|STARTED|Exposure Pair 1, 30 Minutes||9
31851|NCT02100410|77450|P5|STARTED|Exposure Pair 1, 30 Minutes||8
31852|NCT02100410|77451|P4|STARTED|Exposure Pair 1, 30 Minutes||8
31853|NCT02100410|77452|P3|STARTED|Exposure Pair 1, 30 Minutes||8
31854|NCT02100410|77453|P2|STARTED|Exposure Pair 1, 30 Minutes||8
31855|NCT02100410|77454|P1|STARTED|Exposure Pair 1, 30 Minutes||8
31856|NCT02100280|77472|P2|NOT COMPLETED|Overall Study||4
31857|NCT02100280|77473|P1|NOT COMPLETED|Overall Study||4
31858|NCT02100280|77472|P2|COMPLETED|Overall Study||44
31859|NCT02100280|77473|P1|COMPLETED|Overall Study||44
31860|NCT02100280|77472|P2|STARTED|Overall Study||48
31861|NCT02100280|77473|P1|STARTED|Overall Study||48
31862|NCT02100228|77489|P2|NOT COMPLETED|Overall Study||90
31863|NCT02100228|77490|P1|NOT COMPLETED|Overall Study||75
31864|NCT02100228|77489|P2|COMPLETED|Overall Study||657
31865|NCT02100228|77490|P1|COMPLETED|Overall Study||678
31866|NCT02100228|77489|P2|STARTED|Overall Study|721 treated with Usual Care|747
31867|NCT02100228|77490|P1|STARTED|Overall Study|735 treated with Apixaban|753
31868|NCT02100189|77516|P1|NOT COMPLETED|Overall Study||0
31869|NCT02100189|77516|P1|COMPLETED|Overall Study||50
31870|NCT02100189|77516|P1|STARTED|Overall Study||50
31871|NCT02100007|77523|P1|NOT COMPLETED|Overall Study||0
31872|NCT02100007|77523|P1|COMPLETED|Overall Study||46
31873|NCT02100007|77523|P1|STARTED|Overall Study||46
31874|NCT02099838|77536|P2|NOT COMPLETED|Overall Study||2
31875|NCT02099838|77537|P1|NOT COMPLETED|Overall Study||4
31876|NCT02099838|77536|P2|COMPLETED|Overall Study||49
31877|NCT02099838|77537|P1|COMPLETED|Overall Study||43
31878|NCT02099838|77536|P2|STARTED|Overall Study||51
31879|NCT02099838|77537|P1|STARTED|Overall Study||47
31880|NCT02099708|77567|P1|NOT COMPLETED|Overall Study||200
31881|NCT02099708|77567|P1|COMPLETED|Overall Study||3302
31882|NCT02099708|77567|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
31883|NCT02099708|77567|P1|STARTED|Overall Study|Number of cases.|3502
31884|NCT02099682|77578|P1|NOT COMPLETED|Overall Study||111
31885|NCT02099682|77578|P1|COMPLETED|Overall Study||3255
31886|NCT02099682|77578|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
31887|NCT02099682|77578|P1|STARTED|Overall Study|Number of cases.|3366
31888|NCT02099461|77592|P3|NOT COMPLETED|Overall Study||0
31889|NCT02099461|77593|P2|NOT COMPLETED|Overall Study||0
31890|NCT02099461|77594|P1|NOT COMPLETED|Overall Study||0
31891|NCT02099461|77592|P3|COMPLETED|Overall Study||28
31892|NCT02099461|77593|P2|COMPLETED|Overall Study||27
31893|NCT02099461|77594|P1|COMPLETED|Overall Study||27
31894|NCT02099461|77592|P3|STARTED|Overall Study||28
31895|NCT02099461|77593|P2|STARTED|Overall Study||27
31896|NCT02099461|77594|P1|STARTED|Overall Study||27
31897|NCT02099344|77604|P2|NOT COMPLETED|Overall Study||0
31898|NCT02099344|77605|P1|NOT COMPLETED|Overall Study||1
31899|NCT02099344|77604|P2|COMPLETED|Overall Study||0
31900|NCT02099344|77605|P1|COMPLETED|Overall Study||0
31901|NCT02099344|77604|P2|STARTED|Overall Study||0
31902|NCT02099344|77605|P1|STARTED|Overall Study||1
31903|NCT02099318|77613|P2|NOT COMPLETED|Overall Study||0
31904|NCT02099318|77614|P1|NOT COMPLETED|Overall Study||0
31905|NCT02099318|77613|P2|COMPLETED|Overall Study||20
31906|NCT02099318|77614|P1|COMPLETED|Overall Study||20
31907|NCT02099318|77613|P2|STARTED|Overall Study||20
31908|NCT02099318|77614|P1|STARTED|Overall Study||20
31909|NCT02099266|77628|P1|NOT COMPLETED|Overall Study||0
31910|NCT02099266|77628|P1|COMPLETED|Overall Study||15
31911|NCT02099266|77628|P1|STARTED|Overall Study||15
31912|NCT02099110|77640|P5|NOT COMPLETED|Overall Study||27
31913|NCT02099110|77641|P4|NOT COMPLETED|Overall Study||22
31914|NCT02099110|77642|P3|NOT COMPLETED|Overall Study||28
31915|NCT02099110|77643|P2|NOT COMPLETED|Overall Study||31
31916|NCT02099110|77644|P1|NOT COMPLETED|Overall Study||24
31917|NCT02099110|77640|P5|COMPLETED|Overall Study||218
31918|NCT02099110|77641|P4|COMPLETED|Overall Study||221
31919|NCT02099110|77642|P3|COMPLETED|Overall Study||219
31920|NCT02099110|77643|P2|COMPLETED|Overall Study||217
31921|NCT02099110|77644|P1|COMPLETED|Overall Study||226
31922|NCT02099110|77640|P5|Treated|Overall Study||244
31923|NCT02099110|77641|P4|Treated|Overall Study||243
31924|NCT02099110|77642|P3|Treated|Overall Study||247
31925|NCT02099110|77643|P2|Treated|Overall Study||248
31926|NCT02099110|77644|P1|Treated|Overall Study||250
31927|NCT02099110|77640|P5|STARTED|Overall Study||245
31928|NCT02099110|77641|P4|STARTED|Overall Study||243
31929|NCT02099110|77642|P3|STARTED|Overall Study||247
31930|NCT02099110|77643|P2|STARTED|Overall Study||248
31931|NCT02099110|77644|P1|STARTED|Overall Study||250
31932|NCT02099084|77691|P2|NOT COMPLETED|Second Intervention||0
31933|NCT02099084|77692|P1|NOT COMPLETED|Second Intervention||0
31934|NCT02099084|77691|P2|COMPLETED|Second Intervention||4
31935|NCT02099084|77692|P1|COMPLETED|Second Intervention||4
31936|NCT02099084|77691|P2|STARTED|Second Intervention||4
31937|NCT02099084|77692|P1|STARTED|Second Intervention||4
31938|NCT02099084|77691|P2|NOT COMPLETED|Washout Period of 14 Days||0
31939|NCT02099084|77692|P1|NOT COMPLETED|Washout Period of 14 Days||0
31940|NCT02099084|77691|P2|COMPLETED|Washout Period of 14 Days||4
31941|NCT02099084|77692|P1|COMPLETED|Washout Period of 14 Days||4
31942|NCT02099084|77691|P2|STARTED|Washout Period of 14 Days||4
31943|NCT02099084|77692|P1|STARTED|Washout Period of 14 Days||4
31944|NCT02099084|77691|P2|NOT COMPLETED|First Intervention||0
31945|NCT02099084|77692|P1|NOT COMPLETED|First Intervention||0
31946|NCT02099084|77691|P2|COMPLETED|First Intervention||4
31947|NCT02099084|77692|P1|COMPLETED|First Intervention||4
31948|NCT02099084|77691|P2|STARTED|First Intervention||4
31949|NCT02099084|77692|P1|STARTED|First Intervention||4
31950|NCT02099006|77710|P1|NOT COMPLETED|Overall Study||1
31951|NCT02099006|77710|P1|COMPLETED|Overall Study||8
31952|NCT02099006|77710|P1|Received Gabapentin|Overall Study||8
31953|NCT02099006|77710|P1|Received Ketamine|Overall Study||6
31954|NCT02099006|77710|P1|Received Loperamide|Overall Study||7
31955|NCT02099006|77710|P1|Received Ketoprofen|Overall Study||3
31956|NCT02099006|77710|P1|Received Amitriptyline/ Baclofen|Overall Study||7
31957|NCT02099006|77710|P1|Received Placebo|Overall Study||9
31958|NCT02099006|77710|P1|STARTED|Overall Study||9
31959|NCT02098746|77718|P1|NOT COMPLETED|Overall Study||5
31960|NCT02098746|77718|P1|COMPLETED|Overall Study||289
31961|NCT02098746|77718|P1|STARTED|Overall Study||294
31962|NCT02098733|77726|P1|NOT COMPLETED|Overall Study||10
31963|NCT02098733|77726|P1|COMPLETED|Overall Study||1158
31964|NCT02098733|77726|P1|STARTED|Overall Study||1168
31965|NCT02098395|77740|P4|NOT COMPLETED|Overall Study||27
31966|NCT02098395|77741|P3|NOT COMPLETED|Overall Study||42
31967|NCT02098395|77742|P2|NOT COMPLETED|Overall Study||32
31968|NCT02098395|77743|P1|NOT COMPLETED|Overall Study||26
31969|NCT02098395|77740|P4|COMPLETED|Overall Study||180
31970|NCT02098395|77741|P3|COMPLETED|Overall Study||165
31971|NCT02098395|77742|P2|COMPLETED|Overall Study||177
31972|NCT02098395|77743|P1|COMPLETED|Overall Study||186
31973|NCT02098395|77740|P4|Exposed|Overall Study||206
31974|NCT02098395|77741|P3|Exposed|Overall Study||206
31975|NCT02098395|77742|P2|Exposed|Overall Study||209
31976|NCT02098395|77743|P1|Exposed|Overall Study||211
31977|NCT02098395|77740|P4|STARTED|Overall Study||207
31978|NCT02098395|77741|P3|STARTED|Overall Study||207
31979|NCT02098395|77742|P2|STARTED|Overall Study||209
31980|NCT02098395|77743|P1|STARTED|Overall Study||212
31981|NCT02098304|77761|P1|NOT COMPLETED|Overall Study||0
31982|NCT02098304|77761|P1|COMPLETED|Overall Study||42
31983|NCT02098304|77761|P1|STARTED|Overall Study||42
31984|NCT02098109|77770|P2|NOT COMPLETED|Overall Study||0
31985|NCT02098109|77771|P1|NOT COMPLETED|Overall Study||3
31986|NCT02098109|77770|P2|COMPLETED|Overall Study||51
31987|NCT02098109|77771|P1|COMPLETED|Overall Study||46
31988|NCT02098109|77770|P2|STARTED|Overall Study||51
31989|NCT02098109|77771|P1|STARTED|Overall Study||49
31990|NCT02097992|77797|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
31991|NCT02097992|77798|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
31992|NCT02097992|77799|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
31993|NCT02097992|77800|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
31994|NCT02097992|77797|P4|COMPLETED|Treatment 3 (4 Weeks)||2
31995|NCT02097992|77798|P3|COMPLETED|Treatment 3 (4 Weeks)||4
31996|NCT02097992|77799|P2|COMPLETED|Treatment 3 (4 Weeks)||3
31997|NCT02097992|77800|P1|COMPLETED|Treatment 3 (4 Weeks)||2
31998|NCT02097992|77797|P4|STARTED|Treatment 3 (4 Weeks)||2
31999|NCT02097992|77798|P3|STARTED|Treatment 3 (4 Weeks)||4
32000|NCT02097992|77799|P2|STARTED|Treatment 3 (4 Weeks)||3
32001|NCT02097992|77800|P1|STARTED|Treatment 3 (4 Weeks)||2
32002|NCT02097992|77797|P4|NOT COMPLETED|Washout (4 Weeks)||0
32003|NCT02097992|77798|P3|NOT COMPLETED|Washout (4 Weeks)||0
32004|NCT02097992|77799|P2|NOT COMPLETED|Washout (4 Weeks)||0
32005|NCT02097992|77800|P1|NOT COMPLETED|Washout (4 Weeks)||0
32006|NCT02097992|77797|P4|COMPLETED|Washout (4 Weeks)||2
32007|NCT02097992|77798|P3|COMPLETED|Washout (4 Weeks)||4
32008|NCT02097992|77799|P2|COMPLETED|Washout (4 Weeks)||3
32009|NCT02097992|77800|P1|COMPLETED|Washout (4 Weeks)||2
32010|NCT02097992|77797|P4|STARTED|Washout (4 Weeks)||2
32011|NCT02097992|77798|P3|STARTED|Washout (4 Weeks)||4
32012|NCT02097992|77799|P2|STARTED|Washout (4 Weeks)||3
32013|NCT02097992|77800|P1|STARTED|Washout (4 Weeks)||2
32014|NCT02097992|77797|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
32015|NCT02097992|77798|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
32016|NCT02097992|77799|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
32017|NCT02097992|77800|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
32018|NCT02097992|77797|P4|COMPLETED|Treatment 2 (4 Weeks)||2
32019|NCT02097992|77798|P3|COMPLETED|Treatment 2 (4 Weeks)||4
32020|NCT02097992|77799|P2|COMPLETED|Treatment 2 (4 Weeks)||3
32021|NCT02097992|77800|P1|COMPLETED|Treatment 2 (4 Weeks)||2
32022|NCT02097992|77797|P4|STARTED|Treatment 2 (4 Weeks)||2
32023|NCT02097992|77798|P3|STARTED|Treatment 2 (4 Weeks)||4
32024|NCT02097992|77799|P2|STARTED|Treatment 2 (4 Weeks)||3
32025|NCT02097992|77800|P1|STARTED|Treatment 2 (4 Weeks)||2
32026|NCT02097992|77797|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
32027|NCT02097992|77798|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
32028|NCT02097992|77799|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
32029|NCT02097992|77800|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
32030|NCT02097992|77797|P4|COMPLETED|Treatment 1 (1 Day)||2
32031|NCT02097992|77798|P3|COMPLETED|Treatment 1 (1 Day)||4
32032|NCT02097992|77799|P2|COMPLETED|Treatment 1 (1 Day)||3
32033|NCT02097992|77800|P1|COMPLETED|Treatment 1 (1 Day)||2
32034|NCT02097992|77797|P4|STARTED|Treatment 1 (1 Day)||2
32035|NCT02097992|77798|P3|STARTED|Treatment 1 (1 Day)||4
32036|NCT02097992|77799|P2|STARTED|Treatment 1 (1 Day)||3
32037|NCT02097992|77800|P1|STARTED|Treatment 1 (1 Day)||2
32038|NCT02097849|77810|P2|NOT COMPLETED|Overall Study||0
32039|NCT02097849|77811|P1|NOT COMPLETED|Overall Study||0
32040|NCT02097849|77810|P2|COMPLETED|Overall Study||38
32041|NCT02097849|77811|P1|COMPLETED|Overall Study||33
32042|NCT02097849|77810|P2|STARTED|Overall Study||38
32043|NCT02097849|77811|P1|STARTED|Overall Study||33
32044|NCT02097823|77849|P2|NOT COMPLETED|Overall Study||1
32045|NCT02097823|77850|P1|NOT COMPLETED|Overall Study||1
32046|NCT02097823|77849|P2|COMPLETED|Overall Study||3
32047|NCT02097823|77850|P1|COMPLETED|Overall Study||10
32048|NCT02097823|77849|P2|STARTED|Overall Study||4
32049|NCT02097823|77850|P1|STARTED|Overall Study||11
32050|NCT02097745|77865|P1|NOT COMPLETED|Overall Study||178
32051|NCT02097745|77865|P1|COMPLETED|Overall Study||157
32052|NCT02097745|77865|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
32053|NCT02097732|77889|P2|NOT COMPLETED|Overall Study||0
32054|NCT02097732|77890|P1|NOT COMPLETED|Overall Study||0
32055|NCT02097732|77889|P2|COMPLETED|Overall Study||3
32056|NCT02097732|77890|P1|COMPLETED|Overall Study||1
32057|NCT02097732|77889|P2|STARTED|Overall Study||3
32058|NCT02097732|77890|P1|STARTED|Overall Study||1
32059|NCT02097719|77901|P2|NOT COMPLETED|Overall Study||1
32060|NCT02097719|77902|P1|NOT COMPLETED|Overall Study||3
32061|NCT02097719|77901|P2|COMPLETED|Overall Study||50
32062|NCT02097719|77902|P1|COMPLETED|Overall Study||46
32063|NCT02097719|77901|P2|STARTED|Overall Study||51
32064|NCT02097719|77902|P1|STARTED|Overall Study||49
32065|NCT02097537|77908|P1|NOT COMPLETED|Overall Study||0
32066|NCT02097537|77908|P1|COMPLETED|Overall Study||10
32067|NCT02097537|77908|P1|Follow-Up|Overall Study||10
32068|NCT02097537|77908|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
32069|NCT02097537|77908|P1|STARTED|Overall Study||10
32070|NCT02097303|77914|P1|NOT COMPLETED|Overall Study||5
32071|NCT02097303|77914|P1|COMPLETED|Overall Study||31
32072|NCT02097303|77914|P1|STARTED|Overall Study||36
32073|NCT02097290|77924|P1|NOT COMPLETED|Overall Study||17
32074|NCT02097290|77924|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
32075|NCT02097290|77924|P1|STARTED|Overall Study||210
32076|NCT02097238|77934|P1|NOT COMPLETED|Overall Study||19
32077|NCT02097238|77934|P1|COMPLETED|Overall Study||0
32078|NCT02097238|77934|P1|STARTED|Overall Study||19
32079|NCT02097108|77940|P1|NOT COMPLETED|Overall Study||2
32080|NCT02097108|77940|P1|COMPLETED|Overall Study||9
32081|NCT02097108|77940|P1|STARTED|Overall Study||11
32082|NCT02097056|77947|P1|NOT COMPLETED|Overall Study||58
32083|NCT02097056|77947|P1|COMPLETED|Overall Study||113
32084|NCT02097056|77947|P1|ParticipantsTreated|Overall Study||170
32085|NCT02097056|77947|P1|STARTED|Overall Study||171
32086|NCT02097030|77955|P2|NOT COMPLETED|Second Intervention (3 Days)||0
32087|NCT02097030|77956|P1|NOT COMPLETED|Second Intervention (3 Days)||0
32088|NCT02097030|77955|P2|COMPLETED|Second Intervention (3 Days)||16
32089|NCT02097030|77956|P1|COMPLETED|Second Intervention (3 Days)||14
32090|NCT02097030|77955|P2|STARTED|Second Intervention (3 Days)||16
32091|NCT02097030|77956|P1|STARTED|Second Intervention (3 Days)||14
32092|NCT02097030|77955|P2|NOT COMPLETED|First Intervention (3 Days)||1
32093|NCT02097030|77956|P1|NOT COMPLETED|First Intervention (3 Days)||1
32094|NCT02097030|77955|P2|COMPLETED|First Intervention (3 Days)||16
32095|NCT02097030|77956|P1|COMPLETED|First Intervention (3 Days)||14
32096|NCT02097030|77955|P2|STARTED|First Intervention (3 Days)||17
32097|NCT02097030|77956|P1|STARTED|First Intervention (3 Days)||15
32098|NCT02096952|78017|P1|NOT COMPLETED|Overall Study||1
32099|NCT02096952|78017|P1|COMPLETED|Overall Study||14
32100|NCT02096952|78017|P1|STARTED|Overall Study||15
32101|NCT02096900|78023|P2|NOT COMPLETED|Overall Study||2
32102|NCT02096900|78024|P1|NOT COMPLETED|Overall Study||4
32103|NCT02096900|78023|P2|COMPLETED|Overall Study||42
32104|NCT02096900|78024|P1|COMPLETED|Overall Study||38
32105|NCT02096900|78023|P2|STARTED|Overall Study|Allocated to Zolpidem|44
32106|NCT02096900|78024|P1|STARTED|Overall Study|Allocated to Midazolam|42
32107|NCT02096861|78042|P4|NOT COMPLETED|Overall Study||10
32108|NCT02096861|78043|P3|NOT COMPLETED|Overall Study||17
32109|NCT02096861|78044|P2|NOT COMPLETED|Overall Study||15
32110|NCT02096861|78045|P1|NOT COMPLETED|Overall Study||12
32111|NCT02096861|78042|P4|COMPLETED|Overall Study||45
32112|NCT02096861|78043|P3|COMPLETED|Overall Study||37
32113|NCT02096861|78044|P2|COMPLETED|Overall Study||40
32114|NCT02096861|78045|P1|COMPLETED|Overall Study||44
32115|NCT02096861|78042|P4|Drug Switching at Week 30|Overall Study||47
32116|NCT02096861|78043|P3|Drug Switching at Week 30|Overall Study||41
32117|NCT02096861|78044|P2|Drug Switching at Week 30|Overall Study||44
32118|NCT02096861|78045|P1|Drug Switching at Week 30|Overall Study||48
32119|NCT02096861|78042|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
32120|NCT02096861|78043|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
32121|NCT02096861|78044|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
32122|NCT02096861|78045|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
32123|NCT02096835|78076|P3|NOT COMPLETED|Overall Study||1
32124|NCT02096835|78077|P2|NOT COMPLETED|Overall Study||0
32125|NCT02096835|78078|P1|NOT COMPLETED|Overall Study||3
32126|NCT02096835|78076|P3|COMPLETED|Overall Study||50
32127|NCT02096835|78077|P2|COMPLETED|Overall Study||53
32128|NCT02096835|78078|P1|COMPLETED|Overall Study||50
32129|NCT02096835|78076|P3|STARTED|Overall Study||51
32130|NCT02096835|78077|P2|STARTED|Overall Study||53
32131|NCT02096835|78078|P1|STARTED|Overall Study||53
32132|NCT02096744|78095|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
32133|NCT02096744|78096|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
32134|NCT02096744|78095|P2|COMPLETED|Treatment Period 3 (7 Days)||27
32135|NCT02096744|78096|P1|COMPLETED|Treatment Period 3 (7 Days)||28
32136|NCT02096744|78095|P2|STARTED|Treatment Period 3 (7 Days)||28
32137|NCT02096744|78096|P1|STARTED|Treatment Period 3 (7 Days)||28
32138|NCT02096744|78095|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
32139|NCT02096744|78096|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
32140|NCT02096744|78095|P2|COMPLETED|Washout Period 2 (3 Days)||28
32141|NCT02096744|78096|P1|COMPLETED|Washout Period 2 (3 Days)||28
32142|NCT02096744|78095|P2|STARTED|Washout Period 2 (3 Days)||28
32143|NCT02096744|78096|P1|STARTED|Washout Period 2 (3 Days)||28
32144|NCT02096744|78095|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
32145|NCT02096744|78096|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
32146|NCT02096744|78095|P2|COMPLETED|Treatment Period 2 (7 Days)||28
32147|NCT02096744|78096|P1|COMPLETED|Treatment Period 2 (7 Days)||28
32148|NCT02096744|78095|P2|STARTED|Treatment Period 2 (7 Days)||28
32149|NCT02096744|78096|P1|STARTED|Treatment Period 2 (7 Days)||28
32150|NCT02096744|78095|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
32151|NCT02096744|78096|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
32152|NCT02096744|78095|P2|COMPLETED|Washout Period 1(7 Days)||28
32153|NCT02096744|78096|P1|COMPLETED|Washout Period 1(7 Days)||28
32154|NCT02096744|78095|P2|STARTED|Washout Period 1(7 Days)||28
32155|NCT02096744|78096|P1|STARTED|Washout Period 1(7 Days)||28
32156|NCT02096744|78095|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
32157|NCT02096744|78096|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
32158|NCT02096744|78095|P2|COMPLETED|Treatment Period 1(7 Days)||28
32159|NCT02096744|78096|P1|COMPLETED|Treatment Period 1(7 Days)||28
32160|NCT02096744|78095|P2|STARTED|Treatment Period 1(7 Days)||29
32161|NCT02096744|78096|P1|STARTED|Treatment Period 1(7 Days)||29
32162|NCT02096731|78111|P2|NOT COMPLETED|Overall Study||0
32163|NCT02096731|78112|P1|NOT COMPLETED|Overall Study||0
32164|NCT02096731|78111|P2|COMPLETED|Overall Study||88955
32165|NCT02096731|78112|P1|COMPLETED|Overall Study||26442
32166|NCT02096731|78111|P2|STARTED|Overall Study||88955
32167|NCT02096731|78112|P1|STARTED|Overall Study||26442
32168|NCT02096718|78129|P3|NOT COMPLETED|Overall Study||0
32169|NCT02096718|78130|P2|NOT COMPLETED|Overall Study||0
32170|NCT02096718|78131|P1|NOT COMPLETED|Overall Study||0
32171|NCT02096718|78129|P3|COMPLETED|Overall Study||14
32172|NCT02096718|78130|P2|COMPLETED|Overall Study||8
32173|NCT02096718|78131|P1|COMPLETED|Overall Study||8
32174|NCT02096718|78129|P3|STARTED|Overall Study||14
32175|NCT02096718|78130|P2|STARTED|Overall Study||8
32176|NCT02096718|78131|P1|STARTED|Overall Study||8
32177|NCT02096705|78150|P2|NOT COMPLETED|Follow-up||4
32178|NCT02096705|78151|P1|NOT COMPLETED|Follow-up||4
32179|NCT02096705|78150|P2|COMPLETED|Follow-up||135
32180|NCT02096705|78151|P1|COMPLETED|Follow-up||125
32181|NCT02096705|78150|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
32182|NCT02096705|78151|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
32183|NCT02096705|78150|P2|NOT COMPLETED|Treatment||5
32184|NCT02096705|78151|P1|NOT COMPLETED|Treatment||9
32185|NCT02096705|78150|P2|COMPLETED|Treatment||134
32186|NCT02096705|78151|P1|COMPLETED|Treatment||124
32187|NCT02096705|78150|P2|STARTED|Treatment||139
32188|NCT02096705|78151|P1|STARTED|Treatment||133
32189|NCT02096692|78163|P1|NOT COMPLETED|Overall Study||4
32190|NCT02096692|78163|P1|COMPLETED|Overall Study||150
32191|NCT02096692|78163|P1|STARTED|Overall Study||154
32192|NCT02096679|78169|P1|NOT COMPLETED|Overall Study||0
32193|NCT02096679|78169|P1|COMPLETED|Overall Study||8
32194|NCT02096679|78169|P1|STARTED|Overall Study||8
32195|NCT02096575|78194|P3|NOT COMPLETED|Overall Study||5
32196|NCT02096575|78195|P2|NOT COMPLETED|Overall Study||0
32197|NCT02096575|78196|P1|NOT COMPLETED|Overall Study||0
32198|NCT02096575|78194|P3|COMPLETED|Overall Study||0
32199|NCT02096575|78195|P2|COMPLETED|Overall Study||67
32200|NCT02096575|78196|P1|COMPLETED|Overall Study||68
32201|NCT02096575|78194|P3|STARTED|Overall Study||5
32202|NCT02096575|78195|P2|STARTED|Overall Study||67
32203|NCT02096575|78196|P1|STARTED|Overall Study||68
32204|NCT02096458|78210|P1|NOT COMPLETED|Overall Study||0
32205|NCT02096458|78210|P1|COMPLETED|Overall Study||8
32206|NCT02096458|78210|P1|STARTED|Overall Study||8
32207|NCT02096081|78216|P2|NOT COMPLETED|Overall Study||4
32208|NCT02096081|78217|P1|NOT COMPLETED|Overall Study||3
32209|NCT02096081|78216|P2|COMPLETED|Overall Study||124
32210|NCT02096081|78217|P1|COMPLETED|Overall Study||119
32211|NCT02096081|78216|P2|STARTED|Overall Study||128
32212|NCT02096081|78217|P1|STARTED|Overall Study||122
32213|NCT02096042|78249|P3|NOT COMPLETED|Overall Study||0
32214|NCT02096042|78250|P2|NOT COMPLETED|Overall Study||0
32215|NCT02096042|78251|P1|NOT COMPLETED|Overall Study||1
32216|NCT02096042|78249|P3|COMPLETED|Overall Study||0
32217|NCT02096042|78250|P2|COMPLETED|Overall Study||0
32218|NCT02096042|78251|P1|COMPLETED|Overall Study||0
32219|NCT02096042|78249|P3|STARTED|Overall Study||0
32220|NCT02096042|78250|P2|STARTED|Overall Study||0
32221|NCT02096042|78251|P1|STARTED|Overall Study||1
32222|NCT02095873|78260|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
32223|NCT02095873|78261|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
32224|NCT02095873|78260|P2|COMPLETED|Second Intervention (8 Weeks)||16
32225|NCT02095873|78261|P1|COMPLETED|Second Intervention (8 Weeks)||13
32226|NCT02095873|78260|P2|STARTED|Second Intervention (8 Weeks)||16
32227|NCT02095873|78261|P1|STARTED|Second Intervention (8 Weeks)||15
32228|NCT02095873|78260|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
32229|NCT02095873|78261|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
32230|NCT02095873|78260|P2|COMPLETED|First Intervention (8 Weeks)||16
32231|NCT02095873|78261|P1|COMPLETED|First Intervention (8 Weeks)||15
32232|NCT02095873|78260|P2|STARTED|First Intervention (8 Weeks)||16
32233|NCT02095873|78261|P1|STARTED|First Intervention (8 Weeks)||16
32234|NCT02095691|78273|P1|NOT COMPLETED|Overall Study||1
32235|NCT02095691|78273|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
32236|NCT02095691|78273|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
32237|NCT02095561|78292|P2|NOT COMPLETED|Overall Study||0
32238|NCT02095561|78293|P1|NOT COMPLETED|Overall Study||0
32239|NCT02095561|78292|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
32240|NCT02095561|78293|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
32241|NCT02095561|78292|P2|HPV Tested at Health Centers|Overall Study||599
32242|NCT02095561|78293|P1|HPV Tested at Health Centers|Overall Study||99
32243|NCT02095561|78292|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
32244|NCT02095561|78293|P1|HPV Self-tested Women|Overall Study||2519
32245|NCT02095561|78292|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
32246|NCT02095561|78293|P1|Self-testing Acceptability|Overall Study||2616
32247|NCT02095561|78292|P2|STARTED|Overall Study||2964
32248|NCT02095561|78293|P1|STARTED|Overall Study||3049
32249|NCT02095535|78305|P1|NOT COMPLETED|Analysis||0
32250|NCT02095535|78305|P1|COMPLETED|Analysis||18
32251|NCT02095535|78305|P1|STARTED|Analysis||18
32252|NCT02095535|78305|P1|NOT COMPLETED|Recruitment||2
32253|NCT02095535|78305|P1|COMPLETED|Recruitment||18
32254|NCT02095535|78305|P1|STARTED|Recruitment||20
32255|NCT02095223|78311|P2|NOT COMPLETED|Overall Study||0
32256|NCT02095223|78312|P1|NOT COMPLETED|Overall Study||1
32257|NCT02095223|78311|P2|COMPLETED|Overall Study||2
32258|NCT02095223|78312|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
32259|NCT02095223|78311|P2|STARTED|Overall Study||2
32260|NCT02095223|78312|P1|STARTED|Overall Study||2
32261|NCT02095197|78322|P2|NOT COMPLETED|Overall Study||3
32262|NCT02095197|78323|P1|NOT COMPLETED|Overall Study||0
32263|NCT02095197|78322|P2|COMPLETED|Overall Study||36
32264|NCT02095197|78323|P1|COMPLETED|Overall Study||40
32265|NCT02095197|78322|P2|STARTED|Overall Study||39
32266|NCT02095197|78323|P1|STARTED|Overall Study||40
32267|NCT02095158|78335|P1|NOT COMPLETED|Overall Study||75
32268|NCT02095158|78335|P1|COMPLETED|Overall Study||365
32269|NCT02095158|78335|P1|STARTED|Overall Study||440
32270|NCT02095106|78342|P2|NOT COMPLETED|Second Intervention (14 Days)||1
32271|NCT02095106|78343|P1|NOT COMPLETED|Second Intervention (14 Days)||0
32272|NCT02095106|78342|P2|COMPLETED|Second Intervention (14 Days)||12
32273|NCT02095106|78343|P1|COMPLETED|Second Intervention (14 Days)||14
32274|NCT02095106|78342|P2|STARTED|Second Intervention (14 Days)||13
32275|NCT02095106|78343|P1|STARTED|Second Intervention (14 Days)||14
32276|NCT02095106|78342|P2|NOT COMPLETED|First Intervention (14 Days)||0
32277|NCT02095106|78343|P1|NOT COMPLETED|First Intervention (14 Days)||0
32278|NCT02095106|78342|P2|COMPLETED|First Intervention (14 Days)||13
32279|NCT02095106|78343|P1|COMPLETED|First Intervention (14 Days)||14
32280|NCT02095106|78342|P2|STARTED|First Intervention (14 Days)||13
32281|NCT02095106|78343|P1|STARTED|First Intervention (14 Days)||14
32282|NCT02094937|78359|P4|NOT COMPLETED|12 Weeks in Period 2||12
32283|NCT02094937|78360|P3|NOT COMPLETED|12 Weeks in Period 2||12
32284|NCT02094937|78361|P2|NOT COMPLETED|12 Weeks in Period 2||11
32285|NCT02094937|78362|P1|NOT COMPLETED|12 Weeks in Period 2||0
32286|NCT02094937|78359|P4|COMPLETED|12 Weeks in Period 2||112
32287|NCT02094937|78360|P3|COMPLETED|12 Weeks in Period 2||112
32288|NCT02094937|78361|P2|COMPLETED|12 Weeks in Period 2||112
32289|NCT02094937|78362|P1|COMPLETED|12 Weeks in Period 2||0
32290|NCT02094937|78359|P4|STARTED|12 Weeks in Period 2||124
32291|NCT02094937|78360|P3|STARTED|12 Weeks in Period 2||124
32292|NCT02094937|78361|P2|STARTED|12 Weeks in Period 2||123
32293|NCT02094937|78362|P1|STARTED|12 Weeks in Period 2||0
32294|NCT02094937|78359|P4|NOT COMPLETED|8 Weeks in Period 1||0
32295|NCT02094937|78360|P3|NOT COMPLETED|8 Weeks in Period 1||0
32296|NCT02094937|78361|P2|NOT COMPLETED|8 Weeks in Period 1||0
32297|NCT02094937|78362|P1|NOT COMPLETED|8 Weeks in Period 1||60
32298|NCT02094937|78359|P4|COMPLETED|8 Weeks in Period 1||0
32299|NCT02094937|78360|P3|COMPLETED|8 Weeks in Period 1||0
32300|NCT02094937|78361|P2|COMPLETED|8 Weeks in Period 1||0
32301|NCT02094937|78362|P1|COMPLETED|8 Weeks in Period 1||370
32302|NCT02094937|78359|P4|STARTED|8 Weeks in Period 1||0
32303|NCT02094937|78360|P3|STARTED|8 Weeks in Period 1||0
32304|NCT02094937|78361|P2|STARTED|8 Weeks in Period 1||0
32305|NCT02094937|78362|P1|STARTED|8 Weeks in Period 1||430
32306|NCT02094898|78392|P1|NOT COMPLETED|Overall Study||5
32307|NCT02094898|78392|P1|COMPLETED|Overall Study||7
32308|NCT02094898|78392|P1|STARTED|Overall Study||12
32309|NCT02094885|78439|P2|NOT COMPLETED|Overall Study||5
32310|NCT02094885|78440|P1|NOT COMPLETED|Overall Study||2
32311|NCT02094885|78439|P2|COMPLETED|Overall Study||122
32312|NCT02094885|78440|P1|COMPLETED|Overall Study||123
32313|NCT02094885|78439|P2|STARTED|Overall Study||127
32314|NCT02094885|78440|P1|STARTED|Overall Study||125
32315|NCT02094677|78454|P2|NOT COMPLETED|Overall Study||1
32316|NCT02094677|78455|P1|NOT COMPLETED|Overall Study||3
32317|NCT02094677|78454|P2|COMPLETED|Overall Study||30
32318|NCT02094677|78455|P1|COMPLETED|Overall Study||40
32319|NCT02094677|78454|P2|STARTED|Overall Study||31
32320|NCT02094677|78455|P1|STARTED|Overall Study||43
32321|NCT02094664|78519|P2|NOT COMPLETED|Overall Study||0
32322|NCT02094664|78520|P1|NOT COMPLETED|Overall Study||0
32323|NCT02094664|78519|P2|COMPLETED|Overall Study||16
32324|NCT02094664|78520|P1|COMPLETED|Overall Study||16
32325|NCT02094664|78519|P2|STARTED|Overall Study||16
32326|NCT02094664|78520|P1|STARTED|Overall Study||16
32327|NCT02094612|78534|P2|NOT COMPLETED|Overall Study||70
32328|NCT02094612|78535|P1|NOT COMPLETED|Overall Study||79
32329|NCT02094612|78534|P2|COMPLETED|Overall Study||25
32330|NCT02094612|78535|P1|COMPLETED|Overall Study||33
32331|NCT02094612|78534|P2|6 Month Follow up|Overall Study||25
32332|NCT02094612|78535|P1|6 Month Follow up|Overall Study||33
32333|NCT02094612|78534|P2|3 Month Follow up|Overall Study||43
32334|NCT02094612|78535|P1|3 Month Follow up|Overall Study||50
32335|NCT02094612|78534|P2|1 Month Follow up|Overall Study||50
32336|NCT02094612|78535|P1|1 Month Follow up|Overall Study||67
32337|NCT02094612|78534|P2|STARTED|Overall Study||95
32338|NCT02094612|78535|P1|STARTED|Overall Study||112
32339|NCT02094573|78555|P2|NOT COMPLETED|Overall Study||110
32340|NCT02094573|78556|P1|NOT COMPLETED|Overall Study||112
32341|NCT02094573|78555|P2|COMPLETED|Overall Study||0
32342|NCT02094573|78556|P1|COMPLETED|Overall Study||0
32343|NCT02094573|78555|P2|Treated|Overall Study||110
32344|NCT02094573|78556|P1|Treated|Overall Study||109
32345|NCT02094573|78555|P2|STARTED|Overall Study||110
32346|NCT02094573|78556|P1|STARTED|Overall Study||112
32347|NCT02094534|78590|P2|NOT COMPLETED|Overall Study||0
32348|NCT02094534|78591|P1|NOT COMPLETED|Overall Study||0
32349|NCT02094534|78590|P2|COMPLETED|Overall Study||10
32350|NCT02094534|78591|P1|COMPLETED|Overall Study||15
32351|NCT02094534|78590|P2|STARTED|Overall Study||10
32352|NCT02094534|78591|P1|STARTED|Overall Study||15
32353|NCT02094443|78601|P2|NOT COMPLETED|Overall Study||17
32354|NCT02094443|78602|P1|NOT COMPLETED|Overall Study||15
32355|NCT02094443|78601|P2|COMPLETED|Overall Study||9
32356|NCT02094443|78602|P1|COMPLETED|Overall Study||11
32357|NCT02094443|78601|P2|Completed at Week 24|Overall Study||8
32358|NCT02094443|78602|P1|Completed at Week 24|Overall Study||11
32359|NCT02094443|78601|P2|Completed at Week 12|Overall Study||1
32360|NCT02094443|78602|P1|Completed at Week 12|Overall Study||0
32361|NCT02094443|78601|P2|STARTED|Overall Study||26
32362|NCT02094443|78602|P1|STARTED|Overall Study||26
32363|NCT02094352|78622|P2|NOT COMPLETED|Overall Study||0
32364|NCT02094352|78623|P1|NOT COMPLETED|Overall Study||0
32365|NCT02094352|78622|P2|COMPLETED|Overall Study||1
32366|NCT02094352|78623|P1|COMPLETED|Overall Study||2
32367|NCT02094352|78622|P2|STARTED|Overall Study||1
32368|NCT02094352|78623|P1|STARTED|Overall Study||2
32369|NCT02094326|78629|P1|NOT COMPLETED|Overall Study||0
32370|NCT02094326|78629|P1|COMPLETED|Overall Study||301
32371|NCT02094326|78629|P1|STARTED|Overall Study||301
32372|NCT02094300|78638|P1|NOT COMPLETED|Overall Study||20
32373|NCT02094300|78638|P1|COMPLETED|Overall Study||6
32374|NCT02094300|78638|P1|30 Days|Overall Study||24
32375|NCT02094300|78638|P1|STARTED|Overall Study||26
32376|NCT02094261|78642|P1|NOT COMPLETED|Overall Study||210
32377|NCT02094261|78642|P1|COMPLETED|Overall Study||0
32378|NCT02094261|78642|P1|STARTED|Overall Study||210
32379|NCT02093962|78651|P2|NOT COMPLETED|Overall Study||131
32380|NCT02093962|78652|P1|NOT COMPLETED|Overall Study||134
32381|NCT02093962|78651|P2|COMPLETED|Overall Study||0
32382|NCT02093962|78652|P1|COMPLETED|Overall Study||0
32383|NCT02093962|78651|P2|Received Treatment|Overall Study||130
32384|NCT02093962|78652|P1|Received Treatment|Overall Study||130
32385|NCT02093962|78651|P2|STARTED|Overall Study||131
32386|NCT02093962|78652|P1|STARTED|Overall Study||134
32387|NCT02093949|78660|P2|NOT COMPLETED|Overall Study||0
32388|NCT02093949|78661|P1|NOT COMPLETED|Overall Study||0
32389|NCT02093949|78660|P2|COMPLETED|Overall Study||47
32390|NCT02093949|78661|P1|COMPLETED|Overall Study||105
32391|NCT02093949|78660|P2|STARTED|Overall Study||47
32392|NCT02093949|78661|P1|STARTED|Overall Study||105
32393|NCT02093923|78684|P5|NOT COMPLETED|Overall Study||0
32394|NCT02093923|78685|P4|NOT COMPLETED|Overall Study||2
32395|NCT02093923|78686|P3|NOT COMPLETED|Overall Study||0
32396|NCT02093923|78687|P2|NOT COMPLETED|Overall Study||0
32397|NCT02093923|78688|P1|NOT COMPLETED|Overall Study||0
32398|NCT02093923|78684|P5|COMPLETED|Overall Study||13
32399|NCT02093923|78685|P4|COMPLETED|Overall Study||10
32400|NCT02093923|78686|P3|COMPLETED|Overall Study||5
32401|NCT02093923|78687|P2|COMPLETED|Overall Study||4
32402|NCT02093923|78688|P1|COMPLETED|Overall Study||4
32403|NCT02093923|78684|P5|Treated - 2 Doses:|Overall Study||13
32404|NCT02093923|78685|P4|Treated - 2 Doses:|Overall Study||10
32405|NCT02093923|78686|P3|Treated - 2 Doses:|Overall Study||5
32406|NCT02093923|78687|P2|Treated - 2 Doses:|Overall Study||4
32407|NCT02093923|78688|P1|Treated - 2 Doses:|Overall Study||4
32408|NCT02093923|78684|P5|Treated - 1 Dose Only:|Overall Study||0
32409|NCT02093923|78685|P4|Treated - 1 Dose Only:|Overall Study||1
32410|NCT02093923|78686|P3|Treated - 1 Dose Only:|Overall Study||0
32411|NCT02093923|78687|P2|Treated - 1 Dose Only:|Overall Study||0
32412|NCT02093923|78688|P1|Treated - 1 Dose Only:|Overall Study||0
32413|NCT02093923|78684|P5|Total Treated|Overall Study||13
32414|NCT02093923|78685|P4|Total Treated|Overall Study||11
32415|NCT02093923|78686|P3|Total Treated|Overall Study||5
32416|NCT02093923|78687|P2|Total Treated|Overall Study||4
32417|NCT02093923|78688|P1|Total Treated|Overall Study||4
32418|NCT02093923|78684|P5|STARTED|Overall Study||13
32419|NCT02093923|78685|P4|STARTED|Overall Study||12
32420|NCT02093923|78686|P3|STARTED|Overall Study||5
32421|NCT02093923|78687|P2|STARTED|Overall Study||4
32422|NCT02093923|78688|P1|STARTED|Overall Study||4
32423|NCT02093897|78743|P1|NOT COMPLETED|Overall Study||19
32424|NCT02093897|78743|P1|COMPLETED|Overall Study||65
32425|NCT02093897|78743|P1|STARTED|Overall Study||84
32426|NCT02093819|78771|P8|NOT COMPLETED|Overall Study||0
32427|NCT02093819|78772|P7|NOT COMPLETED|Overall Study||0
32428|NCT02093819|78773|P6|NOT COMPLETED|Overall Study||0
32429|NCT02093819|78774|P5|NOT COMPLETED|Overall Study||0
32430|NCT02093819|78775|P4|NOT COMPLETED|Overall Study||0
32431|NCT02093819|78776|P3|NOT COMPLETED|Overall Study||0
32432|NCT02093819|78777|P2|NOT COMPLETED|Overall Study||0
32433|NCT02093819|78778|P1|NOT COMPLETED|Overall Study||0
32434|NCT02093819|78771|P8|COMPLETED|Overall Study||6
32435|NCT02093819|78772|P7|COMPLETED|Overall Study||5
32436|NCT02093819|78773|P6|COMPLETED|Overall Study||6
32437|NCT02093819|78774|P5|COMPLETED|Overall Study||6
32438|NCT02093819|78775|P4|COMPLETED|Overall Study||6
32439|NCT02093819|78776|P3|COMPLETED|Overall Study||10
32440|NCT02093819|78777|P2|COMPLETED|Overall Study||6
32441|NCT02093819|78778|P1|COMPLETED|Overall Study||15
32442|NCT02093819|78771|P8|STARTED|Overall Study||6
32443|NCT02093819|78772|P7|STARTED|Overall Study||5
32444|NCT02093819|78773|P6|STARTED|Overall Study||6
32445|NCT02093819|78774|P5|STARTED|Overall Study||6
32446|NCT02093819|78775|P4|STARTED|Overall Study||6
32447|NCT02093819|78776|P3|STARTED|Overall Study||10
32448|NCT02093819|78777|P2|STARTED|Overall Study||6
32449|NCT02093819|78778|P1|STARTED|Overall Study||15
32450|NCT02093702|78814|P2|NOT COMPLETED|Overall Study||0
32451|NCT02093702|78815|P1|NOT COMPLETED|Overall Study||0
32452|NCT02093702|78814|P2|COMPLETED|Overall Study||3
32453|NCT02093702|78815|P1|COMPLETED|Overall Study||2
32454|NCT02093702|78814|P2|STARTED|Overall Study||3
32455|NCT02093702|78815|P1|STARTED|Overall Study||2
32456|NCT02093689|78846|P3|NOT COMPLETED|Overall Study||0
32457|NCT02093689|78847|P2|NOT COMPLETED|Overall Study||0
32458|NCT02093689|78848|P1|NOT COMPLETED|Overall Study||4
32459|NCT02093689|78846|P3|COMPLETED|Overall Study||0
32460|NCT02093689|78847|P2|COMPLETED|Overall Study||0
32461|NCT02093689|78848|P1|COMPLETED|Overall Study||14
32462|NCT02093689|78846|P3|STARTED|Overall Study||0
32463|NCT02093689|78847|P2|STARTED|Overall Study||0
32464|NCT02093689|78848|P1|STARTED|Overall Study||18
32465|NCT02093520|78856|P2|NOT COMPLETED|Overall Study||22
32466|NCT02093520|78857|P1|NOT COMPLETED|Overall Study||6
32467|NCT02093520|78856|P2|COMPLETED|Overall Study||131
32468|NCT02093520|78857|P1|COMPLETED|Overall Study||143
32469|NCT02093520|78856|P2|STARTED|Overall Study||153
32470|NCT02093520|78857|P1|STARTED|Overall Study||149
32471|NCT02093390|78869|P2|NOT COMPLETED|Overall Study||1
32472|NCT02093390|78870|P1|NOT COMPLETED|Overall Study||0
32473|NCT02093390|78869|P2|COMPLETED|Overall Study||19
32474|NCT02093390|78870|P1|COMPLETED|Overall Study||20
32475|NCT02093390|78869|P2|STARTED|Overall Study||20
32476|NCT02093390|78870|P1|STARTED|Overall Study||20
32477|NCT02093351|78909|P3|NOT COMPLETED|Overall Study||3
32478|NCT02093351|78910|P2|NOT COMPLETED|Overall Study||2
32479|NCT02093351|78911|P1|NOT COMPLETED|Overall Study||2
32480|NCT02093351|78909|P3|COMPLETED|Overall Study||23
32481|NCT02093351|78910|P2|COMPLETED|Overall Study||21
32482|NCT02093351|78911|P1|COMPLETED|Overall Study||28
32483|NCT02093351|78909|P3|Completing Treatment Period 3|Overall Study||23
32484|NCT02093351|78910|P2|Completing Treatment Period 3|Overall Study||21
32485|NCT02093351|78911|P1|Completing Treatment Period 3|Overall Study||28
32486|NCT02093351|78909|P3|Completing Treatment Period 2|Overall Study||23
32487|NCT02093351|78910|P2|Completing Treatment Period 2|Overall Study||21
32488|NCT02093351|78911|P1|Completing Treatment Period 2|Overall Study||29
32489|NCT02093351|78909|P3|Completing Treatment Period 1|Overall Study||23
32490|NCT02093351|78910|P2|Completing Treatment Period 1|Overall Study||22
32491|NCT02093351|78911|P1|Completing Treatment Period 1|Overall Study||29
32492|NCT02093351|78909|P3|STARTED|Overall Study||26
32493|NCT02093351|78910|P2|STARTED|Overall Study||23
32494|NCT02093351|78911|P1|STARTED|Overall Study||30
32495|NCT02093234|78943|P3|NOT COMPLETED|Overall Study||4
32496|NCT02093234|78944|P2|NOT COMPLETED|Overall Study||4
32497|NCT02093234|78945|P1|NOT COMPLETED|Overall Study||3
32498|NCT02093234|78943|P3|COMPLETED|Overall Study||50
32499|NCT02093234|78944|P2|COMPLETED|Overall Study||52
32500|NCT02093234|78945|P1|COMPLETED|Overall Study||53
32501|NCT02093234|78943|P3|STARTED|Overall Study||54
32502|NCT02093234|78944|P2|STARTED|Overall Study||56
32503|NCT02093234|78945|P1|STARTED|Overall Study||56
32504|NCT02093221|78967|P5|NOT COMPLETED|Overall Study||8
32505|NCT02093221|78968|P4|NOT COMPLETED|Overall Study||8
32506|NCT02093221|78969|P3|NOT COMPLETED|Overall Study||9
32507|NCT02093221|78970|P2|NOT COMPLETED|Overall Study||8
32508|NCT02093221|78971|P1|NOT COMPLETED|Overall Study||10
32509|NCT02093221|78967|P5|COMPLETED|Overall Study||7
32510|NCT02093221|78968|P4|COMPLETED|Overall Study||7
32511|NCT02093221|78969|P3|COMPLETED|Overall Study||6
32512|NCT02093221|78970|P2|COMPLETED|Overall Study||8
32513|NCT02093221|78971|P1|COMPLETED|Overall Study||5
32514|NCT02093221|78967|P5|STARTED|Overall Study||15
32515|NCT02093221|78968|P4|STARTED|Overall Study||15
32516|NCT02093221|78969|P3|STARTED|Overall Study||15
32517|NCT02093221|78970|P2|STARTED|Overall Study||16
32518|NCT02093221|78971|P1|STARTED|Overall Study||15
32519|NCT02093026|79008|P1|NOT COMPLETED|Overall Study||193
32520|NCT02093026|79008|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
32521|NCT02093026|79008|P1|STARTED|Overall Study||465
32522|NCT02092961|79030|P3|NOT COMPLETED|Overall Study||16
32523|NCT02092961|79031|P2|NOT COMPLETED|Overall Study||14
32524|NCT02092961|79032|P1|NOT COMPLETED|Overall Study||21
32525|NCT02092961|79030|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
32526|NCT02092961|79031|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
32527|NCT02092961|79032|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
32528|NCT02092961|79030|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
32529|NCT02092961|79031|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
32530|NCT02092961|79032|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
32531|NCT02092961|79030|P3|STARTED|Overall Study|Patients who received treatment|29
32532|NCT02092961|79031|P2|STARTED|Overall Study|Patients who received treatment|28
32533|NCT02092961|79032|P1|STARTED|Overall Study|Patients who received treatment|33
32534|NCT02092857|79056|P3|NOT COMPLETED|Overall Study||13
32535|NCT02092857|79057|P2|NOT COMPLETED|Overall Study||12
32536|NCT02092857|79058|P1|NOT COMPLETED|Overall Study||10
32537|NCT02092857|79056|P3|COMPLETED|Overall Study||16
32538|NCT02092857|79057|P2|COMPLETED|Overall Study||18
32539|NCT02092857|79058|P1|COMPLETED|Overall Study||20
32540|NCT02092857|79056|P3|STARTED|Overall Study||29
32541|NCT02092857|79057|P2|STARTED|Overall Study||30
32542|NCT02092857|79058|P1|STARTED|Overall Study||30
32543|NCT02092662|79068|P2|NOT COMPLETED|Overall Study||0
32544|NCT02092662|79069|P1|NOT COMPLETED|Overall Study||13
32545|NCT02092662|79068|P2|COMPLETED|Overall Study||19
32546|NCT02092662|79069|P1|COMPLETED|Overall Study||25
32547|NCT02092662|79068|P2|Recruited|Overall Study||19
32548|NCT02092662|79069|P1|Recruited|Overall Study||38
32549|NCT02092662|79068|P2|STARTED|Overall Study||19
32550|NCT02092662|79069|P1|STARTED|Overall Study||38
32551|NCT02092649|79078|P2|NOT COMPLETED|Overall Study||0
32552|NCT02092649|79079|P1|NOT COMPLETED|Overall Study||0
32553|NCT02092649|79078|P2|COMPLETED|Overall Study|13 participants finished study|13
32554|NCT02092649|79079|P1|COMPLETED|Overall Study|13 participants finished study|13
32555|NCT02092649|79078|P2|STARTED|Overall Study|13 participants recruited|13
32556|NCT02092649|79079|P1|STARTED|Overall Study|13 participants recruited|13
32557|NCT02092610|79097|P2|NOT COMPLETED|Overall Study||12
32558|NCT02092610|79098|P1|NOT COMPLETED|Overall Study||8
32559|NCT02092610|79097|P2|COMPLETED|Overall Study||40
32560|NCT02092610|79098|P1|COMPLETED|Overall Study||17
32561|NCT02092610|79097|P2|STARTED|Overall Study||52
32562|NCT02092610|79098|P1|STARTED|Overall Study||25
32563|NCT02092441|79112|P2|NOT COMPLETED|Overall Study||0
32564|NCT02092441|79113|P1|NOT COMPLETED|Overall Study||0
32565|NCT02092441|79112|P2|COMPLETED|Overall Study||43
32566|NCT02092441|79113|P1|COMPLETED|Overall Study||37
32567|NCT02092441|79112|P2|STARTED|Overall Study||43
32568|NCT02092441|79113|P1|STARTED|Overall Study||37
32569|NCT02092415|79123|P1|NOT COMPLETED|Overall Study||0
32570|NCT02092415|79123|P1|COMPLETED|Overall Study||10
32571|NCT02092415|79123|P1|STARTED|Overall Study||10
32572|NCT02092389|79128|P1|NOT COMPLETED|Overall Study||6
32573|NCT02092389|79128|P1|COMPLETED|Overall Study||4
32574|NCT02092389|79128|P1|STARTED|Overall Study||10
32575|NCT02092350|79140|P2|NOT COMPLETED|Overall Study||12
32576|NCT02092350|79141|P1|NOT COMPLETED|Overall Study||10
32577|NCT02092350|79140|P2|COMPLETED|Overall Study||102
32578|NCT02092350|79141|P1|COMPLETED|Overall Study||113
32579|NCT02092350|79140|P2|STARTED|Overall Study||114
32580|NCT02092350|79141|P1|STARTED|Overall Study||123
32581|NCT02092311|79158|P2|NOT COMPLETED|Overall Study||0
32582|NCT02092311|79159|P1|NOT COMPLETED|Overall Study||0
32583|NCT02092311|79158|P2|COMPLETED|Overall Study||285
32584|NCT02092311|79159|P1|COMPLETED|Overall Study||285
32585|NCT02092311|79158|P2|STARTED|Overall Study||285
32586|NCT02092311|79159|P1|STARTED|Overall Study||285
32587|NCT02092285|79169|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
32588|NCT02092285|79169|P1|COMPLETED|Maintenance Phase & Follow-up||60
32589|NCT02092285|79169|P1|STARTED|Maintenance Phase & Follow-up||170
32590|NCT02092285|79169|P1|NOT COMPLETED|Induction Phase||35
32591|NCT02092285|79169|P1|COMPLETED|Induction Phase||170
32592|NCT02092285|79169|P1|STARTED|Induction Phase||205
32593|NCT02092220|79173|P2|NOT COMPLETED|Period 2||1
32594|NCT02092220|79174|P1|NOT COMPLETED|Period 2||1
32595|NCT02092220|79173|P2|COMPLETED|Period 2||19
32596|NCT02092220|79174|P1|COMPLETED|Period 2||20
32597|NCT02092220|79173|P2|STARTED|Period 2||20
32598|NCT02092220|79174|P1|STARTED|Period 2||21
32599|NCT02092220|79173|P2|NOT COMPLETED|Period 1||2
32600|NCT02092220|79174|P1|NOT COMPLETED|Period 1||0
32601|NCT02092220|79173|P2|COMPLETED|Period 1||20
32602|NCT02092220|79174|P1|COMPLETED|Period 1||21
32603|NCT02092220|79173|P2|STARTED|Period 1||22
32604|NCT02092220|79174|P1|STARTED|Period 1||21
32605|NCT02092168|79234|P2|NOT COMPLETED|Overall Study||0
32606|NCT02092168|79235|P1|NOT COMPLETED|Overall Study||0
32607|NCT02092168|79234|P2|COMPLETED|Overall Study||12
32608|NCT02092168|79235|P1|COMPLETED|Overall Study||12
32609|NCT02092168|79234|P2|STARTED|Overall Study||12
32610|NCT02092168|79235|P1|STARTED|Overall Study||12
32611|NCT02092116|79247|P2|NOT COMPLETED|Overall Study||4
32612|NCT02092116|79248|P1|NOT COMPLETED|Overall Study||0
32613|NCT02092116|79247|P2|COMPLETED|Overall Study||16
32614|NCT02092116|79248|P1|COMPLETED|Overall Study||6
32615|NCT02092116|79247|P2|STARTED|Overall Study||20
32616|NCT02092116|79248|P1|STARTED|Overall Study||6
32617|NCT02091986|79260|P3|NOT COMPLETED|Overall Study||8
32618|NCT02091986|79261|P2|NOT COMPLETED|Overall Study||11
32619|NCT02091986|79262|P1|NOT COMPLETED|Overall Study||7
32620|NCT02091986|79260|P3|COMPLETED|Overall Study||84
32621|NCT02091986|79261|P2|COMPLETED|Overall Study||84
32622|NCT02091986|79262|P1|COMPLETED|Overall Study||85
32623|NCT02091986|79260|P3|STARTED|Overall Study||92
32624|NCT02091986|79261|P2|STARTED|Overall Study||95
32625|NCT02091986|79262|P1|STARTED|Overall Study||92
32626|NCT02091960|79309|P1|NOT COMPLETED|Overall Study||51
32627|NCT02091960|79309|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
32628|NCT02091960|79309|P1|Received Treatment|Overall Study||103
32629|NCT02091960|79309|P1|STARTED|Overall Study||103
32630|NCT02091869|79322|P2|NOT COMPLETED|Overall Study||3
32631|NCT02091869|79323|P1|NOT COMPLETED|Overall Study||0
32632|NCT02091869|79322|P2|COMPLETED|Overall Study||14
32633|NCT02091869|79323|P1|COMPLETED|Overall Study||17
32634|NCT02091869|79322|P2|STARTED|Overall Study||17
32635|NCT02091869|79323|P1|STARTED|Overall Study||17
32636|NCT02091856|79338|P3|NOT COMPLETED|Follow-up Assessment||0
32637|NCT02091856|79339|P2|NOT COMPLETED|Follow-up Assessment||3
32638|NCT02091856|79340|P1|NOT COMPLETED|Follow-up Assessment||5
32639|NCT02091856|79338|P3|COMPLETED|Follow-up Assessment||0
32640|NCT02091856|79339|P2|COMPLETED|Follow-up Assessment||9
32641|NCT02091856|79340|P1|COMPLETED|Follow-up Assessment||10
32642|NCT02091856|79338|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
32643|NCT02091856|79339|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
32644|NCT02091856|79340|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
32645|NCT02091856|79338|P3|NOT COMPLETED|Active Intervention Interval||7
32646|NCT02091856|79339|P2|NOT COMPLETED|Active Intervention Interval||7
32647|NCT02091856|79340|P1|NOT COMPLETED|Active Intervention Interval||19
32648|NCT02091856|79338|P3|COMPLETED|Active Intervention Interval||19
32649|NCT02091856|79339|P2|COMPLETED|Active Intervention Interval||12
32650|NCT02091856|79340|P1|COMPLETED|Active Intervention Interval||15
32651|NCT02091856|79338|P3|STARTED|Active Intervention Interval||26
32652|NCT02091856|79339|P2|STARTED|Active Intervention Interval||19
32653|NCT02091856|79340|P1|STARTED|Active Intervention Interval||34
32654|NCT02091778|79360|P1|NOT COMPLETED|Overall Study||1
32655|NCT02091778|79360|P1|COMPLETED|Overall Study||20
32656|NCT02091778|79360|P1|STARTED|Overall Study||21
32657|NCT02091752|79364|P1|NOT COMPLETED|Overall Study||3
32658|NCT02091752|79364|P1|COMPLETED|Overall Study||0
32659|NCT02091752|79364|P1|STARTED|Overall Study||3
32660|NCT02091739|79378|P5|NOT COMPLETED|EP: 48 Weeks||14
32661|NCT02091739|79379|P4|NOT COMPLETED|EP: 48 Weeks||8
32662|NCT02091739|79380|P3|NOT COMPLETED|EP: 48 Weeks||0
32663|NCT02091739|79381|P2|NOT COMPLETED|EP: 48 Weeks||0
32664|NCT02091739|79382|P1|NOT COMPLETED|EP: 48 Weeks||0
32665|NCT02091739|79378|P5|COMPLETED|EP: 48 Weeks||75
32666|NCT02091739|79379|P4|COMPLETED|EP: 48 Weeks||76
32667|NCT02091739|79380|P3|COMPLETED|EP: 48 Weeks||0
32668|NCT02091739|79381|P2|COMPLETED|EP: 48 Weeks||0
32669|NCT02091739|79382|P1|COMPLETED|EP: 48 Weeks||0
32670|NCT02091739|79378|P5|STARTED|EP: 48 Weeks||89
32671|NCT02091739|79379|P4|STARTED|EP: 48 Weeks||84
32672|NCT02091739|79380|P3|STARTED|EP: 48 Weeks||0
32673|NCT02091739|79381|P2|STARTED|EP: 48 Weeks||0
32674|NCT02091739|79382|P1|STARTED|EP: 48 Weeks||0
32675|NCT02091739|79378|P5|NOT COMPLETED|MP: 16 Weeks||0
32676|NCT02091739|79379|P4|NOT COMPLETED|MP: 16 Weeks||0
32677|NCT02091739|79380|P3|NOT COMPLETED|MP: 16 Weeks||2
32678|NCT02091739|79381|P2|NOT COMPLETED|MP: 16 Weeks||5
32679|NCT02091739|79382|P1|NOT COMPLETED|MP: 16 Weeks||4
32680|NCT02091739|79378|P5|COMPLETED|MP: 16 Weeks||0
32681|NCT02091739|79379|P4|COMPLETED|MP: 16 Weeks||0
32682|NCT02091739|79380|P3|COMPLETED|MP: 16 Weeks||72
32683|NCT02091739|79381|P2|COMPLETED|MP: 16 Weeks||69
32684|NCT02091739|79382|P1|COMPLETED|MP: 16 Weeks||32
32685|NCT02091739|79378|P5|STARTED|MP: 16 Weeks||0
32686|NCT02091739|79379|P4|STARTED|MP: 16 Weeks||0
32687|NCT02091739|79380|P3|STARTED|MP: 16 Weeks||74
32688|NCT02091739|79381|P2|STARTED|MP: 16 Weeks||74
32689|NCT02091739|79382|P1|STARTED|MP: 16 Weeks||36
32690|NCT02091726|79401|P1|NOT COMPLETED|Overall Study||6
32691|NCT02091726|79401|P1|COMPLETED|Overall Study||104
32692|NCT02091726|79401|P1|4 Week Followup|Overall Study||104
32693|NCT02091726|79401|P1|1 Week Followup|Overall Study||110
32694|NCT02091726|79401|P1|STARTED|Overall Study||110
32695|NCT02091466|79411|P2|NOT COMPLETED|Overall Study||0
32696|NCT02091466|79412|P1|NOT COMPLETED|Overall Study||0
32697|NCT02091466|79411|P2|COMPLETED|Overall Study||20
32698|NCT02091466|79412|P1|COMPLETED|Overall Study||20
32699|NCT02091466|79411|P2|STARTED|Overall Study||20
32700|NCT02091466|79412|P1|STARTED|Overall Study||20
32701|NCT02091414|79418|P1|NOT COMPLETED|Overall Study||4
32702|NCT02091414|79418|P1|COMPLETED|Overall Study||32
32703|NCT02091414|79418|P1|STARTED|Overall Study||36
32704|NCT02090855|79430|P1|NOT COMPLETED|Overall Study||2
32705|NCT02090855|79430|P1|COMPLETED|Overall Study||106
32706|NCT02090855|79430|P1|STARTED|Overall Study||108
32707|NCT02090777|79437|P1|NOT COMPLETED|Overall Study||0
32708|NCT02090777|79437|P1|COMPLETED|Overall Study||4
32709|NCT02090777|79437|P1|STARTED|Overall Study||4
32710|NCT02090764|79443|P2|NOT COMPLETED|Overall Study||20
32711|NCT02090764|79444|P1|NOT COMPLETED|Overall Study||6
32712|NCT02090764|79443|P2|COMPLETED|Overall Study||186
32713|NCT02090764|79444|P1|COMPLETED|Overall Study||200
32714|NCT02090764|79443|P2|STARTED|Overall Study||206
32715|NCT02090764|79444|P1|STARTED|Overall Study||206
32716|NCT02090413|79453|P3|NOT COMPLETED|Overall Study||23
32717|NCT02090413|79454|P2|NOT COMPLETED|Overall Study||20
32718|NCT02090413|79455|P1|NOT COMPLETED|Overall Study||19
32719|NCT02090413|79453|P3|COMPLETED|Overall Study||57
32720|NCT02090413|79454|P2|COMPLETED|Overall Study||60
32721|NCT02090413|79455|P1|COMPLETED|Overall Study||62
32722|NCT02090413|79453|P3|STARTED|Overall Study||80
32723|NCT02090413|79454|P2|STARTED|Overall Study||80
32724|NCT02090413|79455|P1|STARTED|Overall Study||81
32725|NCT02090088|79529|P1|NOT COMPLETED|Overall Study||0
32726|NCT02090088|79529|P1|COMPLETED|Overall Study||4
32727|NCT02090088|79529|P1|Gave Birth|Overall Study||4
32728|NCT02090088|79529|P1|STARTED|Overall Study||4
32729|NCT02089737|79541|P1|NOT COMPLETED|Overall Study||6
32730|NCT02089737|79541|P1|COMPLETED|Overall Study||3085
32731|NCT02089737|79541|P1|STARTED|Overall Study||3091
32732|NCT02089347|79550|P2|NOT COMPLETED|Overall Study||0
32733|NCT02089347|79551|P1|NOT COMPLETED|Overall Study||1
32734|NCT02089347|79550|P2|COMPLETED|Overall Study||178
32735|NCT02089347|79551|P1|COMPLETED|Overall Study||355
32736|NCT02089347|79550|P2|STARTED|Overall Study||178
32737|NCT02089347|79551|P1|STARTED|Overall Study||356
32738|NCT02089191|79573|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
32739|NCT02089191|79574|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
32740|NCT02089191|79573|P2|COMPLETED|Period 2, Second 12 Hours||15
32741|NCT02089191|79574|P1|COMPLETED|Period 2, Second 12 Hours||15
32742|NCT02089191|79573|P2|STARTED|Period 2, Second 12 Hours||15
32743|NCT02089191|79574|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
32744|NCT02089191|79573|P2|NOT COMPLETED|Period 1, First 12 Hours||0
32745|NCT02089191|79574|P1|NOT COMPLETED|Period 1, First 12 Hours||0
32746|NCT02089191|79573|P2|COMPLETED|Period 1, First 12 Hours||15
32747|NCT02089191|79574|P1|COMPLETED|Period 1, First 12 Hours||16
32748|NCT02089191|79573|P2|STARTED|Period 1, First 12 Hours||15
32749|NCT02089191|79574|P1|STARTED|Period 1, First 12 Hours||16
32750|NCT02089113|79584|P2|NOT COMPLETED|Overall Study||0
32751|NCT02089113|79585|P1|NOT COMPLETED|Overall Study||1
32752|NCT02089113|79584|P2|COMPLETED|Overall Study||80
32753|NCT02089113|79585|P1|COMPLETED|Overall Study||160
32754|NCT02089113|79584|P2|STARTED|Overall Study||80
32755|NCT02089113|79585|P1|STARTED|Overall Study||161
32756|NCT02088957|79591|P2|NOT COMPLETED|Overall Study||0
32757|NCT02088957|79592|P1|NOT COMPLETED|Overall Study||1
32758|NCT02088957|79591|P2|COMPLETED|Overall Study||0
32759|NCT02088957|79592|P1|COMPLETED|Overall Study||0
32760|NCT02088957|79591|P2|STARTED|Overall Study||0
32761|NCT02088957|79592|P1|STARTED|Overall Study||1
32762|NCT02088177|79608|P1|NOT COMPLETED|Overall Study||3
32763|NCT02088177|79608|P1|COMPLETED|Overall Study||9
32764|NCT02088177|79608|P1|STARTED|Overall Study||12
32765|NCT02087995|79613|P1|NOT COMPLETED|Overall Study||0
32766|NCT02087995|79613|P1|COMPLETED|Overall Study||51
32767|NCT02087995|79613|P1|STARTED|Overall Study||51
32768|NCT02087943|79620|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
32769|NCT02087943|79621|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
32770|NCT02087943|79622|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
32771|NCT02087943|79623|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
32772|NCT02087943|79624|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
32773|NCT02087943|79620|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
32774|NCT02087943|79621|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
32775|NCT02087943|79622|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
32776|NCT02087943|79623|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
32777|NCT02087943|79624|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
32778|NCT02087943|79620|P5|STARTED|Observational Follow-up Phase Week 24-30||23
32779|NCT02087943|79621|P4|STARTED|Observational Follow-up Phase Week 24-30||24
32780|NCT02087943|79622|P3|STARTED|Observational Follow-up Phase Week 24-30||48
32781|NCT02087943|79623|P2|STARTED|Observational Follow-up Phase Week 24-30||46
32782|NCT02087943|79624|P1|STARTED|Observational Follow-up Phase Week 24-30||0
32783|NCT02087943|79620|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
32784|NCT02087943|79621|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
32785|NCT02087943|79622|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
32786|NCT02087943|79623|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
32787|NCT02087943|79624|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
32788|NCT02087943|79620|P5|COMPLETED|Active Treatment Phase Week 12-24||21
32789|NCT02087943|79621|P4|COMPLETED|Active Treatment Phase Week 12-24||22
32790|NCT02087943|79622|P3|COMPLETED|Active Treatment Phase Week 12-24||44
32791|NCT02087943|79623|P2|COMPLETED|Active Treatment Phase Week 12-24||42
32792|NCT02087943|79624|P1|COMPLETED|Active Treatment Phase Week 12-24||0
32793|NCT02087943|79620|P5|STARTED|Active Treatment Phase Week 12-24||23
32794|NCT02087943|79621|P4|STARTED|Active Treatment Phase Week 12-24||24
32795|NCT02087943|79622|P3|STARTED|Active Treatment Phase Week 12-24||49
32796|NCT02087943|79623|P2|STARTED|Active Treatment Phase Week 12-24||46
32797|NCT02087943|79624|P1|STARTED|Active Treatment Phase Week 12-24||0
32798|NCT02087943|79620|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
32799|NCT02087943|79621|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
32800|NCT02087943|79622|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
32801|NCT02087943|79623|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
32802|NCT02087943|79624|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
32803|NCT02087943|79620|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
32804|NCT02087943|79621|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
32805|NCT02087943|79622|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
32806|NCT02087943|79623|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
32807|NCT02087943|79624|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
32808|NCT02087943|79620|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
32809|NCT02087943|79621|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
32810|NCT02087943|79622|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
32811|NCT02087943|79623|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
32812|NCT02087943|79624|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
32813|NCT02087943|79620|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
32814|NCT02087943|79621|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
32815|NCT02087943|79622|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
32816|NCT02087943|79623|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
32817|NCT02087943|79624|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
32818|NCT02087774|79650|P2|NOT COMPLETED|Overall Study||20
32819|NCT02087774|79651|P1|NOT COMPLETED|Overall Study||8
32820|NCT02087774|79650|P2|COMPLETED|Overall Study||130
32821|NCT02087774|79651|P1|COMPLETED|Overall Study||142
32822|NCT02087774|79650|P2|STARTED|Overall Study||150
32823|NCT02087774|79651|P1|STARTED|Overall Study||150
32824|NCT02087748|79659|P1|NOT COMPLETED|Overall Study||0
32825|NCT02087748|79659|P1|COMPLETED|Overall Study||24
32826|NCT02087748|79659|P1|STARTED|Overall Study||24
32827|NCT02087670|79671|P2|NOT COMPLETED|Overall Study||2
32828|NCT02087670|79672|P1|NOT COMPLETED|Overall Study||3
32829|NCT02087670|79671|P2|COMPLETED|Overall Study||20
32830|NCT02087670|79672|P1|COMPLETED|Overall Study||17
32831|NCT02087670|79671|P2|STARTED|Overall Study||22
32832|NCT02087670|79672|P1|STARTED|Overall Study||20
32833|NCT02087514|79686|P6|NOT COMPLETED|Overall Study||1
32834|NCT02087514|79687|P5|NOT COMPLETED|Overall Study||0
32835|NCT02087514|79688|P4|NOT COMPLETED|Overall Study||2
32836|NCT02087514|79689|P3|NOT COMPLETED|Overall Study||3
32837|NCT02087514|79690|P2|NOT COMPLETED|Overall Study||0
32838|NCT02087514|79691|P1|NOT COMPLETED|Overall Study||2
32839|NCT02087514|79686|P6|COMPLETED|Overall Study||9
32840|NCT02087514|79687|P5|COMPLETED|Overall Study||10
32841|NCT02087514|79688|P4|COMPLETED|Overall Study||8
32842|NCT02087514|79689|P3|COMPLETED|Overall Study||7
32843|NCT02087514|79690|P2|COMPLETED|Overall Study||10
32844|NCT02087514|79691|P1|COMPLETED|Overall Study||8
32845|NCT02087514|79686|P6|STARTED|Overall Study||10
32846|NCT02087514|79687|P5|STARTED|Overall Study||10
32847|NCT02087514|79688|P4|STARTED|Overall Study||10
32848|NCT02087514|79689|P3|STARTED|Overall Study||10
32849|NCT02087514|79690|P2|STARTED|Overall Study||10
32850|NCT02087514|79691|P1|STARTED|Overall Study||10
32851|NCT02087423|79708|P3|NOT COMPLETED|Overall Study||58
32852|NCT02087423|79709|P2|NOT COMPLETED|Overall Study||205
32853|NCT02087423|79710|P1|NOT COMPLETED|Overall Study||103
32854|NCT02087423|79708|P3|COMPLETED|Overall Study|Completed maximum 12-month treatment period|10
32855|NCT02087423|79709|P2|COMPLETED|Overall Study|Completed maximum 12-month treatment period|60
32856|NCT02087423|79710|P1|COMPLETED|Overall Study|Completed maximum 12-month treatment period|8
32857|NCT02087423|79708|P3|STARTED|Overall Study|Treated|68
32858|NCT02087423|79709|P2|STARTED|Overall Study|Treated|265
32859|NCT02087423|79710|P1|STARTED|Overall Study|Treated|111
32860|NCT02087241|79734|P4|NOT COMPLETED|Overall Study||7
32861|NCT02087241|79735|P3|NOT COMPLETED|Overall Study||1
32862|NCT02087241|79736|P2|NOT COMPLETED|Overall Study||3
32863|NCT02087241|79737|P1|NOT COMPLETED|Overall Study||3
32864|NCT02087241|79734|P4|COMPLETED|Overall Study||0
32865|NCT02087241|79735|P3|COMPLETED|Overall Study||0
32866|NCT02087241|79736|P2|COMPLETED|Overall Study||0
32867|NCT02087241|79737|P1|COMPLETED|Overall Study||0
32868|NCT02087241|79734|P4|STARTED|Overall Study||7
32869|NCT02087241|79735|P3|STARTED|Overall Study||1
32870|NCT02087241|79736|P2|STARTED|Overall Study||3
32871|NCT02087241|79737|P1|STARTED|Overall Study||3
32872|NCT02087176|79763|P1|NOT COMPLETED|Overall Study||32
32873|NCT02087176|79763|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
32874|NCT02087176|79763|P1|STARTED|Overall Study||32
32875|NCT02087059|79768|P1|NOT COMPLETED|Overall Study||7
32876|NCT02087059|79768|P1|COMPLETED|Overall Study||44
32877|NCT02087059|79768|P1|STARTED|Overall Study||51
32878|NCT02086786|79778|P2|NOT COMPLETED|Overall Study||16
32879|NCT02086786|79779|P1|NOT COMPLETED|Overall Study||18
32880|NCT02086786|79778|P2|COMPLETED|Overall Study||19
32881|NCT02086786|79779|P1|COMPLETED|Overall Study||17
32882|NCT02086786|79778|P2|STARTED|Overall Study||35
32883|NCT02086786|79779|P1|STARTED|Overall Study||35
32884|NCT02086708|79803|P1|NOT COMPLETED|Overall Study||0
32885|NCT02086708|79803|P1|COMPLETED|Overall Study||24
32886|NCT02086708|79803|P1|STARTED|Overall Study||24
32887|NCT02086591|79815|P1|NOT COMPLETED|Overall Study||5
32888|NCT02086591|79815|P1|COMPLETED|Overall Study||2
32889|NCT02086591|79815|P1|STARTED|Overall Study||7
32890|NCT02085785|79823|P2|NOT COMPLETED|Overall Study||2
32891|NCT02085785|79824|P1|NOT COMPLETED|Overall Study||2
32892|NCT02085785|79823|P2|COMPLETED|Overall Study||6
32893|NCT02085785|79824|P1|COMPLETED|Overall Study||5
32894|NCT02085785|79823|P2|STARTED|Overall Study||8
32895|NCT02085785|79824|P1|STARTED|Overall Study||7
32896|NCT02085720|79836|P1|NOT COMPLETED|Overall Study||0
32897|NCT02085720|79836|P1|COMPLETED|Overall Study||819
32898|NCT02085720|79836|P1|STARTED|Overall Study||819
32899|NCT02085161|79848|P4|NOT COMPLETED|Overall Study||10
32900|NCT02085161|79849|P3|NOT COMPLETED|Overall Study||5
32901|NCT02085161|79850|P2|NOT COMPLETED|Overall Study||10
32902|NCT02085161|79851|P1|NOT COMPLETED|Overall Study||12
32903|NCT02085161|79848|P4|COMPLETED|Overall Study||66
32904|NCT02085161|79849|P3|COMPLETED|Overall Study||71
32905|NCT02085161|79850|P2|COMPLETED|Overall Study||66
32906|NCT02085161|79851|P1|COMPLETED|Overall Study||64
32907|NCT02085161|79848|P4|STARTED|Overall Study||76
32908|NCT02085161|79849|P3|STARTED|Overall Study||76
32909|NCT02085161|79850|P2|STARTED|Overall Study||76
32910|NCT02085161|79851|P1|STARTED|Overall Study||76
32911|NCT02084797|79890|P1|NOT COMPLETED|Overall Study||0
32912|NCT02084797|79890|P1|COMPLETED|Overall Study||10
32913|NCT02084797|79890|P1|STARTED|Overall Study||10
32914|NCT02084706|79899|P2|NOT COMPLETED|Overall Study||0
32915|NCT02084706|79900|P1|NOT COMPLETED|Overall Study||0
32916|NCT02084706|79899|P2|COMPLETED|Overall Study||31
32917|NCT02084706|79900|P1|COMPLETED|Overall Study||29
32918|NCT02084706|79899|P2|STARTED|Overall Study||31
32919|NCT02084706|79900|P1|STARTED|Overall Study||29
32920|NCT02084628|79906|P1|NOT COMPLETED|Overall Study||0
32921|NCT02084628|79906|P1|COMPLETED|Overall Study||1
32922|NCT02084628|79906|P1|STARTED|Overall Study||1
32923|NCT02084238|79919|P1|NOT COMPLETED|Overall Study||2
32924|NCT02084238|79919|P1|COMPLETED|Overall Study||38
32925|NCT02084238|79919|P1|STARTED|Overall Study||40
32926|NCT02084134|79932|P2|NOT COMPLETED|Overall Study||3
32927|NCT02084134|79933|P1|NOT COMPLETED|Overall Study||4
32928|NCT02084134|79932|P2|COMPLETED|Overall Study||17
32929|NCT02084134|79933|P1|COMPLETED|Overall Study||19
32930|NCT02084134|79932|P2|STARTED|Overall Study||20
32931|NCT02084134|79933|P1|STARTED|Overall Study||23
32932|NCT02084082|79943|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32933|NCT02084082|79944|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32934|NCT02084082|79945|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32935|NCT02084082|79946|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32936|NCT02084082|79943|P4|COMPLETED|Treatment Period 2 (4 Days)||6
32937|NCT02084082|79944|P3|COMPLETED|Treatment Period 2 (4 Days)||7
32938|NCT02084082|79945|P2|COMPLETED|Treatment Period 2 (4 Days)||26
32939|NCT02084082|79946|P1|COMPLETED|Treatment Period 2 (4 Days)||26
32940|NCT02084082|79943|P4|STARTED|Treatment Period 2 (4 Days)||6
32941|NCT02084082|79944|P3|STARTED|Treatment Period 2 (4 Days)||7
32942|NCT02084082|79945|P2|STARTED|Treatment Period 2 (4 Days)||26
32943|NCT02084082|79946|P1|STARTED|Treatment Period 2 (4 Days)||26
32944|NCT02084082|79943|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
32945|NCT02084082|79944|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
32946|NCT02084082|79945|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
32947|NCT02084082|79946|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
32948|NCT02084082|79943|P4|COMPLETED|Washout Period 1 (35 Days)||6
32949|NCT02084082|79944|P3|COMPLETED|Washout Period 1 (35 Days)||7
32950|NCT02084082|79945|P2|COMPLETED|Washout Period 1 (35 Days)||26
32951|NCT02084082|79946|P1|COMPLETED|Washout Period 1 (35 Days)||26
32952|NCT02084082|79943|P4|STARTED|Washout Period 1 (35 Days)||8
32953|NCT02084082|79944|P3|STARTED|Washout Period 1 (35 Days)||8
32954|NCT02084082|79945|P2|STARTED|Washout Period 1 (35 Days)||26
32955|NCT02084082|79946|P1|STARTED|Washout Period 1 (35 Days)||26
32956|NCT02084082|79943|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32957|NCT02084082|79944|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32958|NCT02084082|79945|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32959|NCT02084082|79946|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32960|NCT02084082|79943|P4|COMPLETED|Treatment Period 1 (4 Days)||8
32961|NCT02084082|79944|P3|COMPLETED|Treatment Period 1 (4 Days)||8
32962|NCT02084082|79945|P2|COMPLETED|Treatment Period 1 (4 Days)||26
32963|NCT02084082|79946|P1|COMPLETED|Treatment Period 1 (4 Days)||26
32964|NCT02084082|79943|P4|STARTED|Treatment Period 1 (4 Days)||8
32965|NCT02084082|79944|P3|STARTED|Treatment Period 1 (4 Days)||8
32966|NCT02084082|79945|P2|STARTED|Treatment Period 1 (4 Days)||26
32967|NCT02084082|79946|P1|STARTED|Treatment Period 1 (4 Days)||26
32968|NCT02084069|79978|P2|NOT COMPLETED|Overall Study||0
32969|NCT02084069|79979|P1|NOT COMPLETED|Overall Study||0
32970|NCT02084069|79978|P2|COMPLETED|Overall Study||29
32971|NCT02084069|79979|P1|COMPLETED|Overall Study||29
32972|NCT02084069|79978|P2|STARTED|Overall Study||29
32973|NCT02084069|79979|P1|STARTED|Overall Study||29
32974|NCT02084056|79987|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32975|NCT02084056|79988|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32976|NCT02084056|79989|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32977|NCT02084056|79990|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32978|NCT02084056|79987|P4|COMPLETED|Treatment Period 2 (4 Days)||8
32979|NCT02084056|79988|P3|COMPLETED|Treatment Period 2 (4 Days)||8
32980|NCT02084056|79989|P2|COMPLETED|Treatment Period 2 (4 Days)||30
32981|NCT02084056|79990|P1|COMPLETED|Treatment Period 2 (4 Days)||26
32982|NCT02084056|79987|P4|STARTED|Treatment Period 2 (4 Days)||8
32983|NCT02084056|79988|P3|STARTED|Treatment Period 2 (4 Days)||8
32984|NCT02084056|79989|P2|STARTED|Treatment Period 2 (4 Days)||30
32985|NCT02084056|79990|P1|STARTED|Treatment Period 2 (4 Days)||26
32986|NCT02084056|79987|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
32987|NCT02084056|79988|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
32988|NCT02084056|79989|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
32989|NCT02084056|79990|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
32990|NCT02084056|79987|P4|COMPLETED|Washout Period 1 (35 Days)||8
32991|NCT02084056|79988|P3|COMPLETED|Washout Period 1 (35 Days)||8
32992|NCT02084056|79989|P2|COMPLETED|Washout Period 1 (35 Days)||30
32993|NCT02084056|79990|P1|COMPLETED|Washout Period 1 (35 Days)||26
32994|NCT02084056|79987|P4|STARTED|Washout Period 1 (35 Days)||8
32995|NCT02084056|79988|P3|STARTED|Washout Period 1 (35 Days)||8
32996|NCT02084056|79989|P2|STARTED|Washout Period 1 (35 Days)||30
32997|NCT02084056|79990|P1|STARTED|Washout Period 1 (35 Days)||27
32998|NCT02084056|79987|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32999|NCT02084056|79988|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
33000|NCT02084056|79989|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
33001|NCT02084056|79990|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
33002|NCT02084056|79987|P4|COMPLETED|Treatment Period 1 (4 Days)||8
33003|NCT02084056|79988|P3|COMPLETED|Treatment Period 1 (4 Days)||8
33004|NCT02084056|79989|P2|COMPLETED|Treatment Period 1 (4 Days)||30
33005|NCT02084056|79990|P1|COMPLETED|Treatment Period 1 (4 Days)||27
33006|NCT02084056|79987|P4|STARTED|Treatment Period 1 (4 Days)||8
33007|NCT02084056|79988|P3|STARTED|Treatment Period 1 (4 Days)||8
33008|NCT02084056|79989|P2|STARTED|Treatment Period 1 (4 Days)||30
33009|NCT02084056|79990|P1|STARTED|Treatment Period 1 (4 Days)||28
33010|NCT02083965|80022|P2|NOT COMPLETED|Treatment Period||0
33011|NCT02083965|80023|P1|NOT COMPLETED|Treatment Period||1
33012|NCT02083965|80022|P2|COMPLETED|Treatment Period||8
33013|NCT02083965|80023|P1|COMPLETED|Treatment Period||9
33014|NCT02083965|80022|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
33015|NCT02083965|80023|P1|STARTED|Treatment Period||10
33016|NCT02083965|80022|P2|NOT COMPLETED|PK Period 2||0
33017|NCT02083965|80023|P1|NOT COMPLETED|PK Period 2||0
33018|NCT02083965|80022|P2|COMPLETED|PK Period 2||9
33019|NCT02083965|80023|P1|COMPLETED|PK Period 2||10
33020|NCT02083965|80022|P2|STARTED|PK Period 2||9
33021|NCT02083965|80023|P1|STARTED|PK Period 2||10
33022|NCT02083965|80022|P2|NOT COMPLETED|Washout Period||0
33023|NCT02083965|80023|P1|NOT COMPLETED|Washout Period||0
33024|NCT02083965|80022|P2|COMPLETED|Washout Period||9
33025|NCT02083965|80023|P1|COMPLETED|Washout Period||10
33026|NCT02083965|80022|P2|STARTED|Washout Period||9
33027|NCT02083965|80023|P1|STARTED|Washout Period||10
33028|NCT02083965|80022|P2|NOT COMPLETED|PK Period 1||0
33029|NCT02083965|80023|P1|NOT COMPLETED|PK Period 1||0
33030|NCT02083965|80022|P2|COMPLETED|PK Period 1||9
33031|NCT02083965|80023|P1|COMPLETED|PK Period 1||10
33032|NCT02083965|80022|P2|STARTED|PK Period 1||9
33033|NCT02083965|80023|P1|STARTED|PK Period 1||10
33034|NCT02083861|80081|P2|NOT COMPLETED|Overall Study||3
33035|NCT02083861|80082|P1|NOT COMPLETED|Overall Study||6
33036|NCT02083861|80081|P2|COMPLETED|Overall Study||33
33037|NCT02083861|80082|P1|COMPLETED|Overall Study||51
33038|NCT02083861|80081|P2|Treated|Overall Study||35
33039|NCT02083861|80082|P1|Treated|Overall Study||55
33040|NCT02083861|80081|P2|STARTED|Overall Study||36
33041|NCT02083861|80082|P1|STARTED|Overall Study||57
33042|NCT02083679|80098|P4|NOT COMPLETED|Overall Study||0
33043|NCT02083679|80099|P3|NOT COMPLETED|Overall Study||0
33044|NCT02083679|80100|P2|NOT COMPLETED|Overall Study||0
33045|NCT02083679|80101|P1|NOT COMPLETED|Overall Study||0
33046|NCT02083679|80098|P4|COMPLETED|Overall Study||3
33047|NCT02083679|80099|P3|COMPLETED|Overall Study||3
33048|NCT02083679|80100|P2|COMPLETED|Overall Study||6
33049|NCT02083679|80101|P1|COMPLETED|Overall Study||3
33050|NCT02083679|80098|P4|STARTED|Overall Study||3
33051|NCT02083679|80099|P3|STARTED|Overall Study||3
33052|NCT02083679|80100|P2|STARTED|Overall Study||6
33053|NCT02083679|80101|P1|STARTED|Overall Study||3
33054|NCT02083406|80118|P3|NOT COMPLETED|Overall Study||0
33055|NCT02083406|80119|P2|NOT COMPLETED|Overall Study||0
33056|NCT02083406|80120|P1|NOT COMPLETED|Overall Study||0
33057|NCT02083406|80118|P3|COMPLETED|Overall Study||7
33058|NCT02083406|80119|P2|COMPLETED|Overall Study||8
33059|NCT02083406|80120|P1|COMPLETED|Overall Study||7
33060|NCT02083406|80118|P3|STARTED|Overall Study||7
33061|NCT02083406|80119|P2|STARTED|Overall Study||8
33062|NCT02083406|80120|P1|STARTED|Overall Study||7
33063|NCT02083380|80140|P3|NOT COMPLETED|Overall Study||84
33064|NCT02083380|80141|P2|NOT COMPLETED|Overall Study||95
33065|NCT02083380|80142|P1|NOT COMPLETED|Overall Study||91
33066|NCT02083380|80140|P3|COMPLETED|Overall Study||65
33067|NCT02083380|80141|P2|COMPLETED|Overall Study||56
33068|NCT02083380|80142|P1|COMPLETED|Overall Study||57
33069|NCT02083380|80140|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
33070|NCT02083380|80141|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
33071|NCT02083380|80142|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
33072|NCT02083263|80237|P2|NOT COMPLETED|Overall Study||0
33073|NCT02083263|80238|P1|NOT COMPLETED|Overall Study||0
33074|NCT02083263|80237|P2|COMPLETED|Overall Study||16
33075|NCT02083263|80238|P1|COMPLETED|Overall Study||16
33076|NCT02083263|80237|P2|STARTED|Overall Study||16
33077|NCT02083263|80238|P1|STARTED|Overall Study||16
33078|NCT02083185|80247|P3|NOT COMPLETED|Overall Study||7
33079|NCT02083185|80248|P2|NOT COMPLETED|Overall Study||29
33080|NCT02083185|80249|P1|NOT COMPLETED|Overall Study||20
33081|NCT02083185|80247|P3|COMPLETED|Overall Study||17
33082|NCT02083185|80248|P2|COMPLETED|Overall Study||27
33083|NCT02083185|80249|P1|COMPLETED|Overall Study||36
33084|NCT02083185|80247|P3|Safety Population|Overall Study||24
33085|NCT02083185|80248|P2|Safety Population|Overall Study||54
33086|NCT02083185|80249|P1|Safety Population|Overall Study||56
33087|NCT02083185|80247|P3|STARTED|Overall Study||24
33088|NCT02083185|80248|P2|STARTED|Overall Study||56
33089|NCT02083185|80249|P1|STARTED|Overall Study||56
33090|NCT02083107|80307|P3|NOT COMPLETED|Overall Study||0
33091|NCT02083107|80308|P2|NOT COMPLETED|Overall Study||0
33092|NCT02083107|80309|P1|NOT COMPLETED|Overall Study||0
33093|NCT02083107|80307|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
33094|NCT02083107|80308|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
33095|NCT02083107|80309|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
33096|NCT02083107|80307|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
33097|NCT02083107|80308|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
33098|NCT02083107|80309|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
33099|NCT02082912|80346|P2|NOT COMPLETED|Overall Study||1
33100|NCT02082912|80347|P1|NOT COMPLETED|Overall Study||0
33101|NCT02082912|80346|P2|COMPLETED|Overall Study||6
33102|NCT02082912|80347|P1|COMPLETED|Overall Study||7
33103|NCT02082912|80346|P2|STARTED|Overall Study||7
33104|NCT02082912|80347|P1|STARTED|Overall Study||7
33105|NCT02082769|80356|P3|NOT COMPLETED|Overall Study||36
33106|NCT02082769|80357|P2|NOT COMPLETED|Overall Study||27
33107|NCT02082769|80358|P1|NOT COMPLETED|Overall Study||24
33108|NCT02082769|80356|P3|COMPLETED|Overall Study||132
33109|NCT02082769|80357|P2|COMPLETED|Overall Study||141
33110|NCT02082769|80358|P1|COMPLETED|Overall Study||144
33111|NCT02082769|80356|P3|STARTED|Overall Study||168
33112|NCT02082769|80357|P2|STARTED|Overall Study||168
33113|NCT02082769|80358|P1|STARTED|Overall Study||168
33114|NCT02082392|80374|P2|NOT COMPLETED|Overall Study||0
33115|NCT02082392|80375|P1|NOT COMPLETED|Overall Study||0
33116|NCT02082392|80374|P2|COMPLETED|Overall Study||1
33117|NCT02082392|80375|P1|COMPLETED|Overall Study||2
33118|NCT02082392|80374|P2|STARTED|Overall Study||1
33119|NCT02082392|80375|P1|STARTED|Overall Study||2
33120|NCT02082288|80407|P1|NOT COMPLETED|Overall Study||0
33121|NCT02082288|80407|P1|COMPLETED|Overall Study||243
33122|NCT02082288|80407|P1|STARTED|Overall Study||243
33123|NCT02082262|80411|P1|NOT COMPLETED|Overall Study||51
33124|NCT02082262|80411|P1|COMPLETED|Overall Study||89
33125|NCT02082262|80411|P1|STARTED|Overall Study||140
33126|NCT02082184|80417|P2|NOT COMPLETED|Overall Study||13
33127|NCT02082184|80418|P1|NOT COMPLETED|Overall Study||10
33128|NCT02082184|80417|P2|COMPLETED|Overall Study||62
33129|NCT02082184|80418|P1|COMPLETED|Overall Study||139
33130|NCT02082184|80417|P2|STARTED|Overall Study||75
33131|NCT02082184|80418|P1|STARTED|Overall Study||149
33132|NCT02082158|80443|P6|NOT COMPLETED|Overall Study||7
33133|NCT02082158|80444|P5|NOT COMPLETED|Overall Study||4
33134|NCT02082158|80445|P4|NOT COMPLETED|Overall Study||4
33135|NCT02082158|80446|P3|NOT COMPLETED|Overall Study||14
33136|NCT02082158|80447|P2|NOT COMPLETED|Overall Study||8
33137|NCT02082158|80448|P1|NOT COMPLETED|Overall Study||8
33138|NCT02082158|80443|P6|COMPLETED|Overall Study||56
33139|NCT02082158|80444|P5|COMPLETED|Overall Study||64
33140|NCT02082158|80445|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
33141|NCT02082158|80446|P3|COMPLETED|Overall Study||38
33142|NCT02082158|80447|P2|COMPLETED|Overall Study||53
33143|NCT02082158|80448|P1|COMPLETED|Overall Study||58
33144|NCT02082158|80443|P6|STARTED|Overall Study||63
33145|NCT02082158|80444|P5|STARTED|Overall Study||68
33146|NCT02082158|80445|P4|STARTED|Overall Study||72
33147|NCT02082158|80446|P3|STARTED|Overall Study||52
33148|NCT02082158|80447|P2|STARTED|Overall Study||61
33149|NCT02082158|80448|P1|STARTED|Overall Study||66
33150|NCT02081859|80470|P2|NOT COMPLETED|Overall Study||31
33151|NCT02081859|80471|P1|NOT COMPLETED|Overall Study||34
33152|NCT02081859|80470|P2|COMPLETED|Overall Study||119
33153|NCT02081859|80471|P1|COMPLETED|Overall Study||116
33154|NCT02081859|80470|P2|STARTED|Overall Study||150
33155|NCT02081859|80471|P1|STARTED|Overall Study||150
33156|NCT02081690|80479|P1|NOT COMPLETED|Overall Study||7
33157|NCT02081690|80479|P1|COMPLETED|Overall Study||81
33158|NCT02081690|80479|P1|STARTED|Overall Study||88
33159|NCT02081677|80490|P4|NOT COMPLETED|Overall Study||0
33160|NCT02081677|80491|P3|NOT COMPLETED|Overall Study||2
33161|NCT02081677|80492|P2|NOT COMPLETED|Overall Study||1
33162|NCT02081677|80493|P1|NOT COMPLETED|Overall Study||1
33163|NCT02081677|80490|P4|COMPLETED|Overall Study||19
33164|NCT02081677|80491|P3|COMPLETED|Overall Study||17
33165|NCT02081677|80492|P2|COMPLETED|Overall Study||18
33166|NCT02081677|80493|P1|COMPLETED|Overall Study||18
33167|NCT02081677|80490|P4|STARTED|Overall Study||19
33168|NCT02081677|80491|P3|STARTED|Overall Study||19
33169|NCT02081677|80492|P2|STARTED|Overall Study||19
33170|NCT02081677|80493|P1|STARTED|Overall Study||19
33171|NCT02081599|80585|P2|NOT COMPLETED|Period 2：Open-label Period||4
33172|NCT02081599|80586|P1|NOT COMPLETED|Period 2：Open-label Period||6
33173|NCT02081599|80585|P2|COMPLETED|Period 2：Open-label Period||71
33174|NCT02081599|80586|P1|COMPLETED|Period 2：Open-label Period||57
33175|NCT02081599|80585|P2|STARTED|Period 2：Open-label Period||75
33176|NCT02081599|80586|P1|STARTED|Period 2：Open-label Period||63
33177|NCT02081599|80585|P2|NOT COMPLETED|Period 1：Double-blind Period||2
33178|NCT02081599|80586|P1|NOT COMPLETED|Period 1：Double-blind Period||8
33179|NCT02081599|80585|P2|COMPLETED|Period 1：Double-blind Period||75
33180|NCT02081599|80586|P1|COMPLETED|Period 1：Double-blind Period||63
33181|NCT02081599|80585|P2|STARTED|Period 1：Double-blind Period||77
33182|NCT02081599|80586|P1|STARTED|Period 1：Double-blind Period||71
33183|NCT02081586|80604|P4|NOT COMPLETED|Overall Study||1
33184|NCT02081586|80605|P3|NOT COMPLETED|Overall Study||1
33185|NCT02081586|80606|P2|NOT COMPLETED|Overall Study||1
33186|NCT02081586|80607|P1|NOT COMPLETED|Overall Study||0
33187|NCT02081586|80604|P4|COMPLETED|Overall Study||2
33188|NCT02081586|80605|P3|COMPLETED|Overall Study||3
33189|NCT02081586|80606|P2|COMPLETED|Overall Study||2
33190|NCT02081586|80607|P1|COMPLETED|Overall Study||3
33191|NCT02081586|80604|P4|STARTED|Overall Study||3
33192|NCT02081586|80605|P3|STARTED|Overall Study||4
33193|NCT02081586|80606|P2|STARTED|Overall Study||3
33194|NCT02081586|80607|P1|STARTED|Overall Study||3
33195|NCT02081573|80634|P1|NOT COMPLETED|Overall Study||0
33196|NCT02081573|80634|P1|COMPLETED|Overall Study||10
33197|NCT02081573|80634|P1|STARTED|Overall Study||10
33198|NCT02081443|80645|P2|NOT COMPLETED|Overall Study||0
33199|NCT02081443|80646|P1|NOT COMPLETED|Overall Study||0
33200|NCT02081443|80645|P2|COMPLETED|Overall Study||30
33201|NCT02081443|80646|P1|COMPLETED|Overall Study||30
33202|NCT02081443|80645|P2|STARTED|Overall Study||30
33203|NCT02081443|80646|P1|STARTED|Overall Study||30
33204|NCT02081365|80658|P2|NOT COMPLETED|Overall Study||23
33205|NCT02081365|80659|P1|NOT COMPLETED|Overall Study||30
33206|NCT02081365|80658|P2|COMPLETED|Overall Study||54
33207|NCT02081365|80659|P1|COMPLETED|Overall Study||44
33208|NCT02081365|80658|P2|Received Allocated Intervention|Overall Study||59
33209|NCT02081365|80659|P1|Received Allocated Intervention|Overall Study||46
33210|NCT02081365|80658|P2|STARTED|Overall Study||77
33211|NCT02081365|80659|P1|STARTED|Overall Study||74
33212|NCT02081183|80673|P2|NOT COMPLETED|Overall Study||4
33213|NCT02081183|80674|P1|NOT COMPLETED|Overall Study||4
33214|NCT02081183|80673|P2|COMPLETED|Overall Study||2
33215|NCT02081183|80674|P1|COMPLETED|Overall Study||1
33216|NCT02081183|80673|P2|STARTED|Overall Study||6
33217|NCT02081183|80674|P1|STARTED|Overall Study||5
33218|NCT02081079|80690|P2|NOT COMPLETED|Overall Study||2
33219|NCT02081079|80691|P1|NOT COMPLETED|Overall Study||4
33220|NCT02081079|80690|P2|COMPLETED|Overall Study||39
33221|NCT02081079|80691|P1|COMPLETED|Overall Study||40
33222|NCT02081079|80690|P2|STARTED|Overall Study||41
33223|NCT02081079|80691|P1|STARTED|Overall Study||44
33224|NCT02081014|80713|P6|NOT COMPLETED|Overall Study||0
33225|NCT02081014|80714|P5|NOT COMPLETED|Overall Study||0
33226|NCT02081014|80715|P4|NOT COMPLETED|Overall Study||0
33227|NCT02081014|80716|P3|NOT COMPLETED|Overall Study||0
33228|NCT02081014|80717|P2|NOT COMPLETED|Overall Study||0
33229|NCT02081014|80718|P1|NOT COMPLETED|Overall Study||0
33230|NCT02081014|80713|P6|COMPLETED|Overall Study||2
33231|NCT02081014|80714|P5|COMPLETED|Overall Study||2
33232|NCT02081014|80715|P4|COMPLETED|Overall Study||2
33233|NCT02081014|80716|P3|COMPLETED|Overall Study||2
33234|NCT02081014|80717|P2|COMPLETED|Overall Study||2
33235|NCT02081014|80718|P1|COMPLETED|Overall Study||2
33236|NCT02081014|80713|P6|STARTED|Overall Study||2
33237|NCT02081014|80714|P5|STARTED|Overall Study||2
33238|NCT02081014|80715|P4|STARTED|Overall Study||2
33239|NCT02081014|80716|P3|STARTED|Overall Study||2
33240|NCT02081014|80717|P2|STARTED|Overall Study||2
33241|NCT02081014|80718|P1|STARTED|Overall Study||2
33242|NCT02081001|80764|P12|NOT COMPLETED|Overall Study||0
33243|NCT02081001|80765|P11|NOT COMPLETED|Overall Study||0
33244|NCT02081001|80766|P10|NOT COMPLETED|Overall Study||0
33245|NCT02081001|80767|P9|NOT COMPLETED|Overall Study||0
33246|NCT02081001|80768|P8|NOT COMPLETED|Overall Study||0
33247|NCT02081001|80769|P7|NOT COMPLETED|Overall Study||0
33248|NCT02081001|80770|P6|NOT COMPLETED|Overall Study||0
33249|NCT02081001|80771|P5|NOT COMPLETED|Overall Study||1
33250|NCT02081001|80772|P4|NOT COMPLETED|Overall Study||0
33251|NCT02081001|80773|P3|NOT COMPLETED|Overall Study||0
33252|NCT02081001|80774|P2|NOT COMPLETED|Overall Study||0
33253|NCT02081001|80775|P1|NOT COMPLETED|Overall Study||0
33254|NCT02081001|80764|P12|COMPLETED|Overall Study||1
33255|NCT02081001|80765|P11|COMPLETED|Overall Study||2
33256|NCT02081001|80766|P10|COMPLETED|Overall Study||1
33257|NCT02081001|80767|P9|COMPLETED|Overall Study||2
33258|NCT02081001|80768|P8|COMPLETED|Overall Study||1
33259|NCT02081001|80769|P7|COMPLETED|Overall Study||2
33260|NCT02081001|80770|P6|COMPLETED|Overall Study||1
33261|NCT02081001|80771|P5|COMPLETED|Overall Study||2
33262|NCT02081001|80772|P4|COMPLETED|Overall Study||1
33263|NCT02081001|80773|P3|COMPLETED|Overall Study||2
33264|NCT02081001|80774|P2|COMPLETED|Overall Study||1
33265|NCT02081001|80775|P1|COMPLETED|Overall Study||2
33266|NCT02081001|80764|P12|STARTED|Overall Study||1
33267|NCT02081001|80765|P11|STARTED|Overall Study||2
33268|NCT02081001|80766|P10|STARTED|Overall Study||1
33269|NCT02081001|80767|P9|STARTED|Overall Study||2
33270|NCT02081001|80768|P8|STARTED|Overall Study||1
33271|NCT02081001|80769|P7|STARTED|Overall Study||2
33272|NCT02081001|80770|P6|STARTED|Overall Study||1
33273|NCT02081001|80771|P5|STARTED|Overall Study||3
33274|NCT02081001|80772|P4|STARTED|Overall Study||1
33275|NCT02081001|80773|P3|STARTED|Overall Study||2
33276|NCT02081001|80774|P2|STARTED|Overall Study||1
33277|NCT02081001|80775|P1|STARTED|Overall Study||2
33278|NCT02080832|80842|P3|NOT COMPLETED|Overall Study||16
33279|NCT02080832|80843|P2|NOT COMPLETED|Overall Study||12
33280|NCT02080832|80844|P1|NOT COMPLETED|Overall Study||9
33281|NCT02080832|80842|P3|COMPLETED|Overall Study||6
33282|NCT02080832|80843|P2|COMPLETED|Overall Study||5
33283|NCT02080832|80844|P1|COMPLETED|Overall Study||6
33284|NCT02080832|80842|P3|STARTED|Overall Study||22
33285|NCT02080832|80843|P2|STARTED|Overall Study||17
33286|NCT02080832|80844|P1|STARTED|Overall Study||15
33287|NCT02080819|80861|P3|NOT COMPLETED|Overall Study||22
33288|NCT02080819|80862|P2|NOT COMPLETED|Overall Study||26
33289|NCT02080819|80863|P1|NOT COMPLETED|Overall Study||25
33290|NCT02080819|80861|P3|COMPLETED|Overall Study||11
33291|NCT02080819|80862|P2|COMPLETED|Overall Study||9
33292|NCT02080819|80863|P1|COMPLETED|Overall Study||38
33293|NCT02080819|80861|P3|STARTED|Overall Study||33
33294|NCT02080819|80862|P2|STARTED|Overall Study||35
33295|NCT02080819|80863|P1|STARTED|Overall Study||63
33296|NCT02080780|80871|P1|NOT COMPLETED|Overall Study||0
33297|NCT02080780|80871|P1|COMPLETED|Overall Study||24
33298|NCT02080780|80871|P1|STARTED|Overall Study||24
33299|NCT02080546|80880|P2|NOT COMPLETED|Overall Study||11
33300|NCT02080546|80881|P1|NOT COMPLETED|Overall Study||8
33301|NCT02080546|80880|P2|COMPLETED|Overall Study||52
33302|NCT02080546|80881|P1|COMPLETED|Overall Study||49
33303|NCT02080546|80880|P2|STARTED|Overall Study||63
33304|NCT02080546|80881|P1|STARTED|Overall Study||57
33305|NCT02080507|80891|P2|NOT COMPLETED|Overall Study||0
33306|NCT02080507|80892|P1|NOT COMPLETED|Overall Study||0
33307|NCT02080507|80891|P2|COMPLETED|Overall Study||7
33308|NCT02080507|80892|P1|COMPLETED|Overall Study||5
33309|NCT02080507|80891|P2|STARTED|Overall Study||7
33310|NCT02080507|80892|P1|STARTED|Overall Study||5
33311|NCT02080481|80902|P2|NOT COMPLETED|Overall Study||0
33312|NCT02080481|80903|P1|NOT COMPLETED|Overall Study||1
33313|NCT02080481|80902|P2|COMPLETED|Overall Study||67
33314|NCT02080481|80903|P1|COMPLETED|Overall Study||67
33315|NCT02080481|80902|P2|STARTED|Overall Study||67
33316|NCT02080481|80903|P1|STARTED|Overall Study||68
33317|NCT02080312|80915|P1|NOT COMPLETED|Overall Study||0
33318|NCT02080312|80915|P1|COMPLETED|Overall Study||6
33319|NCT02080312|80915|P1|STARTED|Overall Study||6
33320|NCT02080091|80921|P1|NOT COMPLETED|Overall Study||25
33321|NCT02080091|80921|P1|COMPLETED|Overall Study||0
33322|NCT02080091|80921|P1|STARTED|Overall Study||25
33323|NCT02079844|80930|P3|NOT COMPLETED|Treatment Period 3||0
33324|NCT02079844|80931|P2|NOT COMPLETED|Treatment Period 3||0
33325|NCT02079844|80932|P1|NOT COMPLETED|Treatment Period 3||0
33326|NCT02079844|80930|P3|COMPLETED|Treatment Period 3||5
33327|NCT02079844|80931|P2|COMPLETED|Treatment Period 3||5
33328|NCT02079844|80932|P1|COMPLETED|Treatment Period 3||5
33329|NCT02079844|80930|P3|STARTED|Treatment Period 3||5
33330|NCT02079844|80931|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
33331|NCT02079844|80932|P1|STARTED|Treatment Period 3||5
33332|NCT02079844|80930|P3|NOT COMPLETED|Treatment Period 2||0
33333|NCT02079844|80931|P2|NOT COMPLETED|Treatment Period 2||1
33334|NCT02079844|80932|P1|NOT COMPLETED|Treatment Period 2||0
33335|NCT02079844|80930|P3|COMPLETED|Treatment Period 2||5
33336|NCT02079844|80931|P2|COMPLETED|Treatment Period 2||6
33337|NCT02079844|80932|P1|COMPLETED|Treatment Period 2||5
33338|NCT02079844|80930|P3|STARTED|Treatment Period 2||5
33339|NCT02079844|80931|P2|STARTED|Treatment Period 2||7
33340|NCT02079844|80932|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
33341|NCT02079844|80930|P3|NOT COMPLETED|Treatment Period 1||2
33342|NCT02079844|80931|P2|NOT COMPLETED|Treatment Period 1||0
33343|NCT02079844|80932|P1|NOT COMPLETED|Treatment Period 1||0
33344|NCT02079844|80930|P3|COMPLETED|Treatment Period 1||5
33345|NCT02079844|80931|P2|COMPLETED|Treatment Period 1||7
33346|NCT02079844|80932|P1|COMPLETED|Treatment Period 1||6
33347|NCT02079844|80930|P3|STARTED|Treatment Period 1||7
33348|NCT02079844|80931|P2|STARTED|Treatment Period 1||7
33349|NCT02079844|80932|P1|STARTED|Treatment Period 1||6
33350|NCT02079805|80990|P2|NOT COMPLETED|Overall Study||2
33351|NCT02079805|80991|P1|NOT COMPLETED|Overall Study||0
33352|NCT02079805|80990|P2|COMPLETED|Overall Study||15
33353|NCT02079805|80991|P1|COMPLETED|Overall Study||16
33354|NCT02079805|80990|P2|STARTED|Overall Study||17
33355|NCT02079805|80991|P1|STARTED|Overall Study||16
33356|NCT02079649|81013|P4|NOT COMPLETED|Overall Study||2
33357|NCT02079649|81014|P3|NOT COMPLETED|Overall Study||1
33358|NCT02079649|81015|P2|NOT COMPLETED|Overall Study||0
33359|NCT02079649|81016|P1|NOT COMPLETED|Overall Study||1
33360|NCT02079649|81013|P4|COMPLETED|Overall Study||38
33361|NCT02079649|81014|P3|COMPLETED|Overall Study||40
33362|NCT02079649|81015|P2|COMPLETED|Overall Study||41
33363|NCT02079649|81016|P1|COMPLETED|Overall Study||41
33364|NCT02079649|81013|P4|Treated|Overall Study||40
33365|NCT02079649|81014|P3|Treated|Overall Study||40
33366|NCT02079649|81015|P2|Treated|Overall Study||41
33367|NCT02079649|81016|P1|Treated|Overall Study||41
33368|NCT02079649|81013|P4|STARTED|Overall Study||40
33369|NCT02079649|81014|P3|STARTED|Overall Study||41
33370|NCT02079649|81015|P2|STARTED|Overall Study||41
33371|NCT02079649|81016|P1|STARTED|Overall Study||42
33372|NCT02079610|81033|P2|NOT COMPLETED|Overall Study||1
33373|NCT02079610|81034|P1|NOT COMPLETED|Overall Study||1
33374|NCT02079610|81033|P2|COMPLETED|Overall Study||16
33375|NCT02079610|81034|P1|COMPLETED|Overall Study||18
33376|NCT02079610|81033|P2|STARTED|Overall Study||17
33377|NCT02079610|81034|P1|STARTED|Overall Study||19
33378|NCT02079532|81044|P1|NOT COMPLETED|Overall Study||29
33379|NCT02079532|81044|P1|COMPLETED|Overall Study||273
33380|NCT02079532|81044|P1|STARTED|Overall Study||302
33381|NCT02079519|81066|P1|NOT COMPLETED|Overall Study||10
33382|NCT02079519|81066|P1|COMPLETED|Overall Study||0
33383|NCT02079519|81066|P1|STARTED|Overall Study||10
33384|NCT02079311|81072|P2|NOT COMPLETED|Overall Study||1
33385|NCT02079311|81073|P1|NOT COMPLETED|Overall Study||0
33386|NCT02079311|81072|P2|COMPLETED|Overall Study||26
33387|NCT02079311|81073|P1|COMPLETED|Overall Study||28
33388|NCT02079311|81072|P2|STARTED|Overall Study||27
33389|NCT02079311|81073|P1|STARTED|Overall Study||28
33390|NCT02078492|81082|P3|NOT COMPLETED|Overall Study||0
33391|NCT02078492|81083|P2|NOT COMPLETED|Overall Study||0
33392|NCT02078492|81084|P1|NOT COMPLETED|Overall Study||0
33393|NCT02078492|81082|P3|COMPLETED|Overall Study||80
33394|NCT02078492|81083|P2|COMPLETED|Overall Study||80
33395|NCT02078492|81084|P1|COMPLETED|Overall Study||80
33396|NCT02078492|81082|P3|STARTED|Overall Study||80
33397|NCT02078492|81083|P2|STARTED|Overall Study||80
33398|NCT02078492|81084|P1|STARTED|Overall Study||80
33399|NCT02078193|81101|P1|NOT COMPLETED|Overall Study||0
33400|NCT02078193|81101|P1|COMPLETED|Overall Study||3
33401|NCT02078193|81101|P1|STARTED|Overall Study||3
33402|NCT02078180|81107|P1|NOT COMPLETED|Overall Study||5
33403|NCT02078180|81107|P1|COMPLETED|Overall Study||29
33404|NCT02078180|81107|P1|XL 300|Overall Study||32
33405|NCT02078180|81107|P1|XL 150|Overall Study||31
33406|NCT02078180|81107|P1|SR150|Overall Study||32
33407|NCT02078180|81107|P1|SR100|Overall Study||31
33408|NCT02078180|81107|P1|IR100|Overall Study||31
33409|NCT02078180|81107|P1|IR75|Overall Study||30
33410|NCT02078180|81107|P1|STARTED|Overall Study||34
33411|NCT02077374|81124|P2|NOT COMPLETED|Overall Study||2
33412|NCT02077374|81125|P1|NOT COMPLETED|Overall Study||0
33413|NCT02077374|81124|P2|COMPLETED|Overall Study||17
33414|NCT02077374|81125|P1|COMPLETED|Overall Study||19
33415|NCT02077374|81124|P2|STARTED|Overall Study||19
33416|NCT02077374|81125|P1|STARTED|Overall Study||19
33417|NCT02077140|81146|P5|NOT COMPLETED|Overall Study||5
33418|NCT02077140|81147|P4|NOT COMPLETED|Overall Study||4
33419|NCT02077140|81148|P3|NOT COMPLETED|Overall Study||2
33420|NCT02077140|81149|P2|NOT COMPLETED|Overall Study||2
33421|NCT02077140|81150|P1|NOT COMPLETED|Overall Study||4
33422|NCT02077140|81146|P5|COMPLETED|Overall Study||43
33423|NCT02077140|81147|P4|COMPLETED|Overall Study||32
33424|NCT02077140|81148|P3|COMPLETED|Overall Study||34
33425|NCT02077140|81149|P2|COMPLETED|Overall Study||34
33426|NCT02077140|81150|P1|COMPLETED|Overall Study||32
33427|NCT02077140|81146|P5|STARTED|Overall Study||48
33428|NCT02077140|81147|P4|STARTED|Overall Study||36
33429|NCT02077140|81148|P3|STARTED|Overall Study||36
33430|NCT02077140|81149|P2|STARTED|Overall Study||36
33431|NCT02077140|81150|P1|STARTED|Overall Study||36
33432|NCT02076919|81249|P4|NOT COMPLETED|Overall Study||0
33433|NCT02076919|81250|P3|NOT COMPLETED|Overall Study||0
33434|NCT02076919|81251|P2|NOT COMPLETED|Overall Study||0
33435|NCT02076919|81252|P1|NOT COMPLETED|Overall Study||0
33436|NCT02076919|81249|P4|COMPLETED|Overall Study||12
33437|NCT02076919|81250|P3|COMPLETED|Overall Study||36
33438|NCT02076919|81251|P2|COMPLETED|Overall Study||8
33439|NCT02076919|81252|P1|COMPLETED|Overall Study||24
33440|NCT02076919|81249|P4|STARTED|Overall Study||12
33441|NCT02076919|81250|P3|STARTED|Overall Study||36
33442|NCT02076919|81251|P2|STARTED|Overall Study||8
33443|NCT02076919|81252|P1|STARTED|Overall Study||24
33444|NCT02076334|81354|P4|NOT COMPLETED|Overall Study||1
33445|NCT02076334|81355|P3|NOT COMPLETED|Overall Study||1
33446|NCT02076334|81356|P2|NOT COMPLETED|Overall Study||1
33447|NCT02076334|81357|P1|NOT COMPLETED|Overall Study||1
33448|NCT02076334|81354|P4|COMPLETED|Overall Study||20
33449|NCT02076334|81355|P3|COMPLETED|Overall Study||20
33450|NCT02076334|81356|P2|COMPLETED|Overall Study||20
33451|NCT02076334|81357|P1|COMPLETED|Overall Study||20
33452|NCT02076334|81354|P4|STARTED|Overall Study||21
33453|NCT02076334|81355|P3|STARTED|Overall Study||21
33454|NCT02076334|81356|P2|STARTED|Overall Study||21
33455|NCT02076334|81357|P1|STARTED|Overall Study||21
33456|NCT02076321|81373|P2|NOT COMPLETED|Overall Study||2
33457|NCT02076321|81374|P1|NOT COMPLETED|Overall Study||5
33458|NCT02076321|81373|P2|COMPLETED|Overall Study||49
33459|NCT02076321|81374|P1|COMPLETED|Overall Study||46
33460|NCT02076321|81373|P2|STARTED|Overall Study||51
33461|NCT02076321|81374|P1|STARTED|Overall Study||51
33462|NCT02076243|81380|P1|NOT COMPLETED|Overall Study||2
33463|NCT02076243|81380|P1|COMPLETED|Overall Study||0
33464|NCT02076243|81380|P1|STARTED|Overall Study||2
33465|NCT02076178|81390|P2|NOT COMPLETED|Injection Phase||7
33466|NCT02076178|81391|P1|NOT COMPLETED|Injection Phase||1
33467|NCT02076178|81390|P2|COMPLETED|Injection Phase||87
33468|NCT02076178|81391|P1|COMPLETED|Injection Phase||20
33469|NCT02076178|81390|P2|STARTED|Injection Phase||94
33470|NCT02076178|81391|P1|STARTED|Injection Phase||21
33471|NCT02076178|81390|P2|NOT COMPLETED|Oral Phase||12
33472|NCT02076178|81391|P1|NOT COMPLETED|Oral Phase||0
33473|NCT02076178|81390|P2|COMPLETED|Oral Phase||94
33474|NCT02076178|81391|P1|COMPLETED|Oral Phase||21
33475|NCT02076178|81390|P2|STARTED|Oral Phase||106
33476|NCT02076178|81391|P1|STARTED|Oral Phase||21
33477|NCT02076009|81425|P2|NOT COMPLETED|Overall Study||286
33478|NCT02076009|81426|P1|NOT COMPLETED|Overall Study||283
33479|NCT02076009|81425|P2|COMPLETED|Overall Study||0
33480|NCT02076009|81426|P1|COMPLETED|Overall Study||0
33481|NCT02076009|81425|P2|Treated|Overall Study||283
33482|NCT02076009|81426|P1|Treated|Overall Study||281
33483|NCT02076009|81425|P2|STARTED|Overall Study||286
33484|NCT02076009|81426|P1|STARTED|Overall Study||283
33485|NCT02075840|81448|P2|NOT COMPLETED|Overall Study||151
33486|NCT02075840|81449|P1|NOT COMPLETED|Overall Study||152
33487|NCT02075840|81448|P2|COMPLETED|Overall Study||0
33488|NCT02075840|81449|P1|COMPLETED|Overall Study||0
33489|NCT02075840|81448|P2|STARTED|Overall Study||151
33490|NCT02075840|81449|P1|STARTED|Overall Study||152
33491|NCT02075658|81505|P2|NOT COMPLETED|Overall Study||2
33492|NCT02075658|81506|P1|NOT COMPLETED|Overall Study||2
33493|NCT02075658|81505|P2|COMPLETED|Overall Study||28
33494|NCT02075658|81506|P1|COMPLETED|Overall Study||28
33495|NCT02075658|81505|P2|STARTED|Overall Study||30
33496|NCT02075658|81506|P1|STARTED|Overall Study||30
33497|NCT02075632|81516|P2|NOT COMPLETED|Overall Study||5
33498|NCT02075632|81517|P1|NOT COMPLETED|Overall Study||1
33499|NCT02075632|81516|P2|COMPLETED|Overall Study||143
33500|NCT02075632|81517|P1|COMPLETED|Overall Study||161
33501|NCT02075632|81516|P2|STARTED|Overall Study||148
33502|NCT02075632|81517|P1|STARTED|Overall Study||162
33503|NCT02075515|81530|P3|NOT COMPLETED|Overall Study||8
33504|NCT02075515|81531|P2|NOT COMPLETED|Overall Study||5
33505|NCT02075515|81532|P1|NOT COMPLETED|Overall Study||4
33506|NCT02075515|81530|P3|COMPLETED|Overall Study||208
33507|NCT02075515|81531|P2|COMPLETED|Overall Study||212
33508|NCT02075515|81532|P1|COMPLETED|Overall Study||214
33509|NCT02075515|81530|P3|STARTED|Overall Study||216
33510|NCT02075515|81531|P2|STARTED|Overall Study||217
33511|NCT02075515|81532|P1|STARTED|Overall Study||218
33512|NCT02075463|81567|P1|NOT COMPLETED|Overall Study||8
33513|NCT02075463|81567|P1|COMPLETED|Overall Study||7
33514|NCT02075463|81567|P1|STARTED|Overall Study||15
33515|NCT02075411|81596|P4|NOT COMPLETED|Overall Study||0
33516|NCT02075411|81597|P3|NOT COMPLETED|Overall Study||0
33517|NCT02075411|81598|P2|NOT COMPLETED|Overall Study||0
33518|NCT02075411|81599|P1|NOT COMPLETED|Overall Study||0
33519|NCT02075411|81596|P4|COMPLETED|Overall Study||1
33520|NCT02075411|81597|P3|COMPLETED|Overall Study||0
33521|NCT02075411|81598|P2|COMPLETED|Overall Study||0
33522|NCT02075411|81599|P1|COMPLETED|Overall Study||0
33523|NCT02075411|81596|P4|STARTED|Overall Study||1
33524|NCT02075411|81597|P3|STARTED|Overall Study||0
33525|NCT02075411|81598|P2|STARTED|Overall Study||0
33526|NCT02075411|81599|P1|STARTED|Overall Study||0
33527|NCT02075320|81617|P1|NOT COMPLETED|Overall Study||2
33528|NCT02075320|81617|P1|COMPLETED|Overall Study||48
33529|NCT02075320|81617|P1|STARTED|Overall Study||50
33530|NCT02075255|81627|P3|NOT COMPLETED|Overall Study||3
33531|NCT02075255|81628|P2|NOT COMPLETED|Overall Study||4
33532|NCT02075255|81629|P1|NOT COMPLETED|Overall Study||4
33533|NCT02075255|81627|P3|COMPLETED|Overall Study||72
33534|NCT02075255|81628|P2|COMPLETED|Overall Study||69
33535|NCT02075255|81629|P1|COMPLETED|Overall Study||68
33536|NCT02075255|81627|P3|STARTED|Overall Study||75
33537|NCT02075255|81628|P2|STARTED|Overall Study||73
33538|NCT02075255|81629|P1|STARTED|Overall Study||72
33539|NCT02075125|81738|P2|NOT COMPLETED|Overall Study||1
33540|NCT02075125|81739|P1|NOT COMPLETED|Overall Study||0
33541|NCT02075125|81738|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
33542|NCT02075125|81739|P1|COMPLETED|Overall Study||19
33543|NCT02075125|81738|P2|STARTED|Overall Study||20
33544|NCT02075125|81739|P1|STARTED|Overall Study||19
33545|NCT02075073|81760|P3|NOT COMPLETED|Overall Study||0
33546|NCT02075073|81761|P2|NOT COMPLETED|Overall Study||1
33547|NCT02075073|81762|P1|NOT COMPLETED|Overall Study||0
33548|NCT02075073|81760|P3|COMPLETED|Overall Study||36
33549|NCT02075073|81761|P2|COMPLETED|Overall Study||36
33550|NCT02075073|81762|P1|COMPLETED|Overall Study||36
33551|NCT02075073|81760|P3|STARTED|Overall Study||36
33552|NCT02075073|81761|P2|STARTED|Overall Study||37
33553|NCT02075073|81762|P1|STARTED|Overall Study||36
33554|NCT02075021|81779|P1|NOT COMPLETED|Overall Study||0
33555|NCT02075021|81779|P1|COMPLETED|Overall Study||3
33556|NCT02075021|81779|P1|STARTED|Overall Study||3
33557|NCT02075008|81784|P1|NOT COMPLETED|Overall Study||176
33558|NCT02075008|81784|P1|COMPLETED|Overall Study||94
33559|NCT02075008|81784|P1|STARTED|Overall Study||270
33560|NCT02074995|81788|P3|NOT COMPLETED|Overall Study||0
33561|NCT02074995|81789|P2|NOT COMPLETED|Overall Study||0
33562|NCT02074995|81790|P1|NOT COMPLETED|Overall Study||0
33563|NCT02074995|81788|P3|COMPLETED|Overall Study||0
33564|NCT02074995|81789|P2|COMPLETED|Overall Study||0
33565|NCT02074995|81790|P1|COMPLETED|Overall Study||1
33566|NCT02074995|81788|P3|STARTED|Overall Study||0
33567|NCT02074995|81789|P2|STARTED|Overall Study||0
33568|NCT02074995|81790|P1|STARTED|Overall Study||1
33569|NCT02074982|81807|P2|NOT COMPLETED|Overall Study||54
33570|NCT02074982|81808|P1|NOT COMPLETED|Overall Study||51
33571|NCT02074982|81807|P2|COMPLETED|Overall Study||285
33572|NCT02074982|81808|P1|COMPLETED|Overall Study||286
33573|NCT02074982|81807|P2|Safety Set (SF)|Overall Study||336
33574|NCT02074982|81808|P1|Safety Set (SF)|Overall Study||335
33575|NCT02074982|81807|P2|Full Analysis Set (FAS)|Overall Study||339
33576|NCT02074982|81808|P1|Full Analysis Set (FAS)|Overall Study||336
33577|NCT02074982|81807|P2|STARTED|Overall Study||339
33578|NCT02074982|81808|P1|STARTED|Overall Study||337
33579|NCT02074904|81820|P2|NOT COMPLETED|Overall Study||0
33580|NCT02074904|81821|P1|NOT COMPLETED|Overall Study||0
33581|NCT02074904|81820|P2|COMPLETED|Overall Study||0
33582|NCT02074904|81821|P1|COMPLETED|Overall Study||1
33583|NCT02074904|81820|P2|STARTED|Overall Study||0
33584|NCT02074904|81821|P1|STARTED|Overall Study||1
33585|NCT02074709|81837|P2|NOT COMPLETED|Overall Study||1
33586|NCT02074709|81838|P1|NOT COMPLETED|Overall Study||1
33587|NCT02074709|81837|P2|COMPLETED|Overall Study||29
33588|NCT02074709|81838|P1|COMPLETED|Overall Study||29
33589|NCT02074709|81837|P2|STARTED|Overall Study||30
33590|NCT02074709|81838|P1|STARTED|Overall Study||30
33591|NCT02074553|81846|P8|NOT COMPLETED|Intervention Period 4||0
33592|NCT02074553|81847|P7|NOT COMPLETED|Intervention Period 4||0
33593|NCT02074553|81848|P6|NOT COMPLETED|Intervention Period 4||0
33594|NCT02074553|81849|P5|NOT COMPLETED|Intervention Period 4||0
33595|NCT02074553|81850|P4|NOT COMPLETED|Intervention Period 4||0
33596|NCT02074553|81851|P3|NOT COMPLETED|Intervention Period 4||0
33597|NCT02074553|81852|P2|NOT COMPLETED|Intervention Period 4||0
33598|NCT02074553|81853|P1|NOT COMPLETED|Intervention Period 4||0
33599|NCT02074553|81846|P8|COMPLETED|Intervention Period 4||11
33600|NCT02074553|81847|P7|COMPLETED|Intervention Period 4||11
33601|NCT02074553|81848|P6|COMPLETED|Intervention Period 4||10
33602|NCT02074553|81849|P5|COMPLETED|Intervention Period 4||12
33603|NCT02074553|81850|P4|COMPLETED|Intervention Period 4||11
33604|NCT02074553|81851|P3|COMPLETED|Intervention Period 4||11
33605|NCT02074553|81852|P2|COMPLETED|Intervention Period 4||12
33606|NCT02074553|81853|P1|COMPLETED|Intervention Period 4||11
33607|NCT02074553|81846|P8|STARTED|Intervention Period 4||11
33608|NCT02074553|81847|P7|STARTED|Intervention Period 4||11
33609|NCT02074553|81848|P6|STARTED|Intervention Period 4||10
33610|NCT02074553|81849|P5|STARTED|Intervention Period 4||12
33611|NCT02074553|81850|P4|STARTED|Intervention Period 4||11
33612|NCT02074553|81851|P3|STARTED|Intervention Period 4||11
33613|NCT02074553|81852|P2|STARTED|Intervention Period 4||12
33614|NCT02074553|81853|P1|STARTED|Intervention Period 4||11
33615|NCT02074553|81846|P8|NOT COMPLETED|Washout Period 3||1
33616|NCT02074553|81847|P7|NOT COMPLETED|Washout Period 3||0
33617|NCT02074553|81848|P6|NOT COMPLETED|Washout Period 3||0
33618|NCT02074553|81849|P5|NOT COMPLETED|Washout Period 3||0
33619|NCT02074553|81850|P4|NOT COMPLETED|Washout Period 3||0
33620|NCT02074553|81851|P3|NOT COMPLETED|Washout Period 3||0
33621|NCT02074553|81852|P2|NOT COMPLETED|Washout Period 3||0
33622|NCT02074553|81853|P1|NOT COMPLETED|Washout Period 3||0
33623|NCT02074553|81846|P8|COMPLETED|Washout Period 3||11
33624|NCT02074553|81847|P7|COMPLETED|Washout Period 3||11
33625|NCT02074553|81848|P6|COMPLETED|Washout Period 3||10
33626|NCT02074553|81849|P5|COMPLETED|Washout Period 3||12
33627|NCT02074553|81850|P4|COMPLETED|Washout Period 3||11
33628|NCT02074553|81851|P3|COMPLETED|Washout Period 3||11
33629|NCT02074553|81852|P2|COMPLETED|Washout Period 3||12
33630|NCT02074553|81853|P1|COMPLETED|Washout Period 3||11
33631|NCT02074553|81846|P8|STARTED|Washout Period 3||12
33632|NCT02074553|81847|P7|STARTED|Washout Period 3||11
33633|NCT02074553|81848|P6|STARTED|Washout Period 3||10
33634|NCT02074553|81849|P5|STARTED|Washout Period 3||12
33635|NCT02074553|81850|P4|STARTED|Washout Period 3||11
33636|NCT02074553|81851|P3|STARTED|Washout Period 3||11
33637|NCT02074553|81852|P2|STARTED|Washout Period 3||12
33638|NCT02074553|81853|P1|STARTED|Washout Period 3||11
33639|NCT02074553|81846|P8|NOT COMPLETED|Intervention Period 3||0
33640|NCT02074553|81847|P7|NOT COMPLETED|Intervention Period 3||0
33641|NCT02074553|81848|P6|NOT COMPLETED|Intervention Period 3||0
33642|NCT02074553|81849|P5|NOT COMPLETED|Intervention Period 3||0
33643|NCT02074553|81850|P4|NOT COMPLETED|Intervention Period 3||0
33644|NCT02074553|81851|P3|NOT COMPLETED|Intervention Period 3||0
33645|NCT02074553|81852|P2|NOT COMPLETED|Intervention Period 3||0
33646|NCT02074553|81853|P1|NOT COMPLETED|Intervention Period 3||0
33647|NCT02074553|81846|P8|COMPLETED|Intervention Period 3||12
33648|NCT02074553|81847|P7|COMPLETED|Intervention Period 3||11
33649|NCT02074553|81848|P6|COMPLETED|Intervention Period 3||10
33650|NCT02074553|81849|P5|COMPLETED|Intervention Period 3||12
33651|NCT02074553|81850|P4|COMPLETED|Intervention Period 3||11
33652|NCT02074553|81851|P3|COMPLETED|Intervention Period 3||11
33653|NCT02074553|81852|P2|COMPLETED|Intervention Period 3||12
33654|NCT02074553|81853|P1|COMPLETED|Intervention Period 3||11
33655|NCT02074553|81846|P8|STARTED|Intervention Period 3||12
33656|NCT02074553|81847|P7|STARTED|Intervention Period 3||11
33657|NCT02074553|81848|P6|STARTED|Intervention Period 3||10
33658|NCT02074553|81849|P5|STARTED|Intervention Period 3||12
33659|NCT02074553|81850|P4|STARTED|Intervention Period 3||11
33660|NCT02074553|81851|P3|STARTED|Intervention Period 3||11
33661|NCT02074553|81852|P2|STARTED|Intervention Period 3||12
33662|NCT02074553|81853|P1|STARTED|Intervention Period 3||11
33663|NCT02074553|81846|P8|NOT COMPLETED|Washout Period 2||0
33664|NCT02074553|81847|P7|NOT COMPLETED|Washout Period 2||1
33665|NCT02074553|81848|P6|NOT COMPLETED|Washout Period 2||1
33666|NCT02074553|81849|P5|NOT COMPLETED|Washout Period 2||0
33667|NCT02074553|81850|P4|NOT COMPLETED|Washout Period 2||0
33668|NCT02074553|81851|P3|NOT COMPLETED|Washout Period 2||1
33669|NCT02074553|81852|P2|NOT COMPLETED|Washout Period 2||0
33670|NCT02074553|81853|P1|NOT COMPLETED|Washout Period 2||0
33671|NCT02074553|81846|P8|COMPLETED|Washout Period 2||12
33672|NCT02074553|81847|P7|COMPLETED|Washout Period 2||11
33673|NCT02074553|81848|P6|COMPLETED|Washout Period 2||10
33674|NCT02074553|81849|P5|COMPLETED|Washout Period 2||12
33675|NCT02074553|81850|P4|COMPLETED|Washout Period 2||11
33676|NCT02074553|81851|P3|COMPLETED|Washout Period 2||11
33677|NCT02074553|81852|P2|COMPLETED|Washout Period 2||12
33678|NCT02074553|81853|P1|COMPLETED|Washout Period 2||11
33679|NCT02074553|81846|P8|STARTED|Washout Period 2||12
33680|NCT02074553|81847|P7|STARTED|Washout Period 2||12
33681|NCT02074553|81848|P6|STARTED|Washout Period 2||11
33682|NCT02074553|81849|P5|STARTED|Washout Period 2||12
33683|NCT02074553|81850|P4|STARTED|Washout Period 2||11
33684|NCT02074553|81851|P3|STARTED|Washout Period 2||12
33685|NCT02074553|81852|P2|STARTED|Washout Period 2||12
33686|NCT02074553|81853|P1|STARTED|Washout Period 2||11
33687|NCT02074553|81846|P8|NOT COMPLETED|Intervention Period 2||0
33688|NCT02074553|81847|P7|NOT COMPLETED|Intervention Period 2||0
33689|NCT02074553|81848|P6|NOT COMPLETED|Intervention Period 2||0
33690|NCT02074553|81849|P5|NOT COMPLETED|Intervention Period 2||0
33691|NCT02074553|81850|P4|NOT COMPLETED|Intervention Period 2||0
33692|NCT02074553|81851|P3|NOT COMPLETED|Intervention Period 2||0
33693|NCT02074553|81852|P2|NOT COMPLETED|Intervention Period 2||0
33694|NCT02074553|81853|P1|NOT COMPLETED|Intervention Period 2||0
33695|NCT02074553|81846|P8|COMPLETED|Intervention Period 2||12
33696|NCT02074553|81847|P7|COMPLETED|Intervention Period 2||12
33697|NCT02074553|81848|P6|COMPLETED|Intervention Period 2||11
33698|NCT02074553|81849|P5|COMPLETED|Intervention Period 2||12
33699|NCT02074553|81850|P4|COMPLETED|Intervention Period 2||11
33700|NCT02074553|81851|P3|COMPLETED|Intervention Period 2||12
33701|NCT02074553|81852|P2|COMPLETED|Intervention Period 2||12
33702|NCT02074553|81853|P1|COMPLETED|Intervention Period 2||11
33703|NCT02074553|81846|P8|STARTED|Intervention Period 2||12
33704|NCT02074553|81847|P7|STARTED|Intervention Period 2||12
33705|NCT02074553|81848|P6|STARTED|Intervention Period 2||11
33706|NCT02074553|81849|P5|STARTED|Intervention Period 2||12
33707|NCT02074553|81850|P4|STARTED|Intervention Period 2||11
33708|NCT02074553|81851|P3|STARTED|Intervention Period 2||12
33709|NCT02074553|81852|P2|STARTED|Intervention Period 2||12
33710|NCT02074553|81853|P1|STARTED|Intervention Period 2||11
33711|NCT02074553|81846|P8|NOT COMPLETED|Washout Period 1||0
33712|NCT02074553|81847|P7|NOT COMPLETED|Washout Period 1||0
33713|NCT02074553|81848|P6|NOT COMPLETED|Washout Period 1||1
33714|NCT02074553|81849|P5|NOT COMPLETED|Washout Period 1||0
33715|NCT02074553|81850|P4|NOT COMPLETED|Washout Period 1||1
33716|NCT02074553|81851|P3|NOT COMPLETED|Washout Period 1||0
33717|NCT02074553|81852|P2|NOT COMPLETED|Washout Period 1||0
33718|NCT02074553|81853|P1|NOT COMPLETED|Washout Period 1||1
33719|NCT02074553|81846|P8|COMPLETED|Washout Period 1||12
33720|NCT02074553|81847|P7|COMPLETED|Washout Period 1||12
33721|NCT02074553|81848|P6|COMPLETED|Washout Period 1||11
33722|NCT02074553|81849|P5|COMPLETED|Washout Period 1||12
33723|NCT02074553|81850|P4|COMPLETED|Washout Period 1||11
33724|NCT02074553|81851|P3|COMPLETED|Washout Period 1||12
33725|NCT02074553|81852|P2|COMPLETED|Washout Period 1||12
33726|NCT02074553|81853|P1|COMPLETED|Washout Period 1||11
33727|NCT02074553|81846|P8|STARTED|Washout Period 1||12
33728|NCT02074553|81847|P7|STARTED|Washout Period 1||12
33729|NCT02074553|81848|P6|STARTED|Washout Period 1||12
33730|NCT02074553|81849|P5|STARTED|Washout Period 1||12
33731|NCT02074553|81850|P4|STARTED|Washout Period 1||12
33732|NCT02074553|81851|P3|STARTED|Washout Period 1||12
33733|NCT02074553|81852|P2|STARTED|Washout Period 1||12
33734|NCT02074553|81853|P1|STARTED|Washout Period 1||12
33735|NCT02074553|81846|P8|NOT COMPLETED|Intervention Period 1||0
33736|NCT02074553|81847|P7|NOT COMPLETED|Intervention Period 1||0
33737|NCT02074553|81848|P6|NOT COMPLETED|Intervention Period 1||0
33738|NCT02074553|81849|P5|NOT COMPLETED|Intervention Period 1||0
33739|NCT02074553|81850|P4|NOT COMPLETED|Intervention Period 1||1
33740|NCT02074553|81851|P3|NOT COMPLETED|Intervention Period 1||0
33741|NCT02074553|81852|P2|NOT COMPLETED|Intervention Period 1||0
33742|NCT02074553|81853|P1|NOT COMPLETED|Intervention Period 1||0
33743|NCT02074553|81846|P8|COMPLETED|Intervention Period 1||12
33744|NCT02074553|81847|P7|COMPLETED|Intervention Period 1||12
33745|NCT02074553|81848|P6|COMPLETED|Intervention Period 1||12
33746|NCT02074553|81849|P5|COMPLETED|Intervention Period 1||12
33747|NCT02074553|81850|P4|COMPLETED|Intervention Period 1||12
33748|NCT02074553|81851|P3|COMPLETED|Intervention Period 1||12
33749|NCT02074553|81852|P2|COMPLETED|Intervention Period 1||12
33750|NCT02074553|81853|P1|COMPLETED|Intervention Period 1||12
33751|NCT02074553|81846|P8|STARTED|Intervention Period 1||12
33752|NCT02074553|81847|P7|STARTED|Intervention Period 1||12
33753|NCT02074553|81848|P6|STARTED|Intervention Period 1||12
33754|NCT02074553|81849|P5|STARTED|Intervention Period 1||12
33755|NCT02074553|81850|P4|STARTED|Intervention Period 1||13
33756|NCT02074553|81851|P3|STARTED|Intervention Period 1||12
33757|NCT02074553|81852|P2|STARTED|Intervention Period 1||12
33758|NCT02074553|81853|P1|STARTED|Intervention Period 1||12
33759|NCT02074514|82035|P2|NOT COMPLETED|Overall Study||4
33760|NCT02074514|82036|P1|NOT COMPLETED|Overall Study||3
33761|NCT02074514|82035|P2|COMPLETED|Overall Study||54
33762|NCT02074514|82036|P1|COMPLETED|Overall Study||56
33763|NCT02074514|82035|P2|STARTED|Overall Study||58
33764|NCT02074514|82036|P1|STARTED|Overall Study||59
33765|NCT02074384|82057|P3|NOT COMPLETED|Overall Study||0
33766|NCT02074384|82058|P2|NOT COMPLETED|Overall Study||0
33767|NCT02074384|82059|P1|NOT COMPLETED|Overall Study||0
33768|NCT02074384|82057|P3|COMPLETED|Overall Study||17
33769|NCT02074384|82058|P2|COMPLETED|Overall Study||70
33770|NCT02074384|82059|P1|COMPLETED|Overall Study||74
33771|NCT02074384|82057|P3|STARTED|Overall Study||17
33772|NCT02074384|82058|P2|STARTED|Overall Study||70
33773|NCT02074384|82059|P1|STARTED|Overall Study||74
33774|NCT02074358|82067|P6|NOT COMPLETED|Overall Study||0
33775|NCT02074358|82068|P5|NOT COMPLETED|Overall Study||0
33776|NCT02074358|82069|P4|NOT COMPLETED|Overall Study||0
33777|NCT02074358|82070|P3|NOT COMPLETED|Overall Study||0
33778|NCT02074358|82071|P2|NOT COMPLETED|Overall Study||0
33779|NCT02074358|82072|P1|NOT COMPLETED|Overall Study||0
33780|NCT02074358|82067|P6|COMPLETED|Overall Study||2
33781|NCT02074358|82068|P5|COMPLETED|Overall Study||3
33782|NCT02074358|82069|P4|COMPLETED|Overall Study||2
33783|NCT02074358|82070|P3|COMPLETED|Overall Study||2
33784|NCT02074358|82071|P2|COMPLETED|Overall Study||3
33785|NCT02074358|82072|P1|COMPLETED|Overall Study||3
33786|NCT02074358|82067|P6|STARTED|Overall Study||2
33787|NCT02074358|82068|P5|STARTED|Overall Study||3
33788|NCT02074358|82069|P4|STARTED|Overall Study||2
33789|NCT02074358|82070|P3|STARTED|Overall Study||2
33790|NCT02074358|82071|P2|STARTED|Overall Study||3
33791|NCT02074358|82072|P1|STARTED|Overall Study||3
33792|NCT02074345|82161|P1|NOT COMPLETED|Overall Study||0
33793|NCT02074345|82161|P1|COMPLETED|Overall Study||31
33794|NCT02074345|82161|P1|STARTED|Overall Study||31
33795|NCT02074059|82177|P6|NOT COMPLETED|Overall Study||1
33796|NCT02074059|82178|P5|NOT COMPLETED|Overall Study||1
33797|NCT02074059|82179|P4|NOT COMPLETED|Overall Study||0
33798|NCT02074059|82180|P3|NOT COMPLETED|Overall Study||0
33799|NCT02074059|82181|P2|NOT COMPLETED|Overall Study||0
33800|NCT02074059|82182|P1|NOT COMPLETED|Overall Study||0
33801|NCT02074059|82177|P6|COMPLETED|Overall Study||39
33802|NCT02074059|82178|P5|COMPLETED|Overall Study||7
33803|NCT02074059|82179|P4|COMPLETED|Overall Study||8
33804|NCT02074059|82180|P3|COMPLETED|Overall Study||8
33805|NCT02074059|82181|P2|COMPLETED|Overall Study||8
33806|NCT02074059|82182|P1|COMPLETED|Overall Study||8
33807|NCT02074059|82177|P6|STARTED|Overall Study||40
33808|NCT02074059|82178|P5|STARTED|Overall Study||8
33809|NCT02074059|82179|P4|STARTED|Overall Study||8
33810|NCT02074059|82180|P3|STARTED|Overall Study||8
33811|NCT02074059|82181|P2|STARTED|Overall Study||8
33812|NCT02074059|82182|P1|STARTED|Overall Study||8
33813|NCT02073747|82222|P2|NOT COMPLETED|Overall Study||1
33814|NCT02073747|82223|P1|NOT COMPLETED|Overall Study||1
33815|NCT02073747|82222|P2|COMPLETED|Overall Study||14
33816|NCT02073747|82223|P1|COMPLETED|Overall Study||14
33817|NCT02073747|82222|P2|STARTED|Overall Study||15
33818|NCT02073747|82223|P1|STARTED|Overall Study||15
33819|NCT02073656|82229|P1|NOT COMPLETED|Retreatment Substudy||0
33820|NCT02073656|82229|P1|COMPLETED|Retreatment Substudy||9
33821|NCT02073656|82229|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
33822|NCT02073656|82229|P1|NOT COMPLETED|Primary Study||8
33823|NCT02073656|82229|P1|COMPLETED|Primary Study||327
33824|NCT02073656|82229|P1|STARTED|Primary Study||335
33825|NCT02073461|82248|P3|NOT COMPLETED|Overall Study||1
33826|NCT02073461|82249|P2|NOT COMPLETED|Overall Study||1
33827|NCT02073461|82250|P1|NOT COMPLETED|Overall Study||4
33828|NCT02073461|82248|P3|COMPLETED|Overall Study||78
33829|NCT02073461|82249|P2|COMPLETED|Overall Study||77
33830|NCT02073461|82250|P1|COMPLETED|Overall Study||75
33831|NCT02073461|82248|P3|STARTED|Overall Study||79
33832|NCT02073461|82249|P2|STARTED|Overall Study||78
33833|NCT02073461|82250|P1|STARTED|Overall Study||79
33834|NCT02073448|82279|P3|NOT COMPLETED|Overall Study||5
33835|NCT02073448|82280|P2|NOT COMPLETED|Overall Study||12
33836|NCT02073448|82281|P1|NOT COMPLETED|Overall Study||2
33837|NCT02073448|82279|P3|COMPLETED|Overall Study||99
33838|NCT02073448|82280|P2|COMPLETED|Overall Study||200
33839|NCT02073448|82281|P1|COMPLETED|Overall Study||99
33840|NCT02073448|82279|P3|STARTED|Overall Study||104
33841|NCT02073448|82280|P2|STARTED|Overall Study||212
33842|NCT02073448|82281|P1|STARTED|Overall Study||101
33843|NCT02072980|82307|P2|NOT COMPLETED|Period 2, Second Wear||1
33844|NCT02072980|82308|P1|NOT COMPLETED|Period 2, Second Wear||0
33845|NCT02072980|82307|P2|COMPLETED|Period 2, Second Wear||7
33846|NCT02072980|82308|P1|COMPLETED|Period 2, Second Wear||7
33847|NCT02072980|82307|P2|STARTED|Period 2, Second Wear||8
33848|NCT02072980|82308|P1|STARTED|Period 2, Second Wear||7
33849|NCT02072980|82307|P2|NOT COMPLETED|Period 1, First Wear||0
33850|NCT02072980|82308|P1|NOT COMPLETED|Period 1, First Wear||0
33851|NCT02072980|82307|P2|COMPLETED|Period 1, First Wear||8
33852|NCT02072980|82308|P1|COMPLETED|Period 1, First Wear||7
33853|NCT02072980|82307|P2|STARTED|Period 1, First Wear||8
33854|NCT02072980|82308|P1|STARTED|Period 1, First Wear||7
33855|NCT02072928|82314|P1|NOT COMPLETED|Overall Study||0
33856|NCT02072928|82314|P1|COMPLETED|Overall Study||55
33857|NCT02072928|82314|P1|STARTED|Overall Study||55
33858|NCT02072421|82318|P1|NOT COMPLETED|Overall Study||390
33859|NCT02072421|82318|P1|COMPLETED|Overall Study||2489
33860|NCT02072421|82318|P1|STARTED|Overall Study||2879
33861|NCT02072200|82326|P1|NOT COMPLETED|Overall Study||2
33862|NCT02072200|82326|P1|COMPLETED|Overall Study||145
33863|NCT02072200|82326|P1|STARTED|Overall Study||147
33864|NCT02072096|82334|P2|NOT COMPLETED|Overall Study||78
33865|NCT02072096|82335|P1|NOT COMPLETED|Overall Study||85
33866|NCT02072096|82334|P2|COMPLETED|Overall Study||15
33867|NCT02072096|82335|P1|COMPLETED|Overall Study||14
33868|NCT02072096|82334|P2|Received at Least One Dose of Study Drug|Overall Study||93
33869|NCT02072096|82335|P1|Received at Least One Dose of Study Drug|Overall Study||98
33870|NCT02072096|82334|P2|STARTED|Overall Study||93
33871|NCT02072096|82335|P1|STARTED|Overall Study||99
33872|NCT02071849|82357|P1|NOT COMPLETED|2-year Extended Follow-up||1
33873|NCT02071849|82357|P1|COMPLETED|2-year Extended Follow-up||14
33874|NCT02071849|82357|P1|STARTED|2-year Extended Follow-up||15
33875|NCT02071849|82357|P1|NOT COMPLETED|6-month Primary Endpoint||5
33876|NCT02071849|82357|P1|COMPLETED|6-month Primary Endpoint||15
33877|NCT02071849|82357|P1|STARTED|6-month Primary Endpoint||20
33878|NCT02071823|82391|P2|NOT COMPLETED|Overall Study||0
33879|NCT02071823|82392|P1|NOT COMPLETED|Overall Study||1
33880|NCT02071823|82391|P2|COMPLETED|Overall Study||6
33881|NCT02071823|82392|P1|COMPLETED|Overall Study||5
33882|NCT02071823|82391|P2|STARTED|Overall Study||6
33883|NCT02071823|82392|P1|STARTED|Overall Study||6
33884|NCT02071810|82407|P5|NOT COMPLETED|Overall Study||1
33885|NCT02071810|82408|P4|NOT COMPLETED|Overall Study||1
33886|NCT02071810|82409|P3|NOT COMPLETED|Overall Study||0
33887|NCT02071810|82410|P2|NOT COMPLETED|Overall Study||0
33888|NCT02071810|82411|P1|NOT COMPLETED|Overall Study||0
33889|NCT02071810|82407|P5|COMPLETED|Overall Study||8
33890|NCT02071810|82408|P4|COMPLETED|Overall Study||6
33891|NCT02071810|82409|P3|COMPLETED|Overall Study||6
33892|NCT02071810|82410|P2|COMPLETED|Overall Study||6
33893|NCT02071810|82411|P1|COMPLETED|Overall Study||6
33894|NCT02071810|82407|P5|STARTED|Overall Study||9
33895|NCT02071810|82408|P4|STARTED|Overall Study||7
33896|NCT02071810|82409|P3|STARTED|Overall Study||6
33897|NCT02071810|82410|P2|STARTED|Overall Study||6
33898|NCT02071810|82411|P1|STARTED|Overall Study||6
33899|NCT02071771|82423|P2|NOT COMPLETED|Period 2: Second 10 Days||0
33900|NCT02071771|82424|P1|NOT COMPLETED|Period 2: Second 10 Days||0
33901|NCT02071771|82423|P2|COMPLETED|Period 2: Second 10 Days||38
33902|NCT02071771|82424|P1|COMPLETED|Period 2: Second 10 Days||39
33903|NCT02071771|82423|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
33904|NCT02071771|82424|P1|STARTED|Period 2: Second 10 Days||39
33905|NCT02071771|82423|P2|NOT COMPLETED|Period 1: First 10 Days||0
33906|NCT02071771|82424|P1|NOT COMPLETED|Period 1: First 10 Days||2
33907|NCT02071771|82423|P2|COMPLETED|Period 1: First 10 Days||39
33908|NCT02071771|82424|P1|COMPLETED|Period 1: First 10 Days||39
33909|NCT02071771|82423|P2|Dispensed|Period 1: First 10 Days||39
33910|NCT02071771|82424|P1|Dispensed|Period 1: First 10 Days||39
33911|NCT02071771|82423|P2|STARTED|Period 1: First 10 Days||39
33912|NCT02071771|82424|P1|STARTED|Period 1: First 10 Days||41
33913|NCT02071420|82434|P2|NOT COMPLETED|Overall Study||3
33914|NCT02071420|82435|P1|NOT COMPLETED|Overall Study||3
33915|NCT02071420|82434|P2|COMPLETED|Overall Study||27
33916|NCT02071420|82435|P1|COMPLETED|Overall Study||27
33917|NCT02071420|82434|P2|STARTED|Overall Study||30
33918|NCT02071420|82435|P1|STARTED|Overall Study||30
33919|NCT02071108|82441|P1|NOT COMPLETED|Overall Study||0
33920|NCT02071108|82441|P1|COMPLETED|Overall Study||35
33921|NCT02071108|82441|P1|STARTED|Overall Study||35
33922|NCT02071095|82462|P2|NOT COMPLETED|Overall Study||0
33923|NCT02071095|82463|P1|NOT COMPLETED|Overall Study||0
33924|NCT02071095|82462|P2|COMPLETED|Overall Study||3
33925|NCT02071095|82463|P1|COMPLETED|Overall Study||12
33926|NCT02071095|82462|P2|STARTED|Overall Study||3
33927|NCT02071095|82463|P1|STARTED|Overall Study||12
33928|NCT02071082|82479|P2|NOT COMPLETED|Overall Study||7
33929|NCT02071082|82480|P1|NOT COMPLETED|Overall Study||2
33930|NCT02071082|82479|P2|COMPLETED|Overall Study||68
33931|NCT02071082|82480|P1|COMPLETED|Overall Study||2
33932|NCT02071082|82479|P2|STARTED|Overall Study||75
33933|NCT02071082|82480|P1|STARTED|Overall Study||4
33934|NCT02070965|82511|P3|NOT COMPLETED|Overall Study||1
33935|NCT02070965|82512|P2|NOT COMPLETED|Overall Study||2
33936|NCT02070965|82513|P1|NOT COMPLETED|Overall Study||2
33937|NCT02070965|82511|P3|COMPLETED|Overall Study||24
33938|NCT02070965|82512|P2|COMPLETED|Overall Study||21
33939|NCT02070965|82513|P1|COMPLETED|Overall Study||25
33940|NCT02070965|82511|P3|STARTED|Overall Study||25
33941|NCT02070965|82512|P2|STARTED|Overall Study||23
33942|NCT02070965|82513|P1|STARTED|Overall Study||27
33943|NCT02070744|82525|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
33944|NCT02070744|82526|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
33945|NCT02070744|82527|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
33946|NCT02070744|82528|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
33947|NCT02070744|82529|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
33948|NCT02070744|82525|P5|COMPLETED|OLE Phase (48 Weeks)||24
33949|NCT02070744|82526|P4|COMPLETED|OLE Phase (48 Weeks)||0
33950|NCT02070744|82527|P3|COMPLETED|OLE Phase (48 Weeks)||0
33951|NCT02070744|82528|P2|COMPLETED|OLE Phase (48 Weeks)||0
33952|NCT02070744|82529|P1|COMPLETED|OLE Phase (48 Weeks)||0
33953|NCT02070744|82525|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
33954|NCT02070744|82526|P4|STARTED|OLE Phase (48 Weeks)||0
33955|NCT02070744|82527|P3|STARTED|OLE Phase (48 Weeks)||0
33956|NCT02070744|82528|P2|STARTED|OLE Phase (48 Weeks)||0
33957|NCT02070744|82529|P1|STARTED|OLE Phase (48 Weeks)||0
33958|NCT02070744|82525|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
33959|NCT02070744|82526|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
33960|NCT02070744|82527|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
33961|NCT02070744|82528|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
33962|NCT02070744|82529|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
33963|NCT02070744|82525|P5|COMPLETED|PC Phase (12 Weeks)||0
33964|NCT02070744|82526|P4|COMPLETED|PC Phase (12 Weeks)||13
33965|NCT02070744|82527|P3|COMPLETED|PC Phase (12 Weeks)||15
33966|NCT02070744|82528|P2|COMPLETED|PC Phase (12 Weeks)||5
33967|NCT02070744|82529|P1|COMPLETED|PC Phase (12 Weeks)||6
33968|NCT02070744|82525|P5|Treated|PC Phase (12 Weeks)||0
33969|NCT02070744|82526|P4|Treated|PC Phase (12 Weeks)||13
33970|NCT02070744|82527|P3|Treated|PC Phase (12 Weeks)||15
33971|NCT02070744|82528|P2|Treated|PC Phase (12 Weeks)||5
33972|NCT02070744|82529|P1|Treated|PC Phase (12 Weeks)||6
33973|NCT02070744|82525|P5|STARTED|PC Phase (12 Weeks)||0
33974|NCT02070744|82526|P4|STARTED|PC Phase (12 Weeks)||14
33975|NCT02070744|82527|P3|STARTED|PC Phase (12 Weeks)||15
33976|NCT02070744|82528|P2|STARTED|PC Phase (12 Weeks)||5
33977|NCT02070744|82529|P1|STARTED|PC Phase (12 Weeks)||6
33978|NCT02070692|82581|P2|NOT COMPLETED|Overall Study||12
33979|NCT02070692|82582|P1|NOT COMPLETED|Overall Study||10
33980|NCT02070692|82581|P2|COMPLETED|Overall Study||16
33981|NCT02070692|82582|P1|COMPLETED|Overall Study||18
33982|NCT02070692|82581|P2|STARTED|Overall Study||28
33983|NCT02070692|82582|P1|STARTED|Overall Study||28
33984|NCT02070640|82598|P2|NOT COMPLETED|Overall Study||0
33985|NCT02070640|82599|P1|NOT COMPLETED|Overall Study||11
33986|NCT02070640|82598|P2|COMPLETED|Overall Study||6
33987|NCT02070640|82599|P1|COMPLETED|Overall Study||82
33988|NCT02070640|82598|P2|STARTED|Overall Study||6
33989|NCT02070640|82599|P1|STARTED|Overall Study||93
33990|NCT02070588|82612|P3|NOT COMPLETED|Overall Study||0
33991|NCT02070588|82613|P2|NOT COMPLETED|Overall Study||1
33992|NCT02070588|82614|P1|NOT COMPLETED|Overall Study||39
33993|NCT02070588|82612|P3|COMPLETED|Overall Study||0
33994|NCT02070588|82613|P2|COMPLETED|Overall Study||25
33995|NCT02070588|82614|P1|COMPLETED|Overall Study||47
33996|NCT02070588|82612|P3|STARTED|Overall Study||0
33997|NCT02070588|82613|P2|STARTED|Overall Study||26
33998|NCT02070588|82614|P1|STARTED|Overall Study||86
33999|NCT02070380|82632|P4|NOT COMPLETED|Second Injection||5
34000|NCT02070380|82633|P3|NOT COMPLETED|Second Injection||1
34001|NCT02070380|82634|P2|NOT COMPLETED|Second Injection||2
34002|NCT02070380|82635|P1|NOT COMPLETED|Second Injection||0
34003|NCT02070380|82632|P4|COMPLETED|Second Injection||46
34004|NCT02070380|82633|P3|COMPLETED|Second Injection||50
34005|NCT02070380|82634|P2|COMPLETED|Second Injection||32
34006|NCT02070380|82635|P1|COMPLETED|Second Injection||31
34007|NCT02070380|82632|P4|STARTED|Second Injection||51
34008|NCT02070380|82633|P3|STARTED|Second Injection||51
34009|NCT02070380|82634|P2|STARTED|Second Injection||34
34010|NCT02070380|82635|P1|STARTED|Second Injection||31
34011|NCT02070380|82632|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
34012|NCT02070380|82633|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
34013|NCT02070380|82634|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
34014|NCT02070380|82635|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
34015|NCT02070380|82632|P4|COMPLETED|Washout (no Second Injection/MRI)||51
34016|NCT02070380|82633|P3|COMPLETED|Washout (no Second Injection/MRI)||51
34017|NCT02070380|82634|P2|COMPLETED|Washout (no Second Injection/MRI)||34
34018|NCT02070380|82635|P1|COMPLETED|Washout (no Second Injection/MRI)||31
34019|NCT02070380|82632|P4|STARTED|Washout (no Second Injection/MRI)||54
34020|NCT02070380|82633|P3|STARTED|Washout (no Second Injection/MRI)||53
34021|NCT02070380|82634|P2|STARTED|Washout (no Second Injection/MRI)||39
34022|NCT02070380|82635|P1|STARTED|Washout (no Second Injection/MRI)||31
34023|NCT02070380|82632|P4|NOT COMPLETED|First Injection||0
34024|NCT02070380|82633|P3|NOT COMPLETED|First Injection||0
34025|NCT02070380|82634|P2|NOT COMPLETED|First Injection||0
34026|NCT02070380|82635|P1|NOT COMPLETED|First Injection||0
34027|NCT02070380|82632|P4|COMPLETED|First Injection||54
34028|NCT02070380|82633|P3|COMPLETED|First Injection||53
34029|NCT02070380|82634|P2|COMPLETED|First Injection||39
34030|NCT02070380|82635|P1|COMPLETED|First Injection||31
34031|NCT02070380|82632|P4|STARTED|First Injection||54
34032|NCT02070380|82633|P3|STARTED|First Injection||53
34033|NCT02070380|82634|P2|STARTED|First Injection||39
34034|NCT02070380|82635|P1|STARTED|First Injection||31
34035|NCT02070302|82685|P2|NOT COMPLETED|Overall Study||0
34036|NCT02070302|82686|P1|NOT COMPLETED|Overall Study||0
34037|NCT02070302|82685|P2|COMPLETED|Overall Study||5
34038|NCT02070302|82686|P1|COMPLETED|Overall Study||5
34039|NCT02070302|82685|P2|STARTED|Overall Study||5
34040|NCT02070302|82686|P1|STARTED|Overall Study||5
34041|NCT02070237|82704|P2|NOT COMPLETED|Overall Study||3
34042|NCT02070237|82705|P1|NOT COMPLETED|Overall Study||3
34043|NCT02070237|82704|P2|COMPLETED|Overall Study||42
34044|NCT02070237|82705|P1|COMPLETED|Overall Study||42
34045|NCT02070237|82704|P2|STARTED|Overall Study||45
34046|NCT02070237|82705|P1|STARTED|Overall Study||45
34047|NCT02069093|82713|P1|NOT COMPLETED|Overall Study||30
34048|NCT02069093|82713|P1|COMPLETED|Overall Study||56
34049|NCT02069093|82713|P1|Pharmacokinetic Analysis Set|Overall Study||50
34050|NCT02069093|82713|P1|STARTED|Overall Study||86
34051|NCT02068547|82724|P2|NOT COMPLETED|Overall Study||3
34052|NCT02068547|82725|P1|NOT COMPLETED|Overall Study||4
34053|NCT02068547|82724|P2|COMPLETED|Overall Study||1
34054|NCT02068547|82725|P1|COMPLETED|Overall Study||0
34055|NCT02068547|82724|P2|STARTED|Overall Study||4
34056|NCT02068547|82725|P1|STARTED|Overall Study||4
34057|NCT02068443|82738|P3|NOT COMPLETED|Overall Study||3
34058|NCT02068443|82739|P2|NOT COMPLETED|Overall Study||6
34059|NCT02068443|82740|P1|NOT COMPLETED|Overall Study||7
34060|NCT02068443|82738|P3|COMPLETED|Overall Study||148
34061|NCT02068443|82739|P2|COMPLETED|Overall Study||146
34062|NCT02068443|82740|P1|COMPLETED|Overall Study||64
34063|NCT02068443|82738|P3|STARTED|Overall Study||151
34064|NCT02068443|82739|P2|STARTED|Overall Study||152
34065|NCT02068443|82740|P1|STARTED|Overall Study||71
34066|NCT02068222|82775|P1|NOT COMPLETED|Overall Study||1
34067|NCT02068222|82775|P1|COMPLETED|Overall Study||9
34068|NCT02068222|82775|P1|STARTED|Overall Study||10
34069|NCT02068157|82782|P1|NOT COMPLETED|Overall Study||0
34070|NCT02068157|82782|P1|COMPLETED|Overall Study||3
34071|NCT02068157|82782|P1|STARTED|Overall Study||3
34072|NCT02068027|82789|P2|NOT COMPLETED|Overall Study||16
34073|NCT02068027|82790|P1|NOT COMPLETED|Overall Study||13
34074|NCT02068027|82789|P2|COMPLETED|Overall Study||114
34075|NCT02068027|82790|P1|COMPLETED|Overall Study||117
34076|NCT02068027|82789|P2|STARTED|Overall Study||130
34077|NCT02068027|82790|P1|STARTED|Overall Study||130
34078|NCT02067728|82800|P2|NOT COMPLETED|6 Month Measurements||97
34079|NCT02067728|82801|P1|NOT COMPLETED|6 Month Measurements||114
34080|NCT02067728|82800|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
34081|NCT02067728|82801|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
34082|NCT02067728|82800|P2|STARTED|6 Month Measurements||210
34083|NCT02067728|82801|P1|STARTED|6 Month Measurements||220
34084|NCT02067728|82800|P2|NOT COMPLETED|6 Month Follow up Survey||60
34085|NCT02067728|82801|P1|NOT COMPLETED|6 Month Follow up Survey||48
34086|NCT02067728|82800|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
34087|NCT02067728|82801|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
34088|NCT02067728|82800|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
34089|NCT02067728|82801|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
34090|NCT02067728|82800|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
34091|NCT02067728|82801|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
34092|NCT02067728|82800|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
34093|NCT02067728|82801|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
34094|NCT02067728|82800|P2|STARTED|Baseline - 1 Month Follow up Survey||210
34095|NCT02067728|82801|P1|STARTED|Baseline - 1 Month Follow up Survey||220
34096|NCT02067676|82835|P6|NOT COMPLETED|Overall Study||0
34097|NCT02067676|82836|P5|NOT COMPLETED|Overall Study||0
34098|NCT02067676|82837|P4|NOT COMPLETED|Overall Study||0
34099|NCT02067676|82838|P3|NOT COMPLETED|Overall Study||0
34100|NCT02067676|82839|P2|NOT COMPLETED|Overall Study||0
34101|NCT02067676|82840|P1|NOT COMPLETED|Overall Study||1
34102|NCT02067676|82835|P6|COMPLETED|Overall Study||8
34103|NCT02067676|82836|P5|COMPLETED|Overall Study||8
34104|NCT02067676|82837|P4|COMPLETED|Overall Study||8
34105|NCT02067676|82838|P3|COMPLETED|Overall Study||8
34106|NCT02067676|82839|P2|COMPLETED|Overall Study||8
34107|NCT02067676|82840|P1|COMPLETED|Overall Study||7
34108|NCT02067676|82835|P6|STARTED|Overall Study||8
34109|NCT02067676|82836|P5|STARTED|Overall Study||8
34110|NCT02067676|82837|P4|STARTED|Overall Study||8
34111|NCT02067676|82838|P3|STARTED|Overall Study||8
34112|NCT02067676|82839|P2|STARTED|Overall Study||8
34113|NCT02067676|82840|P1|STARTED|Overall Study||8
34114|NCT02067611|82878|P3|NOT COMPLETED|Overall Study||4
34115|NCT02067611|82879|P2|NOT COMPLETED|Overall Study||6
34116|NCT02067611|82880|P1|NOT COMPLETED|Overall Study||6
34117|NCT02067611|82878|P3|COMPLETED|Overall Study||68
34118|NCT02067611|82879|P2|COMPLETED|Overall Study||66
34119|NCT02067611|82880|P1|COMPLETED|Overall Study||66
34120|NCT02067611|82878|P3|STARTED|Overall Study||72
34121|NCT02067611|82879|P2|STARTED|Overall Study||72
34122|NCT02067611|82880|P1|STARTED|Overall Study||72
34123|NCT02067585|82918|P3|NOT COMPLETED|Overall Study||0
34124|NCT02067585|82919|P2|NOT COMPLETED|Overall Study||0
34125|NCT02067585|82920|P1|NOT COMPLETED|Overall Study||0
34126|NCT02067585|82918|P3|COMPLETED|Overall Study||16
34127|NCT02067585|82919|P2|COMPLETED|Overall Study||16
34128|NCT02067585|82920|P1|COMPLETED|Overall Study||16
34129|NCT02067585|82918|P3|STARTED|Overall Study||16
34130|NCT02067585|82919|P2|STARTED|Overall Study||16
34131|NCT02067585|82920|P1|STARTED|Overall Study||16
34132|NCT02067533|82957|P2|NOT COMPLETED|Overall Study||2
34133|NCT02067533|82958|P1|NOT COMPLETED|Overall Study||4
34134|NCT02067533|82957|P2|COMPLETED|Overall Study||44
34135|NCT02067533|82958|P1|COMPLETED|Overall Study||41
34136|NCT02067533|82957|P2|STARTED|Overall Study||46
34137|NCT02067533|82958|P1|STARTED|Overall Study||45
34138|NCT02067273|82966|P2|NOT COMPLETED|Overall Study||3
34139|NCT02067273|82967|P1|NOT COMPLETED|Overall Study||0
34140|NCT02067273|82966|P2|COMPLETED|Overall Study||12
34141|NCT02067273|82967|P1|COMPLETED|Overall Study||5
34142|NCT02067273|82966|P2|STARTED|Overall Study||15
34143|NCT02067273|82967|P1|STARTED|Overall Study||5
34144|NCT02066922|82973|P1|NOT COMPLETED|Overall Study||1
34145|NCT02066922|82973|P1|COMPLETED|Overall Study||14
34146|NCT02066922|82973|P1|STARTED|Overall Study||15
34147|NCT02066896|82983|P2|NOT COMPLETED|Overall Study||0
34148|NCT02066896|82984|P1|NOT COMPLETED|Overall Study||0
34149|NCT02066896|82983|P2|COMPLETED|Overall Study||33
34150|NCT02066896|82984|P1|COMPLETED|Overall Study||33
34151|NCT02066896|82983|P2|STARTED|Overall Study||33
34152|NCT02066896|82984|P1|STARTED|Overall Study||33
34153|NCT02066857|82996|P2|NOT COMPLETED|Overall Study||1
34154|NCT02066857|82997|P1|NOT COMPLETED|Overall Study||1
34155|NCT02066857|82996|P2|COMPLETED|Overall Study||3
34156|NCT02066857|82997|P1|COMPLETED|Overall Study||0
34157|NCT02066857|82996|P2|STARTED|Overall Study||4
34158|NCT02066857|82997|P1|STARTED|Overall Study||1
34159|NCT02066740|83011|P1|NOT COMPLETED|Overall Study||2
34160|NCT02066740|83011|P1|COMPLETED|Overall Study||32
34161|NCT02066740|83011|P1|STARTED|Overall Study||34
34162|NCT02066727|83018|P2|NOT COMPLETED|Overall Study||0
34163|NCT02066727|83019|P1|NOT COMPLETED|Overall Study||0
34164|NCT02066727|83018|P2|COMPLETED|Overall Study||30
34165|NCT02066727|83019|P1|COMPLETED|Overall Study||30
34166|NCT02066727|83018|P2|STARTED|Overall Study||30
34167|NCT02066727|83019|P1|STARTED|Overall Study||30
34168|NCT02066402|83027|P2|NOT COMPLETED|Overall Study||23
34169|NCT02066402|83028|P1|NOT COMPLETED|Overall Study||26
34170|NCT02066402|83027|P2|COMPLETED|Overall Study||275
34171|NCT02066402|83028|P1|COMPLETED|Overall Study||274
34172|NCT02066402|83027|P2|Completed Study Treatment Period|Overall Study||256
34173|NCT02066402|83028|P1|Completed Study Treatment Period|Overall Study||261
34174|NCT02066402|83027|P2|Participants Received Treatment|Overall Study||297
34175|NCT02066402|83028|P1|Participants Received Treatment|Overall Study||292
34176|NCT02066402|83027|P2|STARTED|Overall Study||298
34177|NCT02066402|83028|P1|STARTED|Overall Study||300
34178|NCT02066233|83056|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
34179|NCT02066233|83057|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
34180|NCT02066233|83056|P2|COMPLETED|Standard Endoscopy (Day 2)||44
34181|NCT02066233|83057|P1|COMPLETED|Standard Endoscopy (Day 2)||44
34182|NCT02066233|83056|P2|STARTED|Standard Endoscopy (Day 2)||44
34183|NCT02066233|83057|P1|STARTED|Standard Endoscopy (Day 2)||44
34184|NCT02066233|83056|P2|NOT COMPLETED|EG Scan II (Day 1)||6
34185|NCT02066233|83057|P1|NOT COMPLETED|EG Scan II (Day 1)||6
34186|NCT02066233|83056|P2|COMPLETED|EG Scan II (Day 1)||44
34187|NCT02066233|83057|P1|COMPLETED|EG Scan II (Day 1)||44
34188|NCT02066233|83056|P2|STARTED|EG Scan II (Day 1)||50
34189|NCT02066233|83057|P1|STARTED|EG Scan II (Day 1)||50
34190|NCT02066051|83065|P1|NOT COMPLETED|Overall Study||1
34191|NCT02066051|83065|P1|COMPLETED|Overall Study||7
34192|NCT02066051|83065|P1|STARTED|Overall Study||8
34193|NCT02065895|83070|P6|NOT COMPLETED|Overall Study||0
34194|NCT02065895|83071|P5|NOT COMPLETED|Overall Study||0
34195|NCT02065895|83072|P4|NOT COMPLETED|Overall Study||1
34196|NCT02065895|83073|P3|NOT COMPLETED|Overall Study||0
34197|NCT02065895|83074|P2|NOT COMPLETED|Overall Study||1
34198|NCT02065895|83075|P1|NOT COMPLETED|Overall Study||1
34199|NCT02065895|83070|P6|COMPLETED|Overall Study||1
34200|NCT02065895|83071|P5|COMPLETED|Overall Study||1
34201|NCT02065895|83072|P4|COMPLETED|Overall Study||0
34202|NCT02065895|83073|P3|COMPLETED|Overall Study||1
34203|NCT02065895|83074|P2|COMPLETED|Overall Study||2
34204|NCT02065895|83075|P1|COMPLETED|Overall Study||0
34205|NCT02065895|83070|P6|STARTED|Overall Study||1
34206|NCT02065895|83071|P5|STARTED|Overall Study||1
34207|NCT02065895|83072|P4|STARTED|Overall Study||1
34208|NCT02065895|83073|P3|STARTED|Overall Study||1
34209|NCT02065895|83074|P2|STARTED|Overall Study||3
34210|NCT02065895|83075|P1|STARTED|Overall Study||1
34211|NCT02065453|83094|P2|NOT COMPLETED|Overall Study||4
34212|NCT02065453|83095|P1|NOT COMPLETED|Overall Study||3
34213|NCT02065453|83094|P2|COMPLETED|Overall Study||21
34214|NCT02065453|83095|P1|COMPLETED|Overall Study||24
34215|NCT02065453|83094|P2|STARTED|Overall Study||25
34216|NCT02065453|83095|P1|STARTED|Overall Study||27
34217|NCT02064985|83103|P3|NOT COMPLETED|Overall Study||0
34218|NCT02064985|83104|P2|NOT COMPLETED|Overall Study||0
34219|NCT02064985|83105|P1|NOT COMPLETED|Overall Study||0
34220|NCT02064985|83103|P3|COMPLETED|Overall Study||12
34221|NCT02064985|83104|P2|COMPLETED|Overall Study||12
34222|NCT02064985|83105|P1|COMPLETED|Overall Study||12
34223|NCT02064985|83103|P3|STARTED|Overall Study||12
34224|NCT02064985|83104|P2|STARTED|Overall Study||12
34225|NCT02064985|83105|P1|STARTED|Overall Study||12
34226|NCT02064920|83268|P2|NOT COMPLETED|Overall Study||9
34227|NCT02064920|83269|P1|NOT COMPLETED|Overall Study||1
34228|NCT02064920|83268|P2|COMPLETED|Overall Study||21
34229|NCT02064920|83269|P1|COMPLETED|Overall Study||5
34230|NCT02064920|83268|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
34231|NCT02064920|83269|P1|Treated|Overall Study||6
34232|NCT02064920|83268|P2|STARTED|Overall Study||30
34233|NCT02064920|83269|P1|STARTED|Overall Study||6
34234|NCT02064907|83279|P2|NOT COMPLETED|Period 2||0
34235|NCT02064907|83280|P1|NOT COMPLETED|Period 2||0
34236|NCT02064907|83279|P2|COMPLETED|Period 2||26
34237|NCT02064907|83280|P1|COMPLETED|Period 2||26
34238|NCT02064907|83279|P2|STARTED|Period 2||26
34239|NCT02064907|83280|P1|STARTED|Period 2||26
34240|NCT02064907|83279|P2|NOT COMPLETED|Period 1||0
34241|NCT02064907|83280|P1|NOT COMPLETED|Period 1||0
34242|NCT02064907|83279|P2|COMPLETED|Period 1||26
34243|NCT02064907|83280|P1|COMPLETED|Period 1||26
34244|NCT02064907|83279|P2|STARTED|Period 1||26
34245|NCT02064907|83280|P1|STARTED|Period 1||26
34246|NCT02064894|83299|P3|NOT COMPLETED|Overall Study||115
34247|NCT02064894|83300|P2|NOT COMPLETED|Overall Study||102
34248|NCT02064894|83301|P1|NOT COMPLETED|Overall Study||43
34249|NCT02064894|83299|P3|COMPLETED|Overall Study||86
34250|NCT02064894|83300|P2|COMPLETED|Overall Study||99
34251|NCT02064894|83301|P1|COMPLETED|Overall Study||56
34252|NCT02064894|83299|P3|Avalaible at T-90|Overall Study||129
34253|NCT02064894|83300|P2|Avalaible at T-90|Overall Study||134
34254|NCT02064894|83301|P1|Avalaible at T-90|Overall Study||74
34255|NCT02064894|83299|P3|Available at T-60|Overall Study||177
34256|NCT02064894|83300|P2|Available at T-60|Overall Study||188
34257|NCT02064894|83301|P1|Available at T-60|Overall Study||91
34258|NCT02064894|83299|P3|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
34259|NCT02064894|83300|P2|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
34260|NCT02064894|83301|P1|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
34261|NCT02064439|83315|P3|NOT COMPLETED|Overall Study||182
34262|NCT02064439|83316|P2|NOT COMPLETED|Overall Study||138
34263|NCT02064439|83317|P1|NOT COMPLETED|Overall Study||143
34264|NCT02064439|83315|P3|COMPLETED|Overall Study||949
34265|NCT02064439|83316|P2|COMPLETED|Overall Study||969
34266|NCT02064439|83317|P1|COMPLETED|Overall Study||984
34267|NCT02064439|83315|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
34268|NCT02064439|83316|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
34269|NCT02064439|83317|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
34270|NCT02064270|83336|P2|NOT COMPLETED|Overall Study||32
34271|NCT02064270|83337|P1|NOT COMPLETED|Overall Study||62
34272|NCT02064270|83336|P2|COMPLETED|Overall Study||231
34273|NCT02064270|83337|P1|COMPLETED|Overall Study||201
34274|NCT02064270|83336|P2|STARTED|Overall Study||263
34275|NCT02064270|83337|P1|STARTED|Overall Study||263
34276|NCT02064231|83352|P4|NOT COMPLETED|Third Test Period (Own Product)||0
34277|NCT02064231|83353|P3|NOT COMPLETED|Third Test Period (Own Product)||0
34278|NCT02064231|83354|P2|NOT COMPLETED|Third Test Period (Own Product)||0
34279|NCT02064231|83355|P1|NOT COMPLETED|Third Test Period (Own Product)||0
34280|NCT02064231|83352|P4|COMPLETED|Third Test Period (Own Product)||1
34281|NCT02064231|83353|P3|COMPLETED|Third Test Period (Own Product)||0
34282|NCT02064231|83354|P2|COMPLETED|Third Test Period (Own Product)||8
34283|NCT02064231|83355|P1|COMPLETED|Third Test Period (Own Product)||8
34284|NCT02064231|83352|P4|STARTED|Third Test Period (Own Product)||1
34285|NCT02064231|83353|P3|STARTED|Third Test Period (Own Product)||0
34286|NCT02064231|83354|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
34287|NCT02064231|83355|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
34288|NCT02064231|83352|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
34289|NCT02064231|83353|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
34290|NCT02064231|83354|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
34291|NCT02064231|83355|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
34292|NCT02064231|83352|P4|COMPLETED|Second Test Period (Test B or Test D)||1
34293|NCT02064231|83353|P3|COMPLETED|Second Test Period (Test B or Test D)||0
34294|NCT02064231|83354|P2|COMPLETED|Second Test Period (Test B or Test D)||7
34295|NCT02064231|83355|P1|COMPLETED|Second Test Period (Test B or Test D)||6
34296|NCT02064231|83352|P4|STARTED|Second Test Period (Test B or Test D)||1
34297|NCT02064231|83353|P3|STARTED|Second Test Period (Test B or Test D)||0
34298|NCT02064231|83354|P2|STARTED|Second Test Period (Test B or Test D)||8
34299|NCT02064231|83355|P1|STARTED|Second Test Period (Test B or Test D)||7
34300|NCT02064231|83352|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
34301|NCT02064231|83353|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
34302|NCT02064231|83354|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
34303|NCT02064231|83355|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
34304|NCT02064231|83352|P4|COMPLETED|First Test Period (Test A or Test C)||1
34305|NCT02064231|83353|P3|COMPLETED|First Test Period (Test A or Test C)||0
34306|NCT02064231|83354|P2|COMPLETED|First Test Period (Test A or Test C)||8
34307|NCT02064231|83355|P1|COMPLETED|First Test Period (Test A or Test C)||7
34308|NCT02064231|83352|P4|STARTED|First Test Period (Test A or Test C)||1
34309|NCT02064231|83353|P3|STARTED|First Test Period (Test A or Test C)||1
34310|NCT02064231|83354|P2|STARTED|First Test Period (Test A or Test C)||12
34311|NCT02064231|83355|P1|STARTED|First Test Period (Test A or Test C)||14
34312|NCT02064205|83367|P1|NOT COMPLETED|Overall Study||1
34313|NCT02064205|83367|P1|COMPLETED|Overall Study||31
34314|NCT02064205|83367|P1|Condition D|Overall Study||32
34315|NCT02064205|83367|P1|Condition C|Overall Study||31
34316|NCT02064205|83367|P1|Condition B|Overall Study||32
34317|NCT02064205|83367|P1|Condition A|Overall Study||32
34318|NCT02064205|83367|P1|STARTED|Overall Study||32
34319|NCT02063880|83385|P2|NOT COMPLETED|Overall Study||27
34320|NCT02063880|83386|P1|NOT COMPLETED|Overall Study||28
34321|NCT02063880|83385|P2|COMPLETED|Overall Study||66
34322|NCT02063880|83386|P1|COMPLETED|Overall Study||62
34323|NCT02063880|83385|P2|STARTED|Overall Study||93
34324|NCT02063880|83386|P1|STARTED|Overall Study||90
34325|NCT02063854|83403|P7|NOT COMPLETED|Overall Study||6
34326|NCT02063854|83404|P6|NOT COMPLETED|Overall Study||31
34327|NCT02063854|83405|P5|NOT COMPLETED|Overall Study||11
34328|NCT02063854|83406|P4|NOT COMPLETED|Overall Study||10
34329|NCT02063854|83407|P3|NOT COMPLETED|Overall Study||30
34330|NCT02063854|83408|P2|NOT COMPLETED|Overall Study||12
34331|NCT02063854|83409|P1|NOT COMPLETED|Overall Study||21
34332|NCT02063854|83403|P7|COMPLETED|Overall Study||60
34333|NCT02063854|83404|P6|COMPLETED|Overall Study||170
34334|NCT02063854|83405|P5|COMPLETED|Overall Study||54
34335|NCT02063854|83406|P4|COMPLETED|Overall Study||58
34336|NCT02063854|83407|P3|COMPLETED|Overall Study||176
34337|NCT02063854|83408|P2|COMPLETED|Overall Study||54
34338|NCT02063854|83409|P1|COMPLETED|Overall Study||178
34339|NCT02063854|83403|P7|Full Analysis Set: Received Study Drug|Overall Study||66
34340|NCT02063854|83404|P6|Full Analysis Set: Received Study Drug|Overall Study||200
34341|NCT02063854|83405|P5|Full Analysis Set: Received Study Drug|Overall Study||65
34342|NCT02063854|83406|P4|Full Analysis Set: Received Study Drug|Overall Study||68
34343|NCT02063854|83407|P3|Full Analysis Set: Received Study Drug|Overall Study||206
34344|NCT02063854|83408|P2|Full Analysis Set: Received Study Drug|Overall Study||66
34345|NCT02063854|83409|P1|Full Analysis Set: Received Study Drug|Overall Study||199
34346|NCT02063854|83403|P7|STARTED|Overall Study||66
34347|NCT02063854|83404|P6|STARTED|Overall Study||201
34348|NCT02063854|83405|P5|STARTED|Overall Study||65
34349|NCT02063854|83406|P4|STARTED|Overall Study||68
34350|NCT02063854|83407|P3|STARTED|Overall Study||206
34351|NCT02063854|83408|P2|STARTED|Overall Study||66
34352|NCT02063854|83409|P1|STARTED|Overall Study||199
34353|NCT02063737|83493|P2|NOT COMPLETED|Overall Study||4
34354|NCT02063737|83494|P1|NOT COMPLETED|Overall Study||11
34355|NCT02063737|83493|P2|COMPLETED|Overall Study||44
34356|NCT02063737|83494|P1|COMPLETED|Overall Study||41
34357|NCT02063737|83493|P2|STARTED|Overall Study||48
34358|NCT02063737|83494|P1|STARTED|Overall Study||52
34359|NCT02063672|83528|P2|NOT COMPLETED|Overall Study||22
34360|NCT02063672|83529|P1|NOT COMPLETED|Overall Study||35
34361|NCT02063672|83528|P2|COMPLETED|Overall Study||7
34362|NCT02063672|83529|P1|COMPLETED|Overall Study||18
34363|NCT02063672|83528|P2|STARTED|Overall Study||29
34364|NCT02063672|83529|P1|STARTED|Overall Study||53
34365|NCT02063659|83576|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
34366|NCT02063659|83577|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
34367|NCT02063659|83578|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
34368|NCT02063659|83579|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
34369|NCT02063659|83576|P4|COMPLETED|Open-Label Extension Period (OLE)||47
34370|NCT02063659|83577|P3|COMPLETED|Open-Label Extension Period (OLE)||0
34371|NCT02063659|83578|P2|COMPLETED|Open-Label Extension Period (OLE)||0
34372|NCT02063659|83579|P1|COMPLETED|Open-Label Extension Period (OLE)||0
34373|NCT02063659|83576|P4|STARTED|Open-Label Extension Period (OLE)||67
34374|NCT02063659|83577|P3|STARTED|Open-Label Extension Period (OLE)||0
34375|NCT02063659|83578|P2|STARTED|Open-Label Extension Period (OLE)||0
34376|NCT02063659|83579|P1|STARTED|Open-Label Extension Period (OLE)||0
34377|NCT02063659|83576|P4|NOT COMPLETED|Double-Blind Treatment Period||0
34378|NCT02063659|83577|P3|NOT COMPLETED|Double-Blind Treatment Period||3
34379|NCT02063659|83578|P2|NOT COMPLETED|Double-Blind Treatment Period||3
34380|NCT02063659|83579|P1|NOT COMPLETED|Double-Blind Treatment Period||2
34381|NCT02063659|83576|P4|COMPLETED|Double-Blind Treatment Period||0
34382|NCT02063659|83577|P3|COMPLETED|Double-Blind Treatment Period||22
34383|NCT02063659|83578|P2|COMPLETED|Double-Blind Treatment Period||22
34384|NCT02063659|83579|P1|COMPLETED|Double-Blind Treatment Period||24
34385|NCT02063659|83576|P4|STARTED|Double-Blind Treatment Period||0
34386|NCT02063659|83577|P3|STARTED|Double-Blind Treatment Period||25
34387|NCT02063659|83578|P2|STARTED|Double-Blind Treatment Period||25
34388|NCT02063659|83579|P1|STARTED|Double-Blind Treatment Period||26
34389|NCT02063516|83611|P2|NOT COMPLETED|Overall Study||0
34390|NCT02063516|83612|P1|NOT COMPLETED|Overall Study||0
34391|NCT02063516|83611|P2|COMPLETED|Overall Study||40
34392|NCT02063516|83612|P1|COMPLETED|Overall Study||40
34393|NCT02063516|83611|P2|STARTED|Overall Study||40
34394|NCT02063516|83612|P1|STARTED|Overall Study||40
34395|NCT02063230|83626|P4|NOT COMPLETED|Overall Study||0
34396|NCT02063230|83627|P3|NOT COMPLETED|Overall Study||0
34397|NCT02063230|83628|P2|NOT COMPLETED|Overall Study||0
34398|NCT02063230|83629|P1|NOT COMPLETED|Overall Study||0
34399|NCT02063230|83626|P4|COMPLETED|Overall Study||8
34400|NCT02063230|83627|P3|COMPLETED|Overall Study||8
34401|NCT02063230|83628|P2|COMPLETED|Overall Study||8
34402|NCT02063230|83629|P1|COMPLETED|Overall Study||8
34403|NCT02063230|83626|P4|Received Treatment|Overall Study||8
34404|NCT02063230|83627|P3|Received Treatment|Overall Study||8
34405|NCT02063230|83628|P2|Received Treatment|Overall Study||8
34406|NCT02063230|83629|P1|Received Treatment|Overall Study||8
34407|NCT02063230|83626|P4|STARTED|Overall Study||8
34408|NCT02063230|83627|P3|STARTED|Overall Study||8
34409|NCT02063230|83628|P2|STARTED|Overall Study||8
34410|NCT02063230|83629|P1|STARTED|Overall Study||8
34411|NCT02063217|83662|P3|NOT COMPLETED|Overall Study||0
34412|NCT02063217|83663|P2|NOT COMPLETED|Overall Study||0
34413|NCT02063217|83664|P1|NOT COMPLETED|Overall Study||1
34414|NCT02063217|83662|P3|COMPLETED|Overall Study||12
34415|NCT02063217|83663|P2|COMPLETED|Overall Study||12
34416|NCT02063217|83664|P1|COMPLETED|Overall Study||11
34417|NCT02063217|83662|P3|STARTED|Overall Study||12
34418|NCT02063217|83663|P2|STARTED|Overall Study||12
34419|NCT02063217|83664|P1|STARTED|Overall Study||12
34420|NCT02063035|83674|P2|NOT COMPLETED|Overall Study||0
34421|NCT02063035|83675|P1|NOT COMPLETED|Overall Study||0
34422|NCT02063035|83674|P2|COMPLETED|Overall Study||17
34423|NCT02063035|83675|P1|COMPLETED|Overall Study||12
34424|NCT02063035|83674|P2|STARTED|Overall Study||17
34425|NCT02063035|83675|P1|STARTED|Overall Study||12
34426|NCT02062905|83689|P2|NOT COMPLETED|Overall Study||2
34427|NCT02062905|83690|P1|NOT COMPLETED|Overall Study||7
34428|NCT02062905|83689|P2|COMPLETED|Overall Study||31
34429|NCT02062905|83690|P1|COMPLETED|Overall Study||28
34430|NCT02062905|83689|P2|STARTED|Overall Study||33
34431|NCT02062905|83690|P1|STARTED|Overall Study||35
34432|NCT02062879|83700|P2|NOT COMPLETED|Overall Study||1
34433|NCT02062879|83701|P1|NOT COMPLETED|Overall Study||4
34434|NCT02062879|83700|P2|COMPLETED|Overall Study||9
34435|NCT02062879|83701|P1|COMPLETED|Overall Study||6
34436|NCT02062879|83700|P2|STARTED|Overall Study||10
34437|NCT02062879|83701|P1|STARTED|Overall Study||10
34438|NCT02062801|83713|P2|NOT COMPLETED|Overall Study||4
34439|NCT02062801|83714|P1|NOT COMPLETED|Overall Study||2
34440|NCT02062801|83713|P2|COMPLETED|Overall Study||297
34441|NCT02062801|83714|P1|COMPLETED|Overall Study||299
34442|NCT02062801|83713|P2|STARTED|Overall Study||301
34443|NCT02062801|83714|P1|STARTED|Overall Study||301
34444|NCT02062710|83724|P6|NOT COMPLETED|Overall Study||0
34445|NCT02062710|83725|P5|NOT COMPLETED|Overall Study||0
34446|NCT02062710|83726|P4|NOT COMPLETED|Overall Study||0
34447|NCT02062710|83727|P3|NOT COMPLETED|Overall Study||0
34448|NCT02062710|83728|P2|NOT COMPLETED|Overall Study||0
34449|NCT02062710|83729|P1|NOT COMPLETED|Overall Study||0
34450|NCT02062710|83724|P6|COMPLETED|Overall Study||4
34451|NCT02062710|83725|P5|COMPLETED|Overall Study||3
34452|NCT02062710|83726|P4|COMPLETED|Overall Study||3
34453|NCT02062710|83727|P3|COMPLETED|Overall Study||5
34454|NCT02062710|83728|P2|COMPLETED|Overall Study||4
34455|NCT02062710|83729|P1|COMPLETED|Overall Study||3
34456|NCT02062710|83724|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
34457|NCT02062710|83725|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
34458|NCT02062710|83726|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
34459|NCT02062710|83727|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
34460|NCT02062710|83728|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
34461|NCT02062710|83729|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
34462|NCT02062658|83737|P1|NOT COMPLETED|Overall Study||2
34463|NCT02062658|83737|P1|COMPLETED|Overall Study||8
34464|NCT02062658|83737|P1|STARTED|Overall Study||10
34465|NCT02062645|83741|P1|NOT COMPLETED|Overall Study||15
34466|NCT02062645|83741|P1|COMPLETED|Overall Study||100
34467|NCT02062645|83741|P1|STARTED|Overall Study||115
34468|NCT02062580|83751|P2|NOT COMPLETED|Overall Study||13
34469|NCT02062580|83752|P1|NOT COMPLETED|Overall Study||12
34470|NCT02062580|83751|P2|COMPLETED|Overall Study||65
34471|NCT02062580|83752|P1|COMPLETED|Overall Study||59
34472|NCT02062580|83751|P2|STARTED|Overall Study||78
34473|NCT02062580|83752|P1|STARTED|Overall Study||71
34474|NCT02062502|83762|P2|NOT COMPLETED|Overall Study||35
34475|NCT02062502|83763|P1|NOT COMPLETED|Overall Study||43
34476|NCT02062502|83762|P2|COMPLETED|Overall Study||270
34477|NCT02062502|83763|P1|COMPLETED|Overall Study||263
34478|NCT02062502|83762|P2|Vaccinated Dose 1|Overall Study||305
34479|NCT02062502|83763|P1|Vaccinated Dose 1|Overall Study||306
34480|NCT02062502|83762|P2|STARTED|Overall Study||305
34481|NCT02062502|83763|P1|STARTED|Overall Study||306
34482|NCT02062450|83783|P1|NOT COMPLETED|Overall Study||124
34483|NCT02062450|83783|P1|COMPLETED|Overall Study||255
34484|NCT02062450|83783|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
34485|NCT02062450|83783|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
34486|NCT02062437|83797|P1|NOT COMPLETED|Overall Study||52
34487|NCT02062437|83797|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
34488|NCT02062437|83797|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
34489|NCT02062385|83810|P4|NOT COMPLETED|Overall Study||9
34490|NCT02062385|83811|P3|NOT COMPLETED|Overall Study||12
34491|NCT02062385|83812|P2|NOT COMPLETED|Overall Study||65
34492|NCT02062385|83813|P1|NOT COMPLETED|Overall Study||78
34493|NCT02062385|83810|P4|COMPLETED|Overall Study||391
34494|NCT02062385|83811|P3|COMPLETED|Overall Study||388
34495|NCT02062385|83812|P2|COMPLETED|Overall Study||1555
34496|NCT02062385|83813|P1|COMPLETED|Overall Study||1542
34497|NCT02062385|83810|P4|Received Vaccination 3|Overall Study||392
34498|NCT02062385|83811|P3|Received Vaccination 3|Overall Study||389
34499|NCT02062385|83812|P2|Received Vaccination 3|Overall Study||1554
34500|NCT02062385|83813|P1|Received Vaccination 3|Overall Study||1543
34501|NCT02062385|83810|P4|Received Vaccination 2|Overall Study||393
34502|NCT02062385|83811|P3|Received Vaccination 2|Overall Study||392
34503|NCT02062385|83812|P2|Received Vaccination 2|Overall Study||1566
34504|NCT02062385|83813|P1|Received Vaccination 2|Overall Study||1554
34505|NCT02062385|83810|P4|Received Vaccination 1|Overall Study||400
34506|NCT02062385|83811|P3|Received Vaccination 1|Overall Study||400
34507|NCT02062385|83812|P2|Received Vaccination 1|Overall Study||1619
34508|NCT02062385|83813|P1|Received Vaccination 1|Overall Study||1618
34509|NCT02062385|83810|P4|STARTED|Overall Study||400
34510|NCT02062385|83811|P3|STARTED|Overall Study||400
34511|NCT02062385|83812|P2|STARTED|Overall Study||1620
34512|NCT02062385|83813|P1|STARTED|Overall Study||1620
34513|NCT02062359|83833|P1|NOT COMPLETED|Overall Study||0
34514|NCT02062359|83833|P1|COMPLETED|Overall Study||2
34515|NCT02062359|83833|P1|STARTED|Overall Study||2
34516|NCT02062294|83839|P1|NOT COMPLETED|Overall Study||0
34517|NCT02062294|83839|P1|COMPLETED|Overall Study||14
34518|NCT02062294|83839|P1|STARTED|Overall Study||14
34519|NCT02062177|83846|P2|NOT COMPLETED|Overall Study||0
34520|NCT02062177|83847|P1|NOT COMPLETED|Overall Study||0
34521|NCT02062177|83846|P2|COMPLETED|Overall Study||70
34522|NCT02062177|83847|P1|COMPLETED|Overall Study||70
34523|NCT02062177|83846|P2|STARTED|Overall Study||70
34524|NCT02062177|83847|P1|STARTED|Overall Study||70
34525|NCT02061748|83859|P2|NOT COMPLETED|Overall Study||0
34526|NCT02061748|83860|P1|NOT COMPLETED|Overall Study||0
34527|NCT02061748|83859|P2|COMPLETED|Overall Study||30853
34528|NCT02061748|83860|P1|COMPLETED|Overall Study||7646
34529|NCT02061748|83859|P2|STARTED|Overall Study||30853
34530|NCT02061748|83860|P1|STARTED|Overall Study||7646
34531|NCT02061696|83934|P2|NOT COMPLETED|Overall Study||0
34532|NCT02061696|83935|P1|NOT COMPLETED|Overall Study||0
34533|NCT02061696|83934|P2|COMPLETED|Overall Study||22
34534|NCT02061696|83935|P1|COMPLETED|Overall Study||17
34535|NCT02061696|83934|P2|STARTED|Overall Study||22
34536|NCT02061696|83935|P1|STARTED|Overall Study||17
34537|NCT02061683|83959|P1|NOT COMPLETED|Overall Study||60
34538|NCT02061683|83959|P1|COMPLETED|Overall Study||203
34539|NCT02061683|83959|P1|STARTED|Overall Study||263
34540|NCT02061592|83966|P2|NOT COMPLETED|Period 2||1
34541|NCT02061592|83967|P1|NOT COMPLETED|Period 2||0
34542|NCT02061592|83966|P2|COMPLETED|Period 2||61
34543|NCT02061592|83967|P1|COMPLETED|Period 2||64
34544|NCT02061592|83966|P2|STARTED|Period 2||62
34545|NCT02061592|83967|P1|STARTED|Period 2||64
34546|NCT02061592|83966|P2|NOT COMPLETED|Period 1||0
34547|NCT02061592|83967|P1|NOT COMPLETED|Period 1||2
34548|NCT02061592|83966|P2|COMPLETED|Period 1||62
34549|NCT02061592|83967|P1|COMPLETED|Period 1||64
34550|NCT02061592|83966|P2|STARTED|Period 1||62
34551|NCT02061592|83967|P1|STARTED|Period 1||66
34552|NCT02061540|83979|P1|NOT COMPLETED|Overall Study||4
34553|NCT02061540|83979|P1|COMPLETED|Overall Study||23
34554|NCT02061540|83979|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
34555|NCT02061540|83979|P1|STARTED|Overall Study||27
34556|NCT02061358|84001|P9|NOT COMPLETED|Overall Study||0
34557|NCT02061358|84002|P8|NOT COMPLETED|Overall Study||0
34558|NCT02061358|84003|P7|NOT COMPLETED|Overall Study||0
34559|NCT02061358|84004|P6|NOT COMPLETED|Overall Study||0
34560|NCT02061358|84005|P5|NOT COMPLETED|Overall Study||0
34561|NCT02061358|84006|P4|NOT COMPLETED|Overall Study||0
34562|NCT02061358|84007|P3|NOT COMPLETED|Overall Study||0
34563|NCT02061358|84008|P2|NOT COMPLETED|Overall Study||0
34564|NCT02061358|84009|P1|NOT COMPLETED|Overall Study||0
34565|NCT02061358|84001|P9|COMPLETED|Overall Study||16
34566|NCT02061358|84002|P8|COMPLETED|Overall Study||6
34567|NCT02061358|84003|P7|COMPLETED|Overall Study||6
34568|NCT02061358|84004|P6|COMPLETED|Overall Study||6
34569|NCT02061358|84005|P5|COMPLETED|Overall Study||6
34570|NCT02061358|84006|P4|COMPLETED|Overall Study||6
34571|NCT02061358|84007|P3|COMPLETED|Overall Study||6
34572|NCT02061358|84008|P2|COMPLETED|Overall Study||6
34573|NCT02061358|84009|P1|COMPLETED|Overall Study||6
34574|NCT02061358|84001|P9|STARTED|Overall Study||16
34575|NCT02061358|84002|P8|STARTED|Overall Study||6
34576|NCT02061358|84003|P7|STARTED|Overall Study||6
34577|NCT02061358|84004|P6|STARTED|Overall Study||6
34578|NCT02061358|84005|P5|STARTED|Overall Study||6
34579|NCT02061358|84006|P4|STARTED|Overall Study||6
34580|NCT02061358|84007|P3|STARTED|Overall Study||6
34581|NCT02061358|84008|P2|STARTED|Overall Study||6
34582|NCT02061358|84009|P1|STARTED|Overall Study||6
34583|NCT02061280|84147|P2|NOT COMPLETED|Overall Study||12
34584|NCT02061280|84148|P1|NOT COMPLETED|Overall Study||18
34585|NCT02061280|84147|P2|COMPLETED|Overall Study||25
34586|NCT02061280|84148|P1|COMPLETED|Overall Study||53
34587|NCT02061280|84147|P2|Randomized to Treatment|Overall Study||25
34588|NCT02061280|84148|P1|Randomized to Treatment|Overall Study||54
34589|NCT02061280|84147|P2|STARTED|Overall Study||37
34590|NCT02061280|84148|P1|STARTED|Overall Study||71
34591|NCT02060890|84160|P1|NOT COMPLETED|Overall Study||4
34592|NCT02060890|84160|P1|COMPLETED|Overall Study||16
34593|NCT02060890|84160|P1|STARTED|Overall Study||20
34594|NCT02060838|84169|P2|NOT COMPLETED|Overall Study||0
34595|NCT02060838|84170|P1|NOT COMPLETED|Overall Study||0
34596|NCT02060838|84169|P2|COMPLETED|Overall Study||22
34597|NCT02060838|84170|P1|COMPLETED|Overall Study||28
34598|NCT02060838|84169|P2|STARTED|Overall Study||22
34599|NCT02060838|84170|P1|STARTED|Overall Study||28
34600|NCT02060539|84178|P1|NOT COMPLETED|Overall Study||0
34601|NCT02060539|84178|P1|COMPLETED|Overall Study||19
34602|NCT02060539|84178|P1|STARTED|Overall Study||19
34603|NCT02060526|84226|P3|NOT COMPLETED|Overall Study||0
34604|NCT02060526|84227|P2|NOT COMPLETED|Overall Study||0
34605|NCT02060526|84228|P1|NOT COMPLETED|Overall Study||0
34606|NCT02060526|84226|P3|COMPLETED|Overall Study||7
34607|NCT02060526|84227|P2|COMPLETED|Overall Study||7
34608|NCT02060526|84228|P1|COMPLETED|Overall Study||7
34609|NCT02060526|84226|P3|STARTED|Overall Study||7
34610|NCT02060526|84227|P2|STARTED|Overall Study||7
34611|NCT02060526|84228|P1|STARTED|Overall Study||7
34612|NCT02060461|84264|P1|NOT COMPLETED|Overall Study||0
34613|NCT02060461|84264|P1|COMPLETED|Overall Study||33
34614|NCT02060461|84264|P1|STARTED|Overall Study||33
34615|NCT02060058|84273|P3|NOT COMPLETED|Overall Study||0
34616|NCT02060058|84274|P2|NOT COMPLETED|Overall Study||0
34617|NCT02060058|84275|P1|NOT COMPLETED|Overall Study||0
34618|NCT02060058|84273|P3|COMPLETED|Overall Study||8
34619|NCT02060058|84274|P2|COMPLETED|Overall Study||0
34620|NCT02060058|84275|P1|COMPLETED|Overall Study||4
34621|NCT02060058|84273|P3|STARTED|Overall Study||8
34622|NCT02060058|84274|P2|STARTED|Overall Study||0
34623|NCT02060058|84275|P1|STARTED|Overall Study||4
34624|NCT02059993|84291|P2|NOT COMPLETED|Overall Study||4
34625|NCT02059993|84292|P1|NOT COMPLETED|Overall Study||2
34626|NCT02059993|84291|P2|COMPLETED|Overall Study||37
34627|NCT02059993|84292|P1|COMPLETED|Overall Study||40
34628|NCT02059993|84291|P2|STARTED|Overall Study||41
34629|NCT02059993|84292|P1|STARTED|Overall Study||42
34630|NCT02059928|84298|P1|NOT COMPLETED|Overall Study||0
34631|NCT02059928|84298|P1|COMPLETED|Overall Study||20
34632|NCT02059928|84298|P1|STARTED|Overall Study||20
34633|NCT02059902|84304|P2|NOT COMPLETED|Overall Study||4
34634|NCT02059902|84305|P1|NOT COMPLETED|Overall Study||4
34635|NCT02059902|84304|P2|COMPLETED|Overall Study||14
34636|NCT02059902|84305|P1|COMPLETED|Overall Study||14
34637|NCT02059902|84304|P2|STARTED|Overall Study||18
34638|NCT02059902|84305|P1|STARTED|Overall Study||18
34639|NCT02059642|84313|P2|NOT COMPLETED|Overall Study||24
34640|NCT02059642|84314|P1|NOT COMPLETED|Overall Study||27
34641|NCT02059642|84313|P2|COMPLETED|Overall Study||128
34642|NCT02059642|84314|P1|COMPLETED|Overall Study||121
34643|NCT02059642|84313|P2|STARTED|Overall Study||152
34644|NCT02059642|84314|P1|STARTED|Overall Study||148
34645|NCT02059395|84324|P2|NOT COMPLETED|Overall Study||4
34646|NCT02059395|84325|P1|NOT COMPLETED|Overall Study||2
34647|NCT02059395|84324|P2|COMPLETED|Overall Study||23
34648|NCT02059395|84325|P1|COMPLETED|Overall Study||20
34649|NCT02059395|84324|P2|STARTED|Overall Study||27
34650|NCT02059395|84325|P1|STARTED|Overall Study||22
34651|NCT02059291|84340|P25|NOT COMPLETED|Epoch 4||0
34652|NCT02059291|84341|P24|NOT COMPLETED|Epoch 4||1
34653|NCT02059291|84342|P23|NOT COMPLETED|Epoch 4||1
34654|NCT02059291|84343|P22|NOT COMPLETED|Epoch 4||0
34655|NCT02059291|84344|P21|NOT COMPLETED|Epoch 4||1
34656|NCT02059291|84345|P20|NOT COMPLETED|Epoch 4||0
34657|NCT02059291|84346|P19|NOT COMPLETED|Epoch 4||0
34658|NCT02059291|84347|P18|NOT COMPLETED|Epoch 4||0
34659|NCT02059291|84348|P17|NOT COMPLETED|Epoch 4||2
34660|NCT02059291|84349|P16|NOT COMPLETED|Epoch 4||0
34661|NCT02059291|84350|P15|NOT COMPLETED|Epoch 4||0
34662|NCT02059291|84351|P14|NOT COMPLETED|Epoch 4||0
34663|NCT02059291|84352|P13|NOT COMPLETED|Epoch 4||0
34664|NCT02059291|84353|P12|NOT COMPLETED|Epoch 4||0
34665|NCT02059291|84354|P11|NOT COMPLETED|Epoch 4||0
34666|NCT02059291|84355|P10|NOT COMPLETED|Epoch 4||0
34667|NCT02059291|84356|P9|NOT COMPLETED|Epoch 4||0
34668|NCT02059291|84357|P8|NOT COMPLETED|Epoch 4||0
34669|NCT02059291|84358|P7|NOT COMPLETED|Epoch 4||0
34670|NCT02059291|84359|P6|NOT COMPLETED|Epoch 4||0
34671|NCT02059291|84360|P5|NOT COMPLETED|Epoch 4||0
34672|NCT02059291|84361|P4|NOT COMPLETED|Epoch 4||0
34673|NCT02059291|84362|P3|NOT COMPLETED|Epoch 4||0
34674|NCT02059291|84363|P2|NOT COMPLETED|Epoch 4||0
34675|NCT02059291|84364|P1|NOT COMPLETED|Epoch 4||0
34676|NCT02059291|84340|P25|COMPLETED|Epoch 4||0
34677|NCT02059291|84341|P24|COMPLETED|Epoch 4||21
34678|NCT02059291|84342|P23|COMPLETED|Epoch 4||30
34679|NCT02059291|84343|P22|COMPLETED|Epoch 4||14
34680|NCT02059291|84344|P21|COMPLETED|Epoch 4||33
34681|NCT02059291|84345|P20|COMPLETED|Epoch 4||18
34682|NCT02059291|84346|P19|COMPLETED|Epoch 4||2
34683|NCT02059291|84347|P18|COMPLETED|Epoch 4||14
34684|NCT02059291|84348|P17|COMPLETED|Epoch 4||41
34685|NCT02059291|84349|P16|COMPLETED|Epoch 4||0
34686|NCT02059291|84350|P15|COMPLETED|Epoch 4||0
34687|NCT02059291|84351|P14|COMPLETED|Epoch 4||0
34688|NCT02059291|84352|P13|COMPLETED|Epoch 4||0
34689|NCT02059291|84353|P12|COMPLETED|Epoch 4||0
34690|NCT02059291|84354|P11|COMPLETED|Epoch 4||0
34691|NCT02059291|84355|P10|COMPLETED|Epoch 4||0
34692|NCT02059291|84356|P9|COMPLETED|Epoch 4||0
34693|NCT02059291|84357|P8|COMPLETED|Epoch 4||0
34694|NCT02059291|84358|P7|COMPLETED|Epoch 4||0
34695|NCT02059291|84359|P6|COMPLETED|Epoch 4||0
34696|NCT02059291|84360|P5|COMPLETED|Epoch 4||0
34697|NCT02059291|84361|P4|COMPLETED|Epoch 4||0
34698|NCT02059291|84362|P3|COMPLETED|Epoch 4||0
34699|NCT02059291|84363|P2|COMPLETED|Epoch 4||0
34700|NCT02059291|84364|P1|COMPLETED|Epoch 4||0
34701|NCT02059291|84340|P25|STARTED|Epoch 4||0
34702|NCT02059291|84341|P24|STARTED|Epoch 4||22
34703|NCT02059291|84342|P23|STARTED|Epoch 4||31
34704|NCT02059291|84343|P22|STARTED|Epoch 4||14
34705|NCT02059291|84344|P21|STARTED|Epoch 4||34
34706|NCT02059291|84345|P20|STARTED|Epoch 4||18
34707|NCT02059291|84346|P19|STARTED|Epoch 4||2
34708|NCT02059291|84347|P18|STARTED|Epoch 4||14
34709|NCT02059291|84348|P17|STARTED|Epoch 4||43
34710|NCT02059291|84349|P16|STARTED|Epoch 4||0
34711|NCT02059291|84350|P15|STARTED|Epoch 4||0
34712|NCT02059291|84351|P14|STARTED|Epoch 4||0
34713|NCT02059291|84352|P13|STARTED|Epoch 4||0
34714|NCT02059291|84353|P12|STARTED|Epoch 4||0
34715|NCT02059291|84354|P11|STARTED|Epoch 4||0
34716|NCT02059291|84355|P10|STARTED|Epoch 4||0
34717|NCT02059291|84356|P9|STARTED|Epoch 4||0
34718|NCT02059291|84357|P8|STARTED|Epoch 4||0
34719|NCT02059291|84358|P7|STARTED|Epoch 4||0
34720|NCT02059291|84359|P6|STARTED|Epoch 4||0
34721|NCT02059291|84360|P5|STARTED|Epoch 4||0
34722|NCT02059291|84361|P4|STARTED|Epoch 4||0
34723|NCT02059291|84362|P3|STARTED|Epoch 4||0
34724|NCT02059291|84363|P2|STARTED|Epoch 4||0
34725|NCT02059291|84364|P1|STARTED|Epoch 4||0
34726|NCT02059291|84340|P25|NOT COMPLETED|Epoch 3||0
34727|NCT02059291|84341|P24|NOT COMPLETED|Epoch 3||0
34728|NCT02059291|84342|P23|NOT COMPLETED|Epoch 3||0
34729|NCT02059291|84343|P22|NOT COMPLETED|Epoch 3||0
34730|NCT02059291|84344|P21|NOT COMPLETED|Epoch 3||0
34731|NCT02059291|84345|P20|NOT COMPLETED|Epoch 3||0
34732|NCT02059291|84346|P19|NOT COMPLETED|Epoch 3||0
34733|NCT02059291|84347|P18|NOT COMPLETED|Epoch 3||0
34734|NCT02059291|84348|P17|NOT COMPLETED|Epoch 3||0
34735|NCT02059291|84349|P16|NOT COMPLETED|Epoch 3||6
34736|NCT02059291|84350|P15|NOT COMPLETED|Epoch 3||0
34737|NCT02059291|84351|P14|NOT COMPLETED|Epoch 3||1
34738|NCT02059291|84352|P13|NOT COMPLETED|Epoch 3||0
34739|NCT02059291|84353|P12|NOT COMPLETED|Epoch 3||0
34740|NCT02059291|84354|P11|NOT COMPLETED|Epoch 3||0
34741|NCT02059291|84355|P10|NOT COMPLETED|Epoch 3||0
34742|NCT02059291|84356|P9|NOT COMPLETED|Epoch 3||0
34743|NCT02059291|84357|P8|NOT COMPLETED|Epoch 3||0
34744|NCT02059291|84358|P7|NOT COMPLETED|Epoch 3||0
34745|NCT02059291|84359|P6|NOT COMPLETED|Epoch 3||0
34746|NCT02059291|84360|P5|NOT COMPLETED|Epoch 3||0
34747|NCT02059291|84361|P4|NOT COMPLETED|Epoch 3||0
34748|NCT02059291|84362|P3|NOT COMPLETED|Epoch 3||0
34749|NCT02059291|84363|P2|NOT COMPLETED|Epoch 3||0
34750|NCT02059291|84364|P1|NOT COMPLETED|Epoch 3||0
34751|NCT02059291|84340|P25|COMPLETED|Epoch 3||0
34752|NCT02059291|84341|P24|COMPLETED|Epoch 3||0
34753|NCT02059291|84342|P23|COMPLETED|Epoch 3||0
34754|NCT02059291|84343|P22|COMPLETED|Epoch 3||0
34755|NCT02059291|84344|P21|COMPLETED|Epoch 3||0
34756|NCT02059291|84345|P20|COMPLETED|Epoch 3||0
34757|NCT02059291|84346|P19|COMPLETED|Epoch 3||0
34758|NCT02059291|84347|P18|COMPLETED|Epoch 3||0
34759|NCT02059291|84348|P17|COMPLETED|Epoch 3||0
34760|NCT02059291|84349|P16|COMPLETED|Epoch 3||120
34761|NCT02059291|84350|P15|COMPLETED|Epoch 3||5
34762|NCT02059291|84351|P14|COMPLETED|Epoch 3||3
34763|NCT02059291|84352|P13|COMPLETED|Epoch 3||7
34764|NCT02059291|84353|P12|COMPLETED|Epoch 3||6
34765|NCT02059291|84354|P11|COMPLETED|Epoch 3||10
34766|NCT02059291|84355|P10|COMPLETED|Epoch 3||9
34767|NCT02059291|84356|P9|COMPLETED|Epoch 3||0
34768|NCT02059291|84357|P8|COMPLETED|Epoch 3||1
34769|NCT02059291|84358|P7|COMPLETED|Epoch 3||2
34770|NCT02059291|84359|P6|COMPLETED|Epoch 3||0
34771|NCT02059291|84360|P5|COMPLETED|Epoch 3||0
34772|NCT02059291|84361|P4|COMPLETED|Epoch 3||0
34773|NCT02059291|84362|P3|COMPLETED|Epoch 3||0
34774|NCT02059291|84363|P2|COMPLETED|Epoch 3||0
34775|NCT02059291|84364|P1|COMPLETED|Epoch 3||0
34776|NCT02059291|84340|P25|STARTED|Epoch 3||0
34777|NCT02059291|84341|P24|STARTED|Epoch 3||0
34778|NCT02059291|84342|P23|STARTED|Epoch 3||0
34779|NCT02059291|84343|P22|STARTED|Epoch 3||0
34780|NCT02059291|84344|P21|STARTED|Epoch 3||0
34781|NCT02059291|84345|P20|STARTED|Epoch 3||0
34782|NCT02059291|84346|P19|STARTED|Epoch 3||0
34783|NCT02059291|84347|P18|STARTED|Epoch 3||0
34784|NCT02059291|84348|P17|STARTED|Epoch 3||0
34785|NCT02059291|84349|P16|STARTED|Epoch 3||126
34786|NCT02059291|84350|P15|STARTED|Epoch 3||5
34787|NCT02059291|84351|P14|STARTED|Epoch 3||4
34788|NCT02059291|84352|P13|STARTED|Epoch 3||7
34789|NCT02059291|84353|P12|STARTED|Epoch 3||6
34790|NCT02059291|84354|P11|STARTED|Epoch 3||10
34791|NCT02059291|84355|P10|STARTED|Epoch 3||9
34792|NCT02059291|84356|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
34793|NCT02059291|84357|P8|STARTED|Epoch 3||1
34794|NCT02059291|84358|P7|STARTED|Epoch 3||2
34795|NCT02059291|84359|P6|STARTED|Epoch 3||0
34796|NCT02059291|84360|P5|STARTED|Epoch 3||0
34797|NCT02059291|84361|P4|STARTED|Epoch 3||0
34798|NCT02059291|84362|P3|STARTED|Epoch 3||0
34799|NCT02059291|84363|P2|STARTED|Epoch 3||0
34800|NCT02059291|84364|P1|STARTED|Epoch 3||0
34801|NCT02059291|84340|P25|NOT COMPLETED|Epoch 2||0
34802|NCT02059291|84341|P24|NOT COMPLETED|Epoch 2||0
34803|NCT02059291|84342|P23|NOT COMPLETED|Epoch 2||0
34804|NCT02059291|84343|P22|NOT COMPLETED|Epoch 2||0
34805|NCT02059291|84344|P21|NOT COMPLETED|Epoch 2||0
34806|NCT02059291|84345|P20|NOT COMPLETED|Epoch 2||0
34807|NCT02059291|84346|P19|NOT COMPLETED|Epoch 2||0
34808|NCT02059291|84347|P18|NOT COMPLETED|Epoch 2||0
34809|NCT02059291|84348|P17|NOT COMPLETED|Epoch 2||0
34810|NCT02059291|84349|P16|NOT COMPLETED|Epoch 2||0
34811|NCT02059291|84350|P15|NOT COMPLETED|Epoch 2||0
34812|NCT02059291|84351|P14|NOT COMPLETED|Epoch 2||0
34813|NCT02059291|84352|P13|NOT COMPLETED|Epoch 2||0
34814|NCT02059291|84353|P12|NOT COMPLETED|Epoch 2||0
34815|NCT02059291|84354|P11|NOT COMPLETED|Epoch 2||0
34816|NCT02059291|84355|P10|NOT COMPLETED|Epoch 2||0
34817|NCT02059291|84356|P9|NOT COMPLETED|Epoch 2||2
34818|NCT02059291|84357|P8|NOT COMPLETED|Epoch 2||1
34819|NCT02059291|84358|P7|NOT COMPLETED|Epoch 2||0
34820|NCT02059291|84359|P6|NOT COMPLETED|Epoch 2||2
34821|NCT02059291|84360|P5|NOT COMPLETED|Epoch 2||0
34822|NCT02059291|84361|P4|NOT COMPLETED|Epoch 2||2
34823|NCT02059291|84362|P3|NOT COMPLETED|Epoch 2||1
34824|NCT02059291|84363|P2|NOT COMPLETED|Epoch 2||1
34825|NCT02059291|84364|P1|NOT COMPLETED|Epoch 2||0
34826|NCT02059291|84340|P25|COMPLETED|Epoch 2||0
34827|NCT02059291|84341|P24|COMPLETED|Epoch 2||0
34828|NCT02059291|84342|P23|COMPLETED|Epoch 2||0
34829|NCT02059291|84343|P22|COMPLETED|Epoch 2||0
34830|NCT02059291|84344|P21|COMPLETED|Epoch 2||0
34831|NCT02059291|84345|P20|COMPLETED|Epoch 2||0
34832|NCT02059291|84346|P19|COMPLETED|Epoch 2||0
34833|NCT02059291|84347|P18|COMPLETED|Epoch 2||0
34834|NCT02059291|84348|P17|COMPLETED|Epoch 2||0
34835|NCT02059291|84349|P16|COMPLETED|Epoch 2||0
34836|NCT02059291|84350|P15|COMPLETED|Epoch 2||0
34837|NCT02059291|84351|P14|COMPLETED|Epoch 2||0
34838|NCT02059291|84352|P13|COMPLETED|Epoch 2||0
34839|NCT02059291|84353|P12|COMPLETED|Epoch 2||0
34840|NCT02059291|84354|P11|COMPLETED|Epoch 2||0
34841|NCT02059291|84355|P10|COMPLETED|Epoch 2||0
34842|NCT02059291|84356|P9|COMPLETED|Epoch 2||16
34843|NCT02059291|84357|P8|COMPLETED|Epoch 2||1
34844|NCT02059291|84358|P7|COMPLETED|Epoch 2||2
34845|NCT02059291|84359|P6|COMPLETED|Epoch 2||22
34846|NCT02059291|84360|P5|COMPLETED|Epoch 2||22
34847|NCT02059291|84361|P4|COMPLETED|Epoch 2||33
34848|NCT02059291|84362|P3|COMPLETED|Epoch 2||36
34849|NCT02059291|84363|P2|COMPLETED|Epoch 2||31
34850|NCT02059291|84364|P1|COMPLETED|Epoch 2||31
34851|NCT02059291|84340|P25|STARTED|Epoch 2||0
34852|NCT02059291|84341|P24|STARTED|Epoch 2||0
34853|NCT02059291|84342|P23|STARTED|Epoch 2||0
34854|NCT02059291|84343|P22|STARTED|Epoch 2||0
34855|NCT02059291|84344|P21|STARTED|Epoch 2||0
34856|NCT02059291|84345|P20|STARTED|Epoch 2||0
34857|NCT02059291|84346|P19|STARTED|Epoch 2||0
34858|NCT02059291|84347|P18|STARTED|Epoch 2||0
34859|NCT02059291|84348|P17|STARTED|Epoch 2||0
34860|NCT02059291|84349|P16|STARTED|Epoch 2||0
34861|NCT02059291|84350|P15|STARTED|Epoch 2||0
34862|NCT02059291|84351|P14|STARTED|Epoch 2||0
34863|NCT02059291|84352|P13|STARTED|Epoch 2||0
34864|NCT02059291|84353|P12|STARTED|Epoch 2||0
34865|NCT02059291|84354|P11|STARTED|Epoch 2||0
34866|NCT02059291|84355|P10|STARTED|Epoch 2||0
34867|NCT02059291|84356|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
34868|NCT02059291|84357|P8|STARTED|Epoch 2||2
34869|NCT02059291|84358|P7|STARTED|Epoch 2||2
34870|NCT02059291|84359|P6|STARTED|Epoch 2||24
34871|NCT02059291|84360|P5|STARTED|Epoch 2||22
34872|NCT02059291|84361|P4|STARTED|Epoch 2||35
34873|NCT02059291|84362|P3|STARTED|Epoch 2||37
34874|NCT02059291|84363|P2|STARTED|Epoch 2||32
34875|NCT02059291|84364|P1|STARTED|Epoch 2||31
34876|NCT02059187|84418|P2|NOT COMPLETED|Overall Study||22
34877|NCT02059187|84419|P1|NOT COMPLETED|Overall Study||25
34878|NCT02059187|84418|P2|COMPLETED|Overall Study||244
34879|NCT02059187|84419|P1|COMPLETED|Overall Study||240
34880|NCT02059187|84418|P2|STARTED|Overall Study||266
34881|NCT02059187|84419|P1|STARTED|Overall Study||265
34882|NCT02059174|84445|P2|NOT COMPLETED|Period 4||0
34883|NCT02059174|84446|P1|NOT COMPLETED|Period 4||0
34884|NCT02059174|84445|P2|COMPLETED|Period 4||35
34885|NCT02059174|84446|P1|COMPLETED|Period 4||35
34886|NCT02059174|84445|P2|STARTED|Period 4||35
34887|NCT02059174|84446|P1|STARTED|Period 4||35
34888|NCT02059174|84445|P2|NOT COMPLETED|Period 3||0
34889|NCT02059174|84446|P1|NOT COMPLETED|Period 3||1
34890|NCT02059174|84445|P2|COMPLETED|Period 3||35
34891|NCT02059174|84446|P1|COMPLETED|Period 3||35
34892|NCT02059174|84445|P2|STARTED|Period 3||35
34893|NCT02059174|84446|P1|STARTED|Period 3||36
34894|NCT02059174|84445|P2|NOT COMPLETED|Period 2||2
34895|NCT02059174|84446|P1|NOT COMPLETED|Period 2||1
34896|NCT02059174|84445|P2|COMPLETED|Period 2||35
34897|NCT02059174|84446|P1|COMPLETED|Period 2||36
34898|NCT02059174|84445|P2|STARTED|Period 2||37
34899|NCT02059174|84446|P1|STARTED|Period 2||37
34900|NCT02059174|84445|P2|NOT COMPLETED|Period 1||2
34901|NCT02059174|84446|P1|NOT COMPLETED|Period 1||0
34902|NCT02059174|84445|P2|COMPLETED|Period 1||37
34903|NCT02059174|84446|P1|COMPLETED|Period 1||37
34904|NCT02059174|84445|P2|STARTED|Period 1||39
34905|NCT02059174|84446|P1|STARTED|Period 1||37
34906|NCT02059161|84470|P2|NOT COMPLETED|Overall Study||41
34907|NCT02059161|84471|P1|NOT COMPLETED|Overall Study||49
34908|NCT02059161|84470|P2|COMPLETED|Overall Study||222
34909|NCT02059161|84471|P1|COMPLETED|Overall Study||196
34910|NCT02059161|84470|P2|Treated|Overall Study||258
34911|NCT02059161|84471|P1|Treated|Overall Study||241
34912|NCT02059161|84470|P2|STARTED|Overall Study||263
34913|NCT02059161|84471|P1|STARTED|Overall Study||245
34914|NCT02059135|84533|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
34915|NCT02059135|84534|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
34916|NCT02059135|84533|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
34917|NCT02059135|84534|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
34918|NCT02059135|84533|P2|STARTED|Neonatal Follow-up (Safety Population)||54
34919|NCT02059135|84534|P1|STARTED|Neonatal Follow-up (Safety Population)||60
34920|NCT02059135|84533|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
34921|NCT02059135|84534|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
34922|NCT02059135|84533|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
34923|NCT02059135|84534|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
34924|NCT02059135|84533|P2|STARTED|Maternal Follow-up (ITT Population)||58
34925|NCT02059135|84534|P1|STARTED|Maternal Follow-up (ITT Population)||62
34926|NCT02059070|84548|P2|NOT COMPLETED|Overall Study||4
34927|NCT02059070|84549|P1|NOT COMPLETED|Overall Study||5
34928|NCT02059070|84548|P2|COMPLETED|Overall Study||16
34929|NCT02059070|84549|P1|COMPLETED|Overall Study||14
34930|NCT02059070|84548|P2|STARTED|Overall Study||20
34931|NCT02059070|84549|P1|STARTED|Overall Study||19
34932|NCT02058992|84561|P1|NOT COMPLETED|Overall Study||116
34933|NCT02058992|84561|P1|COMPLETED|Overall Study||3223
34934|NCT02058992|84561|P1|STARTED|Overall Study||3339
34935|NCT02058836|84572|P2|NOT COMPLETED|Overall Study||1
34936|NCT02058836|84573|P1|NOT COMPLETED|Overall Study||1
34937|NCT02058836|84572|P2|COMPLETED|Overall Study||3
34938|NCT02058836|84573|P1|COMPLETED|Overall Study||3
34939|NCT02058836|84572|P2|STARTED|Overall Study||4
34940|NCT02058836|84573|P1|STARTED|Overall Study||4
34941|NCT02058628|84603|P2|NOT COMPLETED|Overall Study||8
34942|NCT02058628|84604|P1|NOT COMPLETED|Overall Study||7
34943|NCT02058628|84603|P2|COMPLETED|Overall Study||102
34944|NCT02058628|84604|P1|COMPLETED|Overall Study||104
34945|NCT02058628|84603|P2|STARTED|Overall Study||110
34946|NCT02058628|84604|P1|STARTED|Overall Study||111
34947|NCT02058563|84636|P2|NOT COMPLETED|Overall Study||24
34948|NCT02058563|84637|P1|NOT COMPLETED|Overall Study||28
34949|NCT02058563|84636|P2|COMPLETED|Overall Study||433
34950|NCT02058563|84637|P1|COMPLETED|Overall Study||426
34951|NCT02058563|84636|P2|STARTED|Overall Study||457
34952|NCT02058563|84637|P1|STARTED|Overall Study||454
34953|NCT02058537|84673|P1|NOT COMPLETED|Overall Study||1
34954|NCT02058537|84673|P1|COMPLETED|Overall Study||2
34955|NCT02058537|84673|P1|STARTED|Overall Study||3
34956|NCT02058498|84679|P1|NOT COMPLETED|Overall Study||4
34957|NCT02058498|84679|P1|COMPLETED|Overall Study||8
34958|NCT02058498|84679|P1|6 Weeks|Overall Study||8
34959|NCT02058498|84679|P1|STARTED|Overall Study||12
34960|NCT02058290|84687|P2|NOT COMPLETED|Overall Study||9
34961|NCT02058290|84688|P1|NOT COMPLETED|Overall Study||11
34962|NCT02058290|84687|P2|COMPLETED|Overall Study||36
34963|NCT02058290|84688|P1|COMPLETED|Overall Study||66
34964|NCT02058290|84687|P2|STARTED|Overall Study||45
34965|NCT02058290|84688|P1|STARTED|Overall Study||77
34966|NCT02058160|84704|P2|NOT COMPLETED|Overall Study||14
34967|NCT02058160|84705|P1|NOT COMPLETED|Overall Study||31
34968|NCT02058160|84704|P2|COMPLETED|Overall Study||355
34969|NCT02058160|84705|P1|COMPLETED|Overall Study||336
34970|NCT02058160|84704|P2|Treated|Overall Study||365
34971|NCT02058160|84705|P1|Treated|Overall Study||365
34972|NCT02058160|84704|P2|STARTED|Overall Study||369
34973|NCT02058160|84705|P1|STARTED|Overall Study||367
34974|NCT02058147|84742|P3|NOT COMPLETED|Overall Study||29
34975|NCT02058147|84743|P2|NOT COMPLETED|Overall Study||27
34976|NCT02058147|84744|P1|NOT COMPLETED|Overall Study||29
34977|NCT02058147|84742|P3|COMPLETED|Overall Study||205
34978|NCT02058147|84743|P2|COMPLETED|Overall Study||440
34979|NCT02058147|84744|P1|COMPLETED|Overall Study||440
34980|NCT02058147|84742|P3|Treated|Overall Study||233
34981|NCT02058147|84743|P2|Treated|Overall Study||467
34982|NCT02058147|84744|P1|Treated|Overall Study||469
34983|NCT02058147|84742|P3|STARTED|Overall Study||234
34984|NCT02058147|84743|P2|STARTED|Overall Study||467
34985|NCT02058147|84744|P1|STARTED|Overall Study||469
34986|NCT02058069|84793|P1|NOT COMPLETED|Overall Study||11
34987|NCT02058069|84793|P1|COMPLETED|Overall Study||89
34988|NCT02058069|84793|P1|STARTED|Overall Study||100
34989|NCT02057952|84805|P3|NOT COMPLETED|Overall Study||22
34990|NCT02057952|84806|P2|NOT COMPLETED|Overall Study||10
34991|NCT02057952|84807|P1|NOT COMPLETED|Overall Study||8
34992|NCT02057952|84805|P3|COMPLETED|Overall Study||28
34993|NCT02057952|84806|P2|COMPLETED|Overall Study||39
34994|NCT02057952|84807|P1|COMPLETED|Overall Study||43
34995|NCT02057952|84805|P3|STARTED|Overall Study||50
34996|NCT02057952|84806|P2|STARTED|Overall Study||49
34997|NCT02057952|84807|P1|STARTED|Overall Study||51
34998|NCT02057835|84852|P10|NOT COMPLETED|Overall Study||0
34999|NCT02057835|84853|P9|NOT COMPLETED|Overall Study||0
35000|NCT02057835|84854|P8|NOT COMPLETED|Overall Study||0
35001|NCT02057835|84855|P7|NOT COMPLETED|Overall Study||0
35002|NCT02057835|84856|P6|NOT COMPLETED|Overall Study||0
35003|NCT02057835|84857|P5|NOT COMPLETED|Overall Study||0
35004|NCT02057835|84858|P4|NOT COMPLETED|Overall Study||0
35005|NCT02057835|84859|P3|NOT COMPLETED|Overall Study||0
35006|NCT02057835|84860|P2|NOT COMPLETED|Overall Study||2
35007|NCT02057835|84861|P1|NOT COMPLETED|Overall Study||0
35008|NCT02057835|84852|P10|COMPLETED|Overall Study||6
35009|NCT02057835|84853|P9|COMPLETED|Overall Study||6
35010|NCT02057835|84854|P8|COMPLETED|Overall Study||6
35011|NCT02057835|84855|P7|COMPLETED|Overall Study||6
35012|NCT02057835|84856|P6|COMPLETED|Overall Study||8
35013|NCT02057835|84857|P5|COMPLETED|Overall Study||6
35014|NCT02057835|84858|P4|COMPLETED|Overall Study||6
35015|NCT02057835|84859|P3|COMPLETED|Overall Study||6
35016|NCT02057835|84860|P2|COMPLETED|Overall Study||4
35017|NCT02057835|84861|P1|COMPLETED|Overall Study||8
35018|NCT02057835|84852|P10|STARTED|Overall Study||6
35019|NCT02057835|84853|P9|STARTED|Overall Study||6
35020|NCT02057835|84854|P8|STARTED|Overall Study||6
35021|NCT02057835|84855|P7|STARTED|Overall Study||6
35022|NCT02057835|84856|P6|STARTED|Overall Study||8
35023|NCT02057835|84857|P5|STARTED|Overall Study||6
35024|NCT02057835|84858|P4|STARTED|Overall Study||6
35025|NCT02057835|84859|P3|STARTED|Overall Study||6
35026|NCT02057835|84860|P2|STARTED|Overall Study||6
35027|NCT02057835|84861|P1|STARTED|Overall Study||8
35028|NCT02057692|84942|P4|NOT COMPLETED|Overall Study||1
35029|NCT02057692|84943|P3|NOT COMPLETED|Overall Study||0
35030|NCT02057692|84944|P2|NOT COMPLETED|Overall Study||0
35031|NCT02057692|84945|P1|NOT COMPLETED|Overall Study||1
35032|NCT02057692|84942|P4|COMPLETED|Overall Study||11
35033|NCT02057692|84943|P3|COMPLETED|Overall Study||6
35034|NCT02057692|84944|P2|COMPLETED|Overall Study||11
35035|NCT02057692|84945|P1|COMPLETED|Overall Study||7
35036|NCT02057692|84942|P4|STARTED|Overall Study||12
35037|NCT02057692|84943|P3|STARTED|Overall Study||6
35038|NCT02057692|84944|P2|STARTED|Overall Study||11
35039|NCT02057692|84945|P1|STARTED|Overall Study||8
35040|NCT02057549|84971|P2|NOT COMPLETED|Overall Study||0
35041|NCT02057549|84972|P1|NOT COMPLETED|Overall Study||3
35042|NCT02057549|84971|P2|COMPLETED|Overall Study||18
35043|NCT02057549|84972|P1|COMPLETED|Overall Study||15
35044|NCT02057549|84971|P2|STARTED|Overall Study||18
35045|NCT02057549|84972|P1|STARTED|Overall Study||18
35046|NCT02057406|84995|P3|NOT COMPLETED|Overall Study||4
35047|NCT02057406|84996|P2|NOT COMPLETED|Overall Study||3
35048|NCT02057406|84997|P1|NOT COMPLETED|Overall Study||1
35049|NCT02057406|84995|P3|COMPLETED|Overall Study||32
35050|NCT02057406|84996|P2|COMPLETED|Overall Study||33
35051|NCT02057406|84997|P1|COMPLETED|Overall Study||35
35052|NCT02057406|84995|P3|STARTED|Overall Study||36
35053|NCT02057406|84996|P2|STARTED|Overall Study||36
35054|NCT02057406|84997|P1|STARTED|Overall Study||36
35055|NCT02057393|85008|P1|NOT COMPLETED|Overall Study||2
35056|NCT02057393|85008|P1|COMPLETED|Overall Study||87
35057|NCT02057393|85008|P1|STARTED|Overall Study||89
35058|NCT02057276|85014|P2|NOT COMPLETED|Overall Study||0
35059|NCT02057276|85015|P1|NOT COMPLETED|Overall Study||0
35060|NCT02057276|85014|P2|COMPLETED|Overall Study||0
35061|NCT02057276|85015|P1|COMPLETED|Overall Study||0
35062|NCT02057276|85014|P2|STARTED|Overall Study||0
35063|NCT02057276|85015|P1|STARTED|Overall Study||0
35064|NCT02057250|85029|P5|NOT COMPLETED|Extension Phase||36
35065|NCT02057250|85030|P4|NOT COMPLETED|Extension Phase||0
35066|NCT02057250|85031|P3|NOT COMPLETED|Extension Phase||0
35067|NCT02057250|85032|P2|NOT COMPLETED|Extension Phase||0
35068|NCT02057250|85033|P1|NOT COMPLETED|Extension Phase||0
35069|NCT02057250|85029|P5|COMPLETED|Extension Phase||156
35070|NCT02057250|85030|P4|COMPLETED|Extension Phase||0
35071|NCT02057250|85031|P3|COMPLETED|Extension Phase||0
35072|NCT02057250|85032|P2|COMPLETED|Extension Phase||0
35073|NCT02057250|85033|P1|COMPLETED|Extension Phase||0
35074|NCT02057250|85029|P5|Treated|Extension Phase||188
35075|NCT02057250|85030|P4|Treated|Extension Phase||0
35076|NCT02057250|85031|P3|Treated|Extension Phase||0
35077|NCT02057250|85032|P2|Treated|Extension Phase||0
35078|NCT02057250|85033|P1|Treated|Extension Phase||0
35079|NCT02057250|85029|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
35080|NCT02057250|85030|P4|STARTED|Extension Phase||0
35081|NCT02057250|85031|P3|STARTED|Extension Phase||0
35082|NCT02057250|85032|P2|STARTED|Extension Phase||0
35083|NCT02057250|85033|P1|STARTED|Extension Phase||0
35084|NCT02057250|85029|P5|NOT COMPLETED|AID Assessment Phase||0
35085|NCT02057250|85030|P4|NOT COMPLETED|AID Assessment Phase||2
35086|NCT02057250|85031|P3|NOT COMPLETED|AID Assessment Phase||7
35087|NCT02057250|85032|P2|NOT COMPLETED|AID Assessment Phase||3
35088|NCT02057250|85033|P1|NOT COMPLETED|AID Assessment Phase||4
35089|NCT02057250|85029|P5|COMPLETED|AID Assessment Phase||0
35090|NCT02057250|85030|P4|COMPLETED|AID Assessment Phase||54
35091|NCT02057250|85031|P3|COMPLETED|AID Assessment Phase||45
35092|NCT02057250|85032|P2|COMPLETED|AID Assessment Phase||50
35093|NCT02057250|85033|P1|COMPLETED|AID Assessment Phase||52
35094|NCT02057250|85029|P5|STARTED|AID Assessment Phase||0
35095|NCT02057250|85030|P4|STARTED|AID Assessment Phase||56
35096|NCT02057250|85031|P3|STARTED|AID Assessment Phase||52
35097|NCT02057250|85032|P2|STARTED|AID Assessment Phase||53
35098|NCT02057250|85033|P1|STARTED|AID Assessment Phase||56
35099|NCT02057237|85046|P1|NOT COMPLETED|Overall Study||0
35100|NCT02057237|85046|P1|COMPLETED|Overall Study||1
35101|NCT02057237|85046|P1|STARTED|Overall Study||1
35102|NCT02057068|85053|P2|NOT COMPLETED|Overall Study||8
35103|NCT02057068|85054|P1|NOT COMPLETED|Overall Study||8
35104|NCT02057068|85053|P2|COMPLETED|Overall Study||28
35105|NCT02057068|85054|P1|COMPLETED|Overall Study||52
35106|NCT02057068|85053|P2|STARTED|Overall Study||36
35107|NCT02057068|85054|P1|STARTED|Overall Study||60
35108|NCT02056834|85064|P1|NOT COMPLETED|Overall Study||7
35109|NCT02056834|85064|P1|COMPLETED|Overall Study||29
35110|NCT02056834|85064|P1|6 Months|Overall Study||31
35111|NCT02056834|85064|P1|6 Weeks|Overall Study||34
35112|NCT02056834|85064|P1|STARTED|Overall Study||36
35113|NCT02056652|85085|P2|NOT COMPLETED|Overall Study||3
35114|NCT02056652|85086|P1|NOT COMPLETED|Overall Study||1
35115|NCT02056652|85085|P2|COMPLETED|Overall Study||58
35116|NCT02056652|85086|P1|COMPLETED|Overall Study||60
35117|NCT02056652|85085|P2|STARTED|Overall Study||61
35118|NCT02056652|85086|P1|STARTED|Overall Study||61
35119|NCT02056639|85104|P2|NOT COMPLETED|Overall Study||0
35120|NCT02056639|85105|P1|NOT COMPLETED|Overall Study||0
35121|NCT02056639|85104|P2|COMPLETED|Overall Study||23
35122|NCT02056639|85105|P1|COMPLETED|Overall Study||23
35123|NCT02056639|85104|P2|STARTED|Overall Study||23
35124|NCT02056639|85105|P1|STARTED|Overall Study||23
35125|NCT02056431|85121|P2|NOT COMPLETED|Overall Study||47
35126|NCT02056431|85122|P1|NOT COMPLETED|Overall Study||44
35127|NCT02056431|85121|P2|COMPLETED|Overall Study||619
35128|NCT02056431|85122|P1|COMPLETED|Overall Study||560
35129|NCT02056431|85121|P2|STARTED|Overall Study||666
35130|NCT02056431|85122|P1|STARTED|Overall Study||604
35131|NCT02056392|85136|P6|NOT COMPLETED|Overall Study||0
35132|NCT02056392|85137|P5|NOT COMPLETED|Overall Study||1
35133|NCT02056392|85138|P4|NOT COMPLETED|Overall Study||0
35134|NCT02056392|85139|P3|NOT COMPLETED|Overall Study||3
35135|NCT02056392|85140|P2|NOT COMPLETED|Overall Study||1
35136|NCT02056392|85141|P1|NOT COMPLETED|Overall Study||2
35137|NCT02056392|85136|P6|COMPLETED|Overall Study||9
35138|NCT02056392|85137|P5|COMPLETED|Overall Study||7
35139|NCT02056392|85138|P4|COMPLETED|Overall Study||9
35140|NCT02056392|85139|P3|COMPLETED|Overall Study||6
35141|NCT02056392|85140|P2|COMPLETED|Overall Study||8
35142|NCT02056392|85141|P1|COMPLETED|Overall Study||8
35143|NCT02056392|85136|P6|STARTED|Overall Study||9
35144|NCT02056392|85137|P5|STARTED|Overall Study||8
35145|NCT02056392|85138|P4|STARTED|Overall Study||9
35146|NCT02056392|85139|P3|STARTED|Overall Study||9
35147|NCT02056392|85140|P2|STARTED|Overall Study||9
35148|NCT02056392|85141|P1|STARTED|Overall Study||10
35149|NCT02056171|85178|P2|NOT COMPLETED|Overall Study||0
35150|NCT02056171|85179|P1|NOT COMPLETED|Overall Study||0
35151|NCT02056171|85178|P2|COMPLETED|Overall Study||3
35152|NCT02056171|85179|P1|COMPLETED|Overall Study||3
35153|NCT02056171|85178|P2|STARTED|Overall Study||3
35154|NCT02056171|85179|P1|STARTED|Overall Study||3
35155|NCT02055430|85191|P2|NOT COMPLETED|Overall Study||0
35156|NCT02055430|85192|P1|NOT COMPLETED|Overall Study||0
35157|NCT02055430|85191|P2|COMPLETED|Overall Study||45
35158|NCT02055430|85192|P1|COMPLETED|Overall Study||45
35159|NCT02055430|85191|P2|STARTED|Overall Study||45
35160|NCT02055430|85192|P1|STARTED|Overall Study||45
35161|NCT02055404|85198|P1|NOT COMPLETED|Overall Study||0
35162|NCT02055404|85198|P1|COMPLETED|Overall Study||3
35163|NCT02055404|85198|P1|STARTED|Overall Study||3
35164|NCT02055365|85211|P1|NOT COMPLETED|Overall Study||1
35165|NCT02055365|85211|P1|COMPLETED|Overall Study||9
35166|NCT02055365|85211|P1|STARTED|Overall Study||10
35167|NCT02055352|85224|P2|NOT COMPLETED|Overall Study||17
35168|NCT02055352|85225|P1|NOT COMPLETED|Overall Study||6
35169|NCT02055352|85224|P2|COMPLETED|Overall Study||96
35170|NCT02055352|85225|P1|COMPLETED|Overall Study||103
35171|NCT02055352|85224|P2|Per-Protocol Set (PPS)|Overall Study||111
35172|NCT02055352|85225|P1|Per-Protocol Set (PPS)|Overall Study||108
35173|NCT02055352|85224|P2|STARTED|Overall Study||113
35174|NCT02055352|85225|P1|STARTED|Overall Study||109
35175|NCT02054910|85241|P2|NOT COMPLETED|Overall Study||1
35176|NCT02054910|85242|P1|NOT COMPLETED|Overall Study||4
35177|NCT02054910|85241|P2|COMPLETED|Overall Study||0
35178|NCT02054910|85242|P1|COMPLETED|Overall Study||0
35179|NCT02054910|85241|P2|STARTED|Overall Study||1
35180|NCT02054910|85242|P1|STARTED|Overall Study||4
35181|NCT02054897|85261|P3|NOT COMPLETED|Overall Study||12
35182|NCT02054897|85262|P2|NOT COMPLETED|Overall Study||7
35183|NCT02054897|85263|P1|NOT COMPLETED|Overall Study||10
35184|NCT02054897|85261|P3|COMPLETED|Overall Study||117
35185|NCT02054897|85262|P2|COMPLETED|Overall Study||123
35186|NCT02054897|85263|P1|COMPLETED|Overall Study||119
35187|NCT02054897|85261|P3|Exposed|Overall Study||129
35188|NCT02054897|85262|P2|Exposed|Overall Study||130
35189|NCT02054897|85263|P1|Exposed|Overall Study||128
35190|NCT02054897|85261|P3|STARTED|Overall Study||129
35191|NCT02054897|85262|P2|STARTED|Overall Study||130
35192|NCT02054897|85263|P1|STARTED|Overall Study||129
35193|NCT02054754|85288|P6|NOT COMPLETED|Overall Study||0
35194|NCT02054754|85289|P5|NOT COMPLETED|Overall Study||0
35195|NCT02054754|85290|P4|NOT COMPLETED|Overall Study||0
35196|NCT02054754|85291|P3|NOT COMPLETED|Overall Study||0
35197|NCT02054754|85292|P2|NOT COMPLETED|Overall Study||0
35198|NCT02054754|85293|P1|NOT COMPLETED|Overall Study||0
35199|NCT02054754|85288|P6|COMPLETED|Overall Study||10
35200|NCT02054754|85289|P5|COMPLETED|Overall Study||6
35201|NCT02054754|85290|P4|COMPLETED|Overall Study||6
35202|NCT02054754|85291|P3|COMPLETED|Overall Study||6
35203|NCT02054754|85292|P2|COMPLETED|Overall Study||6
35204|NCT02054754|85293|P1|COMPLETED|Overall Study||6
35205|NCT02054754|85288|P6|STARTED|Overall Study||10
35206|NCT02054754|85289|P5|STARTED|Overall Study||6
35207|NCT02054754|85290|P4|STARTED|Overall Study||6
35208|NCT02054754|85291|P3|STARTED|Overall Study||6
35209|NCT02054754|85292|P2|STARTED|Overall Study||6
35210|NCT02054754|85293|P1|STARTED|Overall Study||6
35211|NCT02054715|85310|P2|NOT COMPLETED|Follow-up 2||19
35212|NCT02054715|85311|P1|NOT COMPLETED|Follow-up 2||19
35213|NCT02054715|85310|P2|COMPLETED|Follow-up 2||173
35214|NCT02054715|85311|P1|COMPLETED|Follow-up 2||192
35215|NCT02054715|85310|P2|STARTED|Follow-up 2||192
35216|NCT02054715|85311|P1|STARTED|Follow-up 2||211
35217|NCT02054715|85310|P2|NOT COMPLETED|Baseline/Follow-up 1||7
35218|NCT02054715|85311|P1|NOT COMPLETED|Baseline/Follow-up 1||8
35219|NCT02054715|85310|P2|COMPLETED|Baseline/Follow-up 1||192
35220|NCT02054715|85311|P1|COMPLETED|Baseline/Follow-up 1||211
35221|NCT02054715|85310|P2|STARTED|Baseline/Follow-up 1||199
35222|NCT02054715|85311|P1|STARTED|Baseline/Follow-up 1||219
35223|NCT02054702|85325|P2|NOT COMPLETED|Overall Study||12
35224|NCT02054702|85326|P1|NOT COMPLETED|Overall Study||24
35225|NCT02054702|85325|P2|COMPLETED|Overall Study||21
35226|NCT02054702|85326|P1|COMPLETED|Overall Study||40
35227|NCT02054702|85325|P2|STARTED|Overall Study||33
35228|NCT02054702|85326|P1|STARTED|Overall Study||64
35229|NCT02054572|85354|P1|NOT COMPLETED|Overall Study||0
35230|NCT02054572|85354|P1|COMPLETED|Overall Study||6
35231|NCT02054572|85354|P1|STARTED|Overall Study||6
35232|NCT02054481|85381|P4|NOT COMPLETED|Overall Study||1
35233|NCT02054481|85382|P3|NOT COMPLETED|Overall Study||2
35234|NCT02054481|85383|P2|NOT COMPLETED|Overall Study||2
35235|NCT02054481|85384|P1|NOT COMPLETED|Overall Study||4
35236|NCT02054481|85381|P4|COMPLETED|Overall Study||39
35237|NCT02054481|85382|P3|COMPLETED|Overall Study||40
35238|NCT02054481|85383|P2|COMPLETED|Overall Study||39
35239|NCT02054481|85384|P1|COMPLETED|Overall Study||39
35240|NCT02054481|85381|P4|STARTED|Overall Study||40
35241|NCT02054481|85382|P3|STARTED|Overall Study||42
35242|NCT02054481|85383|P2|STARTED|Overall Study||41
35243|NCT02054481|85384|P1|STARTED|Overall Study||43
35244|NCT02054325|85432|P2|NOT COMPLETED|Overall Study||5
35245|NCT02054325|85433|P1|NOT COMPLETED|Overall Study||8
35246|NCT02054325|85432|P2|COMPLETED|Overall Study||50
35247|NCT02054325|85433|P1|COMPLETED|Overall Study||43
35248|NCT02054325|85432|P2|STARTED|Overall Study||55
35249|NCT02054325|85433|P1|STARTED|Overall Study||51
35250|NCT02053753|85443|P2|NOT COMPLETED|Overall Study||8
35251|NCT02053753|85444|P1|NOT COMPLETED|Overall Study||7
35252|NCT02053753|85443|P2|COMPLETED|Overall Study||66
35253|NCT02053753|85444|P1|COMPLETED|Overall Study||65
35254|NCT02053753|85443|P2|Received Treatment|Overall Study||71
35255|NCT02053753|85444|P1|Received Treatment|Overall Study||71
35256|NCT02053753|85443|P2|STARTED|Overall Study||74
35257|NCT02053753|85444|P1|STARTED|Overall Study||72
35258|NCT02053610|85468|P2|NOT COMPLETED|Overall Study||174
35259|NCT02053610|85469|P1|NOT COMPLETED|Overall Study||235
35260|NCT02053610|85468|P2|COMPLETED|Overall Study|Completed=Completed Treatment|159
35261|NCT02053610|85469|P1|COMPLETED|Overall Study|Completed=Completed Treatment|95
35262|NCT02053610|85468|P2|Received Study Drug|Overall Study||331
35263|NCT02053610|85469|P1|Received Study Drug|Overall Study||326
35264|NCT02053610|85468|P2|STARTED|Overall Study||333
35265|NCT02053610|85469|P1|STARTED|Overall Study||330
35266|NCT02053493|85501|P2|NOT COMPLETED|Overall Study||1
35267|NCT02053493|85502|P1|NOT COMPLETED|Overall Study||1
35268|NCT02053493|85501|P2|COMPLETED|Overall Study||58
35269|NCT02053493|85502|P1|COMPLETED|Overall Study||50
35270|NCT02053493|85501|P2|STARTED|Overall Study||59
35271|NCT02053493|85502|P1|STARTED|Overall Study||51
35272|NCT02053168|85540|P1|NOT COMPLETED|Overall Study||3
35273|NCT02053168|85540|P1|COMPLETED|Overall Study||22
35274|NCT02053168|85540|P1|STARTED|Overall Study||25
35275|NCT02052895|85557|P3|NOT COMPLETED|Overall Study||0
35276|NCT02052895|85558|P2|NOT COMPLETED|Overall Study||0
35277|NCT02052895|85559|P1|NOT COMPLETED|Overall Study||0
35278|NCT02052895|85557|P3|COMPLETED|Overall Study||15
35279|NCT02052895|85558|P2|COMPLETED|Overall Study||15
35280|NCT02052895|85559|P1|COMPLETED|Overall Study||196
35281|NCT02052895|85557|P3|STARTED|Overall Study||15
35282|NCT02052895|85558|P2|STARTED|Overall Study||15
35283|NCT02052895|85559|P1|STARTED|Overall Study||196
35284|NCT02052752|85569|P3|NOT COMPLETED|Overall Study||0
35285|NCT02052752|85570|P2|NOT COMPLETED|Overall Study||0
35286|NCT02052752|85571|P1|NOT COMPLETED|Overall Study||0
35287|NCT02052752|85569|P3|COMPLETED|Overall Study||30
35288|NCT02052752|85570|P2|COMPLETED|Overall Study||30
35289|NCT02052752|85571|P1|COMPLETED|Overall Study||30
35290|NCT02052752|85569|P3|STARTED|Overall Study||30
35291|NCT02052752|85570|P2|STARTED|Overall Study||30
35292|NCT02052752|85571|P1|STARTED|Overall Study||30
35293|NCT02052661|85594|P1|NOT COMPLETED|Overall Study||0
35294|NCT02052661|85594|P1|COMPLETED|Overall Study||300
35295|NCT02052661|85594|P1|STARTED|Overall Study||300
35296|NCT02052635|85608|P2|NOT COMPLETED|Overall Study||0
35297|NCT02052635|85609|P1|NOT COMPLETED|Overall Study||0
35298|NCT02052635|85608|P2|COMPLETED|Overall Study||6
35299|NCT02052635|85609|P1|COMPLETED|Overall Study||7
35300|NCT02052635|85608|P2|STARTED|Overall Study||6
35301|NCT02052635|85609|P1|STARTED|Overall Study||7
35302|NCT02052596|85619|P2|NOT COMPLETED|Safety Phase||35
35303|NCT02052596|85620|P1|NOT COMPLETED|Safety Phase||27
35304|NCT02052596|85619|P2|COMPLETED|Safety Phase||383
35305|NCT02052596|85620|P1|COMPLETED|Safety Phase||385
35306|NCT02052596|85619|P2|STARTED|Safety Phase||418
35307|NCT02052596|85620|P1|STARTED|Safety Phase||412
35308|NCT02052596|85619|P2|NOT COMPLETED|Active Phase||20
35309|NCT02052596|85620|P1|NOT COMPLETED|Active Phase||16
35310|NCT02052596|85619|P2|COMPLETED|Active Phase||398
35311|NCT02052596|85620|P1|COMPLETED|Active Phase||396
35312|NCT02052596|85619|P2|STARTED|Active Phase||418
35313|NCT02052596|85620|P1|STARTED|Active Phase||412
35314|NCT02052544|85645|P1|NOT COMPLETED|Overall Study||0
35315|NCT02052544|85645|P1|COMPLETED|Overall Study|Last Subject Out|123
35316|NCT02052544|85645|P1|STARTED|Overall Study|First Subject In|123
35317|NCT02052466|85650|P1|NOT COMPLETED|Overall Study||2
35318|NCT02052466|85650|P1|COMPLETED|Overall Study||30
35319|NCT02052466|85650|P1|STARTED|Overall Study||32
35320|NCT02052440|85667|P2|NOT COMPLETED|Overall Study||1
35321|NCT02052440|85668|P1|NOT COMPLETED|Overall Study||0
35322|NCT02052440|85667|P2|COMPLETED|Overall Study||51
35323|NCT02052440|85668|P1|COMPLETED|Overall Study||50
35324|NCT02052440|85667|P2|STARTED|Overall Study||52
35325|NCT02052440|85668|P1|STARTED|Overall Study||50
35326|NCT02052414|85680|P1|NOT COMPLETED|Overall Study||17
35327|NCT02052414|85680|P1|COMPLETED|Overall Study||17
35328|NCT02052414|85680|P1|STARTED|Overall Study||34
35329|NCT02052011|85690|P2|NOT COMPLETED|Overall Study||2
35330|NCT02052011|85691|P1|NOT COMPLETED|Overall Study||4
35331|NCT02052011|85690|P2|COMPLETED|Overall Study||8
35332|NCT02052011|85691|P1|COMPLETED|Overall Study||17
35333|NCT02052011|85690|P2|STARTED|Overall Study||10
35334|NCT02052011|85691|P1|STARTED|Overall Study||21
35335|NCT02051816|85701|P4|NOT COMPLETED|Overall Study||0
35336|NCT02051816|85702|P3|NOT COMPLETED|Overall Study||0
35337|NCT02051816|85703|P2|NOT COMPLETED|Overall Study||0
35338|NCT02051816|85704|P1|NOT COMPLETED|Overall Study||0
35339|NCT02051816|85701|P4|COMPLETED|Overall Study||36
35340|NCT02051816|85702|P3|COMPLETED|Overall Study||37
35341|NCT02051816|85703|P2|COMPLETED|Overall Study||40
35342|NCT02051816|85704|P1|COMPLETED|Overall Study||37
35343|NCT02051816|85701|P4|STARTED|Overall Study||36
35344|NCT02051816|85702|P3|STARTED|Overall Study||37
35345|NCT02051816|85703|P2|STARTED|Overall Study||40
35346|NCT02051816|85704|P1|STARTED|Overall Study||37
35347|NCT02051790|85742|P1|NOT COMPLETED|Overall Study||0
35348|NCT02051790|85742|P1|COMPLETED|Overall Study||241
35349|NCT02051790|85742|P1|STARTED|Overall Study||241
35350|NCT02051686|85748|P2|NOT COMPLETED|Overall Study||0
35351|NCT02051686|85749|P1|NOT COMPLETED|Overall Study||0
35352|NCT02051686|85748|P2|COMPLETED|Overall Study||46
35353|NCT02051686|85749|P1|COMPLETED|Overall Study||42
35354|NCT02051686|85748|P2|STARTED|Overall Study||46
35355|NCT02051686|85749|P1|STARTED|Overall Study||42
35356|NCT02051595|85757|P1|NOT COMPLETED|Overall Study||0
35357|NCT02051595|85757|P1|COMPLETED|Overall Study||25
35358|NCT02051595|85757|P1|STARTED|Overall Study||25
35359|NCT02051426|85763|P2|NOT COMPLETED|Second Intervention||0
35360|NCT02051426|85764|P1|NOT COMPLETED|Second Intervention||0
35361|NCT02051426|85763|P2|COMPLETED|Second Intervention||19
35362|NCT02051426|85764|P1|COMPLETED|Second Intervention||16
35363|NCT02051426|85763|P2|STARTED|Second Intervention||19
35364|NCT02051426|85764|P1|STARTED|Second Intervention||16
35365|NCT02051426|85763|P2|NOT COMPLETED|Washout Period of 1 Month||0
35366|NCT02051426|85764|P1|NOT COMPLETED|Washout Period of 1 Month||0
35367|NCT02051426|85763|P2|COMPLETED|Washout Period of 1 Month||19
35368|NCT02051426|85764|P1|COMPLETED|Washout Period of 1 Month||16
35369|NCT02051426|85763|P2|STARTED|Washout Period of 1 Month||19
35370|NCT02051426|85764|P1|STARTED|Washout Period of 1 Month||16
35371|NCT02051426|85763|P2|NOT COMPLETED|First Intervention||0
35372|NCT02051426|85764|P1|NOT COMPLETED|First Intervention||0
35373|NCT02051426|85763|P2|COMPLETED|First Intervention||19
35374|NCT02051426|85764|P1|COMPLETED|First Intervention||16
35375|NCT02051426|85763|P2|STARTED|First Intervention||19
35376|NCT02051426|85764|P1|STARTED|First Intervention||16
35377|NCT02051335|85778|P4|NOT COMPLETED|Period 4||0
35378|NCT02051335|85779|P3|NOT COMPLETED|Period 4||0
35379|NCT02051335|85780|P2|NOT COMPLETED|Period 4||0
35380|NCT02051335|85781|P1|NOT COMPLETED|Period 4||0
35381|NCT02051335|85778|P4|COMPLETED|Period 4||4
35382|NCT02051335|85779|P3|COMPLETED|Period 4||5
35383|NCT02051335|85780|P2|COMPLETED|Period 4||7
35384|NCT02051335|85781|P1|COMPLETED|Period 4||7
35385|NCT02051335|85778|P4|STARTED|Period 4||4
35386|NCT02051335|85779|P3|STARTED|Period 4||5
35387|NCT02051335|85780|P2|STARTED|Period 4||7
35388|NCT02051335|85781|P1|STARTED|Period 4||7
35389|NCT02051335|85778|P4|NOT COMPLETED|Period 3||0
35390|NCT02051335|85779|P3|NOT COMPLETED|Period 3||0
35391|NCT02051335|85780|P2|NOT COMPLETED|Period 3||0
35392|NCT02051335|85781|P1|NOT COMPLETED|Period 3||0
35393|NCT02051335|85778|P4|COMPLETED|Period 3||4
35394|NCT02051335|85779|P3|COMPLETED|Period 3||5
35395|NCT02051335|85780|P2|COMPLETED|Period 3||7
35396|NCT02051335|85781|P1|COMPLETED|Period 3||7
35397|NCT02051335|85778|P4|STARTED|Period 3||4
35398|NCT02051335|85779|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
35399|NCT02051335|85780|P2|STARTED|Period 3||7
35400|NCT02051335|85781|P1|STARTED|Period 3||7
35401|NCT02051335|85778|P4|NOT COMPLETED|Period 2||0
35402|NCT02051335|85779|P3|NOT COMPLETED|Period 2||0
35403|NCT02051335|85780|P2|NOT COMPLETED|Period 2||0
35404|NCT02051335|85781|P1|NOT COMPLETED|Period 2||0
35405|NCT02051335|85778|P4|COMPLETED|Period 2||4
35406|NCT02051335|85779|P3|COMPLETED|Period 2||7
35407|NCT02051335|85780|P2|COMPLETED|Period 2||7
35408|NCT02051335|85781|P1|COMPLETED|Period 2||7
35409|NCT02051335|85778|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
35410|NCT02051335|85779|P3|STARTED|Period 2||7
35411|NCT02051335|85780|P2|STARTED|Period 2||7
35412|NCT02051335|85781|P1|STARTED|Period 2||7
35413|NCT02051335|85778|P4|NOT COMPLETED|Period 1||0
35414|NCT02051335|85779|P3|NOT COMPLETED|Period 1||0
35415|NCT02051335|85780|P2|NOT COMPLETED|Period 1||0
35416|NCT02051335|85781|P1|NOT COMPLETED|Period 1||0
35417|NCT02051335|85778|P4|COMPLETED|Period 1||6
35418|NCT02051335|85779|P3|COMPLETED|Period 1||7
35419|NCT02051335|85780|P2|COMPLETED|Period 1||7
35420|NCT02051335|85781|P1|COMPLETED|Period 1||7
35421|NCT02051335|85778|P4|STARTED|Period 1||6
35422|NCT02051335|85779|P3|STARTED|Period 1||7
35423|NCT02051335|85780|P2|STARTED|Period 1||7
35424|NCT02051335|85781|P1|STARTED|Period 1||7
35425|NCT02050334|85833|P2|NOT COMPLETED|Overall Study||0
35426|NCT02050334|85834|P1|NOT COMPLETED|Overall Study||0
35427|NCT02050334|85833|P2|COMPLETED|Overall Study||9
35428|NCT02050334|85834|P1|COMPLETED|Overall Study||9
35429|NCT02050334|85833|P2|STARTED|Overall Study||9
35430|NCT02050334|85834|P1|STARTED|Overall Study||9
35431|NCT02050321|85842|P1|NOT COMPLETED|Overall Study||2
35432|NCT02050321|85842|P1|COMPLETED|Overall Study||0
35433|NCT02050321|85842|P1|STARTED|Overall Study||2
35434|NCT02050048|85849|P2|NOT COMPLETED|Overall Study||2
35435|NCT02050048|85850|P1|NOT COMPLETED|Overall Study||5
35436|NCT02050048|85849|P2|COMPLETED|Overall Study||10
35437|NCT02050048|85850|P1|COMPLETED|Overall Study||9
35438|NCT02050048|85849|P2|STARTED|Overall Study||12
35439|NCT02050048|85850|P1|STARTED|Overall Study||14
35440|NCT02049931|85859|P3|NOT COMPLETED|Overall Study||3
35441|NCT02049931|85860|P2|NOT COMPLETED|Overall Study||5
35442|NCT02049931|85861|P1|NOT COMPLETED|Overall Study||3
35443|NCT02049931|85859|P3|COMPLETED|Overall Study||17
35444|NCT02049931|85860|P2|COMPLETED|Overall Study||15
35445|NCT02049931|85861|P1|COMPLETED|Overall Study||17
35446|NCT02049931|85859|P3|STARTED|Overall Study||20
35447|NCT02049931|85860|P2|STARTED|Overall Study||20
35448|NCT02049931|85861|P1|STARTED|Overall Study||20
35449|NCT02049450|85869|P1|NOT COMPLETED|Overall Study||4
35450|NCT02049450|85869|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
35451|NCT02049450|85869|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
35452|NCT02049450|85869|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
35453|NCT02049450|85869|P1|STARTED|Overall Study||30
35454|NCT02049385|85883|P2|NOT COMPLETED|Second Intervention||2
35455|NCT02049385|85884|P1|NOT COMPLETED|Second Intervention||0
35456|NCT02049385|85883|P2|COMPLETED|Second Intervention||0
35457|NCT02049385|85884|P1|COMPLETED|Second Intervention||1
35458|NCT02049385|85883|P2|STARTED|Second Intervention||2
35459|NCT02049385|85884|P1|STARTED|Second Intervention||1
35460|NCT02049385|85883|P2|NOT COMPLETED|First Intervention||0
35461|NCT02049385|85884|P1|NOT COMPLETED|First Intervention||3
35462|NCT02049385|85883|P2|COMPLETED|First Intervention||2
35463|NCT02049385|85884|P1|COMPLETED|First Intervention||1
35464|NCT02049385|85883|P2|STARTED|First Intervention||2
35465|NCT02049385|85884|P1|STARTED|First Intervention||4
35466|NCT02049151|85892|P2|NOT COMPLETED|Overall Study||0
35467|NCT02049151|85893|P1|NOT COMPLETED|Overall Study||0
35468|NCT02049151|85892|P2|COMPLETED|Overall Study||17
35469|NCT02049151|85893|P1|COMPLETED|Overall Study||15
35470|NCT02049151|85892|P2|STARTED|Overall Study|1 subject did not receive treatment|17
35471|NCT02049151|85893|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
35472|NCT02048904|85907|P1|NOT COMPLETED|Overall Study||77
35473|NCT02048904|85907|P1|COMPLETED|Overall Study||65
35474|NCT02048904|85907|P1|STARTED|Overall Study||142
35475|NCT02048891|85913|P2|NOT COMPLETED|Overall Study||0
35476|NCT02048891|85914|P1|NOT COMPLETED|Overall Study||0
35477|NCT02048891|85913|P2|COMPLETED|Overall Study||1
35478|NCT02048891|85914|P1|COMPLETED|Overall Study||2
35479|NCT02048891|85913|P2|STARTED|Overall Study||1
35480|NCT02048891|85914|P1|STARTED|Overall Study||2
35481|NCT02048241|85922|P2|NOT COMPLETED|Overall Study||1
35482|NCT02048241|85923|P1|NOT COMPLETED|Overall Study||0
35483|NCT02048241|85922|P2|COMPLETED|Overall Study||5
35484|NCT02048241|85923|P1|COMPLETED|Overall Study||5
35485|NCT02048241|85922|P2|STARTED|Overall Study||6
35486|NCT02048241|85923|P1|STARTED|Overall Study||5
35487|NCT02048072|85929|P1|NOT COMPLETED|Overall Study||4
35488|NCT02048072|85929|P1|COMPLETED|Overall Study||29
35489|NCT02048072|85929|P1|STARTED|Overall Study||33
35490|NCT02047747|85933|P1|NOT COMPLETED|Overall Study||3
35491|NCT02047747|85933|P1|COMPLETED|Overall Study||1
35492|NCT02047747|85933|P1|STARTED|Overall Study||4
35493|NCT02047500|85938|P1|NOT COMPLETED|Overall Study||19
35494|NCT02047500|85938|P1|COMPLETED|Overall Study||0
35495|NCT02047500|85938|P1|STARTED|Overall Study||19
35496|NCT02047227|85944|P2|NOT COMPLETED|Overall Study||130
35497|NCT02047227|85945|P1|NOT COMPLETED|Overall Study||144
35498|NCT02047227|85944|P2|COMPLETED|Overall Study||347
35499|NCT02047227|85945|P1|COMPLETED|Overall Study||318
35500|NCT02047227|85944|P2|Completed Ovarian Stimulation Phase|Overall Study||440
35501|NCT02047227|85945|P1|Completed Ovarian Stimulation Phase|Overall Study||424
35502|NCT02047227|85944|P2|STARTED|Overall Study||477
35503|NCT02047227|85945|P1|STARTED|Overall Study||462
35504|NCT02046993|85963|P2|NOT COMPLETED|Overall Study||11
35505|NCT02046993|85964|P1|NOT COMPLETED|Overall Study||3
35506|NCT02046993|85963|P2|COMPLETED|Overall Study||94
35507|NCT02046993|85964|P1|COMPLETED|Overall Study||102
35508|NCT02046993|85963|P2|6th Month|Overall Study||94
35509|NCT02046993|85964|P1|6th Month|Overall Study||102
35510|NCT02046993|85963|P2|3rd Month|Overall Study||97
35511|NCT02046993|85964|P1|3rd Month|Overall Study||104
35512|NCT02046993|85963|P2|STARTED|Overall Study||105
35513|NCT02046993|85964|P1|STARTED|Overall Study||105
35514|NCT02046980|85983|P3|NOT COMPLETED|Overall Study||1
35515|NCT02046980|85984|P2|NOT COMPLETED|Overall Study||5
35516|NCT02046980|85985|P1|NOT COMPLETED|Overall Study||2
35517|NCT02046980|85983|P3|COMPLETED|Overall Study||72
35518|NCT02046980|85984|P2|COMPLETED|Overall Study||67
35519|NCT02046980|85985|P1|COMPLETED|Overall Study||70
35520|NCT02046980|85983|P3|STARTED|Overall Study||73
35521|NCT02046980|85984|P2|STARTED|Overall Study||72
35522|NCT02046980|85985|P1|STARTED|Overall Study||72
35523|NCT02046863|85993|P1|NOT COMPLETED|Overall Study||0
35524|NCT02046863|85993|P1|COMPLETED|Overall Study||7
35525|NCT02046863|85993|P1|STARTED|Overall Study||7
35526|NCT02046772|85999|P2|NOT COMPLETED|Overall Study||0
35527|NCT02046772|86000|P1|NOT COMPLETED|Overall Study||0
35528|NCT02046772|85999|P2|COMPLETED|Overall Study||33
35529|NCT02046772|86000|P1|COMPLETED|Overall Study||30
35530|NCT02046772|85999|P2|STARTED|Overall Study||33
35531|NCT02046772|86000|P1|STARTED|Overall Study||30
35532|NCT02046616|86014|P1|NOT COMPLETED|8-Week FU Period||1
35533|NCT02046616|86014|P1|COMPLETED|8-Week FU Period||113
35534|NCT02046616|86014|P1|STARTED|8-Week FU Period||114
35535|NCT02046616|86014|P1|NOT COMPLETED|24-Week Treatment Period||19
35536|NCT02046616|86014|P1|COMPLETED|24-Week Treatment Period||114
35537|NCT02046616|86014|P1|STARTED|24-Week Treatment Period||133
35538|NCT02046564|86036|P2|NOT COMPLETED|Overall Study||20
35539|NCT02046564|86037|P1|NOT COMPLETED|Overall Study||15
35540|NCT02046564|86036|P2|COMPLETED|Overall Study||183
35541|NCT02046564|86037|P1|COMPLETED|Overall Study||194
35542|NCT02046564|86036|P2|STARTED|Overall Study||203
35543|NCT02046564|86037|P1|STARTED|Overall Study||209
35544|NCT02046382|86061|P2|NOT COMPLETED|Overall Study||20
35545|NCT02046382|86062|P1|NOT COMPLETED|Overall Study||8
35546|NCT02046382|86061|P2|COMPLETED|Overall Study||47
35547|NCT02046382|86062|P1|COMPLETED|Overall Study||57
35548|NCT02046382|86061|P2|STARTED|Overall Study||67
35549|NCT02046382|86062|P1|STARTED|Overall Study||65
35550|NCT02046369|86076|P2|NOT COMPLETED|Overall Study||18
35551|NCT02046369|86077|P1|NOT COMPLETED|Overall Study||14
35552|NCT02046369|86076|P2|COMPLETED|Overall Study||156
35553|NCT02046369|86077|P1|COMPLETED|Overall Study||162
35554|NCT02046369|86076|P2|STARTED|Overall Study||174
35555|NCT02046369|86077|P1|STARTED|Overall Study||176
35556|NCT02046265|86097|P4|NOT COMPLETED|Overall Study||2
35557|NCT02046265|86098|P3|NOT COMPLETED|Overall Study||2
35558|NCT02046265|86099|P2|NOT COMPLETED|Overall Study||2
35559|NCT02046265|86100|P1|NOT COMPLETED|Overall Study||1
35560|NCT02046265|86097|P4|COMPLETED|Overall Study||12
35561|NCT02046265|86098|P3|COMPLETED|Overall Study||10
35562|NCT02046265|86099|P2|COMPLETED|Overall Study||15
35563|NCT02046265|86100|P1|COMPLETED|Overall Study||16
35564|NCT02046265|86097|P4|STARTED|Overall Study||14
35565|NCT02046265|86098|P3|STARTED|Overall Study||12
35566|NCT02046265|86099|P2|STARTED|Overall Study||17
35567|NCT02046265|86100|P1|STARTED|Overall Study||17
35568|NCT02046226|86110|P1|NOT COMPLETED|Overall Study||7
35569|NCT02046226|86110|P1|COMPLETED|Overall Study||0
35570|NCT02046226|86110|P1|STARTED|Overall Study||7
35571|NCT02046200|86117|P2|NOT COMPLETED|Second Intervention (1 Day)||0
35572|NCT02046200|86118|P1|NOT COMPLETED|Second Intervention (1 Day)||0
35573|NCT02046200|86117|P2|COMPLETED|Second Intervention (1 Day)||6
35574|NCT02046200|86118|P1|COMPLETED|Second Intervention (1 Day)||5
35575|NCT02046200|86117|P2|STARTED|Second Intervention (1 Day)||6
35576|NCT02046200|86118|P1|STARTED|Second Intervention (1 Day)||5
35577|NCT02046200|86117|P2|NOT COMPLETED|First Intervention (1 Day)||0
35578|NCT02046200|86118|P1|NOT COMPLETED|First Intervention (1 Day)||0
35579|NCT02046200|86117|P2|COMPLETED|First Intervention (1 Day)||6
35580|NCT02046200|86118|P1|COMPLETED|First Intervention (1 Day)||5
35581|NCT02046200|86117|P2|STARTED|First Intervention (1 Day)||6
35582|NCT02046200|86118|P1|STARTED|First Intervention (1 Day)||5
35583|NCT02046148|86158|P2|NOT COMPLETED|Overall Study||3
35584|NCT02046148|86159|P1|NOT COMPLETED|Overall Study||1
35585|NCT02046148|86158|P2|COMPLETED|Overall Study||23
35586|NCT02046148|86159|P1|COMPLETED|Overall Study||48
35587|NCT02046148|86158|P2|STARTED|Overall Study||26
35588|NCT02046148|86159|P1|STARTED|Overall Study||49
35589|NCT02045836|86205|P2|NOT COMPLETED|Overall Study||14
35590|NCT02045836|86206|P1|NOT COMPLETED|Overall Study||9
35591|NCT02045836|86205|P2|COMPLETED|Overall Study||419
35592|NCT02045836|86206|P1|COMPLETED|Overall Study||423
35593|NCT02045836|86205|P2|STARTED|Overall Study||433
35594|NCT02045836|86206|P1|STARTED|Overall Study||432
35595|NCT02045797|86238|P3|NOT COMPLETED|Overall Study||1
35596|NCT02045797|86239|P2|NOT COMPLETED|Overall Study||7
35597|NCT02045797|86240|P1|NOT COMPLETED|Overall Study||7
35598|NCT02045797|86238|P3|COMPLETED|Overall Study||24
35599|NCT02045797|86239|P2|COMPLETED|Overall Study||32
35600|NCT02045797|86240|P1|COMPLETED|Overall Study||51
35601|NCT02045797|86238|P3|STARTED|Overall Study||25
35602|NCT02045797|86239|P2|STARTED|Overall Study||39
35603|NCT02045797|86240|P1|STARTED|Overall Study||58
35604|NCT02045732|86385|P2|NOT COMPLETED|Overall Study||1
35605|NCT02045732|86386|P1|NOT COMPLETED|Overall Study||1
35606|NCT02045732|86385|P2|COMPLETED|Overall Study||2
35607|NCT02045732|86386|P1|COMPLETED|Overall Study||0
35608|NCT02045732|86385|P2|STARTED|Overall Study||3
35609|NCT02045732|86386|P1|STARTED|Overall Study||1
35610|NCT02045511|86406|P2|NOT COMPLETED|Overall Study||0
35611|NCT02045511|86407|P1|NOT COMPLETED|Overall Study||0
35612|NCT02045511|86406|P2|COMPLETED|Overall Study||7
35613|NCT02045511|86407|P1|COMPLETED|Overall Study||8
35614|NCT02045511|86406|P2|STARTED|Overall Study||7
35615|NCT02045511|86407|P1|STARTED|Overall Study||8
35616|NCT02045264|86423|P1|NOT COMPLETED|Overall Study||0
35617|NCT02045264|86423|P1|COMPLETED|Overall Study||12
35618|NCT02045264|86423|P1|STARTED|Overall Study||12
35619|NCT02045238|86440|P2|NOT COMPLETED|Overall Study||1
35620|NCT02045238|86441|P1|NOT COMPLETED|Overall Study||7
35621|NCT02045238|86440|P2|COMPLETED|Overall Study||14
35622|NCT02045238|86441|P1|COMPLETED|Overall Study||9
35623|NCT02045238|86440|P2|STARTED|Overall Study||15
35624|NCT02045238|86441|P1|STARTED|Overall Study||16
35625|NCT02045108|86453|P4|NOT COMPLETED|Overall Study||1
35626|NCT02045108|86454|P3|NOT COMPLETED|Overall Study||2
35627|NCT02045108|86455|P2|NOT COMPLETED|Overall Study||3
35628|NCT02045108|86456|P1|NOT COMPLETED|Overall Study||1
35629|NCT02045108|86453|P4|COMPLETED|Overall Study||19
35630|NCT02045108|86454|P3|COMPLETED|Overall Study||18
35631|NCT02045108|86455|P2|COMPLETED|Overall Study||12
35632|NCT02045108|86456|P1|COMPLETED|Overall Study||21
35633|NCT02045108|86453|P4|STARTED|Overall Study||20
35634|NCT02045108|86454|P3|STARTED|Overall Study||20
35635|NCT02045108|86455|P2|STARTED|Overall Study||15
35636|NCT02045108|86456|P1|STARTED|Overall Study||22
35637|NCT02044991|86504|P2|NOT COMPLETED|Overall Study||0
35638|NCT02044991|86505|P1|NOT COMPLETED|Overall Study||0
35639|NCT02044991|86504|P2|COMPLETED|Overall Study||0
35640|NCT02044991|86505|P1|COMPLETED|Overall Study||2
35641|NCT02044991|86504|P2|STARTED|Overall Study||0
35642|NCT02044991|86505|P1|STARTED|Overall Study||2
35643|NCT02044848|86517|P2|NOT COMPLETED|Overall Study||3
35644|NCT02044848|86518|P1|NOT COMPLETED|Overall Study||2
35645|NCT02044848|86517|P2|COMPLETED|Overall Study||0
35646|NCT02044848|86518|P1|COMPLETED|Overall Study||0
35647|NCT02044848|86517|P2|STARTED|Overall Study||3
35648|NCT02044848|86518|P1|STARTED|Overall Study||2
35649|NCT02044822|86524|P1|NOT COMPLETED|Overall Study||93
35650|NCT02044822|86524|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
35651|NCT02044822|86524|P1|STARTED|Overall Study||102
35652|NCT02044458|86536|P2|NOT COMPLETED|Overall Study||8
35653|NCT02044458|86537|P1|NOT COMPLETED|Overall Study||3
35654|NCT02044458|86536|P2|COMPLETED|Overall Study||61
35655|NCT02044458|86537|P1|COMPLETED|Overall Study||62
35656|NCT02044458|86536|P2|STARTED|Overall Study||69
35657|NCT02044458|86537|P1|STARTED|Overall Study||65
35658|NCT02044419|86550|P3|NOT COMPLETED|Third Intervention||0
35659|NCT02044419|86551|P2|NOT COMPLETED|Third Intervention||0
35660|NCT02044419|86552|P1|NOT COMPLETED|Third Intervention||0
35661|NCT02044419|86550|P3|COMPLETED|Third Intervention||10
35662|NCT02044419|86551|P2|COMPLETED|Third Intervention||9
35663|NCT02044419|86552|P1|COMPLETED|Third Intervention||11
35664|NCT02044419|86550|P3|STARTED|Third Intervention||10
35665|NCT02044419|86551|P2|STARTED|Third Intervention||9
35666|NCT02044419|86552|P1|STARTED|Third Intervention||11
35667|NCT02044419|86550|P3|NOT COMPLETED|Second Intervention||0
35668|NCT02044419|86551|P2|NOT COMPLETED|Second Intervention||0
35669|NCT02044419|86552|P1|NOT COMPLETED|Second Intervention||0
35670|NCT02044419|86550|P3|COMPLETED|Second Intervention||10
35671|NCT02044419|86551|P2|COMPLETED|Second Intervention||9
35672|NCT02044419|86552|P1|COMPLETED|Second Intervention||11
35673|NCT02044419|86550|P3|STARTED|Second Intervention||10
35674|NCT02044419|86551|P2|STARTED|Second Intervention||9
35675|NCT02044419|86552|P1|STARTED|Second Intervention||11
35676|NCT02044419|86550|P3|NOT COMPLETED|First Intervention||1
35677|NCT02044419|86551|P2|NOT COMPLETED|First Intervention||1
35678|NCT02044419|86552|P1|NOT COMPLETED|First Intervention||0
35679|NCT02044419|86550|P3|COMPLETED|First Intervention||10
35680|NCT02044419|86551|P2|COMPLETED|First Intervention||9
35681|NCT02044419|86552|P1|COMPLETED|First Intervention||11
35682|NCT02044419|86550|P3|STARTED|First Intervention||11
35683|NCT02044419|86551|P2|STARTED|First Intervention||10
35684|NCT02044419|86552|P1|STARTED|First Intervention||11
35685|NCT02044393|86577|P2|NOT COMPLETED|Period 2||0
35686|NCT02044393|86578|P1|NOT COMPLETED|Period 2||0
35687|NCT02044393|86577|P2|COMPLETED|Period 2||10
35688|NCT02044393|86578|P1|COMPLETED|Period 2||10
35689|NCT02044393|86577|P2|STARTED|Period 2||10
35690|NCT02044393|86578|P1|STARTED|Period 2||10
35691|NCT02044393|86577|P2|NOT COMPLETED|Period 1||0
35692|NCT02044393|86578|P1|NOT COMPLETED|Period 1||0
35693|NCT02044393|86577|P2|COMPLETED|Period 1||10
35694|NCT02044393|86578|P1|COMPLETED|Period 1||10
35695|NCT02044393|86577|P2|STARTED|Period 1||10
35696|NCT02044393|86578|P1|STARTED|Period 1||10
35697|NCT02044380|86591|P1|NOT COMPLETED|Overall Study||0
35698|NCT02044380|86591|P1|COMPLETED|Overall Study||14
35699|NCT02044380|86591|P1|STARTED|Overall Study|Started are the treated patients|14
35700|NCT02044367|86595|P6|NOT COMPLETED|Overall Study||0
35701|NCT02044367|86596|P5|NOT COMPLETED|Overall Study||0
35702|NCT02044367|86597|P4|NOT COMPLETED|Overall Study||0
35703|NCT02044367|86598|P3|NOT COMPLETED|Overall Study||0
35704|NCT02044367|86599|P2|NOT COMPLETED|Overall Study||0
35705|NCT02044367|86600|P1|NOT COMPLETED|Overall Study||0
35706|NCT02044367|86595|P6|COMPLETED|Overall Study||9
35707|NCT02044367|86596|P5|COMPLETED|Overall Study||9
35708|NCT02044367|86597|P4|COMPLETED|Overall Study||9
35709|NCT02044367|86598|P3|COMPLETED|Overall Study||9
35710|NCT02044367|86599|P2|COMPLETED|Overall Study||9
35711|NCT02044367|86600|P1|COMPLETED|Overall Study||9
35712|NCT02044367|86595|P6|STARTED|Overall Study||9
35713|NCT02044367|86596|P5|STARTED|Overall Study||9
35714|NCT02044367|86597|P4|STARTED|Overall Study||9
35715|NCT02044367|86598|P3|STARTED|Overall Study||9
35716|NCT02044367|86599|P2|STARTED|Overall Study||9
35717|NCT02044367|86600|P1|STARTED|Overall Study||9
35718|NCT02044302|86623|P2|NOT COMPLETED|Overall Study||0
35719|NCT02044302|86624|P1|NOT COMPLETED|Overall Study||2
35720|NCT02044302|86623|P2|COMPLETED|Overall Study||0
35721|NCT02044302|86624|P1|COMPLETED|Overall Study||0
35722|NCT02044302|86623|P2|STARTED|Overall Study||0
35723|NCT02044302|86624|P1|STARTED|Overall Study||2
35724|NCT02044094|86630|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
35725|NCT02044094|86630|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
35726|NCT02044094|86630|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
35727|NCT02044094|86630|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
35728|NCT02044094|86630|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
35729|NCT02044094|86630|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
35730|NCT02044094|86630|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
35731|NCT02044094|86630|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
35732|NCT02043938|86687|P1|NOT COMPLETED|Overall Study||10
35733|NCT02043938|86687|P1|COMPLETED|Overall Study||36
35734|NCT02043938|86687|P1|STARTED|Overall Study||46
35735|NCT02043808|86699|P2|NOT COMPLETED|Overall Study||0
35736|NCT02043808|86700|P1|NOT COMPLETED|Overall Study||0
35737|NCT02043808|86699|P2|COMPLETED|Overall Study||12793
35738|NCT02043808|86700|P1|COMPLETED|Overall Study||12793
35739|NCT02043808|86699|P2|STARTED|Overall Study||12793
35740|NCT02043808|86700|P1|STARTED|Overall Study||12793
35741|NCT02043782|86738|P6|NOT COMPLETED|Period 3||0
35742|NCT02043782|86739|P5|NOT COMPLETED|Period 3||0
35743|NCT02043782|86740|P4|NOT COMPLETED|Period 3||0
35744|NCT02043782|86741|P3|NOT COMPLETED|Period 3||0
35745|NCT02043782|86742|P2|NOT COMPLETED|Period 3||0
35746|NCT02043782|86743|P1|NOT COMPLETED|Period 3||0
35747|NCT02043782|86738|P6|COMPLETED|Period 3||6
35748|NCT02043782|86739|P5|COMPLETED|Period 3||6
35749|NCT02043782|86740|P4|COMPLETED|Period 3||6
35750|NCT02043782|86741|P3|COMPLETED|Period 3||6
35751|NCT02043782|86742|P2|COMPLETED|Period 3||6
35752|NCT02043782|86743|P1|COMPLETED|Period 3||7
35753|NCT02043782|86738|P6|STARTED|Period 3||6
35754|NCT02043782|86739|P5|STARTED|Period 3||6
35755|NCT02043782|86740|P4|STARTED|Period 3||6
35756|NCT02043782|86741|P3|STARTED|Period 3||6
35757|NCT02043782|86742|P2|STARTED|Period 3||6
35758|NCT02043782|86743|P1|STARTED|Period 3||7
35759|NCT02043782|86738|P6|NOT COMPLETED|Period 2||0
35760|NCT02043782|86739|P5|NOT COMPLETED|Period 2||0
35761|NCT02043782|86740|P4|NOT COMPLETED|Period 2||0
35762|NCT02043782|86741|P3|NOT COMPLETED|Period 2||0
35763|NCT02043782|86742|P2|NOT COMPLETED|Period 2||0
35764|NCT02043782|86743|P1|NOT COMPLETED|Period 2||0
35765|NCT02043782|86738|P6|COMPLETED|Period 2||6
35766|NCT02043782|86739|P5|COMPLETED|Period 2||6
35767|NCT02043782|86740|P4|COMPLETED|Period 2||6
35768|NCT02043782|86741|P3|COMPLETED|Period 2||6
35769|NCT02043782|86742|P2|COMPLETED|Period 2||6
35770|NCT02043782|86743|P1|COMPLETED|Period 2||7
35771|NCT02043782|86738|P6|STARTED|Period 2||6
35772|NCT02043782|86739|P5|STARTED|Period 2||6
35773|NCT02043782|86740|P4|STARTED|Period 2||6
35774|NCT02043782|86741|P3|STARTED|Period 2||6
35775|NCT02043782|86742|P2|STARTED|Period 2||6
35776|NCT02043782|86743|P1|STARTED|Period 2||7
35777|NCT02043782|86738|P6|NOT COMPLETED|Period 1||0
35778|NCT02043782|86739|P5|NOT COMPLETED|Period 1||0
35779|NCT02043782|86740|P4|NOT COMPLETED|Period 1||0
35780|NCT02043782|86741|P3|NOT COMPLETED|Period 1||1
35781|NCT02043782|86742|P2|NOT COMPLETED|Period 1||0
35782|NCT02043782|86743|P1|NOT COMPLETED|Period 1||0
35783|NCT02043782|86738|P6|COMPLETED|Period 1||6
35784|NCT02043782|86739|P5|COMPLETED|Period 1||6
35785|NCT02043782|86740|P4|COMPLETED|Period 1||6
35786|NCT02043782|86741|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
35787|NCT02043782|86742|P2|COMPLETED|Period 1||6
35788|NCT02043782|86743|P1|COMPLETED|Period 1||7
35789|NCT02043782|86738|P6|STARTED|Period 1||6
35790|NCT02043782|86739|P5|STARTED|Period 1||6
35791|NCT02043782|86740|P4|STARTED|Period 1||6
35792|NCT02043782|86741|P3|STARTED|Period 1||7
35793|NCT02043782|86742|P2|STARTED|Period 1||6
35794|NCT02043782|86743|P1|STARTED|Period 1||7
35795|NCT02043704|86753|P2|NOT COMPLETED|Overall Study||7
35796|NCT02043704|86754|P1|NOT COMPLETED|Overall Study||3
35797|NCT02043704|86753|P2|COMPLETED|Overall Study||43
35798|NCT02043704|86754|P1|COMPLETED|Overall Study||47
35799|NCT02043704|86753|P2|STARTED|Overall Study||50
35800|NCT02043704|86754|P1|STARTED|Overall Study||50
35801|NCT02043652|86784|P1|NOT COMPLETED|Overall Study||26
35802|NCT02043652|86784|P1|COMPLETED|Overall Study||93
35803|NCT02043652|86784|P1|STARTED|Overall Study||119
35804|NCT02043379|86791|P2|NOT COMPLETED|Overall Study||0
35805|NCT02043379|86792|P1|NOT COMPLETED|Overall Study||0
35806|NCT02043379|86791|P2|COMPLETED|Overall Study||20
35807|NCT02043379|86792|P1|COMPLETED|Overall Study||30
35808|NCT02043379|86791|P2|STARTED|Overall Study||20
35809|NCT02043379|86792|P1|STARTED|Overall Study||30
35810|NCT02043366|86854|P6|NOT COMPLETED|Overall Study||2
35811|NCT02043366|86855|P5|NOT COMPLETED|Overall Study||2
35812|NCT02043366|86856|P4|NOT COMPLETED|Overall Study||2
35813|NCT02043366|86857|P3|NOT COMPLETED|Overall Study||2
35814|NCT02043366|86858|P2|NOT COMPLETED|Overall Study||2
35815|NCT02043366|86859|P1|NOT COMPLETED|Overall Study||2
35816|NCT02043366|86854|P6|COMPLETED|Overall Study||28
35817|NCT02043366|86855|P5|COMPLETED|Overall Study||28
35818|NCT02043366|86856|P4|COMPLETED|Overall Study||28
35819|NCT02043366|86857|P3|COMPLETED|Overall Study||28
35820|NCT02043366|86858|P2|COMPLETED|Overall Study||28
35821|NCT02043366|86859|P1|COMPLETED|Overall Study||28
35822|NCT02043366|86854|P6|STARTED|Overall Study||30
35823|NCT02043366|86855|P5|STARTED|Overall Study||30
35824|NCT02043366|86856|P4|STARTED|Overall Study||30
35825|NCT02043366|86857|P3|STARTED|Overall Study||30
35826|NCT02043366|86858|P2|STARTED|Overall Study||30
35827|NCT02043366|86859|P1|STARTED|Overall Study||30
35828|NCT02043145|86882|P3|NOT COMPLETED|Overall Study||0
35829|NCT02043145|86883|P2|NOT COMPLETED|Overall Study||0
35830|NCT02043145|86884|P1|NOT COMPLETED|Overall Study||0
35831|NCT02043145|86882|P3|COMPLETED|Overall Study||425
35832|NCT02043145|86883|P2|COMPLETED|Overall Study||247
35833|NCT02043145|86884|P1|COMPLETED|Overall Study||55
35834|NCT02043145|86882|P3|STARTED|Overall Study||425
35835|NCT02043145|86883|P2|STARTED|Overall Study||247
35836|NCT02043145|86884|P1|STARTED|Overall Study||55
35837|NCT02043132|86897|P2|NOT COMPLETED|Overall Study||9
35838|NCT02043132|86898|P1|NOT COMPLETED|Overall Study||5
35839|NCT02043132|86897|P2|COMPLETED|Overall Study||49
35840|NCT02043132|86898|P1|COMPLETED|Overall Study||53
35841|NCT02043132|86897|P2|STARTED|Overall Study||58
35842|NCT02043132|86898|P1|STARTED|Overall Study||58
35843|NCT02043015|86918|P1|NOT COMPLETED|Overall Study||28
35844|NCT02043015|86918|P1|COMPLETED|Overall Study||87
35845|NCT02043015|86918|P1|STARTED|Overall Study||115
35846|NCT02042924|86931|P1|NOT COMPLETED|Overall Study||1
35847|NCT02042924|86931|P1|COMPLETED|Overall Study||1
35848|NCT02042924|86931|P1|STARTED|Overall Study||2
35849|NCT02042911|86937|P1|NOT COMPLETED|Overall Study||1
35850|NCT02042911|86937|P1|COMPLETED|Overall Study||9
35851|NCT02042911|86937|P1|STARTED|Overall Study||10
35852|NCT02042872|86951|P2|NOT COMPLETED|Overall Study||5
35853|NCT02042872|86952|P1|NOT COMPLETED|Overall Study||0
35854|NCT02042872|86951|P2|COMPLETED|Overall Study||8
35855|NCT02042872|86952|P1|COMPLETED|Overall Study||8
35856|NCT02042872|86951|P2|STARTED|Overall Study||13
35857|NCT02042872|86952|P1|STARTED|Overall Study||8
35858|NCT02042534|86962|P2|NOT COMPLETED|Overall Study||0
35859|NCT02042534|86963|P1|NOT COMPLETED|Overall Study||0
35860|NCT02042534|86962|P2|COMPLETED|Overall Study||94
35861|NCT02042534|86963|P1|COMPLETED|Overall Study||101
35862|NCT02042534|86962|P2|STARTED|Overall Study||94
35863|NCT02042534|86963|P1|STARTED|Overall Study||101
35864|NCT02042443|86979|P2|NOT COMPLETED|Overall Study||26
35865|NCT02042443|86980|P1|NOT COMPLETED|Overall Study||27
35866|NCT02042443|86979|P2|COMPLETED|Overall Study||0
35867|NCT02042443|86980|P1|COMPLETED|Overall Study||0
35868|NCT02042443|86979|P2|Eligible and Analyzable|Overall Study||20
35869|NCT02042443|86980|P1|Eligible and Analyzable|Overall Study||24
35870|NCT02042443|86979|P2|STARTED|Overall Study||26
35871|NCT02042443|86980|P1|STARTED|Overall Study||27
35872|NCT02042404|86992|P2|NOT COMPLETED|Overall Study||0
35873|NCT02042404|86993|P1|NOT COMPLETED|Overall Study||5
35874|NCT02042404|86992|P2|COMPLETED|Overall Study||5
35875|NCT02042404|86993|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
35876|NCT02042404|86992|P2|STARTED|Overall Study||5
35877|NCT02042404|86993|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
35878|NCT02042274|87004|P1|NOT COMPLETED|Overall Study||0
35879|NCT02042274|87004|P1|COMPLETED|Overall Study||12
35880|NCT02042274|87004|P1|STARTED|Overall Study||12
35881|NCT02042131|87012|P3|NOT COMPLETED|Overall Study||0
35882|NCT02042131|87013|P2|NOT COMPLETED|Overall Study||0
35883|NCT02042131|87014|P1|NOT COMPLETED|Overall Study||0
35884|NCT02042131|87012|P3|COMPLETED|Overall Study||33
35885|NCT02042131|87013|P2|COMPLETED|Overall Study||32
35886|NCT02042131|87014|P1|COMPLETED|Overall Study||32
35887|NCT02042131|87012|P3|STARTED|Overall Study||33
35888|NCT02042131|87013|P2|STARTED|Overall Study||32
35889|NCT02042131|87014|P1|STARTED|Overall Study||32
35890|NCT02041533|87033|P2|NOT COMPLETED|Overall Study||258
35891|NCT02041533|87034|P1|NOT COMPLETED|Overall Study||228
35892|NCT02041533|87033|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
35893|NCT02041533|87034|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
35894|NCT02041533|87033|P2|Began Treatment|Overall Study||263
35895|NCT02041533|87034|P1|Began Treatment|Overall Study||267
35896|NCT02041533|87033|P2|STARTED|Overall Study||270
35897|NCT02041533|87034|P1|STARTED|Overall Study||271
35898|NCT02041520|87056|P2|NOT COMPLETED|Overall Study||7
35899|NCT02041520|87057|P1|NOT COMPLETED|Overall Study||6
35900|NCT02041520|87056|P2|COMPLETED|Overall Study||28
35901|NCT02041520|87057|P1|COMPLETED|Overall Study||29
35902|NCT02041520|87056|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
35903|NCT02041520|87057|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
35904|NCT02041377|87077|P1|NOT COMPLETED|Overall Study||0
35905|NCT02041377|87077|P1|COMPLETED|Overall Study||134
35906|NCT02041377|87077|P1|STARTED|Overall Study||134
35907|NCT02041325|87087|P2|NOT COMPLETED|Overall Study||3
35908|NCT02041325|87088|P1|NOT COMPLETED|Overall Study||3
35909|NCT02041325|87087|P2|COMPLETED|Overall Study||13
35910|NCT02041325|87088|P1|COMPLETED|Overall Study||19
35911|NCT02041325|87087|P2|STARTED|Overall Study||16
35912|NCT02041325|87088|P1|STARTED|Overall Study||22
35913|NCT02041286|87100|P1|NOT COMPLETED|Overall Study||1
35914|NCT02041286|87100|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
35915|NCT02041286|87100|P1|STARTED|Overall Study||136
35916|NCT02041221|87114|P6|NOT COMPLETED|Part 2||0
35917|NCT02041221|87115|P5|NOT COMPLETED|Part 2||0
35918|NCT02041221|87116|P4|NOT COMPLETED|Part 2||0
35919|NCT02041221|87117|P3|NOT COMPLETED|Part 2||1
35920|NCT02041221|87118|P2|NOT COMPLETED|Part 2||0
35921|NCT02041221|87119|P1|NOT COMPLETED|Part 2||0
35922|NCT02041221|87114|P6|COMPLETED|Part 2||6
35923|NCT02041221|87115|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
35924|NCT02041221|87116|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
35925|NCT02041221|87117|P3|COMPLETED|Part 2||5
35926|NCT02041221|87118|P2|COMPLETED|Part 2||6
35927|NCT02041221|87119|P1|COMPLETED|Part 2||6
35928|NCT02041221|87114|P6|STARTED|Part 2||6
35929|NCT02041221|87115|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
35930|NCT02041221|87116|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
35931|NCT02041221|87117|P3|STARTED|Part 2||6
35932|NCT02041221|87118|P2|STARTED|Part 2||6
35933|NCT02041221|87119|P1|STARTED|Part 2||6
35934|NCT02041221|87114|P6|NOT COMPLETED|Part 1||0
35935|NCT02041221|87115|P5|NOT COMPLETED|Part 1||0
35936|NCT02041221|87116|P4|NOT COMPLETED|Part 1||0
35937|NCT02041221|87117|P3|NOT COMPLETED|Part 1||0
35938|NCT02041221|87118|P2|NOT COMPLETED|Part 1||0
35939|NCT02041221|87119|P1|NOT COMPLETED|Part 1||0
35940|NCT02041221|87114|P6|COMPLETED|Part 1||10
35941|NCT02041221|87115|P5|COMPLETED|Part 1||6
35942|NCT02041221|87116|P4|COMPLETED|Part 1||6
35943|NCT02041221|87117|P3|COMPLETED|Part 1||6
35944|NCT02041221|87118|P2|COMPLETED|Part 1||6
35945|NCT02041221|87119|P1|COMPLETED|Part 1||6
35946|NCT02041221|87114|P6|STARTED|Part 1||10
35947|NCT02041221|87115|P5|STARTED|Part 1||6
35948|NCT02041221|87116|P4|STARTED|Part 1||6
35949|NCT02041221|87117|P3|STARTED|Part 1||6
35950|NCT02041221|87118|P2|STARTED|Part 1||6
35951|NCT02041221|87119|P1|STARTED|Part 1||6
35952|NCT02040844|87136|P3|NOT COMPLETED|Overall Study||47
35953|NCT02040844|87137|P2|NOT COMPLETED|Overall Study||39
35954|NCT02040844|87138|P1|NOT COMPLETED|Overall Study||50
35955|NCT02040844|87136|P3|COMPLETED|Overall Study||97
35956|NCT02040844|87137|P2|COMPLETED|Overall Study||109
35957|NCT02040844|87138|P1|COMPLETED|Overall Study||88
35958|NCT02040844|87136|P3|STARTED|Overall Study||144
35959|NCT02040844|87137|P2|STARTED|Overall Study||148
35960|NCT02040844|87138|P1|STARTED|Overall Study||138
35961|NCT02040792|87166|P5|NOT COMPLETED|Overall Study||7
35962|NCT02040792|87167|P4|NOT COMPLETED|Overall Study||7
35963|NCT02040792|87168|P3|NOT COMPLETED|Overall Study||3
35964|NCT02040792|87169|P2|NOT COMPLETED|Overall Study||3
35965|NCT02040792|87170|P1|NOT COMPLETED|Overall Study||6
35966|NCT02040792|87166|P5|COMPLETED|Overall Study||67
35967|NCT02040792|87167|P4|COMPLETED|Overall Study||64
35968|NCT02040792|87168|P3|COMPLETED|Overall Study||68
35969|NCT02040792|87169|P2|COMPLETED|Overall Study||65
35970|NCT02040792|87170|P1|COMPLETED|Overall Study||64
35971|NCT02040792|87166|P5|STARTED|Overall Study||74
35972|NCT02040792|87167|P4|STARTED|Overall Study||71
35973|NCT02040792|87168|P3|STARTED|Overall Study||71
35974|NCT02040792|87169|P2|STARTED|Overall Study||68
35975|NCT02040792|87170|P1|STARTED|Overall Study||70
35976|NCT02040779|87185|P3|NOT COMPLETED|Overall Study||4
35977|NCT02040779|87186|P2|NOT COMPLETED|Overall Study||7
35978|NCT02040779|87187|P1|NOT COMPLETED|Overall Study||12
35979|NCT02040779|87185|P3|COMPLETED|Overall Study||88
35980|NCT02040779|87186|P2|COMPLETED|Overall Study||83
35981|NCT02040779|87187|P1|COMPLETED|Overall Study||79
35982|NCT02040779|87185|P3|Full Analysis Set (FAS)|Overall Study||92
35983|NCT02040779|87186|P2|Full Analysis Set (FAS)|Overall Study||88
35984|NCT02040779|87187|P1|Full Analysis Set (FAS)|Overall Study||90
35985|NCT02040779|87185|P3|STARTED|Overall Study||92
35986|NCT02040779|87186|P2|STARTED|Overall Study||90
35987|NCT02040779|87187|P1|STARTED|Overall Study||91
35988|NCT02040766|87227|P5|NOT COMPLETED|Overall Study||13
35989|NCT02040766|87228|P4|NOT COMPLETED|Overall Study||13
35990|NCT02040766|87229|P3|NOT COMPLETED|Overall Study||12
35991|NCT02040766|87230|P2|NOT COMPLETED|Overall Study||10
35992|NCT02040766|87231|P1|NOT COMPLETED|Overall Study||18
35993|NCT02040766|87227|P5|COMPLETED|Overall Study||112
35994|NCT02040766|87228|P4|COMPLETED|Overall Study||112
35995|NCT02040766|87229|P3|COMPLETED|Overall Study||113
35996|NCT02040766|87230|P2|COMPLETED|Overall Study||116
35997|NCT02040766|87231|P1|COMPLETED|Overall Study||109
35998|NCT02040766|87227|P5|STARTED|Overall Study||125
35999|NCT02040766|87228|P4|STARTED|Overall Study||125
36000|NCT02040766|87229|P3|STARTED|Overall Study||125
36001|NCT02040766|87230|P2|STARTED|Overall Study||126
36002|NCT02040766|87231|P1|STARTED|Overall Study||127
36003|NCT02040623|87272|P3|NOT COMPLETED|Overall Study||2
36004|NCT02040623|87273|P2|NOT COMPLETED|Overall Study||6
36005|NCT02040623|87274|P1|NOT COMPLETED|Overall Study||4
36006|NCT02040623|87272|P3|COMPLETED|Overall Study||10
36007|NCT02040623|87273|P2|COMPLETED|Overall Study||6
36008|NCT02040623|87274|P1|COMPLETED|Overall Study||7
36009|NCT02040623|87272|P3|STARTED|Overall Study||12
36010|NCT02040623|87273|P2|STARTED|Overall Study||12
36011|NCT02040623|87274|P1|STARTED|Overall Study||11
36012|NCT02040532|87282|P1|NOT COMPLETED|Overall Study||12
36013|NCT02040532|87282|P1|COMPLETED|Overall Study||20
36014|NCT02040532|87282|P1|Received at Least One Dose of Medication|Overall Study||26
36015|NCT02040532|87282|P1|STARTED|Overall Study||32
36016|NCT02040428|87295|P2|NOT COMPLETED|Overall Study||4
36017|NCT02040428|87296|P1|NOT COMPLETED|Overall Study||5
36018|NCT02040428|87295|P2|COMPLETED|Overall Study||77
36019|NCT02040428|87296|P1|COMPLETED|Overall Study||70
36020|NCT02040428|87295|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
36021|NCT02040428|87296|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
36022|NCT02040428|87295|P2|STARTED|Overall Study||81
36023|NCT02040428|87296|P1|STARTED|Overall Study||75
36024|NCT02040116|87308|P1|NOT COMPLETED|Overall Study||0
36025|NCT02040116|87308|P1|COMPLETED|Overall Study||19
36026|NCT02040116|87308|P1|STARTED|Overall Study||19
36027|NCT02040077|87319|P3|NOT COMPLETED|Overall Study||0
36028|NCT02040077|87320|P2|NOT COMPLETED|Overall Study||0
36029|NCT02040077|87321|P1|NOT COMPLETED|Overall Study||0
36030|NCT02040077|87319|P3|COMPLETED|Overall Study||25
36031|NCT02040077|87320|P2|COMPLETED|Overall Study||24
36032|NCT02040077|87321|P1|COMPLETED|Overall Study||27
36033|NCT02040077|87319|P3|STARTED|Overall Study||25
36034|NCT02040077|87320|P2|STARTED|Overall Study||24
36035|NCT02040077|87321|P1|STARTED|Overall Study||27
36036|NCT02039817|87334|P2|NOT COMPLETED|Overall Study||0
36037|NCT02039817|87335|P1|NOT COMPLETED|Overall Study||0
36038|NCT02039817|87334|P2|COMPLETED|Overall Study||8
36039|NCT02039817|87335|P1|COMPLETED|Overall Study||8
36040|NCT02039817|87334|P2|STARTED|Overall Study||8
36041|NCT02039817|87335|P1|STARTED|Overall Study||8
36042|NCT02039778|87344|P1|NOT COMPLETED|Overall Study||4
36043|NCT02039778|87344|P1|COMPLETED|Overall Study||0
36044|NCT02039778|87344|P1|STARTED|Overall Study||4
36045|NCT02039687|87356|P4|NOT COMPLETED|Overall Study||0
36046|NCT02039687|87357|P3|NOT COMPLETED|Overall Study||3
36047|NCT02039687|87358|P2|NOT COMPLETED|Overall Study||1
36048|NCT02039687|87359|P1|NOT COMPLETED|Overall Study||0
36049|NCT02039687|87356|P4|COMPLETED|Overall Study||16
36050|NCT02039687|87357|P3|COMPLETED|Overall Study||13
36051|NCT02039687|87358|P2|COMPLETED|Overall Study||15
36052|NCT02039687|87359|P1|COMPLETED|Overall Study||16
36053|NCT02039687|87356|P4|STARTED|Overall Study||16
36054|NCT02039687|87357|P3|STARTED|Overall Study||16
36055|NCT02039687|87358|P2|STARTED|Overall Study||16
36056|NCT02039687|87359|P1|STARTED|Overall Study||16
36057|NCT02039674|87394|P9|NOT COMPLETED|Overall Study||45
36058|NCT02039674|87395|P8|NOT COMPLETED|Overall Study||63
36059|NCT02039674|87396|P7|NOT COMPLETED|Overall Study||60
36060|NCT02039674|87397|P6|NOT COMPLETED|Overall Study||7
36061|NCT02039674|87398|P5|NOT COMPLETED|Overall Study||12
36062|NCT02039674|87399|P4|NOT COMPLETED|Overall Study||6
36063|NCT02039674|87400|P3|NOT COMPLETED|Overall Study||24
36064|NCT02039674|87401|P2|NOT COMPLETED|Overall Study||25
36065|NCT02039674|87402|P1|NOT COMPLETED|Overall Study||24
36066|NCT02039674|87394|P9|COMPLETED|Overall Study||0
36067|NCT02039674|87395|P8|COMPLETED|Overall Study||0
36068|NCT02039674|87396|P7|COMPLETED|Overall Study||0
36069|NCT02039674|87397|P6|COMPLETED|Overall Study||0
36070|NCT02039674|87398|P5|COMPLETED|Overall Study||0
36071|NCT02039674|87399|P4|COMPLETED|Overall Study||0
36072|NCT02039674|87400|P3|COMPLETED|Overall Study||0
36073|NCT02039674|87401|P2|COMPLETED|Overall Study||0
36074|NCT02039674|87402|P1|COMPLETED|Overall Study||1
36075|NCT02039674|87394|P9|Treated|Overall Study||45
36076|NCT02039674|87395|P8|Treated|Overall Study|One participant was randomized but did not receive study treatment|62
36077|NCT02039674|87396|P7|Treated|Overall Study|One participant was randomized but did not receive study treatment.|59
36078|NCT02039674|87397|P6|Treated|Overall Study||7
36079|NCT02039674|87398|P5|Treated|Overall Study||12
36080|NCT02039674|87399|P4|Treated|Overall Study||6
36081|NCT02039674|87400|P3|Treated|Overall Study||24
36082|NCT02039674|87401|P2|Treated|Overall Study|One participant was randomized but did not receive study treatment.|24
36083|NCT02039674|87402|P1|Treated|Overall Study||25
36084|NCT02039674|87394|P9|STARTED|Overall Study||45
36085|NCT02039674|87395|P8|STARTED|Overall Study||63
36086|NCT02039674|87396|P7|STARTED|Overall Study||60
36087|NCT02039674|87397|P6|STARTED|Overall Study||7
36088|NCT02039674|87398|P5|STARTED|Overall Study||12
36089|NCT02039674|87399|P4|STARTED|Overall Study||6
36090|NCT02039674|87400|P3|STARTED|Overall Study||24
36091|NCT02039674|87401|P2|STARTED|Overall Study||25
36092|NCT02039674|87402|P1|STARTED|Overall Study||25
36093|NCT02039427|87438|P4|NOT COMPLETED|Overall Study||5
36094|NCT02039427|87439|P3|NOT COMPLETED|Overall Study||3
36095|NCT02039427|87440|P2|NOT COMPLETED|Overall Study||1
36096|NCT02039427|87441|P1|NOT COMPLETED|Overall Study||3
36097|NCT02039427|87438|P4|COMPLETED|Overall Study||43
36098|NCT02039427|87439|P3|COMPLETED|Overall Study||45
36099|NCT02039427|87440|P2|COMPLETED|Overall Study||47
36100|NCT02039427|87441|P1|COMPLETED|Overall Study||45
36101|NCT02039427|87438|P4|STARTED|Overall Study||48
36102|NCT02039427|87439|P3|STARTED|Overall Study||48
36103|NCT02039427|87440|P2|STARTED|Overall Study||48
36104|NCT02039427|87441|P1|STARTED|Overall Study||48
36105|NCT02039414|87461|P2|NOT COMPLETED|Overall Study||2
36106|NCT02039414|87462|P1|NOT COMPLETED|Overall Study||6
36107|NCT02039414|87461|P2|COMPLETED|Overall Study||16
36108|NCT02039414|87462|P1|COMPLETED|Overall Study||16
36109|NCT02039414|87461|P2|STARTED|Overall Study||18
36110|NCT02039414|87462|P1|STARTED|Overall Study||22
36111|NCT02039115|87476|P2|NOT COMPLETED|Overall Study||0
36112|NCT02039115|87477|P1|NOT COMPLETED|Overall Study||0
36113|NCT02039115|87476|P2|COMPLETED|Overall Study||0
36114|NCT02039115|87477|P1|COMPLETED|Overall Study||1
36115|NCT02039115|87476|P2|STARTED|Overall Study||0
36116|NCT02039115|87477|P1|STARTED|Overall Study||1
36117|NCT02038959|87485|P2|NOT COMPLETED|Overall Study||8
36118|NCT02038959|87486|P1|NOT COMPLETED|Overall Study||6
36119|NCT02038959|87485|P2|COMPLETED|Overall Study||89
36120|NCT02038959|87486|P1|COMPLETED|Overall Study||92
36121|NCT02038959|87485|P2|STARTED|Overall Study||97
36122|NCT02038959|87486|P1|STARTED|Overall Study||98
36123|NCT02038933|87514|P1|NOT COMPLETED|Follow-up||19
36124|NCT02038933|87514|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
36125|NCT02038933|87514|P1|STARTED|Follow-up||121
36126|NCT02038933|87514|P1|NOT COMPLETED|Treatment||114
36127|NCT02038933|87514|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
36128|NCT02038933|87514|P1|STARTED|Treatment||121
36129|NCT02038907|87547|P14|NOT COMPLETED|Overall Study||0
36130|NCT02038907|87548|P13|NOT COMPLETED|Overall Study||0
36131|NCT02038907|87549|P12|NOT COMPLETED|Overall Study||0
36132|NCT02038907|87550|P11|NOT COMPLETED|Overall Study||2
36133|NCT02038907|87551|P10|NOT COMPLETED|Overall Study||0
36134|NCT02038907|87552|P9|NOT COMPLETED|Overall Study||0
36135|NCT02038907|87553|P8|NOT COMPLETED|Overall Study||0
36136|NCT02038907|87554|P7|NOT COMPLETED|Overall Study||0
36137|NCT02038907|87555|P6|NOT COMPLETED|Overall Study||0
36138|NCT02038907|87556|P5|NOT COMPLETED|Overall Study||0
36139|NCT02038907|87557|P4|NOT COMPLETED|Overall Study||0
36140|NCT02038907|87558|P3|NOT COMPLETED|Overall Study||0
36141|NCT02038907|87559|P2|NOT COMPLETED|Overall Study||0
36142|NCT02038907|87560|P1|NOT COMPLETED|Overall Study||0
36143|NCT02038907|87547|P14|COMPLETED|Overall Study||31
36144|NCT02038907|87548|P13|COMPLETED|Overall Study||29
36145|NCT02038907|87549|P12|COMPLETED|Overall Study||28
36146|NCT02038907|87550|P11|COMPLETED|Overall Study||27
36147|NCT02038907|87551|P10|COMPLETED|Overall Study||30
36148|NCT02038907|87552|P9|COMPLETED|Overall Study||29
36149|NCT02038907|87553|P8|COMPLETED|Overall Study||32
36150|NCT02038907|87554|P7|COMPLETED|Overall Study||30
36151|NCT02038907|87555|P6|COMPLETED|Overall Study||31
36152|NCT02038907|87556|P5|COMPLETED|Overall Study||30
36153|NCT02038907|87557|P4|COMPLETED|Overall Study||31
36154|NCT02038907|87558|P3|COMPLETED|Overall Study||30
36155|NCT02038907|87559|P2|COMPLETED|Overall Study||30
36156|NCT02038907|87560|P1|COMPLETED|Overall Study||30
36157|NCT02038907|87547|P14|STARTED|Overall Study||31
36158|NCT02038907|87548|P13|STARTED|Overall Study||29
36159|NCT02038907|87549|P12|STARTED|Overall Study||28
36160|NCT02038907|87550|P11|STARTED|Overall Study||29
36161|NCT02038907|87551|P10|STARTED|Overall Study||30
36162|NCT02038907|87552|P9|STARTED|Overall Study||29
36163|NCT02038907|87553|P8|STARTED|Overall Study||32
36164|NCT02038907|87554|P7|STARTED|Overall Study||30
36165|NCT02038907|87555|P6|STARTED|Overall Study||31
36166|NCT02038907|87556|P5|STARTED|Overall Study||30
36167|NCT02038907|87557|P4|STARTED|Overall Study||31
36168|NCT02038907|87558|P3|STARTED|Overall Study||30
36169|NCT02038907|87559|P2|STARTED|Overall Study||30
36170|NCT02038907|87560|P1|STARTED|Overall Study||30
36171|NCT02038829|88088|P12|NOT COMPLETED|Treatment Period 6||0
36172|NCT02038829|88089|P11|NOT COMPLETED|Treatment Period 6||0
36173|NCT02038829|88090|P10|NOT COMPLETED|Treatment Period 6||0
36174|NCT02038829|88091|P9|NOT COMPLETED|Treatment Period 6||0
36175|NCT02038829|88092|P8|NOT COMPLETED|Treatment Period 6||0
36176|NCT02038829|88093|P7|NOT COMPLETED|Treatment Period 6||0
36177|NCT02038829|88094|P6|NOT COMPLETED|Treatment Period 6||0
36178|NCT02038829|88095|P5|NOT COMPLETED|Treatment Period 6||0
36179|NCT02038829|88096|P4|NOT COMPLETED|Treatment Period 6||0
36180|NCT02038829|88097|P3|NOT COMPLETED|Treatment Period 6||1
36181|NCT02038829|88098|P2|NOT COMPLETED|Treatment Period 6||0
36182|NCT02038829|88099|P1|NOT COMPLETED|Treatment Period 6||0
36183|NCT02038829|88088|P12|COMPLETED|Treatment Period 6||8
36184|NCT02038829|88089|P11|COMPLETED|Treatment Period 6||7
36185|NCT02038829|88090|P10|COMPLETED|Treatment Period 6||8
36186|NCT02038829|88091|P9|COMPLETED|Treatment Period 6||7
36187|NCT02038829|88092|P8|COMPLETED|Treatment Period 6||8
36188|NCT02038829|88093|P7|COMPLETED|Treatment Period 6||7
36189|NCT02038829|88094|P6|COMPLETED|Treatment Period 6||7
36190|NCT02038829|88095|P5|COMPLETED|Treatment Period 6||7
36191|NCT02038829|88096|P4|COMPLETED|Treatment Period 6||8
36192|NCT02038829|88097|P3|COMPLETED|Treatment Period 6||7
36193|NCT02038829|88098|P2|COMPLETED|Treatment Period 6||7
36194|NCT02038829|88099|P1|COMPLETED|Treatment Period 6||7
36195|NCT02038829|88088|P12|STARTED|Treatment Period 6||8
36196|NCT02038829|88089|P11|STARTED|Treatment Period 6||7
36197|NCT02038829|88090|P10|STARTED|Treatment Period 6||8
36198|NCT02038829|88091|P9|STARTED|Treatment Period 6||7
36199|NCT02038829|88092|P8|STARTED|Treatment Period 6||8
36200|NCT02038829|88093|P7|STARTED|Treatment Period 6||7
36201|NCT02038829|88094|P6|STARTED|Treatment Period 6||7
36202|NCT02038829|88095|P5|STARTED|Treatment Period 6||7
36203|NCT02038829|88096|P4|STARTED|Treatment Period 6||8
36204|NCT02038829|88097|P3|STARTED|Treatment Period 6||8
36205|NCT02038829|88098|P2|STARTED|Treatment Period 6||7
36206|NCT02038829|88099|P1|STARTED|Treatment Period 6||7
36207|NCT02038829|88088|P12|NOT COMPLETED|Washout Period 5||0
36208|NCT02038829|88089|P11|NOT COMPLETED|Washout Period 5||0
36209|NCT02038829|88090|P10|NOT COMPLETED|Washout Period 5||0
36210|NCT02038829|88091|P9|NOT COMPLETED|Washout Period 5||0
36211|NCT02038829|88092|P8|NOT COMPLETED|Washout Period 5||0
36212|NCT02038829|88093|P7|NOT COMPLETED|Washout Period 5||0
36213|NCT02038829|88094|P6|NOT COMPLETED|Washout Period 5||0
36214|NCT02038829|88095|P5|NOT COMPLETED|Washout Period 5||0
36215|NCT02038829|88096|P4|NOT COMPLETED|Washout Period 5||0
36216|NCT02038829|88097|P3|NOT COMPLETED|Washout Period 5||0
36217|NCT02038829|88098|P2|NOT COMPLETED|Washout Period 5||0
36218|NCT02038829|88099|P1|NOT COMPLETED|Washout Period 5||0
36219|NCT02038829|88088|P12|COMPLETED|Washout Period 5||8
36220|NCT02038829|88089|P11|COMPLETED|Washout Period 5||7
36221|NCT02038829|88090|P10|COMPLETED|Washout Period 5||8
36222|NCT02038829|88091|P9|COMPLETED|Washout Period 5||7
36223|NCT02038829|88092|P8|COMPLETED|Washout Period 5||8
36224|NCT02038829|88093|P7|COMPLETED|Washout Period 5||7
36225|NCT02038829|88094|P6|COMPLETED|Washout Period 5||7
36226|NCT02038829|88095|P5|COMPLETED|Washout Period 5||7
36227|NCT02038829|88096|P4|COMPLETED|Washout Period 5||8
36228|NCT02038829|88097|P3|COMPLETED|Washout Period 5||8
36229|NCT02038829|88098|P2|COMPLETED|Washout Period 5||7
36230|NCT02038829|88099|P1|COMPLETED|Washout Period 5||7
36231|NCT02038829|88088|P12|STARTED|Washout Period 5||8
36232|NCT02038829|88089|P11|STARTED|Washout Period 5||7
36233|NCT02038829|88090|P10|STARTED|Washout Period 5||8
36234|NCT02038829|88091|P9|STARTED|Washout Period 5||7
36235|NCT02038829|88092|P8|STARTED|Washout Period 5||8
36236|NCT02038829|88093|P7|STARTED|Washout Period 5||7
36237|NCT02038829|88094|P6|STARTED|Washout Period 5||7
36238|NCT02038829|88095|P5|STARTED|Washout Period 5||7
36239|NCT02038829|88096|P4|STARTED|Washout Period 5||8
36240|NCT02038829|88097|P3|STARTED|Washout Period 5||8
36241|NCT02038829|88098|P2|STARTED|Washout Period 5||7
36242|NCT02038829|88099|P1|STARTED|Washout Period 5||7
36243|NCT02038829|88088|P12|NOT COMPLETED|Treatment Period 5||0
36244|NCT02038829|88089|P11|NOT COMPLETED|Treatment Period 5||0
36245|NCT02038829|88090|P10|NOT COMPLETED|Treatment Period 5||0
36246|NCT02038829|88091|P9|NOT COMPLETED|Treatment Period 5||0
36247|NCT02038829|88092|P8|NOT COMPLETED|Treatment Period 5||0
36248|NCT02038829|88093|P7|NOT COMPLETED|Treatment Period 5||0
36249|NCT02038829|88094|P6|NOT COMPLETED|Treatment Period 5||0
36250|NCT02038829|88095|P5|NOT COMPLETED|Treatment Period 5||0
36251|NCT02038829|88096|P4|NOT COMPLETED|Treatment Period 5||0
36252|NCT02038829|88097|P3|NOT COMPLETED|Treatment Period 5||0
36253|NCT02038829|88098|P2|NOT COMPLETED|Treatment Period 5||0
36254|NCT02038829|88099|P1|NOT COMPLETED|Treatment Period 5||0
36255|NCT02038829|88088|P12|COMPLETED|Treatment Period 5||8
36256|NCT02038829|88089|P11|COMPLETED|Treatment Period 5||7
36257|NCT02038829|88090|P10|COMPLETED|Treatment Period 5||8
36258|NCT02038829|88091|P9|COMPLETED|Treatment Period 5||7
36259|NCT02038829|88092|P8|COMPLETED|Treatment Period 5||8
36260|NCT02038829|88093|P7|COMPLETED|Treatment Period 5||7
36261|NCT02038829|88094|P6|COMPLETED|Treatment Period 5||7
36262|NCT02038829|88095|P5|COMPLETED|Treatment Period 5||7
36263|NCT02038829|88096|P4|COMPLETED|Treatment Period 5||8
36264|NCT02038829|88097|P3|COMPLETED|Treatment Period 5||8
36265|NCT02038829|88098|P2|COMPLETED|Treatment Period 5||7
36266|NCT02038829|88099|P1|COMPLETED|Treatment Period 5||7
36267|NCT02038829|88088|P12|STARTED|Treatment Period 5||8
36268|NCT02038829|88089|P11|STARTED|Treatment Period 5||7
36269|NCT02038829|88090|P10|STARTED|Treatment Period 5||8
36270|NCT02038829|88091|P9|STARTED|Treatment Period 5||7
36271|NCT02038829|88092|P8|STARTED|Treatment Period 5||8
36272|NCT02038829|88093|P7|STARTED|Treatment Period 5||7
36273|NCT02038829|88094|P6|STARTED|Treatment Period 5||7
36274|NCT02038829|88095|P5|STARTED|Treatment Period 5||7
36275|NCT02038829|88096|P4|STARTED|Treatment Period 5||8
36276|NCT02038829|88097|P3|STARTED|Treatment Period 5||8
36277|NCT02038829|88098|P2|STARTED|Treatment Period 5||7
36278|NCT02038829|88099|P1|STARTED|Treatment Period 5||7
36279|NCT02038829|88088|P12|NOT COMPLETED|Washout Period 4||0
36280|NCT02038829|88089|P11|NOT COMPLETED|Washout Period 4||0
36281|NCT02038829|88090|P10|NOT COMPLETED|Washout Period 4||0
36282|NCT02038829|88091|P9|NOT COMPLETED|Washout Period 4||0
36283|NCT02038829|88092|P8|NOT COMPLETED|Washout Period 4||0
36284|NCT02038829|88093|P7|NOT COMPLETED|Washout Period 4||1
36285|NCT02038829|88094|P6|NOT COMPLETED|Washout Period 4||0
36286|NCT02038829|88095|P5|NOT COMPLETED|Washout Period 4||0
36287|NCT02038829|88096|P4|NOT COMPLETED|Washout Period 4||0
36288|NCT02038829|88097|P3|NOT COMPLETED|Washout Period 4||0
36289|NCT02038829|88098|P2|NOT COMPLETED|Washout Period 4||0
36290|NCT02038829|88099|P1|NOT COMPLETED|Washout Period 4||0
36291|NCT02038829|88088|P12|COMPLETED|Washout Period 4||8
36292|NCT02038829|88089|P11|COMPLETED|Washout Period 4||7
36293|NCT02038829|88090|P10|COMPLETED|Washout Period 4||8
36294|NCT02038829|88091|P9|COMPLETED|Washout Period 4||7
36295|NCT02038829|88092|P8|COMPLETED|Washout Period 4||8
36296|NCT02038829|88093|P7|COMPLETED|Washout Period 4||7
36297|NCT02038829|88094|P6|COMPLETED|Washout Period 4||7
36298|NCT02038829|88095|P5|COMPLETED|Washout Period 4||7
36299|NCT02038829|88096|P4|COMPLETED|Washout Period 4||8
36300|NCT02038829|88097|P3|COMPLETED|Washout Period 4||8
36301|NCT02038829|88098|P2|COMPLETED|Washout Period 4||7
36302|NCT02038829|88099|P1|COMPLETED|Washout Period 4||7
36303|NCT02038829|88088|P12|STARTED|Washout Period 4||8
36304|NCT02038829|88089|P11|STARTED|Washout Period 4||7
36305|NCT02038829|88090|P10|STARTED|Washout Period 4||8
36306|NCT02038829|88091|P9|STARTED|Washout Period 4||7
36307|NCT02038829|88092|P8|STARTED|Washout Period 4||8
36308|NCT02038829|88093|P7|STARTED|Washout Period 4||8
36309|NCT02038829|88094|P6|STARTED|Washout Period 4||7
36310|NCT02038829|88095|P5|STARTED|Washout Period 4||7
36311|NCT02038829|88096|P4|STARTED|Washout Period 4||8
36312|NCT02038829|88097|P3|STARTED|Washout Period 4||8
36313|NCT02038829|88098|P2|STARTED|Washout Period 4||7
36314|NCT02038829|88099|P1|STARTED|Washout Period 4||7
36315|NCT02038829|88088|P12|NOT COMPLETED|Treatment Period 4||0
36316|NCT02038829|88089|P11|NOT COMPLETED|Treatment Period 4||0
36317|NCT02038829|88090|P10|NOT COMPLETED|Treatment Period 4||0
36318|NCT02038829|88091|P9|NOT COMPLETED|Treatment Period 4||0
36319|NCT02038829|88092|P8|NOT COMPLETED|Treatment Period 4||0
36320|NCT02038829|88093|P7|NOT COMPLETED|Treatment Period 4||0
36321|NCT02038829|88094|P6|NOT COMPLETED|Treatment Period 4||0
36322|NCT02038829|88095|P5|NOT COMPLETED|Treatment Period 4||0
36323|NCT02038829|88096|P4|NOT COMPLETED|Treatment Period 4||0
36324|NCT02038829|88097|P3|NOT COMPLETED|Treatment Period 4||0
36325|NCT02038829|88098|P2|NOT COMPLETED|Treatment Period 4||1
36326|NCT02038829|88099|P1|NOT COMPLETED|Treatment Period 4||0
36327|NCT02038829|88088|P12|COMPLETED|Treatment Period 4||8
36328|NCT02038829|88089|P11|COMPLETED|Treatment Period 4||7
36329|NCT02038829|88090|P10|COMPLETED|Treatment Period 4||8
36330|NCT02038829|88091|P9|COMPLETED|Treatment Period 4||7
36331|NCT02038829|88092|P8|COMPLETED|Treatment Period 4||8
36332|NCT02038829|88093|P7|COMPLETED|Treatment Period 4||8
36333|NCT02038829|88094|P6|COMPLETED|Treatment Period 4||7
36334|NCT02038829|88095|P5|COMPLETED|Treatment Period 4||7
36335|NCT02038829|88096|P4|COMPLETED|Treatment Period 4||8
36336|NCT02038829|88097|P3|COMPLETED|Treatment Period 4||8
36337|NCT02038829|88098|P2|COMPLETED|Treatment Period 4||7
36338|NCT02038829|88099|P1|COMPLETED|Treatment Period 4||7
36339|NCT02038829|88088|P12|STARTED|Treatment Period 4||8
36340|NCT02038829|88089|P11|STARTED|Treatment Period 4||7
36341|NCT02038829|88090|P10|STARTED|Treatment Period 4||8
36342|NCT02038829|88091|P9|STARTED|Treatment Period 4||7
36343|NCT02038829|88092|P8|STARTED|Treatment Period 4||8
36344|NCT02038829|88093|P7|STARTED|Treatment Period 4||8
36345|NCT02038829|88094|P6|STARTED|Treatment Period 4||7
36346|NCT02038829|88095|P5|STARTED|Treatment Period 4||7
36347|NCT02038829|88096|P4|STARTED|Treatment Period 4||8
36348|NCT02038829|88097|P3|STARTED|Treatment Period 4||8
36349|NCT02038829|88098|P2|STARTED|Treatment Period 4||8
36350|NCT02038829|88099|P1|STARTED|Treatment Period 4||7
36351|NCT02038829|88088|P12|NOT COMPLETED|Washout Period 3||0
36352|NCT02038829|88089|P11|NOT COMPLETED|Washout Period 3||0
36353|NCT02038829|88090|P10|NOT COMPLETED|Washout Period 3||0
36354|NCT02038829|88091|P9|NOT COMPLETED|Washout Period 3||0
36355|NCT02038829|88092|P8|NOT COMPLETED|Washout Period 3||0
36356|NCT02038829|88093|P7|NOT COMPLETED|Washout Period 3||0
36357|NCT02038829|88094|P6|NOT COMPLETED|Washout Period 3||0
36358|NCT02038829|88095|P5|NOT COMPLETED|Washout Period 3||0
36359|NCT02038829|88096|P4|NOT COMPLETED|Washout Period 3||0
36360|NCT02038829|88097|P3|NOT COMPLETED|Washout Period 3||0
36361|NCT02038829|88098|P2|NOT COMPLETED|Washout Period 3||0
36362|NCT02038829|88099|P1|NOT COMPLETED|Washout Period 3||0
36363|NCT02038829|88088|P12|COMPLETED|Washout Period 3||8
36364|NCT02038829|88089|P11|COMPLETED|Washout Period 3||7
36365|NCT02038829|88090|P10|COMPLETED|Washout Period 3||8
36366|NCT02038829|88091|P9|COMPLETED|Washout Period 3||7
36367|NCT02038829|88092|P8|COMPLETED|Washout Period 3||8
36368|NCT02038829|88093|P7|COMPLETED|Washout Period 3||8
36369|NCT02038829|88094|P6|COMPLETED|Washout Period 3||7
36370|NCT02038829|88095|P5|COMPLETED|Washout Period 3||7
36371|NCT02038829|88096|P4|COMPLETED|Washout Period 3||8
36372|NCT02038829|88097|P3|COMPLETED|Washout Period 3||8
36373|NCT02038829|88098|P2|COMPLETED|Washout Period 3||8
36374|NCT02038829|88099|P1|COMPLETED|Washout Period 3||7
36375|NCT02038829|88088|P12|STARTED|Washout Period 3||8
36376|NCT02038829|88089|P11|STARTED|Washout Period 3||7
36377|NCT02038829|88090|P10|STARTED|Washout Period 3||8
36378|NCT02038829|88091|P9|STARTED|Washout Period 3||7
36379|NCT02038829|88092|P8|STARTED|Washout Period 3||8
36380|NCT02038829|88093|P7|STARTED|Washout Period 3||8
36381|NCT02038829|88094|P6|STARTED|Washout Period 3||7
36382|NCT02038829|88095|P5|STARTED|Washout Period 3||7
36383|NCT02038829|88096|P4|STARTED|Washout Period 3||8
36384|NCT02038829|88097|P3|STARTED|Washout Period 3||8
36385|NCT02038829|88098|P2|STARTED|Washout Period 3||8
36386|NCT02038829|88099|P1|STARTED|Washout Period 3||7
36387|NCT02038829|88088|P12|NOT COMPLETED|Treatment Period 3||0
36388|NCT02038829|88089|P11|NOT COMPLETED|Treatment Period 3||0
36389|NCT02038829|88090|P10|NOT COMPLETED|Treatment Period 3||0
36390|NCT02038829|88091|P9|NOT COMPLETED|Treatment Period 3||0
36391|NCT02038829|88092|P8|NOT COMPLETED|Treatment Period 3||0
36392|NCT02038829|88093|P7|NOT COMPLETED|Treatment Period 3||0
36393|NCT02038829|88094|P6|NOT COMPLETED|Treatment Period 3||0
36394|NCT02038829|88095|P5|NOT COMPLETED|Treatment Period 3||0
36395|NCT02038829|88096|P4|NOT COMPLETED|Treatment Period 3||0
36396|NCT02038829|88097|P3|NOT COMPLETED|Treatment Period 3||0
36397|NCT02038829|88098|P2|NOT COMPLETED|Treatment Period 3||0
36398|NCT02038829|88099|P1|NOT COMPLETED|Treatment Period 3||0
36399|NCT02038829|88088|P12|COMPLETED|Treatment Period 3||8
36400|NCT02038829|88089|P11|COMPLETED|Treatment Period 3||7
36401|NCT02038829|88090|P10|COMPLETED|Treatment Period 3||8
36402|NCT02038829|88091|P9|COMPLETED|Treatment Period 3||7
36403|NCT02038829|88092|P8|COMPLETED|Treatment Period 3||8
36404|NCT02038829|88093|P7|COMPLETED|Treatment Period 3||8
36405|NCT02038829|88094|P6|COMPLETED|Treatment Period 3||7
36406|NCT02038829|88095|P5|COMPLETED|Treatment Period 3||7
36407|NCT02038829|88096|P4|COMPLETED|Treatment Period 3||8
36408|NCT02038829|88097|P3|COMPLETED|Treatment Period 3||8
36409|NCT02038829|88098|P2|COMPLETED|Treatment Period 3||8
36410|NCT02038829|88099|P1|COMPLETED|Treatment Period 3||7
36411|NCT02038829|88088|P12|STARTED|Treatment Period 3||8
36412|NCT02038829|88089|P11|STARTED|Treatment Period 3||7
36413|NCT02038829|88090|P10|STARTED|Treatment Period 3||8
36414|NCT02038829|88091|P9|STARTED|Treatment Period 3||7
36415|NCT02038829|88092|P8|STARTED|Treatment Period 3||8
36416|NCT02038829|88093|P7|STARTED|Treatment Period 3||8
36417|NCT02038829|88094|P6|STARTED|Treatment Period 3||7
36418|NCT02038829|88095|P5|STARTED|Treatment Period 3||7
36419|NCT02038829|88096|P4|STARTED|Treatment Period 3||8
36420|NCT02038829|88097|P3|STARTED|Treatment Period 3||8
36421|NCT02038829|88098|P2|STARTED|Treatment Period 3||8
36422|NCT02038829|88099|P1|STARTED|Treatment Period 3||7
36423|NCT02038829|88088|P12|NOT COMPLETED|Washout Period 2||0
36424|NCT02038829|88089|P11|NOT COMPLETED|Washout Period 2||0
36425|NCT02038829|88090|P10|NOT COMPLETED|Washout Period 2||0
36426|NCT02038829|88091|P9|NOT COMPLETED|Washout Period 2||1
36427|NCT02038829|88092|P8|NOT COMPLETED|Washout Period 2||0
36428|NCT02038829|88093|P7|NOT COMPLETED|Washout Period 2||0
36429|NCT02038829|88094|P6|NOT COMPLETED|Washout Period 2||1
36430|NCT02038829|88095|P5|NOT COMPLETED|Washout Period 2||0
36431|NCT02038829|88096|P4|NOT COMPLETED|Washout Period 2||0
36432|NCT02038829|88097|P3|NOT COMPLETED|Washout Period 2||0
36433|NCT02038829|88098|P2|NOT COMPLETED|Washout Period 2||0
36434|NCT02038829|88099|P1|NOT COMPLETED|Washout Period 2||0
36435|NCT02038829|88088|P12|COMPLETED|Washout Period 2||8
36436|NCT02038829|88089|P11|COMPLETED|Washout Period 2||7
36437|NCT02038829|88090|P10|COMPLETED|Washout Period 2||8
36438|NCT02038829|88091|P9|COMPLETED|Washout Period 2||7
36439|NCT02038829|88092|P8|COMPLETED|Washout Period 2||8
36440|NCT02038829|88093|P7|COMPLETED|Washout Period 2||8
36441|NCT02038829|88094|P6|COMPLETED|Washout Period 2||7
36442|NCT02038829|88095|P5|COMPLETED|Washout Period 2||7
36443|NCT02038829|88096|P4|COMPLETED|Washout Period 2||8
36444|NCT02038829|88097|P3|COMPLETED|Washout Period 2||8
36445|NCT02038829|88098|P2|COMPLETED|Washout Period 2||8
36446|NCT02038829|88099|P1|COMPLETED|Washout Period 2||7
36447|NCT02038829|88088|P12|STARTED|Washout Period 2||8
36448|NCT02038829|88089|P11|STARTED|Washout Period 2||7
36449|NCT02038829|88090|P10|STARTED|Washout Period 2||8
36450|NCT02038829|88091|P9|STARTED|Washout Period 2||8
36451|NCT02038829|88092|P8|STARTED|Washout Period 2||8
36452|NCT02038829|88093|P7|STARTED|Washout Period 2||8
36453|NCT02038829|88094|P6|STARTED|Washout Period 2||8
36454|NCT02038829|88095|P5|STARTED|Washout Period 2||7
36455|NCT02038829|88096|P4|STARTED|Washout Period 2||8
36456|NCT02038829|88097|P3|STARTED|Washout Period 2||8
36457|NCT02038829|88098|P2|STARTED|Washout Period 2||8
36458|NCT02038829|88099|P1|STARTED|Washout Period 2||7
36459|NCT02038829|88088|P12|NOT COMPLETED|Treatment Period 2||0
36460|NCT02038829|88089|P11|NOT COMPLETED|Treatment Period 2||1
36461|NCT02038829|88090|P10|NOT COMPLETED|Treatment Period 2||0
36462|NCT02038829|88091|P9|NOT COMPLETED|Treatment Period 2||0
36463|NCT02038829|88092|P8|NOT COMPLETED|Treatment Period 2||0
36464|NCT02038829|88093|P7|NOT COMPLETED|Treatment Period 2||0
36465|NCT02038829|88094|P6|NOT COMPLETED|Treatment Period 2||0
36466|NCT02038829|88095|P5|NOT COMPLETED|Treatment Period 2||0
36467|NCT02038829|88096|P4|NOT COMPLETED|Treatment Period 2||0
36468|NCT02038829|88097|P3|NOT COMPLETED|Treatment Period 2||0
36469|NCT02038829|88098|P2|NOT COMPLETED|Treatment Period 2||0
36470|NCT02038829|88099|P1|NOT COMPLETED|Treatment Period 2||1
36471|NCT02038829|88088|P12|COMPLETED|Treatment Period 2||8
36472|NCT02038829|88089|P11|COMPLETED|Treatment Period 2||7
36473|NCT02038829|88090|P10|COMPLETED|Treatment Period 2||8
36474|NCT02038829|88091|P9|COMPLETED|Treatment Period 2||8
36475|NCT02038829|88092|P8|COMPLETED|Treatment Period 2||8
36476|NCT02038829|88093|P7|COMPLETED|Treatment Period 2||8
36477|NCT02038829|88094|P6|COMPLETED|Treatment Period 2||8
36478|NCT02038829|88095|P5|COMPLETED|Treatment Period 2||7
36479|NCT02038829|88096|P4|COMPLETED|Treatment Period 2||8
36480|NCT02038829|88097|P3|COMPLETED|Treatment Period 2||8
36481|NCT02038829|88098|P2|COMPLETED|Treatment Period 2||8
36482|NCT02038829|88099|P1|COMPLETED|Treatment Period 2||7
36483|NCT02038829|88088|P12|STARTED|Treatment Period 2||8
36484|NCT02038829|88089|P11|STARTED|Treatment Period 2||8
36485|NCT02038829|88090|P10|STARTED|Treatment Period 2||8
36486|NCT02038829|88091|P9|STARTED|Treatment Period 2||8
36487|NCT02038829|88092|P8|STARTED|Treatment Period 2||8
36488|NCT02038829|88093|P7|STARTED|Treatment Period 2||8
36489|NCT02038829|88094|P6|STARTED|Treatment Period 2||8
36490|NCT02038829|88095|P5|STARTED|Treatment Period 2||7
36491|NCT02038829|88096|P4|STARTED|Treatment Period 2||8
36492|NCT02038829|88097|P3|STARTED|Treatment Period 2||8
36493|NCT02038829|88098|P2|STARTED|Treatment Period 2||8
36494|NCT02038829|88099|P1|STARTED|Treatment Period 2||8
36495|NCT02038829|88088|P12|NOT COMPLETED|Washout Period 1||0
36496|NCT02038829|88089|P11|NOT COMPLETED|Washout Period 1||0
36497|NCT02038829|88090|P10|NOT COMPLETED|Washout Period 1||0
36498|NCT02038829|88091|P9|NOT COMPLETED|Washout Period 1||0
36499|NCT02038829|88092|P8|NOT COMPLETED|Washout Period 1||0
36500|NCT02038829|88093|P7|NOT COMPLETED|Washout Period 1||0
36501|NCT02038829|88094|P6|NOT COMPLETED|Washout Period 1||0
36502|NCT02038829|88095|P5|NOT COMPLETED|Washout Period 1||1
36503|NCT02038829|88096|P4|NOT COMPLETED|Washout Period 1||0
36504|NCT02038829|88097|P3|NOT COMPLETED|Washout Period 1||0
36505|NCT02038829|88098|P2|NOT COMPLETED|Washout Period 1||0
36506|NCT02038829|88099|P1|NOT COMPLETED|Washout Period 1||0
36507|NCT02038829|88088|P12|COMPLETED|Washout Period 1||8
36508|NCT02038829|88089|P11|COMPLETED|Washout Period 1||8
36509|NCT02038829|88090|P10|COMPLETED|Washout Period 1||8
36510|NCT02038829|88091|P9|COMPLETED|Washout Period 1||8
36511|NCT02038829|88092|P8|COMPLETED|Washout Period 1||8
36512|NCT02038829|88093|P7|COMPLETED|Washout Period 1||8
36513|NCT02038829|88094|P6|COMPLETED|Washout Period 1||8
36514|NCT02038829|88095|P5|COMPLETED|Washout Period 1||7
36515|NCT02038829|88096|P4|COMPLETED|Washout Period 1||8
36516|NCT02038829|88097|P3|COMPLETED|Washout Period 1||8
36517|NCT02038829|88098|P2|COMPLETED|Washout Period 1||8
36518|NCT02038829|88099|P1|COMPLETED|Washout Period 1||8
36519|NCT02038829|88088|P12|STARTED|Washout Period 1||8
36520|NCT02038829|88089|P11|STARTED|Washout Period 1||8
36521|NCT02038829|88090|P10|STARTED|Washout Period 1||8
36522|NCT02038829|88091|P9|STARTED|Washout Period 1||8
36523|NCT02038829|88092|P8|STARTED|Washout Period 1||8
36524|NCT02038829|88093|P7|STARTED|Washout Period 1||8
36525|NCT02038829|88094|P6|STARTED|Washout Period 1||8
36526|NCT02038829|88095|P5|STARTED|Washout Period 1||8
36527|NCT02038829|88096|P4|STARTED|Washout Period 1||8
36528|NCT02038829|88097|P3|STARTED|Washout Period 1||8
36529|NCT02038829|88098|P2|STARTED|Washout Period 1||8
36530|NCT02038829|88099|P1|STARTED|Washout Period 1||8
36531|NCT02038829|88088|P12|NOT COMPLETED|Treatment Period 1||0
36532|NCT02038829|88089|P11|NOT COMPLETED|Treatment Period 1||0
36533|NCT02038829|88090|P10|NOT COMPLETED|Treatment Period 1||0
36534|NCT02038829|88091|P9|NOT COMPLETED|Treatment Period 1||0
36535|NCT02038829|88092|P8|NOT COMPLETED|Treatment Period 1||0
36536|NCT02038829|88093|P7|NOT COMPLETED|Treatment Period 1||0
36537|NCT02038829|88094|P6|NOT COMPLETED|Treatment Period 1||0
36538|NCT02038829|88095|P5|NOT COMPLETED|Treatment Period 1||0
36539|NCT02038829|88096|P4|NOT COMPLETED|Treatment Period 1||0
36540|NCT02038829|88097|P3|NOT COMPLETED|Treatment Period 1||0
36541|NCT02038829|88098|P2|NOT COMPLETED|Treatment Period 1||0
36542|NCT02038829|88099|P1|NOT COMPLETED|Treatment Period 1||0
36543|NCT02038829|88088|P12|COMPLETED|Treatment Period 1||8
36544|NCT02038829|88089|P11|COMPLETED|Treatment Period 1||8
36545|NCT02038829|88090|P10|COMPLETED|Treatment Period 1||8
36546|NCT02038829|88091|P9|COMPLETED|Treatment Period 1||8
36547|NCT02038829|88092|P8|COMPLETED|Treatment Period 1||8
36548|NCT02038829|88093|P7|COMPLETED|Treatment Period 1||8
36549|NCT02038829|88094|P6|COMPLETED|Treatment Period 1||8
36550|NCT02038829|88095|P5|COMPLETED|Treatment Period 1||8
36551|NCT02038829|88096|P4|COMPLETED|Treatment Period 1||8
36552|NCT02038829|88097|P3|COMPLETED|Treatment Period 1||8
36553|NCT02038829|88098|P2|COMPLETED|Treatment Period 1||8
36554|NCT02038829|88099|P1|COMPLETED|Treatment Period 1||8
36555|NCT02038829|88088|P12|STARTED|Treatment Period 1||8
36556|NCT02038829|88089|P11|STARTED|Treatment Period 1||8
36557|NCT02038829|88090|P10|STARTED|Treatment Period 1||8
36558|NCT02038829|88091|P9|STARTED|Treatment Period 1||8
36559|NCT02038829|88092|P8|STARTED|Treatment Period 1||8
36560|NCT02038829|88093|P7|STARTED|Treatment Period 1||8
36561|NCT02038829|88094|P6|STARTED|Treatment Period 1||8
36562|NCT02038829|88095|P5|STARTED|Treatment Period 1||8
36563|NCT02038829|88096|P4|STARTED|Treatment Period 1||8
36564|NCT02038829|88097|P3|STARTED|Treatment Period 1||8
36565|NCT02038829|88098|P2|STARTED|Treatment Period 1||8
36566|NCT02038829|88099|P1|STARTED|Treatment Period 1||8
36567|NCT02038790|88133|P2|NOT COMPLETED|Day 1 - Second Treatment||0
36568|NCT02038790|88134|P1|NOT COMPLETED|Day 1 - Second Treatment||0
36569|NCT02038790|88133|P2|COMPLETED|Day 1 - Second Treatment||16
36570|NCT02038790|88134|P1|COMPLETED|Day 1 - Second Treatment||15
36571|NCT02038790|88133|P2|STARTED|Day 1 - Second Treatment||16
36572|NCT02038790|88134|P1|STARTED|Day 1 - Second Treatment||15
36573|NCT02038790|88133|P2|NOT COMPLETED|Day 0 - First Treatment||1
36574|NCT02038790|88134|P1|NOT COMPLETED|Day 0 - First Treatment||1
36575|NCT02038790|88133|P2|COMPLETED|Day 0 - First Treatment||16
36576|NCT02038790|88134|P1|COMPLETED|Day 0 - First Treatment||15
36577|NCT02038790|88133|P2|STARTED|Day 0 - First Treatment||17
36578|NCT02038790|88134|P1|STARTED|Day 0 - First Treatment||16
36579|NCT02038543|88169|P4|NOT COMPLETED|Overall Study||2
36580|NCT02038543|88170|P3|NOT COMPLETED|Overall Study||0
36581|NCT02038543|88171|P2|NOT COMPLETED|Overall Study||0
36582|NCT02038543|88172|P1|NOT COMPLETED|Overall Study||0
36583|NCT02038543|88169|P4|COMPLETED|Overall Study||1
36584|NCT02038543|88170|P3|COMPLETED|Overall Study||8
36585|NCT02038543|88171|P2|COMPLETED|Overall Study||4
36586|NCT02038543|88172|P1|COMPLETED|Overall Study||7
36587|NCT02038543|88169|P4|STARTED|Overall Study||3
36588|NCT02038543|88170|P3|STARTED|Overall Study||8
36589|NCT02038543|88171|P2|STARTED|Overall Study||4
36590|NCT02038543|88172|P1|STARTED|Overall Study||7
36591|NCT02038075|88188|P2|NOT COMPLETED|Overall Study||0
36592|NCT02038075|88189|P1|NOT COMPLETED|Overall Study||3
36593|NCT02038075|88188|P2|COMPLETED|Overall Study||76
36594|NCT02038075|88189|P1|COMPLETED|Overall Study||73
36595|NCT02038075|88188|P2|STARTED|Overall Study||76
36596|NCT02038075|88189|P1|STARTED|Overall Study||76
36597|NCT02037776|88197|P2|NOT COMPLETED|Overall Study||4
36598|NCT02037776|88198|P1|NOT COMPLETED|Overall Study||5
36599|NCT02037776|88197|P2|COMPLETED|Overall Study||60
36600|NCT02037776|88198|P1|COMPLETED|Overall Study||56
36601|NCT02037776|88197|P2|STARTED|Overall Study||64
36602|NCT02037776|88198|P1|STARTED|Overall Study||61
36603|NCT02037607|88214|P1|NOT COMPLETED|Overall Study||9
36604|NCT02037607|88214|P1|COMPLETED|Overall Study||91
36605|NCT02037607|88214|P1|STARTED|Overall Study||100
36606|NCT02037568|88220|P2|NOT COMPLETED|Overall Study||39
36607|NCT02037568|88221|P1|NOT COMPLETED|Overall Study||36
36608|NCT02037568|88220|P2|COMPLETED|Overall Study||37
36609|NCT02037568|88221|P1|COMPLETED|Overall Study||47
36610|NCT02037568|88220|P2|Month 6 (Post Transplantation)|Overall Study||52
36611|NCT02037568|88221|P1|Month 6 (Post Transplantation)|Overall Study||63
36612|NCT02037568|88220|P2|Month 3 (Post Transplantation)|Overall Study||62
36613|NCT02037568|88221|P1|Month 3 (Post Transplantation)|Overall Study||66
36614|NCT02037568|88220|P2|Month 1.5 (Post Transplantation)|Overall Study||76
36615|NCT02037568|88221|P1|Month 1.5 (Post Transplantation)|Overall Study||79
36616|NCT02037568|88220|P2|STARTED|Overall Study||76
36617|NCT02037568|88221|P1|STARTED|Overall Study||83
36618|NCT02037477|88247|P4|NOT COMPLETED|Treatment Period 2||0
36619|NCT02037477|88248|P3|NOT COMPLETED|Treatment Period 2||0
36620|NCT02037477|88249|P2|NOT COMPLETED|Treatment Period 2||0
36621|NCT02037477|88250|P1|NOT COMPLETED|Treatment Period 2||0
36622|NCT02037477|88247|P4|COMPLETED|Treatment Period 2||5
36623|NCT02037477|88248|P3|COMPLETED|Treatment Period 2||4
36624|NCT02037477|88249|P2|COMPLETED|Treatment Period 2||5
36625|NCT02037477|88250|P1|COMPLETED|Treatment Period 2||5
36626|NCT02037477|88247|P4|STARTED|Treatment Period 2||5
36627|NCT02037477|88248|P3|STARTED|Treatment Period 2||4
36628|NCT02037477|88249|P2|STARTED|Treatment Period 2||5
36629|NCT02037477|88250|P1|STARTED|Treatment Period 2||5
36630|NCT02037477|88247|P4|NOT COMPLETED|Treatment Period 1||0
36631|NCT02037477|88248|P3|NOT COMPLETED|Treatment Period 1||1
36632|NCT02037477|88249|P2|NOT COMPLETED|Treatment Period 1||0
36633|NCT02037477|88250|P1|NOT COMPLETED|Treatment Period 1||0
36634|NCT02037477|88247|P4|COMPLETED|Treatment Period 1||5
36635|NCT02037477|88248|P3|COMPLETED|Treatment Period 1||4
36636|NCT02037477|88249|P2|COMPLETED|Treatment Period 1||5
36637|NCT02037477|88250|P1|COMPLETED|Treatment Period 1||5
36638|NCT02037477|88247|P4|STARTED|Treatment Period 1||5
36639|NCT02037477|88248|P3|STARTED|Treatment Period 1||5
36640|NCT02037477|88249|P2|STARTED|Treatment Period 1||5
36641|NCT02037477|88250|P1|STARTED|Treatment Period 1||5
36642|NCT02037425|88276|P1|NOT COMPLETED|Overall Study||26
36643|NCT02037425|88276|P1|COMPLETED|Overall Study||18
36644|NCT02037425|88276|P1|Randomized to Treatment|Overall Study||32
36645|NCT02037425|88276|P1|STARTED|Overall Study||44
36646|NCT02037347|88318|P1|NOT COMPLETED|Overall Study||0
36647|NCT02037347|88318|P1|COMPLETED|Overall Study||1
36648|NCT02037347|88318|P1|STARTED|Overall Study||1
36649|NCT02036840|88324|P1|NOT COMPLETED|Overall Study||0
36650|NCT02036840|88324|P1|COMPLETED|Overall Study||513
36651|NCT02036840|88324|P1|STARTED|Overall Study||513
36652|NCT02036775|88328|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
36653|NCT02036775|88329|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
36654|NCT02036775|88330|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
36655|NCT02036775|88331|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
36656|NCT02036775|88332|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
36657|NCT02036775|88333|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
36658|NCT02036775|88328|P6|COMPLETED|Treatment Period 3 (6 Days)||3
36659|NCT02036775|88329|P5|COMPLETED|Treatment Period 3 (6 Days)||4
36660|NCT02036775|88330|P4|COMPLETED|Treatment Period 3 (6 Days)||4
36661|NCT02036775|88331|P3|COMPLETED|Treatment Period 3 (6 Days)||4
36662|NCT02036775|88332|P2|COMPLETED|Treatment Period 3 (6 Days)||4
36663|NCT02036775|88333|P1|COMPLETED|Treatment Period 3 (6 Days)||4
36664|NCT02036775|88328|P6|STARTED|Treatment Period 3 (6 Days)||3
36665|NCT02036775|88329|P5|STARTED|Treatment Period 3 (6 Days)||4
36666|NCT02036775|88330|P4|STARTED|Treatment Period 3 (6 Days)||4
36667|NCT02036775|88331|P3|STARTED|Treatment Period 3 (6 Days)||4
36668|NCT02036775|88332|P2|STARTED|Treatment Period 3 (6 Days)||4
36669|NCT02036775|88333|P1|STARTED|Treatment Period 3 (6 Days)||4
36670|NCT02036775|88328|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
36671|NCT02036775|88329|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
36672|NCT02036775|88330|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
36673|NCT02036775|88331|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
36674|NCT02036775|88332|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
36675|NCT02036775|88333|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
36676|NCT02036775|88328|P6|COMPLETED|Treatment Period 2 (6 Days)||3
36677|NCT02036775|88329|P5|COMPLETED|Treatment Period 2 (6 Days)||4
36678|NCT02036775|88330|P4|COMPLETED|Treatment Period 2 (6 Days)||4
36679|NCT02036775|88331|P3|COMPLETED|Treatment Period 2 (6 Days)||4
36680|NCT02036775|88332|P2|COMPLETED|Treatment Period 2 (6 Days)||4
36681|NCT02036775|88333|P1|COMPLETED|Treatment Period 2 (6 Days)||4
36682|NCT02036775|88328|P6|STARTED|Treatment Period 2 (6 Days)||4
36683|NCT02036775|88329|P5|STARTED|Treatment Period 2 (6 Days)||4
36684|NCT02036775|88330|P4|STARTED|Treatment Period 2 (6 Days)||4
36685|NCT02036775|88331|P3|STARTED|Treatment Period 2 (6 Days)||4
36686|NCT02036775|88332|P2|STARTED|Treatment Period 2 (6 Days)||4
36687|NCT02036775|88333|P1|STARTED|Treatment Period 2 (6 Days)||4
36688|NCT02036775|88328|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
36689|NCT02036775|88329|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
36690|NCT02036775|88330|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
36691|NCT02036775|88331|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
36692|NCT02036775|88332|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
36693|NCT02036775|88333|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
36694|NCT02036775|88328|P6|COMPLETED|Treatment Period 1 (6 Days)||4
36695|NCT02036775|88329|P5|COMPLETED|Treatment Period 1 (6 Days)||4
36696|NCT02036775|88330|P4|COMPLETED|Treatment Period 1 (6 Days)||4
36697|NCT02036775|88331|P3|COMPLETED|Treatment Period 1 (6 Days)||4
36698|NCT02036775|88332|P2|COMPLETED|Treatment Period 1 (6 Days)||4
36699|NCT02036775|88333|P1|COMPLETED|Treatment Period 1 (6 Days)||4
36700|NCT02036775|88328|P6|STARTED|Treatment Period 1 (6 Days)||4
36701|NCT02036775|88329|P5|STARTED|Treatment Period 1 (6 Days)||4
36702|NCT02036775|88330|P4|STARTED|Treatment Period 1 (6 Days)||4
36703|NCT02036775|88331|P3|STARTED|Treatment Period 1 (6 Days)||4
36704|NCT02036775|88332|P2|STARTED|Treatment Period 1 (6 Days)||4
36705|NCT02036775|88333|P1|STARTED|Treatment Period 1 (6 Days)||4
36706|NCT02036580|88374|P3|NOT COMPLETED|Overall Study||0
36707|NCT02036580|88375|P2|NOT COMPLETED|Overall Study||1
36708|NCT02036580|88376|P1|NOT COMPLETED|Overall Study||1
36709|NCT02036580|88374|P3|COMPLETED|Overall Study||4
36710|NCT02036580|88375|P2|COMPLETED|Overall Study||7
36711|NCT02036580|88376|P1|COMPLETED|Overall Study||7
36712|NCT02036580|88374|P3|STARTED|Overall Study||4
36713|NCT02036580|88375|P2|STARTED|Overall Study||8
36714|NCT02036580|88376|P1|STARTED|Overall Study||8
36715|NCT02036541|88389|P1|NOT COMPLETED|Overall Study||16
36716|NCT02036541|88389|P1|COMPLETED|Overall Study||49
36717|NCT02036541|88389|P1|Completed Endpoint Visit|Overall Study||54
36718|NCT02036541|88389|P1|STARTED|Overall Study||65
36719|NCT02036515|88397|P3|NOT COMPLETED|Overall Study||14
36720|NCT02036515|88398|P2|NOT COMPLETED|Overall Study||12
36721|NCT02036515|88399|P1|NOT COMPLETED|Overall Study||5
36722|NCT02036515|88397|P3|COMPLETED|Overall Study||139
36723|NCT02036515|88398|P2|COMPLETED|Overall Study||143
36724|NCT02036515|88399|P1|COMPLETED|Overall Study||151
36725|NCT02036515|88397|P3|Treated|Overall Study||153
36726|NCT02036515|88398|P2|Treated|Overall Study||153
36727|NCT02036515|88399|P1|Treated|Overall Study||156
36728|NCT02036515|88397|P3|STARTED|Overall Study||153
36729|NCT02036515|88398|P2|STARTED|Overall Study||155
36730|NCT02036515|88399|P1|STARTED|Overall Study||156
36731|NCT02036424|88478|P2|NOT COMPLETED|Overall Study||0
36732|NCT02036424|88479|P1|NOT COMPLETED|Overall Study||0
36733|NCT02036424|88478|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
36734|NCT02036424|88479|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
36735|NCT02036424|88478|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
36736|NCT02036424|88479|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
36737|NCT02036320|88487|P2|NOT COMPLETED|Period 2||0
36738|NCT02036320|88488|P1|NOT COMPLETED|Period 2||0
36739|NCT02036320|88487|P2|COMPLETED|Period 2||95
36740|NCT02036320|88488|P1|COMPLETED|Period 2||95
36741|NCT02036320|88487|P2|STARTED|Period 2||95
36742|NCT02036320|88488|P1|STARTED|Period 2||95
36743|NCT02036320|88487|P2|NOT COMPLETED|Period 1||0
36744|NCT02036320|88488|P1|NOT COMPLETED|Period 1||0
36745|NCT02036320|88487|P2|COMPLETED|Period 1||95
36746|NCT02036320|88488|P1|COMPLETED|Period 1||95
36747|NCT02036320|88487|P2|STARTED|Period 1||95
36748|NCT02036320|88488|P1|STARTED|Period 1||95
36749|NCT02035748|88498|P1|NOT COMPLETED|Overall Study||20
36750|NCT02035748|88498|P1|COMPLETED|Overall Study||448
36751|NCT02035748|88498|P1|STARTED|Overall Study||468
36752|NCT02035696|88512|P4|NOT COMPLETED|Overall Study||3
36753|NCT02035696|88513|P3|NOT COMPLETED|Overall Study||3
36754|NCT02035696|88514|P2|NOT COMPLETED|Overall Study||3
36755|NCT02035696|88515|P1|NOT COMPLETED|Overall Study||3
36756|NCT02035696|88512|P4|COMPLETED|Overall Study||161
36757|NCT02035696|88513|P3|COMPLETED|Overall Study||164
36758|NCT02035696|88514|P2|COMPLETED|Overall Study||163
36759|NCT02035696|88515|P1|COMPLETED|Overall Study||171
36760|NCT02035696|88512|P4|STARTED|Overall Study||164
36761|NCT02035696|88513|P3|STARTED|Overall Study||167
36762|NCT02035696|88514|P2|STARTED|Overall Study||166
36763|NCT02035696|88515|P1|STARTED|Overall Study||174
36764|NCT02035553|88571|P2|NOT COMPLETED|Overall Study||23
36765|NCT02035553|88572|P1|NOT COMPLETED|Overall Study||18
36766|NCT02035553|88571|P2|COMPLETED|Overall Study||67
36767|NCT02035553|88572|P1|COMPLETED|Overall Study||73
36768|NCT02035553|88571|P2|STARTED|Overall Study||90
36769|NCT02035553|88572|P1|STARTED|Overall Study||91
36770|NCT02035475|88578|P1|NOT COMPLETED|Overall Study||6
36771|NCT02035475|88578|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
36772|NCT02035475|88578|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
36773|NCT02035345|88584|P1|NOT COMPLETED|Overall Study||0
36774|NCT02035345|88584|P1|COMPLETED|Overall Study||15
36775|NCT02035345|88584|P1|STARTED|Overall Study||15
36776|NCT02035332|88589|P1|NOT COMPLETED|Overall Study||1
36777|NCT02035332|88589|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
36778|NCT02035332|88589|P1|Treated|Overall Study|Treatment Completed|20
36779|NCT02035332|88589|P1|STARTED|Overall Study|Treatment Attempted|21
36780|NCT02034916|88597|P2|NOT COMPLETED|Overall Study||35
36781|NCT02034916|88598|P1|NOT COMPLETED|Overall Study||49
36782|NCT02034916|88597|P2|COMPLETED|Overall Study||0
36783|NCT02034916|88598|P1|COMPLETED|Overall Study||0
36784|NCT02034916|88597|P2|Treated|Overall Study||35
36785|NCT02034916|88598|P1|Treated|Overall Study||48
36786|NCT02034916|88597|P2|STARTED|Overall Study||35
36787|NCT02034916|88598|P1|STARTED|Overall Study||49
36788|NCT02034877|88633|P2|NOT COMPLETED|Overall Study||6
36789|NCT02034877|88634|P1|NOT COMPLETED|Overall Study||0
36790|NCT02034877|88633|P2|COMPLETED|Overall Study||993
36791|NCT02034877|88634|P1|COMPLETED|Overall Study||200
36792|NCT02034877|88633|P2|STARTED|Overall Study||999
36793|NCT02034877|88634|P1|STARTED|Overall Study||200
36794|NCT02034799|88652|P2|NOT COMPLETED|Overall Study||4
36795|NCT02034799|88653|P1|NOT COMPLETED|Overall Study||2
36796|NCT02034799|88652|P2|COMPLETED|Overall Study||123
36797|NCT02034799|88653|P1|COMPLETED|Overall Study||127
36798|NCT02034799|88652|P2|STARTED|Overall Study||127
36799|NCT02034799|88653|P1|STARTED|Overall Study||129
36800|NCT02034708|88667|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
36801|NCT02034708|88668|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
36802|NCT02034708|88667|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
36803|NCT02034708|88668|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
36804|NCT02034708|88667|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
36805|NCT02034708|88668|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
36806|NCT02034708|88667|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
36807|NCT02034708|88668|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
36808|NCT02034708|88667|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
36809|NCT02034708|88668|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
36810|NCT02034708|88667|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
36811|NCT02034708|88668|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
36812|NCT02034708|88667|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
36813|NCT02034708|88668|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
36814|NCT02034708|88667|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
36815|NCT02034708|88668|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
36816|NCT02034708|88667|P2|STARTED|First Contrast Agent Injection (1 Day)||130
36817|NCT02034708|88668|P1|STARTED|First Contrast Agent Injection (1 Day)||138
36818|NCT02034591|88679|P6|NOT COMPLETED|Overall Study||0
36819|NCT02034591|88680|P5|NOT COMPLETED|Overall Study||1
36820|NCT02034591|88681|P4|NOT COMPLETED|Overall Study||0
36821|NCT02034591|88682|P3|NOT COMPLETED|Overall Study||0
36822|NCT02034591|88683|P2|NOT COMPLETED|Overall Study||0
36823|NCT02034591|88684|P1|NOT COMPLETED|Overall Study||0
36824|NCT02034591|88679|P6|COMPLETED|Overall Study||3
36825|NCT02034591|88680|P5|COMPLETED|Overall Study||3
36826|NCT02034591|88681|P4|COMPLETED|Overall Study||3
36827|NCT02034591|88682|P3|COMPLETED|Overall Study||4
36828|NCT02034591|88683|P2|COMPLETED|Overall Study||3
36829|NCT02034591|88684|P1|COMPLETED|Overall Study||4
36830|NCT02034591|88679|P6|STARTED|Overall Study||3
36831|NCT02034591|88680|P5|STARTED|Overall Study||4
36832|NCT02034591|88681|P4|STARTED|Overall Study||3
36833|NCT02034591|88682|P3|STARTED|Overall Study||4
36834|NCT02034591|88683|P2|STARTED|Overall Study||3
36835|NCT02034591|88684|P1|STARTED|Overall Study||4
36836|NCT02034578|88707|P6|NOT COMPLETED|Overall Study||0
36837|NCT02034578|88708|P5|NOT COMPLETED|Overall Study||0
36838|NCT02034578|88709|P4|NOT COMPLETED|Overall Study||0
36839|NCT02034578|88710|P3|NOT COMPLETED|Overall Study||0
36840|NCT02034578|88711|P2|NOT COMPLETED|Overall Study||0
36841|NCT02034578|88712|P1|NOT COMPLETED|Overall Study||0
36842|NCT02034578|88707|P6|COMPLETED|Overall Study||3
36843|NCT02034578|88708|P5|COMPLETED|Overall Study||4
36844|NCT02034578|88709|P4|COMPLETED|Overall Study||3
36845|NCT02034578|88710|P3|COMPLETED|Overall Study||4
36846|NCT02034578|88711|P2|COMPLETED|Overall Study||3
36847|NCT02034578|88712|P1|COMPLETED|Overall Study||4
36848|NCT02034578|88707|P6|STARTED|Overall Study||3
36849|NCT02034578|88708|P5|STARTED|Overall Study||4
36850|NCT02034578|88709|P4|STARTED|Overall Study||3
36851|NCT02034578|88710|P3|STARTED|Overall Study||4
36852|NCT02034578|88711|P2|STARTED|Overall Study||3
36853|NCT02034578|88712|P1|STARTED|Overall Study||4
36854|NCT02034565|88739|P2|NOT COMPLETED|Overall Study||0
36855|NCT02034565|88740|P1|NOT COMPLETED|Overall Study||1
36856|NCT02034565|88739|P2|COMPLETED|Overall Study||7
36857|NCT02034565|88740|P1|COMPLETED|Overall Study||6
36858|NCT02034565|88739|P2|STARTED|Overall Study||7
36859|NCT02034565|88740|P1|STARTED|Overall Study||7
36860|NCT02034552|88757|P3|NOT COMPLETED|Overall Study||15
36861|NCT02034552|88758|P2|NOT COMPLETED|Overall Study||17
36862|NCT02034552|88759|P1|NOT COMPLETED|Overall Study||6
36863|NCT02034552|88757|P3|COMPLETED|Overall Study||7
36864|NCT02034552|88758|P2|COMPLETED|Overall Study||7
36865|NCT02034552|88759|P1|COMPLETED|Overall Study||16
36866|NCT02034552|88757|P3|Received Treatment|Overall Study||22
36867|NCT02034552|88758|P2|Received Treatment|Overall Study||22
36868|NCT02034552|88759|P1|Received Treatment|Overall Study||19
36869|NCT02034552|88757|P3|STARTED|Overall Study||22
36870|NCT02034552|88758|P2|STARTED|Overall Study||24
36871|NCT02034552|88759|P1|STARTED|Overall Study||22
36872|NCT02034513|88784|P2|NOT COMPLETED|Overall Study||57
36873|NCT02034513|88785|P1|NOT COMPLETED|Overall Study||49
36874|NCT02034513|88784|P2|COMPLETED|Overall Study||195
36875|NCT02034513|88785|P1|COMPLETED|Overall Study||200
36876|NCT02034513|88784|P2|Exposed|Overall Study||251
36877|NCT02034513|88785|P1|Exposed|Overall Study||249
36878|NCT02034513|88784|P2|STARTED|Overall Study||252
36879|NCT02034513|88785|P1|STARTED|Overall Study||249
36880|NCT02034162|88803|P3|NOT COMPLETED|Open-label||0
36881|NCT02034162|88804|P2|NOT COMPLETED|Open-label||0
36882|NCT02034162|88805|P1|NOT COMPLETED|Open-label||0
36883|NCT02034162|88803|P3|COMPLETED|Open-label||278
36884|NCT02034162|88804|P2|COMPLETED|Open-label||0
36885|NCT02034162|88805|P1|COMPLETED|Open-label||0
36886|NCT02034162|88803|P3|STARTED|Open-label||278
36887|NCT02034162|88804|P2|STARTED|Open-label||0
36888|NCT02034162|88805|P1|STARTED|Open-label||0
36889|NCT02034162|88803|P3|NOT COMPLETED|Double-blind||0
36890|NCT02034162|88804|P2|NOT COMPLETED|Double-blind||8
36891|NCT02034162|88805|P1|NOT COMPLETED|Double-blind||9
36892|NCT02034162|88803|P3|COMPLETED|Double-blind||0
36893|NCT02034162|88804|P2|COMPLETED|Double-blind||141
36894|NCT02034162|88805|P1|COMPLETED|Double-blind||137
36895|NCT02034162|88803|P3|STARTED|Double-blind||0
36896|NCT02034162|88804|P2|STARTED|Double-blind||149
36897|NCT02034162|88805|P1|STARTED|Double-blind||146
36898|NCT02033499|88836|P3|NOT COMPLETED|Overall Study||9
36899|NCT02033499|88837|P2|NOT COMPLETED|Overall Study||8
36900|NCT02033499|88838|P1|NOT COMPLETED|Overall Study||5
36901|NCT02033499|88836|P3|COMPLETED|Overall Study||139
36902|NCT02033499|88837|P2|COMPLETED|Overall Study||142
36903|NCT02033499|88838|P1|COMPLETED|Overall Study||147
36904|NCT02033499|88836|P3|STARTED|Overall Study||148
36905|NCT02033499|88837|P2|STARTED|Overall Study||150
36906|NCT02033499|88838|P1|STARTED|Overall Study||152
36907|NCT02033369|88878|P2|NOT COMPLETED|Overall Study||5
36908|NCT02033369|88879|P1|NOT COMPLETED|Overall Study||5
36909|NCT02033369|88878|P2|COMPLETED|Overall Study||21
36910|NCT02033369|88879|P1|COMPLETED|Overall Study||21
36911|NCT02033369|88878|P2|STARTED|Overall Study||26
36912|NCT02033369|88879|P1|STARTED|Overall Study||26
36913|NCT02033317|88889|P1|NOT COMPLETED|Overall Study||0
36914|NCT02033317|88889|P1|COMPLETED|Overall Study||6
36915|NCT02033317|88889|P1|STARTED|Overall Study||6
36916|NCT02033213|88896|P2|NOT COMPLETED|Overall Study||0
36917|NCT02033213|88897|P1|NOT COMPLETED|Overall Study||0
36918|NCT02033213|88896|P2|COMPLETED|Overall Study||8
36919|NCT02033213|88897|P1|COMPLETED|Overall Study||8
36920|NCT02033213|88896|P2|STARTED|Overall Study||8
36921|NCT02033213|88897|P1|STARTED|Overall Study||8
36922|NCT02033200|88915|P2|NOT COMPLETED|Overall Study||0
36923|NCT02033200|88916|P1|NOT COMPLETED|Overall Study||0
36924|NCT02033200|88915|P2|COMPLETED|Overall Study||40
36925|NCT02033200|88916|P1|COMPLETED|Overall Study||40
36926|NCT02033200|88915|P2|STARTED|Overall Study||40
36927|NCT02033200|88916|P1|STARTED|Overall Study||40
36928|NCT02033174|88936|P2|NOT COMPLETED|Second Intervention||0
36929|NCT02033174|88937|P1|NOT COMPLETED|Second Intervention||0
36930|NCT02033174|88936|P2|COMPLETED|Second Intervention||8
36931|NCT02033174|88937|P1|COMPLETED|Second Intervention||8
36932|NCT02033174|88936|P2|STARTED|Second Intervention||8
36933|NCT02033174|88937|P1|STARTED|Second Intervention||8
36934|NCT02033174|88936|P2|NOT COMPLETED|Washout (1 Week)||0
36935|NCT02033174|88937|P1|NOT COMPLETED|Washout (1 Week)||0
36936|NCT02033174|88936|P2|COMPLETED|Washout (1 Week)||8
36937|NCT02033174|88937|P1|COMPLETED|Washout (1 Week)||8
36938|NCT02033174|88936|P2|STARTED|Washout (1 Week)||8
36939|NCT02033174|88937|P1|STARTED|Washout (1 Week)||8
36940|NCT02033174|88936|P2|NOT COMPLETED|First Intervention||0
36941|NCT02033174|88937|P1|NOT COMPLETED|First Intervention||0
36942|NCT02033174|88936|P2|COMPLETED|First Intervention||8
36943|NCT02033174|88937|P1|COMPLETED|First Intervention||8
36944|NCT02033174|88936|P2|STARTED|First Intervention||8
36945|NCT02033174|88937|P1|STARTED|First Intervention||8
36946|NCT02032901|88945|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
36947|NCT02032901|88946|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
36948|NCT02032901|88945|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
36949|NCT02032901|88946|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
36950|NCT02032901|88945|P2|STARTED|Follow-Up Period (24 Weeks)||51
36951|NCT02032901|88946|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
36952|NCT02032901|88945|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
36953|NCT02032901|88946|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
36954|NCT02032901|88945|P2|COMPLETED|Treatment Period (12 Weeks)||51
36955|NCT02032901|88946|P1|COMPLETED|Treatment Period (12 Weeks)||100
36956|NCT02032901|88945|P2|STARTED|Treatment Period (12 Weeks)||51
36957|NCT02032901|88946|P1|STARTED|Treatment Period (12 Weeks)||101
36958|NCT02032888|88970|P3|NOT COMPLETED|Follow-up Period||0
36959|NCT02032888|88971|P2|NOT COMPLETED|Follow-up Period||2
36960|NCT02032888|88972|P1|NOT COMPLETED|Follow-up Period||3
36961|NCT02032888|88970|P3|COMPLETED|Follow-up Period||52
36962|NCT02032888|88971|P2|COMPLETED|Follow-up Period||47
36963|NCT02032888|88972|P1|COMPLETED|Follow-up Period||97
36964|NCT02032888|88970|P3|STARTED|Follow-up Period||52
36965|NCT02032888|88971|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
36966|NCT02032888|88972|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
36967|NCT02032888|88970|P3|NOT COMPLETED|Treatment Period||0
36968|NCT02032888|88971|P2|NOT COMPLETED|Treatment Period||2
36969|NCT02032888|88972|P1|NOT COMPLETED|Treatment Period||2
36970|NCT02032888|88970|P3|COMPLETED|Treatment Period||52
36971|NCT02032888|88971|P2|COMPLETED|Treatment Period||48
36972|NCT02032888|88972|P1|COMPLETED|Treatment Period||99
36973|NCT02032888|88970|P3|STARTED|Treatment Period||52
36974|NCT02032888|88971|P2|STARTED|Treatment Period||50
36975|NCT02032888|88972|P1|STARTED|Treatment Period||101
36976|NCT02032875|89003|P2|NOT COMPLETED|Follow-up Period||11
36977|NCT02032875|89004|P1|NOT COMPLETED|Follow-up Period||3
36978|NCT02032875|89003|P2|COMPLETED|Follow-up Period||46
36979|NCT02032875|89004|P1|COMPLETED|Follow-up Period||50
36980|NCT02032875|89003|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
36981|NCT02032875|89004|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
36982|NCT02032875|89003|P2|NOT COMPLETED|Treatment Period||4
36983|NCT02032875|89004|P1|NOT COMPLETED|Treatment Period||1
36984|NCT02032875|89003|P2|COMPLETED|Treatment Period||56
36985|NCT02032875|89004|P1|COMPLETED|Treatment Period||52
36986|NCT02032875|89003|P2|STARTED|Treatment Period||60
36987|NCT02032875|89004|P1|STARTED|Treatment Period||53
36988|NCT02032758|89024|P2|NOT COMPLETED|Overall Study||0
36989|NCT02032758|89025|P1|NOT COMPLETED|Overall Study||0
36990|NCT02032758|89024|P2|COMPLETED|Overall Study||11
36991|NCT02032758|89025|P1|COMPLETED|Overall Study||27
36992|NCT02032758|89024|P2|STARTED|Overall Study||11
36993|NCT02032758|89025|P1|STARTED|Overall Study||27
36994|NCT02032706|89033|P1|NOT COMPLETED|Overall Study||6
36995|NCT02032706|89033|P1|COMPLETED|Overall Study||30
36996|NCT02032706|89033|P1|STARTED|Overall Study||36
36997|NCT02032641|89046|P1|NOT COMPLETED|Overall Study||1
36998|NCT02032641|89046|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
36999|NCT02032641|89046|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
37000|NCT02032433|89058|P2|NOT COMPLETED|Overall Study||0
37001|NCT02032433|89059|P1|NOT COMPLETED|Overall Study||0
37002|NCT02032433|89058|P2|COMPLETED|Overall Study||287
37003|NCT02032433|89059|P1|COMPLETED|Overall Study||283
37004|NCT02032433|89058|P2|STARTED|Overall Study||287
37005|NCT02032433|89059|P1|STARTED|Overall Study||283
37006|NCT02032420|89077|P2|NOT COMPLETED|Overall Study||0
37007|NCT02032420|89078|P1|NOT COMPLETED|Overall Study||0
37008|NCT02032420|89077|P2|COMPLETED|Overall Study||17
37009|NCT02032420|89078|P1|COMPLETED|Overall Study||18
37010|NCT02032420|89077|P2|STARTED|Overall Study||17
37011|NCT02032420|89078|P1|STARTED|Overall Study||18
37012|NCT02032407|89090|P1|NOT COMPLETED|Overall Study||5
37013|NCT02032407|89090|P1|COMPLETED|Overall Study||63
37014|NCT02032407|89090|P1|STARTED|Overall Study||68
37015|NCT02032238|89103|P2|NOT COMPLETED|Overall Study||0
37016|NCT02032238|89104|P1|NOT COMPLETED|Overall Study||2
37017|NCT02032238|89103|P2|COMPLETED|Overall Study||0
37018|NCT02032238|89104|P1|COMPLETED|Overall Study||10
37019|NCT02032238|89103|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
37020|NCT02032238|89104|P1|STARTED|Overall Study||12
37021|NCT02032212|89114|P4|NOT COMPLETED|Overall Study||0
37022|NCT02032212|89115|P3|NOT COMPLETED|Overall Study||0
37023|NCT02032212|89116|P2|NOT COMPLETED|Overall Study||0
37024|NCT02032212|89117|P1|NOT COMPLETED|Overall Study||0
37025|NCT02032212|89114|P4|COMPLETED|Overall Study||3
37026|NCT02032212|89115|P3|COMPLETED|Overall Study||3
37027|NCT02032212|89116|P2|COMPLETED|Overall Study||3
37028|NCT02032212|89117|P1|COMPLETED|Overall Study||3
37029|NCT02032212|89114|P4|STARTED|Overall Study||3
37030|NCT02032212|89115|P3|STARTED|Overall Study||3
37031|NCT02032212|89116|P2|STARTED|Overall Study||3
37032|NCT02032212|89117|P1|STARTED|Overall Study||3
37033|NCT02031679|89145|P2|NOT COMPLETED|Overall Study||2
37034|NCT02031679|89146|P1|NOT COMPLETED|Overall Study||0
37035|NCT02031679|89145|P2|COMPLETED|Overall Study||12
37036|NCT02031679|89146|P1|COMPLETED|Overall Study||14
37037|NCT02031679|89145|P2|STARTED|Overall Study||14
37038|NCT02031679|89146|P1|STARTED|Overall Study||14
37039|NCT02031640|89161|P6|NOT COMPLETED|Double-blind Treatment Period||3
37040|NCT02031640|89162|P5|NOT COMPLETED|Double-blind Treatment Period||11
37041|NCT02031640|89163|P4|NOT COMPLETED|Double-blind Treatment Period||7
37042|NCT02031640|89164|P3|NOT COMPLETED|Double-blind Treatment Period||6
37043|NCT02031640|89165|P2|NOT COMPLETED|Double-blind Treatment Period||22
37044|NCT02031640|89166|P1|NOT COMPLETED|Double-blind Treatment Period||0
37045|NCT02031640|89161|P6|COMPLETED|Double-blind Treatment Period||104
37046|NCT02031640|89162|P5|COMPLETED|Double-blind Treatment Period||96
37047|NCT02031640|89163|P4|COMPLETED|Double-blind Treatment Period||99
37048|NCT02031640|89164|P3|COMPLETED|Double-blind Treatment Period||100
37049|NCT02031640|89165|P2|COMPLETED|Double-blind Treatment Period||84
37050|NCT02031640|89166|P1|COMPLETED|Double-blind Treatment Period||0
37051|NCT02031640|89161|P6|Full Analysis Set|Double-blind Treatment Period||107
37052|NCT02031640|89162|P5|Full Analysis Set|Double-blind Treatment Period||106
37053|NCT02031640|89163|P4|Full Analysis Set|Double-blind Treatment Period||106
37054|NCT02031640|89164|P3|Full Analysis Set|Double-blind Treatment Period||104
37055|NCT02031640|89165|P2|Full Analysis Set|Double-blind Treatment Period||106
37056|NCT02031640|89166|P1|Full Analysis Set|Double-blind Treatment Period||0
37057|NCT02031640|89161|P6|STARTED|Double-blind Treatment Period||107
37058|NCT02031640|89162|P5|STARTED|Double-blind Treatment Period||107
37059|NCT02031640|89163|P4|STARTED|Double-blind Treatment Period||106
37060|NCT02031640|89164|P3|STARTED|Double-blind Treatment Period||106
37061|NCT02031640|89165|P2|STARTED|Double-blind Treatment Period||106
37062|NCT02031640|89166|P1|STARTED|Double-blind Treatment Period||0
37063|NCT02031640|89161|P6|NOT COMPLETED|Run-In Period||0
37064|NCT02031640|89162|P5|NOT COMPLETED|Run-In Period||0
37065|NCT02031640|89163|P4|NOT COMPLETED|Run-In Period||0
37066|NCT02031640|89164|P3|NOT COMPLETED|Run-In Period||0
37067|NCT02031640|89165|P2|NOT COMPLETED|Run-In Period||0
37068|NCT02031640|89166|P1|NOT COMPLETED|Run-In Period||169
37069|NCT02031640|89161|P6|COMPLETED|Run-In Period||0
37070|NCT02031640|89162|P5|COMPLETED|Run-In Period||0
37071|NCT02031640|89163|P4|COMPLETED|Run-In Period||0
37072|NCT02031640|89164|P3|COMPLETED|Run-In Period||0
37073|NCT02031640|89165|P2|COMPLETED|Run-In Period||0
37074|NCT02031640|89166|P1|COMPLETED|Run-In Period||532
37075|NCT02031640|89161|P6|STARTED|Run-In Period||0
37076|NCT02031640|89162|P5|STARTED|Run-In Period||0
37077|NCT02031640|89163|P4|STARTED|Run-In Period||0
37078|NCT02031640|89164|P3|STARTED|Run-In Period||0
37079|NCT02031640|89165|P2|STARTED|Run-In Period||0
37080|NCT02031640|89166|P1|STARTED|Run-In Period||701
37081|NCT02031640|89161|P6|NOT COMPLETED|Screening Period||0
37082|NCT02031640|89162|P5|NOT COMPLETED|Screening Period||0
37083|NCT02031640|89163|P4|NOT COMPLETED|Screening Period||0
37084|NCT02031640|89164|P3|NOT COMPLETED|Screening Period||0
37085|NCT02031640|89165|P2|NOT COMPLETED|Screening Period||0
37086|NCT02031640|89166|P1|NOT COMPLETED|Screening Period||412
37087|NCT02031640|89161|P6|COMPLETED|Screening Period||0
37088|NCT02031640|89162|P5|COMPLETED|Screening Period||0
37089|NCT02031640|89163|P4|COMPLETED|Screening Period||0
37090|NCT02031640|89164|P3|COMPLETED|Screening Period||0
37091|NCT02031640|89165|P2|COMPLETED|Screening Period||0
37092|NCT02031640|89166|P1|COMPLETED|Screening Period||701
37093|NCT02031640|89161|P6|STARTED|Screening Period||0
37094|NCT02031640|89162|P5|STARTED|Screening Period||0
37095|NCT02031640|89163|P4|STARTED|Screening Period||0
37096|NCT02031640|89164|P3|STARTED|Screening Period||0
37097|NCT02031640|89165|P2|STARTED|Screening Period||0
37098|NCT02031640|89166|P1|STARTED|Screening Period|Consented|1113
37099|NCT02031471|89209|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
37100|NCT02031471|89209|P1|COMPLETED|Long Term Extension (LTE) Period||37
37101|NCT02031471|89209|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
37102|NCT02031471|89209|P1|NOT COMPLETED|24 Week Treatment Period||11
37103|NCT02031471|89209|P1|COMPLETED|24 Week Treatment Period||46
37104|NCT02031471|89209|P1|STARTED|24 Week Treatment Period||57
37105|NCT02031458|89242|P3|NOT COMPLETED|Overall Study||253
37106|NCT02031458|89243|P2|NOT COMPLETED|Overall Study||267
37107|NCT02031458|89244|P1|NOT COMPLETED|Overall Study||139
37108|NCT02031458|89242|P3|COMPLETED|Overall Study||0
37109|NCT02031458|89243|P2|COMPLETED|Overall Study||0
37110|NCT02031458|89244|P1|COMPLETED|Overall Study||0
37111|NCT02031458|89242|P3|STARTED|Overall Study||253
37112|NCT02031458|89243|P2|STARTED|Overall Study||267
37113|NCT02031458|89244|P1|STARTED|Overall Study||139
37114|NCT02030600|89340|P2|NOT COMPLETED|Treatment Period 2||18
37115|NCT02030600|89341|P1|NOT COMPLETED|Treatment Period 2||25
37116|NCT02030600|89340|P2|COMPLETED|Treatment Period 2||297
37117|NCT02030600|89341|P1|COMPLETED|Treatment Period 2||283
37118|NCT02030600|89340|P2|STARTED|Treatment Period 2||315
37119|NCT02030600|89341|P1|STARTED|Treatment Period 2||308
37120|NCT02030600|89340|P2|NOT COMPLETED|Treatment Period 1||45
37121|NCT02030600|89341|P1|NOT COMPLETED|Treatment Period 1||53
37122|NCT02030600|89340|P2|COMPLETED|Treatment Period 1||315
37123|NCT02030600|89341|P1|COMPLETED|Treatment Period 1||308
37124|NCT02030600|89340|P2|Exposed|Treatment Period 1||357
37125|NCT02030600|89341|P1|Exposed|Treatment Period 1||356
37126|NCT02030600|89340|P2|STARTED|Treatment Period 1||360
37127|NCT02030600|89341|P1|STARTED|Treatment Period 1||361
37128|NCT02030574|89357|P1|NOT COMPLETED|Overall Study||0
37129|NCT02030574|89357|P1|COMPLETED|Overall Study||2
37130|NCT02030574|89357|P1|STARTED|Overall Study||2
37131|NCT02030535|89362|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
37132|NCT02030535|89362|P1|COMPLETED|Treatment Period 3 (1 Day)||52
37133|NCT02030535|89362|P1|STARTED|Treatment Period 3 (1 Day)||52
37134|NCT02030535|89362|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
37135|NCT02030535|89362|P1|COMPLETED|Washout Period 2 (21 Days)||52
37136|NCT02030535|89362|P1|STARTED|Washout Period 2 (21 Days)||52
37137|NCT02030535|89362|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
37138|NCT02030535|89362|P1|COMPLETED|Treatment Period 2 (1 Day)||52
37139|NCT02030535|89362|P1|STARTED|Treatment Period 2 (1 Day)||52
37140|NCT02030535|89362|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
37141|NCT02030535|89362|P1|COMPLETED|Washout Period 1 (21 Days)||52
37142|NCT02030535|89362|P1|STARTED|Washout Period 1 (21 Days)||53
37143|NCT02030535|89362|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
37144|NCT02030535|89362|P1|COMPLETED|Treatment Period 1 (1 Day)||53
37145|NCT02030535|89362|P1|STARTED|Treatment Period 1 (1 Day)||53
37146|NCT02030405|89430|P1|NOT COMPLETED|Overall Study||2
37147|NCT02030405|89430|P1|COMPLETED|Overall Study||2
37148|NCT02030405|89430|P1|STARTED|Overall Study||4
37149|NCT02030119|89439|P4|NOT COMPLETED|Overall Study||3
37150|NCT02030119|89440|P3|NOT COMPLETED|Overall Study||6
37151|NCT02030119|89441|P2|NOT COMPLETED|Overall Study||2
37152|NCT02030119|89442|P1|NOT COMPLETED|Overall Study||3
37153|NCT02030119|89439|P4|COMPLETED|Overall Study||67
37154|NCT02030119|89440|P3|COMPLETED|Overall Study||65
37155|NCT02030119|89441|P2|COMPLETED|Overall Study||68
37156|NCT02030119|89442|P1|COMPLETED|Overall Study||67
37157|NCT02030119|89439|P4|STARTED|Overall Study||70
37158|NCT02030119|89440|P3|STARTED|Overall Study||71
37159|NCT02030119|89441|P2|STARTED|Overall Study||70
37160|NCT02030119|89442|P1|STARTED|Overall Study||70
37161|NCT02030080|89460|P4|NOT COMPLETED|Overall Study||2
37162|NCT02030080|89461|P3|NOT COMPLETED|Overall Study||0
37163|NCT02030080|89462|P2|NOT COMPLETED|Overall Study||0
37164|NCT02030080|89463|P1|NOT COMPLETED|Overall Study||0
37165|NCT02030080|89460|P4|COMPLETED|Overall Study||42
37166|NCT02030080|89461|P3|COMPLETED|Overall Study||80
37167|NCT02030080|89462|P2|COMPLETED|Overall Study||64
37168|NCT02030080|89463|P1|COMPLETED|Overall Study||100
37169|NCT02030080|89460|P4|STARTED|Overall Study|11 teams|44
37170|NCT02030080|89461|P3|STARTED|Overall Study|20 teams|80
37171|NCT02030080|89462|P2|STARTED|Overall Study|16 teams|64
37172|NCT02030080|89463|P1|STARTED|Overall Study|25 teams|100
37173|NCT02030041|89480|P3|NOT COMPLETED|Overall Study||1
37174|NCT02030041|89481|P2|NOT COMPLETED|Overall Study||2
37175|NCT02030041|89482|P1|NOT COMPLETED|Overall Study||2
37176|NCT02030041|89480|P3|COMPLETED|Overall Study||10
37177|NCT02030041|89481|P2|COMPLETED|Overall Study||9
37178|NCT02030041|89482|P1|COMPLETED|Overall Study||9
37179|NCT02030041|89480|P3|STARTED|Overall Study||11
37180|NCT02030041|89481|P2|STARTED|Overall Study||11
37181|NCT02030041|89482|P1|STARTED|Overall Study||11
37182|NCT02029989|89495|P2|NOT COMPLETED|Overall Study||11
37183|NCT02029989|89496|P1|NOT COMPLETED|Overall Study||16
37184|NCT02029989|89495|P2|COMPLETED|Overall Study||49
37185|NCT02029989|89496|P1|COMPLETED|Overall Study||45
37186|NCT02029989|89495|P2|STARTED|Overall Study||60
37187|NCT02029989|89496|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
37188|NCT02029911|89502|P1|NOT COMPLETED|Overall Study||0
37189|NCT02029911|89502|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
37190|NCT02029911|89502|P1|Treated|Overall Study|Treatment Completed|60
37191|NCT02029911|89502|P1|STARTED|Overall Study|Treatment Attempted|60
37192|NCT02029872|89510|P2|NOT COMPLETED|Overall Study||3
37193|NCT02029872|89511|P1|NOT COMPLETED|Overall Study||2
37194|NCT02029872|89510|P2|COMPLETED|Overall Study||6
37195|NCT02029872|89511|P1|COMPLETED|Overall Study||7
37196|NCT02029872|89510|P2|STARTED|Overall Study||9
37197|NCT02029872|89511|P1|STARTED|Overall Study||9
37198|NCT02029846|89519|P2|NOT COMPLETED|Overall Study||1
37199|NCT02029846|89520|P1|NOT COMPLETED|Overall Study||1
37200|NCT02029846|89519|P2|COMPLETED|Overall Study||0
37201|NCT02029846|89520|P1|COMPLETED|Overall Study||0
37202|NCT02029846|89519|P2|STARTED|Overall Study||1
37203|NCT02029846|89520|P1|STARTED|Overall Study||1
37204|NCT02029755|89533|P3|NOT COMPLETED|Overall Study||0
37205|NCT02029755|89534|P2|NOT COMPLETED|Overall Study||0
37206|NCT02029755|89535|P1|NOT COMPLETED|Overall Study||0
37207|NCT02029755|89533|P3|COMPLETED|Overall Study||36
37208|NCT02029755|89534|P2|COMPLETED|Overall Study||36
37209|NCT02029755|89535|P1|COMPLETED|Overall Study||36
37210|NCT02029755|89533|P3|STARTED|Overall Study||36
37211|NCT02029755|89534|P2|STARTED|Overall Study||36
37212|NCT02029755|89535|P1|STARTED|Overall Study||36
37213|NCT02029703|89548|P2|NOT COMPLETED|Overall Study||0
37214|NCT02029703|89549|P1|NOT COMPLETED|Overall Study||0
37215|NCT02029703|89548|P2|COMPLETED|Overall Study||22
37216|NCT02029703|89549|P1|COMPLETED|Overall Study||20
37217|NCT02029703|89548|P2|STARTED|Overall Study||22
37218|NCT02029703|89549|P1|STARTED|Overall Study||20
37219|NCT02029521|89557|P2|NOT COMPLETED|Overall Study||1
37220|NCT02029521|89558|P1|NOT COMPLETED|Overall Study||2
37221|NCT02029521|89557|P2|COMPLETED|Overall Study||22
37222|NCT02029521|89558|P1|COMPLETED|Overall Study||22
37223|NCT02029521|89557|P2|STARTED|Overall Study||23
37224|NCT02029521|89558|P1|STARTED|Overall Study||24
37225|NCT02029495|89643|P3|NOT COMPLETED|Overall Study||2
37226|NCT02029495|89644|P2|NOT COMPLETED|Overall Study||0
37227|NCT02029495|89645|P1|NOT COMPLETED|Overall Study||1
37228|NCT02029495|89643|P3|COMPLETED|Overall Study||159
37229|NCT02029495|89644|P2|COMPLETED|Overall Study||158
37230|NCT02029495|89645|P1|COMPLETED|Overall Study||158
37231|NCT02029495|89643|P3|STARTED|Overall Study||161
37232|NCT02029495|89644|P2|STARTED|Overall Study||158
37233|NCT02029495|89645|P1|STARTED|Overall Study||159
37234|NCT02029417|89656|P1|NOT COMPLETED|Overall Study||2
37235|NCT02029417|89656|P1|COMPLETED|Overall Study||0
37236|NCT02029417|89656|P1|STARTED|Overall Study||2
37237|NCT02029196|89663|P2|NOT COMPLETED|Overall Study||1
37238|NCT02029196|89664|P1|NOT COMPLETED|Overall Study||20
37239|NCT02029196|89663|P2|COMPLETED|Overall Study||101
37240|NCT02029196|89664|P1|COMPLETED|Overall Study||286
37241|NCT02029196|89663|P2|STARTED|Overall Study||102
37242|NCT02029196|89664|P1|STARTED|Overall Study||306
37243|NCT02028780|89684|P12|NOT COMPLETED|Follow up Phase||0
37244|NCT02028780|89685|P11|NOT COMPLETED|Follow up Phase||0
37245|NCT02028780|89686|P10|NOT COMPLETED|Follow up Phase||0
37246|NCT02028780|89687|P9|NOT COMPLETED|Follow up Phase||0
37247|NCT02028780|89688|P8|NOT COMPLETED|Follow up Phase||0
37248|NCT02028780|89689|P7|NOT COMPLETED|Follow up Phase||0
37249|NCT02028780|89690|P6|NOT COMPLETED|Follow up Phase||0
37250|NCT02028780|89691|P5|NOT COMPLETED|Follow up Phase||0
37251|NCT02028780|89692|P4|NOT COMPLETED|Follow up Phase||0
37252|NCT02028780|89693|P3|NOT COMPLETED|Follow up Phase||0
37253|NCT02028780|89694|P2|NOT COMPLETED|Follow up Phase||0
37254|NCT02028780|89695|P1|NOT COMPLETED|Follow up Phase||0
37255|NCT02028780|89684|P12|COMPLETED|Follow up Phase||9
37256|NCT02028780|89685|P11|COMPLETED|Follow up Phase||9
37257|NCT02028780|89686|P10|COMPLETED|Follow up Phase||9
37258|NCT02028780|89687|P9|COMPLETED|Follow up Phase||9
37259|NCT02028780|89688|P8|COMPLETED|Follow up Phase||3
37260|NCT02028780|89689|P7|COMPLETED|Follow up Phase||9
37261|NCT02028780|89690|P6|COMPLETED|Follow up Phase||6
37262|NCT02028780|89691|P5|COMPLETED|Follow up Phase||6
37263|NCT02028780|89692|P4|COMPLETED|Follow up Phase||6
37264|NCT02028780|89693|P3|COMPLETED|Follow up Phase||6
37265|NCT02028780|89694|P2|COMPLETED|Follow up Phase||2
37266|NCT02028780|89695|P1|COMPLETED|Follow up Phase||6
37267|NCT02028780|89684|P12|STARTED|Follow up Phase||9
37268|NCT02028780|89685|P11|STARTED|Follow up Phase||9
37269|NCT02028780|89686|P10|STARTED|Follow up Phase||9
37270|NCT02028780|89687|P9|STARTED|Follow up Phase||9
37271|NCT02028780|89688|P8|STARTED|Follow up Phase||3
37272|NCT02028780|89689|P7|STARTED|Follow up Phase||9
37273|NCT02028780|89690|P6|STARTED|Follow up Phase||6
37274|NCT02028780|89691|P5|STARTED|Follow up Phase||6
37275|NCT02028780|89692|P4|STARTED|Follow up Phase||6
37276|NCT02028780|89693|P3|STARTED|Follow up Phase||6
37277|NCT02028780|89694|P2|STARTED|Follow up Phase||2
37278|NCT02028780|89695|P1|STARTED|Follow up Phase||6
37279|NCT02028780|89684|P12|NOT COMPLETED|Observation Phase||0
37280|NCT02028780|89685|P11|NOT COMPLETED|Observation Phase||0
37281|NCT02028780|89686|P10|NOT COMPLETED|Observation Phase||0
37282|NCT02028780|89687|P9|NOT COMPLETED|Observation Phase||0
37283|NCT02028780|89688|P8|NOT COMPLETED|Observation Phase||0
37284|NCT02028780|89689|P7|NOT COMPLETED|Observation Phase||0
37285|NCT02028780|89690|P6|NOT COMPLETED|Observation Phase||0
37286|NCT02028780|89691|P5|NOT COMPLETED|Observation Phase||0
37287|NCT02028780|89692|P4|NOT COMPLETED|Observation Phase||0
37288|NCT02028780|89693|P3|NOT COMPLETED|Observation Phase||0
37289|NCT02028780|89694|P2|NOT COMPLETED|Observation Phase||0
37290|NCT02028780|89695|P1|NOT COMPLETED|Observation Phase||0
37291|NCT02028780|89684|P12|COMPLETED|Observation Phase||9
37292|NCT02028780|89685|P11|COMPLETED|Observation Phase||9
37293|NCT02028780|89686|P10|COMPLETED|Observation Phase||9
37294|NCT02028780|89687|P9|COMPLETED|Observation Phase||9
37295|NCT02028780|89688|P8|COMPLETED|Observation Phase||3
37296|NCT02028780|89689|P7|COMPLETED|Observation Phase||9
37297|NCT02028780|89690|P6|COMPLETED|Observation Phase||6
37298|NCT02028780|89691|P5|COMPLETED|Observation Phase||6
37299|NCT02028780|89692|P4|COMPLETED|Observation Phase||6
37300|NCT02028780|89693|P3|COMPLETED|Observation Phase||6
37301|NCT02028780|89694|P2|COMPLETED|Observation Phase||2
37302|NCT02028780|89695|P1|COMPLETED|Observation Phase||6
37303|NCT02028780|89684|P12|STARTED|Observation Phase||9
37304|NCT02028780|89685|P11|STARTED|Observation Phase||9
37305|NCT02028780|89686|P10|STARTED|Observation Phase||9
37306|NCT02028780|89687|P9|STARTED|Observation Phase||9
37307|NCT02028780|89688|P8|STARTED|Observation Phase||3
37308|NCT02028780|89689|P7|STARTED|Observation Phase||9
37309|NCT02028780|89690|P6|STARTED|Observation Phase||6
37310|NCT02028780|89691|P5|STARTED|Observation Phase||6
37311|NCT02028780|89692|P4|STARTED|Observation Phase||6
37312|NCT02028780|89693|P3|STARTED|Observation Phase||6
37313|NCT02028780|89694|P2|STARTED|Observation Phase||2
37314|NCT02028780|89695|P1|STARTED|Observation Phase||6
37315|NCT02028767|89760|P2|NOT COMPLETED|Treatment Period 2||0
37316|NCT02028767|89761|P1|NOT COMPLETED|Treatment Period 2||2
37317|NCT02028767|89760|P2|COMPLETED|Treatment Period 2||16
37318|NCT02028767|89761|P1|COMPLETED|Treatment Period 2||14
37319|NCT02028767|89760|P2|STARTED|Treatment Period 2||16
37320|NCT02028767|89761|P1|STARTED|Treatment Period 2||16
37321|NCT02028767|89760|P2|NOT COMPLETED|Treatment Period 1||0
37322|NCT02028767|89761|P1|NOT COMPLETED|Treatment Period 1||0
37323|NCT02028767|89760|P2|COMPLETED|Treatment Period 1||16
37324|NCT02028767|89761|P1|COMPLETED|Treatment Period 1||16
37325|NCT02028767|89760|P2|STARTED|Treatment Period 1||16
37326|NCT02028767|89761|P1|STARTED|Treatment Period 1||16
37327|NCT02028754|89773|P2|NOT COMPLETED|Overall Study||8
37328|NCT02028754|89774|P1|NOT COMPLETED|Overall Study||7
37329|NCT02028754|89773|P2|COMPLETED|Overall Study||82
37330|NCT02028754|89774|P1|COMPLETED|Overall Study||83
37331|NCT02028754|89773|P2|STARTED|Overall Study||90
37332|NCT02028754|89774|P1|STARTED|Overall Study||90
37333|NCT02028676|89801|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37334|NCT02028676|89802|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37335|NCT02028676|89803|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37336|NCT02028676|89804|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37337|NCT02028676|89805|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37338|NCT02028676|89806|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37339|NCT02028676|89807|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37340|NCT02028676|89808|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37341|NCT02028676|89809|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
37342|NCT02028676|89801|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
37343|NCT02028676|89802|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
37344|NCT02028676|89803|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
37345|NCT02028676|89804|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
37346|NCT02028676|89805|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
37347|NCT02028676|89806|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
37348|NCT02028676|89807|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
37349|NCT02028676|89808|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
37350|NCT02028676|89809|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
37351|NCT02028676|89801|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
37352|NCT02028676|89802|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
37353|NCT02028676|89803|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
37354|NCT02028676|89804|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
37355|NCT02028676|89805|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
37356|NCT02028676|89806|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
37357|NCT02028676|89807|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
37358|NCT02028676|89808|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
37359|NCT02028676|89809|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
37360|NCT02028676|89801|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37361|NCT02028676|89802|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37362|NCT02028676|89803|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37363|NCT02028676|89804|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37364|NCT02028676|89805|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37365|NCT02028676|89806|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37366|NCT02028676|89807|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37367|NCT02028676|89808|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37368|NCT02028676|89809|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37369|NCT02028676|89801|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37370|NCT02028676|89802|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37371|NCT02028676|89803|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
37372|NCT02028676|89804|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
37373|NCT02028676|89805|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37374|NCT02028676|89806|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37375|NCT02028676|89807|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37376|NCT02028676|89808|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37377|NCT02028676|89809|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
37378|NCT02028676|89801|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
37379|NCT02028676|89802|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
37380|NCT02028676|89803|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
37381|NCT02028676|89804|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
37382|NCT02028676|89805|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
37383|NCT02028676|89806|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
37384|NCT02028676|89807|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
37385|NCT02028676|89808|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
37386|NCT02028676|89809|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
37387|NCT02028676|89801|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
37388|NCT02028676|89802|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
37389|NCT02028676|89803|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
37390|NCT02028676|89804|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
37391|NCT02028676|89805|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
37392|NCT02028676|89806|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
37393|NCT02028676|89807|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
37394|NCT02028676|89808|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
37395|NCT02028676|89809|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
37396|NCT02028676|89801|P9|COMPLETED|Initial Enrolment: Induction ART||0
37397|NCT02028676|89802|P8|COMPLETED|Initial Enrolment: Induction ART||0
37398|NCT02028676|89803|P7|COMPLETED|Initial Enrolment: Induction ART||0
37399|NCT02028676|89804|P6|COMPLETED|Initial Enrolment: Induction ART||0
37400|NCT02028676|89805|P5|COMPLETED|Initial Enrolment: Induction ART||405
37401|NCT02028676|89806|P4|COMPLETED|Initial Enrolment: Induction ART||404
37402|NCT02028676|89807|P3|COMPLETED|Initial Enrolment: Induction ART||397
37403|NCT02028676|89808|P2|COMPLETED|Initial Enrolment: Induction ART||0
37404|NCT02028676|89809|P1|COMPLETED|Initial Enrolment: Induction ART||0
37405|NCT02028676|89801|P9|STARTED|Initial Enrolment: Induction ART||0
37406|NCT02028676|89802|P8|STARTED|Initial Enrolment: Induction ART||0
37407|NCT02028676|89803|P7|STARTED|Initial Enrolment: Induction ART||0
37408|NCT02028676|89804|P6|STARTED|Initial Enrolment: Induction ART||0
37409|NCT02028676|89805|P5|STARTED|Initial Enrolment: Induction ART||405
37410|NCT02028676|89806|P4|STARTED|Initial Enrolment: Induction ART||404
37411|NCT02028676|89807|P3|STARTED|Initial Enrolment: Induction ART||397
37412|NCT02028676|89808|P2|STARTED|Initial Enrolment: Induction ART||0
37413|NCT02028676|89809|P1|STARTED|Initial Enrolment: Induction ART||0
37414|NCT02028676|89801|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37415|NCT02028676|89802|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37416|NCT02028676|89803|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37417|NCT02028676|89804|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37418|NCT02028676|89805|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37419|NCT02028676|89806|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37420|NCT02028676|89807|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37421|NCT02028676|89808|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37422|NCT02028676|89809|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
37423|NCT02028676|89801|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
37424|NCT02028676|89802|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
37425|NCT02028676|89803|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
37426|NCT02028676|89804|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
37427|NCT02028676|89805|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
37428|NCT02028676|89806|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
37429|NCT02028676|89807|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
37430|NCT02028676|89808|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
37431|NCT02028676|89809|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
37432|NCT02028676|89801|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
37433|NCT02028676|89802|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
37434|NCT02028676|89803|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
37435|NCT02028676|89804|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
37436|NCT02028676|89805|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
37437|NCT02028676|89806|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
37438|NCT02028676|89807|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
37439|NCT02028676|89808|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
37440|NCT02028676|89809|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
37441|NCT02028325|89982|P1|NOT COMPLETED|Overall Study||10
37442|NCT02028325|89982|P1|COMPLETED|Overall Study||126
37443|NCT02028325|89982|P1|STARTED|Overall Study||136
37444|NCT02028169|89986|P1|NOT COMPLETED|Overall Study||28
37445|NCT02028169|89986|P1|COMPLETED|Overall Study||92
37446|NCT02028169|89986|P1|STARTED|Overall Study||120
37447|NCT02028065|90012|P3|NOT COMPLETED|Treatment Through Study Completion||14
37448|NCT02028065|90013|P2|NOT COMPLETED|Treatment Through Study Completion||15
37449|NCT02028065|90014|P1|NOT COMPLETED|Treatment Through Study Completion||12
37450|NCT02028065|90012|P3|COMPLETED|Treatment Through Study Completion||134
37451|NCT02028065|90013|P2|COMPLETED|Treatment Through Study Completion||136
37452|NCT02028065|90014|P1|COMPLETED|Treatment Through Study Completion||64
37453|NCT02028065|90012|P3|Received Third Dose|Treatment Through Study Completion||134
37454|NCT02028065|90013|P2|Received Third Dose|Treatment Through Study Completion||136
37455|NCT02028065|90014|P1|Received Third Dose|Treatment Through Study Completion||64
37456|NCT02028065|90012|P3|Received Second Dose|Treatment Through Study Completion||138
37457|NCT02028065|90013|P2|Received Second Dose|Treatment Through Study Completion||140
37458|NCT02028065|90014|P1|Received Second Dose|Treatment Through Study Completion||69
37459|NCT02028065|90012|P3|Received First Dose|Treatment Through Study Completion||148
37460|NCT02028065|90013|P2|Received First Dose|Treatment Through Study Completion||151
37461|NCT02028065|90014|P1|Received First Dose|Treatment Through Study Completion||76
37462|NCT02028065|90012|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
37463|NCT02028065|90013|P2|STARTED|Treatment Through Study Completion||151
37464|NCT02028065|90014|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
37465|NCT02028065|90012|P3|NOT COMPLETED|Randomization Through Start Treatment||3
37466|NCT02028065|90013|P2|NOT COMPLETED|Randomization Through Start Treatment||3
37467|NCT02028065|90014|P1|NOT COMPLETED|Randomization Through Start Treatment||1
37468|NCT02028065|90012|P3|COMPLETED|Randomization Through Start Treatment||149
37469|NCT02028065|90013|P2|COMPLETED|Randomization Through Start Treatment||151
37470|NCT02028065|90014|P1|COMPLETED|Randomization Through Start Treatment||75
37646|NCT02024386|90394|P3|COMPLETED|Overall Study||5
37471|NCT02028065|90012|P3|STARTED|Randomization Through Start Treatment|Randomized|152
37472|NCT02028065|90013|P2|STARTED|Randomization Through Start Treatment|Randomized|154
37473|NCT02028065|90014|P1|STARTED|Randomization Through Start Treatment|Randomized|76
37474|NCT02027883|90027|P2|NOT COMPLETED|Overall Study||0
37475|NCT02027883|90028|P1|NOT COMPLETED|Overall Study||0
37476|NCT02027883|90027|P2|COMPLETED|Overall Study||50
37477|NCT02027883|90028|P1|COMPLETED|Overall Study||50
37478|NCT02027883|90027|P2|STARTED|Overall Study||50
37479|NCT02027883|90028|P1|STARTED|Overall Study||50
37480|NCT02027844|90041|P3|NOT COMPLETED|Overall Study||2
37481|NCT02027844|90042|P2|NOT COMPLETED|Overall Study||6
37482|NCT02027844|90043|P1|NOT COMPLETED|Overall Study||5
37483|NCT02027844|90041|P3|COMPLETED|Overall Study||37
37484|NCT02027844|90042|P2|COMPLETED|Overall Study||33
37485|NCT02027844|90043|P1|COMPLETED|Overall Study||34
37486|NCT02027844|90041|P3|STARTED|Overall Study||39
37487|NCT02027844|90042|P2|STARTED|Overall Study||39
37488|NCT02027844|90043|P1|STARTED|Overall Study||39
37489|NCT02027402|90062|P2|NOT COMPLETED|Overall Study||1
37490|NCT02027402|90063|P1|NOT COMPLETED|Overall Study||4
37491|NCT02027402|90062|P2|COMPLETED|Overall Study||99
37492|NCT02027402|90063|P1|COMPLETED|Overall Study||94
37493|NCT02027402|90062|P2|STARTED|Overall Study||100
37494|NCT02027402|90063|P1|STARTED|Overall Study||98
37495|NCT02027311|90077|P2|NOT COMPLETED|Overall Study||2
37496|NCT02027311|90078|P1|NOT COMPLETED|Overall Study||3
37497|NCT02027311|90077|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
37498|NCT02027311|90078|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
37499|NCT02027311|90077|P2|STARTED|Overall Study||35
37500|NCT02027311|90078|P1|STARTED|Overall Study||33
37501|NCT02027272|90088|P2|NOT COMPLETED|Overall Study||1
37502|NCT02027272|90089|P1|NOT COMPLETED|Overall Study||0
37503|NCT02027272|90088|P2|COMPLETED|Overall Study||0
37504|NCT02027272|90089|P1|COMPLETED|Overall Study||0
37505|NCT02027272|90088|P2|STARTED|Overall Study||1
37506|NCT02027272|90089|P1|STARTED|Overall Study||0
37507|NCT02026453|90098|P3|NOT COMPLETED|Overall Study||13
37508|NCT02026453|90099|P2|NOT COMPLETED|Overall Study||9
37509|NCT02026453|90100|P1|NOT COMPLETED|Overall Study||6
37510|NCT02026453|90098|P3|COMPLETED|Overall Study||89
37511|NCT02026453|90099|P2|COMPLETED|Overall Study||94
37512|NCT02026453|90100|P1|COMPLETED|Overall Study||95
37513|NCT02026453|90098|P3|STARTED|Overall Study||102
37514|NCT02026453|90099|P2|STARTED|Overall Study||103
37515|NCT02026453|90100|P1|STARTED|Overall Study||101
37516|NCT02026258|90113|P2|NOT COMPLETED|Recieved Allocated Intervention||2
37517|NCT02026258|90114|P1|NOT COMPLETED|Recieved Allocated Intervention||1
37518|NCT02026258|90113|P2|COMPLETED|Recieved Allocated Intervention||17
37519|NCT02026258|90114|P1|COMPLETED|Recieved Allocated Intervention||15
37520|NCT02026258|90113|P2|STARTED|Recieved Allocated Intervention||19
37521|NCT02026258|90114|P1|STARTED|Recieved Allocated Intervention||16
37522|NCT02026258|90113|P2|NOT COMPLETED|Randomized||2
37523|NCT02026258|90114|P1|NOT COMPLETED|Randomized||4
37524|NCT02026258|90113|P2|COMPLETED|Randomized||19
37525|NCT02026258|90114|P1|COMPLETED|Randomized||16
37526|NCT02026258|90113|P2|STARTED|Randomized||21
37527|NCT02026258|90114|P1|STARTED|Randomized||20
37528|NCT02026206|90128|P2|NOT COMPLETED|Overall Study||8
37529|NCT02026206|90129|P1|NOT COMPLETED|Overall Study||4
37530|NCT02026206|90128|P2|COMPLETED|Overall Study||36
37531|NCT02026206|90129|P1|COMPLETED|Overall Study||40
37532|NCT02026206|90128|P2|STARTED|Overall Study||44
37533|NCT02026206|90129|P1|STARTED|Overall Study||44
37534|NCT02026193|90139|P2|NOT COMPLETED|Overall Study||0
37535|NCT02026193|90140|P1|NOT COMPLETED|Overall Study||0
37536|NCT02026193|90139|P2|COMPLETED|Overall Study||8
37537|NCT02026193|90140|P1|COMPLETED|Overall Study||3
37538|NCT02026193|90139|P2|STARTED|Overall Study||8
37539|NCT02026193|90140|P1|STARTED|Overall Study||3
37540|NCT02026141|90148|P2|NOT COMPLETED|Overall Study||1
37541|NCT02026141|90149|P1|NOT COMPLETED|Overall Study||0
37542|NCT02026141|90148|P2|COMPLETED|Overall Study||19
37543|NCT02026141|90149|P1|COMPLETED|Overall Study||20
37544|NCT02026141|90148|P2|STARTED|Overall Study||20
37545|NCT02026141|90149|P1|STARTED|Overall Study||20
37546|NCT02025907|90157|P2|NOT COMPLETED|Overall Study||12
37547|NCT02025907|90158|P1|NOT COMPLETED|Overall Study||27
37548|NCT02025907|90157|P2|COMPLETED|Overall Study||96
37549|NCT02025907|90158|P1|COMPLETED|Overall Study||81
37550|NCT02025907|90157|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
37551|NCT02025907|90158|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
37552|NCT02025829|90174|P2|NOT COMPLETED|Overall Study||0
37553|NCT02025829|90175|P1|NOT COMPLETED|Overall Study||0
37554|NCT02025829|90174|P2|COMPLETED|Overall Study||11
37555|NCT02025829|90175|P1|COMPLETED|Overall Study||3
37556|NCT02025829|90174|P2|STARTED|Overall Study||11
37557|NCT02025829|90175|P1|STARTED|Overall Study||3
37558|NCT02025647|90184|P1|NOT COMPLETED|Overall Study||0
37559|NCT02025647|90184|P1|COMPLETED|Overall Study||139
37560|NCT02025647|90184|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
37647|NCT02024386|90395|P2|COMPLETED|Overall Study||11
37561|NCT02025647|90184|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
37562|NCT02025647|90184|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
37563|NCT02025647|90184|P1|Session 1 (Narrative Module)|Overall Study||139
37564|NCT02025647|90184|P1|STARTED|Overall Study||139
37565|NCT02025621|90215|P2|NOT COMPLETED|Overall Study||19
37566|NCT02025621|90216|P1|NOT COMPLETED|Overall Study||14
37567|NCT02025621|90215|P2|COMPLETED|Overall Study||421
37568|NCT02025621|90216|P1|COMPLETED|Overall Study||428
37569|NCT02025621|90215|P2|STARTED|Overall Study||440
37570|NCT02025621|90216|P1|STARTED|Overall Study||442
37571|NCT02025075|90236|P2|NOT COMPLETED|Overall Study||2
37572|NCT02025075|90237|P1|NOT COMPLETED|Overall Study||0
37573|NCT02025075|90236|P2|COMPLETED|Overall Study||19
37574|NCT02025075|90237|P1|COMPLETED|Overall Study||16
37575|NCT02025075|90236|P2|STARTED|Overall Study||21
37576|NCT02025075|90237|P1|STARTED|Overall Study||16
37577|NCT02024971|90261|P1|NOT COMPLETED|Overall Study||36
37578|NCT02024971|90261|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
37579|NCT02024971|90261|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
37580|NCT02024971|90261|P1|STARTED|Overall Study||1103
37581|NCT02024932|90274|P6|NOT COMPLETED|Overall Study||0
37582|NCT02024932|90275|P5|NOT COMPLETED|Overall Study||2
37583|NCT02024932|90276|P4|NOT COMPLETED|Overall Study||2
37584|NCT02024932|90277|P3|NOT COMPLETED|Overall Study||0
37585|NCT02024932|90278|P2|NOT COMPLETED|Overall Study||3
37586|NCT02024932|90279|P1|NOT COMPLETED|Overall Study||2
37587|NCT02024932|90274|P6|COMPLETED|Overall Study||9
37588|NCT02024932|90275|P5|COMPLETED|Overall Study||16
37589|NCT02024932|90276|P4|COMPLETED|Overall Study||0
37590|NCT02024932|90277|P3|COMPLETED|Overall Study||2
37591|NCT02024932|90278|P2|COMPLETED|Overall Study||1
37592|NCT02024932|90279|P1|COMPLETED|Overall Study||0
37593|NCT02024932|90274|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
37594|NCT02024932|90275|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
37595|NCT02024932|90276|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
37596|NCT02024932|90277|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
37597|NCT02024932|90278|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
37598|NCT02024932|90279|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
37599|NCT02024932|90274|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
37600|NCT02024932|90275|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
37601|NCT02024932|90276|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
37602|NCT02024932|90277|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
37603|NCT02024932|90278|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
37604|NCT02024932|90279|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
37605|NCT02024932|90274|P6|Safety Analysis Set|Overall Study||9
37606|NCT02024932|90275|P5|Safety Analysis Set|Overall Study||18
37607|NCT02024932|90276|P4|Safety Analysis Set|Overall Study||2
37608|NCT02024932|90277|P3|Safety Analysis Set|Overall Study||2
37609|NCT02024932|90278|P2|Safety Analysis Set|Overall Study||4
37610|NCT02024932|90279|P1|Safety Analysis Set|Overall Study||2
37611|NCT02024932|90274|P6|STARTED|Overall Study||9
37612|NCT02024932|90275|P5|STARTED|Overall Study||18
37613|NCT02024932|90276|P4|STARTED|Overall Study||2
37614|NCT02024932|90277|P3|STARTED|Overall Study||2
37615|NCT02024932|90278|P2|STARTED|Overall Study||4
37616|NCT02024932|90279|P1|STARTED|Overall Study||2
37617|NCT02024867|90338|P2|NOT COMPLETED|Overall Study||7
37618|NCT02024867|90339|P1|NOT COMPLETED|Overall Study||9
37619|NCT02024867|90338|P2|COMPLETED|Overall Study||124
37620|NCT02024867|90339|P1|COMPLETED|Overall Study||125
37621|NCT02024867|90338|P2|STARTED|Overall Study||131
37622|NCT02024867|90339|P1|STARTED|Overall Study||134
37623|NCT02024724|90357|P2|NOT COMPLETED|Overall Study||0
37624|NCT02024724|90358|P1|NOT COMPLETED|Overall Study||1
37625|NCT02024724|90357|P2|COMPLETED|Overall Study||30
37626|NCT02024724|90358|P1|COMPLETED|Overall Study||29
37627|NCT02024724|90357|P2|STARTED|Overall Study||30
37628|NCT02024724|90358|P1|STARTED|Overall Study||30
37629|NCT02024698|90364|P2|NOT COMPLETED|Second Intervention (7 Days)||0
37630|NCT02024698|90365|P1|NOT COMPLETED|Second Intervention (7 Days)||0
37631|NCT02024698|90364|P2|COMPLETED|Second Intervention (7 Days)||26
37632|NCT02024698|90365|P1|COMPLETED|Second Intervention (7 Days)||16
37633|NCT02024698|90364|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
37634|NCT02024698|90365|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
37635|NCT02024698|90364|P2|STARTED|Second Intervention (7 Days)||26
37636|NCT02024698|90365|P1|STARTED|Second Intervention (7 Days)||16
37637|NCT02024698|90364|P2|NOT COMPLETED|First Intervention (7 Days)||1
37638|NCT02024698|90365|P1|NOT COMPLETED|First Intervention (7 Days)||0
37639|NCT02024698|90364|P2|COMPLETED|First Intervention (7 Days)||26
37640|NCT02024698|90365|P1|COMPLETED|First Intervention (7 Days)||16
37641|NCT02024698|90364|P2|STARTED|First Intervention (7 Days)||27
37642|NCT02024698|90365|P1|STARTED|First Intervention (7 Days)||16
37643|NCT02024386|90394|P3|NOT COMPLETED|Overall Study||0
37644|NCT02024386|90395|P2|NOT COMPLETED|Overall Study||0
37645|NCT02024386|90396|P1|NOT COMPLETED|Overall Study||0
37648|NCT02024386|90396|P1|COMPLETED|Overall Study||6
37649|NCT02024386|90394|P3|STARTED|Overall Study||5
37650|NCT02024386|90395|P2|STARTED|Overall Study||11
37651|NCT02024386|90396|P1|STARTED|Overall Study||6
37652|NCT02024165|90419|P1|NOT COMPLETED|Overall Study||0
37653|NCT02024165|90419|P1|COMPLETED|Overall Study||71
37654|NCT02024165|90419|P1|STARTED|Overall Study||71
37655|NCT02023983|90426|P2|NOT COMPLETED|Overall Study||0
37656|NCT02023983|90427|P1|NOT COMPLETED|Overall Study||0
37657|NCT02023983|90426|P2|COMPLETED|Overall Study||75
37658|NCT02023983|90427|P1|COMPLETED|Overall Study||76
37659|NCT02023983|90426|P2|STARTED|Overall Study||75
37660|NCT02023983|90427|P1|STARTED|Overall Study||76
37661|NCT02023918|90435|P1|NOT COMPLETED|Overall Study||0
37662|NCT02023918|90435|P1|COMPLETED|Overall Study||6
37663|NCT02023918|90435|P1|STARTED|Overall Study||6
37664|NCT02023879|90443|P3|NOT COMPLETED|Overall Study||9
37665|NCT02023879|90444|P2|NOT COMPLETED|Overall Study||9
37666|NCT02023879|90445|P1|NOT COMPLETED|Overall Study||4
37667|NCT02023879|90443|P3|COMPLETED|Overall Study|48 participants entered open-label extension treatment period.|50
37668|NCT02023879|90444|P2|COMPLETED|Overall Study|106 participants entered open-label extension treatment period.|107
37669|NCT02023879|90445|P1|COMPLETED|Overall Study|51 participants entered open-label extension treatment period.|54
37670|NCT02023879|90443|P3|Treated|Overall Study||58
37671|NCT02023879|90444|P2|Treated|Overall Study||115
37672|NCT02023879|90445|P1|Treated|Overall Study||58
37673|NCT02023879|90443|P3|STARTED|Overall Study||59
37674|NCT02023879|90444|P2|STARTED|Overall Study||116
37675|NCT02023879|90445|P1|STARTED|Overall Study||58
37676|NCT02023866|90528|P1|NOT COMPLETED|Overall Study||6
37677|NCT02023866|90528|P1|COMPLETED|Overall Study||30
37678|NCT02023866|90528|P1|STARTED|Overall Study||36
37679|NCT02023801|90541|P1|NOT COMPLETED|Overall Study||0
37680|NCT02023801|90541|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
37681|NCT02023801|90541|P1|Treated|Overall Study|Treatment Completed|24
37682|NCT02023801|90541|P1|STARTED|Overall Study|Treatment Attempted|24
37683|NCT02023515|90549|P2|NOT COMPLETED|Overall Study||3
37684|NCT02023515|90550|P1|NOT COMPLETED|Overall Study||1
37685|NCT02023515|90549|P2|COMPLETED|Overall Study||22
37686|NCT02023515|90550|P1|COMPLETED|Overall Study||23
37687|NCT02023515|90549|P2|STARTED|Overall Study||25
37688|NCT02023515|90550|P1|STARTED|Overall Study||24
37689|NCT02023268|90560|P2|NOT COMPLETED|Overall Study||4
37690|NCT02023268|90561|P1|NOT COMPLETED|Overall Study||0
37691|NCT02023268|90560|P2|COMPLETED|Overall Study||49
37692|NCT02023268|90561|P1|COMPLETED|Overall Study||52
37693|NCT02023268|90560|P2|STARTED|Overall Study||53
37694|NCT02023268|90561|P1|STARTED|Overall Study||52
37695|NCT02023151|90567|P1|NOT COMPLETED|Overall Study||4
37696|NCT02023151|90567|P1|COMPLETED|Overall Study||13
37697|NCT02023151|90567|P1|STARTED|Overall Study||17
37698|NCT02023125|90574|P3|NOT COMPLETED|Period 2||0
37699|NCT02023125|90575|P2|NOT COMPLETED|Period 2||0
37700|NCT02023125|90576|P1|NOT COMPLETED|Period 2||0
37701|NCT02023125|90574|P3|COMPLETED|Period 2||24
37702|NCT02023125|90575|P2|COMPLETED|Period 2||9
37703|NCT02023125|90576|P1|COMPLETED|Period 2||9
37704|NCT02023125|90574|P3|STARTED|Period 2||24
37705|NCT02023125|90575|P2|STARTED|Period 2||9
37706|NCT02023125|90576|P1|STARTED|Period 2||9
37707|NCT02023125|90574|P3|NOT COMPLETED|Washout Period||0
37708|NCT02023125|90575|P2|NOT COMPLETED|Washout Period||0
37709|NCT02023125|90576|P1|NOT COMPLETED|Washout Period||0
37710|NCT02023125|90574|P3|COMPLETED|Washout Period||24
37711|NCT02023125|90575|P2|COMPLETED|Washout Period||9
37712|NCT02023125|90576|P1|COMPLETED|Washout Period||9
37713|NCT02023125|90574|P3|STARTED|Washout Period||24
37714|NCT02023125|90575|P2|STARTED|Washout Period||9
37715|NCT02023125|90576|P1|STARTED|Washout Period||9
37716|NCT02023125|90574|P3|NOT COMPLETED|Period 1||0
37717|NCT02023125|90575|P2|NOT COMPLETED|Period 1||0
37718|NCT02023125|90576|P1|NOT COMPLETED|Period 1||0
37719|NCT02023125|90574|P3|COMPLETED|Period 1||24
37720|NCT02023125|90575|P2|COMPLETED|Period 1||9
37721|NCT02023125|90576|P1|COMPLETED|Period 1||9
37722|NCT02023125|90574|P3|STARTED|Period 1||24
37723|NCT02023125|90575|P2|STARTED|Period 1||9
37724|NCT02023125|90576|P1|STARTED|Period 1||9
37725|NCT02023112|90637|P2|NOT COMPLETED|Overall Study||1
37726|NCT02023112|90638|P1|NOT COMPLETED|Overall Study||2
37727|NCT02023112|90637|P2|COMPLETED|Overall Study||85
37728|NCT02023112|90638|P1|COMPLETED|Overall Study||83
37729|NCT02023112|90637|P2|STARTED|Overall Study||86
37730|NCT02023112|90638|P1|STARTED|Overall Study||85
37731|NCT02023099|90659|P3|NOT COMPLETED|Overall Study||3
37732|NCT02023099|90660|P2|NOT COMPLETED|Overall Study||0
37733|NCT02023099|90661|P1|NOT COMPLETED|Overall Study||3
37734|NCT02023099|90659|P3|COMPLETED|Overall Study||39
37735|NCT02023099|90660|P2|COMPLETED|Overall Study||106
37736|NCT02023099|90661|P1|COMPLETED|Overall Study||212
37737|NCT02023099|90659|P3|STARTED|Overall Study||42
37738|NCT02023099|90660|P2|STARTED|Overall Study||106
37739|NCT02023099|90661|P1|STARTED|Overall Study||215
37740|NCT02022826|90677|P1|NOT COMPLETED|Overall Study||28
37741|NCT02022826|90677|P1|COMPLETED|Overall Study||139
37742|NCT02022826|90677|P1|STARTED|Overall Study||167
37743|NCT02022748|90684|P3|NOT COMPLETED|Overall Study||0
37744|NCT02022748|90685|P2|NOT COMPLETED|Overall Study||2
37745|NCT02022748|90686|P1|NOT COMPLETED|Overall Study||1
37746|NCT02022748|90684|P3|COMPLETED|Overall Study||13
37747|NCT02022748|90685|P2|COMPLETED|Overall Study||4
37748|NCT02022748|90686|P1|COMPLETED|Overall Study||7
37749|NCT02022748|90684|P3|Subjects Who Completed Treatment|Overall Study||13
37750|NCT02022748|90685|P2|Subjects Who Completed Treatment|Overall Study||4
37751|NCT02022748|90686|P1|Subjects Who Completed Treatment|Overall Study||7
37752|NCT02022748|90684|P3|Subject Who Started Treatment|Overall Study||13
37753|NCT02022748|90685|P2|Subject Who Started Treatment|Overall Study||6
37754|NCT02022748|90686|P1|Subject Who Started Treatment|Overall Study||8
37755|NCT02022748|90684|P3|STARTED|Overall Study||13
37756|NCT02022748|90685|P2|STARTED|Overall Study||6
37757|NCT02022748|90686|P1|STARTED|Overall Study||8
37758|NCT02022670|90712|P3|NOT COMPLETED|Overall Study||1
37759|NCT02022670|90713|P2|NOT COMPLETED|Overall Study||0
37760|NCT02022670|90714|P1|NOT COMPLETED|Overall Study||1
37761|NCT02022670|90712|P3|COMPLETED|Overall Study||11
37762|NCT02022670|90713|P2|COMPLETED|Overall Study||10
37763|NCT02022670|90714|P1|COMPLETED|Overall Study||10
37764|NCT02022670|90712|P3|STARTED|Overall Study||12
37765|NCT02022670|90713|P2|STARTED|Overall Study||10
37766|NCT02022670|90714|P1|STARTED|Overall Study||11
37767|NCT02022085|90728|P1|NOT COMPLETED|Overall Study||1
37768|NCT02022085|90728|P1|COMPLETED|Overall Study||53
37769|NCT02022085|90728|P1|STARTED|Overall Study||54
37770|NCT02022020|90749|P1|NOT COMPLETED|Overall Study||0
37771|NCT02022020|90749|P1|COMPLETED|Overall Study||220
37772|NCT02022020|90749|P1|STARTED|Overall Study||220
37773|NCT02022007|90758|P3|NOT COMPLETED|Overall Study||2
37774|NCT02022007|90759|P2|NOT COMPLETED|Overall Study||1
37775|NCT02022007|90760|P1|NOT COMPLETED|Overall Study||1
37776|NCT02022007|90758|P3|COMPLETED|Overall Study||11
37777|NCT02022007|90759|P2|COMPLETED|Overall Study||11
37778|NCT02022007|90760|P1|COMPLETED|Overall Study||12
37779|NCT02022007|90758|P3|STARTED|Overall Study||13
37780|NCT02022007|90759|P2|STARTED|Overall Study||12
37781|NCT02022007|90760|P1|STARTED|Overall Study||13
37782|NCT02021942|90801|P1|NOT COMPLETED|Overall Study||0
37783|NCT02021942|90801|P1|COMPLETED|Overall Study||16
37784|NCT02021942|90801|P1|STARTED|Overall Study||16
37785|NCT02021812|90811|P1|NOT COMPLETED|Overall Study||26
37786|NCT02021812|90811|P1|COMPLETED|Overall Study||5
37787|NCT02021812|90811|P1|STARTED|Overall Study||31
37788|NCT02021643|90825|P4|NOT COMPLETED|Overall Study||12
37789|NCT02021643|90826|P3|NOT COMPLETED|Overall Study||0
37790|NCT02021643|90827|P2|NOT COMPLETED|Overall Study||10
37791|NCT02021643|90828|P1|NOT COMPLETED|Overall Study||9
37792|NCT02021643|90825|P4|COMPLETED|Overall Study||218
37793|NCT02021643|90826|P3|COMPLETED|Overall Study||11
37794|NCT02021643|90827|P2|COMPLETED|Overall Study||280
37795|NCT02021643|90828|P1|COMPLETED|Overall Study||147
37796|NCT02021643|90825|P4|STARTED|Overall Study||230
37797|NCT02021643|90826|P3|STARTED|Overall Study||11
37798|NCT02021643|90827|P2|STARTED|Overall Study||290
37799|NCT02021643|90828|P1|STARTED|Overall Study||156
37800|NCT02021565|90870|P2|NOT COMPLETED|3-month Follow-up||2
37801|NCT02021565|90871|P1|NOT COMPLETED|3-month Follow-up||10
37802|NCT02021565|90870|P2|COMPLETED|3-month Follow-up||34
37803|NCT02021565|90871|P1|COMPLETED|3-month Follow-up||50
37804|NCT02021565|90870|P2|Care Recipients|3-month Follow-up||18
37805|NCT02021565|90871|P1|Care Recipients|3-month Follow-up||30
37806|NCT02021565|90870|P2|Caregivers|3-month Follow-up||18
37807|NCT02021565|90871|P1|Caregivers|3-month Follow-up||30
37808|NCT02021565|90870|P2|STARTED|3-month Follow-up||36
37809|NCT02021565|90871|P1|STARTED|3-month Follow-up||60
37810|NCT02021565|90870|P2|NOT COMPLETED|Baseline Through Intervention||18
37811|NCT02021565|90871|P1|NOT COMPLETED|Baseline Through Intervention||12
37812|NCT02021565|90870|P2|COMPLETED|Baseline Through Intervention||36
37813|NCT02021565|90871|P1|COMPLETED|Baseline Through Intervention||60
37814|NCT02021565|90870|P2|Care Recipients|Baseline Through Intervention||27
37815|NCT02021565|90871|P1|Care Recipients|Baseline Through Intervention||36
37816|NCT02021565|90870|P2|Caregivers|Baseline Through Intervention||27
37817|NCT02021565|90871|P1|Caregivers|Baseline Through Intervention||36
37818|NCT02021565|90870|P2|STARTED|Baseline Through Intervention||54
37819|NCT02021565|90871|P1|STARTED|Baseline Through Intervention||72
37820|NCT02021461|90883|P1|NOT COMPLETED|Overall Study||0
37821|NCT02021461|90883|P1|COMPLETED|Overall Study||38
37822|NCT02021461|90883|P1|STARTED|Overall Study||38
37823|NCT02021331|90891|P2|NOT COMPLETED|Overall Study||2
37824|NCT02021331|90892|P1|NOT COMPLETED|Overall Study||0
37825|NCT02021331|90891|P2|COMPLETED|Overall Study||1
37826|NCT02021331|90892|P1|COMPLETED|Overall Study||2
37827|NCT02021331|90891|P2|STARTED|Overall Study||3
37828|NCT02021331|90892|P1|STARTED|Overall Study||2
37829|NCT02021292|90904|P2|NOT COMPLETED|Overall Study||3
37830|NCT02021292|90905|P1|NOT COMPLETED|Overall Study||0
37831|NCT02021292|90904|P2|COMPLETED|Overall Study||37
37832|NCT02021292|90905|P1|COMPLETED|Overall Study||40
37833|NCT02021292|90904|P2|STARTED|Overall Study||40
37834|NCT02021292|90905|P1|STARTED|Overall Study||40
37835|NCT02021071|90919|P2|NOT COMPLETED|Overall Study||0
37836|NCT02021071|90920|P1|NOT COMPLETED|Overall Study||0
37837|NCT02021071|90919|P2|COMPLETED|Overall Study||12
37838|NCT02021071|90920|P1|COMPLETED|Overall Study||12
37839|NCT02021071|90919|P2|STARTED|Overall Study||12
37840|NCT02021071|90920|P1|STARTED|Overall Study||12
37841|NCT02020941|90927|P1|NOT COMPLETED|Overall Study||8
37842|NCT02020941|90927|P1|COMPLETED|Overall Study||2
37843|NCT02020941|90927|P1|STARTED|Overall Study||10
37844|NCT02020889|90938|P2|NOT COMPLETED|Overall Study||3
37845|NCT02020889|90939|P1|NOT COMPLETED|Overall Study||7
37846|NCT02020889|90938|P2|COMPLETED|Overall Study||65
37847|NCT02020889|90939|P1|COMPLETED|Overall Study||61
37848|NCT02020889|90938|P2|STARTED|Overall Study||68
37849|NCT02020889|90939|P1|STARTED|Overall Study||68
37850|NCT02020863|90993|P1|NOT COMPLETED|Overall Study||5
37851|NCT02020863|90993|P1|COMPLETED|Overall Study||35
37852|NCT02020863|90993|P1|STARTED|Overall Study||40
37853|NCT02020837|90997|P1|NOT COMPLETED|Overall Study||0
37854|NCT02020837|90997|P1|COMPLETED|Overall Study||2
37855|NCT02020837|90997|P1|STARTED|Overall Study||2
37856|NCT02020616|91008|P7|NOT COMPLETED|Overall Study||4
37857|NCT02020616|91009|P6|NOT COMPLETED|Overall Study||5
37858|NCT02020616|91010|P5|NOT COMPLETED|Overall Study||2
37859|NCT02020616|91011|P4|NOT COMPLETED|Overall Study||2
37860|NCT02020616|91012|P3|NOT COMPLETED|Overall Study||2
37861|NCT02020616|91013|P2|NOT COMPLETED|Overall Study||1
37862|NCT02020616|91014|P1|NOT COMPLETED|Overall Study||0
37863|NCT02020616|91008|P7|COMPLETED|Overall Study||6
37864|NCT02020616|91009|P6|COMPLETED|Overall Study||3
37865|NCT02020616|91010|P5|COMPLETED|Overall Study||6
37866|NCT02020616|91011|P4|COMPLETED|Overall Study||6
37867|NCT02020616|91012|P3|COMPLETED|Overall Study||6
37868|NCT02020616|91013|P2|COMPLETED|Overall Study||7
37869|NCT02020616|91014|P1|COMPLETED|Overall Study||10
37870|NCT02020616|91008|P7|Received at Least One Dose of Study Drug|Overall Study||10
37871|NCT02020616|91009|P6|Received at Least One Dose of Study Drug|Overall Study||8
37872|NCT02020616|91010|P5|Received at Least One Dose of Study Drug|Overall Study||8
37873|NCT02020616|91011|P4|Received at Least One Dose of Study Drug|Overall Study||7
37874|NCT02020616|91012|P3|Received at Least One Dose of Study Drug|Overall Study||8
37875|NCT02020616|91013|P2|Received at Least One Dose of Study Drug|Overall Study||8
37876|NCT02020616|91014|P1|Received at Least One Dose of Study Drug|Overall Study||10
37877|NCT02020616|91008|P7|STARTED|Overall Study||10
37878|NCT02020616|91009|P6|STARTED|Overall Study||8
37879|NCT02020616|91010|P5|STARTED|Overall Study||8
37880|NCT02020616|91011|P4|STARTED|Overall Study||8
37881|NCT02020616|91012|P3|STARTED|Overall Study||8
37882|NCT02020616|91013|P2|STARTED|Overall Study||8
37883|NCT02020616|91014|P1|STARTED|Overall Study||10
37884|NCT02020577|91107|P2|NOT COMPLETED|Overall Study||55
37885|NCT02020577|91108|P1|NOT COMPLETED|Overall Study||3
37886|NCT02020577|91107|P2|COMPLETED|Overall Study||0
37887|NCT02020577|91108|P1|COMPLETED|Overall Study||0
37888|NCT02020577|91107|P2|STARTED|Overall Study||55
37889|NCT02020577|91108|P1|STARTED|Overall Study||3
37890|NCT02020512|91135|P1|NOT COMPLETED|Overall Study||8
37891|NCT02020512|91135|P1|COMPLETED|Overall Study||79
37892|NCT02020512|91135|P1|STARTED|Overall Study||87
37893|NCT02020369|91141|P2|NOT COMPLETED|Overall Study||2
37894|NCT02020369|91142|P1|NOT COMPLETED|Overall Study||3
37895|NCT02020369|91141|P2|COMPLETED|Overall Study||11
37896|NCT02020369|91142|P1|COMPLETED|Overall Study||11
37897|NCT02020369|91141|P2|STARTED|Overall Study||13
37898|NCT02020369|91142|P1|STARTED|Overall Study||14
37899|NCT02020304|91158|P2|NOT COMPLETED|Overall Study||2
37900|NCT02020304|91159|P1|NOT COMPLETED|Overall Study||3
37901|NCT02020304|91158|P2|COMPLETED|Overall Study||26
37902|NCT02020304|91159|P1|COMPLETED|Overall Study||27
37903|NCT02020304|91158|P2|STARTED|Overall Study||28
37904|NCT02020304|91159|P1|STARTED|Overall Study||30
37905|NCT02020135|91175|P1|NOT COMPLETED|Overall Study||9
37906|NCT02020135|91175|P1|COMPLETED|Overall Study||0
37907|NCT02020135|91175|P1|STARTED|Overall Study||9
37908|NCT02020031|91187|P2|NOT COMPLETED|Overall Study||1
37909|NCT02020031|91188|P1|NOT COMPLETED|Overall Study||1
37910|NCT02020031|91187|P2|COMPLETED|Overall Study||10
37911|NCT02020031|91188|P1|COMPLETED|Overall Study||10
37912|NCT02020031|91187|P2|STARTED|Overall Study||11
37913|NCT02020031|91188|P1|STARTED|Overall Study||11
37914|NCT02019979|91196|P1|NOT COMPLETED|Overall Study||14
37915|NCT02019979|91196|P1|COMPLETED|Overall Study||0
37916|NCT02019979|91196|P1|STARTED|Overall Study||14
37917|NCT02019719|91207|P5|NOT COMPLETED|Overall Study||2
37918|NCT02019719|91208|P4|NOT COMPLETED|Overall Study||2
37919|NCT02019719|91209|P3|NOT COMPLETED|Overall Study||0
37920|NCT02019719|91210|P2|NOT COMPLETED|Overall Study||1
37921|NCT02019719|91211|P1|NOT COMPLETED|Overall Study||6
37922|NCT02019719|91207|P5|COMPLETED|Overall Study||18
37923|NCT02019719|91208|P4|COMPLETED|Overall Study||17
37924|NCT02019719|91209|P3|COMPLETED|Overall Study||20
37925|NCT02019719|91210|P2|COMPLETED|Overall Study||18
37926|NCT02019719|91211|P1|COMPLETED|Overall Study||13
37927|NCT02019719|91207|P5|STARTED|Overall Study||20
37928|NCT02019719|91208|P4|STARTED|Overall Study||19
37929|NCT02019719|91209|P3|STARTED|Overall Study||20
37930|NCT02019719|91210|P2|STARTED|Overall Study||19
37931|NCT02019719|91211|P1|STARTED|Overall Study||19
37932|NCT02019563|91310|P2|NOT COMPLETED|Overall Study||0
37933|NCT02019563|91311|P1|NOT COMPLETED|Overall Study||0
37934|NCT02019563|91310|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
37935|NCT02019563|91311|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
37936|NCT02019563|91310|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
37937|NCT02019563|91311|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
37938|NCT02019550|91327|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
37939|NCT02019550|91328|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
37940|NCT02019550|91327|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
37941|NCT02019550|91328|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
37942|NCT02019550|91327|P2|STARTED|Treatment Period 2 (4 Weeks)||50
37943|NCT02019550|91328|P1|STARTED|Treatment Period 2 (4 Weeks)||46
37944|NCT02019550|91327|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
37945|NCT02019550|91328|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
37946|NCT02019550|91327|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
37947|NCT02019550|91328|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
37948|NCT02019550|91327|P2|STARTED|Treatment Period 1 (4 Weeks)||51
37949|NCT02019550|91328|P1|STARTED|Treatment Period 1 (4 Weeks)||46
37950|NCT02019472|91369|P3|NOT COMPLETED|Overall Study||42
37951|NCT02019472|91370|P2|NOT COMPLETED|Overall Study||52
37952|NCT02019472|91371|P1|NOT COMPLETED|Overall Study||37
37953|NCT02019472|91369|P3|COMPLETED|Overall Study||145
37954|NCT02019472|91370|P2|COMPLETED|Overall Study||134
37955|NCT02019472|91371|P1|COMPLETED|Overall Study||149
37956|NCT02019472|91369|P3|STARTED|Overall Study||187
37957|NCT02019472|91370|P2|STARTED|Overall Study||186
37958|NCT02019472|91371|P1|STARTED|Overall Study||186
37959|NCT02018809|91396|P4|NOT COMPLETED|Overall Study||0
37960|NCT02018809|91397|P3|NOT COMPLETED|Overall Study||0
37961|NCT02018809|91398|P2|NOT COMPLETED|Overall Study||0
37962|NCT02018809|91399|P1|NOT COMPLETED|Overall Study||0
37963|NCT02018809|91396|P4|COMPLETED|Overall Study||50
37964|NCT02018809|91397|P3|COMPLETED|Overall Study||50
37965|NCT02018809|91398|P2|COMPLETED|Overall Study||50
37966|NCT02018809|91399|P1|COMPLETED|Overall Study||50
37967|NCT02018809|91396|P4|STARTED|Overall Study||50
37968|NCT02018809|91397|P3|STARTED|Overall Study||50
37969|NCT02018809|91398|P2|STARTED|Overall Study||50
37970|NCT02018809|91399|P1|STARTED|Overall Study||50
37971|NCT02018562|91415|P2|NOT COMPLETED|Overall Study||0
37972|NCT02018562|91416|P1|NOT COMPLETED|Overall Study||3
37973|NCT02018562|91415|P2|COMPLETED|Overall Study||25
37974|NCT02018562|91416|P1|COMPLETED|Overall Study||22
37975|NCT02018562|91415|P2|STARTED|Overall Study||25
37976|NCT02018562|91416|P1|STARTED|Overall Study||25
37977|NCT02017574|91436|P2|NOT COMPLETED|Overall Study||0
37978|NCT02017574|91437|P1|NOT COMPLETED|Overall Study||0
37979|NCT02017574|91436|P2|COMPLETED|Overall Study||12
37980|NCT02017574|91437|P1|COMPLETED|Overall Study||12
37981|NCT02017574|91436|P2|STARTED|Overall Study||12
37982|NCT02017574|91437|P1|STARTED|Overall Study||12
37983|NCT02017093|91447|P2|NOT COMPLETED|Overall Study||0
37984|NCT02017093|91448|P1|NOT COMPLETED|Overall Study||0
37985|NCT02017093|91447|P2|COMPLETED|Overall Study||3
37986|NCT02017093|91448|P1|COMPLETED|Overall Study||4
37987|NCT02017093|91447|P2|STARTED|Overall Study||3
37988|NCT02017093|91448|P1|STARTED|Overall Study||4
37989|NCT02017015|91456|P1|NOT COMPLETED|Overall Study||69
37990|NCT02017015|91456|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
37991|NCT02017015|91456|P1|Safety Population|Overall Study||83
37992|NCT02017015|91456|P1|STARTED|Overall Study||83
37993|NCT02016963|91463|P1|NOT COMPLETED|Overall Study||0
37994|NCT02016963|91463|P1|COMPLETED|Overall Study||20
37995|NCT02016963|91463|P1|STARTED|Overall Study||20
37996|NCT02016898|91481|P2|NOT COMPLETED|Overall Study||5
37997|NCT02016898|91482|P1|NOT COMPLETED|Overall Study||5
37998|NCT02016898|91481|P2|COMPLETED|Overall Study||40
37999|NCT02016898|91482|P1|COMPLETED|Overall Study||45
38000|NCT02016898|91481|P2|STARTED|Overall Study||45
38001|NCT02016898|91482|P1|STARTED|Overall Study||50
38002|NCT02016690|91490|P1|NOT COMPLETED|Overall Study||24
38003|NCT02016690|91490|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
38004|NCT02016690|91490|P1|Safety Analysis Set (SAS)|Overall Study||304
38005|NCT02016690|91490|P1|Treated|Overall Study||312
38006|NCT02016690|91490|P1|STARTED|Overall Study||312
38007|NCT02016625|91503|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
38008|NCT02016625|91504|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
38009|NCT02016625|91503|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
38010|NCT02016625|91504|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
38011|NCT02016625|91503|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
38012|NCT02016625|91504|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
38013|NCT02016625|91503|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
38014|NCT02016625|91504|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
38015|NCT02016625|91503|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
38016|NCT02016625|91504|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
38017|NCT02016625|91503|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
38018|NCT02016625|91504|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
38019|NCT02016612|91540|P4|NOT COMPLETED|Overall Study||0
38020|NCT02016612|91541|P3|NOT COMPLETED|Overall Study||0
38021|NCT02016612|91542|P2|NOT COMPLETED|Overall Study||0
38022|NCT02016612|91543|P1|NOT COMPLETED|Overall Study||0
38023|NCT02016612|91540|P4|COMPLETED|Overall Study||61
38024|NCT02016612|91541|P3|COMPLETED|Overall Study||26
38025|NCT02016612|91542|P2|COMPLETED|Overall Study||25
38026|NCT02016612|91543|P1|COMPLETED|Overall Study||25
38027|NCT02016612|91540|P4|STARTED|Overall Study||61
38028|NCT02016612|91541|P3|STARTED|Overall Study||26
38029|NCT02016612|91542|P2|STARTED|Overall Study||25
38030|NCT02016612|91543|P1|STARTED|Overall Study||25
38031|NCT02016482|91559|P2|NOT COMPLETED|Period B||7
38032|NCT02016482|91560|P1|NOT COMPLETED|Period B||13
38033|NCT02016482|91559|P2|COMPLETED|Period B||87
38034|NCT02016482|91560|P1|COMPLETED|Period B||81
38035|NCT02016482|91559|P2|STARTED|Period B||94
38036|NCT02016482|91560|P1|STARTED|Period B||94
38037|NCT02016482|91559|P2|NOT COMPLETED|Period A||15
38038|NCT02016482|91560|P1|NOT COMPLETED|Period A||14
38039|NCT02016482|91559|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
38040|NCT02016482|91560|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
38041|NCT02016482|91559|P2|STARTED|Period A||109
38042|NCT02016482|91560|P1|STARTED|Period A||108
38043|NCT02016170|91651|P3|NOT COMPLETED|Overall Study||0
38044|NCT02016170|91652|P2|NOT COMPLETED|Overall Study||1
38045|NCT02016170|91653|P1|NOT COMPLETED|Overall Study||2
38046|NCT02016170|91651|P3|COMPLETED|Overall Study||27
38047|NCT02016170|91652|P2|COMPLETED|Overall Study||27
38048|NCT02016170|91653|P1|COMPLETED|Overall Study||25
38049|NCT02016170|91651|P3|STARTED|Overall Study||27
38050|NCT02016170|91652|P2|STARTED|Overall Study||28
38051|NCT02016170|91653|P1|STARTED|Overall Study||27
38052|NCT02016105|91664|P6|NOT COMPLETED|EXTENSION PERIOD||6
38053|NCT02016105|91665|P5|NOT COMPLETED|EXTENSION PERIOD||6
38054|NCT02016105|91666|P4|NOT COMPLETED|EXTENSION PERIOD||5
38055|NCT02016105|91667|P3|NOT COMPLETED|EXTENSION PERIOD||5
38056|NCT02016105|91668|P2|NOT COMPLETED|EXTENSION PERIOD||0
38057|NCT02016105|91669|P1|NOT COMPLETED|EXTENSION PERIOD||0
38058|NCT02016105|91664|P6|COMPLETED|EXTENSION PERIOD||100
38059|NCT02016105|91665|P5|COMPLETED|EXTENSION PERIOD||50
38060|NCT02016105|91666|P4|COMPLETED|EXTENSION PERIOD||104
38061|NCT02016105|91667|P3|COMPLETED|EXTENSION PERIOD||47
38062|NCT02016105|91668|P2|COMPLETED|EXTENSION PERIOD||0
38063|NCT02016105|91669|P1|COMPLETED|EXTENSION PERIOD||0
38064|NCT02016105|91664|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
38065|NCT02016105|91665|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
38066|NCT02016105|91666|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
38067|NCT02016105|91667|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
38068|NCT02016105|91668|P2|STARTED|EXTENSION PERIOD||0
38069|NCT02016105|91669|P1|STARTED|EXTENSION PERIOD||0
38070|NCT02016105|91664|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
38071|NCT02016105|91665|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
38072|NCT02016105|91666|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
38073|NCT02016105|91667|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
38074|NCT02016105|91668|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
38075|NCT02016105|91669|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
38076|NCT02016105|91664|P6|COMPLETED|TREATMENT PERIOD 2||112
38077|NCT02016105|91665|P5|COMPLETED|TREATMENT PERIOD 2||59
38078|NCT02016105|91666|P4|COMPLETED|TREATMENT PERIOD 2||116
38079|NCT02016105|91667|P3|COMPLETED|TREATMENT PERIOD 2||57
38080|NCT02016105|91668|P2|COMPLETED|TREATMENT PERIOD 2||0
38081|NCT02016105|91669|P1|COMPLETED|TREATMENT PERIOD 2||0
38082|NCT02016105|91664|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
38083|NCT02016105|91665|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
38084|NCT02016105|91666|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
38085|NCT02016105|91667|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
38086|NCT02016105|91668|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
38087|NCT02016105|91669|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
38088|NCT02016105|91664|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
38089|NCT02016105|91665|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
38090|NCT02016105|91666|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
38091|NCT02016105|91667|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
38092|NCT02016105|91668|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
38093|NCT02016105|91669|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
38094|NCT02016105|91664|P6|COMPLETED|TREATMENT PERIOD 1||0
38095|NCT02016105|91665|P5|COMPLETED|TREATMENT PERIOD 1||0
38096|NCT02016105|91666|P4|COMPLETED|TREATMENT PERIOD 1||0
38097|NCT02016105|91667|P3|COMPLETED|TREATMENT PERIOD 1||0
38187|NCT02015195|91914|P6|STARTED|Overall Study||16
38098|NCT02016105|91668|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
38099|NCT02016105|91669|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
38100|NCT02016105|91664|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
38101|NCT02016105|91665|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
38102|NCT02016105|91666|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
38103|NCT02016105|91667|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
38104|NCT02016105|91668|P2|STARTED|TREATMENT PERIOD 1||234
38105|NCT02016105|91669|P1|STARTED|TREATMENT PERIOD 1||231
38106|NCT02015910|91719|P2|NOT COMPLETED|Overall Study||0
38107|NCT02015910|91720|P1|NOT COMPLETED|Overall Study||0
38108|NCT02015910|91719|P2|COMPLETED|Overall Study||1
38109|NCT02015910|91720|P1|COMPLETED|Overall Study||0
38110|NCT02015910|91719|P2|STARTED|Overall Study||1
38111|NCT02015910|91720|P1|STARTED|Overall Study||0
38112|NCT02015793|91728|P2|NOT COMPLETED|Overall Study||4
38113|NCT02015793|91729|P1|NOT COMPLETED|Overall Study||4
38114|NCT02015793|91728|P2|COMPLETED|Overall Study||11
38115|NCT02015793|91729|P1|COMPLETED|Overall Study||11
38116|NCT02015793|91728|P2|Entered Open-label Extension Period|Overall Study||14
38117|NCT02015793|91729|P1|Entered Open-label Extension Period|Overall Study||13
38118|NCT02015793|91728|P2|Completed Double-Blind Period|Overall Study||14
38119|NCT02015793|91729|P1|Completed Double-Blind Period|Overall Study||14
38120|NCT02015793|91728|P2|STARTED|Overall Study||15
38121|NCT02015793|91729|P1|STARTED|Overall Study||15
38122|NCT02015754|91759|P1|NOT COMPLETED|Overall Study||11
38123|NCT02015754|91759|P1|COMPLETED|Overall Study||3
38124|NCT02015754|91759|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
38125|NCT02015754|91759|P1|Completed First TACE|Overall Study||14
38126|NCT02015754|91759|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
38127|NCT02015676|91779|P3|NOT COMPLETED|Overall Study||3
38128|NCT02015676|91780|P2|NOT COMPLETED|Overall Study||34
38129|NCT02015676|91781|P1|NOT COMPLETED|Overall Study||9
38130|NCT02015676|91779|P3|COMPLETED|Overall Study||3
38131|NCT02015676|91780|P2|COMPLETED|Overall Study||14
38132|NCT02015676|91781|P1|COMPLETED|Overall Study||6
38133|NCT02015676|91779|P3|STARTED|Overall Study||6
38134|NCT02015676|91780|P2|STARTED|Overall Study||48
38135|NCT02015676|91781|P1|STARTED|Overall Study||15
38136|NCT02015663|91797|P2|NOT COMPLETED|Overall Study||12
38137|NCT02015663|91798|P1|NOT COMPLETED|Overall Study||15
38138|NCT02015663|91797|P2|COMPLETED|Overall Study||4
38139|NCT02015663|91798|P1|COMPLETED|Overall Study||1
38140|NCT02015663|91797|P2|STARTED|Overall Study||16
38141|NCT02015663|91798|P1|STARTED|Overall Study||16
38142|NCT02015637|91829|P2|NOT COMPLETED|Overall Study||5
38143|NCT02015637|91830|P1|NOT COMPLETED|Overall Study||8
38144|NCT02015637|91829|P2|COMPLETED|Overall Study||149
38145|NCT02015637|91830|P1|COMPLETED|Overall Study||298
38146|NCT02015637|91829|P2|STARTED|Overall Study||154
38147|NCT02015637|91830|P1|STARTED|Overall Study||306
38148|NCT02015546|91841|P3|NOT COMPLETED|Overall Study||4
38149|NCT02015546|91842|P2|NOT COMPLETED|Overall Study||2
38150|NCT02015546|91843|P1|NOT COMPLETED|Overall Study||3
38151|NCT02015546|91841|P3|COMPLETED|Overall Study||22
38152|NCT02015546|91842|P2|COMPLETED|Overall Study||19
38153|NCT02015546|91843|P1|COMPLETED|Overall Study||20
38154|NCT02015546|91841|P3|STARTED|Overall Study||26
38155|NCT02015546|91842|P2|STARTED|Overall Study||21
38156|NCT02015546|91843|P1|STARTED|Overall Study||23
38157|NCT02015481|91875|P1|NOT COMPLETED|Overall Study||1
38158|NCT02015481|91875|P1|COMPLETED|Overall Study||24
38159|NCT02015481|91875|P1|STARTED|Overall Study||25
38160|NCT02015234|91884|P2|NOT COMPLETED|Overall Study||25
38161|NCT02015234|91885|P1|NOT COMPLETED|Overall Study||36
38162|NCT02015234|91884|P2|COMPLETED|Overall Study||54
38163|NCT02015234|91885|P1|COMPLETED|Overall Study||43
38164|NCT02015234|91884|P2|STARTED|Overall Study||79
38165|NCT02015234|91885|P1|STARTED|Overall Study||79
38166|NCT02015221|91899|P2|NOT COMPLETED|Overall Study||6
38167|NCT02015221|91900|P1|NOT COMPLETED|Overall Study||9
38168|NCT02015221|91899|P2|COMPLETED|Overall Study||34
38169|NCT02015221|91900|P1|COMPLETED|Overall Study||32
38170|NCT02015221|91899|P2|STARTED|Overall Study||40
38171|NCT02015221|91900|P1|STARTED|Overall Study||41
38172|NCT02015195|91913|P7|NOT COMPLETED|Overall Study||0
38173|NCT02015195|91914|P6|NOT COMPLETED|Overall Study||0
38174|NCT02015195|91915|P5|NOT COMPLETED|Overall Study||0
38175|NCT02015195|91916|P4|NOT COMPLETED|Overall Study||1
38176|NCT02015195|91917|P3|NOT COMPLETED|Overall Study||0
38177|NCT02015195|91918|P2|NOT COMPLETED|Overall Study||0
38178|NCT02015195|91919|P1|NOT COMPLETED|Overall Study||0
38179|NCT02015195|91913|P7|COMPLETED|Overall Study||16
38180|NCT02015195|91914|P6|COMPLETED|Overall Study||16
38181|NCT02015195|91915|P5|COMPLETED|Overall Study||16
38182|NCT02015195|91916|P4|COMPLETED|Overall Study||0
38183|NCT02015195|91917|P3|COMPLETED|Overall Study||16
38184|NCT02015195|91918|P2|COMPLETED|Overall Study||16
38185|NCT02015195|91919|P1|COMPLETED|Overall Study||16
38186|NCT02015195|91913|P7|STARTED|Overall Study||16
38188|NCT02015195|91915|P5|STARTED|Overall Study||16
38189|NCT02015195|91916|P4|STARTED|Overall Study||1
38190|NCT02015195|91917|P3|STARTED|Overall Study||16
38191|NCT02015195|91918|P2|STARTED|Overall Study||16
38192|NCT02015195|91919|P1|STARTED|Overall Study||16
38193|NCT02015039|91942|P2|NOT COMPLETED|Overall Study||1
38194|NCT02015039|91943|P1|NOT COMPLETED|Overall Study||0
38195|NCT02015039|91942|P2|COMPLETED|Overall Study||6
38196|NCT02015039|91943|P1|COMPLETED|Overall Study||6
38197|NCT02015039|91942|P2|STARTED|Overall Study||7
38198|NCT02015039|91943|P1|STARTED|Overall Study||6
38199|NCT02014740|91963|P2|NOT COMPLETED|Overall Study||5
38200|NCT02014740|91964|P1|NOT COMPLETED|Overall Study||6
38201|NCT02014740|91963|P2|COMPLETED|Overall Study||40
38202|NCT02014740|91964|P1|COMPLETED|Overall Study||49
38203|NCT02014740|91963|P2|STARTED|Overall Study||45
38204|NCT02014740|91964|P1|STARTED|Overall Study||55
38205|NCT02014584|91972|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38206|NCT02014584|91973|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
38207|NCT02014584|91974|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38208|NCT02014584|91975|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38209|NCT02014584|91976|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38210|NCT02014584|91977|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38211|NCT02014584|91972|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
38212|NCT02014584|91973|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
38213|NCT02014584|91974|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38214|NCT02014584|91975|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38215|NCT02014584|91976|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38216|NCT02014584|91977|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
38217|NCT02014584|91972|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
38218|NCT02014584|91973|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
38219|NCT02014584|91974|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
38220|NCT02014584|91975|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
38221|NCT02014584|91976|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
38222|NCT02014584|91977|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
38223|NCT02014584|91972|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
38224|NCT02014584|91973|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
38225|NCT02014584|91974|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
38226|NCT02014584|91975|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
38227|NCT02014584|91976|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
38228|NCT02014584|91977|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
38229|NCT02014584|91972|P6|COMPLETED|Open-Label Period (24 Weeks)||0
38230|NCT02014584|91973|P5|COMPLETED|Open-Label Period (24 Weeks)||0
38231|NCT02014584|91974|P4|COMPLETED|Open-Label Period (24 Weeks)||47
38232|NCT02014584|91975|P3|COMPLETED|Open-Label Period (24 Weeks)||44
38233|NCT02014584|91976|P2|COMPLETED|Open-Label Period (24 Weeks)||0
38234|NCT02014584|91977|P1|COMPLETED|Open-Label Period (24 Weeks)||0
38235|NCT02014584|91972|P6|STARTED|Open-Label Period (24 Weeks)||0
38236|NCT02014584|91973|P5|STARTED|Open-Label Period (24 Weeks)||0
38237|NCT02014584|91974|P4|STARTED|Open-Label Period (24 Weeks)||48
38238|NCT02014584|91975|P3|STARTED|Open-Label Period (24 Weeks)||49
38239|NCT02014584|91976|P2|STARTED|Open-Label Period (24 Weeks)||0
38240|NCT02014584|91977|P1|STARTED|Open-Label Period (24 Weeks)||0
38241|NCT02014584|91972|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
38242|NCT02014584|91973|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
38243|NCT02014584|91974|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
38244|NCT02014584|91975|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
38245|NCT02014584|91976|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
38246|NCT02014584|91977|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
38247|NCT02014584|91972|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
38248|NCT02014584|91973|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
38249|NCT02014584|91974|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
38250|NCT02014584|91975|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
38251|NCT02014584|91976|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
38252|NCT02014584|91977|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
38253|NCT02014584|91972|P6|STARTED|Double-Blind Period (24 Weeks)||0
38254|NCT02014584|91973|P5|STARTED|Double-Blind Period (24 Weeks)||0
38255|NCT02014584|91974|P4|STARTED|Double-Blind Period (24 Weeks)||0
38256|NCT02014584|91975|P3|STARTED|Double-Blind Period (24 Weeks)||0
38257|NCT02014584|91976|P2|STARTED|Double-Blind Period (24 Weeks)||58
38258|NCT02014584|91977|P1|STARTED|Double-Blind Period (24 Weeks)||59
38259|NCT02014480|92094|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
38260|NCT02014480|92095|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
38261|NCT02014480|92096|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
38262|NCT02014480|92097|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
38263|NCT02014480|92098|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
38264|NCT02014480|92099|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
38265|NCT02014480|92094|P6|COMPLETED|Treatment Period 3 (14 Days)||32
38266|NCT02014480|92095|P5|COMPLETED|Treatment Period 3 (14 Days)||34
38267|NCT02014480|92096|P4|COMPLETED|Treatment Period 3 (14 Days)||31
38268|NCT02014480|92097|P3|COMPLETED|Treatment Period 3 (14 Days)||29
38269|NCT02014480|92098|P2|COMPLETED|Treatment Period 3 (14 Days)||32
38270|NCT02014480|92099|P1|COMPLETED|Treatment Period 3 (14 Days)||34
38271|NCT02014480|92094|P6|STARTED|Treatment Period 3 (14 Days)||34
38272|NCT02014480|92095|P5|STARTED|Treatment Period 3 (14 Days)||34
38273|NCT02014480|92096|P4|STARTED|Treatment Period 3 (14 Days)||31
38274|NCT02014480|92097|P3|STARTED|Treatment Period 3 (14 Days)||30
38275|NCT02014480|92098|P2|STARTED|Treatment Period 3 (14 Days)||33
38276|NCT02014480|92099|P1|STARTED|Treatment Period 3 (14 Days)||34
38277|NCT02014480|92094|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
38278|NCT02014480|92095|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
38279|NCT02014480|92096|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
38280|NCT02014480|92097|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
38281|NCT02014480|92098|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
38282|NCT02014480|92099|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
38283|NCT02014480|92094|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
38284|NCT02014480|92095|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
38285|NCT02014480|92096|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
38286|NCT02014480|92097|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
38287|NCT02014480|92098|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
38288|NCT02014480|92099|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
38289|NCT02014480|92094|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
38290|NCT02014480|92095|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
38291|NCT02014480|92096|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
38292|NCT02014480|92097|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
38293|NCT02014480|92098|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
38294|NCT02014480|92099|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
38295|NCT02014480|92094|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
38296|NCT02014480|92095|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
38297|NCT02014480|92096|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
38298|NCT02014480|92097|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
38299|NCT02014480|92098|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
38300|NCT02014480|92099|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
38301|NCT02014480|92094|P6|COMPLETED|Treatment Period 2 (14 Days)||34
38302|NCT02014480|92095|P5|COMPLETED|Treatment Period 2 (14 Days)||34
38303|NCT02014480|92096|P4|COMPLETED|Treatment Period 2 (14 Days)||31
38304|NCT02014480|92097|P3|COMPLETED|Treatment Period 2 (14 Days)||30
38305|NCT02014480|92098|P2|COMPLETED|Treatment Period 2 (14 Days)||33
38306|NCT02014480|92099|P1|COMPLETED|Treatment Period 2 (14 Days)||34
38307|NCT02014480|92094|P6|STARTED|Treatment Period 2 (14 Days)||34
38308|NCT02014480|92095|P5|STARTED|Treatment Period 2 (14 Days)||34
38309|NCT02014480|92096|P4|STARTED|Treatment Period 2 (14 Days)||32
38310|NCT02014480|92097|P3|STARTED|Treatment Period 2 (14 Days)||32
38311|NCT02014480|92098|P2|STARTED|Treatment Period 2 (14 Days)||34
38312|NCT02014480|92099|P1|STARTED|Treatment Period 2 (14 Days)||35
38313|NCT02014480|92094|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
38314|NCT02014480|92095|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
38315|NCT02014480|92096|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
38316|NCT02014480|92097|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
38317|NCT02014480|92098|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
38318|NCT02014480|92099|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
38319|NCT02014480|92094|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
38320|NCT02014480|92095|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
38321|NCT02014480|92096|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
38322|NCT02014480|92097|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
38323|NCT02014480|92098|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
38324|NCT02014480|92099|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
38325|NCT02014480|92094|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
38326|NCT02014480|92095|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
38327|NCT02014480|92096|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
38328|NCT02014480|92097|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
38329|NCT02014480|92098|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
38330|NCT02014480|92099|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
38331|NCT02014480|92094|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
38332|NCT02014480|92095|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
38333|NCT02014480|92096|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
38334|NCT02014480|92097|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
38335|NCT02014480|92098|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
38336|NCT02014480|92099|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
38337|NCT02014480|92094|P6|COMPLETED|Treatment Period 1 (14 Days)||34
38338|NCT02014480|92095|P5|COMPLETED|Treatment Period 1 (14 Days)||34
38339|NCT02014480|92096|P4|COMPLETED|Treatment Period 1 (14 Days)||32
38340|NCT02014480|92097|P3|COMPLETED|Treatment Period 1 (14 Days)||33
38341|NCT02014480|92098|P2|COMPLETED|Treatment Period 1 (14 Days)||34
38342|NCT02014480|92099|P1|COMPLETED|Treatment Period 1 (14 Days)||35
38343|NCT02014480|92094|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
38344|NCT02014480|92095|P5|STARTED|Treatment Period 1 (14 Days)||35
38345|NCT02014480|92096|P4|STARTED|Treatment Period 1 (14 Days)||34
38346|NCT02014480|92097|P3|STARTED|Treatment Period 1 (14 Days)||34
38347|NCT02014480|92098|P2|STARTED|Treatment Period 1 (14 Days)||35
38348|NCT02014480|92099|P1|STARTED|Treatment Period 1 (14 Days)||35
38349|NCT02014467|92118|P2|NOT COMPLETED|Overall Study||7
38350|NCT02014467|92119|P1|NOT COMPLETED|Overall Study||25
38351|NCT02014467|92118|P2|COMPLETED|Overall Study||112
38352|NCT02014467|92119|P1|COMPLETED|Overall Study||340
38353|NCT02014467|92118|P2|STARTED|Overall Study||119
38354|NCT02014467|92119|P1|STARTED|Overall Study||365
38355|NCT02014441|92179|P1|NOT COMPLETED|Overall Study||30
38356|NCT02014441|92179|P1|COMPLETED|Overall Study||31
38357|NCT02014441|92179|P1|Received Treatment|Overall Study||60
38358|NCT02014441|92179|P1|STARTED|Overall Study||61
38359|NCT02014402|92275|P4|NOT COMPLETED|Overall Study||3
38360|NCT02014402|92276|P3|NOT COMPLETED|Overall Study||3
38361|NCT02014402|92277|P2|NOT COMPLETED|Overall Study||3
38362|NCT02014402|92278|P1|NOT COMPLETED|Overall Study||2
38363|NCT02014402|92275|P4|COMPLETED|Overall Study||82
38364|NCT02014402|92276|P3|COMPLETED|Overall Study||32
38365|NCT02014402|92277|P2|COMPLETED|Overall Study||27
38366|NCT02014402|92278|P1|COMPLETED|Overall Study||29
38367|NCT02014402|92275|P4|Bovine Thrombin|Overall Study||28
38368|NCT02014402|92276|P3|Bovine Thrombin|Overall Study||12
38369|NCT02014402|92277|P2|Bovine Thrombin|Overall Study||10
38370|NCT02014402|92278|P1|Bovine Thrombin|Overall Study||11
38371|NCT02014402|92275|P4|Human Thrombin|Overall Study||57
38372|NCT02014402|92276|P3|Human Thrombin|Overall Study||23
38373|NCT02014402|92277|P2|Human Thrombin|Overall Study||20
38374|NCT02014402|92278|P1|Human Thrombin|Overall Study||20
38375|NCT02014402|92275|P4|STARTED|Overall Study||85
38376|NCT02014402|92276|P3|STARTED|Overall Study||35
38377|NCT02014402|92277|P2|STARTED|Overall Study||30
38378|NCT02014402|92278|P1|STARTED|Overall Study||31
38379|NCT02014363|92308|P3|NOT COMPLETED|Overall Study||24
38380|NCT02014363|92309|P2|NOT COMPLETED|Overall Study||19
38381|NCT02014363|92310|P1|NOT COMPLETED|Overall Study||17
38382|NCT02014363|92308|P3|COMPLETED|Overall Study||31
38383|NCT02014363|92309|P2|COMPLETED|Overall Study||35
38384|NCT02014363|92310|P1|COMPLETED|Overall Study||38
38385|NCT02014363|92308|P3|STARTED|Overall Study||55
38386|NCT02014363|92309|P2|STARTED|Overall Study||54
38387|NCT02014363|92310|P1|STARTED|Overall Study||55
38388|NCT02014272|92318|P2|NOT COMPLETED|Intervention Period 2||0
38389|NCT02014272|92319|P1|NOT COMPLETED|Intervention Period 2||0
38390|NCT02014272|92318|P2|COMPLETED|Intervention Period 2||13
38391|NCT02014272|92319|P1|COMPLETED|Intervention Period 2||13
38392|NCT02014272|92318|P2|STARTED|Intervention Period 2||13
38393|NCT02014272|92319|P1|STARTED|Intervention Period 2||13
38394|NCT02014272|92318|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
38395|NCT02014272|92319|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
38396|NCT02014272|92318|P2|COMPLETED|Washout Period 1 (7 Days)||13
38397|NCT02014272|92319|P1|COMPLETED|Washout Period 1 (7 Days)||13
38398|NCT02014272|92318|P2|STARTED|Washout Period 1 (7 Days)||13
38399|NCT02014272|92319|P1|STARTED|Washout Period 1 (7 Days)||13
38400|NCT02014272|92318|P2|NOT COMPLETED|Intervention Period 1||1
38401|NCT02014272|92319|P1|NOT COMPLETED|Intervention Period 1||1
38402|NCT02014272|92318|P2|COMPLETED|Intervention Period 1||13
38403|NCT02014272|92319|P1|COMPLETED|Intervention Period 1||13
38404|NCT02014272|92318|P2|STARTED|Intervention Period 1||14
38405|NCT02014272|92319|P1|STARTED|Intervention Period 1||14
38406|NCT02014051|92337|P2|NOT COMPLETED|Overall Study||1
38407|NCT02014051|92338|P1|NOT COMPLETED|Overall Study||1
38408|NCT02014051|92337|P2|COMPLETED|Overall Study||5
38409|NCT02014051|92338|P1|COMPLETED|Overall Study||2
38410|NCT02014051|92337|P2|STARTED|Overall Study||6
38411|NCT02014051|92338|P1|STARTED|Overall Study||3
38412|NCT02013830|92351|P1|NOT COMPLETED|Overall Study||30
38413|NCT02013830|92351|P1|COMPLETED|Overall Study||15
38414|NCT02013830|92351|P1|STARTED|Overall Study||45
38415|NCT02013817|92362|P1|NOT COMPLETED|Overall Study||27
38416|NCT02013817|92362|P1|COMPLETED|Overall Study||16
38417|NCT02013817|92362|P1|STARTED|Overall Study||43
38418|NCT02013791|92380|P9|NOT COMPLETED|Period 2||0
38419|NCT02013791|92381|P8|NOT COMPLETED|Period 2||0
38420|NCT02013791|92382|P7|NOT COMPLETED|Period 2||0
38421|NCT02013791|92383|P6|NOT COMPLETED|Period 2||0
38422|NCT02013791|92384|P5|NOT COMPLETED|Period 2||0
38423|NCT02013791|92385|P4|NOT COMPLETED|Period 2||0
38424|NCT02013791|92386|P3|NOT COMPLETED|Period 2||0
38425|NCT02013791|92387|P2|NOT COMPLETED|Period 2||0
38426|NCT02013791|92388|P1|NOT COMPLETED|Period 2||0
38427|NCT02013791|92380|P9|COMPLETED|Period 2||0
38428|NCT02013791|92381|P8|COMPLETED|Period 2||0
38429|NCT02013791|92382|P7|COMPLETED|Period 2||3
38430|NCT02013791|92383|P6|COMPLETED|Period 2||0
38431|NCT02013791|92384|P5|COMPLETED|Period 2||0
38432|NCT02013791|92385|P4|COMPLETED|Period 2||0
38433|NCT02013791|92386|P3|COMPLETED|Period 2||2
38434|NCT02013791|92387|P2|COMPLETED|Period 2||0
38435|NCT02013791|92388|P1|COMPLETED|Period 2||0
38436|NCT02013791|92380|P9|STARTED|Period 2||0
38437|NCT02013791|92381|P8|STARTED|Period 2||0
38438|NCT02013791|92382|P7|STARTED|Period 2||3
38439|NCT02013791|92383|P6|STARTED|Period 2||0
38440|NCT02013791|92384|P5|STARTED|Period 2||0
38441|NCT02013791|92385|P4|STARTED|Period 2||0
38442|NCT02013791|92386|P3|STARTED|Period 2||2
38443|NCT02013791|92387|P2|STARTED|Period 2||0
38444|NCT02013791|92388|P1|STARTED|Period 2||0
38445|NCT02013791|92380|P9|NOT COMPLETED|Period 1||0
38446|NCT02013791|92381|P8|NOT COMPLETED|Period 1||1
38447|NCT02013791|92382|P7|NOT COMPLETED|Period 1||1
38448|NCT02013791|92383|P6|NOT COMPLETED|Period 1||0
38449|NCT02013791|92384|P5|NOT COMPLETED|Period 1||0
38450|NCT02013791|92385|P4|NOT COMPLETED|Period 1||1
38451|NCT02013791|92386|P3|NOT COMPLETED|Period 1||0
38452|NCT02013791|92387|P2|NOT COMPLETED|Period 1||2
38453|NCT02013791|92388|P1|NOT COMPLETED|Period 1||0
38454|NCT02013791|92380|P9|COMPLETED|Period 1||3
38455|NCT02013791|92381|P8|COMPLETED|Period 1||7
38456|NCT02013791|92382|P7|COMPLETED|Period 1||3
38457|NCT02013791|92383|P6|COMPLETED|Period 1||8
38458|NCT02013791|92384|P5|COMPLETED|Period 1||4
38459|NCT02013791|92385|P4|COMPLETED|Period 1||7
38460|NCT02013791|92386|P3|COMPLETED|Period 1||4
38461|NCT02013791|92387|P2|COMPLETED|Period 1||6
38462|NCT02013791|92388|P1|COMPLETED|Period 1||8
38463|NCT02013791|92380|P9|STARTED|Period 1||3
38464|NCT02013791|92381|P8|STARTED|Period 1||8
38465|NCT02013791|92382|P7|STARTED|Period 1||4
38466|NCT02013791|92383|P6|STARTED|Period 1||8
38467|NCT02013791|92384|P5|STARTED|Period 1||4
38468|NCT02013791|92385|P4|STARTED|Period 1||8
38469|NCT02013791|92386|P3|STARTED|Period 1||4
38470|NCT02013791|92387|P2|STARTED|Period 1||8
38471|NCT02013791|92388|P1|STARTED|Period 1||8
38472|NCT02013765|92409|P1|NOT COMPLETED|Overall Study||1
38473|NCT02013765|92409|P1|COMPLETED|Overall Study||4
38474|NCT02013765|92409|P1|STARTED|Overall Study||5
38475|NCT02013687|92423|P4|NOT COMPLETED|Overall Study||2
38476|NCT02013687|92424|P3|NOT COMPLETED|Overall Study||2
38477|NCT02013687|92425|P2|NOT COMPLETED|Overall Study||0
38478|NCT02013687|92426|P1|NOT COMPLETED|Overall Study||0
38479|NCT02013687|92423|P4|COMPLETED|Overall Study||14
38480|NCT02013687|92424|P3|COMPLETED|Overall Study||14
38481|NCT02013687|92425|P2|COMPLETED|Overall Study||6
38482|NCT02013687|92426|P1|COMPLETED|Overall Study||6
38483|NCT02013687|92423|P4|STARTED|Overall Study||16
38484|NCT02013687|92424|P3|STARTED|Overall Study||16
38485|NCT02013687|92425|P2|STARTED|Overall Study||6
38486|NCT02013687|92426|P1|STARTED|Overall Study||6
38487|NCT02013622|92456|P1|NOT COMPLETED|Overall Study||24
38488|NCT02013622|92456|P1|COMPLETED|Overall Study||25
38489|NCT02013622|92456|P1|STARTED|Overall Study||49
38490|NCT02013609|92476|P1|NOT COMPLETED|Overall Study||18
38491|NCT02013609|92476|P1|COMPLETED|Overall Study||29
38492|NCT02013609|92476|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
38493|NCT02013544|92501|P2|NOT COMPLETED|Overall Study||20
38494|NCT02013544|92502|P1|NOT COMPLETED|Overall Study||11
38495|NCT02013544|92501|P2|COMPLETED|Overall Study||356
38496|NCT02013544|92502|P1|COMPLETED|Overall Study||171
38497|NCT02013544|92501|P2|ITT Population|Overall Study||325
38498|NCT02013544|92502|P1|ITT Population|Overall Study||157
38499|NCT02013544|92501|P2|Safety Population|Overall Study||374
38500|NCT02013544|92502|P1|Safety Population|Overall Study||180
38501|NCT02013544|92501|P2|STARTED|Overall Study||376
38502|NCT02013544|92502|P1|STARTED|Overall Study||182
38503|NCT02013531|92524|P1|NOT COMPLETED|Overall Study||5
38504|NCT02013531|92524|P1|COMPLETED|Overall Study||32
38505|NCT02013531|92524|P1|STARTED|Overall Study||37
38506|NCT02013388|92554|P8|NOT COMPLETED|Overall Study||0
38507|NCT02013388|92555|P7|NOT COMPLETED|Overall Study||0
38508|NCT02013388|92556|P6|NOT COMPLETED|Overall Study||0
38509|NCT02013388|92557|P5|NOT COMPLETED|Overall Study||1
38510|NCT02013388|92558|P4|NOT COMPLETED|Overall Study||0
38511|NCT02013388|92559|P3|NOT COMPLETED|Overall Study||0
38512|NCT02013388|92560|P2|NOT COMPLETED|Overall Study||0
38513|NCT02013388|92561|P1|NOT COMPLETED|Overall Study||1
38514|NCT02013388|92554|P8|COMPLETED|Overall Study||4
38515|NCT02013388|92555|P7|COMPLETED|Overall Study||6
38516|NCT02013388|92556|P6|COMPLETED|Overall Study||6
38517|NCT02013388|92557|P5|COMPLETED|Overall Study||5
38518|NCT02013388|92558|P4|COMPLETED|Overall Study||6
38519|NCT02013388|92559|P3|COMPLETED|Overall Study||6
38520|NCT02013388|92560|P2|COMPLETED|Overall Study||6
38521|NCT02013388|92561|P1|COMPLETED|Overall Study||8
38522|NCT02013388|92554|P8|STARTED|Overall Study||4
38523|NCT02013388|92555|P7|STARTED|Overall Study||6
38524|NCT02013388|92556|P6|STARTED|Overall Study||6
38525|NCT02013388|92557|P5|STARTED|Overall Study||6
38526|NCT02013388|92558|P4|STARTED|Overall Study||6
38527|NCT02013388|92559|P3|STARTED|Overall Study||6
38528|NCT02013388|92560|P2|STARTED|Overall Study||6
38529|NCT02013388|92561|P1|STARTED|Overall Study||9
38530|NCT02013245|92599|P4|NOT COMPLETED|Overall Study||0
38531|NCT02013245|92600|P3|NOT COMPLETED|Overall Study||0
38532|NCT02013245|92601|P2|NOT COMPLETED|Overall Study||1
38533|NCT02013245|92602|P1|NOT COMPLETED|Overall Study||0
38534|NCT02013245|92599|P4|COMPLETED|Overall Study||9
38535|NCT02013245|92600|P3|COMPLETED|Overall Study||9
38536|NCT02013245|92601|P2|COMPLETED|Overall Study||8
38537|NCT02013245|92602|P1|COMPLETED|Overall Study||9
38538|NCT02013245|92599|P4|STARTED|Overall Study||9
38539|NCT02013245|92600|P3|STARTED|Overall Study||9
38540|NCT02013245|92601|P2|STARTED|Overall Study||9
38541|NCT02013245|92602|P1|STARTED|Overall Study||9
38542|NCT02013206|92618|P2|NOT COMPLETED|Overall Study||22
38543|NCT02013206|92619|P1|NOT COMPLETED|Overall Study||27
38544|NCT02013206|92618|P2|COMPLETED|Overall Study||1
38545|NCT02013206|92619|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
38546|NCT02013206|92618|P2|Received Study Drug|Overall Study||23
38547|NCT02013206|92619|P1|Received Study Drug|Overall Study||26
38548|NCT02013206|92618|P2|STARTED|Overall Study||23
38549|NCT02013206|92619|P1|STARTED|Overall Study||29
38550|NCT02013167|92641|P2|NOT COMPLETED|Overall Study||178
38551|NCT02013167|92642|P1|NOT COMPLETED|Overall Study||101
38552|NCT02013167|92641|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
38553|NCT02013167|92642|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
38554|NCT02013167|92641|P2|Received Treatment|Overall Study||267
38555|NCT02013167|92642|P1|Received Treatment|Overall Study||109
38556|NCT02013167|92641|P2|STARTED|Overall Study||271
38557|NCT02013167|92642|P1|STARTED|Overall Study||134
38558|NCT02013050|92673|P4|NOT COMPLETED|Overall Study||4
38559|NCT02013050|92674|P3|NOT COMPLETED|Overall Study||0
38560|NCT02013050|92675|P2|NOT COMPLETED|Overall Study||5
38561|NCT02013050|92676|P1|NOT COMPLETED|Overall Study||4
38562|NCT02013050|92673|P4|COMPLETED|Overall Study||19
38563|NCT02013050|92674|P3|COMPLETED|Overall Study||3
38564|NCT02013050|92675|P2|COMPLETED|Overall Study||36
38565|NCT02013050|92676|P1|COMPLETED|Overall Study||38
38566|NCT02013050|92673|P4|STARTED|Overall Study||23
38567|NCT02013050|92674|P3|STARTED|Overall Study||3
38568|NCT02013050|92675|P2|STARTED|Overall Study||41
38569|NCT02013050|92676|P1|STARTED|Overall Study||42
38570|NCT02012686|92720|P2|NOT COMPLETED|Overall Study||2
38571|NCT02012686|92721|P1|NOT COMPLETED|Overall Study||0
38572|NCT02012686|92720|P2|COMPLETED|Overall Study||48
38573|NCT02012686|92721|P1|COMPLETED|Overall Study||50
38574|NCT02012686|92720|P2|STARTED|Overall Study||50
38575|NCT02012686|92721|P1|STARTED|Overall Study||50
38576|NCT02012582|92737|P4|NOT COMPLETED|Overall Study||1
38577|NCT02012582|92738|P3|NOT COMPLETED|Overall Study||0
38578|NCT02012582|92739|P2|NOT COMPLETED|Overall Study||0
38579|NCT02012582|92740|P1|NOT COMPLETED|Overall Study||0
38580|NCT02012582|92737|P4|COMPLETED|Overall Study||7
38581|NCT02012582|92738|P3|COMPLETED|Overall Study||8
38582|NCT02012582|92739|P2|COMPLETED|Overall Study||8
38583|NCT02012582|92740|P1|COMPLETED|Overall Study||8
38584|NCT02012582|92737|P4|STARTED|Overall Study||8
38585|NCT02012582|92738|P3|STARTED|Overall Study||8
38586|NCT02012582|92739|P2|STARTED|Overall Study||8
38587|NCT02012582|92740|P1|STARTED|Overall Study||8
38588|NCT02012452|92768|P2|NOT COMPLETED|Overall Study||1
38589|NCT02012452|92769|P1|NOT COMPLETED|Overall Study||6
38590|NCT02012452|92768|P2|COMPLETED|Overall Study||1
38591|NCT02012452|92769|P1|COMPLETED|Overall Study||1
38592|NCT02012452|92768|P2|STARTED|Overall Study||2
38593|NCT02012452|92769|P1|STARTED|Overall Study||7
38594|NCT02012218|92782|P5|NOT COMPLETED|Overall Study||1
38595|NCT02012218|92783|P4|NOT COMPLETED|Overall Study||2
38596|NCT02012218|92784|P3|NOT COMPLETED|Overall Study||2
38597|NCT02012218|92785|P2|NOT COMPLETED|Overall Study||1
38598|NCT02012218|92786|P1|NOT COMPLETED|Overall Study||4
38599|NCT02012218|92782|P5|COMPLETED|Overall Study||5
38600|NCT02012218|92783|P4|COMPLETED|Overall Study||17
38601|NCT02012218|92784|P3|COMPLETED|Overall Study||11
38602|NCT02012218|92785|P2|COMPLETED|Overall Study||10
38603|NCT02012218|92786|P1|COMPLETED|Overall Study||8
38604|NCT02012218|92782|P5|STARTED|Overall Study||6
38605|NCT02012218|92783|P4|STARTED|Overall Study||19
38606|NCT02012218|92784|P3|STARTED|Overall Study||13
38607|NCT02012218|92785|P2|STARTED|Overall Study||11
38608|NCT02012218|92786|P1|STARTED|Overall Study||12
38609|NCT02011893|92798|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
38610|NCT02011893|92799|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
38611|NCT02011893|92800|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
38612|NCT02011893|92798|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
38613|NCT02011893|92799|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
38614|NCT02011893|92800|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
38615|NCT02011893|92798|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
38616|NCT02011893|92799|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
38617|NCT02011893|92800|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
38618|NCT02011893|92798|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
38619|NCT02011893|92799|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
38620|NCT02011893|92800|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
38621|NCT02011893|92798|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
38622|NCT02011893|92799|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
38623|NCT02011893|92800|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
38624|NCT02011893|92798|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
38625|NCT02011893|92799|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
38626|NCT02011893|92800|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
38627|NCT02011893|92798|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
38628|NCT02011893|92799|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
38629|NCT02011893|92800|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
38630|NCT02011893|92798|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
38631|NCT02011893|92799|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
38632|NCT02011893|92800|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
38633|NCT02011893|92798|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
38634|NCT02011893|92799|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
38635|NCT02011893|92800|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
38636|NCT02011893|92798|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
38637|NCT02011893|92799|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
38638|NCT02011893|92800|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
38639|NCT02011893|92798|P3|NOT COMPLETED|Enrollment to Randomization||0
38640|NCT02011893|92799|P2|NOT COMPLETED|Enrollment to Randomization||0
38641|NCT02011893|92800|P1|NOT COMPLETED|Enrollment to Randomization||73
38642|NCT02011893|92798|P3|COMPLETED|Enrollment to Randomization||0
38643|NCT02011893|92799|P2|COMPLETED|Enrollment to Randomization||0
38644|NCT02011893|92800|P1|COMPLETED|Enrollment to Randomization||100
38645|NCT02011893|92798|P3|Randomization|Enrollment to Randomization||0
38646|NCT02011893|92799|P2|Randomization|Enrollment to Randomization||0
38647|NCT02011893|92800|P1|Randomization|Enrollment to Randomization||100
38648|NCT02011893|92798|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
38649|NCT02011893|92799|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
38650|NCT02011893|92800|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
38651|NCT02011893|92798|P3|Trial Stimulation Implant|Enrollment to Randomization||0
38652|NCT02011893|92799|P2|Trial Stimulation Implant|Enrollment to Randomization||0
38653|NCT02011893|92800|P1|Trial Stimulation Implant|Enrollment to Randomization||121
38654|NCT02011893|92798|P3|Baseline|Enrollment to Randomization||0
38655|NCT02011893|92799|P2|Baseline|Enrollment to Randomization||0
38656|NCT02011893|92800|P1|Baseline|Enrollment to Randomization||141
38657|NCT02011893|92798|P3|STARTED|Enrollment to Randomization||0
38658|NCT02011893|92799|P2|STARTED|Enrollment to Randomization||0
38659|NCT02011893|92800|P1|STARTED|Enrollment to Randomization||173
38660|NCT02011542|92811|P1|NOT COMPLETED|Overall Study||1
38661|NCT02011542|92811|P1|COMPLETED|Overall Study||29
38662|NCT02011542|92811|P1|STARTED|Overall Study||30
38663|NCT02011516|92818|P2|NOT COMPLETED|Overall Study||2
38664|NCT02011516|92819|P1|NOT COMPLETED|Overall Study||4
38665|NCT02011516|92818|P2|COMPLETED|Overall Study||6
38666|NCT02011516|92819|P1|COMPLETED|Overall Study||4
38667|NCT02011516|92818|P2|STARTED|Overall Study||8
38668|NCT02011516|92819|P1|STARTED|Overall Study||8
38669|NCT02011490|92828|P6|NOT COMPLETED|Part 2||0
38670|NCT02011490|92829|P5|NOT COMPLETED|Part 2||0
38671|NCT02011490|92830|P4|NOT COMPLETED|Part 2||0
38672|NCT02011490|92831|P3|NOT COMPLETED|Part 2||0
38673|NCT02011490|92832|P2|NOT COMPLETED|Part 2||0
38674|NCT02011490|92833|P1|NOT COMPLETED|Part 2||0
38675|NCT02011490|92828|P6|COMPLETED|Part 2||6
38676|NCT02011490|92829|P5|COMPLETED|Part 2||6
38677|NCT02011490|92830|P4|COMPLETED|Part 2||6
38678|NCT02011490|92831|P3|COMPLETED|Part 2||0
38679|NCT02011490|92832|P2|COMPLETED|Part 2||0
38680|NCT02011490|92833|P1|COMPLETED|Part 2||0
38681|NCT02011490|92828|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
38682|NCT02011490|92829|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
38683|NCT02011490|92830|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
38684|NCT02011490|92831|P3|STARTED|Part 2||0
38685|NCT02011490|92832|P2|STARTED|Part 2||0
38686|NCT02011490|92833|P1|STARTED|Part 2||0
38687|NCT02011490|92828|P6|NOT COMPLETED|Part 1||0
38688|NCT02011490|92829|P5|NOT COMPLETED|Part 1||0
38689|NCT02011490|92830|P4|NOT COMPLETED|Part 1||0
38690|NCT02011490|92831|P3|NOT COMPLETED|Part 1||0
38691|NCT02011490|92832|P2|NOT COMPLETED|Part 1||0
38692|NCT02011490|92833|P1|NOT COMPLETED|Part 1||0
38693|NCT02011490|92828|P6|COMPLETED|Part 1||0
38694|NCT02011490|92829|P5|COMPLETED|Part 1||0
38695|NCT02011490|92830|P4|COMPLETED|Part 1||0
38696|NCT02011490|92831|P3|COMPLETED|Part 1||8
38697|NCT02011490|92832|P2|COMPLETED|Part 1||8
38698|NCT02011490|92833|P1|COMPLETED|Part 1||8
38699|NCT02011490|92828|P6|STARTED|Part 1||0
38700|NCT02011490|92829|P5|STARTED|Part 1||0
38701|NCT02011490|92830|P4|STARTED|Part 1||0
38702|NCT02011490|92831|P3|STARTED|Part 1||8
38703|NCT02011490|92832|P2|STARTED|Part 1||8
38704|NCT02011490|92833|P1|STARTED|Part 1||8
38705|NCT02011464|92921|P2|NOT COMPLETED|Overall Study||0
38706|NCT02011464|92922|P1|NOT COMPLETED|Overall Study||0
38707|NCT02011464|92921|P2|COMPLETED|Overall Study||10
38708|NCT02011464|92922|P1|COMPLETED|Overall Study||10
38709|NCT02011464|92921|P2|STARTED|Overall Study||10
38710|NCT02011464|92922|P1|STARTED|Overall Study||10
38711|NCT02011113|92942|P1|NOT COMPLETED|Overall Study||36
38712|NCT02011113|92942|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
38713|NCT02011113|92942|P1|STARTED|Overall Study||36
38714|NCT02010996|92958|P2|NOT COMPLETED|Overall Study||0
38715|NCT02010996|92959|P1|NOT COMPLETED|Overall Study||0
38716|NCT02010996|92958|P2|COMPLETED|Overall Study||36
38717|NCT02010996|92959|P1|COMPLETED|Overall Study||36
38718|NCT02010996|92958|P2|STARTED|Overall Study||36
38719|NCT02010996|92959|P1|STARTED|Overall Study||36
38720|NCT02010684|92971|P2|NOT COMPLETED|Overall Study||23
38721|NCT02010684|92972|P1|NOT COMPLETED|Overall Study||12
38722|NCT02010684|92971|P2|COMPLETED|Overall Study||59
38723|NCT02010684|92972|P1|COMPLETED|Overall Study||27
38724|NCT02010684|92971|P2|STARTED|Overall Study||82
38725|NCT02010684|92972|P1|STARTED|Overall Study||39
38726|NCT02010632|92990|P2|NOT COMPLETED|Second Intervention (7 Days)||0
38727|NCT02010632|92991|P1|NOT COMPLETED|Second Intervention (7 Days)||1
38728|NCT02010632|92990|P2|COMPLETED|Second Intervention (7 Days)||16
38729|NCT02010632|92991|P1|COMPLETED|Second Intervention (7 Days)||15
38730|NCT02010632|92990|P2|STARTED|Second Intervention (7 Days)||16
38731|NCT02010632|92991|P1|STARTED|Second Intervention (7 Days)||16
38732|NCT02010632|92990|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
38733|NCT02010632|92991|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
38734|NCT02010632|92990|P2|COMPLETED|Wash Out Period (14 Days)||16
38735|NCT02010632|92991|P1|COMPLETED|Wash Out Period (14 Days)||16
38736|NCT02010632|92990|P2|STARTED|Wash Out Period (14 Days)||16
38737|NCT02010632|92991|P1|STARTED|Wash Out Period (14 Days)||16
38738|NCT02010632|92990|P2|NOT COMPLETED|First Intervention (7 Days)||0
38739|NCT02010632|92991|P1|NOT COMPLETED|First Intervention (7 Days)||0
38740|NCT02010632|92990|P2|COMPLETED|First Intervention (7 Days)||16
38741|NCT02010632|92991|P1|COMPLETED|First Intervention (7 Days)||16
38742|NCT02010632|92990|P2|STARTED|First Intervention (7 Days)||16
38743|NCT02010632|92991|P1|STARTED|First Intervention (7 Days)||16
38744|NCT02010567|93002|P5|NOT COMPLETED|Overall Study||1
38745|NCT02010567|93003|P4|NOT COMPLETED|Overall Study||0
38746|NCT02010567|93004|P3|NOT COMPLETED|Overall Study||1
38747|NCT02010567|93005|P2|NOT COMPLETED|Overall Study||0
38748|NCT02010567|93006|P1|NOT COMPLETED|Overall Study||0
38749|NCT02010567|93002|P5|COMPLETED|Overall Study||5
38750|NCT02010567|93003|P4|COMPLETED|Overall Study||3
38751|NCT02010567|93004|P3|COMPLETED|Overall Study||13
38752|NCT02010567|93005|P2|COMPLETED|Overall Study||6
38753|NCT02010567|93006|P1|COMPLETED|Overall Study||3
38754|NCT02010567|93002|P5|STARTED|Overall Study||6
38755|NCT02010567|93003|P4|STARTED|Overall Study||3
38756|NCT02010567|93004|P3|STARTED|Overall Study||14
38757|NCT02010567|93005|P2|STARTED|Overall Study||6
38758|NCT02010567|93006|P1|STARTED|Overall Study||3
38759|NCT02010255|93031|P14|NOT COMPLETED|Overall Study||1
38760|NCT02010255|93032|P13|NOT COMPLETED|Overall Study||0
38761|NCT02010255|93033|P12|NOT COMPLETED|Overall Study||1
38762|NCT02010255|93034|P11|NOT COMPLETED|Overall Study||2
38763|NCT02010255|93035|P10|NOT COMPLETED|Overall Study||0
38764|NCT02010255|93036|P9|NOT COMPLETED|Overall Study||1
38765|NCT02010255|93037|P8|NOT COMPLETED|Overall Study||1
38766|NCT02010255|93038|P7|NOT COMPLETED|Overall Study||1
38767|NCT02010255|93039|P6|NOT COMPLETED|Overall Study||0
38768|NCT02010255|93040|P5|NOT COMPLETED|Overall Study||4
38769|NCT02010255|93041|P4|NOT COMPLETED|Overall Study||6
38770|NCT02010255|93042|P3|NOT COMPLETED|Overall Study||7
38771|NCT02010255|93043|P2|NOT COMPLETED|Overall Study||2
38772|NCT02010255|93044|P1|NOT COMPLETED|Overall Study||6
38773|NCT02010255|93031|P14|COMPLETED|Overall Study||2
38774|NCT02010255|93032|P13|COMPLETED|Overall Study||3
38775|NCT02010255|93033|P12|COMPLETED|Overall Study||4
38776|NCT02010255|93034|P11|COMPLETED|Overall Study||1
38777|NCT02010255|93035|P10|COMPLETED|Overall Study||23
38778|NCT02010255|93036|P9|COMPLETED|Overall Study||21
38779|NCT02010255|93037|P8|COMPLETED|Overall Study||32
38780|NCT02010255|93038|P7|COMPLETED|Overall Study||33
38781|NCT02010255|93039|P6|COMPLETED|Overall Study||49
38782|NCT02010255|93040|P5|COMPLETED|Overall Study||48
38783|NCT02010255|93041|P4|COMPLETED|Overall Study||20
38784|NCT02010255|93042|P3|COMPLETED|Overall Study||18
38785|NCT02010255|93043|P2|COMPLETED|Overall Study||26
38786|NCT02010255|93044|P1|COMPLETED|Overall Study||22
38787|NCT02010255|93031|P14|STARTED|Overall Study||3
38788|NCT02010255|93032|P13|STARTED|Overall Study||3
38789|NCT02010255|93033|P12|STARTED|Overall Study||5
38790|NCT02010255|93034|P11|STARTED|Overall Study||3
38791|NCT02010255|93035|P10|STARTED|Overall Study||23
38792|NCT02010255|93036|P9|STARTED|Overall Study||22
38793|NCT02010255|93037|P8|STARTED|Overall Study||33
38794|NCT02010255|93038|P7|STARTED|Overall Study||34
38795|NCT02010255|93039|P6|STARTED|Overall Study||49
38796|NCT02010255|93040|P5|STARTED|Overall Study||52
38797|NCT02010255|93041|P4|STARTED|Overall Study||26
38798|NCT02010255|93042|P3|STARTED|Overall Study||25
38799|NCT02010255|93043|P2|STARTED|Overall Study||28
38800|NCT02010255|93044|P1|STARTED|Overall Study||28
38801|NCT02010216|93368|P1|NOT COMPLETED|Overall Study||0
38802|NCT02010216|93368|P1|COMPLETED|Overall Study||23
38803|NCT02010216|93368|P1|STARTED|Overall Study||23
38804|NCT02009982|93376|P2|NOT COMPLETED|Overall Study||0
38805|NCT02009982|93377|P1|NOT COMPLETED|Overall Study||0
38806|NCT02009982|93376|P2|COMPLETED|Overall Study||2
38807|NCT02009982|93377|P1|COMPLETED|Overall Study||1
38808|NCT02009982|93376|P2|STARTED|Overall Study||2
38809|NCT02009982|93377|P1|STARTED|Overall Study||1
38810|NCT02009878|93388|P3|NOT COMPLETED|Overall Study||0
38811|NCT02009878|93389|P2|NOT COMPLETED|Overall Study||1
38812|NCT02009878|93390|P1|NOT COMPLETED|Overall Study||0
38813|NCT02009878|93388|P3|COMPLETED|Overall Study||9
38814|NCT02009878|93389|P2|COMPLETED|Overall Study||10
38815|NCT02009878|93390|P1|COMPLETED|Overall Study||10
38816|NCT02009878|93388|P3|STARTED|Overall Study||9
38817|NCT02009878|93389|P2|STARTED|Overall Study||11
38818|NCT02009878|93390|P1|STARTED|Overall Study||10
38819|NCT02009865|93424|P2|NOT COMPLETED|Overall Study||5
38820|NCT02009865|93425|P1|NOT COMPLETED|Overall Study||1
38821|NCT02009865|93424|P2|COMPLETED|Overall Study||76
38822|NCT02009865|93425|P1|COMPLETED|Overall Study||80
38823|NCT02009865|93424|P2|STARTED|Overall Study||81
38824|NCT02009865|93425|P1|STARTED|Overall Study||81
38825|NCT02009722|93441|P2|NOT COMPLETED|Overall Study||3
38826|NCT02009722|93442|P1|NOT COMPLETED|Overall Study||1
38827|NCT02009722|93441|P2|COMPLETED|Overall Study||40
38828|NCT02009722|93442|P1|COMPLETED|Overall Study||40
38829|NCT02009722|93441|P2|Received Intervention|Overall Study||42
38830|NCT02009722|93442|P1|Received Intervention|Overall Study||41
38831|NCT02009722|93441|P2|STARTED|Overall Study||43
38832|NCT02009722|93442|P1|STARTED|Overall Study||41
38833|NCT02009696|93466|P1|NOT COMPLETED|Overall Study||2
38834|NCT02009696|93466|P1|COMPLETED|Overall Study||219
38835|NCT02009696|93466|P1|STARTED|Overall Study||221
38836|NCT02009163|93474|P3|NOT COMPLETED|Randomized-withdrawal Period||35
38837|NCT02009163|93475|P2|NOT COMPLETED|Randomized-withdrawal Period||88
38838|NCT02009163|93476|P1|NOT COMPLETED|Randomized-withdrawal Period||0
38839|NCT02009163|93474|P3|COMPLETED|Randomized-withdrawal Period||102
38840|NCT02009163|93475|P2|COMPLETED|Randomized-withdrawal Period||50
38841|NCT02009163|93476|P1|COMPLETED|Randomized-withdrawal Period||0
38842|NCT02009163|93474|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
38843|NCT02009163|93475|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
38844|NCT02009163|93476|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
38845|NCT02009163|93474|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
38846|NCT02009163|93475|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
38847|NCT02009163|93476|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
38848|NCT02009163|93474|P3|COMPLETED|Open-label Period (Non-randomized)||0
38849|NCT02009163|93475|P2|COMPLETED|Open-label Period (Non-randomized)||0
38850|NCT02009163|93476|P1|COMPLETED|Open-label Period (Non-randomized)||275
38851|NCT02009163|93474|P3|STARTED|Open-label Period (Non-randomized)||0
38852|NCT02009163|93475|P2|STARTED|Open-label Period (Non-randomized)||0
38853|NCT02009163|93476|P1|STARTED|Open-label Period (Non-randomized)||418
38854|NCT02008942|93509|P2|NOT COMPLETED|Second Intervention||0
38855|NCT02008942|93510|P1|NOT COMPLETED|Second Intervention||1
38856|NCT02008942|93509|P2|COMPLETED|Second Intervention||30
38857|NCT02008942|93510|P1|COMPLETED|Second Intervention||25
38858|NCT02008942|93509|P2|STARTED|Second Intervention||30
38859|NCT02008942|93510|P1|STARTED|Second Intervention||26
38860|NCT02008942|93509|P2|NOT COMPLETED|First Intervention||0
38861|NCT02008942|93510|P1|NOT COMPLETED|First Intervention||0
38862|NCT02008942|93509|P2|COMPLETED|First Intervention||30
38863|NCT02008942|93510|P1|COMPLETED|First Intervention||27
38864|NCT02008942|93509|P2|STARTED|First Intervention||30
38865|NCT02008942|93510|P1|STARTED|First Intervention||27
38866|NCT02008682|93518|P2|NOT COMPLETED|Overall Study||14
38867|NCT02008682|93519|P1|NOT COMPLETED|Overall Study||27
38868|NCT02008682|93518|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
38869|NCT02008682|93519|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
38870|NCT02008682|93518|P2|Exposed|Overall Study||184
38871|NCT02008682|93519|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
38872|NCT02008682|93518|P2|STARTED|Overall Study||184
38873|NCT02008682|93519|P1|STARTED|Overall Study||184
38874|NCT02008617|93537|P2|NOT COMPLETED|Overall Study||0
38875|NCT02008617|93538|P1|NOT COMPLETED|Overall Study||0
38876|NCT02008617|93537|P2|COMPLETED|Overall Study||10
38877|NCT02008617|93538|P1|COMPLETED|Overall Study||8
38878|NCT02008617|93537|P2|STARTED|Overall Study||10
38879|NCT02008617|93538|P1|STARTED|Overall Study||8
38880|NCT02008526|93553|P3|NOT COMPLETED|Overall Study||9
38881|NCT02008526|93554|P2|NOT COMPLETED|Overall Study||14
38882|NCT02008526|93555|P1|NOT COMPLETED|Overall Study||8
38883|NCT02008526|93553|P3|COMPLETED|Overall Study||84
38884|NCT02008526|93554|P2|COMPLETED|Overall Study||85
38885|NCT02008526|93555|P1|COMPLETED|Overall Study||86
38886|NCT02008526|93553|P3|STARTED|Overall Study||93
38887|NCT02008526|93554|P2|STARTED|Overall Study||99
38888|NCT02008526|93555|P1|STARTED|Overall Study||94
38889|NCT02008227|93568|P2|NOT COMPLETED|Overall Study||613
38890|NCT02008227|93569|P1|NOT COMPLETED|Overall Study||612
38891|NCT02008227|93568|P2|COMPLETED|Overall Study||0
38892|NCT02008227|93569|P1|COMPLETED|Overall Study||0
38893|NCT02008227|93568|P2|Treated|Overall Study||608
38894|NCT02008227|93569|P1|Treated|Overall Study||579
38895|NCT02008227|93568|P2|STARTED|Overall Study||613
38896|NCT02008227|93569|P1|STARTED|Overall Study||612
38897|NCT02007954|93630|P1|NOT COMPLETED|Overall Study||7
38898|NCT02007954|93630|P1|COMPLETED|Overall Study||17
38899|NCT02007954|93630|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
38900|NCT02007954|93630|P1|Completed First TACE|Overall Study||24
38901|NCT02007954|93630|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
38902|NCT02007863|93643|P1|NOT COMPLETED|Overall Study||0
38903|NCT02007863|93643|P1|COMPLETED|Overall Study||2
38904|NCT02007863|93643|P1|STARTED|Overall Study||2
38905|NCT02007577|93649|P2|NOT COMPLETED|Overall Study||1
38906|NCT02007577|93650|P1|NOT COMPLETED|Overall Study||1
38907|NCT02007577|93649|P2|COMPLETED|Overall Study||13
38908|NCT02007577|93650|P1|COMPLETED|Overall Study||26
38909|NCT02007577|93649|P2|STARTED|Overall Study||14
38910|NCT02007577|93650|P1|STARTED|Overall Study||27
38911|NCT02007512|93662|P4|NOT COMPLETED|Open Label Treatment Period||12
38912|NCT02007512|93663|P3|NOT COMPLETED|Open Label Treatment Period||0
38913|NCT02007512|93664|P2|NOT COMPLETED|Open Label Treatment Period||21
38914|NCT02007512|93665|P1|NOT COMPLETED|Open Label Treatment Period||0
38915|NCT02007512|93662|P4|COMPLETED|Open Label Treatment Period||0
38916|NCT02007512|93663|P3|COMPLETED|Open Label Treatment Period||0
38917|NCT02007512|93664|P2|COMPLETED|Open Label Treatment Period||0
38918|NCT02007512|93665|P1|COMPLETED|Open Label Treatment Period||0
38919|NCT02007512|93662|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
38920|NCT02007512|93663|P3|STARTED|Open Label Treatment Period||0
38921|NCT02007512|93664|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
38922|NCT02007512|93665|P1|STARTED|Open Label Treatment Period||0
38923|NCT02007512|93662|P4|NOT COMPLETED|Double Blind Treatment Period||60
38924|NCT02007512|93663|P3|NOT COMPLETED|Double Blind Treatment Period||60
38925|NCT02007512|93664|P2|NOT COMPLETED|Double Blind Treatment Period||64
38926|NCT02007512|93665|P1|NOT COMPLETED|Double Blind Treatment Period||63
38927|NCT02007512|93662|P4|COMPLETED|Double Blind Treatment Period||0
38928|NCT02007512|93663|P3|COMPLETED|Double Blind Treatment Period||0
38929|NCT02007512|93664|P2|COMPLETED|Double Blind Treatment Period||0
38930|NCT02007512|93665|P1|COMPLETED|Double Blind Treatment Period||0
38931|NCT02007512|93662|P4|Treated|Double Blind Treatment Period||60
38932|NCT02007512|93663|P3|Treated|Double Blind Treatment Period||60
38933|NCT02007512|93664|P2|Treated|Double Blind Treatment Period||63
38934|NCT02007512|93665|P1|Treated|Double Blind Treatment Period||62
38935|NCT02007512|93662|P4|STARTED|Double Blind Treatment Period||60
38936|NCT02007512|93663|P3|STARTED|Double Blind Treatment Period||60
38937|NCT02007512|93664|P2|STARTED|Double Blind Treatment Period||64
38938|NCT02007512|93665|P1|STARTED|Double Blind Treatment Period||63
38939|NCT02007434|93735|P8|NOT COMPLETED|Overall Study||0
38940|NCT02007434|93736|P7|NOT COMPLETED|Overall Study||0
38941|NCT02007434|93737|P6|NOT COMPLETED|Overall Study||0
38942|NCT02007434|93738|P5|NOT COMPLETED|Overall Study||0
38943|NCT02007434|93739|P4|NOT COMPLETED|Overall Study||0
38944|NCT02007434|93740|P3|NOT COMPLETED|Overall Study||1
38945|NCT02007434|93741|P2|NOT COMPLETED|Overall Study||1
38946|NCT02007434|93742|P1|NOT COMPLETED|Overall Study||1
38947|NCT02007434|93735|P8|COMPLETED|Overall Study||4
38948|NCT02007434|93736|P7|COMPLETED|Overall Study||18
38949|NCT02007434|93737|P6|COMPLETED|Overall Study||4
38950|NCT02007434|93738|P5|COMPLETED|Overall Study||16
38951|NCT02007434|93739|P4|COMPLETED|Overall Study||4
38952|NCT02007434|93740|P3|COMPLETED|Overall Study||16
38953|NCT02007434|93741|P2|COMPLETED|Overall Study||3
38954|NCT02007434|93742|P1|COMPLETED|Overall Study||16
38955|NCT02007434|93735|P8|Received Treatment|Overall Study||4
38956|NCT02007434|93736|P7|Received Treatment|Overall Study||18
38957|NCT02007434|93737|P6|Received Treatment|Overall Study||4
38958|NCT02007434|93738|P5|Received Treatment|Overall Study||16
38959|NCT02007434|93739|P4|Received Treatment|Overall Study||4
38960|NCT02007434|93740|P3|Received Treatment|Overall Study||17
38961|NCT02007434|93741|P2|Received Treatment|Overall Study||3
38962|NCT02007434|93742|P1|Received Treatment|Overall Study||17
38963|NCT02007434|93735|P8|STARTED|Overall Study||4
38964|NCT02007434|93736|P7|STARTED|Overall Study||18
38965|NCT02007434|93737|P6|STARTED|Overall Study||4
38966|NCT02007434|93738|P5|STARTED|Overall Study||16
38967|NCT02007434|93739|P4|STARTED|Overall Study||4
38968|NCT02007434|93740|P3|STARTED|Overall Study||17
38969|NCT02007434|93741|P2|STARTED|Overall Study||4
38970|NCT02007434|93742|P1|STARTED|Overall Study||17
38971|NCT02007369|93843|P3|NOT COMPLETED|Overall Study||0
38972|NCT02007369|93844|P2|NOT COMPLETED|Overall Study||0
38973|NCT02007369|93845|P1|NOT COMPLETED|Overall Study||0
38974|NCT02007369|93843|P3|COMPLETED|Overall Study||54
38975|NCT02007369|93844|P2|COMPLETED|Overall Study||40
38976|NCT02007369|93845|P1|COMPLETED|Overall Study||42
38977|NCT02007369|93843|P3|STARTED|Overall Study||54
38978|NCT02007369|93844|P2|STARTED|Overall Study||40
38979|NCT02007369|93845|P1|STARTED|Overall Study||42
38980|NCT02007278|93864|P2|NOT COMPLETED|Overall Study||3
38981|NCT02007278|93865|P1|NOT COMPLETED|Overall Study||2
38982|NCT02007278|93864|P2|COMPLETED|Overall Study||17
38983|NCT02007278|93865|P1|COMPLETED|Overall Study||18
38984|NCT02007278|93864|P2|STARTED|Overall Study||20
38985|NCT02007278|93865|P1|STARTED|Overall Study||20
38986|NCT02007252|93887|P2|NOT COMPLETED|Overall Study||11
38987|NCT02007252|93888|P1|NOT COMPLETED|Overall Study||11
38988|NCT02007252|93887|P2|COMPLETED|Overall Study||22
38989|NCT02007252|93888|P1|COMPLETED|Overall Study||20
38990|NCT02007252|93887|P2|Pharmacodynamic Analysis Set|Overall Study||33
38991|NCT02007252|93888|P1|Pharmacodynamic Analysis Set|Overall Study||31
38992|NCT02007252|93887|P2|Safety Analysis Set|Overall Study||33
38993|NCT02007252|93888|P1|Safety Analysis Set|Overall Study||31
38994|NCT02007252|93887|P2|STARTED|Overall Study||33
38995|NCT02007252|93888|P1|STARTED|Overall Study||31
38996|NCT02007200|93894|P1|NOT COMPLETED|Overall Study||0
38997|NCT02007200|93894|P1|COMPLETED|Overall Study||55
38998|NCT02007200|93894|P1|STARTED|Overall Study||55
38999|NCT02007096|93903|P2|NOT COMPLETED|Overall Study||16
39000|NCT02007096|93904|P1|NOT COMPLETED|Overall Study||11
39001|NCT02007096|93903|P2|COMPLETED|Overall Study||48
39002|NCT02007096|93904|P1|COMPLETED|Overall Study||52
39003|NCT02007096|93903|P2|STARTED|Overall Study||64
39004|NCT02007096|93904|P1|STARTED|Overall Study||63
39005|NCT02007070|93916|P1|NOT COMPLETED|Overall Study||33
39006|NCT02007070|93916|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
39007|NCT02007070|93916|P1|STARTED|Overall Study||38
39008|NCT02006888|93938|P3|NOT COMPLETED|Overall Study||22
39009|NCT02006888|93939|P2|NOT COMPLETED|Overall Study||34
39010|NCT02006888|93940|P1|NOT COMPLETED|Overall Study||36
39011|NCT02006888|93938|P3|COMPLETED|Overall Study||58
39012|NCT02006888|93939|P2|COMPLETED|Overall Study||122
39013|NCT02006888|93940|P1|COMPLETED|Overall Study||122
39014|NCT02006888|93938|P3|STARTED|Overall Study||80
39015|NCT02006888|93939|P2|STARTED|Overall Study||156
39016|NCT02006888|93940|P1|STARTED|Overall Study||158
39017|NCT02006836|93951|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
39018|NCT02006836|93952|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
39019|NCT02006836|93953|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
39020|NCT02006836|93951|P3|COMPLETED|Self-control Period: Month 7-month 12||19
39021|NCT02006836|93952|P2|COMPLETED|Self-control Period: Month 7-month 12||0
39022|NCT02006836|93953|P1|COMPLETED|Self-control Period: Month 7-month 12||0
39023|NCT02006836|93951|P3|STARTED|Self-control Period: Month 7-month 12||19
39024|NCT02006836|93952|P2|STARTED|Self-control Period: Month 7-month 12||0
39025|NCT02006836|93953|P1|STARTED|Self-control Period: Month 7-month 12||0
39026|NCT02006836|93951|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
39027|NCT02006836|93952|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
39028|NCT02006836|93953|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
39029|NCT02006836|93951|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
39030|NCT02006836|93952|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
39031|NCT02006836|93953|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
39032|NCT02006836|93951|P3|STARTED|Case-control Period: Month 1- Month 6||0
39033|NCT02006836|93952|P2|STARTED|Case-control Period: Month 1- Month 6||20
39034|NCT02006836|93953|P1|STARTED|Case-control Period: Month 1- Month 6||20
39035|NCT02006732|93973|P4|NOT COMPLETED|Overall Study||4
39036|NCT02006732|93974|P3|NOT COMPLETED|Overall Study||9
39037|NCT02006732|93975|P2|NOT COMPLETED|Overall Study||12
39038|NCT02006732|93976|P1|NOT COMPLETED|Overall Study||20
39039|NCT02006732|93973|P4|COMPLETED|Overall Study||198
39040|NCT02006732|93974|P3|COMPLETED|Overall Study||193
39041|NCT02006732|93975|P2|COMPLETED|Overall Study||191
39042|NCT02006732|93976|P1|COMPLETED|Overall Study||182
39043|NCT02006732|93973|P4|STARTED|Overall Study||202
39044|NCT02006732|93974|P3|STARTED|Overall Study||202
39045|NCT02006732|93975|P2|STARTED|Overall Study||203
39046|NCT02006732|93976|P1|STARTED|Overall Study||202
39047|NCT02006719|94016|P2|NOT COMPLETED|Overall Study||5
39048|NCT02006719|94017|P1|NOT COMPLETED|Overall Study||18
39049|NCT02006719|94016|P2|COMPLETED|Overall Study||80
39050|NCT02006719|94017|P1|COMPLETED|Overall Study||219
39051|NCT02006719|94016|P2|STARTED|Overall Study||85
39052|NCT02006719|94017|P1|STARTED|Overall Study||237
39053|NCT02006706|94047|P1|NOT COMPLETED|Overall Study||1
39054|NCT02006706|94047|P1|COMPLETED|Overall Study||14
39055|NCT02006706|94047|P1|STARTED|Overall Study||15
39056|NCT02006667|94052|P1|NOT COMPLETED|Overall Study||6
39057|NCT02006667|94052|P1|COMPLETED|Overall Study||7
39058|NCT02006667|94052|P1|STARTED|Overall Study||13
39059|NCT02006654|94064|P2|NOT COMPLETED|Overall Study||44
39060|NCT02006654|94065|P1|NOT COMPLETED|Overall Study||45
39061|NCT02006654|94064|P2|COMPLETED|Overall Study||321
39062|NCT02006654|94065|P1|COMPLETED|Overall Study||324
39063|NCT02006654|94064|P2|Treated|Overall Study||363
39064|NCT02006654|94065|P1|Treated|Overall Study||365
39065|NCT02006654|94064|P2|STARTED|Overall Study||365
39066|NCT02006654|94065|P1|STARTED|Overall Study||369
39067|NCT02006641|94094|P3|NOT COMPLETED|Overall Study||36
39068|NCT02006641|94095|P2|NOT COMPLETED|Overall Study||33
39069|NCT02006641|94096|P1|NOT COMPLETED|Overall Study||26
39070|NCT02006641|94094|P3|COMPLETED|Overall Study||248
39071|NCT02006641|94095|P2|COMPLETED|Overall Study||257
39072|NCT02006641|94096|P1|COMPLETED|Overall Study||258
39073|NCT02006641|94094|P3|Treated|Overall Study||281
39074|NCT02006641|94095|P2|Treated|Overall Study||285
39075|NCT02006641|94096|P1|Treated|Overall Study||282
39076|NCT02006641|94094|P3|STARTED|Overall Study||284
39077|NCT02006641|94095|P2|STARTED|Overall Study||290
39078|NCT02006641|94096|P1|STARTED|Overall Study||284
39079|NCT02006407|94134|P1|NOT COMPLETED|Overall Study||0
39080|NCT02006407|94134|P1|COMPLETED|Overall Study||5
39081|NCT02006407|94134|P1|STARTED|Overall Study||5
39082|NCT02006342|94142|P2|NOT COMPLETED|Overall Study||0
39083|NCT02006342|94143|P1|NOT COMPLETED|Overall Study||1
39084|NCT02006342|94142|P2|COMPLETED|Overall Study||20
39085|NCT02006342|94143|P1|COMPLETED|Overall Study||19
39086|NCT02006342|94142|P2|STARTED|Overall Study||20
39087|NCT02006342|94143|P1|STARTED|Overall Study||20
39088|NCT02006108|94157|P1|NOT COMPLETED|Overall Study||2
39089|NCT02006108|94157|P1|COMPLETED|Overall Study||19
39090|NCT02006108|94157|P1|MR Imaging|Overall Study||19
39091|NCT02006108|94157|P1|STARTED|Overall Study||21
39092|NCT02005692|94162|P1|NOT COMPLETED|Overall Study||7
39093|NCT02005692|94162|P1|COMPLETED|Overall Study||63
39094|NCT02005692|94162|P1|STARTED|Overall Study||70
39095|NCT02005601|94169|P2|NOT COMPLETED|Overall Study||0
39096|NCT02005601|94170|P1|NOT COMPLETED|Overall Study||0
39097|NCT02005601|94169|P2|COMPLETED|Overall Study||53
39098|NCT02005601|94170|P1|COMPLETED|Overall Study||53
39099|NCT02005601|94169|P2|STARTED|Overall Study||53
39100|NCT02005601|94170|P1|STARTED|Overall Study||53
39101|NCT02005562|94182|P2|NOT COMPLETED|Overall Study||15
39102|NCT02005562|94183|P1|NOT COMPLETED|Overall Study||12
39103|NCT02005562|94182|P2|COMPLETED|Overall Study||110
39104|NCT02005562|94183|P1|COMPLETED|Overall Study||115
39105|NCT02005562|94182|P2|Transplanted|Overall Study||121
39106|NCT02005562|94183|P1|Transplanted|Overall Study||126
39107|NCT02005562|94182|P2|STARTED|Overall Study||125
39108|NCT02005562|94183|P1|STARTED|Overall Study||127
39109|NCT02005549|94211|P1|NOT COMPLETED|Overall Study||0
39110|NCT02005549|94211|P1|COMPLETED|Overall Study||18
39111|NCT02005549|94211|P1|STARTED|Overall Study||18
39112|NCT02005536|94217|P1|NOT COMPLETED|Overall Study||0
39113|NCT02005536|94217|P1|COMPLETED|Overall Study||60
39114|NCT02005536|94217|P1|STARTED|Overall Study||60
39115|NCT02005484|94225|P1|NOT COMPLETED|Overall Study||4
39116|NCT02005484|94225|P1|COMPLETED|Overall Study||2
39117|NCT02005484|94225|P1|STARTED|Overall Study||6
39118|NCT02005393|94235|P1|NOT COMPLETED|Overall Study||0
39119|NCT02005393|94235|P1|COMPLETED|Overall Study||20
39120|NCT02005393|94235|P1|STARTED|Overall Study||20
39121|NCT02005211|94246|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39122|NCT02005211|94247|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39123|NCT02005211|94248|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
39124|NCT02005211|94249|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39125|NCT02005211|94250|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39126|NCT02005211|94251|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39127|NCT02005211|94252|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39128|NCT02005211|94246|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
39129|NCT02005211|94247|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
39130|NCT02005211|94248|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
39131|NCT02005211|94249|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39132|NCT02005211|94250|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39133|NCT02005211|94251|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39134|NCT02005211|94252|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39135|NCT02005211|94246|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
39136|NCT02005211|94247|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
39137|NCT02005211|94248|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
39138|NCT02005211|94249|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39139|NCT02005211|94250|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39140|NCT02005211|94251|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39141|NCT02005211|94252|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
39142|NCT02005211|94246|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39143|NCT02005211|94247|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39144|NCT02005211|94248|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39145|NCT02005211|94249|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39146|NCT02005211|94250|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39147|NCT02005211|94251|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39148|NCT02005211|94252|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39149|NCT02005211|94246|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39150|NCT02005211|94247|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39151|NCT02005211|94248|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
39152|NCT02005211|94249|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
39153|NCT02005211|94250|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
39154|NCT02005211|94251|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
39155|NCT02005211|94252|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
39156|NCT02005211|94246|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
39157|NCT02005211|94247|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
39158|NCT02005211|94248|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
39159|NCT02005211|94249|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
39160|NCT02005211|94250|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
39161|NCT02005211|94251|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
39162|NCT02005211|94252|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
39163|NCT02005029|94287|P2|NOT COMPLETED|Second Intervention (1 Day)||0
39164|NCT02005029|94288|P1|NOT COMPLETED|Second Intervention (1 Day)||0
39165|NCT02005029|94287|P2|COMPLETED|Second Intervention (1 Day)||5
39166|NCT02005029|94288|P1|COMPLETED|Second Intervention (1 Day)||4
39167|NCT02005029|94287|P2|STARTED|Second Intervention (1 Day)||5
39168|NCT02005029|94288|P1|STARTED|Second Intervention (1 Day)||4
39169|NCT02005029|94287|P2|NOT COMPLETED|Washout (2 Weeks)||0
39170|NCT02005029|94288|P1|NOT COMPLETED|Washout (2 Weeks)||0
39171|NCT02005029|94287|P2|COMPLETED|Washout (2 Weeks)||5
39172|NCT02005029|94288|P1|COMPLETED|Washout (2 Weeks)||4
39173|NCT02005029|94287|P2|STARTED|Washout (2 Weeks)||5
39174|NCT02005029|94288|P1|STARTED|Washout (2 Weeks)||4
39175|NCT02005029|94287|P2|NOT COMPLETED|First Intervention (1 Day)||0
39176|NCT02005029|94288|P1|NOT COMPLETED|First Intervention (1 Day)||1
39177|NCT02005029|94287|P2|COMPLETED|First Intervention (1 Day)||5
39178|NCT02005029|94288|P1|COMPLETED|First Intervention (1 Day)||4
39179|NCT02005029|94287|P2|STARTED|First Intervention (1 Day)||5
39180|NCT02005029|94288|P1|STARTED|First Intervention (1 Day)||5
39181|NCT02004990|94314|P1|NOT COMPLETED|Overall Study||0
39182|NCT02004990|94314|P1|COMPLETED|Overall Study||12
39183|NCT02004990|94314|P1|STARTED|Overall Study||12
39184|NCT02004977|94321|P2|NOT COMPLETED|Overall Study||5
39185|NCT02004977|94322|P1|NOT COMPLETED|Overall Study||54
39186|NCT02004977|94321|P2|COMPLETED|Overall Study||436
39187|NCT02004977|94322|P1|COMPLETED|Overall Study||409
39188|NCT02004977|94321|P2|STARTED|Overall Study||441
39189|NCT02004977|94322|P1|STARTED|Overall Study||463
39190|NCT02004886|94340|P4|NOT COMPLETED|Overall Study||0
39191|NCT02004886|94341|P3|NOT COMPLETED|Overall Study||0
39192|NCT02004886|94342|P2|NOT COMPLETED|Overall Study||1
39193|NCT02004886|94343|P1|NOT COMPLETED|Overall Study||1
39194|NCT02004886|94340|P4|COMPLETED|Overall Study||19
39195|NCT02004886|94341|P3|COMPLETED|Overall Study||18
39196|NCT02004886|94342|P2|COMPLETED|Overall Study||17
39197|NCT02004886|94343|P1|COMPLETED|Overall Study||18
39198|NCT02004886|94340|P4|STARTED|Overall Study||19
39199|NCT02004886|94341|P3|STARTED|Overall Study||18
39200|NCT02004886|94342|P2|STARTED|Overall Study||18
39201|NCT02004886|94343|P1|STARTED|Overall Study||19
39202|NCT02004873|94393|P1|NOT COMPLETED|Overall Study||424
39203|NCT02004873|94393|P1|COMPLETED|Overall Study|6-Month Follow-up|301
39204|NCT02004873|94393|P1|Micra Implant Success|Overall Study||719
39205|NCT02004873|94393|P1|STARTED|Overall Study|Micra Implant Attempt|725
39206|NCT02004847|94402|P2|NOT COMPLETED|Overall Study||1
39207|NCT02004847|94403|P1|NOT COMPLETED|Overall Study||1
39208|NCT02004847|94402|P2|COMPLETED|Overall Study||22
39209|NCT02004847|94403|P1|COMPLETED|Overall Study||23
39210|NCT02004847|94402|P2|STARTED|Overall Study||23
39211|NCT02004847|94403|P1|STARTED|Overall Study||24
39212|NCT02004262|94453|P6|NOT COMPLETED|Overall Study||30
39213|NCT02004262|94454|P5|NOT COMPLETED|Overall Study||31
39214|NCT02004262|94455|P4|NOT COMPLETED|Overall Study||29
39215|NCT02004262|94456|P3|NOT COMPLETED|Overall Study||72
39216|NCT02004262|94457|P2|NOT COMPLETED|Overall Study||68
39217|NCT02004262|94458|P1|NOT COMPLETED|Overall Study||73
39218|NCT02004262|94453|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
39219|NCT02004262|94454|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
39220|NCT02004262|94455|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
39221|NCT02004262|94456|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
39222|NCT02004262|94457|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
39223|NCT02004262|94458|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
39224|NCT02004262|94453|P6|Treated|Overall Study||11
39225|NCT02004262|94454|P5|Treated|Overall Study||29
39226|NCT02004262|94455|P4|Treated|Overall Study||26
39227|NCT02004262|94456|P3|Treated|Overall Study||43
39228|NCT02004262|94457|P2|Treated|Overall Study||58
39229|NCT02004262|94458|P1|Treated|Overall Study||68
39230|NCT02004262|94453|P6|STARTED|Overall Study||30
39231|NCT02004262|94454|P5|STARTED|Overall Study||31
39232|NCT02004262|94455|P4|STARTED|Overall Study||29
39233|NCT02004262|94456|P3|STARTED|Overall Study||72
39234|NCT02004262|94457|P2|STARTED|Overall Study||68
39235|NCT02004262|94458|P1|STARTED|Overall Study||73
39236|NCT02004236|94478|P3|NOT COMPLETED|Overall Study||16
39237|NCT02004236|94479|P2|NOT COMPLETED|Overall Study||0
39238|NCT02004236|94480|P1|NOT COMPLETED|Overall Study||0
39239|NCT02004236|94478|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
39240|NCT02004236|94479|P2|COMPLETED|Overall Study||75
39241|NCT02004236|94480|P1|COMPLETED|Overall Study||75
39242|NCT02004236|94478|P3|STARTED|Overall Study||75
39243|NCT02004236|94479|P2|STARTED|Overall Study||75
39244|NCT02004236|94480|P1|STARTED|Overall Study||75
39245|NCT02004158|94524|P1|NOT COMPLETED|Overall Study||3
39246|NCT02004158|94524|P1|COMPLETED|Overall Study||20
39247|NCT02004158|94524|P1|STARTED|Overall Study||23
39248|NCT02004132|94532|P1|NOT COMPLETED|Overall Study||0
39249|NCT02004132|94532|P1|COMPLETED|Overall Study||12
39250|NCT02004132|94532|P1|Received Study Drug|Overall Study||12
39251|NCT02004132|94532|P1|STARTED|Overall Study||12
39252|NCT02004093|94540|P2|NOT COMPLETED|Overall Study||73
39253|NCT02004093|94541|P1|NOT COMPLETED|Overall Study||74
39254|NCT02004093|94540|P2|COMPLETED|Overall Study||1
39255|NCT02004093|94541|P1|COMPLETED|Overall Study||1
39256|NCT02004093|94540|P2|STARTED|Overall Study||74
39257|NCT02004093|94541|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
39258|NCT02003963|94573|P2|NOT COMPLETED|Overall Study||1
39259|NCT02003963|94574|P1|NOT COMPLETED|Overall Study||2
39260|NCT02003963|94573|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
39261|NCT02003963|94574|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
39262|NCT02003963|94573|P2|STARTED|Overall Study||19
39263|NCT02003963|94574|P1|STARTED|Overall Study||22
39264|NCT02003638|94596|P2|NOT COMPLETED|Overall Study||0
39265|NCT02003638|94597|P1|NOT COMPLETED|Overall Study||1
39266|NCT02003638|94596|P2|COMPLETED|Overall Study||3
39267|NCT02003638|94597|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
39268|NCT02003638|94596|P2|STARTED|Overall Study||3
39269|NCT02003638|94597|P1|STARTED|Overall Study||6
39270|NCT02003534|94603|P1|NOT COMPLETED|Overall Study||47
39271|NCT02003534|94603|P1|COMPLETED|Overall Study||329
39272|NCT02003534|94603|P1|STARTED|Overall Study||376
39273|NCT02003404|94607|P1|NOT COMPLETED|Overall Study||0
39274|NCT02003404|94607|P1|COMPLETED|Overall Study||17
39275|NCT02003404|94607|P1|STARTED|Overall Study||17
39276|NCT02003391|94615|P2|NOT COMPLETED|Overall Study||2
39277|NCT02003391|94616|P1|NOT COMPLETED|Overall Study||3
39278|NCT02003391|94615|P2|COMPLETED|Overall Study||73
39279|NCT02003391|94616|P1|COMPLETED|Overall Study||78
39280|NCT02003391|94615|P2|Intent to Treat Population|Overall Study||73
39281|NCT02003391|94616|P1|Intent to Treat Population|Overall Study||78
39282|NCT02003391|94615|P2|Safety Population|Overall Study||75
39283|NCT02003391|94616|P1|Safety Population|Overall Study||81
39284|NCT02003391|94615|P2|STARTED|Overall Study||75
39285|NCT02003391|94616|P1|STARTED|Overall Study||81
39286|NCT02003365|94629|P3|NOT COMPLETED|Overall Study||1
39287|NCT02003365|94630|P2|NOT COMPLETED|Overall Study||0
39288|NCT02003365|94631|P1|NOT COMPLETED|Overall Study||0
39289|NCT02003365|94629|P3|COMPLETED|Overall Study||9
39290|NCT02003365|94630|P2|COMPLETED|Overall Study||30
39291|NCT02003365|94631|P1|COMPLETED|Overall Study||10
39292|NCT02003365|94629|P3|STARTED|Overall Study||10
39293|NCT02003365|94630|P2|STARTED|Overall Study||30
39294|NCT02003365|94631|P1|STARTED|Overall Study||10
39295|NCT02003352|94642|P1|NOT COMPLETED|Overall Study||0
39296|NCT02003352|94642|P1|COMPLETED|Overall Study||98
39297|NCT02003352|94642|P1|STARTED|Overall Study||98
39298|NCT02003053|94648|P2|NOT COMPLETED|Overall Study||0
39299|NCT02003053|94649|P1|NOT COMPLETED|Overall Study||0
39300|NCT02003053|94648|P2|COMPLETED|Overall Study||3
39301|NCT02003053|94649|P1|COMPLETED|Overall Study||4
39302|NCT02003053|94648|P2|STARTED|Overall Study||3
39303|NCT02003053|94649|P1|STARTED|Overall Study||4
39304|NCT02003014|94655|P1|NOT COMPLETED|Overall Study||19
39305|NCT02003014|94655|P1|COMPLETED|Overall Study||880
39306|NCT02003014|94655|P1|STARTED|Overall Study||899
39307|NCT02002936|94665|P1|NOT COMPLETED|Overall Study||0
39308|NCT02002936|94665|P1|COMPLETED|Overall Study||1
39309|NCT02002936|94665|P1|STARTED|Overall Study||1
39310|NCT02002871|94674|P1|NOT COMPLETED|Overall Study||1
39311|NCT02002871|94674|P1|COMPLETED|Overall Study||20
39312|NCT02002871|94674|P1|STARTED|Overall Study||21
39313|NCT02002702|94703|P3|NOT COMPLETED|Overall Study||0
39314|NCT02002702|94704|P2|NOT COMPLETED|Overall Study||0
39315|NCT02002702|94705|P1|NOT COMPLETED|Overall Study||0
39316|NCT02002702|94703|P3|COMPLETED|Overall Study||15
39317|NCT02002702|94704|P2|COMPLETED|Overall Study||15
39318|NCT02002702|94705|P1|COMPLETED|Overall Study||16
39319|NCT02002702|94703|P3|STARTED|Overall Study||15
39320|NCT02002702|94704|P2|STARTED|Overall Study||15
39321|NCT02002702|94705|P1|STARTED|Overall Study||16
39322|NCT02002689|94737|P1|NOT COMPLETED|Overall Study||10
39323|NCT02002689|94737|P1|COMPLETED|Overall Study||0
39324|NCT02002689|94737|P1|STARTED|Overall Study||10
39325|NCT02002650|94745|P2|NOT COMPLETED|Overall Study||0
39326|NCT02002650|94746|P1|NOT COMPLETED|Overall Study||0
39327|NCT02002650|94745|P2|COMPLETED|Overall Study||1303
39328|NCT02002650|94746|P1|COMPLETED|Overall Study||1297
39329|NCT02002650|94745|P2|STARTED|Overall Study||1303
39330|NCT02002650|94746|P1|STARTED|Overall Study||1297
39331|NCT02002533|94756|P2|NOT COMPLETED|Overall Study||18
39332|NCT02002533|94757|P1|NOT COMPLETED|Overall Study||6
39333|NCT02002533|94756|P2|COMPLETED|Overall Study||19
39334|NCT02002533|94757|P1|COMPLETED|Overall Study||28
39335|NCT02002533|94756|P2|STARTED|Overall Study||37
39336|NCT02002533|94757|P1|STARTED|Overall Study||34
39337|NCT02002221|94782|P2|NOT COMPLETED|Overall Study||3
39338|NCT02002221|94783|P1|NOT COMPLETED|Overall Study||2
39339|NCT02002221|94782|P2|COMPLETED|Overall Study||75
39340|NCT02002221|94783|P1|COMPLETED|Overall Study||76
39341|NCT02002221|94782|P2|STARTED|Overall Study||78
39342|NCT02002221|94783|P1|STARTED|Overall Study||78
39343|NCT02002208|94799|P2|NOT COMPLETED|Overall Study||40
39344|NCT02002208|94800|P1|NOT COMPLETED|Overall Study||37
39345|NCT02002208|94799|P2|COMPLETED|Overall Study||30
39346|NCT02002208|94800|P1|COMPLETED|Overall Study||32
39347|NCT02002208|94799|P2|STARTED|Overall Study||70
39348|NCT02002208|94800|P1|STARTED|Overall Study||69
39349|NCT02001714|94810|P2|NOT COMPLETED|Overall Study||12
39350|NCT02001714|94811|P1|NOT COMPLETED|Overall Study||22
39351|NCT02001714|94810|P2|COMPLETED|Overall Study||219
39352|NCT02001714|94811|P1|COMPLETED|Overall Study||210
39353|NCT02001714|94810|P2|STARTED|Overall Study||231
39354|NCT02001714|94811|P1|STARTED|Overall Study||232
39355|NCT02001181|94819|P2|NOT COMPLETED|Overall Study||3
39356|NCT02001181|94820|P1|NOT COMPLETED|Overall Study||1
39357|NCT02001181|94819|P2|COMPLETED|Overall Study||31
39358|NCT02001181|94820|P1|COMPLETED|Overall Study||34
39359|NCT02001181|94819|P2|STARTED|Overall Study||34
39360|NCT02001181|94820|P1|STARTED|Overall Study||35
39361|NCT02001051|94836|P2|NOT COMPLETED|Overall Study||1
39362|NCT02001051|94837|P1|NOT COMPLETED|Overall Study||0
39363|NCT02001051|94836|P2|COMPLETED|Overall Study||1
39364|NCT02001051|94837|P1|COMPLETED|Overall Study||2
39365|NCT02001051|94836|P2|STARTED|Overall Study||2
39366|NCT02001051|94837|P1|STARTED|Overall Study||2
39367|NCT02000973|94861|P4|NOT COMPLETED|Overall Study||0
39368|NCT02000973|94862|P3|NOT COMPLETED|Overall Study||0
39369|NCT02000973|94863|P2|NOT COMPLETED|Overall Study||0
39370|NCT02000973|94864|P1|NOT COMPLETED|Overall Study||0
39371|NCT02000973|94861|P4|COMPLETED|Overall Study||20
39372|NCT02000973|94862|P3|COMPLETED|Overall Study||20
39373|NCT02000973|94863|P2|COMPLETED|Overall Study||20
39374|NCT02000973|94864|P1|COMPLETED|Overall Study||20
39375|NCT02000973|94861|P4|STARTED|Overall Study||20
39376|NCT02000973|94862|P3|STARTED|Overall Study||20
39377|NCT02000973|94863|P2|STARTED|Overall Study||20
39378|NCT02000973|94864|P1|STARTED|Overall Study||20
39379|NCT02000921|94889|P3|NOT COMPLETED|Overall Study||10
39380|NCT02000921|94890|P2|NOT COMPLETED|Overall Study||16
39381|NCT02000921|94891|P1|NOT COMPLETED|Overall Study||5
39382|NCT02000921|94889|P3|COMPLETED|Overall Study||46
39383|NCT02000921|94890|P2|COMPLETED|Overall Study||37
39384|NCT02000921|94891|P1|COMPLETED|Overall Study||22
39385|NCT02000921|94889|P3|STARTED|Overall Study||56
39386|NCT02000921|94890|P2|STARTED|Overall Study||53
39387|NCT02000921|94891|P1|STARTED|Overall Study||27
39388|NCT02000752|94910|P2|NOT COMPLETED|Overall Study||13
39389|NCT02000752|94911|P1|NOT COMPLETED|Overall Study||31
39390|NCT02000752|94910|P2|COMPLETED|Overall Study||47
39391|NCT02000752|94911|P1|COMPLETED|Overall Study||29
39392|NCT02000752|94910|P2|STARTED|Overall Study||60
39393|NCT02000752|94911|P1|STARTED|Overall Study||60
39394|NCT02000622|94925|P2|NOT COMPLETED|Overall Study||53
39395|NCT02000622|94926|P1|NOT COMPLETED|Overall Study||101
39396|NCT02000622|94925|P2|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|44
39397|NCT02000622|94926|P1|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|104
39398|NCT02000622|94925|P2|STARTED|Overall Study||97
39399|NCT02000622|94926|P1|STARTED|Overall Study||205
39400|NCT02000531|94948|P2|NOT COMPLETED|Overall Study||8
39401|NCT02000531|94949|P1|NOT COMPLETED|Overall Study||4
39402|NCT02000531|94948|P2|COMPLETED|Overall Study||16
39403|NCT02000531|94949|P1|COMPLETED|Overall Study||17
39404|NCT02000531|94948|P2|Safety Population|Overall Study||24
39405|NCT02000531|94949|P1|Safety Population|Overall Study||21
39406|NCT02000531|94948|P2|STARTED|Overall Study||24
39407|NCT02000531|94949|P1|STARTED|Overall Study||21
39408|NCT02000440|94957|P1|NOT COMPLETED|Overall Study||4
39409|NCT02000440|94957|P1|COMPLETED|Overall Study||13
39410|NCT02000440|94957|P1|STARTED|Overall Study||17
39411|NCT02000427|94977|P1|NOT COMPLETED|Overall Study||22
39412|NCT02000427|94977|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
39413|NCT02000427|94977|P1|STARTED|Overall Study||45
39414|NCT02000180|94994|P2|NOT COMPLETED|Overall Study||0
39415|NCT02000180|94995|P1|NOT COMPLETED|Overall Study||0
39416|NCT02000180|94994|P2|COMPLETED|Overall Study||19
39417|NCT02000180|94995|P1|COMPLETED|Overall Study||18
39418|NCT02000180|94994|P2|STARTED|Overall Study||19
39419|NCT02000180|94995|P1|STARTED|Overall Study||18
39420|NCT02000154|95007|P1|NOT COMPLETED|Overall Study||0
39421|NCT02000154|95007|P1|COMPLETED|Overall Study||1
39422|NCT02000154|95007|P1|STARTED|Overall Study||1
39423|NCT01999920|95017|P2|NOT COMPLETED|Overall Study||2
39424|NCT01999920|95018|P1|NOT COMPLETED|Overall Study||6
39425|NCT01999920|95017|P2|COMPLETED|Overall Study||9
39426|NCT01999920|95018|P1|COMPLETED|Overall Study||7
39427|NCT01999920|95017|P2|STARTED|Overall Study||11
39428|NCT01999920|95018|P1|STARTED|Overall Study||13
39429|NCT01999894|95034|P1|NOT COMPLETED|Overall Study||36
39430|NCT01999894|95034|P1|COMPLETED|Overall Study||66
39431|NCT01999894|95034|P1|STARTED|Overall Study||102
39432|NCT01999400|95039|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
39433|NCT01999400|95040|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
39434|NCT01999400|95041|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
39435|NCT01999400|95042|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
39436|NCT01999400|95043|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
39437|NCT01999400|95044|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
39438|NCT01999400|95039|P6|COMPLETED|Fourth Intervention (1 Day)||0
39439|NCT01999400|95040|P5|COMPLETED|Fourth Intervention (1 Day)||0
39440|NCT01999400|95041|P4|COMPLETED|Fourth Intervention (1 Day)||0
39441|NCT01999400|95042|P3|COMPLETED|Fourth Intervention (1 Day)||1
39442|NCT01999400|95043|P2|COMPLETED|Fourth Intervention (1 Day)||0
39443|NCT01999400|95044|P1|COMPLETED|Fourth Intervention (1 Day)||1
39444|NCT01999400|95039|P6|STARTED|Fourth Intervention (1 Day)||0
39445|NCT01999400|95040|P5|STARTED|Fourth Intervention (1 Day)||0
39446|NCT01999400|95041|P4|STARTED|Fourth Intervention (1 Day)||0
39447|NCT01999400|95042|P3|STARTED|Fourth Intervention (1 Day)||1
39448|NCT01999400|95043|P2|STARTED|Fourth Intervention (1 Day)||0
39449|NCT01999400|95044|P1|STARTED|Fourth Intervention (1 Day)||1
39450|NCT01999400|95039|P6|NOT COMPLETED|Washout (10 Days)||0
39451|NCT01999400|95040|P5|NOT COMPLETED|Washout (10 Days)||0
39452|NCT01999400|95041|P4|NOT COMPLETED|Washout (10 Days)||0
39453|NCT01999400|95042|P3|NOT COMPLETED|Washout (10 Days)||0
39454|NCT01999400|95043|P2|NOT COMPLETED|Washout (10 Days)||0
39455|NCT01999400|95044|P1|NOT COMPLETED|Washout (10 Days)||0
39456|NCT01999400|95039|P6|COMPLETED|Washout (10 Days)||0
39457|NCT01999400|95040|P5|COMPLETED|Washout (10 Days)||0
39458|NCT01999400|95041|P4|COMPLETED|Washout (10 Days)||0
39459|NCT01999400|95042|P3|COMPLETED|Washout (10 Days)||1
39460|NCT01999400|95043|P2|COMPLETED|Washout (10 Days)||0
39461|NCT01999400|95044|P1|COMPLETED|Washout (10 Days)||1
39462|NCT01999400|95039|P6|STARTED|Washout (10 Days)||0
39463|NCT01999400|95040|P5|STARTED|Washout (10 Days)||0
39464|NCT01999400|95041|P4|STARTED|Washout (10 Days)||0
39465|NCT01999400|95042|P3|STARTED|Washout (10 Days)||1
39466|NCT01999400|95043|P2|STARTED|Washout (10 Days)||0
39467|NCT01999400|95044|P1|STARTED|Washout (10 Days)||1
39468|NCT01999400|95039|P6|NOT COMPLETED|Third Intervention (1 Day)||1
39469|NCT01999400|95040|P5|NOT COMPLETED|Third Intervention (1 Day)||0
39470|NCT01999400|95041|P4|NOT COMPLETED|Third Intervention (1 Day)||0
39471|NCT01999400|95042|P3|NOT COMPLETED|Third Intervention (1 Day)||0
39472|NCT01999400|95043|P2|NOT COMPLETED|Third Intervention (1 Day)||0
39473|NCT01999400|95044|P1|NOT COMPLETED|Third Intervention (1 Day)||0
39474|NCT01999400|95039|P6|COMPLETED|Third Intervention (1 Day)||0
39475|NCT01999400|95040|P5|COMPLETED|Third Intervention (1 Day)||1
39476|NCT01999400|95041|P4|COMPLETED|Third Intervention (1 Day)||1
39477|NCT01999400|95042|P3|COMPLETED|Third Intervention (1 Day)||1
39478|NCT01999400|95043|P2|COMPLETED|Third Intervention (1 Day)||0
39479|NCT01999400|95044|P1|COMPLETED|Third Intervention (1 Day)||2
39480|NCT01999400|95039|P6|STARTED|Third Intervention (1 Day)||1
39481|NCT01999400|95040|P5|STARTED|Third Intervention (1 Day)||1
39482|NCT01999400|95041|P4|STARTED|Third Intervention (1 Day)||1
39483|NCT01999400|95042|P3|STARTED|Third Intervention (1 Day)||1
39484|NCT01999400|95043|P2|STARTED|Third Intervention (1 Day)||0
39485|NCT01999400|95044|P1|STARTED|Third Intervention (1 Day)||2
39486|NCT01999400|95039|P6|NOT COMPLETED|Washout (10 Days)||0
39487|NCT01999400|95040|P5|NOT COMPLETED|Washout (10 Days)||0
39488|NCT01999400|95041|P4|NOT COMPLETED|Washout (10 Days)||0
39489|NCT01999400|95042|P3|NOT COMPLETED|Washout (10 Days)||0
39490|NCT01999400|95043|P2|NOT COMPLETED|Washout (10 Days)||0
39491|NCT01999400|95044|P1|NOT COMPLETED|Washout (10 Days)||0
39492|NCT01999400|95039|P6|COMPLETED|Washout (10 Days)||1
39493|NCT01999400|95040|P5|COMPLETED|Washout (10 Days)||1
39494|NCT01999400|95041|P4|COMPLETED|Washout (10 Days)||1
39495|NCT01999400|95042|P3|COMPLETED|Washout (10 Days)||1
39496|NCT01999400|95043|P2|COMPLETED|Washout (10 Days)||0
39497|NCT01999400|95044|P1|COMPLETED|Washout (10 Days)||2
39498|NCT01999400|95039|P6|STARTED|Washout (10 Days)||1
39499|NCT01999400|95040|P5|STARTED|Washout (10 Days)||1
39500|NCT01999400|95041|P4|STARTED|Washout (10 Days)||1
39501|NCT01999400|95042|P3|STARTED|Washout (10 Days)||1
39502|NCT01999400|95043|P2|STARTED|Washout (10 Days)||0
39503|NCT01999400|95044|P1|STARTED|Washout (10 Days)||2
39504|NCT01999400|95039|P6|NOT COMPLETED|Second Intervention (1 Day)||0
39505|NCT01999400|95040|P5|NOT COMPLETED|Second Intervention (1 Day)||0
39506|NCT01999400|95041|P4|NOT COMPLETED|Second Intervention (1 Day)||0
39507|NCT01999400|95042|P3|NOT COMPLETED|Second Intervention (1 Day)||0
39508|NCT01999400|95043|P2|NOT COMPLETED|Second Intervention (1 Day)||0
39509|NCT01999400|95044|P1|NOT COMPLETED|Second Intervention (1 Day)||0
39510|NCT01999400|95039|P6|COMPLETED|Second Intervention (1 Day)||3
39511|NCT01999400|95040|P5|COMPLETED|Second Intervention (1 Day)||3
39512|NCT01999400|95041|P4|COMPLETED|Second Intervention (1 Day)||2
39513|NCT01999400|95042|P3|COMPLETED|Second Intervention (1 Day)||3
39514|NCT01999400|95043|P2|COMPLETED|Second Intervention (1 Day)||4
39515|NCT01999400|95044|P1|COMPLETED|Second Intervention (1 Day)||5
39516|NCT01999400|95039|P6|STARTED|Second Intervention (1 Day)||3
39517|NCT01999400|95040|P5|STARTED|Second Intervention (1 Day)||3
39518|NCT01999400|95041|P4|STARTED|Second Intervention (1 Day)||2
39519|NCT01999400|95042|P3|STARTED|Second Intervention (1 Day)||3
39520|NCT01999400|95043|P2|STARTED|Second Intervention (1 Day)||4
39521|NCT01999400|95044|P1|STARTED|Second Intervention (1 Day)||5
39522|NCT01999400|95039|P6|NOT COMPLETED|Washout (10 Days)||0
39523|NCT01999400|95040|P5|NOT COMPLETED|Washout (10 Days)||0
39524|NCT01999400|95041|P4|NOT COMPLETED|Washout (10 Days)||0
39525|NCT01999400|95042|P3|NOT COMPLETED|Washout (10 Days)||0
39526|NCT01999400|95043|P2|NOT COMPLETED|Washout (10 Days)||0
39527|NCT01999400|95044|P1|NOT COMPLETED|Washout (10 Days)||0
39528|NCT01999400|95039|P6|COMPLETED|Washout (10 Days)||3
39529|NCT01999400|95040|P5|COMPLETED|Washout (10 Days)||3
39530|NCT01999400|95041|P4|COMPLETED|Washout (10 Days)||2
39531|NCT01999400|95042|P3|COMPLETED|Washout (10 Days)||3
39532|NCT01999400|95043|P2|COMPLETED|Washout (10 Days)||4
39533|NCT01999400|95044|P1|COMPLETED|Washout (10 Days)||5
39534|NCT01999400|95039|P6|STARTED|Washout (10 Days)||3
39535|NCT01999400|95040|P5|STARTED|Washout (10 Days)||3
39536|NCT01999400|95041|P4|STARTED|Washout (10 Days)||2
39537|NCT01999400|95042|P3|STARTED|Washout (10 Days)||3
39538|NCT01999400|95043|P2|STARTED|Washout (10 Days)||4
39539|NCT01999400|95044|P1|STARTED|Washout (10 Days)||5
39540|NCT01999400|95039|P6|NOT COMPLETED|First Intervention (1 Day)||1
39541|NCT01999400|95040|P5|NOT COMPLETED|First Intervention (1 Day)||0
39542|NCT01999400|95041|P4|NOT COMPLETED|First Intervention (1 Day)||3
39543|NCT01999400|95042|P3|NOT COMPLETED|First Intervention (1 Day)||2
39544|NCT01999400|95043|P2|NOT COMPLETED|First Intervention (1 Day)||2
39545|NCT01999400|95044|P1|NOT COMPLETED|First Intervention (1 Day)||2
39546|NCT01999400|95039|P6|COMPLETED|First Intervention (1 Day)||3
39547|NCT01999400|95040|P5|COMPLETED|First Intervention (1 Day)||4
39548|NCT01999400|95041|P4|COMPLETED|First Intervention (1 Day)||2
39549|NCT01999400|95042|P3|COMPLETED|First Intervention (1 Day)||3
39550|NCT01999400|95043|P2|COMPLETED|First Intervention (1 Day)||4
39551|NCT01999400|95044|P1|COMPLETED|First Intervention (1 Day)||4
39552|NCT01999400|95039|P6|STARTED|First Intervention (1 Day)||4
39553|NCT01999400|95040|P5|STARTED|First Intervention (1 Day)||4
39554|NCT01999400|95041|P4|STARTED|First Intervention (1 Day)||5
39555|NCT01999400|95042|P3|STARTED|First Intervention (1 Day)||5
39556|NCT01999400|95043|P2|STARTED|First Intervention (1 Day)||6
39557|NCT01999400|95044|P1|STARTED|First Intervention (1 Day)||6
39558|NCT01999348|95064|P1|NOT COMPLETED|Overall Study||120
39559|NCT01999348|95064|P1|COMPLETED|Overall Study||1433
39560|NCT01999348|95064|P1|STARTED|Overall Study||1553
39561|NCT01999322|95076|P2|NOT COMPLETED|Overall Study||0
39562|NCT01999322|95077|P1|NOT COMPLETED|Overall Study||1
39563|NCT01999322|95076|P2|COMPLETED|Overall Study||12
39564|NCT01999322|95077|P1|COMPLETED|Overall Study||24
39565|NCT01999322|95076|P2|STARTED|Overall Study||12
39566|NCT01999322|95077|P1|STARTED|Overall Study||25
39567|NCT01999231|95093|P4|NOT COMPLETED|Overall Study||0
39568|NCT01999231|95094|P3|NOT COMPLETED|Overall Study||0
39569|NCT01999231|95095|P2|NOT COMPLETED|Overall Study||0
39570|NCT01999231|95096|P1|NOT COMPLETED|Overall Study||0
39571|NCT01999231|95093|P4|COMPLETED|Overall Study||6
39572|NCT01999231|95094|P3|COMPLETED|Overall Study||6
39573|NCT01999231|95095|P2|COMPLETED|Overall Study||6
39574|NCT01999231|95096|P1|COMPLETED|Overall Study||6
39575|NCT01999231|95093|P4|STARTED|Overall Study||6
39576|NCT01999231|95094|P3|STARTED|Overall Study||6
39577|NCT01999231|95095|P2|STARTED|Overall Study||6
39578|NCT01999231|95096|P1|STARTED|Overall Study||6
39579|NCT01999218|95129|P3|NOT COMPLETED|Overall Study||110
39580|NCT01999218|95130|P2|NOT COMPLETED|Overall Study||101
39581|NCT01999218|95131|P1|NOT COMPLETED|Overall Study||109
39582|NCT01999218|95129|P3|COMPLETED|Overall Study||327
39583|NCT01999218|95130|P2|COMPLETED|Overall Study||340
39584|NCT01999218|95131|P1|COMPLETED|Overall Study||339
39585|NCT01999218|95129|P3|Site Issue|Overall Study||435
39586|NCT01999218|95130|P2|Site Issue|Overall Study||435
39587|NCT01999218|95131|P1|Site Issue|Overall Study||445
39588|NCT01999218|95129|P3|Treated|Overall Study||437
39589|NCT01999218|95130|P2|Treated|Overall Study||440
39590|NCT01999218|95131|P1|Treated|Overall Study||448
39591|NCT01999218|95129|P3|STARTED|Overall Study||437
39592|NCT01999218|95130|P2|STARTED|Overall Study||441
39593|NCT01999218|95131|P1|STARTED|Overall Study||448
39594|NCT01999192|95158|P4|NOT COMPLETED|Extension Phase||0
39595|NCT01999192|95159|P3|NOT COMPLETED|Extension Phase||24
39596|NCT01999192|95160|P2|NOT COMPLETED|Extension Phase||18
39597|NCT01999192|95161|P1|NOT COMPLETED|Extension Phase||13
39598|NCT01999192|95158|P4|COMPLETED|Extension Phase||0
39599|NCT01999192|95159|P3|COMPLETED|Extension Phase||44
39600|NCT01999192|95160|P2|COMPLETED|Extension Phase||38
39601|NCT01999192|95161|P1|COMPLETED|Extension Phase||41
39602|NCT01999192|95158|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
39603|NCT01999192|95159|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
39604|NCT01999192|95160|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
39605|NCT01999192|95161|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
39606|NCT01999192|95158|P4|NOT COMPLETED|Main Phase II||1
39607|NCT01999192|95159|P3|NOT COMPLETED|Main Phase II||22
39608|NCT01999192|95160|P2|NOT COMPLETED|Main Phase II||9
39609|NCT01999192|95161|P1|NOT COMPLETED|Main Phase II||9
39610|NCT01999192|95158|P4|COMPLETED|Main Phase II||43
39611|NCT01999192|95159|P3|COMPLETED|Main Phase II||76
39612|NCT01999192|95160|P2|COMPLETED|Main Phase II||66
39613|NCT01999192|95161|P1|COMPLETED|Main Phase II||55
39614|NCT01999192|95158|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
39615|NCT01999192|95159|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
39616|NCT01999192|95160|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
39617|NCT01999192|95161|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
39618|NCT01999192|95158|P4|NOT COMPLETED|Main Phase I||8
39619|NCT01999192|95159|P3|NOT COMPLETED|Main Phase I||8
39620|NCT01999192|95160|P2|NOT COMPLETED|Main Phase I||10
39621|NCT01999192|95161|P1|NOT COMPLETED|Main Phase I||11
39622|NCT01999192|95158|P4|COMPLETED|Main Phase I||72
39623|NCT01999192|95159|P3|COMPLETED|Main Phase I||70
39624|NCT01999192|95160|P2|COMPLETED|Main Phase I||70
39625|NCT01999192|95161|P1|COMPLETED|Main Phase I||72
39626|NCT01999192|95158|P4|STARTED|Main Phase I||80
39627|NCT01999192|95159|P3|STARTED|Main Phase I||78
39628|NCT01999192|95160|P2|STARTED|Main Phase I||80
39629|NCT01999192|95161|P1|STARTED|Main Phase I||83
39630|NCT01998919|95173|P2|NOT COMPLETED|Overall Study||35
39631|NCT01998919|95174|P1|NOT COMPLETED|Overall Study||42
39632|NCT01998919|95173|P2|COMPLETED|Overall Study||39
39633|NCT01998919|95174|P1|COMPLETED|Overall Study||37
39634|NCT01998919|95173|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
39635|NCT01998919|95174|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
39636|NCT01998919|95173|P2|STARTED|Overall Study||74
39637|NCT01998919|95174|P1|STARTED|Overall Study||79
39638|NCT01998906|95195|P3|NOT COMPLETED|Overall Study||98
39639|NCT01998906|95196|P2|NOT COMPLETED|Overall Study||114
39640|NCT01998906|95197|P1|NOT COMPLETED|Overall Study||114
39641|NCT01998906|95195|P3|COMPLETED|Overall Study||1
39642|NCT01998906|95196|P2|COMPLETED|Overall Study||2
39643|NCT01998906|95197|P1|COMPLETED|Overall Study||1
39644|NCT01998906|95195|P3|STARTED|Overall Study||99
39645|NCT01998906|95196|P2|STARTED|Overall Study||116
39646|NCT01998906|95197|P1|STARTED|Overall Study||115
39647|NCT01998893|95241|P1|NOT COMPLETED|Overall Study||17
39648|NCT01998893|95241|P1|COMPLETED|Overall Study||21
39649|NCT01998893|95241|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
39650|NCT01998893|95241|P1|2nd Treatment Cycle Started|Overall Study||5
39651|NCT01998893|95241|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
39652|NCT01998893|95241|P1|STARTED|Overall Study||38
39653|NCT01998880|95253|P2|NOT COMPLETED|Overall Study||40
39654|NCT01998880|95254|P1|NOT COMPLETED|Overall Study||29
39655|NCT01998880|95253|P2|COMPLETED|Overall Study||78
39656|NCT01998880|95254|P1|COMPLETED|Overall Study|Completed=Completed treatment.|204
39657|NCT01998880|95253|P2|Received Study Drug|Overall Study||116
39658|NCT01998880|95254|P1|Received Study Drug|Overall Study||230
39659|NCT01998880|95253|P2|STARTED|Overall Study||118
39660|NCT01998880|95254|P1|STARTED|Overall Study||233
39661|NCT01998737|95272|P2|NOT COMPLETED|Overall Study||0
39662|NCT01998737|95273|P1|NOT COMPLETED|Overall Study||23
39663|NCT01998737|95272|P2|COMPLETED|Overall Study||100
39664|NCT01998737|95273|P1|COMPLETED|Overall Study||888
39665|NCT01998737|95272|P2|STARTED|Overall Study||100
39666|NCT01998737|95273|P1|STARTED|Overall Study||911
39667|NCT01998581|95285|P2|NOT COMPLETED|Overall Study||12
39668|NCT01998581|95286|P1|NOT COMPLETED|Overall Study||46
39669|NCT01998581|95285|P2|COMPLETED|Overall Study||44
39670|NCT01998581|95286|P1|COMPLETED|Overall Study||123
39671|NCT01998581|95285|P2|STARTED|Overall Study||56
39672|NCT01998581|95286|P1|STARTED|Overall Study||169
39673|NCT01998477|95298|P2|NOT COMPLETED|Overall Study||5
39674|NCT01998477|95299|P1|NOT COMPLETED|Overall Study||10
39675|NCT01998477|95298|P2|COMPLETED|Overall Study||143
39676|NCT01998477|95299|P1|COMPLETED|Overall Study||272
39677|NCT01998477|95298|P2|STARTED|Overall Study||148
39678|NCT01998477|95299|P1|STARTED|Overall Study||282
39679|NCT01998438|95333|P3|NOT COMPLETED|Overall Study||0
39680|NCT01998438|95334|P2|NOT COMPLETED|Overall Study||0
39681|NCT01998438|95335|P1|NOT COMPLETED|Overall Study||0
39682|NCT01998438|95333|P3|COMPLETED|Overall Study||318
39683|NCT01998438|95334|P2|COMPLETED|Overall Study||318
39684|NCT01998438|95335|P1|COMPLETED|Overall Study||319
39685|NCT01998438|95333|P3|STARTED|Overall Study||318
39686|NCT01998438|95334|P2|STARTED|Overall Study||318
39687|NCT01998438|95335|P1|STARTED|Overall Study||319
39688|NCT01998399|95345|P2|NOT COMPLETED|Overall Study||9
39689|NCT01998399|95346|P1|NOT COMPLETED|Overall Study||8
39690|NCT01998399|95345|P2|COMPLETED|Overall Study||4
39691|NCT01998399|95346|P1|COMPLETED|Overall Study||4
39692|NCT01998399|95345|P2|STARTED|Overall Study||13
39693|NCT01998399|95346|P1|STARTED|Overall Study||12
39694|NCT01998360|95380|P2|NOT COMPLETED|Overall Study||0
39695|NCT01998360|95381|P1|NOT COMPLETED|Overall Study||0
39696|NCT01998360|95380|P2|COMPLETED|Overall Study||50
39697|NCT01998360|95381|P1|COMPLETED|Overall Study||50
39698|NCT01998360|95380|P2|STARTED|Overall Study||50
39699|NCT01998360|95381|P1|STARTED|Overall Study||50
39700|NCT01998269|95395|P1|NOT COMPLETED|Overall Study||0
39701|NCT01998269|95395|P1|COMPLETED|Overall Study||193
39702|NCT01998269|95395|P1|STARTED|Overall Study||193
39703|NCT01997905|95399|P1|NOT COMPLETED|Overall Study||3
39704|NCT01997905|95399|P1|COMPLETED|Overall Study||10
39705|NCT01997905|95399|P1|Baseline Completed|Overall Study||11
39706|NCT01997905|95399|P1|STARTED|Overall Study||13
39707|NCT01997892|95408|P1|NOT COMPLETED|Overall Study||68
39708|NCT01997892|95408|P1|COMPLETED|Overall Study||959
39709|NCT01997892|95408|P1|Received Darbepoetin Alfa|Overall Study||987
39710|NCT01997892|95408|P1|STARTED|Overall Study||1027
39711|NCT01997723|95420|P1|NOT COMPLETED|Overall Study||0
39712|NCT01997723|95420|P1|COMPLETED|Overall Study||75
39713|NCT01997723|95420|P1|STARTED|Overall Study||75
39714|NCT01997567|95428|P2|NOT COMPLETED|Overall Study||0
39715|NCT01997567|95429|P1|NOT COMPLETED|Overall Study||0
39716|NCT01997567|95428|P2|COMPLETED|Overall Study||0
39717|NCT01997567|95429|P1|COMPLETED|Overall Study||0
39718|NCT01997567|95428|P2|STARTED|Overall Study||0
39719|NCT01997567|95429|P1|STARTED|Overall Study||0
39720|NCT01997437|95435|P1|NOT COMPLETED|Overall Study||0
39721|NCT01997437|95435|P1|COMPLETED|Overall Study||6
39722|NCT01997437|95435|P1|STARTED|Overall Study||6
39723|NCT01997411|95447|P8|NOT COMPLETED|Overall Study||0
39724|NCT01997411|95448|P7|NOT COMPLETED|Overall Study||0
39725|NCT01997411|95449|P6|NOT COMPLETED|Overall Study||1
39726|NCT01997411|95450|P5|NOT COMPLETED|Overall Study||0
39727|NCT01997411|95451|P4|NOT COMPLETED|Overall Study||0
39728|NCT01997411|95452|P3|NOT COMPLETED|Overall Study||0
39729|NCT01997411|95453|P2|NOT COMPLETED|Overall Study||0
39730|NCT01997411|95454|P1|NOT COMPLETED|Overall Study||0
39731|NCT01997411|95447|P8|COMPLETED|Overall Study||6
39732|NCT01997411|95448|P7|COMPLETED|Overall Study||6
39733|NCT01997411|95449|P6|COMPLETED|Overall Study||5
39734|NCT01997411|95450|P5|COMPLETED|Overall Study||6
39735|NCT01997411|95451|P4|COMPLETED|Overall Study||6
39736|NCT01997411|95452|P3|COMPLETED|Overall Study||6
39737|NCT01997411|95453|P2|COMPLETED|Overall Study||6
39738|NCT01997411|95454|P1|COMPLETED|Overall Study||6
39739|NCT01997411|95447|P8|STARTED|Overall Study||6
39740|NCT01997411|95448|P7|STARTED|Overall Study||6
39741|NCT01997411|95449|P6|STARTED|Overall Study||6
39742|NCT01997411|95450|P5|STARTED|Overall Study||6
39743|NCT01997411|95451|P4|STARTED|Overall Study||6
39744|NCT01997411|95452|P3|STARTED|Overall Study||6
39745|NCT01997411|95453|P2|STARTED|Overall Study||6
39746|NCT01997411|95454|P1|STARTED|Overall Study||6
39747|NCT01997398|95544|P1|NOT COMPLETED|Overall Study||1
39748|NCT01997398|95544|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
39749|NCT01997398|95544|P1|STARTED|Overall Study||35
39750|NCT01997229|95555|P2|NOT COMPLETED|Overall Study||2
39751|NCT01997229|95556|P1|NOT COMPLETED|Overall Study||5
39752|NCT01997229|95555|P2|COMPLETED|Overall Study||61
39753|NCT01997229|95556|P1|COMPLETED|Overall Study||57
39754|NCT01997229|95555|P2|STARTED|Overall Study||63
39755|NCT01997229|95556|P1|STARTED|Overall Study||62
39756|NCT01997216|95562|P2|NOT COMPLETED|Second 9 Hours||0
39757|NCT01997216|95563|P1|NOT COMPLETED|Second 9 Hours||0
39758|NCT01997216|95562|P2|COMPLETED|Second 9 Hours||21
39759|NCT01997216|95563|P1|COMPLETED|Second 9 Hours||19
39760|NCT01997216|95562|P2|STARTED|Second 9 Hours||21
39761|NCT01997216|95563|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
39762|NCT01997216|95562|P2|NOT COMPLETED|First 9 Hours||0
39763|NCT01997216|95563|P1|NOT COMPLETED|First 9 Hours||0
39764|NCT01997216|95562|P2|COMPLETED|First 9 Hours||21
39765|NCT01997216|95563|P1|COMPLETED|First 9 Hours||18
39766|NCT01997216|95562|P2|STARTED|First 9 Hours||21
39767|NCT01997216|95563|P1|STARTED|First 9 Hours||18
39768|NCT01996904|95575|P2|NOT COMPLETED|Overall Study||27
39769|NCT01996904|95576|P1|NOT COMPLETED|Overall Study||38
39770|NCT01996904|95575|P2|COMPLETED|Overall Study||90
39771|NCT01996904|95576|P1|COMPLETED|Overall Study||101
39772|NCT01996904|95575|P2|STARTED|Overall Study||117
39773|NCT01996904|95576|P1|STARTED|Overall Study||139
39774|NCT01996813|95582|P1|NOT COMPLETED|Overall Study||0
39775|NCT01996813|95582|P1|COMPLETED|Overall Study||23
39776|NCT01996813|95582|P1|STARTED|Overall Study||23
39777|NCT01996748|95589|P2|NOT COMPLETED|Overall Study||6
39778|NCT01996748|95590|P1|NOT COMPLETED|Overall Study||8
39779|NCT01996748|95589|P2|COMPLETED|Overall Study||63
39780|NCT01996748|95590|P1|COMPLETED|Overall Study||58
39781|NCT01996748|95589|P2|STARTED|Overall Study||69
39782|NCT01996748|95590|P1|STARTED|Overall Study||66
39783|NCT01996709|95604|P2|NOT COMPLETED|Overall Study||1
39784|NCT01996709|95605|P1|NOT COMPLETED|Overall Study||5
39785|NCT01996709|95604|P2|COMPLETED|Overall Study||67
39786|NCT01996709|95605|P1|COMPLETED|Overall Study||61
39787|NCT01996709|95604|P2|STARTED|Overall Study||68
39788|NCT01996709|95605|P1|STARTED|Overall Study||66
39789|NCT01996657|95622|P3|NOT COMPLETED|Overall Study||14
39790|NCT01996657|95623|P2|NOT COMPLETED|Overall Study||11
39791|NCT01996657|95624|P1|NOT COMPLETED|Overall Study||13
39792|NCT01996657|95622|P3|COMPLETED|Overall Study||234
39793|NCT01996657|95623|P2|COMPLETED|Overall Study||239
39794|NCT01996657|95624|P1|COMPLETED|Overall Study||237
39795|NCT01996657|95622|P3|STARTED|Overall Study||248
39796|NCT01996657|95623|P2|STARTED|Overall Study||250
39797|NCT01996657|95624|P1|STARTED|Overall Study||250
39798|NCT01996644|95640|P2|NOT COMPLETED|Overall Study||0
39799|NCT01996644|95641|P1|NOT COMPLETED|Overall Study||0
39800|NCT01996644|95640|P2|COMPLETED|Overall Study||16
39801|NCT01996644|95641|P1|COMPLETED|Overall Study||20
39802|NCT01996644|95640|P2|STARTED|Overall Study||16
39803|NCT01996644|95641|P1|STARTED|Overall Study||20
39804|NCT01996410|95660|P8|NOT COMPLETED|Overall Study||0
39805|NCT01996410|95661|P7|NOT COMPLETED|Overall Study||0
39806|NCT01996410|95662|P6|NOT COMPLETED|Overall Study||0
39807|NCT01996410|95663|P5|NOT COMPLETED|Overall Study||0
39808|NCT01996410|95664|P4|NOT COMPLETED|Overall Study||0
39809|NCT01996410|95665|P3|NOT COMPLETED|Overall Study||0
39810|NCT01996410|95666|P2|NOT COMPLETED|Overall Study||0
39811|NCT01996410|95667|P1|NOT COMPLETED|Overall Study||0
39812|NCT01996410|95660|P8|COMPLETED|Overall Study||0
39813|NCT01996410|95661|P7|COMPLETED|Overall Study||0
39814|NCT01996410|95662|P6|COMPLETED|Overall Study||2
39815|NCT01996410|95663|P5|COMPLETED|Overall Study||2
39816|NCT01996410|95664|P4|COMPLETED|Overall Study||0
39817|NCT01996410|95665|P3|COMPLETED|Overall Study||0
39818|NCT01996410|95666|P2|COMPLETED|Overall Study||3
39819|NCT01996410|95667|P1|COMPLETED|Overall Study||3
39820|NCT01996410|95660|P8|STARTED|Overall Study||0
39821|NCT01996410|95661|P7|STARTED|Overall Study||0
39822|NCT01996410|95662|P6|STARTED|Overall Study||2
39823|NCT01996410|95663|P5|STARTED|Overall Study||2
39824|NCT01996410|95664|P4|STARTED|Overall Study||0
39825|NCT01996410|95665|P3|STARTED|Overall Study||0
39826|NCT01996410|95666|P2|STARTED|Overall Study||3
39827|NCT01996410|95667|P1|STARTED|Overall Study||3
39828|NCT01996332|95679|P1|NOT COMPLETED|Overall Study||1805
39829|NCT01996332|95679|P1|COMPLETED|Overall Study||0
39830|NCT01996332|95679|P1|STARTED|Overall Study||1805
39831|NCT01996319|95687|P2|NOT COMPLETED|Overall Study||3
39832|NCT01996319|95688|P1|NOT COMPLETED|Overall Study||8
39833|NCT01996319|95687|P2|COMPLETED|Overall Study||95
39834|NCT01996319|95688|P1|COMPLETED|Overall Study||88
39835|NCT01996319|95687|P2|STARTED|Overall Study||98
39836|NCT01996319|95688|P1|STARTED|Overall Study||96
39837|NCT01995513|95708|P3|NOT COMPLETED|Double Blind Treatment Period||125
39838|NCT01995513|95709|P2|NOT COMPLETED|Double Blind Treatment Period||126
39839|NCT01995513|95710|P1|NOT COMPLETED|Double Blind Treatment Period||0
39840|NCT01995513|95708|P3|COMPLETED|Double Blind Treatment Period||0
39841|NCT01995513|95709|P2|COMPLETED|Double Blind Treatment Period||0
39842|NCT01995513|95710|P1|COMPLETED|Double Blind Treatment Period||0
39843|NCT01995513|95708|P3|Treated|Double Blind Treatment Period||124
39844|NCT01995513|95709|P2|Treated|Double Blind Treatment Period||125
39845|NCT01995513|95710|P1|Treated|Double Blind Treatment Period||0
39846|NCT01995513|95708|P3|STARTED|Double Blind Treatment Period||125
39847|NCT01995513|95709|P2|STARTED|Double Blind Treatment Period||126
39848|NCT01995513|95710|P1|STARTED|Double Blind Treatment Period||0
39849|NCT01995513|95708|P3|NOT COMPLETED|Open Label Treatment Period||0
39850|NCT01995513|95709|P2|NOT COMPLETED|Open Label Treatment Period||0
39851|NCT01995513|95710|P1|NOT COMPLETED|Open Label Treatment Period||258
39852|NCT01995513|95708|P3|COMPLETED|Open Label Treatment Period||0
39853|NCT01995513|95709|P2|COMPLETED|Open Label Treatment Period||0
39854|NCT01995513|95710|P1|COMPLETED|Open Label Treatment Period||251
39855|NCT01995513|95708|P3|STARTED|Open Label Treatment Period||0
39856|NCT01995513|95709|P2|STARTED|Open Label Treatment Period||0
39857|NCT01995513|95710|P1|STARTED|Open Label Treatment Period||509
39858|NCT01995461|95753|P1|NOT COMPLETED|Overall Study||5
39859|NCT01995461|95753|P1|COMPLETED|Overall Study||21
39860|NCT01995461|95753|P1|STARTED|Overall Study||26
39861|NCT01995357|95759|P6|NOT COMPLETED|Period 5||0
39862|NCT01995357|95760|P5|NOT COMPLETED|Period 5||0
39863|NCT01995357|95761|P4|NOT COMPLETED|Period 5||0
39864|NCT01995357|95762|P3|NOT COMPLETED|Period 5||1
39865|NCT01995357|95763|P2|NOT COMPLETED|Period 5||0
39866|NCT01995357|95764|P1|NOT COMPLETED|Period 5||2
39867|NCT01995357|95759|P6|COMPLETED|Period 5||4
39868|NCT01995357|95760|P5|COMPLETED|Period 5||4
39869|NCT01995357|95761|P4|COMPLETED|Period 5||3
39870|NCT01995357|95762|P3|COMPLETED|Period 5||3
39871|NCT01995357|95763|P2|COMPLETED|Period 5||3
39872|NCT01995357|95764|P1|COMPLETED|Period 5||2
39873|NCT01995357|95759|P6|STARTED|Period 5||4
39874|NCT01995357|95760|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
39875|NCT01995357|95761|P4|STARTED|Period 5||3
39876|NCT01995357|95762|P3|STARTED|Period 5||4
39877|NCT01995357|95763|P2|STARTED|Period 5||3
39878|NCT01995357|95764|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
39879|NCT01995357|95759|P6|NOT COMPLETED|Period 4||0
39880|NCT01995357|95760|P5|NOT COMPLETED|Period 4||0
39881|NCT01995357|95761|P4|NOT COMPLETED|Period 4||0
39882|NCT01995357|95762|P3|NOT COMPLETED|Period 4||0
39883|NCT01995357|95763|P2|NOT COMPLETED|Period 4||0
39884|NCT01995357|95764|P1|NOT COMPLETED|Period 4||0
39885|NCT01995357|95759|P6|COMPLETED|Period 4||4
39886|NCT01995357|95760|P5|COMPLETED|Period 4||4
39887|NCT01995357|95761|P4|COMPLETED|Period 4||3
39888|NCT01995357|95762|P3|COMPLETED|Period 4||4
39889|NCT01995357|95763|P2|COMPLETED|Period 4||3
39890|NCT01995357|95764|P1|COMPLETED|Period 4||4
39891|NCT01995357|95759|P6|STARTED|Period 4||4
39892|NCT01995357|95760|P5|STARTED|Period 4||4
39893|NCT01995357|95761|P4|STARTED|Period 4||3
39894|NCT01995357|95762|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
39895|NCT01995357|95763|P2|STARTED|Period 4||3
39896|NCT01995357|95764|P1|STARTED|Period 4||4
39897|NCT01995357|95759|P6|NOT COMPLETED|Period 3||0
39898|NCT01995357|95760|P5|NOT COMPLETED|Period 3||0
39899|NCT01995357|95761|P4|NOT COMPLETED|Period 3||0
39900|NCT01995357|95762|P3|NOT COMPLETED|Period 3||0
39901|NCT01995357|95763|P2|NOT COMPLETED|Period 3||0
39902|NCT01995357|95764|P1|NOT COMPLETED|Period 3||0
39903|NCT01995357|95759|P6|COMPLETED|Period 3||4
39904|NCT01995357|95760|P5|COMPLETED|Period 3||4
39905|NCT01995357|95761|P4|COMPLETED|Period 3||3
39906|NCT01995357|95762|P3|COMPLETED|Period 3||4
39907|NCT01995357|95763|P2|COMPLETED|Period 3||3
39908|NCT01995357|95764|P1|COMPLETED|Period 3||4
39909|NCT01995357|95759|P6|STARTED|Period 3||4
39910|NCT01995357|95760|P5|STARTED|Period 3||4
39911|NCT01995357|95761|P4|STARTED|Period 3||3
39912|NCT01995357|95762|P3|STARTED|Period 3||4
39913|NCT01995357|95763|P2|STARTED|Period 3||3
39914|NCT01995357|95764|P1|STARTED|Period 3||4
39915|NCT01995357|95759|P6|NOT COMPLETED|Period 2||0
39916|NCT01995357|95760|P5|NOT COMPLETED|Period 2||0
39917|NCT01995357|95761|P4|NOT COMPLETED|Period 2||0
39918|NCT01995357|95762|P3|NOT COMPLETED|Period 2||0
39919|NCT01995357|95763|P2|NOT COMPLETED|Period 2||0
39920|NCT01995357|95764|P1|NOT COMPLETED|Period 2||0
39921|NCT01995357|95759|P6|COMPLETED|Period 2||4
39922|NCT01995357|95760|P5|COMPLETED|Period 2||4
39923|NCT01995357|95761|P4|COMPLETED|Period 2||3
39924|NCT01995357|95762|P3|COMPLETED|Period 2||4
39925|NCT01995357|95763|P2|COMPLETED|Period 2||3
39926|NCT01995357|95764|P1|COMPLETED|Period 2||4
39927|NCT01995357|95759|P6|STARTED|Period 2||4
39928|NCT01995357|95760|P5|STARTED|Period 2||4
39929|NCT01995357|95761|P4|STARTED|Period 2||3
39930|NCT01995357|95762|P3|STARTED|Period 2||4
39931|NCT01995357|95763|P2|STARTED|Period 2||3
39932|NCT01995357|95764|P1|STARTED|Period 2||4
39933|NCT01995357|95759|P6|NOT COMPLETED|Period 1||0
39934|NCT01995357|95760|P5|NOT COMPLETED|Period 1||0
39935|NCT01995357|95761|P4|NOT COMPLETED|Period 1||0
39936|NCT01995357|95762|P3|NOT COMPLETED|Period 1||0
39937|NCT01995357|95763|P2|NOT COMPLETED|Period 1||0
39938|NCT01995357|95764|P1|NOT COMPLETED|Period 1||0
39939|NCT01995357|95759|P6|COMPLETED|Period 1||4
39940|NCT01995357|95760|P5|COMPLETED|Period 1||4
39941|NCT01995357|95761|P4|COMPLETED|Period 1||3
39942|NCT01995357|95762|P3|COMPLETED|Period 1||4
39943|NCT01995357|95763|P2|COMPLETED|Period 1||3
39944|NCT01995357|95764|P1|COMPLETED|Period 1||4
39945|NCT01995357|95759|P6|STARTED|Period 1||4
39946|NCT01995357|95760|P5|STARTED|Period 1||4
39947|NCT01995357|95761|P4|STARTED|Period 1||3
39948|NCT01995357|95762|P3|STARTED|Period 1||4
39949|NCT01995357|95763|P2|STARTED|Period 1||3
39950|NCT01995357|95764|P1|STARTED|Period 1||4
39951|NCT01995201|95782|P7|NOT COMPLETED|From Week 24 Until Week 48||2
39952|NCT01995201|95783|P6|NOT COMPLETED|From Week 24 Until Week 48||8
39953|NCT01995201|95784|P5|NOT COMPLETED|From Week 24 Until Week 48||6
39954|NCT01995201|95785|P4|NOT COMPLETED|From Week 24 Until Week 48||1
39955|NCT01995201|95786|P3|NOT COMPLETED|From Week 24 Until Week 48||5
39956|NCT01995201|95787|P2|NOT COMPLETED|From Week 24 Until Week 48||0
39957|NCT01995201|95788|P1|NOT COMPLETED|From Week 24 Until Week 48||0
39958|NCT01995201|95782|P7|COMPLETED|From Week 24 Until Week 48||0
39959|NCT01995201|95783|P6|COMPLETED|From Week 24 Until Week 48||59
39960|NCT01995201|95784|P5|COMPLETED|From Week 24 Until Week 48||89
39961|NCT01995201|95785|P4|COMPLETED|From Week 24 Until Week 48||89
39962|NCT01995201|95786|P3|COMPLETED|From Week 24 Until Week 48||84
39963|NCT01995201|95787|P2|COMPLETED|From Week 24 Until Week 48||0
39964|NCT01995201|95788|P1|COMPLETED|From Week 24 Until Week 48||0
39965|NCT01995201|95782|P7|STARTED|From Week 24 Until Week 48||2
39966|NCT01995201|95783|P6|STARTED|From Week 24 Until Week 48||67
39967|NCT01995201|95784|P5|STARTED|From Week 24 Until Week 48||95
39968|NCT01995201|95785|P4|STARTED|From Week 24 Until Week 48||90
39969|NCT01995201|95786|P3|STARTED|From Week 24 Until Week 48||89
39970|NCT01995201|95787|P2|STARTED|From Week 24 Until Week 48||0
39971|NCT01995201|95788|P1|STARTED|From Week 24 Until Week 48||0
39972|NCT01995201|95782|P7|NOT COMPLETED|From Baseline Until Week 24||0
39973|NCT01995201|95783|P6|NOT COMPLETED|From Baseline Until Week 24||0
39974|NCT01995201|95784|P5|NOT COMPLETED|From Baseline Until Week 24||0
39975|NCT01995201|95785|P4|NOT COMPLETED|From Baseline Until Week 24||0
39976|NCT01995201|95786|P3|NOT COMPLETED|From Baseline Until Week 24||0
39977|NCT01995201|95787|P2|NOT COMPLETED|From Baseline Until Week 24||46
39978|NCT01995201|95788|P1|NOT COMPLETED|From Baseline Until Week 24||10
39979|NCT01995201|95782|P7|COMPLETED|From Baseline Until Week 24||0
39980|NCT01995201|95783|P6|COMPLETED|From Baseline Until Week 24||0
39981|NCT01995201|95784|P5|COMPLETED|From Baseline Until Week 24||0
39982|NCT01995201|95785|P4|COMPLETED|From Baseline Until Week 24||0
39983|NCT01995201|95786|P3|COMPLETED|From Baseline Until Week 24||0
39984|NCT01995201|95787|P2|COMPLETED|From Baseline Until Week 24||281
39985|NCT01995201|95788|P1|COMPLETED|From Baseline Until Week 24||64
39986|NCT01995201|95782|P7|STARTED|From Baseline Until Week 24||0
39987|NCT01995201|95783|P6|STARTED|From Baseline Until Week 24||0
39988|NCT01995201|95784|P5|STARTED|From Baseline Until Week 24||0
39989|NCT01995201|95785|P4|STARTED|From Baseline Until Week 24||0
39990|NCT01995201|95786|P3|STARTED|From Baseline Until Week 24||0
39991|NCT01995201|95787|P2|STARTED|From Baseline Until Week 24||327
39992|NCT01995201|95788|P1|STARTED|From Baseline Until Week 24||74
39993|NCT01995136|95897|P1|NOT COMPLETED|Overall Study||1
39994|NCT01995136|95897|P1|COMPLETED|Overall Study||31
39995|NCT01995136|95897|P1|STARTED|Overall Study||32
39996|NCT01995071|95913|P12|NOT COMPLETED|Overall Study||0
39997|NCT01995071|95914|P11|NOT COMPLETED|Overall Study||1
39998|NCT01995071|95915|P10|NOT COMPLETED|Overall Study||0
39999|NCT01995071|95916|P9|NOT COMPLETED|Overall Study||1
40000|NCT01995071|95917|P8|NOT COMPLETED|Overall Study||2
40001|NCT01995071|95918|P7|NOT COMPLETED|Overall Study||1
40002|NCT01995071|95919|P6|NOT COMPLETED|Overall Study||0
40003|NCT01995071|95920|P5|NOT COMPLETED|Overall Study||1
40004|NCT01995071|95921|P4|NOT COMPLETED|Overall Study||0
40005|NCT01995071|95922|P3|NOT COMPLETED|Overall Study||1
40006|NCT01995071|95923|P2|NOT COMPLETED|Overall Study||0
40007|NCT01995071|95924|P1|NOT COMPLETED|Overall Study||1
40008|NCT01995071|95913|P12|COMPLETED|Overall Study||0
40009|NCT01995071|95914|P11|COMPLETED|Overall Study||7
40010|NCT01995071|95915|P10|COMPLETED|Overall Study||8
40011|NCT01995071|95916|P9|COMPLETED|Overall Study||7
40012|NCT01995071|95917|P8|COMPLETED|Overall Study||6
40013|NCT01995071|95918|P7|COMPLETED|Overall Study||7
40014|NCT01995071|95919|P6|COMPLETED|Overall Study||8
40015|NCT01995071|95920|P5|COMPLETED|Overall Study||7
40016|NCT01995071|95921|P4|COMPLETED|Overall Study||8
40017|NCT01995071|95922|P3|COMPLETED|Overall Study||8
40018|NCT01995071|95923|P2|COMPLETED|Overall Study||8
40019|NCT01995071|95924|P1|COMPLETED|Overall Study||7
40020|NCT01995071|95913|P12|STARTED|Overall Study||0
40021|NCT01995071|95914|P11|STARTED|Overall Study||8
40022|NCT01995071|95915|P10|STARTED|Overall Study||8
40023|NCT01995071|95916|P9|STARTED|Overall Study||8
40024|NCT01995071|95917|P8|STARTED|Overall Study||8
40025|NCT01995071|95918|P7|STARTED|Overall Study||8
40026|NCT01995071|95919|P6|STARTED|Overall Study||8
40027|NCT01995071|95920|P5|STARTED|Overall Study||8
40028|NCT01995071|95921|P4|STARTED|Overall Study||8
40029|NCT01995071|95922|P3|STARTED|Overall Study||9
40030|NCT01995071|95923|P2|STARTED|Overall Study||8
40031|NCT01995071|95924|P1|STARTED|Overall Study||8
40032|NCT01995045|95985|P2|NOT COMPLETED|Overall Study||0
40033|NCT01995045|95986|P1|NOT COMPLETED|Overall Study||0
40034|NCT01995045|95985|P2|COMPLETED|Overall Study||28
40035|NCT01995045|95986|P1|COMPLETED|Overall Study||29
40036|NCT01995045|95985|P2|STARTED|Overall Study||28
40037|NCT01995045|95986|P1|STARTED|Overall Study||29
40038|NCT01994993|96003|P5|NOT COMPLETED|Overall Study||2
40039|NCT01994993|96004|P4|NOT COMPLETED|Overall Study||46
40040|NCT01994993|96005|P3|NOT COMPLETED|Overall Study||47
40041|NCT01994993|96006|P2|NOT COMPLETED|Overall Study||35
40042|NCT01994993|96007|P1|NOT COMPLETED|Overall Study||35
40043|NCT01994993|96003|P5|COMPLETED|Overall Study||22
40044|NCT01994993|96004|P4|COMPLETED|Overall Study||9
40045|NCT01994993|96005|P3|COMPLETED|Overall Study||23
40046|NCT01994993|96006|P2|COMPLETED|Overall Study||12
40047|NCT01994993|96007|P1|COMPLETED|Overall Study||28
40048|NCT01994993|96003|P5|STARTED|Overall Study||24
40049|NCT01994993|96004|P4|STARTED|Overall Study||55
40050|NCT01994993|96005|P3|STARTED|Overall Study||70
40051|NCT01994993|96006|P2|STARTED|Overall Study||47
40052|NCT01994993|96007|P1|STARTED|Overall Study||63
40053|NCT01994902|96059|P2|NOT COMPLETED|Test Period 2||6
40054|NCT01994902|96060|P1|NOT COMPLETED|Test Period 2||0
40055|NCT01994902|96059|P2|COMPLETED|Test Period 2||55
40056|NCT01994902|96060|P1|COMPLETED|Test Period 2||57
40057|NCT01994902|96059|P2|STARTED|Test Period 2||61
40058|NCT01994902|96060|P1|STARTED|Test Period 2||57
40059|NCT01994902|96059|P2|NOT COMPLETED|Test Period 1||3
40060|NCT01994902|96060|P1|NOT COMPLETED|Test Period 1||6
40061|NCT01994902|96059|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
40062|NCT01994902|96060|P1|COMPLETED|Test Period 1||57
40063|NCT01994902|96059|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
40064|NCT01994902|96060|P1|STARTED|Test Period 1||63
40065|NCT01994876|96066|P2|NOT COMPLETED|Test Period 2||1
40066|NCT01994876|96067|P1|NOT COMPLETED|Test Period 2||1
40067|NCT01994876|96066|P2|COMPLETED|Test Period 2||6
40068|NCT01994876|96067|P1|COMPLETED|Test Period 2||8
40069|NCT01994876|96066|P2|STARTED|Test Period 2||7
40070|NCT01994876|96067|P1|STARTED|Test Period 2||9
40071|NCT01994876|96066|P2|NOT COMPLETED|Test Period 1||2
40072|NCT01994876|96067|P1|NOT COMPLETED|Test Period 1||0
40073|NCT01994876|96066|P2|COMPLETED|Test Period 1||7
40074|NCT01994876|96067|P1|COMPLETED|Test Period 1||9
40075|NCT01994876|96066|P2|STARTED|Test Period 1||9
40076|NCT01994876|96067|P1|STARTED|Test Period 1||9
40077|NCT01994876|96066|P2|NOT COMPLETED|Baseline - Own Product||0
40078|NCT01994876|96067|P1|NOT COMPLETED|Baseline - Own Product||0
40079|NCT01994876|96066|P2|COMPLETED|Baseline - Own Product||9
40080|NCT01994876|96067|P1|COMPLETED|Baseline - Own Product||9
40081|NCT01994876|96066|P2|STARTED|Baseline - Own Product||9
40082|NCT01994876|96067|P1|STARTED|Baseline - Own Product||9
40083|NCT01994863|96075|P2|NOT COMPLETED|Period 2||4
40084|NCT01994863|96076|P1|NOT COMPLETED|Period 2||1
40085|NCT01994863|96075|P2|COMPLETED|Period 2||5
40086|NCT01994863|96076|P1|COMPLETED|Period 2||7
40087|NCT01994863|96075|P2|STARTED|Period 2||9
40088|NCT01994863|96076|P1|STARTED|Period 2||8
40089|NCT01994863|96075|P2|NOT COMPLETED|Period 1||3
40090|NCT01994863|96076|P1|NOT COMPLETED|Period 1||7
40091|NCT01994863|96075|P2|COMPLETED|Period 1||9
40092|NCT01994863|96076|P1|COMPLETED|Period 1||4
40093|NCT01994863|96075|P2|STARTED|Period 1||12
40094|NCT01994863|96076|P1|STARTED|Period 1||11
40095|NCT01994837|96082|P1|NOT COMPLETED|Overall Study||32
40096|NCT01994837|96082|P1|COMPLETED|Overall Study||0
40097|NCT01994837|96082|P1|Treated|Overall Study||32
40098|NCT01994837|96082|P1|STARTED|Overall Study||32
40099|NCT01994785|96099|P4|NOT COMPLETED|Overall Study||3
40100|NCT01994785|96100|P3|NOT COMPLETED|Overall Study||0
40101|NCT01994785|96101|P2|NOT COMPLETED|Overall Study||1
40102|NCT01994785|96102|P1|NOT COMPLETED|Overall Study||8
40103|NCT01994785|96099|P4|COMPLETED|Overall Study||114
40104|NCT01994785|96100|P3|COMPLETED|Overall Study||117
40105|NCT01994785|96101|P2|COMPLETED|Overall Study||108
40106|NCT01994785|96102|P1|COMPLETED|Overall Study||101
40107|NCT01994785|96099|P4|STARTED|Overall Study||117
40108|NCT01994785|96100|P3|STARTED|Overall Study||117
40109|NCT01994785|96101|P2|STARTED|Overall Study||109
40110|NCT01994785|96102|P1|STARTED|Overall Study||109
40111|NCT01994746|96112|P2|NOT COMPLETED|Second Visit||0
40112|NCT01994746|96113|P1|NOT COMPLETED|Second Visit||0
40113|NCT01994746|96112|P2|COMPLETED|Second Visit||38
40114|NCT01994746|96113|P1|COMPLETED|Second Visit|Safety population|38
40115|NCT01994746|96112|P2|Efficacy|Second Visit||38
40116|NCT01994746|96113|P1|Efficacy|Second Visit|Those who completed both visits were included in the efficacy population.|37
40117|NCT01994746|96112|P2|STARTED|Second Visit||38
40118|NCT01994746|96113|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
40119|NCT01994746|96112|P2|NOT COMPLETED|First Visit||0
40120|NCT01994746|96113|P1|NOT COMPLETED|First Visit||0
40121|NCT01994746|96112|P2|COMPLETED|First Visit||38
40122|NCT01994746|96113|P1|COMPLETED|First Visit|Safety population|39
40123|NCT01994746|96112|P2|Efficacy|First Visit||38
40124|NCT01994746|96113|P1|Efficacy|First Visit|Those who completed both visits were included in the efficacy population.|37
40125|NCT01994746|96112|P2|STARTED|First Visit||38
40126|NCT01994746|96113|P1|STARTED|First Visit||39
40127|NCT01994720|96121|P2|NOT COMPLETED|Overall Study||56
40128|NCT01994720|96122|P1|NOT COMPLETED|Overall Study||46
40129|NCT01994720|96121|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
40130|NCT01994720|96122|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
40131|NCT01994720|96121|P2|STARTED|Overall Study||6610
40132|NCT01994720|96122|P1|STARTED|Overall Study||6589
40133|NCT01994629|96164|P2|NOT COMPLETED|Overall Study||3
40134|NCT01994629|96165|P1|NOT COMPLETED|Overall Study||1
40135|NCT01994629|96164|P2|COMPLETED|Overall Study||99
40136|NCT01994629|96165|P1|COMPLETED|Overall Study||99
40137|NCT01994629|96164|P2|STARTED|Overall Study||102
40138|NCT01994629|96165|P1|STARTED|Overall Study||100
40139|NCT01994486|96189|P1|NOT COMPLETED|Overall Study||0
40140|NCT01994486|96189|P1|COMPLETED|Overall Study||20
40141|NCT01994486|96189|P1|STARTED|Overall Study||20
40142|NCT01994395|96200|P2|NOT COMPLETED|Overall Study||2
40143|NCT01994395|96201|P1|NOT COMPLETED|Overall Study||1
40144|NCT01994395|96200|P2|COMPLETED|Overall Study||25
40145|NCT01994395|96201|P1|COMPLETED|Overall Study||25
40146|NCT01994395|96200|P2|STARTED|Overall Study||27
40147|NCT01994395|96201|P1|STARTED|Overall Study||26
40148|NCT01994291|96226|P3|NOT COMPLETED|Overall Study||9
40149|NCT01994291|96227|P2|NOT COMPLETED|Overall Study||7
40150|NCT01994291|96228|P1|NOT COMPLETED|Overall Study||15
40151|NCT01994291|96226|P3|COMPLETED|Overall Study||47
40152|NCT01994291|96227|P2|COMPLETED|Overall Study||36
40153|NCT01994291|96228|P1|COMPLETED|Overall Study||84
40154|NCT01994291|96226|P3|Received Treatment|Overall Study||56
40155|NCT01994291|96227|P2|Received Treatment|Overall Study||43
40156|NCT01994291|96228|P1|Received Treatment|Overall Study||99
40157|NCT01994291|96226|P3|STARTED|Overall Study||56
40158|NCT01994291|96227|P2|STARTED|Overall Study||43
40159|NCT01994291|96228|P1|STARTED|Overall Study||99
40160|NCT01994226|96284|P2|NOT COMPLETED|Overall Study||21
40161|NCT01994226|96285|P1|NOT COMPLETED|Overall Study||19
40162|NCT01994226|96284|P2|COMPLETED|Overall Study||179
40163|NCT01994226|96285|P1|COMPLETED|Overall Study||180
40164|NCT01994226|96284|P2|STARTED|Overall Study||200
40165|NCT01994226|96285|P1|STARTED|Overall Study||199
40166|NCT01993940|96293|P2|NOT COMPLETED|Overall Study||44
40167|NCT01993940|96294|P1|NOT COMPLETED|Overall Study||40
40168|NCT01993940|96293|P2|COMPLETED|Overall Study||232
40169|NCT01993940|96294|P1|COMPLETED|Overall Study||237
40170|NCT01993940|96293|P2|Received Treatment|Overall Study||276
40171|NCT01993940|96294|P1|Received Treatment|Overall Study||272
40172|NCT01993940|96293|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
40173|NCT01993940|96294|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
40174|NCT01993888|96310|P2|NOT COMPLETED|Overall Study||3
40175|NCT01993888|96311|P1|NOT COMPLETED|Overall Study||2
40176|NCT01993888|96310|P2|COMPLETED|Overall Study||49
40177|NCT01993888|96311|P1|COMPLETED|Overall Study||48
40178|NCT01993888|96310|P2|STARTED|Overall Study||52
40179|NCT01993888|96311|P1|STARTED|Overall Study||50
40180|NCT01993823|96329|P2|NOT COMPLETED|Overall Study||16
40181|NCT01993823|96330|P1|NOT COMPLETED|Overall Study||7
40182|NCT01993823|96329|P2|COMPLETED|Overall Study||79
40183|NCT01993823|96330|P1|COMPLETED|Overall Study||88
40184|NCT01993823|96329|P2|STARTED|Overall Study||95
40185|NCT01993823|96330|P1|STARTED|Overall Study||95
40186|NCT01993238|96338|P1|NOT COMPLETED|Overall Study||0
40187|NCT01993238|96338|P1|COMPLETED|Overall Study||11
40188|NCT01993238|96338|P1|STARTED|Overall Study||11
40189|NCT01993030|96345|P2|NOT COMPLETED|Overall Study||4
40190|NCT01993030|96346|P1|NOT COMPLETED|Overall Study||0
40191|NCT01993030|96345|P2|COMPLETED|Overall Study||31
40192|NCT01993030|96346|P1|COMPLETED|Overall Study||36
40193|NCT01993030|96345|P2|STARTED|Overall Study||35
40194|NCT01993030|96346|P1|STARTED|Overall Study||36
40195|NCT01992874|96360|P3|NOT COMPLETED|Part B||0
40196|NCT01992874|96361|P2|NOT COMPLETED|Part B||0
40197|NCT01992874|96362|P1|NOT COMPLETED|Part B||0
40198|NCT01992874|96360|P3|COMPLETED|Part B||38
40199|NCT01992874|96361|P2|COMPLETED|Part B||0
40200|NCT01992874|96362|P1|COMPLETED|Part B||0
40201|NCT01992874|96360|P3|STARTED|Part B||38
40202|NCT01992874|96361|P2|STARTED|Part B||0
40203|NCT01992874|96362|P1|STARTED|Part B||0
40204|NCT01992874|96360|P3|NOT COMPLETED|Part A||0
40205|NCT01992874|96361|P2|NOT COMPLETED|Part A||0
40206|NCT01992874|96362|P1|NOT COMPLETED|Part A||0
40207|NCT01992874|96360|P3|COMPLETED|Part A||0
40208|NCT01992874|96361|P2|COMPLETED|Part A||17
40209|NCT01992874|96362|P1|COMPLETED|Part A||21
40210|NCT01992874|96360|P3|STARTED|Part A||0
40211|NCT01992874|96361|P2|STARTED|Part A||17
40212|NCT01992874|96362|P1|STARTED|Part A||21
40213|NCT01992536|96400|P10|NOT COMPLETED|Overall Study||1
40214|NCT01992536|96401|P9|NOT COMPLETED|Overall Study||1
40215|NCT01992536|96402|P8|NOT COMPLETED|Overall Study||0
40216|NCT01992536|96403|P7|NOT COMPLETED|Overall Study||7
40217|NCT01992536|96404|P6|NOT COMPLETED|Overall Study||1
40218|NCT01992536|96405|P5|NOT COMPLETED|Overall Study||0
40219|NCT01992536|96406|P4|NOT COMPLETED|Overall Study||2
40220|NCT01992536|96407|P3|NOT COMPLETED|Overall Study||1
40221|NCT01992536|96408|P2|NOT COMPLETED|Overall Study||3
40222|NCT01992536|96409|P1|NOT COMPLETED|Overall Study||4
40223|NCT01992536|96400|P10|COMPLETED|Overall Study||18
40224|NCT01992536|96401|P9|COMPLETED|Overall Study||18
40225|NCT01992536|96402|P8|COMPLETED|Overall Study||21
40226|NCT01992536|96403|P7|COMPLETED|Overall Study||0
40227|NCT01992536|96404|P6|COMPLETED|Overall Study||20
40228|NCT01992536|96405|P5|COMPLETED|Overall Study||11
40229|NCT01992536|96406|P4|COMPLETED|Overall Study||22
40230|NCT01992536|96407|P3|COMPLETED|Overall Study||16
40231|NCT01992536|96408|P2|COMPLETED|Overall Study||22
40232|NCT01992536|96409|P1|COMPLETED|Overall Study||22
40233|NCT01992536|96400|P10|STARTED|Overall Study||19
40234|NCT01992536|96401|P9|STARTED|Overall Study||19
40235|NCT01992536|96402|P8|STARTED|Overall Study||21
40236|NCT01992536|96403|P7|STARTED|Overall Study||7
40237|NCT01992536|96404|P6|STARTED|Overall Study||21
40238|NCT01992536|96405|P5|STARTED|Overall Study||11
40239|NCT01992536|96406|P4|STARTED|Overall Study||24
40240|NCT01992536|96407|P3|STARTED|Overall Study||17
40241|NCT01992536|96408|P2|STARTED|Overall Study||25
40242|NCT01992536|96409|P1|STARTED|Overall Study||26
40243|NCT01992523|96626|P2|NOT COMPLETED|Overall Study||0
40244|NCT01992523|96627|P1|NOT COMPLETED|Overall Study||0
40245|NCT01992523|96626|P2|COMPLETED|Overall Study||41
40246|NCT01992523|96627|P1|COMPLETED|Overall Study||41
40247|NCT01992523|96626|P2|STARTED|Overall Study||41
40248|NCT01992523|96627|P1|STARTED|Overall Study||41
40249|NCT01992185|96641|P2|NOT COMPLETED|Overall Study||0
40250|NCT01992185|96642|P1|NOT COMPLETED|Overall Study||0
40251|NCT01992185|96641|P2|COMPLETED|Overall Study||8
40252|NCT01992185|96642|P1|COMPLETED|Overall Study||7
40253|NCT01992185|96641|P2|STARTED|Overall Study||8
40254|NCT01992185|96642|P1|STARTED|Overall Study||7
40255|NCT01992172|96650|P2|NOT COMPLETED|Overall Study||0
40256|NCT01992172|96651|P1|NOT COMPLETED|Overall Study||0
40257|NCT01992172|96650|P2|COMPLETED|Overall Study||0
40258|NCT01992172|96651|P1|COMPLETED|Overall Study||7
40259|NCT01992172|96650|P2|STARTED|Overall Study||0
40260|NCT01992172|96651|P1|STARTED|Overall Study||7
40261|NCT01992107|96660|P3|NOT COMPLETED|Overall Study||36
40262|NCT01992107|96661|P2|NOT COMPLETED|Overall Study||33
40263|NCT01992107|96662|P1|NOT COMPLETED|Overall Study||68
40264|NCT01992107|96660|P3|COMPLETED|Overall Study||545
40265|NCT01992107|96661|P2|COMPLETED|Overall Study||560
40266|NCT01992107|96662|P1|COMPLETED|Overall Study||1091
40267|NCT01992107|96660|P3|STARTED|Overall Study||581
40268|NCT01992107|96661|P2|STARTED|Overall Study||593
40269|NCT01992107|96662|P1|STARTED|Overall Study||1159
40270|NCT01992094|96718|P3|NOT COMPLETED|Overall Study||21
40271|NCT01992094|96719|P2|NOT COMPLETED|Overall Study||24
40272|NCT01992094|96720|P1|NOT COMPLETED|Overall Study||50
40273|NCT01992094|96718|P3|COMPLETED|Overall Study||648
40274|NCT01992094|96719|P2|COMPLETED|Overall Study||652
40275|NCT01992094|96720|P1|COMPLETED|Overall Study||1285
40276|NCT01992094|96718|P3|STARTED|Overall Study||669
40277|NCT01992094|96719|P2|STARTED|Overall Study||676
40278|NCT01992094|96720|P1|STARTED|Overall Study||1335
40279|NCT01991990|96778|P2|NOT COMPLETED|Overall Study||0
40280|NCT01991990|96779|P1|NOT COMPLETED|Overall Study||0
40281|NCT01991990|96778|P2|COMPLETED|Overall Study||12
40282|NCT01991990|96779|P1|COMPLETED|Overall Study||6
40283|NCT01991990|96778|P2|STARTED|Overall Study||12
40284|NCT01991990|96779|P1|STARTED|Overall Study||6
40285|NCT01991548|96819|P1|NOT COMPLETED|Overall Study||1
40286|NCT01991548|96819|P1|COMPLETED|Overall Study||39
40287|NCT01991548|96819|P1|STARTED|Overall Study||40
40288|NCT01991314|96825|P2|NOT COMPLETED|Overall Study||11
40289|NCT01991314|96826|P1|NOT COMPLETED|Overall Study||11
40290|NCT01991314|96825|P2|COMPLETED|Overall Study||32
40291|NCT01991314|96826|P1|COMPLETED|Overall Study||34
40292|NCT01991314|96825|P2|STARTED|Overall Study||43
40293|NCT01991314|96826|P1|STARTED|Overall Study||45
40294|NCT01990898|96844|P1|NOT COMPLETED|Overall Study||4
40295|NCT01990898|96844|P1|COMPLETED|Overall Study||22
40296|NCT01990898|96844|P1|3 Months|Overall Study||22
40297|NCT01990898|96844|P1|STARTED|Overall Study||26
40298|NCT01990859|96848|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
40299|NCT01990859|96848|P1|COMPLETED|90 Day Follow Up for All Participants||20
40300|NCT01990859|96848|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
40301|NCT01990859|96848|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
40302|NCT01990859|96848|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
40303|NCT01990859|96848|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
40304|NCT01990859|96848|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
40305|NCT01990859|96848|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
40306|NCT01990859|96848|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
40307|NCT01990794|96859|P1|NOT COMPLETED|Overall Study||3
40308|NCT01990794|96859|P1|COMPLETED|Overall Study||10
40309|NCT01990794|96859|P1|One Month Into Study|Overall Study||10
40310|NCT01990794|96859|P1|STARTED|Overall Study||13
40311|NCT01990703|96973|P2|NOT COMPLETED|Overall Study||45
40312|NCT01990703|96974|P1|NOT COMPLETED|Overall Study||39
40313|NCT01990703|96973|P2|COMPLETED|Overall Study||93
40314|NCT01990703|96974|P1|COMPLETED|Overall Study||108
40315|NCT01990703|96973|P2|STARTED|Overall Study||138
40316|NCT01990703|96974|P1|STARTED|Overall Study||147
40317|NCT01990677|96984|P2|NOT COMPLETED|Overall Study||1
40318|NCT01990677|96985|P1|NOT COMPLETED|Overall Study||2
40319|NCT01990677|96984|P2|COMPLETED|Overall Study||5
40320|NCT01990677|96985|P1|COMPLETED|Overall Study||10
40321|NCT01990677|96984|P2|STARTED|Overall Study||6
40322|NCT01990677|96985|P1|STARTED|Overall Study||12
40323|NCT01990664|96997|P2|NOT COMPLETED|Overall Study||11
40324|NCT01990664|96998|P1|NOT COMPLETED|Overall Study||7
40325|NCT01990664|96997|P2|COMPLETED|Overall Study||79
40326|NCT01990664|96998|P1|COMPLETED|Overall Study||95
40327|NCT01990664|96997|P2|STARTED|Overall Study||90
40328|NCT01990664|96998|P1|STARTED|Overall Study||102
40329|NCT01990560|97004|P1|NOT COMPLETED|Overall Study||1
40330|NCT01990560|97004|P1|COMPLETED|Overall Study||7
40331|NCT01990560|97004|P1|STARTED|Overall Study||8
40332|NCT01990534|97018|P1|NOT COMPLETED|Overall Study||60
40333|NCT01990534|97018|P1|COMPLETED|Overall Study||0
40334|NCT01990534|97018|P1|Ongoing|Overall Study||36
40335|NCT01990534|97018|P1|STARTED|Overall Study||60
40336|NCT01990339|97034|P1|NOT COMPLETED|Overall Study||2312
40337|NCT01990339|97034|P1|COMPLETED|Overall Study||12653
40338|NCT01990339|97034|P1|STARTED|Overall Study||14965
40339|NCT01990313|97039|P1|NOT COMPLETED|Overall Study||1
40340|NCT01990313|97039|P1|COMPLETED|Overall Study||14
40341|NCT01990313|97039|P1|STARTED|Overall Study||15
40342|NCT01990261|97044|P1|NOT COMPLETED|Overall Study||25
40343|NCT01990261|97044|P1|COMPLETED|Overall Study||8
40344|NCT01990261|97044|P1|Treated|Overall Study||29
40345|NCT01990261|97044|P1|STARTED|Overall Study||33
40346|NCT01989689|97056|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
40347|NCT01989689|97057|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
40348|NCT01989689|97056|P2|COMPLETED|Treatment Period ( 3 Months)||10
40349|NCT01989689|97057|P1|COMPLETED|Treatment Period ( 3 Months)||11
40350|NCT01989689|97056|P2|STARTED|Treatment Period ( 3 Months)||10
40351|NCT01989689|97057|P1|STARTED|Treatment Period ( 3 Months)||11
40352|NCT01989689|97056|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
40353|NCT01989689|97057|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
40354|NCT01989689|97056|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
40355|NCT01989689|97057|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
40356|NCT01989689|97056|P2|STARTED|Treatment Period 1 ( 3 Months)||13
40357|NCT01989689|97057|P1|STARTED|Treatment Period 1 ( 3 Months)||11
40358|NCT01989689|97056|P2|NOT COMPLETED|Baseline||0
40359|NCT01989689|97057|P1|NOT COMPLETED|Baseline||0
40360|NCT01989689|97056|P2|COMPLETED|Baseline||13
40361|NCT01989689|97057|P1|COMPLETED|Baseline||11
40362|NCT01989689|97056|P2|STARTED|Baseline||13
40363|NCT01989689|97057|P1|STARTED|Baseline||11
40364|NCT01989676|97069|P2|NOT COMPLETED|Overall Study||347
40365|NCT01989676|97070|P1|NOT COMPLETED|Overall Study||338
40366|NCT01989676|97069|P2|COMPLETED|Overall Study||6
40367|NCT01989676|97070|P1|COMPLETED|Overall Study||11
40368|NCT01989676|97069|P2|STARTED|Overall Study|Treated (355 randomized)|353
40369|NCT01989676|97070|P1|STARTED|Overall Study|Treated (352 randomized)|349
40370|NCT01989572|97096|P6|NOT COMPLETED|Overall Study||110
40371|NCT01989572|97097|P5|NOT COMPLETED|Overall Study||98
40372|NCT01989572|97098|P4|NOT COMPLETED|Overall Study||51
40373|NCT01989572|97099|P3|NOT COMPLETED|Overall Study||62
40374|NCT01989572|97100|P2|NOT COMPLETED|Overall Study||58
40375|NCT01989572|97101|P1|NOT COMPLETED|Overall Study||55
40376|NCT01989572|97096|P6|COMPLETED|Overall Study||79
40377|NCT01989572|97097|P5|COMPLETED|Overall Study||92
40378|NCT01989572|97098|P4|COMPLETED|Overall Study||56
40379|NCT01989572|97099|P3|COMPLETED|Overall Study||47
40380|NCT01989572|97100|P2|COMPLETED|Overall Study||53
40381|NCT01989572|97101|P1|COMPLETED|Overall Study||54
40382|NCT01989572|97096|P6|Treated|Overall Study||171
40383|NCT01989572|97097|P5|Treated|Overall Study||186
40384|NCT01989572|97098|P4|Treated|Overall Study||104
40385|NCT01989572|97099|P3|Treated|Overall Study||107
40386|NCT01989572|97100|P2|Treated|Overall Study||110
40387|NCT01989572|97101|P1|Treated|Overall Study||104
40388|NCT01989572|97096|P6|STARTED|Overall Study||189
40389|NCT01989572|97097|P5|STARTED|Overall Study||190
40390|NCT01989572|97098|P4|STARTED|Overall Study||107
40391|NCT01989572|97099|P3|STARTED|Overall Study||109
40392|NCT01989572|97100|P2|STARTED|Overall Study||111
40393|NCT01989572|97101|P1|STARTED|Overall Study||109
40394|NCT01989455|97134|P5|NOT COMPLETED|Overall Study||1
40395|NCT01989455|97135|P4|NOT COMPLETED|Overall Study||0
40396|NCT01989455|97136|P3|NOT COMPLETED|Overall Study||1
40397|NCT01989455|97137|P2|NOT COMPLETED|Overall Study||2
40398|NCT01989455|97138|P1|NOT COMPLETED|Overall Study||0
40399|NCT01989455|97134|P5|COMPLETED|Overall Study||7
40400|NCT01989455|97135|P4|COMPLETED|Overall Study||14
40401|NCT01989455|97136|P3|COMPLETED|Overall Study||13
40402|NCT01989455|97137|P2|COMPLETED|Overall Study||12
40403|NCT01989455|97138|P1|COMPLETED|Overall Study||14
40404|NCT01989455|97134|P5|STARTED|Overall Study||8
40405|NCT01989455|97135|P4|STARTED|Overall Study||14
40406|NCT01989455|97136|P3|STARTED|Overall Study||14
40407|NCT01989455|97137|P2|STARTED|Overall Study||14
40408|NCT01989455|97138|P1|STARTED|Overall Study||14
40409|NCT01989195|97172|P1|NOT COMPLETED|Overall Study||0
40410|NCT01989195|97172|P1|COMPLETED|Overall Study||6
40411|NCT01989195|97172|P1|STARTED|Overall Study||6
40412|NCT01989169|97182|P2|NOT COMPLETED|Period 2||1
40413|NCT01989169|97183|P1|NOT COMPLETED|Period 2||0
40414|NCT01989169|97182|P2|COMPLETED|Period 2||14
40415|NCT01989169|97183|P1|COMPLETED|Period 2||15
40416|NCT01989169|97182|P2|STARTED|Period 2||15
40417|NCT01989169|97183|P1|STARTED|Period 2||15
40418|NCT01989169|97182|P2|NOT COMPLETED|Period 1||0
40419|NCT01989169|97183|P1|NOT COMPLETED|Period 1||0
40420|NCT01989169|97182|P2|COMPLETED|Period 1||15
40421|NCT01989169|97183|P1|COMPLETED|Period 1||15
40422|NCT01989169|97182|P2|STARTED|Period 1||15
40423|NCT01989169|97183|P1|STARTED|Period 1||15
40424|NCT01989156|97196|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
40425|NCT01989156|97197|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
40426|NCT01989156|97198|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
40427|NCT01989156|97196|P3|COMPLETED|End of Study (Population at Day 90)||31
40428|NCT01989156|97197|P2|COMPLETED|End of Study (Population at Day 90)||35
40429|NCT01989156|97198|P1|COMPLETED|End of Study (Population at Day 90)||73
40430|NCT01989156|97196|P3|STARTED|End of Study (Population at Day 90)||34
40431|NCT01989156|97197|P2|STARTED|End of Study (Population at Day 90)||40
40432|NCT01989156|97198|P1|STARTED|End of Study (Population at Day 90)||80
40433|NCT01989156|97196|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
40434|NCT01989156|97197|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
40435|NCT01989156|97198|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
40436|NCT01989156|97196|P3|COMPLETED|Confinement Period (Population at Day 5)||34
40437|NCT01989156|97197|P2|COMPLETED|Confinement Period (Population at Day 5)||40
40438|NCT01989156|97198|P1|COMPLETED|Confinement Period (Population at Day 5)||80
40439|NCT01989156|97196|P3|STARTED|Confinement Period (Population at Day 5)||39
40440|NCT01989156|97197|P2|STARTED|Confinement Period (Population at Day 5)||41
40441|NCT01989156|97198|P1|STARTED|Confinement Period (Population at Day 5)||80
40442|NCT01989130|97220|P2|NOT COMPLETED|Overall Study||0
40443|NCT01989130|97221|P1|NOT COMPLETED|Overall Study||0
40444|NCT01989130|97220|P2|COMPLETED|Overall Study||27
40445|NCT01989130|97221|P1|COMPLETED|Overall Study||43
40446|NCT01989130|97220|P2|STARTED|Overall Study||27
40447|NCT01989130|97221|P1|STARTED|Overall Study||43
40448|NCT01988922|97236|P3|NOT COMPLETED|Overall Study||0
40449|NCT01988922|97237|P2|NOT COMPLETED|Overall Study||0
40450|NCT01988922|97238|P1|NOT COMPLETED|Overall Study||0
40451|NCT01988922|97236|P3|COMPLETED|Overall Study||10
40452|NCT01988922|97237|P2|COMPLETED|Overall Study||10
40453|NCT01988922|97238|P1|COMPLETED|Overall Study||10
40454|NCT01988922|97236|P3|STARTED|Overall Study||10
40455|NCT01988922|97237|P2|STARTED|Overall Study||10
40456|NCT01988922|97238|P1|STARTED|Overall Study||10
40457|NCT01988857|97249|P1|NOT COMPLETED|Overall Study||0
40458|NCT01988857|97249|P1|COMPLETED|Overall Study||300
40459|NCT01988857|97249|P1|STARTED|Overall Study||300
40460|NCT01988662|97258|P2|NOT COMPLETED|Overall Study||2
40461|NCT01988662|97259|P1|NOT COMPLETED|Overall Study||4
40462|NCT01988662|97258|P2|COMPLETED|Overall Study||99
40463|NCT01988662|97259|P1|COMPLETED|Overall Study||100
40464|NCT01988662|97258|P2|STARTED|Overall Study||101
40465|NCT01988662|97259|P1|STARTED|Overall Study||104
40466|NCT01988415|97276|P1|NOT COMPLETED|Overall Study||0
40467|NCT01988415|97276|P1|COMPLETED|Overall Study||26
40468|NCT01988415|97276|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
40469|NCT01988402|97286|P2|NOT COMPLETED|Overall Study||2
40470|NCT01988402|97287|P1|NOT COMPLETED|Overall Study||2
40471|NCT01988402|97286|P2|COMPLETED|Overall Study||17
40472|NCT01988402|97287|P1|COMPLETED|Overall Study||14
40473|NCT01988402|97286|P2|STARTED|Overall Study||19
40474|NCT01988402|97287|P1|STARTED|Overall Study||16
40475|NCT01988129|97301|P2|NOT COMPLETED|Overall Study||0
40476|NCT01988129|97302|P1|NOT COMPLETED|Overall Study||0
40477|NCT01988129|97301|P2|COMPLETED|Overall Study||588
40478|NCT01988129|97302|P1|COMPLETED|Overall Study||601
40479|NCT01988129|97301|P2|Completed 1-year Follow-up Survey|Overall Study||4
40480|NCT01988129|97302|P1|Completed 1-year Follow-up Survey|Overall Study||100
40481|NCT01988129|97301|P2|Screened for Sleep Disorders|Overall Study||15
40482|NCT01988129|97302|P1|Screened for Sleep Disorders|Overall Study||416
40483|NCT01988129|97301|P2|Attended Education Session|Overall Study||18
40484|NCT01988129|97302|P1|Attended Education Session|Overall Study||542
40485|NCT01988129|97301|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
40486|NCT01988129|97302|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
40487|NCT01988012|97329|P1|NOT COMPLETED|Overall Study||15
40488|NCT01988012|97329|P1|COMPLETED|Overall Study||85
40489|NCT01988012|97329|P1|STARTED|Overall Study||100
40490|NCT01987986|97355|P4|NOT COMPLETED|Overall Study||0
40491|NCT01987986|97356|P3|NOT COMPLETED|Overall Study||2
40492|NCT01987986|97357|P2|NOT COMPLETED|Overall Study||0
40493|NCT01987986|97358|P1|NOT COMPLETED|Overall Study||2
40494|NCT01987986|97355|P4|COMPLETED|Overall Study||24
40495|NCT01987986|97356|P3|COMPLETED|Overall Study||38
40496|NCT01987986|97357|P2|COMPLETED|Overall Study||43
40497|NCT01987986|97358|P1|COMPLETED|Overall Study||41
40498|NCT01987986|97355|P4|STARTED|Overall Study||24
40499|NCT01987986|97356|P3|STARTED|Overall Study||40
40500|NCT01987986|97357|P2|STARTED|Overall Study||43
40501|NCT01987986|97358|P1|STARTED|Overall Study||43
40502|NCT01987960|97398|P4|NOT COMPLETED|Period 3||71
40503|NCT01987960|97399|P3|NOT COMPLETED|Period 3||0
40504|NCT01987960|97400|P2|NOT COMPLETED|Period 3||0
40505|NCT01987960|97401|P1|NOT COMPLETED|Period 3||0
40506|NCT01987960|97398|P4|COMPLETED|Period 3||119
40507|NCT01987960|97399|P3|COMPLETED|Period 3||0
40508|NCT01987960|97400|P2|COMPLETED|Period 3||0
40509|NCT01987960|97401|P1|COMPLETED|Period 3||0
40510|NCT01987960|97398|P4|STARTED|Period 3||190
40511|NCT01987960|97399|P3|STARTED|Period 3||0
40512|NCT01987960|97400|P2|STARTED|Period 3||0
40513|NCT01987960|97401|P1|STARTED|Period 3||0
40514|NCT01987960|97398|P4|NOT COMPLETED|Period 2||0
40515|NCT01987960|97399|P3|NOT COMPLETED|Period 2||9
40516|NCT01987960|97400|P2|NOT COMPLETED|Period 2||5
40517|NCT01987960|97401|P1|NOT COMPLETED|Period 2||0
40518|NCT01987960|97398|P4|COMPLETED|Period 2||0
40519|NCT01987960|97399|P3|COMPLETED|Period 2||14
40520|NCT01987960|97400|P2|COMPLETED|Period 2||12
40521|NCT01987960|97401|P1|COMPLETED|Period 2||0
40522|NCT01987960|97398|P4|STARTED|Period 2||0
40523|NCT01987960|97399|P3|STARTED|Period 2||23
40524|NCT01987960|97400|P2|STARTED|Period 2||17
40525|NCT01987960|97401|P1|STARTED|Period 2||0
40526|NCT01987960|97398|P4|NOT COMPLETED|Period 1||0
40527|NCT01987960|97399|P3|NOT COMPLETED|Period 1||0
40528|NCT01987960|97400|P2|NOT COMPLETED|Period 1||0
40529|NCT01987960|97401|P1|NOT COMPLETED|Period 1||186
40530|NCT01987960|97398|P4|COMPLETED|Period 1||0
40531|NCT01987960|97399|P3|COMPLETED|Period 1||0
40532|NCT01987960|97400|P2|COMPLETED|Period 1||0
40533|NCT01987960|97401|P1|COMPLETED|Period 1||231
40534|NCT01987960|97398|P4|STARTED|Period 1||0
40535|NCT01987960|97399|P3|STARTED|Period 1||0
40536|NCT01987960|97400|P2|STARTED|Period 1||0
40537|NCT01987960|97401|P1|STARTED|Period 1||417
40538|NCT01987908|97413|P3|NOT COMPLETED|Post-Treatment Observation Period||0
40539|NCT01987908|97414|P2|NOT COMPLETED|Post-Treatment Observation Period||3
40540|NCT01987908|97415|P1|NOT COMPLETED|Post-Treatment Observation Period||0
40541|NCT01987908|97413|P3|COMPLETED|Post-Treatment Observation Period||2
40542|NCT01987908|97414|P2|COMPLETED|Post-Treatment Observation Period||7
40543|NCT01987908|97415|P1|COMPLETED|Post-Treatment Observation Period||0
40544|NCT01987908|97413|P3|STARTED|Post-Treatment Observation Period||2
40545|NCT01987908|97414|P2|STARTED|Post-Treatment Observation Period||10
40546|NCT01987908|97415|P1|STARTED|Post-Treatment Observation Period||0
40547|NCT01987908|97413|P3|NOT COMPLETED|Treatment Period||1
40548|NCT01987908|97414|P2|NOT COMPLETED|Treatment Period||1
40549|NCT01987908|97415|P1|NOT COMPLETED|Treatment Period||0
40550|NCT01987908|97413|P3|COMPLETED|Treatment Period||2
40551|NCT01987908|97414|P2|COMPLETED|Treatment Period||10
40552|NCT01987908|97415|P1|COMPLETED|Treatment Period||0
40553|NCT01987908|97413|P3|STARTED|Treatment Period||3
40554|NCT01987908|97414|P2|STARTED|Treatment Period||11
40555|NCT01987908|97415|P1|STARTED|Treatment Period||0
40556|NCT01987908|97413|P3|NOT COMPLETED|Placebo Lead-in Period||0
40557|NCT01987908|97414|P2|NOT COMPLETED|Placebo Lead-in Period||0
40558|NCT01987908|97415|P1|NOT COMPLETED|Placebo Lead-in Period||9
40559|NCT01987908|97413|P3|COMPLETED|Placebo Lead-in Period||0
40560|NCT01987908|97414|P2|COMPLETED|Placebo Lead-in Period||0
40561|NCT01987908|97415|P1|COMPLETED|Placebo Lead-in Period||14
40562|NCT01987908|97413|P3|STARTED|Placebo Lead-in Period||0
40563|NCT01987908|97414|P2|STARTED|Placebo Lead-in Period||0
40564|NCT01987908|97415|P1|STARTED|Placebo Lead-in Period||23
40565|NCT01987895|97498|P2|NOT COMPLETED|Overall Study||30
40566|NCT01987895|97499|P1|NOT COMPLETED|Overall Study||30
40567|NCT01987895|97498|P2|COMPLETED|Overall Study||296
40568|NCT01987895|97499|P1|COMPLETED|Overall Study||276
40569|NCT01987895|97498|P2|STARTED|Overall Study||326
40570|NCT01987895|97499|P1|STARTED|Overall Study||306
40571|NCT01987765|97523|P1|NOT COMPLETED|Overall Study||102
40572|NCT01987765|97523|P1|COMPLETED|Overall Study||745
40573|NCT01987765|97523|P1|STARTED|Overall Study||847
40574|NCT01987752|97528|P1|NOT COMPLETED|Overall Study||0
40575|NCT01987752|97528|P1|COMPLETED|Overall Study||732
40576|NCT01987752|97528|P1|STARTED|Overall Study||732
40577|NCT01987583|97535|P2|NOT COMPLETED|Overall Study||2
40578|NCT01987583|97536|P1|NOT COMPLETED|Overall Study||3
40579|NCT01987583|97535|P2|COMPLETED|Overall Study||38
40580|NCT01987583|97536|P1|COMPLETED|Overall Study||37
40581|NCT01987583|97535|P2|STARTED|Overall Study||40
40582|NCT01987583|97536|P1|STARTED|Overall Study||40
40583|NCT01987557|97547|P3|NOT COMPLETED|Overall Study||3
40584|NCT01987557|97548|P2|NOT COMPLETED|Overall Study||3
40585|NCT01987557|97549|P1|NOT COMPLETED|Overall Study||3
40586|NCT01987557|97547|P3|COMPLETED|Overall Study||13
40587|NCT01987557|97548|P2|COMPLETED|Overall Study||13
40588|NCT01987557|97549|P1|COMPLETED|Overall Study||13
40589|NCT01987557|97547|P3|STARTED|Overall Study||16
40590|NCT01987557|97548|P2|STARTED|Overall Study||16
40591|NCT01987557|97549|P1|STARTED|Overall Study||16
40592|NCT01987479|97557|P1|NOT COMPLETED|Overall Study||17
40593|NCT01987479|97557|P1|COMPLETED|Overall Study||133
40594|NCT01987479|97557|P1|STARTED|Overall Study||150
40595|NCT01987453|97585|P3|NOT COMPLETED|Overall Study||1
40596|NCT01987453|97586|P2|NOT COMPLETED|Overall Study||12
40597|NCT01987453|97587|P1|NOT COMPLETED|Overall Study||1
40598|NCT01987453|97585|P3|COMPLETED|Overall Study||7
40599|NCT01987453|97586|P2|COMPLETED|Overall Study||29
40600|NCT01987453|97587|P1|COMPLETED|Overall Study||50
40601|NCT01987453|97585|P3|STARTED|Overall Study||8
40602|NCT01987453|97586|P2|STARTED|Overall Study||41
40603|NCT01987453|97587|P1|STARTED|Overall Study||51
40604|NCT01987349|97618|P8|NOT COMPLETED|Overall Study||1
40605|NCT01987349|97619|P7|NOT COMPLETED|Overall Study||0
40606|NCT01987349|97620|P6|NOT COMPLETED|Overall Study||0
40607|NCT01987349|97621|P5|NOT COMPLETED|Overall Study||0
40608|NCT01987349|97622|P4|NOT COMPLETED|Overall Study||0
40609|NCT01987349|97623|P3|NOT COMPLETED|Overall Study||0
40610|NCT01987349|97624|P2|NOT COMPLETED|Overall Study||0
40611|NCT01987349|97625|P1|NOT COMPLETED|Overall Study||0
40612|NCT01987349|97618|P8|COMPLETED|Overall Study||24
40613|NCT01987349|97619|P7|COMPLETED|Overall Study||10
40614|NCT01987349|97620|P6|COMPLETED|Overall Study||6
40615|NCT01987349|97621|P5|COMPLETED|Overall Study||6
40616|NCT01987349|97622|P4|COMPLETED|Overall Study||6
40617|NCT01987349|97623|P3|COMPLETED|Overall Study||8
40618|NCT01987349|97624|P2|COMPLETED|Overall Study||6
40619|NCT01987349|97625|P1|COMPLETED|Overall Study||6
40620|NCT01987349|97618|P8|STARTED|Overall Study||25
40621|NCT01987349|97619|P7|STARTED|Overall Study||10
40622|NCT01987349|97620|P6|STARTED|Overall Study||6
40623|NCT01987349|97621|P5|STARTED|Overall Study||6
40624|NCT01987349|97622|P4|STARTED|Overall Study||6
40625|NCT01987349|97623|P3|STARTED|Overall Study||8
40626|NCT01987349|97624|P2|STARTED|Overall Study||6
40627|NCT01987349|97625|P1|STARTED|Overall Study||6
40628|NCT01987232|97656|P5|NOT COMPLETED|Overall Study||0
40629|NCT01987232|97657|P4|NOT COMPLETED|Overall Study||1
40630|NCT01987232|97658|P3|NOT COMPLETED|Overall Study||0
40631|NCT01987232|97659|P2|NOT COMPLETED|Overall Study||0
40632|NCT01987232|97660|P1|NOT COMPLETED|Overall Study||0
40633|NCT01987232|97656|P5|COMPLETED|Overall Study||6
40634|NCT01987232|97657|P4|COMPLETED|Overall Study||14
40635|NCT01987232|97658|P3|COMPLETED|Overall Study||3
40636|NCT01987232|97659|P2|COMPLETED|Overall Study||3
40637|NCT01987232|97660|P1|COMPLETED|Overall Study||5
40638|NCT01987232|97656|P5|STARTED|Overall Study||6
40639|NCT01987232|97657|P4|STARTED|Overall Study||15
40640|NCT01987232|97658|P3|STARTED|Overall Study||3
40641|NCT01987232|97659|P2|STARTED|Overall Study||3
40642|NCT01987232|97660|P1|STARTED|Overall Study||5
40643|NCT01987219|97725|P6|NOT COMPLETED|Overall Study||0
40644|NCT01987219|97726|P5|NOT COMPLETED|Overall Study||0
40645|NCT01987219|97727|P4|NOT COMPLETED|Overall Study||0
40646|NCT01987219|97728|P3|NOT COMPLETED|Overall Study||1
40647|NCT01987219|97729|P2|NOT COMPLETED|Overall Study||0
40648|NCT01987219|97730|P1|NOT COMPLETED|Overall Study||0
40649|NCT01987219|97725|P6|COMPLETED|Overall Study||1
40650|NCT01987219|97726|P5|COMPLETED|Overall Study||1
40651|NCT01987219|97727|P4|COMPLETED|Overall Study||2
40652|NCT01987219|97728|P3|COMPLETED|Overall Study||6
40653|NCT01987219|97729|P2|COMPLETED|Overall Study||2
40654|NCT01987219|97730|P1|COMPLETED|Overall Study||2
40655|NCT01987219|97725|P6|STARTED|Overall Study||1
40656|NCT01987219|97726|P5|STARTED|Overall Study||1
40657|NCT01987219|97727|P4|STARTED|Overall Study||2
40658|NCT01987219|97728|P3|STARTED|Overall Study||7
40659|NCT01987219|97729|P2|STARTED|Overall Study||2
40660|NCT01987219|97730|P1|STARTED|Overall Study||2
40661|NCT01986985|97747|P1|NOT COMPLETED|Overall Study||7
40662|NCT01986985|97747|P1|COMPLETED|Overall Study||51
40663|NCT01986985|97747|P1|STARTED|Overall Study||58
40664|NCT01986946|97753|P2|NOT COMPLETED|Overall Study||0
40665|NCT01986946|97754|P1|NOT COMPLETED|Overall Study||0
40666|NCT01986946|97753|P2|COMPLETED|Overall Study||9
40667|NCT01986946|97754|P1|COMPLETED|Overall Study||5
40668|NCT01986946|97753|P2|STARTED|Overall Study||9
40669|NCT01986946|97754|P1|STARTED|Overall Study||5
40670|NCT01986855|97787|P3|NOT COMPLETED|Overall Study||11
40671|NCT01986855|97788|P2|NOT COMPLETED|Overall Study||14
40672|NCT01986855|97789|P1|NOT COMPLETED|Overall Study||13
40673|NCT01986855|97787|P3|COMPLETED|Overall Study||143
40674|NCT01986855|97788|P2|COMPLETED|Overall Study||142
40675|NCT01986855|97789|P1|COMPLETED|Overall Study||145
40676|NCT01986855|97787|P3|Treated|Overall Study||154
40677|NCT01986855|97788|P2|Treated|Overall Study||155
40678|NCT01986855|97789|P1|Treated|Overall Study||158
40679|NCT01986855|97787|P3|STARTED|Overall Study||154
40680|NCT01986855|97788|P2|STARTED|Overall Study||156
40681|NCT01986855|97789|P1|STARTED|Overall Study||158
40682|NCT01986790|97821|P3|NOT COMPLETED|Overall Study||0
40683|NCT01986790|97822|P2|NOT COMPLETED|Overall Study||0
40684|NCT01986790|97823|P1|NOT COMPLETED|Overall Study||0
40685|NCT01986790|97821|P3|COMPLETED|Overall Study||98
40686|NCT01986790|97822|P2|COMPLETED|Overall Study||154
40687|NCT01986790|97823|P1|COMPLETED|Overall Study||91
40688|NCT01986790|97821|P3|STARTED|Overall Study||98
40689|NCT01986790|97822|P2|STARTED|Overall Study||154
40690|NCT01986790|97823|P1|STARTED|Overall Study||91
40691|NCT01986751|97839|P2|NOT COMPLETED|Overall Study||2
40692|NCT01986751|97840|P1|NOT COMPLETED|Overall Study||10
40693|NCT01986751|97839|P2|COMPLETED|Overall Study||2
40694|NCT01986751|97840|P1|COMPLETED|Overall Study||0
40695|NCT01986751|97839|P2|STARTED|Overall Study||4
40696|NCT01986751|97840|P1|STARTED|Overall Study||10
40697|NCT01986686|97862|P2|NOT COMPLETED|Overall Study||0
40698|NCT01986686|97863|P1|NOT COMPLETED|Overall Study||0
40699|NCT01986686|97862|P2|COMPLETED|Overall Study||26
40700|NCT01986686|97863|P1|COMPLETED|Overall Study||81
40701|NCT01986686|97862|P2|STARTED|Overall Study||26
40702|NCT01986686|97863|P1|STARTED|Overall Study||81
40703|NCT01986361|97871|P2|NOT COMPLETED|Overall Study||0
40704|NCT01986361|97872|P1|NOT COMPLETED|Overall Study||0
40705|NCT01986361|97871|P2|COMPLETED|Overall Study||21
40706|NCT01986361|97872|P1|COMPLETED|Overall Study||101
40707|NCT01986361|97871|P2|STARTED|Overall Study||21
40708|NCT01986361|97872|P1|STARTED|Overall Study||101
40709|NCT01986231|97894|P1|NOT COMPLETED|Overall Study||1
40710|NCT01986231|97894|P1|COMPLETED|Overall Study||11
40711|NCT01986231|97894|P1|STARTED|Overall Study||12
40712|NCT01986062|97901|P2|NOT COMPLETED|Overall Study||1
40713|NCT01986062|97902|P1|NOT COMPLETED|Overall Study||1
40714|NCT01986062|97901|P2|COMPLETED|Overall Study||49
40715|NCT01986062|97902|P1|COMPLETED|Overall Study||46
40716|NCT01986062|97901|P2|STARTED|Overall Study||50
40717|NCT01986062|97902|P1|STARTED|Overall Study||47
40718|NCT01985685|97920|P2|NOT COMPLETED|Overall Study||0
40719|NCT01985685|97921|P1|NOT COMPLETED|Overall Study||0
40720|NCT01985685|97920|P2|COMPLETED|Overall Study||29
40721|NCT01985685|97921|P1|COMPLETED|Overall Study||27
40722|NCT01985685|97920|P2|STARTED|Overall Study||29
40723|NCT01985685|97921|P1|STARTED|Overall Study||27
40724|NCT01985581|97933|P2|NOT COMPLETED|Second Intervention||4
40725|NCT01985581|97934|P1|NOT COMPLETED|Second Intervention||2
40726|NCT01985581|97933|P2|COMPLETED|Second Intervention||19
40727|NCT01985581|97934|P1|COMPLETED|Second Intervention||20
40728|NCT01985581|97933|P2|STARTED|Second Intervention||23
40729|NCT01985581|97934|P1|STARTED|Second Intervention||22
40730|NCT01985581|97933|P2|NOT COMPLETED|First Intervention||2
40731|NCT01985581|97934|P1|NOT COMPLETED|First Intervention||3
40732|NCT01985581|97933|P2|COMPLETED|First Intervention||23
40733|NCT01985581|97934|P1|COMPLETED|First Intervention||22
40734|NCT01985581|97933|P2|STARTED|First Intervention||25
40735|NCT01985581|97934|P1|STARTED|First Intervention||25
40736|NCT01985425|97954|P2|NOT COMPLETED|Overall Study||0
40737|NCT01985425|97955|P1|NOT COMPLETED|Overall Study||0
40738|NCT01985425|97954|P2|COMPLETED|Overall Study||51
40739|NCT01985425|97955|P1|COMPLETED|Overall Study||49
40740|NCT01985425|97954|P2|STARTED|Overall Study||51
40741|NCT01985425|97955|P1|STARTED|Overall Study||49
40742|NCT01985321|97975|P2|NOT COMPLETED|Overall Study||5
40743|NCT01985321|97976|P1|NOT COMPLETED|Overall Study||11
40744|NCT01985321|97975|P2|COMPLETED|Overall Study||78
40745|NCT01985321|97976|P1|COMPLETED|Overall Study||79
40746|NCT01985321|97975|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
40747|NCT01985321|97976|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
40748|NCT01985126|97986|P2|NOT COMPLETED|Overall Study||106
40749|NCT01985126|97987|P1|NOT COMPLETED|Overall Study||18
40750|NCT01985126|97986|P2|COMPLETED|Overall Study||0
40751|NCT01985126|97987|P1|COMPLETED|Overall Study||0
40752|NCT01985126|97986|P2|STARTED|Overall Study||106
40753|NCT01985126|97987|P1|STARTED|Overall Study||18
40754|NCT01984892|98005|P1|NOT COMPLETED|Overall Study||7
40755|NCT01984892|98005|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
40756|NCT01984892|98005|P1|STARTED|Overall Study||8
40757|NCT01984697|98016|P5|NOT COMPLETED|Overall Study||314
40758|NCT01984697|98017|P4|NOT COMPLETED|Overall Study||301
40759|NCT01984697|98018|P3|NOT COMPLETED|Overall Study||301
40760|NCT01984697|98019|P2|NOT COMPLETED|Overall Study||301
40761|NCT01984697|98020|P1|NOT COMPLETED|Overall Study||301
40762|NCT01984697|98016|P5|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
40763|NCT01984697|98017|P4|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
40764|NCT01984697|98018|P3|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
40765|NCT01984697|98019|P2|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
40766|NCT01984697|98020|P1|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
40767|NCT01984697|98016|P5|Vaccination 3|Overall Study||311
40768|NCT01984697|98017|P4|Vaccination 3|Overall Study||293
40769|NCT01984697|98018|P3|Vaccination 3|Overall Study||0
40770|NCT01984697|98019|P2|Vaccination 3|Overall Study||0
40771|NCT01984697|98020|P1|Vaccination 3|Overall Study||0
40772|NCT01984697|98016|P5|Vaccination 2|Overall Study||313
40773|NCT01984697|98017|P4|Vaccination 2|Overall Study||298
40774|NCT01984697|98018|P3|Vaccination 2|Overall Study||291
40775|NCT01984697|98019|P2|Vaccination 2|Overall Study||296
40776|NCT01984697|98020|P1|Vaccination 2|Overall Study||293
40777|NCT01984697|98016|P5|Vaccination 1|Overall Study||314
40778|NCT01984697|98017|P4|Vaccination 1|Overall Study||300
40779|NCT01984697|98018|P3|Vaccination 1|Overall Study||300
40780|NCT01984697|98019|P2|Vaccination 1|Overall Study||301
40781|NCT01984697|98020|P1|Vaccination 1|Overall Study||301
40782|NCT01984697|98016|P5|STARTED|Overall Study||314
40783|NCT01984697|98017|P4|STARTED|Overall Study||301
40784|NCT01984697|98018|P3|STARTED|Overall Study||301
40785|NCT01984697|98019|P2|STARTED|Overall Study||301
40786|NCT01984697|98020|P1|STARTED|Overall Study||301
40787|NCT01984684|98119|P2|NOT COMPLETED|Overall Study||59
40788|NCT01984684|98120|P1|NOT COMPLETED|Overall Study||57
40789|NCT01984684|98119|P2|COMPLETED|Overall Study||368
40790|NCT01984684|98120|P1|COMPLETED|Overall Study||366
40791|NCT01984684|98119|P2|STARTED|Overall Study||427
40792|NCT01984684|98120|P1|STARTED|Overall Study||423
40793|NCT01984515|98130|P1|NOT COMPLETED|Overall Study||19
40794|NCT01984515|98130|P1|COMPLETED|Overall Study||40
40795|NCT01984515|98130|P1|Received CBT Session|Overall Study||40
40796|NCT01984515|98130|P1|STARTED|Overall Study||59
40797|NCT01984424|98138|P2|NOT COMPLETED|Overall Study||7
40798|NCT01984424|98139|P1|NOT COMPLETED|Overall Study||3
40799|NCT01984424|98138|P2|COMPLETED|Overall Study||138
40800|NCT01984424|98139|P1|COMPLETED|Overall Study||70
40801|NCT01984424|98138|P2|STARTED|Overall Study||145
40802|NCT01984424|98139|P1|STARTED|Overall Study||73
40803|NCT01984294|98194|P3|NOT COMPLETED|Overall Study||7
40804|NCT01984294|98195|P2|NOT COMPLETED|Overall Study||3
40805|NCT01984294|98196|P1|NOT COMPLETED|Overall Study||4
40806|NCT01984294|98194|P3|COMPLETED|Overall Study||27
40807|NCT01984294|98195|P2|COMPLETED|Overall Study||29
40808|NCT01984294|98196|P1|COMPLETED|Overall Study||31
40809|NCT01984294|98194|P3|STARTED|Overall Study||34
40810|NCT01984294|98195|P2|STARTED|Overall Study||32
40811|NCT01984294|98196|P1|STARTED|Overall Study||35
40812|NCT01984242|98219|P3|NOT COMPLETED|Overall Study||101
40813|NCT01984242|98220|P2|NOT COMPLETED|Overall Study||103
40814|NCT01984242|98221|P1|NOT COMPLETED|Overall Study||101
40815|NCT01984242|98219|P3|COMPLETED|Overall Study||0
40816|NCT01984242|98220|P2|COMPLETED|Overall Study||0
40817|NCT01984242|98221|P1|COMPLETED|Overall Study||0
40818|NCT01984242|98219|P3|Crossover Population|Overall Study||57
40819|NCT01984242|98220|P2|Crossover Population|Overall Study||44
40820|NCT01984242|98221|P1|Crossover Population|Overall Study||0
40821|NCT01984242|98219|P3|Treated|Overall Study||100
40822|NCT01984242|98220|P2|Treated|Overall Study||103
40823|NCT01984242|98221|P1|Treated|Overall Study||101
40824|NCT01984242|98219|P3|STARTED|Overall Study||101
40825|NCT01984242|98220|P2|STARTED|Overall Study||103
40826|NCT01984242|98221|P1|STARTED|Overall Study||101
40827|NCT01984229|98371|P2|NOT COMPLETED|Safety Follow-up Period||1
40828|NCT01984229|98372|P1|NOT COMPLETED|Safety Follow-up Period||2
40829|NCT01984229|98371|P2|COMPLETED|Safety Follow-up Period||16
40830|NCT01984229|98372|P1|COMPLETED|Safety Follow-up Period||4
40831|NCT01984229|98371|P2|STARTED|Safety Follow-up Period||17
40832|NCT01984229|98372|P1|STARTED|Safety Follow-up Period||6
40833|NCT01984229|98371|P2|NOT COMPLETED|Period 3||0
40834|NCT01984229|98372|P1|NOT COMPLETED|Period 3||0
40835|NCT01984229|98371|P2|COMPLETED|Period 3||17
40836|NCT01984229|98372|P1|COMPLETED|Period 3||6
40837|NCT01984229|98371|P2|STARTED|Period 3||17
40838|NCT01984229|98372|P1|STARTED|Period 3||6
40839|NCT01984229|98371|P2|NOT COMPLETED|Period 2||0
40840|NCT01984229|98372|P1|NOT COMPLETED|Period 2||0
40841|NCT01984229|98371|P2|COMPLETED|Period 2||17
40842|NCT01984229|98372|P1|COMPLETED|Period 2||6
40843|NCT01984229|98371|P2|STARTED|Period 2||17
40844|NCT01984229|98372|P1|STARTED|Period 2||6
40845|NCT01984229|98371|P2|NOT COMPLETED|Period 1||0
40846|NCT01984229|98372|P1|NOT COMPLETED|Period 1||0
40847|NCT01984229|98371|P2|COMPLETED|Period 1||17
40848|NCT01984229|98372|P1|COMPLETED|Period 1||6
40849|NCT01984229|98371|P2|STARTED|Period 1||17
40850|NCT01984229|98372|P1|STARTED|Period 1||6
40851|NCT01983878|98422|P1|NOT COMPLETED|Overall Study||0
40852|NCT01983878|98422|P1|COMPLETED|Overall Study||36
40853|NCT01983878|98422|P1|Received At Least One Dose of Study Drug|Overall Study||36
40854|NCT01983878|98422|P1|STARTED|Overall Study||36
40855|NCT01983839|98433|P1|NOT COMPLETED|Overall Study||0
40856|NCT01983839|98433|P1|COMPLETED|Overall Study||18
40857|NCT01983839|98433|P1|STARTED|Overall Study||18
40858|NCT01983787|98438|P1|NOT COMPLETED|Overall Study||0
40859|NCT01983787|98438|P1|COMPLETED|Overall Study||10
40860|NCT01983787|98438|P1|STARTED|Overall Study||10
40861|NCT01983683|98463|P2|NOT COMPLETED|Overall Study||51
40862|NCT01983683|98464|P1|NOT COMPLETED|Overall Study||38
40863|NCT01983683|98463|P2|COMPLETED|Overall Study||260
40864|NCT01983683|98464|P1|COMPLETED|Overall Study||260
40865|NCT01983683|98463|P2|STARTED|Overall Study||311
40866|NCT01983683|98464|P1|STARTED|Overall Study||298
40867|NCT01983566|98492|P4|NOT COMPLETED|Test Period 4||0
40868|NCT01983566|98493|P3|NOT COMPLETED|Test Period 4||0
40869|NCT01983566|98494|P2|NOT COMPLETED|Test Period 4||0
40870|NCT01983566|98495|P1|NOT COMPLETED|Test Period 4||0
40871|NCT01983566|98492|P4|COMPLETED|Test Period 4||0
40872|NCT01983566|98493|P3|COMPLETED|Test Period 4||0
40873|NCT01983566|98494|P2|COMPLETED|Test Period 4||0
40874|NCT01983566|98495|P1|COMPLETED|Test Period 4||0
40875|NCT01983566|98492|P4|STARTED|Test Period 4||0
40876|NCT01983566|98493|P3|STARTED|Test Period 4||0
40877|NCT01983566|98494|P2|STARTED|Test Period 4||0
40878|NCT01983566|98495|P1|STARTED|Test Period 4||0
40879|NCT01983566|98492|P4|NOT COMPLETED|Wash-Out 3||0
40880|NCT01983566|98493|P3|NOT COMPLETED|Wash-Out 3||0
40881|NCT01983566|98494|P2|NOT COMPLETED|Wash-Out 3||0
40882|NCT01983566|98495|P1|NOT COMPLETED|Wash-Out 3||0
40883|NCT01983566|98492|P4|COMPLETED|Wash-Out 3||0
40884|NCT01983566|98493|P3|COMPLETED|Wash-Out 3||0
40885|NCT01983566|98494|P2|COMPLETED|Wash-Out 3||0
40886|NCT01983566|98495|P1|COMPLETED|Wash-Out 3||0
40887|NCT01983566|98492|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
40888|NCT01983566|98493|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
40889|NCT01983566|98494|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
40890|NCT01983566|98495|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
40891|NCT01983566|98492|P4|NOT COMPLETED|Test Period 3||0
40892|NCT01983566|98493|P3|NOT COMPLETED|Test Period 3||0
40893|NCT01983566|98494|P2|NOT COMPLETED|Test Period 3||0
40894|NCT01983566|98495|P1|NOT COMPLETED|Test Period 3||0
40895|NCT01983566|98492|P4|COMPLETED|Test Period 3||4
40896|NCT01983566|98493|P3|COMPLETED|Test Period 3||2
40897|NCT01983566|98494|P2|COMPLETED|Test Period 3||3
40898|NCT01983566|98495|P1|COMPLETED|Test Period 3||2
40899|NCT01983566|98492|P4|STARTED|Test Period 3||4
40900|NCT01983566|98493|P3|STARTED|Test Period 3||2
40901|NCT01983566|98494|P2|STARTED|Test Period 3||3
40902|NCT01983566|98495|P1|STARTED|Test Period 3||2
40903|NCT01983566|98492|P4|NOT COMPLETED|Wash-Out 2||0
40904|NCT01983566|98493|P3|NOT COMPLETED|Wash-Out 2||0
40905|NCT01983566|98494|P2|NOT COMPLETED|Wash-Out 2||0
40906|NCT01983566|98495|P1|NOT COMPLETED|Wash-Out 2||0
40907|NCT01983566|98492|P4|COMPLETED|Wash-Out 2||4
40908|NCT01983566|98493|P3|COMPLETED|Wash-Out 2||2
40909|NCT01983566|98494|P2|COMPLETED|Wash-Out 2||3
40910|NCT01983566|98495|P1|COMPLETED|Wash-Out 2||2
40911|NCT01983566|98492|P4|STARTED|Wash-Out 2||4
40912|NCT01983566|98493|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
40913|NCT01983566|98494|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
40914|NCT01983566|98495|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
40915|NCT01983566|98492|P4|NOT COMPLETED|Test Period 2||0
40916|NCT01983566|98493|P3|NOT COMPLETED|Test Period 2||0
40917|NCT01983566|98494|P2|NOT COMPLETED|Test Period 2||0
40918|NCT01983566|98495|P1|NOT COMPLETED|Test Period 2||0
40919|NCT01983566|98492|P4|COMPLETED|Test Period 2||4
40920|NCT01983566|98493|P3|COMPLETED|Test Period 2||4
40921|NCT01983566|98494|P2|COMPLETED|Test Period 2||4
40922|NCT01983566|98495|P1|COMPLETED|Test Period 2||4
40923|NCT01983566|98492|P4|STARTED|Test Period 2||4
40924|NCT01983566|98493|P3|STARTED|Test Period 2||4
40925|NCT01983566|98494|P2|STARTED|Test Period 2||4
40926|NCT01983566|98495|P1|STARTED|Test Period 2||4
40927|NCT01983566|98492|P4|NOT COMPLETED|Wash-Out 1||0
40928|NCT01983566|98493|P3|NOT COMPLETED|Wash-Out 1||0
40929|NCT01983566|98494|P2|NOT COMPLETED|Wash-Out 1||0
40930|NCT01983566|98495|P1|NOT COMPLETED|Wash-Out 1||0
40931|NCT01983566|98492|P4|COMPLETED|Wash-Out 1||4
40932|NCT01983566|98493|P3|COMPLETED|Wash-Out 1||4
40933|NCT01983566|98494|P2|COMPLETED|Wash-Out 1||4
40934|NCT01983566|98495|P1|COMPLETED|Wash-Out 1||4
40935|NCT01983566|98492|P4|STARTED|Wash-Out 1||4
40936|NCT01983566|98493|P3|STARTED|Wash-Out 1||4
40937|NCT01983566|98494|P2|STARTED|Wash-Out 1||4
40938|NCT01983566|98495|P1|STARTED|Wash-Out 1||4
40939|NCT01983566|98492|P4|NOT COMPLETED|Test Period 1||0
40940|NCT01983566|98493|P3|NOT COMPLETED|Test Period 1||0
40941|NCT01983566|98494|P2|NOT COMPLETED|Test Period 1||0
40942|NCT01983566|98495|P1|NOT COMPLETED|Test Period 1||0
40943|NCT01983566|98492|P4|COMPLETED|Test Period 1||4
40944|NCT01983566|98493|P3|COMPLETED|Test Period 1||4
40945|NCT01983566|98494|P2|COMPLETED|Test Period 1||4
40946|NCT01983566|98495|P1|COMPLETED|Test Period 1||4
40947|NCT01983566|98492|P4|STARTED|Test Period 1||4
40948|NCT01983566|98493|P3|STARTED|Test Period 1||4
40949|NCT01983566|98494|P2|STARTED|Test Period 1||4
40950|NCT01983566|98495|P1|STARTED|Test Period 1||4
40951|NCT01983254|98516|P2|NOT COMPLETED|Overall Study||30
40952|NCT01983254|98517|P1|NOT COMPLETED|Overall Study||34
40953|NCT01983254|98516|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
40954|NCT01983254|98517|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
40955|NCT01983254|98516|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
40956|NCT01983254|98517|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
40957|NCT01983254|98516|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
40958|NCT01983254|98517|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
40959|NCT01983254|98516|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
40960|NCT01983254|98517|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
40961|NCT01983254|98516|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
40962|NCT01983254|98517|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
40963|NCT01983111|98529|P2|NOT COMPLETED|Overall Study||7
40964|NCT01983111|98530|P1|NOT COMPLETED|Overall Study||12
40965|NCT01983111|98529|P2|COMPLETED|Overall Study||59
40966|NCT01983111|98530|P1|COMPLETED|Overall Study||58
40967|NCT01983111|98529|P2|STARTED|Overall Study||66
40968|NCT01983111|98530|P1|STARTED|Overall Study||70
40969|NCT01983020|98550|P4|NOT COMPLETED|Overall Study||0
40970|NCT01983020|98551|P3|NOT COMPLETED|Overall Study||0
40971|NCT01983020|98552|P2|NOT COMPLETED|Overall Study||0
40972|NCT01983020|98553|P1|NOT COMPLETED|Overall Study||0
40973|NCT01983020|98550|P4|COMPLETED|Overall Study||11
40974|NCT01983020|98551|P3|COMPLETED|Overall Study||12
40975|NCT01983020|98552|P2|COMPLETED|Overall Study||11
40976|NCT01983020|98553|P1|COMPLETED|Overall Study||12
40977|NCT01983020|98550|P4|STARTED|Overall Study||11
40978|NCT01983020|98551|P3|STARTED|Overall Study||12
40979|NCT01983020|98552|P2|STARTED|Overall Study||11
40980|NCT01983020|98553|P1|STARTED|Overall Study||12
40981|NCT01982812|98565|P2|NOT COMPLETED|Overall Study||10
40982|NCT01982812|98566|P1|NOT COMPLETED|Overall Study||1
40983|NCT01982812|98565|P2|COMPLETED|Overall Study||11
40984|NCT01982812|98566|P1|COMPLETED|Overall Study||22
40985|NCT01982812|98565|P2|STARTED|Overall Study||21
40986|NCT01982812|98566|P1|STARTED|Overall Study||23
40987|NCT01982773|98580|P2|NOT COMPLETED|Overall Study||4
40988|NCT01982773|98581|P1|NOT COMPLETED|Overall Study||8
40989|NCT01982773|98580|P2|COMPLETED|Overall Study||56
40990|NCT01982773|98581|P1|COMPLETED|Overall Study||50
40991|NCT01982773|98580|P2|STARTED|Overall Study||60
40992|NCT01982773|98581|P1|STARTED|Overall Study||58
40993|NCT01982695|98595|P2|NOT COMPLETED|Overall Study||1
40994|NCT01982695|98596|P1|NOT COMPLETED|Overall Study||0
40995|NCT01982695|98595|P2|COMPLETED|Overall Study||10
40996|NCT01982695|98596|P1|COMPLETED|Overall Study||12
40997|NCT01982695|98595|P2|STARTED|Overall Study||11
40998|NCT01982695|98596|P1|STARTED|Overall Study||12
40999|NCT01982539|98602|P1|NOT COMPLETED|Overall Study||0
41000|NCT01982539|98602|P1|COMPLETED|Overall Study||25
41001|NCT01982539|98602|P1|STARTED|Overall Study||25
41002|NCT01982435|98608|P2|NOT COMPLETED|Overall Study||0
41003|NCT01982435|98609|P1|NOT COMPLETED|Overall Study||1
41004|NCT01982435|98608|P2|COMPLETED|Overall Study||12
41005|NCT01982435|98609|P1|COMPLETED|Overall Study||14
41006|NCT01982435|98608|P2|STARTED|Overall Study||12
41007|NCT01982435|98609|P1|STARTED|Overall Study||15
41008|NCT01982383|98639|P2|NOT COMPLETED|Overall Study||0
41009|NCT01982383|98640|P1|NOT COMPLETED|Overall Study||0
41010|NCT01982383|98639|P2|COMPLETED|Overall Study||0
41011|NCT01982383|98640|P1|COMPLETED|Overall Study||2
41012|NCT01982383|98639|P2|STARTED|Overall Study||0
41013|NCT01982383|98640|P1|STARTED|Overall Study||2
41014|NCT01982292|98648|P2|NOT COMPLETED|Overall Study||1
41015|NCT01982292|98649|P1|NOT COMPLETED|Overall Study||12
41016|NCT01982292|98648|P2|COMPLETED|Overall Study||107
41017|NCT01982292|98649|P1|COMPLETED|Overall Study||203
41018|NCT01982292|98648|P2|Safety Set|Overall Study||108
41019|NCT01982292|98649|P1|Safety Set|Overall Study||212
41020|NCT01982292|98648|P2|Full Analaysis Set (FAS)|Overall Study||108
41021|NCT01982292|98649|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
41022|NCT01982292|98648|P2|STARTED|Overall Study||108
41023|NCT01982292|98649|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
41024|NCT01982253|98670|P3|NOT COMPLETED|Overall Study||4
41025|NCT01982253|98671|P2|NOT COMPLETED|Overall Study||4
41026|NCT01982253|98672|P1|NOT COMPLETED|Overall Study||2
41027|NCT01982253|98670|P3|COMPLETED|Overall Study||0
41028|NCT01982253|98671|P2|COMPLETED|Overall Study||0
41029|NCT01982253|98672|P1|COMPLETED|Overall Study||0
41030|NCT01982253|98670|P3|STARTED|Overall Study||4
41031|NCT01982253|98671|P2|STARTED|Overall Study||4
41032|NCT01982253|98672|P1|STARTED|Overall Study||2
41033|NCT01981967|98685|P2|NOT COMPLETED|Overall Study||0
41034|NCT01981967|98686|P1|NOT COMPLETED|Overall Study||0
41035|NCT01981967|98685|P2|COMPLETED|Overall Study||3149
41036|NCT01981967|98686|P1|COMPLETED|Overall Study||6851
41037|NCT01981967|98685|P2|STARTED|Overall Study||3149
41038|NCT01981967|98686|P1|STARTED|Overall Study||6851
41039|NCT01981863|98698|P2|NOT COMPLETED|Overall Study||0
41040|NCT01981863|98699|P1|NOT COMPLETED|Overall Study||0
41041|NCT01981863|98698|P2|COMPLETED|Overall Study||20
41042|NCT01981863|98699|P1|COMPLETED|Overall Study||20
41043|NCT01981863|98698|P2|STARTED|Overall Study||20
41044|NCT01981863|98699|P1|STARTED|Overall Study||20
41045|NCT01981616|98711|P2|NOT COMPLETED|Overall Study||1
41046|NCT01981616|98712|P1|NOT COMPLETED|Overall Study||1
41047|NCT01981616|98711|P2|COMPLETED|Overall Study||62
41048|NCT01981616|98712|P1|COMPLETED|Overall Study||63
41049|NCT01981616|98711|P2|STARTED|Overall Study||63
41050|NCT01981616|98712|P1|STARTED|Overall Study||64
41051|NCT01981564|98726|P2|NOT COMPLETED|Overall Study||9
41052|NCT01981564|98727|P1|NOT COMPLETED|Overall Study||9
41053|NCT01981564|98726|P2|COMPLETED|Overall Study||106
41054|NCT01981564|98727|P1|COMPLETED|Overall Study||98
41055|NCT01981564|98726|P2|STARTED|Overall Study||115
41056|NCT01981564|98727|P1|STARTED|Overall Study||107
41057|NCT01981473|98738|P3|NOT COMPLETED|Overall Study||8
41058|NCT01981473|98739|P2|NOT COMPLETED|Overall Study||0
41059|NCT01981473|98740|P1|NOT COMPLETED|Overall Study||2
41060|NCT01981473|98738|P3|COMPLETED|Overall Study||196
41061|NCT01981473|98739|P2|COMPLETED|Overall Study||199
41062|NCT01981473|98740|P1|COMPLETED|Overall Study||200
41063|NCT01981473|98738|P3|STARTED|Overall Study||204
41064|NCT01981473|98739|P2|STARTED|Overall Study||199
41065|NCT01981473|98740|P1|STARTED|Overall Study||202
41066|NCT01981356|98781|P2|NOT COMPLETED|Overall Study||2
41067|NCT01981356|98782|P1|NOT COMPLETED|Overall Study||7
41068|NCT01981356|98781|P2|COMPLETED|Overall Study||4
41069|NCT01981356|98782|P1|COMPLETED|Overall Study||5
41070|NCT01981356|98781|P2|STARTED|Overall Study||6
41071|NCT01981356|98782|P1|STARTED|Overall Study||12
41072|NCT01981057|98809|P2|NOT COMPLETED|Overall Study||0
41073|NCT01981057|98810|P1|NOT COMPLETED|Overall Study||0
41074|NCT01981057|98809|P2|COMPLETED|Overall Study||50
41075|NCT01981057|98810|P1|COMPLETED|Overall Study||50
41076|NCT01981057|98809|P2|STARTED|Overall Study||50
41077|NCT01981057|98810|P1|STARTED|Overall Study||50
41078|NCT01980992|98818|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
41079|NCT01980992|98819|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
41080|NCT01980992|98818|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
41081|NCT01980992|98819|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
41082|NCT01980992|98818|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
41083|NCT01980992|98819|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
41084|NCT01980992|98818|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
41085|NCT01980992|98819|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
41086|NCT01980992|98818|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
41087|NCT01980992|98819|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
41088|NCT01980992|98818|P2|STARTED|52 Weeks Blinded Study Treatment||23
41089|NCT01980992|98819|P1|STARTED|52 Weeks Blinded Study Treatment||23
41090|NCT01980940|98844|P8|NOT COMPLETED|Overall Study||0
41091|NCT01980940|98845|P7|NOT COMPLETED|Overall Study||0
41092|NCT01980940|98846|P6|NOT COMPLETED|Overall Study||2
41093|NCT01980940|98847|P5|NOT COMPLETED|Overall Study||0
41094|NCT01980940|98848|P4|NOT COMPLETED|Overall Study||0
41095|NCT01980940|98849|P3|NOT COMPLETED|Overall Study||0
41096|NCT01980940|98850|P2|NOT COMPLETED|Overall Study||0
41097|NCT01980940|98851|P1|NOT COMPLETED|Overall Study||0
41098|NCT01980940|98844|P8|COMPLETED|Overall Study||24
41099|NCT01980940|98845|P7|COMPLETED|Overall Study||24
41100|NCT01980940|98846|P6|COMPLETED|Overall Study||0
41101|NCT01980940|98847|P5|COMPLETED|Overall Study||2
41102|NCT01980940|98848|P4|COMPLETED|Overall Study||3
41103|NCT01980940|98849|P3|COMPLETED|Overall Study||5
41104|NCT01980940|98850|P2|COMPLETED|Overall Study||5
41105|NCT01980940|98851|P1|COMPLETED|Overall Study||5
41106|NCT01980940|98844|P8|Treated|Overall Study||24
41107|NCT01980940|98845|P7|Treated|Overall Study||24
41108|NCT01980940|98846|P6|Treated|Overall Study||2
41109|NCT01980940|98847|P5|Treated|Overall Study||2
41110|NCT01980940|98848|P4|Treated|Overall Study||3
41111|NCT01980940|98849|P3|Treated|Overall Study||5
41112|NCT01980940|98850|P2|Treated|Overall Study||5
41113|NCT01980940|98851|P1|Treated|Overall Study||5
41114|NCT01980940|98844|P8|STARTED|Overall Study||24
41115|NCT01980940|98845|P7|STARTED|Overall Study||24
41116|NCT01980940|98846|P6|STARTED|Overall Study||2
41117|NCT01980940|98847|P5|STARTED|Overall Study||2
41118|NCT01980940|98848|P4|STARTED|Overall Study||3
41119|NCT01980940|98849|P3|STARTED|Overall Study||5
41120|NCT01980940|98850|P2|STARTED|Overall Study||5
41121|NCT01980940|98851|P1|STARTED|Overall Study||5
41122|NCT01980888|98905|P2|NOT COMPLETED|Overall Study||133
41123|NCT01980888|98906|P1|NOT COMPLETED|Overall Study||144
41124|NCT01980888|98905|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
41125|NCT01980888|98906|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
41126|NCT01980888|98905|P2|STARTED|Overall Study||154
41127|NCT01980888|98906|P1|STARTED|Overall Study||157
41128|NCT01980875|98925|P3|NOT COMPLETED|Overall Study||24
41129|NCT01980875|98926|P2|NOT COMPLETED|Overall Study||25
41130|NCT01980875|98927|P1|NOT COMPLETED|Overall Study||8
41131|NCT01980875|98925|P3|COMPLETED|Overall Study||0
41132|NCT01980875|98926|P2|COMPLETED|Overall Study||0
41133|NCT01980875|98927|P1|COMPLETED|Overall Study||0
41134|NCT01980875|98925|P3|STARTED|Overall Study||24
41135|NCT01980875|98926|P2|STARTED|Overall Study||25
41136|NCT01980875|98927|P1|STARTED|Overall Study||8
41137|NCT01980628|98950|P1|NOT COMPLETED|Overall Study||39
41138|NCT01980628|98950|P1|COMPLETED|Overall Study|Participants who remain on treatment at Primary Completion.|24
41139|NCT01980628|98950|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
41140|NCT01980589|98958|P3|NOT COMPLETED|Overall Study||0
41141|NCT01980589|98959|P2|NOT COMPLETED|Overall Study||0
41142|NCT01980589|98960|P1|NOT COMPLETED|Overall Study||0
41143|NCT01980589|98958|P3|COMPLETED|Overall Study||16
41144|NCT01980589|98959|P2|COMPLETED|Overall Study||3
41145|NCT01980589|98960|P1|COMPLETED|Overall Study||3
41146|NCT01980589|98958|P3|STARTED|Overall Study||16
41147|NCT01980589|98959|P2|STARTED|Overall Study||3
41148|NCT01980589|98960|P1|STARTED|Overall Study||3
41149|NCT01980524|98977|P2|NOT COMPLETED|Study Day 2||0
41150|NCT01980524|98978|P1|NOT COMPLETED|Study Day 2||0
41151|NCT01980524|98977|P2|COMPLETED|Study Day 2||4
41152|NCT01980524|98978|P1|COMPLETED|Study Day 2||4
41153|NCT01980524|98977|P2|STARTED|Study Day 2||4
41154|NCT01980524|98978|P1|STARTED|Study Day 2||4
41155|NCT01980524|98977|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
41156|NCT01980524|98978|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
41157|NCT01980524|98977|P2|COMPLETED|Washout (at Least 2 Weeks)||4
41158|NCT01980524|98978|P1|COMPLETED|Washout (at Least 2 Weeks)||4
41159|NCT01980524|98977|P2|STARTED|Washout (at Least 2 Weeks)||4
41160|NCT01980524|98978|P1|STARTED|Washout (at Least 2 Weeks)||4
41161|NCT01980524|98977|P2|NOT COMPLETED|Study Day 1||0
41162|NCT01980524|98978|P1|NOT COMPLETED|Study Day 1||0
41163|NCT01980524|98977|P2|COMPLETED|Study Day 1||4
41164|NCT01980524|98978|P1|COMPLETED|Study Day 1||4
41165|NCT01980524|98977|P2|STARTED|Study Day 1||4
41166|NCT01980524|98978|P1|STARTED|Study Day 1||4
41167|NCT01980342|98988|P1|NOT COMPLETED|Overall Study||1
41168|NCT01980342|98988|P1|COMPLETED|Overall Study||0
41169|NCT01980342|98988|P1|STARTED|Overall Study||1
41170|NCT01980095|98998|P2|NOT COMPLETED|Overall Study||11
41171|NCT01980095|98999|P1|NOT COMPLETED|Overall Study||14
41172|NCT01980095|98998|P2|COMPLETED|Overall Study||30
41173|NCT01980095|98999|P1|COMPLETED|Overall Study||63
41174|NCT01980095|98998|P2|Treated|Overall Study||41
41175|NCT01980095|98999|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
41176|NCT01980095|98998|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
41177|NCT01980095|98999|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|77
41178|NCT01979952|99009|P2|NOT COMPLETED|Overall Study||6
41179|NCT01979952|99010|P1|NOT COMPLETED|Overall Study||8
41180|NCT01979952|99009|P2|COMPLETED|Overall Study||51
41181|NCT01979952|99010|P1|COMPLETED|Overall Study||48
41182|NCT01979952|99009|P2|STARTED|Overall Study||57
41183|NCT01979952|99010|P1|STARTED|Overall Study||56
41184|NCT01979445|99040|P4|NOT COMPLETED|Overall Study||0
41185|NCT01979445|99041|P3|NOT COMPLETED|Overall Study||0
41186|NCT01979445|99042|P2|NOT COMPLETED|Overall Study||0
41187|NCT01979445|99043|P1|NOT COMPLETED|Overall Study||0
41188|NCT01979445|99040|P4|COMPLETED|Overall Study||3
41189|NCT01979445|99041|P3|COMPLETED|Overall Study||6
41190|NCT01979445|99042|P2|COMPLETED|Overall Study||3
41191|NCT01979445|99043|P1|COMPLETED|Overall Study||3
41192|NCT01979445|99040|P4|ITT Population|Overall Study||3
41193|NCT01979445|99041|P3|ITT Population|Overall Study||6
41194|NCT01979445|99042|P2|ITT Population|Overall Study||3
41195|NCT01979445|99043|P1|ITT Population|Overall Study||3
41196|NCT01979445|99040|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
41197|NCT01979445|99041|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
41198|NCT01979445|99042|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
41199|NCT01979445|99043|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
41200|NCT01979445|99040|P4|STARTED|Overall Study||3
41201|NCT01979445|99041|P3|STARTED|Overall Study||6
41202|NCT01979445|99042|P2|STARTED|Overall Study||3
41203|NCT01979445|99043|P1|STARTED|Overall Study||3
41204|NCT01979276|99069|P1|NOT COMPLETED|Overall Study||0
41205|NCT01979276|99069|P1|COMPLETED|Overall Study||2
41206|NCT01979276|99069|P1|STARTED|Overall Study||2
41207|NCT01979185|99077|P2|NOT COMPLETED|Period 2||1
41208|NCT01979185|99078|P1|NOT COMPLETED|Period 2||0
41209|NCT01979185|99077|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
41210|NCT01979185|99078|P1|COMPLETED|Period 2||15
41211|NCT01979185|99077|P2|STARTED|Period 2||15
41212|NCT01979185|99078|P1|STARTED|Period 2||15
41213|NCT01979185|99077|P2|NOT COMPLETED|Period 1||0
41214|NCT01979185|99078|P1|NOT COMPLETED|Period 1||0
41215|NCT01979185|99077|P2|COMPLETED|Period 1||15
41216|NCT01979185|99078|P1|COMPLETED|Period 1||15
41217|NCT01979185|99077|P2|STARTED|Period 1||15
41218|NCT01979185|99078|P1|STARTED|Period 1||15
41219|NCT01979133|99088|P1|NOT COMPLETED|Overall Study||3
41220|NCT01979133|99088|P1|COMPLETED|Overall Study||7
41221|NCT01979133|99088|P1|STARTED|Overall Study||10
41222|NCT01979029|99107|P2|NOT COMPLETED|Overall Study||0
41223|NCT01979029|99108|P1|NOT COMPLETED|Overall Study||0
41224|NCT01979029|99107|P2|COMPLETED|Overall Study||28
41225|NCT01979029|99108|P1|COMPLETED|Overall Study||29
41226|NCT01979029|99107|P2|STARTED|Overall Study||28
41227|NCT01979029|99108|P1|STARTED|Overall Study||29
41228|NCT01978743|99118|P1|NOT COMPLETED|Overall Study||0
41229|NCT01978743|99118|P1|COMPLETED|Overall Study||10
41230|NCT01978743|99118|P1|STARTED|Overall Study||10
41231|NCT01978600|99132|P2|NOT COMPLETED|Overall Study||0
41232|NCT01978600|99133|P1|NOT COMPLETED|Overall Study||0
41233|NCT01978600|99132|P2|COMPLETED|Overall Study||42
41234|NCT01978600|99133|P1|COMPLETED|Overall Study||44
41235|NCT01978600|99132|P2|STARTED|Overall Study||42
41236|NCT01978600|99133|P1|STARTED|Overall Study||44
41237|NCT01978535|99145|P2|NOT COMPLETED|Overall Study||0
41238|NCT01978535|99146|P1|NOT COMPLETED|Overall Study||0
41239|NCT01978535|99145|P2|COMPLETED|Overall Study||2
41240|NCT01978535|99146|P1|COMPLETED|Overall Study||1
41241|NCT01978535|99145|P2|STARTED|Overall Study||2
41242|NCT01978535|99146|P1|STARTED|Overall Study||1
41243|NCT01978314|99157|P5|NOT COMPLETED|Overall Study||0
41244|NCT01978314|99158|P4|NOT COMPLETED|Overall Study||0
41245|NCT01978314|99159|P3|NOT COMPLETED|Overall Study||0
41246|NCT01978314|99160|P2|NOT COMPLETED|Overall Study||0
41247|NCT01978314|99161|P1|NOT COMPLETED|Overall Study||0
41248|NCT01978314|99157|P5|COMPLETED|Overall Study||8
41249|NCT01978314|99158|P4|COMPLETED|Overall Study||1
41250|NCT01978314|99159|P3|COMPLETED|Overall Study||8
41251|NCT01978314|99160|P2|COMPLETED|Overall Study||8
41252|NCT01978314|99161|P1|COMPLETED|Overall Study||8
41253|NCT01978314|99157|P5|STARTED|Overall Study||8
41254|NCT01978314|99158|P4|STARTED|Overall Study||1
41255|NCT01978314|99159|P3|STARTED|Overall Study||8
41256|NCT01978314|99160|P2|STARTED|Overall Study||8
41257|NCT01978314|99161|P1|STARTED|Overall Study||8
41258|NCT01978145|99243|P2|NOT COMPLETED|Treatment Period 2||14
41259|NCT01978145|99244|P1|NOT COMPLETED|Treatment Period 2||19
41260|NCT01978145|99243|P2|COMPLETED|Treatment Period 2||179
41261|NCT01978145|99244|P1|COMPLETED|Treatment Period 2||185
41262|NCT01978145|99243|P2|STARTED|Treatment Period 2||193
41263|NCT01978145|99244|P1|STARTED|Treatment Period 2||204
41264|NCT01978145|99243|P2|NOT COMPLETED|Washout Period 1||3
41265|NCT01978145|99244|P1|NOT COMPLETED|Washout Period 1||1
41266|NCT01978145|99243|P2|COMPLETED|Washout Period 1||193
41267|NCT01978145|99244|P1|COMPLETED|Washout Period 1||204
41268|NCT01978145|99243|P2|STARTED|Washout Period 1||196
41269|NCT01978145|99244|P1|STARTED|Washout Period 1||205
41270|NCT01978145|99243|P2|NOT COMPLETED|Treatment Period 1||16
41271|NCT01978145|99244|P1|NOT COMPLETED|Treatment Period 1||9
41272|NCT01978145|99243|P2|COMPLETED|Treatment Period 1||196
41273|NCT01978145|99244|P1|COMPLETED|Treatment Period 1||205
41274|NCT01978145|99243|P2|STARTED|Treatment Period 1||212
41275|NCT01978145|99244|P1|STARTED|Treatment Period 1||214
41276|NCT01978119|99260|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
41277|NCT01978119|99261|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
41278|NCT01978119|99260|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
41279|NCT01978119|99261|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
41280|NCT01978119|99260|P2|STARTED|Treatment Period 2 (12 Weeks)||42
41281|NCT01978119|99261|P1|STARTED|Treatment Period 2 (12 Weeks)||38
41282|NCT01978119|99260|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
41283|NCT01978119|99261|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
41284|NCT01978119|99260|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
41285|NCT01978119|99261|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
41286|NCT01978119|99260|P2|STARTED|Washout Period 1 (3 Weeks)||42
41287|NCT01978119|99261|P1|STARTED|Washout Period 1 (3 Weeks)||38
41288|NCT01978119|99260|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
41289|NCT01978119|99261|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
41290|NCT01978119|99260|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
41291|NCT01978119|99261|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
41292|NCT01978119|99260|P2|STARTED|Treatment Period 1 (12 Weeks)||42
41293|NCT01978119|99261|P1|STARTED|Treatment Period 1 (12 Weeks)||40
41294|NCT01977820|99287|P2|NOT COMPLETED|Overall Study||1
41295|NCT01977820|99288|P1|NOT COMPLETED|Overall Study||1
41296|NCT01977820|99287|P2|COMPLETED|Overall Study||0
41297|NCT01977820|99288|P1|COMPLETED|Overall Study||0
41298|NCT01977820|99287|P2|STARTED|Overall Study||1
41299|NCT01977820|99288|P1|STARTED|Overall Study||1
41300|NCT01977794|99296|P2|NOT COMPLETED|Overall Study||6
41301|NCT01977794|99297|P1|NOT COMPLETED|Overall Study||8
41302|NCT01977794|99296|P2|COMPLETED|Overall Study||94
41303|NCT01977794|99297|P1|COMPLETED|Overall Study||92
41304|NCT01977794|99296|P2|STARTED|Overall Study||100
41305|NCT01977794|99297|P1|STARTED|Overall Study||100
41306|NCT01977781|99313|P2|NOT COMPLETED|Overall Study||1
41307|NCT01977781|99314|P1|NOT COMPLETED|Overall Study||6
41308|NCT01977781|99313|P2|COMPLETED|Overall Study||15
41309|NCT01977781|99314|P1|COMPLETED|Overall Study||18
41310|NCT01977781|99313|P2|STARTED|Overall Study||16
41311|NCT01977781|99314|P1|STARTED|Overall Study||24
41312|NCT01977729|99332|P1|NOT COMPLETED|Overall Study||1
41313|NCT01977729|99332|P1|COMPLETED|Overall Study||0
41314|NCT01977729|99332|P1|STARTED|Overall Study||1
41315|NCT01977690|99344|P2|NOT COMPLETED|Overall Study||4
41316|NCT01977690|99345|P1|NOT COMPLETED|Overall Study||0
41317|NCT01977690|99344|P2|COMPLETED|Overall Study||11
41318|NCT01977690|99345|P1|COMPLETED|Overall Study||15
41319|NCT01977690|99344|P2|STARTED|Overall Study||15
41320|NCT01977690|99345|P1|STARTED|Overall Study||15
41321|NCT01977625|99351|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
41322|NCT01977625|99352|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
41323|NCT01977625|99351|P2|COMPLETED|Second Intervention (4 Weeks)||7
41324|NCT01977625|99352|P1|COMPLETED|Second Intervention (4 Weeks)||7
41325|NCT01977625|99351|P2|STARTED|Second Intervention (4 Weeks)||7
41326|NCT01977625|99352|P1|STARTED|Second Intervention (4 Weeks)||8
41327|NCT01977625|99351|P2|NOT COMPLETED|Washout (2 Weeks)||0
41328|NCT01977625|99352|P1|NOT COMPLETED|Washout (2 Weeks)||0
41329|NCT01977625|99351|P2|COMPLETED|Washout (2 Weeks)||7
41330|NCT01977625|99352|P1|COMPLETED|Washout (2 Weeks)||8
41331|NCT01977625|99351|P2|STARTED|Washout (2 Weeks)||7
41332|NCT01977625|99352|P1|STARTED|Washout (2 Weeks)||8
41333|NCT01977625|99351|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
41334|NCT01977625|99352|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
41335|NCT01977625|99351|P2|COMPLETED|First Intervention (4 Weeks)||7
41336|NCT01977625|99352|P1|COMPLETED|First Intervention (4 Weeks)||8
41337|NCT01977625|99351|P2|STARTED|First Intervention (4 Weeks)||7
41338|NCT01977625|99352|P1|STARTED|First Intervention (4 Weeks)||11
41339|NCT01977612|99362|P2|NOT COMPLETED|Overall Study||1
41340|NCT01977612|99363|P1|NOT COMPLETED|Overall Study||1
41341|NCT01977612|99362|P2|COMPLETED|Overall Study||79
41342|NCT01977612|99363|P1|COMPLETED|Overall Study||84
41343|NCT01977612|99362|P2|STARTED|Overall Study||80
41344|NCT01977612|99363|P1|STARTED|Overall Study||85
41345|NCT01977573|99385|P4|NOT COMPLETED|Overall Study||3
41346|NCT01977573|99386|P3|NOT COMPLETED|Overall Study||4
41347|NCT01977573|99387|P2|NOT COMPLETED|Overall Study||3
41348|NCT01977573|99388|P1|NOT COMPLETED|Overall Study||20
41349|NCT01977573|99385|P4|COMPLETED|Overall Study||33
41350|NCT01977573|99386|P3|COMPLETED|Overall Study||32
41351|NCT01977573|99387|P2|COMPLETED|Overall Study||41
41352|NCT01977573|99388|P1|COMPLETED|Overall Study||116
41353|NCT01977573|99385|P4|STARTED|Overall Study||36
41354|NCT01977573|99386|P3|STARTED|Overall Study||36
41355|NCT01977573|99387|P2|STARTED|Overall Study||44
41356|NCT01977573|99388|P1|STARTED|Overall Study||136
41357|NCT01977482|99502|P6|NOT COMPLETED|Overall Study||5
41358|NCT01977482|99503|P5|NOT COMPLETED|Overall Study||3
41359|NCT01977482|99504|P4|NOT COMPLETED|Overall Study||4
41360|NCT01977482|99505|P3|NOT COMPLETED|Overall Study||5
41361|NCT01977482|99506|P2|NOT COMPLETED|Overall Study||9
41362|NCT01977482|99507|P1|NOT COMPLETED|Overall Study||3
41363|NCT01977482|99502|P6|COMPLETED|Overall Study||14
41364|NCT01977482|99503|P5|COMPLETED|Overall Study||37
41365|NCT01977482|99504|P4|COMPLETED|Overall Study||35
41366|NCT01977482|99505|P3|COMPLETED|Overall Study||35
41367|NCT01977482|99506|P2|COMPLETED|Overall Study||30
41368|NCT01977482|99507|P1|COMPLETED|Overall Study||36
41369|NCT01977482|99502|P6|STARTED|Overall Study||19
41370|NCT01977482|99503|P5|STARTED|Overall Study||40
41371|NCT01977482|99504|P4|STARTED|Overall Study||39
41372|NCT01977482|99505|P3|STARTED|Overall Study||40
41373|NCT01977482|99506|P2|STARTED|Overall Study||39
41374|NCT01977482|99507|P1|STARTED|Overall Study||39
41375|NCT01977456|99622|P1|NOT COMPLETED|Overall Study||5
41376|NCT01977456|99622|P1|COMPLETED|Overall Study||22
41377|NCT01977456|99622|P1|STARTED|Overall Study||27
41378|NCT01977352|99631|P2|NOT COMPLETED|Overall Study||2
41379|NCT01977352|99632|P1|NOT COMPLETED|Overall Study||1
41380|NCT01977352|99631|P2|COMPLETED|Overall Study||19
41381|NCT01977352|99632|P1|COMPLETED|Overall Study||20
41382|NCT01977352|99631|P2|STARTED|Overall Study||21
41383|NCT01977352|99632|P1|STARTED|Overall Study||21
41384|NCT01977222|99650|P1|NOT COMPLETED|Overall Study||1
41385|NCT01977222|99650|P1|COMPLETED|Overall Study||11
41386|NCT01977222|99650|P1|STARTED|Overall Study||12
41387|NCT01976988|99663|P2|NOT COMPLETED|Overall Study||18
41388|NCT01976988|99664|P1|NOT COMPLETED|Overall Study||16
41389|NCT01976988|99663|P2|COMPLETED|Overall Study||184
41390|NCT01976988|99664|P1|COMPLETED|Overall Study||192
41391|NCT01976988|99663|P2|STARTED|Overall Study||202
41392|NCT01976988|99664|P1|STARTED|Overall Study||208
41393|NCT01976871|99680|P1|NOT COMPLETED|Overall Study||1
41394|NCT01976871|99680|P1|COMPLETED|Overall Study||20
41395|NCT01976871|99680|P1|STARTED|Overall Study||21
41396|NCT01976845|99692|P3|NOT COMPLETED|Overall Study||3
41397|NCT01976845|99693|P2|NOT COMPLETED|Overall Study||8
41398|NCT01976845|99694|P1|NOT COMPLETED|Overall Study||8
41399|NCT01976845|99692|P3|COMPLETED|Overall Study||40
41400|NCT01976845|99693|P2|COMPLETED|Overall Study||40
41401|NCT01976845|99694|P1|COMPLETED|Overall Study||40
41402|NCT01976845|99692|P3|STARTED|Overall Study||43
41403|NCT01976845|99693|P2|STARTED|Overall Study||48
41404|NCT01976845|99694|P1|STARTED|Overall Study||48
41405|NCT01976819|99708|P1|NOT COMPLETED|Overall Study||5
41406|NCT01976819|99708|P1|COMPLETED|Overall Study||11
41407|NCT01976819|99708|P1|STARTED|Overall Study||16
41408|NCT01976806|99719|P2|NOT COMPLETED|Overall Study||6
41409|NCT01976806|99720|P1|NOT COMPLETED|Overall Study||3
41410|NCT01976806|99719|P2|COMPLETED|Overall Study||22
41411|NCT01976806|99720|P1|COMPLETED|Overall Study||24
41412|NCT01976806|99719|P2|STARTED|Overall Study||28
41413|NCT01976806|99720|P1|STARTED|Overall Study||27
41414|NCT01976663|99748|P1|NOT COMPLETED|Overall Study||42
41415|NCT01976663|99748|P1|COMPLETED|Overall Study||84
41416|NCT01976663|99748|P1|STARTED|Overall Study||126
41417|NCT01976650|99762|P1|NOT COMPLETED|Overall Study||6
41418|NCT01976650|99762|P1|COMPLETED|Overall Study||718
41419|NCT01976650|99762|P1|STARTED|Overall Study||724
41420|NCT01976624|99767|P1|NOT COMPLETED|Overall Study||14
41421|NCT01976624|99767|P1|COMPLETED|Overall Study||742
41422|NCT01976624|99767|P1|STARTED|Overall Study||756
41423|NCT01976572|99772|P3|NOT COMPLETED|Overall Study||0
41424|NCT01976572|99773|P2|NOT COMPLETED|Overall Study||0
41425|NCT01976572|99774|P1|NOT COMPLETED|Overall Study||0
41426|NCT01976572|99772|P3|COMPLETED|Overall Study||6
41427|NCT01976572|99773|P2|COMPLETED|Overall Study||6
41428|NCT01976572|99774|P1|COMPLETED|Overall Study||6
41429|NCT01976572|99772|P3|STARTED|Overall Study||6
41430|NCT01976572|99773|P2|STARTED|Overall Study||6
41431|NCT01976572|99774|P1|STARTED|Overall Study||6
41432|NCT01976507|99795|P1|NOT COMPLETED|Overall Study||7
41433|NCT01976507|99795|P1|COMPLETED|Overall Study||94
41434|NCT01976507|99795|P1|Received Initial Dose of Dabigatran|Overall Study||100
41435|NCT01976507|99795|P1|STARTED|Overall Study||101
41436|NCT01976442|99804|P2|NOT COMPLETED|Overall Study||0
41437|NCT01976442|99805|P1|NOT COMPLETED|Overall Study||0
41438|NCT01976442|99804|P2|COMPLETED|Overall Study||31
41439|NCT01976442|99805|P1|COMPLETED|Overall Study||69
41440|NCT01976442|99804|P2|STARTED|Overall Study||31
41441|NCT01976442|99805|P1|STARTED|Overall Study||69
41442|NCT01976338|99819|P2|NOT COMPLETED|Overall Study||4
41443|NCT01976338|99820|P1|NOT COMPLETED|Overall Study||13
41444|NCT01976338|99819|P2|COMPLETED|Overall Study|12 months|89
41445|NCT01976338|99820|P1|COMPLETED|Overall Study|12 months|177
41446|NCT01976338|99819|P2|Discontinued Study Prior to 6 Months|Overall Study||2
41447|NCT01976338|99820|P1|Discontinued Study Prior to 6 Months|Overall Study||5
41448|NCT01976338|99819|P2|Completed 6 Months|Overall Study||91
41449|NCT01976338|99820|P1|Completed 6 Months|Overall Study||185
41450|NCT01976338|99819|P2|STARTED|Overall Study||93
41451|NCT01976338|99820|P1|STARTED|Overall Study||190
41452|NCT01976312|99847|P2|NOT COMPLETED|Overall Study||9
41453|NCT01976312|99848|P1|NOT COMPLETED|Overall Study||17
41454|NCT01976312|99847|P2|COMPLETED|Overall Study|Completed study at 12 months|53
41455|NCT01976312|99848|P1|COMPLETED|Overall Study|Completed study at 12 months|173
41456|NCT01976312|99847|P2|Discontinued Study Prior to 3 Months|Overall Study||2
41457|NCT01976312|99848|P1|Discontinued Study Prior to 3 Months|Overall Study||4
41458|NCT01976312|99847|P2|Completed 3 Months|Overall Study||60
41459|NCT01976312|99848|P1|Completed 3 Months|Overall Study||186
41460|NCT01976312|99847|P2|STARTED|Overall Study||62
41461|NCT01976312|99848|P1|STARTED|Overall Study||190
41462|NCT01976299|99869|P2|NOT COMPLETED|Overall Study||6
41463|NCT01976299|99870|P1|NOT COMPLETED|Overall Study||23
41464|NCT01976299|99869|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
41465|NCT01976299|99870|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
41466|NCT01976299|99869|P2|Completed Procedure|Overall Study||284
41467|NCT01976299|99870|P1|Completed Procedure|Overall Study||283
41468|NCT01976299|99869|P2|STARTED|Overall Study||286
41469|NCT01976299|99870|P1|STARTED|Overall Study||292
41470|NCT01976273|99886|P2|NOT COMPLETED|Overall Study||1
41471|NCT01976273|99887|P1|NOT COMPLETED|Overall Study||1
41472|NCT01976273|99886|P2|COMPLETED|Overall Study||9
41473|NCT01976273|99887|P1|COMPLETED|Overall Study||9
41474|NCT01976273|99886|P2|STARTED|Overall Study||10
41475|NCT01976273|99887|P1|STARTED|Overall Study||10
41476|NCT01976104|99897|P4|NOT COMPLETED|Overall Study||3
41477|NCT01976104|99898|P3|NOT COMPLETED|Overall Study||2
41478|NCT01976104|99899|P2|NOT COMPLETED|Overall Study||2
41479|NCT01976104|99900|P1|NOT COMPLETED|Overall Study||6
41480|NCT01976104|99897|P4|COMPLETED|Overall Study||55
41481|NCT01976104|99898|P3|COMPLETED|Overall Study||31
41482|NCT01976104|99899|P2|COMPLETED|Overall Study||68
41483|NCT01976104|99900|P1|COMPLETED|Overall Study||37
41484|NCT01976104|99897|P4|STARTED|Overall Study||58
41485|NCT01976104|99898|P3|STARTED|Overall Study||33
41486|NCT01976104|99899|P2|STARTED|Overall Study||70
41487|NCT01976104|99900|P1|STARTED|Overall Study||43
41488|NCT01975974|99926|P1|NOT COMPLETED|Overall Study||0
41489|NCT01975974|99926|P1|COMPLETED|Overall Study||100
41490|NCT01975974|99926|P1|STARTED|Overall Study||100
41491|NCT01975948|99934|P4|NOT COMPLETED|Overall Study||6
41492|NCT01975948|99935|P3|NOT COMPLETED|Overall Study||7
41493|NCT01975948|99936|P2|NOT COMPLETED|Overall Study||21
41494|NCT01975948|99937|P1|NOT COMPLETED|Overall Study||17
41495|NCT01975948|99934|P4|COMPLETED|Overall Study||51
41496|NCT01975948|99935|P3|COMPLETED|Overall Study||65
41497|NCT01975948|99936|P2|COMPLETED|Overall Study||34
41498|NCT01975948|99937|P1|COMPLETED|Overall Study||39
41499|NCT01975948|99934|P4|STARTED|Overall Study||57
41500|NCT01975948|99935|P3|STARTED|Overall Study||72
41501|NCT01975948|99936|P2|STARTED|Overall Study||55
41502|NCT01975948|99937|P1|STARTED|Overall Study||56
41503|NCT01975935|99963|P2|NOT COMPLETED|Overall Study||1
41504|NCT01975935|99964|P1|NOT COMPLETED|Overall Study||3
41505|NCT01975935|99963|P2|COMPLETED|Overall Study||20
41506|NCT01975935|99964|P1|COMPLETED|Overall Study||18
41507|NCT01975935|99963|P2|STARTED|Overall Study||21
41508|NCT01975935|99964|P1|STARTED|Overall Study||21
41509|NCT01975922|99976|P2|NOT COMPLETED|Overall Study||9
41510|NCT01975922|99977|P1|NOT COMPLETED|Overall Study||0
41511|NCT01975922|99976|P2|COMPLETED|Overall Study||43
41512|NCT01975922|99977|P1|COMPLETED|Overall Study||45
41513|NCT01975922|99976|P2|STARTED|Overall Study||52
41514|NCT01975922|99977|P1|STARTED|Overall Study||45
41515|NCT01975909|99987|P2|NOT COMPLETED|Overall Study||0
41516|NCT01975909|99988|P1|NOT COMPLETED|Overall Study||0
41517|NCT01975909|99987|P2|COMPLETED|Overall Study||10
41518|NCT01975909|99988|P1|COMPLETED|Overall Study||10
41519|NCT01975909|99987|P2|STARTED|Overall Study||10
41520|NCT01975909|99988|P1|STARTED|Overall Study||10
41521|NCT01975675|100008|P4|NOT COMPLETED|Overall Study||0
41522|NCT01975675|100009|P3|NOT COMPLETED|Overall Study||0
41523|NCT01975675|100010|P2|NOT COMPLETED|Overall Study||1
41524|NCT01975675|100011|P1|NOT COMPLETED|Overall Study||0
41525|NCT01975675|100008|P4|COMPLETED|Overall Study||87
41526|NCT01975675|100009|P3|COMPLETED|Overall Study||88
41527|NCT01975675|100010|P2|COMPLETED|Overall Study||82
41528|NCT01975675|100011|P1|COMPLETED|Overall Study||83
41529|NCT01975675|100008|P4|STARTED|Overall Study||87
41530|NCT01975675|100009|P3|STARTED|Overall Study||88
41531|NCT01975675|100010|P2|STARTED|Overall Study||83
41532|NCT01975675|100011|P1|STARTED|Overall Study||83
41533|NCT01975467|100033|P2|NOT COMPLETED|Overall Study||0
41534|NCT01975467|100034|P1|NOT COMPLETED|Overall Study||0
41535|NCT01975467|100033|P2|COMPLETED|Overall Study||0
41536|NCT01975467|100034|P1|COMPLETED|Overall Study||0
41537|NCT01975467|100033|P2|STARTED|Overall Study|Study terminated before enrollment|0
41538|NCT01975467|100034|P1|STARTED|Overall Study|Study terminated before enrollment|0
41539|NCT01975285|100044|P2|NOT COMPLETED|Overall Study||2
41540|NCT01975285|100045|P1|NOT COMPLETED|Overall Study||2
41541|NCT01975285|100044|P2|COMPLETED|Overall Study||28
41542|NCT01975285|100045|P1|COMPLETED|Overall Study||28
41543|NCT01975285|100044|P2|STARTED|Overall Study||30
41544|NCT01975285|100045|P1|STARTED|Overall Study||30
41545|NCT01975246|100061|P2|NOT COMPLETED|Overall Study||2
41546|NCT01975246|100062|P1|NOT COMPLETED|Overall Study||4
41547|NCT01975246|100061|P2|COMPLETED|Overall Study||158
41548|NCT01975246|100062|P1|COMPLETED|Overall Study||145
41549|NCT01975246|100061|P2|STARTED|Overall Study||160
41550|NCT01975246|100062|P1|STARTED|Overall Study||149
41551|NCT01975220|100075|P6|NOT COMPLETED|Test Period 2||0
41552|NCT01975220|100076|P5|NOT COMPLETED|Test Period 2||0
41553|NCT01975220|100077|P4|NOT COMPLETED|Test Period 2||0
41554|NCT01975220|100078|P3|NOT COMPLETED|Test Period 2||0
41555|NCT01975220|100079|P2|NOT COMPLETED|Test Period 2||0
41556|NCT01975220|100080|P1|NOT COMPLETED|Test Period 2||0
41557|NCT01975220|100075|P6|COMPLETED|Test Period 2||12
41558|NCT01975220|100076|P5|COMPLETED|Test Period 2||12
41559|NCT01975220|100077|P4|COMPLETED|Test Period 2||12
41560|NCT01975220|100078|P3|COMPLETED|Test Period 2||12
41561|NCT01975220|100079|P2|COMPLETED|Test Period 2||11
41562|NCT01975220|100080|P1|COMPLETED|Test Period 2||12
41563|NCT01975220|100075|P6|STARTED|Test Period 2||12
41564|NCT01975220|100076|P5|STARTED|Test Period 2||12
41565|NCT01975220|100077|P4|STARTED|Test Period 2||12
41566|NCT01975220|100078|P3|STARTED|Test Period 2||12
41567|NCT01975220|100079|P2|STARTED|Test Period 2||11
41568|NCT01975220|100080|P1|STARTED|Test Period 2||12
41569|NCT01975220|100075|P6|NOT COMPLETED|Test Period 1||0
41570|NCT01975220|100076|P5|NOT COMPLETED|Test Period 1||0
41571|NCT01975220|100077|P4|NOT COMPLETED|Test Period 1||0
41572|NCT01975220|100078|P3|NOT COMPLETED|Test Period 1||0
41573|NCT01975220|100079|P2|NOT COMPLETED|Test Period 1||1
41574|NCT01975220|100080|P1|NOT COMPLETED|Test Period 1||0
41575|NCT01975220|100075|P6|COMPLETED|Test Period 1||12
41576|NCT01975220|100076|P5|COMPLETED|Test Period 1||12
41577|NCT01975220|100077|P4|COMPLETED|Test Period 1||12
41578|NCT01975220|100078|P3|COMPLETED|Test Period 1||12
41579|NCT01975220|100079|P2|COMPLETED|Test Period 1||11
41580|NCT01975220|100080|P1|COMPLETED|Test Period 1||12
41581|NCT01975220|100075|P6|STARTED|Test Period 1||12
41582|NCT01975220|100076|P5|STARTED|Test Period 1||12
41583|NCT01975220|100077|P4|STARTED|Test Period 1||12
41584|NCT01975220|100078|P3|STARTED|Test Period 1||12
41585|NCT01975220|100079|P2|STARTED|Test Period 1||12
41586|NCT01975220|100080|P1|STARTED|Test Period 1||12
41587|NCT01975090|100124|P1|NOT COMPLETED|Overall Study||12
41588|NCT01975090|100124|P1|COMPLETED|Overall Study||117
41589|NCT01975090|100124|P1|6-month Follow-up|Overall Study||117
41590|NCT01975090|100124|P1|STARTED|Overall Study||129
41591|NCT01974895|100136|P2|NOT COMPLETED|Overall Study||15
41592|NCT01974895|100137|P1|NOT COMPLETED|Overall Study||15
41593|NCT01974895|100136|P2|COMPLETED|Overall Study||141
41594|NCT01974895|100137|P1|COMPLETED|Overall Study||143
41595|NCT01974895|100136|P2|STARTED|Overall Study||156
41596|NCT01974895|100137|P1|STARTED|Overall Study||158
41597|NCT01974817|100167|P1|NOT COMPLETED|Overall Study||8
41598|NCT01974817|100167|P1|COMPLETED|Overall Study||17
41599|NCT01974817|100167|P1|STARTED|Overall Study||25
41600|NCT01974752|100173|P2|NOT COMPLETED|Overall Study||15
41601|NCT01974752|100174|P1|NOT COMPLETED|Overall Study||37
41602|NCT01974752|100173|P2|COMPLETED|Overall Study||17
41603|NCT01974752|100174|P1|COMPLETED|Overall Study||60
41604|NCT01974752|100173|P2|STARTED|Overall Study||32
41605|NCT01974752|100174|P1|STARTED|Overall Study||97
41606|NCT01974700|100188|P2|NOT COMPLETED|Overall Study||0
41607|NCT01974700|100189|P1|NOT COMPLETED|Overall Study||0
41608|NCT01974700|100188|P2|COMPLETED|Overall Study||3
41609|NCT01974700|100189|P1|COMPLETED|Overall Study||5
41610|NCT01974700|100188|P2|STARTED|Overall Study||3
41611|NCT01974700|100189|P1|STARTED|Overall Study||5
41612|NCT01974323|100201|P2|NOT COMPLETED|Overall Study||93
41613|NCT01974323|100202|P1|NOT COMPLETED|Overall Study||92
41614|NCT01974323|100201|P2|COMPLETED|Overall Study||1027
41615|NCT01974323|100202|P1|COMPLETED|Overall Study||1026
41616|NCT01974323|100201|P2|STARTED|Overall Study||1120
41617|NCT01974323|100202|P1|STARTED|Overall Study||1118
41618|NCT01974245|100226|P2|NOT COMPLETED|Overall Study||8
41619|NCT01974245|100227|P1|NOT COMPLETED|Overall Study||9
41620|NCT01974245|100226|P2|COMPLETED|Overall Study||20
41621|NCT01974245|100227|P1|COMPLETED|Overall Study||18
41622|NCT01974245|100226|P2|STARTED|Overall Study||28
41623|NCT01974245|100227|P1|STARTED|Overall Study||27
41624|NCT01974141|100235|P2|NOT COMPLETED|Overall Study||82
41625|NCT01974141|100236|P1|NOT COMPLETED|Overall Study||96
41626|NCT01974141|100235|P2|COMPLETED|Overall Study||976
41627|NCT01974141|100236|P1|COMPLETED|Overall Study||948
41628|NCT01974141|100235|P2|STARTED|Overall Study||1058
41629|NCT01974141|100236|P1|STARTED|Overall Study||1044
41630|NCT01974050|100258|P1|NOT COMPLETED|Overall Study||25
41631|NCT01974050|100258|P1|COMPLETED|Overall Study||141
41632|NCT01974050|100258|P1|STARTED|Overall Study||166
41633|NCT01973777|100265|P1|NOT COMPLETED|Overall Study||7
41634|NCT01973777|100265|P1|COMPLETED|Overall Study||44
41635|NCT01973777|100265|P1|One Year Follow-up|Overall Study||44
41636|NCT01973777|100265|P1|STARTED|Overall Study|January 2014|51
41637|NCT01973608|100275|P4|NOT COMPLETED|Overall Study||0
41638|NCT01973608|100276|P3|NOT COMPLETED|Overall Study||0
41639|NCT01973608|100277|P2|NOT COMPLETED|Overall Study||0
41640|NCT01973608|100278|P1|NOT COMPLETED|Overall Study||0
41641|NCT01973608|100275|P4|COMPLETED|Overall Study||2
41642|NCT01973608|100276|P3|COMPLETED|Overall Study||6
41643|NCT01973608|100277|P2|COMPLETED|Overall Study||2
41644|NCT01973608|100278|P1|COMPLETED|Overall Study||2
41645|NCT01973608|100275|P4|STARTED|Overall Study||2
41646|NCT01973608|100276|P3|STARTED|Overall Study||6
41647|NCT01973608|100277|P2|STARTED|Overall Study||2
41648|NCT01973608|100278|P1|STARTED|Overall Study||2
41649|NCT01973595|100300|P4|NOT COMPLETED|Intervention Phase 2||0
41650|NCT01973595|100301|P3|NOT COMPLETED|Intervention Phase 2||0
41651|NCT01973595|100302|P2|NOT COMPLETED|Intervention Phase 2||0
41652|NCT01973595|100303|P1|NOT COMPLETED|Intervention Phase 2||0
41653|NCT01973595|100300|P4|COMPLETED|Intervention Phase 2||14
41654|NCT01973595|100301|P3|COMPLETED|Intervention Phase 2||14
41655|NCT01973595|100302|P2|COMPLETED|Intervention Phase 2||14
41656|NCT01973595|100303|P1|COMPLETED|Intervention Phase 2||14
41657|NCT01973595|100300|P4|STARTED|Intervention Phase 2||14
41658|NCT01973595|100301|P3|STARTED|Intervention Phase 2||14
41659|NCT01973595|100302|P2|STARTED|Intervention Phase 2||14
41660|NCT01973595|100303|P1|STARTED|Intervention Phase 2||14
41661|NCT01973595|100300|P4|NOT COMPLETED|Washout||0
41662|NCT01973595|100301|P3|NOT COMPLETED|Washout||1
41663|NCT01973595|100302|P2|NOT COMPLETED|Washout||0
41664|NCT01973595|100303|P1|NOT COMPLETED|Washout||1
41665|NCT01973595|100300|P4|COMPLETED|Washout||14
41666|NCT01973595|100301|P3|COMPLETED|Washout||14
41667|NCT01973595|100302|P2|COMPLETED|Washout||14
41668|NCT01973595|100303|P1|COMPLETED|Washout||14
41669|NCT01973595|100300|P4|STARTED|Washout||14
41670|NCT01973595|100301|P3|STARTED|Washout||15
41671|NCT01973595|100302|P2|STARTED|Washout||14
41672|NCT01973595|100303|P1|STARTED|Washout||15
41673|NCT01973595|100300|P4|NOT COMPLETED|Intervention Phase 1||0
41674|NCT01973595|100301|P3|NOT COMPLETED|Intervention Phase 1||0
41675|NCT01973595|100302|P2|NOT COMPLETED|Intervention Phase 1||0
41676|NCT01973595|100303|P1|NOT COMPLETED|Intervention Phase 1||0
41677|NCT01973595|100300|P4|COMPLETED|Intervention Phase 1||14
41678|NCT01973595|100301|P3|COMPLETED|Intervention Phase 1||15
41679|NCT01973595|100302|P2|COMPLETED|Intervention Phase 1||14
41680|NCT01973595|100303|P1|COMPLETED|Intervention Phase 1||15
41681|NCT01973595|100300|P4|STARTED|Intervention Phase 1||14
41682|NCT01973595|100301|P3|STARTED|Intervention Phase 1||15
41683|NCT01973595|100302|P2|STARTED|Intervention Phase 1||14
41684|NCT01973595|100303|P1|STARTED|Intervention Phase 1||15
41685|NCT01973491|100317|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
41686|NCT01973491|100317|P1|COMPLETED|Treatment Period (16 Weeks)||18
41687|NCT01973491|100317|P1|STARTED|Treatment Period (16 Weeks)||19
41688|NCT01973491|100317|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
41689|NCT01973491|100317|P1|COMPLETED|Titration Period(4 Weeks)||19
41690|NCT01973491|100317|P1|STARTED|Titration Period(4 Weeks)||19
41691|NCT01973491|100317|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
41692|NCT01973491|100317|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
41693|NCT01973491|100317|P1|STARTED|Baseline Control Period (8 Weeks)||37
41694|NCT01973439|100333|P1|NOT COMPLETED|Overall Study||5
41695|NCT01973439|100333|P1|COMPLETED|Overall Study||18
41696|NCT01973439|100333|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
41697|NCT01973439|100333|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
41698|NCT01973439|100333|P1|STARTED|Overall Study||23
41699|NCT01973413|100342|P2|NOT COMPLETED|Overall Study||0
41700|NCT01973413|100343|P1|NOT COMPLETED|Overall Study||1
41701|NCT01973413|100342|P2|COMPLETED|Overall Study||20
41702|NCT01973413|100343|P1|COMPLETED|Overall Study||11
41703|NCT01973413|100342|P2|STARTED|Overall Study||20
41704|NCT01973413|100343|P1|STARTED|Overall Study||12
41705|NCT01973387|100355|P2|NOT COMPLETED|Overall Study||18
41706|NCT01973387|100356|P1|NOT COMPLETED|Overall Study||106
41707|NCT01973387|100355|P2|COMPLETED|Overall Study||36
41708|NCT01973387|100356|P1|COMPLETED|Overall Study||0
41709|NCT01973387|100355|P2|Treated|Overall Study||52
41710|NCT01973387|100356|P1|Treated|Overall Study||104
41711|NCT01973387|100355|P2|STARTED|Overall Study||54
41712|NCT01973387|100356|P1|STARTED|Overall Study||106
41713|NCT01973348|100370|P4|NOT COMPLETED|Overall Study||0
41714|NCT01973348|100371|P3|NOT COMPLETED|Overall Study||0
41715|NCT01973348|100372|P2|NOT COMPLETED|Overall Study||3
41716|NCT01973348|100373|P1|NOT COMPLETED|Overall Study||8
41717|NCT01973348|100370|P4|COMPLETED|Overall Study||0
41718|NCT01973348|100371|P3|COMPLETED|Overall Study||0
41719|NCT01973348|100372|P2|COMPLETED|Overall Study||15
41720|NCT01973348|100373|P1|COMPLETED|Overall Study||19
41721|NCT01973348|100370|P4|STARTED|Overall Study||0
41722|NCT01973348|100371|P3|STARTED|Overall Study||0
41723|NCT01973348|100372|P2|STARTED|Overall Study||18
41724|NCT01973348|100373|P1|STARTED|Overall Study||27
41725|NCT01973231|100393|P2|NOT COMPLETED|Overall Study||12
41726|NCT01973231|100394|P1|NOT COMPLETED|Overall Study||11
41727|NCT01973231|100393|P2|COMPLETED|Overall Study||190
41728|NCT01973231|100394|P1|COMPLETED|Overall Study||191
41729|NCT01973231|100393|P2|STARTED|Overall Study||202
41730|NCT01973231|100394|P1|STARTED|Overall Study||202
41731|NCT01973218|100414|P2|NOT COMPLETED|Overall Study||0
41732|NCT01973218|100415|P1|NOT COMPLETED|Overall Study||2
41733|NCT01973218|100414|P2|COMPLETED|Overall Study||88
41734|NCT01973218|100415|P1|COMPLETED|Overall Study||174
41735|NCT01973218|100414|P2|STARTED|Overall Study||88
41736|NCT01973218|100415|P1|STARTED|Overall Study||176
41737|NCT01973205|100438|P2|NOT COMPLETED|Overall Study||22
41738|NCT01973205|100439|P1|NOT COMPLETED|Overall Study||30
41739|NCT01973205|100438|P2|COMPLETED|Overall Study||425
41740|NCT01973205|100439|P1|COMPLETED|Overall Study||423
41741|NCT01973205|100438|P2|STARTED|Overall Study||447
41742|NCT01973205|100439|P1|STARTED|Overall Study||453
41743|NCT01972776|100457|P6|NOT COMPLETED|Part 2||7
41744|NCT01972776|100458|P5|NOT COMPLETED|Part 2||13
41745|NCT01972776|100459|P4|NOT COMPLETED|Part 2||0
41746|NCT01972776|100460|P3|NOT COMPLETED|Part 2||0
41747|NCT01972776|100461|P2|NOT COMPLETED|Part 2||0
41748|NCT01972776|100462|P1|NOT COMPLETED|Part 2||0
41749|NCT01972776|100457|P6|COMPLETED|Part 2||0
41750|NCT01972776|100458|P5|COMPLETED|Part 2||1
41751|NCT01972776|100459|P4|COMPLETED|Part 2||0
41752|NCT01972776|100460|P3|COMPLETED|Part 2||0
41753|NCT01972776|100461|P2|COMPLETED|Part 2||0
41754|NCT01972776|100462|P1|COMPLETED|Part 2||0
41755|NCT01972776|100457|P6|STARTED|Part 2||7
41756|NCT01972776|100458|P5|STARTED|Part 2||14
41757|NCT01972776|100459|P4|STARTED|Part 2||0
41758|NCT01972776|100460|P3|STARTED|Part 2||0
41759|NCT01972776|100461|P2|STARTED|Part 2||0
41760|NCT01972776|100462|P1|STARTED|Part 2||0
41761|NCT01972776|100457|P6|NOT COMPLETED|Part 1||0
41762|NCT01972776|100458|P5|NOT COMPLETED|Part 1||0
41763|NCT01972776|100459|P4|NOT COMPLETED|Part 1||1
41764|NCT01972776|100460|P3|NOT COMPLETED|Part 1||2
41765|NCT01972776|100461|P2|NOT COMPLETED|Part 1||0
41766|NCT01972776|100462|P1|NOT COMPLETED|Part 1||0
41767|NCT01972776|100457|P6|COMPLETED|Part 1||0
41768|NCT01972776|100458|P5|COMPLETED|Part 1||0
41769|NCT01972776|100459|P4|COMPLETED|Part 1||6
41770|NCT01972776|100460|P3|COMPLETED|Part 1||6
41771|NCT01972776|100461|P2|COMPLETED|Part 1||6
41772|NCT01972776|100462|P1|COMPLETED|Part 1||6
41773|NCT01972776|100457|P6|STARTED|Part 1||0
41774|NCT01972776|100458|P5|STARTED|Part 1||0
41775|NCT01972776|100459|P4|STARTED|Part 1||7
41776|NCT01972776|100460|P3|STARTED|Part 1||8
41777|NCT01972776|100461|P2|STARTED|Part 1||6
41778|NCT01972776|100462|P1|STARTED|Part 1||6
41779|NCT01972659|100532|P2|NOT COMPLETED|Overall Study||3
41780|NCT01972659|100533|P1|NOT COMPLETED|Overall Study||4
41781|NCT01972659|100532|P2|COMPLETED|Overall Study||37
41782|NCT01972659|100533|P1|COMPLETED|Overall Study||36
41783|NCT01972659|100532|P2|STARTED|Overall Study||40
41784|NCT01972659|100533|P1|STARTED|Overall Study||40
41785|NCT01972568|100542|P3|NOT COMPLETED|Overall Study||16
41786|NCT01972568|100543|P2|NOT COMPLETED|Overall Study||12
41787|NCT01972568|100544|P1|NOT COMPLETED|Overall Study||16
41788|NCT01972568|100542|P3|COMPLETED|Overall Study||84
41789|NCT01972568|100543|P2|COMPLETED|Overall Study||92
41790|NCT01972568|100544|P1|COMPLETED|Overall Study||86
41791|NCT01972568|100542|P3|STARTED|Overall Study||100
41792|NCT01972568|100543|P2|STARTED|Overall Study||104
41793|NCT01972568|100544|P1|STARTED|Overall Study||102
41794|NCT01972529|100583|P4|NOT COMPLETED|Overall Study||4
41795|NCT01972529|100584|P3|NOT COMPLETED|Overall Study||2
41796|NCT01972529|100585|P2|NOT COMPLETED|Overall Study||5
41797|NCT01972529|100586|P1|NOT COMPLETED|Overall Study||2
41798|NCT01972529|100583|P4|COMPLETED|Overall Study||55
41799|NCT01972529|100584|P3|COMPLETED|Overall Study||32
41800|NCT01972529|100585|P2|COMPLETED|Overall Study||85
41801|NCT01972529|100586|P1|COMPLETED|Overall Study||46
41802|NCT01972529|100583|P4|STARTED|Overall Study||59
41803|NCT01972529|100584|P3|STARTED|Overall Study||34
41804|NCT01972529|100585|P2|STARTED|Overall Study||90
41805|NCT01972529|100586|P1|STARTED|Overall Study||48
41806|NCT01972516|100614|P2|NOT COMPLETED|Overall Study||0
41807|NCT01972516|100615|P1|NOT COMPLETED|Overall Study||0
41808|NCT01972516|100614|P2|COMPLETED|Overall Study||1
41809|NCT01972516|100615|P1|COMPLETED|Overall Study||3
41810|NCT01972516|100614|P2|STARTED|Overall Study||1
41811|NCT01972516|100615|P1|STARTED|Overall Study||3
41812|NCT01972464|100631|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
41813|NCT01972464|100632|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
41814|NCT01972464|100631|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
41815|NCT01972464|100632|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
41816|NCT01972464|100631|P2|STARTED|3-Month Follow-Up (Week 20)||18
41817|NCT01972464|100632|P1|STARTED|3-Month Follow-Up (Week 20)||16
41818|NCT01972464|100631|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
41819|NCT01972464|100632|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
41820|NCT01972464|100631|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
41821|NCT01972464|100632|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
41822|NCT01972464|100631|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
41823|NCT01972464|100632|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
41824|NCT01972438|100648|P2|NOT COMPLETED|Post Month 12 Study Period||4
41825|NCT01972438|100649|P1|NOT COMPLETED|Post Month 12 Study Period||3
41826|NCT01972438|100648|P2|COMPLETED|Post Month 12 Study Period||0
41827|NCT01972438|100649|P1|COMPLETED|Post Month 12 Study Period||0
41828|NCT01972438|100648|P2|STARTED|Post Month 12 Study Period||4
41829|NCT01972438|100649|P1|STARTED|Post Month 12 Study Period||3
41830|NCT01972438|100648|P2|NOT COMPLETED|Months 6-12 Study Period||2
41831|NCT01972438|100649|P1|NOT COMPLETED|Months 6-12 Study Period||3
41832|NCT01972438|100648|P2|COMPLETED|Months 6-12 Study Period||4
41833|NCT01972438|100649|P1|COMPLETED|Months 6-12 Study Period||3
41834|NCT01972438|100648|P2|STARTED|Months 6-12 Study Period||6
41835|NCT01972438|100649|P1|STARTED|Months 6-12 Study Period||6
41836|NCT01972438|100648|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
41837|NCT01972438|100649|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
41838|NCT01972438|100648|P2|COMPLETED|Months 3-6 Crossover Period||6
41839|NCT01972438|100649|P1|COMPLETED|Months 3-6 Crossover Period||6
41840|NCT01972438|100648|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
41841|NCT01972438|100649|P1|STARTED|Months 3-6 Crossover Period||6
41842|NCT01972438|100648|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
41843|NCT01972438|100649|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
41844|NCT01972438|100648|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
41845|NCT01972438|100649|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
41846|NCT01972438|100648|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
41847|NCT01972438|100649|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
41848|NCT01972152|100701|P6|NOT COMPLETED|Third Treatment Visit||0
41849|NCT01972152|100702|P5|NOT COMPLETED|Third Treatment Visit||0
41850|NCT01972152|100703|P4|NOT COMPLETED|Third Treatment Visit||0
41851|NCT01972152|100704|P3|NOT COMPLETED|Third Treatment Visit||0
41852|NCT01972152|100705|P2|NOT COMPLETED|Third Treatment Visit||0
41853|NCT01972152|100706|P1|NOT COMPLETED|Third Treatment Visit||0
41854|NCT01972152|100701|P6|COMPLETED|Third Treatment Visit||5
41855|NCT01972152|100702|P5|COMPLETED|Third Treatment Visit||5
41856|NCT01972152|100703|P4|COMPLETED|Third Treatment Visit||5
41857|NCT01972152|100704|P3|COMPLETED|Third Treatment Visit||5
41858|NCT01972152|100705|P2|COMPLETED|Third Treatment Visit||3
41859|NCT01972152|100706|P1|COMPLETED|Third Treatment Visit||5
41860|NCT01972152|100701|P6|STARTED|Third Treatment Visit||5
41861|NCT01972152|100702|P5|STARTED|Third Treatment Visit||5
41862|NCT01972152|100703|P4|STARTED|Third Treatment Visit||5
41863|NCT01972152|100704|P3|STARTED|Third Treatment Visit||5
41864|NCT01972152|100705|P2|STARTED|Third Treatment Visit||3
41865|NCT01972152|100706|P1|STARTED|Third Treatment Visit||5
41866|NCT01972152|100701|P6|NOT COMPLETED|Second Treatment Visit||0
41867|NCT01972152|100702|P5|NOT COMPLETED|Second Treatment Visit||0
41868|NCT01972152|100703|P4|NOT COMPLETED|Second Treatment Visit||0
41869|NCT01972152|100704|P3|NOT COMPLETED|Second Treatment Visit||0
41870|NCT01972152|100705|P2|NOT COMPLETED|Second Treatment Visit||1
41871|NCT01972152|100706|P1|NOT COMPLETED|Second Treatment Visit||0
41872|NCT01972152|100701|P6|COMPLETED|Second Treatment Visit||5
41873|NCT01972152|100702|P5|COMPLETED|Second Treatment Visit||5
41874|NCT01972152|100703|P4|COMPLETED|Second Treatment Visit||5
41875|NCT01972152|100704|P3|COMPLETED|Second Treatment Visit||5
41876|NCT01972152|100705|P2|COMPLETED|Second Treatment Visit||3
41877|NCT01972152|100706|P1|COMPLETED|Second Treatment Visit||5
41878|NCT01972152|100701|P6|STARTED|Second Treatment Visit||5
41879|NCT01972152|100702|P5|STARTED|Second Treatment Visit||5
41880|NCT01972152|100703|P4|STARTED|Second Treatment Visit||5
41881|NCT01972152|100704|P3|STARTED|Second Treatment Visit||5
41882|NCT01972152|100705|P2|STARTED|Second Treatment Visit||4
41883|NCT01972152|100706|P1|STARTED|Second Treatment Visit||5
41884|NCT01972152|100701|P6|NOT COMPLETED|First Treatment Visit||0
41885|NCT01972152|100702|P5|NOT COMPLETED|First Treatment Visit||0
41886|NCT01972152|100703|P4|NOT COMPLETED|First Treatment Visit||0
41887|NCT01972152|100704|P3|NOT COMPLETED|First Treatment Visit||0
41888|NCT01972152|100705|P2|NOT COMPLETED|First Treatment Visit||1
41889|NCT01972152|100706|P1|NOT COMPLETED|First Treatment Visit||0
41890|NCT01972152|100701|P6|COMPLETED|First Treatment Visit||5
41891|NCT01972152|100702|P5|COMPLETED|First Treatment Visit||5
41892|NCT01972152|100703|P4|COMPLETED|First Treatment Visit||5
41893|NCT01972152|100704|P3|COMPLETED|First Treatment Visit||5
41894|NCT01972152|100705|P2|COMPLETED|First Treatment Visit||4
41895|NCT01972152|100706|P1|COMPLETED|First Treatment Visit||5
41896|NCT01972152|100701|P6|STARTED|First Treatment Visit||5
41897|NCT01972152|100702|P5|STARTED|First Treatment Visit||5
41898|NCT01972152|100703|P4|STARTED|First Treatment Visit||5
41899|NCT01972152|100704|P3|STARTED|First Treatment Visit||5
41900|NCT01972152|100705|P2|STARTED|First Treatment Visit||5
41901|NCT01972152|100706|P1|STARTED|First Treatment Visit||5
41902|NCT01971723|100743|P2|NOT COMPLETED|Overall Study||3
41903|NCT01971723|100744|P1|NOT COMPLETED|Overall Study||2
41904|NCT01971723|100743|P2|COMPLETED|Overall Study||13
41905|NCT01971723|100744|P1|COMPLETED|Overall Study||14
41906|NCT01971723|100743|P2|STARTED|Overall Study||16
41907|NCT01971723|100744|P1|STARTED|Overall Study||16
41908|NCT01971645|100777|P3|NOT COMPLETED|Overall Study||2
41909|NCT01971645|100778|P2|NOT COMPLETED|Overall Study||0
41910|NCT01971645|100779|P1|NOT COMPLETED|Overall Study||2
41911|NCT01971645|100777|P3|COMPLETED|Overall Study||23
41912|NCT01971645|100778|P2|COMPLETED|Overall Study||27
41913|NCT01971645|100779|P1|COMPLETED|Overall Study||23
41914|NCT01971645|100777|P3|STARTED|Overall Study||25
41915|NCT01971645|100778|P2|STARTED|Overall Study||27
41916|NCT01971645|100779|P1|STARTED|Overall Study||25
41917|NCT01971593|100790|P2|NOT COMPLETED|Overall Study||4
41918|NCT01971593|100791|P1|NOT COMPLETED|Overall Study||5
41919|NCT01971593|100790|P2|COMPLETED|Overall Study||8
41920|NCT01971593|100791|P1|COMPLETED|Overall Study||9
41921|NCT01971593|100790|P2|STARTED|Overall Study||12
41922|NCT01971593|100791|P1|STARTED|Overall Study||14
41923|NCT01971580|100802|P2|NOT COMPLETED|Overall Study||5
41924|NCT01971580|100803|P1|NOT COMPLETED|Overall Study||4
41925|NCT01971580|100802|P2|COMPLETED|Overall Study||9
41926|NCT01971580|100803|P1|COMPLETED|Overall Study||10
41927|NCT01971580|100802|P2|STARTED|Overall Study||14
41928|NCT01971580|100803|P1|STARTED|Overall Study||14
41929|NCT01971567|100813|P2|NOT COMPLETED|Overall Study||2
41930|NCT01971567|100814|P1|NOT COMPLETED|Overall Study||4
41931|NCT01971567|100813|P2|COMPLETED|Overall Study||49
41932|NCT01971567|100814|P1|COMPLETED|Overall Study||52
41933|NCT01971567|100813|P2|STARTED|Overall Study||51
41934|NCT01971567|100814|P1|STARTED|Overall Study||56
41935|NCT01971554|100840|P4|NOT COMPLETED|Overall Study||0
41936|NCT01971554|100841|P3|NOT COMPLETED|Overall Study||0
41937|NCT01971554|100842|P2|NOT COMPLETED|Overall Study||0
41938|NCT01971554|100843|P1|NOT COMPLETED|Overall Study||1
41939|NCT01971554|100840|P4|COMPLETED|Overall Study||18
41940|NCT01971554|100841|P3|COMPLETED|Overall Study||18
41941|NCT01971554|100842|P2|COMPLETED|Overall Study||18
41942|NCT01971554|100843|P1|COMPLETED|Overall Study||8
41943|NCT01971554|100840|P4|STARTED|Overall Study||18
41944|NCT01971554|100841|P3|STARTED|Overall Study||18
41945|NCT01971554|100842|P2|STARTED|Overall Study||18
41946|NCT01971554|100843|P1|STARTED|Overall Study||9
41947|NCT01971385|100880|P3|NOT COMPLETED|Overall Study||4
41948|NCT01971385|100881|P2|NOT COMPLETED|Overall Study||5
41949|NCT01971385|100882|P1|NOT COMPLETED|Overall Study||3
41950|NCT01971385|100880|P3|COMPLETED|Overall Study||15
41951|NCT01971385|100881|P2|COMPLETED|Overall Study||13
41952|NCT01971385|100882|P1|COMPLETED|Overall Study||14
41953|NCT01971385|100880|P3|STARTED|Overall Study||19
41954|NCT01971385|100881|P2|STARTED|Overall Study||18
41955|NCT01971385|100882|P1|STARTED|Overall Study||17
41956|NCT01971255|100891|P2|NOT COMPLETED|Overall Study||2
41957|NCT01971255|100892|P1|NOT COMPLETED|Overall Study||1
41958|NCT01971255|100891|P2|COMPLETED|Overall Study||40
41959|NCT01971255|100892|P1|COMPLETED|Overall Study||31
41960|NCT01971255|100891|P2|STARTED|Overall Study||42
41961|NCT01971255|100892|P1|STARTED|Overall Study||32
41962|NCT01971203|100910|P2|NOT COMPLETED|Overall Study||8
41963|NCT01971203|100911|P1|NOT COMPLETED|Overall Study||9
41964|NCT01971203|100910|P2|COMPLETED|Overall Study||21
41965|NCT01971203|100911|P1|COMPLETED|Overall Study||17
41966|NCT01971203|100910|P2|STARTED|Overall Study||29
41967|NCT01971203|100911|P1|STARTED|Overall Study||26
41968|NCT01971086|100923|P1|NOT COMPLETED|Overall Study||0
41969|NCT01971086|100923|P1|COMPLETED|Overall Study||300
41970|NCT01971086|100923|P1|STARTED|Overall Study||300
41971|NCT01970995|100938|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
41972|NCT01970995|100939|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
41973|NCT01970995|100940|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
41974|NCT01970995|100938|P3|COMPLETED|End of Study (Population at Day 90)||38
41975|NCT01970995|100939|P2|COMPLETED|End of Study (Population at Day 90)||41
41976|NCT01970995|100940|P1|COMPLETED|End of Study (Population at Day 90)||76
41977|NCT01970995|100938|P3|STARTED|End of Study (Population at Day 90)||39
41978|NCT01970995|100939|P2|STARTED|End of Study (Population at Day 90)||41
41979|NCT01970995|100940|P1|STARTED|End of Study (Population at Day 90)||77
41980|NCT01970995|100938|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
41981|NCT01970995|100939|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
41982|NCT01970995|100940|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
41983|NCT01970995|100938|P3|COMPLETED|Confinement Period (Population at Day 5)||39
41984|NCT01970995|100939|P2|COMPLETED|Confinement Period (Population at Day 5)||41
41985|NCT01970995|100940|P1|COMPLETED|Confinement Period (Population at Day 5)||77
41986|NCT01970995|100938|P3|STARTED|Confinement Period (Population at Day 5)||40
41987|NCT01970995|100939|P2|STARTED|Confinement Period (Population at Day 5)||42
41988|NCT01970995|100940|P1|STARTED|Confinement Period (Population at Day 5)||78
41989|NCT01970982|100963|P3|NOT COMPLETED|Overall Study||2
41990|NCT01970982|100964|P2|NOT COMPLETED|Overall Study||0
41991|NCT01970982|100965|P1|NOT COMPLETED|Overall Study||0
41992|NCT01970982|100963|P3|COMPLETED|Overall Study||38
41993|NCT01970982|100964|P2|COMPLETED|Overall Study||40
41994|NCT01970982|100965|P1|COMPLETED|Overall Study||80
41995|NCT01970982|100963|P3|STARTED|Overall Study||40
41996|NCT01970982|100964|P2|STARTED|Overall Study||40
41997|NCT01970982|100965|P1|STARTED|Overall Study||80
41998|NCT01970878|100987|P4|NOT COMPLETED|Overall Study||24
41999|NCT01970878|100988|P3|NOT COMPLETED|Overall Study||26
42000|NCT01970878|100989|P2|NOT COMPLETED|Overall Study||27
42001|NCT01970878|100990|P1|NOT COMPLETED|Overall Study||37
42002|NCT01970878|100987|P4|COMPLETED|Overall Study||147
42003|NCT01970878|100988|P3|COMPLETED|Overall Study||187
42004|NCT01970878|100989|P2|COMPLETED|Overall Study||191
42005|NCT01970878|100990|P1|COMPLETED|Overall Study||253
42006|NCT01970878|100987|P4|STARTED|Overall Study||171
42007|NCT01970878|100988|P3|STARTED|Overall Study||213
42008|NCT01970878|100989|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
42009|NCT01970878|100990|P1|STARTED|Overall Study||290
42010|NCT01970865|101033|P17|NOT COMPLETED|Overall Study||3
42011|NCT01970865|101034|P16|NOT COMPLETED|Overall Study||47
42012|NCT01970865|101035|P15|NOT COMPLETED|Overall Study||46
42013|NCT01970865|101036|P14|NOT COMPLETED|Overall Study||66
42014|NCT01970865|101037|P13|NOT COMPLETED|Overall Study||60
42015|NCT01970865|101038|P12|NOT COMPLETED|Overall Study||27
42016|NCT01970865|101039|P11|NOT COMPLETED|Overall Study||30
42017|NCT01970865|101040|P10|NOT COMPLETED|Overall Study||4
42018|NCT01970865|101041|P9|NOT COMPLETED|Overall Study||3
42019|NCT01970865|101042|P8|NOT COMPLETED|Overall Study||3
42020|NCT01970865|101043|P7|NOT COMPLETED|Overall Study||3
42021|NCT01970865|101044|P6|NOT COMPLETED|Overall Study||3
42022|NCT01970865|101045|P5|NOT COMPLETED|Overall Study||17
42023|NCT01970865|101046|P4|NOT COMPLETED|Overall Study||13
42024|NCT01970865|101047|P3|NOT COMPLETED|Overall Study||3
42025|NCT01970865|101048|P2|NOT COMPLETED|Overall Study||3
42026|NCT01970865|101049|P1|NOT COMPLETED|Overall Study||3
42027|NCT01970865|101033|P17|COMPLETED|Overall Study||0
42028|NCT01970865|101034|P16|COMPLETED|Overall Study||0
42029|NCT01970865|101035|P15|COMPLETED|Overall Study||0
42030|NCT01970865|101036|P14|COMPLETED|Overall Study||0
42031|NCT01970865|101037|P13|COMPLETED|Overall Study||0
42032|NCT01970865|101038|P12|COMPLETED|Overall Study||0
42033|NCT01970865|101039|P11|COMPLETED|Overall Study||0
42034|NCT01970865|101040|P10|COMPLETED|Overall Study||0
42035|NCT01970865|101041|P9|COMPLETED|Overall Study||0
42036|NCT01970865|101042|P8|COMPLETED|Overall Study||0
42037|NCT01970865|101043|P7|COMPLETED|Overall Study||0
42038|NCT01970865|101044|P6|COMPLETED|Overall Study||0
42039|NCT01970865|101045|P5|COMPLETED|Overall Study||0
42040|NCT01970865|101046|P4|COMPLETED|Overall Study||0
42041|NCT01970865|101047|P3|COMPLETED|Overall Study||0
42042|NCT01970865|101048|P2|COMPLETED|Overall Study||0
42043|NCT01970865|101049|P1|COMPLETED|Overall Study||0
42044|NCT01970865|101033|P17|Received Treatment|Overall Study||3
42045|NCT01970865|101034|P16|Received Treatment|Overall Study||47
42046|NCT01970865|101035|P15|Received Treatment|Overall Study||46
42047|NCT01970865|101036|P14|Received Treatment|Overall Study||65
42048|NCT01970865|101037|P13|Received Treatment|Overall Study||60
42049|NCT01970865|101038|P12|Received Treatment|Overall Study||27
42050|NCT01970865|101039|P11|Received Treatment|Overall Study||30
42051|NCT01970865|101040|P10|Received Treatment|Overall Study||4
42052|NCT01970865|101041|P9|Received Treatment|Overall Study||3
42053|NCT01970865|101042|P8|Received Treatment|Overall Study||3
42054|NCT01970865|101043|P7|Received Treatment|Overall Study||3
42055|NCT01970865|101044|P6|Received Treatment|Overall Study||3
42056|NCT01970865|101045|P5|Received Treatment|Overall Study||17
42057|NCT01970865|101046|P4|Received Treatment|Overall Study||12
42058|NCT01970865|101047|P3|Received Treatment|Overall Study||3
42059|NCT01970865|101048|P2|Received Treatment|Overall Study||3
42060|NCT01970865|101049|P1|Received Treatment|Overall Study||3
42061|NCT01970865|101033|P17|STARTED|Overall Study||3
42062|NCT01970865|101034|P16|STARTED|Overall Study||47
42063|NCT01970865|101035|P15|STARTED|Overall Study||46
42064|NCT01970865|101036|P14|STARTED|Overall Study||66
42065|NCT01970865|101037|P13|STARTED|Overall Study||60
42066|NCT01970865|101038|P12|STARTED|Overall Study||27
42067|NCT01970865|101039|P11|STARTED|Overall Study||30
42068|NCT01970865|101040|P10|STARTED|Overall Study||4
42069|NCT01970865|101041|P9|STARTED|Overall Study||3
42070|NCT01970865|101042|P8|STARTED|Overall Study||3
42071|NCT01970865|101043|P7|STARTED|Overall Study||3
42072|NCT01970865|101044|P6|STARTED|Overall Study||3
42073|NCT01970865|101045|P5|STARTED|Overall Study||17
42074|NCT01970865|101046|P4|STARTED|Overall Study||13
42075|NCT01970865|101047|P3|STARTED|Overall Study||3
42076|NCT01970865|101048|P2|STARTED|Overall Study||3
42077|NCT01970865|101049|P1|STARTED|Overall Study||3
42078|NCT01970787|101473|P1|NOT COMPLETED|Overall Study||1
42079|NCT01970787|101473|P1|COMPLETED|Overall Study||21
42080|NCT01970787|101473|P1|STARTED|Overall Study||22
42081|NCT01970488|101483|P5|NOT COMPLETED|Part 2: Post Week 16||8
42082|NCT01970488|101484|P4|NOT COMPLETED|Part 2: Post Week 16||8
42083|NCT01970488|101485|P3|NOT COMPLETED|Part 2: Post Week 16||17
42084|NCT01970488|101486|P2|NOT COMPLETED|Part 2: Post Week 16||0
42085|NCT01970488|101487|P1|NOT COMPLETED|Part 2: Post Week 16||0
42086|NCT01970488|101483|P5|COMPLETED|Part 2: Post Week 16||69
42087|NCT01970488|101484|P4|COMPLETED|Part 2: Post Week 16||71
42088|NCT01970488|101485|P3|COMPLETED|Part 2: Post Week 16||135
42089|NCT01970488|101486|P2|COMPLETED|Part 2: Post Week 16||0
42090|NCT01970488|101487|P1|COMPLETED|Part 2: Post Week 16||0
42091|NCT01970488|101483|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
42092|NCT01970488|101484|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
42093|NCT01970488|101485|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
42094|NCT01970488|101486|P2|STARTED|Part 2: Post Week 16||0
42095|NCT01970488|101487|P1|STARTED|Part 2: Post Week 16||0
42096|NCT01970488|101483|P5|NOT COMPLETED|Part 1: Through Week 16||0
42097|NCT01970488|101484|P4|NOT COMPLETED|Part 1: Through Week 16||0
42098|NCT01970488|101485|P3|NOT COMPLETED|Part 1: Through Week 16||0
42099|NCT01970488|101486|P2|NOT COMPLETED|Part 1: Through Week 16||13
42100|NCT01970488|101487|P1|NOT COMPLETED|Part 1: Through Week 16||11
42101|NCT01970488|101483|P5|COMPLETED|Part 1: Through Week 16||0
42102|NCT01970488|101484|P4|COMPLETED|Part 1: Through Week 16||0
42103|NCT01970488|101485|P3|COMPLETED|Part 1: Through Week 16||0
42104|NCT01970488|101486|P2|COMPLETED|Part 1: Through Week 16||162
42105|NCT01970488|101487|P1|COMPLETED|Part 1: Through Week 16||164
42106|NCT01970488|101483|P5|Received Treatment|Part 1: Through Week 16||0
42107|NCT01970488|101484|P4|Received Treatment|Part 1: Through Week 16||0
42108|NCT01970488|101485|P3|Received Treatment|Part 1: Through Week 16||0
42109|NCT01970488|101486|P2|Received Treatment|Part 1: Through Week 16||173
42110|NCT01970488|101487|P1|Received Treatment|Part 1: Through Week 16||174
42111|NCT01970488|101483|P5|STARTED|Part 1: Through Week 16||0
42112|NCT01970488|101484|P4|STARTED|Part 1: Through Week 16||0
42113|NCT01970488|101485|P3|STARTED|Part 1: Through Week 16||0
42114|NCT01970488|101486|P2|STARTED|Part 1: Through Week 16||175
42115|NCT01970488|101487|P1|STARTED|Part 1: Through Week 16||175
42116|NCT01970475|101554|P2|NOT COMPLETED|Overall Study||11
42117|NCT01970475|101555|P1|NOT COMPLETED|Overall Study||21
42118|NCT01970475|101554|P2|COMPLETED|Overall Study||251
42119|NCT01970475|101555|P1|COMPLETED|Overall Study||243
42120|NCT01970475|101554|P2|STARTED|Overall Study||262
42121|NCT01970475|101555|P1|STARTED|Overall Study||264
42122|NCT01970462|101575|P2|NOT COMPLETED|Overall Study||2
42123|NCT01970462|101576|P1|NOT COMPLETED|Overall Study||0
42124|NCT01970462|101575|P2|COMPLETED|Overall Study||2
42125|NCT01970462|101576|P1|COMPLETED|Overall Study||1
42126|NCT01970462|101575|P2|STARTED|Overall Study||4
42127|NCT01970462|101576|P1|STARTED|Overall Study||1
42128|NCT01970397|101590|P2|NOT COMPLETED|Overall Study||5
42129|NCT01970397|101591|P1|NOT COMPLETED|Overall Study||2
42130|NCT01970397|101590|P2|COMPLETED|Overall Study||64
42131|NCT01970397|101591|P1|COMPLETED|Overall Study||67
42132|NCT01970397|101590|P2|STARTED|Overall Study||69
42133|NCT01970397|101591|P1|STARTED|Overall Study||69
42134|NCT01969799|101603|P2|NOT COMPLETED|Overall Study||14
42135|NCT01969799|101604|P1|NOT COMPLETED|Overall Study||17
42136|NCT01969799|101603|P2|COMPLETED|Overall Study||58
42137|NCT01969799|101604|P1|COMPLETED|Overall Study||54
42138|NCT01969799|101603|P2|STARTED|Overall Study||72
42139|NCT01969799|101604|P1|STARTED|Overall Study||71
42140|NCT01969747|101628|P4|NOT COMPLETED|Overall Study||0
42141|NCT01969747|101629|P3|NOT COMPLETED|Overall Study||0
42142|NCT01969747|101630|P2|NOT COMPLETED|Overall Study||0
42143|NCT01969747|101631|P1|NOT COMPLETED|Overall Study||0
42144|NCT01969747|101628|P4|COMPLETED|Overall Study||18
42145|NCT01969747|101629|P3|COMPLETED|Overall Study||19
42146|NCT01969747|101630|P2|COMPLETED|Overall Study||19
42147|NCT01969747|101631|P1|COMPLETED|Overall Study||19
42148|NCT01969747|101628|P4|STARTED|Overall Study||18
42149|NCT01969747|101629|P3|STARTED|Overall Study||19
42150|NCT01969747|101630|P2|STARTED|Overall Study||19
42151|NCT01969747|101631|P1|STARTED|Overall Study||19
42152|NCT01969721|101641|P4|NOT COMPLETED|Overall Study||6
42153|NCT01969721|101642|P3|NOT COMPLETED|Overall Study||5
42154|NCT01969721|101643|P2|NOT COMPLETED|Overall Study||12
42155|NCT01969721|101644|P1|NOT COMPLETED|Overall Study||4
42156|NCT01969721|101641|P4|COMPLETED|Overall Study||46
42157|NCT01969721|101642|P3|COMPLETED|Overall Study||45
42158|NCT01969721|101643|P2|COMPLETED|Overall Study||57
42159|NCT01969721|101644|P1|COMPLETED|Overall Study||54
42160|NCT01969721|101641|P4|STARTED|Overall Study||52
42161|NCT01969721|101642|P3|STARTED|Overall Study||50
42162|NCT01969721|101643|P2|STARTED|Overall Study||69
42163|NCT01969721|101644|P1|STARTED|Overall Study||58
42164|NCT01969565|101670|P1|NOT COMPLETED|Overall Study||1
42165|NCT01969565|101670|P1|COMPLETED|Overall Study||0
42166|NCT01969565|101670|P1|STARTED|Overall Study||1
42167|NCT01969539|101676|P1|NOT COMPLETED|Overall Study||0
42168|NCT01969539|101676|P1|COMPLETED|Overall Study||11
42169|NCT01969539|101676|P1|STARTED|Overall Study||11
42170|NCT01969448|101685|P3|NOT COMPLETED|Overall Study||0
42171|NCT01969448|101686|P2|NOT COMPLETED|Overall Study||0
42172|NCT01969448|101687|P1|NOT COMPLETED|Overall Study||0
42173|NCT01969448|101685|P3|COMPLETED|Overall Study||0
42174|NCT01969448|101686|P2|COMPLETED|Overall Study||24
42175|NCT01969448|101687|P1|COMPLETED|Overall Study||55
42176|NCT01969448|101685|P3|STARTED|Overall Study||0
42177|NCT01969448|101686|P2|STARTED|Overall Study||24
42178|NCT01969448|101687|P1|STARTED|Overall Study||55
42179|NCT01969435|101710|P1|NOT COMPLETED|Overall Study||0
42180|NCT01969435|101710|P1|COMPLETED|Overall Study||50
42181|NCT01969435|101710|P1|STARTED|Overall Study||50
42182|NCT01969162|101724|P1|NOT COMPLETED|Overall Study||0
42183|NCT01969162|101724|P1|COMPLETED|Overall Study||35
42184|NCT01969162|101724|P1|STARTED|Overall Study||35
42185|NCT01969084|101730|P2|NOT COMPLETED|Overall Study||1
42186|NCT01969084|101731|P1|NOT COMPLETED|Overall Study||0
42187|NCT01969084|101730|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
42188|NCT01969084|101731|P1|COMPLETED|Overall Study||19
42189|NCT01969084|101730|P2|STARTED|Overall Study||22
42190|NCT01969084|101731|P1|STARTED|Overall Study||19
42191|NCT01969058|101747|P2|NOT COMPLETED|Overall Study||0
42192|NCT01969058|101748|P1|NOT COMPLETED|Overall Study||3
42193|NCT01969058|101747|P2|COMPLETED|Overall Study||26
42194|NCT01969058|101748|P1|COMPLETED|Overall Study||47
42195|NCT01969058|101747|P2|STARTED|Overall Study||26
42196|NCT01969058|101748|P1|STARTED|Overall Study||50
42197|NCT01968980|101784|P2|NOT COMPLETED|Overall Study||14
42198|NCT01968980|101785|P1|NOT COMPLETED|Overall Study||16
42199|NCT01968980|101784|P2|COMPLETED|Overall Study||171
42200|NCT01968980|101785|P1|COMPLETED|Overall Study||169
42201|NCT01968980|101784|P2|STARTED|Overall Study||185
42202|NCT01968980|101785|P1|STARTED|Overall Study||185
42203|NCT01968967|101847|P2|NOT COMPLETED|Overall Study||134
42204|NCT01968967|101848|P1|NOT COMPLETED|Overall Study||146
42205|NCT01968967|101847|P2|COMPLETED|Overall Study||934
42206|NCT01968967|101848|P1|COMPLETED|Overall Study||925
42207|NCT01968967|101847|P2|Treated|Overall Study||1063
42208|NCT01968967|101848|P1|Treated|Overall Study||1065
42209|NCT01968967|101847|P2|STARTED|Overall Study||1068
42210|NCT01968967|101848|P1|STARTED|Overall Study||1071
42211|NCT01968954|101909|P2|NOT COMPLETED|Overall Study||43
42212|NCT01968954|101910|P1|NOT COMPLETED|Overall Study||40
42213|NCT01968954|101909|P2|COMPLETED|Overall Study||314
42214|NCT01968954|101910|P1|COMPLETED|Overall Study||314
42215|NCT01968954|101909|P2|Treated|Overall Study||356
42216|NCT01968954|101910|P1|Treated|Overall Study||353
42217|NCT01968954|101909|P2|STARTED|Overall Study||357
42218|NCT01968954|101910|P1|STARTED|Overall Study||354
42219|NCT01968811|101974|P1|NOT COMPLETED|Overall Study||5
42220|NCT01968811|101974|P1|COMPLETED|Overall Study||5
42221|NCT01968811|101974|P1|STARTED|Overall Study||10
42222|NCT01968694|101981|P2|NOT COMPLETED|Visit 2 (1 Day)||0
42223|NCT01968694|101982|P1|NOT COMPLETED|Visit 2 (1 Day)||0
42224|NCT01968694|101981|P2|COMPLETED|Visit 2 (1 Day)||8
42225|NCT01968694|101982|P1|COMPLETED|Visit 2 (1 Day)||10
42226|NCT01968694|101981|P2|STARTED|Visit 2 (1 Day)||8
42227|NCT01968694|101982|P1|STARTED|Visit 2 (1 Day)||10
42228|NCT01968694|101981|P2|NOT COMPLETED|Washout (1 Month)||1
42229|NCT01968694|101982|P1|NOT COMPLETED|Washout (1 Month)||0
42230|NCT01968694|101981|P2|COMPLETED|Washout (1 Month)||8
42231|NCT01968694|101982|P1|COMPLETED|Washout (1 Month)||10
42232|NCT01968694|101981|P2|STARTED|Washout (1 Month)||9
42233|NCT01968694|101982|P1|STARTED|Washout (1 Month)||10
42234|NCT01968694|101981|P2|NOT COMPLETED|Visit 1 (1 Day)||0
42235|NCT01968694|101982|P1|NOT COMPLETED|Visit 1 (1 Day)||0
42236|NCT01968694|101981|P2|COMPLETED|Visit 1 (1 Day)||9
42237|NCT01968694|101982|P1|COMPLETED|Visit 1 (1 Day)||10
42238|NCT01968694|101981|P2|STARTED|Visit 1 (1 Day)||9
42239|NCT01968694|101982|P1|STARTED|Visit 1 (1 Day)||10
42240|NCT01968551|101999|P3|NOT COMPLETED|Extension Phase||4
42241|NCT01968551|102000|P2|NOT COMPLETED|Extension Phase||1
42242|NCT01968551|102001|P1|NOT COMPLETED|Extension Phase||1
42243|NCT01968551|101999|P3|COMPLETED|Extension Phase||30
42244|NCT01968551|102000|P2|COMPLETED|Extension Phase||86
42245|NCT01968551|102001|P1|COMPLETED|Extension Phase||19
42246|NCT01968551|101999|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
42247|NCT01968551|102000|P2|STARTED|Extension Phase||87
42248|NCT01968551|102001|P1|STARTED|Extension Phase||20
42249|NCT01968551|101999|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
42250|NCT01968551|102000|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
42251|NCT01968551|102001|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
42252|NCT01968551|101999|P3|COMPLETED|Open Label Phase (48 Weeks)||41
42253|NCT01968551|102000|P2|COMPLETED|Open Label Phase (48 Weeks)||87
42254|NCT01968551|102001|P1|COMPLETED|Open Label Phase (48 Weeks)||20
42255|NCT01968551|101999|P3|STARTED|Open Label Phase (48 Weeks)||46
42256|NCT01968551|102000|P2|STARTED|Open Label Phase (48 Weeks)||90
42257|NCT01968551|102001|P1|STARTED|Open Label Phase (48 Weeks)||22
42258|NCT01968434|102017|P2|NOT COMPLETED|Overall Study||6
42259|NCT01968434|102018|P1|NOT COMPLETED|Overall Study||3
42260|NCT01968434|102017|P2|COMPLETED|Overall Study||66
42261|NCT01968434|102018|P1|COMPLETED|Overall Study||75
42262|NCT01968434|102017|P2|STARTED|Overall Study||72
42263|NCT01968434|102018|P1|STARTED|Overall Study||78
42264|NCT01968226|102028|P1|NOT COMPLETED|Overall Study||2
42265|NCT01968226|102028|P1|COMPLETED|Overall Study||1
42266|NCT01968226|102028|P1|STARTED|Overall Study||3
42267|NCT01968135|102034|P2|NOT COMPLETED|Overall Study||0
42268|NCT01968135|102035|P1|NOT COMPLETED|Overall Study||0
42269|NCT01968135|102034|P2|COMPLETED|Overall Study||16
42270|NCT01968135|102035|P1|COMPLETED|Overall Study||16
42271|NCT01968135|102034|P2|STARTED|Overall Study||16
42272|NCT01968135|102035|P1|STARTED|Overall Study||16
42273|NCT01968057|102047|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
42274|NCT01968057|102047|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
42275|NCT01968057|102047|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
42276|NCT01968057|102047|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
42277|NCT01968057|102047|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
42278|NCT01968057|102047|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
42279|NCT01968057|102047|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
42280|NCT01968057|102047|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
42281|NCT01967940|102060|P3|NOT COMPLETED|Part 2||14
42282|NCT01967940|102061|P2|NOT COMPLETED|Part 2||16
42283|NCT01967940|102062|P1|NOT COMPLETED|Part 2||8
42284|NCT01967940|102060|P3|COMPLETED|Part 2||0
42285|NCT01967940|102061|P2|COMPLETED|Part 2||0
42286|NCT01967940|102062|P1|COMPLETED|Part 2||0
42287|NCT01967940|102060|P3|STARTED|Part 2|1 participant completed Part 1, but did not enter Part 2 of the study|14
42288|NCT01967940|102061|P2|STARTED|Part 2|12 participants completed Part 1, but did not enter Part 2 of the study|16
42289|NCT01967940|102062|P1|STARTED|Part 2|4 participants completed Part 1, but did not enter Part 2 of the study|8
42290|NCT01967940|102060|P3|NOT COMPLETED|Part 1||0
42291|NCT01967940|102061|P2|NOT COMPLETED|Part 1||0
42292|NCT01967940|102062|P1|NOT COMPLETED|Part 1||0
42293|NCT01967940|102060|P3|COMPLETED|Part 1||15
42294|NCT01967940|102061|P2|COMPLETED|Part 1||28
42295|NCT01967940|102062|P1|COMPLETED|Part 1||12
42296|NCT01967940|102060|P3|STARTED|Part 1||15
42297|NCT01967940|102061|P2|STARTED|Part 1||28
42298|NCT01967940|102062|P1|STARTED|Part 1||12
42299|NCT01967836|102073|P1|NOT COMPLETED|Overall Study||9
42300|NCT01967836|102073|P1|COMPLETED|Overall Study||11
42301|NCT01967836|102073|P1|STARTED|Overall Study||20
42302|NCT01967784|102079|P1|NOT COMPLETED|Overall Study||0
42303|NCT01967784|102079|P1|COMPLETED|Overall Study||100
42304|NCT01967784|102079|P1|STARTED|Overall Study||100
42305|NCT01967732|102089|P4|NOT COMPLETED|Second Intervention (Day 3)||0
42306|NCT01967732|102090|P3|NOT COMPLETED|Second Intervention (Day 3)||0
42307|NCT01967732|102091|P2|NOT COMPLETED|Second Intervention (Day 3)||0
42308|NCT01967732|102092|P1|NOT COMPLETED|Second Intervention (Day 3)||0
42309|NCT01967732|102089|P4|COMPLETED|Second Intervention (Day 3)||9
42310|NCT01967732|102090|P3|COMPLETED|Second Intervention (Day 3)||9
42311|NCT01967732|102091|P2|COMPLETED|Second Intervention (Day 3)||20
42312|NCT01967732|102092|P1|COMPLETED|Second Intervention (Day 3)||22
42313|NCT01967732|102089|P4|STARTED|Second Intervention (Day 3)||9
42314|NCT01967732|102090|P3|STARTED|Second Intervention (Day 3)||9
42315|NCT01967732|102091|P2|STARTED|Second Intervention (Day 3)||20
42316|NCT01967732|102092|P1|STARTED|Second Intervention (Day 3)||22
42317|NCT01967732|102089|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42318|NCT01967732|102090|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42319|NCT01967732|102091|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42320|NCT01967732|102092|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42321|NCT01967732|102089|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
42322|NCT01967732|102090|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
42323|NCT01967732|102091|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
42324|NCT01967732|102092|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
42325|NCT01967732|102089|P4|STARTED|Washout Period of 1 Day (Day 2)||9
42326|NCT01967732|102090|P3|STARTED|Washout Period of 1 Day (Day 2)||9
42327|NCT01967732|102091|P2|STARTED|Washout Period of 1 Day (Day 2)||20
42328|NCT01967732|102092|P1|STARTED|Washout Period of 1 Day (Day 2)||22
42329|NCT01967732|102089|P4|NOT COMPLETED|First Intervention (Day 1)||0
42330|NCT01967732|102090|P3|NOT COMPLETED|First Intervention (Day 1)||0
42331|NCT01967732|102091|P2|NOT COMPLETED|First Intervention (Day 1)||1
42332|NCT01967732|102092|P1|NOT COMPLETED|First Intervention (Day 1)||0
42333|NCT01967732|102089|P4|COMPLETED|First Intervention (Day 1)||9
42334|NCT01967732|102090|P3|COMPLETED|First Intervention (Day 1)||9
42335|NCT01967732|102091|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
42336|NCT01967732|102092|P1|COMPLETED|First Intervention (Day 1)||22
42337|NCT01967732|102089|P4|STARTED|First Intervention (Day 1)||9
42338|NCT01967732|102090|P3|STARTED|First Intervention (Day 1)||9
42339|NCT01967732|102091|P2|STARTED|First Intervention (Day 1)||21
42340|NCT01967732|102092|P1|STARTED|First Intervention (Day 1)||22
42341|NCT01967732|102089|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42342|NCT01967732|102090|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42343|NCT01967732|102091|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
42344|NCT01967732|102092|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42345|NCT01967732|102089|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
42346|NCT01967732|102090|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
42347|NCT01967732|102091|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
42348|NCT01967732|102092|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
42349|NCT01967732|102089|P4|STARTED|Washout Period of 1 Day (Day 0)||9
42350|NCT01967732|102090|P3|STARTED|Washout Period of 1 Day (Day 0)||9
42351|NCT01967732|102091|P2|STARTED|Washout Period of 1 Day (Day 0)||22
42352|NCT01967732|102092|P1|STARTED|Washout Period of 1 Day (Day 0)||22
42353|NCT01967719|102106|P4|NOT COMPLETED|Second Intervention (Day 3)||0
42354|NCT01967719|102107|P3|NOT COMPLETED|Second Intervention (Day 3)||0
42355|NCT01967719|102108|P2|NOT COMPLETED|Second Intervention (Day 3)||1
42356|NCT01967719|102109|P1|NOT COMPLETED|Second Intervention (Day 3)||0
42357|NCT01967719|102106|P4|COMPLETED|Second Intervention (Day 3)||8
42358|NCT01967719|102107|P3|COMPLETED|Second Intervention (Day 3)||9
42359|NCT01967719|102108|P2|COMPLETED|Second Intervention (Day 3)||20
42360|NCT01967719|102109|P1|COMPLETED|Second Intervention (Day 3)||22
42361|NCT01967719|102106|P4|STARTED|Second Intervention (Day 3)||8
42362|NCT01967719|102107|P3|STARTED|Second Intervention (Day 3)||9
42363|NCT01967719|102108|P2|STARTED|Second Intervention (Day 3)||21
42364|NCT01967719|102109|P1|STARTED|Second Intervention (Day 3)||22
42365|NCT01967719|102106|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42366|NCT01967719|102107|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42367|NCT01967719|102108|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42368|NCT01967719|102109|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42369|NCT01967719|102106|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
42370|NCT01967719|102107|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
42371|NCT01967719|102108|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
42372|NCT01967719|102109|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
42373|NCT01967719|102106|P4|STARTED|Washout Period of 1 Day (Day 2)||8
42374|NCT01967719|102107|P3|STARTED|Washout Period of 1 Day (Day 2)||9
42375|NCT01967719|102108|P2|STARTED|Washout Period of 1 Day (Day 2)||21
42376|NCT01967719|102109|P1|STARTED|Washout Period of 1 Day (Day 2)||22
42377|NCT01967719|102106|P4|NOT COMPLETED|First Intervention (Day 1)||1
42378|NCT01967719|102107|P3|NOT COMPLETED|First Intervention (Day 1)||0
42379|NCT01967719|102108|P2|NOT COMPLETED|First Intervention (Day 1)||1
42380|NCT01967719|102109|P1|NOT COMPLETED|First Intervention (Day 1)||0
42381|NCT01967719|102106|P4|COMPLETED|First Intervention (Day 1)||8
42382|NCT01967719|102107|P3|COMPLETED|First Intervention (Day 1)||9
42383|NCT01967719|102108|P2|COMPLETED|First Intervention (Day 1)||21
42384|NCT01967719|102109|P1|COMPLETED|First Intervention (Day 1)||22
42385|NCT01967719|102106|P4|STARTED|First Intervention (Day 1)||9
42386|NCT01967719|102107|P3|STARTED|First Intervention (Day 1)||9
42387|NCT01967719|102108|P2|STARTED|First Intervention (Day 1)||22
42388|NCT01967719|102109|P1|STARTED|First Intervention (Day 1)||22
42389|NCT01967719|102106|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42390|NCT01967719|102107|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42391|NCT01967719|102108|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42392|NCT01967719|102109|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42393|NCT01967719|102106|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
42394|NCT01967719|102107|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
42395|NCT01967719|102108|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
42396|NCT01967719|102109|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
42397|NCT01967719|102106|P4|STARTED|Washout Period of 1 Day (Day 0)||9
42398|NCT01967719|102107|P3|STARTED|Washout Period of 1 Day (Day 0)||9
42399|NCT01967719|102108|P2|STARTED|Washout Period of 1 Day (Day 0)||22
42400|NCT01967719|102109|P1|STARTED|Washout Period of 1 Day (Day 0)||22
42401|NCT01967706|102124|P4|NOT COMPLETED|Second Intervention (Day 3)||0
42402|NCT01967706|102125|P3|NOT COMPLETED|Second Intervention (Day 3)||0
42403|NCT01967706|102126|P2|NOT COMPLETED|Second Intervention (Day 3)||0
42404|NCT01967706|102127|P1|NOT COMPLETED|Second Intervention (Day 3)||0
42405|NCT01967706|102124|P4|COMPLETED|Second Intervention (Day 3)||9
42406|NCT01967706|102125|P3|COMPLETED|Second Intervention (Day 3)||9
42407|NCT01967706|102126|P2|COMPLETED|Second Intervention (Day 3)||22
42408|NCT01967706|102127|P1|COMPLETED|Second Intervention (Day 3)||21
42409|NCT01967706|102124|P4|STARTED|Second Intervention (Day 3)||9
42410|NCT01967706|102125|P3|STARTED|Second Intervention (Day 3)||9
42411|NCT01967706|102126|P2|STARTED|Second Intervention (Day 3)||22
42412|NCT01967706|102127|P1|STARTED|Second Intervention (Day 3)||21
42413|NCT01967706|102124|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42414|NCT01967706|102125|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42415|NCT01967706|102126|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42416|NCT01967706|102127|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
42417|NCT01967706|102124|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
42418|NCT01967706|102125|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
42419|NCT01967706|102126|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
42420|NCT01967706|102127|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
42421|NCT01967706|102124|P4|STARTED|Washout Period of 1 Day (Day 2)||9
42422|NCT01967706|102125|P3|STARTED|Washout Period of 1 Day (Day 2)||9
42423|NCT01967706|102126|P2|STARTED|Washout Period of 1 Day (Day 2)||22
42424|NCT01967706|102127|P1|STARTED|Washout Period of 1 Day (Day 2)||21
42425|NCT01967706|102124|P4|NOT COMPLETED|First Intervention (Day 1)||0
42426|NCT01967706|102125|P3|NOT COMPLETED|First Intervention (Day 1)||0
42427|NCT01967706|102126|P2|NOT COMPLETED|First Intervention (Day 1)||0
42428|NCT01967706|102127|P1|NOT COMPLETED|First Intervention (Day 1)||1
42429|NCT01967706|102124|P4|COMPLETED|First Intervention (Day 1)||9
42430|NCT01967706|102125|P3|COMPLETED|First Intervention (Day 1)||9
42431|NCT01967706|102126|P2|COMPLETED|First Intervention (Day 1)||22
42432|NCT01967706|102127|P1|COMPLETED|First Intervention (Day 1)||21
42433|NCT01967706|102124|P4|STARTED|First Intervention (Day 1)||9
42434|NCT01967706|102125|P3|STARTED|First Intervention (Day 1)||9
42435|NCT01967706|102126|P2|STARTED|First Intervention (Day 1)||22
42436|NCT01967706|102127|P1|STARTED|First Intervention (Day 1)||22
42437|NCT01967706|102124|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42438|NCT01967706|102125|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42439|NCT01967706|102126|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42440|NCT01967706|102127|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
42441|NCT01967706|102124|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
42442|NCT01967706|102125|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
42443|NCT01967706|102126|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
42444|NCT01967706|102127|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
42445|NCT01967706|102124|P4|STARTED|Washout Period of 1 Day (Day 0)||9
42446|NCT01967706|102125|P3|STARTED|Washout Period of 1 Day (Day 0)||9
42447|NCT01967706|102126|P2|STARTED|Washout Period of 1 Day (Day 0)||22
42448|NCT01967706|102127|P1|STARTED|Washout Period of 1 Day (Day 0)||22
42449|NCT01967628|102142|P2|NOT COMPLETED|Overall Study||31
42450|NCT01967628|102143|P1|NOT COMPLETED|Overall Study||27
42451|NCT01967628|102142|P2|COMPLETED|Overall Study||19
42452|NCT01967628|102143|P1|COMPLETED|Overall Study||21
42453|NCT01967628|102142|P2|STARTED|Overall Study||50
42454|NCT01967628|102143|P1|STARTED|Overall Study||48
42455|NCT01967550|102151|P2|NOT COMPLETED|Overall Study||2
42456|NCT01967550|102152|P1|NOT COMPLETED|Overall Study||5
42457|NCT01967550|102151|P2|COMPLETED|Overall Study||149
42458|NCT01967550|102152|P1|COMPLETED|Overall Study||148
42459|NCT01967550|102151|P2|STARTED|Overall Study||151
42460|NCT01967550|102152|P1|STARTED|Overall Study||153
42461|NCT01967342|102161|P3|NOT COMPLETED|Overall Study||29
42462|NCT01967342|102162|P2|NOT COMPLETED|Overall Study||25
42463|NCT01967342|102163|P1|NOT COMPLETED|Overall Study||27
42464|NCT01967342|102161|P3|COMPLETED|Overall Study||68
42465|NCT01967342|102162|P2|COMPLETED|Overall Study||70
42466|NCT01967342|102163|P1|COMPLETED|Overall Study||71
42467|NCT01967342|102161|P3|10-week Follow-up|Overall Study||80
42468|NCT01967342|102162|P2|10-week Follow-up|Overall Study||83
42469|NCT01967342|102163|P1|10-week Follow-up|Overall Study||78
42470|NCT01967342|102161|P3|5-week Follow-up|Overall Study||76
42471|NCT01967342|102162|P2|5-week Follow-up|Overall Study||78
42472|NCT01967342|102163|P1|5-week Follow-up|Overall Study||83
42473|NCT01967342|102161|P3|STARTED|Overall Study||97
42474|NCT01967342|102162|P2|STARTED|Overall Study||95
42475|NCT01967342|102163|P1|STARTED|Overall Study||98
42476|NCT01967277|102182|P2|NOT COMPLETED|Overall Study||3
42477|NCT01967277|102183|P1|NOT COMPLETED|Overall Study||1
42478|NCT01967277|102182|P2|COMPLETED|Overall Study||19
42479|NCT01967277|102183|P1|COMPLETED|Overall Study||21
42480|NCT01967277|102182|P2|STARTED|Overall Study||22
42481|NCT01967277|102183|P1|STARTED|Overall Study||22
42482|NCT01967147|102193|P2|NOT COMPLETED|Overall Study||20
42483|NCT01967147|102194|P1|NOT COMPLETED|Overall Study||13
42484|NCT01967147|102193|P2|COMPLETED|Overall Study||82
42485|NCT01967147|102194|P1|COMPLETED|Overall Study||99
42486|NCT01967147|102193|P2|STARTED|Overall Study||102
42487|NCT01967147|102194|P1|STARTED|Overall Study||112
42488|NCT01967121|102212|P3|NOT COMPLETED|Overall Study||0
42489|NCT01967121|102213|P2|NOT COMPLETED|Overall Study||0
42490|NCT01967121|102214|P1|NOT COMPLETED|Overall Study||0
42491|NCT01967121|102212|P3|COMPLETED|Overall Study||25
42492|NCT01967121|102213|P2|COMPLETED|Overall Study||25
42493|NCT01967121|102214|P1|COMPLETED|Overall Study||25
42494|NCT01967121|102212|P3|STARTED|Overall Study||25
42495|NCT01967121|102213|P2|STARTED|Overall Study||25
42496|NCT01967121|102214|P1|STARTED|Overall Study||25
42497|NCT01967069|102224|P2|NOT COMPLETED|Overall Study||8
42498|NCT01967069|102225|P1|NOT COMPLETED|Overall Study||8
42499|NCT01967069|102224|P2|COMPLETED|Overall Study||87
42500|NCT01967069|102225|P1|COMPLETED|Overall Study||174
42501|NCT01967069|102224|P2|STARTED|Overall Study||95
42502|NCT01967069|102225|P1|STARTED|Overall Study||182
42503|NCT01966926|102233|P2|NOT COMPLETED|Overall Study||0
42504|NCT01966926|102234|P1|NOT COMPLETED|Overall Study||0
42505|NCT01966926|102233|P2|COMPLETED|Overall Study||15
42506|NCT01966926|102234|P1|COMPLETED|Overall Study||15
42507|NCT01966926|102233|P2|STARTED|Overall Study||15
42508|NCT01966926|102234|P1|STARTED|Overall Study||15
42509|NCT01966770|102250|P1|NOT COMPLETED|Overall Study||0
42510|NCT01966770|102250|P1|COMPLETED|Overall Study||20
42511|NCT01966770|102250|P1|STARTED|Overall Study||20
42512|NCT01966718|102359|P1|NOT COMPLETED|Overall Study||0
42513|NCT01966718|102359|P1|COMPLETED|Overall Study||8
42514|NCT01966718|102359|P1|STARTED|Overall Study||8
42515|NCT01966458|102369|P2|NOT COMPLETED|Overall Study||2
42516|NCT01966458|102370|P1|NOT COMPLETED|Overall Study||4
42517|NCT01966458|102369|P2|COMPLETED|Overall Study||155
42518|NCT01966458|102370|P1|COMPLETED|Overall Study||304
42519|NCT01966458|102369|P2|STARTED|Overall Study||157
42520|NCT01966458|102370|P1|STARTED|Overall Study||308
42521|NCT01966432|102382|P3|NOT COMPLETED|Overall Study||26
42522|NCT01966432|102383|P2|NOT COMPLETED|Overall Study||13
42523|NCT01966432|102384|P1|NOT COMPLETED|Overall Study||5
42524|NCT01966432|102382|P3|COMPLETED|Overall Study||28
42525|NCT01966432|102383|P2|COMPLETED|Overall Study||21
42526|NCT01966432|102384|P1|COMPLETED|Overall Study||5
42527|NCT01966432|102382|P3|STARTED|Overall Study||54
42528|NCT01966432|102383|P2|STARTED|Overall Study||34
42529|NCT01966432|102384|P1|STARTED|Overall Study||10
42530|NCT01966380|102404|P2|NOT COMPLETED|Overall Study||1
42531|NCT01966380|102405|P1|NOT COMPLETED|Overall Study||0
42532|NCT01966380|102404|P2|COMPLETED|Overall Study||2
42533|NCT01966380|102405|P1|COMPLETED|Overall Study||3
42534|NCT01966380|102404|P2|STARTED|Overall Study||3
42535|NCT01966380|102405|P1|STARTED|Overall Study||3
42536|NCT01966354|102414|P3|NOT COMPLETED|Overall Study||0
42537|NCT01966354|102415|P2|NOT COMPLETED|Overall Study||0
42538|NCT01966354|102416|P1|NOT COMPLETED|Overall Study||0
42539|NCT01966354|102414|P3|COMPLETED|Overall Study||72
42540|NCT01966354|102415|P2|COMPLETED|Overall Study||73
42541|NCT01966354|102416|P1|COMPLETED|Overall Study||75
42542|NCT01966354|102414|P3|STARTED|Overall Study||72
42543|NCT01966354|102415|P2|STARTED|Overall Study||73
42544|NCT01966354|102416|P1|STARTED|Overall Study||75
42545|NCT01966159|102441|P2|NOT COMPLETED|Overall Study||0
42546|NCT01966159|102442|P1|NOT COMPLETED|Overall Study||0
42547|NCT01966159|102441|P2|COMPLETED|Overall Study||207
42548|NCT01966159|102442|P1|COMPLETED|Overall Study||205
42549|NCT01966159|102441|P2|STARTED|Overall Study||207
42550|NCT01966159|102442|P1|STARTED|Overall Study||205
42551|NCT01966120|102454|P2|NOT COMPLETED|Overall Study||6
42552|NCT01966120|102455|P1|NOT COMPLETED|Overall Study||1
42553|NCT01966120|102454|P2|COMPLETED|Overall Study||26
42554|NCT01966120|102455|P1|COMPLETED|Overall Study||54
42555|NCT01966120|102454|P2|STARTED|Overall Study||32
42556|NCT01966120|102455|P1|STARTED|Overall Study||55
42557|NCT01966068|102479|P1|NOT COMPLETED|Overall Study||138
42558|NCT01966068|102479|P1|COMPLETED|Overall Study||156
42559|NCT01966068|102479|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
42560|NCT01966068|102479|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
42561|NCT01966068|102479|P1|STARTED|Overall Study||294
42562|NCT01966042|102484|P1|NOT COMPLETED|Overall Study||2
42563|NCT01966042|102484|P1|COMPLETED|Overall Study||11
42564|NCT01966042|102484|P1|STARTED|Overall Study||13
42565|NCT01966003|102493|P2|NOT COMPLETED|Overall Study||270
42566|NCT01966003|102494|P1|NOT COMPLETED|Overall Study||270
42567|NCT01966003|102493|P2|COMPLETED|Overall Study||44
42568|NCT01966003|102494|P1|COMPLETED|Overall Study||58
42569|NCT01966003|102493|P2|Received Study Drug|Overall Study||309
42570|NCT01966003|102494|P1|Received Study Drug|Overall Study||324
42571|NCT01966003|102493|P2|STARTED|Overall Study||314
42572|NCT01966003|102494|P1|STARTED|Overall Study||328
42573|NCT01965938|102512|P2|NOT COMPLETED|Overall Study||0
42574|NCT01965938|102513|P1|NOT COMPLETED|Overall Study||1
42575|NCT01965938|102512|P2|COMPLETED|Overall Study||20
42576|NCT01965938|102513|P1|COMPLETED|Overall Study||20
42577|NCT01965938|102512|P2|STARTED|Overall Study||20
42578|NCT01965938|102513|P1|STARTED|Overall Study||21
42579|NCT01965899|102533|P1|NOT COMPLETED|Overall Study||6
42580|NCT01965899|102533|P1|COMPLETED|Overall Study||145
42581|NCT01965899|102533|P1|STARTED|Overall Study||151
42582|NCT01965834|102544|P1|NOT COMPLETED|Overall Study||4
42583|NCT01965834|102544|P1|COMPLETED|Overall Study||2
42584|NCT01965834|102544|P1|STARTED|Overall Study||6
42585|NCT01965756|102552|P2|NOT COMPLETED|Overall Study||0
42586|NCT01965756|102553|P1|NOT COMPLETED|Overall Study||0
42587|NCT01965756|102552|P2|COMPLETED|Overall Study||10
42588|NCT01965756|102553|P1|COMPLETED|Overall Study||10
42589|NCT01965756|102552|P2|STARTED|Overall Study||10
42590|NCT01965756|102553|P1|STARTED|Overall Study||10
42591|NCT01965665|102567|P1|NOT COMPLETED|Overall Study||1
42592|NCT01965665|102567|P1|COMPLETED|Overall Study||19
42593|NCT01965665|102567|P1|STARTED|Overall Study||20
42594|NCT01965652|102575|P2|NOT COMPLETED|Overall Study||210
42595|NCT01965652|102576|P1|NOT COMPLETED|Overall Study||210
42596|NCT01965652|102575|P2|COMPLETED|Overall Study||413
42597|NCT01965652|102576|P1|COMPLETED|Overall Study||413
42598|NCT01965652|102575|P2|Received Treatment|Overall Study||623
42599|NCT01965652|102576|P1|Received Treatment|Overall Study||622
42600|NCT01965652|102575|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
42601|NCT01965652|102576|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
42602|NCT01965600|102606|P4|NOT COMPLETED|Second Intervention||2
42603|NCT01965600|102607|P3|NOT COMPLETED|Second Intervention||2
42604|NCT01965600|102608|P2|NOT COMPLETED|Second Intervention||0
42605|NCT01965600|102609|P1|NOT COMPLETED|Second Intervention||0
42606|NCT01965600|102606|P4|COMPLETED|Second Intervention||0
42607|NCT01965600|102607|P3|COMPLETED|Second Intervention||1
42608|NCT01965600|102608|P2|COMPLETED|Second Intervention||4
42609|NCT01965600|102609|P1|COMPLETED|Second Intervention||4
42610|NCT01965600|102606|P4|STARTED|Second Intervention||2
42611|NCT01965600|102607|P3|STARTED|Second Intervention||3
42612|NCT01965600|102608|P2|STARTED|Second Intervention||4
42613|NCT01965600|102609|P1|STARTED|Second Intervention||4
42614|NCT01965600|102606|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
42615|NCT01965600|102607|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
42616|NCT01965600|102608|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
42617|NCT01965600|102609|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
42618|NCT01965600|102606|P4|COMPLETED|Washout Period of Approximately 15 Days||2
42619|NCT01965600|102607|P3|COMPLETED|Washout Period of Approximately 15 Days||3
42620|NCT01965600|102608|P2|COMPLETED|Washout Period of Approximately 15 Days||4
42621|NCT01965600|102609|P1|COMPLETED|Washout Period of Approximately 15 Days||4
42622|NCT01965600|102606|P4|STARTED|Washout Period of Approximately 15 Days||4
42623|NCT01965600|102607|P3|STARTED|Washout Period of Approximately 15 Days||5
42624|NCT01965600|102608|P2|STARTED|Washout Period of Approximately 15 Days||8
42625|NCT01965600|102609|P1|STARTED|Washout Period of Approximately 15 Days||6
42626|NCT01965600|102606|P4|NOT COMPLETED|First Intervention||0
42627|NCT01965600|102607|P3|NOT COMPLETED|First Intervention||0
42628|NCT01965600|102608|P2|NOT COMPLETED|First Intervention||0
42629|NCT01965600|102609|P1|NOT COMPLETED|First Intervention||0
42630|NCT01965600|102606|P4|COMPLETED|First Intervention||4
42631|NCT01965600|102607|P3|COMPLETED|First Intervention||5
42632|NCT01965600|102608|P2|COMPLETED|First Intervention||8
42633|NCT01965600|102609|P1|COMPLETED|First Intervention||6
42634|NCT01965600|102606|P4|Received at Least One Dose of Drug|First Intervention||4
42635|NCT01965600|102607|P3|Received at Least One Dose of Drug|First Intervention||5
42636|NCT01965600|102608|P2|Received at Least One Dose of Drug|First Intervention||8
42637|NCT01965600|102609|P1|Received at Least One Dose of Drug|First Intervention||6
42638|NCT01965600|102606|P4|STARTED|First Intervention||4
42639|NCT01965600|102607|P3|STARTED|First Intervention||5
42640|NCT01965600|102608|P2|STARTED|First Intervention||8
42641|NCT01965600|102609|P1|STARTED|First Intervention||6
42642|NCT01965561|102653|P1|NOT COMPLETED|Overall Study||0
42643|NCT01965561|102653|P1|COMPLETED|Overall Study||10
42644|NCT01965561|102653|P1|STARTED|Overall Study||10
42645|NCT01965535|102666|P2|NOT COMPLETED|Overall Study||1
42646|NCT01965535|102667|P1|NOT COMPLETED|Overall Study||2
42647|NCT01965535|102666|P2|COMPLETED|Overall Study||76
42648|NCT01965535|102667|P1|COMPLETED|Overall Study||76
42649|NCT01965535|102666|P2|STARTED|Overall Study||77
42650|NCT01965535|102667|P1|STARTED|Overall Study||78
42651|NCT01965431|102681|P6|NOT COMPLETED|Overall Study||6
42652|NCT01965431|102682|P5|NOT COMPLETED|Overall Study||6
42653|NCT01965431|102683|P4|NOT COMPLETED|Overall Study||6
42654|NCT01965431|102684|P3|NOT COMPLETED|Overall Study||6
42655|NCT01965431|102685|P2|NOT COMPLETED|Overall Study||6
42656|NCT01965431|102686|P1|NOT COMPLETED|Overall Study||6
42657|NCT01965431|102681|P6|COMPLETED|Overall Study||2
42658|NCT01965431|102682|P5|COMPLETED|Overall Study||2
42659|NCT01965431|102683|P4|COMPLETED|Overall Study||2
42660|NCT01965431|102684|P3|COMPLETED|Overall Study||2
42661|NCT01965431|102685|P2|COMPLETED|Overall Study||2
42662|NCT01965431|102686|P1|COMPLETED|Overall Study||2
42663|NCT01965431|102681|P6|STARTED|Overall Study||8
42664|NCT01965431|102682|P5|STARTED|Overall Study||8
42665|NCT01965431|102683|P4|STARTED|Overall Study||8
42666|NCT01965431|102684|P3|STARTED|Overall Study||8
42667|NCT01965431|102685|P2|STARTED|Overall Study||8
42668|NCT01965431|102686|P1|STARTED|Overall Study|Started are actually Treated subjects|8
42669|NCT01965327|102699|P1|NOT COMPLETED|Overall Study||2
42670|NCT01965327|102699|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
42671|NCT01965327|102699|P1|STARTED|Overall Study||12
42672|NCT01965288|102706|P2|NOT COMPLETED|Overall Study||0
42673|NCT01965288|102707|P1|NOT COMPLETED|Overall Study||0
42674|NCT01965288|102706|P2|COMPLETED|Overall Study||30
42675|NCT01965288|102707|P1|COMPLETED|Overall Study||30
42676|NCT01965288|102706|P2|STARTED|Overall Study||30
42677|NCT01965288|102707|P1|STARTED|Overall Study||30
42678|NCT01965262|102913|P2|NOT COMPLETED|Second Intervention (7 Days)||10
42679|NCT01965262|102914|P1|NOT COMPLETED|Second Intervention (7 Days)||1
42680|NCT01965262|102913|P2|COMPLETED|Second Intervention (7 Days)||5
42681|NCT01965262|102914|P1|COMPLETED|Second Intervention (7 Days)||14
42682|NCT01965262|102913|P2|STARTED|Second Intervention (7 Days)||15
42683|NCT01965262|102914|P1|STARTED|Second Intervention (7 Days)||15
42684|NCT01965262|102913|P2|NOT COMPLETED|First Intervention (7 Days)||0
42685|NCT01965262|102914|P1|NOT COMPLETED|First Intervention (7 Days)||0
42686|NCT01965262|102913|P2|COMPLETED|First Intervention (7 Days)||15
42687|NCT01965262|102914|P1|COMPLETED|First Intervention (7 Days)||15
42688|NCT01965262|102913|P2|STARTED|First Intervention (7 Days)||15
42689|NCT01965262|102914|P1|STARTED|First Intervention (7 Days)||15
42690|NCT01965158|102978|P2|NOT COMPLETED|Overall Study||35
42691|NCT01965158|102979|P1|NOT COMPLETED|Overall Study||41
42692|NCT01965158|102978|P2|COMPLETED|Overall Study||238
42693|NCT01965158|102979|P1|COMPLETED|Overall Study||233
42694|NCT01965158|102978|P2|Received Treatment|Overall Study||273
42695|NCT01965158|102979|P1|Received Treatment|Overall Study||272
42696|NCT01965158|102978|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
42697|NCT01965158|102979|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
42698|NCT01965067|102995|P2|NOT COMPLETED|Overall Study||0
42699|NCT01965067|102996|P1|NOT COMPLETED|Overall Study||0
42700|NCT01965067|102995|P2|COMPLETED|Overall Study||30
42701|NCT01965067|102996|P1|COMPLETED|Overall Study||30
42702|NCT01965067|102995|P2|STARTED|Overall Study||30
42703|NCT01965067|102996|P1|STARTED|Overall Study||30
42704|NCT01965002|103012|P1|NOT COMPLETED|Overall Study||0
42705|NCT01965002|103012|P1|COMPLETED|Overall Study||5
42706|NCT01965002|103012|P1|STARTED|Overall Study||5
42707|NCT01964976|103020|P1|NOT COMPLETED|Overall Study||31
42708|NCT01964976|103020|P1|COMPLETED|Overall Study||1065
42709|NCT01964976|103020|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
42710|NCT01964950|103034|P1|NOT COMPLETED|Overall Study||25
42711|NCT01964950|103034|P1|COMPLETED|Overall Study||1076
42712|NCT01964950|103034|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
42713|NCT01964898|103048|P2|NOT COMPLETED|Overall Study||7
42714|NCT01964898|103049|P1|NOT COMPLETED|Overall Study||7
42715|NCT01964898|103048|P2|COMPLETED|Overall Study||26
42716|NCT01964898|103049|P1|COMPLETED|Overall Study||24
42717|NCT01964898|103048|P2|12 Week Assessment|Overall Study||30
42718|NCT01964898|103049|P1|12 Week Assessment|Overall Study||25
42719|NCT01964898|103048|P2|STARTED|Overall Study||33
42720|NCT01964898|103049|P1|STARTED|Overall Study||31
42721|NCT01964716|103071|P2|NOT COMPLETED|Overall Study||6
42722|NCT01964716|103072|P1|NOT COMPLETED|Overall Study||5
42723|NCT01964716|103071|P2|COMPLETED|Overall Study||244
42724|NCT01964716|103072|P1|COMPLETED|Overall Study||245
42725|NCT01964716|103071|P2|Vaccinated Dose 3|Overall Study||244
42726|NCT01964716|103072|P1|Vaccinated Dose 3|Overall Study||247
42727|NCT01964716|103071|P2|Vaccinated Dose 2|Overall Study||248
42728|NCT01964716|103072|P1|Vaccinated Dose 2|Overall Study||249
42729|NCT01964716|103071|P2|Vaccinated Dose 1|Overall Study||250
42730|NCT01964716|103072|P1|Vaccinated Dose 1|Overall Study||250
42731|NCT01964716|103071|P2|STARTED|Overall Study||250
42732|NCT01964716|103072|P1|STARTED|Overall Study||250
42733|NCT01964547|103110|P2|NOT COMPLETED|Overall Study||11
42734|NCT01964547|103111|P1|NOT COMPLETED|Overall Study||12
42735|NCT01964547|103110|P2|COMPLETED|Overall Study||48
42736|NCT01964547|103111|P1|COMPLETED|Overall Study||50
42737|NCT01964547|103110|P2|STARTED|Overall Study||59
42738|NCT01964547|103111|P1|STARTED|Overall Study||62
42739|NCT01964352|103139|P4|NOT COMPLETED|Overall Study||8
42740|NCT01964352|103140|P3|NOT COMPLETED|Overall Study||6
42741|NCT01964352|103141|P2|NOT COMPLETED|Overall Study||11
42742|NCT01964352|103142|P1|NOT COMPLETED|Overall Study||26
42743|NCT01964352|103139|P4|COMPLETED|Overall Study||195
42744|NCT01964352|103140|P3|COMPLETED|Overall Study||196
42745|NCT01964352|103141|P2|COMPLETED|Overall Study||192
42746|NCT01964352|103142|P1|COMPLETED|Overall Study||178
42747|NCT01964352|103139|P4|STARTED|Overall Study||203
42748|NCT01964352|103140|P3|STARTED|Overall Study||202
42749|NCT01964352|103141|P2|STARTED|Overall Study||203
42750|NCT01964352|103142|P1|STARTED|Overall Study||204
42751|NCT01964326|103172|P1|NOT COMPLETED|Overall Study||297
42752|NCT01964326|103172|P1|COMPLETED|Overall Study||1014
42753|NCT01964326|103172|P1|STARTED|Overall Study||1311
42754|NCT01964222|103181|P2|NOT COMPLETED|Overall Study||11
42755|NCT01964222|103182|P1|NOT COMPLETED|Overall Study||15
42756|NCT01964222|103181|P2|COMPLETED|Overall Study||89
42757|NCT01964222|103182|P1|COMPLETED|Overall Study||86
42758|NCT01964222|103181|P2|STARTED|Overall Study||100
42759|NCT01964222|103182|P1|STARTED|Overall Study||101
42760|NCT01964105|103199|P3|NOT COMPLETED|Overall Study||0
42761|NCT01964105|103200|P2|NOT COMPLETED|Overall Study||13
42762|NCT01964105|103201|P1|NOT COMPLETED|Overall Study||2
42763|NCT01964105|103199|P3|COMPLETED|Overall Study||10
42764|NCT01964105|103200|P2|COMPLETED|Overall Study||62
42765|NCT01964105|103201|P1|COMPLETED|Overall Study||13
42766|NCT01964105|103199|P3|STARTED|Overall Study||10
42767|NCT01964105|103200|P2|STARTED|Overall Study||75
42768|NCT01964105|103201|P1|STARTED|Overall Study||15
42769|NCT01963845|103211|P2|NOT COMPLETED|Overall Study||0
42770|NCT01963845|103212|P1|NOT COMPLETED|Overall Study||0
42771|NCT01963845|103211|P2|COMPLETED|Overall Study||25
42772|NCT01963845|103212|P1|COMPLETED|Overall Study||25
42773|NCT01963845|103211|P2|STARTED|Overall Study||25
42774|NCT01963845|103212|P1|STARTED|Overall Study||25
42775|NCT01963767|103228|P2|NOT COMPLETED|Overall Study||2
42776|NCT01963767|103229|P1|NOT COMPLETED|Overall Study||6
42777|NCT01963767|103228|P2|COMPLETED|Overall Study||53
42778|NCT01963767|103229|P1|COMPLETED|Overall Study||52
42779|NCT01963767|103228|P2|STARTED|Overall Study||55
42780|NCT01963767|103229|P1|STARTED|Overall Study||58
42781|NCT01963676|103239|P2|NOT COMPLETED|Overall Study||0
42782|NCT01963676|103240|P1|NOT COMPLETED|Overall Study||1
42783|NCT01963676|103239|P2|COMPLETED|Overall Study||13
42784|NCT01963676|103240|P1|COMPLETED|Overall Study||13
42785|NCT01963676|103239|P2|STARTED|Overall Study||13
42786|NCT01963676|103240|P1|STARTED|Overall Study||14
42787|NCT01963611|103253|P5|NOT COMPLETED|Overall Study||51
42788|NCT01963611|103254|P4|NOT COMPLETED|Overall Study||52
42789|NCT01963611|103255|P3|NOT COMPLETED|Overall Study||52
42790|NCT01963611|103256|P2|NOT COMPLETED|Overall Study||49
42791|NCT01963611|103257|P1|NOT COMPLETED|Overall Study||51
42792|NCT01963611|103253|P5|COMPLETED|Overall Study||0
42793|NCT01963611|103254|P4|COMPLETED|Overall Study||0
42794|NCT01963611|103255|P3|COMPLETED|Overall Study||0
42795|NCT01963611|103256|P2|COMPLETED|Overall Study||0
42796|NCT01963611|103257|P1|COMPLETED|Overall Study||0
42797|NCT01963611|103253|P5|Safety Analysis Set|Overall Study||50
42798|NCT01963611|103254|P4|Safety Analysis Set|Overall Study||52
42799|NCT01963611|103255|P3|Safety Analysis Set|Overall Study||52
42800|NCT01963611|103256|P2|Safety Analysis Set|Overall Study||49
42801|NCT01963611|103257|P1|Safety Analysis Set|Overall Study||51
42802|NCT01963611|103253|P5|STARTED|Overall Study||51
42803|NCT01963611|103254|P4|STARTED|Overall Study||52
42804|NCT01963611|103255|P3|STARTED|Overall Study||52
42805|NCT01963611|103256|P2|STARTED|Overall Study||49
42806|NCT01963611|103257|P1|STARTED|Overall Study||51
42807|NCT01963403|103316|P2|NOT COMPLETED|Overall Study||4
42808|NCT01963403|103317|P1|NOT COMPLETED|Overall Study||2
42809|NCT01963403|103316|P2|COMPLETED|Overall Study|Follow-up over three months|9
42810|NCT01963403|103317|P1|COMPLETED|Overall Study|Follow-up over three months|11
42811|NCT01963403|103316|P2|STARTED|Overall Study||13
42812|NCT01963403|103317|P1|STARTED|Overall Study||13
42813|NCT01963260|103339|P10|NOT COMPLETED|Overall Study||0
42814|NCT01963260|103340|P9|NOT COMPLETED|Overall Study||0
42815|NCT01963260|103341|P8|NOT COMPLETED|Overall Study||0
42816|NCT01963260|103342|P7|NOT COMPLETED|Overall Study||0
42817|NCT01963260|103343|P6|NOT COMPLETED|Overall Study||0
42818|NCT01963260|103344|P5|NOT COMPLETED|Overall Study||2
42819|NCT01963260|103345|P4|NOT COMPLETED|Overall Study||1
42820|NCT01963260|103346|P3|NOT COMPLETED|Overall Study||0
42821|NCT01963260|103347|P2|NOT COMPLETED|Overall Study||0
42822|NCT01963260|103348|P1|NOT COMPLETED|Overall Study||2
42823|NCT01963260|103339|P10|COMPLETED|Overall Study||4
42824|NCT01963260|103340|P9|COMPLETED|Overall Study||1
42825|NCT01963260|103341|P8|COMPLETED|Overall Study||2
42826|NCT01963260|103342|P7|COMPLETED|Overall Study||3
42827|NCT01963260|103343|P6|COMPLETED|Overall Study||10
42828|NCT01963260|103344|P5|COMPLETED|Overall Study||4
42829|NCT01963260|103345|P4|COMPLETED|Overall Study||5
42830|NCT01963260|103346|P3|COMPLETED|Overall Study||6
42831|NCT01963260|103347|P2|COMPLETED|Overall Study||6
42832|NCT01963260|103348|P1|COMPLETED|Overall Study||4
42833|NCT01963260|103339|P10|Treated|Overall Study||4
42834|NCT01963260|103340|P9|Treated|Overall Study||1
42835|NCT01963260|103341|P8|Treated|Overall Study||2
42836|NCT01963260|103342|P7|Treated|Overall Study||3
42837|NCT01963260|103343|P6|Treated|Overall Study||10
42838|NCT01963260|103344|P5|Treated|Overall Study||6
42839|NCT01963260|103345|P4|Treated|Overall Study||6
42840|NCT01963260|103346|P3|Treated|Overall Study||6
42841|NCT01963260|103347|P2|Treated|Overall Study||6
42842|NCT01963260|103348|P1|Treated|Overall Study||6
42843|NCT01963260|103339|P10|STARTED|Overall Study||4
42844|NCT01963260|103340|P9|STARTED|Overall Study||1
42845|NCT01963260|103341|P8|STARTED|Overall Study||2
42846|NCT01963260|103342|P7|STARTED|Overall Study||3
42847|NCT01963260|103343|P6|STARTED|Overall Study||10
42848|NCT01963260|103344|P5|STARTED|Overall Study||6
42849|NCT01963260|103345|P4|STARTED|Overall Study||6
42850|NCT01963260|103346|P3|STARTED|Overall Study||6
42851|NCT01963260|103347|P2|STARTED|Overall Study||6
42852|NCT01963260|103348|P1|STARTED|Overall Study||6
42853|NCT01963143|103403|P3|NOT COMPLETED|Overall Study||1
42854|NCT01963143|103404|P2|NOT COMPLETED|Overall Study||1
42855|NCT01963143|103405|P1|NOT COMPLETED|Overall Study||0
42856|NCT01963143|103403|P3|COMPLETED|Overall Study||14
42857|NCT01963143|103404|P2|COMPLETED|Overall Study||18
42858|NCT01963143|103405|P1|COMPLETED|Overall Study||14
42859|NCT01963143|103403|P3|STARTED|Overall Study||15
42860|NCT01963143|103404|P2|STARTED|Overall Study||19
42861|NCT01963143|103405|P1|STARTED|Overall Study||14
42862|NCT01963091|103417|P2|NOT COMPLETED|Overall Study||0
42863|NCT01963091|103418|P1|NOT COMPLETED|Overall Study||0
42864|NCT01963091|103417|P2|COMPLETED|Overall Study||16
42865|NCT01963091|103418|P1|COMPLETED|Overall Study||17
42866|NCT01963091|103417|P2|STARTED|Overall Study||16
42867|NCT01963091|103418|P1|STARTED|Overall Study||17
42868|NCT01962974|103428|P1|NOT COMPLETED|Overall Study||7
42869|NCT01962974|103428|P1|COMPLETED|Overall Study||0
42870|NCT01962974|103428|P1|STARTED|Overall Study||7
42871|NCT01962961|103437|P3|NOT COMPLETED|Overall Study||1
42872|NCT01962961|103438|P2|NOT COMPLETED|Overall Study||1
42873|NCT01962961|103439|P1|NOT COMPLETED|Overall Study||0
42874|NCT01962961|103437|P3|COMPLETED|Overall Study||6
42875|NCT01962961|103438|P2|COMPLETED|Overall Study||7
42876|NCT01962961|103439|P1|COMPLETED|Overall Study||9
42877|NCT01962961|103437|P3|STARTED|Overall Study||7
42878|NCT01962961|103438|P2|STARTED|Overall Study||8
42879|NCT01962961|103439|P1|STARTED|Overall Study||9
42880|NCT01962922|103455|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
42881|NCT01962922|103456|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
42882|NCT01962922|103455|P2|COMPLETED|Extendion Portion (up to Month 6)||20
42883|NCT01962922|103456|P1|COMPLETED|Extendion Portion (up to Month 6)||18
42884|NCT01962922|103455|P2|STARTED|Extendion Portion (up to Month 6)||23
42885|NCT01962922|103456|P1|STARTED|Extendion Portion (up to Month 6)||23
42886|NCT01962922|103455|P2|NOT COMPLETED|PK Portion Day 21||0
42887|NCT01962922|103456|P1|NOT COMPLETED|PK Portion Day 21||0
42888|NCT01962922|103455|P2|COMPLETED|PK Portion Day 21||23
42889|NCT01962922|103456|P1|COMPLETED|PK Portion Day 21||23
42890|NCT01962922|103455|P2|STARTED|PK Portion Day 21||23
42891|NCT01962922|103456|P1|STARTED|PK Portion Day 21||23
42892|NCT01962922|103455|P2|NOT COMPLETED|PK Portion Day 14||0
42893|NCT01962922|103456|P1|NOT COMPLETED|PK Portion Day 14||0
42894|NCT01962922|103455|P2|COMPLETED|PK Portion Day 14||23
42895|NCT01962922|103456|P1|COMPLETED|PK Portion Day 14||23
42896|NCT01962922|103455|P2|STARTED|PK Portion Day 14||23
42897|NCT01962922|103456|P1|STARTED|PK Portion Day 14||23
42898|NCT01962922|103455|P2|NOT COMPLETED|PK Portion Day 7||0
42899|NCT01962922|103456|P1|NOT COMPLETED|PK Portion Day 7||4
42900|NCT01962922|103455|P2|COMPLETED|PK Portion Day 7||23
42901|NCT01962922|103456|P1|COMPLETED|PK Portion Day 7||23
42902|NCT01962922|103455|P2|STARTED|PK Portion Day 7||23
42903|NCT01962922|103456|P1|STARTED|PK Portion Day 7||27
42904|NCT01962675|103480|P2|NOT COMPLETED|Overall Study||0
42905|NCT01962675|103481|P1|NOT COMPLETED|Overall Study||0
42906|NCT01962675|103480|P2|COMPLETED|Overall Study||7
42907|NCT01962675|103481|P1|COMPLETED|Overall Study||7
42908|NCT01962675|103480|P2|STARTED|Overall Study||7
42909|NCT01962675|103481|P1|STARTED|Overall Study||7
42910|NCT01962558|103495|P2|NOT COMPLETED|Overall Study||0
42911|NCT01962558|103496|P1|NOT COMPLETED|Overall Study||0
42912|NCT01962558|103495|P2|COMPLETED|Overall Study||14
42913|NCT01962558|103496|P1|COMPLETED|Overall Study||16
42914|NCT01962558|103495|P2|12-Weeks|Overall Study||14
42915|NCT01962558|103496|P1|12-Weeks|Overall Study||16
42916|NCT01962558|103495|P2|Acute Study|Overall Study||14
42917|NCT01962558|103496|P1|Acute Study|Overall Study||16
42918|NCT01962558|103495|P2|STARTED|Overall Study||14
42919|NCT01962558|103496|P1|STARTED|Overall Study||16
42920|NCT01962493|103514|P2|NOT COMPLETED|Overall Study||5
42921|NCT01962493|103515|P1|NOT COMPLETED|Overall Study||5
42922|NCT01962493|103514|P2|COMPLETED|Overall Study||77
42923|NCT01962493|103515|P1|COMPLETED|Overall Study||73
42924|NCT01962493|103514|P2|STARTED|Overall Study||82
42925|NCT01962493|103515|P1|STARTED|Overall Study||78
42926|NCT01962441|103538|P3|NOT COMPLETED|Retreatment Substudy||0
42927|NCT01962441|103539|P2|NOT COMPLETED|Retreatment Substudy||0
42928|NCT01962441|103540|P1|NOT COMPLETED|Retreatment Substudy||2
42929|NCT01962441|103538|P3|COMPLETED|Retreatment Substudy||0
42930|NCT01962441|103539|P2|COMPLETED|Retreatment Substudy||10
42931|NCT01962441|103540|P1|COMPLETED|Retreatment Substudy||18
42932|NCT01962441|103538|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
42933|NCT01962441|103539|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
42934|NCT01962441|103540|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
42935|NCT01962441|103538|P3|NOT COMPLETED|Randomized Period||11
42936|NCT01962441|103539|P2|NOT COMPLETED|Randomized Period||11
42937|NCT01962441|103540|P1|NOT COMPLETED|Randomized Period||10
42938|NCT01962441|103538|P3|COMPLETED|Randomized Period||189
42939|NCT01962441|103539|P2|COMPLETED|Randomized Period||190
42940|NCT01962441|103540|P1|COMPLETED|Randomized Period||190
42941|NCT01962441|103538|P3|STARTED|Randomized Period||200
42942|NCT01962441|103539|P2|STARTED|Randomized Period||201
42943|NCT01962441|103540|P1|STARTED|Randomized Period||200
42944|NCT01962428|103572|P2|NOT COMPLETED|Overall Study||6
42945|NCT01962428|103573|P1|NOT COMPLETED|Overall Study||10
42946|NCT01962428|103572|P2|COMPLETED|Overall Study||133
42947|NCT01962428|103573|P1|COMPLETED|Overall Study||129
42948|NCT01962428|103572|P2|STARTED|Overall Study||139
42949|NCT01962428|103573|P1|STARTED|Overall Study||139
42950|NCT01961544|103579|P1|NOT COMPLETED|Overall Study||13
42951|NCT01961544|103579|P1|COMPLETED|Overall Study||88
42952|NCT01961544|103579|P1|STARTED|Overall Study||101
42953|NCT01961349|103587|P3|NOT COMPLETED|Overall Study||2
42954|NCT01961349|103588|P2|NOT COMPLETED|Overall Study||6
42955|NCT01961349|103589|P1|NOT COMPLETED|Overall Study||3
42956|NCT01961349|103587|P3|COMPLETED|Overall Study||109
42957|NCT01961349|103588|P2|COMPLETED|Overall Study||101
42958|NCT01961349|103589|P1|COMPLETED|Overall Study||51
42959|NCT01961349|103587|P3|STARTED|Overall Study||111
42960|NCT01961349|103588|P2|STARTED|Overall Study||107
42961|NCT01961349|103589|P1|STARTED|Overall Study||54
42962|NCT01961323|103600|P1|NOT COMPLETED|Overall Study||49
42963|NCT01961323|103600|P1|COMPLETED|Overall Study||21
42964|NCT01961323|103600|P1|STARTED|Overall Study||70
42965|NCT01961297|103608|P2|NOT COMPLETED|Overall Study||1
42966|NCT01961297|103609|P1|NOT COMPLETED|Overall Study||2
42967|NCT01961297|103608|P2|COMPLETED|Overall Study||22
42968|NCT01961297|103609|P1|COMPLETED|Overall Study||28
42969|NCT01961297|103608|P2|STARTED|Overall Study||23
42970|NCT01961297|103609|P1|STARTED|Overall Study||30
42971|NCT01961271|103623|P1|NOT COMPLETED|Overall Study||50
42972|NCT01961271|103623|P1|COMPLETED|Overall Study||64
42973|NCT01961271|103623|P1|STARTED|Overall Study||114
42974|NCT01961115|103635|P3|NOT COMPLETED|Overall Study||4
42975|NCT01961115|103636|P2|NOT COMPLETED|Overall Study||0
42976|NCT01961115|103637|P1|NOT COMPLETED|Overall Study||2
42977|NCT01961115|103635|P3|COMPLETED|Overall Study||5
42978|NCT01961115|103636|P2|COMPLETED|Overall Study||0
42979|NCT01961115|103637|P1|COMPLETED|Overall Study||0
42980|NCT01961115|103635|P3|STARTED|Overall Study||9
42981|NCT01961115|103636|P2|STARTED|Overall Study||0
42982|NCT01961115|103637|P1|STARTED|Overall Study||2
42983|NCT01961089|103672|P1|NOT COMPLETED|Overall Study||0
42984|NCT01961089|103672|P1|COMPLETED|Overall Study||40
42985|NCT01961089|103672|P1|STARTED|Overall Study||40
42986|NCT01960907|103680|P2|NOT COMPLETED|Overall Study||45
42987|NCT01960907|103681|P1|NOT COMPLETED|Overall Study||36
42988|NCT01960907|103680|P2|COMPLETED|Overall Study||109
42989|NCT01960907|103681|P1|COMPLETED|Overall Study||122
42990|NCT01960907|103680|P2|STARTED|Overall Study||154
42991|NCT01960907|103681|P1|STARTED|Overall Study||158
42992|NCT01960842|103691|P1|NOT COMPLETED|Overall Study||3
42993|NCT01960842|103691|P1|COMPLETED|Overall Study||28
42994|NCT01960842|103691|P1|STARTED|Overall Study||31
42995|NCT01960816|103714|P1|NOT COMPLETED|Overall Study||1
42996|NCT01960816|103714|P1|COMPLETED|Overall Study||32
42997|NCT01960816|103714|P1|STARTED|Overall Study||33
42998|NCT01960725|103722|P2|NOT COMPLETED|Overall Study||5
42999|NCT01960725|103723|P1|NOT COMPLETED|Overall Study||6
43000|NCT01960725|103722|P2|COMPLETED|Overall Study||28
43001|NCT01960725|103723|P1|COMPLETED|Overall Study||27
43002|NCT01960725|103722|P2|Received Third Vaccine|Overall Study||32
43003|NCT01960725|103723|P1|Received Third Vaccine|Overall Study||32
43004|NCT01960725|103722|P2|Recieved Second Vaccine|Overall Study||33
43005|NCT01960725|103723|P1|Recieved Second Vaccine|Overall Study||33
43006|NCT01960725|103722|P2|Received First Vaccine|Overall Study||33
43007|NCT01960725|103723|P1|Received First Vaccine|Overall Study||33
43008|NCT01960725|103722|P2|STARTED|Overall Study||33
43009|NCT01960725|103723|P1|STARTED|Overall Study||33
43010|NCT01960530|103745|P1|NOT COMPLETED|Overall Study||0
43011|NCT01960530|103745|P1|COMPLETED|Overall Study||14
43012|NCT01960530|103745|P1|STARTED|Overall Study||14
43013|NCT01960400|103780|P2|NOT COMPLETED|Overall Study||0
43014|NCT01960400|103781|P1|NOT COMPLETED|Overall Study||0
43015|NCT01960400|103780|P2|COMPLETED|Overall Study||11
43016|NCT01960400|103781|P1|COMPLETED|Overall Study||11
43017|NCT01960400|103780|P2|STARTED|Overall Study||11
43018|NCT01960400|103781|P1|STARTED|Overall Study||11
43019|NCT01960387|103793|P1|NOT COMPLETED|Overall Study||0
43020|NCT01960387|103793|P1|COMPLETED|Overall Study||2
43021|NCT01960387|103793|P1|STARTED|Overall Study||2
43022|NCT01960296|103802|P2|NOT COMPLETED|Overall Study||3
43023|NCT01960296|103803|P1|NOT COMPLETED|Overall Study||2
43024|NCT01960296|103802|P2|COMPLETED|Overall Study||22
43025|NCT01960296|103803|P1|COMPLETED|Overall Study||21
43026|NCT01960296|103802|P2|STARTED|Overall Study||25
43027|NCT01960296|103803|P1|STARTED|Overall Study||23
43028|NCT01960140|103823|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
43029|NCT01960140|103823|P1|COMPLETED|Period 2 (Days 3-18)||38
43030|NCT01960140|103823|P1|Received Simvastatin|Period 2 (Days 3-18)||38
43031|NCT01960140|103823|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
43032|NCT01960140|103823|P1|STARTED|Period 2 (Days 3-18)||40
43033|NCT01960140|103823|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
43034|NCT01960140|103823|P1|COMPLETED|Period 1 (Days 1-2)||40
43035|NCT01960140|103823|P1|Received Simvastatin|Period 1 (Days 1-2)||40
43036|NCT01960140|103823|P1|STARTED|Period 1 (Days 1-2)||40
43037|NCT01960114|103834|P2|NOT COMPLETED|Overall Study||1
43038|NCT01960114|103835|P1|NOT COMPLETED|Overall Study||1
43039|NCT01960114|103834|P2|COMPLETED|Overall Study||268
43040|NCT01960114|103835|P1|COMPLETED|Overall Study||133
43041|NCT01960114|103834|P2|STARTED|Overall Study||269
43042|NCT01960114|103835|P1|STARTED|Overall Study||134
43043|NCT01959945|103853|P4|NOT COMPLETED|Overall Study||16
43044|NCT01959945|103854|P3|NOT COMPLETED|Overall Study||19
43045|NCT01959945|103855|P2|NOT COMPLETED|Overall Study||3
43046|NCT01959945|103856|P1|NOT COMPLETED|Overall Study||4
43047|NCT01959945|103853|P4|COMPLETED|Overall Study||15
43048|NCT01959945|103854|P3|COMPLETED|Overall Study||9
43049|NCT01959945|103855|P2|COMPLETED|Overall Study||75
43050|NCT01959945|103856|P1|COMPLETED|Overall Study||76
43051|NCT01959945|103853|P4|STARTED|Overall Study||31
43052|NCT01959945|103854|P3|STARTED|Overall Study||28
43053|NCT01959945|103855|P2|STARTED|Overall Study||78
43054|NCT01959945|103856|P1|STARTED|Overall Study||80
43055|NCT01959932|103881|P3|NOT COMPLETED|Overall Study||0
43056|NCT01959932|103882|P2|NOT COMPLETED|Overall Study||0
43057|NCT01959932|103883|P1|NOT COMPLETED|Overall Study||1
43058|NCT01959932|103881|P3|COMPLETED|Overall Study||39
43059|NCT01959932|103882|P2|COMPLETED|Overall Study||41
43060|NCT01959932|103883|P1|COMPLETED|Overall Study||79
43061|NCT01959932|103881|P3|STARTED|Overall Study||39
43062|NCT01959932|103882|P2|STARTED|Overall Study||41
43063|NCT01959932|103883|P1|STARTED|Overall Study||80
43064|NCT01959880|103905|P4|NOT COMPLETED|Overall Study||181
43065|NCT01959880|103906|P3|NOT COMPLETED|Overall Study||208
43066|NCT01959880|103907|P2|NOT COMPLETED|Overall Study||369
43067|NCT01959880|103908|P1|NOT COMPLETED|Overall Study||1132
43068|NCT01959880|103905|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
43069|NCT01959880|103906|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
43070|NCT01959880|103907|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
43071|NCT01959880|103908|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
43072|NCT01959880|103905|P4|STARTED|Overall Study||181
43073|NCT01959880|103906|P3|STARTED|Overall Study||209
43074|NCT01959880|103907|P2|STARTED|Overall Study||369
43075|NCT01959880|103908|P1|STARTED|Overall Study||1132
43076|NCT01959685|103930|P1|NOT COMPLETED|Overall Study||0
43077|NCT01959685|103930|P1|COMPLETED|Overall Study||9
43078|NCT01959685|103930|P1|STARTED|Overall Study||9
43079|NCT01959607|103937|P4|NOT COMPLETED|Second Intervention (Day 3)||0
43080|NCT01959607|103938|P3|NOT COMPLETED|Second Intervention (Day 3)||0
43081|NCT01959607|103939|P2|NOT COMPLETED|Second Intervention (Day 3)||0
43082|NCT01959607|103940|P1|NOT COMPLETED|Second Intervention (Day 3)||0
43083|NCT01959607|103937|P4|COMPLETED|Second Intervention (Day 3)||9
43084|NCT01959607|103938|P3|COMPLETED|Second Intervention (Day 3)||9
43085|NCT01959607|103939|P2|COMPLETED|Second Intervention (Day 3)||21
43086|NCT01959607|103940|P1|COMPLETED|Second Intervention (Day 3)||21
43087|NCT01959607|103937|P4|STARTED|Second Intervention (Day 3)||9
43088|NCT01959607|103938|P3|STARTED|Second Intervention (Day 3)||9
43089|NCT01959607|103939|P2|STARTED|Second Intervention (Day 3)||21
43090|NCT01959607|103940|P1|STARTED|Second Intervention (Day 3)||21
43091|NCT01959607|103937|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
43092|NCT01959607|103938|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
43093|NCT01959607|103939|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
43094|NCT01959607|103940|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
43095|NCT01959607|103937|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
43096|NCT01959607|103938|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
43097|NCT01959607|103939|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
43098|NCT01959607|103940|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
43099|NCT01959607|103937|P4|STARTED|Washout Period of 1 Day (Day 2)||9
43100|NCT01959607|103938|P3|STARTED|Washout Period of 1 Day (Day 2)||9
43101|NCT01959607|103939|P2|STARTED|Washout Period of 1 Day (Day 2)||21
43102|NCT01959607|103940|P1|STARTED|Washout Period of 1 Day (Day 2)||21
43103|NCT01959607|103937|P4|NOT COMPLETED|First Intervention (Day 1)||0
43104|NCT01959607|103938|P3|NOT COMPLETED|First Intervention (Day 1)||0
43105|NCT01959607|103939|P2|NOT COMPLETED|First Intervention (Day 1)||1
43106|NCT01959607|103940|P1|NOT COMPLETED|First Intervention (Day 1)||1
43107|NCT01959607|103937|P4|COMPLETED|First Intervention (Day 1)||9
43108|NCT01959607|103938|P3|COMPLETED|First Intervention (Day 1)||9
43109|NCT01959607|103939|P2|COMPLETED|First Intervention (Day 1)||21
43110|NCT01959607|103940|P1|COMPLETED|First Intervention (Day 1)||21
43111|NCT01959607|103937|P4|STARTED|First Intervention (Day 1)||9
43112|NCT01959607|103938|P3|STARTED|First Intervention (Day 1)||9
43113|NCT01959607|103939|P2|STARTED|First Intervention (Day 1)||22
43114|NCT01959607|103940|P1|STARTED|First Intervention (Day 1)||22
43115|NCT01959607|103937|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
43116|NCT01959607|103938|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
43117|NCT01959607|103939|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
43118|NCT01959607|103940|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
43119|NCT01959607|103937|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
43120|NCT01959607|103938|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
43121|NCT01959607|103939|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
43122|NCT01959607|103940|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
43123|NCT01959607|103937|P4|STARTED|Washout Period of 1 Day (Day 0)||9
43124|NCT01959607|103938|P3|STARTED|Washout Period of 1 Day (Day 0)||9
43125|NCT01959607|103939|P2|STARTED|Washout Period of 1 Day (Day 0)||22
43126|NCT01959607|103940|P1|STARTED|Washout Period of 1 Day (Day 0)||22
43127|NCT01959581|103953|P1|NOT COMPLETED|Overall Study||5
43128|NCT01959581|103953|P1|COMPLETED|Overall Study||25
43129|NCT01959581|103953|P1|STARTED|Overall Study||30
43130|NCT01959529|103959|P2|NOT COMPLETED|Overall Study||72
43131|NCT01959529|103960|P1|NOT COMPLETED|Overall Study||76
43132|NCT01959529|103959|P2|COMPLETED|Overall Study||3747
43133|NCT01959529|103960|P1|COMPLETED|Overall Study||3742
43134|NCT01959529|103959|P2|Exposed|Overall Study||3806
43135|NCT01959529|103960|P1|Exposed|Overall Study||3809
43136|NCT01959529|103959|P2|STARTED|Overall Study||3819
43137|NCT01959529|103960|P1|STARTED|Overall Study||3818
43138|NCT01959516|103972|P2|NOT COMPLETED|Epoch 2||1
43139|NCT01959516|103973|P1|NOT COMPLETED|Epoch 2||2
43140|NCT01959516|103972|P2|COMPLETED|Epoch 2||62
43141|NCT01959516|103973|P1|COMPLETED|Epoch 2||61
43142|NCT01959516|103972|P2|STARTED|Epoch 2||63
43143|NCT01959516|103973|P1|STARTED|Epoch 2||63
43144|NCT01959516|103972|P2|NOT COMPLETED|Epoch 1||5
43145|NCT01959516|103973|P1|NOT COMPLETED|Epoch 1||10
43146|NCT01959516|103972|P2|COMPLETED|Epoch 1||58
43147|NCT01959516|103973|P1|COMPLETED|Epoch 1||53
43148|NCT01959516|103972|P2|ITT Population|Epoch 1||62
43149|NCT01959516|103973|P1|ITT Population|Epoch 1||62
43150|NCT01959516|103972|P2|Safety Population|Epoch 1||62
43151|NCT01959516|103973|P1|Safety Population|Epoch 1||62
43152|NCT01959516|103972|P2|STARTED|Epoch 1||63
43153|NCT01959516|103973|P1|STARTED|Epoch 1||63
43154|NCT01959503|103983|P2|NOT COMPLETED|Overall Study||2
43155|NCT01959503|103984|P1|NOT COMPLETED|Overall Study||3
43156|NCT01959503|103983|P2|COMPLETED|Overall Study||49
43157|NCT01959503|103984|P1|COMPLETED|Overall Study||104
43158|NCT01959503|103983|P2|STARTED|Overall Study||51
43159|NCT01959503|103984|P1|STARTED|Overall Study||107
43160|NCT01959412|104004|P6|NOT COMPLETED|Overall Study||0
43161|NCT01959412|104005|P5|NOT COMPLETED|Overall Study||3
43162|NCT01959412|104006|P4|NOT COMPLETED|Overall Study||2
43163|NCT01959412|104007|P3|NOT COMPLETED|Overall Study||0
43164|NCT01959412|104008|P2|NOT COMPLETED|Overall Study||1
43165|NCT01959412|104009|P1|NOT COMPLETED|Overall Study||1
43166|NCT01959412|104004|P6|COMPLETED|Overall Study||15
43167|NCT01959412|104005|P5|COMPLETED|Overall Study||13
43168|NCT01959412|104006|P4|COMPLETED|Overall Study||13
43169|NCT01959412|104007|P3|COMPLETED|Overall Study||15
43170|NCT01959412|104008|P2|COMPLETED|Overall Study||14
43171|NCT01959412|104009|P1|COMPLETED|Overall Study||14
43172|NCT01959412|104004|P6|STARTED|Overall Study||15
43173|NCT01959412|104005|P5|STARTED|Overall Study||16
43174|NCT01959412|104006|P4|STARTED|Overall Study||15
43175|NCT01959412|104007|P3|STARTED|Overall Study||15
43176|NCT01959412|104008|P2|STARTED|Overall Study||15
43177|NCT01959412|104009|P1|STARTED|Overall Study||15
43178|NCT01959035|104047|P1|NOT COMPLETED|Overall Study||11
43179|NCT01959035|104047|P1|COMPLETED|Overall Study||77
43180|NCT01959035|104047|P1|STARTED|Overall Study||88
43181|NCT01958827|104073|P1|NOT COMPLETED|Overall Study||10
43182|NCT01958827|104073|P1|COMPLETED|Overall Study||18
43183|NCT01958827|104073|P1|STARTED|Overall Study||28
43184|NCT01958788|104091|P1|NOT COMPLETED|Overall Study||0
43185|NCT01958788|104091|P1|COMPLETED|Overall Study||7
43186|NCT01958788|104091|P1|STARTED|Overall Study||7
43187|NCT01958671|104104|P3|NOT COMPLETED|Overall Study||32
43188|NCT01958671|104105|P2|NOT COMPLETED|Overall Study||24
43189|NCT01958671|104106|P1|NOT COMPLETED|Overall Study||19
43190|NCT01958671|104104|P3|COMPLETED|Overall Study||121
43191|NCT01958671|104105|P2|COMPLETED|Overall Study||128
43192|NCT01958671|104106|P1|COMPLETED|Overall Study||137
43193|NCT01958671|104104|P3|STARTED|Overall Study||153
43194|NCT01958671|104105|P2|STARTED|Overall Study||152
43195|NCT01958671|104106|P1|STARTED|Overall Study||156
43196|NCT01958645|104150|P3|NOT COMPLETED|Overall Study||0
43197|NCT01958645|104151|P2|NOT COMPLETED|Overall Study||0
43198|NCT01958645|104152|P1|NOT COMPLETED|Overall Study||0
43199|NCT01958645|104150|P3|COMPLETED|Overall Study||4
43200|NCT01958645|104151|P2|COMPLETED|Overall Study||4
43201|NCT01958645|104152|P1|COMPLETED|Overall Study||4
43202|NCT01958645|104150|P3|STARTED|Overall Study||4
43203|NCT01958645|104151|P2|STARTED|Overall Study||4
43204|NCT01958645|104152|P1|STARTED|Overall Study||4
43205|NCT01958619|104180|P4|NOT COMPLETED|Overall Study||0
43206|NCT01958619|104181|P3|NOT COMPLETED|Overall Study||1
43207|NCT01958619|104182|P2|NOT COMPLETED|Overall Study||0
43208|NCT01958619|104183|P1|NOT COMPLETED|Overall Study||2
43209|NCT01958619|104180|P4|COMPLETED|Overall Study||12
43210|NCT01958619|104181|P3|COMPLETED|Overall Study||13
43211|NCT01958619|104182|P2|COMPLETED|Overall Study||14
43212|NCT01958619|104183|P1|COMPLETED|Overall Study||13
43213|NCT01958619|104180|P4|STARTED|Overall Study||12
43214|NCT01958619|104181|P3|STARTED|Overall Study||14
43215|NCT01958619|104182|P2|STARTED|Overall Study||14
43216|NCT01958619|104183|P1|STARTED|Overall Study||15
43217|NCT01958606|104205|P2|NOT COMPLETED|Overall Study||0
43218|NCT01958606|104206|P1|NOT COMPLETED|Overall Study||2
43219|NCT01958606|104205|P2|COMPLETED|Overall Study||5
43220|NCT01958606|104206|P1|COMPLETED|Overall Study||11
43221|NCT01958606|104205|P2|STARTED|Overall Study||5
43222|NCT01958606|104206|P1|STARTED|Overall Study||13
43223|NCT01958346|104246|P2|NOT COMPLETED|Overall Study||0
43224|NCT01958346|104247|P1|NOT COMPLETED|Overall Study||0
43225|NCT01958346|104246|P2|COMPLETED|Overall Study||39
43226|NCT01958346|104247|P1|COMPLETED|Overall Study||39
43227|NCT01958346|104246|P2|STARTED|Overall Study||39
43228|NCT01958346|104247|P1|STARTED|Overall Study||39
43229|NCT01958164|104257|P2|NOT COMPLETED|Overall Study||5
43230|NCT01958164|104258|P1|NOT COMPLETED|Overall Study||2
43231|NCT01958164|104257|P2|COMPLETED|Overall Study||5
43232|NCT01958164|104258|P1|COMPLETED|Overall Study||4
43233|NCT01958164|104257|P2|STARTED|Overall Study|Randomised and treated|10
43234|NCT01958164|104258|P1|STARTED|Overall Study|Randomised and treated|6
43235|NCT01958060|104277|P6|NOT COMPLETED|Overall Study||0
43236|NCT01958060|104278|P5|NOT COMPLETED|Overall Study||1
43237|NCT01958060|104279|P4|NOT COMPLETED|Overall Study||0
43238|NCT01958060|104280|P3|NOT COMPLETED|Overall Study||0
43239|NCT01958060|104281|P2|NOT COMPLETED|Overall Study||0
43240|NCT01958060|104282|P1|NOT COMPLETED|Overall Study||2
43241|NCT01958060|104277|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
43242|NCT01958060|104278|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
43243|NCT01958060|104279|P4|COMPLETED|Overall Study||5
43244|NCT01958060|104280|P3|COMPLETED|Overall Study||6
43245|NCT01958060|104281|P2|COMPLETED|Overall Study||6
43246|NCT01958060|104282|P1|COMPLETED|Overall Study||8
43247|NCT01958060|104277|P6|STARTED|Overall Study||1
43248|NCT01958060|104278|P5|STARTED|Overall Study||7
43249|NCT01958060|104279|P4|STARTED|Overall Study||5
43250|NCT01958060|104280|P3|STARTED|Overall Study||6
43251|NCT01958060|104281|P2|STARTED|Overall Study||6
43252|NCT01958060|104282|P1|STARTED|Overall Study||10
43253|NCT01958021|104307|P2|NOT COMPLETED|Overall Study||180
43254|NCT01958021|104308|P1|NOT COMPLETED|Overall Study||139
43255|NCT01958021|104307|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
43256|NCT01958021|104308|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
43257|NCT01958021|104307|P2|Patients Treated|Overall Study||330
43258|NCT01958021|104308|P1|Patients Treated|Overall Study||334
43259|NCT01958021|104307|P2|Patients Untreated|Overall Study||4
43260|NCT01958021|104308|P1|Patients Untreated|Overall Study||0
43261|NCT01958021|104307|P2|STARTED|Overall Study||334
43262|NCT01958021|104308|P1|STARTED|Overall Study||334
43263|NCT01958008|104320|P4|NOT COMPLETED|Overall Study||0
43264|NCT01958008|104321|P3|NOT COMPLETED|Overall Study||1
43265|NCT01958008|104322|P2|NOT COMPLETED|Overall Study||0
43266|NCT01958008|104323|P1|NOT COMPLETED|Overall Study||1
43267|NCT01958008|104320|P4|COMPLETED|Overall Study||21
43268|NCT01958008|104321|P3|COMPLETED|Overall Study||20
43269|NCT01958008|104322|P2|COMPLETED|Overall Study||21
43270|NCT01958008|104323|P1|COMPLETED|Overall Study||20
43271|NCT01958008|104320|P4|STARTED|Overall Study||21
43272|NCT01958008|104321|P3|STARTED|Overall Study||21
43273|NCT01958008|104322|P2|STARTED|Overall Study||21
43274|NCT01958008|104323|P1|STARTED|Overall Study||21
43275|NCT01957930|104353|P2|NOT COMPLETED|Overall Study||0
43276|NCT01957930|104354|P1|NOT COMPLETED|Overall Study||0
43277|NCT01957930|104353|P2|COMPLETED|Overall Study||37
43278|NCT01957930|104354|P1|COMPLETED|Overall Study||35
43279|NCT01957930|104353|P2|STARTED|Overall Study||37
43280|NCT01957930|104354|P1|STARTED|Overall Study||35
43281|NCT01957865|104363|P3|NOT COMPLETED|Overall Study||3
43282|NCT01957865|104364|P2|NOT COMPLETED|Overall Study||2
43283|NCT01957865|104365|P1|NOT COMPLETED|Overall Study||0
43284|NCT01957865|104363|P3|COMPLETED|Overall Study||19
43285|NCT01957865|104364|P2|COMPLETED|Overall Study||18
43286|NCT01957865|104365|P1|COMPLETED|Overall Study||21
43287|NCT01957865|104363|P3|STARTED|Overall Study||22
43288|NCT01957865|104364|P2|STARTED|Overall Study||20
43289|NCT01957865|104365|P1|STARTED|Overall Study||21
43290|NCT01957761|104376|P1|NOT COMPLETED|Overall Study||0
43291|NCT01957761|104376|P1|COMPLETED|Overall Study||189
43292|NCT01957761|104376|P1|STARTED|Overall Study||189
43293|NCT01957657|104380|P1|NOT COMPLETED|Overall Study||0
43294|NCT01957657|104380|P1|COMPLETED|Overall Study||4
43295|NCT01957657|104380|P1|STARTED|Overall Study||4
43296|NCT01957579|104398|P4|NOT COMPLETED|Overall Study||0
43297|NCT01957579|104399|P3|NOT COMPLETED|Overall Study||2
43298|NCT01957579|104400|P2|NOT COMPLETED|Overall Study||1
43299|NCT01957579|104401|P1|NOT COMPLETED|Overall Study||0
43300|NCT01957579|104398|P4|COMPLETED|Overall Study||6
43301|NCT01957579|104399|P3|COMPLETED|Overall Study||2
43302|NCT01957579|104400|P2|COMPLETED|Overall Study||6
43303|NCT01957579|104401|P1|COMPLETED|Overall Study||3
43304|NCT01957579|104398|P4|STARTED|Overall Study||6
43305|NCT01957579|104399|P3|STARTED|Overall Study||4
43306|NCT01957579|104400|P2|STARTED|Overall Study||7
43307|NCT01957579|104401|P1|STARTED|Overall Study||3
43308|NCT01957553|104468|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
43309|NCT01957553|104469|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
43310|NCT01957553|104468|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
43311|NCT01957553|104469|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
43312|NCT01957553|104468|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
43313|NCT01957553|104469|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
43314|NCT01957553|104468|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
43315|NCT01957553|104469|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
43316|NCT01957553|104468|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
43317|NCT01957553|104469|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
43318|NCT01957553|104468|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
43319|NCT01957553|104469|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
43320|NCT01957488|104475|P6|NOT COMPLETED|Test Period 3||0
43321|NCT01957488|104476|P5|NOT COMPLETED|Test Period 3||0
43322|NCT01957488|104477|P4|NOT COMPLETED|Test Period 3||0
43323|NCT01957488|104478|P3|NOT COMPLETED|Test Period 3||0
43324|NCT01957488|104479|P2|NOT COMPLETED|Test Period 3||1
43325|NCT01957488|104480|P1|NOT COMPLETED|Test Period 3||1
43326|NCT01957488|104475|P6|COMPLETED|Test Period 3||23
43327|NCT01957488|104476|P5|COMPLETED|Test Period 3||25
43328|NCT01957488|104477|P4|COMPLETED|Test Period 3||28
43329|NCT01957488|104478|P3|COMPLETED|Test Period 3||25
43330|NCT01957488|104479|P2|COMPLETED|Test Period 3||26
43331|NCT01957488|104480|P1|COMPLETED|Test Period 3||23
43332|NCT01957488|104475|P6|STARTED|Test Period 3||23
43333|NCT01957488|104476|P5|STARTED|Test Period 3||25
43334|NCT01957488|104477|P4|STARTED|Test Period 3||28
43335|NCT01957488|104478|P3|STARTED|Test Period 3||25
43336|NCT01957488|104479|P2|STARTED|Test Period 3||27
43337|NCT01957488|104480|P1|STARTED|Test Period 3||24
43338|NCT01957488|104475|P6|NOT COMPLETED|Test Period 2||1
43339|NCT01957488|104476|P5|NOT COMPLETED|Test Period 2||2
43340|NCT01957488|104477|P4|NOT COMPLETED|Test Period 2||1
43341|NCT01957488|104478|P3|NOT COMPLETED|Test Period 2||1
43342|NCT01957488|104479|P2|NOT COMPLETED|Test Period 2||1
43343|NCT01957488|104480|P1|NOT COMPLETED|Test Period 2||3
43344|NCT01957488|104475|P6|COMPLETED|Test Period 2||23
43345|NCT01957488|104476|P5|COMPLETED|Test Period 2||25
43346|NCT01957488|104477|P4|COMPLETED|Test Period 2||28
43347|NCT01957488|104478|P3|COMPLETED|Test Period 2||25
43348|NCT01957488|104479|P2|COMPLETED|Test Period 2||27
43349|NCT01957488|104480|P1|COMPLETED|Test Period 2||24
43350|NCT01957488|104475|P6|STARTED|Test Period 2||24
43351|NCT01957488|104476|P5|STARTED|Test Period 2||27
43352|NCT01957488|104477|P4|STARTED|Test Period 2||29
43353|NCT01957488|104478|P3|STARTED|Test Period 2||26
43354|NCT01957488|104479|P2|STARTED|Test Period 2||28
43355|NCT01957488|104480|P1|STARTED|Test Period 2||27
43356|NCT01957488|104475|P6|NOT COMPLETED|Test Period 1||6
43357|NCT01957488|104476|P5|NOT COMPLETED|Test Period 1||3
43358|NCT01957488|104477|P4|NOT COMPLETED|Test Period 1||3
43359|NCT01957488|104478|P3|NOT COMPLETED|Test Period 1||4
43360|NCT01957488|104479|P2|NOT COMPLETED|Test Period 1||3
43361|NCT01957488|104480|P1|NOT COMPLETED|Test Period 1||3
43362|NCT01957488|104475|P6|COMPLETED|Test Period 1||24
43363|NCT01957488|104476|P5|COMPLETED|Test Period 1||27
43364|NCT01957488|104477|P4|COMPLETED|Test Period 1||29
43365|NCT01957488|104478|P3|COMPLETED|Test Period 1||26
43366|NCT01957488|104479|P2|COMPLETED|Test Period 1||28
43367|NCT01957488|104480|P1|COMPLETED|Test Period 1||27
43368|NCT01957488|104475|P6|STARTED|Test Period 1||30
43369|NCT01957488|104476|P5|STARTED|Test Period 1||30
43370|NCT01957488|104477|P4|STARTED|Test Period 1||32
43371|NCT01957488|104478|P3|STARTED|Test Period 1||30
43372|NCT01957488|104479|P2|STARTED|Test Period 1||31
43373|NCT01957488|104480|P1|STARTED|Test Period 1||30
43374|NCT01957475|104488|P2|NOT COMPLETED|Test Period 2||0
43375|NCT01957475|104489|P1|NOT COMPLETED|Test Period 2||1
43376|NCT01957475|104488|P2|COMPLETED|Test Period 2||8
43377|NCT01957475|104489|P1|COMPLETED|Test Period 2||8
43378|NCT01957475|104488|P2|STARTED|Test Period 2||8
43379|NCT01957475|104489|P1|STARTED|Test Period 2||9
43380|NCT01957475|104488|P2|NOT COMPLETED|Test Period 1||1
43381|NCT01957475|104489|P1|NOT COMPLETED|Test Period 1||2
43382|NCT01957475|104488|P2|COMPLETED|Test Period 1||9
43383|NCT01957475|104489|P1|COMPLETED|Test Period 1||8
43384|NCT01957475|104488|P2|STARTED|Test Period 1||10
43385|NCT01957475|104489|P1|STARTED|Test Period 1||10
43386|NCT01957462|104495|P2|NOT COMPLETED|Test Period 2||0
43387|NCT01957462|104496|P1|NOT COMPLETED|Test Period 2||0
43388|NCT01957462|104495|P2|COMPLETED|Test Period 2||15
43389|NCT01957462|104496|P1|COMPLETED|Test Period 2||14
43390|NCT01957462|104495|P2|STARTED|Test Period 2||15
43391|NCT01957462|104496|P1|STARTED|Test Period 2||14
43392|NCT01957462|104495|P2|NOT COMPLETED|Test Period 1||0
43393|NCT01957462|104496|P1|NOT COMPLETED|Test Period 1||2
43394|NCT01957462|104495|P2|COMPLETED|Test Period 1||15
43395|NCT01957462|104496|P1|COMPLETED|Test Period 1||14
43396|NCT01957462|104495|P2|STARTED|Test Period 1||15
43397|NCT01957462|104496|P1|STARTED|Test Period 1||16
43398|NCT01957410|104502|P1|NOT COMPLETED|Optional Open Label||0
43399|NCT01957410|104502|P1|COMPLETED|Optional Open Label||13
43400|NCT01957410|104502|P1|STARTED|Optional Open Label||13
43401|NCT01957410|104502|P1|NOT COMPLETED|Open Label||0
43402|NCT01957410|104502|P1|COMPLETED|Open Label||13
43403|NCT01957410|104502|P1|STARTED|Open Label||13
43404|NCT01957397|104507|P2|NOT COMPLETED|Test Period 3||2
43405|NCT01957397|104508|P1|NOT COMPLETED|Test Period 3||2
43406|NCT01957397|104507|P2|COMPLETED|Test Period 3||9
43407|NCT01957397|104508|P1|COMPLETED|Test Period 3||9
43408|NCT01957397|104507|P2|STARTED|Test Period 3||11
43409|NCT01957397|104508|P1|STARTED|Test Period 3||11
43410|NCT01957397|104507|P2|NOT COMPLETED|Test Period 2||1
43411|NCT01957397|104508|P1|NOT COMPLETED|Test Period 2||0
43412|NCT01957397|104507|P2|COMPLETED|Test Period 2||11
43413|NCT01957397|104508|P1|COMPLETED|Test Period 2||11
43414|NCT01957397|104507|P2|STARTED|Test Period 2||12
43415|NCT01957397|104508|P1|STARTED|Test Period 2||11
43416|NCT01957397|104507|P2|NOT COMPLETED|Test Period 1||1
43417|NCT01957397|104508|P1|NOT COMPLETED|Test Period 1||2
43418|NCT01957397|104507|P2|COMPLETED|Test Period 1||12
43419|NCT01957397|104508|P1|COMPLETED|Test Period 1||11
43420|NCT01957397|104507|P2|STARTED|Test Period 1||13
43421|NCT01957397|104508|P1|STARTED|Test Period 1||13
43422|NCT01957397|104507|P2|NOT COMPLETED|Baseline Own Product||0
43423|NCT01957397|104508|P1|NOT COMPLETED|Baseline Own Product||0
43424|NCT01957397|104507|P2|COMPLETED|Baseline Own Product||13
43425|NCT01957397|104508|P1|COMPLETED|Baseline Own Product||13
43426|NCT01957397|104507|P2|STARTED|Baseline Own Product||13
43427|NCT01957397|104508|P1|STARTED|Baseline Own Product||13
43428|NCT01957384|104518|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
43429|NCT01957384|104519|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
43430|NCT01957384|104520|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
43431|NCT01957384|104521|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
43432|NCT01957384|104522|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
43433|NCT01957384|104523|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
43434|NCT01957384|104518|P6|COMPLETED|Test Period 3 (14 Days)||3
43435|NCT01957384|104519|P5|COMPLETED|Test Period 3 (14 Days)||3
43436|NCT01957384|104520|P4|COMPLETED|Test Period 3 (14 Days)||4
43437|NCT01957384|104521|P3|COMPLETED|Test Period 3 (14 Days)||4
43438|NCT01957384|104522|P2|COMPLETED|Test Period 3 (14 Days)||4
43439|NCT01957384|104523|P1|COMPLETED|Test Period 3 (14 Days)||4
43440|NCT01957384|104518|P6|STARTED|Test Period 3 (14 Days)||3
43441|NCT01957384|104519|P5|STARTED|Test Period 3 (14 Days)||3
43442|NCT01957384|104520|P4|STARTED|Test Period 3 (14 Days)||4
43443|NCT01957384|104521|P3|STARTED|Test Period 3 (14 Days)||4
43444|NCT01957384|104522|P2|STARTED|Test Period 3 (14 Days)||4
43445|NCT01957384|104523|P1|STARTED|Test Period 3 (14 Days)||4
43446|NCT01957384|104518|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
43447|NCT01957384|104519|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
43448|NCT01957384|104520|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
43449|NCT01957384|104521|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
43450|NCT01957384|104522|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
43451|NCT01957384|104523|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
43452|NCT01957384|104518|P6|COMPLETED|Test Period 2 (14 Days)||3
43453|NCT01957384|104519|P5|COMPLETED|Test Period 2 (14 Days)||3
43454|NCT01957384|104520|P4|COMPLETED|Test Period 2 (14 Days)||4
43455|NCT01957384|104521|P3|COMPLETED|Test Period 2 (14 Days)||4
43456|NCT01957384|104522|P2|COMPLETED|Test Period 2 (14 Days)||4
43457|NCT01957384|104523|P1|COMPLETED|Test Period 2 (14 Days)||4
43458|NCT01957384|104518|P6|STARTED|Test Period 2 (14 Days)||3
43459|NCT01957384|104519|P5|STARTED|Test Period 2 (14 Days)||3
43460|NCT01957384|104520|P4|STARTED|Test Period 2 (14 Days)||4
43461|NCT01957384|104521|P3|STARTED|Test Period 2 (14 Days)||4
43462|NCT01957384|104522|P2|STARTED|Test Period 2 (14 Days)||4
43463|NCT01957384|104523|P1|STARTED|Test Period 2 (14 Days)||4
43464|NCT01957384|104518|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
43465|NCT01957384|104519|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
43466|NCT01957384|104520|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
43467|NCT01957384|104521|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
43468|NCT01957384|104522|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
43469|NCT01957384|104523|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
43470|NCT01957384|104518|P6|COMPLETED|Test Period 1 (14 Days)||3
43471|NCT01957384|104519|P5|COMPLETED|Test Period 1 (14 Days)||3
43472|NCT01957384|104520|P4|COMPLETED|Test Period 1 (14 Days)||4
43473|NCT01957384|104521|P3|COMPLETED|Test Period 1 (14 Days)||4
43474|NCT01957384|104522|P2|COMPLETED|Test Period 1 (14 Days)||4
43475|NCT01957384|104523|P1|COMPLETED|Test Period 1 (14 Days)||4
43476|NCT01957384|104518|P6|STARTED|Test Period 1 (14 Days)||3
43477|NCT01957384|104519|P5|STARTED|Test Period 1 (14 Days)||3
43478|NCT01957384|104520|P4|STARTED|Test Period 1 (14 Days)||4
43479|NCT01957384|104521|P3|STARTED|Test Period 1 (14 Days)||4
43480|NCT01957384|104522|P2|STARTED|Test Period 1 (14 Days)||4
43481|NCT01957384|104523|P1|STARTED|Test Period 1 (14 Days)||4
43482|NCT01957215|104533|P2|NOT COMPLETED|Overall Study||12
43483|NCT01957215|104534|P1|NOT COMPLETED|Overall Study||13
43484|NCT01957215|104533|P2|COMPLETED|Overall Study||123
43485|NCT01957215|104534|P1|COMPLETED|Overall Study||122
43486|NCT01957215|104533|P2|STARTED|Overall Study||135
43487|NCT01957215|104534|P1|STARTED|Overall Study||135
43488|NCT01957202|104562|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43489|NCT01957202|104563|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
43490|NCT01957202|104564|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43491|NCT01957202|104565|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43492|NCT01957202|104566|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43493|NCT01957202|104567|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43494|NCT01957202|104568|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43495|NCT01957202|104569|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43496|NCT01957202|104570|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43497|NCT01957202|104571|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43498|NCT01957202|104572|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43499|NCT01957202|104573|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43500|NCT01957202|104574|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43501|NCT01957202|104575|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43502|NCT01957202|104576|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43503|NCT01957202|104577|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43504|NCT01957202|104578|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43505|NCT01957202|104579|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
43506|NCT01957202|104562|P18|COMPLETED|Treatment Period 3 (8 Days)||3
43507|NCT01957202|104563|P17|COMPLETED|Treatment Period 3 (8 Days)||4
43508|NCT01957202|104564|P16|COMPLETED|Treatment Period 3 (8 Days)||3
43509|NCT01957202|104565|P15|COMPLETED|Treatment Period 3 (8 Days)||6
43510|NCT01957202|104566|P14|COMPLETED|Treatment Period 3 (8 Days)||3
43511|NCT01957202|104567|P13|COMPLETED|Treatment Period 3 (8 Days)||3
43512|NCT01957202|104568|P12|COMPLETED|Treatment Period 3 (8 Days)||6
43513|NCT01957202|104569|P11|COMPLETED|Treatment Period 3 (8 Days)||3
43514|NCT01957202|104570|P10|COMPLETED|Treatment Period 3 (8 Days)||6
43515|NCT01957202|104571|P9|COMPLETED|Treatment Period 3 (8 Days)||3
43516|NCT01957202|104572|P8|COMPLETED|Treatment Period 3 (8 Days)||3
43517|NCT01957202|104573|P7|COMPLETED|Treatment Period 3 (8 Days)||3
43518|NCT01957202|104574|P6|COMPLETED|Treatment Period 3 (8 Days)||2
43519|NCT01957202|104575|P5|COMPLETED|Treatment Period 3 (8 Days)||3
43520|NCT01957202|104576|P4|COMPLETED|Treatment Period 3 (8 Days)||3
43521|NCT01957202|104577|P3|COMPLETED|Treatment Period 3 (8 Days)||6
43522|NCT01957202|104578|P2|COMPLETED|Treatment Period 3 (8 Days)||5
43523|NCT01957202|104579|P1|COMPLETED|Treatment Period 3 (8 Days)||3
43524|NCT01957202|104562|P18|STARTED|Treatment Period 3 (8 Days)||3
43525|NCT01957202|104563|P17|STARTED|Treatment Period 3 (8 Days)||5
43526|NCT01957202|104564|P16|STARTED|Treatment Period 3 (8 Days)||3
43527|NCT01957202|104565|P15|STARTED|Treatment Period 3 (8 Days)||6
43528|NCT01957202|104566|P14|STARTED|Treatment Period 3 (8 Days)||3
43529|NCT01957202|104567|P13|STARTED|Treatment Period 3 (8 Days)||3
43530|NCT01957202|104568|P12|STARTED|Treatment Period 3 (8 Days)||6
43531|NCT01957202|104569|P11|STARTED|Treatment Period 3 (8 Days)||3
43532|NCT01957202|104570|P10|STARTED|Treatment Period 3 (8 Days)||6
43533|NCT01957202|104571|P9|STARTED|Treatment Period 3 (8 Days)||3
43534|NCT01957202|104572|P8|STARTED|Treatment Period 3 (8 Days)||3
43535|NCT01957202|104573|P7|STARTED|Treatment Period 3 (8 Days)||3
43536|NCT01957202|104574|P6|STARTED|Treatment Period 3 (8 Days)||2
43537|NCT01957202|104575|P5|STARTED|Treatment Period 3 (8 Days)||3
43538|NCT01957202|104576|P4|STARTED|Treatment Period 3 (8 Days)||3
43539|NCT01957202|104577|P3|STARTED|Treatment Period 3 (8 Days)||6
43540|NCT01957202|104578|P2|STARTED|Treatment Period 3 (8 Days)||5
43541|NCT01957202|104579|P1|STARTED|Treatment Period 3 (8 Days)||3
43542|NCT01957202|104562|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43543|NCT01957202|104563|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43544|NCT01957202|104564|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43545|NCT01957202|104565|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43546|NCT01957202|104566|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43547|NCT01957202|104567|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43548|NCT01957202|104568|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43549|NCT01957202|104569|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43550|NCT01957202|104570|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43551|NCT01957202|104571|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43552|NCT01957202|104572|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43553|NCT01957202|104573|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43554|NCT01957202|104574|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43555|NCT01957202|104575|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43556|NCT01957202|104576|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43557|NCT01957202|104577|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43558|NCT01957202|104578|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43559|NCT01957202|104579|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
43560|NCT01957202|104562|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43561|NCT01957202|104563|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
43562|NCT01957202|104564|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43563|NCT01957202|104565|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
43564|NCT01957202|104566|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43565|NCT01957202|104567|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43566|NCT01957202|104568|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
43567|NCT01957202|104569|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43568|NCT01957202|104570|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
43569|NCT01957202|104571|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43570|NCT01957202|104572|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43571|NCT01957202|104573|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43572|NCT01957202|104574|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
43573|NCT01957202|104575|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43574|NCT01957202|104576|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43575|NCT01957202|104577|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
43576|NCT01957202|104578|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
43577|NCT01957202|104579|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
43578|NCT01957202|104562|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
43579|NCT01957202|104563|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
43580|NCT01957202|104564|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
43581|NCT01957202|104565|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
43582|NCT01957202|104566|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
43583|NCT01957202|104567|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
43584|NCT01957202|104568|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
43585|NCT01957202|104569|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
43586|NCT01957202|104570|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
43587|NCT01957202|104571|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
43588|NCT01957202|104572|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
43589|NCT01957202|104573|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
43590|NCT01957202|104574|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
43591|NCT01957202|104575|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
43592|NCT01957202|104576|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
43593|NCT01957202|104577|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
43594|NCT01957202|104578|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
43595|NCT01957202|104579|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
43596|NCT01957202|104562|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43597|NCT01957202|104563|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
43598|NCT01957202|104564|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43599|NCT01957202|104565|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43600|NCT01957202|104566|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43601|NCT01957202|104567|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43602|NCT01957202|104568|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43603|NCT01957202|104569|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43604|NCT01957202|104570|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43605|NCT01957202|104571|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43606|NCT01957202|104572|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43607|NCT01957202|104573|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43608|NCT01957202|104574|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43609|NCT01957202|104575|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43610|NCT01957202|104576|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43611|NCT01957202|104577|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43612|NCT01957202|104578|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
43613|NCT01957202|104579|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
43614|NCT01957202|104562|P18|COMPLETED|Treatment Period 2 (8 Days)||3
43615|NCT01957202|104563|P17|COMPLETED|Treatment Period 2 (8 Days)||5
43616|NCT01957202|104564|P16|COMPLETED|Treatment Period 2 (8 Days)||3
43617|NCT01957202|104565|P15|COMPLETED|Treatment Period 2 (8 Days)||6
43618|NCT01957202|104566|P14|COMPLETED|Treatment Period 2 (8 Days)||3
43619|NCT01957202|104567|P13|COMPLETED|Treatment Period 2 (8 Days)||3
43620|NCT01957202|104568|P12|COMPLETED|Treatment Period 2 (8 Days)||6
43621|NCT01957202|104569|P11|COMPLETED|Treatment Period 2 (8 Days)||3
43622|NCT01957202|104570|P10|COMPLETED|Treatment Period 2 (8 Days)||6
43623|NCT01957202|104571|P9|COMPLETED|Treatment Period 2 (8 Days)||3
43624|NCT01957202|104572|P8|COMPLETED|Treatment Period 2 (8 Days)||3
43625|NCT01957202|104573|P7|COMPLETED|Treatment Period 2 (8 Days)||3
43626|NCT01957202|104574|P6|COMPLETED|Treatment Period 2 (8 Days)||2
43627|NCT01957202|104575|P5|COMPLETED|Treatment Period 2 (8 Days)||3
43628|NCT01957202|104576|P4|COMPLETED|Treatment Period 2 (8 Days)||3
43629|NCT01957202|104577|P3|COMPLETED|Treatment Period 2 (8 Days)||6
43630|NCT01957202|104578|P2|COMPLETED|Treatment Period 2 (8 Days)||5
43631|NCT01957202|104579|P1|COMPLETED|Treatment Period 2 (8 Days)||3
43632|NCT01957202|104562|P18|STARTED|Treatment Period 2 (8 Days)||3
43633|NCT01957202|104563|P17|STARTED|Treatment Period 2 (8 Days)||6
43634|NCT01957202|104564|P16|STARTED|Treatment Period 2 (8 Days)||3
43635|NCT01957202|104565|P15|STARTED|Treatment Period 2 (8 Days)||6
43636|NCT01957202|104566|P14|STARTED|Treatment Period 2 (8 Days)||3
43637|NCT01957202|104567|P13|STARTED|Treatment Period 2 (8 Days)||3
43638|NCT01957202|104568|P12|STARTED|Treatment Period 2 (8 Days)||6
43639|NCT01957202|104569|P11|STARTED|Treatment Period 2 (8 Days)||3
43640|NCT01957202|104570|P10|STARTED|Treatment Period 2 (8 Days)||6
43641|NCT01957202|104571|P9|STARTED|Treatment Period 2 (8 Days)||3
43642|NCT01957202|104572|P8|STARTED|Treatment Period 2 (8 Days)||3
43643|NCT01957202|104573|P7|STARTED|Treatment Period 2 (8 Days)||3
43644|NCT01957202|104574|P6|STARTED|Treatment Period 2 (8 Days)||2
43645|NCT01957202|104575|P5|STARTED|Treatment Period 2 (8 Days)||3
43646|NCT01957202|104576|P4|STARTED|Treatment Period 2 (8 Days)||3
43647|NCT01957202|104577|P3|STARTED|Treatment Period 2 (8 Days)||6
43648|NCT01957202|104578|P2|STARTED|Treatment Period 2 (8 Days)||6
43649|NCT01957202|104579|P1|STARTED|Treatment Period 2 (8 Days)||3
43650|NCT01957202|104562|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43651|NCT01957202|104563|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43652|NCT01957202|104564|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43653|NCT01957202|104565|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43654|NCT01957202|104566|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43655|NCT01957202|104567|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43656|NCT01957202|104568|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43657|NCT01957202|104569|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43658|NCT01957202|104570|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43659|NCT01957202|104571|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43660|NCT01957202|104572|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43661|NCT01957202|104573|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43662|NCT01957202|104574|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43663|NCT01957202|104575|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43664|NCT01957202|104576|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43665|NCT01957202|104577|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43666|NCT01957202|104578|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43667|NCT01957202|104579|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
43668|NCT01957202|104562|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43669|NCT01957202|104563|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
43670|NCT01957202|104564|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43671|NCT01957202|104565|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
43672|NCT01957202|104566|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43673|NCT01957202|104567|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43674|NCT01957202|104568|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
43675|NCT01957202|104569|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43676|NCT01957202|104570|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
43677|NCT01957202|104571|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43678|NCT01957202|104572|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43679|NCT01957202|104573|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43680|NCT01957202|104574|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
43681|NCT01957202|104575|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43682|NCT01957202|104576|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43683|NCT01957202|104577|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
43684|NCT01957202|104578|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
43685|NCT01957202|104579|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
43686|NCT01957202|104562|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
43687|NCT01957202|104563|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
43688|NCT01957202|104564|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
43689|NCT01957202|104565|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
43690|NCT01957202|104566|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
43691|NCT01957202|104567|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
43692|NCT01957202|104568|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
43693|NCT01957202|104569|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
43694|NCT01957202|104570|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
43695|NCT01957202|104571|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
43696|NCT01957202|104572|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
43697|NCT01957202|104573|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
43698|NCT01957202|104574|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
43699|NCT01957202|104575|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
43700|NCT01957202|104576|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
43701|NCT01957202|104577|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
43702|NCT01957202|104578|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
43703|NCT01957202|104579|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
43704|NCT01957202|104562|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43705|NCT01957202|104563|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43706|NCT01957202|104564|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43707|NCT01957202|104565|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43708|NCT01957202|104566|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43709|NCT01957202|104567|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43710|NCT01957202|104568|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43711|NCT01957202|104569|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43712|NCT01957202|104570|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43713|NCT01957202|104571|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43714|NCT01957202|104572|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43715|NCT01957202|104573|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43716|NCT01957202|104574|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43717|NCT01957202|104575|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43718|NCT01957202|104576|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43719|NCT01957202|104577|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43720|NCT01957202|104578|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43721|NCT01957202|104579|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
43722|NCT01957202|104562|P18|COMPLETED|Treatment Period 1 (8 Days)||3
43723|NCT01957202|104563|P17|COMPLETED|Treatment Period 1 (8 Days)||6
43724|NCT01957202|104564|P16|COMPLETED|Treatment Period 1 (8 Days)||3
43725|NCT01957202|104565|P15|COMPLETED|Treatment Period 1 (8 Days)||6
43726|NCT01957202|104566|P14|COMPLETED|Treatment Period 1 (8 Days)||3
43727|NCT01957202|104567|P13|COMPLETED|Treatment Period 1 (8 Days)||3
43728|NCT01957202|104568|P12|COMPLETED|Treatment Period 1 (8 Days)||6
43729|NCT01957202|104569|P11|COMPLETED|Treatment Period 1 (8 Days)||3
43730|NCT01957202|104570|P10|COMPLETED|Treatment Period 1 (8 Days)||6
43731|NCT01957202|104571|P9|COMPLETED|Treatment Period 1 (8 Days)||3
43732|NCT01957202|104572|P8|COMPLETED|Treatment Period 1 (8 Days)||3
43733|NCT01957202|104573|P7|COMPLETED|Treatment Period 1 (8 Days)||3
43734|NCT01957202|104574|P6|COMPLETED|Treatment Period 1 (8 Days)||2
43735|NCT01957202|104575|P5|COMPLETED|Treatment Period 1 (8 Days)||3
43736|NCT01957202|104576|P4|COMPLETED|Treatment Period 1 (8 Days)||3
43737|NCT01957202|104577|P3|COMPLETED|Treatment Period 1 (8 Days)||6
43738|NCT01957202|104578|P2|COMPLETED|Treatment Period 1 (8 Days)||6
43739|NCT01957202|104579|P1|COMPLETED|Treatment Period 1 (8 Days)||3
43740|NCT01957202|104562|P18|STARTED|Treatment Period 1 (8 Days)||3
43741|NCT01957202|104563|P17|STARTED|Treatment Period 1 (8 Days)||6
43742|NCT01957202|104564|P16|STARTED|Treatment Period 1 (8 Days)||3
43743|NCT01957202|104565|P15|STARTED|Treatment Period 1 (8 Days)||6
43744|NCT01957202|104566|P14|STARTED|Treatment Period 1 (8 Days)||3
43745|NCT01957202|104567|P13|STARTED|Treatment Period 1 (8 Days)||3
43746|NCT01957202|104568|P12|STARTED|Treatment Period 1 (8 Days)||6
43747|NCT01957202|104569|P11|STARTED|Treatment Period 1 (8 Days)||3
43748|NCT01957202|104570|P10|STARTED|Treatment Period 1 (8 Days)||6
43749|NCT01957202|104571|P9|STARTED|Treatment Period 1 (8 Days)||3
43750|NCT01957202|104572|P8|STARTED|Treatment Period 1 (8 Days)||3
43751|NCT01957202|104573|P7|STARTED|Treatment Period 1 (8 Days)||3
43752|NCT01957202|104574|P6|STARTED|Treatment Period 1 (8 Days)||2
43753|NCT01957202|104575|P5|STARTED|Treatment Period 1 (8 Days)||3
43754|NCT01957202|104576|P4|STARTED|Treatment Period 1 (8 Days)||3
43755|NCT01957202|104577|P3|STARTED|Treatment Period 1 (8 Days)||6
43756|NCT01957202|104578|P2|STARTED|Treatment Period 1 (8 Days)||6
43757|NCT01957202|104579|P1|STARTED|Treatment Period 1 (8 Days)||3
43758|NCT01957163|104604|P3|NOT COMPLETED|Overall Study||18
43759|NCT01957163|104605|P2|NOT COMPLETED|Overall Study||11
43760|NCT01957163|104606|P1|NOT COMPLETED|Overall Study||15
43761|NCT01957163|104604|P3|COMPLETED|Overall Study||189
43762|NCT01957163|104605|P2|COMPLETED|Overall Study||195
43763|NCT01957163|104606|P1|COMPLETED|Overall Study||191
43764|NCT01957163|104604|P3|STARTED|Overall Study||207
43765|NCT01957163|104605|P2|STARTED|Overall Study||206
43766|NCT01957163|104606|P1|STARTED|Overall Study||206
43767|NCT01957137|104617|P1|NOT COMPLETED|No Stimulation||0
43768|NCT01957137|104617|P1|COMPLETED|No Stimulation||28
43769|NCT01957137|104617|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
43770|NCT01957137|104617|P1|NOT COMPLETED|Randomized Portion||2
43771|NCT01957137|104617|P1|COMPLETED|Randomized Portion||28
43772|NCT01957137|104617|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
43773|NCT01957137|104617|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
43774|NCT01957137|104617|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
43775|NCT01957137|104617|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
43776|NCT01957137|104617|P1|STARTED|Randomized Portion||30
43777|NCT01957111|104647|P2|NOT COMPLETED|Overall Study||1
43778|NCT01957111|104648|P1|NOT COMPLETED|Overall Study||1
43779|NCT01957111|104647|P2|COMPLETED|Overall Study||15
43780|NCT01957111|104648|P1|COMPLETED|Overall Study||15
43781|NCT01957111|104647|P2|STARTED|Overall Study||16
43782|NCT01957111|104648|P1|STARTED|Overall Study||16
43783|NCT01956435|104656|P2|NOT COMPLETED|Overall Study||0
43784|NCT01956435|104657|P1|NOT COMPLETED|Overall Study||0
43785|NCT01956435|104656|P2|COMPLETED|Overall Study||3
43786|NCT01956435|104657|P1|COMPLETED|Overall Study||3
43787|NCT01956435|104656|P2|STARTED|Overall Study||3
43788|NCT01956435|104657|P1|STARTED|Overall Study||3
43789|NCT01956240|104666|P2|NOT COMPLETED|Overall Study||24
43790|NCT01956240|104667|P1|NOT COMPLETED|Overall Study||23
43791|NCT01956240|104666|P2|COMPLETED|Overall Study||25
43792|NCT01956240|104667|P1|COMPLETED|Overall Study||25
43793|NCT01956240|104666|P2|STARTED|Overall Study||49
43794|NCT01956240|104667|P1|STARTED|Overall Study||48
43795|NCT01956097|104678|P3|NOT COMPLETED|Overall Study||0
43796|NCT01956097|104679|P2|NOT COMPLETED|Overall Study||2
43797|NCT01956097|104680|P1|NOT COMPLETED|Overall Study||6
43798|NCT01956097|104678|P3|COMPLETED|Overall Study||15
43799|NCT01956097|104679|P2|COMPLETED|Overall Study||28
43800|NCT01956097|104680|P1|COMPLETED|Overall Study||24
43801|NCT01956097|104678|P3|STARTED|Overall Study||15
43802|NCT01956097|104679|P2|STARTED|Overall Study||30
43803|NCT01956097|104680|P1|STARTED|Overall Study||30
43804|NCT01956032|104697|P1|NOT COMPLETED|Overall Study||0
43805|NCT01956032|104697|P1|COMPLETED|Overall Study||15
43806|NCT01956032|104697|P1|STARTED|Overall Study||15
43807|NCT01955954|104744|P1|NOT COMPLETED|Overall Study||36
43808|NCT01955954|104744|P1|COMPLETED|Overall Study|12-months|33
43809|NCT01955954|104744|P1|Completed 6-month Assessement|Overall Study||42
43810|NCT01955954|104744|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
43811|NCT01955954|104744|P1|Completed Post-treatment Assessement|Overall Study||48
43812|NCT01955954|104744|P1|Completed Treatment|Overall Study||53
43813|NCT01955954|104744|P1|Received Treatment|Overall Study||66
43814|NCT01955954|104744|P1|STARTED|Overall Study||69
43815|NCT01955733|104756|P3|NOT COMPLETED|Period 2||21
43816|NCT01955733|104757|P2|NOT COMPLETED|Period 2||19
43817|NCT01955733|104758|P1|NOT COMPLETED|Period 2||12
43818|NCT01955733|104756|P3|COMPLETED|Period 2||8
43819|NCT01955733|104757|P2|COMPLETED|Period 2||10
43820|NCT01955733|104758|P1|COMPLETED|Period 2||20
43821|NCT01955733|104756|P3|STARTED|Period 2||29
43822|NCT01955733|104757|P2|STARTED|Period 2||29
43823|NCT01955733|104758|P1|STARTED|Period 2||32
43824|NCT01955733|104756|P3|NOT COMPLETED|Period 1||0
43825|NCT01955733|104757|P2|NOT COMPLETED|Period 1||0
43826|NCT01955733|104758|P1|NOT COMPLETED|Period 1||1
43827|NCT01955733|104756|P3|COMPLETED|Period 1||29
43828|NCT01955733|104757|P2|COMPLETED|Period 1||29
43829|NCT01955733|104758|P1|COMPLETED|Period 1||32
43830|NCT01955733|104756|P3|STARTED|Period 1||29
43831|NCT01955733|104757|P2|STARTED|Period 1||29
43832|NCT01955733|104758|P1|STARTED|Period 1||33
43833|NCT01955720|104778|P6|NOT COMPLETED|Overall Study||0
43834|NCT01955720|104779|P5|NOT COMPLETED|Overall Study||0
43835|NCT01955720|104780|P4|NOT COMPLETED|Overall Study||0
43836|NCT01955720|104781|P3|NOT COMPLETED|Overall Study||0
43837|NCT01955720|104782|P2|NOT COMPLETED|Overall Study||0
43838|NCT01955720|104783|P1|NOT COMPLETED|Overall Study||0
43839|NCT01955720|104778|P6|COMPLETED|Overall Study||7
43840|NCT01955720|104779|P5|COMPLETED|Overall Study||7
43841|NCT01955720|104780|P4|COMPLETED|Overall Study||3
43842|NCT01955720|104781|P3|COMPLETED|Overall Study||3
43843|NCT01955720|104782|P2|COMPLETED|Overall Study||13
43844|NCT01955720|104783|P1|COMPLETED|Overall Study||13
43845|NCT01955720|104778|P6|Subjects With Moderate Renal Impairment|Overall Study||0
43846|NCT01955720|104779|P5|Subjects With Moderate Renal Impairment|Overall Study||0
43847|NCT01955720|104780|P4|Subjects With Moderate Renal Impairment|Overall Study||0
43848|NCT01955720|104781|P3|Subjects With Moderate Renal Impairment|Overall Study||0
43849|NCT01955720|104782|P2|Subjects With Moderate Renal Impairment|Overall Study||3
43850|NCT01955720|104783|P1|Subjects With Moderate Renal Impairment|Overall Study||3
43851|NCT01955720|104778|P6|Subjects With Mild Renal Impairment|Overall Study||3
43852|NCT01955720|104779|P5|Subjects With Mild Renal Impairment|Overall Study||3
43853|NCT01955720|104780|P4|Subjects With Mild Renal Impairment|Overall Study||0
43854|NCT01955720|104781|P3|Subjects With Mild Renal Impairment|Overall Study||0
43855|NCT01955720|104782|P2|Subjects With Mild Renal Impairment|Overall Study||3
43856|NCT01955720|104783|P1|Subjects With Mild Renal Impairment|Overall Study||3
43857|NCT01955720|104778|P6|Healthy Subjects Aged 65-80|Overall Study||4
43858|NCT01955720|104779|P5|Healthy Subjects Aged 65-80|Overall Study||4
43859|NCT01955720|104780|P4|Healthy Subjects Aged 65-80|Overall Study||0
43860|NCT01955720|104781|P3|Healthy Subjects Aged 65-80|Overall Study||0
43861|NCT01955720|104782|P2|Healthy Subjects Aged 65-80|Overall Study||4
43862|NCT01955720|104783|P1|Healthy Subjects Aged 65-80|Overall Study||4
43863|NCT01955720|104778|P6|Healthy Subjects Aged 45-64|Overall Study||0
43864|NCT01955720|104779|P5|Healthy Subjects Aged 45-64|Overall Study||0
43865|NCT01955720|104780|P4|Healthy Subjects Aged 45-64|Overall Study||3
43866|NCT01955720|104781|P3|Healthy Subjects Aged 45-64|Overall Study||3
43867|NCT01955720|104782|P2|Healthy Subjects Aged 45-64|Overall Study||3
43868|NCT01955720|104783|P1|Healthy Subjects Aged 45-64|Overall Study||3
43869|NCT01955720|104778|P6|STARTED|Overall Study||7
43870|NCT01955720|104779|P5|STARTED|Overall Study||7
43871|NCT01955720|104780|P4|STARTED|Overall Study||3
43872|NCT01955720|104781|P3|STARTED|Overall Study||3
43873|NCT01955720|104782|P2|STARTED|Overall Study||13
43874|NCT01955720|104783|P1|STARTED|Overall Study||13
43875|NCT01955707|104851|P2|NOT COMPLETED|Overall Study||22
43876|NCT01955707|104852|P1|NOT COMPLETED|Overall Study||20
43877|NCT01955707|104851|P2|COMPLETED|Overall Study||57
43878|NCT01955707|104852|P1|COMPLETED|Overall Study||62
43879|NCT01955707|104851|P2|Received Total Volume of Study Drug|Overall Study||77
43880|NCT01955707|104852|P1|Received Total Volume of Study Drug|Overall Study||82
43881|NCT01955707|104851|P2|Dosed|Overall Study||78
43882|NCT01955707|104852|P1|Dosed|Overall Study||82
43883|NCT01955707|104851|P2|Withdrew Prior to Dosing|Overall Study||1
43884|NCT01955707|104852|P1|Withdrew Prior to Dosing|Overall Study||0
43885|NCT01955707|104851|P2|STARTED|Overall Study||79
43886|NCT01955707|104852|P1|STARTED|Overall Study||82
43887|NCT01955629|104876|P1|NOT COMPLETED|Overall Study||0
43888|NCT01955629|104876|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
43889|NCT01955629|104876|P1|STARTED|Overall Study||4
43890|NCT01955564|104895|P7|NOT COMPLETED|Overall Study||0
43891|NCT01955564|104896|P6|NOT COMPLETED|Overall Study||0
43892|NCT01955564|104897|P5|NOT COMPLETED|Overall Study||0
43893|NCT01955564|104898|P4|NOT COMPLETED|Overall Study||0
43894|NCT01955564|104899|P3|NOT COMPLETED|Overall Study||0
43895|NCT01955564|104900|P2|NOT COMPLETED|Overall Study||0
43896|NCT01955564|104901|P1|NOT COMPLETED|Overall Study||0
43897|NCT01955564|104895|P7|COMPLETED|Overall Study||6
43898|NCT01955564|104896|P6|COMPLETED|Overall Study||6
43899|NCT01955564|104897|P5|COMPLETED|Overall Study||6
43900|NCT01955564|104898|P4|COMPLETED|Overall Study||6
43901|NCT01955564|104899|P3|COMPLETED|Overall Study||6
43902|NCT01955564|104900|P2|COMPLETED|Overall Study||6
43903|NCT01955564|104901|P1|COMPLETED|Overall Study||18
43904|NCT01955564|104895|P7|STARTED|Overall Study||6
43905|NCT01955564|104896|P6|STARTED|Overall Study||6
43906|NCT01955564|104897|P5|STARTED|Overall Study||6
43907|NCT01955564|104898|P4|STARTED|Overall Study||6
43908|NCT01955564|104899|P3|STARTED|Overall Study||6
43909|NCT01955564|104900|P2|STARTED|Overall Study||6
43910|NCT01955564|104901|P1|STARTED|Overall Study||18
43911|NCT01955473|104934|P5|NOT COMPLETED|Overall Study||0
43912|NCT01955473|104935|P4|NOT COMPLETED|Overall Study||0
43913|NCT01955473|104936|P3|NOT COMPLETED|Overall Study||0
43914|NCT01955473|104937|P2|NOT COMPLETED|Overall Study||0
43915|NCT01955473|104938|P1|NOT COMPLETED|Overall Study||0
43916|NCT01955473|104934|P5|COMPLETED|Overall Study||30
43917|NCT01955473|104935|P4|COMPLETED|Overall Study||6
43918|NCT01955473|104936|P3|COMPLETED|Overall Study||6
43919|NCT01955473|104937|P2|COMPLETED|Overall Study||6
43920|NCT01955473|104938|P1|COMPLETED|Overall Study||3
43921|NCT01955473|104934|P5|STARTED|Overall Study||30
43922|NCT01955473|104935|P4|STARTED|Overall Study||6
43923|NCT01955473|104936|P3|STARTED|Overall Study||6
43924|NCT01955473|104937|P2|STARTED|Overall Study||6
43925|NCT01955473|104938|P1|STARTED|Overall Study||3
43926|NCT01955434|105092|P1|NOT COMPLETED|Overall Study||0
43927|NCT01955434|105092|P1|COMPLETED|Overall Study||25
43928|NCT01955434|105092|P1|STARTED|Overall Study||25
43929|NCT01955382|105102|P2|NOT COMPLETED|Overall Study||0
43930|NCT01955382|105103|P1|NOT COMPLETED|Overall Study||0
43931|NCT01955382|105102|P2|COMPLETED|Overall Study||35
43932|NCT01955382|105103|P1|COMPLETED|Overall Study||35
43933|NCT01955382|105102|P2|STARTED|Overall Study||35
43934|NCT01955382|105103|P1|STARTED|Overall Study||35
43935|NCT01955369|105111|P1|NOT COMPLETED|Overall Study||0
43936|NCT01955369|105111|P1|COMPLETED|Overall Study||200
43937|NCT01955369|105111|P1|STARTED|Overall Study||200
43938|NCT01955161|105120|P3|NOT COMPLETED|Overall Study||35
43939|NCT01955161|105121|P2|NOT COMPLETED|Overall Study||25
43940|NCT01955161|105122|P1|NOT COMPLETED|Overall Study||27
43941|NCT01955161|105120|P3|COMPLETED|Overall Study||275
43942|NCT01955161|105121|P2|COMPLETED|Overall Study||288
43943|NCT01955161|105122|P1|COMPLETED|Overall Study||283
43944|NCT01955161|105120|P3|Treated|Overall Study||309
43945|NCT01955161|105121|P2|Treated|Overall Study||313
43946|NCT01955161|105122|P1|Treated|Overall Study||308
43947|NCT01955161|105120|P3|STARTED|Overall Study||310
43948|NCT01955161|105121|P2|STARTED|Overall Study||313
43949|NCT01955161|105122|P1|STARTED|Overall Study||310
43950|NCT01955122|105162|P2|NOT COMPLETED|Overall Study||5
43951|NCT01955122|105163|P1|NOT COMPLETED|Overall Study||5
43952|NCT01955122|105162|P2|COMPLETED|Overall Study||57
43953|NCT01955122|105163|P1|COMPLETED|Overall Study||59
43954|NCT01955122|105162|P2|No. Patients Completed Double Procedure|Overall Study||57
43955|NCT01955122|105163|P1|No. Patients Completed Double Procedure|Overall Study||59
43956|NCT01955122|105162|P2|No.Patients Enrolled|Overall Study||62
43957|NCT01955122|105163|P1|No.Patients Enrolled|Overall Study||64
43958|NCT01955122|105162|P2|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
43959|NCT01955122|105163|P1|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
43960|NCT01955083|105183|P2|NOT COMPLETED|Overall Study||1
43961|NCT01955083|105184|P1|NOT COMPLETED|Overall Study||1
43962|NCT01955083|105183|P2|COMPLETED|Overall Study||14
43963|NCT01955083|105184|P1|COMPLETED|Overall Study||14
43964|NCT01955083|105183|P2|STARTED|Overall Study||15
43965|NCT01955083|105184|P1|STARTED|Overall Study||15
43966|NCT01955044|105217|P3|NOT COMPLETED|Overall Study||0
43967|NCT01955044|105218|P2|NOT COMPLETED|Overall Study||1
43968|NCT01955044|105219|P1|NOT COMPLETED|Overall Study||1
43969|NCT01955044|105217|P3|COMPLETED|Overall Study||10
43970|NCT01955044|105218|P2|COMPLETED|Overall Study||9
43971|NCT01955044|105219|P1|COMPLETED|Overall Study||9
43972|NCT01955044|105217|P3|STARTED|Overall Study||10
43973|NCT01955044|105218|P2|STARTED|Overall Study||10
43974|NCT01955044|105219|P1|STARTED|Overall Study||10
43975|NCT01955005|105232|P2|NOT COMPLETED|Overall Study||5
43976|NCT01955005|105233|P1|NOT COMPLETED|Overall Study||3
43977|NCT01955005|105232|P2|COMPLETED|Overall Study||25
43978|NCT01955005|105233|P1|COMPLETED|Overall Study||27
43979|NCT01955005|105232|P2|STARTED|Overall Study||30
43980|NCT01955005|105233|P1|STARTED|Overall Study||30
43981|NCT01954771|105246|P3|NOT COMPLETED|Overall Study||3
43982|NCT01954771|105247|P2|NOT COMPLETED|Overall Study||3
43983|NCT01954771|105248|P1|NOT COMPLETED|Overall Study||7
43984|NCT01954771|105246|P3|COMPLETED|Overall Study||25
43985|NCT01954771|105247|P2|COMPLETED|Overall Study||29
43986|NCT01954771|105248|P1|COMPLETED|Overall Study||22
43987|NCT01954771|105246|P3|STARTED|Overall Study||28
43988|NCT01954771|105247|P2|STARTED|Overall Study||32
43989|NCT01954771|105248|P1|STARTED|Overall Study||29
43990|NCT01954745|105265|P1|NOT COMPLETED|Overall Study||19
43991|NCT01954745|105265|P1|COMPLETED|Overall Study||0
43992|NCT01954745|105265|P1|STARTED|Overall Study||19
43993|NCT01954628|105274|P2|NOT COMPLETED|Overall Study||27
43994|NCT01954628|105275|P1|NOT COMPLETED|Overall Study||31
43995|NCT01954628|105274|P2|COMPLETED|Overall Study||173
43996|NCT01954628|105275|P1|COMPLETED|Overall Study||169
43997|NCT01954628|105274|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
43998|NCT01954628|105275|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
43999|NCT01954628|105274|P2|Pharmacokinetic Population|Overall Study||0
44000|NCT01954628|105275|P1|Pharmacokinetic Population|Overall Study||181
44001|NCT01954628|105274|P2|Safety Set|Overall Study||200
44002|NCT01954628|105275|P1|Safety Set|Overall Study||200
44003|NCT01954628|105274|P2|Full Analysis Set (FAS)|Overall Study||198
44004|NCT01954628|105275|P1|Full Analysis Set (FAS)|Overall Study||200
44005|NCT01954628|105274|P2|STARTED|Overall Study||200
44006|NCT01954628|105275|P1|STARTED|Overall Study||200
44007|NCT01954251|105296|P2|NOT COMPLETED|Overall Study||19
44008|NCT01954251|105297|P1|NOT COMPLETED|Overall Study||13
44009|NCT01954251|105296|P2|COMPLETED|Overall Study||396
44010|NCT01954251|105297|P1|COMPLETED|Overall Study||400
44011|NCT01954251|105296|P2|STARTED|Overall Study||415
44012|NCT01954251|105297|P1|STARTED|Overall Study||413
44013|NCT01954160|105333|P2|NOT COMPLETED|Overall Study||0
44014|NCT01954160|105334|P1|NOT COMPLETED|Overall Study||5
44015|NCT01954160|105333|P2|COMPLETED|Overall Study||0
44016|NCT01954160|105334|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
44017|NCT01954160|105333|P2|STARTED|Overall Study|Not started|0
44018|NCT01954160|105334|P1|STARTED|Overall Study||5
44019|NCT01954121|105394|P2|NOT COMPLETED|Overall Study||91
44020|NCT01954121|105395|P1|NOT COMPLETED|Overall Study||127
44021|NCT01954121|105394|P2|COMPLETED|Overall Study||125
44022|NCT01954121|105395|P1|COMPLETED|Overall Study||93
44023|NCT01954121|105394|P2|STARTED|Overall Study||216
44024|NCT01954121|105395|P1|STARTED|Overall Study||220
44025|NCT01953874|105411|P2|NOT COMPLETED|Overall Study||0
44026|NCT01953874|105412|P1|NOT COMPLETED|Overall Study||0
44027|NCT01953874|105411|P2|COMPLETED|Overall Study||61
44028|NCT01953874|105412|P1|COMPLETED|Overall Study||65
44029|NCT01953874|105411|P2|STARTED|Overall Study||61
44030|NCT01953874|105412|P1|STARTED|Overall Study||65
44031|NCT01953354|105457|P2|NOT COMPLETED|Overall Study||2
44032|NCT01953354|105458|P1|NOT COMPLETED|Overall Study||1
44033|NCT01953354|105457|P2|COMPLETED|Overall Study||5
44034|NCT01953354|105458|P1|COMPLETED|Overall Study||8
44035|NCT01953354|105457|P2|STARTED|Overall Study||7
44036|NCT01953354|105458|P1|STARTED|Overall Study||9
44037|NCT01953328|105486|P8|NOT COMPLETED|Overall Study||0
44038|NCT01953328|105487|P7|NOT COMPLETED|Overall Study||0
44039|NCT01953328|105488|P6|NOT COMPLETED|Overall Study||0
44040|NCT01953328|105489|P5|NOT COMPLETED|Overall Study||2
44041|NCT01953328|105490|P4|NOT COMPLETED|Overall Study||0
44042|NCT01953328|105491|P3|NOT COMPLETED|Overall Study||0
44043|NCT01953328|105492|P2|NOT COMPLETED|Overall Study||0
44044|NCT01953328|105493|P1|NOT COMPLETED|Overall Study||0
44045|NCT01953328|105486|P8|COMPLETED|Overall Study||51
44046|NCT01953328|105487|P7|COMPLETED|Overall Study||51
44047|NCT01953328|105488|P6|COMPLETED|Overall Study||51
44048|NCT01953328|105489|P5|COMPLETED|Overall Study||50
44049|NCT01953328|105490|P4|COMPLETED|Overall Study||50
44050|NCT01953328|105491|P3|COMPLETED|Overall Study||50
44051|NCT01953328|105492|P2|COMPLETED|Overall Study||50
44052|NCT01953328|105493|P1|COMPLETED|Overall Study||49
44053|NCT01953328|105486|P8|Received Treatment|Overall Study||51
44054|NCT01953328|105487|P7|Received Treatment|Overall Study||51
44055|NCT01953328|105488|P6|Received Treatment|Overall Study||51
44056|NCT01953328|105489|P5|Received Treatment|Overall Study||52
44057|NCT01953328|105490|P4|Received Treatment|Overall Study||50
44058|NCT01953328|105491|P3|Received Treatment|Overall Study||50
44059|NCT01953328|105492|P2|Received Treatment|Overall Study||50
44060|NCT01953328|105493|P1|Received Treatment|Overall Study||49
44061|NCT01953328|105486|P8|STARTED|Overall Study||51
44062|NCT01953328|105487|P7|STARTED|Overall Study||51
44063|NCT01953328|105488|P6|STARTED|Overall Study||51
44064|NCT01953328|105489|P5|STARTED|Overall Study||52
44065|NCT01953328|105490|P4|STARTED|Overall Study||50
44066|NCT01953328|105491|P3|STARTED|Overall Study||50
44067|NCT01953328|105492|P2|STARTED|Overall Study||50
44068|NCT01953328|105493|P1|STARTED|Overall Study||49
44069|NCT01953237|105697|P2|NOT COMPLETED|Overall Study||0
44070|NCT01953237|105698|P1|NOT COMPLETED|Overall Study||0
44071|NCT01953237|105697|P2|COMPLETED|Overall Study||21
44072|NCT01953237|105698|P1|COMPLETED|Overall Study||10
44073|NCT01953237|105697|P2|STARTED|Overall Study||21
44074|NCT01953237|105698|P1|STARTED|Overall Study||10
44075|NCT01953081|105706|P2|NOT COMPLETED|Overall Study||3
44076|NCT01953081|105707|P1|NOT COMPLETED|Overall Study||2
44077|NCT01953081|105706|P2|COMPLETED|Overall Study||3
44078|NCT01953081|105707|P1|COMPLETED|Overall Study||5
44079|NCT01953081|105706|P2|STARTED|Overall Study||6
44080|NCT01953081|105707|P1|STARTED|Overall Study||7
44081|NCT01952834|105723|P1|NOT COMPLETED|Overall Study||1
44082|NCT01952834|105723|P1|COMPLETED|Overall Study||20
44083|NCT01952834|105723|P1|STARTED|Overall Study||21
44084|NCT01952691|105730|P1|NOT COMPLETED|Overall Study||2
44085|NCT01952691|105730|P1|COMPLETED|Overall Study||20
44086|NCT01952691|105730|P1|STARTED|Overall Study||22
44087|NCT01952665|105738|P2|NOT COMPLETED|Overall Study||6
44088|NCT01952665|105739|P1|NOT COMPLETED|Overall Study||6
44089|NCT01952665|105738|P2|COMPLETED|Overall Study||20
44090|NCT01952665|105739|P1|COMPLETED|Overall Study||31
44091|NCT01952665|105738|P2|STARTED|Overall Study||26
44092|NCT01952665|105739|P1|STARTED|Overall Study||37
44093|NCT01952600|105880|P3|NOT COMPLETED|Overall Study||7
44094|NCT01952600|105881|P2|NOT COMPLETED|Overall Study||13
44095|NCT01952600|105882|P1|NOT COMPLETED|Overall Study||15
44096|NCT01952600|105880|P3|COMPLETED|Overall Study||38
44097|NCT01952600|105881|P2|COMPLETED|Overall Study||77
44098|NCT01952600|105882|P1|COMPLETED|Overall Study||65
44099|NCT01952600|105880|P3|STARTED|Overall Study||45
44100|NCT01952600|105881|P2|STARTED|Overall Study||90
44101|NCT01952600|105882|P1|STARTED|Overall Study||80
44102|NCT01952418|105892|P2|NOT COMPLETED|Overall Study||0
44103|NCT01952418|105893|P1|NOT COMPLETED|Overall Study||0
44104|NCT01952418|105892|P2|COMPLETED|Overall Study||895
44105|NCT01952418|105893|P1|COMPLETED|Overall Study||910
44106|NCT01952418|105892|P2|STARTED|Overall Study||895
44107|NCT01952418|105893|P1|STARTED|Overall Study||910
44108|NCT01952366|105905|P1|NOT COMPLETED|Overall Study||31
44109|NCT01952366|105905|P1|COMPLETED|Overall Study||138
44110|NCT01952366|105905|P1|STARTED|Overall Study||169
44111|NCT01952301|105911|P1|NOT COMPLETED|Overall Study||0
44112|NCT01952301|105911|P1|COMPLETED|Overall Study||30
44113|NCT01952301|105911|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
44114|NCT01952145|105919|P2|NOT COMPLETED|Overall Study||14
44115|NCT01952145|105920|P1|NOT COMPLETED|Overall Study||28
44116|NCT01952145|105919|P2|COMPLETED|Overall Study||265
44117|NCT01952145|105920|P1|COMPLETED|Overall Study||250
44118|NCT01952145|105919|P2|STARTED|Overall Study||279
44119|NCT01952145|105920|P1|STARTED|Overall Study||278
44120|NCT01952080|105934|P4|NOT COMPLETED|Overall Study||1
44121|NCT01952080|105935|P3|NOT COMPLETED|Overall Study||0
44122|NCT01952080|105936|P2|NOT COMPLETED|Overall Study||1
44123|NCT01952080|105937|P1|NOT COMPLETED|Overall Study||0
44124|NCT01952080|105934|P4|COMPLETED|Overall Study||14
44125|NCT01952080|105935|P3|COMPLETED|Overall Study||14
44126|NCT01952080|105936|P2|COMPLETED|Overall Study||7
44127|NCT01952080|105937|P1|COMPLETED|Overall Study||5
44128|NCT01952080|105934|P4|Treated|Overall Study||15
44129|NCT01952080|105935|P3|Treated|Overall Study||14
44130|NCT01952080|105936|P2|Treated|Overall Study||8
44131|NCT01952080|105937|P1|Treated|Overall Study||5
44132|NCT01952080|105934|P4|STARTED|Overall Study||15
44133|NCT01952080|105935|P3|STARTED|Overall Study||14
44134|NCT01952080|105936|P2|STARTED|Overall Study||8
44135|NCT01952080|105937|P1|STARTED|Overall Study||5
44136|NCT01951963|105985|P2|NOT COMPLETED|Overall Study||0
44137|NCT01951963|105986|P1|NOT COMPLETED|Overall Study||0
44138|NCT01951963|105985|P2|COMPLETED|Overall Study||32
44139|NCT01951963|105986|P1|COMPLETED|Overall Study||31
44140|NCT01951963|105985|P2|STARTED|Overall Study||32
44141|NCT01951963|105986|P1|STARTED|Overall Study||31
44142|NCT01951950|105998|P2|NOT COMPLETED|Overall Study||6
44143|NCT01951950|105999|P1|NOT COMPLETED|Overall Study||6
44144|NCT01951950|105998|P2|COMPLETED|Overall Study||20
44145|NCT01951950|105999|P1|COMPLETED|Overall Study||20
44146|NCT01951950|105998|P2|STARTED|Overall Study||26
44147|NCT01951950|105999|P1|STARTED|Overall Study||26
44148|NCT01951820|106007|P2|NOT COMPLETED|Overall Study||0
44149|NCT01951820|106008|P1|NOT COMPLETED|Overall Study||0
44150|NCT01951820|106007|P2|COMPLETED|Overall Study||30
44151|NCT01951820|106008|P1|COMPLETED|Overall Study||34
44152|NCT01951820|106007|P2|STARTED|Overall Study||30
44153|NCT01951820|106008|P1|STARTED|Overall Study||34
44154|NCT01951703|106016|P2|NOT COMPLETED|Second Intervention||2
44155|NCT01951703|106017|P1|NOT COMPLETED|Second Intervention||0
44156|NCT01951703|106016|P2|COMPLETED|Second Intervention||60
44157|NCT01951703|106017|P1|COMPLETED|Second Intervention||61
44158|NCT01951703|106016|P2|STARTED|Second Intervention||62
44159|NCT01951703|106017|P1|STARTED|Second Intervention||61
44160|NCT01951703|106016|P2|NOT COMPLETED|First Intervention||1
44161|NCT01951703|106017|P1|NOT COMPLETED|First Intervention||3
44162|NCT01951703|106016|P2|COMPLETED|First Intervention||62
44163|NCT01951703|106017|P1|COMPLETED|First Intervention||61
44164|NCT01951703|106016|P2|STARTED|First Intervention||63
44165|NCT01951703|106017|P1|STARTED|First Intervention||64
44166|NCT01951651|106027|P2|NOT COMPLETED|Overall Study||2
44167|NCT01951651|106028|P1|NOT COMPLETED|Overall Study||4
44168|NCT01951651|106027|P2|COMPLETED|Overall Study||10
44169|NCT01951651|106028|P1|COMPLETED|Overall Study||8
44170|NCT01951651|106027|P2|STARTED|Overall Study||12
44171|NCT01951651|106028|P1|STARTED|Overall Study||12
44172|NCT01951586|106042|P2|NOT COMPLETED|Overall Study||113
44173|NCT01951586|106043|P1|NOT COMPLETED|Overall Study||59
44174|NCT01951586|106042|P2|COMPLETED|Overall Study||35
44175|NCT01951586|106043|P1|COMPLETED|Overall Study||19
44176|NCT01951586|106042|P2|Received Study Drug|Overall Study||145
44177|NCT01951586|106043|P1|Received Study Drug|Overall Study||76
44178|NCT01951586|106042|P2|STARTED|Overall Study||148
44179|NCT01951586|106043|P1|STARTED|Overall Study||78
44180|NCT01951573|106067|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
44181|NCT01951573|106068|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
44182|NCT01951573|106067|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
44183|NCT01951573|106068|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
44184|NCT01951573|106067|P2|STARTED|Period 2, Second 9 Hours of Wear||16
44185|NCT01951573|106068|P1|STARTED|Period 2, Second 9 Hours of Wear||17
44186|NCT01951573|106067|P2|NOT COMPLETED|Washout Period||1
44187|NCT01951573|106068|P1|NOT COMPLETED|Washout Period||0
44188|NCT01951573|106067|P2|COMPLETED|Washout Period||16
44189|NCT01951573|106068|P1|COMPLETED|Washout Period||17
44190|NCT01951573|106067|P2|STARTED|Washout Period||17
44191|NCT01951573|106068|P1|STARTED|Washout Period||17
44192|NCT01951573|106067|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
44193|NCT01951573|106068|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
44194|NCT01951573|106067|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
44195|NCT01951573|106068|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
44196|NCT01951573|106067|P2|STARTED|Period 1, First 9 Hours of Wear||17
44197|NCT01951573|106068|P1|STARTED|Period 1, First 9 Hours of Wear||17
44198|NCT01951417|106078|P1|NOT COMPLETED|Overall Study||9
44199|NCT01951417|106078|P1|COMPLETED|Overall Study||72
44200|NCT01951417|106078|P1|STARTED|Overall Study||81
44201|NCT01951170|106101|P1|NOT COMPLETED|Overall Study||1
44202|NCT01951170|106101|P1|COMPLETED|Overall Study||51
44203|NCT01951170|106101|P1|STARTED|Overall Study||52
44204|NCT01951092|106124|P1|NOT COMPLETED|Overall Study||12
44205|NCT01951092|106124|P1|COMPLETED|Overall Study||20
44206|NCT01951092|106124|P1|STARTED|Overall Study||32
44207|NCT01951066|106129|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
44208|NCT01951066|106130|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
44209|NCT01951066|106129|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
44210|NCT01951066|106130|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
44211|NCT01951066|106129|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
44212|NCT01951066|106130|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
44213|NCT01951066|106129|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
44214|NCT01951066|106130|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
44215|NCT01951066|106129|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
44216|NCT01951066|106130|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
44217|NCT01951066|106129|P2|STARTED|First Intervention (Baseline to Week 16)||10
44218|NCT01951066|106130|P1|STARTED|First Intervention (Baseline to Week 16)||10
44219|NCT01950741|106135|P1|NOT COMPLETED|Overall Study||3
44220|NCT01950741|106135|P1|COMPLETED|Overall Study||45
44221|NCT01950741|106135|P1|STARTED|Overall Study||48
44222|NCT01950663|106144|P1|NOT COMPLETED|Overall Study||1
44223|NCT01950663|106144|P1|COMPLETED|Overall Study||467
44224|NCT01950663|106144|P1|STARTED|Overall Study||468
44225|NCT01950364|106150|P2|NOT COMPLETED|Overall Study||10
44226|NCT01950364|106151|P1|NOT COMPLETED|Overall Study||10
44227|NCT01950364|106150|P2|COMPLETED|Overall Study||0
44228|NCT01950364|106151|P1|COMPLETED|Overall Study||0
44229|NCT01950364|106150|P2|STARTED|Overall Study||10
44230|NCT01950364|106151|P1|STARTED|Overall Study||10
44231|NCT01950078|106251|P2|NOT COMPLETED|Overall Study||12
44232|NCT01950078|106252|P1|NOT COMPLETED|Overall Study||20
44233|NCT01950078|106251|P2|COMPLETED|Overall Study||496
44234|NCT01950078|106252|P1|COMPLETED|Overall Study||1005
44235|NCT01950078|106251|P2|STARTED|Overall Study||508
44236|NCT01950078|106252|P1|STARTED|Overall Study||1025
44237|NCT01949870|106260|P1|NOT COMPLETED|Overall Study||6
44238|NCT01949870|106260|P1|COMPLETED|Overall Study||0
44239|NCT01949870|106260|P1|Received Treatment|Overall Study||4
44240|NCT01949870|106260|P1|STARTED|Overall Study||6
44241|NCT01949545|106268|P4|NOT COMPLETED|Overall Study||0
44242|NCT01949545|106269|P3|NOT COMPLETED|Overall Study||0
44243|NCT01949545|106270|P2|NOT COMPLETED|Overall Study||0
44244|NCT01949545|106271|P1|NOT COMPLETED|Overall Study||0
44245|NCT01949545|106268|P4|COMPLETED|Overall Study||4
44246|NCT01949545|106269|P3|COMPLETED|Overall Study||14
44247|NCT01949545|106270|P2|COMPLETED|Overall Study||17
44248|NCT01949545|106271|P1|COMPLETED|Overall Study||11
44249|NCT01949545|106268|P4|STARTED|Overall Study||4
44250|NCT01949545|106269|P3|STARTED|Overall Study||14
44251|NCT01949545|106270|P2|STARTED|Overall Study||17
44252|NCT01949545|106271|P1|STARTED|Overall Study||11
44253|NCT01949532|106419|P2|NOT COMPLETED|Overall Study||3
44254|NCT01949532|106420|P1|NOT COMPLETED|Overall Study||3
44255|NCT01949532|106419|P2|COMPLETED|Overall Study||8
44256|NCT01949532|106420|P1|COMPLETED|Overall Study||12
44257|NCT01949532|106419|P2|STARTED|Overall Study||11
44258|NCT01949532|106420|P1|STARTED|Overall Study||15
44259|NCT01949389|106488|P1|NOT COMPLETED|Overall Study||0
44260|NCT01949389|106488|P1|COMPLETED|Overall Study||51
44261|NCT01949389|106488|P1|STARTED|Overall Study||51
44262|NCT01949155|106495|P2|NOT COMPLETED|Overall Study||0
44263|NCT01949155|106496|P1|NOT COMPLETED|Overall Study||2
44264|NCT01949155|106495|P2|COMPLETED|Overall Study||88
44265|NCT01949155|106496|P1|COMPLETED|Overall Study||176
44266|NCT01949155|106495|P2|STARTED|Overall Study||88
44267|NCT01949155|106496|P1|STARTED|Overall Study||178
44268|NCT01949142|106508|P2|NOT COMPLETED|Overall Study||1
44269|NCT01949142|106509|P1|NOT COMPLETED|Overall Study||3
44270|NCT01949142|106508|P2|COMPLETED|Overall Study||86
44271|NCT01949142|106509|P1|COMPLETED|Overall Study||176
44272|NCT01949142|106508|P2|STARTED|Overall Study||87
44273|NCT01949142|106509|P1|STARTED|Overall Study||179
44274|NCT01949116|106521|P2|NOT COMPLETED|Overall Study||6
44275|NCT01949116|106522|P1|NOT COMPLETED|Overall Study||8
44276|NCT01949116|106521|P2|COMPLETED|Overall Study||84
44277|NCT01949116|106522|P1|COMPLETED|Overall Study||78
44278|NCT01949116|106521|P2|STARTED|Overall Study||90
44279|NCT01949116|106522|P1|STARTED|Overall Study||86
44280|NCT01949090|106559|P5|NOT COMPLETED|Overall Study||4
44281|NCT01949090|106560|P4|NOT COMPLETED|Overall Study||1
44282|NCT01949090|106561|P3|NOT COMPLETED|Overall Study||2
44283|NCT01949090|106562|P2|NOT COMPLETED|Overall Study||2
44284|NCT01949090|106563|P1|NOT COMPLETED|Overall Study||4
44285|NCT01949090|106559|P5|COMPLETED|Overall Study||116
44286|NCT01949090|106560|P4|COMPLETED|Overall Study||59
44287|NCT01949090|106561|P3|COMPLETED|Overall Study||58
44288|NCT01949090|106562|P2|COMPLETED|Overall Study||58
44289|NCT01949090|106563|P1|COMPLETED|Overall Study||56
44290|NCT01949090|106559|P5|STARTED|Overall Study||120
44291|NCT01949090|106560|P4|STARTED|Overall Study||60
44292|NCT01949090|106561|P3|STARTED|Overall Study||60
44293|NCT01949090|106562|P2|STARTED|Overall Study||60
44294|NCT01949090|106563|P1|STARTED|Overall Study||60
44295|NCT01949051|106740|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
44296|NCT01949051|106741|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
44297|NCT01949051|106742|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
44298|NCT01949051|106743|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
44299|NCT01949051|106744|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
44300|NCT01949051|106745|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
44301|NCT01949051|106740|P6|COMPLETED|Treatment Period 3 (7 Days)||12
44302|NCT01949051|106741|P5|COMPLETED|Treatment Period 3 (7 Days)||13
44303|NCT01949051|106742|P4|COMPLETED|Treatment Period 3 (7 Days)||12
44304|NCT01949051|106743|P3|COMPLETED|Treatment Period 3 (7 Days)||12
44305|NCT01949051|106744|P2|COMPLETED|Treatment Period 3 (7 Days)||12
44306|NCT01949051|106745|P1|COMPLETED|Treatment Period 3 (7 Days)||11
44307|NCT01949051|106740|P6|STARTED|Treatment Period 3 (7 Days)||12
44308|NCT01949051|106741|P5|STARTED|Treatment Period 3 (7 Days)||13
44309|NCT01949051|106742|P4|STARTED|Treatment Period 3 (7 Days)||12
44310|NCT01949051|106743|P3|STARTED|Treatment Period 3 (7 Days)||12
44311|NCT01949051|106744|P2|STARTED|Treatment Period 3 (7 Days)||12
44312|NCT01949051|106745|P1|STARTED|Treatment Period 3 (7 Days)||11
44313|NCT01949051|106740|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
44314|NCT01949051|106741|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
44315|NCT01949051|106742|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
44316|NCT01949051|106743|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
44317|NCT01949051|106744|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
44318|NCT01949051|106745|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
44319|NCT01949051|106740|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
44320|NCT01949051|106741|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
44321|NCT01949051|106742|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
44322|NCT01949051|106743|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
44323|NCT01949051|106744|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
44324|NCT01949051|106745|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
44325|NCT01949051|106740|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
44326|NCT01949051|106741|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
44327|NCT01949051|106742|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
44328|NCT01949051|106743|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
44329|NCT01949051|106744|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
44330|NCT01949051|106745|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
44331|NCT01949051|106740|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
44332|NCT01949051|106741|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
44333|NCT01949051|106742|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
44334|NCT01949051|106743|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
44335|NCT01949051|106744|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
44336|NCT01949051|106745|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
44337|NCT01949051|106740|P6|COMPLETED|Treatment Period 2 (7 Days)||12
44338|NCT01949051|106741|P5|COMPLETED|Treatment Period 2 (7 Days)||13
44339|NCT01949051|106742|P4|COMPLETED|Treatment Period 2 (7 Days)||12
44340|NCT01949051|106743|P3|COMPLETED|Treatment Period 2 (7 Days)||12
44341|NCT01949051|106744|P2|COMPLETED|Treatment Period 2 (7 Days)||12
44342|NCT01949051|106745|P1|COMPLETED|Treatment Period 2 (7 Days)||11
44343|NCT01949051|106740|P6|STARTED|Treatment Period 2 (7 Days)||13
44344|NCT01949051|106741|P5|STARTED|Treatment Period 2 (7 Days)||13
44345|NCT01949051|106742|P4|STARTED|Treatment Period 2 (7 Days)||12
44346|NCT01949051|106743|P3|STARTED|Treatment Period 2 (7 Days)||13
44347|NCT01949051|106744|P2|STARTED|Treatment Period 2 (7 Days)||13
44348|NCT01949051|106745|P1|STARTED|Treatment Period 2 (7 Days)||11
44349|NCT01949051|106740|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
44350|NCT01949051|106741|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
44351|NCT01949051|106742|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
44352|NCT01949051|106743|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
44353|NCT01949051|106744|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
44354|NCT01949051|106745|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
44355|NCT01949051|106740|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
44356|NCT01949051|106741|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
44357|NCT01949051|106742|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
44358|NCT01949051|106743|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
44359|NCT01949051|106744|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
44360|NCT01949051|106745|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
44361|NCT01949051|106740|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
44362|NCT01949051|106741|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
44363|NCT01949051|106742|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
44364|NCT01949051|106743|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
44365|NCT01949051|106744|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
44366|NCT01949051|106745|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
44367|NCT01949051|106740|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
44368|NCT01949051|106741|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
44369|NCT01949051|106742|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
44370|NCT01949051|106743|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
44371|NCT01949051|106744|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
44372|NCT01949051|106745|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
44373|NCT01949051|106740|P6|COMPLETED|Treatment Period 1 (7 Days)||13
44374|NCT01949051|106741|P5|COMPLETED|Treatment Period 1 (7 Days)||13
44375|NCT01949051|106742|P4|COMPLETED|Treatment Period 1 (7 Days)||12
44376|NCT01949051|106743|P3|COMPLETED|Treatment Period 1 (7 Days)||13
44377|NCT01949051|106744|P2|COMPLETED|Treatment Period 1 (7 Days)||13
44378|NCT01949051|106745|P1|COMPLETED|Treatment Period 1 (7 Days)||11
44379|NCT01949051|106740|P6|STARTED|Treatment Period 1 (7 Days)||13
44380|NCT01949051|106741|P5|STARTED|Treatment Period 1 (7 Days)||13
44381|NCT01949051|106742|P4|STARTED|Treatment Period 1 (7 Days)||13
44382|NCT01949051|106743|P3|STARTED|Treatment Period 1 (7 Days)||13
44383|NCT01949051|106744|P2|STARTED|Treatment Period 1 (7 Days)||13
44384|NCT01949051|106745|P1|STARTED|Treatment Period 1 (7 Days)||13
44385|NCT01948947|106758|P2|NOT COMPLETED|Overall Study||0
44386|NCT01948947|106759|P1|NOT COMPLETED|Overall Study||0
44387|NCT01948947|106758|P2|COMPLETED|Overall Study||15
44388|NCT01948947|106759|P1|COMPLETED|Overall Study||14
44389|NCT01948947|106758|P2|STARTED|Overall Study||15
44390|NCT01948947|106759|P1|STARTED|Overall Study||14
44391|NCT01948908|106774|P3|NOT COMPLETED|Overall Study||2
44392|NCT01948908|106775|P2|NOT COMPLETED|Overall Study||0
44393|NCT01948908|106776|P1|NOT COMPLETED|Overall Study||1
44394|NCT01948908|106774|P3|COMPLETED|Overall Study||31
44395|NCT01948908|106775|P2|COMPLETED|Overall Study||33
44396|NCT01948908|106776|P1|COMPLETED|Overall Study||32
44397|NCT01948908|106774|P3|STARTED|Overall Study||33
44398|NCT01948908|106775|P2|STARTED|Overall Study||33
44399|NCT01948908|106776|P1|STARTED|Overall Study||33
44400|NCT01948830|106792|P2|NOT COMPLETED|Overall Study||32
44401|NCT01948830|106793|P1|NOT COMPLETED|Overall Study||33
44402|NCT01948830|106792|P2|COMPLETED|Overall Study||295
44403|NCT01948830|106793|P1|COMPLETED|Overall Study||290
44404|NCT01948830|106792|P2|Safety Set|Overall Study||326
44405|NCT01948830|106793|P1|Safety Set|Overall Study||323
44406|NCT01948830|106792|P2|STARTED|Overall Study||327
44407|NCT01948830|106793|P1|STARTED|Overall Study||323
44408|NCT01948791|106825|P1|NOT COMPLETED|Overall Study||71
44409|NCT01948791|106825|P1|COMPLETED|Overall Study||151
44410|NCT01948791|106825|P1|STARTED|Overall Study||222
44411|NCT01948518|106833|P1|NOT COMPLETED|Overall Study||0
44412|NCT01948518|106833|P1|COMPLETED|Overall Study||15
44413|NCT01948518|106833|P1|STARTED|Overall Study||15
44414|NCT01948375|106840|P2|NOT COMPLETED|Overall Study||0
44415|NCT01948375|106841|P1|NOT COMPLETED|Overall Study||0
44416|NCT01948375|106840|P2|COMPLETED|Overall Study||30
44417|NCT01948375|106841|P1|COMPLETED|Overall Study||30
44418|NCT01948375|106840|P2|STARTED|Overall Study||30
44419|NCT01948375|106841|P1|STARTED|Overall Study||30
44420|NCT01948310|106857|P2|NOT COMPLETED|Overall Study||5
44421|NCT01948310|106858|P1|NOT COMPLETED|Overall Study||3
44422|NCT01948310|106857|P2|COMPLETED|Overall Study||13
44423|NCT01948310|106858|P1|COMPLETED|Overall Study||16
44424|NCT01948310|106857|P2|STARTED|Overall Study||18
44425|NCT01948310|106858|P1|STARTED|Overall Study||19
44426|NCT01948193|106868|P1|NOT COMPLETED|Overall Study||9
44427|NCT01948193|106868|P1|COMPLETED|Overall Study||168
44428|NCT01948193|106868|P1|STARTED|Overall Study||177
44429|NCT01948141|106877|P1|NOT COMPLETED|Overall Study||0
44430|NCT01948141|106877|P1|COMPLETED|Overall Study||6
44431|NCT01948141|106877|P1|STARTED|Overall Study||6
44432|NCT01948076|106890|P2|NOT COMPLETED|Overall Study||1
44433|NCT01948076|106891|P1|NOT COMPLETED|Overall Study||0
44434|NCT01948076|106890|P2|COMPLETED|Overall Study||19
44435|NCT01948076|106891|P1|COMPLETED|Overall Study||20
44436|NCT01948076|106890|P2|STARTED|Overall Study||20
44437|NCT01948076|106891|P1|STARTED|Overall Study||20
44438|NCT01948063|106901|P2|NOT COMPLETED|Overall Study||2
44439|NCT01948063|106902|P1|NOT COMPLETED|Overall Study||1
44440|NCT01948063|106901|P2|COMPLETED|Overall Study||19
44441|NCT01948063|106902|P1|COMPLETED|Overall Study||19
44442|NCT01948063|106901|P2|STARTED|Overall Study||21
44443|NCT01948063|106902|P1|STARTED|Overall Study||20
44444|NCT01948050|106910|P2|NOT COMPLETED|Overall Study||1
44445|NCT01948050|106911|P1|NOT COMPLETED|Overall Study||0
44446|NCT01948050|106910|P2|COMPLETED|Overall Study||7
44447|NCT01948050|106911|P1|COMPLETED|Overall Study||16
44448|NCT01948050|106910|P2|STARTED|Overall Study||8
44449|NCT01948050|106911|P1|STARTED|Overall Study||16
44450|NCT01947946|106920|P3|NOT COMPLETED|Overall Study||5
44451|NCT01947946|106921|P2|NOT COMPLETED|Overall Study||5
44452|NCT01947946|106922|P1|NOT COMPLETED|Overall Study||3
44453|NCT01947946|106920|P3|COMPLETED|Overall Study||0
44454|NCT01947946|106921|P2|COMPLETED|Overall Study||0
44455|NCT01947946|106922|P1|COMPLETED|Overall Study|Study Stopped|0
44456|NCT01947946|106920|P3|STARTED|Overall Study||5
44457|NCT01947946|106921|P2|STARTED|Overall Study||5
44458|NCT01947946|106922|P1|STARTED|Overall Study||3
44459|NCT01947907|106934|P4|NOT COMPLETED|Overall Study||0
44460|NCT01947907|106935|P3|NOT COMPLETED|Overall Study||0
44461|NCT01947907|106936|P2|NOT COMPLETED|Overall Study||0
44462|NCT01947907|106937|P1|NOT COMPLETED|Overall Study||0
44463|NCT01947907|106934|P4|COMPLETED|Overall Study||13
44464|NCT01947907|106935|P3|COMPLETED|Overall Study||14
44465|NCT01947907|106936|P2|COMPLETED|Overall Study||14
44466|NCT01947907|106937|P1|COMPLETED|Overall Study||12
44467|NCT01947907|106934|P4|STARTED|Overall Study||13
44468|NCT01947907|106935|P3|STARTED|Overall Study||14
44469|NCT01947907|106936|P2|STARTED|Overall Study||14
44470|NCT01947907|106937|P1|STARTED|Overall Study||12
44471|NCT01947855|106979|P3|NOT COMPLETED|Overall Study||0
44472|NCT01947855|106980|P2|NOT COMPLETED|Overall Study||0
44473|NCT01947855|106981|P1|NOT COMPLETED|Overall Study||1
44474|NCT01947855|106979|P3|COMPLETED|Overall Study||19
44475|NCT01947855|106980|P2|COMPLETED|Overall Study||20
44476|NCT01947855|106981|P1|COMPLETED|Overall Study||20
44477|NCT01947855|106979|P3|STARTED|Overall Study||19
44478|NCT01947855|106980|P2|STARTED|Overall Study||20
44479|NCT01947855|106981|P1|STARTED|Overall Study||21
44480|NCT01947582|106989|P1|NOT COMPLETED|Overall Study||1
44481|NCT01947582|106989|P1|COMPLETED|Overall Study||1
44482|NCT01947582|106989|P1|STARTED|Overall Study||2
44483|NCT01947517|106998|P2|NOT COMPLETED|Overall Study||1
44484|NCT01947517|106999|P1|NOT COMPLETED|Overall Study||1
44485|NCT01947517|106998|P2|COMPLETED|Overall Study||25
44486|NCT01947517|106999|P1|COMPLETED|Overall Study||25
44487|NCT01947517|106998|P2|STARTED|Overall Study||26
44488|NCT01947517|106999|P1|STARTED|Overall Study||26
44489|NCT01947491|107017|P4|NOT COMPLETED|Overall Study||5
44490|NCT01947491|107018|P3|NOT COMPLETED|Overall Study||2
44491|NCT01947491|107019|P2|NOT COMPLETED|Overall Study||6
44492|NCT01947491|107020|P1|NOT COMPLETED|Overall Study||8
44493|NCT01947491|107017|P4|COMPLETED|Overall Study||38
44494|NCT01947491|107018|P3|COMPLETED|Overall Study||88
44495|NCT01947491|107019|P2|COMPLETED|Overall Study||81
44496|NCT01947491|107020|P1|COMPLETED|Overall Study||166
44497|NCT01947491|107017|P4|STARTED|Overall Study||43
44498|NCT01947491|107018|P3|STARTED|Overall Study||90
44499|NCT01947491|107019|P2|STARTED|Overall Study||87
44500|NCT01947491|107020|P1|STARTED|Overall Study||174
44501|NCT01947335|107032|P2|NOT COMPLETED|Overall Study||0
44502|NCT01947335|107033|P1|NOT COMPLETED|Overall Study||0
44503|NCT01947335|107032|P2|COMPLETED|Overall Study||41
44504|NCT01947335|107033|P1|COMPLETED|Overall Study||42
44505|NCT01947335|107032|P2|STARTED|Overall Study||41
44506|NCT01947335|107033|P1|STARTED|Overall Study||42
44507|NCT01947153|107043|P2|NOT COMPLETED|Test Period 2||0
44508|NCT01947153|107044|P1|NOT COMPLETED|Test Period 2||0
44509|NCT01947153|107043|P2|COMPLETED|Test Period 2||18
44510|NCT01947153|107044|P1|COMPLETED|Test Period 2||18
44511|NCT01947153|107043|P2|STARTED|Test Period 2||18
44512|NCT01947153|107044|P1|STARTED|Test Period 2||18
44513|NCT01947153|107043|P2|NOT COMPLETED|Test Period 1||0
44514|NCT01947153|107044|P1|NOT COMPLETED|Test Period 1||0
44515|NCT01947153|107043|P2|COMPLETED|Test Period 1||18
44516|NCT01947153|107044|P1|COMPLETED|Test Period 1||18
44517|NCT01947153|107043|P2|STARTED|Test Period 1||18
44518|NCT01947153|107044|P1|STARTED|Test Period 1||18
44519|NCT01947127|107064|P2|NOT COMPLETED|Overall Study||43
44520|NCT01947127|107065|P1|NOT COMPLETED|Overall Study||23
44521|NCT01947127|107064|P2|COMPLETED|Overall Study||249
44522|NCT01947127|107065|P1|COMPLETED|Overall Study||143
44523|NCT01947127|107064|P2|STARTED|Overall Study||292
44524|NCT01947127|107065|P1|STARTED|Overall Study||166
44525|NCT01946542|107077|P2|NOT COMPLETED|Testing Visit 2||0
44526|NCT01946542|107078|P1|NOT COMPLETED|Testing Visit 2||0
44527|NCT01946542|107077|P2|COMPLETED|Testing Visit 2||1
44528|NCT01946542|107078|P1|COMPLETED|Testing Visit 2||1
44529|NCT01946542|107077|P2|STARTED|Testing Visit 2||1
44530|NCT01946542|107078|P1|STARTED|Testing Visit 2||1
44531|NCT01946542|107077|P2|NOT COMPLETED|Testing Visit 1||0
44532|NCT01946542|107078|P1|NOT COMPLETED|Testing Visit 1||0
44533|NCT01946542|107077|P2|COMPLETED|Testing Visit 1||1
44534|NCT01946542|107078|P1|COMPLETED|Testing Visit 1||1
44535|NCT01946542|107077|P2|STARTED|Testing Visit 1||1
44536|NCT01946542|107078|P1|STARTED|Testing Visit 1||1
44537|NCT01946529|107089|P3|NOT COMPLETED|Completion of All Therapy||6
44538|NCT01946529|107090|P2|NOT COMPLETED|Completion of All Therapy||16
44539|NCT01946529|107091|P1|NOT COMPLETED|Completion of All Therapy||1
44540|NCT01946529|107089|P3|COMPLETED|Completion of All Therapy||0
44541|NCT01946529|107090|P2|COMPLETED|Completion of All Therapy||0
44542|NCT01946529|107091|P1|COMPLETED|Completion of All Therapy||0
44543|NCT01946529|107089|P3|STARTED|Completion of All Therapy||6
44544|NCT01946529|107090|P2|STARTED|Completion of All Therapy||16
44545|NCT01946529|107091|P1|STARTED|Completion of All Therapy||1
44546|NCT01946529|107089|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
44547|NCT01946529|107090|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
44548|NCT01946529|107091|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
44549|NCT01946529|107089|P3|COMPLETED|End of Window Therapy (2 Courses)||6
44550|NCT01946529|107090|P2|COMPLETED|End of Window Therapy (2 Courses)||16
44551|NCT01946529|107091|P1|COMPLETED|End of Window Therapy (2 Courses)||1
44552|NCT01946529|107089|P3|STARTED|End of Window Therapy (2 Courses)||6
44553|NCT01946529|107090|P2|STARTED|End of Window Therapy (2 Courses)||17
44554|NCT01946529|107091|P1|STARTED|End of Window Therapy (2 Courses)||1
44555|NCT01946438|107102|P4|NOT COMPLETED|Overall Study||1
44556|NCT01946438|107103|P3|NOT COMPLETED|Overall Study||1
44557|NCT01946438|107104|P2|NOT COMPLETED|Overall Study||0
44558|NCT01946438|107105|P1|NOT COMPLETED|Overall Study||2
44559|NCT01946438|107102|P4|COMPLETED|Overall Study||51
44560|NCT01946438|107103|P3|COMPLETED|Overall Study||51
44561|NCT01946438|107104|P2|COMPLETED|Overall Study||52
44562|NCT01946438|107105|P1|COMPLETED|Overall Study||50
44563|NCT01946438|107102|P4|STARTED|Overall Study||52
44564|NCT01946438|107103|P3|STARTED|Overall Study||52
44565|NCT01946438|107104|P2|STARTED|Overall Study||52
44566|NCT01946438|107105|P1|STARTED|Overall Study||52
44567|NCT01946425|107133|P2|NOT COMPLETED|Overall Study||0
44568|NCT01946425|107134|P1|NOT COMPLETED|Overall Study||2
44569|NCT01946425|107133|P2|COMPLETED|Overall Study||30
44570|NCT01946425|107134|P1|COMPLETED|Overall Study||28
44571|NCT01946425|107133|P2|STARTED|Overall Study||30
44572|NCT01946425|107134|P1|STARTED|Overall Study||30
44573|NCT01946412|107148|P1|NOT COMPLETED|Overall Study||5
44574|NCT01946412|107148|P1|COMPLETED|Overall Study||28
44575|NCT01946412|107148|P1|STARTED|Overall Study||33
44576|NCT01946243|107170|P1|NOT COMPLETED|Overall Study||0
44577|NCT01946243|107170|P1|COMPLETED|Overall Study||96
44578|NCT01946243|107170|P1|STARTED|Overall Study||96
44579|NCT01946178|107191|P1|NOT COMPLETED|Overall Study||2
44580|NCT01946178|107191|P1|COMPLETED|Overall Study||71
44581|NCT01946178|107191|P1|STARTED|Overall Study||73
44582|NCT01946126|107201|P2|NOT COMPLETED|Overall Study||0
44583|NCT01946126|107202|P1|NOT COMPLETED|Overall Study||0
44584|NCT01946126|107201|P2|COMPLETED|Overall Study||275
44585|NCT01946126|107202|P1|COMPLETED|Overall Study||184
44586|NCT01946126|107201|P2|STARTED|Overall Study||275
44587|NCT01946126|107202|P1|STARTED|Overall Study||184
44588|NCT01945970|107216|P6|NOT COMPLETED|Overall Study||0
44589|NCT01945970|107217|P5|NOT COMPLETED|Overall Study||0
44590|NCT01945970|107218|P4|NOT COMPLETED|Overall Study||0
44591|NCT01945970|107219|P3|NOT COMPLETED|Overall Study||0
44592|NCT01945970|107220|P2|NOT COMPLETED|Overall Study||0
44593|NCT01945970|107221|P1|NOT COMPLETED|Overall Study||0
44594|NCT01945970|107216|P6|COMPLETED|Overall Study||5
44595|NCT01945970|107217|P5|COMPLETED|Overall Study||5
44596|NCT01945970|107218|P4|COMPLETED|Overall Study||5
44597|NCT01945970|107219|P3|COMPLETED|Overall Study||5
44598|NCT01945970|107220|P2|COMPLETED|Overall Study||5
44599|NCT01945970|107221|P1|COMPLETED|Overall Study||5
44600|NCT01945970|107216|P6|STARTED|Overall Study||5
44601|NCT01945970|107217|P5|STARTED|Overall Study||5
44602|NCT01945970|107218|P4|STARTED|Overall Study||5
44603|NCT01945970|107219|P3|STARTED|Overall Study||5
44604|NCT01945970|107220|P2|STARTED|Overall Study||5
44605|NCT01945970|107221|P1|STARTED|Overall Study||5
44606|NCT01945944|107260|P2|NOT COMPLETED|Overall Study||3
44607|NCT01945944|107261|P1|NOT COMPLETED|Overall Study||1
44608|NCT01945944|107260|P2|COMPLETED|Overall Study||6
44609|NCT01945944|107261|P1|COMPLETED|Overall Study||8
44610|NCT01945944|107260|P2|STARTED|Overall Study||9
44611|NCT01945944|107261|P1|STARTED|Overall Study||9
44612|NCT01945489|107285|P2|NOT COMPLETED|Cycle 2||1
44613|NCT01945489|107286|P1|NOT COMPLETED|Cycle 2||1
44614|NCT01945489|107285|P2|COMPLETED|Cycle 2||106
44615|NCT01945489|107286|P1|COMPLETED|Cycle 2||87
44616|NCT01945489|107285|P2|STARTED|Cycle 2||107
44617|NCT01945489|107286|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
44618|NCT01945489|107285|P2|NOT COMPLETED|Cycle 1||4
44619|NCT01945489|107286|P1|NOT COMPLETED|Cycle 1||13
44620|NCT01945489|107285|P2|COMPLETED|Cycle 1||121
44621|NCT01945489|107286|P1|COMPLETED|Cycle 1||116
44622|NCT01945489|107285|P2|STARTED|Cycle 1||125
44623|NCT01945489|107286|P1|STARTED|Cycle 1||129
44624|NCT01945294|107306|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
44625|NCT01945294|107307|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
44626|NCT01945294|107308|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
44627|NCT01945294|107309|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
44628|NCT01945294|107306|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
44629|NCT01945294|107307|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
44630|NCT01945294|107308|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
44631|NCT01945294|107309|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
44632|NCT01945294|107306|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
44633|NCT01945294|107307|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
44634|NCT01945294|107308|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
44635|NCT01945294|107309|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
44636|NCT01945294|107306|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
44637|NCT01945294|107307|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
44638|NCT01945294|107308|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
44639|NCT01945294|107309|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
44640|NCT01945294|107306|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
44641|NCT01945294|107307|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
44642|NCT01945294|107308|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
44643|NCT01945294|107309|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
44644|NCT01945294|107306|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
44645|NCT01945294|107307|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
44646|NCT01945294|107308|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
44647|NCT01945294|107309|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
44648|NCT01945242|107340|P2|NOT COMPLETED|Overall Study||3
44649|NCT01945242|107341|P1|NOT COMPLETED|Overall Study||3
44650|NCT01945242|107340|P2|COMPLETED|Overall Study||120
44651|NCT01945242|107341|P1|COMPLETED|Overall Study||1248
44652|NCT01945242|107340|P2|STARTED|Overall Study||123
44653|NCT01945242|107341|P1|STARTED|Overall Study||1251
44654|NCT01945138|107355|P2|NOT COMPLETED|Overall Study||0
44655|NCT01945138|107356|P1|NOT COMPLETED|Overall Study||0
44656|NCT01945138|107355|P2|COMPLETED|Overall Study||7
44657|NCT01945138|107356|P1|COMPLETED|Overall Study||7
44658|NCT01945138|107355|P2|STARTED|Overall Study||7
44659|NCT01945138|107356|P1|STARTED|Overall Study||7
44660|NCT01945112|107390|P2|NOT COMPLETED|Overall Study||0
44661|NCT01945112|107391|P1|NOT COMPLETED|Overall Study||0
44662|NCT01945112|107390|P2|COMPLETED|Overall Study||51
44663|NCT01945112|107391|P1|COMPLETED|Overall Study||77
44664|NCT01945112|107390|P2|STARTED|Overall Study|total number of sites where tape was applied|51
44665|NCT01945112|107391|P1|STARTED|Overall Study|total number of sites where tape was applied|77
44666|NCT01945086|107399|P3|NOT COMPLETED|Overall Study||2
44667|NCT01945086|107400|P2|NOT COMPLETED|Overall Study||0
44668|NCT01945086|107401|P1|NOT COMPLETED|Overall Study||1
44669|NCT01945086|107399|P3|COMPLETED|Overall Study||26
44670|NCT01945086|107400|P2|COMPLETED|Overall Study||24
44671|NCT01945086|107401|P1|COMPLETED|Overall Study||26
44672|NCT01945086|107399|P3|STARTED|Overall Study||28
44673|NCT01945086|107400|P2|STARTED|Overall Study||24
44674|NCT01945086|107401|P1|STARTED|Overall Study||27
44675|NCT01945034|107445|P3|NOT COMPLETED|Overall Study||7
44676|NCT01945034|107446|P2|NOT COMPLETED|Overall Study||5
44677|NCT01945034|107447|P1|NOT COMPLETED|Overall Study||1
44678|NCT01945034|107445|P3|COMPLETED|Overall Study||145
44679|NCT01945034|107446|P2|COMPLETED|Overall Study||80
44680|NCT01945034|107447|P1|COMPLETED|Overall Study||66
44681|NCT01945034|107445|P3|STARTED|Overall Study||152
44682|NCT01945034|107446|P2|STARTED|Overall Study||85
44683|NCT01945034|107447|P1|STARTED|Overall Study||67
44684|NCT01945021|107497|P1|NOT COMPLETED|Overall Study||47
44685|NCT01945021|107497|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
44686|NCT01945021|107497|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
44687|NCT01945021|107497|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
44688|NCT01945021|107497|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
44689|NCT01945021|107497|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
44690|NCT01944969|107511|P1|NOT COMPLETED|Overall Study||26
44691|NCT01944969|107511|P1|COMPLETED|Overall Study||0
44692|NCT01944969|107511|P1|STARTED|Overall Study||26
44693|NCT01944878|107524|P2|NOT COMPLETED|Overall Study||0
44694|NCT01944878|107525|P1|NOT COMPLETED|Overall Study||0
44695|NCT01944878|107524|P2|COMPLETED|Overall Study||328
44696|NCT01944878|107525|P1|COMPLETED|Overall Study||127
44697|NCT01944878|107524|P2|STARTED|Overall Study||328
44698|NCT01944878|107525|P1|STARTED|Overall Study||127
44699|NCT01944774|107536|P3|NOT COMPLETED|Overall Study||8
44700|NCT01944774|107537|P2|NOT COMPLETED|Overall Study||8
44701|NCT01944774|107538|P1|NOT COMPLETED|Overall Study||6
44702|NCT01944774|107536|P3|COMPLETED|Overall Study||62
44703|NCT01944774|107537|P2|COMPLETED|Overall Study||60
44704|NCT01944774|107538|P1|COMPLETED|Overall Study||63
44705|NCT01944774|107536|P3|Received Treatment|Overall Study||70
44706|NCT01944774|107537|P2|Received Treatment|Overall Study||67
44707|NCT01944774|107538|P1|Received Treatment|Overall Study||68
44708|NCT01944774|107536|P3|STARTED|Overall Study||70
44709|NCT01944774|107537|P2|STARTED|Overall Study||68
44710|NCT01944774|107538|P1|STARTED|Overall Study||69
44711|NCT01944722|107581|P1|NOT COMPLETED|Overall Study||9515
44712|NCT01944722|107581|P1|COMPLETED|Overall Study||24343
44713|NCT01944722|107581|P1|STARTED|Overall Study||33858
44714|NCT01944670|107615|P1|NOT COMPLETED|Overall Study||2
44715|NCT01944670|107615|P1|COMPLETED|Overall Study||24
44716|NCT01944670|107615|P1|STARTED|Overall Study||26
44717|NCT01944631|107622|P2|NOT COMPLETED|Overall Study||2
44718|NCT01944631|107623|P1|NOT COMPLETED|Overall Study||4
44719|NCT01944631|107622|P2|COMPLETED|Overall Study||98
44720|NCT01944631|107623|P1|COMPLETED|Overall Study||96
44721|NCT01944631|107622|P2|STARTED|Overall Study||100
44722|NCT01944631|107623|P1|STARTED|Overall Study||100
44723|NCT01944462|107639|P1|NOT COMPLETED|Optional Vaccination||0
44724|NCT01944462|107639|P1|COMPLETED|Optional Vaccination||20
44725|NCT01944462|107639|P1|STARTED|Optional Vaccination||20
44726|NCT01944462|107639|P1|NOT COMPLETED|PPPP Educational Program||60
44727|NCT01944462|107639|P1|COMPLETED|PPPP Educational Program||143
44728|NCT01944462|107639|P1|3 Month Follow-Up|PPPP Educational Program||143
44729|NCT01944462|107639|P1|Post-Test|PPPP Educational Program||187
44730|NCT01944462|107639|P1|Baseline|PPPP Educational Program||203
44731|NCT01944462|107639|P1|STARTED|PPPP Educational Program||203
44732|NCT01944345|107648|P1|NOT COMPLETED|Overall Study||0
44733|NCT01944345|107648|P1|COMPLETED|Overall Study||69
44734|NCT01944345|107648|P1|STARTED|Overall Study||69
44735|NCT01944319|107656|P2|NOT COMPLETED|Overall Study||0
44736|NCT01944319|107657|P1|NOT COMPLETED|Overall Study||0
44737|NCT01944319|107656|P2|COMPLETED|Overall Study||39
44738|NCT01944319|107657|P1|COMPLETED|Overall Study||40
44739|NCT01944319|107656|P2|STARTED|Overall Study||39
44740|NCT01944319|107657|P1|STARTED|Overall Study||40
44741|NCT01944098|107669|P2|NOT COMPLETED|Overall Study||0
44742|NCT01944098|107670|P1|NOT COMPLETED|Overall Study||1
44743|NCT01944098|107669|P2|COMPLETED|Overall Study||10
44744|NCT01944098|107670|P1|COMPLETED|Overall Study||9
44745|NCT01944098|107669|P2|STARTED|Overall Study||10
44746|NCT01944098|107670|P1|STARTED|Overall Study||10
44747|NCT01944059|107682|P1|NOT COMPLETED|Overall Study||7
44748|NCT01944059|107682|P1|COMPLETED|Overall Study||24
44749|NCT01944059|107682|P1|STARTED|Overall Study||31
44750|NCT01943864|107691|P1|NOT COMPLETED|Overall Study||0
44751|NCT01943864|107691|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
44752|NCT01943864|107691|P1|STARTED|Overall Study||20
44753|NCT01943565|107722|P3|NOT COMPLETED|Overall Study||0
44754|NCT01943565|107723|P2|NOT COMPLETED|Overall Study||0
44755|NCT01943565|107724|P1|NOT COMPLETED|Overall Study||0
44756|NCT01943565|107722|P3|COMPLETED|Overall Study||9
44757|NCT01943565|107723|P2|COMPLETED|Overall Study||9
44758|NCT01943565|107724|P1|COMPLETED|Overall Study||11
44759|NCT01943565|107722|P3|STARTED|Overall Study||9
44760|NCT01943565|107723|P2|STARTED|Overall Study||9
44761|NCT01943565|107724|P1|STARTED|Overall Study||11
44762|NCT01943552|107755|P2|NOT COMPLETED|Overall Study||25
44763|NCT01943552|107756|P1|NOT COMPLETED|Overall Study||25
44764|NCT01943552|107755|P2|COMPLETED|Overall Study||69
44765|NCT01943552|107756|P1|COMPLETED|Overall Study||71
44766|NCT01943552|107755|P2|STARTED|Overall Study||94
44767|NCT01943552|107756|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
44768|NCT01943539|107772|P2|NOT COMPLETED|Overall Study||0
44769|NCT01943539|107773|P1|NOT COMPLETED|Overall Study||4
44770|NCT01943539|107772|P2|COMPLETED|Overall Study||40
44771|NCT01943539|107773|P1|COMPLETED|Overall Study||40
44772|NCT01943539|107772|P2|STARTED|Overall Study||40
44773|NCT01943539|107773|P1|STARTED|Overall Study||44
44774|NCT01943474|107784|P2|NOT COMPLETED|Overall Study||0
44775|NCT01943474|107785|P1|NOT COMPLETED|Overall Study||0
44776|NCT01943474|107784|P2|COMPLETED|Overall Study||125
44777|NCT01943474|107785|P1|COMPLETED|Overall Study||123
44778|NCT01943474|107784|P2|STARTED|Overall Study||125
44779|NCT01943474|107785|P1|STARTED|Overall Study||123
44780|NCT01943435|107809|P3|NOT COMPLETED|6 Month Follow up||15
44781|NCT01943435|107810|P2|NOT COMPLETED|6 Month Follow up||7
44782|NCT01943435|107811|P1|NOT COMPLETED|6 Month Follow up||12
44783|NCT01943435|107809|P3|COMPLETED|6 Month Follow up||65
44784|NCT01943435|107810|P2|COMPLETED|6 Month Follow up||59
44785|NCT01943435|107811|P1|COMPLETED|6 Month Follow up||67
44786|NCT01943435|107809|P3|STARTED|6 Month Follow up||80
44787|NCT01943435|107810|P2|STARTED|6 Month Follow up||66
44788|NCT01943435|107811|P1|STARTED|6 Month Follow up||79
44789|NCT01943435|107809|P3|NOT COMPLETED|2 Month Follow up||0
44790|NCT01943435|107810|P2|NOT COMPLETED|2 Month Follow up||3
44791|NCT01943435|107811|P1|NOT COMPLETED|2 Month Follow up||2
44792|NCT01943435|107809|P3|COMPLETED|2 Month Follow up||80
44793|NCT01943435|107810|P2|COMPLETED|2 Month Follow up||66
44794|NCT01943435|107811|P1|COMPLETED|2 Month Follow up||79
44795|NCT01943435|107809|P3|STARTED|2 Month Follow up||80
44796|NCT01943435|107810|P2|STARTED|2 Month Follow up||69
44797|NCT01943435|107811|P1|STARTED|2 Month Follow up||81
44798|NCT01943435|107809|P3|NOT COMPLETED|Intervention Period||4
44799|NCT01943435|107810|P2|NOT COMPLETED|Intervention Period||3
44800|NCT01943435|107811|P1|NOT COMPLETED|Intervention Period||3
44801|NCT01943435|107809|P3|COMPLETED|Intervention Period||80
44802|NCT01943435|107810|P2|COMPLETED|Intervention Period||69
44803|NCT01943435|107811|P1|COMPLETED|Intervention Period||81
44804|NCT01943435|107809|P3|STARTED|Intervention Period||84
44805|NCT01943435|107810|P2|STARTED|Intervention Period||72
44806|NCT01943435|107811|P1|STARTED|Intervention Period||84
44807|NCT01943435|107809|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
44808|NCT01943435|107810|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
44809|NCT01943435|107811|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
44810|NCT01943435|107809|P3|COMPLETED|Baseline Eligibility and Randomization||84
44811|NCT01943435|107810|P2|COMPLETED|Baseline Eligibility and Randomization||72
44812|NCT01943435|107811|P1|COMPLETED|Baseline Eligibility and Randomization||84
44813|NCT01943435|107809|P3|STARTED|Baseline Eligibility and Randomization||87
44814|NCT01943435|107810|P2|STARTED|Baseline Eligibility and Randomization||84
44815|NCT01943435|107811|P1|STARTED|Baseline Eligibility and Randomization||88
44816|NCT01943344|107825|P1|NOT COMPLETED|Overall Study||3
44817|NCT01943344|107825|P1|COMPLETED|Overall Study||9
44818|NCT01943344|107825|P1|STARTED|Overall Study||12
44819|NCT01943292|107832|P3|NOT COMPLETED|Overall Study||0
44820|NCT01943292|107833|P2|NOT COMPLETED|Overall Study||0
44821|NCT01943292|107834|P1|NOT COMPLETED|Overall Study||1
44822|NCT01943292|107832|P3|COMPLETED|Overall Study||3
44823|NCT01943292|107833|P2|COMPLETED|Overall Study||3
44824|NCT01943292|107834|P1|COMPLETED|Overall Study||2
44825|NCT01943292|107832|P3|Completed Follow-Up|Overall Study||3
44826|NCT01943292|107833|P2|Completed Follow-Up|Overall Study||3
44827|NCT01943292|107834|P1|Completed Follow-Up|Overall Study||2
44828|NCT01943292|107832|P3|Completed Treatment|Overall Study||3
44829|NCT01943292|107833|P2|Completed Treatment|Overall Study||3
44830|NCT01943292|107834|P1|Completed Treatment|Overall Study||3
44831|NCT01943292|107832|P3|Completed Cycle 1|Overall Study||3
44832|NCT01943292|107833|P2|Completed Cycle 1|Overall Study||3
44833|NCT01943292|107834|P1|Completed Cycle 1|Overall Study||3
44834|NCT01943292|107832|P3|STARTED|Overall Study||3
44835|NCT01943292|107833|P2|STARTED|Overall Study||3
44836|NCT01943292|107834|P1|STARTED|Overall Study||3
44837|NCT01943110|107845|P1|NOT COMPLETED|Overall Study||0
44838|NCT01943110|107845|P1|COMPLETED|Overall Study||30
44839|NCT01943110|107845|P1|STARTED|Overall Study||30
44840|NCT01942785|107861|P1|NOT COMPLETED|Overall Study||4
44841|NCT01942785|107861|P1|COMPLETED|Overall Study||50
44842|NCT01942785|107861|P1|STARTED|Overall Study||54
44843|NCT01942733|107890|P1|NOT COMPLETED|Overall Study||3
44844|NCT01942733|107890|P1|COMPLETED|Overall Study||41
44845|NCT01942733|107890|P1|STARTED|Overall Study||44
44846|NCT01942720|107919|P1|NOT COMPLETED|Overall Study||21
44847|NCT01942720|107919|P1|COMPLETED|Overall Study||53
44848|NCT01942720|107919|P1|STARTED|Overall Study||74
44849|NCT01942707|107929|P2|NOT COMPLETED|Overall Study||0
44850|NCT01942707|107930|P1|NOT COMPLETED|Overall Study||0
44851|NCT01942707|107929|P2|COMPLETED|Overall Study||23
44852|NCT01942707|107930|P1|COMPLETED|Overall Study||23
44853|NCT01942707|107929|P2|STARTED|Overall Study||23
44854|NCT01942707|107930|P1|STARTED|Overall Study||23
44855|NCT01942590|107942|P2|NOT COMPLETED|Overall Study||1
44856|NCT01942590|107943|P1|NOT COMPLETED|Overall Study||1
44857|NCT01942590|107942|P2|COMPLETED|Overall Study||4
44858|NCT01942590|107943|P1|COMPLETED|Overall Study||7
44859|NCT01942590|107942|P2|STARTED|Overall Study||5
44860|NCT01942590|107943|P1|STARTED|Overall Study||8
44861|NCT01942161|107976|P3|NOT COMPLETED|Overall Study||6
44862|NCT01942161|107977|P2|NOT COMPLETED|Overall Study||6
44863|NCT01942161|107978|P1|NOT COMPLETED|Overall Study||8
44864|NCT01942161|107976|P3|COMPLETED|Overall Study||35
44865|NCT01942161|107977|P2|COMPLETED|Overall Study||24
44866|NCT01942161|107978|P1|COMPLETED|Overall Study||27
44867|NCT01942161|107976|P3|STARTED|Overall Study||41
44868|NCT01942161|107977|P2|STARTED|Overall Study||30
44869|NCT01942161|107978|P1|STARTED|Overall Study||35
44870|NCT01942148|107998|P1|NOT COMPLETED|Overall Study||27
44871|NCT01942148|107998|P1|COMPLETED|Overall Study||41
44872|NCT01942148|107998|P1|STARTED|Overall Study||68
44873|NCT01942135|108006|P2|NOT COMPLETED|Overall Study||174
44874|NCT01942135|108007|P1|NOT COMPLETED|Overall Study||347
44875|NCT01942135|108006|P2|COMPLETED|Overall Study||0
44876|NCT01942135|108007|P1|COMPLETED|Overall Study||0
44877|NCT01942135|108006|P2|STARTED|Overall Study||174
44878|NCT01942135|108007|P1|STARTED|Overall Study||347
44879|NCT01941940|108044|P1|NOT COMPLETED|Overall Study||33
44880|NCT01941940|108044|P1|COMPLETED|Overall Study||194
44881|NCT01941940|108044|P1|STARTED|Overall Study||227
44882|NCT01941615|108084|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
44883|NCT01941615|108084|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
44884|NCT01941615|108084|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
44885|NCT01941615|108084|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
44886|NCT01941615|108084|P1|COMPLETED|Reference Treatment: Microgynon®||0
44887|NCT01941615|108084|P1|STARTED|Reference Treatment: Microgynon®||0
44888|NCT01941615|108084|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
44889|NCT01941615|108084|P1|COMPLETED|Run in Treatment: Microgynon®||16
44890|NCT01941615|108084|P1|STARTED|Run in Treatment: Microgynon®||16
44891|NCT01941498|108093|P1|NOT COMPLETED|Overall Study||1
44892|NCT01941498|108093|P1|COMPLETED|Overall Study||96
44893|NCT01941498|108093|P1|STARTED|Overall Study||97
44894|NCT01941485|108139|P1|NOT COMPLETED|Overall Study||0
44895|NCT01941485|108139|P1|COMPLETED|Overall Study||59
44896|NCT01941485|108139|P1|STARTED|Overall Study||59
44897|NCT01941472|108205|P1|NOT COMPLETED|Overall Study||0
44898|NCT01941472|108205|P1|COMPLETED|Overall Study||40
44899|NCT01941472|108205|P1|STARTED|Overall Study||40
44900|NCT01941186|108211|P2|NOT COMPLETED|Follow-up||0
44901|NCT01941186|108212|P1|NOT COMPLETED|Follow-up||1
44902|NCT01941186|108211|P2|COMPLETED|Follow-up||33
44903|NCT01941186|108212|P1|COMPLETED|Follow-up||30
44904|NCT01941186|108211|P2|STARTED|Follow-up||33
44905|NCT01941186|108212|P1|STARTED|Follow-up||31
44906|NCT01941186|108211|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
44907|NCT01941186|108212|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
44908|NCT01941186|108211|P2|COMPLETED|Randomization/Allocation to Study Group||33
44909|NCT01941186|108212|P1|COMPLETED|Randomization/Allocation to Study Group||31
44910|NCT01941186|108211|P2|STARTED|Randomization/Allocation to Study Group||33
44911|NCT01941186|108212|P1|STARTED|Randomization/Allocation to Study Group||31
44912|NCT01940523|108240|P2|NOT COMPLETED|Overall Study||0
44913|NCT01940523|108241|P1|NOT COMPLETED|Overall Study||0
44914|NCT01940523|108240|P2|COMPLETED|Overall Study||320
44915|NCT01940523|108241|P1|COMPLETED|Overall Study||320
44916|NCT01940523|108240|P2|STARTED|Overall Study||320
44917|NCT01940523|108241|P1|STARTED|Overall Study||320
44918|NCT01940510|108249|P1|NOT COMPLETED|Overall Study||0
44919|NCT01940510|108249|P1|COMPLETED|Overall Study||24
44920|NCT01940510|108249|P1|STARTED|Overall Study||24
44921|NCT01940497|108282|P2|NOT COMPLETED|Overall Study||118
44922|NCT01940497|108283|P1|NOT COMPLETED|Overall Study||120
44923|NCT01940497|108282|P2|COMPLETED|Overall Study||1
44924|NCT01940497|108283|P1|COMPLETED|Overall Study||1
44925|NCT01940497|108282|P2|Treated: Neoadjuvant|Overall Study||21
44926|NCT01940497|108283|P1|Treated: Neoadjuvant|Overall Study||20
44927|NCT01940497|108282|P2|Treated: Adjuvant|Overall Study||92
44928|NCT01940497|108283|P1|Treated: Adjuvant|Overall Study||95
44929|NCT01940497|108282|P2|Treated|Overall Study||113
44930|NCT01940497|108283|P1|Treated|Overall Study||115
44931|NCT01940497|108282|P2|STARTED|Overall Study||119
44932|NCT01940497|108283|P1|STARTED|Overall Study||121
44933|NCT01940484|108322|P1|NOT COMPLETED|Overall Study||10
44934|NCT01940484|108322|P1|COMPLETED|Overall Study||88
44935|NCT01940484|108322|P1|STARTED|Overall Study||98
44936|NCT01940471|108342|P2|NOT COMPLETED|Open-Label Extension||8
44937|NCT01940471|108343|P1|NOT COMPLETED|Open-Label Extension||14
44938|NCT01940471|108342|P2|COMPLETED|Open-Label Extension||0
44939|NCT01940471|108343|P1|COMPLETED|Open-Label Extension||0
44940|NCT01940471|108342|P2|STARTED|Open-Label Extension||8
44941|NCT01940471|108343|P1|STARTED|Open-Label Extension||14
44942|NCT01940471|108342|P2|NOT COMPLETED|Double-Blind Phase||285
44943|NCT01940471|108343|P1|NOT COMPLETED|Double-Blind Phase||568
44944|NCT01940471|108342|P2|COMPLETED|Double-Blind Phase||8
44945|NCT01940471|108343|P1|COMPLETED|Double-Blind Phase||14
44946|NCT01940471|108342|P2|STARTED|Double-Blind Phase||293
44947|NCT01940471|108343|P1|STARTED|Double-Blind Phase||582
44948|NCT01940354|108361|P2|NOT COMPLETED|Overall Study||2
44949|NCT01940354|108362|P1|NOT COMPLETED|Overall Study||4
44950|NCT01940354|108361|P2|COMPLETED|Overall Study||108
44951|NCT01940354|108362|P1|COMPLETED|Overall Study||106
44952|NCT01940354|108361|P2|STARTED|Overall Study||110
44953|NCT01940354|108362|P1|STARTED|Overall Study||110
44954|NCT01940341|108374|P2|NOT COMPLETED|Open-label Extension Phase||1
44955|NCT01940341|108375|P1|NOT COMPLETED|Open-label Extension Phase||4
44956|NCT01940341|108374|P2|COMPLETED|Open-label Extension Phase||0
44957|NCT01940341|108375|P1|COMPLETED|Open-label Extension Phase||0
44958|NCT01940341|108374|P2|STARTED|Open-label Extension Phase||1
44959|NCT01940341|108375|P1|STARTED|Open-label Extension Phase||4
44960|NCT01940341|108374|P2|NOT COMPLETED|Double-Blind Phase||140
44961|NCT01940341|108375|P1|NOT COMPLETED|Double-Blind Phase||281
44962|NCT01940341|108374|P2|COMPLETED|Double-Blind Phase||1
44963|NCT01940341|108375|P1|COMPLETED|Double-Blind Phase||4
44964|NCT01940341|108374|P2|STARTED|Double-Blind Phase||141
44965|NCT01940341|108375|P1|STARTED|Double-Blind Phase||285
44966|NCT01940146|108393|P4|NOT COMPLETED|Overall Study||2
44967|NCT01940146|108394|P3|NOT COMPLETED|Overall Study||1
44968|NCT01940146|108395|P2|NOT COMPLETED|Overall Study||0
44969|NCT01940146|108396|P1|NOT COMPLETED|Overall Study||1
44970|NCT01940146|108393|P4|COMPLETED|Overall Study||53
44971|NCT01940146|108394|P3|COMPLETED|Overall Study||55
44972|NCT01940146|108395|P2|COMPLETED|Overall Study||55
44973|NCT01940146|108396|P1|COMPLETED|Overall Study||55
44974|NCT01940146|108393|P4|STARTED|Overall Study||55
44975|NCT01940146|108394|P3|STARTED|Overall Study||56
44976|NCT01940146|108395|P2|STARTED|Overall Study||55
44977|NCT01940146|108396|P1|STARTED|Overall Study||56
44978|NCT01940120|108406|P1|NOT COMPLETED|Overall Study||48
44979|NCT01940120|108406|P1|COMPLETED|Overall Study||30
44980|NCT01940120|108406|P1|STARTED|Overall Study||78
44981|NCT01939938|108560|P1|NOT COMPLETED|Overall Study||0
44982|NCT01939938|108560|P1|COMPLETED|Overall Study||10
44983|NCT01939938|108560|P1|STARTED|Overall Study||10
44984|NCT01939548|108568|P3|NOT COMPLETED|Overall Study||30
44985|NCT01939548|108569|P2|NOT COMPLETED|Overall Study||49
44986|NCT01939548|108570|P1|NOT COMPLETED|Overall Study||37
44987|NCT01939548|108568|P3|COMPLETED|Overall Study||50
44988|NCT01939548|108569|P2|COMPLETED|Overall Study||33
44989|NCT01939548|108570|P1|COMPLETED|Overall Study||41
44990|NCT01939548|108568|P3|STARTED|Overall Study||80
44991|NCT01939548|108569|P2|STARTED|Overall Study||82
44992|NCT01939548|108570|P1|STARTED|Overall Study||78
44993|NCT01939496|108644|P3|NOT COMPLETED|Overall Study||2
44994|NCT01939496|108645|P2|NOT COMPLETED|Overall Study||3
44995|NCT01939496|108646|P1|NOT COMPLETED|Overall Study||9
44996|NCT01939496|108644|P3|COMPLETED|Overall Study||54
44997|NCT01939496|108645|P2|COMPLETED|Overall Study||54
44998|NCT01939496|108646|P1|COMPLETED|Overall Study||47
44999|NCT01939496|108644|P3|STARTED|Overall Study||56
45000|NCT01939496|108645|P2|STARTED|Overall Study||57
45001|NCT01939496|108646|P1|STARTED|Overall Study||56
45002|NCT01939405|108698|P2|NOT COMPLETED|Overall Study||2
45003|NCT01939405|108699|P1|NOT COMPLETED|Overall Study||3
45004|NCT01939405|108698|P2|COMPLETED|Overall Study||28
45005|NCT01939405|108699|P1|COMPLETED|Overall Study||27
45006|NCT01939405|108698|P2|STARTED|Overall Study||30
45007|NCT01939405|108699|P1|STARTED|Overall Study||30
45008|NCT01939314|108713|P2|NOT COMPLETED|Overall Study||8
45009|NCT01939314|108714|P1|NOT COMPLETED|Overall Study||9
45010|NCT01939314|108713|P2|COMPLETED|Overall Study||40
45011|NCT01939314|108714|P1|COMPLETED|Overall Study||36
45012|NCT01939314|108713|P2|24 Hour Endpoint|Overall Study||40
45013|NCT01939314|108714|P1|24 Hour Endpoint|Overall Study||36
45014|NCT01939314|108713|P2|15 Minute Endpoint|Overall Study||46
45015|NCT01939314|108714|P1|15 Minute Endpoint|Overall Study||41
45016|NCT01939314|108713|P2|STARTED|Overall Study||48
45017|NCT01939314|108714|P1|STARTED|Overall Study||45
45018|NCT01939301|108726|P2|NOT COMPLETED|Overall Study||1
45019|NCT01939301|108727|P1|NOT COMPLETED|Overall Study||1
45020|NCT01939301|108726|P2|COMPLETED|Overall Study||38
45021|NCT01939301|108727|P1|COMPLETED|Overall Study||38
45022|NCT01939301|108726|P2|STARTED|Overall Study||39
45023|NCT01939301|108727|P1|STARTED|Overall Study||39
45024|NCT01939223|108735|P2|NOT COMPLETED|Overall Study||11
45025|NCT01939223|108736|P1|NOT COMPLETED|Overall Study||13
45026|NCT01939223|108735|P2|COMPLETED|Overall Study||0
45027|NCT01939223|108736|P1|COMPLETED|Overall Study||1
45028|NCT01939223|108735|P2|Participants Received Treatment|Overall Study||11
45029|NCT01939223|108736|P1|Participants Received Treatment|Overall Study||14
45030|NCT01939223|108735|P2|STARTED|Overall Study||11
45031|NCT01939223|108736|P1|STARTED|Overall Study||14
45032|NCT01939197|108751|P7|NOT COMPLETED|Overall Study||2
45033|NCT01939197|108752|P6|NOT COMPLETED|Overall Study||1
45034|NCT01939197|108753|P5|NOT COMPLETED|Overall Study||4
45035|NCT01939197|108754|P4|NOT COMPLETED|Overall Study||1
45036|NCT01939197|108755|P3|NOT COMPLETED|Overall Study||0
45037|NCT01939197|108756|P2|NOT COMPLETED|Overall Study||1
45038|NCT01939197|108757|P1|NOT COMPLETED|Overall Study||1
45039|NCT01939197|108751|P7|COMPLETED|Overall Study||26
45040|NCT01939197|108752|P6|COMPLETED|Overall Study||4
45041|NCT01939197|108753|P5|COMPLETED|Overall Study||196
45042|NCT01939197|108754|P4|COMPLETED|Overall Study||11
45043|NCT01939197|108755|P3|COMPLETED|Overall Study||10
45044|NCT01939197|108756|P2|COMPLETED|Overall Study||31
45045|NCT01939197|108757|P1|COMPLETED|Overall Study||30
45046|NCT01939197|108751|P7|STARTED|Overall Study||28
45047|NCT01939197|108752|P6|STARTED|Overall Study||5
45048|NCT01939197|108753|P5|STARTED|Overall Study||200
45049|NCT01939197|108754|P4|STARTED|Overall Study||12
45050|NCT01939197|108755|P3|STARTED|Overall Study||10
45051|NCT01939197|108756|P2|STARTED|Overall Study||32
45052|NCT01939197|108757|P1|STARTED|Overall Study||31
45053|NCT01939145|108817|P2|NOT COMPLETED|Overall Study||7
45054|NCT01939145|108818|P1|NOT COMPLETED|Overall Study||2
45055|NCT01939145|108817|P2|COMPLETED|Overall Study||44
45056|NCT01939145|108818|P1|COMPLETED|Overall Study||47
45057|NCT01939145|108817|P2|STARTED|Overall Study||51
45058|NCT01939145|108818|P1|STARTED|Overall Study||49
45059|NCT01939002|108828|P2|NOT COMPLETED|Overall Study||18
45060|NCT01939002|108829|P1|NOT COMPLETED|Overall Study||19
45061|NCT01939002|108828|P2|COMPLETED|Overall Study||80
45062|NCT01939002|108829|P1|COMPLETED|Overall Study||84
45063|NCT01939002|108828|P2|STARTED|Overall Study||98
45064|NCT01939002|108829|P1|STARTED|Overall Study||103
45065|NCT01938989|108895|P2|NOT COMPLETED|Overall Study||0
45066|NCT01938989|108896|P1|NOT COMPLETED|Overall Study||0
45067|NCT01938989|108895|P2|COMPLETED|Overall Study||77
45068|NCT01938989|108896|P1|COMPLETED|Overall Study||77
45069|NCT01938989|108895|P2|STARTED|Overall Study||77
45070|NCT01938989|108896|P1|STARTED|Overall Study||77
45071|NCT01938833|108902|P1|NOT COMPLETED|Overall Study||0
45072|NCT01938833|108902|P1|COMPLETED|Overall Study||9
45073|NCT01938833|108902|P1|STARTED|Overall Study||9
45074|NCT01938573|108910|P2|NOT COMPLETED|Overall Study||0
45075|NCT01938573|108911|P1|NOT COMPLETED|Overall Study||2
45076|NCT01938573|108910|P2|COMPLETED|Overall Study||6
45077|NCT01938573|108911|P1|COMPLETED|Overall Study||13
45078|NCT01938573|108910|P2|STARTED|Overall Study||6
45079|NCT01938573|108911|P1|STARTED|Overall Study||15
45080|NCT01938430|108931|P14|NOT COMPLETED|Overall Study||1
45081|NCT01938430|108932|P13|NOT COMPLETED|Overall Study||0
45082|NCT01938430|108933|P12|NOT COMPLETED|Overall Study||1
45083|NCT01938430|108934|P11|NOT COMPLETED|Overall Study||3
45084|NCT01938430|108935|P10|NOT COMPLETED|Overall Study||3
45085|NCT01938430|108936|P9|NOT COMPLETED|Overall Study||4
45086|NCT01938430|108937|P8|NOT COMPLETED|Overall Study||1
45087|NCT01938430|108938|P7|NOT COMPLETED|Overall Study||2
45088|NCT01938430|108939|P6|NOT COMPLETED|Overall Study||1
45089|NCT01938430|108940|P5|NOT COMPLETED|Overall Study||0
45090|NCT01938430|108941|P4|NOT COMPLETED|Overall Study||2
45091|NCT01938430|108942|P3|NOT COMPLETED|Overall Study||5
45092|NCT01938430|108943|P2|NOT COMPLETED|Overall Study||3
45093|NCT01938430|108944|P1|NOT COMPLETED|Overall Study||4
45094|NCT01938430|108931|P14|COMPLETED|Overall Study||2
45095|NCT01938430|108932|P13|COMPLETED|Overall Study||4
45096|NCT01938430|108933|P12|COMPLETED|Overall Study||3
45097|NCT01938430|108934|P11|COMPLETED|Overall Study||3
45098|NCT01938430|108935|P10|COMPLETED|Overall Study||23
45099|NCT01938430|108936|P9|COMPLETED|Overall Study||22
45100|NCT01938430|108937|P8|COMPLETED|Overall Study||24
45101|NCT01938430|108938|P7|COMPLETED|Overall Study||24
45102|NCT01938430|108939|P6|COMPLETED|Overall Study||55
45103|NCT01938430|108940|P5|COMPLETED|Overall Study||55
45104|NCT01938430|108941|P4|COMPLETED|Overall Study||24
45105|NCT01938430|108942|P3|COMPLETED|Overall Study||18
45106|NCT01938430|108943|P2|COMPLETED|Overall Study||26
45107|NCT01938430|108944|P1|COMPLETED|Overall Study||26
45108|NCT01938430|108931|P14|STARTED|Overall Study||3
45109|NCT01938430|108932|P13|STARTED|Overall Study||4
45110|NCT01938430|108933|P12|STARTED|Overall Study||4
45111|NCT01938430|108934|P11|STARTED|Overall Study||6
45112|NCT01938430|108935|P10|STARTED|Overall Study||26
45113|NCT01938430|108936|P9|STARTED|Overall Study||26
45114|NCT01938430|108937|P8|STARTED|Overall Study||25
45115|NCT01938430|108938|P7|STARTED|Overall Study||26
45116|NCT01938430|108939|P6|STARTED|Overall Study||56
45117|NCT01938430|108940|P5|STARTED|Overall Study||55
45118|NCT01938430|108941|P4|STARTED|Overall Study||26
45119|NCT01938430|108942|P3|STARTED|Overall Study||23
45120|NCT01938430|108943|P2|STARTED|Overall Study||29
45121|NCT01938430|108944|P1|STARTED|Overall Study||30
45122|NCT01938391|109269|P1|NOT COMPLETED|12 Month Follow up||2
45123|NCT01938391|109269|P1|COMPLETED|12 Month Follow up||22
45124|NCT01938391|109269|P1|STARTED|12 Month Follow up||24
45125|NCT01938391|109269|P1|NOT COMPLETED|6 Month Follow up||1
45126|NCT01938391|109269|P1|COMPLETED|6 Month Follow up||24
45127|NCT01938391|109269|P1|STARTED|6 Month Follow up||25
45128|NCT01938391|109269|P1|NOT COMPLETED|2 Week Follow up||0
45129|NCT01938391|109269|P1|COMPLETED|2 Week Follow up||25
45130|NCT01938391|109269|P1|STARTED|2 Week Follow up||25
45131|NCT01938391|109269|P1|NOT COMPLETED|Baseline||0
45132|NCT01938391|109269|P1|COMPLETED|Baseline||25
45133|NCT01938391|109269|P1|STARTED|Baseline||25
45134|NCT01938170|109279|P1|NOT COMPLETED|Overall Study||0
45135|NCT01938170|109279|P1|COMPLETED|Overall Study||41
45136|NCT01938170|109279|P1|STARTED|Overall Study||41
45137|NCT01938079|109286|P2|NOT COMPLETED|Overall Study||0
45138|NCT01938079|109287|P1|NOT COMPLETED|Overall Study||0
45139|NCT01938079|109286|P2|COMPLETED|Overall Study||10
45140|NCT01938079|109287|P1|COMPLETED|Overall Study||10
45141|NCT01938079|109286|P2|STARTED|Overall Study||10
45142|NCT01938079|109287|P1|STARTED|Overall Study||10
45143|NCT01938066|109295|P2|NOT COMPLETED|Overall Study||2
45144|NCT01938066|109296|P1|NOT COMPLETED|Overall Study||1
45145|NCT01938066|109295|P2|COMPLETED|Overall Study||13
45146|NCT01938066|109296|P1|COMPLETED|Overall Study||14
45147|NCT01938066|109295|P2|STARTED|Overall Study||15
45148|NCT01938066|109296|P1|STARTED|Overall Study||15
45149|NCT01938040|109306|P2|NOT COMPLETED|Overall Study||0
45150|NCT01938040|109307|P1|NOT COMPLETED|Overall Study||0
45151|NCT01938040|109306|P2|COMPLETED|Overall Study||27
45152|NCT01938040|109307|P1|COMPLETED|Overall Study||28
45153|NCT01938040|109306|P2|Behavior Metrics|Overall Study||27
45154|NCT01938040|109307|P1|Behavior Metrics|Overall Study||28
45155|NCT01938040|109306|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
45156|NCT01938040|109307|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
45157|NCT01938040|109306|P2|STARTED|Overall Study||27
45158|NCT01938040|109307|P1|STARTED|Overall Study||28
45159|NCT01937975|109336|P3|NOT COMPLETED|Overall Study||0
45160|NCT01937975|109337|P2|NOT COMPLETED|Overall Study||0
45161|NCT01937975|109338|P1|NOT COMPLETED|Overall Study||0
45162|NCT01937975|109336|P3|COMPLETED|Overall Study||8
45163|NCT01937975|109337|P2|COMPLETED|Overall Study||8
45164|NCT01937975|109338|P1|COMPLETED|Overall Study||8
45165|NCT01937975|109336|P3|STARTED|Overall Study||8
45166|NCT01937975|109337|P2|STARTED|Overall Study||8
45167|NCT01937975|109338|P1|STARTED|Overall Study||8
45168|NCT01937871|109388|P3|NOT COMPLETED|Overall Study||11
45169|NCT01937871|109389|P2|NOT COMPLETED|Overall Study||17
45170|NCT01937871|109390|P1|NOT COMPLETED|Overall Study||24
45171|NCT01937871|109388|P3|COMPLETED|Overall Study||174
45172|NCT01937871|109389|P2|COMPLETED|Overall Study||346
45173|NCT01937871|109390|P1|COMPLETED|Overall Study||337
45174|NCT01937871|109388|P3|Received at Least One Dose of Study Drug|Overall Study||185
45175|NCT01937871|109389|P2|Received at Least One Dose of Study Drug|Overall Study||362
45176|NCT01937871|109390|P1|Received at Least One Dose of Study Drug|Overall Study||361
45177|NCT01937871|109388|P3|STARTED|Overall Study||185
45178|NCT01937871|109389|P2|STARTED|Overall Study||363
45179|NCT01937871|109390|P1|STARTED|Overall Study||361
45180|NCT01937715|109466|P5|NOT COMPLETED|Overall Study||2
45181|NCT01937715|109467|P4|NOT COMPLETED|Overall Study||4
45182|NCT01937715|109468|P3|NOT COMPLETED|Overall Study||0
45183|NCT01937715|109469|P2|NOT COMPLETED|Overall Study||1
45184|NCT01937715|109470|P1|NOT COMPLETED|Overall Study||0
45185|NCT01937715|109466|P5|COMPLETED|Overall Study||1
45186|NCT01937715|109467|P4|COMPLETED|Overall Study||1
45187|NCT01937715|109468|P3|COMPLETED|Overall Study||3
45188|NCT01937715|109469|P2|COMPLETED|Overall Study||3
45189|NCT01937715|109470|P1|COMPLETED|Overall Study||3
45190|NCT01937715|109466|P5|STARTED|Overall Study||3
45191|NCT01937715|109467|P4|STARTED|Overall Study||5
45192|NCT01937715|109468|P3|STARTED|Overall Study||3
45193|NCT01937715|109469|P2|STARTED|Overall Study||4
45194|NCT01937715|109470|P1|STARTED|Overall Study||3
45195|NCT01937598|109592|P2|NOT COMPLETED|Overall Study||0
45196|NCT01937598|109593|P1|NOT COMPLETED|Overall Study||0
45197|NCT01937598|109592|P2|COMPLETED|Overall Study||8
45198|NCT01937598|109593|P1|COMPLETED|Overall Study||8
45199|NCT01937598|109592|P2|STARTED|Overall Study||8
45200|NCT01937598|109593|P1|STARTED|Overall Study||8
45201|NCT01937520|109617|P2|NOT COMPLETED|Overall Study||0
45202|NCT01937520|109618|P1|NOT COMPLETED|Overall Study||0
45203|NCT01937520|109617|P2|COMPLETED|Overall Study||9
45204|NCT01937520|109618|P1|COMPLETED|Overall Study||11
45205|NCT01937520|109617|P2|STARTED|Overall Study||9
45206|NCT01937520|109618|P1|STARTED|Overall Study||11
45207|NCT01937507|109654|P1|NOT COMPLETED|Overall Study||2
45208|NCT01937507|109654|P1|COMPLETED|Overall Study||0
45209|NCT01937507|109654|P1|STARTED|Overall Study||2
45210|NCT01937364|109663|P2|NOT COMPLETED|Overall Study||1
45211|NCT01937364|109664|P1|NOT COMPLETED|Overall Study||2
45212|NCT01937364|109663|P2|COMPLETED|Overall Study||7
45213|NCT01937364|109664|P1|COMPLETED|Overall Study||7
45214|NCT01937364|109663|P2|STARTED|Overall Study||8
45215|NCT01937364|109664|P1|STARTED|Overall Study||9
45216|NCT01937351|109676|P2|NOT COMPLETED|Overall Study||2
45217|NCT01937351|109677|P1|NOT COMPLETED|Overall Study||9
45218|NCT01937351|109676|P2|COMPLETED|Overall Study||26
45219|NCT01937351|109677|P1|COMPLETED|Overall Study||125
45220|NCT01937351|109676|P2|6-Month Follow-up|Overall Study||26
45221|NCT01937351|109677|P1|6-Month Follow-up|Overall Study||125
45222|NCT01937351|109676|P2|30-Day Follow-up|Overall Study||27
45223|NCT01937351|109677|P1|30-Day Follow-up|Overall Study||128
45224|NCT01937351|109676|P2|Treated w Study Device|Overall Study||28
45225|NCT01937351|109677|P1|Treated w Study Device|Overall Study||130
45226|NCT01937351|109676|P2|STARTED|Overall Study||28
45227|NCT01937351|109677|P1|STARTED|Overall Study||134
45228|NCT01937312|109685|P2|NOT COMPLETED|Overall Study||3
45229|NCT01937312|109686|P1|NOT COMPLETED|Overall Study||11
45230|NCT01937312|109685|P2|COMPLETED|Overall Study||92
45231|NCT01937312|109686|P1|COMPLETED|Overall Study||83
45232|NCT01937312|109685|P2|Treated|Overall Study||95
45233|NCT01937312|109686|P1|Treated|Overall Study||93
45234|NCT01937312|109685|P2|STARTED|Overall Study||95
45235|NCT01937312|109686|P1|STARTED|Overall Study||94
45236|NCT01937299|109701|P2|NOT COMPLETED|Overall Study||4
45237|NCT01937299|109702|P1|NOT COMPLETED|Overall Study||14
45238|NCT01937299|109701|P2|COMPLETED|Overall Study||112
45239|NCT01937299|109702|P1|COMPLETED|Overall Study||103
45240|NCT01937299|109701|P2|STARTED|Overall Study||116
45241|NCT01937299|109702|P1|STARTED|Overall Study||117
45242|NCT01937260|109715|P2|NOT COMPLETED|Overall Study||0
45243|NCT01937260|109716|P1|NOT COMPLETED|Overall Study||1
45244|NCT01937260|109715|P2|COMPLETED|Overall Study||10
45245|NCT01937260|109716|P1|COMPLETED|Overall Study||20
45246|NCT01937260|109715|P2|STARTED|Overall Study||10
45247|NCT01937260|109716|P1|STARTED|Overall Study||21
45248|NCT01937195|109723|P1|NOT COMPLETED|Overall Study||0
45249|NCT01937195|109723|P1|COMPLETED|Overall Study||95
45250|NCT01937195|109723|P1|STARTED|Overall Study||95
45251|NCT01937130|109737|P4|NOT COMPLETED|Overall Study||2
45252|NCT01937130|109738|P3|NOT COMPLETED|Overall Study||3
45253|NCT01937130|109739|P2|NOT COMPLETED|Overall Study||4
45254|NCT01937130|109740|P1|NOT COMPLETED|Overall Study||5
45255|NCT01937130|109737|P4|COMPLETED|Overall Study||2
45256|NCT01937130|109738|P3|COMPLETED|Overall Study||2
45257|NCT01937130|109739|P2|COMPLETED|Overall Study||3
45258|NCT01937130|109740|P1|COMPLETED|Overall Study||0
45259|NCT01937130|109737|P4|STARTED|Overall Study||4
45260|NCT01937130|109738|P3|STARTED|Overall Study||5
45261|NCT01937130|109739|P2|STARTED|Overall Study||7
45262|NCT01937130|109740|P1|STARTED|Overall Study||5
45263|NCT01937026|109767|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
45264|NCT01937026|109767|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
45265|NCT01937026|109767|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
45266|NCT01937026|109767|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
45267|NCT01937026|109767|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
45268|NCT01937026|109767|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
45269|NCT01937026|109767|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
45270|NCT01937026|109767|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
45271|NCT01937026|109767|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
45272|NCT01936974|109778|P2|NOT COMPLETED|Overall Study||5
45273|NCT01936974|109779|P1|NOT COMPLETED|Overall Study||2
45274|NCT01936974|109778|P2|COMPLETED|Overall Study||0
45275|NCT01936974|109779|P1|COMPLETED|Overall Study||0
45276|NCT01936974|109778|P2|STARTED|Overall Study||5
45277|NCT01936974|109779|P1|STARTED|Overall Study||2
45278|NCT01936909|109788|P3|NOT COMPLETED|Overall Study||6
45279|NCT01936909|109789|P2|NOT COMPLETED|Overall Study||8
45280|NCT01936909|109790|P1|NOT COMPLETED|Overall Study||10
45281|NCT01936909|109788|P3|COMPLETED|Overall Study||14
45282|NCT01936909|109789|P2|COMPLETED|Overall Study||12
45283|NCT01936909|109790|P1|COMPLETED|Overall Study||10
45284|NCT01936909|109788|P3|STARTED|Overall Study||20
45285|NCT01936909|109789|P2|STARTED|Overall Study||20
45286|NCT01936909|109790|P1|STARTED|Overall Study||20
45287|NCT01936896|109804|P1|NOT COMPLETED|Overall Study||0
45288|NCT01936896|109804|P1|COMPLETED|Overall Study||10
45289|NCT01936896|109804|P1|STARTED|Overall Study||10
45290|NCT01936870|109809|P1|NOT COMPLETED|Overall Study||189
45291|NCT01936870|109809|P1|COMPLETED|Overall Study||2303
45292|NCT01936870|109809|P1|STARTED|Overall Study||2492
45293|NCT01936844|109824|P2|NOT COMPLETED|Overall Study||7
45294|NCT01936844|109825|P1|NOT COMPLETED|Overall Study||6
45295|NCT01936844|109824|P2|COMPLETED|Overall Study||8
45296|NCT01936844|109825|P1|COMPLETED|Overall Study||9
45297|NCT01936844|109824|P2|STARTED|Overall Study||15
45298|NCT01936844|109825|P1|STARTED|Overall Study||15
45299|NCT01936662|109837|P2|NOT COMPLETED|Overall Study||0
45300|NCT01936662|109838|P1|NOT COMPLETED|Overall Study||0
45301|NCT01936662|109837|P2|COMPLETED|Overall Study||42
45302|NCT01936662|109838|P1|COMPLETED|Overall Study||42
45303|NCT01936662|109837|P2|STARTED|Overall Study||42
45304|NCT01936662|109838|P1|STARTED|Overall Study||42
45305|NCT01936649|109846|P1|NOT COMPLETED|Overall Study||13
45306|NCT01936649|109846|P1|COMPLETED|Overall Study||50
45307|NCT01936649|109846|P1|Treated|Overall Study||51
45308|NCT01936649|109846|P1|STARTED|Overall Study||63
45309|NCT01936623|109853|P2|NOT COMPLETED|Overall Study||5
45310|NCT01936623|109854|P1|NOT COMPLETED|Overall Study||0
45311|NCT01936623|109853|P2|COMPLETED|Overall Study||35
45312|NCT01936623|109854|P1|COMPLETED|Overall Study||40
45313|NCT01936623|109853|P2|STARTED|Overall Study||40
45314|NCT01936623|109854|P1|STARTED|Overall Study||40
45315|NCT01936467|109868|P2|NOT COMPLETED|Overall Study||0
45316|NCT01936467|109869|P1|NOT COMPLETED|Overall Study||0
45317|NCT01936467|109868|P2|COMPLETED|Overall Study||61
45318|NCT01936467|109869|P1|COMPLETED|Overall Study||60
45319|NCT01936467|109868|P2|STARTED|Overall Study||61
45320|NCT01936467|109869|P1|STARTED|Overall Study||60
45321|NCT01936389|109889|P2|NOT COMPLETED|Overall Study||0
45322|NCT01936389|109890|P1|NOT COMPLETED|Overall Study||1
45323|NCT01936389|109889|P2|COMPLETED|Overall Study||5
45324|NCT01936389|109890|P1|COMPLETED|Overall Study||4
45325|NCT01936389|109889|P2|STARTED|Overall Study||5
45326|NCT01936389|109890|P1|STARTED|Overall Study||5
45327|NCT01936363|109898|P2|NOT COMPLETED|Overall Study||5
45328|NCT01936363|109899|P1|NOT COMPLETED|Overall Study||7
45329|NCT01936363|109898|P2|COMPLETED|Overall Study||28
45330|NCT01936363|109899|P1|COMPLETED|Overall Study||25
45331|NCT01936363|109898|P2|STARTED|Overall Study||33
45332|NCT01936363|109899|P1|STARTED|Overall Study||32
45333|NCT01936181|109925|P4|NOT COMPLETED|Transition-extension||5
45334|NCT01936181|109926|P3|NOT COMPLETED|Transition-extension||6
45335|NCT01936181|109927|P2|NOT COMPLETED|Transition-extension||0
45336|NCT01936181|109928|P1|NOT COMPLETED|Transition-extension||15
45337|NCT01936181|109925|P4|COMPLETED|Transition-extension||96
45338|NCT01936181|109926|P3|COMPLETED|Transition-extension||88
45339|NCT01936181|109927|P2|COMPLETED|Transition-extension||0
45340|NCT01936181|109928|P1|COMPLETED|Transition-extension||186
45341|NCT01936181|109925|P4|STARTED|Transition-extension||101
45342|NCT01936181|109926|P3|STARTED|Transition-extension||94
45343|NCT01936181|109927|P2|STARTED|Transition-extension||0
45344|NCT01936181|109928|P1|STARTED|Transition-extension||201
45345|NCT01936181|109925|P4|NOT COMPLETED|Randomised, Double-blind||0
45346|NCT01936181|109926|P3|NOT COMPLETED|Randomised, Double-blind||0
45347|NCT01936181|109927|P2|NOT COMPLETED|Randomised, Double-blind||68
45348|NCT01936181|109928|P1|NOT COMPLETED|Randomised, Double-blind||64
45349|NCT01936181|109925|P4|COMPLETED|Randomised, Double-blind||0
45350|NCT01936181|109926|P3|COMPLETED|Randomised, Double-blind||0
45351|NCT01936181|109927|P2|COMPLETED|Randomised, Double-blind||225
45352|NCT01936181|109928|P1|COMPLETED|Randomised, Double-blind||227
45353|NCT01936181|109925|P4|STARTED|Randomised, Double-blind||0
45354|NCT01936181|109926|P3|STARTED|Randomised, Double-blind||0
45355|NCT01936181|109927|P2|STARTED|Randomised, Double-blind||293
45356|NCT01936181|109928|P1|STARTED|Randomised, Double-blind||291
45357|NCT01935622|109942|P3|NOT COMPLETED|Overall Study||0
45358|NCT01935622|109943|P2|NOT COMPLETED|Overall Study||2
45359|NCT01935622|109944|P1|NOT COMPLETED|Overall Study||2
45360|NCT01935622|109942|P3|COMPLETED|Overall Study||4
45361|NCT01935622|109943|P2|COMPLETED|Overall Study||1
45362|NCT01935622|109944|P1|COMPLETED|Overall Study||1
45363|NCT01935622|109942|P3|STARTED|Overall Study||4
45364|NCT01935622|109943|P2|STARTED|Overall Study||3
45365|NCT01935622|109944|P1|STARTED|Overall Study||3
45366|NCT01935180|109954|P2|NOT COMPLETED|Overall Study||14
45367|NCT01935180|109955|P1|NOT COMPLETED|Overall Study||21
45368|NCT01935180|109954|P2|COMPLETED|Overall Study||561
45369|NCT01935180|109955|P1|COMPLETED|Overall Study||552
45370|NCT01935180|109954|P2|STARTED|Overall Study||575
45371|NCT01935180|109955|P1|STARTED|Overall Study||573
45372|NCT01934894|109975|P2|NOT COMPLETED|Overall Study||5
45373|NCT01934894|109976|P1|NOT COMPLETED|Overall Study||6
45374|NCT01934894|109975|P2|COMPLETED|Overall Study||0
45375|NCT01934894|109976|P1|COMPLETED|Overall Study||0
45376|NCT01934894|109975|P2|STARTED|Overall Study||5
45377|NCT01934894|109976|P1|STARTED|Overall Study||6
45378|NCT01934790|109991|P1|NOT COMPLETED|Long Term Follow up||0
45379|NCT01934790|109991|P1|COMPLETED|Long Term Follow up||12
45380|NCT01934790|109991|P1|STARTED|Long Term Follow up||12
45381|NCT01934790|109991|P1|NOT COMPLETED|Active Follow up||24
45382|NCT01934790|109991|P1|COMPLETED|Active Follow up||10
45383|NCT01934790|109991|P1|STARTED|Active Follow up||34
45384|NCT01934790|109991|P1|NOT COMPLETED|Treatment||16
45385|NCT01934790|109991|P1|COMPLETED|Treatment||29
45386|NCT01934790|109991|P1|Participants Received Study Treatment|Treatment||44
45387|NCT01934790|109991|P1|STARTED|Treatment|Eligible for treatment|45
45388|NCT01934582|110019|P1|NOT COMPLETED|Overall Study||0
45389|NCT01934582|110019|P1|COMPLETED|Overall Study||13
45390|NCT01934582|110019|P1|STARTED|Overall Study||13
45391|NCT01934517|110033|P1|NOT COMPLETED|Overall Study||0
45392|NCT01934517|110033|P1|COMPLETED|Overall Study||25
45393|NCT01934517|110033|P1|STARTED|Overall Study||25
45394|NCT01934504|110045|P4|NOT COMPLETED|Overall Study||7
45395|NCT01934504|110046|P3|NOT COMPLETED|Overall Study||5
45396|NCT01934504|110047|P2|NOT COMPLETED|Overall Study||0
45397|NCT01934504|110048|P1|NOT COMPLETED|Overall Study||1
45398|NCT01934504|110045|P4|COMPLETED|Overall Study||1
45399|NCT01934504|110046|P3|COMPLETED|Overall Study||11
45400|NCT01934504|110047|P2|COMPLETED|Overall Study||3
45401|NCT01934504|110048|P1|COMPLETED|Overall Study||5
45402|NCT01934504|110045|P4|STARTED|Overall Study||8
45403|NCT01934504|110046|P3|STARTED|Overall Study||16
45404|NCT01934504|110047|P2|STARTED|Overall Study||3
45405|NCT01934504|110048|P1|STARTED|Overall Study||6
45406|NCT01934231|110070|P1|NOT COMPLETED|Overall Study||0
45407|NCT01934231|110070|P1|COMPLETED|Overall Study||27
45408|NCT01934231|110070|P1|STARTED|Overall Study||27
45409|NCT01934218|110081|P2|NOT COMPLETED|Open-Label Phase||24
45410|NCT01934218|110082|P1|NOT COMPLETED|Open-Label Phase||26
45411|NCT01934218|110081|P2|COMPLETED|Open-Label Phase||304
45412|NCT01934218|110082|P1|COMPLETED|Open-Label Phase||290
45413|NCT01934218|110081|P2|STARTED|Open-Label Phase||328
45414|NCT01934218|110082|P1|STARTED|Open-Label Phase||316
45415|NCT01934218|110081|P2|NOT COMPLETED|Double-blind Phase||54
45416|NCT01934218|110082|P1|NOT COMPLETED|Double-blind Phase||48
45417|NCT01934218|110081|P2|COMPLETED|Double-blind Phase||356
45418|NCT01934218|110082|P1|COMPLETED|Double-blind Phase||356
45419|NCT01934218|110081|P2|Analyzed Participants|Double-blind Phase||407
45420|NCT01934218|110082|P1|Analyzed Participants|Double-blind Phase||402
45421|NCT01934218|110081|P2|STARTED|Double-blind Phase||410
45422|NCT01934218|110082|P1|STARTED|Double-blind Phase||404
45423|NCT01934192|110093|P4|NOT COMPLETED|Overall Study||1
45424|NCT01934192|110094|P3|NOT COMPLETED|Overall Study||1
45425|NCT01934192|110095|P2|NOT COMPLETED|Overall Study||7
45426|NCT01934192|110096|P1|NOT COMPLETED|Overall Study||9
45427|NCT01934192|110093|P4|COMPLETED|Overall Study||3
45428|NCT01934192|110094|P3|COMPLETED|Overall Study||3
45429|NCT01934192|110095|P2|COMPLETED|Overall Study||37
45430|NCT01934192|110096|P1|COMPLETED|Overall Study||31
45431|NCT01934192|110093|P4|STARTED|Overall Study||4
45432|NCT01934192|110094|P3|STARTED|Overall Study||4
45433|NCT01934192|110095|P2|STARTED|Overall Study||44
45434|NCT01934192|110096|P1|STARTED|Overall Study||40
45435|NCT01934010|110233|P3|NOT COMPLETED|Overall Study||2
45436|NCT01934010|110234|P2|NOT COMPLETED|Overall Study||11
45437|NCT01934010|110235|P1|NOT COMPLETED|Overall Study||23
45438|NCT01934010|110233|P3|COMPLETED|Overall Study||74
45439|NCT01934010|110234|P2|COMPLETED|Overall Study||56
45440|NCT01934010|110235|P1|COMPLETED|Overall Study||91
45441|NCT01934010|110233|P3|STARTED|Overall Study||76
45442|NCT01934010|110234|P2|STARTED|Overall Study||67
45443|NCT01934010|110235|P1|STARTED|Overall Study||114
45444|NCT01933932|110254|P2|NOT COMPLETED|Overall Study||178
45445|NCT01933932|110255|P1|NOT COMPLETED|Overall Study||184
45446|NCT01933932|110254|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
45447|NCT01933932|110255|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
45448|NCT01933932|110254|P2|STARTED|Overall Study||256
45449|NCT01933932|110255|P1|STARTED|Overall Study||254
45450|NCT01933919|110273|P2|NOT COMPLETED|Open-label Long-term Phase||6
45451|NCT01933919|110274|P1|NOT COMPLETED|Open-label Long-term Phase||7
45452|NCT01933919|110273|P2|COMPLETED|Open-label Long-term Phase||9
45453|NCT01933919|110274|P1|COMPLETED|Open-label Long-term Phase||12
45454|NCT01933919|110273|P2|STARTED|Open-label Long-term Phase||15
45455|NCT01933919|110274|P1|STARTED|Open-label Long-term Phase||19
45456|NCT01933919|110273|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
45457|NCT01933919|110274|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
45458|NCT01933919|110273|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
45459|NCT01933919|110274|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
45460|NCT01933919|110273|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
45461|NCT01933919|110274|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
45462|NCT01933919|110273|P2|STARTED|Double-blind Placebo-controlled Phase||19
45463|NCT01933919|110274|P1|STARTED|Double-blind Placebo-controlled Phase||19
45464|NCT01933880|110310|P2|NOT COMPLETED|Overall Study||1
45465|NCT01933880|110311|P1|NOT COMPLETED|Overall Study||30
45466|NCT01933880|110310|P2|COMPLETED|Overall Study||40
45467|NCT01933880|110311|P1|COMPLETED|Overall Study||123
45468|NCT01933880|110310|P2|STARTED|Overall Study||41
45469|NCT01933880|110311|P1|STARTED|Overall Study||153
45470|NCT01933776|110378|P2|NOT COMPLETED|Overall Study||0
45471|NCT01933776|110379|P1|NOT COMPLETED|Overall Study||0
45472|NCT01933776|110378|P2|COMPLETED|Overall Study||20
45473|NCT01933776|110379|P1|COMPLETED|Overall Study||20
45474|NCT01933776|110378|P2|STARTED|Overall Study||20
45475|NCT01933776|110379|P1|STARTED|Overall Study||20
45476|NCT01933672|110387|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
45477|NCT01933672|110388|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
45478|NCT01933672|110389|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
45479|NCT01933672|110390|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
45480|NCT01933672|110391|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
45481|NCT01933672|110392|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
45482|NCT01933672|110393|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
45483|NCT01933672|110387|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
45484|NCT01933672|110388|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
45485|NCT01933672|110389|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
45486|NCT01933672|110390|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
45487|NCT01933672|110391|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
45488|NCT01933672|110392|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
45489|NCT01933672|110393|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
45490|NCT01933672|110387|P7|STARTED|Third Intervention Period (12-16 Days)||6
45491|NCT01933672|110388|P6|STARTED|Third Intervention Period (12-16 Days)||4
45492|NCT01933672|110389|P5|STARTED|Third Intervention Period (12-16 Days)||6
45493|NCT01933672|110390|P4|STARTED|Third Intervention Period (12-16 Days)||5
45494|NCT01933672|110391|P3|STARTED|Third Intervention Period (12-16 Days)||1
45495|NCT01933672|110392|P2|STARTED|Third Intervention Period (12-16 Days)||6
45496|NCT01933672|110393|P1|STARTED|Third Intervention Period (12-16 Days)||0
45497|NCT01933672|110387|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
45498|NCT01933672|110388|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
45499|NCT01933672|110389|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
45500|NCT01933672|110390|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
45501|NCT01933672|110391|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
45502|NCT01933672|110392|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
45503|NCT01933672|110393|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
45504|NCT01933672|110387|P7|COMPLETED|Second Washout Period (7-14 Days)||6
45505|NCT01933672|110388|P6|COMPLETED|Second Washout Period (7-14 Days)||4
45506|NCT01933672|110389|P5|COMPLETED|Second Washout Period (7-14 Days)||6
45507|NCT01933672|110390|P4|COMPLETED|Second Washout Period (7-14 Days)||5
45508|NCT01933672|110391|P3|COMPLETED|Second Washout Period (7-14 Days)||1
45509|NCT01933672|110392|P2|COMPLETED|Second Washout Period (7-14 Days)||6
45510|NCT01933672|110393|P1|COMPLETED|Second Washout Period (7-14 Days)||0
45511|NCT01933672|110387|P7|STARTED|Second Washout Period (7-14 Days)||6
45512|NCT01933672|110388|P6|STARTED|Second Washout Period (7-14 Days)||4
45513|NCT01933672|110389|P5|STARTED|Second Washout Period (7-14 Days)||6
45514|NCT01933672|110390|P4|STARTED|Second Washout Period (7-14 Days)||5
45515|NCT01933672|110391|P3|STARTED|Second Washout Period (7-14 Days)||1
45516|NCT01933672|110392|P2|STARTED|Second Washout Period (7-14 Days)||6
45517|NCT01933672|110393|P1|STARTED|Second Washout Period (7-14 Days)||0
45518|NCT01933672|110387|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
45519|NCT01933672|110388|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
45520|NCT01933672|110389|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
45521|NCT01933672|110390|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
45522|NCT01933672|110391|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
45523|NCT01933672|110392|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
45524|NCT01933672|110393|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
45525|NCT01933672|110387|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
45526|NCT01933672|110388|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
45527|NCT01933672|110389|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
45528|NCT01933672|110390|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
45529|NCT01933672|110391|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
45530|NCT01933672|110392|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
45531|NCT01933672|110393|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
45532|NCT01933672|110387|P7|STARTED|Second Intervention Period (12-16 Days)||6
45533|NCT01933672|110388|P6|STARTED|Second Intervention Period (12-16 Days)||4
45534|NCT01933672|110389|P5|STARTED|Second Intervention Period (12-16 Days)||6
45535|NCT01933672|110390|P4|STARTED|Second Intervention Period (12-16 Days)||5
45536|NCT01933672|110391|P3|STARTED|Second Intervention Period (12-16 Days)||2
45537|NCT01933672|110392|P2|STARTED|Second Intervention Period (12-16 Days)||7
45538|NCT01933672|110393|P1|STARTED|Second Intervention Period (12-16 Days)||0
45539|NCT01933672|110387|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
45540|NCT01933672|110388|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
45541|NCT01933672|110389|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
45542|NCT01933672|110390|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
45543|NCT01933672|110391|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
45544|NCT01933672|110392|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
45545|NCT01933672|110393|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
45546|NCT01933672|110387|P7|COMPLETED|First Washout Period (7-14 Days)||6
45547|NCT01933672|110388|P6|COMPLETED|First Washout Period (7-14 Days)||4
45548|NCT01933672|110389|P5|COMPLETED|First Washout Period (7-14 Days)||6
45549|NCT01933672|110390|P4|COMPLETED|First Washout Period (7-14 Days)||5
45550|NCT01933672|110391|P3|COMPLETED|First Washout Period (7-14 Days)||2
45551|NCT01933672|110392|P2|COMPLETED|First Washout Period (7-14 Days)||7
45552|NCT01933672|110393|P1|COMPLETED|First Washout Period (7-14 Days)||0
45553|NCT01933672|110387|P7|STARTED|First Washout Period (7-14 Days)||6
45554|NCT01933672|110388|P6|STARTED|First Washout Period (7-14 Days)||4
45555|NCT01933672|110389|P5|STARTED|First Washout Period (7-14 Days)||6
45556|NCT01933672|110390|P4|STARTED|First Washout Period (7-14 Days)||5
45557|NCT01933672|110391|P3|STARTED|First Washout Period (7-14 Days)||2
45558|NCT01933672|110392|P2|STARTED|First Washout Period (7-14 Days)||7
45559|NCT01933672|110393|P1|STARTED|First Washout Period (7-14 Days)||0
45560|NCT01933672|110387|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
45561|NCT01933672|110388|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
45562|NCT01933672|110389|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
45563|NCT01933672|110390|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
45564|NCT01933672|110391|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
45565|NCT01933672|110392|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
45566|NCT01933672|110393|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
45567|NCT01933672|110387|P7|COMPLETED|First Intervention Period (12-16 Days)||6
45568|NCT01933672|110388|P6|COMPLETED|First Intervention Period (12-16 Days)||4
45569|NCT01933672|110389|P5|COMPLETED|First Intervention Period (12-16 Days)||6
45570|NCT01933672|110390|P4|COMPLETED|First Intervention Period (12-16 Days)||5
45571|NCT01933672|110391|P3|COMPLETED|First Intervention Period (12-16 Days)||2
45572|NCT01933672|110392|P2|COMPLETED|First Intervention Period (12-16 Days)||7
45573|NCT01933672|110393|P1|COMPLETED|First Intervention Period (12-16 Days)||0
45574|NCT01933672|110387|P7|STARTED|First Intervention Period (12-16 Days)||6
45575|NCT01933672|110388|P6|STARTED|First Intervention Period (12-16 Days)||5
45576|NCT01933672|110389|P5|STARTED|First Intervention Period (12-16 Days)||7
45577|NCT01933672|110390|P4|STARTED|First Intervention Period (12-16 Days)||5
45578|NCT01933672|110391|P3|STARTED|First Intervention Period (12-16 Days)||3
45579|NCT01933672|110392|P2|STARTED|First Intervention Period (12-16 Days)||7
45580|NCT01933672|110393|P1|STARTED|First Intervention Period (12-16 Days)||0
45581|NCT01933672|110387|P7|NOT COMPLETED|Metformin Run-in Period||0
45582|NCT01933672|110388|P6|NOT COMPLETED|Metformin Run-in Period||0
45583|NCT01933672|110389|P5|NOT COMPLETED|Metformin Run-in Period||0
45584|NCT01933672|110390|P4|NOT COMPLETED|Metformin Run-in Period||0
45585|NCT01933672|110391|P3|NOT COMPLETED|Metformin Run-in Period||0
45586|NCT01933672|110392|P2|NOT COMPLETED|Metformin Run-in Period||0
45587|NCT01933672|110393|P1|NOT COMPLETED|Metformin Run-in Period||10
45588|NCT01933672|110387|P7|COMPLETED|Metformin Run-in Period||0
45589|NCT01933672|110388|P6|COMPLETED|Metformin Run-in Period||0
45590|NCT01933672|110389|P5|COMPLETED|Metformin Run-in Period||0
45591|NCT01933672|110390|P4|COMPLETED|Metformin Run-in Period||0
45592|NCT01933672|110391|P3|COMPLETED|Metformin Run-in Period||0
45593|NCT01933672|110392|P2|COMPLETED|Metformin Run-in Period||0
45594|NCT01933672|110393|P1|COMPLETED|Metformin Run-in Period||33
45595|NCT01933672|110387|P7|Received Treatment|Metformin Run-in Period||0
45596|NCT01933672|110388|P6|Received Treatment|Metformin Run-in Period||0
45597|NCT01933672|110389|P5|Received Treatment|Metformin Run-in Period||0
45598|NCT01933672|110390|P4|Received Treatment|Metformin Run-in Period||0
45599|NCT01933672|110391|P3|Received Treatment|Metformin Run-in Period||0
45600|NCT01933672|110392|P2|Received Treatment|Metformin Run-in Period||0
45601|NCT01933672|110393|P1|Received Treatment|Metformin Run-in Period||43
45602|NCT01933672|110387|P7|STARTED|Metformin Run-in Period||0
45603|NCT01933672|110388|P6|STARTED|Metformin Run-in Period||0
45604|NCT01933672|110389|P5|STARTED|Metformin Run-in Period||0
45605|NCT01933672|110390|P4|STARTED|Metformin Run-in Period||0
45606|NCT01933672|110391|P3|STARTED|Metformin Run-in Period||0
45607|NCT01933672|110392|P2|STARTED|Metformin Run-in Period||0
45608|NCT01933672|110393|P1|STARTED|Metformin Run-in Period||43
45609|NCT01933425|110439|P2|NOT COMPLETED|Overall Study||0
45610|NCT01933425|110440|P1|NOT COMPLETED|Overall Study||0
45611|NCT01933425|110439|P2|COMPLETED|Overall Study||7
45612|NCT01933425|110440|P1|COMPLETED|Overall Study||7
45613|NCT01933425|110439|P2|STARTED|Overall Study||7
45614|NCT01933425|110440|P1|STARTED|Overall Study||7
45615|NCT01933399|110453|P3|NOT COMPLETED|Overall Study||0
45616|NCT01933399|110454|P2|NOT COMPLETED|Overall Study||0
45617|NCT01933399|110455|P1|NOT COMPLETED|Overall Study||0
45618|NCT01933399|110453|P3|COMPLETED|Overall Study||37
45619|NCT01933399|110454|P2|COMPLETED|Overall Study||32
45620|NCT01933399|110455|P1|COMPLETED|Overall Study||29
45621|NCT01933399|110453|P3|STARTED|Overall Study||37
45622|NCT01933399|110454|P2|STARTED|Overall Study||32
45623|NCT01933399|110455|P1|STARTED|Overall Study||29
45624|NCT01933334|110468|P2|NOT COMPLETED|Overall Study||2
45625|NCT01933334|110469|P1|NOT COMPLETED|Overall Study||5
45626|NCT01933334|110468|P2|COMPLETED|Overall Study||29
45627|NCT01933334|110469|P1|COMPLETED|Overall Study||27
45628|NCT01933334|110468|P2|STARTED|Overall Study||31
45629|NCT01933334|110469|P1|STARTED|Overall Study||32
45630|NCT01933243|110481|P2|NOT COMPLETED|Overall Study||4
45631|NCT01933243|110482|P1|NOT COMPLETED|Overall Study||2
45632|NCT01933243|110481|P2|COMPLETED|Overall Study||8
45633|NCT01933243|110482|P1|COMPLETED|Overall Study||10
45634|NCT01933243|110481|P2|STARTED|Overall Study||12
45635|NCT01933243|110482|P1|STARTED|Overall Study||12
45636|NCT01933230|110492|P1|NOT COMPLETED|Overall Study||0
45637|NCT01933230|110492|P1|COMPLETED|Overall Study||2
45638|NCT01933230|110492|P1|STARTED|Overall Study||2
45639|NCT01933048|110498|P2|NOT COMPLETED|Overall Study||28
45640|NCT01933048|110499|P1|NOT COMPLETED|Overall Study||25
45641|NCT01933048|110498|P2|COMPLETED|Overall Study||501
45642|NCT01933048|110499|P1|COMPLETED|Overall Study||523
45643|NCT01933048|110498|P2|STARTED|Overall Study||529
45644|NCT01933048|110499|P1|STARTED|Overall Study||548
45645|NCT01932970|110512|P1|NOT COMPLETED|Overall Study||18
45646|NCT01932970|110512|P1|COMPLETED|Overall Study||140
45647|NCT01932970|110512|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
45648|NCT01932970|110512|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
45649|NCT01932762|110524|P4|NOT COMPLETED|Overall Study||1
45650|NCT01932762|110525|P3|NOT COMPLETED|Overall Study||0
45651|NCT01932762|110526|P2|NOT COMPLETED|Overall Study||2
45652|NCT01932762|110527|P1|NOT COMPLETED|Overall Study||6
45653|NCT01932762|110524|P4|COMPLETED|Overall Study||18
45654|NCT01932762|110525|P3|COMPLETED|Overall Study||19
45655|NCT01932762|110526|P2|COMPLETED|Overall Study||28
45656|NCT01932762|110527|P1|COMPLETED|Overall Study||24
45657|NCT01932762|110524|P4|STARTED|Overall Study||19
45658|NCT01932762|110525|P3|STARTED|Overall Study||19
45659|NCT01932762|110526|P2|STARTED|Overall Study||30
45660|NCT01932762|110527|P1|STARTED|Overall Study||30
45661|NCT01932606|110563|P2|NOT COMPLETED|Overall Study||0
45662|NCT01932606|110564|P1|NOT COMPLETED|Overall Study||0
45663|NCT01932606|110563|P2|COMPLETED|Overall Study||14
45664|NCT01932606|110564|P1|COMPLETED|Overall Study||14
45665|NCT01932606|110563|P2|STARTED|Overall Study||14
45666|NCT01932606|110564|P1|STARTED|Overall Study||14
45667|NCT01932164|110614|P1|NOT COMPLETED|Overall Study||0
45668|NCT01932164|110614|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
45669|NCT01932164|110614|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
45670|NCT01932164|110614|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
45671|NCT01932164|110614|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
45672|NCT01932164|110614|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
45673|NCT01932164|110614|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
45674|NCT01932164|110614|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
45675|NCT01932112|110619|P1|NOT COMPLETED|Overall Study||0
45676|NCT01932112|110619|P1|COMPLETED|Overall Study||378
45677|NCT01932112|110619|P1|STARTED|Overall Study||378
45678|NCT01932060|110625|P2|NOT COMPLETED|Overall Study||0
45679|NCT01932060|110626|P1|NOT COMPLETED|Overall Study||0
45680|NCT01932060|110625|P2|COMPLETED|Overall Study||24
45681|NCT01932060|110626|P1|COMPLETED|Overall Study||27
45682|NCT01932060|110625|P2|STARTED|Overall Study||24
45683|NCT01932060|110626|P1|STARTED|Overall Study||27
45684|NCT01931956|110636|P2|NOT COMPLETED|4 Years Follow-up Period||0
45685|NCT01931956|110637|P1|NOT COMPLETED|4 Years Follow-up Period||14
45686|NCT01931956|110636|P2|COMPLETED|4 Years Follow-up Period||0
45687|NCT01931956|110637|P1|COMPLETED|4 Years Follow-up Period||1
45688|NCT01931956|110636|P2|STARTED|4 Years Follow-up Period||0
45689|NCT01931956|110637|P1|STARTED|4 Years Follow-up Period||15
45690|NCT01931956|110636|P2|NOT COMPLETED|3 Years Follow-up Period||0
45691|NCT01931956|110637|P1|NOT COMPLETED|3 Years Follow-up Period||6
45692|NCT01931956|110636|P2|COMPLETED|3 Years Follow-up Period||0
45693|NCT01931956|110637|P1|COMPLETED|3 Years Follow-up Period||15
45694|NCT01931956|110636|P2|STARTED|3 Years Follow-up Period||0
45695|NCT01931956|110637|P1|STARTED|3 Years Follow-up Period||21
45696|NCT01931956|110636|P2|NOT COMPLETED|2 Years Follow-up Period||1
45697|NCT01931956|110637|P1|NOT COMPLETED|2 Years Follow-up Period||12
45698|NCT01931956|110636|P2|COMPLETED|2 Years Follow-up Period||0
45699|NCT01931956|110637|P1|COMPLETED|2 Years Follow-up Period||21
45700|NCT01931956|110636|P2|STARTED|2 Years Follow-up Period||1
45701|NCT01931956|110637|P1|STARTED|2 Years Follow-up Period||33
45702|NCT01931956|110636|P2|NOT COMPLETED|12 Months Follow-up Period||1
45703|NCT01931956|110637|P1|NOT COMPLETED|12 Months Follow-up Period||10
45704|NCT01931956|110636|P2|COMPLETED|12 Months Follow-up Period||1
45705|NCT01931956|110637|P1|COMPLETED|12 Months Follow-up Period||33
45706|NCT01931956|110636|P2|STARTED|12 Months Follow-up Period||2
45707|NCT01931956|110637|P1|STARTED|12 Months Follow-up Period||43
45708|NCT01931956|110636|P2|NOT COMPLETED|6 Months Follow-up Period||2
45709|NCT01931956|110637|P1|NOT COMPLETED|6 Months Follow-up Period||10
45710|NCT01931956|110636|P2|COMPLETED|6 Months Follow-up Period||2
45711|NCT01931956|110637|P1|COMPLETED|6 Months Follow-up Period||43
45712|NCT01931956|110636|P2|STARTED|6 Months Follow-up Period||4
45713|NCT01931956|110637|P1|STARTED|6 Months Follow-up Period||53
45714|NCT01931956|110636|P2|NOT COMPLETED|30 Days Follow-up Period||3
45715|NCT01931956|110637|P1|NOT COMPLETED|30 Days Follow-up Period||6
45716|NCT01931956|110636|P2|COMPLETED|30 Days Follow-up Period||4
45717|NCT01931956|110637|P1|COMPLETED|30 Days Follow-up Period||53
45718|NCT01931956|110636|P2|STARTED|30 Days Follow-up Period||7
45719|NCT01931956|110637|P1|STARTED|30 Days Follow-up Period||59
45720|NCT01931878|110763|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
45721|NCT01931878|110764|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
45722|NCT01931878|110763|P2|COMPLETED|Second Intervention (After 3 Months)||12
45723|NCT01931878|110764|P1|COMPLETED|Second Intervention (After 3 Months)||9
45724|NCT01931878|110763|P2|STARTED|Second Intervention (After 3 Months)||14
45725|NCT01931878|110764|P1|STARTED|Second Intervention (After 3 Months)||9
45726|NCT01931878|110763|P2|NOT COMPLETED|First Intervention||0
45727|NCT01931878|110764|P1|NOT COMPLETED|First Intervention||1
45728|NCT01931878|110763|P2|COMPLETED|First Intervention||14
45729|NCT01931878|110764|P1|COMPLETED|First Intervention||9
45730|NCT01931878|110763|P2|STARTED|First Intervention||14
45731|NCT01931878|110764|P1|STARTED|First Intervention||10
45732|NCT01931865|110774|P1|NOT COMPLETED|Overall Study||4
45733|NCT01931865|110774|P1|COMPLETED|Overall Study||8
45734|NCT01931865|110774|P1|STARTED|Overall Study||12
45735|NCT01931839|110787|P7|NOT COMPLETED|Overall Study||4
45736|NCT01931839|110788|P6|NOT COMPLETED|Overall Study||5
45737|NCT01931839|110789|P5|NOT COMPLETED|Overall Study||1
45738|NCT01931839|110790|P4|NOT COMPLETED|Overall Study||14
45739|NCT01931839|110791|P3|NOT COMPLETED|Overall Study||39
45740|NCT01931839|110792|P2|NOT COMPLETED|Overall Study||26
45741|NCT01931839|110793|P1|NOT COMPLETED|Overall Study||41
45742|NCT01931839|110787|P7|COMPLETED|Overall Study||56
45743|NCT01931839|110788|P6|COMPLETED|Overall Study||50
45744|NCT01931839|110789|P5|COMPLETED|Overall Study||18
45745|NCT01931839|110790|P4|COMPLETED|Overall Study||162
45746|NCT01931839|110791|P3|COMPLETED|Overall Study||301
45747|NCT01931839|110792|P2|COMPLETED|Overall Study||152
45748|NCT01931839|110793|P1|COMPLETED|Overall Study||294
45749|NCT01931839|110787|P7|Safety Analysis Set (As Dosed)|Overall Study||60
45750|NCT01931839|110788|P6|Safety Analysis Set (As Dosed)|Overall Study||55
45751|NCT01931839|110789|P5|Safety Analysis Set (As Dosed)|Overall Study||19
45752|NCT01931839|110790|P4|Safety Analysis Set (As Dosed)|Overall Study||176
45753|NCT01931839|110791|P3|Safety Analysis Set (As Dosed)|Overall Study||340
45754|NCT01931839|110792|P2|Safety Analysis Set (As Dosed)|Overall Study||178
45755|NCT01931839|110793|P1|Safety Analysis Set (As Dosed)|Overall Study||335
45756|NCT01931839|110787|P7|Full Analysis Set (As Randomized)|Overall Study||60
45757|NCT01931839|110788|P6|Full Analysis Set (As Randomized)|Overall Study||55
45758|NCT01931839|110789|P5|Full Analysis Set (As Randomized)|Overall Study||19
45759|NCT01931839|110790|P4|Full Analysis Set (As Randomized)|Overall Study||176
45760|NCT01931839|110791|P3|Full Analysis Set (As Randomized)|Overall Study||340
45761|NCT01931839|110792|P2|Full Analysis Set (As Randomized)|Overall Study||179
45762|NCT01931839|110793|P1|Full Analysis Set (As Randomized)|Overall Study||334
45763|NCT01931839|110787|P7|STARTED|Overall Study||60
45764|NCT01931839|110788|P6|STARTED|Overall Study||55
45765|NCT01931839|110789|P5|STARTED|Overall Study||19
45766|NCT01931839|110790|P4|STARTED|Overall Study||176
45767|NCT01931839|110791|P3|STARTED|Overall Study||340
45768|NCT01931839|110792|P2|STARTED|Overall Study||178
45769|NCT01931839|110793|P1|STARTED|Overall Study||335
45770|NCT01931709|110861|P1|NOT COMPLETED|Overall Study||0
45771|NCT01931709|110861|P1|COMPLETED|Overall Study||35
45772|NCT01931709|110861|P1|STARTED|Overall Study||35
45773|NCT01931527|110873|P2|NOT COMPLETED|Overall Study||0
45774|NCT01931527|110874|P1|NOT COMPLETED|Overall Study||0
45775|NCT01931527|110873|P2|COMPLETED|Overall Study||15
45776|NCT01931527|110874|P1|COMPLETED|Overall Study||16
45777|NCT01931527|110873|P2|STARTED|Overall Study||15
45778|NCT01931527|110874|P1|STARTED|Overall Study||16
45779|NCT01931475|110884|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
45780|NCT01931475|110885|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
45781|NCT01931475|110884|P2|COMPLETED|Period 2: Extension Treatment Phase||157
45782|NCT01931475|110885|P1|COMPLETED|Period 2: Extension Treatment Phase||162
45783|NCT01931475|110884|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
45784|NCT01931475|110885|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
45785|NCT01931475|110884|P2|STARTED|Period 2: Extension Treatment Phase||176
45786|NCT01931475|110885|P1|STARTED|Period 2: Extension Treatment Phase||166
45787|NCT01931475|110884|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
45788|NCT01931475|110885|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
45789|NCT01931475|110884|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
45790|NCT01931475|110885|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
45791|NCT01931475|110884|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
45792|NCT01931475|110885|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
45793|NCT01931475|110884|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
45794|NCT01931475|110885|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
45795|NCT01931462|110912|P1|NOT COMPLETED|Overall Study||1
45796|NCT01931462|110912|P1|COMPLETED|Overall Study||1
45797|NCT01931462|110912|P1|STARTED|Overall Study||2
45798|NCT01931397|110923|P1|NOT COMPLETED|Overall Study||11
45799|NCT01931397|110923|P1|COMPLETED|Overall Study||19
45800|NCT01931397|110923|P1|STARTED|Overall Study||30
45801|NCT01931150|110934|P2|NOT COMPLETED|Overall Study||2
45802|NCT01931150|110935|P1|NOT COMPLETED|Overall Study||1
45803|NCT01931150|110934|P2|COMPLETED|Overall Study||4
45804|NCT01931150|110935|P1|COMPLETED|Overall Study||4
45805|NCT01931150|110934|P2|STARTED|Overall Study||6
45806|NCT01931150|110935|P1|STARTED|Overall Study||5
45807|NCT01931059|110943|P2|NOT COMPLETED|Day3||0
45808|NCT01931059|110944|P1|NOT COMPLETED|Day3||1
45809|NCT01931059|110943|P2|COMPLETED|Day3||4
45810|NCT01931059|110944|P1|COMPLETED|Day3||5
45811|NCT01931059|110943|P2|STARTED|Day3||4
45812|NCT01931059|110944|P1|STARTED|Day3||6
45813|NCT01931059|110943|P2|NOT COMPLETED|Day2||0
45814|NCT01931059|110944|P1|NOT COMPLETED|Day2||0
45815|NCT01931059|110943|P2|COMPLETED|Day2||4
45816|NCT01931059|110944|P1|COMPLETED|Day2||6
45817|NCT01931059|110943|P2|STARTED|Day2||4
45818|NCT01931059|110944|P1|STARTED|Day2||6
45819|NCT01931059|110943|P2|NOT COMPLETED|Day 1||1
45820|NCT01931059|110944|P1|NOT COMPLETED|Day 1||0
45821|NCT01931059|110943|P2|COMPLETED|Day 1||4
45822|NCT01931059|110944|P1|COMPLETED|Day 1||6
45823|NCT01931059|110943|P2|STARTED|Day 1||5
45824|NCT01931059|110944|P1|STARTED|Day 1||6
45825|NCT01930890|110960|P4|NOT COMPLETED|Overall Study||27
45826|NCT01930890|110961|P3|NOT COMPLETED|Overall Study||13
45827|NCT01930890|110962|P2|NOT COMPLETED|Overall Study||33
45828|NCT01930890|110963|P1|NOT COMPLETED|Overall Study||14
45829|NCT01930890|110960|P4|COMPLETED|Overall Study||0
45830|NCT01930890|110961|P3|COMPLETED|Overall Study||0
45831|NCT01930890|110962|P2|COMPLETED|Overall Study||0
45832|NCT01930890|110963|P1|COMPLETED|Overall Study||0
45833|NCT01930890|110960|P4|STARTED|Overall Study||27
45834|NCT01930890|110961|P3|STARTED|Overall Study||13
45835|NCT01930890|110962|P2|STARTED|Overall Study||33
45836|NCT01930890|110963|P1|STARTED|Overall Study||14
45837|NCT01930799|110977|P1|NOT COMPLETED|Overall Study||8
45838|NCT01930799|110977|P1|COMPLETED|Overall Study||112
45839|NCT01930799|110977|P1|STARTED|Overall Study||120
45840|NCT01930487|110982|P2|NOT COMPLETED|Second Intervention (30 Days)||0
45841|NCT01930487|110983|P1|NOT COMPLETED|Second Intervention (30 Days)||0
45842|NCT01930487|110982|P2|COMPLETED|Second Intervention (30 Days)||23
45843|NCT01930487|110983|P1|COMPLETED|Second Intervention (30 Days)||19
45844|NCT01930487|110982|P2|STARTED|Second Intervention (30 Days)||23
45845|NCT01930487|110983|P1|STARTED|Second Intervention (30 Days)||19
45846|NCT01930487|110982|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
45847|NCT01930487|110983|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
45848|NCT01930487|110982|P2|COMPLETED|Washout Period (3 Weeks)||23
45849|NCT01930487|110983|P1|COMPLETED|Washout Period (3 Weeks)||19
45850|NCT01930487|110982|P2|STARTED|Washout Period (3 Weeks)||23
45851|NCT01930487|110983|P1|STARTED|Washout Period (3 Weeks)||19
45852|NCT01930487|110982|P2|NOT COMPLETED|First Intervention (30 Days)||2
45853|NCT01930487|110983|P1|NOT COMPLETED|First Intervention (30 Days)||2
45854|NCT01930487|110982|P2|COMPLETED|First Intervention (30 Days)||23
45855|NCT01930487|110983|P1|COMPLETED|First Intervention (30 Days)||19
45856|NCT01930487|110982|P2|STARTED|First Intervention (30 Days)||25
45857|NCT01930487|110983|P1|STARTED|First Intervention (30 Days)||21
45858|NCT01930435|111077|P1|NOT COMPLETED|Overall Study||0
45859|NCT01930435|111077|P1|COMPLETED|Overall Study||20
45860|NCT01930435|111077|P1|STARTED|Overall Study||20
45861|NCT01930162|111085|P1|NOT COMPLETED|Overall Study||5
45862|NCT01930162|111085|P1|COMPLETED|Overall Study||4
45863|NCT01930162|111085|P1|STARTED|Overall Study||9
45864|NCT01930058|111097|P3|NOT COMPLETED|Overall Study||0
45865|NCT01930058|111098|P2|NOT COMPLETED|Overall Study||0
45866|NCT01930058|111099|P1|NOT COMPLETED|Overall Study||0
45867|NCT01930058|111097|P3|COMPLETED|Overall Study||3
45868|NCT01930058|111098|P2|COMPLETED|Overall Study||3
45869|NCT01930058|111099|P1|COMPLETED|Overall Study||3
45870|NCT01930058|111097|P3|STARTED|Overall Study||3
45871|NCT01930058|111098|P2|STARTED|Overall Study||3
45872|NCT01930058|111099|P1|STARTED|Overall Study||3
45873|NCT01930045|111121|P6|NOT COMPLETED|Part 2 - Period 5||0
45874|NCT01930045|111122|P5|NOT COMPLETED|Part 2 - Period 5||0
45875|NCT01930045|111123|P4|NOT COMPLETED|Part 2 - Period 5||0
45876|NCT01930045|111124|P3|NOT COMPLETED|Part 2 - Period 5||0
45877|NCT01930045|111125|P2|NOT COMPLETED|Part 2 - Period 5||0
45878|NCT01930045|111126|P1|NOT COMPLETED|Part 2 - Period 5||0
45879|NCT01930045|111121|P6|COMPLETED|Part 2 - Period 5||1
45880|NCT01930045|111122|P5|COMPLETED|Part 2 - Period 5||3
45881|NCT01930045|111123|P4|COMPLETED|Part 2 - Period 5||3
45882|NCT01930045|111124|P3|COMPLETED|Part 2 - Period 5||3
45883|NCT01930045|111125|P2|COMPLETED|Part 2 - Period 5||3
45884|NCT01930045|111126|P1|COMPLETED|Part 2 - Period 5||3
45885|NCT01930045|111121|P6|STARTED|Part 2 - Period 5||1
45886|NCT01930045|111122|P5|STARTED|Part 2 - Period 5||3
45887|NCT01930045|111123|P4|STARTED|Part 2 - Period 5||3
45888|NCT01930045|111124|P3|STARTED|Part 2 - Period 5||3
45889|NCT01930045|111125|P2|STARTED|Part 2 - Period 5||3
45890|NCT01930045|111126|P1|STARTED|Part 2 - Period 5||3
45891|NCT01930045|111121|P6|NOT COMPLETED|Part 2 - Period 4||0
45892|NCT01930045|111122|P5|NOT COMPLETED|Part 2 - Period 4||0
45893|NCT01930045|111123|P4|NOT COMPLETED|Part 2 - Period 4||0
45894|NCT01930045|111124|P3|NOT COMPLETED|Part 2 - Period 4||0
45895|NCT01930045|111125|P2|NOT COMPLETED|Part 2 - Period 4||0
45896|NCT01930045|111126|P1|NOT COMPLETED|Part 2 - Period 4||0
45897|NCT01930045|111121|P6|COMPLETED|Part 2 - Period 4||1
45898|NCT01930045|111122|P5|COMPLETED|Part 2 - Period 4||3
45899|NCT01930045|111123|P4|COMPLETED|Part 2 - Period 4||3
45900|NCT01930045|111124|P3|COMPLETED|Part 2 - Period 4||3
45901|NCT01930045|111125|P2|COMPLETED|Part 2 - Period 4||3
45902|NCT01930045|111126|P1|COMPLETED|Part 2 - Period 4||3
45903|NCT01930045|111121|P6|STARTED|Part 2 - Period 4||1
45904|NCT01930045|111122|P5|STARTED|Part 2 - Period 4||3
45905|NCT01930045|111123|P4|STARTED|Part 2 - Period 4||3
45906|NCT01930045|111124|P3|STARTED|Part 2 - Period 4||3
45907|NCT01930045|111125|P2|STARTED|Part 2 - Period 4||3
45908|NCT01930045|111126|P1|STARTED|Part 2 - Period 4||3
45909|NCT01930045|111121|P6|NOT COMPLETED|Pause (up to 37 Days)||2
45910|NCT01930045|111122|P5|NOT COMPLETED|Pause (up to 37 Days)||0
45911|NCT01930045|111123|P4|NOT COMPLETED|Pause (up to 37 Days)||0
45912|NCT01930045|111124|P3|NOT COMPLETED|Pause (up to 37 Days)||0
45913|NCT01930045|111125|P2|NOT COMPLETED|Pause (up to 37 Days)||0
45914|NCT01930045|111126|P1|NOT COMPLETED|Pause (up to 37 Days)||0
45915|NCT01930045|111121|P6|COMPLETED|Pause (up to 37 Days)||1
45916|NCT01930045|111122|P5|COMPLETED|Pause (up to 37 Days)||3
45917|NCT01930045|111123|P4|COMPLETED|Pause (up to 37 Days)||3
45918|NCT01930045|111124|P3|COMPLETED|Pause (up to 37 Days)||3
45919|NCT01930045|111125|P2|COMPLETED|Pause (up to 37 Days)||3
45920|NCT01930045|111126|P1|COMPLETED|Pause (up to 37 Days)||3
45921|NCT01930045|111121|P6|STARTED|Pause (up to 37 Days)||3
45922|NCT01930045|111122|P5|STARTED|Pause (up to 37 Days)||3
45923|NCT01930045|111123|P4|STARTED|Pause (up to 37 Days)||3
45924|NCT01930045|111124|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
45925|NCT01930045|111125|P2|STARTED|Pause (up to 37 Days)||3
45926|NCT01930045|111126|P1|STARTED|Pause (up to 37 Days)||3
45927|NCT01930045|111121|P6|NOT COMPLETED|Part 1 - Period 3||0
45928|NCT01930045|111122|P5|NOT COMPLETED|Part 1 - Period 3||0
45929|NCT01930045|111123|P4|NOT COMPLETED|Part 1 - Period 3||0
45930|NCT01930045|111124|P3|NOT COMPLETED|Part 1 - Period 3||0
45931|NCT01930045|111125|P2|NOT COMPLETED|Part 1 - Period 3||0
45932|NCT01930045|111126|P1|NOT COMPLETED|Part 1 - Period 3||0
45933|NCT01930045|111121|P6|COMPLETED|Part 1 - Period 3||3
45934|NCT01930045|111122|P5|COMPLETED|Part 1 - Period 3||3
45935|NCT01930045|111123|P4|COMPLETED|Part 1 - Period 3||3
45936|NCT01930045|111124|P3|COMPLETED|Part 1 - Period 3||2
45937|NCT01930045|111125|P2|COMPLETED|Part 1 - Period 3||3
45938|NCT01930045|111126|P1|COMPLETED|Part 1 - Period 3||3
45939|NCT01930045|111121|P6|STARTED|Part 1 - Period 3||3
45940|NCT01930045|111122|P5|STARTED|Part 1 - Period 3||3
45941|NCT01930045|111123|P4|STARTED|Part 1 - Period 3||3
45942|NCT01930045|111124|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
45943|NCT01930045|111125|P2|STARTED|Part 1 - Period 3||3
45944|NCT01930045|111126|P1|STARTED|Part 1 - Period 3||3
45945|NCT01930045|111121|P6|NOT COMPLETED|Part 1 - Period 2||0
45946|NCT01930045|111122|P5|NOT COMPLETED|Part 1 - Period 2||0
45947|NCT01930045|111123|P4|NOT COMPLETED|Part 1 - Period 2||0
45948|NCT01930045|111124|P3|NOT COMPLETED|Part 1 - Period 2||0
45949|NCT01930045|111125|P2|NOT COMPLETED|Part 1 - Period 2||0
45950|NCT01930045|111126|P1|NOT COMPLETED|Part 1 - Period 2||0
45951|NCT01930045|111121|P6|COMPLETED|Part 1 - Period 2||3
45952|NCT01930045|111122|P5|COMPLETED|Part 1 - Period 2||3
45953|NCT01930045|111123|P4|COMPLETED|Part 1 - Period 2||3
45954|NCT01930045|111124|P3|COMPLETED|Part 1 - Period 2||3
45955|NCT01930045|111125|P2|COMPLETED|Part 1 - Period 2||3
45956|NCT01930045|111126|P1|COMPLETED|Part 1 - Period 2||3
45957|NCT01930045|111121|P6|STARTED|Part 1 - Period 2||3
45958|NCT01930045|111122|P5|STARTED|Part 1 - Period 2||3
45959|NCT01930045|111123|P4|STARTED|Part 1 - Period 2||3
45960|NCT01930045|111124|P3|STARTED|Part 1 - Period 2||3
45961|NCT01930045|111125|P2|STARTED|Part 1 - Period 2||3
45962|NCT01930045|111126|P1|STARTED|Part 1 - Period 2||3
45963|NCT01930045|111121|P6|NOT COMPLETED|Part 1 - Period 1||0
45964|NCT01930045|111122|P5|NOT COMPLETED|Part 1 - Period 1||0
45965|NCT01930045|111123|P4|NOT COMPLETED|Part 1 - Period 1||0
45966|NCT01930045|111124|P3|NOT COMPLETED|Part 1 - Period 1||0
45967|NCT01930045|111125|P2|NOT COMPLETED|Part 1 - Period 1||0
45968|NCT01930045|111126|P1|NOT COMPLETED|Part 1 - Period 1||0
45969|NCT01930045|111121|P6|COMPLETED|Part 1 - Period 1||3
45970|NCT01930045|111122|P5|COMPLETED|Part 1 - Period 1||3
45971|NCT01930045|111123|P4|COMPLETED|Part 1 - Period 1||3
45972|NCT01930045|111124|P3|COMPLETED|Part 1 - Period 1||3
45973|NCT01930045|111125|P2|COMPLETED|Part 1 - Period 1||3
45974|NCT01930045|111126|P1|COMPLETED|Part 1 - Period 1||3
45975|NCT01930045|111121|P6|STARTED|Part 1 - Period 1||3
45976|NCT01930045|111122|P5|STARTED|Part 1 - Period 1||3
45977|NCT01930045|111123|P4|STARTED|Part 1 - Period 1||3
45978|NCT01930045|111124|P3|STARTED|Part 1 - Period 1||3
45979|NCT01930045|111125|P2|STARTED|Part 1 - Period 1||3
45980|NCT01930045|111126|P1|STARTED|Part 1 - Period 1||3
45981|NCT01929993|111153|P2|NOT COMPLETED|Overall Study||28
45982|NCT01929993|111154|P1|NOT COMPLETED|Overall Study||30
45983|NCT01929993|111153|P2|COMPLETED|Overall Study||54
45984|NCT01929993|111154|P1|COMPLETED|Overall Study||52
45985|NCT01929993|111153|P2|STARTED|Overall Study||82
45986|NCT01929993|111154|P1|STARTED|Overall Study||82
45987|NCT01929980|111160|P1|NOT COMPLETED|Overall Study||1
45988|NCT01929980|111160|P1|COMPLETED|Overall Study||3
45989|NCT01929980|111160|P1|STARTED|Overall Study||4
45990|NCT01929889|111164|P1|NOT COMPLETED|Overall Study||5
45991|NCT01929889|111164|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
45992|NCT01929889|111164|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
45993|NCT01929876|111168|P1|NOT COMPLETED|Period 2||1
45994|NCT01929876|111168|P1|COMPLETED|Period 2||15
45995|NCT01929876|111168|P1|STARTED|Period 2||16
45996|NCT01929876|111168|P1|NOT COMPLETED|Period 1||0
45997|NCT01929876|111168|P1|COMPLETED|Period 1||16
45998|NCT01929876|111168|P1|STARTED|Period 1||16
45999|NCT01929863|111181|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
46000|NCT01929863|111182|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
46001|NCT01929863|111181|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
46002|NCT01929863|111182|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
46003|NCT01929863|111181|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
46004|NCT01929863|111182|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
46005|NCT01929863|111181|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
46006|NCT01929863|111182|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
46007|NCT01929863|111181|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
46008|NCT01929863|111182|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
46009|NCT01929863|111181|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
46010|NCT01929863|111182|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
46011|NCT01929863|111181|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
46012|NCT01929863|111182|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
46013|NCT01929863|111181|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
46014|NCT01929863|111182|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
46015|NCT01929863|111181|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
46016|NCT01929863|111182|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
46017|NCT01929863|111181|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
46018|NCT01929863|111182|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
46019|NCT01929863|111181|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
46020|NCT01929863|111182|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
46021|NCT01929863|111181|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
46022|NCT01929863|111182|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
46023|NCT01929759|111225|P1|NOT COMPLETED|Overall Study||0
46024|NCT01929759|111225|P1|COMPLETED|Overall Study||10
46025|NCT01929759|111225|P1|STARTED|Overall Study||10
46026|NCT01929681|111239|P2|NOT COMPLETED|Overall Study||1
46027|NCT01929681|111240|P1|NOT COMPLETED|Overall Study||2
46028|NCT01929681|111239|P2|COMPLETED|Overall Study||24
46029|NCT01929681|111240|P1|COMPLETED|Overall Study||26
46030|NCT01929681|111239|P2|STARTED|Overall Study||25
46031|NCT01929681|111240|P1|STARTED|Overall Study||28
46032|NCT01929473|111254|P1|NOT COMPLETED|Overall Study||587
46033|NCT01929473|111254|P1|COMPLETED|Overall Study||3243
46034|NCT01929473|111254|P1|365 Day|Overall Study||3589
46035|NCT01929473|111254|P1|STARTED|Overall Study|0 day|3830
46036|NCT01929460|111260|P2|NOT COMPLETED|Overall Study||0
46037|NCT01929460|111261|P1|NOT COMPLETED|Overall Study||0
46038|NCT01929460|111260|P2|COMPLETED|Overall Study||13
46039|NCT01929460|111261|P1|COMPLETED|Overall Study||13
46040|NCT01929460|111260|P2|STARTED|Overall Study||13
46041|NCT01929460|111261|P1|STARTED|Overall Study||13
46042|NCT01929317|111285|P2|NOT COMPLETED|Long-term Phase||4
46043|NCT01929317|111286|P1|NOT COMPLETED|Long-term Phase||19
46044|NCT01929317|111285|P2|COMPLETED|Long-term Phase||14
46045|NCT01929317|111286|P1|COMPLETED|Long-term Phase||25
46046|NCT01929317|111285|P2|STARTED|Long-term Phase||18
46047|NCT01929317|111286|P1|STARTED|Long-term Phase||44
46048|NCT01929317|111285|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
46049|NCT01929317|111286|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
46050|NCT01929317|111285|P2|COMPLETED|Dose Increase Effect Verification Phase||19
46051|NCT01929317|111286|P1|COMPLETED|Dose Increase Effect Verification Phase||52
46052|NCT01929317|111285|P2|STARTED|Dose Increase Effect Verification Phase||20
46053|NCT01929317|111286|P1|STARTED|Dose Increase Effect Verification Phase||61
46054|NCT01929135|111355|P2|NOT COMPLETED|Overall Study||1
46055|NCT01929135|111356|P1|NOT COMPLETED|Overall Study||1
46056|NCT01929135|111355|P2|COMPLETED|Overall Study||18
46057|NCT01929135|111356|P1|COMPLETED|Overall Study||18
46058|NCT01929135|111355|P2|STARTED|Overall Study||19
46059|NCT01929135|111356|P1|STARTED|Overall Study||19
46060|NCT01929083|111370|P2|NOT COMPLETED|Intervention 2||1
46061|NCT01929083|111371|P1|NOT COMPLETED|Intervention 2||0
46062|NCT01929083|111370|P2|COMPLETED|Intervention 2||8
46063|NCT01929083|111371|P1|COMPLETED|Intervention 2||7
46064|NCT01929083|111370|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
46065|NCT01929083|111371|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
46066|NCT01929083|111370|P2|STARTED|Intervention 2||9
46067|NCT01929083|111371|P1|STARTED|Intervention 2||7
46068|NCT01929083|111370|P2|NOT COMPLETED|Intervention 1||0
46069|NCT01929083|111371|P1|NOT COMPLETED|Intervention 1||3
46070|NCT01929083|111370|P2|COMPLETED|Intervention 1||9
46071|NCT01929083|111371|P1|COMPLETED|Intervention 1||7
46072|NCT01929083|111370|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
46073|NCT01929083|111371|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
46074|NCT01929083|111370|P2|STARTED|Intervention 1||9
46075|NCT01929083|111371|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
46076|NCT01929044|111397|P2|NOT COMPLETED|Overall Study||17
46077|NCT01929044|111398|P1|NOT COMPLETED|Overall Study||11
46078|NCT01929044|111397|P2|COMPLETED|Overall Study||129
46079|NCT01929044|111398|P1|COMPLETED|Overall Study||142
46080|NCT01929044|111397|P2|STARTED|Overall Study||146
46081|NCT01929044|111398|P1|STARTED|Overall Study||153
46082|NCT01929031|111420|P6|NOT COMPLETED|Overall Study||1
46083|NCT01929031|111421|P5|NOT COMPLETED|Overall Study||1
46084|NCT01929031|111422|P4|NOT COMPLETED|Overall Study||0
46085|NCT01929031|111423|P3|NOT COMPLETED|Overall Study||1
46086|NCT01929031|111424|P2|NOT COMPLETED|Overall Study||2
46087|NCT01929031|111425|P1|NOT COMPLETED|Overall Study||4
46088|NCT01929031|111420|P6|COMPLETED|Overall Study||35
46089|NCT01929031|111421|P5|COMPLETED|Overall Study||33
46090|NCT01929031|111422|P4|COMPLETED|Overall Study||35
46091|NCT01929031|111423|P3|COMPLETED|Overall Study||34
46092|NCT01929031|111424|P2|COMPLETED|Overall Study||207
46093|NCT01929031|111425|P1|COMPLETED|Overall Study||209
46094|NCT01929031|111420|P6|STARTED|Overall Study||36
46095|NCT01929031|111421|P5|STARTED|Overall Study||34
46096|NCT01929031|111422|P4|STARTED|Overall Study||35
46097|NCT01929031|111423|P3|STARTED|Overall Study||35
46098|NCT01929031|111424|P2|STARTED|Overall Study||209
46099|NCT01929031|111425|P1|STARTED|Overall Study||213
46100|NCT01928940|111449|P2|NOT COMPLETED|Overall Study||1
46101|NCT01928940|111450|P1|NOT COMPLETED|Overall Study||0
46102|NCT01928940|111449|P2|COMPLETED|Overall Study||5
46103|NCT01928940|111450|P1|COMPLETED|Overall Study||6
46104|NCT01928940|111449|P2|STARTED|Overall Study||6
46105|NCT01928940|111450|P1|STARTED|Overall Study||6
46106|NCT01928927|111493|P2|NOT COMPLETED|Overall Study||1
46107|NCT01928927|111494|P1|NOT COMPLETED|Overall Study||2
46108|NCT01928927|111493|P2|COMPLETED|Overall Study||14
46109|NCT01928927|111494|P1|COMPLETED|Overall Study||27
46110|NCT01928927|111493|P2|STARTED|Overall Study||15
46111|NCT01928927|111494|P1|STARTED|Overall Study||29
46112|NCT01928862|111621|P5|NOT COMPLETED|Overall Study||1
46113|NCT01928862|111622|P4|NOT COMPLETED|Overall Study||0
46114|NCT01928862|111623|P3|NOT COMPLETED|Overall Study||0
46115|NCT01928862|111624|P2|NOT COMPLETED|Overall Study||0
46116|NCT01928862|111625|P1|NOT COMPLETED|Overall Study||1
46117|NCT01928862|111621|P5|COMPLETED|Overall Study||13
46118|NCT01928862|111622|P4|COMPLETED|Overall Study||16
46119|NCT01928862|111623|P3|COMPLETED|Overall Study||16
46120|NCT01928862|111624|P2|COMPLETED|Overall Study||16
46121|NCT01928862|111625|P1|COMPLETED|Overall Study||15
46122|NCT01928862|111621|P5|STARTED|Overall Study||14
46123|NCT01928862|111622|P4|STARTED|Overall Study||16
46124|NCT01928862|111623|P3|STARTED|Overall Study||16
46125|NCT01928862|111624|P2|STARTED|Overall Study||16
46126|NCT01928862|111625|P1|STARTED|Overall Study||16
46127|NCT01928797|111664|P2|NOT COMPLETED|Overall Study||0
46128|NCT01928797|111665|P1|NOT COMPLETED|Overall Study||0
46129|NCT01928797|111664|P2|COMPLETED|Overall Study||30
46130|NCT01928797|111665|P1|COMPLETED|Overall Study||30
46131|NCT01928797|111664|P2|STARTED|Overall Study||30
46132|NCT01928797|111665|P1|STARTED|Overall Study||30
46133|NCT01928771|111678|P3|NOT COMPLETED|Overall Study||40
46134|NCT01928771|111679|P2|NOT COMPLETED|Overall Study||40
46135|NCT01928771|111680|P1|NOT COMPLETED|Overall Study||46
46136|NCT01928771|111678|P3|COMPLETED|Overall Study||367
46137|NCT01928771|111679|P2|COMPLETED|Overall Study||358
46138|NCT01928771|111680|P1|COMPLETED|Overall Study||354
46139|NCT01928771|111678|P3|Received Treatment|Overall Study||407
46140|NCT01928771|111679|P2|Received Treatment|Overall Study||398
46141|NCT01928771|111680|P1|Received Treatment|Overall Study||399
46142|NCT01928771|111678|P3|STARTED|Overall Study||407
46143|NCT01928771|111679|P2|STARTED|Overall Study||398
46144|NCT01928771|111680|P1|STARTED|Overall Study||400
46145|NCT01928693|111760|P3|NOT COMPLETED|Overall Study||0
46146|NCT01928693|111761|P2|NOT COMPLETED|Overall Study||0
46147|NCT01928693|111762|P1|NOT COMPLETED|Overall Study||0
46148|NCT01928693|111760|P3|COMPLETED|Overall Study||1
46149|NCT01928693|111761|P2|COMPLETED|Overall Study||1
46150|NCT01928693|111762|P1|COMPLETED|Overall Study||0
46151|NCT01928693|111760|P3|STARTED|Overall Study||1
46152|NCT01928693|111761|P2|STARTED|Overall Study||1
46153|NCT01928693|111762|P1|STARTED|Overall Study||0
46154|NCT01928680|111788|P1|NOT COMPLETED|Overall Study||0
46155|NCT01928680|111788|P1|COMPLETED|Overall Study||33
46156|NCT01928680|111788|P1|STARTED|Overall Study||33
46157|NCT01928615|111792|P1|NOT COMPLETED|Overall Study||2
46158|NCT01928615|111792|P1|COMPLETED|Overall Study||0
46159|NCT01928615|111792|P1|STARTED|Overall Study||2
46160|NCT01928472|111811|P4|NOT COMPLETED|Overall Study||2
46161|NCT01928472|111812|P3|NOT COMPLETED|Overall Study||7
46162|NCT01928472|111813|P2|NOT COMPLETED|Overall Study||8
46163|NCT01928472|111814|P1|NOT COMPLETED|Overall Study||8
46164|NCT01928472|111811|P4|COMPLETED|Overall Study||100
46165|NCT01928472|111812|P3|COMPLETED|Overall Study||91
46166|NCT01928472|111813|P2|COMPLETED|Overall Study||96
46167|NCT01928472|111814|P1|COMPLETED|Overall Study||90
46168|NCT01928472|111811|P4|STARTED|Overall Study||102
46169|NCT01928472|111812|P3|STARTED|Overall Study||98
46170|NCT01928472|111813|P2|STARTED|Overall Study||104
46171|NCT01928472|111814|P1|STARTED|Overall Study||98
46172|NCT01928433|111884|P3|NOT COMPLETED|Overall Study||28
46173|NCT01928433|111885|P2|NOT COMPLETED|Overall Study||21
46174|NCT01928433|111886|P1|NOT COMPLETED|Overall Study||20
46175|NCT01928433|111884|P3|COMPLETED|Overall Study||46
46176|NCT01928433|111885|P2|COMPLETED|Overall Study||54
46177|NCT01928433|111886|P1|COMPLETED|Overall Study||56
46178|NCT01928433|111884|P3|STARTED|Overall Study||74
46179|NCT01928433|111885|P2|STARTED|Overall Study||75
46180|NCT01928433|111886|P1|STARTED|Overall Study||76
46181|NCT01928381|111909|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
46182|NCT01928381|111910|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
46183|NCT01928381|111911|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
46184|NCT01928381|111912|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
46185|NCT01928381|111913|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
46186|NCT01928381|111914|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
46187|NCT01928381|111915|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
46188|NCT01928381|111909|P7|COMPLETED|Part 2 - Post Third Intervention||5
46189|NCT01928381|111910|P6|COMPLETED|Part 2 - Post Third Intervention||5
46190|NCT01928381|111911|P5|COMPLETED|Part 2 - Post Third Intervention||3
46191|NCT01928381|111912|P4|COMPLETED|Part 2 - Post Third Intervention||4
46192|NCT01928381|111913|P3|COMPLETED|Part 2 - Post Third Intervention||3
46193|NCT01928381|111914|P2|COMPLETED|Part 2 - Post Third Intervention||5
46194|NCT01928381|111915|P1|COMPLETED|Part 2 - Post Third Intervention||0
46195|NCT01928381|111909|P7|STARTED|Part 2 - Post Third Intervention||5
46196|NCT01928381|111910|P6|STARTED|Part 2 - Post Third Intervention||5
46197|NCT01928381|111911|P5|STARTED|Part 2 - Post Third Intervention||3
46198|NCT01928381|111912|P4|STARTED|Part 2 - Post Third Intervention||4
46199|NCT01928381|111913|P3|STARTED|Part 2 - Post Third Intervention||4
46200|NCT01928381|111914|P2|STARTED|Part 2 - Post Third Intervention||5
46201|NCT01928381|111915|P1|STARTED|Part 2 - Post Third Intervention||0
46202|NCT01928381|111909|P7|NOT COMPLETED|Part 2 - Third Intervention||0
46203|NCT01928381|111910|P6|NOT COMPLETED|Part 2 - Third Intervention||0
46204|NCT01928381|111911|P5|NOT COMPLETED|Part 2 - Third Intervention||0
46205|NCT01928381|111912|P4|NOT COMPLETED|Part 2 - Third Intervention||0
46206|NCT01928381|111913|P3|NOT COMPLETED|Part 2 - Third Intervention||0
46207|NCT01928381|111914|P2|NOT COMPLETED|Part 2 - Third Intervention||0
46208|NCT01928381|111915|P1|NOT COMPLETED|Part 2 - Third Intervention||0
46209|NCT01928381|111909|P7|COMPLETED|Part 2 - Third Intervention||5
46210|NCT01928381|111910|P6|COMPLETED|Part 2 - Third Intervention||5
46211|NCT01928381|111911|P5|COMPLETED|Part 2 - Third Intervention||3
46212|NCT01928381|111912|P4|COMPLETED|Part 2 - Third Intervention||4
46213|NCT01928381|111913|P3|COMPLETED|Part 2 - Third Intervention||4
46214|NCT01928381|111914|P2|COMPLETED|Part 2 - Third Intervention||5
46215|NCT01928381|111915|P1|COMPLETED|Part 2 - Third Intervention||0
46216|NCT01928381|111909|P7|STARTED|Part 2 - Third Intervention||5
46217|NCT01928381|111910|P6|STARTED|Part 2 - Third Intervention||5
46218|NCT01928381|111911|P5|STARTED|Part 2 - Third Intervention||3
46219|NCT01928381|111912|P4|STARTED|Part 2 - Third Intervention||4
46220|NCT01928381|111913|P3|STARTED|Part 2 - Third Intervention||4
46221|NCT01928381|111914|P2|STARTED|Part 2 - Third Intervention||5
46222|NCT01928381|111915|P1|STARTED|Part 2 - Third Intervention||0
46223|NCT01928381|111909|P7|NOT COMPLETED|Washout Second Intervention||0
46224|NCT01928381|111910|P6|NOT COMPLETED|Washout Second Intervention||0
46225|NCT01928381|111911|P5|NOT COMPLETED|Washout Second Intervention||0
46226|NCT01928381|111912|P4|NOT COMPLETED|Washout Second Intervention||0
46227|NCT01928381|111913|P3|NOT COMPLETED|Washout Second Intervention||0
46228|NCT01928381|111914|P2|NOT COMPLETED|Washout Second Intervention||0
46229|NCT01928381|111915|P1|NOT COMPLETED|Washout Second Intervention||0
46230|NCT01928381|111909|P7|COMPLETED|Washout Second Intervention||5
46231|NCT01928381|111910|P6|COMPLETED|Washout Second Intervention||5
46232|NCT01928381|111911|P5|COMPLETED|Washout Second Intervention||3
46233|NCT01928381|111912|P4|COMPLETED|Washout Second Intervention||4
46234|NCT01928381|111913|P3|COMPLETED|Washout Second Intervention||4
46235|NCT01928381|111914|P2|COMPLETED|Washout Second Intervention||5
46236|NCT01928381|111915|P1|COMPLETED|Washout Second Intervention||0
46237|NCT01928381|111909|P7|STARTED|Washout Second Intervention||5
46238|NCT01928381|111910|P6|STARTED|Washout Second Intervention||5
46239|NCT01928381|111911|P5|STARTED|Washout Second Intervention||3
46240|NCT01928381|111912|P4|STARTED|Washout Second Intervention||4
46241|NCT01928381|111913|P3|STARTED|Washout Second Intervention||4
46242|NCT01928381|111914|P2|STARTED|Washout Second Intervention||5
46243|NCT01928381|111915|P1|STARTED|Washout Second Intervention||0
46244|NCT01928381|111909|P7|NOT COMPLETED|Part 2 - Second Intervention||0
46245|NCT01928381|111910|P6|NOT COMPLETED|Part 2 - Second Intervention||0
46246|NCT01928381|111911|P5|NOT COMPLETED|Part 2 - Second Intervention||0
46247|NCT01928381|111912|P4|NOT COMPLETED|Part 2 - Second Intervention||1
46248|NCT01928381|111913|P3|NOT COMPLETED|Part 2 - Second Intervention||0
46249|NCT01928381|111914|P2|NOT COMPLETED|Part 2 - Second Intervention||1
46250|NCT01928381|111915|P1|NOT COMPLETED|Part 2 - Second Intervention||0
46251|NCT01928381|111909|P7|COMPLETED|Part 2 - Second Intervention||5
46252|NCT01928381|111910|P6|COMPLETED|Part 2 - Second Intervention||5
46253|NCT01928381|111911|P5|COMPLETED|Part 2 - Second Intervention||3
46254|NCT01928381|111912|P4|COMPLETED|Part 2 - Second Intervention||4
46255|NCT01928381|111913|P3|COMPLETED|Part 2 - Second Intervention||4
46256|NCT01928381|111914|P2|COMPLETED|Part 2 - Second Intervention||5
46257|NCT01928381|111915|P1|COMPLETED|Part 2 - Second Intervention||0
46258|NCT01928381|111909|P7|STARTED|Part 2 - Second Intervention||5
46259|NCT01928381|111910|P6|STARTED|Part 2 - Second Intervention||5
46260|NCT01928381|111911|P5|STARTED|Part 2 - Second Intervention||3
46261|NCT01928381|111912|P4|STARTED|Part 2 - Second Intervention||5
46262|NCT01928381|111913|P3|STARTED|Part 2 - Second Intervention||4
46263|NCT01928381|111914|P2|STARTED|Part 2 - Second Intervention||6
46264|NCT01928381|111915|P1|STARTED|Part 2 - Second Intervention||0
46265|NCT01928381|111909|P7|NOT COMPLETED|Washout First Intervention||0
46266|NCT01928381|111910|P6|NOT COMPLETED|Washout First Intervention||0
46267|NCT01928381|111911|P5|NOT COMPLETED|Washout First Intervention||1
46268|NCT01928381|111912|P4|NOT COMPLETED|Washout First Intervention||0
46269|NCT01928381|111913|P3|NOT COMPLETED|Washout First Intervention||0
46270|NCT01928381|111914|P2|NOT COMPLETED|Washout First Intervention||0
46271|NCT01928381|111915|P1|NOT COMPLETED|Washout First Intervention||0
46272|NCT01928381|111909|P7|COMPLETED|Washout First Intervention||5
46273|NCT01928381|111910|P6|COMPLETED|Washout First Intervention||5
46274|NCT01928381|111911|P5|COMPLETED|Washout First Intervention||3
46275|NCT01928381|111912|P4|COMPLETED|Washout First Intervention||5
46276|NCT01928381|111913|P3|COMPLETED|Washout First Intervention||4
46277|NCT01928381|111914|P2|COMPLETED|Washout First Intervention||6
46278|NCT01928381|111915|P1|COMPLETED|Washout First Intervention||0
46279|NCT01928381|111909|P7|STARTED|Washout First Intervention||5
46280|NCT01928381|111910|P6|STARTED|Washout First Intervention||5
46281|NCT01928381|111911|P5|STARTED|Washout First Intervention||4
46282|NCT01928381|111912|P4|STARTED|Washout First Intervention||5
46283|NCT01928381|111913|P3|STARTED|Washout First Intervention||4
46284|NCT01928381|111914|P2|STARTED|Washout First Intervention||6
46285|NCT01928381|111915|P1|STARTED|Washout First Intervention||0
46286|NCT01928381|111909|P7|NOT COMPLETED|Part 2 - First Intervention||1
46287|NCT01928381|111910|P6|NOT COMPLETED|Part 2 - First Intervention||1
46288|NCT01928381|111911|P5|NOT COMPLETED|Part 2 - First Intervention||0
46289|NCT01928381|111912|P4|NOT COMPLETED|Part 2 - First Intervention||1
46290|NCT01928381|111913|P3|NOT COMPLETED|Part 2 - First Intervention||2
46291|NCT01928381|111914|P2|NOT COMPLETED|Part 2 - First Intervention||0
46292|NCT01928381|111915|P1|NOT COMPLETED|Part 2 - First Intervention||0
46293|NCT01928381|111909|P7|COMPLETED|Part 2 - First Intervention||5
46294|NCT01928381|111910|P6|COMPLETED|Part 2 - First Intervention||5
46295|NCT01928381|111911|P5|COMPLETED|Part 2 - First Intervention||4
46296|NCT01928381|111912|P4|COMPLETED|Part 2 - First Intervention||5
46297|NCT01928381|111913|P3|COMPLETED|Part 2 - First Intervention||4
46298|NCT01928381|111914|P2|COMPLETED|Part 2 - First Intervention||6
46299|NCT01928381|111915|P1|COMPLETED|Part 2 - First Intervention||0
46300|NCT01928381|111909|P7|STARTED|Part 2 - First Intervention||6
46301|NCT01928381|111910|P6|STARTED|Part 2 - First Intervention||6
46302|NCT01928381|111911|P5|STARTED|Part 2 - First Intervention||4
46303|NCT01928381|111912|P4|STARTED|Part 2 - First Intervention||6
46304|NCT01928381|111913|P3|STARTED|Part 2 - First Intervention||6
46305|NCT01928381|111914|P2|STARTED|Part 2 - First Intervention||6
46306|NCT01928381|111915|P1|STARTED|Part 2 - First Intervention||0
46307|NCT01928381|111909|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
46308|NCT01928381|111910|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
46309|NCT01928381|111911|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
46310|NCT01928381|111912|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
46311|NCT01928381|111913|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
46312|NCT01928381|111914|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
46313|NCT01928381|111915|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
46314|NCT01928381|111909|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
46315|NCT01928381|111910|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
46316|NCT01928381|111911|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
46317|NCT01928381|111912|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
46318|NCT01928381|111913|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
46319|NCT01928381|111914|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
46320|NCT01928381|111915|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
46321|NCT01928381|111909|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
46322|NCT01928381|111910|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
46323|NCT01928381|111911|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
46324|NCT01928381|111912|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
46325|NCT01928381|111913|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
46326|NCT01928381|111914|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
46327|NCT01928381|111915|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
46328|NCT01928381|111909|P7|NOT COMPLETED|Part 1 - Pain Training||0
46329|NCT01928381|111910|P6|NOT COMPLETED|Part 1 - Pain Training||0
46330|NCT01928381|111911|P5|NOT COMPLETED|Part 1 - Pain Training||0
46331|NCT01928381|111912|P4|NOT COMPLETED|Part 1 - Pain Training||0
46332|NCT01928381|111913|P3|NOT COMPLETED|Part 1 - Pain Training||0
46333|NCT01928381|111914|P2|NOT COMPLETED|Part 1 - Pain Training||0
46334|NCT01928381|111915|P1|NOT COMPLETED|Part 1 - Pain Training||35
46335|NCT01928381|111909|P7|COMPLETED|Part 1 - Pain Training||0
46336|NCT01928381|111910|P6|COMPLETED|Part 1 - Pain Training||0
46337|NCT01928381|111911|P5|COMPLETED|Part 1 - Pain Training||0
46338|NCT01928381|111912|P4|COMPLETED|Part 1 - Pain Training||0
46339|NCT01928381|111913|P3|COMPLETED|Part 1 - Pain Training||0
46340|NCT01928381|111914|P2|COMPLETED|Part 1 - Pain Training||0
46341|NCT01928381|111915|P1|COMPLETED|Part 1 - Pain Training||48
46342|NCT01928381|111909|P7|STARTED|Part 1 - Pain Training||0
46343|NCT01928381|111910|P6|STARTED|Part 1 - Pain Training||0
46344|NCT01928381|111911|P5|STARTED|Part 1 - Pain Training||0
46345|NCT01928381|111912|P4|STARTED|Part 1 - Pain Training||0
46346|NCT01928381|111913|P3|STARTED|Part 1 - Pain Training||0
46347|NCT01928381|111914|P2|STARTED|Part 1 - Pain Training||0
46348|NCT01928381|111915|P1|STARTED|Part 1 - Pain Training||83
46349|NCT01928381|111909|P7|NOT COMPLETED|Screening for Pain Training||0
46350|NCT01928381|111910|P6|NOT COMPLETED|Screening for Pain Training||0
46351|NCT01928381|111911|P5|NOT COMPLETED|Screening for Pain Training||0
46352|NCT01928381|111912|P4|NOT COMPLETED|Screening for Pain Training||0
46353|NCT01928381|111913|P3|NOT COMPLETED|Screening for Pain Training||0
46354|NCT01928381|111914|P2|NOT COMPLETED|Screening for Pain Training||0
46355|NCT01928381|111915|P1|NOT COMPLETED|Screening for Pain Training||60
46356|NCT01928381|111909|P7|COMPLETED|Screening for Pain Training||0
46357|NCT01928381|111910|P6|COMPLETED|Screening for Pain Training||0
46358|NCT01928381|111911|P5|COMPLETED|Screening for Pain Training||0
46359|NCT01928381|111912|P4|COMPLETED|Screening for Pain Training||0
46360|NCT01928381|111913|P3|COMPLETED|Screening for Pain Training||0
46361|NCT01928381|111914|P2|COMPLETED|Screening for Pain Training||0
46362|NCT01928381|111915|P1|COMPLETED|Screening for Pain Training||83
46363|NCT01928381|111909|P7|STARTED|Screening for Pain Training||0
46364|NCT01928381|111910|P6|STARTED|Screening for Pain Training||0
46365|NCT01928381|111911|P5|STARTED|Screening for Pain Training||0
46366|NCT01928381|111912|P4|STARTED|Screening for Pain Training||0
46367|NCT01928381|111913|P3|STARTED|Screening for Pain Training||0
46368|NCT01928381|111914|P2|STARTED|Screening for Pain Training||0
46369|NCT01928381|111915|P1|STARTED|Screening for Pain Training||143
46370|NCT01928186|111928|P1|NOT COMPLETED|Overall Study||0
46371|NCT01928186|111928|P1|COMPLETED|Overall Study||28
46372|NCT01928186|111928|P1|STARTED|Overall Study||28
46373|NCT01928082|111942|P1|NOT COMPLETED|Overall Study||1
46374|NCT01928082|111942|P1|COMPLETED|Overall Study||0
46375|NCT01928082|111942|P1|STARTED|Overall Study||1
46376|NCT01928030|111946|P3|NOT COMPLETED|Overall Study||0
46377|NCT01928030|111947|P2|NOT COMPLETED|Overall Study||0
46378|NCT01928030|111948|P1|NOT COMPLETED|Overall Study||0
46379|NCT01928030|111946|P3|COMPLETED|Overall Study||0
46380|NCT01928030|111947|P2|COMPLETED|Overall Study||0
46381|NCT01928030|111948|P1|COMPLETED|Overall Study||3
46382|NCT01928030|111946|P3|STARTED|Overall Study||0
46383|NCT01928030|111947|P2|STARTED|Overall Study||0
46384|NCT01928030|111948|P1|STARTED|Overall Study||3
46385|NCT01927887|111955|P1|NOT COMPLETED|Overall Study||0
46386|NCT01927887|111955|P1|COMPLETED|Overall Study||12
46387|NCT01927887|111955|P1|STARTED|Overall Study||12
46388|NCT01927757|111960|P1|NOT COMPLETED|Overall Study||23
46389|NCT01927757|111960|P1|COMPLETED|Overall Study||67
46390|NCT01927757|111960|P1|Received Etanercept|Overall Study||88
46391|NCT01927757|111960|P1|STARTED|Overall Study||90
46392|NCT01927575|111978|P1|NOT COMPLETED|Overall Study||0
46393|NCT01927575|111978|P1|COMPLETED|Overall Study||1
46394|NCT01927575|111978|P1|STARTED|Overall Study||1
46395|NCT01927419|111988|P2|NOT COMPLETED|Overall Study||28
46396|NCT01927419|111989|P1|NOT COMPLETED|Overall Study||70
46397|NCT01927419|111988|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
46398|NCT01927419|111989|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
46399|NCT01927419|111988|P2|Received Treatment|Overall Study||46
46400|NCT01927419|111989|P1|Received Treatment|Overall Study||94
46401|NCT01927419|111988|P2|STARTED|Overall Study||47
46402|NCT01927419|111989|P1|STARTED|Overall Study||95
46403|NCT01927120|112005|P1|NOT COMPLETED|Overall Study||10
46404|NCT01927120|112005|P1|COMPLETED|Overall Study||10
46405|NCT01927120|112005|P1|STARTED|Overall Study||20
46406|NCT01927055|112023|P3|NOT COMPLETED|Double-Blind||13
46407|NCT01927055|112024|P2|NOT COMPLETED|Double-Blind||11
46408|NCT01927055|112025|P1|NOT COMPLETED|Double-Blind||0
46409|NCT01927055|112023|P3|COMPLETED|Double-Blind||10
46410|NCT01927055|112024|P2|COMPLETED|Double-Blind||11
46411|NCT01927055|112025|P1|COMPLETED|Double-Blind||0
46412|NCT01927055|112023|P3|STARTED|Double-Blind||23
46413|NCT01927055|112024|P2|STARTED|Double-Blind||22
46414|NCT01927055|112025|P1|STARTED|Double-Blind||0
46415|NCT01927055|112023|P3|NOT COMPLETED|Open-label||0
46416|NCT01927055|112024|P2|NOT COMPLETED|Open-label||0
46417|NCT01927055|112025|P1|NOT COMPLETED|Open-label||16
46418|NCT01927055|112023|P3|COMPLETED|Open-label||0
46419|NCT01927055|112024|P2|COMPLETED|Open-label||0
46420|NCT01927055|112025|P1|COMPLETED|Open-label||45
46421|NCT01927055|112023|P3|STARTED|Open-label||0
46422|NCT01927055|112024|P2|STARTED|Open-label||0
46423|NCT01927055|112025|P1|STARTED|Open-label||61
46424|NCT01926977|112034|P2|NOT COMPLETED|Overall Study||0
46425|NCT01926977|112035|P1|NOT COMPLETED|Overall Study||0
46426|NCT01926977|112034|P2|COMPLETED|Overall Study||53
46427|NCT01926977|112035|P1|COMPLETED|Overall Study||47
46428|NCT01926977|112034|P2|STARTED|Overall Study||53
46429|NCT01926977|112035|P1|STARTED|Overall Study||47
46430|NCT01926782|112049|P6|NOT COMPLETED|Overall Study||41
46431|NCT01926782|112050|P5|NOT COMPLETED|Overall Study||8
46432|NCT01926782|112051|P4|NOT COMPLETED|Overall Study||20
46433|NCT01926782|112052|P3|NOT COMPLETED|Overall Study||40
46434|NCT01926782|112053|P2|NOT COMPLETED|Overall Study||13
46435|NCT01926782|112054|P1|NOT COMPLETED|Overall Study||28
46436|NCT01926782|112049|P6|COMPLETED|Overall Study||105
46437|NCT01926782|112050|P5|COMPLETED|Overall Study||29
46438|NCT01926782|112051|P4|COMPLETED|Overall Study||53
46439|NCT01926782|112052|P3|COMPLETED|Overall Study||272
46440|NCT01926782|112053|P2|COMPLETED|Overall Study||65
46441|NCT01926782|112054|P1|COMPLETED|Overall Study||129
46442|NCT01926782|112049|P6|Completed 24 Weeks Treatment Period|Overall Study||120
46443|NCT01926782|112050|P5|Completed 24 Weeks Treatment Period|Overall Study||31
46444|NCT01926782|112051|P4|Completed 24 Weeks Treatment Period|Overall Study||58
46445|NCT01926782|112052|P3|Completed 24 Weeks Treatment Period|Overall Study||285
46446|NCT01926782|112053|P2|Completed 24 Weeks Treatment Period|Overall Study||68
46447|NCT01926782|112054|P1|Completed 24 Weeks Treatment Period|Overall Study||137
46448|NCT01926782|112049|P6|Treated|Overall Study||146
46449|NCT01926782|112050|P5|Treated|Overall Study||37
46450|NCT01926782|112051|P4|Treated|Overall Study||72
46451|NCT01926782|112052|P3|Treated|Overall Study||312
46452|NCT01926782|112053|P2|Treated|Overall Study||78
46453|NCT01926782|112054|P1|Treated|Overall Study||157
46454|NCT01926782|112049|P6|STARTED|Overall Study||146
46455|NCT01926782|112050|P5|STARTED|Overall Study||37
46456|NCT01926782|112051|P4|STARTED|Overall Study||73
46457|NCT01926782|112052|P3|STARTED|Overall Study||312
46458|NCT01926782|112053|P2|STARTED|Overall Study||78
46459|NCT01926782|112054|P1|STARTED|Overall Study||157
46460|NCT01926626|112203|P1|NOT COMPLETED|Overall Study||22
46461|NCT01926626|112203|P1|COMPLETED|Overall Study||16
46462|NCT01926626|112203|P1|Received Moclobemide|Overall Study||37
46463|NCT01926626|112203|P1|STARTED|Overall Study||38
46464|NCT01926119|112213|P1|NOT COMPLETED|Overall Study||1
46465|NCT01926119|112213|P1|COMPLETED|Overall Study||3
46466|NCT01926119|112213|P1|STARTED|Overall Study||4
46467|NCT01926015|112225|P2|NOT COMPLETED|Overall Study||1
46468|NCT01926015|112226|P1|NOT COMPLETED|Overall Study||2
46469|NCT01926015|112225|P2|COMPLETED|Overall Study||95
46470|NCT01926015|112226|P1|COMPLETED|Overall Study||94
46471|NCT01926015|112225|P2|Received >=1 Vaccination|Overall Study||96
46472|NCT01926015|112226|P1|Received >=1 Vaccination|Overall Study||94
46473|NCT01926015|112225|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
46474|NCT01926015|112226|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
46475|NCT01925781|112258|P2|NOT COMPLETED|Overall Study||4
46476|NCT01925781|112259|P1|NOT COMPLETED|Overall Study||2
46477|NCT01925781|112258|P2|COMPLETED|Overall Study||1
46478|NCT01925781|112259|P1|COMPLETED|Overall Study||3
46479|NCT01925781|112258|P2|STARTED|Overall Study||5
46480|NCT01925781|112259|P1|STARTED|Overall Study||5
46481|NCT01925768|112269|P2|NOT COMPLETED|Overall Study||23
46482|NCT01925768|112270|P1|NOT COMPLETED|Overall Study||11
46483|NCT01925768|112269|P2|COMPLETED|Overall Study|Completed = participants who completed week 24|87
46484|NCT01925768|112270|P1|COMPLETED|Overall Study|Completed = participants who completed week 24|98
46485|NCT01925768|112269|P2|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|13
46486|NCT01925768|112270|P1|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|35
46487|NCT01925768|112269|P2|Completed Week 16|Overall Study||91
46488|NCT01925768|112270|P1|Completed Week 16|Overall Study||101
46489|NCT01925768|112269|P2|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
46490|NCT01925768|112270|P1|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
46491|NCT01925768|112269|P2|Received Treatment|Overall Study||109
46492|NCT01925768|112270|P1|Received Treatment|Overall Study||109
46493|NCT01925768|112269|P2|STARTED|Overall Study||110
46494|NCT01925768|112270|P1|STARTED|Overall Study||109
46495|NCT01925703|112278|P1|NOT COMPLETED|Overall Study||4
46496|NCT01925703|112278|P1|COMPLETED|Overall Study||9
46497|NCT01925703|112278|P1|Follow-up Completed|Overall Study||9
46498|NCT01925703|112278|P1|Full Iron Repletion Achieved|Overall Study||11
46499|NCT01925703|112278|P1|Dosing Regimen Completed|Overall Study||12
46500|NCT01925703|112278|P1|STARTED|Overall Study||13
46501|NCT01925469|112286|P2|NOT COMPLETED|Overall Study||0
46502|NCT01925469|112287|P1|NOT COMPLETED|Overall Study||1
46503|NCT01925469|112286|P2|COMPLETED|Overall Study||15
46504|NCT01925469|112287|P1|COMPLETED|Overall Study||14
46505|NCT01925469|112286|P2|STARTED|Overall Study||15
46506|NCT01925469|112287|P1|STARTED|Overall Study||15
46507|NCT01925417|112297|P1|NOT COMPLETED|Overall Study||3
46508|NCT01925417|112297|P1|COMPLETED|Overall Study||31
46509|NCT01925417|112297|P1|STARTED|Overall Study||34
46510|NCT01925274|112307|P3|NOT COMPLETED|Overall Study||6
46511|NCT01925274|112308|P2|NOT COMPLETED|Overall Study||6
46512|NCT01925274|112309|P1|NOT COMPLETED|Overall Study||7
46513|NCT01925274|112307|P3|COMPLETED|Overall Study||0
46514|NCT01925274|112308|P2|COMPLETED|Overall Study||0
46515|NCT01925274|112309|P1|COMPLETED|Overall Study||0
46516|NCT01925274|112307|P3|STARTED|Overall Study||6
46517|NCT01925274|112308|P2|STARTED|Overall Study||6
46518|NCT01925274|112309|P1|STARTED|Overall Study||7
46519|NCT01925209|112390|P4|NOT COMPLETED|Follow-up||4
46520|NCT01925209|112391|P3|NOT COMPLETED|Follow-up||1
46521|NCT01925209|112392|P2|NOT COMPLETED|Follow-up||6
46522|NCT01925209|112393|P1|NOT COMPLETED|Follow-up||1
46523|NCT01925209|112390|P4|COMPLETED|Follow-up||54
46524|NCT01925209|112391|P3|COMPLETED|Follow-up||55
46525|NCT01925209|112392|P2|COMPLETED|Follow-up||55
46526|NCT01925209|112393|P1|COMPLETED|Follow-up||56
46527|NCT01925209|112390|P4|STARTED|Follow-up||58
46528|NCT01925209|112391|P3|STARTED|Follow-up||56
46529|NCT01925209|112392|P2|STARTED|Follow-up||61
46530|NCT01925209|112393|P1|STARTED|Follow-up||57
46531|NCT01925209|112390|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
46532|NCT01925209|112391|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
46533|NCT01925209|112392|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
46534|NCT01925209|112393|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
46535|NCT01925209|112390|P4|COMPLETED|Maintenance Treatment Epoch||48
46536|NCT01925209|112391|P3|COMPLETED|Maintenance Treatment Epoch||50
46537|NCT01925209|112392|P2|COMPLETED|Maintenance Treatment Epoch||45
46538|NCT01925209|112393|P1|COMPLETED|Maintenance Treatment Epoch||49
46539|NCT01925209|112390|P4|STARTED|Maintenance Treatment Epoch||50
46540|NCT01925209|112391|P3|STARTED|Maintenance Treatment Epoch||52
46541|NCT01925209|112392|P2|STARTED|Maintenance Treatment Epoch||46
46542|NCT01925209|112393|P1|STARTED|Maintenance Treatment Epoch||49
46543|NCT01925209|112390|P4|NOT COMPLETED|Treatment Epoch||5
46544|NCT01925209|112391|P3|NOT COMPLETED|Treatment Epoch||7
46545|NCT01925209|112392|P2|NOT COMPLETED|Treatment Epoch||8
46546|NCT01925209|112393|P1|NOT COMPLETED|Treatment Epoch||9
46547|NCT01925209|112390|P4|COMPLETED|Treatment Epoch||57
46548|NCT01925209|112391|P3|COMPLETED|Treatment Epoch||56
46549|NCT01925209|112392|P2|COMPLETED|Treatment Epoch||55
46550|NCT01925209|112393|P1|COMPLETED|Treatment Epoch||54
46551|NCT01925209|112390|P4|Full Analysis Set|Treatment Epoch||62
46552|NCT01925209|112391|P3|Full Analysis Set|Treatment Epoch||63
46553|NCT01925209|112392|P2|Full Analysis Set|Treatment Epoch||63
46554|NCT01925209|112393|P1|Full Analysis Set|Treatment Epoch||63
46555|NCT01925209|112390|P4|STARTED|Treatment Epoch||62
46556|NCT01925209|112391|P3|STARTED|Treatment Epoch||63
46557|NCT01925209|112392|P2|STARTED|Treatment Epoch||63
46558|NCT01925209|112393|P1|STARTED|Treatment Epoch||63
46559|NCT01925183|112425|P2|NOT COMPLETED|Overall Study||0
46560|NCT01925183|112426|P1|NOT COMPLETED|Overall Study||1
46561|NCT01925183|112425|P2|COMPLETED|Overall Study||3
46562|NCT01925183|112426|P1|COMPLETED|Overall Study||2
46563|NCT01925183|112425|P2|STARTED|Overall Study||3
46564|NCT01925183|112426|P1|STARTED|Overall Study||3
46565|NCT01925170|112434|P1|NOT COMPLETED|Overall Study||53
46566|NCT01925170|112434|P1|COMPLETED|Overall Study||1585
46567|NCT01925170|112434|P1|STARTED|Overall Study||1638
46568|NCT01925144|112452|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
46569|NCT01925144|112452|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
46570|NCT01925144|112452|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
46571|NCT01925144|112452|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
46572|NCT01925144|112452|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
46573|NCT01925144|112452|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
46574|NCT01925144|112452|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
46575|NCT01925144|112452|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
46576|NCT01925144|112452|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
46577|NCT01924975|112465|P2|NOT COMPLETED|Overall Study||0
46578|NCT01924975|112466|P1|NOT COMPLETED|Overall Study||0
46579|NCT01924975|112465|P2|COMPLETED|Overall Study||51
46580|NCT01924975|112466|P1|COMPLETED|Overall Study||51
46581|NCT01924975|112465|P2|STARTED|Overall Study||51
46582|NCT01924975|112466|P1|STARTED|Overall Study||51
46583|NCT01924949|112476|P1|NOT COMPLETED|Overall Study||0
46584|NCT01924949|112476|P1|COMPLETED|Overall Study||5
46585|NCT01924949|112476|P1|STARTED|Overall Study||5
46586|NCT01924871|112487|P2|NOT COMPLETED|Overall Study||2
46587|NCT01924871|112488|P1|NOT COMPLETED|Overall Study||6
46588|NCT01924871|112487|P2|COMPLETED|Overall Study||29
46589|NCT01924871|112488|P1|COMPLETED|Overall Study||25
46590|NCT01924871|112487|P2|STARTED|Overall Study||31
46591|NCT01924871|112488|P1|STARTED|Overall Study||31
46592|NCT01924767|112499|P5|NOT COMPLETED|Overall Study||0
46593|NCT01924767|112500|P4|NOT COMPLETED|Overall Study||0
46594|NCT01924767|112501|P3|NOT COMPLETED|Overall Study||1
46595|NCT01924767|112502|P2|NOT COMPLETED|Overall Study||0
46596|NCT01924767|112503|P1|NOT COMPLETED|Overall Study||1
46597|NCT01924767|112499|P5|COMPLETED|Overall Study||9
46598|NCT01924767|112500|P4|COMPLETED|Overall Study||9
46599|NCT01924767|112501|P3|COMPLETED|Overall Study||8
46600|NCT01924767|112502|P2|COMPLETED|Overall Study||9
46601|NCT01924767|112503|P1|COMPLETED|Overall Study||11
46602|NCT01924767|112499|P5|STARTED|Overall Study||9
46603|NCT01924767|112500|P4|STARTED|Overall Study||9
46604|NCT01924767|112501|P3|STARTED|Overall Study||9
46605|NCT01924767|112502|P2|STARTED|Overall Study||9
46606|NCT01924767|112503|P1|STARTED|Overall Study||12
46607|NCT01924559|112603|P1|NOT COMPLETED|Overall Study||0
46608|NCT01924559|112603|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
46609|NCT01924559|112603|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
46610|NCT01924390|112619|P2|NOT COMPLETED|Overall Study||1
46611|NCT01924390|112620|P1|NOT COMPLETED|Overall Study||1
46612|NCT01924390|112619|P2|COMPLETED|Overall Study||21
46613|NCT01924390|112620|P1|COMPLETED|Overall Study||21
46614|NCT01924390|112619|P2|STARTED|Overall Study||22
46615|NCT01924390|112620|P1|STARTED|Overall Study||22
46616|NCT01924364|112630|P1|NOT COMPLETED|Overall Study||3
46617|NCT01924364|112630|P1|COMPLETED|Overall Study||4
46618|NCT01924364|112630|P1|STARTED|Overall Study||7
46619|NCT01924299|112647|P2|NOT COMPLETED|Period 2||1
46620|NCT01924299|112648|P1|NOT COMPLETED|Period 2||1
46621|NCT01924299|112647|P2|COMPLETED|Period 2||17
46622|NCT01924299|112648|P1|COMPLETED|Period 2||17
46623|NCT01924299|112647|P2|Received Baricitinib|Period 2||17
46624|NCT01924299|112648|P1|Received Baricitinib|Period 2||17
46625|NCT01924299|112647|P2|Received at Least 1 Dose of Study Drug|Period 2||18
46626|NCT01924299|112648|P1|Received at Least 1 Dose of Study Drug|Period 2||18
46627|NCT01924299|112647|P2|STARTED|Period 2||18
46628|NCT01924299|112648|P1|STARTED|Period 2||18
46629|NCT01924299|112647|P2|NOT COMPLETED|Period 1||0
46630|NCT01924299|112648|P1|NOT COMPLETED|Period 1||0
46631|NCT01924299|112647|P2|COMPLETED|Period 1||18
46632|NCT01924299|112648|P1|COMPLETED|Period 1||18
46633|NCT01924299|112647|P2|Received Baricitinib|Period 1||18
46634|NCT01924299|112648|P1|Received Baricitinib|Period 1||18
46635|NCT01924299|112647|P2|STARTED|Period 1||18
46636|NCT01924299|112648|P1|STARTED|Period 1||18
46637|NCT01924182|112670|P2|NOT COMPLETED|Overall Study||0
46638|NCT01924182|112671|P1|NOT COMPLETED|Overall Study||1
46639|NCT01924182|112670|P2|COMPLETED|Overall Study||0
46640|NCT01924182|112671|P1|COMPLETED|Overall Study||2
46641|NCT01924182|112670|P2|STARTED|Overall Study||0
46642|NCT01924182|112671|P1|STARTED|Overall Study||3
46643|NCT01924169|112683|P1|NOT COMPLETED|Overall Study||0
46644|NCT01924169|112683|P1|COMPLETED|Overall Study||3
46645|NCT01924169|112683|P1|STARTED|Overall Study||3
46646|NCT01923896|112690|P2|NOT COMPLETED|Overall Study||0
46647|NCT01923896|112691|P1|NOT COMPLETED|Overall Study||1
46648|NCT01923896|112690|P2|COMPLETED|Overall Study||8
46649|NCT01923896|112691|P1|COMPLETED|Overall Study||7
46650|NCT01923896|112690|P2|STARTED|Overall Study||8
46651|NCT01923896|112691|P1|STARTED|Overall Study||8
46652|NCT01923805|112705|P2|NOT COMPLETED|Overall Study||5
46653|NCT01923805|112706|P1|NOT COMPLETED|Overall Study||3
46654|NCT01923805|112705|P2|COMPLETED|Overall Study||0
46655|NCT01923805|112706|P1|COMPLETED|Overall Study||0
46656|NCT01923805|112705|P2|STARTED|Overall Study|early termination|5
46657|NCT01923805|112706|P1|STARTED|Overall Study|early termination|3
46658|NCT01923740|112714|P2|NOT COMPLETED|1 Year Clinical Follow-up||0
46659|NCT01923740|112715|P1|NOT COMPLETED|1 Year Clinical Follow-up||0
46660|NCT01923740|112714|P2|COMPLETED|1 Year Clinical Follow-up||228
46661|NCT01923740|112715|P1|COMPLETED|1 Year Clinical Follow-up||227
46662|NCT01923740|112714|P2|STARTED|1 Year Clinical Follow-up||228
46663|NCT01923740|112715|P1|STARTED|1 Year Clinical Follow-up||227
46664|NCT01923740|112714|P2|NOT COMPLETED|270-day Clinical Follow-up||4
46665|NCT01923740|112715|P1|NOT COMPLETED|270-day Clinical Follow-up||0
46666|NCT01923740|112714|P2|COMPLETED|270-day Clinical Follow-up||228
46667|NCT01923740|112715|P1|COMPLETED|270-day Clinical Follow-up||227
46668|NCT01923740|112714|P2|STARTED|270-day Clinical Follow-up||232
46669|NCT01923740|112715|P1|STARTED|270-day Clinical Follow-up||227
46670|NCT01923740|112714|P2|NOT COMPLETED|180-day Clinical Follow-up||0
46671|NCT01923740|112715|P1|NOT COMPLETED|180-day Clinical Follow-up||0
46672|NCT01923740|112714|P2|COMPLETED|180-day Clinical Follow-up||232
46673|NCT01923740|112715|P1|COMPLETED|180-day Clinical Follow-up||227
46674|NCT01923740|112714|P2|STARTED|180-day Clinical Follow-up||232
46675|NCT01923740|112715|P1|STARTED|180-day Clinical Follow-up||227
46676|NCT01923740|112714|P2|NOT COMPLETED|30-day Clinical Follow-up||0
46677|NCT01923740|112715|P1|NOT COMPLETED|30-day Clinical Follow-up||0
46678|NCT01923740|112714|P2|COMPLETED|30-day Clinical Follow-up||232
46679|NCT01923740|112715|P1|COMPLETED|30-day Clinical Follow-up||227
46680|NCT01923740|112714|P2|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|232
46681|NCT01923740|112715|P1|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|227
46682|NCT01923480|112880|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
46683|NCT01923480|112881|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
46684|NCT01923480|112882|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
46685|NCT01923480|112883|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
46686|NCT01923480|112884|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
46687|NCT01923480|112885|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
46688|NCT01923480|112880|P6|COMPLETED|Period 2 (Hours 1-7)||2
46689|NCT01923480|112881|P5|COMPLETED|Period 2 (Hours 1-7)||2
46690|NCT01923480|112882|P4|COMPLETED|Period 2 (Hours 1-7)||2
46691|NCT01923480|112883|P3|COMPLETED|Period 2 (Hours 1-7)||2
46692|NCT01923480|112884|P2|COMPLETED|Period 2 (Hours 1-7)||1
46693|NCT01923480|112885|P1|COMPLETED|Period 2 (Hours 1-7)||1
46694|NCT01923480|112880|P6|STARTED|Period 2 (Hours 1-7)||2
46695|NCT01923480|112881|P5|STARTED|Period 2 (Hours 1-7)||2
46696|NCT01923480|112882|P4|STARTED|Period 2 (Hours 1-7)||2
46697|NCT01923480|112883|P3|STARTED|Period 2 (Hours 1-7)||2
46698|NCT01923480|112884|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
46699|NCT01923480|112885|P1|STARTED|Period 2 (Hours 1-7)||1
46700|NCT01923480|112880|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
46701|NCT01923480|112881|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
46702|NCT01923480|112882|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
46703|NCT01923480|112883|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
46704|NCT01923480|112884|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
46705|NCT01923480|112885|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
46706|NCT01923480|112880|P6|COMPLETED|Period 1 (Hours 1-7)||2
46707|NCT01923480|112881|P5|COMPLETED|Period 1 (Hours 1-7)||2
46708|NCT01923480|112882|P4|COMPLETED|Period 1 (Hours 1-7)||2
46709|NCT01923480|112883|P3|COMPLETED|Period 1 (Hours 1-7)||2
46710|NCT01923480|112884|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
46711|NCT01923480|112885|P1|COMPLETED|Period 1 (Hours 1-7)||1
46712|NCT01923480|112880|P6|STARTED|Period 1 (Hours 1-7)||2
46713|NCT01923480|112881|P5|STARTED|Period 1 (Hours 1-7)||2
46714|NCT01923480|112882|P4|STARTED|Period 1 (Hours 1-7)||2
46715|NCT01923480|112883|P3|STARTED|Period 1 (Hours 1-7)||2
46716|NCT01923480|112884|P2|STARTED|Period 1 (Hours 1-7)||2
46717|NCT01923480|112885|P1|STARTED|Period 1 (Hours 1-7)||1
46718|NCT01923467|113040|P1|NOT COMPLETED|Overall Study||541
46719|NCT01923467|113040|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
46720|NCT01923467|113040|P1|Baseline Completed, Enrolled|Overall Study||288
46721|NCT01923467|113040|P1|STARTED|Overall Study|Offered stop smoking program|767
46722|NCT01923389|113046|P2|NOT COMPLETED|Overall Study||0
46723|NCT01923389|113047|P1|NOT COMPLETED|Overall Study||1
46724|NCT01923389|113046|P2|COMPLETED|Overall Study||2
46725|NCT01923389|113047|P1|COMPLETED|Overall Study||1
46726|NCT01923389|113046|P2|STARTED|Overall Study||2
46727|NCT01923389|113047|P1|STARTED|Overall Study||2
46728|NCT01922986|113071|P2|NOT COMPLETED|Overall Study||0
46729|NCT01922986|113072|P1|NOT COMPLETED|Overall Study||0
46730|NCT01922986|113071|P2|COMPLETED|Overall Study||2
46731|NCT01922986|113072|P1|COMPLETED|Overall Study||2
46732|NCT01922986|113071|P2|STARTED|Overall Study||2
46733|NCT01922986|113072|P1|STARTED|Overall Study||2
46734|NCT01922934|113084|P2|NOT COMPLETED|Visit 12 / Final Visits||290
46735|NCT01922934|113085|P1|NOT COMPLETED|Visit 12 / Final Visits||6
46736|NCT01922934|113084|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
46737|NCT01922934|113085|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
46738|NCT01922934|113084|P2|STARTED|Visit 12 / Final Visits||2930
46739|NCT01922934|113085|P1|STARTED|Visit 12 / Final Visits||119
46740|NCT01922934|113084|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
46741|NCT01922934|113085|P1|NOT COMPLETED|Visit 1- Weight Measured||21
46742|NCT01922934|113084|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
46743|NCT01922934|113085|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
46744|NCT01922934|113084|P2|STARTED|Visit 1- Weight Measured||4214
46745|NCT01922934|113085|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
46746|NCT01922934|113084|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
46747|NCT01922934|113085|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
46748|NCT01922934|113084|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
46749|NCT01922934|113085|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
46750|NCT01922934|113084|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
46751|NCT01922934|113085|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
46752|NCT01922934|113084|P2|NOT COMPLETED|Eligible Patients||88
46753|NCT01922934|113085|P1|NOT COMPLETED|Eligible Patients||53
46754|NCT01922934|113084|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
46755|NCT01922934|113085|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
46756|NCT01922934|113084|P2|STARTED|Eligible Patients||4302
46757|NCT01922934|113085|P1|STARTED|Eligible Patients||428
46758|NCT01922739|113097|P1|NOT COMPLETED|Open-label Treatment Period||34
46759|NCT01922739|113097|P1|COMPLETED|Open-label Treatment Period||136
46760|NCT01922739|113097|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
46761|NCT01922739|113097|P1|STARTED|Open-label Treatment Period||170
46762|NCT01922739|113097|P1|NOT COMPLETED|Titration/Adjustment Period||12
46763|NCT01922739|113097|P1|COMPLETED|Titration/Adjustment Period||170
46764|NCT01922739|113097|P1|Safety Analysis Set|Titration/Adjustment Period||182
46765|NCT01922739|113097|P1|STARTED|Titration/Adjustment Period||182
46766|NCT01922349|113126|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
46767|NCT01922349|113127|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
46768|NCT01922349|113128|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
46769|NCT01922349|113129|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
46770|NCT01922349|113126|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
46771|NCT01922349|113127|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
46772|NCT01922349|113128|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
46773|NCT01922349|113129|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
46774|NCT01922349|113126|P4|STARTED|Multiple Rising Dose (MRD) Period||27
46775|NCT01922349|113127|P3|STARTED|Multiple Rising Dose (MRD) Period||18
46776|NCT01922349|113128|P2|STARTED|Multiple Rising Dose (MRD) Period||27
46777|NCT01922349|113129|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
46778|NCT01922349|113126|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
46779|NCT01922349|113127|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
46780|NCT01922349|113128|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
46781|NCT01922349|113129|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
46782|NCT01922349|113126|P4|COMPLETED|Single Rising Dose (SRD) Period||27
46783|NCT01922349|113127|P3|COMPLETED|Single Rising Dose (SRD) Period||18
46784|NCT01922349|113128|P2|COMPLETED|Single Rising Dose (SRD) Period||27
46785|NCT01922349|113129|P1|COMPLETED|Single Rising Dose (SRD) Period||25
46786|NCT01922349|113126|P4|STARTED|Single Rising Dose (SRD) Period||27
46787|NCT01922349|113127|P3|STARTED|Single Rising Dose (SRD) Period||18
46788|NCT01922349|113128|P2|STARTED|Single Rising Dose (SRD) Period||27
46789|NCT01922349|113129|P1|STARTED|Single Rising Dose (SRD) Period||25
46790|NCT01922271|113236|P2|NOT COMPLETED|PERIOD 2||0
46791|NCT01922271|113237|P1|NOT COMPLETED|PERIOD 2||0
46792|NCT01922271|113236|P2|COMPLETED|PERIOD 2||76
46793|NCT01922271|113237|P1|COMPLETED|PERIOD 2||75
46794|NCT01922271|113236|P2|STARTED|PERIOD 2||76
46795|NCT01922271|113237|P1|STARTED|PERIOD 2||75
46796|NCT01922271|113236|P2|NOT COMPLETED|WASHOUT Period||0
46797|NCT01922271|113237|P1|NOT COMPLETED|WASHOUT Period||1
46798|NCT01922271|113236|P2|COMPLETED|WASHOUT Period||76
46799|NCT01922271|113237|P1|COMPLETED|WASHOUT Period||75
46800|NCT01922271|113236|P2|STARTED|WASHOUT Period||76
46801|NCT01922271|113237|P1|STARTED|WASHOUT Period||76
46802|NCT01922271|113236|P2|NOT COMPLETED|PERIOD 1||0
46803|NCT01922271|113237|P1|NOT COMPLETED|PERIOD 1||0
46804|NCT01922271|113236|P2|COMPLETED|PERIOD 1||76
46805|NCT01922271|113237|P1|COMPLETED|PERIOD 1||76
46806|NCT01922271|113236|P2|STARTED|PERIOD 1||76
46807|NCT01922271|113237|P1|STARTED|PERIOD 1||76
46808|NCT01922219|113255|P1|NOT COMPLETED|Overall Study||9
46809|NCT01922219|113255|P1|COMPLETED|Overall Study||28
46810|NCT01922219|113255|P1|STARTED|Overall Study||37
46811|NCT01922115|113263|P2|NOT COMPLETED|Overall Study||7
46812|NCT01922115|113264|P1|NOT COMPLETED|Overall Study||7
46813|NCT01922115|113263|P2|COMPLETED|Overall Study||24
46814|NCT01922115|113264|P1|COMPLETED|Overall Study||21
46815|NCT01922115|113263|P2|STARTED|Overall Study||31
46816|NCT01922115|113264|P1|STARTED|Overall Study||28
46817|NCT01922089|113278|P2|NOT COMPLETED|Overall Study||30
46818|NCT01922089|113279|P1|NOT COMPLETED|Overall Study||39
46819|NCT01922089|113278|P2|COMPLETED|Overall Study||221
46820|NCT01922089|113279|P1|COMPLETED|Overall Study||208
46821|NCT01922089|113278|P2|Safety Set|Overall Study||251
46822|NCT01922089|113279|P1|Safety Set|Overall Study||246
46823|NCT01922089|113278|P2|STARTED|Overall Study||251
46824|NCT01922089|113279|P1|STARTED|Overall Study||247
46825|NCT01922037|113291|P2|NOT COMPLETED|Overall Study||174
46826|NCT01922037|113292|P1|NOT COMPLETED|Overall Study||10
46827|NCT01922037|113291|P2|COMPLETED|Overall Study||563
46828|NCT01922037|113292|P1|COMPLETED|Overall Study||59
46829|NCT01922037|113291|P2|Treated|Overall Study||732
46830|NCT01922037|113292|P1|Treated|Overall Study||69
46831|NCT01922037|113291|P2|STARTED|Overall Study||737
46832|NCT01922037|113292|P1|STARTED|Overall Study||69
46833|NCT01922011|113386|P2|NOT COMPLETED|Overall Study||5
46834|NCT01922011|113387|P1|NOT COMPLETED|Overall Study||6
46835|NCT01922011|113386|P2|COMPLETED|Overall Study||69
46836|NCT01922011|113387|P1|COMPLETED|Overall Study||69
46837|NCT01922011|113386|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
46838|NCT01922011|113387|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
46839|NCT01922011|113386|P2|Treated|Overall Study|Treated Participants|73
46840|NCT01922011|113387|P1|Treated|Overall Study|Treated Participants|73
46841|NCT01922011|113386|P2|STARTED|Overall Study|Randomized participants|74
46842|NCT01922011|113387|P1|STARTED|Overall Study|Randomized participants|75
46843|NCT01921894|113430|P3|NOT COMPLETED|Overall Study||0
46844|NCT01921894|113431|P2|NOT COMPLETED|Overall Study||0
46845|NCT01921894|113432|P1|NOT COMPLETED|Overall Study||0
46846|NCT01921894|113430|P3|COMPLETED|Overall Study||8
46847|NCT01921894|113431|P2|COMPLETED|Overall Study||8
46848|NCT01921894|113432|P1|COMPLETED|Overall Study||8
46849|NCT01921894|113430|P3|STARTED|Overall Study||8
46850|NCT01921894|113431|P2|STARTED|Overall Study||8
46851|NCT01921894|113432|P1|STARTED|Overall Study||8
46852|NCT01921829|113454|P2|NOT COMPLETED|Overall Study||1
46853|NCT01921829|113455|P1|NOT COMPLETED|Overall Study||0
46854|NCT01921829|113454|P2|COMPLETED|Overall Study||8
46855|NCT01921829|113455|P1|COMPLETED|Overall Study||10
46856|NCT01921829|113454|P2|STARTED|Overall Study||9
46857|NCT01921829|113455|P1|STARTED|Overall Study||10
46858|NCT01921751|113504|P3|NOT COMPLETED|Overall Study||0
46859|NCT01921751|113505|P2|NOT COMPLETED|Overall Study||0
46860|NCT01921751|113506|P1|NOT COMPLETED|Overall Study||0
46861|NCT01921751|113504|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
46862|NCT01921751|113505|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
46863|NCT01921751|113506|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
46864|NCT01921751|113504|P3|STARTED|Overall Study||5
46865|NCT01921751|113505|P2|STARTED|Overall Study||4
46866|NCT01921751|113506|P1|STARTED|Overall Study||4
46867|NCT01921452|113524|P1|NOT COMPLETED|Overall Study||0
46868|NCT01921452|113524|P1|COMPLETED|Overall Study||283
46869|NCT01921452|113524|P1|STARTED|Overall Study||283
46870|NCT01921348|113531|P2|NOT COMPLETED|Overall Study||2
46871|NCT01921348|113532|P1|NOT COMPLETED|Overall Study||1
46872|NCT01921348|113531|P2|COMPLETED|Overall Study||7
46873|NCT01921348|113532|P1|COMPLETED|Overall Study||8
46874|NCT01921348|113531|P2|STARTED|Overall Study||9
46875|NCT01921348|113532|P1|STARTED|Overall Study||9
46876|NCT01921322|113544|P2|NOT COMPLETED|Overall Study||17
46877|NCT01921322|113545|P1|NOT COMPLETED|Overall Study||15
46878|NCT01921322|113544|P2|COMPLETED|Overall Study||44
46879|NCT01921322|113545|P1|COMPLETED|Overall Study||42
46880|NCT01921322|113544|P2|STARTED|Overall Study||61
46881|NCT01921322|113545|P1|STARTED|Overall Study||57
46882|NCT01921296|113553|P1|NOT COMPLETED|Overall Study||0
46883|NCT01921296|113553|P1|COMPLETED|Overall Study||2
46884|NCT01921296|113553|P1|STARTED|Overall Study||2
46885|NCT01921270|113561|P1|NOT COMPLETED|Overall Study||1
46886|NCT01921270|113561|P1|COMPLETED|Overall Study||17
46887|NCT01921270|113561|P1|STARTED|Overall Study||18
46888|NCT01921257|113577|P1|NOT COMPLETED|Overall Study||3
46889|NCT01921257|113577|P1|COMPLETED|Overall Study||13
46890|NCT01921257|113577|P1|Active Treatment|Overall Study||13
46891|NCT01921257|113577|P1|Placebo run-in|Overall Study||16
46892|NCT01921257|113577|P1|STARTED|Overall Study||16
46893|NCT01921205|113584|P2|NOT COMPLETED|Overall Study||20
46894|NCT01921205|113585|P1|NOT COMPLETED|Overall Study||21
46895|NCT01921205|113584|P2|COMPLETED|Overall Study||151
46896|NCT01921205|113585|P1|COMPLETED|Overall Study||151
46897|NCT01921205|113584|P2|STARTED|Overall Study||171
46898|NCT01921205|113585|P1|STARTED|Overall Study||172
46899|NCT01921166|113615|P2|NOT COMPLETED|Overall Study||0
46900|NCT01921166|113616|P1|NOT COMPLETED|Overall Study||0
46901|NCT01921166|113615|P2|COMPLETED|Overall Study||15
46902|NCT01921166|113616|P1|COMPLETED|Overall Study||8
46903|NCT01921166|113615|P2|STARTED|Overall Study||15
46904|NCT01921166|113616|P1|STARTED|Overall Study||8
46905|NCT01921101|113626|P2|NOT COMPLETED|Overall Study||6
46906|NCT01921101|113627|P1|NOT COMPLETED|Overall Study||16
46907|NCT01921101|113626|P2|COMPLETED|Overall Study||32
46908|NCT01921101|113627|P1|COMPLETED|Overall Study||24
46909|NCT01921101|113626|P2|STARTED|Overall Study||38
46910|NCT01921101|113627|P1|STARTED|Overall Study||40
46911|NCT01920958|113635|P1|NOT COMPLETED|Overall Study||5
46912|NCT01920958|113635|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
46913|NCT01920958|113635|P1|STARTED|Overall Study||233
46914|NCT01920893|113653|P2|NOT COMPLETED|Overall Study||2
46915|NCT01920893|113654|P1|NOT COMPLETED|Overall Study||7
46916|NCT01920893|113653|P2|COMPLETED|Overall Study||28
46917|NCT01920893|113654|P1|COMPLETED|Overall Study||23
46918|NCT01920893|113653|P2|Treated (Safety Population)|Overall Study||30
46919|NCT01920893|113654|P1|Treated (Safety Population)|Overall Study||30
46920|NCT01920893|113653|P2|STARTED|Overall Study||30
46921|NCT01920893|113654|P1|STARTED|Overall Study||30
46922|NCT01920854|113687|P7|NOT COMPLETED|Overall Study||1
46923|NCT01920854|113688|P6|NOT COMPLETED|Overall Study||0
46924|NCT01920854|113689|P5|NOT COMPLETED|Overall Study||1
46925|NCT01920854|113690|P4|NOT COMPLETED|Overall Study||0
46926|NCT01920854|113691|P3|NOT COMPLETED|Overall Study||0
46927|NCT01920854|113692|P2|NOT COMPLETED|Overall Study||0
46928|NCT01920854|113693|P1|NOT COMPLETED|Overall Study||1
46929|NCT01920854|113687|P7|COMPLETED|Overall Study||5
46930|NCT01920854|113688|P6|COMPLETED|Overall Study||6
46931|NCT01920854|113689|P5|COMPLETED|Overall Study||5
46932|NCT01920854|113690|P4|COMPLETED|Overall Study||6
46933|NCT01920854|113691|P3|COMPLETED|Overall Study||6
46934|NCT01920854|113692|P2|COMPLETED|Overall Study||6
46935|NCT01920854|113693|P1|COMPLETED|Overall Study||11
46936|NCT01920854|113687|P7|STARTED|Overall Study||6
46937|NCT01920854|113688|P6|STARTED|Overall Study||6
46938|NCT01920854|113689|P5|STARTED|Overall Study||6
46939|NCT01920854|113690|P4|STARTED|Overall Study||6
46940|NCT01920854|113691|P3|STARTED|Overall Study||6
46941|NCT01920854|113692|P2|STARTED|Overall Study||6
46942|NCT01920854|113693|P1|STARTED|Overall Study||12
46943|NCT01920802|113820|P3|NOT COMPLETED|Overall Study||1
46944|NCT01920802|113821|P2|NOT COMPLETED|Overall Study||2
46945|NCT01920802|113822|P1|NOT COMPLETED|Overall Study||4
46946|NCT01920802|113820|P3|COMPLETED|Overall Study||10
46947|NCT01920802|113821|P2|COMPLETED|Overall Study||7
46948|NCT01920802|113822|P1|COMPLETED|Overall Study||7
46949|NCT01920802|113820|P3|STARTED|Overall Study||11
46950|NCT01920802|113821|P2|STARTED|Overall Study||9
46951|NCT01920802|113822|P1|STARTED|Overall Study||11
46952|NCT01920594|113853|P2|NOT COMPLETED|Overall Study||3
46953|NCT01920594|113854|P1|NOT COMPLETED|Overall Study||7
46954|NCT01920594|113853|P2|COMPLETED|Overall Study||25
46955|NCT01920594|113854|P1|COMPLETED|Overall Study||20
46956|NCT01920594|113853|P2|STARTED|Overall Study||28
46957|NCT01920594|113854|P1|STARTED|Overall Study||27
46958|NCT01920568|113904|P2|NOT COMPLETED|Overall Study||84
46959|NCT01920568|113905|P1|NOT COMPLETED|Overall Study||151
46960|NCT01920568|113904|P2|COMPLETED|Overall Study||75
46961|NCT01920568|113905|P1|COMPLETED|Overall Study||175
46962|NCT01920568|113904|P2|STARTED|Overall Study||159
46963|NCT01920568|113905|P1|STARTED|Overall Study||326
46964|NCT01920555|113931|P5|NOT COMPLETED|Overall Study||1
46965|NCT01920555|113932|P4|NOT COMPLETED|Overall Study||3
46966|NCT01920555|113933|P3|NOT COMPLETED|Overall Study||1
46967|NCT01920555|113934|P2|NOT COMPLETED|Overall Study||4
46968|NCT01920555|113935|P1|NOT COMPLETED|Overall Study||4
46969|NCT01920555|113931|P5|COMPLETED|Overall Study||18
46970|NCT01920555|113932|P4|COMPLETED|Overall Study||17
46971|NCT01920555|113933|P3|COMPLETED|Overall Study||21
46972|NCT01920555|113934|P2|COMPLETED|Overall Study||16
46973|NCT01920555|113935|P1|COMPLETED|Overall Study||14
46974|NCT01920555|113931|P5|STARTED|Overall Study||19
46975|NCT01920555|113932|P4|STARTED|Overall Study||20
46976|NCT01920555|113933|P3|STARTED|Overall Study||22
46977|NCT01920555|113934|P2|STARTED|Overall Study||20
46978|NCT01920555|113935|P1|STARTED|Overall Study||18
46979|NCT01920282|113995|P3|NOT COMPLETED|Overall Study||0
46980|NCT01920282|113996|P2|NOT COMPLETED|Overall Study||0
46981|NCT01920282|113997|P1|NOT COMPLETED|Overall Study||0
46982|NCT01920282|113995|P3|COMPLETED|Overall Study||15
46983|NCT01920282|113996|P2|COMPLETED|Overall Study||15
46984|NCT01920282|113997|P1|COMPLETED|Overall Study||15
46985|NCT01920282|113995|P3|STARTED|Overall Study||15
46986|NCT01920282|113996|P2|STARTED|Overall Study||15
46987|NCT01920282|113997|P1|STARTED|Overall Study||15
46988|NCT01920178|114010|P2|NOT COMPLETED|Overall Study||1
46989|NCT01920178|114011|P1|NOT COMPLETED|Overall Study||2
46990|NCT01920178|114010|P2|COMPLETED|Overall Study||1
46991|NCT01920178|114011|P1|COMPLETED|Overall Study||3
46992|NCT01920178|114010|P2|STARTED|Overall Study||2
46993|NCT01920178|114011|P1|STARTED|Overall Study||5
46994|NCT01919996|114021|P1|NOT COMPLETED|Overall Study||0
46995|NCT01919996|114021|P1|COMPLETED|Overall Study||8
46996|NCT01919996|114021|P1|STARTED|Overall Study||8
46997|NCT01919801|114029|P2|NOT COMPLETED|Overall Study||3
46998|NCT01919801|114030|P1|NOT COMPLETED|Overall Study||1
46999|NCT01919801|114029|P2|COMPLETED|Overall Study||57
47000|NCT01919801|114030|P1|COMPLETED|Overall Study||60
47001|NCT01919801|114029|P2|STARTED|Overall Study||60
47002|NCT01919801|114030|P1|STARTED|Overall Study||61
47003|NCT01919723|114055|P2|NOT COMPLETED|Overall Study||2
47004|NCT01919723|114056|P1|NOT COMPLETED|Overall Study||2
47005|NCT01919723|114055|P2|COMPLETED|Overall Study||33
47006|NCT01919723|114056|P1|COMPLETED|Overall Study||33
47007|NCT01919723|114055|P2|STARTED|Overall Study||35
47008|NCT01919723|114056|P1|STARTED|Overall Study||35
47009|NCT01919606|114070|P2|NOT COMPLETED|Overall Study||0
47010|NCT01919606|114071|P1|NOT COMPLETED|Overall Study||0
47011|NCT01919606|114070|P2|COMPLETED|Overall Study||0
47012|NCT01919606|114071|P1|COMPLETED|Overall Study||1
47013|NCT01919606|114070|P2|STARTED|Overall Study||0
47014|NCT01919606|114071|P1|STARTED|Overall Study||1
47015|NCT01919450|114083|P4|NOT COMPLETED|Overall Study||1
47016|NCT01919450|114084|P3|NOT COMPLETED|Overall Study||0
47017|NCT01919450|114085|P2|NOT COMPLETED|Overall Study||0
47018|NCT01919450|114086|P1|NOT COMPLETED|Overall Study||0
47019|NCT01919450|114083|P4|COMPLETED|Overall Study||19
47020|NCT01919450|114084|P3|COMPLETED|Overall Study||20
47021|NCT01919450|114085|P2|COMPLETED|Overall Study||20
47022|NCT01919450|114086|P1|COMPLETED|Overall Study||20
47023|NCT01919450|114083|P4|STARTED|Overall Study||20
47024|NCT01919450|114084|P3|STARTED|Overall Study||20
47025|NCT01919450|114085|P2|STARTED|Overall Study||20
47026|NCT01919450|114086|P1|STARTED|Overall Study||20
47027|NCT01919307|114096|P1|NOT COMPLETED|Overall Study||9
47028|NCT01919307|114096|P1|COMPLETED|Overall Study||20
47029|NCT01919307|114096|P1|STARTED|Overall Study||29
47030|NCT01919229|114106|P3|NOT COMPLETED|Overall Study||1
47031|NCT01919229|114107|P2|NOT COMPLETED|Overall Study||0
47032|NCT01919229|114108|P1|NOT COMPLETED|Overall Study||0
47033|NCT01919229|114106|P3|COMPLETED|Overall Study||3
47034|NCT01919229|114107|P2|COMPLETED|Overall Study||6
47035|NCT01919229|114108|P1|COMPLETED|Overall Study||4
47036|NCT01919229|114106|P3|STARTED|Overall Study||4
47037|NCT01919229|114107|P2|STARTED|Overall Study||6
47038|NCT01919229|114108|P1|STARTED|Overall Study||4
47039|NCT01919216|114140|P3|NOT COMPLETED|Overall Study||1
47040|NCT01919216|114141|P2|NOT COMPLETED|Overall Study||1
47041|NCT01919216|114142|P1|NOT COMPLETED|Overall Study||2
47042|NCT01919216|114140|P3|COMPLETED|Overall Study||4
47043|NCT01919216|114141|P2|COMPLETED|Overall Study||20
47044|NCT01919216|114142|P1|COMPLETED|Overall Study||26
47045|NCT01919216|114140|P3|STARTED|Overall Study||5
47046|NCT01919216|114141|P2|STARTED|Overall Study||21
47047|NCT01919216|114142|P1|STARTED|Overall Study||28
47048|NCT01918800|114152|P2|NOT COMPLETED|Overall Study||5
47049|NCT01918800|114153|P1|NOT COMPLETED|Overall Study||9
47050|NCT01918800|114152|P2|COMPLETED|Overall Study||104
47051|NCT01918800|114153|P1|COMPLETED|Overall Study||100
47052|NCT01918800|114152|P2|STARTED|Overall Study||109
47053|NCT01918800|114153|P1|STARTED|Overall Study||109
47054|NCT01918371|114173|P2|NOT COMPLETED|Overall Study||1
47055|NCT01918371|114174|P1|NOT COMPLETED|Overall Study||1
47056|NCT01918371|114173|P2|COMPLETED|Overall Study||156
47057|NCT01918371|114174|P1|COMPLETED|Overall Study||165
47058|NCT01918371|114173|P2|Participants With Complete Data|Overall Study||156
47059|NCT01918371|114174|P1|Participants With Complete Data|Overall Study||165
47060|NCT01918371|114173|P2|STARTED|Overall Study||157
47061|NCT01918371|114174|P1|STARTED|Overall Study||166
47062|NCT01918332|114252|P4|NOT COMPLETED|Overall Study||7
47063|NCT01918332|114253|P3|NOT COMPLETED|Overall Study||9
47064|NCT01918332|114254|P2|NOT COMPLETED|Overall Study||5
47065|NCT01918332|114255|P1|NOT COMPLETED|Overall Study||8
47066|NCT01918332|114252|P4|COMPLETED|Overall Study||38
47067|NCT01918332|114253|P3|COMPLETED|Overall Study||30
47068|NCT01918332|114254|P2|COMPLETED|Overall Study||36
47069|NCT01918332|114255|P1|COMPLETED|Overall Study||35
47070|NCT01918332|114252|P4|STARTED|Overall Study||45
47071|NCT01918332|114253|P3|STARTED|Overall Study||39
47072|NCT01918332|114254|P2|STARTED|Overall Study||41
47073|NCT01918332|114255|P1|STARTED|Overall Study||43
47074|NCT01918306|114267|P4|NOT COMPLETED|Overall Study||3
47075|NCT01918306|114268|P3|NOT COMPLETED|Overall Study||2
47076|NCT01918306|114269|P2|NOT COMPLETED|Overall Study||0
47077|NCT01918306|114270|P1|NOT COMPLETED|Overall Study||6
47078|NCT01918306|114267|P4|COMPLETED|Overall Study||0
47079|NCT01918306|114268|P3|COMPLETED|Overall Study||0
47080|NCT01918306|114269|P2|COMPLETED|Overall Study||0
47081|NCT01918306|114270|P1|COMPLETED|Overall Study||0
47082|NCT01918306|114267|P4|STARTED|Overall Study||3
47083|NCT01918306|114268|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
47084|NCT01918306|114269|P2|STARTED|Overall Study|No patients enrolled|0
47085|NCT01918306|114270|P1|STARTED|Overall Study||6
47086|NCT01918085|114292|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
47087|NCT01918085|114293|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
47088|NCT01918085|114292|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
47089|NCT01918085|114293|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
47090|NCT01918085|114292|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
47091|NCT01918085|114293|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
47092|NCT01918085|114292|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
47093|NCT01918085|114293|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
47094|NCT01918085|114292|P2|COMPLETED|Test Period 2: Strata Strip||11
47095|NCT01918085|114293|P1|COMPLETED|Test Period 2: Strata Strip||10
47096|NCT01918085|114292|P2|STARTED|Test Period 2: Strata Strip||11
47097|NCT01918085|114293|P1|STARTED|Test Period 2: Strata Strip||10
47098|NCT01918085|114292|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
47099|NCT01918085|114293|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
47100|NCT01918085|114292|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
47101|NCT01918085|114293|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
47102|NCT01918085|114292|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
47103|NCT01918085|114293|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
47104|NCT01918085|114292|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
47105|NCT01918085|114293|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
47106|NCT01918085|114292|P2|COMPLETED|Test Period 1: Strata Strip||11
47107|NCT01918085|114293|P1|COMPLETED|Test Period 1: Strata Strip||10
47108|NCT01918085|114292|P2|STARTED|Test Period 1: Strata Strip||12
47109|NCT01918085|114293|P1|STARTED|Test Period 1: Strata Strip||10
47110|NCT01918033|114304|P3|NOT COMPLETED|Overall Study||3
47111|NCT01918033|114305|P2|NOT COMPLETED|Overall Study||2
47112|NCT01918033|114306|P1|NOT COMPLETED|Overall Study||5
47113|NCT01918033|114304|P3|COMPLETED|Overall Study||199
47114|NCT01918033|114305|P2|COMPLETED|Overall Study||201
47115|NCT01918033|114306|P1|COMPLETED|Overall Study||198
47116|NCT01918033|114304|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
47117|NCT01918033|114305|P2|Treated|Overall Study||203
47118|NCT01918033|114306|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
47119|NCT01918033|114304|P3|STARTED|Overall Study||202
47120|NCT01918033|114305|P2|STARTED|Overall Study||203
47121|NCT01918033|114306|P1|STARTED|Overall Study||203
47122|NCT01917812|114347|P3|NOT COMPLETED|Overall Study||0
47123|NCT01917812|114348|P2|NOT COMPLETED|Overall Study||0
47124|NCT01917812|114349|P1|NOT COMPLETED|Overall Study||1
47125|NCT01917812|114347|P3|COMPLETED|Overall Study||16
47126|NCT01917812|114348|P2|COMPLETED|Overall Study||16
47127|NCT01917812|114349|P1|COMPLETED|Overall Study||15
47128|NCT01917812|114347|P3|STARTED|Overall Study||16
47129|NCT01917812|114348|P2|STARTED|Overall Study||16
47130|NCT01917812|114349|P1|STARTED|Overall Study||16
47131|NCT01917773|114369|P1|NOT COMPLETED|Overall Study||0
47132|NCT01917773|114369|P1|COMPLETED|Overall Study||13
47133|NCT01917773|114369|P1|STARTED|Overall Study||13
47134|NCT01917656|114377|P2|NOT COMPLETED|Overall Study||24
47135|NCT01917656|114378|P1|NOT COMPLETED|Overall Study||26
47136|NCT01917656|114377|P2|COMPLETED|Overall Study||147
47137|NCT01917656|114378|P1|COMPLETED|Overall Study||146
47138|NCT01917656|114377|P2|Exposed During Ramadan (Fasting)|Overall Study||163
47139|NCT01917656|114378|P1|Exposed During Ramadan (Fasting)|Overall Study||152
47140|NCT01917656|114377|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
47141|NCT01917656|114378|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
47142|NCT01917656|114377|P2|STARTED|Overall Study||171
47143|NCT01917656|114378|P1|STARTED|Overall Study||172
47144|NCT01917526|114404|P2|NOT COMPLETED|Overall Study||1
47145|NCT01917526|114405|P1|NOT COMPLETED|Overall Study||1
47146|NCT01917526|114404|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
47147|NCT01917526|114405|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
47148|NCT01917526|114404|P2|STARTED|Overall Study||250
47149|NCT01917526|114405|P1|STARTED|Overall Study||250
47150|NCT01917513|114415|P2|NOT COMPLETED|Overall Study||102
47151|NCT01917513|114416|P1|NOT COMPLETED|Overall Study||95
47152|NCT01917513|114415|P2|COMPLETED|Overall Study||396
47153|NCT01917513|114416|P1|COMPLETED|Overall Study||407
47154|NCT01917513|114415|P2|STARTED|Overall Study||498
47155|NCT01917513|114416|P1|STARTED|Overall Study||502
47156|NCT01917344|114422|P1|NOT COMPLETED|Overall Study||1
47157|NCT01917344|114422|P1|COMPLETED|Overall Study||9
47158|NCT01917344|114422|P1|STARTED|Overall Study||10
47159|NCT01917214|114426|P1|NOT COMPLETED|Overall Study||0
47160|NCT01917214|114426|P1|COMPLETED|Overall Study||212
47161|NCT01917214|114426|P1|STARTED|Overall Study||212
47162|NCT01916980|114437|P2|NOT COMPLETED|Overall Study||4
47163|NCT01916980|114438|P1|NOT COMPLETED|Overall Study||7
47164|NCT01916980|114437|P2|COMPLETED|Overall Study||25
47165|NCT01916980|114438|P1|COMPLETED|Overall Study||58
47166|NCT01916980|114437|P2|STARTED|Overall Study||29
47167|NCT01916980|114438|P1|STARTED|Overall Study||65
47168|NCT01916967|114457|P3|NOT COMPLETED|Overall Study||9
47169|NCT01916967|114458|P2|NOT COMPLETED|Overall Study||1
47170|NCT01916967|114459|P1|NOT COMPLETED|Overall Study||0
47171|NCT01916967|114457|P3|COMPLETED|Overall Study||71
47172|NCT01916967|114458|P2|COMPLETED|Overall Study||78
47173|NCT01916967|114459|P1|COMPLETED|Overall Study||80
47174|NCT01916967|114457|P3|STARTED|Overall Study||80
47175|NCT01916967|114458|P2|STARTED|Overall Study||79
47176|NCT01916967|114459|P1|STARTED|Overall Study||80
47177|NCT01916941|114502|P2|NOT COMPLETED|Overall Study||4
47178|NCT01916941|114503|P1|NOT COMPLETED|Overall Study||5
47179|NCT01916941|114502|P2|COMPLETED|Overall Study||14
47180|NCT01916941|114503|P1|COMPLETED|Overall Study||13
47181|NCT01916941|114502|P2|STARTED|Overall Study||18
47182|NCT01916941|114503|P1|STARTED|Overall Study||18
47183|NCT01916928|114509|P1|NOT COMPLETED|Overall Study||0
47184|NCT01916928|114509|P1|COMPLETED|Overall Study||50
47185|NCT01916928|114509|P1|STARTED|Overall Study||50
47186|NCT01916824|114515|P2|NOT COMPLETED|Overall Study||9
47187|NCT01916824|114516|P1|NOT COMPLETED|Overall Study||7
47188|NCT01916824|114515|P2|COMPLETED|Overall Study||20
47189|NCT01916824|114516|P1|COMPLETED|Overall Study||17
47190|NCT01916824|114515|P2|STARTED|Overall Study||29
47191|NCT01916824|114516|P1|STARTED|Overall Study||24
47192|NCT01916681|114526|P4|NOT COMPLETED|Overall Study||0
47193|NCT01916681|114527|P3|NOT COMPLETED|Overall Study||0
47194|NCT01916681|114528|P2|NOT COMPLETED|Overall Study||0
47195|NCT01916681|114529|P1|NOT COMPLETED|Overall Study||0
47196|NCT01916681|114526|P4|COMPLETED|Overall Study||125
47197|NCT01916681|114527|P3|COMPLETED|Overall Study||123
47198|NCT01916681|114528|P2|COMPLETED|Overall Study||120
47199|NCT01916681|114529|P1|COMPLETED|Overall Study||123
47200|NCT01916681|114526|P4|STARTED|Overall Study||125
47201|NCT01916681|114527|P3|STARTED|Overall Study||123
47202|NCT01916681|114528|P2|STARTED|Overall Study||120
47203|NCT01916681|114529|P1|STARTED|Overall Study||123
47204|NCT01916629|114569|P2|NOT COMPLETED|Overall Study||0
47205|NCT01916629|114570|P1|NOT COMPLETED|Overall Study||0
47206|NCT01916629|114569|P2|COMPLETED|Overall Study||5
47207|NCT01916629|114570|P1|COMPLETED|Overall Study||7
47208|NCT01916629|114569|P2|STARTED|Overall Study||5
47209|NCT01916629|114570|P1|STARTED|Overall Study||7
47210|NCT01916590|114578|P2|NOT COMPLETED|Overall Study||0
47211|NCT01916590|114579|P1|NOT COMPLETED|Overall Study||0
47212|NCT01916590|114578|P2|COMPLETED|Overall Study||3
47213|NCT01916590|114579|P1|COMPLETED|Overall Study||4
47214|NCT01916590|114578|P2|STARTED|Overall Study||3
47215|NCT01916590|114579|P1|STARTED|Overall Study||4
47216|NCT01916304|114585|P1|NOT COMPLETED|Overall Study||17
47217|NCT01916304|114585|P1|COMPLETED|Overall Study||84
47218|NCT01916304|114585|P1|Intent-to-Treat Set|Overall Study||84
47219|NCT01916304|114585|P1|Safety Set|Overall Study||101
47220|NCT01916304|114585|P1|STARTED|Overall Study||101
47221|NCT01916226|114597|P4|NOT COMPLETED|Overall Study||4
47222|NCT01916226|114598|P3|NOT COMPLETED|Overall Study||3
47223|NCT01916226|114599|P2|NOT COMPLETED|Overall Study||1
47224|NCT01916226|114600|P1|NOT COMPLETED|Overall Study||1
47225|NCT01916226|114597|P4|COMPLETED|Overall Study||167
47226|NCT01916226|114598|P3|COMPLETED|Overall Study||168
47227|NCT01916226|114599|P2|COMPLETED|Overall Study||169
47228|NCT01916226|114600|P1|COMPLETED|Overall Study||169
47229|NCT01916226|114597|P4|STARTED|Overall Study||171
47230|NCT01916226|114598|P3|STARTED|Overall Study||171
47231|NCT01916226|114599|P2|STARTED|Overall Study||170
47232|NCT01916226|114600|P1|STARTED|Overall Study||170
47233|NCT01916109|114634|P1|NOT COMPLETED|Overall Study||1
47234|NCT01916109|114634|P1|COMPLETED|Overall Study||3
47235|NCT01916109|114634|P1|STARTED|Overall Study||4
47236|NCT01915940|114640|P3|NOT COMPLETED|Treatment Period||4
47237|NCT01915940|114641|P2|NOT COMPLETED|Treatment Period||11
47238|NCT01915940|114642|P1|NOT COMPLETED|Treatment Period||0
47239|NCT01915940|114640|P3|COMPLETED|Treatment Period||62
47240|NCT01915940|114641|P2|COMPLETED|Treatment Period||53
47241|NCT01915940|114642|P1|COMPLETED|Treatment Period||0
47242|NCT01915940|114640|P3|STARTED|Treatment Period||66
47243|NCT01915940|114641|P2|STARTED|Treatment Period||64
47244|NCT01915940|114642|P1|STARTED|Treatment Period||0
47245|NCT01915940|114640|P3|NOT COMPLETED|Pre-randomization Washout Period||0
47246|NCT01915940|114641|P2|NOT COMPLETED|Pre-randomization Washout Period||0
47247|NCT01915940|114642|P1|NOT COMPLETED|Pre-randomization Washout Period||39
47248|NCT01915940|114640|P3|COMPLETED|Pre-randomization Washout Period||0
47249|NCT01915940|114641|P2|COMPLETED|Pre-randomization Washout Period||0
47250|NCT01915940|114642|P1|COMPLETED|Pre-randomization Washout Period||130
47251|NCT01915940|114640|P3|STARTED|Pre-randomization Washout Period||0
47252|NCT01915940|114641|P2|STARTED|Pre-randomization Washout Period||0
47253|NCT01915940|114642|P1|STARTED|Pre-randomization Washout Period||169
47254|NCT01915914|114658|P4|NOT COMPLETED|Follow-up Phase||2
47255|NCT01915914|114659|P3|NOT COMPLETED|Follow-up Phase||0
47256|NCT01915914|114660|P2|NOT COMPLETED|Follow-up Phase||0
47257|NCT01915914|114661|P1|NOT COMPLETED|Follow-up Phase||0
47258|NCT01915914|114658|P4|COMPLETED|Follow-up Phase||64
47259|NCT01915914|114659|P3|COMPLETED|Follow-up Phase||0
47260|NCT01915914|114660|P2|COMPLETED|Follow-up Phase||0
47261|NCT01915914|114661|P1|COMPLETED|Follow-up Phase||0
47262|NCT01915914|114658|P4|STARTED|Follow-up Phase||66
47263|NCT01915914|114659|P3|STARTED|Follow-up Phase||0
47264|NCT01915914|114660|P2|STARTED|Follow-up Phase||0
47265|NCT01915914|114661|P1|STARTED|Follow-up Phase||0
47266|NCT01915914|114658|P4|NOT COMPLETED|Maintenance Phase||0
47267|NCT01915914|114659|P3|NOT COMPLETED|Maintenance Phase||2
47268|NCT01915914|114660|P2|NOT COMPLETED|Maintenance Phase||6
47269|NCT01915914|114661|P1|NOT COMPLETED|Maintenance Phase||0
47270|NCT01915914|114658|P4|COMPLETED|Maintenance Phase||0
47271|NCT01915914|114659|P3|COMPLETED|Maintenance Phase||51
47272|NCT01915914|114660|P2|COMPLETED|Maintenance Phase||48
47273|NCT01915914|114661|P1|COMPLETED|Maintenance Phase||0
47274|NCT01915914|114658|P4|STARTED|Maintenance Phase||0
47275|NCT01915914|114659|P3|STARTED|Maintenance Phase||53
47276|NCT01915914|114660|P2|STARTED|Maintenance Phase||54
47277|NCT01915914|114661|P1|STARTED|Maintenance Phase||0
47278|NCT01915914|114658|P4|NOT COMPLETED|Acute Phase||0
47279|NCT01915914|114659|P3|NOT COMPLETED|Acute Phase||0
47280|NCT01915914|114660|P2|NOT COMPLETED|Acute Phase||0
47281|NCT01915914|114661|P1|NOT COMPLETED|Acute Phase||12
47282|NCT01915914|114658|P4|COMPLETED|Acute Phase||0
47283|NCT01915914|114659|P3|COMPLETED|Acute Phase||0
47284|NCT01915914|114660|P2|COMPLETED|Acute Phase||0
47285|NCT01915914|114661|P1|COMPLETED|Acute Phase||111
47286|NCT01915914|114658|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
47287|NCT01915914|114659|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
47288|NCT01915914|114660|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
47289|NCT01915914|114661|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
47290|NCT01915914|114658|P4|STARTED|Acute Phase||0
47291|NCT01915914|114659|P3|STARTED|Acute Phase||0
47292|NCT01915914|114660|P2|STARTED|Acute Phase||0
47293|NCT01915914|114661|P1|STARTED|Acute Phase||123
47294|NCT01915849|114693|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
47295|NCT01915849|114694|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
47296|NCT01915849|114695|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
47297|NCT01915849|114696|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
47298|NCT01915849|114693|P4|COMPLETED|Treatment Period 4 (4 Days)||3
47299|NCT01915849|114694|P3|COMPLETED|Treatment Period 4 (4 Days)||3
47300|NCT01915849|114695|P2|COMPLETED|Treatment Period 4 (4 Days)||3
47301|NCT01915849|114696|P1|COMPLETED|Treatment Period 4 (4 Days)||3
47302|NCT01915849|114693|P4|STARTED|Treatment Period 4 (4 Days)||3
47303|NCT01915849|114694|P3|STARTED|Treatment Period 4 (4 Days)||3
47304|NCT01915849|114695|P2|STARTED|Treatment Period 4 (4 Days)||3
47305|NCT01915849|114696|P1|STARTED|Treatment Period 4 (4 Days)||3
47306|NCT01915849|114693|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
47307|NCT01915849|114694|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
47308|NCT01915849|114695|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
47309|NCT01915849|114696|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
47310|NCT01915849|114693|P4|COMPLETED|Treatment Period 3 (4 Days)||3
47311|NCT01915849|114694|P3|COMPLETED|Treatment Period 3 (4 Days)||3
47312|NCT01915849|114695|P2|COMPLETED|Treatment Period 3 (4 Days)||3
47313|NCT01915849|114696|P1|COMPLETED|Treatment Period 3 (4 Days)||3
47314|NCT01915849|114693|P4|STARTED|Treatment Period 3 (4 Days)||3
47315|NCT01915849|114694|P3|STARTED|Treatment Period 3 (4 Days)||3
47316|NCT01915849|114695|P2|STARTED|Treatment Period 3 (4 Days)||3
47317|NCT01915849|114696|P1|STARTED|Treatment Period 3 (4 Days)||3
47318|NCT01915849|114693|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
47319|NCT01915849|114694|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
47320|NCT01915849|114695|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
47321|NCT01915849|114696|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
47322|NCT01915849|114693|P4|COMPLETED|Treatment Period 2 (4 Days)||3
47323|NCT01915849|114694|P3|COMPLETED|Treatment Period 2 (4 Days)||3
47324|NCT01915849|114695|P2|COMPLETED|Treatment Period 2 (4 Days)||3
47325|NCT01915849|114696|P1|COMPLETED|Treatment Period 2 (4 Days)||3
47326|NCT01915849|114693|P4|STARTED|Treatment Period 2 (4 Days)||3
47327|NCT01915849|114694|P3|STARTED|Treatment Period 2 (4 Days)||3
47328|NCT01915849|114695|P2|STARTED|Treatment Period 2 (4 Days)||3
47329|NCT01915849|114696|P1|STARTED|Treatment Period 2 (4 Days)||3
47330|NCT01915849|114693|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
47331|NCT01915849|114694|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
47332|NCT01915849|114695|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
47333|NCT01915849|114696|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
47334|NCT01915849|114693|P4|COMPLETED|Treatment Period 1 (4 Days)||3
47335|NCT01915849|114694|P3|COMPLETED|Treatment Period 1 (4 Days)||3
47336|NCT01915849|114695|P2|COMPLETED|Treatment Period 1 (4 Days)||3
47337|NCT01915849|114696|P1|COMPLETED|Treatment Period 1 (4 Days)||3
47338|NCT01915849|114693|P4|STARTED|Treatment Period 1 (4 Days)||3
47339|NCT01915849|114694|P3|STARTED|Treatment Period 1 (4 Days)||3
47340|NCT01915849|114695|P2|STARTED|Treatment Period 1 (4 Days)||3
47341|NCT01915849|114696|P1|STARTED|Treatment Period 1 (4 Days)||5
47342|NCT01915823|114708|P2|NOT COMPLETED|Overall Study||2
47343|NCT01915823|114709|P1|NOT COMPLETED|Overall Study||2
47344|NCT01915823|114708|P2|COMPLETED|Overall Study||173
47345|NCT01915823|114709|P1|COMPLETED|Overall Study||171
47346|NCT01915823|114708|P2|STARTED|Overall Study||175
47347|NCT01915823|114709|P1|STARTED|Overall Study||173
47348|NCT01915732|114721|P2|NOT COMPLETED|Overall Study||71
47349|NCT01915732|114722|P1|NOT COMPLETED|Overall Study||70
47350|NCT01915732|114721|P2|COMPLETED|Overall Study||445
47351|NCT01915732|114722|P1|COMPLETED|Overall Study||430
47352|NCT01915732|114721|P2|STARTED|Overall Study||516
47353|NCT01915732|114722|P1|STARTED|Overall Study||500
47354|NCT01915173|114750|P4|NOT COMPLETED|Overall Study||0
47355|NCT01915173|114751|P3|NOT COMPLETED|Overall Study||0
47356|NCT01915173|114752|P2|NOT COMPLETED|Overall Study||0
47357|NCT01915173|114753|P1|NOT COMPLETED|Overall Study||0
47358|NCT01915173|114750|P4|COMPLETED|Overall Study||6
47359|NCT01915173|114751|P3|COMPLETED|Overall Study||6
47360|NCT01915173|114752|P2|COMPLETED|Overall Study||6
47361|NCT01915173|114753|P1|COMPLETED|Overall Study||6
47362|NCT01915173|114750|P4|STARTED|Overall Study||6
47363|NCT01915173|114751|P3|STARTED|Overall Study||6
47364|NCT01915173|114752|P2|STARTED|Overall Study||6
47365|NCT01915173|114753|P1|STARTED|Overall Study||6
47366|NCT01915108|114775|P4|NOT COMPLETED|Overall Study||2
47367|NCT01915108|114776|P3|NOT COMPLETED|Overall Study||1
47368|NCT01915108|114777|P2|NOT COMPLETED|Overall Study||3
47369|NCT01915108|114778|P1|NOT COMPLETED|Overall Study||2
47370|NCT01915108|114775|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
47371|NCT01915108|114776|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
47372|NCT01915108|114777|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
47373|NCT01915108|114778|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
47374|NCT01915108|114775|P4|STARTED|Overall Study||32
47375|NCT01915108|114776|P3|STARTED|Overall Study||32
47376|NCT01915108|114777|P2|STARTED|Overall Study||32
47377|NCT01915108|114778|P1|STARTED|Overall Study||32
47378|NCT01914926|114790|P2|NOT COMPLETED|Overall Study||1
47379|NCT01914926|114791|P1|NOT COMPLETED|Overall Study||1
47380|NCT01914926|114790|P2|COMPLETED|Overall Study||24
47381|NCT01914926|114791|P1|COMPLETED|Overall Study||28
47382|NCT01914926|114790|P2|STARTED|Overall Study||25
47383|NCT01914926|114791|P1|STARTED|Overall Study||29
47384|NCT01914757|114800|P3|NOT COMPLETED|Overall Study||38
47385|NCT01914757|114801|P2|NOT COMPLETED|Overall Study||51
47386|NCT01914757|114802|P1|NOT COMPLETED|Overall Study||36
47387|NCT01914757|114800|P3|COMPLETED|Overall Study||402
47388|NCT01914757|114801|P2|COMPLETED|Overall Study||390
47389|NCT01914757|114802|P1|COMPLETED|Overall Study||389
47390|NCT01914757|114800|P3|STARTED|Overall Study||440
47391|NCT01914757|114801|P2|STARTED|Overall Study||441
47392|NCT01914757|114802|P1|STARTED|Overall Study||425
47393|NCT01914679|114876|P1|NOT COMPLETED|Overall Study||5
47394|NCT01914679|114876|P1|COMPLETED|Overall Study||12
47395|NCT01914679|114876|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
47396|NCT01914679|114876|P1|STARTED|Overall Study||17
47397|NCT01914666|114883|P3|NOT COMPLETED|Tapering Period||0
47398|NCT01914666|114884|P2|NOT COMPLETED|Tapering Period||0
47399|NCT01914666|114885|P1|NOT COMPLETED|Tapering Period||0
47400|NCT01914666|114883|P3|COMPLETED|Tapering Period||40
47401|NCT01914666|114884|P2|COMPLETED|Tapering Period||39
47402|NCT01914666|114885|P1|COMPLETED|Tapering Period||59
47403|NCT01914666|114883|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
47404|NCT01914666|114884|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
47405|NCT01914666|114885|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
47406|NCT01914666|114883|P3|NOT COMPLETED|Treatment Period||8
47407|NCT01914666|114884|P2|NOT COMPLETED|Treatment Period||6
47408|NCT01914666|114885|P1|NOT COMPLETED|Treatment Period||13
47409|NCT01914666|114883|P3|COMPLETED|Treatment Period||33
47410|NCT01914666|114884|P2|COMPLETED|Treatment Period||36
47411|NCT01914666|114885|P1|COMPLETED|Treatment Period||55
47412|NCT01914666|114883|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
47413|NCT01914666|114884|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
47414|NCT01914666|114885|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
47415|NCT01914666|114883|P3|STARTED|Treatment Period||41
47416|NCT01914666|114884|P2|STARTED|Treatment Period||42
47417|NCT01914666|114885|P1|STARTED|Treatment Period||68
47418|NCT01914003|114920|P2|NOT COMPLETED|Overall Study||12
47419|NCT01914003|114921|P1|NOT COMPLETED|Overall Study||8
47420|NCT01914003|114920|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
47421|NCT01914003|114921|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
47422|NCT01914003|114920|P2|STARTED|Overall Study||26
47423|NCT01914003|114921|P1|STARTED|Overall Study||27
47424|NCT01913795|114931|P4|NOT COMPLETED|Overall Study||1
47425|NCT01913795|114932|P3|NOT COMPLETED|Overall Study||0
47426|NCT01913795|114933|P2|NOT COMPLETED|Overall Study||3
47427|NCT01913795|114934|P1|NOT COMPLETED|Overall Study||0
47428|NCT01913795|114931|P4|COMPLETED|Overall Study||5
47429|NCT01913795|114932|P3|COMPLETED|Overall Study||9
47430|NCT01913795|114933|P2|COMPLETED|Overall Study||7
47431|NCT01913795|114934|P1|COMPLETED|Overall Study||4
47432|NCT01913795|114931|P4|STARTED|Overall Study||6
47433|NCT01913795|114932|P3|STARTED|Overall Study||9
47434|NCT01913795|114933|P2|STARTED|Overall Study||10
47435|NCT01913795|114934|P1|STARTED|Overall Study||4
47436|NCT01913600|114952|P1|NOT COMPLETED|Overall Study||1
47437|NCT01913600|114952|P1|COMPLETED|Overall Study||55
47438|NCT01913600|114952|P1|STARTED|Overall Study||56
47439|NCT01913535|114974|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
47440|NCT01913535|114975|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
47441|NCT01913535|114976|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
47442|NCT01913535|114977|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
47443|NCT01913535|114978|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
47444|NCT01913535|114974|P5|COMPLETED|Phase 2 (Days 3-5)||1
47445|NCT01913535|114975|P4|COMPLETED|Phase 2 (Days 3-5)||2
47446|NCT01913535|114976|P3|COMPLETED|Phase 2 (Days 3-5)||1
47447|NCT01913535|114977|P2|COMPLETED|Phase 2 (Days 3-5)||2
47448|NCT01913535|114978|P1|COMPLETED|Phase 2 (Days 3-5)||2
47449|NCT01913535|114974|P5|STARTED|Phase 2 (Days 3-5)||1
47450|NCT01913535|114975|P4|STARTED|Phase 2 (Days 3-5)||2
47451|NCT01913535|114976|P3|STARTED|Phase 2 (Days 3-5)||1
47452|NCT01913535|114977|P2|STARTED|Phase 2 (Days 3-5)||2
47453|NCT01913535|114978|P1|STARTED|Phase 2 (Days 3-5)||2
47454|NCT01913535|114974|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
47455|NCT01913535|114975|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
47456|NCT01913535|114976|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
47457|NCT01913535|114977|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
47458|NCT01913535|114978|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
47459|NCT01913535|114974|P5|COMPLETED|Phase 1 (Days 0-2)||1
47460|NCT01913535|114975|P4|COMPLETED|Phase 1 (Days 0-2)||2
47461|NCT01913535|114976|P3|COMPLETED|Phase 1 (Days 0-2)||1
47462|NCT01913535|114977|P2|COMPLETED|Phase 1 (Days 0-2)||2
47463|NCT01913535|114978|P1|COMPLETED|Phase 1 (Days 0-2)||2
47464|NCT01913535|114974|P5|STARTED|Phase 1 (Days 0-2)||1
47465|NCT01913535|114975|P4|STARTED|Phase 1 (Days 0-2)||2
47466|NCT01913535|114976|P3|STARTED|Phase 1 (Days 0-2)||1
47467|NCT01913535|114977|P2|STARTED|Phase 1 (Days 0-2)||2
47468|NCT01913535|114978|P1|STARTED|Phase 1 (Days 0-2)||2
47469|NCT01913483|115011|P2|NOT COMPLETED|Overall Study||22
47470|NCT01913483|115012|P1|NOT COMPLETED|Overall Study||21
47471|NCT01913483|115011|P2|COMPLETED|Overall Study||343
47472|NCT01913483|115012|P1|COMPLETED|Overall Study||346
47473|NCT01913483|115011|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
47474|NCT01913483|115012|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
47475|NCT01913483|115011|P2|STARTED|Overall Study||365
47476|NCT01913483|115012|P1|STARTED|Overall Study||367
47477|NCT01913470|115024|P2|NOT COMPLETED|Overall Study||3
47478|NCT01913470|115025|P1|NOT COMPLETED|Overall Study||0
47479|NCT01913470|115024|P2|COMPLETED|Overall Study||4
47480|NCT01913470|115025|P1|COMPLETED|Overall Study||5
47481|NCT01913470|115024|P2|STARTED|Overall Study||7
47482|NCT01913470|115025|P1|STARTED|Overall Study||5
47483|NCT01913405|115043|P1|NOT COMPLETED|Overall Study||2
47484|NCT01913405|115043|P1|COMPLETED|Overall Study||20
47485|NCT01913405|115043|P1|STARTED|Overall Study||22
47486|NCT01913041|115097|P1|NOT COMPLETED|Overall Study||39
47487|NCT01913041|115097|P1|COMPLETED|Overall Study||830
47488|NCT01913041|115097|P1|STARTED|Overall Study||869
47489|NCT01912781|115103|P2|NOT COMPLETED|Overall Study||0
47490|NCT01912781|115104|P1|NOT COMPLETED|Overall Study||2
47491|NCT01912781|115103|P2|COMPLETED|Overall Study||35
47492|NCT01912781|115104|P1|COMPLETED|Overall Study||69
47493|NCT01912781|115103|P2|STARTED|Overall Study||35
47494|NCT01912781|115104|P1|STARTED|Overall Study||71
47495|NCT01912768|115135|P2|NOT COMPLETED|Overall Study||4
47496|NCT01912768|115136|P1|NOT COMPLETED|Overall Study||10
47497|NCT01912768|115135|P2|COMPLETED|Overall Study||109
47498|NCT01912768|115136|P1|COMPLETED|Overall Study||229
47499|NCT01912768|115135|P2|STARTED|Overall Study||113
47500|NCT01912768|115136|P1|STARTED|Overall Study||239
47501|NCT01912599|115167|P2|NOT COMPLETED|Overall Study||1
47502|NCT01912599|115168|P1|NOT COMPLETED|Overall Study||0
47503|NCT01912599|115167|P2|COMPLETED|Overall Study||15
47504|NCT01912599|115168|P1|COMPLETED|Overall Study||20
47505|NCT01912599|115167|P2|STARTED|Overall Study||16
47506|NCT01912599|115168|P1|STARTED|Overall Study||20
47507|NCT01912495|115182|P1|NOT COMPLETED|Overall Study||0
47508|NCT01912495|115182|P1|COMPLETED|Overall Study||57
47509|NCT01912495|115182|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
47510|NCT01912404|115193|P2|NOT COMPLETED|Overall Study||0
47511|NCT01912404|115194|P1|NOT COMPLETED|Overall Study||1
47512|NCT01912404|115193|P2|COMPLETED|Overall Study||2
47513|NCT01912404|115194|P1|COMPLETED|Overall Study||2
47514|NCT01912404|115193|P2|STARTED|Overall Study||2
47515|NCT01912404|115194|P1|STARTED|Overall Study||3
47516|NCT01912352|115200|P1|NOT COMPLETED|Overall Study||5
47517|NCT01912352|115200|P1|COMPLETED|Overall Study||78
47518|NCT01912352|115200|P1|STARTED|Overall Study||83
47519|NCT01912339|115207|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
47520|NCT01912339|115208|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
47521|NCT01912339|115209|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
47522|NCT01912339|115207|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
47523|NCT01912339|115208|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
47524|NCT01912339|115209|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
47525|NCT01912339|115207|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
47526|NCT01912339|115208|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
47527|NCT01912339|115209|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
47528|NCT01912339|115207|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
47529|NCT01912339|115208|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
47530|NCT01912339|115209|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
47531|NCT01912339|115207|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
47532|NCT01912339|115208|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
47533|NCT01912339|115209|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
47534|NCT01912339|115207|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
47535|NCT01912339|115208|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
47536|NCT01912339|115209|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
47537|NCT01912339|115207|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
47538|NCT01912339|115208|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
47539|NCT01912339|115209|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
47540|NCT01912339|115207|P3|COMPLETED|Blinded (0 to 3 Months)||0
47541|NCT01912339|115208|P2|COMPLETED|Blinded (0 to 3 Months)||61
47542|NCT01912339|115209|P1|COMPLETED|Blinded (0 to 3 Months)||134
47543|NCT01912339|115207|P3|STARTED|Blinded (0 to 3 Months)||0
47544|NCT01912339|115208|P2|STARTED|Blinded (0 to 3 Months)||61
47545|NCT01912339|115209|P1|STARTED|Blinded (0 to 3 Months)||136
47546|NCT01912222|115226|P3|NOT COMPLETED|Part B: Treatment Period||20
47547|NCT01912222|115227|P2|NOT COMPLETED|Part B: Treatment Period||15
47548|NCT01912222|115228|P1|NOT COMPLETED|Part B: Treatment Period||13
47549|NCT01912222|115226|P3|COMPLETED|Part B: Treatment Period||0
47550|NCT01912222|115227|P2|COMPLETED|Part B: Treatment Period||0
47551|NCT01912222|115228|P1|COMPLETED|Part B: Treatment Period||0
47552|NCT01912222|115226|P3|STARTED|Part B: Treatment Period||20
47553|NCT01912222|115227|P2|STARTED|Part B: Treatment Period||15
47554|NCT01912222|115228|P1|STARTED|Part B: Treatment Period||13
47555|NCT01912222|115226|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
47556|NCT01912222|115227|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
47557|NCT01912222|115228|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
47558|NCT01912222|115226|P3|COMPLETED|Part A: Pharmacokinetic Period||18
47559|NCT01912222|115227|P2|COMPLETED|Part A: Pharmacokinetic Period||13
47560|NCT01912222|115228|P1|COMPLETED|Part A: Pharmacokinetic Period||12
47561|NCT01912222|115226|P3|STARTED|Part A: Pharmacokinetic Period||20
47562|NCT01912222|115227|P2|STARTED|Part A: Pharmacokinetic Period||15
47563|NCT01912222|115228|P1|STARTED|Part A: Pharmacokinetic Period||13
47564|NCT01911845|115251|P1|NOT COMPLETED|Overall Study||6
47565|NCT01911845|115251|P1|COMPLETED|Overall Study||32
47566|NCT01911845|115251|P1|Completed Study Drug|Overall Study||37
47567|NCT01911845|115251|P1|STARTED|Overall Study||38
47568|NCT01911819|115268|P3|NOT COMPLETED|Overall Study||0
47569|NCT01911819|115269|P2|NOT COMPLETED|Overall Study||2
47570|NCT01911819|115270|P1|NOT COMPLETED|Overall Study||1
47571|NCT01911819|115268|P3|COMPLETED|Overall Study||10
47572|NCT01911819|115269|P2|COMPLETED|Overall Study||9
47573|NCT01911819|115270|P1|COMPLETED|Overall Study||9
47574|NCT01911819|115268|P3|STARTED|Overall Study||10
47575|NCT01911819|115269|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
47576|NCT01911819|115270|P1|STARTED|Overall Study||10
47577|NCT01911793|115283|P2|NOT COMPLETED|Overall Study||5
47578|NCT01911793|115284|P1|NOT COMPLETED|Overall Study||1
47579|NCT01911793|115283|P2|COMPLETED|Overall Study||0
47580|NCT01911793|115284|P1|COMPLETED|Overall Study||0
47581|NCT01911793|115283|P2|STARTED|Overall Study||5
47582|NCT01911793|115284|P1|STARTED|Overall Study||1
47583|NCT01911780|115308|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
47584|NCT01911780|115309|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
47585|NCT01911780|115308|P2|COMPLETED|Extension Period (52 Weeks)||58
47586|NCT01911780|115309|P1|COMPLETED|Extension Period (52 Weeks)||61
47587|NCT01911780|115308|P2|STARTED|Extension Period (52 Weeks)||61
47588|NCT01911780|115309|P1|STARTED|Extension Period (52 Weeks)||65
47589|NCT01911780|115308|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
47590|NCT01911780|115309|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
47591|NCT01911780|115308|P2|COMPLETED|Double-blind Period (8 Weeks)||61
47592|NCT01911780|115309|P1|COMPLETED|Double-blind Period (8 Weeks)||65
47593|NCT01911780|115308|P2|STARTED|Double-blind Period (8 Weeks)||64
47594|NCT01911780|115309|P1|STARTED|Double-blind Period (8 Weeks)||68
47595|NCT01911689|115329|P2|NOT COMPLETED|Overall Study||0
47596|NCT01911689|115330|P1|NOT COMPLETED|Overall Study||0
47597|NCT01911689|115329|P2|COMPLETED|Overall Study||51
47598|NCT01911689|115330|P1|COMPLETED|Overall Study||117
47599|NCT01911689|115329|P2|STARTED|Overall Study||51
47600|NCT01911689|115330|P1|STARTED|Overall Study||117
47601|NCT01911546|115343|P1|NOT COMPLETED|Overall Study||6
47602|NCT01911546|115343|P1|COMPLETED|Overall Study||14
47603|NCT01911546|115343|P1|STARTED|Overall Study||20
47604|NCT01911442|115353|P3|NOT COMPLETED|Overall Study||12
47605|NCT01911442|115354|P2|NOT COMPLETED|Overall Study||4
47606|NCT01911442|115355|P1|NOT COMPLETED|Overall Study||6
47607|NCT01911442|115353|P3|COMPLETED|Overall Study||38
47608|NCT01911442|115354|P2|COMPLETED|Overall Study||47
47609|NCT01911442|115355|P1|COMPLETED|Overall Study||43
47610|NCT01911442|115353|P3|STARTED|Overall Study||50
47611|NCT01911442|115354|P2|STARTED|Overall Study||51
47612|NCT01911442|115355|P1|STARTED|Overall Study||49
47613|NCT01911429|115384|P3|NOT COMPLETED|Overall Study||20
47614|NCT01911429|115385|P2|NOT COMPLETED|Overall Study||10
47615|NCT01911429|115386|P1|NOT COMPLETED|Overall Study||12
47616|NCT01911429|115384|P3|COMPLETED|Overall Study||93
47617|NCT01911429|115385|P2|COMPLETED|Overall Study||96
47618|NCT01911429|115386|P1|COMPLETED|Overall Study||96
47619|NCT01911429|115384|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
47620|NCT01911429|115385|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
47621|NCT01911429|115386|P1|STARTED|Overall Study||108
47622|NCT01911403|115420|P2|NOT COMPLETED|Overall Study||3
47623|NCT01911403|115421|P1|NOT COMPLETED|Overall Study||9
47624|NCT01911403|115420|P2|COMPLETED|Overall Study||59
47625|NCT01911403|115421|P1|COMPLETED|Overall Study||52
47626|NCT01911403|115420|P2|STARTED|Overall Study||62
47627|NCT01911403|115421|P1|STARTED|Overall Study||61
47628|NCT01911390|115442|P4|NOT COMPLETED|Overall Study||1
47629|NCT01911390|115443|P3|NOT COMPLETED|Overall Study||1
47630|NCT01911390|115444|P2|NOT COMPLETED|Overall Study||0
47631|NCT01911390|115445|P1|NOT COMPLETED|Overall Study||1
47632|NCT01911390|115442|P4|COMPLETED|Overall Study||10
47633|NCT01911390|115443|P3|COMPLETED|Overall Study||9
47634|NCT01911390|115444|P2|COMPLETED|Overall Study||10
47635|NCT01911390|115445|P1|COMPLETED|Overall Study||9
47636|NCT01911390|115442|P4|STARTED|Overall Study||11
47637|NCT01911390|115443|P3|STARTED|Overall Study||10
47638|NCT01911390|115444|P2|STARTED|Overall Study||10
47639|NCT01911390|115445|P1|STARTED|Overall Study||10
47640|NCT01911351|115461|P2|NOT COMPLETED|Overall Study||0
47641|NCT01911351|115462|P1|NOT COMPLETED|Overall Study||0
47642|NCT01911351|115461|P2|COMPLETED|Overall Study||43
47643|NCT01911351|115462|P1|COMPLETED|Overall Study||39
47644|NCT01911351|115461|P2|STARTED|Overall Study||43
47645|NCT01911351|115462|P1|STARTED|Overall Study||39
47646|NCT01911273|115478|P2|NOT COMPLETED|Overall Study||2
47647|NCT01911273|115479|P1|NOT COMPLETED|Overall Study||1
47648|NCT01911273|115478|P2|COMPLETED|Overall Study||0
47649|NCT01911273|115479|P1|COMPLETED|Overall Study||0
47650|NCT01911273|115478|P2|STARTED|Overall Study||2
47651|NCT01911273|115479|P1|STARTED|Overall Study||1
47652|NCT01911260|115513|P4|NOT COMPLETED|Follow-up Period||12
47653|NCT01911260|115514|P3|NOT COMPLETED|Follow-up Period||15
47654|NCT01911260|115515|P2|NOT COMPLETED|Follow-up Period||20
47655|NCT01911260|115516|P1|NOT COMPLETED|Follow-up Period||13
47656|NCT01911260|115513|P4|COMPLETED|Follow-up Period||30
47657|NCT01911260|115514|P3|COMPLETED|Follow-up Period||24
47658|NCT01911260|115515|P2|COMPLETED|Follow-up Period||18
47659|NCT01911260|115516|P1|COMPLETED|Follow-up Period||27
47660|NCT01911260|115513|P4|STARTED|Follow-up Period||42
47661|NCT01911260|115514|P3|STARTED|Follow-up Period||39
47662|NCT01911260|115515|P2|STARTED|Follow-up Period||38
47663|NCT01911260|115516|P1|STARTED|Follow-up Period||40
47664|NCT01911260|115513|P4|NOT COMPLETED|Supplementation Period||8
47665|NCT01911260|115514|P3|NOT COMPLETED|Supplementation Period||10
47666|NCT01911260|115515|P2|NOT COMPLETED|Supplementation Period||12
47667|NCT01911260|115516|P1|NOT COMPLETED|Supplementation Period||10
47668|NCT01911260|115513|P4|COMPLETED|Supplementation Period||42
47669|NCT01911260|115514|P3|COMPLETED|Supplementation Period||39
47670|NCT01911260|115515|P2|COMPLETED|Supplementation Period||38
47671|NCT01911260|115516|P1|COMPLETED|Supplementation Period||40
47672|NCT01911260|115513|P4|STARTED|Supplementation Period||50
47673|NCT01911260|115514|P3|STARTED|Supplementation Period||49
47674|NCT01911260|115515|P2|STARTED|Supplementation Period||50
47675|NCT01911260|115516|P1|STARTED|Supplementation Period||50
47676|NCT01911221|115526|P1|NOT COMPLETED|Overall Study||0
47677|NCT01911221|115526|P1|COMPLETED|Overall Study||13
47678|NCT01911221|115526|P1|STARTED|Overall Study||13
47679|NCT01911169|115542|P2|NOT COMPLETED|Overall Study||0
47680|NCT01911169|115543|P1|NOT COMPLETED|Overall Study||0
47681|NCT01911169|115542|P2|COMPLETED|Overall Study||3
47682|NCT01911169|115543|P1|COMPLETED|Overall Study||6
47683|NCT01911169|115542|P2|STARTED|Overall Study||3
47684|NCT01911169|115543|P1|STARTED|Overall Study||6
47685|NCT01911065|115553|P2|NOT COMPLETED|Overall Study||0
47686|NCT01911065|115554|P1|NOT COMPLETED|Overall Study||0
47687|NCT01911065|115553|P2|COMPLETED|Overall Study||9
47688|NCT01911065|115554|P1|COMPLETED|Overall Study||45
47689|NCT01911065|115553|P2|STARTED|Overall Study||9
47690|NCT01911065|115554|P1|STARTED|Overall Study||45
47691|NCT01910831|115562|P1|NOT COMPLETED|Overall Study||1
47692|NCT01910831|115562|P1|COMPLETED|Overall Study||19
47693|NCT01910831|115562|P1|STARTED|Overall Study||20
47694|NCT01910792|115571|P2|NOT COMPLETED|Overall Study||0
47695|NCT01910792|115572|P1|NOT COMPLETED|Overall Study||0
47696|NCT01910792|115571|P2|COMPLETED|Overall Study||10
47697|NCT01910792|115572|P1|COMPLETED|Overall Study||9
47698|NCT01910792|115571|P2|STARTED|Overall Study||10
47699|NCT01910792|115572|P1|STARTED|Overall Study||9
47700|NCT01910688|115578|P1|NOT COMPLETED|Overall Study||5
47701|NCT01910688|115578|P1|COMPLETED|Overall Study||20
47702|NCT01910688|115578|P1|12months|Overall Study||22
47703|NCT01910688|115578|P1|3rd RFA Treatment|Overall Study||18
47704|NCT01910688|115578|P1|7.5months|Overall Study||24
47705|NCT01910688|115578|P1|2nd RFA Treatment|Overall Study||22
47706|NCT01910688|115578|P1|3.5month|Overall Study||25
47707|NCT01910688|115578|P1|STARTED|Overall Study||25
47708|NCT01910636|115587|P2|NOT COMPLETED|Overall Study||0
47709|NCT01910636|115588|P1|NOT COMPLETED|Overall Study||0
47710|NCT01910636|115587|P2|COMPLETED|Overall Study||63
47711|NCT01910636|115588|P1|COMPLETED|Overall Study||90
47712|NCT01910636|115587|P2|STARTED|Overall Study||63
47713|NCT01910636|115588|P1|STARTED|Overall Study||90
47714|NCT01910441|115602|P2|NOT COMPLETED|Overall Study||10
47715|NCT01910441|115603|P1|NOT COMPLETED|Overall Study||7
47716|NCT01910441|115602|P2|COMPLETED|Overall Study||37
47717|NCT01910441|115603|P1|COMPLETED|Overall Study||41
47718|NCT01910441|115602|P2|STARTED|Overall Study||47
47719|NCT01910441|115603|P1|STARTED|Overall Study||48
47720|NCT01910402|115611|P2|NOT COMPLETED|Continuation Phase||0
47721|NCT01910402|115612|P1|NOT COMPLETED|Continuation Phase||90
47722|NCT01910402|115611|P2|COMPLETED|Continuation Phase||0
47723|NCT01910402|115612|P1|COMPLETED|Continuation Phase||30
47724|NCT01910402|115611|P2|STARTED|Continuation Phase||0
47725|NCT01910402|115612|P1|STARTED|Continuation Phase||120
47726|NCT01910402|115611|P2|NOT COMPLETED|Randomized Phase||55
47727|NCT01910402|115612|P1|NOT COMPLETED|Randomized Phase||42
47728|NCT01910402|115611|P2|COMPLETED|Randomized Phase||192
47729|NCT01910402|115612|P1|COMPLETED|Randomized Phase||206
47730|NCT01910402|115611|P2|STARTED|Randomized Phase||247
47731|NCT01910402|115612|P1|STARTED|Randomized Phase||248
47732|NCT01910389|115682|P2|NOT COMPLETED|Overall Study||8
47733|NCT01910389|115683|P1|NOT COMPLETED|Overall Study||15
47734|NCT01910389|115682|P2|COMPLETED|Overall Study||0
47735|NCT01910389|115683|P1|COMPLETED|Overall Study||0
47736|NCT01910389|115682|P2|STARTED|Overall Study||8
47737|NCT01910389|115683|P1|STARTED|Overall Study||15
47738|NCT01910311|115713|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
47739|NCT01910311|115713|P1|COMPLETED|Period 2 (Days 3-32)||18
47740|NCT01910311|115713|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
47741|NCT01910311|115713|P1|Received Baricitinib|Period 2 (Days 3-32)||18
47742|NCT01910311|115713|P1|STARTED|Period 2 (Days 3-32)||18
47743|NCT01910311|115713|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
47744|NCT01910311|115713|P1|COMPLETED|Period 1 (Days 1-2)||18
47745|NCT01910311|115713|P1|Received Baricitinib|Period 1 (Days 1-2)||18
47746|NCT01910311|115713|P1|STARTED|Period 1 (Days 1-2)||18
47747|NCT01910181|115724|P1|NOT COMPLETED|Overall Study||46
47748|NCT01910181|115724|P1|COMPLETED|Overall Study||0
47749|NCT01910181|115724|P1|Expansion Cohort|Overall Study||26
47750|NCT01910181|115724|P1|PK Cohort|Overall Study||20
47751|NCT01910181|115724|P1|STARTED|Overall Study||46
47752|NCT01910116|115751|P2|NOT COMPLETED|Overall Study||16
47753|NCT01910116|115752|P1|NOT COMPLETED|Overall Study||14
47754|NCT01910116|115751|P2|COMPLETED|Overall Study||94
47755|NCT01910116|115752|P1|COMPLETED|Overall Study||96
47756|NCT01910116|115751|P2|Week 16|Overall Study||94
47757|NCT01910116|115752|P1|Week 16|Overall Study||96
47758|NCT01910116|115751|P2|Week 12|Overall Study||96
47759|NCT01910116|115752|P1|Week 12|Overall Study||97
47760|NCT01910116|115751|P2|Week 8|Overall Study||99
47761|NCT01910116|115752|P1|Week 8|Overall Study||98
47762|NCT01910116|115751|P2|Week 4|Overall Study||102
47763|NCT01910116|115752|P1|Week 4|Overall Study||106
47764|NCT01910116|115751|P2|STARTED|Overall Study||110
47765|NCT01910116|115752|P1|STARTED|Overall Study||110
47766|NCT01910064|115828|P1|NOT COMPLETED|Overall Study||45
47767|NCT01910064|115828|P1|COMPLETED|Overall Study||391
47768|NCT01910064|115828|P1|STARTED|Overall Study||436
47769|NCT01909804|115849|P12|NOT COMPLETED|Overall Study||3
47770|NCT01909804|115850|P11|NOT COMPLETED|Overall Study||1
47771|NCT01909804|115851|P10|NOT COMPLETED|Overall Study||1
47772|NCT01909804|115852|P9|NOT COMPLETED|Overall Study||0
47773|NCT01909804|115853|P8|NOT COMPLETED|Overall Study||1
47774|NCT01909804|115854|P7|NOT COMPLETED|Overall Study||2
47775|NCT01909804|115855|P6|NOT COMPLETED|Overall Study||4
47776|NCT01909804|115856|P5|NOT COMPLETED|Overall Study||8
47777|NCT01909804|115857|P4|NOT COMPLETED|Overall Study||0
47778|NCT01909804|115858|P3|NOT COMPLETED|Overall Study||0
47779|NCT01909804|115859|P2|NOT COMPLETED|Overall Study||1
47780|NCT01909804|115860|P1|NOT COMPLETED|Overall Study||4
47781|NCT01909804|115849|P12|COMPLETED|Overall Study||26
47782|NCT01909804|115850|P11|COMPLETED|Overall Study||26
47783|NCT01909804|115851|P10|COMPLETED|Overall Study||28
47784|NCT01909804|115852|P9|COMPLETED|Overall Study||27
47785|NCT01909804|115853|P8|COMPLETED|Overall Study||25
47786|NCT01909804|115854|P7|COMPLETED|Overall Study||25
47787|NCT01909804|115855|P6|COMPLETED|Overall Study||21
47788|NCT01909804|115856|P5|COMPLETED|Overall Study||18
47789|NCT01909804|115857|P4|COMPLETED|Overall Study||26
47790|NCT01909804|115858|P3|COMPLETED|Overall Study||27
47791|NCT01909804|115859|P2|COMPLETED|Overall Study||27
47792|NCT01909804|115860|P1|COMPLETED|Overall Study||22
47793|NCT01909804|115849|P12|STARTED|Overall Study||29
47794|NCT01909804|115850|P11|STARTED|Overall Study||27
47795|NCT01909804|115851|P10|STARTED|Overall Study||29
47796|NCT01909804|115852|P9|STARTED|Overall Study||27
47797|NCT01909804|115853|P8|STARTED|Overall Study||26
47798|NCT01909804|115854|P7|STARTED|Overall Study||27
47799|NCT01909804|115855|P6|STARTED|Overall Study||25
47800|NCT01909804|115856|P5|STARTED|Overall Study||26
47801|NCT01909804|115857|P4|STARTED|Overall Study||26
47802|NCT01909804|115858|P3|STARTED|Overall Study||27
47803|NCT01909804|115859|P2|STARTED|Overall Study||28
47804|NCT01909804|115860|P1|STARTED|Overall Study||26
47805|NCT01909778|115906|P1|NOT COMPLETED|Overall Study||1
47806|NCT01909778|115906|P1|COMPLETED|Overall Study||1
47807|NCT01909778|115906|P1|STARTED|Overall Study||2
47808|NCT01909713|115930|P1|NOT COMPLETED|Overall Study||0
47809|NCT01909713|115930|P1|COMPLETED|Overall Study||35
47810|NCT01909713|115930|P1|STARTED|Overall Study||35
47811|NCT01909674|115985|P2|NOT COMPLETED|Overall Study||2
47812|NCT01909674|115986|P1|NOT COMPLETED|Overall Study||5
47813|NCT01909674|115985|P2|COMPLETED|Overall Study||7
47814|NCT01909674|115986|P1|COMPLETED|Overall Study||7
47815|NCT01909674|115985|P2|STARTED|Overall Study||9
47816|NCT01909674|115986|P1|STARTED|Overall Study||12
47817|NCT01909570|115994|P2|NOT COMPLETED|Overall Study||27
47818|NCT01909570|115995|P1|NOT COMPLETED|Overall Study||27
47819|NCT01909570|115994|P2|COMPLETED|Overall Study||64
47820|NCT01909570|115995|P1|COMPLETED|Overall Study||57
47821|NCT01909570|115994|P2|STARTED|Overall Study||91
47822|NCT01909570|115995|P1|STARTED|Overall Study||84
47823|NCT01909466|116005|P2|NOT COMPLETED|Overall Study||23
47824|NCT01909466|116006|P1|NOT COMPLETED|Overall Study||22
47825|NCT01909466|116005|P2|COMPLETED|Overall Study||50
47826|NCT01909466|116006|P1|COMPLETED|Overall Study||46
47827|NCT01909466|116005|P2|STARTED|Overall Study||73
47828|NCT01909466|116006|P1|STARTED|Overall Study||68
47829|NCT01909336|116029|P3|NOT COMPLETED|Overall Study||3
47830|NCT01909336|116030|P2|NOT COMPLETED|Overall Study||3
47831|NCT01909336|116031|P1|NOT COMPLETED|Overall Study||4
47832|NCT01909336|116029|P3|COMPLETED|Overall Study||52
47833|NCT01909336|116030|P2|COMPLETED|Overall Study||50
47834|NCT01909336|116031|P1|COMPLETED|Overall Study||49
47835|NCT01909336|116029|P3|STARTED|Overall Study||55
47836|NCT01909336|116030|P2|STARTED|Overall Study||53
47837|NCT01909336|116031|P1|STARTED|Overall Study||53
47838|NCT01909180|116045|P1|NOT COMPLETED|Overall Study||0
47839|NCT01909180|116045|P1|COMPLETED|Overall Study||49
47840|NCT01909180|116045|P1|STARTED|Overall Study||49
47841|NCT01909141|116053|P2|NOT COMPLETED|Overall Study||0
47842|NCT01909141|116054|P1|NOT COMPLETED|Overall Study||0
47843|NCT01909141|116053|P2|COMPLETED|Overall Study||50
47844|NCT01909141|116054|P1|COMPLETED|Overall Study||50
47845|NCT01909141|116053|P2|STARTED|Overall Study||50
47846|NCT01909141|116054|P1|STARTED|Overall Study||50
47847|NCT01909011|116070|P2|NOT COMPLETED|Overall Study||0
47848|NCT01909011|116071|P1|NOT COMPLETED|Overall Study||0
47849|NCT01909011|116070|P2|COMPLETED|Overall Study||9
47850|NCT01909011|116071|P1|COMPLETED|Overall Study||7
47851|NCT01909011|116070|P2|STARTED|Overall Study||9
47852|NCT01909011|116071|P1|STARTED|Overall Study||7
47853|NCT01908907|116083|P2|NOT COMPLETED|Overall Study||0
47854|NCT01908907|116084|P1|NOT COMPLETED|Overall Study||2
47855|NCT01908907|116083|P2|COMPLETED|Overall Study||29
47856|NCT01908907|116084|P1|COMPLETED|Overall Study||29
47857|NCT01908907|116083|P2|STARTED|Overall Study||29
47858|NCT01908907|116084|P1|STARTED|Overall Study||31
47859|NCT01908842|116106|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
47860|NCT01908842|116107|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
47861|NCT01908842|116106|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
47862|NCT01908842|116107|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
47863|NCT01908842|116106|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
47864|NCT01908842|116107|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
47865|NCT01908842|116106|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
47866|NCT01908842|116107|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
47867|NCT01908842|116106|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
47868|NCT01908842|116107|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
47869|NCT01908842|116106|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
47870|NCT01908842|116107|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
47871|NCT01908842|116106|P2|NOT COMPLETED|Induction||31
47872|NCT01908842|116107|P1|NOT COMPLETED|Induction||26
47873|NCT01908842|116106|P2|COMPLETED|Induction||344
47874|NCT01908842|116107|P1|COMPLETED|Induction||357
47875|NCT01908842|116106|P2|STARTED|Induction||375
47876|NCT01908842|116107|P1|STARTED|Induction||383
47877|NCT01908829|116128|P3|NOT COMPLETED|Overall Study||39
47878|NCT01908829|116129|P2|NOT COMPLETED|Overall Study||49
47879|NCT01908829|116130|P1|NOT COMPLETED|Overall Study||49
47880|NCT01908829|116128|P3|COMPLETED|Overall Study||680
47881|NCT01908829|116129|P2|COMPLETED|Overall Study||679
47882|NCT01908829|116130|P1|COMPLETED|Overall Study||678
47883|NCT01908829|116128|P3|Treated With Double-blind Drug|Overall Study||719
47884|NCT01908829|116129|P2|Treated With Double-blind Drug|Overall Study||728
47885|NCT01908829|116130|P1|Treated With Double-blind Drug|Overall Study||725
47886|NCT01908829|116128|P3|STARTED|Overall Study||719
47887|NCT01908829|116129|P2|STARTED|Overall Study||728
47888|NCT01908829|116130|P1|STARTED|Overall Study||727
47889|NCT01908803|116245|P2|NOT COMPLETED|Overall Study||1
47890|NCT01908803|116246|P1|NOT COMPLETED|Overall Study||4
47891|NCT01908803|116245|P2|COMPLETED|Overall Study||23
47892|NCT01908803|116246|P1|COMPLETED|Overall Study||42
47893|NCT01908803|116245|P2|Treated|Overall Study||24
47894|NCT01908803|116246|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
47895|NCT01908803|116245|P2|STARTED|Overall Study||24
47896|NCT01908803|116246|P1|STARTED|Overall Study||46
47897|NCT01908140|116259|P2|NOT COMPLETED|Overall Study||79
47898|NCT01908140|116260|P1|NOT COMPLETED|Overall Study||66
47899|NCT01908140|116259|P2|COMPLETED|Overall Study||386
47900|NCT01908140|116260|P1|COMPLETED|Overall Study||402
47901|NCT01908140|116259|P2|STARTED|Overall Study||465
47902|NCT01908140|116260|P1|STARTED|Overall Study||468
47903|NCT01908127|116270|P2|NOT COMPLETED|Overall Study||0
47904|NCT01908127|116271|P1|NOT COMPLETED|Overall Study||1
47905|NCT01908127|116270|P2|COMPLETED|Overall Study||23
47906|NCT01908127|116271|P1|COMPLETED|Overall Study||22
47907|NCT01908127|116270|P2|STARTED|Overall Study||23
47908|NCT01908127|116271|P1|STARTED|Overall Study||23
47909|NCT01907906|116281|P2|NOT COMPLETED|Overall Study||1
47910|NCT01907906|116282|P1|NOT COMPLETED|Overall Study||4
47911|NCT01907906|116281|P2|COMPLETED|Overall Study||12
47912|NCT01907906|116282|P1|COMPLETED|Overall Study||12
47913|NCT01907906|116281|P2|STARTED|Overall Study||13
47914|NCT01907906|116282|P1|STARTED|Overall Study||16
47915|NCT01907854|116362|P2|NOT COMPLETED|Overall Study||13
47916|NCT01907854|116363|P1|NOT COMPLETED|Overall Study||16
47917|NCT01907854|116362|P2|COMPLETED|Overall Study||191
47918|NCT01907854|116363|P1|COMPLETED|Overall Study||187
47919|NCT01907854|116362|P2|Exposed|Overall Study||204
47920|NCT01907854|116363|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
47921|NCT01907854|116362|P2|STARTED|Overall Study||204
47922|NCT01907854|116363|P1|STARTED|Overall Study||203
47923|NCT01907815|116383|P2|NOT COMPLETED|Overall Study||0
47924|NCT01907815|116384|P1|NOT COMPLETED|Overall Study||1
47925|NCT01907815|116383|P2|COMPLETED|Overall Study||7
47926|NCT01907815|116384|P1|COMPLETED|Overall Study||16
47927|NCT01907815|116383|P2|STARTED|Overall Study||7
47928|NCT01907815|116384|P1|STARTED|Overall Study||17
47929|NCT01907516|116400|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
47930|NCT01907516|116401|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
47931|NCT01907516|116400|P2|COMPLETED|Second Intervention (3 Weeks)||34
47932|NCT01907516|116401|P1|COMPLETED|Second Intervention (3 Weeks)||40
47933|NCT01907516|116400|P2|STARTED|Second Intervention (3 Weeks)||34
47934|NCT01907516|116401|P1|STARTED|Second Intervention (3 Weeks)||40
47935|NCT01907516|116400|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
47936|NCT01907516|116401|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
47937|NCT01907516|116400|P2|COMPLETED|First Intervention (3 Weeks)||34
47938|NCT01907516|116401|P1|COMPLETED|First Intervention (3 Weeks)||40
47939|NCT01907516|116400|P2|STARTED|First Intervention (3 Weeks)||50
47940|NCT01907516|116401|P1|STARTED|First Intervention (3 Weeks)||50
47941|NCT01907490|116408|P1|NOT COMPLETED|Overall Study||0
47942|NCT01907490|116408|P1|COMPLETED|Overall Study||38
47943|NCT01907490|116408|P1|STARTED|Overall Study||38
47944|NCT01907334|116412|P2|NOT COMPLETED|Overall Study||0
47945|NCT01907334|116413|P1|NOT COMPLETED|Overall Study||0
47946|NCT01907334|116412|P2|COMPLETED|Overall Study||4
47947|NCT01907334|116413|P1|COMPLETED|Overall Study||6
47948|NCT01907334|116412|P2|STARTED|Overall Study||4
47949|NCT01907334|116413|P1|STARTED|Overall Study||6
47950|NCT01907321|116418|P1|NOT COMPLETED|Overall Study||2
47951|NCT01907321|116418|P1|COMPLETED|Overall Study||12
47952|NCT01907321|116418|P1|STARTED|Overall Study||14
47953|NCT01907113|116428|P5|NOT COMPLETED|Overall Study||0
47954|NCT01907113|116429|P4|NOT COMPLETED|Overall Study||0
47955|NCT01907113|116430|P3|NOT COMPLETED|Overall Study||0
47956|NCT01907113|116431|P2|NOT COMPLETED|Overall Study||0
47957|NCT01907113|116432|P1|NOT COMPLETED|Overall Study||0
47958|NCT01907113|116428|P5|COMPLETED|Overall Study||8
47959|NCT01907113|116429|P4|COMPLETED|Overall Study||8
47960|NCT01907113|116430|P3|COMPLETED|Overall Study||7
47961|NCT01907113|116431|P2|COMPLETED|Overall Study||9
47962|NCT01907113|116432|P1|COMPLETED|Overall Study||8
47963|NCT01907113|116428|P5|STARTED|Overall Study||8
47964|NCT01907113|116429|P4|STARTED|Overall Study||8
47965|NCT01907113|116430|P3|STARTED|Overall Study||7
47966|NCT01907113|116431|P2|STARTED|Overall Study||9
47967|NCT01907113|116432|P1|STARTED|Overall Study||8
47968|NCT01906658|116523|P4|NOT COMPLETED|Overall Study||0
47969|NCT01906658|116524|P3|NOT COMPLETED|Overall Study||3
47970|NCT01906658|116525|P2|NOT COMPLETED|Overall Study||1
47971|NCT01906658|116526|P1|NOT COMPLETED|Overall Study||2
47972|NCT01906658|116523|P4|COMPLETED|Overall Study||11
47973|NCT01906658|116524|P3|COMPLETED|Overall Study||7
47974|NCT01906658|116525|P2|COMPLETED|Overall Study||10
47975|NCT01906658|116526|P1|COMPLETED|Overall Study||9
47976|NCT01906658|116523|P4|STARTED|Overall Study||11
47977|NCT01906658|116524|P3|STARTED|Overall Study||10
47978|NCT01906658|116525|P2|STARTED|Overall Study||11
47979|NCT01906658|116526|P1|STARTED|Overall Study||11
47980|NCT01906515|116550|P2|NOT COMPLETED|Overall Study||0
47981|NCT01906515|116551|P1|NOT COMPLETED|Overall Study||0
47982|NCT01906515|116550|P2|COMPLETED|Overall Study||61
47983|NCT01906515|116551|P1|COMPLETED|Overall Study||45
47984|NCT01906515|116550|P2|STARTED|Overall Study||61
47985|NCT01906515|116551|P1|STARTED|Overall Study||45
47986|NCT01906372|116559|P1|NOT COMPLETED|Overall Study||2
47987|NCT01906372|116559|P1|COMPLETED|Overall Study||10
47988|NCT01906372|116559|P1|Visit 10: Follow up Phase Completed|Overall Study||8
47989|NCT01906372|116559|P1|Visit 7: Treatment Phase Completed|Overall Study||10
47990|NCT01906372|116559|P1|STARTED|Overall Study||12
47991|NCT01905956|116566|P2|NOT COMPLETED|Overall Study||11
47992|NCT01905956|116567|P1|NOT COMPLETED|Overall Study||6
47993|NCT01905956|116566|P2|COMPLETED|Overall Study|Per-protocol population|48
47994|NCT01905956|116567|P1|COMPLETED|Overall Study|Per-protocol population|54
47995|NCT01905956|116566|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
47996|NCT01905956|116567|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
47997|NCT01905956|116566|P2|STARTED|Overall Study|Randomized|59
47998|NCT01905956|116567|P1|STARTED|Overall Study|Randomized|60
47999|NCT01905683|116589|P1|NOT COMPLETED|Overall Study||51
48000|NCT01905683|116589|P1|COMPLETED|Overall Study||319
48001|NCT01905683|116589|P1|STARTED|Overall Study||370
48002|NCT01905657|116605|P3|NOT COMPLETED|Overall Study||328
48003|NCT01905657|116606|P2|NOT COMPLETED|Overall Study||346
48004|NCT01905657|116607|P1|NOT COMPLETED|Overall Study||345
48005|NCT01905657|116605|P3|COMPLETED|Overall Study||15
48006|NCT01905657|116606|P2|COMPLETED|Overall Study||0
48007|NCT01905657|116607|P1|COMPLETED|Overall Study||0
48008|NCT01905657|116605|P3|Treated|Overall Study||309
48009|NCT01905657|116606|P2|Treated|Overall Study||343
48010|NCT01905657|116607|P1|Treated|Overall Study||339
48011|NCT01905657|116605|P3|STARTED|Overall Study||343
48012|NCT01905657|116606|P2|STARTED|Overall Study||346
48013|NCT01905657|116607|P1|STARTED|Overall Study||345
48014|NCT01905553|116632|P2|NOT COMPLETED|Period 2||0
48015|NCT01905553|116633|P1|NOT COMPLETED|Period 2||1
48016|NCT01905553|116632|P2|COMPLETED|Period 2||4
48017|NCT01905553|116633|P1|COMPLETED|Period 2||4
48018|NCT01905553|116632|P2|STARTED|Period 2||4
48019|NCT01905553|116633|P1|STARTED|Period 2||5
48020|NCT01905553|116632|P2|NOT COMPLETED|Period 1||0
48021|NCT01905553|116633|P1|NOT COMPLETED|Period 1||0
48022|NCT01905553|116632|P2|COMPLETED|Period 1||4
48023|NCT01905553|116633|P1|COMPLETED|Period 1||5
48024|NCT01905553|116632|P2|STARTED|Period 1||4
48025|NCT01905553|116633|P1|STARTED|Period 1||5
48026|NCT01905540|116647|P4|NOT COMPLETED|Period 3||1
48027|NCT01905540|116648|P3|NOT COMPLETED|Period 3||1
48028|NCT01905540|116649|P2|NOT COMPLETED|Period 3||0
48029|NCT01905540|116650|P1|NOT COMPLETED|Period 3||1
48030|NCT01905540|116647|P4|COMPLETED|Period 3||6
48031|NCT01905540|116648|P3|COMPLETED|Period 3||6
48032|NCT01905540|116649|P2|COMPLETED|Period 3||7
48033|NCT01905540|116650|P1|COMPLETED|Period 3||6
48034|NCT01905540|116647|P4|STARTED|Period 3||7
48035|NCT01905540|116648|P3|STARTED|Period 3||7
48036|NCT01905540|116649|P2|STARTED|Period 3||7
48037|NCT01905540|116650|P1|STARTED|Period 3||7
48038|NCT01905540|116647|P4|NOT COMPLETED|Period 2||0
48039|NCT01905540|116648|P3|NOT COMPLETED|Period 2||0
48040|NCT01905540|116649|P2|NOT COMPLETED|Period 2||0
48041|NCT01905540|116650|P1|NOT COMPLETED|Period 2||0
48042|NCT01905540|116647|P4|COMPLETED|Period 2||7
48043|NCT01905540|116648|P3|COMPLETED|Period 2||7
48044|NCT01905540|116649|P2|COMPLETED|Period 2||7
48045|NCT01905540|116650|P1|COMPLETED|Period 2||7
48046|NCT01905540|116647|P4|STARTED|Period 2||7
48047|NCT01905540|116648|P3|STARTED|Period 2||7
48048|NCT01905540|116649|P2|STARTED|Period 2||7
48049|NCT01905540|116650|P1|STARTED|Period 2||7
48050|NCT01905540|116647|P4|NOT COMPLETED|Period 1||0
48051|NCT01905540|116648|P3|NOT COMPLETED|Period 1||0
48052|NCT01905540|116649|P2|NOT COMPLETED|Period 1||0
48053|NCT01905540|116650|P1|NOT COMPLETED|Period 1||0
48054|NCT01905540|116647|P4|COMPLETED|Period 1||7
48055|NCT01905540|116648|P3|COMPLETED|Period 1||7
48056|NCT01905540|116649|P2|COMPLETED|Period 1||7
48057|NCT01905540|116650|P1|COMPLETED|Period 1||7
48058|NCT01905540|116647|P4|STARTED|Period 1||7
48059|NCT01905540|116648|P3|STARTED|Period 1||7
48060|NCT01905540|116649|P2|STARTED|Period 1||7
48061|NCT01905540|116650|P1|STARTED|Period 1||7
48062|NCT01905423|116672|P4|NOT COMPLETED|Overall Study||0
48063|NCT01905423|116673|P3|NOT COMPLETED|Overall Study||0
48064|NCT01905423|116674|P2|NOT COMPLETED|Overall Study||0
48065|NCT01905423|116675|P1|NOT COMPLETED|Overall Study||0
48066|NCT01905423|116672|P4|COMPLETED|Overall Study||3324
48067|NCT01905423|116673|P3|COMPLETED|Overall Study||4119
48068|NCT01905423|116674|P2|COMPLETED|Overall Study||4111
48069|NCT01905423|116675|P1|COMPLETED|Overall Study||7753
48070|NCT01905423|116672|P4|Year 3 Follow-up|Overall Study||0
48071|NCT01905423|116673|P3|Year 3 Follow-up|Overall Study||0
48072|NCT01905423|116674|P2|Year 3 Follow-up|Overall Study||1028
48073|NCT01905423|116675|P1|Year 3 Follow-up|Overall Study||1776
48074|NCT01905423|116672|P4|Year 2 Follow-up|Overall Study||0
48075|NCT01905423|116673|P3|Year 2 Follow-up|Overall Study||0
48076|NCT01905423|116674|P2|Year 2 Follow-up|Overall Study||1043
48077|NCT01905423|116675|P1|Year 2 Follow-up|Overall Study||1972
48078|NCT01905423|116672|P4|Year 1 Follow-up|Overall Study||1690
48079|NCT01905423|116673|P3|Year 1 Follow-up|Overall Study||2037
48080|NCT01905423|116674|P2|Year 1 Follow-up|Overall Study||1007
48081|NCT01905423|116675|P1|Year 1 Follow-up|Overall Study||1840
48082|NCT01905423|116672|P4|Baseline|Overall Study||1634
48083|NCT01905423|116673|P3|Baseline|Overall Study||2082
48084|NCT01905423|116674|P2|Baseline|Overall Study||1033
48085|NCT01905423|116675|P1|Baseline|Overall Study||2165
48086|NCT01905423|116672|P4|STARTED|Overall Study||3324
48087|NCT01905423|116673|P3|STARTED|Overall Study||4119
48088|NCT01905423|116674|P2|STARTED|Overall Study||4111
48089|NCT01905423|116675|P1|STARTED|Overall Study||7753
48090|NCT01905254|116683|P1|NOT COMPLETED|Overall Study||0
48091|NCT01905254|116683|P1|COMPLETED|Overall Study||34
48092|NCT01905254|116683|P1|STARTED|Overall Study||34
48093|NCT01904864|116689|P2|NOT COMPLETED|Overall Study||12
48094|NCT01904864|116690|P1|NOT COMPLETED|Overall Study||9
48095|NCT01904864|116689|P2|COMPLETED|Overall Study||28
48096|NCT01904864|116690|P1|COMPLETED|Overall Study||31
48097|NCT01904864|116689|P2|STARTED|Overall Study||40
48098|NCT01904864|116690|P1|STARTED|Overall Study||40
48099|NCT01904773|116696|P9|NOT COMPLETED|Sixth Intervention||0
48100|NCT01904773|116697|P8|NOT COMPLETED|Sixth Intervention||0
48101|NCT01904773|116698|P7|NOT COMPLETED|Sixth Intervention||0
48102|NCT01904773|116699|P6|NOT COMPLETED|Sixth Intervention||0
48103|NCT01904773|116700|P5|NOT COMPLETED|Sixth Intervention||0
48104|NCT01904773|116701|P4|NOT COMPLETED|Sixth Intervention||0
48105|NCT01904773|116702|P3|NOT COMPLETED|Sixth Intervention||0
48106|NCT01904773|116703|P2|NOT COMPLETED|Sixth Intervention||0
48107|NCT01904773|116704|P1|NOT COMPLETED|Sixth Intervention||0
48108|NCT01904773|116696|P9|COMPLETED|Sixth Intervention||4
48109|NCT01904773|116697|P8|COMPLETED|Sixth Intervention||2
48110|NCT01904773|116698|P7|COMPLETED|Sixth Intervention||3
48111|NCT01904773|116699|P6|COMPLETED|Sixth Intervention||4
48112|NCT01904773|116700|P5|COMPLETED|Sixth Intervention||3
48113|NCT01904773|116701|P4|COMPLETED|Sixth Intervention||2
48114|NCT01904773|116702|P3|COMPLETED|Sixth Intervention||1
48115|NCT01904773|116703|P2|COMPLETED|Sixth Intervention||0
48116|NCT01904773|116704|P1|COMPLETED|Sixth Intervention||0
48117|NCT01904773|116696|P9|STARTED|Sixth Intervention||4
48118|NCT01904773|116697|P8|STARTED|Sixth Intervention||2
48119|NCT01904773|116698|P7|STARTED|Sixth Intervention||3
48120|NCT01904773|116699|P6|STARTED|Sixth Intervention||4
48121|NCT01904773|116700|P5|STARTED|Sixth Intervention||3
48122|NCT01904773|116701|P4|STARTED|Sixth Intervention||2
48123|NCT01904773|116702|P3|STARTED|Sixth Intervention||1
48124|NCT01904773|116703|P2|STARTED|Sixth Intervention||0
48125|NCT01904773|116704|P1|STARTED|Sixth Intervention||0
48126|NCT01904773|116696|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48127|NCT01904773|116697|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48128|NCT01904773|116698|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48129|NCT01904773|116699|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48130|NCT01904773|116700|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48131|NCT01904773|116701|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48132|NCT01904773|116702|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48133|NCT01904773|116703|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
48134|NCT01904773|116704|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
48135|NCT01904773|116696|P9|COMPLETED|Placebo Washout Fifth Intervention||4
48136|NCT01904773|116697|P8|COMPLETED|Placebo Washout Fifth Intervention||2
48137|NCT01904773|116698|P7|COMPLETED|Placebo Washout Fifth Intervention||3
48138|NCT01904773|116699|P6|COMPLETED|Placebo Washout Fifth Intervention||4
48139|NCT01904773|116700|P5|COMPLETED|Placebo Washout Fifth Intervention||3
48140|NCT01904773|116701|P4|COMPLETED|Placebo Washout Fifth Intervention||2
48141|NCT01904773|116702|P3|COMPLETED|Placebo Washout Fifth Intervention||1
48142|NCT01904773|116703|P2|COMPLETED|Placebo Washout Fifth Intervention||0
48143|NCT01904773|116704|P1|COMPLETED|Placebo Washout Fifth Intervention||0
48144|NCT01904773|116696|P9|STARTED|Placebo Washout Fifth Intervention||4
48145|NCT01904773|116697|P8|STARTED|Placebo Washout Fifth Intervention||2
48146|NCT01904773|116698|P7|STARTED|Placebo Washout Fifth Intervention||3
48147|NCT01904773|116699|P6|STARTED|Placebo Washout Fifth Intervention||4
48148|NCT01904773|116700|P5|STARTED|Placebo Washout Fifth Intervention||3
48149|NCT01904773|116701|P4|STARTED|Placebo Washout Fifth Intervention||2
48150|NCT01904773|116702|P3|STARTED|Placebo Washout Fifth Intervention||1
48151|NCT01904773|116703|P2|STARTED|Placebo Washout Fifth Intervention||1
48152|NCT01904773|116704|P1|STARTED|Placebo Washout Fifth Intervention||0
48153|NCT01904773|116696|P9|NOT COMPLETED|Fifth Intervention||0
48154|NCT01904773|116697|P8|NOT COMPLETED|Fifth Intervention||1
48155|NCT01904773|116698|P7|NOT COMPLETED|Fifth Intervention||0
48156|NCT01904773|116699|P6|NOT COMPLETED|Fifth Intervention||0
48157|NCT01904773|116700|P5|NOT COMPLETED|Fifth Intervention||0
48158|NCT01904773|116701|P4|NOT COMPLETED|Fifth Intervention||0
48159|NCT01904773|116702|P3|NOT COMPLETED|Fifth Intervention||0
48160|NCT01904773|116703|P2|NOT COMPLETED|Fifth Intervention||0
48161|NCT01904773|116704|P1|NOT COMPLETED|Fifth Intervention||0
48162|NCT01904773|116696|P9|COMPLETED|Fifth Intervention||4
48163|NCT01904773|116697|P8|COMPLETED|Fifth Intervention||2
48164|NCT01904773|116698|P7|COMPLETED|Fifth Intervention||3
48165|NCT01904773|116699|P6|COMPLETED|Fifth Intervention||4
48166|NCT01904773|116700|P5|COMPLETED|Fifth Intervention||3
48167|NCT01904773|116701|P4|COMPLETED|Fifth Intervention||2
48168|NCT01904773|116702|P3|COMPLETED|Fifth Intervention||1
48169|NCT01904773|116703|P2|COMPLETED|Fifth Intervention||1
48170|NCT01904773|116704|P1|COMPLETED|Fifth Intervention||0
48171|NCT01904773|116696|P9|STARTED|Fifth Intervention||4
48172|NCT01904773|116697|P8|STARTED|Fifth Intervention||3
48173|NCT01904773|116698|P7|STARTED|Fifth Intervention||3
48174|NCT01904773|116699|P6|STARTED|Fifth Intervention||4
48175|NCT01904773|116700|P5|STARTED|Fifth Intervention||3
48176|NCT01904773|116701|P4|STARTED|Fifth Intervention||2
48177|NCT01904773|116702|P3|STARTED|Fifth Intervention||1
48178|NCT01904773|116703|P2|STARTED|Fifth Intervention||1
48179|NCT01904773|116704|P1|STARTED|Fifth Intervention||0
48180|NCT01904773|116696|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48181|NCT01904773|116697|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48182|NCT01904773|116698|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48183|NCT01904773|116699|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48184|NCT01904773|116700|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48185|NCT01904773|116701|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48186|NCT01904773|116702|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48187|NCT01904773|116703|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48188|NCT01904773|116704|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
48189|NCT01904773|116696|P9|COMPLETED|Placebo Washout Fourth Intervention||4
48190|NCT01904773|116697|P8|COMPLETED|Placebo Washout Fourth Intervention||3
48191|NCT01904773|116698|P7|COMPLETED|Placebo Washout Fourth Intervention||3
48192|NCT01904773|116699|P6|COMPLETED|Placebo Washout Fourth Intervention||4
48193|NCT01904773|116700|P5|COMPLETED|Placebo Washout Fourth Intervention||3
48194|NCT01904773|116701|P4|COMPLETED|Placebo Washout Fourth Intervention||2
48195|NCT01904773|116702|P3|COMPLETED|Placebo Washout Fourth Intervention||1
48196|NCT01904773|116703|P2|COMPLETED|Placebo Washout Fourth Intervention||1
48197|NCT01904773|116704|P1|COMPLETED|Placebo Washout Fourth Intervention||0
48198|NCT01904773|116696|P9|STARTED|Placebo Washout Fourth Intervention||4
48199|NCT01904773|116697|P8|STARTED|Placebo Washout Fourth Intervention||3
48200|NCT01904773|116698|P7|STARTED|Placebo Washout Fourth Intervention||3
48201|NCT01904773|116699|P6|STARTED|Placebo Washout Fourth Intervention||4
48202|NCT01904773|116700|P5|STARTED|Placebo Washout Fourth Intervention||3
48203|NCT01904773|116701|P4|STARTED|Placebo Washout Fourth Intervention||2
48204|NCT01904773|116702|P3|STARTED|Placebo Washout Fourth Intervention||1
48205|NCT01904773|116703|P2|STARTED|Placebo Washout Fourth Intervention||1
48206|NCT01904773|116704|P1|STARTED|Placebo Washout Fourth Intervention||0
48207|NCT01904773|116696|P9|NOT COMPLETED|Fourth Intervention||0
48208|NCT01904773|116697|P8|NOT COMPLETED|Fourth Intervention||0
48209|NCT01904773|116698|P7|NOT COMPLETED|Fourth Intervention||0
48210|NCT01904773|116699|P6|NOT COMPLETED|Fourth Intervention||0
48211|NCT01904773|116700|P5|NOT COMPLETED|Fourth Intervention||0
48212|NCT01904773|116701|P4|NOT COMPLETED|Fourth Intervention||0
48213|NCT01904773|116702|P3|NOT COMPLETED|Fourth Intervention||0
48214|NCT01904773|116703|P2|NOT COMPLETED|Fourth Intervention||0
48215|NCT01904773|116704|P1|NOT COMPLETED|Fourth Intervention||0
48216|NCT01904773|116696|P9|COMPLETED|Fourth Intervention||4
48217|NCT01904773|116697|P8|COMPLETED|Fourth Intervention||3
48218|NCT01904773|116698|P7|COMPLETED|Fourth Intervention||3
48219|NCT01904773|116699|P6|COMPLETED|Fourth Intervention||4
48220|NCT01904773|116700|P5|COMPLETED|Fourth Intervention||3
48221|NCT01904773|116701|P4|COMPLETED|Fourth Intervention||2
48222|NCT01904773|116702|P3|COMPLETED|Fourth Intervention||1
48223|NCT01904773|116703|P2|COMPLETED|Fourth Intervention||1
48224|NCT01904773|116704|P1|COMPLETED|Fourth Intervention||0
48225|NCT01904773|116696|P9|STARTED|Fourth Intervention||4
48226|NCT01904773|116697|P8|STARTED|Fourth Intervention||3
48227|NCT01904773|116698|P7|STARTED|Fourth Intervention||3
48228|NCT01904773|116699|P6|STARTED|Fourth Intervention||4
48229|NCT01904773|116700|P5|STARTED|Fourth Intervention||3
48230|NCT01904773|116701|P4|STARTED|Fourth Intervention||2
48231|NCT01904773|116702|P3|STARTED|Fourth Intervention||1
48232|NCT01904773|116703|P2|STARTED|Fourth Intervention||1
48233|NCT01904773|116704|P1|STARTED|Fourth Intervention||0
48234|NCT01904773|116696|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
48235|NCT01904773|116697|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
48236|NCT01904773|116698|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
48237|NCT01904773|116699|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
48238|NCT01904773|116700|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
48239|NCT01904773|116701|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
48240|NCT01904773|116702|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
48241|NCT01904773|116703|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
48242|NCT01904773|116704|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
48243|NCT01904773|116696|P9|COMPLETED|Placebo Washout Third Intervention||4
48244|NCT01904773|116697|P8|COMPLETED|Placebo Washout Third Intervention||3
48245|NCT01904773|116698|P7|COMPLETED|Placebo Washout Third Intervention||3
48246|NCT01904773|116699|P6|COMPLETED|Placebo Washout Third Intervention||4
48247|NCT01904773|116700|P5|COMPLETED|Placebo Washout Third Intervention||3
48248|NCT01904773|116701|P4|COMPLETED|Placebo Washout Third Intervention||2
48249|NCT01904773|116702|P3|COMPLETED|Placebo Washout Third Intervention||1
48250|NCT01904773|116703|P2|COMPLETED|Placebo Washout Third Intervention||1
48251|NCT01904773|116704|P1|COMPLETED|Placebo Washout Third Intervention||0
48252|NCT01904773|116696|P9|STARTED|Placebo Washout Third Intervention||4
48253|NCT01904773|116697|P8|STARTED|Placebo Washout Third Intervention||3
48254|NCT01904773|116698|P7|STARTED|Placebo Washout Third Intervention||3
48255|NCT01904773|116699|P6|STARTED|Placebo Washout Third Intervention||4
48256|NCT01904773|116700|P5|STARTED|Placebo Washout Third Intervention||3
48257|NCT01904773|116701|P4|STARTED|Placebo Washout Third Intervention||2
48258|NCT01904773|116702|P3|STARTED|Placebo Washout Third Intervention||1
48259|NCT01904773|116703|P2|STARTED|Placebo Washout Third Intervention||1
48260|NCT01904773|116704|P1|STARTED|Placebo Washout Third Intervention||0
48261|NCT01904773|116696|P9|NOT COMPLETED|Third Intervention||0
48262|NCT01904773|116697|P8|NOT COMPLETED|Third Intervention||0
48263|NCT01904773|116698|P7|NOT COMPLETED|Third Intervention||0
48264|NCT01904773|116699|P6|NOT COMPLETED|Third Intervention||0
48265|NCT01904773|116700|P5|NOT COMPLETED|Third Intervention||0
48266|NCT01904773|116701|P4|NOT COMPLETED|Third Intervention||0
48267|NCT01904773|116702|P3|NOT COMPLETED|Third Intervention||0
48268|NCT01904773|116703|P2|NOT COMPLETED|Third Intervention||0
48269|NCT01904773|116704|P1|NOT COMPLETED|Third Intervention||0
48270|NCT01904773|116696|P9|COMPLETED|Third Intervention||4
48271|NCT01904773|116697|P8|COMPLETED|Third Intervention||3
48272|NCT01904773|116698|P7|COMPLETED|Third Intervention||3
48273|NCT01904773|116699|P6|COMPLETED|Third Intervention||4
48274|NCT01904773|116700|P5|COMPLETED|Third Intervention||3
48275|NCT01904773|116701|P4|COMPLETED|Third Intervention||2
48276|NCT01904773|116702|P3|COMPLETED|Third Intervention||1
48277|NCT01904773|116703|P2|COMPLETED|Third Intervention||1
48278|NCT01904773|116704|P1|COMPLETED|Third Intervention||0
48279|NCT01904773|116696|P9|STARTED|Third Intervention||4
48280|NCT01904773|116697|P8|STARTED|Third Intervention||3
48281|NCT01904773|116698|P7|STARTED|Third Intervention||3
48282|NCT01904773|116699|P6|STARTED|Third Intervention||4
48283|NCT01904773|116700|P5|STARTED|Third Intervention||3
48284|NCT01904773|116701|P4|STARTED|Third Intervention||2
48285|NCT01904773|116702|P3|STARTED|Third Intervention||1
48286|NCT01904773|116703|P2|STARTED|Third Intervention||1
48287|NCT01904773|116704|P1|STARTED|Third Intervention||0
48288|NCT01904773|116696|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
48289|NCT01904773|116697|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
48290|NCT01904773|116698|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
48291|NCT01904773|116699|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
48292|NCT01904773|116700|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
48293|NCT01904773|116701|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
48294|NCT01904773|116702|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
48295|NCT01904773|116703|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
48296|NCT01904773|116704|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
48297|NCT01904773|116696|P9|COMPLETED|Placebo Washout Second Intervention||4
48298|NCT01904773|116697|P8|COMPLETED|Placebo Washout Second Intervention||3
48299|NCT01904773|116698|P7|COMPLETED|Placebo Washout Second Intervention||3
48300|NCT01904773|116699|P6|COMPLETED|Placebo Washout Second Intervention||4
48301|NCT01904773|116700|P5|COMPLETED|Placebo Washout Second Intervention||3
48302|NCT01904773|116701|P4|COMPLETED|Placebo Washout Second Intervention||2
48303|NCT01904773|116702|P3|COMPLETED|Placebo Washout Second Intervention||1
48304|NCT01904773|116703|P2|COMPLETED|Placebo Washout Second Intervention||1
48305|NCT01904773|116704|P1|COMPLETED|Placebo Washout Second Intervention||0
48306|NCT01904773|116696|P9|STARTED|Placebo Washout Second Intervention||4
48307|NCT01904773|116697|P8|STARTED|Placebo Washout Second Intervention||3
48308|NCT01904773|116698|P7|STARTED|Placebo Washout Second Intervention||3
48309|NCT01904773|116699|P6|STARTED|Placebo Washout Second Intervention||4
48310|NCT01904773|116700|P5|STARTED|Placebo Washout Second Intervention||3
48311|NCT01904773|116701|P4|STARTED|Placebo Washout Second Intervention||2
48312|NCT01904773|116702|P3|STARTED|Placebo Washout Second Intervention||1
48313|NCT01904773|116703|P2|STARTED|Placebo Washout Second Intervention||1
48314|NCT01904773|116704|P1|STARTED|Placebo Washout Second Intervention||0
48315|NCT01904773|116696|P9|NOT COMPLETED|Second Intervention||0
48316|NCT01904773|116697|P8|NOT COMPLETED|Second Intervention||0
48317|NCT01904773|116698|P7|NOT COMPLETED|Second Intervention||0
48318|NCT01904773|116699|P6|NOT COMPLETED|Second Intervention||0
48319|NCT01904773|116700|P5|NOT COMPLETED|Second Intervention||0
48320|NCT01904773|116701|P4|NOT COMPLETED|Second Intervention||0
48321|NCT01904773|116702|P3|NOT COMPLETED|Second Intervention||0
48322|NCT01904773|116703|P2|NOT COMPLETED|Second Intervention||0
48323|NCT01904773|116704|P1|NOT COMPLETED|Second Intervention||0
48324|NCT01904773|116696|P9|COMPLETED|Second Intervention||4
48325|NCT01904773|116697|P8|COMPLETED|Second Intervention||3
48326|NCT01904773|116698|P7|COMPLETED|Second Intervention||3
48327|NCT01904773|116699|P6|COMPLETED|Second Intervention||4
48328|NCT01904773|116700|P5|COMPLETED|Second Intervention||3
48329|NCT01904773|116701|P4|COMPLETED|Second Intervention||2
48330|NCT01904773|116702|P3|COMPLETED|Second Intervention||1
48331|NCT01904773|116703|P2|COMPLETED|Second Intervention||1
48332|NCT01904773|116704|P1|COMPLETED|Second Intervention||0
48333|NCT01904773|116696|P9|STARTED|Second Intervention||4
48334|NCT01904773|116697|P8|STARTED|Second Intervention||3
48335|NCT01904773|116698|P7|STARTED|Second Intervention||3
48336|NCT01904773|116699|P6|STARTED|Second Intervention||4
48337|NCT01904773|116700|P5|STARTED|Second Intervention||3
48338|NCT01904773|116701|P4|STARTED|Second Intervention||2
48339|NCT01904773|116702|P3|STARTED|Second Intervention||1
48340|NCT01904773|116703|P2|STARTED|Second Intervention||1
48341|NCT01904773|116704|P1|STARTED|Second Intervention||0
48342|NCT01904773|116696|P9|NOT COMPLETED|Placebo Washout First Intervention||0
48343|NCT01904773|116697|P8|NOT COMPLETED|Placebo Washout First Intervention||0
48344|NCT01904773|116698|P7|NOT COMPLETED|Placebo Washout First Intervention||0
48345|NCT01904773|116699|P6|NOT COMPLETED|Placebo Washout First Intervention||0
48346|NCT01904773|116700|P5|NOT COMPLETED|Placebo Washout First Intervention||0
48347|NCT01904773|116701|P4|NOT COMPLETED|Placebo Washout First Intervention||0
48348|NCT01904773|116702|P3|NOT COMPLETED|Placebo Washout First Intervention||0
48349|NCT01904773|116703|P2|NOT COMPLETED|Placebo Washout First Intervention||1
48350|NCT01904773|116704|P1|NOT COMPLETED|Placebo Washout First Intervention||0
48351|NCT01904773|116696|P9|COMPLETED|Placebo Washout First Intervention||4
48352|NCT01904773|116697|P8|COMPLETED|Placebo Washout First Intervention||3
48353|NCT01904773|116698|P7|COMPLETED|Placebo Washout First Intervention||3
48354|NCT01904773|116699|P6|COMPLETED|Placebo Washout First Intervention||4
48355|NCT01904773|116700|P5|COMPLETED|Placebo Washout First Intervention||3
48356|NCT01904773|116701|P4|COMPLETED|Placebo Washout First Intervention||2
48357|NCT01904773|116702|P3|COMPLETED|Placebo Washout First Intervention||1
48358|NCT01904773|116703|P2|COMPLETED|Placebo Washout First Intervention||1
48359|NCT01904773|116704|P1|COMPLETED|Placebo Washout First Intervention||0
48360|NCT01904773|116696|P9|STARTED|Placebo Washout First Intervention||4
48361|NCT01904773|116697|P8|STARTED|Placebo Washout First Intervention||3
48362|NCT01904773|116698|P7|STARTED|Placebo Washout First Intervention||3
48363|NCT01904773|116699|P6|STARTED|Placebo Washout First Intervention||4
48364|NCT01904773|116700|P5|STARTED|Placebo Washout First Intervention||3
48365|NCT01904773|116701|P4|STARTED|Placebo Washout First Intervention||2
48366|NCT01904773|116702|P3|STARTED|Placebo Washout First Intervention||1
48367|NCT01904773|116703|P2|STARTED|Placebo Washout First Intervention||2
48368|NCT01904773|116704|P1|STARTED|Placebo Washout First Intervention||0
48369|NCT01904773|116696|P9|NOT COMPLETED|First Intervention||0
48370|NCT01904773|116697|P8|NOT COMPLETED|First Intervention||0
48371|NCT01904773|116698|P7|NOT COMPLETED|First Intervention||1
48372|NCT01904773|116699|P6|NOT COMPLETED|First Intervention||0
48373|NCT01904773|116700|P5|NOT COMPLETED|First Intervention||0
48374|NCT01904773|116701|P4|NOT COMPLETED|First Intervention||0
48375|NCT01904773|116702|P3|NOT COMPLETED|First Intervention||0
48376|NCT01904773|116703|P2|NOT COMPLETED|First Intervention||0
48377|NCT01904773|116704|P1|NOT COMPLETED|First Intervention||0
48378|NCT01904773|116696|P9|COMPLETED|First Intervention||4
48379|NCT01904773|116697|P8|COMPLETED|First Intervention||3
48380|NCT01904773|116698|P7|COMPLETED|First Intervention||3
48381|NCT01904773|116699|P6|COMPLETED|First Intervention||4
48382|NCT01904773|116700|P5|COMPLETED|First Intervention||3
48383|NCT01904773|116701|P4|COMPLETED|First Intervention||2
48384|NCT01904773|116702|P3|COMPLETED|First Intervention||1
48385|NCT01904773|116703|P2|COMPLETED|First Intervention||2
48386|NCT01904773|116704|P1|COMPLETED|First Intervention||0
48387|NCT01904773|116696|P9|STARTED|First Intervention||4
48388|NCT01904773|116697|P8|STARTED|First Intervention||3
48389|NCT01904773|116698|P7|STARTED|First Intervention||4
48390|NCT01904773|116699|P6|STARTED|First Intervention||4
48391|NCT01904773|116700|P5|STARTED|First Intervention||3
48392|NCT01904773|116701|P4|STARTED|First Intervention||2
48393|NCT01904773|116702|P3|STARTED|First Intervention||1
48394|NCT01904773|116703|P2|STARTED|First Intervention||2
48395|NCT01904773|116704|P1|STARTED|First Intervention||0
48396|NCT01904773|116696|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48397|NCT01904773|116697|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48398|NCT01904773|116698|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48399|NCT01904773|116699|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48400|NCT01904773|116700|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48401|NCT01904773|116701|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48402|NCT01904773|116702|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48403|NCT01904773|116703|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48404|NCT01904773|116704|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
48405|NCT01904773|116696|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48406|NCT01904773|116697|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48407|NCT01904773|116698|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48408|NCT01904773|116699|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48409|NCT01904773|116700|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48410|NCT01904773|116701|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48411|NCT01904773|116702|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48412|NCT01904773|116703|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48413|NCT01904773|116704|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
48414|NCT01904773|116696|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48415|NCT01904773|116697|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48416|NCT01904773|116698|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48417|NCT01904773|116699|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48418|NCT01904773|116700|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48419|NCT01904773|116701|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48420|NCT01904773|116702|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48421|NCT01904773|116703|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48422|NCT01904773|116704|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
48423|NCT01904773|116696|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48424|NCT01904773|116697|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48425|NCT01904773|116698|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48426|NCT01904773|116699|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48427|NCT01904773|116700|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48428|NCT01904773|116701|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48429|NCT01904773|116702|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48430|NCT01904773|116703|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48431|NCT01904773|116704|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
48432|NCT01904773|116696|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48433|NCT01904773|116697|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48434|NCT01904773|116698|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48435|NCT01904773|116699|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48436|NCT01904773|116700|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48437|NCT01904773|116701|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48438|NCT01904773|116702|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48439|NCT01904773|116703|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
48440|NCT01904773|116704|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
48441|NCT01904773|116696|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48442|NCT01904773|116697|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48443|NCT01904773|116698|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48444|NCT01904773|116699|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48445|NCT01904773|116700|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48446|NCT01904773|116701|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48447|NCT01904773|116702|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48448|NCT01904773|116703|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48449|NCT01904773|116704|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48450|NCT01904773|116696|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48451|NCT01904773|116697|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48452|NCT01904773|116698|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48453|NCT01904773|116699|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48454|NCT01904773|116700|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48455|NCT01904773|116701|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48456|NCT01904773|116702|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48457|NCT01904773|116703|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48458|NCT01904773|116704|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
48459|NCT01904773|116696|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48460|NCT01904773|116697|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48461|NCT01904773|116698|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48462|NCT01904773|116699|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48463|NCT01904773|116700|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48464|NCT01904773|116701|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48465|NCT01904773|116702|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48466|NCT01904773|116703|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
48467|NCT01904773|116704|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
48468|NCT01904773|116696|P9|NOT COMPLETED|Screen||0
48469|NCT01904773|116697|P8|NOT COMPLETED|Screen||0
48470|NCT01904773|116698|P7|NOT COMPLETED|Screen||0
48471|NCT01904773|116699|P6|NOT COMPLETED|Screen||0
48472|NCT01904773|116700|P5|NOT COMPLETED|Screen||0
48473|NCT01904773|116701|P4|NOT COMPLETED|Screen||0
48474|NCT01904773|116702|P3|NOT COMPLETED|Screen||0
48475|NCT01904773|116703|P2|NOT COMPLETED|Screen||0
48476|NCT01904773|116704|P1|NOT COMPLETED|Screen||4
48477|NCT01904773|116696|P9|COMPLETED|Screen||0
48478|NCT01904773|116697|P8|COMPLETED|Screen||0
48479|NCT01904773|116698|P7|COMPLETED|Screen||0
48480|NCT01904773|116699|P6|COMPLETED|Screen||0
48481|NCT01904773|116700|P5|COMPLETED|Screen||0
48482|NCT01904773|116701|P4|COMPLETED|Screen||0
48483|NCT01904773|116702|P3|COMPLETED|Screen||0
48484|NCT01904773|116703|P2|COMPLETED|Screen||0
48485|NCT01904773|116704|P1|COMPLETED|Screen||24
48486|NCT01904773|116696|P9|STARTED|Screen||0
48487|NCT01904773|116697|P8|STARTED|Screen||0
48488|NCT01904773|116698|P7|STARTED|Screen||0
48489|NCT01904773|116699|P6|STARTED|Screen||0
48490|NCT01904773|116700|P5|STARTED|Screen||0
48491|NCT01904773|116701|P4|STARTED|Screen||0
48492|NCT01904773|116702|P3|STARTED|Screen||0
48493|NCT01904773|116703|P2|STARTED|Screen||0
48494|NCT01904773|116704|P1|STARTED|Screen||28
48495|NCT01904760|116721|P2|NOT COMPLETED|Overall Study||0
48496|NCT01904760|116722|P1|NOT COMPLETED|Overall Study||1
48497|NCT01904760|116721|P2|COMPLETED|Overall Study||40
48498|NCT01904760|116722|P1|COMPLETED|Overall Study||39
48499|NCT01904760|116721|P2|STARTED|Overall Study||40
48500|NCT01904760|116722|P1|STARTED|Overall Study||40
48501|NCT01904721|116737|P7|NOT COMPLETED|Overall Study||7
48502|NCT01904721|116738|P6|NOT COMPLETED|Overall Study||9
48503|NCT01904721|116739|P5|NOT COMPLETED|Overall Study||8
48504|NCT01904721|116740|P4|NOT COMPLETED|Overall Study||1
48505|NCT01904721|116741|P3|NOT COMPLETED|Overall Study||1
48506|NCT01904721|116742|P2|NOT COMPLETED|Overall Study||0
48507|NCT01904721|116743|P1|NOT COMPLETED|Overall Study||0
48508|NCT01904721|116737|P7|COMPLETED|Overall Study||57
48509|NCT01904721|116738|P6|COMPLETED|Overall Study||56
48510|NCT01904721|116739|P5|COMPLETED|Overall Study||57
48511|NCT01904721|116740|P4|COMPLETED|Overall Study||11
48512|NCT01904721|116741|P3|COMPLETED|Overall Study||11
48513|NCT01904721|116742|P2|COMPLETED|Overall Study||13
48514|NCT01904721|116743|P1|COMPLETED|Overall Study||13
48515|NCT01904721|116737|P7|STARTED|Overall Study||64
48516|NCT01904721|116738|P6|STARTED|Overall Study||65
48517|NCT01904721|116739|P5|STARTED|Overall Study||65
48518|NCT01904721|116740|P4|STARTED|Overall Study||12
48519|NCT01904721|116741|P3|STARTED|Overall Study||12
48520|NCT01904721|116742|P2|STARTED|Overall Study||13
48521|NCT01904721|116743|P1|STARTED|Overall Study||13
48522|NCT01904604|116773|P3|NOT COMPLETED|Overall Study||0
48523|NCT01904604|116774|P2|NOT COMPLETED|Overall Study||4
48524|NCT01904604|116775|P1|NOT COMPLETED|Overall Study||3
48525|NCT01904604|116773|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|25
48526|NCT01904604|116774|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|21
48527|NCT01904604|116775|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|22
48528|NCT01904604|116773|P3|STARTED|Overall Study||25
48529|NCT01904604|116774|P2|STARTED|Overall Study||25
48530|NCT01904604|116775|P1|STARTED|Overall Study||25
48531|NCT01904526|116791|P1|NOT COMPLETED|Overall Study||0
48532|NCT01904526|116791|P1|COMPLETED|Overall Study||5
48533|NCT01904526|116791|P1|STARTED|Overall Study||5
48534|NCT01904279|116807|P2|NOT COMPLETED|Overall Study||3
48535|NCT01904279|116808|P1|NOT COMPLETED|Overall Study||3
48536|NCT01904279|116807|P2|COMPLETED|Overall Study||22
48537|NCT01904279|116808|P1|COMPLETED|Overall Study||24
48538|NCT01904279|116807|P2|STARTED|Overall Study||25
48539|NCT01904279|116808|P1|STARTED|Overall Study||27
48540|NCT01904149|116834|P6|NOT COMPLETED|Overall Study||3
48541|NCT01904149|116835|P5|NOT COMPLETED|Overall Study||5
48542|NCT01904149|116836|P4|NOT COMPLETED|Overall Study||4
48543|NCT01904149|116837|P3|NOT COMPLETED|Overall Study||2
48544|NCT01904149|116838|P2|NOT COMPLETED|Overall Study||11
48545|NCT01904149|116839|P1|NOT COMPLETED|Overall Study||5
48546|NCT01904149|116834|P6|COMPLETED|Overall Study||48
48547|NCT01904149|116835|P5|COMPLETED|Overall Study||46
48548|NCT01904149|116836|P4|COMPLETED|Overall Study||47
48549|NCT01904149|116837|P3|COMPLETED|Overall Study||148
48550|NCT01904149|116838|P2|COMPLETED|Overall Study||140
48551|NCT01904149|116839|P1|COMPLETED|Overall Study||147
48552|NCT01904149|116834|P6|Multiple-dose Phase|Overall Study||49
48553|NCT01904149|116835|P5|Multiple-dose Phase|Overall Study||48
48554|NCT01904149|116836|P4|Multiple-dose Phase|Overall Study||48
48555|NCT01904149|116837|P3|Multiple-dose Phase|Overall Study||149
48556|NCT01904149|116838|P2|Multiple-dose Phase|Overall Study||146
48557|NCT01904149|116839|P1|Multiple-dose Phase|Overall Study||150
48558|NCT01904149|116834|P6|Single-dose Phase|Overall Study||51
48559|NCT01904149|116835|P5|Single-dose Phase|Overall Study||51
48560|NCT01904149|116836|P4|Single-dose Phase|Overall Study||51
48561|NCT01904149|116837|P3|Single-dose Phase|Overall Study||150
48562|NCT01904149|116838|P2|Single-dose Phase|Overall Study||151
48563|NCT01904149|116839|P1|Single-dose Phase|Overall Study||152
48564|NCT01904149|116834|P6|STARTED|Overall Study||51
48565|NCT01904149|116835|P5|STARTED|Overall Study||51
48566|NCT01904149|116836|P4|STARTED|Overall Study||51
48567|NCT01904149|116837|P3|STARTED|Overall Study||150
48568|NCT01904149|116838|P2|STARTED|Overall Study||151
48569|NCT01904149|116839|P1|STARTED|Overall Study||152
48570|NCT01904071|116864|P3|NOT COMPLETED|Overall Study||0
48571|NCT01904071|116865|P2|NOT COMPLETED|Overall Study||0
48572|NCT01904071|116866|P1|NOT COMPLETED|Overall Study||0
48573|NCT01904071|116864|P3|COMPLETED|Overall Study||20
48574|NCT01904071|116865|P2|COMPLETED|Overall Study||20
48575|NCT01904071|116866|P1|COMPLETED|Overall Study||24
48576|NCT01904071|116864|P3|STARTED|Overall Study||20
48577|NCT01904071|116865|P2|STARTED|Overall Study||20
48578|NCT01904071|116866|P1|STARTED|Overall Study||24
48579|NCT01904058|116890|P4|NOT COMPLETED|Overall Study||1
48580|NCT01904058|116891|P3|NOT COMPLETED|Overall Study||1
48581|NCT01904058|116892|P2|NOT COMPLETED|Overall Study||0
48582|NCT01904058|116893|P1|NOT COMPLETED|Overall Study||3
48583|NCT01904058|116890|P4|COMPLETED|Overall Study||12
48584|NCT01904058|116891|P3|COMPLETED|Overall Study||10
48585|NCT01904058|116892|P2|COMPLETED|Overall Study||21
48586|NCT01904058|116893|P1|COMPLETED|Overall Study||18
48587|NCT01904058|116890|P4|STARTED|Overall Study||13
48588|NCT01904058|116891|P3|STARTED|Overall Study||11
48589|NCT01904058|116892|P2|STARTED|Overall Study||21
48590|NCT01904058|116893|P1|STARTED|Overall Study||21
48591|NCT01903993|116933|P2|NOT COMPLETED|Overall Study||95
48592|NCT01903993|116934|P1|NOT COMPLETED|Overall Study||123
48593|NCT01903993|116933|P2|COMPLETED|Overall Study||49
48594|NCT01903993|116934|P1|COMPLETED|Overall Study||20
48595|NCT01903993|116933|P2|Received Treatment|Overall Study||142
48596|NCT01903993|116934|P1|Received Treatment|Overall Study||135
48597|NCT01903993|116933|P2|STARTED|Overall Study||144
48598|NCT01903993|116934|P1|STARTED|Overall Study||143
48599|NCT01903876|116951|P2|NOT COMPLETED|Six-Month Follow-up Period||145
48600|NCT01903876|116952|P1|NOT COMPLETED|Six-Month Follow-up Period||91
48601|NCT01903876|116951|P2|COMPLETED|Six-Month Follow-up Period||123
48602|NCT01903876|116952|P1|COMPLETED|Six-Month Follow-up Period||92
48603|NCT01903876|116951|P2|STARTED|Six-Month Follow-up Period||268
48604|NCT01903876|116952|P1|STARTED|Six-Month Follow-up Period||183
48605|NCT01903876|116951|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
48606|NCT01903876|116952|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
48607|NCT01903876|116951|P2|COMPLETED|Baseline to Post-Intervention Period||268
48608|NCT01903876|116952|P1|COMPLETED|Baseline to Post-Intervention Period||183
48609|NCT01903876|116951|P2|STARTED|Baseline to Post-Intervention Period||376
48610|NCT01903876|116952|P1|STARTED|Baseline to Post-Intervention Period||367
48611|NCT01903863|116962|P2|NOT COMPLETED|Overall Study||0
48612|NCT01903863|116963|P1|NOT COMPLETED|Overall Study||2
48613|NCT01903863|116962|P2|COMPLETED|Overall Study||16
48614|NCT01903863|116963|P1|COMPLETED|Overall Study||13
48615|NCT01903863|116962|P2|STARTED|Overall Study||16
48616|NCT01903863|116963|P1|STARTED|Overall Study||15
48617|NCT01903720|116983|P1|NOT COMPLETED|Overall Study||12
48618|NCT01903720|116983|P1|COMPLETED|Overall Study||59
48619|NCT01903720|116983|P1|STARTED|Overall Study||71
48620|NCT01903564|117000|P2|NOT COMPLETED|Overall Study||0
48621|NCT01903564|117001|P1|NOT COMPLETED|Overall Study||0
48622|NCT01903564|117000|P2|COMPLETED|Overall Study||29
48623|NCT01903564|117001|P1|COMPLETED|Overall Study||10
48624|NCT01903564|117000|P2|STARTED|Overall Study||29
48625|NCT01903564|117001|P1|STARTED|Overall Study||10
48626|NCT01903460|117021|P4|NOT COMPLETED|Overall Study||1
48627|NCT01903460|117022|P3|NOT COMPLETED|Overall Study||0
48628|NCT01903460|117023|P2|NOT COMPLETED|Overall Study||0
48629|NCT01903460|117024|P1|NOT COMPLETED|Overall Study||0
48630|NCT01903460|117021|P4|COMPLETED|Overall Study||2
48631|NCT01903460|117022|P3|COMPLETED|Overall Study||3
48632|NCT01903460|117023|P2|COMPLETED|Overall Study||8
48633|NCT01903460|117024|P1|COMPLETED|Overall Study||6
48634|NCT01903460|117021|P4|STARTED|Overall Study||3
48635|NCT01903460|117022|P3|STARTED|Overall Study||3
48636|NCT01903460|117023|P2|STARTED|Overall Study||8
48637|NCT01903460|117024|P1|STARTED|Overall Study||6
48638|NCT01903265|117043|P2|NOT COMPLETED|Overall Study||17
48639|NCT01903265|117044|P1|NOT COMPLETED|Overall Study||14
48640|NCT01903265|117043|P2|COMPLETED|Overall Study||85
48641|NCT01903265|117044|P1|COMPLETED|Overall Study||89
48642|NCT01903265|117043|P2|STARTED|Overall Study||102
48643|NCT01903265|117044|P1|STARTED|Overall Study||103
48644|NCT01903187|117060|P2|NOT COMPLETED|12 Month||0
48645|NCT01903187|117061|P1|NOT COMPLETED|12 Month||0
48646|NCT01903187|117060|P2|COMPLETED|12 Month||0
48647|NCT01903187|117061|P1|COMPLETED|12 Month||2
48648|NCT01903187|117060|P2|STARTED|12 Month||0
48649|NCT01903187|117061|P1|STARTED|12 Month||2
48650|NCT01903187|117060|P2|NOT COMPLETED|6 Month||0
48651|NCT01903187|117061|P1|NOT COMPLETED|6 Month||0
48652|NCT01903187|117060|P2|COMPLETED|6 Month||0
48653|NCT01903187|117061|P1|COMPLETED|6 Month||2
48654|NCT01903187|117060|P2|STARTED|6 Month||0
48655|NCT01903187|117061|P1|STARTED|6 Month||2
48656|NCT01903187|117060|P2|NOT COMPLETED|3 Month||0
48657|NCT01903187|117061|P1|NOT COMPLETED|3 Month||0
48658|NCT01903187|117060|P2|COMPLETED|3 Month||0
48659|NCT01903187|117061|P1|COMPLETED|3 Month||2
48660|NCT01903187|117060|P2|STARTED|3 Month||0
48661|NCT01903187|117061|P1|STARTED|3 Month||2
48662|NCT01903187|117060|P2|NOT COMPLETED|1 Month||0
48663|NCT01903187|117061|P1|NOT COMPLETED|1 Month||0
48664|NCT01903187|117060|P2|COMPLETED|1 Month||2
48665|NCT01903187|117061|P1|COMPLETED|1 Month||2
48666|NCT01903187|117060|P2|STARTED|1 Month||2
48667|NCT01903187|117061|P1|STARTED|1 Month||2
48668|NCT01903187|117060|P2|NOT COMPLETED|Procedure||0
48669|NCT01903187|117061|P1|NOT COMPLETED|Procedure||0
48670|NCT01903187|117060|P2|COMPLETED|Procedure||2
48671|NCT01903187|117061|P1|COMPLETED|Procedure||2
48672|NCT01903187|117060|P2|STARTED|Procedure||2
48673|NCT01903187|117061|P1|STARTED|Procedure||2
48674|NCT01903148|117075|P1|NOT COMPLETED|Overall Study||0
48675|NCT01903148|117075|P1|COMPLETED|Overall Study||441
48676|NCT01903148|117075|P1|STARTED|Overall Study||441
48677|NCT01903031|117094|P3|NOT COMPLETED|Overall Study||5
48678|NCT01903031|117095|P2|NOT COMPLETED|Overall Study||3
48679|NCT01903031|117096|P1|NOT COMPLETED|Overall Study||2
48680|NCT01903031|117094|P3|COMPLETED|Overall Study||24
48681|NCT01903031|117095|P2|COMPLETED|Overall Study||25
48682|NCT01903031|117096|P1|COMPLETED|Overall Study||25
48683|NCT01903031|117094|P3|STARTED|Overall Study||29
48684|NCT01903031|117095|P2|STARTED|Overall Study||28
48685|NCT01903031|117096|P1|STARTED|Overall Study||27
48686|NCT01903005|117124|P1|NOT COMPLETED|Overall Study||373
48687|NCT01903005|117124|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
48688|NCT01903005|117124|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
48689|NCT01902888|117138|P1|NOT COMPLETED|Overall Study||3
48690|NCT01902888|117138|P1|COMPLETED|Overall Study||0
48691|NCT01902888|117138|P1|STARTED|Overall Study||3
48692|NCT01902758|117145|P2|NOT COMPLETED|Overall Study||0
48693|NCT01902758|117146|P1|NOT COMPLETED|Overall Study||0
48694|NCT01902758|117145|P2|COMPLETED|Overall Study||14
48695|NCT01902758|117146|P1|COMPLETED|Overall Study||14
48696|NCT01902758|117145|P2|STARTED|Overall Study||14
48697|NCT01902758|117146|P1|STARTED|Overall Study||14
48698|NCT01902459|117154|P2|NOT COMPLETED|Overall Study||0
48699|NCT01902459|117155|P1|NOT COMPLETED|Overall Study||0
48700|NCT01902459|117154|P2|COMPLETED|Overall Study||75
48701|NCT01902459|117155|P1|COMPLETED|Overall Study||75
48702|NCT01902459|117154|P2|STARTED|Overall Study||75
48703|NCT01902459|117155|P1|STARTED|Overall Study||75
48704|NCT01902303|117173|P2|NOT COMPLETED|Overall Study||24
48705|NCT01902303|117174|P1|NOT COMPLETED|Overall Study||23
48706|NCT01902303|117173|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
48707|NCT01902303|117174|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
48708|NCT01902303|117173|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
48709|NCT01902303|117174|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
48710|NCT01902303|117173|P2|STARTED|Overall Study|Allocated to active treatment|81
48711|NCT01902303|117174|P1|STARTED|Overall Study|Allocated to placebo|77
48712|NCT01902134|117188|P6|NOT COMPLETED|Overall Study||9
48713|NCT01902134|117189|P5|NOT COMPLETED|Overall Study||7
48714|NCT01902134|117190|P4|NOT COMPLETED|Overall Study||2
48715|NCT01902134|117191|P3|NOT COMPLETED|Overall Study||15
48716|NCT01902134|117192|P2|NOT COMPLETED|Overall Study||11
48717|NCT01902134|117193|P1|NOT COMPLETED|Overall Study||8
48718|NCT01902134|117188|P6|COMPLETED|Overall Study||45
48719|NCT01902134|117189|P5|COMPLETED|Overall Study||46
48720|NCT01902134|117190|P4|COMPLETED|Overall Study||52
48721|NCT01902134|117191|P3|COMPLETED|Overall Study||145
48722|NCT01902134|117192|P2|COMPLETED|Overall Study||150
48723|NCT01902134|117193|P1|COMPLETED|Overall Study||151
48724|NCT01902134|117188|P6|Multiple-dose Phase|Overall Study||52
48725|NCT01902134|117189|P5|Multiple-dose Phase|Overall Study||53
48726|NCT01902134|117190|P4|Multiple-dose Phase|Overall Study||54
48727|NCT01902134|117191|P3|Multiple-dose Phase|Overall Study||160
48728|NCT01902134|117192|P2|Multiple-dose Phase|Overall Study||160
48729|NCT01902134|117193|P1|Multiple-dose Phase|Overall Study||159
48730|NCT01902134|117188|P6|Single-dose Phase|Overall Study||54
48731|NCT01902134|117189|P5|Single-dose Phase|Overall Study||53
48732|NCT01902134|117190|P4|Single-dose Phase|Overall Study||54
48733|NCT01902134|117191|P3|Single-dose Phase|Overall Study||160
48734|NCT01902134|117192|P2|Single-dose Phase|Overall Study||161
48735|NCT01902134|117193|P1|Single-dose Phase|Overall Study||159
48736|NCT01902134|117188|P6|STARTED|Overall Study||54
48737|NCT01902134|117189|P5|STARTED|Overall Study||53
48738|NCT01902134|117190|P4|STARTED|Overall Study||54
48739|NCT01902134|117191|P3|STARTED|Overall Study||160
48740|NCT01902134|117192|P2|STARTED|Overall Study||161
48741|NCT01902134|117193|P1|STARTED|Overall Study||159
48742|NCT01901809|117219|P4|NOT COMPLETED|Overall Study||2
48743|NCT01901809|117220|P3|NOT COMPLETED|Overall Study||3
48744|NCT01901809|117221|P2|NOT COMPLETED|Overall Study||0
48745|NCT01901809|117222|P1|NOT COMPLETED|Overall Study||0
48746|NCT01901809|117219|P4|COMPLETED|Overall Study||22
48747|NCT01901809|117220|P3|COMPLETED|Overall Study||21
48748|NCT01901809|117221|P2|COMPLETED|Overall Study||23
48749|NCT01901809|117222|P1|COMPLETED|Overall Study||19
48750|NCT01901809|117219|P4|STARTED|Overall Study||24
48751|NCT01901809|117220|P3|STARTED|Overall Study||24
48752|NCT01901809|117221|P2|STARTED|Overall Study||23
48753|NCT01901809|117222|P1|STARTED|Overall Study||19
48754|NCT01901588|117238|P2|NOT COMPLETED|Overall Study||0
48755|NCT01901588|117239|P1|NOT COMPLETED|Overall Study||0
48756|NCT01901588|117238|P2|COMPLETED|Overall Study||31
48757|NCT01901588|117239|P1|COMPLETED|Overall Study||32
48758|NCT01901588|117238|P2|STARTED|Overall Study||31
48759|NCT01901588|117239|P1|STARTED|Overall Study||32
48760|NCT01901575|117255|P1|NOT COMPLETED|Overall Study||0
48761|NCT01901575|117255|P1|COMPLETED|Overall Study||16
48762|NCT01901575|117255|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
48763|NCT01901393|117262|P2|NOT COMPLETED|Overall Study||0
48764|NCT01901393|117263|P1|NOT COMPLETED|Overall Study||1
48765|NCT01901393|117262|P2|COMPLETED|Overall Study||49
48766|NCT01901393|117263|P1|COMPLETED|Overall Study||50
48767|NCT01901393|117262|P2|STARTED|Overall Study||49
48768|NCT01901393|117263|P1|STARTED|Overall Study||51
48769|NCT01901341|117281|P2|NOT COMPLETED|Overall Study||21
48770|NCT01901341|117282|P1|NOT COMPLETED|Overall Study||20
48771|NCT01901341|117281|P2|COMPLETED|Overall Study||1
48772|NCT01901341|117282|P1|COMPLETED|Overall Study||2
48773|NCT01901341|117281|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
48774|NCT01901341|117282|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
48775|NCT01901341|117281|P2|STARTED|Overall Study||22
48776|NCT01901341|117282|P1|STARTED|Overall Study||22
48777|NCT01901328|117296|P2|NOT COMPLETED|Overall Study||21
48778|NCT01901328|117297|P1|NOT COMPLETED|Overall Study||22
48779|NCT01901328|117296|P2|COMPLETED|Overall Study||2
48780|NCT01901328|117297|P1|COMPLETED|Overall Study||4
48781|NCT01901328|117296|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
48782|NCT01901328|117297|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
48783|NCT01901328|117296|P2|STARTED|Overall Study||23
48784|NCT01901328|117297|P1|STARTED|Overall Study||26
48785|NCT01901302|117311|P2|NOT COMPLETED|Overall Study||23
48786|NCT01901302|117312|P1|NOT COMPLETED|Overall Study||27
48787|NCT01901302|117311|P2|COMPLETED|Overall Study||7
48788|NCT01901302|117312|P1|COMPLETED|Overall Study||4
48789|NCT01901302|117311|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
48790|NCT01901302|117312|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
48791|NCT01901302|117311|P2|STARTED|Overall Study||30
48792|NCT01901302|117312|P1|STARTED|Overall Study||31
48793|NCT01901250|117326|P2|NOT COMPLETED|Overall Study||126
48794|NCT01901250|117327|P1|NOT COMPLETED|Overall Study||138
48795|NCT01901250|117326|P2|COMPLETED|Overall Study||139
48796|NCT01901250|117327|P1|COMPLETED|Overall Study||122
48797|NCT01901250|117326|P2|End of 1st Grade|Overall Study||151
48798|NCT01901250|117327|P1|End of 1st Grade|Overall Study||143
48799|NCT01901250|117326|P2|Start of 1st Grade|Overall Study||176
48800|NCT01901250|117327|P1|Start of 1st Grade|Overall Study||173
48801|NCT01901250|117326|P2|End of Kidergarten|Overall Study||212
48802|NCT01901250|117327|P1|End of Kidergarten|Overall Study||215
48803|NCT01901250|117326|P2|STARTED|Overall Study||265
48804|NCT01901250|117327|P1|STARTED|Overall Study||260
48805|NCT01901211|117335|P2|NOT COMPLETED|Second Ten-week Period||0
48806|NCT01901211|117336|P1|NOT COMPLETED|Second Ten-week Period||0
48807|NCT01901211|117335|P2|COMPLETED|Second Ten-week Period||5
48808|NCT01901211|117336|P1|COMPLETED|Second Ten-week Period||6
48809|NCT01901211|117335|P2|STARTED|Second Ten-week Period||5
48810|NCT01901211|117336|P1|STARTED|Second Ten-week Period||6
48811|NCT01901211|117335|P2|NOT COMPLETED|Washout (6 Weeks)||0
48812|NCT01901211|117336|P1|NOT COMPLETED|Washout (6 Weeks)||0
48813|NCT01901211|117335|P2|COMPLETED|Washout (6 Weeks)||5
48814|NCT01901211|117336|P1|COMPLETED|Washout (6 Weeks)||6
48815|NCT01901211|117335|P2|STARTED|Washout (6 Weeks)||5
48816|NCT01901211|117336|P1|STARTED|Washout (6 Weeks)||6
48817|NCT01901211|117335|P2|NOT COMPLETED|First Ten-week Period||0
48818|NCT01901211|117336|P1|NOT COMPLETED|First Ten-week Period||0
48819|NCT01901211|117335|P2|COMPLETED|First Ten-week Period||5
48820|NCT01901211|117336|P1|COMPLETED|First Ten-week Period||6
48821|NCT01901211|117335|P2|STARTED|First Ten-week Period||5
48822|NCT01901211|117336|P1|STARTED|First Ten-week Period||6
48823|NCT01901185|117359|P1|NOT COMPLETED|Overall Study||2
48824|NCT01901185|117359|P1|COMPLETED|Overall Study||75
48825|NCT01901185|117359|P1|Received Etanercept With Autoinjector A|Overall Study||75
48826|NCT01901185|117359|P1|STARTED|Overall Study||77
48827|NCT01900665|117368|P2|NOT COMPLETED|Open Label Period||859
48828|NCT01900665|117369|P1|NOT COMPLETED|Open Label Period||881
48829|NCT01900665|117368|P2|COMPLETED|Open Label Period||0
48830|NCT01900665|117369|P1|COMPLETED|Open Label Period||0
48831|NCT01900665|117368|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
48832|NCT01900665|117369|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
48833|NCT01900665|117368|P2|NOT COMPLETED|Placebo Controlled Period||164
48834|NCT01900665|117369|P1|NOT COMPLETED|Placebo Controlled Period||143
48835|NCT01900665|117368|P2|COMPLETED|Placebo Controlled Period||908
48836|NCT01900665|117369|P1|COMPLETED|Placebo Controlled Period||914
48837|NCT01900665|117368|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
48838|NCT01900665|117369|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
48839|NCT01900665|117368|P2|STARTED|Placebo Controlled Period||1072
48840|NCT01900665|117369|P1|STARTED|Placebo Controlled Period||1057
48841|NCT01900444|117410|P1|NOT COMPLETED|Overall Study||3
48842|NCT01900444|117410|P1|COMPLETED|Overall Study||116
48843|NCT01900444|117410|P1|STARTED|Overall Study||119
48844|NCT01900431|117423|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
48845|NCT01900431|117424|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
48846|NCT01900431|117425|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
48847|NCT01900431|117423|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
48848|NCT01900431|117424|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
48849|NCT01900431|117425|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
48850|NCT01900431|117423|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
48851|NCT01900431|117424|P2|STARTED|Open-Label Treatment Period (Part C)||0
48852|NCT01900431|117425|P1|STARTED|Open-Label Treatment Period (Part C)||0
48853|NCT01900431|117423|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
48854|NCT01900431|117424|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
48855|NCT01900431|117425|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
48856|NCT01900431|117423|P3|COMPLETED|Extended Treatment Period (Part B)||0
48857|NCT01900431|117424|P2|COMPLETED|Extended Treatment Period (Part B)||12
48858|NCT01900431|117425|P1|COMPLETED|Extended Treatment Period (Part B)||7
48859|NCT01900431|117423|P3|STARTED|Extended Treatment Period (Part B)||0
48860|NCT01900431|117424|P2|STARTED|Extended Treatment Period (Part B)||22
48861|NCT01900431|117425|P1|STARTED|Extended Treatment Period (Part B)||8
48862|NCT01900431|117423|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
48863|NCT01900431|117424|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
48864|NCT01900431|117425|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
48865|NCT01900431|117423|P3|COMPLETED|Principal Treatment Period (Part A)||0
48866|NCT01900431|117424|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
48867|NCT01900431|117425|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
48868|NCT01900431|117423|P3|STARTED|Principal Treatment Period (Part A)||0
48869|NCT01900431|117424|P2|STARTED|Principal Treatment Period (Part A)||38
48870|NCT01900431|117425|P1|STARTED|Principal Treatment Period (Part A)||20
48871|NCT01900314|117451|P2|NOT COMPLETED|Overall Study||4
48872|NCT01900314|117452|P1|NOT COMPLETED|Overall Study||4
48873|NCT01900314|117451|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
48874|NCT01900314|117452|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
48875|NCT01900314|117451|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
48876|NCT01900314|117452|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
48877|NCT01900314|117451|P2|STARTED|Overall Study||20
48878|NCT01900314|117452|P1|STARTED|Overall Study||20
48879|NCT01900249|117463|P3|NOT COMPLETED|Overall Study||4
48880|NCT01900249|117464|P2|NOT COMPLETED|Overall Study||5
48881|NCT01900249|117465|P1|NOT COMPLETED|Overall Study||3
48882|NCT01900249|117463|P3|COMPLETED|Overall Study||65
48883|NCT01900249|117464|P2|COMPLETED|Overall Study||63
48884|NCT01900249|117465|P1|COMPLETED|Overall Study||64
48885|NCT01900249|117463|P3|STARTED|Overall Study||69
48886|NCT01900249|117464|P2|STARTED|Overall Study||68
48887|NCT01900249|117465|P1|STARTED|Overall Study||67
48888|NCT01900067|117475|P2|NOT COMPLETED|Overall Study||13
48889|NCT01900067|117476|P1|NOT COMPLETED|Overall Study||12
48890|NCT01900067|117475|P2|COMPLETED|Overall Study||124
48891|NCT01900067|117476|P1|COMPLETED|Overall Study||122
48892|NCT01900067|117475|P2|STARTED|Overall Study||137
48893|NCT01900067|117476|P1|STARTED|Overall Study||134
48894|NCT01900054|117482|P1|NOT COMPLETED|Overall Study||2
48895|NCT01900054|117482|P1|COMPLETED|Overall Study||56
48896|NCT01900054|117482|P1|STARTED|Overall Study||58
48897|NCT01899911|117487|P1|NOT COMPLETED|Overall Study||0
48898|NCT01899911|117487|P1|COMPLETED|Overall Study||12
48899|NCT01899911|117487|P1|STARTED|Overall Study||12
48900|NCT01899768|117491|P1|NOT COMPLETED|Part C||0
48901|NCT01899768|117491|P1|COMPLETED|Part C||11
48902|NCT01899768|117491|P1|STARTED|Part C||11
48903|NCT01899768|117491|P1|NOT COMPLETED|Part B||2
48904|NCT01899768|117491|P1|COMPLETED|Part B||11
48905|NCT01899768|117491|P1|STARTED|Part B||13
48906|NCT01899768|117491|P1|NOT COMPLETED|Part A||3
48907|NCT01899768|117491|P1|COMPLETED|Part A||13
48908|NCT01899768|117491|P1|STARTED|Part A||16
48909|NCT01899742|117565|P2|NOT COMPLETED|Overall Study||16
48910|NCT01899742|117566|P1|NOT COMPLETED|Overall Study||17
48911|NCT01899742|117565|P2|COMPLETED|Overall Study||231
48912|NCT01899742|117566|P1|COMPLETED|Overall Study||230
48913|NCT01899742|117565|P2|STARTED|Overall Study||247
48914|NCT01899742|117566|P1|STARTED|Overall Study||247
48915|NCT01899677|117576|P2|NOT COMPLETED|Overall Study||7
48916|NCT01899677|117577|P1|NOT COMPLETED|Overall Study||10
48917|NCT01899677|117576|P2|COMPLETED|Overall Study||28
48918|NCT01899677|117577|P1|COMPLETED|Overall Study||25
48919|NCT01899677|117576|P2|STARTED|Overall Study||35
48920|NCT01899677|117577|P1|STARTED|Overall Study||35
48921|NCT01899144|117605|P1|NOT COMPLETED|Treatment Period 5||1
48922|NCT01899144|117605|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
48923|NCT01899144|117605|P1|STARTED|Treatment Period 5||58
48924|NCT01899144|117605|P1|NOT COMPLETED|Treatment Period 4||0
48925|NCT01899144|117605|P1|COMPLETED|Treatment Period 4||58
48926|NCT01899144|117605|P1|STARTED|Treatment Period 4||58
48927|NCT01899144|117605|P1|NOT COMPLETED|Treatment Period 3||2
48928|NCT01899144|117605|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
48929|NCT01899144|117605|P1|STARTED|Treatment Period 3||60
48930|NCT01899144|117605|P1|NOT COMPLETED|Treatment Period 2||1
48931|NCT01899144|117605|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
48932|NCT01899144|117605|P1|STARTED|Treatment Period 2||61
48933|NCT01899144|117605|P1|NOT COMPLETED|Treatment Period 1||0
48934|NCT01899144|117605|P1|COMPLETED|Treatment Period 1||61
48935|NCT01899144|117605|P1|STARTED|Treatment Period 1||61
48936|NCT01898884|117632|P9|NOT COMPLETED|Multiple Dose Period||1
48937|NCT01898884|117633|P8|NOT COMPLETED|Multiple Dose Period||0
48938|NCT01898884|117634|P7|NOT COMPLETED|Multiple Dose Period||1
48939|NCT01898884|117635|P6|NOT COMPLETED|Multiple Dose Period||0
48940|NCT01898884|117636|P5|NOT COMPLETED|Multiple Dose Period||0
48941|NCT01898884|117637|P4|NOT COMPLETED|Multiple Dose Period||0
48942|NCT01898884|117638|P3|NOT COMPLETED|Multiple Dose Period||0
48943|NCT01898884|117639|P2|NOT COMPLETED|Multiple Dose Period||0
48944|NCT01898884|117640|P1|NOT COMPLETED|Multiple Dose Period||0
48945|NCT01898884|117632|P9|COMPLETED|Multiple Dose Period||5
48946|NCT01898884|117633|P8|COMPLETED|Multiple Dose Period||6
48947|NCT01898884|117634|P7|COMPLETED|Multiple Dose Period||5
48948|NCT01898884|117635|P6|COMPLETED|Multiple Dose Period||6
48949|NCT01898884|117636|P5|COMPLETED|Multiple Dose Period||0
48950|NCT01898884|117637|P4|COMPLETED|Multiple Dose Period||0
48951|NCT01898884|117638|P3|COMPLETED|Multiple Dose Period||0
48952|NCT01898884|117639|P2|COMPLETED|Multiple Dose Period||0
48953|NCT01898884|117640|P1|COMPLETED|Multiple Dose Period||0
48954|NCT01898884|117632|P9|Treated|Multiple Dose Period||5
48955|NCT01898884|117633|P8|Treated|Multiple Dose Period||6
48956|NCT01898884|117634|P7|Treated|Multiple Dose Period||6
48957|NCT01898884|117635|P6|Treated|Multiple Dose Period||6
48958|NCT01898884|117636|P5|Treated|Multiple Dose Period||0
48959|NCT01898884|117637|P4|Treated|Multiple Dose Period||0
48960|NCT01898884|117638|P3|Treated|Multiple Dose Period||0
48961|NCT01898884|117639|P2|Treated|Multiple Dose Period||0
48962|NCT01898884|117640|P1|Treated|Multiple Dose Period||0
48963|NCT01898884|117632|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
48964|NCT01898884|117633|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
48965|NCT01898884|117634|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
49055|NCT01897792|117926|P2|NOT COMPLETED|Overall Study||0
48966|NCT01898884|117635|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
48967|NCT01898884|117636|P5|STARTED|Multiple Dose Period||0
48968|NCT01898884|117637|P4|STARTED|Multiple Dose Period||0
48969|NCT01898884|117638|P3|STARTED|Multiple Dose Period||0
48970|NCT01898884|117639|P2|STARTED|Multiple Dose Period||0
48971|NCT01898884|117640|P1|STARTED|Multiple Dose Period||0
48972|NCT01898884|117632|P9|NOT COMPLETED|Single Dose Period||0
48973|NCT01898884|117633|P8|NOT COMPLETED|Single Dose Period||0
48974|NCT01898884|117634|P7|NOT COMPLETED|Single Dose Period||0
48975|NCT01898884|117635|P6|NOT COMPLETED|Single Dose Period||0
48976|NCT01898884|117636|P5|NOT COMPLETED|Single Dose Period||0
48977|NCT01898884|117637|P4|NOT COMPLETED|Single Dose Period||0
48978|NCT01898884|117638|P3|NOT COMPLETED|Single Dose Period||0
48979|NCT01898884|117639|P2|NOT COMPLETED|Single Dose Period||0
48980|NCT01898884|117640|P1|NOT COMPLETED|Single Dose Period||0
48981|NCT01898884|117632|P9|COMPLETED|Single Dose Period||0
48982|NCT01898884|117633|P8|COMPLETED|Single Dose Period||0
48983|NCT01898884|117634|P7|COMPLETED|Single Dose Period||0
48984|NCT01898884|117635|P6|COMPLETED|Single Dose Period||0
48985|NCT01898884|117636|P5|COMPLETED|Single Dose Period||6
48986|NCT01898884|117637|P4|COMPLETED|Single Dose Period||6
48987|NCT01898884|117638|P3|COMPLETED|Single Dose Period||6
48988|NCT01898884|117639|P2|COMPLETED|Single Dose Period||6
48989|NCT01898884|117640|P1|COMPLETED|Single Dose Period||8
48990|NCT01898884|117632|P9|STARTED|Single Dose Period||0
48991|NCT01898884|117633|P8|STARTED|Single Dose Period||0
48992|NCT01898884|117634|P7|STARTED|Single Dose Period||0
48993|NCT01898884|117635|P6|STARTED|Single Dose Period||0
48994|NCT01898884|117636|P5|STARTED|Single Dose Period||6
48995|NCT01898884|117637|P4|STARTED|Single Dose Period||6
48996|NCT01898884|117638|P3|STARTED|Single Dose Period||6
48997|NCT01898884|117639|P2|STARTED|Single Dose Period||6
48998|NCT01898884|117640|P1|STARTED|Single Dose Period||8
48999|NCT01898598|117792|P2|NOT COMPLETED|Overall Study||2
49000|NCT01898598|117793|P1|NOT COMPLETED|Overall Study||4
49001|NCT01898598|117792|P2|COMPLETED|Overall Study||4
49002|NCT01898598|117793|P1|COMPLETED|Overall Study||8
49003|NCT01898598|117792|P2|Treated|Overall Study||5
49004|NCT01898598|117793|P1|Treated|Overall Study||11
49005|NCT01898598|117792|P2|STARTED|Overall Study||6
49006|NCT01898598|117793|P1|STARTED|Overall Study||12
49007|NCT01898442|117812|P3|NOT COMPLETED|Overall Study||3
49008|NCT01898442|117813|P2|NOT COMPLETED|Overall Study||2
49009|NCT01898442|117814|P1|NOT COMPLETED|Overall Study||1
49010|NCT01898442|117812|P3|COMPLETED|Overall Study||15
49011|NCT01898442|117813|P2|COMPLETED|Overall Study||15
49012|NCT01898442|117814|P1|COMPLETED|Overall Study||16
49013|NCT01898442|117812|P3|STARTED|Overall Study||18
49014|NCT01898442|117813|P2|STARTED|Overall Study||17
49015|NCT01898442|117814|P1|STARTED|Overall Study||17
49016|NCT01898403|117837|P1|NOT COMPLETED|Overall Study||0
49017|NCT01898403|117837|P1|COMPLETED|Overall Study||50
49018|NCT01898403|117837|P1|STARTED|Overall Study||50
49019|NCT01898286|117843|P1|NOT COMPLETED|Overall Study||3
49020|NCT01898286|117843|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
49021|NCT01898286|117843|P1|STARTED|Overall Study||38
49022|NCT01898208|117853|P3|NOT COMPLETED|Overall Study||37
49023|NCT01898208|117854|P2|NOT COMPLETED|Overall Study||49
49024|NCT01898208|117855|P1|NOT COMPLETED|Overall Study||40
49025|NCT01898208|117853|P3|COMPLETED|Overall Study||212
49026|NCT01898208|117854|P2|COMPLETED|Overall Study||198
49027|NCT01898208|117855|P1|COMPLETED|Overall Study||207
49028|NCT01898208|117853|P3|STARTED|Overall Study||249
49029|NCT01898208|117854|P2|STARTED|Overall Study||247
49030|NCT01898208|117855|P1|STARTED|Overall Study||247
49031|NCT01898195|117902|P3|NOT COMPLETED|Smoking Abstinence||36
49032|NCT01898195|117903|P2|NOT COMPLETED|Smoking Abstinence||38
49033|NCT01898195|117904|P1|NOT COMPLETED|Smoking Abstinence||35
49034|NCT01898195|117902|P3|COMPLETED|Smoking Abstinence||15
49035|NCT01898195|117903|P2|COMPLETED|Smoking Abstinence||16
49036|NCT01898195|117904|P1|COMPLETED|Smoking Abstinence||18
49037|NCT01898195|117902|P3|STARTED|Smoking Abstinence||51
49038|NCT01898195|117903|P2|STARTED|Smoking Abstinence||54
49039|NCT01898195|117904|P1|STARTED|Smoking Abstinence||53
49040|NCT01898195|117902|P3|NOT COMPLETED|Varenicline Adherence||36
49041|NCT01898195|117903|P2|NOT COMPLETED|Varenicline Adherence||38
49042|NCT01898195|117904|P1|NOT COMPLETED|Varenicline Adherence||35
49043|NCT01898195|117902|P3|COMPLETED|Varenicline Adherence||15
49044|NCT01898195|117903|P2|COMPLETED|Varenicline Adherence||16
49045|NCT01898195|117904|P1|COMPLETED|Varenicline Adherence||18
49046|NCT01898195|117902|P3|STARTED|Varenicline Adherence||51
49047|NCT01898195|117903|P2|STARTED|Varenicline Adherence||54
49048|NCT01898195|117904|P1|STARTED|Varenicline Adherence||53
49049|NCT01898091|117917|P2|NOT COMPLETED|Overall Study||6
49050|NCT01898091|117918|P1|NOT COMPLETED|Overall Study||2
49051|NCT01898091|117917|P2|COMPLETED|Overall Study||19
49052|NCT01898091|117918|P1|COMPLETED|Overall Study||23
49053|NCT01898091|117917|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
49054|NCT01898091|117918|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
49056|NCT01897792|117927|P1|NOT COMPLETED|Overall Study||0
49057|NCT01897792|117926|P2|COMPLETED|Overall Study||5
49058|NCT01897792|117927|P1|COMPLETED|Overall Study||6
49059|NCT01897792|117926|P2|STARTED|Overall Study||5
49060|NCT01897792|117927|P1|STARTED|Overall Study||6
49061|NCT01897727|117953|P2|NOT COMPLETED|Overall Study||1
49062|NCT01897727|117954|P1|NOT COMPLETED|Overall Study||0
49063|NCT01897727|117953|P2|COMPLETED|Overall Study||8
49064|NCT01897727|117954|P1|COMPLETED|Overall Study||8
49065|NCT01897727|117953|P2|STARTED|Overall Study||9
49066|NCT01897727|117954|P1|STARTED|Overall Study||8
49067|NCT01897402|117962|P2|NOT COMPLETED|Overall Study||16
49068|NCT01897402|117963|P1|NOT COMPLETED|Overall Study||19
49069|NCT01897402|117962|P2|COMPLETED|Overall Study||244
49070|NCT01897402|117963|P1|COMPLETED|Overall Study||246
49071|NCT01897402|117962|P2|STARTED|Overall Study||260
49072|NCT01897402|117963|P1|STARTED|Overall Study||265
49073|NCT01897285|117975|P1|NOT COMPLETED|Overall Study||0
49074|NCT01897285|117975|P1|COMPLETED|Overall Study||20
49075|NCT01897285|117975|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
49076|NCT01897233|117983|P1|NOT COMPLETED|Part B (24 Weeks)||4
49077|NCT01897233|117983|P1|COMPLETED|Part B (24 Weeks)||54
49078|NCT01897233|117983|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
49079|NCT01897233|117983|P1|NOT COMPLETED|Part A (14 Days)||0
49080|NCT01897233|117983|P1|COMPLETED|Part A (14 Days)||10
49081|NCT01897233|117983|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
49082|NCT01897233|117983|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
49083|NCT01897233|117983|P1|STARTED|Part A (14 Days)||10
49084|NCT01897025|118007|P2|NOT COMPLETED|Overall Study||0
49085|NCT01897025|118008|P1|NOT COMPLETED|Overall Study||0
49086|NCT01897025|118007|P2|COMPLETED|Overall Study||9
49087|NCT01897025|118008|P1|COMPLETED|Overall Study||10
49088|NCT01897025|118007|P2|STARTED|Overall Study||9
49089|NCT01897025|118008|P1|STARTED|Overall Study||10
49090|NCT01896986|118016|P2|NOT COMPLETED|Overall Study||23
49091|NCT01896986|118017|P1|NOT COMPLETED|Overall Study||14
49092|NCT01896986|118016|P2|COMPLETED|Overall Study||0
49093|NCT01896986|118017|P1|COMPLETED|Overall Study||0
49094|NCT01896986|118016|P2|STARTED|Overall Study||23
49095|NCT01896986|118017|P1|STARTED|Overall Study||14
49096|NCT01896934|118023|P1|NOT COMPLETED|Overall Study||2
49097|NCT01896934|118023|P1|COMPLETED|Overall Study||19
49098|NCT01896934|118023|P1|STARTED|Overall Study||21
49099|NCT01896895|118032|P4|NOT COMPLETED|OLEX Period||0
49100|NCT01896895|118033|P3|NOT COMPLETED|OLEX Period||0
49101|NCT01896895|118034|P2|NOT COMPLETED|OLEX Period||0
49102|NCT01896895|118035|P1|NOT COMPLETED|OLEX Period||0
49103|NCT01896895|118032|P4|COMPLETED|OLEX Period||39
49104|NCT01896895|118033|P3|COMPLETED|OLEX Period||0
49105|NCT01896895|118034|P2|COMPLETED|OLEX Period||0
49106|NCT01896895|118035|P1|COMPLETED|OLEX Period||0
49107|NCT01896895|118032|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
49108|NCT01896895|118033|P3|STARTED|OLEX Period||0
49109|NCT01896895|118034|P2|STARTED|OLEX Period||0
49110|NCT01896895|118035|P1|STARTED|OLEX Period||0
49111|NCT01896895|118032|P4|NOT COMPLETED|Double-blind MP||0
49112|NCT01896895|118033|P3|NOT COMPLETED|Double-blind MP||3
49113|NCT01896895|118034|P2|NOT COMPLETED|Double-blind MP||2
49114|NCT01896895|118035|P1|NOT COMPLETED|Double-blind MP||1
49115|NCT01896895|118032|P4|COMPLETED|Double-blind MP||0
49116|NCT01896895|118033|P3|COMPLETED|Double-blind MP||16
49117|NCT01896895|118034|P2|COMPLETED|Double-blind MP||20
49118|NCT01896895|118035|P1|COMPLETED|Double-blind MP||19
49119|NCT01896895|118032|P4|STARTED|Double-blind MP||0
49120|NCT01896895|118033|P3|STARTED|Double-blind MP||19
49121|NCT01896895|118034|P2|STARTED|Double-blind MP||22
49122|NCT01896895|118035|P1|STARTED|Double-blind MP||20
49123|NCT01896726|118050|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
49124|NCT01896726|118050|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
49125|NCT01896726|118050|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
49126|NCT01896726|118050|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
49127|NCT01896726|118050|P1|STARTED|Treatment Period 2 (Days 23-31)||20
49128|NCT01896726|118050|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
49129|NCT01896726|118050|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
49130|NCT01896726|118050|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
49131|NCT01896726|118050|P1|STARTED|Treatment Period 1 (Days 1-22)||20
49132|NCT01896700|118065|P2|NOT COMPLETED|Overall Study||6
49133|NCT01896700|118066|P1|NOT COMPLETED|Overall Study||4
49134|NCT01896700|118065|P2|COMPLETED|Overall Study||6
49135|NCT01896700|118066|P1|COMPLETED|Overall Study||8
49136|NCT01896700|118065|P2|STARTED|Overall Study||12
49137|NCT01896700|118066|P1|STARTED|Overall Study||12
49138|NCT01896687|118088|P2|NOT COMPLETED|Overall Study||0
49139|NCT01896687|118089|P1|NOT COMPLETED|Overall Study||0
49140|NCT01896687|118088|P2|COMPLETED|Overall Study||15
49141|NCT01896687|118089|P1|COMPLETED|Overall Study||15
49142|NCT01896687|118088|P2|STARTED|Overall Study||15
49143|NCT01896687|118089|P1|STARTED|Overall Study||15
49144|NCT01896557|118097|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
49145|NCT01896557|118098|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
49146|NCT01896557|118097|P2|COMPLETED|Clopidogrel + GI Protector||44
49147|NCT01896557|118098|P1|COMPLETED|Clopidogrel + GI Protector||41
49148|NCT01896557|118097|P2|STARTED|Clopidogrel + GI Protector||48
49149|NCT01896557|118098|P1|STARTED|Clopidogrel + GI Protector||43
49150|NCT01896557|118097|P2|NOT COMPLETED|Clopidogrel Alone||0
49151|NCT01896557|118098|P1|NOT COMPLETED|Clopidogrel Alone||1
49152|NCT01896557|118097|P2|COMPLETED|Clopidogrel Alone||48
49153|NCT01896557|118098|P1|COMPLETED|Clopidogrel Alone||43
49154|NCT01896557|118097|P2|STARTED|Clopidogrel Alone||48
49155|NCT01896557|118098|P1|STARTED|Clopidogrel Alone||44
49156|NCT01896544|118109|P3|NOT COMPLETED|Overall Study||0
49157|NCT01896544|118110|P2|NOT COMPLETED|Overall Study||0
49158|NCT01896544|118111|P1|NOT COMPLETED|Overall Study||0
49159|NCT01896544|118109|P3|COMPLETED|Overall Study||10
49160|NCT01896544|118110|P2|COMPLETED|Overall Study||10
49161|NCT01896544|118111|P1|COMPLETED|Overall Study||10
49162|NCT01896544|118109|P3|STARTED|Overall Study||10
49163|NCT01896544|118110|P2|STARTED|Overall Study||10
49164|NCT01896544|118111|P1|STARTED|Overall Study||10
49165|NCT01896297|118131|P1|NOT COMPLETED|Overall Study||1
49166|NCT01896297|118131|P1|COMPLETED|Overall Study||59
49167|NCT01896297|118131|P1|STARTED|Overall Study||60
49168|NCT01896232|118138|P2|NOT COMPLETED|Overall Study||53
49169|NCT01896232|118139|P1|NOT COMPLETED|Overall Study||49
49170|NCT01896232|118138|P2|COMPLETED|Overall Study||287
49171|NCT01896232|118139|P1|COMPLETED|Overall Study||294
49172|NCT01896232|118138|P2|Received Treatment|Overall Study||338
49173|NCT01896232|118139|P1|Received Treatment|Overall Study||341
49174|NCT01896232|118138|P2|STARTED|Overall Study||340
49175|NCT01896232|118139|P1|STARTED|Overall Study||343
49176|NCT01896206|118159|P1|NOT COMPLETED|Overall Study||0
49177|NCT01896206|118159|P1|COMPLETED|Overall Study||21
49178|NCT01896206|118159|P1|STARTED|Overall Study||21
49179|NCT01896193|118167|P2|NOT COMPLETED|Overall Study||12
49180|NCT01896193|118168|P1|NOT COMPLETED|Overall Study||21
49181|NCT01896193|118167|P2|COMPLETED|Overall Study||53
49182|NCT01896193|118168|P1|COMPLETED|Overall Study||41
49183|NCT01896193|118167|P2|STARTED|Overall Study||65
49184|NCT01896193|118168|P1|STARTED|Overall Study||62
49185|NCT01896115|118194|P2|NOT COMPLETED|Overall Study||0
49186|NCT01896115|118195|P1|NOT COMPLETED|Overall Study||1
49187|NCT01896115|118194|P2|COMPLETED|Overall Study||24
49188|NCT01896115|118195|P1|COMPLETED|Overall Study||15
49189|NCT01896115|118194|P2|Phase 2 Steering|Overall Study||24
49190|NCT01896115|118195|P1|Phase 2 Steering|Overall Study||0
49191|NCT01896115|118194|P2|Phase 2 Single Contact|Overall Study||24
49192|NCT01896115|118195|P1|Phase 2 Single Contact|Overall Study||0
49193|NCT01896115|118194|P2|Phase 1 Ventral Steering|Overall Study||0
49194|NCT01896115|118195|P1|Phase 1 Ventral Steering|Overall Study||15
49195|NCT01896115|118194|P2|Phase 1 Dorsal Steering|Overall Study||0
49196|NCT01896115|118195|P1|Phase 1 Dorsal Steering|Overall Study||15
49197|NCT01896115|118194|P2|Phase 1 Conventional PW|Overall Study||0
49198|NCT01896115|118195|P1|Phase 1 Conventional PW|Overall Study||15
49199|NCT01896115|118194|P2|Phase 1 Short PW|Overall Study||0
49200|NCT01896115|118195|P1|Phase 1 Short PW|Overall Study||15
49201|NCT01896115|118194|P2|STARTED|Overall Study||24
49202|NCT01896115|118195|P1|STARTED|Overall Study||16
49203|NCT01896050|118220|P2|NOT COMPLETED|Overall Study||2
49204|NCT01896050|118221|P1|NOT COMPLETED|Overall Study||38
49205|NCT01896050|118220|P2|COMPLETED|Overall Study||20
49206|NCT01896050|118221|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
49207|NCT01896050|118220|P2|STARTED|Overall Study||22
49208|NCT01896050|118221|P1|STARTED|Overall Study||93
49209|NCT01895946|118233|P2|NOT COMPLETED|Overall Study||0
49210|NCT01895946|118234|P1|NOT COMPLETED|Overall Study||0
49211|NCT01895946|118233|P2|COMPLETED|Overall Study||12
49212|NCT01895946|118234|P1|COMPLETED|Overall Study||18
49213|NCT01895946|118233|P2|STARTED|Overall Study||12
49214|NCT01895946|118234|P1|STARTED|Overall Study||18
49215|NCT01895634|118252|P1|NOT COMPLETED|Overall Study||3
49216|NCT01895634|118252|P1|COMPLETED|Overall Study||46
49217|NCT01895634|118252|P1|STARTED|Overall Study||49
49218|NCT01895608|118264|P4|NOT COMPLETED|Overall Study||0
49219|NCT01895608|118265|P3|NOT COMPLETED|Overall Study||3
49220|NCT01895608|118266|P2|NOT COMPLETED|Overall Study||1
49221|NCT01895608|118267|P1|NOT COMPLETED|Overall Study||0
49222|NCT01895608|118264|P4|COMPLETED|Overall Study||6
49223|NCT01895608|118265|P3|COMPLETED|Overall Study||8
49224|NCT01895608|118266|P2|COMPLETED|Overall Study||6
49225|NCT01895608|118267|P1|COMPLETED|Overall Study||10
49226|NCT01895608|118264|P4|STARTED|Overall Study||6
49227|NCT01895608|118265|P3|STARTED|Overall Study||11
49228|NCT01895608|118266|P2|STARTED|Overall Study||7
49229|NCT01895608|118267|P1|STARTED|Overall Study||10
49230|NCT01895543|118297|P1|NOT COMPLETED|Overall Study||129
49231|NCT01895543|118297|P1|COMPLETED|Overall Study||282
49232|NCT01895543|118297|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
49233|NCT01895543|118297|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
49234|NCT01895543|118297|P1|STARTED|Overall Study||411
49235|NCT01895452|118313|P2|NOT COMPLETED|Overall Study||28
49236|NCT01895452|118314|P1|NOT COMPLETED|Overall Study||4
49237|NCT01895452|118313|P2|COMPLETED|Overall Study||198
49238|NCT01895452|118314|P1|COMPLETED|Overall Study||61
49239|NCT01895452|118313|P2|STARTED|Overall Study||226
49240|NCT01895452|118314|P1|STARTED|Overall Study||65
49241|NCT01895335|118324|P1|NOT COMPLETED|Overall Study||215
49242|NCT01895335|118324|P1|COMPLETED|Overall Study||786
49243|NCT01895335|118324|P1|Treated|Overall Study||1000
49244|NCT01895335|118324|P1|STARTED|Overall Study||1001
49245|NCT01895322|118341|P1|NOT COMPLETED|Overall Study||13
49246|NCT01895322|118341|P1|COMPLETED|Overall Study||7
49247|NCT01895322|118341|P1|STARTED|Overall Study||20
49248|NCT01895309|118350|P2|NOT COMPLETED|Overall Study||51
49249|NCT01895309|118351|P1|NOT COMPLETED|Overall Study||40
49250|NCT01895309|118350|P2|COMPLETED|Overall Study||246
49251|NCT01895309|118351|P1|COMPLETED|Overall Study||259
49252|NCT01895309|118350|P2|STARTED|Overall Study||297
49253|NCT01895309|118351|P1|STARTED|Overall Study||299
49254|NCT01895270|118365|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
49255|NCT01895270|118366|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
49256|NCT01895270|118365|P2|COMPLETED|Isradipine Taper (W7-8)||0
49257|NCT01895270|118366|P1|COMPLETED|Isradipine Taper (W7-8)||2
49258|NCT01895270|118365|P2|STARTED|Isradipine Taper (W7-8)||2
49259|NCT01895270|118366|P1|STARTED|Isradipine Taper (W7-8)||2
49260|NCT01895270|118365|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
49261|NCT01895270|118366|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
49262|NCT01895270|118365|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
49263|NCT01895270|118366|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
49264|NCT01895270|118365|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
49265|NCT01895270|118366|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
49266|NCT01895270|118365|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
49267|NCT01895270|118366|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
49268|NCT01895270|118365|P2|COMPLETED|Study Medications Induction (W1-4)||8
49269|NCT01895270|118366|P1|COMPLETED|Study Medications Induction (W1-4)||5
49270|NCT01895270|118365|P2|STARTED|Study Medications Induction (W1-4)||14
49271|NCT01895270|118366|P1|STARTED|Study Medications Induction (W1-4)||11
49272|NCT01895127|118374|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
49273|NCT01895127|118375|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
49274|NCT01895127|118374|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
49275|NCT01895127|118375|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
49276|NCT01895127|118374|P2|STARTED|Long Term Follow-up (Month 3-12)||7
49277|NCT01895127|118375|P1|STARTED|Long Term Follow-up (Month 3-12)||3
49278|NCT01895127|118374|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
49279|NCT01895127|118375|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
49280|NCT01895127|118374|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
49281|NCT01895127|118375|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
49282|NCT01895127|118374|P2|STARTED|Month 3 Follow-up & Biopsy||7
49283|NCT01895127|118375|P1|STARTED|Month 3 Follow-up & Biopsy||3
49284|NCT01895127|118374|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
49285|NCT01895127|118375|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
49286|NCT01895127|118374|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
49287|NCT01895127|118375|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
49288|NCT01895127|118374|P2|STARTED|Treatment Period (Week 0-Month 3)||7
49289|NCT01895127|118375|P1|STARTED|Treatment Period (Week 0-Month 3)||3
49290|NCT01895127|118374|P2|NOT COMPLETED|Screening||0
49291|NCT01895127|118375|P1|NOT COMPLETED|Screening||0
49292|NCT01895127|118374|P2|COMPLETED|Screening||7
49293|NCT01895127|118375|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
49294|NCT01895127|118374|P2|STARTED|Screening||7
49295|NCT01895127|118375|P1|STARTED|Screening||4
49296|NCT01895101|118385|P3|NOT COMPLETED|Overall Study||5
49297|NCT01895101|118386|P2|NOT COMPLETED|Overall Study||5
49298|NCT01895101|118387|P1|NOT COMPLETED|Overall Study||1
49299|NCT01895101|118385|P3|COMPLETED|Overall Study||245
49300|NCT01895101|118386|P2|COMPLETED|Overall Study||245
49301|NCT01895101|118387|P1|COMPLETED|Overall Study||249
49302|NCT01895101|118385|P3|STARTED|Overall Study||250
49303|NCT01895101|118386|P2|STARTED|Overall Study||250
49304|NCT01895101|118387|P1|STARTED|Overall Study||250
49305|NCT01895088|118401|P1|NOT COMPLETED|Overall Study||18
49306|NCT01895088|118401|P1|COMPLETED|Overall Study||253
49307|NCT01895088|118401|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
49308|NCT01895062|118407|P2|NOT COMPLETED|Overall Study||0
49309|NCT01895062|118408|P1|NOT COMPLETED|Overall Study||0
49310|NCT01895062|118407|P2|COMPLETED|Overall Study||24
49311|NCT01895062|118408|P1|COMPLETED|Overall Study||30
49312|NCT01895062|118407|P2|STARTED|Overall Study||24
49313|NCT01895062|118408|P1|STARTED|Overall Study||30
49314|NCT01895036|118416|P1|NOT COMPLETED|Overall Study||0
49315|NCT01895036|118416|P1|COMPLETED|Overall Study||6
49316|NCT01895036|118416|P1|STARTED|Overall Study||6
49317|NCT01894984|118422|P2|NOT COMPLETED|Overall Study||175
49318|NCT01894984|118423|P1|NOT COMPLETED|Overall Study||314
49319|NCT01894984|118422|P2|COMPLETED|Overall Study||69
49320|NCT01894984|118423|P1|COMPLETED|Overall Study||82
49321|NCT01894984|118422|P2|STARTED|Overall Study||244
49322|NCT01894984|118423|P1|STARTED|Overall Study||396
49323|NCT01894906|118441|P2|NOT COMPLETED|Overall Study||0
49324|NCT01894906|118442|P1|NOT COMPLETED|Overall Study||0
49325|NCT01894906|118441|P2|COMPLETED|Overall Study||6
49326|NCT01894906|118442|P1|COMPLETED|Overall Study||6
49327|NCT01894906|118441|P2|Treatment F|Overall Study||6
49328|NCT01894906|118442|P1|Treatment F|Overall Study||6
49329|NCT01894906|118441|P2|Treatment E|Overall Study||6
49330|NCT01894906|118442|P1|Treatment E|Overall Study||6
49331|NCT01894906|118441|P2|Treatment D|Overall Study||6
49332|NCT01894906|118442|P1|Treatment D|Overall Study||6
49333|NCT01894906|118441|P2|Treatment C|Overall Study||6
49334|NCT01894906|118442|P1|Treatment C|Overall Study||6
49335|NCT01894906|118441|P2|Treatment B|Overall Study||6
49336|NCT01894906|118442|P1|Treatment B|Overall Study||6
49337|NCT01894906|118441|P2|Treatment A|Overall Study||6
49338|NCT01894906|118442|P1|Treatment A|Overall Study||6
49339|NCT01894906|118441|P2|STARTED|Overall Study||6
49340|NCT01894906|118442|P1|STARTED|Overall Study||6
49341|NCT01894672|118472|P1|NOT COMPLETED|Overall Study||0
49342|NCT01894672|118472|P1|COMPLETED|Overall Study||7
49343|NCT01894672|118472|P1|STARTED|Overall Study||7
49344|NCT01894620|118480|P2|NOT COMPLETED|Overall Study||1
49345|NCT01894620|118481|P1|NOT COMPLETED|Overall Study||0
49346|NCT01894620|118480|P2|COMPLETED|Overall Study||4
49347|NCT01894620|118481|P1|COMPLETED|Overall Study||6
49348|NCT01894620|118480|P2|STARTED|Overall Study||5
49349|NCT01894620|118481|P1|STARTED|Overall Study||6
49350|NCT01894607|118489|P1|NOT COMPLETED|Overall Study||1
49351|NCT01894607|118489|P1|COMPLETED|Overall Study||10
49352|NCT01894607|118489|P1|STARTED|Overall Study||11
49353|NCT01894581|118496|P2|NOT COMPLETED|Overall Study||7
49354|NCT01894581|118497|P1|NOT COMPLETED|Overall Study||5
49355|NCT01894581|118496|P2|COMPLETED|Overall Study||12
49356|NCT01894581|118497|P1|COMPLETED|Overall Study||15
49357|NCT01894581|118496|P2|STARTED|Overall Study||19
49358|NCT01894581|118497|P1|STARTED|Overall Study||20
49359|NCT01894555|118503|P1|NOT COMPLETED|Overall Study||0
49360|NCT01894555|118503|P1|COMPLETED|Overall Study||33
49361|NCT01894555|118503|P1|STARTED|Overall Study||33
49362|NCT01894477|118509|P2|NOT COMPLETED|Overall Study||2
49363|NCT01894477|118510|P1|NOT COMPLETED|Overall Study||0
49364|NCT01894477|118509|P2|COMPLETED|Overall Study||65
49365|NCT01894477|118510|P1|COMPLETED|Overall Study||35
49366|NCT01894477|118509|P2|STARTED|Overall Study||67
49367|NCT01894477|118510|P1|STARTED|Overall Study||35
49368|NCT01894256|118521|P3|NOT COMPLETED|Part B||14
49369|NCT01894256|118522|P2|NOT COMPLETED|Part B||14
49370|NCT01894256|118523|P1|NOT COMPLETED|Part B||15
49371|NCT01894256|118521|P3|COMPLETED|Part B||0
49372|NCT01894256|118522|P2|COMPLETED|Part B||0
49373|NCT01894256|118523|P1|COMPLETED|Part B||0
49374|NCT01894256|118521|P3|STARTED|Part B||14
49375|NCT01894256|118522|P2|STARTED|Part B||14
49376|NCT01894256|118523|P1|STARTED|Part B||15
49377|NCT01894256|118521|P3|NOT COMPLETED|Part A||0
49378|NCT01894256|118522|P2|NOT COMPLETED|Part A||1
49379|NCT01894256|118523|P1|NOT COMPLETED|Part A||0
49380|NCT01894256|118521|P3|COMPLETED|Part A||14
49381|NCT01894256|118522|P2|COMPLETED|Part A||14
49382|NCT01894256|118523|P1|COMPLETED|Part A||15
49383|NCT01894256|118521|P3|STARTED|Part A||14
49384|NCT01894256|118522|P2|STARTED|Part A||15
49385|NCT01894256|118523|P1|STARTED|Part A||15
49386|NCT01894230|118569|P2|NOT COMPLETED|Overall Study||7
49387|NCT01894230|118570|P1|NOT COMPLETED|Overall Study||7
49388|NCT01894230|118569|P2|COMPLETED|Overall Study||69
49389|NCT01894230|118570|P1|COMPLETED|Overall Study||76
49390|NCT01894230|118569|P2|STARTED|Overall Study||76
49391|NCT01894230|118570|P1|STARTED|Overall Study||83
49392|NCT01894100|118596|P2|NOT COMPLETED|Overall Study||1
49393|NCT01894100|118597|P1|NOT COMPLETED|Overall Study||3
49394|NCT01894100|118596|P2|COMPLETED|Overall Study||14
49395|NCT01894100|118597|P1|COMPLETED|Overall Study||12
49396|NCT01894100|118596|P2|STARTED|Overall Study||15
49397|NCT01894100|118597|P1|STARTED|Overall Study||15
49398|NCT01894087|118607|P2|NOT COMPLETED|Overall Study||0
49399|NCT01894087|118608|P1|NOT COMPLETED|Overall Study||6
49400|NCT01894087|118607|P2|COMPLETED|Overall Study||102
49401|NCT01894087|118608|P1|COMPLETED|Overall Study||96
49402|NCT01894087|118607|P2|STARTED|Overall Study||102
49403|NCT01894087|118608|P1|STARTED|Overall Study||102
49404|NCT01894022|118622|P2|NOT COMPLETED|Overall Study||10
49405|NCT01894022|118623|P1|NOT COMPLETED|Overall Study||9
49406|NCT01894022|118622|P2|COMPLETED|Overall Study||0
49407|NCT01894022|118623|P1|COMPLETED|Overall Study||0
49408|NCT01894022|118622|P2|STARTED|Overall Study||10
49409|NCT01894022|118623|P1|STARTED|Overall Study||9
49410|NCT01893905|118677|P2|NOT COMPLETED|Overall Study||14
49411|NCT01893905|118678|P1|NOT COMPLETED|Overall Study||25
49412|NCT01893905|118677|P2|COMPLETED|Overall Study||64
49413|NCT01893905|118678|P1|COMPLETED|Overall Study||55
49414|NCT01893905|118677|P2|STARTED|Overall Study||78
49415|NCT01893905|118678|P1|STARTED|Overall Study||80
49416|NCT01893879|118686|P2|NOT COMPLETED|Overall Study||3
49417|NCT01893879|118687|P1|NOT COMPLETED|Overall Study||2
49418|NCT01893879|118686|P2|COMPLETED|Overall Study||4
49419|NCT01893879|118687|P1|COMPLETED|Overall Study||5
49420|NCT01893879|118686|P2|STARTED|Overall Study||7
49421|NCT01893879|118687|P1|STARTED|Overall Study||7
49422|NCT01893567|118693|P1|NOT COMPLETED|Overall Study||0
49423|NCT01893567|118693|P1|COMPLETED|Overall Study||28
49424|NCT01893567|118693|P1|STARTED|Overall Study||28
49425|NCT01893411|118700|P3|NOT COMPLETED|Overall Study||9
49426|NCT01893411|118701|P2|NOT COMPLETED|Overall Study||7
49427|NCT01893411|118702|P1|NOT COMPLETED|Overall Study||17
49428|NCT01893411|118700|P3|COMPLETED|Overall Study||69
49429|NCT01893411|118701|P2|COMPLETED|Overall Study||70
49430|NCT01893411|118702|P1|COMPLETED|Overall Study||139
49431|NCT01893411|118700|P3|STARTED|Overall Study||78
49432|NCT01893411|118701|P2|STARTED|Overall Study||77
49433|NCT01893411|118702|P1|STARTED|Overall Study||156
49434|NCT01893359|118767|P3|NOT COMPLETED|Overall Study||0
49435|NCT01893359|118768|P2|NOT COMPLETED|Overall Study||0
49436|NCT01893359|118769|P1|NOT COMPLETED|Overall Study||0
49437|NCT01893359|118767|P3|COMPLETED|Overall Study||0
49438|NCT01893359|118768|P2|COMPLETED|Overall Study||2
49439|NCT01893359|118769|P1|COMPLETED|Overall Study||0
49440|NCT01893359|118767|P3|STARTED|Overall Study||0
49441|NCT01893359|118768|P2|STARTED|Overall Study||2
49442|NCT01893359|118769|P1|STARTED|Overall Study||0
49443|NCT01893346|118784|P4|NOT COMPLETED|Overall Study||0
49444|NCT01893346|118785|P3|NOT COMPLETED|Overall Study||0
49445|NCT01893346|118786|P2|NOT COMPLETED|Overall Study||1
49446|NCT01893346|118787|P1|NOT COMPLETED|Overall Study||3
49447|NCT01893346|118784|P4|COMPLETED|Overall Study||8
49448|NCT01893346|118785|P3|COMPLETED|Overall Study||8
49449|NCT01893346|118786|P2|COMPLETED|Overall Study||7
49450|NCT01893346|118787|P1|COMPLETED|Overall Study||8
49451|NCT01893346|118784|P4|Patients Who Received Full Infusion|Overall Study||8
49452|NCT01893346|118785|P3|Patients Who Received Full Infusion|Overall Study||8
49453|NCT01893346|118786|P2|Patients Who Received Full Infusion|Overall Study||8
49454|NCT01893346|118787|P1|Patients Who Received Full Infusion|Overall Study||8
49455|NCT01893346|118784|P4|STARTED|Overall Study||8
49456|NCT01893346|118785|P3|STARTED|Overall Study||8
49457|NCT01893346|118786|P2|STARTED|Overall Study||8
49458|NCT01893346|118787|P1|STARTED|Overall Study||11
49459|NCT01893281|118801|P1|NOT COMPLETED|Overall Study||3
49460|NCT01893281|118801|P1|COMPLETED|Overall Study||75
49461|NCT01893281|118801|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
49462|NCT01893281|118801|P1|STARTED|Overall Study||78
49463|NCT01893203|118808|P1|NOT COMPLETED|Overall Study||1
49464|NCT01893203|118808|P1|COMPLETED|Overall Study||13
49465|NCT01893203|118808|P1|STARTED|Overall Study||14
49466|NCT01892865|118817|P2|NOT COMPLETED|Overall Study||0
49467|NCT01892865|118818|P1|NOT COMPLETED|Overall Study||0
49468|NCT01892865|118817|P2|COMPLETED|Overall Study||379
49469|NCT01892865|118818|P1|COMPLETED|Overall Study||356
49470|NCT01892865|118817|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
49471|NCT01892865|118818|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
49472|NCT01892709|118830|P1|NOT COMPLETED|Overall Study||0
49473|NCT01892709|118830|P1|COMPLETED|Overall Study||215
49474|NCT01892709|118830|P1|STARTED|Overall Study||215
49475|NCT01892657|118840|P1|NOT COMPLETED|Overall Study||18
49476|NCT01892657|118840|P1|COMPLETED|Overall Study||110
49477|NCT01892657|118840|P1|STARTED|Overall Study||128
49478|NCT01892306|118858|P2|NOT COMPLETED|Overall Study||6
49479|NCT01892306|118859|P1|NOT COMPLETED|Overall Study||5
49480|NCT01892306|118858|P2|COMPLETED|Overall Study||10
49481|NCT01892306|118859|P1|COMPLETED|Overall Study||8
49482|NCT01892306|118858|P2|STARTED|Overall Study||16
49483|NCT01892306|118859|P1|STARTED|Overall Study||13
49484|NCT01892267|118881|P2|NOT COMPLETED|Overall Study||0
49485|NCT01892267|118882|P1|NOT COMPLETED|Overall Study||0
49486|NCT01892267|118881|P2|COMPLETED|Overall Study||10
49487|NCT01892267|118882|P1|COMPLETED|Overall Study||9
49488|NCT01892267|118881|P2|STARTED|Overall Study||10
49489|NCT01892267|118882|P1|STARTED|Overall Study||9
49490|NCT01892189|118917|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
49491|NCT01892189|118918|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
49492|NCT01892189|118919|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
49493|NCT01892189|118920|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
49494|NCT01892189|118921|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
49495|NCT01892189|118922|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
49496|NCT01892189|118923|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
49497|NCT01892189|118924|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
49498|NCT01892189|118925|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
49499|NCT01892189|118917|P9|COMPLETED|Third Intervention Period (1 Day)||1
49500|NCT01892189|118918|P8|COMPLETED|Third Intervention Period (1 Day)||3
49501|NCT01892189|118919|P7|COMPLETED|Third Intervention Period (1 Day)||2
49502|NCT01892189|118920|P6|COMPLETED|Third Intervention Period (1 Day)||2
49503|NCT01892189|118921|P5|COMPLETED|Third Intervention Period (1 Day)||3
49504|NCT01892189|118922|P4|COMPLETED|Third Intervention Period (1 Day)||2
49505|NCT01892189|118923|P3|COMPLETED|Third Intervention Period (1 Day)||1
49506|NCT01892189|118924|P2|COMPLETED|Third Intervention Period (1 Day)||3
49507|NCT01892189|118925|P1|COMPLETED|Third Intervention Period (1 Day)||3
49508|NCT01892189|118917|P9|STARTED|Third Intervention Period (1 Day)||1
49509|NCT01892189|118918|P8|STARTED|Third Intervention Period (1 Day)||3
49510|NCT01892189|118919|P7|STARTED|Third Intervention Period (1 Day)||2
49511|NCT01892189|118920|P6|STARTED|Third Intervention Period (1 Day)||2
49512|NCT01892189|118921|P5|STARTED|Third Intervention Period (1 Day)||3
49513|NCT01892189|118922|P4|STARTED|Third Intervention Period (1 Day)||2
49514|NCT01892189|118923|P3|STARTED|Third Intervention Period (1 Day)||1
49515|NCT01892189|118924|P2|STARTED|Third Intervention Period (1 Day)||3
49516|NCT01892189|118925|P1|STARTED|Third Intervention Period (1 Day)||3
49517|NCT01892189|118917|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
49518|NCT01892189|118918|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
49519|NCT01892189|118919|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
49520|NCT01892189|118920|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
49521|NCT01892189|118921|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
49522|NCT01892189|118922|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
49523|NCT01892189|118923|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
49524|NCT01892189|118924|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
49525|NCT01892189|118925|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
49526|NCT01892189|118917|P9|COMPLETED|Washout Period 2 (7 Days)||1
49527|NCT01892189|118918|P8|COMPLETED|Washout Period 2 (7 Days)||3
49528|NCT01892189|118919|P7|COMPLETED|Washout Period 2 (7 Days)||2
49529|NCT01892189|118920|P6|COMPLETED|Washout Period 2 (7 Days)||2
49530|NCT01892189|118921|P5|COMPLETED|Washout Period 2 (7 Days)||3
49531|NCT01892189|118922|P4|COMPLETED|Washout Period 2 (7 Days)||2
49532|NCT01892189|118923|P3|COMPLETED|Washout Period 2 (7 Days)||1
49533|NCT01892189|118924|P2|COMPLETED|Washout Period 2 (7 Days)||3
49534|NCT01892189|118925|P1|COMPLETED|Washout Period 2 (7 Days)||3
49535|NCT01892189|118917|P9|STARTED|Washout Period 2 (7 Days)||1
49536|NCT01892189|118918|P8|STARTED|Washout Period 2 (7 Days)||3
49537|NCT01892189|118919|P7|STARTED|Washout Period 2 (7 Days)||2
49538|NCT01892189|118920|P6|STARTED|Washout Period 2 (7 Days)||2
49539|NCT01892189|118921|P5|STARTED|Washout Period 2 (7 Days)||3
49540|NCT01892189|118922|P4|STARTED|Washout Period 2 (7 Days)||2
49541|NCT01892189|118923|P3|STARTED|Washout Period 2 (7 Days)||1
49542|NCT01892189|118924|P2|STARTED|Washout Period 2 (7 Days)||3
49543|NCT01892189|118925|P1|STARTED|Washout Period 2 (7 Days)||3
49544|NCT01892189|118917|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
49545|NCT01892189|118918|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
49546|NCT01892189|118919|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
49547|NCT01892189|118920|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
49548|NCT01892189|118921|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
49549|NCT01892189|118922|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
49550|NCT01892189|118923|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
49551|NCT01892189|118924|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
49552|NCT01892189|118925|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
49553|NCT01892189|118917|P9|COMPLETED|Second Intervention Period (1 Day)||1
49554|NCT01892189|118918|P8|COMPLETED|Second Intervention Period (1 Day)||3
49555|NCT01892189|118919|P7|COMPLETED|Second Intervention Period (1 Day)||2
49556|NCT01892189|118920|P6|COMPLETED|Second Intervention Period (1 Day)||2
49557|NCT01892189|118921|P5|COMPLETED|Second Intervention Period (1 Day)||3
49558|NCT01892189|118922|P4|COMPLETED|Second Intervention Period (1 Day)||2
49559|NCT01892189|118923|P3|COMPLETED|Second Intervention Period (1 Day)||1
49560|NCT01892189|118924|P2|COMPLETED|Second Intervention Period (1 Day)||3
49561|NCT01892189|118925|P1|COMPLETED|Second Intervention Period (1 Day)||3
49562|NCT01892189|118917|P9|STARTED|Second Intervention Period (1 Day)||1
49563|NCT01892189|118918|P8|STARTED|Second Intervention Period (1 Day)||3
49564|NCT01892189|118919|P7|STARTED|Second Intervention Period (1 Day)||2
49565|NCT01892189|118920|P6|STARTED|Second Intervention Period (1 Day)||2
49566|NCT01892189|118921|P5|STARTED|Second Intervention Period (1 Day)||3
49567|NCT01892189|118922|P4|STARTED|Second Intervention Period (1 Day)||2
49568|NCT01892189|118923|P3|STARTED|Second Intervention Period (1 Day)||1
49569|NCT01892189|118924|P2|STARTED|Second Intervention Period (1 Day)||3
49570|NCT01892189|118925|P1|STARTED|Second Intervention Period (1 Day)||3
49571|NCT01892189|118917|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
49572|NCT01892189|118918|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
49573|NCT01892189|118919|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
49574|NCT01892189|118920|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
49575|NCT01892189|118921|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
49576|NCT01892189|118922|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
49577|NCT01892189|118923|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
49578|NCT01892189|118924|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
49579|NCT01892189|118925|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
49580|NCT01892189|118917|P9|COMPLETED|Washout Period 1 (7 Days)||1
49581|NCT01892189|118918|P8|COMPLETED|Washout Period 1 (7 Days)||3
49582|NCT01892189|118919|P7|COMPLETED|Washout Period 1 (7 Days)||2
49583|NCT01892189|118920|P6|COMPLETED|Washout Period 1 (7 Days)||2
49584|NCT01892189|118921|P5|COMPLETED|Washout Period 1 (7 Days)||3
49585|NCT01892189|118922|P4|COMPLETED|Washout Period 1 (7 Days)||2
49586|NCT01892189|118923|P3|COMPLETED|Washout Period 1 (7 Days)||1
49587|NCT01892189|118924|P2|COMPLETED|Washout Period 1 (7 Days)||3
49588|NCT01892189|118925|P1|COMPLETED|Washout Period 1 (7 Days)||3
49589|NCT01892189|118917|P9|STARTED|Washout Period 1 (7 Days)||3
49590|NCT01892189|118918|P8|STARTED|Washout Period 1 (7 Days)||3
49591|NCT01892189|118919|P7|STARTED|Washout Period 1 (7 Days)||3
49592|NCT01892189|118920|P6|STARTED|Washout Period 1 (7 Days)||3
49593|NCT01892189|118921|P5|STARTED|Washout Period 1 (7 Days)||3
49594|NCT01892189|118922|P4|STARTED|Washout Period 1 (7 Days)||3
49595|NCT01892189|118923|P3|STARTED|Washout Period 1 (7 Days)||3
49596|NCT01892189|118924|P2|STARTED|Washout Period 1 (7 Days)||3
49597|NCT01892189|118925|P1|STARTED|Washout Period 1 (7 Days)||3
49598|NCT01892189|118917|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
49599|NCT01892189|118918|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
49600|NCT01892189|118919|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
49601|NCT01892189|118920|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
49602|NCT01892189|118921|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
49603|NCT01892189|118922|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
49604|NCT01892189|118923|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
49605|NCT01892189|118924|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
49606|NCT01892189|118925|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
49607|NCT01892189|118917|P9|COMPLETED|First Intervention Period (1 Day)||3
49608|NCT01892189|118918|P8|COMPLETED|First Intervention Period (1 Day)||3
49609|NCT01892189|118919|P7|COMPLETED|First Intervention Period (1 Day)||3
49610|NCT01892189|118920|P6|COMPLETED|First Intervention Period (1 Day)||3
49611|NCT01892189|118921|P5|COMPLETED|First Intervention Period (1 Day)||3
49612|NCT01892189|118922|P4|COMPLETED|First Intervention Period (1 Day)||3
49613|NCT01892189|118923|P3|COMPLETED|First Intervention Period (1 Day)||3
49614|NCT01892189|118924|P2|COMPLETED|First Intervention Period (1 Day)||3
49615|NCT01892189|118925|P1|COMPLETED|First Intervention Period (1 Day)||3
49616|NCT01892189|118917|P9|STARTED|First Intervention Period (1 Day)||3
49617|NCT01892189|118918|P8|STARTED|First Intervention Period (1 Day)||3
49618|NCT01892189|118919|P7|STARTED|First Intervention Period (1 Day)||3
49619|NCT01892189|118920|P6|STARTED|First Intervention Period (1 Day)||3
49620|NCT01892189|118921|P5|STARTED|First Intervention Period (1 Day)||3
49621|NCT01892189|118922|P4|STARTED|First Intervention Period (1 Day)||3
49622|NCT01892189|118923|P3|STARTED|First Intervention Period (1 Day)||3
49623|NCT01892189|118924|P2|STARTED|First Intervention Period (1 Day)||3
49624|NCT01892189|118925|P1|STARTED|First Intervention Period (1 Day)||3
49625|NCT01892163|118967|P2|NOT COMPLETED|Overall Study||1
49626|NCT01892163|118968|P1|NOT COMPLETED|Overall Study||2
49627|NCT01892163|118967|P2|COMPLETED|Overall Study||49
49628|NCT01892163|118968|P1|COMPLETED|Overall Study||48
49629|NCT01892163|118967|P2|STARTED|Overall Study||50
49630|NCT01892163|118968|P1|STARTED|Overall Study||50
49631|NCT01892020|118980|P2|NOT COMPLETED|Period 2||0
49632|NCT01892020|118981|P1|NOT COMPLETED|Period 2||1
49633|NCT01892020|118980|P2|COMPLETED|Period 2||74
49634|NCT01892020|118981|P1|COMPLETED|Period 2||77
49635|NCT01892020|118980|P2|STARTED|Period 2||74
49636|NCT01892020|118981|P1|STARTED|Period 2||78
49637|NCT01892020|118980|P2|NOT COMPLETED|Period 1||6
49638|NCT01892020|118981|P1|NOT COMPLETED|Period 1||3
49639|NCT01892020|118980|P2|COMPLETED|Period 1||74
49640|NCT01892020|118981|P1|COMPLETED|Period 1||78
49641|NCT01892020|118980|P2|STARTED|Period 1||80
49642|NCT01892020|118981|P1|STARTED|Period 1||81
49643|NCT01891968|118999|P1|NOT COMPLETED|Overall Study||0
49644|NCT01891968|118999|P1|COMPLETED|Overall Study||15
49645|NCT01891968|118999|P1|STARTED|Overall Study||15
49646|NCT01891890|119006|P3|NOT COMPLETED|Overall Study||7
49647|NCT01891890|119007|P2|NOT COMPLETED|Overall Study||3
49648|NCT01891890|119008|P1|NOT COMPLETED|Overall Study||7
49649|NCT01891890|119006|P3|COMPLETED|Overall Study||14
49650|NCT01891890|119007|P2|COMPLETED|Overall Study||24
49651|NCT01891890|119008|P1|COMPLETED|Overall Study||17
49652|NCT01891890|119006|P3|STARTED|Overall Study||21
49653|NCT01891890|119007|P2|STARTED|Overall Study||27
49654|NCT01891890|119008|P1|STARTED|Overall Study||24
49655|NCT01891864|119051|P6|NOT COMPLETED|Extension Period||0
49656|NCT01891864|119052|P5|NOT COMPLETED|Extension Period||7
49657|NCT01891864|119053|P4|NOT COMPLETED|Extension Period||5
49658|NCT01891864|119054|P3|NOT COMPLETED|Extension Period||8
49659|NCT01891864|119055|P2|NOT COMPLETED|Extension Period||0
49660|NCT01891864|119056|P1|NOT COMPLETED|Extension Period||0
49661|NCT01891864|119051|P6|COMPLETED|Extension Period||90
49662|NCT01891864|119052|P5|COMPLETED|Extension Period||88
49663|NCT01891864|119053|P4|COMPLETED|Extension Period||137
49664|NCT01891864|119054|P3|COMPLETED|Extension Period||132
49665|NCT01891864|119055|P2|COMPLETED|Extension Period||0
49666|NCT01891864|119056|P1|COMPLETED|Extension Period||0
49667|NCT01891864|119051|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
49668|NCT01891864|119052|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
49669|NCT01891864|119053|P4|STARTED|Extension Period||142
49670|NCT01891864|119054|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
49671|NCT01891864|119055|P2|STARTED|Extension Period||0
49672|NCT01891864|119056|P1|STARTED|Extension Period||0
49673|NCT01891864|119051|P6|NOT COMPLETED|Treatment Period 2||5
49674|NCT01891864|119052|P5|NOT COMPLETED|Treatment Period 2||4
49675|NCT01891864|119053|P4|NOT COMPLETED|Treatment Period 2||9
49676|NCT01891864|119054|P3|NOT COMPLETED|Treatment Period 2||7
49677|NCT01891864|119055|P2|NOT COMPLETED|Treatment Period 2||0
49678|NCT01891864|119056|P1|NOT COMPLETED|Treatment Period 2||0
49679|NCT01891864|119051|P6|COMPLETED|Treatment Period 2||91
49680|NCT01891864|119052|P5|COMPLETED|Treatment Period 2||96
49681|NCT01891864|119053|P4|COMPLETED|Treatment Period 2||142
49682|NCT01891864|119054|P3|COMPLETED|Treatment Period 2||143
49683|NCT01891864|119055|P2|COMPLETED|Treatment Period 2||0
49684|NCT01891864|119056|P1|COMPLETED|Treatment Period 2||0
49685|NCT01891864|119051|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
49686|NCT01891864|119052|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
49687|NCT01891864|119053|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
49688|NCT01891864|119054|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
49689|NCT01891864|119055|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
49690|NCT01891864|119056|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
49691|NCT01891864|119051|P6|NOT COMPLETED|Treatment Period 1||0
49692|NCT01891864|119052|P5|NOT COMPLETED|Treatment Period 1||0
49693|NCT01891864|119053|P4|NOT COMPLETED|Treatment Period 1||0
49694|NCT01891864|119054|P3|NOT COMPLETED|Treatment Period 1||0
49695|NCT01891864|119055|P2|NOT COMPLETED|Treatment Period 1||12
49696|NCT01891864|119056|P1|NOT COMPLETED|Treatment Period 1||8
49697|NCT01891864|119051|P6|COMPLETED|Treatment Period 1||0
49698|NCT01891864|119052|P5|COMPLETED|Treatment Period 1||0
49699|NCT01891864|119053|P4|COMPLETED|Treatment Period 1||0
49700|NCT01891864|119054|P3|COMPLETED|Treatment Period 1||0
49701|NCT01891864|119055|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
49702|NCT01891864|119056|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
49703|NCT01891864|119051|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
49704|NCT01891864|119052|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
49705|NCT01891864|119053|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
49706|NCT01891864|119054|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
49707|NCT01891864|119055|P2|STARTED|Treatment Period 1||267
49708|NCT01891864|119056|P1|STARTED|Treatment Period 1||264
49709|NCT01891734|119078|P2|NOT COMPLETED|Overall Study||3
49710|NCT01891734|119079|P1|NOT COMPLETED|Overall Study||3
49711|NCT01891734|119078|P2|COMPLETED|Overall Study||13
49712|NCT01891734|119079|P1|COMPLETED|Overall Study||14
49713|NCT01891734|119078|P2|STARTED|Overall Study||16
49714|NCT01891734|119079|P1|STARTED|Overall Study||17
49715|NCT01891669|119099|P10|NOT COMPLETED|Overall Study||2
49716|NCT01891669|119100|P9|NOT COMPLETED|Overall Study||1
49717|NCT01891669|119101|P8|NOT COMPLETED|Overall Study||4
49718|NCT01891669|119102|P7|NOT COMPLETED|Overall Study||1
49719|NCT01891669|119103|P6|NOT COMPLETED|Overall Study||0
49720|NCT01891669|119104|P5|NOT COMPLETED|Overall Study||0
49721|NCT01891669|119105|P4|NOT COMPLETED|Overall Study||0
49722|NCT01891669|119106|P3|NOT COMPLETED|Overall Study||0
49723|NCT01891669|119107|P2|NOT COMPLETED|Overall Study||1
49724|NCT01891669|119108|P1|NOT COMPLETED|Overall Study||2
49725|NCT01891669|119099|P10|COMPLETED|Overall Study||1
49726|NCT01891669|119100|P9|COMPLETED|Overall Study||2
49727|NCT01891669|119101|P8|COMPLETED|Overall Study||2
49728|NCT01891669|119102|P7|COMPLETED|Overall Study||1
49729|NCT01891669|119103|P6|COMPLETED|Overall Study||2
49730|NCT01891669|119104|P5|COMPLETED|Overall Study||2
49731|NCT01891669|119105|P4|COMPLETED|Overall Study||2
49732|NCT01891669|119106|P3|COMPLETED|Overall Study||2
49733|NCT01891669|119107|P2|COMPLETED|Overall Study||1
49734|NCT01891669|119108|P1|COMPLETED|Overall Study||0
49735|NCT01891669|119099|P10|STARTED|Overall Study||3
49736|NCT01891669|119100|P9|STARTED|Overall Study||3
49737|NCT01891669|119101|P8|STARTED|Overall Study||6
49738|NCT01891669|119102|P7|STARTED|Overall Study||2
49739|NCT01891669|119103|P6|STARTED|Overall Study||2
49740|NCT01891669|119104|P5|STARTED|Overall Study||2
49741|NCT01891669|119105|P4|STARTED|Overall Study||2
49742|NCT01891669|119106|P3|STARTED|Overall Study||2
49743|NCT01891669|119107|P2|STARTED|Overall Study||2
49744|NCT01891669|119108|P1|STARTED|Overall Study||2
49745|NCT01890967|119265|P6|NOT COMPLETED|Overall Study||13
49746|NCT01890967|119266|P5|NOT COMPLETED|Overall Study||10
49747|NCT01890967|119267|P4|NOT COMPLETED|Overall Study||11
49748|NCT01890967|119268|P3|NOT COMPLETED|Overall Study||10
49749|NCT01890967|119269|P2|NOT COMPLETED|Overall Study||11
49750|NCT01890967|119270|P1|NOT COMPLETED|Overall Study||10
49751|NCT01890967|119265|P6|COMPLETED|Overall Study||75
49752|NCT01890967|119266|P5|COMPLETED|Overall Study||77
49753|NCT01890967|119267|P4|COMPLETED|Overall Study||77
49754|NCT01890967|119268|P3|COMPLETED|Overall Study||78
49755|NCT01890967|119269|P2|COMPLETED|Overall Study||77
49756|NCT01890967|119270|P1|COMPLETED|Overall Study||78
49757|NCT01890967|119265|P6|Received at Least One Dose of Study Drug|Overall Study||87
49758|NCT01890967|119266|P5|Received at Least One Dose of Study Drug|Overall Study||86
49759|NCT01890967|119267|P4|Received at Least One Dose of Study Drug|Overall Study||86
49760|NCT01890967|119268|P3|Received at Least One Dose of Study Drug|Overall Study||86
49761|NCT01890967|119269|P2|Received at Least One Dose of Study Drug|Overall Study||87
49762|NCT01890967|119270|P1|Received at Least One Dose of Study Drug|Overall Study||87
49763|NCT01890967|119265|P6|STARTED|Overall Study||88
49764|NCT01890967|119266|P5|STARTED|Overall Study||87
49765|NCT01890967|119267|P4|STARTED|Overall Study||88
49766|NCT01890967|119268|P3|STARTED|Overall Study||88
49767|NCT01890967|119269|P2|STARTED|Overall Study||88
49768|NCT01890967|119270|P1|STARTED|Overall Study||88
49769|NCT01890954|119339|P2|NOT COMPLETED|Overall Study||0
49770|NCT01890954|119340|P1|NOT COMPLETED|Overall Study||1
49771|NCT01890954|119339|P2|COMPLETED|Overall Study||8
49772|NCT01890954|119340|P1|COMPLETED|Overall Study||8
49773|NCT01890954|119339|P2|STARTED|Overall Study||8
49774|NCT01890954|119340|P1|STARTED|Overall Study||9
49775|NCT01890915|119348|P2|NOT COMPLETED|Overall Study||1
49776|NCT01890915|119349|P1|NOT COMPLETED|Overall Study||3
49777|NCT01890915|119348|P2|COMPLETED|Overall Study||9
49778|NCT01890915|119349|P1|COMPLETED|Overall Study||8
49779|NCT01890915|119348|P2|STARTED|Overall Study||10
49780|NCT01890915|119349|P1|STARTED|Overall Study||11
49781|NCT01890785|119365|P6|NOT COMPLETED|Third Intervention||0
49782|NCT01890785|119366|P5|NOT COMPLETED|Third Intervention||0
49783|NCT01890785|119367|P4|NOT COMPLETED|Third Intervention||0
49784|NCT01890785|119368|P3|NOT COMPLETED|Third Intervention||0
49785|NCT01890785|119369|P2|NOT COMPLETED|Third Intervention||1
49786|NCT01890785|119370|P1|NOT COMPLETED|Third Intervention||0
49787|NCT01890785|119365|P6|COMPLETED|Third Intervention||5
49788|NCT01890785|119366|P5|COMPLETED|Third Intervention||5
49789|NCT01890785|119367|P4|COMPLETED|Third Intervention||5
49790|NCT01890785|119368|P3|COMPLETED|Third Intervention||5
49791|NCT01890785|119369|P2|COMPLETED|Third Intervention||4
49792|NCT01890785|119370|P1|COMPLETED|Third Intervention||5
49793|NCT01890785|119365|P6|STARTED|Third Intervention||5
49794|NCT01890785|119366|P5|STARTED|Third Intervention||5
49795|NCT01890785|119367|P4|STARTED|Third Intervention||5
49796|NCT01890785|119368|P3|STARTED|Third Intervention||5
49797|NCT01890785|119369|P2|STARTED|Third Intervention||5
49798|NCT01890785|119370|P1|STARTED|Third Intervention||5
49799|NCT01890785|119365|P6|NOT COMPLETED|Second Intervention||0
49800|NCT01890785|119366|P5|NOT COMPLETED|Second Intervention||0
49801|NCT01890785|119367|P4|NOT COMPLETED|Second Intervention||0
49802|NCT01890785|119368|P3|NOT COMPLETED|Second Intervention||0
49803|NCT01890785|119369|P2|NOT COMPLETED|Second Intervention||0
49804|NCT01890785|119370|P1|NOT COMPLETED|Second Intervention||0
49805|NCT01890785|119365|P6|COMPLETED|Second Intervention||5
49806|NCT01890785|119366|P5|COMPLETED|Second Intervention||5
49807|NCT01890785|119367|P4|COMPLETED|Second Intervention||5
49808|NCT01890785|119368|P3|COMPLETED|Second Intervention||5
49809|NCT01890785|119369|P2|COMPLETED|Second Intervention||5
49810|NCT01890785|119370|P1|COMPLETED|Second Intervention||5
49811|NCT01890785|119365|P6|STARTED|Second Intervention||5
49812|NCT01890785|119366|P5|STARTED|Second Intervention||5
49813|NCT01890785|119367|P4|STARTED|Second Intervention||5
49814|NCT01890785|119368|P3|STARTED|Second Intervention||5
49815|NCT01890785|119369|P2|STARTED|Second Intervention||5
49816|NCT01890785|119370|P1|STARTED|Second Intervention||5
49817|NCT01890785|119365|P6|NOT COMPLETED|First Intervention||0
49818|NCT01890785|119366|P5|NOT COMPLETED|First Intervention||0
49819|NCT01890785|119367|P4|NOT COMPLETED|First Intervention||0
49820|NCT01890785|119368|P3|NOT COMPLETED|First Intervention||0
49821|NCT01890785|119369|P2|NOT COMPLETED|First Intervention||0
49822|NCT01890785|119370|P1|NOT COMPLETED|First Intervention||0
49823|NCT01890785|119365|P6|COMPLETED|First Intervention||5
49824|NCT01890785|119366|P5|COMPLETED|First Intervention||5
49825|NCT01890785|119367|P4|COMPLETED|First Intervention||5
49826|NCT01890785|119368|P3|COMPLETED|First Intervention||5
49827|NCT01890785|119369|P2|COMPLETED|First Intervention||5
49828|NCT01890785|119370|P1|COMPLETED|First Intervention||5
49829|NCT01890785|119365|P6|STARTED|First Intervention||5
49830|NCT01890785|119366|P5|STARTED|First Intervention||5
49831|NCT01890785|119367|P4|STARTED|First Intervention||5
49832|NCT01890785|119368|P3|STARTED|First Intervention||5
49833|NCT01890785|119369|P2|STARTED|First Intervention||5
49834|NCT01890785|119370|P1|STARTED|First Intervention||5
49835|NCT01890759|119389|P2|NOT COMPLETED|Overall Study||12
49836|NCT01890759|119390|P1|NOT COMPLETED|Overall Study||2
49837|NCT01890759|119389|P2|COMPLETED|Overall Study||188
49838|NCT01890759|119390|P1|COMPLETED|Overall Study||98
49839|NCT01890759|119389|P2|STARTED|Overall Study||200
49840|NCT01890759|119390|P1|STARTED|Overall Study||100
49841|NCT01890746|119424|P2|NOT COMPLETED|Overall Study||74
49842|NCT01890746|119425|P1|NOT COMPLETED|Overall Study||74
49843|NCT01890746|119424|P2|COMPLETED|Overall Study||0
49844|NCT01890746|119425|P1|COMPLETED|Overall Study||0
49845|NCT01890746|119424|P2|STARTED|Overall Study||74
49846|NCT01890746|119425|P1|STARTED|Overall Study||74
49847|NCT01890694|119451|P2|NOT COMPLETED|Overall Study||1
49848|NCT01890694|119452|P1|NOT COMPLETED|Overall Study||1
49849|NCT01890694|119451|P2|COMPLETED|Overall Study||0
49850|NCT01890694|119452|P1|COMPLETED|Overall Study||0
49851|NCT01890694|119451|P2|STARTED|Overall Study||1
49852|NCT01890694|119452|P1|STARTED|Overall Study||1
49853|NCT01890642|119487|P3|NOT COMPLETED|Overall Study||0
49854|NCT01890642|119488|P2|NOT COMPLETED|Overall Study||0
49855|NCT01890642|119489|P1|NOT COMPLETED|Overall Study||0
49856|NCT01890642|119487|P3|COMPLETED|Overall Study||96
49857|NCT01890642|119488|P2|COMPLETED|Overall Study||53
49858|NCT01890642|119489|P1|COMPLETED|Overall Study||56
49859|NCT01890642|119487|P3|STARTED|Overall Study||96
49860|NCT01890642|119488|P2|STARTED|Overall Study||53
49861|NCT01890642|119489|P1|STARTED|Overall Study||56
49862|NCT01890577|119509|P1|NOT COMPLETED|Overall Study||28
49863|NCT01890577|119509|P1|COMPLETED|Overall Study||0
49864|NCT01890577|119509|P1|STARTED|Overall Study||28
49865|NCT01890512|119522|P1|NOT COMPLETED|Overall Study||3
49866|NCT01890512|119522|P1|COMPLETED|Overall Study||17
49867|NCT01890512|119522|P1|STARTED|Overall Study||20
49868|NCT01890473|119528|P2|NOT COMPLETED|Overall Study||0
49869|NCT01890473|119529|P1|NOT COMPLETED|Overall Study||2
49870|NCT01890473|119528|P2|COMPLETED|Overall Study||113
49871|NCT01890473|119529|P1|COMPLETED|Overall Study||109
49872|NCT01890473|119528|P2|STARTED|Overall Study||113
49873|NCT01890473|119529|P1|STARTED|Overall Study||111
49874|NCT01890434|119555|P1|NOT COMPLETED|Overall Study||20
49875|NCT01890434|119555|P1|COMPLETED|Overall Study||458
49876|NCT01890434|119555|P1|Evaluated for Efficacy|Overall Study||389
49877|NCT01890434|119555|P1|STARTED|Overall Study||478
49878|NCT01890421|119585|P1|NOT COMPLETED|Overall Study||11
49879|NCT01890421|119585|P1|COMPLETED|Overall Study||415
49880|NCT01890421|119585|P1|STARTED|Overall Study||426
49881|NCT01890343|119611|P3|NOT COMPLETED|Overall Study||0
49882|NCT01890343|119612|P2|NOT COMPLETED|Overall Study||0
49883|NCT01890343|119613|P1|NOT COMPLETED|Overall Study||0
49884|NCT01890343|119611|P3|COMPLETED|Overall Study||10
49885|NCT01890343|119612|P2|COMPLETED|Overall Study||10
49886|NCT01890343|119613|P1|COMPLETED|Overall Study||8
49887|NCT01890343|119611|P3|STARTED|Overall Study||10
49888|NCT01890343|119612|P2|STARTED|Overall Study||10
49889|NCT01890343|119613|P1|STARTED|Overall Study||8
49890|NCT01890148|119624|P1|NOT COMPLETED|Overall Study||1
49891|NCT01890148|119624|P1|COMPLETED|Overall Study||4
49892|NCT01890148|119624|P1|STARTED|Overall Study||5
49893|NCT01890122|119644|P4|NOT COMPLETED|Overall Study||59
49894|NCT01890122|119645|P3|NOT COMPLETED|Overall Study||13
49895|NCT01890122|119646|P2|NOT COMPLETED|Overall Study||37
49896|NCT01890122|119647|P1|NOT COMPLETED|Overall Study||27
49897|NCT01890122|119644|P4|COMPLETED|Overall Study||104
49898|NCT01890122|119645|P3|COMPLETED|Overall Study||146
49899|NCT01890122|119646|P2|COMPLETED|Overall Study||126
49900|NCT01890122|119647|P1|COMPLETED|Overall Study||135
49901|NCT01890122|119644|P4|Treated|Overall Study||163
49902|NCT01890122|119645|P3|Treated|Overall Study||159
49903|NCT01890122|119646|P2|Treated|Overall Study||162
49904|NCT01890122|119647|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
49905|NCT01890122|119644|P4|STARTED|Overall Study||163
49906|NCT01890122|119645|P3|STARTED|Overall Study||159
49907|NCT01890122|119646|P2|STARTED|Overall Study||163
49908|NCT01890122|119647|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
49909|NCT01890031|119714|P5|NOT COMPLETED|Overall Study||0
49910|NCT01890031|119715|P4|NOT COMPLETED|Overall Study||0
49911|NCT01890031|119716|P3|NOT COMPLETED|Overall Study||0
49912|NCT01890031|119717|P2|NOT COMPLETED|Overall Study||0
49913|NCT01890031|119718|P1|NOT COMPLETED|Overall Study||0
49914|NCT01890031|119714|P5|COMPLETED|Overall Study||8
49915|NCT01890031|119715|P4|COMPLETED|Overall Study||11
49916|NCT01890031|119716|P3|COMPLETED|Overall Study||12
49917|NCT01890031|119717|P2|COMPLETED|Overall Study||50
49918|NCT01890031|119718|P1|COMPLETED|Overall Study||50
49919|NCT01890031|119714|P5|STARTED|Overall Study||8
49920|NCT01890031|119715|P4|STARTED|Overall Study||11
49921|NCT01890031|119716|P3|STARTED|Overall Study||12
49922|NCT01890031|119717|P2|STARTED|Overall Study||50
49923|NCT01890031|119718|P1|STARTED|Overall Study||50
49924|NCT01889797|119737|P2|NOT COMPLETED|Overall Study||0
49925|NCT01889797|119738|P1|NOT COMPLETED|Overall Study||0
49926|NCT01889797|119737|P2|COMPLETED|Overall Study||16
49927|NCT01889797|119738|P1|COMPLETED|Overall Study||16
49928|NCT01889797|119737|P2|STARTED|Overall Study||16
49929|NCT01889797|119738|P1|STARTED|Overall Study||16
49930|NCT01889667|119753|P3|NOT COMPLETED|Overall Study||0
49931|NCT01889667|119754|P2|NOT COMPLETED|Overall Study||0
49932|NCT01889667|119755|P1|NOT COMPLETED|Overall Study||0
49933|NCT01889667|119753|P3|COMPLETED|Overall Study||10
49934|NCT01889667|119754|P2|COMPLETED|Overall Study||10
49935|NCT01889667|119755|P1|COMPLETED|Overall Study||10
49936|NCT01889667|119753|P3|STARTED|Overall Study||10
49937|NCT01889667|119754|P2|STARTED|Overall Study||10
49938|NCT01889667|119755|P1|STARTED|Overall Study||10
49939|NCT01889563|119777|P2|NOT COMPLETED|Overall Study||5
49940|NCT01889563|119778|P1|NOT COMPLETED|Overall Study||7
49941|NCT01889563|119777|P2|COMPLETED|Overall Study||10
49942|NCT01889563|119778|P1|COMPLETED|Overall Study||10
49943|NCT01889563|119777|P2|STARTED|Overall Study||15
49944|NCT01889563|119778|P1|STARTED|Overall Study||17
49945|NCT01889420|119786|P1|NOT COMPLETED|Overall Study||0
49946|NCT01889420|119786|P1|COMPLETED|Overall Study||1
49947|NCT01889420|119786|P1|STARTED|Overall Study||1
49948|NCT01889251|119794|P2|NOT COMPLETED|Overall Study||0
49949|NCT01889251|119795|P1|NOT COMPLETED|Overall Study||1
49950|NCT01889251|119794|P2|COMPLETED|Overall Study||57
49951|NCT01889251|119795|P1|COMPLETED|Overall Study||114
49952|NCT01889251|119794|P2|STARTED|Overall Study||57
49953|NCT01889251|119795|P1|STARTED|Overall Study||115
49954|NCT01888965|119801|P1|NOT COMPLETED|Overall Study||9
49955|NCT01888965|119801|P1|COMPLETED|Overall Study||0
49956|NCT01888965|119801|P1|STARTED|Overall Study||9
49957|NCT01888952|119807|P1|NOT COMPLETED|Overall Study||0
49958|NCT01888952|119807|P1|COMPLETED|Overall Study||10
49959|NCT01888952|119807|P1|STARTED|Overall Study||10
49960|NCT01888900|119813|P2|NOT COMPLETED|Overall Study||2
49961|NCT01888900|119814|P1|NOT COMPLETED|Overall Study||0
49962|NCT01888900|119813|P2|COMPLETED|Overall Study||11
49963|NCT01888900|119814|P1|COMPLETED|Overall Study||22
49964|NCT01888900|119813|P2|STARTED|Overall Study||13
49965|NCT01888900|119814|P1|STARTED|Overall Study||22
49966|NCT01888367|119837|P3|NOT COMPLETED|Overall Study||5
49967|NCT01888367|119838|P2|NOT COMPLETED|Overall Study||5
49968|NCT01888367|119839|P1|NOT COMPLETED|Overall Study||8
49969|NCT01888367|119837|P3|COMPLETED|Overall Study||73
49970|NCT01888367|119838|P2|COMPLETED|Overall Study||66
49971|NCT01888367|119839|P1|COMPLETED|Overall Study||288
49972|NCT01888367|119837|P3|STARTED|Overall Study||78
49973|NCT01888367|119838|P2|STARTED|Overall Study||71
49974|NCT01888367|119839|P1|STARTED|Overall Study||296
49975|NCT01888003|119859|P3|NOT COMPLETED|Overall Study||40
49976|NCT01888003|119860|P2|NOT COMPLETED|Overall Study||6
49977|NCT01888003|119861|P1|NOT COMPLETED|Overall Study||5
49978|NCT01888003|119859|P3|COMPLETED|Overall Study||0
49979|NCT01888003|119860|P2|COMPLETED|Overall Study||0
49980|NCT01888003|119861|P1|COMPLETED|Overall Study||0
49981|NCT01888003|119859|P3|STARTED|Overall Study||40
49982|NCT01888003|119860|P2|STARTED|Overall Study||6
49983|NCT01888003|119861|P1|STARTED|Overall Study||5
49984|NCT01887990|119882|P4|NOT COMPLETED|Overall Study||0
49985|NCT01887990|119883|P3|NOT COMPLETED|Overall Study||0
49986|NCT01887990|119884|P2|NOT COMPLETED|Overall Study||0
49987|NCT01887990|119885|P1|NOT COMPLETED|Overall Study||0
49988|NCT01887990|119882|P4|COMPLETED|Overall Study||2
49989|NCT01887990|119883|P3|COMPLETED|Overall Study||2
49990|NCT01887990|119884|P2|COMPLETED|Overall Study||7
49991|NCT01887990|119885|P1|COMPLETED|Overall Study||7
49992|NCT01887990|119882|P4|STARTED|Overall Study||2
49993|NCT01887990|119883|P3|STARTED|Overall Study||2
49994|NCT01887990|119884|P2|STARTED|Overall Study||7
49995|NCT01887990|119885|P1|STARTED|Overall Study||7
49996|NCT01887678|119901|P2|NOT COMPLETED|Overall Study||28
49997|NCT01887678|119902|P1|NOT COMPLETED|Overall Study||17
49998|NCT01887678|119901|P2|COMPLETED|Overall Study||85
49999|NCT01887678|119902|P1|COMPLETED|Overall Study||102
50000|NCT01887678|119901|P2|STARTED|Overall Study||113
50001|NCT01887678|119902|P1|STARTED|Overall Study||119
50002|NCT01887470|119948|P4|NOT COMPLETED|Overall Study||0
50003|NCT01887470|119949|P3|NOT COMPLETED|Overall Study||0
50004|NCT01887470|119950|P2|NOT COMPLETED|Overall Study||0
50005|NCT01887470|119951|P1|NOT COMPLETED|Overall Study||0
50006|NCT01887470|119948|P4|COMPLETED|Overall Study||10
50007|NCT01887470|119949|P3|COMPLETED|Overall Study||10
50008|NCT01887470|119950|P2|COMPLETED|Overall Study||10
50009|NCT01887470|119951|P1|COMPLETED|Overall Study||10
50010|NCT01887470|119948|P4|STARTED|Overall Study||10
50011|NCT01887470|119949|P3|STARTED|Overall Study||10
50012|NCT01887470|119950|P2|STARTED|Overall Study||10
50013|NCT01887470|119951|P1|STARTED|Overall Study||10
50014|NCT01887418|119970|P3|NOT COMPLETED|Overall Study||1
50015|NCT01887418|119971|P2|NOT COMPLETED|Overall Study||0
50016|NCT01887418|119972|P1|NOT COMPLETED|Overall Study||0
50017|NCT01887418|119970|P3|COMPLETED|Overall Study||9
50018|NCT01887418|119971|P2|COMPLETED|Overall Study||14
50019|NCT01887418|119972|P1|COMPLETED|Overall Study||15
50020|NCT01887418|119970|P3|STARTED|Overall Study||10
50021|NCT01887418|119971|P2|STARTED|Overall Study||14
50022|NCT01887418|119972|P1|STARTED|Overall Study||15
50023|NCT01887353|119991|P2|NOT COMPLETED|Overall Study||3
50024|NCT01887353|119992|P1|NOT COMPLETED|Overall Study||4
50025|NCT01887353|119991|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
50026|NCT01887353|119992|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
50027|NCT01887353|119991|P2|STARTED|Overall Study||4
50028|NCT01887353|119992|P1|STARTED|Overall Study||4
50029|NCT01887288|119998|P1|NOT COMPLETED|Overall Study||16
50030|NCT01887288|119998|P1|COMPLETED|Overall Study||0
50031|NCT01887288|119998|P1|STARTED|Overall Study||16
50032|NCT01887171|120005|P2|NOT COMPLETED|Overall Study||0
50033|NCT01887171|120006|P1|NOT COMPLETED|Overall Study||0
50034|NCT01887171|120005|P2|COMPLETED|Overall Study||43
50035|NCT01887171|120006|P1|COMPLETED|Overall Study||43
50036|NCT01887171|120005|P2|STARTED|Overall Study||43
50037|NCT01887171|120006|P1|STARTED|Overall Study||43
50038|NCT01887132|120012|P1|NOT COMPLETED|Overall Study||0
50039|NCT01887132|120012|P1|COMPLETED|Overall Study||4
50040|NCT01887132|120012|P1|STARTED|Overall Study||4
50041|NCT01886963|120019|P2|NOT COMPLETED|Overall Study||4
50042|NCT01886963|120020|P1|NOT COMPLETED|Overall Study||5
50043|NCT01886963|120019|P2|COMPLETED|Overall Study||49
50044|NCT01886963|120020|P1|COMPLETED|Overall Study||46
50045|NCT01886963|120019|P2|12 Week Follow Up|Overall Study||22
50046|NCT01886963|120020|P1|12 Week Follow Up|Overall Study||24
50047|NCT01886963|120019|P2|4 Week Follow Up|Overall Study||26
50048|NCT01886963|120020|P1|4 Week Follow Up|Overall Study||24
50049|NCT01886963|120019|P2|2 Week Follow Up|Overall Study||35
50050|NCT01886963|120020|P1|2 Week Follow Up|Overall Study||38
50051|NCT01886963|120019|P2|STARTED|Overall Study||53
50052|NCT01886963|120020|P1|STARTED|Overall Study||51
50053|NCT01886937|120028|P2|NOT COMPLETED|Overall Study||0
50054|NCT01886937|120029|P1|NOT COMPLETED|Overall Study||0
50055|NCT01886937|120028|P2|COMPLETED|Overall Study||6
50056|NCT01886937|120029|P1|COMPLETED|Overall Study||7
50057|NCT01886937|120028|P2|STARTED|Overall Study||6
50058|NCT01886937|120029|P1|STARTED|Overall Study||7
50059|NCT01886807|120038|P3|NOT COMPLETED|Overall Study||10
50060|NCT01886807|120039|P2|NOT COMPLETED|Overall Study||10
50061|NCT01886807|120040|P1|NOT COMPLETED|Overall Study||5
50062|NCT01886807|120038|P3|COMPLETED|Overall Study||153
50063|NCT01886807|120039|P2|COMPLETED|Overall Study||145
50064|NCT01886807|120040|P1|COMPLETED|Overall Study||159
50065|NCT01886807|120038|P3|STARTED|Overall Study||163
50066|NCT01886807|120039|P2|STARTED|Overall Study||155
50067|NCT01886807|120040|P1|STARTED|Overall Study||164
50068|NCT01886781|120050|P2|NOT COMPLETED|Overall Study||2
50069|NCT01886781|120051|P1|NOT COMPLETED|Overall Study||14
50070|NCT01886781|120050|P2|COMPLETED|Overall Study||25
50071|NCT01886781|120051|P1|COMPLETED|Overall Study||40
50072|NCT01886781|120050|P2|STARTED|Overall Study||27
50073|NCT01886781|120051|P1|STARTED|Overall Study||54
50074|NCT01886716|120061|P4|NOT COMPLETED|1-Month Post Follow-Up||0
50075|NCT01886716|120062|P3|NOT COMPLETED|1-Month Post Follow-Up||0
50076|NCT01886716|120063|P2|NOT COMPLETED|1-Month Post Follow-Up||0
50077|NCT01886716|120064|P1|NOT COMPLETED|1-Month Post Follow-Up||0
50078|NCT01886716|120061|P4|COMPLETED|1-Month Post Follow-Up||14
50079|NCT01886716|120062|P3|COMPLETED|1-Month Post Follow-Up||19
50080|NCT01886716|120063|P2|COMPLETED|1-Month Post Follow-Up||17
50081|NCT01886716|120064|P1|COMPLETED|1-Month Post Follow-Up||20
50082|NCT01886716|120061|P4|STARTED|1-Month Post Follow-Up||14
50083|NCT01886716|120062|P3|STARTED|1-Month Post Follow-Up||19
50084|NCT01886716|120063|P2|STARTED|1-Month Post Follow-Up||17
50085|NCT01886716|120064|P1|STARTED|1-Month Post Follow-Up||20
50086|NCT01886716|120061|P4|NOT COMPLETED|1-Week Post Follow-Up||0
50087|NCT01886716|120062|P3|NOT COMPLETED|1-Week Post Follow-Up||0
50088|NCT01886716|120063|P2|NOT COMPLETED|1-Week Post Follow-Up||0
50089|NCT01886716|120064|P1|NOT COMPLETED|1-Week Post Follow-Up||0
50090|NCT01886716|120061|P4|COMPLETED|1-Week Post Follow-Up||14
50091|NCT01886716|120062|P3|COMPLETED|1-Week Post Follow-Up||19
50092|NCT01886716|120063|P2|COMPLETED|1-Week Post Follow-Up||17
50093|NCT01886716|120064|P1|COMPLETED|1-Week Post Follow-Up||20
50094|NCT01886716|120061|P4|STARTED|1-Week Post Follow-Up||14
50095|NCT01886716|120062|P3|STARTED|1-Week Post Follow-Up||19
50096|NCT01886716|120063|P2|STARTED|1-Week Post Follow-Up||17
50097|NCT01886716|120064|P1|STARTED|1-Week Post Follow-Up||20
50098|NCT01886716|120061|P4|NOT COMPLETED|Week 4||0
50099|NCT01886716|120062|P3|NOT COMPLETED|Week 4||0
50100|NCT01886716|120063|P2|NOT COMPLETED|Week 4||0
50101|NCT01886716|120064|P1|NOT COMPLETED|Week 4||0
50102|NCT01886716|120061|P4|COMPLETED|Week 4||14
50103|NCT01886716|120062|P3|COMPLETED|Week 4||19
50104|NCT01886716|120063|P2|COMPLETED|Week 4||17
50105|NCT01886716|120064|P1|COMPLETED|Week 4||20
50106|NCT01886716|120061|P4|STARTED|Week 4||14
50107|NCT01886716|120062|P3|STARTED|Week 4||19
50108|NCT01886716|120063|P2|STARTED|Week 4||17
50109|NCT01886716|120064|P1|STARTED|Week 4||20
50110|NCT01886716|120061|P4|NOT COMPLETED|Week 3||1
50111|NCT01886716|120062|P3|NOT COMPLETED|Week 3||0
50112|NCT01886716|120063|P2|NOT COMPLETED|Week 3||1
50113|NCT01886716|120064|P1|NOT COMPLETED|Week 3||1
50114|NCT01886716|120061|P4|COMPLETED|Week 3||14
50115|NCT01886716|120062|P3|COMPLETED|Week 3||19
50116|NCT01886716|120063|P2|COMPLETED|Week 3||17
50117|NCT01886716|120064|P1|COMPLETED|Week 3||20
50118|NCT01886716|120061|P4|STARTED|Week 3||15
50119|NCT01886716|120062|P3|STARTED|Week 3||19
50120|NCT01886716|120063|P2|STARTED|Week 3||18
50121|NCT01886716|120064|P1|STARTED|Week 3||21
50122|NCT01886716|120061|P4|NOT COMPLETED|Week 2||3
50123|NCT01886716|120062|P3|NOT COMPLETED|Week 2||1
50124|NCT01886716|120063|P2|NOT COMPLETED|Week 2||2
50125|NCT01886716|120064|P1|NOT COMPLETED|Week 2||3
50126|NCT01886716|120061|P4|COMPLETED|Week 2||15
50127|NCT01886716|120062|P3|COMPLETED|Week 2||19
50128|NCT01886716|120063|P2|COMPLETED|Week 2||18
50129|NCT01886716|120064|P1|COMPLETED|Week 2||21
50130|NCT01886716|120061|P4|STARTED|Week 2||18
50131|NCT01886716|120062|P3|STARTED|Week 2||20
50132|NCT01886716|120063|P2|STARTED|Week 2||20
50133|NCT01886716|120064|P1|STARTED|Week 2||24
50134|NCT01886716|120061|P4|NOT COMPLETED|Week 1||2
50135|NCT01886716|120062|P3|NOT COMPLETED|Week 1||2
50136|NCT01886716|120063|P2|NOT COMPLETED|Week 1||0
50137|NCT01886716|120064|P1|NOT COMPLETED|Week 1||0
50138|NCT01886716|120061|P4|COMPLETED|Week 1||18
50139|NCT01886716|120062|P3|COMPLETED|Week 1||20
50140|NCT01886716|120063|P2|COMPLETED|Week 1||20
50141|NCT01886716|120064|P1|COMPLETED|Week 1||24
50142|NCT01886716|120061|P4|STARTED|Week 1||20
50143|NCT01886716|120062|P3|STARTED|Week 1||22
50144|NCT01886716|120063|P2|STARTED|Week 1||20
50145|NCT01886716|120064|P1|STARTED|Week 1||24
50146|NCT01886690|120080|P2|NOT COMPLETED|Overall Study||2
50147|NCT01886690|120081|P1|NOT COMPLETED|Overall Study||0
50148|NCT01886690|120080|P2|COMPLETED|Overall Study||71
50149|NCT01886690|120081|P1|COMPLETED|Overall Study||75
50150|NCT01886690|120080|P2|STARTED|Overall Study||73
50151|NCT01886690|120081|P1|STARTED|Overall Study||75
50152|NCT01886313|120097|P2|NOT COMPLETED|Overall Study||1
50153|NCT01886313|120098|P1|NOT COMPLETED|Overall Study||1
50154|NCT01886313|120097|P2|COMPLETED|Overall Study||4
50155|NCT01886313|120098|P1|COMPLETED|Overall Study||5
50156|NCT01886313|120097|P2|STARTED|Overall Study||5
50157|NCT01886313|120098|P1|STARTED|Overall Study||6
50158|NCT01886300|120104|P1|NOT COMPLETED|Overall Study||16
50159|NCT01886300|120104|P1|COMPLETED|Overall Study||0
50160|NCT01886300|120104|P1|STARTED|Overall Study||16
50161|NCT01886287|120115|P1|NOT COMPLETED|Overall Study||2
50162|NCT01886287|120115|P1|COMPLETED|Overall Study||0
50163|NCT01886287|120115|P1|STARTED|Overall Study||2
50164|NCT01886235|120120|P1|NOT COMPLETED|Overall Study||0
50165|NCT01886235|120120|P1|COMPLETED|Overall Study||10
50166|NCT01886235|120120|P1|STARTED|Overall Study||10
50167|NCT01885936|120133|P2|NOT COMPLETED|Overall Study||0
50168|NCT01885936|120134|P1|NOT COMPLETED|Overall Study||1
50169|NCT01885936|120133|P2|COMPLETED|Overall Study||5
50170|NCT01885936|120134|P1|COMPLETED|Overall Study||7
50171|NCT01885936|120133|P2|STARTED|Overall Study||5
50172|NCT01885936|120134|P1|STARTED|Overall Study||8
50173|NCT01885910|120144|P1|NOT COMPLETED|Overall Study||8
50174|NCT01885910|120144|P1|COMPLETED|Overall Study||24
50175|NCT01885910|120144|P1|STARTED|Overall Study||32
50176|NCT01885871|120158|P1|NOT COMPLETED|Overall Study||0
50177|NCT01885871|120158|P1|COMPLETED|Overall Study||20
50178|NCT01885871|120158|P1|STARTED|Overall Study||20
50179|NCT01885559|120168|P2|NOT COMPLETED|Overall Study||36
50180|NCT01885559|120169|P1|NOT COMPLETED|Overall Study||24
50181|NCT01885559|120168|P2|COMPLETED|Overall Study||208
50182|NCT01885559|120169|P1|COMPLETED|Overall Study||218
50183|NCT01885559|120168|P2|STARTED|Overall Study||244
50184|NCT01885559|120169|P1|STARTED|Overall Study||242
50185|NCT01885208|120191|P2|NOT COMPLETED|Overall Study||38
50186|NCT01885208|120192|P1|NOT COMPLETED|Overall Study||32
50187|NCT01885208|120191|P2|COMPLETED|Overall Study||369
50188|NCT01885208|120192|P1|COMPLETED|Overall Study||374
50189|NCT01885208|120191|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
50190|NCT01885208|120192|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
50191|NCT01885208|120191|P2|Exposed|Overall Study||405
50192|NCT01885208|120192|P1|Exposed|Overall Study||404
50193|NCT01885208|120191|P2|STARTED|Overall Study||407
50194|NCT01885208|120192|P1|STARTED|Overall Study||406
50195|NCT01885117|120210|P2|NOT COMPLETED|Overall Study||0
50196|NCT01885117|120211|P1|NOT COMPLETED|Overall Study||0
50197|NCT01885117|120210|P2|COMPLETED|Overall Study||64
50198|NCT01885117|120211|P1|COMPLETED|Overall Study||61
50199|NCT01885117|120210|P2|STARTED|Overall Study||64
50200|NCT01885117|120211|P1|STARTED|Overall Study||61
50201|NCT01885104|120233|P2|NOT COMPLETED|Overall Study||1
50202|NCT01885104|120234|P1|NOT COMPLETED|Overall Study||2
50203|NCT01885104|120233|P2|COMPLETED|Overall Study||33
50204|NCT01885104|120234|P1|COMPLETED|Overall Study||29
50205|NCT01885104|120233|P2|STARTED|Overall Study||34
50206|NCT01885104|120234|P1|STARTED|Overall Study||31
50207|NCT01885000|120244|P2|NOT COMPLETED|Overall Study||2
50208|NCT01885000|120245|P1|NOT COMPLETED|Overall Study||2
50209|NCT01885000|120244|P2|COMPLETED|Overall Study||42
50210|NCT01885000|120245|P1|COMPLETED|Overall Study||46
50211|NCT01885000|120244|P2|STARTED|Overall Study||44
50212|NCT01885000|120245|P1|STARTED|Overall Study||48
50213|NCT01884688|120257|P1|NOT COMPLETED|Overall Study||2
50214|NCT01884688|120257|P1|COMPLETED|Overall Study||1
50215|NCT01884688|120257|P1|STARTED|Overall Study||3
50216|NCT01884675|120263|P2|NOT COMPLETED|Overall Study||2
50217|NCT01884675|120264|P1|NOT COMPLETED|Overall Study||3
50218|NCT01884675|120263|P2|COMPLETED|Overall Study||15
50219|NCT01884675|120264|P1|COMPLETED|Overall Study||13
50220|NCT01884675|120263|P2|STARTED|Overall Study||17
50221|NCT01884675|120264|P1|STARTED|Overall Study||16
50222|NCT01884597|120307|P3|NOT COMPLETED|Overall Study||1
50223|NCT01884597|120308|P2|NOT COMPLETED|Overall Study||1
50224|NCT01884597|120309|P1|NOT COMPLETED|Overall Study||1
50225|NCT01884597|120307|P3|COMPLETED|Overall Study||15
50226|NCT01884597|120308|P2|COMPLETED|Overall Study||2
50227|NCT01884597|120309|P1|COMPLETED|Overall Study||4
50228|NCT01884597|120307|P3|STARTED|Overall Study||16
50229|NCT01884597|120308|P2|STARTED|Overall Study||3
50230|NCT01884597|120309|P1|STARTED|Overall Study||5
50231|NCT01884571|120338|P1|NOT COMPLETED|Overall Study||8
50232|NCT01884571|120338|P1|COMPLETED|Overall Study||23
50233|NCT01884571|120338|P1|STARTED|Overall Study||31
50234|NCT01884545|120353|P4|NOT COMPLETED|Overall Study||9
50235|NCT01884545|120354|P3|NOT COMPLETED|Overall Study||14
50236|NCT01884545|120355|P2|NOT COMPLETED|Overall Study||18
50237|NCT01884545|120356|P1|NOT COMPLETED|Overall Study||13
50238|NCT01884545|120353|P4|COMPLETED|Overall Study||43
50239|NCT01884545|120354|P3|COMPLETED|Overall Study||35
50240|NCT01884545|120355|P2|COMPLETED|Overall Study||31
50241|NCT01884545|120356|P1|COMPLETED|Overall Study||37
50242|NCT01884545|120353|P4|STARTED|Overall Study||52
50243|NCT01884545|120354|P3|STARTED|Overall Study||49
50244|NCT01884545|120355|P2|STARTED|Overall Study||49
50245|NCT01884545|120356|P1|STARTED|Overall Study||50
50246|NCT01884519|120464|P2|NOT COMPLETED|Overall Study||0
50247|NCT01884519|120465|P1|NOT COMPLETED|Overall Study||0
50248|NCT01884519|120464|P2|COMPLETED|Overall Study||60
50249|NCT01884519|120465|P1|COMPLETED|Overall Study||60
50250|NCT01884519|120464|P2|STARTED|Overall Study||60
50251|NCT01884519|120465|P1|STARTED|Overall Study||60
50252|NCT01884064|120509|P2|NOT COMPLETED|Overall Study||0
50253|NCT01884064|120510|P1|NOT COMPLETED|Overall Study||0
50254|NCT01884064|120509|P2|COMPLETED|Overall Study||5
50255|NCT01884064|120510|P1|COMPLETED|Overall Study||12
50256|NCT01884064|120509|P2|STARTED|Overall Study||5
50257|NCT01884064|120510|P1|STARTED|Overall Study||12
50258|NCT01883999|120516|P1|NOT COMPLETED|Overall Study||3
50259|NCT01883999|120516|P1|COMPLETED|Overall Study||61
50260|NCT01883999|120516|P1|STARTED|Overall Study||64
50261|NCT01883986|120524|P2|NOT COMPLETED|Overall Study||1
50262|NCT01883986|120525|P1|NOT COMPLETED|Overall Study||3
50263|NCT01883986|120524|P2|COMPLETED|Overall Study|Completed study|19
50264|NCT01883986|120525|P1|COMPLETED|Overall Study|Received allocated intervention|17
50265|NCT01883986|120524|P2|Did Not Complete Study|Overall Study|Did not completed study|1
50266|NCT01883986|120525|P1|Did Not Complete Study|Overall Study||3
50267|NCT01883986|120524|P2|STARTED|Overall Study|Allocated to usual care arm|20
50268|NCT01883986|120525|P1|STARTED|Overall Study|Allocated to intervention arm|20
50269|NCT01883908|120539|P2|NOT COMPLETED|Overall Study||0
50270|NCT01883908|120540|P1|NOT COMPLETED|Overall Study||0
50271|NCT01883908|120539|P2|COMPLETED|Overall Study||1
50272|NCT01883908|120540|P1|COMPLETED|Overall Study||3
50273|NCT01883908|120539|P2|STARTED|Overall Study||1
50274|NCT01883908|120540|P1|STARTED|Overall Study||3
50275|NCT01883895|120548|P1|NOT COMPLETED|Overall Study||2
50276|NCT01883895|120548|P1|COMPLETED|Overall Study||32
50277|NCT01883895|120548|P1|STARTED|Overall Study||34
50278|NCT01883804|120553|P1|NOT COMPLETED|Overall Study||5
50279|NCT01883804|120553|P1|COMPLETED|Overall Study||20
50280|NCT01883804|120553|P1|STARTED|Overall Study||25
50281|NCT01883635|120562|P2|NOT COMPLETED|Overall Study||0
50282|NCT01883635|120563|P1|NOT COMPLETED|Overall Study||4
50283|NCT01883635|120562|P2|COMPLETED|Overall Study||20
50284|NCT01883635|120563|P1|COMPLETED|Overall Study||20
50285|NCT01883635|120562|P2|STARTED|Overall Study||20
50286|NCT01883635|120563|P1|STARTED|Overall Study||24
50287|NCT01883453|120577|P2|NOT COMPLETED|Overall Study||23
50288|NCT01883453|120578|P1|NOT COMPLETED|Overall Study||25
50289|NCT01883453|120577|P2|COMPLETED|Overall Study||50
50290|NCT01883453|120578|P1|COMPLETED|Overall Study||48
50291|NCT01883453|120577|P2|STARTED|Overall Study||73
50292|NCT01883453|120578|P1|STARTED|Overall Study||73
50293|NCT01883440|120586|P2|NOT COMPLETED|Overall Study||0
50294|NCT01883440|120587|P1|NOT COMPLETED|Overall Study||3
50295|NCT01883440|120586|P2|COMPLETED|Overall Study||45
50296|NCT01883440|120587|P1|COMPLETED|Overall Study||42
50297|NCT01883440|120586|P2|STARTED|Overall Study||45
50298|NCT01883440|120587|P1|STARTED|Overall Study||45
50299|NCT01883427|120597|P2|NOT COMPLETED|Overall Study||0
50300|NCT01883427|120598|P1|NOT COMPLETED|Overall Study||0
50301|NCT01883427|120597|P2|COMPLETED|Overall Study||20
50302|NCT01883427|120598|P1|COMPLETED|Overall Study||20
50303|NCT01883427|120597|P2|STARTED|Overall Study||20
50304|NCT01883427|120598|P1|STARTED|Overall Study||20
50305|NCT01882907|120606|P2|NOT COMPLETED|Overall Study||28
50306|NCT01882907|120607|P1|NOT COMPLETED|Overall Study||14
50307|NCT01882907|120606|P2|COMPLETED|Overall Study||83
50308|NCT01882907|120607|P1|COMPLETED|Overall Study||103
50309|NCT01882907|120606|P2|STARTED|Overall Study||111
50310|NCT01882907|120607|P1|STARTED|Overall Study||117
50311|NCT01882868|120613|P1|NOT COMPLETED|Overall Study||0
50312|NCT01882868|120613|P1|COMPLETED|Overall Study||62
50313|NCT01882868|120613|P1|STARTED|Overall Study||62
50314|NCT01882725|120643|P1|NOT COMPLETED|Overall Study||0
50315|NCT01882725|120643|P1|COMPLETED|Overall Study||14
50316|NCT01882725|120643|P1|STARTED|Overall Study||14
50317|NCT01882647|120650|P2|NOT COMPLETED|Overall Study||6
50318|NCT01882647|120651|P1|NOT COMPLETED|Overall Study||2
50319|NCT01882647|120650|P2|COMPLETED|Overall Study||106
50320|NCT01882647|120651|P1|COMPLETED|Overall Study||108
50321|NCT01882647|120650|P2|STARTED|Overall Study||112
50322|NCT01882647|120651|P1|STARTED|Overall Study||110
50323|NCT01882543|120669|P2|NOT COMPLETED|Overall Study||3
50324|NCT01882543|120670|P1|NOT COMPLETED|Overall Study||4
50325|NCT01882543|120669|P2|COMPLETED|Overall Study||29
50326|NCT01882543|120670|P1|COMPLETED|Overall Study||33
50327|NCT01882543|120669|P2|STARTED|Overall Study||32
50328|NCT01882543|120670|P1|STARTED|Overall Study||37
50329|NCT01882465|120691|P7|NOT COMPLETED|Period 3||0
50330|NCT01882465|120692|P6|NOT COMPLETED|Period 3||0
50331|NCT01882465|120693|P5|NOT COMPLETED|Period 3||0
50332|NCT01882465|120694|P4|NOT COMPLETED|Period 3||0
50333|NCT01882465|120695|P3|NOT COMPLETED|Period 3||0
50334|NCT01882465|120696|P2|NOT COMPLETED|Period 3||0
50335|NCT01882465|120697|P1|NOT COMPLETED|Period 3||0
50336|NCT01882465|120691|P7|COMPLETED|Period 3||0
50337|NCT01882465|120692|P6|COMPLETED|Period 3||5
50338|NCT01882465|120693|P5|COMPLETED|Period 3||4
50339|NCT01882465|120694|P4|COMPLETED|Period 3||5
50340|NCT01882465|120695|P3|COMPLETED|Period 3||5
50341|NCT01882465|120696|P2|COMPLETED|Period 3||6
50342|NCT01882465|120697|P1|COMPLETED|Period 3||6
50343|NCT01882465|120691|P7|STARTED|Period 3||0
50344|NCT01882465|120692|P6|STARTED|Period 3||5
50345|NCT01882465|120693|P5|STARTED|Period 3||4
50346|NCT01882465|120694|P4|STARTED|Period 3||5
50347|NCT01882465|120695|P3|STARTED|Period 3||5
50348|NCT01882465|120696|P2|STARTED|Period 3||6
50349|NCT01882465|120697|P1|STARTED|Period 3||6
50350|NCT01882465|120691|P7|NOT COMPLETED|Period 2||0
50351|NCT01882465|120692|P6|NOT COMPLETED|Period 2||0
50352|NCT01882465|120693|P5|NOT COMPLETED|Period 2||1
50353|NCT01882465|120694|P4|NOT COMPLETED|Period 2||0
50354|NCT01882465|120695|P3|NOT COMPLETED|Period 2||0
50355|NCT01882465|120696|P2|NOT COMPLETED|Period 2||0
50356|NCT01882465|120697|P1|NOT COMPLETED|Period 2||0
50357|NCT01882465|120691|P7|COMPLETED|Period 2||0
50358|NCT01882465|120692|P6|COMPLETED|Period 2||5
50359|NCT01882465|120693|P5|COMPLETED|Period 2||4
50360|NCT01882465|120694|P4|COMPLETED|Period 2||5
50361|NCT01882465|120695|P3|COMPLETED|Period 2||5
50362|NCT01882465|120696|P2|COMPLETED|Period 2||6
50363|NCT01882465|120697|P1|COMPLETED|Period 2||6
50364|NCT01882465|120691|P7|STARTED|Period 2||0
50365|NCT01882465|120692|P6|STARTED|Period 2||5
50366|NCT01882465|120693|P5|STARTED|Period 2||5
50367|NCT01882465|120694|P4|STARTED|Period 2||5
50368|NCT01882465|120695|P3|STARTED|Period 2||5
50369|NCT01882465|120696|P2|STARTED|Period 2||6
50370|NCT01882465|120697|P1|STARTED|Period 2||6
50371|NCT01882465|120691|P7|NOT COMPLETED|Period 1||1
50372|NCT01882465|120692|P6|NOT COMPLETED|Period 1||0
50373|NCT01882465|120693|P5|NOT COMPLETED|Period 1||0
50374|NCT01882465|120694|P4|NOT COMPLETED|Period 1||1
50375|NCT01882465|120695|P3|NOT COMPLETED|Period 1||0
50376|NCT01882465|120696|P2|NOT COMPLETED|Period 1||0
50377|NCT01882465|120697|P1|NOT COMPLETED|Period 1||0
50378|NCT01882465|120691|P7|COMPLETED|Period 1||0
50379|NCT01882465|120692|P6|COMPLETED|Period 1||5
50380|NCT01882465|120693|P5|COMPLETED|Period 1||5
50381|NCT01882465|120694|P4|COMPLETED|Period 1||5
50382|NCT01882465|120695|P3|COMPLETED|Period 1||5
50383|NCT01882465|120696|P2|COMPLETED|Period 1||6
50384|NCT01882465|120697|P1|COMPLETED|Period 1||6
50385|NCT01882465|120691|P7|STARTED|Period 1||1
50386|NCT01882465|120692|P6|STARTED|Period 1||5
50387|NCT01882465|120693|P5|STARTED|Period 1||5
50388|NCT01882465|120694|P4|STARTED|Period 1||6
50389|NCT01882465|120695|P3|STARTED|Period 1||5
50390|NCT01882465|120696|P2|STARTED|Period 1||6
50391|NCT01882465|120697|P1|STARTED|Period 1||6
50392|NCT01882439|120709|P4|NOT COMPLETED|Overall Study||9
50393|NCT01882439|120710|P3|NOT COMPLETED|Overall Study||10
50394|NCT01882439|120711|P2|NOT COMPLETED|Overall Study||21
50395|NCT01882439|120712|P1|NOT COMPLETED|Overall Study||9
50396|NCT01882439|120709|P4|COMPLETED|Overall Study||56
50397|NCT01882439|120710|P3|COMPLETED|Overall Study||56
50398|NCT01882439|120711|P2|COMPLETED|Overall Study||111
50399|NCT01882439|120712|P1|COMPLETED|Overall Study||122
50400|NCT01882439|120709|P4|STARTED|Overall Study|Received treatment|65
50401|NCT01882439|120710|P3|STARTED|Overall Study|Received treatment|66
50402|NCT01882439|120711|P2|STARTED|Overall Study|Received treatment|132
50403|NCT01882439|120712|P1|STARTED|Overall Study|Received treatment|131
50404|NCT01882413|120892|P1|NOT COMPLETED|Overall Study||0
50405|NCT01882413|120892|P1|COMPLETED|Overall Study||204
50406|NCT01882413|120892|P1|STARTED|Overall Study||204
50407|NCT01882257|120909|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
50408|NCT01882257|120910|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
50409|NCT01882257|120911|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
50410|NCT01882257|120909|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
50411|NCT01882257|120910|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
50412|NCT01882257|120911|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
50413|NCT01882257|120909|P3|STARTED|Therapy Portion of Study (12 Months)||22
50414|NCT01882257|120910|P2|STARTED|Therapy Portion of Study (12 Months)||38
50415|NCT01882257|120911|P1|STARTED|Therapy Portion of Study (12 Months)||11
50416|NCT01882257|120909|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
50417|NCT01882257|120910|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
50418|NCT01882257|120911|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
50419|NCT01882257|120909|P3|COMPLETED|Study Origination to Beginning Therapy||22
50420|NCT01882257|120910|P2|COMPLETED|Study Origination to Beginning Therapy||38
50504|NCT01880736|121108|P2|COMPLETED|Overall Study||113
50421|NCT01882257|120911|P1|COMPLETED|Study Origination to Beginning Therapy||11
50422|NCT01882257|120909|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
50423|NCT01882257|120910|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
50424|NCT01882257|120911|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
50425|NCT01882257|120909|P3|STARTED|Study Origination to Beginning Therapy||23
50426|NCT01882257|120910|P2|STARTED|Study Origination to Beginning Therapy||40
50427|NCT01882257|120911|P1|STARTED|Study Origination to Beginning Therapy||11
50428|NCT01882062|120918|P1|NOT COMPLETED|Overall Study||0
50429|NCT01882062|120918|P1|COMPLETED|Overall Study|18th of july 2013|10
50430|NCT01882062|120918|P1|STARTED|Overall Study|16th of may 2013|10
50431|NCT01881984|120922|P1|NOT COMPLETED|Overall Study||0
50432|NCT01881984|120922|P1|COMPLETED|Overall Study||4
50433|NCT01881984|120922|P1|STARTED|Overall Study||4
50434|NCT01881932|120930|P3|NOT COMPLETED|Overall Study||0
50435|NCT01881932|120931|P2|NOT COMPLETED|Overall Study||0
50436|NCT01881932|120932|P1|NOT COMPLETED|Overall Study||0
50437|NCT01881932|120930|P3|COMPLETED|Overall Study||13
50438|NCT01881932|120931|P2|COMPLETED|Overall Study||4
50439|NCT01881932|120932|P1|COMPLETED|Overall Study||2
50440|NCT01881932|120930|P3|STARTED|Overall Study||13
50441|NCT01881932|120931|P2|STARTED|Overall Study||4
50442|NCT01881932|120932|P1|STARTED|Overall Study||2
50443|NCT01881776|120943|P3|NOT COMPLETED|Overall Study||2
50444|NCT01881776|120944|P2|NOT COMPLETED|Overall Study||4
50445|NCT01881776|120945|P1|NOT COMPLETED|Overall Study||1
50446|NCT01881776|120943|P3|COMPLETED|Overall Study||20
50447|NCT01881776|120944|P2|COMPLETED|Overall Study||20
50448|NCT01881776|120945|P1|COMPLETED|Overall Study||23
50449|NCT01881776|120943|P3|STARTED|Overall Study||22
50450|NCT01881776|120944|P2|STARTED|Overall Study||24
50451|NCT01881776|120945|P1|STARTED|Overall Study||24
50452|NCT01881737|120971|P1|NOT COMPLETED|Overall Study||5
50453|NCT01881737|120971|P1|COMPLETED|Overall Study||10
50454|NCT01881737|120971|P1|Number Screened|Overall Study||15
50455|NCT01881737|120971|P1|STARTED|Overall Study|This is a pilot study|15
50456|NCT01881230|120983|P3|NOT COMPLETED|Overall Study||66
50457|NCT01881230|120984|P2|NOT COMPLETED|Overall Study||64
50458|NCT01881230|120985|P1|NOT COMPLETED|Overall Study||61
50459|NCT01881230|120983|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
50460|NCT01881230|120984|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
50461|NCT01881230|120985|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
50462|NCT01881230|120983|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
50463|NCT01881230|120984|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
50464|NCT01881230|120985|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
50465|NCT01881230|120983|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
50466|NCT01881230|120984|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
50467|NCT01881230|120985|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
50468|NCT01881230|120983|P3|STARTED|Overall Study||66
50469|NCT01881230|120984|P2|STARTED|Overall Study||64
50470|NCT01881230|120985|P1|STARTED|Overall Study||61
50471|NCT01881126|121013|P2|NOT COMPLETED|Overall Study||2
50472|NCT01881126|121014|P1|NOT COMPLETED|Overall Study||1
50473|NCT01881126|121013|P2|COMPLETED|Overall Study||44
50474|NCT01881126|121014|P1|COMPLETED|Overall Study||46
50475|NCT01881126|121013|P2|STARTED|Overall Study||46
50476|NCT01881126|121014|P1|STARTED|Overall Study||47
50477|NCT01881113|121022|P2|NOT COMPLETED|Overall Study||6
50478|NCT01881113|121023|P1|NOT COMPLETED|Overall Study||8
50479|NCT01881113|121022|P2|COMPLETED|Overall Study||44
50480|NCT01881113|121023|P1|COMPLETED|Overall Study||43
50481|NCT01881113|121022|P2|STARTED|Overall Study||50
50482|NCT01881113|121023|P1|STARTED|Overall Study||51
50483|NCT01881087|121080|P3|NOT COMPLETED|Overall Study||2
50484|NCT01881087|121081|P2|NOT COMPLETED|Overall Study||0
50485|NCT01881087|121082|P1|NOT COMPLETED|Overall Study||1
50486|NCT01881087|121080|P3|COMPLETED|Overall Study||60
50487|NCT01881087|121081|P2|COMPLETED|Overall Study||61
50488|NCT01881087|121082|P1|COMPLETED|Overall Study||59
50489|NCT01881087|121080|P3|STARTED|Overall Study||62
50490|NCT01881087|121081|P2|STARTED|Overall Study||61
50491|NCT01881087|121082|P1|STARTED|Overall Study||60
50492|NCT01880840|121095|P2|NOT COMPLETED|Overall Study||5
50493|NCT01880840|121096|P1|NOT COMPLETED|Overall Study||8
50494|NCT01880840|121095|P2|COMPLETED|Overall Study||91
50495|NCT01880840|121096|P1|COMPLETED|Overall Study||87
50496|NCT01880840|121095|P2|STARTED|Overall Study||96
50497|NCT01880840|121096|P1|STARTED|Overall Study||95
50498|NCT01880736|121106|P4|NOT COMPLETED|Overall Study||6
50499|NCT01880736|121107|P3|NOT COMPLETED|Overall Study||1
50500|NCT01880736|121108|P2|NOT COMPLETED|Overall Study||2
50501|NCT01880736|121109|P1|NOT COMPLETED|Overall Study||1
50502|NCT01880736|121106|P4|COMPLETED|Overall Study||108
50503|NCT01880736|121107|P3|COMPLETED|Overall Study||114
50505|NCT01880736|121109|P1|COMPLETED|Overall Study||113
50506|NCT01880736|121106|P4|STARTED|Overall Study||114
50507|NCT01880736|121107|P3|STARTED|Overall Study||115
50508|NCT01880736|121108|P2|STARTED|Overall Study||115
50509|NCT01880736|121109|P1|STARTED|Overall Study||114
50510|NCT01880723|121153|P2|NOT COMPLETED|Overall Study||0
50511|NCT01880723|121154|P1|NOT COMPLETED|Overall Study||0
50512|NCT01880723|121153|P2|COMPLETED|Overall Study||16
50513|NCT01880723|121154|P1|COMPLETED|Overall Study||16
50514|NCT01880723|121153|P2|STARTED|Overall Study||16
50515|NCT01880723|121154|P1|STARTED|Overall Study||16
50516|NCT01880697|121170|P2|NOT COMPLETED|Overall Study||1
50517|NCT01880697|121171|P1|NOT COMPLETED|Overall Study||0
50518|NCT01880697|121170|P2|COMPLETED|Overall Study||62
50519|NCT01880697|121171|P1|COMPLETED|Overall Study||63
50520|NCT01880697|121170|P2|STARTED|Overall Study||63
50521|NCT01880697|121171|P1|STARTED|Overall Study||63
50522|NCT01880515|121193|P2|NOT COMPLETED|Overall Study||9
50523|NCT01880515|121194|P1|NOT COMPLETED|Overall Study||8
50524|NCT01880515|121193|P2|COMPLETED|Overall Study||45
50525|NCT01880515|121194|P1|COMPLETED|Overall Study||45
50526|NCT01880515|121193|P2|STARTED|Overall Study||54
50527|NCT01880515|121194|P1|STARTED|Overall Study||53
50528|NCT01880437|121205|P3|NOT COMPLETED|Overall Study||19
50529|NCT01880437|121206|P2|NOT COMPLETED|Overall Study||4
50530|NCT01880437|121207|P1|NOT COMPLETED|Overall Study||15
50531|NCT01880437|121205|P3|COMPLETED|Overall Study||0
50532|NCT01880437|121206|P2|COMPLETED|Overall Study||0
50533|NCT01880437|121207|P1|COMPLETED|Overall Study||0
50534|NCT01880437|121205|P3|STARTED|Overall Study||19
50535|NCT01880437|121206|P2|STARTED|Overall Study||4
50536|NCT01880437|121207|P1|STARTED|Overall Study||15
50537|NCT01880424|121233|P2|NOT COMPLETED|Overall Study||55
50538|NCT01880424|121234|P1|NOT COMPLETED|Overall Study||33
50539|NCT01880424|121233|P2|COMPLETED|Overall Study||367
50540|NCT01880424|121234|P1|COMPLETED|Overall Study||384
50541|NCT01880424|121233|P2|STARTED|Overall Study||422
50542|NCT01880424|121234|P1|STARTED|Overall Study||417
50543|NCT01880320|121259|P3|NOT COMPLETED|Overall Study||8
50544|NCT01880320|121260|P2|NOT COMPLETED|Overall Study||25
50545|NCT01880320|121261|P1|NOT COMPLETED|Overall Study||20
50546|NCT01880320|121259|P3|COMPLETED|Overall Study||61
50547|NCT01880320|121260|P2|COMPLETED|Overall Study||192
50548|NCT01880320|121261|P1|COMPLETED|Overall Study||197
50549|NCT01880320|121259|P3|STARTED|Overall Study||69
50550|NCT01880320|121260|P2|STARTED|Overall Study||217
50551|NCT01880320|121261|P1|STARTED|Overall Study||217
50552|NCT01880099|121278|P3|NOT COMPLETED|Overall Study||7
50553|NCT01880099|121279|P2|NOT COMPLETED|Overall Study||10
50554|NCT01880099|121280|P1|NOT COMPLETED|Overall Study||8
50555|NCT01880099|121278|P3|COMPLETED|Overall Study||15
50556|NCT01880099|121279|P2|COMPLETED|Overall Study||11
50557|NCT01880099|121280|P1|COMPLETED|Overall Study||9
50558|NCT01880099|121278|P3|STARTED|Overall Study||22
50559|NCT01880099|121279|P2|STARTED|Overall Study||21
50560|NCT01880099|121280|P1|STARTED|Overall Study||17
50561|NCT01880086|121290|P2|NOT COMPLETED|Overall Study||1
50562|NCT01880086|121291|P1|NOT COMPLETED|Overall Study||1
50563|NCT01880086|121290|P2|COMPLETED|Overall Study||6
50564|NCT01880086|121291|P1|COMPLETED|Overall Study||5
50565|NCT01880086|121290|P2|STARTED|Overall Study||7
50566|NCT01880086|121291|P1|STARTED|Overall Study||6
50567|NCT01879852|121311|P2|NOT COMPLETED|Overall Study||0
50568|NCT01879852|121312|P1|NOT COMPLETED|Overall Study||2
50569|NCT01879852|121311|P2|COMPLETED|Overall Study||13
50570|NCT01879852|121312|P1|COMPLETED|Overall Study||12
50571|NCT01879852|121311|P2|STARTED|Overall Study||13
50572|NCT01879852|121312|P1|STARTED|Overall Study||14
50573|NCT01879800|121326|P2|NOT COMPLETED|Overall Study||4
50574|NCT01879800|121327|P1|NOT COMPLETED|Overall Study||0
50575|NCT01879800|121326|P2|COMPLETED|Overall Study||26
50576|NCT01879800|121327|P1|COMPLETED|Overall Study||14
50577|NCT01879800|121326|P2|STARTED|Overall Study||30
50578|NCT01879800|121327|P1|STARTED|Overall Study||14
50579|NCT01879735|121339|P2|NOT COMPLETED|Overall Study||0
50580|NCT01879735|121340|P1|NOT COMPLETED|Overall Study||0
50581|NCT01879735|121339|P2|COMPLETED|Overall Study||16
50582|NCT01879735|121340|P1|COMPLETED|Overall Study||6
50583|NCT01879735|121339|P2|STARTED|Overall Study||16
50584|NCT01879735|121340|P1|STARTED|Overall Study||6
50585|NCT01879722|121356|P10|NOT COMPLETED|Overall Study||0
50586|NCT01879722|121357|P9|NOT COMPLETED|Overall Study||2
50587|NCT01879722|121358|P8|NOT COMPLETED|Overall Study||1
50588|NCT01879722|121359|P7|NOT COMPLETED|Overall Study||0
50589|NCT01879722|121360|P6|NOT COMPLETED|Overall Study||0
50590|NCT01879722|121361|P5|NOT COMPLETED|Overall Study||1
50591|NCT01879722|121362|P4|NOT COMPLETED|Overall Study||1
50592|NCT01879722|121363|P3|NOT COMPLETED|Overall Study||0
50593|NCT01879722|121364|P2|NOT COMPLETED|Overall Study||1
50594|NCT01879722|121365|P1|NOT COMPLETED|Overall Study||0
50595|NCT01879722|121356|P10|COMPLETED|Overall Study||6
50596|NCT01879722|121357|P9|COMPLETED|Overall Study||6
50597|NCT01879722|121358|P8|COMPLETED|Overall Study||7
50598|NCT01879722|121359|P7|COMPLETED|Overall Study||8
50599|NCT01879722|121360|P6|COMPLETED|Overall Study||9
50600|NCT01879722|121361|P5|COMPLETED|Overall Study||7
50601|NCT01879722|121362|P4|COMPLETED|Overall Study||7
50602|NCT01879722|121363|P3|COMPLETED|Overall Study||7
50603|NCT01879722|121364|P2|COMPLETED|Overall Study||7
50604|NCT01879722|121365|P1|COMPLETED|Overall Study||7
50605|NCT01879722|121356|P10|STARTED|Overall Study||6
50606|NCT01879722|121357|P9|STARTED|Overall Study||8
50607|NCT01879722|121358|P8|STARTED|Overall Study||8
50608|NCT01879722|121359|P7|STARTED|Overall Study||8
50609|NCT01879722|121360|P6|STARTED|Overall Study||9
50610|NCT01879722|121361|P5|STARTED|Overall Study||8
50611|NCT01879722|121362|P4|STARTED|Overall Study||8
50612|NCT01879722|121363|P3|STARTED|Overall Study||7
50613|NCT01879722|121364|P2|STARTED|Overall Study||8
50614|NCT01879722|121365|P1|STARTED|Overall Study||7
50615|NCT01879683|121513|P1|NOT COMPLETED|Overall Study||1
50616|NCT01879683|121513|P1|COMPLETED|Overall Study||9
50617|NCT01879683|121513|P1|STARTED|Overall Study||10
50618|NCT01879618|121520|P1|NOT COMPLETED|Overall Study||21
50619|NCT01879618|121520|P1|COMPLETED|Overall Study||131
50620|NCT01879618|121520|P1|STARTED|Overall Study||152
50621|NCT01879579|121527|P2|NOT COMPLETED|Overall Study||2
50622|NCT01879579|121528|P1|NOT COMPLETED|Overall Study||5
50623|NCT01879579|121527|P2|COMPLETED|Overall Study||26
50624|NCT01879579|121528|P1|COMPLETED|Overall Study||28
50625|NCT01879579|121527|P2|STARTED|Overall Study||28
50626|NCT01879579|121528|P1|STARTED|Overall Study||33
50627|NCT01879553|121558|P2|NOT COMPLETED|Overall Study||0
50628|NCT01879553|121559|P1|NOT COMPLETED|Overall Study||1
50629|NCT01879553|121558|P2|COMPLETED|Overall Study||63
50630|NCT01879553|121559|P1|COMPLETED|Overall Study||62
50631|NCT01879553|121558|P2|STARTED|Overall Study||63
50632|NCT01879553|121559|P1|STARTED|Overall Study||63
50633|NCT01879540|121580|P1|NOT COMPLETED|Overall Study||0
50634|NCT01879540|121580|P1|COMPLETED|Overall Study||63
50635|NCT01879540|121580|P1|STARTED|Overall Study||63
50636|NCT01879410|121593|P2|NOT COMPLETED|Overall Study||38
50637|NCT01879410|121594|P1|NOT COMPLETED|Overall Study||24
50638|NCT01879410|121593|P2|COMPLETED|Overall Study||312
50639|NCT01879410|121594|P1|COMPLETED|Overall Study||326
50640|NCT01879410|121593|P2|Intent-to-Treat Population|Overall Study||348
50641|NCT01879410|121594|P1|Intent-to-Treat Population|Overall Study||349
50642|NCT01879410|121593|P2|STARTED|Overall Study||350
50643|NCT01879410|121594|P1|STARTED|Overall Study||350
50644|NCT01879371|121608|P6|NOT COMPLETED|Overall Study||0
50645|NCT01879371|121609|P5|NOT COMPLETED|Overall Study||0
50646|NCT01879371|121610|P4|NOT COMPLETED|Overall Study||0
50647|NCT01879371|121611|P3|NOT COMPLETED|Overall Study||0
50648|NCT01879371|121612|P2|NOT COMPLETED|Overall Study||0
50649|NCT01879371|121613|P1|NOT COMPLETED|Overall Study||0
50650|NCT01879371|121608|P6|COMPLETED|Overall Study||6
50651|NCT01879371|121609|P5|COMPLETED|Overall Study||6
50652|NCT01879371|121610|P4|COMPLETED|Overall Study||6
50653|NCT01879371|121611|P3|COMPLETED|Overall Study||6
50654|NCT01879371|121612|P2|COMPLETED|Overall Study||6
50655|NCT01879371|121613|P1|COMPLETED|Overall Study||6
50656|NCT01879371|121608|P6|STARTED|Overall Study||6
50657|NCT01879371|121609|P5|STARTED|Overall Study||6
50658|NCT01879371|121610|P4|STARTED|Overall Study||6
50659|NCT01879371|121611|P3|STARTED|Overall Study||6
50660|NCT01879371|121612|P2|STARTED|Overall Study||6
50661|NCT01879371|121613|P1|STARTED|Overall Study||6
50662|NCT01879345|121630|P3|NOT COMPLETED|7-day Multiple-dose Period||0
50663|NCT01879345|121631|P2|NOT COMPLETED|7-day Multiple-dose Period||0
50664|NCT01879345|121632|P1|NOT COMPLETED|7-day Multiple-dose Period||0
50665|NCT01879345|121630|P3|COMPLETED|7-day Multiple-dose Period||6
50666|NCT01879345|121631|P2|COMPLETED|7-day Multiple-dose Period||6
50667|NCT01879345|121632|P1|COMPLETED|7-day Multiple-dose Period||6
50668|NCT01879345|121630|P3|STARTED|7-day Multiple-dose Period||6
50669|NCT01879345|121631|P2|STARTED|7-day Multiple-dose Period||6
50670|NCT01879345|121632|P1|STARTED|7-day Multiple-dose Period||6
50671|NCT01879345|121630|P3|NOT COMPLETED|Single-dose Period||0
50672|NCT01879345|121631|P2|NOT COMPLETED|Single-dose Period||0
50673|NCT01879345|121632|P1|NOT COMPLETED|Single-dose Period||0
50674|NCT01879345|121630|P3|COMPLETED|Single-dose Period||6
50675|NCT01879345|121631|P2|COMPLETED|Single-dose Period||6
50676|NCT01879345|121632|P1|COMPLETED|Single-dose Period||6
50677|NCT01879345|121630|P3|STARTED|Single-dose Period||6
50678|NCT01879345|121631|P2|STARTED|Single-dose Period||6
50679|NCT01879345|121632|P1|STARTED|Single-dose Period||6
50680|NCT01879332|121649|P3|NOT COMPLETED|Overall Study||4
50681|NCT01879332|121650|P2|NOT COMPLETED|Overall Study||6
50682|NCT01879332|121651|P1|NOT COMPLETED|Overall Study||6
50683|NCT01879332|121649|P3|COMPLETED|Overall Study||0
50684|NCT01879332|121650|P2|COMPLETED|Overall Study||0
50685|NCT01879332|121651|P1|COMPLETED|Overall Study||0
50686|NCT01879332|121649|P3|STARTED|Overall Study||4
50687|NCT01879332|121650|P2|STARTED|Overall Study||6
50688|NCT01879332|121651|P1|STARTED|Overall Study||6
50689|NCT01879319|121661|P2|NOT COMPLETED|Overall Study||5
50690|NCT01879319|121662|P1|NOT COMPLETED|Overall Study||2
50691|NCT01879319|121661|P2|COMPLETED|Overall Study||77
50692|NCT01879319|121662|P1|COMPLETED|Overall Study||80
50693|NCT01879319|121661|P2|Received Treatment|Overall Study||82
50694|NCT01879319|121662|P1|Received Treatment|Overall Study||82
50695|NCT01879319|121661|P2|STARTED|Overall Study||82
50696|NCT01879319|121662|P1|STARTED|Overall Study||82
50697|NCT01879176|121672|P2|NOT COMPLETED|Overall Study||6
50698|NCT01879176|121673|P1|NOT COMPLETED|Overall Study||8
50699|NCT01879176|121672|P2|COMPLETED|Overall Study||16
50700|NCT01879176|121673|P1|COMPLETED|Overall Study||16
50701|NCT01879176|121672|P2|STARTED|Overall Study||22
50702|NCT01879176|121673|P1|STARTED|Overall Study||24
50703|NCT01879072|121679|P1|NOT COMPLETED|Overall Study||48
50704|NCT01879072|121679|P1|COMPLETED|Overall Study||1709
50705|NCT01879072|121679|P1|STARTED|Overall Study||1757
50706|NCT01879059|121683|P1|NOT COMPLETED|Overall Study||0
50707|NCT01879059|121683|P1|COMPLETED|Overall Study||13
50708|NCT01879059|121683|P1|STARTED|Overall Study||13
50709|NCT01878825|121689|P2|NOT COMPLETED|Overall Study||0
50710|NCT01878825|121690|P1|NOT COMPLETED|Overall Study||0
50711|NCT01878825|121689|P2|COMPLETED|Overall Study||60
50712|NCT01878825|121690|P1|COMPLETED|Overall Study||60
50713|NCT01878825|121689|P2|STARTED|Overall Study||60
50714|NCT01878825|121690|P1|STARTED|Overall Study||60
50715|NCT01878812|121728|P2|NOT COMPLETED|Overall Study||0
50716|NCT01878812|121729|P1|NOT COMPLETED|Overall Study||0
50717|NCT01878812|121728|P2|COMPLETED|Overall Study||57
50718|NCT01878812|121729|P1|COMPLETED|Overall Study||60
50719|NCT01878812|121728|P2|STARTED|Overall Study||57
50720|NCT01878812|121729|P1|STARTED|Overall Study||60
50721|NCT01878799|121765|P2|NOT COMPLETED|Overall Study||0
50722|NCT01878799|121766|P1|NOT COMPLETED|Overall Study||1
50723|NCT01878799|121765|P2|COMPLETED|Overall Study||13
50724|NCT01878799|121766|P1|COMPLETED|Overall Study||36
50725|NCT01878799|121765|P2|STARTED|Overall Study||13
50726|NCT01878799|121766|P1|STARTED|Overall Study||37
50727|NCT01878656|121774|P2|NOT COMPLETED|Overall Study||0
50728|NCT01878656|121775|P1|NOT COMPLETED|Overall Study||0
50729|NCT01878656|121774|P2|COMPLETED|Overall Study||72
50730|NCT01878656|121775|P1|COMPLETED|Overall Study||72
50731|NCT01878656|121774|P2|STARTED|Overall Study||72
50732|NCT01878656|121775|P1|STARTED|Overall Study||72
50733|NCT01878604|121781|P1|NOT COMPLETED|Overall Study||0
50734|NCT01878604|121781|P1|COMPLETED|Overall Study||5
50735|NCT01878604|121781|P1|STARTED|Overall Study||5
50736|NCT01878526|121788|P2|NOT COMPLETED|Overall Study||2
50737|NCT01878526|121789|P1|NOT COMPLETED|Overall Study||3
50738|NCT01878526|121788|P2|COMPLETED|Overall Study||38
50739|NCT01878526|121789|P1|COMPLETED|Overall Study||37
50740|NCT01878526|121788|P2|STARTED|Overall Study||40
50741|NCT01878526|121789|P1|STARTED|Overall Study||40
50742|NCT01878214|121804|P2|NOT COMPLETED|Overall Study||44
50743|NCT01878214|121805|P1|NOT COMPLETED|Overall Study||53
50744|NCT01878214|121804|P2|COMPLETED|Overall Study||175
50745|NCT01878214|121805|P1|COMPLETED|Overall Study||170
50746|NCT01878214|121804|P2|STARTED|Overall Study||219
50747|NCT01878214|121805|P1|STARTED|Overall Study||223
50748|NCT01878175|121819|P1|NOT COMPLETED|Overall Study||2
50749|NCT01878175|121819|P1|COMPLETED|Overall Study||13
50750|NCT01878175|121819|P1|STARTED|Overall Study||15
50751|NCT01878149|121838|P2|NOT COMPLETED|Overall Study||2
50752|NCT01878149|121839|P1|NOT COMPLETED|Overall Study||2
50753|NCT01878149|121838|P2|COMPLETED|Overall Study||15
50754|NCT01878149|121839|P1|COMPLETED|Overall Study||19
50755|NCT01878149|121838|P2|STARTED|Overall Study||17
50756|NCT01878149|121839|P1|STARTED|Overall Study||21
50757|NCT01878097|121847|P2|NOT COMPLETED|Implementation Year 5||3007
50758|NCT01878097|121848|P1|NOT COMPLETED|Implementation Year 5||3604
50759|NCT01878097|121847|P2|COMPLETED|Implementation Year 5||6607
50760|NCT01878097|121848|P1|COMPLETED|Implementation Year 5||6981
50761|NCT01878097|121847|P2|STARTED|Implementation Year 5||9614
50762|NCT01878097|121848|P1|STARTED|Implementation Year 5||10585
50763|NCT01878097|121847|P2|NOT COMPLETED|Implementation Year 3||2980
50764|NCT01878097|121848|P1|NOT COMPLETED|Implementation Year 3||3494
50765|NCT01878097|121847|P2|COMPLETED|Implementation Year 3||6770
50766|NCT01878097|121848|P1|COMPLETED|Implementation Year 3||7046
50767|NCT01878097|121847|P2|STARTED|Implementation Year 3||9750
50768|NCT01878097|121848|P1|STARTED|Implementation Year 3||10540
50769|NCT01878097|121847|P2|NOT COMPLETED|Implementation Year 2||2841
50770|NCT01878097|121848|P1|NOT COMPLETED|Implementation Year 2||3281
50771|NCT01878097|121847|P2|COMPLETED|Implementation Year 2||6770
50772|NCT01878097|121848|P1|COMPLETED|Implementation Year 2||8286
50773|NCT01878097|121847|P2|STARTED|Implementation Year 2||9611
50774|NCT01878097|121848|P1|STARTED|Implementation Year 2||11567
50775|NCT01878097|121847|P2|NOT COMPLETED|Implementation Year 1||2549
50776|NCT01878097|121848|P1|NOT COMPLETED|Implementation Year 1||3202
50777|NCT01878097|121847|P2|COMPLETED|Implementation Year 1||7317
50778|NCT01878097|121848|P1|COMPLETED|Implementation Year 1||8540
50779|NCT01878097|121847|P2|STARTED|Implementation Year 1||9866
50780|NCT01878097|121848|P1|STARTED|Implementation Year 1||11742
50781|NCT01878097|121847|P2|NOT COMPLETED|Baseline||1800
50782|NCT01878097|121848|P1|NOT COMPLETED|Baseline||2497
50783|NCT01878097|121847|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
50784|NCT01878097|121848|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
50785|NCT01878097|121847|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
50786|NCT01878097|121848|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
50787|NCT01877941|121858|P1|NOT COMPLETED|Overall Study||0
50788|NCT01877941|121858|P1|COMPLETED|Overall Study||39
50789|NCT01877941|121858|P1|STARTED|Overall Study||39
50790|NCT01877720|121864|P2|NOT COMPLETED|Overall Study||0
50791|NCT01877720|121865|P1|NOT COMPLETED|Overall Study||1
50792|NCT01877720|121864|P2|COMPLETED|Overall Study||8
50793|NCT01877720|121865|P1|COMPLETED|Overall Study||7
50794|NCT01877720|121864|P2|2nd Intervention|Overall Study||8
50795|NCT01877720|121865|P1|2nd Intervention|Overall Study||7
50796|NCT01877720|121864|P2|1st Intervention|Overall Study||8
50797|NCT01877720|121865|P1|1st Intervention|Overall Study||7
50798|NCT01877720|121864|P2|STARTED|Overall Study||8
50799|NCT01877720|121865|P1|STARTED|Overall Study||8
50800|NCT01877668|121894|P5|NOT COMPLETED|Overall Study||10
50801|NCT01877668|121895|P4|NOT COMPLETED|Overall Study||8
50802|NCT01877668|121896|P3|NOT COMPLETED|Overall Study||12
50803|NCT01877668|121897|P2|NOT COMPLETED|Overall Study||8
50804|NCT01877668|121898|P1|NOT COMPLETED|Overall Study||11
50805|NCT01877668|121894|P5|COMPLETED|Overall Study||43
50806|NCT01877668|121895|P4|COMPLETED|Overall Study||44
50807|NCT01877668|121896|P3|COMPLETED|Overall Study||94
50808|NCT01877668|121897|P2|COMPLETED|Overall Study||96
50809|NCT01877668|121898|P1|COMPLETED|Overall Study||96
50810|NCT01877668|121894|P5|STARTED|Overall Study|Received treatment|53
50811|NCT01877668|121895|P4|STARTED|Overall Study|Received treatment|52
50812|NCT01877668|121896|P3|STARTED|Overall Study|Received treatment|106
50813|NCT01877668|121897|P2|STARTED|Overall Study|Received treatment|104
50814|NCT01877668|121898|P1|STARTED|Overall Study|Received treatment|107
50815|NCT01877642|122129|P7|NOT COMPLETED|Overall Study||0
50816|NCT01877642|122130|P6|NOT COMPLETED|Overall Study||0
50817|NCT01877642|122131|P5|NOT COMPLETED|Overall Study||0
50818|NCT01877642|122132|P4|NOT COMPLETED|Overall Study||0
50819|NCT01877642|122133|P3|NOT COMPLETED|Overall Study||0
50820|NCT01877642|122134|P2|NOT COMPLETED|Overall Study||0
50821|NCT01877642|122135|P1|NOT COMPLETED|Overall Study||0
50822|NCT01877642|122129|P7|COMPLETED|Overall Study||3
50823|NCT01877642|122130|P6|COMPLETED|Overall Study||3
50824|NCT01877642|122131|P5|COMPLETED|Overall Study||3
50825|NCT01877642|122132|P4|COMPLETED|Overall Study||3
50826|NCT01877642|122133|P3|COMPLETED|Overall Study||3
50827|NCT01877642|122134|P2|COMPLETED|Overall Study||3
50828|NCT01877642|122135|P1|COMPLETED|Overall Study||4
50829|NCT01877642|122129|P7|STARTED|Overall Study||3
50830|NCT01877642|122130|P6|STARTED|Overall Study||3
50831|NCT01877642|122131|P5|STARTED|Overall Study||3
50832|NCT01877642|122132|P4|STARTED|Overall Study||3
50833|NCT01877642|122133|P3|STARTED|Overall Study||3
50834|NCT01877642|122134|P2|STARTED|Overall Study||3
50835|NCT01877642|122135|P1|STARTED|Overall Study||4
50836|NCT01877564|122158|P2|NOT COMPLETED|Overall Study||0
50837|NCT01877564|122159|P1|NOT COMPLETED|Overall Study||0
50838|NCT01877564|122158|P2|COMPLETED|Overall Study||4
50839|NCT01877564|122159|P1|COMPLETED|Overall Study||6
50840|NCT01877564|122158|P2|STARTED|Overall Study||4
50841|NCT01877564|122159|P1|STARTED|Overall Study||6
50842|NCT01877538|122165|P1|NOT COMPLETED|Overall Study||0
50843|NCT01877538|122165|P1|COMPLETED|Overall Study||7
50844|NCT01877538|122165|P1|STARTED|Overall Study||7
50845|NCT01877421|122202|P18|NOT COMPLETED|Phase 2||0
50846|NCT01877421|122203|P17|NOT COMPLETED|Phase 2||0
50847|NCT01877421|122204|P16|NOT COMPLETED|Phase 2||1
50848|NCT01877421|122205|P15|NOT COMPLETED|Phase 2||0
50849|NCT01877421|122206|P14|NOT COMPLETED|Phase 2||0
50850|NCT01877421|122207|P13|NOT COMPLETED|Phase 2||1
50851|NCT01877421|122208|P12|NOT COMPLETED|Phase 2||0
50852|NCT01877421|122209|P11|NOT COMPLETED|Phase 2||2
50853|NCT01877421|122210|P10|NOT COMPLETED|Phase 2||0
50854|NCT01877421|122211|P9|NOT COMPLETED|Phase 2||1
50855|NCT01877421|122212|P8|NOT COMPLETED|Phase 2||0
50856|NCT01877421|122213|P7|NOT COMPLETED|Phase 2||1
50857|NCT01877421|122214|P6|NOT COMPLETED|Phase 2||0
50858|NCT01877421|122215|P5|NOT COMPLETED|Phase 2||0
50859|NCT01877421|122216|P4|NOT COMPLETED|Phase 2||0
50860|NCT01877421|122217|P3|NOT COMPLETED|Phase 2||0
50861|NCT01877421|122218|P2|NOT COMPLETED|Phase 2||0
50862|NCT01877421|122219|P1|NOT COMPLETED|Phase 2||0
50863|NCT01877421|122202|P18|COMPLETED|Phase 2||0
50864|NCT01877421|122203|P17|COMPLETED|Phase 2||0
50865|NCT01877421|122204|P16|COMPLETED|Phase 2||2
50866|NCT01877421|122205|P15|COMPLETED|Phase 2||7
50867|NCT01877421|122206|P14|COMPLETED|Phase 2||3
50868|NCT01877421|122207|P13|COMPLETED|Phase 2||6
50869|NCT01877421|122208|P12|COMPLETED|Phase 2||3
50870|NCT01877421|122209|P11|COMPLETED|Phase 2||5
50871|NCT01877421|122210|P10|COMPLETED|Phase 2||3
50872|NCT01877421|122211|P9|COMPLETED|Phase 2||5
50873|NCT01877421|122212|P8|COMPLETED|Phase 2||2
50874|NCT01877421|122213|P7|COMPLETED|Phase 2||6
50875|NCT01877421|122214|P6|COMPLETED|Phase 2||3
50876|NCT01877421|122215|P5|COMPLETED|Phase 2||7
50877|NCT01877421|122216|P4|COMPLETED|Phase 2||2
50878|NCT01877421|122217|P3|COMPLETED|Phase 2||4
50879|NCT01877421|122218|P2|COMPLETED|Phase 2||0
50880|NCT01877421|122219|P1|COMPLETED|Phase 2||0
50881|NCT01877421|122202|P18|STARTED|Phase 2||0
50882|NCT01877421|122203|P17|STARTED|Phase 2||0
50883|NCT01877421|122204|P16|STARTED|Phase 2||3
50884|NCT01877421|122205|P15|STARTED|Phase 2||7
50885|NCT01877421|122206|P14|STARTED|Phase 2||3
50886|NCT01877421|122207|P13|STARTED|Phase 2||7
50887|NCT01877421|122208|P12|STARTED|Phase 2||3
50888|NCT01877421|122209|P11|STARTED|Phase 2||7
50889|NCT01877421|122210|P10|STARTED|Phase 2||3
50890|NCT01877421|122211|P9|STARTED|Phase 2||6
50891|NCT01877421|122212|P8|STARTED|Phase 2||2
50892|NCT01877421|122213|P7|STARTED|Phase 2||7
50893|NCT01877421|122214|P6|STARTED|Phase 2||3
50894|NCT01877421|122215|P5|STARTED|Phase 2||7
50895|NCT01877421|122216|P4|STARTED|Phase 2||2
50896|NCT01877421|122217|P3|STARTED|Phase 2||4
50897|NCT01877421|122218|P2|STARTED|Phase 2||0
50898|NCT01877421|122219|P1|STARTED|Phase 2||0
50899|NCT01877421|122202|P18|NOT COMPLETED|Phase 1||0
50900|NCT01877421|122203|P17|NOT COMPLETED|Phase 1||0
50901|NCT01877421|122204|P16|NOT COMPLETED|Phase 1||0
50902|NCT01877421|122205|P15|NOT COMPLETED|Phase 1||0
50903|NCT01877421|122206|P14|NOT COMPLETED|Phase 1||0
50904|NCT01877421|122207|P13|NOT COMPLETED|Phase 1||0
50905|NCT01877421|122208|P12|NOT COMPLETED|Phase 1||0
50906|NCT01877421|122209|P11|NOT COMPLETED|Phase 1||0
50907|NCT01877421|122210|P10|NOT COMPLETED|Phase 1||0
50908|NCT01877421|122211|P9|NOT COMPLETED|Phase 1||0
50909|NCT01877421|122212|P8|NOT COMPLETED|Phase 1||0
50910|NCT01877421|122213|P7|NOT COMPLETED|Phase 1||0
50911|NCT01877421|122214|P6|NOT COMPLETED|Phase 1||0
50912|NCT01877421|122215|P5|NOT COMPLETED|Phase 1||0
50913|NCT01877421|122216|P4|NOT COMPLETED|Phase 1||0
50914|NCT01877421|122217|P3|NOT COMPLETED|Phase 1||0
50915|NCT01877421|122218|P2|NOT COMPLETED|Phase 1||0
50916|NCT01877421|122219|P1|NOT COMPLETED|Phase 1||0
50917|NCT01877421|122202|P18|COMPLETED|Phase 1||3
50918|NCT01877421|122203|P17|COMPLETED|Phase 1||7
50919|NCT01877421|122204|P16|COMPLETED|Phase 1||3
50920|NCT01877421|122205|P15|COMPLETED|Phase 1||7
50921|NCT01877421|122206|P14|COMPLETED|Phase 1||3
50922|NCT01877421|122207|P13|COMPLETED|Phase 1||7
50923|NCT01877421|122208|P12|COMPLETED|Phase 1||3
50924|NCT01877421|122209|P11|COMPLETED|Phase 1||7
50925|NCT01877421|122210|P10|COMPLETED|Phase 1||3
50926|NCT01877421|122211|P9|COMPLETED|Phase 1||7
50927|NCT01877421|122212|P8|COMPLETED|Phase 1||2
50928|NCT01877421|122213|P7|COMPLETED|Phase 1||4
50929|NCT01877421|122214|P6|COMPLETED|Phase 1||2
50930|NCT01877421|122215|P5|COMPLETED|Phase 1||4
50931|NCT01877421|122216|P4|COMPLETED|Phase 1||2
50932|NCT01877421|122217|P3|COMPLETED|Phase 1||4
50933|NCT01877421|122218|P2|COMPLETED|Phase 1||1
50934|NCT01877421|122219|P1|COMPLETED|Phase 1||2
50935|NCT01877421|122202|P18|STARTED|Phase 1||3
50936|NCT01877421|122203|P17|STARTED|Phase 1||7
50937|NCT01877421|122204|P16|STARTED|Phase 1||3
50938|NCT01877421|122205|P15|STARTED|Phase 1||7
50939|NCT01877421|122206|P14|STARTED|Phase 1||3
50940|NCT01877421|122207|P13|STARTED|Phase 1||7
50941|NCT01877421|122208|P12|STARTED|Phase 1||3
50942|NCT01877421|122209|P11|STARTED|Phase 1||7
50943|NCT01877421|122210|P10|STARTED|Phase 1||3
50944|NCT01877421|122211|P9|STARTED|Phase 1||7
50945|NCT01877421|122212|P8|STARTED|Phase 1||2
50946|NCT01877421|122213|P7|STARTED|Phase 1||4
50947|NCT01877421|122214|P6|STARTED|Phase 1||2
50948|NCT01877421|122215|P5|STARTED|Phase 1||4
50949|NCT01877421|122216|P4|STARTED|Phase 1||2
50950|NCT01877421|122217|P3|STARTED|Phase 1||4
50951|NCT01877421|122218|P2|STARTED|Phase 1||1
50952|NCT01877421|122219|P1|STARTED|Phase 1||2
50953|NCT01877408|122329|P2|NOT COMPLETED|Overall Study||2
50954|NCT01877408|122330|P1|NOT COMPLETED|Overall Study||0
50955|NCT01877408|122329|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
50956|NCT01877408|122330|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
50957|NCT01877408|122329|P2|STARTED|Overall Study||100
50958|NCT01877408|122330|P1|STARTED|Overall Study||50
50959|NCT01877343|122350|P7|NOT COMPLETED|Overall Study||0
50960|NCT01877343|122351|P6|NOT COMPLETED|Overall Study||0
50961|NCT01877343|122352|P5|NOT COMPLETED|Overall Study||0
50962|NCT01877343|122353|P4|NOT COMPLETED|Overall Study||0
50963|NCT01877343|122354|P3|NOT COMPLETED|Overall Study||0
50964|NCT01877343|122355|P2|NOT COMPLETED|Overall Study||0
50965|NCT01877343|122356|P1|NOT COMPLETED|Overall Study||0
50966|NCT01877343|122350|P7|COMPLETED|Overall Study||0
50967|NCT01877343|122351|P6|COMPLETED|Overall Study||5
50968|NCT01877343|122352|P5|COMPLETED|Overall Study||0
50969|NCT01877343|122353|P4|COMPLETED|Overall Study||0
50970|NCT01877343|122354|P3|COMPLETED|Overall Study||0
50971|NCT01877343|122355|P2|COMPLETED|Overall Study||3
50972|NCT01877343|122356|P1|COMPLETED|Overall Study||2
50973|NCT01877343|122350|P7|STARTED|Overall Study||0
50974|NCT01877343|122351|P6|STARTED|Overall Study||5
50975|NCT01877343|122352|P5|STARTED|Overall Study||0
50976|NCT01877343|122353|P4|STARTED|Overall Study||0
50977|NCT01877343|122354|P3|STARTED|Overall Study||0
50978|NCT01877343|122355|P2|STARTED|Overall Study||3
50979|NCT01877343|122356|P1|STARTED|Overall Study||2
50980|NCT01877278|122363|P2|NOT COMPLETED|Overall Study||3
50981|NCT01877278|122364|P1|NOT COMPLETED|Overall Study||3
50982|NCT01877278|122363|P2|COMPLETED|Overall Study||30
50983|NCT01877278|122364|P1|COMPLETED|Overall Study||30
50984|NCT01877278|122363|P2|STARTED|Overall Study||33
50985|NCT01877278|122364|P1|STARTED|Overall Study||33
50986|NCT01877161|122372|P1|NOT COMPLETED|Third Session of Stimulation||0
50987|NCT01877161|122372|P1|COMPLETED|Third Session of Stimulation||12
50988|NCT01877161|122372|P1|STARTED|Third Session of Stimulation||12
50989|NCT01877161|122372|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
50990|NCT01877161|122372|P1|COMPLETED|Washout (at Least 3 Days)||12
50991|NCT01877161|122372|P1|STARTED|Washout (at Least 3 Days)||12
50992|NCT01877161|122372|P1|NOT COMPLETED|Second Session of Stimulation||0
50993|NCT01877161|122372|P1|COMPLETED|Second Session of Stimulation||12
50994|NCT01877161|122372|P1|STARTED|Second Session of Stimulation||12
50995|NCT01877161|122372|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
50996|NCT01877161|122372|P1|COMPLETED|Washout (at Least 3 Days)||12
50997|NCT01877161|122372|P1|STARTED|Washout (at Least 3 Days)||12
50998|NCT01877161|122372|P1|NOT COMPLETED|First Session of Stimulation||0
50999|NCT01877161|122372|P1|COMPLETED|First Session of Stimulation||12
51000|NCT01877161|122372|P1|STARTED|First Session of Stimulation||12
51001|NCT01877148|122382|P2|NOT COMPLETED|Overall Study||1
51002|NCT01877148|122383|P1|NOT COMPLETED|Overall Study||1
51003|NCT01877148|122382|P2|COMPLETED|Overall Study||5
51004|NCT01877148|122383|P1|COMPLETED|Overall Study||5
51005|NCT01877148|122382|P2|STARTED|Overall Study||6
51006|NCT01877148|122383|P1|STARTED|Overall Study||6
51007|NCT01876992|122397|P2|NOT COMPLETED|Overall Study||0
51008|NCT01876992|122398|P1|NOT COMPLETED|Overall Study||0
51009|NCT01876992|122397|P2|COMPLETED|Overall Study||5
51010|NCT01876992|122398|P1|COMPLETED|Overall Study||5
51011|NCT01876992|122397|P2|STARTED|Overall Study||5
51012|NCT01876992|122398|P1|STARTED|Overall Study||5
51013|NCT01876979|122412|P2|NOT COMPLETED|Overall Study||3
51014|NCT01876979|122413|P1|NOT COMPLETED|Overall Study||2
51015|NCT01876979|122412|P2|COMPLETED|Overall Study||0
51016|NCT01876979|122413|P1|COMPLETED|Overall Study||0
51017|NCT01876979|122412|P2|STARTED|Overall Study||3
51018|NCT01876979|122413|P1|STARTED|Overall Study||2
51019|NCT01876823|122419|P1|NOT COMPLETED|Overall Study||9
51020|NCT01876823|122419|P1|COMPLETED|Overall Study||26
51021|NCT01876823|122419|P1|STARTED|Overall Study||35
51022|NCT01876810|122432|P2|NOT COMPLETED|Overall Study||1
51023|NCT01876810|122433|P1|NOT COMPLETED|Overall Study||0
51024|NCT01876810|122432|P2|COMPLETED|Overall Study||13
51025|NCT01876810|122433|P1|COMPLETED|Overall Study||14
51026|NCT01876810|122432|P2|STARTED|Overall Study||14
51027|NCT01876810|122433|P1|STARTED|Overall Study||14
51028|NCT01876784|122445|P2|NOT COMPLETED|Overall Study||119
51029|NCT01876784|122446|P1|NOT COMPLETED|Overall Study||119
51030|NCT01876784|122445|P2|COMPLETED|Overall Study||0
51031|NCT01876784|122446|P1|COMPLETED|Overall Study||0
51032|NCT01876784|122445|P2|Treated|Overall Study||118
51033|NCT01876784|122446|P1|Treated|Overall Study||117
51034|NCT01876784|122445|P2|STARTED|Overall Study||119
51035|NCT01876784|122446|P1|STARTED|Overall Study||119
51036|NCT01876732|122452|P1|NOT COMPLETED|Overall Study||75
51037|NCT01876732|122452|P1|COMPLETED|Overall Study||57
51038|NCT01876732|122452|P1|STARTED|Overall Study||132
51039|NCT01876706|122457|P1|NOT COMPLETED|Overall Study||4
51040|NCT01876706|122457|P1|COMPLETED|Overall Study||47
51041|NCT01876706|122457|P1|12 Months|Overall Study||41
51042|NCT01876706|122457|P1|1 Month|Overall Study||51
51043|NCT01876706|122457|P1|STARTED|Overall Study||51
51044|NCT01876368|122476|P2|NOT COMPLETED|Overall Study||13
51045|NCT01876368|122477|P1|NOT COMPLETED|Overall Study||9
51046|NCT01876368|122476|P2|COMPLETED|Overall Study||175
51047|NCT01876368|122477|P1|COMPLETED|Overall Study||179
51048|NCT01876368|122476|P2|Safety Set (SAF)|Overall Study||187
51049|NCT01876368|122477|P1|Safety Set (SAF)|Overall Study||188
51050|NCT01876368|122476|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
51051|NCT01876368|122477|P1|Full Analysis Set (FAS)|Overall Study||188
51052|NCT01876368|122476|P2|STARTED|Overall Study||188
51053|NCT01876368|122477|P1|STARTED|Overall Study||188
51054|NCT01876329|122506|P3|NOT COMPLETED|Overall Study||0
51055|NCT01876329|122507|P2|NOT COMPLETED|Overall Study||0
51056|NCT01876329|122508|P1|NOT COMPLETED|Overall Study||0
51057|NCT01876329|122506|P3|COMPLETED|Overall Study||44
51058|NCT01876329|122507|P2|COMPLETED|Overall Study||36
51059|NCT01876329|122508|P1|COMPLETED|Overall Study||45
51060|NCT01876329|122506|P3|STARTED|Overall Study||44
51061|NCT01876329|122507|P2|STARTED|Overall Study||36
51062|NCT01876329|122508|P1|STARTED|Overall Study||45
51063|NCT01875991|122521|P2|NOT COMPLETED|Overall Study||6
51064|NCT01875991|122522|P1|NOT COMPLETED|Overall Study||7
51065|NCT01875991|122521|P2|COMPLETED|Overall Study||103
51066|NCT01875991|122522|P1|COMPLETED|Overall Study||101
51067|NCT01875991|122521|P2|Received Etanercept in Period 2|Overall Study||103
51068|NCT01875991|122522|P1|Received Etanercept in Period 2|Overall Study||102
51069|NCT01875991|122521|P2|Received Etanercept in Period 1|Overall Study||108
51070|NCT01875991|122522|P1|Received Etanercept in Period 1|Overall Study||108
51071|NCT01875991|122521|P2|STARTED|Overall Study||109
51072|NCT01875991|122522|P1|STARTED|Overall Study||108
51073|NCT01875978|122545|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
51074|NCT01875978|122546|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
51075|NCT01875978|122545|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
51076|NCT01875978|122546|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
51077|NCT01875978|122545|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
51078|NCT01875978|122546|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
51079|NCT01875978|122545|P2|NOT COMPLETED|Study 4weeks||0
51080|NCT01875978|122546|P1|NOT COMPLETED|Study 4weeks||0
51081|NCT01875978|122545|P2|COMPLETED|Study 4weeks||20
51082|NCT01875978|122546|P1|COMPLETED|Study 4weeks||20
51083|NCT01875978|122545|P2|STARTED|Study 4weeks||20
51084|NCT01875978|122546|P1|STARTED|Study 4weeks||20
51085|NCT01875848|122560|P2|NOT COMPLETED|Overall Study||0
51086|NCT01875848|122561|P1|NOT COMPLETED|Overall Study||2
51087|NCT01875848|122560|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
51088|NCT01875848|122561|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
51089|NCT01875848|122560|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
51090|NCT01875848|122561|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
51091|NCT01875783|122569|P1|NOT COMPLETED|Overall Study||0
51092|NCT01875783|122569|P1|COMPLETED|Overall Study||385
51093|NCT01875783|122569|P1|STARTED|Overall Study||385
51094|NCT01875731|122578|P2|NOT COMPLETED|Overall Study||0
51095|NCT01875731|122579|P1|NOT COMPLETED|Overall Study||1
51096|NCT01875731|122578|P2|COMPLETED|Overall Study||32
51097|NCT01875731|122579|P1|COMPLETED|Overall Study||33
51098|NCT01875731|122578|P2|STARTED|Overall Study||32
51099|NCT01875731|122579|P1|STARTED|Overall Study||34
51100|NCT01875510|122589|P2|NOT COMPLETED|Overall Study||0
51101|NCT01875510|122590|P1|NOT COMPLETED|Overall Study||0
51102|NCT01875510|122589|P2|COMPLETED|Overall Study||40
51103|NCT01875510|122590|P1|COMPLETED|Overall Study||40
51104|NCT01875510|122589|P2|STARTED|Overall Study||40
51105|NCT01875510|122590|P1|STARTED|Overall Study||40
51106|NCT01875471|122598|P2|NOT COMPLETED|Overall Study||1
51107|NCT01875471|122599|P1|NOT COMPLETED|Overall Study||1
51108|NCT01875471|122598|P2|COMPLETED|Overall Study||137
51109|NCT01875471|122599|P1|COMPLETED|Overall Study||136
51110|NCT01875471|122598|P2|Completed Per Protocol|Overall Study||123
51111|NCT01875471|122599|P1|Completed Per Protocol|Overall Study||127
51112|NCT01875471|122598|P2|STARTED|Overall Study||138
51113|NCT01875471|122599|P1|STARTED|Overall Study||137
51114|NCT01875445|122607|P2|NOT COMPLETED|Overall Study||0
51115|NCT01875445|122608|P1|NOT COMPLETED|Overall Study||7
51116|NCT01875445|122607|P2|COMPLETED|Overall Study||19
51117|NCT01875445|122608|P1|COMPLETED|Overall Study||12
51118|NCT01875445|122607|P2|STARTED|Overall Study||19
51119|NCT01875445|122608|P1|STARTED|Overall Study||19
51120|NCT01875185|122618|P2|NOT COMPLETED|Overall Study||48
51121|NCT01875185|122619|P1|NOT COMPLETED|Overall Study||52
51122|NCT01875185|122618|P2|COMPLETED|Overall Study||0
51123|NCT01875185|122619|P1|COMPLETED|Overall Study||0
51124|NCT01875185|122618|P2|STARTED|Overall Study||48
51125|NCT01875185|122619|P1|STARTED|Overall Study||52
51126|NCT01875159|122633|P2|NOT COMPLETED|Overall Study||0
51127|NCT01875159|122634|P1|NOT COMPLETED|Overall Study||3
51128|NCT01875159|122633|P2|COMPLETED|Overall Study||53
51129|NCT01875159|122634|P1|COMPLETED|Overall Study||42
51130|NCT01875159|122633|P2|STARTED|Overall Study||53
51131|NCT01875159|122634|P1|STARTED|Overall Study||45
51132|NCT01874951|122644|P2|NOT COMPLETED|Overall Study||0
51133|NCT01874951|122645|P1|NOT COMPLETED|Overall Study||0
51134|NCT01874951|122644|P2|COMPLETED|Overall Study||6
51135|NCT01874951|122645|P1|COMPLETED|Overall Study||6
51136|NCT01874951|122644|P2|STARTED|Overall Study||6
51137|NCT01874951|122645|P1|STARTED|Overall Study||6
51138|NCT01874665|122667|P2|NOT COMPLETED|Overall Study||15
51139|NCT01874665|122668|P1|NOT COMPLETED|Overall Study||30
51140|NCT01874665|122667|P2|COMPLETED|Overall Study||0
51141|NCT01874665|122668|P1|COMPLETED|Overall Study||0
51142|NCT01874665|122667|P2|STARTED|Overall Study||15
51143|NCT01874665|122668|P1|STARTED|Overall Study||30
51144|NCT01874353|122696|P2|NOT COMPLETED|Overall Study||37
51145|NCT01874353|122697|P1|NOT COMPLETED|Overall Study||55
51146|NCT01874353|122696|P2|COMPLETED|Overall Study||62
51147|NCT01874353|122697|P1|COMPLETED|Overall Study||141
51148|NCT01874353|122696|P2|STARTED|Overall Study||99
51149|NCT01874353|122697|P1|STARTED|Overall Study||196
51150|NCT01874340|122724|P4|NOT COMPLETED|Overall Study||5
51151|NCT01874340|122725|P3|NOT COMPLETED|Overall Study||8
51152|NCT01874340|122726|P2|NOT COMPLETED|Overall Study||8
51153|NCT01874340|122727|P1|NOT COMPLETED|Overall Study||6
51154|NCT01874340|122724|P4|COMPLETED|Overall Study||1
51155|NCT01874340|122725|P3|COMPLETED|Overall Study||0
51156|NCT01874340|122726|P2|COMPLETED|Overall Study||0
51157|NCT01874340|122727|P1|COMPLETED|Overall Study||0
51158|NCT01874340|122724|P4|STARTED|Overall Study||6
51159|NCT01874340|122725|P3|STARTED|Overall Study||8
51160|NCT01874340|122726|P2|STARTED|Overall Study||8
51161|NCT01874340|122727|P1|STARTED|Overall Study||6
51162|NCT01874275|122755|P2|NOT COMPLETED|Overall Study||0
51163|NCT01874275|122756|P1|NOT COMPLETED|Overall Study||1
51164|NCT01874275|122755|P2|COMPLETED|Overall Study||2
51165|NCT01874275|122756|P1|COMPLETED|Overall Study||3
51166|NCT01874275|122755|P2|STARTED|Overall Study||2
51167|NCT01874275|122756|P1|STARTED|Overall Study||4
51168|NCT01874262|122770|P2|NOT COMPLETED|Overall Study||3
51169|NCT01874262|122771|P1|NOT COMPLETED|Overall Study||5
51170|NCT01874262|122770|P2|COMPLETED|Overall Study||80
51171|NCT01874262|122771|P1|COMPLETED|Overall Study||86
51172|NCT01874262|122770|P2|Not Included Due to Tehnical Issues|Overall Study||3
51173|NCT01874262|122771|P1|Not Included Due to Tehnical Issues|Overall Study||3
51174|NCT01874262|122770|P2|Not Correctly Randomised|Overall Study||0
51175|NCT01874262|122771|P1|Not Correctly Randomised|Overall Study||2
51176|NCT01874262|122770|P2|STARTED|Overall Study||83
51177|NCT01874262|122771|P1|STARTED|Overall Study||91
51178|NCT01874145|122779|P2|NOT COMPLETED|Extension Period||4
51179|NCT01874145|122780|P1|NOT COMPLETED|Extension Period||6
51180|NCT01874145|122779|P2|COMPLETED|Extension Period||97
51181|NCT01874145|122780|P1|COMPLETED|Extension Period||91
51182|NCT01874145|122779|P2|Full Analysis Set|Extension Period||101
51183|NCT01874145|122780|P1|Full Analysis Set|Extension Period||95
51184|NCT01874145|122779|P2|STARTED|Extension Period|Non-Switchers|101
51185|NCT01874145|122780|P1|STARTED|Extension Period|Switchers|97
51186|NCT01874145|122779|P2|NOT COMPLETED|Core Period||7
51187|NCT01874145|122780|P1|NOT COMPLETED|Core Period||3
51188|NCT01874145|122779|P2|COMPLETED|Core Period||101
51189|NCT01874145|122780|P1|COMPLETED|Core Period||98
51190|NCT01874145|122779|P2|Full Analysis Set|Core Period||108
51191|NCT01874145|122780|P1|Full Analysis Set|Core Period||100
51192|NCT01874145|122779|P2|STARTED|Core Period||108
51193|NCT01874145|122780|P1|STARTED|Core Period||101
51194|NCT01874132|122819|P3|NOT COMPLETED|Overall Study||3
51195|NCT01874132|122820|P2|NOT COMPLETED|Overall Study||4
51196|NCT01874132|122821|P1|NOT COMPLETED|Overall Study||4
51197|NCT01874132|122819|P3|COMPLETED|Overall Study||19
51198|NCT01874132|122820|P2|COMPLETED|Overall Study||18
51199|NCT01874132|122821|P1|COMPLETED|Overall Study||18
51200|NCT01874132|122819|P3|STARTED|Overall Study||22
51201|NCT01874132|122820|P2|STARTED|Overall Study||22
51202|NCT01874132|122821|P1|STARTED|Overall Study||22
51203|NCT01874119|122832|P2|NOT COMPLETED|Second Intervention (6 Days)||0
51204|NCT01874119|122833|P1|NOT COMPLETED|Second Intervention (6 Days)||0
51205|NCT01874119|122832|P2|COMPLETED|Second Intervention (6 Days)||3
51206|NCT01874119|122833|P1|COMPLETED|Second Intervention (6 Days)||4
51207|NCT01874119|122832|P2|STARTED|Second Intervention (6 Days)||3
51208|NCT01874119|122833|P1|STARTED|Second Intervention (6 Days)||4
51209|NCT01874119|122832|P2|NOT COMPLETED|Washout (7 Days)||2
51210|NCT01874119|122833|P1|NOT COMPLETED|Washout (7 Days)||3
51211|NCT01874119|122832|P2|COMPLETED|Washout (7 Days)||3
51212|NCT01874119|122833|P1|COMPLETED|Washout (7 Days)||4
51213|NCT01874119|122832|P2|STARTED|Washout (7 Days)||5
51214|NCT01874119|122833|P1|STARTED|Washout (7 Days)||7
51215|NCT01874119|122832|P2|NOT COMPLETED|First Intervention (6 Days)||0
51216|NCT01874119|122833|P1|NOT COMPLETED|First Intervention (6 Days)||1
51217|NCT01874119|122832|P2|COMPLETED|First Intervention (6 Days)||5
51218|NCT01874119|122833|P1|COMPLETED|First Intervention (6 Days)||7
51219|NCT01874119|122832|P2|STARTED|First Intervention (6 Days)||5
51220|NCT01874119|122833|P1|STARTED|First Intervention (6 Days)||8
51221|NCT01874054|122839|P1|NOT COMPLETED|Follow-up Period||49
51222|NCT01874054|122839|P1|COMPLETED|Follow-up Period||2
51223|NCT01874054|122839|P1|STARTED|Follow-up Period|4 patients withdrew consent and did not enter the follow-up period.|51
51224|NCT01874054|122839|P1|NOT COMPLETED|Treatment Period||38
51225|NCT01874054|122839|P1|COMPLETED|Treatment Period||17
51226|NCT01874054|122839|P1|STARTED|Treatment Period||55
51227|NCT01873989|122850|P2|NOT COMPLETED|Overall Study||1
51228|NCT01873989|122851|P1|NOT COMPLETED|Overall Study||1
51229|NCT01873989|122850|P2|COMPLETED|Overall Study||6
51230|NCT01873989|122851|P1|COMPLETED|Overall Study||7
51231|NCT01873989|122850|P2|STARTED|Overall Study||7
51232|NCT01873989|122851|P1|STARTED|Overall Study||8
51233|NCT01873950|122861|P5|NOT COMPLETED|Period 5||0
51234|NCT01873950|122862|P4|NOT COMPLETED|Period 5||1
51235|NCT01873950|122863|P3|NOT COMPLETED|Period 5||0
51236|NCT01873950|122864|P2|NOT COMPLETED|Period 5||0
51237|NCT01873950|122865|P1|NOT COMPLETED|Period 5||0
51238|NCT01873950|122861|P5|COMPLETED|Period 5||4
51239|NCT01873950|122862|P4|COMPLETED|Period 5||3
51240|NCT01873950|122863|P3|COMPLETED|Period 5||4
51241|NCT01873950|122864|P2|COMPLETED|Period 5||5
51242|NCT01873950|122865|P1|COMPLETED|Period 5||4
51243|NCT01873950|122861|P5|STARTED|Period 5||4
51244|NCT01873950|122862|P4|STARTED|Period 5||4
51245|NCT01873950|122863|P3|STARTED|Period 5||4
51246|NCT01873950|122864|P2|STARTED|Period 5||5
51247|NCT01873950|122865|P1|STARTED|Period 5||4
51248|NCT01873950|122861|P5|NOT COMPLETED|Period 4||0
51249|NCT01873950|122862|P4|NOT COMPLETED|Period 4||0
51250|NCT01873950|122863|P3|NOT COMPLETED|Period 4||0
51251|NCT01873950|122864|P2|NOT COMPLETED|Period 4||0
51252|NCT01873950|122865|P1|NOT COMPLETED|Period 4||0
51253|NCT01873950|122861|P5|COMPLETED|Period 4||5
51254|NCT01873950|122862|P4|COMPLETED|Period 4||4
51255|NCT01873950|122863|P3|COMPLETED|Period 4||4
51256|NCT01873950|122864|P2|COMPLETED|Period 4||5
51257|NCT01873950|122865|P1|COMPLETED|Period 4||4
51258|NCT01873950|122861|P5|STARTED|Period 4||5
51259|NCT01873950|122862|P4|STARTED|Period 4||4
51260|NCT01873950|122863|P3|STARTED|Period 4||4
51261|NCT01873950|122864|P2|STARTED|Period 4||5
51262|NCT01873950|122865|P1|STARTED|Period 4||4
51263|NCT01873950|122861|P5|NOT COMPLETED|Period 3||0
51264|NCT01873950|122862|P4|NOT COMPLETED|Period 3||0
51265|NCT01873950|122863|P3|NOT COMPLETED|Period 3||0
51266|NCT01873950|122864|P2|NOT COMPLETED|Period 3||0
51267|NCT01873950|122865|P1|NOT COMPLETED|Period 3||0
51268|NCT01873950|122861|P5|COMPLETED|Period 3||4
51269|NCT01873950|122862|P4|COMPLETED|Period 3||5
51270|NCT01873950|122863|P3|COMPLETED|Period 3||5
51271|NCT01873950|122864|P2|COMPLETED|Period 3||4
51272|NCT01873950|122865|P1|COMPLETED|Period 3||4
51273|NCT01873950|122861|P5|STARTED|Period 3||4
51274|NCT01873950|122862|P4|STARTED|Period 3||5
51275|NCT01873950|122863|P3|STARTED|Period 3||5
51276|NCT01873950|122864|P2|STARTED|Period 3||4
51277|NCT01873950|122865|P1|STARTED|Period 3||4
51278|NCT01873950|122861|P5|NOT COMPLETED|Period 2||0
51279|NCT01873950|122862|P4|NOT COMPLETED|Period 2||0
51280|NCT01873950|122863|P3|NOT COMPLETED|Period 2||0
51281|NCT01873950|122864|P2|NOT COMPLETED|Period 2||0
51282|NCT01873950|122865|P1|NOT COMPLETED|Period 2||0
51283|NCT01873950|122861|P5|COMPLETED|Period 2||5
51284|NCT01873950|122862|P4|COMPLETED|Period 2||4
51285|NCT01873950|122863|P3|COMPLETED|Period 2||4
51286|NCT01873950|122864|P2|COMPLETED|Period 2||4
51287|NCT01873950|122865|P1|COMPLETED|Period 2||5
51288|NCT01873950|122861|P5|STARTED|Period 2||5
51289|NCT01873950|122862|P4|STARTED|Period 2||4
51290|NCT01873950|122863|P3|STARTED|Period 2||4
51291|NCT01873950|122864|P2|STARTED|Period 2||4
51292|NCT01873950|122865|P1|STARTED|Period 2||5
51293|NCT01873950|122861|P5|NOT COMPLETED|Period 1||0
51294|NCT01873950|122862|P4|NOT COMPLETED|Period 1||0
51295|NCT01873950|122863|P3|NOT COMPLETED|Period 1||0
51296|NCT01873950|122864|P2|NOT COMPLETED|Period 1||0
51297|NCT01873950|122865|P1|NOT COMPLETED|Period 1||0
51298|NCT01873950|122861|P5|COMPLETED|Period 1||4
51299|NCT01873950|122862|P4|COMPLETED|Period 1||4
51300|NCT01873950|122863|P3|COMPLETED|Period 1||5
51301|NCT01873950|122864|P2|COMPLETED|Period 1||4
51302|NCT01873950|122865|P1|COMPLETED|Period 1||5
51303|NCT01873950|122861|P5|STARTED|Period 1||4
51304|NCT01873950|122862|P4|STARTED|Period 1||4
51305|NCT01873950|122863|P3|STARTED|Period 1||5
51306|NCT01873950|122864|P2|STARTED|Period 1||4
51307|NCT01873950|122865|P1|STARTED|Period 1||5
51308|NCT01873859|122902|P2|NOT COMPLETED|Overall Study||4
51309|NCT01873859|122903|P1|NOT COMPLETED|Overall Study||0
51310|NCT01873859|122902|P2|COMPLETED|Overall Study||79
51311|NCT01873859|122903|P1|COMPLETED|Overall Study||83
51312|NCT01873859|122902|P2|STARTED|Overall Study||83
51313|NCT01873859|122903|P1|STARTED|Overall Study||83
51314|NCT01873729|122911|P1|NOT COMPLETED|Overall Study||1
51315|NCT01873729|122911|P1|COMPLETED|Overall Study||2
51316|NCT01873729|122911|P1|STARTED|Overall Study||3
51317|NCT01873417|122916|P1|NOT COMPLETED|Overall Study||35
51318|NCT01873417|122916|P1|COMPLETED|Overall Study||202
51319|NCT01873417|122916|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
51320|NCT01873417|122916|P1|STARTED|Overall Study||237
51321|NCT01872910|122933|P6|NOT COMPLETED|Overall Study||0
51322|NCT01872910|122934|P5|NOT COMPLETED|Overall Study||0
51323|NCT01872910|122935|P4|NOT COMPLETED|Overall Study||0
51324|NCT01872910|122936|P3|NOT COMPLETED|Overall Study||2
51325|NCT01872910|122937|P2|NOT COMPLETED|Overall Study||0
51326|NCT01872910|122938|P1|NOT COMPLETED|Overall Study||2
51327|NCT01872910|122933|P6|COMPLETED|Overall Study||3
51328|NCT01872910|122934|P5|COMPLETED|Overall Study||15
51329|NCT01872910|122935|P4|COMPLETED|Overall Study||15
51330|NCT01872910|122936|P3|COMPLETED|Overall Study||28
51331|NCT01872910|122937|P2|COMPLETED|Overall Study||31
51332|NCT01872910|122938|P1|COMPLETED|Overall Study||28
51333|NCT01872910|122933|P6|Received Any Study Drug|Overall Study||3
51334|NCT01872910|122934|P5|Received Any Study Drug|Overall Study||15
51335|NCT01872910|122935|P4|Received Any Study Drug|Overall Study||15
51336|NCT01872910|122936|P3|Received Any Study Drug|Overall Study||30
51337|NCT01872910|122937|P2|Received Any Study Drug|Overall Study||31
51338|NCT01872910|122938|P1|Received Any Study Drug|Overall Study||30
51339|NCT01872910|122933|P6|STARTED|Overall Study||3
51340|NCT01872910|122934|P5|STARTED|Overall Study||15
51341|NCT01872910|122935|P4|STARTED|Overall Study||15
51342|NCT01872910|122936|P3|STARTED|Overall Study||30
51343|NCT01872910|122937|P2|STARTED|Overall Study||31
51344|NCT01872910|122938|P1|STARTED|Overall Study||30
51345|NCT01872819|122978|P1|NOT COMPLETED|Overall Study||0
51346|NCT01872819|122978|P1|COMPLETED|Overall Study||14
51347|NCT01872819|122978|P1|STARTED|Overall Study||14
51348|NCT01872715|122983|P1|NOT COMPLETED|Overall Study||4
51349|NCT01872715|122983|P1|COMPLETED|Overall Study||20
51350|NCT01872715|122983|P1|STARTED|Overall Study||24
51351|NCT01872611|123000|P2|NOT COMPLETED|Overall Study||12
51352|NCT01872611|123001|P1|NOT COMPLETED|Overall Study||24
51353|NCT01872611|123000|P2|COMPLETED|Overall Study||292
51354|NCT01872611|123001|P1|COMPLETED|Overall Study||277
51355|NCT01872611|123000|P2|Full Analysis Set|Overall Study||293
51356|NCT01872611|123001|P1|Full Analysis Set|Overall Study||289
51357|NCT01872611|123000|P2|Treated (Safety Analysis Set)|Overall Study||295
51358|NCT01872611|123001|P1|Treated (Safety Analysis Set)|Overall Study||293
51359|NCT01872611|123000|P2|Randomized|Overall Study||304
51360|NCT01872611|123001|P1|Randomized|Overall Study||301
51361|NCT01872611|123000|P2|STARTED|Overall Study||304
51362|NCT01872611|123001|P1|STARTED|Overall Study||301
51363|NCT01872078|123023|P4|NOT COMPLETED|Overall Study||2
51364|NCT01872078|123024|P3|NOT COMPLETED|Overall Study||3
51365|NCT01872078|123025|P2|NOT COMPLETED|Overall Study||0
51366|NCT01872078|123026|P1|NOT COMPLETED|Overall Study||0
51367|NCT01872078|123023|P4|COMPLETED|Overall Study||15
51368|NCT01872078|123024|P3|COMPLETED|Overall Study||14
51369|NCT01872078|123025|P2|COMPLETED|Overall Study||15
51370|NCT01872078|123026|P1|COMPLETED|Overall Study||16
51371|NCT01872078|123023|P4|STARTED|Overall Study||17
51372|NCT01872078|123024|P3|STARTED|Overall Study||17
51373|NCT01872078|123025|P2|STARTED|Overall Study||15
51374|NCT01872078|123026|P1|STARTED|Overall Study||16
51375|NCT01871870|123036|P1|NOT COMPLETED|Overall Study||9
51376|NCT01871870|123036|P1|COMPLETED|Overall Study||11
51377|NCT01871870|123036|P1|STARTED|Overall Study||20
51378|NCT01871805|123047|P6|NOT COMPLETED|Phase II||87
51379|NCT01871805|123048|P5|NOT COMPLETED|Phase II||0
51380|NCT01871805|123049|P4|NOT COMPLETED|Phase II||0
51381|NCT01871805|123050|P3|NOT COMPLETED|Phase II||0
51382|NCT01871805|123051|P2|NOT COMPLETED|Phase II||0
51383|NCT01871805|123052|P1|NOT COMPLETED|Phase II||0
51384|NCT01871805|123047|P6|COMPLETED|Phase II||0
51385|NCT01871805|123048|P5|COMPLETED|Phase II||0
51386|NCT01871805|123049|P4|COMPLETED|Phase II||0
51387|NCT01871805|123050|P3|COMPLETED|Phase II||0
51388|NCT01871805|123051|P2|COMPLETED|Phase II||0
51389|NCT01871805|123052|P1|COMPLETED|Phase II||0
51390|NCT01871805|123047|P6|STARTED|Phase II||87
51391|NCT01871805|123048|P5|STARTED|Phase II||0
51392|NCT01871805|123049|P4|STARTED|Phase II||0
51393|NCT01871805|123050|P3|STARTED|Phase II||0
51394|NCT01871805|123051|P2|STARTED|Phase II||0
51395|NCT01871805|123052|P1|STARTED|Phase II||0
51396|NCT01871805|123047|P6|NOT COMPLETED|Phase I||0
51397|NCT01871805|123048|P5|NOT COMPLETED|Phase I||13
51398|NCT01871805|123049|P4|NOT COMPLETED|Phase I||7
51399|NCT01871805|123050|P3|NOT COMPLETED|Phase I||13
51400|NCT01871805|123051|P2|NOT COMPLETED|Phase I||7
51401|NCT01871805|123052|P1|NOT COMPLETED|Phase I||7
51402|NCT01871805|123047|P6|COMPLETED|Phase I||0
51403|NCT01871805|123048|P5|COMPLETED|Phase I||0
51404|NCT01871805|123049|P4|COMPLETED|Phase I||0
51405|NCT01871805|123050|P3|COMPLETED|Phase I||0
51406|NCT01871805|123051|P2|COMPLETED|Phase I||0
51407|NCT01871805|123052|P1|COMPLETED|Phase I||0
51408|NCT01871805|123047|P6|STARTED|Phase I||0
51409|NCT01871805|123048|P5|STARTED|Phase I||13
51410|NCT01871805|123049|P4|STARTED|Phase I||7
51411|NCT01871805|123050|P3|STARTED|Phase I||13
51412|NCT01871805|123051|P2|STARTED|Phase I||7
51413|NCT01871805|123052|P1|STARTED|Phase I||7
51414|NCT01871558|123120|P2|NOT COMPLETED|Overall Study||2
51415|NCT01871558|123121|P1|NOT COMPLETED|Overall Study||3
51416|NCT01871558|123120|P2|COMPLETED|Overall Study||19
51417|NCT01871558|123121|P1|COMPLETED|Overall Study||18
51418|NCT01871558|123120|P2|STARTED|Overall Study||21
51419|NCT01871558|123121|P1|STARTED|Overall Study||21
51420|NCT01871532|123141|P2|NOT COMPLETED|Overall Study||2
51421|NCT01871532|123142|P1|NOT COMPLETED|Overall Study||1
51422|NCT01871532|123141|P2|COMPLETED|Overall Study||10
51423|NCT01871532|123142|P1|COMPLETED|Overall Study||11
51424|NCT01871532|123141|P2|Subjects Received hCG Treatment|Overall Study||9
51425|NCT01871532|123142|P1|Subjects Received hCG Treatment|Overall Study||11
51426|NCT01871532|123141|P2|STARTED|Overall Study||12
51427|NCT01871532|123142|P1|STARTED|Overall Study||12
51428|NCT01871519|123176|P1|NOT COMPLETED|Overall Study||90
51429|NCT01871519|123176|P1|COMPLETED|Overall Study||260
51430|NCT01871519|123176|P1|STARTED|Overall Study||350
51431|NCT01871441|123197|P1|NOT COMPLETED|Overall Study||0
51432|NCT01871441|123197|P1|COMPLETED|Overall Study||4
51433|NCT01871441|123197|P1|STARTED|Overall Study||4
51434|NCT01871402|123206|P2|NOT COMPLETED|Overall Study||3
51435|NCT01871402|123207|P1|NOT COMPLETED|Overall Study||1
51436|NCT01871402|123206|P2|COMPLETED|Overall Study||108
51437|NCT01871402|123207|P1|COMPLETED|Overall Study||109
51438|NCT01871402|123206|P2|STARTED|Overall Study||111
51439|NCT01871402|123207|P1|STARTED|Overall Study||110
51440|NCT01871285|123225|P4|NOT COMPLETED|Second Intervention (1 Day)||0
51441|NCT01871285|123226|P3|NOT COMPLETED|Second Intervention (1 Day)||0
51442|NCT01871285|123227|P2|NOT COMPLETED|Second Intervention (1 Day)||0
51443|NCT01871285|123228|P1|NOT COMPLETED|Second Intervention (1 Day)||0
51444|NCT01871285|123225|P4|COMPLETED|Second Intervention (1 Day)||2
51445|NCT01871285|123226|P3|COMPLETED|Second Intervention (1 Day)||3
51446|NCT01871285|123227|P2|COMPLETED|Second Intervention (1 Day)||14
51447|NCT01871285|123228|P1|COMPLETED|Second Intervention (1 Day)||17
51448|NCT01871285|123225|P4|STARTED|Second Intervention (1 Day)||2
51449|NCT01871285|123226|P3|STARTED|Second Intervention (1 Day)||3
51450|NCT01871285|123227|P2|STARTED|Second Intervention (1 Day)||14
51451|NCT01871285|123228|P1|STARTED|Second Intervention (1 Day)||17
51452|NCT01871285|123225|P4|NOT COMPLETED|First Intervention (1 Day)||0
51453|NCT01871285|123226|P3|NOT COMPLETED|First Intervention (1 Day)||1
51454|NCT01871285|123227|P2|NOT COMPLETED|First Intervention (1 Day)||1
51455|NCT01871285|123228|P1|NOT COMPLETED|First Intervention (1 Day)||1
51456|NCT01871285|123225|P4|COMPLETED|First Intervention (1 Day)||2
51457|NCT01871285|123226|P3|COMPLETED|First Intervention (1 Day)||3
51458|NCT01871285|123227|P2|COMPLETED|First Intervention (1 Day)||14
51459|NCT01871285|123228|P1|COMPLETED|First Intervention (1 Day)||17
51460|NCT01871285|123225|P4|STARTED|First Intervention (1 Day)||2
51461|NCT01871285|123226|P3|STARTED|First Intervention (1 Day)||4
51462|NCT01871285|123227|P2|STARTED|First Intervention (1 Day)||15
51463|NCT01871285|123228|P1|STARTED|First Intervention (1 Day)||18
51464|NCT01871142|123254|P1|NOT COMPLETED|Overall Study||1
51465|NCT01871142|123254|P1|COMPLETED|Overall Study||11
51466|NCT01871142|123254|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
51467|NCT01871142|123254|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
51468|NCT01871142|123254|P1|Received Placebo + Hypoxia|Overall Study||12
51469|NCT01871142|123254|P1|Received Placebo + Normoixa|Overall Study||11
51470|NCT01871142|123254|P1|STARTED|Overall Study||12
51471|NCT01871090|123270|P2|NOT COMPLETED|Overall Study||23
51472|NCT01871090|123271|P1|NOT COMPLETED|Overall Study||2
51473|NCT01871090|123270|P2|COMPLETED|Overall Study||25
51474|NCT01871090|123271|P1|COMPLETED|Overall Study||33
51475|NCT01871090|123270|P2|STARTED|Overall Study||48
51476|NCT01871090|123271|P1|STARTED|Overall Study||35
51477|NCT01870999|123284|P3|NOT COMPLETED|Overall Study||7
51478|NCT01870999|123285|P2|NOT COMPLETED|Overall Study||8
51479|NCT01870999|123286|P1|NOT COMPLETED|Overall Study||4
51480|NCT01870999|123284|P3|COMPLETED|Overall Study||4
51481|NCT01870999|123285|P2|COMPLETED|Overall Study||8
51482|NCT01870999|123286|P1|COMPLETED|Overall Study||10
51483|NCT01870999|123284|P3|Safety Population; Received Study Drug|Overall Study||10
51484|NCT01870999|123285|P2|Safety Population; Received Study Drug|Overall Study||15
51485|NCT01870999|123286|P1|Safety Population; Received Study Drug|Overall Study||14
51486|NCT01870999|123284|P3|STARTED|Overall Study||11
51487|NCT01870999|123285|P2|STARTED|Overall Study||16
51488|NCT01870999|123286|P1|STARTED|Overall Study||14
51489|NCT01870973|123344|P2|NOT COMPLETED|Overall Study||3
51490|NCT01870973|123345|P1|NOT COMPLETED|Overall Study||10
51491|NCT01870973|123344|P2|COMPLETED|Overall Study||49
51492|NCT01870973|123345|P1|COMPLETED|Overall Study||46
51493|NCT01870973|123344|P2|STARTED|Overall Study||52
51494|NCT01870973|123345|P1|STARTED|Overall Study||56
51495|NCT01870921|123351|P1|NOT COMPLETED|Overall Study||90
51496|NCT01870921|123351|P1|COMPLETED|Overall Study||1914
51497|NCT01870921|123351|P1|STARTED|Overall Study||2004
51498|NCT01870856|123359|P2|NOT COMPLETED|Overall Study||0
51499|NCT01870856|123360|P1|NOT COMPLETED|Overall Study||0
51500|NCT01870856|123359|P2|COMPLETED|Overall Study||27
51501|NCT01870856|123360|P1|COMPLETED|Overall Study||25
51502|NCT01870856|123359|P2|STARTED|Overall Study||27
51503|NCT01870856|123360|P1|STARTED|Overall Study||25
51504|NCT01870843|123370|P1|NOT COMPLETED|Overall Study||53
51505|NCT01870843|123370|P1|COMPLETED|Overall Study||208
51506|NCT01870843|123370|P1|STARTED|Overall Study||261
51507|NCT01870778|123385|P2|NOT COMPLETED|Overall Study||9
51508|NCT01870778|123386|P1|NOT COMPLETED|Overall Study||8
51509|NCT01870778|123385|P2|COMPLETED|Overall Study||3262
51510|NCT01870778|123386|P1|COMPLETED|Overall Study||3266
51511|NCT01870778|123385|P2|Biomarker Analysis Set|Overall Study||510
51512|NCT01870778|123386|P1|Biomarker Analysis Set|Overall Study||521
51513|NCT01870778|123385|P2|Full Analysis Set|Overall Study||3271
51514|NCT01870778|123386|P1|Full Analysis Set|Overall Study||3274
51515|NCT01870778|123385|P2|Safety Set|Overall Study||3248
51516|NCT01870778|123386|P1|Safety Set|Overall Study||3257
51517|NCT01870778|123385|P2|STARTED|Overall Study||3271
51518|NCT01870778|123386|P1|STARTED|Overall Study||3274
51519|NCT01870739|123412|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
51520|NCT01870739|123413|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
51521|NCT01870739|123412|P2|COMPLETED|Add-on Period (40 Weeks)||51
51522|NCT01870739|123413|P1|COMPLETED|Add-on Period (40 Weeks)||51
51523|NCT01870739|123412|P2|STARTED|Add-on Period (40 Weeks)||53
51524|NCT01870739|123413|P1|STARTED|Add-on Period (40 Weeks)||54
51525|NCT01870739|123412|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
51526|NCT01870739|123413|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
51527|NCT01870739|123412|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
51528|NCT01870739|123413|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
51529|NCT01870739|123412|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
51530|NCT01870739|123413|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
51531|NCT01870739|123412|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
51532|NCT01870739|123413|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
51533|NCT01870739|123412|P2|STARTED|Single Drug Treatment (12 Weeks)||57
51534|NCT01870739|123413|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
51535|NCT01870726|123452|P7|NOT COMPLETED|Overall Study||10
51536|NCT01870726|123453|P6|NOT COMPLETED|Overall Study||5
51537|NCT01870726|123454|P5|NOT COMPLETED|Overall Study||7
51538|NCT01870726|123455|P4|NOT COMPLETED|Overall Study||6
51539|NCT01870726|123456|P3|NOT COMPLETED|Overall Study||4
51540|NCT01870726|123457|P2|NOT COMPLETED|Overall Study||6
51541|NCT01870726|123458|P1|NOT COMPLETED|Overall Study||5
51542|NCT01870726|123452|P7|COMPLETED|Overall Study||0
51543|NCT01870726|123453|P6|COMPLETED|Overall Study||0
51544|NCT01870726|123454|P5|COMPLETED|Overall Study||0
51545|NCT01870726|123455|P4|COMPLETED|Overall Study||0
51546|NCT01870726|123456|P3|COMPLETED|Overall Study||0
51547|NCT01870726|123457|P2|COMPLETED|Overall Study||0
51548|NCT01870726|123458|P1|COMPLETED|Overall Study||0
51549|NCT01870726|123452|P7|STARTED|Overall Study||10
51550|NCT01870726|123453|P6|STARTED|Overall Study||5
51551|NCT01870726|123454|P5|STARTED|Overall Study||7
51552|NCT01870726|123455|P4|STARTED|Overall Study||6
51553|NCT01870726|123456|P3|STARTED|Overall Study||4
51554|NCT01870726|123457|P2|STARTED|Overall Study||6
51555|NCT01870726|123458|P1|STARTED|Overall Study||5
51556|NCT01870596|123543|P2|NOT COMPLETED|Overall Study||0
51557|NCT01870596|123544|P1|NOT COMPLETED|Overall Study||0
51558|NCT01870596|123543|P2|COMPLETED|Overall Study||18
51559|NCT01870596|123544|P1|COMPLETED|Overall Study||14
51560|NCT01870596|123543|P2|STARTED|Overall Study||18
51561|NCT01870596|123544|P1|STARTED|Overall Study||14
51562|NCT01870583|123553|P3|NOT COMPLETED|Overall Study||8
51563|NCT01870583|123554|P2|NOT COMPLETED|Overall Study||18
51564|NCT01870583|123555|P1|NOT COMPLETED|Overall Study||11
51565|NCT01870583|123553|P3|COMPLETED|Overall Study||455
51566|NCT01870583|123554|P2|COMPLETED|Overall Study||456
51567|NCT01870583|123555|P1|COMPLETED|Overall Study||456
51568|NCT01870583|123553|P3|STARTED|Overall Study||463
51569|NCT01870583|123554|P2|STARTED|Overall Study||474
51570|NCT01870583|123555|P1|STARTED|Overall Study||467
51571|NCT01870388|123565|P2|NOT COMPLETED|Overall Study||0
51572|NCT01870388|123566|P1|NOT COMPLETED|Overall Study||0
51573|NCT01870388|123565|P2|COMPLETED|Overall Study||8
51574|NCT01870388|123566|P1|COMPLETED|Overall Study||8
51575|NCT01870388|123565|P2|Received 1 Dose of Study Drug|Overall Study||8
51576|NCT01870388|123566|P1|Received 1 Dose of Study Drug|Overall Study||8
51577|NCT01870388|123565|P2|STARTED|Overall Study||8
51578|NCT01870388|123566|P1|STARTED|Overall Study||8
51579|NCT01870076|123578|P4|NOT COMPLETED|Overall Study||0
51580|NCT01870076|123579|P3|NOT COMPLETED|Overall Study||1
51581|NCT01870076|123580|P2|NOT COMPLETED|Overall Study||0
51582|NCT01870076|123581|P1|NOT COMPLETED|Overall Study||1
51583|NCT01870076|123578|P4|COMPLETED|Overall Study||11
51584|NCT01870076|123579|P3|COMPLETED|Overall Study||7
51585|NCT01870076|123580|P2|COMPLETED|Overall Study||12
51586|NCT01870076|123581|P1|COMPLETED|Overall Study||9
51587|NCT01870076|123578|P4|STARTED|Overall Study||11
51588|NCT01870076|123579|P3|STARTED|Overall Study||8
51589|NCT01870076|123580|P2|STARTED|Overall Study||12
51590|NCT01870076|123581|P1|STARTED|Overall Study||10
51591|NCT01869959|123599|P5|NOT COMPLETED|Treatment Period||0
51592|NCT01869959|123600|P4|NOT COMPLETED|Treatment Period||2
51593|NCT01869959|123601|P3|NOT COMPLETED|Treatment Period||3
51594|NCT01869959|123602|P2|NOT COMPLETED|Treatment Period||2
51595|NCT01869959|123603|P1|NOT COMPLETED|Treatment Period||1
51596|NCT01869959|123599|P5|COMPLETED|Treatment Period||0
51597|NCT01869959|123600|P4|COMPLETED|Treatment Period||8
51598|NCT01869959|123601|P3|COMPLETED|Treatment Period||12
51599|NCT01869959|123602|P2|COMPLETED|Treatment Period||8
51600|NCT01869959|123603|P1|COMPLETED|Treatment Period||10
51601|NCT01869959|123599|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
51602|NCT01869959|123600|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
51603|NCT01869959|123601|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
51604|NCT01869959|123602|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
51605|NCT01869959|123603|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
51606|NCT01869959|123599|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
51607|NCT01869959|123600|P4|STARTED|Treatment Period||10
51608|NCT01869959|123601|P3|STARTED|Treatment Period||15
51609|NCT01869959|123602|P2|STARTED|Treatment Period||10
51610|NCT01869959|123603|P1|STARTED|Treatment Period||11
51611|NCT01869959|123599|P5|NOT COMPLETED|Randomization Period||1
51612|NCT01869959|123600|P4|NOT COMPLETED|Randomization Period||0
51613|NCT01869959|123601|P3|NOT COMPLETED|Randomization Period||0
51614|NCT01869959|123602|P2|NOT COMPLETED|Randomization Period||0
51615|NCT01869959|123603|P1|NOT COMPLETED|Randomization Period||0
51616|NCT01869959|123599|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
51617|NCT01869959|123600|P4|COMPLETED|Randomization Period||0
51618|NCT01869959|123601|P3|COMPLETED|Randomization Period||0
51619|NCT01869959|123602|P2|COMPLETED|Randomization Period||0
51620|NCT01869959|123603|P1|COMPLETED|Randomization Period||0
51621|NCT01869959|123599|P5|STARTED|Randomization Period||47
51622|NCT01869959|123600|P4|STARTED|Randomization Period||0
51623|NCT01869959|123601|P3|STARTED|Randomization Period||0
51624|NCT01869959|123602|P2|STARTED|Randomization Period||0
51625|NCT01869959|123603|P1|STARTED|Randomization Period||0
51626|NCT01869699|123673|P2|NOT COMPLETED|Overall Study||0
51627|NCT01869699|123674|P1|NOT COMPLETED|Overall Study||1
51628|NCT01869699|123673|P2|COMPLETED|Overall Study||20
51629|NCT01869699|123674|P1|COMPLETED|Overall Study||20
51630|NCT01869699|123673|P2|STARTED|Overall Study||20
51631|NCT01869699|123674|P1|STARTED|Overall Study||21
51632|NCT01869686|123692|P1|NOT COMPLETED|Overall Study||0
51633|NCT01869686|123692|P1|COMPLETED|Overall Study||12
51634|NCT01869686|123692|P1|STARTED|Overall Study||12
51635|NCT01869647|123707|P3|NOT COMPLETED|Overall Study||0
51636|NCT01869647|123708|P2|NOT COMPLETED|Overall Study||6
51637|NCT01869647|123709|P1|NOT COMPLETED|Overall Study||1
51638|NCT01869647|123707|P3|COMPLETED|Overall Study||62
51639|NCT01869647|123708|P2|COMPLETED|Overall Study||130
51640|NCT01869647|123709|P1|COMPLETED|Overall Study||65
51641|NCT01869647|123707|P3|STARTED|Overall Study||62
51642|NCT01869647|123708|P2|STARTED|Overall Study||136
51643|NCT01869647|123709|P1|STARTED|Overall Study||66
51644|NCT01869478|123722|P2|NOT COMPLETED|Overall Study||0
51645|NCT01869478|123723|P1|NOT COMPLETED|Overall Study||0
51646|NCT01869478|123722|P2|COMPLETED|Overall Study||1
51647|NCT01869478|123723|P1|COMPLETED|Overall Study||0
51648|NCT01869478|123722|P2|STARTED|Overall Study||1
51649|NCT01869478|123723|P1|STARTED|Overall Study||0
51650|NCT01869439|123731|P1|NOT COMPLETED|Overall Study||0
51651|NCT01869439|123731|P1|COMPLETED|Overall Study||40
51652|NCT01869439|123731|P1|STARTED|Overall Study||40
51653|NCT01869348|123737|P2|NOT COMPLETED|Overall Study||1
51654|NCT01869348|123738|P1|NOT COMPLETED|Overall Study||1
51655|NCT01869348|123737|P2|COMPLETED|Overall Study||19
51656|NCT01869348|123738|P1|COMPLETED|Overall Study||19
51657|NCT01869348|123737|P2|STARTED|Overall Study||20
51658|NCT01869348|123738|P1|STARTED|Overall Study||20
51659|NCT01869075|123750|P6|NOT COMPLETED|Phase 2||0
51660|NCT01869075|123751|P5|NOT COMPLETED|Phase 2||0
51661|NCT01869075|123752|P4|NOT COMPLETED|Phase 2||0
51662|NCT01869075|123753|P3|NOT COMPLETED|Phase 2||0
51663|NCT01869075|123754|P2|NOT COMPLETED|Phase 2||0
51664|NCT01869075|123755|P1|NOT COMPLETED|Phase 2||0
51665|NCT01869075|123750|P6|COMPLETED|Phase 2||45
51666|NCT01869075|123751|P5|COMPLETED|Phase 2||75
51667|NCT01869075|123752|P4|COMPLETED|Phase 2||45
51668|NCT01869075|123753|P3|COMPLETED|Phase 2||75
51669|NCT01869075|123754|P2|COMPLETED|Phase 2||30
51670|NCT01869075|123755|P1|COMPLETED|Phase 2||90
51671|NCT01869075|123750|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
51672|NCT01869075|123751|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
51673|NCT01869075|123752|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
51674|NCT01869075|123753|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
51675|NCT01869075|123754|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
51676|NCT01869075|123755|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
51677|NCT01869075|123750|P6|NOT COMPLETED|Phase 1||0
51678|NCT01869075|123751|P5|NOT COMPLETED|Phase 1||0
51679|NCT01869075|123752|P4|NOT COMPLETED|Phase 1||0
51680|NCT01869075|123753|P3|NOT COMPLETED|Phase 1||0
51681|NCT01869075|123754|P2|NOT COMPLETED|Phase 1||0
51682|NCT01869075|123755|P1|NOT COMPLETED|Phase 1||0
51683|NCT01869075|123750|P6|COMPLETED|Phase 1||90
51684|NCT01869075|123751|P5|COMPLETED|Phase 1||30
51685|NCT01869075|123752|P4|COMPLETED|Phase 1||75
51686|NCT01869075|123753|P3|COMPLETED|Phase 1||45
51687|NCT01869075|123754|P2|COMPLETED|Phase 1||75
51688|NCT01869075|123755|P1|COMPLETED|Phase 1||45
51689|NCT01869075|123750|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
51690|NCT01869075|123751|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
51691|NCT01869075|123752|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
51692|NCT01869075|123753|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
51693|NCT01869075|123754|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
51694|NCT01869075|123755|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
51695|NCT01869075|123750|P6|NOT COMPLETED|Phase 0 (Baseline)||0
51696|NCT01869075|123751|P5|NOT COMPLETED|Phase 0 (Baseline)||0
51697|NCT01869075|123752|P4|NOT COMPLETED|Phase 0 (Baseline)||0
51698|NCT01869075|123753|P3|NOT COMPLETED|Phase 0 (Baseline)||0
51699|NCT01869075|123754|P2|NOT COMPLETED|Phase 0 (Baseline)||0
51700|NCT01869075|123755|P1|NOT COMPLETED|Phase 0 (Baseline)||0
51701|NCT01869075|123750|P6|COMPLETED|Phase 0 (Baseline)||341
51702|NCT01869075|123751|P5|COMPLETED|Phase 0 (Baseline)||0
51703|NCT01869075|123752|P4|COMPLETED|Phase 0 (Baseline)||416
51704|NCT01869075|123753|P3|COMPLETED|Phase 0 (Baseline)||0
51705|NCT01869075|123754|P2|COMPLETED|Phase 0 (Baseline)||418
51706|NCT01869075|123755|P1|COMPLETED|Phase 0 (Baseline)||0
51707|NCT01869075|123750|P6|STARTED|Phase 0 (Baseline)||341
51708|NCT01869075|123751|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
51709|NCT01869075|123752|P4|STARTED|Phase 0 (Baseline)||416
51710|NCT01869075|123753|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
51711|NCT01869075|123754|P2|STARTED|Phase 0 (Baseline)||418
51712|NCT01869075|123755|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
51713|NCT01868997|123771|P2|NOT COMPLETED|Overall Study||6
51714|NCT01868997|123772|P1|NOT COMPLETED|Overall Study||7
51715|NCT01868997|123771|P2|COMPLETED|Overall Study||36
51716|NCT01868997|123772|P1|COMPLETED|Overall Study||38
51717|NCT01868997|123771|P2|STARTED|Overall Study|randomized and treated|42
51718|NCT01868997|123772|P1|STARTED|Overall Study|randomized and treated|45
51719|NCT01868893|123788|P1|NOT COMPLETED|Overall Study||20
51720|NCT01868893|123788|P1|COMPLETED|Overall Study||0
51721|NCT01868893|123788|P1|STARTED|Overall Study||20
51722|NCT01868789|123797|P2|NOT COMPLETED|Overall Study||2
51723|NCT01868789|123798|P1|NOT COMPLETED|Overall Study||2
51724|NCT01868789|123797|P2|COMPLETED|Overall Study||12
51725|NCT01868789|123798|P1|COMPLETED|Overall Study||7
51726|NCT01868789|123797|P2|STARTED|Overall Study||14
51727|NCT01868789|123798|P1|STARTED|Overall Study||9
51728|NCT01868776|123808|P2|NOT COMPLETED|Overall Study||0
51729|NCT01868776|123809|P1|NOT COMPLETED|Overall Study||0
51730|NCT01868776|123808|P2|COMPLETED|Overall Study||50
51731|NCT01868776|123809|P1|COMPLETED|Overall Study||50
51732|NCT01868776|123808|P2|STARTED|Overall Study||50
51733|NCT01868776|123809|P1|STARTED|Overall Study||50
51734|NCT01868633|123817|P2|NOT COMPLETED|Overall Study||0
51735|NCT01868633|123818|P1|NOT COMPLETED|Overall Study||0
51736|NCT01868633|123817|P2|COMPLETED|Overall Study||26
51737|NCT01868633|123818|P1|COMPLETED|Overall Study||26
51738|NCT01868633|123817|P2|STARTED|Overall Study||26
51739|NCT01868633|123818|P1|STARTED|Overall Study||26
51740|NCT01868542|123834|P2|NOT COMPLETED|Overall Study||2
51741|NCT01868542|123835|P1|NOT COMPLETED|Overall Study||0
51742|NCT01868542|123834|P2|COMPLETED|Overall Study||21
51743|NCT01868542|123835|P1|COMPLETED|Overall Study||23
51744|NCT01868542|123834|P2|STARTED|Overall Study||23
51745|NCT01868542|123835|P1|STARTED|Overall Study||23
51746|NCT01868503|123853|P1|NOT COMPLETED|Overall Study||2
51747|NCT01868503|123853|P1|COMPLETED|Overall Study||5
51748|NCT01868503|123853|P1|STARTED|Overall Study||7
51749|NCT01868334|123865|P4|NOT COMPLETED|Year 2 Pre-post Study||0
51750|NCT01868334|123866|P3|NOT COMPLETED|Year 2 Pre-post Study||0
51751|NCT01868334|123867|P2|NOT COMPLETED|Year 2 Pre-post Study||0
51752|NCT01868334|123868|P1|NOT COMPLETED|Year 2 Pre-post Study||0
51753|NCT01868334|123865|P4|COMPLETED|Year 2 Pre-post Study||19274
51754|NCT01868334|123866|P3|COMPLETED|Year 2 Pre-post Study||20904
51755|NCT01868334|123867|P2|COMPLETED|Year 2 Pre-post Study||8047
51756|NCT01868334|123868|P1|COMPLETED|Year 2 Pre-post Study||22324
51757|NCT01868334|123865|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
51758|NCT01868334|123866|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
51759|NCT01868334|123867|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
51760|NCT01868334|123868|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
51761|NCT01868334|123865|P4|NOT COMPLETED|Year 1 RCCT Study||0
51762|NCT01868334|123866|P3|NOT COMPLETED|Year 1 RCCT Study||0
51763|NCT01868334|123867|P2|NOT COMPLETED|Year 1 RCCT Study||0
51764|NCT01868334|123868|P1|NOT COMPLETED|Year 1 RCCT Study||0
51765|NCT01868334|123865|P4|COMPLETED|Year 1 RCCT Study||20904
51766|NCT01868334|123866|P3|COMPLETED|Year 1 RCCT Study||19274
51767|NCT01868334|123867|P2|COMPLETED|Year 1 RCCT Study||17185
51768|NCT01868334|123868|P1|COMPLETED|Year 1 RCCT Study||13186
51769|NCT01868334|123865|P4|STARTED|Year 1 RCCT Study||20904
51770|NCT01868334|123866|P3|STARTED|Year 1 RCCT Study||19274
51771|NCT01868334|123867|P2|STARTED|Year 1 RCCT Study||17185
51772|NCT01868334|123868|P1|STARTED|Year 1 RCCT Study||13186
51773|NCT01868243|123908|P2|NOT COMPLETED|Overall Study||1
51774|NCT01868243|123909|P1|NOT COMPLETED|Overall Study||0
51775|NCT01868243|123908|P2|COMPLETED|Overall Study||11
51776|NCT01868243|123909|P1|COMPLETED|Overall Study||15
51777|NCT01868243|123908|P2|STARTED|Overall Study||12
51778|NCT01868243|123909|P1|STARTED|Overall Study||15
51779|NCT01868074|123919|P2|NOT COMPLETED|Overall Study||4
51780|NCT01868074|123920|P1|NOT COMPLETED|Overall Study||7
51781|NCT01868074|123919|P2|COMPLETED|Overall Study||32
51782|NCT01868074|123920|P1|COMPLETED|Overall Study||29
51783|NCT01868074|123919|P2|STARTED|Overall Study||36
51784|NCT01868074|123920|P1|STARTED|Overall Study||36
51785|NCT01868035|123930|P1|NOT COMPLETED|Overall Study||7
51786|NCT01868035|123930|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
51787|NCT01868035|123930|P1|STARTED|Overall Study||15
51788|NCT01868009|123946|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
51789|NCT01868009|123947|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
51790|NCT01868009|123946|P2|COMPLETED|Period 2 (5-9 Days)||142
51791|NCT01868009|123947|P1|COMPLETED|Period 2 (5-9 Days)||141
51792|NCT01868009|123946|P2|STARTED|Period 2 (5-9 Days)||142
51793|NCT01868009|123947|P1|STARTED|Period 2 (5-9 Days)||143
51794|NCT01868009|123946|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
51795|NCT01868009|123947|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
51796|NCT01868009|123946|P2|COMPLETED|Period 1 (5-9 Days)||142
51797|NCT01868009|123947|P1|COMPLETED|Period 1 (5-9 Days)||143
51798|NCT01868009|123946|P2|STARTED|Period 1 (5-9 Days)||144
51799|NCT01868009|123947|P1|STARTED|Period 1 (5-9 Days)||143
51800|NCT01867710|123961|P4|NOT COMPLETED|Overall Study||7
51801|NCT01867710|123962|P3|NOT COMPLETED|Overall Study||9
51802|NCT01867710|123963|P2|NOT COMPLETED|Overall Study||7
51803|NCT01867710|123964|P1|NOT COMPLETED|Overall Study||8
51804|NCT01867710|123961|P4|COMPLETED|Overall Study||35
51805|NCT01867710|123962|P3|COMPLETED|Overall Study||31
51806|NCT01867710|123963|P2|COMPLETED|Overall Study||34
51807|NCT01867710|123964|P1|COMPLETED|Overall Study||33
51808|NCT01867710|123961|P4|Treated|Overall Study||42
51809|NCT01867710|123962|P3|Treated|Overall Study||39
51810|NCT01867710|123963|P2|Treated|Overall Study||41
51811|NCT01867710|123964|P1|Treated|Overall Study||41
51812|NCT01867710|123961|P4|STARTED|Overall Study||42
51813|NCT01867710|123962|P3|STARTED|Overall Study||40
51814|NCT01867710|123963|P2|STARTED|Overall Study||41
51815|NCT01867710|123964|P1|STARTED|Overall Study||41
51816|NCT01867658|123978|P1|NOT COMPLETED|Overall Study||9
51817|NCT01867658|123978|P1|COMPLETED|Overall Study||103
51818|NCT01867658|123978|P1|STARTED|Overall Study||112
51819|NCT01867632|123991|P2|NOT COMPLETED|Overall Study||0
51820|NCT01867632|123992|P1|NOT COMPLETED|Overall Study||0
51821|NCT01867632|123991|P2|COMPLETED|Overall Study||66
51822|NCT01867632|123992|P1|COMPLETED|Overall Study||65
51823|NCT01867632|123991|P2|STARTED|Overall Study||66
51824|NCT01867632|123992|P1|STARTED|Overall Study||65
51825|NCT01867580|124002|P2|NOT COMPLETED|Overall Study||24
51826|NCT01867580|124003|P1|NOT COMPLETED|Overall Study||28
51827|NCT01867580|124002|P2|COMPLETED|Overall Study||64
51828|NCT01867580|124003|P1|COMPLETED|Overall Study||65
51829|NCT01867580|124002|P2|STARTED|Overall Study||88
51830|NCT01867580|124003|P1|STARTED|Overall Study||93
51831|NCT01867515|124016|P3|NOT COMPLETED|Overall Study||11
51832|NCT01867515|124017|P2|NOT COMPLETED|Overall Study||1
51833|NCT01867515|124018|P1|NOT COMPLETED|Overall Study||0
51834|NCT01867515|124016|P3|COMPLETED|Overall Study||14
51835|NCT01867515|124017|P2|COMPLETED|Overall Study||11
51836|NCT01867515|124018|P1|COMPLETED|Overall Study||13
51837|NCT01867515|124016|P3|STARTED|Overall Study||25
51838|NCT01867515|124017|P2|STARTED|Overall Study||12
51839|NCT01867515|124018|P1|STARTED|Overall Study||13
51840|NCT01867424|124028|P2|NOT COMPLETED|Overall Study||1
51841|NCT01867424|124029|P1|NOT COMPLETED|Overall Study||2
51842|NCT01867424|124028|P2|COMPLETED|Overall Study||11
51843|NCT01867424|124029|P1|COMPLETED|Overall Study||10
51844|NCT01867424|124028|P2|STARTED|Overall Study||12
51845|NCT01867424|124029|P1|STARTED|Overall Study||12
51846|NCT01867307|124043|P2|NOT COMPLETED|Overall Study||3
51847|NCT01867307|124044|P1|NOT COMPLETED|Overall Study||3
51848|NCT01867307|124043|P2|COMPLETED|Overall Study||16
51849|NCT01867307|124044|P1|COMPLETED|Overall Study||15
51850|NCT01867307|124043|P2|STARTED|Overall Study|Started are the treated patients|19
51851|NCT01867307|124044|P1|STARTED|Overall Study|Started are the treated patients|18
51852|NCT01867164|124052|P2|NOT COMPLETED|Overall Study||0
51853|NCT01867164|124053|P1|NOT COMPLETED|Overall Study||0
51854|NCT01867164|124052|P2|COMPLETED|Overall Study||79
51855|NCT01867164|124053|P1|COMPLETED|Overall Study||81
51856|NCT01867164|124052|P2|STARTED|Overall Study||79
51857|NCT01867164|124053|P1|STARTED|Overall Study||81
51858|NCT01867086|124067|P1|NOT COMPLETED|Overall Study||0
51859|NCT01867086|124067|P1|COMPLETED|Overall Study||1
51860|NCT01867086|124067|P1|STARTED|Overall Study||1
51861|NCT01867047|124076|P2|NOT COMPLETED|Overall Study||5
51862|NCT01867047|124077|P1|NOT COMPLETED|Overall Study||8
51863|NCT01867047|124076|P2|COMPLETED|Overall Study||23
51864|NCT01867047|124077|P1|COMPLETED|Overall Study||23
51865|NCT01867047|124076|P2|STARTED|Overall Study||28
51866|NCT01867047|124077|P1|STARTED|Overall Study||31
51867|NCT01867021|124097|P2|NOT COMPLETED|Overall Study||10
51868|NCT01867021|124098|P1|NOT COMPLETED|Overall Study||2
51869|NCT01867021|124097|P2|COMPLETED|Overall Study||1440
51870|NCT01867021|124098|P1|COMPLETED|Overall Study||1450
51871|NCT01867021|124097|P2|STARTED|Overall Study||1450
51872|NCT01867021|124098|P1|STARTED|Overall Study||1452
51873|NCT01866943|124117|P2|NOT COMPLETED|Overall Study||22
51874|NCT01866943|124118|P1|NOT COMPLETED|Overall Study||19
51875|NCT01866943|124117|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
51876|NCT01866943|124118|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
51877|NCT01866943|124117|P2|STARTED|Overall Study||22
51878|NCT01866943|124118|P1|STARTED|Overall Study||19
51879|NCT01866709|124129|P2|NOT COMPLETED|Overall Study||0
51880|NCT01866709|124130|P1|NOT COMPLETED|Overall Study||1
51881|NCT01866709|124129|P2|COMPLETED|Overall Study||17
51882|NCT01866709|124130|P1|COMPLETED|Overall Study||14
51883|NCT01866709|124129|P2|STARTED|Overall Study||17
51884|NCT01866709|124130|P1|STARTED|Overall Study||15
51885|NCT01866592|124138|P1|NOT COMPLETED|Overall Study||23
51886|NCT01866592|124138|P1|COMPLETED|Overall Study||58
51887|NCT01866592|124138|P1|STARTED|Overall Study||81
51888|NCT01866423|124171|P1|NOT COMPLETED|Overall Study||4
51889|NCT01866423|124171|P1|COMPLETED|Overall Study||0
51890|NCT01866423|124171|P1|STARTED|Overall Study||4
51891|NCT01866319|124184|P3|NOT COMPLETED|Overall Study||277
51892|NCT01866319|124185|P2|NOT COMPLETED|Overall Study||279
51893|NCT01866319|124186|P1|NOT COMPLETED|Overall Study||277
51894|NCT01866319|124184|P3|COMPLETED|Overall Study||0
51895|NCT01866319|124185|P2|COMPLETED|Overall Study||0
51896|NCT01866319|124186|P1|COMPLETED|Overall Study||1
51897|NCT01866319|124184|P3|Treated|Overall Study||277
51898|NCT01866319|124185|P2|Treated|Overall Study||278
51899|NCT01866319|124186|P1|Treated|Overall Study||256
51900|NCT01866319|124184|P3|STARTED|Overall Study||277
51901|NCT01866319|124185|P2|STARTED|Overall Study||279
51902|NCT01866319|124186|P1|STARTED|Overall Study||278
51903|NCT01866306|124207|P7|NOT COMPLETED|Overall Study||0
51904|NCT01866306|124208|P6|NOT COMPLETED|Overall Study||0
51905|NCT01866306|124209|P5|NOT COMPLETED|Overall Study||0
51906|NCT01866306|124210|P4|NOT COMPLETED|Overall Study||0
51907|NCT01866306|124211|P3|NOT COMPLETED|Overall Study||0
51908|NCT01866306|124212|P2|NOT COMPLETED|Overall Study||0
51909|NCT01866306|124213|P1|NOT COMPLETED|Overall Study||0
51910|NCT01866306|124207|P7|COMPLETED|Overall Study||23
51911|NCT01866306|124208|P6|COMPLETED|Overall Study||6
51912|NCT01866306|124209|P5|COMPLETED|Overall Study||6
51913|NCT01866306|124210|P4|COMPLETED|Overall Study||6
51914|NCT01866306|124211|P3|COMPLETED|Overall Study||6
51915|NCT01866306|124212|P2|COMPLETED|Overall Study||6
51916|NCT01866306|124213|P1|COMPLETED|Overall Study||6
51917|NCT01866306|124207|P7|STARTED|Overall Study||23
51918|NCT01866306|124208|P6|STARTED|Overall Study||6
51919|NCT01866306|124209|P5|STARTED|Overall Study||6
51920|NCT01866306|124210|P4|STARTED|Overall Study||6
51921|NCT01866306|124211|P3|STARTED|Overall Study||6
51922|NCT01866306|124212|P2|STARTED|Overall Study||6
51923|NCT01866306|124213|P1|STARTED|Overall Study||6
51924|NCT01866293|124285|P1|NOT COMPLETED|Overall Study||2
51925|NCT01866293|124285|P1|COMPLETED|Overall Study||9
51926|NCT01866293|124285|P1|STARTED|Overall Study||11
51927|NCT01866163|124295|P2|NOT COMPLETED|Overall Study||4
51928|NCT01866163|124296|P1|NOT COMPLETED|Overall Study||10
51929|NCT01866163|124295|P2|COMPLETED|Overall Study||99
51930|NCT01866163|124296|P1|COMPLETED|Overall Study||313
51931|NCT01866163|124295|P2|STARTED|Overall Study||103
51932|NCT01866163|124296|P1|STARTED|Overall Study||323
51933|NCT01866150|124306|P1|NOT COMPLETED|Overall Study||0
51934|NCT01866150|124306|P1|COMPLETED|Overall Study||450
51935|NCT01866150|124306|P1|STARTED|Overall Study||450
51936|NCT01865812|124327|P1|NOT COMPLETED|Overall Study||2
51937|NCT01865812|124327|P1|COMPLETED|Overall Study||24
51938|NCT01865812|124327|P1|STARTED|Overall Study||26
51939|NCT01865747|124335|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
51940|NCT01865747|124336|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
51941|NCT01865747|124335|P2|COMPLETED|Primary Intent to Treat (PITT)||36
51942|NCT01865747|124336|P1|COMPLETED|Primary Intent to Treat (PITT)||56
51943|NCT01865747|124335|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
51944|NCT01865747|124336|P1|STARTED|Primary Intent to Treat (PITT)||187
51945|NCT01865747|124335|P2|NOT COMPLETED|Overall Study (ITT)||255
51946|NCT01865747|124336|P1|NOT COMPLETED|Overall Study (ITT)||198
51947|NCT01865747|124335|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
51948|NCT01865747|124336|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
51949|NCT01865747|124335|P2|STARTED|Overall Study (ITT)||328
51950|NCT01865747|124336|P1|STARTED|Overall Study (ITT)||330
51951|NCT01865708|124346|P1|NOT COMPLETED|Overall Study||0
51952|NCT01865708|124346|P1|COMPLETED|Overall Study||10
51953|NCT01865708|124346|P1|STARTED|Overall Study||10
51954|NCT01865084|124354|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
51955|NCT01865084|124355|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
51956|NCT01865084|124356|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
51957|NCT01865084|124354|P3|COMPLETED|Open Label Extension (OLE) Period||158
51958|NCT01865084|124355|P2|COMPLETED|Open Label Extension (OLE) Period||139
51959|NCT01865084|124356|P1|COMPLETED|Open Label Extension (OLE) Period||0
51960|NCT01865084|124354|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
51961|NCT01865084|124355|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
51962|NCT01865084|124356|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
51963|NCT01865084|124354|P3|NOT COMPLETED|Double Blind Period (DB)||6
51964|NCT01865084|124355|P2|NOT COMPLETED|Double Blind Period (DB)||4
51965|NCT01865084|124356|P1|NOT COMPLETED|Double Blind Period (DB)||5
51966|NCT01865084|124354|P3|COMPLETED|Double Blind Period (DB)||107
51967|NCT01865084|124355|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
51968|NCT01865084|124356|P1|COMPLETED|Double Blind Period (DB)||111
51969|NCT01865084|124354|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
51970|NCT01865084|124355|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
51971|NCT01865084|124356|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
51972|NCT01865084|124354|P3|STARTED|Double Blind Period (DB)||113
51973|NCT01865084|124355|P2|STARTED|Double Blind Period (DB)||102
51974|NCT01865084|124356|P1|STARTED|Double Blind Period (DB)||116
51975|NCT01864538|124382|P1|NOT COMPLETED|Overall Study||11
51976|NCT01864538|124382|P1|COMPLETED|Overall Study||0
51977|NCT01864538|124382|P1|STARTED|Overall Study||11
51978|NCT01864434|124388|P2|NOT COMPLETED|Overall Study||0
51979|NCT01864434|124389|P1|NOT COMPLETED|Overall Study||0
51980|NCT01864434|124388|P2|COMPLETED|Overall Study||25
51981|NCT01864434|124389|P1|COMPLETED|Overall Study||25
51982|NCT01864434|124388|P2|STARTED|Overall Study||25
51983|NCT01864434|124389|P1|STARTED|Overall Study||25
51984|NCT01864200|124401|P2|NOT COMPLETED|Overall Study||3
51985|NCT01864200|124402|P1|NOT COMPLETED|Overall Study||2
51986|NCT01864200|124401|P2|COMPLETED|Overall Study||26
51987|NCT01864200|124402|P1|COMPLETED|Overall Study||43
51988|NCT01864200|124401|P2|STARTED|Overall Study||29
51989|NCT01864200|124402|P1|STARTED|Overall Study||45
51990|NCT01864174|124410|P2|NOT COMPLETED|Off Treatment Follow-Up||0
51991|NCT01864174|124411|P1|NOT COMPLETED|Off Treatment Follow-Up||3
51992|NCT01864174|124410|P2|COMPLETED|Off Treatment Follow-Up||1
51993|NCT01864174|124411|P1|COMPLETED|Off Treatment Follow-Up||6
51994|NCT01864174|124410|P2|STARTED|Off Treatment Follow-Up||1
51995|NCT01864174|124411|P1|STARTED|Off Treatment Follow-Up||9
51996|NCT01864174|124410|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
51997|NCT01864174|124411|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
51998|NCT01864174|124410|P2|COMPLETED|Double Blind - Compliant Randomized||245
51999|NCT01864174|124411|P1|COMPLETED|Double Blind - Compliant Randomized||245
52000|NCT01864174|124410|P2|STARTED|Double Blind - Compliant Randomized||271
52001|NCT01864174|124411|P1|STARTED|Double Blind - Compliant Randomized||268
52002|NCT01864174|124410|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
52003|NCT01864174|124411|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
52004|NCT01864174|124410|P2|COMPLETED|Double Blind Treatment - All Treated||271
52005|NCT01864174|124411|P1|COMPLETED|Double Blind Treatment - All Treated||268
52006|NCT01864174|124410|P2|STARTED|Double Blind Treatment - All Treated||285
52007|NCT01864174|124411|P1|STARTED|Double Blind Treatment - All Treated||283
52008|NCT01864148|124430|P5|NOT COMPLETED|Overall Study||23
52009|NCT01864148|124431|P4|NOT COMPLETED|Overall Study||26
52010|NCT01864148|124432|P3|NOT COMPLETED|Overall Study||11
52011|NCT01864148|124433|P2|NOT COMPLETED|Overall Study||5
52012|NCT01864148|124434|P1|NOT COMPLETED|Overall Study||20
52013|NCT01864148|124430|P5|COMPLETED|Overall Study||69
52014|NCT01864148|124431|P4|COMPLETED|Overall Study||68
52015|NCT01864148|124432|P3|COMPLETED|Overall Study||84
52016|NCT01864148|124433|P2|COMPLETED|Overall Study||40
52017|NCT01864148|124434|P1|COMPLETED|Overall Study||73
52018|NCT01864148|124430|P5|Randomized and Dosed|Overall Study||92
52019|NCT01864148|124431|P4|Randomized and Dosed|Overall Study||93
52020|NCT01864148|124432|P3|Randomized and Dosed|Overall Study||95
52021|NCT01864148|124433|P2|Randomized and Dosed|Overall Study||45
52022|NCT01864148|124434|P1|Randomized and Dosed|Overall Study||93
52023|NCT01864148|124430|P5|STARTED|Overall Study||92
52024|NCT01864148|124431|P4|STARTED|Overall Study||94
52025|NCT01864148|124432|P3|STARTED|Overall Study||95
52026|NCT01864148|124433|P2|STARTED|Overall Study||45
52027|NCT01864148|124434|P1|STARTED|Overall Study||93
52028|NCT01864005|124463|P2|NOT COMPLETED|Overall Study||6
52029|NCT01864005|124464|P1|NOT COMPLETED|Overall Study||3
52030|NCT01864005|124463|P2|COMPLETED|Overall Study||25
52031|NCT01864005|124464|P1|COMPLETED|Overall Study||26
52032|NCT01864005|124463|P2|STARTED|Overall Study||31
52033|NCT01864005|124464|P1|STARTED|Overall Study||29
52034|NCT01863953|124481|P3|NOT COMPLETED|Overall Study||1
52035|NCT01863953|124482|P2|NOT COMPLETED|Overall Study||0
52036|NCT01863953|124483|P1|NOT COMPLETED|Overall Study||0
52037|NCT01863953|124481|P3|COMPLETED|Overall Study||37
52038|NCT01863953|124482|P2|COMPLETED|Overall Study||36
52039|NCT01863953|124483|P1|COMPLETED|Overall Study||38
52040|NCT01863953|124481|P3|STARTED|Overall Study||38
52041|NCT01863953|124482|P2|STARTED|Overall Study||36
52042|NCT01863953|124483|P1|STARTED|Overall Study||38
52043|NCT01863771|124497|P4|NOT COMPLETED|Maintenance Phase||43
52044|NCT01863771|124498|P3|NOT COMPLETED|Maintenance Phase||12
52045|NCT01863771|124499|P2|NOT COMPLETED|Maintenance Phase||5
52046|NCT01863771|124500|P1|NOT COMPLETED|Maintenance Phase||0
52047|NCT01863771|124497|P4|COMPLETED|Maintenance Phase||17
52048|NCT01863771|124498|P3|COMPLETED|Maintenance Phase||19
52049|NCT01863771|124499|P2|COMPLETED|Maintenance Phase||27
52050|NCT01863771|124500|P1|COMPLETED|Maintenance Phase||0
52051|NCT01863771|124497|P4|STARTED|Maintenance Phase||60
52052|NCT01863771|124498|P3|STARTED|Maintenance Phase||31
52053|NCT01863771|124499|P2|STARTED|Maintenance Phase||32
52054|NCT01863771|124500|P1|STARTED|Maintenance Phase||0
52055|NCT01863771|124497|P4|NOT COMPLETED|Induction Phase||0
52056|NCT01863771|124498|P3|NOT COMPLETED|Induction Phase||0
52057|NCT01863771|124499|P2|NOT COMPLETED|Induction Phase||0
52058|NCT01863771|124500|P1|NOT COMPLETED|Induction Phase||21
52059|NCT01863771|124497|P4|COMPLETED|Induction Phase||0
52060|NCT01863771|124498|P3|COMPLETED|Induction Phase||0
52061|NCT01863771|124499|P2|COMPLETED|Induction Phase||0
52062|NCT01863771|124500|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
52063|NCT01863771|124497|P4|STARTED|Induction Phase||0
52064|NCT01863771|124498|P3|STARTED|Induction Phase||0
52065|NCT01863771|124499|P2|STARTED|Induction Phase||0
52066|NCT01863771|124500|P1|STARTED|Induction Phase||144
52067|NCT01863758|124512|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
52068|NCT01863758|124512|P1|COMPLETED|Prophylactic Treatment-Phase II||64
52069|NCT01863758|124512|P1|STARTED|Prophylactic Treatment-Phase II||66
52070|NCT01863758|124512|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
52071|NCT01863758|124512|P1|COMPLETED|Prophylactic Treatment-Phase I||66
52072|NCT01863758|124512|P1|STARTED|Prophylactic Treatment-Phase I||66
52073|NCT01863758|124512|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
52074|NCT01863758|124512|P1|COMPLETED|Pharmacokinetic Assessment||66
52075|NCT01863758|124512|P1|STARTED|Pharmacokinetic Assessment||66
52076|NCT01863680|124520|P1|NOT COMPLETED|Overall Study||57
52077|NCT01863680|124520|P1|COMPLETED|Overall Study||121
52078|NCT01863680|124520|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
52079|NCT01863680|124520|P1|Subjects Received Study Drug|Overall Study||149
52080|NCT01863680|124520|P1|Subjects Received hCG Injection|Overall Study||162
52081|NCT01863680|124520|P1|Subjects Started COS Treatment|Overall Study||169
52082|NCT01863680|124520|P1|STARTED|Overall Study||178
52083|NCT01863667|124528|P2|NOT COMPLETED|Overall Study||32
52084|NCT01863667|124529|P1|NOT COMPLETED|Overall Study||33
52085|NCT01863667|124528|P2|COMPLETED|Overall Study||0
52086|NCT01863667|124529|P1|COMPLETED|Overall Study||0
52087|NCT01863667|124528|P2|STARTED|Overall Study||32
52088|NCT01863667|124529|P1|STARTED|Overall Study||33
52089|NCT01863563|124549|P1|NOT COMPLETED|Overall Study||0
52090|NCT01863563|124549|P1|COMPLETED|Overall Study||100
52091|NCT01863563|124549|P1|STARTED|Overall Study||100
52092|NCT01863433|124553|P1|NOT COMPLETED|Overall Study||1
52093|NCT01863433|124553|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
52094|NCT01863433|124553|P1|STARTED|Overall Study||120
52095|NCT01863368|124563|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
52096|NCT01863368|124564|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
52097|NCT01863368|124563|P2|COMPLETED|Phase II, Day 35 to Day 90||41
52098|NCT01863368|124564|P1|COMPLETED|Phase II, Day 35 to Day 90||41
52099|NCT01863368|124563|P2|STARTED|Phase II, Day 35 to Day 90||41
52100|NCT01863368|124564|P1|STARTED|Phase II, Day 35 to Day 90||43
52101|NCT01863368|124563|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
52102|NCT01863368|124564|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
52103|NCT01863368|124563|P2|COMPLETED|Phase I, Day 0 to Day 35||41
52104|NCT01863368|124564|P1|COMPLETED|Phase I, Day 0 to Day 35||43
52105|NCT01863368|124563|P2|Treated|Phase I, Day 0 to Day 35||47
52106|NCT01863368|124564|P1|Treated|Phase I, Day 0 to Day 35||46
52107|NCT01863368|124563|P2|STARTED|Phase I, Day 0 to Day 35||48
52108|NCT01863368|124564|P1|STARTED|Phase I, Day 0 to Day 35||46
52109|NCT01863134|124579|P2|NOT COMPLETED|Overall Study||0
52110|NCT01863134|124580|P1|NOT COMPLETED|Overall Study||0
52111|NCT01863134|124579|P2|COMPLETED|Overall Study||68
52112|NCT01863134|124580|P1|COMPLETED|Overall Study||72
52113|NCT01863134|124579|P2|STARTED|Overall Study||68
52114|NCT01863134|124580|P1|STARTED|Overall Study||72
52115|NCT01862991|124589|P3|NOT COMPLETED|Overall Study||1
52116|NCT01862991|124590|P2|NOT COMPLETED|Overall Study||1
52117|NCT01862991|124591|P1|NOT COMPLETED|Overall Study||3
52118|NCT01862991|124589|P3|COMPLETED|Overall Study||27
52119|NCT01862991|124590|P2|COMPLETED|Overall Study||27
52120|NCT01862991|124591|P1|COMPLETED|Overall Study||21
52121|NCT01862991|124589|P3|STARTED|Overall Study||28
52122|NCT01862991|124590|P2|STARTED|Overall Study||28
52123|NCT01862991|124591|P1|STARTED|Overall Study||24
52124|NCT01862484|124604|P2|NOT COMPLETED|Overall Study||8
52125|NCT01862484|124605|P1|NOT COMPLETED|Overall Study||2
52126|NCT01862484|124604|P2|COMPLETED|Overall Study||6
52127|NCT01862484|124605|P1|COMPLETED|Overall Study||13
52128|NCT01862484|124604|P2|STARTED|Overall Study||14
52129|NCT01862484|124605|P1|STARTED|Overall Study||15
52130|NCT01862419|124613|P2|NOT COMPLETED|Overall Study||0
52131|NCT01862419|124614|P1|NOT COMPLETED|Overall Study||0
52132|NCT01862419|124613|P2|COMPLETED|Overall Study||1192
52133|NCT01862419|124614|P1|COMPLETED|Overall Study||1201
52134|NCT01862419|124613|P2|STARTED|Overall Study||1192
52135|NCT01862419|124614|P1|STARTED|Overall Study||1201
52136|NCT01862250|124624|P1|NOT COMPLETED|Overall Study||4
52137|NCT01862250|124624|P1|COMPLETED|Overall Study||8
52138|NCT01862250|124624|P1|STARTED|Overall Study||12
52139|NCT01862159|124631|P1|NOT COMPLETED|Overall Study||0
52140|NCT01862159|124631|P1|COMPLETED|Overall Study||25038
52141|NCT01862159|124631|P1|STARTED|Overall Study||25038
52142|NCT01862133|124638|P2|NOT COMPLETED|Overall Study||0
52143|NCT01862133|124639|P1|NOT COMPLETED|Overall Study||0
52144|NCT01862133|124638|P2|COMPLETED|Overall Study||31
52145|NCT01862133|124639|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
52146|NCT01862133|124638|P2|Returned During 6 mo Study|Overall Study||31
52147|NCT01862133|124639|P1|Returned During 6 mo Study|Overall Study||92
52148|NCT01862133|124638|P2|STARTED|Overall Study||31
52149|NCT01862133|124639|P1|STARTED|Overall Study||105
52150|NCT01861925|124648|P3|NOT COMPLETED|Overall Study||0
52151|NCT01861925|124649|P2|NOT COMPLETED|Overall Study||0
52152|NCT01861925|124650|P1|NOT COMPLETED|Overall Study||0
52153|NCT01861925|124648|P3|COMPLETED|Overall Study||8
52154|NCT01861925|124649|P2|COMPLETED|Overall Study||8
52155|NCT01861925|124650|P1|COMPLETED|Overall Study||34
52156|NCT01861925|124648|P3|STARTED|Overall Study||8
52157|NCT01861925|124649|P2|STARTED|Overall Study||8
52158|NCT01861925|124650|P1|STARTED|Overall Study||34
52159|NCT01861756|124673|P2|NOT COMPLETED|Overall Study||18
52160|NCT01861756|124674|P1|NOT COMPLETED|Overall Study||13
52161|NCT01861756|124673|P2|COMPLETED|Overall Study||85
52162|NCT01861756|124674|P1|COMPLETED|Overall Study||88
52163|NCT01861756|124673|P2|STARTED|Overall Study||103
52164|NCT01861756|124674|P1|STARTED|Overall Study||101
52165|NCT01861704|124682|P2|NOT COMPLETED|Overall Study||3
52166|NCT01861704|124683|P1|NOT COMPLETED|Overall Study||3
52167|NCT01861704|124682|P2|COMPLETED|Overall Study||104
52168|NCT01861704|124683|P1|COMPLETED|Overall Study||67
52169|NCT01861704|124682|P2|STARTED|Overall Study||107
52170|NCT01861704|124683|P1|STARTED|Overall Study||70
52171|NCT01861665|124691|P2|NOT COMPLETED|Overall Study||0
52172|NCT01861665|124692|P1|NOT COMPLETED|Overall Study||0
52173|NCT01861665|124691|P2|COMPLETED|Overall Study||17
52174|NCT01861665|124692|P1|COMPLETED|Overall Study||10
52175|NCT01861665|124691|P2|STARTED|Overall Study||17
52176|NCT01861665|124692|P1|STARTED|Overall Study||10
52177|NCT01861522|124700|P2|NOT COMPLETED|Overall Study||0
52178|NCT01861522|124701|P1|NOT COMPLETED|Overall Study||3
52179|NCT01861522|124700|P2|COMPLETED|Overall Study||232
52180|NCT01861522|124701|P1|COMPLETED|Overall Study||237
52181|NCT01861522|124700|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
52182|NCT01861522|124701|P1|STARTED|Overall Study||240
52183|NCT01861457|124709|P2|NOT COMPLETED|Overall Study||0
52184|NCT01861457|124710|P1|NOT COMPLETED|Overall Study||0
52185|NCT01861457|124709|P2|COMPLETED|Overall Study||19
52186|NCT01861457|124710|P1|COMPLETED|Overall Study||20
52187|NCT01861457|124709|P2|STARTED|Overall Study||19
52188|NCT01861457|124710|P1|STARTED|Overall Study||20
52189|NCT01861301|124718|P1|NOT COMPLETED|Overall Study||0
52190|NCT01861301|124718|P1|COMPLETED|Overall Study||18
52191|NCT01861301|124718|P1|STARTED|Overall Study||18
52192|NCT01860989|124725|P1|NOT COMPLETED|Overall Study||5
52193|NCT01860989|124725|P1|COMPLETED|Overall Study||6
52194|NCT01860989|124725|P1|STARTED|Overall Study||11
52195|NCT01860976|124731|P2|NOT COMPLETED|Long Term Extension||107
52196|NCT01860976|124732|P1|NOT COMPLETED|Long Term Extension||113
52197|NCT01860976|124731|P2|COMPLETED|Long Term Extension||8
52198|NCT01860976|124732|P1|COMPLETED|Long Term Extension||0
52199|NCT01860976|124731|P2|STARTED|Long Term Extension||115
52200|NCT01860976|124732|P1|STARTED|Long Term Extension||113
52201|NCT01860976|124731|P2|NOT COMPLETED|Open-Label||64
52202|NCT01860976|124732|P1|NOT COMPLETED|Open-Label||74
52203|NCT01860976|124731|P2|COMPLETED|Open-Label||121
52204|NCT01860976|124732|P1|COMPLETED|Open-Label||123
52205|NCT01860976|124731|P2|STARTED|Open-Label||185
52206|NCT01860976|124732|P1|STARTED|Open-Label||197
52207|NCT01860976|124731|P2|NOT COMPLETED|Blinded Treatment||113
52208|NCT01860976|124732|P1|NOT COMPLETED|Blinded Treatment||88
52209|NCT01860976|124731|P2|COMPLETED|Blinded Treatment||98
52210|NCT01860976|124732|P1|COMPLETED|Blinded Treatment||125
52211|NCT01860976|124731|P2|STARTED|Blinded Treatment||211
52212|NCT01860976|124732|P1|STARTED|Blinded Treatment||213
52213|NCT01860846|124754|P1|NOT COMPLETED|Overall Study||33
52214|NCT01860846|124754|P1|COMPLETED|Overall Study||73
52215|NCT01860846|124754|P1|Month 12|Overall Study||73
52216|NCT01860846|124754|P1|Month 6|Overall Study||85
52217|NCT01860846|124754|P1|Month 4|Overall Study||82
52218|NCT01860846|124754|P1|Month 2|Overall Study||83
52219|NCT01860846|124754|P1|Month 1|Overall Study||97
52220|NCT01860846|124754|P1|STARTED|Overall Study||106
52221|NCT01860703|124765|P4|NOT COMPLETED|Overall Study||2
52222|NCT01860703|124766|P3|NOT COMPLETED|Overall Study||1
52223|NCT01860703|124767|P2|NOT COMPLETED|Overall Study||5
52224|NCT01860703|124768|P1|NOT COMPLETED|Overall Study||2
52225|NCT01860703|124765|P4|COMPLETED|Overall Study||10
52226|NCT01860703|124766|P3|COMPLETED|Overall Study||11
52227|NCT01860703|124767|P2|COMPLETED|Overall Study||8
52228|NCT01860703|124768|P1|COMPLETED|Overall Study||11
52229|NCT01860703|124765|P4|STARTED|Overall Study||12
52230|NCT01860703|124766|P3|STARTED|Overall Study||12
52231|NCT01860703|124767|P2|STARTED|Overall Study||13
52232|NCT01860703|124768|P1|STARTED|Overall Study||13
52233|NCT01860677|124800|P2|NOT COMPLETED|Second Intervention (1 Day)||0
52234|NCT01860677|124801|P1|NOT COMPLETED|Second Intervention (1 Day)||7
52235|NCT01860677|124800|P2|COMPLETED|Second Intervention (1 Day)||0
52236|NCT01860677|124801|P1|COMPLETED|Second Intervention (1 Day)||1
52237|NCT01860677|124800|P2|STARTED|Second Intervention (1 Day)||0
52238|NCT01860677|124801|P1|STARTED|Second Intervention (1 Day)||8
52239|NCT01860677|124800|P2|NOT COMPLETED|First Intervention (1 Day)||0
52240|NCT01860677|124801|P1|NOT COMPLETED|First Intervention (1 Day)||0
52241|NCT01860677|124800|P2|COMPLETED|First Intervention (1 Day)||0
52242|NCT01860677|124801|P1|COMPLETED|First Intervention (1 Day)||8
52243|NCT01860677|124800|P2|STARTED|First Intervention (1 Day)||0
52244|NCT01860677|124801|P1|STARTED|First Intervention (1 Day)||8
52245|NCT01860586|124810|P1|NOT COMPLETED|Overall Study||0
52246|NCT01860586|124810|P1|COMPLETED|Overall Study||20
52247|NCT01860586|124810|P1|STARTED|Overall Study||20
52248|NCT01860573|124818|P2|NOT COMPLETED|Overall Study||0
52249|NCT01860573|124819|P1|NOT COMPLETED|Overall Study||0
52250|NCT01860573|124818|P2|COMPLETED|Overall Study||85
52251|NCT01860573|124819|P1|COMPLETED|Overall Study||83
52252|NCT01860573|124818|P2|STARTED|Overall Study||85
52253|NCT01860573|124819|P1|STARTED|Overall Study||83
52254|NCT01860534|124839|P2|NOT COMPLETED|ROP #2||0
52255|NCT01860534|124840|P1|NOT COMPLETED|ROP #2||1
52256|NCT01860534|124839|P2|COMPLETED|ROP #2||13
52257|NCT01860534|124840|P1|COMPLETED|ROP #2||13
52258|NCT01860534|124839|P2|STARTED|ROP #2||13
52259|NCT01860534|124840|P1|STARTED|ROP #2||14
52260|NCT01860534|124839|P2|NOT COMPLETED|ROP #1||1
52261|NCT01860534|124840|P1|NOT COMPLETED|ROP #1||0
52262|NCT01860534|124839|P2|COMPLETED|ROP #1||13
52263|NCT01860534|124840|P1|COMPLETED|ROP #1||14
52264|NCT01860534|124839|P2|STARTED|ROP #1||14
52265|NCT01860534|124840|P1|STARTED|ROP #1||14
52266|NCT01860521|124854|P2|NOT COMPLETED|Overall Study||0
52267|NCT01860521|124855|P1|NOT COMPLETED|Overall Study||0
52268|NCT01860521|124854|P2|COMPLETED|Overall Study|June 2013|52
52269|NCT01860521|124855|P1|COMPLETED|Overall Study|June 2013|52
52270|NCT01860521|124854|P2|STARTED|Overall Study|September 2011|52
52271|NCT01860521|124855|P1|STARTED|Overall Study|September 2011|52
52272|NCT01860170|124870|P3|NOT COMPLETED|Overall Study||0
52273|NCT01860170|124871|P2|NOT COMPLETED|Overall Study||0
52274|NCT01860170|124872|P1|NOT COMPLETED|Overall Study||0
52275|NCT01860170|124870|P3|COMPLETED|Overall Study||22
52276|NCT01860170|124871|P2|COMPLETED|Overall Study||3
52277|NCT01860170|124872|P1|COMPLETED|Overall Study||3
52278|NCT01860170|124870|P3|STARTED|Overall Study||22
52279|NCT01860170|124871|P2|STARTED|Overall Study||3
52280|NCT01860170|124872|P1|STARTED|Overall Study||3
52281|NCT01860079|124888|P2|NOT COMPLETED|Overall Study||22
52282|NCT01860079|124889|P1|NOT COMPLETED|Overall Study||14
52283|NCT01860079|124888|P2|COMPLETED|Overall Study||363
52284|NCT01860079|124889|P1|COMPLETED|Overall Study||370
52285|NCT01860079|124888|P2|STARTED|Overall Study||385
52286|NCT01860079|124889|P1|STARTED|Overall Study||384
52287|NCT01860040|124897|P2|NOT COMPLETED|Overall Study||0
52288|NCT01860040|124898|P1|NOT COMPLETED|Overall Study||1
52289|NCT01860040|124897|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
52290|NCT01860040|124898|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
52291|NCT01860040|124897|P2|STARTED|Overall Study|did not meet recruitment goal|0
52292|NCT01860040|124898|P1|STARTED|Overall Study|did not meet recruitment goal|1
52293|NCT01859988|124909|P6|NOT COMPLETED|Overall Study||19
52294|NCT01859988|124910|P5|NOT COMPLETED|Overall Study||23
52295|NCT01859988|124911|P4|NOT COMPLETED|Overall Study||10
52296|NCT01859988|124912|P3|NOT COMPLETED|Overall Study||28
52297|NCT01859988|124913|P2|NOT COMPLETED|Overall Study||12
52298|NCT01859988|124914|P1|NOT COMPLETED|Overall Study||11
52299|NCT01859988|124909|P6|COMPLETED|Overall Study||42
52300|NCT01859988|124910|P5|COMPLETED|Overall Study||42
52301|NCT01859988|124911|P4|COMPLETED|Overall Study||55
52302|NCT01859988|124912|P3|COMPLETED|Overall Study||34
52303|NCT01859988|124913|P2|COMPLETED|Overall Study||52
52304|NCT01859988|124914|P1|COMPLETED|Overall Study||52
52305|NCT01859988|124909|P6|Treated|Overall Study||61
52306|NCT01859988|124910|P5|Treated|Overall Study||65
52307|NCT01859988|124911|P4|Treated|Overall Study||65
52308|NCT01859988|124912|P3|Treated|Overall Study||61
52309|NCT01859988|124913|P2|Treated|Overall Study||64
52310|NCT01859988|124914|P1|Treated|Overall Study||63
52311|NCT01859988|124909|P6|STARTED|Overall Study||61
52312|NCT01859988|124910|P5|STARTED|Overall Study||65
52313|NCT01859988|124911|P4|STARTED|Overall Study||65
52314|NCT01859988|124912|P3|STARTED|Overall Study||62
52315|NCT01859988|124913|P2|STARTED|Overall Study||64
52316|NCT01859988|124914|P1|STARTED|Overall Study||63
52317|NCT01859949|125008|P2|NOT COMPLETED|Overall Study||17
52318|NCT01859949|125009|P1|NOT COMPLETED|Overall Study||14
52319|NCT01859949|125008|P2|COMPLETED|Overall Study||15
52320|NCT01859949|125009|P1|COMPLETED|Overall Study||15
52321|NCT01859949|125008|P2|STARTED|Overall Study|Treated participants|32
52322|NCT01859949|125009|P1|STARTED|Overall Study|Treated participants|29
52323|NCT01859793|125027|P2|NOT COMPLETED|2nd Intervention Period||0
52324|NCT01859793|125028|P1|NOT COMPLETED|2nd Intervention Period||0
52325|NCT01859793|125027|P2|COMPLETED|2nd Intervention Period||16
52326|NCT01859793|125028|P1|COMPLETED|2nd Intervention Period||14
52327|NCT01859793|125027|P2|STARTED|2nd Intervention Period||16
52328|NCT01859793|125028|P1|STARTED|2nd Intervention Period||14
52329|NCT01859793|125027|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
52330|NCT01859793|125028|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
52331|NCT01859793|125027|P2|COMPLETED|Washout Period (4 Weeks)||16
52332|NCT01859793|125028|P1|COMPLETED|Washout Period (4 Weeks)||14
52333|NCT01859793|125027|P2|STARTED|Washout Period (4 Weeks)||17
52334|NCT01859793|125028|P1|STARTED|Washout Period (4 Weeks)||15
52335|NCT01859793|125027|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
52336|NCT01859793|125028|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
52337|NCT01859793|125027|P2|COMPLETED|First Intervention (8 Weeks)||17
52338|NCT01859793|125028|P1|COMPLETED|First Intervention (8 Weeks)||15
52339|NCT01859793|125027|P2|STARTED|First Intervention (8 Weeks)||18
52340|NCT01859793|125028|P1|STARTED|First Intervention (8 Weeks)||20
52341|NCT01859715|125041|P3|NOT COMPLETED|Overall Study||23
52342|NCT01859715|125042|P2|NOT COMPLETED|Overall Study||8
52343|NCT01859715|125043|P1|NOT COMPLETED|Overall Study||16
52344|NCT01859715|125041|P3|COMPLETED|Overall Study||93
52345|NCT01859715|125042|P2|COMPLETED|Overall Study||83
52346|NCT01859715|125043|P1|COMPLETED|Overall Study||125
52347|NCT01859715|125041|P3|STARTED|Overall Study||116
52348|NCT01859715|125042|P2|STARTED|Overall Study||91
52349|NCT01859715|125043|P1|STARTED|Overall Study||141
52350|NCT01859702|125054|P1|NOT COMPLETED|Overall Study||5
52351|NCT01859702|125054|P1|COMPLETED|Overall Study||31
52352|NCT01859702|125054|P1|STARTED|Overall Study||36
52353|NCT01859637|125058|P1|NOT COMPLETED|Overall Study||0
52354|NCT01859637|125058|P1|COMPLETED|Overall Study||6
52355|NCT01859637|125058|P1|STARTED|Overall Study||6
52356|NCT01859611|125064|P1|NOT COMPLETED|Overall Study||8
52357|NCT01859611|125064|P1|COMPLETED|Overall Study||43
52358|NCT01859611|125064|P1|STARTED|Overall Study||51
52359|NCT01859598|125068|P1|NOT COMPLETED|Visit 3 at 6 Months||912
52360|NCT01859598|125068|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
52361|NCT01859598|125068|P1|STARTED|Visit 3 at 6 Months||17253
52362|NCT01859598|125068|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
52363|NCT01859598|125068|P1|COMPLETED|Visit 2 at 3 Months||17253
52364|NCT01859598|125068|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
52365|NCT01859507|125076|P1|NOT COMPLETED|Overall Study||4
52366|NCT01859507|125076|P1|COMPLETED|Overall Study||28
52367|NCT01859507|125076|P1|STARTED|Overall Study||32
52368|NCT01859494|125081|P1|NOT COMPLETED|Overall Study||1
52369|NCT01859494|125081|P1|COMPLETED|Overall Study||218
52370|NCT01859494|125081|P1|STARTED|Overall Study||219
52371|NCT01859390|125092|P2|NOT COMPLETED|Overall Study||7
52372|NCT01859390|125093|P1|NOT COMPLETED|Overall Study||1
52373|NCT01859390|125092|P2|COMPLETED|Overall Study||30
52374|NCT01859390|125093|P1|COMPLETED|Overall Study||35
52375|NCT01859390|125092|P2|Withdrawals|Overall Study||2
52376|NCT01859390|125093|P1|Withdrawals|Overall Study||2
52377|NCT01859390|125092|P2|STARTED|Overall Study||37
52378|NCT01859390|125093|P1|STARTED|Overall Study||36
52379|NCT01859325|125117|P3|NOT COMPLETED|Overall Study||0
52380|NCT01859325|125118|P2|NOT COMPLETED|Overall Study||4
52381|NCT01859325|125119|P1|NOT COMPLETED|Overall Study||3
52382|NCT01859325|125117|P3|COMPLETED|Overall Study||2
52383|NCT01859325|125118|P2|COMPLETED|Overall Study||12
52384|NCT01859325|125119|P1|COMPLETED|Overall Study||12
52385|NCT01859325|125117|P3|STARTED|Overall Study||2
52386|NCT01859325|125118|P2|STARTED|Overall Study||16
52387|NCT01859325|125119|P1|STARTED|Overall Study||15
52388|NCT01859312|125127|P1|NOT COMPLETED|Overall Study||0
52389|NCT01859312|125127|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
52390|NCT01859312|125127|P1|STARTED|Overall Study||8
52391|NCT01859247|125182|P8|NOT COMPLETED|Overall Study||0
52392|NCT01859247|125183|P7|NOT COMPLETED|Overall Study||0
52393|NCT01859247|125184|P6|NOT COMPLETED|Overall Study||0
52394|NCT01859247|125185|P5|NOT COMPLETED|Overall Study||0
52395|NCT01859247|125186|P4|NOT COMPLETED|Overall Study||0
52396|NCT01859247|125187|P3|NOT COMPLETED|Overall Study||0
52397|NCT01859247|125188|P2|NOT COMPLETED|Overall Study||0
52398|NCT01859247|125189|P1|NOT COMPLETED|Overall Study||0
52399|NCT01859247|125182|P8|COMPLETED|Overall Study||1
52400|NCT01859247|125183|P7|COMPLETED|Overall Study||1
52401|NCT01859247|125184|P6|COMPLETED|Overall Study||1
52402|NCT01859247|125185|P5|COMPLETED|Overall Study||1
52403|NCT01859247|125186|P4|COMPLETED|Overall Study||1
52404|NCT01859247|125187|P3|COMPLETED|Overall Study||1
52405|NCT01859247|125188|P2|COMPLETED|Overall Study||1
52406|NCT01859247|125189|P1|COMPLETED|Overall Study||1
52407|NCT01859247|125182|P8|STARTED|Overall Study||1
52408|NCT01859247|125183|P7|STARTED|Overall Study||1
52409|NCT01859247|125184|P6|STARTED|Overall Study||1
52410|NCT01859247|125185|P5|STARTED|Overall Study||1
52411|NCT01859247|125186|P4|STARTED|Overall Study||1
52412|NCT01859247|125187|P3|STARTED|Overall Study||1
52413|NCT01859247|125188|P2|STARTED|Overall Study||1
52414|NCT01859247|125189|P1|STARTED|Overall Study||1
52415|NCT01859195|125216|P2|NOT COMPLETED|Overall Study||0
52416|NCT01859195|125217|P1|NOT COMPLETED|Overall Study||0
52417|NCT01859195|125216|P2|COMPLETED|Overall Study||12
52418|NCT01859195|125217|P1|COMPLETED|Overall Study||24
52419|NCT01859195|125216|P2|STARTED|Overall Study||12
52420|NCT01859195|125217|P1|STARTED|Overall Study||24
52421|NCT01859143|125227|P2|NOT COMPLETED|Overall Study||0
52422|NCT01859143|125228|P1|NOT COMPLETED|Overall Study||2
52423|NCT01859143|125227|P2|COMPLETED|Overall Study||60
52424|NCT01859143|125228|P1|COMPLETED|Overall Study||238
52425|NCT01859143|125227|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
52426|NCT01859143|125228|P1|STARTED|Overall Study||240
52427|NCT01859078|125242|P1|NOT COMPLETED|Overall Study||0
52428|NCT01859078|125242|P1|COMPLETED|Overall Study||28
52429|NCT01859078|125242|P1|STARTED|Overall Study||28
52430|NCT01859013|125258|P2|NOT COMPLETED|Overall Study||5
52431|NCT01859013|125259|P1|NOT COMPLETED|Overall Study||4
52432|NCT01859013|125258|P2|COMPLETED|Overall Study||9
52433|NCT01859013|125259|P1|COMPLETED|Overall Study||12
52434|NCT01859013|125258|P2|STARTED|Overall Study||14
52435|NCT01859013|125259|P1|STARTED|Overall Study||16
52436|NCT01858766|125284|P19|NOT COMPLETED|Overall Study||4
52437|NCT01858766|125285|P18|NOT COMPLETED|Overall Study||4
52438|NCT01858766|125286|P17|NOT COMPLETED|Overall Study||3
52439|NCT01858766|125287|P16|NOT COMPLETED|Overall Study||6
52440|NCT01858766|125288|P15|NOT COMPLETED|Overall Study||8
52441|NCT01858766|125289|P14|NOT COMPLETED|Overall Study||3
52442|NCT01858766|125290|P13|NOT COMPLETED|Overall Study||5
52443|NCT01858766|125291|P12|NOT COMPLETED|Overall Study||5
52444|NCT01858766|125292|P11|NOT COMPLETED|Overall Study||0
52445|NCT01858766|125293|P10|NOT COMPLETED|Overall Study||0
52446|NCT01858766|125294|P9|NOT COMPLETED|Overall Study||0
52447|NCT01858766|125295|P8|NOT COMPLETED|Overall Study||2
52448|NCT01858766|125296|P7|NOT COMPLETED|Overall Study||0
52449|NCT01858766|125297|P6|NOT COMPLETED|Overall Study||4
52450|NCT01858766|125298|P5|NOT COMPLETED|Overall Study||1
52451|NCT01858766|125299|P4|NOT COMPLETED|Overall Study||0
52452|NCT01858766|125300|P3|NOT COMPLETED|Overall Study||1
52453|NCT01858766|125301|P2|NOT COMPLETED|Overall Study||0
52454|NCT01858766|125302|P1|NOT COMPLETED|Overall Study||1
52455|NCT01858766|125284|P19|COMPLETED|Overall Study||22
52456|NCT01858766|125285|P18|COMPLETED|Overall Study||23
52457|NCT01858766|125286|P17|COMPLETED|Overall Study||22
52458|NCT01858766|125287|P16|COMPLETED|Overall Study||20
52459|NCT01858766|125288|P15|COMPLETED|Overall Study||23
52460|NCT01858766|125289|P14|COMPLETED|Overall Study||26
52461|NCT01858766|125290|P13|COMPLETED|Overall Study||25
52462|NCT01858766|125291|P12|COMPLETED|Overall Study||25
52463|NCT01858766|125292|P11|COMPLETED|Overall Study||5
52464|NCT01858766|125293|P10|COMPLETED|Overall Study||4
52465|NCT01858766|125294|P9|COMPLETED|Overall Study||1
52466|NCT01858766|125295|P8|COMPLETED|Overall Study||5
52467|NCT01858766|125296|P7|COMPLETED|Overall Study||7
52468|NCT01858766|125297|P6|COMPLETED|Overall Study||24
52469|NCT01858766|125298|P5|COMPLETED|Overall Study||26
52470|NCT01858766|125299|P4|COMPLETED|Overall Study||10
52471|NCT01858766|125300|P3|COMPLETED|Overall Study||10
52472|NCT01858766|125301|P2|COMPLETED|Overall Study||28
52473|NCT01858766|125302|P1|COMPLETED|Overall Study||26
52474|NCT01858766|125284|P19|STARTED|Overall Study||26
52475|NCT01858766|125285|P18|STARTED|Overall Study||27
52476|NCT01858766|125286|P17|STARTED|Overall Study||25
52477|NCT01858766|125287|P16|STARTED|Overall Study||26
52478|NCT01858766|125288|P15|STARTED|Overall Study||31
52479|NCT01858766|125289|P14|STARTED|Overall Study||29
52480|NCT01858766|125290|P13|STARTED|Overall Study||30
52481|NCT01858766|125291|P12|STARTED|Overall Study||30
52482|NCT01858766|125292|P11|STARTED|Overall Study||5
52483|NCT01858766|125293|P10|STARTED|Overall Study||4
52484|NCT01858766|125294|P9|STARTED|Overall Study||1
52485|NCT01858766|125295|P8|STARTED|Overall Study||7
52486|NCT01858766|125296|P7|STARTED|Overall Study||7
52487|NCT01858766|125297|P6|STARTED|Overall Study||28
52488|NCT01858766|125298|P5|STARTED|Overall Study||27
52489|NCT01858766|125299|P4|STARTED|Overall Study||10
52490|NCT01858766|125300|P3|STARTED|Overall Study||11
52491|NCT01858766|125301|P2|STARTED|Overall Study||28
52492|NCT01858766|125302|P1|STARTED|Overall Study||27
52493|NCT01858701|125373|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
52494|NCT01858701|125374|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
52495|NCT01858701|125373|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
52496|NCT01858701|125374|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
52497|NCT01858701|125373|P2|STARTED|Period 2, Second 30 Days of Wear||17
52498|NCT01858701|125374|P1|STARTED|Period 2, Second 30 Days of Wear||18
52499|NCT01858701|125373|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
52500|NCT01858701|125374|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
52501|NCT01858701|125373|P2|COMPLETED|Washout Period, 1-13 Days||17
52502|NCT01858701|125374|P1|COMPLETED|Washout Period, 1-13 Days||18
52503|NCT01858701|125373|P2|STARTED|Washout Period, 1-13 Days||19
52504|NCT01858701|125374|P1|STARTED|Washout Period, 1-13 Days||20
52505|NCT01858701|125373|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
52506|NCT01858701|125374|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
52507|NCT01858701|125373|P2|COMPLETED|Period 1, First 30 Days of Wear||19
52508|NCT01858701|125374|P1|COMPLETED|Period 1, First 30 Days of Wear||20
52509|NCT01858701|125373|P2|STARTED|Period 1, First 30 Days of Wear||20
52510|NCT01858701|125374|P1|STARTED|Period 1, First 30 Days of Wear||20
52511|NCT01858636|125380|P1|NOT COMPLETED|Overall Study||28
52512|NCT01858636|125380|P1|COMPLETED|Overall Study||207
52513|NCT01858636|125380|P1|Device Deployment|Overall Study||211
52514|NCT01858636|125380|P1|STARTED|Overall Study|Subjects consented|235
52515|NCT01858545|125387|P2|NOT COMPLETED|Overall Study||6
52516|NCT01858545|125388|P1|NOT COMPLETED|Overall Study||4
52517|NCT01858545|125387|P2|COMPLETED|Overall Study||23
52518|NCT01858545|125388|P1|COMPLETED|Overall Study||23
52519|NCT01858545|125387|P2|STARTED|Overall Study||29
52520|NCT01858545|125388|P1|STARTED|Overall Study||27
52521|NCT01858428|125396|P2|NOT COMPLETED|Overall Study||10
52522|NCT01858428|125397|P1|NOT COMPLETED|Overall Study||1
52523|NCT01858428|125396|P2|COMPLETED|Overall Study||190
52524|NCT01858428|125397|P1|COMPLETED|Overall Study||99
52525|NCT01858428|125396|P2|STARTED|Overall Study||200
52526|NCT01858428|125397|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
52527|NCT01858389|125433|P2|NOT COMPLETED|Overall Study||25
52528|NCT01858389|125434|P1|NOT COMPLETED|Overall Study||16
52529|NCT01858389|125433|P2|COMPLETED|Overall Study||0
52530|NCT01858389|125434|P1|COMPLETED|Overall Study||0
52531|NCT01858389|125433|P2|Received Treatment|Overall Study||22
52532|NCT01858389|125434|P1|Received Treatment|Overall Study||16
52533|NCT01858389|125433|P2|STARTED|Overall Study|Enrolled|25
52534|NCT01858389|125434|P1|STARTED|Overall Study|Enrolled|16
52535|NCT01858376|125449|P1|NOT COMPLETED|Overall Study||4
52536|NCT01858376|125449|P1|COMPLETED|Overall Study||20
52537|NCT01858376|125449|P1|STARTED|Overall Study||24
52538|NCT01857986|125457|P2|NOT COMPLETED|Overall Study||7
52539|NCT01857986|125458|P1|NOT COMPLETED|Overall Study||5
52540|NCT01857986|125457|P2|COMPLETED|Overall Study||30
52541|NCT01857986|125458|P1|COMPLETED|Overall Study||34
52542|NCT01857986|125457|P2|STARTED|Overall Study||37
52543|NCT01857986|125458|P1|STARTED|Overall Study||39
52544|NCT01857882|125470|P2|NOT COMPLETED|Overall Study||0
52545|NCT01857882|125471|P1|NOT COMPLETED|Overall Study||0
52546|NCT01857882|125470|P2|COMPLETED|Overall Study||20
52547|NCT01857882|125471|P1|COMPLETED|Overall Study||21
52548|NCT01857882|125470|P2|STARTED|Overall Study||20
52549|NCT01857882|125471|P1|STARTED|Overall Study||21
52550|NCT01857713|125477|P1|NOT COMPLETED|Overall Study||6
52551|NCT01857713|125477|P1|COMPLETED|Overall Study||89
52552|NCT01857713|125477|P1|STARTED|Overall Study||95
52553|NCT01857622|125487|P3|NOT COMPLETED|Overall Study||2
52554|NCT01857622|125488|P2|NOT COMPLETED|Overall Study||1
52555|NCT01857622|125489|P1|NOT COMPLETED|Overall Study||11
52556|NCT01857622|125487|P3|COMPLETED|Overall Study||19
52557|NCT01857622|125488|P2|COMPLETED|Overall Study||21
52558|NCT01857622|125489|P1|COMPLETED|Overall Study||39
52559|NCT01857622|125487|P3|STARTED|Overall Study||21
52560|NCT01857622|125488|P2|STARTED|Overall Study||22
52561|NCT01857622|125489|P1|STARTED|Overall Study||50
52562|NCT01857583|125501|P4|NOT COMPLETED|Overall Study||4
52563|NCT01857583|125502|P3|NOT COMPLETED|Overall Study||3
52564|NCT01857583|125503|P2|NOT COMPLETED|Overall Study||1
52565|NCT01857583|125504|P1|NOT COMPLETED|Overall Study||1
52566|NCT01857583|125501|P4|COMPLETED|Overall Study||17
52567|NCT01857583|125502|P3|COMPLETED|Overall Study||19
52568|NCT01857583|125503|P2|COMPLETED|Overall Study||6
52569|NCT01857583|125504|P1|COMPLETED|Overall Study||29
52570|NCT01857583|125501|P4|Safety Analysis Population|Overall Study||20
52571|NCT01857583|125502|P3|Safety Analysis Population|Overall Study||22
52572|NCT01857583|125503|P2|Safety Analysis Population|Overall Study||7
52573|NCT01857583|125504|P1|Safety Analysis Population|Overall Study||30
52574|NCT01857583|125501|P4|STARTED|Overall Study||21
52575|NCT01857583|125502|P3|STARTED|Overall Study||22
52576|NCT01857583|125503|P2|STARTED|Overall Study||7
52577|NCT01857583|125504|P1|STARTED|Overall Study||30
52578|NCT01857531|125514|P1|NOT COMPLETED|Overall Study||4
52579|NCT01857531|125514|P1|COMPLETED|Overall Study||12
52580|NCT01857531|125514|P1|STARTED|Overall Study||16
52581|NCT01857362|125523|P2|NOT COMPLETED|Overall Study||0
52582|NCT01857362|125524|P1|NOT COMPLETED|Overall Study||0
52583|NCT01857362|125523|P2|COMPLETED|Overall Study||6
52584|NCT01857362|125524|P1|COMPLETED|Overall Study||6
52585|NCT01857362|125523|P2|STARTED|Overall Study||6
52586|NCT01857362|125524|P1|STARTED|Overall Study||6
52587|NCT01857323|125532|P1|NOT COMPLETED|Overall Study||64
52588|NCT01857323|125532|P1|COMPLETED|Overall Study||253
52589|NCT01857323|125532|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
52590|NCT01857323|125532|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
52591|NCT01857297|125543|P2|NOT COMPLETED|Overall Study||0
52592|NCT01857297|125544|P1|NOT COMPLETED|Overall Study||0
52593|NCT01857297|125543|P2|COMPLETED|Overall Study||60
52594|NCT01857297|125544|P1|COMPLETED|Overall Study||60
52595|NCT01857297|125543|P2|STARTED|Overall Study||60
52596|NCT01857297|125544|P1|STARTED|Overall Study||60
52597|NCT01857258|125558|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
52598|NCT01857258|125559|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
52599|NCT01857258|125558|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
52600|NCT01857258|125559|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
52601|NCT01857258|125558|P2|STARTED|Second Intervention (3 h Postprandially)||7
52602|NCT01857258|125559|P1|STARTED|Second Intervention (3 h Postprandially)||8
52603|NCT01857258|125558|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
52604|NCT01857258|125559|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
52605|NCT01857258|125558|P2|COMPLETED|Wash-out Period (7 Days)||7
52606|NCT01857258|125559|P1|COMPLETED|Wash-out Period (7 Days)||8
52607|NCT01857258|125558|P2|STARTED|Wash-out Period (7 Days)||7
52608|NCT01857258|125559|P1|STARTED|Wash-out Period (7 Days)||8
52609|NCT01857258|125558|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
52610|NCT01857258|125559|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
52611|NCT01857258|125558|P2|COMPLETED|First Intervention (3 h Postprandially)||7
52612|NCT01857258|125559|P1|COMPLETED|First Intervention (3 h Postprandially)||8
52613|NCT01857258|125558|P2|STARTED|First Intervention (3 h Postprandially)||7
52614|NCT01857258|125559|P1|STARTED|First Intervention (3 h Postprandially)||8
52615|NCT01857206|125581|P2|NOT COMPLETED|Overall Study||10
52616|NCT01857206|125582|P1|NOT COMPLETED|Overall Study||13
52617|NCT01857206|125581|P2|COMPLETED|Overall Study||673
52618|NCT01857206|125582|P1|COMPLETED|Overall Study||1359
52619|NCT01857206|125581|P2|STARTED|Overall Study||683
52620|NCT01857206|125582|P1|STARTED|Overall Study||1372
52621|NCT01857102|125600|P2|NOT COMPLETED|Period 2||0
52622|NCT01857102|125601|P1|NOT COMPLETED|Period 2||2
52623|NCT01857102|125600|P2|COMPLETED|Period 2||51
52624|NCT01857102|125601|P1|COMPLETED|Period 2||53
52625|NCT01857102|125600|P2|Neophytes|Period 2||4
52626|NCT01857102|125601|P1|Neophytes|Period 2||7
52627|NCT01857102|125600|P2|Habitual Users|Period 2||47
52628|NCT01857102|125601|P1|Habitual Users|Period 2||48
52629|NCT01857102|125600|P2|STARTED|Period 2||51
52630|NCT01857102|125601|P1|STARTED|Period 2||55
52631|NCT01857102|125600|P2|NOT COMPLETED|Period 1||5
52632|NCT01857102|125601|P1|NOT COMPLETED|Period 1||3
52633|NCT01857102|125600|P2|COMPLETED|Period 1||51
52634|NCT01857102|125601|P1|COMPLETED|Period 1||55
52635|NCT01857102|125600|P2|Neophtyes|Period 1||4
52636|NCT01857102|125601|P1|Neophtyes|Period 1||7
52637|NCT01857102|125600|P2|Habitual Users|Period 1||52
52638|NCT01857102|125601|P1|Habitual Users|Period 1||51
52639|NCT01857102|125600|P2|STARTED|Period 1||56
52640|NCT01857102|125601|P1|STARTED|Period 1||58
52641|NCT01857063|125611|P2|NOT COMPLETED|Period 2 (7 Days)||2
52642|NCT01857063|125612|P1|NOT COMPLETED|Period 2 (7 Days)||4
52643|NCT01857063|125611|P2|COMPLETED|Period 2 (7 Days)||104
52644|NCT01857063|125612|P1|COMPLETED|Period 2 (7 Days)||104
52645|NCT01857063|125611|P2|STARTED|Period 2 (7 Days)||106
52646|NCT01857063|125612|P1|STARTED|Period 2 (7 Days)||108
52647|NCT01857063|125611|P2|NOT COMPLETED|Period 1 (7 Days)||4
52648|NCT01857063|125612|P1|NOT COMPLETED|Period 1 (7 Days)||2
52649|NCT01857063|125611|P2|COMPLETED|Period 1 (7 Days)||106
52650|NCT01857063|125612|P1|COMPLETED|Period 1 (7 Days)||108
52651|NCT01857063|125611|P2|STARTED|Period 1 (7 Days)||110
52652|NCT01857063|125612|P1|STARTED|Period 1 (7 Days)||110
52653|NCT01856933|125638|P1|NOT COMPLETED|Overall Study||0
52654|NCT01856933|125638|P1|COMPLETED|Overall Study||6
52655|NCT01856933|125638|P1|STARTED|Overall Study||6
52656|NCT01856907|125645|P3|NOT COMPLETED|Overall Study||0
52657|NCT01856907|125646|P2|NOT COMPLETED|Overall Study||3
52658|NCT01856907|125647|P1|NOT COMPLETED|Overall Study||0
52659|NCT01856907|125645|P3|COMPLETED|Overall Study||12
52660|NCT01856907|125646|P2|COMPLETED|Overall Study||9
52661|NCT01856907|125647|P1|COMPLETED|Overall Study||12
52662|NCT01856907|125645|P3|STARTED|Overall Study||12
52663|NCT01856907|125646|P2|STARTED|Overall Study||12
52664|NCT01856907|125647|P1|STARTED|Overall Study||12
52665|NCT01856764|125687|P2|NOT COMPLETED|Overall Study||0
52666|NCT01856764|125688|P1|NOT COMPLETED|Overall Study||0
52667|NCT01856764|125687|P2|COMPLETED|Overall Study||20
52668|NCT01856764|125688|P1|COMPLETED|Overall Study||20
52669|NCT01856764|125687|P2|STARTED|Overall Study||20
52670|NCT01856764|125688|P1|STARTED|Overall Study||20
52671|NCT01856686|125700|P2|NOT COMPLETED|Overall Study||11
52672|NCT01856686|125701|P1|NOT COMPLETED|Overall Study||5
52673|NCT01856686|125700|P2|COMPLETED|Overall Study||22
52674|NCT01856686|125701|P1|COMPLETED|Overall Study||26
52675|NCT01856686|125700|P2|STARTED|Overall Study||33
52676|NCT01856686|125701|P1|STARTED|Overall Study||31
52677|NCT01856673|125744|P3|NOT COMPLETED|Overall Study||34
52678|NCT01856673|125745|P2|NOT COMPLETED|Overall Study||85
52679|NCT01856673|125746|P1|NOT COMPLETED|Overall Study||98
52680|NCT01856673|125744|P3|COMPLETED|Overall Study||137
52681|NCT01856673|125745|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
52682|NCT01856673|125746|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
52683|NCT01856673|125744|P3|Quibdó Participants|Overall Study||83
52684|NCT01856673|125745|P2|Quibdó Participants|Overall Study||86
52685|NCT01856673|125746|P1|Quibdó Participants|Overall Study||83
52686|NCT01856673|125744|P3|Buenaventura Participants|Overall Study||88
52687|NCT01856673|125745|P2|Buenaventura Participants|Overall Study||89
52688|NCT01856673|125746|P1|Buenaventura Participants|Overall Study||92
52689|NCT01856673|125744|P3|STARTED|Overall Study||171
52690|NCT01856673|125745|P2|STARTED|Overall Study||175
52691|NCT01856673|125746|P1|STARTED|Overall Study||175
52692|NCT01856569|125757|P1|NOT COMPLETED|Overall Study||13
52693|NCT01856569|125757|P1|COMPLETED|Overall Study||139
52694|NCT01856569|125757|P1|Full Analysis Set|Overall Study||144
52695|NCT01856569|125757|P1|STARTED|Overall Study||152
52696|NCT01856530|125768|P2|NOT COMPLETED|Overall Study||0
52697|NCT01856530|125769|P1|NOT COMPLETED|Overall Study||0
52698|NCT01856530|125768|P2|COMPLETED|Overall Study||27
52699|NCT01856530|125769|P1|COMPLETED|Overall Study||27
52700|NCT01856530|125768|P2|STARTED|Overall Study||27
52701|NCT01856530|125769|P1|STARTED|Overall Study||27
52702|NCT01856491|125785|P1|NOT COMPLETED|Overall Study||15
52703|NCT01856491|125785|P1|COMPLETED|Overall Study||152
52704|NCT01856491|125785|P1|STARTED|Overall Study||167
52705|NCT01856361|125794|P2|NOT COMPLETED|Overall Study||0
52706|NCT01856361|125795|P1|NOT COMPLETED|Overall Study||0
52707|NCT01856361|125794|P2|COMPLETED|Overall Study||1
52708|NCT01856361|125795|P1|COMPLETED|Overall Study||1
52709|NCT01856361|125794|P2|STARTED|Overall Study||1
52710|NCT01856361|125795|P1|STARTED|Overall Study||1
52711|NCT01856322|125812|P3|NOT COMPLETED|Overall Study||3
52712|NCT01856322|125813|P2|NOT COMPLETED|Overall Study||0
52713|NCT01856322|125814|P1|NOT COMPLETED|Overall Study||0
52714|NCT01856322|125812|P3|COMPLETED|Overall Study||0
52715|NCT01856322|125813|P2|COMPLETED|Overall Study||0
52716|NCT01856322|125814|P1|COMPLETED|Overall Study||0
52717|NCT01856322|125812|P3|STARTED|Overall Study||3
52718|NCT01856322|125813|P2|STARTED|Overall Study||0
52719|NCT01856322|125814|P1|STARTED|Overall Study||0
52720|NCT01856270|125823|P2|NOT COMPLETED|Overall Study||12
52721|NCT01856270|125824|P1|NOT COMPLETED|Overall Study||11
52722|NCT01856270|125823|P2|COMPLETED|Overall Study||14
52723|NCT01856270|125824|P1|COMPLETED|Overall Study||13
52724|NCT01856270|125823|P2|STARTED|Overall Study||26
52725|NCT01856270|125824|P1|STARTED|Overall Study||24
52726|NCT01856257|125847|P4|NOT COMPLETED|Overall Study||2
52727|NCT01856257|125848|P3|NOT COMPLETED|Overall Study||0
52728|NCT01856257|125849|P2|NOT COMPLETED|Overall Study||1
52729|NCT01856257|125850|P1|NOT COMPLETED|Overall Study||3
52730|NCT01856257|125847|P4|COMPLETED|Overall Study||0
52731|NCT01856257|125848|P3|COMPLETED|Overall Study||11
52732|NCT01856257|125849|P2|COMPLETED|Overall Study||28
52733|NCT01856257|125850|P1|COMPLETED|Overall Study||26
52734|NCT01856257|125847|P4|STARTED|Overall Study||2
52735|NCT01856257|125848|P3|STARTED|Overall Study||11
52736|NCT01856257|125849|P2|STARTED|Overall Study||29
52737|NCT01856257|125850|P1|STARTED|Overall Study||29
52738|NCT01856218|125949|P1|NOT COMPLETED|Long-Term Extension Phase||0
52739|NCT01856218|125949|P1|COMPLETED|Long-Term Extension Phase||3
52740|NCT01856218|125949|P1|STARTED|Long-Term Extension Phase||3
52741|NCT01856218|125949|P1|NOT COMPLETED|First Phase||0
52742|NCT01856218|125949|P1|COMPLETED|First Phase||3
52743|NCT01856218|125949|P1|STARTED|First Phase||3
52744|NCT01855997|125963|P1|NOT COMPLETED|Overall Study||0
52745|NCT01855997|125963|P1|COMPLETED|Overall Study||1669
52746|NCT01855997|125963|P1|STARTED|Overall Study||1669
52747|NCT01855958|126018|P2|NOT COMPLETED|Overall Study||0
52748|NCT01855958|126019|P1|NOT COMPLETED|Overall Study||1
52749|NCT01855958|126018|P2|COMPLETED|Overall Study||13
52750|NCT01855958|126019|P1|COMPLETED|Overall Study||12
52751|NCT01855958|126018|P2|STARTED|Overall Study||13
52752|NCT01855958|126019|P1|STARTED|Overall Study||13
52753|NCT01855945|126049|P12|NOT COMPLETED|Overall Study||3
52754|NCT01855945|126050|P11|NOT COMPLETED|Overall Study||5
52755|NCT01855945|126051|P10|NOT COMPLETED|Overall Study||2
52756|NCT01855945|126052|P9|NOT COMPLETED|Overall Study||2
52757|NCT01855945|126053|P8|NOT COMPLETED|Overall Study||8
52758|NCT01855945|126054|P7|NOT COMPLETED|Overall Study||10
52759|NCT01855945|126055|P6|NOT COMPLETED|Overall Study||3
52760|NCT01855945|126056|P5|NOT COMPLETED|Overall Study||1
52761|NCT01855945|126057|P4|NOT COMPLETED|Overall Study||4
52762|NCT01855945|126058|P3|NOT COMPLETED|Overall Study||12
52763|NCT01855945|126059|P2|NOT COMPLETED|Overall Study||11
52764|NCT01855945|126060|P1|NOT COMPLETED|Overall Study||16
52765|NCT01855945|126049|P12|COMPLETED|Overall Study||49
52766|NCT01855945|126050|P11|COMPLETED|Overall Study||46
52767|NCT01855945|126051|P10|COMPLETED|Overall Study||49
52768|NCT01855945|126052|P9|COMPLETED|Overall Study||46
52769|NCT01855945|126053|P8|COMPLETED|Overall Study||47
52770|NCT01855945|126054|P7|COMPLETED|Overall Study||43
52771|NCT01855945|126055|P6|COMPLETED|Overall Study||50
52772|NCT01855945|126056|P5|COMPLETED|Overall Study||50
52773|NCT01855945|126057|P4|COMPLETED|Overall Study||49
52774|NCT01855945|126058|P3|COMPLETED|Overall Study||39
52775|NCT01855945|126059|P2|COMPLETED|Overall Study||44
52776|NCT01855945|126060|P1|COMPLETED|Overall Study||38
52777|NCT01855945|126049|P12|STARTED|Overall Study||52
52778|NCT01855945|126050|P11|STARTED|Overall Study||51
52779|NCT01855945|126051|P10|STARTED|Overall Study||51
52780|NCT01855945|126052|P9|STARTED|Overall Study||48
52781|NCT01855945|126053|P8|STARTED|Overall Study||55
52782|NCT01855945|126054|P7|STARTED|Overall Study||53
52783|NCT01855945|126055|P6|STARTED|Overall Study||53
52784|NCT01855945|126056|P5|STARTED|Overall Study||51
52785|NCT01855945|126057|P4|STARTED|Overall Study||53
52786|NCT01855945|126058|P3|STARTED|Overall Study||51
52787|NCT01855945|126059|P2|STARTED|Overall Study||55
52788|NCT01855945|126060|P1|STARTED|Overall Study||54
52789|NCT01855919|126196|P2|NOT COMPLETED|Overall Study||26
52790|NCT01855919|126197|P1|NOT COMPLETED|Overall Study||23
52791|NCT01855919|126196|P2|COMPLETED|Overall Study||200
52792|NCT01855919|126197|P1|COMPLETED|Overall Study||209
52793|NCT01855919|126196|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
52794|NCT01855919|126197|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
52795|NCT01855919|126196|P2|STARTED|Overall Study||226
52796|NCT01855919|126197|P1|STARTED|Overall Study||232
52797|NCT01855789|126229|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
52798|NCT01855789|126230|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
52799|NCT01855789|126231|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
52800|NCT01855789|126232|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
52801|NCT01855789|126229|P4|COMPLETED|2) Week 24 up to End of Study||250
52802|NCT01855789|126230|P3|COMPLETED|2) Week 24 up to End of Study||129
52803|NCT01855789|126231|P2|COMPLETED|2) Week 24 up to End of Study||132
52804|NCT01855789|126232|P1|COMPLETED|2) Week 24 up to End of Study||0
52805|NCT01855789|126229|P4|STARTED|2) Week 24 up to End of Study||308
52806|NCT01855789|126230|P3|STARTED|2) Week 24 up to End of Study||147
52807|NCT01855789|126231|P2|STARTED|2) Week 24 up to End of Study||147
52808|NCT01855789|126232|P1|STARTED|2) Week 24 up to End of Study||0
52809|NCT01855789|126229|P4|NOT COMPLETED|1) Baseline up to Week 24||0
52810|NCT01855789|126230|P3|NOT COMPLETED|1) Baseline up to Week 24||0
52811|NCT01855789|126231|P2|NOT COMPLETED|1) Baseline up to Week 24||0
52812|NCT01855789|126232|P1|NOT COMPLETED|1) Baseline up to Week 24||116
52813|NCT01855789|126229|P4|COMPLETED|1) Baseline up to Week 24||0
52814|NCT01855789|126230|P3|COMPLETED|1) Baseline up to Week 24||0
52815|NCT01855789|126231|P2|COMPLETED|1) Baseline up to Week 24||0
52816|NCT01855789|126232|P1|COMPLETED|1) Baseline up to Week 24||602
52817|NCT01855789|126229|P4|STARTED|1) Baseline up to Week 24||0
52818|NCT01855789|126230|P3|STARTED|1) Baseline up to Week 24||0
52819|NCT01855789|126231|P2|STARTED|1) Baseline up to Week 24||0
52820|NCT01855789|126232|P1|STARTED|1) Baseline up to Week 24||718
52821|NCT01855074|126254|P1|NOT COMPLETED|Overall Study||14
52822|NCT01855074|126254|P1|COMPLETED|Overall Study||66
52823|NCT01855074|126254|P1|Treated|Overall Study||79
52824|NCT01855074|126254|P1|STARTED|Overall Study||80
52825|NCT01854944|126266|P3|NOT COMPLETED|Overall Study||1
52826|NCT01854944|126267|P2|NOT COMPLETED|Overall Study||0
52827|NCT01854944|126268|P1|NOT COMPLETED|Overall Study||0
52828|NCT01854944|126266|P3|COMPLETED|Overall Study||3
52829|NCT01854944|126267|P2|COMPLETED|Overall Study||4
52830|NCT01854944|126268|P1|COMPLETED|Overall Study||4
52831|NCT01854944|126266|P3|STARTED|Overall Study||4
52832|NCT01854944|126267|P2|STARTED|Overall Study||4
52833|NCT01854944|126268|P1|STARTED|Overall Study||4
52834|NCT01854905|126318|P1|NOT COMPLETED|Overall Study||0
52835|NCT01854905|126318|P1|COMPLETED|Overall Study||400
52836|NCT01854905|126318|P1|STARTED|Overall Study||400
52837|NCT01854827|126322|P1|NOT COMPLETED|Overall Study||1
52838|NCT01854827|126322|P1|COMPLETED|Overall Study||29
52839|NCT01854827|126322|P1|STARTED|Overall Study||30
52840|NCT01854710|126334|P6|NOT COMPLETED|Overall Study||2
52841|NCT01854710|126335|P5|NOT COMPLETED|Overall Study||2
52842|NCT01854710|126336|P4|NOT COMPLETED|Overall Study||2
52843|NCT01854710|126337|P3|NOT COMPLETED|Overall Study||2
52844|NCT01854710|126338|P2|NOT COMPLETED|Overall Study||3
52845|NCT01854710|126339|P1|NOT COMPLETED|Overall Study||4
52846|NCT01854710|126334|P6|COMPLETED|Overall Study||8
52847|NCT01854710|126335|P5|COMPLETED|Overall Study||8
52848|NCT01854710|126336|P4|COMPLETED|Overall Study||8
52849|NCT01854710|126337|P3|COMPLETED|Overall Study||8
52850|NCT01854710|126338|P2|COMPLETED|Overall Study||7
52851|NCT01854710|126339|P1|COMPLETED|Overall Study||6
52852|NCT01854710|126334|P6|STARTED|Overall Study||10
52853|NCT01854710|126335|P5|STARTED|Overall Study||10
52854|NCT01854710|126336|P4|STARTED|Overall Study||10
52855|NCT01854710|126337|P3|STARTED|Overall Study||10
52856|NCT01854710|126338|P2|STARTED|Overall Study||10
52857|NCT01854710|126339|P1|STARTED|Overall Study||10
52858|NCT01854697|126360|P5|NOT COMPLETED|Overall Study||2
52859|NCT01854697|126361|P4|NOT COMPLETED|Overall Study||3
52860|NCT01854697|126362|P3|NOT COMPLETED|Overall Study||2
52861|NCT01854697|126363|P2|NOT COMPLETED|Overall Study||3
52862|NCT01854697|126364|P1|NOT COMPLETED|Overall Study||6
52863|NCT01854697|126360|P5|COMPLETED|Overall Study||39
52864|NCT01854697|126361|P4|COMPLETED|Overall Study||80
52865|NCT01854697|126362|P3|COMPLETED|Overall Study||82
52866|NCT01854697|126363|P2|COMPLETED|Overall Study||31
52867|NCT01854697|126364|P1|COMPLETED|Overall Study||63
52868|NCT01854697|126360|P5|STARTED|Overall Study||41
52869|NCT01854697|126361|P4|STARTED|Overall Study||83
52870|NCT01854697|126362|P3|STARTED|Overall Study||84
52871|NCT01854697|126363|P2|STARTED|Overall Study||34
52872|NCT01854697|126364|P1|STARTED|Overall Study||69
52873|NCT01854658|126408|P4|NOT COMPLETED|Overall Study||59
52874|NCT01854658|126409|P3|NOT COMPLETED|Overall Study||80
52875|NCT01854658|126410|P2|NOT COMPLETED|Overall Study||75
52876|NCT01854658|126411|P1|NOT COMPLETED|Overall Study||93
52877|NCT01854658|126408|P4|COMPLETED|Overall Study||165
52878|NCT01854658|126409|P3|COMPLETED|Overall Study||432
52879|NCT01854658|126410|P2|COMPLETED|Overall Study||365
52880|NCT01854658|126411|P1|COMPLETED|Overall Study||346
52881|NCT01854658|126408|P4|STARTED|Overall Study||224
52882|NCT01854658|126409|P3|STARTED|Overall Study||512
52883|NCT01854658|126410|P2|STARTED|Overall Study||440
52884|NCT01854658|126411|P1|STARTED|Overall Study||439
52885|NCT01854645|126446|P5|NOT COMPLETED|Overall Study||60
52886|NCT01854645|126447|P4|NOT COMPLETED|Overall Study||62
52887|NCT01854645|126448|P3|NOT COMPLETED|Overall Study||82
52888|NCT01854645|126449|P2|NOT COMPLETED|Overall Study||106
52889|NCT01854645|126450|P1|NOT COMPLETED|Overall Study||98
52890|NCT01854645|126446|P5|COMPLETED|Overall Study||160
52891|NCT01854645|126447|P4|COMPLETED|Overall Study||391
52892|NCT01854645|126448|P3|COMPLETED|Overall Study||370
52893|NCT01854645|126449|P2|COMPLETED|Overall Study||345
52894|NCT01854645|126450|P1|COMPLETED|Overall Study||429
52895|NCT01854645|126446|P5|STARTED|Overall Study||220
52896|NCT01854645|126447|P4|STARTED|Overall Study||453
52897|NCT01854645|126448|P3|STARTED|Overall Study||452
52898|NCT01854645|126449|P2|STARTED|Overall Study||451
52899|NCT01854645|126450|P1|STARTED|Overall Study||527
52900|NCT01854632|126489|P2|NOT COMPLETED|Overall Study||13
52901|NCT01854632|126490|P1|NOT COMPLETED|Overall Study||26
52902|NCT01854632|126489|P2|COMPLETED|Overall Study||574
52903|NCT01854632|126490|P1|COMPLETED|Overall Study||1148
52904|NCT01854632|126489|P2|STARTED|Overall Study||587
52905|NCT01854632|126490|P1|STARTED|Overall Study||1174
52906|NCT01854593|126498|P2|NOT COMPLETED|Overall Study||1
52907|NCT01854593|126499|P1|NOT COMPLETED|Overall Study||2
52908|NCT01854593|126498|P2|COMPLETED|Overall Study||34
52909|NCT01854593|126499|P1|COMPLETED|Overall Study||32
52910|NCT01854593|126498|P2|STARTED|Overall Study||35
52911|NCT01854593|126499|P1|STARTED|Overall Study||34
52912|NCT01854528|126531|P2|NOT COMPLETED|Overall Study||15
52913|NCT01854528|126532|P1|NOT COMPLETED|Overall Study||0
52914|NCT01854528|126531|P2|COMPLETED|Overall Study||32
52915|NCT01854528|126532|P1|COMPLETED|Overall Study||101
52916|NCT01854528|126531|P2|STARTED|Overall Study||47
52917|NCT01854528|126532|P1|STARTED|Overall Study||101
52918|NCT01854281|126552|P4|NOT COMPLETED|Overall Study||0
52919|NCT01854281|126553|P3|NOT COMPLETED|Overall Study||0
52920|NCT01854281|126554|P2|NOT COMPLETED|Overall Study||0
52921|NCT01854281|126555|P1|NOT COMPLETED|Overall Study||0
52922|NCT01854281|126552|P4|COMPLETED|Overall Study||8
52923|NCT01854281|126553|P3|COMPLETED|Overall Study||5
52924|NCT01854281|126554|P2|COMPLETED|Overall Study||19
52925|NCT01854281|126555|P1|COMPLETED|Overall Study||15
52926|NCT01854281|126552|P4|STARTED|Overall Study||8
52927|NCT01854281|126553|P3|STARTED|Overall Study||5
52928|NCT01854281|126554|P2|STARTED|Overall Study||19
52929|NCT01854281|126555|P1|STARTED|Overall Study||15
52930|NCT01854268|126565|P1|NOT COMPLETED|Overall Study||0
52931|NCT01854268|126565|P1|COMPLETED|Overall Study||25
52932|NCT01854268|126565|P1|STARTED|Overall Study||25
52933|NCT01854242|126571|P1|NOT COMPLETED|Overall Study||0
52934|NCT01854242|126571|P1|COMPLETED|Overall Study||50
52935|NCT01854242|126571|P1|STARTED|Overall Study||50
52936|NCT01854047|126580|P5|NOT COMPLETED|Overall Study||19
52937|NCT01854047|126581|P4|NOT COMPLETED|Overall Study||15
52938|NCT01854047|126582|P3|NOT COMPLETED|Overall Study||13
52939|NCT01854047|126583|P2|NOT COMPLETED|Overall Study||8
52940|NCT01854047|126584|P1|NOT COMPLETED|Overall Study||12
52941|NCT01854047|126580|P5|COMPLETED|Overall Study||135
52942|NCT01854047|126581|P4|COMPLETED|Overall Study||142
52943|NCT01854047|126582|P3|COMPLETED|Overall Study||137
52944|NCT01854047|126583|P2|COMPLETED|Overall Study||149
52945|NCT01854047|126584|P1|COMPLETED|Overall Study||146
52946|NCT01854047|126580|P5|Completed 12-week Study Treatment|Overall Study||143
52947|NCT01854047|126581|P4|Completed 12-week Study Treatment|Overall Study||146
52948|NCT01854047|126582|P3|Completed 12-week Study Treatment|Overall Study||141
52949|NCT01854047|126583|P2|Completed 12-week Study Treatment|Overall Study||149
52950|NCT01854047|126584|P1|Completed 12-week Study Treatment|Overall Study||153
52951|NCT01854047|126580|P5|Treated|Overall Study||150
52952|NCT01854047|126581|P4|Treated|Overall Study||157
52953|NCT01854047|126582|P3|Treated|Overall Study||148
52954|NCT01854047|126583|P2|Treated|Overall Study||156
52955|NCT01854047|126584|P1|Treated|Overall Study||158
52956|NCT01854047|126580|P5|STARTED|Overall Study||154
52957|NCT01854047|126581|P4|STARTED|Overall Study||157
52958|NCT01854047|126582|P3|STARTED|Overall Study||150
52959|NCT01854047|126583|P2|STARTED|Overall Study||157
52960|NCT01854047|126584|P1|STARTED|Overall Study||158
52961|NCT01854034|126706|P1|NOT COMPLETED|Overall Study||0
52962|NCT01854034|126706|P1|COMPLETED|Overall Study||29
52963|NCT01854034|126706|P1|STARTED|Overall Study||29
52964|NCT01853982|126715|P2|NOT COMPLETED|Overall Study||1
52965|NCT01853982|126716|P1|NOT COMPLETED|Overall Study||2
52966|NCT01853982|126715|P2|COMPLETED|Overall Study||1
52967|NCT01853982|126716|P1|COMPLETED|Overall Study||0
52968|NCT01853982|126715|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
52969|NCT01853982|126716|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
52970|NCT01853982|126715|P2|STARTED|Overall Study||2
52971|NCT01853982|126716|P1|STARTED|Overall Study||2
52972|NCT01853839|126722|P1|NOT COMPLETED|Overall Study||429
52973|NCT01853839|126722|P1|COMPLETED|Overall Study||1663
52974|NCT01853839|126722|P1|STARTED|Overall Study||2092
52975|NCT01853696|126744|P2|NOT COMPLETED|Overall Study||5
52976|NCT01853696|126745|P1|NOT COMPLETED|Overall Study||6
52977|NCT01853696|126744|P2|COMPLETED|Overall Study||78
52978|NCT01853696|126745|P1|COMPLETED|Overall Study||78
52979|NCT01853696|126744|P2|STARTED|Overall Study||83
52980|NCT01853696|126745|P1|STARTED|Overall Study||84
52981|NCT01853605|126757|P4|NOT COMPLETED|Overall Study||0
52982|NCT01853605|126758|P3|NOT COMPLETED|Overall Study||0
52983|NCT01853605|126759|P2|NOT COMPLETED|Overall Study||0
52984|NCT01853605|126760|P1|NOT COMPLETED|Overall Study||0
52985|NCT01853605|126757|P4|COMPLETED|Overall Study||428
52986|NCT01853605|126758|P3|COMPLETED|Overall Study||751
52987|NCT01853605|126759|P2|COMPLETED|Overall Study||693
52988|NCT01853605|126760|P1|COMPLETED|Overall Study||1939
52989|NCT01853605|126757|P4|STARTED|Overall Study||428
52990|NCT01853605|126758|P3|STARTED|Overall Study||751
52991|NCT01853605|126759|P2|STARTED|Overall Study||693
52992|NCT01853605|126760|P1|STARTED|Overall Study||1939
52993|NCT01853475|126781|P3|NOT COMPLETED|Overall Study||0
52994|NCT01853475|126782|P2|NOT COMPLETED|Overall Study||1
52995|NCT01853475|126783|P1|NOT COMPLETED|Overall Study||0
52996|NCT01853475|126781|P3|COMPLETED|Overall Study||8
52997|NCT01853475|126782|P2|COMPLETED|Overall Study||7
52998|NCT01853475|126783|P1|COMPLETED|Overall Study||8
52999|NCT01853475|126781|P3|STARTED|Overall Study||8
53000|NCT01853475|126782|P2|STARTED|Overall Study||8
53001|NCT01853475|126783|P1|STARTED|Overall Study||8
53002|NCT01853397|126804|P4|NOT COMPLETED|Overall Study||2
53003|NCT01853397|126805|P3|NOT COMPLETED|Overall Study||0
53004|NCT01853397|126806|P2|NOT COMPLETED|Overall Study||0
53005|NCT01853397|126807|P1|NOT COMPLETED|Overall Study||0
53006|NCT01853397|126804|P4|COMPLETED|Overall Study||15
53007|NCT01853397|126805|P3|COMPLETED|Overall Study||17
53008|NCT01853397|126806|P2|COMPLETED|Overall Study||20
53009|NCT01853397|126807|P1|COMPLETED|Overall Study||18
53010|NCT01853397|126804|P4|STARTED|Overall Study||17
53011|NCT01853397|126805|P3|STARTED|Overall Study||17
53012|NCT01853397|126806|P2|STARTED|Overall Study||20
53013|NCT01853397|126807|P1|STARTED|Overall Study||18
53014|NCT01853384|126835|P2|NOT COMPLETED|Completed Follow up Visit 2||3
53015|NCT01853384|126836|P1|NOT COMPLETED|Completed Follow up Visit 2||3
53016|NCT01853384|126835|P2|COMPLETED|Completed Follow up Visit 2||91
53017|NCT01853384|126836|P1|COMPLETED|Completed Follow up Visit 2||93
53018|NCT01853384|126835|P2|STARTED|Completed Follow up Visit 2||94
53019|NCT01853384|126836|P1|STARTED|Completed Follow up Visit 2||96
53020|NCT01853384|126835|P2|NOT COMPLETED|Completed Follow up Visit 1||9
53021|NCT01853384|126836|P1|NOT COMPLETED|Completed Follow up Visit 1||14
53022|NCT01853384|126835|P2|COMPLETED|Completed Follow up Visit 1||85
53023|NCT01853384|126836|P1|COMPLETED|Completed Follow up Visit 1||82
53024|NCT01853384|126835|P2|STARTED|Completed Follow up Visit 1||94
53025|NCT01853384|126836|P1|STARTED|Completed Follow up Visit 1||96
53026|NCT01853384|126835|P2|NOT COMPLETED|Enrolled in Follow up Period||0
53027|NCT01853384|126836|P1|NOT COMPLETED|Enrolled in Follow up Period||0
53028|NCT01853384|126835|P2|COMPLETED|Enrolled in Follow up Period||94
53029|NCT01853384|126836|P1|COMPLETED|Enrolled in Follow up Period||96
53030|NCT01853384|126835|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
53031|NCT01853384|126836|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
53032|NCT01853384|126835|P2|STARTED|Enrolled in Follow up Period||94
53033|NCT01853384|126836|P1|STARTED|Enrolled in Follow up Period||96
53034|NCT01853384|126835|P2|NOT COMPLETED|Randomized||46
53035|NCT01853384|126836|P1|NOT COMPLETED|Randomized||62
53036|NCT01853384|126835|P2|COMPLETED|Randomized||75
53037|NCT01853384|126836|P1|COMPLETED|Randomized||69
53038|NCT01853384|126835|P2|STARTED|Randomized||121
53039|NCT01853384|126836|P1|STARTED|Randomized||131
53040|NCT01853371|126856|P2|NOT COMPLETED|Overall Study||2
53041|NCT01853371|126857|P1|NOT COMPLETED|Overall Study||0
53042|NCT01853371|126856|P2|COMPLETED|Overall Study||8
53043|NCT01853371|126857|P1|COMPLETED|Overall Study||10
53044|NCT01853371|126856|P2|STARTED|Overall Study||10
53045|NCT01853371|126857|P1|STARTED|Overall Study||10
53046|NCT01853332|126865|P1|NOT COMPLETED|Overall Study||59
53047|NCT01853332|126865|P1|COMPLETED|Overall Study||151
53048|NCT01853332|126865|P1|STARTED|Overall Study||210
53049|NCT01853280|126876|P2|NOT COMPLETED|Overall Study||6
53050|NCT01853280|126877|P1|NOT COMPLETED|Overall Study||2
53051|NCT01853280|126876|P2|COMPLETED|Overall Study||16
53052|NCT01853280|126877|P1|COMPLETED|Overall Study||20
53053|NCT01853280|126876|P2|STARTED|Overall Study||22
53054|NCT01853280|126877|P1|STARTED|Overall Study||22
53055|NCT01853254|126883|P1|NOT COMPLETED|Overall Study||104
53056|NCT01853254|126883|P1|COMPLETED|Overall Study||168
53057|NCT01853254|126883|P1|STARTED|Overall Study||272
53058|NCT01853215|126887|P1|NOT COMPLETED|Overall Study||0
53059|NCT01853215|126887|P1|COMPLETED|Overall Study||24
53060|NCT01853215|126887|P1|STARTED|Overall Study||24
53061|NCT01853176|126900|P2|NOT COMPLETED|Overall Study||0
53062|NCT01853176|126901|P1|NOT COMPLETED|Overall Study||4
53063|NCT01853176|126900|P2|COMPLETED|Overall Study||0
53064|NCT01853176|126901|P1|COMPLETED|Overall Study||0
53065|NCT01853176|126900|P2|STARTED|Overall Study||0
53066|NCT01853176|126901|P1|STARTED|Overall Study||4
53067|NCT01853085|126907|P1|NOT COMPLETED|Overall Study||235
53068|NCT01853085|126907|P1|COMPLETED|Overall Study||1595
53069|NCT01853085|126907|P1|STARTED|Overall Study||1830
53070|NCT01853072|126920|P2|NOT COMPLETED|Overall Study||21
53071|NCT01853072|126921|P1|NOT COMPLETED|Overall Study||12
53072|NCT01853072|126920|P2|COMPLETED|Overall Study||286
53073|NCT01853072|126921|P1|COMPLETED|Overall Study||296
53074|NCT01853072|126920|P2|Full Analysis Set|Overall Study||300
53075|NCT01853072|126921|P1|Full Analysis Set|Overall Study||298
53076|NCT01853072|126920|P2|Treated (Safety Analysis Set)|Overall Study||302
53077|NCT01853072|126921|P1|Treated (Safety Analysis Set)|Overall Study||301
53078|NCT01853072|126920|P2|Randomized|Overall Study||307
53079|NCT01853072|126921|P1|Randomized|Overall Study||308
53080|NCT01853072|126920|P2|STARTED|Overall Study||307
53081|NCT01853072|126921|P1|STARTED|Overall Study||308
53082|NCT01853046|126941|P2|NOT COMPLETED|Overall Study||6
53083|NCT01853046|126942|P1|NOT COMPLETED|Overall Study||18
53084|NCT01853046|126941|P2|COMPLETED|Overall Study||0
53085|NCT01853046|126942|P1|COMPLETED|Overall Study||0
53086|NCT01853046|126941|P2|Received Treatment|Overall Study||6
53087|NCT01853046|126942|P1|Received Treatment|Overall Study||18
53088|NCT01853046|126941|P2|STARTED|Overall Study||6
53089|NCT01853046|126942|P1|STARTED|Overall Study||18
53090|NCT01852955|126996|P2|NOT COMPLETED|Overall Study||3
53091|NCT01852955|126997|P1|NOT COMPLETED|Overall Study||2
53092|NCT01852955|126996|P2|COMPLETED|Overall Study||32
53093|NCT01852955|126997|P1|COMPLETED|Overall Study||33
53094|NCT01852955|126996|P2|STARTED|Overall Study||35
53095|NCT01852955|126997|P1|STARTED|Overall Study||35
53096|NCT01852825|127010|P3|NOT COMPLETED|Overall Study||0
53097|NCT01852825|127011|P2|NOT COMPLETED|Overall Study||0
53098|NCT01852825|127012|P1|NOT COMPLETED|Overall Study||2
53099|NCT01852825|127010|P3|COMPLETED|Overall Study||3
53100|NCT01852825|127011|P2|COMPLETED|Overall Study||7
53101|NCT01852825|127012|P1|COMPLETED|Overall Study||14
53102|NCT01852825|127010|P3|STARTED|Overall Study||3
53103|NCT01852825|127011|P2|STARTED|Overall Study||7
53104|NCT01852825|127012|P1|STARTED|Overall Study||16
53105|NCT01852812|127038|P3|NOT COMPLETED|Overall Study||1
53106|NCT01852812|127039|P2|NOT COMPLETED|Overall Study||1
53107|NCT01852812|127040|P1|NOT COMPLETED|Overall Study||0
53108|NCT01852812|127038|P3|COMPLETED|Overall Study||17
53109|NCT01852812|127039|P2|COMPLETED|Overall Study||17
53110|NCT01852812|127040|P1|COMPLETED|Overall Study||51
53111|NCT01852812|127038|P3|STARTED|Overall Study||18
53112|NCT01852812|127039|P2|STARTED|Overall Study||18
53113|NCT01852812|127040|P1|STARTED|Overall Study||51
53114|NCT01852669|127062|P2|NOT COMPLETED|Overall Study||1
53115|NCT01852669|127063|P1|NOT COMPLETED|Overall Study||0
53116|NCT01852669|127062|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
53117|NCT01852669|127063|P1|COMPLETED|Overall Study||71
53118|NCT01852669|127062|P2|STARTED|Overall Study||69
53119|NCT01852669|127063|P1|STARTED|Overall Study||71
53120|NCT01852591|127069|P1|NOT COMPLETED|Overall Study||3
53121|NCT01852591|127069|P1|COMPLETED|Overall Study||5
53122|NCT01852591|127069|P1|STARTED|Overall Study||8
53123|NCT01852383|127076|P1|NOT COMPLETED|Overall Study||11
53124|NCT01852383|127076|P1|COMPLETED|Overall Study||19
53125|NCT01852383|127076|P1|STARTED|Overall Study||30
53126|NCT01852344|127087|P4|NOT COMPLETED|Overall Study||0
53127|NCT01852344|127088|P3|NOT COMPLETED|Overall Study||0
53128|NCT01852344|127089|P2|NOT COMPLETED|Overall Study||0
53129|NCT01852344|127090|P1|NOT COMPLETED|Overall Study||0
53130|NCT01852344|127087|P4|COMPLETED|Overall Study||27
53131|NCT01852344|127088|P3|COMPLETED|Overall Study||27
53132|NCT01852344|127089|P2|COMPLETED|Overall Study||27
53133|NCT01852344|127090|P1|COMPLETED|Overall Study||27
53134|NCT01852344|127087|P4|Actual Participation in First Assignment|Overall Study||27
53135|NCT01852344|127088|P3|Actual Participation in First Assignment|Overall Study||27
53136|NCT01852344|127089|P2|Actual Participation in First Assignment|Overall Study||27
53137|NCT01852344|127090|P1|Actual Participation in First Assignment|Overall Study||27
53138|NCT01852344|127087|P4|STARTED|Overall Study||27
53139|NCT01852344|127088|P3|STARTED|Overall Study||27
53140|NCT01852344|127089|P2|STARTED|Overall Study||27
53141|NCT01852344|127090|P1|STARTED|Overall Study||27
53142|NCT01852214|127108|P2|NOT COMPLETED|Period 2||0
53143|NCT01852214|127109|P1|NOT COMPLETED|Period 2||0
53144|NCT01852214|127108|P2|COMPLETED|Period 2||20
53145|NCT01852214|127109|P1|COMPLETED|Period 2||25
53146|NCT01852214|127108|P2|STARTED|Period 2||20
53147|NCT01852214|127109|P1|STARTED|Period 2||25
53148|NCT01852214|127108|P2|NOT COMPLETED|Washout Period||1
53149|NCT01852214|127109|P1|NOT COMPLETED|Washout Period||0
53150|NCT01852214|127108|P2|COMPLETED|Washout Period||20
53151|NCT01852214|127109|P1|COMPLETED|Washout Period||25
53152|NCT01852214|127108|P2|STARTED|Washout Period||21
53153|NCT01852214|127109|P1|STARTED|Washout Period||25
53154|NCT01852214|127108|P2|NOT COMPLETED|Period 1||3
53155|NCT01852214|127109|P1|NOT COMPLETED|Period 1||1
53156|NCT01852214|127108|P2|COMPLETED|Period 1||21
53157|NCT01852214|127109|P1|COMPLETED|Period 1||25
53158|NCT01852214|127108|P2|STARTED|Period 1||24
53159|NCT01852214|127109|P1|STARTED|Period 1||26
53160|NCT01852175|127123|P2|NOT COMPLETED|Overall Study||0
53161|NCT01852175|127124|P1|NOT COMPLETED|Overall Study||0
53162|NCT01852175|127123|P2|COMPLETED|Overall Study||55
53163|NCT01852175|127124|P1|COMPLETED|Overall Study||55
53164|NCT01852175|127123|P2|STARTED|Overall Study||55
53165|NCT01852175|127124|P1|STARTED|Overall Study||55
53166|NCT01852162|127136|P2|NOT COMPLETED|Overall Study||1
53167|NCT01852162|127137|P1|NOT COMPLETED|Overall Study||4
53168|NCT01852162|127136|P2|COMPLETED|Overall Study||16
53169|NCT01852162|127137|P1|COMPLETED|Overall Study||14
53170|NCT01852162|127136|P2|STARTED|Overall Study||17
53171|NCT01852162|127137|P1|STARTED|Overall Study||18
53172|NCT01852110|127153|P6|NOT COMPLETED|Overall Study||0
53173|NCT01852110|127154|P5|NOT COMPLETED|Overall Study||0
53174|NCT01852110|127155|P4|NOT COMPLETED|Overall Study||0
53175|NCT01852110|127156|P3|NOT COMPLETED|Overall Study||0
53176|NCT01852110|127157|P2|NOT COMPLETED|Overall Study||46
53177|NCT01852110|127158|P1|NOT COMPLETED|Overall Study||50
53178|NCT01852110|127153|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53179|NCT01852110|127154|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53180|NCT01852110|127155|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53181|NCT01852110|127156|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53182|NCT01852110|127157|P2|COMPLETED|Overall Study||74
53183|NCT01852110|127158|P1|COMPLETED|Overall Study||70
53184|NCT01852110|127153|P6|Treated|Overall Study||0
53185|NCT01852110|127154|P5|Treated|Overall Study||0
53186|NCT01852110|127155|P4|Treated|Overall Study||0
53187|NCT01852110|127156|P3|Treated|Overall Study||0
53188|NCT01852110|127157|P2|Treated|Overall Study||120
53189|NCT01852110|127158|P1|Treated|Overall Study||119
53190|NCT01852110|127153|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53191|NCT01852110|127154|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53192|NCT01852110|127155|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53193|NCT01852110|127156|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
53194|NCT01852110|127157|P2|STARTED|Overall Study||120
53195|NCT01852110|127158|P1|STARTED|Overall Study||120
53196|NCT01852032|127186|P1|NOT COMPLETED|Overall Study||0
53197|NCT01852032|127186|P1|COMPLETED|Overall Study||23
53198|NCT01852032|127186|P1|STARTED|Overall Study||23
53199|NCT01852019|127196|P5|NOT COMPLETED|Day 8||0
53200|NCT01852019|127197|P4|NOT COMPLETED|Day 8||0
53201|NCT01852019|127198|P3|NOT COMPLETED|Day 8||0
53202|NCT01852019|127199|P2|NOT COMPLETED|Day 8||0
53203|NCT01852019|127200|P1|NOT COMPLETED|Day 8||0
53204|NCT01852019|127196|P5|COMPLETED|Day 8||6
53205|NCT01852019|127197|P4|COMPLETED|Day 8||6
53206|NCT01852019|127198|P3|COMPLETED|Day 8||0
53207|NCT01852019|127199|P2|COMPLETED|Day 8||0
53208|NCT01852019|127200|P1|COMPLETED|Day 8||0
53209|NCT01852019|127196|P5|STARTED|Day 8||6
53210|NCT01852019|127197|P4|STARTED|Day 8||6
53211|NCT01852019|127198|P3|STARTED|Day 8||0
53212|NCT01852019|127199|P2|STARTED|Day 8||0
53213|NCT01852019|127200|P1|STARTED|Day 8||0
53214|NCT01852019|127196|P5|NOT COMPLETED|Day 1||0
53215|NCT01852019|127197|P4|NOT COMPLETED|Day 1||0
53216|NCT01852019|127198|P3|NOT COMPLETED|Day 1||0
53217|NCT01852019|127199|P2|NOT COMPLETED|Day 1||0
53218|NCT01852019|127200|P1|NOT COMPLETED|Day 1||0
53219|NCT01852019|127196|P5|COMPLETED|Day 1||0
53220|NCT01852019|127197|P4|COMPLETED|Day 1||0
53221|NCT01852019|127198|P3|COMPLETED|Day 1||6
53222|NCT01852019|127199|P2|COMPLETED|Day 1||3
53223|NCT01852019|127200|P1|COMPLETED|Day 1||3
53224|NCT01852019|127196|P5|STARTED|Day 1||0
53225|NCT01852019|127197|P4|STARTED|Day 1||0
53226|NCT01852019|127198|P3|STARTED|Day 1||6
53227|NCT01852019|127199|P2|STARTED|Day 1||3
53228|NCT01852019|127200|P1|STARTED|Day 1||3
53229|NCT01851876|127221|P2|NOT COMPLETED|Overall Study||0
53230|NCT01851876|127222|P1|NOT COMPLETED|Overall Study||0
53231|NCT01851876|127221|P2|COMPLETED|Overall Study||62
53232|NCT01851876|127222|P1|COMPLETED|Overall Study||56
53233|NCT01851876|127221|P2|STARTED|Overall Study||62
53234|NCT01851876|127222|P1|STARTED|Overall Study||56
53235|NCT01851863|127232|P4|NOT COMPLETED|Overall Study||3
53236|NCT01851863|127233|P3|NOT COMPLETED|Overall Study||5
53237|NCT01851863|127234|P2|NOT COMPLETED|Overall Study||9
53238|NCT01851863|127235|P1|NOT COMPLETED|Overall Study||5
53239|NCT01851863|127232|P4|COMPLETED|Overall Study||63
53240|NCT01851863|127233|P3|COMPLETED|Overall Study||60
53241|NCT01851863|127234|P2|COMPLETED|Overall Study||57
53242|NCT01851863|127235|P1|COMPLETED|Overall Study||60
53243|NCT01851863|127232|P4|STARTED|Overall Study||66
53244|NCT01851863|127233|P3|STARTED|Overall Study||65
53245|NCT01851863|127234|P2|STARTED|Overall Study||66
53246|NCT01851863|127235|P1|STARTED|Overall Study||65
53247|NCT01851772|127256|P1|NOT COMPLETED|Overall Study||0
53248|NCT01851772|127256|P1|COMPLETED|Overall Study||3
53249|NCT01851772|127256|P1|STARTED|Overall Study||3
53250|NCT01851720|127264|P2|NOT COMPLETED|Overall Study||1
53251|NCT01851720|127265|P1|NOT COMPLETED|Overall Study||0
53252|NCT01851720|127264|P2|COMPLETED|Overall Study||0
53253|NCT01851720|127265|P1|COMPLETED|Overall Study||0
53254|NCT01851720|127264|P2|STARTED|Overall Study||1
53255|NCT01851720|127265|P1|STARTED|Overall Study||0
53256|NCT01851655|127273|P2|NOT COMPLETED|Overall Study||0
53257|NCT01851655|127274|P1|NOT COMPLETED|Overall Study||0
53258|NCT01851655|127273|P2|COMPLETED|Overall Study||12
53259|NCT01851655|127274|P1|COMPLETED|Overall Study||12
53260|NCT01851655|127273|P2|STARTED|Overall Study||12
53261|NCT01851655|127274|P1|STARTED|Overall Study||12
53262|NCT01851590|127295|P3|NOT COMPLETED|Overall Study||3
53263|NCT01851590|127296|P2|NOT COMPLETED|Overall Study||1
53264|NCT01851590|127297|P1|NOT COMPLETED|Overall Study||0
53265|NCT01851590|127295|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
53266|NCT01851590|127296|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
53267|NCT01851590|127297|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
53268|NCT01851590|127295|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
53269|NCT01851590|127296|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
53270|NCT01851590|127297|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
53271|NCT01851590|127295|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
53272|NCT01851590|127296|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
53358|NCT01849692|127526|P6|COMPLETED|Overall Study||3
53273|NCT01851590|127297|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
53274|NCT01851590|127295|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
53275|NCT01851590|127296|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
53276|NCT01851590|127297|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
53277|NCT01851590|127295|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
53278|NCT01851590|127296|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
53279|NCT01851590|127297|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
53280|NCT01851590|127295|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
53281|NCT01851590|127296|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
53282|NCT01851590|127297|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
53283|NCT01851330|127320|P3|NOT COMPLETED|Overall Study||12
53284|NCT01851330|127321|P2|NOT COMPLETED|Overall Study||16
53285|NCT01851330|127322|P1|NOT COMPLETED|Overall Study||13
53286|NCT01851330|127320|P3|COMPLETED|Overall Study||204
53287|NCT01851330|127321|P2|COMPLETED|Overall Study||200
53288|NCT01851330|127322|P1|COMPLETED|Overall Study||202
53289|NCT01851330|127320|P3|STARTED|Overall Study||216
53290|NCT01851330|127321|P2|STARTED|Overall Study||216
53291|NCT01851330|127322|P1|STARTED|Overall Study||215
53292|NCT01851174|127357|P1|NOT COMPLETED|Overall Study||0
53293|NCT01851174|127357|P1|COMPLETED|Overall Study||15
53294|NCT01851174|127357|P1|STARTED|Overall Study||15
53295|NCT01850615|127364|P2|NOT COMPLETED|Overall Study||5
53296|NCT01850615|127365|P1|NOT COMPLETED|Overall Study||9
53297|NCT01850615|127364|P2|COMPLETED|Overall Study||115
53298|NCT01850615|127365|P1|COMPLETED|Overall Study||107
53299|NCT01850615|127364|P2|Exposed|Overall Study||120
53300|NCT01850615|127365|P1|Exposed|Overall Study||115
53301|NCT01850615|127364|P2|STARTED|Overall Study||120
53302|NCT01850615|127365|P1|STARTED|Overall Study||116
53303|NCT01850589|127383|P2|NOT COMPLETED|Overall Study||0
53304|NCT01850589|127384|P1|NOT COMPLETED|Overall Study||8
53305|NCT01850589|127383|P2|COMPLETED|Overall Study||22
53306|NCT01850589|127384|P1|COMPLETED|Overall Study||14
53307|NCT01850589|127383|P2|STARTED|Overall Study||22
53308|NCT01850589|127384|P1|STARTED|Overall Study||22
53309|NCT01850550|127392|P2|NOT COMPLETED|Overall Study||3
53310|NCT01850550|127393|P1|NOT COMPLETED|Overall Study||0
53311|NCT01850550|127392|P2|COMPLETED|Overall Study||37
53312|NCT01850550|127393|P1|COMPLETED|Overall Study||40
53313|NCT01850550|127392|P2|STARTED|Overall Study||40
53314|NCT01850550|127393|P1|STARTED|Overall Study||40
53315|NCT01850485|127403|P2|NOT COMPLETED|Overall Study||0
53316|NCT01850485|127404|P1|NOT COMPLETED|Overall Study||0
53317|NCT01850485|127403|P2|COMPLETED|Overall Study||13
53318|NCT01850485|127404|P1|COMPLETED|Overall Study||9
53319|NCT01850485|127403|P2|STARTED|Overall Study||13
53320|NCT01850485|127404|P1|STARTED|Overall Study||9
53321|NCT01850394|127425|P3|NOT COMPLETED|Overall Study||0
53322|NCT01850394|127426|P2|NOT COMPLETED|Overall Study||0
53323|NCT01850394|127427|P1|NOT COMPLETED|Overall Study||0
53324|NCT01850394|127425|P3|COMPLETED|Overall Study||45
53325|NCT01850394|127426|P2|COMPLETED|Overall Study||45
53326|NCT01850394|127427|P1|COMPLETED|Overall Study||45
53327|NCT01850394|127425|P3|STARTED|Overall Study||45
53328|NCT01850394|127426|P2|STARTED|Overall Study||45
53329|NCT01850394|127427|P1|STARTED|Overall Study||45
53330|NCT01850030|127449|P2|NOT COMPLETED|Overall Study||369
53331|NCT01850030|127450|P1|NOT COMPLETED|Overall Study||347
53332|NCT01850030|127449|P2|COMPLETED|Overall Study||142
53333|NCT01850030|127450|P1|COMPLETED|Overall Study||173
53334|NCT01850030|127449|P2|STARTED|Overall Study||511
53335|NCT01850030|127450|P1|STARTED|Overall Study||520
53336|NCT01849848|127462|P1|NOT COMPLETED|Overall Study||4
53337|NCT01849848|127462|P1|COMPLETED|Overall Study||13
53338|NCT01849848|127462|P1|STARTED|Overall Study||17
53339|NCT01849770|127479|P3|NOT COMPLETED|Overall Study||1
53340|NCT01849770|127480|P2|NOT COMPLETED|Overall Study||4
53341|NCT01849770|127481|P1|NOT COMPLETED|Overall Study||0
53342|NCT01849770|127479|P3|COMPLETED|Overall Study||19
53343|NCT01849770|127480|P2|COMPLETED|Overall Study||15
53344|NCT01849770|127481|P1|COMPLETED|Overall Study||20
53345|NCT01849770|127479|P3|STARTED|Overall Study||20
53346|NCT01849770|127480|P2|STARTED|Overall Study||19
53347|NCT01849770|127481|P1|STARTED|Overall Study||20
53348|NCT01849692|127524|P8|NOT COMPLETED|Overall Study||0
53349|NCT01849692|127525|P7|NOT COMPLETED|Overall Study||0
53350|NCT01849692|127526|P6|NOT COMPLETED|Overall Study||0
53351|NCT01849692|127527|P5|NOT COMPLETED|Overall Study||0
53352|NCT01849692|127528|P4|NOT COMPLETED|Overall Study||0
53353|NCT01849692|127529|P3|NOT COMPLETED|Overall Study||0
53354|NCT01849692|127530|P2|NOT COMPLETED|Overall Study||0
53355|NCT01849692|127531|P1|NOT COMPLETED|Overall Study||0
53356|NCT01849692|127524|P8|COMPLETED|Overall Study||3
53357|NCT01849692|127525|P7|COMPLETED|Overall Study||10
53359|NCT01849692|127527|P5|COMPLETED|Overall Study||10
53360|NCT01849692|127528|P4|COMPLETED|Overall Study||3
53361|NCT01849692|127529|P3|COMPLETED|Overall Study||10
53362|NCT01849692|127530|P2|COMPLETED|Overall Study||3
53363|NCT01849692|127531|P1|COMPLETED|Overall Study||10
53364|NCT01849692|127524|P8|STARTED|Overall Study||3
53365|NCT01849692|127525|P7|STARTED|Overall Study||10
53366|NCT01849692|127526|P6|STARTED|Overall Study||3
53367|NCT01849692|127527|P5|STARTED|Overall Study||10
53368|NCT01849692|127528|P4|STARTED|Overall Study||3
53369|NCT01849692|127529|P3|STARTED|Overall Study||10
53370|NCT01849692|127530|P2|STARTED|Overall Study||3
53371|NCT01849692|127531|P1|STARTED|Overall Study||10
53372|NCT01849588|127560|P1|NOT COMPLETED|Overall Study||3
53373|NCT01849588|127560|P1|COMPLETED|Overall Study||0
53374|NCT01849588|127560|P1|STARTED|Overall Study||3
53375|NCT01849562|127570|P3|NOT COMPLETED|Overall Study||0
53376|NCT01849562|127571|P2|NOT COMPLETED|Overall Study||0
53377|NCT01849562|127572|P1|NOT COMPLETED|Overall Study||2
53378|NCT01849562|127570|P3|COMPLETED|Overall Study||10
53379|NCT01849562|127571|P2|COMPLETED|Overall Study||10
53380|NCT01849562|127572|P1|COMPLETED|Overall Study||8
53381|NCT01849562|127570|P3|STARTED|Overall Study||10
53382|NCT01849562|127571|P2|STARTED|Overall Study||10
53383|NCT01849562|127572|P1|STARTED|Overall Study||10
53384|NCT01849497|127585|P2|NOT COMPLETED|Overall Study||4
53385|NCT01849497|127586|P1|NOT COMPLETED|Overall Study||1
53386|NCT01849497|127585|P2|COMPLETED|Overall Study||70
53387|NCT01849497|127586|P1|COMPLETED|Overall Study||74
53388|NCT01849497|127585|P2|Received Treatment|Overall Study||74
53389|NCT01849497|127586|P1|Received Treatment|Overall Study||75
53390|NCT01849497|127585|P2|STARTED|Overall Study||74
53391|NCT01849497|127586|P1|STARTED|Overall Study||75
53392|NCT01849458|127594|P1|NOT COMPLETED|Overall Study||4
53393|NCT01849458|127594|P1|COMPLETED|Overall Study||46
53394|NCT01849458|127594|P1|6 Months Follow-up|Overall Study||50
53395|NCT01849458|127594|P1|STARTED|Overall Study||50
53396|NCT01849419|127604|P1|NOT COMPLETED|Overall Study||0
53397|NCT01849419|127604|P1|COMPLETED|Overall Study||65
53398|NCT01849419|127604|P1|STARTED|Overall Study||65
53399|NCT01849289|127633|P2|NOT COMPLETED|Overall Study||24
53400|NCT01849289|127634|P1|NOT COMPLETED|Overall Study||32
53401|NCT01849289|127633|P2|COMPLETED|Overall Study||254
53402|NCT01849289|127634|P1|COMPLETED|Overall Study||523
53403|NCT01849289|127633|P2|Exposed|Overall Study||278
53404|NCT01849289|127634|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
53405|NCT01849289|127633|P2|STARTED|Overall Study||278
53406|NCT01849289|127634|P1|STARTED|Overall Study||555
53407|NCT01849263|127650|P1|NOT COMPLETED|Overall Study||0
53408|NCT01849263|127650|P1|COMPLETED|Overall Study||40
53409|NCT01849263|127650|P1|STARTED|Overall Study||40
53410|NCT01849068|127662|P2|NOT COMPLETED|Overall Study||0
53411|NCT01849068|127663|P1|NOT COMPLETED|Overall Study||0
53412|NCT01849068|127662|P2|COMPLETED|Overall Study||10
53413|NCT01849068|127663|P1|COMPLETED|Overall Study||10
53414|NCT01849068|127662|P2|STARTED|Overall Study||10
53415|NCT01849068|127663|P1|STARTED|Overall Study||10
53416|NCT01848990|127678|P3|NOT COMPLETED|Overall Study||11
53417|NCT01848990|127679|P2|NOT COMPLETED|Overall Study||9
53418|NCT01848990|127680|P1|NOT COMPLETED|Overall Study||33
53419|NCT01848990|127678|P3|COMPLETED|Overall Study||103
53420|NCT01848990|127679|P2|COMPLETED|Overall Study||106
53421|NCT01848990|127680|P1|COMPLETED|Overall Study||194
53422|NCT01848990|127678|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
53423|NCT01848990|127679|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
53424|NCT01848990|127680|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
53425|NCT01848990|127678|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
53426|NCT01848990|127679|P2|STARTED|Overall Study||115
53427|NCT01848990|127680|P1|STARTED|Overall Study||227
53428|NCT01848977|127695|P1|NOT COMPLETED|Overall Study||0
53429|NCT01848977|127695|P1|COMPLETED|Overall Study||20
53430|NCT01848977|127695|P1|STARTED|Overall Study||20
53431|NCT01848938|127706|P2|NOT COMPLETED|Overall Study||1
53432|NCT01848938|127707|P1|NOT COMPLETED|Overall Study||1
53433|NCT01848938|127706|P2|COMPLETED|Overall Study||60
53434|NCT01848938|127707|P1|COMPLETED|Overall Study||61
53435|NCT01848938|127706|P2|STARTED|Overall Study||61
53436|NCT01848938|127707|P1|STARTED|Overall Study||62
53437|NCT01848899|127725|P2|NOT COMPLETED|Overall Study||0
53438|NCT01848899|127726|P1|NOT COMPLETED|Overall Study||0
53439|NCT01848899|127725|P2|COMPLETED|Overall Study||50
53440|NCT01848899|127726|P1|COMPLETED|Overall Study||50
53441|NCT01848899|127725|P2|STARTED|Overall Study||50
53442|NCT01848899|127726|P1|STARTED|Overall Study||50
53443|NCT01848847|127742|P2|NOT COMPLETED|Overall Study||3
53444|NCT01848847|127743|P1|NOT COMPLETED|Overall Study||2
53445|NCT01848847|127742|P2|COMPLETED|Overall Study||48
53446|NCT01848847|127743|P1|COMPLETED|Overall Study||49
53447|NCT01848847|127742|P2|STARTED|Overall Study||51
53448|NCT01848847|127743|P1|STARTED|Overall Study||51
53449|NCT01848834|127756|P5|NOT COMPLETED|Overall Study||132
53450|NCT01848834|127757|P4|NOT COMPLETED|Overall Study||37
53451|NCT01848834|127758|P3|NOT COMPLETED|Overall Study||32
53452|NCT01848834|127759|P2|NOT COMPLETED|Overall Study||60
53453|NCT01848834|127760|P1|NOT COMPLETED|Overall Study||30
53454|NCT01848834|127756|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
53455|NCT01848834|127757|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
53456|NCT01848834|127758|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
53457|NCT01848834|127759|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
53458|NCT01848834|127760|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
53459|NCT01848834|127756|P5|Treated|Overall Study||132
53460|NCT01848834|127757|P4|Treated|Overall Study||39
53461|NCT01848834|127758|P3|Treated|Overall Study||33
53462|NCT01848834|127759|P2|Treated|Overall Study||60
53463|NCT01848834|127760|P1|Treated|Overall Study||32
53464|NCT01848834|127756|P5|STARTED|Overall Study||132
53465|NCT01848834|127757|P4|STARTED|Overall Study||39
53466|NCT01848834|127758|P3|STARTED|Overall Study||33
53467|NCT01848834|127759|P2|STARTED|Overall Study||61
53468|NCT01848834|127760|P1|STARTED|Overall Study||32
53469|NCT01848756|127795|P1|NOT COMPLETED|Overall Study||3
53470|NCT01848756|127795|P1|COMPLETED|Overall Study|Cycle 1|12
53471|NCT01848756|127795|P1|STARTED|Overall Study||15
53472|NCT01848366|127805|P1|NOT COMPLETED|Overall Study||0
53473|NCT01848366|127805|P1|COMPLETED|Overall Study||8
53474|NCT01848366|127805|P1|STARTED|Overall Study||8
53475|NCT01848288|127809|P1|NOT COMPLETED|Overall Study||3
53476|NCT01848288|127809|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
53477|NCT01848288|127809|P1|STARTED|Overall Study||100
53478|NCT01848210|127820|P2|NOT COMPLETED|Overall Study||78
53479|NCT01848210|127821|P1|NOT COMPLETED|Overall Study||88
53480|NCT01848210|127820|P2|COMPLETED|Overall Study||340
53481|NCT01848210|127821|P1|COMPLETED|Overall Study||323
53482|NCT01848210|127820|P2|Per Protocol Population|Overall Study||245
53483|NCT01848210|127821|P1|Per Protocol Population|Overall Study||222
53484|NCT01848210|127820|P2|Intent-to-Treat (ITT) Population|Overall Study||388
53485|NCT01848210|127821|P1|Intent-to-Treat (ITT) Population|Overall Study||383
53486|NCT01848210|127820|P2|Safety Population-Received Study Drug|Overall Study||398
53487|NCT01848210|127821|P1|Safety Population-Received Study Drug|Overall Study||394
53488|NCT01848210|127820|P2|STARTED|Overall Study||418
53489|NCT01848210|127821|P1|STARTED|Overall Study||411
53490|NCT01848145|127833|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
53491|NCT01848145|127833|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
53492|NCT01848145|127833|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
53493|NCT01848145|127833|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
53494|NCT01848145|127833|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
53495|NCT01848145|127833|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
53496|NCT01848145|127833|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
53497|NCT01848145|127833|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
53498|NCT01848145|127833|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
53499|NCT01848145|127833|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
53500|NCT01848145|127833|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
53501|NCT01848145|127833|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
53502|NCT01848145|127833|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
53503|NCT01848145|127833|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
53504|NCT01848145|127833|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
53505|NCT01848067|127842|P1|NOT COMPLETED|Overall Study||0
53506|NCT01848067|127842|P1|COMPLETED|Overall Study||9
53507|NCT01848067|127842|P1|STARTED|Overall Study||9
53508|NCT01848054|127850|P2|NOT COMPLETED|Stabilization/Maintenance||40
53509|NCT01848054|127851|P1|NOT COMPLETED|Stabilization/Maintenance||40
53510|NCT01848054|127850|P2|COMPLETED|Stabilization/Maintenance||107
53511|NCT01848054|127851|P1|COMPLETED|Stabilization/Maintenance||92
53512|NCT01848054|127850|P2|STARTED|Stabilization/Maintenance||147
53513|NCT01848054|127851|P1|STARTED|Stabilization/Maintenance||132
53514|NCT01848054|127850|P2|NOT COMPLETED|Induction Phase||8
53515|NCT01848054|127851|P1|NOT COMPLETED|Induction Phase||23
53516|NCT01848054|127850|P2|COMPLETED|Induction Phase||147
53517|NCT01848054|127851|P1|COMPLETED|Induction Phase||132
53518|NCT01848054|127850|P2|STARTED|Induction Phase||155
53519|NCT01848054|127851|P1|STARTED|Induction Phase||155
53520|NCT01847885|127873|P3|NOT COMPLETED|Randomization||2
53521|NCT01847885|127874|P2|NOT COMPLETED|Randomization||4
53522|NCT01847885|127875|P1|NOT COMPLETED|Randomization||0
53523|NCT01847885|127873|P3|COMPLETED|Randomization||13
53524|NCT01847885|127874|P2|COMPLETED|Randomization||27
53525|NCT01847885|127875|P1|COMPLETED|Randomization||0
53526|NCT01847885|127873|P3|Per Protocol Set|Randomization||13
53527|NCT01847885|127874|P2|Per Protocol Set|Randomization||27
53528|NCT01847885|127875|P1|Per Protocol Set|Randomization||0
53529|NCT01847885|127873|P3|Safety Set|Randomization||13
53530|NCT01847885|127874|P2|Safety Set|Randomization||28
53531|NCT01847885|127875|P1|Safety Set|Randomization||0
53532|NCT01847885|127873|P3|Full Analysis Set|Randomization||15
53533|NCT01847885|127874|P2|Full Analysis Set|Randomization||28
53534|NCT01847885|127875|P1|Full Analysis Set|Randomization||0
53535|NCT01847885|127873|P3|STARTED|Randomization||15
53536|NCT01847885|127874|P2|STARTED|Randomization||31
53537|NCT01847885|127875|P1|STARTED|Randomization||0
53538|NCT01847885|127873|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
53539|NCT01847885|127874|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
53540|NCT01847885|127875|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
53541|NCT01847885|127873|P3|COMPLETED|Initial Enrollment (Consented)||0
53542|NCT01847885|127874|P2|COMPLETED|Initial Enrollment (Consented)||0
53543|NCT01847885|127875|P1|COMPLETED|Initial Enrollment (Consented)||40
53544|NCT01847885|127873|P3|Per Protocol Set|Initial Enrollment (Consented)||0
53545|NCT01847885|127874|P2|Per Protocol Set|Initial Enrollment (Consented)||0
53546|NCT01847885|127875|P1|Per Protocol Set|Initial Enrollment (Consented)||40
53547|NCT01847885|127873|P3|Safety Set|Initial Enrollment (Consented)||0
53548|NCT01847885|127874|P2|Safety Set|Initial Enrollment (Consented)||0
53549|NCT01847885|127875|P1|Safety Set|Initial Enrollment (Consented)||41
53550|NCT01847885|127873|P3|Full Analysis Set|Initial Enrollment (Consented)||0
53551|NCT01847885|127874|P2|Full Analysis Set|Initial Enrollment (Consented)||0
53552|NCT01847885|127875|P1|Full Analysis Set|Initial Enrollment (Consented)||43
53553|NCT01847885|127873|P3|Randomized|Initial Enrollment (Consented)||0
53554|NCT01847885|127874|P2|Randomized|Initial Enrollment (Consented)||0
53555|NCT01847885|127875|P1|Randomized|Initial Enrollment (Consented)||46
53556|NCT01847885|127873|P3|STARTED|Initial Enrollment (Consented)||0
53557|NCT01847885|127874|P2|STARTED|Initial Enrollment (Consented)||0
53558|NCT01847885|127875|P1|STARTED|Initial Enrollment (Consented)||88
53559|NCT01847547|127909|P2|NOT COMPLETED|Overall Study||0
53560|NCT01847547|127910|P1|NOT COMPLETED|Overall Study||0
53561|NCT01847547|127909|P2|COMPLETED|Overall Study||2991
53562|NCT01847547|127910|P1|COMPLETED|Overall Study||2991
53563|NCT01847547|127909|P2|STARTED|Overall Study||2991
53564|NCT01847547|127910|P1|STARTED|Overall Study||2991
53565|NCT01847443|127952|P4|NOT COMPLETED|Study Period 4||0
53566|NCT01847443|127953|P3|NOT COMPLETED|Study Period 4||0
53567|NCT01847443|127954|P2|NOT COMPLETED|Study Period 4||0
53568|NCT01847443|127955|P1|NOT COMPLETED|Study Period 4||0
53569|NCT01847443|127952|P4|COMPLETED|Study Period 4||21
53570|NCT01847443|127953|P3|COMPLETED|Study Period 4||21
53571|NCT01847443|127954|P2|COMPLETED|Study Period 4||19
53572|NCT01847443|127955|P1|COMPLETED|Study Period 4||16
53573|NCT01847443|127952|P4|STARTED|Study Period 4||21
53574|NCT01847443|127953|P3|STARTED|Study Period 4||21
53575|NCT01847443|127954|P2|STARTED|Study Period 4||19
53576|NCT01847443|127955|P1|STARTED|Study Period 4||16
53577|NCT01847443|127952|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
53578|NCT01847443|127953|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
53579|NCT01847443|127954|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
53580|NCT01847443|127955|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
53581|NCT01847443|127952|P4|COMPLETED|Washout Period Before Study Period 4||21
53582|NCT01847443|127953|P3|COMPLETED|Washout Period Before Study Period 4||21
53583|NCT01847443|127954|P2|COMPLETED|Washout Period Before Study Period 4||19
53584|NCT01847443|127955|P1|COMPLETED|Washout Period Before Study Period 4||16
53585|NCT01847443|127952|P4|STARTED|Washout Period Before Study Period 4||21
53586|NCT01847443|127953|P3|STARTED|Washout Period Before Study Period 4||21
53587|NCT01847443|127954|P2|STARTED|Washout Period Before Study Period 4||19
53588|NCT01847443|127955|P1|STARTED|Washout Period Before Study Period 4||18
53589|NCT01847443|127952|P4|NOT COMPLETED|Study Period 3||0
53590|NCT01847443|127953|P3|NOT COMPLETED|Study Period 3||0
53591|NCT01847443|127954|P2|NOT COMPLETED|Study Period 3||0
53592|NCT01847443|127955|P1|NOT COMPLETED|Study Period 3||0
53593|NCT01847443|127952|P4|COMPLETED|Study Period 3||21
53594|NCT01847443|127953|P3|COMPLETED|Study Period 3||21
53595|NCT01847443|127954|P2|COMPLETED|Study Period 3||19
53596|NCT01847443|127955|P1|COMPLETED|Study Period 3||18
53597|NCT01847443|127952|P4|STARTED|Study Period 3||21
53598|NCT01847443|127953|P3|STARTED|Study Period 3||21
53599|NCT01847443|127954|P2|STARTED|Study Period 3||19
53600|NCT01847443|127955|P1|STARTED|Study Period 3||18
53601|NCT01847443|127952|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
53602|NCT01847443|127953|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
53603|NCT01847443|127954|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
53604|NCT01847443|127955|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
53605|NCT01847443|127952|P4|COMPLETED|Washout Period Before Study Period 3||21
53606|NCT01847443|127953|P3|COMPLETED|Washout Period Before Study Period 3||21
53607|NCT01847443|127954|P2|COMPLETED|Washout Period Before Study Period 3||19
53608|NCT01847443|127955|P1|COMPLETED|Washout Period Before Study Period 3||18
53609|NCT01847443|127952|P4|STARTED|Washout Period Before Study Period 3||21
53610|NCT01847443|127953|P3|STARTED|Washout Period Before Study Period 3||21
53611|NCT01847443|127954|P2|STARTED|Washout Period Before Study Period 3||19
53612|NCT01847443|127955|P1|STARTED|Washout Period Before Study Period 3||19
53613|NCT01847443|127952|P4|NOT COMPLETED|Study Period 2||0
53614|NCT01847443|127953|P3|NOT COMPLETED|Study Period 2||0
53615|NCT01847443|127954|P2|NOT COMPLETED|Study Period 2||0
53616|NCT01847443|127955|P1|NOT COMPLETED|Study Period 2||0
53617|NCT01847443|127952|P4|COMPLETED|Study Period 2||21
53618|NCT01847443|127953|P3|COMPLETED|Study Period 2||21
53619|NCT01847443|127954|P2|COMPLETED|Study Period 2||19
53620|NCT01847443|127955|P1|COMPLETED|Study Period 2||19
53621|NCT01847443|127952|P4|STARTED|Study Period 2||21
53622|NCT01847443|127953|P3|STARTED|Study Period 2||21
53623|NCT01847443|127954|P2|STARTED|Study Period 2||19
53624|NCT01847443|127955|P1|STARTED|Study Period 2||19
53625|NCT01847443|127952|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
53626|NCT01847443|127953|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
53627|NCT01847443|127954|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
53628|NCT01847443|127955|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
53629|NCT01847443|127952|P4|COMPLETED|Washout Period Before Study Period 2||21
53630|NCT01847443|127953|P3|COMPLETED|Washout Period Before Study Period 2||21
53631|NCT01847443|127954|P2|COMPLETED|Washout Period Before Study Period 2||19
53632|NCT01847443|127955|P1|COMPLETED|Washout Period Before Study Period 2||19
53633|NCT01847443|127952|P4|STARTED|Washout Period Before Study Period 2||21
53634|NCT01847443|127953|P3|STARTED|Washout Period Before Study Period 2||21
53635|NCT01847443|127954|P2|STARTED|Washout Period Before Study Period 2||20
53636|NCT01847443|127955|P1|STARTED|Washout Period Before Study Period 2||21
53637|NCT01847443|127952|P4|NOT COMPLETED|Study Period 1||0
53638|NCT01847443|127953|P3|NOT COMPLETED|Study Period 1||0
53639|NCT01847443|127954|P2|NOT COMPLETED|Study Period 1||1
53640|NCT01847443|127955|P1|NOT COMPLETED|Study Period 1||0
53641|NCT01847443|127952|P4|COMPLETED|Study Period 1||21
53642|NCT01847443|127953|P3|COMPLETED|Study Period 1||21
53643|NCT01847443|127954|P2|COMPLETED|Study Period 1||20
53644|NCT01847443|127955|P1|COMPLETED|Study Period 1||21
53645|NCT01847443|127952|P4|STARTED|Study Period 1||21
53646|NCT01847443|127953|P3|STARTED|Study Period 1||21
53647|NCT01847443|127954|P2|STARTED|Study Period 1||21
53648|NCT01847443|127955|P1|STARTED|Study Period 1||21
53649|NCT01847430|127985|P1|NOT COMPLETED|Overall Study||0
53650|NCT01847430|127985|P1|COMPLETED|Overall Study||302
53651|NCT01847430|127985|P1|STARTED|Overall Study||302
53652|NCT01847196|127996|P1|NOT COMPLETED|Overall Study||0
53653|NCT01847196|127996|P1|COMPLETED|Overall Study||5
53654|NCT01847196|127996|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
53655|NCT01847131|128003|P2|NOT COMPLETED|Overall Study||0
53656|NCT01847131|128004|P1|NOT COMPLETED|Overall Study||0
53657|NCT01847131|128003|P2|COMPLETED|Overall Study||25
53658|NCT01847131|128004|P1|COMPLETED|Overall Study||25
53659|NCT01847131|128003|P2|STARTED|Overall Study||25
53660|NCT01847131|128004|P1|STARTED|Overall Study||25
53661|NCT01846741|128012|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
53662|NCT01846741|128012|P1|COMPLETED|Implantation to 18-Month/End of Study||20
53663|NCT01846741|128012|P1|STARTED|Implantation to 18-Month/End of Study||20
53664|NCT01846741|128012|P1|NOT COMPLETED|Baseline Visit||2
53665|NCT01846741|128012|P1|COMPLETED|Baseline Visit||20
53666|NCT01846741|128012|P1|STARTED|Baseline Visit||22
53667|NCT01846455|128073|P5|NOT COMPLETED|Overall Study||0
53668|NCT01846455|128074|P4|NOT COMPLETED|Overall Study||0
53669|NCT01846455|128075|P3|NOT COMPLETED|Overall Study||0
53670|NCT01846455|128076|P2|NOT COMPLETED|Overall Study||0
53671|NCT01846455|128077|P1|NOT COMPLETED|Overall Study||0
53672|NCT01846455|128073|P5|COMPLETED|Overall Study||8
53673|NCT01846455|128074|P4|COMPLETED|Overall Study||10
53674|NCT01846455|128075|P3|COMPLETED|Overall Study||8
53675|NCT01846455|128076|P2|COMPLETED|Overall Study||8
53676|NCT01846455|128077|P1|COMPLETED|Overall Study||9
53677|NCT01846455|128073|P5|PK Population|Overall Study||8
53678|NCT01846455|128074|P4|PK Population|Overall Study||6
53679|NCT01846455|128075|P3|PK Population|Overall Study||6
53680|NCT01846455|128076|P2|PK Population|Overall Study||7
53681|NCT01846455|128077|P1|PK Population|Overall Study||6
53682|NCT01846455|128073|P5|STARTED|Overall Study||8
53683|NCT01846455|128074|P4|STARTED|Overall Study||10
53684|NCT01846455|128075|P3|STARTED|Overall Study||8
53685|NCT01846455|128076|P2|STARTED|Overall Study||8
53686|NCT01846455|128077|P1|STARTED|Overall Study||9
53687|NCT01846442|128138|P4|NOT COMPLETED|Overall Study||3
53688|NCT01846442|128139|P3|NOT COMPLETED|Overall Study||4
53689|NCT01846442|128140|P2|NOT COMPLETED|Overall Study||6
53690|NCT01846442|128141|P1|NOT COMPLETED|Overall Study||6
53691|NCT01846442|128138|P4|COMPLETED|Overall Study||51
53692|NCT01846442|128139|P3|COMPLETED|Overall Study||52
53693|NCT01846442|128140|P2|COMPLETED|Overall Study||48
53694|NCT01846442|128141|P1|COMPLETED|Overall Study||48
53695|NCT01846442|128138|P4|ITT Population|Overall Study||54
53696|NCT01846442|128139|P3|ITT Population|Overall Study||56
53697|NCT01846442|128140|P2|ITT Population|Overall Study||53
53698|NCT01846442|128141|P1|ITT Population|Overall Study||53
53699|NCT01846442|128138|P4|Safety Population|Overall Study||54
53700|NCT01846442|128139|P3|Safety Population|Overall Study||56
53701|NCT01846442|128140|P2|Safety Population|Overall Study||53
53702|NCT01846442|128141|P1|Safety Population|Overall Study||54
53703|NCT01846442|128138|P4|STARTED|Overall Study||54
53704|NCT01846442|128139|P3|STARTED|Overall Study||56
53705|NCT01846442|128140|P2|STARTED|Overall Study||54
53706|NCT01846442|128141|P1|STARTED|Overall Study||54
53707|NCT01846416|128182|P3|NOT COMPLETED|Overall Study||13
53708|NCT01846416|128183|P2|NOT COMPLETED|Overall Study||93
53709|NCT01846416|128184|P1|NOT COMPLETED|Overall Study||31
53710|NCT01846416|128182|P3|COMPLETED|Overall Study||0
53711|NCT01846416|128183|P2|COMPLETED|Overall Study||0
53712|NCT01846416|128184|P1|COMPLETED|Overall Study||0
53713|NCT01846416|128182|P3|STARTED|Overall Study||13
53714|NCT01846416|128183|P2|STARTED|Overall Study||93
53715|NCT01846416|128184|P1|STARTED|Overall Study||31
53716|NCT01846299|128229|P2|NOT COMPLETED|Overall Study||10
53717|NCT01846299|128230|P1|NOT COMPLETED|Overall Study||12
53718|NCT01846299|128229|P2|COMPLETED|Overall Study||50
53719|NCT01846299|128230|P1|COMPLETED|Overall Study||106
53720|NCT01846299|128229|P2|Safety Set|Overall Study||58
53721|NCT01846299|128230|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
53722|NCT01846299|128229|P2|Full Analysis Set|Overall Study||60
53723|NCT01846299|128230|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
53724|NCT01846299|128229|P2|STARTED|Overall Study||60
53725|NCT01846299|128230|P1|STARTED|Overall Study||118
53726|NCT01846221|128268|P2|NOT COMPLETED|Overall Study||0
53727|NCT01846221|128269|P1|NOT COMPLETED|Overall Study||3
53728|NCT01846221|128268|P2|COMPLETED|Overall Study||51
53729|NCT01846221|128269|P1|COMPLETED|Overall Study||47
53730|NCT01846221|128268|P2|STARTED|Overall Study||51
53731|NCT01846221|128269|P1|STARTED|Overall Study||50
53732|NCT01846104|128283|P1|NOT COMPLETED|Overall Study||1
53733|NCT01846104|128283|P1|COMPLETED|Overall Study||3
53734|NCT01846104|128283|P1|STARTED|Overall Study||4
53735|NCT01846039|128289|P1|NOT COMPLETED|Overall Study||2
53736|NCT01846039|128289|P1|COMPLETED|Overall Study||27
53737|NCT01846039|128289|P1|STARTED|Overall Study||29
53738|NCT01845974|128301|P2|NOT COMPLETED|Overall Study||0
53739|NCT01845974|128302|P1|NOT COMPLETED|Overall Study||1
53740|NCT01845974|128301|P2|COMPLETED|Overall Study||9
53741|NCT01845974|128302|P1|COMPLETED|Overall Study||3
53742|NCT01845974|128301|P2|STARTED|Overall Study||9
53743|NCT01845974|128302|P1|STARTED|Overall Study||4
53744|NCT01845831|128310|P5|NOT COMPLETED|Outpatient Phase||0
53745|NCT01845831|128311|P4|NOT COMPLETED|Outpatient Phase||0
53746|NCT01845831|128312|P3|NOT COMPLETED|Outpatient Phase||0
53747|NCT01845831|128313|P2|NOT COMPLETED|Outpatient Phase||0
53748|NCT01845831|128314|P1|NOT COMPLETED|Outpatient Phase||0
53749|NCT01845831|128310|P5|COMPLETED|Outpatient Phase||87
53750|NCT01845831|128311|P4|COMPLETED|Outpatient Phase||98
53751|NCT01845831|128312|P3|COMPLETED|Outpatient Phase||68
53752|NCT01845831|128313|P2|COMPLETED|Outpatient Phase||0
53753|NCT01845831|128314|P1|COMPLETED|Outpatient Phase||0
53754|NCT01845831|128310|P5|STARTED|Outpatient Phase||87
53755|NCT01845831|128311|P4|STARTED|Outpatient Phase||98
53756|NCT01845831|128312|P3|STARTED|Outpatient Phase||68
53757|NCT01845831|128313|P2|STARTED|Outpatient Phase||0
53758|NCT01845831|128314|P1|STARTED|Outpatient Phase||0
53759|NCT01845831|128310|P5|NOT COMPLETED|Inpatient Phase||0
53760|NCT01845831|128311|P4|NOT COMPLETED|Inpatient Phase||0
53761|NCT01845831|128312|P3|NOT COMPLETED|Inpatient Phase||0
53762|NCT01845831|128313|P2|NOT COMPLETED|Inpatient Phase||1
53763|NCT01845831|128314|P1|NOT COMPLETED|Inpatient Phase||1
53764|NCT01845831|128310|P5|COMPLETED|Inpatient Phase||0
53765|NCT01845831|128311|P4|COMPLETED|Inpatient Phase||0
53766|NCT01845831|128312|P3|COMPLETED|Inpatient Phase||0
53767|NCT01845831|128313|P2|COMPLETED|Inpatient Phase||138
53768|NCT01845831|128314|P1|COMPLETED|Inpatient Phase||139
53769|NCT01845831|128310|P5|STARTED|Inpatient Phase||0
53770|NCT01845831|128311|P4|STARTED|Inpatient Phase||0
53771|NCT01845831|128312|P3|STARTED|Inpatient Phase||0
53772|NCT01845831|128313|P2|STARTED|Inpatient Phase||139
53773|NCT01845831|128314|P1|STARTED|Inpatient Phase||140
53774|NCT01845636|128341|P1|NOT COMPLETED|Overall Study||4
53775|NCT01845636|128341|P1|COMPLETED|Overall Study||37
53776|NCT01845636|128341|P1|STARTED|Overall Study||41
53777|NCT01845220|128349|P2|NOT COMPLETED|Overall Study||0
53778|NCT01845220|128350|P1|NOT COMPLETED|Overall Study||0
53779|NCT01845220|128349|P2|COMPLETED|Overall Study||30
53780|NCT01845220|128350|P1|COMPLETED|Overall Study||30
53781|NCT01845220|128349|P2|STARTED|Overall Study||30
53782|NCT01845220|128350|P1|STARTED|Overall Study||30
53783|NCT01845155|128358|P2|NOT COMPLETED|Overall Study||0
53784|NCT01845155|128359|P1|NOT COMPLETED|Overall Study||1
53785|NCT01845155|128358|P2|COMPLETED|Overall Study||144
53786|NCT01845155|128359|P1|COMPLETED|Overall Study||145
53787|NCT01845155|128358|P2|STARTED|Overall Study||144
53788|NCT01845155|128359|P1|STARTED|Overall Study||146
53789|NCT01845103|128367|P1|NOT COMPLETED|Overall Study||0
53790|NCT01845103|128367|P1|COMPLETED|Overall Study||1
53791|NCT01845103|128367|P1|STARTED|Overall Study||1
53792|NCT01845077|128375|P6|NOT COMPLETED|Treatment Period 2||0
53793|NCT01845077|128376|P5|NOT COMPLETED|Treatment Period 2||0
53794|NCT01845077|128377|P4|NOT COMPLETED|Treatment Period 2||0
53795|NCT01845077|128378|P3|NOT COMPLETED|Treatment Period 2||0
53796|NCT01845077|128379|P2|NOT COMPLETED|Treatment Period 2||0
53797|NCT01845077|128380|P1|NOT COMPLETED|Treatment Period 2||0
53798|NCT01845077|128375|P6|COMPLETED|Treatment Period 2||11
53799|NCT01845077|128376|P5|COMPLETED|Treatment Period 2||11
53800|NCT01845077|128377|P4|COMPLETED|Treatment Period 2||10
53801|NCT01845077|128378|P3|COMPLETED|Treatment Period 2||11
53802|NCT01845077|128379|P2|COMPLETED|Treatment Period 2||11
53803|NCT01845077|128380|P1|COMPLETED|Treatment Period 2||11
53804|NCT01845077|128375|P6|STARTED|Treatment Period 2||11
53805|NCT01845077|128376|P5|STARTED|Treatment Period 2||11
53806|NCT01845077|128377|P4|STARTED|Treatment Period 2||10
53807|NCT01845077|128378|P3|STARTED|Treatment Period 2||11
53808|NCT01845077|128379|P2|STARTED|Treatment Period 2||11
53809|NCT01845077|128380|P1|STARTED|Treatment Period 2||11
53810|NCT01845077|128375|P6|NOT COMPLETED|Washout Period||1
53811|NCT01845077|128376|P5|NOT COMPLETED|Washout Period||1
53812|NCT01845077|128377|P4|NOT COMPLETED|Washout Period||2
53813|NCT01845077|128378|P3|NOT COMPLETED|Washout Period||1
53814|NCT01845077|128379|P2|NOT COMPLETED|Washout Period||1
53815|NCT01845077|128380|P1|NOT COMPLETED|Washout Period||1
53816|NCT01845077|128375|P6|COMPLETED|Washout Period||11
53817|NCT01845077|128376|P5|COMPLETED|Washout Period||11
53818|NCT01845077|128377|P4|COMPLETED|Washout Period||10
53819|NCT01845077|128378|P3|COMPLETED|Washout Period||11
53820|NCT01845077|128379|P2|COMPLETED|Washout Period||11
53821|NCT01845077|128380|P1|COMPLETED|Washout Period||11
53822|NCT01845077|128375|P6|STARTED|Washout Period||12
53823|NCT01845077|128376|P5|STARTED|Washout Period||12
53824|NCT01845077|128377|P4|STARTED|Washout Period||12
53825|NCT01845077|128378|P3|STARTED|Washout Period||12
53826|NCT01845077|128379|P2|STARTED|Washout Period||12
53827|NCT01845077|128380|P1|STARTED|Washout Period||12
53828|NCT01845077|128375|P6|NOT COMPLETED|Treatment Period 1||0
53829|NCT01845077|128376|P5|NOT COMPLETED|Treatment Period 1||0
53830|NCT01845077|128377|P4|NOT COMPLETED|Treatment Period 1||0
53831|NCT01845077|128378|P3|NOT COMPLETED|Treatment Period 1||0
53832|NCT01845077|128379|P2|NOT COMPLETED|Treatment Period 1||0
53833|NCT01845077|128380|P1|NOT COMPLETED|Treatment Period 1||0
53834|NCT01845077|128375|P6|COMPLETED|Treatment Period 1||12
53835|NCT01845077|128376|P5|COMPLETED|Treatment Period 1||12
53836|NCT01845077|128377|P4|COMPLETED|Treatment Period 1||12
53837|NCT01845077|128378|P3|COMPLETED|Treatment Period 1||12
53838|NCT01845077|128379|P2|COMPLETED|Treatment Period 1||12
53839|NCT01845077|128380|P1|COMPLETED|Treatment Period 1||12
53840|NCT01845077|128375|P6|STARTED|Treatment Period 1||12
53841|NCT01845077|128376|P5|STARTED|Treatment Period 1||12
53842|NCT01845077|128377|P4|STARTED|Treatment Period 1||12
53843|NCT01845077|128378|P3|STARTED|Treatment Period 1||12
53844|NCT01845077|128379|P2|STARTED|Treatment Period 1||12
53845|NCT01845077|128380|P1|STARTED|Treatment Period 1||12
53846|NCT01845025|128426|P2|NOT COMPLETED|Overall Study||77
53847|NCT01845025|128427|P1|NOT COMPLETED|Overall Study||85
53848|NCT01845025|128426|P2|COMPLETED|Overall Study||332
53849|NCT01845025|128427|P1|COMPLETED|Overall Study||326
53850|NCT01845025|128426|P2|STARTED|Overall Study||409
53851|NCT01845025|128427|P1|STARTED|Overall Study||411
53852|NCT01844895|128449|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
53853|NCT01844895|128449|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
53854|NCT01844895|128449|P1|STARTED|Day 29 - Day113 - Autoinjector||117
53855|NCT01844895|128449|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
53856|NCT01844895|128449|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
53857|NCT01844895|128449|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
53858|NCT01844856|128467|P2|NOT COMPLETED|Overall Study||16
53859|NCT01844856|128468|P1|NOT COMPLETED|Overall Study||24
53860|NCT01844856|128467|P2|COMPLETED|Overall Study||255
53861|NCT01844856|128468|P1|COMPLETED|Overall Study||246
53862|NCT01844856|128467|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
53863|NCT01844856|128468|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
53864|NCT01844856|128467|P2|STARTED|Overall Study||271
53865|NCT01844856|128468|P1|STARTED|Overall Study||270
53866|NCT01844830|128480|P2|NOT COMPLETED|Overall Study||0
53867|NCT01844830|128481|P1|NOT COMPLETED|Overall Study||1
53868|NCT01844830|128480|P2|COMPLETED|Overall Study||30
53869|NCT01844830|128481|P1|COMPLETED|Overall Study||59
53870|NCT01844830|128480|P2|400 µL Dose|Overall Study||10
53871|NCT01844830|128481|P1|400 µL Dose|Overall Study||20
53872|NCT01844830|128480|P2|200 µL Dose|Overall Study||12
53873|NCT01844830|128481|P1|200 µL Dose|Overall Study||24
53874|NCT01844830|128480|P2|100 µL Dose|Overall Study||8
53875|NCT01844830|128481|P1|100 µL Dose|Overall Study||16
53876|NCT01844830|128480|P2|STARTED|Overall Study||30
53877|NCT01844830|128481|P1|STARTED|Overall Study||60
53878|NCT01844817|128511|P2|NOT COMPLETED|Treatment||63
53879|NCT01844817|128512|P1|NOT COMPLETED|Treatment||64
53880|NCT01844817|128511|P2|COMPLETED|Treatment||0
53881|NCT01844817|128512|P1|COMPLETED|Treatment||0
53882|NCT01844817|128511|P2|STARTED|Treatment||63
53883|NCT01844817|128512|P1|STARTED|Treatment||64
53884|NCT01844817|128511|P2|NOT COMPLETED|Enrolled and Randomized||3
53885|NCT01844817|128512|P1|NOT COMPLETED|Enrolled and Randomized||2
53886|NCT01844817|128511|P2|COMPLETED|Enrolled and Randomized||63
53887|NCT01844817|128512|P1|COMPLETED|Enrolled and Randomized||64
53888|NCT01844817|128511|P2|STARTED|Enrolled and Randomized||66
53889|NCT01844817|128512|P1|STARTED|Enrolled and Randomized||66
53890|NCT01844778|128525|P3|NOT COMPLETED|Overall Study||4
53891|NCT01844778|128526|P2|NOT COMPLETED|Overall Study||3
53892|NCT01844778|128527|P1|NOT COMPLETED|Overall Study||2
53893|NCT01844778|128525|P3|COMPLETED|Overall Study||14
53894|NCT01844778|128526|P2|COMPLETED|Overall Study||25
53895|NCT01844778|128527|P1|COMPLETED|Overall Study||12
53896|NCT01844778|128525|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
53897|NCT01844778|128526|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
53898|NCT01844778|128527|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
53899|NCT01844778|128525|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
53900|NCT01844778|128526|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
53901|NCT01844778|128527|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
53902|NCT01844778|128525|P3|STARTED|Overall Study||18
53903|NCT01844778|128526|P2|STARTED|Overall Study||28
53904|NCT01844778|128527|P1|STARTED|Overall Study||14
53905|NCT01844765|128553|P2|NOT COMPLETED|Overall Study||6
53906|NCT01844765|128554|P1|NOT COMPLETED|Overall Study||9
53907|NCT01844765|128553|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
53908|NCT01844765|128554|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
53909|NCT01844765|128553|P2|Untreated|Overall Study||0
53910|NCT01844765|128554|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
53911|NCT01844765|128553|P2|Treated|Overall Study||25
53912|NCT01844765|128554|P1|Treated|Overall Study||33
53913|NCT01844765|128553|P2|STARTED|Overall Study||25
53914|NCT01844765|128554|P1|STARTED|Overall Study||34
53915|NCT01844700|128574|P2|NOT COMPLETED|Overall Study||1
53916|NCT01844700|128575|P1|NOT COMPLETED|Overall Study||3
53917|NCT01844700|128574|P2|COMPLETED|Overall Study||2
53918|NCT01844700|128575|P1|COMPLETED|Overall Study||1
53919|NCT01844700|128574|P2|STARTED|Overall Study||3
53920|NCT01844700|128575|P1|STARTED|Overall Study||4
53921|NCT01844687|128587|P1|NOT COMPLETED|Visit 8||0
53922|NCT01844687|128587|P1|COMPLETED|Visit 8||31
53923|NCT01844687|128587|P1|STARTED|Visit 8||31
53924|NCT01844687|128587|P1|NOT COMPLETED|Visit 7||0
53925|NCT01844687|128587|P1|COMPLETED|Visit 7||31
53926|NCT01844687|128587|P1|STARTED|Visit 7||31
53927|NCT01844687|128587|P1|NOT COMPLETED|Visit 6||0
53928|NCT01844687|128587|P1|COMPLETED|Visit 6||31
53929|NCT01844687|128587|P1|STARTED|Visit 6||31
53930|NCT01844687|128587|P1|NOT COMPLETED|Visit 5||0
53931|NCT01844687|128587|P1|COMPLETED|Visit 5||31
53932|NCT01844687|128587|P1|STARTED|Visit 5||31
53933|NCT01844687|128587|P1|NOT COMPLETED|Visit 4||4
53934|NCT01844687|128587|P1|COMPLETED|Visit 4||31
53935|NCT01844687|128587|P1|STARTED|Visit 4||35
53936|NCT01844687|128587|P1|NOT COMPLETED|Visit 3||5
53937|NCT01844687|128587|P1|COMPLETED|Visit 3||35
53938|NCT01844687|128587|P1|STARTED|Visit 3||40
53939|NCT01844687|128587|P1|NOT COMPLETED|Visit 2||2
53940|NCT01844687|128587|P1|COMPLETED|Visit 2||40
53941|NCT01844687|128587|P1|STARTED|Visit 2||42
53942|NCT01844687|128587|P1|NOT COMPLETED|Visit 1||8
53943|NCT01844687|128587|P1|COMPLETED|Visit 1||42
53944|NCT01844687|128587|P1|STARTED|Visit 1||50
53945|NCT01844531|128650|P4|NOT COMPLETED|Overall Study||0
53946|NCT01844531|128651|P3|NOT COMPLETED|Overall Study||0
53947|NCT01844531|128652|P2|NOT COMPLETED|Overall Study||1
53948|NCT01844531|128653|P1|NOT COMPLETED|Overall Study||0
53949|NCT01844531|128650|P4|COMPLETED|Overall Study||6
53950|NCT01844531|128651|P3|COMPLETED|Overall Study||6
53951|NCT01844531|128652|P2|COMPLETED|Overall Study||5
53952|NCT01844531|128653|P1|COMPLETED|Overall Study||6
53953|NCT01844531|128650|P4|STARTED|Overall Study||6
53954|NCT01844531|128651|P3|STARTED|Overall Study||6
53955|NCT01844531|128652|P2|STARTED|Overall Study||6
53956|NCT01844531|128653|P1|STARTED|Overall Study||6
53957|NCT01844518|128683|P1|NOT COMPLETED|Long-Term Extension||157
53958|NCT01844518|128683|P1|COMPLETED|Long-Term Extension|Study is on-going|0
53959|NCT01844518|128683|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
53960|NCT01844518|128683|P1|NOT COMPLETED|Short-Term (ST) Period||9
53961|NCT01844518|128683|P1|COMPLETED|Short-Term (ST) Period||164
53962|NCT01844518|128683|P1|STARTED|Short-Term (ST) Period||173
53963|NCT01844505|128700|P3|NOT COMPLETED|Overall Study||295
53964|NCT01844505|128701|P2|NOT COMPLETED|Overall Study||269
53965|NCT01844505|128702|P1|NOT COMPLETED|Overall Study||249
53966|NCT01844505|128700|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
53967|NCT01844505|128701|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
53968|NCT01844505|128702|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
53969|NCT01844505|128700|P3|STARTED|Overall Study||311
53970|NCT01844505|128701|P2|STARTED|Overall Study||313
53971|NCT01844505|128702|P1|STARTED|Overall Study||313
53972|NCT01844479|128752|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
53973|NCT01844479|128753|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
53974|NCT01844479|128752|P2|COMPLETED|Second Intervention up to 30 Minutes||13
53975|NCT01844479|128753|P1|COMPLETED|Second Intervention up to 30 Minutes||14
53976|NCT01844479|128752|P2|STARTED|Second Intervention up to 30 Minutes||13
53977|NCT01844479|128753|P1|STARTED|Second Intervention up to 30 Minutes||14
53978|NCT01844479|128752|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
53979|NCT01844479|128753|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
53980|NCT01844479|128752|P2|COMPLETED|First Intervention up to 30 Minutes||13
53981|NCT01844479|128753|P1|COMPLETED|First Intervention up to 30 Minutes||14
53982|NCT01844479|128752|P2|STARTED|First Intervention up to 30 Minutes||13
53983|NCT01844479|128753|P1|STARTED|First Intervention up to 30 Minutes||14
53984|NCT01844388|128783|P2|NOT COMPLETED|Overall Study||7
53985|NCT01844388|128784|P1|NOT COMPLETED|Overall Study||8
53986|NCT01844388|128783|P2|COMPLETED|Overall Study||114
53987|NCT01844388|128784|P1|COMPLETED|Overall Study||236
53988|NCT01844388|128783|P2|STARTED|Overall Study||121
53989|NCT01844388|128784|P1|STARTED|Overall Study||244
53990|NCT01844206|128796|P2|NOT COMPLETED|Overall Study||1
53991|NCT01844206|128797|P1|NOT COMPLETED|Overall Study||0
53992|NCT01844206|128796|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
53993|NCT01844206|128797|P1|COMPLETED|Overall Study||2
53994|NCT01844206|128796|P2|STARTED|Overall Study||3
53995|NCT01844206|128797|P1|STARTED|Overall Study||2
53996|NCT01843972|128813|P10|NOT COMPLETED|Overall Study||0
53997|NCT01843972|128814|P9|NOT COMPLETED|Overall Study||0
53998|NCT01843972|128815|P8|NOT COMPLETED|Overall Study||0
53999|NCT01843972|128816|P7|NOT COMPLETED|Overall Study||0
54000|NCT01843972|128817|P6|NOT COMPLETED|Overall Study||0
54001|NCT01843972|128818|P5|NOT COMPLETED|Overall Study||1
54002|NCT01843972|128819|P4|NOT COMPLETED|Overall Study||0
54003|NCT01843972|128820|P3|NOT COMPLETED|Overall Study||0
54004|NCT01843972|128821|P2|NOT COMPLETED|Overall Study||0
54005|NCT01843972|128822|P1|NOT COMPLETED|Overall Study||0
54006|NCT01843972|128813|P10|COMPLETED|Overall Study||12
54007|NCT01843972|128814|P9|COMPLETED|Overall Study||17
54008|NCT01843972|128815|P8|COMPLETED|Overall Study||5
54009|NCT01843972|128816|P7|COMPLETED|Overall Study||5
54010|NCT01843972|128817|P6|COMPLETED|Overall Study||6
54011|NCT01843972|128818|P5|COMPLETED|Overall Study||5
54012|NCT01843972|128819|P4|COMPLETED|Overall Study||6
54013|NCT01843972|128820|P3|COMPLETED|Overall Study||5
54014|NCT01843972|128821|P2|COMPLETED|Overall Study||6
54015|NCT01843972|128822|P1|COMPLETED|Overall Study||13
54016|NCT01843972|128813|P10|STARTED|Overall Study||12
54017|NCT01843972|128814|P9|STARTED|Overall Study||17
54018|NCT01843972|128815|P8|STARTED|Overall Study||5
54019|NCT01843972|128816|P7|STARTED|Overall Study||5
54020|NCT01843972|128817|P6|STARTED|Overall Study||6
54021|NCT01843972|128818|P5|STARTED|Overall Study||6
54022|NCT01843972|128819|P4|STARTED|Overall Study||6
54023|NCT01843972|128820|P3|STARTED|Overall Study||5
54024|NCT01843972|128821|P2|STARTED|Overall Study||6
54025|NCT01843972|128822|P1|STARTED|Overall Study||13
54026|NCT01843933|128892|P2|NOT COMPLETED|Overall Study||4
54027|NCT01843933|128893|P1|NOT COMPLETED|Overall Study||6
54028|NCT01843933|128892|P2|COMPLETED|Overall Study||103
54029|NCT01843933|128893|P1|COMPLETED|Overall Study||98
54030|NCT01843933|128892|P2|STARTED|Overall Study||107
54031|NCT01843933|128893|P1|STARTED|Overall Study||104
54032|NCT01843920|128901|P2|NOT COMPLETED|Overall Study||0
54033|NCT01843920|128902|P1|NOT COMPLETED|Overall Study||0
54034|NCT01843920|128901|P2|COMPLETED|Overall Study||9
54035|NCT01843920|128902|P1|COMPLETED|Overall Study||12
54036|NCT01843920|128901|P2|STARTED|Overall Study||9
54037|NCT01843920|128902|P1|STARTED|Overall Study||12
54038|NCT01843777|128912|P2|NOT COMPLETED|Overall Study||0
54039|NCT01843777|128913|P1|NOT COMPLETED|Overall Study||1
54040|NCT01843777|128912|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
54041|NCT01843777|128913|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
54042|NCT01843777|128912|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
54043|NCT01843777|128913|P1|Per Protocol Population|Overall Study||11
54044|NCT01843777|128912|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
54045|NCT01843777|128913|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
54046|NCT01843673|128921|P1|NOT COMPLETED|Overall Study||6
54047|NCT01843673|128921|P1|COMPLETED|Overall Study||10
54048|NCT01843673|128921|P1|STARTED|Overall Study||16
54049|NCT01843660|128933|P1|NOT COMPLETED|Overall Study||30
54050|NCT01843660|128933|P1|COMPLETED|Overall Study||1029
54051|NCT01843660|128933|P1|STARTED|Overall Study||1059
54052|NCT01843465|128951|P1|NOT COMPLETED|Overall Study||0
54053|NCT01843465|128951|P1|COMPLETED|Overall Study||34
54054|NCT01843465|128951|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
54055|NCT01843374|128957|P2|NOT COMPLETED|Overall Study||321
54056|NCT01843374|128958|P1|NOT COMPLETED|Overall Study||164
54057|NCT01843374|128957|P2|COMPLETED|Overall Study||61
54058|NCT01843374|128958|P1|COMPLETED|Overall Study||25
54059|NCT01843374|128957|P2|RANDOMIZED|Overall Study||382
54060|NCT01843374|128958|P1|RANDOMIZED|Overall Study||189
54061|NCT01843374|128957|P2|STARTED|Overall Study||382
54062|NCT01843374|128958|P1|STARTED|Overall Study||189
54063|NCT01843348|128985|P3|NOT COMPLETED|Overall Study||41
54064|NCT01843348|128986|P2|NOT COMPLETED|Overall Study||40
54065|NCT01843348|128987|P1|NOT COMPLETED|Overall Study||23
54066|NCT01843348|128985|P3|COMPLETED|Overall Study||158
54067|NCT01843348|128986|P2|COMPLETED|Overall Study||168
54068|NCT01843348|128987|P1|COMPLETED|Overall Study||182
54069|NCT01843348|128985|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
54070|NCT01843348|128986|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
54071|NCT01843348|128987|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
54072|NCT01843348|128985|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
54073|NCT01843348|128986|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
54074|NCT01843348|128987|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
54075|NCT01843348|128985|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
54076|NCT01843348|128986|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
54077|NCT01843348|128987|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
54078|NCT01843348|128985|P3|STARTED|Overall Study||199
54079|NCT01843348|128986|P2|STARTED|Overall Study||208
54080|NCT01843348|128987|P1|STARTED|Overall Study||205
54081|NCT01843205|129027|P2|NOT COMPLETED|Second Treatment (11 Days)||0
54082|NCT01843205|129028|P1|NOT COMPLETED|Second Treatment (11 Days)||0
54083|NCT01843205|129027|P2|COMPLETED|Second Treatment (11 Days)||4
54084|NCT01843205|129028|P1|COMPLETED|Second Treatment (11 Days)||4
54085|NCT01843205|129027|P2|STARTED|Second Treatment (11 Days)||4
54086|NCT01843205|129028|P1|STARTED|Second Treatment (11 Days)||4
54087|NCT01843205|129027|P2|NOT COMPLETED|First Treatment (11 Days)||0
54088|NCT01843205|129028|P1|NOT COMPLETED|First Treatment (11 Days)||1
54089|NCT01843205|129027|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
54090|NCT01843205|129028|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
54091|NCT01843205|129027|P2|STARTED|First Treatment (11 Days)||4
54092|NCT01843205|129028|P1|STARTED|First Treatment (11 Days)||5
54093|NCT01843192|129089|P3|NOT COMPLETED|Overall Study||2
54094|NCT01843192|129090|P2|NOT COMPLETED|Overall Study||6
54095|NCT01843192|129091|P1|NOT COMPLETED|Overall Study||2
54096|NCT01843192|129089|P3|COMPLETED|Overall Study||9
54097|NCT01843192|129090|P2|COMPLETED|Overall Study||28
54098|NCT01843192|129091|P1|COMPLETED|Overall Study||24
54099|NCT01843192|129089|P3|STARTED|Overall Study||11
54100|NCT01843192|129090|P2|STARTED|Overall Study||34
54101|NCT01843192|129091|P1|STARTED|Overall Study||26
54102|NCT01842958|129122|P2|NOT COMPLETED|Overall Study||1
54103|NCT01842958|129123|P1|NOT COMPLETED|Overall Study||1
54104|NCT01842958|129122|P2|COMPLETED|Overall Study||24
54105|NCT01842958|129123|P1|COMPLETED|Overall Study||24
54106|NCT01842958|129122|P2|Randomized|Overall Study||25
54107|NCT01842958|129123|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
54108|NCT01842958|129122|P2|STARTED|Overall Study||25
54109|NCT01842958|129123|P1|STARTED|Overall Study||25
54110|NCT01842906|129143|P2|NOT COMPLETED|Overall Study||0
54111|NCT01842906|129144|P1|NOT COMPLETED|Overall Study||0
54112|NCT01842906|129143|P2|COMPLETED|Overall Study||104
54113|NCT01842906|129144|P1|COMPLETED|Overall Study||115
54114|NCT01842906|129143|P2|STARTED|Overall Study||104
54115|NCT01842906|129144|P1|STARTED|Overall Study||115
54116|NCT01842841|129156|P1|NOT COMPLETED|Overall Study||0
54117|NCT01842841|129156|P1|COMPLETED|Overall Study||5
54118|NCT01842841|129156|P1|STARTED|Overall Study||5
54119|NCT01842789|129177|P2|NOT COMPLETED|Overall Study||0
54120|NCT01842789|129178|P1|NOT COMPLETED|Overall Study||0
54121|NCT01842789|129177|P2|COMPLETED|Overall Study||8
54122|NCT01842789|129178|P1|COMPLETED|Overall Study||10
54123|NCT01842789|129177|P2|STARTED|Overall Study||8
54124|NCT01842789|129178|P1|STARTED|Overall Study||10
54125|NCT01842646|129187|P1|NOT COMPLETED|Overall Study||0
54126|NCT01842646|129187|P1|COMPLETED|Overall Study||35
54127|NCT01842646|129187|P1|STARTED|Overall Study||35
54128|NCT01842633|129196|P3|NOT COMPLETED|Overall Study||0
54129|NCT01842633|129197|P2|NOT COMPLETED|Overall Study||2
54130|NCT01842633|129198|P1|NOT COMPLETED|Overall Study||3
54131|NCT01842633|129196|P3|COMPLETED|Overall Study||34
54132|NCT01842633|129197|P2|COMPLETED|Overall Study||64
54133|NCT01842633|129198|P1|COMPLETED|Overall Study||62
54134|NCT01842633|129196|P3|STARTED|Overall Study||34
54135|NCT01842633|129197|P2|STARTED|Overall Study||66
54136|NCT01842633|129198|P1|STARTED|Overall Study||65
54137|NCT01842620|129245|P2|NOT COMPLETED|Period 2||0
54138|NCT01842620|129246|P1|NOT COMPLETED|Period 2||0
54139|NCT01842620|129245|P2|COMPLETED|Period 2||12
54140|NCT01842620|129246|P1|COMPLETED|Period 2||12
54141|NCT01842620|129245|P2|STARTED|Period 2||12
54142|NCT01842620|129246|P1|STARTED|Period 2||12
54143|NCT01842620|129245|P2|NOT COMPLETED|Washout Period||0
54144|NCT01842620|129246|P1|NOT COMPLETED|Washout Period||0
54145|NCT01842620|129245|P2|COMPLETED|Washout Period||12
54146|NCT01842620|129246|P1|COMPLETED|Washout Period||12
54147|NCT01842620|129245|P2|STARTED|Washout Period||12
54148|NCT01842620|129246|P1|STARTED|Washout Period||12
54149|NCT01842620|129245|P2|NOT COMPLETED|Period 1||0
54150|NCT01842620|129246|P1|NOT COMPLETED|Period 1||1
54151|NCT01842620|129245|P2|COMPLETED|Period 1||12
54152|NCT01842620|129246|P1|COMPLETED|Period 1||12
54153|NCT01842620|129245|P2|STARTED|Period 1||12
54154|NCT01842620|129246|P1|STARTED|Period 1||13
54155|NCT01842607|129262|P1|NOT COMPLETED|Overall Study||66
54156|NCT01842607|129262|P1|COMPLETED|Overall Study||585
54157|NCT01842607|129262|P1|STARTED|Overall Study||651
54158|NCT01842594|129281|P1|NOT COMPLETED|Overall Study||3
54159|NCT01842594|129281|P1|COMPLETED|Overall Study||10
54160|NCT01842594|129281|P1|STARTED|Overall Study||13
54161|NCT01842464|129286|P1|NOT COMPLETED|Overall Study||0
54162|NCT01842464|129286|P1|COMPLETED|Overall Study||44
54163|NCT01842464|129286|P1|STARTED|Overall Study||44
54164|NCT01842438|129294|P2|NOT COMPLETED|T2: 6month Follow-up||4
54165|NCT01842438|129295|P1|NOT COMPLETED|T2: 6month Follow-up||4
54166|NCT01842438|129294|P2|COMPLETED|T2: 6month Follow-up||32
54167|NCT01842438|129295|P1|COMPLETED|T2: 6month Follow-up||32
54168|NCT01842438|129294|P2|STARTED|T2: 6month Follow-up||36
54169|NCT01842438|129295|P1|STARTED|T2: 6month Follow-up||36
54170|NCT01842438|129294|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
54171|NCT01842438|129295|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
54172|NCT01842438|129294|P2|COMPLETED|T1: Immediately After the Intervention||36
54173|NCT01842438|129295|P1|COMPLETED|T1: Immediately After the Intervention||36
54174|NCT01842438|129294|P2|STARTED|T1: Immediately After the Intervention||44
54175|NCT01842438|129295|P1|STARTED|T1: Immediately After the Intervention||42
54176|NCT01841970|129307|P1|NOT COMPLETED|Overall Study||11
54177|NCT01841970|129307|P1|COMPLETED|Overall Study||9
54178|NCT01841970|129307|P1|STARTED|Overall Study||20
54179|NCT01841931|129323|P1|NOT COMPLETED|Overall Study||4
54180|NCT01841931|129323|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
54181|NCT01841931|129323|P1|STARTED|Overall Study||4
54182|NCT01841697|129333|P2|NOT COMPLETED|Overall Study||18
54183|NCT01841697|129334|P1|NOT COMPLETED|Overall Study||20
54184|NCT01841697|129333|P2|COMPLETED|Overall Study||302
54185|NCT01841697|129334|P1|COMPLETED|Overall Study||302
54186|NCT01841697|129333|P2|STARTED|Overall Study||320
54187|NCT01841697|129334|P1|STARTED|Overall Study||322
54188|NCT01841619|129350|P1|NOT COMPLETED|Overall Study||0
54189|NCT01841619|129350|P1|COMPLETED|Overall Study||16
54190|NCT01841619|129350|P1|STARTED|Overall Study||16
54191|NCT01841606|129360|P2|NOT COMPLETED|Overall Study||0
54192|NCT01841606|129361|P1|NOT COMPLETED|Overall Study||0
54193|NCT01841606|129360|P2|COMPLETED|Overall Study||27
54194|NCT01841606|129361|P1|COMPLETED|Overall Study||25
54195|NCT01841606|129360|P2|STARTED|Overall Study||27
54196|NCT01841606|129361|P1|STARTED|Overall Study||25
54197|NCT01841593|129369|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
54198|NCT01841593|129370|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
54199|NCT01841593|129369|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
54200|NCT01841593|129370|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
54201|NCT01841593|129369|P2|STARTED|Third Intervention (Days 15 to 21)||6
54202|NCT01841593|129370|P1|STARTED|Third Intervention (Days 15 to 21)||11
54203|NCT01841593|129369|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
54204|NCT01841593|129370|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
54205|NCT01841593|129369|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
54206|NCT01841593|129370|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
54207|NCT01841593|129369|P2|STARTED|Second Intervention (Days 8 to 14)||6
54208|NCT01841593|129370|P1|STARTED|Second Intervention (Days 8 to 14)||12
54209|NCT01841593|129369|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
54210|NCT01841593|129370|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
54211|NCT01841593|129369|P2|COMPLETED|First Intervention (Days 1 to 7)||6
54212|NCT01841593|129370|P1|COMPLETED|First Intervention (Days 1 to 7)||12
54213|NCT01841593|129369|P2|STARTED|First Intervention (Days 1 to 7)||7
54214|NCT01841593|129370|P1|STARTED|First Intervention (Days 1 to 7)||12
54215|NCT01841567|129386|P1|NOT COMPLETED|Overall Study||3
54216|NCT01841567|129386|P1|COMPLETED|Overall Study||57
54217|NCT01841567|129386|P1|STARTED|Overall Study||60
54218|NCT01841216|129393|P2|NOT COMPLETED|Overall Study||0
54219|NCT01841216|129394|P1|NOT COMPLETED|Overall Study||0
54220|NCT01841216|129393|P2|COMPLETED|Overall Study||15
54221|NCT01841216|129394|P1|COMPLETED|Overall Study||15
54222|NCT01841216|129393|P2|STARTED|Overall Study||15
54223|NCT01841216|129394|P1|STARTED|Overall Study||15
54224|NCT01841021|129402|P1|NOT COMPLETED|Overall Study||0
54225|NCT01841021|129402|P1|COMPLETED|Overall Study||1
54226|NCT01841021|129402|P1|STARTED|Overall Study||1
54227|NCT01840943|129414|P2|NOT COMPLETED|Overall Study||12
54228|NCT01840943|129415|P1|NOT COMPLETED|Overall Study||13
54229|NCT01840943|129414|P2|COMPLETED|Overall Study||0
54230|NCT01840943|129415|P1|COMPLETED|Overall Study||1
54231|NCT01840943|129414|P2|STARTED|Overall Study||12
54232|NCT01840943|129415|P1|STARTED|Overall Study||14
54233|NCT01840605|129451|P2|NOT COMPLETED|Overall Study||2
54234|NCT01840605|129452|P1|NOT COMPLETED|Overall Study||2
54235|NCT01840605|129451|P2|COMPLETED|Overall Study||150
54236|NCT01840605|129452|P1|COMPLETED|Overall Study||149
54237|NCT01840605|129451|P2|STARTED|Overall Study||152
54238|NCT01840605|129452|P1|STARTED|Overall Study||151
54239|NCT01840410|129466|P2|NOT COMPLETED|Overall Study||4
54240|NCT01840410|129467|P1|NOT COMPLETED|Overall Study||7
54241|NCT01840410|129466|P2|COMPLETED|Overall Study||55
54242|NCT01840410|129467|P1|COMPLETED|Overall Study||112
54243|NCT01840410|129466|P2|Full Analysis Set|Overall Study||59
54244|NCT01840410|129467|P1|Full Analysis Set|Overall Study||119
54245|NCT01840410|129466|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
54246|NCT01840410|129467|P1|Safety Set|Overall Study||119
54247|NCT01840410|129466|P2|STARTED|Overall Study||59
54248|NCT01840410|129467|P1|STARTED|Overall Study||119
54249|NCT01840345|129503|P1|NOT COMPLETED|Overall Study||1
54250|NCT01840345|129503|P1|COMPLETED|Overall Study||10
54251|NCT01840345|129503|P1|STARTED|Overall Study||11
54252|NCT01840319|129510|P1|NOT COMPLETED|Overall Study||0
54253|NCT01840319|129510|P1|COMPLETED|Overall Study||156
54254|NCT01840319|129510|P1|STARTED|Overall Study||156
54255|NCT01840072|129516|P2|NOT COMPLETED|Overall Study||47
54256|NCT01840072|129517|P1|NOT COMPLETED|Overall Study||7
54257|NCT01840072|129516|P2|COMPLETED|Overall Study||1986
54258|NCT01840072|129517|P1|COMPLETED|Overall Study||2031
54259|NCT01840072|129516|P2|STARTED|Overall Study||2033
54260|NCT01840072|129517|P1|STARTED|Overall Study||2038
54261|NCT01839708|129541|P2|NOT COMPLETED|Overall Study||67
54262|NCT01839708|129542|P1|NOT COMPLETED|Overall Study||76
54263|NCT01839708|129541|P2|COMPLETED|Overall Study||115
54264|NCT01839708|129542|P1|COMPLETED|Overall Study||311
54265|NCT01839708|129541|P2|STARTED|Overall Study||182
54266|NCT01839708|129542|P1|STARTED|Overall Study||387
54267|NCT01839695|129574|P1|NOT COMPLETED|Overall Study||0
54268|NCT01839695|129574|P1|COMPLETED|Overall Study||9
54269|NCT01839695|129574|P1|STARTED|Overall Study||9
54270|NCT01839604|129584|P5|NOT COMPLETED|Overall Study||0
54271|NCT01839604|129585|P4|NOT COMPLETED|Overall Study||0
54272|NCT01839604|129586|P3|NOT COMPLETED|Overall Study||0
54273|NCT01839604|129587|P2|NOT COMPLETED|Overall Study||0
54274|NCT01839604|129588|P1|NOT COMPLETED|Overall Study||0
54275|NCT01839604|129584|P5|COMPLETED|Overall Study||15
54276|NCT01839604|129585|P4|COMPLETED|Overall Study||5
54277|NCT01839604|129586|P3|COMPLETED|Overall Study||7
54278|NCT01839604|129587|P2|COMPLETED|Overall Study||6
54279|NCT01839604|129588|P1|COMPLETED|Overall Study||6
54280|NCT01839604|129584|P5|STARTED|Overall Study||15
54281|NCT01839604|129585|P4|STARTED|Overall Study||5
54282|NCT01839604|129586|P3|STARTED|Overall Study||7
54283|NCT01839604|129587|P2|STARTED|Overall Study||6
54284|NCT01839604|129588|P1|STARTED|Overall Study||6
54285|NCT01839318|129615|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
54286|NCT01839318|129616|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
54287|NCT01839318|129617|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
54288|NCT01839318|129618|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
54289|NCT01839318|129619|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
54290|NCT01839318|129620|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
54291|NCT01839318|129615|P6|COMPLETED|Period 3, Third Day of Wear||2
54292|NCT01839318|129616|P5|COMPLETED|Period 3, Third Day of Wear||7
54293|NCT01839318|129617|P4|COMPLETED|Period 3, Third Day of Wear||6
54294|NCT01839318|129618|P3|COMPLETED|Period 3, Third Day of Wear||5
54295|NCT01839318|129619|P2|COMPLETED|Period 3, Third Day of Wear||4
54296|NCT01839318|129620|P1|COMPLETED|Period 3, Third Day of Wear||4
54297|NCT01839318|129615|P6|STARTED|Period 3, Third Day of Wear||2
54298|NCT01839318|129616|P5|STARTED|Period 3, Third Day of Wear||7
54299|NCT01839318|129617|P4|STARTED|Period 3, Third Day of Wear||6
54300|NCT01839318|129618|P3|STARTED|Period 3, Third Day of Wear||5
54301|NCT01839318|129619|P2|STARTED|Period 3, Third Day of Wear||4
54302|NCT01839318|129620|P1|STARTED|Period 3, Third Day of Wear||4
54303|NCT01839318|129615|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
54304|NCT01839318|129616|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
54305|NCT01839318|129617|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
54306|NCT01839318|129618|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
54307|NCT01839318|129619|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
54308|NCT01839318|129620|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
54309|NCT01839318|129615|P6|COMPLETED|Period 2, Second Day of Wear||2
54310|NCT01839318|129616|P5|COMPLETED|Period 2, Second Day of Wear||7
54311|NCT01839318|129617|P4|COMPLETED|Period 2, Second Day of Wear||6
54312|NCT01839318|129618|P3|COMPLETED|Period 2, Second Day of Wear||5
54313|NCT01839318|129619|P2|COMPLETED|Period 2, Second Day of Wear||4
54314|NCT01839318|129620|P1|COMPLETED|Period 2, Second Day of Wear||4
54315|NCT01839318|129615|P6|STARTED|Period 2, Second Day of Wear||2
54316|NCT01839318|129616|P5|STARTED|Period 2, Second Day of Wear||7
54317|NCT01839318|129617|P4|STARTED|Period 2, Second Day of Wear||6
54318|NCT01839318|129618|P3|STARTED|Period 2, Second Day of Wear||5
54319|NCT01839318|129619|P2|STARTED|Period 2, Second Day of Wear||4
54320|NCT01839318|129620|P1|STARTED|Period 2, Second Day of Wear||4
54321|NCT01839318|129615|P6|NOT COMPLETED|Period 1, First Day of Wear||0
54322|NCT01839318|129616|P5|NOT COMPLETED|Period 1, First Day of Wear||0
54323|NCT01839318|129617|P4|NOT COMPLETED|Period 1, First Day of Wear||0
54324|NCT01839318|129618|P3|NOT COMPLETED|Period 1, First Day of Wear||0
54325|NCT01839318|129619|P2|NOT COMPLETED|Period 1, First Day of Wear||0
54326|NCT01839318|129620|P1|NOT COMPLETED|Period 1, First Day of Wear||0
54327|NCT01839318|129615|P6|COMPLETED|Period 1, First Day of Wear||2
54328|NCT01839318|129616|P5|COMPLETED|Period 1, First Day of Wear||7
54329|NCT01839318|129617|P4|COMPLETED|Period 1, First Day of Wear||6
54330|NCT01839318|129618|P3|COMPLETED|Period 1, First Day of Wear||5
54331|NCT01839318|129619|P2|COMPLETED|Period 1, First Day of Wear||4
54332|NCT01839318|129620|P1|COMPLETED|Period 1, First Day of Wear||4
54333|NCT01839318|129615|P6|STARTED|Period 1, First Day of Wear||2
54334|NCT01839318|129616|P5|STARTED|Period 1, First Day of Wear||7
54335|NCT01839318|129617|P4|STARTED|Period 1, First Day of Wear||6
54336|NCT01839318|129618|P3|STARTED|Period 1, First Day of Wear||5
54337|NCT01839318|129619|P2|STARTED|Period 1, First Day of Wear||4
54338|NCT01839318|129620|P1|STARTED|Period 1, First Day of Wear||4
54339|NCT01839279|129634|P3|NOT COMPLETED|Overall Study||2
54340|NCT01839279|129635|P2|NOT COMPLETED|Overall Study||2
54341|NCT01839279|129636|P1|NOT COMPLETED|Overall Study||13
54342|NCT01839279|129634|P3|COMPLETED|Overall Study||30
54343|NCT01839279|129635|P2|COMPLETED|Overall Study||30
54344|NCT01839279|129636|P1|COMPLETED|Overall Study||59
54345|NCT01839279|129634|P3|PK/QTc Analysis Set|Overall Study||0
54346|NCT01839279|129635|P2|PK/QTc Analysis Set|Overall Study||0
54347|NCT01839279|129636|P1|PK/QTc Analysis Set|Overall Study||70
54348|NCT01839279|129634|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
54349|NCT01839279|129635|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
54350|NCT01839279|129636|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
54351|NCT01839279|129634|P3|PK Analysis Set|Overall Study||0
54352|NCT01839279|129635|P2|PK Analysis Set|Overall Study||0
54353|NCT01839279|129636|P1|PK Analysis Set|Overall Study||70
54354|NCT01839279|129634|P3|QT/QTc Analysis Set|Overall Study||32
54355|NCT01839279|129635|P2|QT/QTc Analysis Set|Overall Study||32
54356|NCT01839279|129636|P1|QT/QTc Analysis Set|Overall Study||72
54357|NCT01839279|129634|P3|STARTED|Overall Study||32
54358|NCT01839279|129635|P2|STARTED|Overall Study||32
54359|NCT01839279|129636|P1|STARTED|Overall Study||72
54360|NCT01839058|129657|P2|NOT COMPLETED|Overall Study||3
54361|NCT01839058|129658|P1|NOT COMPLETED|Overall Study||4
54362|NCT01839058|129657|P2|COMPLETED|Overall Study||16
54363|NCT01839058|129658|P1|COMPLETED|Overall Study||17
54364|NCT01839058|129657|P2|STARTED|Overall Study||19
54365|NCT01839058|129658|P1|STARTED|Overall Study||21
54366|NCT01838980|129664|P1|NOT COMPLETED|Overall Study||0
54367|NCT01838980|129664|P1|COMPLETED|Overall Study||15
54368|NCT01838980|129664|P1|STARTED|Overall Study||15
54369|NCT01838941|129668|P1|NOT COMPLETED|Overall Study||2
54370|NCT01838941|129668|P1|COMPLETED|Overall Study||10
54371|NCT01838941|129668|P1|STARTED|Overall Study||12
54372|NCT01838785|129673|P1|NOT COMPLETED|Overall Study||0
54373|NCT01838785|129673|P1|COMPLETED|Overall Study||25
54374|NCT01838785|129673|P1|STARTED|Overall Study||25
54375|NCT01838694|129680|P2|NOT COMPLETED|Overall Study||1
54376|NCT01838694|129681|P1|NOT COMPLETED|Overall Study||0
54377|NCT01838694|129680|P2|COMPLETED|Overall Study||21
54378|NCT01838694|129681|P1|COMPLETED|Overall Study||8
54379|NCT01838694|129680|P2|STARTED|Overall Study||22
54380|NCT01838694|129681|P1|STARTED|Overall Study||8
54381|NCT01838681|129690|P4|NOT COMPLETED|Period B/A+||117
54382|NCT01838681|129691|P3|NOT COMPLETED|Period B/A+||95
54383|NCT01838681|129692|P2|NOT COMPLETED|Period B/A+||62
54384|NCT01838681|129693|P1|NOT COMPLETED|Period B/A+||0
54385|NCT01838681|129690|P4|COMPLETED|Period B/A+||653
54386|NCT01838681|129691|P3|COMPLETED|Period B/A+||349
54387|NCT01838681|129692|P2|COMPLETED|Period B/A+||380
54388|NCT01838681|129693|P1|COMPLETED|Period B/A+||0
54389|NCT01838681|129690|P4|STARTED|Period B/A+||770
54390|NCT01838681|129691|P3|STARTED|Period B/A+||444
54391|NCT01838681|129692|P2|STARTED|Period B/A+||442
54392|NCT01838681|129693|P1|STARTED|Period B/A+||0
54393|NCT01838681|129690|P4|NOT COMPLETED|Period A||0
54394|NCT01838681|129691|P3|NOT COMPLETED|Period A||0
54395|NCT01838681|129692|P2|NOT COMPLETED|Period A||0
54396|NCT01838681|129693|P1|NOT COMPLETED|Period A||325
54397|NCT01838681|129690|P4|COMPLETED|Period A||0
54398|NCT01838681|129691|P3|COMPLETED|Period A||0
54399|NCT01838681|129692|P2|COMPLETED|Period A||0
54400|NCT01838681|129693|P1|COMPLETED|Period A||1661
54401|NCT01838681|129690|P4|STARTED|Period A||0
54402|NCT01838681|129691|P3|STARTED|Period A||0
54403|NCT01838681|129692|P2|STARTED|Period A||0
54404|NCT01838681|129693|P1|STARTED|Period A||1986
54405|NCT01838655|129733|P1|NOT COMPLETED|Overall Study||0
54406|NCT01838655|129733|P1|COMPLETED|Overall Study||5
54407|NCT01838655|129733|P1|STARTED|Overall Study||5
54408|NCT01838642|129801|P1|NOT COMPLETED|Overall Study||1
54409|NCT01838642|129801|P1|COMPLETED|Overall Study||2
54410|NCT01838642|129801|P1|STARTED|Overall Study||3
54411|NCT01838616|129814|P2|NOT COMPLETED|Pick-up Arm||0
54412|NCT01838616|129815|P1|NOT COMPLETED|Pick-up Arm||15
54413|NCT01838616|129814|P2|COMPLETED|Pick-up Arm||0
54414|NCT01838616|129815|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
54415|NCT01838616|129814|P2|Full Analysis Set|Pick-up Arm||0
54416|NCT01838616|129815|P1|Full Analysis Set|Pick-up Arm||49
54417|NCT01838616|129814|P2|STARTED|Pick-up Arm||0
54418|NCT01838616|129815|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
54419|NCT01838616|129814|P2|NOT COMPLETED|Continuation Period||14
54420|NCT01838616|129815|P1|NOT COMPLETED|Continuation Period||14
54421|NCT01838616|129814|P2|COMPLETED|Continuation Period||48
54422|NCT01838616|129815|P1|COMPLETED|Continuation Period||86
54423|NCT01838616|129814|P2|Switched to Pick-up Arm|Continuation Period||7
54424|NCT01838616|129815|P1|Switched to Pick-up Arm|Continuation Period||0
54425|NCT01838616|129814|P2|STARTED|Continuation Period||62
54426|NCT01838616|129815|P1|STARTED|Continuation Period||100
54427|NCT01838616|129814|P2|NOT COMPLETED|Titration Period||66
54428|NCT01838616|129815|P1|NOT COMPLETED|Titration Period||30
54429|NCT01838616|129814|P2|COMPLETED|Titration Period||62
54430|NCT01838616|129815|P1|COMPLETED|Titration Period||100
54431|NCT01838616|129814|P2|Per Protocol Set|Titration Period||112
54432|NCT01838616|129815|P1|Per Protocol Set|Titration Period||117
54433|NCT01838616|129814|P2|Full Analysis Set|Titration Period||128
54434|NCT01838616|129815|P1|Full Analysis Set|Titration Period||130
54435|NCT01838616|129814|P2|Switched to Pick-up Arm|Titration Period||43
54436|NCT01838616|129815|P1|Switched to Pick-up Arm|Titration Period||0
54437|NCT01838616|129814|P2|Major Protocol Deviations|Titration Period||16
54438|NCT01838616|129815|P1|Major Protocol Deviations|Titration Period||13
54439|NCT01838616|129814|P2|No Post Baseline Pain Intensity Values|Titration Period||2
54440|NCT01838616|129815|P1|No Post Baseline Pain Intensity Values|Titration Period||0
54441|NCT01838616|129814|P2|STARTED|Titration Period||128
54442|NCT01838616|129815|P1|STARTED|Titration Period||130
54443|NCT01838590|129886|P2|NOT COMPLETED|Overall Study||5
54444|NCT01838590|129887|P1|NOT COMPLETED|Overall Study||12
54445|NCT01838590|129886|P2|COMPLETED|Overall Study||46
54446|NCT01838590|129887|P1|COMPLETED|Overall Study||40
54447|NCT01838590|129886|P2|STARTED|Overall Study||51
54448|NCT01838590|129887|P1|STARTED|Overall Study||52
54449|NCT01838499|129911|P2|NOT COMPLETED|Overall Study||17
54450|NCT01838499|129912|P1|NOT COMPLETED|Overall Study||24
54451|NCT01838499|129911|P2|COMPLETED|Overall Study||37
54452|NCT01838499|129912|P1|COMPLETED|Overall Study||31
54453|NCT01838499|129911|P2|STARTED|Overall Study||54
54454|NCT01838499|129912|P1|STARTED|Overall Study||55
54455|NCT01838304|129924|P2|NOT COMPLETED|Overall Study||0
54456|NCT01838304|129925|P1|NOT COMPLETED|Overall Study||1
54457|NCT01838304|129924|P2|COMPLETED|Overall Study||20
54458|NCT01838304|129925|P1|COMPLETED|Overall Study||19
54459|NCT01838304|129924|P2|STARTED|Overall Study||20
54460|NCT01838304|129925|P1|STARTED|Overall Study||20
54461|NCT01838213|129939|P2|NOT COMPLETED|Overall Study||191
54462|NCT01838213|129940|P1|NOT COMPLETED|Overall Study||166
54463|NCT01838213|129939|P2|COMPLETED|Overall Study||262
54464|NCT01838213|129940|P1|COMPLETED|Overall Study||81
54465|NCT01838213|129939|P2|STARTED|Overall Study||453
54466|NCT01838213|129940|P1|STARTED|Overall Study||247
54467|NCT01838044|129948|P2|NOT COMPLETED|Overall Study||16
54468|NCT01838044|129949|P1|NOT COMPLETED|Overall Study||8
54469|NCT01838044|129948|P2|COMPLETED|Overall Study||75
54470|NCT01838044|129949|P1|COMPLETED|Overall Study||81
54471|NCT01838044|129948|P2|STARTED|Overall Study||91
54472|NCT01838044|129949|P1|STARTED|Overall Study||89
54473|NCT01837966|129982|P2|NOT COMPLETED|Overall Study||1
54474|NCT01837966|129983|P1|NOT COMPLETED|Overall Study||2
54475|NCT01837966|129982|P2|COMPLETED|Overall Study||45
54476|NCT01837966|129983|P1|COMPLETED|Overall Study||45
54477|NCT01837966|129982|P2|STARTED|Overall Study||46
54478|NCT01837966|129983|P1|STARTED|Overall Study||47
54479|NCT01837823|129989|P1|NOT COMPLETED|Overall Study||6
54480|NCT01837823|129989|P1|COMPLETED|Overall Study||85
54481|NCT01837823|129989|P1|STARTED|Overall Study||91
54482|NCT01837797|130020|P5|NOT COMPLETED|Period 3||23
54483|NCT01837797|130021|P4|NOT COMPLETED|Period 3||0
54484|NCT01837797|130022|P3|NOT COMPLETED|Period 3||0
54485|NCT01837797|130023|P2|NOT COMPLETED|Period 3||0
54486|NCT01837797|130024|P1|NOT COMPLETED|Period 3||0
54487|NCT01837797|130020|P5|COMPLETED|Period 3||24
54488|NCT01837797|130021|P4|COMPLETED|Period 3||0
54489|NCT01837797|130022|P3|COMPLETED|Period 3||0
54490|NCT01837797|130023|P2|COMPLETED|Period 3||0
54491|NCT01837797|130024|P1|COMPLETED|Period 3||0
54492|NCT01837797|130020|P5|STARTED|Period 3||47
54493|NCT01837797|130021|P4|STARTED|Period 3||0
54494|NCT01837797|130022|P3|STARTED|Period 3||0
54495|NCT01837797|130023|P2|STARTED|Period 3||0
54496|NCT01837797|130024|P1|STARTED|Period 3||0
54497|NCT01837797|130020|P5|NOT COMPLETED|Period 2||0
54498|NCT01837797|130021|P4|NOT COMPLETED|Period 2||5
54499|NCT01837797|130022|P3|NOT COMPLETED|Period 2||2
54500|NCT01837797|130023|P2|NOT COMPLETED|Period 2||5
54501|NCT01837797|130024|P1|NOT COMPLETED|Period 2||0
54502|NCT01837797|130020|P5|COMPLETED|Period 2||0
54503|NCT01837797|130021|P4|COMPLETED|Period 2||1
54504|NCT01837797|130022|P3|COMPLETED|Period 2||1
54505|NCT01837797|130023|P2|COMPLETED|Period 2||1
54506|NCT01837797|130024|P1|COMPLETED|Period 2||0
54507|NCT01837797|130020|P5|STARTED|Period 2||0
54508|NCT01837797|130021|P4|STARTED|Period 2||6
54509|NCT01837797|130022|P3|STARTED|Period 2||3
54510|NCT01837797|130023|P2|STARTED|Period 2||6
54511|NCT01837797|130024|P1|STARTED|Period 2||0
54512|NCT01837797|130020|P5|NOT COMPLETED|Period 1||0
54513|NCT01837797|130021|P4|NOT COMPLETED|Period 1||0
54514|NCT01837797|130022|P3|NOT COMPLETED|Period 1||0
54515|NCT01837797|130023|P2|NOT COMPLETED|Period 1||0
54516|NCT01837797|130024|P1|NOT COMPLETED|Period 1||102
54517|NCT01837797|130020|P5|COMPLETED|Period 1||0
54518|NCT01837797|130021|P4|COMPLETED|Period 1||0
54519|NCT01837797|130022|P3|COMPLETED|Period 1||0
54520|NCT01837797|130023|P2|COMPLETED|Period 1||0
54521|NCT01837797|130024|P1|COMPLETED|Period 1||27
54522|NCT01837797|130020|P5|STARTED|Period 1||0
54523|NCT01837797|130021|P4|STARTED|Period 1||0
54524|NCT01837797|130022|P3|STARTED|Period 1||0
54525|NCT01837797|130023|P2|STARTED|Period 1||0
54526|NCT01837797|130024|P1|STARTED|Period 1||129
54527|NCT01837719|130059|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
54528|NCT01837719|130059|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
54529|NCT01837719|130059|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
54530|NCT01837719|130059|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
54531|NCT01837719|130059|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
54532|NCT01837719|130059|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
54533|NCT01837719|130059|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
54534|NCT01837719|130059|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
54535|NCT01837719|130059|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
54536|NCT01837719|130059|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
54537|NCT01837719|130059|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
54538|NCT01837719|130059|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
54539|NCT01837719|130059|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
54540|NCT01837719|130059|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
54541|NCT01837719|130059|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
54542|NCT01837680|130128|P2|NOT COMPLETED|Overall Study||8
54543|NCT01837680|130129|P1|NOT COMPLETED|Overall Study||10
54544|NCT01837680|130128|P2|COMPLETED|Overall Study||45
54545|NCT01837680|130129|P1|COMPLETED|Overall Study||42
54546|NCT01837680|130128|P2|STARTED|Overall Study||53
54547|NCT01837680|130129|P1|STARTED|Overall Study||52
54548|NCT01837550|130167|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
54549|NCT01837550|130168|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
54550|NCT01837550|130167|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
54551|NCT01837550|130168|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
54552|NCT01837550|130167|P2|STARTED|T0-T2, 6 Months Follow-up||37
54553|NCT01837550|130168|P1|STARTED|T0-T2, 6 Months Follow-up||37
54554|NCT01837550|130167|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
54555|NCT01837550|130168|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
54556|NCT01837550|130167|P2|COMPLETED|T0-T1, 5 Weeks||37
54557|NCT01837550|130168|P1|COMPLETED|T0-T1, 5 Weeks||37
54558|NCT01837550|130167|P2|STARTED|T0-T1, 5 Weeks||37
54559|NCT01837550|130168|P1|STARTED|T0-T1, 5 Weeks||37
54560|NCT01837537|130180|P1|NOT COMPLETED|Overall Study||0
54561|NCT01837537|130180|P1|COMPLETED|Overall Study||90
54562|NCT01837537|130180|P1|STARTED|Overall Study||90
54563|NCT01837524|130187|P2|NOT COMPLETED|Overall Study||2
54564|NCT01837524|130188|P1|NOT COMPLETED|Overall Study||3
54565|NCT01837524|130187|P2|COMPLETED|Overall Study||25
54566|NCT01837524|130188|P1|COMPLETED|Overall Study||25
54567|NCT01837524|130187|P2|STARTED|Overall Study||27
54568|NCT01837524|130188|P1|STARTED|Overall Study||28
54569|NCT01836809|130198|P4|NOT COMPLETED|Overall Study||2
54570|NCT01836809|130199|P3|NOT COMPLETED|Overall Study||0
54571|NCT01836809|130200|P2|NOT COMPLETED|Overall Study||0
54572|NCT01836809|130201|P1|NOT COMPLETED|Overall Study||0
54573|NCT01836809|130198|P4|COMPLETED|Overall Study||0
54574|NCT01836809|130199|P3|COMPLETED|Overall Study||0
54575|NCT01836809|130200|P2|COMPLETED|Overall Study||0
54576|NCT01836809|130201|P1|COMPLETED|Overall Study||0
54577|NCT01836809|130198|P4|STARTED|Overall Study||2
54578|NCT01836809|130199|P3|STARTED|Overall Study||0
54579|NCT01836809|130200|P2|STARTED|Overall Study||0
54580|NCT01836809|130201|P1|STARTED|Overall Study||0
54581|NCT01836523|130235|P4|NOT COMPLETED|Overall Study||74
54582|NCT01836523|130236|P3|NOT COMPLETED|Overall Study||91
54583|NCT01836523|130237|P2|NOT COMPLETED|Overall Study||85
54584|NCT01836523|130238|P1|NOT COMPLETED|Overall Study||51
54585|NCT01836523|130235|P4|COMPLETED|Overall Study||274
54586|NCT01836523|130236|P3|COMPLETED|Overall Study||258
54587|NCT01836523|130237|P2|COMPLETED|Overall Study||265
54588|NCT01836523|130238|P1|COMPLETED|Overall Study||300
54589|NCT01836523|130235|P4|Exposed|Overall Study||348
54590|NCT01836523|130236|P3|Exposed|Overall Study||347
54591|NCT01836523|130237|P2|Exposed|Overall Study||348
54592|NCT01836523|130238|P1|Exposed|Overall Study||350
54593|NCT01836523|130235|P4|STARTED|Overall Study||348
54594|NCT01836523|130236|P3|STARTED|Overall Study||349
54595|NCT01836523|130237|P2|STARTED|Overall Study||350
54596|NCT01836523|130238|P1|STARTED|Overall Study||351
54597|NCT01836471|130265|P5|NOT COMPLETED|Overall Study||5
54598|NCT01836471|130266|P4|NOT COMPLETED|Overall Study||2
54599|NCT01836471|130267|P3|NOT COMPLETED|Overall Study||2
54600|NCT01836471|130268|P2|NOT COMPLETED|Overall Study||9
54601|NCT01836471|130269|P1|NOT COMPLETED|Overall Study||11
54602|NCT01836471|130265|P5|COMPLETED|Overall Study||49
54603|NCT01836471|130266|P4|COMPLETED|Overall Study||40
54604|NCT01836471|130267|P3|COMPLETED|Overall Study||49
54605|NCT01836471|130268|P2|COMPLETED|Overall Study||85
54606|NCT01836471|130269|P1|COMPLETED|Overall Study||82
54607|NCT01836471|130265|P5|STARTED|Overall Study||54
54608|NCT01836471|130266|P4|STARTED|Overall Study||42
54609|NCT01836471|130267|P3|STARTED|Overall Study||51
54610|NCT01836471|130268|P2|STARTED|Overall Study||94
54611|NCT01836471|130269|P1|STARTED|Overall Study||93
54612|NCT01836458|130298|P4|NOT COMPLETED|Overall Study||6
54613|NCT01836458|130299|P3|NOT COMPLETED|Overall Study||5
54614|NCT01836458|130300|P2|NOT COMPLETED|Overall Study||2
54615|NCT01836458|130301|P1|NOT COMPLETED|Overall Study||3
54616|NCT01836458|130298|P4|COMPLETED|Overall Study||1
54617|NCT01836458|130299|P3|COMPLETED|Overall Study||2
54618|NCT01836458|130300|P2|COMPLETED|Overall Study||2
54619|NCT01836458|130301|P1|COMPLETED|Overall Study||4
54620|NCT01836458|130298|P4|STARTED|Overall Study||7
54621|NCT01836458|130299|P3|STARTED|Overall Study||7
54622|NCT01836458|130300|P2|STARTED|Overall Study||4
54623|NCT01836458|130301|P1|STARTED|Overall Study||7
54624|NCT01836133|130323|P1|NOT COMPLETED|Overall Study||0
54625|NCT01836133|130323|P1|COMPLETED|Overall Study||70
54626|NCT01836133|130323|P1|STARTED|Overall Study||70
54627|NCT01836042|130332|P3|NOT COMPLETED|Overall Study||0
54628|NCT01836042|130333|P2|NOT COMPLETED|Overall Study||0
54629|NCT01836042|130334|P1|NOT COMPLETED|Overall Study||0
54630|NCT01836042|130332|P3|COMPLETED|Overall Study||22
54631|NCT01836042|130333|P2|COMPLETED|Overall Study||35
54632|NCT01836042|130334|P1|COMPLETED|Overall Study||51
54633|NCT01836042|130332|P3|STARTED|Overall Study||22
54634|NCT01836042|130333|P2|STARTED|Overall Study||35
54635|NCT01836042|130334|P1|STARTED|Overall Study||51
54636|NCT01835912|130342|P1|NOT COMPLETED|Overall Study||0
54637|NCT01835912|130342|P1|COMPLETED|Overall Study||10
54638|NCT01835912|130342|P1|Chronic Placebo|Overall Study||10
54639|NCT01835912|130342|P1|Chronic|Overall Study||10
54640|NCT01835912|130342|P1|Acute Placebo|Overall Study||10
54641|NCT01835912|130342|P1|Acute|Overall Study||10
54642|NCT01835912|130342|P1|STARTED|Overall Study||10
54643|NCT01835899|130363|P3|NOT COMPLETED|Overall Study||1
54644|NCT01835899|130364|P2|NOT COMPLETED|Overall Study||1
54645|NCT01835899|130365|P1|NOT COMPLETED|Overall Study||0
54646|NCT01835899|130363|P3|COMPLETED|Overall Study||8
54647|NCT01835899|130364|P2|COMPLETED|Overall Study||8
54648|NCT01835899|130365|P1|COMPLETED|Overall Study||6
54649|NCT01835899|130363|P3|STARTED|Overall Study||9
54650|NCT01835899|130364|P2|STARTED|Overall Study||9
54651|NCT01835899|130365|P1|STARTED|Overall Study||6
54652|NCT01835756|130385|P2|NOT COMPLETED|Overall Study||0
54653|NCT01835756|130386|P1|NOT COMPLETED|Overall Study||0
54654|NCT01835756|130385|P2|COMPLETED|Overall Study||31
54655|NCT01835756|130386|P1|COMPLETED|Overall Study||31
54656|NCT01835756|130385|P2|STARTED|Overall Study||31
54657|NCT01835756|130386|P1|STARTED|Overall Study||31
54658|NCT01835743|130398|P2|NOT COMPLETED|Overall Study||0
54659|NCT01835743|130399|P1|NOT COMPLETED|Overall Study||0
54660|NCT01835743|130398|P2|COMPLETED|Overall Study||32
54661|NCT01835743|130399|P1|COMPLETED|Overall Study||37
54662|NCT01835743|130398|P2|STARTED|Overall Study||32
54663|NCT01835743|130399|P1|STARTED|Overall Study||37
54664|NCT01835548|130409|P3|NOT COMPLETED|Double-Blind Treatment Period||0
54665|NCT01835548|130410|P2|NOT COMPLETED|Double-Blind Treatment Period||2
54666|NCT01835548|130411|P1|NOT COMPLETED|Double-Blind Treatment Period||0
54667|NCT01835548|130409|P3|COMPLETED|Double-Blind Treatment Period||0
54668|NCT01835548|130410|P2|COMPLETED|Double-Blind Treatment Period||39
54669|NCT01835548|130411|P1|COMPLETED|Double-Blind Treatment Period||44
54670|NCT01835548|130409|P3|STARTED|Double-Blind Treatment Period||0
54671|NCT01835548|130410|P2|STARTED|Double-Blind Treatment Period||41
54672|NCT01835548|130411|P1|STARTED|Double-Blind Treatment Period||44
54673|NCT01835548|130409|P3|NOT COMPLETED|Dose Stabilization Period||0
54674|NCT01835548|130410|P2|NOT COMPLETED|Dose Stabilization Period||0
54675|NCT01835548|130411|P1|NOT COMPLETED|Dose Stabilization Period||0
54676|NCT01835548|130409|P3|COMPLETED|Dose Stabilization Period||85
54677|NCT01835548|130410|P2|COMPLETED|Dose Stabilization Period||0
54678|NCT01835548|130411|P1|COMPLETED|Dose Stabilization Period||0
54679|NCT01835548|130409|P3|STARTED|Dose Stabilization Period||85
54680|NCT01835548|130410|P2|STARTED|Dose Stabilization Period||0
54681|NCT01835548|130411|P1|STARTED|Dose Stabilization Period||0
54682|NCT01835548|130409|P3|NOT COMPLETED|Dose Optimization Period||2
54683|NCT01835548|130410|P2|NOT COMPLETED|Dose Optimization Period||0
54684|NCT01835548|130411|P1|NOT COMPLETED|Dose Optimization Period||0
54685|NCT01835548|130409|P3|COMPLETED|Dose Optimization Period||85
54686|NCT01835548|130410|P2|COMPLETED|Dose Optimization Period||0
54687|NCT01835548|130411|P1|COMPLETED|Dose Optimization Period||0
54688|NCT01835548|130409|P3|STARTED|Dose Optimization Period||87
54689|NCT01835548|130410|P2|STARTED|Dose Optimization Period||0
54690|NCT01835548|130411|P1|STARTED|Dose Optimization Period||0
54691|NCT01835548|130409|P3|NOT COMPLETED|Screening/Washout Period||0
54692|NCT01835548|130410|P2|NOT COMPLETED|Screening/Washout Period||0
54693|NCT01835548|130411|P1|NOT COMPLETED|Screening/Washout Period||0
54694|NCT01835548|130409|P3|COMPLETED|Screening/Washout Period||87
54695|NCT01835548|130410|P2|COMPLETED|Screening/Washout Period||0
54696|NCT01835548|130411|P1|COMPLETED|Screening/Washout Period||0
54697|NCT01835548|130409|P3|STARTED|Screening/Washout Period||87
54698|NCT01835548|130410|P2|STARTED|Screening/Washout Period||0
54699|NCT01835548|130411|P1|STARTED|Screening/Washout Period||0
54700|NCT01835496|130431|P1|NOT COMPLETED|Overall Study||0
54701|NCT01835496|130431|P1|COMPLETED|Overall Study||8
54702|NCT01835496|130431|P1|STARTED|Overall Study||8
54703|NCT01835470|130440|P1|NOT COMPLETED|Long Term Treatment Period||2
54704|NCT01835470|130440|P1|COMPLETED|Long Term Treatment Period|Completed=Still on Treatment|18
54705|NCT01835470|130440|P1|STARTED|Long Term Treatment Period||20
54706|NCT01835470|130440|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
54707|NCT01835470|130440|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
54708|NCT01835470|130440|P1|STARTED|Short Term Treatment Period (to Week 16)||20
54709|NCT01835431|130452|P2|NOT COMPLETED|Overall Study||12
54710|NCT01835431|130453|P1|NOT COMPLETED|Overall Study||8
54711|NCT01835431|130452|P2|COMPLETED|Overall Study||168
54712|NCT01835431|130453|P1|COMPLETED|Overall Study||174
54713|NCT01835431|130452|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
54714|NCT01835431|130453|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
54715|NCT01835431|130452|P2|STARTED|Overall Study||180
54716|NCT01835431|130453|P1|STARTED|Overall Study||182
54717|NCT01835379|130473|P2|NOT COMPLETED|Overall Study||0
54718|NCT01835379|130474|P1|NOT COMPLETED|Overall Study||0
54719|NCT01835379|130473|P2|COMPLETED|Overall Study||41
54720|NCT01835379|130474|P1|COMPLETED|Overall Study||41
54721|NCT01835379|130473|P2|STARTED|Overall Study||41
54722|NCT01835379|130474|P1|STARTED|Overall Study||41
54723|NCT01835262|130484|P2|NOT COMPLETED|Overall Study||0
54724|NCT01835262|130485|P1|NOT COMPLETED|Overall Study||0
54725|NCT01835262|130484|P2|COMPLETED|Overall Study||45
54726|NCT01835262|130485|P1|COMPLETED|Overall Study||45
54727|NCT01835262|130484|P2|STARTED|Overall Study||45
54728|NCT01835262|130485|P1|STARTED|Overall Study||45
54729|NCT01835132|130491|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
54730|NCT01835132|130491|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
54731|NCT01835132|130491|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
54732|NCT01835132|130491|P1|NOT COMPLETED|1st Extension Phase||0
54733|NCT01835132|130491|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
54734|NCT01835132|130491|P1|STARTED|1st Extension Phase||6
54735|NCT01835132|130491|P1|NOT COMPLETED|Initial Phase||2
54736|NCT01835132|130491|P1|COMPLETED|Initial Phase||6
54737|NCT01835132|130491|P1|STARTED|Initial Phase||8
54738|NCT01835015|130536|P5|NOT COMPLETED|Overall Study||0
54739|NCT01835015|130537|P4|NOT COMPLETED|Overall Study||0
54740|NCT01835015|130538|P3|NOT COMPLETED|Overall Study||1
54741|NCT01835015|130539|P2|NOT COMPLETED|Overall Study||0
54742|NCT01835015|130540|P1|NOT COMPLETED|Overall Study||0
54743|NCT01835015|130536|P5|COMPLETED|Overall Study||6
54744|NCT01835015|130537|P4|COMPLETED|Overall Study||6
54745|NCT01835015|130538|P3|COMPLETED|Overall Study||6
54746|NCT01835015|130539|P2|COMPLETED|Overall Study||6
54747|NCT01835015|130540|P1|COMPLETED|Overall Study||6
54748|NCT01835015|130536|P5|STARTED|Overall Study||6
54749|NCT01835015|130537|P4|STARTED|Overall Study||6
54750|NCT01835015|130538|P3|STARTED|Overall Study||7
54751|NCT01835015|130539|P2|STARTED|Overall Study||6
54752|NCT01835015|130540|P1|STARTED|Overall Study||6
54753|NCT01834651|130613|P1|NOT COMPLETED|Overall Study||1
54754|NCT01834651|130613|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
54755|NCT01834651|130613|P1|STARTED|Overall Study||17
54756|NCT01834586|130623|P1|NOT COMPLETED|Overall Study||1
54757|NCT01834586|130623|P1|COMPLETED|Overall Study||29
54758|NCT01834586|130623|P1|STARTED|Overall Study||30
54759|NCT01834404|130630|P2|NOT COMPLETED|Overall Study||0
54760|NCT01834404|130631|P1|NOT COMPLETED|Overall Study||0
54761|NCT01834404|130630|P2|COMPLETED|Overall Study||12
54762|NCT01834404|130631|P1|COMPLETED|Overall Study||12
54763|NCT01834404|130630|P2|STARTED|Overall Study||12
54764|NCT01834404|130631|P1|STARTED|Overall Study||12
54765|NCT01834274|130663|P2|NOT COMPLETED|Overall Study||41
54766|NCT01834274|130664|P1|NOT COMPLETED|Overall Study||47
54767|NCT01834274|130663|P2|COMPLETED|Overall Study||5
54768|NCT01834274|130664|P1|COMPLETED|Overall Study||3
54769|NCT01834274|130663|P2|STARTED|Overall Study||46
54770|NCT01834274|130664|P1|STARTED|Overall Study||50
54771|NCT01834261|130676|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
54772|NCT01834261|130677|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
54773|NCT01834261|130676|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
54774|NCT01834261|130677|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
54775|NCT01834261|130676|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
54776|NCT01834261|130677|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
54777|NCT01834261|130676|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
54778|NCT01834261|130677|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
54779|NCT01834261|130676|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
54780|NCT01834261|130677|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
54781|NCT01834261|130676|P2|STARTED|MIT fMRI and MEG Resting State Study||10
54782|NCT01834261|130677|P1|STARTED|MIT fMRI and MEG Resting State Study||11
54783|NCT01834222|130687|P1|NOT COMPLETED|Overall Study||1
54784|NCT01834222|130687|P1|COMPLETED|Overall Study||658
54785|NCT01834222|130687|P1|Treated|Overall Study||658
54786|NCT01834222|130687|P1|STARTED|Overall Study||659
54787|NCT01834027|130698|P2|NOT COMPLETED|Overall Study||0
54788|NCT01834027|130699|P1|NOT COMPLETED|Overall Study||0
54789|NCT01834027|130698|P2|COMPLETED|Overall Study||28
54790|NCT01834027|130699|P1|COMPLETED|Overall Study||28
54791|NCT01834027|130698|P2|STARTED|Overall Study||28
54792|NCT01834027|130699|P1|STARTED|Overall Study||28
54793|NCT01833988|130709|P2|NOT COMPLETED|Overall Study||0
54794|NCT01833988|130710|P1|NOT COMPLETED|Overall Study||0
54795|NCT01833988|130709|P2|COMPLETED|Overall Study||16
54796|NCT01833988|130710|P1|COMPLETED|Overall Study||16
54797|NCT01833988|130709|P2|STARTED|Overall Study||16
54798|NCT01833988|130710|P1|STARTED|Overall Study||16
54799|NCT01833936|130766|P2|NOT COMPLETED|Overall Study||2
54800|NCT01833936|130767|P1|NOT COMPLETED|Overall Study||4
54801|NCT01833936|130766|P2|COMPLETED|Overall Study||18
54802|NCT01833936|130767|P1|COMPLETED|Overall Study||16
54803|NCT01833936|130766|P2|STARTED|Overall Study||20
54804|NCT01833936|130767|P1|STARTED|Overall Study||20
54805|NCT01833897|130773|P1|NOT COMPLETED|Overall Study||1
54806|NCT01833897|130773|P1|COMPLETED|Overall Study||7
54807|NCT01833897|130773|P1|STARTED|Overall Study||8
54808|NCT01833845|130781|P1|NOT COMPLETED|Overall Study||0
54809|NCT01833845|130781|P1|COMPLETED|Overall Study||4
54810|NCT01833845|130781|P1|STARTED|Overall Study||4
54811|NCT01833741|130785|P1|NOT COMPLETED|Overall Study||140
54812|NCT01833741|130785|P1|COMPLETED|Overall Study||997
54813|NCT01833741|130785|P1|STARTED|Overall Study||1137
54814|NCT01833533|130800|P2|NOT COMPLETED|Overall Study||21
54815|NCT01833533|130801|P1|NOT COMPLETED|Overall Study||6
54816|NCT01833533|130800|P2|COMPLETED|Overall Study||184
54817|NCT01833533|130801|P1|COMPLETED|Overall Study||94
54818|NCT01833533|130800|P2|STARTED|Overall Study||205
54819|NCT01833533|130801|P1|STARTED|Overall Study||100
54820|NCT01833481|130818|P3|NOT COMPLETED|Overall Study||0
54821|NCT01833481|130819|P2|NOT COMPLETED|Overall Study||0
54822|NCT01833481|130820|P1|NOT COMPLETED|Overall Study||0
54823|NCT01833481|130818|P3|COMPLETED|Overall Study||10
54824|NCT01833481|130819|P2|COMPLETED|Overall Study||10
54825|NCT01833481|130820|P1|COMPLETED|Overall Study||10
54826|NCT01833481|130818|P3|STARTED|Overall Study||10
54827|NCT01833481|130819|P2|STARTED|Overall Study||10
54828|NCT01833481|130820|P1|STARTED|Overall Study||10
54829|NCT01833403|130834|P1|NOT COMPLETED|Overall Study||0
54830|NCT01833403|130834|P1|COMPLETED|Overall Study||4
54831|NCT01833403|130834|P1|STARTED|Overall Study||4
54832|NCT01833247|130839|P1|NOT COMPLETED|Overall Study||0
54833|NCT01833247|130839|P1|COMPLETED|Overall Study||12
54834|NCT01833247|130839|P1|STARTED|Overall Study||12
54835|NCT01833169|130845|P1|NOT COMPLETED|Overall Study||146
54836|NCT01833169|130845|P1|COMPLETED|Overall Study||0
54837|NCT01833169|130845|P1|Consented to be Followed for Survival|Overall Study||128
54838|NCT01833169|130845|P1|STARTED|Overall Study||146
54839|NCT01833130|130858|P2|NOT COMPLETED|Overall Study||19
54840|NCT01833130|130859|P1|NOT COMPLETED|Overall Study||10
54841|NCT01833130|130858|P2|COMPLETED|Overall Study||8
54842|NCT01833130|130859|P1|COMPLETED|Overall Study||15
54843|NCT01833130|130858|P2|STARTED|Overall Study||27
54844|NCT01833130|130859|P1|STARTED|Overall Study||25
54845|NCT01833117|130897|P2|NOT COMPLETED|Overall Study||0
54846|NCT01833117|130898|P1|NOT COMPLETED|Overall Study||0
54847|NCT01833117|130897|P2|COMPLETED|Overall Study||19
54848|NCT01833117|130898|P1|COMPLETED|Overall Study||43
54849|NCT01833117|130897|P2|STARTED|Overall Study||19
54850|NCT01833117|130898|P1|STARTED|Overall Study||43
54851|NCT01833078|130906|P1|NOT COMPLETED|Overall Study||0
54852|NCT01833078|130906|P1|COMPLETED|Overall Study||5
54853|NCT01833078|130906|P1|STARTED|Overall Study||5
54854|NCT01833065|130914|P5|NOT COMPLETED|Overall Study||36
54855|NCT01833065|130915|P4|NOT COMPLETED|Overall Study||9
54856|NCT01833065|130916|P3|NOT COMPLETED|Overall Study||12
54857|NCT01833065|130917|P2|NOT COMPLETED|Overall Study||13
54858|NCT01833065|130918|P1|NOT COMPLETED|Overall Study||24
54859|NCT01833065|130914|P5|COMPLETED|Overall Study||74
54860|NCT01833065|130915|P4|COMPLETED|Overall Study||41
54861|NCT01833065|130916|P3|COMPLETED|Overall Study||23
54862|NCT01833065|130917|P2|COMPLETED|Overall Study||40
54863|NCT01833065|130918|P1|COMPLETED|Overall Study||41
54864|NCT01833065|130914|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
54865|NCT01833065|130915|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
54866|NCT01833065|130916|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
54867|NCT01833065|130917|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
54868|NCT01833065|130918|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
54869|NCT01833065|130914|P5|STARTED|Overall Study|Randomized patients - As treated|110
54870|NCT01833065|130915|P4|STARTED|Overall Study|Randomized patients - As treated|50
54871|NCT01833065|130916|P3|STARTED|Overall Study|Randomized patients - As treated|35
54872|NCT01833065|130917|P2|STARTED|Overall Study|Randomized patients - As treated|53
54873|NCT01833065|130918|P1|STARTED|Overall Study|Randomized patients - As treated|65
54874|NCT01832766|130949|P2|NOT COMPLETED|Second Intervention||0
54875|NCT01832766|130950|P1|NOT COMPLETED|Second Intervention||0
54876|NCT01832766|130949|P2|COMPLETED|Second Intervention||5
54877|NCT01832766|130950|P1|COMPLETED|Second Intervention||7
54878|NCT01832766|130949|P2|STARTED|Second Intervention||5
54879|NCT01832766|130950|P1|STARTED|Second Intervention||7
54880|NCT01832766|130949|P2|NOT COMPLETED|Washout||1
54881|NCT01832766|130950|P1|NOT COMPLETED|Washout||0
54882|NCT01832766|130949|P2|COMPLETED|Washout||5
54883|NCT01832766|130950|P1|COMPLETED|Washout||7
54884|NCT01832766|130949|P2|STARTED|Washout||6
54885|NCT01832766|130950|P1|STARTED|Washout||7
54886|NCT01832766|130949|P2|NOT COMPLETED|First Intervention||0
54887|NCT01832766|130950|P1|NOT COMPLETED|First Intervention||0
54888|NCT01832766|130949|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
54889|NCT01832766|130950|P1|COMPLETED|First Intervention||7
54890|NCT01832766|130949|P2|STARTED|First Intervention||6
54891|NCT01832766|130950|P1|STARTED|First Intervention||7
54892|NCT01832506|130963|P3|NOT COMPLETED|Overall Study||0
54893|NCT01832506|130964|P2|NOT COMPLETED|Overall Study||0
54894|NCT01832506|130965|P1|NOT COMPLETED|Overall Study||0
54895|NCT01832506|130963|P3|COMPLETED|Overall Study||6
54896|NCT01832506|130964|P2|COMPLETED|Overall Study||3
54897|NCT01832506|130965|P1|COMPLETED|Overall Study||3
54898|NCT01832506|130963|P3|STARTED|Overall Study||6
54899|NCT01832506|130964|P2|STARTED|Overall Study||3
54900|NCT01832506|130965|P1|STARTED|Overall Study||3
54901|NCT01832493|131016|P1|NOT COMPLETED|Overall Study||8
54902|NCT01832493|131016|P1|COMPLETED|Overall Study||42
54903|NCT01832493|131016|P1|STARTED|Overall Study||50
54904|NCT01832155|131025|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
54905|NCT01832155|131026|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
54906|NCT01832155|131025|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
54907|NCT01832155|131026|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
54908|NCT01832155|131025|P2|STARTED|End of Study: 4 - 8 Weeks||18
54909|NCT01832155|131026|P1|STARTED|End of Study: 4 - 8 Weeks||16
54910|NCT01832155|131025|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
54911|NCT01832155|131026|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
54912|NCT01832155|131025|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
54913|NCT01832155|131026|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
54914|NCT01832155|131025|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
54915|NCT01832155|131026|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
54916|NCT01832155|131025|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
54917|NCT01832155|131026|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
54918|NCT01832155|131025|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
54919|NCT01832155|131026|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
54920|NCT01832155|131025|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
54921|NCT01832155|131026|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
54922|NCT01832090|131049|P2|NOT COMPLETED|Overall Study||1
54923|NCT01832090|131050|P1|NOT COMPLETED|Overall Study||6
54924|NCT01832090|131049|P2|COMPLETED|Overall Study||28
54925|NCT01832090|131050|P1|COMPLETED|Overall Study||83
54926|NCT01832090|131049|P2|STARTED|Overall Study||29
54927|NCT01832090|131050|P1|STARTED|Overall Study||89
54928|NCT01831934|131095|P2|NOT COMPLETED|Overall Study||0
54929|NCT01831934|131096|P1|NOT COMPLETED|Overall Study||1
54930|NCT01831934|131095|P2|COMPLETED|Overall Study||10
54931|NCT01831934|131096|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
54932|NCT01831934|131095|P2|STARTED|Overall Study||10
54933|NCT01831934|131096|P1|STARTED|Overall Study||12
54934|NCT01831817|131106|P4|NOT COMPLETED|Overall Study||0
54935|NCT01831817|131107|P3|NOT COMPLETED|Overall Study||0
54936|NCT01831817|131108|P2|NOT COMPLETED|Overall Study||0
54937|NCT01831817|131109|P1|NOT COMPLETED|Overall Study||4
54938|NCT01831817|131106|P4|COMPLETED|Overall Study||36
54939|NCT01831817|131107|P3|COMPLETED|Overall Study||35
54940|NCT01831817|131108|P2|COMPLETED|Overall Study||34
54941|NCT01831817|131109|P1|COMPLETED|Overall Study||31
54942|NCT01831817|131106|P4|STARTED|Overall Study||36
54943|NCT01831817|131107|P3|STARTED|Overall Study||35
54944|NCT01831817|131108|P2|STARTED|Overall Study||34
54945|NCT01831817|131109|P1|STARTED|Overall Study||35
54946|NCT01831791|131147|P1|NOT COMPLETED|Overall Study||10
54947|NCT01831791|131147|P1|COMPLETED|Overall Study||110
54948|NCT01831791|131147|P1|STARTED|Overall Study||120
54949|NCT01831765|131176|P3|NOT COMPLETED|Overall Study||42
54950|NCT01831765|131177|P2|NOT COMPLETED|Overall Study||27
54951|NCT01831765|131178|P1|NOT COMPLETED|Overall Study||44
54952|NCT01831765|131176|P3|COMPLETED|Overall Study||338
54953|NCT01831765|131177|P2|COMPLETED|Overall Study||355
54954|NCT01831765|131178|P1|COMPLETED|Overall Study||337
54955|NCT01831765|131176|P3|Completed 52 Weeks|Overall Study||338
54956|NCT01831765|131177|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
54957|NCT01831765|131178|P1|Completed 52 Weeks|Overall Study||337
54958|NCT01831765|131176|P3|Completed 26 Weeks|Overall Study||356
54959|NCT01831765|131177|P2|Completed 26 Weeks|Overall Study||355
54960|NCT01831765|131178|P1|Completed 26 Weeks|Overall Study||351
54961|NCT01831765|131176|P3|STARTED|Overall Study||380
54962|NCT01831765|131177|P2|STARTED|Overall Study||382
54963|NCT01831765|131178|P1|STARTED|Overall Study||381
54964|NCT01831726|131204|P1|NOT COMPLETED|Overall Study||80
54965|NCT01831726|131204|P1|COMPLETED|Overall Study||0
54966|NCT01831726|131204|P1|STARTED|Overall Study||80
54967|NCT01831466|131223|P12|NOT COMPLETED|Overall Study||4
54968|NCT01831466|131224|P11|NOT COMPLETED|Overall Study||2
54969|NCT01831466|131225|P10|NOT COMPLETED|Overall Study||5
54970|NCT01831466|131226|P9|NOT COMPLETED|Overall Study||3
54971|NCT01831466|131227|P8|NOT COMPLETED|Overall Study||2
54972|NCT01831466|131228|P7|NOT COMPLETED|Overall Study||1
54973|NCT01831466|131229|P6|NOT COMPLETED|Overall Study||26
54974|NCT01831466|131230|P5|NOT COMPLETED|Overall Study||17
54975|NCT01831466|131231|P4|NOT COMPLETED|Overall Study||19
54976|NCT01831466|131232|P3|NOT COMPLETED|Overall Study||23
54977|NCT01831466|131233|P2|NOT COMPLETED|Overall Study||18
54978|NCT01831466|131234|P1|NOT COMPLETED|Overall Study||16
54979|NCT01831466|131223|P12|COMPLETED|Overall Study||3
54980|NCT01831466|131224|P11|COMPLETED|Overall Study||4
54981|NCT01831466|131225|P10|COMPLETED|Overall Study||2
54982|NCT01831466|131226|P9|COMPLETED|Overall Study||4
54983|NCT01831466|131227|P8|COMPLETED|Overall Study||5
54984|NCT01831466|131228|P7|COMPLETED|Overall Study||6
54985|NCT01831466|131229|P6|COMPLETED|Overall Study||48
54986|NCT01831466|131230|P5|COMPLETED|Overall Study||57
54987|NCT01831466|131231|P4|COMPLETED|Overall Study||51
54988|NCT01831466|131232|P3|COMPLETED|Overall Study||48
54989|NCT01831466|131233|P2|COMPLETED|Overall Study||52
54990|NCT01831466|131234|P1|COMPLETED|Overall Study||55
54991|NCT01831466|131223|P12|STARTED|Overall Study|Treated|7
54992|NCT01831466|131224|P11|STARTED|Overall Study|Treated|6
54993|NCT01831466|131225|P10|STARTED|Overall Study|Treated|7
54994|NCT01831466|131226|P9|STARTED|Overall Study|Treated|7
54995|NCT01831466|131227|P8|STARTED|Overall Study|Treated|7
54996|NCT01831466|131228|P7|STARTED|Overall Study|Treated|7
54997|NCT01831466|131229|P6|STARTED|Overall Study|Treated|74
54998|NCT01831466|131230|P5|STARTED|Overall Study|Treated|74
54999|NCT01831466|131231|P4|STARTED|Overall Study|Treated|70
55000|NCT01831466|131232|P3|STARTED|Overall Study|Treated|71
55001|NCT01831466|131233|P2|STARTED|Overall Study|Treated|70
55002|NCT01831466|131234|P1|STARTED|Overall Study|Treated|71
55003|NCT01831258|131356|P2|NOT COMPLETED|Overall Study||3
55004|NCT01831258|131357|P1|NOT COMPLETED|Overall Study||5
55005|NCT01831258|131356|P2|COMPLETED|Overall Study||32
55006|NCT01831258|131357|P1|COMPLETED|Overall Study||30
55007|NCT01831258|131356|P2|STARTED|Overall Study||35
55008|NCT01831258|131357|P1|STARTED|Overall Study||35
55009|NCT01831232|131383|P1|NOT COMPLETED|Overall Study||0
55010|NCT01831232|131383|P1|COMPLETED|Overall Study||24
55011|NCT01831232|131383|P1|STARTED|Overall Study||24
55012|NCT01831219|131394|P2|NOT COMPLETED|Overall Study||24
55013|NCT01831219|131395|P1|NOT COMPLETED|Overall Study||33
55014|NCT01831219|131394|P2|COMPLETED|Overall Study||21
55015|NCT01831219|131395|P1|COMPLETED|Overall Study||40
55016|NCT01831219|131394|P2|STARTED|Overall Study||45
55017|NCT01831219|131395|P1|STARTED|Overall Study||73
55018|NCT01831154|131416|P3|NOT COMPLETED|Overall Study||0
55019|NCT01831154|131417|P2|NOT COMPLETED|Overall Study||0
55020|NCT01831154|131418|P1|NOT COMPLETED|Overall Study||0
55021|NCT01831154|131416|P3|COMPLETED|Overall Study||11
55022|NCT01831154|131417|P2|COMPLETED|Overall Study||11
55023|NCT01831154|131418|P1|COMPLETED|Overall Study||15
55024|NCT01831154|131416|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
55025|NCT01831154|131417|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
55026|NCT01831154|131418|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
55027|NCT01830972|131443|P2|NOT COMPLETED|Part IV||1
55028|NCT01830972|131444|P1|NOT COMPLETED|Part IV||3
55029|NCT01830972|131443|P2|COMPLETED|Part IV||10
55030|NCT01830972|131444|P1|COMPLETED|Part IV||39
55031|NCT01830972|131443|P2|STARTED|Part IV||11
55032|NCT01830972|131444|P1|STARTED|Part IV||42
55033|NCT01830972|131443|P2|NOT COMPLETED|Part III||0
55034|NCT01830972|131444|P1|NOT COMPLETED|Part III||2
55035|NCT01830972|131443|P2|COMPLETED|Part III||11
55036|NCT01830972|131444|P1|COMPLETED|Part III||42
55037|NCT01830972|131443|P2|STARTED|Part III||11
55038|NCT01830972|131444|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
55039|NCT01830972|131443|P2|NOT COMPLETED|Part II||2
55040|NCT01830972|131444|P1|NOT COMPLETED|Part II||2
55041|NCT01830972|131443|P2|COMPLETED|Part II||11
55042|NCT01830972|131444|P1|COMPLETED|Part II||44
55043|NCT01830972|131443|P2|STARTED|Part II|Entered study at Part 2|13
55044|NCT01830972|131444|P1|STARTED|Part II||46
55045|NCT01830972|131443|P2|NOT COMPLETED|Part I||0
55046|NCT01830972|131444|P1|NOT COMPLETED|Part I||0
55047|NCT01830972|131443|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
55048|NCT01830972|131444|P1|COMPLETED|Part I||46
55049|NCT01830972|131443|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
55050|NCT01830972|131444|P1|STARTED|Part I||46
55051|NCT01830933|131470|P2|NOT COMPLETED|Overall Study||232
55052|NCT01830933|131471|P1|NOT COMPLETED|Overall Study||168
55053|NCT01830933|131470|P2|COMPLETED|Overall Study||580
55054|NCT01830933|131471|P1|COMPLETED|Overall Study||655
55055|NCT01830933|131470|P2|Completed Meet-up|Overall Study||603
55056|NCT01830933|131471|P1|Completed Meet-up|Overall Study||675
55057|NCT01830933|131470|P2|STARTED|Overall Study||812
55058|NCT01830933|131471|P1|STARTED|Overall Study||823
55059|NCT01830920|131488|P5|NOT COMPLETED|Overall Study||8
55060|NCT01830920|131489|P4|NOT COMPLETED|Overall Study||16
55061|NCT01830920|131490|P3|NOT COMPLETED|Overall Study||8
55062|NCT01830920|131491|P2|NOT COMPLETED|Overall Study||6
55063|NCT01830920|131492|P1|NOT COMPLETED|Overall Study||21
55064|NCT01830920|131488|P5|COMPLETED|Overall Study||99
55065|NCT01830920|131489|P4|COMPLETED|Overall Study||109
55066|NCT01830920|131490|P3|COMPLETED|Overall Study||40
55067|NCT01830920|131491|P2|COMPLETED|Overall Study||40
55068|NCT01830920|131492|P1|COMPLETED|Overall Study||105
55069|NCT01830920|131488|P5|Received Allocated Drug|Overall Study||105
55070|NCT01830920|131489|P4|Received Allocated Drug|Overall Study||119
55071|NCT01830920|131490|P3|Received Allocated Drug|Overall Study||47
55072|NCT01830920|131491|P2|Received Allocated Drug|Overall Study||45
55073|NCT01830920|131492|P1|Received Allocated Drug|Overall Study||115
55074|NCT01830920|131488|P5|STARTED|Overall Study||107
55075|NCT01830920|131489|P4|STARTED|Overall Study||125
55076|NCT01830920|131490|P3|STARTED|Overall Study||48
55077|NCT01830920|131491|P2|STARTED|Overall Study||46
55078|NCT01830920|131492|P1|STARTED|Overall Study||126
55079|NCT01830881|131531|P2|NOT COMPLETED|Overall Study||1
55080|NCT01830881|131532|P1|NOT COMPLETED|Overall Study||0
55081|NCT01830881|131531|P2|COMPLETED|Overall Study||61
55082|NCT01830881|131532|P1|COMPLETED|Overall Study||62
55083|NCT01830881|131531|P2|STARTED|Overall Study||62
55084|NCT01830881|131532|P1|STARTED|Overall Study||62
55085|NCT01830855|131576|P4|NOT COMPLETED|Overall Study||82
55086|NCT01830855|131577|P3|NOT COMPLETED|Overall Study||66
55087|NCT01830855|131578|P2|NOT COMPLETED|Overall Study||61
55088|NCT01830855|131579|P1|NOT COMPLETED|Overall Study||155
55089|NCT01830855|131576|P4|COMPLETED|Overall Study||815
55090|NCT01830855|131577|P3|COMPLETED|Overall Study||521
55091|NCT01830855|131578|P2|COMPLETED|Overall Study||537
55092|NCT01830855|131579|P1|COMPLETED|Overall Study||1353
55093|NCT01830855|131576|P4|STARTED|Overall Study||897
55094|NCT01830855|131577|P3|STARTED|Overall Study||587
55095|NCT01830855|131578|P2|STARTED|Overall Study||598
55096|NCT01830855|131579|P1|STARTED|Overall Study||1508
55097|NCT01830842|131685|P2|NOT COMPLETED|Overall Study||2
55098|NCT01830842|131686|P1|NOT COMPLETED|Overall Study||5
55099|NCT01830842|131685|P2|COMPLETED|Overall Study||22
55100|NCT01830842|131686|P1|COMPLETED|Overall Study||25
55101|NCT01830842|131685|P2|STARTED|Overall Study||24
55102|NCT01830842|131686|P1|STARTED|Overall Study||30
55103|NCT01830790|131694|P2|NOT COMPLETED|Overall Study||0
55104|NCT01830790|131695|P1|NOT COMPLETED|Overall Study||0
55105|NCT01830790|131694|P2|COMPLETED|Overall Study||10
55106|NCT01830790|131695|P1|COMPLETED|Overall Study||0
55107|NCT01830790|131694|P2|STARTED|Overall Study||10
55108|NCT01830790|131695|P1|STARTED|Overall Study||0
55109|NCT01830699|131705|P2|NOT COMPLETED|Overall Study||0
55110|NCT01830699|131706|P1|NOT COMPLETED|Overall Study||0
55111|NCT01830699|131705|P2|COMPLETED|Overall Study||20
55112|NCT01830699|131706|P1|COMPLETED|Overall Study||13
55113|NCT01830699|131705|P2|STARTED|Overall Study||20
55114|NCT01830699|131706|P1|STARTED|Overall Study||13
55115|NCT01830543|131719|P3|NOT COMPLETED|Overall Study||214
55116|NCT01830543|131720|P2|NOT COMPLETED|Overall Study||152
55117|NCT01830543|131721|P1|NOT COMPLETED|Overall Study||159
55118|NCT01830543|131719|P3|COMPLETED|Overall Study||492
55119|NCT01830543|131720|P2|COMPLETED|Overall Study||557
55120|NCT01830543|131721|P1|COMPLETED|Overall Study||550
55121|NCT01830543|131719|P3|Treated|Overall Study||697
55122|NCT01830543|131720|P2|Treated|Overall Study||706
55123|NCT01830543|131721|P1|Treated|Overall Study||696
55124|NCT01830543|131719|P3|STARTED|Overall Study||706
55125|NCT01830543|131720|P2|STARTED|Overall Study||709
55126|NCT01830543|131721|P1|STARTED|Overall Study||709
55127|NCT01830205|131757|P4|NOT COMPLETED|Overall Study||0
55128|NCT01830205|131758|P3|NOT COMPLETED|Overall Study||0
55129|NCT01830205|131759|P2|NOT COMPLETED|Overall Study||0
55130|NCT01830205|131760|P1|NOT COMPLETED|Overall Study||0
55131|NCT01830205|131757|P4|COMPLETED|Overall Study||12
55132|NCT01830205|131758|P3|COMPLETED|Overall Study||6
55133|NCT01830205|131759|P2|COMPLETED|Overall Study||6
55134|NCT01830205|131760|P1|COMPLETED|Overall Study||12
55135|NCT01830205|131757|P4|STARTED|Overall Study||12
55136|NCT01830205|131758|P3|STARTED|Overall Study||6
55137|NCT01830205|131759|P2|STARTED|Overall Study||6
55138|NCT01830205|131760|P1|STARTED|Overall Study||12
55139|NCT01830140|131844|P2|NOT COMPLETED|Overall Study||4
55140|NCT01830140|131845|P1|NOT COMPLETED|Overall Study||7
55141|NCT01830140|131844|P2|COMPLETED|Overall Study||229
55142|NCT01830140|131845|P1|COMPLETED|Overall Study||226
55143|NCT01830140|131844|P2|STARTED|Overall Study||233
55144|NCT01830140|131845|P1|STARTED|Overall Study||233
55145|NCT01830127|131853|P2|NOT COMPLETED|Overall Study||9
55146|NCT01830127|131854|P1|NOT COMPLETED|Overall Study||5
55147|NCT01830127|131853|P2|COMPLETED|Overall Study||8
55148|NCT01830127|131854|P1|COMPLETED|Overall Study||13
55149|NCT01830127|131853|P2|STARTED|Overall Study||17
55150|NCT01830127|131854|P1|STARTED|Overall Study||18
55151|NCT01829919|131862|P1|NOT COMPLETED|Overall Study||0
55152|NCT01829919|131862|P1|COMPLETED|Overall Study||24
55153|NCT01829919|131862|P1|STARTED|Overall Study||24
55154|NCT01829516|131878|P2|NOT COMPLETED|2nd Intervention||0
55155|NCT01829516|131879|P1|NOT COMPLETED|2nd Intervention||0
55156|NCT01829516|131878|P2|COMPLETED|2nd Intervention||14
55157|NCT01829516|131879|P1|COMPLETED|2nd Intervention||18
55158|NCT01829516|131878|P2|STARTED|2nd Intervention||14
55159|NCT01829516|131879|P1|STARTED|2nd Intervention||18
55160|NCT01829516|131878|P2|NOT COMPLETED|Washout Period - 1 Week||0
55161|NCT01829516|131879|P1|NOT COMPLETED|Washout Period - 1 Week||0
55162|NCT01829516|131878|P2|COMPLETED|Washout Period - 1 Week||14
55163|NCT01829516|131879|P1|COMPLETED|Washout Period - 1 Week||18
55164|NCT01829516|131878|P2|STARTED|Washout Period - 1 Week||14
55165|NCT01829516|131879|P1|STARTED|Washout Period - 1 Week||18
55166|NCT01829516|131878|P2|NOT COMPLETED|First Intervention||0
55167|NCT01829516|131879|P1|NOT COMPLETED|First Intervention||0
55168|NCT01829516|131878|P2|COMPLETED|First Intervention||14
55169|NCT01829516|131879|P1|COMPLETED|First Intervention||18
55170|NCT01829516|131878|P2|STARTED|First Intervention||14
55171|NCT01829516|131879|P1|STARTED|First Intervention||18
55172|NCT01829503|131887|P1|NOT COMPLETED|Overall Study||0
55173|NCT01829503|131887|P1|COMPLETED|Overall Study||44
55174|NCT01829503|131887|P1|STARTED|Overall Study||44
55175|NCT01829477|131903|P2|NOT COMPLETED|Overall Study||15
55176|NCT01829477|131904|P1|NOT COMPLETED|Overall Study||16
55177|NCT01829477|131903|P2|COMPLETED|Overall Study||1
55178|NCT01829477|131904|P1|COMPLETED|Overall Study||1
55179|NCT01829477|131903|P2|STARTED|Overall Study||16
55180|NCT01829477|131904|P1|STARTED|Overall Study||17
55181|NCT01829464|131917|P3|NOT COMPLETED|Overall Study||26
55182|NCT01829464|131918|P2|NOT COMPLETED|Overall Study||29
55183|NCT01829464|131919|P1|NOT COMPLETED|Overall Study||28
55184|NCT01829464|131917|P3|COMPLETED|Overall Study||3
55185|NCT01829464|131918|P2|COMPLETED|Overall Study||2
55186|NCT01829464|131919|P1|COMPLETED|Overall Study||2
55187|NCT01829464|131917|P3|STARTED|Overall Study||29
55188|NCT01829464|131918|P2|STARTED|Overall Study||31
55189|NCT01829464|131919|P1|STARTED|Overall Study||30
55190|NCT01829399|131935|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
55191|NCT01829399|131936|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
55192|NCT01829399|131935|P2|COMPLETED|Visit 2 (One Month Later)||12
55193|NCT01829399|131936|P1|COMPLETED|Visit 2 (One Month Later)||12
55194|NCT01829399|131935|P2|STARTED|Visit 2 (One Month Later)||12
55195|NCT01829399|131936|P1|STARTED|Visit 2 (One Month Later)||12
55196|NCT01829399|131935|P2|NOT COMPLETED|Visit 1||0
55197|NCT01829399|131936|P1|NOT COMPLETED|Visit 1||0
55198|NCT01829399|131935|P2|COMPLETED|Visit 1||12
55199|NCT01829399|131936|P1|COMPLETED|Visit 1||12
55200|NCT01829399|131935|P2|STARTED|Visit 1||12
55201|NCT01829399|131936|P1|STARTED|Visit 1||12
55202|NCT01829243|131944|P2|NOT COMPLETED|Second Intervention||0
55203|NCT01829243|131945|P1|NOT COMPLETED|Second Intervention||0
55204|NCT01829243|131944|P2|COMPLETED|Second Intervention||13
55205|NCT01829243|131945|P1|COMPLETED|Second Intervention||7
55206|NCT01829243|131944|P2|STARTED|Second Intervention||13
55207|NCT01829243|131945|P1|STARTED|Second Intervention||7
55208|NCT01829243|131944|P2|NOT COMPLETED|Washout Period of 1 Week||0
55209|NCT01829243|131945|P1|NOT COMPLETED|Washout Period of 1 Week||0
55210|NCT01829243|131944|P2|COMPLETED|Washout Period of 1 Week||13
55211|NCT01829243|131945|P1|COMPLETED|Washout Period of 1 Week||7
55212|NCT01829243|131944|P2|STARTED|Washout Period of 1 Week||13
55213|NCT01829243|131945|P1|STARTED|Washout Period of 1 Week||7
55214|NCT01829243|131944|P2|NOT COMPLETED|First Intervention||2
55215|NCT01829243|131945|P1|NOT COMPLETED|First Intervention||4
55216|NCT01829243|131944|P2|COMPLETED|First Intervention||13
55217|NCT01829243|131945|P1|COMPLETED|First Intervention||7
55218|NCT01829243|131944|P2|STARTED|First Intervention||15
55219|NCT01829243|131945|P1|STARTED|First Intervention||11
55220|NCT01829230|131959|P2|NOT COMPLETED|Overall Study||4
55221|NCT01829230|131960|P1|NOT COMPLETED|Overall Study||1
55222|NCT01829230|131959|P2|COMPLETED|Overall Study||38
55223|NCT01829230|131960|P1|COMPLETED|Overall Study||39
55224|NCT01829230|131959|P2|STARTED|Overall Study||42
55225|NCT01829230|131960|P1|STARTED|Overall Study||40
55226|NCT01829191|131970|P2|NOT COMPLETED|Overall Study||14
55227|NCT01829191|131971|P1|NOT COMPLETED|Overall Study||7
55228|NCT01829191|131970|P2|COMPLETED|Overall Study||50
55229|NCT01829191|131971|P1|COMPLETED|Overall Study||56
55230|NCT01829191|131970|P2|STARTED|Overall Study||64
55231|NCT01829191|131971|P1|STARTED|Overall Study||63
55232|NCT01829165|131980|P2|NOT COMPLETED|Overall Study||0
55233|NCT01829165|131981|P1|NOT COMPLETED|Overall Study||2
55234|NCT01829165|131980|P2|COMPLETED|Overall Study||13
55235|NCT01829165|131981|P1|COMPLETED|Overall Study||18
55236|NCT01829165|131980|P2|STARTED|Overall Study||13
55237|NCT01829165|131981|P1|STARTED|Overall Study||20
55238|NCT01828983|131989|P2|NOT COMPLETED|Overall Study||0
55239|NCT01828983|131990|P1|NOT COMPLETED|Overall Study||0
55240|NCT01828983|131989|P2|COMPLETED|Overall Study||81
55241|NCT01828983|131990|P1|COMPLETED|Overall Study||80
55242|NCT01828983|131989|P2|STARTED|Overall Study||81
55243|NCT01828983|131990|P1|STARTED|Overall Study||80
55244|NCT01828593|132003|P3|NOT COMPLETED|Placebo-Free Phase||6
55245|NCT01828593|132004|P2|NOT COMPLETED|Placebo-Free Phase||6
55246|NCT01828593|132005|P1|NOT COMPLETED|Placebo-Free Phase||0
55247|NCT01828593|132003|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
55248|NCT01828593|132004|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
55249|NCT01828593|132005|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
55250|NCT01828593|132003|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
55251|NCT01828593|132004|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
55252|NCT01828593|132005|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
55253|NCT01828593|132003|P3|NOT COMPLETED|Placebo-Controlled Phase||1
55254|NCT01828593|132004|P2|NOT COMPLETED|Placebo-Controlled Phase||0
55255|NCT01828593|132005|P1|NOT COMPLETED|Placebo-Controlled Phase||0
55256|NCT01828593|132003|P3|COMPLETED|Placebo-Controlled Phase||32
55257|NCT01828593|132004|P2|COMPLETED|Placebo-Controlled Phase||34
55258|NCT01828593|132005|P1|COMPLETED|Placebo-Controlled Phase||36
55259|NCT01828593|132003|P3|STARTED|Placebo-Controlled Phase||33
55260|NCT01828593|132004|P2|STARTED|Placebo-Controlled Phase||34
55261|NCT01828593|132005|P1|STARTED|Placebo-Controlled Phase||36
55262|NCT01828476|132028|P2|NOT COMPLETED|Overall Study||0
55263|NCT01828476|132029|P1|NOT COMPLETED|Overall Study||0
55264|NCT01828476|132028|P2|COMPLETED|Overall Study||0
55265|NCT01828476|132029|P1|COMPLETED|Overall Study||13
55266|NCT01828476|132028|P2|STARTED|Overall Study||0
55267|NCT01828476|132029|P1|STARTED|Overall Study||13
55268|NCT01828281|132051|P2|NOT COMPLETED|Overall Study||0
55269|NCT01828281|132052|P1|NOT COMPLETED|Overall Study||1
55270|NCT01828281|132051|P2|COMPLETED|Overall Study||45
55271|NCT01828281|132052|P1|COMPLETED|Overall Study||44
55272|NCT01828281|132051|P2|STARTED|Overall Study||45
55273|NCT01828281|132052|P1|STARTED|Overall Study||45
55274|NCT01828216|132064|P2|NOT COMPLETED|Overall Study||0
55275|NCT01828216|132065|P1|NOT COMPLETED|Overall Study||0
55276|NCT01828216|132064|P2|COMPLETED|Overall Study||157
55277|NCT01828216|132065|P1|COMPLETED|Overall Study||159
55278|NCT01828216|132064|P2|STARTED|Overall Study||157
55279|NCT01828216|132065|P1|STARTED|Overall Study||159
55280|NCT01828164|132073|P1|NOT COMPLETED|Overall Study||17
55281|NCT01828164|132073|P1|COMPLETED|Overall Study||32
55282|NCT01828164|132073|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
55283|NCT01828112|132085|P2|NOT COMPLETED|Overall Study||108
55284|NCT01828112|132086|P1|NOT COMPLETED|Overall Study||82
55285|NCT01828112|132085|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
55286|NCT01828112|132086|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
55287|NCT01828112|132085|P2|Treated|Overall Study||113
55288|NCT01828112|132086|P1|Treated|Overall Study||115
55289|NCT01828112|132085|P2|Untreated|Overall Study||3
55290|NCT01828112|132086|P1|Untreated|Overall Study||0
55291|NCT01828112|132085|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
55292|NCT01828112|132086|P1|Untreated Patients|Overall Study||0
55293|NCT01828112|132085|P2|Discontinued From Study|Overall Study||10
55294|NCT01828112|132086|P1|Discontinued From Study|Overall Study||14
55295|NCT01828112|132085|P2|Entered Survival Follow-up Phase|Overall Study||19
55296|NCT01828112|132086|P1|Entered Survival Follow-up Phase|Overall Study||61
55297|NCT01828112|132085|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
55298|NCT01828112|132086|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
55299|NCT01828112|132085|P2|Entered Extension Treatment Phase|Overall Study||74
55300|NCT01828112|132086|P1|Entered Extension Treatment Phase|Overall Study||0
55301|NCT01828112|132085|P2|STARTED|Overall Study||116
55302|NCT01828112|132086|P1|STARTED|Overall Study||115
55303|NCT01828099|132094|P2|NOT COMPLETED|Overall Study||157
55304|NCT01828099|132095|P1|NOT COMPLETED|Overall Study||94
55305|NCT01828099|132094|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
55306|NCT01828099|132095|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
55307|NCT01828099|132094|P2|Discontinued From Study|Overall Study||29
55308|NCT01828099|132095|P1|Discontinued From Study|Overall Study||20
55309|NCT01828099|132094|P2|Entered Survival Follow-up Phase|Overall Study||31
55310|NCT01828099|132095|P1|Entered Survival Follow-up Phase|Overall Study||64
55311|NCT01828099|132094|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
55312|NCT01828099|132095|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
55313|NCT01828099|132094|P2|Entered Extension-treatment Phase|Overall Study||81
55314|NCT01828099|132095|P1|Entered Extension-treatment Phase|Overall Study||0
55315|NCT01828099|132094|P2|Discontinued From Treatment Phase|Overall Study||157
55316|NCT01828099|132095|P1|Discontinued From Treatment Phase|Overall Study||94
55317|NCT01828099|132094|P2|Treated|Overall Study||175
55318|NCT01828099|132095|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
55319|NCT01828099|132094|P2|Untreated Patients|Overall Study||12
55320|NCT01828099|132095|P1|Untreated Patients|Overall Study||0
55321|NCT01828099|132094|P2|STARTED|Overall Study||187
55322|NCT01828099|132095|P1|STARTED|Overall Study||189
55323|NCT01827839|132101|P1|NOT COMPLETED|Overall Study||3
55324|NCT01827839|132101|P1|COMPLETED|Overall Study||93
55325|NCT01827839|132101|P1|STARTED|Overall Study||96
55326|NCT01827670|132125|P2|NOT COMPLETED|Overall Study||3
55327|NCT01827670|132126|P1|NOT COMPLETED|Overall Study||3
55328|NCT01827670|132125|P2|COMPLETED|Overall Study||56
55329|NCT01827670|132126|P1|COMPLETED|Overall Study||57
55330|NCT01827670|132125|P2|STARTED|Overall Study||59
55331|NCT01827670|132126|P1|STARTED|Overall Study||60
55332|NCT01827592|132145|P3|NOT COMPLETED|Overall Study||76
55333|NCT01827592|132146|P2|NOT COMPLETED|Overall Study||80
55334|NCT01827592|132147|P1|NOT COMPLETED|Overall Study||74
55335|NCT01827592|132145|P3|COMPLETED|Overall Study||48
55336|NCT01827592|132146|P2|COMPLETED|Overall Study||46
55337|NCT01827592|132147|P1|COMPLETED|Overall Study||52
55338|NCT01827592|132145|P3|Safety Analysis Set|Overall Study||124
55339|NCT01827592|132146|P2|Safety Analysis Set|Overall Study||126
55340|NCT01827592|132147|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
55341|NCT01827592|132145|P3|STARTED|Overall Study|Randomized patients.|124
55342|NCT01827592|132146|P2|STARTED|Overall Study|Randomized patients.|126
55343|NCT01827592|132147|P1|STARTED|Overall Study|Randomized patients.|126
55344|NCT01827475|132179|P3|NOT COMPLETED|Overall Study||0
55345|NCT01827475|132180|P2|NOT COMPLETED|Overall Study||0
55346|NCT01827475|132181|P1|NOT COMPLETED|Overall Study||0
55347|NCT01827475|132179|P3|COMPLETED|Overall Study||30
55348|NCT01827475|132180|P2|COMPLETED|Overall Study||30
55349|NCT01827475|132181|P1|COMPLETED|Overall Study||30
55350|NCT01827475|132179|P3|STARTED|Overall Study||30
55351|NCT01827475|132180|P2|STARTED|Overall Study||30
55352|NCT01827475|132181|P1|STARTED|Overall Study||30
55353|NCT01827462|132195|P3|NOT COMPLETED|Overall Study||28
55354|NCT01827462|132196|P2|NOT COMPLETED|Overall Study||18
55355|NCT01827462|132197|P1|NOT COMPLETED|Overall Study||41
55356|NCT01827462|132195|P3|COMPLETED|Overall Study||12
55357|NCT01827462|132196|P2|COMPLETED|Overall Study||19
55358|NCT01827462|132197|P1|COMPLETED|Overall Study||18
55359|NCT01827462|132195|P3|STARTED|Overall Study||40
55360|NCT01827462|132196|P2|STARTED|Overall Study||37
55361|NCT01827462|132197|P1|STARTED|Overall Study||59
55362|NCT01827371|132212|P4|NOT COMPLETED|Overall Study||23
55363|NCT01827371|132213|P3|NOT COMPLETED|Overall Study||11
55364|NCT01827371|132214|P2|NOT COMPLETED|Overall Study||7
55365|NCT01827371|132215|P1|NOT COMPLETED|Overall Study||13
55366|NCT01827371|132212|P4|COMPLETED|Overall Study||97
55367|NCT01827371|132213|P3|COMPLETED|Overall Study||93
55368|NCT01827371|132214|P2|COMPLETED|Overall Study||89
55369|NCT01827371|132215|P1|COMPLETED|Overall Study||102
55370|NCT01827371|132212|P4|STARTED|Overall Study||120
55371|NCT01827371|132213|P3|STARTED|Overall Study||104
55372|NCT01827371|132214|P2|STARTED|Overall Study||96
55373|NCT01827371|132215|P1|STARTED|Overall Study||115
55374|NCT01827358|132239|P2|NOT COMPLETED|Overall Study||31
55375|NCT01827358|132240|P1|NOT COMPLETED|Overall Study||35
55376|NCT01827358|132239|P2|COMPLETED|Overall Study||44
55377|NCT01827358|132240|P1|COMPLETED|Overall Study||45
55378|NCT01827358|132239|P2|STARTED|Overall Study||75
55379|NCT01827358|132240|P1|STARTED|Overall Study||80
55380|NCT01827332|132274|P2|NOT COMPLETED|Overall Study||1
55381|NCT01827332|132275|P1|NOT COMPLETED|Overall Study||2
55382|NCT01827332|132274|P2|COMPLETED|Overall Study||7
55383|NCT01827332|132275|P1|COMPLETED|Overall Study||6
55384|NCT01827332|132274|P2|STARTED|Overall Study||8
55385|NCT01827332|132275|P1|STARTED|Overall Study||8
55386|NCT01827319|132283|P1|NOT COMPLETED|Overall Study||3
55387|NCT01827319|132283|P1|COMPLETED|Overall Study||200
55388|NCT01827319|132283|P1|STARTED|Overall Study||203
55389|NCT01827306|132291|P2|NOT COMPLETED|Overall Study||5
55390|NCT01827306|132292|P1|NOT COMPLETED|Overall Study||11
55391|NCT01827306|132291|P2|COMPLETED|Overall Study||8
55392|NCT01827306|132292|P1|COMPLETED|Overall Study||10
55393|NCT01827306|132291|P2|STARTED|Overall Study||13
55394|NCT01827306|132292|P1|STARTED|Overall Study||21
55395|NCT01827267|132306|P2|NOT COMPLETED|Overall Study||12
55396|NCT01827267|132307|P1|NOT COMPLETED|Overall Study||5
55397|NCT01827267|132306|P2|COMPLETED|Overall Study||32
55398|NCT01827267|132307|P1|COMPLETED|Overall Study||13
55399|NCT01827267|132306|P2|Recieved Study Drug|Overall Study||43
55400|NCT01827267|132307|P1|Recieved Study Drug|Overall Study||17
55401|NCT01827267|132306|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
55402|NCT01827267|132307|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
55403|NCT01827254|132322|P1|NOT COMPLETED|Overall Study||59
55404|NCT01827254|132322|P1|COMPLETED|Overall Study||2
55405|NCT01827254|132322|P1|Evaluable Population|Overall Study||52
55406|NCT01827254|132322|P1|STARTED|Overall Study||61
55407|NCT01826981|132347|P15|NOT COMPLETED|Overall Study||0
55408|NCT01826981|132348|P14|NOT COMPLETED|Overall Study||5
55409|NCT01826981|132349|P13|NOT COMPLETED|Overall Study||1
55410|NCT01826981|132350|P12|NOT COMPLETED|Overall Study||2
55411|NCT01826981|132351|P11|NOT COMPLETED|Overall Study||2
55412|NCT01826981|132352|P10|NOT COMPLETED|Overall Study||1
55413|NCT01826981|132353|P9|NOT COMPLETED|Overall Study||7
55414|NCT01826981|132354|P8|NOT COMPLETED|Overall Study||11
55415|NCT01826981|132355|P7|NOT COMPLETED|Overall Study||1
55416|NCT01826981|132356|P6|NOT COMPLETED|Overall Study||1
55417|NCT01826981|132357|P5|NOT COMPLETED|Overall Study||7
55418|NCT01826981|132358|P4|NOT COMPLETED|Overall Study||0
55419|NCT01826981|132359|P3|NOT COMPLETED|Overall Study||0
55420|NCT01826981|132360|P2|NOT COMPLETED|Overall Study||1
55421|NCT01826981|132361|P1|NOT COMPLETED|Overall Study||0
55422|NCT01826981|132347|P15|COMPLETED|Overall Study||8
55423|NCT01826981|132348|P14|COMPLETED|Overall Study||15
55424|NCT01826981|132349|P13|COMPLETED|Overall Study||25
55425|NCT01826981|132350|P12|COMPLETED|Overall Study||25
55426|NCT01826981|132351|P11|COMPLETED|Overall Study||22
55427|NCT01826981|132352|P10|COMPLETED|Overall Study||26
55428|NCT01826981|132353|P9|COMPLETED|Overall Study||13
55429|NCT01826981|132354|P8|COMPLETED|Overall Study||40
55430|NCT01826981|132355|P7|COMPLETED|Overall Study||24
55431|NCT01826981|132356|P6|COMPLETED|Overall Study||25
55432|NCT01826981|132357|P5|COMPLETED|Overall Study||18
55433|NCT01826981|132358|P4|COMPLETED|Overall Study||26
55434|NCT01826981|132359|P3|COMPLETED|Overall Study||25
55435|NCT01826981|132360|P2|COMPLETED|Overall Study||9
55436|NCT01826981|132361|P1|COMPLETED|Overall Study||19
55437|NCT01826981|132347|P15|STARTED|Overall Study||8
55438|NCT01826981|132348|P14|STARTED|Overall Study||20
55439|NCT01826981|132349|P13|STARTED|Overall Study||26
55440|NCT01826981|132350|P12|STARTED|Overall Study||27
55441|NCT01826981|132351|P11|STARTED|Overall Study||24
55442|NCT01826981|132352|P10|STARTED|Overall Study||27
55443|NCT01826981|132353|P9|STARTED|Overall Study||20
55444|NCT01826981|132354|P8|STARTED|Overall Study||51
55445|NCT01826981|132355|P7|STARTED|Overall Study||25
55446|NCT01826981|132356|P6|STARTED|Overall Study||26
55447|NCT01826981|132357|P5|STARTED|Overall Study||25
55448|NCT01826981|132358|P4|STARTED|Overall Study||26
55449|NCT01826981|132359|P3|STARTED|Overall Study||25
55450|NCT01826981|132360|P2|STARTED|Overall Study||10
55451|NCT01826981|132361|P1|STARTED|Overall Study||19
55452|NCT01826812|132509|P2|NOT COMPLETED|Overall Study||1
55453|NCT01826812|132510|P1|NOT COMPLETED|Overall Study||0
55454|NCT01826812|132509|P2|COMPLETED|Overall Study||32
55455|NCT01826812|132510|P1|COMPLETED|Overall Study||167
55456|NCT01826812|132509|P2|STARTED|Overall Study||33
55457|NCT01826812|132510|P1|STARTED|Overall Study||167
55458|NCT01826604|132526|P2|NOT COMPLETED|Overall Study||9
55459|NCT01826604|132527|P1|NOT COMPLETED|Overall Study||8
55460|NCT01826604|132526|P2|COMPLETED|Overall Study||148
55461|NCT01826604|132527|P1|COMPLETED|Overall Study||136
55462|NCT01826604|132526|P2|STARTED|Overall Study||157
55463|NCT01826604|132527|P1|STARTED|Overall Study||144
55464|NCT01826513|132538|P3|NOT COMPLETED|Overall Study||0
55465|NCT01826513|132539|P2|NOT COMPLETED|Overall Study||0
55466|NCT01826513|132540|P1|NOT COMPLETED|Overall Study||0
55467|NCT01826513|132538|P3|COMPLETED|Overall Study||10
55468|NCT01826513|132539|P2|COMPLETED|Overall Study||10
55469|NCT01826513|132540|P1|COMPLETED|Overall Study||5
55470|NCT01826513|132538|P3|STARTED|Overall Study||10
55471|NCT01826513|132539|P2|STARTED|Overall Study||10
55472|NCT01826513|132540|P1|STARTED|Overall Study||5
55473|NCT01826422|132571|P2|NOT COMPLETED|Overall Study||3
55474|NCT01826422|132572|P1|NOT COMPLETED|Overall Study||1
55475|NCT01826422|132571|P2|COMPLETED|Overall Study||19
55476|NCT01826422|132572|P1|COMPLETED|Overall Study||17
55477|NCT01826422|132571|P2|STARTED|Overall Study||22
55478|NCT01826422|132572|P1|STARTED|Overall Study||18
55479|NCT01826370|132616|P1|NOT COMPLETED|Overall Study||20
55480|NCT01826370|132616|P1|COMPLETED|Overall Study||658
55481|NCT01826370|132616|P1|STARTED|Overall Study||678
55482|NCT01826227|132622|P1|NOT COMPLETED|Overall Study||0
55483|NCT01826227|132622|P1|COMPLETED|Overall Study||5
55484|NCT01826227|132622|P1|STARTED|Overall Study||5
55485|NCT01826214|132628|P2|NOT COMPLETED|Overall Study||34
55486|NCT01826214|132629|P1|NOT COMPLETED|Overall Study||35
55487|NCT01826214|132628|P2|COMPLETED|Overall Study||0
55488|NCT01826214|132629|P1|COMPLETED|Overall Study||0
55489|NCT01826214|132628|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
55490|NCT01826214|132629|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
55491|NCT01826214|132628|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
55492|NCT01826214|132629|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
55493|NCT01826214|132628|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
55494|NCT01826214|132629|P1|STARTED|Overall Study||35
55495|NCT01826201|132647|P1|NOT COMPLETED|Overall Study||4
55496|NCT01826201|132647|P1|COMPLETED|Overall Study||17
55497|NCT01826201|132647|P1|STARTED|Overall Study|Subjects in each arm are same|21
55498|NCT01825837|132657|P4|NOT COMPLETED|PART II||0
55499|NCT01825837|132658|P3|NOT COMPLETED|PART II||19
55500|NCT01825837|132659|P2|NOT COMPLETED|PART II||14
55501|NCT01825837|132660|P1|NOT COMPLETED|PART II||19
55502|NCT01825837|132657|P4|COMPLETED|PART II||0
55503|NCT01825837|132658|P3|COMPLETED|PART II||7
55504|NCT01825837|132659|P2|COMPLETED|PART II||12
55505|NCT01825837|132660|P1|COMPLETED|PART II||16
55506|NCT01825837|132657|P4|Per-Protocol Population|PART II||0
55507|NCT01825837|132658|P3|Per-Protocol Population|PART II||24
55508|NCT01825837|132659|P2|Per-Protocol Population|PART II||23
55509|NCT01825837|132660|P1|Per-Protocol Population|PART II||32
55510|NCT01825837|132657|P4|Intent-to-Treat Population|PART II||0
55511|NCT01825837|132658|P3|Intent-to-Treat Population|PART II||26
55512|NCT01825837|132659|P2|Intent-to-Treat Population|PART II||25
55513|NCT01825837|132660|P1|Intent-to-Treat Population|PART II||34
55514|NCT01825837|132657|P4|Safety Population (Double-Blind)|PART II||0
55515|NCT01825837|132658|P3|Safety Population (Double-Blind)|PART II||26
55516|NCT01825837|132659|P2|Safety Population (Double-Blind)|PART II||26
55517|NCT01825837|132660|P1|Safety Population (Double-Blind)|PART II||35
55518|NCT01825837|132657|P4|Randomized Patients|PART II||0
55519|NCT01825837|132658|P3|Randomized Patients|PART II||26
55520|NCT01825837|132659|P2|Randomized Patients|PART II||26
55521|NCT01825837|132660|P1|Randomized Patients|PART II||35
55522|NCT01825837|132657|P4|STARTED|PART II||0
55523|NCT01825837|132658|P3|STARTED|PART II||26
55524|NCT01825837|132659|P2|STARTED|PART II||26
55525|NCT01825837|132660|P1|STARTED|PART II||35
55526|NCT01825837|132657|P4|NOT COMPLETED|PART I||17
55527|NCT01825837|132658|P3|NOT COMPLETED|PART I||0
55528|NCT01825837|132659|P2|NOT COMPLETED|PART I||0
55529|NCT01825837|132660|P1|NOT COMPLETED|PART I||0
55530|NCT01825837|132657|P4|COMPLETED|PART I||87
55531|NCT01825837|132658|P3|COMPLETED|PART I||0
55532|NCT01825837|132659|P2|COMPLETED|PART I||0
55533|NCT01825837|132660|P1|COMPLETED|PART I||0
55534|NCT01825837|132657|P4|Safety Population (Open-Label)|PART I||104
55535|NCT01825837|132658|P3|Safety Population (Open-Label)|PART I||0
55536|NCT01825837|132659|P2|Safety Population (Open-Label)|PART I||0
55537|NCT01825837|132660|P1|Safety Population (Open-Label)|PART I||0
55538|NCT01825837|132657|P4|Enrolled|PART I||104
55539|NCT01825837|132658|P3|Enrolled|PART I||0
55540|NCT01825837|132659|P2|Enrolled|PART I||0
55541|NCT01825837|132660|P1|Enrolled|PART I||0
55542|NCT01825837|132657|P4|STARTED|PART I||104
55543|NCT01825837|132658|P3|STARTED|PART I||0
55544|NCT01825837|132659|P2|STARTED|PART I||0
55545|NCT01825837|132660|P1|STARTED|PART I||0
55546|NCT01825798|132670|P2|NOT COMPLETED|Overall Study||5
55547|NCT01825798|132671|P1|NOT COMPLETED|Overall Study||2
55548|NCT01825798|132670|P2|COMPLETED|Overall Study||23
55549|NCT01825798|132671|P1|COMPLETED|Overall Study||30
55550|NCT01825798|132670|P2|STARTED|Overall Study||28
55551|NCT01825798|132671|P1|STARTED|Overall Study||32
55552|NCT01825577|132699|P1|NOT COMPLETED|Overall Study||8
55553|NCT01825577|132699|P1|COMPLETED|Overall Study||6
55554|NCT01825577|132699|P1|STARTED|Overall Study||14
55555|NCT01825408|132708|P4|NOT COMPLETED|Overall Study||0
55556|NCT01825408|132709|P3|NOT COMPLETED|Overall Study||0
55557|NCT01825408|132710|P2|NOT COMPLETED|Overall Study||0
55558|NCT01825408|132711|P1|NOT COMPLETED|Overall Study||0
55559|NCT01825408|132708|P4|COMPLETED|Overall Study||12
55560|NCT01825408|132709|P3|COMPLETED|Overall Study||14
55561|NCT01825408|132710|P2|COMPLETED|Overall Study||7
55562|NCT01825408|132711|P1|COMPLETED|Overall Study||7
55563|NCT01825408|132708|P4|STARTED|Overall Study||12
55564|NCT01825408|132709|P3|STARTED|Overall Study||14
55565|NCT01825408|132710|P2|STARTED|Overall Study||7
55566|NCT01825408|132711|P1|STARTED|Overall Study||7
55567|NCT01825200|132723|P2|NOT COMPLETED|Overall Study||7
55568|NCT01825200|132724|P1|NOT COMPLETED|Overall Study||5
55569|NCT01825200|132723|P2|COMPLETED|Overall Study||1314
55570|NCT01825200|132724|P1|COMPLETED|Overall Study||1314
55571|NCT01825200|132723|P2|STARTED|Overall Study||1321
55572|NCT01825200|132724|P1|STARTED|Overall Study||1319
55573|NCT01825122|132738|P2|NOT COMPLETED|Overall Study||19
55574|NCT01825122|132739|P1|NOT COMPLETED|Overall Study||10
55575|NCT01825122|132738|P2|COMPLETED|Overall Study||59
55576|NCT01825122|132739|P1|COMPLETED|Overall Study||67
55577|NCT01825122|132738|P2|STARTED|Overall Study||78
55578|NCT01825122|132739|P1|STARTED|Overall Study||77
55579|NCT01824979|132747|P2|NOT COMPLETED|Overall Study||13
55580|NCT01824979|132748|P1|NOT COMPLETED|Overall Study||13
55581|NCT01824979|132747|P2|COMPLETED|Overall Study||37
55582|NCT01824979|132748|P1|COMPLETED|Overall Study||37
55583|NCT01824979|132747|P2|STARTED|Overall Study||50
55584|NCT01824979|132748|P1|STARTED|Overall Study||50
55585|NCT01824901|132756|P4|NOT COMPLETED|Overall Study||0
55586|NCT01824901|132757|P3|NOT COMPLETED|Overall Study||0
55587|NCT01824901|132758|P2|NOT COMPLETED|Overall Study||0
55588|NCT01824901|132759|P1|NOT COMPLETED|Overall Study||0
55589|NCT01824901|132756|P4|COMPLETED|Overall Study||0
55590|NCT01824901|132757|P3|COMPLETED|Overall Study||0
55591|NCT01824901|132758|P2|COMPLETED|Overall Study||0
55592|NCT01824901|132759|P1|COMPLETED|Overall Study||2
55593|NCT01824901|132756|P4|STARTED|Overall Study||0
55594|NCT01824901|132757|P3|STARTED|Overall Study||0
55595|NCT01824901|132758|P2|STARTED|Overall Study||0
55596|NCT01824901|132759|P1|STARTED|Overall Study||2
55597|NCT01824823|132765|P2|NOT COMPLETED|Overall Study||1
55598|NCT01824823|132766|P1|NOT COMPLETED|Overall Study||2
55599|NCT01824823|132765|P2|COMPLETED|Overall Study||0
55600|NCT01824823|132766|P1|COMPLETED|Overall Study||0
55601|NCT01824823|132765|P2|STARTED|Overall Study||1
55602|NCT01824823|132766|P1|STARTED|Overall Study||2
55603|NCT01824602|132776|P4|NOT COMPLETED|Overall Study||5
55604|NCT01824602|132777|P3|NOT COMPLETED|Overall Study||4
55605|NCT01824602|132778|P2|NOT COMPLETED|Overall Study||0
55606|NCT01824602|132779|P1|NOT COMPLETED|Overall Study||1
55607|NCT01824602|132776|P4|COMPLETED|Overall Study||5
55608|NCT01824602|132777|P3|COMPLETED|Overall Study||5
55609|NCT01824602|132778|P2|COMPLETED|Overall Study||8
55610|NCT01824602|132779|P1|COMPLETED|Overall Study||10
55611|NCT01824602|132776|P4|Intent-to-treat Population|Overall Study||9
55612|NCT01824602|132777|P3|Intent-to-treat Population|Overall Study||9
55613|NCT01824602|132778|P2|Intent-to-treat Population|Overall Study||8
55614|NCT01824602|132779|P1|Intent-to-treat Population|Overall Study||11
55615|NCT01824602|132776|P4|Safety Population|Overall Study||10
55616|NCT01824602|132777|P3|Safety Population|Overall Study||9
55617|NCT01824602|132778|P2|Safety Population|Overall Study||8
55618|NCT01824602|132779|P1|Safety Population|Overall Study||11
55619|NCT01824602|132776|P4|STARTED|Overall Study||10
55620|NCT01824602|132777|P3|STARTED|Overall Study||9
55621|NCT01824602|132778|P2|STARTED|Overall Study||8
55622|NCT01824602|132779|P1|STARTED|Overall Study||11
55623|NCT01824589|132793|P4|NOT COMPLETED|Overall Study||0
55624|NCT01824589|132794|P3|NOT COMPLETED|Overall Study||0
55625|NCT01824589|132795|P2|NOT COMPLETED|Overall Study||0
55626|NCT01824589|132796|P1|NOT COMPLETED|Overall Study||0
55627|NCT01824589|132793|P4|COMPLETED|Overall Study||0
55628|NCT01824589|132794|P3|COMPLETED|Overall Study||0
55629|NCT01824589|132795|P2|COMPLETED|Overall Study||0
55630|NCT01824589|132796|P1|COMPLETED|Overall Study||1
55631|NCT01824589|132793|P4|STARTED|Overall Study||0
55632|NCT01824589|132794|P3|STARTED|Overall Study||0
55633|NCT01824589|132795|P2|STARTED|Overall Study||0
55634|NCT01824589|132796|P1|STARTED|Overall Study||1
55635|NCT01824576|132818|P1|NOT COMPLETED|Overall Study||2
55636|NCT01824576|132818|P1|COMPLETED|Overall Study||7
55637|NCT01824576|132818|P1|STARTED|Overall Study||9
55638|NCT01824498|132836|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
55639|NCT01824498|132837|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
55640|NCT01824498|132838|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
55641|NCT01824498|132839|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
55642|NCT01824498|132840|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
55643|NCT01824498|132841|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
55644|NCT01824498|132836|P6|COMPLETED|3rd Intervention (8 Weeks)||4
55645|NCT01824498|132837|P5|COMPLETED|3rd Intervention (8 Weeks)||3
55646|NCT01824498|132838|P4|COMPLETED|3rd Intervention (8 Weeks)||2
55647|NCT01824498|132839|P3|COMPLETED|3rd Intervention (8 Weeks)||4
55648|NCT01824498|132840|P2|COMPLETED|3rd Intervention (8 Weeks)||2
55649|NCT01824498|132841|P1|COMPLETED|3rd Intervention (8 Weeks)||3
55650|NCT01824498|132836|P6|STARTED|3rd Intervention (8 Weeks)||4
55651|NCT01824498|132837|P5|STARTED|3rd Intervention (8 Weeks)||3
55652|NCT01824498|132838|P4|STARTED|3rd Intervention (8 Weeks)||2
55653|NCT01824498|132839|P3|STARTED|3rd Intervention (8 Weeks)||4
55654|NCT01824498|132840|P2|STARTED|3rd Intervention (8 Weeks)||2
55655|NCT01824498|132841|P1|STARTED|3rd Intervention (8 Weeks)||3
55656|NCT01824498|132836|P6|NOT COMPLETED|Washout (8 Weeks)||0
55657|NCT01824498|132837|P5|NOT COMPLETED|Washout (8 Weeks)||0
55658|NCT01824498|132838|P4|NOT COMPLETED|Washout (8 Weeks)||0
55659|NCT01824498|132839|P3|NOT COMPLETED|Washout (8 Weeks)||0
55660|NCT01824498|132840|P2|NOT COMPLETED|Washout (8 Weeks)||0
55661|NCT01824498|132841|P1|NOT COMPLETED|Washout (8 Weeks)||0
55662|NCT01824498|132836|P6|COMPLETED|Washout (8 Weeks)||4
55663|NCT01824498|132837|P5|COMPLETED|Washout (8 Weeks)||3
55664|NCT01824498|132838|P4|COMPLETED|Washout (8 Weeks)||2
55665|NCT01824498|132839|P3|COMPLETED|Washout (8 Weeks)||4
55666|NCT01824498|132840|P2|COMPLETED|Washout (8 Weeks)||2
55667|NCT01824498|132841|P1|COMPLETED|Washout (8 Weeks)||3
55668|NCT01824498|132836|P6|STARTED|Washout (8 Weeks)||4
55669|NCT01824498|132837|P5|STARTED|Washout (8 Weeks)||3
55670|NCT01824498|132838|P4|STARTED|Washout (8 Weeks)||2
55671|NCT01824498|132839|P3|STARTED|Washout (8 Weeks)||4
55672|NCT01824498|132840|P2|STARTED|Washout (8 Weeks)||2
55673|NCT01824498|132841|P1|STARTED|Washout (8 Weeks)||3
55674|NCT01824498|132836|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
55675|NCT01824498|132837|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
55676|NCT01824498|132838|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
55677|NCT01824498|132839|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
55678|NCT01824498|132840|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
55679|NCT01824498|132841|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
55680|NCT01824498|132836|P6|COMPLETED|2nd Intervention (8 Weeks)||4
55681|NCT01824498|132837|P5|COMPLETED|2nd Intervention (8 Weeks)||3
55682|NCT01824498|132838|P4|COMPLETED|2nd Intervention (8 Weeks)||2
55683|NCT01824498|132839|P3|COMPLETED|2nd Intervention (8 Weeks)||4
55684|NCT01824498|132840|P2|COMPLETED|2nd Intervention (8 Weeks)||2
55685|NCT01824498|132841|P1|COMPLETED|2nd Intervention (8 Weeks)||3
55686|NCT01824498|132836|P6|STARTED|2nd Intervention (8 Weeks)||4
55687|NCT01824498|132837|P5|STARTED|2nd Intervention (8 Weeks)||3
55688|NCT01824498|132838|P4|STARTED|2nd Intervention (8 Weeks)||2
55689|NCT01824498|132839|P3|STARTED|2nd Intervention (8 Weeks)||4
55690|NCT01824498|132840|P2|STARTED|2nd Intervention (8 Weeks)||2
55691|NCT01824498|132841|P1|STARTED|2nd Intervention (8 Weeks)||3
55692|NCT01824498|132836|P6|NOT COMPLETED|Washout (8 Weeks)||0
55693|NCT01824498|132837|P5|NOT COMPLETED|Washout (8 Weeks)||1
55694|NCT01824498|132838|P4|NOT COMPLETED|Washout (8 Weeks)||1
55695|NCT01824498|132839|P3|NOT COMPLETED|Washout (8 Weeks)||2
55696|NCT01824498|132840|P2|NOT COMPLETED|Washout (8 Weeks)||0
55697|NCT01824498|132841|P1|NOT COMPLETED|Washout (8 Weeks)||2
55698|NCT01824498|132836|P6|COMPLETED|Washout (8 Weeks)||4
55699|NCT01824498|132837|P5|COMPLETED|Washout (8 Weeks)||3
55700|NCT01824498|132838|P4|COMPLETED|Washout (8 Weeks)||2
55701|NCT01824498|132839|P3|COMPLETED|Washout (8 Weeks)||4
55702|NCT01824498|132840|P2|COMPLETED|Washout (8 Weeks)||2
55703|NCT01824498|132841|P1|COMPLETED|Washout (8 Weeks)||3
55704|NCT01824498|132836|P6|STARTED|Washout (8 Weeks)||4
55705|NCT01824498|132837|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
55706|NCT01824498|132838|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
55707|NCT01824498|132839|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
55708|NCT01824498|132840|P2|STARTED|Washout (8 Weeks)||2
55709|NCT01824498|132841|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
55710|NCT01824498|132836|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
55711|NCT01824498|132837|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
55712|NCT01824498|132838|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
55713|NCT01824498|132839|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
55714|NCT01824498|132840|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
55715|NCT01824498|132841|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
55716|NCT01824498|132836|P6|COMPLETED|1st Intervention (8 Weeks)||4
55717|NCT01824498|132837|P5|COMPLETED|1st Intervention (8 Weeks)||4
55718|NCT01824498|132838|P4|COMPLETED|1st Intervention (8 Weeks)||3
55719|NCT01824498|132839|P3|COMPLETED|1st Intervention (8 Weeks)||6
55720|NCT01824498|132840|P2|COMPLETED|1st Intervention (8 Weeks)||2
55721|NCT01824498|132841|P1|COMPLETED|1st Intervention (8 Weeks)||5
55722|NCT01824498|132836|P6|STARTED|1st Intervention (8 Weeks)||4
55723|NCT01824498|132837|P5|STARTED|1st Intervention (8 Weeks)||4
55724|NCT01824498|132838|P4|STARTED|1st Intervention (8 Weeks)||3
55725|NCT01824498|132839|P3|STARTED|1st Intervention (8 Weeks)||6
55726|NCT01824498|132840|P2|STARTED|1st Intervention (8 Weeks)||2
55727|NCT01824498|132841|P1|STARTED|1st Intervention (8 Weeks)||5
55728|NCT01824446|132849|P1|NOT COMPLETED|Overall Study||0
55729|NCT01824446|132849|P1|COMPLETED|Overall Study||6
55730|NCT01824446|132849|P1|STARTED|Overall Study||6
55731|NCT01824355|132872|P1|NOT COMPLETED|Overall Study||3
55732|NCT01824355|132872|P1|COMPLETED|Overall Study||110
55733|NCT01824355|132872|P1|STARTED|Overall Study||113
55734|NCT01824342|132883|P2|NOT COMPLETED|Overall Study||5
55735|NCT01824342|132884|P1|NOT COMPLETED|Overall Study||9
55736|NCT01824342|132883|P2|COMPLETED|Overall Study||2
55737|NCT01824342|132884|P1|COMPLETED|Overall Study||2
55738|NCT01824342|132883|P2|STARTED|Overall Study||7
55739|NCT01824342|132884|P1|STARTED|Overall Study||11
55740|NCT01824303|132898|P2|NOT COMPLETED|Open Label Extension||0
55741|NCT01824303|132899|P1|NOT COMPLETED|Open Label Extension||0
55742|NCT01824303|132898|P2|COMPLETED|Open Label Extension||11
55743|NCT01824303|132899|P1|COMPLETED|Open Label Extension||12
55744|NCT01824303|132898|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
55745|NCT01824303|132899|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
55746|NCT01824303|132898|P2|NOT COMPLETED|Randomized Study||1
55747|NCT01824303|132899|P1|NOT COMPLETED|Randomized Study||2
55748|NCT01824303|132898|P2|COMPLETED|Randomized Study||13
55749|NCT01824303|132899|P1|COMPLETED|Randomized Study||14
55750|NCT01824303|132898|P2|STARTED|Randomized Study||14
55751|NCT01824303|132899|P1|STARTED|Randomized Study||16
55752|NCT01824160|132923|P1|NOT COMPLETED|Overall Study||0
55753|NCT01824160|132923|P1|COMPLETED|Overall Study||50
55754|NCT01824160|132923|P1|STARTED|Overall Study||50
55755|NCT01823679|132927|P1|NOT COMPLETED|Overall Study||1
55756|NCT01823679|132927|P1|COMPLETED|Overall Study||1
55757|NCT01823679|132927|P1|STARTED|Overall Study||2
55758|NCT01823653|132935|P1|NOT COMPLETED|Overall Study||0
55759|NCT01823653|132935|P1|COMPLETED|Overall Study||60
55760|NCT01823653|132935|P1|STARTED|Overall Study||60
55761|NCT01823614|132949|P6|NOT COMPLETED|Overall Study||0
55762|NCT01823614|132950|P5|NOT COMPLETED|Overall Study||0
55763|NCT01823614|132951|P4|NOT COMPLETED|Overall Study||0
55764|NCT01823614|132952|P3|NOT COMPLETED|Overall Study||0
55765|NCT01823614|132953|P2|NOT COMPLETED|Overall Study||0
55766|NCT01823614|132954|P1|NOT COMPLETED|Overall Study||0
55767|NCT01823614|132949|P6|COMPLETED|Overall Study||154
55768|NCT01823614|132950|P5|COMPLETED|Overall Study||172
55769|NCT01823614|132951|P4|COMPLETED|Overall Study||122
55770|NCT01823614|132952|P3|COMPLETED|Overall Study||176
55771|NCT01823614|132953|P2|COMPLETED|Overall Study||140
55772|NCT01823614|132954|P1|COMPLETED|Overall Study||179
55773|NCT01823614|132949|P6|STARTED|Overall Study||154
55774|NCT01823614|132950|P5|STARTED|Overall Study||172
55775|NCT01823614|132951|P4|STARTED|Overall Study||122
55776|NCT01823614|132952|P3|STARTED|Overall Study||176
55777|NCT01823614|132953|P2|STARTED|Overall Study||140
55778|NCT01823614|132954|P1|STARTED|Overall Study||179
55779|NCT01823536|132980|P6|NOT COMPLETED|Overall Study||0
55780|NCT01823536|132981|P5|NOT COMPLETED|Overall Study||2
55781|NCT01823536|132982|P4|NOT COMPLETED|Overall Study||2
55782|NCT01823536|132983|P3|NOT COMPLETED|Overall Study||1
55783|NCT01823536|132984|P2|NOT COMPLETED|Overall Study||2
55784|NCT01823536|132985|P1|NOT COMPLETED|Overall Study||2
55785|NCT01823536|132980|P6|COMPLETED|Overall Study||2
55786|NCT01823536|132981|P5|COMPLETED|Overall Study||99
55787|NCT01823536|132982|P4|COMPLETED|Overall Study||64
55788|NCT01823536|132983|P3|COMPLETED|Overall Study||119
55789|NCT01823536|132984|P2|COMPLETED|Overall Study||101
55790|NCT01823536|132985|P1|COMPLETED|Overall Study||71
55791|NCT01823536|132980|P6|STARTED|Overall Study||2
55792|NCT01823536|132981|P5|STARTED|Overall Study||101
55793|NCT01823536|132982|P4|STARTED|Overall Study||66
55794|NCT01823536|132983|P3|STARTED|Overall Study||120
55795|NCT01823536|132984|P2|STARTED|Overall Study||103
55796|NCT01823536|132985|P1|STARTED|Overall Study||73
55797|NCT01823510|133023|P2|NOT COMPLETED|Days 22-28||0
55798|NCT01823510|133024|P1|NOT COMPLETED|Days 22-28||0
55799|NCT01823510|133023|P2|COMPLETED|Days 22-28||10
55800|NCT01823510|133024|P1|COMPLETED|Days 22-28||10
55801|NCT01823510|133023|P2|STARTED|Days 22-28||10
55802|NCT01823510|133024|P1|STARTED|Days 22-28||10
55803|NCT01823510|133023|P2|NOT COMPLETED|Days 8-21||0
55804|NCT01823510|133024|P1|NOT COMPLETED|Days 8-21||0
55805|NCT01823510|133023|P2|COMPLETED|Days 8-21||10
55806|NCT01823510|133024|P1|COMPLETED|Days 8-21||10
55807|NCT01823510|133023|P2|STARTED|Days 8-21||10
55808|NCT01823510|133024|P1|STARTED|Days 8-21||10
55809|NCT01823510|133023|P2|NOT COMPLETED|Days 1-7||0
55810|NCT01823510|133024|P1|NOT COMPLETED|Days 1-7||0
55811|NCT01823510|133023|P2|COMPLETED|Days 1-7||10
55812|NCT01823510|133024|P1|COMPLETED|Days 1-7||10
55813|NCT01823510|133023|P2|STARTED|Days 1-7||10
55814|NCT01823510|133024|P1|STARTED|Days 1-7||10
55815|NCT01823341|133036|P1|NOT COMPLETED|Overall Study||15
55816|NCT01823341|133036|P1|COMPLETED|Overall Study||82
55817|NCT01823341|133036|P1|STARTED|Overall Study||97
55818|NCT01823289|133079|P1|NOT COMPLETED|Overall Study||24
55819|NCT01823289|133079|P1|COMPLETED|Overall Study||47
55820|NCT01823289|133079|P1|STARTED|Overall Study||71
55821|NCT01823224|133087|P2|NOT COMPLETED|Overall Study||11
55822|NCT01823224|133088|P1|NOT COMPLETED|Overall Study||6
55823|NCT01823224|133087|P2|COMPLETED|Overall Study||22
55824|NCT01823224|133088|P1|COMPLETED|Overall Study||28
55825|NCT01823224|133087|P2|STARTED|Overall Study||33
55826|NCT01823224|133088|P1|STARTED|Overall Study||34
55827|NCT01823146|133098|P2|NOT COMPLETED|Overall Study||2
55828|NCT01823146|133099|P1|NOT COMPLETED|Overall Study||2
55829|NCT01823146|133098|P2|COMPLETED|Overall Study||49
55830|NCT01823146|133099|P1|COMPLETED|Overall Study||53
55831|NCT01823146|133098|P2|STARTED|Overall Study||51
55832|NCT01823146|133099|P1|STARTED|Overall Study||55
55833|NCT01822899|133111|P2|NOT COMPLETED|Overall Study||18
55834|NCT01822899|133112|P1|NOT COMPLETED|Overall Study||24
55835|NCT01822899|133111|P2|COMPLETED|Overall Study||340
55836|NCT01822899|133112|P1|COMPLETED|Overall Study||334
55837|NCT01822899|133111|P2|STARTED|Overall Study||358
55838|NCT01822899|133112|P1|STARTED|Overall Study||358
55839|NCT01822821|133122|P2|NOT COMPLETED|Overall Study||1
55840|NCT01822821|133123|P1|NOT COMPLETED|Overall Study||2
55841|NCT01822821|133122|P2|COMPLETED|Overall Study||74
55842|NCT01822821|133123|P1|COMPLETED|Overall Study||73
55843|NCT01822821|133122|P2|STARTED|Overall Study||75
55844|NCT01822821|133123|P1|STARTED|Overall Study||75
55845|NCT01822756|133152|P5|NOT COMPLETED|Overall Study||7
55846|NCT01822756|133153|P4|NOT COMPLETED|Overall Study||4
55847|NCT01822756|133154|P3|NOT COMPLETED|Overall Study||10
55848|NCT01822756|133155|P2|NOT COMPLETED|Overall Study||4
55849|NCT01822756|133156|P1|NOT COMPLETED|Overall Study||16
55850|NCT01822756|133152|P5|COMPLETED|Overall Study||1
55851|NCT01822756|133153|P4|COMPLETED|Overall Study||0
55852|NCT01822756|133154|P3|COMPLETED|Overall Study||0
55853|NCT01822756|133155|P2|COMPLETED|Overall Study||0
55854|NCT01822756|133156|P1|COMPLETED|Overall Study||0
55855|NCT01822756|133152|P5|Discontinued From the Study|Overall Study||7
55856|NCT01822756|133153|P4|Discontinued From the Study|Overall Study||4
55857|NCT01822756|133154|P3|Discontinued From the Study|Overall Study||10
55858|NCT01822756|133155|P2|Discontinued From the Study|Overall Study||4
55859|NCT01822756|133156|P1|Discontinued From the Study|Overall Study||16
55860|NCT01822756|133152|P5|STARTED|Overall Study||8
55861|NCT01822756|133153|P4|STARTED|Overall Study||4
55862|NCT01822756|133154|P3|STARTED|Overall Study||10
55863|NCT01822756|133155|P2|STARTED|Overall Study||4
55864|NCT01822756|133156|P1|STARTED|Overall Study||16
55865|NCT01822691|133198|P1|NOT COMPLETED|Overall Study||2
55866|NCT01822691|133198|P1|COMPLETED|Overall Study||13
55867|NCT01822691|133198|P1|STARTED|Overall Study||15
55868|NCT01822678|133209|P3|NOT COMPLETED|Overall Study||11
55869|NCT01822678|133210|P2|NOT COMPLETED|Overall Study||15
55870|NCT01822678|133211|P1|NOT COMPLETED|Overall Study||12
55871|NCT01822678|133209|P3|COMPLETED|Overall Study||29
55872|NCT01822678|133210|P2|COMPLETED|Overall Study||49
55873|NCT01822678|133211|P1|COMPLETED|Overall Study||45
55874|NCT01822678|133209|P3|Per Protocol Population|Overall Study||34
55875|NCT01822678|133210|P2|Per Protocol Population|Overall Study||52
55876|NCT01822678|133211|P1|Per Protocol Population|Overall Study||45
55877|NCT01822678|133209|P3|Intention-to-Treat Population (ITT)|Overall Study||40
55878|NCT01822678|133210|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
55879|NCT01822678|133211|P1|Intention-to-Treat Population (ITT)|Overall Study||57
55880|NCT01822678|133209|P3|Safety Population|Overall Study||40
55881|NCT01822678|133210|P2|Safety Population|Overall Study||64
55882|NCT01822678|133211|P1|Safety Population|Overall Study||57
55883|NCT01822678|133209|P3|Treated|Overall Study||40
55884|NCT01822678|133210|P2|Treated|Overall Study||64
55885|NCT01822678|133211|P1|Treated|Overall Study||57
55886|NCT01822678|133209|P3|STARTED|Overall Study||40
55887|NCT01822678|133210|P2|STARTED|Overall Study||64
55888|NCT01822678|133211|P1|STARTED|Overall Study||57
55889|NCT01822665|133219|P1|NOT COMPLETED|Overall Study||8
55890|NCT01822665|133219|P1|COMPLETED|Overall Study||20
55891|NCT01822665|133219|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
55892|NCT01822665|133219|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
55893|NCT01822665|133219|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
55894|NCT01822665|133219|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
55895|NCT01822665|133219|P1|STARTED|Overall Study||28
55896|NCT01822574|133246|P3|NOT COMPLETED|Overall Study||0
55897|NCT01822574|133247|P2|NOT COMPLETED|Overall Study||0
55898|NCT01822574|133248|P1|NOT COMPLETED|Overall Study||0
55899|NCT01822574|133246|P3|COMPLETED|Overall Study||30
55900|NCT01822574|133247|P2|COMPLETED|Overall Study||30
55901|NCT01822574|133248|P1|COMPLETED|Overall Study||30
55902|NCT01822574|133246|P3|STARTED|Overall Study||30
55903|NCT01822574|133247|P2|STARTED|Overall Study||30
55904|NCT01822574|133248|P1|STARTED|Overall Study||30
55905|NCT01822561|133262|P1|NOT COMPLETED|Overall Study||2
55906|NCT01822561|133262|P1|COMPLETED|Overall Study||13
55907|NCT01822561|133262|P1|STARTED|Overall Study||15
55908|NCT01822548|133272|P2|NOT COMPLETED|Overall Study||0
55909|NCT01822548|133273|P1|NOT COMPLETED|Overall Study||0
55910|NCT01822548|133272|P2|COMPLETED|Overall Study||24
55911|NCT01822548|133273|P1|COMPLETED|Overall Study||40
55912|NCT01822548|133272|P2|Discontinued Intervention|Overall Study||5
55913|NCT01822548|133273|P1|Discontinued Intervention|Overall Study||0
55914|NCT01822548|133272|P2|STARTED|Overall Study||24
55915|NCT01822548|133273|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
55916|NCT01822535|133283|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
55917|NCT01822535|133284|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
55918|NCT01822535|133283|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
55919|NCT01822535|133284|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
55920|NCT01822535|133283|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
55921|NCT01822535|133284|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
55922|NCT01822535|133283|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
55923|NCT01822535|133284|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
55924|NCT01822535|133283|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
55925|NCT01822535|133284|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
55926|NCT01822535|133283|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
55927|NCT01822535|133284|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
55928|NCT01822301|133296|P1|NOT COMPLETED|Overall Study||0
55929|NCT01822301|133296|P1|COMPLETED|Overall Study||5
55930|NCT01822301|133296|P1|STARTED|Overall Study||5
55931|NCT01822223|133308|P2|NOT COMPLETED|Overall Study||1
55932|NCT01822223|133309|P1|NOT COMPLETED|Overall Study||0
55933|NCT01822223|133308|P2|COMPLETED|Overall Study||9
55934|NCT01822223|133309|P1|COMPLETED|Overall Study||10
55935|NCT01822223|133308|P2|STARTED|Overall Study||10
55936|NCT01822223|133309|P1|STARTED|Overall Study||10
55937|NCT01822197|133325|P1|NOT COMPLETED|Overall Study||0
55938|NCT01822197|133325|P1|COMPLETED|Overall Study||30
55939|NCT01822197|133325|P1|STARTED|Overall Study||30
55940|NCT01822119|133331|P1|NOT COMPLETED|Overall Study||0
55941|NCT01822119|133331|P1|COMPLETED|Overall Study||27
55942|NCT01822119|133331|P1|STARTED|Overall Study||27
55943|NCT01821963|133354|P1|NOT COMPLETED|Overall Study||1
55944|NCT01821963|133354|P1|COMPLETED|Overall Study||0
55945|NCT01821963|133354|P1|STARTED|Overall Study||1
55946|NCT01821937|133360|P2|NOT COMPLETED|Overall Study||3
55947|NCT01821937|133361|P1|NOT COMPLETED|Overall Study||0
55948|NCT01821937|133360|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
55949|NCT01821937|133361|P1|COMPLETED|Overall Study||10
55950|NCT01821937|133360|P2|STARTED|Overall Study||15
55951|NCT01821937|133361|P1|STARTED|Overall Study||10
55952|NCT01821859|133379|P1|NOT COMPLETED|Overall Study||5
55953|NCT01821859|133379|P1|COMPLETED|Overall Study||0
55954|NCT01821859|133379|P1|STARTED|Overall Study||5
55955|NCT01821807|133385|P2|NOT COMPLETED|Overall Study||1
55956|NCT01821807|133386|P1|NOT COMPLETED|Overall Study||3
55957|NCT01821807|133385|P2|COMPLETED|Overall Study||109
55958|NCT01821807|133386|P1|COMPLETED|Overall Study||147
55959|NCT01821807|133385|P2|STARTED|Overall Study||110
55960|NCT01821807|133386|P1|STARTED|Overall Study||150
55961|NCT01821534|133394|P1|NOT COMPLETED|Overall Study||0
55962|NCT01821534|133394|P1|COMPLETED|Overall Study||201
55963|NCT01821534|133394|P1|STARTED|Overall Study||201
55964|NCT01821417|133403|P2|NOT COMPLETED|Overall Study||0
55965|NCT01821417|133404|P1|NOT COMPLETED|Overall Study||0
55966|NCT01821417|133403|P2|COMPLETED|Overall Study||31
55967|NCT01821417|133404|P1|COMPLETED|Overall Study||37
55968|NCT01821417|133403|P2|STARTED|Overall Study||31
55969|NCT01821417|133404|P1|STARTED|Overall Study||37
55970|NCT01821378|133417|P3|NOT COMPLETED|Overall Study||42
55971|NCT01821378|133418|P2|NOT COMPLETED|Overall Study||54
55972|NCT01821378|133419|P1|NOT COMPLETED|Overall Study||27
55973|NCT01821378|133417|P3|COMPLETED|Overall Study||70
55974|NCT01821378|133418|P2|COMPLETED|Overall Study||145
55975|NCT01821378|133419|P1|COMPLETED|Overall Study||74
55976|NCT01821378|133417|P3|STARTED|Overall Study||112
55977|NCT01821378|133418|P2|STARTED|Overall Study||199
55978|NCT01821378|133419|P1|STARTED|Overall Study||101
55979|NCT01821352|133457|P2|NOT COMPLETED|Overall Study||0
55980|NCT01821352|133458|P1|NOT COMPLETED|Overall Study||0
55981|NCT01821352|133457|P2|COMPLETED|Overall Study||25
55982|NCT01821352|133458|P1|COMPLETED|Overall Study||28
55983|NCT01821352|133457|P2|STARTED|Overall Study||25
55984|NCT01821352|133458|P1|STARTED|Overall Study||28
55985|NCT01821326|133468|P1|NOT COMPLETED|Overall Study||0
55986|NCT01821326|133468|P1|COMPLETED|Overall Study||339
55987|NCT01821326|133468|P1|STARTED|Overall Study||339
55988|NCT01821118|133474|P2|NOT COMPLETED|Overall Study||1
55989|NCT01821118|133475|P1|NOT COMPLETED|Overall Study||0
55990|NCT01821118|133474|P2|COMPLETED|Overall Study||11
55991|NCT01821118|133475|P1|COMPLETED|Overall Study||24
55992|NCT01821118|133474|P2|STARTED|Overall Study||12
55993|NCT01821118|133475|P1|STARTED|Overall Study||24
55994|NCT01821105|133508|P1|NOT COMPLETED|Overall Study||0
55995|NCT01821105|133508|P1|COMPLETED|Overall Study||21
55996|NCT01821105|133508|P1|STARTED|Overall Study||21
55997|NCT01820754|133514|P1|NOT COMPLETED|Overall Study||0
55998|NCT01820754|133514|P1|COMPLETED|Overall Study||24
55999|NCT01820754|133514|P1|STARTED|Overall Study||24
56000|NCT01820585|133526|P4|NOT COMPLETED|Overall Study||49
56001|NCT01820585|133527|P3|NOT COMPLETED|Overall Study||34
56002|NCT01820585|133528|P2|NOT COMPLETED|Overall Study||32
56003|NCT01820585|133529|P1|NOT COMPLETED|Overall Study||27
56004|NCT01820585|133526|P4|COMPLETED|Overall Study||83
56005|NCT01820585|133527|P3|COMPLETED|Overall Study||101
56006|NCT01820585|133528|P2|COMPLETED|Overall Study||98
56007|NCT01820585|133529|P1|COMPLETED|Overall Study||104
56008|NCT01820585|133526|P4|Completed Maintenance Period|Overall Study||84
56009|NCT01820585|133527|P3|Completed Maintenance Period|Overall Study||101
56010|NCT01820585|133528|P2|Completed Maintenance Period|Overall Study||98
56011|NCT01820585|133529|P1|Completed Maintenance Period|Overall Study||105
56012|NCT01820585|133526|P4|Entered Maintenance Period|Overall Study||123
56013|NCT01820585|133527|P3|Entered Maintenance Period|Overall Study||131
56014|NCT01820585|133528|P2|Entered Maintenance Period|Overall Study||124
56015|NCT01820585|133529|P1|Entered Maintenance Period|Overall Study||128
56016|NCT01820585|133526|P4|Completed Titration Period|Overall Study||126
56017|NCT01820585|133527|P3|Completed Titration Period|Overall Study||131
56018|NCT01820585|133528|P2|Completed Titration Period|Overall Study||125
56019|NCT01820585|133529|P1|Completed Titration Period|Overall Study||128
56020|NCT01820585|133526|P4|Full Analysis Set|Overall Study||129
56021|NCT01820585|133527|P3|Full Analysis Set|Overall Study||135
56022|NCT01820585|133528|P2|Full Analysis Set|Overall Study||130
56023|NCT01820585|133529|P1|Full Analysis Set|Overall Study||131
56024|NCT01820585|133526|P4|Randomized and Treated|Overall Study||132
56025|NCT01820585|133527|P3|Randomized and Treated|Overall Study||135
56026|NCT01820585|133528|P2|Randomized and Treated|Overall Study||130
56027|NCT01820585|133529|P1|Randomized and Treated|Overall Study||131
56028|NCT01820585|133526|P4|STARTED|Overall Study||132
56029|NCT01820585|133527|P3|STARTED|Overall Study||135
56030|NCT01820585|133528|P2|STARTED|Overall Study||130
56031|NCT01820585|133529|P1|STARTED|Overall Study||131
56032|NCT01820559|133542|P3|NOT COMPLETED|Overall Study||29
56033|NCT01820559|133543|P2|NOT COMPLETED|Overall Study||13
56034|NCT01820559|133544|P1|NOT COMPLETED|Overall Study||14
56035|NCT01820559|133542|P3|COMPLETED|Overall Study||110
56036|NCT01820559|133543|P2|COMPLETED|Overall Study||122
56037|NCT01820559|133544|P1|COMPLETED|Overall Study||122
56038|NCT01820559|133542|P3|Completed Maintenance Period|Overall Study||110
56039|NCT01820559|133543|P2|Completed Maintenance Period|Overall Study||123
56040|NCT01820559|133544|P1|Completed Maintenance Period|Overall Study||122
56041|NCT01820559|133542|P3|Entered Maintenance Period|Overall Study||129
56042|NCT01820559|133543|P2|Entered Maintenance Period|Overall Study||133
56043|NCT01820559|133544|P1|Entered Maintenance Period|Overall Study||129
56044|NCT01820559|133542|P3|Completed Tutration Period|Overall Study||131
56045|NCT01820559|133543|P2|Completed Tutration Period|Overall Study||134
56046|NCT01820559|133544|P1|Completed Tutration Period|Overall Study||130
56047|NCT01820559|133542|P3|Randomized and Treated|Overall Study||139
56048|NCT01820559|133543|P2|Randomized and Treated|Overall Study||135
56049|NCT01820559|133544|P1|Randomized and Treated|Overall Study||136
56050|NCT01820559|133542|P3|STARTED|Overall Study||139
56051|NCT01820559|133543|P2|STARTED|Overall Study||135
56052|NCT01820559|133544|P1|STARTED|Overall Study||136
56053|NCT01820416|133555|P3|NOT COMPLETED|Overall Study||0
56054|NCT01820416|133556|P2|NOT COMPLETED|Overall Study||2
56055|NCT01820416|133557|P1|NOT COMPLETED|Overall Study||3
56056|NCT01820416|133555|P3|COMPLETED|Overall Study||11
56057|NCT01820416|133556|P2|COMPLETED|Overall Study||10
56058|NCT01820416|133557|P1|COMPLETED|Overall Study||9
56059|NCT01820416|133555|P3|STARTED|Overall Study||11
56060|NCT01820416|133556|P2|STARTED|Overall Study||12
56061|NCT01820416|133557|P1|STARTED|Overall Study||12
56062|NCT01820364|133565|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
56063|NCT01820364|133566|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
56064|NCT01820364|133565|P2|COMPLETED|Part II: LGX818 + MEK162||0
56065|NCT01820364|133566|P1|COMPLETED|Part II: LGX818 + MEK162||0
56066|NCT01820364|133565|P2|STARTED|Part II: LGX818 + MEK162||1
56067|NCT01820364|133566|P1|STARTED|Part II: LGX818 + MEK162||0
56068|NCT01820364|133565|P2|NOT COMPLETED|Part I: LGX818||0
56069|NCT01820364|133566|P1|NOT COMPLETED|Part I: LGX818||14
56070|NCT01820364|133565|P2|COMPLETED|Part I: LGX818||0
56071|NCT01820364|133566|P1|COMPLETED|Part I: LGX818||1
56072|NCT01820364|133565|P2|STARTED|Part I: LGX818||0
56073|NCT01820364|133566|P1|STARTED|Part I: LGX818||15
56074|NCT01819935|133580|P2|NOT COMPLETED|Overall Study||0
56075|NCT01819935|133581|P1|NOT COMPLETED|Overall Study||0
56076|NCT01819935|133580|P2|COMPLETED|Overall Study||4943
56077|NCT01819935|133581|P1|COMPLETED|Overall Study||328
56078|NCT01819935|133580|P2|STARTED|Overall Study||4943
56079|NCT01819935|133581|P1|STARTED|Overall Study||328
56080|NCT01819922|133601|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
56081|NCT01819922|133602|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
56082|NCT01819922|133601|P2|COMPLETED|Second Intervention Period (1 Day)||6
56083|NCT01819922|133602|P1|COMPLETED|Second Intervention Period (1 Day)||6
56084|NCT01819922|133601|P2|STARTED|Second Intervention Period (1 Day)||6
56085|NCT01819922|133602|P1|STARTED|Second Intervention Period (1 Day)||6
56086|NCT01819922|133601|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
56087|NCT01819922|133602|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
56088|NCT01819922|133601|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
56089|NCT01819922|133602|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
56090|NCT01819922|133601|P2|STARTED|Washout Period (at Least 7-10 Days)||6
56091|NCT01819922|133602|P1|STARTED|Washout Period (at Least 7-10 Days)||6
56092|NCT01819922|133601|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
56093|NCT01819922|133602|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
56094|NCT01819922|133601|P2|COMPLETED|First Intervention Period (1 Day)||6
56095|NCT01819922|133602|P1|COMPLETED|First Intervention Period (1 Day)||6
56096|NCT01819922|133601|P2|STARTED|First Intervention Period (1 Day)||6
56097|NCT01819922|133602|P1|STARTED|First Intervention Period (1 Day)||6
56098|NCT01819844|133686|P1|NOT COMPLETED|Overall Study||0
56099|NCT01819844|133686|P1|COMPLETED|Overall Study||12
56100|NCT01819844|133686|P1|STARTED|Overall Study||12
56101|NCT01819415|133703|P4|NOT COMPLETED|Overall Study||2
56102|NCT01819415|133704|P3|NOT COMPLETED|Overall Study||1
56103|NCT01819415|133705|P2|NOT COMPLETED|Overall Study||4
56104|NCT01819415|133706|P1|NOT COMPLETED|Overall Study||3
56105|NCT01819415|133703|P4|COMPLETED|Overall Study||8
56106|NCT01819415|133704|P3|COMPLETED|Overall Study||9
56107|NCT01819415|133705|P2|COMPLETED|Overall Study||6
56108|NCT01819415|133706|P1|COMPLETED|Overall Study||7
56109|NCT01819415|133703|P4|STARTED|Overall Study||10
56110|NCT01819415|133704|P3|STARTED|Overall Study||10
56111|NCT01819415|133705|P2|STARTED|Overall Study||10
56112|NCT01819415|133706|P1|STARTED|Overall Study||10
56113|NCT01819311|133718|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
56114|NCT01819311|133719|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
56115|NCT01819311|133718|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
56116|NCT01819311|133719|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
56117|NCT01819311|133718|P2|STARTED|Follow-up Phase (8 Weeks)||30
56118|NCT01819311|133719|P1|STARTED|Follow-up Phase (8 Weeks)||31
56119|NCT01819311|133718|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
56120|NCT01819311|133719|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
56121|NCT01819311|133718|P2|COMPLETED|Treatment Phase (4 Weeks)||30
56122|NCT01819311|133719|P1|COMPLETED|Treatment Phase (4 Weeks)||31
56123|NCT01819311|133718|P2|STARTED|Treatment Phase (4 Weeks)||31
56124|NCT01819311|133719|P1|STARTED|Treatment Phase (4 Weeks)||33
56125|NCT01819272|133741|P6|NOT COMPLETED|Overall Study||7
56126|NCT01819272|133742|P5|NOT COMPLETED|Overall Study||4
56127|NCT01819272|133743|P4|NOT COMPLETED|Overall Study||5
56128|NCT01819272|133744|P3|NOT COMPLETED|Overall Study||3
56129|NCT01819272|133745|P2|NOT COMPLETED|Overall Study||3
56130|NCT01819272|133746|P1|NOT COMPLETED|Overall Study||6
56131|NCT01819272|133741|P6|COMPLETED|Overall Study||33
56132|NCT01819272|133742|P5|COMPLETED|Overall Study||36
56133|NCT01819272|133743|P4|COMPLETED|Overall Study||35
56134|NCT01819272|133744|P3|COMPLETED|Overall Study||37
56135|NCT01819272|133745|P2|COMPLETED|Overall Study||36
56136|NCT01819272|133746|P1|COMPLETED|Overall Study||35
56137|NCT01819272|133741|P6|STARTED|Overall Study||40
56138|NCT01819272|133742|P5|STARTED|Overall Study||40
56139|NCT01819272|133743|P4|STARTED|Overall Study||40
56140|NCT01819272|133744|P3|STARTED|Overall Study||40
56141|NCT01819272|133745|P2|STARTED|Overall Study||39
56142|NCT01819272|133746|P1|STARTED|Overall Study||41
56143|NCT01819194|133772|P1|NOT COMPLETED|Overall Study||2
56144|NCT01819194|133772|P1|COMPLETED|Overall Study||60
56145|NCT01819194|133772|P1|STARTED|Overall Study||62
56146|NCT01819129|133779|P2|NOT COMPLETED|Overall Study||39
56147|NCT01819129|133780|P1|NOT COMPLETED|Overall Study||44
56148|NCT01819129|133779|P2|COMPLETED|Overall Study||305
56149|NCT01819129|133780|P1|COMPLETED|Overall Study||301
56150|NCT01819129|133779|P2|Exposed|Overall Study||341
56151|NCT01819129|133780|P1|Exposed|Overall Study||341
56152|NCT01819129|133779|P2|STARTED|Overall Study||344
56153|NCT01819129|133780|P1|STARTED|Overall Study||345
56154|NCT01818752|133794|P2|NOT COMPLETED|Overall Study||198
56155|NCT01818752|133795|P1|NOT COMPLETED|Overall Study||187
56156|NCT01818752|133794|P2|COMPLETED|Overall Study|Completed treatment|280
56157|NCT01818752|133795|P1|COMPLETED|Overall Study|Completed treatment|290
56158|NCT01818752|133794|P2|Received Treatment|Overall Study||474
56159|NCT01818752|133795|P1|Received Treatment|Overall Study||470
56160|NCT01818752|133794|P2|STARTED|Overall Study||478
56161|NCT01818752|133795|P1|STARTED|Overall Study||477
56162|NCT01818700|133813|P1|NOT COMPLETED|Overall Study||104
56163|NCT01818700|133813|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
56164|NCT01818700|133813|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
56165|NCT01818700|133813|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
56166|NCT01818700|133813|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
56167|NCT01818700|133813|P1|STARTED|Overall Study|The No. of enrolled patients|245
56168|NCT01818596|133824|P2|NOT COMPLETED|Overall Study||6
56169|NCT01818596|133825|P1|NOT COMPLETED|Overall Study||246
56170|NCT01818596|133824|P2|COMPLETED|Overall Study||0
56171|NCT01818596|133825|P1|COMPLETED|Overall Study||0
56172|NCT01818596|133824|P2|STARTED|Overall Study||6
56173|NCT01818596|133825|P1|STARTED|Overall Study||246
56174|NCT01818414|133858|P2|NOT COMPLETED|Overall Study||0
56175|NCT01818414|133859|P1|NOT COMPLETED|Overall Study||0
56176|NCT01818414|133858|P2|COMPLETED|Overall Study||15
56177|NCT01818414|133859|P1|COMPLETED|Overall Study||14
56178|NCT01818414|133858|P2|STARTED|Overall Study||15
56179|NCT01818414|133859|P1|STARTED|Overall Study||14
56180|NCT01818336|133873|P2|NOT COMPLETED|Overall Study||12
56181|NCT01818336|133874|P1|NOT COMPLETED|Overall Study||0
56182|NCT01818336|133873|P2|COMPLETED|Overall Study||47
56183|NCT01818336|133874|P1|COMPLETED|Overall Study||391
56184|NCT01818336|133873|P2|STARTED|Overall Study||59
56185|NCT01818336|133874|P1|STARTED|Overall Study||391
56186|NCT01818297|133882|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
56187|NCT01818297|133883|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
56188|NCT01818297|133882|P2|COMPLETED|Open Label Phase (3-12 Months)||19
56189|NCT01818297|133883|P1|COMPLETED|Open Label Phase (3-12 Months)||14
56190|NCT01818297|133882|P2|STARTED|Open Label Phase (3-12 Months)||29
56191|NCT01818297|133883|P1|STARTED|Open Label Phase (3-12 Months)||32
56192|NCT01818297|133882|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
56193|NCT01818297|133883|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
56194|NCT01818297|133882|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
56195|NCT01818297|133883|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
56196|NCT01818297|133882|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
56197|NCT01818297|133883|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
56198|NCT01818297|133882|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
56199|NCT01818297|133883|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
56200|NCT01818297|133882|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
56201|NCT01818297|133883|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
56202|NCT01818141|133901|P2|NOT COMPLETED|Overall Study||3
56203|NCT01818141|133902|P1|NOT COMPLETED|Overall Study||3
56204|NCT01818141|133901|P2|COMPLETED|Overall Study||13
56205|NCT01818141|133902|P1|COMPLETED|Overall Study||15
56206|NCT01818141|133901|P2|STARTED|Overall Study||16
56207|NCT01818141|133902|P1|STARTED|Overall Study||18
56208|NCT01818063|133912|P2|NOT COMPLETED|Overall Study||0
56209|NCT01818063|133913|P1|NOT COMPLETED|Overall Study||0
56210|NCT01818063|133912|P2|COMPLETED|Overall Study||4
56211|NCT01818063|133913|P1|COMPLETED|Overall Study||5
56212|NCT01818063|133912|P2|STARTED|Overall Study||4
56213|NCT01818063|133913|P1|STARTED|Overall Study||5
56214|NCT01817907|133921|P2|NOT COMPLETED|Second Intervention||0
56215|NCT01817907|133922|P1|NOT COMPLETED|Second Intervention||0
56216|NCT01817907|133921|P2|COMPLETED|Second Intervention||7
56217|NCT01817907|133922|P1|COMPLETED|Second Intervention||8
56218|NCT01817907|133921|P2|STARTED|Second Intervention||7
56219|NCT01817907|133922|P1|STARTED|Second Intervention||8
56220|NCT01817907|133921|P2|NOT COMPLETED|Washout Period||0
56221|NCT01817907|133922|P1|NOT COMPLETED|Washout Period||0
56222|NCT01817907|133921|P2|COMPLETED|Washout Period||7
56223|NCT01817907|133922|P1|COMPLETED|Washout Period||8
56224|NCT01817907|133921|P2|STARTED|Washout Period||7
56225|NCT01817907|133922|P1|STARTED|Washout Period||8
56226|NCT01817907|133921|P2|NOT COMPLETED|First Intervention||0
56227|NCT01817907|133922|P1|NOT COMPLETED|First Intervention||0
56228|NCT01817907|133921|P2|COMPLETED|First Intervention||7
56229|NCT01817907|133922|P1|COMPLETED|First Intervention||8
56230|NCT01817907|133921|P2|STARTED|First Intervention||7
56231|NCT01817907|133922|P1|STARTED|First Intervention||8
56232|NCT01817855|133934|P4|NOT COMPLETED|Overall Study||0
56233|NCT01817855|133935|P3|NOT COMPLETED|Overall Study||2
56234|NCT01817855|133936|P2|NOT COMPLETED|Overall Study||2
56235|NCT01817855|133937|P1|NOT COMPLETED|Overall Study||0
56236|NCT01817855|133934|P4|COMPLETED|Overall Study||5
56237|NCT01817855|133935|P3|COMPLETED|Overall Study||9
56238|NCT01817855|133936|P2|COMPLETED|Overall Study||6
56239|NCT01817855|133937|P1|COMPLETED|Overall Study||23
56240|NCT01817855|133934|P4|STARTED|Overall Study||5
56241|NCT01817855|133935|P3|STARTED|Overall Study||11
56242|NCT01817855|133936|P2|STARTED|Overall Study||8
56243|NCT01817855|133937|P1|STARTED|Overall Study||23
56244|NCT01817790|133967|P2|NOT COMPLETED|Overall Study||8
56245|NCT01817790|133968|P1|NOT COMPLETED|Overall Study||4
56246|NCT01817790|133967|P2|COMPLETED|Overall Study||304
56247|NCT01817790|133968|P1|COMPLETED|Overall Study||310
56248|NCT01817790|133967|P2|STARTED|Overall Study||312
56249|NCT01817790|133968|P1|STARTED|Overall Study||314
56250|NCT01817777|134012|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
56251|NCT01817777|134013|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
56252|NCT01817777|134014|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
56253|NCT01817777|134012|P3|COMPLETED|Interventional Phase (20 Weeks)||10
56254|NCT01817777|134013|P2|COMPLETED|Interventional Phase (20 Weeks)||11
56255|NCT01817777|134014|P1|COMPLETED|Interventional Phase (20 Weeks)||0
56256|NCT01817777|134012|P3|STARTED|Interventional Phase (20 Weeks)||15
56257|NCT01817777|134013|P2|STARTED|Interventional Phase (20 Weeks)||16
56258|NCT01817777|134014|P1|STARTED|Interventional Phase (20 Weeks)||0
56259|NCT01817777|134012|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
56260|NCT01817777|134013|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
56261|NCT01817777|134014|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
56262|NCT01817777|134012|P3|COMPLETED|Observational Phase (8 Weeks)||0
56263|NCT01817777|134013|P2|COMPLETED|Observational Phase (8 Weeks)||0
56264|NCT01817777|134014|P1|COMPLETED|Observational Phase (8 Weeks)||31
56265|NCT01817777|134012|P3|STARTED|Observational Phase (8 Weeks)||0
56266|NCT01817777|134013|P2|STARTED|Observational Phase (8 Weeks)||0
56267|NCT01817777|134014|P1|STARTED|Observational Phase (8 Weeks)||36
56268|NCT01817764|134038|P2|NOT COMPLETED|Overall Study||38
56269|NCT01817764|134039|P1|NOT COMPLETED|Overall Study||34
56270|NCT01817764|134038|P2|COMPLETED|Overall Study||315
56271|NCT01817764|134039|P1|COMPLETED|Overall Study||319
56272|NCT01817764|134038|P2|STARTED|Overall Study||353
56273|NCT01817764|134039|P1|STARTED|Overall Study||353
56274|NCT01817725|134047|P1|NOT COMPLETED|Overall Study||1
56275|NCT01817725|134047|P1|COMPLETED|Overall Study||19
56276|NCT01817725|134047|P1|STARTED|Overall Study||20
56277|NCT01817374|134052|P1|NOT COMPLETED|Overall Study||0
56278|NCT01817374|134052|P1|COMPLETED|Overall Study||6
56279|NCT01817374|134052|P1|STARTED|Overall Study||6
56280|NCT01816893|134066|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
56281|NCT01816893|134067|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
56282|NCT01816893|134066|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
56283|NCT01816893|134067|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
56284|NCT01816893|134066|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
56285|NCT01816893|134067|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
56286|NCT01816893|134066|P2|NOT COMPLETED|Washout Period||0
56287|NCT01816893|134067|P1|NOT COMPLETED|Washout Period||2
56288|NCT01816893|134066|P2|COMPLETED|Washout Period||11
56289|NCT01816893|134067|P1|COMPLETED|Washout Period||9
56290|NCT01816893|134066|P2|STARTED|Washout Period||11
56291|NCT01816893|134067|P1|STARTED|Washout Period||11
56292|NCT01816893|134066|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
56293|NCT01816893|134067|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
56294|NCT01816893|134066|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
56295|NCT01816893|134067|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
56296|NCT01816893|134066|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
56297|NCT01816893|134067|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
56298|NCT01816776|134079|P2|NOT COMPLETED|Overall Study||8
56299|NCT01816776|134080|P1|NOT COMPLETED|Overall Study||13
56300|NCT01816776|134079|P2|COMPLETED|Overall Study||70
56301|NCT01816776|134080|P1|COMPLETED|Overall Study||60
56302|NCT01816776|134079|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
56303|NCT01816776|134080|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
56304|NCT01816776|134079|P2|STARTED|Overall Study||78
56305|NCT01816776|134080|P1|STARTED|Overall Study||73
56306|NCT01816685|134102|P2|NOT COMPLETED|Overall Study||11
56307|NCT01816685|134103|P1|NOT COMPLETED|Overall Study||10
56308|NCT01816685|134102|P2|COMPLETED|Overall Study||56
56309|NCT01816685|134103|P1|COMPLETED|Overall Study||58
56310|NCT01816685|134102|P2|STARTED|Overall Study||67
56311|NCT01816685|134103|P1|STARTED|Overall Study||68
56312|NCT01816477|134113|P2|NOT COMPLETED|Overall Study||1
56313|NCT01816477|134114|P1|NOT COMPLETED|Overall Study||16
56314|NCT01816477|134113|P2|COMPLETED|Overall Study||41
56315|NCT01816477|134114|P1|COMPLETED|Overall Study||27
56316|NCT01816477|134113|P2|STARTED|Overall Study||42
56317|NCT01816477|134114|P1|STARTED|Overall Study||43
56318|NCT01816451|134127|P3|NOT COMPLETED|Overall Study||0
56319|NCT01816451|134128|P2|NOT COMPLETED|Overall Study||0
56320|NCT01816451|134129|P1|NOT COMPLETED|Overall Study||0
56321|NCT01816451|134127|P3|COMPLETED|Overall Study||8
56322|NCT01816451|134128|P2|COMPLETED|Overall Study||11
56323|NCT01816451|134129|P1|COMPLETED|Overall Study||13
56324|NCT01816451|134127|P3|STARTED|Overall Study||8
56325|NCT01816451|134128|P2|STARTED|Overall Study||11
56326|NCT01816451|134129|P1|STARTED|Overall Study||13
56327|NCT01816295|134168|P2|NOT COMPLETED|OLE Phase||56
56328|NCT01816295|134169|P1|NOT COMPLETED|OLE Phase||53
56329|NCT01816295|134168|P2|COMPLETED|OLE Phase||227
56330|NCT01816295|134169|P1|COMPLETED|OLE Phase||222
56331|NCT01816295|134168|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
56332|NCT01816295|134169|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
56333|NCT01816295|134168|P2|NOT COMPLETED|Double Blind Phase||56
56334|NCT01816295|134169|P1|NOT COMPLETED|Double Blind Phase||63
56335|NCT01816295|134168|P2|COMPLETED|Double Blind Phase||302
56336|NCT01816295|134169|P1|COMPLETED|Double Blind Phase||294
56337|NCT01816295|134168|P2|Received Study Drug|Double Blind Phase||354
56338|NCT01816295|134169|P1|Received Study Drug|Double Blind Phase||356
56339|NCT01816295|134168|P2|STARTED|Double Blind Phase||358
56340|NCT01816295|134169|P1|STARTED|Double Blind Phase||357
56341|NCT01816243|134184|P1|NOT COMPLETED|Overall Study||12
56342|NCT01816243|134184|P1|COMPLETED|Overall Study||27
56343|NCT01816243|134184|P1|STARTED|Overall Study||39
56344|NCT01816074|134195|P4|NOT COMPLETED|Phase 2||1
56345|NCT01816074|134196|P3|NOT COMPLETED|Phase 2||0
56346|NCT01816074|134197|P2|NOT COMPLETED|Phase 2||2
56347|NCT01816074|134198|P1|NOT COMPLETED|Phase 2||2
56348|NCT01816074|134195|P4|COMPLETED|Phase 2||9
56349|NCT01816074|134196|P3|COMPLETED|Phase 2||10
56350|NCT01816074|134197|P2|COMPLETED|Phase 2||7
56351|NCT01816074|134198|P1|COMPLETED|Phase 2||9
56352|NCT01816074|134195|P4|STARTED|Phase 2||10
56353|NCT01816074|134196|P3|STARTED|Phase 2||10
56354|NCT01816074|134197|P2|STARTED|Phase 2||9
56355|NCT01816074|134198|P1|STARTED|Phase 2||11
56356|NCT01816074|134195|P4|NOT COMPLETED|Phase 1||0
56357|NCT01816074|134196|P3|NOT COMPLETED|Phase 1||1
56358|NCT01816074|134197|P2|NOT COMPLETED|Phase 1||0
56359|NCT01816074|134198|P1|NOT COMPLETED|Phase 1||0
56360|NCT01816074|134195|P4|COMPLETED|Phase 1||10
56361|NCT01816074|134196|P3|COMPLETED|Phase 1||10
56362|NCT01816074|134197|P2|COMPLETED|Phase 1||9
56363|NCT01816074|134198|P1|COMPLETED|Phase 1||11
56364|NCT01816074|134195|P4|STARTED|Phase 1||10
56365|NCT01816074|134196|P3|STARTED|Phase 1||11
56366|NCT01816074|134197|P2|STARTED|Phase 1||9
56367|NCT01816074|134198|P1|STARTED|Phase 1||11
56368|NCT01816048|134226|P1|NOT COMPLETED|Overall Study||6
56369|NCT01816048|134226|P1|COMPLETED|Overall Study||2
56370|NCT01816048|134226|P1|STARTED|Overall Study||8
56371|NCT01815918|134241|P2|NOT COMPLETED|Overall Study||19
56372|NCT01815918|134242|P1|NOT COMPLETED|Overall Study||18
56373|NCT01815918|134241|P2|COMPLETED|Overall Study||11
56374|NCT01815918|134242|P1|COMPLETED|Overall Study||12
56375|NCT01815918|134241|P2|STARTED|Overall Study||30
56376|NCT01815918|134242|P1|STARTED|Overall Study||30
56377|NCT01815840|134258|P2|NOT COMPLETED|Overall Study||63
56378|NCT01815840|134259|P1|NOT COMPLETED|Overall Study||59
56379|NCT01815840|134258|P2|COMPLETED|Overall Study||50
56380|NCT01815840|134259|P1|COMPLETED|Overall Study||57
56381|NCT01815840|134258|P2|STARTED|Overall Study||113
56382|NCT01815840|134259|P1|STARTED|Overall Study||116
56383|NCT01815736|134289|P2|NOT COMPLETED|Overall Study||478
56384|NCT01815736|134290|P1|NOT COMPLETED|Overall Study||961
56385|NCT01815736|134289|P2|COMPLETED|Overall Study||2
56386|NCT01815736|134290|P1|COMPLETED|Overall Study||2
56387|NCT01815736|134289|P2|STARTED|Overall Study||480
56388|NCT01815736|134290|P1|STARTED|Overall Study||963
56389|NCT01815671|134306|P2|NOT COMPLETED|Overall Study||0
56390|NCT01815671|134307|P1|NOT COMPLETED|Overall Study||0
56391|NCT01815671|134306|P2|COMPLETED|Overall Study||85
56392|NCT01815671|134307|P1|COMPLETED|Overall Study||88
56393|NCT01815671|134306|P2|STARTED|Overall Study||85
56394|NCT01815671|134307|P1|STARTED|Overall Study||88
56395|NCT01815645|134319|P2|NOT COMPLETED|Overall Study||0
56396|NCT01815645|134320|P1|NOT COMPLETED|Overall Study||0
56397|NCT01815645|134319|P2|COMPLETED|Overall Study||33
56398|NCT01815645|134320|P1|COMPLETED|Overall Study||32
56399|NCT01815645|134319|P2|STARTED|Overall Study||33
56400|NCT01815645|134320|P1|STARTED|Overall Study||32
56401|NCT01815138|134338|P2|NOT COMPLETED|Overall Study||6
56402|NCT01815138|134339|P1|NOT COMPLETED|Overall Study||8
56403|NCT01815138|134338|P2|COMPLETED|Overall Study||31
56404|NCT01815138|134339|P1|COMPLETED|Overall Study||26
56405|NCT01815138|134338|P2|STARTED|Overall Study||37
56406|NCT01815138|134339|P1|STARTED|Overall Study||34
56407|NCT01815099|134351|P1|NOT COMPLETED|Overall Study||2
56408|NCT01815099|134351|P1|COMPLETED|Overall Study||2
56409|NCT01815099|134351|P1|Began rTMS Treatment|Overall Study||3
56410|NCT01815099|134351|P1|STARTED|Overall Study||4
56411|NCT01815008|134356|P1|NOT COMPLETED|Overall Study||4
56412|NCT01815008|134356|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
56413|NCT01815008|134356|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
56414|NCT01814878|134365|P2|NOT COMPLETED|Overall Study||30
56415|NCT01814878|134366|P1|NOT COMPLETED|Overall Study||46
56416|NCT01814878|134365|P2|COMPLETED|Overall Study||128
56417|NCT01814878|134366|P1|COMPLETED|Overall Study||116
56418|NCT01814878|134365|P2|STARTED|Overall Study||158
56419|NCT01814878|134366|P1|STARTED|Overall Study||162
56420|NCT01814800|134386|P1|NOT COMPLETED|Overall Study||5
56421|NCT01814800|134386|P1|COMPLETED|Overall Study||54
56422|NCT01814800|134386|P1|STARTED|Overall Study||59
56423|NCT01814787|134425|P2|NOT COMPLETED|Overall Study||0
56424|NCT01814787|134426|P1|NOT COMPLETED|Overall Study||0
56425|NCT01814787|134425|P2|COMPLETED|Overall Study||684
56426|NCT01814787|134426|P1|COMPLETED|Overall Study||685
56427|NCT01814787|134425|P2|STARTED|Overall Study||684
56428|NCT01814787|134426|P1|STARTED|Overall Study||685
56429|NCT01814774|134432|P1|NOT COMPLETED|Overall Study||0
56430|NCT01814774|134432|P1|COMPLETED|Overall Study||48
56431|NCT01814774|134432|P1|STARTED|Overall Study||48
56432|NCT01814761|134446|P2|NOT COMPLETED|Overall Study||30
56433|NCT01814761|134447|P1|NOT COMPLETED|Overall Study||8
56434|NCT01814761|134446|P2|COMPLETED|Overall Study||240
56435|NCT01814761|134447|P1|COMPLETED|Overall Study||34
56436|NCT01814761|134446|P2|STARTED|Overall Study||270
56437|NCT01814761|134447|P1|STARTED|Overall Study||42
56438|NCT01814748|134461|P2|NOT COMPLETED|Overall Study||7
56439|NCT01814748|134462|P1|NOT COMPLETED|Overall Study||8
56440|NCT01814748|134461|P2|COMPLETED|Overall Study||94
56441|NCT01814748|134462|P1|COMPLETED|Overall Study||94
56442|NCT01814748|134461|P2|STARTED|Overall Study||101
56443|NCT01814748|134462|P1|STARTED|Overall Study||102
56444|NCT01814722|134485|P3|NOT COMPLETED|Overall Study||0
56445|NCT01814722|134486|P2|NOT COMPLETED|Overall Study||0
56446|NCT01814722|134487|P1|NOT COMPLETED|Overall Study||0
56447|NCT01814722|134485|P3|COMPLETED|Overall Study||6
56448|NCT01814722|134486|P2|COMPLETED|Overall Study||21
56449|NCT01814722|134487|P1|COMPLETED|Overall Study||36
56450|NCT01814722|134485|P3|STARTED|Overall Study||6
56451|NCT01814722|134486|P2|STARTED|Overall Study||21
56452|NCT01814722|134487|P1|STARTED|Overall Study||36
56453|NCT01814696|134506|P2|NOT COMPLETED|Overall Study||0
56454|NCT01814696|134507|P1|NOT COMPLETED|Overall Study||2
56455|NCT01814696|134506|P2|COMPLETED|Overall Study||11
56456|NCT01814696|134507|P1|COMPLETED|Overall Study||13
56457|NCT01814696|134506|P2|STARTED|Overall Study||11
56458|NCT01814696|134507|P1|STARTED|Overall Study||15
56459|NCT01814670|134525|P1|NOT COMPLETED|Overall Study||12
56460|NCT01814670|134525|P1|COMPLETED|Overall Study||173
56461|NCT01814670|134525|P1|STARTED|Overall Study||185
56462|NCT01814553|134535|P2|NOT COMPLETED|Overall Study||22
56463|NCT01814553|134536|P1|NOT COMPLETED|Overall Study||18
56464|NCT01814553|134535|P2|COMPLETED|Overall Study||0
56465|NCT01814553|134536|P1|COMPLETED|Overall Study||0
56466|NCT01814553|134535|P2|STARTED|Overall Study||22
56467|NCT01814553|134536|P1|STARTED|Overall Study||18
56468|NCT01814397|134550|P1|NOT COMPLETED|Overall Study||14
56469|NCT01814397|134550|P1|COMPLETED|Overall Study||36
56470|NCT01814397|134550|P1|3 Month Evaluation|Overall Study||43
56471|NCT01814397|134550|P1|STARTED|Overall Study||50
56472|NCT01814332|134559|P2|NOT COMPLETED|Overall Study||16
56473|NCT01814332|134560|P1|NOT COMPLETED|Overall Study||16
56474|NCT01814332|134559|P2|COMPLETED|Overall Study||49
56475|NCT01814332|134560|P1|COMPLETED|Overall Study||47
56476|NCT01814332|134559|P2|STARTED|Overall Study||65
56477|NCT01814332|134560|P1|STARTED|Overall Study||63
56478|NCT01814241|134572|P1|NOT COMPLETED|Overall Study||4
56479|NCT01814241|134572|P1|COMPLETED|Overall Study||16
56480|NCT01814241|134572|P1|STARTED|Overall Study||20
56481|NCT01814137|134582|P2|NOT COMPLETED|Overall Study||5
56482|NCT01814137|134583|P1|NOT COMPLETED|Overall Study||5
56483|NCT01814137|134582|P2|COMPLETED|Overall Study||15
56484|NCT01814137|134583|P1|COMPLETED|Overall Study||15
56485|NCT01814137|134582|P2|STARTED|Overall Study||20
56486|NCT01814137|134583|P1|STARTED|Overall Study||20
56487|NCT01814046|134599|P3|NOT COMPLETED|Retreatment||0
56488|NCT01814046|134600|P2|NOT COMPLETED|Retreatment||0
56489|NCT01814046|134601|P1|NOT COMPLETED|Retreatment||0
56490|NCT01814046|134599|P3|COMPLETED|Retreatment||3
56491|NCT01814046|134600|P2|COMPLETED|Retreatment||0
56492|NCT01814046|134601|P1|COMPLETED|Retreatment||0
56493|NCT01814046|134599|P3|STARTED|Retreatment||3
56494|NCT01814046|134600|P2|STARTED|Retreatment||0
56495|NCT01814046|134601|P1|STARTED|Retreatment||0
56496|NCT01814046|134599|P3|NOT COMPLETED|Drug Administration||0
56497|NCT01814046|134600|P2|NOT COMPLETED|Drug Administration||0
56498|NCT01814046|134601|P1|NOT COMPLETED|Drug Administration||1
56499|NCT01814046|134599|P3|COMPLETED|Drug Administration||0
56500|NCT01814046|134600|P2|COMPLETED|Drug Administration||2
56501|NCT01814046|134601|P1|COMPLETED|Drug Administration||21
56502|NCT01814046|134599|P3|STARTED|Drug Administration||0
56503|NCT01814046|134600|P2|STARTED|Drug Administration||2
56504|NCT01814046|134601|P1|STARTED|Drug Administration||22
56505|NCT01813890|134615|P3|NOT COMPLETED|Overall Study||6
56506|NCT01813890|134616|P2|NOT COMPLETED|Overall Study||4
56507|NCT01813890|134617|P1|NOT COMPLETED|Overall Study||9
56508|NCT01813890|134615|P3|COMPLETED|Overall Study||13
56509|NCT01813890|134616|P2|COMPLETED|Overall Study||17
56510|NCT01813890|134617|P1|COMPLETED|Overall Study||11
56511|NCT01813890|134615|P3|STARTED|Overall Study||19
56512|NCT01813890|134616|P2|STARTED|Overall Study||21
56513|NCT01813890|134617|P1|STARTED|Overall Study||20
56514|NCT01813721|134646|P1|NOT COMPLETED|Overall Study||64
56515|NCT01813721|134646|P1|COMPLETED|Overall Study||943
56516|NCT01813721|134646|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
56517|NCT01813474|134701|P3|NOT COMPLETED|Overall Study||11
56518|NCT01813474|134702|P2|NOT COMPLETED|Overall Study||7
56519|NCT01813474|134703|P1|NOT COMPLETED|Overall Study||3
56520|NCT01813474|134701|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
56521|NCT01813474|134702|P2|COMPLETED|Overall Study||0
56522|NCT01813474|134703|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
56523|NCT01813474|134701|P3|STARTED|Overall Study||12
56524|NCT01813474|134702|P2|STARTED|Overall Study||7
56525|NCT01813474|134703|P1|STARTED|Overall Study||4
56526|NCT01813422|134727|P2|NOT COMPLETED|Overall Study||16
56527|NCT01813422|134728|P1|NOT COMPLETED|Overall Study||20
56528|NCT01813422|134727|P2|COMPLETED|Overall Study||468
56529|NCT01813422|134728|P1|COMPLETED|Overall Study||466
56530|NCT01813422|134727|P2|Received Treatment|Overall Study||484
56531|NCT01813422|134728|P1|Received Treatment|Overall Study||484
56532|NCT01813422|134727|P2|STARTED|Overall Study||484
56533|NCT01813422|134728|P1|STARTED|Overall Study||486
56534|NCT01813110|134740|P2|NOT COMPLETED|Overall Study||1
56535|NCT01813110|134741|P1|NOT COMPLETED|Overall Study||0
56536|NCT01813110|134740|P2|COMPLETED|Overall Study||10
56537|NCT01813110|134741|P1|COMPLETED|Overall Study||10
56538|NCT01813110|134740|P2|STARTED|Overall Study||11
56539|NCT01813110|134741|P1|STARTED|Overall Study||10
56540|NCT01813019|134753|P2|NOT COMPLETED|Overall Study||6
56541|NCT01813019|134754|P1|NOT COMPLETED|Overall Study||7
56542|NCT01813019|134753|P2|COMPLETED|Overall Study||20
56543|NCT01813019|134754|P1|COMPLETED|Overall Study||17
56544|NCT01813019|134753|P2|STARTED|Overall Study||26
56545|NCT01813019|134754|P1|STARTED|Overall Study||24
56546|NCT01812837|134765|P3|NOT COMPLETED|Overall Study||0
56547|NCT01812837|134766|P2|NOT COMPLETED|Overall Study||1
56548|NCT01812837|134767|P1|NOT COMPLETED|Overall Study||2
56549|NCT01812837|134765|P3|COMPLETED|Overall Study||17
56550|NCT01812837|134766|P2|COMPLETED|Overall Study||16
56551|NCT01812837|134767|P1|COMPLETED|Overall Study||15
56552|NCT01812837|134765|P3|STARTED|Overall Study||17
56553|NCT01812837|134766|P2|STARTED|Overall Study||17
56554|NCT01812837|134767|P1|STARTED|Overall Study||17
56555|NCT01812707|134779|P4|NOT COMPLETED|Overall Study||2
56556|NCT01812707|134780|P3|NOT COMPLETED|Overall Study||0
56557|NCT01812707|134781|P2|NOT COMPLETED|Overall Study||0
56558|NCT01812707|134782|P1|NOT COMPLETED|Overall Study||2
56559|NCT01812707|134779|P4|COMPLETED|Overall Study||23
56560|NCT01812707|134780|P3|COMPLETED|Overall Study||25
56561|NCT01812707|134781|P2|COMPLETED|Overall Study||25
56562|NCT01812707|134782|P1|COMPLETED|Overall Study||23
56563|NCT01812707|134779|P4|Treated|Overall Study||25
56564|NCT01812707|134780|P3|Treated|Overall Study||25
56565|NCT01812707|134781|P2|Treated|Overall Study||25
56566|NCT01812707|134782|P1|Treated|Overall Study||25
56567|NCT01812707|134779|P4|STARTED|Overall Study||25
56568|NCT01812707|134780|P3|STARTED|Overall Study||25
56569|NCT01812707|134781|P2|STARTED|Overall Study||25
56570|NCT01812707|134782|P1|STARTED|Overall Study||25
56571|NCT01812681|134818|P2|NOT COMPLETED|Overall Study||0
56572|NCT01812681|134819|P1|NOT COMPLETED|Overall Study||3
56573|NCT01812681|134818|P2|COMPLETED|Overall Study||24
56574|NCT01812681|134819|P1|COMPLETED|Overall Study||57
56575|NCT01812681|134818|P2|STARTED|Overall Study||24
56576|NCT01812681|134819|P1|STARTED|Overall Study||60
56577|NCT01812655|134830|P3|NOT COMPLETED|Overall Study||0
56578|NCT01812655|134831|P2|NOT COMPLETED|Overall Study||1
56579|NCT01812655|134832|P1|NOT COMPLETED|Overall Study||1
56580|NCT01812655|134830|P3|COMPLETED|Overall Study||10
56581|NCT01812655|134831|P2|COMPLETED|Overall Study||10
56582|NCT01812655|134832|P1|COMPLETED|Overall Study||8
56583|NCT01812655|134830|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
56584|NCT01812655|134831|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
56585|NCT01812655|134832|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
56586|NCT01812473|134848|P2|NOT COMPLETED|Overall Study||0
56587|NCT01812473|134849|P1|NOT COMPLETED|Overall Study||0
56588|NCT01812473|134848|P2|COMPLETED|Overall Study||13
56589|NCT01812473|134849|P1|COMPLETED|Overall Study||22
56590|NCT01812473|134848|P2|STARTED|Overall Study||13
56591|NCT01812473|134849|P1|STARTED|Overall Study||22
56592|NCT01812057|134857|P2|NOT COMPLETED|Overall Study||0
56593|NCT01812057|134858|P1|NOT COMPLETED|Overall Study||2
56594|NCT01812057|134857|P2|COMPLETED|Overall Study||24
56595|NCT01812057|134858|P1|COMPLETED|Overall Study||23
56596|NCT01812057|134857|P2|STARTED|Overall Study||24
56597|NCT01812057|134858|P1|STARTED|Overall Study||25
56598|NCT01812044|134899|P3|NOT COMPLETED|Overall Study||0
56599|NCT01812044|134900|P2|NOT COMPLETED|Overall Study||0
56600|NCT01812044|134901|P1|NOT COMPLETED|Overall Study||0
56601|NCT01812044|134899|P3|COMPLETED|Overall Study||16
56602|NCT01812044|134900|P2|COMPLETED|Overall Study||17
56603|NCT01812044|134901|P1|COMPLETED|Overall Study||17
56604|NCT01812044|134899|P3|STARTED|Overall Study||16
56605|NCT01812044|134900|P2|STARTED|Overall Study||17
56606|NCT01812044|134901|P1|STARTED|Overall Study||17
56607|NCT01811953|134936|P6|NOT COMPLETED|Overall Study||1
56608|NCT01811953|134937|P5|NOT COMPLETED|Overall Study||1
56609|NCT01811953|134938|P4|NOT COMPLETED|Overall Study||1
56610|NCT01811953|134939|P3|NOT COMPLETED|Overall Study||0
56611|NCT01811953|134940|P2|NOT COMPLETED|Overall Study||0
56612|NCT01811953|134941|P1|NOT COMPLETED|Overall Study||0
56613|NCT01811953|134936|P6|COMPLETED|Overall Study||11
56614|NCT01811953|134937|P5|COMPLETED|Overall Study||11
56615|NCT01811953|134938|P4|COMPLETED|Overall Study||5
56616|NCT01811953|134939|P3|COMPLETED|Overall Study||6
56617|NCT01811953|134940|P2|COMPLETED|Overall Study||6
56618|NCT01811953|134941|P1|COMPLETED|Overall Study||6
56619|NCT01811953|134936|P6|STARTED|Overall Study||12
56620|NCT01811953|134937|P5|STARTED|Overall Study||12
56621|NCT01811953|134938|P4|STARTED|Overall Study||6
56622|NCT01811953|134939|P3|STARTED|Overall Study||6
56623|NCT01811953|134940|P2|STARTED|Overall Study||6
56624|NCT01811953|134941|P1|STARTED|Overall Study||6
56625|NCT01811732|134987|P2|NOT COMPLETED|Overall Study||58
56626|NCT01811732|134988|P1|NOT COMPLETED|Overall Study||55
56627|NCT01811732|134987|P2|COMPLETED|Overall Study||271
56628|NCT01811732|134988|P1|COMPLETED|Overall Study||276
56629|NCT01811732|134987|P2|STARTED|Overall Study||329
56630|NCT01811732|134988|P1|STARTED|Overall Study||331
56631|NCT01811706|134998|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
56632|NCT01811706|134999|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
56633|NCT01811706|134998|P2|COMPLETED|Second Intervention (4 Weeks)||10
56634|NCT01811706|134999|P1|COMPLETED|Second Intervention (4 Weeks)||9
56635|NCT01811706|134998|P2|STARTED|Second Intervention (4 Weeks)||10
56636|NCT01811706|134999|P1|STARTED|Second Intervention (4 Weeks)||9
56637|NCT01811706|134998|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
56638|NCT01811706|134999|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
56639|NCT01811706|134998|P2|COMPLETED|Washout ( 2 Weeks)||10
56640|NCT01811706|134999|P1|COMPLETED|Washout ( 2 Weeks)||9
56641|NCT01811706|134998|P2|STARTED|Washout ( 2 Weeks)||10
56642|NCT01811706|134999|P1|STARTED|Washout ( 2 Weeks)||9
56643|NCT01811706|134998|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
56644|NCT01811706|134999|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
56645|NCT01811706|134998|P2|COMPLETED|First Intervention ( 4 Weeks)||10
56646|NCT01811706|134999|P1|COMPLETED|First Intervention ( 4 Weeks)||9
56647|NCT01811706|134998|P2|STARTED|First Intervention ( 4 Weeks)||10
56648|NCT01811706|134999|P1|STARTED|First Intervention ( 4 Weeks)||10
56649|NCT01811680|135009|P1|NOT COMPLETED|Overall Study||0
56650|NCT01811680|135009|P1|COMPLETED|Overall Study||10
56651|NCT01811680|135009|P1|STARTED|Overall Study||10
56652|NCT01811563|135016|P2|NOT COMPLETED|Overall Study||3
56653|NCT01811563|135017|P1|NOT COMPLETED|Overall Study||5
56654|NCT01811563|135016|P2|COMPLETED|Overall Study||20
56655|NCT01811563|135017|P1|COMPLETED|Overall Study||20
56656|NCT01811563|135016|P2|STARTED|Overall Study||23
56657|NCT01811563|135017|P1|STARTED|Overall Study||25
56658|NCT01811485|135046|P3|NOT COMPLETED|Overall Study||5
56659|NCT01811485|135047|P2|NOT COMPLETED|Overall Study||4
56660|NCT01811485|135048|P1|NOT COMPLETED|Overall Study||2
56661|NCT01811485|135046|P3|COMPLETED|Overall Study||51
56662|NCT01811485|135047|P2|COMPLETED|Overall Study||55
56663|NCT01811485|135048|P1|COMPLETED|Overall Study||54
56664|NCT01811485|135046|P3|STARTED|Overall Study||56
56665|NCT01811485|135047|P2|STARTED|Overall Study||59
56666|NCT01811485|135048|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
56667|NCT01811472|135068|P3|NOT COMPLETED|Overall Study||5
56668|NCT01811472|135069|P2|NOT COMPLETED|Overall Study||0
56669|NCT01811472|135070|P1|NOT COMPLETED|Overall Study||2
56670|NCT01811472|135068|P3|COMPLETED|Overall Study||16
56671|NCT01811472|135069|P2|COMPLETED|Overall Study||11
56672|NCT01811472|135070|P1|COMPLETED|Overall Study||18
56673|NCT01811472|135068|P3|STARTED|Overall Study||21
56674|NCT01811472|135069|P2|STARTED|Overall Study||11
56675|NCT01811472|135070|P1|STARTED|Overall Study||20
56676|NCT01811355|135115|P2|NOT COMPLETED|Second Dose||0
56677|NCT01811355|135116|P1|NOT COMPLETED|Second Dose||0
56678|NCT01811355|135115|P2|COMPLETED|Second Dose||12
56679|NCT01811355|135116|P1|COMPLETED|Second Dose||9
56680|NCT01811355|135115|P2|STARTED|Second Dose||12
56681|NCT01811355|135116|P1|STARTED|Second Dose||9
56682|NCT01811355|135115|P2|NOT COMPLETED|Washout||0
56683|NCT01811355|135116|P1|NOT COMPLETED|Washout||0
56684|NCT01811355|135115|P2|COMPLETED|Washout||12
56685|NCT01811355|135116|P1|COMPLETED|Washout||9
56686|NCT01811355|135115|P2|STARTED|Washout||12
56687|NCT01811355|135116|P1|STARTED|Washout||9
56688|NCT01811355|135115|P2|NOT COMPLETED|First Dose||0
56689|NCT01811355|135116|P1|NOT COMPLETED|First Dose||2
56690|NCT01811355|135115|P2|COMPLETED|First Dose||12
56691|NCT01811355|135116|P1|COMPLETED|First Dose||9
56692|NCT01811355|135115|P2|STARTED|First Dose||12
56693|NCT01811355|135116|P1|STARTED|First Dose||11
56694|NCT01811316|135127|P3|NOT COMPLETED|Overall Study||0
56695|NCT01811316|135128|P2|NOT COMPLETED|Overall Study||0
56696|NCT01811316|135129|P1|NOT COMPLETED|Overall Study||3
56697|NCT01811316|135127|P3|COMPLETED|Overall Study||19
56698|NCT01811316|135128|P2|COMPLETED|Overall Study||22
56699|NCT01811316|135129|P1|COMPLETED|Overall Study||18
56700|NCT01811316|135127|P3|Visit 12 Weeks|Overall Study||19
56701|NCT01811316|135128|P2|Visit 12 Weeks|Overall Study||22
56702|NCT01811316|135129|P1|Visit 12 Weeks|Overall Study||18
56703|NCT01811316|135127|P3|Visit 4 Weeks|Overall Study||19
56704|NCT01811316|135128|P2|Visit 4 Weeks|Overall Study||22
56705|NCT01811316|135129|P1|Visit 4 Weeks|Overall Study||19
56706|NCT01811316|135127|P3|STARTED|Overall Study||19
56707|NCT01811316|135128|P2|STARTED|Overall Study||22
56708|NCT01811316|135129|P1|STARTED|Overall Study||21
56709|NCT01811303|135146|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
56710|NCT01811303|135147|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
56711|NCT01811303|135148|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
56712|NCT01811303|135149|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
56713|NCT01811303|135146|P4|COMPLETED|Fourth Intervention (1 Day)||2
56714|NCT01811303|135147|P3|COMPLETED|Fourth Intervention (1 Day)||4
56715|NCT01811303|135148|P2|COMPLETED|Fourth Intervention (1 Day)||4
56716|NCT01811303|135149|P1|COMPLETED|Fourth Intervention (1 Day)||4
56717|NCT01811303|135146|P4|STARTED|Fourth Intervention (1 Day)||2
56718|NCT01811303|135147|P3|STARTED|Fourth Intervention (1 Day)||4
56719|NCT01811303|135148|P2|STARTED|Fourth Intervention (1 Day)||4
56720|NCT01811303|135149|P1|STARTED|Fourth Intervention (1 Day)||4
56721|NCT01811303|135146|P4|NOT COMPLETED|Washout (2 Days or More)||0
56722|NCT01811303|135147|P3|NOT COMPLETED|Washout (2 Days or More)||0
56723|NCT01811303|135148|P2|NOT COMPLETED|Washout (2 Days or More)||0
56724|NCT01811303|135149|P1|NOT COMPLETED|Washout (2 Days or More)||0
56725|NCT01811303|135146|P4|COMPLETED|Washout (2 Days or More)||2
56726|NCT01811303|135147|P3|COMPLETED|Washout (2 Days or More)||4
56727|NCT01811303|135148|P2|COMPLETED|Washout (2 Days or More)||4
56728|NCT01811303|135149|P1|COMPLETED|Washout (2 Days or More)||4
56729|NCT01811303|135146|P4|STARTED|Washout (2 Days or More)||2
56730|NCT01811303|135147|P3|STARTED|Washout (2 Days or More)||4
56731|NCT01811303|135148|P2|STARTED|Washout (2 Days or More)||4
56732|NCT01811303|135149|P1|STARTED|Washout (2 Days or More)||4
56733|NCT01811303|135146|P4|NOT COMPLETED|Third Intervention (1 Day)||0
56734|NCT01811303|135147|P3|NOT COMPLETED|Third Intervention (1 Day)||0
56735|NCT01811303|135148|P2|NOT COMPLETED|Third Intervention (1 Day)||0
56736|NCT01811303|135149|P1|NOT COMPLETED|Third Intervention (1 Day)||0
56737|NCT01811303|135146|P4|COMPLETED|Third Intervention (1 Day)||2
56738|NCT01811303|135147|P3|COMPLETED|Third Intervention (1 Day)||4
56739|NCT01811303|135148|P2|COMPLETED|Third Intervention (1 Day)||4
56740|NCT01811303|135149|P1|COMPLETED|Third Intervention (1 Day)||4
56741|NCT01811303|135146|P4|STARTED|Third Intervention (1 Day)||2
56742|NCT01811303|135147|P3|STARTED|Third Intervention (1 Day)||4
56743|NCT01811303|135148|P2|STARTED|Third Intervention (1 Day)||4
56744|NCT01811303|135149|P1|STARTED|Third Intervention (1 Day)||4
56745|NCT01811303|135146|P4|NOT COMPLETED|Washout (2 Days or More)||0
56746|NCT01811303|135147|P3|NOT COMPLETED|Washout (2 Days or More)||0
56747|NCT01811303|135148|P2|NOT COMPLETED|Washout (2 Days or More)||0
56748|NCT01811303|135149|P1|NOT COMPLETED|Washout (2 Days or More)||0
56749|NCT01811303|135146|P4|COMPLETED|Washout (2 Days or More)||2
56750|NCT01811303|135147|P3|COMPLETED|Washout (2 Days or More)||4
56751|NCT01811303|135148|P2|COMPLETED|Washout (2 Days or More)||4
56752|NCT01811303|135149|P1|COMPLETED|Washout (2 Days or More)||4
56753|NCT01811303|135146|P4|STARTED|Washout (2 Days or More)||2
56754|NCT01811303|135147|P3|STARTED|Washout (2 Days or More)||4
56755|NCT01811303|135148|P2|STARTED|Washout (2 Days or More)||4
56756|NCT01811303|135149|P1|STARTED|Washout (2 Days or More)||4
56757|NCT01811303|135146|P4|NOT COMPLETED|Second Intervention (1 Day)||0
56758|NCT01811303|135147|P3|NOT COMPLETED|Second Intervention (1 Day)||0
56759|NCT01811303|135148|P2|NOT COMPLETED|Second Intervention (1 Day)||0
56760|NCT01811303|135149|P1|NOT COMPLETED|Second Intervention (1 Day)||0
56761|NCT01811303|135146|P4|COMPLETED|Second Intervention (1 Day)||2
56762|NCT01811303|135147|P3|COMPLETED|Second Intervention (1 Day)||4
56763|NCT01811303|135148|P2|COMPLETED|Second Intervention (1 Day)||4
56764|NCT01811303|135149|P1|COMPLETED|Second Intervention (1 Day)||4
56765|NCT01811303|135146|P4|STARTED|Second Intervention (1 Day)||2
56766|NCT01811303|135147|P3|STARTED|Second Intervention (1 Day)||4
56767|NCT01811303|135148|P2|STARTED|Second Intervention (1 Day)||4
56768|NCT01811303|135149|P1|STARTED|Second Intervention (1 Day)||4
56769|NCT01811303|135146|P4|NOT COMPLETED|Washout (2 Days or More)||0
56770|NCT01811303|135147|P3|NOT COMPLETED|Washout (2 Days or More)||0
56771|NCT01811303|135148|P2|NOT COMPLETED|Washout (2 Days or More)||0
56772|NCT01811303|135149|P1|NOT COMPLETED|Washout (2 Days or More)||0
56773|NCT01811303|135146|P4|COMPLETED|Washout (2 Days or More)||2
56774|NCT01811303|135147|P3|COMPLETED|Washout (2 Days or More)||4
56775|NCT01811303|135148|P2|COMPLETED|Washout (2 Days or More)||4
56776|NCT01811303|135149|P1|COMPLETED|Washout (2 Days or More)||4
56777|NCT01811303|135146|P4|STARTED|Washout (2 Days or More)||2
56778|NCT01811303|135147|P3|STARTED|Washout (2 Days or More)||4
56779|NCT01811303|135148|P2|STARTED|Washout (2 Days or More)||4
56780|NCT01811303|135149|P1|STARTED|Washout (2 Days or More)||4
56781|NCT01811303|135146|P4|NOT COMPLETED|First Intervention (1 Day)||0
56782|NCT01811303|135147|P3|NOT COMPLETED|First Intervention (1 Day)||0
56783|NCT01811303|135148|P2|NOT COMPLETED|First Intervention (1 Day)||0
56784|NCT01811303|135149|P1|NOT COMPLETED|First Intervention (1 Day)||0
56785|NCT01811303|135146|P4|COMPLETED|First Intervention (1 Day)||2
56786|NCT01811303|135147|P3|COMPLETED|First Intervention (1 Day)||4
56787|NCT01811303|135148|P2|COMPLETED|First Intervention (1 Day)||4
56788|NCT01811303|135149|P1|COMPLETED|First Intervention (1 Day)||4
56789|NCT01811303|135146|P4|STARTED|First Intervention (1 Day)||2
56790|NCT01811303|135147|P3|STARTED|First Intervention (1 Day)||4
56791|NCT01811303|135148|P2|STARTED|First Intervention (1 Day)||4
56792|NCT01811303|135149|P1|STARTED|First Intervention (1 Day)||4
56793|NCT01811238|135157|P1|NOT COMPLETED|Overall Study||81
56794|NCT01811238|135157|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
56795|NCT01811238|135157|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
56796|NCT01811238|135157|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
56797|NCT01811238|135157|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
56798|NCT01811238|135157|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
56799|NCT01811212|135166|P1|NOT COMPLETED|Overall Study||0
56800|NCT01811212|135166|P1|COMPLETED|Overall Study||25
56801|NCT01811212|135166|P1|STARTED|Overall Study||25
56802|NCT01811186|135181|P2|NOT COMPLETED|Overall Study||62
56803|NCT01811186|135182|P1|NOT COMPLETED|Overall Study||71
56804|NCT01811186|135181|P2|COMPLETED|Overall Study||64
56805|NCT01811186|135182|P1|COMPLETED|Overall Study||61
56806|NCT01811186|135181|P2|STARTED|Overall Study||126
56807|NCT01811186|135182|P1|STARTED|Overall Study||132
56808|NCT01810952|135200|P2|NOT COMPLETED|Overall Study||0
56809|NCT01810952|135201|P1|NOT COMPLETED|Overall Study||0
56810|NCT01810952|135200|P2|COMPLETED|Overall Study||17
56811|NCT01810952|135201|P1|COMPLETED|Overall Study||20
56812|NCT01810952|135200|P2|STARTED|Overall Study||17
56813|NCT01810952|135201|P1|STARTED|Overall Study||20
56814|NCT01810939|135215|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
56815|NCT01810939|135216|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
56816|NCT01810939|135217|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
56817|NCT01810939|135215|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
56818|NCT01810939|135216|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
56819|NCT01810939|135217|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
56820|NCT01810939|135215|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
56821|NCT01810939|135216|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
56822|NCT01810939|135217|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
56823|NCT01810939|135215|P3|NOT COMPLETED|Part A Treatment Period||0
56824|NCT01810939|135216|P2|NOT COMPLETED|Part A Treatment Period||0
56825|NCT01810939|135217|P1|NOT COMPLETED|Part A Treatment Period||24
56826|NCT01810939|135215|P3|COMPLETED|Part A Treatment Period||0
56827|NCT01810939|135216|P2|COMPLETED|Part A Treatment Period||0
56828|NCT01810939|135217|P1|COMPLETED|Part A Treatment Period||219
56829|NCT01810939|135215|P3|STARTED|Part A Treatment Period||0
56830|NCT01810939|135216|P2|STARTED|Part A Treatment Period||0
56831|NCT01810939|135217|P1|STARTED|Part A Treatment Period||243
56832|NCT01810783|135230|P1|NOT COMPLETED|Overall Study||109
56833|NCT01810783|135230|P1|COMPLETED|Overall Study||101
56834|NCT01810783|135230|P1|STARTED|Overall Study||210
56835|NCT01810692|135236|P2|NOT COMPLETED|Overall Study||0
56836|NCT01810692|135237|P1|NOT COMPLETED|Overall Study||0
56837|NCT01810692|135236|P2|COMPLETED|Overall Study||77
56838|NCT01810692|135237|P1|COMPLETED|Overall Study||77
56839|NCT01810692|135236|P2|STARTED|Overall Study||77
56840|NCT01810692|135237|P1|STARTED|Overall Study||77
56841|NCT01810666|135249|P1|NOT COMPLETED|Overall Study||0
56842|NCT01810666|135249|P1|COMPLETED|Overall Study||30
56843|NCT01810666|135249|P1|STARTED|Overall Study||30
56844|NCT01810380|135258|P3|NOT COMPLETED|Overall Study||32
56845|NCT01810380|135259|P2|NOT COMPLETED|Overall Study||38
56846|NCT01810380|135260|P1|NOT COMPLETED|Overall Study||55
56847|NCT01810380|135258|P3|COMPLETED|Overall Study||122
56848|NCT01810380|135259|P2|COMPLETED|Overall Study||113
56849|NCT01810380|135260|P1|COMPLETED|Overall Study||108
56850|NCT01810380|135258|P3|Treated|Overall Study||153
56851|NCT01810380|135259|P2|Treated|Overall Study||150
56852|NCT01810380|135260|P1|Treated|Overall Study||161
56853|NCT01810380|135258|P3|STARTED|Overall Study||154
56854|NCT01810380|135259|P2|STARTED|Overall Study||151
56855|NCT01810380|135260|P1|STARTED|Overall Study||163
56856|NCT01810302|135321|P2|NOT COMPLETED|Overall Study||1
56857|NCT01810302|135322|P1|NOT COMPLETED|Overall Study||1
56858|NCT01810302|135321|P2|COMPLETED|Overall Study||0
56859|NCT01810302|135322|P1|COMPLETED|Overall Study||0
56860|NCT01810302|135321|P2|STARTED|Overall Study||1
56861|NCT01810302|135322|P1|STARTED|Overall Study||1
56862|NCT01810289|135332|P2|NOT COMPLETED|Overall Study||0
56863|NCT01810289|135333|P1|NOT COMPLETED|Overall Study||0
56864|NCT01810289|135332|P2|COMPLETED|Overall Study||4747
56865|NCT01810289|135333|P1|COMPLETED|Overall Study||7277
56866|NCT01810289|135332|P2|STARTED|Overall Study||4747
56867|NCT01810289|135333|P1|STARTED|Overall Study||7277
56868|NCT01810263|135341|P2|NOT COMPLETED|Overall Study||7
56869|NCT01810263|135342|P1|NOT COMPLETED|Overall Study||8
56870|NCT01810263|135341|P2|COMPLETED|Overall Study||11
56871|NCT01810263|135342|P1|COMPLETED|Overall Study|2014 July|8
56872|NCT01810263|135341|P2|STARTED|Overall Study||18
56873|NCT01810263|135342|P1|STARTED|Overall Study||16
56874|NCT01810042|135348|P1|NOT COMPLETED|Overall Study||10
56875|NCT01810042|135348|P1|COMPLETED|Overall Study||39
56876|NCT01810042|135348|P1|STARTED|Overall Study||49
56877|NCT01809938|135355|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
56878|NCT01809938|135356|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
56879|NCT01809938|135355|P2|COMPLETED|Second Intervention (170 Minutes)||5
56880|NCT01809938|135356|P1|COMPLETED|Second Intervention (170 Minutes)||5
56881|NCT01809938|135355|P2|STARTED|Second Intervention (170 Minutes)||5
56882|NCT01809938|135356|P1|STARTED|Second Intervention (170 Minutes)||5
56883|NCT01809938|135355|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
56884|NCT01809938|135356|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
56885|NCT01809938|135355|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
56886|NCT01809938|135356|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
56887|NCT01809938|135355|P2|STARTED|Washout (Not Less Than 24 Hours)||5
56888|NCT01809938|135356|P1|STARTED|Washout (Not Less Than 24 Hours)||5
56889|NCT01809938|135355|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
56890|NCT01809938|135356|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
56891|NCT01809938|135355|P2|COMPLETED|First Intervention (170 Minutes)||5
56892|NCT01809938|135356|P1|COMPLETED|First Intervention (170 Minutes)||5
56893|NCT01809938|135355|P2|STARTED|First Intervention (170 Minutes)||5
56894|NCT01809938|135356|P1|STARTED|First Intervention (170 Minutes)||5
56895|NCT01809899|135365|P2|NOT COMPLETED|Overall Study||0
56896|NCT01809899|135366|P1|NOT COMPLETED|Overall Study||0
56897|NCT01809899|135365|P2|COMPLETED|Overall Study||4
56898|NCT01809899|135366|P1|COMPLETED|Overall Study||8
56899|NCT01809899|135365|P2|STARTED|Overall Study||4
56900|NCT01809899|135366|P1|STARTED|Overall Study||8
56901|NCT01809834|135374|P1|NOT COMPLETED|Overall Study||0
56902|NCT01809834|135374|P1|COMPLETED|Overall Study||44
56903|NCT01809834|135374|P1|STARTED|Overall Study||44
56904|NCT01809639|135402|P2|NOT COMPLETED|Overall Study||0
56905|NCT01809639|135403|P1|NOT COMPLETED|Overall Study||0
56906|NCT01809639|135402|P2|COMPLETED|Overall Study||7
56907|NCT01809639|135403|P1|COMPLETED|Overall Study||18
56908|NCT01809639|135402|P2|STARTED|Overall Study||7
56909|NCT01809639|135403|P1|STARTED|Overall Study||18
56910|NCT01809327|135414|P5|NOT COMPLETED|Overall Study||25
56911|NCT01809327|135415|P4|NOT COMPLETED|Overall Study||12
56912|NCT01809327|135416|P3|NOT COMPLETED|Overall Study||22
56913|NCT01809327|135417|P2|NOT COMPLETED|Overall Study||26
56914|NCT01809327|135418|P1|NOT COMPLETED|Overall Study||32
56915|NCT01809327|135414|P5|COMPLETED|Overall Study||212
56916|NCT01809327|135415|P4|COMPLETED|Overall Study||225
56917|NCT01809327|135416|P3|COMPLETED|Overall Study||216
56918|NCT01809327|135417|P2|COMPLETED|Overall Study||211
56919|NCT01809327|135418|P1|COMPLETED|Overall Study||205
56920|NCT01809327|135414|P5|STARTED|Overall Study||237
56921|NCT01809327|135415|P4|STARTED|Overall Study||237
56922|NCT01809327|135416|P3|STARTED|Overall Study||238
56923|NCT01809327|135417|P2|STARTED|Overall Study||237
56924|NCT01809327|135418|P1|STARTED|Overall Study||237
56925|NCT01809314|135460|P1|NOT COMPLETED|Overall Study||745
56926|NCT01809314|135460|P1|COMPLETED|Overall Study||422
56927|NCT01809314|135460|P1|STARTED|Overall Study||1167
56928|NCT01809262|135466|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56929|NCT01809262|135467|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56930|NCT01809262|135468|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56931|NCT01809262|135469|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56932|NCT01809262|135470|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56933|NCT01809262|135471|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56934|NCT01809262|135472|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56935|NCT01809262|135473|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56936|NCT01809262|135474|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56937|NCT01809262|135475|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
56938|NCT01809262|135466|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
56939|NCT01809262|135467|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
56940|NCT01809262|135468|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
56941|NCT01809262|135469|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
56942|NCT01809262|135470|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
56943|NCT01809262|135471|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
56944|NCT01809262|135472|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
56945|NCT01809262|135473|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
56946|NCT01809262|135474|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
56947|NCT01809262|135475|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
56948|NCT01809262|135466|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
56949|NCT01809262|135467|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
56950|NCT01809262|135468|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
56951|NCT01809262|135469|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
56952|NCT01809262|135470|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
56953|NCT01809262|135471|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
56954|NCT01809262|135472|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
56955|NCT01809262|135473|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
56956|NCT01809262|135474|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
56957|NCT01809262|135475|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
56958|NCT01809262|135466|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56959|NCT01809262|135467|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56960|NCT01809262|135468|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56961|NCT01809262|135469|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56962|NCT01809262|135470|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56963|NCT01809262|135471|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56964|NCT01809262|135472|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56965|NCT01809262|135473|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56966|NCT01809262|135474|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56967|NCT01809262|135475|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
56968|NCT01809262|135466|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
56969|NCT01809262|135467|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
56970|NCT01809262|135468|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
56971|NCT01809262|135469|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
56972|NCT01809262|135470|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
56973|NCT01809262|135471|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
56974|NCT01809262|135472|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
56975|NCT01809262|135473|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
56976|NCT01809262|135474|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
56977|NCT01809262|135475|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
56978|NCT01809262|135466|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
56979|NCT01809262|135467|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
56980|NCT01809262|135468|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
56981|NCT01809262|135469|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
56982|NCT01809262|135470|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
56983|NCT01809262|135471|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
56984|NCT01809262|135472|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
56985|NCT01809262|135473|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
56986|NCT01809262|135474|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
56987|NCT01809262|135475|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
56988|NCT01809262|135466|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56989|NCT01809262|135467|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56990|NCT01809262|135468|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56991|NCT01809262|135469|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56992|NCT01809262|135470|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56993|NCT01809262|135471|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56994|NCT01809262|135472|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56995|NCT01809262|135473|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56996|NCT01809262|135474|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
56997|NCT01809262|135475|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
56998|NCT01809262|135466|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
56999|NCT01809262|135467|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
57000|NCT01809262|135468|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
57001|NCT01809262|135469|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
57002|NCT01809262|135470|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
57003|NCT01809262|135471|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
57004|NCT01809262|135472|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
57005|NCT01809262|135473|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
57006|NCT01809262|135474|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
57007|NCT01809262|135475|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
57008|NCT01809262|135466|P10|STARTED|Period 3 (Third Dose + Washout)||4
57009|NCT01809262|135467|P9|STARTED|Period 3 (Third Dose + Washout)||3
57010|NCT01809262|135468|P8|STARTED|Period 3 (Third Dose + Washout)||4
57011|NCT01809262|135469|P7|STARTED|Period 3 (Third Dose + Washout)||3
57012|NCT01809262|135470|P6|STARTED|Period 3 (Third Dose + Washout)||3
57013|NCT01809262|135471|P5|STARTED|Period 3 (Third Dose + Washout)||3
57014|NCT01809262|135472|P4|STARTED|Period 3 (Third Dose + Washout)||3
57015|NCT01809262|135473|P3|STARTED|Period 3 (Third Dose + Washout)||4
57016|NCT01809262|135474|P2|STARTED|Period 3 (Third Dose + Washout)||4
57017|NCT01809262|135475|P1|STARTED|Period 3 (Third Dose + Washout)||4
57018|NCT01809262|135466|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57019|NCT01809262|135467|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57020|NCT01809262|135468|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57021|NCT01809262|135469|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57022|NCT01809262|135470|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57023|NCT01809262|135471|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57024|NCT01809262|135472|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57025|NCT01809262|135473|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57026|NCT01809262|135474|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57027|NCT01809262|135475|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
57028|NCT01809262|135466|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
57029|NCT01809262|135467|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
57030|NCT01809262|135468|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
57031|NCT01809262|135469|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
57032|NCT01809262|135470|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
57033|NCT01809262|135471|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
57034|NCT01809262|135472|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
57035|NCT01809262|135473|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
57036|NCT01809262|135474|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
57037|NCT01809262|135475|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
57038|NCT01809262|135466|P10|STARTED|Period 2 (Second Dose + Washout)||4
57039|NCT01809262|135467|P9|STARTED|Period 2 (Second Dose + Washout)||3
57040|NCT01809262|135468|P8|STARTED|Period 2 (Second Dose + Washout)||4
57041|NCT01809262|135469|P7|STARTED|Period 2 (Second Dose + Washout)||3
57042|NCT01809262|135470|P6|STARTED|Period 2 (Second Dose + Washout)||3
57043|NCT01809262|135471|P5|STARTED|Period 2 (Second Dose + Washout)||3
57044|NCT01809262|135472|P4|STARTED|Period 2 (Second Dose + Washout)||3
57045|NCT01809262|135473|P3|STARTED|Period 2 (Second Dose + Washout)||4
57046|NCT01809262|135474|P2|STARTED|Period 2 (Second Dose + Washout)||4
57047|NCT01809262|135475|P1|STARTED|Period 2 (Second Dose + Washout)||4
57048|NCT01809262|135466|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57049|NCT01809262|135467|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57050|NCT01809262|135468|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57051|NCT01809262|135469|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57052|NCT01809262|135470|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57053|NCT01809262|135471|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
57054|NCT01809262|135472|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57055|NCT01809262|135473|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57056|NCT01809262|135474|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57057|NCT01809262|135475|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
57058|NCT01809262|135466|P10|COMPLETED|Period 1 (First Dose + Washout)||4
57059|NCT01809262|135467|P9|COMPLETED|Period 1 (First Dose + Washout)||3
57060|NCT01809262|135468|P8|COMPLETED|Period 1 (First Dose + Washout)||4
57061|NCT01809262|135469|P7|COMPLETED|Period 1 (First Dose + Washout)||3
57062|NCT01809262|135470|P6|COMPLETED|Period 1 (First Dose + Washout)||3
57063|NCT01809262|135471|P5|COMPLETED|Period 1 (First Dose + Washout)||3
57064|NCT01809262|135472|P4|COMPLETED|Period 1 (First Dose + Washout)||3
57065|NCT01809262|135473|P3|COMPLETED|Period 1 (First Dose + Washout)||4
57066|NCT01809262|135474|P2|COMPLETED|Period 1 (First Dose + Washout)||4
57067|NCT01809262|135475|P1|COMPLETED|Period 1 (First Dose + Washout)||4
57068|NCT01809262|135466|P10|STARTED|Period 1 (First Dose + Washout)||4
57069|NCT01809262|135467|P9|STARTED|Period 1 (First Dose + Washout)||3
57070|NCT01809262|135468|P8|STARTED|Period 1 (First Dose + Washout)||4
57071|NCT01809262|135469|P7|STARTED|Period 1 (First Dose + Washout)||3
57072|NCT01809262|135470|P6|STARTED|Period 1 (First Dose + Washout)||3
57073|NCT01809262|135471|P5|STARTED|Period 1 (First Dose + Washout)||4
57074|NCT01809262|135472|P4|STARTED|Period 1 (First Dose + Washout)||3
57075|NCT01809262|135473|P3|STARTED|Period 1 (First Dose + Washout)||4
57076|NCT01809262|135474|P2|STARTED|Period 1 (First Dose + Washout)||4
57077|NCT01809262|135475|P1|STARTED|Period 1 (First Dose + Washout)||4
57078|NCT01809210|135549|P7|NOT COMPLETED|Overall Study||5
57079|NCT01809210|135550|P6|NOT COMPLETED|Overall Study||3
57080|NCT01809210|135551|P5|NOT COMPLETED|Overall Study||2
57081|NCT01809210|135552|P4|NOT COMPLETED|Overall Study||1
57082|NCT01809210|135553|P3|NOT COMPLETED|Overall Study||3
57083|NCT01809210|135554|P2|NOT COMPLETED|Overall Study||1
57084|NCT01809210|135555|P1|NOT COMPLETED|Overall Study||1
57085|NCT01809210|135549|P7|COMPLETED|Overall Study||7
57086|NCT01809210|135550|P6|COMPLETED|Overall Study||12
57087|NCT01809210|135551|P5|COMPLETED|Overall Study||4
57088|NCT01809210|135552|P4|COMPLETED|Overall Study||2
57089|NCT01809210|135553|P3|COMPLETED|Overall Study||4
57090|NCT01809210|135554|P2|COMPLETED|Overall Study||8
57091|NCT01809210|135555|P1|COMPLETED|Overall Study||2
57092|NCT01809210|135549|P7|STARTED|Overall Study||12
57093|NCT01809210|135550|P6|STARTED|Overall Study||15
57094|NCT01809210|135551|P5|STARTED|Overall Study||6
57095|NCT01809210|135552|P4|STARTED|Overall Study||3
57096|NCT01809210|135553|P3|STARTED|Overall Study||7
57097|NCT01809210|135554|P2|STARTED|Overall Study||9
57098|NCT01809210|135555|P1|STARTED|Overall Study||3
57099|NCT01809197|135629|P2|NOT COMPLETED|Overall Study||8
57100|NCT01809197|135630|P1|NOT COMPLETED|Overall Study||10
57101|NCT01809197|135629|P2|COMPLETED|Overall Study||177
57102|NCT01809197|135630|P1|COMPLETED|Overall Study||177
57103|NCT01809197|135629|P2|STARTED|Overall Study||185
57104|NCT01809197|135630|P1|STARTED|Overall Study||187
57105|NCT01809106|135640|P4|NOT COMPLETED|Overall Study||4
57106|NCT01809106|135641|P3|NOT COMPLETED|Overall Study||3
57107|NCT01809106|135642|P2|NOT COMPLETED|Overall Study||5
57108|NCT01809106|135643|P1|NOT COMPLETED|Overall Study||8
57109|NCT01809106|135640|P4|COMPLETED|Overall Study||124
57110|NCT01809106|135641|P3|COMPLETED|Overall Study||127
57111|NCT01809106|135642|P2|COMPLETED|Overall Study||125
57112|NCT01809106|135643|P1|COMPLETED|Overall Study||122
57113|NCT01809106|135640|P4|STARTED|Overall Study||128
57114|NCT01809106|135641|P3|STARTED|Overall Study||130
57115|NCT01809106|135642|P2|STARTED|Overall Study||130
57116|NCT01809106|135643|P1|STARTED|Overall Study||130
57117|NCT01809054|135663|P2|NOT COMPLETED|Overall Study||0
57118|NCT01809054|135664|P1|NOT COMPLETED|Overall Study||0
57119|NCT01809054|135663|P2|COMPLETED|Overall Study||22
57120|NCT01809054|135664|P1|COMPLETED|Overall Study||27
57121|NCT01809054|135663|P2|STARTED|Overall Study||22
57122|NCT01809054|135664|P1|STARTED|Overall Study||27
57123|NCT01808963|135672|P1|NOT COMPLETED|Overall Study||0
57124|NCT01808963|135672|P1|COMPLETED|Overall Study||13
57125|NCT01808963|135672|P1|STARTED|Overall Study||13
57126|NCT01808950|135679|P3|NOT COMPLETED|Overall Study||0
57127|NCT01808950|135680|P2|NOT COMPLETED|Overall Study||0
57128|NCT01808950|135681|P1|NOT COMPLETED|Overall Study||0
57129|NCT01808950|135679|P3|COMPLETED|Overall Study||0
57130|NCT01808950|135680|P2|COMPLETED|Overall Study||3
57131|NCT01808950|135681|P1|COMPLETED|Overall Study||1
57132|NCT01808950|135679|P3|STARTED|Overall Study||0
57133|NCT01808950|135680|P2|STARTED|Overall Study||3
57134|NCT01808950|135681|P1|STARTED|Overall Study||1
57135|NCT01808755|135692|P2|NOT COMPLETED|Overall Study||0
57136|NCT01808755|135693|P1|NOT COMPLETED|Overall Study||0
57137|NCT01808755|135692|P2|COMPLETED|Overall Study||30
57138|NCT01808755|135693|P1|COMPLETED|Overall Study||30
57139|NCT01808755|135692|P2|STARTED|Overall Study||30
57140|NCT01808755|135693|P1|STARTED|Overall Study||30
57141|NCT01808651|135701|P3|NOT COMPLETED|Study Period 2||0
57142|NCT01808651|135702|P2|NOT COMPLETED|Study Period 2||0
57143|NCT01808651|135703|P1|NOT COMPLETED|Study Period 2||0
57144|NCT01808651|135701|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
57145|NCT01808651|135702|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
57146|NCT01808651|135703|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
57147|NCT01808651|135701|P3|STARTED|Study Period 2||33
57148|NCT01808651|135702|P2|STARTED|Study Period 2||52
57149|NCT01808651|135703|P1|STARTED|Study Period 2||77
57150|NCT01808651|135701|P3|NOT COMPLETED|Study Period 1||5
57151|NCT01808651|135702|P2|NOT COMPLETED|Study Period 1||17
57152|NCT01808651|135703|P1|NOT COMPLETED|Study Period 1||26
57153|NCT01808651|135701|P3|COMPLETED|Study Period 1||31
57154|NCT01808651|135702|P2|COMPLETED|Study Period 1||48
57155|NCT01808651|135703|P1|COMPLETED|Study Period 1||73
57156|NCT01808651|135701|P3|Received at Least One Dose of Study Drug|Study Period 1||36
57157|NCT01808651|135702|P2|Received at Least One Dose of Study Drug|Study Period 1||65
57158|NCT01808651|135703|P1|Received at Least One Dose of Study Drug|Study Period 1||98
57159|NCT01808651|135701|P3|STARTED|Study Period 1||36
57160|NCT01808651|135702|P2|STARTED|Study Period 1||65
57161|NCT01808651|135703|P1|STARTED|Study Period 1||99
57162|NCT01808612|135738|P3|NOT COMPLETED|Discontinuation Period||0
57163|NCT01808612|135739|P2|NOT COMPLETED|Discontinuation Period||1
57164|NCT01808612|135740|P1|NOT COMPLETED|Discontinuation Period||2
57165|NCT01808612|135738|P3|COMPLETED|Discontinuation Period||145
57166|NCT01808612|135739|P2|COMPLETED|Discontinuation Period||37
57167|NCT01808612|135740|P1|COMPLETED|Discontinuation Period||85
57168|NCT01808612|135738|P3|STARTED|Discontinuation Period||145
57169|NCT01808612|135739|P2|STARTED|Discontinuation Period||38
57170|NCT01808612|135740|P1|STARTED|Discontinuation Period||87
57171|NCT01808612|135738|P3|NOT COMPLETED|Treatment Period||14
57172|NCT01808612|135739|P2|NOT COMPLETED|Treatment Period||7
57173|NCT01808612|135740|P1|NOT COMPLETED|Treatment Period||15
57174|NCT01808612|135738|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
57175|NCT01808612|135739|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
57176|NCT01808612|135740|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
57177|NCT01808612|135738|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
57178|NCT01808612|135739|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
57179|NCT01808612|135740|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
57180|NCT01808612|135738|P3|STARTED|Treatment Period||260
57181|NCT01808612|135739|P2|STARTED|Treatment Period||84
57182|NCT01808612|135740|P1|STARTED|Treatment Period||169
57183|NCT01808560|135772|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
57184|NCT01808560|135773|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
57185|NCT01808560|135774|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
57186|NCT01808560|135772|P3|COMPLETED|4-Month After Cataract Surgery||13
57187|NCT01808560|135773|P2|COMPLETED|4-Month After Cataract Surgery||0
57188|NCT01808560|135774|P1|COMPLETED|4-Month After Cataract Surgery||0
57189|NCT01808560|135772|P3|STARTED|4-Month After Cataract Surgery||13
57190|NCT01808560|135773|P2|STARTED|4-Month After Cataract Surgery||0
57191|NCT01808560|135774|P1|STARTED|4-Month After Cataract Surgery||0
57192|NCT01808560|135772|P3|NOT COMPLETED|Crossover Treatment||0
57193|NCT01808560|135773|P2|NOT COMPLETED|Crossover Treatment||0
57194|NCT01808560|135774|P1|NOT COMPLETED|Crossover Treatment||0
57195|NCT01808560|135772|P3|COMPLETED|Crossover Treatment||13
57196|NCT01808560|135773|P2|COMPLETED|Crossover Treatment||0
57197|NCT01808560|135774|P1|COMPLETED|Crossover Treatment||0
57198|NCT01808560|135772|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
57199|NCT01808560|135773|P2|STARTED|Crossover Treatment||0
57200|NCT01808560|135774|P1|STARTED|Crossover Treatment||0
57201|NCT01808560|135772|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
57202|NCT01808560|135773|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
57203|NCT01808560|135774|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
57204|NCT01808560|135772|P3|COMPLETED|3-Month After Cataract Surgery||0
57205|NCT01808560|135773|P2|COMPLETED|3-Month After Cataract Surgery||13
57206|NCT01808560|135774|P1|COMPLETED|3-Month After Cataract Surgery||17
57207|NCT01808560|135772|P3|STARTED|3-Month After Cataract Surgery||0
57208|NCT01808560|135773|P2|STARTED|3-Month After Cataract Surgery||13
57209|NCT01808560|135774|P1|STARTED|3-Month After Cataract Surgery||17
57210|NCT01808560|135772|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
57211|NCT01808560|135773|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
57212|NCT01808560|135774|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
57213|NCT01808560|135772|P3|COMPLETED|1-Month After Cataract Surgery||0
57214|NCT01808560|135773|P2|COMPLETED|1-Month After Cataract Surgery||13
57215|NCT01808560|135774|P1|COMPLETED|1-Month After Cataract Surgery||16
57216|NCT01808560|135772|P3|STARTED|1-Month After Cataract Surgery||0
57217|NCT01808560|135773|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
57218|NCT01808560|135774|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
57219|NCT01808560|135772|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
57220|NCT01808560|135773|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
57221|NCT01808560|135774|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
57222|NCT01808560|135772|P3|COMPLETED|Randomization and Treatment Allocation||0
57223|NCT01808560|135773|P2|COMPLETED|Randomization and Treatment Allocation||16
57224|NCT01808560|135774|P1|COMPLETED|Randomization and Treatment Allocation||18
57225|NCT01808560|135772|P3|STARTED|Randomization and Treatment Allocation||0
57226|NCT01808560|135773|P2|STARTED|Randomization and Treatment Allocation||16
57227|NCT01808560|135774|P1|STARTED|Randomization and Treatment Allocation||18
57228|NCT01808547|135799|P2|NOT COMPLETED|Overall Study||46
57229|NCT01808547|135800|P1|NOT COMPLETED|Overall Study||37
57230|NCT01808547|135799|P2|COMPLETED|Overall Study||48
57231|NCT01808547|135800|P1|COMPLETED|Overall Study||137
57232|NCT01808547|135799|P2|mITT Population|Overall Study||85
57233|NCT01808547|135800|P1|mITT Population|Overall Study||168
57234|NCT01808547|135799|P2|Safety Population|Overall Study||85
57235|NCT01808547|135800|P1|Safety Population|Overall Study||170
57236|NCT01808547|135799|P2|STARTED|Overall Study||94
57237|NCT01808547|135800|P1|STARTED|Overall Study||174
57238|NCT01808534|135806|P1|NOT COMPLETED|Overall Study||4
57239|NCT01808534|135806|P1|COMPLETED|Overall Study||1
57240|NCT01808534|135806|P1|STARTED|Overall Study||5
57241|NCT01808508|135817|P3|NOT COMPLETED|Overall Study||0
57242|NCT01808508|135818|P2|NOT COMPLETED|Overall Study||0
57243|NCT01808508|135819|P1|NOT COMPLETED|Overall Study||1
57244|NCT01808508|135817|P3|COMPLETED|Overall Study||3
57245|NCT01808508|135818|P2|COMPLETED|Overall Study||9
57246|NCT01808508|135819|P1|COMPLETED|Overall Study||10
57247|NCT01808508|135817|P3|STARTED|Overall Study||3
57248|NCT01808508|135818|P2|STARTED|Overall Study||9
57249|NCT01808508|135819|P1|STARTED|Overall Study||11
57250|NCT01808339|135836|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
57251|NCT01808339|135837|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
57252|NCT01808339|135838|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
57253|NCT01808339|135839|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
57254|NCT01808339|135840|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
57255|NCT01808339|135841|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
57256|NCT01808339|135836|P6|COMPLETED|Treatment Period 3 (14 Days)||5
57257|NCT01808339|135837|P5|COMPLETED|Treatment Period 3 (14 Days)||4
57258|NCT01808339|135838|P4|COMPLETED|Treatment Period 3 (14 Days)||2
57259|NCT01808339|135839|P3|COMPLETED|Treatment Period 3 (14 Days)||3
57260|NCT01808339|135840|P2|COMPLETED|Treatment Period 3 (14 Days)||3
57261|NCT01808339|135841|P1|COMPLETED|Treatment Period 3 (14 Days)||4
57262|NCT01808339|135836|P6|STARTED|Treatment Period 3 (14 Days)||5
57263|NCT01808339|135837|P5|STARTED|Treatment Period 3 (14 Days)||4
57264|NCT01808339|135838|P4|STARTED|Treatment Period 3 (14 Days)||2
57265|NCT01808339|135839|P3|STARTED|Treatment Period 3 (14 Days)||4
57266|NCT01808339|135840|P2|STARTED|Treatment Period 3 (14 Days)||3
57267|NCT01808339|135841|P1|STARTED|Treatment Period 3 (14 Days)||4
57268|NCT01808339|135836|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
57269|NCT01808339|135837|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
57270|NCT01808339|135838|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
57271|NCT01808339|135839|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
57272|NCT01808339|135840|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
57273|NCT01808339|135841|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
57274|NCT01808339|135836|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
57275|NCT01808339|135837|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
57276|NCT01808339|135838|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
57277|NCT01808339|135839|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
57278|NCT01808339|135840|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
57279|NCT01808339|135841|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
57280|NCT01808339|135836|P6|STARTED|Washout Period 2 (14-21 Days)||5
57281|NCT01808339|135837|P5|STARTED|Washout Period 2 (14-21 Days)||4
57282|NCT01808339|135838|P4|STARTED|Washout Period 2 (14-21 Days)||2
57283|NCT01808339|135839|P3|STARTED|Washout Period 2 (14-21 Days)||4
57284|NCT01808339|135840|P2|STARTED|Washout Period 2 (14-21 Days)||3
57285|NCT01808339|135841|P1|STARTED|Washout Period 2 (14-21 Days)||4
57286|NCT01808339|135836|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
57287|NCT01808339|135837|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
57288|NCT01808339|135838|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
57289|NCT01808339|135839|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
57290|NCT01808339|135840|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
57291|NCT01808339|135841|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
57292|NCT01808339|135836|P6|COMPLETED|Treatment Period 2 (14 Days)||5
57293|NCT01808339|135837|P5|COMPLETED|Treatment Period 2 (14 Days)||4
57294|NCT01808339|135838|P4|COMPLETED|Treatment Period 2 (14 Days)||2
57295|NCT01808339|135839|P3|COMPLETED|Treatment Period 2 (14 Days)||4
57296|NCT01808339|135840|P2|COMPLETED|Treatment Period 2 (14 Days)||3
57297|NCT01808339|135841|P1|COMPLETED|Treatment Period 2 (14 Days)||4
57298|NCT01808339|135836|P6|STARTED|Treatment Period 2 (14 Days)||5
57299|NCT01808339|135837|P5|STARTED|Treatment Period 2 (14 Days)||4
57300|NCT01808339|135838|P4|STARTED|Treatment Period 2 (14 Days)||2
57301|NCT01808339|135839|P3|STARTED|Treatment Period 2 (14 Days)||4
57302|NCT01808339|135840|P2|STARTED|Treatment Period 2 (14 Days)||3
57303|NCT01808339|135841|P1|STARTED|Treatment Period 2 (14 Days)||4
57304|NCT01808339|135836|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
57305|NCT01808339|135837|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
57306|NCT01808339|135838|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
57307|NCT01808339|135839|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
57308|NCT01808339|135840|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
57309|NCT01808339|135841|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
57310|NCT01808339|135836|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
57311|NCT01808339|135837|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
57312|NCT01808339|135838|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
57313|NCT01808339|135839|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
57314|NCT01808339|135840|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
57315|NCT01808339|135841|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
57316|NCT01808339|135836|P6|STARTED|Washout Period 1 (14-21 Days)||5
57317|NCT01808339|135837|P5|STARTED|Washout Period 1 (14-21 Days)||4
57318|NCT01808339|135838|P4|STARTED|Washout Period 1 (14-21 Days)||2
57319|NCT01808339|135839|P3|STARTED|Washout Period 1 (14-21 Days)||4
57320|NCT01808339|135840|P2|STARTED|Washout Period 1 (14-21 Days)||3
57321|NCT01808339|135841|P1|STARTED|Washout Period 1 (14-21 Days)||4
57322|NCT01808339|135836|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
57323|NCT01808339|135837|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
57324|NCT01808339|135838|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
57325|NCT01808339|135839|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
57326|NCT01808339|135840|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
57327|NCT01808339|135841|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
57328|NCT01808339|135836|P6|COMPLETED|Treatment Period 1 (14 Days)||5
57329|NCT01808339|135837|P5|COMPLETED|Treatment Period 1 (14 Days)||4
57330|NCT01808339|135838|P4|COMPLETED|Treatment Period 1 (14 Days)||2
57331|NCT01808339|135839|P3|COMPLETED|Treatment Period 1 (14 Days)||4
57332|NCT01808339|135840|P2|COMPLETED|Treatment Period 1 (14 Days)||3
57333|NCT01808339|135841|P1|COMPLETED|Treatment Period 1 (14 Days)||4
57334|NCT01808339|135836|P6|STARTED|Treatment Period 1 (14 Days)||6
57335|NCT01808339|135837|P5|STARTED|Treatment Period 1 (14 Days)||6
57336|NCT01808339|135838|P4|STARTED|Treatment Period 1 (14 Days)||4
57337|NCT01808339|135839|P3|STARTED|Treatment Period 1 (14 Days)||4
57338|NCT01808339|135840|P2|STARTED|Treatment Period 1 (14 Days)||4
57339|NCT01808339|135841|P1|STARTED|Treatment Period 1 (14 Days)||4
57340|NCT01808326|135858|P1|NOT COMPLETED|Overall Study||0
57341|NCT01808326|135858|P1|COMPLETED|Overall Study||5
57342|NCT01808326|135858|P1|STARTED|Overall Study||5
57343|NCT01808313|135885|P1|NOT COMPLETED|Overall Study||10
57344|NCT01808313|135885|P1|COMPLETED|Overall Study||123
57345|NCT01808313|135885|P1|STARTED|Overall Study||133
57346|NCT01808261|135915|P2|NOT COMPLETED|Overall Study||33
57347|NCT01808261|135916|P1|NOT COMPLETED|Overall Study||36
57348|NCT01808261|135915|P2|COMPLETED|Overall Study||32
57349|NCT01808261|135916|P1|COMPLETED|Overall Study||32
57350|NCT01808261|135915|P2|STARTED|Overall Study||65
57351|NCT01808261|135916|P1|STARTED|Overall Study||68
57352|NCT01808248|135972|P1|NOT COMPLETED|Overall Study||5
57353|NCT01808248|135972|P1|COMPLETED|Overall Study||42
57354|NCT01808248|135972|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
57355|NCT01808248|135972|P1|STARTED|Overall Study||47
57356|NCT01808209|135986|P2|NOT COMPLETED|Overall Study||1
57357|NCT01808209|135987|P1|NOT COMPLETED|Overall Study||0
57358|NCT01808209|135986|P2|COMPLETED|Overall Study||26
57359|NCT01808209|135987|P1|COMPLETED|Overall Study||33
57360|NCT01808209|135986|P2|STARTED|Overall Study||27
57361|NCT01808209|135987|P1|STARTED|Overall Study||33
57362|NCT01808144|136031|P2|NOT COMPLETED|Overall Study||48
57363|NCT01808144|136032|P1|NOT COMPLETED|Overall Study||40
57364|NCT01808144|136031|P2|COMPLETED|Overall Study||51
57365|NCT01808144|136032|P1|COMPLETED|Overall Study||57
57366|NCT01808144|136031|P2|STARTED|Overall Study||99
57367|NCT01808144|136032|P1|STARTED|Overall Study||97
57368|NCT01808118|136040|P3|NOT COMPLETED|Period 2||8
57369|NCT01808118|136041|P2|NOT COMPLETED|Period 2||13
57370|NCT01808118|136042|P1|NOT COMPLETED|Period 2||0
57371|NCT01808118|136040|P3|COMPLETED|Period 2||144
57372|NCT01808118|136041|P2|COMPLETED|Period 2||140
57373|NCT01808118|136042|P1|COMPLETED|Period 2||0
57374|NCT01808118|136040|P3|STARTED|Period 2||152
57375|NCT01808118|136041|P2|STARTED|Period 2||153
57376|NCT01808118|136042|P1|STARTED|Period 2||0
57377|NCT01808118|136040|P3|NOT COMPLETED|Period 1||0
57378|NCT01808118|136041|P2|NOT COMPLETED|Period 1||0
57379|NCT01808118|136042|P1|NOT COMPLETED|Period 1||368
57380|NCT01808118|136040|P3|COMPLETED|Period 1||0
57381|NCT01808118|136041|P2|COMPLETED|Period 1||0
57382|NCT01808118|136042|P1|COMPLETED|Period 1||305
57383|NCT01808118|136040|P3|STARTED|Period 1||0
57384|NCT01808118|136041|P2|STARTED|Period 1||0
57385|NCT01808118|136042|P1|STARTED|Period 1||673
57386|NCT01808092|136105|P2|NOT COMPLETED|Overall Study||45
57387|NCT01808092|136106|P1|NOT COMPLETED|Overall Study||54
57388|NCT01808092|136105|P2|COMPLETED|Overall Study||363
57389|NCT01808092|136106|P1|COMPLETED|Overall Study||355
57390|NCT01808092|136105|P2|STARTED|Overall Study||408
57391|NCT01808092|136106|P1|STARTED|Overall Study||409
57392|NCT01808066|136208|P1|NOT COMPLETED|Overall Study||15
57393|NCT01808066|136208|P1|COMPLETED|Overall Study||6
57394|NCT01808066|136208|P1|STARTED|Overall Study||21
57395|NCT01807949|136215|P3|NOT COMPLETED|Overall Study||9
57396|NCT01807949|136216|P2|NOT COMPLETED|Overall Study||7
57397|NCT01807949|136217|P1|NOT COMPLETED|Overall Study||2
57398|NCT01807949|136215|P3|COMPLETED|Overall Study||180
57399|NCT01807949|136216|P2|COMPLETED|Overall Study||180
57400|NCT01807949|136217|P1|COMPLETED|Overall Study||185
57401|NCT01807949|136215|P3|STARTED|Overall Study||189
57402|NCT01807949|136216|P2|STARTED|Overall Study||187
57403|NCT01807949|136217|P1|STARTED|Overall Study||187
57404|NCT01807923|136269|P3|NOT COMPLETED|Overall Study||11
57405|NCT01807923|136270|P2|NOT COMPLETED|Overall Study||6
57406|NCT01807923|136271|P1|NOT COMPLETED|Overall Study||5
57407|NCT01807923|136269|P3|COMPLETED|Overall Study||176
57408|NCT01807923|136270|P2|COMPLETED|Overall Study||179
57409|NCT01807923|136271|P1|COMPLETED|Overall Study||182
57410|NCT01807923|136269|P3|STARTED|Overall Study||187
57411|NCT01807923|136270|P2|STARTED|Overall Study||185
57412|NCT01807923|136271|P1|STARTED|Overall Study||187
57413|NCT01807871|136322|P2|NOT COMPLETED|Overall Study||218
57414|NCT01807871|136323|P1|NOT COMPLETED|Overall Study||178
57415|NCT01807871|136322|P2|COMPLETED|Overall Study||127
57416|NCT01807871|136323|P1|COMPLETED|Overall Study||178
57417|NCT01807871|136322|P2|STARTED|Overall Study||345
57418|NCT01807871|136323|P1|STARTED|Overall Study||356
57419|NCT01807624|136333|P1|NOT COMPLETED|Overall Study||0
57420|NCT01807624|136333|P1|COMPLETED|Overall Study||24
57421|NCT01807624|136333|P1|STARTED|Overall Study||24
57422|NCT01807520|136352|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
57423|NCT01807520|136353|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
57424|NCT01807520|136354|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
57425|NCT01807520|136355|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
57426|NCT01807520|136356|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
57427|NCT01807520|136357|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
57428|NCT01807520|136358|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
57429|NCT01807520|136352|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
57430|NCT01807520|136353|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
57431|NCT01807520|136354|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
57432|NCT01807520|136355|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
57433|NCT01807520|136356|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
57434|NCT01807520|136357|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
57435|NCT01807520|136358|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
57436|NCT01807520|136352|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
57437|NCT01807520|136353|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
57438|NCT01807520|136354|P5|STARTED|Follow-up Period (132-140 Weeks)||0
57439|NCT01807520|136355|P4|STARTED|Follow-up Period (132-140 Weeks)||0
57440|NCT01807520|136356|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
57441|NCT01807520|136357|P2|STARTED|Follow-up Period (132-140 Weeks)||0
57442|NCT01807520|136358|P1|STARTED|Follow-up Period (132-140 Weeks)||0
57443|NCT01807520|136352|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
57444|NCT01807520|136353|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
57445|NCT01807520|136354|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
57446|NCT01807520|136355|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
57447|NCT01807520|136356|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
57448|NCT01807520|136357|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
57449|NCT01807520|136358|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
57450|NCT01807520|136352|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
57451|NCT01807520|136353|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
57452|NCT01807520|136354|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
57453|NCT01807520|136355|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
57454|NCT01807520|136356|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
57455|NCT01807520|136357|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
57456|NCT01807520|136358|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
57457|NCT01807520|136352|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
57458|NCT01807520|136353|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
57459|NCT01807520|136354|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
57460|NCT01807520|136355|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
57461|NCT01807520|136356|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
57462|NCT01807520|136357|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
57463|NCT01807520|136358|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
57464|NCT01807520|136352|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
57465|NCT01807520|136353|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
57466|NCT01807520|136354|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
57467|NCT01807520|136355|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
57468|NCT01807520|136356|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
57469|NCT01807520|136357|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
57470|NCT01807520|136358|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
57471|NCT01807520|136352|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
57472|NCT01807520|136353|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
57473|NCT01807520|136354|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
57474|NCT01807520|136355|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
57475|NCT01807520|136356|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
57476|NCT01807520|136357|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
57477|NCT01807520|136358|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
57478|NCT01807520|136352|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57479|NCT01807520|136353|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57480|NCT01807520|136354|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57481|NCT01807520|136355|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57482|NCT01807520|136356|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
57483|NCT01807520|136357|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
57484|NCT01807520|136358|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
57485|NCT01807520|136352|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57486|NCT01807520|136353|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57487|NCT01807520|136354|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57488|NCT01807520|136355|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
57489|NCT01807520|136356|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
57490|NCT01807520|136357|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
57491|NCT01807520|136358|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
57492|NCT01807520|136352|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
57493|NCT01807520|136353|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
57494|NCT01807520|136354|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
57495|NCT01807520|136355|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
57496|NCT01807520|136356|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
57497|NCT01807520|136357|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
57498|NCT01807520|136358|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
57499|NCT01807520|136352|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
57500|NCT01807520|136353|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
57501|NCT01807520|136354|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
57502|NCT01807520|136355|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
57503|NCT01807520|136356|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
57504|NCT01807520|136357|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
57505|NCT01807520|136358|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
57506|NCT01807520|136352|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
57507|NCT01807520|136353|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
57508|NCT01807520|136354|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
57509|NCT01807520|136355|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
57510|NCT01807520|136356|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
57511|NCT01807520|136357|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
57512|NCT01807520|136358|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
57513|NCT01807455|136377|P1|NOT COMPLETED|Overall Study||0
57514|NCT01807455|136377|P1|COMPLETED|Overall Study||12
57515|NCT01807455|136377|P1|STARTED|Overall Study||12
57516|NCT01807234|136391|P6|NOT COMPLETED|Overall Study||4
57517|NCT01807234|136392|P5|NOT COMPLETED|Overall Study||4
57518|NCT01807234|136393|P4|NOT COMPLETED|Overall Study||2
57519|NCT01807234|136394|P3|NOT COMPLETED|Overall Study||2
57520|NCT01807234|136395|P2|NOT COMPLETED|Overall Study||6
57521|NCT01807234|136396|P1|NOT COMPLETED|Overall Study||5
57522|NCT01807234|136391|P6|COMPLETED|Overall Study||8
57523|NCT01807234|136392|P5|COMPLETED|Overall Study||8
57524|NCT01807234|136393|P4|COMPLETED|Overall Study||10
57525|NCT01807234|136394|P3|COMPLETED|Overall Study||10
57526|NCT01807234|136395|P2|COMPLETED|Overall Study||6
57527|NCT01807234|136396|P1|COMPLETED|Overall Study||7
57528|NCT01807234|136391|P6|Completed Only 1 Attack|Overall Study||1
57529|NCT01807234|136392|P5|Completed Only 1 Attack|Overall Study||0
57530|NCT01807234|136393|P4|Completed Only 1 Attack|Overall Study||1
57531|NCT01807234|136394|P3|Completed Only 1 Attack|Overall Study||0
57532|NCT01807234|136395|P2|Completed Only 1 Attack|Overall Study||1
57533|NCT01807234|136396|P1|Completed Only 1 Attack|Overall Study||2
57534|NCT01807234|136391|P6|Randomized, But Did Not Take Drug|Overall Study||3
57535|NCT01807234|136392|P5|Randomized, But Did Not Take Drug|Overall Study||4
57536|NCT01807234|136393|P4|Randomized, But Did Not Take Drug|Overall Study||1
57537|NCT01807234|136394|P3|Randomized, But Did Not Take Drug|Overall Study||2
57538|NCT01807234|136395|P2|Randomized, But Did Not Take Drug|Overall Study||5
57539|NCT01807234|136396|P1|Randomized, But Did Not Take Drug|Overall Study||3
57540|NCT01807234|136391|P6|STARTED|Overall Study||12
57541|NCT01807234|136392|P5|STARTED|Overall Study||12
57542|NCT01807234|136393|P4|STARTED|Overall Study||12
57543|NCT01807234|136394|P3|STARTED|Overall Study||12
57544|NCT01807234|136395|P2|STARTED|Overall Study||12
57545|NCT01807234|136396|P1|STARTED|Overall Study||12
57546|NCT01807156|136431|P1|NOT COMPLETED|Overall Study||1
57547|NCT01807156|136431|P1|COMPLETED|Overall Study||6
57548|NCT01807156|136431|P1|STARTED|Overall Study||7
57549|NCT01807000|136436|P1|NOT COMPLETED|Overall Study||0
57550|NCT01807000|136436|P1|COMPLETED|Overall Study||6
57551|NCT01807000|136436|P1|STARTED|Overall Study||6
57552|NCT01806961|136455|P1|NOT COMPLETED|Overall Study||16
57553|NCT01806961|136455|P1|COMPLETED|Overall Study||0
57554|NCT01806961|136455|P1|STARTED|Overall Study||16
57555|NCT01806896|136461|P2|NOT COMPLETED|Overall Study||0
57556|NCT01806896|136462|P1|NOT COMPLETED|Overall Study||3
57557|NCT01806896|136461|P2|COMPLETED|Overall Study||17
57558|NCT01806896|136462|P1|COMPLETED|Overall Study||17
57559|NCT01806896|136461|P2|Received Treatment|Overall Study||17
57560|NCT01806896|136462|P1|Received Treatment|Overall Study||19
57561|NCT01806896|136461|P2|STARTED|Overall Study||17
57562|NCT01806896|136462|P1|STARTED|Overall Study||20
57563|NCT01806857|136490|P2|NOT COMPLETED|Overall Study||0
57564|NCT01806857|136491|P1|NOT COMPLETED|Overall Study||1
57565|NCT01806857|136490|P2|COMPLETED|Overall Study||29
57566|NCT01806857|136491|P1|COMPLETED|Overall Study||30
57567|NCT01806857|136490|P2|STARTED|Overall Study||29
57568|NCT01806857|136491|P1|STARTED|Overall Study||31
57569|NCT01806779|136529|P3|NOT COMPLETED|Overall Study||23
57570|NCT01806779|136530|P2|NOT COMPLETED|Overall Study||44
57571|NCT01806779|136531|P1|NOT COMPLETED|Overall Study||42
57572|NCT01806779|136529|P3|COMPLETED|Overall Study||0
57573|NCT01806779|136530|P2|COMPLETED|Overall Study||40
57574|NCT01806779|136531|P1|COMPLETED|Overall Study||48
57575|NCT01806779|136529|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
57576|NCT01806779|136530|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
57577|NCT01806779|136531|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
57578|NCT01806779|136529|P3|Randomized at Visit 2|Overall Study||0
57579|NCT01806779|136530|P2|Randomized at Visit 2|Overall Study||84
57580|NCT01806779|136531|P1|Randomized at Visit 2|Overall Study||90
57581|NCT01806779|136529|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
57582|NCT01806779|136530|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
57583|NCT01806779|136531|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
57584|NCT01806779|136529|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
57585|NCT01806779|136530|P2|STARTED|Overall Study||84
57586|NCT01806779|136531|P1|STARTED|Overall Study||90
57587|NCT01806714|136546|P2|NOT COMPLETED|Overall Study||170
57588|NCT01806714|136547|P1|NOT COMPLETED|Overall Study||200
57589|NCT01806714|136546|P2|COMPLETED|Overall Study||1919
57590|NCT01806714|136547|P1|COMPLETED|Overall Study||1893
57591|NCT01806714|136546|P2|STARTED|Overall Study||2089
57592|NCT01806714|136547|P1|STARTED|Overall Study||2093
57593|NCT01806662|136557|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
57594|NCT01806662|136558|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
57595|NCT01806662|136557|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
57596|NCT01806662|136558|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
57597|NCT01806662|136557|P2|STARTED|Second Intervention (Weeks 16-32)||15
57598|NCT01806662|136558|P1|STARTED|Second Intervention (Weeks 16-32)||12
57599|NCT01806662|136557|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
57600|NCT01806662|136558|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
57601|NCT01806662|136557|P2|COMPLETED|First Intervention (Weeks 0-16)||15
57602|NCT01806662|136558|P1|COMPLETED|First Intervention (Weeks 0-16)||12
57603|NCT01806662|136557|P2|Received Intervention|First Intervention (Weeks 0-16)||15
57604|NCT01806662|136558|P1|Received Intervention|First Intervention (Weeks 0-16)||12
57605|NCT01806662|136557|P2|STARTED|First Intervention (Weeks 0-16)||16
57606|NCT01806662|136558|P1|STARTED|First Intervention (Weeks 0-16)||16
57607|NCT01806623|136564|P1|NOT COMPLETED|Overall Study||58
57608|NCT01806623|136564|P1|COMPLETED|Overall Study||99
57609|NCT01806623|136564|P1|STARTED|Overall Study||157
57610|NCT01806597|136584|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
57611|NCT01806597|136585|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57612|NCT01806597|136586|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57613|NCT01806597|136587|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57614|NCT01806597|136588|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57615|NCT01806597|136589|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57616|NCT01806597|136584|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
57617|NCT01806597|136585|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
57618|NCT01806597|136586|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57619|NCT01806597|136587|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57620|NCT01806597|136588|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57621|NCT01806597|136589|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
57622|NCT01806597|136584|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
57623|NCT01806597|136585|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
57624|NCT01806597|136586|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
57625|NCT01806597|136587|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
57626|NCT01806597|136588|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
57627|NCT01806597|136589|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
57628|NCT01806597|136584|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
57629|NCT01806597|136585|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
57630|NCT01806597|136586|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
57631|NCT01806597|136587|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
57632|NCT01806597|136588|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
57633|NCT01806597|136589|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
57634|NCT01806597|136584|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
57635|NCT01806597|136585|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
57636|NCT01806597|136586|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
57637|NCT01806597|136587|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
57638|NCT01806597|136588|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
57639|NCT01806597|136589|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
57640|NCT01806597|136584|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
57641|NCT01806597|136585|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
57642|NCT01806597|136586|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
57643|NCT01806597|136587|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
57644|NCT01806597|136588|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
57645|NCT01806597|136589|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
57646|NCT01806597|136584|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
57647|NCT01806597|136585|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
57648|NCT01806597|136586|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
57649|NCT01806597|136587|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
57650|NCT01806597|136588|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
57651|NCT01806597|136589|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
57652|NCT01806597|136584|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
57653|NCT01806597|136585|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
57654|NCT01806597|136586|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
57655|NCT01806597|136587|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
57656|NCT01806597|136588|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
57657|NCT01806597|136589|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
57658|NCT01806597|136584|P6|STARTED|Period 1 (Baseline to Week 16)||0
57659|NCT01806597|136585|P5|STARTED|Period 1 (Baseline to Week 16)||68
57660|NCT01806597|136586|P4|STARTED|Period 1 (Baseline to Week 16)||0
57661|NCT01806597|136587|P3|STARTED|Period 1 (Baseline to Week 16)||0
57662|NCT01806597|136588|P2|STARTED|Period 1 (Baseline to Week 16)||69
57663|NCT01806597|136589|P1|STARTED|Period 1 (Baseline to Week 16)||68
57664|NCT01806584|136625|P2|NOT COMPLETED|Overall Study||18
57665|NCT01806584|136626|P1|NOT COMPLETED|Overall Study||14
57666|NCT01806584|136625|P2|COMPLETED|Overall Study||0
57667|NCT01806584|136626|P1|COMPLETED|Overall Study||0
57668|NCT01806584|136625|P2|STARTED|Overall Study||18
57669|NCT01806584|136626|P1|STARTED|Overall Study||14
57670|NCT01806545|136640|P2|NOT COMPLETED|Overall Study||5
57671|NCT01806545|136641|P1|NOT COMPLETED|Overall Study||6
57672|NCT01806545|136640|P2|COMPLETED|Overall Study||30
57673|NCT01806545|136641|P1|COMPLETED|Overall Study||23
57674|NCT01806545|136640|P2|STARTED|Overall Study||35
57675|NCT01806545|136641|P1|STARTED|Overall Study||29
57676|NCT01806389|136663|P1|NOT COMPLETED|Overall Study||4
57677|NCT01806389|136663|P1|COMPLETED|Overall Study||10
57678|NCT01806389|136663|P1|STARTED|Overall Study||14
57679|NCT01806298|136677|P1|NOT COMPLETED|Overall Study||10
57680|NCT01806298|136677|P1|COMPLETED|Overall Study||68
57681|NCT01806298|136677|P1|STARTED|Overall Study||78
57682|NCT01806051|136687|P1|NOT COMPLETED|Overall Study||6
57683|NCT01806051|136687|P1|COMPLETED|Overall Study||0
57684|NCT01806051|136687|P1|STARTED|Overall Study||6
57685|NCT01805895|136695|P2|NOT COMPLETED|Overall Study||0
57686|NCT01805895|136696|P1|NOT COMPLETED|Overall Study||0
57687|NCT01805895|136695|P2|COMPLETED|Overall Study||8
57688|NCT01805895|136696|P1|COMPLETED|Overall Study||8
57689|NCT01805895|136695|P2|STARTED|Overall Study||8
57690|NCT01805895|136696|P1|STARTED|Overall Study||8
57691|NCT01805882|136713|P9|NOT COMPLETED|Overall Study||1
57692|NCT01805882|136714|P8|NOT COMPLETED|Overall Study||0
57693|NCT01805882|136715|P7|NOT COMPLETED|Overall Study||2
57694|NCT01805882|136716|P6|NOT COMPLETED|Overall Study||1
57695|NCT01805882|136717|P5|NOT COMPLETED|Overall Study||0
57696|NCT01805882|136718|P4|NOT COMPLETED|Overall Study||2
57697|NCT01805882|136719|P3|NOT COMPLETED|Overall Study||1
57698|NCT01805882|136720|P2|NOT COMPLETED|Overall Study||0
57699|NCT01805882|136721|P1|NOT COMPLETED|Overall Study||0
57700|NCT01805882|136713|P9|COMPLETED|Overall Study||24
57701|NCT01805882|136714|P8|COMPLETED|Overall Study||25
57702|NCT01805882|136715|P7|COMPLETED|Overall Study||48
57703|NCT01805882|136716|P6|COMPLETED|Overall Study||20
57704|NCT01805882|136717|P5|COMPLETED|Overall Study||14
57705|NCT01805882|136718|P4|COMPLETED|Overall Study||32
57706|NCT01805882|136719|P3|COMPLETED|Overall Study||19
57707|NCT01805882|136720|P2|COMPLETED|Overall Study||20
57708|NCT01805882|136721|P1|COMPLETED|Overall Study||20
57709|NCT01805882|136713|P9|STARTED|Overall Study||25
57710|NCT01805882|136714|P8|STARTED|Overall Study||25
57711|NCT01805882|136715|P7|STARTED|Overall Study||50
57712|NCT01805882|136716|P6|STARTED|Overall Study||21
57713|NCT01805882|136717|P5|STARTED|Overall Study||14
57714|NCT01805882|136718|P4|STARTED|Overall Study||34
57715|NCT01805882|136719|P3|STARTED|Overall Study||20
57716|NCT01805882|136720|P2|STARTED|Overall Study||20
57717|NCT01805882|136721|P1|STARTED|Overall Study||20
57718|NCT01805687|136741|P1|NOT COMPLETED|Overall Study||0
57719|NCT01805687|136741|P1|COMPLETED|Overall Study||25
57720|NCT01805687|136741|P1|STARTED|Overall Study||25
57721|NCT01805440|136748|P3|NOT COMPLETED|Overall Study||0
57722|NCT01805440|136749|P2|NOT COMPLETED|Overall Study||0
57723|NCT01805440|136750|P1|NOT COMPLETED|Overall Study||1
57724|NCT01805440|136748|P3|COMPLETED|Overall Study||26
57725|NCT01805440|136749|P2|COMPLETED|Overall Study||17
57726|NCT01805440|136750|P1|COMPLETED|Overall Study||18
57727|NCT01805440|136748|P3|STARTED|Overall Study||26
57728|NCT01805440|136749|P2|STARTED|Overall Study||17
57729|NCT01805440|136750|P1|STARTED|Overall Study||19
57730|NCT01805323|136763|P1|NOT COMPLETED|Overall Study||0
57731|NCT01805323|136763|P1|COMPLETED|Overall Study||101
57732|NCT01805323|136763|P1|STARTED|Overall Study||101
57733|NCT01805297|136770|P2|NOT COMPLETED|Overall Study||3
57734|NCT01805297|136771|P1|NOT COMPLETED|Overall Study||2
57735|NCT01805297|136770|P2|COMPLETED|Overall Study||3
57736|NCT01805297|136771|P1|COMPLETED|Overall Study||4
57737|NCT01805297|136770|P2|STARTED|Overall Study||6
57738|NCT01805297|136771|P1|STARTED|Overall Study||6
57739|NCT01805180|136785|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
57740|NCT01805180|136786|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
57741|NCT01805180|136787|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
57742|NCT01805180|136785|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
57743|NCT01805180|136786|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
57744|NCT01805180|136787|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
57745|NCT01805180|136785|P3|STARTED|Pivotal Randomization Through Study Exit||20
57746|NCT01805180|136786|P2|STARTED|Pivotal Randomization Through Study Exit||22
57747|NCT01805180|136787|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
57748|NCT01805180|136785|P3|NOT COMPLETED|Lead-in Donor Phase||0
57749|NCT01805180|136786|P2|NOT COMPLETED|Lead-in Donor Phase||0
57750|NCT01805180|136787|P1|NOT COMPLETED|Lead-in Donor Phase||1
57751|NCT01805180|136785|P3|COMPLETED|Lead-in Donor Phase||0
57752|NCT01805180|136786|P2|COMPLETED|Lead-in Donor Phase||0
57753|NCT01805180|136787|P1|COMPLETED|Lead-in Donor Phase||6
57754|NCT01805180|136785|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
57755|NCT01805180|136786|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
57756|NCT01805180|136787|P1|STARTED|Lead-in Donor Phase||7
57757|NCT01805089|136812|P2|NOT COMPLETED|Overall Study||4
57758|NCT01805089|136813|P1|NOT COMPLETED|Overall Study||5
57759|NCT01805089|136812|P2|COMPLETED|Overall Study||43
57760|NCT01805089|136813|P1|COMPLETED|Overall Study||43
57761|NCT01805089|136812|P2|STARTED|Overall Study||47
57762|NCT01805089|136813|P1|STARTED|Overall Study||48
57763|NCT01804946|136825|P2|NOT COMPLETED|Overall Study||4
57764|NCT01804946|136826|P1|NOT COMPLETED|Overall Study||2
57765|NCT01804946|136825|P2|COMPLETED|Overall Study||76
57766|NCT01804946|136826|P1|COMPLETED|Overall Study||79
57767|NCT01804946|136825|P2|STARTED|Overall Study||80
57768|NCT01804946|136826|P1|STARTED|Overall Study||81
57769|NCT01804881|136850|P2|NOT COMPLETED|Overall Study||4
57770|NCT01804881|136851|P1|NOT COMPLETED|Overall Study||5
57771|NCT01804881|136850|P2|COMPLETED|Overall Study||10
57772|NCT01804881|136851|P1|COMPLETED|Overall Study||11
57773|NCT01804881|136850|P2|STARTED|Overall Study||14
57774|NCT01804881|136851|P1|STARTED|Overall Study||16
57775|NCT01804842|136864|P3|NOT COMPLETED|Overall Study||1
57776|NCT01804842|136865|P2|NOT COMPLETED|Overall Study||2
57777|NCT01804842|136866|P1|NOT COMPLETED|Overall Study||3
57778|NCT01804842|136864|P3|COMPLETED|Overall Study||8
57779|NCT01804842|136865|P2|COMPLETED|Overall Study||6
57780|NCT01804842|136866|P1|COMPLETED|Overall Study||6
57781|NCT01804842|136864|P3|Completed Treatment C|Overall Study||9
57782|NCT01804842|136865|P2|Completed Treatment C|Overall Study||7
57783|NCT01804842|136866|P1|Completed Treatment C|Overall Study||7
57784|NCT01804842|136864|P3|Completed Treatment B|Overall Study||8
57785|NCT01804842|136865|P2|Completed Treatment B|Overall Study||8
57786|NCT01804842|136866|P1|Completed Treatment B|Overall Study||8
57787|NCT01804842|136864|P3|Completed Treatment A|Overall Study||8
57788|NCT01804842|136865|P2|Completed Treatment A|Overall Study||6
57789|NCT01804842|136866|P1|Completed Treatment A|Overall Study||9
57790|NCT01804842|136864|P3|STARTED|Overall Study||9
57791|NCT01804842|136865|P2|STARTED|Overall Study||8
57792|NCT01804842|136866|P1|STARTED|Overall Study||9
57793|NCT01804673|136883|P1|NOT COMPLETED|Overall Study||140
57794|NCT01804673|136883|P1|COMPLETED|Overall Study||34
57795|NCT01804673|136883|P1|Completed Hour 72|Overall Study||36
57796|NCT01804673|136883|P1|Completed Hour 48|Overall Study||79
57797|NCT01804673|136883|P1|Completed Hour 24|Overall Study||170
57798|NCT01804673|136883|P1|STARTED|Overall Study||174
57799|NCT01804257|136899|P1|NOT COMPLETED|Overall Study||1
57800|NCT01804257|136899|P1|COMPLETED|Overall Study||27
57801|NCT01804257|136899|P1|STARTED|Overall Study||28
57802|NCT01804140|136903|P1|NOT COMPLETED|Overall Study||114
57803|NCT01804140|136903|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
57804|NCT01804140|136903|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
57805|NCT01804101|136910|P2|NOT COMPLETED|Overall Study||0
57806|NCT01804101|136911|P1|NOT COMPLETED|Overall Study||0
57807|NCT01804101|136910|P2|COMPLETED|Overall Study||10
57808|NCT01804101|136911|P1|COMPLETED|Overall Study||38
57809|NCT01804101|136910|P2|STARTED|Overall Study||10
57810|NCT01804101|136911|P1|STARTED|Overall Study||38
57811|NCT01804075|136921|P2|NOT COMPLETED|Overall Study||0
57812|NCT01804075|136922|P1|NOT COMPLETED|Overall Study||0
57813|NCT01804075|136921|P2|COMPLETED|Overall Study||16
57814|NCT01804075|136922|P1|COMPLETED|Overall Study||15
57815|NCT01804075|136921|P2|STARTED|Overall Study||16
57816|NCT01804075|136922|P1|STARTED|Overall Study||15
57817|NCT01804062|136930|P1|NOT COMPLETED|Overall Study||0
57818|NCT01804062|136930|P1|COMPLETED|Overall Study||30
57819|NCT01804062|136930|P1|STARTED|Overall Study||30
57820|NCT01804036|136937|P2|NOT COMPLETED|Overall Study||20
57821|NCT01804036|136938|P1|NOT COMPLETED|Overall Study||13
57822|NCT01804036|136937|P2|COMPLETED|Overall Study||21
57823|NCT01804036|136938|P1|COMPLETED|Overall Study||18
57824|NCT01804036|136937|P2|STARTED|Overall Study||41
57825|NCT01804036|136938|P1|STARTED|Overall Study||31
57826|NCT01803737|136972|P2|NOT COMPLETED|Overall Study||3
57827|NCT01803737|136973|P1|NOT COMPLETED|Overall Study||1
57828|NCT01803737|136972|P2|COMPLETED|Overall Study||10
57829|NCT01803737|136973|P1|COMPLETED|Overall Study||12
57830|NCT01803737|136972|P2|STARTED|Overall Study||13
57831|NCT01803737|136973|P1|STARTED|Overall Study||13
57832|NCT01803711|136997|P2|NOT COMPLETED|Overall Study||1
57833|NCT01803711|136998|P1|NOT COMPLETED|Overall Study||1
57834|NCT01803711|136997|P2|COMPLETED|Overall Study||2
57835|NCT01803711|136998|P1|COMPLETED|Overall Study||1
57836|NCT01803711|136997|P2|STARTED|Overall Study||3
57837|NCT01803711|136998|P1|STARTED|Overall Study||2
57838|NCT01803646|137016|P2|NOT COMPLETED|Overall Study||10
57839|NCT01803646|137017|P1|NOT COMPLETED|Overall Study||17
57840|NCT01803646|137016|P2|COMPLETED|Overall Study||129
57841|NCT01803646|137017|P1|COMPLETED|Overall Study||187
57842|NCT01803646|137016|P2|STARTED|Overall Study||139
57843|NCT01803646|137017|P1|STARTED|Overall Study||204
57844|NCT01803607|137029|P2|NOT COMPLETED|Overall Study||67
57845|NCT01803607|137030|P1|NOT COMPLETED|Overall Study||68
57846|NCT01803607|137029|P2|COMPLETED|Overall Study||0
57847|NCT01803607|137030|P1|COMPLETED|Overall Study||0
57848|NCT01803607|137029|P2|STARTED|Overall Study||67
57849|NCT01803607|137030|P1|STARTED|Overall Study||68
57850|NCT01803464|137054|P4|NOT COMPLETED|Overall Study||0
57851|NCT01803464|137055|P3|NOT COMPLETED|Overall Study||4
57852|NCT01803464|137056|P2|NOT COMPLETED|Overall Study||0
57853|NCT01803464|137057|P1|NOT COMPLETED|Overall Study||1
57854|NCT01803464|137054|P4|COMPLETED|Overall Study||10
57855|NCT01803464|137055|P3|COMPLETED|Overall Study||6
57856|NCT01803464|137056|P2|COMPLETED|Overall Study||4
57857|NCT01803464|137057|P1|COMPLETED|Overall Study||4
57858|NCT01803464|137054|P4|STARTED|Overall Study||10
57859|NCT01803464|137055|P3|STARTED|Overall Study||10
57860|NCT01803464|137056|P2|STARTED|Overall Study||4
57861|NCT01803464|137057|P1|STARTED|Overall Study||5
57862|NCT01802775|137077|P2|NOT COMPLETED|Overall Study||12
57863|NCT01802775|137078|P1|NOT COMPLETED|Overall Study||6
57864|NCT01802775|137077|P2|COMPLETED|Overall Study||89
57865|NCT01802775|137078|P1|COMPLETED|Overall Study||96
57866|NCT01802775|137077|P2|Received Drug (Safety Analysis Set)|Overall Study||100
57867|NCT01802775|137078|P1|Received Drug (Safety Analysis Set)|Overall Study||101
57868|NCT01802775|137077|P2|STARTED|Overall Study||101
57869|NCT01802775|137078|P1|STARTED|Overall Study||102
57870|NCT01802632|137100|P6|NOT COMPLETED|Overall Study||28
57871|NCT01802632|137101|P5|NOT COMPLETED|Overall Study||12
57872|NCT01802632|137102|P4|NOT COMPLETED|Overall Study||60
57873|NCT01802632|137103|P3|NOT COMPLETED|Overall Study||271
57874|NCT01802632|137104|P2|NOT COMPLETED|Overall Study||31
57875|NCT01802632|137105|P1|NOT COMPLETED|Overall Study||201
57876|NCT01802632|137100|P6|COMPLETED|Overall Study||0
57877|NCT01802632|137101|P5|COMPLETED|Overall Study||0
57878|NCT01802632|137102|P4|COMPLETED|Overall Study||0
57879|NCT01802632|137103|P3|COMPLETED|Overall Study||0
57880|NCT01802632|137104|P2|COMPLETED|Overall Study||0
57881|NCT01802632|137105|P1|COMPLETED|Overall Study||0
57882|NCT01802632|137100|P6|STARTED|Overall Study||28
57883|NCT01802632|137101|P5|STARTED|Overall Study||12
57884|NCT01802632|137102|P4|STARTED|Overall Study||60
57885|NCT01802632|137103|P3|STARTED|Overall Study||271
57886|NCT01802632|137104|P2|STARTED|Overall Study||31
57887|NCT01802632|137105|P1|STARTED|Overall Study||201
57888|NCT01802554|137121|P2|NOT COMPLETED|Overall Study||6
57889|NCT01802554|137122|P1|NOT COMPLETED|Overall Study||8
57890|NCT01802554|137121|P2|COMPLETED|Overall Study||43
57891|NCT01802554|137122|P1|COMPLETED|Overall Study||43
57892|NCT01802554|137121|P2|STARTED|Overall Study||49
57893|NCT01802554|137122|P1|STARTED|Overall Study||51
57894|NCT01802515|137139|P3|NOT COMPLETED|Overall Study||0
57895|NCT01802515|137140|P2|NOT COMPLETED|Overall Study||0
57896|NCT01802515|137141|P1|NOT COMPLETED|Overall Study||3
57897|NCT01802515|137139|P3|COMPLETED|Overall Study||4
57898|NCT01802515|137140|P2|COMPLETED|Overall Study||5
57899|NCT01802515|137141|P1|COMPLETED|Overall Study||2
57900|NCT01802515|137139|P3|STARTED|Overall Study||4
57901|NCT01802515|137140|P2|STARTED|Overall Study||5
57902|NCT01802515|137141|P1|STARTED|Overall Study||5
57903|NCT01802320|137152|P1|NOT COMPLETED|Overall Study||2
57904|NCT01802320|137152|P1|COMPLETED|Overall Study||16
57905|NCT01802320|137152|P1|STARTED|Overall Study||18
57906|NCT01802151|137161|P4|NOT COMPLETED|Overall Study||0
57907|NCT01802151|137162|P3|NOT COMPLETED|Overall Study||2
57908|NCT01802151|137163|P2|NOT COMPLETED|Overall Study||0
57909|NCT01802151|137164|P1|NOT COMPLETED|Overall Study||0
57910|NCT01802151|137161|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
57911|NCT01802151|137162|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
57912|NCT01802151|137163|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
57913|NCT01802151|137164|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
57914|NCT01802151|137161|P4|STARTED|Overall Study||20
57915|NCT01802151|137162|P3|STARTED|Overall Study||22
57916|NCT01802151|137163|P2|STARTED|Overall Study||21
57917|NCT01802151|137164|P1|STARTED|Overall Study||20
57918|NCT01801982|137226|P1|NOT COMPLETED|Overall Study||1
57919|NCT01801982|137226|P1|COMPLETED|Overall Study||0
57920|NCT01801982|137226|P1|STARTED|Overall Study||1
57921|NCT01801917|137240|P4|NOT COMPLETED|Extension - All Active||0
57922|NCT01801917|137241|P3|NOT COMPLETED|Extension - All Active||0
57923|NCT01801917|137242|P2|NOT COMPLETED|Extension - All Active||0
57924|NCT01801917|137243|P1|NOT COMPLETED|Extension - All Active||0
57925|NCT01801917|137240|P4|COMPLETED|Extension - All Active||0
57926|NCT01801917|137241|P3|COMPLETED|Extension - All Active||3
57927|NCT01801917|137242|P2|COMPLETED|Extension - All Active||0
57928|NCT01801917|137243|P1|COMPLETED|Extension - All Active||6
57929|NCT01801917|137240|P4|STARTED|Extension - All Active||0
57930|NCT01801917|137241|P3|STARTED|Extension - All Active||3
57931|NCT01801917|137242|P2|STARTED|Extension - All Active||0
57932|NCT01801917|137243|P1|STARTED|Extension - All Active||6
57933|NCT01801917|137240|P4|NOT COMPLETED|Period 1 - Randomized||0
57934|NCT01801917|137241|P3|NOT COMPLETED|Period 1 - Randomized||1
57935|NCT01801917|137242|P2|NOT COMPLETED|Period 1 - Randomized||0
57936|NCT01801917|137243|P1|NOT COMPLETED|Period 1 - Randomized||1
57937|NCT01801917|137240|P4|COMPLETED|Period 1 - Randomized||1
57938|NCT01801917|137241|P3|COMPLETED|Period 1 - Randomized||3
57939|NCT01801917|137242|P2|COMPLETED|Period 1 - Randomized||2
57940|NCT01801917|137243|P1|COMPLETED|Period 1 - Randomized||6
57941|NCT01801917|137240|P4|STARTED|Period 1 - Randomized||1
57942|NCT01801917|137241|P3|STARTED|Period 1 - Randomized||4
57943|NCT01801917|137242|P2|STARTED|Period 1 - Randomized||2
57944|NCT01801917|137243|P1|STARTED|Period 1 - Randomized||7
57945|NCT01801735|137263|P1|NOT COMPLETED|Overall Study||210
57946|NCT01801735|137263|P1|COMPLETED|Overall Study||390
57947|NCT01801735|137263|P1|STARTED|Overall Study||600
57948|NCT01801475|137270|P5|NOT COMPLETED|Overall Study||1
57949|NCT01801475|137271|P4|NOT COMPLETED|Overall Study||0
57950|NCT01801475|137272|P3|NOT COMPLETED|Overall Study||0
57951|NCT01801475|137273|P2|NOT COMPLETED|Overall Study||0
57952|NCT01801475|137274|P1|NOT COMPLETED|Overall Study||0
57953|NCT01801475|137270|P5|COMPLETED|Overall Study||39
57954|NCT01801475|137271|P4|COMPLETED|Overall Study||10
57955|NCT01801475|137272|P3|COMPLETED|Overall Study||10
57956|NCT01801475|137273|P2|COMPLETED|Overall Study||30
57957|NCT01801475|137274|P1|COMPLETED|Overall Study||10
57958|NCT01801475|137270|P5|STARTED|Overall Study||40
57959|NCT01801475|137271|P4|STARTED|Overall Study||10
57960|NCT01801475|137272|P3|STARTED|Overall Study||10
57961|NCT01801475|137273|P2|STARTED|Overall Study||30
57962|NCT01801475|137274|P1|STARTED|Overall Study||10
57963|NCT01801449|137285|P1|NOT COMPLETED|Overall Study||0
57964|NCT01801449|137285|P1|COMPLETED|Overall Study||6
57965|NCT01801449|137285|P1|STARTED|Overall Study||6
57966|NCT01801436|137299|P1|NOT COMPLETED|Overall Study||9
57967|NCT01801436|137299|P1|COMPLETED|Overall Study||5
57968|NCT01801436|137299|P1|STARTED|Overall Study||14
57969|NCT01801358|137337|P6|NOT COMPLETED|Overall Study||8
57970|NCT01801358|137338|P5|NOT COMPLETED|Overall Study||6
57971|NCT01801358|137339|P4|NOT COMPLETED|Overall Study||6
57972|NCT01801358|137340|P3|NOT COMPLETED|Overall Study||6
57973|NCT01801358|137341|P2|NOT COMPLETED|Overall Study||6
57974|NCT01801358|137342|P1|NOT COMPLETED|Overall Study||6
57975|NCT01801358|137337|P6|COMPLETED|Overall Study||0
57976|NCT01801358|137338|P5|COMPLETED|Overall Study||0
57977|NCT01801358|137339|P4|COMPLETED|Overall Study||0
57978|NCT01801358|137340|P3|COMPLETED|Overall Study||0
57979|NCT01801358|137341|P2|COMPLETED|Overall Study||0
57980|NCT01801358|137342|P1|COMPLETED|Overall Study||0
57981|NCT01801358|137337|P6|STARTED|Overall Study||8
57982|NCT01801358|137338|P5|STARTED|Overall Study||6
57983|NCT01801358|137339|P4|STARTED|Overall Study||6
57984|NCT01801358|137340|P3|STARTED|Overall Study||6
57985|NCT01801358|137341|P2|STARTED|Overall Study||6
57986|NCT01801358|137342|P1|STARTED|Overall Study||6
57987|NCT01801280|137464|P4|NOT COMPLETED|Period 4||0
57988|NCT01801280|137465|P3|NOT COMPLETED|Period 4||1
57989|NCT01801280|137466|P2|NOT COMPLETED|Period 4||0
57990|NCT01801280|137467|P1|NOT COMPLETED|Period 4||0
57991|NCT01801280|137464|P4|COMPLETED|Period 4||5
57992|NCT01801280|137465|P3|COMPLETED|Period 4||4
57993|NCT01801280|137466|P2|COMPLETED|Period 4||4
57994|NCT01801280|137467|P1|COMPLETED|Period 4||4
57995|NCT01801280|137464|P4|STARTED|Period 4||5
57996|NCT01801280|137465|P3|STARTED|Period 4||5
57997|NCT01801280|137466|P2|STARTED|Period 4||4
57998|NCT01801280|137467|P1|STARTED|Period 4||4
57999|NCT01801280|137464|P4|NOT COMPLETED|Period 3||0
58000|NCT01801280|137465|P3|NOT COMPLETED|Period 3||0
58001|NCT01801280|137466|P2|NOT COMPLETED|Period 3||0
58002|NCT01801280|137467|P1|NOT COMPLETED|Period 3||0
58003|NCT01801280|137464|P4|COMPLETED|Period 3||5
58004|NCT01801280|137465|P3|COMPLETED|Period 3||5
58005|NCT01801280|137466|P2|COMPLETED|Period 3||4
58006|NCT01801280|137467|P1|COMPLETED|Period 3||4
58007|NCT01801280|137464|P4|STARTED|Period 3||5
58008|NCT01801280|137465|P3|STARTED|Period 3||5
58009|NCT01801280|137466|P2|STARTED|Period 3||4
58010|NCT01801280|137467|P1|STARTED|Period 3||4
58011|NCT01801280|137464|P4|NOT COMPLETED|Period 2||0
58012|NCT01801280|137465|P3|NOT COMPLETED|Period 2||0
58013|NCT01801280|137466|P2|NOT COMPLETED|Period 2||0
58014|NCT01801280|137467|P1|NOT COMPLETED|Period 2||1
58015|NCT01801280|137464|P4|COMPLETED|Period 2||5
58016|NCT01801280|137465|P3|COMPLETED|Period 2||5
58017|NCT01801280|137466|P2|COMPLETED|Period 2||4
58018|NCT01801280|137467|P1|COMPLETED|Period 2||4
58019|NCT01801280|137464|P4|STARTED|Period 2||5
58020|NCT01801280|137465|P3|STARTED|Period 2||5
58021|NCT01801280|137466|P2|STARTED|Period 2||4
58022|NCT01801280|137467|P1|STARTED|Period 2||5
58023|NCT01801280|137464|P4|NOT COMPLETED|Period 1||0
58024|NCT01801280|137465|P3|NOT COMPLETED|Period 1||0
58025|NCT01801280|137466|P2|NOT COMPLETED|Period 1||1
58026|NCT01801280|137467|P1|NOT COMPLETED|Period 1||0
58027|NCT01801280|137464|P4|COMPLETED|Period 1||5
58028|NCT01801280|137465|P3|COMPLETED|Period 1||5
58029|NCT01801280|137466|P2|COMPLETED|Period 1||4
58030|NCT01801280|137467|P1|COMPLETED|Period 1||5
58031|NCT01801280|137464|P4|STARTED|Period 1||5
58032|NCT01801280|137465|P3|STARTED|Period 1||5
58033|NCT01801280|137466|P2|STARTED|Period 1||5
58034|NCT01801280|137467|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
58035|NCT01801124|137477|P1|NOT COMPLETED|Overall Study||0
58036|NCT01801124|137477|P1|COMPLETED|Overall Study||13
58037|NCT01801124|137477|P1|STARTED|Overall Study||13
58038|NCT01801111|137482|P1|NOT COMPLETED|Overall Study||138
58039|NCT01801111|137482|P1|COMPLETED|Overall Study||0
58040|NCT01801111|137482|P1|STARTED|Overall Study||138
58041|NCT01800968|137507|P2|NOT COMPLETED|Overall Study||32
58042|NCT01800968|137508|P1|NOT COMPLETED|Overall Study||36
58043|NCT01800968|137507|P2|COMPLETED|Overall Study||114
58044|NCT01800968|137508|P1|COMPLETED|Overall Study||118
58045|NCT01800968|137507|P2|STARTED|Overall Study||146
58046|NCT01800968|137508|P1|STARTED|Overall Study||154
58047|NCT01800916|137550|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
58048|NCT01800916|137551|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
58049|NCT01800916|137552|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
58050|NCT01800916|137553|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
58051|NCT01800916|137554|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
58052|NCT01800916|137555|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
58053|NCT01800916|137556|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
58054|NCT01800916|137557|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
58055|NCT01800916|137558|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
58056|NCT01800916|137550|P9|COMPLETED|Test Period 3 (1 Week)||7
58057|NCT01800916|137551|P8|COMPLETED|Test Period 3 (1 Week)||7
58058|NCT01800916|137552|P7|COMPLETED|Test Period 3 (1 Week)||7
58059|NCT01800916|137553|P6|COMPLETED|Test Period 3 (1 Week)||7
58060|NCT01800916|137554|P5|COMPLETED|Test Period 3 (1 Week)||7
58061|NCT01800916|137555|P4|COMPLETED|Test Period 3 (1 Week)||6
58062|NCT01800916|137556|P3|COMPLETED|Test Period 3 (1 Week)||7
58063|NCT01800916|137557|P2|COMPLETED|Test Period 3 (1 Week)||7
58064|NCT01800916|137558|P1|COMPLETED|Test Period 3 (1 Week)||7
58065|NCT01800916|137550|P9|STARTED|Test Period 3 (1 Week)||7
58066|NCT01800916|137551|P8|STARTED|Test Period 3 (1 Week)||7
58067|NCT01800916|137552|P7|STARTED|Test Period 3 (1 Week)||7
58068|NCT01800916|137553|P6|STARTED|Test Period 3 (1 Week)||7
58069|NCT01800916|137554|P5|STARTED|Test Period 3 (1 Week)||7
58070|NCT01800916|137555|P4|STARTED|Test Period 3 (1 Week)||6
58071|NCT01800916|137556|P3|STARTED|Test Period 3 (1 Week)||7
58072|NCT01800916|137557|P2|STARTED|Test Period 3 (1 Week)||7
58073|NCT01800916|137558|P1|STARTED|Test Period 3 (1 Week)||7
58074|NCT01800916|137550|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
58075|NCT01800916|137551|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
58076|NCT01800916|137552|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
58077|NCT01800916|137553|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
58078|NCT01800916|137554|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
58079|NCT01800916|137555|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
58080|NCT01800916|137556|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
58081|NCT01800916|137557|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
58082|NCT01800916|137558|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
58083|NCT01800916|137550|P9|COMPLETED|Test Period 2 (1 Week)||7
58084|NCT01800916|137551|P8|COMPLETED|Test Period 2 (1 Week)||7
58085|NCT01800916|137552|P7|COMPLETED|Test Period 2 (1 Week)||7
58086|NCT01800916|137553|P6|COMPLETED|Test Period 2 (1 Week)||7
58087|NCT01800916|137554|P5|COMPLETED|Test Period 2 (1 Week)||7
58088|NCT01800916|137555|P4|COMPLETED|Test Period 2 (1 Week)||6
58089|NCT01800916|137556|P3|COMPLETED|Test Period 2 (1 Week)||7
58090|NCT01800916|137557|P2|COMPLETED|Test Period 2 (1 Week)||7
58091|NCT01800916|137558|P1|COMPLETED|Test Period 2 (1 Week)||7
58092|NCT01800916|137550|P9|STARTED|Test Period 2 (1 Week)||7
58093|NCT01800916|137551|P8|STARTED|Test Period 2 (1 Week)||7
58094|NCT01800916|137552|P7|STARTED|Test Period 2 (1 Week)||7
58095|NCT01800916|137553|P6|STARTED|Test Period 2 (1 Week)||7
58096|NCT01800916|137554|P5|STARTED|Test Period 2 (1 Week)||7
58097|NCT01800916|137555|P4|STARTED|Test Period 2 (1 Week)||6
58098|NCT01800916|137556|P3|STARTED|Test Period 2 (1 Week)||7
58099|NCT01800916|137557|P2|STARTED|Test Period 2 (1 Week)||7
58100|NCT01800916|137558|P1|STARTED|Test Period 2 (1 Week)||7
58101|NCT01800916|137550|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
58102|NCT01800916|137551|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
58103|NCT01800916|137552|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
58104|NCT01800916|137553|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
58105|NCT01800916|137554|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
58106|NCT01800916|137555|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
58107|NCT01800916|137556|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
58108|NCT01800916|137557|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
58109|NCT01800916|137558|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
58110|NCT01800916|137550|P9|COMPLETED|Test Period 1 (1 Week)||7
58111|NCT01800916|137551|P8|COMPLETED|Test Period 1 (1 Week)||7
58112|NCT01800916|137552|P7|COMPLETED|Test Period 1 (1 Week)||7
58113|NCT01800916|137553|P6|COMPLETED|Test Period 1 (1 Week)||7
58114|NCT01800916|137554|P5|COMPLETED|Test Period 1 (1 Week)||7
58115|NCT01800916|137555|P4|COMPLETED|Test Period 1 (1 Week)||6
58116|NCT01800916|137556|P3|COMPLETED|Test Period 1 (1 Week)||7
58117|NCT01800916|137557|P2|COMPLETED|Test Period 1 (1 Week)||7
58118|NCT01800916|137558|P1|COMPLETED|Test Period 1 (1 Week)||7
58119|NCT01800916|137550|P9|STARTED|Test Period 1 (1 Week)||7
58120|NCT01800916|137551|P8|STARTED|Test Period 1 (1 Week)||7
58121|NCT01800916|137552|P7|STARTED|Test Period 1 (1 Week)||7
58122|NCT01800916|137553|P6|STARTED|Test Period 1 (1 Week)||7
58123|NCT01800916|137554|P5|STARTED|Test Period 1 (1 Week)||8
58124|NCT01800916|137555|P4|STARTED|Test Period 1 (1 Week)||7
58125|NCT01800916|137556|P3|STARTED|Test Period 1 (1 Week)||7
58126|NCT01800916|137557|P2|STARTED|Test Period 1 (1 Week)||7
58127|NCT01800916|137558|P1|STARTED|Test Period 1 (1 Week)||7
58128|NCT01800903|137568|P6|NOT COMPLETED|Third Test Period||0
58129|NCT01800903|137569|P5|NOT COMPLETED|Third Test Period||0
58130|NCT01800903|137570|P4|NOT COMPLETED|Third Test Period||0
58131|NCT01800903|137571|P3|NOT COMPLETED|Third Test Period||0
58132|NCT01800903|137572|P2|NOT COMPLETED|Third Test Period||0
58133|NCT01800903|137573|P1|NOT COMPLETED|Third Test Period||0
58134|NCT01800903|137568|P6|COMPLETED|Third Test Period||6
58135|NCT01800903|137569|P5|COMPLETED|Third Test Period||6
58136|NCT01800903|137570|P4|COMPLETED|Third Test Period||7
58137|NCT01800903|137571|P3|COMPLETED|Third Test Period||4
58138|NCT01800903|137572|P2|COMPLETED|Third Test Period||6
58139|NCT01800903|137573|P1|COMPLETED|Third Test Period||6
58140|NCT01800903|137568|P6|STARTED|Third Test Period||6
58141|NCT01800903|137569|P5|STARTED|Third Test Period||6
58142|NCT01800903|137570|P4|STARTED|Third Test Period||7
58143|NCT01800903|137571|P3|STARTED|Third Test Period||4
58144|NCT01800903|137572|P2|STARTED|Third Test Period||6
58145|NCT01800903|137573|P1|STARTED|Third Test Period||6
58146|NCT01800903|137568|P6|NOT COMPLETED|Second Test Period||0
58147|NCT01800903|137569|P5|NOT COMPLETED|Second Test Period||0
58148|NCT01800903|137570|P4|NOT COMPLETED|Second Test Period||0
58149|NCT01800903|137571|P3|NOT COMPLETED|Second Test Period||0
58150|NCT01800903|137572|P2|NOT COMPLETED|Second Test Period||0
58151|NCT01800903|137573|P1|NOT COMPLETED|Second Test Period||1
58152|NCT01800903|137568|P6|COMPLETED|Second Test Period||6
58153|NCT01800903|137569|P5|COMPLETED|Second Test Period||6
58154|NCT01800903|137570|P4|COMPLETED|Second Test Period||7
58155|NCT01800903|137571|P3|COMPLETED|Second Test Period||4
58156|NCT01800903|137572|P2|COMPLETED|Second Test Period||6
58157|NCT01800903|137573|P1|COMPLETED|Second Test Period||6
58158|NCT01800903|137568|P6|STARTED|Second Test Period||6
58159|NCT01800903|137569|P5|STARTED|Second Test Period||6
58160|NCT01800903|137570|P4|STARTED|Second Test Period||7
58161|NCT01800903|137571|P3|STARTED|Second Test Period||4
58162|NCT01800903|137572|P2|STARTED|Second Test Period||6
58163|NCT01800903|137573|P1|STARTED|Second Test Period||7
58164|NCT01800903|137568|P6|NOT COMPLETED|First Test Period||0
58165|NCT01800903|137569|P5|NOT COMPLETED|First Test Period||0
58166|NCT01800903|137570|P4|NOT COMPLETED|First Test Period||0
58167|NCT01800903|137571|P3|NOT COMPLETED|First Test Period||0
58168|NCT01800903|137572|P2|NOT COMPLETED|First Test Period||0
58169|NCT01800903|137573|P1|NOT COMPLETED|First Test Period||0
58170|NCT01800903|137568|P6|COMPLETED|First Test Period||6
58171|NCT01800903|137569|P5|COMPLETED|First Test Period||6
58172|NCT01800903|137570|P4|COMPLETED|First Test Period||7
58173|NCT01800903|137571|P3|COMPLETED|First Test Period||4
58174|NCT01800903|137572|P2|COMPLETED|First Test Period||6
58175|NCT01800903|137573|P1|COMPLETED|First Test Period||7
58176|NCT01800903|137568|P6|STARTED|First Test Period||6
58177|NCT01800903|137569|P5|STARTED|First Test Period||6
58178|NCT01800903|137570|P4|STARTED|First Test Period||7
58179|NCT01800903|137571|P3|STARTED|First Test Period||4
58180|NCT01800903|137572|P2|STARTED|First Test Period||6
58181|NCT01800903|137573|P1|STARTED|First Test Period||7
58182|NCT01800890|137579|P9|NOT COMPLETED|Test Period 3||0
58183|NCT01800890|137580|P8|NOT COMPLETED|Test Period 3||0
58184|NCT01800890|137581|P7|NOT COMPLETED|Test Period 3||0
58185|NCT01800890|137582|P6|NOT COMPLETED|Test Period 3||0
58186|NCT01800890|137583|P5|NOT COMPLETED|Test Period 3||0
58187|NCT01800890|137584|P4|NOT COMPLETED|Test Period 3||0
58188|NCT01800890|137585|P3|NOT COMPLETED|Test Period 3||0
58189|NCT01800890|137586|P2|NOT COMPLETED|Test Period 3||0
58190|NCT01800890|137587|P1|NOT COMPLETED|Test Period 3||0
58191|NCT01800890|137579|P9|COMPLETED|Test Period 3||3
58192|NCT01800890|137580|P8|COMPLETED|Test Period 3||3
58193|NCT01800890|137581|P7|COMPLETED|Test Period 3||3
58194|NCT01800890|137582|P6|COMPLETED|Test Period 3||4
58195|NCT01800890|137583|P5|COMPLETED|Test Period 3||4
58196|NCT01800890|137584|P4|COMPLETED|Test Period 3||2
58197|NCT01800890|137585|P3|COMPLETED|Test Period 3||3
58198|NCT01800890|137586|P2|COMPLETED|Test Period 3||3
58199|NCT01800890|137587|P1|COMPLETED|Test Period 3||3
58200|NCT01800890|137579|P9|STARTED|Test Period 3||3
58201|NCT01800890|137580|P8|STARTED|Test Period 3||3
58202|NCT01800890|137581|P7|STARTED|Test Period 3||3
58203|NCT01800890|137582|P6|STARTED|Test Period 3||4
58204|NCT01800890|137583|P5|STARTED|Test Period 3||4
58205|NCT01800890|137584|P4|STARTED|Test Period 3||2
58206|NCT01800890|137585|P3|STARTED|Test Period 3||3
58207|NCT01800890|137586|P2|STARTED|Test Period 3||3
58208|NCT01800890|137587|P1|STARTED|Test Period 3||3
58209|NCT01800890|137579|P9|NOT COMPLETED|Test Period 2||0
58210|NCT01800890|137580|P8|NOT COMPLETED|Test Period 2||0
58211|NCT01800890|137581|P7|NOT COMPLETED|Test Period 2||0
58212|NCT01800890|137582|P6|NOT COMPLETED|Test Period 2||0
58213|NCT01800890|137583|P5|NOT COMPLETED|Test Period 2||0
58214|NCT01800890|137584|P4|NOT COMPLETED|Test Period 2||0
58215|NCT01800890|137585|P3|NOT COMPLETED|Test Period 2||0
58216|NCT01800890|137586|P2|NOT COMPLETED|Test Period 2||0
58217|NCT01800890|137587|P1|NOT COMPLETED|Test Period 2||0
58218|NCT01800890|137579|P9|COMPLETED|Test Period 2||3
58219|NCT01800890|137580|P8|COMPLETED|Test Period 2||3
58220|NCT01800890|137581|P7|COMPLETED|Test Period 2||3
58221|NCT01800890|137582|P6|COMPLETED|Test Period 2||4
58222|NCT01800890|137583|P5|COMPLETED|Test Period 2||4
58223|NCT01800890|137584|P4|COMPLETED|Test Period 2||2
58224|NCT01800890|137585|P3|COMPLETED|Test Period 2||3
58225|NCT01800890|137586|P2|COMPLETED|Test Period 2||3
58226|NCT01800890|137587|P1|COMPLETED|Test Period 2||3
58227|NCT01800890|137579|P9|STARTED|Test Period 2||3
58228|NCT01800890|137580|P8|STARTED|Test Period 2||3
58229|NCT01800890|137581|P7|STARTED|Test Period 2||3
58230|NCT01800890|137582|P6|STARTED|Test Period 2||4
58231|NCT01800890|137583|P5|STARTED|Test Period 2||4
58232|NCT01800890|137584|P4|STARTED|Test Period 2||2
58233|NCT01800890|137585|P3|STARTED|Test Period 2||3
58234|NCT01800890|137586|P2|STARTED|Test Period 2||3
58235|NCT01800890|137587|P1|STARTED|Test Period 2||3
58236|NCT01800890|137579|P9|NOT COMPLETED|Test Period 1||0
58237|NCT01800890|137580|P8|NOT COMPLETED|Test Period 1||0
58238|NCT01800890|137581|P7|NOT COMPLETED|Test Period 1||0
58239|NCT01800890|137582|P6|NOT COMPLETED|Test Period 1||0
58240|NCT01800890|137583|P5|NOT COMPLETED|Test Period 1||0
58241|NCT01800890|137584|P4|NOT COMPLETED|Test Period 1||1
58242|NCT01800890|137585|P3|NOT COMPLETED|Test Period 1||0
58243|NCT01800890|137586|P2|NOT COMPLETED|Test Period 1||0
58244|NCT01800890|137587|P1|NOT COMPLETED|Test Period 1||0
58245|NCT01800890|137579|P9|COMPLETED|Test Period 1||3
58246|NCT01800890|137580|P8|COMPLETED|Test Period 1||3
58247|NCT01800890|137581|P7|COMPLETED|Test Period 1||3
58248|NCT01800890|137582|P6|COMPLETED|Test Period 1||4
58249|NCT01800890|137583|P5|COMPLETED|Test Period 1||4
58250|NCT01800890|137584|P4|COMPLETED|Test Period 1||2
58251|NCT01800890|137585|P3|COMPLETED|Test Period 1||3
58252|NCT01800890|137586|P2|COMPLETED|Test Period 1||3
58253|NCT01800890|137587|P1|COMPLETED|Test Period 1||3
58254|NCT01800890|137579|P9|STARTED|Test Period 1||3
58255|NCT01800890|137580|P8|STARTED|Test Period 1||3
58256|NCT01800890|137581|P7|STARTED|Test Period 1||3
58257|NCT01800890|137582|P6|STARTED|Test Period 1||4
58258|NCT01800890|137583|P5|STARTED|Test Period 1||4
58259|NCT01800890|137584|P4|STARTED|Test Period 1||3
58260|NCT01800890|137585|P3|STARTED|Test Period 1||3
58261|NCT01800890|137586|P2|STARTED|Test Period 1||3
58262|NCT01800890|137587|P1|STARTED|Test Period 1||3
58263|NCT01800786|137599|P2|NOT COMPLETED|Overall Study||1
58264|NCT01800786|137600|P1|NOT COMPLETED|Overall Study||2
58265|NCT01800786|137599|P2|COMPLETED|Overall Study||15
58266|NCT01800786|137600|P1|COMPLETED|Overall Study||15
58267|NCT01800786|137599|P2|STARTED|Overall Study||16
58268|NCT01800786|137600|P1|STARTED|Overall Study||17
58269|NCT01800318|137610|P4|NOT COMPLETED|Overall Study||1
58270|NCT01800318|137611|P3|NOT COMPLETED|Overall Study||1
58271|NCT01800318|137612|P2|NOT COMPLETED|Overall Study||5
58272|NCT01800318|137613|P1|NOT COMPLETED|Overall Study||2
58273|NCT01800318|137610|P4|COMPLETED|Overall Study||39
58274|NCT01800318|137611|P3|COMPLETED|Overall Study||40
58275|NCT01800318|137612|P2|COMPLETED|Overall Study||37
58276|NCT01800318|137613|P1|COMPLETED|Overall Study||37
58277|NCT01800318|137610|P4|STARTED|Overall Study||40
58278|NCT01800318|137611|P3|STARTED|Overall Study||41
58279|NCT01800318|137612|P2|STARTED|Overall Study||42
58280|NCT01800318|137613|P1|STARTED|Overall Study||39
58281|NCT01800162|137642|P3|NOT COMPLETED|Overall Study||0
58282|NCT01800162|137643|P2|NOT COMPLETED|Overall Study||0
58283|NCT01800162|137644|P1|NOT COMPLETED|Overall Study||0
58284|NCT01800162|137642|P3|COMPLETED|Overall Study||1
58285|NCT01800162|137643|P2|COMPLETED|Overall Study||0
58286|NCT01800162|137644|P1|COMPLETED|Overall Study||1
58287|NCT01800162|137642|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
58288|NCT01800162|137643|P2|STARTED|Overall Study||0
58289|NCT01800162|137644|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
58290|NCT01799941|137668|P1|NOT COMPLETED|Overall Study||96
58291|NCT01799941|137668|P1|COMPLETED|Overall Study||271
58292|NCT01799941|137668|P1|STARTED|Overall Study||367
58293|NCT01799720|137725|P3|NOT COMPLETED|Overall Study||1
58294|NCT01799720|137726|P2|NOT COMPLETED|Overall Study||1
58295|NCT01799720|137727|P1|NOT COMPLETED|Overall Study||3
58296|NCT01799720|137725|P3|COMPLETED|Overall Study||18
58297|NCT01799720|137726|P2|COMPLETED|Overall Study||17
58298|NCT01799720|137727|P1|COMPLETED|Overall Study||17
58299|NCT01799720|137725|P3|Began the Treatment and Finished it|Overall Study||18
58300|NCT01799720|137726|P2|Began the Treatment and Finished it|Overall Study||17
58301|NCT01799720|137727|P1|Began the Treatment and Finished it|Overall Study||17
58302|NCT01799720|137725|P3|Began the Treatment|Overall Study||19
58303|NCT01799720|137726|P2|Began the Treatment|Overall Study||18
58304|NCT01799720|137727|P1|Began the Treatment|Overall Study||20
58305|NCT01799720|137725|P3|STARTED|Overall Study||19
58306|NCT01799720|137726|P2|STARTED|Overall Study||18
58307|NCT01799720|137727|P1|STARTED|Overall Study||20
58308|NCT01799590|137765|P3|NOT COMPLETED|Overall Study||14
58309|NCT01799590|137766|P2|NOT COMPLETED|Overall Study||16
58310|NCT01799590|137767|P1|NOT COMPLETED|Overall Study||26
58311|NCT01799590|137765|P3|COMPLETED|Overall Study||77
58312|NCT01799590|137766|P2|COMPLETED|Overall Study||78
58313|NCT01799590|137767|P1|COMPLETED|Overall Study||85
58314|NCT01799590|137765|P3|STARTED|Overall Study||91
58315|NCT01799590|137766|P2|STARTED|Overall Study||94
58316|NCT01799590|137767|P1|STARTED|Overall Study||111
58317|NCT01799278|137802|P1|NOT COMPLETED|Overall Study||0
58318|NCT01799278|137802|P1|COMPLETED|Overall Study||60
58319|NCT01799278|137802|P1|STARTED|Overall Study||60
58320|NCT01799239|137810|P2|NOT COMPLETED|Period 2 (7 Days)||1
58321|NCT01799239|137811|P1|NOT COMPLETED|Period 2 (7 Days)||2
58322|NCT01799239|137810|P2|COMPLETED|Period 2 (7 Days)||14
58323|NCT01799239|137811|P1|COMPLETED|Period 2 (7 Days)||11
58324|NCT01799239|137810|P2|STARTED|Period 2 (7 Days)||15
58325|NCT01799239|137811|P1|STARTED|Period 2 (7 Days)||13
58326|NCT01799239|137810|P2|NOT COMPLETED|Period 1 (7 Days)||1
58327|NCT01799239|137811|P1|NOT COMPLETED|Period 1 (7 Days)||3
58328|NCT01799239|137810|P2|COMPLETED|Period 1 (7 Days)||15
58329|NCT01799239|137811|P1|COMPLETED|Period 1 (7 Days)||12
58330|NCT01799239|137810|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
58331|NCT01799239|137811|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
58332|NCT01799226|137819|P2|NOT COMPLETED|Overall Study||0
58333|NCT01799226|137820|P1|NOT COMPLETED|Overall Study||2
58334|NCT01799226|137819|P2|COMPLETED|Overall Study||16
58335|NCT01799226|137820|P1|COMPLETED|Overall Study||14
58336|NCT01799226|137819|P2|Left Stent Side|Overall Study||8
58337|NCT01799226|137820|P1|Left Stent Side|Overall Study||8
58338|NCT01799226|137819|P2|Right Stent Side|Overall Study||8
58339|NCT01799226|137820|P1|Right Stent Side|Overall Study||8
58340|NCT01799226|137819|P2|STARTED|Overall Study||16
58341|NCT01799226|137820|P1|STARTED|Overall Study||16
58342|NCT01798992|137832|P4|NOT COMPLETED|Overall Study||1
58343|NCT01798992|137833|P3|NOT COMPLETED|Overall Study||2
58344|NCT01798992|137834|P2|NOT COMPLETED|Overall Study||2
58345|NCT01798992|137835|P1|NOT COMPLETED|Overall Study||0
58346|NCT01798992|137832|P4|COMPLETED|Overall Study||16
58347|NCT01798992|137833|P3|COMPLETED|Overall Study||14
58348|NCT01798992|137834|P2|COMPLETED|Overall Study||17
58349|NCT01798992|137835|P1|COMPLETED|Overall Study||4
58350|NCT01798992|137832|P4|STARTED|Overall Study||17
58351|NCT01798992|137833|P3|STARTED|Overall Study||16
58352|NCT01798992|137834|P2|STARTED|Overall Study||19
58353|NCT01798992|137835|P1|STARTED|Overall Study||4
58354|NCT01798966|137849|P1|NOT COMPLETED|Overall Study||0
58355|NCT01798966|137849|P1|COMPLETED|Overall Study||10
58356|NCT01798966|137849|P1|STARTED|Overall Study||10
58357|NCT01798927|137855|P1|NOT COMPLETED|Overall Study||1
58358|NCT01798927|137855|P1|COMPLETED|Overall Study||3
58359|NCT01798927|137855|P1|STARTED|Overall Study||4
58360|NCT01798706|137863|P2|NOT COMPLETED|Overall Study||21
58361|NCT01798706|137864|P1|NOT COMPLETED|Overall Study||21
58362|NCT01798706|137863|P2|COMPLETED|Overall Study||153
58363|NCT01798706|137864|P1|COMPLETED|Overall Study||155
58364|NCT01798706|137863|P2|STARTED|Overall Study||174
58365|NCT01798706|137864|P1|STARTED|Overall Study||176
58366|NCT01798550|137892|P2|NOT COMPLETED|Overall Study||6
58367|NCT01798550|137893|P1|NOT COMPLETED|Overall Study||2
58368|NCT01798550|137892|P2|COMPLETED|Overall Study||26
58369|NCT01798550|137893|P1|COMPLETED|Overall Study||28
58370|NCT01798550|137892|P2|STARTED|Overall Study||32
58371|NCT01798550|137893|P1|STARTED|Overall Study||30
58372|NCT01798485|137909|P2|NOT COMPLETED|Overall Study||290
58373|NCT01798485|137910|P1|NOT COMPLETED|Overall Study||346
58374|NCT01798485|137909|P2|COMPLETED|Overall Study||59
58375|NCT01798485|137910|P1|COMPLETED|Overall Study||1
58376|NCT01798485|137909|P2|Randomized as of 19 October 2015|Overall Study||337
58377|NCT01798485|137910|P1|Randomized as of 19 October 2015|Overall Study||335
58378|NCT01798485|137909|P2|Safety Population as of 23 Dec 2015|Overall Study||342
58379|NCT01798485|137910|P1|Safety Population as of 23 Dec 2015|Overall Study||338
58380|NCT01798485|137909|P2|STARTED|Overall Study||349
58381|NCT01798485|137910|P1|STARTED|Overall Study||347
58382|NCT01798394|137946|P2|NOT COMPLETED|Overall Study||3
58383|NCT01798394|137947|P1|NOT COMPLETED|Overall Study||3
58384|NCT01798394|137946|P2|COMPLETED|Overall Study||19
58385|NCT01798394|137947|P1|COMPLETED|Overall Study||21
58386|NCT01798394|137946|P2|STARTED|Overall Study||22
58387|NCT01798394|137947|P1|STARTED|Overall Study||24
58388|NCT01798316|137967|P2|NOT COMPLETED|Overall Study||0
58389|NCT01798316|137968|P1|NOT COMPLETED|Overall Study||0
58390|NCT01798316|137967|P2|COMPLETED|Overall Study||53
58391|NCT01798316|137968|P1|COMPLETED|Overall Study||52
58392|NCT01798316|137967|P2|STARTED|Overall Study||53
58393|NCT01798316|137968|P1|STARTED|Overall Study||52
58394|NCT01798264|137990|P4|NOT COMPLETED|Overall Study||4
58395|NCT01798264|137991|P3|NOT COMPLETED|Overall Study||0
58396|NCT01798264|137992|P2|NOT COMPLETED|Overall Study||0
58397|NCT01798264|137993|P1|NOT COMPLETED|Overall Study||1
58398|NCT01798264|137990|P4|COMPLETED|Overall Study||7
58399|NCT01798264|137991|P3|COMPLETED|Overall Study||10
58400|NCT01798264|137992|P2|COMPLETED|Overall Study||11
58401|NCT01798264|137993|P1|COMPLETED|Overall Study||11
58402|NCT01798264|137990|P4|STARTED|Overall Study||11
58403|NCT01798264|137991|P3|STARTED|Overall Study||10
58404|NCT01798264|137992|P2|STARTED|Overall Study||11
58405|NCT01798264|137993|P1|STARTED|Overall Study||12
58406|NCT01798186|138019|P4|NOT COMPLETED|Overall Study||0
58407|NCT01798186|138020|P3|NOT COMPLETED|Overall Study||0
58408|NCT01798186|138021|P2|NOT COMPLETED|Overall Study||0
58409|NCT01798186|138022|P1|NOT COMPLETED|Overall Study||0
58410|NCT01798186|138019|P4|COMPLETED|Overall Study||8
58411|NCT01798186|138020|P3|COMPLETED|Overall Study||6
58412|NCT01798186|138021|P2|COMPLETED|Overall Study||6
58413|NCT01798186|138022|P1|COMPLETED|Overall Study||6
58414|NCT01798186|138019|P4|STARTED|Overall Study||8
58415|NCT01798186|138020|P3|STARTED|Overall Study||6
58416|NCT01798186|138021|P2|STARTED|Overall Study||6
58417|NCT01798186|138022|P1|STARTED|Overall Study||6
58418|NCT01798134|138036|P1|NOT COMPLETED|Overall Study||16
58419|NCT01798134|138036|P1|COMPLETED|Overall Study||9
58420|NCT01798134|138036|P1|STARTED|Overall Study||25
58421|NCT01798004|138043|P1|NOT COMPLETED|Overall Study||87
58422|NCT01798004|138043|P1|COMPLETED|Overall Study||63
58423|NCT01798004|138043|P1|STARTED|Overall Study||150
58424|NCT01797783|138049|P2|NOT COMPLETED|Overall Study||1
58425|NCT01797783|138050|P1|NOT COMPLETED|Overall Study||2
58426|NCT01797783|138049|P2|COMPLETED|Overall Study||26
58427|NCT01797783|138050|P1|COMPLETED|Overall Study||50
58428|NCT01797783|138049|P2|STARTED|Overall Study||27
58429|NCT01797783|138050|P1|STARTED|Overall Study||52
58430|NCT01797731|138074|P2|NOT COMPLETED|Overall Study||3
58431|NCT01797731|138075|P1|NOT COMPLETED|Overall Study||3
58432|NCT01797731|138074|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
58433|NCT01797731|138075|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
58434|NCT01797731|138074|P2|STARTED|Overall Study||50
58435|NCT01797731|138075|P1|STARTED|Overall Study||50
58436|NCT01797705|138083|P1|NOT COMPLETED|Overall Study||5
58437|NCT01797705|138083|P1|COMPLETED|Overall Study||28
58438|NCT01797705|138083|P1|STARTED|Overall Study||33
58439|NCT01797575|138091|P4|NOT COMPLETED|Week 8 Re-Randomization||3
58440|NCT01797575|138092|P3|NOT COMPLETED|Week 8 Re-Randomization||1
58441|NCT01797575|138093|P2|NOT COMPLETED|Week 8 Re-Randomization||0
58442|NCT01797575|138094|P1|NOT COMPLETED|Week 8 Re-Randomization||0
58443|NCT01797575|138091|P4|COMPLETED|Week 8 Re-Randomization||7
58444|NCT01797575|138092|P3|COMPLETED|Week 8 Re-Randomization||4
58445|NCT01797575|138093|P2|COMPLETED|Week 8 Re-Randomization||5
58446|NCT01797575|138094|P1|COMPLETED|Week 8 Re-Randomization||4
58447|NCT01797575|138091|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
58448|NCT01797575|138092|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
58449|NCT01797575|138093|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
58450|NCT01797575|138094|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
58451|NCT01797575|138091|P4|NOT COMPLETED|Baseline Allocation||7
58452|NCT01797575|138092|P3|NOT COMPLETED|Baseline Allocation||5
58453|NCT01797575|138093|P2|NOT COMPLETED|Baseline Allocation||1
58454|NCT01797575|138094|P1|NOT COMPLETED|Baseline Allocation||1
58455|NCT01797575|138091|P4|COMPLETED|Baseline Allocation||8
58456|NCT01797575|138092|P3|COMPLETED|Baseline Allocation||4
58457|NCT01797575|138093|P2|COMPLETED|Baseline Allocation||8
58458|NCT01797575|138094|P1|COMPLETED|Baseline Allocation||4
58459|NCT01797575|138091|P4|STARTED|Baseline Allocation||15
58460|NCT01797575|138092|P3|STARTED|Baseline Allocation||9
58461|NCT01797575|138093|P2|STARTED|Baseline Allocation||9
58462|NCT01797575|138094|P1|STARTED|Baseline Allocation||5
58463|NCT01797536|138148|P4|NOT COMPLETED|Overall Study||0
58464|NCT01797536|138149|P3|NOT COMPLETED|Overall Study||0
58465|NCT01797536|138150|P2|NOT COMPLETED|Overall Study||1
58466|NCT01797536|138151|P1|NOT COMPLETED|Overall Study||0
58467|NCT01797536|138148|P4|COMPLETED|Overall Study||8
58468|NCT01797536|138149|P3|COMPLETED|Overall Study||7
58469|NCT01797536|138150|P2|COMPLETED|Overall Study||10
58470|NCT01797536|138151|P1|COMPLETED|Overall Study||8
58471|NCT01797536|138148|P4|STARTED|Overall Study||8
58472|NCT01797536|138149|P3|STARTED|Overall Study||7
58473|NCT01797536|138150|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
58474|NCT01797536|138151|P1|STARTED|Overall Study||8
58475|NCT01797484|138183|P2|NOT COMPLETED|Overall Study||0
58476|NCT01797484|138184|P1|NOT COMPLETED|Overall Study||0
58477|NCT01797484|138183|P2|COMPLETED|Overall Study||10
58478|NCT01797484|138184|P1|COMPLETED|Overall Study||10
58479|NCT01797484|138183|P2|STARTED|Overall Study||10
58480|NCT01797484|138184|P1|STARTED|Overall Study||10
58481|NCT01797471|138190|P1|NOT COMPLETED|Overall Study||0
58482|NCT01797471|138190|P1|COMPLETED|Overall Study||1
58483|NCT01797471|138190|P1|STARTED|Overall Study||1
58484|NCT01797458|138202|P3|NOT COMPLETED|Overall Study||7
58485|NCT01797458|138203|P2|NOT COMPLETED|Overall Study||9
58486|NCT01797458|138204|P1|NOT COMPLETED|Overall Study||12
58487|NCT01797458|138202|P3|COMPLETED|Overall Study||58
58488|NCT01797458|138203|P2|COMPLETED|Overall Study||43
58489|NCT01797458|138204|P1|COMPLETED|Overall Study||40
58490|NCT01797458|138202|P3|STARTED|Overall Study||65
58491|NCT01797458|138203|P2|STARTED|Overall Study||52
58492|NCT01797458|138204|P1|STARTED|Overall Study||52
58493|NCT01797445|138223|P2|NOT COMPLETED|Overall Study||437
58494|NCT01797445|138224|P1|NOT COMPLETED|Overall Study||435
58495|NCT01797445|138223|P2|COMPLETED|Overall Study||0
58496|NCT01797445|138224|P1|COMPLETED|Overall Study||0
58497|NCT01797445|138223|P2|STARTED|Overall Study||437
58498|NCT01797445|138224|P1|STARTED|Overall Study||435
58499|NCT01797380|138264|P2|NOT COMPLETED|Overall Study||2
58500|NCT01797380|138265|P1|NOT COMPLETED|Overall Study||3
58501|NCT01797380|138264|P2|COMPLETED|Overall Study||0
58502|NCT01797380|138265|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
58503|NCT01797380|138264|P2|STARTED|Overall Study||2
58504|NCT01797380|138265|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
58505|NCT01797328|138273|P2|NOT COMPLETED|Overall Study||0
58506|NCT01797328|138274|P1|NOT COMPLETED|Overall Study||2
58507|NCT01797328|138273|P2|COMPLETED|Overall Study||12
58508|NCT01797328|138274|P1|COMPLETED|Overall Study||14
58509|NCT01797328|138273|P2|STARTED|Overall Study||12
58510|NCT01797328|138274|P1|STARTED|Overall Study||16
58511|NCT01797120|138282|P2|NOT COMPLETED|Overall Study||65
58512|NCT01797120|138283|P1|NOT COMPLETED|Overall Study||66
58513|NCT01797120|138282|P2|COMPLETED|Overall Study||0
58514|NCT01797120|138283|P1|COMPLETED|Overall Study||0
58515|NCT01797120|138282|P2|STARTED|Overall Study||65
58516|NCT01797120|138283|P1|STARTED|Overall Study||66
58517|NCT01797094|138297|P2|NOT COMPLETED|Overall Study||2
58518|NCT01797094|138298|P1|NOT COMPLETED|Overall Study||6
58519|NCT01797094|138297|P2|COMPLETED|Overall Study||51
58520|NCT01797094|138298|P1|COMPLETED|Overall Study||42
58521|NCT01797094|138297|P2|STARTED|Overall Study||53
58522|NCT01797094|138298|P1|STARTED|Overall Study||48
58523|NCT01797081|138320|P4|NOT COMPLETED|Overall Study||9
58524|NCT01797081|138321|P3|NOT COMPLETED|Overall Study||5
58525|NCT01797081|138322|P2|NOT COMPLETED|Overall Study||4
58526|NCT01797081|138323|P1|NOT COMPLETED|Overall Study||14
58527|NCT01797081|138320|P4|COMPLETED|Overall Study||40
58528|NCT01797081|138321|P3|COMPLETED|Overall Study||43
58529|NCT01797081|138322|P2|COMPLETED|Overall Study||95
58530|NCT01797081|138323|P1|COMPLETED|Overall Study||90
58531|NCT01797081|138320|P4|STARTED|Overall Study||49
58532|NCT01797081|138321|P3|STARTED|Overall Study||48
58533|NCT01797081|138322|P2|STARTED|Overall Study||99
58534|NCT01797081|138323|P1|STARTED|Overall Study||104
58535|NCT01797029|138342|P2|NOT COMPLETED|Overall Study||61
58536|NCT01797029|138343|P1|NOT COMPLETED|Overall Study||159
58537|NCT01797029|138342|P2|COMPLETED|Overall Study||526
58538|NCT01797029|138343|P1|COMPLETED|Overall Study||1015
58539|NCT01797029|138342|P2|STARTED|Overall Study||587
58540|NCT01797029|138343|P1|STARTED|Overall Study||1174
58541|NCT01796977|138351|P1|NOT COMPLETED|Overall Study||0
58542|NCT01796977|138351|P1|COMPLETED|Overall Study||27
58543|NCT01796977|138351|P1|STARTED|Overall Study||27
58544|NCT01796964|138364|P2|NOT COMPLETED|Overall Study||3
58545|NCT01796964|138365|P1|NOT COMPLETED|Overall Study||3
58546|NCT01796964|138364|P2|COMPLETED|Overall Study||42
58547|NCT01796964|138365|P1|COMPLETED|Overall Study||41
58548|NCT01796964|138364|P2|STARTED|Overall Study||45
58549|NCT01796964|138365|P1|STARTED|Overall Study||44
58550|NCT01796860|138387|P1|NOT COMPLETED|Overall Study||3
58551|NCT01796860|138387|P1|COMPLETED|Overall Study||7
58552|NCT01796860|138387|P1|STARTED|Overall Study||10
58553|NCT01796548|138393|P1|NOT COMPLETED|Overall Study||3
58554|NCT01796548|138393|P1|COMPLETED|Overall Study||14
58555|NCT01796548|138393|P1|Treated|Overall Study||15
58556|NCT01796548|138393|P1|STARTED|Overall Study||17
58557|NCT01796236|138407|P2|NOT COMPLETED|Overall Study||2
58558|NCT01796236|138408|P1|NOT COMPLETED|Overall Study||2
58559|NCT01796236|138407|P2|COMPLETED|Overall Study||50
58560|NCT01796236|138408|P1|COMPLETED|Overall Study||49
58561|NCT01796236|138407|P2|STARTED|Overall Study||52
58562|NCT01796236|138408|P1|STARTED|Overall Study||51
58563|NCT01795937|138427|P3|NOT COMPLETED|Overall Study||0
58564|NCT01795937|138428|P2|NOT COMPLETED|Overall Study||1
58565|NCT01795937|138429|P1|NOT COMPLETED|Overall Study||1
58566|NCT01795937|138427|P3|COMPLETED|Overall Study||17
58567|NCT01795937|138428|P2|COMPLETED|Overall Study||15
58568|NCT01795937|138429|P1|COMPLETED|Overall Study||17
58569|NCT01795937|138427|P3|STARTED|Overall Study||17
58570|NCT01795937|138428|P2|STARTED|Overall Study||16
58571|NCT01795937|138429|P1|STARTED|Overall Study||18
58572|NCT01795898|138458|P1|NOT COMPLETED|Overall Study||60
58573|NCT01795898|138458|P1|COMPLETED|Overall Study||177
58574|NCT01795898|138458|P1|STARTED|Overall Study||237
58575|NCT01795859|138468|P2|NOT COMPLETED|Overall Study||2
58576|NCT01795859|138469|P1|NOT COMPLETED|Overall Study||1
58577|NCT01795859|138468|P2|COMPLETED|Overall Study||43
58578|NCT01795859|138469|P1|COMPLETED|Overall Study||44
58579|NCT01795859|138468|P2|STARTED|Overall Study||45
58580|NCT01795859|138469|P1|STARTED|Overall Study||45
58581|NCT01795716|138485|P2|NOT COMPLETED|Second Intervention (13 Days)||0
58582|NCT01795716|138486|P1|NOT COMPLETED|Second Intervention (13 Days)||0
58583|NCT01795716|138485|P2|COMPLETED|Second Intervention (13 Days)||11
58584|NCT01795716|138486|P1|COMPLETED|Second Intervention (13 Days)||10
58585|NCT01795716|138485|P2|STARTED|Second Intervention (13 Days)||11
58586|NCT01795716|138486|P1|STARTED|Second Intervention (13 Days)||10
58587|NCT01795716|138485|P2|NOT COMPLETED|Washout (10 Days)||0
58588|NCT01795716|138486|P1|NOT COMPLETED|Washout (10 Days)||0
58589|NCT01795716|138485|P2|COMPLETED|Washout (10 Days)||11
58590|NCT01795716|138486|P1|COMPLETED|Washout (10 Days)||10
58591|NCT01795716|138485|P2|STARTED|Washout (10 Days)||11
58592|NCT01795716|138486|P1|STARTED|Washout (10 Days)||10
58593|NCT01795716|138485|P2|NOT COMPLETED|First Intervention (13 Days)||0
58594|NCT01795716|138486|P1|NOT COMPLETED|First Intervention (13 Days)||0
58595|NCT01795716|138485|P2|COMPLETED|First Intervention (13 Days)||11
58596|NCT01795716|138486|P1|COMPLETED|First Intervention (13 Days)||10
58597|NCT01795716|138485|P2|STARTED|First Intervention (13 Days)||11
58598|NCT01795716|138486|P1|STARTED|First Intervention (13 Days)||10
58599|NCT01795547|138494|P2|NOT COMPLETED|Overall Study||64
58600|NCT01795547|138495|P1|NOT COMPLETED|Overall Study||48
58601|NCT01795547|138494|P2|COMPLETED|Overall Study||83
58602|NCT01795547|138495|P1|COMPLETED|Overall Study||100
58603|NCT01795547|138494|P2|STARTED|Overall Study||147
58604|NCT01795547|138495|P1|STARTED|Overall Study||148
58605|NCT01795534|138517|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
58606|NCT01795534|138518|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
58607|NCT01795534|138517|P2|COMPLETED|Second Intervention (Second Shot)||5
58608|NCT01795534|138518|P1|COMPLETED|Second Intervention (Second Shot)||5
58609|NCT01795534|138517|P2|STARTED|Second Intervention (Second Shot)||5
58610|NCT01795534|138518|P1|STARTED|Second Intervention (Second Shot)||5
58611|NCT01795534|138517|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
58612|NCT01795534|138518|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
58613|NCT01795534|138517|P2|COMPLETED|Wash Out Period (4 Days)||5
58614|NCT01795534|138518|P1|COMPLETED|Wash Out Period (4 Days)||5
58615|NCT01795534|138517|P2|STARTED|Wash Out Period (4 Days)||5
58616|NCT01795534|138518|P1|STARTED|Wash Out Period (4 Days)||5
58617|NCT01795534|138517|P2|NOT COMPLETED|First Intervention (First Shot)||0
58618|NCT01795534|138518|P1|NOT COMPLETED|First Intervention (First Shot)||0
58619|NCT01795534|138517|P2|COMPLETED|First Intervention (First Shot)||5
58620|NCT01795534|138518|P1|COMPLETED|First Intervention (First Shot)||5
58621|NCT01795534|138517|P2|STARTED|First Intervention (First Shot)||5
58622|NCT01795534|138518|P1|STARTED|First Intervention (First Shot)||5
58623|NCT01795495|138527|P3|NOT COMPLETED|Overall Study||2
58624|NCT01795495|138528|P2|NOT COMPLETED|Overall Study||0
58625|NCT01795495|138529|P1|NOT COMPLETED|Overall Study||1
58626|NCT01795495|138527|P3|COMPLETED|Overall Study||19
58627|NCT01795495|138528|P2|COMPLETED|Overall Study||22
58628|NCT01795495|138529|P1|COMPLETED|Overall Study||19
58629|NCT01795495|138527|P3|STARTED|Overall Study||21
58630|NCT01795495|138528|P2|STARTED|Overall Study||22
58631|NCT01795495|138529|P1|STARTED|Overall Study||20
58632|NCT01794949|138542|P2|NOT COMPLETED|Overall Study||0
58633|NCT01794949|138543|P1|NOT COMPLETED|Overall Study||1
58634|NCT01794949|138542|P2|COMPLETED|Overall Study||1
58635|NCT01794949|138543|P1|COMPLETED|Overall Study||6
58636|NCT01794949|138542|P2|6 Month Follow-up|Overall Study||1
58637|NCT01794949|138543|P1|6 Month Follow-up|Overall Study||6
58638|NCT01794949|138542|P2|STARTED|Overall Study||1
58639|NCT01794949|138543|P1|STARTED|Overall Study||7
58640|NCT01794936|138549|P1|NOT COMPLETED|Overall Study||0
58641|NCT01794936|138549|P1|COMPLETED|Overall Study||9
58642|NCT01794936|138549|P1|STARTED|Overall Study||9
58643|NCT01794845|138554|P1|NOT COMPLETED|Overall Study||1
58644|NCT01794845|138554|P1|COMPLETED|Overall Study||4
58645|NCT01794845|138554|P1|STARTED|Overall Study||5
58646|NCT01794806|138563|P2|NOT COMPLETED|Overall Study||1
58647|NCT01794806|138564|P1|NOT COMPLETED|Overall Study||5
58648|NCT01794806|138563|P2|COMPLETED|Overall Study||27
58649|NCT01794806|138564|P1|COMPLETED|Overall Study||26
58650|NCT01794806|138563|P2|4 Weeks|Overall Study||27
58651|NCT01794806|138564|P1|4 Weeks|Overall Study||26
58652|NCT01794806|138563|P2|1 Week|Overall Study||28
58653|NCT01794806|138564|P1|1 Week|Overall Study||28
58654|NCT01794806|138563|P2|STARTED|Overall Study||28
58655|NCT01794806|138564|P1|STARTED|Overall Study||31
58656|NCT01794741|138576|P2|NOT COMPLETED|Overall Study||9
58657|NCT01794741|138577|P1|NOT COMPLETED|Overall Study||19
58658|NCT01794741|138576|P2|COMPLETED|Overall Study||92
58659|NCT01794741|138577|P1|COMPLETED|Overall Study||285
58660|NCT01794741|138576|P2|STARTED|Overall Study||101
58661|NCT01794741|138577|P1|STARTED|Overall Study||304
58662|NCT01794455|138585|P2|NOT COMPLETED|Overall Study||0
58663|NCT01794455|138586|P1|NOT COMPLETED|Overall Study||0
58664|NCT01794455|138585|P2|COMPLETED|Overall Study||1
58665|NCT01794455|138586|P1|COMPLETED|Overall Study||0
58666|NCT01794455|138585|P2|STARTED|Overall Study||1
58667|NCT01794455|138586|P1|STARTED|Overall Study||0
58668|NCT01794000|138604|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
58669|NCT01794000|138605|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
58670|NCT01794000|138604|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
58671|NCT01794000|138605|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
58672|NCT01794000|138604|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
58673|NCT01794000|138605|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
58674|NCT01794000|138604|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
58675|NCT01794000|138605|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
58676|NCT01794000|138604|P2|COMPLETED|Double-Blind Phase (DBP)||4
58677|NCT01794000|138605|P1|COMPLETED|Double-Blind Phase (DBP)||2
58678|NCT01794000|138604|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
58679|NCT01794000|138605|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
58680|NCT01794000|138604|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
58681|NCT01794000|138605|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
58682|NCT01794000|138604|P2|STARTED|Double-Blind Phase (DBP)||170
58683|NCT01794000|138605|P1|STARTED|Double-Blind Phase (DBP)||171
58684|NCT01793935|138638|P2|NOT COMPLETED|Overall Study||3
58685|NCT01793935|138639|P1|NOT COMPLETED|Overall Study||6
58686|NCT01793935|138638|P2|COMPLETED|Overall Study||31
58687|NCT01793935|138639|P1|COMPLETED|Overall Study||28
58688|NCT01793935|138638|P2|STARTED|Overall Study||34
58689|NCT01793935|138639|P1|STARTED|Overall Study||34
58690|NCT01793883|138676|P3|NOT COMPLETED|Overall Study||8
58691|NCT01793883|138677|P2|NOT COMPLETED|Overall Study||10
58692|NCT01793883|138678|P1|NOT COMPLETED|Overall Study||12
58693|NCT01793883|138676|P3|COMPLETED|Overall Study||204
58694|NCT01793883|138677|P2|COMPLETED|Overall Study||204
58695|NCT01793883|138678|P1|COMPLETED|Overall Study||201
58696|NCT01793883|138676|P3|STARTED|Overall Study||212
58697|NCT01793883|138677|P2|STARTED|Overall Study||214
58698|NCT01793883|138678|P1|STARTED|Overall Study||213
58699|NCT01793688|138686|P1|NOT COMPLETED|Overall Study||2
58700|NCT01793688|138686|P1|COMPLETED|Overall Study||980
58701|NCT01793688|138686|P1|STARTED|Overall Study||982
58702|NCT01793285|138693|P1|NOT COMPLETED|Overall Study||0
58703|NCT01793285|138693|P1|COMPLETED|Overall Study||85
58704|NCT01793285|138693|P1|STARTED|Overall Study||85
58705|NCT01792986|138713|P1|NOT COMPLETED|Overall Study||0
58706|NCT01792986|138713|P1|COMPLETED|Overall Study||12
58707|NCT01792986|138713|P1|STARTED|Overall Study||12
58708|NCT01792830|138728|P7|NOT COMPLETED|Overall Study||3
58709|NCT01792830|138729|P6|NOT COMPLETED|Overall Study||0
58710|NCT01792830|138730|P5|NOT COMPLETED|Overall Study||12
58711|NCT01792830|138731|P4|NOT COMPLETED|Overall Study||5
58712|NCT01792830|138732|P3|NOT COMPLETED|Overall Study||0
58713|NCT01792830|138733|P2|NOT COMPLETED|Overall Study||0
58714|NCT01792830|138734|P1|NOT COMPLETED|Overall Study||25
58715|NCT01792830|138728|P7|COMPLETED|Overall Study||9
58716|NCT01792830|138729|P6|COMPLETED|Overall Study||4
58717|NCT01792830|138730|P5|COMPLETED|Overall Study||29
58718|NCT01792830|138731|P4|COMPLETED|Overall Study||22
58719|NCT01792830|138732|P3|COMPLETED|Overall Study||4
58720|NCT01792830|138733|P2|COMPLETED|Overall Study||3
58721|NCT01792830|138734|P1|COMPLETED|Overall Study||59
58722|NCT01792830|138728|P7|STARTED|Overall Study||12
58723|NCT01792830|138729|P6|STARTED|Overall Study||4
58724|NCT01792830|138730|P5|STARTED|Overall Study||41
58725|NCT01792830|138731|P4|STARTED|Overall Study||27
58726|NCT01792830|138732|P3|STARTED|Overall Study||4
58727|NCT01792830|138733|P2|STARTED|Overall Study||3
58728|NCT01792830|138734|P1|STARTED|Overall Study||84
58729|NCT01792817|138764|P3|NOT COMPLETED|Phase 2 Open Label||26
58730|NCT01792817|138765|P2|NOT COMPLETED|Phase 2 Open Label||0
58731|NCT01792817|138766|P1|NOT COMPLETED|Phase 2 Open Label||0
58732|NCT01792817|138764|P3|COMPLETED|Phase 2 Open Label||74
58733|NCT01792817|138765|P2|COMPLETED|Phase 2 Open Label||0
58734|NCT01792817|138766|P1|COMPLETED|Phase 2 Open Label||0
58735|NCT01792817|138764|P3|STARTED|Phase 2 Open Label||100
58736|NCT01792817|138765|P2|STARTED|Phase 2 Open Label||0
58737|NCT01792817|138766|P1|STARTED|Phase 2 Open Label||0
58738|NCT01792817|138764|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
58739|NCT01792817|138765|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
58740|NCT01792817|138766|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
58741|NCT01792817|138764|P3|COMPLETED|Phase 1 Double Blind Period||0
58742|NCT01792817|138765|P2|COMPLETED|Phase 1 Double Blind Period||42
58743|NCT01792817|138766|P1|COMPLETED|Phase 1 Double Blind Period||58
58744|NCT01792817|138764|P3|STARTED|Phase 1 Double Blind Period||0
58745|NCT01792817|138765|P2|STARTED|Phase 1 Double Blind Period||73
58746|NCT01792817|138766|P1|STARTED|Phase 1 Double Blind Period||77
58747|NCT01792635|138782|P3|NOT COMPLETED|Part B||4
58748|NCT01792635|138783|P2|NOT COMPLETED|Part B||4
58749|NCT01792635|138784|P1|NOT COMPLETED|Part B||0
58750|NCT01792635|138782|P3|COMPLETED|Part B||3
58751|NCT01792635|138783|P2|COMPLETED|Part B||2
58752|NCT01792635|138784|P1|COMPLETED|Part B||0
58753|NCT01792635|138782|P3|STARTED|Part B||7
58754|NCT01792635|138783|P2|STARTED|Part B||6
58755|NCT01792635|138784|P1|STARTED|Part B||0
58756|NCT01792635|138782|P3|NOT COMPLETED|Part A||0
58757|NCT01792635|138783|P2|NOT COMPLETED|Part A||0
58758|NCT01792635|138784|P1|NOT COMPLETED|Part A||0
58759|NCT01792635|138782|P3|COMPLETED|Part A||0
58760|NCT01792635|138783|P2|COMPLETED|Part A||0
58761|NCT01792635|138784|P1|COMPLETED|Part A||6
58762|NCT01792635|138782|P3|STARTED|Part A||0
58763|NCT01792635|138783|P2|STARTED|Part A||0
58764|NCT01792635|138784|P1|STARTED|Part A||6
58765|NCT01792518|138812|P2|NOT COMPLETED|Overall Study||7
58766|NCT01792518|138813|P1|NOT COMPLETED|Overall Study||8
58767|NCT01792518|138812|P2|COMPLETED|Overall Study||175
58768|NCT01792518|138813|P1|COMPLETED|Overall Study||170
58769|NCT01792518|138812|P2|STARTED|Overall Study||182
58770|NCT01792518|138813|P1|STARTED|Overall Study||178
58771|NCT01792284|138823|P3|NOT COMPLETED|Randomization Period 2||0
58772|NCT01792284|138824|P2|NOT COMPLETED|Randomization Period 2||3
58773|NCT01792284|138825|P1|NOT COMPLETED|Randomization Period 2||0
58774|NCT01792284|138823|P3|COMPLETED|Randomization Period 2||85
58775|NCT01792284|138824|P2|COMPLETED|Randomization Period 2||87
58776|NCT01792284|138825|P1|COMPLETED|Randomization Period 2||0
58777|NCT01792284|138823|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
58778|NCT01792284|138824|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
58779|NCT01792284|138825|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
58780|NCT01792284|138823|P3|STARTED|Randomization Period 2||85
58781|NCT01792284|138824|P2|STARTED|Randomization Period 2||90
58782|NCT01792284|138825|P1|STARTED|Randomization Period 2||0
58783|NCT01792284|138823|P3|NOT COMPLETED|Randomization Period 1||5
58784|NCT01792284|138824|P2|NOT COMPLETED|Randomization Period 1||2
58785|NCT01792284|138825|P1|NOT COMPLETED|Randomization Period 1||0
58786|NCT01792284|138823|P3|COMPLETED|Randomization Period 1||85
58787|NCT01792284|138824|P2|COMPLETED|Randomization Period 1||90
58788|NCT01792284|138825|P1|COMPLETED|Randomization Period 1||0
58789|NCT01792284|138823|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
58790|NCT01792284|138824|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
58791|NCT01792284|138825|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
58792|NCT01792284|138823|P3|STARTED|Randomization Period 1||90
58793|NCT01792284|138824|P2|STARTED|Randomization Period 1||92
58794|NCT01792284|138825|P1|STARTED|Randomization Period 1||0
58795|NCT01792284|138823|P3|NOT COMPLETED|Lead-in Period||0
58796|NCT01792284|138824|P2|NOT COMPLETED|Lead-in Period||0
58797|NCT01792284|138825|P1|NOT COMPLETED|Lead-in Period||30
58798|NCT01792284|138823|P3|COMPLETED|Lead-in Period||0
58799|NCT01792284|138824|P2|COMPLETED|Lead-in Period||0
58800|NCT01792284|138825|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
58801|NCT01792284|138823|P3|STARTED|Lead-in Period||0
58802|NCT01792284|138824|P2|STARTED|Lead-in Period||0
58803|NCT01792284|138825|P1|STARTED|Lead-in Period||212
58804|NCT01792024|138863|P1|NOT COMPLETED|Overall Study||0
58805|NCT01792024|138863|P1|COMPLETED|Overall Study||27
58806|NCT01792024|138863|P1|STARTED|Overall Study||27
58807|NCT01791972|138873|P2|NOT COMPLETED|Overall Study||0
58808|NCT01791972|138874|P1|NOT COMPLETED|Overall Study||0
58809|NCT01791972|138873|P2|COMPLETED|Overall Study||19
58810|NCT01791972|138874|P1|COMPLETED|Overall Study||19
58811|NCT01791972|138873|P2|STARTED|Overall Study||19
58812|NCT01791972|138874|P1|STARTED|Overall Study||19
58813|NCT01791894|138884|P1|NOT COMPLETED|Overall Study||1
58814|NCT01791894|138884|P1|COMPLETED|Overall Study||4
58815|NCT01791894|138884|P1|STARTED|Overall Study||5
58816|NCT01791803|138895|P4|NOT COMPLETED|Overall Study||5
58817|NCT01791803|138896|P3|NOT COMPLETED|Overall Study||2
58818|NCT01791803|138897|P2|NOT COMPLETED|Overall Study||2
58819|NCT01791803|138898|P1|NOT COMPLETED|Overall Study||0
58820|NCT01791803|138895|P4|COMPLETED|Overall Study||37
58821|NCT01791803|138896|P3|COMPLETED|Overall Study||38
58822|NCT01791803|138897|P2|COMPLETED|Overall Study||39
58823|NCT01791803|138898|P1|COMPLETED|Overall Study||41
58824|NCT01791803|138895|P4|STARTED|Overall Study||42
58825|NCT01791803|138896|P3|STARTED|Overall Study||40
58826|NCT01791803|138897|P2|STARTED|Overall Study||41
58827|NCT01791803|138898|P1|STARTED|Overall Study||41
58828|NCT01791725|138916|P3|NOT COMPLETED|Overall Study||0
58829|NCT01791725|138917|P2|NOT COMPLETED|Overall Study||1
58830|NCT01791725|138918|P1|NOT COMPLETED|Overall Study||0
58831|NCT01791725|138916|P3|COMPLETED|Overall Study||6
58832|NCT01791725|138917|P2|COMPLETED|Overall Study||4
58833|NCT01791725|138918|P1|COMPLETED|Overall Study||12
58834|NCT01791725|138916|P3|STARTED|Overall Study||6
58835|NCT01791725|138917|P2|STARTED|Overall Study||5
58836|NCT01791725|138918|P1|STARTED|Overall Study||12
58837|NCT01791517|138941|P12|NOT COMPLETED|Phase II||1
58838|NCT01791517|138942|P11|NOT COMPLETED|Phase II||1
58839|NCT01791517|138943|P10|NOT COMPLETED|Phase II||3
58840|NCT01791517|138944|P9|NOT COMPLETED|Phase II||2
58841|NCT01791517|138945|P8|NOT COMPLETED|Phase II||3
58842|NCT01791517|138946|P7|NOT COMPLETED|Phase II||2
58843|NCT01791517|138947|P6|NOT COMPLETED|Phase II||4
58844|NCT01791517|138948|P5|NOT COMPLETED|Phase II||2
58845|NCT01791517|138949|P4|NOT COMPLETED|Phase II||0
58846|NCT01791517|138950|P3|NOT COMPLETED|Phase II||1
58847|NCT01791517|138951|P2|NOT COMPLETED|Phase II||0
58848|NCT01791517|138952|P1|NOT COMPLETED|Phase II||2
58849|NCT01791517|138941|P12|COMPLETED|Phase II||17
58850|NCT01791517|138942|P11|COMPLETED|Phase II||15
58851|NCT01791517|138943|P10|COMPLETED|Phase II||15
58852|NCT01791517|138944|P9|COMPLETED|Phase II||17
58853|NCT01791517|138945|P8|COMPLETED|Phase II||17
58854|NCT01791517|138946|P7|COMPLETED|Phase II||17
58855|NCT01791517|138947|P6|COMPLETED|Phase II||14
58856|NCT01791517|138948|P5|COMPLETED|Phase II||16
58857|NCT01791517|138949|P4|COMPLETED|Phase II||15
58858|NCT01791517|138950|P3|COMPLETED|Phase II||15
58859|NCT01791517|138951|P2|COMPLETED|Phase II||14
58860|NCT01791517|138952|P1|COMPLETED|Phase II||15
58861|NCT01791517|138941|P12|STARTED|Phase II||18
58862|NCT01791517|138942|P11|STARTED|Phase II||16
58863|NCT01791517|138943|P10|STARTED|Phase II||18
58864|NCT01791517|138944|P9|STARTED|Phase II||19
58865|NCT01791517|138945|P8|STARTED|Phase II||20
58866|NCT01791517|138946|P7|STARTED|Phase II||19
58867|NCT01791517|138947|P6|STARTED|Phase II||18
58868|NCT01791517|138948|P5|STARTED|Phase II||18
58869|NCT01791517|138949|P4|STARTED|Phase II||15
58870|NCT01791517|138950|P3|STARTED|Phase II||16
58871|NCT01791517|138951|P2|STARTED|Phase II||14
58872|NCT01791517|138952|P1|STARTED|Phase II||17
58873|NCT01791517|138941|P12|NOT COMPLETED|Phase I: Period 4||0
58874|NCT01791517|138942|P11|NOT COMPLETED|Phase I: Period 4||0
58875|NCT01791517|138943|P10|NOT COMPLETED|Phase I: Period 4||0
58876|NCT01791517|138944|P9|NOT COMPLETED|Phase I: Period 4||0
58877|NCT01791517|138945|P8|NOT COMPLETED|Phase I: Period 4||0
58878|NCT01791517|138946|P7|NOT COMPLETED|Phase I: Period 4||0
58879|NCT01791517|138947|P6|NOT COMPLETED|Phase I: Period 4||0
58880|NCT01791517|138948|P5|NOT COMPLETED|Phase I: Period 4||0
58881|NCT01791517|138949|P4|NOT COMPLETED|Phase I: Period 4||0
58882|NCT01791517|138950|P3|NOT COMPLETED|Phase I: Period 4||0
58883|NCT01791517|138951|P2|NOT COMPLETED|Phase I: Period 4||0
58884|NCT01791517|138952|P1|NOT COMPLETED|Phase I: Period 4||0
58885|NCT01791517|138941|P12|COMPLETED|Phase I: Period 4||18
58886|NCT01791517|138942|P11|COMPLETED|Phase I: Period 4||16
58887|NCT01791517|138943|P10|COMPLETED|Phase I: Period 4||18
58888|NCT01791517|138944|P9|COMPLETED|Phase I: Period 4||19
58889|NCT01791517|138945|P8|COMPLETED|Phase I: Period 4||20
58890|NCT01791517|138946|P7|COMPLETED|Phase I: Period 4||19
58891|NCT01791517|138947|P6|COMPLETED|Phase I: Period 4||18
58892|NCT01791517|138948|P5|COMPLETED|Phase I: Period 4||18
58893|NCT01791517|138949|P4|COMPLETED|Phase I: Period 4||15
58894|NCT01791517|138950|P3|COMPLETED|Phase I: Period 4||16
58895|NCT01791517|138951|P2|COMPLETED|Phase I: Period 4||14
58896|NCT01791517|138952|P1|COMPLETED|Phase I: Period 4||17
58897|NCT01791517|138941|P12|STARTED|Phase I: Period 4||18
58898|NCT01791517|138942|P11|STARTED|Phase I: Period 4||16
58899|NCT01791517|138943|P10|STARTED|Phase I: Period 4||18
58900|NCT01791517|138944|P9|STARTED|Phase I: Period 4||19
58901|NCT01791517|138945|P8|STARTED|Phase I: Period 4||20
58902|NCT01791517|138946|P7|STARTED|Phase I: Period 4||19
58903|NCT01791517|138947|P6|STARTED|Phase I: Period 4||18
58904|NCT01791517|138948|P5|STARTED|Phase I: Period 4||18
58905|NCT01791517|138949|P4|STARTED|Phase I: Period 4||15
58906|NCT01791517|138950|P3|STARTED|Phase I: Period 4||16
58907|NCT01791517|138951|P2|STARTED|Phase I: Period 4||14
58908|NCT01791517|138952|P1|STARTED|Phase I: Period 4||17
58909|NCT01791517|138941|P12|NOT COMPLETED|Phase I: Period 3||1
58910|NCT01791517|138942|P11|NOT COMPLETED|Phase I: Period 3||0
58911|NCT01791517|138943|P10|NOT COMPLETED|Phase I: Period 3||0
58912|NCT01791517|138944|P9|NOT COMPLETED|Phase I: Period 3||0
58913|NCT01791517|138945|P8|NOT COMPLETED|Phase I: Period 3||0
58914|NCT01791517|138946|P7|NOT COMPLETED|Phase I: Period 3||0
58915|NCT01791517|138947|P6|NOT COMPLETED|Phase I: Period 3||0
58916|NCT01791517|138948|P5|NOT COMPLETED|Phase I: Period 3||1
58917|NCT01791517|138949|P4|NOT COMPLETED|Phase I: Period 3||1
58918|NCT01791517|138950|P3|NOT COMPLETED|Phase I: Period 3||0
58919|NCT01791517|138951|P2|NOT COMPLETED|Phase I: Period 3||1
58920|NCT01791517|138952|P1|NOT COMPLETED|Phase I: Period 3||0
58921|NCT01791517|138941|P12|COMPLETED|Phase I: Period 3||18
58922|NCT01791517|138942|P11|COMPLETED|Phase I: Period 3||16
58923|NCT01791517|138943|P10|COMPLETED|Phase I: Period 3||18
58924|NCT01791517|138944|P9|COMPLETED|Phase I: Period 3||19
58925|NCT01791517|138945|P8|COMPLETED|Phase I: Period 3||20
58926|NCT01791517|138946|P7|COMPLETED|Phase I: Period 3||19
58927|NCT01791517|138947|P6|COMPLETED|Phase I: Period 3||18
58928|NCT01791517|138948|P5|COMPLETED|Phase I: Period 3||18
58929|NCT01791517|138949|P4|COMPLETED|Phase I: Period 3||15
58930|NCT01791517|138950|P3|COMPLETED|Phase I: Period 3||16
58931|NCT01791517|138951|P2|COMPLETED|Phase I: Period 3||14
58932|NCT01791517|138952|P1|COMPLETED|Phase I: Period 3||17
58933|NCT01791517|138941|P12|STARTED|Phase I: Period 3||19
58934|NCT01791517|138942|P11|STARTED|Phase I: Period 3||16
58935|NCT01791517|138943|P10|STARTED|Phase I: Period 3||18
58936|NCT01791517|138944|P9|STARTED|Phase I: Period 3||19
58937|NCT01791517|138945|P8|STARTED|Phase I: Period 3||20
58938|NCT01791517|138946|P7|STARTED|Phase I: Period 3||19
58939|NCT01791517|138947|P6|STARTED|Phase I: Period 3||18
58940|NCT01791517|138948|P5|STARTED|Phase I: Period 3||19
58941|NCT01791517|138949|P4|STARTED|Phase I: Period 3||16
58942|NCT01791517|138950|P3|STARTED|Phase I: Period 3||16
58943|NCT01791517|138951|P2|STARTED|Phase I: Period 3||15
58944|NCT01791517|138952|P1|STARTED|Phase I: Period 3||17
58945|NCT01791517|138941|P12|NOT COMPLETED|Phase I: Period 2||0
58946|NCT01791517|138942|P11|NOT COMPLETED|Phase I: Period 2||2
58947|NCT01791517|138943|P10|NOT COMPLETED|Phase I: Period 2||1
58948|NCT01791517|138944|P9|NOT COMPLETED|Phase I: Period 2||0
58949|NCT01791517|138945|P8|NOT COMPLETED|Phase I: Period 2||0
58950|NCT01791517|138946|P7|NOT COMPLETED|Phase I: Period 2||0
58951|NCT01791517|138947|P6|NOT COMPLETED|Phase I: Period 2||1
58952|NCT01791517|138948|P5|NOT COMPLETED|Phase I: Period 2||0
58953|NCT01791517|138949|P4|NOT COMPLETED|Phase I: Period 2||1
58954|NCT01791517|138950|P3|NOT COMPLETED|Phase I: Period 2||2
58955|NCT01791517|138951|P2|NOT COMPLETED|Phase I: Period 2||3
58956|NCT01791517|138952|P1|NOT COMPLETED|Phase I: Period 2||1
58957|NCT01791517|138941|P12|COMPLETED|Phase I: Period 2||19
58958|NCT01791517|138942|P11|COMPLETED|Phase I: Period 2||16
58959|NCT01791517|138943|P10|COMPLETED|Phase I: Period 2||18
58960|NCT01791517|138944|P9|COMPLETED|Phase I: Period 2||19
58961|NCT01791517|138945|P8|COMPLETED|Phase I: Period 2||20
58962|NCT01791517|138946|P7|COMPLETED|Phase I: Period 2||19
58963|NCT01791517|138947|P6|COMPLETED|Phase I: Period 2||18
58964|NCT01791517|138948|P5|COMPLETED|Phase I: Period 2||19
58965|NCT01791517|138949|P4|COMPLETED|Phase I: Period 2||16
58966|NCT01791517|138950|P3|COMPLETED|Phase I: Period 2||16
58967|NCT01791517|138951|P2|COMPLETED|Phase I: Period 2||15
58968|NCT01791517|138952|P1|COMPLETED|Phase I: Period 2||17
58969|NCT01791517|138941|P12|STARTED|Phase I: Period 2||19
58970|NCT01791517|138942|P11|STARTED|Phase I: Period 2||18
58971|NCT01791517|138943|P10|STARTED|Phase I: Period 2||19
58972|NCT01791517|138944|P9|STARTED|Phase I: Period 2||19
58973|NCT01791517|138945|P8|STARTED|Phase I: Period 2||20
58974|NCT01791517|138946|P7|STARTED|Phase I: Period 2||19
58975|NCT01791517|138947|P6|STARTED|Phase I: Period 2||19
58976|NCT01791517|138948|P5|STARTED|Phase I: Period 2||19
58977|NCT01791517|138949|P4|STARTED|Phase I: Period 2||17
58978|NCT01791517|138950|P3|STARTED|Phase I: Period 2||18
58979|NCT01791517|138951|P2|STARTED|Phase I: Period 2||18
58980|NCT01791517|138952|P1|STARTED|Phase I: Period 2||18
58981|NCT01791517|138941|P12|NOT COMPLETED|Phase I: Period 1||1
58982|NCT01791517|138942|P11|NOT COMPLETED|Phase I: Period 1||0
58983|NCT01791517|138943|P10|NOT COMPLETED|Phase I: Period 1||1
58984|NCT01791517|138944|P9|NOT COMPLETED|Phase I: Period 1||1
58985|NCT01791517|138945|P8|NOT COMPLETED|Phase I: Period 1||0
58986|NCT01791517|138946|P7|NOT COMPLETED|Phase I: Period 1||1
58987|NCT01791517|138947|P6|NOT COMPLETED|Phase I: Period 1||1
58988|NCT01791517|138948|P5|NOT COMPLETED|Phase I: Period 1||1
58989|NCT01791517|138949|P4|NOT COMPLETED|Phase I: Period 1||2
58990|NCT01791517|138950|P3|NOT COMPLETED|Phase I: Period 1||2
58991|NCT01791517|138951|P2|NOT COMPLETED|Phase I: Period 1||2
58992|NCT01791517|138952|P1|NOT COMPLETED|Phase I: Period 1||1
58993|NCT01791517|138941|P12|COMPLETED|Phase I: Period 1||19
58994|NCT01791517|138942|P11|COMPLETED|Phase I: Period 1||18
58995|NCT01791517|138943|P10|COMPLETED|Phase I: Period 1||19
58996|NCT01791517|138944|P9|COMPLETED|Phase I: Period 1||19
58997|NCT01791517|138945|P8|COMPLETED|Phase I: Period 1||20
58998|NCT01791517|138946|P7|COMPLETED|Phase I: Period 1||19
58999|NCT01791517|138947|P6|COMPLETED|Phase I: Period 1||19
59000|NCT01791517|138948|P5|COMPLETED|Phase I: Period 1||19
59001|NCT01791517|138949|P4|COMPLETED|Phase I: Period 1||17
59002|NCT01791517|138950|P3|COMPLETED|Phase I: Period 1||18
59003|NCT01791517|138951|P2|COMPLETED|Phase I: Period 1||18
59004|NCT01791517|138952|P1|COMPLETED|Phase I: Period 1||18
59005|NCT01791517|138941|P12|STARTED|Phase I: Period 1||20
59006|NCT01791517|138942|P11|STARTED|Phase I: Period 1||18
59007|NCT01791517|138943|P10|STARTED|Phase I: Period 1||20
59008|NCT01791517|138944|P9|STARTED|Phase I: Period 1||20
59009|NCT01791517|138945|P8|STARTED|Phase I: Period 1||20
59010|NCT01791517|138946|P7|STARTED|Phase I: Period 1||20
59011|NCT01791517|138947|P6|STARTED|Phase I: Period 1||20
59012|NCT01791517|138948|P5|STARTED|Phase I: Period 1||20
59013|NCT01791517|138949|P4|STARTED|Phase I: Period 1||19
59014|NCT01791517|138950|P3|STARTED|Phase I: Period 1||20
59015|NCT01791517|138951|P2|STARTED|Phase I: Period 1||20
59016|NCT01791517|138952|P1|STARTED|Phase I: Period 1||19
59017|NCT01791491|138978|P1|NOT COMPLETED|Overall Study||0
59018|NCT01791491|138978|P1|COMPLETED|Overall Study||9
59019|NCT01791491|138978|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
59020|NCT01791465|138990|P1|NOT COMPLETED|Overall Study||0
59021|NCT01791465|138990|P1|COMPLETED|Overall Study||6
59022|NCT01791465|138990|P1|STARTED|Overall Study||6
59023|NCT01791413|139016|P2|NOT COMPLETED|Overall Study||1
59024|NCT01791413|139017|P1|NOT COMPLETED|Overall Study||5
59025|NCT01791413|139016|P2|COMPLETED|Overall Study||19
59026|NCT01791413|139017|P1|COMPLETED|Overall Study||15
59027|NCT01791413|139016|P2|STARTED|Overall Study||20
59028|NCT01791413|139017|P1|STARTED|Overall Study||20
59029|NCT01791244|139026|P2|NOT COMPLETED|Overall Study||18
59030|NCT01791244|139027|P1|NOT COMPLETED|Overall Study||15
59031|NCT01791244|139026|P2|COMPLETED|Overall Study||29
59032|NCT01791244|139027|P1|COMPLETED|Overall Study||31
59033|NCT01791244|139026|P2|Intent to Treat (ITT)|Overall Study||39
59034|NCT01791244|139027|P1|Intent to Treat (ITT)|Overall Study||38
59035|NCT01791244|139026|P2|STARTED|Overall Study||47
59036|NCT01791244|139027|P1|STARTED|Overall Study||46
59037|NCT01791205|139063|P2|NOT COMPLETED|Phase II||0
59038|NCT01791205|139064|P1|NOT COMPLETED|Phase II||12
59039|NCT01791205|139063|P2|COMPLETED|Phase II||0
59040|NCT01791205|139064|P1|COMPLETED|Phase II||92
59041|NCT01791205|139063|P2|STARTED|Phase II||0
59042|NCT01791205|139064|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
59043|NCT01791205|139063|P2|NOT COMPLETED|Phase I||0
59044|NCT01791205|139064|P1|NOT COMPLETED|Phase I||0
59045|NCT01791205|139063|P2|COMPLETED|Phase I||152
59046|NCT01791205|139064|P1|COMPLETED|Phase I||152
59047|NCT01791205|139063|P2|STARTED|Phase I||152
59048|NCT01791205|139064|P1|STARTED|Phase I||152
59049|NCT01791153|139148|P4|NOT COMPLETED|Overall Study||5
59050|NCT01791153|139149|P3|NOT COMPLETED|Overall Study||6
59051|NCT01791153|139150|P2|NOT COMPLETED|Overall Study||8
59052|NCT01791153|139151|P1|NOT COMPLETED|Overall Study||15
59053|NCT01791153|139148|P4|COMPLETED|Overall Study|Completed Study to Week 52|46
59054|NCT01791153|139149|P3|COMPLETED|Overall Study|Completed Study to Week 52|44
59055|NCT01791153|139150|P2|COMPLETED|Overall Study|Completed Study to Week 52|41
59056|NCT01791153|139151|P1|COMPLETED|Overall Study|Completed Study to Week 52|85
59057|NCT01791153|139148|P4|STARTED|Overall Study||51
59058|NCT01791153|139149|P3|STARTED|Overall Study||50
59059|NCT01791153|139150|P2|STARTED|Overall Study||49
59060|NCT01791153|139151|P1|STARTED|Overall Study||100
59061|NCT01790828|139207|P1|NOT COMPLETED|Overall Study||34
59062|NCT01790828|139207|P1|COMPLETED|Overall Study||8
59063|NCT01790828|139207|P1|STARTED|Overall Study||42
59064|NCT01790750|139230|P1|NOT COMPLETED|Overall Study||0
59065|NCT01790750|139230|P1|COMPLETED|Overall Study||50
59066|NCT01790750|139230|P1|STARTED|Overall Study||50
59067|NCT01790685|139237|P2|NOT COMPLETED|Overall Study||0
59068|NCT01790685|139238|P1|NOT COMPLETED|Overall Study||0
59069|NCT01790685|139237|P2|COMPLETED|Overall Study||17
59070|NCT01790685|139238|P1|COMPLETED|Overall Study||23
59071|NCT01790685|139237|P2|STARTED|Overall Study||17
59072|NCT01790685|139238|P1|STARTED|Overall Study||23
59073|NCT01790659|139246|P2|NOT COMPLETED|Overall Study||6
59074|NCT01790659|139247|P1|NOT COMPLETED|Overall Study||6
59075|NCT01790659|139246|P2|COMPLETED|Overall Study||192
59076|NCT01790659|139247|P1|COMPLETED|Overall Study||195
59077|NCT01790659|139246|P2|STARTED|Overall Study||198
59078|NCT01790659|139247|P1|STARTED|Overall Study||201
59079|NCT01790633|139265|P2|NOT COMPLETED|Overall Study||5
59080|NCT01790633|139266|P1|NOT COMPLETED|Overall Study||48
59081|NCT01790633|139265|P2|COMPLETED|Overall Study||159
59082|NCT01790633|139266|P1|COMPLETED|Overall Study||115
59083|NCT01790633|139265|P2|STARTED|Overall Study||164
59084|NCT01790633|139266|P1|STARTED|Overall Study||163
59085|NCT01790594|139279|P3|NOT COMPLETED|Overall Study||3
59086|NCT01790594|139280|P2|NOT COMPLETED|Overall Study||3
59087|NCT01790594|139281|P1|NOT COMPLETED|Overall Study||5
59088|NCT01790594|139279|P3|COMPLETED|Overall Study||0
59089|NCT01790594|139280|P2|COMPLETED|Overall Study||18
59090|NCT01790594|139281|P1|COMPLETED|Overall Study||17
59091|NCT01790594|139279|P3|STARTED|Overall Study||3
59092|NCT01790594|139280|P2|STARTED|Overall Study||21
59093|NCT01790594|139281|P1|STARTED|Overall Study||22
59094|NCT01790581|139349|P2|NOT COMPLETED|Overall Study||0
59095|NCT01790581|139350|P1|NOT COMPLETED|Overall Study||0
59096|NCT01790581|139349|P2|COMPLETED|Overall Study||12
59097|NCT01790581|139350|P1|COMPLETED|Overall Study||12
59098|NCT01790581|139349|P2|STARTED|Overall Study||12
59099|NCT01790581|139350|P1|STARTED|Overall Study||12
59100|NCT01790568|139358|P2|NOT COMPLETED|Overall Study||1
59101|NCT01790568|139359|P1|NOT COMPLETED|Overall Study||0
59102|NCT01790568|139358|P2|COMPLETED|Overall Study||25
59103|NCT01790568|139359|P1|COMPLETED|Overall Study||12
59104|NCT01790568|139358|P2|STARTED|Overall Study||26
59105|NCT01790568|139359|P1|STARTED|Overall Study||12
59106|NCT01790516|139367|P2|NOT COMPLETED|Overall Study||0
59107|NCT01790516|139368|P1|NOT COMPLETED|Overall Study||1
59108|NCT01790516|139367|P2|COMPLETED|Overall Study||1
59109|NCT01790516|139368|P1|COMPLETED|Overall Study||0
59110|NCT01790516|139367|P2|STARTED|Overall Study||1
59111|NCT01790516|139368|P1|STARTED|Overall Study||1
59112|NCT01790490|139377|P3|NOT COMPLETED|Overall Study||0
59113|NCT01790490|139378|P2|NOT COMPLETED|Overall Study||0
59114|NCT01790490|139379|P1|NOT COMPLETED|Overall Study||0
59115|NCT01790490|139377|P3|COMPLETED|Overall Study||2
59116|NCT01790490|139378|P2|COMPLETED|Overall Study||3
59117|NCT01790490|139379|P1|COMPLETED|Overall Study||3
59118|NCT01790490|139377|P3|STARTED|Overall Study||2
59119|NCT01790490|139378|P2|STARTED|Overall Study||3
59120|NCT01790490|139379|P1|STARTED|Overall Study||3
59121|NCT01790438|139392|P2|NOT COMPLETED|Overall Study||11
59122|NCT01790438|139393|P1|NOT COMPLETED|Overall Study||35
59123|NCT01790438|139392|P2|COMPLETED|Overall Study||202
59124|NCT01790438|139393|P1|COMPLETED|Overall Study||393
59125|NCT01790438|139392|P2|Received at Least One Dose of Study Drug|Overall Study||212
59126|NCT01790438|139393|P1|Received at Least One Dose of Study Drug|Overall Study||427
59127|NCT01790438|139392|P2|STARTED|Overall Study||213
59128|NCT01790438|139393|P1|STARTED|Overall Study||428
59129|NCT01790178|139445|P2|NOT COMPLETED|Overall Study||0
59130|NCT01790178|139446|P1|NOT COMPLETED|Overall Study||0
59131|NCT01790178|139445|P2|COMPLETED|Overall Study||24
59132|NCT01790178|139446|P1|COMPLETED|Overall Study||16
59133|NCT01790178|139445|P2|STARTED|Overall Study||24
59134|NCT01790178|139446|P1|STARTED|Overall Study||16
59135|NCT01789970|139462|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
59136|NCT01789970|139463|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
59137|NCT01789970|139464|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
59138|NCT01789970|139462|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
59139|NCT01789970|139463|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
59140|NCT01789970|139464|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
59141|NCT01789970|139462|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
59142|NCT01789970|139463|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
59143|NCT01789970|139464|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
59144|NCT01789970|139462|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
59145|NCT01789970|139463|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
59146|NCT01789970|139464|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
59147|NCT01789970|139462|P3|NOT COMPLETED|Open-label Titration Period||0
59148|NCT01789970|139463|P2|NOT COMPLETED|Open-label Titration Period||0
59149|NCT01789970|139464|P1|NOT COMPLETED|Open-label Titration Period||254
59150|NCT01789970|139462|P3|COMPLETED|Open-label Titration Period||0
59151|NCT01789970|139463|P2|COMPLETED|Open-label Titration Period||0
59152|NCT01789970|139464|P1|COMPLETED|Open-label Titration Period||371
59153|NCT01789970|139462|P3|Safety Analysis Set|Open-label Titration Period||0
59154|NCT01789970|139463|P2|Safety Analysis Set|Open-label Titration Period||0
59155|NCT01789970|139464|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
59156|NCT01789970|139462|P3|STARTED|Open-label Titration Period||0
59157|NCT01789970|139463|P2|STARTED|Open-label Titration Period||0
59158|NCT01789970|139464|P1|STARTED|Open-label Titration Period||625
59159|NCT01789814|139498|P2|NOT COMPLETED|Overall Study||0
59160|NCT01789814|139499|P1|NOT COMPLETED|Overall Study||0
59161|NCT01789814|139498|P2|COMPLETED|Overall Study||12
59162|NCT01789814|139499|P1|COMPLETED|Overall Study||12
59163|NCT01789814|139498|P2|STARTED|Overall Study||12
59164|NCT01789814|139499|P1|STARTED|Overall Study||12
59165|NCT01789775|139507|P2|NOT COMPLETED|Overall Study||7
59166|NCT01789775|139508|P1|NOT COMPLETED|Overall Study||2
59167|NCT01789775|139507|P2|COMPLETED|Overall Study||50
59168|NCT01789775|139508|P1|COMPLETED|Overall Study||53
59169|NCT01789775|139507|P2|STARTED|Overall Study||57
59170|NCT01789775|139508|P1|STARTED|Overall Study||55
59171|NCT01789606|139516|P2|NOT COMPLETED|Overall Study||450
59172|NCT01789606|139517|P1|NOT COMPLETED|Overall Study||23
59173|NCT01789606|139516|P2|COMPLETED|Overall Study||382
59174|NCT01789606|139517|P1|COMPLETED|Overall Study||228
59175|NCT01789606|139516|P2|STARTED|Overall Study||832
59176|NCT01789606|139517|P1|STARTED|Overall Study||251
59177|NCT01789476|139537|P2|NOT COMPLETED|Overall Study||2
59178|NCT01789476|139538|P1|NOT COMPLETED|Overall Study||8
59179|NCT01789476|139537|P2|COMPLETED|Overall Study||15
59180|NCT01789476|139538|P1|COMPLETED|Overall Study||26
59181|NCT01789476|139537|P2|STARTED|Overall Study||17
59182|NCT01789476|139538|P1|STARTED|Overall Study||34
59183|NCT01789255|139548|P1|NOT COMPLETED|Overall Study||0
59184|NCT01789255|139548|P1|COMPLETED|Overall Study||12
59185|NCT01789255|139548|P1|STARTED|Overall Study||12
59186|NCT01789138|139555|P2|NOT COMPLETED|Overall Study||52
59187|NCT01789138|139556|P1|NOT COMPLETED|Overall Study||41
59188|NCT01789138|139555|P2|COMPLETED|Overall Study||206
59189|NCT01789138|139556|P1|COMPLETED|Overall Study||213
59190|NCT01789138|139555|P2|STARTED|Overall Study||258
59191|NCT01789138|139556|P1|STARTED|Overall Study||254
59192|NCT01788943|139566|P2|NOT COMPLETED|Overall Study||0
59193|NCT01788943|139567|P1|NOT COMPLETED|Overall Study||1
59194|NCT01788943|139566|P2|COMPLETED|Overall Study||12
59195|NCT01788943|139567|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
59196|NCT01788943|139566|P2|STARTED|Overall Study||12
59197|NCT01788943|139567|P1|STARTED|Overall Study|Recruitment for study began.|13
59198|NCT01788631|139577|P2|NOT COMPLETED|Overall Study||1
59199|NCT01788631|139578|P1|NOT COMPLETED|Overall Study||3
59200|NCT01788631|139577|P2|COMPLETED|Overall Study||43
59201|NCT01788631|139578|P1|COMPLETED|Overall Study||49
59202|NCT01788631|139577|P2|Randomized|Overall Study||47
59203|NCT01788631|139578|P1|Randomized|Overall Study||53
59204|NCT01788631|139577|P2|STARTED|Overall Study||44
59205|NCT01788631|139578|P1|STARTED|Overall Study||52
59206|NCT01788566|139596|P1|NOT COMPLETED|Overall Study||8
59207|NCT01788566|139596|P1|COMPLETED|Overall Study||53
59208|NCT01788566|139596|P1|STARTED|Overall Study||61
59209|NCT01788358|139606|P1|NOT COMPLETED|Overall Study||98
59210|NCT01788358|139606|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
59211|NCT01788358|139606|P1|Completed Week 52|Overall Study||193
59212|NCT01788358|139606|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
59213|NCT01788358|139606|P1|Completed Week 28|Overall Study||417
59214|NCT01788358|139606|P1|Treated|Overall Study||508
59215|NCT01788358|139606|P1|STARTED|Overall Study||508
59216|NCT01788228|139620|P2|NOT COMPLETED|Overall Study||0
59217|NCT01788228|139621|P1|NOT COMPLETED|Overall Study||1
59218|NCT01788228|139620|P2|COMPLETED|Overall Study||1
59219|NCT01788228|139621|P1|COMPLETED|Overall Study||48
59220|NCT01788228|139620|P2|STARTED|Overall Study||1
59221|NCT01788228|139621|P1|STARTED|Overall Study||49
59222|NCT01788215|139640|P2|NOT COMPLETED|Overall Study||1
59223|NCT01788215|139641|P1|NOT COMPLETED|Overall Study||2
59224|NCT01788215|139640|P2|COMPLETED|Overall Study||4
59225|NCT01788215|139641|P1|COMPLETED|Overall Study||3
59226|NCT01788215|139640|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
59227|NCT01788215|139641|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
59228|NCT01788215|139640|P2|STARTED|Overall Study||5
59229|NCT01788215|139641|P1|STARTED|Overall Study||5
59230|NCT01788163|139670|P9|NOT COMPLETED|Overall Study||16
59231|NCT01788163|139671|P8|NOT COMPLETED|Overall Study||48
59232|NCT01788163|139672|P7|NOT COMPLETED|Overall Study||1
59233|NCT01788163|139673|P6|NOT COMPLETED|Overall Study||7
59234|NCT01788163|139674|P5|NOT COMPLETED|Overall Study||0
59235|NCT01788163|139675|P4|NOT COMPLETED|Overall Study||0
59236|NCT01788163|139676|P3|NOT COMPLETED|Overall Study||0
59237|NCT01788163|139677|P2|NOT COMPLETED|Overall Study||0
59238|NCT01788163|139678|P1|NOT COMPLETED|Overall Study||55
59239|NCT01788163|139670|P9|COMPLETED|Overall Study||956
59240|NCT01788163|139671|P8|COMPLETED|Overall Study||254
59241|NCT01788163|139672|P7|COMPLETED|Overall Study||49
59242|NCT01788163|139673|P6|COMPLETED|Overall Study||95
59243|NCT01788163|139674|P5|COMPLETED|Overall Study||94
59244|NCT01788163|139675|P4|COMPLETED|Overall Study||71
59245|NCT01788163|139676|P3|COMPLETED|Overall Study||62
59246|NCT01788163|139677|P2|COMPLETED|Overall Study||271
59247|NCT01788163|139678|P1|COMPLETED|Overall Study||1403
59248|NCT01788163|139670|P9|STARTED|Overall Study||972
59249|NCT01788163|139671|P8|STARTED|Overall Study||302
59250|NCT01788163|139672|P7|STARTED|Overall Study||50
59251|NCT01788163|139673|P6|STARTED|Overall Study||102
59252|NCT01788163|139674|P5|STARTED|Overall Study||94
59253|NCT01788163|139675|P4|STARTED|Overall Study||71
59254|NCT01788163|139676|P3|STARTED|Overall Study||62
59255|NCT01788163|139677|P2|STARTED|Overall Study||271
59256|NCT01788163|139678|P1|STARTED|Overall Study||1458
59257|NCT01788046|139841|P2|NOT COMPLETED|Overall Study||37
59258|NCT01788046|139842|P1|NOT COMPLETED|Overall Study||56
59259|NCT01788046|139841|P2|COMPLETED|Overall Study||218
59260|NCT01788046|139842|P1|COMPLETED|Overall Study||204
59261|NCT01788046|139841|P2|Received Treatment|Overall Study||252
59262|NCT01788046|139842|P1|Received Treatment|Overall Study||259
59263|NCT01788046|139841|P2|STARTED|Overall Study||255
59264|NCT01788046|139842|P1|STARTED|Overall Study||260
59265|NCT01787916|139858|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
59266|NCT01787916|139859|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
59267|NCT01787916|139858|P2|COMPLETED|Second Intervention (24 Weeks)||7
59268|NCT01787916|139859|P1|COMPLETED|Second Intervention (24 Weeks)||8
59269|NCT01787916|139858|P2|STARTED|Second Intervention (24 Weeks)||7
59270|NCT01787916|139859|P1|STARTED|Second Intervention (24 Weeks)||8
59271|NCT01787916|139858|P2|NOT COMPLETED|Washout (4 Weeks)||0
59272|NCT01787916|139859|P1|NOT COMPLETED|Washout (4 Weeks)||0
59273|NCT01787916|139858|P2|COMPLETED|Washout (4 Weeks)||7
59274|NCT01787916|139859|P1|COMPLETED|Washout (4 Weeks)||8
59275|NCT01787916|139858|P2|STARTED|Washout (4 Weeks)||7
59276|NCT01787916|139859|P1|STARTED|Washout (4 Weeks)||8
59277|NCT01787916|139858|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
59278|NCT01787916|139859|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
59279|NCT01787916|139858|P2|COMPLETED|First Intervention (24 Weeks)||7
59280|NCT01787916|139859|P1|COMPLETED|First Intervention (24 Weeks)||8
59281|NCT01787916|139858|P2|STARTED|First Intervention (24 Weeks)||7
59282|NCT01787916|139859|P1|STARTED|First Intervention (24 Weeks)||8
59283|NCT01787838|139865|P1|NOT COMPLETED|Overall Study||1413
59284|NCT01787838|139865|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
59285|NCT01787838|139865|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
59286|NCT01787825|139869|P2|NOT COMPLETED|Overall Study||1
59287|NCT01787825|139870|P1|NOT COMPLETED|Overall Study||6
59288|NCT01787825|139869|P2|COMPLETED|Overall Study||60
59289|NCT01787825|139870|P1|COMPLETED|Overall Study||54
59290|NCT01787825|139869|P2|STARTED|Overall Study||61
59291|NCT01787825|139870|P1|STARTED|Overall Study||60
59292|NCT01787799|139881|P1|NOT COMPLETED|Overall Study||0
59293|NCT01787799|139881|P1|COMPLETED|Overall Study||100
59294|NCT01787799|139881|P1|STARTED|Overall Study||100
59295|NCT01787760|139888|P3|NOT COMPLETED|Overall Study||5
59296|NCT01787760|139889|P2|NOT COMPLETED|Overall Study||16
59297|NCT01787760|139890|P1|NOT COMPLETED|Overall Study||26
59298|NCT01787760|139888|P3|COMPLETED|Overall Study||46
59299|NCT01787760|139889|P2|COMPLETED|Overall Study||34
59300|NCT01787760|139890|P1|COMPLETED|Overall Study||25
59301|NCT01787760|139888|P3|STARTED|Overall Study||51
59302|NCT01787760|139889|P2|STARTED|Overall Study||50
59303|NCT01787760|139890|P1|STARTED|Overall Study||51
59304|NCT01787591|139904|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
59305|NCT01787591|139905|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
59306|NCT01787591|139906|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
59307|NCT01787591|139907|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
59308|NCT01787591|139904|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
59309|NCT01787591|139905|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
59310|NCT01787591|139906|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
59311|NCT01787591|139907|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
59312|NCT01787591|139904|P4|STARTED|Period 4 (Cross-over Arm 4)||5
59313|NCT01787591|139905|P3|STARTED|Period 4 (Cross-over Arm 4)||5
59314|NCT01787591|139906|P2|STARTED|Period 4 (Cross-over Arm 4)||5
59315|NCT01787591|139907|P1|STARTED|Period 4 (Cross-over Arm 4)||5
59316|NCT01787591|139904|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
59317|NCT01787591|139905|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
59318|NCT01787591|139906|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
59319|NCT01787591|139907|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
59320|NCT01787591|139904|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
59321|NCT01787591|139905|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
59322|NCT01787591|139906|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
59323|NCT01787591|139907|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
59324|NCT01787591|139904|P4|STARTED|Period 3 (Cross-over Arm 3)||5
59325|NCT01787591|139905|P3|STARTED|Period 3 (Cross-over Arm 3)||5
59326|NCT01787591|139906|P2|STARTED|Period 3 (Cross-over Arm 3)||5
59327|NCT01787591|139907|P1|STARTED|Period 3 (Cross-over Arm 3)||5
59328|NCT01787591|139904|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
59329|NCT01787591|139905|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
59330|NCT01787591|139906|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
59331|NCT01787591|139907|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
59332|NCT01787591|139904|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
59333|NCT01787591|139905|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
59334|NCT01787591|139906|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
59335|NCT01787591|139907|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
59336|NCT01787591|139904|P4|STARTED|Period 2 (Cross-over Arm 2)||5
59337|NCT01787591|139905|P3|STARTED|Period 2 (Cross-over Arm 2)||5
59338|NCT01787591|139906|P2|STARTED|Period 2 (Cross-over Arm 2)||5
59339|NCT01787591|139907|P1|STARTED|Period 2 (Cross-over Arm 2)||5
59340|NCT01787591|139904|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
59341|NCT01787591|139905|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
59342|NCT01787591|139906|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
59343|NCT01787591|139907|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
59344|NCT01787591|139904|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
59345|NCT01787591|139905|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
59346|NCT01787591|139906|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
59347|NCT01787591|139907|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
59348|NCT01787591|139904|P4|STARTED|Period 1 (Cross-over Arm 1)||6
59349|NCT01787591|139905|P3|STARTED|Period 1 (Cross-over Arm 1)||5
59350|NCT01787591|139906|P2|STARTED|Period 1 (Cross-over Arm 1)||5
59351|NCT01787591|139907|P1|STARTED|Period 1 (Cross-over Arm 1)||5
59352|NCT01787461|139935|P2|NOT COMPLETED|Overall Study||9
59353|NCT01787461|139936|P1|NOT COMPLETED|Overall Study||14
59354|NCT01787461|139935|P2|COMPLETED|Overall Study||89
59355|NCT01787461|139936|P1|COMPLETED|Overall Study||82
59356|NCT01787461|139935|P2|STARTED|Overall Study||98
59357|NCT01787461|139936|P1|STARTED|Overall Study||96
59358|NCT01787383|139964|P2|NOT COMPLETED|Overall Study||22
59359|NCT01787383|139965|P1|NOT COMPLETED|Overall Study||9
59360|NCT01787383|139964|P2|COMPLETED|Overall Study||76
59361|NCT01787383|139965|P1|COMPLETED|Overall Study||92
59362|NCT01787383|139964|P2|STARTED|Overall Study||98
59363|NCT01787383|139965|P1|STARTED|Overall Study||101
59364|NCT01787279|139985|P1|NOT COMPLETED|Overall Study||3
59365|NCT01787279|139985|P1|COMPLETED|Overall Study||56
59366|NCT01787279|139985|P1|STARTED|Overall Study||59
59367|NCT01787240|139996|P2|NOT COMPLETED|Overall Study||1
59368|NCT01787240|139997|P1|NOT COMPLETED|Overall Study||5
59369|NCT01787240|139996|P2|COMPLETED|Overall Study||4
59370|NCT01787240|139997|P1|COMPLETED|Overall Study||10
59371|NCT01787240|139996|P2|STARTED|Overall Study||5
59372|NCT01787240|139997|P1|STARTED|Overall Study||15
59373|NCT01787188|140011|P3|NOT COMPLETED|Overall Study||18
59374|NCT01787188|140012|P2|NOT COMPLETED|Overall Study||18
59375|NCT01787188|140013|P1|NOT COMPLETED|Overall Study||17
59376|NCT01787188|140011|P3|COMPLETED|Overall Study||116
59377|NCT01787188|140012|P2|COMPLETED|Overall Study||112
59378|NCT01787188|140013|P1|COMPLETED|Overall Study||122
59379|NCT01787188|140011|P3|STARTED|Overall Study||134
59380|NCT01787188|140012|P2|STARTED|Overall Study||130
59381|NCT01787188|140013|P1|STARTED|Overall Study||139
59382|NCT01787175|140068|P2|NOT COMPLETED|Overall Study||0
59383|NCT01787175|140069|P1|NOT COMPLETED|Overall Study||0
59384|NCT01787175|140068|P2|COMPLETED|Overall Study||28
59385|NCT01787175|140069|P1|COMPLETED|Overall Study||30
59386|NCT01787175|140068|P2|STARTED|Overall Study||28
59387|NCT01787175|140069|P1|STARTED|Overall Study||30
59388|NCT01787032|140085|P6|NOT COMPLETED|Overall Study||1
59389|NCT01787032|140086|P5|NOT COMPLETED|Overall Study||1
59390|NCT01787032|140087|P4|NOT COMPLETED|Overall Study||0
59391|NCT01787032|140088|P3|NOT COMPLETED|Overall Study||0
59392|NCT01787032|140089|P2|NOT COMPLETED|Overall Study||0
59393|NCT01787032|140090|P1|NOT COMPLETED|Overall Study||0
59394|NCT01787032|140085|P6|COMPLETED|Overall Study||3
59395|NCT01787032|140086|P5|COMPLETED|Overall Study||3
59396|NCT01787032|140087|P4|COMPLETED|Overall Study||3
59397|NCT01787032|140088|P3|COMPLETED|Overall Study||3
59398|NCT01787032|140089|P2|COMPLETED|Overall Study||3
59399|NCT01787032|140090|P1|COMPLETED|Overall Study||3
59400|NCT01787032|140085|P6|Received T2|Overall Study||4
59401|NCT01787032|140086|P5|Received T2|Overall Study||4
59402|NCT01787032|140087|P4|Received T2|Overall Study||3
59403|NCT01787032|140088|P3|Received T2|Overall Study||3
59404|NCT01787032|140089|P2|Received T2|Overall Study||3
59405|NCT01787032|140090|P1|Received T2|Overall Study||3
59406|NCT01787032|140085|P6|Received T1|Overall Study||4
59407|NCT01787032|140086|P5|Received T1|Overall Study||3
59408|NCT01787032|140087|P4|Received T1|Overall Study||3
59409|NCT01787032|140088|P3|Received T1|Overall Study||3
59410|NCT01787032|140089|P2|Received T1|Overall Study||3
59411|NCT01787032|140090|P1|Received T1|Overall Study||3
59412|NCT01787032|140085|P6|Received R|Overall Study||3
59413|NCT01787032|140086|P5|Received R|Overall Study||4
59414|NCT01787032|140087|P4|Received R|Overall Study||3
59415|NCT01787032|140088|P3|Received R|Overall Study||3
59416|NCT01787032|140089|P2|Received R|Overall Study||3
59417|NCT01787032|140090|P1|Received R|Overall Study||3
59418|NCT01787032|140085|P6|STARTED|Overall Study||4
59419|NCT01787032|140086|P5|STARTED|Overall Study||4
59420|NCT01787032|140087|P4|STARTED|Overall Study||3
59421|NCT01787032|140088|P3|STARTED|Overall Study||3
59422|NCT01787032|140089|P2|STARTED|Overall Study||3
59423|NCT01787032|140090|P1|STARTED|Overall Study||3
59424|NCT01786993|140114|P2|NOT COMPLETED|Overall Study||10
59425|NCT01786993|140115|P1|NOT COMPLETED|Overall Study||12
59426|NCT01786993|140114|P2|COMPLETED|Overall Study||170
59427|NCT01786993|140115|P1|COMPLETED|Overall Study||189
59428|NCT01786993|140114|P2|Per Protocol Population at 9 Months|Overall Study||170
59429|NCT01786993|140115|P1|Per Protocol Population at 9 Months|Overall Study||189
59430|NCT01786993|140114|P2|STARTED|Overall Study||180
59431|NCT01786993|140115|P1|STARTED|Overall Study||201
59432|NCT01786954|140122|P2|NOT COMPLETED|Overall Study||0
59433|NCT01786954|140123|P1|NOT COMPLETED|Overall Study||0
59434|NCT01786954|140122|P2|COMPLETED|Overall Study||34
59435|NCT01786954|140123|P1|COMPLETED|Overall Study||34
59436|NCT01786954|140122|P2|STARTED|Overall Study||34
59437|NCT01786954|140123|P1|STARTED|Overall Study||34
59438|NCT01786902|140135|P2|NOT COMPLETED|Overall Study||3
59439|NCT01786902|140136|P1|NOT COMPLETED|Overall Study||4
59440|NCT01786902|140135|P2|COMPLETED|Overall Study||31
59441|NCT01786902|140136|P1|COMPLETED|Overall Study||32
59442|NCT01786902|140135|P2|STARTED|Overall Study||34
59443|NCT01786902|140136|P1|STARTED|Overall Study||36
59444|NCT01786876|140146|P1|NOT COMPLETED|Overall Study||0
59445|NCT01786876|140146|P1|COMPLETED|Overall Study||6
59446|NCT01786876|140146|P1|STARTED|Overall Study||6
59447|NCT01786707|140165|P2|NOT COMPLETED|Overall Study||1
59448|NCT01786707|140166|P1|NOT COMPLETED|Overall Study||1
59449|NCT01786707|140165|P2|COMPLETED|Overall Study||0
59450|NCT01786707|140166|P1|COMPLETED|Overall Study||0
59451|NCT01786707|140165|P2|STARTED|Overall Study||1
59452|NCT01786707|140166|P1|STARTED|Overall Study||1
59453|NCT01786668|140178|P4|NOT COMPLETED|Overall Study||4
59454|NCT01786668|140179|P3|NOT COMPLETED|Overall Study||5
59455|NCT01786668|140180|P2|NOT COMPLETED|Overall Study||1
59456|NCT01786668|140181|P1|NOT COMPLETED|Overall Study||1
59457|NCT01786668|140178|P4|COMPLETED|Overall Study||47
59458|NCT01786668|140179|P3|COMPLETED|Overall Study||47
59459|NCT01786668|140180|P2|COMPLETED|Overall Study||51
59460|NCT01786668|140181|P1|COMPLETED|Overall Study||51
59461|NCT01786668|140178|P4|STARTED|Overall Study||51
59462|NCT01786668|140179|P3|STARTED|Overall Study||52
59463|NCT01786668|140180|P2|STARTED|Overall Study||52
59464|NCT01786668|140181|P1|STARTED|Overall Study||52
59465|NCT01786629|140281|P2|NOT COMPLETED|Overall Study||5
59466|NCT01786629|140282|P1|NOT COMPLETED|Overall Study||0
59467|NCT01786629|140281|P2|COMPLETED|Overall Study||164
59468|NCT01786629|140282|P1|COMPLETED|Overall Study||169
59469|NCT01786629|140281|P2|STARTED|Overall Study||169
59470|NCT01786629|140282|P1|STARTED|Overall Study||169
59471|NCT01786551|140288|P1|NOT COMPLETED|Overall Study||2
59472|NCT01786551|140288|P1|COMPLETED|Overall Study||14
59473|NCT01786551|140288|P1|STARTED|Overall Study||16
59474|NCT01786330|140296|P2|NOT COMPLETED|Overall Study||3
59475|NCT01786330|140297|P1|NOT COMPLETED|Overall Study||1
59476|NCT01786330|140296|P2|COMPLETED|Overall Study||27
59477|NCT01786330|140297|P1|COMPLETED|Overall Study||29
59478|NCT01786330|140296|P2|STARTED|Overall Study||30
59479|NCT01786330|140297|P1|STARTED|Overall Study||30
59480|NCT01786252|140311|P2|NOT COMPLETED|Overall Study||0
59481|NCT01786252|140312|P1|NOT COMPLETED|Overall Study||0
59482|NCT01786252|140311|P2|COMPLETED|Overall Study||8
59483|NCT01786252|140312|P1|COMPLETED|Overall Study||7
59484|NCT01786252|140311|P2|STARTED|Overall Study||8
59485|NCT01786252|140312|P1|STARTED|Overall Study||7
59486|NCT01786239|140326|P2|NOT COMPLETED|Overall Study||11
59487|NCT01786239|140327|P1|NOT COMPLETED|Overall Study||11
59488|NCT01786239|140326|P2|COMPLETED|Overall Study||14
59489|NCT01786239|140327|P1|COMPLETED|Overall Study||14
59490|NCT01786239|140326|P2|STARTED|Overall Study||25
59491|NCT01786239|140327|P1|STARTED|Overall Study||25
59492|NCT01786174|140335|P2|NOT COMPLETED|Overall Study||0
59493|NCT01786174|140336|P1|NOT COMPLETED|Overall Study||2
59494|NCT01786174|140335|P2|COMPLETED|Overall Study||10
59495|NCT01786174|140336|P1|COMPLETED|Overall Study||16
59496|NCT01786174|140335|P2|Randomized|Overall Study||11
59497|NCT01786174|140336|P1|Randomized|Overall Study||19
59498|NCT01786174|140335|P2|STARTED|Overall Study||10
59499|NCT01786174|140336|P1|STARTED|Overall Study||18
59500|NCT01786161|140352|P2|NOT COMPLETED|Overall Study||0
59501|NCT01786161|140353|P1|NOT COMPLETED|Overall Study||0
59502|NCT01786161|140352|P2|COMPLETED|Overall Study||22
59503|NCT01786161|140353|P1|COMPLETED|Overall Study||22
59504|NCT01786161|140352|P2|STARTED|Overall Study||22
59505|NCT01786161|140353|P1|STARTED|Overall Study||22
59506|NCT01786109|140366|P3|NOT COMPLETED|Overall Study||2
59507|NCT01786109|140367|P2|NOT COMPLETED|Overall Study||0
59508|NCT01786109|140368|P1|NOT COMPLETED|Overall Study||1
59509|NCT01786109|140366|P3|COMPLETED|Overall Study||25
59510|NCT01786109|140367|P2|COMPLETED|Overall Study||24
59511|NCT01786109|140368|P1|COMPLETED|Overall Study||23
59512|NCT01786109|140366|P3|STARTED|Overall Study||27
59513|NCT01786109|140367|P2|STARTED|Overall Study||24
59514|NCT01786109|140368|P1|STARTED|Overall Study||24
59515|NCT01785875|140397|P3|NOT COMPLETED|Overall Study||107
59516|NCT01785875|140398|P2|NOT COMPLETED|Overall Study||289
59517|NCT01785875|140399|P1|NOT COMPLETED|Overall Study||294
59518|NCT01785875|140397|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
59519|NCT01785875|140398|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
59520|NCT01785875|140399|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
59521|NCT01785875|140397|P3|Received Etelcalcetide|Overall Study||123
59522|NCT01785875|140398|P2|Received Etelcalcetide|Overall Study||384
59523|NCT01785875|140399|P1|Received Etelcalcetide|Overall Study||383
59524|NCT01785875|140397|P3|STARTED|Overall Study||123
59525|NCT01785875|140398|P2|STARTED|Overall Study||384
59526|NCT01785875|140399|P1|STARTED|Overall Study||384
59527|NCT01785849|140468|P2|NOT COMPLETED|Overall Study||34
59528|NCT01785849|140469|P1|NOT COMPLETED|Overall Study||61
59529|NCT01785849|140468|P2|COMPLETED|Overall Study||220
59530|NCT01785849|140469|P1|COMPLETED|Overall Study||193
59531|NCT01785849|140468|P2|Received Treatment|Overall Study||251
59532|NCT01785849|140469|P1|Received Treatment|Overall Study||254
59533|NCT01785849|140468|P2|STARTED|Overall Study||254
59534|NCT01785849|140469|P1|STARTED|Overall Study||254
59535|NCT01785628|140487|P2|NOT COMPLETED|Overall Study||3
59536|NCT01785628|140488|P1|NOT COMPLETED|Overall Study||2
59537|NCT01785628|140487|P2|COMPLETED|Overall Study||12
59538|NCT01785628|140488|P1|COMPLETED|Overall Study||13
59539|NCT01785628|140487|P2|STARTED|Overall Study||15
59540|NCT01785628|140488|P1|STARTED|Overall Study||15
59541|NCT01785615|140511|P4|NOT COMPLETED|Atorvastatin Phase||0
59542|NCT01785615|140512|P3|NOT COMPLETED|Atorvastatin Phase||0
59543|NCT01785615|140513|P2|NOT COMPLETED|Atorvastatin Phase||0
59544|NCT01785615|140514|P1|NOT COMPLETED|Atorvastatin Phase||0
59545|NCT01785615|140511|P4|COMPLETED|Atorvastatin Phase||0
59546|NCT01785615|140512|P3|COMPLETED|Atorvastatin Phase||0
59547|NCT01785615|140513|P2|COMPLETED|Atorvastatin Phase||44
59548|NCT01785615|140514|P1|COMPLETED|Atorvastatin Phase||44
59549|NCT01785615|140511|P4|STARTED|Atorvastatin Phase||0
59550|NCT01785615|140512|P3|STARTED|Atorvastatin Phase||0
59551|NCT01785615|140513|P2|STARTED|Atorvastatin Phase||44
59552|NCT01785615|140514|P1|STARTED|Atorvastatin Phase||44
59553|NCT01785615|140511|P4|NOT COMPLETED|Dietary Phase||24
59554|NCT01785615|140512|P3|NOT COMPLETED|Dietary Phase||0
59555|NCT01785615|140513|P2|NOT COMPLETED|Dietary Phase||0
59556|NCT01785615|140514|P1|NOT COMPLETED|Dietary Phase||0
59557|NCT01785615|140511|P4|COMPLETED|Dietary Phase||116
59558|NCT01785615|140512|P3|COMPLETED|Dietary Phase||35
59559|NCT01785615|140513|P2|COMPLETED|Dietary Phase||0
59560|NCT01785615|140514|P1|COMPLETED|Dietary Phase||0
59561|NCT01785615|140511|P4|STARTED|Dietary Phase||140
59562|NCT01785615|140512|P3|STARTED|Dietary Phase||35
59563|NCT01785615|140513|P2|STARTED|Dietary Phase||0
59564|NCT01785615|140514|P1|STARTED|Dietary Phase||0
59565|NCT01785602|140586|P2|NOT COMPLETED|Overall Study||9
59566|NCT01785602|140587|P1|NOT COMPLETED|Overall Study||13
59567|NCT01785602|140586|P2|COMPLETED|Overall Study||18
59568|NCT01785602|140587|P1|COMPLETED|Overall Study||63
59569|NCT01785602|140586|P2|STARTED|Overall Study||27
59570|NCT01785602|140587|P1|STARTED|Overall Study||76
59571|NCT01785524|140597|P2|NOT COMPLETED|Overall Study||2
59572|NCT01785524|140598|P1|NOT COMPLETED|Overall Study||2
59573|NCT01785524|140597|P2|COMPLETED|Overall Study||2
59574|NCT01785524|140598|P1|COMPLETED|Overall Study||5
59575|NCT01785524|140597|P2|STARTED|Overall Study||4
59576|NCT01785524|140598|P1|STARTED|Overall Study||7
59577|NCT01785472|140617|P3|NOT COMPLETED|Overall Study||22
59578|NCT01785472|140618|P2|NOT COMPLETED|Overall Study||19
59579|NCT01785472|140619|P1|NOT COMPLETED|Overall Study||24
59580|NCT01785472|140617|P3|COMPLETED|Overall Study||464
59581|NCT01785472|140618|P2|COMPLETED|Overall Study||454
59582|NCT01785472|140619|P1|COMPLETED|Overall Study||455
59583|NCT01785472|140617|P3|Safety Set (SAF)|Overall Study||484
59584|NCT01785472|140618|P2|Safety Set (SAF)|Overall Study||472
59585|NCT01785472|140619|P1|Safety Set (SAF)|Overall Study||478
59586|NCT01785472|140617|P3|Full Analysis Set (FAS)|Overall Study||484
59587|NCT01785472|140618|P2|Full Analysis Set (FAS)|Overall Study||472
59588|NCT01785472|140619|P1|Full Analysis Set (FAS)|Overall Study||479
59589|NCT01785472|140617|P3|STARTED|Overall Study||486
59590|NCT01785472|140618|P2|STARTED|Overall Study||473
59591|NCT01785472|140619|P1|STARTED|Overall Study||479
59592|NCT01785186|140666|P5|NOT COMPLETED|Overall Study||6
59593|NCT01785186|140667|P4|NOT COMPLETED|Overall Study||5
59594|NCT01785186|140668|P3|NOT COMPLETED|Overall Study||5
59595|NCT01785186|140669|P2|NOT COMPLETED|Overall Study||6
59596|NCT01785186|140670|P1|NOT COMPLETED|Overall Study||6
59597|NCT01785186|140666|P5|COMPLETED|Overall Study||117
59598|NCT01785186|140667|P4|COMPLETED|Overall Study||58
59599|NCT01785186|140668|P3|COMPLETED|Overall Study||52
59600|NCT01785186|140669|P2|COMPLETED|Overall Study||57
59601|NCT01785186|140670|P1|COMPLETED|Overall Study||53
59602|NCT01785186|140666|P5|STARTED|Overall Study||123
59603|NCT01785186|140667|P4|STARTED|Overall Study||63
59604|NCT01785186|140668|P3|STARTED|Overall Study||57
59605|NCT01785186|140669|P2|STARTED|Overall Study||63
59606|NCT01785186|140670|P1|STARTED|Overall Study||59
59607|NCT01785160|140692|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
59608|NCT01785160|140692|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
59609|NCT01785160|140692|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
59610|NCT01785160|140692|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
59611|NCT01785160|140692|P1|COMPLETED|Washout Period of at Least 7 Days||23
59612|NCT01785160|140692|P1|STARTED|Washout Period of at Least 7 Days||24
59613|NCT01785160|140692|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
59614|NCT01785160|140692|P1|COMPLETED|Treatment Period 1: Raltegravir||24
59615|NCT01785160|140692|P1|STARTED|Treatment Period 1: Raltegravir||25
59616|NCT01785134|140702|P2|NOT COMPLETED|Overall Study||7
59617|NCT01785134|140703|P1|NOT COMPLETED|Overall Study||12
59618|NCT01785134|140702|P2|COMPLETED|Overall Study||33
59619|NCT01785134|140703|P1|COMPLETED|Overall Study||29
59620|NCT01785134|140702|P2|STARTED|Overall Study||40
59621|NCT01785134|140703|P1|STARTED|Overall Study||41
59622|NCT01785095|140717|P1|NOT COMPLETED|Overall Study||3
59623|NCT01785095|140717|P1|COMPLETED|Overall Study||24
59624|NCT01785095|140717|P1|STARTED|Overall Study||27
59625|NCT01784965|140727|P2|NOT COMPLETED|Overall Study||11
59626|NCT01784965|140728|P1|NOT COMPLETED|Overall Study||6
59627|NCT01784965|140727|P2|COMPLETED|Overall Study||24
59628|NCT01784965|140728|P1|COMPLETED|Overall Study||27
59629|NCT01784965|140727|P2|STARTED|Overall Study||35
59630|NCT01784965|140728|P1|STARTED|Overall Study||33
59631|NCT01784770|140738|P1|NOT COMPLETED|Overall Study||0
59632|NCT01784770|140738|P1|COMPLETED|Overall Study||21
59633|NCT01784770|140738|P1|STARTED|Overall Study||21
59634|NCT01784666|140746|P3|NOT COMPLETED|Overall Study||0
59635|NCT01784666|140747|P2|NOT COMPLETED|Overall Study||0
59636|NCT01784666|140748|P1|NOT COMPLETED|Overall Study||0
59637|NCT01784666|140746|P3|COMPLETED|Overall Study||1
59638|NCT01784666|140747|P2|COMPLETED|Overall Study||0
59639|NCT01784666|140748|P1|COMPLETED|Overall Study||1
59640|NCT01784666|140746|P3|STARTED|Overall Study||1
59641|NCT01784666|140747|P2|STARTED|Overall Study||0
59642|NCT01784666|140748|P1|STARTED|Overall Study||1
59643|NCT01784614|140756|P8|NOT COMPLETED|Period 4||0
59644|NCT01784614|140757|P7|NOT COMPLETED|Period 4||0
59645|NCT01784614|140758|P6|NOT COMPLETED|Period 4||0
59646|NCT01784614|140759|P5|NOT COMPLETED|Period 4||0
59647|NCT01784614|140760|P4|NOT COMPLETED|Period 4||0
59648|NCT01784614|140761|P3|NOT COMPLETED|Period 4||0
59649|NCT01784614|140762|P2|NOT COMPLETED|Period 4||0
59650|NCT01784614|140763|P1|NOT COMPLETED|Period 4||0
59651|NCT01784614|140756|P8|COMPLETED|Period 4||2
59652|NCT01784614|140757|P7|COMPLETED|Period 4||3
59653|NCT01784614|140758|P6|COMPLETED|Period 4||3
59654|NCT01784614|140759|P5|COMPLETED|Period 4||3
59655|NCT01784614|140760|P4|COMPLETED|Period 4||3
59656|NCT01784614|140761|P3|COMPLETED|Period 4||3
59657|NCT01784614|140762|P2|COMPLETED|Period 4||2
59658|NCT01784614|140763|P1|COMPLETED|Period 4||3
59659|NCT01784614|140756|P8|STARTED|Period 4||2
59660|NCT01784614|140757|P7|STARTED|Period 4||3
59661|NCT01784614|140758|P6|STARTED|Period 4||3
59662|NCT01784614|140759|P5|STARTED|Period 4||3
59663|NCT01784614|140760|P4|STARTED|Period 4||3
59664|NCT01784614|140761|P3|STARTED|Period 4||3
59665|NCT01784614|140762|P2|STARTED|Period 4||2
59666|NCT01784614|140763|P1|STARTED|Period 4||3
59667|NCT01784614|140756|P8|NOT COMPLETED|Period 3||0
59668|NCT01784614|140757|P7|NOT COMPLETED|Period 3||0
59669|NCT01784614|140758|P6|NOT COMPLETED|Period 3||0
59670|NCT01784614|140759|P5|NOT COMPLETED|Period 3||0
59671|NCT01784614|140760|P4|NOT COMPLETED|Period 3||0
59672|NCT01784614|140761|P3|NOT COMPLETED|Period 3||0
59673|NCT01784614|140762|P2|NOT COMPLETED|Period 3||0
59674|NCT01784614|140763|P1|NOT COMPLETED|Period 3||0
59675|NCT01784614|140756|P8|COMPLETED|Period 3||2
59676|NCT01784614|140757|P7|COMPLETED|Period 3||3
59677|NCT01784614|140758|P6|COMPLETED|Period 3||3
59678|NCT01784614|140759|P5|COMPLETED|Period 3||3
59679|NCT01784614|140760|P4|COMPLETED|Period 3||3
59680|NCT01784614|140761|P3|COMPLETED|Period 3||3
59681|NCT01784614|140762|P2|COMPLETED|Period 3||2
59682|NCT01784614|140763|P1|COMPLETED|Period 3||3
59683|NCT01784614|140756|P8|STARTED|Period 3||2
59684|NCT01784614|140757|P7|STARTED|Period 3||3
59685|NCT01784614|140758|P6|STARTED|Period 3||3
59686|NCT01784614|140759|P5|STARTED|Period 3||3
59687|NCT01784614|140760|P4|STARTED|Period 3||3
59688|NCT01784614|140761|P3|STARTED|Period 3||3
59689|NCT01784614|140762|P2|STARTED|Period 3||2
59690|NCT01784614|140763|P1|STARTED|Period 3||3
59691|NCT01784614|140756|P8|NOT COMPLETED|Period 2||0
59692|NCT01784614|140757|P7|NOT COMPLETED|Period 2||0
59693|NCT01784614|140758|P6|NOT COMPLETED|Period 2||0
59694|NCT01784614|140759|P5|NOT COMPLETED|Period 2||0
59695|NCT01784614|140760|P4|NOT COMPLETED|Period 2||0
59696|NCT01784614|140761|P3|NOT COMPLETED|Period 2||0
59697|NCT01784614|140762|P2|NOT COMPLETED|Period 2||0
59698|NCT01784614|140763|P1|NOT COMPLETED|Period 2||0
59699|NCT01784614|140756|P8|COMPLETED|Period 2||2
59700|NCT01784614|140757|P7|COMPLETED|Period 2||3
59701|NCT01784614|140758|P6|COMPLETED|Period 2||3
59702|NCT01784614|140759|P5|COMPLETED|Period 2||3
59703|NCT01784614|140760|P4|COMPLETED|Period 2||3
59704|NCT01784614|140761|P3|COMPLETED|Period 2||3
59705|NCT01784614|140762|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
59706|NCT01784614|140763|P1|COMPLETED|Period 2||3
59707|NCT01784614|140756|P8|STARTED|Period 2||2
59708|NCT01784614|140757|P7|STARTED|Period 2||3
59709|NCT01784614|140758|P6|STARTED|Period 2||3
59710|NCT01784614|140759|P5|STARTED|Period 2||3
59711|NCT01784614|140760|P4|STARTED|Period 2||3
59712|NCT01784614|140761|P3|STARTED|Period 2||3
59713|NCT01784614|140762|P2|STARTED|Period 2||3
59714|NCT01784614|140763|P1|STARTED|Period 2||3
59715|NCT01784614|140756|P8|NOT COMPLETED|Period 1||0
59716|NCT01784614|140757|P7|NOT COMPLETED|Period 1||0
59717|NCT01784614|140758|P6|NOT COMPLETED|Period 1||0
59718|NCT01784614|140759|P5|NOT COMPLETED|Period 1||0
59719|NCT01784614|140760|P4|NOT COMPLETED|Period 1||0
59720|NCT01784614|140761|P3|NOT COMPLETED|Period 1||0
59721|NCT01784614|140762|P2|NOT COMPLETED|Period 1||0
59722|NCT01784614|140763|P1|NOT COMPLETED|Period 1||0
59723|NCT01784614|140756|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
59724|NCT01784614|140757|P7|COMPLETED|Period 1||3
59725|NCT01784614|140758|P6|COMPLETED|Period 1||3
59726|NCT01784614|140759|P5|COMPLETED|Period 1||3
59727|NCT01784614|140760|P4|COMPLETED|Period 1||3
59728|NCT01784614|140761|P3|COMPLETED|Period 1||3
59729|NCT01784614|140762|P2|COMPLETED|Period 1||3
59730|NCT01784614|140763|P1|COMPLETED|Period 1||3
59731|NCT01784614|140756|P8|Received at Least 1 Dose of Study Drug|Period 1||3
59732|NCT01784614|140757|P7|Received at Least 1 Dose of Study Drug|Period 1||3
59733|NCT01784614|140758|P6|Received at Least 1 Dose of Study Drug|Period 1||3
59734|NCT01784614|140759|P5|Received at Least 1 Dose of Study Drug|Period 1||3
59735|NCT01784614|140760|P4|Received at Least 1 Dose of Study Drug|Period 1||3
59736|NCT01784614|140761|P3|Received at Least 1 Dose of Study Drug|Period 1||3
59737|NCT01784614|140762|P2|Received at Least 1 Dose of Study Drug|Period 1||3
59738|NCT01784614|140763|P1|Received at Least 1 Dose of Study Drug|Period 1||3
59739|NCT01784614|140756|P8|STARTED|Period 1||3
59740|NCT01784614|140757|P7|STARTED|Period 1||3
59741|NCT01784614|140758|P6|STARTED|Period 1||3
59742|NCT01784614|140759|P5|STARTED|Period 1||3
59743|NCT01784614|140760|P4|STARTED|Period 1||3
59744|NCT01784614|140761|P3|STARTED|Period 1||3
59745|NCT01784614|140762|P2|STARTED|Period 1||3
59746|NCT01784614|140763|P1|STARTED|Period 1||3
59747|NCT01784055|140797|P1|NOT COMPLETED|Overall Study||26
59748|NCT01784055|140797|P1|COMPLETED|Overall Study||100
59749|NCT01784055|140797|P1|STARTED|Overall Study||126
59750|NCT01783938|140803|P2|NOT COMPLETED|Overall Study||53
59751|NCT01783938|140804|P1|NOT COMPLETED|Overall Study||47
59752|NCT01783938|140803|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
59753|NCT01783938|140804|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
59754|NCT01783938|140803|P2|STARTED|Overall Study||70
59755|NCT01783938|140804|P1|STARTED|Overall Study||68
59756|NCT01783912|140819|P3|NOT COMPLETED|Overall Study||23
59757|NCT01783912|140820|P2|NOT COMPLETED|Overall Study||46
59758|NCT01783912|140821|P1|NOT COMPLETED|Overall Study||30
59759|NCT01783912|140819|P3|COMPLETED|Overall Study||25
59760|NCT01783912|140820|P2|COMPLETED|Overall Study||58
59761|NCT01783912|140821|P1|COMPLETED|Overall Study||88
59762|NCT01783912|140819|P3|STARTED|Overall Study||48
59763|NCT01783912|140820|P2|STARTED|Overall Study||104
59764|NCT01783912|140821|P1|STARTED|Overall Study||118
59765|NCT01783886|140832|P3|NOT COMPLETED|Overall Study||10
59766|NCT01783886|140833|P2|NOT COMPLETED|Overall Study||11
59767|NCT01783886|140834|P1|NOT COMPLETED|Overall Study||5
59768|NCT01783886|140832|P3|COMPLETED|Overall Study||117
59769|NCT01783886|140833|P2|COMPLETED|Overall Study||116
59770|NCT01783886|140834|P1|COMPLETED|Overall Study||122
59771|NCT01783886|140832|P3|Participants Received Treatment|Overall Study||124
59772|NCT01783886|140833|P2|Participants Received Treatment|Overall Study||127
59773|NCT01783886|140834|P1|Participants Received Treatment|Overall Study||127
59774|NCT01783886|140832|P3|STARTED|Overall Study||127
59775|NCT01783886|140833|P2|STARTED|Overall Study||127
59776|NCT01783886|140834|P1|STARTED|Overall Study||127
59777|NCT01783860|140862|P2|NOT COMPLETED|Overall Study||0
59778|NCT01783860|140863|P1|NOT COMPLETED|Overall Study||0
59779|NCT01783860|140862|P2|COMPLETED|Overall Study||50
59780|NCT01783860|140863|P1|COMPLETED|Overall Study||50
59781|NCT01783860|140862|P2|STARTED|Overall Study||50
59782|NCT01783860|140863|P1|STARTED|Overall Study||50
59783|NCT01783821|140881|P2|NOT COMPLETED|Overall Study||1
59784|NCT01783821|140882|P1|NOT COMPLETED|Overall Study||1
59785|NCT01783821|140881|P2|COMPLETED|Overall Study||30
59786|NCT01783821|140882|P1|COMPLETED|Overall Study||29
59787|NCT01783821|140881|P2|STARTED|Overall Study||31
59788|NCT01783821|140882|P1|STARTED|Overall Study||30
59789|NCT01783743|140900|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
59790|NCT01783743|140901|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
59791|NCT01783743|140900|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
59792|NCT01783743|140901|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
59793|NCT01783743|140900|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
59794|NCT01783743|140901|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
59795|NCT01783743|140900|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
59796|NCT01783743|140901|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
59797|NCT01783743|140900|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
59798|NCT01783743|140901|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
59799|NCT01783743|140900|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
59800|NCT01783743|140901|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
59801|NCT01783743|140900|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
59802|NCT01783743|140901|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
59803|NCT01783743|140900|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
59804|NCT01783743|140901|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
59805|NCT01783743|140900|P2|STARTED|Screening of Subjects by CTA During MDA||13964
59806|NCT01783743|140901|P1|STARTED|Screening of Subjects by CTA During MDA||13509
59807|NCT01783730|140915|P1|NOT COMPLETED|Overall Study||6
59808|NCT01783730|140915|P1|COMPLETED|Overall Study||157
59809|NCT01783730|140915|P1|STARTED|Overall Study||163
59810|NCT01783678|140940|P6|NOT COMPLETED|Overall Study||5
59811|NCT01783678|140941|P5|NOT COMPLETED|Overall Study||7
59812|NCT01783678|140942|P4|NOT COMPLETED|Overall Study||8
59813|NCT01783678|140943|P3|NOT COMPLETED|Overall Study||1
59814|NCT01783678|140944|P2|NOT COMPLETED|Overall Study||18
59815|NCT01783678|140945|P1|NOT COMPLETED|Overall Study||2
59816|NCT01783678|140940|P6|COMPLETED|Overall Study||26
59817|NCT01783678|140941|P5|COMPLETED|Overall Study||42
59818|NCT01783678|140942|P4|COMPLETED|Overall Study||50
59819|NCT01783678|140943|P3|COMPLETED|Overall Study||5
59820|NCT01783678|140944|P2|COMPLETED|Overall Study||94
59821|NCT01783678|140945|P1|COMPLETED|Overall Study||17
59822|NCT01783678|140940|P6|STARTED|Overall Study||31
59823|NCT01783678|140941|P5|STARTED|Overall Study||49
59824|NCT01783678|140942|P4|STARTED|Overall Study||58
59825|NCT01783678|140943|P3|STARTED|Overall Study||6
59826|NCT01783678|140944|P2|STARTED|Overall Study||112
59827|NCT01783678|140945|P1|STARTED|Overall Study||19
59828|NCT01783639|141017|P1|NOT COMPLETED|Overall Study||0
59829|NCT01783639|141017|P1|COMPLETED|Overall Study||120
59830|NCT01783639|141017|P1|STARTED|Overall Study||120
59831|NCT01783574|141023|P2|NOT COMPLETED|Overall Study||9
59832|NCT01783574|141024|P1|NOT COMPLETED|Overall Study||5
59833|NCT01783574|141023|P2|COMPLETED|Overall Study||41
59834|NCT01783574|141024|P1|COMPLETED|Overall Study||46
59835|NCT01783574|141023|P2|STARTED|Overall Study||50
59836|NCT01783574|141024|P1|STARTED|Overall Study||51
59837|NCT01783561|141036|P2|NOT COMPLETED|Overall Study||0
59838|NCT01783561|141037|P1|NOT COMPLETED|Overall Study||0
59839|NCT01783561|141036|P2|COMPLETED|Overall Study||10
59840|NCT01783561|141037|P1|COMPLETED|Overall Study||11
59841|NCT01783561|141036|P2|STARTED|Overall Study||10
59842|NCT01783561|141037|P1|STARTED|Overall Study||11
59843|NCT01783548|141047|P2|NOT COMPLETED|Overall Study||18
59844|NCT01783548|141048|P1|NOT COMPLETED|Overall Study||34
59845|NCT01783548|141047|P2|COMPLETED|Overall Study||167
59846|NCT01783548|141048|P1|COMPLETED|Overall Study||328
59847|NCT01783548|141047|P2|Full Analysis Set (FAS)|Overall Study||184
59848|NCT01783548|141048|P1|Full Analysis Set (FAS)|Overall Study||358
59849|NCT01783548|141047|P2|STARTED|Overall Study|Randomized|185
59850|NCT01783548|141048|P1|STARTED|Overall Study|Randomized|362
59851|NCT01783496|141066|P6|NOT COMPLETED|Overall Study||1
59852|NCT01783496|141067|P5|NOT COMPLETED|Overall Study||0
59853|NCT01783496|141068|P4|NOT COMPLETED|Overall Study||2
59854|NCT01783496|141069|P3|NOT COMPLETED|Overall Study||0
59855|NCT01783496|141070|P2|NOT COMPLETED|Overall Study||0
59856|NCT01783496|141071|P1|NOT COMPLETED|Overall Study||1
59857|NCT01783496|141066|P6|COMPLETED|Overall Study||4
59858|NCT01783496|141067|P5|COMPLETED|Overall Study||5
59859|NCT01783496|141068|P4|COMPLETED|Overall Study||8
59860|NCT01783496|141069|P3|COMPLETED|Overall Study||10
59861|NCT01783496|141070|P2|COMPLETED|Overall Study||10
59862|NCT01783496|141071|P1|COMPLETED|Overall Study||9
59863|NCT01783496|141066|P6|STARTED|Overall Study||5
59864|NCT01783496|141067|P5|STARTED|Overall Study||5
59865|NCT01783496|141068|P4|STARTED|Overall Study||10
59866|NCT01783496|141069|P3|STARTED|Overall Study||10
59867|NCT01783496|141070|P2|STARTED|Overall Study||10
59868|NCT01783496|141071|P1|STARTED|Overall Study||10
59869|NCT01783483|141099|P2|NOT COMPLETED|Overall Study||15
59870|NCT01783483|141100|P1|NOT COMPLETED|Overall Study||20
59871|NCT01783483|141099|P2|COMPLETED|Overall Study||101
59872|NCT01783483|141100|P1|COMPLETED|Overall Study||100
59873|NCT01783483|141099|P2|STARTED|Overall Study||116
59874|NCT01783483|141100|P1|STARTED|Overall Study||120
59875|NCT01783470|141128|P2|NOT COMPLETED|Overall Study||0
59876|NCT01783470|141129|P1|NOT COMPLETED|Overall Study||0
59877|NCT01783470|141128|P2|COMPLETED|Overall Study||6
59878|NCT01783470|141129|P1|COMPLETED|Overall Study||6
59879|NCT01783470|141128|P2|STARTED|Overall Study|Single-dose|6
59880|NCT01783470|141129|P1|STARTED|Overall Study||6
59881|NCT01783418|141138|P2|NOT COMPLETED|Overall Study||0
59882|NCT01783418|141139|P1|NOT COMPLETED|Overall Study||1
59883|NCT01783418|141138|P2|COMPLETED|Overall Study||6
59884|NCT01783418|141139|P1|COMPLETED|Overall Study||7
59885|NCT01783418|141138|P2|STARTED|Overall Study||6
59886|NCT01783418|141139|P1|STARTED|Overall Study||8
59887|NCT01783236|141159|P2|NOT COMPLETED|Overall Study||0
59888|NCT01783236|141160|P1|NOT COMPLETED|Overall Study||2
59889|NCT01783236|141159|P2|COMPLETED|Overall Study||8
59890|NCT01783236|141160|P1|COMPLETED|Overall Study||6
59891|NCT01783236|141159|P2|STARTED|Overall Study||8
59892|NCT01783236|141160|P1|STARTED|Overall Study||8
59893|NCT01783080|141174|P1|NOT COMPLETED|Overall Study||0
59894|NCT01783080|141174|P1|COMPLETED|Overall Study||16
59895|NCT01783080|141174|P1|STARTED|Overall Study||16
59896|NCT01783054|141181|P1|NOT COMPLETED|Overall Study||0
59897|NCT01783054|141181|P1|COMPLETED|Overall Study||2
59898|NCT01783054|141181|P1|STARTED|Overall Study||2
59899|NCT01783015|141192|P3|NOT COMPLETED|Open Label Treatment||6
59900|NCT01783015|141193|P2|NOT COMPLETED|Open Label Treatment||0
59901|NCT01783015|141194|P1|NOT COMPLETED|Open Label Treatment||0
59902|NCT01783015|141192|P3|COMPLETED|Open Label Treatment||5
59903|NCT01783015|141193|P2|COMPLETED|Open Label Treatment||0
59904|NCT01783015|141194|P1|COMPLETED|Open Label Treatment||0
59905|NCT01783015|141192|P3|STARTED|Open Label Treatment||11
59906|NCT01783015|141193|P2|STARTED|Open Label Treatment||0
59907|NCT01783015|141194|P1|STARTED|Open Label Treatment||0
59908|NCT01783015|141192|P3|NOT COMPLETED|Blinded Treatment||0
59909|NCT01783015|141193|P2|NOT COMPLETED|Blinded Treatment||3
59910|NCT01783015|141194|P1|NOT COMPLETED|Blinded Treatment||2
59911|NCT01783015|141192|P3|COMPLETED|Blinded Treatment||0
59912|NCT01783015|141193|P2|COMPLETED|Blinded Treatment||2
59913|NCT01783015|141194|P1|COMPLETED|Blinded Treatment||9
59914|NCT01783015|141192|P3|Treated|Blinded Treatment||0
59915|NCT01783015|141193|P2|Treated|Blinded Treatment||5
59916|NCT01783015|141194|P1|Treated|Blinded Treatment||11
59917|NCT01783015|141192|P3|STARTED|Blinded Treatment||0
59918|NCT01783015|141193|P2|STARTED|Blinded Treatment||5
59919|NCT01783015|141194|P1|STARTED|Blinded Treatment||11
59920|NCT01782963|141279|P1|NOT COMPLETED|Overall Study||0
59921|NCT01782963|141279|P1|COMPLETED|Overall Study||50
59922|NCT01782963|141279|P1|STARTED|Overall Study||50
59923|NCT01782898|141290|P2|NOT COMPLETED|Overall Study||6
59924|NCT01782898|141291|P1|NOT COMPLETED|Overall Study||6
59925|NCT01782898|141290|P2|COMPLETED|Overall Study||29
59926|NCT01782898|141291|P1|COMPLETED|Overall Study||29
59927|NCT01782898|141290|P2|STARTED|Overall Study||35
59928|NCT01782898|141291|P1|STARTED|Overall Study||35
59929|NCT01782885|141303|P2|NOT COMPLETED|Overall Study||6
59930|NCT01782885|141304|P1|NOT COMPLETED|Overall Study||4
59931|NCT01782885|141303|P2|COMPLETED|Overall Study||33
59932|NCT01782885|141304|P1|COMPLETED|Overall Study||32
59933|NCT01782885|141303|P2|STARTED|Overall Study||39
59934|NCT01782885|141304|P1|STARTED|Overall Study||36
59935|NCT01782872|141330|P4|NOT COMPLETED|Overall Study||1
59936|NCT01782872|141331|P3|NOT COMPLETED|Overall Study||0
59937|NCT01782872|141332|P2|NOT COMPLETED|Overall Study||1
59938|NCT01782872|141333|P1|NOT COMPLETED|Overall Study||0
59939|NCT01782872|141330|P4|COMPLETED|Overall Study||19
59940|NCT01782872|141331|P3|COMPLETED|Overall Study||20
59941|NCT01782872|141332|P2|COMPLETED|Overall Study||19
59942|NCT01782872|141333|P1|COMPLETED|Overall Study||20
59943|NCT01782872|141330|P4|STARTED|Overall Study||20
59944|NCT01782872|141331|P3|STARTED|Overall Study||20
59945|NCT01782872|141332|P2|STARTED|Overall Study||20
59946|NCT01782872|141333|P1|STARTED|Overall Study||20
59947|NCT01782859|141357|P2|NOT COMPLETED|Overall Study||7
59948|NCT01782859|141358|P1|NOT COMPLETED|Overall Study||6
59949|NCT01782859|141357|P2|COMPLETED|Overall Study||13
59950|NCT01782859|141358|P1|COMPLETED|Overall Study||14
59951|NCT01782859|141357|P2|STARTED|Overall Study||20
59952|NCT01782859|141358|P1|STARTED|Overall Study||20
59953|NCT01782742|141374|P2|NOT COMPLETED|Open Label Phase||0
59954|NCT01782742|141375|P1|NOT COMPLETED|Open Label Phase||0
59955|NCT01782742|141374|P2|COMPLETED|Open Label Phase||0
59956|NCT01782742|141375|P1|COMPLETED|Open Label Phase||19
59957|NCT01782742|141374|P2|STARTED|Open Label Phase||0
59958|NCT01782742|141375|P1|STARTED|Open Label Phase||19
59959|NCT01782742|141374|P2|NOT COMPLETED|Double-blind Treatment Phase||0
59960|NCT01782742|141375|P1|NOT COMPLETED|Double-blind Treatment Phase||1
59961|NCT01782742|141374|P2|COMPLETED|Double-blind Treatment Phase||4
59962|NCT01782742|141375|P1|COMPLETED|Double-blind Treatment Phase||15
59963|NCT01782742|141374|P2|STARTED|Double-blind Treatment Phase||4
59964|NCT01782742|141375|P1|STARTED|Double-blind Treatment Phase||16
59965|NCT01782664|141414|P6|NOT COMPLETED|Overall Study||0
59966|NCT01782664|141415|P5|NOT COMPLETED|Overall Study||0
59967|NCT01782664|141416|P4|NOT COMPLETED|Overall Study||5
59968|NCT01782664|141417|P3|NOT COMPLETED|Overall Study||4
59969|NCT01782664|141418|P2|NOT COMPLETED|Overall Study||5
59970|NCT01782664|141419|P1|NOT COMPLETED|Overall Study||6
59971|NCT01782664|141414|P6|COMPLETED|Overall Study||2
59972|NCT01782664|141415|P5|COMPLETED|Overall Study||6
59973|NCT01782664|141416|P4|COMPLETED|Overall Study||9
59974|NCT01782664|141417|P3|COMPLETED|Overall Study||12
59975|NCT01782664|141418|P2|COMPLETED|Overall Study||10
59976|NCT01782664|141419|P1|COMPLETED|Overall Study||8
59977|NCT01782664|141414|P6|STARTED|Overall Study||2
59978|NCT01782664|141415|P5|STARTED|Overall Study||6
59979|NCT01782664|141416|P4|STARTED|Overall Study||14
59980|NCT01782664|141417|P3|STARTED|Overall Study||16
59981|NCT01782664|141418|P2|STARTED|Overall Study||15
59982|NCT01782664|141419|P1|STARTED|Overall Study||14
59983|NCT01782495|141576|P11|NOT COMPLETED|Overall Study||0
59984|NCT01782495|141577|P10|NOT COMPLETED|Overall Study||0
59985|NCT01782495|141578|P9|NOT COMPLETED|Overall Study||0
59986|NCT01782495|141579|P8|NOT COMPLETED|Overall Study||3
59987|NCT01782495|141580|P7|NOT COMPLETED|Overall Study||0
59988|NCT01782495|141581|P6|NOT COMPLETED|Overall Study||0
59989|NCT01782495|141582|P5|NOT COMPLETED|Overall Study||0
59990|NCT01782495|141583|P4|NOT COMPLETED|Overall Study||0
59991|NCT01782495|141584|P3|NOT COMPLETED|Overall Study||0
59992|NCT01782495|141585|P2|NOT COMPLETED|Overall Study||1
59993|NCT01782495|141586|P1|NOT COMPLETED|Overall Study||0
59994|NCT01782495|141576|P11|COMPLETED|Overall Study||1
59995|NCT01782495|141577|P10|COMPLETED|Overall Study||2
59996|NCT01782495|141578|P9|COMPLETED|Overall Study||3
59997|NCT01782495|141579|P8|COMPLETED|Overall Study||6
59998|NCT01782495|141580|P7|COMPLETED|Overall Study||12
59999|NCT01782495|141581|P6|COMPLETED|Overall Study||22
60000|NCT01782495|141582|P5|COMPLETED|Overall Study||2
60001|NCT01782495|141583|P4|COMPLETED|Overall Study||4
60002|NCT01782495|141584|P3|COMPLETED|Overall Study||13
60003|NCT01782495|141585|P2|COMPLETED|Overall Study||26
60004|NCT01782495|141586|P1|COMPLETED|Overall Study||34
60005|NCT01782495|141576|P11|STARTED|Overall Study||1
60006|NCT01782495|141577|P10|STARTED|Overall Study||2
60007|NCT01782495|141578|P9|STARTED|Overall Study||3
60008|NCT01782495|141579|P8|STARTED|Overall Study||9
60009|NCT01782495|141580|P7|STARTED|Overall Study||12
60010|NCT01782495|141581|P6|STARTED|Overall Study||22
60011|NCT01782495|141582|P5|STARTED|Overall Study||2
60012|NCT01782495|141583|P4|STARTED|Overall Study||4
60013|NCT01782495|141584|P3|STARTED|Overall Study||13
60014|NCT01782495|141585|P2|STARTED|Overall Study||27
60015|NCT01782495|141586|P1|STARTED|Overall Study||34
60016|NCT01782482|141645|P2|NOT COMPLETED|Overall Study||10
60017|NCT01782482|141646|P1|NOT COMPLETED|Overall Study||10
60018|NCT01782482|141645|P2|COMPLETED|Overall Study||270
60019|NCT01782482|141646|P1|COMPLETED|Overall Study||271
60020|NCT01782482|141645|P2|STARTED|Overall Study||280
60021|NCT01782482|141646|P1|STARTED|Overall Study||281
60022|NCT01782469|141654|P1|NOT COMPLETED|Overall Study||1
60023|NCT01782469|141654|P1|COMPLETED|Overall Study||15
60024|NCT01782469|141654|P1|STARTED|Overall Study||16
60025|NCT01782326|141664|P2|NOT COMPLETED|Double-blind Treatment||320
60026|NCT01782326|141665|P1|NOT COMPLETED|Double-blind Treatment||278
60027|NCT01782326|141664|P2|COMPLETED|Double-blind Treatment||1360
60028|NCT01782326|141665|P1|COMPLETED|Double-blind Treatment||1400
60029|NCT01782326|141664|P2|STARTED|Double-blind Treatment||1680
60030|NCT01782326|141665|P1|STARTED|Double-blind Treatment||1678
60031|NCT01782326|141664|P2|NOT COMPLETED|Planned Treatment Epoch||208
60032|NCT01782326|141665|P1|NOT COMPLETED|Planned Treatment Epoch||202
60033|NCT01782326|141664|P2|COMPLETED|Planned Treatment Epoch||1474
60034|NCT01782326|141665|P1|COMPLETED|Planned Treatment Epoch||1478
60035|NCT01782326|141664|P2|Urine Cortisol Set|Planned Treatment Epoch||269
60036|NCT01782326|141665|P1|Urine Cortisol Set|Planned Treatment Epoch||266
60037|NCT01782326|141664|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
60038|NCT01782326|141665|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
60039|NCT01782326|141664|P2|Serial Spirometry Set|Planned Treatment Epoch||279
60040|NCT01782326|141665|P1|Serial Spirometry Set|Planned Treatment Epoch||280
60041|NCT01782326|141664|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
60042|NCT01782326|141665|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
60043|NCT01782326|141664|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
60044|NCT01782326|141665|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
60045|NCT01782326|141664|P2|STARTED|Planned Treatment Epoch||1682
60046|NCT01782326|141665|P1|STARTED|Planned Treatment Epoch||1680
60047|NCT01782222|141728|P3|NOT COMPLETED|Overall Study||4
60048|NCT01782222|141729|P2|NOT COMPLETED|Overall Study||11
60049|NCT01782222|141730|P1|NOT COMPLETED|Overall Study||8
60050|NCT01782222|141728|P3|COMPLETED|Overall Study||37
60051|NCT01782222|141729|P2|COMPLETED|Overall Study||30
60052|NCT01782222|141730|P1|COMPLETED|Overall Study||32
60053|NCT01782222|141728|P3|STARTED|Overall Study||41
60054|NCT01782222|141729|P2|STARTED|Overall Study||41
60055|NCT01782222|141730|P1|STARTED|Overall Study||40
60056|NCT01781962|141762|P1|NOT COMPLETED|Overall Study||5
60057|NCT01781962|141762|P1|COMPLETED|Overall Study||201
60058|NCT01781962|141762|P1|STARTED|Overall Study||206
60059|NCT01781832|141768|P1|NOT COMPLETED|Overall Study||1
60060|NCT01781832|141768|P1|COMPLETED|Overall Study||25
60061|NCT01781832|141768|P1|STARTED|Overall Study||26
60062|NCT01781806|141775|P2|NOT COMPLETED|Overall Study||3
60063|NCT01781806|141776|P1|NOT COMPLETED|Overall Study||79
60064|NCT01781806|141775|P2|COMPLETED|Overall Study||1
60065|NCT01781806|141776|P1|COMPLETED|Overall Study||218
60066|NCT01781806|141775|P2|Week 48|Overall Study||1
60067|NCT01781806|141776|P1|Week 48|Overall Study||222
60068|NCT01781806|141775|P2|Week 36|Overall Study||1
60069|NCT01781806|141776|P1|Week 36|Overall Study||247
60070|NCT01781806|141775|P2|Week 24|Overall Study||1
60071|NCT01781806|141776|P1|Week 24|Overall Study||260
60072|NCT01781806|141775|P2|Week 12|Overall Study||2
60073|NCT01781806|141776|P1|Week 12|Overall Study||272
60074|NCT01781806|141775|P2|Week 8|Overall Study||4
60075|NCT01781806|141776|P1|Week 8|Overall Study||278
60076|NCT01781806|141775|P2|Week 4|Overall Study||4
60077|NCT01781806|141776|P1|Week 4|Overall Study||284
60078|NCT01781806|141775|P2|Week 0|Overall Study||4
60079|NCT01781806|141776|P1|Week 0|Overall Study||297
60080|NCT01781806|141775|P2|STARTED|Overall Study||4
60081|NCT01781806|141776|P1|STARTED|Overall Study||297
60082|NCT01781637|141788|P2|NOT COMPLETED|Overall Study||6
60083|NCT01781637|141789|P1|NOT COMPLETED|Overall Study||4
60084|NCT01781637|141788|P2|COMPLETED|Overall Study||2
60085|NCT01781637|141789|P1|COMPLETED|Overall Study||24
60086|NCT01781637|141788|P2|STARTED|Overall Study||8
60087|NCT01781637|141789|P1|STARTED|Overall Study||28
60088|NCT01781481|141797|P1|NOT COMPLETED|Overall Study||0
60089|NCT01781481|141797|P1|COMPLETED|Overall Study||148
60090|NCT01781481|141797|P1|STARTED|Overall Study||148
60091|NCT01781403|141856|P3|NOT COMPLETED|Overall Study||0
60092|NCT01781403|141857|P2|NOT COMPLETED|Overall Study||0
60093|NCT01781403|141858|P1|NOT COMPLETED|Overall Study||0
60094|NCT01781403|141856|P3|COMPLETED|Overall Study||18
60095|NCT01781403|141857|P2|COMPLETED|Overall Study||2
60096|NCT01781403|141858|P1|COMPLETED|Overall Study||2
60097|NCT01781403|141856|P3|STARTED|Overall Study||18
60098|NCT01781403|141857|P2|STARTED|Overall Study||2
60099|NCT01781403|141858|P1|STARTED|Overall Study||2
60100|NCT01781299|141876|P2|NOT COMPLETED|Overall Study||1
60101|NCT01781299|141877|P1|NOT COMPLETED|Overall Study||0
60102|NCT01781299|141876|P2|COMPLETED|Overall Study||4
60103|NCT01781299|141877|P1|COMPLETED|Overall Study||4
60104|NCT01781299|141876|P2|STARTED|Overall Study||5
60105|NCT01781299|141877|P1|STARTED|Overall Study||4
60106|NCT01781208|141885|P1|NOT COMPLETED|Overall Study||0
60107|NCT01781208|141885|P1|COMPLETED|Overall Study||62
60108|NCT01781208|141885|P1|Overall Study|Overall Study||62
60109|NCT01781208|141885|P1|STARTED|Overall Study||62
60110|NCT01781169|141892|P2|NOT COMPLETED|Overall Study||0
60111|NCT01781169|141893|P1|NOT COMPLETED|Overall Study||1
60112|NCT01781169|141892|P2|COMPLETED|Overall Study||21
60113|NCT01781169|141893|P1|COMPLETED|Overall Study||21
60114|NCT01781169|141892|P2|STARTED|Overall Study||21
60115|NCT01781169|141893|P1|STARTED|Overall Study||22
60116|NCT01781078|141901|P3|NOT COMPLETED|Overall Study||16
60117|NCT01781078|141902|P2|NOT COMPLETED|Overall Study||5
60118|NCT01781078|141903|P1|NOT COMPLETED|Overall Study||12
60119|NCT01781078|141901|P3|COMPLETED|Overall Study||0
60120|NCT01781078|141902|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
60121|NCT01781078|141903|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
60122|NCT01781078|141901|P3|STARTED|Overall Study||16
60123|NCT01781078|141902|P2|STARTED|Overall Study|Randomized post implantation|118
60124|NCT01781078|141903|P1|STARTED|Overall Study|Randomized post implantation|229
60125|NCT01781026|141913|P1|NOT COMPLETED|Overall Study||2
60126|NCT01781026|141913|P1|COMPLETED|Overall Study||0
60127|NCT01781026|141913|P1|STARTED|Overall Study||2
60128|NCT01780987|141919|P2|NOT COMPLETED|Overall Study||6
60129|NCT01780987|141920|P1|NOT COMPLETED|Overall Study||3
60130|NCT01780987|141919|P2|COMPLETED|Overall Study||34
60131|NCT01780987|141920|P1|COMPLETED|Overall Study||37
60132|NCT01780987|141919|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
60133|NCT01780987|141920|P1|STARTED|Overall Study||40
60134|NCT01780974|141938|P2|NOT COMPLETED|Overall Study||3
60135|NCT01780974|141939|P1|NOT COMPLETED|Overall Study||2
60136|NCT01780974|141938|P2|COMPLETED|Overall Study||18
60137|NCT01780974|141939|P1|COMPLETED|Overall Study||19
60138|NCT01780974|141938|P2|STARTED|Overall Study||21
60139|NCT01780974|141939|P1|STARTED|Overall Study||21
60140|NCT01780935|141949|P2|NOT COMPLETED|Overall Study||336
60141|NCT01780935|141950|P1|NOT COMPLETED|Overall Study||335
60142|NCT01780935|141949|P2|COMPLETED|Overall Study||0
60143|NCT01780935|141950|P1|COMPLETED|Overall Study||0
60144|NCT01780935|141949|P2|Safety Set|Overall Study||336
60145|NCT01780935|141950|P1|Safety Set|Overall Study||334
60146|NCT01780935|141949|P2|STARTED|Overall Study||336
60147|NCT01780935|141950|P1|STARTED|Overall Study||335
60148|NCT01780922|141980|P6|NOT COMPLETED|Third Intervention (1 Day)||0
60149|NCT01780922|141981|P5|NOT COMPLETED|Third Intervention (1 Day)||0
60150|NCT01780922|141982|P4|NOT COMPLETED|Third Intervention (1 Day)||0
60151|NCT01780922|141983|P3|NOT COMPLETED|Third Intervention (1 Day)||0
60152|NCT01780922|141984|P2|NOT COMPLETED|Third Intervention (1 Day)||0
60153|NCT01780922|141985|P1|NOT COMPLETED|Third Intervention (1 Day)||0
60154|NCT01780922|141980|P6|COMPLETED|Third Intervention (1 Day)||2
60155|NCT01780922|141981|P5|COMPLETED|Third Intervention (1 Day)||2
60156|NCT01780922|141982|P4|COMPLETED|Third Intervention (1 Day)||2
60157|NCT01780922|141983|P3|COMPLETED|Third Intervention (1 Day)||2
60158|NCT01780922|141984|P2|COMPLETED|Third Intervention (1 Day)||2
60159|NCT01780922|141985|P1|COMPLETED|Third Intervention (1 Day)||2
60160|NCT01780922|141980|P6|STARTED|Third Intervention (1 Day)||2
60161|NCT01780922|141981|P5|STARTED|Third Intervention (1 Day)||2
60162|NCT01780922|141982|P4|STARTED|Third Intervention (1 Day)||2
60163|NCT01780922|141983|P3|STARTED|Third Intervention (1 Day)||2
60164|NCT01780922|141984|P2|STARTED|Third Intervention (1 Day)||2
60165|NCT01780922|141985|P1|STARTED|Third Intervention (1 Day)||2
60166|NCT01780922|141980|P6|NOT COMPLETED|Washout (7 Days)||0
60167|NCT01780922|141981|P5|NOT COMPLETED|Washout (7 Days)||0
60168|NCT01780922|141982|P4|NOT COMPLETED|Washout (7 Days)||0
60169|NCT01780922|141983|P3|NOT COMPLETED|Washout (7 Days)||0
60170|NCT01780922|141984|P2|NOT COMPLETED|Washout (7 Days)||0
60171|NCT01780922|141985|P1|NOT COMPLETED|Washout (7 Days)||0
60172|NCT01780922|141980|P6|COMPLETED|Washout (7 Days)||2
60173|NCT01780922|141981|P5|COMPLETED|Washout (7 Days)||2
60174|NCT01780922|141982|P4|COMPLETED|Washout (7 Days)||2
60175|NCT01780922|141983|P3|COMPLETED|Washout (7 Days)||2
60176|NCT01780922|141984|P2|COMPLETED|Washout (7 Days)||2
60177|NCT01780922|141985|P1|COMPLETED|Washout (7 Days)||2
60178|NCT01780922|141980|P6|STARTED|Washout (7 Days)||2
60179|NCT01780922|141981|P5|STARTED|Washout (7 Days)||2
60180|NCT01780922|141982|P4|STARTED|Washout (7 Days)||2
60181|NCT01780922|141983|P3|STARTED|Washout (7 Days)||2
60182|NCT01780922|141984|P2|STARTED|Washout (7 Days)||2
60183|NCT01780922|141985|P1|STARTED|Washout (7 Days)||2
60184|NCT01780922|141980|P6|NOT COMPLETED|Second Intervention (1 Day)||0
60185|NCT01780922|141981|P5|NOT COMPLETED|Second Intervention (1 Day)||0
60186|NCT01780922|141982|P4|NOT COMPLETED|Second Intervention (1 Day)||0
60187|NCT01780922|141983|P3|NOT COMPLETED|Second Intervention (1 Day)||0
60188|NCT01780922|141984|P2|NOT COMPLETED|Second Intervention (1 Day)||0
60189|NCT01780922|141985|P1|NOT COMPLETED|Second Intervention (1 Day)||0
60190|NCT01780922|141980|P6|COMPLETED|Second Intervention (1 Day)||2
60191|NCT01780922|141981|P5|COMPLETED|Second Intervention (1 Day)||2
60192|NCT01780922|141982|P4|COMPLETED|Second Intervention (1 Day)||2
60193|NCT01780922|141983|P3|COMPLETED|Second Intervention (1 Day)||2
60194|NCT01780922|141984|P2|COMPLETED|Second Intervention (1 Day)||2
60195|NCT01780922|141985|P1|COMPLETED|Second Intervention (1 Day)||2
60196|NCT01780922|141980|P6|STARTED|Second Intervention (1 Day)||2
60197|NCT01780922|141981|P5|STARTED|Second Intervention (1 Day)||2
60198|NCT01780922|141982|P4|STARTED|Second Intervention (1 Day)||2
60199|NCT01780922|141983|P3|STARTED|Second Intervention (1 Day)||2
60200|NCT01780922|141984|P2|STARTED|Second Intervention (1 Day)||2
60201|NCT01780922|141985|P1|STARTED|Second Intervention (1 Day)||2
60202|NCT01780922|141980|P6|NOT COMPLETED|Washout (7 Days)||0
60203|NCT01780922|141981|P5|NOT COMPLETED|Washout (7 Days)||0
60204|NCT01780922|141982|P4|NOT COMPLETED|Washout (7 Days)||0
60205|NCT01780922|141983|P3|NOT COMPLETED|Washout (7 Days)||0
60206|NCT01780922|141984|P2|NOT COMPLETED|Washout (7 Days)||0
60207|NCT01780922|141985|P1|NOT COMPLETED|Washout (7 Days)||0
60208|NCT01780922|141980|P6|COMPLETED|Washout (7 Days)||2
60209|NCT01780922|141981|P5|COMPLETED|Washout (7 Days)||2
60210|NCT01780922|141982|P4|COMPLETED|Washout (7 Days)||2
60211|NCT01780922|141983|P3|COMPLETED|Washout (7 Days)||2
60212|NCT01780922|141984|P2|COMPLETED|Washout (7 Days)||2
60213|NCT01780922|141985|P1|COMPLETED|Washout (7 Days)||2
60214|NCT01780922|141980|P6|STARTED|Washout (7 Days)||2
60215|NCT01780922|141981|P5|STARTED|Washout (7 Days)||2
60216|NCT01780922|141982|P4|STARTED|Washout (7 Days)||2
60217|NCT01780922|141983|P3|STARTED|Washout (7 Days)||2
60218|NCT01780922|141984|P2|STARTED|Washout (7 Days)||2
60219|NCT01780922|141985|P1|STARTED|Washout (7 Days)||2
60220|NCT01780922|141980|P6|NOT COMPLETED|First Intervention (1 Day)||0
60221|NCT01780922|141981|P5|NOT COMPLETED|First Intervention (1 Day)||0
60222|NCT01780922|141982|P4|NOT COMPLETED|First Intervention (1 Day)||0
60223|NCT01780922|141983|P3|NOT COMPLETED|First Intervention (1 Day)||0
60224|NCT01780922|141984|P2|NOT COMPLETED|First Intervention (1 Day)||0
60225|NCT01780922|141985|P1|NOT COMPLETED|First Intervention (1 Day)||0
60226|NCT01780922|141980|P6|COMPLETED|First Intervention (1 Day)||2
60227|NCT01780922|141981|P5|COMPLETED|First Intervention (1 Day)||2
60228|NCT01780922|141982|P4|COMPLETED|First Intervention (1 Day)||2
60229|NCT01780922|141983|P3|COMPLETED|First Intervention (1 Day)||2
60230|NCT01780922|141984|P2|COMPLETED|First Intervention (1 Day)||2
60231|NCT01780922|141985|P1|COMPLETED|First Intervention (1 Day)||2
60232|NCT01780922|141980|P6|STARTED|First Intervention (1 Day)||2
60233|NCT01780922|141981|P5|STARTED|First Intervention (1 Day)||2
60234|NCT01780922|141982|P4|STARTED|First Intervention (1 Day)||2
60235|NCT01780922|141983|P3|STARTED|First Intervention (1 Day)||2
60236|NCT01780922|141984|P2|STARTED|First Intervention (1 Day)||2
60237|NCT01780922|141985|P1|STARTED|First Intervention (1 Day)||2
60238|NCT01780870|142040|P2|NOT COMPLETED|Overall Study||0
60239|NCT01780870|142041|P1|NOT COMPLETED|Overall Study||0
60240|NCT01780870|142040|P2|COMPLETED|Overall Study||5
60241|NCT01780870|142041|P1|COMPLETED|Overall Study||0
60242|NCT01780870|142040|P2|STARTED|Overall Study||5
60243|NCT01780870|142041|P1|STARTED|Overall Study||0
60244|NCT01780584|142054|P3|NOT COMPLETED|Overall Study||2
60245|NCT01780584|142055|P2|NOT COMPLETED|Overall Study||1
60246|NCT01780584|142056|P1|NOT COMPLETED|Overall Study||1
60247|NCT01780584|142054|P3|COMPLETED|Overall Study||13
60248|NCT01780584|142055|P2|COMPLETED|Overall Study||14
60249|NCT01780584|142056|P1|COMPLETED|Overall Study||14
60250|NCT01780584|142054|P3|STARTED|Overall Study||15
60251|NCT01780584|142055|P2|STARTED|Overall Study||15
60252|NCT01780584|142056|P1|STARTED|Overall Study||15
60253|NCT01780545|142078|P2|NOT COMPLETED|Overall Study||2
60254|NCT01780545|142079|P1|NOT COMPLETED|Overall Study||4
60255|NCT01780545|142078|P2|COMPLETED|Overall Study||99
60256|NCT01780545|142079|P1|COMPLETED|Overall Study||95
60257|NCT01780545|142078|P2|STARTED|Overall Study||101
60258|NCT01780545|142079|P1|STARTED|Overall Study||99
60259|NCT01780506|142097|P2|NOT COMPLETED|Overall Study||434
60260|NCT01780506|142098|P1|NOT COMPLETED|Overall Study||438
60261|NCT01780506|142097|P2|COMPLETED|Overall Study||0
60262|NCT01780506|142098|P1|COMPLETED|Overall Study||0
60263|NCT01780506|142097|P2|STARTED|Overall Study||434
60264|NCT01780506|142098|P1|STARTED|Overall Study||438
60265|NCT01780389|142136|P1|NOT COMPLETED|Overall Study||1
60266|NCT01780389|142136|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
60267|NCT01780389|142136|P1|STARTED|Overall Study||5
60268|NCT01780350|142147|P1|NOT COMPLETED|Overall Study||0
60269|NCT01780350|142147|P1|COMPLETED|Overall Study||200
60270|NCT01780350|142147|P1|STARTED|Overall Study||200
60271|NCT01780337|142154|P2|NOT COMPLETED|Overall Study||0
60272|NCT01780337|142155|P1|NOT COMPLETED|Overall Study||0
60273|NCT01780337|142154|P2|COMPLETED|Overall Study||6
60274|NCT01780337|142155|P1|COMPLETED|Overall Study||6
60275|NCT01780337|142154|P2|STARTED|Overall Study||6
60276|NCT01780337|142155|P1|STARTED|Overall Study||6
60277|NCT01780324|142167|P2|NOT COMPLETED|Overall Study||6
60278|NCT01780324|142168|P1|NOT COMPLETED|Overall Study||1
60279|NCT01780324|142167|P2|COMPLETED|Overall Study||33
60280|NCT01780324|142168|P1|COMPLETED|Overall Study||40
60281|NCT01780324|142167|P2|STARTED|Overall Study||39
60282|NCT01780324|142168|P1|STARTED|Overall Study||41
60283|NCT01779648|142176|P2|NOT COMPLETED|Overall Study||0
60284|NCT01779648|142177|P1|NOT COMPLETED|Overall Study||1
60285|NCT01779648|142176|P2|COMPLETED|Overall Study||27
60286|NCT01779648|142177|P1|COMPLETED|Overall Study||27
60287|NCT01779648|142176|P2|STARTED|Overall Study||27
60288|NCT01779648|142177|P1|STARTED|Overall Study||28
60289|NCT01779219|142207|P2|NOT COMPLETED|Overall Study||0
60290|NCT01779219|142208|P1|NOT COMPLETED|Overall Study||0
60291|NCT01779219|142207|P2|COMPLETED|Overall Study|First interim analysis|21
60292|NCT01779219|142208|P1|COMPLETED|Overall Study|First interim analysis|21
60293|NCT01779219|142207|P2|STARTED|Overall Study|First interim analysis|21
60294|NCT01779219|142208|P1|STARTED|Overall Study|First interim analysis|21
60295|NCT01779167|142220|P1|NOT COMPLETED|Overall Study||1
60296|NCT01779167|142220|P1|COMPLETED|Overall Study||3
60297|NCT01779167|142220|P1|STARTED|Overall Study||4
60298|NCT01778985|142227|P2|NOT COMPLETED|Overall Study||3
60299|NCT01778985|142228|P1|NOT COMPLETED|Overall Study||7
60300|NCT01778985|142227|P2|COMPLETED|Overall Study||12
60301|NCT01778985|142228|P1|COMPLETED|Overall Study||8
60302|NCT01778985|142227|P2|STARTED|Overall Study||15
60303|NCT01778985|142228|P1|STARTED|Overall Study||15
60304|NCT01778855|142274|P2|NOT COMPLETED|Overall Study||1
60305|NCT01778855|142275|P1|NOT COMPLETED|Overall Study||0
60306|NCT01778855|142274|P2|COMPLETED|Overall Study||3
60307|NCT01778855|142275|P1|COMPLETED|Overall Study||2
60308|NCT01778855|142274|P2|STARTED|Overall Study||4
60309|NCT01778855|142275|P1|STARTED|Overall Study||2
60310|NCT01778751|142283|P2|NOT COMPLETED|Overall Study||2
60311|NCT01778751|142284|P1|NOT COMPLETED|Overall Study||2
60312|NCT01778751|142283|P2|COMPLETED|Overall Study||23
60313|NCT01778751|142284|P1|COMPLETED|Overall Study||23
60314|NCT01778751|142283|P2|STARTED|Overall Study||25
60315|NCT01778751|142284|P1|STARTED|Overall Study||25
60316|NCT01778634|142298|P2|NOT COMPLETED|Overall Study||0
60317|NCT01778634|142299|P1|NOT COMPLETED|Overall Study||0
60318|NCT01778634|142298|P2|COMPLETED|Overall Study||60
60319|NCT01778634|142299|P1|COMPLETED|Overall Study||61
60320|NCT01778634|142298|P2|STARTED|Overall Study||60
60321|NCT01778634|142299|P1|STARTED|Overall Study||61
60322|NCT01778530|142335|P1|NOT COMPLETED|Overall Study||2
60323|NCT01778530|142335|P1|COMPLETED|Overall Study||0
60324|NCT01778530|142335|P1|STARTED|Overall Study||2
60325|NCT01778296|142340|P1|NOT COMPLETED|Overall Study||0
60326|NCT01778296|142340|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
60327|NCT01778296|142340|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
60328|NCT01778127|142347|P3|NOT COMPLETED|Overall Study||6
60329|NCT01778127|142348|P2|NOT COMPLETED|Overall Study||2
60330|NCT01778127|142349|P1|NOT COMPLETED|Overall Study||8
60331|NCT01778127|142347|P3|COMPLETED|Overall Study||26
60332|NCT01778127|142348|P2|COMPLETED|Overall Study||31
60333|NCT01778127|142349|P1|COMPLETED|Overall Study||25
60334|NCT01778127|142347|P3|STARTED|Overall Study||32
60335|NCT01778127|142348|P2|STARTED|Overall Study||33
60336|NCT01778127|142349|P1|STARTED|Overall Study||33
60337|NCT01778062|142392|P2|NOT COMPLETED|Overall Study||11
60338|NCT01778062|142393|P1|NOT COMPLETED|Overall Study||6
60339|NCT01778062|142392|P2|COMPLETED|Overall Study||57
60340|NCT01778062|142393|P1|COMPLETED|Overall Study||62
60341|NCT01778062|142392|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
60342|NCT01778062|142393|P1|Intent to Treat (ITT)|Overall Study||68
60343|NCT01778062|142392|P2|Safety Set|Overall Study||68
60344|NCT01778062|142393|P1|Safety Set|Overall Study||68
60345|NCT01778062|142392|P2|STARTED|Overall Study||68
60346|NCT01778062|142393|P1|STARTED|Overall Study||68
60347|NCT01778049|142407|P6|NOT COMPLETED|Double Blind Treatment Period||7
60348|NCT01778049|142408|P5|NOT COMPLETED|Double Blind Treatment Period||12
60349|NCT01778049|142409|P4|NOT COMPLETED|Double Blind Treatment Period||12
60350|NCT01778049|142410|P3|NOT COMPLETED|Double Blind Treatment Period||15
60351|NCT01778049|142411|P2|NOT COMPLETED|Double Blind Treatment Period||0
60352|NCT01778049|142412|P1|NOT COMPLETED|Double Blind Treatment Period||0
60353|NCT01778049|142407|P6|COMPLETED|Double Blind Treatment Period||105
60354|NCT01778049|142408|P5|COMPLETED|Double Blind Treatment Period||102
60355|NCT01778049|142409|P4|COMPLETED|Double Blind Treatment Period||118
60356|NCT01778049|142410|P3|COMPLETED|Double Blind Treatment Period||111
60357|NCT01778049|142411|P2|COMPLETED|Double Blind Treatment Period||0
60358|NCT01778049|142412|P1|COMPLETED|Double Blind Treatment Period||0
60359|NCT01778049|142407|P6|STARTED|Double Blind Treatment Period||112
60360|NCT01778049|142408|P5|STARTED|Double Blind Treatment Period||114
60361|NCT01778049|142409|P4|STARTED|Double Blind Treatment Period||130
60362|NCT01778049|142410|P3|STARTED|Double Blind Treatment Period||126
60363|NCT01778049|142411|P2|STARTED|Double Blind Treatment Period||0
60364|NCT01778049|142412|P1|STARTED|Double Blind Treatment Period||0
60365|NCT01778049|142407|P6|NOT COMPLETED|Open Label Treatment Period||0
60366|NCT01778049|142408|P5|NOT COMPLETED|Open Label Treatment Period||0
60367|NCT01778049|142409|P4|NOT COMPLETED|Open Label Treatment Period||0
60368|NCT01778049|142410|P3|NOT COMPLETED|Open Label Treatment Period||0
60369|NCT01778049|142411|P2|NOT COMPLETED|Open Label Treatment Period||129
60370|NCT01778049|142412|P1|NOT COMPLETED|Open Label Treatment Period||98
60371|NCT01778049|142407|P6|COMPLETED|Open Label Treatment Period||0
60372|NCT01778049|142408|P5|COMPLETED|Open Label Treatment Period||0
60373|NCT01778049|142409|P4|COMPLETED|Open Label Treatment Period||0
60374|NCT01778049|142410|P3|COMPLETED|Open Label Treatment Period||0
60375|NCT01778049|142411|P2|COMPLETED|Open Label Treatment Period||226
60376|NCT01778049|142412|P1|COMPLETED|Open Label Treatment Period||256
60377|NCT01778049|142407|P6|STARTED|Open Label Treatment Period||0
60378|NCT01778049|142408|P5|STARTED|Open Label Treatment Period||0
60379|NCT01778049|142409|P4|STARTED|Open Label Treatment Period||0
60380|NCT01778049|142410|P3|STARTED|Open Label Treatment Period||0
60381|NCT01778049|142411|P2|STARTED|Open Label Treatment Period||355
60382|NCT01778049|142412|P1|STARTED|Open Label Treatment Period||354
60383|NCT01778023|142430|P2|NOT COMPLETED|Overall Study||3
60384|NCT01778023|142431|P1|NOT COMPLETED|Overall Study||0
60385|NCT01778023|142430|P2|COMPLETED|Overall Study||15
60386|NCT01778023|142431|P1|COMPLETED|Overall Study||36
60387|NCT01778023|142430|P2|Exposed|Overall Study||15
60388|NCT01778023|142431|P1|Exposed|Overall Study||36
60389|NCT01778023|142430|P2|STARTED|Overall Study||18
60390|NCT01778023|142431|P1|STARTED|Overall Study||36
60391|NCT01778010|142448|P1|NOT COMPLETED|Overall Study||5
60392|NCT01778010|142448|P1|COMPLETED|Overall Study||8
60393|NCT01778010|142448|P1|STARTED|Overall Study||13
60394|NCT01777997|142489|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
60395|NCT01777997|142489|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
60396|NCT01777997|142489|P1|STARTED|Weeks 48 to 72/96 on ART||28
60397|NCT01777997|142489|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
60398|NCT01777997|142489|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
60399|NCT01777997|142489|P1|STARTED|Weeks 0 to 24/48 on ART||36
60400|NCT01777997|142489|P1|NOT COMPLETED|12 Week lead-in of no ART||2
60401|NCT01777997|142489|P1|COMPLETED|12 Week lead-in of no ART||36
60402|NCT01777997|142489|P1|STARTED|12 Week lead-in of no ART||38
60403|NCT01777945|142501|P1|NOT COMPLETED|Overall Study||0
60404|NCT01777945|142501|P1|COMPLETED|Overall Study||46
60405|NCT01777945|142501|P1|Evaluable Participants|Overall Study||45
60406|NCT01777945|142501|P1|STARTED|Overall Study||46
60407|NCT01777932|142511|P1|NOT COMPLETED|Overall Study||205
60408|NCT01777932|142511|P1|COMPLETED|Overall Study||15
60409|NCT01777932|142511|P1|STARTED|Overall Study||220
60410|NCT01777776|142529|P4|NOT COMPLETED|Overall Study||4
60411|NCT01777776|142530|P3|NOT COMPLETED|Overall Study||6
60412|NCT01777776|142531|P2|NOT COMPLETED|Overall Study||12
60413|NCT01777776|142532|P1|NOT COMPLETED|Overall Study||6
60414|NCT01777776|142529|P4|COMPLETED|Overall Study||0
60415|NCT01777776|142530|P3|COMPLETED|Overall Study||0
60416|NCT01777776|142531|P2|COMPLETED|Overall Study||0
60417|NCT01777776|142532|P1|COMPLETED|Overall Study||0
60418|NCT01777776|142529|P4|STARTED|Overall Study||4
60419|NCT01777776|142530|P3|STARTED|Overall Study||6
60420|NCT01777776|142531|P2|STARTED|Overall Study||12
60421|NCT01777776|142532|P1|STARTED|Overall Study||6
60422|NCT01777763|142591|P2|NOT COMPLETED|Overall Study||47
60423|NCT01777763|142592|P1|NOT COMPLETED|Overall Study||4
60424|NCT01777763|142591|P2|COMPLETED|Overall Study||163
60425|NCT01777763|142592|P1|COMPLETED|Overall Study||16
60426|NCT01777763|142591|P2|STARTED|Overall Study||210
60427|NCT01777763|142592|P1|STARTED|Overall Study||20
60428|NCT01777620|142616|P2|NOT COMPLETED|Overall Study||0
60429|NCT01777620|142617|P1|NOT COMPLETED|Overall Study||1
60430|NCT01777620|142616|P2|COMPLETED|Overall Study||62
60431|NCT01777620|142617|P1|COMPLETED|Overall Study||62
60432|NCT01777620|142616|P2|STARTED|Overall Study||62
60433|NCT01777620|142617|P1|STARTED|Overall Study||63
60434|NCT01777581|142643|P2|NOT COMPLETED|Overall Study||2
60435|NCT01777581|142644|P1|NOT COMPLETED|Overall Study||3
60436|NCT01777581|142643|P2|COMPLETED|Overall Study||3
60437|NCT01777581|142644|P1|COMPLETED|Overall Study||5
60438|NCT01777581|142643|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
60439|NCT01777581|142644|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
60440|NCT01777542|142662|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
60441|NCT01777542|142663|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
60442|NCT01777542|142662|P2|COMPLETED|Second Intervention (20 Weeks)||14
60443|NCT01777542|142663|P1|COMPLETED|Second Intervention (20 Weeks)||15
60444|NCT01777542|142662|P2|STARTED|Second Intervention (20 Weeks)||15
60445|NCT01777542|142663|P1|STARTED|Second Intervention (20 Weeks)||15
60446|NCT01777542|142662|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
60447|NCT01777542|142663|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
60448|NCT01777542|142662|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
60449|NCT01777542|142663|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
60450|NCT01777542|142662|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
60451|NCT01777542|142663|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
60452|NCT01777542|142662|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
60453|NCT01777542|142663|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
60454|NCT01777542|142662|P2|COMPLETED|First Intervention (20 Weeks)||15
60455|NCT01777542|142663|P1|COMPLETED|First Intervention (20 Weeks)||15
60456|NCT01777542|142662|P2|STARTED|First Intervention (20 Weeks)||15
60457|NCT01777542|142663|P1|STARTED|First Intervention (20 Weeks)||15
60458|NCT01777438|142704|P2|NOT COMPLETED|Overall Study||0
60459|NCT01777438|142705|P1|NOT COMPLETED|Overall Study||0
60460|NCT01777438|142704|P2|COMPLETED|Overall Study||82
60461|NCT01777438|142705|P1|COMPLETED|Overall Study||352
60462|NCT01777438|142704|P2|STARTED|Overall Study||82
60463|NCT01777438|142705|P1|STARTED|Overall Study||352
60464|NCT01777425|142717|P1|NOT COMPLETED|Overall Study||0
60465|NCT01777425|142717|P1|COMPLETED|Overall Study||389
60466|NCT01777425|142717|P1|STARTED|Overall Study||389
60467|NCT01777412|142723|P1|NOT COMPLETED|Overall Study||0
60468|NCT01777412|142723|P1|COMPLETED|Overall Study||10
60469|NCT01777412|142723|P1|STARTED|Overall Study||10
60470|NCT01777334|142731|P2|NOT COMPLETED|Overall Study||63
60471|NCT01777334|142732|P1|NOT COMPLETED|Overall Study||53
60472|NCT01777334|142731|P2|COMPLETED|Overall Study||388
60473|NCT01777334|142732|P1|COMPLETED|Overall Study||401
60474|NCT01777334|142731|P2|STARTED|Overall Study||451
60475|NCT01777334|142732|P1|STARTED|Overall Study||454
60476|NCT01777321|142742|P2|NOT COMPLETED|Overall Study||1
60477|NCT01777321|142743|P1|NOT COMPLETED|Overall Study||0
60478|NCT01777321|142742|P2|COMPLETED|Overall Study||29
60479|NCT01777321|142743|P1|COMPLETED|Overall Study||30
60480|NCT01777321|142742|P2|STARTED|Overall Study||30
60481|NCT01777321|142743|P1|STARTED|Overall Study||30
60482|NCT01777282|142784|P5|NOT COMPLETED|Overall Study||7
60483|NCT01777282|142785|P4|NOT COMPLETED|Overall Study||2
60484|NCT01777282|142786|P3|NOT COMPLETED|Overall Study||6
60485|NCT01777282|142787|P2|NOT COMPLETED|Overall Study||4
60486|NCT01777282|142788|P1|NOT COMPLETED|Overall Study||11
60487|NCT01777282|142784|P5|COMPLETED|Overall Study||54
60488|NCT01777282|142785|P4|COMPLETED|Overall Study||59
60489|NCT01777282|142786|P3|COMPLETED|Overall Study||59
60490|NCT01777282|142787|P2|COMPLETED|Overall Study||63
60491|NCT01777282|142788|P1|COMPLETED|Overall Study||109
60492|NCT01777282|142784|P5|Completing Follow-up Period|Overall Study||54
60493|NCT01777282|142785|P4|Completing Follow-up Period|Overall Study||59
60494|NCT01777282|142786|P3|Completing Follow-up Period|Overall Study||59
60495|NCT01777282|142787|P2|Completing Follow-up Period|Overall Study||63
60496|NCT01777282|142788|P1|Completing Follow-up Period|Overall Study||109
60497|NCT01777282|142784|P5|Completing Treatment Period|Overall Study||54
60498|NCT01777282|142785|P4|Completing Treatment Period|Overall Study||59
60499|NCT01777282|142786|P3|Completing Treatment Period|Overall Study||59
60500|NCT01777282|142787|P2|Completing Treatment Period|Overall Study||63
60501|NCT01777282|142788|P1|Completing Treatment Period|Overall Study||109
60502|NCT01777282|142784|P5|STARTED|Overall Study||61
60503|NCT01777282|142785|P4|STARTED|Overall Study||61
60504|NCT01777282|142786|P3|STARTED|Overall Study||65
60505|NCT01777282|142787|P2|STARTED|Overall Study||67
60506|NCT01777282|142788|P1|STARTED|Overall Study||120
60507|NCT01777269|142832|P2|NOT COMPLETED|Overall Study||59
60508|NCT01777269|142833|P1|NOT COMPLETED|Overall Study||55
60509|NCT01777269|142832|P2|COMPLETED|Overall Study||184
60510|NCT01777269|142833|P1|COMPLETED|Overall Study||191
60511|NCT01777269|142832|P2|STARTED|Overall Study||243
60512|NCT01777269|142833|P1|STARTED|Overall Study||246
60513|NCT01777217|142861|P2|NOT COMPLETED|Overall Study||0
60514|NCT01777217|142862|P1|NOT COMPLETED|Overall Study||0
60515|NCT01777217|142861|P2|COMPLETED|Overall Study||4
60516|NCT01777217|142862|P1|COMPLETED|Overall Study||4
60517|NCT01777217|142861|P2|STARTED|Overall Study||4
60518|NCT01777217|142862|P1|STARTED|Overall Study||4
60519|NCT01777191|142870|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
60520|NCT01777191|142871|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
60521|NCT01777191|142870|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
60522|NCT01777191|142871|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
60523|NCT01777191|142870|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
60524|NCT01777191|142871|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
60525|NCT01777191|142870|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
60526|NCT01777191|142871|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
60527|NCT01777191|142870|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
60528|NCT01777191|142871|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
60529|NCT01777191|142870|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
60530|NCT01777191|142871|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
60531|NCT01777126|142901|P2|NOT COMPLETED|Overall Study||0
60532|NCT01777126|142902|P1|NOT COMPLETED|Overall Study||0
60533|NCT01777126|142901|P2|COMPLETED|Overall Study||46
60534|NCT01777126|142902|P1|COMPLETED|Overall Study||48
60535|NCT01777126|142901|P2|STARTED|Overall Study||46
60536|NCT01777126|142902|P1|STARTED|Overall Study||48
60537|NCT01776645|142925|P2|NOT COMPLETED|Overall Study||14
60538|NCT01776645|142926|P1|NOT COMPLETED|Overall Study||14
60539|NCT01776645|142925|P2|COMPLETED|Overall Study||14
60540|NCT01776645|142926|P1|COMPLETED|Overall Study||14
60541|NCT01776645|142925|P2|STARTED|Overall Study||28
60542|NCT01776645|142926|P1|STARTED|Overall Study||28
60543|NCT01776554|142934|P2|NOT COMPLETED|Overall Study||23
60544|NCT01776554|142935|P1|NOT COMPLETED|Overall Study||17
60545|NCT01776554|142934|P2|COMPLETED|Overall Study||307
60546|NCT01776554|142935|P1|COMPLETED|Overall Study||315
60547|NCT01776554|142934|P2|STARTED|Overall Study||330
60548|NCT01776554|142935|P1|STARTED|Overall Study||332
60549|NCT01776541|142978|P2|NOT COMPLETED|Overall Study||75
60550|NCT01776541|142979|P1|NOT COMPLETED|Overall Study||56
60551|NCT01776541|142978|P2|COMPLETED|Overall Study||416
60552|NCT01776541|142979|P1|COMPLETED|Overall Study||432
60553|NCT01776541|142978|P2|STARTED|Overall Study||491
60554|NCT01776541|142979|P1|STARTED|Overall Study||488
60555|NCT01776268|143000|P2|NOT COMPLETED|Overall Study||0
60556|NCT01776268|143001|P1|NOT COMPLETED|Overall Study||0
60557|NCT01776268|143000|P2|COMPLETED|Overall Study||51
60558|NCT01776268|143001|P1|COMPLETED|Overall Study||48
60559|NCT01776268|143000|P2|STARTED|Overall Study||51
60560|NCT01776268|143001|P1|STARTED|Overall Study||48
60561|NCT01776008|143009|P1|NOT COMPLETED|Overall Study||2
60562|NCT01776008|143009|P1|COMPLETED|Overall Study||14
60563|NCT01776008|143009|P1|STARTED|Overall Study||16
60564|NCT01775995|143023|P2|NOT COMPLETED|Overall Study||1
60565|NCT01775995|143024|P1|NOT COMPLETED|Overall Study||1
60566|NCT01775995|143023|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
60567|NCT01775995|143024|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
60568|NCT01775995|143023|P2|STARTED|Overall Study||14
60569|NCT01775995|143024|P1|STARTED|Overall Study||21
60570|NCT01775865|143087|P3|NOT COMPLETED|Overall Study||0
60571|NCT01775865|143088|P2|NOT COMPLETED|Overall Study||1
60572|NCT01775865|143089|P1|NOT COMPLETED|Overall Study||3
60573|NCT01775865|143087|P3|COMPLETED|Overall Study||17
60574|NCT01775865|143088|P2|COMPLETED|Overall Study||13
60575|NCT01775865|143089|P1|COMPLETED|Overall Study||11
60576|NCT01775865|143087|P3|STARTED|Overall Study||17
60577|NCT01775865|143088|P2|STARTED|Overall Study||14
60578|NCT01775865|143089|P1|STARTED|Overall Study||14
60579|NCT01775852|143105|P2|NOT COMPLETED|Overall Study||1
60580|NCT01775852|143106|P1|NOT COMPLETED|Overall Study||0
60581|NCT01775852|143105|P2|COMPLETED|Overall Study||13
60582|NCT01775852|143106|P1|COMPLETED|Overall Study||31
60583|NCT01775852|143105|P2|STARTED|Overall Study||14
60584|NCT01775852|143106|P1|STARTED|Overall Study||31
60585|NCT01775787|143118|P2|NOT COMPLETED|Second 7-10 Days||2
60586|NCT01775787|143119|P1|NOT COMPLETED|Second 7-10 Days||0
60587|NCT01775787|143118|P2|COMPLETED|Second 7-10 Days||6
60588|NCT01775787|143119|P1|COMPLETED|Second 7-10 Days||12
60589|NCT01775787|143118|P2|STARTED|Second 7-10 Days||8
60590|NCT01775787|143119|P1|STARTED|Second 7-10 Days||12
60591|NCT01775787|143118|P2|NOT COMPLETED|First 7-10 Days||6
60592|NCT01775787|143119|P1|NOT COMPLETED|First 7-10 Days||1
60593|NCT01775787|143118|P2|COMPLETED|First 7-10 Days||8
60594|NCT01775787|143119|P1|COMPLETED|First 7-10 Days||12
60595|NCT01775787|143118|P2|STARTED|First 7-10 Days||14
60596|NCT01775787|143119|P1|STARTED|First 7-10 Days||13
60597|NCT01775774|143130|P3|NOT COMPLETED|Overall Study||0
60598|NCT01775774|143131|P2|NOT COMPLETED|Overall Study||0
60599|NCT01775774|143132|P1|NOT COMPLETED|Overall Study||0
60600|NCT01775774|143130|P3|COMPLETED|Overall Study||3
60601|NCT01775774|143131|P2|COMPLETED|Overall Study||3
60602|NCT01775774|143132|P1|COMPLETED|Overall Study||3
60603|NCT01775774|143130|P3|STARTED|Overall Study||3
60604|NCT01775774|143131|P2|STARTED|Overall Study||3
60605|NCT01775774|143132|P1|STARTED|Overall Study||3
60606|NCT01775722|143158|P1|NOT COMPLETED|Overall Study||2
60607|NCT01775722|143158|P1|COMPLETED|Overall Study||20
60608|NCT01775722|143158|P1|STARTED|Overall Study||22
60609|NCT01775670|143166|P2|NOT COMPLETED|Overall Study||1
60610|NCT01775670|143167|P1|NOT COMPLETED|Overall Study||1
60611|NCT01775670|143166|P2|COMPLETED|Overall Study||2
60612|NCT01775670|143167|P1|COMPLETED|Overall Study||0
60613|NCT01775670|143166|P2|STARTED|Overall Study||3
60614|NCT01775670|143167|P1|STARTED|Overall Study||1
60615|NCT01775553|143193|P1|NOT COMPLETED|Overall Study||13
60616|NCT01775553|143193|P1|COMPLETED|Overall Study||0
60617|NCT01775553|143193|P1|STARTED|Overall Study||13
60618|NCT01775189|143201|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
60619|NCT01775189|143202|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
60620|NCT01775189|143203|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
60621|NCT01775189|143204|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
60622|NCT01775189|143205|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
60623|NCT01775189|143206|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
60624|NCT01775189|143207|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
60625|NCT01775189|143201|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
60626|NCT01775189|143202|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
60627|NCT01775189|143203|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
60628|NCT01775189|143204|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
60629|NCT01775189|143205|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
60630|NCT01775189|143206|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
60631|NCT01775189|143207|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
60632|NCT01775189|143201|P7|STARTED|Treatment Phase: Fourth Intervention||7
60633|NCT01775189|143202|P6|STARTED|Treatment Phase: Fourth Intervention||7
60634|NCT01775189|143203|P5|STARTED|Treatment Phase: Fourth Intervention||8
60635|NCT01775189|143204|P4|STARTED|Treatment Phase: Fourth Intervention||6
60636|NCT01775189|143205|P3|STARTED|Treatment Phase: Fourth Intervention||0
60637|NCT01775189|143206|P2|STARTED|Treatment Phase: Fourth Intervention||0
60638|NCT01775189|143207|P1|STARTED|Treatment Phase: Fourth Intervention||0
60795|NCT01775189|143203|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
60639|NCT01775189|143201|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
60640|NCT01775189|143202|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
60641|NCT01775189|143203|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
60642|NCT01775189|143204|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
60643|NCT01775189|143205|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
60644|NCT01775189|143206|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
60645|NCT01775189|143207|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
60646|NCT01775189|143201|P7|COMPLETED|Treatment Phase: Washout Period 3||7
60647|NCT01775189|143202|P6|COMPLETED|Treatment Phase: Washout Period 3||7
60648|NCT01775189|143203|P5|COMPLETED|Treatment Phase: Washout Period 3||8
60649|NCT01775189|143204|P4|COMPLETED|Treatment Phase: Washout Period 3||6
60650|NCT01775189|143205|P3|COMPLETED|Treatment Phase: Washout Period 3||0
60651|NCT01775189|143206|P2|COMPLETED|Treatment Phase: Washout Period 3||0
60652|NCT01775189|143207|P1|COMPLETED|Treatment Phase: Washout Period 3||0
60653|NCT01775189|143201|P7|STARTED|Treatment Phase: Washout Period 3||8
60654|NCT01775189|143202|P6|STARTED|Treatment Phase: Washout Period 3||7
60655|NCT01775189|143203|P5|STARTED|Treatment Phase: Washout Period 3||8
60656|NCT01775189|143204|P4|STARTED|Treatment Phase: Washout Period 3||7
60657|NCT01775189|143205|P3|STARTED|Treatment Phase: Washout Period 3||0
60658|NCT01775189|143206|P2|STARTED|Treatment Phase: Washout Period 3||0
60659|NCT01775189|143207|P1|STARTED|Treatment Phase: Washout Period 3||0
60660|NCT01775189|143201|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
60661|NCT01775189|143202|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
60662|NCT01775189|143203|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
60663|NCT01775189|143204|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
60664|NCT01775189|143205|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
60665|NCT01775189|143206|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
60666|NCT01775189|143207|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
60667|NCT01775189|143201|P7|COMPLETED|Treatment Phase: Third Intervention||8
60668|NCT01775189|143202|P6|COMPLETED|Treatment Phase: Third Intervention||7
60669|NCT01775189|143203|P5|COMPLETED|Treatment Phase: Third Intervention||8
60670|NCT01775189|143204|P4|COMPLETED|Treatment Phase: Third Intervention||7
60671|NCT01775189|143205|P3|COMPLETED|Treatment Phase: Third Intervention||0
60672|NCT01775189|143206|P2|COMPLETED|Treatment Phase: Third Intervention||0
60673|NCT01775189|143207|P1|COMPLETED|Treatment Phase: Third Intervention||0
60674|NCT01775189|143201|P7|STARTED|Treatment Phase: Third Intervention||8
60675|NCT01775189|143202|P6|STARTED|Treatment Phase: Third Intervention||7
60676|NCT01775189|143203|P5|STARTED|Treatment Phase: Third Intervention||8
60677|NCT01775189|143204|P4|STARTED|Treatment Phase: Third Intervention||7
60678|NCT01775189|143205|P3|STARTED|Treatment Phase: Third Intervention||0
60679|NCT01775189|143206|P2|STARTED|Treatment Phase: Third Intervention||0
60680|NCT01775189|143207|P1|STARTED|Treatment Phase: Third Intervention||0
60681|NCT01775189|143201|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
60682|NCT01775189|143202|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
60683|NCT01775189|143203|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
60684|NCT01775189|143204|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
60685|NCT01775189|143205|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
60686|NCT01775189|143206|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
60687|NCT01775189|143207|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
60688|NCT01775189|143201|P7|COMPLETED|Treatment Phase: Washout Period 2||8
60689|NCT01775189|143202|P6|COMPLETED|Treatment Phase: Washout Period 2||7
60690|NCT01775189|143203|P5|COMPLETED|Treatment Phase: Washout Period 2||8
60691|NCT01775189|143204|P4|COMPLETED|Treatment Phase: Washout Period 2||7
60692|NCT01775189|143205|P3|COMPLETED|Treatment Phase: Washout Period 2||0
60693|NCT01775189|143206|P2|COMPLETED|Treatment Phase: Washout Period 2||0
60694|NCT01775189|143207|P1|COMPLETED|Treatment Phase: Washout Period 2||0
60695|NCT01775189|143201|P7|STARTED|Treatment Phase: Washout Period 2||8
60696|NCT01775189|143202|P6|STARTED|Treatment Phase: Washout Period 2||7
60697|NCT01775189|143203|P5|STARTED|Treatment Phase: Washout Period 2||8
60698|NCT01775189|143204|P4|STARTED|Treatment Phase: Washout Period 2||8
60699|NCT01775189|143205|P3|STARTED|Treatment Phase: Washout Period 2||0
60700|NCT01775189|143206|P2|STARTED|Treatment Phase: Washout Period 2||0
60701|NCT01775189|143207|P1|STARTED|Treatment Phase: Washout Period 2||0
60702|NCT01775189|143201|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
60703|NCT01775189|143202|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
60704|NCT01775189|143203|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
60705|NCT01775189|143204|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
60706|NCT01775189|143205|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
60707|NCT01775189|143206|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
60708|NCT01775189|143207|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
60709|NCT01775189|143201|P7|COMPLETED|Treatment Phase: Second Intervention||8
60710|NCT01775189|143202|P6|COMPLETED|Treatment Phase: Second Intervention||7
60711|NCT01775189|143203|P5|COMPLETED|Treatment Phase: Second Intervention||8
60712|NCT01775189|143204|P4|COMPLETED|Treatment Phase: Second Intervention||8
60713|NCT01775189|143205|P3|COMPLETED|Treatment Phase: Second Intervention||0
60714|NCT01775189|143206|P2|COMPLETED|Treatment Phase: Second Intervention||0
60715|NCT01775189|143207|P1|COMPLETED|Treatment Phase: Second Intervention||0
60716|NCT01775189|143201|P7|STARTED|Treatment Phase: Second Intervention||8
60717|NCT01775189|143202|P6|STARTED|Treatment Phase: Second Intervention||7
60718|NCT01775189|143203|P5|STARTED|Treatment Phase: Second Intervention||8
60719|NCT01775189|143204|P4|STARTED|Treatment Phase: Second Intervention||8
60720|NCT01775189|143205|P3|STARTED|Treatment Phase: Second Intervention||0
60721|NCT01775189|143206|P2|STARTED|Treatment Phase: Second Intervention||0
60722|NCT01775189|143207|P1|STARTED|Treatment Phase: Second Intervention||0
60723|NCT01775189|143201|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
60724|NCT01775189|143202|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
60725|NCT01775189|143203|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
60726|NCT01775189|143204|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
60727|NCT01775189|143205|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
60728|NCT01775189|143206|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
60729|NCT01775189|143207|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
60730|NCT01775189|143201|P7|COMPLETED|Treatment Phase: Washout Period 1||8
60731|NCT01775189|143202|P6|COMPLETED|Treatment Phase: Washout Period 1||7
60732|NCT01775189|143203|P5|COMPLETED|Treatment Phase: Washout Period 1||8
60733|NCT01775189|143204|P4|COMPLETED|Treatment Phase: Washout Period 1||8
60734|NCT01775189|143205|P3|COMPLETED|Treatment Phase: Washout Period 1||0
60735|NCT01775189|143206|P2|COMPLETED|Treatment Phase: Washout Period 1||0
60736|NCT01775189|143207|P1|COMPLETED|Treatment Phase: Washout Period 1||0
60737|NCT01775189|143201|P7|STARTED|Treatment Phase: Washout Period 1||8
60738|NCT01775189|143202|P6|STARTED|Treatment Phase: Washout Period 1||8
60739|NCT01775189|143203|P5|STARTED|Treatment Phase: Washout Period 1||8
60740|NCT01775189|143204|P4|STARTED|Treatment Phase: Washout Period 1||8
60741|NCT01775189|143205|P3|STARTED|Treatment Phase: Washout Period 1||0
60742|NCT01775189|143206|P2|STARTED|Treatment Phase: Washout Period 1||0
60743|NCT01775189|143207|P1|STARTED|Treatment Phase: Washout Period 1||0
60744|NCT01775189|143201|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
60745|NCT01775189|143202|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
60746|NCT01775189|143203|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
60747|NCT01775189|143204|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
60748|NCT01775189|143205|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
60749|NCT01775189|143206|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
60750|NCT01775189|143207|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
60751|NCT01775189|143201|P7|COMPLETED|Treatment Phase: First Intervention||8
60752|NCT01775189|143202|P6|COMPLETED|Treatment Phase: First Intervention||8
60753|NCT01775189|143203|P5|COMPLETED|Treatment Phase: First Intervention||8
60754|NCT01775189|143204|P4|COMPLETED|Treatment Phase: First Intervention||8
60755|NCT01775189|143205|P3|COMPLETED|Treatment Phase: First Intervention||0
60756|NCT01775189|143206|P2|COMPLETED|Treatment Phase: First Intervention||0
60757|NCT01775189|143207|P1|COMPLETED|Treatment Phase: First Intervention||0
60758|NCT01775189|143201|P7|STARTED|Treatment Phase: First Intervention||8
60759|NCT01775189|143202|P6|STARTED|Treatment Phase: First Intervention||8
60760|NCT01775189|143203|P5|STARTED|Treatment Phase: First Intervention||8
60761|NCT01775189|143204|P4|STARTED|Treatment Phase: First Intervention||8
60762|NCT01775189|143205|P3|STARTED|Treatment Phase: First Intervention||0
60763|NCT01775189|143206|P2|STARTED|Treatment Phase: First Intervention||0
60764|NCT01775189|143207|P1|STARTED|Treatment Phase: First Intervention||0
60765|NCT01775189|143201|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
60766|NCT01775189|143202|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
60767|NCT01775189|143203|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
60768|NCT01775189|143204|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
60769|NCT01775189|143205|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
60770|NCT01775189|143206|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
60771|NCT01775189|143207|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
60772|NCT01775189|143201|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
60773|NCT01775189|143202|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
60774|NCT01775189|143203|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
60775|NCT01775189|143204|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
60776|NCT01775189|143205|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
60777|NCT01775189|143206|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
60778|NCT01775189|143207|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
60779|NCT01775189|143201|P7|STARTED|Drug Discrimination Phase: Day 2||0
60780|NCT01775189|143202|P6|STARTED|Drug Discrimination Phase: Day 2||0
60781|NCT01775189|143203|P5|STARTED|Drug Discrimination Phase: Day 2||0
60782|NCT01775189|143204|P4|STARTED|Drug Discrimination Phase: Day 2||0
60783|NCT01775189|143205|P3|STARTED|Drug Discrimination Phase: Day 2||23
60784|NCT01775189|143206|P2|STARTED|Drug Discrimination Phase: Day 2||19
60785|NCT01775189|143207|P1|STARTED|Drug Discrimination Phase: Day 2||0
60786|NCT01775189|143201|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
60787|NCT01775189|143202|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
60788|NCT01775189|143203|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
60789|NCT01775189|143204|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
60790|NCT01775189|143205|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
60791|NCT01775189|143206|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
60792|NCT01775189|143207|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
60793|NCT01775189|143201|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
60794|NCT01775189|143202|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
60796|NCT01775189|143204|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
60797|NCT01775189|143205|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
60798|NCT01775189|143206|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
60799|NCT01775189|143207|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
60800|NCT01775189|143201|P7|STARTED|Drug Discrimination Phase: Day 1||0
60801|NCT01775189|143202|P6|STARTED|Drug Discrimination Phase: Day 1||0
60802|NCT01775189|143203|P5|STARTED|Drug Discrimination Phase: Day 1||0
60803|NCT01775189|143204|P4|STARTED|Drug Discrimination Phase: Day 1||0
60804|NCT01775189|143205|P3|STARTED|Drug Discrimination Phase: Day 1||23
60805|NCT01775189|143206|P2|STARTED|Drug Discrimination Phase: Day 1||22
60806|NCT01775189|143207|P1|STARTED|Drug Discrimination Phase: Day 1||0
60807|NCT01775189|143201|P7|NOT COMPLETED|Naloxone Challenge Phase||0
60808|NCT01775189|143202|P6|NOT COMPLETED|Naloxone Challenge Phase||0
60809|NCT01775189|143203|P5|NOT COMPLETED|Naloxone Challenge Phase||0
60810|NCT01775189|143204|P4|NOT COMPLETED|Naloxone Challenge Phase||0
60811|NCT01775189|143205|P3|NOT COMPLETED|Naloxone Challenge Phase||0
60812|NCT01775189|143206|P2|NOT COMPLETED|Naloxone Challenge Phase||0
60813|NCT01775189|143207|P1|NOT COMPLETED|Naloxone Challenge Phase||0
60814|NCT01775189|143201|P7|COMPLETED|Naloxone Challenge Phase||0
60815|NCT01775189|143202|P6|COMPLETED|Naloxone Challenge Phase||0
60816|NCT01775189|143203|P5|COMPLETED|Naloxone Challenge Phase||0
60817|NCT01775189|143204|P4|COMPLETED|Naloxone Challenge Phase||0
60818|NCT01775189|143205|P3|COMPLETED|Naloxone Challenge Phase||0
60819|NCT01775189|143206|P2|COMPLETED|Naloxone Challenge Phase||0
60820|NCT01775189|143207|P1|COMPLETED|Naloxone Challenge Phase||45
60821|NCT01775189|143201|P7|STARTED|Naloxone Challenge Phase||0
60822|NCT01775189|143202|P6|STARTED|Naloxone Challenge Phase||0
60823|NCT01775189|143203|P5|STARTED|Naloxone Challenge Phase||0
60824|NCT01775189|143204|P4|STARTED|Naloxone Challenge Phase||0
60825|NCT01775189|143205|P3|STARTED|Naloxone Challenge Phase||0
60826|NCT01775189|143206|P2|STARTED|Naloxone Challenge Phase||0
60827|NCT01775189|143207|P1|STARTED|Naloxone Challenge Phase||45
60828|NCT01775137|143426|P1|NOT COMPLETED|Overall Study||11
60829|NCT01775137|143426|P1|COMPLETED|Overall Study||34
60830|NCT01775137|143426|P1|STARTED|Overall Study||45
60831|NCT01775124|143453|P2|NOT COMPLETED|Extension Period||18
60832|NCT01775124|143454|P1|NOT COMPLETED|Extension Period||12
60833|NCT01775124|143453|P2|COMPLETED|Extension Period||138
60834|NCT01775124|143454|P1|COMPLETED|Extension Period||145
60835|NCT01775124|143453|P2|STARTED|Extension Period||156
60836|NCT01775124|143454|P1|STARTED|Extension Period||157
60837|NCT01775124|143453|P2|NOT COMPLETED|Core Period||10
60838|NCT01775124|143454|P1|NOT COMPLETED|Core Period||11
60839|NCT01775124|143453|P2|COMPLETED|Core Period||156
60840|NCT01775124|143454|P1|COMPLETED|Core Period||157
60841|NCT01775124|143453|P2|Safety Set|Core Period||166
60842|NCT01775124|143454|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
60843|NCT01775124|143453|P2|Per Protocol Set|Core Period||155
60844|NCT01775124|143454|P1|Per Protocol Set|Core Period||157
60845|NCT01775124|143453|P2|Full Analysis Set|Core Period||166
60846|NCT01775124|143454|P1|Full Analysis Set|Core Period||167
60847|NCT01775124|143453|P2|STARTED|Core Period||166
60848|NCT01775124|143454|P1|STARTED|Core Period||168
60849|NCT01774981|143489|P8|NOT COMPLETED|Overall Study||1
60850|NCT01774981|143490|P7|NOT COMPLETED|Overall Study||0
60851|NCT01774981|143491|P6|NOT COMPLETED|Overall Study||1
60852|NCT01774981|143492|P5|NOT COMPLETED|Overall Study||1
60853|NCT01774981|143493|P4|NOT COMPLETED|Overall Study||0
60854|NCT01774981|143494|P3|NOT COMPLETED|Overall Study||0
60855|NCT01774981|143495|P2|NOT COMPLETED|Overall Study||0
60856|NCT01774981|143496|P1|NOT COMPLETED|Overall Study||0
60857|NCT01774981|143489|P8|COMPLETED|Overall Study||11
60858|NCT01774981|143490|P7|COMPLETED|Overall Study||13
60859|NCT01774981|143491|P6|COMPLETED|Overall Study||13
60860|NCT01774981|143492|P5|COMPLETED|Overall Study||5
60861|NCT01774981|143493|P4|COMPLETED|Overall Study||4
60862|NCT01774981|143494|P3|COMPLETED|Overall Study||4
60863|NCT01774981|143495|P2|COMPLETED|Overall Study||4
60864|NCT01774981|143496|P1|COMPLETED|Overall Study||3
60865|NCT01774981|143489|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
60866|NCT01774981|143490|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
60867|NCT01774981|143491|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
60868|NCT01774981|143492|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
60869|NCT01774981|143493|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
60870|NCT01774981|143494|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
60871|NCT01774981|143495|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
60872|NCT01774981|143496|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
60873|NCT01774981|143489|P8|STARTED|Overall Study||12
60874|NCT01774981|143490|P7|STARTED|Overall Study||13
60875|NCT01774981|143491|P6|STARTED|Overall Study||14
60876|NCT01774981|143492|P5|STARTED|Overall Study||6
60877|NCT01774981|143493|P4|STARTED|Overall Study||4
60878|NCT01774981|143494|P3|STARTED|Overall Study||4
60879|NCT01774981|143495|P2|STARTED|Overall Study||4
60880|NCT01774981|143496|P1|STARTED|Overall Study||3
60881|NCT01774968|143528|P2|NOT COMPLETED|Overall Study||35
60882|NCT01774968|143529|P1|NOT COMPLETED|Overall Study||30
60883|NCT01774968|143528|P2|COMPLETED|Overall Study||128
60884|NCT01774968|143529|P1|COMPLETED|Overall Study||132
60885|NCT01774968|143528|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
60886|NCT01774968|143529|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
60887|NCT01774968|143528|P2|STARTED|Overall Study||163
60888|NCT01774968|143529|P1|STARTED|Overall Study||162
60889|NCT01774929|143563|P1|NOT COMPLETED|Overall Study||3
60890|NCT01774929|143563|P1|COMPLETED|Overall Study||32
60891|NCT01774929|143563|P1|STARTED|Overall Study||35
60892|NCT01774903|143569|P1|NOT COMPLETED|Overall Study||11
60893|NCT01774903|143569|P1|COMPLETED|Overall Study||34
60894|NCT01774903|143569|P1|STARTED|Overall Study||45
60895|NCT01774851|143578|P2|NOT COMPLETED|Overall Study||0
60896|NCT01774851|143579|P1|NOT COMPLETED|Overall Study||0
60897|NCT01774851|143578|P2|COMPLETED|Overall Study||42
60898|NCT01774851|143579|P1|COMPLETED|Overall Study||42
60899|NCT01774851|143578|P2|STARTED|Overall Study||42
60900|NCT01774851|143579|P1|STARTED|Overall Study||42
60901|NCT01774786|143587|P2|NOT COMPLETED|Overall Study||392
60902|NCT01774786|143588|P1|NOT COMPLETED|Overall Study||388
60903|NCT01774786|143587|P2|COMPLETED|Overall Study||0
60904|NCT01774786|143588|P1|COMPLETED|Overall Study||0
60905|NCT01774786|143587|P2|Received at Least One Dose of Placebo|Overall Study||388
60906|NCT01774786|143588|P1|Received at Least One Dose of Placebo|Overall Study||0
60907|NCT01774786|143587|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
60908|NCT01774786|143588|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
60909|NCT01774786|143587|P2|Did Not Receive Study Drug|Overall Study||3
60910|NCT01774786|143588|P1|Did Not Receive Study Drug|Overall Study||4
60911|NCT01774786|143587|P2|STARTED|Overall Study||392
60912|NCT01774786|143588|P1|STARTED|Overall Study||388
60913|NCT01774604|143618|P2|NOT COMPLETED|Overall Study||0
60914|NCT01774604|143619|P1|NOT COMPLETED|Overall Study||0
60915|NCT01774604|143618|P2|COMPLETED|Overall Study||226
60916|NCT01774604|143619|P1|COMPLETED|Overall Study||223
60917|NCT01774604|143618|P2|STARTED|Overall Study||226
60918|NCT01774604|143619|P1|STARTED|Overall Study||223
60919|NCT01774591|143639|P2|NOT COMPLETED|Overall Study||4
60920|NCT01774591|143640|P1|NOT COMPLETED|Overall Study||1
60921|NCT01774591|143639|P2|COMPLETED|Overall Study||7
60922|NCT01774591|143640|P1|COMPLETED|Overall Study||9
60923|NCT01774591|143639|P2|STARTED|Overall Study||11
60924|NCT01774591|143640|P1|STARTED|Overall Study||10
60925|NCT01774344|143652|P2|NOT COMPLETED|Overall Study||148
60926|NCT01774344|143653|P1|NOT COMPLETED|Overall Study||32
60927|NCT01774344|143652|P2|COMPLETED|Overall Study||231
60928|NCT01774344|143653|P1|COMPLETED|Overall Study||162
60929|NCT01774344|143652|P2|Treated|Overall Study||374
60930|NCT01774344|143653|P1|Treated|Overall Study||193
60931|NCT01774344|143652|P2|STARTED|Overall Study||379
60932|NCT01774344|143653|P1|STARTED|Overall Study||194
60933|NCT01774305|143669|P2|NOT COMPLETED|Overall Study||0
60934|NCT01774305|143670|P1|NOT COMPLETED|Overall Study||1
60935|NCT01774305|143669|P2|COMPLETED|Overall Study||71
60936|NCT01774305|143670|P1|COMPLETED|Overall Study||70
60937|NCT01774305|143669|P2|STARTED|Overall Study||71
60938|NCT01774305|143670|P1|STARTED|Overall Study||71
60939|NCT01774253|143678|P1|NOT COMPLETED|Overall Study||9
60940|NCT01774253|143678|P1|COMPLETED|Overall Study||0
60941|NCT01774253|143678|P1|STARTED|Overall Study||9
60942|NCT01774149|143688|P2|NOT COMPLETED|Overall Study||3
60943|NCT01774149|143689|P1|NOT COMPLETED|Overall Study||1
60944|NCT01774149|143688|P2|COMPLETED|Overall Study||12
60945|NCT01774149|143689|P1|COMPLETED|Overall Study||14
60946|NCT01774149|143688|P2|STARTED|Overall Study||15
60947|NCT01774149|143689|P1|STARTED|Overall Study||15
60948|NCT01774110|143697|P1|NOT COMPLETED|Overall Study||7
60949|NCT01774110|143697|P1|COMPLETED|Overall Study||5
60950|NCT01774110|143697|P1|STARTED|Overall Study||12
60951|NCT01774097|143705|P2|NOT COMPLETED|Overall Study||2
60952|NCT01774097|143706|P1|NOT COMPLETED|Overall Study||2
60953|NCT01774097|143705|P2|COMPLETED|Overall Study||40
60954|NCT01774097|143706|P1|COMPLETED|Overall Study||38
60955|NCT01774097|143705|P2|STARTED|Overall Study||42
60956|NCT01774097|143706|P1|STARTED|Overall Study||40
60957|NCT01774084|143736|P2|NOT COMPLETED|Overall Study||0
60958|NCT01774084|143737|P1|NOT COMPLETED|Overall Study||1
60959|NCT01774084|143736|P2|COMPLETED|Overall Study||12
60960|NCT01774084|143737|P1|COMPLETED|Overall Study||10
60961|NCT01774084|143736|P2|STARTED|Overall Study||12
60962|NCT01774084|143737|P1|STARTED|Overall Study||11
60963|NCT01774045|143747|P2|NOT COMPLETED|Overall Study||0
60964|NCT01774045|143748|P1|NOT COMPLETED|Overall Study||0
60965|NCT01774045|143747|P2|COMPLETED|Overall Study||7
60966|NCT01774045|143748|P1|COMPLETED|Overall Study||23
60967|NCT01774045|143747|P2|STARTED|Overall Study||7
60968|NCT01774045|143748|P1|STARTED|Overall Study||23
60969|NCT01773954|143762|P1|NOT COMPLETED|Overall Study||9
60970|NCT01773954|143762|P1|COMPLETED|Overall Study||31
60971|NCT01773954|143762|P1|STARTED|Overall Study||40
60972|NCT01773889|143767|P1|NOT COMPLETED|Overall Study||2
60973|NCT01773889|143767|P1|COMPLETED|Overall Study||0
60974|NCT01773889|143767|P1|STARTED|Overall Study||2
60975|NCT01773473|143773|P2|NOT COMPLETED|Overall Study||19
60976|NCT01773473|143774|P1|NOT COMPLETED|Overall Study||16
60977|NCT01773473|143773|P2|COMPLETED|Overall Study||177
60978|NCT01773473|143774|P1|COMPLETED|Overall Study||191
60979|NCT01773473|143773|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
60980|NCT01773473|143774|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
60981|NCT01773473|143773|P2|STARTED|Overall Study||196
60982|NCT01773473|143774|P1|STARTED|Overall Study||207
60983|NCT01773291|143795|P3|NOT COMPLETED|Overall Study||1
60984|NCT01773291|143796|P2|NOT COMPLETED|Overall Study||0
60985|NCT01773291|143797|P1|NOT COMPLETED|Overall Study||1
60986|NCT01773291|143795|P3|COMPLETED|Overall Study||6
60987|NCT01773291|143796|P2|COMPLETED|Overall Study||9
60988|NCT01773291|143797|P1|COMPLETED|Overall Study||7
60989|NCT01773291|143795|P3|STARTED|Overall Study||7
60990|NCT01773291|143796|P2|STARTED|Overall Study||9
60991|NCT01773291|143797|P1|STARTED|Overall Study||8
60992|NCT01773226|143808|P1|NOT COMPLETED|Overall Study||1
60993|NCT01773226|143808|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
60994|NCT01773226|143808|P1|STARTED|Overall Study||11
60995|NCT01773135|143818|P1|NOT COMPLETED|Overall Study||0
60996|NCT01773135|143818|P1|COMPLETED|Overall Study||262
60997|NCT01773135|143818|P1|STARTED|Overall Study||262
60998|NCT01773122|143827|P4|NOT COMPLETED|Overall Study||1
60999|NCT01773122|143828|P3|NOT COMPLETED|Overall Study||0
61000|NCT01773122|143829|P2|NOT COMPLETED|Overall Study||1
61001|NCT01773122|143830|P1|NOT COMPLETED|Overall Study||3
61002|NCT01773122|143827|P4|COMPLETED|Overall Study||18
61003|NCT01773122|143828|P3|COMPLETED|Overall Study||19
61004|NCT01773122|143829|P2|COMPLETED|Overall Study||18
61005|NCT01773122|143830|P1|COMPLETED|Overall Study||17
61006|NCT01773122|143827|P4|STARTED|Overall Study||19
61007|NCT01773122|143828|P3|STARTED|Overall Study||19
61008|NCT01773122|143829|P2|STARTED|Overall Study||19
61009|NCT01773122|143830|P1|STARTED|Overall Study||20
61010|NCT01773070|143844|P1|NOT COMPLETED|Overall Study||81
61011|NCT01773070|143844|P1|COMPLETED|Overall Study||397
61012|NCT01773070|143844|P1|STARTED|Overall Study||478
61013|NCT01772823|143854|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
61014|NCT01772823|143855|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
61015|NCT01772823|143854|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
61016|NCT01772823|143855|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
61017|NCT01772823|143854|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
61018|NCT01772823|143855|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
61019|NCT01772823|143854|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
61020|NCT01772823|143855|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
61021|NCT01772823|143854|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
61022|NCT01772823|143855|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
61023|NCT01772823|143854|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
61024|NCT01772823|143855|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
61025|NCT01772823|143854|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
61026|NCT01772823|143855|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
61027|NCT01772823|143854|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
61028|NCT01772823|143855|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
61029|NCT01772823|143854|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
61030|NCT01772823|143855|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
61031|NCT01772758|143955|P4|NOT COMPLETED|Overall Study||0
61032|NCT01772758|143956|P3|NOT COMPLETED|Overall Study||0
61033|NCT01772758|143957|P2|NOT COMPLETED|Overall Study||0
61034|NCT01772758|143958|P1|NOT COMPLETED|Overall Study||0
61035|NCT01772758|143955|P4|COMPLETED|Overall Study||17
61036|NCT01772758|143956|P3|COMPLETED|Overall Study||12
61037|NCT01772758|143957|P2|COMPLETED|Overall Study||17
61038|NCT01772758|143958|P1|COMPLETED|Overall Study||18
61039|NCT01772758|143955|P4|STARTED|Overall Study||17
61040|NCT01772758|143956|P3|STARTED|Overall Study||12
61041|NCT01772758|143957|P2|STARTED|Overall Study||17
61042|NCT01772758|143958|P1|STARTED|Overall Study||18
61043|NCT01772654|143970|P2|NOT COMPLETED|Overall Study||0
61044|NCT01772654|143971|P1|NOT COMPLETED|Overall Study||0
61045|NCT01772654|143970|P2|COMPLETED|Overall Study||15
61046|NCT01772654|143971|P1|COMPLETED|Overall Study||2
61047|NCT01772654|143970|P2|STARTED|Overall Study||15
61048|NCT01772654|143971|P1|STARTED|Overall Study||2
61049|NCT01772576|143977|P1|NOT COMPLETED|Overall Study||34
61050|NCT01772576|143977|P1|COMPLETED|Overall Study||133
61051|NCT01772576|143977|P1|STARTED|Overall Study||167
61052|NCT01772550|143989|P3|NOT COMPLETED|Overall Study||6
61053|NCT01772550|143990|P2|NOT COMPLETED|Overall Study||1
61054|NCT01772550|143991|P1|NOT COMPLETED|Overall Study||1
61055|NCT01772550|143989|P3|COMPLETED|Overall Study||27
61056|NCT01772550|143990|P2|COMPLETED|Overall Study||102
61057|NCT01772550|143991|P1|COMPLETED|Overall Study||101
61058|NCT01772550|143989|P3|CT Cardiac|Overall Study||1
61059|NCT01772550|143990|P2|CT Cardiac|Overall Study||7
61060|NCT01772550|143991|P1|CT Cardiac|Overall Study||7
61061|NCT01772550|143989|P3|CT Kidney|Overall Study||6
61062|NCT01772550|143990|P2|CT Kidney|Overall Study||19
61063|NCT01772550|143991|P1|CT Kidney|Overall Study||12
61064|NCT01772550|143989|P3|CT Liver|Overall Study||8
61065|NCT01772550|143990|P2|CT Liver|Overall Study||14
61066|NCT01772550|143991|P1|CT Liver|Overall Study||18
61067|NCT01772550|143989|P3|CT Angiogram|Overall Study||4
61068|NCT01772550|143990|P2|CT Angiogram|Overall Study||25
61069|NCT01772550|143991|P1|CT Angiogram|Overall Study||24
61070|NCT01772550|143989|P3|CT Pancreas|Overall Study||8
61071|NCT01772550|143990|P2|CT Pancreas|Overall Study||36
61072|NCT01772550|143991|P1|CT Pancreas|Overall Study||40
61073|NCT01772550|143989|P3|STARTED|Overall Study||33
61074|NCT01772550|143990|P2|STARTED|Overall Study||103
61075|NCT01772550|143991|P1|STARTED|Overall Study||102
61076|NCT01772537|144032|P3|NOT COMPLETED|Overall Study||0
61077|NCT01772537|144033|P2|NOT COMPLETED|Overall Study||0
61078|NCT01772537|144034|P1|NOT COMPLETED|Overall Study||1
61079|NCT01772537|144032|P3|COMPLETED|Overall Study||6
61080|NCT01772537|144033|P2|COMPLETED|Overall Study||3
61081|NCT01772537|144034|P1|COMPLETED|Overall Study||4
61082|NCT01772537|144032|P3|STARTED|Overall Study||6
61083|NCT01772537|144033|P2|STARTED|Overall Study||3
61084|NCT01772537|144034|P1|STARTED|Overall Study||5
61085|NCT01772368|144048|P1|NOT COMPLETED|Overall Study||7
61086|NCT01772368|144048|P1|COMPLETED|Overall Study||65
61087|NCT01772368|144048|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
61088|NCT01772368|144048|P1|Received FS MDPI 100/50 mcg|Overall Study||68
61089|NCT01772368|144048|P1|Received FS MDPI 100/25 mcg|Overall Study||67
61090|NCT01772368|144048|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
61091|NCT01772368|144048|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
61092|NCT01772368|144048|P1|Received Fp MDPI 100 mcg|Overall Study||67
61093|NCT01772368|144048|P1|STARTED|Overall Study||72
61094|NCT01772316|144094|P1|NOT COMPLETED|Overall Study||7
61095|NCT01772316|144094|P1|COMPLETED|Overall Study||40
61096|NCT01772316|144094|P1|STARTED|Overall Study||47
61097|NCT01772147|144115|P3|NOT COMPLETED|Overall Study||18
61098|NCT01772147|144116|P2|NOT COMPLETED|Overall Study||25
61099|NCT01772147|144117|P1|NOT COMPLETED|Overall Study||31
61100|NCT01772147|144115|P3|COMPLETED|Overall Study||184
61101|NCT01772147|144116|P2|COMPLETED|Overall Study||178
61102|NCT01772147|144117|P1|COMPLETED|Overall Study||170
61103|NCT01772147|144115|P3|STARTED|Overall Study||202
61104|NCT01772147|144116|P2|STARTED|Overall Study||203
61105|NCT01772147|144117|P1|STARTED|Overall Study||201
61106|NCT01772134|144137|P3|NOT COMPLETED|Overall Study||22
61107|NCT01772134|144138|P2|NOT COMPLETED|Overall Study||14
61108|NCT01772134|144139|P1|NOT COMPLETED|Overall Study||29
61109|NCT01772134|144137|P3|COMPLETED|Overall Study||184
61110|NCT01772134|144138|P2|COMPLETED|Overall Study||190
61111|NCT01772134|144139|P1|COMPLETED|Overall Study||178
61112|NCT01772134|144137|P3|Received Randomized Study Medication|Overall Study||205
61113|NCT01772134|144138|P2|Received Randomized Study Medication|Overall Study||204
61114|NCT01772134|144139|P1|Received Randomized Study Medication|Overall Study||205
61115|NCT01772134|144137|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
61116|NCT01772134|144138|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
61117|NCT01772134|144139|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
61118|NCT01771991|144158|P2|NOT COMPLETED|Overall Study||6
61119|NCT01771991|144159|P1|NOT COMPLETED|Overall Study||8
61120|NCT01771991|144158|P2|COMPLETED|Overall Study||30
61121|NCT01771991|144159|P1|COMPLETED|Overall Study||30
61122|NCT01771991|144158|P2|Started Treatment|Overall Study||34
61123|NCT01771991|144159|P1|Started Treatment|Overall Study||37
61124|NCT01771991|144158|P2|STARTED|Overall Study||36
61125|NCT01771991|144159|P1|STARTED|Overall Study||38
61126|NCT01771965|144167|P2|NOT COMPLETED|Overall Study||5
61127|NCT01771965|144168|P1|NOT COMPLETED|Overall Study||3
61128|NCT01771965|144167|P2|COMPLETED|Overall Study||4
61129|NCT01771965|144168|P1|COMPLETED|Overall Study||7
61130|NCT01771965|144167|P2|STARTED|Overall Study||9
61131|NCT01771965|144168|P1|STARTED|Overall Study||10
61132|NCT01771913|144176|P2|NOT COMPLETED|Overall Study||0
61133|NCT01771913|144177|P1|NOT COMPLETED|Overall Study||1
61134|NCT01771913|144176|P2|COMPLETED|Overall Study||11
61135|NCT01771913|144177|P1|COMPLETED|Overall Study||8
61136|NCT01771913|144176|P2|STARTED|Overall Study||11
61137|NCT01771913|144177|P1|STARTED|Overall Study||9
61138|NCT01771666|144187|P1|NOT COMPLETED|Overall Study||0
61139|NCT01771666|144187|P1|COMPLETED|Overall Study||23
61140|NCT01771666|144187|P1|STARTED|Overall Study||23
61141|NCT01771172|144192|P1|NOT COMPLETED|Overall Study||2
61142|NCT01771172|144192|P1|COMPLETED|Overall Study||46
61143|NCT01771172|144192|P1|STARTED|Overall Study||48
61144|NCT01770860|144196|P1|NOT COMPLETED|Overall Study||6
61145|NCT01770860|144196|P1|COMPLETED|Overall Study||40
61146|NCT01770860|144196|P1|Randomization|Overall Study|One participant withdrew before randomization|45
61147|NCT01770860|144196|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
61148|NCT01770743|144244|P5|NOT COMPLETED|Overall Study||2
61149|NCT01770743|144245|P4|NOT COMPLETED|Overall Study||2
61150|NCT01770743|144246|P3|NOT COMPLETED|Overall Study||1
61151|NCT01770743|144247|P2|NOT COMPLETED|Overall Study||3
61152|NCT01770743|144248|P1|NOT COMPLETED|Overall Study||2
61153|NCT01770743|144244|P5|COMPLETED|Overall Study||21
61154|NCT01770743|144245|P4|COMPLETED|Overall Study||42
61155|NCT01770743|144246|P3|COMPLETED|Overall Study||22
61156|NCT01770743|144247|P2|COMPLETED|Overall Study||31
61157|NCT01770743|144248|P1|COMPLETED|Overall Study||42
61158|NCT01770743|144244|P5|Treated|Overall Study||23
61159|NCT01770743|144245|P4|Treated|Overall Study||44
61160|NCT01770743|144246|P3|Treated|Overall Study||23
61161|NCT01770743|144247|P2|Treated|Overall Study||34
61162|NCT01770743|144248|P1|Treated|Overall Study||44
61163|NCT01770743|144244|P5|STARTED|Overall Study||23
61164|NCT01770743|144245|P4|STARTED|Overall Study||44
61165|NCT01770743|144246|P3|STARTED|Overall Study||23
61166|NCT01770743|144247|P2|STARTED|Overall Study||34
61167|NCT01770743|144248|P1|STARTED|Overall Study||44
61168|NCT01770691|144300|P1|NOT COMPLETED|Overall Study||0
61169|NCT01770691|144300|P1|COMPLETED|Overall Study||7
61170|NCT01770691|144300|P1|STARTED|Overall Study||7
61171|NCT01770652|144311|P4|NOT COMPLETED|Overall Study||0
61172|NCT01770652|144312|P3|NOT COMPLETED|Overall Study||0
61173|NCT01770652|144313|P2|NOT COMPLETED|Overall Study||0
61174|NCT01770652|144314|P1|NOT COMPLETED|Overall Study||0
61175|NCT01770652|144311|P4|COMPLETED|Overall Study||8
61176|NCT01770652|144312|P3|COMPLETED|Overall Study||8
61177|NCT01770652|144313|P2|COMPLETED|Overall Study||8
61178|NCT01770652|144314|P1|COMPLETED|Overall Study||8
61179|NCT01770652|144311|P4|STARTED|Overall Study||8
61180|NCT01770652|144312|P3|STARTED|Overall Study||8
61181|NCT01770652|144313|P2|STARTED|Overall Study||8
61182|NCT01770652|144314|P1|STARTED|Overall Study||8
61183|NCT01770509|144350|P2|NOT COMPLETED|Overall Study||3
61184|NCT01770509|144351|P1|NOT COMPLETED|Overall Study||1
61185|NCT01770509|144350|P2|COMPLETED|Overall Study||14
61186|NCT01770509|144351|P1|COMPLETED|Overall Study||11
61187|NCT01770509|144350|P2|STARTED|Overall Study||17
61188|NCT01770509|144351|P1|STARTED|Overall Study||12
61189|NCT01770483|144367|P2|NOT COMPLETED|Overall Study||0
61190|NCT01770483|144368|P1|NOT COMPLETED|Overall Study||0
61191|NCT01770483|144367|P2|COMPLETED|Overall Study||33
61192|NCT01770483|144368|P1|COMPLETED|Overall Study||33
61193|NCT01770483|144367|P2|STARTED|Overall Study||33
61194|NCT01770483|144368|P1|STARTED|Overall Study||33
61195|NCT01770431|144378|P2|NOT COMPLETED|Overall Study||32
61196|NCT01770431|144379|P1|NOT COMPLETED|Overall Study||10
61197|NCT01770431|144378|P2|COMPLETED|Overall Study||316
61198|NCT01770431|144379|P1|COMPLETED|Overall Study||686
61199|NCT01770431|144378|P2|STARTED|Overall Study||348
61200|NCT01770431|144379|P1|STARTED|Overall Study||696
61201|NCT01770392|144387|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
61202|NCT01770392|144387|P1|COMPLETED|Nintedanib+ Rifampicin||25
61203|NCT01770392|144387|P1|STARTED|Nintedanib+ Rifampicin||25
61204|NCT01770392|144387|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
61205|NCT01770392|144387|P1|COMPLETED|Washout Period of at Least 14 Days||25
61206|NCT01770392|144387|P1|STARTED|Washout Period of at Least 14 Days||26
61207|NCT01770392|144387|P1|NOT COMPLETED|Nintedanib||0
61208|NCT01770392|144387|P1|COMPLETED|Nintedanib||26
61209|NCT01770392|144387|P1|STARTED|Nintedanib||26
61210|NCT01770379|144402|P3|NOT COMPLETED|Overall Study||42
61211|NCT01770379|144403|P2|NOT COMPLETED|Overall Study||44
61212|NCT01770379|144404|P1|NOT COMPLETED|Overall Study||39
61213|NCT01770379|144402|P3|COMPLETED|Overall Study||39
61214|NCT01770379|144403|P2|COMPLETED|Overall Study||37
61215|NCT01770379|144404|P1|COMPLETED|Overall Study||41
61216|NCT01770379|144402|P3|STARTED|Overall Study||81
61217|NCT01770379|144403|P2|STARTED|Overall Study||81
61218|NCT01770379|144404|P1|STARTED|Overall Study||80
61219|NCT01770366|144423|P2|NOT COMPLETED|Overall Study||2
61220|NCT01770366|144424|P1|NOT COMPLETED|Overall Study||2
61221|NCT01770366|144423|P2|COMPLETED|Overall Study||4
61222|NCT01770366|144424|P1|COMPLETED|Overall Study||2
61223|NCT01770366|144423|P2|STARTED|Overall Study||6
61224|NCT01770366|144424|P1|STARTED|Overall Study||4
61225|NCT01770314|144432|P2|NOT COMPLETED|Overall Study||0
61226|NCT01770314|144433|P1|NOT COMPLETED|Overall Study||0
61227|NCT01770314|144432|P2|COMPLETED|Overall Study||90
61228|NCT01770314|144433|P1|COMPLETED|Overall Study||86
61229|NCT01770314|144432|P2|Contributed Data to One-month Follow-up|Overall Study||66
61230|NCT01770314|144433|P1|Contributed Data to One-month Follow-up|Overall Study||61
61231|NCT01770314|144432|P2|Contributed Data to Post-test|Overall Study||67
61232|NCT01770314|144433|P1|Contributed Data to Post-test|Overall Study||65
61233|NCT01770314|144432|P2|Contributed Data to Baseline|Overall Study||72
61234|NCT01770314|144433|P1|Contributed Data to Baseline|Overall Study||68
61235|NCT01770314|144432|P2|STARTED|Overall Study||90
61236|NCT01770314|144433|P1|STARTED|Overall Study||86
61237|NCT01770145|144441|P1|NOT COMPLETED|Treatment||4
61238|NCT01770145|144441|P1|COMPLETED|Treatment||97
61239|NCT01770145|144441|P1|STARTED|Treatment||101
61240|NCT01770145|144441|P1|NOT COMPLETED|Baseline||26
61241|NCT01770145|144441|P1|COMPLETED|Baseline||101
61242|NCT01770145|144441|P1|STARTED|Baseline||127
61243|NCT01769612|144446|P1|NOT COMPLETED|Overall Study||0
61244|NCT01769612|144446|P1|COMPLETED|Overall Study||168
61245|NCT01769612|144446|P1|STARTED|Overall Study||168
61246|NCT01769586|144454|P2|NOT COMPLETED|Overall Study||0
61247|NCT01769586|144455|P1|NOT COMPLETED|Overall Study||0
61248|NCT01769586|144454|P2|COMPLETED|Overall Study||100
61249|NCT01769586|144455|P1|COMPLETED|Overall Study||100
61250|NCT01769586|144454|P2|STARTED|Overall Study||100
61251|NCT01769586|144455|P1|STARTED|Overall Study||100
61252|NCT01769508|144461|P1|NOT COMPLETED|Overall Study||6
61253|NCT01769508|144461|P1|COMPLETED|Overall Study||6
61254|NCT01769508|144461|P1|STARTED|Overall Study||12
61255|NCT01769456|144470|P1|NOT COMPLETED|Overall Study||37
61256|NCT01769456|144470|P1|COMPLETED|Overall Study||41
61257|NCT01769456|144470|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
61258|NCT01769443|144491|P2|NOT COMPLETED|Overall Study||0
61259|NCT01769443|144492|P1|NOT COMPLETED|Overall Study||1
61260|NCT01769443|144491|P2|COMPLETED|Overall Study||1
61261|NCT01769443|144492|P1|COMPLETED|Overall Study||0
61262|NCT01769443|144491|P2|STARTED|Overall Study||1
61263|NCT01769443|144492|P1|STARTED|Overall Study||1
61264|NCT01769391|144536|P2|NOT COMPLETED|Overall Study||9
61265|NCT01769391|144537|P1|NOT COMPLETED|Overall Study||20
61266|NCT01769391|144536|P2|COMPLETED|Overall Study||48
61267|NCT01769391|144537|P1|COMPLETED|Overall Study||90
61268|NCT01769391|144536|P2|Received at Least One Dose of Study Drug|Overall Study||55
61269|NCT01769391|144537|P1|Received at Least One Dose of Study Drug|Overall Study||106
61270|NCT01769391|144536|P2|STARTED|Overall Study||57
61271|NCT01769391|144537|P1|STARTED|Overall Study||110
61272|NCT01769378|144556|P2|NOT COMPLETED|Overall Study||4
61273|NCT01769378|144557|P1|NOT COMPLETED|Overall Study||25
61274|NCT01769378|144556|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
61275|NCT01769378|144557|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
61276|NCT01769378|144556|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
61277|NCT01769378|144557|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
61278|NCT01769378|144556|P2|STARTED|Overall Study||60
61279|NCT01769378|144557|P1|STARTED|Overall Study||240
61280|NCT01769365|144595|P3|NOT COMPLETED|Overall Study||2
61281|NCT01769365|144596|P2|NOT COMPLETED|Overall Study||2
61282|NCT01769365|144597|P1|NOT COMPLETED|Overall Study||0
61283|NCT01769365|144595|P3|COMPLETED|Overall Study||101
61284|NCT01769365|144596|P2|COMPLETED|Overall Study||100
61285|NCT01769365|144597|P1|COMPLETED|Overall Study||102
61286|NCT01769365|144595|P3|STARTED|Overall Study||103
61287|NCT01769365|144596|P2|STARTED|Overall Study||102
61288|NCT01769365|144597|P1|STARTED|Overall Study||102
61289|NCT01769352|144609|P4|NOT COMPLETED|Overall Study||0
61290|NCT01769352|144610|P3|NOT COMPLETED|Overall Study||0
61291|NCT01769352|144611|P2|NOT COMPLETED|Overall Study||0
61292|NCT01769352|144612|P1|NOT COMPLETED|Overall Study||0
61293|NCT01769352|144609|P4|COMPLETED|Overall Study||8
61294|NCT01769352|144610|P3|COMPLETED|Overall Study||9
61295|NCT01769352|144611|P2|COMPLETED|Overall Study||12
61296|NCT01769352|144612|P1|COMPLETED|Overall Study||13
61297|NCT01769352|144609|P4|STARTED|Overall Study||8
61298|NCT01769352|144610|P3|STARTED|Overall Study||9
61299|NCT01769352|144611|P2|STARTED|Overall Study||12
61300|NCT01769352|144612|P1|STARTED|Overall Study||13
61301|NCT01769339|144637|P1|NOT COMPLETED|Overall Study||43
61302|NCT01769339|144637|P1|COMPLETED|Overall Study||72
61303|NCT01769339|144637|P1|STARTED|Overall Study||115
61304|NCT01769326|144648|P4|NOT COMPLETED|Overall Study||0
61305|NCT01769326|144649|P3|NOT COMPLETED|Overall Study||1
61306|NCT01769326|144650|P2|NOT COMPLETED|Overall Study||4
61307|NCT01769326|144651|P1|NOT COMPLETED|Overall Study||2
61308|NCT01769326|144648|P4|COMPLETED|Overall Study||8
61309|NCT01769326|144649|P3|COMPLETED|Overall Study||8
61310|NCT01769326|144650|P2|COMPLETED|Overall Study||8
61311|NCT01769326|144651|P1|COMPLETED|Overall Study||9
61312|NCT01769326|144648|P4|STARTED|Overall Study||8
61313|NCT01769326|144649|P3|STARTED|Overall Study||9
61314|NCT01769326|144650|P2|STARTED|Overall Study||12
61315|NCT01769326|144651|P1|STARTED|Overall Study||11
61316|NCT01769248|144663|P2|NOT COMPLETED|Overall Study||12
61317|NCT01769248|144664|P1|NOT COMPLETED|Overall Study||28
61318|NCT01769248|144663|P2|COMPLETED|Overall Study||58
61319|NCT01769248|144664|P1|COMPLETED|Overall Study||42
61320|NCT01769248|144663|P2|Participants Who Crossed-over|Overall Study||12
61321|NCT01769248|144664|P1|Participants Who Crossed-over|Overall Study||28
61322|NCT01769248|144663|P2|STARTED|Overall Study||70
61323|NCT01769248|144664|P1|STARTED|Overall Study||70
61324|NCT01769222|144676|P2|NOT COMPLETED|Overall Study||0
61325|NCT01769222|144677|P1|NOT COMPLETED|Overall Study||0
61326|NCT01769222|144676|P2|COMPLETED|Overall Study||0
61327|NCT01769222|144677|P1|COMPLETED|Overall Study||3
61328|NCT01769222|144676|P2|STARTED|Overall Study||0
61329|NCT01769222|144677|P1|STARTED|Overall Study||3
61330|NCT01769196|144693|P2|NOT COMPLETED|Overall Study||272
61331|NCT01769196|144694|P1|NOT COMPLETED|Overall Study||272
61332|NCT01769196|144693|P2|COMPLETED|Overall Study||0
61333|NCT01769196|144694|P1|COMPLETED|Overall Study||0
61334|NCT01769196|144693|P2|STARTED|Overall Study||272
61335|NCT01769196|144694|P1|STARTED|Overall Study||272
61336|NCT01769105|144724|P2|NOT COMPLETED|Cross-over||0
61337|NCT01769105|144725|P1|NOT COMPLETED|Cross-over||5
61338|NCT01769105|144724|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
61339|NCT01769105|144725|P1|COMPLETED|Cross-over||9
61340|NCT01769105|144724|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
61341|NCT01769105|144725|P1|STARTED|Cross-over||14
61342|NCT01769105|144724|P2|NOT COMPLETED|First Intervention||2
61343|NCT01769105|144725|P1|NOT COMPLETED|First Intervention||2
61344|NCT01769105|144724|P2|COMPLETED|First Intervention||17
61345|NCT01769105|144725|P1|COMPLETED|First Intervention||14
61346|NCT01769105|144724|P2|STARTED|First Intervention||19
61347|NCT01769105|144725|P1|STARTED|First Intervention||16
61348|NCT01768676|144746|P2|NOT COMPLETED|Overall Study||31
61349|NCT01768676|144747|P1|NOT COMPLETED|Overall Study||24
61350|NCT01768676|144746|P2|COMPLETED|Overall Study||60
61351|NCT01768676|144747|P1|COMPLETED|Overall Study||66
61352|NCT01768676|144746|P2|STARTED|Overall Study||91
61353|NCT01768676|144747|P1|STARTED|Overall Study||90
61354|NCT01768572|144764|P3|NOT COMPLETED|Overall Study||6
61355|NCT01768572|144765|P2|NOT COMPLETED|Overall Study||12
61356|NCT01768572|144766|P1|NOT COMPLETED|Overall Study||9
61357|NCT01768572|144764|P3|COMPLETED|Overall Study||96
61358|NCT01768572|144765|P2|COMPLETED|Overall Study||39
61359|NCT01768572|144766|P1|COMPLETED|Overall Study||40
61360|NCT01768572|144764|P3|STARTED|Overall Study||102
61361|NCT01768572|144765|P2|STARTED|Overall Study||51
61362|NCT01768572|144766|P1|STARTED|Overall Study||49
61363|NCT01768559|144777|P3|NOT COMPLETED|Overall Study||13
61364|NCT01768559|144778|P2|NOT COMPLETED|Overall Study||17
61365|NCT01768559|144779|P1|NOT COMPLETED|Overall Study||30
61366|NCT01768559|144777|P3|COMPLETED|Overall Study||285
61367|NCT01768559|144778|P2|COMPLETED|Overall Study||281
61368|NCT01768559|144779|P1|COMPLETED|Overall Study||268
61369|NCT01768559|144777|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
61370|NCT01768559|144778|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
61371|NCT01768559|144779|P1|Treated|Overall Study||298
61372|NCT01768559|144777|P3|STARTED|Overall Study||298
61373|NCT01768559|144778|P2|STARTED|Overall Study||298
61374|NCT01768559|144779|P1|STARTED|Overall Study||298
61375|NCT01768325|144829|P2|NOT COMPLETED|Overall Study||0
61376|NCT01768325|144830|P1|NOT COMPLETED|Overall Study||0
61377|NCT01768325|144829|P2|COMPLETED|Overall Study||41
61378|NCT01768325|144830|P1|COMPLETED|Overall Study||37
61379|NCT01768325|144829|P2|STARTED|Overall Study||41
61380|NCT01768325|144830|P1|STARTED|Overall Study||37
61381|NCT01768286|144844|P4|NOT COMPLETED|Overall Study||1
61382|NCT01768286|144845|P3|NOT COMPLETED|Overall Study||2
61383|NCT01768286|144846|P2|NOT COMPLETED|Overall Study||4
61384|NCT01768286|144847|P1|NOT COMPLETED|Overall Study||7
61385|NCT01768286|144844|P4|COMPLETED|Overall Study||110
61386|NCT01768286|144845|P3|COMPLETED|Overall Study||108
61387|NCT01768286|144846|P2|COMPLETED|Overall Study||107
61388|NCT01768286|144847|P1|COMPLETED|Overall Study||102
61389|NCT01768286|144844|P4|STARTED|Overall Study||111
61390|NCT01768286|144845|P3|STARTED|Overall Study||110
61391|NCT01768286|144846|P2|STARTED|Overall Study||111
61392|NCT01768286|144847|P1|STARTED|Overall Study||109
61393|NCT01768117|144909|P1|NOT COMPLETED|Overall Study||6
61394|NCT01768117|144909|P1|COMPLETED|Overall Study||7
61395|NCT01768117|144909|P1|STARTED|Overall Study||13
61396|NCT01768013|144917|P1|NOT COMPLETED|Overall Study||0
61397|NCT01768013|144917|P1|COMPLETED|Overall Study||13
61398|NCT01768013|144917|P1|STARTED|Overall Study||13
61399|NCT01768000|144950|P4|NOT COMPLETED|Overall Study||2
61400|NCT01768000|144951|P3|NOT COMPLETED|Overall Study||1
61401|NCT01768000|144952|P2|NOT COMPLETED|Overall Study||2
61402|NCT01768000|144953|P1|NOT COMPLETED|Overall Study||1
61403|NCT01768000|144950|P4|COMPLETED|Overall Study||8
61404|NCT01768000|144951|P3|COMPLETED|Overall Study||9
61405|NCT01768000|144952|P2|COMPLETED|Overall Study||8
61406|NCT01768000|144953|P1|COMPLETED|Overall Study||9
61407|NCT01768000|144950|P4|STARTED|Overall Study||10
61408|NCT01768000|144951|P3|STARTED|Overall Study||10
61409|NCT01768000|144952|P2|STARTED|Overall Study||10
61410|NCT01768000|144953|P1|STARTED|Overall Study||10
61411|NCT01767987|144973|P2|NOT COMPLETED|Overall Study||1
61412|NCT01767987|144974|P1|NOT COMPLETED|Overall Study||4
61413|NCT01767987|144973|P2|COMPLETED|Overall Study||1
61414|NCT01767987|144974|P1|COMPLETED|Overall Study||0
61415|NCT01767987|144973|P2|STARTED|Overall Study||2
61416|NCT01767987|144974|P1|STARTED|Overall Study||4
61417|NCT01767935|144996|P1|NOT COMPLETED|Overall Study||0
61418|NCT01767935|144996|P1|COMPLETED|Overall Study||1
61419|NCT01767935|144996|P1|STARTED|Overall Study||1
61420|NCT01767701|145004|P1|NOT COMPLETED|Overall Study||0
61421|NCT01767701|145004|P1|COMPLETED|Overall Study||20
61422|NCT01767701|145004|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
61423|NCT01767688|145017|P2|NOT COMPLETED|Overall Study||0
61424|NCT01767688|145018|P1|NOT COMPLETED|Overall Study||0
61425|NCT01767688|145017|P2|COMPLETED|Overall Study||8
61426|NCT01767688|145018|P1|COMPLETED|Overall Study||8
61427|NCT01767688|145017|P2|STARTED|Overall Study||8
61428|NCT01767688|145018|P1|STARTED|Overall Study||8
61429|NCT01767597|145040|P2|NOT COMPLETED|Overall Study||1
61430|NCT01767597|145041|P1|NOT COMPLETED|Overall Study||4
61431|NCT01767597|145040|P2|COMPLETED|Overall Study||499
61432|NCT01767597|145041|P1|COMPLETED|Overall Study||496
61433|NCT01767597|145040|P2|STARTED|Overall Study||500
61434|NCT01767597|145041|P1|STARTED|Overall Study||500
61435|NCT01767519|145050|P3|NOT COMPLETED|Overall Study||5
61436|NCT01767519|145051|P2|NOT COMPLETED|Overall Study||13
61437|NCT01767519|145052|P1|NOT COMPLETED|Overall Study||14
61438|NCT01767519|145050|P3|COMPLETED|Overall Study||55
61439|NCT01767519|145051|P2|COMPLETED|Overall Study||138
61440|NCT01767519|145052|P1|COMPLETED|Overall Study||131
61441|NCT01767519|145050|P3|STARTED|Overall Study||60
61442|NCT01767519|145051|P2|STARTED|Overall Study||151
61443|NCT01767519|145052|P1|STARTED|Overall Study||145
61444|NCT01767506|145080|P2|NOT COMPLETED|Overall Study||0
61445|NCT01767506|145081|P1|NOT COMPLETED|Overall Study||0
61446|NCT01767506|145080|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
61447|NCT01767506|145081|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
61448|NCT01767506|145080|P2|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|0
61449|NCT01767506|145081|P1|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|0
61450|NCT01767467|145093|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
61451|NCT01767467|145094|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
61452|NCT01767467|145093|P2|COMPLETED|End of Study Phase (up to Month 13)||216
61453|NCT01767467|145094|P1|COMPLETED|End of Study Phase (up to Month 13)||236
61454|NCT01767467|145093|P2|STARTED|End of Study Phase (up to Month 13)||279
61455|NCT01767467|145094|P1|STARTED|End of Study Phase (up to Month 13)||283
61456|NCT01767467|145093|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
61457|NCT01767467|145094|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
61458|NCT01767467|145093|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
61459|NCT01767467|145094|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
61460|NCT01767467|145093|P2|STARTED|Vaccination Phase (up to Month 2)||279
61461|NCT01767467|145094|P1|STARTED|Vaccination Phase (up to Month 2)||283
61462|NCT01767376|145145|P3|NOT COMPLETED|Overall Study||0
61463|NCT01767376|145146|P2|NOT COMPLETED|Overall Study||3
61464|NCT01767376|145147|P1|NOT COMPLETED|Overall Study||4
61465|NCT01767376|145145|P3|COMPLETED|Overall Study||232
61466|NCT01767376|145146|P2|COMPLETED|Overall Study||225
61467|NCT01767376|145147|P1|COMPLETED|Overall Study||227
61468|NCT01767376|145145|P3|STARTED|Overall Study||232
61469|NCT01767376|145146|P2|STARTED|Overall Study||228
61470|NCT01767376|145147|P1|STARTED|Overall Study||231
61471|NCT01767285|145194|P2|NOT COMPLETED|Overall Study||6
61472|NCT01767285|145195|P1|NOT COMPLETED|Overall Study||7
61473|NCT01767285|145194|P2|COMPLETED|Overall Study||24
61474|NCT01767285|145195|P1|COMPLETED|Overall Study||22
61475|NCT01767285|145194|P2|STARTED|Overall Study||30
61476|NCT01767285|145195|P1|STARTED|Overall Study||29
61477|NCT01767116|145213|P2|NOT COMPLETED|Overall Study||2
61478|NCT01767116|145214|P1|NOT COMPLETED|Overall Study||2
61479|NCT01767116|145213|P2|COMPLETED|Overall Study||207
61480|NCT01767116|145214|P1|COMPLETED|Overall Study||208
61481|NCT01767116|145213|P2|STARTED|Overall Study||209
61482|NCT01767116|145214|P1|STARTED|Overall Study||210
61483|NCT01767103|145233|P3|NOT COMPLETED|Overall Study||0
61484|NCT01767103|145234|P2|NOT COMPLETED|Overall Study||0
61485|NCT01767103|145235|P1|NOT COMPLETED|Overall Study||0
61486|NCT01767103|145233|P3|COMPLETED|Overall Study||7
61487|NCT01767103|145234|P2|COMPLETED|Overall Study||7
61488|NCT01767103|145235|P1|COMPLETED|Overall Study||7
61489|NCT01767103|145233|P3|STARTED|Overall Study||7
61490|NCT01767103|145234|P2|STARTED|Overall Study||7
61491|NCT01767103|145235|P1|STARTED|Overall Study||7
61492|NCT01767064|145263|P2|NOT COMPLETED|Overall Study||0
61493|NCT01767064|145264|P1|NOT COMPLETED|Overall Study||0
61494|NCT01767064|145263|P2|COMPLETED|Overall Study||7
61495|NCT01767064|145264|P1|COMPLETED|Overall Study||7
61496|NCT01767064|145263|P2|STARTED|Overall Study||7
61497|NCT01767064|145264|P1|STARTED|Overall Study||7
61498|NCT01766921|145272|P2|NOT COMPLETED|Overall Study||17
61499|NCT01766921|145273|P1|NOT COMPLETED|Overall Study||24
61500|NCT01766921|145272|P2|COMPLETED|Overall Study||676
61501|NCT01766921|145273|P1|COMPLETED|Overall Study||676
61502|NCT01766921|145272|P2|STARTED|Overall Study||693
61503|NCT01766921|145273|P1|STARTED|Overall Study||700
61504|NCT01766778|145294|P2|NOT COMPLETED|Overall Study||4
61505|NCT01766778|145295|P1|NOT COMPLETED|Overall Study||5
61506|NCT01766778|145294|P2|COMPLETED|Overall Study||57
61507|NCT01766778|145295|P1|COMPLETED|Overall Study||51
61508|NCT01766778|145294|P2|STARTED|Overall Study||61
61509|NCT01766778|145295|P1|STARTED|Overall Study|Intent to treat population|56
61510|NCT01766713|145313|P2|NOT COMPLETED|Overall Study||2
61511|NCT01766713|145314|P1|NOT COMPLETED|Overall Study||2
61512|NCT01766713|145313|P2|COMPLETED|Overall Study||23
61513|NCT01766713|145314|P1|COMPLETED|Overall Study||23
61514|NCT01766713|145313|P2|STARTED|Overall Study||25
61515|NCT01766713|145314|P1|STARTED|Overall Study||25
61516|NCT01766466|145322|P4|NOT COMPLETED|Day 5||0
61517|NCT01766466|145323|P3|NOT COMPLETED|Day 5||0
61518|NCT01766466|145324|P2|NOT COMPLETED|Day 5||0
61519|NCT01766466|145325|P1|NOT COMPLETED|Day 5||0
61520|NCT01766466|145322|P4|COMPLETED|Day 5||6
61521|NCT01766466|145323|P3|COMPLETED|Day 5||0
61522|NCT01766466|145324|P2|COMPLETED|Day 5||6
61523|NCT01766466|145325|P1|COMPLETED|Day 5||0
61524|NCT01766466|145322|P4|STARTED|Day 5||6
61525|NCT01766466|145323|P3|STARTED|Day 5||0
61526|NCT01766466|145324|P2|STARTED|Day 5||6
61527|NCT01766466|145325|P1|STARTED|Day 5||0
61528|NCT01766466|145322|P4|NOT COMPLETED|Day 1||0
61529|NCT01766466|145323|P3|NOT COMPLETED|Day 1||0
61530|NCT01766466|145324|P2|NOT COMPLETED|Day 1||0
61531|NCT01766466|145325|P1|NOT COMPLETED|Day 1||0
61532|NCT01766466|145322|P4|COMPLETED|Day 1||0
61533|NCT01766466|145323|P3|COMPLETED|Day 1||6
61534|NCT01766466|145324|P2|COMPLETED|Day 1||0
61535|NCT01766466|145325|P1|COMPLETED|Day 1||6
61536|NCT01766466|145322|P4|STARTED|Day 1||0
61537|NCT01766466|145323|P3|STARTED|Day 1||6
61538|NCT01766466|145324|P2|STARTED|Day 1||0
61539|NCT01766466|145325|P1|STARTED|Day 1||6
61540|NCT01766440|145338|P1|NOT COMPLETED|Overall Study||1
61541|NCT01766440|145338|P1|COMPLETED|Overall Study||17
61542|NCT01766440|145338|P1|STARTED|Overall Study||18
61543|NCT01766336|145349|P2|NOT COMPLETED|Overall Study||75
61544|NCT01766336|145350|P1|NOT COMPLETED|Overall Study||90
61545|NCT01766336|145349|P2|COMPLETED|Overall Study||71
61546|NCT01766336|145350|P1|COMPLETED|Overall Study||60
61547|NCT01766336|145349|P2|STARTED|Overall Study||146
61548|NCT01766336|145350|P1|STARTED|Overall Study||150
61549|NCT01766310|145358|P2|NOT COMPLETED|Overall Study||3
61550|NCT01766310|145359|P1|NOT COMPLETED|Overall Study||1
61551|NCT01766310|145358|P2|COMPLETED|Overall Study||23
61552|NCT01766310|145359|P1|COMPLETED|Overall Study||23
61553|NCT01766310|145358|P2|STARTED|Overall Study||26
61554|NCT01766310|145359|P1|STARTED|Overall Study||24
61555|NCT01766102|145369|P2|NOT COMPLETED|Overall Study||0
61556|NCT01766102|145370|P1|NOT COMPLETED|Overall Study||0
61557|NCT01766102|145369|P2|COMPLETED|Overall Study||36
61558|NCT01766102|145370|P1|COMPLETED|Overall Study||36
61559|NCT01766102|145369|P2|STARTED|Overall Study||36
61560|NCT01766102|145370|P1|STARTED|Overall Study||36
61561|NCT01766076|145380|P2|NOT COMPLETED|Overall Study||0
61562|NCT01766076|145381|P1|NOT COMPLETED|Overall Study||0
61563|NCT01766076|145380|P2|COMPLETED|Overall Study||15
61564|NCT01766076|145381|P1|COMPLETED|Overall Study||15
61565|NCT01766076|145380|P2|STARTED|Overall Study||15
61566|NCT01766076|145381|P1|STARTED|Overall Study||15
61567|NCT01766050|145387|P1|NOT COMPLETED|Overall Study||4
61568|NCT01766050|145387|P1|COMPLETED|Overall Study||18
61569|NCT01766050|145387|P1|STARTED|Overall Study||22
61570|NCT01766037|145522|P2|NOT COMPLETED|Overall Study||29
61571|NCT01766037|145523|P1|NOT COMPLETED|Overall Study||29
61572|NCT01766037|145522|P2|COMPLETED|Overall Study||31
61573|NCT01766037|145523|P1|COMPLETED|Overall Study||82
61574|NCT01766037|145522|P2|STARTED|Overall Study||60
61575|NCT01766037|145523|P1|STARTED|Overall Study||111
61576|NCT01766024|145560|P2|NOT COMPLETED|Overall Study||0
61577|NCT01766024|145561|P1|NOT COMPLETED|Overall Study||0
61578|NCT01766024|145560|P2|COMPLETED|Overall Study||16
61579|NCT01766024|145561|P1|COMPLETED|Overall Study||16
61580|NCT01766024|145560|P2|STARTED|Overall Study||16
61581|NCT01766024|145561|P1|STARTED|Overall Study||16
61582|NCT01765972|145571|P4|NOT COMPLETED|Overall Study||0
61583|NCT01765972|145572|P3|NOT COMPLETED|Overall Study||0
61584|NCT01765972|145573|P2|NOT COMPLETED|Overall Study||0
61585|NCT01765972|145574|P1|NOT COMPLETED|Overall Study||0
61586|NCT01765972|145571|P4|COMPLETED|Overall Study||6
61587|NCT01765972|145572|P3|COMPLETED|Overall Study||6
61588|NCT01765972|145573|P2|COMPLETED|Overall Study||6
61589|NCT01765972|145574|P1|COMPLETED|Overall Study||6
61590|NCT01765972|145571|P4|STARTED|Overall Study||6
61591|NCT01765972|145572|P3|STARTED|Overall Study||6
61592|NCT01765972|145573|P2|STARTED|Overall Study||6
61593|NCT01765972|145574|P1|STARTED|Overall Study||6
61594|NCT01765803|145584|P1|NOT COMPLETED|Overall Study||0
61595|NCT01765803|145584|P1|COMPLETED|Overall Study||6
61596|NCT01765803|145584|P1|STARTED|Overall Study||6
61597|NCT01765764|145592|P3|NOT COMPLETED|Post-treatment Period||0
61598|NCT01765764|145593|P2|NOT COMPLETED|Post-treatment Period||0
61599|NCT01765764|145594|P1|NOT COMPLETED|Post-treatment Period||0
61600|NCT01765764|145592|P3|COMPLETED|Post-treatment Period||112
61601|NCT01765764|145593|P2|COMPLETED|Post-treatment Period||107
61602|NCT01765764|145594|P1|COMPLETED|Post-treatment Period||114
61603|NCT01765764|145592|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
61604|NCT01765764|145593|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
61605|NCT01765764|145594|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
61606|NCT01765764|145592|P3|NOT COMPLETED|Treatment Period||6
61607|NCT01765764|145593|P2|NOT COMPLETED|Treatment Period||9
61608|NCT01765764|145594|P1|NOT COMPLETED|Treatment Period||3
61609|NCT01765764|145592|P3|COMPLETED|Treatment Period||115
61610|NCT01765764|145593|P2|COMPLETED|Treatment Period||109
61611|NCT01765764|145594|P1|COMPLETED|Treatment Period||115
61612|NCT01765764|145592|P3|STARTED|Treatment Period||121
61613|NCT01765764|145593|P2|STARTED|Treatment Period||118
61614|NCT01765764|145594|P1|STARTED|Treatment Period||118
61615|NCT01765751|145614|P3|NOT COMPLETED|Overall Study||1
61616|NCT01765751|145615|P2|NOT COMPLETED|Overall Study||2
61617|NCT01765751|145616|P1|NOT COMPLETED|Overall Study||0
61618|NCT01765751|145614|P3|COMPLETED|Overall Study||15
61619|NCT01765751|145615|P2|COMPLETED|Overall Study||14
61620|NCT01765751|145616|P1|COMPLETED|Overall Study||16
61621|NCT01765751|145614|P3|STARTED|Overall Study||16
61622|NCT01765751|145615|P2|STARTED|Overall Study||16
61623|NCT01765751|145616|P1|STARTED|Overall Study||16
61624|NCT01765673|145648|P1|NOT COMPLETED|Overall Study||1
61625|NCT01765673|145648|P1|COMPLETED|Overall Study||11
61626|NCT01765673|145648|P1|STARTED|Overall Study||12
61627|NCT01765582|145674|P3|NOT COMPLETED|Overall Study||95
61628|NCT01765582|145675|P2|NOT COMPLETED|Overall Study||92
61629|NCT01765582|145676|P1|NOT COMPLETED|Overall Study||93
61630|NCT01765582|145674|P3|COMPLETED|Overall Study||0
61631|NCT01765582|145675|P2|COMPLETED|Overall Study||0
61632|NCT01765582|145676|P1|COMPLETED|Overall Study||0
61633|NCT01765582|145674|P3|STARTED|Overall Study||95
61634|NCT01765582|145675|P2|STARTED|Overall Study||92
61635|NCT01765582|145676|P1|STARTED|Overall Study||93
61636|NCT01765569|145709|P1|NOT COMPLETED|Period C||1
61637|NCT01765569|145709|P1|COMPLETED|Period C||27
61638|NCT01765569|145709|P1|STARTED|Period C||28
61639|NCT01765569|145709|P1|NOT COMPLETED|Period B||1
61640|NCT01765569|145709|P1|COMPLETED|Period B||28
61641|NCT01765569|145709|P1|STARTED|Period B||29
61642|NCT01765569|145709|P1|NOT COMPLETED|Period A||0
61643|NCT01765569|145709|P1|COMPLETED|Period A||29
61644|NCT01765569|145709|P1|STARTED|Period A||29
61645|NCT01765543|145730|P1|NOT COMPLETED|Overall Study||3
61646|NCT01765543|145730|P1|COMPLETED|Overall Study||24
61647|NCT01765543|145730|P1|STARTED|Overall Study||27
61648|NCT01765530|145754|P2|NOT COMPLETED|Overall Study||1
61649|NCT01765530|145755|P1|NOT COMPLETED|Overall Study||1
61650|NCT01765530|145754|P2|COMPLETED|Overall Study||36
61651|NCT01765530|145755|P1|COMPLETED|Overall Study||36
61652|NCT01765530|145754|P2|STARTED|Overall Study||37
61653|NCT01765530|145755|P1|STARTED|Overall Study||37
61654|NCT01765465|145765|P2|NOT COMPLETED|Overall Study||4
61655|NCT01765465|145766|P1|NOT COMPLETED|Overall Study||7
61656|NCT01765465|145765|P2|COMPLETED|Overall Study||63
61657|NCT01765465|145766|P1|COMPLETED|Overall Study||64
61658|NCT01765465|145765|P2|STARTED|Overall Study||67
61659|NCT01765465|145766|P1|STARTED|Overall Study||71
61660|NCT01765426|145782|P4|NOT COMPLETED|Overall Study||0
61661|NCT01765426|145783|P3|NOT COMPLETED|Overall Study||0
61662|NCT01765426|145784|P2|NOT COMPLETED|Overall Study||1
61663|NCT01765426|145785|P1|NOT COMPLETED|Overall Study||0
61664|NCT01765426|145782|P4|COMPLETED|Overall Study||15
61665|NCT01765426|145783|P3|COMPLETED|Overall Study||17
61666|NCT01765426|145784|P2|COMPLETED|Overall Study||16
61667|NCT01765426|145785|P1|COMPLETED|Overall Study||18
61668|NCT01765426|145782|P4|Completed All Vaccinations|Overall Study||15
61669|NCT01765426|145783|P3|Completed All Vaccinations|Overall Study||17
61670|NCT01765426|145784|P2|Completed All Vaccinations|Overall Study||16
61671|NCT01765426|145785|P1|Completed All Vaccinations|Overall Study||17
61672|NCT01765426|145782|P4|STARTED|Overall Study||15
61673|NCT01765426|145783|P3|STARTED|Overall Study||17
61674|NCT01765426|145784|P2|STARTED|Overall Study||17
61675|NCT01765426|145785|P1|STARTED|Overall Study||18
61676|NCT01765270|145841|P2|NOT COMPLETED|Overall Study||1
61677|NCT01765270|145842|P1|NOT COMPLETED|Overall Study||1
61678|NCT01765270|145841|P2|COMPLETED|Overall Study||6
61679|NCT01765270|145842|P1|COMPLETED|Overall Study||4
61680|NCT01765270|145841|P2|STARTED|Overall Study||7
61681|NCT01765270|145842|P1|STARTED|Overall Study||5
61682|NCT01765192|145864|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
61683|NCT01765192|145865|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
61684|NCT01765192|145864|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
61685|NCT01765192|145865|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
61686|NCT01765192|145864|P2|STARTED|End of Treatment Period 2 to Final Visit||28
61687|NCT01765192|145865|P1|STARTED|End of Treatment Period 2 to Final Visit||30
61688|NCT01765192|145864|P2|NOT COMPLETED|Treatment Period 2||2
61689|NCT01765192|145865|P1|NOT COMPLETED|Treatment Period 2||0
61690|NCT01765192|145864|P2|COMPLETED|Treatment Period 2||28
61691|NCT01765192|145865|P1|COMPLETED|Treatment Period 2||30
61692|NCT01765192|145864|P2|STARTED|Treatment Period 2||30
61693|NCT01765192|145865|P1|STARTED|Treatment Period 2||30
61694|NCT01765192|145864|P2|NOT COMPLETED|Washout Period||1
61695|NCT01765192|145865|P1|NOT COMPLETED|Washout Period||2
61696|NCT01765192|145864|P2|COMPLETED|Washout Period||30
61697|NCT01765192|145865|P1|COMPLETED|Washout Period||30
61698|NCT01765192|145864|P2|STARTED|Washout Period||31
61699|NCT01765192|145865|P1|STARTED|Washout Period||32
61700|NCT01765192|145864|P2|NOT COMPLETED|Treatment Period 1||1
61701|NCT01765192|145865|P1|NOT COMPLETED|Treatment Period 1||0
61702|NCT01765192|145864|P2|COMPLETED|Treatment Period 1||31
61703|NCT01765192|145865|P1|COMPLETED|Treatment Period 1||32
61704|NCT01765192|145864|P2|STARTED|Treatment Period 1||32
61705|NCT01765192|145865|P1|STARTED|Treatment Period 1||32
61706|NCT01765179|145883|P1|NOT COMPLETED|Overall Study||27
61707|NCT01765179|145883|P1|COMPLETED|Overall Study||117
61708|NCT01765179|145883|P1|STARTED|Overall Study||144
61709|NCT01765153|145890|P2|NOT COMPLETED|Rest Phase 2||1
61710|NCT01765153|145891|P1|NOT COMPLETED|Rest Phase 2||2
61711|NCT01765153|145890|P2|COMPLETED|Rest Phase 2||7
61712|NCT01765153|145891|P1|COMPLETED|Rest Phase 2||8
61713|NCT01765153|145890|P2|STARTED|Rest Phase 2||8
61714|NCT01765153|145891|P1|STARTED|Rest Phase 2||10
61715|NCT01765153|145890|P2|NOT COMPLETED|Training Phase 2||1
61716|NCT01765153|145891|P1|NOT COMPLETED|Training Phase 2||0
61717|NCT01765153|145890|P2|COMPLETED|Training Phase 2||8
61718|NCT01765153|145891|P1|COMPLETED|Training Phase 2||10
61719|NCT01765153|145890|P2|STARTED|Training Phase 2||9
61720|NCT01765153|145891|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
61721|NCT01765153|145890|P2|NOT COMPLETED|Rest Phase 1||1
61722|NCT01765153|145891|P1|NOT COMPLETED|Rest Phase 1||0
61723|NCT01765153|145890|P2|COMPLETED|Rest Phase 1||9
61724|NCT01765153|145891|P1|COMPLETED|Rest Phase 1||9
61725|NCT01765153|145890|P2|STARTED|Rest Phase 1||10
61726|NCT01765153|145891|P1|STARTED|Rest Phase 1||9
61727|NCT01765153|145890|P2|NOT COMPLETED|Training Phase 1||1
61728|NCT01765153|145891|P1|NOT COMPLETED|Training Phase 1||1
61729|NCT01765153|145890|P2|COMPLETED|Training Phase 1||10
61730|NCT01765153|145891|P1|COMPLETED|Training Phase 1||9
61731|NCT01765153|145890|P2|STARTED|Training Phase 1||11
61732|NCT01765153|145891|P1|STARTED|Training Phase 1||10
61733|NCT01764997|145998|P5|NOT COMPLETED|Study Drug Treatment Period||36
61734|NCT01764997|145999|P4|NOT COMPLETED|Study Drug Treatment Period||0
61735|NCT01764997|146000|P3|NOT COMPLETED|Study Drug Treatment Period||0
61736|NCT01764997|146001|P2|NOT COMPLETED|Study Drug Treatment Period||1
61737|NCT01764997|146002|P1|NOT COMPLETED|Study Drug Treatment Period||0
61738|NCT01764997|145998|P5|COMPLETED|Study Drug Treatment Period||286
61739|NCT01764997|145999|P4|COMPLETED|Study Drug Treatment Period||13
61740|NCT01764997|146000|P3|COMPLETED|Study Drug Treatment Period||13
61741|NCT01764997|146001|P2|COMPLETED|Study Drug Treatment Period||16
61742|NCT01764997|146002|P1|COMPLETED|Study Drug Treatment Period||0
61743|NCT01764997|145998|P5|STARTED|Study Drug Treatment Period||322
61744|NCT01764997|145999|P4|STARTED|Study Drug Treatment Period||13
61745|NCT01764997|146000|P3|STARTED|Study Drug Treatment Period||13
61746|NCT01764997|146001|P2|STARTED|Study Drug Treatment Period||17
61747|NCT01764997|146002|P1|STARTED|Study Drug Treatment Period||0
61748|NCT01764997|145998|P5|NOT COMPLETED|Run-in Period||0
61749|NCT01764997|145999|P4|NOT COMPLETED|Run-in Period||0
61750|NCT01764997|146000|P3|NOT COMPLETED|Run-in Period||0
61751|NCT01764997|146001|P2|NOT COMPLETED|Run-in Period||0
61752|NCT01764997|146002|P1|NOT COMPLETED|Run-in Period||38
61753|NCT01764997|145998|P5|COMPLETED|Run-in Period||0
61754|NCT01764997|145999|P4|COMPLETED|Run-in Period||0
61755|NCT01764997|146000|P3|COMPLETED|Run-in Period||0
61756|NCT01764997|146001|P2|COMPLETED|Run-in Period||0
61757|NCT01764997|146002|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
61758|NCT01764997|145998|P5|STARTED|Run-in Period||0
61759|NCT01764997|145999|P4|STARTED|Run-in Period||0
61760|NCT01764997|146000|P3|STARTED|Run-in Period||0
61761|NCT01764997|146001|P2|STARTED|Run-in Period||0
61762|NCT01764997|146002|P1|STARTED|Run-in Period||776
61763|NCT01764945|146029|P8|NOT COMPLETED|Overall Study||0
61764|NCT01764945|146030|P7|NOT COMPLETED|Overall Study||1
61765|NCT01764945|146031|P6|NOT COMPLETED|Overall Study||0
61766|NCT01764945|146032|P5|NOT COMPLETED|Overall Study||0
61767|NCT01764945|146033|P4|NOT COMPLETED|Overall Study||0
61768|NCT01764945|146034|P3|NOT COMPLETED|Overall Study||0
61769|NCT01764945|146035|P2|NOT COMPLETED|Overall Study||1
61770|NCT01764945|146036|P1|NOT COMPLETED|Overall Study||0
61771|NCT01764945|146029|P8|COMPLETED|Overall Study||9
61772|NCT01764945|146030|P7|COMPLETED|Overall Study||8
61773|NCT01764945|146031|P6|COMPLETED|Overall Study||8
61774|NCT01764945|146032|P5|COMPLETED|Overall Study||10
61775|NCT01764945|146033|P4|COMPLETED|Overall Study||5
61776|NCT01764945|146034|P3|COMPLETED|Overall Study||5
61777|NCT01764945|146035|P2|COMPLETED|Overall Study||4
61778|NCT01764945|146036|P1|COMPLETED|Overall Study||5
61779|NCT01764945|146029|P8|STARTED|Overall Study||9
61780|NCT01764945|146030|P7|STARTED|Overall Study||9
61781|NCT01764945|146031|P6|STARTED|Overall Study||8
61782|NCT01764945|146032|P5|STARTED|Overall Study||10
61783|NCT01764945|146033|P4|STARTED|Overall Study||5
61784|NCT01764945|146034|P3|STARTED|Overall Study||5
61785|NCT01764945|146035|P2|STARTED|Overall Study||5
61786|NCT01764945|146036|P1|STARTED|Overall Study||5
61787|NCT01764919|146070|P1|NOT COMPLETED|Overall Study||0
61788|NCT01764919|146070|P1|COMPLETED|Overall Study||4
61789|NCT01764919|146070|P1|STARTED|Overall Study||4
61790|NCT01764841|146082|P4|NOT COMPLETED|Overall Study||19
61791|NCT01764841|146083|P3|NOT COMPLETED|Overall Study||14
61792|NCT01764841|146084|P2|NOT COMPLETED|Overall Study||26
61793|NCT01764841|146085|P1|NOT COMPLETED|Overall Study||23
61794|NCT01764841|146082|P4|COMPLETED|Overall Study||49
61795|NCT01764841|146083|P3|COMPLETED|Overall Study||56
61796|NCT01764841|146084|P2|COMPLETED|Overall Study||111
61797|NCT01764841|146085|P1|COMPLETED|Overall Study||118
61798|NCT01764841|146082|P4|Participants Received Treatment|Overall Study|safety population|68
61799|NCT01764841|146083|P3|Participants Received Treatment|Overall Study|safety population|69
61800|NCT01764841|146084|P2|Participants Received Treatment|Overall Study|safety population|136
61801|NCT01764841|146085|P1|Participants Received Treatment|Overall Study|safety population|141
61802|NCT01764841|146082|P4|STARTED|Overall Study||68
61803|NCT01764841|146083|P3|STARTED|Overall Study||70
61804|NCT01764841|146084|P2|STARTED|Overall Study||137
61805|NCT01764841|146085|P1|STARTED|Overall Study||141
61806|NCT01764685|146119|P2|NOT COMPLETED|Overall Study||1
61807|NCT01764685|146120|P1|NOT COMPLETED|Overall Study||0
61808|NCT01764685|146119|P2|COMPLETED|Overall Study||3
61809|NCT01764685|146120|P1|COMPLETED|Overall Study||0
61810|NCT01764685|146119|P2|STARTED|Overall Study||4
61811|NCT01764685|146120|P1|STARTED|Overall Study||0
61812|NCT01764633|146128|P2|NOT COMPLETED|Overall Study||93
61813|NCT01764633|146129|P1|NOT COMPLETED|Overall Study||118
61814|NCT01764633|146128|P2|COMPLETED|Overall Study||13691
61815|NCT01764633|146129|P1|COMPLETED|Overall Study||13662
61816|NCT01764633|146128|P2|Received Treatment|Overall Study||13769
61817|NCT01764633|146129|P1|Received Treatment|Overall Study||13756
61818|NCT01764633|146128|P2|STARTED|Overall Study||13784
61819|NCT01764633|146129|P1|STARTED|Overall Study||13780
61820|NCT01764607|146151|P1|NOT COMPLETED|Overall Study||0
61821|NCT01764607|146151|P1|COMPLETED|Overall Study||1
61822|NCT01764607|146151|P1|STARTED|Overall Study||1
61823|NCT01764386|146158|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
61824|NCT01764386|146159|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
61825|NCT01764386|146158|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
61826|NCT01764386|146159|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
61827|NCT01764386|146158|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
61828|NCT01764386|146159|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
61829|NCT01764386|146158|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
61830|NCT01764386|146159|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
61831|NCT01764386|146158|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
61832|NCT01764386|146159|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
61833|NCT01764386|146158|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
61834|NCT01764386|146159|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
61835|NCT01764386|146158|P2|STARTED|Controlled Treatment Period (CTP)||89
61836|NCT01764386|146159|P1|STARTED|Controlled Treatment Period (CTP)||153
61837|NCT01764022|146202|P2|NOT COMPLETED|Overall Study||12
61838|NCT01764022|146203|P1|NOT COMPLETED|Overall Study||21
61839|NCT01764022|146202|P2|COMPLETED|Overall Study||49
61840|NCT01764022|146203|P1|COMPLETED|Overall Study||44
61841|NCT01764022|146202|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
61842|NCT01764022|146203|P1|Received at Least 1 Dose of Study Drug|Overall Study||63
61843|NCT01764022|146202|P2|STARTED|Overall Study||61
61844|NCT01764022|146203|P1|STARTED|Overall Study||65
61845|NCT01763996|146231|P2|NOT COMPLETED|Treatment Period 2||1
61846|NCT01763996|146232|P1|NOT COMPLETED|Treatment Period 2||0
61847|NCT01763996|146231|P2|COMPLETED|Treatment Period 2||14
61848|NCT01763996|146232|P1|COMPLETED|Treatment Period 2||15
61849|NCT01763996|146231|P2|STARTED|Treatment Period 2||15
61850|NCT01763996|146232|P1|STARTED|Treatment Period 2||15
61851|NCT01763996|146231|P2|NOT COMPLETED|Treatment Period 1||0
61852|NCT01763996|146232|P1|NOT COMPLETED|Treatment Period 1||0
61853|NCT01763996|146231|P2|COMPLETED|Treatment Period 1||15
61854|NCT01763996|146232|P1|COMPLETED|Treatment Period 1||15
61855|NCT01763996|146231|P2|STARTED|Treatment Period 1||15
61856|NCT01763996|146232|P1|STARTED|Treatment Period 1||15
61857|NCT01763918|146262|P4|NOT COMPLETED|Overall Study||2
61858|NCT01763918|146263|P3|NOT COMPLETED|Overall Study||10
61859|NCT01763918|146264|P2|NOT COMPLETED|Overall Study||1
61860|NCT01763918|146265|P1|NOT COMPLETED|Overall Study||6
61861|NCT01763918|146262|P4|COMPLETED|Overall Study||108
61862|NCT01763918|146263|P3|COMPLETED|Overall Study||101
61863|NCT01763918|146264|P2|COMPLETED|Overall Study||54
61864|NCT01763918|146265|P1|COMPLETED|Overall Study||49
61865|NCT01763918|146262|P4|Received Treatment|Overall Study||110
61866|NCT01763918|146263|P3|Received Treatment|Overall Study||110
61867|NCT01763918|146264|P2|Received Treatment|Overall Study||55
61868|NCT01763918|146265|P1|Received Treatment|Overall Study||54
61869|NCT01763918|146262|P4|STARTED|Overall Study||110
61870|NCT01763918|146263|P3|STARTED|Overall Study||111
61871|NCT01763918|146264|P2|STARTED|Overall Study||55
61872|NCT01763918|146265|P1|STARTED|Overall Study||55
61873|NCT01763905|146363|P4|NOT COMPLETED|Overall Study||1
61874|NCT01763905|146364|P3|NOT COMPLETED|Overall Study||9
61875|NCT01763905|146365|P2|NOT COMPLETED|Overall Study||1
61876|NCT01763905|146366|P1|NOT COMPLETED|Overall Study||6
61877|NCT01763905|146363|P4|COMPLETED|Overall Study||101
61878|NCT01763905|146364|P3|COMPLETED|Overall Study||94
61879|NCT01763905|146365|P2|COMPLETED|Overall Study||50
61880|NCT01763905|146366|P1|COMPLETED|Overall Study||45
61881|NCT01763905|146363|P4|STARTED|Overall Study||102
61882|NCT01763905|146364|P3|STARTED|Overall Study||103
61883|NCT01763905|146365|P2|STARTED|Overall Study||51
61884|NCT01763905|146366|P1|STARTED|Overall Study||51
61885|NCT01763866|146484|P24|NOT COMPLETED|Overall Study||2
61886|NCT01763866|146485|P23|NOT COMPLETED|Overall Study||3
61887|NCT01763866|146486|P22|NOT COMPLETED|Overall Study||1
61888|NCT01763866|146487|P21|NOT COMPLETED|Overall Study||4
61889|NCT01763866|146488|P20|NOT COMPLETED|Overall Study||2
61890|NCT01763866|146489|P19|NOT COMPLETED|Overall Study||6
61891|NCT01763866|146490|P18|NOT COMPLETED|Overall Study||1
61892|NCT01763866|146491|P17|NOT COMPLETED|Overall Study||1
61893|NCT01763866|146492|P16|NOT COMPLETED|Overall Study||3
61894|NCT01763866|146493|P15|NOT COMPLETED|Overall Study||12
61895|NCT01763866|146494|P14|NOT COMPLETED|Overall Study||0
61896|NCT01763866|146495|P13|NOT COMPLETED|Overall Study||4
61897|NCT01763866|146496|P12|NOT COMPLETED|Overall Study||2
61898|NCT01763866|146497|P11|NOT COMPLETED|Overall Study||8
61899|NCT01763866|146498|P10|NOT COMPLETED|Overall Study||1
61900|NCT01763866|146499|P9|NOT COMPLETED|Overall Study||3
61901|NCT01763866|146500|P8|NOT COMPLETED|Overall Study||0
61902|NCT01763866|146501|P7|NOT COMPLETED|Overall Study||7
61903|NCT01763866|146502|P6|NOT COMPLETED|Overall Study||3
61904|NCT01763866|146503|P5|NOT COMPLETED|Overall Study||2
61905|NCT01763866|146504|P4|NOT COMPLETED|Overall Study||0
61906|NCT01763866|146505|P3|NOT COMPLETED|Overall Study||5
61907|NCT01763866|146506|P2|NOT COMPLETED|Overall Study||1
61908|NCT01763866|146507|P1|NOT COMPLETED|Overall Study||2
61909|NCT01763866|146484|P24|COMPLETED|Overall Study||113
61910|NCT01763866|146485|P23|COMPLETED|Overall Study||109
61911|NCT01763866|146486|P22|COMPLETED|Overall Study||54
61912|NCT01763866|146487|P21|COMPLETED|Overall Study||52
61913|NCT01763866|146488|P20|COMPLETED|Overall Study||110
61914|NCT01763866|146489|P19|COMPLETED|Overall Study||105
61915|NCT01763866|146490|P18|COMPLETED|Overall Study||55
61916|NCT01763866|146491|P17|COMPLETED|Overall Study||55
61917|NCT01763866|146492|P16|COMPLETED|Overall Study||112
61918|NCT01763866|146493|P15|COMPLETED|Overall Study||102
61919|NCT01763866|146494|P14|COMPLETED|Overall Study||57
61920|NCT01763866|146495|P13|COMPLETED|Overall Study||54
61921|NCT01763866|146496|P12|COMPLETED|Overall Study||108
61922|NCT01763866|146497|P11|COMPLETED|Overall Study||102
61923|NCT01763866|146498|P10|COMPLETED|Overall Study||53
61924|NCT01763866|146499|P9|COMPLETED|Overall Study||53
61925|NCT01763866|146500|P8|COMPLETED|Overall Study||55
61926|NCT01763866|146501|P7|COMPLETED|Overall Study||48
61927|NCT01763866|146502|P6|COMPLETED|Overall Study||107
61928|NCT01763866|146503|P5|COMPLETED|Overall Study||108
61929|NCT01763866|146504|P4|COMPLETED|Overall Study||55
61930|NCT01763866|146505|P3|COMPLETED|Overall Study||51
61931|NCT01763866|146506|P2|COMPLETED|Overall Study||54
61932|NCT01763866|146507|P1|COMPLETED|Overall Study||54
61933|NCT01763866|146484|P24|Received Treatment|Overall Study||115
61934|NCT01763866|146485|P23|Received Treatment|Overall Study||112
61935|NCT01763866|146486|P22|Received Treatment|Overall Study||55
61936|NCT01763866|146487|P21|Received Treatment|Overall Study||56
61937|NCT01763866|146488|P20|Received Treatment|Overall Study||112
61938|NCT01763866|146489|P19|Received Treatment|Overall Study||111
61939|NCT01763866|146490|P18|Received Treatment|Overall Study||55
61940|NCT01763866|146491|P17|Received Treatment|Overall Study||56
61941|NCT01763866|146492|P16|Received Treatment|Overall Study||115
61942|NCT01763866|146493|P15|Received Treatment|Overall Study||113
61943|NCT01763866|146494|P14|Received Treatment|Overall Study||57
61944|NCT01763866|146495|P13|Received Treatment|Overall Study||58
61945|NCT01763866|146496|P12|Received Treatment|Overall Study||110
61946|NCT01763866|146497|P11|Received Treatment|Overall Study||109
61947|NCT01763866|146498|P10|Received Treatment|Overall Study||54
61948|NCT01763866|146499|P9|Received Treatment|Overall Study||56
61949|NCT01763866|146500|P8|Received Treatment|Overall Study||55
61950|NCT01763866|146501|P7|Received Treatment|Overall Study||55
61951|NCT01763866|146502|P6|Received Treatment|Overall Study||110
61952|NCT01763866|146503|P5|Received Treatment|Overall Study||110
61953|NCT01763866|146504|P4|Received Treatment|Overall Study||55
61954|NCT01763866|146505|P3|Received Treatment|Overall Study||56
61955|NCT01763866|146506|P2|Received Treatment|Overall Study||55
61956|NCT01763866|146507|P1|Received Treatment|Overall Study||56
61957|NCT01763866|146484|P24|STARTED|Overall Study||115
61958|NCT01763866|146485|P23|STARTED|Overall Study||112
61959|NCT01763866|146486|P22|STARTED|Overall Study||55
61960|NCT01763866|146487|P21|STARTED|Overall Study||56
61961|NCT01763866|146488|P20|STARTED|Overall Study||112
61962|NCT01763866|146489|P19|STARTED|Overall Study||111
61963|NCT01763866|146490|P18|STARTED|Overall Study||56
61964|NCT01763866|146491|P17|STARTED|Overall Study||56
61965|NCT01763866|146492|P16|STARTED|Overall Study||115
61966|NCT01763866|146493|P15|STARTED|Overall Study||114
61967|NCT01763866|146494|P14|STARTED|Overall Study||57
61968|NCT01763866|146495|P13|STARTED|Overall Study||58
61969|NCT01763866|146496|P12|STARTED|Overall Study||110
61970|NCT01763866|146497|P11|STARTED|Overall Study||110
61971|NCT01763866|146498|P10|STARTED|Overall Study||54
61972|NCT01763866|146499|P9|STARTED|Overall Study||56
61973|NCT01763866|146500|P8|STARTED|Overall Study||55
61974|NCT01763866|146501|P7|STARTED|Overall Study||55
61975|NCT01763866|146502|P6|STARTED|Overall Study||110
61976|NCT01763866|146503|P5|STARTED|Overall Study||110
61977|NCT01763866|146504|P4|STARTED|Overall Study||55
61978|NCT01763866|146505|P3|STARTED|Overall Study||56
61979|NCT01763866|146506|P2|STARTED|Overall Study||55
61980|NCT01763866|146507|P1|STARTED|Overall Study||56
61981|NCT01763827|147067|P6|NOT COMPLETED|Overall Study||2
61982|NCT01763827|147068|P5|NOT COMPLETED|Overall Study||6
61983|NCT01763827|147069|P4|NOT COMPLETED|Overall Study||1
61984|NCT01763827|147070|P3|NOT COMPLETED|Overall Study||4
61985|NCT01763827|147071|P2|NOT COMPLETED|Overall Study||1
61986|NCT01763827|147072|P1|NOT COMPLETED|Overall Study||3
61987|NCT01763827|147067|P6|COMPLETED|Overall Study||151
61988|NCT01763827|147068|P5|COMPLETED|Overall Study||147
61989|NCT01763827|147069|P4|COMPLETED|Overall Study||76
61990|NCT01763827|147070|P3|COMPLETED|Overall Study||73
61991|NCT01763827|147071|P2|COMPLETED|Overall Study||77
61992|NCT01763827|147072|P1|COMPLETED|Overall Study||74
61993|NCT01763827|147067|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
61994|NCT01763827|147068|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
61995|NCT01763827|147069|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
61996|NCT01763827|147070|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
61997|NCT01763827|147071|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
61998|NCT01763827|147072|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
61999|NCT01763827|147067|P6|STARTED|Overall Study||153
62000|NCT01763827|147068|P5|STARTED|Overall Study||153
62001|NCT01763827|147069|P4|STARTED|Overall Study||77
62002|NCT01763827|147070|P3|STARTED|Overall Study||77
62003|NCT01763827|147071|P2|STARTED|Overall Study||78
62004|NCT01763827|147072|P1|STARTED|Overall Study||77
62005|NCT01763645|147214|P2|NOT COMPLETED|Overall Study||24
62006|NCT01763645|147215|P1|NOT COMPLETED|Overall Study||26
62007|NCT01763645|147214|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
62008|NCT01763645|147215|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
62009|NCT01763645|147214|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
62010|NCT01763645|147215|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
62011|NCT01763645|147214|P2|STARTED|Overall Study||69
62012|NCT01763645|147215|P1|STARTED|Overall Study||69
62013|NCT01763567|147233|P1|NOT COMPLETED|Overall Study||0
62014|NCT01763567|147233|P1|COMPLETED|Overall Study||19
62015|NCT01763567|147233|P1|STARTED|Overall Study||19
62016|NCT01763047|147243|P2|NOT COMPLETED|Period 2||5
62017|NCT01763047|147244|P1|NOT COMPLETED|Period 2||4
62018|NCT01763047|147243|P2|COMPLETED|Period 2||121
62019|NCT01763047|147244|P1|COMPLETED|Period 2||126
62020|NCT01763047|147243|P2|Hyperopes|Period 2||54
62021|NCT01763047|147244|P1|Hyperopes|Period 2||56
62022|NCT01763047|147243|P2|Myopes|Period 2||72
62023|NCT01763047|147244|P1|Myopes|Period 2||74
62024|NCT01763047|147243|P2|STARTED|Period 2||126
62025|NCT01763047|147244|P1|STARTED|Period 2||130
62026|NCT01763047|147243|P2|NOT COMPLETED|Period 1||11
62027|NCT01763047|147244|P1|NOT COMPLETED|Period 1||9
62028|NCT01763047|147243|P2|COMPLETED|Period 1||126
62029|NCT01763047|147244|P1|COMPLETED|Period 1||130
62030|NCT01763047|147243|P2|Hyperopes|Period 1||61
62031|NCT01763047|147244|P1|Hyperopes|Period 1||62
62032|NCT01763047|147243|P2|Myopes|Period 1||76
62033|NCT01763047|147244|P1|Myopes|Period 1||77
62034|NCT01763047|147243|P2|STARTED|Period 1||137
62035|NCT01763047|147244|P1|STARTED|Period 1||139
62036|NCT01762982|147260|P1|NOT COMPLETED|Overall Study||0
62037|NCT01762982|147260|P1|COMPLETED|Overall Study||36
62038|NCT01762982|147260|P1|Received Empty Finn Chamber|Overall Study||36
62039|NCT01762982|147260|P1|Received SLS|Overall Study||36
62040|NCT01762982|147260|P1|Received Benzalkonium Chloride|Overall Study||36
62041|NCT01762982|147260|P1|Received Saline Water|Overall Study||36
62042|NCT01762982|147260|P1|STARTED|Overall Study||36
62043|NCT01762943|147283|P2|NOT COMPLETED|Overall Study||2
62044|NCT01762943|147284|P1|NOT COMPLETED|Overall Study||4
62045|NCT01762943|147283|P2|COMPLETED|Overall Study||15
62046|NCT01762943|147284|P1|COMPLETED|Overall Study||15
62047|NCT01762943|147283|P2|Withdrawal|Overall Study||15
62048|NCT01762943|147284|P1|Withdrawal|Overall Study||15
62049|NCT01762943|147283|P2|Addback|Overall Study||15
62050|NCT01762943|147284|P1|Addback|Overall Study||16
62051|NCT01762943|147283|P2|Hypogonadism|Overall Study||15
62052|NCT01762943|147284|P1|Hypogonadism|Overall Study||18
62053|NCT01762943|147283|P2|STARTED|Overall Study||17
62054|NCT01762943|147284|P1|STARTED|Overall Study||19
62055|NCT01762904|147292|P1|NOT COMPLETED|Overall Study||0
62056|NCT01762904|147292|P1|COMPLETED|Overall Study|October, 2013|135
62057|NCT01762904|147292|P1|STARTED|Overall Study|January, 2013|135
62058|NCT01762800|147301|P2|NOT COMPLETED|Overall Study||21
62059|NCT01762800|147302|P1|NOT COMPLETED|Overall Study||19
62060|NCT01762800|147301|P2|COMPLETED|Overall Study||183
62061|NCT01762800|147302|P1|COMPLETED|Overall Study||183
62062|NCT01762800|147301|P2|STARTED|Overall Study||204
62063|NCT01762800|147302|P1|STARTED|Overall Study||202
62064|NCT01762761|147376|P2|NOT COMPLETED|Overall Study||4
62065|NCT01762761|147377|P1|NOT COMPLETED|Overall Study||2
62066|NCT01762761|147376|P2|COMPLETED|Overall Study||100
62067|NCT01762761|147377|P1|COMPLETED|Overall Study||49
62068|NCT01762761|147376|P2|STARTED|Overall Study||104
62069|NCT01762761|147377|P1|STARTED|Overall Study||51
62070|NCT01762722|147431|P2|NOT COMPLETED|Overall Study||0
62071|NCT01762722|147432|P1|NOT COMPLETED|Overall Study||0
62072|NCT01762722|147431|P2|COMPLETED|Overall Study||11
62073|NCT01762722|147432|P1|COMPLETED|Overall Study||12
62074|NCT01762722|147431|P2|STARTED|Overall Study||11
62075|NCT01762722|147432|P1|STARTED|Overall Study||12
62076|NCT01762501|147440|P2|NOT COMPLETED|Overall Study||23
62077|NCT01762501|147441|P1|NOT COMPLETED|Overall Study||27
62078|NCT01762501|147440|P2|COMPLETED|Overall Study||336
62079|NCT01762501|147441|P1|COMPLETED|Overall Study||332
62080|NCT01762501|147440|P2|STARTED|Overall Study||359
62081|NCT01762501|147441|P1|STARTED|Overall Study||359
62082|NCT01762345|147455|P1|NOT COMPLETED|Overall Study||7
62083|NCT01762345|147455|P1|COMPLETED|Overall Study||76
62084|NCT01762345|147455|P1|STARTED|Overall Study||83
62085|NCT01762059|147465|P1|NOT COMPLETED|Overall Study||0
62086|NCT01762059|147465|P1|COMPLETED|Overall Study||20
62087|NCT01762059|147465|P1|STARTED|Overall Study||20
62088|NCT01761747|147492|P1|NOT COMPLETED|Overall Study||1
62089|NCT01761747|147492|P1|COMPLETED|Overall Study||2
62090|NCT01761747|147492|P1|STARTED|Overall Study||3
62091|NCT01761565|147503|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
62092|NCT01761565|147503|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
62093|NCT01761565|147503|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
62094|NCT01761565|147503|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
62095|NCT01761565|147503|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
62096|NCT01761565|147503|P1|STARTED|Single Dose of SUF NT 15 mcg||40
62097|NCT01761279|147512|P1|NOT COMPLETED|Overall Study||0
62098|NCT01761279|147512|P1|COMPLETED|Overall Study||84
62099|NCT01761279|147512|P1|STARTED|Overall Study||84
62100|NCT01761175|147527|P2|NOT COMPLETED|Overall Study||0
62101|NCT01761175|147528|P1|NOT COMPLETED|Overall Study||0
62102|NCT01761175|147527|P2|COMPLETED|Overall Study||112
62103|NCT01761175|147528|P1|COMPLETED|Overall Study||112
62104|NCT01761175|147527|P2|STARTED|Overall Study||112
62105|NCT01761175|147528|P1|STARTED|Overall Study||112
62106|NCT01761162|147556|P1|NOT COMPLETED|Overall Study||3
62107|NCT01761162|147556|P1|COMPLETED|Overall Study||226
62108|NCT01761162|147556|P1|STARTED|Overall Study||229
62109|NCT01761019|147564|P1|NOT COMPLETED|Overall Study||0
62110|NCT01761019|147564|P1|COMPLETED|Overall Study||8
62111|NCT01761019|147564|P1|STARTED|Overall Study||8
62112|NCT01760993|147572|P1|NOT COMPLETED|Overall Study||0
62113|NCT01760993|147572|P1|COMPLETED|Overall Study||0
62114|NCT01760993|147572|P1|STARTED|Overall Study||0
62115|NCT01760941|147589|P1|NOT COMPLETED|Overall Study||0
62116|NCT01760941|147589|P1|COMPLETED|Overall Study||1
62117|NCT01760941|147589|P1|STARTED|Overall Study||1
62118|NCT01760889|147599|P3|NOT COMPLETED|Overall Study||0
62119|NCT01760889|147600|P2|NOT COMPLETED|Overall Study||0
62120|NCT01760889|147601|P1|NOT COMPLETED|Overall Study||0
62121|NCT01760889|147599|P3|COMPLETED|Overall Study||0
62122|NCT01760889|147600|P2|COMPLETED|Overall Study||0
62123|NCT01760889|147601|P1|COMPLETED|Overall Study||0
62124|NCT01760889|147599|P3|STARTED|Overall Study||0
62125|NCT01760889|147600|P2|STARTED|Overall Study||0
62126|NCT01760889|147601|P1|STARTED|Overall Study||0
62127|NCT01760876|147648|P1|NOT COMPLETED|Overall Study||6
62128|NCT01760876|147648|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
62129|NCT01760876|147648|P1|STARTED|Overall Study||106
62130|NCT01760785|147654|P2|NOT COMPLETED|Overall Study||0
62131|NCT01760785|147655|P1|NOT COMPLETED|Overall Study||0
62132|NCT01760785|147654|P2|COMPLETED|Overall Study||27
62133|NCT01760785|147655|P1|COMPLETED|Overall Study||23
62134|NCT01760785|147654|P2|STARTED|Overall Study||27
62135|NCT01760785|147655|P1|STARTED|Overall Study||23
62136|NCT01760473|147661|P1|NOT COMPLETED|Overall Study||15
62137|NCT01760473|147661|P1|COMPLETED|Overall Study||12
62138|NCT01760473|147661|P1|STARTED|Overall Study||27
62139|NCT01760304|147684|P2|NOT COMPLETED|Overall Study||0
62140|NCT01760304|147685|P1|NOT COMPLETED|Overall Study||0
62141|NCT01760304|147684|P2|COMPLETED|Overall Study||3
62142|NCT01760304|147685|P1|COMPLETED|Overall Study||2
62143|NCT01760304|147684|P2|STARTED|Overall Study||3
62144|NCT01760304|147685|P1|STARTED|Overall Study||2
62145|NCT01759602|147695|P1|NOT COMPLETED|Overall Study||0
62146|NCT01759602|147695|P1|COMPLETED|Overall Study||10
62147|NCT01759602|147695|P1|STARTED|Overall Study||10
62148|NCT01759511|147703|P1|NOT COMPLETED|Overall Study||34
62149|NCT01759511|147703|P1|COMPLETED|Overall Study||0
62150|NCT01759511|147703|P1|STARTED|Overall Study||34
62151|NCT01759420|147711|P1|NOT COMPLETED|Overall Study||6
62152|NCT01759420|147711|P1|COMPLETED|Overall Study||22
62153|NCT01759420|147711|P1|STARTED|Overall Study||28
62154|NCT01759407|147718|P2|NOT COMPLETED|Overall Study||2
62155|NCT01759407|147719|P1|NOT COMPLETED|Overall Study||0
62156|NCT01759407|147718|P2|COMPLETED|Overall Study||7
62157|NCT01759407|147719|P1|COMPLETED|Overall Study||10
62158|NCT01759407|147718|P2|STARTED|Overall Study||9
62159|NCT01759407|147719|P1|STARTED|Overall Study||10
62160|NCT01759381|147731|P2|NOT COMPLETED|Overall Study||0
62161|NCT01759381|147732|P1|NOT COMPLETED|Overall Study||1
62162|NCT01759381|147731|P2|COMPLETED|Overall Study||11
62163|NCT01759381|147732|P1|COMPLETED|Overall Study||7
62164|NCT01759381|147731|P2|STARTED|Overall Study||11
62165|NCT01759381|147732|P1|STARTED|Overall Study||8
62166|NCT01759368|147740|P2|NOT COMPLETED|Overall Study||0
62167|NCT01759368|147741|P1|NOT COMPLETED|Overall Study||1
62168|NCT01759368|147740|P2|COMPLETED|Overall Study||47
62169|NCT01759368|147741|P1|COMPLETED|Overall Study||46
62170|NCT01759368|147740|P2|STARTED|Overall Study||47
62171|NCT01759368|147741|P1|STARTED|Overall Study||47
62172|NCT01759290|147759|P1|NOT COMPLETED|Overall Study||81
62173|NCT01759290|147759|P1|COMPLETED|Overall Study||1719
62174|NCT01759290|147759|P1|STARTED|Overall Study||1800
62175|NCT01759264|147819|P1|NOT COMPLETED|Overall Study||10
62176|NCT01759264|147819|P1|COMPLETED|Overall Study||91
62177|NCT01759264|147819|P1|STARTED|Overall Study||101
62178|NCT01759251|147832|P1|NOT COMPLETED|Follow-up Period||0
62179|NCT01759251|147832|P1|COMPLETED|Follow-up Period||305
62180|NCT01759251|147832|P1|STARTED|Follow-up Period||305
62181|NCT01759251|147832|P1|NOT COMPLETED|60 Days Treatment Period||0
62182|NCT01759251|147832|P1|COMPLETED|60 Days Treatment Period||305
62183|NCT01759251|147832|P1|STARTED|60 Days Treatment Period||305
62184|NCT01759251|147832|P1|NOT COMPLETED|30 Days Treatment Period||4
62185|NCT01759251|147832|P1|COMPLETED|30 Days Treatment Period||305
62186|NCT01759251|147832|P1|STARTED|30 Days Treatment Period||309
62187|NCT01759160|147838|P2|NOT COMPLETED|Overall Study||0
62188|NCT01759160|147839|P1|NOT COMPLETED|Overall Study||0
62189|NCT01759160|147838|P2|COMPLETED|Overall Study||30
62190|NCT01759160|147839|P1|COMPLETED|Overall Study||30
62191|NCT01759160|147838|P2|STARTED|Overall Study||30
62192|NCT01759160|147839|P1|STARTED|Overall Study||30
62193|NCT01758900|147847|P2|NOT COMPLETED|Overall Study||8
62194|NCT01758900|147848|P1|NOT COMPLETED|Overall Study||7
62195|NCT01758900|147847|P2|COMPLETED|Overall Study||100
62196|NCT01758900|147848|P1|COMPLETED|Overall Study||99
62197|NCT01758900|147847|P2|STARTED|Overall Study||108
62198|NCT01758900|147848|P1|STARTED|Overall Study||106
62199|NCT01758289|147866|P1|NOT COMPLETED|Overall Study||53
62200|NCT01758289|147866|P1|COMPLETED|Overall Study||52
62201|NCT01758289|147866|P1|STARTED|Overall Study||105
62202|NCT01757964|147885|P2|NOT COMPLETED|Overall Study||0
62203|NCT01757964|147886|P1|NOT COMPLETED|Overall Study||0
62204|NCT01757964|147885|P2|COMPLETED|Overall Study||4
62205|NCT01757964|147886|P1|COMPLETED|Overall Study||9
62206|NCT01757964|147885|P2|STARTED|Overall Study||4
62207|NCT01757964|147886|P1|STARTED|Overall Study||9
62208|NCT01757847|147892|P2|NOT COMPLETED|Overall Study||4
62209|NCT01757847|147893|P1|NOT COMPLETED|Overall Study||3
62210|NCT01757847|147892|P2|COMPLETED|Overall Study||42
62211|NCT01757847|147893|P1|COMPLETED|Overall Study||41
62212|NCT01757847|147892|P2|STARTED|Overall Study||46
62213|NCT01757847|147893|P1|STARTED|Overall Study||44
62214|NCT01757821|147901|P1|NOT COMPLETED|Overall Study||1
62215|NCT01757821|147901|P1|COMPLETED|Overall Study|10 subjects|10
62216|NCT01757821|147901|P1|STARTED|Overall Study|11 subjects|11
62217|NCT01757717|147909|P1|NOT COMPLETED|Overall Study||0
62218|NCT01757717|147909|P1|COMPLETED|Overall Study||3
62219|NCT01757717|147909|P1|STARTED|Overall Study||3
62220|NCT01757704|147916|P2|NOT COMPLETED|Overall Study||3
62221|NCT01757704|147917|P1|NOT COMPLETED|Overall Study||1
62222|NCT01757704|147916|P2|COMPLETED|Overall Study||10
62223|NCT01757704|147917|P1|COMPLETED|Overall Study||10
62224|NCT01757704|147916|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
62225|NCT01757704|147917|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
62226|NCT01757691|147935|P2|NOT COMPLETED|Overall Study||0
62227|NCT01757691|147936|P1|NOT COMPLETED|Overall Study||2
62228|NCT01757691|147935|P2|COMPLETED|Overall Study||0
62229|NCT01757691|147936|P1|COMPLETED|Overall Study||0
62230|NCT01757691|147935|P2|STARTED|Overall Study||0
62231|NCT01757691|147936|P1|STARTED|Overall Study||2
62232|NCT01757678|147949|P1|NOT COMPLETED|Overall Study||0
62233|NCT01757678|147949|P1|COMPLETED|Overall Study||276
62234|NCT01757678|147949|P1|STARTED|Overall Study||276
62235|NCT01757561|147965|P4|NOT COMPLETED|Overall Study||9
62236|NCT01757561|147966|P3|NOT COMPLETED|Overall Study||7
62237|NCT01757561|147967|P2|NOT COMPLETED|Overall Study||6
62238|NCT01757561|147968|P1|NOT COMPLETED|Overall Study||6
62239|NCT01757561|147965|P4|COMPLETED|Overall Study||25
62240|NCT01757561|147966|P3|COMPLETED|Overall Study||31
62241|NCT01757561|147967|P2|COMPLETED|Overall Study||28
62242|NCT01757561|147968|P1|COMPLETED|Overall Study||32
62243|NCT01757561|147965|P4|STARTED|Overall Study||34
62244|NCT01757561|147966|P3|STARTED|Overall Study||38
62245|NCT01757561|147967|P2|STARTED|Overall Study||34
62246|NCT01757561|147968|P1|STARTED|Overall Study||38
62247|NCT01757405|147984|P2|NOT COMPLETED|Overall Study||2
62248|NCT01757405|147985|P1|NOT COMPLETED|Overall Study||1
62249|NCT01757405|147984|P2|COMPLETED|Overall Study||18
62250|NCT01757405|147985|P1|COMPLETED|Overall Study||17
62251|NCT01757405|147984|P2|STARTED|Overall Study||20
62252|NCT01757405|147985|P1|STARTED|Overall Study||18
62253|NCT01757275|148003|P2|NOT COMPLETED|Overall Study||13
62254|NCT01757275|148004|P1|NOT COMPLETED|Overall Study||9
62255|NCT01757275|148003|P2|COMPLETED|Overall Study||98
62256|NCT01757275|148004|P1|COMPLETED|Overall Study||102
62257|NCT01757275|148003|P2|STARTED|Overall Study||111
62258|NCT01757275|148004|P1|STARTED|Overall Study||111
62259|NCT01757197|148026|P1|NOT COMPLETED|Overall Study||2
62260|NCT01757197|148026|P1|COMPLETED|Overall Study||0
62261|NCT01757197|148026|P1|STARTED|Overall Study||2
62262|NCT01757184|148033|P2|NOT COMPLETED|Open-Label Period||0
62263|NCT01757184|148034|P1|NOT COMPLETED|Open-Label Period||0
62264|NCT01757184|148033|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
62265|NCT01757184|148034|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
62266|NCT01757184|148033|P2|STARTED|Open-Label Period||30
62267|NCT01757184|148034|P1|STARTED|Open-Label Period||35
62268|NCT01757184|148033|P2|NOT COMPLETED|Double-Blind Period||0
62269|NCT01757184|148034|P1|NOT COMPLETED|Double-Blind Period||1
62270|NCT01757184|148033|P2|COMPLETED|Double-Blind Period||30
62271|NCT01757184|148034|P1|COMPLETED|Double-Blind Period||35
62272|NCT01757184|148033|P2|STARTED|Double-Blind Period||30
62273|NCT01757184|148034|P1|STARTED|Double-Blind Period||36
62274|NCT01757171|148058|P2|NOT COMPLETED|Overall Study||1
62275|NCT01757171|148059|P1|NOT COMPLETED|Overall Study||8
62276|NCT01757171|148058|P2|COMPLETED|Overall Study||23
62277|NCT01757171|148059|P1|COMPLETED|Overall Study||53
62278|NCT01757171|148058|P2|STARTED|Overall Study||24
62279|NCT01757171|148059|P1|STARTED|Overall Study||61
62280|NCT01756976|148073|P2|NOT COMPLETED|Overall Study||0
62281|NCT01756976|148074|P1|NOT COMPLETED|Overall Study||3
62282|NCT01756976|148073|P2|COMPLETED|Overall Study||8
62283|NCT01756976|148074|P1|COMPLETED|Overall Study||73
62284|NCT01756976|148073|P2|STARTED|Overall Study||8
62285|NCT01756976|148074|P1|STARTED|Overall Study||76
62286|NCT01756586|148082|P2|NOT COMPLETED|Overall Study||2
62287|NCT01756586|148083|P1|NOT COMPLETED|Overall Study||2
62288|NCT01756586|148082|P2|COMPLETED|Overall Study||0
62289|NCT01756586|148083|P1|COMPLETED|Overall Study||0
62290|NCT01756586|148082|P2|STARTED|Overall Study||2
62291|NCT01756586|148083|P1|STARTED|Overall Study||2
62292|NCT01756391|148089|P1|NOT COMPLETED|Overall Study||32
62293|NCT01756391|148089|P1|COMPLETED|Overall Study||319
62294|NCT01756391|148089|P1|STARTED|Overall Study||351
62295|NCT01756300|148093|P1|NOT COMPLETED|Overall Study||2
62296|NCT01756300|148093|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
62297|NCT01756300|148093|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
62298|NCT01756274|148115|P1|NOT COMPLETED|Overall Study||3
62299|NCT01756274|148115|P1|COMPLETED|Overall Study||159
62300|NCT01756274|148115|P1|STARTED|Overall Study||162
62301|NCT01756235|148122|P1|NOT COMPLETED|Overall Study||2
62302|NCT01756235|148122|P1|COMPLETED|Overall Study||460
62303|NCT01756235|148122|P1|STARTED|Overall Study||462
62304|NCT01756157|148143|P2|NOT COMPLETED|Second Intervention Period||0
62305|NCT01756157|148144|P1|NOT COMPLETED|Second Intervention Period||0
62306|NCT01756157|148143|P2|COMPLETED|Second Intervention Period||22
62307|NCT01756157|148144|P1|COMPLETED|Second Intervention Period||22
62308|NCT01756157|148143|P2|STARTED|Second Intervention Period||22
62309|NCT01756157|148144|P1|STARTED|Second Intervention Period||22
62310|NCT01756157|148143|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
62311|NCT01756157|148144|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
62312|NCT01756157|148143|P2|COMPLETED|Washout Period (at Least 7 Days)||22
62313|NCT01756157|148144|P1|COMPLETED|Washout Period (at Least 7 Days)||22
62314|NCT01756157|148143|P2|STARTED|Washout Period (at Least 7 Days)||22
62315|NCT01756157|148144|P1|STARTED|Washout Period (at Least 7 Days)||22
62316|NCT01756157|148143|P2|NOT COMPLETED|First Intervention Period||2
62317|NCT01756157|148144|P1|NOT COMPLETED|First Intervention Period||1
62318|NCT01756157|148143|P2|COMPLETED|First Intervention Period||22
62319|NCT01756157|148144|P1|COMPLETED|First Intervention Period||22
62320|NCT01756157|148143|P2|STARTED|First Intervention Period||24
62321|NCT01756157|148144|P1|STARTED|First Intervention Period||23
62322|NCT01756079|148158|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
62323|NCT01756079|148158|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
62324|NCT01756079|148158|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
62325|NCT01756079|148158|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
62326|NCT01756079|148158|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
62327|NCT01756079|148158|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
62328|NCT01756079|148158|P1|STARTED|Lead-in: Day 0 to Week 4||58
62329|NCT01756053|148164|P2|NOT COMPLETED|Period 2 (10 Days)||2
62330|NCT01756053|148165|P1|NOT COMPLETED|Period 2 (10 Days)||0
62331|NCT01756053|148164|P2|COMPLETED|Period 2 (10 Days)||6
62332|NCT01756053|148165|P1|COMPLETED|Period 2 (10 Days)||7
62333|NCT01756053|148164|P2|STARTED|Period 2 (10 Days)||8
62334|NCT01756053|148165|P1|STARTED|Period 2 (10 Days)||7
62335|NCT01756053|148164|P2|NOT COMPLETED|Washout Period (~21 Days)||0
62336|NCT01756053|148165|P1|NOT COMPLETED|Washout Period (~21 Days)||0
62337|NCT01756053|148164|P2|COMPLETED|Washout Period (~21 Days)||8
62338|NCT01756053|148165|P1|COMPLETED|Washout Period (~21 Days)||7
62339|NCT01756053|148164|P2|STARTED|Washout Period (~21 Days)||8
62340|NCT01756053|148165|P1|STARTED|Washout Period (~21 Days)||7
62341|NCT01756053|148164|P2|NOT COMPLETED|Period 1 (10 Days)||1
62342|NCT01756053|148165|P1|NOT COMPLETED|Period 1 (10 Days)||1
62343|NCT01756053|148164|P2|COMPLETED|Period 1 (10 Days)||8
62344|NCT01756053|148165|P1|COMPLETED|Period 1 (10 Days)||7
62345|NCT01756053|148164|P2|STARTED|Period 1 (10 Days)||9
62346|NCT01756053|148165|P1|STARTED|Period 1 (10 Days)||8
62347|NCT01755702|148185|P1|NOT COMPLETED|Period III||0
62348|NCT01755702|148185|P1|COMPLETED|Period III||58
62349|NCT01755702|148185|P1|Received Ibuprofen|Period III||18
62350|NCT01755702|148185|P1|Received Paracetamol/Caffeine|Period III||10
62351|NCT01755702|148185|P1|Received Placebo|Period III||13
62352|NCT01755702|148185|P1|Received Paracetamol|Period III||17
62353|NCT01755702|148185|P1|STARTED|Period III||58
62354|NCT01755702|148185|P1|NOT COMPLETED|Washout Period II||5
62355|NCT01755702|148185|P1|COMPLETED|Washout Period II||58
62356|NCT01755702|148185|P1|STARTED|Washout Period II||63
62357|NCT01755702|148185|P1|NOT COMPLETED|Period II||0
62358|NCT01755702|148185|P1|COMPLETED|Period II||63
62359|NCT01755702|148185|P1|Received Paracetamol|Period II||17
62360|NCT01755702|148185|P1|Received Paracetamol/Caffeine|Period II||20
62361|NCT01755702|148185|P1|Received Placebo|Period II||15
62362|NCT01755702|148185|P1|Received Ibuprofen|Period II||11
62363|NCT01755702|148185|P1|STARTED|Period II||63
62364|NCT01755702|148185|P1|NOT COMPLETED|Wash Out Period I||3
62365|NCT01755702|148185|P1|COMPLETED|Wash Out Period I||63
62366|NCT01755702|148185|P1|STARTED|Wash Out Period I||66
62367|NCT01755702|148185|P1|NOT COMPLETED|Period I||0
62368|NCT01755702|148185|P1|COMPLETED|Period I||66
62369|NCT01755702|148185|P1|Received Paracetamol/Caffeine|Period I||17
62370|NCT01755702|148185|P1|Received Ibuprofen|Period I||16
62371|NCT01755702|148185|P1|Received Placebo|Period I||17
62372|NCT01755702|148185|P1|Received Paracetamol|Period I||16
62373|NCT01755702|148185|P1|STARTED|Period I||66
62374|NCT01755637|148227|P2|NOT COMPLETED|Period 2||0
62375|NCT01755637|148228|P1|NOT COMPLETED|Period 2||0
62376|NCT01755637|148227|P2|COMPLETED|Period 2||27
62377|NCT01755637|148228|P1|COMPLETED|Period 2||28
62378|NCT01755637|148227|P2|STARTED|Period 2||27
62379|NCT01755637|148228|P1|STARTED|Period 2||28
62380|NCT01755637|148227|P2|NOT COMPLETED|Period 1||1
62381|NCT01755637|148228|P1|NOT COMPLETED|Period 1||0
62382|NCT01755637|148227|P2|COMPLETED|Period 1||27
62383|NCT01755637|148228|P1|COMPLETED|Period 1||28
62384|NCT01755637|148227|P2|STARTED|Period 1||28
62385|NCT01755637|148228|P1|STARTED|Period 1||28
62386|NCT01755455|148246|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
62387|NCT01755455|148247|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
62388|NCT01755455|148246|P2|COMPLETED|Second Intervention (6 Weeks)||11
62389|NCT01755455|148247|P1|COMPLETED|Second Intervention (6 Weeks)||11
62390|NCT01755455|148246|P2|STARTED|Second Intervention (6 Weeks)||11
62391|NCT01755455|148247|P1|STARTED|Second Intervention (6 Weeks)||11
62392|NCT01755455|148246|P2|NOT COMPLETED|Washout (4 Weeks)||0
62393|NCT01755455|148247|P1|NOT COMPLETED|Washout (4 Weeks)||0
62394|NCT01755455|148246|P2|COMPLETED|Washout (4 Weeks)||11
62395|NCT01755455|148247|P1|COMPLETED|Washout (4 Weeks)||11
62396|NCT01755455|148246|P2|STARTED|Washout (4 Weeks)||11
62397|NCT01755455|148247|P1|STARTED|Washout (4 Weeks)||11
62398|NCT01755455|148246|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
62399|NCT01755455|148247|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
62400|NCT01755455|148246|P2|COMPLETED|First Intervention (6 Weeks)||11
62401|NCT01755455|148247|P1|COMPLETED|First Intervention (6 Weeks)||11
62402|NCT01755455|148246|P2|STARTED|First Intervention (6 Weeks)||11
62403|NCT01755455|148247|P1|STARTED|First Intervention (6 Weeks)||11
62404|NCT01755234|148261|P2|NOT COMPLETED|Overall Study||8
62405|NCT01755234|148262|P1|NOT COMPLETED|Overall Study||15
62406|NCT01755234|148261|P2|COMPLETED|Overall Study||37
62407|NCT01755234|148262|P1|COMPLETED|Overall Study||30
62408|NCT01755234|148261|P2|STARTED|Overall Study||45
62409|NCT01755234|148262|P1|STARTED|Overall Study||45
62410|NCT01755169|148278|P4|NOT COMPLETED|Overall Study||0
62411|NCT01755169|148279|P3|NOT COMPLETED|Overall Study||0
62412|NCT01755169|148280|P2|NOT COMPLETED|Overall Study||0
62413|NCT01755169|148281|P1|NOT COMPLETED|Overall Study||0
62414|NCT01755169|148278|P4|COMPLETED|Overall Study||1
62415|NCT01755169|148279|P3|COMPLETED|Overall Study||0
62416|NCT01755169|148280|P2|COMPLETED|Overall Study||1
62417|NCT01755169|148281|P1|COMPLETED|Overall Study||2
62418|NCT01755169|148278|P4|STARTED|Overall Study||1
62419|NCT01755169|148279|P3|STARTED|Overall Study||0
62420|NCT01755169|148280|P2|STARTED|Overall Study||1
62421|NCT01755169|148281|P1|STARTED|Overall Study||2
62422|NCT01755156|148293|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
62423|NCT01755156|148294|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
62424|NCT01755156|148293|P2|COMPLETED|Phase B (Weeks 24-104)||141
62425|NCT01755156|148294|P1|COMPLETED|Phase B (Weeks 24-104)||144
62426|NCT01755156|148293|P2|STARTED|Phase B (Weeks 24-104)||177
62427|NCT01755156|148294|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
62428|NCT01755156|148293|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
62429|NCT01755156|148294|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
62430|NCT01755156|148293|P2|COMPLETED|Phase A (Weeks 0-24)||177
62431|NCT01755156|148294|P1|COMPLETED|Phase A (Weeks 0-24)||184
62432|NCT01755156|148293|P2|STARTED|Phase A (Weeks 0-24)||201
62433|NCT01755156|148294|P1|STARTED|Phase A (Weeks 0-24)||201
62434|NCT01755143|148340|P2|NOT COMPLETED|Overall Study||3
62435|NCT01755143|148341|P1|NOT COMPLETED|Overall Study||11
62436|NCT01755143|148340|P2|COMPLETED|Overall Study||86
62437|NCT01755143|148341|P1|COMPLETED|Overall Study||166
62438|NCT01755143|148340|P2|STARTED|Overall Study||89
62439|NCT01755143|148341|P1|STARTED|Overall Study||177
62440|NCT01755091|148358|P3|NOT COMPLETED|Overall Study||7
62441|NCT01755091|148359|P2|NOT COMPLETED|Overall Study||3
62442|NCT01755091|148360|P1|NOT COMPLETED|Overall Study||9
62443|NCT01755091|148358|P3|COMPLETED|Overall Study||20
62444|NCT01755091|148359|P2|COMPLETED|Overall Study||19
62445|NCT01755091|148360|P1|COMPLETED|Overall Study||17
62446|NCT01755091|148358|P3|STARTED|Overall Study||27
62447|NCT01755091|148359|P2|STARTED|Overall Study||22
62448|NCT01755091|148360|P1|STARTED|Overall Study||26
62449|NCT01755026|148385|P2|NOT COMPLETED|Overall Study||1
62450|NCT01755026|148386|P1|NOT COMPLETED|Overall Study||2
62451|NCT01755026|148385|P2|COMPLETED|Overall Study||11
62452|NCT01755026|148386|P1|COMPLETED|Overall Study||9
62453|NCT01755026|148385|P2|STARTED|Overall Study||12
62454|NCT01755026|148386|P1|STARTED|Overall Study||11
62455|NCT01754922|148394|P2|NOT COMPLETED|Overall Study||1
62456|NCT01754922|148395|P1|NOT COMPLETED|Overall Study||0
62457|NCT01754922|148394|P2|COMPLETED|Overall Study||17
62458|NCT01754922|148395|P1|COMPLETED|Overall Study||32
62459|NCT01754922|148394|P2|STARTED|Overall Study||18
62460|NCT01754922|148395|P1|STARTED|Overall Study||32
62461|NCT01754766|148408|P3|NOT COMPLETED|Overall Study||0
62462|NCT01754766|148409|P2|NOT COMPLETED|Overall Study||1
62463|NCT01754766|148410|P1|NOT COMPLETED|Overall Study||1
62464|NCT01754766|148408|P3|COMPLETED|Overall Study||30
62465|NCT01754766|148409|P2|COMPLETED|Overall Study||28
62466|NCT01754766|148410|P1|COMPLETED|Overall Study||30
62467|NCT01754766|148408|P3|STARTED|Overall Study||30
62468|NCT01754766|148409|P2|STARTED|Overall Study||29
62469|NCT01754766|148410|P1|STARTED|Overall Study||31
62470|NCT01754727|148424|P1|NOT COMPLETED|Overall Study||2
62471|NCT01754727|148424|P1|COMPLETED|Overall Study||450
62472|NCT01754727|148424|P1|STARTED|Overall Study||452
62473|NCT01754714|148442|P4|NOT COMPLETED|Overall Study||1
62474|NCT01754714|148443|P3|NOT COMPLETED|Overall Study||2
62475|NCT01754714|148444|P2|NOT COMPLETED|Overall Study||1
62476|NCT01754714|148445|P1|NOT COMPLETED|Overall Study||0
62477|NCT01754714|148442|P4|COMPLETED|Overall Study||27
62478|NCT01754714|148443|P3|COMPLETED|Overall Study||24
62479|NCT01754714|148444|P2|COMPLETED|Overall Study||26
62480|NCT01754714|148445|P1|COMPLETED|Overall Study||27
62481|NCT01754714|148442|P4|STARTED|Overall Study||28
62482|NCT01754714|148443|P3|STARTED|Overall Study||26
62483|NCT01754714|148444|P2|STARTED|Overall Study||27
62484|NCT01754714|148445|P1|STARTED|Overall Study||27
62485|NCT01754623|148535|P1|NOT COMPLETED|Overall Study||0
62486|NCT01754623|148535|P1|COMPLETED|Overall Study||9
62487|NCT01754623|148535|P1|STARTED|Overall Study||9
62488|NCT01754519|148542|P1|NOT COMPLETED|Overall Study||0
62489|NCT01754519|148542|P1|COMPLETED|Overall Study||1
62490|NCT01754519|148542|P1|STARTED|Overall Study||1
62491|NCT01754493|148551|P1|NOT COMPLETED|Overall Study||7
62492|NCT01754493|148551|P1|COMPLETED|Overall Study||10
62493|NCT01754493|148551|P1|STARTED|Overall Study||17
62494|NCT01754480|148561|P2|NOT COMPLETED|Primary Part II||11
62495|NCT01754480|148562|P1|NOT COMPLETED|Primary Part II||15
62496|NCT01754480|148561|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
62497|NCT01754480|148562|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
62498|NCT01754480|148561|P2|Completed Study up to Week 6|Primary Part II||108
62499|NCT01754480|148562|P1|Completed Study up to Week 6|Primary Part II||100
62500|NCT01754480|148561|P2|STARTED|Primary Part II||113
62501|NCT01754480|148562|P1|STARTED|Primary Part II||111
62502|NCT01754480|148561|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
62503|NCT01754480|148562|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
62504|NCT01754480|148561|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
62505|NCT01754480|148562|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
62506|NCT01754480|148561|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
62507|NCT01754480|148562|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
62508|NCT01754480|148561|P2|STARTED|Part I + Part II (Overall Study)||162
62509|NCT01754480|148562|P1|STARTED|Part I + Part II (Overall Study)||163
62510|NCT01754467|148576|P1|NOT COMPLETED|Overall Study||1
62511|NCT01754467|148576|P1|COMPLETED|Overall Study||8
62512|NCT01754467|148576|P1|STARTED|Overall Study||9
62513|NCT01754402|148586|P3|NOT COMPLETED|Overall Study||4
62514|NCT01754402|148587|P2|NOT COMPLETED|Overall Study||2
62515|NCT01754402|148588|P1|NOT COMPLETED|Overall Study||2
62516|NCT01754402|148586|P3|COMPLETED|Overall Study||26
62517|NCT01754402|148587|P2|COMPLETED|Overall Study||0
62518|NCT01754402|148588|P1|COMPLETED|Overall Study||4
62519|NCT01754402|148586|P3|STARTED|Overall Study||30
62520|NCT01754402|148587|P2|STARTED|Overall Study||2
62521|NCT01754402|148588|P1|STARTED|Overall Study||6
62522|NCT01754389|148600|P3|NOT COMPLETED|Overall Study||0
62523|NCT01754389|148601|P2|NOT COMPLETED|Overall Study||0
62524|NCT01754389|148602|P1|NOT COMPLETED|Overall Study||0
62525|NCT01754389|148600|P3|COMPLETED|Overall Study||47
62526|NCT01754389|148601|P2|COMPLETED|Overall Study||45
62527|NCT01754389|148602|P1|COMPLETED|Overall Study||46
62528|NCT01754389|148600|P3|STARTED|Overall Study||47
62529|NCT01754389|148601|P2|STARTED|Overall Study||45
62530|NCT01754389|148602|P1|STARTED|Overall Study||46
62531|NCT01754376|148622|P1|NOT COMPLETED|Overall Study||3
62532|NCT01754376|148622|P1|COMPLETED|Overall Study||3
62533|NCT01754376|148622|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
62534|NCT01754376|148622|P1|STARTED|Overall Study||6
62535|NCT01754259|148633|P2|NOT COMPLETED|Overall Study||6
62536|NCT01754259|148634|P1|NOT COMPLETED|Overall Study||5
62537|NCT01754259|148633|P2|COMPLETED|Overall Study||18
62538|NCT01754259|148634|P1|COMPLETED|Overall Study||18
62539|NCT01754259|148633|P2|STARTED|Overall Study||24
62540|NCT01754259|148634|P1|STARTED|Overall Study||23
62541|NCT01754194|148644|P2|NOT COMPLETED|Overall Study||27
62542|NCT01754194|148645|P1|NOT COMPLETED|Overall Study||52
62543|NCT01754194|148644|P2|COMPLETED|Overall Study||97
62544|NCT01754194|148645|P1|COMPLETED|Overall Study||117
62545|NCT01754194|148644|P2|STARTED|Overall Study||124
62546|NCT01754194|148645|P1|STARTED|Overall Study||169
62547|NCT01753856|148667|P2|NOT COMPLETED|Overall Study||2
62548|NCT01753856|148668|P1|NOT COMPLETED|Overall Study||3
62549|NCT01753856|148667|P2|COMPLETED|Overall Study||34
62550|NCT01753856|148668|P1|COMPLETED|Overall Study||30
62551|NCT01753856|148667|P2|Completed 3-Month Bone Biopsy|Overall Study||35
62552|NCT01753856|148668|P1|Completed 3-Month Bone Biopsy|Overall Study||31
62553|NCT01753856|148667|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
62554|NCT01753856|148668|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
62555|NCT01753856|148667|P2|STARTED|Overall Study||36
62556|NCT01753856|148668|P1|STARTED|Overall Study||33
62557|NCT01753713|148720|P2|NOT COMPLETED|Overall Study||0
62558|NCT01753713|148721|P1|NOT COMPLETED|Overall Study||0
62559|NCT01753713|148720|P2|COMPLETED|Overall Study||19
62560|NCT01753713|148721|P1|COMPLETED|Overall Study||14
62561|NCT01753713|148720|P2|STARTED|Overall Study||19
62562|NCT01753713|148721|P1|STARTED|Overall Study||14
62563|NCT01753557|148739|P2|NOT COMPLETED|Overall Study||0
62564|NCT01753557|148740|P1|NOT COMPLETED|Overall Study||0
62565|NCT01753557|148739|P2|COMPLETED|Overall Study||19
62566|NCT01753557|148740|P1|COMPLETED|Overall Study||35
62567|NCT01753557|148739|P2|STARTED|Overall Study||19
62568|NCT01753557|148740|P1|STARTED|Overall Study||35
62569|NCT01753518|148758|P2|NOT COMPLETED|Postpartum Follow-up||15
62570|NCT01753518|148759|P1|NOT COMPLETED|Postpartum Follow-up||22
62571|NCT01753518|148758|P2|COMPLETED|Postpartum Follow-up||88
62572|NCT01753518|148759|P1|COMPLETED|Postpartum Follow-up||81
62573|NCT01753518|148758|P2|STARTED|Postpartum Follow-up||103
62574|NCT01753518|148759|P1|STARTED|Postpartum Follow-up||103
62575|NCT01753518|148758|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
62576|NCT01753518|148759|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
62577|NCT01753518|148758|P2|COMPLETED|Intention-to-Treat Analysis||103
62578|NCT01753518|148759|P1|COMPLETED|Intention-to-Treat Analysis||103
62579|NCT01753518|148758|P2|STARTED|Intention-to-Treat Analysis||110
62580|NCT01753518|148759|P1|STARTED|Intention-to-Treat Analysis||110
62581|NCT01753336|148781|P1|NOT COMPLETED|Overall Study||20
62582|NCT01753336|148781|P1|COMPLETED|Overall Study||92
62583|NCT01753336|148781|P1|Cycle 3|Overall Study||93
62584|NCT01753336|148781|P1|Cycle 2|Overall Study||98
62585|NCT01753336|148781|P1|Cycle 1|Overall Study||112
62586|NCT01753336|148781|P1|STARTED|Overall Study||112
62587|NCT01753323|148793|P3|NOT COMPLETED|Overall Study||9
62588|NCT01753323|148794|P2|NOT COMPLETED|Overall Study||0
62589|NCT01753323|148795|P1|NOT COMPLETED|Overall Study||1
62590|NCT01753323|148793|P3|COMPLETED|Overall Study||13
62591|NCT01753323|148794|P2|COMPLETED|Overall Study||10
62592|NCT01753323|148795|P1|COMPLETED|Overall Study||10
62593|NCT01753323|148793|P3|Intent-to-treat Analysis Set|Overall Study||22
62594|NCT01753323|148794|P2|Intent-to-treat Analysis Set|Overall Study||10
62595|NCT01753323|148795|P1|Intent-to-treat Analysis Set|Overall Study||11
62596|NCT01753323|148793|P3|Safety Set|Overall Study||22
62597|NCT01753323|148794|P2|Safety Set|Overall Study||10
62598|NCT01753323|148795|P1|Safety Set|Overall Study||11
62599|NCT01753323|148793|P3|Pharmacokinetic(PK) Set|Overall Study||21
62600|NCT01753323|148794|P2|Pharmacokinetic(PK) Set|Overall Study||10
62601|NCT01753323|148795|P1|Pharmacokinetic(PK) Set|Overall Study||10
62602|NCT01753323|148793|P3|Pharmacodynamic (PD) Set|Overall Study||21
62603|NCT01753323|148794|P2|Pharmacodynamic (PD) Set|Overall Study||10
62604|NCT01753323|148795|P1|Pharmacodynamic (PD) Set|Overall Study||10
62605|NCT01753323|148793|P3|STARTED|Overall Study||22
62606|NCT01753323|148794|P2|STARTED|Overall Study||10
62607|NCT01753323|148795|P1|STARTED|Overall Study||11
62608|NCT01753310|148833|P2|NOT COMPLETED|Overall Study||24
62609|NCT01753310|148834|P1|NOT COMPLETED|Overall Study||32
62610|NCT01753310|148833|P2|COMPLETED|Overall Study||21
62611|NCT01753310|148834|P1|COMPLETED|Overall Study||57
62612|NCT01753310|148833|P2|STARTED|Overall Study||45
62613|NCT01753310|148834|P1|STARTED|Overall Study||89
62614|NCT01753115|148857|P3|NOT COMPLETED|Overall Study||14
62615|NCT01753115|148858|P2|NOT COMPLETED|Overall Study||15
62616|NCT01753115|148859|P1|NOT COMPLETED|Overall Study||12
62617|NCT01753115|148857|P3|COMPLETED|Overall Study||56
62618|NCT01753115|148858|P2|COMPLETED|Overall Study||25
62619|NCT01753115|148859|P1|COMPLETED|Overall Study||32
62620|NCT01753115|148857|P3|Treated|Overall Study||67
62621|NCT01753115|148858|P2|Treated|Overall Study||39
62622|NCT01753115|148859|P1|Treated|Overall Study||38
62623|NCT01753115|148857|P3|STARTED|Overall Study||70
62624|NCT01753115|148858|P2|STARTED|Overall Study||40
62625|NCT01753115|148859|P1|STARTED|Overall Study||44
62626|NCT01753076|148869|P2|NOT COMPLETED|Overall Study||46
62627|NCT01753076|148870|P1|NOT COMPLETED|Overall Study||41
62628|NCT01753076|148869|P2|COMPLETED|Overall Study||106
62629|NCT01753076|148870|P1|COMPLETED|Overall Study||110
62630|NCT01753076|148869|P2|STARTED|Overall Study||152
62631|NCT01753076|148870|P1|STARTED|Overall Study||151
62632|NCT01752907|148896|P2|NOT COMPLETED|Overall Study||20
62633|NCT01752907|148897|P1|NOT COMPLETED|Overall Study||12
62634|NCT01752907|148896|P2|COMPLETED|Overall Study||133
62635|NCT01752907|148897|P1|COMPLETED|Overall Study||139
62636|NCT01752907|148896|P2|Received Pegfilgrastim|Overall Study||151
62637|NCT01752907|148897|P1|Received Pegfilgrastim|Overall Study||149
62638|NCT01752907|148896|P2|STARTED|Overall Study||153
62639|NCT01752907|148897|P1|STARTED|Overall Study||151
62640|NCT01752855|148917|P2|NOT COMPLETED|Overall Study||4
62641|NCT01752855|148918|P1|NOT COMPLETED|Overall Study||1
62642|NCT01752855|148917|P2|COMPLETED|Overall Study||40
62643|NCT01752855|148918|P1|COMPLETED|Overall Study||43
62644|NCT01752855|148917|P2|STARTED|Overall Study||44
62645|NCT01752855|148918|P1|STARTED|Overall Study||44
62646|NCT01752712|148934|P2|NOT COMPLETED|Overall Study||10
62647|NCT01752712|148935|P1|NOT COMPLETED|Overall Study||9
62648|NCT01752712|148934|P2|COMPLETED|Overall Study||21
62649|NCT01752712|148935|P1|COMPLETED|Overall Study||22
62650|NCT01752712|148934|P2|STARTED|Overall Study||31
62651|NCT01752712|148935|P1|STARTED|Overall Study||31
62652|NCT01752400|148951|P1|NOT COMPLETED|Overall Study||0
62653|NCT01752400|148951|P1|COMPLETED|Overall Study||6
62654|NCT01752400|148951|P1|STARTED|Overall Study||6
62655|NCT01752023|148964|P2|NOT COMPLETED|Overall Study||1
62656|NCT01752023|148965|P1|NOT COMPLETED|Overall Study||2
62657|NCT01752023|148964|P2|COMPLETED|Overall Study||0
62658|NCT01752023|148965|P1|COMPLETED|Overall Study||0
62659|NCT01752023|148964|P2|STARTED|Overall Study||1
62660|NCT01752023|148965|P1|STARTED|Overall Study||2
62661|NCT01751971|148983|P2|NOT COMPLETED|Overall Study||1
62662|NCT01751971|148984|P1|NOT COMPLETED|Overall Study||2
62663|NCT01751971|148983|P2|COMPLETED|Overall Study||24
62664|NCT01751971|148984|P1|COMPLETED|Overall Study||20
62665|NCT01751971|148983|P2|STARTED|Overall Study||25
62666|NCT01751971|148984|P1|STARTED|Overall Study||22
62667|NCT01751906|149001|P2|NOT COMPLETED|Overall Study||9
62668|NCT01751906|149002|P1|NOT COMPLETED|Overall Study||9
62669|NCT01751906|149001|P2|COMPLETED|Overall Study||677
62670|NCT01751906|149002|P1|COMPLETED|Overall Study||1313
62671|NCT01751906|149001|P2|STARTED|Overall Study||686
62672|NCT01751906|149002|P1|STARTED|Overall Study||1322
62673|NCT01751867|149152|P2|NOT COMPLETED|Overall Study||99
62674|NCT01751867|149153|P1|NOT COMPLETED|Overall Study||36
62675|NCT01751867|149152|P2|COMPLETED|Overall Study||0
62676|NCT01751867|149153|P1|COMPLETED|Overall Study||0
62677|NCT01751867|149152|P2|Treated|Overall Study||98
62678|NCT01751867|149153|P1|Treated|Overall Study||34
62679|NCT01751867|149152|P2|STARTED|Overall Study||99
62680|NCT01751867|149153|P1|STARTED|Overall Study||36
62681|NCT01751802|149173|P2|NOT COMPLETED|Overall Study||2
62682|NCT01751802|149174|P1|NOT COMPLETED|Overall Study||4
62683|NCT01751802|149173|P2|COMPLETED|Overall Study||2
62684|NCT01751802|149174|P1|COMPLETED|Overall Study||1
62685|NCT01751802|149173|P2|Completed Period 3|Overall Study||1
62686|NCT01751802|149174|P1|Completed Period 3|Overall Study||2
62687|NCT01751802|149173|P2|Completed Period 2|Overall Study||1
62688|NCT01751802|149174|P1|Completed Period 2|Overall Study||2
62689|NCT01751802|149173|P2|Completed Period 1|Overall Study||4
62690|NCT01751802|149174|P1|Completed Period 1|Overall Study||2
62691|NCT01751802|149173|P2|STARTED|Overall Study||4
62692|NCT01751802|149174|P1|STARTED|Overall Study||5
62693|NCT01751724|149188|P2|NOT COMPLETED|Overall Study||2
62694|NCT01751724|149189|P1|NOT COMPLETED|Overall Study||1
62695|NCT01751724|149188|P2|COMPLETED|Overall Study||42
62696|NCT01751724|149189|P1|COMPLETED|Overall Study||41
62697|NCT01751724|149188|P2|STARTED|Overall Study||44
62698|NCT01751724|149189|P1|STARTED|Overall Study||42
62699|NCT01751412|149215|P1|NOT COMPLETED|Overall Study||1
62700|NCT01751412|149215|P1|COMPLETED|Overall Study||11
62701|NCT01751412|149215|P1|STARTED|Overall Study||12
62702|NCT01751386|149227|P2|NOT COMPLETED|Overall Study||3
62703|NCT01751386|149228|P1|NOT COMPLETED|Overall Study||2
62704|NCT01751386|149227|P2|COMPLETED|Overall Study||16
62705|NCT01751386|149228|P1|COMPLETED|Overall Study||18
62706|NCT01751386|149227|P2|STARTED|Overall Study||19
62707|NCT01751386|149228|P1|STARTED|Overall Study||20
62708|NCT01751308|149239|P5|NOT COMPLETED|Phase 2||0
62709|NCT01751308|149240|P4|NOT COMPLETED|Phase 2||0
62710|NCT01751308|149241|P3|NOT COMPLETED|Phase 2||0
62711|NCT01751308|149242|P2|NOT COMPLETED|Phase 2||0
62712|NCT01751308|149243|P1|NOT COMPLETED|Phase 2||0
62713|NCT01751308|149239|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
62714|NCT01751308|149240|P4|COMPLETED|Phase 2||0
62715|NCT01751308|149241|P3|COMPLETED|Phase 2||0
62716|NCT01751308|149242|P2|COMPLETED|Phase 2||0
62717|NCT01751308|149243|P1|COMPLETED|Phase 2||0
62718|NCT01751308|149239|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
62719|NCT01751308|149240|P4|STARTED|Phase 2||0
62720|NCT01751308|149241|P3|STARTED|Phase 2||0
62721|NCT01751308|149242|P2|STARTED|Phase 2||0
62722|NCT01751308|149243|P1|STARTED|Phase 2||0
62723|NCT01751308|149239|P5|NOT COMPLETED|Phase 1||0
62724|NCT01751308|149240|P4|NOT COMPLETED|Phase 1||0
62725|NCT01751308|149241|P3|NOT COMPLETED|Phase 1||0
62726|NCT01751308|149242|P2|NOT COMPLETED|Phase 1||0
62727|NCT01751308|149243|P1|NOT COMPLETED|Phase 1||0
62728|NCT01751308|149239|P5|COMPLETED|Phase 1||0
62729|NCT01751308|149240|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
62730|NCT01751308|149241|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
62731|NCT01751308|149242|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
62732|NCT01751308|149243|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
62733|NCT01751308|149239|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
62734|NCT01751308|149240|P4|STARTED|Phase 1||7
62735|NCT01751308|149241|P3|STARTED|Phase 1||7
62736|NCT01751308|149242|P2|STARTED|Phase 1||3
62737|NCT01751308|149243|P1|STARTED|Phase 1||6
62738|NCT01751178|149283|P3|NOT COMPLETED|Overall Study||2
62739|NCT01751178|149284|P2|NOT COMPLETED|Overall Study||0
62740|NCT01751178|149285|P1|NOT COMPLETED|Overall Study||3
62741|NCT01751178|149283|P3|COMPLETED|Overall Study||105
62742|NCT01751178|149284|P2|COMPLETED|Overall Study||109
62743|NCT01751178|149285|P1|COMPLETED|Overall Study||105
62744|NCT01751178|149283|P3|STARTED|Overall Study||107
62745|NCT01751178|149284|P2|STARTED|Overall Study||109
62746|NCT01751178|149285|P1|STARTED|Overall Study||108
62747|NCT01751165|149305|P3|NOT COMPLETED|Overall Study||3
62748|NCT01751165|149306|P2|NOT COMPLETED|Overall Study||3
62749|NCT01751165|149307|P1|NOT COMPLETED|Overall Study||2
62750|NCT01751165|149305|P3|COMPLETED|Overall Study||113
62751|NCT01751165|149306|P2|COMPLETED|Overall Study||116
62752|NCT01751165|149307|P1|COMPLETED|Overall Study||117
62753|NCT01751165|149305|P3|STARTED|Overall Study||116
62754|NCT01751165|149306|P2|STARTED|Overall Study||119
62755|NCT01751165|149307|P1|STARTED|Overall Study||119
62756|NCT01751113|149347|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
62757|NCT01751113|149348|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
62758|NCT01751113|149349|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
62759|NCT01751113|149350|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
62760|NCT01751113|149351|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
62761|NCT01751113|149352|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
62762|NCT01751113|149347|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
62763|NCT01751113|149348|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
62764|NCT01751113|149349|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
62765|NCT01751113|149350|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
62766|NCT01751113|149351|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
62767|NCT01751113|149352|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
62768|NCT01751113|149347|P6|STARTED|Treatment Period 3 (4 Weeks)||10
62769|NCT01751113|149348|P5|STARTED|Treatment Period 3 (4 Weeks)||8
62770|NCT01751113|149349|P4|STARTED|Treatment Period 3 (4 Weeks)||8
62771|NCT01751113|149350|P3|STARTED|Treatment Period 3 (4 Weeks)||9
62772|NCT01751113|149351|P2|STARTED|Treatment Period 3 (4 Weeks)||8
62773|NCT01751113|149352|P1|STARTED|Treatment Period 3 (4 Weeks)||8
62774|NCT01751113|149347|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
62775|NCT01751113|149348|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
62776|NCT01751113|149349|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
62777|NCT01751113|149350|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
62778|NCT01751113|149351|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
62779|NCT01751113|149352|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
62780|NCT01751113|149347|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
62781|NCT01751113|149348|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
62782|NCT01751113|149349|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
62783|NCT01751113|149350|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
62784|NCT01751113|149351|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
62785|NCT01751113|149352|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
62786|NCT01751113|149347|P6|STARTED|Washout Period 2 (2 Weeks)||10
62787|NCT01751113|149348|P5|STARTED|Washout Period 2 (2 Weeks)||8
62788|NCT01751113|149349|P4|STARTED|Washout Period 2 (2 Weeks)||8
62789|NCT01751113|149350|P3|STARTED|Washout Period 2 (2 Weeks)||9
62790|NCT01751113|149351|P2|STARTED|Washout Period 2 (2 Weeks)||8
62791|NCT01751113|149352|P1|STARTED|Washout Period 2 (2 Weeks)||8
62792|NCT01751113|149347|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
62793|NCT01751113|149348|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
62794|NCT01751113|149349|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
62795|NCT01751113|149350|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
62796|NCT01751113|149351|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
62797|NCT01751113|149352|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
62798|NCT01751113|149347|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
62799|NCT01751113|149348|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
62800|NCT01751113|149349|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
62801|NCT01751113|149350|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
62802|NCT01751113|149351|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
62803|NCT01751113|149352|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
62804|NCT01751113|149347|P6|STARTED|Treatment Period 2 (4 Weeks)||10
62805|NCT01751113|149348|P5|STARTED|Treatment Period 2 (4 Weeks)||8
62806|NCT01751113|149349|P4|STARTED|Treatment Period 2 (4 Weeks)||8
62807|NCT01751113|149350|P3|STARTED|Treatment Period 2 (4 Weeks)||9
62808|NCT01751113|149351|P2|STARTED|Treatment Period 2 (4 Weeks)||8
62809|NCT01751113|149352|P1|STARTED|Treatment Period 2 (4 Weeks)||8
62810|NCT01751113|149347|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
62811|NCT01751113|149348|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
62812|NCT01751113|149349|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
62813|NCT01751113|149350|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
62814|NCT01751113|149351|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
62815|NCT01751113|149352|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
62816|NCT01751113|149347|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
62817|NCT01751113|149348|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
62818|NCT01751113|149349|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
62819|NCT01751113|149350|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
62820|NCT01751113|149351|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
62821|NCT01751113|149352|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
62822|NCT01751113|149347|P6|STARTED|Washout Period 1 (2 Weeks)||10
62823|NCT01751113|149348|P5|STARTED|Washout Period 1 (2 Weeks)||8
62824|NCT01751113|149349|P4|STARTED|Washout Period 1 (2 Weeks)||8
62825|NCT01751113|149350|P3|STARTED|Washout Period 1 (2 Weeks)||9
62826|NCT01751113|149351|P2|STARTED|Washout Period 1 (2 Weeks)||8
62827|NCT01751113|149352|P1|STARTED|Washout Period 1 (2 Weeks)||8
62828|NCT01751113|149347|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
62829|NCT01751113|149348|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
62830|NCT01751113|149349|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
62831|NCT01751113|149350|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
62832|NCT01751113|149351|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
62833|NCT01751113|149352|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
62834|NCT01751113|149347|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
62835|NCT01751113|149348|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
62836|NCT01751113|149349|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
62837|NCT01751113|149350|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
62838|NCT01751113|149351|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
62839|NCT01751113|149352|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
62840|NCT01751113|149347|P6|STARTED|Treatment Period 1 (4 Weeks)||10
62841|NCT01751113|149348|P5|STARTED|Treatment Period 1 (4 Weeks)||9
62842|NCT01751113|149349|P4|STARTED|Treatment Period 1 (4 Weeks)||9
62843|NCT01751113|149350|P3|STARTED|Treatment Period 1 (4 Weeks)||9
62844|NCT01751113|149351|P2|STARTED|Treatment Period 1 (4 Weeks)||8
62845|NCT01751113|149352|P1|STARTED|Treatment Period 1 (4 Weeks)||8
62846|NCT01751087|149393|P3|NOT COMPLETED|Overall Study||1
62847|NCT01751087|149394|P2|NOT COMPLETED|Overall Study||0
62848|NCT01751087|149395|P1|NOT COMPLETED|Overall Study||1
62849|NCT01751087|149393|P3|COMPLETED|Overall Study||99
62850|NCT01751087|149394|P2|COMPLETED|Overall Study||100
62851|NCT01751087|149395|P1|COMPLETED|Overall Study||99
62852|NCT01751087|149393|P3|STARTED|Overall Study||100
62853|NCT01751087|149394|P2|STARTED|Overall Study||100
62854|NCT01751087|149395|P1|STARTED|Overall Study||100
62855|NCT01751022|149430|P3|NOT COMPLETED|Overall Study||27
62856|NCT01751022|149431|P2|NOT COMPLETED|Overall Study||44
62857|NCT01751022|149432|P1|NOT COMPLETED|Overall Study||56
62858|NCT01751022|149430|P3|COMPLETED|Overall Study|6 month visit|273
62859|NCT01751022|149431|P2|COMPLETED|Overall Study|6 month visit|282
62860|NCT01751022|149432|P1|COMPLETED|Overall Study|6 month visit|443
62861|NCT01751022|149430|P3|STARTED|Overall Study||300
62862|NCT01751022|149431|P2|STARTED|Overall Study||326
62863|NCT01751022|149432|P1|STARTED|Overall Study||499
62864|NCT01750931|149464|P2|NOT COMPLETED|Period 2||0
62865|NCT01750931|149465|P1|NOT COMPLETED|Period 2||0
62866|NCT01750931|149464|P2|COMPLETED|Period 2||14
62867|NCT01750931|149465|P1|COMPLETED|Period 2||14
62868|NCT01750931|149464|P2|STARTED|Period 2||14
62869|NCT01750931|149465|P1|STARTED|Period 2||14
62870|NCT01750931|149464|P2|NOT COMPLETED|Wash Out||0
62871|NCT01750931|149465|P1|NOT COMPLETED|Wash Out||0
62872|NCT01750931|149464|P2|COMPLETED|Wash Out||14
62873|NCT01750931|149465|P1|COMPLETED|Wash Out||14
62874|NCT01750931|149464|P2|STARTED|Wash Out||14
62875|NCT01750931|149465|P1|STARTED|Wash Out||14
62876|NCT01750931|149464|P2|NOT COMPLETED|Period 1||0
62877|NCT01750931|149465|P1|NOT COMPLETED|Period 1||0
62878|NCT01750931|149464|P2|COMPLETED|Period 1||14
62879|NCT01750931|149465|P1|COMPLETED|Period 1||14
62880|NCT01750931|149464|P2|STARTED|Period 1||14
62881|NCT01750931|149465|P1|STARTED|Period 1||14
62882|NCT01750840|149483|P1|NOT COMPLETED|Overall Study||4
62883|NCT01750840|149483|P1|COMPLETED|Overall Study||4
62884|NCT01750840|149483|P1|STARTED|Overall Study||8
62885|NCT01750684|149490|P2|NOT COMPLETED|Overall Study||2
62886|NCT01750684|149491|P1|NOT COMPLETED|Overall Study||2
62887|NCT01750684|149490|P2|COMPLETED|Overall Study||5
62888|NCT01750684|149491|P1|COMPLETED|Overall Study||4
62889|NCT01750684|149490|P2|STARTED|Overall Study||7
62890|NCT01750684|149491|P1|STARTED|Overall Study||6
62891|NCT01750502|149499|P2|NOT COMPLETED|Overall Study||0
62892|NCT01750502|149500|P1|NOT COMPLETED|Overall Study||0
62893|NCT01750502|149499|P2|COMPLETED|Overall Study||186
62894|NCT01750502|149500|P1|COMPLETED|Overall Study||70
62895|NCT01750502|149499|P2|STARTED|Overall Study||186
62896|NCT01750502|149500|P1|STARTED|Overall Study||70
62897|NCT01750398|149513|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
62898|NCT01750398|149513|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
62899|NCT01750398|149513|P1|STARTED|Bipolar Androgen Thearpy Phase||29
62900|NCT01750398|149513|P1|NOT COMPLETED|ADT Lead In Phase||4
62901|NCT01750398|149513|P1|COMPLETED|ADT Lead In Phase||29
62902|NCT01750398|149513|P1|STARTED|ADT Lead In Phase||33
62903|NCT01750346|149526|P3|NOT COMPLETED|Overall Study||0
62904|NCT01750346|149527|P2|NOT COMPLETED|Overall Study||0
62905|NCT01750346|149528|P1|NOT COMPLETED|Overall Study||1
62906|NCT01750346|149526|P3|COMPLETED|Overall Study||3
62907|NCT01750346|149527|P2|COMPLETED|Overall Study||2
62908|NCT01750346|149528|P1|COMPLETED|Overall Study||2
62909|NCT01750346|149526|P3|STARTED|Overall Study||3
62910|NCT01750346|149527|P2|STARTED|Overall Study||2
62911|NCT01750346|149528|P1|STARTED|Overall Study||3
62912|NCT01750294|149554|P1|NOT COMPLETED|Overall Study||2
62913|NCT01750294|149554|P1|COMPLETED|Overall Study||12
62914|NCT01750294|149554|P1|STARTED|Overall Study||14
62915|NCT01750281|149561|P3|NOT COMPLETED|Overall Study||84
62916|NCT01750281|149562|P2|NOT COMPLETED|Overall Study||85
62917|NCT01750281|149563|P1|NOT COMPLETED|Overall Study||43
62918|NCT01750281|149561|P3|COMPLETED|Overall Study||0
62919|NCT01750281|149562|P2|COMPLETED|Overall Study||0
62920|NCT01750281|149563|P1|COMPLETED|Overall Study||0
62921|NCT01750281|149561|P3|Did Not Receive Treatment|Overall Study||0
62922|NCT01750281|149562|P2|Did Not Receive Treatment|Overall Study||1
62923|NCT01750281|149563|P1|Did Not Receive Treatment|Overall Study||0
62924|NCT01750281|149561|P3|Received Treatment|Overall Study||84
62925|NCT01750281|149562|P2|Received Treatment|Overall Study||84
62926|NCT01750281|149563|P1|Received Treatment|Overall Study||43
62927|NCT01750281|149561|P3|STARTED|Overall Study||84
62928|NCT01750281|149562|P2|STARTED|Overall Study||85
62929|NCT01750281|149563|P1|STARTED|Overall Study||43
62930|NCT01750255|149576|P2|NOT COMPLETED|Overall Study||5
62931|NCT01750255|149577|P1|NOT COMPLETED|Overall Study||6
62932|NCT01750255|149576|P2|COMPLETED|Overall Study||38
62933|NCT01750255|149577|P1|COMPLETED|Overall Study||43
62934|NCT01750255|149576|P2|STARTED|Overall Study||43
62935|NCT01750255|149577|P1|STARTED|Overall Study||49
62936|NCT01750242|149593|P1|NOT COMPLETED|Overall Study||3
62937|NCT01750242|149593|P1|COMPLETED|Overall Study||20
62938|NCT01750242|149593|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
62939|NCT01750242|149593|P1|STARTED|Overall Study||23
62940|NCT01750229|149598|P1|NOT COMPLETED|Long-term Follow-up Phase||3
62941|NCT01750229|149598|P1|COMPLETED|Long-term Follow-up Phase||25
62942|NCT01750229|149598|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
62943|NCT01750229|149598|P1|NOT COMPLETED|Randomized Crossover Phase||2
62944|NCT01750229|149598|P1|COMPLETED|Randomized Crossover Phase||28
62945|NCT01750229|149598|P1|Protocol Violation|Randomized Crossover Phase||4
62946|NCT01750229|149598|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
62947|NCT01750229|149598|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
62948|NCT01750229|149598|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
62949|NCT01750229|149598|P1|Subject Received Sham|Randomized Crossover Phase||24
62950|NCT01750229|149598|P1|STARTED|Randomized Crossover Phase||30
62951|NCT01750086|149610|P2|NOT COMPLETED|Overall Study||1
62952|NCT01750086|149611|P1|NOT COMPLETED|Overall Study||1
62953|NCT01750086|149610|P2|COMPLETED|Overall Study||13
62954|NCT01750086|149611|P1|COMPLETED|Overall Study||12
62955|NCT01750086|149610|P2|STARTED|Overall Study||14
62956|NCT01750086|149611|P1|STARTED|Overall Study||13
62957|NCT01749982|149621|P4|NOT COMPLETED|Overall Study||3
62958|NCT01749982|149622|P3|NOT COMPLETED|Overall Study||0
62959|NCT01749982|149623|P2|NOT COMPLETED|Overall Study||0
62960|NCT01749982|149624|P1|NOT COMPLETED|Overall Study||0
62961|NCT01749982|149621|P4|COMPLETED|Overall Study||12
62962|NCT01749982|149622|P3|COMPLETED|Overall Study||15
62963|NCT01749982|149623|P2|COMPLETED|Overall Study||15
62964|NCT01749982|149624|P1|COMPLETED|Overall Study||15
62965|NCT01749982|149621|P4|STARTED|Overall Study||15
62966|NCT01749982|149622|P3|STARTED|Overall Study||15
62967|NCT01749982|149623|P2|STARTED|Overall Study||15
62968|NCT01749982|149624|P1|STARTED|Overall Study||15
62969|NCT01749956|149642|P1|NOT COMPLETED|Overall Study||15
62970|NCT01749956|149642|P1|COMPLETED|Overall Study||24
62971|NCT01749956|149642|P1|STARTED|Overall Study||39
62972|NCT01749800|149655|P3|NOT COMPLETED|Overall Study||0
62973|NCT01749800|149656|P2|NOT COMPLETED|Overall Study||1
62974|NCT01749800|149657|P1|NOT COMPLETED|Overall Study||3
62975|NCT01749800|149655|P3|COMPLETED|Overall Study||0
62976|NCT01749800|149656|P2|COMPLETED|Overall Study||0
62977|NCT01749800|149657|P1|COMPLETED|Overall Study||3
62978|NCT01749800|149655|P3|STARTED|Overall Study||0
62979|NCT01749800|149656|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
62980|NCT01749800|149657|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
62981|NCT01749735|149667|P2|NOT COMPLETED|Overall Study||0
62982|NCT01749735|149668|P1|NOT COMPLETED|Overall Study||1
62983|NCT01749735|149667|P2|COMPLETED|Overall Study||0
62984|NCT01749735|149668|P1|COMPLETED|Overall Study||1
62985|NCT01749735|149667|P2|STARTED|Overall Study||0
62986|NCT01749735|149668|P1|STARTED|Overall Study||2
62987|NCT01749631|149676|P1|NOT COMPLETED|Overall Study||0
62988|NCT01749631|149676|P1|COMPLETED|Overall Study||97
62989|NCT01749631|149676|P1|STARTED|Overall Study||97
62990|NCT01749605|149688|P2|NOT COMPLETED|Overall Study||3
62991|NCT01749605|149689|P1|NOT COMPLETED|Overall Study||4
62992|NCT01749605|149688|P2|COMPLETED|Overall Study||14
62993|NCT01749605|149689|P1|COMPLETED|Overall Study||14
62994|NCT01749605|149688|P2|STARTED|Overall Study||17
62995|NCT01749605|149689|P1|STARTED|Overall Study||18
62996|NCT01749501|149697|P2|NOT COMPLETED|Overall Study||0
62997|NCT01749501|149698|P1|NOT COMPLETED|Overall Study||0
62998|NCT01749501|149697|P2|COMPLETED|Overall Study||23
62999|NCT01749501|149698|P1|COMPLETED|Overall Study||22
63000|NCT01749501|149697|P2|STARTED|Overall Study||23
63001|NCT01749501|149698|P1|STARTED|Overall Study||22
63002|NCT01749410|149706|P1|NOT COMPLETED|Overall Study||0
63003|NCT01749410|149706|P1|COMPLETED|Overall Study||33
63004|NCT01749410|149706|P1|STARTED|Overall Study||33
63005|NCT01748955|149712|P2|NOT COMPLETED|Overall Study||5
63006|NCT01748955|149713|P1|NOT COMPLETED|Overall Study||3
63007|NCT01748955|149712|P2|COMPLETED|Overall Study||4
63008|NCT01748955|149713|P1|COMPLETED|Overall Study||3
63009|NCT01748955|149712|P2|STARTED|Overall Study||9
63010|NCT01748955|149713|P1|STARTED|Overall Study||6
63011|NCT01748942|149723|P2|NOT COMPLETED|Overall Study||4
63012|NCT01748942|149724|P1|NOT COMPLETED|Overall Study||4
63013|NCT01748942|149723|P2|COMPLETED|Overall Study||33
63014|NCT01748942|149724|P1|COMPLETED|Overall Study||35
63015|NCT01748942|149723|P2|STARTED|Overall Study||37
63016|NCT01748942|149724|P1|STARTED|Overall Study||39
63017|NCT01748916|149744|P6|NOT COMPLETED|Overall Study||0
63018|NCT01748916|149745|P5|NOT COMPLETED|Overall Study||0
63019|NCT01748916|149746|P4|NOT COMPLETED|Overall Study||0
63020|NCT01748916|149747|P3|NOT COMPLETED|Overall Study||0
63021|NCT01748916|149748|P2|NOT COMPLETED|Overall Study||0
63022|NCT01748916|149749|P1|NOT COMPLETED|Overall Study||0
63023|NCT01748916|149744|P6|COMPLETED|Overall Study||3
63024|NCT01748916|149745|P5|COMPLETED|Overall Study||3
63025|NCT01748916|149746|P4|COMPLETED|Overall Study||3
63026|NCT01748916|149747|P3|COMPLETED|Overall Study||2
63027|NCT01748916|149748|P2|COMPLETED|Overall Study||3
63028|NCT01748916|149749|P1|COMPLETED|Overall Study||2
63029|NCT01748916|149744|P6|STARTED|Overall Study||3
63030|NCT01748916|149745|P5|STARTED|Overall Study||3
63031|NCT01748916|149746|P4|STARTED|Overall Study||3
63032|NCT01748916|149747|P3|STARTED|Overall Study||2
63033|NCT01748916|149748|P2|STARTED|Overall Study||3
63034|NCT01748916|149749|P1|STARTED|Overall Study||2
63035|NCT01748890|149757|P1|NOT COMPLETED|Overall Study||4
63036|NCT01748890|149757|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
63037|NCT01748890|149757|P1|STARTED|Overall Study||4
63038|NCT01748799|149769|P8|NOT COMPLETED|Overall Study||0
63039|NCT01748799|149770|P7|NOT COMPLETED|Overall Study||1
63040|NCT01748799|149771|P6|NOT COMPLETED|Overall Study||1
63041|NCT01748799|149772|P5|NOT COMPLETED|Overall Study||0
63042|NCT01748799|149773|P4|NOT COMPLETED|Overall Study||0
63043|NCT01748799|149774|P3|NOT COMPLETED|Overall Study||0
63044|NCT01748799|149775|P2|NOT COMPLETED|Overall Study||0
63045|NCT01748799|149776|P1|NOT COMPLETED|Overall Study||5
63046|NCT01748799|149769|P8|COMPLETED|Overall Study||1
63047|NCT01748799|149770|P7|COMPLETED|Overall Study||1
63048|NCT01748799|149771|P6|COMPLETED|Overall Study||1
63049|NCT01748799|149772|P5|COMPLETED|Overall Study||1
63050|NCT01748799|149773|P4|COMPLETED|Overall Study||2
63051|NCT01748799|149774|P3|COMPLETED|Overall Study||1
63052|NCT01748799|149775|P2|COMPLETED|Overall Study||1
63053|NCT01748799|149776|P1|COMPLETED|Overall Study||1
63054|NCT01748799|149769|P8|Completed Self-titrated Sativex|Overall Study||1
63055|NCT01748799|149770|P7|Completed Self-titrated Sativex|Overall Study||1
63056|NCT01748799|149771|P6|Completed Self-titrated Sativex|Overall Study||1
63057|NCT01748799|149772|P5|Completed Self-titrated Sativex|Overall Study||1
63058|NCT01748799|149773|P4|Completed Self-titrated Sativex|Overall Study||2
63059|NCT01748799|149774|P3|Completed Self-titrated Sativex|Overall Study||1
63060|NCT01748799|149775|P2|Completed Self-titrated Sativex|Overall Study||1
63061|NCT01748799|149776|P1|Completed Self-titrated Sativex|Overall Study||1
63062|NCT01748799|149769|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
63063|NCT01748799|149770|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
63064|NCT01748799|149771|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
63065|NCT01748799|149772|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
63066|NCT01748799|149773|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
63067|NCT01748799|149774|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
63068|NCT01748799|149775|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
63069|NCT01748799|149776|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
63070|NCT01748799|149769|P8|Completed Self-titrated Placebo|Overall Study||1
63071|NCT01748799|149770|P7|Completed Self-titrated Placebo|Overall Study||1
63072|NCT01748799|149771|P6|Completed Self-titrated Placebo|Overall Study||2
63073|NCT01748799|149772|P5|Completed Self-titrated Placebo|Overall Study||1
63074|NCT01748799|149773|P4|Completed Self-titrated Placebo|Overall Study||2
63075|NCT01748799|149774|P3|Completed Self-titrated Placebo|Overall Study||1
63076|NCT01748799|149775|P2|Completed Self-titrated Placebo|Overall Study||1
63077|NCT01748799|149776|P1|Completed Self-titrated Placebo|Overall Study||4
63078|NCT01748799|149769|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
63079|NCT01748799|149770|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
63080|NCT01748799|149771|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
63081|NCT01748799|149772|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
63082|NCT01748799|149773|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
63083|NCT01748799|149774|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
63084|NCT01748799|149775|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
63085|NCT01748799|149776|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
63086|NCT01748799|149769|P8|Completed Fixed Dose Sativex|Overall Study||1
63087|NCT01748799|149770|P7|Completed Fixed Dose Sativex|Overall Study||1
63088|NCT01748799|149771|P6|Completed Fixed Dose Sativex|Overall Study||1
63089|NCT01748799|149772|P5|Completed Fixed Dose Sativex|Overall Study||1
63090|NCT01748799|149773|P4|Completed Fixed Dose Sativex|Overall Study||2
63091|NCT01748799|149774|P3|Completed Fixed Dose Sativex|Overall Study||1
63092|NCT01748799|149775|P2|Completed Fixed Dose Sativex|Overall Study||1
63093|NCT01748799|149776|P1|Completed Fixed Dose Sativex|Overall Study||1
63094|NCT01748799|149769|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
63095|NCT01748799|149770|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
63096|NCT01748799|149771|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
63097|NCT01748799|149772|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
63098|NCT01748799|149773|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
63099|NCT01748799|149774|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
63100|NCT01748799|149775|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
63101|NCT01748799|149776|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
63102|NCT01748799|149769|P8|Completed Fixed Dose Placebo|Overall Study||1
63103|NCT01748799|149770|P7|Completed Fixed Dose Placebo|Overall Study||1
63104|NCT01748799|149771|P6|Completed Fixed Dose Placebo|Overall Study||1
63105|NCT01748799|149772|P5|Completed Fixed Dose Placebo|Overall Study||1
63106|NCT01748799|149773|P4|Completed Fixed Dose Placebo|Overall Study||2
63107|NCT01748799|149774|P3|Completed Fixed Dose Placebo|Overall Study||1
63108|NCT01748799|149775|P2|Completed Fixed Dose Placebo|Overall Study||1
63109|NCT01748799|149776|P1|Completed Fixed Dose Placebo|Overall Study||2
63110|NCT01748799|149769|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
63111|NCT01748799|149770|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
63112|NCT01748799|149771|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
63113|NCT01748799|149772|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
63114|NCT01748799|149773|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
63115|NCT01748799|149774|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
63116|NCT01748799|149775|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
63117|NCT01748799|149776|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
63118|NCT01748799|149769|P8|STARTED|Overall Study||1
63119|NCT01748799|149770|P7|STARTED|Overall Study||2
63120|NCT01748799|149771|P6|STARTED|Overall Study||2
63121|NCT01748799|149772|P5|STARTED|Overall Study||1
63122|NCT01748799|149773|P4|STARTED|Overall Study||2
63123|NCT01748799|149774|P3|STARTED|Overall Study||1
63124|NCT01748799|149775|P2|STARTED|Overall Study||1
63125|NCT01748799|149776|P1|STARTED|Overall Study||6
63126|NCT01748760|149812|P2|NOT COMPLETED|Overall Study||2
63127|NCT01748760|149813|P1|NOT COMPLETED|Overall Study||6
63128|NCT01748760|149812|P2|COMPLETED|Overall Study||23
63129|NCT01748760|149813|P1|COMPLETED|Overall Study||19
63130|NCT01748760|149812|P2|STARTED|Overall Study||25
63131|NCT01748760|149813|P1|STARTED|Overall Study||25
63132|NCT01748695|149819|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
63133|NCT01748695|149820|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
63134|NCT01748695|149819|P2|COMPLETED|Second Intervention (4 Weeks)||11
63135|NCT01748695|149820|P1|COMPLETED|Second Intervention (4 Weeks)||14
63136|NCT01748695|149819|P2|STARTED|Second Intervention (4 Weeks)||11
63137|NCT01748695|149820|P1|STARTED|Second Intervention (4 Weeks)||14
63138|NCT01748695|149819|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
63139|NCT01748695|149820|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
63140|NCT01748695|149819|P2|COMPLETED|First Intervention (4 Weeks)||11
63141|NCT01748695|149820|P1|COMPLETED|First Intervention (4 Weeks)||14
63142|NCT01748695|149819|P2|STARTED|First Intervention (4 Weeks)||11
63143|NCT01748695|149820|P1|STARTED|First Intervention (4 Weeks)||14
63144|NCT01748643|149830|P2|NOT COMPLETED|Overall Study||0
63145|NCT01748643|149831|P1|NOT COMPLETED|Overall Study||0
63146|NCT01748643|149830|P2|COMPLETED|Overall Study||30
63147|NCT01748643|149831|P1|COMPLETED|Overall Study||30
63148|NCT01748643|149830|P2|STARTED|Overall Study||30
63149|NCT01748643|149831|P1|STARTED|Overall Study||30
63150|NCT01748292|149849|P2|NOT COMPLETED|Overall Study||12
63151|NCT01748292|149850|P1|NOT COMPLETED|Overall Study||2
63152|NCT01748292|149849|P2|COMPLETED|Overall Study||28
63153|NCT01748292|149850|P1|COMPLETED|Overall Study||18
63154|NCT01748292|149849|P2|STARTED|Overall Study||40
63155|NCT01748292|149850|P1|STARTED|Overall Study||20
63156|NCT01748227|149866|P1|NOT COMPLETED|Overall Study||3
63157|NCT01748227|149866|P1|COMPLETED|Overall Study||17
63158|NCT01748227|149866|P1|STARTED|Overall Study||20
63159|NCT01748162|149876|P2|NOT COMPLETED|Overall Study||5
63160|NCT01748162|149877|P1|NOT COMPLETED|Overall Study||5
63161|NCT01748162|149876|P2|COMPLETED|Overall Study||0
63162|NCT01748162|149877|P1|COMPLETED|Overall Study||0
63163|NCT01748162|149876|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
63164|NCT01748162|149877|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
63165|NCT01748162|149876|P2|Completed 6 Month Initial Treatment|Overall Study||0
63166|NCT01748162|149877|P1|Completed 6 Month Initial Treatment|Overall Study||0
63167|NCT01748162|149876|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
63168|NCT01748162|149877|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
63169|NCT01748162|149876|P2|STARTED|Overall Study||5
63170|NCT01748162|149877|P1|STARTED|Overall Study||5
63171|NCT01748071|149888|P3|NOT COMPLETED|Overall Study||0
63172|NCT01748071|149889|P2|NOT COMPLETED|Overall Study||2
63173|NCT01748071|149890|P1|NOT COMPLETED|Overall Study||2
63174|NCT01748071|149888|P3|COMPLETED|Overall Study||40
63175|NCT01748071|149889|P2|COMPLETED|Overall Study||38
63176|NCT01748071|149890|P1|COMPLETED|Overall Study||38
63177|NCT01748071|149888|P3|STARTED|Overall Study||40
63178|NCT01748071|149889|P2|STARTED|Overall Study||40
63179|NCT01748071|149890|P1|STARTED|Overall Study||40
63180|NCT01748045|149912|P2|NOT COMPLETED|Overall Study||0
63181|NCT01748045|149913|P1|NOT COMPLETED|Overall Study||0
63182|NCT01748045|149912|P2|COMPLETED|Overall Study||1
63183|NCT01748045|149913|P1|COMPLETED|Overall Study||2
63184|NCT01748045|149912|P2|STARTED|Overall Study||1
63185|NCT01748045|149913|P1|STARTED|Overall Study||2
63186|NCT01747928|149939|P8|NOT COMPLETED|Overall Study||0
63187|NCT01747928|149940|P7|NOT COMPLETED|Overall Study||0
63188|NCT01747928|149941|P6|NOT COMPLETED|Overall Study||0
63189|NCT01747928|149942|P5|NOT COMPLETED|Overall Study||0
63190|NCT01747928|149943|P4|NOT COMPLETED|Overall Study||0
63191|NCT01747928|149944|P3|NOT COMPLETED|Overall Study||0
63192|NCT01747928|149945|P2|NOT COMPLETED|Overall Study||0
63193|NCT01747928|149946|P1|NOT COMPLETED|Overall Study||0
63194|NCT01747928|149939|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63195|NCT01747928|149940|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63196|NCT01747928|149941|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63197|NCT01747928|149942|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63198|NCT01747928|149943|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63199|NCT01747928|149944|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63200|NCT01747928|149945|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63201|NCT01747928|149946|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
63202|NCT01747928|149939|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63203|NCT01747928|149940|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63204|NCT01747928|149941|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63205|NCT01747928|149942|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63206|NCT01747928|149943|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63207|NCT01747928|149944|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63208|NCT01747928|149945|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63209|NCT01747928|149946|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
63210|NCT01747850|150153|P3|NOT COMPLETED|Overall Study||6
63211|NCT01747850|150154|P2|NOT COMPLETED|Overall Study||7
63212|NCT01747850|150155|P1|NOT COMPLETED|Overall Study||1
63213|NCT01747850|150153|P3|COMPLETED|Overall Study||14
63214|NCT01747850|150154|P2|COMPLETED|Overall Study||13
63215|NCT01747850|150155|P1|COMPLETED|Overall Study||4
63216|NCT01747850|150153|P3|STARTED|Overall Study||20
63217|NCT01747850|150154|P2|STARTED|Overall Study||20
63218|NCT01747850|150155|P1|STARTED|Overall Study||5
63219|NCT01747811|150177|P2|NOT COMPLETED|Overall Study||4
63220|NCT01747811|150178|P1|NOT COMPLETED|Overall Study||2
63221|NCT01747811|150177|P2|COMPLETED|Overall Study||12
63222|NCT01747811|150178|P1|COMPLETED|Overall Study||14
63223|NCT01747811|150177|P2|STARTED|Overall Study||16
63224|NCT01747811|150178|P1|STARTED|Overall Study||16
63225|NCT01747772|150194|P1|NOT COMPLETED|Overall Study||9
63226|NCT01747772|150194|P1|COMPLETED|Overall Study||171
63227|NCT01747772|150194|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
63228|NCT01747772|150194|P1|STARTED|Overall Study||180
63229|NCT01747655|150202|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
63230|NCT01747655|150203|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
63231|NCT01747655|150202|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
63232|NCT01747655|150203|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
63233|NCT01747655|150202|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
63234|NCT01747655|150203|P1|STARTED|PEG-J Period (Continued Treatment)||41
63235|NCT01747655|150202|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
63236|NCT01747655|150203|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
63237|NCT01747655|150202|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
63238|NCT01747655|150203|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
63239|NCT01747655|150202|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
63240|NCT01747655|150203|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
63241|NCT01747655|150202|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
63242|NCT01747655|150203|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
63243|NCT01747655|150202|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
63244|NCT01747655|150203|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
63245|NCT01747655|150202|P2|STARTED|Temporary Naso-jejunal Tube Period||0
63246|NCT01747655|150203|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
63247|NCT01747629|150233|P2|NOT COMPLETED|Overall Study||6
63248|NCT01747629|150234|P1|NOT COMPLETED|Overall Study||8
63249|NCT01747629|150233|P2|COMPLETED|Overall Study||69
63250|NCT01747629|150234|P1|COMPLETED|Overall Study||77
63251|NCT01747629|150233|P2|Treated|Overall Study|Safety set and full analysis set|75
63252|NCT01747629|150234|P1|Treated|Overall Study|Safety set and full analysis set|84
63253|NCT01747629|150233|P2|STARTED|Overall Study||75
63254|NCT01747629|150234|P1|STARTED|Overall Study||85
63255|NCT01747551|150268|P2|NOT COMPLETED|Overall Study||21
63256|NCT01747551|150269|P1|NOT COMPLETED|Overall Study||43
63257|NCT01747551|150268|P2|COMPLETED|Overall Study||0
63258|NCT01747551|150269|P1|COMPLETED|Overall Study||0
63259|NCT01747551|150268|P2|STARTED|Overall Study||21
63260|NCT01747551|150269|P1|STARTED|Overall Study||43
63261|NCT01747343|150281|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
63262|NCT01747343|150281|P1|COMPLETED|Underwear/Differential Reinforcement||4
63263|NCT01747343|150281|P1|STARTED|Underwear/Differential Reinforcement||4
63264|NCT01747343|150281|P1|NOT COMPLETED|Underwear||0
63265|NCT01747343|150281|P1|COMPLETED|Underwear||4
63266|NCT01747343|150281|P1|STARTED|Underwear||4
63267|NCT01747343|150281|P1|NOT COMPLETED|Baseline||0
63268|NCT01747343|150281|P1|COMPLETED|Baseline||4
63269|NCT01747343|150281|P1|STARTED|Baseline||4
63270|NCT01747330|150287|P1|NOT COMPLETED|Overall Study||0
63271|NCT01747330|150287|P1|COMPLETED|Overall Study||40
63272|NCT01747330|150287|P1|STARTED|Overall Study||40
63273|NCT01746979|150301|P2|NOT COMPLETED|Overall Study||347
63274|NCT01746979|150302|P1|NOT COMPLETED|Overall Study||346
63275|NCT01746979|150301|P2|COMPLETED|Overall Study||0
63276|NCT01746979|150302|P1|COMPLETED|Overall Study||0
63277|NCT01746979|150301|P2|STARTED|Overall Study||347
63278|NCT01746979|150302|P1|STARTED|Overall Study||346
63279|NCT01746940|150314|P4|NOT COMPLETED|Safety Second Phase||0
63280|NCT01746940|150315|P3|NOT COMPLETED|Safety Second Phase||0
63281|NCT01746940|150316|P2|NOT COMPLETED|Safety Second Phase||0
63282|NCT01746940|150317|P1|NOT COMPLETED|Safety Second Phase||0
63283|NCT01746940|150314|P4|COMPLETED|Safety Second Phase||0
63284|NCT01746940|150315|P3|COMPLETED|Safety Second Phase||0
63285|NCT01746940|150316|P2|COMPLETED|Safety Second Phase||18
63286|NCT01746940|150317|P1|COMPLETED|Safety Second Phase||18
63287|NCT01746940|150314|P4|STARTED|Safety Second Phase||0
63288|NCT01746940|150315|P3|STARTED|Safety Second Phase||0
63289|NCT01746940|150316|P2|STARTED|Safety Second Phase||18
63290|NCT01746940|150317|P1|STARTED|Safety Second Phase||18
63291|NCT01746940|150314|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
63292|NCT01746940|150315|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
63293|NCT01746940|150316|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
63294|NCT01746940|150317|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
63295|NCT01746940|150314|P4|COMPLETED|Safety and Efficacy First Phase||0
63296|NCT01746940|150315|P3|COMPLETED|Safety and Efficacy First Phase||40
63297|NCT01746940|150316|P2|COMPLETED|Safety and Efficacy First Phase||41
63298|NCT01746940|150317|P1|COMPLETED|Safety and Efficacy First Phase||39
63299|NCT01746940|150314|P4|STARTED|Safety and Efficacy First Phase||3
63300|NCT01746940|150315|P3|STARTED|Safety and Efficacy First Phase||40
63301|NCT01746940|150316|P2|STARTED|Safety and Efficacy First Phase||41
63302|NCT01746940|150317|P1|STARTED|Safety and Efficacy First Phase||39
63303|NCT01746862|150327|P2|NOT COMPLETED|Overall Study||3
63304|NCT01746862|150328|P1|NOT COMPLETED|Overall Study||8
63305|NCT01746862|150327|P2|COMPLETED|Overall Study||27
63306|NCT01746862|150328|P1|COMPLETED|Overall Study||52
63307|NCT01746862|150327|P2|Treated|Overall Study||30
63308|NCT01746862|150328|P1|Treated|Overall Study||59
63309|NCT01746862|150327|P2|STARTED|Overall Study||30
63310|NCT01746862|150328|P1|STARTED|Overall Study||60
63311|NCT01746784|150353|P5|NOT COMPLETED|Overall Study||0
63312|NCT01746784|150354|P4|NOT COMPLETED|Overall Study||0
63313|NCT01746784|150355|P3|NOT COMPLETED|Overall Study||0
63314|NCT01746784|150356|P2|NOT COMPLETED|Overall Study||0
63315|NCT01746784|150357|P1|NOT COMPLETED|Overall Study||0
63316|NCT01746784|150353|P5|COMPLETED|Overall Study||19
63317|NCT01746784|150354|P4|COMPLETED|Overall Study||9
63318|NCT01746784|150355|P3|COMPLETED|Overall Study||9
63319|NCT01746784|150356|P2|COMPLETED|Overall Study||10
63320|NCT01746784|150357|P1|COMPLETED|Overall Study||19
63321|NCT01746784|150353|P5|Enrolled|Overall Study||19
63322|NCT01746784|150354|P4|Enrolled|Overall Study||9
63323|NCT01746784|150355|P3|Enrolled|Overall Study||9
63324|NCT01746784|150356|P2|Enrolled|Overall Study||10
63325|NCT01746784|150357|P1|Enrolled|Overall Study||19
63326|NCT01746784|150353|P5|STARTED|Overall Study||19
63327|NCT01746784|150354|P4|STARTED|Overall Study||9
63328|NCT01746784|150355|P3|STARTED|Overall Study||9
63329|NCT01746784|150356|P2|STARTED|Overall Study||10
63330|NCT01746784|150357|P1|STARTED|Overall Study||19
63331|NCT01746511|150381|P2|NOT COMPLETED|Overall Study||0
63332|NCT01746511|150382|P1|NOT COMPLETED|Overall Study||0
63333|NCT01746511|150381|P2|COMPLETED|Overall Study||39
63334|NCT01746511|150382|P1|COMPLETED|Overall Study||40
63335|NCT01746511|150381|P2|STARTED|Overall Study||39
63336|NCT01746511|150382|P1|STARTED|Overall Study||40
63337|NCT01746368|150398|P2|NOT COMPLETED|Overall Study||1
63338|NCT01746368|150399|P1|NOT COMPLETED|Overall Study||2
63339|NCT01746368|150398|P2|COMPLETED|Overall Study||16
63340|NCT01746368|150399|P1|COMPLETED|Overall Study||31
63341|NCT01746368|150398|P2|Analyzed for Satisfaction|Overall Study||16
63342|NCT01746368|150399|P1|Analyzed for Satisfaction|Overall Study||30
63343|NCT01746368|150398|P2|Analyzed for AD Completion Rate|Overall Study||17
63344|NCT01746368|150399|P1|Analyzed for AD Completion Rate|Overall Study||32
63345|NCT01746368|150398|P2|Assessment Completed|Overall Study||16
63346|NCT01746368|150399|P1|Assessment Completed|Overall Study||31
63347|NCT01746368|150398|P2|Recieved Allocated Intervention|Overall Study||8
63348|NCT01746368|150399|P1|Recieved Allocated Intervention|Overall Study||31
63349|NCT01746368|150398|P2|STARTED|Overall Study||17
63350|NCT01746368|150399|P1|STARTED|Overall Study||33
63351|NCT01746264|150407|P1|NOT COMPLETED|Overall Study||0
63352|NCT01746264|150407|P1|COMPLETED|Overall Study||19
63353|NCT01746264|150407|P1|STARTED|Overall Study||19
63354|NCT01746173|150426|P1|NOT COMPLETED|Overall Study||2
63355|NCT01746173|150426|P1|COMPLETED|Overall Study||3
63356|NCT01746173|150426|P1|STARTED|Overall Study||5
63357|NCT01746108|150434|P3|NOT COMPLETED|Overall Study||0
63358|NCT01746108|150435|P2|NOT COMPLETED|Overall Study||4
63359|NCT01746108|150436|P1|NOT COMPLETED|Overall Study||0
63360|NCT01746108|150434|P3|COMPLETED|Overall Study||6
63361|NCT01746108|150435|P2|COMPLETED|Overall Study||24
63362|NCT01746108|150436|P1|COMPLETED|Overall Study||18
63363|NCT01746108|150434|P3|STARTED|Overall Study||6
63364|NCT01746108|150435|P2|STARTED|Overall Study||28
63365|NCT01746108|150436|P1|STARTED|Overall Study||18
63366|NCT01745952|150472|P3|NOT COMPLETED|Overall Study||0
63367|NCT01745952|150473|P2|NOT COMPLETED|Overall Study||1
63368|NCT01745952|150474|P1|NOT COMPLETED|Overall Study||1
63369|NCT01745952|150472|P3|COMPLETED|Overall Study||3
63370|NCT01745952|150473|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
63371|NCT01745952|150474|P1|COMPLETED|Overall Study||3
63372|NCT01745952|150472|P3|STARTED|Overall Study||3
63373|NCT01745952|150473|P2|STARTED|Overall Study||4
63374|NCT01745952|150474|P1|STARTED|Overall Study||4
63375|NCT01745913|150500|P2|NOT COMPLETED|Overall Study||1
63376|NCT01745913|150501|P1|NOT COMPLETED|Overall Study||1
63377|NCT01745913|150500|P2|COMPLETED|Overall Study||0
63378|NCT01745913|150501|P1|COMPLETED|Overall Study||0
63379|NCT01745913|150500|P2|STARTED|Overall Study||1
63380|NCT01745913|150501|P1|STARTED|Overall Study||1
63381|NCT01745848|150509|P1|NOT COMPLETED|Overall Study||6
63382|NCT01745848|150509|P1|COMPLETED|Overall Study||20
63383|NCT01745848|150509|P1|STARTED|Overall Study||26
63384|NCT01745380|150516|P2|NOT COMPLETED|Overall Study||1
63385|NCT01745380|150517|P1|NOT COMPLETED|Overall Study||1
63386|NCT01745380|150516|P2|COMPLETED|Overall Study||49
63387|NCT01745380|150517|P1|COMPLETED|Overall Study||99
63388|NCT01745380|150516|P2|STARTED|Overall Study||50
63389|NCT01745380|150517|P1|STARTED|Overall Study||100
63390|NCT01745133|150556|P3|NOT COMPLETED|Overall Study||4
63391|NCT01745133|150557|P2|NOT COMPLETED|Overall Study||4
63392|NCT01745133|150558|P1|NOT COMPLETED|Overall Study||6
63393|NCT01745133|150556|P3|COMPLETED|Overall Study||15
63394|NCT01745133|150557|P2|COMPLETED|Overall Study||16
63395|NCT01745133|150558|P1|COMPLETED|Overall Study||13
63396|NCT01745133|150556|P3|STARTED|Overall Study||19
63397|NCT01745133|150557|P2|STARTED|Overall Study||20
63398|NCT01745133|150558|P1|STARTED|Overall Study||19
63399|NCT01745094|150570|P4|NOT COMPLETED|Overall Study||3
63400|NCT01745094|150571|P3|NOT COMPLETED|Overall Study||12
63401|NCT01745094|150572|P2|NOT COMPLETED|Overall Study||0
63402|NCT01745094|150573|P1|NOT COMPLETED|Overall Study||5
63403|NCT01745094|150570|P4|COMPLETED|Overall Study||90
63404|NCT01745094|150571|P3|COMPLETED|Overall Study||46
63405|NCT01745094|150572|P2|COMPLETED|Overall Study||37
63406|NCT01745094|150573|P1|COMPLETED|Overall Study||30
63407|NCT01745094|150570|P4|STARTED|Overall Study||93
63408|NCT01745094|150571|P3|STARTED|Overall Study||58
63409|NCT01745094|150572|P2|STARTED|Overall Study||37
63410|NCT01745094|150573|P1|STARTED|Overall Study||35
63411|NCT01745055|150639|P1|NOT COMPLETED|Overall Study||0
63412|NCT01745055|150639|P1|COMPLETED|Overall Study||12
63413|NCT01745055|150639|P1|STARTED|Overall Study||12
63414|NCT01744977|150674|P2|NOT COMPLETED|Overall Study||5
63415|NCT01744977|150675|P1|NOT COMPLETED|Overall Study||11
63416|NCT01744977|150674|P2|COMPLETED|Overall Study||115
63417|NCT01744977|150675|P1|COMPLETED|Overall Study||109
63418|NCT01744977|150674|P2|6 Month Completed|Overall Study||115
63419|NCT01744977|150675|P1|6 Month Completed|Overall Study||113
63420|NCT01744977|150674|P2|STARTED|Overall Study||120
63421|NCT01744977|150675|P1|STARTED|Overall Study||120
63422|NCT01744860|150683|P1|NOT COMPLETED|Overall Study||0
63423|NCT01744860|150683|P1|COMPLETED|Overall Study||420
63424|NCT01744860|150683|P1|STARTED|Overall Study||420
63425|NCT01744821|150721|P4|NOT COMPLETED|Overall Study||0
63426|NCT01744821|150722|P3|NOT COMPLETED|Overall Study||0
63427|NCT01744821|150723|P2|NOT COMPLETED|Overall Study||0
63428|NCT01744821|150724|P1|NOT COMPLETED|Overall Study||0
63429|NCT01744821|150721|P4|COMPLETED|Overall Study||1
63430|NCT01744821|150722|P3|COMPLETED|Overall Study||2
63431|NCT01744821|150723|P2|COMPLETED|Overall Study||3
63432|NCT01744821|150724|P1|COMPLETED|Overall Study||1
63433|NCT01744821|150721|P4|STARTED|Overall Study||1
63434|NCT01744821|150722|P3|STARTED|Overall Study||2
63435|NCT01744821|150723|P2|STARTED|Overall Study||3
63436|NCT01744821|150724|P1|STARTED|Overall Study||1
63437|NCT01744782|150746|P1|NOT COMPLETED|Overall Study||1
63438|NCT01744782|150746|P1|COMPLETED|Overall Study||16
63439|NCT01744782|150746|P1|STARTED|Overall Study||17
63440|NCT01744730|150759|P5|NOT COMPLETED|Overall Study||0
63441|NCT01744730|150760|P4|NOT COMPLETED|Overall Study||0
63442|NCT01744730|150761|P3|NOT COMPLETED|Overall Study||0
63443|NCT01744730|150762|P2|NOT COMPLETED|Overall Study||0
63444|NCT01744730|150763|P1|NOT COMPLETED|Overall Study||0
63445|NCT01744730|150759|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
63446|NCT01744730|150760|P4|COMPLETED|Overall Study||11
63447|NCT01744730|150761|P3|COMPLETED|Overall Study||4
63448|NCT01744730|150762|P2|COMPLETED|Overall Study||3
63449|NCT01744730|150763|P1|COMPLETED|Overall Study||4
63450|NCT01744730|150759|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
63451|NCT01744730|150760|P4|STARTED|Overall Study||11
63452|NCT01744730|150761|P3|STARTED|Overall Study||4
63453|NCT01744730|150762|P2|STARTED|Overall Study||3
63454|NCT01744730|150763|P1|STARTED|Overall Study||4
63455|NCT01744691|150806|P1|NOT COMPLETED|Overall Study||43
63456|NCT01744691|150806|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
63457|NCT01744691|150806|P1|STARTED|Overall Study|Participants who received study treatment|144
63458|NCT01744496|150813|P2|NOT COMPLETED|Maintenance Period||4
63459|NCT01744496|150814|P1|NOT COMPLETED|Maintenance Period||4
63460|NCT01744496|150813|P2|COMPLETED|Maintenance Period||29
63461|NCT01744496|150814|P1|COMPLETED|Maintenance Period||27
63462|NCT01744496|150813|P2|STARTED|Maintenance Period||33
63463|NCT01744496|150814|P1|STARTED|Maintenance Period||31
63464|NCT01744496|150813|P2|NOT COMPLETED|Titration Period||2
63465|NCT01744496|150814|P1|NOT COMPLETED|Titration Period||2
63466|NCT01744496|150813|P2|COMPLETED|Titration Period||33
63467|NCT01744496|150814|P1|COMPLETED|Titration Period||31
63468|NCT01744496|150813|P2|STARTED|Titration Period||35
63469|NCT01744496|150814|P1|STARTED|Titration Period||33
63470|NCT01744483|150835|P3|NOT COMPLETED|Overall Study||28
63471|NCT01744483|150836|P2|NOT COMPLETED|Overall Study||22
63472|NCT01744483|150837|P1|NOT COMPLETED|Overall Study||29
63473|NCT01744483|150835|P3|COMPLETED|Overall Study||10
63474|NCT01744483|150836|P2|COMPLETED|Overall Study||13
63475|NCT01744483|150837|P1|COMPLETED|Overall Study||15
63476|NCT01744483|150835|P3|STARTED|Overall Study||38
63477|NCT01744483|150836|P2|STARTED|Overall Study||35
63478|NCT01744483|150837|P1|STARTED|Overall Study||44
63479|NCT01744392|150845|P1|NOT COMPLETED|Overall Study||1
63480|NCT01744392|150845|P1|COMPLETED|Overall Study||22
63481|NCT01744392|150845|P1|STARTED|Overall Study||23
63482|NCT01744353|150861|P3|NOT COMPLETED|Overall Study||0
63483|NCT01744353|150862|P2|NOT COMPLETED|Overall Study||0
63484|NCT01744353|150863|P1|NOT COMPLETED|Overall Study||0
63485|NCT01744353|150861|P3|COMPLETED|Overall Study||3
63486|NCT01744353|150862|P2|COMPLETED|Overall Study||26
63487|NCT01744353|150863|P1|COMPLETED|Overall Study||6
63488|NCT01744353|150861|P3|STARTED|Overall Study||3
63489|NCT01744353|150862|P2|STARTED|Overall Study||26
63490|NCT01744353|150863|P1|STARTED|Overall Study||6
63491|NCT01744340|150874|P2|NOT COMPLETED|Overall Study||0
63492|NCT01744340|150875|P1|NOT COMPLETED|Overall Study||0
63493|NCT01744340|150874|P2|COMPLETED|Overall Study||15
63494|NCT01744340|150875|P1|COMPLETED|Overall Study||8
63495|NCT01744340|150874|P2|STARTED|Overall Study||15
63496|NCT01744340|150875|P1|STARTED|Overall Study||8
63497|NCT01744197|150885|P2|NOT COMPLETED|Overall Study||3
63498|NCT01744197|150886|P1|NOT COMPLETED|Overall Study||4
63499|NCT01744197|150885|P2|COMPLETED|Overall Study||26
63500|NCT01744197|150886|P1|COMPLETED|Overall Study||28
63501|NCT01744197|150885|P2|STARTED|Overall Study||29
63502|NCT01744197|150886|P1|STARTED|Overall Study||32
63503|NCT01743963|150898|P2|NOT COMPLETED|Overall Study||0
63504|NCT01743963|150899|P1|NOT COMPLETED|Overall Study||0
63505|NCT01743963|150898|P2|COMPLETED|Overall Study||17
63506|NCT01743963|150899|P1|COMPLETED|Overall Study||21
63507|NCT01743963|150898|P2|STARTED|Overall Study||17
63508|NCT01743963|150899|P1|STARTED|Overall Study||21
63509|NCT01743729|150907|P2|NOT COMPLETED|Overall Study||12
63510|NCT01743729|150908|P1|NOT COMPLETED|Overall Study||37
63511|NCT01743729|150907|P2|COMPLETED|Overall Study||348
63512|NCT01743729|150908|P1|COMPLETED|Overall Study||321
63513|NCT01743729|150907|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
63514|NCT01743729|150908|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
63515|NCT01743521|150920|P4|NOT COMPLETED|Overall Study||0
63516|NCT01743521|150921|P3|NOT COMPLETED|Overall Study||0
63517|NCT01743521|150922|P2|NOT COMPLETED|Overall Study||0
63518|NCT01743521|150923|P1|NOT COMPLETED|Overall Study||0
63519|NCT01743521|150920|P4|COMPLETED|Overall Study||2
63520|NCT01743521|150921|P3|COMPLETED|Overall Study||2
63521|NCT01743521|150922|P2|COMPLETED|Overall Study||3
63522|NCT01743521|150923|P1|COMPLETED|Overall Study||7
63523|NCT01743521|150920|P4|STARTED|Overall Study||2
63524|NCT01743521|150921|P3|STARTED|Overall Study||2
63525|NCT01743521|150922|P2|STARTED|Overall Study||3
63526|NCT01743521|150923|P1|STARTED|Overall Study||7
63527|NCT01743469|150977|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
63528|NCT01743469|150978|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
63529|NCT01743469|150979|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
63530|NCT01743469|150980|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
63531|NCT01743469|150977|P4|COMPLETED|Follow-up Period - Post-Treatment||5
63532|NCT01743469|150978|P3|COMPLETED|Follow-up Period - Post-Treatment||14
63533|NCT01743469|150979|P2|COMPLETED|Follow-up Period - Post-Treatment||5
63534|NCT01743469|150980|P1|COMPLETED|Follow-up Period - Post-Treatment||6
63535|NCT01743469|150977|P4|STARTED|Follow-up Period - Post-Treatment||21
63536|NCT01743469|150978|P3|STARTED|Follow-up Period - Post-Treatment||37
63537|NCT01743469|150979|P2|STARTED|Follow-up Period - Post-Treatment||53
63538|NCT01743469|150980|P1|STARTED|Follow-up Period - Post-Treatment||51
63539|NCT01743469|150977|P4|NOT COMPLETED|Active Treatment Phase||21
63540|NCT01743469|150978|P3|NOT COMPLETED|Active Treatment Phase||38
63541|NCT01743469|150979|P2|NOT COMPLETED|Active Treatment Phase||55
63542|NCT01743469|150980|P1|NOT COMPLETED|Active Treatment Phase||53
63543|NCT01743469|150977|P4|COMPLETED|Active Treatment Phase||0
63544|NCT01743469|150978|P3|COMPLETED|Active Treatment Phase||0
63545|NCT01743469|150979|P2|COMPLETED|Active Treatment Phase||0
63546|NCT01743469|150980|P1|COMPLETED|Active Treatment Phase||0
63547|NCT01743469|150977|P4|STARTED|Active Treatment Phase||21
63548|NCT01743469|150978|P3|STARTED|Active Treatment Phase||38
63549|NCT01743469|150979|P2|STARTED|Active Treatment Phase||55
63550|NCT01743469|150980|P1|STARTED|Active Treatment Phase||53
63551|NCT01743092|151020|P2|NOT COMPLETED|Overall Study||15
63552|NCT01743092|151021|P1|NOT COMPLETED|Overall Study||14
63553|NCT01743092|151020|P2|COMPLETED|Overall Study||11
63554|NCT01743092|151021|P1|COMPLETED|Overall Study||19
63555|NCT01743092|151020|P2|STARTED|Overall Study||26
63556|NCT01743092|151021|P1|STARTED|Overall Study||33
63557|NCT01743027|151033|P4|NOT COMPLETED|Overall Study||1
63558|NCT01743027|151034|P3|NOT COMPLETED|Overall Study||9
63559|NCT01743027|151035|P2|NOT COMPLETED|Overall Study||5
63560|NCT01743027|151036|P1|NOT COMPLETED|Overall Study||5
63561|NCT01743027|151033|P4|COMPLETED|Overall Study||48
63562|NCT01743027|151034|P3|COMPLETED|Overall Study||90
63563|NCT01743027|151035|P2|COMPLETED|Overall Study||94
63564|NCT01743027|151036|P1|COMPLETED|Overall Study||93
63565|NCT01743027|151033|P4|STARTED|Overall Study||49
63566|NCT01743027|151034|P3|STARTED|Overall Study||99
63567|NCT01743027|151035|P2|STARTED|Overall Study||99
63568|NCT01743027|151036|P1|STARTED|Overall Study||98
63569|NCT01743001|151076|P2|NOT COMPLETED|Overall Study||0
63570|NCT01743001|151077|P1|NOT COMPLETED|Overall Study||3
63571|NCT01743001|151076|P2|COMPLETED|Overall Study||112
63572|NCT01743001|151077|P1|COMPLETED|Overall Study||111
63573|NCT01743001|151076|P2|STARTED|Overall Study||112
63574|NCT01743001|151077|P1|STARTED|Overall Study||114
63575|NCT01742936|151091|P2|NOT COMPLETED|Overall Study||0
63576|NCT01742936|151092|P1|NOT COMPLETED|Overall Study||0
63577|NCT01742936|151091|P2|COMPLETED|Overall Study||50
63578|NCT01742936|151092|P1|COMPLETED|Overall Study||50
63579|NCT01742936|151091|P2|STARTED|Overall Study||50
63580|NCT01742936|151092|P1|STARTED|Overall Study||50
63581|NCT01742897|151100|P1|NOT COMPLETED|Overall Study||5
63582|NCT01742897|151100|P1|COMPLETED|Overall Study||30
63583|NCT01742897|151100|P1|Treated|Overall Study||33
63584|NCT01742897|151100|P1|STARTED|Overall Study||35
63585|NCT01742832|151106|P2|NOT COMPLETED|Overall Study||5
63586|NCT01742832|151107|P1|NOT COMPLETED|Overall Study||1
63587|NCT01742832|151106|P2|COMPLETED|Overall Study||23
63588|NCT01742832|151107|P1|COMPLETED|Overall Study||19
63589|NCT01742832|151106|P2|STARTED|Overall Study||28
63590|NCT01742832|151107|P1|STARTED|Overall Study||20
63591|NCT01742364|151117|P4|NOT COMPLETED|Overall Study||0
63592|NCT01742364|151118|P3|NOT COMPLETED|Overall Study||0
63593|NCT01742364|151119|P2|NOT COMPLETED|Overall Study||0
63594|NCT01742364|151120|P1|NOT COMPLETED|Overall Study||0
63595|NCT01742364|151117|P4|COMPLETED|Overall Study||15
63596|NCT01742364|151118|P3|COMPLETED|Overall Study||15
63597|NCT01742364|151119|P2|COMPLETED|Overall Study||33
63598|NCT01742364|151120|P1|COMPLETED|Overall Study||33
63599|NCT01742364|151117|P4|STARTED|Overall Study||15
63600|NCT01742364|151118|P3|STARTED|Overall Study||15
63601|NCT01742364|151119|P2|STARTED|Overall Study||33
63602|NCT01742364|151120|P1|STARTED|Overall Study||33
63603|NCT01741792|151149|P3|NOT COMPLETED|Overall Study||12
63604|NCT01741792|151150|P2|NOT COMPLETED|Overall Study||1
63605|NCT01741792|151151|P1|NOT COMPLETED|Overall Study||6
63606|NCT01741792|151149|P3|COMPLETED|Overall Study||2
63607|NCT01741792|151150|P2|COMPLETED|Overall Study||1
63608|NCT01741792|151151|P1|COMPLETED|Overall Study||3
63609|NCT01741792|151149|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
63610|NCT01741792|151150|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
63611|NCT01741792|151151|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
63612|NCT01741792|151149|P3|STARTED|Overall Study||14
63613|NCT01741792|151150|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
63614|NCT01741792|151151|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
63615|NCT01741701|151218|P2|NOT COMPLETED|Overall Study||2
63616|NCT01741701|151219|P1|NOT COMPLETED|Overall Study||5
63617|NCT01741701|151218|P2|COMPLETED|Overall Study||13
63618|NCT01741701|151219|P1|COMPLETED|Overall Study||13
63619|NCT01741701|151218|P2|STARTED|Overall Study||15
63620|NCT01741701|151219|P1|STARTED|Overall Study||18
63621|NCT01741688|151235|P1|NOT COMPLETED|Overall Study||3
63622|NCT01741688|151235|P1|COMPLETED|Overall Study||13
63623|NCT01741688|151235|P1|STARTED|Overall Study||16
63624|NCT01741350|151254|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
63625|NCT01741350|151255|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
63626|NCT01741350|151254|P2|COMPLETED|12-Month Follow-up Assessment||109
63627|NCT01741350|151255|P1|COMPLETED|12-Month Follow-up Assessment||111
63628|NCT01741350|151254|P2|STARTED|12-Month Follow-up Assessment||111
63629|NCT01741350|151255|P1|STARTED|12-Month Follow-up Assessment||114
63630|NCT01741350|151254|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
63631|NCT01741350|151255|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
63632|NCT01741350|151254|P2|COMPLETED|6-Month Follow-up Assessment||111
63633|NCT01741350|151255|P1|COMPLETED|6-Month Follow-up Assessment||114
63634|NCT01741350|151254|P2|STARTED|6-Month Follow-up Assessment||119
63635|NCT01741350|151255|P1|STARTED|6-Month Follow-up Assessment||129
63636|NCT01741350|151254|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
63637|NCT01741350|151255|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
63638|NCT01741350|151254|P2|COMPLETED|3-Month Follow-up Assessment||119
63639|NCT01741350|151255|P1|COMPLETED|3-Month Follow-up Assessment||129
63640|NCT01741350|151254|P2|STARTED|3-Month Follow-up Assessment||141
63641|NCT01741350|151255|P1|STARTED|3-Month Follow-up Assessment||135
63642|NCT01741350|151254|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
63643|NCT01741350|151255|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
63644|NCT01741350|151254|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
63645|NCT01741350|151255|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
63646|NCT01741350|151254|P2|STARTED|Post Intervention Assessment (at Week 4)||155
63647|NCT01741350|151255|P1|STARTED|Post Intervention Assessment (at Week 4)||149
63648|NCT01741350|151254|P2|NOT COMPLETED|Study Intervention||0
63649|NCT01741350|151255|P1|NOT COMPLETED|Study Intervention||0
63650|NCT01741350|151254|P2|COMPLETED|Study Intervention||155
63651|NCT01741350|151255|P1|COMPLETED|Study Intervention||149
63652|NCT01741350|151254|P2|STARTED|Study Intervention||155
63653|NCT01741350|151255|P1|STARTED|Study Intervention||149
63654|NCT01741272|151391|P2|NOT COMPLETED|Overall Study||0
63655|NCT01741272|151392|P1|NOT COMPLETED|Overall Study||0
63656|NCT01741272|151391|P2|COMPLETED|Overall Study||97
63657|NCT01741272|151392|P1|COMPLETED|Overall Study||92
63658|NCT01741272|151391|P2|STARTED|Overall Study||97
63659|NCT01741272|151392|P1|STARTED|Overall Study||92
63660|NCT01741259|151408|P2|NOT COMPLETED|Overall Study||6
63661|NCT01741259|151409|P1|NOT COMPLETED|Overall Study||6
63662|NCT01741259|151408|P2|COMPLETED|Overall Study||129
63663|NCT01741259|151409|P1|COMPLETED|Overall Study||127
63664|NCT01741259|151408|P2|STARTED|Overall Study||135
63665|NCT01741259|151409|P1|STARTED|Overall Study||133
63666|NCT01740817|151463|P2|NOT COMPLETED|Second Intervention (48 h)||0
63667|NCT01740817|151464|P1|NOT COMPLETED|Second Intervention (48 h)||0
63668|NCT01740817|151463|P2|COMPLETED|Second Intervention (48 h)||4
63669|NCT01740817|151464|P1|COMPLETED|Second Intervention (48 h)||8
63670|NCT01740817|151463|P2|STARTED|Second Intervention (48 h)||4
63671|NCT01740817|151464|P1|STARTED|Second Intervention (48 h)||8
63672|NCT01740817|151463|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
63673|NCT01740817|151464|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
63674|NCT01740817|151463|P2|COMPLETED|Washout (4-6 Weeks)||4
63675|NCT01740817|151464|P1|COMPLETED|Washout (4-6 Weeks)||8
63676|NCT01740817|151463|P2|STARTED|Washout (4-6 Weeks)||4
63677|NCT01740817|151464|P1|STARTED|Washout (4-6 Weeks)||8
63678|NCT01740817|151463|P2|NOT COMPLETED|First Intervention (48 h)||0
63679|NCT01740817|151464|P1|NOT COMPLETED|First Intervention (48 h)||0
63680|NCT01740817|151463|P2|COMPLETED|First Intervention (48 h)||4
63681|NCT01740817|151464|P1|COMPLETED|First Intervention (48 h)||8
63682|NCT01740817|151463|P2|STARTED|First Intervention (48 h)||4
63683|NCT01740817|151464|P1|STARTED|First Intervention (48 h)||8
63684|NCT01740726|151476|P2|NOT COMPLETED|Overall Study||0
63685|NCT01740726|151477|P1|NOT COMPLETED|Overall Study||0
63686|NCT01740726|151476|P2|COMPLETED|Overall Study||1
63687|NCT01740726|151477|P1|COMPLETED|Overall Study||0
63688|NCT01740726|151476|P2|STARTED|Overall Study||1
63689|NCT01740726|151477|P1|STARTED|Overall Study||0
63690|NCT01740713|151502|P3|NOT COMPLETED|Overall Study||1
63691|NCT01740713|151503|P2|NOT COMPLETED|Overall Study||2
63692|NCT01740713|151504|P1|NOT COMPLETED|Overall Study||0
63693|NCT01740713|151502|P3|COMPLETED|Overall Study||6
63694|NCT01740713|151503|P2|COMPLETED|Overall Study||6
63695|NCT01740713|151504|P1|COMPLETED|Overall Study||6
63696|NCT01740713|151502|P3|STARTED|Overall Study||7
63697|NCT01740713|151503|P2|STARTED|Overall Study||8
63698|NCT01740713|151504|P1|STARTED|Overall Study||6
63699|NCT01740440|151528|P1|NOT COMPLETED|Overall Study||3
63700|NCT01740440|151528|P1|COMPLETED|Overall Study||27
63701|NCT01740440|151528|P1|STARTED|Overall Study||30
63702|NCT01740427|151536|P2|NOT COMPLETED|Overall Study||222
63703|NCT01740427|151537|P1|NOT COMPLETED|Overall Study||444
63704|NCT01740427|151536|P2|COMPLETED|Overall Study||0
63705|NCT01740427|151537|P1|COMPLETED|Overall Study||0
63706|NCT01740427|151536|P2|STARTED|Overall Study||222
63707|NCT01740427|151537|P1|STARTED|Overall Study||444
63708|NCT01740414|151566|P2|NOT COMPLETED|Overall Study||8
63709|NCT01740414|151567|P1|NOT COMPLETED|Overall Study||9
63710|NCT01740414|151566|P2|COMPLETED|Overall Study||8
63711|NCT01740414|151567|P1|COMPLETED|Overall Study||3
63712|NCT01740414|151566|P2|STARTED|Overall Study||16
63713|NCT01740414|151567|P1|STARTED|Overall Study||12
63714|NCT01740401|151589|P1|NOT COMPLETED|Overall Study||10
63715|NCT01740401|151589|P1|COMPLETED|Overall Study||0
63716|NCT01740401|151589|P1|STARTED|Overall Study||10
63717|NCT01740388|151598|P2|NOT COMPLETED|Overall Study||44
63718|NCT01740388|151599|P1|NOT COMPLETED|Overall Study||46
63719|NCT01740388|151598|P2|COMPLETED|Overall Study||28
63720|NCT01740388|151599|P1|COMPLETED|Overall Study||18
63721|NCT01740388|151598|P2|STARTED|Overall Study||72
63722|NCT01740388|151599|P1|STARTED|Overall Study||64
63723|NCT01740362|151619|P4|NOT COMPLETED|Overall Study||0
63724|NCT01740362|151620|P3|NOT COMPLETED|Overall Study||0
63725|NCT01740362|151621|P2|NOT COMPLETED|Overall Study||0
63726|NCT01740362|151622|P1|NOT COMPLETED|Overall Study||0
63727|NCT01740362|151619|P4|COMPLETED|Overall Study||6
63728|NCT01740362|151620|P3|COMPLETED|Overall Study||6
63729|NCT01740362|151621|P2|COMPLETED|Overall Study||6
63730|NCT01740362|151622|P1|COMPLETED|Overall Study||6
63731|NCT01740362|151619|P4|STARTED|Overall Study||6
63732|NCT01740362|151620|P3|STARTED|Overall Study||6
63733|NCT01740362|151621|P2|STARTED|Overall Study||6
63734|NCT01740362|151622|P1|STARTED|Overall Study||6
63735|NCT01740297|151651|P3|NOT COMPLETED|Overall Study||98
63736|NCT01740297|151652|P2|NOT COMPLETED|Overall Study||100
63737|NCT01740297|151653|P1|NOT COMPLETED|Overall Study||19
63738|NCT01740297|151651|P3|COMPLETED|Overall Study||0
63739|NCT01740297|151652|P2|COMPLETED|Overall Study||0
63740|NCT01740297|151653|P1|COMPLETED|Overall Study||0
63741|NCT01740297|151651|P3|Received Ipilimumab|Overall Study||92
63742|NCT01740297|151652|P2|Received Ipilimumab|Overall Study||95
63743|NCT01740297|151653|P1|Received Ipilimumab|Overall Study||18
63744|NCT01740297|151651|P3|Received Talimogene Laherparepvec|Overall Study||95
63745|NCT01740297|151652|P2|Received Talimogene Laherparepvec|Overall Study||0
63746|NCT01740297|151653|P1|Received Talimogene Laherparepvec|Overall Study||19
63747|NCT01740297|151651|P3|STARTED|Overall Study||98
63748|NCT01740297|151652|P2|STARTED|Overall Study||100
63749|NCT01740297|151653|P1|STARTED|Overall Study||19
63750|NCT01740206|151685|P2|NOT COMPLETED|Overall Study||0
63751|NCT01740206|151686|P1|NOT COMPLETED|Overall Study||0
63752|NCT01740206|151685|P2|COMPLETED|Overall Study||34
63753|NCT01740206|151686|P1|COMPLETED|Overall Study||14
63754|NCT01740206|151685|P2|STARTED|Overall Study||34
63755|NCT01740206|151686|P1|STARTED|Overall Study||14
63756|NCT01740128|151704|P2|NOT COMPLETED|Overall Study||7
63757|NCT01740128|151705|P1|NOT COMPLETED|Overall Study||6
63758|NCT01740128|151704|P2|COMPLETED|Overall Study||4
63759|NCT01740128|151705|P1|COMPLETED|Overall Study||4
63760|NCT01740128|151704|P2|STARTED|Overall Study||11
63761|NCT01740128|151705|P1|STARTED|Overall Study||10
63762|NCT01740089|151734|P3|NOT COMPLETED|After 12 Weeks||11
63763|NCT01740089|151735|P2|NOT COMPLETED|After 12 Weeks||3
63764|NCT01740089|151736|P1|NOT COMPLETED|After 12 Weeks||7
63765|NCT01740089|151734|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
63766|NCT01740089|151735|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
63767|NCT01740089|151736|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
63768|NCT01740089|151734|P3|STARTED|After 12 Weeks||48
63769|NCT01740089|151735|P2|STARTED|After 12 Weeks||48
63770|NCT01740089|151736|P1|STARTED|After 12 Weeks||50
63771|NCT01740089|151734|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
63772|NCT01740089|151735|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
63773|NCT01740089|151736|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
63774|NCT01740089|151734|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
63775|NCT01740089|151735|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
63776|NCT01740089|151736|P1|COMPLETED|First 12 Weeks of Treatment||50
63777|NCT01740089|151734|P3|STARTED|First 12 Weeks of Treatment||50
63778|NCT01740089|151735|P2|STARTED|First 12 Weeks of Treatment||50
63779|NCT01740089|151736|P1|STARTED|First 12 Weeks of Treatment||50
63780|NCT01739803|151754|P2|NOT COMPLETED|Overall Study||6
63781|NCT01739803|151755|P1|NOT COMPLETED|Overall Study||9
63782|NCT01739803|151754|P2|COMPLETED|Overall Study||68
63783|NCT01739803|151755|P1|COMPLETED|Overall Study||67
63784|NCT01739803|151754|P2|STARTED|Overall Study||74
63785|NCT01739803|151755|P1|STARTED|Overall Study||76
63786|NCT01739790|151767|P2|NOT COMPLETED|Overall Study||4
63787|NCT01739790|151768|P1|NOT COMPLETED|Overall Study||2
63788|NCT01739790|151767|P2|COMPLETED|Overall Study||23
63789|NCT01739790|151768|P1|COMPLETED|Overall Study||22
63790|NCT01739790|151767|P2|STARTED|Overall Study||27
63791|NCT01739790|151768|P1|STARTED|Overall Study||24
63792|NCT01739595|151777|P3|NOT COMPLETED|Overall Study||2
63793|NCT01739595|151778|P2|NOT COMPLETED|Overall Study||1
63794|NCT01739595|151779|P1|NOT COMPLETED|Overall Study||13
63795|NCT01739595|151777|P3|COMPLETED|Overall Study||45
63796|NCT01739595|151778|P2|COMPLETED|Overall Study||21
63797|NCT01739595|151779|P1|COMPLETED|Overall Study||99
63798|NCT01739595|151777|P3|STARTED|Overall Study||47
63799|NCT01739595|151778|P2|STARTED|Overall Study||22
63800|NCT01739595|151779|P1|STARTED|Overall Study||112
63801|NCT01739361|151789|P2|NOT COMPLETED|Overall Study||1
63802|NCT01739361|151790|P1|NOT COMPLETED|Overall Study||3
63803|NCT01739361|151789|P2|COMPLETED|Overall Study||22
63804|NCT01739361|151790|P1|COMPLETED|Overall Study||18
63805|NCT01739361|151789|P2|STARTED|Overall Study||23
63806|NCT01739361|151790|P1|STARTED|Overall Study||21
63807|NCT01739348|151804|P4|NOT COMPLETED|Part II (Extension Study)||396
63808|NCT01739348|151805|P3|NOT COMPLETED|Part II (Extension Study)||61
63809|NCT01739348|151806|P2|NOT COMPLETED|Part II (Extension Study)||366
63810|NCT01739348|151807|P1|NOT COMPLETED|Part II (Extension Study)||379
63811|NCT01739348|151804|P4|COMPLETED|Part II (Extension Study)||0
63812|NCT01739348|151805|P3|COMPLETED|Part II (Extension Study)||0
63813|NCT01739348|151806|P2|COMPLETED|Part II (Extension Study)||0
63814|NCT01739348|151807|P1|COMPLETED|Part II (Extension Study)||0
63815|NCT01739348|151804|P4|Treated|Part II (Extension Study)||394
63816|NCT01739348|151805|P3|Treated|Part II (Extension Study)||61
63817|NCT01739348|151806|P2|Treated|Part II (Extension Study)||365
63818|NCT01739348|151807|P1|Treated|Part II (Extension Study)||379
63819|NCT01739348|151804|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
63820|NCT01739348|151805|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
63821|NCT01739348|151806|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
63822|NCT01739348|151807|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
63823|NCT01739348|151804|P4|NOT COMPLETED|Part I (Base Study)||189
63824|NCT01739348|151805|P3|NOT COMPLETED|Part I (Base Study)||26
63825|NCT01739348|151806|P2|NOT COMPLETED|Part I (Base Study)||203
63826|NCT01739348|151807|P1|NOT COMPLETED|Part I (Base Study)||202
63827|NCT01739348|151804|P4|COMPLETED|Part I (Base Study)||516
63828|NCT01739348|151805|P3|COMPLETED|Part I (Base Study)||77
63829|NCT01739348|151806|P2|COMPLETED|Part I (Base Study)||497
63830|NCT01739348|151807|P1|COMPLETED|Part I (Base Study)||501
63831|NCT01739348|151804|P4|Treated|Part I (Base Study)||705
63832|NCT01739348|151805|P3|Treated|Part I (Base Study)||103
63833|NCT01739348|151806|P2|Treated|Part I (Base Study)||700
63834|NCT01739348|151807|P1|Treated|Part I (Base Study)||702
63835|NCT01739348|151804|P4|STARTED|Part I (Base Study)||705
63836|NCT01739348|151805|P3|STARTED|Part I (Base Study)||103
63837|NCT01739348|151806|P2|STARTED|Part I (Base Study)||700
63838|NCT01739348|151807|P1|STARTED|Part I (Base Study)||703
63839|NCT01739335|151879|P2|NOT COMPLETED|Overall Study||5
63840|NCT01739335|151880|P1|NOT COMPLETED|Overall Study||7
63841|NCT01739335|151879|P2|COMPLETED|Overall Study||35
63842|NCT01739335|151880|P1|COMPLETED|Overall Study||34
63843|NCT01739335|151879|P2|STARTED|Overall Study||40
63844|NCT01739335|151880|P1|STARTED|Overall Study||41
63845|NCT01738984|151914|P2|NOT COMPLETED|Overall Study||39
63846|NCT01738984|151915|P1|NOT COMPLETED|Overall Study||64
63847|NCT01738984|151914|P2|COMPLETED|Overall Study||210
63848|NCT01738984|151915|P1|COMPLETED|Overall Study||186
63849|NCT01738984|151914|P2|STARTED|Overall Study||249
63850|NCT01738984|151915|P1|STARTED|Overall Study||250
63851|NCT01738971|151928|P3|NOT COMPLETED|Overall Study||17
63852|NCT01738971|151929|P2|NOT COMPLETED|Overall Study||30
63853|NCT01738971|151930|P1|NOT COMPLETED|Overall Study||19
63854|NCT01738971|151928|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
63855|NCT01738971|151929|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
63856|NCT01738971|151930|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
63857|NCT01738971|151928|P3|STARTED|Overall Study|56 participants recruited to this arm|56
63858|NCT01738971|151929|P2|STARTED|Overall Study|58 participants recruited to this arm|58
63859|NCT01738971|151930|P1|STARTED|Overall Study|54 participants recruited to this arm|54
63860|NCT01738919|151946|P2|NOT COMPLETED|Overall Study||3
63861|NCT01738919|151947|P1|NOT COMPLETED|Overall Study||1
63862|NCT01738919|151946|P2|COMPLETED|Overall Study||14
63863|NCT01738919|151947|P1|COMPLETED|Overall Study||14
63864|NCT01738919|151946|P2|STARTED|Overall Study||17
63865|NCT01738919|151947|P1|STARTED|Overall Study||15
63866|NCT01738750|151965|P2|NOT COMPLETED|Overall Study||0
63867|NCT01738750|151966|P1|NOT COMPLETED|Overall Study||0
63868|NCT01738750|151965|P2|COMPLETED|Overall Study||51
63869|NCT01738750|151966|P1|COMPLETED|Overall Study||49
63870|NCT01738750|151965|P2|STARTED|Overall Study||51
63871|NCT01738750|151966|P1|STARTED|Overall Study||49
63872|NCT01738737|151979|P5|NOT COMPLETED|Overall Study||4
63873|NCT01738737|151980|P4|NOT COMPLETED|Overall Study||4
63874|NCT01738737|151981|P3|NOT COMPLETED|Overall Study||4
63875|NCT01738737|151982|P2|NOT COMPLETED|Overall Study||4
63876|NCT01738737|151983|P1|NOT COMPLETED|Overall Study||4
63877|NCT01738737|151979|P5|COMPLETED|Overall Study||25
63878|NCT01738737|151980|P4|COMPLETED|Overall Study||25
63879|NCT01738737|151981|P3|COMPLETED|Overall Study||25
63880|NCT01738737|151982|P2|COMPLETED|Overall Study||25
63881|NCT01738737|151983|P1|COMPLETED|Overall Study||25
63882|NCT01738737|151979|P5|STARTED|Overall Study||29
63883|NCT01738737|151980|P4|STARTED|Overall Study||29
63884|NCT01738737|151981|P3|STARTED|Overall Study||29
63885|NCT01738737|151982|P2|STARTED|Overall Study||29
63886|NCT01738737|151983|P1|STARTED|Overall Study||29
63887|NCT01738698|152019|P4|NOT COMPLETED|Overall Study||0
63888|NCT01738698|152020|P3|NOT COMPLETED|Overall Study||0
63889|NCT01738698|152021|P2|NOT COMPLETED|Overall Study||0
63890|NCT01738698|152022|P1|NOT COMPLETED|Overall Study||0
63891|NCT01738698|152019|P4|COMPLETED|Overall Study||0
63892|NCT01738698|152020|P3|COMPLETED|Overall Study||0
63893|NCT01738698|152021|P2|COMPLETED|Overall Study||0
63894|NCT01738698|152022|P1|COMPLETED|Overall Study||0
63895|NCT01738698|152019|P4|STARTED|Overall Study||0
63896|NCT01738698|152020|P3|STARTED|Overall Study||0
63897|NCT01738698|152021|P2|STARTED|Overall Study||0
63898|NCT01738698|152022|P1|STARTED|Overall Study||0
63899|NCT01738672|152088|P1|NOT COMPLETED|Overall Study||5
63900|NCT01738672|152088|P1|COMPLETED|Overall Study||11
63901|NCT01738672|152088|P1|STARTED|Overall Study||16
63902|NCT01738646|152097|P1|NOT COMPLETED|Overall Study||2
63903|NCT01738646|152097|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
63904|NCT01738646|152097|P1|STARTED|Overall Study||40
63905|NCT01738581|152107|P2|NOT COMPLETED|Overall Study||0
63906|NCT01738581|152108|P1|NOT COMPLETED|Overall Study||1
63907|NCT01738581|152107|P2|COMPLETED|Overall Study||4
63908|NCT01738581|152108|P1|COMPLETED|Overall Study||4
63909|NCT01738581|152107|P2|STARTED|Overall Study||4
63910|NCT01738581|152108|P1|STARTED|Overall Study||5
63911|NCT01738503|152132|P7|NOT COMPLETED|PET Imaging Sub-study||1
63912|NCT01738503|152133|P6|NOT COMPLETED|PET Imaging Sub-study||2
63913|NCT01738503|152134|P5|NOT COMPLETED|PET Imaging Sub-study||0
63914|NCT01738503|152135|P4|NOT COMPLETED|PET Imaging Sub-study||0
63915|NCT01738503|152136|P3|NOT COMPLETED|PET Imaging Sub-study||0
63916|NCT01738503|152137|P2|NOT COMPLETED|PET Imaging Sub-study||0
63917|NCT01738503|152138|P1|NOT COMPLETED|PET Imaging Sub-study||0
63918|NCT01738503|152132|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
63919|NCT01738503|152133|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
63920|NCT01738503|152134|P5|COMPLETED|PET Imaging Sub-study||0
63921|NCT01738503|152135|P4|COMPLETED|PET Imaging Sub-study||0
63922|NCT01738503|152136|P3|COMPLETED|PET Imaging Sub-study||0
63923|NCT01738503|152137|P2|COMPLETED|PET Imaging Sub-study||0
63924|NCT01738503|152138|P1|COMPLETED|PET Imaging Sub-study||0
63925|NCT01738503|152132|P7|STARTED|PET Imaging Sub-study||2
63926|NCT01738503|152133|P6|STARTED|PET Imaging Sub-study||3
63927|NCT01738503|152134|P5|STARTED|PET Imaging Sub-study||0
63928|NCT01738503|152135|P4|STARTED|PET Imaging Sub-study||0
63929|NCT01738503|152136|P3|STARTED|PET Imaging Sub-study||0
63930|NCT01738503|152137|P2|STARTED|PET Imaging Sub-study||0
63931|NCT01738503|152138|P1|STARTED|PET Imaging Sub-study||0
63932|NCT01738503|152132|P7|NOT COMPLETED|Treatment Period||8
63933|NCT01738503|152133|P6|NOT COMPLETED|Treatment Period||6
63934|NCT01738503|152134|P5|NOT COMPLETED|Treatment Period||8
63935|NCT01738503|152135|P4|NOT COMPLETED|Treatment Period||6
63936|NCT01738503|152136|P3|NOT COMPLETED|Treatment Period||5
63937|NCT01738503|152137|P2|NOT COMPLETED|Treatment Period||5
63938|NCT01738503|152138|P1|NOT COMPLETED|Treatment Period||0
63939|NCT01738503|152132|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
63940|NCT01738503|152133|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
63941|NCT01738503|152134|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
63942|NCT01738503|152135|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
63943|NCT01738503|152136|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
63944|NCT01738503|152137|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
63945|NCT01738503|152138|P1|COMPLETED|Treatment Period||0
63946|NCT01738503|152132|P7|STARTED|Treatment Period||14
63947|NCT01738503|152133|P6|STARTED|Treatment Period||15
63948|NCT01738503|152134|P5|STARTED|Treatment Period||15
63949|NCT01738503|152135|P4|STARTED|Treatment Period||15
63950|NCT01738503|152136|P3|STARTED|Treatment Period||15
63951|NCT01738503|152137|P2|STARTED|Treatment Period||15
63952|NCT01738503|152138|P1|STARTED|Treatment Period||0
63953|NCT01738503|152132|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63954|NCT01738503|152133|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63955|NCT01738503|152134|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63956|NCT01738503|152135|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63957|NCT01738503|152136|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63958|NCT01738503|152137|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63959|NCT01738503|152138|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
63960|NCT01738503|152132|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63961|NCT01738503|152133|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63962|NCT01738503|152134|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63963|NCT01738503|152135|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63964|NCT01738503|152136|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63965|NCT01738503|152137|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
63966|NCT01738503|152138|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
63967|NCT01738503|152132|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
63968|NCT01738503|152133|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
63969|NCT01738503|152134|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
63970|NCT01738503|152135|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
63971|NCT01738503|152136|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
63972|NCT01738503|152137|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
63973|NCT01738503|152138|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
63974|NCT01738477|152336|P2|NOT COMPLETED|Overall Study||4
63975|NCT01738477|152337|P1|NOT COMPLETED|Overall Study||1
63976|NCT01738477|152336|P2|COMPLETED|Overall Study||124
63977|NCT01738477|152337|P1|COMPLETED|Overall Study||36
63978|NCT01738477|152336|P2|STARTED|Overall Study||128
63979|NCT01738477|152337|P1|STARTED|Overall Study||37
63980|NCT01738438|152365|P1|NOT COMPLETED|Overall Study||35
63981|NCT01738438|152365|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
63982|NCT01738438|152365|P1|STARTED|Overall Study||35
63983|NCT01738321|152373|P2|NOT COMPLETED|Overall Study||0
63984|NCT01738321|152374|P1|NOT COMPLETED|Overall Study||0
63985|NCT01738321|152373|P2|COMPLETED|Overall Study||30
63986|NCT01738321|152374|P1|COMPLETED|Overall Study||33
63987|NCT01738321|152373|P2|STARTED|Overall Study||30
63988|NCT01738321|152374|P1|STARTED|Overall Study||33
63989|NCT01737996|152383|P3|NOT COMPLETED|Overall Study||2
63990|NCT01737996|152384|P2|NOT COMPLETED|Overall Study||1
63991|NCT01737996|152385|P1|NOT COMPLETED|Overall Study||0
63992|NCT01737996|152383|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
63993|NCT01737996|152384|P2|COMPLETED|Overall Study||7
63994|NCT01737996|152385|P1|COMPLETED|Overall Study||8
63995|NCT01737996|152383|P3|STARTED|Overall Study||16
63996|NCT01737996|152384|P2|STARTED|Overall Study||8
63997|NCT01737996|152385|P1|STARTED|Overall Study||8
63998|NCT01737944|152426|P4|NOT COMPLETED|Overall Study||0
63999|NCT01737944|152427|P3|NOT COMPLETED|Overall Study||0
64000|NCT01737944|152428|P2|NOT COMPLETED|Overall Study||0
64001|NCT01737944|152429|P1|NOT COMPLETED|Overall Study||0
64002|NCT01737944|152426|P4|COMPLETED|Overall Study||9
64003|NCT01737944|152427|P3|COMPLETED|Overall Study||9
64004|NCT01737944|152428|P2|COMPLETED|Overall Study||9
64005|NCT01737944|152429|P1|COMPLETED|Overall Study||9
64006|NCT01737944|152426|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
64007|NCT01737944|152427|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
64008|NCT01737944|152428|P2|STARTED|Overall Study||9
64009|NCT01737944|152429|P1|STARTED|Overall Study||9
64010|NCT01737931|152447|P3|NOT COMPLETED|Overall Study||1
64011|NCT01737931|152448|P2|NOT COMPLETED|Overall Study||2
64012|NCT01737931|152449|P1|NOT COMPLETED|Overall Study||0
64013|NCT01737931|152447|P3|COMPLETED|Overall Study||38
64014|NCT01737931|152448|P2|COMPLETED|Overall Study||38
64015|NCT01737931|152449|P1|COMPLETED|Overall Study||38
64016|NCT01737931|152447|P3|STARTED|Overall Study||39
64017|NCT01737931|152448|P2|STARTED|Overall Study||40
64018|NCT01737931|152449|P1|STARTED|Overall Study||38
64019|NCT01737879|152464|P1|NOT COMPLETED|Overall Study||41
64020|NCT01737879|152464|P1|COMPLETED|Overall Study||0
64021|NCT01737879|152464|P1|Transitioned to Epoetin Alfa|Overall Study||0
64022|NCT01737879|152464|P1|Received Peginesatide|Overall Study||34
64023|NCT01737879|152464|P1|STARTED|Overall Study||41
64024|NCT01737840|152473|P2|NOT COMPLETED|Overall Study||2
64025|NCT01737840|152474|P1|NOT COMPLETED|Overall Study||2
64026|NCT01737840|152473|P2|COMPLETED|Overall Study||33
64027|NCT01737840|152474|P1|COMPLETED|Overall Study||33
64028|NCT01737840|152473|P2|STARTED|Overall Study||35
64029|NCT01737840|152474|P1|STARTED|Overall Study||35
64030|NCT01737762|152484|P2|NOT COMPLETED|Overall Study||17
64031|NCT01737762|152485|P1|NOT COMPLETED|Overall Study||20
64032|NCT01737762|152484|P2|COMPLETED|Overall Study||61
64033|NCT01737762|152485|P1|COMPLETED|Overall Study||57
64034|NCT01737762|152484|P2|STARTED|Overall Study||78
64035|NCT01737762|152485|P1|STARTED|Overall Study||77
64036|NCT01737710|152498|P5|NOT COMPLETED|Overall Study||0
64037|NCT01737710|152499|P4|NOT COMPLETED|Overall Study||0
64038|NCT01737710|152500|P3|NOT COMPLETED|Overall Study||3
64039|NCT01737710|152501|P2|NOT COMPLETED|Overall Study||4
64040|NCT01737710|152502|P1|NOT COMPLETED|Overall Study||2
64041|NCT01737710|152498|P5|COMPLETED|Overall Study||21
64042|NCT01737710|152499|P4|COMPLETED|Overall Study||23
64043|NCT01737710|152500|P3|COMPLETED|Overall Study||102
64044|NCT01737710|152501|P2|COMPLETED|Overall Study||101
64045|NCT01737710|152502|P1|COMPLETED|Overall Study||112
64046|NCT01737710|152498|P5|STARTED|Overall Study||21
64047|NCT01737710|152499|P4|STARTED|Overall Study||23
64048|NCT01737710|152500|P3|STARTED|Overall Study||105
64049|NCT01737710|152501|P2|STARTED|Overall Study||105
64050|NCT01737710|152502|P1|STARTED|Overall Study||114
64051|NCT01737684|152541|P3|NOT COMPLETED|Overall Study||0
64052|NCT01737684|152542|P2|NOT COMPLETED|Overall Study||0
64053|NCT01737684|152543|P1|NOT COMPLETED|Overall Study||0
64054|NCT01737684|152541|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
64055|NCT01737684|152542|P2|COMPLETED|Overall Study||8
64056|NCT01737684|152543|P1|COMPLETED|Overall Study||8
64057|NCT01737684|152541|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
64058|NCT01737684|152542|P2|STARTED|Overall Study||8
64059|NCT01737684|152543|P1|STARTED|Overall Study||8
64060|NCT01737593|152562|P3|NOT COMPLETED|Overall Study||0
64061|NCT01737593|152563|P2|NOT COMPLETED|Overall Study||0
64062|NCT01737593|152564|P1|NOT COMPLETED|Overall Study||0
64063|NCT01737593|152562|P3|COMPLETED|Overall Study||39
64064|NCT01737593|152563|P2|COMPLETED|Overall Study||32
64065|NCT01737593|152564|P1|COMPLETED|Overall Study||37
64066|NCT01737593|152562|P3|STARTED|Overall Study||39
64067|NCT01737593|152563|P2|STARTED|Overall Study||32
64068|NCT01737593|152564|P1|STARTED|Overall Study||37
64069|NCT01737268|152593|P1|NOT COMPLETED|Overall Study||9
64070|NCT01737268|152593|P1|COMPLETED|Overall Study||11
64071|NCT01737268|152593|P1|Treated|Overall Study||20
64072|NCT01737268|152593|P1|STARTED|Overall Study||20
64073|NCT01737021|152607|P2|NOT COMPLETED|Overall Study||3
64074|NCT01737021|152608|P1|NOT COMPLETED|Overall Study||5
64075|NCT01737021|152607|P2|COMPLETED|Overall Study||6
64076|NCT01737021|152608|P1|COMPLETED|Overall Study||17
64077|NCT01737021|152607|P2|STARTED|Overall Study||9
64078|NCT01737021|152608|P1|STARTED|Overall Study||22
64079|NCT01736930|152614|P1|NOT COMPLETED|Overall Study||1
64080|NCT01736930|152614|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
64081|NCT01736930|152614|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
64082|NCT01736917|152654|P1|NOT COMPLETED|Overall Study||11
64083|NCT01736917|152654|P1|COMPLETED|Overall Study||54
64084|NCT01736917|152654|P1|STARTED|Overall Study||65
64085|NCT01736696|152668|P7|NOT COMPLETED|Overall Study||0
64086|NCT01736696|152669|P6|NOT COMPLETED|Overall Study||0
64087|NCT01736696|152670|P5|NOT COMPLETED|Overall Study||0
64088|NCT01736696|152671|P4|NOT COMPLETED|Overall Study||0
64089|NCT01736696|152672|P3|NOT COMPLETED|Overall Study||1
64090|NCT01736696|152673|P2|NOT COMPLETED|Overall Study||0
64091|NCT01736696|152674|P1|NOT COMPLETED|Overall Study||0
64092|NCT01736696|152668|P7|COMPLETED|Overall Study||13
64093|NCT01736696|152669|P6|COMPLETED|Overall Study||8
64094|NCT01736696|152670|P5|COMPLETED|Overall Study||9
64095|NCT01736696|152671|P4|COMPLETED|Overall Study||9
64096|NCT01736696|152672|P3|COMPLETED|Overall Study||9
64097|NCT01736696|152673|P2|COMPLETED|Overall Study||5
64098|NCT01736696|152674|P1|COMPLETED|Overall Study||5
64099|NCT01736696|152668|P7|STARTED|Overall Study||13
64100|NCT01736696|152669|P6|STARTED|Overall Study||8
64101|NCT01736696|152670|P5|STARTED|Overall Study||9
64102|NCT01736696|152671|P4|STARTED|Overall Study||9
64103|NCT01736696|152672|P3|STARTED|Overall Study||10
64104|NCT01736696|152673|P2|STARTED|Overall Study||5
64105|NCT01736696|152674|P1|STARTED|Overall Study||5
64106|NCT01736657|152991|P1|NOT COMPLETED|Overall Study||1
64107|NCT01736657|152991|P1|COMPLETED|Overall Study||72
64108|NCT01736657|152991|P1|STARTED|Overall Study||73
64109|NCT01736579|153000|P2|NOT COMPLETED|Overall Study||2
64110|NCT01736579|153001|P1|NOT COMPLETED|Overall Study||2
64111|NCT01736579|153000|P2|COMPLETED|Overall Study||0
64112|NCT01736579|153001|P1|COMPLETED|Overall Study||0
64113|NCT01736579|153000|P2|STARTED|Overall Study||2
64114|NCT01736579|153001|P1|STARTED|Overall Study||2
64115|NCT01736553|153037|P2|NOT COMPLETED|Overall Study||4
64116|NCT01736553|153038|P1|NOT COMPLETED|Overall Study||19
64117|NCT01736553|153037|P2|COMPLETED|Overall Study||23
64118|NCT01736553|153038|P1|COMPLETED|Overall Study||7
64119|NCT01736553|153037|P2|STARTED|Overall Study||27
64120|NCT01736553|153038|P1|STARTED|Overall Study||26
64121|NCT01736540|153089|P1|NOT COMPLETED|Overall Study||15
64122|NCT01736540|153089|P1|COMPLETED|Overall Study||228
64123|NCT01736540|153089|P1|STARTED|Overall Study||243
64124|NCT01736527|153146|P1|NOT COMPLETED|Overall Study||0
64125|NCT01736527|153146|P1|COMPLETED|Overall Study||12
64126|NCT01736527|153146|P1|STARTED|Overall Study||12
64127|NCT01736475|153155|P2|NOT COMPLETED|Overall Study||0
64128|NCT01736475|153156|P1|NOT COMPLETED|Overall Study||12
64129|NCT01736475|153155|P2|COMPLETED|Overall Study||17
64130|NCT01736475|153156|P1|COMPLETED|Overall Study||109
64131|NCT01736475|153155|P2|STARTED|Overall Study||17
64132|NCT01736475|153156|P1|STARTED|Overall Study||121
64133|NCT01736397|153211|P2|NOT COMPLETED|Overall Study||24
64134|NCT01736397|153212|P1|NOT COMPLETED|Overall Study||14
64135|NCT01736397|153211|P2|COMPLETED|Overall Study||50
64136|NCT01736397|153212|P1|COMPLETED|Overall Study||61
64137|NCT01736397|153211|P2|STARTED|Overall Study||74
64138|NCT01736397|153212|P1|STARTED|Overall Study||75
64139|NCT01736215|153224|P1|NOT COMPLETED|Overall Study||14
64140|NCT01736215|153224|P1|COMPLETED|Overall Study||19
64141|NCT01736215|153224|P1|Treated|Overall Study||25
64142|NCT01736215|153224|P1|STARTED|Overall Study||33
64143|NCT01736176|153236|P1|NOT COMPLETED|Overall Study||11
64144|NCT01736176|153236|P1|COMPLETED|Overall Study||28
64145|NCT01736176|153236|P1|Received LCIG|Overall Study||38
64146|NCT01736176|153236|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
64147|NCT01735916|153283|P3|NOT COMPLETED|Overall Study||7
64148|NCT01735916|153284|P2|NOT COMPLETED|Overall Study||19
64149|NCT01735916|153285|P1|NOT COMPLETED|Overall Study||18
64150|NCT01735916|153283|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
64151|NCT01735916|153284|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
64152|NCT01735916|153285|P1|COMPLETED|Overall Study||0
64153|NCT01735916|153283|P3|STARTED|Overall Study||7
64154|NCT01735916|153284|P2|STARTED|Overall Study||19
64155|NCT01735916|153285|P1|STARTED|Overall Study||18
64156|NCT01735877|153306|P2|NOT COMPLETED|Overall Study||0
64157|NCT01735877|153307|P1|NOT COMPLETED|Overall Study||1
64158|NCT01735877|153306|P2|COMPLETED|Overall Study||21
64159|NCT01735877|153307|P1|COMPLETED|Overall Study||26
64160|NCT01735877|153306|P2|STARTED|Overall Study||21
64161|NCT01735877|153307|P1|STARTED|Overall Study||27
64162|NCT01735630|153323|P2|NOT COMPLETED|Overall Study||18
64163|NCT01735630|153324|P1|NOT COMPLETED|Overall Study||18
64164|NCT01735630|153323|P2|COMPLETED|Overall Study||157
64165|NCT01735630|153324|P1|COMPLETED|Overall Study||157
64166|NCT01735630|153323|P2|STARTED|Overall Study||175
64167|NCT01735630|153324|P1|STARTED|Overall Study||175
64168|NCT01735617|153338|P1|NOT COMPLETED|Overall Study||0
64169|NCT01735617|153338|P1|COMPLETED|Overall Study||16
64170|NCT01735617|153338|P1|STARTED|Overall Study||16
64171|NCT01735396|153351|P1|NOT COMPLETED|Overall Study||1
64172|NCT01735396|153351|P1|COMPLETED|Overall Study||10
64173|NCT01735396|153351|P1|STARTED|Overall Study||11
64174|NCT01735214|153360|P1|NOT COMPLETED|Overall Study||0
64175|NCT01735214|153360|P1|COMPLETED|Overall Study||358
64176|NCT01735214|153360|P1|STARTED|Overall Study||358
64177|NCT01735201|153380|P8|NOT COMPLETED|Overall Study||2
64178|NCT01735201|153381|P7|NOT COMPLETED|Overall Study||3
64179|NCT01735201|153382|P6|NOT COMPLETED|Overall Study||5
64180|NCT01735201|153383|P5|NOT COMPLETED|Overall Study||1
64181|NCT01735201|153384|P4|NOT COMPLETED|Overall Study||2
64182|NCT01735201|153385|P3|NOT COMPLETED|Overall Study||0
64183|NCT01735201|153386|P2|NOT COMPLETED|Overall Study||1
64184|NCT01735201|153387|P1|NOT COMPLETED|Overall Study||3
64185|NCT01735201|153380|P8|COMPLETED|Overall Study||42
64186|NCT01735201|153381|P7|COMPLETED|Overall Study||42
64187|NCT01735201|153382|P6|COMPLETED|Overall Study||40
64188|NCT01735201|153383|P5|COMPLETED|Overall Study||44
64189|NCT01735201|153384|P4|COMPLETED|Overall Study||42
64190|NCT01735201|153385|P3|COMPLETED|Overall Study||44
64191|NCT01735201|153386|P2|COMPLETED|Overall Study||43
64192|NCT01735201|153387|P1|COMPLETED|Overall Study||42
64193|NCT01735201|153380|P8|STARTED|Overall Study||44
64194|NCT01735201|153381|P7|STARTED|Overall Study||45
64195|NCT01735201|153382|P6|STARTED|Overall Study||45
64196|NCT01735201|153383|P5|STARTED|Overall Study||45
64197|NCT01735201|153384|P4|STARTED|Overall Study||44
64198|NCT01735201|153385|P3|STARTED|Overall Study||44
64199|NCT01735201|153386|P2|STARTED|Overall Study||44
64200|NCT01735201|153387|P1|STARTED|Overall Study||45
64201|NCT01735175|153423|P2|NOT COMPLETED|Overall Study||13
64202|NCT01735175|153424|P1|NOT COMPLETED|Overall Study||29
64203|NCT01735175|153423|P2|COMPLETED|Overall Study||144
64204|NCT01735175|153424|P1|COMPLETED|Overall Study||130
64205|NCT01735175|153423|P2|Completed the 6-month SFU Visit|Overall Study||138
64206|NCT01735175|153424|P1|Completed the 6-month SFU Visit|Overall Study||120
64207|NCT01735175|153423|P2|Completed All Treatments as Planned|Overall Study||150
64208|NCT01735175|153424|P1|Completed All Treatments as Planned|Overall Study||140
64209|NCT01735175|153423|P2|Completed All Cycles|Overall Study||150
64210|NCT01735175|153424|P1|Completed All Cycles|Overall Study||141
64211|NCT01735175|153423|P2|STARTED|Overall Study||157
64212|NCT01735175|153424|P1|STARTED|Overall Study||159
64213|NCT01734993|153444|P1|NOT COMPLETED|Overall Study||2
64214|NCT01734993|153444|P1|COMPLETED|Overall Study||9
64215|NCT01734993|153444|P1|STARTED|Overall Study||11
64216|NCT01734889|153470|P1|NOT COMPLETED|Overall Study||0
64217|NCT01734889|153470|P1|COMPLETED|Overall Study||18
64218|NCT01734889|153470|P1|STARTED|Overall Study||18
64219|NCT01734785|153481|P4|NOT COMPLETED|Double−Blind Period||0
64220|NCT01734785|153482|P3|NOT COMPLETED|Double−Blind Period||5
64221|NCT01734785|153483|P2|NOT COMPLETED|Double−Blind Period||9
64222|NCT01734785|153484|P1|NOT COMPLETED|Double−Blind Period||5
64223|NCT01734785|153481|P4|COMPLETED|Double−Blind Period||0
64224|NCT01734785|153482|P3|COMPLETED|Double−Blind Period||105
64225|NCT01734785|153483|P2|COMPLETED|Double−Blind Period||103
64226|NCT01734785|153484|P1|COMPLETED|Double−Blind Period||106
64227|NCT01734785|153481|P4|STARTED|Double−Blind Period||0
64228|NCT01734785|153482|P3|STARTED|Double−Blind Period||110
64229|NCT01734785|153483|P2|STARTED|Double−Blind Period||112
64230|NCT01734785|153484|P1|STARTED|Double−Blind Period||111
64231|NCT01734785|153481|P4|NOT COMPLETED|Open−Label Period||273
64232|NCT01734785|153482|P3|NOT COMPLETED|Open−Label Period||0
64233|NCT01734785|153483|P2|NOT COMPLETED|Open−Label Period||0
64234|NCT01734785|153484|P1|NOT COMPLETED|Open−Label Period||0
64235|NCT01734785|153481|P4|COMPLETED|Open−Label Period||333
64236|NCT01734785|153482|P3|COMPLETED|Open−Label Period||0
64237|NCT01734785|153483|P2|COMPLETED|Open−Label Period||0
64238|NCT01734785|153484|P1|COMPLETED|Open−Label Period||0
64239|NCT01734785|153481|P4|STARTED|Open−Label Period||606
64240|NCT01734785|153482|P3|STARTED|Open−Label Period||0
64241|NCT01734785|153483|P2|STARTED|Open−Label Period||0
64242|NCT01734785|153484|P1|STARTED|Open−Label Period||0
64243|NCT01734772|153501|P2|NOT COMPLETED|Overall Study||3
64244|NCT01734772|153502|P1|NOT COMPLETED|Overall Study||1
64245|NCT01734772|153501|P2|COMPLETED|Overall Study||21
64246|NCT01734772|153502|P1|COMPLETED|Overall Study||23
64247|NCT01734772|153501|P2|STARTED|Overall Study||24
64248|NCT01734772|153502|P1|STARTED|Overall Study||24
64249|NCT01734655|153519|P1|NOT COMPLETED|Overall Study||0
64250|NCT01734655|153519|P1|COMPLETED|Overall Study||40
64251|NCT01734655|153519|P1|STARTED|Overall Study||40
64252|NCT01734551|153530|P2|NOT COMPLETED|Overall Study||0
64253|NCT01734551|153531|P1|NOT COMPLETED|Overall Study||0
64254|NCT01734551|153530|P2|COMPLETED|Overall Study||16
64255|NCT01734551|153531|P1|COMPLETED|Overall Study||15
64256|NCT01734551|153530|P2|STARTED|Overall Study||16
64257|NCT01734551|153531|P1|STARTED|Overall Study||15
64258|NCT01734395|153543|P1|NOT COMPLETED|Overall Study||410
64259|NCT01734395|153543|P1|COMPLETED|Overall Study||1472
64260|NCT01734395|153543|P1|STARTED|Overall Study||1882
64261|NCT01734317|153549|P1|NOT COMPLETED|Overall Study||0
64262|NCT01734317|153549|P1|COMPLETED|Overall Study||10
64263|NCT01734317|153549|P1|STARTED|Overall Study||10
64264|NCT01734239|153555|P2|NOT COMPLETED|Overall Study||0
64265|NCT01734239|153556|P1|NOT COMPLETED|Overall Study||0
64266|NCT01734239|153555|P2|COMPLETED|Overall Study||50
64267|NCT01734239|153556|P1|COMPLETED|Overall Study||52
64268|NCT01734239|153555|P2|STARTED|Overall Study||50
64269|NCT01734239|153556|P1|STARTED|Overall Study||52
64270|NCT01734161|153571|P2|NOT COMPLETED|Overall Study||8
64271|NCT01734161|153572|P1|NOT COMPLETED|Overall Study||6
64272|NCT01734161|153571|P2|COMPLETED|Overall Study||53
64273|NCT01734161|153572|P1|COMPLETED|Overall Study||55
64274|NCT01734161|153571|P2|STARTED|Overall Study||61
64275|NCT01734161|153572|P1|STARTED|Overall Study||61
64276|NCT01733953|153580|P2|NOT COMPLETED|Overall Study||7
64277|NCT01733953|153581|P1|NOT COMPLETED|Overall Study||5
64278|NCT01733953|153580|P2|COMPLETED|Overall Study||6
64279|NCT01733953|153581|P1|COMPLETED|Overall Study||9
64280|NCT01733953|153580|P2|STARTED|Overall Study||13
64281|NCT01733953|153581|P1|STARTED|Overall Study||14
64282|NCT01733758|153601|P4|NOT COMPLETED|Overall Study||8
64283|NCT01733758|153602|P3|NOT COMPLETED|Overall Study||15
64284|NCT01733758|153603|P2|NOT COMPLETED|Overall Study||12
64285|NCT01733758|153604|P1|NOT COMPLETED|Overall Study||15
64286|NCT01733758|153601|P4|COMPLETED|Overall Study||95
64287|NCT01733758|153602|P3|COMPLETED|Overall Study||135
64288|NCT01733758|153603|P2|COMPLETED|Overall Study||148
64289|NCT01733758|153604|P1|COMPLETED|Overall Study||62
64290|NCT01733758|153601|P4|STARTED|Overall Study||103
64291|NCT01733758|153602|P3|STARTED|Overall Study||150
64292|NCT01733758|153603|P2|STARTED|Overall Study||160
64293|NCT01733758|153604|P1|STARTED|Overall Study||77
64294|NCT01733745|153657|P2|NOT COMPLETED|Overall Study||0
64295|NCT01733745|153658|P1|NOT COMPLETED|Overall Study||0
64296|NCT01733745|153657|P2|COMPLETED|Overall Study||13
64297|NCT01733745|153658|P1|COMPLETED|Overall Study||13
64298|NCT01733745|153657|P2|STARTED|Overall Study||13
64299|NCT01733745|153658|P1|STARTED|Overall Study||13
64300|NCT01733732|153670|P2|NOT COMPLETED|Overall Study||0
64301|NCT01733732|153671|P1|NOT COMPLETED|Overall Study||2
64302|NCT01733732|153670|P2|COMPLETED|Overall Study||27
64303|NCT01733732|153671|P1|COMPLETED|Overall Study||25
64304|NCT01733732|153670|P2|STARTED|Overall Study||27
64305|NCT01733732|153671|P1|STARTED|Overall Study||27
64306|NCT01733368|153705|P1|NOT COMPLETED|Overall Study||31
64307|NCT01733368|153705|P1|COMPLETED|Overall Study||167
64308|NCT01733368|153705|P1|STARTED|Overall Study||198
64309|NCT01733329|153715|P2|NOT COMPLETED|Overall Study||1
64310|NCT01733329|153716|P1|NOT COMPLETED|Overall Study||2
64311|NCT01733329|153715|P2|COMPLETED|Overall Study||60
64312|NCT01733329|153716|P1|COMPLETED|Overall Study||60
64313|NCT01733329|153715|P2|STARTED|Overall Study||61
64314|NCT01733329|153716|P1|STARTED|Overall Study||62
64315|NCT01733316|153728|P1|NOT COMPLETED|Overall Study||2
64316|NCT01733316|153728|P1|COMPLETED|Overall Study||39
64317|NCT01733316|153728|P1|STARTED|Overall Study||41
64318|NCT01733277|153752|P2|NOT COMPLETED|Overall Study||0
64319|NCT01733277|153753|P1|NOT COMPLETED|Overall Study||0
64320|NCT01733277|153752|P2|COMPLETED|Overall Study||25
64321|NCT01733277|153753|P1|COMPLETED|Overall Study||25
64322|NCT01733277|153752|P2|STARTED|Overall Study||25
64323|NCT01733277|153753|P1|STARTED|Overall Study||25
64324|NCT01733212|153765|P2|NOT COMPLETED|Overall Study||0
64325|NCT01733212|153766|P1|NOT COMPLETED|Overall Study||0
64326|NCT01733212|153765|P2|COMPLETED|Overall Study||123
64327|NCT01733212|153766|P1|COMPLETED|Overall Study||116
64328|NCT01733212|153765|P2|STARTED|Overall Study||123
64329|NCT01733212|153766|P1|STARTED|Overall Study||116
64330|NCT01733121|153774|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
64331|NCT01733121|153775|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
64332|NCT01733121|153774|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
64333|NCT01733121|153775|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
64334|NCT01733121|153774|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
64335|NCT01733121|153775|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
64336|NCT01733121|153774|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
64337|NCT01733121|153775|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
64338|NCT01733121|153774|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
64339|NCT01733121|153775|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
64340|NCT01733121|153774|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
64341|NCT01733121|153775|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
64342|NCT01733069|153789|P2|NOT COMPLETED|Overall Study||0
64343|NCT01733069|153790|P1|NOT COMPLETED|Overall Study||0
64344|NCT01733069|153789|P2|COMPLETED|Overall Study||1598
64345|NCT01733069|153790|P1|COMPLETED|Overall Study||264
64346|NCT01733069|153789|P2|STARTED|Overall Study||1598
64347|NCT01733069|153790|P1|STARTED|Overall Study||264
64348|NCT01733056|153799|P3|NOT COMPLETED|Overall Study||0
64349|NCT01733056|153800|P2|NOT COMPLETED|Overall Study||0
64350|NCT01733056|153801|P1|NOT COMPLETED|Overall Study||0
64351|NCT01733056|153799|P3|COMPLETED|Overall Study||12
64352|NCT01733056|153800|P2|COMPLETED|Overall Study||10
64353|NCT01733056|153801|P1|COMPLETED|Overall Study||21
64354|NCT01733056|153799|P3|STARTED|Overall Study||12
64355|NCT01733056|153800|P2|STARTED|Overall Study||10
64356|NCT01733056|153801|P1|STARTED|Overall Study||21
64357|NCT01732926|153817|P2|NOT COMPLETED|Overall Study||110
64358|NCT01732926|153818|P1|NOT COMPLETED|Overall Study||267
64359|NCT01732926|153817|P2|COMPLETED|Overall Study||45
64360|NCT01732926|153818|P1|COMPLETED|Overall Study||53
64361|NCT01732926|153817|P2|STARTED|Overall Study||155
64362|NCT01732926|153818|P1|STARTED|Overall Study||320
64363|NCT01732913|153834|P2|NOT COMPLETED|Overall Study||69
64364|NCT01732913|153835|P1|NOT COMPLETED|Overall Study||156
64365|NCT01732913|153834|P2|COMPLETED|Overall Study||28
64366|NCT01732913|153835|P1|COMPLETED|Overall Study||42
64367|NCT01732913|153834|P2|STARTED|Overall Study||97
64368|NCT01732913|153835|P1|STARTED|Overall Study||198
64369|NCT01732835|153849|P1|NOT COMPLETED|2-year Extended Follow-up||5
64370|NCT01732835|153849|P1|COMPLETED|2-year Extended Follow-up||39
64371|NCT01732835|153849|P1|STARTED|2-year Extended Follow-up||44
64372|NCT01732835|153849|P1|NOT COMPLETED|6-month Primary Endpoint||24
64373|NCT01732835|153849|P1|COMPLETED|6-month Primary Endpoint||44
64374|NCT01732835|153849|P1|STARTED|6-month Primary Endpoint||68
64375|NCT01732822|153882|P2|NOT COMPLETED|Overall Study||113
64376|NCT01732822|153883|P1|NOT COMPLETED|Overall Study||123
64377|NCT01732822|153882|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
64378|NCT01732822|153883|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
64379|NCT01732822|153882|P2|STARTED|Overall Study||6955
64380|NCT01732822|153883|P1|STARTED|Overall Study||6930
64381|NCT01732796|153956|P3|NOT COMPLETED|Overall Study||13
64382|NCT01732796|153957|P2|NOT COMPLETED|Overall Study||42
64383|NCT01732796|153958|P1|NOT COMPLETED|Overall Study||46
64384|NCT01732796|153956|P3|COMPLETED|Overall Study||38
64385|NCT01732796|153957|P2|COMPLETED|Overall Study||169
64386|NCT01732796|153958|P1|COMPLETED|Overall Study||162
64387|NCT01732796|153956|P3|STARTED|Overall Study||51
64388|NCT01732796|153957|P2|STARTED|Overall Study||211
64389|NCT01732796|153958|P1|STARTED|Overall Study||208
64390|NCT01732770|153976|P2|NOT COMPLETED|Overall Study||8
64391|NCT01732770|153977|P1|NOT COMPLETED|Overall Study||10
64392|NCT01732770|153976|P2|COMPLETED|Overall Study||313
64393|NCT01732770|153977|P1|COMPLETED|Overall Study||312
64394|NCT01732770|153976|P2|Received Study Treatment|Overall Study||320
64395|NCT01732770|153977|P1|Received Study Treatment|Overall Study||320
64396|NCT01732770|153976|P2|STARTED|Overall Study||321
64397|NCT01732770|153977|P1|STARTED|Overall Study||322
64398|NCT01732757|153992|P3|NOT COMPLETED|Overall Study||0
64399|NCT01732757|153993|P2|NOT COMPLETED|Overall Study||0
64400|NCT01732757|153994|P1|NOT COMPLETED|Overall Study||1
64401|NCT01732757|153992|P3|COMPLETED|Overall Study||52
64402|NCT01732757|153993|P2|COMPLETED|Overall Study||52
64403|NCT01732757|153994|P1|COMPLETED|Overall Study||52
64404|NCT01732757|153992|P3|STARTED|Overall Study||52
64405|NCT01732757|153993|P2|STARTED|Overall Study||52
64406|NCT01732757|153994|P1|STARTED|Overall Study||53
64407|NCT01732692|154034|P2|NOT COMPLETED|Overall Study||1
64408|NCT01732692|154035|P1|NOT COMPLETED|Overall Study||0
64409|NCT01732692|154034|P2|COMPLETED|Overall Study||69
64410|NCT01732692|154035|P1|COMPLETED|Overall Study||70
64411|NCT01732692|154034|P2|STARTED|Overall Study||70
64412|NCT01732692|154035|P1|STARTED|Overall Study||70
64413|NCT01732588|154052|P3|NOT COMPLETED|Third Intervention (7 Days)||0
64414|NCT01732588|154053|P2|NOT COMPLETED|Third Intervention (7 Days)||0
64415|NCT01732588|154054|P1|NOT COMPLETED|Third Intervention (7 Days)||0
64416|NCT01732588|154052|P3|COMPLETED|Third Intervention (7 Days)||4
64417|NCT01732588|154053|P2|COMPLETED|Third Intervention (7 Days)||2
64418|NCT01732588|154054|P1|COMPLETED|Third Intervention (7 Days)||4
64419|NCT01732588|154052|P3|STARTED|Third Intervention (7 Days)||4
64420|NCT01732588|154053|P2|STARTED|Third Intervention (7 Days)||2
64421|NCT01732588|154054|P1|STARTED|Third Intervention (7 Days)||4
64422|NCT01732588|154052|P3|NOT COMPLETED|Second Intervention (7 Days)||0
64423|NCT01732588|154053|P2|NOT COMPLETED|Second Intervention (7 Days)||0
64424|NCT01732588|154054|P1|NOT COMPLETED|Second Intervention (7 Days)||0
64425|NCT01732588|154052|P3|COMPLETED|Second Intervention (7 Days)||4
64426|NCT01732588|154053|P2|COMPLETED|Second Intervention (7 Days)||2
64427|NCT01732588|154054|P1|COMPLETED|Second Intervention (7 Days)||4
64428|NCT01732588|154052|P3|STARTED|Second Intervention (7 Days)||4
64429|NCT01732588|154053|P2|STARTED|Second Intervention (7 Days)||2
64430|NCT01732588|154054|P1|STARTED|Second Intervention (7 Days)||4
64431|NCT01732588|154052|P3|NOT COMPLETED|First Intervention (7 Days)||0
64432|NCT01732588|154053|P2|NOT COMPLETED|First Intervention (7 Days)||1
64433|NCT01732588|154054|P1|NOT COMPLETED|First Intervention (7 Days)||0
64434|NCT01732588|154052|P3|COMPLETED|First Intervention (7 Days)||4
64435|NCT01732588|154053|P2|COMPLETED|First Intervention (7 Days)||2
64436|NCT01732588|154054|P1|COMPLETED|First Intervention (7 Days)||4
64437|NCT01732588|154052|P3|STARTED|First Intervention (7 Days)||4
64438|NCT01732588|154053|P2|STARTED|First Intervention (7 Days)||3
64439|NCT01732588|154054|P1|STARTED|First Intervention (7 Days)||4
64440|NCT01732549|154070|P2|NOT COMPLETED|Overall Study||73
64441|NCT01732549|154071|P1|NOT COMPLETED|Overall Study||71
64442|NCT01732549|154070|P2|COMPLETED|Overall Study||0
64443|NCT01732549|154071|P1|COMPLETED|Overall Study||0
64444|NCT01732549|154070|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
64445|NCT01732549|154071|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
64446|NCT01732549|154070|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
64447|NCT01732549|154071|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
64448|NCT01732549|154070|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
64449|NCT01732549|154071|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
64450|NCT01732549|154070|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
64451|NCT01732549|154071|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
64452|NCT01732549|154070|P2|STARTED|Overall Study||73
64453|NCT01732549|154071|P1|STARTED|Overall Study||71
64454|NCT01732510|154098|P7|NOT COMPLETED|Overall Study||8
64455|NCT01732510|154099|P6|NOT COMPLETED|Overall Study||13
64456|NCT01732510|154100|P5|NOT COMPLETED|Overall Study||5
64457|NCT01732510|154101|P4|NOT COMPLETED|Overall Study||5
64458|NCT01732510|154102|P3|NOT COMPLETED|Overall Study||4
64459|NCT01732510|154103|P2|NOT COMPLETED|Overall Study||5
64460|NCT01732510|154104|P1|NOT COMPLETED|Overall Study||1
64461|NCT01732510|154098|P7|COMPLETED|Overall Study||0
64462|NCT01732510|154099|P6|COMPLETED|Overall Study||0
64463|NCT01732510|154100|P5|COMPLETED|Overall Study||3
64464|NCT01732510|154101|P4|COMPLETED|Overall Study||5
64465|NCT01732510|154102|P3|COMPLETED|Overall Study||4
64466|NCT01732510|154103|P2|COMPLETED|Overall Study||4
64467|NCT01732510|154104|P1|COMPLETED|Overall Study||8
64468|NCT01732510|154098|P7|STARTED|Overall Study||8
64469|NCT01732510|154099|P6|STARTED|Overall Study||13
64470|NCT01732510|154100|P5|STARTED|Overall Study||8
64471|NCT01732510|154101|P4|STARTED|Overall Study||10
64472|NCT01732510|154102|P3|STARTED|Overall Study||8
64473|NCT01732510|154103|P2|STARTED|Overall Study||9
64474|NCT01732510|154104|P1|STARTED|Overall Study||9
64475|NCT01732484|154183|P1|NOT COMPLETED|Overall Study||26
64476|NCT01732484|154183|P1|COMPLETED|Overall Study||74
64477|NCT01732484|154183|P1|Allocation|Overall Study||100
64478|NCT01732484|154183|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
64479|NCT01732484|154183|P1|STARTED|Overall Study||100
64480|NCT01732471|154191|P1|NOT COMPLETED|Overall Study||1
64481|NCT01732471|154191|P1|COMPLETED|Overall Study||89
64482|NCT01732471|154191|P1|STARTED|Overall Study||90
64483|NCT01732458|154202|P4|NOT COMPLETED|Overall Study||2
64484|NCT01732458|154203|P3|NOT COMPLETED|Overall Study||3
64485|NCT01732458|154204|P2|NOT COMPLETED|Overall Study||5
64486|NCT01732458|154205|P1|NOT COMPLETED|Overall Study||3
64487|NCT01732458|154202|P4|COMPLETED|Overall Study||50
64488|NCT01732458|154203|P3|COMPLETED|Overall Study||55
64489|NCT01732458|154204|P2|COMPLETED|Overall Study||53
64490|NCT01732458|154205|P1|COMPLETED|Overall Study||57
64491|NCT01732458|154202|P4|Treated|Overall Study||52
64492|NCT01732458|154203|P3|Treated|Overall Study||56
64493|NCT01732458|154204|P2|Treated|Overall Study||55
64494|NCT01732458|154205|P1|Treated|Overall Study||57
64495|NCT01732458|154202|P4|STARTED|Overall Study||52
64496|NCT01732458|154203|P3|STARTED|Overall Study||58
64497|NCT01732458|154204|P2|STARTED|Overall Study||58
64498|NCT01732458|154205|P1|STARTED|Overall Study||60
64499|NCT01732445|154267|P1|NOT COMPLETED|Overall Study||0
64500|NCT01732445|154267|P1|COMPLETED|Overall Study||14
64501|NCT01732445|154267|P1|STARTED|Overall Study||14
64502|NCT01732263|154276|P2|NOT COMPLETED|Overall Study||0
64503|NCT01732263|154277|P1|NOT COMPLETED|Overall Study||0
64504|NCT01732263|154276|P2|COMPLETED|Overall Study||20
64505|NCT01732263|154277|P1|COMPLETED|Overall Study||23
64506|NCT01732263|154276|P2|STARTED|Overall Study||20
64507|NCT01732263|154277|P1|STARTED|Overall Study||23
64508|NCT01731990|154319|P2|NOT COMPLETED|Overall Study||8
64509|NCT01731990|154320|P1|NOT COMPLETED|Overall Study||4
64510|NCT01731990|154319|P2|COMPLETED|Overall Study||12
64511|NCT01731990|154320|P1|COMPLETED|Overall Study||14
64512|NCT01731990|154319|P2|STARTED|Overall Study||20
64513|NCT01731990|154320|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
64514|NCT01731938|154336|P2|NOT COMPLETED|Primary Part II||13
64515|NCT01731938|154337|P1|NOT COMPLETED|Primary Part II||13
64516|NCT01731938|154336|P2|COMPLETED|Primary Part II||95
64517|NCT01731938|154337|P1|COMPLETED|Primary Part II||103
64518|NCT01731938|154336|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
64519|NCT01731938|154337|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
64520|NCT01731938|154336|P2|NOT COMPLETED|Preliminary Part I||8
64521|NCT01731938|154337|P1|NOT COMPLETED|Preliminary Part I||3
64522|NCT01731938|154336|P2|COMPLETED|Preliminary Part I||44
64523|NCT01731938|154337|P1|COMPLETED|Preliminary Part I||48
64524|NCT01731938|154336|P2|STARTED|Preliminary Part I||52
64525|NCT01731938|154337|P1|STARTED|Preliminary Part I||51
64526|NCT01731470|154349|P1|NOT COMPLETED|Overall Study||2
64527|NCT01731470|154349|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
64528|NCT01731470|154349|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
64529|NCT01731119|154354|P1|NOT COMPLETED|Overall Study||2
64530|NCT01731119|154354|P1|COMPLETED|Overall Study||7
64531|NCT01731119|154354|P1|STARTED|Overall Study||9
64532|NCT01731041|154364|P2|NOT COMPLETED|Overall Study||0
64533|NCT01731041|154365|P1|NOT COMPLETED|Overall Study||0
64534|NCT01731041|154364|P2|COMPLETED|Overall Study||30
64535|NCT01731041|154365|P1|COMPLETED|Overall Study||30
64536|NCT01731041|154364|P2|STARTED|Overall Study||30
64537|NCT01731041|154365|P1|STARTED|Overall Study||30
64538|NCT01731002|154376|P3|NOT COMPLETED|Overall Study||3
64539|NCT01731002|154377|P2|NOT COMPLETED|Overall Study||4
64540|NCT01731002|154378|P1|NOT COMPLETED|Overall Study||4
64541|NCT01731002|154376|P3|COMPLETED|Overall Study||74
64542|NCT01731002|154377|P2|COMPLETED|Overall Study||68
64543|NCT01731002|154378|P1|COMPLETED|Overall Study||71
64544|NCT01731002|154376|P3|STARTED|Overall Study||77
64545|NCT01731002|154377|P2|STARTED|Overall Study||72
64546|NCT01731002|154378|P1|STARTED|Overall Study||75
64547|NCT01730846|154392|P3|NOT COMPLETED|Overall Study||0
64548|NCT01730846|154393|P2|NOT COMPLETED|Overall Study||0
64549|NCT01730846|154394|P1|NOT COMPLETED|Overall Study||0
64550|NCT01730846|154392|P3|COMPLETED|Overall Study||13
64551|NCT01730846|154393|P2|COMPLETED|Overall Study||11
64552|NCT01730846|154394|P1|COMPLETED|Overall Study||11
64553|NCT01730846|154392|P3|STARTED|Overall Study||13
64554|NCT01730846|154393|P2|STARTED|Overall Study||11
64555|NCT01730846|154394|P1|STARTED|Overall Study||11
64556|NCT01730378|154407|P2|NOT COMPLETED|Overall Study||0
64557|NCT01730378|154408|P1|NOT COMPLETED|Overall Study||1
64558|NCT01730378|154407|P2|COMPLETED|Overall Study||47
64559|NCT01730378|154408|P1|COMPLETED|Overall Study||83
64560|NCT01730378|154407|P2|STARTED|Overall Study||47
64561|NCT01730378|154408|P1|STARTED|Overall Study||84
64562|NCT01730339|154439|P2|NOT COMPLETED|Overall Study||3
64563|NCT01730339|154440|P1|NOT COMPLETED|Overall Study||5
64564|NCT01730339|154439|P2|COMPLETED|Overall Study||52
64565|NCT01730339|154440|P1|COMPLETED|Overall Study||40
64566|NCT01730339|154439|P2|STARTED|Overall Study||55
64567|NCT01730339|154440|P1|STARTED|Overall Study||45
64568|NCT01730053|154480|P6|NOT COMPLETED|Overall Study||13
64569|NCT01730053|154481|P5|NOT COMPLETED|Overall Study||9
64570|NCT01730053|154482|P4|NOT COMPLETED|Overall Study||8
64571|NCT01730053|154483|P3|NOT COMPLETED|Overall Study||11
64572|NCT01730053|154484|P2|NOT COMPLETED|Overall Study||14
64573|NCT01730053|154485|P1|NOT COMPLETED|Overall Study||5
64574|NCT01730053|154480|P6|COMPLETED|Overall Study||41
64575|NCT01730053|154481|P5|COMPLETED|Overall Study||44
64576|NCT01730053|154482|P4|COMPLETED|Overall Study||45
64577|NCT01730053|154483|P3|COMPLETED|Overall Study||38
64578|NCT01730053|154484|P2|COMPLETED|Overall Study||34
64579|NCT01730053|154485|P1|COMPLETED|Overall Study||43
64580|NCT01730053|154480|P6|Treated|Overall Study||54
64581|NCT01730053|154481|P5|Treated|Overall Study||53
64582|NCT01730053|154482|P4|Treated|Overall Study||53
64583|NCT01730053|154483|P3|Treated|Overall Study||49
64584|NCT01730053|154484|P2|Treated|Overall Study||48
64585|NCT01730053|154485|P1|Treated|Overall Study||48
64586|NCT01730053|154480|P6|STARTED|Overall Study||54
64587|NCT01730053|154481|P5|STARTED|Overall Study||53
64588|NCT01730053|154482|P4|STARTED|Overall Study||53
64589|NCT01730053|154483|P3|STARTED|Overall Study||49
64590|NCT01730053|154484|P2|STARTED|Overall Study||48
64591|NCT01730053|154485|P1|STARTED|Overall Study||48
64592|NCT01730040|154644|P7|NOT COMPLETED|Overall Study||9
64593|NCT01730040|154645|P6|NOT COMPLETED|Overall Study||7
64594|NCT01730040|154646|P5|NOT COMPLETED|Overall Study||6
64595|NCT01730040|154647|P4|NOT COMPLETED|Overall Study||8
64596|NCT01730040|154648|P3|NOT COMPLETED|Overall Study||11
64597|NCT01730040|154649|P2|NOT COMPLETED|Overall Study||15
64598|NCT01730040|154650|P1|NOT COMPLETED|Overall Study||13
64599|NCT01730040|154644|P7|COMPLETED|Overall Study||38
64600|NCT01730040|154645|P6|COMPLETED|Overall Study||40
64601|NCT01730040|154646|P5|COMPLETED|Overall Study||39
64602|NCT01730040|154647|P4|COMPLETED|Overall Study||39
64603|NCT01730040|154648|P3|COMPLETED|Overall Study||46
64604|NCT01730040|154649|P2|COMPLETED|Overall Study||40
64605|NCT01730040|154650|P1|COMPLETED|Overall Study||44
64606|NCT01730040|154644|P7|Treated|Overall Study||47
64607|NCT01730040|154645|P6|Treated|Overall Study||46
64608|NCT01730040|154646|P5|Treated|Overall Study||45
64609|NCT01730040|154647|P4|Treated|Overall Study||47
64610|NCT01730040|154648|P3|Treated|Overall Study||57
64611|NCT01730040|154649|P2|Treated|Overall Study||55
64612|NCT01730040|154650|P1|Treated|Overall Study||57
64613|NCT01730040|154644|P7|STARTED|Overall Study||47
64614|NCT01730040|154645|P6|STARTED|Overall Study||47
64615|NCT01730040|154646|P5|STARTED|Overall Study||45
64616|NCT01730040|154647|P4|STARTED|Overall Study||47
64617|NCT01730040|154648|P3|STARTED|Overall Study||57
64618|NCT01730040|154649|P2|STARTED|Overall Study||55
64619|NCT01730040|154650|P1|STARTED|Overall Study||57
64620|NCT01729923|154827|P1|NOT COMPLETED|Overall Study||27
64621|NCT01729923|154827|P1|COMPLETED|Overall Study||0
64622|NCT01729923|154827|P1|STARTED|Overall Study||27
64623|NCT01729871|154839|P2|NOT COMPLETED|Overall Study||23
64624|NCT01729871|154840|P1|NOT COMPLETED|Overall Study||12
64625|NCT01729871|154839|P2|COMPLETED|Overall Study||101
64626|NCT01729871|154840|P1|COMPLETED|Overall Study||112
64627|NCT01729871|154839|P2|STARTED|Overall Study||124
64628|NCT01729871|154840|P1|STARTED|Overall Study||124
64629|NCT01729845|154859|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
64630|NCT01729845|154860|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
64631|NCT01729845|154861|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
64632|NCT01729845|154859|P3|COMPLETED|Efficacy of Dec/MEC||0
64633|NCT01729845|154860|P2|COMPLETED|Efficacy of Dec/MEC||22
64634|NCT01729845|154861|P1|COMPLETED|Efficacy of Dec/MEC||0
64635|NCT01729845|154859|P3|STARTED|Efficacy of Dec/MEC||0
64636|NCT01729845|154860|P2|STARTED|Efficacy of Dec/MEC||22
64637|NCT01729845|154861|P1|STARTED|Efficacy of Dec/MEC||0
64638|NCT01729845|154859|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
64639|NCT01729845|154860|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
64640|NCT01729845|154861|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
64641|NCT01729845|154859|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
64642|NCT01729845|154860|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
64643|NCT01729845|154861|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
64644|NCT01729845|154859|P3|STARTED|Safety/Tolerability of Dec/MEC||12
64645|NCT01729845|154860|P2|STARTED|Safety/Tolerability of Dec/MEC||34
64646|NCT01729845|154861|P1|STARTED|Safety/Tolerability of Dec/MEC||6
64647|NCT01729728|154875|P3|NOT COMPLETED|Overall Study||1
64648|NCT01729728|154876|P2|NOT COMPLETED|Overall Study||6
64649|NCT01729728|154877|P1|NOT COMPLETED|Overall Study||1
64650|NCT01729728|154875|P3|COMPLETED|Overall Study||16
64651|NCT01729728|154876|P2|COMPLETED|Overall Study||22
64652|NCT01729728|154877|P1|COMPLETED|Overall Study||20
64653|NCT01729728|154875|P3|STARTED|Overall Study||17
64654|NCT01729728|154876|P2|STARTED|Overall Study||28
64655|NCT01729728|154877|P1|STARTED|Overall Study||21
64656|NCT01729559|155010|P2|NOT COMPLETED|Overall Study||28
64657|NCT01729559|155011|P1|NOT COMPLETED|Overall Study||31
64658|NCT01729559|155010|P2|COMPLETED|Overall Study||216
64659|NCT01729559|155011|P1|COMPLETED|Overall Study||220
64660|NCT01729559|155010|P2|STARTED|Overall Study||244
64661|NCT01729559|155011|P1|STARTED|Overall Study||251
64662|NCT01729338|155023|P1|NOT COMPLETED|Overall Study||2
64663|NCT01729338|155023|P1|COMPLETED|Overall Study||14
64664|NCT01729338|155023|P1|STARTED|Overall Study||16
64665|NCT01729247|155038|P1|NOT COMPLETED|Overall Study||0
64666|NCT01729247|155038|P1|COMPLETED|Overall Study||50
64667|NCT01729247|155038|P1|STARTED|Overall Study||50
64668|NCT01729026|155054|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
64669|NCT01729026|155055|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
64670|NCT01729026|155054|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
64671|NCT01729026|155055|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
64672|NCT01729026|155054|P2|STARTED|3-month to 6-month (Final) Follow-up||8
64673|NCT01729026|155055|P1|STARTED|3-month to 6-month (Final) Follow-up||7
64674|NCT01729026|155054|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
64675|NCT01729026|155055|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
64676|NCT01729026|155054|P2|COMPLETED|Randomization to 3-month Follow-up||8
64677|NCT01729026|155055|P1|COMPLETED|Randomization to 3-month Follow-up||7
64678|NCT01729026|155054|P2|STARTED|Randomization to 3-month Follow-up||10
64679|NCT01729026|155055|P1|STARTED|Randomization to 3-month Follow-up||9
64680|NCT01728792|155066|P5|NOT COMPLETED|Overall Study||0
64681|NCT01728792|155067|P4|NOT COMPLETED|Overall Study||3
64682|NCT01728792|155068|P3|NOT COMPLETED|Overall Study||4
64683|NCT01728792|155069|P2|NOT COMPLETED|Overall Study||2
64684|NCT01728792|155070|P1|NOT COMPLETED|Overall Study||3
64685|NCT01728792|155066|P5|COMPLETED|Overall Study||16
64686|NCT01728792|155067|P4|COMPLETED|Overall Study||14
64687|NCT01728792|155068|P3|COMPLETED|Overall Study||13
64688|NCT01728792|155069|P2|COMPLETED|Overall Study||14
64689|NCT01728792|155070|P1|COMPLETED|Overall Study||11
64690|NCT01728792|155066|P5|STARTED|Overall Study||16
64691|NCT01728792|155067|P4|STARTED|Overall Study||17
64692|NCT01728792|155068|P3|STARTED|Overall Study||17
64693|NCT01728792|155069|P2|STARTED|Overall Study||16
64694|NCT01728792|155070|P1|STARTED|Overall Study||14
64695|NCT01728584|155121|P4|NOT COMPLETED|Overall Study||1
64696|NCT01728584|155122|P3|NOT COMPLETED|Overall Study||1
64697|NCT01728584|155123|P2|NOT COMPLETED|Overall Study||0
64698|NCT01728584|155124|P1|NOT COMPLETED|Overall Study||8
64699|NCT01728584|155121|P4|COMPLETED|Overall Study||29
64700|NCT01728584|155122|P3|COMPLETED|Overall Study||30
64701|NCT01728584|155123|P2|COMPLETED|Overall Study||30
64702|NCT01728584|155124|P1|COMPLETED|Overall Study||28
64703|NCT01728584|155121|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
64704|NCT01728584|155122|P3|STARTED|Overall Study|Randomized|31
64705|NCT01728584|155123|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
64706|NCT01728584|155124|P1|STARTED|Overall Study|Randomized|36
64707|NCT01728376|155182|P6|NOT COMPLETED|Overall Study||2
64708|NCT01728376|155183|P5|NOT COMPLETED|Overall Study||2
64709|NCT01728376|155184|P4|NOT COMPLETED|Overall Study||2
64710|NCT01728376|155185|P3|NOT COMPLETED|Overall Study||2
64711|NCT01728376|155186|P2|NOT COMPLETED|Overall Study||2
64712|NCT01728376|155187|P1|NOT COMPLETED|Overall Study||4
64713|NCT01728376|155182|P6|COMPLETED|Overall Study||5
64714|NCT01728376|155183|P5|COMPLETED|Overall Study||12
64715|NCT01728376|155184|P4|COMPLETED|Overall Study||7
64716|NCT01728376|155185|P3|COMPLETED|Overall Study||17
64717|NCT01728376|155186|P2|COMPLETED|Overall Study||9
64718|NCT01728376|155187|P1|COMPLETED|Overall Study||18
64719|NCT01728376|155182|P6|Treated|Overall Study||7
64720|NCT01728376|155183|P5|Treated|Overall Study||14
64721|NCT01728376|155184|P4|Treated|Overall Study||9
64722|NCT01728376|155185|P3|Treated|Overall Study||19
64723|NCT01728376|155186|P2|Treated|Overall Study||10
64724|NCT01728376|155187|P1|Treated|Overall Study||22
64725|NCT01728376|155182|P6|STARTED|Overall Study||7
64726|NCT01728376|155183|P5|STARTED|Overall Study||14
64727|NCT01728376|155184|P4|STARTED|Overall Study||9
64728|NCT01728376|155185|P3|STARTED|Overall Study||19
64729|NCT01728376|155186|P2|STARTED|Overall Study||11
64730|NCT01728376|155187|P1|STARTED|Overall Study||22
64731|NCT01728337|155249|P1|NOT COMPLETED|Overall Study||0
64732|NCT01728337|155249|P1|COMPLETED|Overall Study||80
64733|NCT01728337|155249|P1|STARTED|Overall Study||80
64734|NCT01728324|155260|P3|NOT COMPLETED|Termination of RBV||15
64735|NCT01728324|155261|P2|NOT COMPLETED|Termination of RBV||37
64736|NCT01728324|155262|P1|NOT COMPLETED|Termination of RBV||39
64737|NCT01728324|155260|P3|COMPLETED|Termination of RBV||57
64738|NCT01728324|155261|P2|COMPLETED|Termination of RBV||176
64739|NCT01728324|155262|P1|COMPLETED|Termination of RBV||172
64740|NCT01728324|155260|P3|STARTED|Termination of RBV||72
64741|NCT01728324|155261|P2|STARTED|Termination of RBV||213
64742|NCT01728324|155262|P1|STARTED|Termination of RBV||211
64743|NCT01728324|155260|P3|NOT COMPLETED|Termination of FDV||14
64744|NCT01728324|155261|P2|NOT COMPLETED|Termination of FDV||36
64745|NCT01728324|155262|P1|NOT COMPLETED|Termination of FDV||38
64746|NCT01728324|155260|P3|COMPLETED|Termination of FDV||58
64747|NCT01728324|155261|P2|COMPLETED|Termination of FDV||177
64748|NCT01728324|155262|P1|COMPLETED|Termination of FDV||173
64749|NCT01728324|155260|P3|STARTED|Termination of FDV||72
64750|NCT01728324|155261|P2|STARTED|Termination of FDV||213
64751|NCT01728324|155262|P1|STARTED|Termination of FDV||211
64752|NCT01728324|155260|P3|NOT COMPLETED|Termination of DBV||14
64753|NCT01728324|155261|P2|NOT COMPLETED|Termination of DBV||36
64754|NCT01728324|155262|P1|NOT COMPLETED|Termination of DBV||38
64755|NCT01728324|155260|P3|COMPLETED|Termination of DBV||58
64756|NCT01728324|155261|P2|COMPLETED|Termination of DBV||177
64757|NCT01728324|155262|P1|COMPLETED|Termination of DBV||173
64758|NCT01728324|155260|P3|STARTED|Termination of DBV||72
64759|NCT01728324|155261|P2|STARTED|Termination of DBV||213
64760|NCT01728324|155262|P1|STARTED|Termination of DBV||211
64761|NCT01728246|155283|P2|NOT COMPLETED|Overall Study||36
64762|NCT01728246|155284|P1|NOT COMPLETED|Overall Study||36
64763|NCT01728246|155283|P2|COMPLETED|Overall Study||195
64764|NCT01728246|155284|P1|COMPLETED|Overall Study||206
64765|NCT01728246|155283|P2|STARTED|Overall Study||231
64766|NCT01728246|155284|P1|STARTED|Overall Study||242
64767|NCT01728116|155302|P2|NOT COMPLETED|Overall Study||47
64768|NCT01728116|155303|P1|NOT COMPLETED|Overall Study||161
64769|NCT01728116|155302|P2|COMPLETED|Overall Study|Completed to Week 52|60
64770|NCT01728116|155303|P1|COMPLETED|Overall Study|Completed to Week 78|52
64771|NCT01728116|155302|P2|STARTED|Overall Study|Sham mITT subjects|107
64772|NCT01728116|155303|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
64773|NCT01728077|155328|P2|NOT COMPLETED|Overall Study||5
64774|NCT01728077|155329|P1|NOT COMPLETED|Overall Study||8
64775|NCT01728077|155328|P2|COMPLETED|Overall Study||2
64776|NCT01728077|155329|P1|COMPLETED|Overall Study||11
64777|NCT01728077|155328|P2|STARTED|Overall Study||7
64778|NCT01728077|155329|P1|STARTED|Overall Study||19
64779|NCT01727895|155344|P2|NOT COMPLETED|Overall Study||0
64780|NCT01727895|155345|P1|NOT COMPLETED|Overall Study||0
64781|NCT01727895|155344|P2|COMPLETED|Overall Study||5
64782|NCT01727895|155345|P1|COMPLETED|Overall Study||10
64783|NCT01727895|155344|P2|STARTED|Overall Study||5
64784|NCT01727895|155345|P1|STARTED|Overall Study||10
64785|NCT01727791|155351|P1|NOT COMPLETED|Overall Study||0
64786|NCT01727791|155351|P1|COMPLETED|Overall Study||10
64787|NCT01727791|155351|P1|STARTED|Overall Study||10
64788|NCT01727713|155381|P1|NOT COMPLETED|Overall Study||35
64789|NCT01727713|155381|P1|COMPLETED|Overall Study||75
64790|NCT01727713|155381|P1|STARTED|Overall Study||110
64791|NCT01727700|155408|P3|NOT COMPLETED|Overall Study||2
64792|NCT01727700|155409|P2|NOT COMPLETED|Overall Study||10
64793|NCT01727700|155410|P1|NOT COMPLETED|Overall Study||2
64794|NCT01727700|155408|P3|COMPLETED|Overall Study||42
64795|NCT01727700|155409|P2|COMPLETED|Overall Study||35
64796|NCT01727700|155410|P1|COMPLETED|Overall Study||42
64797|NCT01727700|155408|P3|STARTED|Overall Study||44
64798|NCT01727700|155409|P2|STARTED|Overall Study||45
64799|NCT01727700|155410|P1|STARTED|Overall Study||44
64800|NCT01727505|155433|P2|NOT COMPLETED|Second 24 Hours||1
64801|NCT01727505|155434|P1|NOT COMPLETED|Second 24 Hours||0
64802|NCT01727505|155433|P2|COMPLETED|Second 24 Hours||10
64803|NCT01727505|155434|P1|COMPLETED|Second 24 Hours||14
64804|NCT01727505|155433|P2|STARTED|Second 24 Hours||11
64805|NCT01727505|155434|P1|STARTED|Second 24 Hours||14
64806|NCT01727505|155433|P2|NOT COMPLETED|First 24 Hours||1
64807|NCT01727505|155434|P1|NOT COMPLETED|First 24 Hours||0
64808|NCT01727505|155433|P2|COMPLETED|First 24 Hours||11
64809|NCT01727505|155434|P1|COMPLETED|First 24 Hours||14
64810|NCT01727505|155433|P2|STARTED|First 24 Hours||12
64811|NCT01727505|155434|P1|STARTED|First 24 Hours||14
64812|NCT01727414|155452|P2|NOT COMPLETED|Overall Study||0
64813|NCT01727414|155453|P1|NOT COMPLETED|Overall Study||3
64814|NCT01727414|155452|P2|COMPLETED|Overall Study||45
64815|NCT01727414|155453|P1|COMPLETED|Overall Study||123
64816|NCT01727414|155452|P2|STARTED|Overall Study||45
64817|NCT01727414|155453|P1|STARTED|Overall Study||126
64818|NCT01727297|155459|P2|NOT COMPLETED|Overall Study||51
64819|NCT01727297|155460|P1|NOT COMPLETED|Overall Study||102
64820|NCT01727297|155459|P2|COMPLETED|Overall Study||0
64821|NCT01727297|155460|P1|COMPLETED|Overall Study||293
64822|NCT01727297|155459|P2|STARTED|Overall Study||51
64823|NCT01727297|155460|P1|STARTED|Overall Study||395
64824|NCT01727258|155476|P3|NOT COMPLETED|Overall Study||1
64825|NCT01727258|155477|P2|NOT COMPLETED|Overall Study||3
64826|NCT01727258|155478|P1|NOT COMPLETED|Overall Study||2
64827|NCT01727258|155476|P3|COMPLETED|Overall Study||50
64828|NCT01727258|155477|P2|COMPLETED|Overall Study||48
64829|NCT01727258|155478|P1|COMPLETED|Overall Study||49
64830|NCT01727258|155476|P3|STARTED|Overall Study||51
64831|NCT01727258|155477|P2|STARTED|Overall Study||51
64832|NCT01727258|155478|P1|STARTED|Overall Study||51
64833|NCT01727180|155501|P1|NOT COMPLETED|Overall Study||0
64834|NCT01727180|155501|P1|COMPLETED|Overall Study||108
64835|NCT01727180|155501|P1|STARTED|Overall Study||108
64836|NCT01727167|155507|P2|NOT COMPLETED|Overall Study||0
64837|NCT01727167|155508|P1|NOT COMPLETED|Overall Study||0
64838|NCT01727167|155507|P2|COMPLETED|Overall Study||0
64839|NCT01727167|155508|P1|COMPLETED|Overall Study||1
64840|NCT01727167|155507|P2|STARTED|Overall Study||0
64841|NCT01727167|155508|P1|STARTED|Overall Study||1
64842|NCT01727141|155520|P4|NOT COMPLETED|Overall Study||15
64843|NCT01727141|155521|P3|NOT COMPLETED|Overall Study||3
64844|NCT01727141|155522|P2|NOT COMPLETED|Overall Study||9
64845|NCT01727141|155523|P1|NOT COMPLETED|Overall Study||5
64846|NCT01727141|155520|P4|COMPLETED|Overall Study||246
64847|NCT01727141|155521|P3|COMPLETED|Overall Study||258
64848|NCT01727141|155522|P2|COMPLETED|Overall Study||251
64849|NCT01727141|155523|P1|COMPLETED|Overall Study||255
64850|NCT01727141|155520|P4|Full Analysis Set|Overall Study||261
64851|NCT01727141|155521|P3|Full Analysis Set|Overall Study||261
64852|NCT01727141|155522|P2|Full Analysis Set|Overall Study||260
64853|NCT01727141|155523|P1|Full Analysis Set|Overall Study||258
64854|NCT01727141|155520|P4|Safety Set|Overall Study||260
64855|NCT01727141|155521|P3|Safety Set|Overall Study||262
64856|NCT01727141|155522|P2|Safety Set|Overall Study||260
64857|NCT01727141|155523|P1|Safety Set|Overall Study||258
64858|NCT01727141|155520|P4|STARTED|Overall Study||261
64859|NCT01727141|155521|P3|STARTED|Overall Study||261
64860|NCT01727141|155522|P2|STARTED|Overall Study||260
64861|NCT01727141|155523|P1|STARTED|Overall Study||260
64862|NCT01727024|155573|P2|NOT COMPLETED|Period 2||0
64863|NCT01727024|155574|P1|NOT COMPLETED|Period 2||0
64864|NCT01727024|155573|P2|COMPLETED|Period 2||64
64865|NCT01727024|155574|P1|COMPLETED|Period 2||68
64866|NCT01727024|155573|P2|STARTED|Period 2||64
64867|NCT01727024|155574|P1|STARTED|Period 2||68
64868|NCT01727024|155573|P2|NOT COMPLETED|Period 1||4
64869|NCT01727024|155574|P1|NOT COMPLETED|Period 1||3
64870|NCT01727024|155573|P2|COMPLETED|Period 1||64
64871|NCT01727024|155574|P1|COMPLETED|Period 1||68
64872|NCT01727024|155573|P2|STARTED|Period 1||68
64873|NCT01727024|155574|P1|STARTED|Period 1||71
64874|NCT01726621|155587|P1|NOT COMPLETED|Overall Study||4
64875|NCT01726621|155587|P1|COMPLETED|Overall Study||51
64876|NCT01726621|155587|P1|STARTED|Overall Study||55
64877|NCT01726517|155596|P5|NOT COMPLETED|Overall Study||0
64878|NCT01726517|155597|P4|NOT COMPLETED|Overall Study||0
64879|NCT01726517|155598|P3|NOT COMPLETED|Overall Study||1
64880|NCT01726517|155599|P2|NOT COMPLETED|Overall Study||0
64881|NCT01726517|155600|P1|NOT COMPLETED|Overall Study||0
64882|NCT01726517|155596|P5|COMPLETED|Overall Study||21
64883|NCT01726517|155597|P4|COMPLETED|Overall Study||19
64884|NCT01726517|155598|P3|COMPLETED|Overall Study||18
64885|NCT01726517|155599|P2|COMPLETED|Overall Study||21
64886|NCT01726517|155600|P1|COMPLETED|Overall Study||20
64887|NCT01726517|155596|P5|STARTED|Overall Study||21
64888|NCT01726517|155597|P4|STARTED|Overall Study||19
64889|NCT01726517|155598|P3|STARTED|Overall Study||19
64890|NCT01726517|155599|P2|STARTED|Overall Study||21
64891|NCT01726517|155600|P1|STARTED|Overall Study||20
64892|NCT01726504|155629|P2|NOT COMPLETED|Overall Study||28
64893|NCT01726504|155630|P1|NOT COMPLETED|Overall Study||12
64894|NCT01726504|155629|P2|COMPLETED|Overall Study||511
64895|NCT01726504|155630|P1|COMPLETED|Overall Study||524
64896|NCT01726504|155629|P2|STARTED|Overall Study||539
64897|NCT01726504|155630|P1|STARTED|Overall Study||536
64898|NCT01726335|155656|P1|NOT COMPLETED|Overall Study||24
64899|NCT01726335|155656|P1|COMPLETED|Overall Study||29
64900|NCT01726335|155656|P1|STARTED|Overall Study||53
64901|NCT01726049|155674|P2|NOT COMPLETED|Overall Study||4
64902|NCT01726049|155675|P1|NOT COMPLETED|Overall Study||5
64903|NCT01726049|155674|P2|COMPLETED|Overall Study||22
64904|NCT01726049|155675|P1|COMPLETED|Overall Study||21
64905|NCT01726049|155674|P2|STARTED|Overall Study||26
64906|NCT01726049|155675|P1|STARTED|Overall Study||26
64907|NCT01726023|155689|P2|NOT COMPLETED|Overall Study||26
64908|NCT01726023|155690|P1|NOT COMPLETED|Overall Study||29
64909|NCT01726023|155689|P2|COMPLETED|Overall Study||196
64910|NCT01726023|155690|P1|COMPLETED|Overall Study||190
64911|NCT01726023|155689|P2|STARTED|Overall Study||222
64912|NCT01726023|155690|P1|STARTED|Overall Study||219
64913|NCT01725984|155782|P2|NOT COMPLETED|Overall Study||0
64914|NCT01725984|155783|P1|NOT COMPLETED|Overall Study||0
64915|NCT01725984|155782|P2|COMPLETED|Overall Study||41
64916|NCT01725984|155783|P1|COMPLETED|Overall Study||39
64917|NCT01725984|155782|P2|STARTED|Overall Study||41
64918|NCT01725984|155783|P1|STARTED|Overall Study||39
64919|NCT01725529|155810|P3|NOT COMPLETED|Overall Study||10
64920|NCT01725529|155811|P2|NOT COMPLETED|Overall Study||16
64921|NCT01725529|155812|P1|NOT COMPLETED|Overall Study||15
64922|NCT01725529|155810|P3|COMPLETED|Overall Study||142
64923|NCT01725529|155811|P2|COMPLETED|Overall Study||137
64924|NCT01725529|155812|P1|COMPLETED|Overall Study||137
64925|NCT01725529|155810|P3|STARTED|Overall Study||152
64926|NCT01725529|155811|P2|STARTED|Overall Study||153
64927|NCT01725529|155812|P1|STARTED|Overall Study||152
64928|NCT01725451|155838|P4|NOT COMPLETED|Period 6||0
64929|NCT01725451|155839|P3|NOT COMPLETED|Period 6||0
64930|NCT01725451|155840|P2|NOT COMPLETED|Period 6||0
64931|NCT01725451|155841|P1|NOT COMPLETED|Period 6||0
64932|NCT01725451|155838|P4|COMPLETED|Period 6||7
64933|NCT01725451|155839|P3|COMPLETED|Period 6||6
64934|NCT01725451|155840|P2|COMPLETED|Period 6||6
64935|NCT01725451|155841|P1|COMPLETED|Period 6||7
64936|NCT01725451|155838|P4|STARTED|Period 6||7
64937|NCT01725451|155839|P3|STARTED|Period 6||6
64938|NCT01725451|155840|P2|STARTED|Period 6||6
64939|NCT01725451|155841|P1|STARTED|Period 6||7
64940|NCT01725451|155838|P4|NOT COMPLETED|Washout From Period 5||0
64941|NCT01725451|155839|P3|NOT COMPLETED|Washout From Period 5||0
64942|NCT01725451|155840|P2|NOT COMPLETED|Washout From Period 5||0
64943|NCT01725451|155841|P1|NOT COMPLETED|Washout From Period 5||0
64944|NCT01725451|155838|P4|COMPLETED|Washout From Period 5||7
64945|NCT01725451|155839|P3|COMPLETED|Washout From Period 5||6
64946|NCT01725451|155840|P2|COMPLETED|Washout From Period 5||6
64947|NCT01725451|155841|P1|COMPLETED|Washout From Period 5||7
64948|NCT01725451|155838|P4|STARTED|Washout From Period 5||7
64949|NCT01725451|155839|P3|STARTED|Washout From Period 5||6
64950|NCT01725451|155840|P2|STARTED|Washout From Period 5||6
64951|NCT01725451|155841|P1|STARTED|Washout From Period 5||7
64952|NCT01725451|155838|P4|NOT COMPLETED|Period 5||0
64953|NCT01725451|155839|P3|NOT COMPLETED|Period 5||0
64954|NCT01725451|155840|P2|NOT COMPLETED|Period 5||0
64955|NCT01725451|155841|P1|NOT COMPLETED|Period 5||0
64956|NCT01725451|155838|P4|COMPLETED|Period 5||7
64957|NCT01725451|155839|P3|COMPLETED|Period 5||6
64958|NCT01725451|155840|P2|COMPLETED|Period 5||6
64959|NCT01725451|155841|P1|COMPLETED|Period 5||7
64960|NCT01725451|155838|P4|STARTED|Period 5||7
64961|NCT01725451|155839|P3|STARTED|Period 5||6
64962|NCT01725451|155840|P2|STARTED|Period 5||6
64963|NCT01725451|155841|P1|STARTED|Period 5||7
64964|NCT01725451|155838|P4|NOT COMPLETED|Washout From Period 4||0
64965|NCT01725451|155839|P3|NOT COMPLETED|Washout From Period 4||0
64966|NCT01725451|155840|P2|NOT COMPLETED|Washout From Period 4||0
64967|NCT01725451|155841|P1|NOT COMPLETED|Washout From Period 4||0
64968|NCT01725451|155838|P4|COMPLETED|Washout From Period 4||7
64969|NCT01725451|155839|P3|COMPLETED|Washout From Period 4||6
64970|NCT01725451|155840|P2|COMPLETED|Washout From Period 4||6
64971|NCT01725451|155841|P1|COMPLETED|Washout From Period 4||7
64972|NCT01725451|155838|P4|STARTED|Washout From Period 4||7
64973|NCT01725451|155839|P3|STARTED|Washout From Period 4||6
64974|NCT01725451|155840|P2|STARTED|Washout From Period 4||6
64975|NCT01725451|155841|P1|STARTED|Washout From Period 4||7
64976|NCT01725451|155838|P4|NOT COMPLETED|Period 4||0
64977|NCT01725451|155839|P3|NOT COMPLETED|Period 4||1
64978|NCT01725451|155840|P2|NOT COMPLETED|Period 4||0
64979|NCT01725451|155841|P1|NOT COMPLETED|Period 4||0
64980|NCT01725451|155838|P4|COMPLETED|Period 4||7
64981|NCT01725451|155839|P3|COMPLETED|Period 4||6
64982|NCT01725451|155840|P2|COMPLETED|Period 4||6
64983|NCT01725451|155841|P1|COMPLETED|Period 4||7
64984|NCT01725451|155838|P4|STARTED|Period 4||7
64985|NCT01725451|155839|P3|STARTED|Period 4||7
64986|NCT01725451|155840|P2|STARTED|Period 4||6
64987|NCT01725451|155841|P1|STARTED|Period 4||7
64988|NCT01725451|155838|P4|NOT COMPLETED|Washout From Period 3||0
64989|NCT01725451|155839|P3|NOT COMPLETED|Washout From Period 3||1
64990|NCT01725451|155840|P2|NOT COMPLETED|Washout From Period 3||1
64991|NCT01725451|155841|P1|NOT COMPLETED|Washout From Period 3||0
64992|NCT01725451|155838|P4|COMPLETED|Washout From Period 3||7
64993|NCT01725451|155839|P3|COMPLETED|Washout From Period 3||7
64994|NCT01725451|155840|P2|COMPLETED|Washout From Period 3||6
64995|NCT01725451|155841|P1|COMPLETED|Washout From Period 3||7
64996|NCT01725451|155838|P4|STARTED|Washout From Period 3||7
64997|NCT01725451|155839|P3|STARTED|Washout From Period 3||8
64998|NCT01725451|155840|P2|STARTED|Washout From Period 3||7
64999|NCT01725451|155841|P1|STARTED|Washout From Period 3||7
65000|NCT01725451|155838|P4|NOT COMPLETED|Period 3||0
65001|NCT01725451|155839|P3|NOT COMPLETED|Period 3||0
65002|NCT01725451|155840|P2|NOT COMPLETED|Period 3||0
65003|NCT01725451|155841|P1|NOT COMPLETED|Period 3||0
65004|NCT01725451|155838|P4|COMPLETED|Period 3||7
65005|NCT01725451|155839|P3|COMPLETED|Period 3||8
65006|NCT01725451|155840|P2|COMPLETED|Period 3||7
65007|NCT01725451|155841|P1|COMPLETED|Period 3||7
65008|NCT01725451|155838|P4|STARTED|Period 3||7
65009|NCT01725451|155839|P3|STARTED|Period 3||8
65010|NCT01725451|155840|P2|STARTED|Period 3||7
65011|NCT01725451|155841|P1|STARTED|Period 3||7
65012|NCT01725451|155838|P4|NOT COMPLETED|Washout From Period 2||0
65013|NCT01725451|155839|P3|NOT COMPLETED|Washout From Period 2||0
65014|NCT01725451|155840|P2|NOT COMPLETED|Washout From Period 2||0
65015|NCT01725451|155841|P1|NOT COMPLETED|Washout From Period 2||0
65016|NCT01725451|155838|P4|COMPLETED|Washout From Period 2||7
65017|NCT01725451|155839|P3|COMPLETED|Washout From Period 2||8
65018|NCT01725451|155840|P2|COMPLETED|Washout From Period 2||7
65019|NCT01725451|155841|P1|COMPLETED|Washout From Period 2||7
65020|NCT01725451|155838|P4|STARTED|Washout From Period 2||7
65021|NCT01725451|155839|P3|STARTED|Washout From Period 2||8
65022|NCT01725451|155840|P2|STARTED|Washout From Period 2||7
65023|NCT01725451|155841|P1|STARTED|Washout From Period 2||7
65024|NCT01725451|155838|P4|NOT COMPLETED|Period 2||0
65025|NCT01725451|155839|P3|NOT COMPLETED|Period 2||0
65026|NCT01725451|155840|P2|NOT COMPLETED|Period 2||0
65027|NCT01725451|155841|P1|NOT COMPLETED|Period 2||0
65028|NCT01725451|155838|P4|COMPLETED|Period 2||7
65029|NCT01725451|155839|P3|COMPLETED|Period 2||8
65030|NCT01725451|155840|P2|COMPLETED|Period 2||7
65031|NCT01725451|155841|P1|COMPLETED|Period 2||7
65032|NCT01725451|155838|P4|STARTED|Period 2||7
65033|NCT01725451|155839|P3|STARTED|Period 2||8
65034|NCT01725451|155840|P2|STARTED|Period 2||7
65035|NCT01725451|155841|P1|STARTED|Period 2||7
65036|NCT01725451|155838|P4|NOT COMPLETED|Washout From Period 1||0
65037|NCT01725451|155839|P3|NOT COMPLETED|Washout From Period 1||0
65038|NCT01725451|155840|P2|NOT COMPLETED|Washout From Period 1||0
65039|NCT01725451|155841|P1|NOT COMPLETED|Washout From Period 1||0
65040|NCT01725451|155838|P4|COMPLETED|Washout From Period 1||7
65041|NCT01725451|155839|P3|COMPLETED|Washout From Period 1||8
65042|NCT01725451|155840|P2|COMPLETED|Washout From Period 1||7
65043|NCT01725451|155841|P1|COMPLETED|Washout From Period 1||7
65044|NCT01725451|155838|P4|STARTED|Washout From Period 1||7
65045|NCT01725451|155839|P3|STARTED|Washout From Period 1||8
65046|NCT01725451|155840|P2|STARTED|Washout From Period 1||7
65047|NCT01725451|155841|P1|STARTED|Washout From Period 1||7
65048|NCT01725451|155838|P4|NOT COMPLETED|Period 1||0
65049|NCT01725451|155839|P3|NOT COMPLETED|Period 1||0
65050|NCT01725451|155840|P2|NOT COMPLETED|Period 1||0
65051|NCT01725451|155841|P1|NOT COMPLETED|Period 1||1
65052|NCT01725451|155838|P4|COMPLETED|Period 1||7
65053|NCT01725451|155839|P3|COMPLETED|Period 1||8
65054|NCT01725451|155840|P2|COMPLETED|Period 1||7
65055|NCT01725451|155841|P1|COMPLETED|Period 1||7
65056|NCT01725451|155838|P4|STARTED|Period 1||7
65057|NCT01725451|155839|P3|STARTED|Period 1||8
65058|NCT01725451|155840|P2|STARTED|Period 1||7
65059|NCT01725451|155841|P1|STARTED|Period 1||8
65060|NCT01725386|155863|P2|NOT COMPLETED|Overall Study||46
65061|NCT01725386|155864|P1|NOT COMPLETED|Overall Study||175
65062|NCT01725386|155863|P2|COMPLETED|Overall Study||17
65063|NCT01725386|155864|P1|COMPLETED|Overall Study||13
65064|NCT01725386|155863|P2|STARTED|Overall Study||63
65065|NCT01725386|155864|P1|STARTED|Overall Study||188
65066|NCT01725308|155883|P3|NOT COMPLETED|Treatment Period II||64
65067|NCT01725308|155884|P2|NOT COMPLETED|Treatment Period II||29
65068|NCT01725308|155885|P1|NOT COMPLETED|Treatment Period II||55
65069|NCT01725308|155883|P3|COMPLETED|Treatment Period II||74
65070|NCT01725308|155884|P2|COMPLETED|Treatment Period II||31
65071|NCT01725308|155885|P1|COMPLETED|Treatment Period II||79
65072|NCT01725308|155883|P3|Treated|Treatment Period II||130
65073|NCT01725308|155884|P2|Treated|Treatment Period II||53
65074|NCT01725308|155885|P1|Treated|Treatment Period II||120
65075|NCT01725308|155883|P3|STARTED|Treatment Period II||138
65076|NCT01725308|155884|P2|STARTED|Treatment Period II||60
65077|NCT01725308|155885|P1|STARTED|Treatment Period II||134
65078|NCT01725308|155883|P3|NOT COMPLETED|Treatment Period I||41
65079|NCT01725308|155884|P2|NOT COMPLETED|Treatment Period I||14
65080|NCT01725308|155885|P1|NOT COMPLETED|Treatment Period I||44
65081|NCT01725308|155883|P3|COMPLETED|Treatment Period I||138
65082|NCT01725308|155884|P2|COMPLETED|Treatment Period I||60
65083|NCT01725308|155885|P1|COMPLETED|Treatment Period I||134
65084|NCT01725308|155883|P3|Treated|Treatment Period I||179
65085|NCT01725308|155884|P2|Treated|Treatment Period I||74
65086|NCT01725308|155885|P1|Treated|Treatment Period I||177
65087|NCT01725308|155883|P3|STARTED|Treatment Period I||179
65088|NCT01725308|155884|P2|STARTED|Treatment Period I||74
65089|NCT01725308|155885|P1|STARTED|Treatment Period I||178
65090|NCT01725282|156032|P4|NOT COMPLETED|Overall Study||7
65091|NCT01725282|156033|P3|NOT COMPLETED|Overall Study||8
65092|NCT01725282|156034|P2|NOT COMPLETED|Overall Study||5
65093|NCT01725282|156035|P1|NOT COMPLETED|Overall Study||2
65094|NCT01725282|156032|P4|COMPLETED|Overall Study||36
65095|NCT01725282|156033|P3|COMPLETED|Overall Study||33
65096|NCT01725282|156034|P2|COMPLETED|Overall Study||39
65097|NCT01725282|156035|P1|COMPLETED|Overall Study||42
65098|NCT01725282|156032|P4|STARTED|Overall Study||43
65099|NCT01725282|156033|P3|STARTED|Overall Study||41
65100|NCT01725282|156034|P2|STARTED|Overall Study||44
65101|NCT01725282|156035|P1|STARTED|Overall Study||44
65102|NCT01725217|156068|P3|NOT COMPLETED|Overall Study||0
65103|NCT01725217|156069|P2|NOT COMPLETED|Overall Study||0
65104|NCT01725217|156070|P1|NOT COMPLETED|Overall Study||1
65105|NCT01725217|156068|P3|COMPLETED|Overall Study||66
65106|NCT01725217|156069|P2|COMPLETED|Overall Study||66
65107|NCT01725217|156070|P1|COMPLETED|Overall Study||65
65108|NCT01725217|156068|P3|STARTED|Overall Study||66
65109|NCT01725217|156069|P2|STARTED|Overall Study||66
65110|NCT01725217|156070|P1|STARTED|Overall Study||66
65111|NCT01725126|156104|P6|NOT COMPLETED|Overall Study||0
65112|NCT01725126|156105|P5|NOT COMPLETED|Overall Study||0
65113|NCT01725126|156106|P4|NOT COMPLETED|Overall Study||1
65114|NCT01725126|156107|P3|NOT COMPLETED|Overall Study||0
65115|NCT01725126|156108|P2|NOT COMPLETED|Overall Study||1
65116|NCT01725126|156109|P1|NOT COMPLETED|Overall Study||0
65117|NCT01725126|156104|P6|COMPLETED|Overall Study||12
65118|NCT01725126|156105|P5|COMPLETED|Overall Study||6
65119|NCT01725126|156106|P4|COMPLETED|Overall Study||13
65120|NCT01725126|156107|P3|COMPLETED|Overall Study||6
65121|NCT01725126|156108|P2|COMPLETED|Overall Study||10
65122|NCT01725126|156109|P1|COMPLETED|Overall Study||4
65123|NCT01725126|156104|P6|STARTED|Overall Study||12
65124|NCT01725126|156105|P5|STARTED|Overall Study||6
65125|NCT01725126|156106|P4|STARTED|Overall Study||14
65126|NCT01725126|156107|P3|STARTED|Overall Study||6
65127|NCT01725126|156108|P2|STARTED|Overall Study||11
65128|NCT01725126|156109|P1|STARTED|Overall Study||4
65129|NCT01724528|156307|P2|NOT COMPLETED|Overall Study||3
65130|NCT01724528|156308|P1|NOT COMPLETED|Overall Study||4
65131|NCT01724528|156307|P2|COMPLETED|Overall Study||170
65132|NCT01724528|156308|P1|COMPLETED|Overall Study||169
65133|NCT01724528|156307|P2|STARTED|Overall Study||173
65134|NCT01724528|156308|P1|STARTED|Overall Study||173
65135|NCT01724359|156322|P1|NOT COMPLETED|Overall Study||31
65136|NCT01724359|156322|P1|COMPLETED|Overall Study||64
65137|NCT01724359|156322|P1|STARTED|Overall Study||95
65138|NCT01724216|156335|P1|NOT COMPLETED|Overall Study||1
65139|NCT01724216|156335|P1|COMPLETED|Overall Study||10
65140|NCT01724216|156335|P1|STARTED|Overall Study||11
65141|NCT01724177|156339|P1|NOT COMPLETED|Overall Study||26
65142|NCT01724177|156339|P1|COMPLETED|Overall Study||0
65143|NCT01724177|156339|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
65144|NCT01724177|156339|P1|STARTED|Overall Study||26
65145|NCT01724021|156352|P2|NOT COMPLETED|Overall Study||133
65146|NCT01724021|156353|P1|NOT COMPLETED|Overall Study||127
65147|NCT01724021|156352|P2|COMPLETED|Overall Study||236
65148|NCT01724021|156353|P1|COMPLETED|Overall Study||244
65149|NCT01724021|156352|P2|STARTED|Overall Study||369
65150|NCT01724021|156353|P1|STARTED|Overall Study||371
65151|NCT01723904|156385|P1|NOT COMPLETED|Overall Study||11
65152|NCT01723904|156385|P1|COMPLETED|Overall Study||79
65153|NCT01723904|156385|P1|STARTED|Overall Study||90
65154|NCT01723722|156397|P2|NOT COMPLETED|Overall Study||0
65155|NCT01723722|156398|P1|NOT COMPLETED|Overall Study||0
65156|NCT01723722|156397|P2|COMPLETED|Overall Study||20
65157|NCT01723722|156398|P1|COMPLETED|Overall Study||20
65158|NCT01723722|156397|P2|STARTED|Overall Study||20
65159|NCT01723722|156398|P1|STARTED|Overall Study||20
65160|NCT01723397|156406|P2|NOT COMPLETED|Study Period 2||1
65161|NCT01723397|156407|P1|NOT COMPLETED|Study Period 2||0
65162|NCT01723397|156406|P2|COMPLETED|Study Period 2||5
65163|NCT01723397|156407|P1|COMPLETED|Study Period 2||7
65164|NCT01723397|156406|P2|STARTED|Study Period 2||6
65165|NCT01723397|156407|P1|STARTED|Study Period 2||7
65166|NCT01723397|156406|P2|NOT COMPLETED|Washout||0
65167|NCT01723397|156407|P1|NOT COMPLETED|Washout||0
65168|NCT01723397|156406|P2|COMPLETED|Washout||6
65169|NCT01723397|156407|P1|COMPLETED|Washout||7
65170|NCT01723397|156406|P2|STARTED|Washout||6
65171|NCT01723397|156407|P1|STARTED|Washout||7
65172|NCT01723397|156406|P2|NOT COMPLETED|Study Period 1||1
65173|NCT01723397|156407|P1|NOT COMPLETED|Study Period 1||0
65174|NCT01723397|156406|P2|COMPLETED|Study Period 1||6
65175|NCT01723397|156407|P1|COMPLETED|Study Period 1||7
65176|NCT01723397|156406|P2|STARTED|Study Period 1||7
65177|NCT01723397|156407|P1|STARTED|Study Period 1||7
65178|NCT01723254|156421|P8|NOT COMPLETED|Overall Study||3
65179|NCT01723254|156422|P7|NOT COMPLETED|Overall Study||1
65180|NCT01723254|156423|P6|NOT COMPLETED|Overall Study||2
65181|NCT01723254|156424|P5|NOT COMPLETED|Overall Study||2
65182|NCT01723254|156425|P4|NOT COMPLETED|Overall Study||2
65183|NCT01723254|156426|P3|NOT COMPLETED|Overall Study||3
65184|NCT01723254|156427|P2|NOT COMPLETED|Overall Study||3
65185|NCT01723254|156428|P1|NOT COMPLETED|Overall Study||1
65186|NCT01723254|156421|P8|COMPLETED|Overall Study||60
65187|NCT01723254|156422|P7|COMPLETED|Overall Study||19
65188|NCT01723254|156423|P6|COMPLETED|Overall Study||18
65189|NCT01723254|156424|P5|COMPLETED|Overall Study||18
65190|NCT01723254|156425|P4|COMPLETED|Overall Study||18
65191|NCT01723254|156426|P3|COMPLETED|Overall Study||17
65192|NCT01723254|156427|P2|COMPLETED|Overall Study||18
65193|NCT01723254|156428|P1|COMPLETED|Overall Study||5
65194|NCT01723254|156421|P8|STARTED|Overall Study||63
65195|NCT01723254|156422|P7|STARTED|Overall Study||20
65196|NCT01723254|156423|P6|STARTED|Overall Study||20
65197|NCT01723254|156424|P5|STARTED|Overall Study||20
65198|NCT01723254|156425|P4|STARTED|Overall Study||20
65199|NCT01723254|156426|P3|STARTED|Overall Study||20
65200|NCT01723254|156427|P2|STARTED|Overall Study||21
65201|NCT01723254|156428|P1|STARTED|Overall Study||6
65202|NCT01723228|156480|P2|NOT COMPLETED|Overall Study||11
65203|NCT01723228|156481|P1|NOT COMPLETED|Overall Study||8
65204|NCT01723228|156480|P2|COMPLETED|Overall Study||73
65205|NCT01723228|156481|P1|COMPLETED|Overall Study||78
65206|NCT01723228|156480|P2|STARTED|Overall Study||84
65207|NCT01723228|156481|P1|STARTED|Overall Study||86
65208|NCT01722994|156499|P2|NOT COMPLETED|Overall Study||17
65209|NCT01722994|156500|P1|NOT COMPLETED|Overall Study||25
65210|NCT01722994|156499|P2|COMPLETED|Overall Study||31
65211|NCT01722994|156500|P1|COMPLETED|Overall Study||24
65212|NCT01722994|156499|P2|STARTED|Overall Study||48
65213|NCT01722994|156500|P1|STARTED|Overall Study||49
65214|NCT01722929|156514|P1|NOT COMPLETED|Overall Study||0
65215|NCT01722929|156514|P1|COMPLETED|Overall Study||4
65216|NCT01722929|156514|P1|STARTED|Overall Study||4
65217|NCT01722877|156519|P1|NOT COMPLETED|Overall Study||2
65218|NCT01722877|156519|P1|COMPLETED|Overall Study||27
65219|NCT01722877|156519|P1|STARTED|Overall Study||29
65220|NCT01722734|156529|P3|NOT COMPLETED|Overall Study||2
65221|NCT01722734|156530|P2|NOT COMPLETED|Overall Study||1
65222|NCT01722734|156531|P1|NOT COMPLETED|Overall Study||2
65223|NCT01722734|156529|P3|COMPLETED|Overall Study||307
65224|NCT01722734|156530|P2|COMPLETED|Overall Study||276
65225|NCT01722734|156531|P1|COMPLETED|Overall Study||552
65226|NCT01722734|156529|P3|STARTED|Overall Study||309
65227|NCT01722734|156530|P2|STARTED|Overall Study||277
65228|NCT01722734|156531|P1|STARTED|Overall Study||554
65229|NCT01722552|156539|P1|NOT COMPLETED|Overall Study||4
65230|NCT01722552|156539|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
65231|NCT01722552|156539|P1|STARTED|Overall Study|Number of subjects enrolled|120
65232|NCT01722487|156549|P2|NOT COMPLETED|Overall Study||7
65233|NCT01722487|156550|P1|NOT COMPLETED|Overall Study||2
65234|NCT01722487|156549|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
65235|NCT01722487|156550|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
65236|NCT01722487|156549|P2|STARTED|Overall Study||133
65237|NCT01722487|156550|P1|STARTED|Overall Study||136
65238|NCT01722435|156568|P1|NOT COMPLETED|Overall Study||0
65239|NCT01722435|156568|P1|COMPLETED|Overall Study||78
65240|NCT01722435|156568|P1|STARTED|Overall Study||78
65241|NCT01722266|156580|P4|NOT COMPLETED|Overall Study||0
65242|NCT01722266|156581|P3|NOT COMPLETED|Overall Study||5
65243|NCT01722266|156582|P2|NOT COMPLETED|Overall Study||3
65244|NCT01722266|156583|P1|NOT COMPLETED|Overall Study||1
65245|NCT01722266|156580|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
65246|NCT01722266|156581|P3|COMPLETED|Overall Study||13
65247|NCT01722266|156582|P2|COMPLETED|Overall Study||15
65248|NCT01722266|156583|P1|COMPLETED|Overall Study||17
65249|NCT01722266|156580|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
65250|NCT01722266|156581|P3|STARTED|Overall Study||18
65251|NCT01722266|156582|P2|STARTED|Overall Study||18
65252|NCT01722266|156583|P1|STARTED|Overall Study||18
65253|NCT01722162|156611|P2|NOT COMPLETED|Overall Study||6
65254|NCT01722162|156612|P1|NOT COMPLETED|Overall Study||5
65255|NCT01722162|156611|P2|COMPLETED|Overall Study||18
65256|NCT01722162|156612|P1|COMPLETED|Overall Study||18
65257|NCT01722162|156611|P2|STARTED|Overall Study||24
65258|NCT01722162|156612|P1|STARTED|Overall Study||23
65259|NCT01722097|156622|P2|NOT COMPLETED|Overall Study||5
65260|NCT01722097|156623|P1|NOT COMPLETED|Overall Study||6
65261|NCT01722097|156622|P2|COMPLETED|Overall Study||50
65262|NCT01722097|156623|P1|COMPLETED|Overall Study||49
65263|NCT01722097|156622|P2|STARTED|Overall Study||55
65264|NCT01722097|156623|P1|STARTED|Overall Study||55
65265|NCT01722071|156631|P2|NOT COMPLETED|Overall Study||0
65266|NCT01722071|156632|P1|NOT COMPLETED|Overall Study||1
65267|NCT01722071|156631|P2|COMPLETED|Overall Study||10
65268|NCT01722071|156632|P1|COMPLETED|Overall Study||9
65269|NCT01722071|156631|P2|STARTED|Overall Study||10
65270|NCT01722071|156632|P1|STARTED|Overall Study||10
65271|NCT01722045|156638|P1|NOT COMPLETED|Overall Study||28
65272|NCT01722045|156638|P1|COMPLETED|Overall Study||126
65273|NCT01722045|156638|P1|STARTED|Overall Study||154
65274|NCT01721967|156648|P1|NOT COMPLETED|Overall Study||3
65275|NCT01721967|156648|P1|COMPLETED|Overall Study||11
65276|NCT01721967|156648|P1|STARTED|Overall Study||14
65277|NCT01721837|156657|P1|NOT COMPLETED|Overall Study||0
65278|NCT01721837|156657|P1|COMPLETED|Overall Study||2120
65279|NCT01721837|156657|P1|STARTED|Overall Study||2120
65280|NCT01721772|156663|P2|NOT COMPLETED|Overall Study||192
65281|NCT01721772|156664|P1|NOT COMPLETED|Overall Study||111
65282|NCT01721772|156663|P2|COMPLETED|Overall Study|Continuing in treatment period|13
65283|NCT01721772|156664|P1|COMPLETED|Overall Study|Continuing in treatment period|95
65284|NCT01721772|156663|P2|STARTED|Overall Study||205
65285|NCT01721772|156664|P1|STARTED|Overall Study||206
65286|NCT01721759|156684|P1|NOT COMPLETED|Overall Study||102
65287|NCT01721759|156684|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
65288|NCT01721759|156684|P1|STARTED|Overall Study||117
65289|NCT01721746|156692|P3|NOT COMPLETED|Follow-Up Period||0
65290|NCT01721746|156693|P2|NOT COMPLETED|Follow-Up Period||0
65291|NCT01721746|156694|P1|NOT COMPLETED|Follow-Up Period||0
65292|NCT01721746|156692|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
65293|NCT01721746|156693|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
65294|NCT01721746|156694|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
65295|NCT01721746|156692|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
65296|NCT01721746|156693|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
65297|NCT01721746|156694|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
65298|NCT01721746|156692|P3|NOT COMPLETED|Treatment Period||57
65299|NCT01721746|156693|P2|NOT COMPLETED|Treatment Period||45
65300|NCT01721746|156694|P1|NOT COMPLETED|Treatment Period||233
65301|NCT01721746|156692|P3|COMPLETED|Treatment Period||0
65302|NCT01721746|156693|P2|COMPLETED|Treatment Period||0
65303|NCT01721746|156694|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
65304|NCT01721746|156692|P3|STARTED|Treatment Period||57
65305|NCT01721746|156693|P2|STARTED|Treatment Period||45
65306|NCT01721746|156694|P1|STARTED|Treatment Period||268
65307|NCT01721681|156710|P1|NOT COMPLETED|Overall Study||0
65308|NCT01721681|156710|P1|COMPLETED|Overall Study||9
65309|NCT01721681|156710|P1|STARTED|Overall Study||9
65310|NCT01721603|156716|P1|NOT COMPLETED|Overall Study||0
65311|NCT01721603|156716|P1|COMPLETED|Overall Study||2
65312|NCT01721603|156716|P1|STARTED|Overall Study||2
65313|NCT01721564|156727|P1|NOT COMPLETED|Overall Study||0
65314|NCT01721564|156727|P1|COMPLETED|Overall Study||8
65315|NCT01721564|156727|P1|STARTED|Overall Study||8
65316|NCT01721486|156734|P2|NOT COMPLETED|Overall Study||1
65317|NCT01721486|156735|P1|NOT COMPLETED|Overall Study||1
65318|NCT01721486|156734|P2|COMPLETED|Overall Study||19
65319|NCT01721486|156735|P1|COMPLETED|Overall Study||20
65320|NCT01721486|156734|P2|STARTED|Overall Study||20
65321|NCT01721486|156735|P1|STARTED|Overall Study||21
65322|NCT01721460|156747|P1|NOT COMPLETED|Overall Study||1
65323|NCT01721460|156747|P1|COMPLETED|Overall Study||5
65324|NCT01721460|156747|P1|STARTED|Overall Study||6
65325|NCT01721408|156756|P2|NOT COMPLETED|Overall Study||24
65326|NCT01721408|156757|P1|NOT COMPLETED|Overall Study||36
65327|NCT01721408|156756|P2|COMPLETED|Overall Study||207
65328|NCT01721408|156757|P1|COMPLETED|Overall Study||196
65329|NCT01721408|156756|P2|STARTED|Overall Study|Number of participants treated.|231
65330|NCT01721408|156757|P1|STARTED|Overall Study|Number of participants treated.|232
65331|NCT01721330|156773|P2|NOT COMPLETED|Overall Study||1
65332|NCT01721330|156774|P1|NOT COMPLETED|Overall Study||0
65333|NCT01721330|156773|P2|COMPLETED|Overall Study||1
65334|NCT01721330|156774|P1|COMPLETED|Overall Study||1
65335|NCT01721330|156773|P2|STARTED|Overall Study||2
65336|NCT01721330|156774|P1|STARTED|Overall Study||1
65337|NCT01721317|156782|P2|NOT COMPLETED|Overall Study||4
65338|NCT01721317|156783|P1|NOT COMPLETED|Overall Study||2
65339|NCT01721317|156782|P2|COMPLETED|Overall Study||0
65340|NCT01721317|156783|P1|COMPLETED|Overall Study||0
65341|NCT01721317|156782|P2|STARTED|Overall Study||4
65342|NCT01721317|156783|P1|STARTED|Overall Study||2
65343|NCT01721226|156851|P2|NOT COMPLETED|Overall Study||7
65344|NCT01721226|156852|P1|NOT COMPLETED|Overall Study||5
65345|NCT01721226|156851|P2|COMPLETED|Overall Study||50
65346|NCT01721226|156852|P1|COMPLETED|Overall Study||50
65347|NCT01721226|156851|P2|Week 24|Overall Study||50
65348|NCT01721226|156852|P1|Week 24|Overall Study||50
65349|NCT01721226|156851|P2|Week 12|Overall Study||53
65350|NCT01721226|156852|P1|Week 12|Overall Study||48
65351|NCT01721226|156851|P2|Baseline|Overall Study||57
65352|NCT01721226|156852|P1|Baseline|Overall Study||53
65353|NCT01721226|156851|P2|STARTED|Overall Study||57
65354|NCT01721226|156852|P1|STARTED|Overall Study||55
65355|NCT01721200|156862|P2|NOT COMPLETED|Overall Study||5
65356|NCT01721200|156863|P1|NOT COMPLETED|Overall Study||3
65357|NCT01721200|156862|P2|COMPLETED|Overall Study||58
65358|NCT01721200|156863|P1|COMPLETED|Overall Study||59
65359|NCT01721200|156862|P2|Completed 2 Week Follow-up|Overall Study||61
65360|NCT01721200|156863|P1|Completed 2 Week Follow-up|Overall Study||60
65361|NCT01721200|156862|P2|STARTED|Overall Study||63
65362|NCT01721200|156863|P1|STARTED|Overall Study||62
65363|NCT01721161|156888|P2|NOT COMPLETED|Overall Study||7
65364|NCT01721161|156889|P1|NOT COMPLETED|Overall Study||4
65365|NCT01721161|156888|P2|COMPLETED|Overall Study||34
65366|NCT01721161|156889|P1|COMPLETED|Overall Study||37
65367|NCT01721161|156888|P2|STARTED|Overall Study||41
65368|NCT01721161|156889|P1|STARTED|Overall Study||41
65369|NCT01721109|156912|P1|NOT COMPLETED|Extension Phase||37
65370|NCT01721109|156912|P1|COMPLETED|Extension Phase|Participants turned 18 years old or the study drug became commercially available in their country.|3
65371|NCT01721109|156912|P1|STARTED|Extension Phase|Only 40 participants entered the optional extension phase.|40
65372|NCT01721109|156912|P1|NOT COMPLETED|Main Phase||1
65373|NCT01721109|156912|P1|COMPLETED|Main Phase||49
65374|NCT01721109|156912|P1|STARTED|Main Phase||50
65375|NCT01721096|156927|P2|NOT COMPLETED|Overall Study||10
65376|NCT01721096|156928|P1|NOT COMPLETED|Overall Study||27
65377|NCT01721096|156927|P2|COMPLETED|Overall Study||203
65378|NCT01721096|156928|P1|COMPLETED|Overall Study||296
65379|NCT01721096|156927|P2|STARTED|Overall Study||213
65380|NCT01721096|156928|P1|STARTED|Overall Study||323
65381|NCT01721070|157077|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
65382|NCT01721070|157077|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
65383|NCT01721070|157077|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
65384|NCT01721070|157077|P1|NOT COMPLETED|SUF NT 15 mcg||0
65385|NCT01721070|157077|P1|COMPLETED|SUF NT 15 mcg||19
65386|NCT01721070|157077|P1|STARTED|SUF NT 15 mcg||19
65387|NCT01721057|157088|P7|NOT COMPLETED|Follow Up||0
65388|NCT01721057|157089|P6|NOT COMPLETED|Follow Up||0
65389|NCT01721057|157090|P5|NOT COMPLETED|Follow Up||0
65390|NCT01721057|157091|P4|NOT COMPLETED|Follow Up||0
65391|NCT01721057|157092|P3|NOT COMPLETED|Follow Up||0
65392|NCT01721057|157093|P2|NOT COMPLETED|Follow Up||0
65393|NCT01721057|157094|P1|NOT COMPLETED|Follow Up||0
65394|NCT01721057|157088|P7|COMPLETED|Follow Up||22
65395|NCT01721057|157089|P6|COMPLETED|Follow Up||19
65396|NCT01721057|157090|P5|COMPLETED|Follow Up||17
65397|NCT01721057|157091|P4|COMPLETED|Follow Up||0
65398|NCT01721057|157092|P3|COMPLETED|Follow Up||0
65399|NCT01721057|157093|P2|COMPLETED|Follow Up||0
65400|NCT01721057|157094|P1|COMPLETED|Follow Up||0
65401|NCT01721057|157088|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
65402|NCT01721057|157089|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
65403|NCT01721057|157090|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
65404|NCT01721057|157091|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
65405|NCT01721057|157092|P3|STARTED|Follow Up||0
65406|NCT01721057|157093|P2|STARTED|Follow Up||0
65407|NCT01721057|157094|P1|STARTED|Follow Up||0
65408|NCT01721057|157088|P7|NOT COMPLETED|Rescue Period||0
65409|NCT01721057|157089|P6|NOT COMPLETED|Rescue Period||0
65410|NCT01721057|157090|P5|NOT COMPLETED|Rescue Period||0
65411|NCT01721057|157091|P4|NOT COMPLETED|Rescue Period||3
65412|NCT01721057|157092|P3|NOT COMPLETED|Rescue Period||0
65413|NCT01721057|157093|P2|NOT COMPLETED|Rescue Period||0
65414|NCT01721057|157094|P1|NOT COMPLETED|Rescue Period||0
65415|NCT01721057|157088|P7|COMPLETED|Rescue Period||0
65416|NCT01721057|157089|P6|COMPLETED|Rescue Period||0
65417|NCT01721057|157090|P5|COMPLETED|Rescue Period||0
65418|NCT01721057|157091|P4|COMPLETED|Rescue Period||88
65419|NCT01721057|157092|P3|COMPLETED|Rescue Period||0
65420|NCT01721057|157093|P2|COMPLETED|Rescue Period||0
65421|NCT01721057|157094|P1|COMPLETED|Rescue Period||0
65422|NCT01721057|157088|P7|STARTED|Rescue Period||0
65423|NCT01721057|157089|P6|STARTED|Rescue Period||0
65424|NCT01721057|157090|P5|STARTED|Rescue Period||0
65425|NCT01721057|157091|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
65426|NCT01721057|157092|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
65427|NCT01721057|157093|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
65428|NCT01721057|157094|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
65429|NCT01721057|157088|P7|NOT COMPLETED|Treatment Period||0
65430|NCT01721057|157089|P6|NOT COMPLETED|Treatment Period||0
65431|NCT01721057|157090|P5|NOT COMPLETED|Treatment Period||0
65432|NCT01721057|157091|P4|NOT COMPLETED|Treatment Period||0
65433|NCT01721057|157092|P3|NOT COMPLETED|Treatment Period||23
65434|NCT01721057|157093|P2|NOT COMPLETED|Treatment Period||19
65435|NCT01721057|157094|P1|NOT COMPLETED|Treatment Period||28
65436|NCT01721057|157088|P7|COMPLETED|Treatment Period||0
65437|NCT01721057|157089|P6|COMPLETED|Treatment Period||0
65438|NCT01721057|157090|P5|COMPLETED|Treatment Period||0
65439|NCT01721057|157091|P4|COMPLETED|Treatment Period||0
65440|NCT01721057|157092|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
65441|NCT01721057|157093|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
65442|NCT01721057|157094|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
65443|NCT01721057|157088|P7|Rescued|Treatment Period||0
65444|NCT01721057|157089|P6|Rescued|Treatment Period||0
65445|NCT01721057|157090|P5|Rescued|Treatment Period||0
65446|NCT01721057|157091|P4|Rescued|Treatment Period||0
65447|NCT01721057|157092|P3|Rescued|Treatment Period||15
65448|NCT01721057|157093|P2|Rescued|Treatment Period||21
65449|NCT01721057|157094|P1|Rescued|Treatment Period||55
65450|NCT01721057|157088|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
65451|NCT01721057|157089|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
65452|NCT01721057|157090|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
65453|NCT01721057|157091|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
65454|NCT01721057|157092|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
65455|NCT01721057|157093|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
65456|NCT01721057|157094|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
65457|NCT01721057|157088|P7|STARTED|Treatment Period||0
65458|NCT01721057|157089|P6|STARTED|Treatment Period||0
65459|NCT01721057|157090|P5|STARTED|Treatment Period||0
65460|NCT01721057|157091|P4|STARTED|Treatment Period||0
65461|NCT01721057|157092|P3|STARTED|Treatment Period||227
65462|NCT01721057|157093|P2|STARTED|Treatment Period||229
65463|NCT01721057|157094|P1|STARTED|Treatment Period||228
65464|NCT01721044|157167|P3|NOT COMPLETED|Follow Up||0
65465|NCT01721044|157168|P2|NOT COMPLETED|Follow Up||0
65466|NCT01721044|157169|P1|NOT COMPLETED|Follow Up||0
65467|NCT01721044|157167|P3|COMPLETED|Follow Up||20
65468|NCT01721044|157168|P2|COMPLETED|Follow Up||9
65469|NCT01721044|157169|P1|COMPLETED|Follow Up||19
65470|NCT01721044|157167|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
65471|NCT01721044|157168|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
65472|NCT01721044|157169|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
65473|NCT01721044|157167|P3|NOT COMPLETED|Treatment Period||19
65474|NCT01721044|157168|P2|NOT COMPLETED|Treatment Period||17
65475|NCT01721044|157169|P1|NOT COMPLETED|Treatment Period||32
65476|NCT01721044|157167|P3|COMPLETED|Treatment Period||158
65477|NCT01721044|157168|P2|COMPLETED|Treatment Period||157
65478|NCT01721044|157169|P1|COMPLETED|Treatment Period||144
65479|NCT01721044|157167|P3|Rescue Week 16-24|Treatment Period||33
65480|NCT01721044|157168|P2|Rescue Week 16-24|Treatment Period||38
65481|NCT01721044|157169|P1|Rescue Week 16-24|Treatment Period||56
65482|NCT01721044|157167|P3|STARTED|Treatment Period||177
65483|NCT01721044|157168|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
65484|NCT01721044|157169|P1|STARTED|Treatment Period||176
65485|NCT01720797|157242|P2|NOT COMPLETED|Overall Study||0
65486|NCT01720797|157243|P1|NOT COMPLETED|Overall Study||3
65487|NCT01720797|157242|P2|COMPLETED|Overall Study||9
65488|NCT01720797|157243|P1|COMPLETED|Overall Study||9
65489|NCT01720797|157242|P2|STARTED|Overall Study||9
65490|NCT01720797|157243|P1|STARTED|Overall Study||12
65491|NCT01720602|157249|P1|NOT COMPLETED|Overall Study||5
65492|NCT01720602|157249|P1|COMPLETED|Overall Study||10
65493|NCT01720602|157249|P1|STARTED|Overall Study||15
65494|NCT01720446|157259|P4|NOT COMPLETED|Overall Study||20
65495|NCT01720446|157260|P3|NOT COMPLETED|Overall Study||20
65496|NCT01720446|157261|P2|NOT COMPLETED|Overall Study||11
65497|NCT01720446|157262|P1|NOT COMPLETED|Overall Study||14
65498|NCT01720446|157259|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
65499|NCT01720446|157260|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
65500|NCT01720446|157261|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
65501|NCT01720446|157262|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
65502|NCT01720446|157259|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
65503|NCT01720446|157260|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
65504|NCT01720446|157261|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
65505|NCT01720446|157262|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
65506|NCT01720446|157259|P4|STARTED|Overall Study||825
65507|NCT01720446|157260|P3|STARTED|Overall Study||824
65508|NCT01720446|157261|P2|STARTED|Overall Study||822
65509|NCT01720446|157262|P1|STARTED|Overall Study||826
65510|NCT01720316|157323|P2|NOT COMPLETED|Open-label Glycine||0
65511|NCT01720316|157324|P1|NOT COMPLETED|Open-label Glycine||0
65512|NCT01720316|157323|P2|COMPLETED|Open-label Glycine||1
65513|NCT01720316|157324|P1|COMPLETED|Open-label Glycine||1
65514|NCT01720316|157323|P2|STARTED|Open-label Glycine||1
65515|NCT01720316|157324|P1|STARTED|Open-label Glycine||1
65516|NCT01720316|157323|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
65517|NCT01720316|157324|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
65518|NCT01720316|157323|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
65519|NCT01720316|157324|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
65520|NCT01720316|157323|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
65521|NCT01720316|157324|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
65522|NCT01720277|157372|P2|NOT COMPLETED|Overall Study||558
65523|NCT01720277|157373|P1|NOT COMPLETED|Overall Study||503
65524|NCT01720277|157372|P2|COMPLETED|Overall Study|intent-to-treat approach|938
65525|NCT01720277|157373|P1|COMPLETED|Overall Study|intent-to-treat approach|958
65526|NCT01720277|157372|P2|STARTED|Overall Study||1496
65527|NCT01720277|157373|P1|STARTED|Overall Study||1461
65528|NCT01720251|157386|P3|NOT COMPLETED|Overall Study||0
65529|NCT01720251|157387|P2|NOT COMPLETED|Overall Study||2
65530|NCT01720251|157388|P1|NOT COMPLETED|Overall Study||1
65531|NCT01720251|157386|P3|COMPLETED|Overall Study||82
65532|NCT01720251|157387|P2|COMPLETED|Overall Study||77
65533|NCT01720251|157388|P1|COMPLETED|Overall Study||78
65534|NCT01720251|157386|P3|STARTED|Overall Study||82
65535|NCT01720251|157387|P2|STARTED|Overall Study||79
65536|NCT01720251|157388|P1|STARTED|Overall Study||79
65537|NCT01720173|157396|P1|NOT COMPLETED|Overall Study||0
65538|NCT01720173|157396|P1|COMPLETED|Overall Study||30
65539|NCT01720173|157396|P1|STARTED|Overall Study||30
65540|NCT01720043|157404|P1|NOT COMPLETED|Overall Study||1
65541|NCT01720043|157404|P1|COMPLETED|Overall Study||7
65542|NCT01720043|157404|P1|STARTED|Overall Study||8
65543|NCT01719861|157408|P1|NOT COMPLETED|Cycle 2||1
65544|NCT01719861|157408|P1|COMPLETED|Cycle 2||1
65545|NCT01719861|157408|P1|STARTED|Cycle 2||2
65546|NCT01719861|157408|P1|NOT COMPLETED|Cycle 1||4
65547|NCT01719861|157408|P1|COMPLETED|Cycle 1||2
65548|NCT01719861|157408|P1|STARTED|Cycle 1||6
65549|NCT01719757|157416|P1|NOT COMPLETED|Overall Study||101
65550|NCT01719757|157416|P1|COMPLETED|Overall Study||258
65551|NCT01719757|157416|P1|STARTED|Overall Study||359
65552|NCT01719744|157424|P1|NOT COMPLETED|Overall Study||0
65553|NCT01719744|157424|P1|COMPLETED|Overall Study||25
65554|NCT01719744|157424|P1|STARTED|Overall Study||25
65555|NCT01719653|157435|P5|NOT COMPLETED|Overall Study||21
65556|NCT01719653|157436|P4|NOT COMPLETED|Overall Study||18
65557|NCT01719653|157437|P3|NOT COMPLETED|Overall Study||18
65558|NCT01719653|157438|P2|NOT COMPLETED|Overall Study||13
65559|NCT01719653|157439|P1|NOT COMPLETED|Overall Study||9
65560|NCT01719653|157435|P5|COMPLETED|Overall Study||200
65561|NCT01719653|157436|P4|COMPLETED|Overall Study||200
65562|NCT01719653|157437|P3|COMPLETED|Overall Study||200
65563|NCT01719653|157438|P2|COMPLETED|Overall Study||200
65564|NCT01719653|157439|P1|COMPLETED|Overall Study||200
65565|NCT01719653|157435|P5|STARTED|Overall Study||221
65566|NCT01719653|157436|P4|STARTED|Overall Study||218
65567|NCT01719653|157437|P3|STARTED|Overall Study||218
65568|NCT01719653|157438|P2|STARTED|Overall Study||213
65569|NCT01719653|157439|P1|STARTED|Overall Study||209
65570|NCT01719224|157461|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
65571|NCT01719224|157462|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
65572|NCT01719224|157461|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
65573|NCT01719224|157462|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
65574|NCT01719224|157461|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
65575|NCT01719224|157462|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
65576|NCT01719224|157461|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
65577|NCT01719224|157462|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
65578|NCT01719224|157461|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
65579|NCT01719224|157462|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
65580|NCT01719224|157461|P2|STARTED|Intervention 1: Sleeping Position 1||18
65581|NCT01719224|157462|P1|STARTED|Intervention 1: Sleeping Position 1||18
65582|NCT01719172|157471|P1|NOT COMPLETED|Overall Study||2
65583|NCT01719172|157471|P1|COMPLETED|Overall Study||28
65584|NCT01719172|157471|P1|STARTED|Overall Study||30
65585|NCT01719003|157485|P9|NOT COMPLETED|Overall Study||4
65586|NCT01719003|157486|P8|NOT COMPLETED|Overall Study||20
65587|NCT01719003|157487|P7|NOT COMPLETED|Overall Study||20
65588|NCT01719003|157488|P6|NOT COMPLETED|Overall Study||12
65589|NCT01719003|157489|P5|NOT COMPLETED|Overall Study||17
65590|NCT01719003|157490|P4|NOT COMPLETED|Overall Study||13
65591|NCT01719003|157491|P3|NOT COMPLETED|Overall Study||17
65592|NCT01719003|157492|P2|NOT COMPLETED|Overall Study||17
65593|NCT01719003|157493|P1|NOT COMPLETED|Overall Study||9
65594|NCT01719003|157485|P9|COMPLETED|Overall Study||49
65595|NCT01719003|157486|P8|COMPLETED|Overall Study||151
65596|NCT01719003|157487|P7|COMPLETED|Overall Study||150
65597|NCT01719003|157488|P6|COMPLETED|Overall Study||160
65598|NCT01719003|157489|P5|COMPLETED|Overall Study||150
65599|NCT01719003|157490|P4|COMPLETED|Overall Study||156
65600|NCT01719003|157491|P3|COMPLETED|Overall Study||154
65601|NCT01719003|157492|P2|COMPLETED|Overall Study||153
65602|NCT01719003|157493|P1|COMPLETED|Overall Study||161
65603|NCT01719003|157485|P9|STARTED|Overall Study||53
65604|NCT01719003|157486|P8|STARTED|Overall Study||171
65605|NCT01719003|157487|P7|STARTED|Overall Study||170
65606|NCT01719003|157488|P6|STARTED|Overall Study||172
65607|NCT01719003|157489|P5|STARTED|Overall Study||167
65608|NCT01719003|157490|P4|STARTED|Overall Study||169
65609|NCT01719003|157491|P3|STARTED|Overall Study||171
65610|NCT01719003|157492|P2|STARTED|Overall Study||170
65611|NCT01719003|157493|P1|STARTED|Overall Study||170
65612|NCT01718691|157530|P2|NOT COMPLETED|Overall Study||1
65613|NCT01718691|157531|P1|NOT COMPLETED|Overall Study||18
65614|NCT01718691|157530|P2|COMPLETED|Overall Study||9
65615|NCT01718691|157531|P1|COMPLETED|Overall Study||42
65616|NCT01718691|157530|P2|STARTED|Overall Study||10
65617|NCT01718691|157531|P1|STARTED|Overall Study||60
65618|NCT01718535|157574|P10|NOT COMPLETED|Overall Study||0
65619|NCT01718535|157575|P9|NOT COMPLETED|Overall Study||0
65620|NCT01718535|157576|P8|NOT COMPLETED|Overall Study||0
65621|NCT01718535|157577|P7|NOT COMPLETED|Overall Study||0
65622|NCT01718535|157578|P6|NOT COMPLETED|Overall Study||0
65623|NCT01718535|157579|P5|NOT COMPLETED|Overall Study||0
65624|NCT01718535|157580|P4|NOT COMPLETED|Overall Study||1
65625|NCT01718535|157581|P3|NOT COMPLETED|Overall Study||0
65626|NCT01718535|157582|P2|NOT COMPLETED|Overall Study||0
65627|NCT01718535|157583|P1|NOT COMPLETED|Overall Study||1
65628|NCT01718535|157574|P10|COMPLETED|Overall Study||1
65629|NCT01718535|157575|P9|COMPLETED|Overall Study||15
65630|NCT01718535|157576|P8|COMPLETED|Overall Study||6
65631|NCT01718535|157577|P7|COMPLETED|Overall Study||11
65632|NCT01718535|157578|P6|COMPLETED|Overall Study||40
65633|NCT01718535|157579|P5|COMPLETED|Overall Study||1
65634|NCT01718535|157580|P4|COMPLETED|Overall Study||7
65635|NCT01718535|157581|P3|COMPLETED|Overall Study||19
65636|NCT01718535|157582|P2|COMPLETED|Overall Study||95
65637|NCT01718535|157583|P1|COMPLETED|Overall Study||130
65638|NCT01718535|157574|P10|First Pass|Overall Study||1
65639|NCT01718535|157575|P9|First Pass|Overall Study||15
65640|NCT01718535|157576|P8|First Pass|Overall Study||6
65641|NCT01718535|157577|P7|First Pass|Overall Study||11
65642|NCT01718535|157578|P6|First Pass|Overall Study||39
65643|NCT01718535|157579|P5|First Pass|Overall Study||1
65644|NCT01718535|157580|P4|First Pass|Overall Study||7
65645|NCT01718535|157581|P3|First Pass|Overall Study||19
65646|NCT01718535|157582|P2|First Pass|Overall Study||94
65647|NCT01718535|157583|P1|First Pass|Overall Study||128
65648|NCT01718535|157574|P10|STARTED|Overall Study||1
65649|NCT01718535|157575|P9|STARTED|Overall Study||15
65650|NCT01718535|157576|P8|STARTED|Overall Study||6
65651|NCT01718535|157577|P7|STARTED|Overall Study||11
65652|NCT01718535|157578|P6|STARTED|Overall Study||40
65653|NCT01718535|157579|P5|STARTED|Overall Study||1
65654|NCT01718535|157580|P4|STARTED|Overall Study||8
65655|NCT01718535|157581|P3|STARTED|Overall Study||19
65656|NCT01718535|157582|P2|STARTED|Overall Study||95
65657|NCT01718535|157583|P1|STARTED|Overall Study||131
65658|NCT01718509|157607|P2|NOT COMPLETED|Overall Study||48
65659|NCT01718509|157608|P1|NOT COMPLETED|Overall Study||48
65660|NCT01718509|157607|P2|COMPLETED|Overall Study||147
65661|NCT01718509|157608|P1|COMPLETED|Overall Study||147
65662|NCT01718509|157607|P2|STARTED|Overall Study||195
65663|NCT01718509|157608|P1|STARTED|Overall Study||195
65664|NCT01718483|157654|P2|NOT COMPLETED|Overall Study||34
65665|NCT01718483|157655|P1|NOT COMPLETED|Overall Study||34
65666|NCT01718483|157654|P2|COMPLETED|Overall Study||158
65667|NCT01718483|157655|P1|COMPLETED|Overall Study||157
65668|NCT01718483|157654|P2|Treated|Overall Study||192
65669|NCT01718483|157655|P1|Treated|Overall Study||187
65670|NCT01718483|157654|P2|STARTED|Overall Study||192
65671|NCT01718483|157655|P1|STARTED|Overall Study||191
65672|NCT01718353|157701|P2|NOT COMPLETED|Overall Study||5
65673|NCT01718353|157702|P1|NOT COMPLETED|Overall Study||12
65674|NCT01718353|157701|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
65675|NCT01718353|157702|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
65676|NCT01718353|157701|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
65677|NCT01718353|157702|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
65678|NCT01718353|157701|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
65679|NCT01718353|157702|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
65680|NCT01718353|157701|P2|Treated|Overall Study||22
65681|NCT01718353|157702|P1|Treated|Overall Study||39
65682|NCT01718353|157701|P2|STARTED|Overall Study||22
65683|NCT01718353|157702|P1|STARTED|Overall Study||41
65684|NCT01718028|157720|P2|NOT COMPLETED|Overall Study||0
65685|NCT01718028|157721|P1|NOT COMPLETED|Overall Study||0
65686|NCT01718028|157720|P2|COMPLETED|Overall Study||24
65687|NCT01718028|157721|P1|COMPLETED|Overall Study||25
65688|NCT01718028|157720|P2|STARTED|Overall Study||24
65689|NCT01718028|157721|P1|STARTED|Overall Study||25
65690|NCT01717989|157733|P1|NOT COMPLETED|Overall Study||1066
65691|NCT01717989|157733|P1|COMPLETED|Overall Study||1182
65692|NCT01717989|157733|P1|STARTED|Overall Study||2248
65693|NCT01717976|157801|P2|NOT COMPLETED|Overall Study||1
65694|NCT01717976|157802|P1|NOT COMPLETED|Overall Study||0
65695|NCT01717976|157801|P2|COMPLETED|Overall Study||256
65696|NCT01717976|157802|P1|COMPLETED|Overall Study||257
65697|NCT01717976|157801|P2|STARTED|Overall Study||257
65698|NCT01717976|157802|P1|STARTED|Overall Study||257
65699|NCT01717898|157816|P4|NOT COMPLETED|Overall Study||0
65700|NCT01717898|157817|P3|NOT COMPLETED|Overall Study||0
65701|NCT01717898|157818|P2|NOT COMPLETED|Overall Study||0
65702|NCT01717898|157819|P1|NOT COMPLETED|Overall Study||6
65703|NCT01717898|157816|P4|COMPLETED|Overall Study||0
65704|NCT01717898|157817|P3|COMPLETED|Overall Study||0
65705|NCT01717898|157818|P2|COMPLETED|Overall Study||0
65706|NCT01717898|157819|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
65707|NCT01717898|157816|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
65708|NCT01717898|157817|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
65709|NCT01717898|157818|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
65710|NCT01717898|157819|P1|STARTED|Overall Study||6
65711|NCT01717872|157846|P2|NOT COMPLETED|Overall Study||0
65712|NCT01717872|157847|P1|NOT COMPLETED|Overall Study||0
65713|NCT01717872|157846|P2|COMPLETED|Overall Study||25
65714|NCT01717872|157847|P1|COMPLETED|Overall Study||25
65715|NCT01717872|157846|P2|STARTED|Overall Study||25
65716|NCT01717872|157847|P1|STARTED|Overall Study||25
65717|NCT01717768|157867|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65718|NCT01717768|157868|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65719|NCT01717768|157869|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
65720|NCT01717768|157870|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65721|NCT01717768|157871|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
65722|NCT01717768|157872|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65723|NCT01717768|157873|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65724|NCT01717768|157874|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65725|NCT01717768|157875|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65726|NCT01717768|157876|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65727|NCT01717768|157877|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65728|NCT01717768|157878|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65729|NCT01717768|157867|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65730|NCT01717768|157868|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65731|NCT01717768|157869|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
65732|NCT01717768|157870|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65733|NCT01717768|157871|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
65734|NCT01717768|157872|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65735|NCT01717768|157873|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65736|NCT01717768|157874|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65737|NCT01717768|157875|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65738|NCT01717768|157876|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65739|NCT01717768|157877|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65740|NCT01717768|157878|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
65741|NCT01717768|157867|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65742|NCT01717768|157868|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65743|NCT01717768|157869|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
65744|NCT01717768|157870|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65745|NCT01717768|157871|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
65746|NCT01717768|157872|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65747|NCT01717768|157873|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65748|NCT01717768|157874|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65749|NCT01717768|157875|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65750|NCT01717768|157876|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65751|NCT01717768|157877|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65752|NCT01717768|157878|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
65753|NCT01717768|157867|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
65754|NCT01717768|157868|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65755|NCT01717768|157869|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65756|NCT01717768|157870|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65757|NCT01717768|157871|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65758|NCT01717768|157872|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65759|NCT01717768|157873|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65760|NCT01717768|157874|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65761|NCT01717768|157875|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65762|NCT01717768|157876|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65763|NCT01717768|157877|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65764|NCT01717768|157878|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65765|NCT01717768|157867|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
65766|NCT01717768|157868|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
65767|NCT01717768|157869|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65768|NCT01717768|157870|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
65769|NCT01717768|157871|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65770|NCT01717768|157872|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
65771|NCT01717768|157873|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65772|NCT01717768|157874|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65773|NCT01717768|157875|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65774|NCT01717768|157876|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65775|NCT01717768|157877|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65776|NCT01717768|157878|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
65777|NCT01717768|157867|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
65778|NCT01717768|157868|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
65779|NCT01717768|157869|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65780|NCT01717768|157870|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
65781|NCT01717768|157871|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65782|NCT01717768|157872|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
65783|NCT01717768|157873|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65784|NCT01717768|157874|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65785|NCT01717768|157875|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65786|NCT01717768|157876|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65787|NCT01717768|157877|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65788|NCT01717768|157878|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
65789|NCT01717768|157867|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65790|NCT01717768|157868|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65791|NCT01717768|157869|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65792|NCT01717768|157870|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65793|NCT01717768|157871|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65794|NCT01717768|157872|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65795|NCT01717768|157873|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65796|NCT01717768|157874|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65797|NCT01717768|157875|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65798|NCT01717768|157876|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65799|NCT01717768|157877|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65800|NCT01717768|157878|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65801|NCT01717768|157867|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65802|NCT01717768|157868|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65803|NCT01717768|157869|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65804|NCT01717768|157870|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65805|NCT01717768|157871|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65806|NCT01717768|157872|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65807|NCT01717768|157873|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
65808|NCT01717768|157874|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
65809|NCT01717768|157875|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
65810|NCT01717768|157876|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65811|NCT01717768|157877|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65812|NCT01717768|157878|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65813|NCT01717768|157867|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65814|NCT01717768|157868|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65815|NCT01717768|157869|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65816|NCT01717768|157870|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65817|NCT01717768|157871|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65818|NCT01717768|157872|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65819|NCT01717768|157873|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
65820|NCT01717768|157874|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
65821|NCT01717768|157875|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
65822|NCT01717768|157876|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65823|NCT01717768|157877|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65824|NCT01717768|157878|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
65825|NCT01717768|157867|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65826|NCT01717768|157868|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65827|NCT01717768|157869|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65828|NCT01717768|157870|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65829|NCT01717768|157871|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65830|NCT01717768|157872|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65831|NCT01717768|157873|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65832|NCT01717768|157874|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65833|NCT01717768|157875|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65834|NCT01717768|157876|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65835|NCT01717768|157877|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65836|NCT01717768|157878|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65837|NCT01717768|157867|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65838|NCT01717768|157868|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65839|NCT01717768|157869|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65840|NCT01717768|157870|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65841|NCT01717768|157871|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65842|NCT01717768|157872|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65843|NCT01717768|157873|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
65844|NCT01717768|157874|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
65845|NCT01717768|157875|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
65846|NCT01717768|157876|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65847|NCT01717768|157877|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65848|NCT01717768|157878|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65849|NCT01717768|157867|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65850|NCT01717768|157868|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65851|NCT01717768|157869|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65852|NCT01717768|157870|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65853|NCT01717768|157871|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65854|NCT01717768|157872|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65855|NCT01717768|157873|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
65856|NCT01717768|157874|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
65857|NCT01717768|157875|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
65858|NCT01717768|157876|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65859|NCT01717768|157877|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65860|NCT01717768|157878|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
65861|NCT01717768|157867|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65862|NCT01717768|157868|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65863|NCT01717768|157869|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65864|NCT01717768|157870|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65865|NCT01717768|157871|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65866|NCT01717768|157872|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65867|NCT01717768|157873|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65868|NCT01717768|157874|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65869|NCT01717768|157875|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65870|NCT01717768|157876|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65871|NCT01717768|157877|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65872|NCT01717768|157878|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65873|NCT01717768|157867|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65874|NCT01717768|157868|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65875|NCT01717768|157869|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65876|NCT01717768|157870|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65877|NCT01717768|157871|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65878|NCT01717768|157872|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65879|NCT01717768|157873|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
65880|NCT01717768|157874|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
65881|NCT01717768|157875|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
65882|NCT01717768|157876|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65883|NCT01717768|157877|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65884|NCT01717768|157878|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65885|NCT01717768|157867|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65886|NCT01717768|157868|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65887|NCT01717768|157869|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65888|NCT01717768|157870|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65889|NCT01717768|157871|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65890|NCT01717768|157872|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65891|NCT01717768|157873|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
65892|NCT01717768|157874|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
65893|NCT01717768|157875|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
65894|NCT01717768|157876|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65895|NCT01717768|157877|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65896|NCT01717768|157878|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
65897|NCT01717768|157867|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65898|NCT01717768|157868|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65899|NCT01717768|157869|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65900|NCT01717768|157870|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65901|NCT01717768|157871|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65902|NCT01717768|157872|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65903|NCT01717768|157873|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65904|NCT01717768|157874|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65905|NCT01717768|157875|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65906|NCT01717768|157876|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65907|NCT01717768|157877|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65908|NCT01717768|157878|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
65909|NCT01717768|157867|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
65910|NCT01717768|157868|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
65911|NCT01717768|157869|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
65912|NCT01717768|157870|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
65913|NCT01717768|157871|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
65914|NCT01717768|157872|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
65915|NCT01717768|157873|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
65916|NCT01717768|157874|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
65917|NCT01717768|157875|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
65918|NCT01717768|157876|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
65919|NCT01717768|157877|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
65920|NCT01717768|157878|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
65921|NCT01717768|157867|P12|STARTED|Part 2 (Duration of 15 Days)||0
65922|NCT01717768|157868|P11|STARTED|Part 2 (Duration of 15 Days)||0
65923|NCT01717768|157869|P10|STARTED|Part 2 (Duration of 15 Days)||0
65924|NCT01717768|157870|P9|STARTED|Part 2 (Duration of 15 Days)||0
65925|NCT01717768|157871|P8|STARTED|Part 2 (Duration of 15 Days)||0
65926|NCT01717768|157872|P7|STARTED|Part 2 (Duration of 15 Days)||0
65927|NCT01717768|157873|P6|STARTED|Part 2 (Duration of 15 Days)||0
65928|NCT01717768|157874|P5|STARTED|Part 2 (Duration of 15 Days)||0
65929|NCT01717768|157875|P4|STARTED|Part 2 (Duration of 15 Days)||0
65930|NCT01717768|157876|P3|STARTED|Part 2 (Duration of 15 Days)||17
65931|NCT01717768|157877|P2|STARTED|Part 2 (Duration of 15 Days)||0
65932|NCT01717768|157878|P1|STARTED|Part 2 (Duration of 15 Days)||0
65933|NCT01717768|157867|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65934|NCT01717768|157868|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65935|NCT01717768|157869|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65936|NCT01717768|157870|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65937|NCT01717768|157871|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65938|NCT01717768|157872|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65939|NCT01717768|157873|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65940|NCT01717768|157874|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65941|NCT01717768|157875|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65942|NCT01717768|157876|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65943|NCT01717768|157877|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
65944|NCT01717768|157878|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
65945|NCT01717768|157867|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
65946|NCT01717768|157868|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
65947|NCT01717768|157869|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
65948|NCT01717768|157870|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
65949|NCT01717768|157871|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
65950|NCT01717768|157872|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
65951|NCT01717768|157873|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
65952|NCT01717768|157874|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
65953|NCT01717768|157875|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
65954|NCT01717768|157876|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
65955|NCT01717768|157877|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
65956|NCT01717768|157878|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
65957|NCT01717768|157867|P12|STARTED|Part 1 (Duration of 15 Days)||0
65958|NCT01717768|157868|P11|STARTED|Part 1 (Duration of 15 Days)||0
65959|NCT01717768|157869|P10|STARTED|Part 1 (Duration of 15 Days)||0
65960|NCT01717768|157870|P9|STARTED|Part 1 (Duration of 15 Days)||0
65961|NCT01717768|157871|P8|STARTED|Part 1 (Duration of 15 Days)||0
65962|NCT01717768|157872|P7|STARTED|Part 1 (Duration of 15 Days)||0
65963|NCT01717768|157873|P6|STARTED|Part 1 (Duration of 15 Days)||0
65964|NCT01717768|157874|P5|STARTED|Part 1 (Duration of 15 Days)||0
65965|NCT01717768|157875|P4|STARTED|Part 1 (Duration of 15 Days)||0
65966|NCT01717768|157876|P3|STARTED|Part 1 (Duration of 15 Days)||0
65967|NCT01717768|157877|P2|STARTED|Part 1 (Duration of 15 Days)||17
65968|NCT01717768|157878|P1|STARTED|Part 1 (Duration of 15 Days)||17
65969|NCT01717638|157929|P13|NOT COMPLETED|Overall Study||19
65970|NCT01717638|157930|P12|NOT COMPLETED|Overall Study||0
65971|NCT01717638|157931|P11|NOT COMPLETED|Overall Study||0
65972|NCT01717638|157932|P10|NOT COMPLETED|Overall Study||1
65973|NCT01717638|157933|P9|NOT COMPLETED|Overall Study||2
65974|NCT01717638|157934|P8|NOT COMPLETED|Overall Study||1
65975|NCT01717638|157935|P7|NOT COMPLETED|Overall Study||2
65976|NCT01717638|157936|P6|NOT COMPLETED|Overall Study||1
65977|NCT01717638|157937|P5|NOT COMPLETED|Overall Study||1
65978|NCT01717638|157938|P4|NOT COMPLETED|Overall Study||0
65979|NCT01717638|157939|P3|NOT COMPLETED|Overall Study||1
65980|NCT01717638|157940|P2|NOT COMPLETED|Overall Study||1
65981|NCT01717638|157941|P1|NOT COMPLETED|Overall Study||0
65982|NCT01717638|157929|P13|COMPLETED|Overall Study||190
65983|NCT01717638|157930|P12|COMPLETED|Overall Study||12
65984|NCT01717638|157931|P11|COMPLETED|Overall Study||11
65985|NCT01717638|157932|P10|COMPLETED|Overall Study||99
65986|NCT01717638|157933|P9|COMPLETED|Overall Study||26
65987|NCT01717638|157934|P8|COMPLETED|Overall Study||28
65988|NCT01717638|157935|P7|COMPLETED|Overall Study||41
65989|NCT01717638|157936|P6|COMPLETED|Overall Study||54
65990|NCT01717638|157937|P5|COMPLETED|Overall Study||63
65991|NCT01717638|157938|P4|COMPLETED|Overall Study||66
65992|NCT01717638|157939|P3|COMPLETED|Overall Study||59
65993|NCT01717638|157940|P2|COMPLETED|Overall Study||60
65994|NCT01717638|157941|P1|COMPLETED|Overall Study||67
65995|NCT01717638|157929|P13|STARTED|Overall Study||209
65996|NCT01717638|157930|P12|STARTED|Overall Study||12
65997|NCT01717638|157931|P11|STARTED|Overall Study||11
65998|NCT01717638|157932|P10|STARTED|Overall Study||100
65999|NCT01717638|157933|P9|STARTED|Overall Study||28
66000|NCT01717638|157934|P8|STARTED|Overall Study||29
66001|NCT01717638|157935|P7|STARTED|Overall Study||43
66002|NCT01717638|157936|P6|STARTED|Overall Study||55
66003|NCT01717638|157937|P5|STARTED|Overall Study||64
66004|NCT01717638|157938|P4|STARTED|Overall Study||66
66005|NCT01717638|157939|P3|STARTED|Overall Study||60
66006|NCT01717638|157940|P2|STARTED|Overall Study||61
66007|NCT01717638|157941|P1|STARTED|Overall Study||67
66008|NCT01717456|158085|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
66009|NCT01717456|158086|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
66010|NCT01717456|158085|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
66011|NCT01717456|158086|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
66012|NCT01717456|158085|P2|STARTED|Follow-Up 6 Months After End of Tx||6
66013|NCT01717456|158086|P1|STARTED|Follow-Up 6 Months After End of Tx||11
66014|NCT01717456|158085|P2|NOT COMPLETED|End of Treatment||2
66015|NCT01717456|158086|P1|NOT COMPLETED|End of Treatment||0
66016|NCT01717456|158085|P2|COMPLETED|End of Treatment||6
66017|NCT01717456|158086|P1|COMPLETED|End of Treatment||11
66018|NCT01717456|158085|P2|STARTED|End of Treatment||8
66019|NCT01717456|158086|P1|STARTED|End of Treatment||11
66020|NCT01717391|158154|P1|NOT COMPLETED|Overall Study||9
66021|NCT01717391|158154|P1|COMPLETED|Overall Study||27
66022|NCT01717391|158154|P1|STARTED|Overall Study||36
66023|NCT01717326|158183|P20|NOT COMPLETED|Overall Study||6
66024|NCT01717326|158184|P19|NOT COMPLETED|Overall Study||4
66025|NCT01717326|158185|P18|NOT COMPLETED|Overall Study||0
66026|NCT01717326|158186|P17|NOT COMPLETED|Overall Study||1
66027|NCT01717326|158187|P16|NOT COMPLETED|Overall Study||3
66028|NCT01717326|158188|P15|NOT COMPLETED|Overall Study||0
66029|NCT01717326|158189|P14|NOT COMPLETED|Overall Study||0
66030|NCT01717326|158190|P13|NOT COMPLETED|Overall Study||1
66031|NCT01717326|158191|P12|NOT COMPLETED|Overall Study||0
66032|NCT01717326|158192|P11|NOT COMPLETED|Overall Study||2
66033|NCT01717326|158193|P10|NOT COMPLETED|Overall Study||2
66034|NCT01717326|158194|P9|NOT COMPLETED|Overall Study||0
66035|NCT01717326|158195|P8|NOT COMPLETED|Overall Study||0
66036|NCT01717326|158196|P7|NOT COMPLETED|Overall Study||1
66037|NCT01717326|158197|P6|NOT COMPLETED|Overall Study||0
66038|NCT01717326|158198|P5|NOT COMPLETED|Overall Study||2
66039|NCT01717326|158199|P4|NOT COMPLETED|Overall Study||2
66040|NCT01717326|158200|P3|NOT COMPLETED|Overall Study||0
66041|NCT01717326|158201|P2|NOT COMPLETED|Overall Study||1
66042|NCT01717326|158202|P1|NOT COMPLETED|Overall Study||3
66043|NCT01717326|158183|P20|COMPLETED|Overall Study||15
66044|NCT01717326|158184|P19|COMPLETED|Overall Study||16
66045|NCT01717326|158185|P18|COMPLETED|Overall Study||31
66046|NCT01717326|158186|P17|COMPLETED|Overall Study||29
66047|NCT01717326|158187|P16|COMPLETED|Overall Study||27
66048|NCT01717326|158188|P15|COMPLETED|Overall Study||29
66049|NCT01717326|158189|P14|COMPLETED|Overall Study||32
66050|NCT01717326|158190|P13|COMPLETED|Overall Study||32
66051|NCT01717326|158191|P12|COMPLETED|Overall Study||33
66052|NCT01717326|158192|P11|COMPLETED|Overall Study||30
66053|NCT01717326|158193|P10|COMPLETED|Overall Study||29
66054|NCT01717326|158194|P9|COMPLETED|Overall Study||32
66055|NCT01717326|158195|P8|COMPLETED|Overall Study||29
66056|NCT01717326|158196|P7|COMPLETED|Overall Study||30
66057|NCT01717326|158197|P6|COMPLETED|Overall Study||31
66058|NCT01717326|158198|P5|COMPLETED|Overall Study||31
66059|NCT01717326|158199|P4|COMPLETED|Overall Study||28
66060|NCT01717326|158200|P3|COMPLETED|Overall Study||13
66061|NCT01717326|158201|P2|COMPLETED|Overall Study||26
66062|NCT01717326|158202|P1|COMPLETED|Overall Study||22
66063|NCT01717326|158183|P20|Treated|Overall Study||21
66064|NCT01717326|158184|P19|Treated|Overall Study||20
66065|NCT01717326|158185|P18|Treated|Overall Study||31
66066|NCT01717326|158186|P17|Treated|Overall Study||30
66067|NCT01717326|158187|P16|Treated|Overall Study||30
66068|NCT01717326|158188|P15|Treated|Overall Study||29
66069|NCT01717326|158189|P14|Treated|Overall Study||32
66070|NCT01717326|158190|P13|Treated|Overall Study||33
66071|NCT01717326|158191|P12|Treated|Overall Study||33
66072|NCT01717326|158192|P11|Treated|Overall Study||32
66073|NCT01717326|158193|P10|Treated|Overall Study||31
66074|NCT01717326|158194|P9|Treated|Overall Study||32
66075|NCT01717326|158195|P8|Treated|Overall Study||29
66076|NCT01717326|158196|P7|Treated|Overall Study||31
66077|NCT01717326|158197|P6|Treated|Overall Study||31
66078|NCT01717326|158198|P5|Treated|Overall Study||33
66079|NCT01717326|158199|P4|Treated|Overall Study||30
66080|NCT01717326|158200|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
66081|NCT01717326|158201|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
66082|NCT01717326|158202|P1|Treated|Overall Study||25
66083|NCT01717326|158183|P20|STARTED|Overall Study||21
66084|NCT01717326|158184|P19|STARTED|Overall Study||20
66085|NCT01717326|158185|P18|STARTED|Overall Study||31
66086|NCT01717326|158186|P17|STARTED|Overall Study||30
66087|NCT01717326|158187|P16|STARTED|Overall Study||30
66088|NCT01717326|158188|P15|STARTED|Overall Study||29
66089|NCT01717326|158189|P14|STARTED|Overall Study||32
66090|NCT01717326|158190|P13|STARTED|Overall Study||33
66091|NCT01717326|158191|P12|STARTED|Overall Study||33
66092|NCT01717326|158192|P11|STARTED|Overall Study||32
66093|NCT01717326|158193|P10|STARTED|Overall Study||31
66094|NCT01717326|158194|P9|STARTED|Overall Study||32
66095|NCT01717326|158195|P8|STARTED|Overall Study||29
66096|NCT01717326|158196|P7|STARTED|Overall Study||31
66097|NCT01717326|158197|P6|STARTED|Overall Study||31
66098|NCT01717326|158198|P5|STARTED|Overall Study||33
66099|NCT01717326|158199|P4|STARTED|Overall Study||30
66100|NCT01717326|158200|P3|STARTED|Overall Study||13
66101|NCT01717326|158201|P2|STARTED|Overall Study||27
66102|NCT01717326|158202|P1|STARTED|Overall Study||25
66103|NCT01717313|158466|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
66104|NCT01717313|158467|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
66105|NCT01717313|158466|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
66106|NCT01717313|158467|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
66107|NCT01717313|158466|P2|STARTED|Phase B (Weeks 24 to 54)||151
66108|NCT01717313|158467|P1|STARTED|Phase B (Weeks 24 to 54)||146
66109|NCT01717313|158466|P2|NOT COMPLETED|Interphase||0
66110|NCT01717313|158467|P1|NOT COMPLETED|Interphase||1
66111|NCT01717313|158466|P2|COMPLETED|Interphase||151
66112|NCT01717313|158467|P1|COMPLETED|Interphase||146
66113|NCT01717313|158466|P2|STARTED|Interphase||151
66114|NCT01717313|158467|P1|STARTED|Interphase||147
66115|NCT01717313|158466|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
66116|NCT01717313|158467|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
66117|NCT01717313|158466|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
66118|NCT01717313|158467|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
66119|NCT01717313|158466|P2|STARTED|Phase A (Weeks 0 to 24)||164
66120|NCT01717313|158467|P1|STARTED|Phase A (Weeks 0 to 24)||165
66121|NCT01717287|158505|P2|NOT COMPLETED|Overall Study||3
66122|NCT01717287|158506|P1|NOT COMPLETED|Overall Study||0
66123|NCT01717287|158505|P2|COMPLETED|Overall Study||25
66124|NCT01717287|158506|P1|COMPLETED|Overall Study||4
66125|NCT01717287|158505|P2|STARTED|Overall Study||28
66126|NCT01717287|158506|P1|STARTED|Overall Study||4
66127|NCT01717209|158528|P1|NOT COMPLETED|Overall Study||0
66128|NCT01717209|158528|P1|COMPLETED|Overall Study||14
66129|NCT01717209|158528|P1|STARTED|Overall Study||14
66130|NCT01717040|158539|P2|NOT COMPLETED|Overall Study||5
66131|NCT01717040|158540|P1|NOT COMPLETED|Overall Study||5
66132|NCT01717040|158539|P2|COMPLETED|Overall Study||15
66133|NCT01717040|158540|P1|COMPLETED|Overall Study||12
66134|NCT01717040|158539|P2|STARTED|Overall Study||20
66135|NCT01717040|158540|P1|STARTED|Overall Study||17
66136|NCT01717014|158546|P1|NOT COMPLETED|Overall Study||0
66137|NCT01717014|158546|P1|COMPLETED|Overall Study||8
66138|NCT01717014|158546|P1|STARTED|Overall Study||8
66139|NCT01716754|158558|P4|NOT COMPLETED|Overall Study||8
66140|NCT01716754|158559|P3|NOT COMPLETED|Overall Study||14
66141|NCT01716754|158560|P2|NOT COMPLETED|Overall Study||4
66142|NCT01716754|158561|P1|NOT COMPLETED|Overall Study||11
66143|NCT01716754|158558|P4|COMPLETED|Overall Study||89
66144|NCT01716754|158559|P3|COMPLETED|Overall Study||121
66145|NCT01716754|158560|P2|COMPLETED|Overall Study||36
66146|NCT01716754|158561|P1|COMPLETED|Overall Study||188
66147|NCT01716754|158558|P4|Safety Set|Overall Study||96
66148|NCT01716754|158559|P3|Safety Set|Overall Study||131
66149|NCT01716754|158560|P2|Safety Set|Overall Study||40
66150|NCT01716754|158561|P1|Safety Set|Overall Study||199
66151|NCT01716754|158558|P4|FAS|Overall Study||96
66152|NCT01716754|158559|P3|FAS|Overall Study||131
66153|NCT01716754|158560|P2|FAS|Overall Study||40
66154|NCT01716754|158561|P1|FAS|Overall Study||199
66155|NCT01716754|158558|P4|STARTED|Overall Study||97
66156|NCT01716754|158559|P3|STARTED|Overall Study||135
66157|NCT01716754|158560|P2|STARTED|Overall Study||40
66158|NCT01716754|158561|P1|STARTED|Overall Study||199
66159|NCT01716663|158582|P1|NOT COMPLETED|Overall Study||6
66160|NCT01716663|158582|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
66161|NCT01716663|158582|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
66162|NCT01716663|158582|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
66163|NCT01716585|158592|P2|NOT COMPLETED|Open-label Treatment||7
66164|NCT01716585|158593|P1|NOT COMPLETED|Open-label Treatment||0
66165|NCT01716585|158592|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
66166|NCT01716585|158593|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
66167|NCT01716585|158592|P2|STARTED|Open-label Treatment||157
66168|NCT01716585|158593|P1|STARTED|Open-label Treatment|not applicable to this arm|0
66169|NCT01716585|158592|P2|NOT COMPLETED|Double-blind Treatment||2
66170|NCT01716585|158593|P1|NOT COMPLETED|Double-blind Treatment||13
66171|NCT01716585|158592|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
66172|NCT01716585|158593|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
66173|NCT01716585|158592|P2|Randomized But Not Treated|Double-blind Treatment||1
66174|NCT01716585|158593|P1|Randomized But Not Treated|Double-blind Treatment||4
66175|NCT01716585|158592|P2|STARTED|Double-blind Treatment||159
66176|NCT01716585|158593|P1|STARTED|Double-blind Treatment||477
66177|NCT01716559|158605|P1|NOT COMPLETED|Overall Study||111
66178|NCT01716559|158605|P1|COMPLETED|Overall Study||49
66179|NCT01716559|158605|P1|STARTED|Overall Study||160
66180|NCT01716520|158613|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
66181|NCT01716520|158614|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
66182|NCT01716520|158615|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
66183|NCT01716520|158616|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
66184|NCT01716520|158617|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
66185|NCT01716520|158618|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
66186|NCT01716520|158613|P6|COMPLETED|Treatment Period 3 (14 Days)||23
66187|NCT01716520|158614|P5|COMPLETED|Treatment Period 3 (14 Days)||29
66188|NCT01716520|158615|P4|COMPLETED|Treatment Period 3 (14 Days)||28
66189|NCT01716520|158616|P3|COMPLETED|Treatment Period 3 (14 Days)||25
66190|NCT01716520|158617|P2|COMPLETED|Treatment Period 3 (14 Days)||27
66191|NCT01716520|158618|P1|COMPLETED|Treatment Period 3 (14 Days)||27
66192|NCT01716520|158613|P6|STARTED|Treatment Period 3 (14 Days)||25
66193|NCT01716520|158614|P5|STARTED|Treatment Period 3 (14 Days)||29
66194|NCT01716520|158615|P4|STARTED|Treatment Period 3 (14 Days)||28
66195|NCT01716520|158616|P3|STARTED|Treatment Period 3 (14 Days)||26
66196|NCT01716520|158617|P2|STARTED|Treatment Period 3 (14 Days)||27
66197|NCT01716520|158618|P1|STARTED|Treatment Period 3 (14 Days)||27
66198|NCT01716520|158613|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
66199|NCT01716520|158614|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
66200|NCT01716520|158615|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
66201|NCT01716520|158616|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
66202|NCT01716520|158617|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
66203|NCT01716520|158618|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
66204|NCT01716520|158613|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
66205|NCT01716520|158614|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
66206|NCT01716520|158615|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
66207|NCT01716520|158616|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
66208|NCT01716520|158617|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
66209|NCT01716520|158618|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
66210|NCT01716520|158613|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
66211|NCT01716520|158614|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
66212|NCT01716520|158615|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
66213|NCT01716520|158616|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
66214|NCT01716520|158617|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
66215|NCT01716520|158618|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
66216|NCT01716520|158613|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
66217|NCT01716520|158614|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
66218|NCT01716520|158615|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
66219|NCT01716520|158616|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
66220|NCT01716520|158617|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
66221|NCT01716520|158618|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
66222|NCT01716520|158613|P6|COMPLETED|Treatment Period 2 (14 Days)||27
66223|NCT01716520|158614|P5|COMPLETED|Treatment Period 2 (14 Days)||29
66224|NCT01716520|158615|P4|COMPLETED|Treatment Period 2 (14 Days)||28
66225|NCT01716520|158616|P3|COMPLETED|Treatment Period 2 (14 Days)||27
66226|NCT01716520|158617|P2|COMPLETED|Treatment Period 2 (14 Days)||28
66227|NCT01716520|158618|P1|COMPLETED|Treatment Period 2 (14 Days)||29
66228|NCT01716520|158613|P6|STARTED|Treatment Period 2 (14 Days)||27
66229|NCT01716520|158614|P5|STARTED|Treatment Period 2 (14 Days)||31
66230|NCT01716520|158615|P4|STARTED|Treatment Period 2 (14 Days)||29
66231|NCT01716520|158616|P3|STARTED|Treatment Period 2 (14 Days)||27
66232|NCT01716520|158617|P2|STARTED|Treatment Period 2 (14 Days)||28
66233|NCT01716520|158618|P1|STARTED|Treatment Period 2 (14 Days)||29
66234|NCT01716520|158613|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
66235|NCT01716520|158614|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
66236|NCT01716520|158615|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
66237|NCT01716520|158616|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
66238|NCT01716520|158617|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
66239|NCT01716520|158618|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
66240|NCT01716520|158613|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
66241|NCT01716520|158614|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
66242|NCT01716520|158615|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
66243|NCT01716520|158616|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
66244|NCT01716520|158617|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
66245|NCT01716520|158618|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
66246|NCT01716520|158613|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
66247|NCT01716520|158614|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
66248|NCT01716520|158615|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
66249|NCT01716520|158616|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
66250|NCT01716520|158617|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
66251|NCT01716520|158618|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
66252|NCT01716520|158613|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
66253|NCT01716520|158614|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
66254|NCT01716520|158615|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
66255|NCT01716520|158616|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
66256|NCT01716520|158617|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
66257|NCT01716520|158618|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
66258|NCT01716520|158613|P6|COMPLETED|Treatment Period 1 (14 Days)||29
66259|NCT01716520|158614|P5|COMPLETED|Treatment Period 1 (14 Days)||31
66260|NCT01716520|158615|P4|COMPLETED|Treatment Period 1 (14 Days)||29
66261|NCT01716520|158616|P3|COMPLETED|Treatment Period 1 (14 Days)||28
66262|NCT01716520|158617|P2|COMPLETED|Treatment Period 1 (14 Days)||29
66263|NCT01716520|158618|P1|COMPLETED|Treatment Period 1 (14 Days)||29
66264|NCT01716520|158613|P6|STARTED|Treatment Period 1 (14 Days)||30
66265|NCT01716520|158614|P5|STARTED|Treatment Period 1 (14 Days)||31
66266|NCT01716520|158615|P4|STARTED|Treatment Period 1 (14 Days)||30
66267|NCT01716520|158616|P3|STARTED|Treatment Period 1 (14 Days)||30
66268|NCT01716520|158617|P2|STARTED|Treatment Period 1 (14 Days)||30
66269|NCT01716520|158618|P1|STARTED|Treatment Period 1 (14 Days)||31
66270|NCT01716468|158634|P1|NOT COMPLETED|Overall Study||6
66271|NCT01716468|158634|P1|COMPLETED|Overall Study||11
66272|NCT01716468|158634|P1|STARTED|Overall Study||17
66273|NCT01716455|158644|P6|NOT COMPLETED|Overall Study||0
66274|NCT01716455|158645|P5|NOT COMPLETED|Overall Study||0
66275|NCT01716455|158646|P4|NOT COMPLETED|Overall Study||0
66276|NCT01716455|158647|P3|NOT COMPLETED|Overall Study||0
66277|NCT01716455|158648|P2|NOT COMPLETED|Overall Study||0
66278|NCT01716455|158649|P1|NOT COMPLETED|Overall Study||0
66279|NCT01716455|158644|P6|COMPLETED|Overall Study||8
66280|NCT01716455|158645|P5|COMPLETED|Overall Study||26
66281|NCT01716455|158646|P4|COMPLETED|Overall Study||8
66282|NCT01716455|158647|P3|COMPLETED|Overall Study||8
66283|NCT01716455|158648|P2|COMPLETED|Overall Study||8
66284|NCT01716455|158649|P1|COMPLETED|Overall Study||8
66285|NCT01716455|158644|P6|STARTED|Overall Study||8
66286|NCT01716455|158645|P5|STARTED|Overall Study||26
66287|NCT01716455|158646|P4|STARTED|Overall Study||8
66288|NCT01716455|158647|P3|STARTED|Overall Study||8
66289|NCT01716455|158648|P2|STARTED|Overall Study||8
66290|NCT01716455|158649|P1|STARTED|Overall Study||8
66291|NCT01716234|158673|P7|NOT COMPLETED|Overall Study||0
66292|NCT01716234|158674|P6|NOT COMPLETED|Overall Study||14
66293|NCT01716234|158675|P5|NOT COMPLETED|Overall Study||5
66294|NCT01716234|158676|P4|NOT COMPLETED|Overall Study||12
66295|NCT01716234|158677|P3|NOT COMPLETED|Overall Study||5
66296|NCT01716234|158678|P2|NOT COMPLETED|Overall Study||10
66297|NCT01716234|158679|P1|NOT COMPLETED|Overall Study||10
66298|NCT01716234|158673|P7|COMPLETED|Overall Study||1
66299|NCT01716234|158674|P6|COMPLETED|Overall Study||18
66300|NCT01716234|158675|P5|COMPLETED|Overall Study||10
66301|NCT01716234|158676|P4|COMPLETED|Overall Study||16
66302|NCT01716234|158677|P3|COMPLETED|Overall Study||15
66303|NCT01716234|158678|P2|COMPLETED|Overall Study||12
66304|NCT01716234|158679|P1|COMPLETED|Overall Study||14
66305|NCT01716234|158673|P7|Treated|Overall Study||1
66306|NCT01716234|158674|P6|Treated|Overall Study||30
66307|NCT01716234|158675|P5|Treated|Overall Study||15
66308|NCT01716234|158676|P4|Treated|Overall Study||28
66309|NCT01716234|158677|P3|Treated|Overall Study||19
66310|NCT01716234|158678|P2|Treated|Overall Study||21
66311|NCT01716234|158679|P1|Treated|Overall Study||22
66312|NCT01716234|158673|P7|STARTED|Overall Study||1
66313|NCT01716234|158674|P6|STARTED|Overall Study||32
66314|NCT01716234|158675|P5|STARTED|Overall Study||15
66315|NCT01716234|158676|P4|STARTED|Overall Study||28
66316|NCT01716234|158677|P3|STARTED|Overall Study||20
66317|NCT01716234|158678|P2|STARTED|Overall Study||22
66318|NCT01716234|158679|P1|STARTED|Overall Study||24
66319|NCT01716221|158716|P1|NOT COMPLETED|Overall Study||0
66320|NCT01716221|158716|P1|COMPLETED|Overall Study||1
66321|NCT01716221|158716|P1|STARTED|Overall Study||1
66322|NCT01716169|158742|P1|NOT COMPLETED|Overall Study||4
66323|NCT01716169|158742|P1|COMPLETED|Overall Study||6
66324|NCT01716169|158742|P1|Standard of Care Dressings Used|Overall Study||7
66325|NCT01716169|158742|P1|STARTED|Overall Study||10
66326|NCT01716156|158751|P3|NOT COMPLETED|Overall Study||2
66327|NCT01716156|158752|P2|NOT COMPLETED|Overall Study||1
66328|NCT01716156|158753|P1|NOT COMPLETED|Overall Study||2
66329|NCT01716156|158751|P3|COMPLETED|Overall Study||11
66330|NCT01716156|158752|P2|COMPLETED|Overall Study||3
66331|NCT01716156|158753|P1|COMPLETED|Overall Study||7
66332|NCT01716156|158751|P3|STARTED|Overall Study||13
66333|NCT01716156|158752|P2|STARTED|Overall Study||4
66334|NCT01716156|158753|P1|STARTED|Overall Study||9
66335|NCT01716052|158779|P2|NOT COMPLETED|Overall Study||1
66336|NCT01716052|158780|P1|NOT COMPLETED|Overall Study||1
66337|NCT01716052|158779|P2|COMPLETED|Overall Study||0
66338|NCT01716052|158780|P1|COMPLETED|Overall Study||0
66339|NCT01716052|158779|P2|STARTED|Overall Study||1
66340|NCT01716052|158780|P1|STARTED|Overall Study||1
66341|NCT01716013|158788|P2|NOT COMPLETED|Overall Study||0
66342|NCT01716013|158789|P1|NOT COMPLETED|Overall Study||3
66343|NCT01716013|158788|P2|COMPLETED|Overall Study||54
66344|NCT01716013|158789|P1|COMPLETED|Overall Study||105
66345|NCT01716013|158788|P2|STARTED|Overall Study||54
66346|NCT01716013|158789|P1|STARTED|Overall Study||108
66347|NCT01715948|158801|P1|NOT COMPLETED|Overall Study||1
66348|NCT01715948|158801|P1|COMPLETED|Overall Study||8
66349|NCT01715948|158801|P1|STARTED|Overall Study||9
66350|NCT01715896|158822|P2|NOT COMPLETED|Overall Study||11
66351|NCT01715896|158823|P1|NOT COMPLETED|Overall Study||3
66352|NCT01715896|158822|P2|COMPLETED|Overall Study||59
66353|NCT01715896|158823|P1|COMPLETED|Overall Study||65
66354|NCT01715896|158822|P2|STARTED|Overall Study||70
66355|NCT01715896|158823|P1|STARTED|Overall Study||68
66356|NCT01715857|158886|P1|NOT COMPLETED|Overall Study||96
66357|NCT01715857|158886|P1|COMPLETED|Overall Study||4004
66358|NCT01715857|158886|P1|STARTED|Overall Study||4100
66359|NCT01715831|158896|P1|NOT COMPLETED|Overall Study||1
66360|NCT01715831|158896|P1|COMPLETED|Overall Study||25
66361|NCT01715831|158896|P1|STARTED|Overall Study||26
66362|NCT01715415|158914|P2|NOT COMPLETED|Open-label Treatment||2
66363|NCT01715415|158915|P1|NOT COMPLETED|Open-label Treatment||0
66364|NCT01715415|158914|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
66365|NCT01715415|158915|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
66366|NCT01715415|158914|P2|STARTED|Open-label Treatment||96
66367|NCT01715415|158915|P1|STARTED|Open-label Treatment|not applicable to this arm|0
66368|NCT01715415|158914|P2|NOT COMPLETED|Double-blind Treatment||2
66369|NCT01715415|158915|P1|NOT COMPLETED|Double-blind Treatment||5
66370|NCT01715415|158914|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
66371|NCT01715415|158915|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
66372|NCT01715415|158914|P2|Randomized But Not Treated|Double-blind Treatment||1
66373|NCT01715415|158915|P1|Randomized But Not Treated|Double-blind Treatment||0
66374|NCT01715415|158914|P2|STARTED|Double-blind Treatment||98
66375|NCT01715415|158915|P1|STARTED|Double-blind Treatment||297
66376|NCT01715298|158929|P2|NOT COMPLETED|Overall Study||11
66377|NCT01715298|158930|P1|NOT COMPLETED|Overall Study||7
66378|NCT01715298|158929|P2|COMPLETED|Overall Study||205
66379|NCT01715298|158930|P1|COMPLETED|Overall Study||209
66380|NCT01715298|158929|P2|Full Analysis Set (FAS)|Overall Study||214
66381|NCT01715298|158930|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
66382|NCT01715298|158929|P2|STARTED|Overall Study||216
66383|NCT01715298|158930|P1|STARTED|Overall Study||216
66384|NCT01715207|158968|P2|NOT COMPLETED|Overall Study||1
66385|NCT01715207|158969|P1|NOT COMPLETED|Overall Study||1
66386|NCT01715207|158968|P2|COMPLETED|Overall Study||14
66387|NCT01715207|158969|P1|COMPLETED|Overall Study||14
66388|NCT01715207|158968|P2|STARTED|Overall Study||15
66389|NCT01715207|158969|P1|STARTED|Overall Study||15
66390|NCT01715129|158977|P1|NOT COMPLETED|Overall Study||9
66391|NCT01715129|158977|P1|COMPLETED|Overall Study||117
66392|NCT01715129|158977|P1|STARTED|Overall Study||126
66393|NCT01715064|158996|P2|NOT COMPLETED|Overall Study||0
66394|NCT01715064|158997|P1|NOT COMPLETED|Overall Study||0
66395|NCT01715064|158996|P2|COMPLETED|Overall Study||18
66396|NCT01715064|158997|P1|COMPLETED|Overall Study||18
66397|NCT01715064|158996|P2|STARTED|Overall Study||18
66398|NCT01715064|158997|P1|STARTED|Overall Study||18
66399|NCT01714817|159005|P2|NOT COMPLETED|Overall Study||42
66400|NCT01714817|159006|P1|NOT COMPLETED|Overall Study||48
66401|NCT01714817|159005|P2|COMPLETED|Overall Study|Completed = continued study through Year 1|161
66402|NCT01714817|159006|P1|COMPLETED|Overall Study|Completed = continued study through Year 1|155
66403|NCT01714817|159005|P2|Treated|Overall Study||203
66404|NCT01714817|159006|P1|Treated|Overall Study||202
66405|NCT01714817|159005|P2|STARTED|Overall Study||203
66406|NCT01714817|159006|P1|STARTED|Overall Study||203
66407|NCT01714804|159027|P2|NOT COMPLETED|Overall Study||0
66408|NCT01714804|159028|P1|NOT COMPLETED|Overall Study||1
66409|NCT01714804|159027|P2|COMPLETED|Overall Study||30
66410|NCT01714804|159028|P1|COMPLETED|Overall Study||29
66411|NCT01714804|159027|P2|STARTED|Overall Study||30
66412|NCT01714804|159028|P1|STARTED|Overall Study||30
66413|NCT01714635|159039|P3|NOT COMPLETED|Overall Study||2
66414|NCT01714635|159040|P2|NOT COMPLETED|Overall Study||0
66415|NCT01714635|159041|P1|NOT COMPLETED|Overall Study||2
66416|NCT01714635|159039|P3|COMPLETED|Overall Study||146
66417|NCT01714635|159040|P2|COMPLETED|Overall Study||150
66418|NCT01714635|159041|P1|COMPLETED|Overall Study||145
66419|NCT01714635|159039|P3|STARTED|Overall Study||148
66420|NCT01714635|159040|P2|STARTED|Overall Study||150
66421|NCT01714635|159041|P1|STARTED|Overall Study||147
66422|NCT01714609|159057|P2|NOT COMPLETED|Overall Study||0
66423|NCT01714609|159058|P1|NOT COMPLETED|Overall Study||1
66424|NCT01714609|159057|P2|COMPLETED|Overall Study||5
66425|NCT01714609|159058|P1|COMPLETED|Overall Study||4
66426|NCT01714609|159057|P2|STARTED|Overall Study||5
66427|NCT01714609|159058|P1|STARTED|Overall Study||5
66428|NCT01714544|159064|P1|NOT COMPLETED|Overall Study||3
66429|NCT01714544|159064|P1|COMPLETED|Overall Study||57
66430|NCT01714544|159064|P1|STARTED|Overall Study||60
66431|NCT01714505|159068|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
66432|NCT01714505|159069|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
66433|NCT01714505|159068|P2|COMPLETED|Admission 2 (40 Hours)||9
66434|NCT01714505|159069|P1|COMPLETED|Admission 2 (40 Hours)||9
66435|NCT01714505|159068|P2|STARTED|Admission 2 (40 Hours)||9
66436|NCT01714505|159069|P1|STARTED|Admission 2 (40 Hours)||9
66437|NCT01714505|159068|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
66438|NCT01714505|159069|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
66439|NCT01714505|159068|P2|COMPLETED|Admission 1 (40 Hours)||9
66440|NCT01714505|159069|P1|COMPLETED|Admission 1 (40 Hours)||9
66441|NCT01714505|159068|P2|STARTED|Admission 1 (40 Hours)||10
66442|NCT01714505|159069|P1|STARTED|Admission 1 (40 Hours)||10
66443|NCT01714492|159079|P1|NOT COMPLETED|Overall Study||0
66444|NCT01714492|159079|P1|COMPLETED|Overall Study||8
66445|NCT01714492|159079|P1|STARTED|Overall Study||8
66446|NCT01714336|159090|P2|NOT COMPLETED|Overall Study||0
66447|NCT01714336|159091|P1|NOT COMPLETED|Overall Study||0
66448|NCT01714336|159090|P2|COMPLETED|Overall Study||69
66449|NCT01714336|159091|P1|COMPLETED|Overall Study||69
66450|NCT01714336|159090|P2|STARTED|Overall Study||69
66451|NCT01714336|159091|P1|STARTED|Overall Study||69
66452|NCT01714310|159114|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
66453|NCT01714310|159115|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
66454|NCT01714310|159116|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
66455|NCT01714310|159114|P3|COMPLETED|Double Blind Adjunctive Treatment||0
66456|NCT01714310|159115|P2|COMPLETED|Double Blind Adjunctive Treatment||11
66457|NCT01714310|159116|P1|COMPLETED|Double Blind Adjunctive Treatment||10
66458|NCT01714310|159114|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
66459|NCT01714310|159115|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
66460|NCT01714310|159116|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
66461|NCT01714310|159114|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
66462|NCT01714310|159115|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
66463|NCT01714310|159116|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
66464|NCT01714310|159114|P3|COMPLETED|Open Lisdexamfetamine Titration||30
66465|NCT01714310|159115|P2|COMPLETED|Open Lisdexamfetamine Titration||0
66466|NCT01714310|159116|P1|COMPLETED|Open Lisdexamfetamine Titration||0
66467|NCT01714310|159114|P3|STARTED|Open Lisdexamfetamine Titration||34
66468|NCT01714310|159115|P2|STARTED|Open Lisdexamfetamine Titration||0
66469|NCT01714310|159116|P1|STARTED|Open Lisdexamfetamine Titration||0
66470|NCT01714232|159163|P1|NOT COMPLETED|Overall Study||0
66471|NCT01714232|159163|P1|COMPLETED|Overall Study||106
66472|NCT01714232|159163|P1|STARTED|Overall Study||106
66473|NCT01714024|159172|P3|NOT COMPLETED|Overall Study||3
66474|NCT01714024|159173|P2|NOT COMPLETED|Overall Study||6
66475|NCT01714024|159174|P1|NOT COMPLETED|Overall Study||1
66476|NCT01714024|159172|P3|COMPLETED|Overall Study||8
66477|NCT01714024|159173|P2|COMPLETED|Overall Study||12
66478|NCT01714024|159174|P1|COMPLETED|Overall Study||12
66479|NCT01714024|159172|P3|STARTED|Overall Study||11
66480|NCT01714024|159173|P2|STARTED|Overall Study||18
66481|NCT01714024|159174|P1|STARTED|Overall Study||13
66482|NCT01713998|159194|P3|NOT COMPLETED|Overall Study||2
66483|NCT01713998|159195|P2|NOT COMPLETED|Overall Study||0
66484|NCT01713998|159196|P1|NOT COMPLETED|Overall Study||3
66485|NCT01713998|159194|P3|COMPLETED|Overall Study||14
66486|NCT01713998|159195|P2|COMPLETED|Overall Study||15
66487|NCT01713998|159196|P1|COMPLETED|Overall Study||13
66488|NCT01713998|159194|P3|STARTED|Overall Study||16
66489|NCT01713998|159195|P2|STARTED|Overall Study||15
66490|NCT01713998|159196|P1|STARTED|Overall Study||16
66491|NCT01713933|159214|P1|NOT COMPLETED|Overall Study||6
66492|NCT01713933|159214|P1|COMPLETED|Overall Study||31
66493|NCT01713933|159214|P1|STARTED|Overall Study||37
66494|NCT01713686|159226|P1|NOT COMPLETED|Overall Study||15
66495|NCT01713686|159226|P1|COMPLETED|Overall Study||110
66496|NCT01713686|159226|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
66497|NCT01713660|159235|P1|NOT COMPLETED|Overall Study||0
66498|NCT01713660|159235|P1|COMPLETED|Overall Study||37
66499|NCT01713660|159235|P1|STARTED|Overall Study||37
66500|NCT01713621|159243|P2|NOT COMPLETED|Overall Study||16
66501|NCT01713621|159244|P1|NOT COMPLETED|Overall Study||7
66502|NCT01713621|159243|P2|COMPLETED|Overall Study||1
66503|NCT01713621|159244|P1|COMPLETED|Overall Study||1
66504|NCT01713621|159243|P2|STARTED|Overall Study||17
66505|NCT01713621|159244|P1|STARTED|Overall Study||8
66506|NCT01713608|159254|P4|NOT COMPLETED|Overall Study||0
66507|NCT01713608|159255|P3|NOT COMPLETED|Overall Study||0
66508|NCT01713608|159256|P2|NOT COMPLETED|Overall Study||0
66509|NCT01713608|159257|P1|NOT COMPLETED|Overall Study||0
66510|NCT01713608|159254|P4|COMPLETED|Overall Study||12
66511|NCT01713608|159255|P3|COMPLETED|Overall Study||8
66512|NCT01713608|159256|P2|COMPLETED|Overall Study||6
66513|NCT01713608|159257|P1|COMPLETED|Overall Study||8
66514|NCT01713608|159254|P4|STARTED|Overall Study||12
66515|NCT01713608|159255|P3|STARTED|Overall Study||8
66516|NCT01713608|159256|P2|STARTED|Overall Study||6
66517|NCT01713608|159257|P1|STARTED|Overall Study||8
66518|NCT01713530|159277|P2|NOT COMPLETED|Overall Study||19
66519|NCT01713530|159278|P1|NOT COMPLETED|Overall Study||25
66520|NCT01713530|159277|P2|COMPLETED|Overall Study||117
66521|NCT01713530|159278|P1|COMPLETED|Overall Study||113
66522|NCT01713530|159277|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
66523|NCT01713530|159278|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
66524|NCT01713530|159277|P2|STARTED|Overall Study||136
66525|NCT01713530|159278|P1|STARTED|Overall Study||138
66526|NCT01713400|159296|P2|NOT COMPLETED|Overall Study||0
66527|NCT01713400|159297|P1|NOT COMPLETED|Overall Study||0
66528|NCT01713400|159296|P2|COMPLETED|Overall Study||15
66529|NCT01713400|159297|P1|COMPLETED|Overall Study||15
66530|NCT01713400|159296|P2|STARTED|Overall Study||15
66531|NCT01713400|159297|P1|STARTED|Overall Study||15
66532|NCT01713348|159309|P4|NOT COMPLETED|Overall Study||0
66533|NCT01713348|159310|P3|NOT COMPLETED|Overall Study||2
66534|NCT01713348|159311|P2|NOT COMPLETED|Overall Study||2
66535|NCT01713348|159312|P1|NOT COMPLETED|Overall Study||4
66536|NCT01713348|159309|P4|COMPLETED|Overall Study||15
66537|NCT01713348|159310|P3|COMPLETED|Overall Study||28
66538|NCT01713348|159311|P2|COMPLETED|Overall Study||11
66539|NCT01713348|159312|P1|COMPLETED|Overall Study||25
66540|NCT01713348|159309|P4|STARTED|Overall Study||15
66541|NCT01713348|159310|P3|STARTED|Overall Study||30
66542|NCT01713348|159311|P2|STARTED|Overall Study||13
66543|NCT01713348|159312|P1|STARTED|Overall Study||29
66544|NCT01713283|159342|P2|NOT COMPLETED|Overall Study||3
66545|NCT01713283|159343|P1|NOT COMPLETED|Overall Study||11
66546|NCT01713283|159342|P2|COMPLETED|Overall Study||26
66547|NCT01713283|159343|P1|COMPLETED|Overall Study||20
66548|NCT01713283|159342|P2|STARTED|Overall Study||29
66549|NCT01713283|159343|P1|STARTED|Overall Study||31
66550|NCT01713036|159365|P1|NOT COMPLETED|Overall Study||1
66551|NCT01713036|159365|P1|COMPLETED|Overall Study||5
66552|NCT01713036|159365|P1|STARTED|Overall Study||6
66553|NCT01712984|159405|P3|NOT COMPLETED|Overall Study||10
66554|NCT01712984|159406|P2|NOT COMPLETED|Overall Study||16
66555|NCT01712984|159407|P1|NOT COMPLETED|Overall Study||16
66556|NCT01712984|159405|P3|COMPLETED|Overall Study||836
66557|NCT01712984|159406|P2|COMPLETED|Overall Study||821
66558|NCT01712984|159407|P1|COMPLETED|Overall Study||1656
66559|NCT01712984|159405|P3|STARTED|Overall Study||846
66560|NCT01712984|159406|P2|STARTED|Overall Study||837
66561|NCT01712984|159407|P1|STARTED|Overall Study||1672
66562|NCT01712854|159427|P1|NOT COMPLETED|Overall Study||1
66563|NCT01712854|159427|P1|COMPLETED|Overall Study||8
66564|NCT01712854|159427|P1|STARTED|Overall Study||9
66565|NCT01712776|159434|P2|NOT COMPLETED|Overall Study||0
66566|NCT01712776|159435|P1|NOT COMPLETED|Overall Study||0
66567|NCT01712776|159434|P2|COMPLETED|Overall Study||50
66568|NCT01712776|159435|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
66569|NCT01712776|159434|P2|STARTED|Overall Study||50
66570|NCT01712776|159435|P1|STARTED|Overall Study||50
66571|NCT01712711|159443|P2|NOT COMPLETED|Overall Study||0
66572|NCT01712711|159444|P1|NOT COMPLETED|Overall Study||0
66573|NCT01712711|159443|P2|COMPLETED|Overall Study||20
66574|NCT01712711|159444|P1|COMPLETED|Overall Study||20
66575|NCT01712711|159443|P2|STARTED|Overall Study||20
66576|NCT01712711|159444|P1|STARTED|Overall Study||20
66577|NCT01712685|159450|P1|NOT COMPLETED|Overall Study||1
66578|NCT01712685|159450|P1|COMPLETED|Overall Study||11
66579|NCT01712685|159450|P1|STARTED|Overall Study||12
66580|NCT01712516|159466|P4|NOT COMPLETED|Overall Study||13
66581|NCT01712516|159467|P3|NOT COMPLETED|Overall Study||6
66582|NCT01712516|159468|P2|NOT COMPLETED|Overall Study||10
66583|NCT01712516|159469|P1|NOT COMPLETED|Overall Study||6
66584|NCT01712516|159466|P4|COMPLETED|Overall Study||236
66585|NCT01712516|159467|P3|COMPLETED|Overall Study||245
66586|NCT01712516|159468|P2|COMPLETED|Overall Study||241
66587|NCT01712516|159469|P1|COMPLETED|Overall Study||244
66588|NCT01712516|159466|P4|Full Analysis Set|Overall Study||247
66589|NCT01712516|159467|P3|Full Analysis Set|Overall Study||250
66590|NCT01712516|159468|P2|Full Analysis Set|Overall Study||251
66591|NCT01712516|159469|P1|Full Analysis Set|Overall Study||250
66592|NCT01712516|159466|P4|Safety Set|Overall Study||248
66593|NCT01712516|159467|P3|Safety Set|Overall Study||251
66594|NCT01712516|159468|P2|Safety Set|Overall Study||251
66595|NCT01712516|159469|P1|Safety Set|Overall Study||250
66596|NCT01712516|159466|P4|STARTED|Overall Study||249
66597|NCT01712516|159467|P3|STARTED|Overall Study||251
66598|NCT01712516|159468|P2|STARTED|Overall Study||251
66599|NCT01712516|159469|P1|STARTED|Overall Study||250
66600|NCT01712399|159519|P1|NOT COMPLETED|Overall Study||397
66601|NCT01712399|159519|P1|COMPLETED|Overall Study||0
66602|NCT01712399|159519|P1|STARTED|Overall Study||397
66603|NCT01712360|159536|P4|NOT COMPLETED|Overall Study||2
66604|NCT01712360|159537|P3|NOT COMPLETED|Overall Study||0
66605|NCT01712360|159538|P2|NOT COMPLETED|Overall Study||1
66606|NCT01712360|159539|P1|NOT COMPLETED|Overall Study||0
66607|NCT01712360|159536|P4|COMPLETED|Overall Study||4
66608|NCT01712360|159537|P3|COMPLETED|Overall Study||6
66609|NCT01712360|159538|P2|COMPLETED|Overall Study||21
66610|NCT01712360|159539|P1|COMPLETED|Overall Study||22
66611|NCT01712360|159536|P4|STARTED|Overall Study||6
66612|NCT01712360|159537|P3|STARTED|Overall Study||6
66613|NCT01712360|159538|P2|STARTED|Overall Study||22
66614|NCT01712360|159539|P1|STARTED|Overall Study||22
66615|NCT01712334|159565|P2|NOT COMPLETED|Treatment Period 2||0
66616|NCT01712334|159566|P1|NOT COMPLETED|Treatment Period 2||0
66617|NCT01712334|159565|P2|COMPLETED|Treatment Period 2||41
66618|NCT01712334|159566|P1|COMPLETED|Treatment Period 2||44
66619|NCT01712334|159565|P2|STARTED|Treatment Period 2||41
66620|NCT01712334|159566|P1|STARTED|Treatment Period 2||44
66621|NCT01712334|159565|P2|NOT COMPLETED|Treatment Period 1||2
66622|NCT01712334|159566|P1|NOT COMPLETED|Treatment Period 1||0
66623|NCT01712334|159565|P2|COMPLETED|Treatment Period 1||41
66624|NCT01712334|159566|P1|COMPLETED|Treatment Period 1||44
66625|NCT01712334|159565|P2|Received Treatment|Treatment Period 1||41
66626|NCT01712334|159566|P1|Received Treatment|Treatment Period 1||44
66627|NCT01712334|159565|P2|STARTED|Treatment Period 1||43
66628|NCT01712334|159566|P1|STARTED|Treatment Period 1||44
66629|NCT01712256|159574|P1|NOT COMPLETED|Overall Study||1
66630|NCT01712256|159574|P1|COMPLETED|Overall Study||32
66631|NCT01712256|159574|P1|STARTED|Overall Study||33
66632|NCT01712204|159585|P2|NOT COMPLETED|Overall Study||5
66633|NCT01712204|159586|P1|NOT COMPLETED|Overall Study||8
66634|NCT01712204|159585|P2|COMPLETED|Overall Study||36
66635|NCT01712204|159586|P1|COMPLETED|Overall Study||33
66636|NCT01712204|159585|P2|STARTED|Overall Study||41
66637|NCT01712204|159586|P1|STARTED|Overall Study||41
66638|NCT01712178|159594|P2|NOT COMPLETED|Overall Study||3
66639|NCT01712178|159595|P1|NOT COMPLETED|Overall Study||1
66640|NCT01712178|159594|P2|COMPLETED|Overall Study||47
66641|NCT01712178|159595|P1|COMPLETED|Overall Study||49
66642|NCT01712178|159594|P2|STARTED|Overall Study||50
66643|NCT01712178|159595|P1|STARTED|Overall Study||50
66644|NCT01712074|159620|P3|NOT COMPLETED|Double Blind Period||8
66645|NCT01712074|159621|P2|NOT COMPLETED|Double Blind Period||14
66646|NCT01712074|159622|P1|NOT COMPLETED|Double Blind Period||0
66647|NCT01712074|159620|P3|COMPLETED|Double Blind Period||86
66648|NCT01712074|159621|P2|COMPLETED|Double Blind Period||77
66649|NCT01712074|159622|P1|COMPLETED|Double Blind Period||0
66650|NCT01712074|159620|P3|STARTED|Double Blind Period||94
66651|NCT01712074|159621|P2|STARTED|Double Blind Period||91
66652|NCT01712074|159622|P1|STARTED|Double Blind Period||0
66653|NCT01712074|159620|P3|NOT COMPLETED|Placebo Run-in Period||0
66654|NCT01712074|159621|P2|NOT COMPLETED|Placebo Run-in Period||0
66655|NCT01712074|159622|P1|NOT COMPLETED|Placebo Run-in Period||10
66656|NCT01712074|159620|P3|COMPLETED|Placebo Run-in Period||0
66657|NCT01712074|159621|P2|COMPLETED|Placebo Run-in Period||0
66658|NCT01712074|159622|P1|COMPLETED|Placebo Run-in Period||185
66659|NCT01712074|159620|P3|STARTED|Placebo Run-in Period||0
66660|NCT01712074|159621|P2|STARTED|Placebo Run-in Period||0
66661|NCT01712074|159622|P1|STARTED|Placebo Run-in Period||195
66662|NCT01712061|159678|P3|NOT COMPLETED|Overall Study||11
66663|NCT01712061|159679|P2|NOT COMPLETED|Overall Study||26
66664|NCT01712061|159680|P1|NOT COMPLETED|Overall Study||10
66665|NCT01712061|159678|P3|COMPLETED|Overall Study||45
66666|NCT01712061|159679|P2|COMPLETED|Overall Study||114
66667|NCT01712061|159680|P1|COMPLETED|Overall Study||20
66668|NCT01712061|159678|P3|STARTED|Overall Study||56
66669|NCT01712061|159679|P2|STARTED|Overall Study||140
66670|NCT01712061|159680|P1|STARTED|Overall Study||30
66671|NCT01712009|159720|P3|NOT COMPLETED|Overall Study||21
66672|NCT01712009|159721|P2|NOT COMPLETED|Overall Study||29
66673|NCT01712009|159722|P1|NOT COMPLETED|Overall Study||38
66674|NCT01712009|159720|P3|COMPLETED|Overall Study||181
66675|NCT01712009|159721|P2|COMPLETED|Overall Study||171
66676|NCT01712009|159722|P1|COMPLETED|Overall Study||160
66677|NCT01712009|159720|P3|Received Naproxen / Loratadine|Overall Study||198
66678|NCT01712009|159721|P2|Received Naproxen / Loratadine|Overall Study||193
66679|NCT01712009|159722|P1|Received Naproxen / Loratadine|Overall Study||0
66680|NCT01712009|159720|P3|Received Pegfilgrastim|Overall Study||200
66681|NCT01712009|159721|P2|Received Pegfilgrastim|Overall Study||196
66682|NCT01712009|159722|P1|Received Pegfilgrastim|Overall Study||191
66683|NCT01712009|159720|P3|STARTED|Overall Study||202
66684|NCT01712009|159721|P2|STARTED|Overall Study||200
66685|NCT01712009|159722|P1|STARTED|Overall Study||198
66686|NCT01711918|159748|P1|NOT COMPLETED|Overall Study||2
66687|NCT01711918|159748|P1|COMPLETED|Overall Study||7
66688|NCT01711918|159748|P1|STARTED|Overall Study||9
66689|NCT01711866|159756|P1|NOT COMPLETED|Overall Study||8
66690|NCT01711866|159756|P1|COMPLETED|Overall Study||79
66691|NCT01711866|159756|P1|STARTED|Overall Study||87
66692|NCT01711853|159761|P1|NOT COMPLETED|Overall Study||3
66693|NCT01711853|159761|P1|COMPLETED|Overall Study||16
66694|NCT01711853|159761|P1|STARTED|Overall Study||19
66695|NCT01711736|159768|P2|NOT COMPLETED|Overall Study||8
66696|NCT01711736|159769|P1|NOT COMPLETED|Overall Study||12
66697|NCT01711736|159768|P2|COMPLETED|Overall Study|Up to Day 180|294
66698|NCT01711736|159769|P1|COMPLETED|Overall Study|Up to Day 180|287
66699|NCT01711736|159768|P2|STARTED|Overall Study||302
66700|NCT01711736|159769|P1|STARTED|Overall Study||299
66701|NCT01711645|159797|P1|NOT COMPLETED|Overall Study||19
66702|NCT01711645|159797|P1|COMPLETED|Overall Study||36
66703|NCT01711645|159797|P1|STARTED|Overall Study||55
66704|NCT01711424|159832|P1|NOT COMPLETED|Overall Study||0
66705|NCT01711424|159832|P1|COMPLETED|Overall Study||1209
66706|NCT01711424|159832|P1|STARTED|Overall Study||1209
66707|NCT01711359|159842|P3|NOT COMPLETED|Follow Up||28
66708|NCT01711359|159843|P2|NOT COMPLETED|Follow Up||15
66709|NCT01711359|159844|P1|NOT COMPLETED|Follow Up||25
66710|NCT01711359|159842|P3|COMPLETED|Follow Up||0
66711|NCT01711359|159843|P2|COMPLETED|Follow Up||0
66712|NCT01711359|159844|P1|COMPLETED|Follow Up||0
66713|NCT01711359|159842|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
66714|NCT01711359|159843|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
66715|NCT01711359|159844|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
66716|NCT01711359|159842|P3|NOT COMPLETED|Treatment Period||42
66717|NCT01711359|159843|P2|NOT COMPLETED|Treatment Period||24
66718|NCT01711359|159844|P1|NOT COMPLETED|Treatment Period||52
66719|NCT01711359|159842|P3|COMPLETED|Treatment Period||173
66720|NCT01711359|159843|P2|COMPLETED|Treatment Period||136
66721|NCT01711359|159844|P1|COMPLETED|Treatment Period||161
66722|NCT01711359|159842|P3|Rescued|Treatment Period||6
66723|NCT01711359|159843|P2|Rescued|Treatment Period||7
66724|NCT01711359|159844|P1|Rescued|Treatment Period||26
66725|NCT01711359|159842|P3|Received at Least One Dose of Study Drug|Treatment Period||215
66726|NCT01711359|159843|P2|Received at Least One Dose of Study Drug|Treatment Period||159
66727|NCT01711359|159844|P1|Received at Least One Dose of Study Drug|Treatment Period||210
66728|NCT01711359|159842|P3|STARTED|Treatment Period||215
66729|NCT01711359|159843|P2|STARTED|Treatment Period||160
66730|NCT01711359|159844|P1|STARTED|Treatment Period||213
66731|NCT01711216|159915|P1|NOT COMPLETED|Overall Study||217
66732|NCT01711216|159915|P1|COMPLETED|Overall Study||782
66733|NCT01711216|159915|P1|STARTED|Overall Study||999
66734|NCT01711177|159939|P3|NOT COMPLETED|Overall Study||0
66735|NCT01711177|159940|P2|NOT COMPLETED|Overall Study||0
66736|NCT01711177|159941|P1|NOT COMPLETED|Overall Study||0
66737|NCT01711177|159939|P3|COMPLETED|Overall Study||3
66738|NCT01711177|159940|P2|COMPLETED|Overall Study||3
66739|NCT01711177|159941|P1|COMPLETED|Overall Study||10
66740|NCT01711177|159939|P3|STARTED|Overall Study||3
66741|NCT01711177|159940|P2|STARTED|Overall Study||3
66742|NCT01711177|159941|P1|STARTED|Overall Study||10
66743|NCT01710839|159951|P2|NOT COMPLETED|Overall Study||6
66744|NCT01710839|159952|P1|NOT COMPLETED|Overall Study||1
66745|NCT01710839|159951|P2|COMPLETED|Overall Study||0
66746|NCT01710839|159952|P1|COMPLETED|Overall Study||23
66747|NCT01710839|159951|P2|STARTED|Overall Study||6
66748|NCT01710839|159952|P1|STARTED|Overall Study||24
66749|NCT01710800|159974|P1|NOT COMPLETED|Overall Study||22
66750|NCT01710800|159974|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
66751|NCT01710800|159974|P1|Received Placebo Intervention|Overall Study||45
66752|NCT01710800|159974|P1|Received PPI Intervention|Overall Study||44
66753|NCT01710800|159974|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
66754|NCT01710787|159983|P3|NOT COMPLETED|Overall Study||0
66755|NCT01710787|159984|P2|NOT COMPLETED|Overall Study||0
66756|NCT01710787|159985|P1|NOT COMPLETED|Overall Study||0
66757|NCT01710787|159983|P3|COMPLETED|Overall Study||22
66758|NCT01710787|159984|P2|COMPLETED|Overall Study||44
66759|NCT01710787|159985|P1|COMPLETED|Overall Study||44
66760|NCT01710787|159983|P3|STARTED|Overall Study||22
66761|NCT01710787|159984|P2|STARTED|Overall Study||44
66762|NCT01710787|159985|P1|STARTED|Overall Study||44
66763|NCT01710657|160041|P3|NOT COMPLETED|Overall Study||32
66764|NCT01710657|160042|P2|NOT COMPLETED|Overall Study||12
66765|NCT01710657|160043|P1|NOT COMPLETED|Overall Study||18
66766|NCT01710657|160041|P3|COMPLETED|Overall Study||148
66767|NCT01710657|160042|P2|COMPLETED|Overall Study||171
66768|NCT01710657|160043|P1|COMPLETED|Overall Study||166
66769|NCT01710657|160041|P3|Maintenance Period (12 Weeks)|Overall Study||168
66770|NCT01710657|160042|P2|Maintenance Period (12 Weeks)|Overall Study||175
66771|NCT01710657|160043|P1|Maintenance Period (12 Weeks)|Overall Study||176
66772|NCT01710657|160041|P3|Titration Period (4 Weeks)|Overall Study||180
66773|NCT01710657|160042|P2|Titration Period (4 Weeks)|Overall Study||183
66774|NCT01710657|160043|P1|Titration Period (4 Weeks)|Overall Study||184
66775|NCT01710657|160041|P3|STARTED|Overall Study||180
66776|NCT01710657|160042|P2|STARTED|Overall Study||183
66777|NCT01710657|160043|P1|STARTED|Overall Study||184
66778|NCT01710527|160060|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
66779|NCT01710527|160061|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
66780|NCT01710527|160060|P2|COMPLETED|Period 3: Intervention Period 2||15
66781|NCT01710527|160061|P1|COMPLETED|Period 3: Intervention Period 2||16
66782|NCT01710527|160060|P2|STARTED|Period 3: Intervention Period 2||15
66783|NCT01710527|160061|P1|STARTED|Period 3: Intervention Period 2||16
66784|NCT01710527|160060|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
66785|NCT01710527|160061|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
66786|NCT01710527|160060|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
66787|NCT01710527|160061|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
66788|NCT01710527|160060|P2|STARTED|Period 2: Washout Period (7 Days)||16
66789|NCT01710527|160061|P1|STARTED|Period 2: Washout Period (7 Days)||16
66790|NCT01710527|160060|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
66791|NCT01710527|160061|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
66792|NCT01710527|160060|P2|COMPLETED|Period 1: Intervention Period 1||16
66793|NCT01710527|160061|P1|COMPLETED|Period 1: Intervention Period 1||16
66794|NCT01710527|160060|P2|STARTED|Period 1: Intervention Period 1||16
66795|NCT01710527|160061|P1|STARTED|Period 1: Intervention Period 1||16
66796|NCT01710514|160087|P2|NOT COMPLETED|Overall Study||7
66797|NCT01710514|160088|P1|NOT COMPLETED|Overall Study||7
66798|NCT01710514|160087|P2|COMPLETED|Overall Study||47
66799|NCT01710514|160088|P1|COMPLETED|Overall Study||47
66800|NCT01710514|160087|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
66801|NCT01710514|160088|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
66802|NCT01710514|160087|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
66803|NCT01710514|160088|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
66804|NCT01710514|160087|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
66805|NCT01710514|160088|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
66806|NCT01710514|160087|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
66807|NCT01710514|160088|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
66808|NCT01710514|160087|P2|STARTED|Overall Study||54
66809|NCT01710514|160088|P1|STARTED|Overall Study||54
66810|NCT01710501|160109|P3|NOT COMPLETED|Overall Study||0
66811|NCT01710501|160110|P2|NOT COMPLETED|Overall Study||0
66812|NCT01710501|160111|P1|NOT COMPLETED|Overall Study||2
66813|NCT01710501|160109|P3|COMPLETED|Overall Study||30
66814|NCT01710501|160110|P2|COMPLETED|Overall Study||28
66815|NCT01710501|160111|P1|COMPLETED|Overall Study||27
66816|NCT01710501|160109|P3|STARTED|Overall Study||30
66817|NCT01710501|160110|P2|STARTED|Overall Study||28
66818|NCT01710501|160111|P1|STARTED|Overall Study||29
66819|NCT01710358|160143|P3|NOT COMPLETED|Follow-up Period||0
66820|NCT01710358|160144|P2|NOT COMPLETED|Follow-up Period||0
66821|NCT01710358|160145|P1|NOT COMPLETED|Follow-up Period||0
66822|NCT01710358|160143|P3|COMPLETED|Follow-up Period||20
66823|NCT01710358|160144|P2|COMPLETED|Follow-up Period||76
66824|NCT01710358|160145|P1|COMPLETED|Follow-up Period||33
66825|NCT01710358|160143|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
66826|NCT01710358|160144|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
66827|NCT01710358|160145|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
66828|NCT01710358|160143|P3|NOT COMPLETED|Rescue Period||0
66829|NCT01710358|160144|P2|NOT COMPLETED|Rescue Period||31
66830|NCT01710358|160145|P1|NOT COMPLETED|Rescue Period||0
66831|NCT01710358|160143|P3|COMPLETED|Rescue Period||0
66832|NCT01710358|160144|P2|COMPLETED|Rescue Period||196
66833|NCT01710358|160145|P1|COMPLETED|Rescue Period||0
66834|NCT01710358|160143|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
66835|NCT01710358|160144|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
66836|NCT01710358|160145|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
66837|NCT01710358|160143|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
66838|NCT01710358|160144|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
66839|NCT01710358|160145|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
66840|NCT01710358|160143|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
66841|NCT01710358|160144|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
66842|NCT01710358|160145|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
66843|NCT01710358|160143|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
66844|NCT01710358|160144|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
66845|NCT01710358|160145|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
66846|NCT01710358|160143|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
66847|NCT01710358|160144|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
66848|NCT01710358|160145|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
66849|NCT01710358|160143|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
66850|NCT01710358|160144|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
66851|NCT01710358|160145|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
66852|NCT01710358|160143|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
66853|NCT01710358|160144|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
66854|NCT01710358|160145|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
66855|NCT01710358|160143|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
66856|NCT01710358|160144|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
66857|NCT01710358|160145|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
66858|NCT01710358|160143|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
66859|NCT01710358|160144|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
66860|NCT01710358|160145|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
66861|NCT01710358|160143|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
66862|NCT01710358|160144|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
66863|NCT01710358|160145|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
66864|NCT01710358|160143|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
66865|NCT01710358|160144|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
66866|NCT01710358|160145|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
66867|NCT01710345|160216|P3|NOT COMPLETED|Overall Study||1
66868|NCT01710345|160217|P2|NOT COMPLETED|Overall Study||5
66869|NCT01710345|160218|P1|NOT COMPLETED|Overall Study||3
66870|NCT01710345|160216|P3|COMPLETED|Overall Study||19
66871|NCT01710345|160217|P2|COMPLETED|Overall Study||35
66872|NCT01710345|160218|P1|COMPLETED|Overall Study||37
66873|NCT01710345|160216|P3|STARTED|Overall Study||20
66874|NCT01710345|160217|P2|STARTED|Overall Study||40
66875|NCT01710345|160218|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
66876|NCT01710332|160228|P2|NOT COMPLETED|Overall Study||0
66877|NCT01710332|160229|P1|NOT COMPLETED|Overall Study||0
66878|NCT01710332|160228|P2|COMPLETED|Overall Study||6
66879|NCT01710332|160229|P1|COMPLETED|Overall Study||6
66880|NCT01710332|160228|P2|STARTED|Overall Study||6
66881|NCT01710332|160229|P1|STARTED|Overall Study||6
66882|NCT01710254|160237|P1|NOT COMPLETED|Overall Study||0
66883|NCT01710254|160237|P1|COMPLETED|Overall Study||30
66884|NCT01710254|160237|P1|STARTED|Overall Study||30
66885|NCT01710046|160245|P2|NOT COMPLETED|Overall Study||0
66886|NCT01710046|160246|P1|NOT COMPLETED|Overall Study||1
66887|NCT01710046|160245|P2|COMPLETED|Overall Study||3
66888|NCT01710046|160246|P1|COMPLETED|Overall Study||8
66889|NCT01710046|160245|P2|STARTED|Overall Study||3
66890|NCT01710046|160246|P1|STARTED|Overall Study||9
66891|NCT01710033|160286|P5|NOT COMPLETED|Stage 2||1
66892|NCT01710033|160287|P4|NOT COMPLETED|Stage 2||0
66893|NCT01710033|160288|P3|NOT COMPLETED|Stage 2||0
66894|NCT01710033|160289|P2|NOT COMPLETED|Stage 2||0
66895|NCT01710033|160290|P1|NOT COMPLETED|Stage 2||0
66896|NCT01710033|160286|P5|COMPLETED|Stage 2||3
66897|NCT01710033|160287|P4|COMPLETED|Stage 2||0
66898|NCT01710033|160288|P3|COMPLETED|Stage 2||0
66899|NCT01710033|160289|P2|COMPLETED|Stage 2||0
66900|NCT01710033|160290|P1|COMPLETED|Stage 2||0
66901|NCT01710033|160286|P5|STARTED|Stage 2||4
66902|NCT01710033|160287|P4|STARTED|Stage 2||0
66903|NCT01710033|160288|P3|STARTED|Stage 2||0
66904|NCT01710033|160289|P2|STARTED|Stage 2||0
66905|NCT01710033|160290|P1|STARTED|Stage 2||0
66906|NCT01710033|160286|P5|NOT COMPLETED|Stage 1||0
66907|NCT01710033|160287|P4|NOT COMPLETED|Stage 1||0
66908|NCT01710033|160288|P3|NOT COMPLETED|Stage 1||0
66909|NCT01710033|160289|P2|NOT COMPLETED|Stage 1||0
66910|NCT01710033|160290|P1|NOT COMPLETED|Stage 1||0
66911|NCT01710033|160286|P5|COMPLETED|Stage 1||0
66912|NCT01710033|160287|P4|COMPLETED|Stage 1||6
66913|NCT01710033|160288|P3|COMPLETED|Stage 1||6
66914|NCT01710033|160289|P2|COMPLETED|Stage 1||6
66915|NCT01710033|160290|P1|COMPLETED|Stage 1||6
66916|NCT01710033|160286|P5|STARTED|Stage 1||0
66917|NCT01710033|160287|P4|STARTED|Stage 1||6
66918|NCT01710033|160288|P3|STARTED|Stage 1||6
66919|NCT01710033|160289|P2|STARTED|Stage 1||6
66920|NCT01710033|160290|P1|STARTED|Stage 1||6
66921|NCT01710020|160371|P1|NOT COMPLETED|Period 2||0
66922|NCT01710020|160371|P1|COMPLETED|Period 2||11
66923|NCT01710020|160371|P1|STARTED|Period 2||11
66924|NCT01710020|160371|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
66925|NCT01710020|160371|P1|COMPLETED|Washout Period (at Least 14 Days)||11
66926|NCT01710020|160371|P1|STARTED|Washout Period (at Least 14 Days)||11
66927|NCT01710020|160371|P1|NOT COMPLETED|Period 1||1
66928|NCT01710020|160371|P1|COMPLETED|Period 1||11
66929|NCT01710020|160371|P1|STARTED|Period 1||12
66930|NCT01709903|160390|P2|NOT COMPLETED|Overall Study||39
66931|NCT01709903|160391|P1|NOT COMPLETED|Overall Study||29
66932|NCT01709903|160390|P2|COMPLETED|Overall Study||333
66933|NCT01709903|160391|P1|COMPLETED|Overall Study||343
66934|NCT01709903|160390|P2|STARTED|Overall Study|Randomized set|372
66935|NCT01709903|160391|P1|STARTED|Overall Study|Randomized set|372
66936|NCT01709864|160415|P2|NOT COMPLETED|Overall Study||11
66937|NCT01709864|160416|P1|NOT COMPLETED|Overall Study||7
66938|NCT01709864|160415|P2|COMPLETED|Overall Study||208
66939|NCT01709864|160416|P1|COMPLETED|Overall Study||215
66940|NCT01709864|160415|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
66941|NCT01709864|160416|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
66942|NCT01709864|160415|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
67038|NCT01709305|160848|P4|COMPLETED|Phase 2||508
66943|NCT01709864|160416|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
66944|NCT01709864|160415|P2|STARTED|Overall Study||219
66945|NCT01709864|160416|P1|STARTED|Overall Study||222
66946|NCT01709799|160453|P3|NOT COMPLETED|Overall Study||3
66947|NCT01709799|160454|P2|NOT COMPLETED|Overall Study||3
66948|NCT01709799|160455|P1|NOT COMPLETED|Overall Study||3
66949|NCT01709799|160453|P3|COMPLETED|Overall Study||15
66950|NCT01709799|160454|P2|COMPLETED|Overall Study||18
66951|NCT01709799|160455|P1|COMPLETED|Overall Study||22
66952|NCT01709799|160453|P3|STARTED|Overall Study||18
66953|NCT01709799|160454|P2|STARTED|Overall Study||21
66954|NCT01709799|160455|P1|STARTED|Overall Study||25
66955|NCT01709786|160478|P1|NOT COMPLETED|Overall Study||0
66956|NCT01709786|160478|P1|COMPLETED|Overall Study||88
66957|NCT01709786|160478|P1|STARTED|Overall Study||88
66958|NCT01709708|160487|P2|NOT COMPLETED|Overall Study||2
66959|NCT01709708|160488|P1|NOT COMPLETED|Overall Study||1
66960|NCT01709708|160487|P2|COMPLETED|Overall Study||12
66961|NCT01709708|160488|P1|COMPLETED|Overall Study||26
66962|NCT01709708|160487|P2|STARTED|Overall Study||14
66963|NCT01709708|160488|P1|STARTED|Overall Study||27
66964|NCT01709695|160512|P2|NOT COMPLETED|Overall Study||1
66965|NCT01709695|160513|P1|NOT COMPLETED|Overall Study||1
66966|NCT01709695|160512|P2|COMPLETED|Overall Study||13
66967|NCT01709695|160513|P1|COMPLETED|Overall Study||12
66968|NCT01709695|160512|P2|STARTED|Overall Study||14
66969|NCT01709695|160513|P1|STARTED|Overall Study||13
66970|NCT01709578|160538|P3|NOT COMPLETED|Overall Study||51
66971|NCT01709578|160539|P2|NOT COMPLETED|Overall Study||56
66972|NCT01709578|160540|P1|NOT COMPLETED|Overall Study||80
66973|NCT01709578|160538|P3|COMPLETED|Overall Study||133
66974|NCT01709578|160539|P2|COMPLETED|Overall Study||125
66975|NCT01709578|160540|P1|COMPLETED|Overall Study||101
66976|NCT01709578|160538|P3|STARTED|Overall Study||184
66977|NCT01709578|160539|P2|STARTED|Overall Study||181
66978|NCT01709578|160540|P1|STARTED|Overall Study||181
66979|NCT01709513|160671|P3|NOT COMPLETED|Overall Study||30
66980|NCT01709513|160672|P2|NOT COMPLETED|Overall Study||43
66981|NCT01709513|160673|P1|NOT COMPLETED|Overall Study||21
66982|NCT01709513|160671|P3|COMPLETED|Overall Study||96
66983|NCT01709513|160672|P2|COMPLETED|Overall Study||82
66984|NCT01709513|160673|P1|COMPLETED|Overall Study||42
66985|NCT01709513|160671|P3|Treated|Overall Study||126
66986|NCT01709513|160672|P2|Treated|Overall Study||124
66987|NCT01709513|160673|P1|Treated|Overall Study||63
66988|NCT01709513|160671|P3|STARTED|Overall Study||126
66989|NCT01709513|160672|P2|STARTED|Overall Study||125
66990|NCT01709513|160673|P1|STARTED|Overall Study||63
66991|NCT01709500|160734|P2|NOT COMPLETED|Overall Study||82
66992|NCT01709500|160735|P1|NOT COMPLETED|Overall Study||167
66993|NCT01709500|160734|P2|COMPLETED|Overall Study||0
66994|NCT01709500|160735|P1|COMPLETED|Overall Study||0
66995|NCT01709500|160734|P2|Treated|Overall Study||81
66996|NCT01709500|160735|P1|Treated|Overall Study||167
66997|NCT01709500|160734|P2|STARTED|Overall Study||82
66998|NCT01709500|160735|P1|STARTED|Overall Study||167
66999|NCT01709474|160791|P2|NOT COMPLETED|Overall Study||0
67000|NCT01709474|160792|P1|NOT COMPLETED|Overall Study||0
67001|NCT01709474|160791|P2|COMPLETED|Overall Study||4
67002|NCT01709474|160792|P1|COMPLETED|Overall Study||3
67003|NCT01709474|160791|P2|STARTED|Overall Study||4
67004|NCT01709474|160792|P1|STARTED|Overall Study||3
67005|NCT01709422|160802|P2|NOT COMPLETED|Overall Study||0
67006|NCT01709422|160803|P1|NOT COMPLETED|Overall Study||0
67007|NCT01709422|160802|P2|COMPLETED|Overall Study||70
67008|NCT01709422|160803|P1|COMPLETED|Overall Study||70
67009|NCT01709422|160802|P2|STARTED|Overall Study||70
67010|NCT01709422|160803|P1|STARTED|Overall Study||70
67011|NCT01709409|160813|P2|NOT COMPLETED|Overall Study||0
67012|NCT01709409|160814|P1|NOT COMPLETED|Overall Study||1
67013|NCT01709409|160813|P2|COMPLETED|Overall Study||45
67014|NCT01709409|160814|P1|COMPLETED|Overall Study||42
67015|NCT01709409|160813|P2|STARTED|Overall Study||45
67016|NCT01709409|160814|P1|STARTED|Overall Study||43
67017|NCT01709383|160822|P2|NOT COMPLETED|Overall Study||0
67018|NCT01709383|160823|P1|NOT COMPLETED|Overall Study||1
67019|NCT01709383|160822|P2|COMPLETED|Overall Study||14
67020|NCT01709383|160823|P1|COMPLETED|Overall Study||23
67021|NCT01709383|160822|P2|Included in Analysis|Overall Study||13
67022|NCT01709383|160823|P1|Included in Analysis|Overall Study||22
67023|NCT01709383|160822|P2|Completed Follow-ups|Overall Study||14
67024|NCT01709383|160823|P1|Completed Follow-ups|Overall Study||23
67025|NCT01709383|160822|P2|Completed Treatment|Overall Study||14
67026|NCT01709383|160823|P1|Completed Treatment|Overall Study||24
67027|NCT01709383|160822|P2|STARTED|Overall Study||14
67028|NCT01709383|160823|P1|STARTED|Overall Study||24
67029|NCT01709331|160841|P1|NOT COMPLETED|Overall Study||1
67030|NCT01709331|160841|P1|COMPLETED|Overall Study||17
67031|NCT01709331|160841|P1|STARTED|Overall Study||18
67032|NCT01709305|160847|P5|NOT COMPLETED|Phase 2||47
67033|NCT01709305|160848|P4|NOT COMPLETED|Phase 2||48
67034|NCT01709305|160849|P3|NOT COMPLETED|Phase 2||45
67035|NCT01709305|160850|P2|NOT COMPLETED|Phase 2||52
67036|NCT01709305|160851|P1|NOT COMPLETED|Phase 2||0
67037|NCT01709305|160847|P5|COMPLETED|Phase 2||507
67039|NCT01709305|160849|P3|COMPLETED|Phase 2||505
67040|NCT01709305|160850|P2|COMPLETED|Phase 2||500
67041|NCT01709305|160851|P1|COMPLETED|Phase 2||0
67042|NCT01709305|160847|P5|STARTED|Phase 2||554
67043|NCT01709305|160848|P4|STARTED|Phase 2||556
67044|NCT01709305|160849|P3|STARTED|Phase 2||550
67045|NCT01709305|160850|P2|STARTED|Phase 2||552
67046|NCT01709305|160851|P1|STARTED|Phase 2||0
67047|NCT01709305|160847|P5|NOT COMPLETED|Phase 1||0
67048|NCT01709305|160848|P4|NOT COMPLETED|Phase 1||0
67049|NCT01709305|160849|P3|NOT COMPLETED|Phase 1||0
67050|NCT01709305|160850|P2|NOT COMPLETED|Phase 1||0
67051|NCT01709305|160851|P1|NOT COMPLETED|Phase 1||637
67052|NCT01709305|160847|P5|COMPLETED|Phase 1||0
67053|NCT01709305|160848|P4|COMPLETED|Phase 1||0
67054|NCT01709305|160849|P3|COMPLETED|Phase 1||0
67055|NCT01709305|160850|P2|COMPLETED|Phase 1||0
67056|NCT01709305|160851|P1|COMPLETED|Phase 1||4933
67057|NCT01709305|160847|P5|STARTED|Phase 1||0
67058|NCT01709305|160848|P4|STARTED|Phase 1||0
67059|NCT01709305|160849|P3|STARTED|Phase 1||0
67060|NCT01709305|160850|P2|STARTED|Phase 1||0
67061|NCT01709305|160851|P1|STARTED|Phase 1||5570
67062|NCT01709227|160888|P2|NOT COMPLETED|Overall Study||9
67063|NCT01709227|160889|P1|NOT COMPLETED|Overall Study||1
67064|NCT01709227|160888|P2|COMPLETED|Overall Study||32
67065|NCT01709227|160889|P1|COMPLETED|Overall Study||31
67066|NCT01709227|160888|P2|STARTED|Overall Study||41
67067|NCT01709227|160889|P1|STARTED|Overall Study||32
67068|NCT01709162|160915|P2|NOT COMPLETED|Overall Study||5
67069|NCT01709162|160916|P1|NOT COMPLETED|Overall Study||6
67070|NCT01709162|160915|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
67071|NCT01709162|160916|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
67072|NCT01709162|160915|P2|Still Receiving Treatment|Overall Study||0
67073|NCT01709162|160916|P1|Still Receiving Treatment|Overall Study||0
67074|NCT01709162|160915|P2|Received Treatment|Overall Study||4
67075|NCT01709162|160916|P1|Received Treatment|Overall Study||18
67076|NCT01709162|160915|P2|STARTED|Overall Study|Randomized|5
67077|NCT01709162|160916|P1|STARTED|Overall Study|Randomized|18
67078|NCT01709136|160928|P1|NOT COMPLETED|Overall Study||0
67079|NCT01709136|160928|P1|COMPLETED|Overall Study||3
67080|NCT01709136|160928|P1|STARTED|Overall Study||3
67081|NCT01709110|160937|P2|NOT COMPLETED|Overall Study||168
67082|NCT01709110|160938|P1|NOT COMPLETED|Overall Study||185
67083|NCT01709110|160937|P2|COMPLETED|Overall Study||515
67084|NCT01709110|160938|P1|COMPLETED|Overall Study||498
67085|NCT01709110|160937|P2|Received at Least One Dose of Study Drug|Overall Study||680
67086|NCT01709110|160938|P1|Received at Least One Dose of Study Drug|Overall Study||680
67087|NCT01709110|160937|P2|STARTED|Overall Study||683
67088|NCT01709110|160938|P1|STARTED|Overall Study||683
67089|NCT01709084|160968|P2|NOT COMPLETED|Overall Study||15
67090|NCT01709084|160969|P1|NOT COMPLETED|Overall Study||16
67091|NCT01709084|160968|P2|COMPLETED|Overall Study||198
67092|NCT01709084|160969|P1|COMPLETED|Overall Study||197
67093|NCT01709084|160968|P2|Treated|Overall Study||211
67094|NCT01709084|160969|P1|Treated|Overall Study||213
67095|NCT01709084|160968|P2|STARTED|Overall Study||213
67096|NCT01709084|160969|P1|STARTED|Overall Study||213
67097|NCT01708967|160987|P2|NOT COMPLETED|Overall Study||7
67098|NCT01708967|160988|P1|NOT COMPLETED|Overall Study||0
67099|NCT01708967|160987|P2|COMPLETED|Overall Study||43
67100|NCT01708967|160988|P1|COMPLETED|Overall Study||50
67101|NCT01708967|160987|P2|STARTED|Overall Study||50
67102|NCT01708967|160988|P1|STARTED|Overall Study||50
67103|NCT01708954|160997|P3|NOT COMPLETED|Step 2||0
67104|NCT01708954|160998|P2|NOT COMPLETED|Step 2||7
67105|NCT01708954|160999|P1|NOT COMPLETED|Step 2||13
67106|NCT01708954|160997|P3|COMPLETED|Step 2||0
67107|NCT01708954|160998|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
67108|NCT01708954|160999|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
67109|NCT01708954|160997|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
67110|NCT01708954|160998|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
67111|NCT01708954|160999|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
67112|NCT01708954|160997|P3|NOT COMPLETED|Step 1||43
67113|NCT01708954|160998|P2|NOT COMPLETED|Step 1||40
67114|NCT01708954|160999|P1|NOT COMPLETED|Step 1||42
67115|NCT01708954|160997|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
67116|NCT01708954|160998|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
67117|NCT01708954|160999|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
67118|NCT01708954|160997|P3|Patients With MET Status Data Available|Step 1||24
67119|NCT01708954|160998|P2|Patients With MET Status Data Available|Step 1||32
67120|NCT01708954|160999|P1|Patients With MET Status Data Available|Step 1||30
67121|NCT01708954|160997|P3|Eligible and Treated|Step 1||35
67122|NCT01708954|160998|P2|Eligible and Treated|Step 1||38
67123|NCT01708954|160999|P1|Eligible and Treated|Step 1||38
67124|NCT01708954|160997|P3|Started Protocol Therapy|Step 1||39
67125|NCT01708954|160998|P2|Started Protocol Therapy|Step 1||40
67126|NCT01708954|160999|P1|Started Protocol Therapy|Step 1||40
67127|NCT01708954|160997|P3|STARTED|Step 1||43
67128|NCT01708954|160998|P2|STARTED|Step 1||40
67129|NCT01708954|160999|P1|STARTED|Step 1||42
67130|NCT01708915|161024|P4|NOT COMPLETED|Overall Study||33
67131|NCT01708915|161025|P3|NOT COMPLETED|Overall Study||46
67132|NCT01708915|161026|P2|NOT COMPLETED|Overall Study||62
67133|NCT01708915|161027|P1|NOT COMPLETED|Overall Study||86
67134|NCT01708915|161024|P4|COMPLETED|Overall Study||169
67135|NCT01708915|161025|P3|COMPLETED|Overall Study||152
67136|NCT01708915|161026|P2|COMPLETED|Overall Study||139
67137|NCT01708915|161027|P1|COMPLETED|Overall Study||118
67138|NCT01708915|161024|P4|STARTED|Overall Study||202
67139|NCT01708915|161025|P3|STARTED|Overall Study||198
67140|NCT01708915|161026|P2|STARTED|Overall Study||201
67141|NCT01708915|161027|P1|STARTED|Overall Study||204
67142|NCT01708902|161056|P7|NOT COMPLETED|Overall Study||7
67143|NCT01708902|161057|P6|NOT COMPLETED|Overall Study||7
67144|NCT01708902|161058|P5|NOT COMPLETED|Overall Study||16
67145|NCT01708902|161059|P4|NOT COMPLETED|Overall Study||10
67146|NCT01708902|161060|P3|NOT COMPLETED|Overall Study||17
67147|NCT01708902|161061|P2|NOT COMPLETED|Overall Study||8
67148|NCT01708902|161062|P1|NOT COMPLETED|Overall Study||17
67149|NCT01708902|161056|P7|COMPLETED|Overall Study||65
67150|NCT01708902|161057|P6|COMPLETED|Overall Study||64
67151|NCT01708902|161058|P5|COMPLETED|Overall Study||131
67152|NCT01708902|161059|P4|COMPLETED|Overall Study||137
67153|NCT01708902|161060|P3|COMPLETED|Overall Study||127
67154|NCT01708902|161061|P2|COMPLETED|Overall Study||137
67155|NCT01708902|161062|P1|COMPLETED|Overall Study||130
67156|NCT01708902|161056|P7|STARTED|Overall Study||72
67157|NCT01708902|161057|P6|STARTED|Overall Study||71
67158|NCT01708902|161058|P5|STARTED|Overall Study||147
67159|NCT01708902|161059|P4|STARTED|Overall Study||147
67160|NCT01708902|161060|P3|STARTED|Overall Study||144
67161|NCT01708902|161061|P2|STARTED|Overall Study||145
67162|NCT01708902|161062|P1|STARTED|Overall Study||147
67163|NCT01708525|161121|P1|NOT COMPLETED|Overall Study||0
67164|NCT01708525|161121|P1|COMPLETED|Overall Study||2
67165|NCT01708525|161121|P1|STARTED|Overall Study||2
67166|NCT01708317|161126|P1|NOT COMPLETED|Final Education Period||0
67167|NCT01708317|161126|P1|COMPLETED|Final Education Period||909
67168|NCT01708317|161126|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
67169|NCT01708317|161126|P1|NOT COMPLETED|ACASI + Education Period||0
67170|NCT01708317|161126|P1|COMPLETED|ACASI + Education Period||2601
67171|NCT01708317|161126|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
67172|NCT01708317|161126|P1|NOT COMPLETED|Initial Education Period||0
67173|NCT01708317|161126|P1|COMPLETED|Initial Education Period||982
67174|NCT01708317|161126|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
67175|NCT01708317|161126|P1|NOT COMPLETED|2010 Control Period||0
67176|NCT01708317|161126|P1|COMPLETED|2010 Control Period||3929
67177|NCT01708317|161126|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
67178|NCT01708291|161135|P2|NOT COMPLETED|Overall Study||1
67179|NCT01708291|161136|P1|NOT COMPLETED|Overall Study||2
67180|NCT01708291|161135|P2|COMPLETED|Overall Study||20
67181|NCT01708291|161136|P1|COMPLETED|Overall Study||19
67182|NCT01708291|161135|P2|STARTED|Overall Study||21
67183|NCT01708291|161136|P1|STARTED|Overall Study||21
67184|NCT01708278|161148|P6|NOT COMPLETED|Overall Study||0
67185|NCT01708278|161149|P5|NOT COMPLETED|Overall Study||0
67186|NCT01708278|161150|P4|NOT COMPLETED|Overall Study||0
67187|NCT01708278|161151|P3|NOT COMPLETED|Overall Study||0
67188|NCT01708278|161152|P2|NOT COMPLETED|Overall Study||0
67189|NCT01708278|161153|P1|NOT COMPLETED|Overall Study||0
67190|NCT01708278|161148|P6|COMPLETED|Overall Study||1
67191|NCT01708278|161149|P5|COMPLETED|Overall Study||1
67192|NCT01708278|161150|P4|COMPLETED|Overall Study||2
67193|NCT01708278|161151|P3|COMPLETED|Overall Study||2
67194|NCT01708278|161152|P2|COMPLETED|Overall Study||2
67195|NCT01708278|161153|P1|COMPLETED|Overall Study||1
67196|NCT01708278|161148|P6|STARTED|Overall Study||1
67197|NCT01708278|161149|P5|STARTED|Overall Study||1
67198|NCT01708278|161150|P4|STARTED|Overall Study||2
67199|NCT01708278|161151|P3|STARTED|Overall Study||2
67200|NCT01708278|161152|P2|STARTED|Overall Study||2
67201|NCT01708278|161153|P1|STARTED|Overall Study||1
67202|NCT01708213|161167|P1|NOT COMPLETED|Overall Study||1
67203|NCT01708213|161167|P1|COMPLETED|Overall Study||71
67204|NCT01708213|161167|P1|STARTED|Overall Study||72
67205|NCT01708187|161175|P2|NOT COMPLETED|Overall Study||1
67206|NCT01708187|161176|P1|NOT COMPLETED|Overall Study||0
67207|NCT01708187|161175|P2|COMPLETED|Overall Study||0
67208|NCT01708187|161176|P1|COMPLETED|Overall Study||1
67209|NCT01708187|161175|P2|STARTED|Overall Study||1
67210|NCT01708187|161176|P1|STARTED|Overall Study||1
67211|NCT01708174|161185|P3|NOT COMPLETED|Survival Follow-up||0
67212|NCT01708174|161186|P2|NOT COMPLETED|Survival Follow-up||0
67213|NCT01708174|161187|P1|NOT COMPLETED|Survival Follow-up||0
67214|NCT01708174|161185|P3|COMPLETED|Survival Follow-up||0
67215|NCT01708174|161186|P2|COMPLETED|Survival Follow-up||10
67216|NCT01708174|161187|P1|COMPLETED|Survival Follow-up||1
67217|NCT01708174|161185|P3|STARTED|Survival Follow-up||0
67218|NCT01708174|161186|P2|STARTED|Survival Follow-up||10
67219|NCT01708174|161187|P1|STARTED|Survival Follow-up||1
67220|NCT01708174|161185|P3|NOT COMPLETED|Treatment Period||1
67221|NCT01708174|161186|P2|NOT COMPLETED|Treatment Period||2
67222|NCT01708174|161187|P1|NOT COMPLETED|Treatment Period||1
67223|NCT01708174|161185|P3|COMPLETED|Treatment Period||3
67224|NCT01708174|161186|P2|COMPLETED|Treatment Period||14
67225|NCT01708174|161187|P1|COMPLETED|Treatment Period||1
67226|NCT01708174|161185|P3|Pharmacokinetic Analysis Set|Treatment Period||0
67227|NCT01708174|161186|P2|Pharmacokinetic Analysis Set|Treatment Period||13
67228|NCT01708174|161187|P1|Pharmacokinetic Analysis Set|Treatment Period||2
67229|NCT01708174|161185|P3|STARTED|Treatment Period||4
67230|NCT01708174|161186|P2|STARTED|Treatment Period||16
67231|NCT01708174|161187|P1|STARTED|Treatment Period||2
67232|NCT01708122|161215|P2|NOT COMPLETED|Overall Study||0
67233|NCT01708122|161216|P1|NOT COMPLETED|Overall Study||0
67234|NCT01708122|161215|P2|COMPLETED|Overall Study||26
67235|NCT01708122|161216|P1|COMPLETED|Overall Study||27
67236|NCT01708122|161215|P2|STARTED|Overall Study||26
67237|NCT01708122|161216|P1|STARTED|Overall Study||27
67238|NCT01708057|161224|P3|NOT COMPLETED|Overall Study||1
67239|NCT01708057|161225|P2|NOT COMPLETED|Overall Study||1
67240|NCT01708057|161226|P1|NOT COMPLETED|Overall Study||1
67241|NCT01708057|161224|P3|COMPLETED|Overall Study||0
67242|NCT01708057|161225|P2|COMPLETED|Overall Study||0
67243|NCT01708057|161226|P1|COMPLETED|Overall Study||0
67244|NCT01708057|161224|P3|STARTED|Overall Study||1
67245|NCT01708057|161225|P2|STARTED|Overall Study||1
67246|NCT01708057|161226|P1|STARTED|Overall Study||1
67247|NCT01707667|161284|P2|NOT COMPLETED|Period 2||0
67248|NCT01707667|161285|P1|NOT COMPLETED|Period 2||0
67249|NCT01707667|161284|P2|COMPLETED|Period 2||6
67250|NCT01707667|161285|P1|COMPLETED|Period 2||6
67251|NCT01707667|161284|P2|STARTED|Period 2||6
67252|NCT01707667|161285|P1|STARTED|Period 2||6
67253|NCT01707667|161284|P2|NOT COMPLETED|Period 1||0
67254|NCT01707667|161285|P1|NOT COMPLETED|Period 1||1
67255|NCT01707667|161284|P2|COMPLETED|Period 1||6
67256|NCT01707667|161285|P1|COMPLETED|Period 1||6
67257|NCT01707667|161284|P2|STARTED|Period 1||6
67258|NCT01707667|161285|P1|STARTED|Period 1||7
67259|NCT01707654|161303|P1|NOT COMPLETED|Overall Study||0
67260|NCT01707654|161303|P1|COMPLETED|Overall Study||9
67261|NCT01707654|161303|P1|STARTED|Overall Study||9
67262|NCT01707290|161309|P2|NOT COMPLETED|Overall Study||1
67263|NCT01707290|161310|P1|NOT COMPLETED|Overall Study||86
67264|NCT01707290|161309|P2|COMPLETED|Overall Study||3
67265|NCT01707290|161310|P1|COMPLETED|Overall Study||35
67266|NCT01707290|161309|P2|STARTED|Overall Study||4
67267|NCT01707290|161310|P1|STARTED|Overall Study||121
67268|NCT01707238|161333|P2|NOT COMPLETED|Overall Study||0
67269|NCT01707238|161334|P1|NOT COMPLETED|Overall Study||0
67270|NCT01707238|161333|P2|COMPLETED|Overall Study||52
67271|NCT01707238|161334|P1|COMPLETED|Overall Study||48
67272|NCT01707238|161333|P2|STARTED|Overall Study||52
67273|NCT01707238|161334|P1|STARTED|Overall Study||48
67274|NCT01707225|161350|P1|NOT COMPLETED|Overall Study||0
67275|NCT01707225|161350|P1|COMPLETED|Overall Study||10
67276|NCT01707225|161350|P1|STARTED|Overall Study||10
67277|NCT01707095|161357|P2|NOT COMPLETED|Overall Study||0
67278|NCT01707095|161358|P1|NOT COMPLETED|Overall Study||0
67279|NCT01707095|161357|P2|COMPLETED|Overall Study||42
67280|NCT01707095|161358|P1|COMPLETED|Overall Study||42
67281|NCT01707095|161357|P2|STARTED|Overall Study||42
67282|NCT01707095|161358|P1|STARTED|Overall Study||42
67283|NCT01707043|161368|P2|NOT COMPLETED|Overall Study||0
67284|NCT01707043|161369|P1|NOT COMPLETED|Overall Study||0
67285|NCT01707043|161368|P2|COMPLETED|Overall Study||10
67286|NCT01707043|161369|P1|COMPLETED|Overall Study||10
67287|NCT01707043|161368|P2|STARTED|Overall Study||10
67288|NCT01707043|161369|P1|STARTED|Overall Study||10
67289|NCT01706965|161379|P2|NOT COMPLETED|Overall Study||1
67290|NCT01706965|161380|P1|NOT COMPLETED|Overall Study||1
67291|NCT01706965|161379|P2|COMPLETED|Overall Study||12
67292|NCT01706965|161380|P1|COMPLETED|Overall Study||13
67293|NCT01706965|161379|P2|STARTED|Overall Study||13
67294|NCT01706965|161380|P1|STARTED|Overall Study||14
67295|NCT01706952|161388|P1|NOT COMPLETED|Overall Study||8
67296|NCT01706952|161388|P1|COMPLETED|Overall Study||37
67297|NCT01706952|161388|P1|STARTED|Overall Study||45
67298|NCT01706926|161404|P4|NOT COMPLETED|Overall Study||5
67299|NCT01706926|161405|P3|NOT COMPLETED|Overall Study||6
67300|NCT01706926|161406|P2|NOT COMPLETED|Overall Study||4
67301|NCT01706926|161407|P1|NOT COMPLETED|Overall Study||6
67302|NCT01706926|161404|P4|COMPLETED|Overall Study||74
67303|NCT01706926|161405|P3|COMPLETED|Overall Study||79
67304|NCT01706926|161406|P2|COMPLETED|Overall Study||77
67305|NCT01706926|161407|P1|COMPLETED|Overall Study||75
67306|NCT01706926|161404|P4|STARTED|Overall Study||79
67307|NCT01706926|161405|P3|STARTED|Overall Study||85
67308|NCT01706926|161406|P2|STARTED|Overall Study||81
67309|NCT01706926|161407|P1|STARTED|Overall Study||81
67310|NCT01706822|161516|P1|NOT COMPLETED|Overall Study||0
67311|NCT01706822|161516|P1|COMPLETED|Overall Study||8
67312|NCT01706822|161516|P1|STARTED|Overall Study||8
67313|NCT01706770|161526|P2|NOT COMPLETED|Overall Study||0
67314|NCT01706770|161527|P1|NOT COMPLETED|Overall Study||2
67315|NCT01706770|161526|P2|COMPLETED|Overall Study||17
67316|NCT01706770|161527|P1|COMPLETED|Overall Study||31
67317|NCT01706770|161526|P2|STARTED|Overall Study||17
67318|NCT01706770|161527|P1|STARTED|Overall Study||33
67319|NCT01706666|161538|P3|NOT COMPLETED|Overall Study||0
67320|NCT01706666|161539|P2|NOT COMPLETED|Overall Study||0
67321|NCT01706666|161540|P1|NOT COMPLETED|Overall Study||0
67322|NCT01706666|161538|P3|COMPLETED|Overall Study||1
67323|NCT01706666|161539|P2|COMPLETED|Overall Study||1
67324|NCT01706666|161540|P1|COMPLETED|Overall Study||1
67325|NCT01706666|161538|P3|STARTED|Overall Study||1
67326|NCT01706666|161539|P2|STARTED|Overall Study||1
67327|NCT01706666|161540|P1|STARTED|Overall Study||1
67328|NCT01706588|161559|P5|NOT COMPLETED|Overall Study||0
67329|NCT01706588|161560|P4|NOT COMPLETED|Overall Study||0
67330|NCT01706588|161561|P3|NOT COMPLETED|Overall Study||0
67331|NCT01706588|161562|P2|NOT COMPLETED|Overall Study||0
67332|NCT01706588|161563|P1|NOT COMPLETED|Overall Study||0
67333|NCT01706588|161559|P5|COMPLETED|Overall Study||16
67334|NCT01706588|161560|P4|COMPLETED|Overall Study||14
67335|NCT01706588|161561|P3|COMPLETED|Overall Study||15
67336|NCT01706588|161562|P2|COMPLETED|Overall Study||15
67337|NCT01706588|161563|P1|COMPLETED|Overall Study||15
67338|NCT01706588|161559|P5|STARTED|Overall Study||16
67339|NCT01706588|161560|P4|STARTED|Overall Study||14
67340|NCT01706588|161561|P3|STARTED|Overall Study||15
67341|NCT01706588|161562|P2|STARTED|Overall Study||15
67342|NCT01706588|161563|P1|STARTED|Overall Study||15
67343|NCT01706575|161575|P1|NOT COMPLETED|Overall Study||12
67344|NCT01706575|161575|P1|COMPLETED|Overall Study||64
67345|NCT01706575|161575|P1|Treated|Overall Study||70
67346|NCT01706575|161575|P1|STARTED|Overall Study||76
67347|NCT01706549|161586|P1|NOT COMPLETED|Overall Study||0
67348|NCT01706549|161586|P1|COMPLETED|Overall Study||16
67349|NCT01706549|161586|P1|STARTED|Overall Study||16
67350|NCT01706536|161596|P5|NOT COMPLETED|Overall Study||2
67351|NCT01706536|161597|P4|NOT COMPLETED|Overall Study||4
67352|NCT01706536|161598|P3|NOT COMPLETED|Overall Study||5
67353|NCT01706536|161599|P2|NOT COMPLETED|Overall Study||4
67354|NCT01706536|161600|P1|NOT COMPLETED|Overall Study||4
67355|NCT01706536|161596|P5|COMPLETED|Overall Study||57
67356|NCT01706536|161597|P4|COMPLETED|Overall Study||53
67357|NCT01706536|161598|P3|COMPLETED|Overall Study||49
67358|NCT01706536|161599|P2|COMPLETED|Overall Study||51
67359|NCT01706536|161600|P1|COMPLETED|Overall Study||53
67360|NCT01706536|161596|P5|STARTED|Overall Study||59
67361|NCT01706536|161597|P4|STARTED|Overall Study||57
67362|NCT01706536|161598|P3|STARTED|Overall Study||54
67363|NCT01706536|161599|P2|STARTED|Overall Study||55
67364|NCT01706536|161600|P1|STARTED|Overall Study||57
67365|NCT01706328|161659|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
67366|NCT01706328|161660|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
67367|NCT01706328|161661|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
67368|NCT01706328|161659|P3|COMPLETED|12-week Double-blind Treatment Period||371
67369|NCT01706328|161660|P2|COMPLETED|12-week Double-blind Treatment Period||366
67370|NCT01706328|161661|P1|COMPLETED|12-week Double-blind Treatment Period||0
67371|NCT01706328|161659|P3|STARTED|12-week Double-blind Treatment Period||416
67372|NCT01706328|161660|P2|STARTED|12-week Double-blind Treatment Period||412
67373|NCT01706328|161661|P1|STARTED|12-week Double-blind Treatment Period||0
67374|NCT01706328|161659|P3|NOT COMPLETED|2-week Run-in Period||0
67375|NCT01706328|161660|P2|NOT COMPLETED|2-week Run-in Period||0
67376|NCT01706328|161661|P1|NOT COMPLETED|2-week Run-in Period||165
67377|NCT01706328|161659|P3|COMPLETED|2-week Run-in Period||0
67378|NCT01706328|161660|P2|COMPLETED|2-week Run-in Period||0
67379|NCT01706328|161661|P1|COMPLETED|2-week Run-in Period||828
67380|NCT01706328|161659|P3|STARTED|2-week Run-in Period||0
67381|NCT01706328|161660|P2|STARTED|2-week Run-in Period||0
67382|NCT01706328|161661|P1|STARTED|2-week Run-in Period||993
67383|NCT01706263|161671|P1|NOT COMPLETED|Overall Study||0
67384|NCT01706263|161671|P1|COMPLETED|Overall Study||28
67385|NCT01706263|161671|P1|STARTED|Overall Study||28
67386|NCT01706250|161680|P1|NOT COMPLETED|Overall Study||2
67387|NCT01706250|161680|P1|COMPLETED|Overall Study||18
67388|NCT01706250|161680|P1|STARTED|Overall Study||20
67389|NCT01706159|161711|P2|NOT COMPLETED|Overall Study||2
67390|NCT01706159|161712|P1|NOT COMPLETED|Overall Study||8
67391|NCT01706159|161711|P2|COMPLETED|Overall Study||4
67392|NCT01706159|161712|P1|COMPLETED|Overall Study||6
67393|NCT01706159|161711|P2|Completers (With Baron Score at Week 8)|Overall Study||3
67394|NCT01706159|161712|P1|Completers (With Baron Score at Week 8)|Overall Study||6
67395|NCT01706159|161711|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
67396|NCT01706159|161712|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
67397|NCT01706159|161711|P2|STARTED|Overall Study||6
67398|NCT01706159|161712|P1|STARTED|Overall Study||14
67399|NCT01706146|161726|P1|NOT COMPLETED|Overall Study||6
67400|NCT01706146|161726|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
67401|NCT01706146|161726|P1|STARTED|Overall Study||59
67402|NCT01705717|161733|P2|NOT COMPLETED|Overall Study||5
67403|NCT01705717|161734|P1|NOT COMPLETED|Overall Study||2
67404|NCT01705717|161733|P2|COMPLETED|Overall Study||7
67405|NCT01705717|161734|P1|COMPLETED|Overall Study||35
67406|NCT01705717|161733|P2|STARTED|Overall Study||12
67407|NCT01705717|161734|P1|STARTED|Overall Study||37
67408|NCT01705652|161751|P2|NOT COMPLETED|Overall Study||3
67409|NCT01705652|161752|P1|NOT COMPLETED|Overall Study||3
67410|NCT01705652|161751|P2|COMPLETED|Overall Study||9
67411|NCT01705652|161752|P1|COMPLETED|Overall Study||6
67412|NCT01705652|161751|P2|STARTED|Overall Study||12
67413|NCT01705652|161752|P1|STARTED|Overall Study||9
67414|NCT01705587|161760|P2|NOT COMPLETED|Overall Study||1
67415|NCT01705587|161761|P1|NOT COMPLETED|Overall Study||0
67416|NCT01705587|161760|P2|COMPLETED|Overall Study||5
67417|NCT01705587|161761|P1|COMPLETED|Overall Study||7
67418|NCT01705587|161760|P2|STARTED|Overall Study||6
67419|NCT01705587|161761|P1|STARTED|Overall Study||7
67420|NCT01705574|161779|P2|NOT COMPLETED|Overall Study||163
67421|NCT01705574|161780|P1|NOT COMPLETED|Overall Study||167
67422|NCT01705574|161779|P2|COMPLETED|Overall Study||127
67423|NCT01705574|161780|P1|COMPLETED|Overall Study||126
67424|NCT01705574|161779|P2|STARTED|Overall Study||290
67425|NCT01705574|161780|P1|STARTED|Overall Study||293
67426|NCT01705496|161788|P1|NOT COMPLETED|Overall Study||4
67427|NCT01705496|161788|P1|COMPLETED|Overall Study||19
67428|NCT01705496|161788|P1|STARTED|Overall Study||23
67429|NCT01705145|161798|P1|NOT COMPLETED|Part B||1
67430|NCT01705145|161798|P1|COMPLETED|Part B||33
67431|NCT01705145|161798|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
67432|NCT01705145|161798|P1|NOT COMPLETED|Part A||0
67433|NCT01705145|161798|P1|COMPLETED|Part A||9
67434|NCT01705145|161798|P1|STARTED|Part A||9
67435|NCT01705106|161826|P1|NOT COMPLETED|Overall Study||0
67436|NCT01705106|161826|P1|COMPLETED|Overall Study||21
67437|NCT01705106|161826|P1|STARTED|Overall Study||21
67438|NCT01704976|161836|P2|NOT COMPLETED|Overall Study||2
67439|NCT01704976|161837|P1|NOT COMPLETED|Overall Study||1
67440|NCT01704976|161836|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
67441|NCT01704976|161837|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
67442|NCT01704976|161836|P2|STARTED|Overall Study||13
67443|NCT01704976|161837|P1|STARTED|Overall Study||14
67444|NCT01704846|161853|P2|NOT COMPLETED|Treatment Period 4||0
67445|NCT01704846|161854|P1|NOT COMPLETED|Treatment Period 4||0
67446|NCT01704846|161853|P2|COMPLETED|Treatment Period 4||29
67447|NCT01704846|161854|P1|COMPLETED|Treatment Period 4||30
67448|NCT01704846|161853|P2|STARTED|Treatment Period 4||29
67449|NCT01704846|161854|P1|STARTED|Treatment Period 4||30
67450|NCT01704846|161853|P2|NOT COMPLETED|Treatment Period 3||0
67451|NCT01704846|161854|P1|NOT COMPLETED|Treatment Period 3||0
67452|NCT01704846|161853|P2|COMPLETED|Treatment Period 3||29
67453|NCT01704846|161854|P1|COMPLETED|Treatment Period 3||30
67454|NCT01704846|161853|P2|STARTED|Treatment Period 3||29
67455|NCT01704846|161854|P1|STARTED|Treatment Period 3||30
67456|NCT01704846|161853|P2|NOT COMPLETED|Treatment Period 2||1
67457|NCT01704846|161854|P1|NOT COMPLETED|Treatment Period 2||0
67458|NCT01704846|161853|P2|COMPLETED|Treatment Period 2||29
67459|NCT01704846|161854|P1|COMPLETED|Treatment Period 2||30
67460|NCT01704846|161853|P2|STARTED|Treatment Period 2||30
67461|NCT01704846|161854|P1|STARTED|Treatment Period 2||30
67462|NCT01704846|161853|P2|NOT COMPLETED|Treatment Period 1||0
67463|NCT01704846|161854|P1|NOT COMPLETED|Treatment Period 1||0
67464|NCT01704846|161853|P2|COMPLETED|Treatment Period 1||30
67465|NCT01704846|161854|P1|COMPLETED|Treatment Period 1||30
67466|NCT01704846|161853|P2|STARTED|Treatment Period 1||30
67467|NCT01704846|161854|P1|STARTED|Treatment Period 1||30
67468|NCT01704781|161877|P5|NOT COMPLETED|Overall Study||0
67469|NCT01704781|161878|P4|NOT COMPLETED|Overall Study||0
67470|NCT01704781|161879|P3|NOT COMPLETED|Overall Study||0
67471|NCT01704781|161880|P2|NOT COMPLETED|Overall Study||0
67472|NCT01704781|161881|P1|NOT COMPLETED|Overall Study||0
67473|NCT01704781|161877|P5|COMPLETED|Overall Study||12
67474|NCT01704781|161878|P4|COMPLETED|Overall Study||12
67475|NCT01704781|161879|P3|COMPLETED|Overall Study||6
67476|NCT01704781|161880|P2|COMPLETED|Overall Study||3
67477|NCT01704781|161881|P1|COMPLETED|Overall Study||3
67478|NCT01704781|161877|P5|STARTED|Overall Study||12
67479|NCT01704781|161878|P4|STARTED|Overall Study||12
67480|NCT01704781|161879|P3|STARTED|Overall Study||6
67481|NCT01704781|161880|P2|STARTED|Overall Study||3
67482|NCT01704781|161881|P1|STARTED|Overall Study||3
67483|NCT01704755|161909|P2|NOT COMPLETED|Overall Study||7
67484|NCT01704755|161910|P1|NOT COMPLETED|Overall Study||12
67485|NCT01704755|161909|P2|COMPLETED|Overall Study||165
67486|NCT01704755|161910|P1|COMPLETED|Overall Study||196
67487|NCT01704755|161909|P2|Completed Study Drug|Overall Study||163
67488|NCT01704755|161910|P1|Completed Study Drug|Overall Study||204
67489|NCT01704755|161909|P2|STARTED|Overall Study||172
67490|NCT01704755|161910|P1|STARTED|Overall Study||208
67491|NCT01704651|161924|P2|NOT COMPLETED|Overall Study||7
67492|NCT01704651|161925|P1|NOT COMPLETED|Overall Study||5
67493|NCT01704651|161924|P2|COMPLETED|Overall Study||68
67494|NCT01704651|161925|P1|COMPLETED|Overall Study||66
67495|NCT01704651|161924|P2|STARTED|Overall Study||75
67496|NCT01704651|161925|P1|STARTED|Overall Study||71
67497|NCT01704599|161933|P1|NOT COMPLETED|Overall Study||1
67498|NCT01704599|161933|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
67499|NCT01704599|161933|P1|STARTED|Overall Study|Study was started January 22, 2010|8
67500|NCT01704521|161962|P2|NOT COMPLETED|Overall Study||0
67501|NCT01704521|161963|P1|NOT COMPLETED|Overall Study||0
67502|NCT01704521|161962|P2|COMPLETED|Overall Study||2
67503|NCT01704521|161963|P1|COMPLETED|Overall Study||3
67504|NCT01704521|161962|P2|STARTED|Overall Study||2
67505|NCT01704521|161963|P1|STARTED|Overall Study||3
67506|NCT01704495|161973|P4|NOT COMPLETED|Optional Safety Extension||31
67507|NCT01704495|161974|P3|NOT COMPLETED|Optional Safety Extension||31
67508|NCT01704495|161975|P2|NOT COMPLETED|Optional Safety Extension||33
67509|NCT01704495|161976|P1|NOT COMPLETED|Optional Safety Extension||29
67510|NCT01704495|161973|P4|COMPLETED|Optional Safety Extension||85
67511|NCT01704495|161974|P3|COMPLETED|Optional Safety Extension||83
67512|NCT01704495|161975|P2|COMPLETED|Optional Safety Extension||88
67513|NCT01704495|161976|P1|COMPLETED|Optional Safety Extension||87
67514|NCT01704495|161973|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
67515|NCT01704495|161974|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
67516|NCT01704495|161975|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
67517|NCT01704495|161976|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
67518|NCT01704495|161973|P4|NOT COMPLETED|Subjects Randomized||17
67519|NCT01704495|161974|P3|NOT COMPLETED|Subjects Randomized||16
67520|NCT01704495|161975|P2|NOT COMPLETED|Subjects Randomized||15
67521|NCT01704495|161976|P1|NOT COMPLETED|Subjects Randomized||22
67522|NCT01704495|161973|P4|COMPLETED|Subjects Randomized||145
67523|NCT01704495|161974|P3|COMPLETED|Subjects Randomized||144
67524|NCT01704495|161975|P2|COMPLETED|Subjects Randomized||141
67525|NCT01704495|161976|P1|COMPLETED|Subjects Randomized||140
67526|NCT01704495|161973|P4|STARTED|Subjects Randomized||162
67527|NCT01704495|161974|P3|STARTED|Subjects Randomized||160
67528|NCT01704495|161975|P2|STARTED|Subjects Randomized||156
67529|NCT01704495|161976|P1|STARTED|Subjects Randomized||162
67530|NCT01704404|162150|P6|NOT COMPLETED|Overall Study||0
67531|NCT01704404|162151|P5|NOT COMPLETED|Overall Study||1
67532|NCT01704404|162152|P4|NOT COMPLETED|Overall Study||3
67533|NCT01704404|162153|P3|NOT COMPLETED|Overall Study||1
67534|NCT01704404|162154|P2|NOT COMPLETED|Overall Study||1
67535|NCT01704404|162155|P1|NOT COMPLETED|Overall Study||1
67536|NCT01704404|162150|P6|COMPLETED|Overall Study||9
67537|NCT01704404|162151|P5|COMPLETED|Overall Study||10
67538|NCT01704404|162152|P4|COMPLETED|Overall Study||8
67539|NCT01704404|162153|P3|COMPLETED|Overall Study||9
67540|NCT01704404|162154|P2|COMPLETED|Overall Study||9
67541|NCT01704404|162155|P1|COMPLETED|Overall Study||10
67542|NCT01704404|162150|P6|STARTED|Overall Study||9
67543|NCT01704404|162151|P5|STARTED|Overall Study||11
67544|NCT01704404|162152|P4|STARTED|Overall Study||11
67545|NCT01704404|162153|P3|STARTED|Overall Study||10
67546|NCT01704404|162154|P2|STARTED|Overall Study||10
67547|NCT01704404|162155|P1|STARTED|Overall Study||11
67548|NCT01704287|162192|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||45
67549|NCT01704287|162193|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||53
67550|NCT01704287|162194|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
67551|NCT01704287|162195|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
67552|NCT01704287|162196|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
67553|NCT01704287|162192|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||0
67554|NCT01704287|162193|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||0
67555|NCT01704287|162194|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
67556|NCT01704287|162195|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
67557|NCT01704287|162196|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
67558|NCT01704287|162192|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
67559|NCT01704287|162193|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
67560|NCT01704287|162194|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
67561|NCT01704287|162195|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
67562|NCT01704287|162196|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
67563|NCT01704287|162192|P5|NOT COMPLETED|Initial Treatment Period||0
67564|NCT01704287|162193|P4|NOT COMPLETED|Initial Treatment Period||0
67565|NCT01704287|162194|P3|NOT COMPLETED|Initial Treatment Period||179
67566|NCT01704287|162195|P2|NOT COMPLETED|Initial Treatment Period||181
67567|NCT01704287|162196|P1|NOT COMPLETED|Initial Treatment Period||180
67568|NCT01704287|162192|P5|COMPLETED|Initial Treatment Period||0
67569|NCT01704287|162193|P4|COMPLETED|Initial Treatment Period||0
67570|NCT01704287|162194|P3|COMPLETED|Initial Treatment Period||0
67571|NCT01704287|162195|P2|COMPLETED|Initial Treatment Period||0
67572|NCT01704287|162196|P1|COMPLETED|Initial Treatment Period||0
67573|NCT01704287|162192|P5|Treated|Initial Treatment Period||0
67574|NCT01704287|162193|P4|Treated|Initial Treatment Period||0
67575|NCT01704287|162194|P3|Treated|Initial Treatment Period||171
67576|NCT01704287|162195|P2|Treated|Initial Treatment Period||179
67577|NCT01704287|162196|P1|Treated|Initial Treatment Period||178
67578|NCT01704287|162192|P5|STARTED|Initial Treatment Period||0
67579|NCT01704287|162193|P4|STARTED|Initial Treatment Period||0
67580|NCT01704287|162194|P3|STARTED|Initial Treatment Period||179
67581|NCT01704287|162195|P2|STARTED|Initial Treatment Period||181
67582|NCT01704287|162196|P1|STARTED|Initial Treatment Period||180
67583|NCT01704261|162231|P2|NOT COMPLETED|Overall Study||15
67584|NCT01704261|162232|P1|NOT COMPLETED|Overall Study||13
67585|NCT01704261|162231|P2|COMPLETED|Overall Study||138
67586|NCT01704261|162232|P1|COMPLETED|Overall Study||141
67587|NCT01704261|162231|P2|STARTED|Overall Study||153
67588|NCT01704261|162232|P1|STARTED|Overall Study||154
67589|NCT01704196|162248|P2|NOT COMPLETED|Overall Study||24
67590|NCT01704196|162249|P1|NOT COMPLETED|Overall Study||19
67591|NCT01704196|162248|P2|COMPLETED|Overall Study||65
67592|NCT01704196|162249|P1|COMPLETED|Overall Study||71
67593|NCT01704196|162248|P2|STARTED|Overall Study||89
67594|NCT01704196|162249|P1|STARTED|Overall Study||90
67595|NCT01704079|162259|P2|NOT COMPLETED|Overall Study||23
67596|NCT01704079|162260|P1|NOT COMPLETED|Overall Study||14
67597|NCT01704079|162259|P2|COMPLETED|Overall Study||121
67598|NCT01704079|162260|P1|COMPLETED|Overall Study||58
67599|NCT01704079|162259|P2|Entered Extension Study|Overall Study||102
67600|NCT01704079|162260|P1|Entered Extension Study|Overall Study||53
67601|NCT01704079|162259|P2|STARTED|Overall Study||144
67602|NCT01704079|162260|P1|STARTED|Overall Study||72
67603|NCT01703988|162276|P4|NOT COMPLETED|Overall Study||1
67604|NCT01703988|162277|P3|NOT COMPLETED|Overall Study||0
67605|NCT01703988|162278|P2|NOT COMPLETED|Overall Study||0
67606|NCT01703988|162279|P1|NOT COMPLETED|Overall Study||0
67607|NCT01703988|162276|P4|COMPLETED|Overall Study||8
67608|NCT01703988|162277|P3|COMPLETED|Overall Study||9
67609|NCT01703988|162278|P2|COMPLETED|Overall Study||8
67610|NCT01703988|162279|P1|COMPLETED|Overall Study||8
67611|NCT01703988|162276|P4|STARTED|Overall Study||9
67612|NCT01703988|162277|P3|STARTED|Overall Study||9
67613|NCT01703988|162278|P2|STARTED|Overall Study||8
67614|NCT01703988|162279|P1|STARTED|Overall Study||8
67615|NCT01703858|162309|P3|NOT COMPLETED|Overall Study||0
67616|NCT01703858|162310|P2|NOT COMPLETED|Overall Study||1
67617|NCT01703858|162311|P1|NOT COMPLETED|Overall Study||0
67618|NCT01703858|162309|P3|COMPLETED|Overall Study||5
67619|NCT01703858|162310|P2|COMPLETED|Overall Study||4
67620|NCT01703858|162311|P1|COMPLETED|Overall Study||5
67621|NCT01703858|162309|P3|STARTED|Overall Study||5
67622|NCT01703858|162310|P2|STARTED|Overall Study||5
67623|NCT01703858|162311|P1|STARTED|Overall Study||5
67624|NCT01703845|162336|P2|NOT COMPLETED|Overall Study||0
67625|NCT01703845|162337|P1|NOT COMPLETED|Overall Study||3
67626|NCT01703845|162336|P2|COMPLETED|Overall Study||16
67627|NCT01703845|162337|P1|COMPLETED|Overall Study||13
67628|NCT01703845|162336|P2|STARTED|Overall Study|started are actually the randomized|16
67629|NCT01703845|162337|P1|STARTED|Overall Study|started are actually the randomized|16
67630|NCT01703832|162374|P2|NOT COMPLETED|Overall Study||0
67631|NCT01703832|162375|P1|NOT COMPLETED|Overall Study||1
67632|NCT01703832|162374|P2|COMPLETED|Overall Study||32
67633|NCT01703832|162375|P1|COMPLETED|Overall Study||32
67634|NCT01703832|162374|P2|STARTED|Overall Study||32
67635|NCT01703832|162375|P1|STARTED|Overall Study||33
67636|NCT01703819|162407|P2|NOT COMPLETED|Overall Study||2
67637|NCT01703819|162408|P1|NOT COMPLETED|Overall Study||0
67638|NCT01703819|162407|P2|COMPLETED|Overall Study||30
67639|NCT01703819|162408|P1|COMPLETED|Overall Study||34
67640|NCT01703819|162407|P2|STARTED|Overall Study||32
67641|NCT01703819|162408|P1|STARTED|Overall Study||34
67642|NCT01703741|162438|P1|NOT COMPLETED|Overall Study||18
67643|NCT01703741|162438|P1|COMPLETED|Overall Study||127
67644|NCT01703741|162438|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
67645|NCT01703741|162438|P1|STARTED|Overall Study||145
67646|NCT01703702|162456|P2|NOT COMPLETED|Overall Study||22
67647|NCT01703702|162457|P1|NOT COMPLETED|Overall Study||36
67648|NCT01703702|162456|P2|COMPLETED|Overall Study||288
67649|NCT01703702|162457|P1|COMPLETED|Overall Study||272
67650|NCT01703702|162456|P2|STARTED|Overall Study||310
67651|NCT01703702|162457|P1|STARTED|Overall Study||308
67652|NCT01703663|162474|P2|NOT COMPLETED|Second Treatment Period||0
67653|NCT01703663|162475|P1|NOT COMPLETED|Second Treatment Period||0
67654|NCT01703663|162474|P2|COMPLETED|Second Treatment Period||8
67655|NCT01703663|162475|P1|COMPLETED|Second Treatment Period||11
67656|NCT01703663|162474|P2|STARTED|Second Treatment Period||8
67657|NCT01703663|162475|P1|STARTED|Second Treatment Period||11
67658|NCT01703663|162474|P2|NOT COMPLETED|First Treatment Period||0
67659|NCT01703663|162475|P1|NOT COMPLETED|First Treatment Period||0
67660|NCT01703663|162474|P2|COMPLETED|First Treatment Period||20
67661|NCT01703663|162475|P1|COMPLETED|First Treatment Period||20
67662|NCT01703663|162474|P2|STARTED|First Treatment Period||20
67663|NCT01703663|162475|P1|STARTED|First Treatment Period||20
67664|NCT01703286|162481|P6|NOT COMPLETED|Period 3 Including Washout||0
67665|NCT01703286|162482|P5|NOT COMPLETED|Period 3 Including Washout||0
67666|NCT01703286|162483|P4|NOT COMPLETED|Period 3 Including Washout||0
67667|NCT01703286|162484|P3|NOT COMPLETED|Period 3 Including Washout||0
67668|NCT01703286|162485|P2|NOT COMPLETED|Period 3 Including Washout||0
67669|NCT01703286|162486|P1|NOT COMPLETED|Period 3 Including Washout||0
67670|NCT01703286|162481|P6|COMPLETED|Period 3 Including Washout||6
67671|NCT01703286|162482|P5|COMPLETED|Period 3 Including Washout||7
67672|NCT01703286|162483|P4|COMPLETED|Period 3 Including Washout||5
67673|NCT01703286|162484|P3|COMPLETED|Period 3 Including Washout||7
67674|NCT01703286|162485|P2|COMPLETED|Period 3 Including Washout||7
67675|NCT01703286|162486|P1|COMPLETED|Period 3 Including Washout||7
67676|NCT01703286|162481|P6|STARTED|Period 3 Including Washout||6
67677|NCT01703286|162482|P5|STARTED|Period 3 Including Washout||7
67678|NCT01703286|162483|P4|STARTED|Period 3 Including Washout||5
67679|NCT01703286|162484|P3|STARTED|Period 3 Including Washout||7
67680|NCT01703286|162485|P2|STARTED|Period 3 Including Washout||7
67681|NCT01703286|162486|P1|STARTED|Period 3 Including Washout||7
67682|NCT01703286|162481|P6|NOT COMPLETED|Period 2 Including Washout||0
67683|NCT01703286|162482|P5|NOT COMPLETED|Period 2 Including Washout||0
67684|NCT01703286|162483|P4|NOT COMPLETED|Period 2 Including Washout||1
67685|NCT01703286|162484|P3|NOT COMPLETED|Period 2 Including Washout||0
67686|NCT01703286|162485|P2|NOT COMPLETED|Period 2 Including Washout||0
67687|NCT01703286|162486|P1|NOT COMPLETED|Period 2 Including Washout||0
67688|NCT01703286|162481|P6|COMPLETED|Period 2 Including Washout||6
67689|NCT01703286|162482|P5|COMPLETED|Period 2 Including Washout||7
67690|NCT01703286|162483|P4|COMPLETED|Period 2 Including Washout||5
67691|NCT01703286|162484|P3|COMPLETED|Period 2 Including Washout||7
67692|NCT01703286|162485|P2|COMPLETED|Period 2 Including Washout||7
67693|NCT01703286|162486|P1|COMPLETED|Period 2 Including Washout||7
67694|NCT01703286|162481|P6|STARTED|Period 2 Including Washout||6
67695|NCT01703286|162482|P5|STARTED|Period 2 Including Washout||7
67696|NCT01703286|162483|P4|STARTED|Period 2 Including Washout||6
67697|NCT01703286|162484|P3|STARTED|Period 2 Including Washout||7
67698|NCT01703286|162485|P2|STARTED|Period 2 Including Washout||7
67699|NCT01703286|162486|P1|STARTED|Period 2 Including Washout||7
67700|NCT01703286|162481|P6|NOT COMPLETED|Period 1 Including Washout||1
67701|NCT01703286|162482|P5|NOT COMPLETED|Period 1 Including Washout||0
67702|NCT01703286|162483|P4|NOT COMPLETED|Period 1 Including Washout||1
67703|NCT01703286|162484|P3|NOT COMPLETED|Period 1 Including Washout||0
67704|NCT01703286|162485|P2|NOT COMPLETED|Period 1 Including Washout||0
67705|NCT01703286|162486|P1|NOT COMPLETED|Period 1 Including Washout||0
67706|NCT01703286|162481|P6|COMPLETED|Period 1 Including Washout||6
67707|NCT01703286|162482|P5|COMPLETED|Period 1 Including Washout||7
67708|NCT01703286|162483|P4|COMPLETED|Period 1 Including Washout||6
67709|NCT01703286|162484|P3|COMPLETED|Period 1 Including Washout||7
67710|NCT01703286|162485|P2|COMPLETED|Period 1 Including Washout||7
67711|NCT01703286|162486|P1|COMPLETED|Period 1 Including Washout||7
67712|NCT01703286|162481|P6|STARTED|Period 1 Including Washout||7
67713|NCT01703286|162482|P5|STARTED|Period 1 Including Washout||7
67714|NCT01703286|162483|P4|STARTED|Period 1 Including Washout||7
67715|NCT01703286|162484|P3|STARTED|Period 1 Including Washout||7
67716|NCT01703286|162485|P2|STARTED|Period 1 Including Washout||7
67717|NCT01703286|162486|P1|STARTED|Period 1 Including Washout||7
67718|NCT01703260|162509|P3|NOT COMPLETED|Overall Study||3
67719|NCT01703260|162510|P2|NOT COMPLETED|Overall Study||4
67720|NCT01703260|162511|P1|NOT COMPLETED|Overall Study||3
67721|NCT01703260|162509|P3|COMPLETED|Overall Study||3
67722|NCT01703260|162510|P2|COMPLETED|Overall Study||3
67723|NCT01703260|162511|P1|COMPLETED|Overall Study||4
67724|NCT01703260|162509|P3|STARTED|Overall Study||6
67725|NCT01703260|162510|P2|STARTED|Overall Study||7
67726|NCT01703260|162511|P1|STARTED|Overall Study||7
67727|NCT01703221|162537|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
67728|NCT01703221|162538|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
67729|NCT01703221|162539|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
67730|NCT01703221|162537|P3|COMPLETED|Phase B - (Week 25 to 52)||75
67731|NCT01703221|162538|P2|COMPLETED|Phase B - (Week 25 to 52)||147
67732|NCT01703221|162539|P1|COMPLETED|Phase B - (Week 25 to 52)||143
67733|NCT01703221|162537|P3|STARTED|Phase B - (Week 25 to 52)||80
67734|NCT01703221|162538|P2|STARTED|Phase B - (Week 25 to 52)||161
67735|NCT01703221|162539|P1|STARTED|Phase B - (Week 25 to 52)||159
67736|NCT01703221|162537|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
67737|NCT01703221|162538|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
67738|NCT01703221|162539|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
67739|NCT01703221|162537|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
67740|NCT01703221|162538|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
67741|NCT01703221|162539|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
67742|NCT01703221|162537|P3|STARTED|Phase A (Up to 24 Weeks)||83
67743|NCT01703221|162538|P2|STARTED|Phase A (Up to 24 Weeks)||165
67744|NCT01703221|162539|P1|STARTED|Phase A (Up to 24 Weeks)||166
67745|NCT01703208|162570|P2|NOT COMPLETED|Overall Study||2102
67746|NCT01703208|162571|P1|NOT COMPLETED|Overall Study||2100
67747|NCT01703208|162570|P2|COMPLETED|Overall Study||0
67748|NCT01703208|162571|P1|COMPLETED|Overall Study||0
67749|NCT01703208|162570|P2|Treated|Overall Study||2100
67750|NCT01703208|162571|P1|Treated|Overall Study||2092
67751|NCT01703208|162570|P2|STARTED|Overall Study||2102
67752|NCT01703208|162571|P1|STARTED|Overall Study||2100
67753|NCT01703169|162625|P1|NOT COMPLETED|Overall Study||0
67754|NCT01703169|162625|P1|COMPLETED|Overall Study||13
67755|NCT01703169|162625|P1|STARTED|Overall Study||13
67756|NCT01703091|162635|P2|NOT COMPLETED|Overall Study||4
67757|NCT01703091|162636|P1|NOT COMPLETED|Overall Study||9
67758|NCT01703091|162635|P2|COMPLETED|Overall Study||95
67759|NCT01703091|162636|P1|COMPLETED|Overall Study||89
67760|NCT01703091|162635|P2|Received at Least One Dose of Study Drug|Overall Study||98
67761|NCT01703091|162636|P1|Received at Least One Dose of Study Drug|Overall Study||94
67762|NCT01703091|162635|P2|STARTED|Overall Study||99
67763|NCT01703091|162636|P1|STARTED|Overall Study||98
67764|NCT01703000|162652|P1|NOT COMPLETED|Overall Study||1
67765|NCT01703000|162652|P1|COMPLETED|Overall Study||99
67766|NCT01703000|162652|P1|STARTED|Overall Study||100
67767|NCT01702987|162685|P2|NOT COMPLETED|Overall Study||0
67768|NCT01702987|162686|P1|NOT COMPLETED|Overall Study||1
67769|NCT01702987|162685|P2|COMPLETED|Overall Study||12
67770|NCT01702987|162686|P1|COMPLETED|Overall Study||9
67771|NCT01702987|162685|P2|STARTED|Overall Study||12
67772|NCT01702987|162686|P1|STARTED|Overall Study||10
67773|NCT01702961|162692|P1|NOT COMPLETED|Overall Study||47
67774|NCT01702961|162692|P1|COMPLETED|Overall Study||28
67775|NCT01702961|162692|P1|STARTED|Overall Study||75
67776|NCT01702909|162698|P1|NOT COMPLETED|Overall Study||0
67777|NCT01702909|162698|P1|COMPLETED|Overall Study||7
67778|NCT01702909|162698|P1|STARTED|Overall Study||7
67779|NCT01702896|162704|P1|NOT COMPLETED|Overall Study||8
67780|NCT01702896|162704|P1|COMPLETED|Overall Study||0
67781|NCT01702896|162704|P1|STARTED|Overall Study||8
67782|NCT01702532|162712|P2|NOT COMPLETED|Overall Study||1
67783|NCT01702532|162713|P1|NOT COMPLETED|Overall Study||0
67784|NCT01702532|162712|P2|COMPLETED|Overall Study||160
67785|NCT01702532|162713|P1|COMPLETED|Overall Study||161
67786|NCT01702532|162712|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
67787|NCT01702532|162713|P1|Safety Population|Overall Study||161
67788|NCT01702532|162712|P2|STARTED|Overall Study||161
67789|NCT01702532|162713|P1|STARTED|Overall Study||161
67790|NCT01702519|162723|P2|NOT COMPLETED|Period 2||0
67791|NCT01702519|162724|P1|NOT COMPLETED|Period 2||0
67792|NCT01702519|162723|P2|COMPLETED|Period 2||18
67793|NCT01702519|162724|P1|COMPLETED|Period 2||19
67794|NCT01702519|162723|P2|STARTED|Period 2||18
67795|NCT01702519|162724|P1|STARTED|Period 2||19
67796|NCT01702519|162723|P2|NOT COMPLETED|Washout Period||2
67797|NCT01702519|162724|P1|NOT COMPLETED|Washout Period||1
67798|NCT01702519|162723|P2|COMPLETED|Washout Period||18
67799|NCT01702519|162724|P1|COMPLETED|Washout Period||19
67800|NCT01702519|162723|P2|STARTED|Washout Period||20
67801|NCT01702519|162724|P1|STARTED|Washout Period||20
67802|NCT01702519|162723|P2|NOT COMPLETED|Period 1||0
67803|NCT01702519|162724|P1|NOT COMPLETED|Period 1||0
67804|NCT01702519|162723|P2|COMPLETED|Period 1||20
67805|NCT01702519|162724|P1|COMPLETED|Period 1||20
67806|NCT01702519|162723|P2|STARTED|Period 1||20
67807|NCT01702519|162724|P1|STARTED|Period 1||20
67808|NCT01702454|162742|P2|NOT COMPLETED|Overall Study||8
67809|NCT01702454|162743|P1|NOT COMPLETED|Overall Study||3
67810|NCT01702454|162742|P2|COMPLETED|Overall Study||221
67811|NCT01702454|162743|P1|COMPLETED|Overall Study||238
67812|NCT01702454|162742|P2|STARTED|Overall Study||229
67813|NCT01702454|162743|P1|STARTED|Overall Study||241
67814|NCT01702363|162821|P1|NOT COMPLETED|Overall Study||20
67815|NCT01702363|162821|P1|COMPLETED|Overall Study||111
67816|NCT01702363|162821|P1|STARTED|Overall Study||131
67817|NCT01702311|162838|P2|NOT COMPLETED|Overall Study||13
67818|NCT01702311|162839|P1|NOT COMPLETED|Overall Study||16
67819|NCT01702311|162838|P2|COMPLETED|Overall Study||100
67820|NCT01702311|162839|P1|COMPLETED|Overall Study||106
67821|NCT01702311|162838|P2|STARTED|Overall Study||113
67822|NCT01702311|162839|P1|STARTED|Overall Study||122
67823|NCT01702298|162869|P1|NOT COMPLETED|Overall Study||1
67824|NCT01702298|162869|P1|COMPLETED|Overall Study||41
67825|NCT01702298|162869|P1|STARTED|Overall Study||42
67826|NCT01702259|162882|P2|NOT COMPLETED|Overall Study||0
67827|NCT01702259|162883|P1|NOT COMPLETED|Overall Study||0
67828|NCT01702259|162882|P2|COMPLETED|Overall Study||34
67829|NCT01702259|162883|P1|COMPLETED|Overall Study||34
67830|NCT01702259|162882|P2|STARTED|Overall Study||34
67831|NCT01702259|162883|P1|STARTED|Overall Study||34
67832|NCT01702246|162897|P1|NOT COMPLETED|Overall Study||5
67833|NCT01702246|162897|P1|COMPLETED|Overall Study||19
67834|NCT01702246|162897|P1|STARTED|Overall Study||24
67835|NCT01702233|162909|P3|NOT COMPLETED|Overall Study||5
67836|NCT01702233|162910|P2|NOT COMPLETED|Overall Study||3
67837|NCT01702233|162911|P1|NOT COMPLETED|Overall Study||6
67838|NCT01702233|162909|P3|COMPLETED|Overall Study||31
67839|NCT01702233|162910|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
67840|NCT01702233|162911|P1|COMPLETED|Overall Study||66
67841|NCT01702233|162909|P3|Per Protocol Set|Overall Study||27
67842|NCT01702233|162910|P2|Per Protocol Set|Overall Study||58
67843|NCT01702233|162911|P1|Per Protocol Set|Overall Study||58
67844|NCT01702233|162909|P3|Full Analysis Set (ITT)|Overall Study||31
67845|NCT01702233|162910|P2|Full Analysis Set (ITT)|Overall Study||63
67846|NCT01702233|162911|P1|Full Analysis Set (ITT)|Overall Study||66
67847|NCT01702233|162909|P3|STARTED|Overall Study||36
67848|NCT01702233|162910|P2|STARTED|Overall Study||67
67849|NCT01702233|162911|P1|STARTED|Overall Study||72
67850|NCT01702025|162951|P4|NOT COMPLETED|Overall Study||0
67851|NCT01702025|162952|P3|NOT COMPLETED|Overall Study||1
67852|NCT01702025|162953|P2|NOT COMPLETED|Overall Study||1
67853|NCT01702025|162954|P1|NOT COMPLETED|Overall Study||2
67854|NCT01702025|162951|P4|COMPLETED|Overall Study||10
67855|NCT01702025|162952|P3|COMPLETED|Overall Study||9
67856|NCT01702025|162953|P2|COMPLETED|Overall Study||9
67857|NCT01702025|162954|P1|COMPLETED|Overall Study||9
67858|NCT01702025|162951|P4|STARTED|Overall Study||10
67859|NCT01702025|162952|P3|STARTED|Overall Study||10
67860|NCT01702025|162953|P2|STARTED|Overall Study||10
67861|NCT01702025|162954|P1|STARTED|Overall Study||11
67862|NCT01701999|162970|P2|NOT COMPLETED|Overall Study||0
67863|NCT01701999|162971|P1|NOT COMPLETED|Overall Study||0
67864|NCT01701999|162970|P2|COMPLETED|Overall Study||37
67865|NCT01701999|162971|P1|COMPLETED|Overall Study||8
67866|NCT01701999|162970|P2|STARTED|Overall Study||37
67867|NCT01701999|162971|P1|STARTED|Overall Study||8
67868|NCT01701973|162983|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67869|NCT01701973|162984|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67870|NCT01701973|162985|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67871|NCT01701973|162986|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67872|NCT01701973|162987|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67873|NCT01701973|162988|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67874|NCT01701973|162989|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67875|NCT01701973|162990|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
67876|NCT01701973|162983|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
67877|NCT01701973|162984|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
67878|NCT01701973|162985|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
67879|NCT01701973|162986|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
67880|NCT01701973|162987|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
67881|NCT01701973|162988|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
67882|NCT01701973|162989|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
67883|NCT01701973|162990|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
67884|NCT01701973|162983|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
67885|NCT01701973|162984|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
67886|NCT01701973|162985|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
67887|NCT01701973|162986|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
67888|NCT01701973|162987|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
67889|NCT01701973|162988|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
67890|NCT01701973|162989|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
67891|NCT01701973|162990|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
67892|NCT01701973|162983|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67893|NCT01701973|162984|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67894|NCT01701973|162985|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67895|NCT01701973|162986|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67896|NCT01701973|162987|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67897|NCT01701973|162988|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67898|NCT01701973|162989|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67899|NCT01701973|162990|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
67900|NCT01701973|162983|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
67901|NCT01701973|162984|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
67902|NCT01701973|162985|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
67903|NCT01701973|162986|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
67904|NCT01701973|162987|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
67905|NCT01701973|162988|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
67906|NCT01701973|162989|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
67907|NCT01701973|162990|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
67908|NCT01701973|162983|P8|STARTED|Aim 2: First Intervention (1 Day)||4
67909|NCT01701973|162984|P7|STARTED|Aim 2: First Intervention (1 Day)||5
67910|NCT01701973|162985|P6|STARTED|Aim 2: First Intervention (1 Day)||3
67911|NCT01701973|162986|P5|STARTED|Aim 2: First Intervention (1 Day)||2
67912|NCT01701973|162987|P4|STARTED|Aim 2: First Intervention (1 Day)||4
67913|NCT01701973|162988|P3|STARTED|Aim 2: First Intervention (1 Day)||5
67914|NCT01701973|162989|P2|STARTED|Aim 2: First Intervention (1 Day)||0
67915|NCT01701973|162990|P1|STARTED|Aim 2: First Intervention (1 Day)||0
67916|NCT01701973|162983|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67917|NCT01701973|162984|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67918|NCT01701973|162985|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67919|NCT01701973|162986|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67920|NCT01701973|162987|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67921|NCT01701973|162988|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67922|NCT01701973|162989|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67923|NCT01701973|162990|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
67924|NCT01701973|162983|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
67925|NCT01701973|162984|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
67926|NCT01701973|162985|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
67927|NCT01701973|162986|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
67928|NCT01701973|162987|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
67929|NCT01701973|162988|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
67930|NCT01701973|162989|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
67931|NCT01701973|162990|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
67932|NCT01701973|162983|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
67933|NCT01701973|162984|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
67934|NCT01701973|162985|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
67935|NCT01701973|162986|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
67936|NCT01701973|162987|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
67937|NCT01701973|162988|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
67938|NCT01701973|162989|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
67939|NCT01701973|162990|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
67940|NCT01701973|162983|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
67941|NCT01701973|162984|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
67942|NCT01701973|162985|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
67943|NCT01701973|162986|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
67944|NCT01701973|162987|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
67945|NCT01701973|162988|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
67946|NCT01701973|162989|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
67947|NCT01701973|162990|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
67948|NCT01701973|162983|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
67949|NCT01701973|162984|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
67950|NCT01701973|162985|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
67951|NCT01701973|162986|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
67952|NCT01701973|162987|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
67953|NCT01701973|162988|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
67954|NCT01701973|162989|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
67955|NCT01701973|162990|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
67956|NCT01701973|162983|P8|STARTED|Aim 1: First Intervention (1 Day)||0
67957|NCT01701973|162984|P7|STARTED|Aim 1: First Intervention (1 Day)||0
67958|NCT01701973|162985|P6|STARTED|Aim 1: First Intervention (1 Day)||0
67959|NCT01701973|162986|P5|STARTED|Aim 1: First Intervention (1 Day)||0
67960|NCT01701973|162987|P4|STARTED|Aim 1: First Intervention (1 Day)||0
67961|NCT01701973|162988|P3|STARTED|Aim 1: First Intervention (1 Day)||0
67962|NCT01701973|162989|P2|STARTED|Aim 1: First Intervention (1 Day)||21
67963|NCT01701973|162990|P1|STARTED|Aim 1: First Intervention (1 Day)||23
67964|NCT01701674|163037|P1|NOT COMPLETED|Overall Study||1
67965|NCT01701674|163037|P1|COMPLETED|Overall Study||12
67966|NCT01701674|163037|P1|STARTED|Overall Study||13
67967|NCT01701622|163044|P1|NOT COMPLETED|Overall Study||0
67968|NCT01701622|163044|P1|COMPLETED|Overall Study||1
67969|NCT01701622|163044|P1|STARTED|Overall Study||1
67970|NCT01701505|163055|P6|NOT COMPLETED|Overall Study||0
67971|NCT01701505|163056|P5|NOT COMPLETED|Overall Study||0
67972|NCT01701505|163057|P4|NOT COMPLETED|Overall Study||0
67973|NCT01701505|163058|P3|NOT COMPLETED|Overall Study||0
67974|NCT01701505|163059|P2|NOT COMPLETED|Overall Study||0
67975|NCT01701505|163060|P1|NOT COMPLETED|Overall Study||0
67976|NCT01701505|163055|P6|COMPLETED|Overall Study||8
67977|NCT01701505|163056|P5|COMPLETED|Overall Study||8
67978|NCT01701505|163057|P4|COMPLETED|Overall Study||8
67979|NCT01701505|163058|P3|COMPLETED|Overall Study||8
67980|NCT01701505|163059|P2|COMPLETED|Overall Study||8
67981|NCT01701505|163060|P1|COMPLETED|Overall Study||8
67982|NCT01701505|163055|P6|STARTED|Overall Study||8
67983|NCT01701505|163056|P5|STARTED|Overall Study||8
67984|NCT01701505|163057|P4|STARTED|Overall Study||8
67985|NCT01701505|163058|P3|STARTED|Overall Study||8
67986|NCT01701505|163059|P2|STARTED|Overall Study||8
67987|NCT01701505|163060|P1|STARTED|Overall Study||8
67988|NCT01701414|163112|P2|NOT COMPLETED|Overall Study||1
67989|NCT01701414|163113|P1|NOT COMPLETED|Overall Study||1
67990|NCT01701414|163112|P2|COMPLETED|Overall Study||18
67991|NCT01701414|163113|P1|COMPLETED|Overall Study||18
67992|NCT01701414|163112|P2|STARTED|Overall Study||19
67993|NCT01701414|163113|P1|STARTED|Overall Study||19
67994|NCT01701401|163123|P4|NOT COMPLETED|Overall Study||6
67995|NCT01701401|163124|P3|NOT COMPLETED|Overall Study||5
67996|NCT01701401|163125|P2|NOT COMPLETED|Overall Study||9
67997|NCT01701401|163126|P1|NOT COMPLETED|Overall Study||10
67998|NCT01701401|163123|P4|COMPLETED|Overall Study||212
67999|NCT01701401|163124|P3|COMPLETED|Overall Study||212
68000|NCT01701401|163125|P2|COMPLETED|Overall Study||209
68001|NCT01701401|163126|P1|COMPLETED|Overall Study||207
68002|NCT01701401|163123|P4|STARTED|Overall Study||218
68003|NCT01701401|163124|P3|STARTED|Overall Study||217
68004|NCT01701401|163125|P2|STARTED|Overall Study||218
68005|NCT01701401|163126|P1|STARTED|Overall Study||217
68006|NCT01701375|163172|P1|NOT COMPLETED|Overall Study||0
68007|NCT01701375|163172|P1|COMPLETED|Overall Study||2
68008|NCT01701375|163172|P1|STARTED|Overall Study||2
68009|NCT01701362|163178|P2|NOT COMPLETED|Overall Study||56
68010|NCT01701362|163179|P1|NOT COMPLETED|Overall Study||42
68011|NCT01701362|163178|P2|COMPLETED|Overall Study||211
68012|NCT01701362|163179|P1|COMPLETED|Overall Study||233
68013|NCT01701362|163178|P2|TREATED|Overall Study||265
68014|NCT01701362|163179|P1|TREATED|Overall Study||274
68015|NCT01701362|163178|P2|STARTED|Overall Study||267
68016|NCT01701362|163179|P1|STARTED|Overall Study||275
68017|NCT01701271|163207|P1|NOT COMPLETED|Overall Study||0
68018|NCT01701271|163207|P1|COMPLETED|Overall Study||20
68019|NCT01701271|163207|P1|STARTED|Overall Study||20
68020|NCT01701258|163217|P13|NOT COMPLETED|EEG (Session 4)||0
68021|NCT01701258|163218|P12|NOT COMPLETED|EEG (Session 4)||0
68022|NCT01701258|163219|P11|NOT COMPLETED|EEG (Session 4)||0
68023|NCT01701258|163220|P10|NOT COMPLETED|EEG (Session 4)||0
68024|NCT01701258|163221|P9|NOT COMPLETED|EEG (Session 4)||0
68025|NCT01701258|163222|P8|NOT COMPLETED|EEG (Session 4)||0
68026|NCT01701258|163223|P7|NOT COMPLETED|EEG (Session 4)||0
68027|NCT01701258|163224|P6|NOT COMPLETED|EEG (Session 4)||0
68028|NCT01701258|163225|P5|NOT COMPLETED|EEG (Session 4)||0
68029|NCT01701258|163226|P4|NOT COMPLETED|EEG (Session 4)||0
68030|NCT01701258|163227|P3|NOT COMPLETED|EEG (Session 4)||0
68031|NCT01701258|163228|P2|NOT COMPLETED|EEG (Session 4)||0
68032|NCT01701258|163229|P1|NOT COMPLETED|EEG (Session 4)||0
68033|NCT01701258|163217|P13|COMPLETED|EEG (Session 4)||0
68034|NCT01701258|163218|P12|COMPLETED|EEG (Session 4)||0
68035|NCT01701258|163219|P11|COMPLETED|EEG (Session 4)||17
68036|NCT01701258|163220|P10|COMPLETED|EEG (Session 4)||0
68037|NCT01701258|163221|P9|COMPLETED|EEG (Session 4)||0
68038|NCT01701258|163222|P8|COMPLETED|EEG (Session 4)||16
68039|NCT01701258|163223|P7|COMPLETED|EEG (Session 4)||0
68040|NCT01701258|163224|P6|COMPLETED|EEG (Session 4)||0
68041|NCT01701258|163225|P5|COMPLETED|EEG (Session 4)||14
68042|NCT01701258|163226|P4|COMPLETED|EEG (Session 4)||0
68043|NCT01701258|163227|P3|COMPLETED|EEG (Session 4)||0
68044|NCT01701258|163228|P2|COMPLETED|EEG (Session 4)||19
68045|NCT01701258|163229|P1|COMPLETED|EEG (Session 4)||0
68046|NCT01701258|163217|P13|STARTED|EEG (Session 4)||0
68047|NCT01701258|163218|P12|STARTED|EEG (Session 4)||0
68048|NCT01701258|163219|P11|STARTED|EEG (Session 4)||17
68049|NCT01701258|163220|P10|STARTED|EEG (Session 4)||0
68050|NCT01701258|163221|P9|STARTED|EEG (Session 4)||0
68051|NCT01701258|163222|P8|STARTED|EEG (Session 4)||16
68052|NCT01701258|163223|P7|STARTED|EEG (Session 4)||0
68053|NCT01701258|163224|P6|STARTED|EEG (Session 4)||0
68054|NCT01701258|163225|P5|STARTED|EEG (Session 4)||14
68055|NCT01701258|163226|P4|STARTED|EEG (Session 4)||0
68056|NCT01701258|163227|P3|STARTED|EEG (Session 4)||0
68057|NCT01701258|163228|P2|STARTED|EEG (Session 4)||19
68058|NCT01701258|163229|P1|STARTED|EEG (Session 4)||0
68059|NCT01701258|163217|P13|NOT COMPLETED|PET (Session 3)||0
68060|NCT01701258|163218|P12|NOT COMPLETED|PET (Session 3)||0
68061|NCT01701258|163219|P11|NOT COMPLETED|PET (Session 3)||0
68062|NCT01701258|163220|P10|NOT COMPLETED|PET (Session 3)||0
68063|NCT01701258|163221|P9|NOT COMPLETED|PET (Session 3)||0
68064|NCT01701258|163222|P8|NOT COMPLETED|PET (Session 3)||0
68065|NCT01701258|163223|P7|NOT COMPLETED|PET (Session 3)||0
68066|NCT01701258|163224|P6|NOT COMPLETED|PET (Session 3)||0
68067|NCT01701258|163225|P5|NOT COMPLETED|PET (Session 3)||0
68068|NCT01701258|163226|P4|NOT COMPLETED|PET (Session 3)||0
68069|NCT01701258|163227|P3|NOT COMPLETED|PET (Session 3)||0
68070|NCT01701258|163228|P2|NOT COMPLETED|PET (Session 3)||0
68071|NCT01701258|163229|P1|NOT COMPLETED|PET (Session 3)||0
68072|NCT01701258|163217|P13|COMPLETED|PET (Session 3)||0
68073|NCT01701258|163218|P12|COMPLETED|PET (Session 3)||0
68074|NCT01701258|163219|P11|COMPLETED|PET (Session 3)||18
68075|NCT01701258|163220|P10|COMPLETED|PET (Session 3)||0
68076|NCT01701258|163221|P9|COMPLETED|PET (Session 3)||0
68077|NCT01701258|163222|P8|COMPLETED|PET (Session 3)||19
68078|NCT01701258|163223|P7|COMPLETED|PET (Session 3)||0
68079|NCT01701258|163224|P6|COMPLETED|PET (Session 3)||0
68080|NCT01701258|163225|P5|COMPLETED|PET (Session 3)||16
68081|NCT01701258|163226|P4|COMPLETED|PET (Session 3)||0
68082|NCT01701258|163227|P3|COMPLETED|PET (Session 3)||0
68083|NCT01701258|163228|P2|COMPLETED|PET (Session 3)||20
68084|NCT01701258|163229|P1|COMPLETED|PET (Session 3)||0
68085|NCT01701258|163217|P13|STARTED|PET (Session 3)||0
68086|NCT01701258|163218|P12|STARTED|PET (Session 3)||0
68087|NCT01701258|163219|P11|STARTED|PET (Session 3)||18
68088|NCT01701258|163220|P10|STARTED|PET (Session 3)||0
68089|NCT01701258|163221|P9|STARTED|PET (Session 3)||0
68090|NCT01701258|163222|P8|STARTED|PET (Session 3)||19
68091|NCT01701258|163223|P7|STARTED|PET (Session 3)||0
68092|NCT01701258|163224|P6|STARTED|PET (Session 3)||0
68093|NCT01701258|163225|P5|STARTED|PET (Session 3)||16
68094|NCT01701258|163226|P4|STARTED|PET (Session 3)||0
68095|NCT01701258|163227|P3|STARTED|PET (Session 3)||0
68096|NCT01701258|163228|P2|STARTED|PET (Session 3)||20
68097|NCT01701258|163229|P1|STARTED|PET (Session 3)||0
68098|NCT01701258|163217|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
68099|NCT01701258|163218|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
68100|NCT01701258|163219|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
68101|NCT01701258|163220|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
68102|NCT01701258|163221|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
68103|NCT01701258|163222|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
68104|NCT01701258|163223|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
68105|NCT01701258|163224|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
68106|NCT01701258|163225|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
68107|NCT01701258|163226|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
68108|NCT01701258|163227|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
68109|NCT01701258|163228|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
68110|NCT01701258|163229|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
68111|NCT01701258|163217|P13|COMPLETED|Drug+fMRI (Session 2)||7
68112|NCT01701258|163218|P12|COMPLETED|Drug+fMRI (Session 2)||10
68113|NCT01701258|163219|P11|COMPLETED|Drug+fMRI (Session 2)||0
68114|NCT01701258|163220|P10|COMPLETED|Drug+fMRI (Session 2)||6
68115|NCT01701258|163221|P9|COMPLETED|Drug+fMRI (Session 2)||6
68116|NCT01701258|163222|P8|COMPLETED|Drug+fMRI (Session 2)||0
68117|NCT01701258|163223|P7|COMPLETED|Drug+fMRI (Session 2)||8
68118|NCT01701258|163224|P6|COMPLETED|Drug+fMRI (Session 2)||9
68119|NCT01701258|163225|P5|COMPLETED|Drug+fMRI (Session 2)||0
68120|NCT01701258|163226|P4|COMPLETED|Drug+fMRI (Session 2)||11
68121|NCT01701258|163227|P3|COMPLETED|Drug+fMRI (Session 2)||11
68122|NCT01701258|163228|P2|COMPLETED|Drug+fMRI (Session 2)||0
68123|NCT01701258|163229|P1|COMPLETED|Drug+fMRI (Session 2)||0
68124|NCT01701258|163217|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
68125|NCT01701258|163218|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
68126|NCT01701258|163219|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
68127|NCT01701258|163220|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
68128|NCT01701258|163221|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
68129|NCT01701258|163222|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
68130|NCT01701258|163223|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
68131|NCT01701258|163224|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
68132|NCT01701258|163225|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
68133|NCT01701258|163226|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
68134|NCT01701258|163227|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
68135|NCT01701258|163228|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
68136|NCT01701258|163229|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
68137|NCT01701258|163217|P13|STARTED|Drug+fMRI (Session 2)||7
68138|NCT01701258|163218|P12|STARTED|Drug+fMRI (Session 2)||10
68139|NCT01701258|163219|P11|STARTED|Drug+fMRI (Session 2)||0
68140|NCT01701258|163220|P10|STARTED|Drug+fMRI (Session 2)||6
68141|NCT01701258|163221|P9|STARTED|Drug+fMRI (Session 2)||6
68142|NCT01701258|163222|P8|STARTED|Drug+fMRI (Session 2)||0
68143|NCT01701258|163223|P7|STARTED|Drug+fMRI (Session 2)||8
68144|NCT01701258|163224|P6|STARTED|Drug+fMRI (Session 2)||9
68145|NCT01701258|163225|P5|STARTED|Drug+fMRI (Session 2)||0
68146|NCT01701258|163226|P4|STARTED|Drug+fMRI (Session 2)||11
68147|NCT01701258|163227|P3|STARTED|Drug+fMRI (Session 2)||11
68148|NCT01701258|163228|P2|STARTED|Drug+fMRI (Session 2)||0
68149|NCT01701258|163229|P1|STARTED|Drug+fMRI (Session 2)||0
68150|NCT01701258|163217|P13|NOT COMPLETED|Assessment and Scheduling||0
68151|NCT01701258|163218|P12|NOT COMPLETED|Assessment and Scheduling||0
68152|NCT01701258|163219|P11|NOT COMPLETED|Assessment and Scheduling||0
68153|NCT01701258|163220|P10|NOT COMPLETED|Assessment and Scheduling||0
68154|NCT01701258|163221|P9|NOT COMPLETED|Assessment and Scheduling||0
68155|NCT01701258|163222|P8|NOT COMPLETED|Assessment and Scheduling||0
68156|NCT01701258|163223|P7|NOT COMPLETED|Assessment and Scheduling||0
68157|NCT01701258|163224|P6|NOT COMPLETED|Assessment and Scheduling||0
68158|NCT01701258|163225|P5|NOT COMPLETED|Assessment and Scheduling||0
68159|NCT01701258|163226|P4|NOT COMPLETED|Assessment and Scheduling||0
68160|NCT01701258|163227|P3|NOT COMPLETED|Assessment and Scheduling||0
68161|NCT01701258|163228|P2|NOT COMPLETED|Assessment and Scheduling||0
68162|NCT01701258|163229|P1|NOT COMPLETED|Assessment and Scheduling||83
68163|NCT01701258|163217|P13|COMPLETED|Assessment and Scheduling||0
68164|NCT01701258|163218|P12|COMPLETED|Assessment and Scheduling||0
68165|NCT01701258|163219|P11|COMPLETED|Assessment and Scheduling||0
68166|NCT01701258|163220|P10|COMPLETED|Assessment and Scheduling||0
68167|NCT01701258|163221|P9|COMPLETED|Assessment and Scheduling||0
68168|NCT01701258|163222|P8|COMPLETED|Assessment and Scheduling||0
68169|NCT01701258|163223|P7|COMPLETED|Assessment and Scheduling||0
68170|NCT01701258|163224|P6|COMPLETED|Assessment and Scheduling||0
68171|NCT01701258|163225|P5|COMPLETED|Assessment and Scheduling||0
68172|NCT01701258|163226|P4|COMPLETED|Assessment and Scheduling||0
68173|NCT01701258|163227|P3|COMPLETED|Assessment and Scheduling||0
68174|NCT01701258|163228|P2|COMPLETED|Assessment and Scheduling||0
68175|NCT01701258|163229|P1|COMPLETED|Assessment and Scheduling||70
68176|NCT01701258|163217|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
68177|NCT01701258|163218|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
68178|NCT01701258|163219|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
68179|NCT01701258|163220|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
68180|NCT01701258|163221|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
68181|NCT01701258|163222|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
68182|NCT01701258|163223|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
68183|NCT01701258|163224|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
68184|NCT01701258|163225|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
68185|NCT01701258|163226|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
68186|NCT01701258|163227|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
68187|NCT01701258|163228|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
68188|NCT01701258|163229|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
68189|NCT01701258|163217|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
68190|NCT01701258|163218|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
68191|NCT01701258|163219|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
68192|NCT01701258|163220|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
68193|NCT01701258|163221|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
68194|NCT01701258|163222|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
68195|NCT01701258|163223|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
68196|NCT01701258|163224|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
68197|NCT01701258|163225|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
68198|NCT01701258|163226|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
68199|NCT01701258|163227|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
68200|NCT01701258|163228|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
68201|NCT01701258|163229|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
68202|NCT01701258|163217|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68203|NCT01701258|163218|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68204|NCT01701258|163219|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68205|NCT01701258|163220|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68206|NCT01701258|163221|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68207|NCT01701258|163222|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68208|NCT01701258|163223|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68209|NCT01701258|163224|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68210|NCT01701258|163225|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68211|NCT01701258|163226|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68212|NCT01701258|163227|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68213|NCT01701258|163228|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
68214|NCT01701258|163229|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
68215|NCT01701258|163217|P13|Eligible After Screening Visit|Assessment and Scheduling||0
68216|NCT01701258|163218|P12|Eligible After Screening Visit|Assessment and Scheduling||0
68217|NCT01701258|163219|P11|Eligible After Screening Visit|Assessment and Scheduling||0
68218|NCT01701258|163220|P10|Eligible After Screening Visit|Assessment and Scheduling||0
68219|NCT01701258|163221|P9|Eligible After Screening Visit|Assessment and Scheduling||0
68220|NCT01701258|163222|P8|Eligible After Screening Visit|Assessment and Scheduling||0
68221|NCT01701258|163223|P7|Eligible After Screening Visit|Assessment and Scheduling||0
68222|NCT01701258|163224|P6|Eligible After Screening Visit|Assessment and Scheduling||0
68223|NCT01701258|163225|P5|Eligible After Screening Visit|Assessment and Scheduling||0
68224|NCT01701258|163226|P4|Eligible After Screening Visit|Assessment and Scheduling||0
68225|NCT01701258|163227|P3|Eligible After Screening Visit|Assessment and Scheduling||0
68226|NCT01701258|163228|P2|Eligible After Screening Visit|Assessment and Scheduling||0
68227|NCT01701258|163229|P1|Eligible After Screening Visit|Assessment and Scheduling||96
68228|NCT01701258|163217|P13|STARTED|Assessment and Scheduling||0
68229|NCT01701258|163218|P12|STARTED|Assessment and Scheduling||0
68230|NCT01701258|163219|P11|STARTED|Assessment and Scheduling||0
68231|NCT01701258|163220|P10|STARTED|Assessment and Scheduling||0
68232|NCT01701258|163221|P9|STARTED|Assessment and Scheduling||0
68233|NCT01701258|163222|P8|STARTED|Assessment and Scheduling||0
68234|NCT01701258|163223|P7|STARTED|Assessment and Scheduling||0
68235|NCT01701258|163224|P6|STARTED|Assessment and Scheduling||0
68236|NCT01701258|163225|P5|STARTED|Assessment and Scheduling||0
68237|NCT01701258|163226|P4|STARTED|Assessment and Scheduling||0
68238|NCT01701258|163227|P3|STARTED|Assessment and Scheduling||0
68239|NCT01701258|163228|P2|STARTED|Assessment and Scheduling||0
68240|NCT01701258|163229|P1|STARTED|Assessment and Scheduling||153
68241|NCT01701245|163283|P2|NOT COMPLETED|Overall Study||15
68242|NCT01701245|163284|P1|NOT COMPLETED|Overall Study||12
68243|NCT01701245|163283|P2|COMPLETED|Overall Study||33
68244|NCT01701245|163284|P1|COMPLETED|Overall Study||37
68245|NCT01701245|163283|P2|FAS Matched Data|Overall Study||32
68246|NCT01701245|163284|P1|FAS Matched Data|Overall Study||42
68247|NCT01701245|163283|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
68248|NCT01701245|163284|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
68249|NCT01701245|163283|P2|STARTED|Overall Study||48
68250|NCT01701245|163284|P1|STARTED|Overall Study||49
68251|NCT01701115|163298|P2|NOT COMPLETED|Overall Study||0
68252|NCT01701115|163299|P1|NOT COMPLETED|Overall Study||2
68253|NCT01701115|163298|P2|COMPLETED|Overall Study||77
68254|NCT01701115|163299|P1|COMPLETED|Overall Study||75
68255|NCT01701115|163298|P2|STARTED|Overall Study||77
68256|NCT01701115|163299|P1|STARTED|Overall Study||77
68257|NCT01701102|163315|P4|NOT COMPLETED|Overall Study||0
68258|NCT01701102|163316|P3|NOT COMPLETED|Overall Study||0
68259|NCT01701102|163317|P2|NOT COMPLETED|Overall Study||0
68260|NCT01701102|163318|P1|NOT COMPLETED|Overall Study||0
68261|NCT01701102|163315|P4|COMPLETED|Overall Study||18
68262|NCT01701102|163316|P3|COMPLETED|Overall Study||10
68263|NCT01701102|163317|P2|COMPLETED|Overall Study||6
68264|NCT01701102|163318|P1|COMPLETED|Overall Study||22
68265|NCT01701102|163315|P4|STARTED|Overall Study||18
68266|NCT01701102|163316|P3|STARTED|Overall Study||10
68267|NCT01701102|163317|P2|STARTED|Overall Study||6
68268|NCT01701102|163318|P1|STARTED|Overall Study||22
68269|NCT01701063|163331|P3|NOT COMPLETED|Overall Study||2
68270|NCT01701063|163332|P2|NOT COMPLETED|Overall Study||1
68271|NCT01701063|163333|P1|NOT COMPLETED|Overall Study||0
68272|NCT01701063|163331|P3|COMPLETED|Overall Study||8
68273|NCT01701063|163332|P2|COMPLETED|Overall Study||18
68274|NCT01701063|163333|P1|COMPLETED|Overall Study||13
68275|NCT01701063|163331|P3|STARTED|Overall Study||10
68276|NCT01701063|163332|P2|STARTED|Overall Study||19
68277|NCT01701063|163333|P1|STARTED|Overall Study||13
68278|NCT01701037|163375|P1|NOT COMPLETED|Overall Study||0
68279|NCT01701037|163375|P1|COMPLETED|Overall Study||13
68280|NCT01701037|163375|P1|STARTED|Overall Study||13
68281|NCT01701024|163386|P2|NOT COMPLETED|Overall Study||9
68282|NCT01701024|163387|P1|NOT COMPLETED|Overall Study||10
68283|NCT01701024|163386|P2|COMPLETED|Overall Study||236
68284|NCT01701024|163387|P1|COMPLETED|Overall Study||243
68285|NCT01701024|163386|P2|STARTED|Overall Study||245
68286|NCT01701024|163387|P1|STARTED|Overall Study||253
68287|NCT01701011|163402|P3|NOT COMPLETED|Overall Study||34
68288|NCT01701011|163403|P2|NOT COMPLETED|Overall Study||24
68289|NCT01701011|163404|P1|NOT COMPLETED|Overall Study||35
68290|NCT01701011|163402|P3|COMPLETED|Overall Study||90
68291|NCT01701011|163403|P2|COMPLETED|Overall Study||102
68292|NCT01701011|163404|P1|COMPLETED|Overall Study||92
68293|NCT01701011|163402|P3|STARTED|Overall Study||124
68294|NCT01701011|163403|P2|STARTED|Overall Study||126
68295|NCT01701011|163404|P1|STARTED|Overall Study||127
68296|NCT01700907|163417|P2|NOT COMPLETED|Overall Study||0
68297|NCT01700907|163418|P1|NOT COMPLETED|Overall Study||0
68298|NCT01700907|163417|P2|COMPLETED|Overall Study||10
68299|NCT01700907|163418|P1|COMPLETED|Overall Study||10
68300|NCT01700907|163417|P2|STARTED|Overall Study||10
68301|NCT01700907|163418|P1|STARTED|Overall Study||10
68302|NCT01700816|163434|P2|NOT COMPLETED|Overall Study||0
68303|NCT01700816|163435|P1|NOT COMPLETED|Overall Study||0
68304|NCT01700816|163434|P2|COMPLETED|Overall Study||19
68305|NCT01700816|163435|P1|COMPLETED|Overall Study||21
68306|NCT01700816|163434|P2|STARTED|Overall Study||19
68307|NCT01700816|163435|P1|STARTED|Overall Study||21
68308|NCT01700530|163464|P3|NOT COMPLETED|Overall Study||1
68309|NCT01700530|163465|P2|NOT COMPLETED|Overall Study||3
68310|NCT01700530|163466|P1|NOT COMPLETED|Overall Study||0
68311|NCT01700530|163464|P3|COMPLETED|Overall Study||19
68312|NCT01700530|163465|P2|COMPLETED|Overall Study||18
68313|NCT01700530|163466|P1|COMPLETED|Overall Study||9
68314|NCT01700530|163464|P3|STARTED|Overall Study||20
68315|NCT01700530|163465|P2|STARTED|Overall Study||21
68316|NCT01700530|163466|P1|STARTED|Overall Study||9
68317|NCT01700517|163480|P3|NOT COMPLETED|Overall Study||0
68318|NCT01700517|163481|P2|NOT COMPLETED|Overall Study||0
68319|NCT01700517|163482|P1|NOT COMPLETED|Overall Study||0
68320|NCT01700517|163480|P3|COMPLETED|Overall Study||40
68321|NCT01700517|163481|P2|COMPLETED|Overall Study||40
68322|NCT01700517|163482|P1|COMPLETED|Overall Study||40
68323|NCT01700517|163480|P3|STARTED|Overall Study||40
68324|NCT01700517|163481|P2|STARTED|Overall Study||40
68325|NCT01700517|163482|P1|STARTED|Overall Study||40
68326|NCT01700439|163490|P1|NOT COMPLETED|Overall Study||889
68327|NCT01700439|163490|P1|COMPLETED|Overall Study||0
68328|NCT01700439|163490|P1|2 Year|Overall Study||215
68329|NCT01700439|163490|P1|1 Year|Overall Study||573
68330|NCT01700439|163490|P1|3 Month|Overall Study||778
68331|NCT01700439|163490|P1|Discharge|Overall Study||831
68332|NCT01700439|163490|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
68333|NCT01700439|163490|P1|STARTED|Overall Study||889
68334|NCT01700387|163515|P2|NOT COMPLETED|Overall Study||4
68335|NCT01700387|163516|P1|NOT COMPLETED|Overall Study||4
68336|NCT01700387|163515|P2|COMPLETED|Overall Study||6
68337|NCT01700387|163516|P1|COMPLETED|Overall Study||6
68338|NCT01700387|163515|P2|STARTED|Overall Study||10
68339|NCT01700387|163516|P1|STARTED|Overall Study||10
68340|NCT01700348|163526|P1|NOT COMPLETED|Overall Study||23
68341|NCT01700348|163526|P1|COMPLETED|Overall Study||93
68342|NCT01700348|163526|P1|STARTED|Overall Study||116
68343|NCT01700335|163530|P2|NOT COMPLETED|Overall Study||4
68344|NCT01700335|163531|P1|NOT COMPLETED|Overall Study||1
68345|NCT01700335|163530|P2|COMPLETED|Overall Study||2
68346|NCT01700335|163531|P1|COMPLETED|Overall Study||2
68347|NCT01700335|163530|P2|STARTED|Overall Study||6
68348|NCT01700335|163531|P1|STARTED|Overall Study||3
68349|NCT01700192|163544|P2|NOT COMPLETED|Overall Study||128
68350|NCT01700192|163545|P1|NOT COMPLETED|Overall Study||180
68351|NCT01700192|163544|P2|COMPLETED|Overall Study||613
68352|NCT01700192|163545|P1|COMPLETED|Overall Study||561
68353|NCT01700192|163544|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
68354|NCT01700192|163545|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
68355|NCT01700192|163544|P2|Treated|Overall Study||741
68356|NCT01700192|163545|P1|Treated|Overall Study||740
68357|NCT01700192|163544|P2|STARTED|Overall Study||741
68358|NCT01700192|163545|P1|STARTED|Overall Study||741
68359|NCT01700179|163563|P1|NOT COMPLETED|Overall Study||2
68360|NCT01700179|163563|P1|COMPLETED|Overall Study||6
68361|NCT01700179|163563|P1|STARTED|Overall Study||8
68362|NCT01700140|163570|P3|NOT COMPLETED|Overall Study||1
68363|NCT01700140|163571|P2|NOT COMPLETED|Overall Study||9
68364|NCT01700140|163572|P1|NOT COMPLETED|Overall Study||6
68365|NCT01700140|163570|P3|COMPLETED|Overall Study||61
68366|NCT01700140|163571|P2|COMPLETED|Overall Study||57
68367|NCT01700140|163572|P1|COMPLETED|Overall Study||55
68368|NCT01700140|163570|P3|STARTED|Overall Study||62
68369|NCT01700140|163571|P2|STARTED|Overall Study||66
68370|NCT01700140|163572|P1|STARTED|Overall Study||61
68371|NCT01700036|163604|P1|NOT COMPLETED|Overall Study||0
68372|NCT01700036|163604|P1|COMPLETED|Overall Study||40
68373|NCT01700036|163604|P1|STARTED|Overall Study||40
68374|NCT01699867|163613|P1|NOT COMPLETED|Overall Study||3
68375|NCT01699867|163613|P1|COMPLETED|Overall Study||47
68376|NCT01699867|163613|P1|STARTED|Overall Study||50
68377|NCT01699815|163620|P2|NOT COMPLETED|Overall Study||8
68378|NCT01699815|163621|P1|NOT COMPLETED|Overall Study||5
68379|NCT01699815|163620|P2|COMPLETED|Overall Study||56
68380|NCT01699815|163621|P1|COMPLETED|Overall Study||57
68381|NCT01699815|163620|P2|STARTED|Overall Study||64
68382|NCT01699815|163621|P1|STARTED|Overall Study||62
68383|NCT01699789|163633|P2|NOT COMPLETED|Overall Study||126
68384|NCT01699789|163634|P1|NOT COMPLETED|Overall Study||102
68385|NCT01699789|163633|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
68386|NCT01699789|163634|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
68387|NCT01699789|163633|P2|12-Month Follow-Up|Overall Study||369
68388|NCT01699789|163634|P1|12-Month Follow-Up|Overall Study||364
68389|NCT01699789|163633|P2|6-Month Follow-Up|Overall Study||379
68390|NCT01699789|163634|P1|6-Month Follow-Up|Overall Study||380
68391|NCT01699789|163633|P2|Baseline|Overall Study||488
68392|NCT01699789|163634|P1|Baseline|Overall Study||492
68393|NCT01699789|163633|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
68394|NCT01699789|163634|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
68395|NCT01699763|163696|P1|NOT COMPLETED|Overall Study||0
68396|NCT01699763|163696|P1|COMPLETED|Overall Study||112
68397|NCT01699763|163696|P1|STARTED|Overall Study||112
68398|NCT01699750|163704|P2|NOT COMPLETED|Overall Study||3
68399|NCT01699750|163705|P1|NOT COMPLETED|Overall Study||0
68400|NCT01699750|163704|P2|COMPLETED|Overall Study||33
68401|NCT01699750|163705|P1|COMPLETED|Overall Study||34
68402|NCT01699750|163704|P2|STARTED|Overall Study||36
68403|NCT01699750|163705|P1|STARTED|Overall Study||34
68404|NCT01699698|163729|P2|NOT COMPLETED|Overall Study||5
68405|NCT01699698|163730|P1|NOT COMPLETED|Overall Study||2
68406|NCT01699698|163729|P2|COMPLETED|Overall Study||56
68407|NCT01699698|163730|P1|COMPLETED|Overall Study||42
68408|NCT01699698|163729|P2|STARTED|Overall Study||61
68409|NCT01699698|163730|P1|STARTED|Overall Study||44
68410|NCT01699685|163740|P2|NOT COMPLETED|Period 2||0
68411|NCT01699685|163741|P1|NOT COMPLETED|Period 2||1
68412|NCT01699685|163740|P2|COMPLETED|Period 2||36
68413|NCT01699685|163741|P1|COMPLETED|Period 2||35
68414|NCT01699685|163740|P2|STARTED|Period 2||36
68415|NCT01699685|163741|P1|STARTED|Period 2||36
68416|NCT01699685|163740|P2|NOT COMPLETED|Period 1||3
68417|NCT01699685|163741|P1|NOT COMPLETED|Period 1||3
68418|NCT01699685|163740|P2|COMPLETED|Period 1||36
68419|NCT01699685|163741|P1|COMPLETED|Period 1||36
68420|NCT01699685|163740|P2|Full Analysis Population (FAS)|Period 1||38
68421|NCT01699685|163741|P1|Full Analysis Population (FAS)|Period 1||38
68422|NCT01699685|163740|P2|Safety Population|Period 1||38
68423|NCT01699685|163741|P1|Safety Population|Period 1||39
68424|NCT01699685|163740|P2|STARTED|Period 1||39
68425|NCT01699685|163741|P1|STARTED|Period 1||39
68426|NCT01699607|163759|P2|NOT COMPLETED|Overall Study||0
68427|NCT01699607|163760|P1|NOT COMPLETED|Overall Study||0
68428|NCT01699607|163759|P2|COMPLETED|Overall Study||4
68429|NCT01699607|163760|P1|COMPLETED|Overall Study||6
68430|NCT01699607|163759|P2|STARTED|Overall Study||4
68431|NCT01699607|163760|P1|STARTED|Overall Study||6
68432|NCT01699373|163767|P2|NOT COMPLETED|Overall Study||0
68433|NCT01699373|163768|P1|NOT COMPLETED|Overall Study||0
68434|NCT01699373|163767|P2|COMPLETED|Overall Study||85
68435|NCT01699373|163768|P1|COMPLETED|Overall Study||85
68436|NCT01699373|163767|P2|STARTED|Overall Study||85
68437|NCT01699373|163768|P1|STARTED|Overall Study||85
68438|NCT01699087|163774|P1|NOT COMPLETED|Overall Study||24
68439|NCT01699087|163774|P1|COMPLETED|Overall Study||152
68440|NCT01699087|163774|P1|Treated|Overall Study||161
68441|NCT01699087|163774|P1|STARTED|Overall Study||176
68442|NCT01699022|163788|P1|NOT COMPLETED|Overall Study||3
68443|NCT01699022|163788|P1|COMPLETED|Overall Study||14
68444|NCT01699022|163788|P1|STARTED|Overall Study||17
68445|NCT01698814|163803|P2|NOT COMPLETED|Overall Study||3
68446|NCT01698814|163804|P1|NOT COMPLETED|Overall Study||2
68447|NCT01698814|163803|P2|COMPLETED|Overall Study||166
68448|NCT01698814|163804|P1|COMPLETED|Overall Study||329
68449|NCT01698814|163803|P2|STARTED|Overall Study||169
68450|NCT01698814|163804|P1|STARTED|Overall Study||331
68451|NCT01698801|163810|P1|NOT COMPLETED|Follow Up Phase||5
68452|NCT01698801|163810|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
68453|NCT01698801|163810|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
68454|NCT01698801|163810|P1|NOT COMPLETED|Treatment Phase||11
68455|NCT01698801|163810|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
68456|NCT01698801|163810|P1|STARTED|Treatment Phase||26
68457|NCT01698775|163821|P2|NOT COMPLETED|Phase B||11
68458|NCT01698775|163822|P1|NOT COMPLETED|Phase B||14
68459|NCT01698775|163821|P2|COMPLETED|Phase B||86
68460|NCT01698775|163822|P1|COMPLETED|Phase B||84
68461|NCT01698775|163821|P2|STARTED|Phase B||97
68462|NCT01698775|163822|P1|STARTED|Phase B||98
68463|NCT01698775|163821|P2|NOT COMPLETED|Phase A||9
68464|NCT01698775|163822|P1|NOT COMPLETED|Phase A||9
68465|NCT01698775|163821|P2|COMPLETED|Phase A||97
68466|NCT01698775|163822|P1|COMPLETED|Phase A||98
68467|NCT01698775|163821|P2|STARTED|Phase A||106
68468|NCT01698775|163822|P1|STARTED|Phase A||107
68469|NCT01698710|163848|P1|NOT COMPLETED|Overall Study||0
68470|NCT01698710|163848|P1|COMPLETED|Overall Study||5
68471|NCT01698710|163848|P1|STARTED|Overall Study||5
68472|NCT01698684|163857|P3|NOT COMPLETED|Overall Study||21
68473|NCT01698684|163858|P2|NOT COMPLETED|Overall Study||23
68474|NCT01698684|163859|P1|NOT COMPLETED|Overall Study||29
68475|NCT01698684|163857|P3|COMPLETED|Overall Study||127
68476|NCT01698684|163858|P2|COMPLETED|Overall Study||124
68477|NCT01698684|163859|P1|COMPLETED|Overall Study||116
68478|NCT01698684|163857|P3|Safety Population|Overall Study||146
68479|NCT01698684|163858|P2|Safety Population|Overall Study||146
68480|NCT01698684|163859|P1|Safety Population|Overall Study||143
68481|NCT01698684|163857|P3|ITT Population|Overall Study||139
68482|NCT01698684|163858|P2|ITT Population|Overall Study||139
68483|NCT01698684|163859|P1|ITT Population|Overall Study||136
68484|NCT01698684|163857|P3|STARTED|Overall Study||148
68485|NCT01698684|163858|P2|STARTED|Overall Study||147
68486|NCT01698684|163859|P1|STARTED|Overall Study||145
68487|NCT01698554|163871|P4|NOT COMPLETED|Overall Study||2
68488|NCT01698554|163872|P3|NOT COMPLETED|Overall Study||2
68489|NCT01698554|163873|P2|NOT COMPLETED|Overall Study||10
68490|NCT01698554|163874|P1|NOT COMPLETED|Overall Study||6
68491|NCT01698554|163871|P4|COMPLETED|Overall Study||77
68492|NCT01698554|163872|P3|COMPLETED|Overall Study||73
68493|NCT01698554|163873|P2|COMPLETED|Overall Study||147
68494|NCT01698554|163874|P1|COMPLETED|Overall Study||147
68495|NCT01698554|163871|P4|STARTED|Overall Study||79
68496|NCT01698554|163872|P3|STARTED|Overall Study||75
68497|NCT01698554|163873|P2|STARTED|Overall Study||157
68498|NCT01698554|163874|P1|STARTED|Overall Study||153
68499|NCT01698528|163902|P2|NOT COMPLETED|Overall Study||4
68500|NCT01698528|163903|P1|NOT COMPLETED|Overall Study||1
68501|NCT01698528|163902|P2|COMPLETED|Overall Study||16
68502|NCT01698528|163903|P1|COMPLETED|Overall Study||19
68503|NCT01698528|163902|P2|STARTED|Overall Study||20
68504|NCT01698528|163903|P1|STARTED|Overall Study||20
68505|NCT01698502|163919|P2|NOT COMPLETED|Overall Study||0
68506|NCT01698502|163920|P1|NOT COMPLETED|Overall Study||0
68507|NCT01698502|163919|P2|COMPLETED|Overall Study||10
68508|NCT01698502|163920|P1|COMPLETED|Overall Study||11
68509|NCT01698502|163919|P2|STARTED|Overall Study||10
68510|NCT01698502|163920|P1|STARTED|Overall Study||11
68511|NCT01698320|163930|P3|NOT COMPLETED|40-Week Open-Label Period||10
68512|NCT01698320|163931|P2|NOT COMPLETED|40-Week Open-Label Period||19
68513|NCT01698320|163932|P1|NOT COMPLETED|40-Week Open-Label Period||0
68514|NCT01698320|163930|P3|COMPLETED|40-Week Open-Label Period||146
68515|NCT01698320|163931|P2|COMPLETED|40-Week Open-Label Period||146
68516|NCT01698320|163932|P1|COMPLETED|40-Week Open-Label Period||0
68517|NCT01698320|163930|P3|STARTED|40-Week Open-Label Period||156
68518|NCT01698320|163931|P2|STARTED|40-Week Open-Label Period||165
68519|NCT01698320|163932|P1|STARTED|40-Week Open-Label Period||0
68520|NCT01698320|163930|P3|NOT COMPLETED|12-Week Double-Blind Period||12
68521|NCT01698320|163931|P2|NOT COMPLETED|12-Week Double-Blind Period||4
68522|NCT01698320|163932|P1|NOT COMPLETED|12-Week Double-Blind Period||0
68523|NCT01698320|163930|P3|COMPLETED|12-Week Double-Blind Period||156
68524|NCT01698320|163931|P2|COMPLETED|12-Week Double-Blind Period||165
68525|NCT01698320|163932|P1|COMPLETED|12-Week Double-Blind Period||0
68526|NCT01698320|163930|P3|Safety Population|12-Week Double-Blind Period||168
68527|NCT01698320|163931|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
68528|NCT01698320|163932|P1|Safety Population|12-Week Double-Blind Period||0
68529|NCT01698320|163930|P3|STARTED|12-Week Double-Blind Period||168
68530|NCT01698320|163931|P2|STARTED|12-Week Double-Blind Period||169
68531|NCT01698320|163932|P1|STARTED|12-Week Double-Blind Period||0
68532|NCT01698320|163930|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
68533|NCT01698320|163931|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
68534|NCT01698320|163932|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
68535|NCT01698320|163930|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
68536|NCT01698320|163931|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
68537|NCT01698320|163932|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
68538|NCT01698320|163930|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
68539|NCT01698320|163931|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
68540|NCT01698320|163932|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
68541|NCT01698268|163952|P2|NOT COMPLETED|Overall Study||1
68542|NCT01698268|163953|P1|NOT COMPLETED|Overall Study||2
68543|NCT01698268|163952|P2|COMPLETED|Overall Study||24
68544|NCT01698268|163953|P1|COMPLETED|Overall Study||23
68545|NCT01698268|163952|P2|STARTED|Overall Study||25
68546|NCT01698268|163953|P1|STARTED|Overall Study||25
68547|NCT01697969|163959|P1|NOT COMPLETED|Overall Study||3
68548|NCT01697969|163959|P1|COMPLETED|Overall Study||10
68549|NCT01697969|163959|P1|STARTED|Overall Study||13
68550|NCT01697956|163966|P2|NOT COMPLETED|Overall Study||1
68551|NCT01697956|163967|P1|NOT COMPLETED|Overall Study||1
68552|NCT01697956|163966|P2|COMPLETED|Overall Study||31
68553|NCT01697956|163967|P1|COMPLETED|Overall Study||66
68554|NCT01697956|163966|P2|Per Protocol Population|Overall Study||31
68555|NCT01697956|163967|P1|Per Protocol Population|Overall Study||66
68556|NCT01697956|163966|P2|STARTED|Overall Study|enrolled and randomized|32
68557|NCT01697956|163967|P1|STARTED|Overall Study|enrolled and randomized|67
68558|NCT01697696|163997|P2|NOT COMPLETED|Overall Study||47
68559|NCT01697696|163998|P1|NOT COMPLETED|Overall Study||47
68560|NCT01697696|163997|P2|COMPLETED|Overall Study||210
68561|NCT01697696|163998|P1|COMPLETED|Overall Study||207
68562|NCT01697696|163997|P2|Full Analysis Set (FAS)|Overall Study||255
68563|NCT01697696|163998|P1|Full Analysis Set (FAS)|Overall Study||251
68564|NCT01697696|163997|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
68565|NCT01697696|163998|P1|Safety Set|Overall Study||251
68566|NCT01697696|163997|P2|STARTED|Overall Study||257
68567|NCT01697696|163998|P1|STARTED|Overall Study||254
68568|NCT01697592|164030|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
68569|NCT01697592|164031|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
68570|NCT01697592|164032|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
68571|NCT01697592|164033|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
68572|NCT01697592|164034|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
68573|NCT01697592|164035|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
68574|NCT01697592|164036|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
68575|NCT01697592|164037|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
68576|NCT01697592|164038|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
68577|NCT01697592|164039|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
68578|NCT01697592|164030|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
68579|NCT01697592|164031|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
68580|NCT01697592|164032|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
68581|NCT01697592|164033|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
68582|NCT01697592|164034|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
68583|NCT01697592|164035|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
68584|NCT01697592|164036|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
68585|NCT01697592|164037|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
68586|NCT01697592|164038|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
68587|NCT01697592|164039|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
68588|NCT01697592|164030|P10|STARTED|Phase B (Week 25 to Week 52)||30
68589|NCT01697592|164031|P9|STARTED|Phase B (Week 25 to Week 52)||34
68590|NCT01697592|164032|P8|STARTED|Phase B (Week 25 to Week 52)||33
68591|NCT01697592|164033|P7|STARTED|Phase B (Week 25 to Week 52)||32
68592|NCT01697592|164034|P6|STARTED|Phase B (Week 25 to Week 52)||62
68593|NCT01697592|164035|P5|STARTED|Phase B (Week 25 to Week 52)||67
68594|NCT01697592|164036|P4|STARTED|Phase B (Week 25 to Week 52)||63
68595|NCT01697592|164037|P3|STARTED|Phase B (Week 25 to Week 52)||65
68596|NCT01697592|164038|P2|STARTED|Phase B (Week 25 to Week 52)||62
68597|NCT01697592|164039|P1|STARTED|Phase B (Week 25 to Week 52)||123
68598|NCT01697592|164030|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
68599|NCT01697592|164031|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
68600|NCT01697592|164032|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
68601|NCT01697592|164033|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
68602|NCT01697592|164034|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
68603|NCT01697592|164035|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
68604|NCT01697592|164036|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
68605|NCT01697592|164037|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
68606|NCT01697592|164038|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
68607|NCT01697592|164039|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
68608|NCT01697592|164030|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
68609|NCT01697592|164031|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
68610|NCT01697592|164032|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
68611|NCT01697592|164033|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
68612|NCT01697592|164034|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
68613|NCT01697592|164035|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
68614|NCT01697592|164036|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
68615|NCT01697592|164037|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
68616|NCT01697592|164038|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
68617|NCT01697592|164039|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
68618|NCT01697592|164030|P10|STARTED|Phase A (Up to 24 Weeks)||32
68619|NCT01697592|164031|P9|STARTED|Phase A (Up to 24 Weeks)||34
68620|NCT01697592|164032|P8|STARTED|Phase A (Up to 24 Weeks)||33
68621|NCT01697592|164033|P7|STARTED|Phase A (Up to 24 Weeks)||34
68622|NCT01697592|164034|P6|STARTED|Phase A (Up to 24 Weeks)||63
68623|NCT01697592|164035|P5|STARTED|Phase A (Up to 24 Weeks)||67
68624|NCT01697592|164036|P4|STARTED|Phase A (Up to 24 Weeks)||65
68625|NCT01697592|164037|P3|STARTED|Phase A (Up to 24 Weeks)||66
68626|NCT01697592|164038|P2|STARTED|Phase A (Up to 24 Weeks)||65
68627|NCT01697592|164039|P1|STARTED|Phase A (Up to 24 Weeks)||126
68628|NCT01697579|164108|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
68629|NCT01697579|164109|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
68630|NCT01697579|164110|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
68631|NCT01697579|164111|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
68632|NCT01697579|164112|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
68633|NCT01697579|164113|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
68634|NCT01697579|164114|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
68635|NCT01697579|164108|P7|COMPLETED|Optional Extension-Cycles 2-6||37
68636|NCT01697579|164109|P6|COMPLETED|Optional Extension-Cycles 2-6||12
68637|NCT01697579|164110|P5|COMPLETED|Optional Extension-Cycles 2-6||0
68638|NCT01697579|164111|P4|COMPLETED|Optional Extension-Cycles 2-6||0
68639|NCT01697579|164112|P3|COMPLETED|Optional Extension-Cycles 2-6||0
68640|NCT01697579|164113|P2|COMPLETED|Optional Extension-Cycles 2-6||0
68641|NCT01697579|164114|P1|COMPLETED|Optional Extension-Cycles 2-6||0
68642|NCT01697579|164108|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
68643|NCT01697579|164109|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
68644|NCT01697579|164110|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
68645|NCT01697579|164111|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
68646|NCT01697579|164112|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
68647|NCT01697579|164113|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
68648|NCT01697579|164114|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
68649|NCT01697579|164108|P7|NOT COMPLETED|Base Study-Cycle 1||0
68650|NCT01697579|164109|P6|NOT COMPLETED|Base Study-Cycle 1||0
68651|NCT01697579|164110|P5|NOT COMPLETED|Base Study-Cycle 1||3
68652|NCT01697579|164111|P4|NOT COMPLETED|Base Study-Cycle 1||1
68653|NCT01697579|164112|P3|NOT COMPLETED|Base Study-Cycle 1||1
68654|NCT01697579|164113|P2|NOT COMPLETED|Base Study-Cycle 1||1
68655|NCT01697579|164114|P1|NOT COMPLETED|Base Study-Cycle 1||2
68656|NCT01697579|164108|P7|COMPLETED|Base Study-Cycle 1||0
68657|NCT01697579|164109|P6|COMPLETED|Base Study-Cycle 1||0
68658|NCT01697579|164110|P5|COMPLETED|Base Study-Cycle 1||35
68659|NCT01697579|164111|P4|COMPLETED|Base Study-Cycle 1||40
68660|NCT01697579|164112|P3|COMPLETED|Base Study-Cycle 1||43
68661|NCT01697579|164113|P2|COMPLETED|Base Study-Cycle 1||42
68662|NCT01697579|164114|P1|COMPLETED|Base Study-Cycle 1||72
68663|NCT01697579|164108|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
68664|NCT01697579|164109|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
68665|NCT01697579|164110|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
68666|NCT01697579|164111|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
68667|NCT01697579|164112|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
68668|NCT01697579|164113|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
68669|NCT01697579|164114|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
68670|NCT01697501|164226|P1|NOT COMPLETED|Overall Study||2
68671|NCT01697501|164226|P1|COMPLETED|Overall Study||86
68672|NCT01697501|164226|P1|STARTED|Overall Study||88
68673|NCT01697462|164269|P1|NOT COMPLETED|Overall Study||77
68674|NCT01697462|164269|P1|COMPLETED|Overall Study||181
68675|NCT01697462|164269|P1|STARTED|Overall Study||258
68676|NCT01697449|164276|P1|NOT COMPLETED|Overall Study||90
68677|NCT01697449|164276|P1|COMPLETED|Overall Study||101
68678|NCT01697449|164276|P1|STARTED|Overall Study||191
68679|NCT01697358|164287|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
68680|NCT01697358|164288|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
68681|NCT01697358|164287|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
68682|NCT01697358|164288|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
68683|NCT01697358|164287|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
68684|NCT01697358|164288|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
68685|NCT01697358|164287|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
68686|NCT01697358|164288|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
68687|NCT01697358|164287|P2|COMPLETED|Period I: Randomization to 6 Months||107
68688|NCT01697358|164288|P1|COMPLETED|Period I: Randomization to 6 Months||97
68689|NCT01697358|164287|P2|STARTED|Period I: Randomization to 6 Months||108
68690|NCT01697358|164288|P1|STARTED|Period I: Randomization to 6 Months||110
68691|NCT01697345|164304|P1|NOT COMPLETED|Overall Study||1
68692|NCT01697345|164304|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
68693|NCT01697345|164304|P1|STARTED|Overall Study||13
68694|NCT01697332|164323|P1|NOT COMPLETED|Overall Study||0
68695|NCT01697332|164323|P1|COMPLETED|Overall Study||1
68696|NCT01697332|164323|P1|STARTED|Overall Study||1
68697|NCT01697319|164329|P1|NOT COMPLETED|Extension Phase||15
68698|NCT01697319|164329|P1|COMPLETED|Extension Phase||0
68699|NCT01697319|164329|P1|STARTED|Extension Phase||15
68700|NCT01697319|164329|P1|NOT COMPLETED|Primary Phase||1
68701|NCT01697319|164329|P1|COMPLETED|Primary Phase||15
68702|NCT01697319|164329|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
68703|NCT01696994|164338|P2|NOT COMPLETED|Overall Study||8437
68704|NCT01696994|164339|P1|NOT COMPLETED|Overall Study||5192
68705|NCT01696994|164338|P2|COMPLETED|Overall Study||30668
68706|NCT01696994|164339|P1|COMPLETED|Overall Study||33919
68707|NCT01696994|164338|P2|STARTED|Overall Study||39105
68708|NCT01696994|164339|P1|STARTED|Overall Study||39111
68709|NCT01696981|164367|P2|NOT COMPLETED|Overall Study||10374
68710|NCT01696981|164368|P1|NOT COMPLETED|Overall Study||1201
68711|NCT01696981|164367|P2|COMPLETED|Overall Study||67071
68712|NCT01696981|164368|P1|COMPLETED|Overall Study||76254
68713|NCT01696981|164367|P2|STARTED|Overall Study||77445
68714|NCT01696981|164368|P1|STARTED|Overall Study||77455
68715|NCT01696968|164388|P2|NOT COMPLETED|Overall Study||6812
68716|NCT01696968|164389|P1|NOT COMPLETED|Overall Study||1201
68717|NCT01696968|164388|P2|COMPLETED|Overall Study||70633
68718|NCT01696968|164389|P1|COMPLETED|Overall Study||76255
68719|NCT01696968|164388|P2|STARTED|Overall Study||77445
68720|NCT01696968|164389|P1|STARTED|Overall Study||77456
68721|NCT01696942|164411|P2|NOT COMPLETED|Overall Study||3
68722|NCT01696942|164412|P1|NOT COMPLETED|Overall Study||2
68723|NCT01696942|164411|P2|COMPLETED|Overall Study||2
68724|NCT01696942|164412|P1|COMPLETED|Overall Study||3
68725|NCT01696942|164411|P2|STARTED|Overall Study||5
68726|NCT01696942|164412|P1|STARTED|Overall Study||5
68727|NCT01696929|164420|P1|NOT COMPLETED|Overall Study||1
68728|NCT01696929|164420|P1|COMPLETED|Overall Study||5
68729|NCT01696929|164420|P1|STARTED|Overall Study||6
68730|NCT01696773|164427|P2|NOT COMPLETED|Day 28, Second Intervention||0
68731|NCT01696773|164428|P1|NOT COMPLETED|Day 28, Second Intervention||0
68732|NCT01696773|164427|P2|COMPLETED|Day 28, Second Intervention||6
68733|NCT01696773|164428|P1|COMPLETED|Day 28, Second Intervention||5
68734|NCT01696773|164427|P2|STARTED|Day 28, Second Intervention||6
68735|NCT01696773|164428|P1|STARTED|Day 28, Second Intervention||5
68736|NCT01696773|164427|P2|NOT COMPLETED|Days 15-27, Washout||0
68737|NCT01696773|164428|P1|NOT COMPLETED|Days 15-27, Washout||1
68738|NCT01696773|164427|P2|COMPLETED|Days 15-27, Washout||6
68739|NCT01696773|164428|P1|COMPLETED|Days 15-27, Washout||5
68740|NCT01696773|164427|P2|STARTED|Days 15-27, Washout||6
68741|NCT01696773|164428|P1|STARTED|Days 15-27, Washout||6
68742|NCT01696773|164427|P2|NOT COMPLETED|Day 14, First Intervention||0
68743|NCT01696773|164428|P1|NOT COMPLETED|Day 14, First Intervention||0
68744|NCT01696773|164427|P2|COMPLETED|Day 14, First Intervention||6
68745|NCT01696773|164428|P1|COMPLETED|Day 14, First Intervention||6
68746|NCT01696773|164427|P2|STARTED|Day 14, First Intervention||6
68747|NCT01696773|164428|P1|STARTED|Day 14, First Intervention||6
68748|NCT01696773|164427|P2|NOT COMPLETED|Days 1-13, Washout||0
68749|NCT01696773|164428|P1|NOT COMPLETED|Days 1-13, Washout||0
68750|NCT01696773|164427|P2|COMPLETED|Days 1-13, Washout||6
68751|NCT01696773|164428|P1|COMPLETED|Days 1-13, Washout||6
68752|NCT01696773|164427|P2|STARTED|Days 1-13, Washout||6
68753|NCT01696773|164428|P1|STARTED|Days 1-13, Washout||6
68754|NCT01696760|164436|P2|NOT COMPLETED|Overall Study||0
68755|NCT01696760|164437|P1|NOT COMPLETED|Overall Study||0
68756|NCT01696760|164436|P2|COMPLETED|Overall Study||3
68757|NCT01696760|164437|P1|COMPLETED|Overall Study||9
68758|NCT01696760|164436|P2|STARTED|Overall Study||3
68759|NCT01696760|164437|P1|STARTED|Overall Study||9
68760|NCT01696695|164455|P1|NOT COMPLETED|Overall Study||882
68761|NCT01696695|164455|P1|COMPLETED|Overall Study||0
68762|NCT01696695|164455|P1|STARTED|Overall Study||882
68763|NCT01696643|164467|P2|NOT COMPLETED|Overall Study||535
68764|NCT01696643|164468|P1|NOT COMPLETED|Overall Study||529
68765|NCT01696643|164467|P2|COMPLETED|Overall Study||169
68766|NCT01696643|164468|P1|COMPLETED|Overall Study||174
68767|NCT01696643|164467|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
68768|NCT01696643|164468|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
68769|NCT01696643|164467|P2|STARTED|Overall Study||704
68770|NCT01696643|164468|P1|STARTED|Overall Study||703
68771|NCT01696357|164485|P2|NOT COMPLETED|Overall Study||1
68772|NCT01696357|164486|P1|NOT COMPLETED|Overall Study||2
68773|NCT01696357|164485|P2|COMPLETED|Overall Study||41
68774|NCT01696357|164486|P1|COMPLETED|Overall Study||40
68775|NCT01696357|164485|P2|STARTED|Overall Study||42
68776|NCT01696357|164486|P1|STARTED|Overall Study||42
68777|NCT01696214|164496|P4|NOT COMPLETED|Overall Study||0
68778|NCT01696214|164497|P3|NOT COMPLETED|Overall Study||0
68779|NCT01696214|164498|P2|NOT COMPLETED|Overall Study||1
68780|NCT01696214|164499|P1|NOT COMPLETED|Overall Study||0
68781|NCT01696214|164496|P4|COMPLETED|Overall Study||5
68782|NCT01696214|164497|P3|COMPLETED|Overall Study||5
68783|NCT01696214|164498|P2|COMPLETED|Overall Study||4
68784|NCT01696214|164499|P1|COMPLETED|Overall Study||5
68785|NCT01696214|164496|P4|STARTED|Overall Study||5
68786|NCT01696214|164497|P3|STARTED|Overall Study||5
68787|NCT01696214|164498|P2|STARTED|Overall Study||5
68788|NCT01696214|164499|P1|STARTED|Overall Study||5
68789|NCT01696188|164511|P2|NOT COMPLETED|Overall Study||1
68790|NCT01696188|164512|P1|NOT COMPLETED|Overall Study||1
68791|NCT01696188|164511|P2|COMPLETED|Overall Study||42
68792|NCT01696188|164512|P1|COMPLETED|Overall Study||40
68793|NCT01696188|164511|P2|STARTED|Overall Study||43
68794|NCT01696188|164512|P1|STARTED|Overall Study||41
68795|NCT01696084|164526|P2|NOT COMPLETED|Overall Study||146
68796|NCT01696084|164527|P1|NOT COMPLETED|Overall Study||131
68797|NCT01696084|164526|P2|COMPLETED|Overall Study||10
68798|NCT01696084|164527|P1|COMPLETED|Overall Study||22
68799|NCT01696084|164526|P2|STARTED|Overall Study||156
68800|NCT01696084|164527|P1|STARTED|Overall Study||153
68801|NCT01696071|164543|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
68802|NCT01696071|164544|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
68803|NCT01696071|164543|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
68804|NCT01696071|164544|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
68805|NCT01696071|164543|P2|STARTED|Treatment Period 2: 4 Weeks||47
68806|NCT01696071|164544|P1|STARTED|Treatment Period 2: 4 Weeks||51
68807|NCT01696071|164543|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
68808|NCT01696071|164544|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
68809|NCT01696071|164543|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
68810|NCT01696071|164544|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
68811|NCT01696071|164543|P2|STARTED|Treatment Period 1: 4 Weeks||47
68812|NCT01696071|164544|P1|STARTED|Treatment Period 1: 4 Weeks||51
68813|NCT01696058|164572|P2|NOT COMPLETED|Overall Study||31
68814|NCT01696058|164573|P1|NOT COMPLETED|Overall Study||43
68815|NCT01696058|164572|P2|COMPLETED|Overall Study||538
68816|NCT01696058|164573|P1|COMPLETED|Overall Study||523
68817|NCT01696058|164572|P2|STARTED|Overall Study||569
68818|NCT01696058|164573|P1|STARTED|Overall Study||566
68819|NCT01696045|164601|P2|NOT COMPLETED|Overall Study||7
68820|NCT01696045|164602|P1|NOT COMPLETED|Overall Study||3
68821|NCT01696045|164601|P2|COMPLETED|Overall Study||1
68822|NCT01696045|164602|P1|COMPLETED|Overall Study||1
68823|NCT01696045|164601|P2|STARTED|Overall Study||8
68824|NCT01696045|164602|P1|STARTED|Overall Study||4
68825|NCT01695993|164621|P3|NOT COMPLETED|Overall Study||6
68826|NCT01695993|164622|P2|NOT COMPLETED|Overall Study||5
68827|NCT01695993|164623|P1|NOT COMPLETED|Overall Study||5
68828|NCT01695993|164621|P3|COMPLETED|Overall Study||75
68829|NCT01695993|164622|P2|COMPLETED|Overall Study||75
68830|NCT01695993|164623|P1|COMPLETED|Overall Study||76
68831|NCT01695993|164621|P3|STARTED|Overall Study||81
68832|NCT01695993|164622|P2|STARTED|Overall Study||80
68833|NCT01695993|164623|P1|STARTED|Overall Study||81
68834|NCT01695772|164631|P1|NOT COMPLETED|Overall Study||38
68835|NCT01695772|164631|P1|COMPLETED|Overall Study||12
68836|NCT01695772|164631|P1|STARTED|Overall Study||50
68837|NCT01695746|164643|P1|NOT COMPLETED|Overall Study||12
68838|NCT01695746|164643|P1|COMPLETED|Overall Study||96
68839|NCT01695746|164643|P1|STARTED|Overall Study||108
68840|NCT01695668|164659|P2|NOT COMPLETED|Overall Study||17
68841|NCT01695668|164660|P1|NOT COMPLETED|Overall Study||15
68842|NCT01695668|164659|P2|COMPLETED|Overall Study||20
68843|NCT01695668|164660|P1|COMPLETED|Overall Study||23
68844|NCT01695668|164659|P2|STARTED|Overall Study||37
68845|NCT01695668|164660|P1|STARTED|Overall Study||38
68846|NCT01695369|164666|P1|NOT COMPLETED|Overall Study||0
68847|NCT01695369|164666|P1|COMPLETED|Overall Study||61
68848|NCT01695369|164666|P1|STARTED|Overall Study||61
68849|NCT01695330|164672|P2|NOT COMPLETED|Overall Study||0
68850|NCT01695330|164673|P1|NOT COMPLETED|Overall Study||47
68851|NCT01695330|164672|P2|COMPLETED|Overall Study||0
68852|NCT01695330|164673|P1|COMPLETED|Overall Study||5
68853|NCT01695330|164672|P2|STARTED|Overall Study||0
68854|NCT01695330|164673|P1|STARTED|Overall Study||52
68855|NCT01695304|164679|P2|NOT COMPLETED|Overall Study||0
68856|NCT01695304|164680|P1|NOT COMPLETED|Overall Study||0
68857|NCT01695304|164679|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
68858|NCT01695304|164680|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
68859|NCT01695304|164679|P2|STARTED|Overall Study||120
68860|NCT01695304|164680|P1|STARTED|Overall Study||120
68861|NCT01695239|164692|P4|NOT COMPLETED|Overall Study||6
68862|NCT01695239|164693|P3|NOT COMPLETED|Overall Study||10
68863|NCT01695239|164694|P2|NOT COMPLETED|Overall Study||4
68864|NCT01695239|164695|P1|NOT COMPLETED|Overall Study||15
68865|NCT01695239|164692|P4|COMPLETED|Overall Study||97
68866|NCT01695239|164693|P3|COMPLETED|Overall Study||97
68867|NCT01695239|164694|P2|COMPLETED|Overall Study||97
68868|NCT01695239|164695|P1|COMPLETED|Overall Study||91
68869|NCT01695239|164692|P4|Classified as Inadequate Responder (IR)|Overall Study||10
68870|NCT01695239|164693|P3|Classified as Inadequate Responder (IR)|Overall Study||11
68871|NCT01695239|164694|P2|Classified as Inadequate Responder (IR)|Overall Study||9
68872|NCT01695239|164695|P1|Classified as Inadequate Responder (IR)|Overall Study||27
68873|NCT01695239|164692|P4|Received at Least 1 Dose of Study Drug|Overall Study||102
68874|NCT01695239|164693|P3|Received at Least 1 Dose of Study Drug|Overall Study||107
68875|NCT01695239|164694|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
68876|NCT01695239|164695|P1|Received at Least 1 Dose of Study Drug|Overall Study||106
68877|NCT01695239|164692|P4|STARTED|Overall Study||103
68878|NCT01695239|164693|P3|STARTED|Overall Study||107
68879|NCT01695239|164694|P2|STARTED|Overall Study||101
68880|NCT01695239|164695|P1|STARTED|Overall Study||106
68881|NCT01695044|164786|P1|NOT COMPLETED|Overall Study||102
68882|NCT01695044|164786|P1|COMPLETED|Overall Study||17
68883|NCT01695044|164786|P1|STARTED|Overall Study||119
68884|NCT01694966|164799|P3|NOT COMPLETED|Overall Study||34
68885|NCT01694966|164800|P2|NOT COMPLETED|Overall Study||15
68886|NCT01694966|164801|P1|NOT COMPLETED|Overall Study||34
68887|NCT01694966|164799|P3|COMPLETED|Overall Study||464
68888|NCT01694966|164800|P2|COMPLETED|Overall Study||232
68889|NCT01694966|164801|P1|COMPLETED|Overall Study||470
68890|NCT01694966|164799|P3|STARTED|Overall Study||498
68891|NCT01694966|164800|P2|STARTED|Overall Study||247
68892|NCT01694966|164801|P1|STARTED|Overall Study||504
68893|NCT01694771|164811|P2|NOT COMPLETED|Overall Study||40
68894|NCT01694771|164812|P1|NOT COMPLETED|Overall Study||40
68895|NCT01694771|164811|P2|COMPLETED|Overall Study||525
68896|NCT01694771|164812|P1|COMPLETED|Overall Study||527
68897|NCT01694771|164811|P2|STARTED|Overall Study||565
68898|NCT01694771|164812|P1|STARTED|Overall Study||567
68899|NCT01694706|164836|P3|NOT COMPLETED|Overall Study||0
68900|NCT01694706|164837|P2|NOT COMPLETED|Overall Study||1
68901|NCT01694706|164838|P1|NOT COMPLETED|Overall Study||1
68902|NCT01694706|164836|P3|COMPLETED|Overall Study||5
68903|NCT01694706|164837|P2|COMPLETED|Overall Study||4
68904|NCT01694706|164838|P1|COMPLETED|Overall Study||4
68905|NCT01694706|164836|P3|Received Faldaprevir Fed|Overall Study||5
68906|NCT01694706|164837|P2|Received Faldaprevir Fed|Overall Study||5
68907|NCT01694706|164838|P1|Received Faldaprevir Fed|Overall Study||4
68908|NCT01694706|164836|P3|Received Faldaprevir +OMP|Overall Study||5
68909|NCT01694706|164837|P2|Received Faldaprevir +OMP|Overall Study||5
68910|NCT01694706|164838|P1|Received Faldaprevir +OMP|Overall Study||5
68911|NCT01694706|164836|P3|Received Faldaprevir|Overall Study||5
68912|NCT01694706|164837|P2|Received Faldaprevir|Overall Study||5
68913|NCT01694706|164838|P1|Received Faldaprevir|Overall Study||5
68914|NCT01694706|164836|P3|STARTED|Overall Study||5
68915|NCT01694706|164837|P2|STARTED|Overall Study||5
68916|NCT01694706|164838|P1|STARTED|Overall Study||5
68917|NCT01694667|164855|P2|NOT COMPLETED|Overall Study||0
68918|NCT01694667|164856|P1|NOT COMPLETED|Overall Study||0
68919|NCT01694667|164855|P2|COMPLETED|Overall Study||28
68920|NCT01694667|164856|P1|COMPLETED|Overall Study||29
68921|NCT01694667|164855|P2|STARTED|Overall Study||28
68922|NCT01694667|164856|P1|STARTED|Overall Study||29
68923|NCT01694641|164874|P2|NOT COMPLETED|Overall Study||10
68924|NCT01694641|164875|P1|NOT COMPLETED|Overall Study||12
68925|NCT01694641|164874|P2|COMPLETED|Overall Study||71
68926|NCT01694641|164875|P1|COMPLETED|Overall Study||68
68927|NCT01694641|164874|P2|STARTED|Overall Study||81
68928|NCT01694641|164875|P1|STARTED|Overall Study||80
68929|NCT01694420|164883|P1|NOT COMPLETED|Overall Study||3
68930|NCT01694420|164883|P1|COMPLETED|Overall Study||30
68931|NCT01694420|164883|P1|STARTED|Overall Study||33
68932|NCT01694199|164894|P2|NOT COMPLETED|Overall Study||0
68933|NCT01694199|164895|P1|NOT COMPLETED|Overall Study||0
68934|NCT01694199|164894|P2|COMPLETED|Overall Study||68
68935|NCT01694199|164895|P1|COMPLETED|Overall Study||71
68936|NCT01694199|164894|P2|STARTED|Overall Study||68
68937|NCT01694199|164895|P1|STARTED|Overall Study||71
68938|NCT01694108|164911|P2|NOT COMPLETED|Overall Study||0
68939|NCT01694108|164912|P1|NOT COMPLETED|Overall Study||0
68940|NCT01694108|164911|P2|COMPLETED|Overall Study|100% follow-up|2133
68941|NCT01694108|164912|P1|COMPLETED|Overall Study|100% follow-up|2129
68942|NCT01694108|164911|P2|STARTED|Overall Study||2133
68943|NCT01694108|164912|P1|STARTED|Overall Study||2129
68944|NCT01693900|164968|P2|NOT COMPLETED|Overall Study||0
68945|NCT01693900|164969|P1|NOT COMPLETED|Overall Study||0
68946|NCT01693900|164968|P2|COMPLETED|Overall Study||25
68947|NCT01693900|164969|P1|COMPLETED|Overall Study||25
68948|NCT01693900|164968|P2|STARTED|Overall Study||25
68949|NCT01693900|164969|P1|STARTED|Overall Study||25
68950|NCT01693653|164983|P2|NOT COMPLETED|Overall Study||0
68951|NCT01693653|164984|P1|NOT COMPLETED|Overall Study||0
68952|NCT01693653|164983|P2|COMPLETED|Overall Study||0
68953|NCT01693653|164984|P1|COMPLETED|Overall Study||1
68954|NCT01693653|164983|P2|STARTED|Overall Study||0
68955|NCT01693653|164984|P1|STARTED|Overall Study||1
68956|NCT01693484|165008|P1|NOT COMPLETED|Overall Study||13
68957|NCT01693484|165008|P1|COMPLETED|Overall Study|Study closed by PI|0
68958|NCT01693484|165008|P1|STARTED|Overall Study||13
68959|NCT01693367|165014|P2|NOT COMPLETED|Overall Study||2
68960|NCT01693367|165015|P1|NOT COMPLETED|Overall Study||1
68961|NCT01693367|165014|P2|COMPLETED|Overall Study||1
68962|NCT01693367|165015|P1|COMPLETED|Overall Study||1
68963|NCT01693367|165014|P2|STARTED|Overall Study||3
68964|NCT01693367|165015|P1|STARTED|Overall Study||2
68965|NCT01693185|165033|P2|NOT COMPLETED|Overall Study||6
68966|NCT01693185|165034|P1|NOT COMPLETED|Overall Study||0
68967|NCT01693185|165033|P2|COMPLETED|Overall Study||27
68968|NCT01693185|165034|P1|COMPLETED|Overall Study||27
68969|NCT01693185|165033|P2|STARTED|Overall Study||33
68970|NCT01693185|165034|P1|STARTED|Overall Study||27
68971|NCT01693120|165050|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
68972|NCT01693120|165050|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
68973|NCT01693120|165050|P1|STARTED|Phased RF Study Procedure and Follow-up||129
68974|NCT01693120|165050|P1|NOT COMPLETED|Enrollment||70
68975|NCT01693120|165050|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
68976|NCT01693120|165050|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
68977|NCT01693068|165059|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
68978|NCT01693068|165060|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
68979|NCT01693068|165061|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
68980|NCT01693068|165059|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
68981|NCT01693068|165060|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
68982|NCT01693068|165061|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
68983|NCT01693068|165059|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
68984|NCT01693068|165060|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
68985|NCT01693068|165061|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
68986|NCT01693068|165059|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
68987|NCT01693068|165060|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
68988|NCT01693068|165061|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
68989|NCT01693068|165059|P3|NOT COMPLETED|Randomization Period||0
68990|NCT01693068|165060|P2|NOT COMPLETED|Randomization Period||5
68991|NCT01693068|165061|P1|NOT COMPLETED|Randomization Period||2
68992|NCT01693068|165059|P3|COMPLETED|Randomization Period||0
68993|NCT01693068|165060|P2|COMPLETED|Randomization Period||125
68994|NCT01693068|165061|P1|COMPLETED|Randomization Period||62
68995|NCT01693068|165059|P3|Treated|Randomization Period||0
68996|NCT01693068|165060|P2|Treated|Randomization Period||130
68997|NCT01693068|165061|P1|Treated|Randomization Period||61
68998|NCT01693068|165059|P3|STARTED|Randomization Period||0
68999|NCT01693068|165060|P2|STARTED|Randomization Period||130
69000|NCT01693068|165061|P1|STARTED|Randomization Period||64
69001|NCT01693029|165093|P2|NOT COMPLETED|Overall Study||57
69002|NCT01693029|165094|P1|NOT COMPLETED|Overall Study||44
69003|NCT01693029|165093|P2|COMPLETED|Overall Study||161
69004|NCT01693029|165094|P1|COMPLETED|Overall Study||173
69005|NCT01693029|165093|P2|STARTED|Overall Study||218
69006|NCT01693029|165094|P1|STARTED|Overall Study||217
69007|NCT01692951|165110|P4|NOT COMPLETED|Overall Study||0
69008|NCT01692951|165111|P3|NOT COMPLETED|Overall Study||0
69009|NCT01692951|165112|P2|NOT COMPLETED|Overall Study||0
69010|NCT01692951|165113|P1|NOT COMPLETED|Overall Study||0
69011|NCT01692951|165110|P4|COMPLETED|Overall Study||54
69012|NCT01692951|165111|P3|COMPLETED|Overall Study||18
69013|NCT01692951|165112|P2|COMPLETED|Overall Study||111
69014|NCT01692951|165113|P1|COMPLETED|Overall Study||37
69015|NCT01692951|165110|P4|STARTED|Overall Study||54
69016|NCT01692951|165111|P3|STARTED|Overall Study||18
69017|NCT01692951|165112|P2|STARTED|Overall Study||111
69018|NCT01692951|165113|P1|STARTED|Overall Study||37
69019|NCT01692938|165125|P2|NOT COMPLETED|Overall Study||4
69020|NCT01692938|165126|P1|NOT COMPLETED|Overall Study||4
69021|NCT01692938|165125|P2|COMPLETED|Overall Study||12
69022|NCT01692938|165126|P1|COMPLETED|Overall Study||12
69023|NCT01692938|165125|P2|STARTED|Overall Study||16
69024|NCT01692938|165126|P1|STARTED|Overall Study||16
69025|NCT01692782|165137|P3|NOT COMPLETED|Overall Study||10
69026|NCT01692782|165138|P2|NOT COMPLETED|Overall Study||56
69027|NCT01692782|165139|P1|NOT COMPLETED|Overall Study||20
69028|NCT01692782|165137|P3|COMPLETED|Overall Study||100
69029|NCT01692782|165138|P2|COMPLETED|Overall Study||59
69030|NCT01692782|165139|P1|COMPLETED|Overall Study||96
69031|NCT01692782|165137|P3|STARTED|Overall Study||110
69032|NCT01692782|165138|P2|STARTED|Overall Study||115
69033|NCT01692782|165139|P1|STARTED|Overall Study||116
69034|NCT01692730|165164|P2|NOT COMPLETED|Overall Study||227
69035|NCT01692730|165165|P1|NOT COMPLETED|Overall Study||225
69036|NCT01692730|165164|P2|COMPLETED|Overall Study||502
69037|NCT01692730|165165|P1|COMPLETED|Overall Study||498
69038|NCT01692730|165164|P2|STARTED|Overall Study||729
69039|NCT01692730|165165|P1|STARTED|Overall Study||723
69040|NCT01692691|165173|P1|NOT COMPLETED|Overall Study||0
69041|NCT01692691|165173|P1|COMPLETED|Overall Study||1
69042|NCT01692691|165173|P1|STARTED|Overall Study||1
69043|NCT01692626|165179|P2|NOT COMPLETED|Overall Study||6
69044|NCT01692626|165180|P1|NOT COMPLETED|Overall Study||4
69045|NCT01692626|165179|P2|COMPLETED|Overall Study||1
69046|NCT01692626|165180|P1|COMPLETED|Overall Study||2
69047|NCT01692626|165179|P2|STARTED|Overall Study||7
69048|NCT01692626|165180|P1|STARTED|Overall Study||6
69049|NCT01692340|165188|P3|NOT COMPLETED|Overall Study||0
69050|NCT01692340|165189|P2|NOT COMPLETED|Overall Study||0
69051|NCT01692340|165190|P1|NOT COMPLETED|Overall Study||0
69052|NCT01692340|165188|P3|COMPLETED|Overall Study||0
69053|NCT01692340|165189|P2|COMPLETED|Overall Study||4
69054|NCT01692340|165190|P1|COMPLETED|Overall Study||8
69055|NCT01692340|165188|P3|STARTED|Overall Study||0
69056|NCT01692340|165189|P2|STARTED|Overall Study||4
69057|NCT01692340|165190|P1|STARTED|Overall Study||8
69058|NCT01692301|165207|P2|NOT COMPLETED|Overall Study||42
69059|NCT01692301|165208|P1|NOT COMPLETED|Overall Study||45
69060|NCT01692301|165207|P2|COMPLETED|Overall Study||183
69061|NCT01692301|165208|P1|COMPLETED|Overall Study||184
69062|NCT01692301|165207|P2|STARTED|Overall Study||225
69063|NCT01692301|165208|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
69064|NCT01691898|165240|P6|NOT COMPLETED|Overall Study||40
69065|NCT01691898|165241|P5|NOT COMPLETED|Overall Study||39
69066|NCT01691898|165242|P4|NOT COMPLETED|Overall Study||9
69067|NCT01691898|165243|P3|NOT COMPLETED|Overall Study||18
69068|NCT01691898|165244|P2|NOT COMPLETED|Overall Study||58
69069|NCT01691898|165245|P1|NOT COMPLETED|Overall Study||60
69070|NCT01691898|165240|P6|COMPLETED|Overall Study||0
69071|NCT01691898|165241|P5|COMPLETED|Overall Study||0
69072|NCT01691898|165242|P4|COMPLETED|Overall Study||0
69073|NCT01691898|165243|P3|COMPLETED|Overall Study||2
69074|NCT01691898|165244|P2|COMPLETED|Overall Study||1
69075|NCT01691898|165245|P1|COMPLETED|Overall Study||3
69076|NCT01691898|165240|P6|STARTED|Overall Study||40
69077|NCT01691898|165241|P5|STARTED|Overall Study||39
69078|NCT01691898|165242|P4|STARTED|Overall Study||9
69079|NCT01691898|165243|P3|STARTED|Overall Study||20
69080|NCT01691898|165244|P2|STARTED|Overall Study||59
69081|NCT01691898|165245|P1|STARTED|Overall Study||63
69082|NCT01691885|165391|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
69083|NCT01691885|165392|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
69084|NCT01691885|165391|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
69085|NCT01691885|165392|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
69086|NCT01691885|165391|P2|STARTED|Treatment Period 2 (7-14 Days)||21
69087|NCT01691885|165392|P1|STARTED|Treatment Period 2 (7-14 Days)||21
69088|NCT01691885|165391|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
69089|NCT01691885|165392|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
69090|NCT01691885|165391|P2|COMPLETED|Washout Period (7-9 Days)||21
69091|NCT01691885|165392|P1|COMPLETED|Washout Period (7-9 Days)||21
69092|NCT01691885|165391|P2|STARTED|Washout Period (7-9 Days)||22
69093|NCT01691885|165392|P1|STARTED|Washout Period (7-9 Days)||21
69094|NCT01691885|165391|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
69095|NCT01691885|165392|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
69096|NCT01691885|165391|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
69097|NCT01691885|165392|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
69098|NCT01691885|165391|P2|STARTED|Treatment Period 1(7-14 Days)||23
69099|NCT01691885|165392|P1|STARTED|Treatment Period 1(7-14 Days)||22
69100|NCT01691859|165398|P1|NOT COMPLETED|Overall Study||347
69101|NCT01691859|165398|P1|COMPLETED|Overall Study||0
69102|NCT01691859|165398|P1|STARTED|Overall Study||347
69103|NCT01691794|165420|P3|NOT COMPLETED|Overall Study||10
69104|NCT01691794|165421|P2|NOT COMPLETED|Overall Study||18
69105|NCT01691794|165422|P1|NOT COMPLETED|Overall Study||1
69106|NCT01691794|165420|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
69107|NCT01691794|165421|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
69108|NCT01691794|165422|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
69109|NCT01691794|165420|P3|STARTED|Overall Study||23
69110|NCT01691794|165421|P2|STARTED|Overall Study||33
69111|NCT01691794|165422|P1|STARTED|Overall Study||3
69112|NCT01691781|165438|P2|NOT COMPLETED|Overall Study||7
69113|NCT01691781|165439|P1|NOT COMPLETED|Overall Study||7
69114|NCT01691781|165438|P2|COMPLETED|Overall Study||15
69115|NCT01691781|165439|P1|COMPLETED|Overall Study||12
69116|NCT01691781|165438|P2|STARTED|Overall Study||22
69117|NCT01691781|165439|P1|STARTED|Overall Study||19
69118|NCT01691690|165451|P2|NOT COMPLETED|Overall Study||4
69119|NCT01691690|165452|P1|NOT COMPLETED|Overall Study||7
69120|NCT01691690|165451|P2|COMPLETED|Overall Study||121
69121|NCT01691690|165452|P1|COMPLETED|Overall Study||118
69122|NCT01691690|165451|P2|STARTED|Overall Study||125
69123|NCT01691690|165452|P1|STARTED|Overall Study||125
69124|NCT01691612|165462|P1|NOT COMPLETED|Overall Study||7
69125|NCT01691612|165462|P1|COMPLETED|Overall Study||7
69126|NCT01691612|165462|P1|Second Visit (Bronchoscopy)|Overall Study||7
69127|NCT01691612|165462|P1|First Visit (Allergen Challenge)|Overall Study||8
69128|NCT01691612|165462|P1|STARTED|Overall Study||14
69129|NCT01691560|165473|P4|NOT COMPLETED|Overall Study||0
69130|NCT01691560|165474|P3|NOT COMPLETED|Overall Study||0
69131|NCT01691560|165475|P2|NOT COMPLETED|Overall Study||0
69132|NCT01691560|165476|P1|NOT COMPLETED|Overall Study||0
69133|NCT01691560|165473|P4|COMPLETED|Overall Study||33
69134|NCT01691560|165474|P3|COMPLETED|Overall Study||34
69135|NCT01691560|165475|P2|COMPLETED|Overall Study||33
69136|NCT01691560|165476|P1|COMPLETED|Overall Study||34
69137|NCT01691560|165473|P4|STARTED|Overall Study||33
69138|NCT01691560|165474|P3|STARTED|Overall Study||34
69139|NCT01691560|165475|P2|STARTED|Overall Study||33
69140|NCT01691560|165476|P1|STARTED|Overall Study||34
69141|NCT01691534|165513|P7|NOT COMPLETED|Overall Study||1
69142|NCT01691534|165514|P6|NOT COMPLETED|Overall Study||1
69143|NCT01691534|165515|P5|NOT COMPLETED|Overall Study||0
69144|NCT01691534|165516|P4|NOT COMPLETED|Overall Study||1
69145|NCT01691534|165517|P3|NOT COMPLETED|Overall Study||1
69146|NCT01691534|165518|P2|NOT COMPLETED|Overall Study||1
69147|NCT01691534|165519|P1|NOT COMPLETED|Overall Study||0
69148|NCT01691534|165513|P7|COMPLETED|Overall Study||14
69149|NCT01691534|165514|P6|COMPLETED|Overall Study||14
69150|NCT01691534|165515|P5|COMPLETED|Overall Study||15
69151|NCT01691534|165516|P4|COMPLETED|Overall Study||14
69152|NCT01691534|165517|P3|COMPLETED|Overall Study||14
69153|NCT01691534|165518|P2|COMPLETED|Overall Study||14
69154|NCT01691534|165519|P1|COMPLETED|Overall Study||15
69155|NCT01691534|165513|P7|STARTED|Overall Study||15
69156|NCT01691534|165514|P6|STARTED|Overall Study||15
69157|NCT01691534|165515|P5|STARTED|Overall Study||15
69158|NCT01691534|165516|P4|STARTED|Overall Study||15
69159|NCT01691534|165517|P3|STARTED|Overall Study||15
69160|NCT01691534|165518|P2|STARTED|Overall Study||15
69161|NCT01691534|165519|P1|STARTED|Overall Study||15
69162|NCT01691521|165573|P3|NOT COMPLETED|Overall Study||9
69163|NCT01691521|165574|P2|NOT COMPLETED|Overall Study||16
69164|NCT01691521|165575|P1|NOT COMPLETED|Overall Study||12
69165|NCT01691521|165573|P3|COMPLETED|Overall Study||185
69166|NCT01691521|165574|P2|COMPLETED|Overall Study||175
69167|NCT01691521|165575|P1|COMPLETED|Overall Study||179
69168|NCT01691521|165573|P3|STARTED|Overall Study||194
69169|NCT01691521|165574|P2|STARTED|Overall Study||191
69170|NCT01691521|165575|P1|STARTED|Overall Study||191
69171|NCT01691508|165597|P2|NOT COMPLETED|Overall Study||3
69172|NCT01691508|165598|P1|NOT COMPLETED|Overall Study||4
69173|NCT01691508|165597|P2|COMPLETED|Overall Study||66
69174|NCT01691508|165598|P1|COMPLETED|Overall Study||62
69175|NCT01691508|165597|P2|STARTED|Overall Study||69
69176|NCT01691508|165598|P1|STARTED|Overall Study||66
69177|NCT01691482|165612|P2|NOT COMPLETED|Treatment Period 2||2
69178|NCT01691482|165613|P1|NOT COMPLETED|Treatment Period 2||1
69179|NCT01691482|165612|P2|COMPLETED|Treatment Period 2||26
69180|NCT01691482|165613|P1|COMPLETED|Treatment Period 2||27
69181|NCT01691482|165612|P2|STARTED|Treatment Period 2||28
69182|NCT01691482|165613|P1|STARTED|Treatment Period 2||28
69183|NCT01691482|165612|P2|NOT COMPLETED|Treatment Period 1||0
69184|NCT01691482|165613|P1|NOT COMPLETED|Treatment Period 1||0
69185|NCT01691482|165612|P2|COMPLETED|Treatment Period 1||28
69186|NCT01691482|165613|P1|COMPLETED|Treatment Period 1||28
69187|NCT01691482|165612|P2|STARTED|Treatment Period 1||28
69188|NCT01691482|165613|P1|STARTED|Treatment Period 1||28
69189|NCT01691430|165631|P2|NOT COMPLETED|Overall Study||20
69190|NCT01691430|165632|P1|NOT COMPLETED|Overall Study||22
69191|NCT01691430|165631|P2|COMPLETED|Overall Study||73
69192|NCT01691430|165632|P1|COMPLETED|Overall Study||70
69193|NCT01691430|165631|P2|Received Medication|Overall Study||93
69194|NCT01691430|165632|P1|Received Medication|Overall Study||92
69195|NCT01691430|165631|P2|STARTED|Overall Study||93
69196|NCT01691430|165632|P1|STARTED|Overall Study||92
69197|NCT01691339|165660|P4|NOT COMPLETED|Overall Study||0
69198|NCT01691339|165661|P3|NOT COMPLETED|Overall Study||0
69199|NCT01691339|165662|P2|NOT COMPLETED|Overall Study||0
69200|NCT01691339|165663|P1|NOT COMPLETED|Overall Study||0
69201|NCT01691339|165660|P4|COMPLETED|Overall Study||49
69202|NCT01691339|165661|P3|COMPLETED|Overall Study||51
69203|NCT01691339|165662|P2|COMPLETED|Overall Study||50
69204|NCT01691339|165663|P1|COMPLETED|Overall Study||50
69205|NCT01691339|165660|P4|STARTED|Overall Study||49
69206|NCT01691339|165661|P3|STARTED|Overall Study||51
69207|NCT01691339|165662|P2|STARTED|Overall Study||50
69208|NCT01691339|165663|P1|STARTED|Overall Study||50
69209|NCT01691326|165691|P2|NOT COMPLETED|Overall Study||0
69210|NCT01691326|165692|P1|NOT COMPLETED|Overall Study||0
69211|NCT01691326|165691|P2|COMPLETED|Overall Study||30
69212|NCT01691326|165692|P1|COMPLETED|Overall Study||30
69213|NCT01691326|165691|P2|STARTED|Overall Study||30
69214|NCT01691326|165692|P1|STARTED|Overall Study||30
69215|NCT01691313|165710|P4|NOT COMPLETED|Overall Study||0
69216|NCT01691313|165711|P3|NOT COMPLETED|Overall Study||0
69217|NCT01691313|165712|P2|NOT COMPLETED|Overall Study||0
69218|NCT01691313|165713|P1|NOT COMPLETED|Overall Study||0
69219|NCT01691313|165710|P4|COMPLETED|Overall Study||25
69220|NCT01691313|165711|P3|COMPLETED|Overall Study||25
69221|NCT01691313|165712|P2|COMPLETED|Overall Study||32
69222|NCT01691313|165713|P1|COMPLETED|Overall Study||22
69223|NCT01691313|165710|P4|STARTED|Overall Study||25
69224|NCT01691313|165711|P3|STARTED|Overall Study||25
69225|NCT01691313|165712|P2|STARTED|Overall Study||32
69226|NCT01691313|165713|P1|STARTED|Overall Study||22
69227|NCT01691248|165729|P2|NOT COMPLETED|Overall Study||114
69228|NCT01691248|165730|P1|NOT COMPLETED|Overall Study||111
69229|NCT01691248|165729|P2|COMPLETED|Overall Study||192
69230|NCT01691248|165730|P1|COMPLETED|Overall Study||194
69231|NCT01691248|165729|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
69232|NCT01691248|165730|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
69233|NCT01691248|165729|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
69234|NCT01691248|165730|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
69235|NCT01691248|165729|P2|STARTED|Overall Study|Randomized|306
69236|NCT01691248|165730|P1|STARTED|Overall Study|Randomized|305
69237|NCT01691092|165740|P1|NOT COMPLETED|Overall Study||41
69238|NCT01691092|165740|P1|COMPLETED|Overall Study||38
69239|NCT01691092|165740|P1|STARTED|Overall Study||79
69240|NCT01691027|165744|P1|NOT COMPLETED|Video Games Training||0
69241|NCT01691027|165744|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
69242|NCT01691027|165744|P1|STARTED|Video Games Training|Four subjects started video game training module|4
69243|NCT01691027|165744|P1|NOT COMPLETED|Line and Circle Tracing Training||0
69244|NCT01691027|165744|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
69245|NCT01691027|165744|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
69246|NCT01691027|165744|P1|NOT COMPLETED|Scotoma Awareness||0
69247|NCT01691027|165744|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
69248|NCT01691027|165744|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
69249|NCT01691014|165753|P4|NOT COMPLETED|Overall Study||5
69250|NCT01691014|165754|P3|NOT COMPLETED|Overall Study||11
69251|NCT01691014|165755|P2|NOT COMPLETED|Overall Study||15
69252|NCT01691014|165756|P1|NOT COMPLETED|Overall Study||3
69253|NCT01691014|165753|P4|COMPLETED|Overall Study||4
69254|NCT01691014|165754|P3|COMPLETED|Overall Study||25
69255|NCT01691014|165755|P2|COMPLETED|Overall Study||11
69256|NCT01691014|165756|P1|COMPLETED|Overall Study||5
69257|NCT01691014|165753|P4|STARTED|Overall Study||9
69258|NCT01691014|165754|P3|STARTED|Overall Study||36
69259|NCT01691014|165755|P2|STARTED|Overall Study||26
69260|NCT01691014|165756|P1|STARTED|Overall Study||8
69261|NCT01690988|165801|P3|NOT COMPLETED|Overall Study||7
69262|NCT01690988|165802|P2|NOT COMPLETED|Overall Study||5
69263|NCT01690988|165803|P1|NOT COMPLETED|Overall Study||6
69264|NCT01690988|165801|P3|COMPLETED|Overall Study||216
69265|NCT01690988|165802|P2|COMPLETED|Overall Study||217
69266|NCT01690988|165803|P1|COMPLETED|Overall Study||221
69267|NCT01690988|165801|P3|STARTED|Overall Study||223
69268|NCT01690988|165802|P2|STARTED|Overall Study||222
69269|NCT01690988|165803|P1|STARTED|Overall Study||227
69270|NCT01690923|165828|P2|NOT COMPLETED|Overall Study||1
69271|NCT01690923|165829|P1|NOT COMPLETED|Overall Study||0
69272|NCT01690923|165828|P2|COMPLETED|Overall Study||10
69273|NCT01690923|165829|P1|COMPLETED|Overall Study||10
69274|NCT01690923|165828|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
69275|NCT01690923|165829|P1|STARTED|Overall Study||10
69276|NCT01690663|165838|P4|NOT COMPLETED|Overall Study||4
69277|NCT01690663|165839|P3|NOT COMPLETED|Overall Study||3
69278|NCT01690663|165840|P2|NOT COMPLETED|Overall Study||3
69279|NCT01690663|165841|P1|NOT COMPLETED|Overall Study||3
69280|NCT01690663|165838|P4|COMPLETED|Overall Study||20
69281|NCT01690663|165839|P3|COMPLETED|Overall Study||19
69282|NCT01690663|165840|P2|COMPLETED|Overall Study||17
69283|NCT01690663|165841|P1|COMPLETED|Overall Study||20
69284|NCT01690663|165838|P4|STARTED|Overall Study||24
69285|NCT01690663|165839|P3|STARTED|Overall Study||22
69286|NCT01690663|165840|P2|STARTED|Overall Study||20
69287|NCT01690663|165841|P1|STARTED|Overall Study||23
69288|NCT01690546|165855|P1|NOT COMPLETED|Overall Study||9
69289|NCT01690546|165855|P1|COMPLETED|Overall Study||26
69290|NCT01690546|165855|P1|Extended Release Injectable NTX|Overall Study||27
69291|NCT01690546|165855|P1|STARTED|Overall Study||35
69292|NCT01690299|165871|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
69293|NCT01690299|165872|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
69294|NCT01690299|165873|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
69295|NCT01690299|165874|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
69296|NCT01690299|165875|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
69297|NCT01690299|165876|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
69298|NCT01690299|165871|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
69299|NCT01690299|165872|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
69300|NCT01690299|165873|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
69301|NCT01690299|165874|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
69302|NCT01690299|165875|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
69303|NCT01690299|165876|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
69304|NCT01690299|165871|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
69305|NCT01690299|165872|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
69306|NCT01690299|165873|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
69307|NCT01690299|165874|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
69308|NCT01690299|165875|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
69309|NCT01690299|165876|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
69310|NCT01690299|165871|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
69311|NCT01690299|165872|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
69312|NCT01690299|165873|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
69313|NCT01690299|165874|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
69314|NCT01690299|165875|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
69315|NCT01690299|165876|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
69316|NCT01690299|165871|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
69317|NCT01690299|165872|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
69318|NCT01690299|165873|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
69319|NCT01690299|165874|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
69320|NCT01690299|165875|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
69321|NCT01690299|165876|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
69322|NCT01690299|165871|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
69323|NCT01690299|165872|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
69324|NCT01690299|165873|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
69325|NCT01690299|165874|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
69326|NCT01690299|165875|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
69327|NCT01690299|165876|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
69328|NCT01690299|165871|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
69329|NCT01690299|165872|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
69330|NCT01690299|165873|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
69331|NCT01690299|165874|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
69332|NCT01690299|165875|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
69333|NCT01690299|165876|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
69334|NCT01690299|165871|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
69335|NCT01690299|165872|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
69336|NCT01690299|165873|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
69337|NCT01690299|165874|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
69338|NCT01690299|165875|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
69339|NCT01690299|165876|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
69340|NCT01690273|165921|P3|NOT COMPLETED|Overall Study||0
69341|NCT01690273|165922|P2|NOT COMPLETED|Overall Study||0
69342|NCT01690273|165923|P1|NOT COMPLETED|Overall Study||0
69343|NCT01690273|165921|P3|COMPLETED|Overall Study||20
69344|NCT01690273|165922|P2|COMPLETED|Overall Study||17
69345|NCT01690273|165923|P1|COMPLETED|Overall Study||18
69346|NCT01690273|165921|P3|STARTED|Overall Study||20
69347|NCT01690273|165922|P2|STARTED|Overall Study||17
69348|NCT01690273|165923|P1|STARTED|Overall Study||18
69349|NCT01690117|165975|P2|NOT COMPLETED|Overall Study||14
69350|NCT01690117|165976|P1|NOT COMPLETED|Overall Study||16
69351|NCT01690117|165975|P2|COMPLETED|Overall Study||31
69352|NCT01690117|165976|P1|COMPLETED|Overall Study||31
69353|NCT01690117|165975|P2|Post-Measurement|Overall Study||40
69354|NCT01690117|165976|P1|Post-Measurement|Overall Study||41
69355|NCT01690117|165975|P2|STARTED|Overall Study||45
69356|NCT01690117|165976|P1|STARTED|Overall Study||47
69357|NCT01690052|166012|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
69358|NCT01690052|166013|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
69359|NCT01690052|166012|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
69360|NCT01690052|166013|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
69361|NCT01690052|166012|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
69362|NCT01690052|166013|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
69363|NCT01690052|166012|P2|NOT COMPLETED|Washout Period of 1 Week||0
69364|NCT01690052|166013|P1|NOT COMPLETED|Washout Period of 1 Week||0
69365|NCT01690052|166012|P2|COMPLETED|Washout Period of 1 Week||6
69366|NCT01690052|166013|P1|COMPLETED|Washout Period of 1 Week||6
69367|NCT01690052|166012|P2|STARTED|Washout Period of 1 Week||6
69368|NCT01690052|166013|P1|STARTED|Washout Period of 1 Week||6
69369|NCT01690052|166012|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
69370|NCT01690052|166013|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
69371|NCT01690052|166012|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
69372|NCT01690052|166013|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
69373|NCT01690052|166012|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
69374|NCT01690052|166013|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
69375|NCT01690000|166021|P2|NOT COMPLETED|Overall Study||6
69376|NCT01690000|166022|P1|NOT COMPLETED|Overall Study||3
69377|NCT01690000|166021|P2|COMPLETED|Overall Study||35
69378|NCT01690000|166022|P1|COMPLETED|Overall Study||37
69379|NCT01690000|166021|P2|STARTED|Overall Study||41
69380|NCT01690000|166022|P1|STARTED|Overall Study||40
69381|NCT01689974|166030|P2|NOT COMPLETED|Overall Study||5
69382|NCT01689974|166031|P1|NOT COMPLETED|Overall Study||5
69383|NCT01689974|166030|P2|COMPLETED|Overall Study||0
69384|NCT01689974|166031|P1|COMPLETED|Overall Study||0
69385|NCT01689974|166030|P2|STARTED|Overall Study||5
69386|NCT01689974|166031|P1|STARTED|Overall Study||5
69387|NCT01689857|166039|P2|NOT COMPLETED|Overall Study||2
69388|NCT01689857|166040|P1|NOT COMPLETED|Overall Study||5
69389|NCT01689857|166039|P2|COMPLETED|Overall Study||18
69390|NCT01689857|166040|P1|COMPLETED|Overall Study||15
69391|NCT01689857|166039|P2|STARTED|Overall Study||20
69392|NCT01689857|166040|P1|STARTED|Overall Study||20
69393|NCT01689779|166048|P2|NOT COMPLETED|Overall Study||0
69394|NCT01689779|166049|P1|NOT COMPLETED|Overall Study||0
69395|NCT01689779|166048|P2|COMPLETED|Overall Study||32
69396|NCT01689779|166049|P1|COMPLETED|Overall Study||28
69397|NCT01689779|166048|P2|STARTED|Overall Study||32
69398|NCT01689779|166049|P1|STARTED|Overall Study||28
69399|NCT01689649|166065|P1|NOT COMPLETED|Overall Study||22
69400|NCT01689649|166065|P1|COMPLETED|Overall Study||117
69401|NCT01689649|166065|P1|STARTED|Overall Study||139
69402|NCT01689532|166077|P2|NOT COMPLETED|Overall Study||9
69403|NCT01689532|166078|P1|NOT COMPLETED|Overall Study||14
69404|NCT01689532|166077|P2|COMPLETED|Overall Study||52
69405|NCT01689532|166078|P1|COMPLETED|Overall Study||47
69406|NCT01689532|166077|P2|STARTED|Overall Study||61
69407|NCT01689532|166078|P1|STARTED|Overall Study||61
69408|NCT01689519|166142|P2|NOT COMPLETED|Overall Study||138
69409|NCT01689519|166143|P1|NOT COMPLETED|Overall Study||166
69410|NCT01689519|166142|P2|COMPLETED|Overall Study||109
69411|NCT01689519|166143|P1|COMPLETED|Overall Study||82
69412|NCT01689519|166142|P2|Received Treatment|Overall Study||246
69413|NCT01689519|166143|P1|Received Treatment|Overall Study||247
69414|NCT01689519|166142|P2|STARTED|Overall Study||247
69415|NCT01689519|166143|P1|STARTED|Overall Study||248
69416|NCT01689441|166159|P2|NOT COMPLETED|Overall Study||0
69417|NCT01689441|166160|P1|NOT COMPLETED|Overall Study||0
69418|NCT01689441|166159|P2|COMPLETED|Overall Study||31
69419|NCT01689441|166160|P1|COMPLETED|Overall Study||36
69420|NCT01689441|166159|P2|STARTED|Overall Study||31
69421|NCT01689441|166160|P1|STARTED|Overall Study||36
69422|NCT01689363|166170|P8|NOT COMPLETED|Overall Study||0
69423|NCT01689363|166171|P7|NOT COMPLETED|Overall Study||0
69424|NCT01689363|166172|P6|NOT COMPLETED|Overall Study||0
69425|NCT01689363|166173|P5|NOT COMPLETED|Overall Study||0
69426|NCT01689363|166174|P4|NOT COMPLETED|Overall Study||0
69427|NCT01689363|166175|P3|NOT COMPLETED|Overall Study||0
69428|NCT01689363|166176|P2|NOT COMPLETED|Overall Study||1
69429|NCT01689363|166177|P1|NOT COMPLETED|Overall Study||0
69430|NCT01689363|166170|P8|COMPLETED|Overall Study||32
69431|NCT01689363|166171|P7|COMPLETED|Overall Study||32
69432|NCT01689363|166172|P6|COMPLETED|Overall Study||31
69433|NCT01689363|166173|P5|COMPLETED|Overall Study||31
69434|NCT01689363|166174|P4|COMPLETED|Overall Study||31
69435|NCT01689363|166175|P3|COMPLETED|Overall Study||32
69436|NCT01689363|166176|P2|COMPLETED|Overall Study||31
69437|NCT01689363|166177|P1|COMPLETED|Overall Study||32
69438|NCT01689363|166170|P8|STARTED|Overall Study||32
69439|NCT01689363|166171|P7|STARTED|Overall Study||32
69440|NCT01689363|166172|P6|STARTED|Overall Study||31
69441|NCT01689363|166173|P5|STARTED|Overall Study||31
69442|NCT01689363|166174|P4|STARTED|Overall Study||31
69443|NCT01689363|166175|P3|STARTED|Overall Study||32
69444|NCT01689363|166176|P2|STARTED|Overall Study||32
69445|NCT01689363|166177|P1|STARTED|Overall Study||32
69446|NCT01689350|166223|P2|NOT COMPLETED|Overall Study||0
69447|NCT01689350|166224|P1|NOT COMPLETED|Overall Study||0
69448|NCT01689350|166223|P2|COMPLETED|Overall Study||45
69449|NCT01689350|166224|P1|COMPLETED|Overall Study||47
69450|NCT01689350|166223|P2|STARTED|Overall Study||45
69451|NCT01689350|166224|P1|STARTED|Overall Study||47
69452|NCT01689337|166232|P1|NOT COMPLETED|Overall Study||1
69453|NCT01689337|166232|P1|COMPLETED|Overall Study||0
69454|NCT01689337|166232|P1|STARTED|Overall Study||1
69455|NCT01689324|166247|P1|NOT COMPLETED|Overall Study||0
69456|NCT01689324|166247|P1|COMPLETED|Overall Study||43
69457|NCT01689324|166247|P1|STARTED|Overall Study||43
69458|NCT01689207|166271|P11|NOT COMPLETED|Overall Study||0
69459|NCT01689207|166272|P10|NOT COMPLETED|Overall Study||0
69460|NCT01689207|166273|P9|NOT COMPLETED|Overall Study||1
69461|NCT01689207|166274|P8|NOT COMPLETED|Overall Study||0
69462|NCT01689207|166275|P7|NOT COMPLETED|Overall Study||0
69463|NCT01689207|166276|P6|NOT COMPLETED|Overall Study||1
69464|NCT01689207|166277|P5|NOT COMPLETED|Overall Study||2
69465|NCT01689207|166278|P4|NOT COMPLETED|Overall Study||0
69466|NCT01689207|166279|P3|NOT COMPLETED|Overall Study||0
69467|NCT01689207|166280|P2|NOT COMPLETED|Overall Study||1
69468|NCT01689207|166281|P1|NOT COMPLETED|Overall Study||0
69469|NCT01689207|166271|P11|COMPLETED|Overall Study|Subjects completed study|8
69470|NCT01689207|166272|P10|COMPLETED|Overall Study|Subjects completed study|10
69471|NCT01689207|166273|P9|COMPLETED|Overall Study|Subjects completed study|5
69472|NCT01689207|166274|P8|COMPLETED|Overall Study|Subjects completed study|10
69473|NCT01689207|166275|P7|COMPLETED|Overall Study|Subjects completed study|10
69474|NCT01689207|166276|P6|COMPLETED|Overall Study|Subjects completed study|7
69475|NCT01689207|166277|P5|COMPLETED|Overall Study|Subjects completed study|2
69476|NCT01689207|166278|P4|COMPLETED|Overall Study|Subjects completed study|8
69477|NCT01689207|166279|P3|COMPLETED|Overall Study|Subjects completed study|16
69478|NCT01689207|166280|P2|COMPLETED|Overall Study|Subjects completed study|7
69479|NCT01689207|166281|P1|COMPLETED|Overall Study|Subjects completed study|4
69480|NCT01689207|166271|P11|STARTED|Overall Study|Subjects randomised|8
69481|NCT01689207|166272|P10|STARTED|Overall Study|Subjects randomised|10
69482|NCT01689207|166273|P9|STARTED|Overall Study|Subjects randomised|6
69483|NCT01689207|166274|P8|STARTED|Overall Study|Subjects randomised|10
69484|NCT01689207|166275|P7|STARTED|Overall Study|Subjects randomised|10
69485|NCT01689207|166276|P6|STARTED|Overall Study|Subjects randomised|8
69486|NCT01689207|166277|P5|STARTED|Overall Study|Subjects randomised|4
69487|NCT01689207|166278|P4|STARTED|Overall Study|Subjects randomised|8
69488|NCT01689207|166279|P3|STARTED|Overall Study|Subjects randomised|16
69489|NCT01689207|166280|P2|STARTED|Overall Study|Subjects randomised|8
69490|NCT01689207|166281|P1|STARTED|Overall Study|Subjects randomised|4
69491|NCT01689155|166377|P1|NOT COMPLETED|Overall Study||0
69492|NCT01689155|166377|P1|COMPLETED|Overall Study||116
69493|NCT01689155|166377|P1|STARTED|Overall Study||116
69494|NCT01688921|166388|P2|NOT COMPLETED|Overall Study||15
69495|NCT01688921|166389|P1|NOT COMPLETED|Overall Study||16
69496|NCT01688921|166388|P2|COMPLETED|Overall Study||608
69497|NCT01688921|166389|P1|COMPLETED|Overall Study||611
69498|NCT01688921|166388|P2|STARTED|Overall Study||623
69499|NCT01688921|166389|P1|STARTED|Overall Study||627
69500|NCT01688882|166414|P2|NOT COMPLETED|Overall Study||1
69501|NCT01688882|166415|P1|NOT COMPLETED|Overall Study||3
69502|NCT01688882|166414|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
69503|NCT01688882|166415|P1|COMPLETED|Overall Study||10
69504|NCT01688882|166414|P2|Safety Follow-up|Overall Study||5
69505|NCT01688882|166415|P1|Safety Follow-up|Overall Study||11
69506|NCT01688882|166414|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
69507|NCT01688882|166415|P1|STARTED|Overall Study||13
69508|NCT01688843|166429|P1|NOT COMPLETED|Overall Study||0
69509|NCT01688843|166429|P1|COMPLETED|Overall Study||1060
69510|NCT01688843|166429|P1|STARTED|Overall Study||1060
69511|NCT01688830|166460|P21|NOT COMPLETED|Overall Study||0
69512|NCT01688830|166461|P20|NOT COMPLETED|Overall Study||0
69513|NCT01688830|166462|P19|NOT COMPLETED|Overall Study||0
69514|NCT01688830|166463|P18|NOT COMPLETED|Overall Study||0
69515|NCT01688830|166464|P17|NOT COMPLETED|Overall Study||0
69516|NCT01688830|166465|P16|NOT COMPLETED|Overall Study||0
69517|NCT01688830|166466|P15|NOT COMPLETED|Overall Study||0
69518|NCT01688830|166467|P14|NOT COMPLETED|Overall Study||0
69519|NCT01688830|166468|P13|NOT COMPLETED|Overall Study||0
69520|NCT01688830|166469|P12|NOT COMPLETED|Overall Study||0
69521|NCT01688830|166470|P11|NOT COMPLETED|Overall Study||1
69522|NCT01688830|166471|P10|NOT COMPLETED|Overall Study||0
69523|NCT01688830|166472|P9|NOT COMPLETED|Overall Study||0
69524|NCT01688830|166473|P8|NOT COMPLETED|Overall Study||0
69525|NCT01688830|166474|P7|NOT COMPLETED|Overall Study||0
69526|NCT01688830|166475|P6|NOT COMPLETED|Overall Study||0
69527|NCT01688830|166476|P5|NOT COMPLETED|Overall Study||0
69528|NCT01688830|166477|P4|NOT COMPLETED|Overall Study||0
69529|NCT01688830|166478|P3|NOT COMPLETED|Overall Study||0
69530|NCT01688830|166479|P2|NOT COMPLETED|Overall Study||0
69531|NCT01688830|166480|P1|NOT COMPLETED|Overall Study||0
69532|NCT01688830|166460|P21|COMPLETED|Overall Study||9
69533|NCT01688830|166461|P20|COMPLETED|Overall Study||3
69534|NCT01688830|166462|P19|COMPLETED|Overall Study||8
69535|NCT01688830|166463|P18|COMPLETED|Overall Study||9
69536|NCT01688830|166464|P17|COMPLETED|Overall Study||9
69537|NCT01688830|166465|P16|COMPLETED|Overall Study||9
69538|NCT01688830|166466|P15|COMPLETED|Overall Study||6
69539|NCT01688830|166467|P14|COMPLETED|Overall Study||6
69540|NCT01688830|166468|P13|COMPLETED|Overall Study||6
69541|NCT01688830|166469|P12|COMPLETED|Overall Study||6
69542|NCT01688830|166470|P11|COMPLETED|Overall Study||5
69543|NCT01688830|166471|P10|COMPLETED|Overall Study||6
69544|NCT01688830|166472|P9|COMPLETED|Overall Study||6
69545|NCT01688830|166473|P8|COMPLETED|Overall Study||6
69546|NCT01688830|166474|P7|COMPLETED|Overall Study||12
69547|NCT01688830|166475|P6|COMPLETED|Overall Study||6
69548|NCT01688830|166476|P5|COMPLETED|Overall Study||5
69549|NCT01688830|166477|P4|COMPLETED|Overall Study||6
69550|NCT01688830|166478|P3|COMPLETED|Overall Study||6
69551|NCT01688830|166479|P2|COMPLETED|Overall Study||6
69552|NCT01688830|166480|P1|COMPLETED|Overall Study||21
69553|NCT01688830|166460|P21|STARTED|Overall Study||9
69554|NCT01688830|166461|P20|STARTED|Overall Study||3
69555|NCT01688830|166462|P19|STARTED|Overall Study||8
69556|NCT01688830|166463|P18|STARTED|Overall Study||9
69557|NCT01688830|166464|P17|STARTED|Overall Study||9
69558|NCT01688830|166465|P16|STARTED|Overall Study||9
69559|NCT01688830|166466|P15|STARTED|Overall Study||6
69560|NCT01688830|166467|P14|STARTED|Overall Study||6
69561|NCT01688830|166468|P13|STARTED|Overall Study||6
69562|NCT01688830|166469|P12|STARTED|Overall Study||6
69563|NCT01688830|166470|P11|STARTED|Overall Study||6
69564|NCT01688830|166471|P10|STARTED|Overall Study||6
69565|NCT01688830|166472|P9|STARTED|Overall Study||6
69566|NCT01688830|166473|P8|STARTED|Overall Study||6
69567|NCT01688830|166474|P7|STARTED|Overall Study||12
69568|NCT01688830|166475|P6|STARTED|Overall Study||6
69569|NCT01688830|166476|P5|STARTED|Overall Study||5
69570|NCT01688830|166477|P4|STARTED|Overall Study||6
69571|NCT01688830|166478|P3|STARTED|Overall Study||6
69572|NCT01688830|166479|P2|STARTED|Overall Study||6
69573|NCT01688830|166480|P1|STARTED|Overall Study||21
69574|NCT01688726|166626|P2|NOT COMPLETED|Overall Study||1
69575|NCT01688726|166627|P1|NOT COMPLETED|Overall Study||1
69576|NCT01688726|166626|P2|COMPLETED|Overall Study||44
69577|NCT01688726|166627|P1|COMPLETED|Overall Study||45
69578|NCT01688726|166626|P2|STARTED|Overall Study||45
69579|NCT01688726|166627|P1|STARTED|Overall Study||46
69580|NCT01688635|166639|P2|NOT COMPLETED|Period 4||0
69581|NCT01688635|166640|P1|NOT COMPLETED|Period 4||0
69582|NCT01688635|166639|P2|COMPLETED|Period 4||42
69583|NCT01688635|166640|P1|COMPLETED|Period 4||40
69584|NCT01688635|166639|P2|STARTED|Period 4||42
69585|NCT01688635|166640|P1|STARTED|Period 4||40
69586|NCT01688635|166639|P2|NOT COMPLETED|Washout 3||0
69587|NCT01688635|166640|P1|NOT COMPLETED|Washout 3||1
69588|NCT01688635|166639|P2|COMPLETED|Washout 3||42
69589|NCT01688635|166640|P1|COMPLETED|Washout 3||40
69590|NCT01688635|166639|P2|STARTED|Washout 3||42
69591|NCT01688635|166640|P1|STARTED|Washout 3||41
69592|NCT01688635|166639|P2|NOT COMPLETED|Period 3||0
69593|NCT01688635|166640|P1|NOT COMPLETED|Period 3||0
69594|NCT01688635|166639|P2|COMPLETED|Period 3||42
69595|NCT01688635|166640|P1|COMPLETED|Period 3||41
69596|NCT01688635|166639|P2|STARTED|Period 3||42
69597|NCT01688635|166640|P1|STARTED|Period 3||41
69598|NCT01688635|166639|P2|NOT COMPLETED|Washout 2||2
69599|NCT01688635|166640|P1|NOT COMPLETED|Washout 2||3
69600|NCT01688635|166639|P2|COMPLETED|Washout 2||42
69601|NCT01688635|166640|P1|COMPLETED|Washout 2||41
69602|NCT01688635|166639|P2|STARTED|Washout 2||44
69603|NCT01688635|166640|P1|STARTED|Washout 2||44
69604|NCT01688635|166639|P2|NOT COMPLETED|Period 2||0
69605|NCT01688635|166640|P1|NOT COMPLETED|Period 2||0
69606|NCT01688635|166639|P2|COMPLETED|Period 2||44
69607|NCT01688635|166640|P1|COMPLETED|Period 2||44
69608|NCT01688635|166639|P2|STARTED|Period 2||44
69609|NCT01688635|166640|P1|STARTED|Period 2||44
69610|NCT01688635|166639|P2|NOT COMPLETED|Washout 1||2
69611|NCT01688635|166640|P1|NOT COMPLETED|Washout 1||1
69612|NCT01688635|166639|P2|COMPLETED|Washout 1||44
69613|NCT01688635|166640|P1|COMPLETED|Washout 1||44
69614|NCT01688635|166639|P2|STARTED|Washout 1||46
69615|NCT01688635|166640|P1|STARTED|Washout 1||45
69616|NCT01688635|166639|P2|NOT COMPLETED|Period 1||0
69617|NCT01688635|166640|P1|NOT COMPLETED|Period 1||0
69618|NCT01688635|166639|P2|COMPLETED|Period 1||46
69619|NCT01688635|166640|P1|COMPLETED|Period 1||45
69620|NCT01688635|166639|P2|Received at Least 1 Dose of Study Drug|Period 1||46
69621|NCT01688635|166640|P1|Received at Least 1 Dose of Study Drug|Period 1||45
69622|NCT01688635|166639|P2|STARTED|Period 1||46
69623|NCT01688635|166640|P1|STARTED|Period 1||45
69624|NCT01688609|166652|P1|NOT COMPLETED|Overall Study||0
69625|NCT01688609|166652|P1|COMPLETED|Overall Study||18
69626|NCT01688609|166652|P1|STARTED|Overall Study||18
69627|NCT01688466|166662|P2|NOT COMPLETED|Overall Study||7
69628|NCT01688466|166663|P1|NOT COMPLETED|Overall Study||2
69629|NCT01688466|166662|P2|COMPLETED|Overall Study||10
69630|NCT01688466|166663|P1|COMPLETED|Overall Study||15
69631|NCT01688466|166662|P2|STARTED|Overall Study||17
69632|NCT01688466|166663|P1|STARTED|Overall Study||17
69633|NCT01688336|166671|P1|NOT COMPLETED|Overall Study||0
69634|NCT01688336|166671|P1|COMPLETED|Overall Study||9
69635|NCT01688336|166671|P1|STARTED|Overall Study||9
69636|NCT01688310|166683|P2|NOT COMPLETED|Overall Study||0
69637|NCT01688310|166684|P1|NOT COMPLETED|Overall Study||0
69638|NCT01688310|166683|P2|COMPLETED|Overall Study||100
69639|NCT01688310|166684|P1|COMPLETED|Overall Study||100
69640|NCT01688310|166683|P2|STARTED|Overall Study||100
69641|NCT01688310|166684|P1|STARTED|Overall Study||100
69642|NCT01688102|166704|P2|NOT COMPLETED|Overall Study||18
69643|NCT01688102|166705|P1|NOT COMPLETED|Overall Study||16
69644|NCT01688102|166704|P2|COMPLETED|Overall Study||40
69645|NCT01688102|166705|P1|COMPLETED|Overall Study||44
69646|NCT01688102|166704|P2|STARTED|Overall Study||58
69647|NCT01688102|166705|P1|STARTED|Overall Study||60
69648|NCT01688050|166733|P1|NOT COMPLETED|Overall Study||50
69649|NCT01688050|166733|P1|COMPLETED|Overall Study||0
69650|NCT01688050|166733|P1|30 Days|Overall Study||50
69651|NCT01688050|166733|P1|STARTED|Overall Study||50
69652|NCT01688037|166742|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
69653|NCT01688037|166743|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
69654|NCT01688037|166744|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
69655|NCT01688037|166742|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
69656|NCT01688037|166743|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
69657|NCT01688037|166744|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
69658|NCT01688037|166742|P3|STARTED|Follow-up Period (Week 12 to 16)||17
69659|NCT01688037|166743|P2|STARTED|Follow-up Period (Week 12 to 16)||22
69660|NCT01688037|166744|P1|STARTED|Follow-up Period (Week 12 to 16)||42
69661|NCT01688037|166742|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
69662|NCT01688037|166743|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
69663|NCT01688037|166744|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
69664|NCT01688037|166742|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
69665|NCT01688037|166743|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
69666|NCT01688037|166744|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
69667|NCT01688037|166742|P3|STARTED|Open-Label Period (Week 6 to 12)||21
69668|NCT01688037|166743|P2|STARTED|Open-Label Period (Week 6 to 12)||25
69669|NCT01688037|166744|P1|STARTED|Open-Label Period (Week 6 to 12)||47
69670|NCT01688037|166742|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
69671|NCT01688037|166743|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
69672|NCT01688037|166744|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
69673|NCT01688037|166742|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
69674|NCT01688037|166743|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
69675|NCT01688037|166744|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
69676|NCT01688037|166742|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
69677|NCT01688037|166743|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
69678|NCT01688037|166744|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
69679|NCT01687998|166760|P2|NOT COMPLETED|Overall Study||120
69680|NCT01687998|166761|P1|NOT COMPLETED|Overall Study||112
69681|NCT01687998|166760|P2|COMPLETED|Overall Study||5934
69682|NCT01687998|166761|P1|COMPLETED|Overall Study||5926
69683|NCT01687998|166760|P2|Received at Least One Dose of Study Drug|Overall Study||6052
69684|NCT01687998|166761|P1|Received at Least One Dose of Study Drug|Overall Study||6036
69685|NCT01687998|166760|P2|STARTED|Overall Study||6054
69686|NCT01687998|166761|P1|STARTED|Overall Study||6038
69687|NCT01687972|166779|P2|NOT COMPLETED|Overall Study||0
69688|NCT01687972|166780|P1|NOT COMPLETED|Overall Study||0
69689|NCT01687972|166779|P2|COMPLETED|Overall Study||44
69690|NCT01687972|166780|P1|COMPLETED|Overall Study||44
69691|NCT01687972|166779|P2|STARTED|Overall Study||44
69692|NCT01687972|166780|P1|STARTED|Overall Study||44
69693|NCT01687790|166790|P1|NOT COMPLETED|Overall Study||0
69694|NCT01687790|166790|P1|COMPLETED|Overall Study||60
69695|NCT01687790|166790|P1|STARTED|Overall Study||60
69696|NCT01687712|166797|P2|NOT COMPLETED|Cycle 3||24
69697|NCT01687712|166798|P1|NOT COMPLETED|Cycle 3||24
69698|NCT01687712|166797|P2|COMPLETED|Cycle 3||0
69699|NCT01687712|166798|P1|COMPLETED|Cycle 3||4
69700|NCT01687712|166797|P2|Clinical Pregnancy|Cycle 3||0
69701|NCT01687712|166798|P1|Clinical Pregnancy|Cycle 3||5
69702|NCT01687712|166797|P2|Biochemically Pregnant|Cycle 3||2
69703|NCT01687712|166798|P1|Biochemically Pregnant|Cycle 3||7
69704|NCT01687712|166797|P2|Embryo Transfer|Cycle 3||24
69705|NCT01687712|166798|P1|Embryo Transfer|Cycle 3||26
69706|NCT01687712|166797|P2|Fertilization Performed|Cycle 3||24
69707|NCT01687712|166798|P1|Fertilization Performed|Cycle 3||27
69708|NCT01687712|166797|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
69709|NCT01687712|166798|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
69710|NCT01687712|166797|P2|Received hCG|Cycle 3||24
69711|NCT01687712|166798|P1|Received hCG|Cycle 3||27
69712|NCT01687712|166797|P2|STARTED|Cycle 3||24
69713|NCT01687712|166798|P1|STARTED|Cycle 3||28
69714|NCT01687712|166797|P2|NOT COMPLETED|Cycle 2||95
69715|NCT01687712|166798|P1|NOT COMPLETED|Cycle 2||93
69716|NCT01687712|166797|P2|COMPLETED|Cycle 2||25
69717|NCT01687712|166798|P1|COMPLETED|Cycle 2||16
69718|NCT01687712|166797|P2|Clinical Pregnancy|Cycle 2||26
69719|NCT01687712|166798|P1|Clinical Pregnancy|Cycle 2||17
69720|NCT01687712|166797|P2|Biochemical Pregnancy|Cycle 2||43
69721|NCT01687712|166798|P1|Biochemical Pregnancy|Cycle 2||35
69722|NCT01687712|166797|P2|Embryo Transfer|Cycle 2||117
69723|NCT01687712|166798|P1|Embryo Transfer|Cycle 2||101
69724|NCT01687712|166797|P2|Fertilization Performed|Cycle 2||119
69725|NCT01687712|166798|P1|Fertilization Performed|Cycle 2||106
69726|NCT01687712|166797|P2|Oocyte/Ovum Pick Up|Cycle 2||119
69727|NCT01687712|166798|P1|Oocyte/Ovum Pick Up|Cycle 2||107
69728|NCT01687712|166797|P2|Received hCG|Cycle 2||119
69729|NCT01687712|166798|P1|Received hCG|Cycle 2||107
69730|NCT01687712|166797|P2|STARTED|Cycle 2||120
69731|NCT01687712|166798|P1|STARTED|Cycle 2||109
69732|NCT01687712|166797|P2|NOT COMPLETED|Cycle 1||429
69733|NCT01687712|166798|P1|NOT COMPLETED|Cycle 1||448
69734|NCT01687712|166797|P2|COMPLETED|Cycle 1||122
69735|NCT01687712|166798|P1|COMPLETED|Cycle 1||101
69736|NCT01687712|166797|P2|Clinical Pregnancy|Cycle 1||138
69737|NCT01687712|166798|P1|Clinical Pregnancy|Cycle 1||114
69738|NCT01687712|166797|P2|Biochemical Pregnancy|Cycle 1||203
69739|NCT01687712|166798|P1|Biochemical Pregnancy|Cycle 1||163
69740|NCT01687712|166797|P2|Embryo Transfer|Cycle 1||483
69741|NCT01687712|166798|P1|Embryo Transfer|Cycle 1||466
69742|NCT01687712|166797|P2|Fertilization Performed|Cycle 1||512
69743|NCT01687712|166798|P1|Fertilization Performed|Cycle 1||508
69744|NCT01687712|166797|P2|Oocyte/Ovum Pick Up|Cycle 1||517
69745|NCT01687712|166798|P1|Oocyte/Ovum Pick Up|Cycle 1||513
69746|NCT01687712|166797|P2|Received hCG|Cycle 1||520
69747|NCT01687712|166798|P1|Received hCG|Cycle 1||516
69748|NCT01687712|166797|P2|STARTED|Cycle 1||551
69749|NCT01687712|166798|P1|STARTED|Cycle 1||549
69750|NCT01687478|166838|P2|NOT COMPLETED|Overall Study||39
69751|NCT01687478|166839|P1|NOT COMPLETED|Overall Study||32
69752|NCT01687478|166838|P2|COMPLETED|Overall Study||49
69753|NCT01687478|166839|P1|COMPLETED|Overall Study||56
69754|NCT01687478|166838|P2|Safety Analysis Set|Overall Study||87
69755|NCT01687478|166839|P1|Safety Analysis Set|Overall Study||88
69756|NCT01687478|166838|P2|STARTED|Overall Study||88
69757|NCT01687478|166839|P1|STARTED|Overall Study||88
69758|NCT01687296|166863|P2|NOT COMPLETED|Overall Study||5
69759|NCT01687296|166864|P1|NOT COMPLETED|Overall Study||7
69760|NCT01687296|166863|P2|COMPLETED|Overall Study||123
69761|NCT01687296|166864|P1|COMPLETED|Overall Study||116
69762|NCT01687296|166863|P2|STARTED|Overall Study||128
69763|NCT01687296|166864|P1|STARTED|Overall Study||123
69764|NCT01687283|166886|P2|NOT COMPLETED|Overall Study||27
69765|NCT01687283|166887|P1|NOT COMPLETED|Overall Study||35
69766|NCT01687283|166886|P2|COMPLETED|Overall Study||130
69767|NCT01687283|166887|P1|COMPLETED|Overall Study||123
69768|NCT01687283|166886|P2|STARTED|Overall Study||157
69769|NCT01687283|166887|P1|STARTED|Overall Study||158
69770|NCT01687270|166910|P1|NOT COMPLETED|Overall Study||12
69771|NCT01687270|166910|P1|COMPLETED|Overall Study||28
69772|NCT01687270|166910|P1|STARTED|Overall Study||40
69773|NCT01687257|166921|P3|NOT COMPLETED|Overall Study||6
69774|NCT01687257|166922|P2|NOT COMPLETED|Overall Study||4
69775|NCT01687257|166923|P1|NOT COMPLETED|Overall Study||8
69776|NCT01687257|166921|P3|COMPLETED|Overall Study||15
69777|NCT01687257|166922|P2|COMPLETED|Overall Study||0
69778|NCT01687257|166923|P1|COMPLETED|Overall Study||17
69779|NCT01687257|166921|P3|STARTED|Overall Study||21
69780|NCT01687257|166922|P2|STARTED|Overall Study||4
69781|NCT01687257|166923|P1|STARTED|Overall Study||25
69782|NCT01687244|166951|P2|NOT COMPLETED|Overall Study||0
69783|NCT01687244|166952|P1|NOT COMPLETED|Overall Study||0
69784|NCT01687244|166951|P2|COMPLETED|Overall Study||19
69785|NCT01687244|166952|P1|COMPLETED|Overall Study||21
69786|NCT01687244|166951|P2|STARTED|Overall Study||19
69787|NCT01687244|166952|P1|STARTED|Overall Study||21
69788|NCT01687218|166988|P6|NOT COMPLETED|Overall Study||0
69789|NCT01687218|166989|P5|NOT COMPLETED|Overall Study||1
69790|NCT01687218|166990|P4|NOT COMPLETED|Overall Study||2
69791|NCT01687218|166991|P3|NOT COMPLETED|Overall Study||1
69792|NCT01687218|166992|P2|NOT COMPLETED|Overall Study||3
69793|NCT01687218|166993|P1|NOT COMPLETED|Overall Study||3
69794|NCT01687218|166988|P6|COMPLETED|Overall Study||32
69795|NCT01687218|166989|P5|COMPLETED|Overall Study||32
69796|NCT01687218|166990|P4|COMPLETED|Overall Study||32
69797|NCT01687218|166991|P3|COMPLETED|Overall Study||30
69798|NCT01687218|166992|P2|COMPLETED|Overall Study||29
69799|NCT01687218|166993|P1|COMPLETED|Overall Study||30
69800|NCT01687218|166988|P6|STARTED|Overall Study||32
69801|NCT01687218|166989|P5|STARTED|Overall Study||33
69802|NCT01687218|166990|P4|STARTED|Overall Study||34
69803|NCT01687218|166991|P3|STARTED|Overall Study||31
69804|NCT01687218|166992|P2|STARTED|Overall Study||32
69805|NCT01687218|166993|P1|STARTED|Overall Study||33
69806|NCT01687114|167013|P1|NOT COMPLETED|Overall Study||0
69807|NCT01687114|167013|P1|COMPLETED|Overall Study||5
69808|NCT01687114|167013|P1|STARTED|Overall Study||5
69809|NCT01687101|167017|P1|NOT COMPLETED|Overall Study||7
69810|NCT01687101|167017|P1|COMPLETED|Overall Study||25
69811|NCT01687101|167017|P1|STARTED|Overall Study||32
69812|NCT01687088|167023|P2|NOT COMPLETED|Overall Study||0
69813|NCT01687088|167024|P1|NOT COMPLETED|Overall Study||0
69814|NCT01687088|167023|P2|COMPLETED|Overall Study||50
69815|NCT01687088|167024|P1|COMPLETED|Overall Study||50
69816|NCT01687088|167023|P2|STARTED|Overall Study||50
69817|NCT01687088|167024|P1|STARTED|Overall Study||50
69818|NCT01687036|167030|P1|NOT COMPLETED|Overall Study||0
69819|NCT01687036|167030|P1|COMPLETED|Overall Study||10
69820|NCT01687036|167030|P1|STARTED|Overall Study||10
69821|NCT01686932|167044|P2|NOT COMPLETED|Period 2||0
69822|NCT01686932|167045|P1|NOT COMPLETED|Period 2||0
69823|NCT01686932|167044|P2|COMPLETED|Period 2||25
69824|NCT01686932|167045|P1|COMPLETED|Period 2||24
69825|NCT01686932|167044|P2|STARTED|Period 2||25
69826|NCT01686932|167045|P1|STARTED|Period 2||24
69827|NCT01686932|167044|P2|NOT COMPLETED|Period 1||1
69828|NCT01686932|167045|P1|NOT COMPLETED|Period 1||1
69829|NCT01686932|167044|P2|COMPLETED|Period 1||25
69830|NCT01686932|167045|P1|COMPLETED|Period 1||24
69831|NCT01686932|167044|P2|STARTED|Period 1||26
69832|NCT01686932|167045|P1|STARTED|Period 1||25
69833|NCT01686828|167075|P4|NOT COMPLETED|Overall Study||0
69834|NCT01686828|167076|P3|NOT COMPLETED|Overall Study||1
69835|NCT01686828|167077|P2|NOT COMPLETED|Overall Study||1
69836|NCT01686828|167078|P1|NOT COMPLETED|Overall Study||1
69837|NCT01686828|167075|P4|COMPLETED|Overall Study||13
69838|NCT01686828|167076|P3|COMPLETED|Overall Study||12
69839|NCT01686828|167077|P2|COMPLETED|Overall Study||13
69840|NCT01686828|167078|P1|COMPLETED|Overall Study||12
69841|NCT01686828|167075|P4|STARTED|Overall Study||13
69842|NCT01686828|167076|P3|STARTED|Overall Study||13
69843|NCT01686828|167077|P2|STARTED|Overall Study||14
69844|NCT01686828|167078|P1|STARTED|Overall Study||13
69845|NCT01686646|167100|P4|NOT COMPLETED|Overall Study||0
69846|NCT01686646|167101|P3|NOT COMPLETED|Overall Study||0
69847|NCT01686646|167102|P2|NOT COMPLETED|Overall Study||0
69848|NCT01686646|167103|P1|NOT COMPLETED|Overall Study||0
69849|NCT01686646|167100|P4|COMPLETED|Overall Study||75
69850|NCT01686646|167101|P3|COMPLETED|Overall Study||75
69851|NCT01686646|167102|P2|COMPLETED|Overall Study||45
69852|NCT01686646|167103|P1|COMPLETED|Overall Study||45
69853|NCT01686646|167100|P4|Safety Population|Overall Study||75
69854|NCT01686646|167101|P3|Safety Population|Overall Study||74
69855|NCT01686646|167102|P2|Safety Population|Overall Study||45
69856|NCT01686646|167103|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
69857|NCT01686646|167100|P4|Intent to Treat Population|Overall Study||75
69858|NCT01686646|167101|P3|Intent to Treat Population|Overall Study||75
69859|NCT01686646|167102|P2|Intent to Treat Population|Overall Study||45
69860|NCT01686646|167103|P1|Intent to Treat Population|Overall Study||45
69861|NCT01686646|167100|P4|STARTED|Overall Study||75
69862|NCT01686646|167101|P3|STARTED|Overall Study||75
69863|NCT01686646|167102|P2|STARTED|Overall Study||45
69864|NCT01686646|167103|P1|STARTED|Overall Study||45
69865|NCT01686633|167152|P3|NOT COMPLETED|Overall Study||25
69866|NCT01686633|167153|P2|NOT COMPLETED|Overall Study||32
69867|NCT01686633|167154|P1|NOT COMPLETED|Overall Study||51
69868|NCT01686633|167152|P3|COMPLETED|Overall Study||321
69869|NCT01686633|167153|P2|COMPLETED|Overall Study||314
69870|NCT01686633|167154|P1|COMPLETED|Overall Study||296
69871|NCT01686633|167152|P3|STARTED|Overall Study||346
69872|NCT01686633|167153|P2|STARTED|Overall Study||346
69873|NCT01686633|167154|P1|STARTED|Overall Study||347
69874|NCT01686568|167179|P2|NOT COMPLETED|Sub-Study||2
69875|NCT01686568|167180|P1|NOT COMPLETED|Sub-Study||2
69876|NCT01686568|167179|P2|COMPLETED|Sub-Study||9
69877|NCT01686568|167180|P1|COMPLETED|Sub-Study||12
69878|NCT01686568|167179|P2|STARTED|Sub-Study||11
69879|NCT01686568|167180|P1|STARTED|Sub-Study||14
69880|NCT01686568|167179|P2|NOT COMPLETED|Main Study||4
69881|NCT01686568|167180|P1|NOT COMPLETED|Main Study||2
69882|NCT01686568|167179|P2|COMPLETED|Main Study||11
69883|NCT01686568|167180|P1|COMPLETED|Main Study||14
69884|NCT01686568|167179|P2|STARTED|Main Study||15
69885|NCT01686568|167180|P1|STARTED|Main Study||16
69886|NCT01686503|167206|P4|NOT COMPLETED|Overall Study||1
69887|NCT01686503|167207|P3|NOT COMPLETED|Overall Study||2
69888|NCT01686503|167208|P2|NOT COMPLETED|Overall Study||3
69889|NCT01686503|167209|P1|NOT COMPLETED|Overall Study||1
69890|NCT01686503|167206|P4|COMPLETED|Overall Study||32
69891|NCT01686503|167207|P3|COMPLETED|Overall Study||64
69892|NCT01686503|167208|P2|COMPLETED|Overall Study||63
69893|NCT01686503|167209|P1|COMPLETED|Overall Study||65
69894|NCT01686503|167206|P4|STARTED|Overall Study||33
69895|NCT01686503|167207|P3|STARTED|Overall Study||66
69896|NCT01686503|167208|P2|STARTED|Overall Study||66
69897|NCT01686503|167209|P1|STARTED|Overall Study||66
69898|NCT01686451|167225|P2|NOT COMPLETED|Overall Study||0
69899|NCT01686451|167226|P1|NOT COMPLETED|Overall Study||0
69900|NCT01686451|167225|P2|COMPLETED|Overall Study||27
69901|NCT01686451|167226|P1|COMPLETED|Overall Study||33
69902|NCT01686451|167225|P2|STARTED|Overall Study||27
69903|NCT01686451|167226|P1|STARTED|Overall Study||33
69904|NCT01685996|167256|P2|NOT COMPLETED|Overall Study||13
69905|NCT01685996|167257|P1|NOT COMPLETED|Overall Study||16
69906|NCT01685996|167256|P2|COMPLETED|Overall Study||27
69907|NCT01685996|167257|P1|COMPLETED|Overall Study||18
69908|NCT01685996|167256|P2|STARTED|Overall Study||40
69909|NCT01685996|167257|P1|STARTED|Overall Study||34
69910|NCT01685983|167265|P1|NOT COMPLETED|Overall Study||82
69911|NCT01685983|167265|P1|COMPLETED|Overall Study||0
69912|NCT01685983|167265|P1|STARTED|Overall Study||82
69913|NCT01685840|167277|P2|NOT COMPLETED|Overall Study||332
69914|NCT01685840|167278|P1|NOT COMPLETED|Overall Study||329
69915|NCT01685840|167277|P2|COMPLETED|Overall Study||114
69916|NCT01685840|167278|P1|COMPLETED|Overall Study||119
69917|NCT01685840|167277|P2|STARTED|Overall Study||446
69918|NCT01685840|167278|P1|STARTED|Overall Study||448
69919|NCT01685801|167322|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
69920|NCT01685801|167323|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
69921|NCT01685801|167324|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
69922|NCT01685801|167325|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
69923|NCT01685801|167322|P4|COMPLETED|Open-label Period (8 Weeks)||4
69924|NCT01685801|167323|P3|COMPLETED|Open-label Period (8 Weeks)||7
69925|NCT01685801|167324|P2|COMPLETED|Open-label Period (8 Weeks)||5
69926|NCT01685801|167325|P1|COMPLETED|Open-label Period (8 Weeks)||5
69927|NCT01685801|167322|P4|STARTED|Open-label Period (8 Weeks)||4
69928|NCT01685801|167323|P3|STARTED|Open-label Period (8 Weeks)||7
69929|NCT01685801|167324|P2|STARTED|Open-label Period (8 Weeks)||5
69930|NCT01685801|167325|P1|STARTED|Open-label Period (8 Weeks)||5
69931|NCT01685801|167322|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
69932|NCT01685801|167323|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
69933|NCT01685801|167324|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
69934|NCT01685801|167325|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
69935|NCT01685801|167322|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
69936|NCT01685801|167323|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
69937|NCT01685801|167324|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
69938|NCT01685801|167325|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
69939|NCT01685801|167322|P4|STARTED|Washout Period 2 (4 Weeks)||4
69940|NCT01685801|167323|P3|STARTED|Washout Period 2 (4 Weeks)||7
69941|NCT01685801|167324|P2|STARTED|Washout Period 2 (4 Weeks)||5
69942|NCT01685801|167325|P1|STARTED|Washout Period 2 (4 Weeks)||5
69943|NCT01685801|167322|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
69944|NCT01685801|167323|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
69945|NCT01685801|167324|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
69946|NCT01685801|167325|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
69947|NCT01685801|167322|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
69948|NCT01685801|167323|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
69949|NCT01685801|167324|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
69950|NCT01685801|167325|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
69951|NCT01685801|167322|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
69952|NCT01685801|167323|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
69953|NCT01685801|167324|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
69954|NCT01685801|167325|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
69955|NCT01685801|167322|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
69956|NCT01685801|167323|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
69957|NCT01685801|167324|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
69958|NCT01685801|167325|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
69959|NCT01685801|167322|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
69960|NCT01685801|167323|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
69961|NCT01685801|167324|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
69962|NCT01685801|167325|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
69963|NCT01685801|167322|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
69964|NCT01685801|167323|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
69965|NCT01685801|167324|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
69966|NCT01685801|167325|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
69967|NCT01685801|167322|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
69968|NCT01685801|167323|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
69969|NCT01685801|167324|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
69970|NCT01685801|167325|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
69971|NCT01685801|167322|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
69972|NCT01685801|167323|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
69973|NCT01685801|167324|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
69974|NCT01685801|167325|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
69975|NCT01685801|167322|P4|STARTED|Washout Period 1 (4 Weeks)||5
69976|NCT01685801|167323|P3|STARTED|Washout Period 1 (4 Weeks)||7
69977|NCT01685801|167324|P2|STARTED|Washout Period 1 (4 Weeks)||6
69978|NCT01685801|167325|P1|STARTED|Washout Period 1 (4 Weeks)||5
69979|NCT01685801|167322|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
69980|NCT01685801|167323|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
69981|NCT01685801|167324|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
69982|NCT01685801|167325|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
69983|NCT01685801|167322|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
69984|NCT01685801|167323|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
69985|NCT01685801|167324|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
69986|NCT01685801|167325|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
69987|NCT01685801|167322|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
69988|NCT01685801|167323|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
69989|NCT01685801|167324|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
69990|NCT01685801|167325|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
69991|NCT01685801|167322|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
69992|NCT01685801|167323|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
69993|NCT01685801|167324|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
69994|NCT01685801|167325|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
69995|NCT01685801|167322|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
69996|NCT01685801|167323|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
69997|NCT01685801|167324|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
69998|NCT01685801|167325|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
69999|NCT01685801|167322|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
70000|NCT01685801|167323|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
70001|NCT01685801|167324|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
70002|NCT01685801|167325|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
70003|NCT01685684|167347|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
70004|NCT01685684|167348|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
70005|NCT01685684|167349|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
70006|NCT01685684|167347|P3|COMPLETED|Double-blind Maintenance Phase||100
70007|NCT01685684|167348|P2|COMPLETED|Double-blind Maintenance Phase||122
70008|NCT01685684|167349|P1|COMPLETED|Double-blind Maintenance Phase||0
70009|NCT01685684|167347|P3|STARTED|Double-blind Maintenance Phase||196
70010|NCT01685684|167348|P2|STARTED|Double-blind Maintenance Phase||193
70011|NCT01685684|167349|P1|STARTED|Double-blind Maintenance Phase||0
70012|NCT01685684|167347|P3|NOT COMPLETED|Titration Phase||0
70013|NCT01685684|167348|P2|NOT COMPLETED|Titration Phase||0
70014|NCT01685684|167349|P1|NOT COMPLETED|Titration Phase||351
70015|NCT01685684|167347|P3|COMPLETED|Titration Phase||0
70016|NCT01685684|167348|P2|COMPLETED|Titration Phase||0
70017|NCT01685684|167349|P1|COMPLETED|Titration Phase||389
70018|NCT01685684|167347|P3|STARTED|Titration Phase||0
70019|NCT01685684|167348|P2|STARTED|Titration Phase||0
70020|NCT01685684|167349|P1|STARTED|Titration Phase||740
70021|NCT01685606|167373|P1|NOT COMPLETED|Overall Study||1
70022|NCT01685606|167373|P1|COMPLETED|Overall Study||5
70023|NCT01685606|167373|P1|STARTED|Overall Study||6
70024|NCT01685567|167378|P1|NOT COMPLETED|Overall Study||0
70025|NCT01685567|167378|P1|COMPLETED|Overall Study||219
70026|NCT01685567|167378|P1|STARTED|Overall Study||219
70027|NCT01685437|167386|P1|NOT COMPLETED|Overall Study||31
70028|NCT01685437|167386|P1|COMPLETED|Overall Study||158
70029|NCT01685437|167386|P1|STARTED|Overall Study||189
70030|NCT01685372|167400|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
70031|NCT01685372|167401|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
70032|NCT01685372|167400|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
70033|NCT01685372|167401|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
70034|NCT01685372|167400|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
70035|NCT01685372|167401|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
70036|NCT01685372|167400|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
70037|NCT01685372|167401|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
70038|NCT01685372|167400|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
70039|NCT01685372|167401|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
70040|NCT01685372|167400|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
70041|NCT01685372|167401|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
70042|NCT01685372|167400|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
70043|NCT01685372|167401|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
70044|NCT01685372|167400|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
70045|NCT01685372|167401|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
70046|NCT01685372|167400|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
70047|NCT01685372|167401|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
70048|NCT01685320|167423|P2|NOT COMPLETED|Overall Study||0
70049|NCT01685320|167424|P1|NOT COMPLETED|Overall Study||0
70050|NCT01685320|167423|P2|COMPLETED|Overall Study||15
70051|NCT01685320|167424|P1|COMPLETED|Overall Study||15
70052|NCT01685320|167423|P2|STARTED|Overall Study||15
70053|NCT01685320|167424|P1|STARTED|Overall Study||15
70054|NCT01685242|167434|P2|NOT COMPLETED|Overall Study||3
70055|NCT01685242|167435|P1|NOT COMPLETED|Overall Study||1
70056|NCT01685242|167434|P2|COMPLETED|Overall Study||47
70057|NCT01685242|167435|P1|COMPLETED|Overall Study||49
70058|NCT01685242|167434|P2|STARTED|Overall Study||50
70059|NCT01685242|167435|P1|STARTED|Overall Study||50
70060|NCT01685216|167489|P1|NOT COMPLETED|Overall Study||1
70061|NCT01685216|167489|P1|COMPLETED|Overall Study||6
70062|NCT01685216|167489|P1|STARTED|Overall Study||7
70063|NCT01685203|167506|P7|NOT COMPLETED|Overall Study||0
70064|NCT01685203|167507|P6|NOT COMPLETED|Overall Study||3
70065|NCT01685203|167508|P5|NOT COMPLETED|Overall Study||0
70066|NCT01685203|167509|P4|NOT COMPLETED|Overall Study||1
70067|NCT01685203|167510|P3|NOT COMPLETED|Overall Study||0
70068|NCT01685203|167511|P2|NOT COMPLETED|Overall Study||3
70069|NCT01685203|167512|P1|NOT COMPLETED|Overall Study||4
70070|NCT01685203|167506|P7|COMPLETED|Overall Study||52
70071|NCT01685203|167507|P6|COMPLETED|Overall Study||44
70072|NCT01685203|167508|P5|COMPLETED|Overall Study||49
70073|NCT01685203|167509|P4|COMPLETED|Overall Study||41
70074|NCT01685203|167510|P3|COMPLETED|Overall Study||40
70075|NCT01685203|167511|P2|COMPLETED|Overall Study||39
70076|NCT01685203|167512|P1|COMPLETED|Overall Study||40
70077|NCT01685203|167506|P7|Completed Study Drug|Overall Study||52
70078|NCT01685203|167507|P6|Completed Study Drug|Overall Study||43
70079|NCT01685203|167508|P5|Completed Study Drug|Overall Study||49
70080|NCT01685203|167509|P4|Completed Study Drug|Overall Study||42
70081|NCT01685203|167510|P3|Completed Study Drug|Overall Study||39
70082|NCT01685203|167511|P2|Completed Study Drug|Overall Study||40
70083|NCT01685203|167512|P1|Completed Study Drug|Overall Study||42
70084|NCT01685203|167506|P7|STARTED|Overall Study||52
70085|NCT01685203|167507|P6|STARTED|Overall Study||47
70086|NCT01685203|167508|P5|STARTED|Overall Study||49
70087|NCT01685203|167509|P4|STARTED|Overall Study||42
70088|NCT01685203|167510|P3|STARTED|Overall Study||40
70089|NCT01685203|167511|P2|STARTED|Overall Study||42
70090|NCT01685203|167512|P1|STARTED|Overall Study||44
70091|NCT01685060|167556|P1|NOT COMPLETED|Overall Study||140
70092|NCT01685060|167556|P1|COMPLETED|Overall Study||0
70093|NCT01685060|167556|P1|Discontinued From Study|Overall Study||35
70094|NCT01685060|167556|P1|Entered Survival Follow up|Overall Study||98
70095|NCT01685060|167556|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
70096|NCT01685060|167556|P1|STARTED|Overall Study||140
70097|NCT01685021|167571|P1|NOT COMPLETED|Overall Study||16
70098|NCT01685021|167571|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
70099|NCT01685021|167571|P1|STARTED|Overall Study||22
70100|NCT01684930|167582|P2|NOT COMPLETED|Overall Study||1
70101|NCT01684930|167583|P1|NOT COMPLETED|Overall Study||3
70102|NCT01684930|167582|P2|COMPLETED|Overall Study||13
70103|NCT01684930|167583|P1|COMPLETED|Overall Study||9
70104|NCT01684930|167582|P2|STARTED|Overall Study||14
70105|NCT01684930|167583|P1|STARTED|Overall Study||12
70106|NCT01684878|167603|P4|NOT COMPLETED|Part 2: Randomized Phase||78
70107|NCT01684878|167604|P3|NOT COMPLETED|Part 2: Randomized Phase||78
70108|NCT01684878|167605|P2|NOT COMPLETED|Part 2: Randomized Phase||0
70109|NCT01684878|167606|P1|NOT COMPLETED|Part 2: Randomized Phase||0
70110|NCT01684878|167603|P4|COMPLETED|Part 2: Randomized Phase||0
70111|NCT01684878|167604|P3|COMPLETED|Part 2: Randomized Phase||0
70112|NCT01684878|167605|P2|COMPLETED|Part 2: Randomized Phase||0
70113|NCT01684878|167606|P1|COMPLETED|Part 2: Randomized Phase||0
70114|NCT01684878|167603|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
70115|NCT01684878|167604|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
70116|NCT01684878|167605|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
70117|NCT01684878|167606|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
70118|NCT01684878|167603|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
70119|NCT01684878|167604|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
70120|NCT01684878|167605|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
70121|NCT01684878|167606|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
70122|NCT01684878|167603|P4|STARTED|Part 2: Randomized Phase||78
70123|NCT01684878|167604|P3|STARTED|Part 2: Randomized Phase||78
70124|NCT01684878|167605|P2|STARTED|Part 2: Randomized Phase||0
70125|NCT01684878|167606|P1|STARTED|Part 2: Randomized Phase||0
70126|NCT01684878|167603|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
70127|NCT01684878|167604|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
70128|NCT01684878|167605|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
70129|NCT01684878|167606|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
70130|NCT01684878|167603|P4|COMPLETED|Part 1: Safety Run in Phase||0
70131|NCT01684878|167604|P3|COMPLETED|Part 1: Safety Run in Phase||0
70132|NCT01684878|167605|P2|COMPLETED|Part 1: Safety Run in Phase||5
70133|NCT01684878|167606|P1|COMPLETED|Part 1: Safety Run in Phase||6
70134|NCT01684878|167603|P4|STARTED|Part 1: Safety Run in Phase||0
70135|NCT01684878|167604|P3|STARTED|Part 1: Safety Run in Phase||0
70136|NCT01684878|167605|P2|STARTED|Part 1: Safety Run in Phase||28
70137|NCT01684878|167606|P1|STARTED|Part 1: Safety Run in Phase||22
70138|NCT01684839|167630|P1|NOT COMPLETED|Overall Study||0
70139|NCT01684839|167630|P1|COMPLETED|Overall Study||9
70140|NCT01684839|167630|P1|STARTED|Overall Study||9
70141|NCT01684826|167634|P1|NOT COMPLETED|Overall Study||10
70142|NCT01684826|167634|P1|COMPLETED|Overall Study||39
70143|NCT01684826|167634|P1|Collected Dose and Image Information|Overall Study||39
70144|NCT01684826|167634|P1|STARTED|Overall Study||49
70145|NCT01684748|167642|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
70146|NCT01684748|167643|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
70147|NCT01684748|167642|P2|COMPLETED|Second Intervention - 8 Weeks||8
70148|NCT01684748|167643|P1|COMPLETED|Second Intervention - 8 Weeks||8
70149|NCT01684748|167642|P2|STARTED|Second Intervention - 8 Weeks||8
70150|NCT01684748|167643|P1|STARTED|Second Intervention - 8 Weeks||8
70151|NCT01684748|167642|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
70152|NCT01684748|167643|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
70153|NCT01684748|167642|P2|COMPLETED|First Intervention - 8 Weeks||8
70154|NCT01684748|167643|P1|COMPLETED|First Intervention - 8 Weeks||8
70155|NCT01684748|167642|P2|STARTED|First Intervention - 8 Weeks||10
70156|NCT01684748|167643|P1|STARTED|First Intervention - 8 Weeks||10
70157|NCT01684592|167652|P2|NOT COMPLETED|Overall Study||24
70158|NCT01684592|167653|P1|NOT COMPLETED|Overall Study||26
70159|NCT01684592|167652|P2|COMPLETED|Overall Study||40
70160|NCT01684592|167653|P1|COMPLETED|Overall Study||38
70161|NCT01684592|167652|P2|STARTED|Overall Study||64
70162|NCT01684592|167653|P1|STARTED|Overall Study||64
70163|NCT01684566|167673|P2|NOT COMPLETED|Overall Study||7
70164|NCT01684566|167674|P1|NOT COMPLETED|Overall Study||16
70165|NCT01684566|167673|P2|COMPLETED|Overall Study||49
70166|NCT01684566|167674|P1|COMPLETED|Overall Study||44
70167|NCT01684566|167673|P2|Treated (ITT)|Overall Study||52
70168|NCT01684566|167674|P1|Treated (ITT)|Overall Study||57
70169|NCT01684566|167673|P2|STARTED|Overall Study||56
70170|NCT01684566|167674|P1|STARTED|Overall Study||60
70171|NCT01684436|167696|P1|NOT COMPLETED|Overall Study||1
70172|NCT01684436|167696|P1|COMPLETED|Overall Study||29
70173|NCT01684436|167696|P1|STARTED|Overall Study||30
70174|NCT01684423|167710|P5|NOT COMPLETED|Overall Study||0
70175|NCT01684423|167711|P4|NOT COMPLETED|Overall Study||0
70176|NCT01684423|167712|P3|NOT COMPLETED|Overall Study||1
70177|NCT01684423|167713|P2|NOT COMPLETED|Overall Study||0
70178|NCT01684423|167714|P1|NOT COMPLETED|Overall Study||0
70179|NCT01684423|167710|P5|COMPLETED|Overall Study||7
70180|NCT01684423|167711|P4|COMPLETED|Overall Study||19
70181|NCT01684423|167712|P3|COMPLETED|Overall Study||12
70182|NCT01684423|167713|P2|COMPLETED|Overall Study||13
70183|NCT01684423|167714|P1|COMPLETED|Overall Study||11
70184|NCT01684423|167710|P5|STARTED|Overall Study||7
70185|NCT01684423|167711|P4|STARTED|Overall Study||19
70186|NCT01684423|167712|P3|STARTED|Overall Study||13
70187|NCT01684423|167713|P2|STARTED|Overall Study||13
70188|NCT01684423|167714|P1|STARTED|Overall Study||11
70189|NCT01684410|167751|P3|NOT COMPLETED|Overall Study||0
70190|NCT01684410|167752|P2|NOT COMPLETED|Overall Study||0
70191|NCT01684410|167753|P1|NOT COMPLETED|Overall Study||0
70192|NCT01684410|167751|P3|COMPLETED|Overall Study||10
70193|NCT01684410|167752|P2|COMPLETED|Overall Study||10
70194|NCT01684410|167753|P1|COMPLETED|Overall Study||10
70195|NCT01684410|167751|P3|STARTED|Overall Study||10
70196|NCT01684410|167752|P2|STARTED|Overall Study||10
70197|NCT01684410|167753|P1|STARTED|Overall Study||10
70198|NCT01684215|167771|P4|NOT COMPLETED|Overall Study||43
70199|NCT01684215|167772|P3|NOT COMPLETED|Overall Study||6
70200|NCT01684215|167773|P2|NOT COMPLETED|Overall Study||6
70201|NCT01684215|167774|P1|NOT COMPLETED|Overall Study||6
70202|NCT01684215|167771|P4|COMPLETED|Overall Study||0
70203|NCT01684215|167772|P3|COMPLETED|Overall Study||0
70204|NCT01684215|167773|P2|COMPLETED|Overall Study||0
70205|NCT01684215|167774|P1|COMPLETED|Overall Study||0
70206|NCT01684215|167771|P4|Treated|Overall Study||42
70207|NCT01684215|167772|P3|Treated|Overall Study||6
70208|NCT01684215|167773|P2|Treated|Overall Study||6
70209|NCT01684215|167774|P1|Treated|Overall Study||6
70210|NCT01684215|167771|P4|STARTED|Overall Study||43
70211|NCT01684215|167772|P3|STARTED|Overall Study||6
70212|NCT01684215|167773|P2|STARTED|Overall Study||6
70213|NCT01684215|167774|P1|STARTED|Overall Study||6
70214|NCT01684046|167848|P2|NOT COMPLETED|Period 2, Second 30 Days||0
70215|NCT01684046|167849|P1|NOT COMPLETED|Period 2, Second 30 Days||0
70216|NCT01684046|167848|P2|COMPLETED|Period 2, Second 30 Days||93
70217|NCT01684046|167849|P1|COMPLETED|Period 2, Second 30 Days||97
70218|NCT01684046|167848|P2|STARTED|Period 2, Second 30 Days||93
70219|NCT01684046|167849|P1|STARTED|Period 2, Second 30 Days||97
70220|NCT01684046|167848|P2|NOT COMPLETED|Period 1, First 30 Days||2
70221|NCT01684046|167849|P1|NOT COMPLETED|Period 1, First 30 Days||0
70222|NCT01684046|167848|P2|COMPLETED|Period 1, First 30 Days||93
70223|NCT01684046|167849|P1|COMPLETED|Period 1, First 30 Days||97
70224|NCT01684046|167848|P2|STARTED|Period 1, First 30 Days||95
70225|NCT01684046|167849|P1|STARTED|Period 1, First 30 Days||97
70226|NCT01684033|167855|P2|NOT COMPLETED|Period 2, Second 30 Days||0
70227|NCT01684033|167856|P1|NOT COMPLETED|Period 2, Second 30 Days||1
70228|NCT01684033|167855|P2|COMPLETED|Period 2, Second 30 Days||98
70229|NCT01684033|167856|P1|COMPLETED|Period 2, Second 30 Days||94
70230|NCT01684033|167855|P2|STARTED|Period 2, Second 30 Days||98
70231|NCT01684033|167856|P1|STARTED|Period 2, Second 30 Days||95
70232|NCT01684033|167855|P2|NOT COMPLETED|Period 1, First 30 Days||1
70233|NCT01684033|167856|P1|NOT COMPLETED|Period 1, First 30 Days||4
70234|NCT01684033|167855|P2|COMPLETED|Period 1, First 30 Days||98
70235|NCT01684033|167856|P1|COMPLETED|Period 1, First 30 Days||95
70236|NCT01684033|167855|P2|STARTED|Period 1, First 30 Days||99
70237|NCT01684033|167856|P1|STARTED|Period 1, First 30 Days||99
70238|NCT01684007|167866|P2|NOT COMPLETED|Overall Study||0
70239|NCT01684007|167867|P1|NOT COMPLETED|Overall Study||0
70240|NCT01684007|167866|P2|COMPLETED|Overall Study||50
70241|NCT01684007|167867|P1|COMPLETED|Overall Study||53
70242|NCT01684007|167866|P2|STARTED|Overall Study||50
70243|NCT01684007|167867|P1|STARTED|Overall Study||53
70244|NCT01683864|167878|P3|NOT COMPLETED|Overall Study||0
70245|NCT01683864|167879|P2|NOT COMPLETED|Overall Study||0
70246|NCT01683864|167880|P1|NOT COMPLETED|Overall Study||0
70247|NCT01683864|167878|P3|COMPLETED|Overall Study||0
70248|NCT01683864|167879|P2|COMPLETED|Overall Study||0
70249|NCT01683864|167880|P1|COMPLETED|Overall Study||0
70250|NCT01683864|167878|P3|STARTED|Overall Study||0
70251|NCT01683864|167879|P2|STARTED|Overall Study||0
70252|NCT01683864|167880|P1|STARTED|Overall Study||0
70253|NCT01683838|167890|P2|NOT COMPLETED|Overall Study||12
70254|NCT01683838|167891|P1|NOT COMPLETED|Overall Study||26
70255|NCT01683838|167890|P2|COMPLETED|Overall Study||88
70256|NCT01683838|167891|P1|COMPLETED|Overall Study||78
70257|NCT01683838|167890|P2|Efficacy Population|Overall Study||93
70258|NCT01683838|167891|P1|Efficacy Population|Overall Study||89
70259|NCT01683838|167890|P2|Safety Population|Overall Study||100
70260|NCT01683838|167891|P1|Safety Population|Overall Study||103
70261|NCT01683838|167890|P2|Intent to Treat (ITT) Population|Overall Study||100
70262|NCT01683838|167891|P1|Intent to Treat (ITT) Population|Overall Study||103
70263|NCT01683838|167890|P2|STARTED|Overall Study||100
70264|NCT01683838|167891|P1|STARTED|Overall Study||104
70265|NCT01683812|167913|P1|NOT COMPLETED|Overall Study||0
70266|NCT01683812|167913|P1|COMPLETED|Overall Study||23
70267|NCT01683812|167913|P1|STARTED|Overall Study||23
70268|NCT01683630|167920|P2|NOT COMPLETED|Overall Study||0
70269|NCT01683630|167921|P1|NOT COMPLETED|Overall Study||0
70270|NCT01683630|167920|P2|COMPLETED|Overall Study||445
70271|NCT01683630|167921|P1|COMPLETED|Overall Study||1404
70272|NCT01683630|167920|P2|STARTED|Overall Study||445
70273|NCT01683630|167921|P1|STARTED|Overall Study||1404
70274|NCT01683604|167931|P1|NOT COMPLETED|Overall Study||5
70275|NCT01683604|167931|P1|COMPLETED|Overall Study||32
70276|NCT01683604|167931|P1|STARTED|Overall Study||37
70277|NCT01683526|168096|P2|NOT COMPLETED|Overall Study||0
70278|NCT01683526|168097|P1|NOT COMPLETED|Overall Study||0
70279|NCT01683526|168096|P2|COMPLETED|Overall Study||57
70280|NCT01683526|168097|P1|COMPLETED|Overall Study||60
70281|NCT01683526|168096|P2|STARTED|Overall Study||57
70282|NCT01683526|168097|P1|STARTED|Overall Study||60
70283|NCT01683409|168116|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
70284|NCT01683409|168117|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
70285|NCT01683409|168118|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
70286|NCT01683409|168119|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
70287|NCT01683409|168120|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
70288|NCT01683409|168116|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
70289|NCT01683409|168117|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
70290|NCT01683409|168118|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
70291|NCT01683409|168119|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
70292|NCT01683409|168120|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
70293|NCT01683409|168116|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
70294|NCT01683409|168117|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
70295|NCT01683409|168118|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
70296|NCT01683409|168119|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
70297|NCT01683409|168120|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
70298|NCT01683409|168116|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
70299|NCT01683409|168117|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
70300|NCT01683409|168118|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
70301|NCT01683409|168119|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
70302|NCT01683409|168120|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
70303|NCT01683409|168116|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
70304|NCT01683409|168117|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
70305|NCT01683409|168118|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
70306|NCT01683409|168119|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
70307|NCT01683409|168120|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
70308|NCT01683409|168116|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
70309|NCT01683409|168117|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
70310|NCT01683409|168118|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
70311|NCT01683409|168119|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
70312|NCT01683409|168120|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
70313|NCT01683409|168116|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
70314|NCT01683409|168117|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
70315|NCT01683409|168118|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
70316|NCT01683409|168119|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
70317|NCT01683409|168120|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
70318|NCT01683409|168116|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
70319|NCT01683409|168117|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
70320|NCT01683409|168118|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
70321|NCT01683409|168119|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
70322|NCT01683409|168120|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
70323|NCT01683409|168116|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
70324|NCT01683409|168117|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
70325|NCT01683409|168118|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
70326|NCT01683409|168119|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
70327|NCT01683409|168120|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
70328|NCT01683409|168116|P5|STARTED|Treatment Period (Weeks 1-24)||25
70329|NCT01683409|168117|P4|STARTED|Treatment Period (Weeks 1-24)||26
70330|NCT01683409|168118|P3|STARTED|Treatment Period (Weeks 1-24)||27
70331|NCT01683409|168119|P2|STARTED|Treatment Period (Weeks 1-24)||25
70332|NCT01683409|168120|P1|STARTED|Treatment Period (Weeks 1-24)||27
70333|NCT01683383|168163|P2|NOT COMPLETED|Overall Study||0
70334|NCT01683383|168164|P1|NOT COMPLETED|Overall Study||1
70335|NCT01683383|168163|P2|COMPLETED|Overall Study||51
70336|NCT01683383|168164|P1|COMPLETED|Overall Study||49
70337|NCT01683383|168163|P2|Transported and Treated|Overall Study||51
70338|NCT01683383|168164|P1|Transported and Treated|Overall Study||49
70339|NCT01683383|168163|P2|STARTED|Overall Study||51
70340|NCT01683383|168164|P1|STARTED|Overall Study||50
70341|NCT01683266|168180|P2|NOT COMPLETED|Overall Study||50
70342|NCT01683266|168181|P1|NOT COMPLETED|Overall Study||55
70343|NCT01683266|168180|P2|COMPLETED|Overall Study||225
70344|NCT01683266|168181|P1|COMPLETED|Overall Study||219
70345|NCT01683266|168180|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
70346|NCT01683266|168181|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
70347|NCT01683266|168180|P2|STARTED|Overall Study||275
70348|NCT01683266|168181|P1|STARTED|Overall Study||274
70349|NCT01683058|168209|P1|NOT COMPLETED|Overall Study||29
70350|NCT01683058|168209|P1|COMPLETED|Overall Study||45
70351|NCT01683058|168209|P1|STARTED|Overall Study||74
70352|NCT01683019|168240|P3|NOT COMPLETED|Overall Study||4
70353|NCT01683019|168241|P2|NOT COMPLETED|Overall Study||1
70354|NCT01683019|168242|P1|NOT COMPLETED|Overall Study||2
70355|NCT01683019|168240|P3|COMPLETED|Overall Study||15
70356|NCT01683019|168241|P2|COMPLETED|Overall Study||14
70357|NCT01683019|168242|P1|COMPLETED|Overall Study||16
70358|NCT01683019|168240|P3|STARTED|Overall Study||19
70359|NCT01683019|168241|P2|STARTED|Overall Study||15
70360|NCT01683019|168242|P1|STARTED|Overall Study||18
70361|NCT01682954|168252|P2|NOT COMPLETED|Overall Study||5
70362|NCT01682954|168253|P1|NOT COMPLETED|Overall Study||5
70363|NCT01682954|168252|P2|COMPLETED|Overall Study||33
70364|NCT01682954|168253|P1|COMPLETED|Overall Study||35
70365|NCT01682954|168252|P2|STARTED|Overall Study||38
70366|NCT01682954|168253|P1|STARTED|Overall Study||40
70367|NCT01682876|168265|P4|NOT COMPLETED|Overall Study||19
70368|NCT01682876|168266|P3|NOT COMPLETED|Overall Study||11
70369|NCT01682876|168267|P2|NOT COMPLETED|Overall Study||20
70370|NCT01682876|168268|P1|NOT COMPLETED|Overall Study||21
70371|NCT01682876|168265|P4|COMPLETED|Overall Study||157
70372|NCT01682876|168266|P3|COMPLETED|Overall Study||169
70373|NCT01682876|168267|P2|COMPLETED|Overall Study||163
70374|NCT01682876|168268|P1|COMPLETED|Overall Study||155
70375|NCT01682876|168265|P4|STARTED|Overall Study||176
70376|NCT01682876|168266|P3|STARTED|Overall Study||180
70377|NCT01682876|168267|P2|STARTED|Overall Study||183
70378|NCT01682876|168268|P1|STARTED|Overall Study||176
70379|NCT01682863|168314|P3|NOT COMPLETED|Overall Study||24
70380|NCT01682863|168315|P2|NOT COMPLETED|Overall Study||17
70381|NCT01682863|168316|P1|NOT COMPLETED|Overall Study||27
70382|NCT01682863|168314|P3|COMPLETED|Overall Study||183
70383|NCT01682863|168315|P2|COMPLETED|Overall Study||187
70384|NCT01682863|168316|P1|COMPLETED|Overall Study||177
70385|NCT01682863|168314|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
70386|NCT01682863|168315|P2|Randomized Set|Overall Study||204
70387|NCT01682863|168316|P1|Randomized Set|Overall Study||204
70388|NCT01682863|168314|P3|Full Analysis Set (FAS)|Overall Study||206
70389|NCT01682863|168315|P2|Full Analysis Set (FAS)|Overall Study||204
70390|NCT01682863|168316|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
70391|NCT01682863|168314|P3|Safety Set|Overall Study||206
70392|NCT01682863|168315|P2|Safety Set|Overall Study||204
70393|NCT01682863|168316|P1|Safety Set|Overall Study||204
70394|NCT01682863|168314|P3|STARTED|Overall Study||207
70395|NCT01682863|168315|P2|STARTED|Overall Study||204
70396|NCT01682863|168316|P1|STARTED|Overall Study||204
70397|NCT01682837|168345|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
70398|NCT01682837|168345|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
70399|NCT01682837|168345|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
70400|NCT01682837|168345|P1|Received KCl|Fourth Intervention (4 Weeks)||8
70401|NCT01682837|168345|P1|Received KCit|Fourth Intervention (4 Weeks)||9
70402|NCT01682837|168345|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
70403|NCT01682837|168345|P1|STARTED|Fourth Intervention (4 Weeks)||30
70404|NCT01682837|168345|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
70405|NCT01682837|168345|P1|COMPLETED|Third Intervention (4 Weeks)||30
70406|NCT01682837|168345|P1|Received Placebo|Third Intervention (4 Weeks)||7
70407|NCT01682837|168345|P1|Received KCl|Third Intervention (4 Weeks)||7
70408|NCT01682837|168345|P1|Received KCit|Third Intervention (4 Weeks)||7
70409|NCT01682837|168345|P1|Received KMgCit|Third Intervention (4 Weeks)||9
70410|NCT01682837|168345|P1|STARTED|Third Intervention (4 Weeks)||30
70411|NCT01682837|168345|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
70412|NCT01682837|168345|P1|COMPLETED|Second Intervention (4 Weeks)||30
70413|NCT01682837|168345|P1|Received Placebo|Second Intervention (4 Weeks)||9
70414|NCT01682837|168345|P1|Received KCl|Second Intervention (4 Weeks)||8
70415|NCT01682837|168345|P1|Received KCit|Second Intervention (4 Weeks)||6
70416|NCT01682837|168345|P1|Received KMgCit|Second Intervention (4 Weeks)||7
70417|NCT01682837|168345|P1|STARTED|Second Intervention (4 Weeks)||30
70418|NCT01682837|168345|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
70419|NCT01682837|168345|P1|COMPLETED|First Intervention (4 Weeks)||30
70420|NCT01682837|168345|P1|Received Placebo|First Intervention (4 Weeks)||7
70421|NCT01682837|168345|P1|Received KCl|First Intervention (4 Weeks)||7
70422|NCT01682837|168345|P1|Received KCit|First Intervention (4 Weeks)||8
70423|NCT01682837|168345|P1|Received KMgCit|First Intervention (4 Weeks)||8
70424|NCT01682837|168345|P1|STARTED|First Intervention (4 Weeks)||30
70425|NCT01682837|168345|P1|NOT COMPLETED|Baseline||5
70426|NCT01682837|168345|P1|COMPLETED|Baseline||30
70427|NCT01682837|168345|P1|STARTED|Baseline||35
70428|NCT01682759|168389|P2|NOT COMPLETED|Overall Study||70
70429|NCT01682759|168390|P1|NOT COMPLETED|Overall Study||69
70430|NCT01682759|168389|P2|COMPLETED|Overall Study||305
70431|NCT01682759|168390|P1|COMPLETED|Overall Study||307
70432|NCT01682759|168389|P2|Treated|Overall Study||375
70433|NCT01682759|168390|P1|Treated|Overall Study||375
70434|NCT01682759|168389|P2|STARTED|Overall Study||375
70435|NCT01682759|168390|P1|STARTED|Overall Study||376
70436|NCT01682720|168414|P4|NOT COMPLETED|Overall Study||39
70437|NCT01682720|168415|P3|NOT COMPLETED|Overall Study||7
70438|NCT01682720|168416|P2|NOT COMPLETED|Overall Study||5
70439|NCT01682720|168417|P1|NOT COMPLETED|Overall Study||85
70440|NCT01682720|168414|P4|COMPLETED|Overall Study||211
70441|NCT01682720|168415|P3|COMPLETED|Overall Study||5
70442|NCT01682720|168416|P2|COMPLETED|Overall Study||69
70443|NCT01682720|168417|P1|COMPLETED|Overall Study||0
70444|NCT01682720|168414|P4|Included in Full Analysis Set|Overall Study||250
70445|NCT01682720|168415|P3|Included in Full Analysis Set|Overall Study||11
70446|NCT01682720|168416|P2|Included in Full Analysis Set|Overall Study||73
70447|NCT01682720|168417|P1|Included in Full Analysis Set|Overall Study||0
70448|NCT01682720|168414|P4|STARTED|Overall Study||250
70449|NCT01682720|168415|P3|STARTED|Overall Study||12
70450|NCT01682720|168416|P2|STARTED|Overall Study||74
70451|NCT01682720|168417|P1|STARTED|Overall Study||85
70452|NCT01682681|168434|P1|NOT COMPLETED|Overall Study||332
70453|NCT01682681|168434|P1|COMPLETED|Overall Study||902
70454|NCT01682681|168434|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
70455|NCT01682681|168434|P1|STARTED|Overall Study||1234
70456|NCT01682642|168444|P2|NOT COMPLETED|Overall Study||1
70457|NCT01682642|168445|P1|NOT COMPLETED|Overall Study||0
70458|NCT01682642|168444|P2|COMPLETED|Overall Study||58
70459|NCT01682642|168445|P1|COMPLETED|Overall Study||61
70460|NCT01682642|168444|P2|STARTED|Overall Study||59
70461|NCT01682642|168445|P1|STARTED|Overall Study||61
70462|NCT01682603|168463|P1|NOT COMPLETED|Overall Study||3
70463|NCT01682603|168463|P1|COMPLETED|Overall Study||34
70464|NCT01682603|168463|P1|STARTED|Overall Study||37
70465|NCT01682538|168477|P1|NOT COMPLETED|Overall Study||0
70466|NCT01682538|168477|P1|COMPLETED|Overall Study||12
70467|NCT01682538|168477|P1|STARTED|Overall Study||12
70468|NCT01682512|168508|P3|NOT COMPLETED|Overall Study||18
70469|NCT01682512|168509|P2|NOT COMPLETED|Overall Study||71
70470|NCT01682512|168510|P1|NOT COMPLETED|Overall Study||72
70471|NCT01682512|168508|P3|COMPLETED|Overall Study||48
70472|NCT01682512|168509|P2|COMPLETED|Overall Study||40
70473|NCT01682512|168510|P1|COMPLETED|Overall Study||44
70474|NCT01682512|168508|P3|Randomized in Part-II|Overall Study||0
70475|NCT01682512|168509|P2|Randomized in Part-II|Overall Study||46
70476|NCT01682512|168510|P1|Randomized in Part-II|Overall Study||50
70477|NCT01682512|168508|P3|Randomized in Part-I|Overall Study||66
70478|NCT01682512|168509|P2|Randomized in Part-I|Overall Study||65
70479|NCT01682512|168510|P1|Randomized in Part-I|Overall Study||66
70480|NCT01682512|168508|P3|STARTED|Overall Study||66
70481|NCT01682512|168509|P2|STARTED|Overall Study||111
70482|NCT01682512|168510|P1|STARTED|Overall Study||116
70483|NCT01682460|168535|P1|NOT COMPLETED|Overall Study||4
70484|NCT01682460|168535|P1|COMPLETED|Overall Study||11
70485|NCT01682460|168535|P1|STARTED|Overall Study||15
70486|NCT01682135|168553|P3|NOT COMPLETED|Overall Study||0
70487|NCT01682135|168554|P2|NOT COMPLETED|Overall Study||0
70488|NCT01682135|168555|P1|NOT COMPLETED|Overall Study||0
70489|NCT01682135|168553|P3|COMPLETED|Overall Study||12
70490|NCT01682135|168554|P2|COMPLETED|Overall Study||10
70491|NCT01682135|168555|P1|COMPLETED|Overall Study||6
70492|NCT01682135|168553|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
70493|NCT01682135|168554|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
70580|NCT01681277|168720|P1|COMPLETED|Overall Study||11
70494|NCT01682135|168555|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
70495|NCT01682135|168553|P3|STARTED|Overall Study||12
70496|NCT01682135|168554|P2|STARTED|Overall Study||10
70497|NCT01682135|168555|P1|STARTED|Overall Study||6
70498|NCT01682044|168587|P1|NOT COMPLETED|Overall Study||4
70499|NCT01682044|168587|P1|COMPLETED|Overall Study||16
70500|NCT01682044|168587|P1|STARTED|Overall Study||20
70501|NCT01682031|168599|P2|NOT COMPLETED|Overall Study||5
70502|NCT01682031|168600|P1|NOT COMPLETED|Overall Study||1
70503|NCT01682031|168599|P2|COMPLETED|Overall Study||5
70504|NCT01682031|168600|P1|COMPLETED|Overall Study||7
70505|NCT01682031|168599|P2|STARTED|Overall Study||10
70506|NCT01682031|168600|P1|STARTED|Overall Study||8
70507|NCT01681849|168623|P3|NOT COMPLETED|Overall Study||39
70508|NCT01681849|168624|P2|NOT COMPLETED|Overall Study||7
70509|NCT01681849|168625|P1|NOT COMPLETED|Overall Study||8
70510|NCT01681849|168623|P3|COMPLETED|Overall Study||17
70511|NCT01681849|168624|P2|COMPLETED|Overall Study||6
70512|NCT01681849|168625|P1|COMPLETED|Overall Study||7
70513|NCT01681849|168623|P3|STARTED|Overall Study||56
70514|NCT01681849|168624|P2|STARTED|Overall Study||13
70515|NCT01681849|168625|P1|STARTED|Overall Study||15
70516|NCT01681628|168636|P2|NOT COMPLETED|19 Months Follow-up||43
70517|NCT01681628|168637|P1|NOT COMPLETED|19 Months Follow-up||62
70518|NCT01681628|168636|P2|COMPLETED|19 Months Follow-up||64
70519|NCT01681628|168637|P1|COMPLETED|19 Months Follow-up||52
70520|NCT01681628|168636|P2|STARTED|19 Months Follow-up||107
70521|NCT01681628|168637|P1|STARTED|19 Months Follow-up||114
70522|NCT01681628|168636|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
70523|NCT01681628|168637|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
70524|NCT01681628|168636|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
70525|NCT01681628|168637|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
70526|NCT01681628|168636|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
70527|NCT01681628|168637|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
70528|NCT01681628|168636|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
70529|NCT01681628|168637|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
70530|NCT01681628|168636|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
70531|NCT01681628|168637|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
70532|NCT01681628|168636|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
70533|NCT01681628|168637|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
70534|NCT01681576|168650|P2|NOT COMPLETED|Period 2||1
70535|NCT01681576|168651|P1|NOT COMPLETED|Period 2||4
70536|NCT01681576|168650|P2|COMPLETED|Period 2||35
70537|NCT01681576|168651|P1|COMPLETED|Period 2||30
70538|NCT01681576|168650|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
70539|NCT01681576|168651|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
70540|NCT01681576|168650|P2|NOT COMPLETED|Period 1||0
70541|NCT01681576|168651|P1|NOT COMPLETED|Period 1||2
70542|NCT01681576|168650|P2|COMPLETED|Period 1||36
70543|NCT01681576|168651|P1|COMPLETED|Period 1||34
70544|NCT01681576|168650|P2|STARTED|Period 1||36
70545|NCT01681576|168651|P1|STARTED|Period 1||36
70546|NCT01681511|168667|P2|NOT COMPLETED|Overall Study||14
70547|NCT01681511|168668|P1|NOT COMPLETED|Overall Study||18
70548|NCT01681511|168667|P2|COMPLETED|Overall Study||35
70549|NCT01681511|168668|P1|COMPLETED|Overall Study||28
70550|NCT01681511|168667|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
70551|NCT01681511|168668|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
70552|NCT01681511|168667|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
70553|NCT01681511|168668|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
70554|NCT01681511|168667|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
70555|NCT01681511|168668|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
70556|NCT01681472|168686|P4|NOT COMPLETED|Overall Study||0
70557|NCT01681472|168687|P3|NOT COMPLETED|Overall Study||0
70558|NCT01681472|168688|P2|NOT COMPLETED|Overall Study||1
70559|NCT01681472|168689|P1|NOT COMPLETED|Overall Study||0
70560|NCT01681472|168686|P4|COMPLETED|Overall Study||8
70561|NCT01681472|168687|P3|COMPLETED|Overall Study||8
70562|NCT01681472|168688|P2|COMPLETED|Overall Study||7
70563|NCT01681472|168689|P1|COMPLETED|Overall Study||8
70564|NCT01681472|168686|P4|STARTED|Overall Study||8
70565|NCT01681472|168687|P3|STARTED|Overall Study||8
70566|NCT01681472|168688|P2|STARTED|Overall Study||8
70567|NCT01681472|168689|P1|STARTED|Overall Study||8
70568|NCT01681368|168699|P1|NOT COMPLETED|Overall Study||2
70569|NCT01681368|168699|P1|COMPLETED|Overall Study||9
70570|NCT01681368|168699|P1|STARTED|Overall Study||11
70571|NCT01681277|168716|P5|NOT COMPLETED|Overall Study||0
70572|NCT01681277|168717|P4|NOT COMPLETED|Overall Study||0
70573|NCT01681277|168718|P3|NOT COMPLETED|Overall Study||0
70574|NCT01681277|168719|P2|NOT COMPLETED|Overall Study||0
70575|NCT01681277|168720|P1|NOT COMPLETED|Overall Study||1
70576|NCT01681277|168716|P5|COMPLETED|Overall Study||9
70577|NCT01681277|168717|P4|COMPLETED|Overall Study||9
70578|NCT01681277|168718|P3|COMPLETED|Overall Study||9
70579|NCT01681277|168719|P2|COMPLETED|Overall Study||9
70581|NCT01681277|168716|P5|STARTED|Overall Study||9
70582|NCT01681277|168717|P4|STARTED|Overall Study||9
70583|NCT01681277|168718|P3|STARTED|Overall Study||9
70584|NCT01681277|168719|P2|STARTED|Overall Study||9
70585|NCT01681277|168720|P1|STARTED|Overall Study||12
70586|NCT01681212|168761|P1|NOT COMPLETED|Overall Study||6
70587|NCT01681212|168761|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
70588|NCT01681212|168761|P1|Received Treatment|Overall Study||15
70589|NCT01681212|168761|P1|STARTED|Overall Study|Enrolled|21
70590|NCT01681121|168769|P2|NOT COMPLETED|Overall Study||11
70591|NCT01681121|168770|P1|NOT COMPLETED|Overall Study||8
70592|NCT01681121|168769|P2|COMPLETED|Overall Study||38
70593|NCT01681121|168770|P1|COMPLETED|Overall Study||36
70594|NCT01681121|168769|P2|STARTED|Overall Study||49
70595|NCT01681121|168770|P1|STARTED|Overall Study||44
70596|NCT01681095|168778|P2|NOT COMPLETED|Overall Study||0
70597|NCT01681095|168779|P1|NOT COMPLETED|Overall Study||0
70598|NCT01681095|168778|P2|COMPLETED|Overall Study||55
70599|NCT01681095|168779|P1|COMPLETED|Overall Study||55
70600|NCT01681095|168778|P2|STARTED|Overall Study||55
70601|NCT01681095|168779|P1|STARTED|Overall Study||55
70602|NCT01681069|168819|P2|NOT COMPLETED|Overall Study||7
70603|NCT01681069|168820|P1|NOT COMPLETED|Overall Study||5
70604|NCT01681069|168819|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
70605|NCT01681069|168820|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
70606|NCT01681069|168819|P2|Full Analysis Set (FAS)|Overall Study||60
70607|NCT01681069|168820|P1|Full Analysis Set (FAS)|Overall Study||57
70608|NCT01681069|168819|P2|STARTED|Overall Study||60
70609|NCT01681069|168820|P1|STARTED|Overall Study||60
70610|NCT01681030|168833|P3|NOT COMPLETED|Overall Study||0
70611|NCT01681030|168834|P2|NOT COMPLETED|Overall Study||0
70612|NCT01681030|168835|P1|NOT COMPLETED|Overall Study||0
70613|NCT01681030|168833|P3|COMPLETED|Overall Study||11
70614|NCT01681030|168834|P2|COMPLETED|Overall Study||18
70615|NCT01681030|168835|P1|COMPLETED|Overall Study||13
70616|NCT01681030|168833|P3|STARTED|Overall Study||11
70617|NCT01681030|168834|P2|STARTED|Overall Study||18
70618|NCT01681030|168835|P1|STARTED|Overall Study||13
70619|NCT01681004|168857|P2|NOT COMPLETED|Study Completion||8
70620|NCT01681004|168858|P1|NOT COMPLETED|Study Completion||12
70621|NCT01681004|168857|P2|COMPLETED|Study Completion||36
70622|NCT01681004|168858|P1|COMPLETED|Study Completion||89
70623|NCT01681004|168857|P2|STARTED|Study Completion||44
70624|NCT01681004|168858|P1|STARTED|Study Completion||101
70625|NCT01681004|168857|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
70626|NCT01681004|168858|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
70627|NCT01681004|168857|P2|COMPLETED|Primary Endpoint: 6 Months||44
70628|NCT01681004|168858|P1|COMPLETED|Primary Endpoint: 6 Months||101
70629|NCT01681004|168857|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
70630|NCT01681004|168858|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
70631|NCT01681004|168857|P2|STARTED|Primary Endpoint: 6 Months||46
70632|NCT01681004|168858|P1|STARTED|Primary Endpoint: 6 Months||102
70633|NCT01680991|168915|P3|NOT COMPLETED|Overall Study||4
70634|NCT01680991|168916|P2|NOT COMPLETED|Overall Study||19
70635|NCT01680991|168917|P1|NOT COMPLETED|Overall Study||8
70636|NCT01680991|168915|P3|COMPLETED|Overall Study||9
70637|NCT01680991|168916|P2|COMPLETED|Overall Study||4
70638|NCT01680991|168917|P1|COMPLETED|Overall Study||4
70639|NCT01680991|168915|P3|STARTED|Overall Study||13
70640|NCT01680991|168916|P2|STARTED|Overall Study||23
70641|NCT01680991|168917|P1|STARTED|Overall Study||12
70642|NCT01680900|168978|P2|NOT COMPLETED|Overall Study||1
70643|NCT01680900|168979|P1|NOT COMPLETED|Overall Study||4
70644|NCT01680900|168978|P2|COMPLETED|Overall Study||11
70645|NCT01680900|168979|P1|COMPLETED|Overall Study||20
70646|NCT01680900|168978|P2|STARTED|Overall Study||12
70647|NCT01680900|168979|P1|STARTED|Overall Study||24
70648|NCT01680861|168997|P2|NOT COMPLETED|First 12 Months Post-transplant||0
70649|NCT01680861|168998|P1|NOT COMPLETED|First 12 Months Post-transplant||0
70650|NCT01680861|168997|P2|COMPLETED|First 12 Months Post-transplant||15
70651|NCT01680861|168998|P1|COMPLETED|First 12 Months Post-transplant||15
70652|NCT01680861|168997|P2|STARTED|First 12 Months Post-transplant||15
70653|NCT01680861|168998|P1|STARTED|First 12 Months Post-transplant||15
70654|NCT01680861|168997|P2|NOT COMPLETED|Early Post-transplant Period||1
70655|NCT01680861|168998|P1|NOT COMPLETED|Early Post-transplant Period||1
70656|NCT01680861|168997|P2|COMPLETED|Early Post-transplant Period||15
70657|NCT01680861|168998|P1|COMPLETED|Early Post-transplant Period||15
70658|NCT01680861|168997|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
70659|NCT01680861|168998|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
70660|NCT01680848|169016|P1|NOT COMPLETED|Overall Study||93
70661|NCT01680848|169016|P1|COMPLETED|Overall Study||189
70662|NCT01680848|169016|P1|STARTED|Overall Study||282
70663|NCT01680783|169022|P2|NOT COMPLETED|Overall Study||0
70664|NCT01680783|169023|P1|NOT COMPLETED|Overall Study||0
70665|NCT01680783|169022|P2|COMPLETED|Overall Study||44
70666|NCT01680783|169023|P1|COMPLETED|Overall Study||39
70667|NCT01680783|169022|P2|STARTED|Overall Study||44
70668|NCT01680783|169023|P1|STARTED|Overall Study||39
70669|NCT01680666|169031|P2|NOT COMPLETED|Overall Study||0
70670|NCT01680666|169032|P1|NOT COMPLETED|Overall Study||0
70671|NCT01680666|169031|P2|COMPLETED|Overall Study||66
70672|NCT01680666|169032|P1|COMPLETED|Overall Study||84
70673|NCT01680666|169031|P2|STARTED|Overall Study||66
70674|NCT01680666|169032|P1|STARTED|Overall Study||84
70675|NCT01680653|169046|P1|NOT COMPLETED|Overall Study||0
70676|NCT01680653|169046|P1|COMPLETED|Overall Study||57
70677|NCT01680653|169046|P1|STARTED|Overall Study||57
70678|NCT01680549|169058|P2|NOT COMPLETED|Overall Study||8
70679|NCT01680549|169059|P1|NOT COMPLETED|Overall Study||5
70680|NCT01680549|169058|P2|COMPLETED|Overall Study||17
70681|NCT01680549|169059|P1|COMPLETED|Overall Study||20
70682|NCT01680549|169058|P2|STARTED|Overall Study||25
70683|NCT01680549|169059|P1|STARTED|Overall Study||25
70684|NCT01680497|169071|P1|NOT COMPLETED|Overall Study||2
70685|NCT01680497|169071|P1|COMPLETED|Overall Study||68
70686|NCT01680497|169071|P1|STARTED|Overall Study||70
70687|NCT01680458|169081|P1|NOT COMPLETED|Overall Study||3
70688|NCT01680458|169081|P1|COMPLETED|Overall Study||27
70689|NCT01680458|169081|P1|STARTED|Overall Study||30
70690|NCT01680341|169092|P2|NOT COMPLETED|Overall Study||17
70691|NCT01680341|169093|P1|NOT COMPLETED|Overall Study||21
70692|NCT01680341|169092|P2|COMPLETED|Overall Study||119
70693|NCT01680341|169093|P1|COMPLETED|Overall Study||115
70694|NCT01680341|169092|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
70695|NCT01680341|169093|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
70696|NCT01680341|169092|P2|STARTED|Overall Study||136
70697|NCT01680341|169093|P1|STARTED|Overall Study||136
70698|NCT01680328|169113|P1|NOT COMPLETED|Overall Study||2
70699|NCT01680328|169113|P1|COMPLETED|Overall Study||80
70700|NCT01680328|169113|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
70701|NCT01680328|169113|P1|STARTED|Overall Study||82
70702|NCT01680172|169151|P2|NOT COMPLETED|Overall Study||0
70703|NCT01680172|169152|P1|NOT COMPLETED|Overall Study||0
70704|NCT01680172|169151|P2|COMPLETED|Overall Study||2
70705|NCT01680172|169152|P1|COMPLETED|Overall Study||3
70706|NCT01680172|169151|P2|STARTED|Overall Study||2
70707|NCT01680172|169152|P1|STARTED|Overall Study||3
70708|NCT01680159|169164|P1|NOT COMPLETED|Increased Dose Period||8
70709|NCT01680159|169164|P1|COMPLETED|Increased Dose Period||43
70710|NCT01680159|169164|P1|STARTED|Increased Dose Period||51
70711|NCT01680159|169164|P1|NOT COMPLETED|Screening Period||7
70712|NCT01680159|169164|P1|COMPLETED|Screening Period||39
70713|NCT01680159|169164|P1|STARTED|Screening Period||46
70714|NCT01680016|169191|P4|NOT COMPLETED|Overall Study||5
70715|NCT01680016|169192|P3|NOT COMPLETED|Overall Study||5
70716|NCT01680016|169193|P2|NOT COMPLETED|Overall Study||8
70717|NCT01680016|169194|P1|NOT COMPLETED|Overall Study||6
70718|NCT01680016|169191|P4|COMPLETED|Overall Study||195
70719|NCT01680016|169192|P3|COMPLETED|Overall Study||196
70720|NCT01680016|169193|P2|COMPLETED|Overall Study||114
70721|NCT01680016|169194|P1|COMPLETED|Overall Study||115
70722|NCT01680016|169191|P4|STARTED|Overall Study||200
70723|NCT01680016|169192|P3|STARTED|Overall Study||201
70724|NCT01680016|169193|P2|STARTED|Overall Study||122
70725|NCT01680016|169194|P1|STARTED|Overall Study||121
70726|NCT01679613|169256|P4|NOT COMPLETED|Overall Study||2
70727|NCT01679613|169257|P3|NOT COMPLETED|Overall Study||2
70728|NCT01679613|169258|P2|NOT COMPLETED|Overall Study||1
70729|NCT01679613|169259|P1|NOT COMPLETED|Overall Study||0
70730|NCT01679613|169256|P4|COMPLETED|Overall Study||11
70731|NCT01679613|169257|P3|COMPLETED|Overall Study||11
70732|NCT01679613|169258|P2|COMPLETED|Overall Study||3
70733|NCT01679613|169259|P1|COMPLETED|Overall Study||4
70734|NCT01679613|169256|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
70735|NCT01679613|169257|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
70736|NCT01679613|169258|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
70737|NCT01679613|169259|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
70738|NCT01679613|169256|P4|Received Nintedanib (Main)|Overall Study||11
70739|NCT01679613|169257|P3|Received Nintedanib (Main)|Overall Study||13
70740|NCT01679613|169258|P2|Received Nintedanib (Main)|Overall Study||0
70741|NCT01679613|169259|P1|Received Nintedanib (Main)|Overall Study||0
70742|NCT01679613|169256|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
70743|NCT01679613|169257|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
70744|NCT01679613|169258|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
70745|NCT01679613|169259|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
70746|NCT01679613|169256|P4|Received Nintedanib (Pilot)|Overall Study||0
70747|NCT01679613|169257|P3|Received Nintedanib (Pilot)|Overall Study||0
70748|NCT01679613|169258|P2|Received Nintedanib (Pilot)|Overall Study||3
70749|NCT01679613|169259|P1|Received Nintedanib (Pilot)|Overall Study||4
70750|NCT01679613|169256|P4|STARTED|Overall Study||13
70751|NCT01679613|169257|P3|STARTED|Overall Study||13
70752|NCT01679613|169258|P2|STARTED|Overall Study||4
70753|NCT01679613|169259|P1|STARTED|Overall Study||4
70754|NCT01679600|169272|P2|NOT COMPLETED|Overall Study||0
70755|NCT01679600|169273|P1|NOT COMPLETED|Overall Study||0
70756|NCT01679600|169272|P2|COMPLETED|Overall Study||7
70757|NCT01679600|169273|P1|COMPLETED|Overall Study||7
70758|NCT01679600|169272|P2|STARTED|Overall Study||7
70759|NCT01679600|169273|P1|STARTED|Overall Study||7
70760|NCT01679314|169281|P2|NOT COMPLETED|Overall Study||0
70761|NCT01679314|169282|P1|NOT COMPLETED|Overall Study||2
70762|NCT01679314|169281|P2|COMPLETED|Overall Study||28
70763|NCT01679314|169282|P1|COMPLETED|Overall Study||24
70764|NCT01679314|169281|P2|STARTED|Overall Study||28
70765|NCT01679314|169282|P1|STARTED|Overall Study||26
70766|NCT01679236|169302|P2|NOT COMPLETED|Overall Study||15
70767|NCT01679236|169303|P1|NOT COMPLETED|Overall Study||15
70768|NCT01679236|169302|P2|COMPLETED|Overall Study||10
70769|NCT01679236|169303|P1|COMPLETED|Overall Study||15
70770|NCT01679236|169302|P2|STARTED|Overall Study||25
70771|NCT01679236|169303|P1|STARTED|Overall Study||30
70772|NCT01679197|169309|P1|NOT COMPLETED|Overall Study||4
70773|NCT01679197|169309|P1|COMPLETED|Overall Study||19
70774|NCT01679197|169309|P1|STARTED|Overall Study||23
70775|NCT01679028|169328|P6|NOT COMPLETED|Overall Study||0
70776|NCT01679028|169329|P5|NOT COMPLETED|Overall Study||0
70777|NCT01679028|169330|P4|NOT COMPLETED|Overall Study||0
70778|NCT01679028|169331|P3|NOT COMPLETED|Overall Study||0
70779|NCT01679028|169332|P2|NOT COMPLETED|Overall Study||0
70780|NCT01679028|169333|P1|NOT COMPLETED|Overall Study||0
70781|NCT01679028|169328|P6|COMPLETED|Overall Study||6
70782|NCT01679028|169329|P5|COMPLETED|Overall Study||2
70783|NCT01679028|169330|P4|COMPLETED|Overall Study||4
70784|NCT01679028|169331|P3|COMPLETED|Overall Study||2
70785|NCT01679028|169332|P2|COMPLETED|Overall Study||4
70786|NCT01679028|169333|P1|COMPLETED|Overall Study||2
70787|NCT01679028|169328|P6|STARTED|Overall Study||6
70788|NCT01679028|169329|P5|STARTED|Overall Study||2
70789|NCT01679028|169330|P4|STARTED|Overall Study||4
70790|NCT01679028|169331|P3|STARTED|Overall Study||2
70791|NCT01679028|169332|P2|STARTED|Overall Study||4
70792|NCT01679028|169333|P1|STARTED|Overall Study||2
70793|NCT01679002|169350|P3|NOT COMPLETED|Overall Study||0
70794|NCT01679002|169351|P2|NOT COMPLETED|Overall Study||1
70795|NCT01679002|169352|P1|NOT COMPLETED|Overall Study||1
70796|NCT01679002|169350|P3|COMPLETED|Overall Study||4
70797|NCT01679002|169351|P2|COMPLETED|Overall Study||3
70798|NCT01679002|169352|P1|COMPLETED|Overall Study||3
70799|NCT01679002|169350|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
70800|NCT01679002|169351|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
70801|NCT01679002|169352|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
70802|NCT01679002|169350|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
70803|NCT01679002|169351|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
70804|NCT01679002|169352|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
70805|NCT01679002|169350|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
70806|NCT01679002|169351|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
70807|NCT01679002|169352|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
70808|NCT01679002|169350|P3|STARTED|Overall Study||4
70809|NCT01679002|169351|P2|STARTED|Overall Study||4
70810|NCT01679002|169352|P1|STARTED|Overall Study||4
70811|NCT01678976|169368|P2|NOT COMPLETED|Second Period||0
70812|NCT01678976|169369|P1|NOT COMPLETED|Second Period||0
70813|NCT01678976|169368|P2|COMPLETED|Second Period||6
70814|NCT01678976|169369|P1|COMPLETED|Second Period||6
70815|NCT01678976|169368|P2|STARTED|Second Period||6
70816|NCT01678976|169369|P1|STARTED|Second Period||6
70817|NCT01678976|169368|P2|NOT COMPLETED|First Period||1
70818|NCT01678976|169369|P1|NOT COMPLETED|First Period||0
70819|NCT01678976|169368|P2|COMPLETED|First Period||6
70820|NCT01678976|169369|P1|COMPLETED|First Period||6
70821|NCT01678976|169368|P2|STARTED|First Period||7
70822|NCT01678976|169369|P1|STARTED|First Period||6
70823|NCT01678911|169379|P2|NOT COMPLETED|Second Intervention||0
70824|NCT01678911|169380|P1|NOT COMPLETED|Second Intervention||2
70825|NCT01678911|169379|P2|COMPLETED|Second Intervention||1
70826|NCT01678911|169380|P1|COMPLETED|Second Intervention||2
70827|NCT01678911|169379|P2|STARTED|Second Intervention||1
70828|NCT01678911|169380|P1|STARTED|Second Intervention||4
70829|NCT01678911|169379|P2|NOT COMPLETED|First Intervention||0
70830|NCT01678911|169380|P1|NOT COMPLETED|First Intervention||0
70831|NCT01678911|169379|P2|COMPLETED|First Intervention||1
70832|NCT01678911|169380|P1|COMPLETED|First Intervention||4
70833|NCT01678911|169379|P2|Cross Over|First Intervention||1
70834|NCT01678911|169380|P1|Cross Over|First Intervention||4
70835|NCT01678911|169379|P2|STARTED|First Intervention||1
70836|NCT01678911|169380|P1|STARTED|First Intervention||4
70837|NCT01678885|169396|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
70838|NCT01678885|169397|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70839|NCT01678885|169398|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70840|NCT01678885|169399|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70841|NCT01678885|169400|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70842|NCT01678885|169396|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
70843|NCT01678885|169397|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70844|NCT01678885|169398|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70845|NCT01678885|169399|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70846|NCT01678885|169400|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
70847|NCT01678885|169396|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
70848|NCT01678885|169397|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
70849|NCT01678885|169398|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
70850|NCT01678885|169399|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
70851|NCT01678885|169400|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
70852|NCT01678885|169396|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
70853|NCT01678885|169397|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
70854|NCT01678885|169398|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
70855|NCT01678885|169399|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
70856|NCT01678885|169400|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
70857|NCT01678885|169396|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
70858|NCT01678885|169397|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
70859|NCT01678885|169398|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
70860|NCT01678885|169399|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
70861|NCT01678885|169400|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
70862|NCT01678885|169396|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
70863|NCT01678885|169397|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
70864|NCT01678885|169398|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
70865|NCT01678885|169399|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
70866|NCT01678885|169400|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
70867|NCT01678846|169410|P2|NOT COMPLETED|Overall Study||0
70868|NCT01678846|169411|P1|NOT COMPLETED|Overall Study||0
70869|NCT01678846|169410|P2|COMPLETED|Overall Study||1899
70870|NCT01678846|169411|P1|COMPLETED|Overall Study||1921
70871|NCT01678846|169410|P2|STARTED|Overall Study||1899
70872|NCT01678846|169411|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
70873|NCT01678820|169426|P3|NOT COMPLETED|Overall Study||57
70874|NCT01678820|169427|P2|NOT COMPLETED|Overall Study||63
70875|NCT01678820|169428|P1|NOT COMPLETED|Overall Study||62
70876|NCT01678820|169426|P3|COMPLETED|Overall Study||43
70877|NCT01678820|169427|P2|COMPLETED|Overall Study||36
70878|NCT01678820|169428|P1|COMPLETED|Overall Study||38
70879|NCT01678820|169426|P3|Treated With Double-blind Study Drug|Overall Study||98
70880|NCT01678820|169427|P2|Treated With Double-blind Study Drug|Overall Study||97
70881|NCT01678820|169428|P1|Treated With Double-blind Study Drug|Overall Study||100
70882|NCT01678820|169426|P3|STARTED|Overall Study||100
70883|NCT01678820|169427|P2|STARTED|Overall Study||99
70884|NCT01678820|169428|P1|STARTED|Overall Study||100
70885|NCT01678807|169473|P3|NOT COMPLETED|Overall Study||0
70886|NCT01678807|169474|P2|NOT COMPLETED|Overall Study||5
70887|NCT01678807|169475|P1|NOT COMPLETED|Overall Study||4
70888|NCT01678807|169473|P3|COMPLETED|Overall Study||65
70889|NCT01678807|169474|P2|COMPLETED|Overall Study||60
70890|NCT01678807|169475|P1|COMPLETED|Overall Study||61
70891|NCT01678807|169473|P3|STARTED|Overall Study||65
70892|NCT01678807|169474|P2|STARTED|Overall Study||65
70893|NCT01678807|169475|P1|STARTED|Overall Study||65
70894|NCT01678443|169486|P1|NOT COMPLETED|Overall Study||0
70895|NCT01678443|169486|P1|COMPLETED|Overall Study||2
70896|NCT01678443|169486|P1|STARTED|Overall Study||2
70897|NCT01678313|169493|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
70898|NCT01678313|169494|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
70899|NCT01678313|169493|P2|COMPLETED|Prostate Biopsy at 3 Months||37
70900|NCT01678313|169494|P1|COMPLETED|Prostate Biopsy at 3 Months||45
70901|NCT01678313|169493|P2|STARTED|Prostate Biopsy at 3 Months||49
70902|NCT01678313|169494|P1|STARTED|Prostate Biopsy at 3 Months||56
70903|NCT01678313|169493|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
70904|NCT01678313|169494|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
70905|NCT01678313|169493|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
70906|NCT01678313|169494|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
70907|NCT01678313|169493|P2|STARTED|PSA >4 ng/dL at 3 Months||58
70908|NCT01678313|169494|P1|STARTED|PSA >4 ng/dL at 3 Months||64
70909|NCT01678313|169493|P2|NOT COMPLETED|Completed the 3-month Therapy||12
70910|NCT01678313|169494|P1|NOT COMPLETED|Completed the 3-month Therapy||6
70911|NCT01678313|169493|P2|COMPLETED|Completed the 3-month Therapy||58
70912|NCT01678313|169494|P1|COMPLETED|Completed the 3-month Therapy||64
70913|NCT01678313|169493|P2|STARTED|Completed the 3-month Therapy||70
70914|NCT01678313|169494|P1|STARTED|Completed the 3-month Therapy||70
70915|NCT01678196|169512|P2|NOT COMPLETED|Overall Study||0
70916|NCT01678196|169513|P1|NOT COMPLETED|Overall Study||0
70917|NCT01678196|169512|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
70918|NCT01678196|169513|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
70919|NCT01678196|169512|P2|STARTED|Overall Study||32
70920|NCT01678196|169513|P1|STARTED|Overall Study||34
70921|NCT01678131|169528|P3|NOT COMPLETED|Overall Study||2
70922|NCT01678131|169529|P2|NOT COMPLETED|Overall Study||1
70923|NCT01678131|169530|P1|NOT COMPLETED|Overall Study||0
70924|NCT01678131|169528|P3|COMPLETED|Overall Study||9
70925|NCT01678131|169529|P2|COMPLETED|Overall Study||9
70926|NCT01678131|169530|P1|COMPLETED|Overall Study||10
70927|NCT01678131|169528|P3|STARTED|Overall Study||11
70928|NCT01678131|169529|P2|STARTED|Overall Study||10
70929|NCT01678131|169530|P1|STARTED|Overall Study||10
70930|NCT01677988|169538|P1|NOT COMPLETED|Overall Study||2
70931|NCT01677988|169538|P1|COMPLETED|Overall Study||1
70932|NCT01677988|169538|P1|STARTED|Overall Study||3
70933|NCT01677936|169551|P2|NOT COMPLETED|Overall Study||5
70934|NCT01677936|169552|P1|NOT COMPLETED|Overall Study||9
70935|NCT01677936|169551|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
70936|NCT01677936|169552|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
70937|NCT01677936|169551|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
70938|NCT01677936|169552|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
70939|NCT01677910|169563|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
70940|NCT01677910|169564|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
70941|NCT01677910|169565|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
70942|NCT01677910|169566|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
70943|NCT01677910|169563|P4|COMPLETED|Open-Label Extension Period (OLE)||79
70944|NCT01677910|169564|P3|COMPLETED|Open-Label Extension Period (OLE)||0
70945|NCT01677910|169565|P2|COMPLETED|Open-Label Extension Period (OLE)||0
70946|NCT01677910|169566|P1|COMPLETED|Open-Label Extension Period (OLE)||0
70947|NCT01677910|169563|P4|STARTED|Open-Label Extension Period (OLE)||115
70948|NCT01677910|169564|P3|STARTED|Open-Label Extension Period (OLE)||0
70949|NCT01677910|169565|P2|STARTED|Open-Label Extension Period (OLE)||0
70950|NCT01677910|169566|P1|STARTED|Open-Label Extension Period (OLE)||0
70951|NCT01677910|169563|P4|NOT COMPLETED|Double-Blind Treatment Period||0
70952|NCT01677910|169564|P3|NOT COMPLETED|Double-Blind Treatment Period||7
70953|NCT01677910|169565|P2|NOT COMPLETED|Double-Blind Treatment Period||3
70954|NCT01677910|169566|P1|NOT COMPLETED|Double-Blind Treatment Period||7
70955|NCT01677910|169563|P4|COMPLETED|Double-Blind Treatment Period||0
70956|NCT01677910|169564|P3|COMPLETED|Double-Blind Treatment Period||38
70957|NCT01677910|169565|P2|COMPLETED|Double-Blind Treatment Period||42
70958|NCT01677910|169566|P1|COMPLETED|Double-Blind Treatment Period||38
70959|NCT01677910|169563|P4|STARTED|Double-Blind Treatment Period||0
70960|NCT01677910|169564|P3|STARTED|Double-Blind Treatment Period||45
70961|NCT01677910|169565|P2|STARTED|Double-Blind Treatment Period||45
70962|NCT01677910|169566|P1|STARTED|Double-Blind Treatment Period||45
70963|NCT01677858|169593|P5|NOT COMPLETED|Overall Study||85
70964|NCT01677858|169594|P4|NOT COMPLETED|Overall Study||6
70965|NCT01677858|169595|P3|NOT COMPLETED|Overall Study||14
70966|NCT01677858|169596|P2|NOT COMPLETED|Overall Study||2
70967|NCT01677858|169597|P1|NOT COMPLETED|Overall Study||3
70968|NCT01677858|169593|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
70969|NCT01677858|169594|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
70970|NCT01677858|169595|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
70971|NCT01677858|169596|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
70972|NCT01677858|169597|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
70973|NCT01677858|169593|P5|STARTED|Overall Study||89
70974|NCT01677858|169594|P4|STARTED|Overall Study||6
70975|NCT01677858|169595|P3|STARTED|Overall Study||15
70976|NCT01677858|169596|P2|STARTED|Overall Study||3
70977|NCT01677858|169597|P1|STARTED|Overall Study||3
70978|NCT01677767|169670|P1|NOT COMPLETED|Overall Study||22
70979|NCT01677767|169670|P1|COMPLETED|Overall Study||102
70980|NCT01677767|169670|P1|STARTED|Overall Study||124
70981|NCT01677624|169684|P1|NOT COMPLETED|Overall Study||1
70982|NCT01677624|169684|P1|COMPLETED|Overall Study||27
70983|NCT01677624|169684|P1|STARTED|Overall Study||28
70984|NCT01677507|169689|P2|NOT COMPLETED|Second Assigment||5
70985|NCT01677507|169690|P1|NOT COMPLETED|Second Assigment||3
70986|NCT01677507|169689|P2|COMPLETED|Second Assigment||51
70987|NCT01677507|169690|P1|COMPLETED|Second Assigment||60
70988|NCT01677507|169689|P2|STARTED|Second Assigment||56
70989|NCT01677507|169690|P1|STARTED|Second Assigment||63
70990|NCT01677507|169689|P2|NOT COMPLETED|Initial Assignment||2
70991|NCT01677507|169690|P1|NOT COMPLETED|Initial Assignment||0
70992|NCT01677507|169689|P2|COMPLETED|Initial Assignment||56
70993|NCT01677507|169690|P1|COMPLETED|Initial Assignment||63
70994|NCT01677507|169689|P2|STARTED|Initial Assignment||58
70995|NCT01677507|169690|P1|STARTED|Initial Assignment||63
70996|NCT01677299|169704|P4|NOT COMPLETED|Overall Study||1
70997|NCT01677299|169705|P3|NOT COMPLETED|Overall Study||1
70998|NCT01677299|169706|P2|NOT COMPLETED|Overall Study||3
70999|NCT01677299|169707|P1|NOT COMPLETED|Overall Study||0
71000|NCT01677299|169704|P4|COMPLETED|Overall Study||5
71001|NCT01677299|169705|P3|COMPLETED|Overall Study||5
71002|NCT01677299|169706|P2|COMPLETED|Overall Study||3
71003|NCT01677299|169707|P1|COMPLETED|Overall Study||6
71004|NCT01677299|169704|P4|STARTED|Overall Study||6
71005|NCT01677299|169705|P3|STARTED|Overall Study||6
71006|NCT01677299|169706|P2|STARTED|Overall Study||6
71007|NCT01677299|169707|P1|STARTED|Overall Study||6
71008|NCT01677286|169729|P1|NOT COMPLETED|Overall Study||11
71009|NCT01677286|169729|P1|COMPLETED|Overall Study||14
71010|NCT01677286|169729|P1|STARTED|Overall Study||25
71011|NCT01677195|169739|P3|NOT COMPLETED|Overall Study||30
71012|NCT01677195|169740|P2|NOT COMPLETED|Overall Study||32
71013|NCT01677195|169741|P1|NOT COMPLETED|Overall Study||29
71014|NCT01677195|169739|P3|COMPLETED|Overall Study||50
71015|NCT01677195|169740|P2|COMPLETED|Overall Study||51
71016|NCT01677195|169741|P1|COMPLETED|Overall Study||42
71017|NCT01677195|169739|P3|STARTED|Overall Study||80
71018|NCT01677195|169740|P2|STARTED|Overall Study||83
71019|NCT01677195|169741|P1|STARTED|Overall Study||71
71020|NCT01677182|169752|P3|NOT COMPLETED|Overall Study||39
71021|NCT01677182|169753|P2|NOT COMPLETED|Overall Study||28
71022|NCT01677182|169754|P1|NOT COMPLETED|Overall Study||34
71023|NCT01677182|169752|P3|COMPLETED|Overall Study||143
71024|NCT01677182|169753|P2|COMPLETED|Overall Study||141
71025|NCT01677182|169754|P1|COMPLETED|Overall Study||150
71026|NCT01677182|169752|P3|STARTED|Overall Study||182
71027|NCT01677182|169753|P2|STARTED|Overall Study||169
71028|NCT01677182|169754|P1|STARTED|Overall Study||184
71029|NCT01676961|169786|P1|NOT COMPLETED|Overall Study||5
71030|NCT01676961|169786|P1|COMPLETED|Overall Study||0
71031|NCT01676961|169786|P1|STARTED|Overall Study||5
71032|NCT01676896|169794|P3|NOT COMPLETED|Overall Study||19
71033|NCT01676896|169795|P2|NOT COMPLETED|Overall Study||7
71034|NCT01676896|169796|P1|NOT COMPLETED|Overall Study||12
71035|NCT01676896|169794|P3|COMPLETED|Overall Study||81
71036|NCT01676896|169795|P2|COMPLETED|Overall Study||89
71037|NCT01676896|169796|P1|COMPLETED|Overall Study||84
71038|NCT01676896|169794|P3|STARTED|Overall Study||100
71039|NCT01676896|169795|P2|STARTED|Overall Study||96
71040|NCT01676896|169796|P1|STARTED|Overall Study||96
71041|NCT01676714|169891|P1|NOT COMPLETED|Overall Study||0
71042|NCT01676714|169891|P1|COMPLETED|Overall Study||10
71043|NCT01676714|169891|P1|STARTED|Overall Study||10
71044|NCT01676701|169900|P2|NOT COMPLETED|Overall Study||4
71045|NCT01676701|169901|P1|NOT COMPLETED|Overall Study||4
71046|NCT01676701|169900|P2|COMPLETED|Overall Study||0
71047|NCT01676701|169901|P1|COMPLETED|Overall Study||0
71048|NCT01676701|169900|P2|Completed Post-Treatment Follow-Up|Overall Study||4
71049|NCT01676701|169901|P1|Completed Post-Treatment Follow-Up|Overall Study||4
71050|NCT01676701|169900|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
71051|NCT01676701|169901|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
71052|NCT01676701|169900|P2|STARTED|Overall Study||4
71053|NCT01676701|169901|P1|STARTED|Overall Study||4
71054|NCT01676532|169927|P1|NOT COMPLETED|Overall Study||0
71055|NCT01676532|169927|P1|COMPLETED|Overall Study||127
71056|NCT01676532|169927|P1|STARTED|Overall Study||127
71057|NCT01676415|169938|P2|NOT COMPLETED|Overall Study||0
71058|NCT01676415|169939|P1|NOT COMPLETED|Overall Study||0
71059|NCT01676415|169938|P2|COMPLETED|Overall Study||5
71060|NCT01676415|169939|P1|COMPLETED|Overall Study||4
71061|NCT01676415|169938|P2|STARTED|Overall Study||5
71062|NCT01676415|169939|P1|STARTED|Overall Study||4
71063|NCT01676298|169959|P8|NOT COMPLETED|Overall Study||0
71064|NCT01676298|169960|P7|NOT COMPLETED|Overall Study||0
71065|NCT01676298|169961|P6|NOT COMPLETED|Overall Study||0
71066|NCT01676298|169962|P5|NOT COMPLETED|Overall Study||0
71067|NCT01676298|169963|P4|NOT COMPLETED|Overall Study||0
71068|NCT01676298|169964|P3|NOT COMPLETED|Overall Study||0
71069|NCT01676298|169965|P2|NOT COMPLETED|Overall Study||0
71070|NCT01676298|169966|P1|NOT COMPLETED|Overall Study||0
71071|NCT01676298|169959|P8|COMPLETED|Overall Study||1
71072|NCT01676298|169960|P7|COMPLETED|Overall Study||1
71073|NCT01676298|169961|P6|COMPLETED|Overall Study||1
71074|NCT01676298|169962|P5|COMPLETED|Overall Study||1
71075|NCT01676298|169963|P4|COMPLETED|Overall Study||1
71076|NCT01676298|169964|P3|COMPLETED|Overall Study||1
71077|NCT01676298|169965|P2|COMPLETED|Overall Study||1
71078|NCT01676298|169966|P1|COMPLETED|Overall Study||1
71079|NCT01676298|169959|P8|Participated in All Tests|Overall Study||1
71080|NCT01676298|169960|P7|Participated in All Tests|Overall Study||1
71081|NCT01676298|169961|P6|Participated in All Tests|Overall Study||1
71082|NCT01676298|169962|P5|Participated in All Tests|Overall Study||1
71083|NCT01676298|169963|P4|Participated in All Tests|Overall Study||1
71084|NCT01676298|169964|P3|Participated in All Tests|Overall Study||1
71085|NCT01676298|169965|P2|Participated in All Tests|Overall Study||1
71086|NCT01676298|169966|P1|Participated in All Tests|Overall Study||1
71087|NCT01676298|169959|P8|All Genotypes Confirmed With Reference|Overall Study||1
71088|NCT01676298|169960|P7|All Genotypes Confirmed With Reference|Overall Study||1
71089|NCT01676298|169961|P6|All Genotypes Confirmed With Reference|Overall Study||1
71090|NCT01676298|169962|P5|All Genotypes Confirmed With Reference|Overall Study||1
71091|NCT01676298|169963|P4|All Genotypes Confirmed With Reference|Overall Study||1
71092|NCT01676298|169964|P3|All Genotypes Confirmed With Reference|Overall Study||1
71093|NCT01676298|169965|P2|All Genotypes Confirmed With Reference|Overall Study||1
71094|NCT01676298|169966|P1|All Genotypes Confirmed With Reference|Overall Study||1
71095|NCT01676298|169959|P8|STARTED|Overall Study||1
71096|NCT01676298|169960|P7|STARTED|Overall Study||1
71097|NCT01676298|169961|P6|STARTED|Overall Study||1
71098|NCT01676298|169962|P5|STARTED|Overall Study||1
71099|NCT01676298|169963|P4|STARTED|Overall Study||1
71100|NCT01676298|169964|P3|STARTED|Overall Study||1
71101|NCT01676298|169965|P2|STARTED|Overall Study||1
71102|NCT01676298|169966|P1|STARTED|Overall Study||1
71103|NCT01676220|169986|P2|NOT COMPLETED|Overall Study||125
71104|NCT01676220|169987|P1|NOT COMPLETED|Overall Study||102
71105|NCT01676220|169986|P2|COMPLETED|Overall Study||314
71106|NCT01676220|169987|P1|COMPLETED|Overall Study||337
71107|NCT01676220|169986|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
71108|NCT01676220|169987|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
71109|NCT01676220|169986|P2|Treated|Overall Study||438
71110|NCT01676220|169987|P1|Treated|Overall Study||435
71111|NCT01676220|169986|P2|STARTED|Overall Study||439
71112|NCT01676220|169987|P1|STARTED|Overall Study||439
71113|NCT01676012|170017|P1|NOT COMPLETED|Overall Study||3
71114|NCT01676012|170017|P1|COMPLETED|Overall Study||29
71115|NCT01676012|170017|P1|STARTED|Overall Study||32
71116|NCT01675830|170021|P1|NOT COMPLETED|Overall Study||0
71117|NCT01675830|170021|P1|COMPLETED|Overall Study||10
71118|NCT01675830|170021|P1|STARTED|Overall Study||10
71119|NCT01675661|170028|P2|NOT COMPLETED|Overall Study||46
71120|NCT01675661|170029|P1|NOT COMPLETED|Overall Study||40
71121|NCT01675661|170028|P2|COMPLETED|Overall Study||103
71122|NCT01675661|170029|P1|COMPLETED|Overall Study||113
71123|NCT01675661|170028|P2|STARTED|Overall Study||149
71124|NCT01675661|170029|P1|STARTED|Overall Study||153
71125|NCT01675635|170037|P2|NOT COMPLETED|Overall Study||0
71126|NCT01675635|170038|P1|NOT COMPLETED|Overall Study||0
71127|NCT01675635|170037|P2|COMPLETED|Overall Study||117
71128|NCT01675635|170038|P1|COMPLETED|Overall Study||117
71129|NCT01675635|170037|P2|STARTED|Overall Study||117
71130|NCT01675635|170038|P1|STARTED|Overall Study||117
71131|NCT01675622|170058|P2|NOT COMPLETED|Overall Study||24
71132|NCT01675622|170059|P1|NOT COMPLETED|Overall Study||26
71133|NCT01675622|170058|P2|COMPLETED|Overall Study||96
71134|NCT01675622|170059|P1|COMPLETED|Overall Study||96
71135|NCT01675622|170058|P2|STARTED|Overall Study||120
71136|NCT01675622|170059|P1|STARTED|Overall Study||122
71137|NCT01675544|170083|P1|NOT COMPLETED|Overall Study||2
71138|NCT01675544|170083|P1|COMPLETED|Overall Study||44
71139|NCT01675544|170083|P1|STARTED|Overall Study||46
71140|NCT01675531|170088|P1|NOT COMPLETED|Overall Study||25
71141|NCT01675531|170088|P1|COMPLETED|Overall Study||41
71142|NCT01675531|170088|P1|STARTED|Overall Study||66
71143|NCT01675492|170095|P1|NOT COMPLETED|Overall Study||42
71144|NCT01675492|170095|P1|COMPLETED|Overall Study||42
71145|NCT01675492|170095|P1|STARTED|Overall Study||84
71146|NCT01675479|170100|P1|NOT COMPLETED|Overall Study||11
71147|NCT01675479|170100|P1|COMPLETED|Overall Study||58
71148|NCT01675479|170100|P1|STARTED|Overall Study||69
71149|NCT01675453|170107|P2|NOT COMPLETED|Overall Study||0
71150|NCT01675453|170108|P1|NOT COMPLETED|Overall Study||0
71151|NCT01675453|170107|P2|COMPLETED|Overall Study||20
71152|NCT01675453|170108|P1|COMPLETED|Overall Study||20
71153|NCT01675453|170107|P2|STARTED|Overall Study||20
71154|NCT01675453|170108|P1|STARTED|Overall Study||20
71155|NCT01675427|170114|P1|NOT COMPLETED|Overall Study||34
71156|NCT01675427|170114|P1|COMPLETED|Overall Study||4732
71157|NCT01675427|170114|P1|STARTED|Overall Study||4766
71158|NCT01675167|170401|P3|NOT COMPLETED|Double-blind Treatment Phase||110
71159|NCT01675167|170402|P2|NOT COMPLETED|Double-blind Treatment Phase||48
71160|NCT01675167|170403|P1|NOT COMPLETED|Double-blind Treatment Phase||0
71161|NCT01675167|170401|P3|COMPLETED|Double-blind Treatment Phase||147
71162|NCT01675167|170402|P2|COMPLETED|Double-blind Treatment Phase||206
71163|NCT01675167|170403|P1|COMPLETED|Double-blind Treatment Phase||0
71164|NCT01675167|170401|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
71165|NCT01675167|170402|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
71166|NCT01675167|170403|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
71167|NCT01675167|170401|P3|NOT COMPLETED|Open-label Titration Phase||0
71168|NCT01675167|170402|P2|NOT COMPLETED|Open-label Titration Phase||0
71169|NCT01675167|170403|P1|NOT COMPLETED|Open-label Titration Phase||304
71170|NCT01675167|170401|P3|COMPLETED|Open-label Titration Phase||0
71171|NCT01675167|170402|P2|COMPLETED|Open-label Titration Phase||0
71172|NCT01675167|170403|P1|COMPLETED|Open-label Titration Phase||511
71173|NCT01675167|170401|P3|STARTED|Open-label Titration Phase||0
71174|NCT01675167|170402|P2|STARTED|Open-label Titration Phase||0
71175|NCT01675167|170403|P1|STARTED|Open-label Titration Phase||815
71176|NCT01675141|170425|P1|NOT COMPLETED|Overall Study||11
71177|NCT01675141|170425|P1|COMPLETED|Overall Study||0
71178|NCT01675141|170425|P1|STARTED|Overall Study||11
71179|NCT01675128|170438|P3|NOT COMPLETED|Overall Study||1
71180|NCT01675128|170439|P2|NOT COMPLETED|Overall Study||2
71181|NCT01675128|170440|P1|NOT COMPLETED|Overall Study||2
71182|NCT01675128|170438|P3|COMPLETED|Overall Study||9
71183|NCT01675128|170439|P2|COMPLETED|Overall Study||8
71184|NCT01675128|170440|P1|COMPLETED|Overall Study||2
71185|NCT01675128|170438|P3|STARTED|Overall Study||10
71186|NCT01675128|170439|P2|STARTED|Overall Study||10
71187|NCT01675128|170440|P1|STARTED|Overall Study||4
71188|NCT01675063|170462|P1|NOT COMPLETED|Overall Study||0
71189|NCT01675063|170462|P1|COMPLETED|Overall Study||77
71190|NCT01675063|170462|P1|STARTED|Overall Study||77
71191|NCT01675050|170468|P2|NOT COMPLETED|Second Period Treatment||0
71192|NCT01675050|170469|P1|NOT COMPLETED|Second Period Treatment||0
71193|NCT01675050|170468|P2|COMPLETED|Second Period Treatment||2
71194|NCT01675050|170469|P1|COMPLETED|Second Period Treatment||1
71195|NCT01675050|170468|P2|STARTED|Second Period Treatment||2
71196|NCT01675050|170469|P1|STARTED|Second Period Treatment||1
71197|NCT01675050|170468|P2|NOT COMPLETED|Wash Out Period||0
71198|NCT01675050|170469|P1|NOT COMPLETED|Wash Out Period||0
71199|NCT01675050|170468|P2|COMPLETED|Wash Out Period||2
71200|NCT01675050|170469|P1|COMPLETED|Wash Out Period||1
71201|NCT01675050|170468|P2|STARTED|Wash Out Period||2
71202|NCT01675050|170469|P1|STARTED|Wash Out Period||1
71203|NCT01675050|170468|P2|NOT COMPLETED|Period One Treatment||0
71204|NCT01675050|170469|P1|NOT COMPLETED|Period One Treatment||1
71205|NCT01675050|170468|P2|COMPLETED|Period One Treatment||2
71206|NCT01675050|170469|P1|COMPLETED|Period One Treatment||1
71207|NCT01675050|170468|P2|STARTED|Period One Treatment||2
71208|NCT01675050|170469|P1|STARTED|Period One Treatment||2
71209|NCT01675011|170479|P2|NOT COMPLETED|Overall Study||1
71210|NCT01675011|170480|P1|NOT COMPLETED|Overall Study||3
71211|NCT01675011|170479|P2|COMPLETED|Overall Study||0
71212|NCT01675011|170480|P1|COMPLETED|Overall Study||0
71213|NCT01675011|170479|P2|STARTED|Overall Study||1
71214|NCT01675011|170480|P1|STARTED|Overall Study||3
71215|NCT01674725|170488|P2|NOT COMPLETED|Overall Study||1
71216|NCT01674725|170489|P1|NOT COMPLETED|Overall Study||3
71217|NCT01674725|170488|P2|COMPLETED|Overall Study||94
71218|NCT01674725|170489|P1|COMPLETED|Overall Study||89
71219|NCT01674725|170488|P2|STARTED|Overall Study||95
71220|NCT01674725|170489|P1|STARTED|Overall Study||92
71221|NCT01674712|170508|P5|NOT COMPLETED|Overall Study||11
71222|NCT01674712|170509|P4|NOT COMPLETED|Overall Study||8
71223|NCT01674712|170510|P3|NOT COMPLETED|Overall Study||9
71224|NCT01674712|170511|P2|NOT COMPLETED|Overall Study||9
71225|NCT01674712|170512|P1|NOT COMPLETED|Overall Study||10
71226|NCT01674712|170508|P5|COMPLETED|Overall Study||102
71227|NCT01674712|170509|P4|COMPLETED|Overall Study||108
71228|NCT01674712|170510|P3|COMPLETED|Overall Study||106
71229|NCT01674712|170511|P2|COMPLETED|Overall Study||108
71230|NCT01674712|170512|P1|COMPLETED|Overall Study||104
71231|NCT01674712|170508|P5|Safety Subject Sample|Overall Study||112
71232|NCT01674712|170509|P4|Safety Subject Sample|Overall Study||115
71233|NCT01674712|170510|P3|Safety Subject Sample|Overall Study||113
71234|NCT01674712|170511|P2|Safety Subject Sample|Overall Study||117
71235|NCT01674712|170512|P1|Safety Subject Sample|Overall Study||111
71236|NCT01674712|170508|P5|Full Analysis Subject Sample|Overall Study||111
71237|NCT01674712|170509|P4|Full Analysis Subject Sample|Overall Study||112
71238|NCT01674712|170510|P3|Full Analysis Subject Sample|Overall Study||110
71239|NCT01674712|170511|P2|Full Analysis Subject Sample|Overall Study||114
71240|NCT01674712|170512|P1|Full Analysis Subject Sample|Overall Study||109
71241|NCT01674712|170508|P5|STARTED|Overall Study||113
71242|NCT01674712|170509|P4|STARTED|Overall Study||116
71243|NCT01674712|170510|P3|STARTED|Overall Study||115
71244|NCT01674712|170511|P2|STARTED|Overall Study||117
71245|NCT01674712|170512|P1|STARTED|Overall Study||114
71246|NCT01674647|170536|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
71247|NCT01674647|170537|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
71248|NCT01674647|170536|P2|COMPLETED|30-day Safety Follow-up Period||446
71249|NCT01674647|170537|P1|COMPLETED|30-day Safety Follow-up Period||924
71250|NCT01674647|170536|P2|STARTED|30-day Safety Follow-up Period||487
71251|NCT01674647|170537|P1|STARTED|30-day Safety Follow-up Period||982
71252|NCT01674647|170536|P2|NOT COMPLETED|Treatment Period||102
71253|NCT01674647|170537|P1|NOT COMPLETED|Treatment Period||156
71254|NCT01674647|170536|P2|COMPLETED|Treatment Period||400
71255|NCT01674647|170537|P1|COMPLETED|Treatment Period||846
71256|NCT01674647|170536|P2|Subjects Received Treatment|Treatment Period||499
71257|NCT01674647|170537|P1|Subjects Received Treatment|Treatment Period||988
71258|NCT01674647|170536|P2|STARTED|Treatment Period||502
71259|NCT01674647|170537|P1|STARTED|Treatment Period||1002
71260|NCT01674634|170563|P1|NOT COMPLETED|Overall Study||6
71261|NCT01674634|170563|P1|COMPLETED|Overall Study||709
71262|NCT01674634|170563|P1|STARTED|Overall Study||715
71263|NCT01674621|170583|P5|NOT COMPLETED|Overall Study||6
71264|NCT01674621|170584|P4|NOT COMPLETED|Overall Study||7
71265|NCT01674621|170585|P3|NOT COMPLETED|Overall Study||8
71266|NCT01674621|170586|P2|NOT COMPLETED|Overall Study||5
71267|NCT01674621|170587|P1|NOT COMPLETED|Overall Study||6
71268|NCT01674621|170583|P5|COMPLETED|Overall Study||45
71269|NCT01674621|170584|P4|COMPLETED|Overall Study||41
71270|NCT01674621|170585|P3|COMPLETED|Overall Study||43
71271|NCT01674621|170586|P2|COMPLETED|Overall Study||45
71272|NCT01674621|170587|P1|COMPLETED|Overall Study||44
71273|NCT01674621|170583|P5|STARTED|Overall Study||51
71274|NCT01674621|170584|P4|STARTED|Overall Study||48
71275|NCT01674621|170585|P3|STARTED|Overall Study||51
71276|NCT01674621|170586|P2|STARTED|Overall Study||50
71277|NCT01674621|170587|P1|STARTED|Overall Study||50
71278|NCT01674062|170611|P2|NOT COMPLETED|Overall Study||29
71279|NCT01674062|170612|P1|NOT COMPLETED|Overall Study||66
71280|NCT01674062|170611|P2|COMPLETED|Overall Study||0
71281|NCT01674062|170612|P1|COMPLETED|Overall Study||0
71282|NCT01674062|170611|P2|STARTED|Overall Study||29
71283|NCT01674062|170612|P1|STARTED|Overall Study||66
71284|NCT01674010|170627|P3|NOT COMPLETED|Randomization Phase 2||61
71285|NCT01674010|170628|P2|NOT COMPLETED|Randomization Phase 2||62
71286|NCT01674010|170629|P1|NOT COMPLETED|Randomization Phase 2||0
71287|NCT01674010|170627|P3|COMPLETED|Randomization Phase 2||3
71288|NCT01674010|170628|P2|COMPLETED|Randomization Phase 2||3
71289|NCT01674010|170629|P1|COMPLETED|Randomization Phase 2||0
71290|NCT01674010|170627|P3|STARTED|Randomization Phase 2||64
71291|NCT01674010|170628|P2|STARTED|Randomization Phase 2||65
71292|NCT01674010|170629|P1|STARTED|Randomization Phase 2||0
71293|NCT01674010|170627|P3|NOT COMPLETED|Open Treatment Phase 1||0
71294|NCT01674010|170628|P2|NOT COMPLETED|Open Treatment Phase 1||0
71295|NCT01674010|170629|P1|NOT COMPLETED|Open Treatment Phase 1||180
71296|NCT01674010|170627|P3|COMPLETED|Open Treatment Phase 1||0
71297|NCT01674010|170628|P2|COMPLETED|Open Treatment Phase 1||0
71298|NCT01674010|170629|P1|COMPLETED|Open Treatment Phase 1||129
71299|NCT01674010|170627|P3|STARTED|Open Treatment Phase 1||0
71300|NCT01674010|170628|P2|STARTED|Open Treatment Phase 1||0
71301|NCT01674010|170629|P1|STARTED|Open Treatment Phase 1||309
71302|NCT01673984|170648|P2|NOT COMPLETED|Overall Study||6
71303|NCT01673984|170649|P1|NOT COMPLETED|Overall Study||10
71304|NCT01673984|170648|P2|COMPLETED|Overall Study||1
71305|NCT01673984|170649|P1|COMPLETED|Overall Study||4
71306|NCT01673984|170648|P2|STARTED|Overall Study||7
71307|NCT01673984|170649|P1|STARTED|Overall Study||14
71308|NCT01673919|170667|P1|NOT COMPLETED|Overall Study||0
71309|NCT01673919|170667|P1|COMPLETED|Overall Study||7
71310|NCT01673919|170667|P1|STARTED|Overall Study||7
71311|NCT01673867|170691|P2|NOT COMPLETED|Treatment||268
71312|NCT01673867|170692|P1|NOT COMPLETED|Treatment||244
71313|NCT01673867|170691|P2|COMPLETED|Treatment||0
71314|NCT01673867|170692|P1|COMPLETED|Treatment||43
71315|NCT01673867|170691|P2|STARTED|Treatment||268
71316|NCT01673867|170692|P1|STARTED|Treatment||287
71317|NCT01673867|170691|P2|NOT COMPLETED|Randomization||22
71318|NCT01673867|170692|P1|NOT COMPLETED|Randomization||5
71319|NCT01673867|170691|P2|COMPLETED|Randomization||268
71320|NCT01673867|170692|P1|COMPLETED|Randomization||287
71321|NCT01673867|170691|P2|STARTED|Randomization||290
71322|NCT01673867|170692|P1|STARTED|Randomization||292
71323|NCT01673854|170718|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
71324|NCT01673854|170718|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
71325|NCT01673854|170718|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
71326|NCT01673854|170718|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
71327|NCT01673854|170718|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
71328|NCT01673854|170718|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
71329|NCT01673854|170718|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
71330|NCT01673854|170718|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
71331|NCT01673854|170718|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
71332|NCT01673828|170728|P2|NOT COMPLETED|Overall Study||0
71333|NCT01673828|170729|P1|NOT COMPLETED|Overall Study||0
71334|NCT01673828|170728|P2|COMPLETED|Overall Study||6
71335|NCT01673828|170729|P1|COMPLETED|Overall Study||7
71336|NCT01673828|170728|P2|STARTED|Overall Study||6
71337|NCT01673828|170729|P1|STARTED|Overall Study||7
71338|NCT01673802|170735|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
71339|NCT01673802|170735|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
71340|NCT01673802|170735|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
71341|NCT01673802|170735|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
71342|NCT01673802|170735|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
71343|NCT01673802|170735|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
71344|NCT01673698|170741|P2|NOT COMPLETED|Overall Study||13
71345|NCT01673698|170742|P1|NOT COMPLETED|Overall Study||51
71346|NCT01673698|170741|P2|COMPLETED|Overall Study||126
71347|NCT01673698|170742|P1|COMPLETED|Overall Study||136
71348|NCT01673698|170741|P2|STARTED|Overall Study||139
71349|NCT01673698|170742|P1|STARTED|Overall Study||187
71350|NCT01673620|170752|P2|NOT COMPLETED|Overall Study||0
71351|NCT01673620|170753|P1|NOT COMPLETED|Overall Study||1
71352|NCT01673620|170752|P2|COMPLETED|Overall Study||22
71353|NCT01673620|170753|P1|COMPLETED|Overall Study||46
71354|NCT01673620|170752|P2|STARTED|Overall Study||22
71355|NCT01673620|170753|P1|STARTED|Overall Study||47
71356|NCT01673594|170763|P2|NOT COMPLETED|Overall Study||6
71357|NCT01673594|170764|P1|NOT COMPLETED|Overall Study||6
71358|NCT01673594|170763|P2|COMPLETED|Overall Study||13
71359|NCT01673594|170764|P1|COMPLETED|Overall Study||12
71360|NCT01673594|170763|P2|STARTED|Overall Study||19
71361|NCT01673594|170764|P1|STARTED|Overall Study||18
71362|NCT01673568|170774|P2|NOT COMPLETED|Overall Study||0
71363|NCT01673568|170775|P1|NOT COMPLETED|Overall Study||0
71364|NCT01673568|170774|P2|COMPLETED|Overall Study||28
71365|NCT01673568|170775|P1|COMPLETED|Overall Study||28
71366|NCT01673568|170774|P2|STARTED|Overall Study||28
71367|NCT01673568|170775|P1|STARTED|Overall Study||28
71368|NCT01673490|170783|P1|NOT COMPLETED|Overall Study||7
71369|NCT01673490|170783|P1|COMPLETED|Overall Study||52
71370|NCT01673490|170783|P1|STARTED|Overall Study||59
71371|NCT01673425|170796|P1|NOT COMPLETED|Overall Study||1
71372|NCT01673425|170796|P1|COMPLETED|Overall Study||4
71373|NCT01673425|170796|P1|STARTED|Overall Study||5
71374|NCT01673347|170800|P1|NOT COMPLETED|Overall Study||7
71375|NCT01673347|170800|P1|COMPLETED|Overall Study||17
71376|NCT01673347|170800|P1|STARTED|Overall Study||24
71377|NCT01673282|170809|P2|NOT COMPLETED|Overall Study||26
71378|NCT01673282|170810|P1|NOT COMPLETED|Overall Study||33
71379|NCT01673282|170809|P2|COMPLETED|Overall Study||132
71380|NCT01673282|170810|P1|COMPLETED|Overall Study||120
71381|NCT01673282|170809|P2|STARTED|Overall Study||158
71382|NCT01673282|170810|P1|STARTED|Overall Study||153
71383|NCT01673256|170816|P1|NOT COMPLETED|Overall Study||0
71384|NCT01673256|170816|P1|COMPLETED|Overall Study||90
71385|NCT01673256|170816|P1|STARTED|Overall Study||90
71386|NCT01673191|170822|P2|NOT COMPLETED|Overall Study||0
71387|NCT01673191|170823|P1|NOT COMPLETED|Overall Study||0
71388|NCT01673191|170822|P2|COMPLETED|Overall Study||11
71389|NCT01673191|170823|P1|COMPLETED|Overall Study||26
71390|NCT01673191|170822|P2|STARTED|Overall Study||11
71391|NCT01673191|170823|P1|STARTED|Overall Study||26
71392|NCT01673178|170846|P5|NOT COMPLETED|Overall Study||2
71393|NCT01673178|170847|P4|NOT COMPLETED|Overall Study||8
71394|NCT01673178|170848|P3|NOT COMPLETED|Overall Study||3
71395|NCT01673178|170849|P2|NOT COMPLETED|Overall Study||2
71396|NCT01673178|170850|P1|NOT COMPLETED|Overall Study||3
71397|NCT01673178|170846|P5|COMPLETED|Overall Study||19
71398|NCT01673178|170847|P4|COMPLETED|Overall Study||14
71399|NCT01673178|170848|P3|COMPLETED|Overall Study||18
71400|NCT01673178|170849|P2|COMPLETED|Overall Study||19
71401|NCT01673178|170850|P1|COMPLETED|Overall Study||19
71402|NCT01673178|170846|P5|STARTED|Overall Study||21
71403|NCT01673178|170847|P4|STARTED|Overall Study||22
71404|NCT01673178|170848|P3|STARTED|Overall Study||21
71405|NCT01673178|170849|P2|STARTED|Overall Study||21
71406|NCT01673178|170850|P1|STARTED|Overall Study||22
71407|NCT01673126|171089|P2|NOT COMPLETED|Overall Study||3
71408|NCT01673126|171090|P1|NOT COMPLETED|Overall Study||4
71409|NCT01673126|171089|P2|COMPLETED|Overall Study||23
71410|NCT01673126|171090|P1|COMPLETED|Overall Study||32
71411|NCT01673126|171089|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
71412|NCT01673126|171090|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
71413|NCT01673113|171098|P2|NOT COMPLETED|Overall Study||0
71414|NCT01673113|171099|P1|NOT COMPLETED|Overall Study||0
71415|NCT01673113|171098|P2|COMPLETED|Overall Study||11
71416|NCT01673113|171099|P1|COMPLETED|Overall Study||11
71417|NCT01673113|171098|P2|STARTED|Overall Study||11
71418|NCT01673113|171099|P1|STARTED|Overall Study||11
71419|NCT01673009|171106|P1|NOT COMPLETED|Overall Study||13
71420|NCT01673009|171106|P1|COMPLETED|Overall Study||23
71421|NCT01673009|171106|P1|STARTED|Overall Study||36
71422|NCT01672996|171118|P3|NOT COMPLETED|Overall Study||0
71423|NCT01672996|171119|P2|NOT COMPLETED|Overall Study||0
71424|NCT01672996|171120|P1|NOT COMPLETED|Overall Study||0
71425|NCT01672996|171118|P3|COMPLETED|Overall Study||6
71426|NCT01672996|171119|P2|COMPLETED|Overall Study||30
71427|NCT01672996|171120|P1|COMPLETED|Overall Study||30
71428|NCT01672996|171118|P3|STARTED|Overall Study||6
71429|NCT01672996|171119|P2|STARTED|Overall Study||30
71430|NCT01672996|171120|P1|STARTED|Overall Study||30
71431|NCT01672983|171156|P6|NOT COMPLETED|Overall Study||0
71432|NCT01672983|171157|P5|NOT COMPLETED|Overall Study||0
71433|NCT01672983|171158|P4|NOT COMPLETED|Overall Study||0
71434|NCT01672983|171159|P3|NOT COMPLETED|Overall Study||0
71435|NCT01672983|171160|P2|NOT COMPLETED|Overall Study||0
71436|NCT01672983|171161|P1|NOT COMPLETED|Overall Study||0
71437|NCT01672983|171156|P6|COMPLETED|Overall Study||18
71438|NCT01672983|171157|P5|COMPLETED|Overall Study||19
71439|NCT01672983|171158|P4|COMPLETED|Overall Study||18
71440|NCT01672983|171159|P3|COMPLETED|Overall Study||19
71441|NCT01672983|171160|P2|COMPLETED|Overall Study||18
71442|NCT01672983|171161|P1|COMPLETED|Overall Study||18
71443|NCT01672983|171156|P6|Completed Study Drug|Overall Study||17
71444|NCT01672983|171157|P5|Completed Study Drug|Overall Study||12
71445|NCT01672983|171158|P4|Completed Study Drug|Overall Study||18
71446|NCT01672983|171159|P3|Completed Study Drug|Overall Study||18
71447|NCT01672983|171160|P2|Completed Study Drug|Overall Study||17
71448|NCT01672983|171161|P1|Completed Study Drug|Overall Study||18
71449|NCT01672983|171156|P6|STARTED|Overall Study||18
71450|NCT01672983|171157|P5|STARTED|Overall Study||19
71451|NCT01672983|171158|P4|STARTED|Overall Study||18
71452|NCT01672983|171159|P3|STARTED|Overall Study||19
71453|NCT01672983|171160|P2|STARTED|Overall Study||18
71454|NCT01672983|171161|P1|STARTED|Overall Study||18
71455|NCT01672970|171191|P1|NOT COMPLETED|Overall Study||47
71456|NCT01672970|171191|P1|COMPLETED|Overall Study||244
71457|NCT01672970|171191|P1|Treated|Overall Study||290
71458|NCT01672970|171191|P1|STARTED|Overall Study||291
71459|NCT01672957|171227|P1|NOT COMPLETED|Overall Study||55
71460|NCT01672957|171227|P1|COMPLETED|Overall Study||73
71461|NCT01672957|171227|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
71462|NCT01672957|171227|P1|STARTED|Overall Study||128
71463|NCT01672892|171242|P2|NOT COMPLETED|Overall Study||3
71464|NCT01672892|171243|P1|NOT COMPLETED|Overall Study||8
71465|NCT01672892|171242|P2|COMPLETED|Overall Study|Eligible subjects available for analysis|149
71466|NCT01672892|171243|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|129
71467|NCT01672892|171242|P2|STARTED|Overall Study||152
71468|NCT01672892|171243|P1|STARTED|Overall Study||137
71469|NCT01672827|171257|P1|NOT COMPLETED|Overall Study||0
71470|NCT01672827|171257|P1|COMPLETED|Overall Study||276
71471|NCT01672827|171257|P1|STARTED|Overall Study||276
71472|NCT01672788|171263|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
71473|NCT01672788|171264|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
71474|NCT01672788|171265|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
71475|NCT01672788|171266|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
71476|NCT01672788|171263|P4|COMPLETED|Treatment Period 4 (3 Days)||8
71477|NCT01672788|171264|P3|COMPLETED|Treatment Period 4 (3 Days)||9
71478|NCT01672788|171265|P2|COMPLETED|Treatment Period 4 (3 Days)||9
71479|NCT01672788|171266|P1|COMPLETED|Treatment Period 4 (3 Days)||9
71480|NCT01672788|171263|P4|STARTED|Treatment Period 4 (3 Days)||8
71481|NCT01672788|171264|P3|STARTED|Treatment Period 4 (3 Days)||9
71482|NCT01672788|171265|P2|STARTED|Treatment Period 4 (3 Days)||9
71483|NCT01672788|171266|P1|STARTED|Treatment Period 4 (3 Days)||9
71484|NCT01672788|171263|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
71485|NCT01672788|171264|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
71486|NCT01672788|171265|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
71487|NCT01672788|171266|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
71488|NCT01672788|171263|P4|COMPLETED|Washout Period 3 (7 Days)||8
71489|NCT01672788|171264|P3|COMPLETED|Washout Period 3 (7 Days)||9
71490|NCT01672788|171265|P2|COMPLETED|Washout Period 3 (7 Days)||9
71491|NCT01672788|171266|P1|COMPLETED|Washout Period 3 (7 Days)||9
71492|NCT01672788|171263|P4|STARTED|Washout Period 3 (7 Days)||8
71493|NCT01672788|171264|P3|STARTED|Washout Period 3 (7 Days)||9
71494|NCT01672788|171265|P2|STARTED|Washout Period 3 (7 Days)||9
71495|NCT01672788|171266|P1|STARTED|Washout Period 3 (7 Days)||9
71496|NCT01672788|171263|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
71497|NCT01672788|171264|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
71498|NCT01672788|171265|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
71499|NCT01672788|171266|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
71500|NCT01672788|171263|P4|COMPLETED|Treatment Period 3 (3 Days)||8
71501|NCT01672788|171264|P3|COMPLETED|Treatment Period 3 (3 Days)||9
71502|NCT01672788|171265|P2|COMPLETED|Treatment Period 3 (3 Days)||9
71503|NCT01672788|171266|P1|COMPLETED|Treatment Period 3 (3 Days)||9
71504|NCT01672788|171263|P4|STARTED|Treatment Period 3 (3 Days)||8
71505|NCT01672788|171264|P3|STARTED|Treatment Period 3 (3 Days)||9
71506|NCT01672788|171265|P2|STARTED|Treatment Period 3 (3 Days)||9
71507|NCT01672788|171266|P1|STARTED|Treatment Period 3 (3 Days)||9
71508|NCT01672788|171263|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
71509|NCT01672788|171264|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
71510|NCT01672788|171265|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
71511|NCT01672788|171266|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
71512|NCT01672788|171263|P4|COMPLETED|Washout Period 2 (7 Days)||8
71513|NCT01672788|171264|P3|COMPLETED|Washout Period 2 (7 Days)||9
71514|NCT01672788|171265|P2|COMPLETED|Washout Period 2 (7 Days)||9
71515|NCT01672788|171266|P1|COMPLETED|Washout Period 2 (7 Days)||9
71516|NCT01672788|171263|P4|STARTED|Washout Period 2 (7 Days)||9
71517|NCT01672788|171264|P3|STARTED|Washout Period 2 (7 Days)||9
71518|NCT01672788|171265|P2|STARTED|Washout Period 2 (7 Days)||9
71519|NCT01672788|171266|P1|STARTED|Washout Period 2 (7 Days)||9
71520|NCT01672788|171263|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
71521|NCT01672788|171264|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
71522|NCT01672788|171265|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
71523|NCT01672788|171266|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
71524|NCT01672788|171263|P4|COMPLETED|Treatment Period 2 (3 Days)||9
71525|NCT01672788|171264|P3|COMPLETED|Treatment Period 2 (3 Days)||9
71526|NCT01672788|171265|P2|COMPLETED|Treatment Period 2 (3 Days)||9
71527|NCT01672788|171266|P1|COMPLETED|Treatment Period 2 (3 Days)||9
71528|NCT01672788|171263|P4|STARTED|Treatment Period 2 (3 Days)||9
71529|NCT01672788|171264|P3|STARTED|Treatment Period 2 (3 Days)||9
71530|NCT01672788|171265|P2|STARTED|Treatment Period 2 (3 Days)||9
71531|NCT01672788|171266|P1|STARTED|Treatment Period 2 (3 Days)||9
71532|NCT01672788|171263|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
71533|NCT01672788|171264|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
71534|NCT01672788|171265|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
71535|NCT01672788|171266|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
71536|NCT01672788|171263|P4|COMPLETED|Washout Period 1 (7 Days)||9
71537|NCT01672788|171264|P3|COMPLETED|Washout Period 1 (7 Days)||9
71538|NCT01672788|171265|P2|COMPLETED|Washout Period 1 (7 Days)||9
71539|NCT01672788|171266|P1|COMPLETED|Washout Period 1 (7 Days)||9
71540|NCT01672788|171263|P4|STARTED|Washout Period 1 (7 Days)||9
71541|NCT01672788|171264|P3|STARTED|Washout Period 1 (7 Days)||9
71542|NCT01672788|171265|P2|STARTED|Washout Period 1 (7 Days)||9
71543|NCT01672788|171266|P1|STARTED|Washout Period 1 (7 Days)||9
71544|NCT01672788|171263|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
71545|NCT01672788|171264|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
71546|NCT01672788|171265|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
71547|NCT01672788|171266|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
71548|NCT01672788|171263|P4|COMPLETED|Treatment Period 1 (3 Days)||9
71549|NCT01672788|171264|P3|COMPLETED|Treatment Period 1 (3 Days)||9
71550|NCT01672788|171265|P2|COMPLETED|Treatment Period 1 (3 Days)||9
71551|NCT01672788|171266|P1|COMPLETED|Treatment Period 1 (3 Days)||9
71552|NCT01672788|171263|P4|STARTED|Treatment Period 1 (3 Days)||9
71553|NCT01672788|171264|P3|STARTED|Treatment Period 1 (3 Days)||9
71554|NCT01672788|171265|P2|STARTED|Treatment Period 1 (3 Days)||9
71555|NCT01672788|171266|P1|STARTED|Treatment Period 1 (3 Days)||9
71556|NCT01672723|171296|P2|NOT COMPLETED|Second Intervention||0
71557|NCT01672723|171297|P1|NOT COMPLETED|Second Intervention||0
71558|NCT01672723|171296|P2|COMPLETED|Second Intervention||15
71559|NCT01672723|171297|P1|COMPLETED|Second Intervention||16
71560|NCT01672723|171296|P2|STARTED|Second Intervention||15
71561|NCT01672723|171297|P1|STARTED|Second Intervention||16
71562|NCT01672723|171296|P2|NOT COMPLETED|Washout Period of 10 Days||0
71563|NCT01672723|171297|P1|NOT COMPLETED|Washout Period of 10 Days||0
71564|NCT01672723|171296|P2|COMPLETED|Washout Period of 10 Days||15
71565|NCT01672723|171297|P1|COMPLETED|Washout Period of 10 Days||16
71566|NCT01672723|171296|P2|STARTED|Washout Period of 10 Days||15
71567|NCT01672723|171297|P1|STARTED|Washout Period of 10 Days||16
71568|NCT01672723|171296|P2|NOT COMPLETED|First Intervention||0
71569|NCT01672723|171297|P1|NOT COMPLETED|First Intervention||3
71570|NCT01672723|171296|P2|COMPLETED|First Intervention||15
71571|NCT01672723|171297|P1|COMPLETED|First Intervention||16
71572|NCT01672723|171296|P2|STARTED|First Intervention||15
71573|NCT01672723|171297|P1|STARTED|First Intervention||19
71574|NCT01672658|171309|P2|NOT COMPLETED|Overall Study||1
71575|NCT01672658|171310|P1|NOT COMPLETED|Overall Study||0
71576|NCT01672658|171309|P2|COMPLETED|Overall Study||14
71577|NCT01672658|171310|P1|COMPLETED|Overall Study||16
71578|NCT01672658|171309|P2|STARTED|Overall Study||15
71579|NCT01672658|171310|P1|STARTED|Overall Study||16
71580|NCT01672294|171334|P4|NOT COMPLETED|Overall Study||13
71581|NCT01672294|171335|P3|NOT COMPLETED|Overall Study||11
71582|NCT01672294|171336|P2|NOT COMPLETED|Overall Study||21
71583|NCT01672294|171337|P1|NOT COMPLETED|Overall Study||6
71584|NCT01672294|171334|P4|COMPLETED|Overall Study||59
71585|NCT01672294|171335|P3|COMPLETED|Overall Study||61
71586|NCT01672294|171336|P2|COMPLETED|Overall Study||50
71587|NCT01672294|171337|P1|COMPLETED|Overall Study||65
71588|NCT01672294|171334|P4|STARTED|Overall Study||72
71589|NCT01672294|171335|P3|STARTED|Overall Study||72
71590|NCT01672294|171336|P2|STARTED|Overall Study||71
71591|NCT01672294|171337|P1|STARTED|Overall Study||71
71592|NCT01672242|171359|P2|NOT COMPLETED|Period 2||0
71593|NCT01672242|171360|P1|NOT COMPLETED|Period 2||0
71594|NCT01672242|171359|P2|COMPLETED|Period 2||2
71595|NCT01672242|171360|P1|COMPLETED|Period 2||4
71596|NCT01672242|171359|P2|STARTED|Period 2||2
71597|NCT01672242|171360|P1|STARTED|Period 2||4
71598|NCT01672242|171359|P2|NOT COMPLETED|Period 1||0
71599|NCT01672242|171360|P1|NOT COMPLETED|Period 1||0
71600|NCT01672242|171359|P2|COMPLETED|Period 1||2
71601|NCT01672242|171360|P1|COMPLETED|Period 1||4
71602|NCT01672242|171359|P2|STARTED|Period 1||2
71603|NCT01672242|171360|P1|STARTED|Period 1||4
71604|NCT01671839|171366|P1|NOT COMPLETED|Overall Study||5
71605|NCT01671839|171366|P1|COMPLETED|Overall Study||50
71606|NCT01671839|171366|P1|STARTED|Overall Study||55
71607|NCT01671748|171377|P2|NOT COMPLETED|12 Week Treatment Phase||0
71608|NCT01671748|171378|P1|NOT COMPLETED|12 Week Treatment Phase||0
71609|NCT01671748|171377|P2|COMPLETED|12 Week Treatment Phase||17
71610|NCT01671748|171378|P1|COMPLETED|12 Week Treatment Phase||19
71611|NCT01671748|171377|P2|STARTED|12 Week Treatment Phase||17
71612|NCT01671748|171378|P1|STARTED|12 Week Treatment Phase||19
71613|NCT01671748|171377|P2|NOT COMPLETED|4 Week run-in Phase||0
71614|NCT01671748|171378|P1|NOT COMPLETED|4 Week run-in Phase||11
71615|NCT01671748|171377|P2|COMPLETED|4 Week run-in Phase||0
71616|NCT01671748|171378|P1|COMPLETED|4 Week run-in Phase||36
71617|NCT01671748|171377|P2|STARTED|4 Week run-in Phase||0
71618|NCT01671748|171378|P1|STARTED|4 Week run-in Phase||47
71619|NCT01671605|171398|P2|NOT COMPLETED|Overall Study||0
71620|NCT01671605|171399|P1|NOT COMPLETED|Overall Study||0
71621|NCT01671605|171398|P2|COMPLETED|Overall Study||31
71622|NCT01671605|171399|P1|COMPLETED|Overall Study||72
71623|NCT01671605|171398|P2|STARTED|Overall Study||31
71624|NCT01671605|171399|P1|STARTED|Overall Study||72
71625|NCT01671488|171405|P1|NOT COMPLETED|Overall Study||1
71626|NCT01671488|171405|P1|COMPLETED|Overall Study||10
71627|NCT01671488|171405|P1|STARTED|Overall Study||11
71628|NCT01671319|171411|P1|NOT COMPLETED|Overall Study||1
71629|NCT01671319|171411|P1|COMPLETED|Overall Study||41
71630|NCT01671319|171411|P1|STARTED|Overall Study||42
71631|NCT01671293|171419|P2|NOT COMPLETED|Overall Study||2
71632|NCT01671293|171420|P1|NOT COMPLETED|Overall Study||3
71633|NCT01671293|171419|P2|COMPLETED|Overall Study||32
71634|NCT01671293|171420|P1|COMPLETED|Overall Study||33
71635|NCT01671293|171419|P2|STARTED|Overall Study||34
71636|NCT01671293|171420|P1|STARTED|Overall Study||36
71637|NCT01671280|171426|P1|NOT COMPLETED|Overall Study||2
71638|NCT01671280|171426|P1|COMPLETED|Overall Study||401
71639|NCT01671280|171426|P1|STARTED|Overall Study|The number is enrollment.|403
71640|NCT01671176|171432|P1|NOT COMPLETED|Overall Study||0
71641|NCT01671176|171432|P1|COMPLETED|Overall Study||30
71642|NCT01671176|171432|P1|STARTED|Overall Study||30
71643|NCT01671111|171437|P1|NOT COMPLETED|Overall Study||30
71644|NCT01671111|171437|P1|COMPLETED|Overall Study||0
71645|NCT01671111|171437|P1|STARTED|Overall Study||30
71646|NCT01671059|171447|P1|NOT COMPLETED|Overall Study||5
71647|NCT01671059|171447|P1|COMPLETED|Overall Study||75
71648|NCT01671059|171447|P1|STARTED|Overall Study||80
71649|NCT01670825|171472|P2|NOT COMPLETED|Overall Study||0
71650|NCT01670825|171473|P1|NOT COMPLETED|Overall Study||0
71651|NCT01670825|171472|P2|COMPLETED|Overall Study||39
71652|NCT01670825|171473|P1|COMPLETED|Overall Study||42
71653|NCT01670825|171472|P2|STARTED|Overall Study||39
71654|NCT01670825|171473|P1|STARTED|Overall Study||42
71655|NCT01670721|171539|P1|NOT COMPLETED|Overall Study||53
71656|NCT01670721|171539|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
71657|NCT01670721|171539|P1|STARTED|Overall Study||175
71658|NCT01670656|171551|P5|NOT COMPLETED|Overall Study||11
71659|NCT01670656|171552|P4|NOT COMPLETED|Overall Study||6
71660|NCT01670656|171553|P3|NOT COMPLETED|Overall Study||8
71661|NCT01670656|171554|P2|NOT COMPLETED|Overall Study||7
71662|NCT01670656|171555|P1|NOT COMPLETED|Overall Study||3
71663|NCT01670656|171551|P5|COMPLETED|Overall Study||79
71664|NCT01670656|171552|P4|COMPLETED|Overall Study||79
71665|NCT01670656|171553|P3|COMPLETED|Overall Study||79
71666|NCT01670656|171554|P2|COMPLETED|Overall Study||84
71667|NCT01670656|171555|P1|COMPLETED|Overall Study||83
71668|NCT01670656|171551|P5|Treated|Overall Study||90
71669|NCT01670656|171552|P4|Treated|Overall Study||85
71670|NCT01670656|171553|P3|Treated|Overall Study||86
71671|NCT01670656|171554|P2|Treated|Overall Study||91
71672|NCT01670656|171555|P1|Treated|Overall Study||86
71673|NCT01670656|171551|P5|STARTED|Overall Study||90
71674|NCT01670656|171552|P4|STARTED|Overall Study||85
71675|NCT01670656|171553|P3|STARTED|Overall Study||87
71676|NCT01670656|171554|P2|STARTED|Overall Study||91
71677|NCT01670656|171555|P1|STARTED|Overall Study||86
71678|NCT01670526|171584|P2|NOT COMPLETED|Overall Study||6
71679|NCT01670526|171585|P1|NOT COMPLETED|Overall Study||12
71680|NCT01670526|171584|P2|COMPLETED|Overall Study||39
71681|NCT01670526|171585|P1|COMPLETED|Overall Study||37
71682|NCT01670526|171584|P2|STARTED|Overall Study||45
71683|NCT01670526|171585|P1|STARTED|Overall Study||49
71684|NCT01670487|171599|P2|NOT COMPLETED|Overall Study||0
71685|NCT01670487|171600|P1|NOT COMPLETED|Overall Study||0
71686|NCT01670487|171599|P2|COMPLETED|Overall Study||150
71687|NCT01670487|171600|P1|COMPLETED|Overall Study||150
71688|NCT01670487|171599|P2|STARTED|Overall Study||150
71689|NCT01670487|171600|P1|STARTED|Overall Study||150
71690|NCT01670292|171606|P1|NOT COMPLETED|Overall Study||14
71691|NCT01670292|171606|P1|COMPLETED|Overall Study||68
71692|NCT01670292|171606|P1|STARTED|Overall Study||82
71693|NCT01670279|171647|P4|NOT COMPLETED|Overall Study||1
71694|NCT01670279|171648|P3|NOT COMPLETED|Overall Study||0
71695|NCT01670279|171649|P2|NOT COMPLETED|Overall Study||2
71696|NCT01670279|171650|P1|NOT COMPLETED|Overall Study||0
71697|NCT01670279|171647|P4|COMPLETED|Overall Study||4
71698|NCT01670279|171648|P3|COMPLETED|Overall Study||0
71699|NCT01670279|171649|P2|COMPLETED|Overall Study||5
71700|NCT01670279|171650|P1|COMPLETED|Overall Study||6
71701|NCT01670279|171647|P4|STARTED|Overall Study||5
71702|NCT01670279|171648|P3|STARTED|Overall Study||0
71703|NCT01670279|171649|P2|STARTED|Overall Study||7
71704|NCT01670279|171650|P1|STARTED|Overall Study||6
71705|NCT01670201|171685|P1|NOT COMPLETED|Overall Study||0
71706|NCT01670201|171685|P1|COMPLETED|Overall Study||8
71707|NCT01670201|171685|P1|STARTED|Overall Study||8
71708|NCT01670188|171692|P2|NOT COMPLETED|Overall Study||1
71709|NCT01670188|171693|P1|NOT COMPLETED|Overall Study||0
71710|NCT01670188|171692|P2|COMPLETED|Overall Study||39
71711|NCT01670188|171693|P1|COMPLETED|Overall Study||38
71712|NCT01670188|171692|P2|STARTED|Overall Study||40
71713|NCT01670188|171693|P1|STARTED|Overall Study||38
71714|NCT01670045|171699|P1|NOT COMPLETED|Overall Study||16
71715|NCT01670045|171699|P1|COMPLETED|Overall Study||27
71716|NCT01670045|171699|P1|STARTED|Overall Study||43
71717|NCT01670019|171717|P2|NOT COMPLETED|Overall Study||0
71718|NCT01670019|171718|P1|NOT COMPLETED|Overall Study||9
71719|NCT01670019|171717|P2|COMPLETED|Overall Study||23
71720|NCT01670019|171718|P1|COMPLETED|Overall Study||14
71721|NCT01670019|171717|P2|STARTED|Overall Study||23
71722|NCT01670019|171718|P1|STARTED|Overall Study||23
71723|NCT01669902|171732|P1|NOT COMPLETED|Overall Study||29
71724|NCT01669902|171732|P1|COMPLETED|Overall Study||78
71725|NCT01669902|171732|P1|STARTED|Overall Study||107
71726|NCT01669863|171759|P1|NOT COMPLETED|Overall Study||0
71727|NCT01669863|171759|P1|COMPLETED|Overall Study||6
71728|NCT01669863|171759|P1|STARTED|Overall Study||6
71729|NCT01669811|171767|P2|NOT COMPLETED|Overall Study||11
71730|NCT01669811|171768|P1|NOT COMPLETED|Overall Study||3
71731|NCT01669811|171767|P2|COMPLETED|Overall Study||131
71732|NCT01669811|171768|P1|COMPLETED|Overall Study||142
71733|NCT01669811|171767|P2|STARTED|Overall Study||142
71734|NCT01669811|171768|P1|STARTED|Overall Study||145
71735|NCT01669785|171789|P3|NOT COMPLETED|Overall Study||0
71736|NCT01669785|171790|P2|NOT COMPLETED|Overall Study||0
71737|NCT01669785|171791|P1|NOT COMPLETED|Overall Study||0
71738|NCT01669785|171789|P3|COMPLETED|Overall Study||46
71739|NCT01669785|171790|P2|COMPLETED|Overall Study||48
71740|NCT01669785|171791|P1|COMPLETED|Overall Study||45
71741|NCT01669785|171789|P3|STARTED|Overall Study||46
71742|NCT01669785|171790|P2|STARTED|Overall Study||48
71743|NCT01669785|171791|P1|STARTED|Overall Study||45
71744|NCT01669720|171828|P2|NOT COMPLETED|Overall Study||0
71745|NCT01669720|171829|P1|NOT COMPLETED|Overall Study||0
71746|NCT01669720|171828|P2|COMPLETED|Overall Study||3
71747|NCT01669720|171829|P1|COMPLETED|Overall Study||7
71748|NCT01669720|171828|P2|STARTED|Overall Study||3
71749|NCT01669720|171829|P1|STARTED|Overall Study||7
71750|NCT01669642|171842|P6|NOT COMPLETED|Overall Study||10
71751|NCT01669642|171843|P5|NOT COMPLETED|Overall Study||0
71752|NCT01669642|171844|P4|NOT COMPLETED|Overall Study||1
71753|NCT01669642|171845|P3|NOT COMPLETED|Overall Study||0
71754|NCT01669642|171846|P2|NOT COMPLETED|Overall Study||0
71755|NCT01669642|171847|P1|NOT COMPLETED|Overall Study||0
71756|NCT01669642|171842|P6|COMPLETED|Overall Study||0
71757|NCT01669642|171843|P5|COMPLETED|Overall Study||20
71758|NCT01669642|171844|P4|COMPLETED|Overall Study||20
71759|NCT01669642|171845|P3|COMPLETED|Overall Study||20
71760|NCT01669642|171846|P2|COMPLETED|Overall Study||20
71761|NCT01669642|171847|P1|COMPLETED|Overall Study||20
71762|NCT01669642|171842|P6|STARTED|Overall Study||10
71763|NCT01669642|171843|P5|STARTED|Overall Study||20
71764|NCT01669642|171844|P4|STARTED|Overall Study||21
71765|NCT01669642|171845|P3|STARTED|Overall Study||20
71766|NCT01669642|171846|P2|STARTED|Overall Study||20
71767|NCT01669642|171847|P1|STARTED|Overall Study||20
71768|NCT01669629|171879|P2|NOT COMPLETED|Period 2||0
71769|NCT01669629|171880|P1|NOT COMPLETED|Period 2||0
71770|NCT01669629|171879|P2|COMPLETED|Period 2||89
71771|NCT01669629|171880|P1|COMPLETED|Period 2||91
71772|NCT01669629|171879|P2|STARTED|Period 2||89
71773|NCT01669629|171880|P1|STARTED|Period 2||91
71774|NCT01669629|171879|P2|NOT COMPLETED|Period 1||2
71775|NCT01669629|171880|P1|NOT COMPLETED|Period 1||1
71776|NCT01669629|171879|P2|COMPLETED|Period 1||89
71777|NCT01669629|171880|P1|COMPLETED|Period 1||91
71778|NCT01669629|171879|P2|STARTED|Period 1||91
71779|NCT01669629|171880|P1|STARTED|Period 1||92
71780|NCT01669603|171896|P2|NOT COMPLETED|Overall Study||38
71781|NCT01669603|171897|P1|NOT COMPLETED|Overall Study||37
71782|NCT01669603|171896|P2|COMPLETED|Overall Study||57
71783|NCT01669603|171897|P1|COMPLETED|Overall Study||58
71784|NCT01669603|171896|P2|STARTED|Overall Study||95
71785|NCT01669603|171897|P1|STARTED|Overall Study||95
71786|NCT01669577|171903|P1|NOT COMPLETED|Overall Study||134
71787|NCT01669577|171903|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
71788|NCT01669577|171903|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
71789|NCT01669434|171909|P2|NOT COMPLETED|Overall Study||7
71790|NCT01669434|171910|P1|NOT COMPLETED|Overall Study||9
71791|NCT01669434|171909|P2|COMPLETED|Overall Study||138
71792|NCT01669434|171910|P1|COMPLETED|Overall Study||137
71793|NCT01669434|171909|P2|STARTED|Overall Study||145
71794|NCT01669434|171910|P1|STARTED|Overall Study||146
71795|NCT01669174|171928|P2|NOT COMPLETED|Overall Study||6
71796|NCT01669174|171929|P1|NOT COMPLETED|Overall Study||6
71797|NCT01669174|171928|P2|COMPLETED|Overall Study||28
71798|NCT01669174|171929|P1|COMPLETED|Overall Study||27
71799|NCT01669174|171928|P2|STARTED|Overall Study||34
71800|NCT01669174|171929|P1|STARTED|Overall Study||33
71801|NCT01669148|171940|P1|NOT COMPLETED|Overall Study||70
71802|NCT01669148|171940|P1|COMPLETED|Overall Study||426
71803|NCT01669148|171940|P1|STARTED|Overall Study||496
71804|NCT01669122|171945|P1|NOT COMPLETED|Period IV||0
71805|NCT01669122|171945|P1|COMPLETED|Period IV||37
71806|NCT01669122|171945|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
71807|NCT01669122|171945|P1|NOT COMPLETED|Period III||0
71808|NCT01669122|171945|P1|COMPLETED|Period III||37
71809|NCT01669122|171945|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
71810|NCT01669122|171945|P1|NOT COMPLETED|Washout Period III||0
71811|NCT01669122|171945|P1|COMPLETED|Washout Period III||37
71812|NCT01669122|171945|P1|STARTED|Washout Period III||37
71813|NCT01669122|171945|P1|NOT COMPLETED|Washout Period II||2
71814|NCT01669122|171945|P1|COMPLETED|Washout Period II||37
71815|NCT01669122|171945|P1|STARTED|Washout Period II||39
71816|NCT01669122|171945|P1|NOT COMPLETED|Period II||0
71817|NCT01669122|171945|P1|COMPLETED|Period II||39
71818|NCT01669122|171945|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
71819|NCT01669122|171945|P1|NOT COMPLETED|Washout Period I||0
71820|NCT01669122|171945|P1|COMPLETED|Washout Period I||39
71821|NCT01669122|171945|P1|STARTED|Washout Period I||39
71822|NCT01669122|171945|P1|NOT COMPLETED|Period I||1
71823|NCT01669122|171945|P1|COMPLETED|Period I||39
71824|NCT01669122|171945|P1|Safety Population|Period I||39
71825|NCT01669122|171945|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
71826|NCT01668836|171979|P4|NOT COMPLETED|Overall Study||0
71827|NCT01668836|171980|P3|NOT COMPLETED|Overall Study||0
71828|NCT01668836|171981|P2|NOT COMPLETED|Overall Study||0
71829|NCT01668836|171982|P1|NOT COMPLETED|Overall Study||0
71830|NCT01668836|171979|P4|COMPLETED|Overall Study||12
71831|NCT01668836|171980|P3|COMPLETED|Overall Study||12
71832|NCT01668836|171981|P2|COMPLETED|Overall Study||12
71833|NCT01668836|171982|P1|COMPLETED|Overall Study||12
71834|NCT01668836|171979|P4|STARTED|Overall Study||12
71835|NCT01668836|171980|P3|STARTED|Overall Study||12
71836|NCT01668836|171981|P2|STARTED|Overall Study||12
71837|NCT01668836|171982|P1|STARTED|Overall Study||12
71838|NCT01668797|172038|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
71839|NCT01668797|172039|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
71840|NCT01668797|172040|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
71841|NCT01668797|172041|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
71842|NCT01668797|172038|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
71843|NCT01668797|172039|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
71844|NCT01668797|172040|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
71845|NCT01668797|172041|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
71846|NCT01668797|172038|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
71847|NCT01668797|172039|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
71848|NCT01668797|172040|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
71849|NCT01668797|172041|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
71850|NCT01668797|172038|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
71851|NCT01668797|172039|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
71852|NCT01668797|172040|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
71853|NCT01668797|172041|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
71854|NCT01668797|172038|P4|COMPLETED|Phase B (Stabilization Phase)||0
71855|NCT01668797|172039|P3|COMPLETED|Phase B (Stabilization Phase)||0
71856|NCT01668797|172040|P2|COMPLETED|Phase B (Stabilization Phase)||202
71857|NCT01668797|172041|P1|COMPLETED|Phase B (Stabilization Phase)||0
71858|NCT01668797|172038|P4|STARTED|Phase B (Stabilization Phase)||0
71859|NCT01668797|172039|P3|STARTED|Phase B (Stabilization Phase)||0
71860|NCT01668797|172040|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
71861|NCT01668797|172041|P1|STARTED|Phase B (Stabilization Phase)||0
71862|NCT01668797|172038|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
71863|NCT01668797|172039|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
71864|NCT01668797|172040|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
71865|NCT01668797|172041|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
71866|NCT01668797|172038|P4|COMPLETED|Phase A (Conversion Phase)||0
71867|NCT01668797|172039|P3|COMPLETED|Phase A (Conversion Phase)||0
71868|NCT01668797|172040|P2|COMPLETED|Phase A (Conversion Phase)||0
71869|NCT01668797|172041|P1|COMPLETED|Phase A (Conversion Phase)||346
71870|NCT01668797|172038|P4|STARTED|Phase A (Conversion Phase)||0
71871|NCT01668797|172039|P3|STARTED|Phase A (Conversion Phase)||0
71872|NCT01668797|172040|P2|STARTED|Phase A (Conversion Phase)||0
71873|NCT01668797|172041|P1|STARTED|Phase A (Conversion Phase)||406
71874|NCT01668784|172106|P2|NOT COMPLETED|Treated (Overall)||369
71875|NCT01668784|172107|P1|NOT COMPLETED|Treated (Overall)||339
71876|NCT01668784|172106|P2|COMPLETED|Treated (Overall)||28
71877|NCT01668784|172107|P1|COMPLETED|Treated (Overall)||67
71878|NCT01668784|172106|P2|STARTED|Treated (Overall)||397
71879|NCT01668784|172107|P1|STARTED|Treated (Overall)||406
71880|NCT01668784|172106|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
71881|NCT01668784|172107|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
71882|NCT01668784|172106|P2|COMPLETED|Randomized (Pre-treatment)||397
71883|NCT01668784|172107|P1|COMPLETED|Randomized (Pre-treatment)||406
71884|NCT01668784|172106|P2|STARTED|Randomized (Pre-treatment)||411
71885|NCT01668784|172107|P1|STARTED|Randomized (Pre-treatment)||410
71886|NCT01668667|172135|P4|NOT COMPLETED|Overall Study||23
71887|NCT01668667|172136|P3|NOT COMPLETED|Overall Study||31
71888|NCT01668667|172137|P2|NOT COMPLETED|Overall Study||26
71889|NCT01668667|172138|P1|NOT COMPLETED|Overall Study||31
71890|NCT01668667|172135|P4|COMPLETED|Overall Study||102
71891|NCT01668667|172136|P3|COMPLETED|Overall Study||94
71892|NCT01668667|172137|P2|COMPLETED|Overall Study||99
71893|NCT01668667|172138|P1|COMPLETED|Overall Study||95
71894|NCT01668667|172135|P4|STARTED|Overall Study||125
71895|NCT01668667|172136|P3|STARTED|Overall Study||125
71896|NCT01668667|172137|P2|STARTED|Overall Study||125
71897|NCT01668667|172138|P1|STARTED|Overall Study||126
71898|NCT01668654|172160|P1|NOT COMPLETED|Overall Study||4
71899|NCT01668654|172160|P1|COMPLETED|Overall Study||0
71900|NCT01668654|172160|P1|STARTED|Overall Study||4
71901|NCT01668628|172203|P3|NOT COMPLETED|Overall Study||0
71902|NCT01668628|172204|P2|NOT COMPLETED|Overall Study||0
71903|NCT01668628|172205|P1|NOT COMPLETED|Overall Study||2
71904|NCT01668628|172203|P3|COMPLETED|Overall Study||367
71905|NCT01668628|172204|P2|COMPLETED|Overall Study||359
71906|NCT01668628|172205|P1|COMPLETED|Overall Study||347
71907|NCT01668628|172203|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
71908|NCT01668628|172204|P2|STARTED|Overall Study||359
71909|NCT01668628|172205|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
71910|NCT01668589|172221|P4|NOT COMPLETED|Overall Study||35
71911|NCT01668589|172222|P3|NOT COMPLETED|Overall Study||35
71912|NCT01668589|172223|P2|NOT COMPLETED|Overall Study||58
71913|NCT01668589|172224|P1|NOT COMPLETED|Overall Study||139
71914|NCT01668589|172221|P4|COMPLETED|Overall Study||266
71915|NCT01668589|172222|P3|COMPLETED|Overall Study||265
71916|NCT01668589|172223|P2|COMPLETED|Overall Study||242
71917|NCT01668589|172224|P1|COMPLETED|Overall Study||461
71918|NCT01668589|172221|P4|Received Denosumab|Overall Study||301
71919|NCT01668589|172222|P3|Received Denosumab|Overall Study||300
71920|NCT01668589|172223|P2|Received Denosumab|Overall Study||300
71921|NCT01668589|172224|P1|Received Denosumab|Overall Study||599
71922|NCT01668589|172221|P4|STARTED|Overall Study||301
71923|NCT01668589|172222|P3|STARTED|Overall Study||300
71924|NCT01668589|172223|P2|STARTED|Overall Study||300
71925|NCT01668589|172224|P1|STARTED|Overall Study||600
71926|NCT01668173|172262|P1|NOT COMPLETED|Overall Study||7
71927|NCT01668173|172262|P1|COMPLETED|Overall Study||0
71928|NCT01668173|172262|P1|STARTED|Overall Study||7
71929|NCT01668030|172266|P2|NOT COMPLETED|Overall Study||0
71930|NCT01668030|172267|P1|NOT COMPLETED|Overall Study||0
71931|NCT01668030|172266|P2|COMPLETED|Overall Study||10
71932|NCT01668030|172267|P1|COMPLETED|Overall Study||10
71933|NCT01668030|172266|P2|STARTED|Overall Study||10
71934|NCT01668030|172267|P1|STARTED|Overall Study||10
71935|NCT01668017|172277|P5|NOT COMPLETED|Overall Study||0
71936|NCT01668017|172278|P4|NOT COMPLETED|Overall Study||0
71937|NCT01668017|172279|P3|NOT COMPLETED|Overall Study||0
71938|NCT01668017|172280|P2|NOT COMPLETED|Overall Study||0
71939|NCT01668017|172281|P1|NOT COMPLETED|Overall Study||0
71940|NCT01668017|172277|P5|COMPLETED|Overall Study||2
71941|NCT01668017|172278|P4|COMPLETED|Overall Study||5
71942|NCT01668017|172279|P3|COMPLETED|Overall Study||6
71943|NCT01668017|172280|P2|COMPLETED|Overall Study||9
71944|NCT01668017|172281|P1|COMPLETED|Overall Study||4
71945|NCT01668017|172277|P5|STARTED|Overall Study||2
71946|NCT01668017|172278|P4|STARTED|Overall Study||5
71947|NCT01668017|172279|P3|STARTED|Overall Study||6
71948|NCT01668017|172280|P2|STARTED|Overall Study||9
71949|NCT01668017|172281|P1|STARTED|Overall Study||4
71950|NCT01668004|172388|P1|NOT COMPLETED|Overall Study||25
71951|NCT01668004|172388|P1|COMPLETED|Overall Study||76
71952|NCT01668004|172388|P1|Treated|Overall Study||101
71953|NCT01668004|172388|P1|STARTED|Overall Study||101
71954|NCT01667978|172401|P2|NOT COMPLETED|Overall Study||0
71955|NCT01667978|172402|P1|NOT COMPLETED|Overall Study||2
71956|NCT01667978|172401|P2|COMPLETED|Overall Study||17
71957|NCT01667978|172402|P1|COMPLETED|Overall Study||16
71958|NCT01667978|172401|P2|STARTED|Overall Study||17
71959|NCT01667978|172402|P1|STARTED|Overall Study||18
71960|NCT01667926|172410|P3|NOT COMPLETED|Overall Study||11
71961|NCT01667926|172411|P2|NOT COMPLETED|Overall Study||4
71962|NCT01667926|172412|P1|NOT COMPLETED|Overall Study||5
71963|NCT01667926|172410|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
71964|NCT01667926|172411|P2|COMPLETED|Overall Study||9
71965|NCT01667926|172412|P1|COMPLETED|Overall Study||8
71966|NCT01667926|172410|P3|STARTED|Overall Study||11
71967|NCT01667926|172411|P2|STARTED|Overall Study||13
71968|NCT01667926|172412|P1|STARTED|Overall Study||13
71969|NCT01667900|172425|P20|NOT COMPLETED|Part B||0
71970|NCT01667900|172426|P19|NOT COMPLETED|Part B||0
71971|NCT01667900|172427|P18|NOT COMPLETED|Part B||0
71972|NCT01667900|172428|P17|NOT COMPLETED|Part B||1
71973|NCT01667900|172429|P16|NOT COMPLETED|Part B||0
71974|NCT01667900|172430|P15|NOT COMPLETED|Part B||0
71975|NCT01667900|172431|P14|NOT COMPLETED|Part B||0
71976|NCT01667900|172432|P13|NOT COMPLETED|Part B||0
71977|NCT01667900|172433|P12|NOT COMPLETED|Part B||0
71978|NCT01667900|172434|P11|NOT COMPLETED|Part B||0
71979|NCT01667900|172435|P10|NOT COMPLETED|Part B||0
71980|NCT01667900|172436|P9|NOT COMPLETED|Part B||0
71981|NCT01667900|172437|P8|NOT COMPLETED|Part B||0
71982|NCT01667900|172438|P7|NOT COMPLETED|Part B||0
71983|NCT01667900|172439|P6|NOT COMPLETED|Part B||0
71984|NCT01667900|172440|P5|NOT COMPLETED|Part B||0
71985|NCT01667900|172441|P4|NOT COMPLETED|Part B||0
71986|NCT01667900|172442|P3|NOT COMPLETED|Part B||0
71987|NCT01667900|172443|P2|NOT COMPLETED|Part B||0
71988|NCT01667900|172444|P1|NOT COMPLETED|Part B||0
71989|NCT01667900|172425|P20|COMPLETED|Part B||10
71990|NCT01667900|172426|P19|COMPLETED|Part B||10
71991|NCT01667900|172427|P18|COMPLETED|Part B||11
71992|NCT01667900|172428|P17|COMPLETED|Part B||10
71993|NCT01667900|172429|P16|COMPLETED|Part B||0
71994|NCT01667900|172430|P15|COMPLETED|Part B||0
71995|NCT01667900|172431|P14|COMPLETED|Part B||0
71996|NCT01667900|172432|P13|COMPLETED|Part B||0
71997|NCT01667900|172433|P12|COMPLETED|Part B||0
71998|NCT01667900|172434|P11|COMPLETED|Part B||0
71999|NCT01667900|172435|P10|COMPLETED|Part B||0
72000|NCT01667900|172436|P9|COMPLETED|Part B||0
72001|NCT01667900|172437|P8|COMPLETED|Part B||0
72002|NCT01667900|172438|P7|COMPLETED|Part B||0
72003|NCT01667900|172439|P6|COMPLETED|Part B||0
72004|NCT01667900|172440|P5|COMPLETED|Part B||0
72005|NCT01667900|172441|P4|COMPLETED|Part B||0
72006|NCT01667900|172442|P3|COMPLETED|Part B||0
72007|NCT01667900|172443|P2|COMPLETED|Part B||0
72008|NCT01667900|172444|P1|COMPLETED|Part B||0
72009|NCT01667900|172425|P20|STARTED|Part B||10
72010|NCT01667900|172426|P19|STARTED|Part B||10
72011|NCT01667900|172427|P18|STARTED|Part B||11
72012|NCT01667900|172428|P17|STARTED|Part B||11
72013|NCT01667900|172429|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
72014|NCT01667900|172430|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
72102|NCT01667900|172438|P7|NOT COMPLETED|Part A, Washout 2||0
72015|NCT01667900|172431|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
72016|NCT01667900|172432|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
72017|NCT01667900|172433|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
72018|NCT01667900|172434|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
72019|NCT01667900|172435|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
72020|NCT01667900|172436|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
72021|NCT01667900|172437|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
72022|NCT01667900|172438|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
72023|NCT01667900|172439|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
72024|NCT01667900|172440|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
72025|NCT01667900|172441|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
72026|NCT01667900|172442|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
72027|NCT01667900|172443|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
72028|NCT01667900|172444|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
72029|NCT01667900|172425|P20|NOT COMPLETED|Part A, Period 3||0
72030|NCT01667900|172426|P19|NOT COMPLETED|Part A, Period 3||0
72031|NCT01667900|172427|P18|NOT COMPLETED|Part A, Period 3||0
72032|NCT01667900|172428|P17|NOT COMPLETED|Part A, Period 3||0
72033|NCT01667900|172429|P16|NOT COMPLETED|Part A, Period 3||0
72034|NCT01667900|172430|P15|NOT COMPLETED|Part A, Period 3||0
72035|NCT01667900|172431|P14|NOT COMPLETED|Part A, Period 3||0
72036|NCT01667900|172432|P13|NOT COMPLETED|Part A, Period 3||0
72037|NCT01667900|172433|P12|NOT COMPLETED|Part A, Period 3||0
72038|NCT01667900|172434|P11|NOT COMPLETED|Part A, Period 3||0
72039|NCT01667900|172435|P10|NOT COMPLETED|Part A, Period 3||0
72040|NCT01667900|172436|P9|NOT COMPLETED|Part A, Period 3||0
72041|NCT01667900|172437|P8|NOT COMPLETED|Part A, Period 3||0
72042|NCT01667900|172438|P7|NOT COMPLETED|Part A, Period 3||0
72043|NCT01667900|172439|P6|NOT COMPLETED|Part A, Period 3||0
72044|NCT01667900|172440|P5|NOT COMPLETED|Part A, Period 3||0
72045|NCT01667900|172441|P4|NOT COMPLETED|Part A, Period 3||0
72046|NCT01667900|172442|P3|NOT COMPLETED|Part A, Period 3||0
72047|NCT01667900|172443|P2|NOT COMPLETED|Part A, Period 3||0
72048|NCT01667900|172444|P1|NOT COMPLETED|Part A, Period 3||0
72049|NCT01667900|172425|P20|COMPLETED|Part A, Period 3||0
72050|NCT01667900|172426|P19|COMPLETED|Part A, Period 3||0
72051|NCT01667900|172427|P18|COMPLETED|Part A, Period 3||0
72052|NCT01667900|172428|P17|COMPLETED|Part A, Period 3||0
72053|NCT01667900|172429|P16|COMPLETED|Part A, Period 3||1
72054|NCT01667900|172430|P15|COMPLETED|Part A, Period 3||1
72055|NCT01667900|172431|P14|COMPLETED|Part A, Period 3||1
72056|NCT01667900|172432|P13|COMPLETED|Part A, Period 3||1
72057|NCT01667900|172433|P12|COMPLETED|Part A, Period 3||1
72058|NCT01667900|172434|P11|COMPLETED|Part A, Period 3||1
72059|NCT01667900|172435|P10|COMPLETED|Part A, Period 3||1
72060|NCT01667900|172436|P9|COMPLETED|Part A, Period 3||1
72061|NCT01667900|172437|P8|COMPLETED|Part A, Period 3||1
72062|NCT01667900|172438|P7|COMPLETED|Part A, Period 3||1
72063|NCT01667900|172439|P6|COMPLETED|Part A, Period 3||1
72064|NCT01667900|172440|P5|COMPLETED|Part A, Period 3||1
72065|NCT01667900|172441|P4|COMPLETED|Part A, Period 3||1
72066|NCT01667900|172442|P3|COMPLETED|Part A, Period 3||1
72067|NCT01667900|172443|P2|COMPLETED|Part A, Period 3||1
72068|NCT01667900|172444|P1|COMPLETED|Part A, Period 3||1
72069|NCT01667900|172425|P20|STARTED|Part A, Period 3||0
72070|NCT01667900|172426|P19|STARTED|Part A, Period 3||0
72071|NCT01667900|172427|P18|STARTED|Part A, Period 3||0
72072|NCT01667900|172428|P17|STARTED|Part A, Period 3||0
72073|NCT01667900|172429|P16|STARTED|Part A, Period 3||1
72074|NCT01667900|172430|P15|STARTED|Part A, Period 3||1
72075|NCT01667900|172431|P14|STARTED|Part A, Period 3||1
72076|NCT01667900|172432|P13|STARTED|Part A, Period 3||1
72077|NCT01667900|172433|P12|STARTED|Part A, Period 3||1
72078|NCT01667900|172434|P11|STARTED|Part A, Period 3||1
72079|NCT01667900|172435|P10|STARTED|Part A, Period 3||1
72080|NCT01667900|172436|P9|STARTED|Part A, Period 3||1
72081|NCT01667900|172437|P8|STARTED|Part A, Period 3||1
72082|NCT01667900|172438|P7|STARTED|Part A, Period 3||1
72083|NCT01667900|172439|P6|STARTED|Part A, Period 3||1
72084|NCT01667900|172440|P5|STARTED|Part A, Period 3||1
72085|NCT01667900|172441|P4|STARTED|Part A, Period 3||1
72086|NCT01667900|172442|P3|STARTED|Part A, Period 3||1
72087|NCT01667900|172443|P2|STARTED|Part A, Period 3||1
72088|NCT01667900|172444|P1|STARTED|Part A, Period 3||1
72089|NCT01667900|172425|P20|NOT COMPLETED|Part A, Washout 2||0
72090|NCT01667900|172426|P19|NOT COMPLETED|Part A, Washout 2||0
72091|NCT01667900|172427|P18|NOT COMPLETED|Part A, Washout 2||0
72092|NCT01667900|172428|P17|NOT COMPLETED|Part A, Washout 2||0
72093|NCT01667900|172429|P16|NOT COMPLETED|Part A, Washout 2||0
72094|NCT01667900|172430|P15|NOT COMPLETED|Part A, Washout 2||0
72095|NCT01667900|172431|P14|NOT COMPLETED|Part A, Washout 2||0
72096|NCT01667900|172432|P13|NOT COMPLETED|Part A, Washout 2||0
72097|NCT01667900|172433|P12|NOT COMPLETED|Part A, Washout 2||0
72098|NCT01667900|172434|P11|NOT COMPLETED|Part A, Washout 2||0
72099|NCT01667900|172435|P10|NOT COMPLETED|Part A, Washout 2||0
72100|NCT01667900|172436|P9|NOT COMPLETED|Part A, Washout 2||0
72101|NCT01667900|172437|P8|NOT COMPLETED|Part A, Washout 2||0
72103|NCT01667900|172439|P6|NOT COMPLETED|Part A, Washout 2||0
72104|NCT01667900|172440|P5|NOT COMPLETED|Part A, Washout 2||0
72105|NCT01667900|172441|P4|NOT COMPLETED|Part A, Washout 2||0
72106|NCT01667900|172442|P3|NOT COMPLETED|Part A, Washout 2||0
72107|NCT01667900|172443|P2|NOT COMPLETED|Part A, Washout 2||0
72108|NCT01667900|172444|P1|NOT COMPLETED|Part A, Washout 2||0
72109|NCT01667900|172425|P20|COMPLETED|Part A, Washout 2||0
72110|NCT01667900|172426|P19|COMPLETED|Part A, Washout 2||0
72111|NCT01667900|172427|P18|COMPLETED|Part A, Washout 2||0
72112|NCT01667900|172428|P17|COMPLETED|Part A, Washout 2||0
72113|NCT01667900|172429|P16|COMPLETED|Part A, Washout 2||1
72114|NCT01667900|172430|P15|COMPLETED|Part A, Washout 2||1
72115|NCT01667900|172431|P14|COMPLETED|Part A, Washout 2||1
72116|NCT01667900|172432|P13|COMPLETED|Part A, Washout 2||1
72117|NCT01667900|172433|P12|COMPLETED|Part A, Washout 2||1
72118|NCT01667900|172434|P11|COMPLETED|Part A, Washout 2||1
72119|NCT01667900|172435|P10|COMPLETED|Part A, Washout 2||1
72120|NCT01667900|172436|P9|COMPLETED|Part A, Washout 2||1
72121|NCT01667900|172437|P8|COMPLETED|Part A, Washout 2||1
72122|NCT01667900|172438|P7|COMPLETED|Part A, Washout 2||1
72123|NCT01667900|172439|P6|COMPLETED|Part A, Washout 2||1
72124|NCT01667900|172440|P5|COMPLETED|Part A, Washout 2||1
72125|NCT01667900|172441|P4|COMPLETED|Part A, Washout 2||1
72126|NCT01667900|172442|P3|COMPLETED|Part A, Washout 2||1
72127|NCT01667900|172443|P2|COMPLETED|Part A, Washout 2||1
72128|NCT01667900|172444|P1|COMPLETED|Part A, Washout 2||1
72129|NCT01667900|172425|P20|STARTED|Part A, Washout 2||0
72130|NCT01667900|172426|P19|STARTED|Part A, Washout 2||0
72131|NCT01667900|172427|P18|STARTED|Part A, Washout 2||0
72132|NCT01667900|172428|P17|STARTED|Part A, Washout 2||0
72133|NCT01667900|172429|P16|STARTED|Part A, Washout 2||1
72134|NCT01667900|172430|P15|STARTED|Part A, Washout 2||1
72135|NCT01667900|172431|P14|STARTED|Part A, Washout 2||1
72136|NCT01667900|172432|P13|STARTED|Part A, Washout 2||1
72137|NCT01667900|172433|P12|STARTED|Part A, Washout 2||1
72138|NCT01667900|172434|P11|STARTED|Part A, Washout 2||1
72139|NCT01667900|172435|P10|STARTED|Part A, Washout 2||1
72140|NCT01667900|172436|P9|STARTED|Part A, Washout 2||1
72141|NCT01667900|172437|P8|STARTED|Part A, Washout 2||1
72142|NCT01667900|172438|P7|STARTED|Part A, Washout 2||1
72143|NCT01667900|172439|P6|STARTED|Part A, Washout 2||1
72144|NCT01667900|172440|P5|STARTED|Part A, Washout 2||1
72145|NCT01667900|172441|P4|STARTED|Part A, Washout 2||1
72146|NCT01667900|172442|P3|STARTED|Part A, Washout 2||1
72147|NCT01667900|172443|P2|STARTED|Part A, Washout 2||1
72148|NCT01667900|172444|P1|STARTED|Part A, Washout 2||1
72149|NCT01667900|172425|P20|NOT COMPLETED|Part A, Period 2||0
72150|NCT01667900|172426|P19|NOT COMPLETED|Part A, Period 2||0
72151|NCT01667900|172427|P18|NOT COMPLETED|Part A, Period 2||0
72152|NCT01667900|172428|P17|NOT COMPLETED|Part A, Period 2||0
72153|NCT01667900|172429|P16|NOT COMPLETED|Part A, Period 2||0
72154|NCT01667900|172430|P15|NOT COMPLETED|Part A, Period 2||0
72155|NCT01667900|172431|P14|NOT COMPLETED|Part A, Period 2||0
72156|NCT01667900|172432|P13|NOT COMPLETED|Part A, Period 2||0
72157|NCT01667900|172433|P12|NOT COMPLETED|Part A, Period 2||0
72158|NCT01667900|172434|P11|NOT COMPLETED|Part A, Period 2||0
72159|NCT01667900|172435|P10|NOT COMPLETED|Part A, Period 2||0
72160|NCT01667900|172436|P9|NOT COMPLETED|Part A, Period 2||0
72161|NCT01667900|172437|P8|NOT COMPLETED|Part A, Period 2||0
72162|NCT01667900|172438|P7|NOT COMPLETED|Part A, Period 2||0
72163|NCT01667900|172439|P6|NOT COMPLETED|Part A, Period 2||0
72164|NCT01667900|172440|P5|NOT COMPLETED|Part A, Period 2||0
72165|NCT01667900|172441|P4|NOT COMPLETED|Part A, Period 2||0
72166|NCT01667900|172442|P3|NOT COMPLETED|Part A, Period 2||0
72167|NCT01667900|172443|P2|NOT COMPLETED|Part A, Period 2||0
72168|NCT01667900|172444|P1|NOT COMPLETED|Part A, Period 2||0
72169|NCT01667900|172425|P20|COMPLETED|Part A, Period 2||0
72170|NCT01667900|172426|P19|COMPLETED|Part A, Period 2||0
72171|NCT01667900|172427|P18|COMPLETED|Part A, Period 2||0
72172|NCT01667900|172428|P17|COMPLETED|Part A, Period 2||0
72173|NCT01667900|172429|P16|COMPLETED|Part A, Period 2||1
72174|NCT01667900|172430|P15|COMPLETED|Part A, Period 2||1
72175|NCT01667900|172431|P14|COMPLETED|Part A, Period 2||1
72176|NCT01667900|172432|P13|COMPLETED|Part A, Period 2||1
72177|NCT01667900|172433|P12|COMPLETED|Part A, Period 2||1
72178|NCT01667900|172434|P11|COMPLETED|Part A, Period 2||1
72179|NCT01667900|172435|P10|COMPLETED|Part A, Period 2||1
72180|NCT01667900|172436|P9|COMPLETED|Part A, Period 2||1
72181|NCT01667900|172437|P8|COMPLETED|Part A, Period 2||1
72182|NCT01667900|172438|P7|COMPLETED|Part A, Period 2||1
72183|NCT01667900|172439|P6|COMPLETED|Part A, Period 2||1
72184|NCT01667900|172440|P5|COMPLETED|Part A, Period 2||1
72185|NCT01667900|172441|P4|COMPLETED|Part A, Period 2||1
72186|NCT01667900|172442|P3|COMPLETED|Part A, Period 2||1
72187|NCT01667900|172443|P2|COMPLETED|Part A, Period 2||1
72188|NCT01667900|172444|P1|COMPLETED|Part A, Period 2||1
72189|NCT01667900|172425|P20|STARTED|Part A, Period 2||0
72190|NCT01667900|172426|P19|STARTED|Part A, Period 2||0
72191|NCT01667900|172427|P18|STARTED|Part A, Period 2||0
72192|NCT01667900|172428|P17|STARTED|Part A, Period 2||0
72193|NCT01667900|172429|P16|STARTED|Part A, Period 2||1
72194|NCT01667900|172430|P15|STARTED|Part A, Period 2||1
72195|NCT01667900|172431|P14|STARTED|Part A, Period 2||1
72196|NCT01667900|172432|P13|STARTED|Part A, Period 2||1
72197|NCT01667900|172433|P12|STARTED|Part A, Period 2||1
72198|NCT01667900|172434|P11|STARTED|Part A, Period 2||1
72199|NCT01667900|172435|P10|STARTED|Part A, Period 2||1
72200|NCT01667900|172436|P9|STARTED|Part A, Period 2||1
72201|NCT01667900|172437|P8|STARTED|Part A, Period 2||1
72202|NCT01667900|172438|P7|STARTED|Part A, Period 2||1
72203|NCT01667900|172439|P6|STARTED|Part A, Period 2||1
72204|NCT01667900|172440|P5|STARTED|Part A, Period 2||1
72205|NCT01667900|172441|P4|STARTED|Part A, Period 2||1
72206|NCT01667900|172442|P3|STARTED|Part A, Period 2||1
72207|NCT01667900|172443|P2|STARTED|Part A, Period 2||1
72208|NCT01667900|172444|P1|STARTED|Part A, Period 2||1
72209|NCT01667900|172425|P20|NOT COMPLETED|Part A, Washout 1||0
72210|NCT01667900|172426|P19|NOT COMPLETED|Part A, Washout 1||0
72211|NCT01667900|172427|P18|NOT COMPLETED|Part A, Washout 1||0
72212|NCT01667900|172428|P17|NOT COMPLETED|Part A, Washout 1||0
72213|NCT01667900|172429|P16|NOT COMPLETED|Part A, Washout 1||0
72214|NCT01667900|172430|P15|NOT COMPLETED|Part A, Washout 1||0
72215|NCT01667900|172431|P14|NOT COMPLETED|Part A, Washout 1||0
72216|NCT01667900|172432|P13|NOT COMPLETED|Part A, Washout 1||0
72217|NCT01667900|172433|P12|NOT COMPLETED|Part A, Washout 1||0
72218|NCT01667900|172434|P11|NOT COMPLETED|Part A, Washout 1||0
72219|NCT01667900|172435|P10|NOT COMPLETED|Part A, Washout 1||0
72220|NCT01667900|172436|P9|NOT COMPLETED|Part A, Washout 1||0
72221|NCT01667900|172437|P8|NOT COMPLETED|Part A, Washout 1||0
72222|NCT01667900|172438|P7|NOT COMPLETED|Part A, Washout 1||0
72223|NCT01667900|172439|P6|NOT COMPLETED|Part A, Washout 1||0
72224|NCT01667900|172440|P5|NOT COMPLETED|Part A, Washout 1||0
72225|NCT01667900|172441|P4|NOT COMPLETED|Part A, Washout 1||0
72226|NCT01667900|172442|P3|NOT COMPLETED|Part A, Washout 1||0
72227|NCT01667900|172443|P2|NOT COMPLETED|Part A, Washout 1||0
72228|NCT01667900|172444|P1|NOT COMPLETED|Part A, Washout 1||0
72229|NCT01667900|172425|P20|COMPLETED|Part A, Washout 1||0
72230|NCT01667900|172426|P19|COMPLETED|Part A, Washout 1||0
72231|NCT01667900|172427|P18|COMPLETED|Part A, Washout 1||0
72232|NCT01667900|172428|P17|COMPLETED|Part A, Washout 1||0
72233|NCT01667900|172429|P16|COMPLETED|Part A, Washout 1||1
72234|NCT01667900|172430|P15|COMPLETED|Part A, Washout 1||1
72235|NCT01667900|172431|P14|COMPLETED|Part A, Washout 1||1
72236|NCT01667900|172432|P13|COMPLETED|Part A, Washout 1||1
72237|NCT01667900|172433|P12|COMPLETED|Part A, Washout 1||1
72238|NCT01667900|172434|P11|COMPLETED|Part A, Washout 1||1
72239|NCT01667900|172435|P10|COMPLETED|Part A, Washout 1||1
72240|NCT01667900|172436|P9|COMPLETED|Part A, Washout 1||1
72241|NCT01667900|172437|P8|COMPLETED|Part A, Washout 1||1
72242|NCT01667900|172438|P7|COMPLETED|Part A, Washout 1||1
72243|NCT01667900|172439|P6|COMPLETED|Part A, Washout 1||1
72244|NCT01667900|172440|P5|COMPLETED|Part A, Washout 1||1
72245|NCT01667900|172441|P4|COMPLETED|Part A, Washout 1||1
72246|NCT01667900|172442|P3|COMPLETED|Part A, Washout 1||1
72247|NCT01667900|172443|P2|COMPLETED|Part A, Washout 1||1
72248|NCT01667900|172444|P1|COMPLETED|Part A, Washout 1||1
72249|NCT01667900|172425|P20|STARTED|Part A, Washout 1||0
72250|NCT01667900|172426|P19|STARTED|Part A, Washout 1||0
72251|NCT01667900|172427|P18|STARTED|Part A, Washout 1||0
72252|NCT01667900|172428|P17|STARTED|Part A, Washout 1||0
72253|NCT01667900|172429|P16|STARTED|Part A, Washout 1||1
72254|NCT01667900|172430|P15|STARTED|Part A, Washout 1||1
72255|NCT01667900|172431|P14|STARTED|Part A, Washout 1||1
72256|NCT01667900|172432|P13|STARTED|Part A, Washout 1||1
72257|NCT01667900|172433|P12|STARTED|Part A, Washout 1||1
72258|NCT01667900|172434|P11|STARTED|Part A, Washout 1||1
72259|NCT01667900|172435|P10|STARTED|Part A, Washout 1||1
72260|NCT01667900|172436|P9|STARTED|Part A, Washout 1||1
72261|NCT01667900|172437|P8|STARTED|Part A, Washout 1||1
72262|NCT01667900|172438|P7|STARTED|Part A, Washout 1||1
72263|NCT01667900|172439|P6|STARTED|Part A, Washout 1||1
72264|NCT01667900|172440|P5|STARTED|Part A, Washout 1||1
72265|NCT01667900|172441|P4|STARTED|Part A, Washout 1||1
72266|NCT01667900|172442|P3|STARTED|Part A, Washout 1||1
72267|NCT01667900|172443|P2|STARTED|Part A, Washout 1||1
72268|NCT01667900|172444|P1|STARTED|Part A, Washout 1||1
72269|NCT01667900|172425|P20|NOT COMPLETED|Part A, Period 1||0
72270|NCT01667900|172426|P19|NOT COMPLETED|Part A, Period 1||0
72271|NCT01667900|172427|P18|NOT COMPLETED|Part A, Period 1||0
72272|NCT01667900|172428|P17|NOT COMPLETED|Part A, Period 1||0
72273|NCT01667900|172429|P16|NOT COMPLETED|Part A, Period 1||0
72274|NCT01667900|172430|P15|NOT COMPLETED|Part A, Period 1||0
72275|NCT01667900|172431|P14|NOT COMPLETED|Part A, Period 1||0
72276|NCT01667900|172432|P13|NOT COMPLETED|Part A, Period 1||0
72277|NCT01667900|172433|P12|NOT COMPLETED|Part A, Period 1||0
72278|NCT01667900|172434|P11|NOT COMPLETED|Part A, Period 1||0
72279|NCT01667900|172435|P10|NOT COMPLETED|Part A, Period 1||0
72280|NCT01667900|172436|P9|NOT COMPLETED|Part A, Period 1||0
72281|NCT01667900|172437|P8|NOT COMPLETED|Part A, Period 1||0
72282|NCT01667900|172438|P7|NOT COMPLETED|Part A, Period 1||0
72283|NCT01667900|172439|P6|NOT COMPLETED|Part A, Period 1||0
72284|NCT01667900|172440|P5|NOT COMPLETED|Part A, Period 1||0
72285|NCT01667900|172441|P4|NOT COMPLETED|Part A, Period 1||0
72286|NCT01667900|172442|P3|NOT COMPLETED|Part A, Period 1||0
72287|NCT01667900|172443|P2|NOT COMPLETED|Part A, Period 1||0
72288|NCT01667900|172444|P1|NOT COMPLETED|Part A, Period 1||0
72289|NCT01667900|172425|P20|COMPLETED|Part A, Period 1||0
72290|NCT01667900|172426|P19|COMPLETED|Part A, Period 1||0
72291|NCT01667900|172427|P18|COMPLETED|Part A, Period 1||0
72292|NCT01667900|172428|P17|COMPLETED|Part A, Period 1||0
72293|NCT01667900|172429|P16|COMPLETED|Part A, Period 1||1
72294|NCT01667900|172430|P15|COMPLETED|Part A, Period 1||1
72295|NCT01667900|172431|P14|COMPLETED|Part A, Period 1||1
72296|NCT01667900|172432|P13|COMPLETED|Part A, Period 1||1
72297|NCT01667900|172433|P12|COMPLETED|Part A, Period 1||1
72298|NCT01667900|172434|P11|COMPLETED|Part A, Period 1||1
72299|NCT01667900|172435|P10|COMPLETED|Part A, Period 1||1
72300|NCT01667900|172436|P9|COMPLETED|Part A, Period 1||1
72301|NCT01667900|172437|P8|COMPLETED|Part A, Period 1||1
72302|NCT01667900|172438|P7|COMPLETED|Part A, Period 1||1
72303|NCT01667900|172439|P6|COMPLETED|Part A, Period 1||1
72304|NCT01667900|172440|P5|COMPLETED|Part A, Period 1||1
72305|NCT01667900|172441|P4|COMPLETED|Part A, Period 1||1
72306|NCT01667900|172442|P3|COMPLETED|Part A, Period 1||1
72307|NCT01667900|172443|P2|COMPLETED|Part A, Period 1||1
72308|NCT01667900|172444|P1|COMPLETED|Part A, Period 1||1
72309|NCT01667900|172425|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
72310|NCT01667900|172426|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
72311|NCT01667900|172427|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
72312|NCT01667900|172428|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
72313|NCT01667900|172429|P16|STARTED|Part A, Period 1||1
72314|NCT01667900|172430|P15|STARTED|Part A, Period 1||1
72315|NCT01667900|172431|P14|STARTED|Part A, Period 1||1
72316|NCT01667900|172432|P13|STARTED|Part A, Period 1||1
72317|NCT01667900|172433|P12|STARTED|Part A, Period 1||1
72318|NCT01667900|172434|P11|STARTED|Part A, Period 1||1
72319|NCT01667900|172435|P10|STARTED|Part A, Period 1||1
72320|NCT01667900|172436|P9|STARTED|Part A, Period 1||1
72321|NCT01667900|172437|P8|STARTED|Part A, Period 1||1
72322|NCT01667900|172438|P7|STARTED|Part A, Period 1||1
72323|NCT01667900|172439|P6|STARTED|Part A, Period 1||1
72324|NCT01667900|172440|P5|STARTED|Part A, Period 1||1
72325|NCT01667900|172441|P4|STARTED|Part A, Period 1||1
72326|NCT01667900|172442|P3|STARTED|Part A, Period 1||1
72327|NCT01667900|172443|P2|STARTED|Part A, Period 1||1
72328|NCT01667900|172444|P1|STARTED|Part A, Period 1||1
72329|NCT01667848|172484|P2|NOT COMPLETED|Overall Study||0
72330|NCT01667848|172485|P1|NOT COMPLETED|Overall Study||0
72331|NCT01667848|172484|P2|COMPLETED|Overall Study||81
72332|NCT01667848|172485|P1|COMPLETED|Overall Study||67
72333|NCT01667848|172484|P2|STARTED|Overall Study||81
72334|NCT01667848|172485|P1|STARTED|Overall Study||67
72335|NCT01667796|172495|P2|NOT COMPLETED|Overall Study||1
72336|NCT01667796|172496|P1|NOT COMPLETED|Overall Study||3
72337|NCT01667796|172495|P2|COMPLETED|Overall Study||29
72338|NCT01667796|172496|P1|COMPLETED|Overall Study||24
72339|NCT01667796|172495|P2|STARTED|Overall Study||30
72340|NCT01667796|172496|P1|STARTED|Overall Study||27
72341|NCT01667731|172507|P5|NOT COMPLETED|Overall Study||28
72342|NCT01667731|172508|P4|NOT COMPLETED|Overall Study||2
72343|NCT01667731|172509|P3|NOT COMPLETED|Overall Study||2
72344|NCT01667731|172510|P2|NOT COMPLETED|Overall Study||16
72345|NCT01667731|172511|P1|NOT COMPLETED|Overall Study||5
72346|NCT01667731|172507|P5|COMPLETED|Overall Study||87
72347|NCT01667731|172508|P4|COMPLETED|Overall Study||15
72348|NCT01667731|172509|P3|COMPLETED|Overall Study||22
72349|NCT01667731|172510|P2|COMPLETED|Overall Study||26
72350|NCT01667731|172511|P1|COMPLETED|Overall Study||21
72351|NCT01667731|172507|P5|STARTED|Overall Study||115
72352|NCT01667731|172508|P4|STARTED|Overall Study||17
72353|NCT01667731|172509|P3|STARTED|Overall Study||24
72354|NCT01667731|172510|P2|STARTED|Overall Study||42
72355|NCT01667731|172511|P1|STARTED|Overall Study||26
72356|NCT01667679|172566|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
72357|NCT01667679|172567|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
72358|NCT01667679|172566|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
72359|NCT01667679|172567|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
72360|NCT01667679|172566|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
72361|NCT01667679|172567|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
72362|NCT01667679|172566|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
72363|NCT01667679|172567|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
72364|NCT01667679|172566|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
72365|NCT01667679|172567|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
72366|NCT01667679|172566|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
72367|NCT01667679|172567|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
72368|NCT01667536|172625|P1|NOT COMPLETED|Overall Study||0
72369|NCT01667536|172625|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
72370|NCT01667536|172625|P1|STARTED|Overall Study||105
72371|NCT01667471|172636|P1|NOT COMPLETED|Overall Study||0
72372|NCT01667471|172636|P1|COMPLETED|Overall Study||7
72373|NCT01667471|172636|P1|STARTED|Overall Study||7
72374|NCT01667432|172652|P1|NOT COMPLETED|Overall Study||57
72375|NCT01667432|172652|P1|COMPLETED|Overall Study||84
72376|NCT01667432|172652|P1|STARTED|Overall Study||141
72377|NCT01667224|172659|P2|NOT COMPLETED|Overall Study||2
72378|NCT01667224|172660|P1|NOT COMPLETED|Overall Study||4
72379|NCT01667224|172659|P2|COMPLETED|Overall Study||38
72380|NCT01667224|172660|P1|COMPLETED|Overall Study||36
72381|NCT01667224|172659|P2|STARTED|Overall Study||40
72382|NCT01667224|172660|P1|STARTED|Overall Study||40
72383|NCT01667107|172674|P2|NOT COMPLETED|Overall Study||7
72384|NCT01667107|172675|P1|NOT COMPLETED|Overall Study||4
72385|NCT01667107|172674|P2|COMPLETED|Overall Study||11
72386|NCT01667107|172675|P1|COMPLETED|Overall Study||4
72387|NCT01667107|172674|P2|STARTED|Overall Study||18
72388|NCT01667107|172675|P1|STARTED|Overall Study||8
72389|NCT01666951|172693|P2|NOT COMPLETED|Overall Study||1
72390|NCT01666951|172694|P1|NOT COMPLETED|Overall Study||1
72391|NCT01666951|172693|P2|COMPLETED|Overall Study||17
72392|NCT01666951|172694|P1|COMPLETED|Overall Study||17
72393|NCT01666951|172693|P2|STARTED|Overall Study||18
72394|NCT01666951|172694|P1|STARTED|Overall Study||18
72395|NCT01666912|172732|P2|NOT COMPLETED|Overall Study||11
72396|NCT01666912|172733|P1|NOT COMPLETED|Overall Study||21
72397|NCT01666912|172732|P2|COMPLETED|Overall Study||37
72398|NCT01666912|172733|P1|COMPLETED|Overall Study||27
72399|NCT01666912|172732|P2|STARTED|Overall Study||48
72400|NCT01666912|172733|P1|STARTED|Overall Study||48
72401|NCT01666782|172745|P2|NOT COMPLETED|Overall Study||1
72402|NCT01666782|172746|P1|NOT COMPLETED|Overall Study||4
72403|NCT01666782|172745|P2|COMPLETED|Overall Study||50
72404|NCT01666782|172746|P1|COMPLETED|Overall Study||50
72405|NCT01666782|172745|P2|STARTED|Overall Study||51
72406|NCT01666782|172746|P1|STARTED|Overall Study||54
72407|NCT01666314|172770|P4|NOT COMPLETED|Overall Study||36
72408|NCT01666314|172771|P3|NOT COMPLETED|Overall Study||36
72409|NCT01666314|172772|P2|NOT COMPLETED|Overall Study||32
72410|NCT01666314|172773|P1|NOT COMPLETED|Overall Study||33
72411|NCT01666314|172770|P4|COMPLETED|Overall Study||0
72412|NCT01666314|172771|P3|COMPLETED|Overall Study||0
72413|NCT01666314|172772|P2|COMPLETED|Overall Study||0
72414|NCT01666314|172773|P1|COMPLETED|Overall Study||0
72415|NCT01666314|172770|P4|STARTED|Overall Study||36
72416|NCT01666314|172771|P3|STARTED|Overall Study||36
72417|NCT01666314|172772|P2|STARTED|Overall Study||32
72418|NCT01666314|172773|P1|STARTED|Overall Study||33
72419|NCT01666210|172884|P2|NOT COMPLETED|Overall Study||1
72420|NCT01666210|172885|P1|NOT COMPLETED|Overall Study||2
72421|NCT01666210|172884|P2|COMPLETED|Overall Study||29
72422|NCT01666210|172885|P1|COMPLETED|Overall Study||28
72423|NCT01666210|172884|P2|STARTED|Overall Study||30
72424|NCT01666210|172885|P1|STARTED|Overall Study||30
72425|NCT01666197|172897|P2|NOT COMPLETED|Overall Study||0
72426|NCT01666197|172898|P1|NOT COMPLETED|Overall Study||0
72427|NCT01666197|172897|P2|COMPLETED|Overall Study||50
72428|NCT01666197|172898|P1|COMPLETED|Overall Study||50
72429|NCT01666197|172897|P2|STARTED|Overall Study||50
72430|NCT01666197|172898|P1|STARTED|Overall Study||50
72431|NCT01666119|172904|P1|NOT COMPLETED|Overall Study||52
72432|NCT01666119|172904|P1|COMPLETED|Overall Study||197
72433|NCT01666119|172904|P1|STARTED|Overall Study||249
72434|NCT01666002|172911|P2|NOT COMPLETED|Overall Study||0
72435|NCT01666002|172912|P1|NOT COMPLETED|Overall Study||5
72436|NCT01666002|172911|P2|COMPLETED|Overall Study||10
72437|NCT01666002|172912|P1|COMPLETED|Overall Study||12
72438|NCT01666002|172911|P2|STARTED|Overall Study||10
72439|NCT01666002|172912|P1|STARTED|Overall Study||17
72440|NCT01665950|172923|P3|NOT COMPLETED|Overall Study||1
72441|NCT01665950|172924|P2|NOT COMPLETED|Overall Study||0
72442|NCT01665950|172925|P1|NOT COMPLETED|Overall Study||1
72443|NCT01665950|172923|P3|COMPLETED|Overall Study||1
72444|NCT01665950|172924|P2|COMPLETED|Overall Study||0
72445|NCT01665950|172925|P1|COMPLETED|Overall Study||1
72446|NCT01665950|172923|P3|STARTED|Overall Study||2
72447|NCT01665950|172924|P2|STARTED|Overall Study||0
72448|NCT01665950|172925|P1|STARTED|Overall Study||2
72449|NCT01665911|172933|P1|NOT COMPLETED|Overall Study||6
72450|NCT01665911|172933|P1|COMPLETED|Overall Study||22
72451|NCT01665911|172933|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
72452|NCT01665911|172933|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
72453|NCT01665911|172933|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
72454|NCT01665911|172933|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
72455|NCT01665911|172933|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
72456|NCT01665911|172933|P1|STARTED|Overall Study||28
72457|NCT01665807|172942|P3|NOT COMPLETED|Overall Study||1
72458|NCT01665807|172943|P2|NOT COMPLETED|Overall Study||0
72459|NCT01665807|172944|P1|NOT COMPLETED|Overall Study||2
72460|NCT01665807|172942|P3|COMPLETED|Overall Study||401
72461|NCT01665807|172943|P2|COMPLETED|Overall Study||58
72462|NCT01665807|172944|P1|COMPLETED|Overall Study||409
72463|NCT01665807|172942|P3|STARTED|Overall Study||402
72464|NCT01665807|172943|P2|STARTED|Overall Study||58
72465|NCT01665807|172944|P1|STARTED|Overall Study||411
72466|NCT01665599|172955|P1|NOT COMPLETED|Overall Study||8
72467|NCT01665599|172955|P1|COMPLETED|Overall Study||172
72468|NCT01665599|172955|P1|STARTED|Overall Study||180
72469|NCT01665508|172975|P1|NOT COMPLETED|Overall Study||5
72470|NCT01665508|172975|P1|COMPLETED|Overall Study||7
72471|NCT01665508|172975|P1|STARTED|Overall Study||12
72472|NCT01665430|172991|P1|NOT COMPLETED|Overall Study||9
72473|NCT01665430|172991|P1|COMPLETED|Overall Study||29
72474|NCT01665430|172991|P1|STARTED|Overall Study||38
72475|NCT01665170|173007|P2|NOT COMPLETED|Overall Study||0
72476|NCT01665170|173008|P1|NOT COMPLETED|Overall Study||0
72477|NCT01665170|173007|P2|COMPLETED|Overall Study||30
72478|NCT01665170|173008|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
72479|NCT01665170|173007|P2|After TSST|Overall Study||30
72480|NCT01665170|173008|P1|After TSST|Overall Study||30
72481|NCT01665170|173007|P2|During TSST|Overall Study||30
72482|NCT01665170|173008|P1|During TSST|Overall Study||30
72483|NCT01665170|173007|P2|Bevore TSST|Overall Study||30
72484|NCT01665170|173008|P1|Bevore TSST|Overall Study||30
72485|NCT01665170|173007|P2|STARTED|Overall Study||30
72486|NCT01665170|173008|P1|STARTED|Overall Study|First patient in|30
72487|NCT01665157|173059|P3|NOT COMPLETED|Overall Study||0
72488|NCT01665157|173060|P2|NOT COMPLETED|Overall Study||0
72489|NCT01665157|173061|P1|NOT COMPLETED|Overall Study||0
72490|NCT01665157|173059|P3|COMPLETED|Overall Study||60
72491|NCT01665157|173060|P2|COMPLETED|Overall Study||60
72492|NCT01665157|173061|P1|COMPLETED|Overall Study||60
72493|NCT01665157|173059|P3|STARTED|Overall Study||60
72494|NCT01665157|173060|P2|STARTED|Overall Study||60
72495|NCT01665157|173061|P1|STARTED|Overall Study||60
72496|NCT01665053|173089|P2|NOT COMPLETED|Overall Study||15
72497|NCT01665053|173090|P1|NOT COMPLETED|Overall Study||32
72498|NCT01665053|173089|P2|COMPLETED|Overall Study||831
72499|NCT01665053|173090|P1|COMPLETED|Overall Study||806
72500|NCT01665053|173089|P2|Death With No 12-month Clinical FU|Overall Study||9
72501|NCT01665053|173090|P1|Death With No 12-month Clinical FU|Overall Study||9
72502|NCT01665053|173089|P2|No 12-Month F/U|Overall Study||15
72503|NCT01665053|173090|P1|No 12-Month F/U|Overall Study||32
72504|NCT01665053|173089|P2|Completed 12-Month Clinical F/U|Overall Study||822
72505|NCT01665053|173090|P1|Completed 12-Month Clinical F/U|Overall Study||797
72506|NCT01665053|173089|P2|STARTED|Overall Study||846
72507|NCT01665053|173090|P1|STARTED|Overall Study||838
72508|NCT01664975|173130|P2|NOT COMPLETED|Overall Study||3
72509|NCT01664975|173131|P1|NOT COMPLETED|Overall Study||5
72510|NCT01664975|173130|P2|COMPLETED|Overall Study||51
72511|NCT01664975|173131|P1|COMPLETED|Overall Study||52
72512|NCT01664975|173130|P2|STARTED|Overall Study||54
72513|NCT01664975|173131|P1|STARTED|Overall Study||57
72514|NCT01664949|173139|P2|NOT COMPLETED|Overall Study||25
72515|NCT01664949|173140|P1|NOT COMPLETED|Overall Study||24
72516|NCT01664949|173139|P2|COMPLETED|Overall Study||211
72517|NCT01664949|173140|P1|COMPLETED|Overall Study||200
72518|NCT01664949|173139|P2|STARTED|Overall Study||236
72519|NCT01664949|173140|P1|STARTED|Overall Study||224
72520|NCT01664923|173156|P2|NOT COMPLETED|Overall Study||158
72521|NCT01664923|173157|P1|NOT COMPLETED|Overall Study||93
72522|NCT01664923|173156|P2|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|40
72523|NCT01664923|173157|P1|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|105
72524|NCT01664923|173156|P2|Received Study Treatment|Overall Study||198
72525|NCT01664923|173157|P1|Received Study Treatment|Overall Study||197
72526|NCT01664923|173156|P2|STARTED|Overall Study||198
72527|NCT01664923|173157|P1|STARTED|Overall Study||198
72528|NCT01664806|173177|P2|NOT COMPLETED|Overall Study||0
72529|NCT01664806|173178|P1|NOT COMPLETED|Overall Study||0
72530|NCT01664806|173177|P2|COMPLETED|Overall Study||20
72531|NCT01664806|173178|P1|COMPLETED|Overall Study||20
72532|NCT01664806|173177|P2|STARTED|Overall Study||20
72533|NCT01664806|173178|P1|STARTED|Overall Study||20
72534|NCT01664793|173188|P2|NOT COMPLETED|Overall Study||0
72535|NCT01664793|173189|P1|NOT COMPLETED|Overall Study||0
72536|NCT01664793|173188|P2|COMPLETED|Overall Study||38626
72537|NCT01664793|173189|P1|COMPLETED|Overall Study||49039
72538|NCT01664793|173188|P2|STARTED|Overall Study||38626
72539|NCT01664793|173189|P1|STARTED|Overall Study||49039
72540|NCT01664624|173201|P4|NOT COMPLETED|Overall Study||0
72541|NCT01664624|173202|P3|NOT COMPLETED|Overall Study||0
72542|NCT01664624|173203|P2|NOT COMPLETED|Overall Study||1
72543|NCT01664624|173204|P1|NOT COMPLETED|Overall Study||0
72544|NCT01664624|173201|P4|COMPLETED|Overall Study||9
72545|NCT01664624|173202|P3|COMPLETED|Overall Study||10
72546|NCT01664624|173203|P2|COMPLETED|Overall Study||10
72547|NCT01664624|173204|P1|COMPLETED|Overall Study||10
72548|NCT01664624|173201|P4|STARTED|Overall Study||9
72549|NCT01664624|173202|P3|STARTED|Overall Study||10
72550|NCT01664624|173203|P2|STARTED|Overall Study||11
72551|NCT01664624|173204|P1|STARTED|Overall Study||10
72552|NCT01664559|173236|P2|NOT COMPLETED|Overall Study||0
72553|NCT01664559|173237|P1|NOT COMPLETED|Overall Study||0
72554|NCT01664559|173236|P2|COMPLETED|Overall Study||33
72555|NCT01664559|173237|P1|COMPLETED|Overall Study||34
72556|NCT01664559|173236|P2|STARTED|Overall Study||33
72557|NCT01664559|173237|P1|STARTED|Overall Study||34
72558|NCT01664533|173251|P1|NOT COMPLETED|Overall Study||57
72559|NCT01664533|173251|P1|COMPLETED|Overall Study||0
72560|NCT01664533|173251|P1|STARTED|Overall Study||57
72561|NCT01664494|173259|P1|NOT COMPLETED|Overall Study||193
72562|NCT01664494|173259|P1|COMPLETED|Overall Study||370
72563|NCT01664494|173259|P1|STARTED|Overall Study||563
72564|NCT01664247|173266|P2|NOT COMPLETED|Overall Study||41
72565|NCT01664247|173267|P1|NOT COMPLETED|Overall Study||14
72566|NCT01664247|173266|P2|COMPLETED|Overall Study||131
72567|NCT01664247|173267|P1|COMPLETED|Overall Study||160
72568|NCT01664247|173266|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
72569|NCT01664247|173267|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
72570|NCT01664247|173266|P2|STARTED|Overall Study||172
72571|NCT01664247|173267|P1|STARTED|Overall Study||174
72572|NCT01664117|173289|P1|NOT COMPLETED|Overall Study||0
72573|NCT01664117|173289|P1|COMPLETED|Overall Study||209
72574|NCT01664117|173289|P1|STARTED|Overall Study||209
72575|NCT01664104|173344|P1|NOT COMPLETED|Overall Study||16
72576|NCT01664104|173344|P1|COMPLETED|Overall Study||120
72577|NCT01664104|173344|P1|STARTED|Overall Study||136
72578|NCT01664052|173413|P2|NOT COMPLETED|Phase 2||4
72579|NCT01664052|173414|P1|NOT COMPLETED|Phase 2||0
72580|NCT01664052|173413|P2|COMPLETED|Phase 2||31
72581|NCT01664052|173414|P1|COMPLETED|Phase 2||0
72582|NCT01664052|173413|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
72583|NCT01664052|173414|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
72584|NCT01664052|173413|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
72585|NCT01664052|173414|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
72586|NCT01664052|173413|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
72587|NCT01664052|173414|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
72588|NCT01664052|173413|P2|HSG 1 Hour Post Placement|Phase 2||31
72589|NCT01664052|173414|P1|HSG 1 Hour Post Placement|Phase 2||0
72590|NCT01664052|173413|P2|Insert Placed|Phase 2||31
72591|NCT01664052|173414|P1|Insert Placed|Phase 2||0
72592|NCT01664052|173413|P2|STARTED|Phase 2||35
72593|NCT01664052|173414|P1|STARTED|Phase 2|Screened and enrolled|0
72594|NCT01664052|173413|P2|NOT COMPLETED|Phase 1||0
72595|NCT01664052|173414|P1|NOT COMPLETED|Phase 1||7
72596|NCT01664052|173413|P2|COMPLETED|Phase 1||0
72597|NCT01664052|173414|P1|COMPLETED|Phase 1||24
72598|NCT01664052|173413|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
72599|NCT01664052|173414|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
72600|NCT01664052|173413|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
72601|NCT01664052|173414|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
72602|NCT01664052|173413|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
72603|NCT01664052|173414|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
72604|NCT01664052|173413|P2|HSG 1 Hour Post Placement|Phase 1||0
72605|NCT01664052|173414|P1|HSG 1 Hour Post Placement|Phase 1||24
72606|NCT01664052|173413|P2|Insert Placed in at Least One Tube|Phase 1||0
72607|NCT01664052|173414|P1|Insert Placed in at Least One Tube|Phase 1||25
72608|NCT01664052|173413|P2|STARTED|Phase 1||0
72609|NCT01664052|173414|P1|STARTED|Phase 1|Screening and enrollment|31
72610|NCT01664039|173432|P2|NOT COMPLETED|Overall Study||9
72611|NCT01664039|173433|P1|NOT COMPLETED|Overall Study||6
72612|NCT01664039|173432|P2|COMPLETED|Overall Study||43
72613|NCT01664039|173433|P1|COMPLETED|Overall Study||46
72614|NCT01664039|173432|P2|STARTED|Overall Study||52
72615|NCT01664039|173433|P1|STARTED|Overall Study||52
72616|NCT01663987|173455|P2|NOT COMPLETED|Overall Study||6
72617|NCT01663987|173456|P1|NOT COMPLETED|Overall Study||13
72618|NCT01663987|173455|P2|COMPLETED|Overall Study||34
72619|NCT01663987|173456|P1|COMPLETED|Overall Study||26
72620|NCT01663987|173455|P2|STARTED|Overall Study||40
72621|NCT01663987|173456|P1|STARTED|Overall Study||39
72622|NCT01663922|173482|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
72623|NCT01663922|173483|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
72624|NCT01663922|173482|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
72625|NCT01663922|173483|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
72626|NCT01663922|173482|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
72627|NCT01663922|173483|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
72628|NCT01663922|173482|P2|NOT COMPLETED|Washout (7 Days)||0
72629|NCT01663922|173483|P1|NOT COMPLETED|Washout (7 Days)||0
72630|NCT01663922|173482|P2|COMPLETED|Washout (7 Days)||9
72631|NCT01663922|173483|P1|COMPLETED|Washout (7 Days)||8
72632|NCT01663922|173482|P2|STARTED|Washout (7 Days)||9
72633|NCT01663922|173483|P1|STARTED|Washout (7 Days)||8
72634|NCT01663922|173482|P2|NOT COMPLETED|Second Intervention (14 Days)||0
72635|NCT01663922|173483|P1|NOT COMPLETED|Second Intervention (14 Days)||0
72636|NCT01663922|173482|P2|COMPLETED|Second Intervention (14 Days)||9
72637|NCT01663922|173483|P1|COMPLETED|Second Intervention (14 Days)||8
72638|NCT01663922|173482|P2|STARTED|Second Intervention (14 Days)||9
72639|NCT01663922|173483|P1|STARTED|Second Intervention (14 Days)||8
72640|NCT01663922|173482|P2|NOT COMPLETED|Washout (7 Days)||0
72641|NCT01663922|173483|P1|NOT COMPLETED|Washout (7 Days)||0
72642|NCT01663922|173482|P2|COMPLETED|Washout (7 Days)||9
72643|NCT01663922|173483|P1|COMPLETED|Washout (7 Days)||8
72644|NCT01663922|173482|P2|STARTED|Washout (7 Days)||9
72645|NCT01663922|173483|P1|STARTED|Washout (7 Days)||8
72646|NCT01663922|173482|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
72647|NCT01663922|173483|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
72648|NCT01663922|173482|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
72649|NCT01663922|173483|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
72650|NCT01663922|173482|P2|STARTED|First Intervention (14 Days or 5 Days)||9
72651|NCT01663922|173483|P1|STARTED|First Intervention (14 Days or 5 Days)||8
72652|NCT01663779|173490|P2|NOT COMPLETED|Overall Study||0
72653|NCT01663779|173491|P1|NOT COMPLETED|Overall Study||0
72654|NCT01663779|173490|P2|COMPLETED|Overall Study||23
72655|NCT01663779|173491|P1|COMPLETED|Overall Study||27
72656|NCT01663779|173490|P2|STARTED|Overall Study||23
72657|NCT01663779|173491|P1|STARTED|Overall Study||27
72658|NCT01663727|173499|P2|NOT COMPLETED|Overall Study||239
72659|NCT01663727|173500|P1|NOT COMPLETED|Overall Study||242
72660|NCT01663727|173499|P2|COMPLETED|Overall Study||0
72661|NCT01663727|173500|P1|COMPLETED|Overall Study||0
72662|NCT01663727|173499|P2|STARTED|Overall Study||239
72663|NCT01663727|173500|P1|STARTED|Overall Study||242
72664|NCT01663714|173528|P1|NOT COMPLETED|Long-Term Follow-Up||6
72665|NCT01663714|173528|P1|COMPLETED|Long-Term Follow-Up||16
72666|NCT01663714|173528|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
72667|NCT01663714|173528|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
72668|NCT01663714|173528|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
72669|NCT01663714|173528|P1|STARTED|Dosimetric and Therapeutic Treatment||30
72670|NCT01663623|173557|P2|NOT COMPLETED|Overall Study||20
72671|NCT01663623|173558|P1|NOT COMPLETED|Overall Study||12
72672|NCT01663623|173557|P2|COMPLETED|Overall Study||33
72673|NCT01663623|173558|P1|COMPLETED|Overall Study||40
72674|NCT01663623|173557|P2|STARTED|Overall Study||53
72675|NCT01663623|173558|P1|STARTED|Overall Study||52
72676|NCT01663532|173568|P2|NOT COMPLETED|Overall Study||107
72677|NCT01663532|173569|P1|NOT COMPLETED|Overall Study||74
72678|NCT01663532|173568|P2|COMPLETED|Overall Study||65
72679|NCT01663532|173569|P1|COMPLETED|Overall Study||94
72680|NCT01663532|173568|P2|STARTED|Overall Study||172
72681|NCT01663532|173569|P1|STARTED|Overall Study||168
72682|NCT01663506|173587|P1|NOT COMPLETED|Overall Study||8
72683|NCT01663506|173587|P1|COMPLETED|Overall Study||15
72684|NCT01663506|173587|P1|STARTED|Overall Study||23
72685|NCT01663363|173616|P1|NOT COMPLETED|Overall Study||0
72686|NCT01663363|173616|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
72687|NCT01663363|173616|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
72688|NCT01663285|173621|P1|NOT COMPLETED|Overall Study||0
72689|NCT01663285|173621|P1|COMPLETED|Overall Study||1
72690|NCT01663285|173621|P1|STARTED|Overall Study||1
72691|NCT01663233|173629|P2|NOT COMPLETED|Overall Study||7
72692|NCT01663233|173630|P1|NOT COMPLETED|Overall Study||4
72693|NCT01663233|173629|P2|COMPLETED|Overall Study||129
72694|NCT01663233|173630|P1|COMPLETED|Overall Study||126
72695|NCT01663233|173629|P2|STARTED|Overall Study||136
72696|NCT01663233|173630|P1|STARTED|Overall Study||130
72697|NCT01663103|173654|P2|NOT COMPLETED|Overall Study||2
72698|NCT01663103|173655|P1|NOT COMPLETED|Overall Study||3
72699|NCT01663103|173654|P2|COMPLETED|Overall Study||19
72700|NCT01663103|173655|P1|COMPLETED|Overall Study||18
72701|NCT01663103|173654|P2|STARTED|Overall Study||21
72702|NCT01663103|173655|P1|STARTED|Overall Study||21
72703|NCT01663012|173671|P1|NOT COMPLETED|Overall Study||0
72704|NCT01663012|173671|P1|COMPLETED|Overall Study||20
72705|NCT01663012|173671|P1|STARTED|Overall Study||20
72706|NCT01662999|173683|P6|NOT COMPLETED|Period 3||0
72707|NCT01662999|173684|P5|NOT COMPLETED|Period 3||0
72708|NCT01662999|173685|P4|NOT COMPLETED|Period 3||0
72709|NCT01662999|173686|P3|NOT COMPLETED|Period 3||0
72710|NCT01662999|173687|P2|NOT COMPLETED|Period 3||1
72711|NCT01662999|173688|P1|NOT COMPLETED|Period 3||0
72712|NCT01662999|173683|P6|COMPLETED|Period 3||7
72713|NCT01662999|173684|P5|COMPLETED|Period 3||7
72714|NCT01662999|173685|P4|COMPLETED|Period 3||7
72715|NCT01662999|173686|P3|COMPLETED|Period 3||7
72716|NCT01662999|173687|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
72717|NCT01662999|173688|P1|COMPLETED|Period 3||7
72718|NCT01662999|173683|P6|STARTED|Period 3||7
72719|NCT01662999|173684|P5|STARTED|Period 3||7
72720|NCT01662999|173685|P4|STARTED|Period 3||7
72721|NCT01662999|173686|P3|STARTED|Period 3||7
72722|NCT01662999|173687|P2|STARTED|Period 3||7
72723|NCT01662999|173688|P1|STARTED|Period 3||7
72724|NCT01662999|173683|P6|NOT COMPLETED|Period 2||0
72725|NCT01662999|173684|P5|NOT COMPLETED|Period 2||0
72726|NCT01662999|173685|P4|NOT COMPLETED|Period 2||0
72727|NCT01662999|173686|P3|NOT COMPLETED|Period 2||0
72728|NCT01662999|173687|P2|NOT COMPLETED|Period 2||0
72729|NCT01662999|173688|P1|NOT COMPLETED|Period 2||0
72730|NCT01662999|173683|P6|COMPLETED|Period 2||7
72731|NCT01662999|173684|P5|COMPLETED|Period 2||7
72732|NCT01662999|173685|P4|COMPLETED|Period 2||7
72733|NCT01662999|173686|P3|COMPLETED|Period 2||7
72734|NCT01662999|173687|P2|COMPLETED|Period 2||7
72735|NCT01662999|173688|P1|COMPLETED|Period 2||7
72736|NCT01662999|173683|P6|STARTED|Period 2||7
72737|NCT01662999|173684|P5|STARTED|Period 2||7
72738|NCT01662999|173685|P4|STARTED|Period 2||7
72739|NCT01662999|173686|P3|STARTED|Period 2||7
72740|NCT01662999|173687|P2|STARTED|Period 2||7
72741|NCT01662999|173688|P1|STARTED|Period 2||7
72742|NCT01662999|173683|P6|NOT COMPLETED|Period 1||0
72743|NCT01662999|173684|P5|NOT COMPLETED|Period 1||0
72744|NCT01662999|173685|P4|NOT COMPLETED|Period 1||0
72745|NCT01662999|173686|P3|NOT COMPLETED|Period 1||0
72746|NCT01662999|173687|P2|NOT COMPLETED|Period 1||0
72747|NCT01662999|173688|P1|NOT COMPLETED|Period 1||0
72748|NCT01662999|173683|P6|COMPLETED|Period 1||7
72749|NCT01662999|173684|P5|COMPLETED|Period 1||7
72750|NCT01662999|173685|P4|COMPLETED|Period 1||7
72751|NCT01662999|173686|P3|COMPLETED|Period 1||7
72752|NCT01662999|173687|P2|COMPLETED|Period 1||7
72753|NCT01662999|173688|P1|COMPLETED|Period 1||7
72754|NCT01662999|173683|P6|STARTED|Period 1||7
72755|NCT01662999|173684|P5|STARTED|Period 1||7
72756|NCT01662999|173685|P4|STARTED|Period 1||7
72757|NCT01662999|173686|P3|STARTED|Period 1||7
72758|NCT01662999|173687|P2|STARTED|Period 1||7
72759|NCT01662999|173688|P1|STARTED|Period 1||7
72760|NCT01662986|173759|P2|NOT COMPLETED|Overall Study||13
72761|NCT01662986|173760|P1|NOT COMPLETED|Overall Study||18
72762|NCT01662986|173759|P2|COMPLETED|Overall Study||26
72763|NCT01662986|173760|P1|COMPLETED|Overall Study||22
72764|NCT01662986|173759|P2|STARTED|Overall Study||39
72765|NCT01662986|173760|P1|STARTED|Overall Study||40
72766|NCT01662908|173792|P2|NOT COMPLETED|Overall Study||5
72767|NCT01662908|173793|P1|NOT COMPLETED|Overall Study||6
72768|NCT01662908|173792|P2|COMPLETED|Overall Study||23
72769|NCT01662908|173793|P1|COMPLETED|Overall Study||50
72770|NCT01662908|173792|P2|STARTED|Overall Study||28
72771|NCT01662908|173793|P1|STARTED|Overall Study||56
72772|NCT01662882|173810|P3|NOT COMPLETED|Overall Study||0
72773|NCT01662882|173811|P2|NOT COMPLETED|Overall Study||0
72774|NCT01662882|173812|P1|NOT COMPLETED|Overall Study||0
72775|NCT01662882|173810|P3|COMPLETED|Overall Study||15
72776|NCT01662882|173811|P2|COMPLETED|Overall Study||18
72777|NCT01662882|173812|P1|COMPLETED|Overall Study||15
72778|NCT01662882|173810|P3|STARTED|Overall Study||15
72779|NCT01662882|173811|P2|STARTED|Overall Study||18
72780|NCT01662882|173812|P1|STARTED|Overall Study||15
72781|NCT01662856|173825|P2|NOT COMPLETED|Primary Part II||2
72782|NCT01662856|173826|P1|NOT COMPLETED|Primary Part II||10
72783|NCT01662856|173825|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
72784|NCT01662856|173826|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
72785|NCT01662856|173825|P2|Completed Study up to Week 6|Primary Part II||56
72786|NCT01662856|173826|P1|Completed Study up to Week 6|Primary Part II||106
72787|NCT01662856|173825|P2|STARTED|Primary Part II||57
72788|NCT01662856|173826|P1|STARTED|Primary Part II||109
72789|NCT01662856|173825|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
72790|NCT01662856|173826|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
72791|NCT01662856|173825|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
72792|NCT01662856|173826|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
72793|NCT01662856|173825|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
72794|NCT01662856|173826|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
72795|NCT01662856|173825|P2|STARTED|Part I + Part II (Overall Study)||57
72796|NCT01662856|173826|P1|STARTED|Part I + Part II (Overall Study)||168
72797|NCT01662791|173840|P2|NOT COMPLETED|Part 2 - Interventional||0
72798|NCT01662791|173841|P1|NOT COMPLETED|Part 2 - Interventional||0
72799|NCT01662791|173840|P2|COMPLETED|Part 2 - Interventional||0
72800|NCT01662791|173841|P1|COMPLETED|Part 2 - Interventional||8
72801|NCT01662791|173840|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
72802|NCT01662791|173841|P1|STARTED|Part 2 - Interventional||8
72803|NCT01662791|173840|P2|NOT COMPLETED|Part 1 - Observational||0
72804|NCT01662791|173841|P1|NOT COMPLETED|Part 1 - Observational||0
72805|NCT01662791|173840|P2|COMPLETED|Part 1 - Observational||41
72806|NCT01662791|173841|P1|COMPLETED|Part 1 - Observational||8
72807|NCT01662791|173840|P2|STARTED|Part 1 - Observational||41
72808|NCT01662791|173841|P1|STARTED|Part 1 - Observational||8
72809|NCT01662765|173865|P2|NOT COMPLETED|Overall Study||2
72810|NCT01662765|173866|P1|NOT COMPLETED|Overall Study||1
72811|NCT01662765|173865|P2|COMPLETED|Overall Study||40
72812|NCT01662765|173866|P1|COMPLETED|Overall Study||41
72813|NCT01662765|173865|P2|STARTED|Overall Study||42
72814|NCT01662765|173866|P1|STARTED|Overall Study||42
72815|NCT01662648|173880|P2|NOT COMPLETED|Overall Study||178
72816|NCT01662648|173881|P1|NOT COMPLETED|Overall Study||147
72817|NCT01662648|173880|P2|COMPLETED|Overall Study||419
72818|NCT01662648|173881|P1|COMPLETED|Overall Study||373
72819|NCT01662648|173880|P2|STARTED|Overall Study||597
72820|NCT01662648|173881|P1|STARTED|Overall Study||520
72821|NCT01662635|173903|P1|NOT COMPLETED|Overall Study||30
72822|NCT01662635|173903|P1|COMPLETED|Overall Study||200
72823|NCT01662635|173903|P1|STARTED|Overall Study||230
72824|NCT01662583|173912|P3|NOT COMPLETED|Overall Study||0
72825|NCT01662583|173913|P2|NOT COMPLETED|Overall Study||0
72826|NCT01662583|173914|P1|NOT COMPLETED|Overall Study||0
72827|NCT01662583|173912|P3|COMPLETED|Overall Study||219
72828|NCT01662583|173913|P2|COMPLETED|Overall Study||225
72829|NCT01662583|173914|P1|COMPLETED|Overall Study||216
72830|NCT01662583|173912|P3|STARTED|Overall Study||219
72831|NCT01662583|173913|P2|STARTED|Overall Study||225
72832|NCT01662583|173914|P1|STARTED|Overall Study||216
72833|NCT01662531|173927|P1|NOT COMPLETED|Overall Study||0
72834|NCT01662531|173927|P1|COMPLETED|Overall Study||27
72835|NCT01662531|173927|P1|STARTED|Overall Study||27
72836|NCT01662492|173954|P3|NOT COMPLETED|Overall Study||6
72837|NCT01662492|173955|P2|NOT COMPLETED|Overall Study||1
72838|NCT01662492|173956|P1|NOT COMPLETED|Overall Study||3
72839|NCT01662492|173954|P3|COMPLETED|Overall Study||31
72840|NCT01662492|173955|P2|COMPLETED|Overall Study||42
72841|NCT01662492|173956|P1|COMPLETED|Overall Study||42
72842|NCT01662492|173954|P3|STARTED|Overall Study||37
72843|NCT01662492|173955|P2|STARTED|Overall Study||43
72844|NCT01662492|173956|P1|STARTED|Overall Study||45
72845|NCT01662440|173980|P4|NOT COMPLETED|Overall Study||4
72846|NCT01662440|173981|P3|NOT COMPLETED|Overall Study||6
72847|NCT01662440|173982|P2|NOT COMPLETED|Overall Study||6
72848|NCT01662440|173983|P1|NOT COMPLETED|Overall Study||9
72849|NCT01662440|173980|P4|COMPLETED|Overall Study||52
72850|NCT01662440|173981|P3|COMPLETED|Overall Study||215
72851|NCT01662440|173982|P2|COMPLETED|Overall Study||211
72852|NCT01662440|173983|P1|COMPLETED|Overall Study||158
72853|NCT01662440|173980|P4|STARTED|Overall Study||56
72854|NCT01662440|173981|P3|STARTED|Overall Study||221
72855|NCT01662440|173982|P2|STARTED|Overall Study||217
72856|NCT01662440|173983|P1|STARTED|Overall Study||167
72857|NCT01662362|174031|P1|NOT COMPLETED|Overall Study||38
72858|NCT01662362|174031|P1|COMPLETED|Overall Study||25
72859|NCT01662362|174031|P1|STARTED|Overall Study||63
72860|NCT01662336|174036|P1|NOT COMPLETED|Overall Study||66
72861|NCT01662336|174036|P1|COMPLETED|Overall Study||107
72862|NCT01662336|174036|P1|Completed Month 12 Visit|Overall Study||109
72863|NCT01662336|174036|P1|Completed Month 6 Visit|Overall Study||142
72864|NCT01662336|174036|P1|STARTED|Overall Study||173
72865|NCT01662310|174062|P5|NOT COMPLETED|Open-Label Extension Phase||10
72866|NCT01662310|174063|P4|NOT COMPLETED|Open-Label Extension Phase||11
72867|NCT01662310|174064|P3|NOT COMPLETED|Open-Label Extension Phase||0
72868|NCT01662310|174065|P2|NOT COMPLETED|Open-Label Extension Phase||0
72869|NCT01662310|174066|P1|NOT COMPLETED|Open-Label Extension Phase||0
72870|NCT01662310|174062|P5|COMPLETED|Open-Label Extension Phase||49
72871|NCT01662310|174063|P4|COMPLETED|Open-Label Extension Phase||36
72872|NCT01662310|174064|P3|COMPLETED|Open-Label Extension Phase||0
72873|NCT01662310|174065|P2|COMPLETED|Open-Label Extension Phase||0
72874|NCT01662310|174066|P1|COMPLETED|Open-Label Extension Phase||0
72875|NCT01662310|174062|P5|STARTED|Open-Label Extension Phase||59
72876|NCT01662310|174063|P4|STARTED|Open-Label Extension Phase||47
72877|NCT01662310|174064|P3|STARTED|Open-Label Extension Phase||0
72878|NCT01662310|174065|P2|STARTED|Open-Label Extension Phase||0
72879|NCT01662310|174066|P1|STARTED|Open-Label Extension Phase||0
72880|NCT01662310|174062|P5|NOT COMPLETED|Double-Blind Phase||0
72881|NCT01662310|174063|P4|NOT COMPLETED|Double-Blind Phase||0
72882|NCT01662310|174064|P3|NOT COMPLETED|Double-Blind Phase||5
72883|NCT01662310|174065|P2|NOT COMPLETED|Double-Blind Phase||15
72884|NCT01662310|174066|P1|NOT COMPLETED|Double-Blind Phase||0
72885|NCT01662310|174062|P5|COMPLETED|Double-Blind Phase||0
72886|NCT01662310|174063|P4|COMPLETED|Double-Blind Phase||0
72887|NCT01662310|174064|P3|COMPLETED|Double-Blind Phase||66
72888|NCT01662310|174065|P2|COMPLETED|Double-Blind Phase||50
72889|NCT01662310|174066|P1|COMPLETED|Double-Blind Phase||0
72890|NCT01662310|174062|P5|Treated|Double-Blind Phase||0
72891|NCT01662310|174063|P4|Treated|Double-Blind Phase||0
72892|NCT01662310|174064|P3|Treated|Double-Blind Phase||71
72893|NCT01662310|174065|P2|Treated|Double-Blind Phase||64
72894|NCT01662310|174066|P1|Treated|Double-Blind Phase||0
72895|NCT01662310|174062|P5|STARTED|Double-Blind Phase||0
72896|NCT01662310|174063|P4|STARTED|Double-Blind Phase||0
72897|NCT01662310|174064|P3|STARTED|Double-Blind Phase||71
72898|NCT01662310|174065|P2|STARTED|Double-Blind Phase||65
72899|NCT01662310|174066|P1|STARTED|Double-Blind Phase||0
72900|NCT01662310|174062|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
72901|NCT01662310|174063|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
72902|NCT01662310|174064|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
72903|NCT01662310|174065|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
72904|NCT01662310|174066|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
72905|NCT01662310|174062|P5|COMPLETED|Run-In or Stabilization Phase||0
72906|NCT01662310|174063|P4|COMPLETED|Run-In or Stabilization Phase||0
72907|NCT01662310|174064|P3|COMPLETED|Run-In or Stabilization Phase||0
72908|NCT01662310|174065|P2|COMPLETED|Run-In or Stabilization Phase||0
72909|NCT01662310|174066|P1|COMPLETED|Run-In or Stabilization Phase||136
72910|NCT01662310|174062|P5|STARTED|Run-In or Stabilization Phase||0
72911|NCT01662310|174063|P4|STARTED|Run-In or Stabilization Phase||0
72912|NCT01662310|174064|P3|STARTED|Run-In or Stabilization Phase||0
72913|NCT01662310|174065|P2|STARTED|Run-In or Stabilization Phase||0
72914|NCT01662310|174066|P1|STARTED|Run-In or Stabilization Phase||201
72915|NCT01662115|174101|P3|NOT COMPLETED|Overall Study||0
72916|NCT01662115|174102|P2|NOT COMPLETED|Overall Study||0
72917|NCT01662115|174103|P1|NOT COMPLETED|Overall Study||0
72918|NCT01662115|174101|P3|COMPLETED|Overall Study||0
72919|NCT01662115|174102|P2|COMPLETED|Overall Study||2
72920|NCT01662115|174103|P1|COMPLETED|Overall Study||2
72921|NCT01662115|174101|P3|STARTED|Overall Study||0
72922|NCT01662115|174102|P2|STARTED|Overall Study||2
72923|NCT01662115|174103|P1|STARTED|Overall Study||2
72924|NCT01662102|174122|P2|NOT COMPLETED|Overall Study||0
72925|NCT01662102|174123|P1|NOT COMPLETED|Overall Study||1
72926|NCT01662102|174122|P2|COMPLETED|Overall Study||0
72927|NCT01662102|174123|P1|COMPLETED|Overall Study||0
72928|NCT01662102|174122|P2|STARTED|Overall Study||0
72929|NCT01662102|174123|P1|STARTED|Overall Study||1
72930|NCT01662063|174131|P3|NOT COMPLETED|Overall Study||1
72931|NCT01662063|174132|P2|NOT COMPLETED|Overall Study||29
72932|NCT01662063|174133|P1|NOT COMPLETED|Overall Study||5
72933|NCT01662063|174131|P3|COMPLETED|Overall Study||0
72934|NCT01662063|174132|P2|COMPLETED|Overall Study||144
72935|NCT01662063|174133|P1|COMPLETED|Overall Study||39
72936|NCT01662063|174131|P3|STARTED|Overall Study||1
72937|NCT01662063|174132|P2|STARTED|Overall Study||173
72938|NCT01662063|174133|P1|STARTED|Overall Study||44
72939|NCT01662024|174212|P1|NOT COMPLETED|Overall Study||5
72940|NCT01662024|174212|P1|COMPLETED|Overall Study||15
72941|NCT01662024|174212|P1|STARTED|Overall Study||20
72942|NCT01661972|174224|P2|NOT COMPLETED|Overall Study||4
72943|NCT01661972|174225|P1|NOT COMPLETED|Overall Study||2
72944|NCT01661972|174224|P2|COMPLETED|Overall Study||46
72945|NCT01661972|174225|P1|COMPLETED|Overall Study||11
72946|NCT01661972|174224|P2|STARTED|Overall Study||50
72947|NCT01661972|174225|P1|STARTED|Overall Study||13
72948|NCT01661933|174235|P1|NOT COMPLETED|High-dose Gluten Challenge||2
72949|NCT01661933|174235|P1|COMPLETED|High-dose Gluten Challenge||8
72950|NCT01661933|174235|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
72951|NCT01661933|174235|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
72952|NCT01661933|174235|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
72953|NCT01661933|174235|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
72954|NCT01661933|174235|P1|NOT COMPLETED|Gluten Micro-challenge||0
72955|NCT01661933|174235|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
72956|NCT01661933|174235|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
72957|NCT01661881|174242|P1|NOT COMPLETED|Overall Study||0
72958|NCT01661881|174242|P1|COMPLETED|Overall Study||23
72959|NCT01661881|174242|P1|STARTED|Overall Study||23
72960|NCT01661790|174250|P2|NOT COMPLETED|Overall Study||2
72961|NCT01661790|174251|P1|NOT COMPLETED|Overall Study||0
72962|NCT01661790|174250|P2|COMPLETED|Overall Study||34
72963|NCT01661790|174251|P1|COMPLETED|Overall Study||36
72964|NCT01661790|174250|P2|STARTED|Overall Study||36
72965|NCT01661790|174251|P1|STARTED|Overall Study||36
72966|NCT01661764|174263|P6|NOT COMPLETED|Overall Study||2
72967|NCT01661764|174264|P5|NOT COMPLETED|Overall Study||3
72968|NCT01661764|174265|P4|NOT COMPLETED|Overall Study||2
72969|NCT01661764|174266|P3|NOT COMPLETED|Overall Study||3
72970|NCT01661764|174267|P2|NOT COMPLETED|Overall Study||5
72971|NCT01661764|174268|P1|NOT COMPLETED|Overall Study||2
72972|NCT01661764|174263|P6|COMPLETED|Overall Study||18
72973|NCT01661764|174264|P5|COMPLETED|Overall Study||16
72974|NCT01661764|174265|P4|COMPLETED|Overall Study||24
72975|NCT01661764|174266|P3|COMPLETED|Overall Study||22
72976|NCT01661764|174267|P2|COMPLETED|Overall Study||20
72977|NCT01661764|174268|P1|COMPLETED|Overall Study||24
72978|NCT01661764|174263|P6|STARTED|Overall Study||20
72979|NCT01661764|174264|P5|STARTED|Overall Study||19
72980|NCT01661764|174265|P4|STARTED|Overall Study||26
72981|NCT01661764|174266|P3|STARTED|Overall Study||25
72982|NCT01661764|174267|P2|STARTED|Overall Study||25
72983|NCT01661764|174268|P1|STARTED|Overall Study||26
72984|NCT01661621|174332|P2|NOT COMPLETED|Overall Study||0
72985|NCT01661621|174333|P1|NOT COMPLETED|Overall Study||0
72986|NCT01661621|174332|P2|COMPLETED|Overall Study||279
72987|NCT01661621|174333|P1|COMPLETED|Overall Study||116
72988|NCT01661621|174332|P2|STARTED|Overall Study||279
72989|NCT01661621|174333|P1|STARTED|Overall Study||116
72990|NCT01661270|174355|P2|NOT COMPLETED|Overall Study||0
72991|NCT01661270|174356|P1|NOT COMPLETED|Overall Study||0
72992|NCT01661270|174355|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
72993|NCT01661270|174356|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
72994|NCT01661270|174355|P2|Other Reasons|Overall Study||2
72995|NCT01661270|174356|P1|Other Reasons|Overall Study||0
72996|NCT01661270|174355|P2|Participant’s Request|Overall Study|Met EOT criteria|48
72997|NCT01661270|174356|P1|Participant’s Request|Overall Study|Met EOT criteria|15
72998|NCT01661270|174355|P2|Physician Decision|Overall Study|Met EOT criteria|8
72999|NCT01661270|174356|P1|Physician Decision|Overall Study|Met EOT criteria|1
73000|NCT01661270|174355|P2|Disease Progression|Overall Study|Met EOT criteria|118
73001|NCT01661270|174356|P1|Disease Progression|Overall Study|Met EOT criteria|67
73002|NCT01661270|174355|P2|Adverse Event|Overall Study|Met EOT criteria|47
73003|NCT01661270|174356|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
73004|NCT01661270|174355|P2|STARTED|Overall Study||223
73005|NCT01661270|174356|P1|STARTED|Overall Study||109
73006|NCT01661205|174367|P1|NOT COMPLETED|Overall Study||2
73007|NCT01661205|174367|P1|COMPLETED|Overall Study||24
73008|NCT01661205|174367|P1|STARTED|Overall Study||26
73009|NCT01661179|174378|P1|NOT COMPLETED|Overall Study||6
73010|NCT01661179|174378|P1|COMPLETED|Overall Study||8
73011|NCT01661179|174378|P1|STARTED|Overall Study||14
73012|NCT01661140|174382|P3|NOT COMPLETED|Double-Blind Period||50
73013|NCT01661140|174383|P2|NOT COMPLETED|Double-Blind Period||41
73014|NCT01661140|174384|P1|NOT COMPLETED|Double-Blind Period||0
73015|NCT01661140|174382|P3|COMPLETED|Double-Blind Period||86
73016|NCT01661140|174383|P2|COMPLETED|Double-Blind Period||95
73017|NCT01661140|174384|P1|COMPLETED|Double-Blind Period||0
73018|NCT01661140|174382|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
73019|NCT01661140|174383|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
73020|NCT01661140|174384|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
73021|NCT01661140|174382|P3|NOT COMPLETED|Open-Label Period||0
73022|NCT01661140|174383|P2|NOT COMPLETED|Open-Label Period||0
73023|NCT01661140|174384|P1|NOT COMPLETED|Open-Label Period||76
73024|NCT01661140|174382|P3|COMPLETED|Open-Label Period||0
73025|NCT01661140|174383|P2|COMPLETED|Open-Label Period||0
73026|NCT01661140|174384|P1|COMPLETED|Open-Label Period||351
73027|NCT01661140|174382|P3|STARTED|Open-Label Period||0
73028|NCT01661140|174383|P2|STARTED|Open-Label Period||0
73029|NCT01661140|174384|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
73030|NCT01661114|174425|P1|NOT COMPLETED|Overall Study||0
73031|NCT01661114|174425|P1|COMPLETED|Overall Study||39
73032|NCT01661114|174425|P1|STARTED|Overall Study||39
73033|NCT01661062|174430|P1|NOT COMPLETED|Overall Study||5
73034|NCT01661062|174430|P1|COMPLETED|Overall Study||18
73035|NCT01661062|174430|P1|STARTED|Overall Study||23
73036|NCT01660906|174435|P1|NOT COMPLETED|Overall Study||3
73037|NCT01660906|174435|P1|COMPLETED|Overall Study||36
73038|NCT01660906|174435|P1|STARTED|Overall Study||39
73039|NCT01660893|174447|P3|NOT COMPLETED|Overall Study||0
73040|NCT01660893|174448|P2|NOT COMPLETED|Overall Study||0
73041|NCT01660893|174449|P1|NOT COMPLETED|Overall Study||0
73042|NCT01660893|174447|P3|COMPLETED|Overall Study||6
73043|NCT01660893|174448|P2|COMPLETED|Overall Study||10
73044|NCT01660893|174449|P1|COMPLETED|Overall Study||10
73045|NCT01660893|174447|P3|STARTED|Overall Study||6
73046|NCT01660893|174448|P2|STARTED|Overall Study||10
73047|NCT01660893|174449|P1|STARTED|Overall Study||10
73048|NCT01660815|174496|P1|NOT COMPLETED|Overall Study||0
73049|NCT01660815|174496|P1|COMPLETED|Overall Study||7
73050|NCT01660815|174496|P1|STARTED|Overall Study||7
73051|NCT01660802|174503|P2|NOT COMPLETED|Overall Study||11
73052|NCT01660802|174504|P1|NOT COMPLETED|Overall Study||4
73053|NCT01660802|174503|P2|COMPLETED|Overall Study||121
73054|NCT01660802|174504|P1|COMPLETED|Overall Study||126
73055|NCT01660802|174503|P2|STARTED|Overall Study||132
73056|NCT01660802|174504|P1|STARTED|Overall Study||130
73057|NCT01660763|174518|P2|NOT COMPLETED|Overall Study||61
73058|NCT01660763|174519|P1|NOT COMPLETED|Overall Study||100
73059|NCT01660763|174518|P2|COMPLETED|Overall Study||43
73060|NCT01660763|174519|P1|COMPLETED|Overall Study||215
73061|NCT01660763|174518|P2|STARTED|Overall Study||104
73062|NCT01660763|174519|P1|STARTED|Overall Study||315
73063|NCT01660737|174525|P1|NOT COMPLETED|Overall Study||0
73064|NCT01660737|174525|P1|COMPLETED|Overall Study||123
73065|NCT01660737|174525|P1|STARTED|Overall Study||123
73066|NCT01660698|174542|P2|NOT COMPLETED|Overall Study||0
73067|NCT01660698|174543|P1|NOT COMPLETED|Overall Study||0
73068|NCT01660698|174542|P2|COMPLETED|Overall Study||10
73069|NCT01660698|174543|P1|COMPLETED|Overall Study||10
73070|NCT01660698|174542|P2|STARTED|Overall Study||10
73071|NCT01660698|174543|P1|STARTED|Overall Study||10
73072|NCT01660672|174553|P1|NOT COMPLETED|Overall Study||0
73073|NCT01660672|174553|P1|COMPLETED|Overall Study||7
73074|NCT01660672|174553|P1|STARTED|Overall Study||7
73075|NCT01660451|174567|P3|NOT COMPLETED|Overall Study||105
73076|NCT01660451|174568|P2|NOT COMPLETED|Overall Study||17
73077|NCT01660451|174569|P1|NOT COMPLETED|Overall Study||17
73078|NCT01660451|174567|P3|COMPLETED|Overall Study||37
73079|NCT01660451|174568|P2|COMPLETED|Overall Study||34
73080|NCT01660451|174569|P1|COMPLETED|Overall Study||16
73081|NCT01660451|174567|P3|STARTED|Overall Study||142
73082|NCT01660451|174568|P2|STARTED|Overall Study||51
73083|NCT01660451|174569|P1|STARTED|Overall Study||33
73084|NCT01660412|174597|P2|NOT COMPLETED|Overall Study||3
73085|NCT01660412|174598|P1|NOT COMPLETED|Overall Study||0
73086|NCT01660412|174597|P2|COMPLETED|Overall Study||28
73087|NCT01660412|174598|P1|COMPLETED|Overall Study||29
73088|NCT01660412|174597|P2|Injection 4|Overall Study||31
73089|NCT01660412|174598|P1|Injection 4|Overall Study||29
73090|NCT01660412|174597|P2|Injection 3|Overall Study||31
73091|NCT01660412|174598|P1|Injection 3|Overall Study||29
73092|NCT01660412|174597|P2|Injection 2|Overall Study||31
73093|NCT01660412|174598|P1|Injection 2|Overall Study||29
73094|NCT01660412|174597|P2|Injection 1|Overall Study||31
73095|NCT01660412|174598|P1|Injection 1|Overall Study||29
73096|NCT01660412|174597|P2|Other|Overall Study||4
73097|NCT01660412|174598|P1|Other|Overall Study||2
73098|NCT01660412|174597|P2|Appendicular Structures|Overall Study||11
73099|NCT01660412|174598|P1|Appendicular Structures|Overall Study||17
73100|NCT01660412|174597|P2|Thorax|Overall Study||9
73101|NCT01660412|174598|P1|Thorax|Overall Study||9
73102|NCT01660412|174597|P2|Head|Overall Study||4
73103|NCT01660412|174598|P1|Head|Overall Study||1
73104|NCT01660412|174597|P2|STARTED|Overall Study||31
73105|NCT01660412|174598|P1|STARTED|Overall Study||29
73106|NCT01660334|174604|P1|NOT COMPLETED|Overall Study||1
73107|NCT01660334|174604|P1|COMPLETED|Overall Study||12
73108|NCT01660334|174604|P1|STARTED|Overall Study||13
73109|NCT01660321|174609|P1|NOT COMPLETED|Overall Study||0
73110|NCT01660321|174609|P1|COMPLETED|Overall Study||26
73111|NCT01660321|174609|P1|STARTED|Overall Study||26
73112|NCT01660230|174633|P12|NOT COMPLETED|Overall Study||0
73113|NCT01660230|174634|P11|NOT COMPLETED|Overall Study||0
73114|NCT01660230|174635|P10|NOT COMPLETED|Overall Study||0
73115|NCT01660230|174636|P9|NOT COMPLETED|Overall Study||0
73116|NCT01660230|174637|P8|NOT COMPLETED|Overall Study||0
73117|NCT01660230|174638|P7|NOT COMPLETED|Overall Study||0
73118|NCT01660230|174639|P6|NOT COMPLETED|Overall Study||0
73119|NCT01660230|174640|P5|NOT COMPLETED|Overall Study||0
73120|NCT01660230|174641|P4|NOT COMPLETED|Overall Study||0
73121|NCT01660230|174642|P3|NOT COMPLETED|Overall Study||0
73122|NCT01660230|174643|P2|NOT COMPLETED|Overall Study||0
73123|NCT01660230|174644|P1|NOT COMPLETED|Overall Study||0
73124|NCT01660230|174633|P12|COMPLETED|Overall Study||14
73125|NCT01660230|174634|P11|COMPLETED|Overall Study||6
73126|NCT01660230|174635|P10|COMPLETED|Overall Study||6
73127|NCT01660230|174636|P9|COMPLETED|Overall Study||6
73128|NCT01660230|174637|P8|COMPLETED|Overall Study||6
73129|NCT01660230|174638|P7|COMPLETED|Overall Study||4
73130|NCT01660230|174639|P6|COMPLETED|Overall Study||2
73131|NCT01660230|174640|P5|COMPLETED|Overall Study||4
73132|NCT01660230|174641|P4|COMPLETED|Overall Study||4
73133|NCT01660230|174642|P3|COMPLETED|Overall Study||4
73134|NCT01660230|174643|P2|COMPLETED|Overall Study||4
73135|NCT01660230|174644|P1|COMPLETED|Overall Study||4
73136|NCT01660230|174633|P12|STARTED|Overall Study||14
73137|NCT01660230|174634|P11|STARTED|Overall Study||6
73138|NCT01660230|174635|P10|STARTED|Overall Study||6
73139|NCT01660230|174636|P9|STARTED|Overall Study||6
73140|NCT01660230|174637|P8|STARTED|Overall Study||6
73141|NCT01660230|174638|P7|STARTED|Overall Study||4
73142|NCT01660230|174639|P6|STARTED|Overall Study||2
73143|NCT01660230|174640|P5|STARTED|Overall Study||4
73144|NCT01660230|174641|P4|STARTED|Overall Study||4
73145|NCT01660230|174642|P3|STARTED|Overall Study||4
73146|NCT01660230|174643|P2|STARTED|Overall Study||4
73147|NCT01660230|174644|P1|STARTED|Overall Study||4
73148|NCT01660191|174816|P3|NOT COMPLETED|End of Treatment||1
73149|NCT01660191|174817|P2|NOT COMPLETED|End of Treatment||6
73150|NCT01660191|174818|P1|NOT COMPLETED|End of Treatment||1
73151|NCT01660191|174816|P3|COMPLETED|End of Treatment||43
73152|NCT01660191|174817|P2|COMPLETED|End of Treatment||39
73153|NCT01660191|174818|P1|COMPLETED|End of Treatment||44
73154|NCT01660191|174816|P3|STARTED|End of Treatment||44
73155|NCT01660191|174817|P2|STARTED|End of Treatment||45
73156|NCT01660191|174818|P1|STARTED|End of Treatment||45
73157|NCT01660191|174816|P3|NOT COMPLETED|Randomization||0
73158|NCT01660191|174817|P2|NOT COMPLETED|Randomization||0
73159|NCT01660191|174818|P1|NOT COMPLETED|Randomization||0
73160|NCT01660191|174816|P3|COMPLETED|Randomization||44
73161|NCT01660191|174817|P2|COMPLETED|Randomization||45
73162|NCT01660191|174818|P1|COMPLETED|Randomization||45
73163|NCT01660191|174816|P3|STARTED|Randomization||44
73164|NCT01660191|174817|P2|STARTED|Randomization||45
73165|NCT01660191|174818|P1|STARTED|Randomization||45
73166|NCT01660191|174816|P3|NOT COMPLETED|Enrollment and Washout||0
73167|NCT01660191|174817|P2|NOT COMPLETED|Enrollment and Washout||0
73168|NCT01660191|174818|P1|NOT COMPLETED|Enrollment and Washout||0
73169|NCT01660191|174816|P3|COMPLETED|Enrollment and Washout||44
73170|NCT01660191|174817|P2|COMPLETED|Enrollment and Washout||45
73171|NCT01660191|174818|P1|COMPLETED|Enrollment and Washout||45
73172|NCT01660191|174816|P3|STARTED|Enrollment and Washout||44
73173|NCT01660191|174817|P2|STARTED|Enrollment and Washout||45
73174|NCT01660191|174818|P1|STARTED|Enrollment and Washout||45
73175|NCT01660022|174847|P6|NOT COMPLETED|Second Sequence (42 Days)||0
73176|NCT01660022|174848|P5|NOT COMPLETED|Second Sequence (42 Days)||0
73177|NCT01660022|174849|P4|NOT COMPLETED|Second Sequence (42 Days)||0
73178|NCT01660022|174850|P3|NOT COMPLETED|Second Sequence (42 Days)||0
73179|NCT01660022|174851|P2|NOT COMPLETED|Second Sequence (42 Days)||0
73180|NCT01660022|174852|P1|NOT COMPLETED|Second Sequence (42 Days)||0
73181|NCT01660022|174847|P6|COMPLETED|Second Sequence (42 Days)||16
73182|NCT01660022|174848|P5|COMPLETED|Second Sequence (42 Days)||6
73183|NCT01660022|174849|P4|COMPLETED|Second Sequence (42 Days)||7
73184|NCT01660022|174850|P3|COMPLETED|Second Sequence (42 Days)||8
73185|NCT01660022|174851|P2|COMPLETED|Second Sequence (42 Days)||7
73186|NCT01660022|174852|P1|COMPLETED|Second Sequence (42 Days)||8
73187|NCT01660022|174847|P6|STARTED|Second Sequence (42 Days)||16
73188|NCT01660022|174848|P5|STARTED|Second Sequence (42 Days)||6
73189|NCT01660022|174849|P4|STARTED|Second Sequence (42 Days)||7
73190|NCT01660022|174850|P3|STARTED|Second Sequence (42 Days)||8
73191|NCT01660022|174851|P2|STARTED|Second Sequence (42 Days)||7
73192|NCT01660022|174852|P1|STARTED|Second Sequence (42 Days)||8
73193|NCT01660022|174847|P6|NOT COMPLETED|First Sequence (7 Days)||4
73194|NCT01660022|174848|P5|NOT COMPLETED|First Sequence (7 Days)||1
73195|NCT01660022|174849|P4|NOT COMPLETED|First Sequence (7 Days)||1
73196|NCT01660022|174850|P3|NOT COMPLETED|First Sequence (7 Days)||0
73197|NCT01660022|174851|P2|NOT COMPLETED|First Sequence (7 Days)||1
73198|NCT01660022|174852|P1|NOT COMPLETED|First Sequence (7 Days)||0
73199|NCT01660022|174847|P6|COMPLETED|First Sequence (7 Days)||16
73200|NCT01660022|174848|P5|COMPLETED|First Sequence (7 Days)||6
73201|NCT01660022|174849|P4|COMPLETED|First Sequence (7 Days)||7
73202|NCT01660022|174850|P3|COMPLETED|First Sequence (7 Days)||8
73203|NCT01660022|174851|P2|COMPLETED|First Sequence (7 Days)||7
73204|NCT01660022|174852|P1|COMPLETED|First Sequence (7 Days)||8
73205|NCT01660022|174847|P6|STARTED|First Sequence (7 Days)||20
73206|NCT01660022|174848|P5|STARTED|First Sequence (7 Days)||7
73207|NCT01660022|174849|P4|STARTED|First Sequence (7 Days)||8
73208|NCT01660022|174850|P3|STARTED|First Sequence (7 Days)||8
73209|NCT01660022|174851|P2|STARTED|First Sequence (7 Days)||8
73210|NCT01660022|174852|P1|STARTED|First Sequence (7 Days)||8
73211|NCT01659996|174911|P3|NOT COMPLETED|Overall Study||11
73212|NCT01659996|174912|P2|NOT COMPLETED|Overall Study||7
73213|NCT01659996|174913|P1|NOT COMPLETED|Overall Study||8
73214|NCT01659996|174911|P3|COMPLETED|Overall Study||461
73215|NCT01659996|174912|P2|COMPLETED|Overall Study||388
73216|NCT01659996|174913|P1|COMPLETED|Overall Study||413
73217|NCT01659996|174911|P3|STARTED|Overall Study||472
73218|NCT01659996|174912|P2|STARTED|Overall Study||395
73219|NCT01659996|174913|P1|STARTED|Overall Study||421
73220|NCT01659853|174945|P2|NOT COMPLETED|Treatment Period 2||0
73221|NCT01659853|174946|P1|NOT COMPLETED|Treatment Period 2||0
73222|NCT01659853|174945|P2|COMPLETED|Treatment Period 2||35
73223|NCT01659853|174946|P1|COMPLETED|Treatment Period 2||33
73224|NCT01659853|174945|P2|STARTED|Treatment Period 2||35
73225|NCT01659853|174946|P1|STARTED|Treatment Period 2||33
73226|NCT01659853|174945|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
73227|NCT01659853|174946|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
73228|NCT01659853|174945|P2|COMPLETED|Washout , 3 to 7 Days||35
73229|NCT01659853|174946|P1|COMPLETED|Washout , 3 to 7 Days||33
73230|NCT01659853|174945|P2|STARTED|Washout , 3 to 7 Days||35
73231|NCT01659853|174946|P1|STARTED|Washout , 3 to 7 Days||35
73232|NCT01659853|174945|P2|NOT COMPLETED|Treatment Period 1||0
73233|NCT01659853|174946|P1|NOT COMPLETED|Treatment Period 1||0
73234|NCT01659853|174945|P2|COMPLETED|Treatment Period 1||35
73235|NCT01659853|174946|P1|COMPLETED|Treatment Period 1||35
73236|NCT01659853|174945|P2|STARTED|Treatment Period 1||35
73237|NCT01659853|174946|P1|STARTED|Treatment Period 1||35
73238|NCT01659736|174956|P2|NOT COMPLETED|3-month Follow-up||1
73239|NCT01659736|174957|P1|NOT COMPLETED|3-month Follow-up||0
73240|NCT01659736|174956|P2|COMPLETED|3-month Follow-up||9
73241|NCT01659736|174957|P1|COMPLETED|3-month Follow-up||9
73242|NCT01659736|174956|P2|STARTED|3-month Follow-up||10
73243|NCT01659736|174957|P1|STARTED|3-month Follow-up||9
73244|NCT01659736|174956|P2|NOT COMPLETED|Treatment Period||2
73245|NCT01659736|174957|P1|NOT COMPLETED|Treatment Period||5
73246|NCT01659736|174956|P2|COMPLETED|Treatment Period||10
73247|NCT01659736|174957|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
73248|NCT01659736|174956|P2|STARTED|Treatment Period||12
73249|NCT01659736|174957|P1|STARTED|Treatment Period||14
73250|NCT01659567|174971|P1|NOT COMPLETED|Overall Study||123
73251|NCT01659567|174971|P1|COMPLETED|Overall Study||393
73252|NCT01659567|174971|P1|STARTED|Overall Study||516
73253|NCT01659554|174988|P1|NOT COMPLETED|Overall Study||4
73254|NCT01659554|174988|P1|COMPLETED|Overall Study||0
73255|NCT01659554|174988|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
73256|NCT01659320|174995|P1|NOT COMPLETED|Overall Study||3
73257|NCT01659320|174995|P1|COMPLETED|Overall Study||13
73258|NCT01659320|174995|P1|STARTED|Overall Study||16
73259|NCT01659268|175001|P2|NOT COMPLETED|Overall Study||0
73260|NCT01659268|175002|P1|NOT COMPLETED|Overall Study||0
73261|NCT01659268|175001|P2|COMPLETED|Overall Study||8
73262|NCT01659268|175002|P1|COMPLETED|Overall Study||9
73263|NCT01659268|175001|P2|STARTED|Overall Study||8
73264|NCT01659268|175002|P1|STARTED|Overall Study||9
73265|NCT01659125|175014|P1|NOT COMPLETED|Overall Study||14
73266|NCT01659125|175014|P1|COMPLETED|Overall Study||12
73267|NCT01659125|175014|P1|Completed 6-month Follow-up|Overall Study||12
73268|NCT01659125|175014|P1|Completed 3-month Follow-up|Overall Study||16
73269|NCT01659125|175014|P1|Completed the Posttreatment Assessment|Overall Study||17
73270|NCT01659125|175014|P1|Initiated Treatment|Overall Study||24
73271|NCT01659125|175014|P1|STARTED|Overall Study||26
73272|NCT01659021|175021|P2|NOT COMPLETED|Overall Study||37
73273|NCT01659021|175022|P1|NOT COMPLETED|Overall Study||88
73274|NCT01659021|175021|P2|COMPLETED|Overall Study||50
73275|NCT01659021|175022|P1|COMPLETED|Overall Study||86
73276|NCT01659021|175021|P2|Randomized and Treated|Overall Study||86
73277|NCT01659021|175022|P1|Randomized and Treated|Overall Study||173
73278|NCT01659021|175021|P2|STARTED|Overall Study||87
73279|NCT01659021|175022|P1|STARTED|Overall Study||174
73280|NCT01658943|175040|P2|NOT COMPLETED|Overall Study||67
73281|NCT01658943|175041|P1|NOT COMPLETED|Overall Study||70
73282|NCT01658943|175040|P2|COMPLETED|Overall Study||0
73283|NCT01658943|175041|P1|COMPLETED|Overall Study||0
73284|NCT01658943|175040|P2|Eligible and Began Protocol Therapy|Overall Study||58
73285|NCT01658943|175041|P1|Eligible and Began Protocol Therapy|Overall Study||62
73286|NCT01658943|175040|P2|Eligible|Overall Study||58
73287|NCT01658943|175041|P1|Eligible|Overall Study||63
73288|NCT01658943|175040|P2|STARTED|Overall Study||67
73289|NCT01658943|175041|P1|STARTED|Overall Study||70
73290|NCT01658904|175056|P3|NOT COMPLETED|Overall Study||0
73291|NCT01658904|175057|P2|NOT COMPLETED|Overall Study||0
73292|NCT01658904|175058|P1|NOT COMPLETED|Overall Study||2
73293|NCT01658904|175056|P3|COMPLETED|Overall Study||0
73294|NCT01658904|175057|P2|COMPLETED|Overall Study||0
73295|NCT01658904|175058|P1|COMPLETED|Overall Study||1
73296|NCT01658904|175056|P3|STARTED|Overall Study||0
73297|NCT01658904|175057|P2|STARTED|Overall Study||0
73298|NCT01658904|175058|P1|STARTED|Overall Study||3
73299|NCT01658839|175075|P1|NOT COMPLETED|Overall Study||0
73300|NCT01658839|175075|P1|COMPLETED|Overall Study||25
73301|NCT01658839|175075|P1|STARTED|Overall Study||25
73302|NCT01658813|175084|P1|NOT COMPLETED|Overall Study||3
73303|NCT01658813|175084|P1|COMPLETED|Overall Study||15
73304|NCT01658813|175084|P1|Treated|Overall Study||18
73305|NCT01658813|175084|P1|Eligible|Overall Study||18
73306|NCT01658813|175084|P1|STARTED|Overall Study||18
73307|NCT01658735|175095|P3|NOT COMPLETED|Overall Study||4
73308|NCT01658735|175096|P2|NOT COMPLETED|Overall Study||7
73309|NCT01658735|175097|P1|NOT COMPLETED|Overall Study||5
73310|NCT01658735|175095|P3|COMPLETED|Overall Study||34
73311|NCT01658735|175096|P2|COMPLETED|Overall Study||29
73312|NCT01658735|175097|P1|COMPLETED|Overall Study||34
73313|NCT01658735|175095|P3|STARTED|Overall Study||38
73314|NCT01658735|175096|P2|STARTED|Overall Study||36
73315|NCT01658735|175097|P1|STARTED|Overall Study||39
73316|NCT01658657|175128|P2|NOT COMPLETED|Overall Study||3
73317|NCT01658657|175129|P1|NOT COMPLETED|Overall Study||3
73318|NCT01658657|175128|P2|COMPLETED|Overall Study||7
73319|NCT01658657|175129|P1|COMPLETED|Overall Study||4
73320|NCT01658657|175128|P2|STARTED|Overall Study||10
73321|NCT01658657|175129|P1|STARTED|Overall Study||7
73322|NCT01658579|175139|P4|NOT COMPLETED|Treatment Period B||1
73323|NCT01658579|175140|P3|NOT COMPLETED|Treatment Period B||0
73324|NCT01658579|175141|P2|NOT COMPLETED|Treatment Period B||0
73325|NCT01658579|175142|P1|NOT COMPLETED|Treatment Period B||0
73326|NCT01658579|175139|P4|COMPLETED|Treatment Period B||12
73327|NCT01658579|175140|P3|COMPLETED|Treatment Period B||14
73328|NCT01658579|175141|P2|COMPLETED|Treatment Period B||15
73329|NCT01658579|175142|P1|COMPLETED|Treatment Period B||14
73330|NCT01658579|175139|P4|STARTED|Treatment Period B||13
73331|NCT01658579|175140|P3|STARTED|Treatment Period B||14
73332|NCT01658579|175141|P2|STARTED|Treatment Period B||15
73333|NCT01658579|175142|P1|STARTED|Treatment Period B||14
73334|NCT01658579|175139|P4|NOT COMPLETED|Treatment Period A||1
73335|NCT01658579|175140|P3|NOT COMPLETED|Treatment Period A||1
73336|NCT01658579|175141|P2|NOT COMPLETED|Treatment Period A||0
73337|NCT01658579|175142|P1|NOT COMPLETED|Treatment Period A||1
73338|NCT01658579|175139|P4|COMPLETED|Treatment Period A||13
73339|NCT01658579|175140|P3|COMPLETED|Treatment Period A||14
73340|NCT01658579|175141|P2|COMPLETED|Treatment Period A||15
73341|NCT01658579|175142|P1|COMPLETED|Treatment Period A||14
73342|NCT01658579|175139|P4|STARTED|Treatment Period A||14
73343|NCT01658579|175140|P3|STARTED|Treatment Period A||15
73344|NCT01658579|175141|P2|STARTED|Treatment Period A||15
73345|NCT01658579|175142|P1|STARTED|Treatment Period A||15
73346|NCT01658514|175170|P3|NOT COMPLETED|Overall Study||2
73347|NCT01658514|175171|P2|NOT COMPLETED|Overall Study||0
73348|NCT01658514|175172|P1|NOT COMPLETED|Overall Study||1
73349|NCT01658514|175170|P3|COMPLETED|Overall Study||12
73350|NCT01658514|175171|P2|COMPLETED|Overall Study||11
73351|NCT01658514|175172|P1|COMPLETED|Overall Study||13
73352|NCT01658514|175170|P3|Completed - Severe RI Cohort Only|Overall Study||3
73353|NCT01658514|175171|P2|Completed - Severe RI Cohort Only|Overall Study||2
73354|NCT01658514|175172|P1|Completed - Severe RI Cohort Only|Overall Study||3
73355|NCT01658514|175170|P3|Started - Severe RI Cohort Only|Overall Study||3
73356|NCT01658514|175171|P2|Started - Severe RI Cohort Only|Overall Study||2
73357|NCT01658514|175172|P1|Started - Severe RI Cohort Only|Overall Study||3
73358|NCT01658514|175170|P3|Completed - Moderate RI Cohort Only|Overall Study||2
73359|NCT01658514|175171|P2|Completed - Moderate RI Cohort Only|Overall Study||4
73360|NCT01658514|175172|P1|Completed - Moderate RI Cohort Only|Overall Study||3
73361|NCT01658514|175170|P3|Started - Moderate RI Cohort Only|Overall Study||4
73362|NCT01658514|175171|P2|Started - Moderate RI Cohort Only|Overall Study||4
73363|NCT01658514|175172|P1|Started - Moderate RI Cohort Only|Overall Study||4
73364|NCT01658514|175170|P3|Completed - Mild RI Cohort Only|Overall Study||4
73365|NCT01658514|175171|P2|Completed - Mild RI Cohort Only|Overall Study||3
73366|NCT01658514|175172|P1|Completed - Mild RI Cohort Only|Overall Study||4
73367|NCT01658514|175170|P3|Started - Mild RI Cohort Only|Overall Study||4
73368|NCT01658514|175171|P2|Started - Mild RI Cohort Only|Overall Study||3
73369|NCT01658514|175172|P1|Started - Mild RI Cohort Only|Overall Study||4
73370|NCT01658514|175170|P3|Completed - Normal RF Cohort Only|Overall Study||3
73371|NCT01658514|175171|P2|Completed - Normal RF Cohort Only|Overall Study||2
73372|NCT01658514|175172|P1|Completed - Normal RF Cohort Only|Overall Study||3
73373|NCT01658514|175170|P3|Started - Normal RF Cohort Only|Overall Study||3
73374|NCT01658514|175171|P2|Started - Normal RF Cohort Only|Overall Study||2
73375|NCT01658514|175172|P1|Started - Normal RF Cohort Only|Overall Study||3
73376|NCT01658514|175170|P3|Completed Treatment C|Overall Study||12
73377|NCT01658514|175171|P2|Completed Treatment C|Overall Study||11
73378|NCT01658514|175172|P1|Completed Treatment C|Overall Study||13
73379|NCT01658514|175170|P3|Completed Treatment B|Overall Study||14
73380|NCT01658514|175171|P2|Completed Treatment B|Overall Study||11
73381|NCT01658514|175172|P1|Completed Treatment B|Overall Study||13
73382|NCT01658514|175170|P3|Completed Treatment A|Overall Study||12
73383|NCT01658514|175171|P2|Completed Treatment A|Overall Study||11
73384|NCT01658514|175172|P1|Completed Treatment A|Overall Study||14
73385|NCT01658514|175170|P3|STARTED|Overall Study||14
73386|NCT01658514|175171|P2|STARTED|Overall Study||11
73387|NCT01658514|175172|P1|STARTED|Overall Study||14
73388|NCT01658436|175183|P2|NOT COMPLETED|Overall Study||11
73389|NCT01658436|175184|P1|NOT COMPLETED|Overall Study||20
73390|NCT01658436|175183|P2|COMPLETED|Overall Study||0
73391|NCT01658436|175184|P1|COMPLETED|Overall Study||0
73392|NCT01658436|175183|P2|STARTED|Overall Study||11
73393|NCT01658436|175184|P1|STARTED|Overall Study||20
73394|NCT01658228|175193|P2|NOT COMPLETED|Overall Study||8
73395|NCT01658228|175194|P1|NOT COMPLETED|Overall Study||7
73396|NCT01658228|175193|P2|COMPLETED|Overall Study||23
73397|NCT01658228|175194|P1|COMPLETED|Overall Study||23
73398|NCT01658228|175193|P2|STARTED|Overall Study||31
73399|NCT01658228|175194|P1|STARTED|Overall Study||30
73400|NCT01658072|175206|P2|NOT COMPLETED|Overall Study||2
73401|NCT01658072|175207|P1|NOT COMPLETED|Overall Study||4
73402|NCT01658072|175206|P2|COMPLETED|Overall Study||43
73403|NCT01658072|175207|P1|COMPLETED|Overall Study||41
73404|NCT01658072|175206|P2|STARTED|Overall Study||45
73405|NCT01658072|175207|P1|STARTED|Overall Study||45
73406|NCT01658020|175215|P2|NOT COMPLETED|Overall Study||9
73407|NCT01658020|175216|P1|NOT COMPLETED|Overall Study||8
73408|NCT01658020|175215|P2|COMPLETED|Overall Study||158
73409|NCT01658020|175216|P1|COMPLETED|Overall Study||167
73410|NCT01658020|175215|P2|STARTED|Overall Study||167
73411|NCT01658020|175216|P1|STARTED|Overall Study||175
73412|NCT01657903|175232|P1|NOT COMPLETED|Overall Study||2
73413|NCT01657903|175232|P1|COMPLETED|Overall Study||54
73414|NCT01657903|175232|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
73415|NCT01657903|175232|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
73416|NCT01657903|175232|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
73417|NCT01657903|175232|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
73418|NCT01657903|175232|P1|STARTED|Overall Study||56
73419|NCT01657877|175254|P1|NOT COMPLETED|Overall Study||14
73420|NCT01657877|175254|P1|COMPLETED|Overall Study||65
73421|NCT01657877|175254|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
73422|NCT01657877|175254|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
73423|NCT01657877|175254|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
73424|NCT01657877|175254|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
73425|NCT01657877|175254|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
73426|NCT01657877|175254|P1|STARTED|Overall Study||79
73427|NCT01657799|175274|P3|NOT COMPLETED|Overall Study||102
73428|NCT01657799|175275|P2|NOT COMPLETED|Overall Study||103
73429|NCT01657799|175276|P1|NOT COMPLETED|Overall Study||102
73430|NCT01657799|175274|P3|COMPLETED|Overall Study||0
73431|NCT01657799|175275|P2|COMPLETED|Overall Study||0
73432|NCT01657799|175276|P1|COMPLETED|Overall Study||0
73433|NCT01657799|175274|P3|Received Treatment|Overall Study||102
73434|NCT01657799|175275|P2|Received Treatment|Overall Study||103
73435|NCT01657799|175276|P1|Received Treatment|Overall Study||101
73436|NCT01657799|175274|P3|STARTED|Overall Study||102
73437|NCT01657799|175275|P2|STARTED|Overall Study||103
73438|NCT01657799|175276|P1|STARTED|Overall Study||102
73439|NCT01657461|175295|P2|NOT COMPLETED|Overall Study||20
73440|NCT01657461|175296|P1|NOT COMPLETED|Overall Study||10
73441|NCT01657461|175295|P2|COMPLETED|Overall Study||78
73442|NCT01657461|175296|P1|COMPLETED|Overall Study||88
73443|NCT01657461|175295|P2|STARTED|Overall Study||98
73444|NCT01657461|175296|P1|STARTED|Overall Study||98
73445|NCT01657370|175326|P6|NOT COMPLETED|Overall Study||4
73446|NCT01657370|175327|P5|NOT COMPLETED|Overall Study||7
73447|NCT01657370|175328|P4|NOT COMPLETED|Overall Study||5
73448|NCT01657370|175329|P3|NOT COMPLETED|Overall Study||7
73449|NCT01657370|175330|P2|NOT COMPLETED|Overall Study||4
73450|NCT01657370|175331|P1|NOT COMPLETED|Overall Study||6
73451|NCT01657370|175326|P6|COMPLETED|Overall Study||27
73452|NCT01657370|175327|P5|COMPLETED|Overall Study||27
73453|NCT01657370|175328|P4|COMPLETED|Overall Study||28
73454|NCT01657370|175329|P3|COMPLETED|Overall Study||25
73455|NCT01657370|175330|P2|COMPLETED|Overall Study||28
73456|NCT01657370|175331|P1|COMPLETED|Overall Study||27
73457|NCT01657370|175326|P6|STARTED|Overall Study||31
73458|NCT01657370|175327|P5|STARTED|Overall Study||34
73459|NCT01657370|175328|P4|STARTED|Overall Study||33
73460|NCT01657370|175329|P3|STARTED|Overall Study||32
73461|NCT01657370|175330|P2|STARTED|Overall Study||32
73462|NCT01657370|175331|P1|STARTED|Overall Study||33
73463|NCT01657305|175413|P1|NOT COMPLETED|Overall Study||25
73464|NCT01657305|175413|P1|COMPLETED|Overall Study||82
73465|NCT01657305|175413|P1|STARTED|Overall Study||107
73466|NCT01657292|175463|P1|NOT COMPLETED|Overall Study||10
73467|NCT01657292|175463|P1|COMPLETED|Overall Study||51
73468|NCT01657292|175463|P1|STARTED|Overall Study||61
73469|NCT01657253|175472|P2|NOT COMPLETED|Overall Study||18
73470|NCT01657253|175473|P1|NOT COMPLETED|Overall Study||17
73471|NCT01657253|175472|P2|COMPLETED|Overall Study||72
73472|NCT01657253|175473|P1|COMPLETED|Overall Study||76
73473|NCT01657253|175472|P2|STARTED|Overall Study||90
73474|NCT01657253|175473|P1|STARTED|Overall Study||93
73475|NCT01657032|175485|P2|NOT COMPLETED|Overall Study||7
73476|NCT01657032|175486|P1|NOT COMPLETED|Overall Study||0
73477|NCT01657032|175485|P2|COMPLETED|Overall Study||37
73478|NCT01657032|175486|P1|COMPLETED|Overall Study||44
73479|NCT01657032|175485|P2|STARTED|Overall Study||44
73480|NCT01657032|175486|P1|STARTED|Overall Study||44
73481|NCT01657019|175512|P1|NOT COMPLETED|Overall Study||235
73482|NCT01657019|175512|P1|COMPLETED|Overall Study||369
73483|NCT01657019|175512|P1|STARTED|Overall Study||604
73484|NCT01656967|175526|P2|NOT COMPLETED|Overall Study||2
73485|NCT01656967|175527|P1|NOT COMPLETED|Overall Study||4
73486|NCT01656967|175526|P2|COMPLETED|Overall Study||31
73487|NCT01656967|175527|P1|COMPLETED|Overall Study||29
73488|NCT01656967|175526|P2|ETT Insertion|Overall Study||31
73489|NCT01656967|175527|P1|ETT Insertion|Overall Study||29
73490|NCT01656967|175526|P2|SGA Placement|Overall Study||33
73491|NCT01656967|175527|P1|SGA Placement|Overall Study||32
73492|NCT01656967|175526|P2|STARTED|Overall Study||33
73493|NCT01656967|175527|P1|STARTED|Overall Study||33
73494|NCT01656889|175549|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
73495|NCT01656889|175550|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
73496|NCT01656889|175549|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
73497|NCT01656889|175550|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
73498|NCT01656889|175549|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
73499|NCT01656889|175550|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
73500|NCT01656889|175549|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
73501|NCT01656889|175550|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
73502|NCT01656889|175549|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
73503|NCT01656889|175550|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
73504|NCT01656889|175549|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
73505|NCT01656889|175550|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
73506|NCT01656850|175570|P2|NOT COMPLETED|Second Intervention (3 Months)||0
73507|NCT01656850|175571|P1|NOT COMPLETED|Second Intervention (3 Months)||0
73508|NCT01656850|175570|P2|COMPLETED|Second Intervention (3 Months)||16
73509|NCT01656850|175571|P1|COMPLETED|Second Intervention (3 Months)||17
73510|NCT01656850|175570|P2|STARTED|Second Intervention (3 Months)||16
73511|NCT01656850|175571|P1|STARTED|Second Intervention (3 Months)||17
73512|NCT01656850|175570|P2|NOT COMPLETED|Washout (2 Weeks)||0
73513|NCT01656850|175571|P1|NOT COMPLETED|Washout (2 Weeks)||0
73514|NCT01656850|175570|P2|COMPLETED|Washout (2 Weeks)||16
73515|NCT01656850|175571|P1|COMPLETED|Washout (2 Weeks)||17
73516|NCT01656850|175570|P2|STARTED|Washout (2 Weeks)||16
73517|NCT01656850|175571|P1|STARTED|Washout (2 Weeks)||17
73518|NCT01656850|175570|P2|NOT COMPLETED|First Intervention (3 Months)||4
73519|NCT01656850|175571|P1|NOT COMPLETED|First Intervention (3 Months)||3
73520|NCT01656850|175570|P2|COMPLETED|First Intervention (3 Months)||16
73521|NCT01656850|175571|P1|COMPLETED|First Intervention (3 Months)||17
73522|NCT01656850|175570|P2|STARTED|First Intervention (3 Months)||20
73523|NCT01656850|175571|P1|STARTED|First Intervention (3 Months)||20
73524|NCT01656772|175651|P2|NOT COMPLETED|Overall Study||0
73525|NCT01656772|175652|P1|NOT COMPLETED|Overall Study||0
73526|NCT01656772|175651|P2|COMPLETED|Overall Study||77
73527|NCT01656772|175652|P1|COMPLETED|Overall Study||43
73528|NCT01656772|175651|P2|STARTED|Overall Study||77
73529|NCT01656772|175652|P1|STARTED|Overall Study||43
73530|NCT01656759|175662|P2|NOT COMPLETED|Overall Study||3
73531|NCT01656759|175663|P1|NOT COMPLETED|Overall Study||2
73532|NCT01656759|175662|P2|COMPLETED|Overall Study||22
73533|NCT01656759|175663|P1|COMPLETED|Overall Study||25
73534|NCT01656759|175662|P2|STARTED|Overall Study||25
73535|NCT01656759|175663|P1|STARTED|Overall Study||27
73536|NCT01656486|175675|P1|NOT COMPLETED|Overall Study||0
73537|NCT01656486|175675|P1|COMPLETED|Overall Study||1
73538|NCT01656486|175675|P1|STARTED|Overall Study||1
73539|NCT01656460|175679|P4|NOT COMPLETED|Overall Study||0
73540|NCT01656460|175680|P3|NOT COMPLETED|Overall Study||0
73541|NCT01656460|175681|P2|NOT COMPLETED|Overall Study||0
73542|NCT01656460|175682|P1|NOT COMPLETED|Overall Study||0
73543|NCT01656460|175679|P4|COMPLETED|Overall Study||3
73544|NCT01656460|175680|P3|COMPLETED|Overall Study||3
73545|NCT01656460|175681|P2|COMPLETED|Overall Study||3
73546|NCT01656460|175682|P1|COMPLETED|Overall Study||3
73547|NCT01656460|175679|P4|STARTED|Overall Study||3
73548|NCT01656460|175680|P3|STARTED|Overall Study||3
73549|NCT01656460|175681|P2|STARTED|Overall Study||3
73550|NCT01656460|175682|P1|STARTED|Overall Study||3
73551|NCT01656434|175694|P2|NOT COMPLETED|Overall Study||580
73552|NCT01656434|175695|P1|NOT COMPLETED|Overall Study||2401
73553|NCT01656434|175694|P2|COMPLETED|Overall Study||40
73554|NCT01656434|175695|P1|COMPLETED|Overall Study||152
73555|NCT01656434|175694|P2|Treated|Overall Study||604
73556|NCT01656434|175695|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
73557|NCT01656434|175694|P2|STARTED|Overall Study||620
73558|NCT01656434|175695|P1|STARTED|Overall Study||2553
73559|NCT01656408|175721|P10|NOT COMPLETED|Overall Study||3
73560|NCT01656408|175722|P9|NOT COMPLETED|Overall Study||2
73561|NCT01656408|175723|P8|NOT COMPLETED|Overall Study||1
73562|NCT01656408|175724|P7|NOT COMPLETED|Overall Study||1
73563|NCT01656408|175725|P6|NOT COMPLETED|Overall Study||2
73564|NCT01656408|175726|P5|NOT COMPLETED|Overall Study||1
73565|NCT01656408|175727|P4|NOT COMPLETED|Overall Study||0
73566|NCT01656408|175728|P3|NOT COMPLETED|Overall Study||2
73567|NCT01656408|175729|P2|NOT COMPLETED|Overall Study||0
73568|NCT01656408|175730|P1|NOT COMPLETED|Overall Study||1
73569|NCT01656408|175721|P10|COMPLETED|Overall Study||15
73570|NCT01656408|175722|P9|COMPLETED|Overall Study||16
73571|NCT01656408|175723|P8|COMPLETED|Overall Study||7
73572|NCT01656408|175724|P7|COMPLETED|Overall Study||9
73573|NCT01656408|175725|P6|COMPLETED|Overall Study||7
73574|NCT01656408|175726|P5|COMPLETED|Overall Study||8
73575|NCT01656408|175727|P4|COMPLETED|Overall Study||7
73576|NCT01656408|175728|P3|COMPLETED|Overall Study||6
73577|NCT01656408|175729|P2|COMPLETED|Overall Study||8
73578|NCT01656408|175730|P1|COMPLETED|Overall Study||7
73579|NCT01656408|175721|P10|STARTED|Overall Study||18
73580|NCT01656408|175722|P9|STARTED|Overall Study||18
73581|NCT01656408|175723|P8|STARTED|Overall Study||8
73582|NCT01656408|175724|P7|STARTED|Overall Study||10
73583|NCT01656408|175725|P6|STARTED|Overall Study||9
73584|NCT01656408|175726|P5|STARTED|Overall Study||9
73585|NCT01656408|175727|P4|STARTED|Overall Study||7
73586|NCT01656408|175728|P3|STARTED|Overall Study||8
73587|NCT01656408|175729|P2|STARTED|Overall Study||8
73588|NCT01656408|175730|P1|STARTED|Overall Study||8
73589|NCT01656304|175919|P1|NOT COMPLETED|Overall Study||1
73590|NCT01656304|175919|P1|COMPLETED|Overall Study||15
73591|NCT01656304|175919|P1|STARTED|Overall Study||16
73592|NCT01656252|175925|P1|NOT COMPLETED|Phase II||0
73593|NCT01656252|175925|P1|COMPLETED|Phase II||0
73594|NCT01656252|175925|P1|STARTED|Phase II||0
73595|NCT01656252|175925|P1|NOT COMPLETED|Phase I||0
73596|NCT01656252|175925|P1|COMPLETED|Phase I||14
73597|NCT01656252|175925|P1|STARTED|Phase I||14
73598|NCT01656161|175957|P1|NOT COMPLETED|Overall Study||7
73599|NCT01656161|175957|P1|COMPLETED|Overall Study|Per protocol analysis set|113
73600|NCT01656161|175957|P1|Received Triptorelin at Day 169|Overall Study||115
73601|NCT01656161|175957|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
73602|NCT01656161|175957|P1|STARTED|Overall Study|Intention to treat analysis set|120
73603|NCT01656031|175971|P1|NOT COMPLETED|Overall Study||0
73604|NCT01656031|175971|P1|COMPLETED|Overall Study||39
73605|NCT01656031|175971|P1|STARTED|Overall Study||39
73606|NCT01655719|175975|P1|NOT COMPLETED|Overall Study||0
73607|NCT01655719|175975|P1|COMPLETED|Overall Study||1
73608|NCT01655719|175975|P1|STARTED|Overall Study||1
73609|NCT01655498|175981|P1|NOT COMPLETED|Overall Study||5
73610|NCT01655498|175981|P1|COMPLETED|Overall Study||56
73611|NCT01655498|175981|P1|STARTED|Overall Study||61
73612|NCT01655381|175988|P1|NOT COMPLETED|Overall Study||3
73613|NCT01655381|175988|P1|COMPLETED|Overall Study||12
73614|NCT01655381|175988|P1|STARTED|Overall Study||15
73615|NCT01655329|176008|P1|NOT COMPLETED|Overall Study||0
73616|NCT01655329|176008|P1|COMPLETED|Overall Study||10
73617|NCT01655329|176008|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
73618|NCT01655069|176028|P4|NOT COMPLETED|Overall Study||4
73619|NCT01655069|176029|P3|NOT COMPLETED|Overall Study||2
73620|NCT01655069|176030|P2|NOT COMPLETED|Overall Study||12
73621|NCT01655069|176031|P1|NOT COMPLETED|Overall Study||8
73622|NCT01655069|176028|P4|COMPLETED|Overall Study||11
73623|NCT01655069|176029|P3|COMPLETED|Overall Study||12
73624|NCT01655069|176030|P2|COMPLETED|Overall Study||46
73625|NCT01655069|176031|P1|COMPLETED|Overall Study||53
73626|NCT01655069|176028|P4|Full Analysis Set (FAS)|Overall Study||15
73627|NCT01655069|176029|P3|Full Analysis Set (FAS)|Overall Study||14
73628|NCT01655069|176030|P2|Full Analysis Set (FAS)|Overall Study||57
73629|NCT01655069|176031|P1|Full Analysis Set (FAS)|Overall Study||60
73630|NCT01655069|176028|P4|Safety Analysis Set (SAF)|Overall Study||15
73631|NCT01655069|176029|P3|Safety Analysis Set (SAF)|Overall Study||14
73632|NCT01655069|176030|P2|Safety Analysis Set (SAF)|Overall Study||57
73633|NCT01655069|176031|P1|Safety Analysis Set (SAF)|Overall Study||61
73634|NCT01655069|176028|P4|STARTED|Overall Study||15
73635|NCT01655069|176029|P3|STARTED|Overall Study||14
73636|NCT01655069|176030|P2|STARTED|Overall Study||58
73637|NCT01655069|176031|P1|STARTED|Overall Study||61
73638|NCT01655043|176046|P1|NOT COMPLETED|Overall Study||0
73639|NCT01655043|176046|P1|COMPLETED|Overall Study||20
73640|NCT01655043|176046|P1|STARTED|Overall Study||20
73641|NCT01654887|176052|P2|NOT COMPLETED|Overall Study||0
73642|NCT01654887|176053|P1|NOT COMPLETED|Overall Study||0
73643|NCT01654887|176052|P2|COMPLETED|Overall Study||88
73644|NCT01654887|176053|P1|COMPLETED|Overall Study||103
73645|NCT01654887|176052|P2|STARTED|Overall Study||88
73646|NCT01654887|176053|P1|STARTED|Overall Study||103
73647|NCT01654861|176069|P1|NOT COMPLETED|Overall Study||0
73648|NCT01654861|176069|P1|COMPLETED|Overall Study||3
73649|NCT01654861|176069|P1|STARTED|Overall Study||3
73650|NCT01654796|176077|P3|NOT COMPLETED|Overall Study||1
73651|NCT01654796|176078|P2|NOT COMPLETED|Overall Study||3
73652|NCT01654796|176079|P1|NOT COMPLETED|Overall Study||1
73653|NCT01654796|176077|P3|COMPLETED|Overall Study||28
73654|NCT01654796|176078|P2|COMPLETED|Overall Study||26
73655|NCT01654796|176079|P1|COMPLETED|Overall Study||25
73656|NCT01654796|176077|P3|STARTED|Overall Study||29
73657|NCT01654796|176078|P2|STARTED|Overall Study||29
73658|NCT01654796|176079|P1|STARTED|Overall Study||26
73659|NCT01654666|176091|P3|NOT COMPLETED|Overall Study||14
73660|NCT01654666|176092|P2|NOT COMPLETED|Overall Study||13
73661|NCT01654666|176093|P1|NOT COMPLETED|Overall Study||15
73662|NCT01654666|176091|P3|COMPLETED|Overall Study||49
73663|NCT01654666|176092|P2|COMPLETED|Overall Study||50
73664|NCT01654666|176093|P1|COMPLETED|Overall Study||48
73665|NCT01654666|176091|P3|Primary Analysis|Overall Study||54
73666|NCT01654666|176092|P2|Primary Analysis|Overall Study||56
73667|NCT01654666|176093|P1|Primary Analysis|Overall Study||52
73668|NCT01654666|176091|P3|STARTED|Overall Study||63
73669|NCT01654666|176092|P2|STARTED|Overall Study||63
73670|NCT01654666|176093|P1|STARTED|Overall Study||63
73671|NCT01654601|176118|P2|NOT COMPLETED|2nd Administration||1
73672|NCT01654601|176119|P1|NOT COMPLETED|2nd Administration||1
73673|NCT01654601|176118|P2|COMPLETED|2nd Administration||11
73674|NCT01654601|176119|P1|COMPLETED|2nd Administration||11
73675|NCT01654601|176118|P2|STARTED|2nd Administration||12
73676|NCT01654601|176119|P1|STARTED|2nd Administration||12
73677|NCT01654601|176118|P2|NOT COMPLETED|1st Administration||2
73678|NCT01654601|176119|P1|NOT COMPLETED|1st Administration||2
73679|NCT01654601|176118|P2|COMPLETED|1st Administration||12
73680|NCT01654601|176119|P1|COMPLETED|1st Administration||12
73681|NCT01654601|176118|P2|STARTED|1st Administration||14
73682|NCT01654601|176119|P1|STARTED|1st Administration||14
73683|NCT01654549|176133|P2|NOT COMPLETED|Overall Study||1
73684|NCT01654549|176134|P1|NOT COMPLETED|Overall Study||0
73685|NCT01654549|176133|P2|COMPLETED|Overall Study||19
73686|NCT01654549|176134|P1|COMPLETED|Overall Study||20
73687|NCT01654549|176133|P2|STARTED|Overall Study||20
73688|NCT01654549|176134|P1|STARTED|Overall Study||20
73689|NCT01654536|176146|P2|NOT COMPLETED|Overall Study||38
73690|NCT01654536|176147|P1|NOT COMPLETED|Overall Study||44
73691|NCT01654536|176146|P2|COMPLETED|Overall Study||331
73692|NCT01654536|176147|P1|COMPLETED|Overall Study||324
73693|NCT01654536|176146|P2|STARTED|Overall Study||369
73694|NCT01654536|176147|P1|STARTED|Overall Study||368
73695|NCT01654523|176183|P1|NOT COMPLETED|Overall Study||1
73696|NCT01654523|176183|P1|COMPLETED|Overall Study||19
73697|NCT01654523|176183|P1|STARTED|Overall Study||20
73698|NCT01654302|176189|P2|NOT COMPLETED|Second Intervention (Day 7)||1
73699|NCT01654302|176190|P1|NOT COMPLETED|Second Intervention (Day 7)||1
73700|NCT01654302|176189|P2|COMPLETED|Second Intervention (Day 7)||19
73701|NCT01654302|176190|P1|COMPLETED|Second Intervention (Day 7)||19
73702|NCT01654302|176189|P2|STARTED|Second Intervention (Day 7)||20
73703|NCT01654302|176190|P1|STARTED|Second Intervention (Day 7)||20
73704|NCT01654302|176189|P2|NOT COMPLETED|First Intervention (Day 1)||0
73705|NCT01654302|176190|P1|NOT COMPLETED|First Intervention (Day 1)||0
73706|NCT01654302|176189|P2|COMPLETED|First Intervention (Day 1)||20
73707|NCT01654302|176190|P1|COMPLETED|First Intervention (Day 1)||20
73708|NCT01654302|176189|P2|STARTED|First Intervention (Day 1)||20
73709|NCT01654302|176190|P1|STARTED|First Intervention (Day 1)||20
73710|NCT01654276|176196|P1|NOT COMPLETED|Overall Study||6
73711|NCT01654276|176196|P1|COMPLETED|Overall Study||18
73712|NCT01654276|176196|P1|Visit 4 (6months)|Overall Study||18
73713|NCT01654276|176196|P1|Visit 3 (4 Months)|Overall Study||18
73714|NCT01654276|176196|P1|Visit 2 (2 Months)|Overall Study||19
73715|NCT01654276|176196|P1|STARTED|Overall Study||24
73716|NCT01654263|176220|P6|NOT COMPLETED|Overall Study||1
73717|NCT01654263|176221|P5|NOT COMPLETED|Overall Study||1
73718|NCT01654263|176222|P4|NOT COMPLETED|Overall Study||1
73719|NCT01654263|176223|P3|NOT COMPLETED|Overall Study||2
73720|NCT01654263|176224|P2|NOT COMPLETED|Overall Study||0
73721|NCT01654263|176225|P1|NOT COMPLETED|Overall Study||0
73722|NCT01654263|176220|P6|COMPLETED|Overall Study||148
73723|NCT01654263|176221|P5|COMPLETED|Overall Study||139
73724|NCT01654263|176222|P4|COMPLETED|Overall Study||144
73725|NCT01654263|176223|P3|COMPLETED|Overall Study||137
73726|NCT01654263|176224|P2|COMPLETED|Overall Study||147
73727|NCT01654263|176225|P1|COMPLETED|Overall Study||164
73728|NCT01654263|176220|P6|STARTED|Overall Study||149
73729|NCT01654263|176221|P5|STARTED|Overall Study||140
73730|NCT01654263|176222|P4|STARTED|Overall Study||145
73731|NCT01654263|176223|P3|STARTED|Overall Study||139
73732|NCT01654263|176224|P2|STARTED|Overall Study||147
73733|NCT01654263|176225|P1|STARTED|Overall Study||164
73734|NCT01654250|176250|P2|NOT COMPLETED|Overall Study||0
73735|NCT01654250|176251|P1|NOT COMPLETED|Overall Study||1
73736|NCT01654250|176250|P2|COMPLETED|Overall Study||42
73737|NCT01654250|176251|P1|COMPLETED|Overall Study||43
73738|NCT01654250|176250|P2|STARTED|Overall Study||42
73739|NCT01654250|176251|P1|STARTED|Overall Study||44
73740|NCT01654224|176268|P2|NOT COMPLETED|Overall Study||12
73741|NCT01654224|176269|P1|NOT COMPLETED|Overall Study||6
73742|NCT01654224|176268|P2|COMPLETED|Overall Study||98
73743|NCT01654224|176269|P1|COMPLETED|Overall Study||89
73744|NCT01654224|176268|P2|STARTED|Overall Study||110
73745|NCT01654224|176269|P1|STARTED|Overall Study||95
73746|NCT01654107|176281|P2|NOT COMPLETED|Overall Study||8
73747|NCT01654107|176282|P1|NOT COMPLETED|Overall Study||3
73748|NCT01654107|176281|P2|COMPLETED|Overall Study||22
73749|NCT01654107|176282|P1|COMPLETED|Overall Study||25
73750|NCT01654107|176281|P2|STARTED|Overall Study||30
73751|NCT01654107|176282|P1|STARTED|Overall Study||28
73752|NCT01653964|176288|P1|NOT COMPLETED|Overall Study||0
73753|NCT01653964|176288|P1|COMPLETED|Overall Study||82
73754|NCT01653964|176288|P1|STARTED|Overall Study||82
73755|NCT01653912|176294|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
73756|NCT01653912|176295|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
73757|NCT01653912|176296|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
73758|NCT01653912|176297|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
73759|NCT01653912|176298|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
73760|NCT01653912|176299|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
73761|NCT01653912|176294|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
73762|NCT01653912|176295|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
73763|NCT01653912|176296|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
73764|NCT01653912|176297|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
73765|NCT01653912|176298|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
73766|NCT01653912|176299|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
73767|NCT01653912|176294|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
73768|NCT01653912|176295|P5|STARTED|Phase 2: GSK2110183 125 mg||0
73769|NCT01653912|176296|P4|STARTED|Phase 2: GSK2110183 125 mg||0
73770|NCT01653912|176297|P3|STARTED|Phase 2: GSK2110183 125 mg||0
73771|NCT01653912|176298|P2|STARTED|Phase 2: GSK2110183 125 mg||0
73772|NCT01653912|176299|P1|STARTED|Phase 2: GSK2110183 125 mg||0
73773|NCT01653912|176294|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73774|NCT01653912|176295|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73775|NCT01653912|176296|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73776|NCT01653912|176297|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73777|NCT01653912|176298|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73778|NCT01653912|176299|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73779|NCT01653912|176294|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73780|NCT01653912|176295|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
73781|NCT01653912|176296|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73782|NCT01653912|176297|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73783|NCT01653912|176298|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73784|NCT01653912|176299|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73785|NCT01653912|176294|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73786|NCT01653912|176295|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
73787|NCT01653912|176296|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73788|NCT01653912|176297|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73789|NCT01653912|176298|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73790|NCT01653912|176299|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
73791|NCT01653912|176294|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73792|NCT01653912|176295|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73793|NCT01653912|176296|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
73794|NCT01653912|176297|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73795|NCT01653912|176298|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73796|NCT01653912|176299|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73797|NCT01653912|176294|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73798|NCT01653912|176295|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73799|NCT01653912|176296|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
73800|NCT01653912|176297|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73801|NCT01653912|176298|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73802|NCT01653912|176299|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73803|NCT01653912|176294|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73804|NCT01653912|176295|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73805|NCT01653912|176296|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
73806|NCT01653912|176297|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73807|NCT01653912|176298|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73808|NCT01653912|176299|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
73809|NCT01653912|176294|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73810|NCT01653912|176295|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73811|NCT01653912|176296|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73812|NCT01653912|176297|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
73813|NCT01653912|176298|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73814|NCT01653912|176299|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73815|NCT01653912|176294|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73816|NCT01653912|176295|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73817|NCT01653912|176296|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73818|NCT01653912|176297|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
73819|NCT01653912|176298|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73820|NCT01653912|176299|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73821|NCT01653912|176294|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73822|NCT01653912|176295|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73823|NCT01653912|176296|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73824|NCT01653912|176297|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
73825|NCT01653912|176298|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73826|NCT01653912|176299|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
73827|NCT01653912|176294|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73828|NCT01653912|176295|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73829|NCT01653912|176296|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73830|NCT01653912|176297|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73831|NCT01653912|176298|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
73832|NCT01653912|176299|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73833|NCT01653912|176294|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73834|NCT01653912|176295|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73835|NCT01653912|176296|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73836|NCT01653912|176297|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73837|NCT01653912|176298|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
73838|NCT01653912|176299|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73839|NCT01653912|176294|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73840|NCT01653912|176295|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73841|NCT01653912|176296|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73842|NCT01653912|176297|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73843|NCT01653912|176298|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
73844|NCT01653912|176299|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
73845|NCT01653912|176294|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73846|NCT01653912|176295|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73847|NCT01653912|176296|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73848|NCT01653912|176297|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73849|NCT01653912|176298|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73850|NCT01653912|176299|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73851|NCT01653912|176294|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73852|NCT01653912|176295|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73853|NCT01653912|176296|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73854|NCT01653912|176297|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73855|NCT01653912|176298|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73856|NCT01653912|176299|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
73857|NCT01653912|176294|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73858|NCT01653912|176295|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73859|NCT01653912|176296|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73860|NCT01653912|176297|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73861|NCT01653912|176298|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
73862|NCT01653912|176299|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
73863|NCT01653782|176317|P3|NOT COMPLETED|Overall Study||6
73864|NCT01653782|176318|P2|NOT COMPLETED|Overall Study||18
73865|NCT01653782|176319|P1|NOT COMPLETED|Overall Study||16
73866|NCT01653782|176317|P3|COMPLETED|Overall Study||46
73867|NCT01653782|176318|P2|COMPLETED|Overall Study||37
73868|NCT01653782|176319|P1|COMPLETED|Overall Study||36
73869|NCT01653782|176317|P3|STARTED|Overall Study||52
73870|NCT01653782|176318|P2|STARTED|Overall Study||55
73871|NCT01653782|176319|P1|STARTED|Overall Study||52
73872|NCT01653743|176329|P2|NOT COMPLETED|Overall Study||0
73873|NCT01653743|176330|P1|NOT COMPLETED|Overall Study||4
73874|NCT01653743|176329|P2|COMPLETED|Overall Study||27
73875|NCT01653743|176330|P1|COMPLETED|Overall Study||50
73876|NCT01653743|176329|P2|STARTED|Overall Study||27
73877|NCT01653743|176330|P1|STARTED|Overall Study||54
73878|NCT01653509|176346|P2|NOT COMPLETED|Overall Study||0
73879|NCT01653509|176347|P1|NOT COMPLETED|Overall Study||0
73880|NCT01653509|176346|P2|COMPLETED|Overall Study||13
73881|NCT01653509|176347|P1|COMPLETED|Overall Study||12
73882|NCT01653509|176346|P2|STARTED|Overall Study||13
73883|NCT01653509|176347|P1|STARTED|Overall Study||12
73884|NCT01653418|176365|P1|NOT COMPLETED|Overall Study||0
73885|NCT01653418|176365|P1|COMPLETED|Overall Study||10
73886|NCT01653418|176365|P1|STARTED|Overall Study||10
73887|NCT01653262|176377|P1|NOT COMPLETED|Overall Study||3
73888|NCT01653262|176377|P1|COMPLETED|Overall Study||26
73889|NCT01653262|176377|P1|STARTED|Overall Study||29
73890|NCT01653158|176390|P8|NOT COMPLETED|Overall Study||15
73891|NCT01653158|176391|P7|NOT COMPLETED|Overall Study||2
73892|NCT01653158|176392|P6|NOT COMPLETED|Overall Study||1
73893|NCT01653158|176393|P5|NOT COMPLETED|Overall Study||1
73894|NCT01653158|176394|P4|NOT COMPLETED|Overall Study||2
73895|NCT01653158|176395|P3|NOT COMPLETED|Overall Study||0
73896|NCT01653158|176396|P2|NOT COMPLETED|Overall Study||0
73897|NCT01653158|176397|P1|NOT COMPLETED|Overall Study||1
73898|NCT01653158|176390|P8|COMPLETED|Overall Study||4
73899|NCT01653158|176391|P7|COMPLETED|Overall Study||7
73900|NCT01653158|176392|P6|COMPLETED|Overall Study||2
73901|NCT01653158|176393|P5|COMPLETED|Overall Study||2
73902|NCT01653158|176394|P4|COMPLETED|Overall Study||1
73903|NCT01653158|176395|P3|COMPLETED|Overall Study||3
73904|NCT01653158|176396|P2|COMPLETED|Overall Study||3
73905|NCT01653158|176397|P1|COMPLETED|Overall Study||2
73906|NCT01653158|176390|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
73907|NCT01653158|176391|P7|STARTED|Overall Study||9
73908|NCT01653158|176392|P6|STARTED|Overall Study||3
73909|NCT01653158|176393|P5|STARTED|Overall Study||3
73910|NCT01653158|176394|P4|STARTED|Overall Study||3
73911|NCT01653158|176395|P3|STARTED|Overall Study||3
73912|NCT01653158|176396|P2|STARTED|Overall Study||3
73913|NCT01653158|176397|P1|STARTED|Overall Study||3
73914|NCT01653132|176669|P2|NOT COMPLETED|Second Intervention||0
73915|NCT01653132|176670|P1|NOT COMPLETED|Second Intervention||0
73916|NCT01653132|176669|P2|COMPLETED|Second Intervention||5
73917|NCT01653132|176670|P1|COMPLETED|Second Intervention||4
73918|NCT01653132|176669|P2|STARTED|Second Intervention||5
73919|NCT01653132|176670|P1|STARTED|Second Intervention||4
73920|NCT01653132|176669|P2|NOT COMPLETED|Washout 1-2 Months||0
73921|NCT01653132|176670|P1|NOT COMPLETED|Washout 1-2 Months||0
73922|NCT01653132|176669|P2|COMPLETED|Washout 1-2 Months||5
73923|NCT01653132|176670|P1|COMPLETED|Washout 1-2 Months||4
73924|NCT01653132|176669|P2|STARTED|Washout 1-2 Months||5
73925|NCT01653132|176670|P1|STARTED|Washout 1-2 Months||4
73926|NCT01653132|176669|P2|NOT COMPLETED|First Intervention||0
73927|NCT01653132|176670|P1|NOT COMPLETED|First Intervention||1
73928|NCT01653132|176669|P2|COMPLETED|First Intervention||5
73929|NCT01653132|176670|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
73930|NCT01653132|176669|P2|STARTED|First Intervention||5
73931|NCT01653132|176670|P1|STARTED|First Intervention||5
73932|NCT01653028|176689|P5|NOT COMPLETED|Overall Study||0
73933|NCT01653028|176690|P4|NOT COMPLETED|Overall Study||0
73934|NCT01653028|176691|P3|NOT COMPLETED|Overall Study||0
73935|NCT01653028|176692|P2|NOT COMPLETED|Overall Study||0
73936|NCT01653028|176693|P1|NOT COMPLETED|Overall Study||0
73937|NCT01653028|176689|P5|COMPLETED|Overall Study||29
73938|NCT01653028|176690|P4|COMPLETED|Overall Study||10
73939|NCT01653028|176691|P3|COMPLETED|Overall Study||11
73940|NCT01653028|176692|P2|COMPLETED|Overall Study||10
73941|NCT01653028|176693|P1|COMPLETED|Overall Study||12
73942|NCT01653028|176689|P5|STARTED|Overall Study||29
73943|NCT01653028|176690|P4|STARTED|Overall Study||10
73944|NCT01653028|176691|P3|STARTED|Overall Study||11
73945|NCT01653028|176692|P2|STARTED|Overall Study||10
73946|NCT01653028|176693|P1|STARTED|Overall Study||12
73947|NCT01652885|176720|P1|NOT COMPLETED|Overall Study||1
73948|NCT01652885|176720|P1|COMPLETED|Overall Study||22
73949|NCT01652885|176720|P1|STARTED|Overall Study||23
73950|NCT01652729|176748|P3|NOT COMPLETED|Overall Study||14
73951|NCT01652729|176749|P2|NOT COMPLETED|Overall Study||13
73952|NCT01652729|176750|P1|NOT COMPLETED|Overall Study||27
73953|NCT01652729|176748|P3|COMPLETED|Overall Study||47
73954|NCT01652729|176749|P2|COMPLETED|Overall Study||109
73955|NCT01652729|176750|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
73956|NCT01652729|176748|P3|Meal Test Evaluable|Overall Study||15
73957|NCT01652729|176749|P2|Meal Test Evaluable|Overall Study||31
73958|NCT01652729|176750|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
73959|NCT01652729|176748|P3|Meal Test Subjects|Overall Study||20
73960|NCT01652729|176749|P2|Meal Test Subjects|Overall Study||41
73961|NCT01652729|176750|P1|Meal Test Subjects|Overall Study||60
73962|NCT01652729|176748|P3|Evaluable|Overall Study||43
73963|NCT01652729|176749|P2|Evaluable|Overall Study||91
73964|NCT01652729|176750|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
73965|NCT01652729|176748|P3|Treated|Overall Study||61
73966|NCT01652729|176749|P2|Treated|Overall Study||122
73967|NCT01652729|176750|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
73968|NCT01652729|176748|P3|Modified Intent-to-Treat|Overall Study||61
73969|NCT01652729|176749|P2|Modified Intent-to-Treat|Overall Study||122
73970|NCT01652729|176750|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
73971|NCT01652729|176748|P3|STARTED|Overall Study||61
73972|NCT01652729|176749|P2|STARTED|Overall Study||122
73973|NCT01652729|176750|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
73974|NCT01652716|176772|P2|NOT COMPLETED|Overall Study||46
73975|NCT01652716|176773|P1|NOT COMPLETED|Overall Study||56
73976|NCT01652716|176772|P2|COMPLETED|Overall Study|* completed study|102
73977|NCT01652716|176773|P1|COMPLETED|Overall Study|* completed study|173
73978|NCT01652716|176772|P2|Completed 28-week|Overall Study||118
73979|NCT01652716|176773|P1|Completed 28-week|Overall Study||197
73980|NCT01652716|176772|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
73981|NCT01652716|176773|P1|STARTED|Overall Study||229
73982|NCT01652703|176793|P6|NOT COMPLETED|Overall Study||2
73983|NCT01652703|176794|P5|NOT COMPLETED|Overall Study||1
73984|NCT01652703|176795|P4|NOT COMPLETED|Overall Study||2
73985|NCT01652703|176796|P3|NOT COMPLETED|Overall Study||3
73986|NCT01652703|176797|P2|NOT COMPLETED|Overall Study||1
73987|NCT01652703|176798|P1|NOT COMPLETED|Overall Study||0
73988|NCT01652703|176793|P6|COMPLETED|Overall Study||51
73989|NCT01652703|176794|P5|COMPLETED|Overall Study||51
73990|NCT01652703|176795|P4|COMPLETED|Overall Study||50
73991|NCT01652703|176796|P3|COMPLETED|Overall Study||47
73992|NCT01652703|176797|P2|COMPLETED|Overall Study||50
73993|NCT01652703|176798|P1|COMPLETED|Overall Study||52
73994|NCT01652703|176793|P6|Received Treatment|Overall Study||53
73995|NCT01652703|176794|P5|Received Treatment|Overall Study||51
73996|NCT01652703|176795|P4|Received Treatment|Overall Study||52
73997|NCT01652703|176796|P3|Received Treatment|Overall Study||49
73998|NCT01652703|176797|P2|Received Treatment|Overall Study||50
73999|NCT01652703|176798|P1|Received Treatment|Overall Study||52
74000|NCT01652703|176793|P6|STARTED|Overall Study||53
74001|NCT01652703|176794|P5|STARTED|Overall Study||52
74002|NCT01652703|176795|P4|STARTED|Overall Study||52
74003|NCT01652703|176796|P3|STARTED|Overall Study||50
74004|NCT01652703|176797|P2|STARTED|Overall Study||51
74005|NCT01652703|176798|P1|STARTED|Overall Study||52
74006|NCT01652690|176856|P2|NOT COMPLETED|Overall Study||21
74007|NCT01652690|176857|P1|NOT COMPLETED|Overall Study||35
74008|NCT01652690|176856|P2|COMPLETED|Overall Study||279
74009|NCT01652690|176857|P1|COMPLETED|Overall Study||265
74010|NCT01652690|176856|P2|STARTED|Overall Study||300
74011|NCT01652690|176857|P1|STARTED|Overall Study||300
74012|NCT01652664|176891|P2|NOT COMPLETED|Overall Study||1
74013|NCT01652664|176892|P1|NOT COMPLETED|Overall Study||6
74014|NCT01652664|176891|P2|COMPLETED|Overall Study||74
74015|NCT01652664|176892|P1|COMPLETED|Overall Study||71
74016|NCT01652664|176891|P2|STARTED|Overall Study||75
74017|NCT01652664|176892|P1|STARTED|Overall Study||77
74018|NCT01652573|176901|P2|NOT COMPLETED|Overall Study||1
74019|NCT01652573|176902|P1|NOT COMPLETED|Overall Study||0
74020|NCT01652573|176901|P2|COMPLETED|Overall Study||10
74021|NCT01652573|176902|P1|COMPLETED|Overall Study||10
74022|NCT01652573|176901|P2|STARTED|Overall Study||11
74023|NCT01652573|176902|P1|STARTED|Overall Study||10
74024|NCT01652495|176944|P2|NOT COMPLETED|Overall Study||2
74025|NCT01652495|176945|P1|NOT COMPLETED|Overall Study||2
74026|NCT01652495|176944|P2|COMPLETED|Overall Study||20
74027|NCT01652495|176945|P1|COMPLETED|Overall Study||20
74028|NCT01652495|176944|P2|STARTED|Overall Study||22
74029|NCT01652495|176945|P1|STARTED|Overall Study||22
74030|NCT01652287|176957|P2|NOT COMPLETED|Overall Study||0
74031|NCT01652287|176958|P1|NOT COMPLETED|Overall Study||2
74032|NCT01652287|176957|P2|COMPLETED|Overall Study||31
74033|NCT01652287|176958|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
74034|NCT01652287|176957|P2|STARTED|Overall Study||31
74035|NCT01652287|176958|P1|STARTED|Overall Study||31
74036|NCT01652040|176966|P2|NOT COMPLETED|Overall Study||2
74037|NCT01652040|176967|P1|NOT COMPLETED|Overall Study||2
74038|NCT01652040|176966|P2|COMPLETED|Overall Study||11
74039|NCT01652040|176967|P1|COMPLETED|Overall Study||11
74040|NCT01652040|176966|P2|STARTED|Overall Study||13
74041|NCT01652040|176967|P1|STARTED|Overall Study||13
74042|NCT01652001|176977|P2|NOT COMPLETED|Overall Study||6
74043|NCT01652001|176978|P1|NOT COMPLETED|Overall Study||9
74044|NCT01652001|176977|P2|COMPLETED|Overall Study||79
74045|NCT01652001|176978|P1|COMPLETED|Overall Study||91
74046|NCT01652001|176977|P2|STARTED|Overall Study||85
74047|NCT01652001|176978|P1|STARTED|Overall Study||100
74048|NCT01651949|176989|P3|NOT COMPLETED|Overall Study||31
74049|NCT01651949|176990|P2|NOT COMPLETED|Overall Study||86
74050|NCT01651949|176991|P1|NOT COMPLETED|Overall Study||53
74051|NCT01651949|176989|P3|COMPLETED|Overall Study||282
74052|NCT01651949|176990|P2|COMPLETED|Overall Study||1015
74053|NCT01651949|176991|P1|COMPLETED|Overall Study||1053
74054|NCT01651949|176989|P3|Vaccination 3|Overall Study||291
74055|NCT01651949|176990|P2|Vaccination 3|Overall Study||1037
74056|NCT01651949|176991|P1|Vaccination 3|Overall Study||1067
74057|NCT01651949|176989|P3|Vaccination 2|Overall Study||298
74058|NCT01651949|176990|P2|Vaccination 2|Overall Study||1069
74059|NCT01651949|176991|P1|Vaccination 2|Overall Study||1089
74060|NCT01651949|176989|P3|Vaccination 1|Overall Study||313
74061|NCT01651949|176990|P2|Vaccination 1|Overall Study||1099
74062|NCT01651949|176991|P1|Vaccination 1|Overall Study||1103
74063|NCT01651949|176989|P3|STARTED|Overall Study||313
74064|NCT01651949|176990|P2|STARTED|Overall Study||1101
74065|NCT01651949|176991|P1|STARTED|Overall Study||1106
74066|NCT01651936|177011|P3|NOT COMPLETED|Extension Study||14
74067|NCT01651936|177012|P2|NOT COMPLETED|Extension Study||0
74068|NCT01651936|177013|P1|NOT COMPLETED|Extension Study||0
74069|NCT01651936|177011|P3|COMPLETED|Extension Study||0
74070|NCT01651936|177012|P2|COMPLETED|Extension Study||0
74071|NCT01651936|177013|P1|COMPLETED|Extension Study||0
74072|NCT01651936|177011|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
74073|NCT01651936|177012|P2|STARTED|Extension Study||0
74074|NCT01651936|177013|P1|STARTED|Extension Study||0
74075|NCT01651936|177011|P3|NOT COMPLETED|Base Study||0
74076|NCT01651936|177012|P2|NOT COMPLETED|Base Study||25
74077|NCT01651936|177013|P1|NOT COMPLETED|Base Study||27
74078|NCT01651936|177011|P3|COMPLETED|Base Study||0
74079|NCT01651936|177012|P2|COMPLETED|Base Study||1
74080|NCT01651936|177013|P1|COMPLETED|Base Study||3
74081|NCT01651936|177011|P3|STARTED|Base Study||0
74082|NCT01651936|177012|P2|STARTED|Base Study||26
74083|NCT01651936|177013|P1|STARTED|Base Study||30
74084|NCT01651806|177039|P5|NOT COMPLETED|Overall Study||0
74085|NCT01651806|177040|P4|NOT COMPLETED|Overall Study||0
74086|NCT01651806|177041|P3|NOT COMPLETED|Overall Study||0
74087|NCT01651806|177042|P2|NOT COMPLETED|Overall Study||0
74088|NCT01651806|177043|P1|NOT COMPLETED|Overall Study||0
74089|NCT01651806|177039|P5|COMPLETED|Overall Study||8
74090|NCT01651806|177040|P4|COMPLETED|Overall Study||7
74091|NCT01651806|177041|P3|COMPLETED|Overall Study||25
74092|NCT01651806|177042|P2|COMPLETED|Overall Study||12
74093|NCT01651806|177043|P1|COMPLETED|Overall Study||13
74094|NCT01651806|177039|P5|STARTED|Overall Study||8
74095|NCT01651806|177040|P4|STARTED|Overall Study||7
74096|NCT01651806|177041|P3|STARTED|Overall Study||25
74097|NCT01651806|177042|P2|STARTED|Overall Study||12
74098|NCT01651806|177043|P1|STARTED|Overall Study||13
74099|NCT01651780|177062|P2|NOT COMPLETED|Overall Study||10
74100|NCT01651780|177063|P1|NOT COMPLETED|Overall Study||11
74101|NCT01651780|177062|P2|COMPLETED|Overall Study||388
74102|NCT01651780|177063|P1|COMPLETED|Overall Study||394
74103|NCT01651780|177062|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
74104|NCT01651780|177063|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
74105|NCT01651780|177062|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
74106|NCT01651780|177063|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
74107|NCT01651780|177062|P2|Intent-To-Treat (ITT) Population|Overall Study||398
74108|NCT01651780|177063|P1|Intent-To-Treat (ITT) Population|Overall Study||404
74109|NCT01651780|177062|P2|STARTED|Overall Study||398
74110|NCT01651780|177063|P1|STARTED|Overall Study||405
74111|NCT01651351|177095|P2|NOT COMPLETED|Overall Study||0
74112|NCT01651351|177096|P1|NOT COMPLETED|Overall Study||0
74113|NCT01651351|177095|P2|COMPLETED|Overall Study||15
74114|NCT01651351|177096|P1|COMPLETED|Overall Study||15
74115|NCT01651351|177095|P2|STARTED|Overall Study||15
74116|NCT01651351|177096|P1|STARTED|Overall Study||15
74117|NCT01651260|177113|P1|NOT COMPLETED|Overall Study||3
74118|NCT01651260|177113|P1|COMPLETED|Overall Study||62
74119|NCT01651260|177113|P1|STARTED|Overall Study||65
74120|NCT01651208|177120|P2|NOT COMPLETED|Overall Study||16
74121|NCT01651208|177121|P1|NOT COMPLETED|Overall Study||14
74122|NCT01651208|177120|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
74123|NCT01651208|177121|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
74124|NCT01651208|177120|P2|STARTED|Overall Study||225
74125|NCT01651208|177121|P1|STARTED|Overall Study||227
74126|NCT01651104|177129|P1|NOT COMPLETED|Overall Study||0
74127|NCT01651104|177129|P1|COMPLETED|Overall Study||63
74128|NCT01651104|177129|P1|STARTED|Overall Study||63
74129|NCT01651039|177136|P1|NOT COMPLETED|Overall Study||30
74130|NCT01651039|177136|P1|COMPLETED|Overall Study||2
74131|NCT01651039|177136|P1|STARTED|Overall Study||32
74132|NCT01651000|177149|P2|NOT COMPLETED|Overall Study||28
74133|NCT01651000|177150|P1|NOT COMPLETED|Overall Study||10
74134|NCT01651000|177149|P2|COMPLETED|Overall Study||113
74135|NCT01651000|177150|P1|COMPLETED|Overall Study||62
74136|NCT01651000|177149|P2|Entered Extension Study|Overall Study||93
74137|NCT01651000|177150|P1|Entered Extension Study|Overall Study||50
74138|NCT01651000|177149|P2|STARTED|Overall Study||141
74139|NCT01651000|177150|P1|STARTED|Overall Study||72
74140|NCT01650844|177164|P2|NOT COMPLETED|Overall Study||4
74141|NCT01650844|177165|P1|NOT COMPLETED|Overall Study||1
74142|NCT01650844|177164|P2|COMPLETED|Overall Study||196
74143|NCT01650844|177165|P1|COMPLETED|Overall Study||199
74144|NCT01650844|177164|P2|STARTED|Overall Study||200
74145|NCT01650844|177165|P1|STARTED|Overall Study||200
74146|NCT01650831|177171|P1|NOT COMPLETED|Overall Study||1
74147|NCT01650831|177171|P1|COMPLETED|Overall Study||112
74148|NCT01650831|177171|P1|STARTED|Overall Study||113
74149|NCT01650805|177181|P2|NOT COMPLETED|Overall Study||0
74150|NCT01650805|177182|P1|NOT COMPLETED|Overall Study||1
74151|NCT01650805|177181|P2|COMPLETED|Overall Study||152
74152|NCT01650805|177182|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
74153|NCT01650805|177181|P2|STARTED|Overall Study||152
74154|NCT01650805|177182|P1|STARTED|Overall Study|Started means patient has been randomized.|155
74155|NCT01650779|177192|P1|NOT COMPLETED|Overall Study||1
74156|NCT01650779|177192|P1|COMPLETED|Overall Study||14
74157|NCT01650779|177192|P1|STARTED|Overall Study||15
74158|NCT01650545|177201|P2|NOT COMPLETED|Overall Study||0
74159|NCT01650545|177202|P1|NOT COMPLETED|Overall Study||0
74160|NCT01650545|177201|P2|COMPLETED|Overall Study||10
74161|NCT01650545|177202|P1|COMPLETED|Overall Study||11
74162|NCT01650545|177201|P2|STARTED|Overall Study||10
74163|NCT01650545|177202|P1|STARTED|Overall Study||11
74164|NCT01650519|177214|P2|NOT COMPLETED|Overall Study||0
74165|NCT01650519|177215|P1|NOT COMPLETED|Overall Study||1
74166|NCT01650519|177214|P2|COMPLETED|Overall Study||31
74167|NCT01650519|177215|P1|COMPLETED|Overall Study||19
74168|NCT01650519|177214|P2|STARTED|Overall Study||31
74169|NCT01650519|177215|P1|STARTED|Overall Study||20
74170|NCT01650350|177233|P1|NOT COMPLETED|Overall Study||0
74171|NCT01650350|177233|P1|COMPLETED|Overall Study||7
74172|NCT01650350|177233|P1|STARTED|Overall Study||7
74173|NCT01650324|177243|P5|NOT COMPLETED|Overall Study||0
74174|NCT01650324|177244|P4|NOT COMPLETED|Overall Study||0
74175|NCT01650324|177245|P3|NOT COMPLETED|Overall Study||0
74176|NCT01650324|177246|P2|NOT COMPLETED|Overall Study||0
74177|NCT01650324|177247|P1|NOT COMPLETED|Overall Study||0
74178|NCT01650324|177243|P5|COMPLETED|Overall Study||6
74179|NCT01650324|177244|P4|COMPLETED|Overall Study||6
74180|NCT01650324|177245|P3|COMPLETED|Overall Study||6
74181|NCT01650324|177246|P2|COMPLETED|Overall Study||6
74182|NCT01650324|177247|P1|COMPLETED|Overall Study||8
74183|NCT01650324|177243|P5|STARTED|Overall Study||6
74184|NCT01650324|177244|P4|STARTED|Overall Study||6
74185|NCT01650324|177245|P3|STARTED|Overall Study||6
74186|NCT01650324|177246|P2|STARTED|Overall Study||6
74187|NCT01650324|177247|P1|STARTED|Overall Study||8
74188|NCT01650285|177276|P1|NOT COMPLETED|Overall Study||1
74189|NCT01650285|177276|P1|COMPLETED|Overall Study||4
74190|NCT01650285|177276|P1|STARTED|Overall Study||5
74191|NCT01650246|177281|P1|NOT COMPLETED|Overall Study||143
74192|NCT01650246|177281|P1|COMPLETED|Overall Study||0
74193|NCT01650246|177281|P1|STARTED|Overall Study||143
74194|NCT01649856|177288|P2|NOT COMPLETED|Overall Study||78
74195|NCT01649856|177289|P1|NOT COMPLETED|Overall Study||139
74196|NCT01649856|177288|P2|COMPLETED|Overall Study||125
74197|NCT01649856|177289|P1|COMPLETED|Overall Study||230
74198|NCT01649856|177288|P2|STARTED|Overall Study||203
74199|NCT01649856|177289|P1|STARTED|Overall Study||369
74200|NCT01649804|177321|P1|NOT COMPLETED|Overall Study||8
74201|NCT01649804|177321|P1|COMPLETED|Overall Study||4
74202|NCT01649804|177321|P1|STARTED|Overall Study||12
74203|NCT01649791|177333|P1|NOT COMPLETED|Overall Study||3
74204|NCT01649791|177333|P1|COMPLETED|Overall Study||5
74205|NCT01649791|177333|P1|STARTED|Overall Study||8
74206|NCT01649609|177342|P2|NOT COMPLETED|Overall Study||0
74207|NCT01649609|177343|P1|NOT COMPLETED|Overall Study||0
74208|NCT01649609|177342|P2|COMPLETED|Overall Study||20
74209|NCT01649609|177343|P1|COMPLETED|Overall Study||20
74210|NCT01649609|177342|P2|STARTED|Overall Study||20
74211|NCT01649609|177343|P1|STARTED|Overall Study||20
74212|NCT01649596|177353|P2|NOT COMPLETED|Overall Study||0
74213|NCT01649596|177354|P1|NOT COMPLETED|Overall Study||0
74214|NCT01649596|177353|P2|COMPLETED|Overall Study||48
74215|NCT01649596|177354|P1|COMPLETED|Overall Study||46
74216|NCT01649596|177353|P2|STARTED|Overall Study||48
74217|NCT01649596|177354|P1|STARTED|Overall Study||46
74218|NCT01649557|177365|P3|NOT COMPLETED|Overall Study||9
74219|NCT01649557|177366|P2|NOT COMPLETED|Overall Study||14
74220|NCT01649557|177367|P1|NOT COMPLETED|Overall Study||44
74221|NCT01649557|177365|P3|COMPLETED|Overall Study||15
74222|NCT01649557|177366|P2|COMPLETED|Overall Study||27
74223|NCT01649557|177367|P1|COMPLETED|Overall Study||135
74224|NCT01649557|177365|P3|52-week Enrollers|Overall Study||2
74225|NCT01649557|177366|P2|52-week Enrollers|Overall Study||6
74226|NCT01649557|177367|P1|52-week Enrollers|Overall Study||20
74227|NCT01649557|177365|P3|6-week Enrollers|Overall Study||22
74228|NCT01649557|177366|P2|6-week Enrollers|Overall Study||35
74229|NCT01649557|177367|P1|6-week Enrollers|Overall Study||159
74230|NCT01649557|177365|P3|STARTED|Overall Study||24
74231|NCT01649557|177366|P2|STARTED|Overall Study||41
74232|NCT01649557|177367|P1|STARTED|Overall Study||179
74233|NCT01649505|177404|P2|NOT COMPLETED|Overall Study||1
74234|NCT01649505|177405|P1|NOT COMPLETED|Overall Study||1
74235|NCT01649505|177404|P2|COMPLETED|Overall Study||0
74236|NCT01649505|177405|P1|COMPLETED|Overall Study||0
74237|NCT01649505|177404|P2|STARTED|Overall Study||1
74238|NCT01649505|177405|P1|STARTED|Overall Study||1
74239|NCT01649362|177413|P2|NOT COMPLETED|Overall Study||14
74240|NCT01649362|177414|P1|NOT COMPLETED|Overall Study||1
74241|NCT01649362|177413|P2|COMPLETED|Overall Study||40
74242|NCT01649362|177414|P1|COMPLETED|Overall Study||46
74243|NCT01649362|177413|P2|STARTED|Overall Study||54
74244|NCT01649362|177414|P1|STARTED|Overall Study||47
74245|NCT01649297|177429|P5|NOT COMPLETED|Overall Study||4
74246|NCT01649297|177430|P4|NOT COMPLETED|Overall Study||19
74247|NCT01649297|177431|P3|NOT COMPLETED|Overall Study||17
74248|NCT01649297|177432|P2|NOT COMPLETED|Overall Study||13
74249|NCT01649297|177433|P1|NOT COMPLETED|Overall Study||14
74250|NCT01649297|177429|P5|COMPLETED|Overall Study||103
74251|NCT01649297|177430|P4|COMPLETED|Overall Study||201
74252|NCT01649297|177431|P3|COMPLETED|Overall Study||202
74253|NCT01649297|177432|P2|COMPLETED|Overall Study||205
74254|NCT01649297|177433|P1|COMPLETED|Overall Study||205
74255|NCT01649297|177429|P5|STARTED|Overall Study|randomised|107
74256|NCT01649297|177430|P4|STARTED|Overall Study|randomised|220
74257|NCT01649297|177431|P3|STARTED|Overall Study|randomised|219
74258|NCT01649297|177432|P2|STARTED|Overall Study|randomised|218
74259|NCT01649297|177433|P1|STARTED|Overall Study|randomised|219
74260|NCT01649271|177452|P2|NOT COMPLETED|Overall Study||7
74261|NCT01649271|177453|P1|NOT COMPLETED|Overall Study||6
74262|NCT01649271|177452|P2|COMPLETED|Overall Study||0
74263|NCT01649271|177453|P1|COMPLETED|Overall Study||0
74264|NCT01649271|177452|P2|STARTED|Overall Study||7
74265|NCT01649271|177453|P1|STARTED|Overall Study||6
74266|NCT01649232|177468|P2|NOT COMPLETED|Overall Study||0
74267|NCT01649232|177469|P1|NOT COMPLETED|Overall Study||2
74268|NCT01649232|177468|P2|COMPLETED|Overall Study||30
74269|NCT01649232|177469|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
74270|NCT01649232|177468|P2|STARTED|Overall Study||30
74271|NCT01649232|177469|P1|STARTED|Overall Study||30
74272|NCT01649180|177489|P1|NOT COMPLETED|Overall Study||0
74273|NCT01649180|177489|P1|COMPLETED|Overall Study||3
74274|NCT01649180|177489|P1|STARTED|Overall Study||3
74275|NCT01648920|177497|P1|NOT COMPLETED|Overall Study||0
74276|NCT01648920|177497|P1|COMPLETED|Overall Study||50
74277|NCT01648920|177497|P1|STARTED|Overall Study||50
74278|NCT01648790|177521|P5|NOT COMPLETED|Treatment 5||0
74279|NCT01648790|177522|P4|NOT COMPLETED|Treatment 5||0
74280|NCT01648790|177523|P3|NOT COMPLETED|Treatment 5||0
74281|NCT01648790|177524|P2|NOT COMPLETED|Treatment 5||0
74282|NCT01648790|177525|P1|NOT COMPLETED|Treatment 5||0
74283|NCT01648790|177521|P5|COMPLETED|Treatment 5||4
74284|NCT01648790|177522|P4|COMPLETED|Treatment 5||3
74285|NCT01648790|177523|P3|COMPLETED|Treatment 5||4
74286|NCT01648790|177524|P2|COMPLETED|Treatment 5||4
74287|NCT01648790|177525|P1|COMPLETED|Treatment 5||4
74288|NCT01648790|177521|P5|STARTED|Treatment 5||4
74289|NCT01648790|177522|P4|STARTED|Treatment 5||3
74290|NCT01648790|177523|P3|STARTED|Treatment 5||4
74291|NCT01648790|177524|P2|STARTED|Treatment 5||4
74292|NCT01648790|177525|P1|STARTED|Treatment 5||4
74293|NCT01648790|177521|P5|NOT COMPLETED|Treatment 4||0
74294|NCT01648790|177522|P4|NOT COMPLETED|Treatment 4||0
74295|NCT01648790|177523|P3|NOT COMPLETED|Treatment 4||0
74296|NCT01648790|177524|P2|NOT COMPLETED|Treatment 4||0
74297|NCT01648790|177525|P1|NOT COMPLETED|Treatment 4||0
74298|NCT01648790|177521|P5|COMPLETED|Treatment 4||4
74299|NCT01648790|177522|P4|COMPLETED|Treatment 4||3
74300|NCT01648790|177523|P3|COMPLETED|Treatment 4||4
74301|NCT01648790|177524|P2|COMPLETED|Treatment 4||4
74302|NCT01648790|177525|P1|COMPLETED|Treatment 4||4
74303|NCT01648790|177521|P5|STARTED|Treatment 4||4
74304|NCT01648790|177522|P4|STARTED|Treatment 4||3
74305|NCT01648790|177523|P3|STARTED|Treatment 4||4
74306|NCT01648790|177524|P2|STARTED|Treatment 4||4
74307|NCT01648790|177525|P1|STARTED|Treatment 4||4
74308|NCT01648790|177521|P5|NOT COMPLETED|Treatment 3||0
74309|NCT01648790|177522|P4|NOT COMPLETED|Treatment 3||1
74310|NCT01648790|177523|P3|NOT COMPLETED|Treatment 3||0
74311|NCT01648790|177524|P2|NOT COMPLETED|Treatment 3||0
74312|NCT01648790|177525|P1|NOT COMPLETED|Treatment 3||0
74313|NCT01648790|177521|P5|COMPLETED|Treatment 3||4
74314|NCT01648790|177522|P4|COMPLETED|Treatment 3||3
74315|NCT01648790|177523|P3|COMPLETED|Treatment 3||4
74316|NCT01648790|177524|P2|COMPLETED|Treatment 3||4
74317|NCT01648790|177525|P1|COMPLETED|Treatment 3||4
74318|NCT01648790|177521|P5|STARTED|Treatment 3||4
74319|NCT01648790|177522|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
74320|NCT01648790|177523|P3|STARTED|Treatment 3||4
74321|NCT01648790|177524|P2|STARTED|Treatment 3||4
74322|NCT01648790|177525|P1|STARTED|Treatment 3||4
74323|NCT01648790|177521|P5|NOT COMPLETED|Treatment 2||0
74324|NCT01648790|177522|P4|NOT COMPLETED|Treatment 2||0
74325|NCT01648790|177523|P3|NOT COMPLETED|Treatment 2||0
74326|NCT01648790|177524|P2|NOT COMPLETED|Treatment 2||0
74327|NCT01648790|177525|P1|NOT COMPLETED|Treatment 2||0
74328|NCT01648790|177521|P5|COMPLETED|Treatment 2||4
74329|NCT01648790|177522|P4|COMPLETED|Treatment 2||4
74330|NCT01648790|177523|P3|COMPLETED|Treatment 2||4
74331|NCT01648790|177524|P2|COMPLETED|Treatment 2||4
74332|NCT01648790|177525|P1|COMPLETED|Treatment 2||4
74333|NCT01648790|177521|P5|STARTED|Treatment 2||4
74334|NCT01648790|177522|P4|STARTED|Treatment 2||4
74335|NCT01648790|177523|P3|STARTED|Treatment 2||4
74336|NCT01648790|177524|P2|STARTED|Treatment 2||4
74337|NCT01648790|177525|P1|STARTED|Treatment 2||4
74338|NCT01648790|177521|P5|NOT COMPLETED|Treatment 1||0
74339|NCT01648790|177522|P4|NOT COMPLETED|Treatment 1||0
74340|NCT01648790|177523|P3|NOT COMPLETED|Treatment 1||0
74341|NCT01648790|177524|P2|NOT COMPLETED|Treatment 1||0
74342|NCT01648790|177525|P1|NOT COMPLETED|Treatment 1||0
74343|NCT01648790|177521|P5|COMPLETED|Treatment 1||4
74344|NCT01648790|177522|P4|COMPLETED|Treatment 1||4
74345|NCT01648790|177523|P3|COMPLETED|Treatment 1||4
74346|NCT01648790|177524|P2|COMPLETED|Treatment 1||4
74347|NCT01648790|177525|P1|COMPLETED|Treatment 1||4
74348|NCT01648790|177521|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
74349|NCT01648790|177522|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
74350|NCT01648790|177523|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
74351|NCT01648790|177524|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
74352|NCT01648790|177525|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
74353|NCT01648790|177521|P5|STARTED|Treatment 1||4
74354|NCT01648790|177522|P4|STARTED|Treatment 1||4
74355|NCT01648790|177523|P3|STARTED|Treatment 1||4
74356|NCT01648790|177524|P2|STARTED|Treatment 1||4
74357|NCT01648790|177525|P1|STARTED|Treatment 1||4
74358|NCT01648699|177546|P1|NOT COMPLETED|Overall Study||5
74359|NCT01648699|177546|P1|COMPLETED|Overall Study||15
74360|NCT01648699|177546|P1|STARTED|Overall Study||20
74361|NCT01648582|177575|P3|NOT COMPLETED|Overall Study||32
74362|NCT01648582|177576|P2|NOT COMPLETED|Overall Study||38
74363|NCT01648582|177577|P1|NOT COMPLETED|Overall Study||32
74364|NCT01648582|177575|P3|COMPLETED|Overall Study||227
74365|NCT01648582|177576|P2|COMPLETED|Overall Study||219
74366|NCT01648582|177577|P1|COMPLETED|Overall Study||226
74367|NCT01648582|177575|P3|Modified Intent-to-Treat Population|Overall Study||250
74368|NCT01648582|177576|P2|Modified Intent-to-Treat Population|Overall Study||252
74369|NCT01648582|177577|P1|Modified Intent-to-Treat Population|Overall Study||253
74370|NCT01648582|177575|P3|Received at Least One Dose of Study Drug|Overall Study||259
74371|NCT01648582|177576|P2|Received at Least One Dose of Study Drug|Overall Study||257
74372|NCT01648582|177577|P1|Received at Least One Dose of Study Drug|Overall Study||258
74373|NCT01648582|177575|P3|STARTED|Overall Study||259
74374|NCT01648582|177576|P2|STARTED|Overall Study||257
74375|NCT01648582|177577|P1|STARTED|Overall Study||258
74376|NCT01648530|177646|P1|NOT COMPLETED|Overall Study||10874
74377|NCT01648530|177646|P1|COMPLETED|Overall Study||5915
74378|NCT01648530|177646|P1|STARTED|Overall Study||16789
74379|NCT01648491|177652|P1|NOT COMPLETED|Overall Study||0
74380|NCT01648491|177652|P1|COMPLETED|Overall Study||1
74381|NCT01648491|177652|P1|STARTED|Overall Study||1
74382|NCT01648452|177659|P1|NOT COMPLETED|Overall Study||0
74383|NCT01648452|177659|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
74384|NCT01648452|177659|P1|STARTED|Overall Study||5
74385|NCT01648348|177680|P6|NOT COMPLETED|Overall Study||6
74386|NCT01648348|177681|P5|NOT COMPLETED|Overall Study||3
74387|NCT01648348|177682|P4|NOT COMPLETED|Overall Study||0
74388|NCT01648348|177683|P3|NOT COMPLETED|Overall Study||1
74389|NCT01648348|177684|P2|NOT COMPLETED|Overall Study||0
74390|NCT01648348|177685|P1|NOT COMPLETED|Overall Study||2
74391|NCT01648348|177680|P6|COMPLETED|Overall Study||43
74392|NCT01648348|177681|P5|COMPLETED|Overall Study||49
74393|NCT01648348|177682|P4|COMPLETED|Overall Study||3
74394|NCT01648348|177683|P3|COMPLETED|Overall Study||3
74395|NCT01648348|177684|P2|COMPLETED|Overall Study||3
74396|NCT01648348|177685|P1|COMPLETED|Overall Study||3
74397|NCT01648348|177680|P6|STARTED|Overall Study||49
74398|NCT01648348|177681|P5|STARTED|Overall Study||52
74399|NCT01648348|177682|P4|STARTED|Overall Study||3
74400|NCT01648348|177683|P3|STARTED|Overall Study||4
74401|NCT01648348|177684|P2|STARTED|Overall Study||3
74402|NCT01648348|177685|P1|STARTED|Overall Study||5
74403|NCT01648322|177714|P4|NOT COMPLETED|Overall Study||4
74404|NCT01648322|177715|P3|NOT COMPLETED|Overall Study||5
74405|NCT01648322|177716|P2|NOT COMPLETED|Overall Study||5
74406|NCT01648322|177717|P1|NOT COMPLETED|Overall Study||2
74407|NCT01648322|177714|P4|COMPLETED|Overall Study||61
74408|NCT01648322|177715|P3|COMPLETED|Overall Study||60
74409|NCT01648322|177716|P2|COMPLETED|Overall Study||62
74410|NCT01648322|177717|P1|COMPLETED|Overall Study||33
74411|NCT01648322|177714|P4|STARTED|Overall Study||65
74412|NCT01648322|177715|P3|STARTED|Overall Study||65
74413|NCT01648322|177716|P2|STARTED|Overall Study||67
74414|NCT01648322|177717|P1|STARTED|Overall Study||35
74415|NCT01648140|177734|P4|NOT COMPLETED|Overall Study||2
74416|NCT01648140|177735|P3|NOT COMPLETED|Overall Study||8
74417|NCT01648140|177736|P2|NOT COMPLETED|Overall Study||12
74418|NCT01648140|177737|P1|NOT COMPLETED|Overall Study||12
74419|NCT01648140|177734|P4|COMPLETED|Overall Study||11
74420|NCT01648140|177735|P3|COMPLETED|Overall Study||9
74421|NCT01648140|177736|P2|COMPLETED|Overall Study||28
74422|NCT01648140|177737|P1|COMPLETED|Overall Study||29
74423|NCT01648140|177734|P4|STARTED|Overall Study||13
74424|NCT01648140|177735|P3|STARTED|Overall Study||17
74425|NCT01648140|177736|P2|STARTED|Overall Study||40
74426|NCT01648140|177737|P1|STARTED|Overall Study||41
74427|NCT01648101|177902|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
74428|NCT01648101|177903|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
74429|NCT01648101|177904|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
74430|NCT01648101|177902|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
74431|NCT01648101|177903|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
74432|NCT01648101|177904|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
74433|NCT01648101|177902|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
74434|NCT01648101|177903|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
74435|NCT01648101|177904|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
74436|NCT01648101|177902|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
74437|NCT01648101|177903|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
74438|NCT01648101|177904|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
74439|NCT01648101|177902|P3|COMPLETED|Transition Phase (4 Weeks)||5
74440|NCT01648101|177903|P2|COMPLETED|Transition Phase (4 Weeks)||13
74441|NCT01648101|177904|P1|COMPLETED|Transition Phase (4 Weeks)||12
74442|NCT01648101|177902|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
74443|NCT01648101|177903|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
74444|NCT01648101|177904|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
74445|NCT01648101|177902|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
74446|NCT01648101|177903|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
74447|NCT01648101|177904|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
74448|NCT01648101|177902|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
74449|NCT01648101|177903|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
74450|NCT01648101|177904|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
74451|NCT01648101|177902|P3|STARTED|Maintenance Phase (12 Weeks)||18
74452|NCT01648101|177903|P2|STARTED|Maintenance Phase (12 Weeks)||23
74453|NCT01648101|177904|P1|STARTED|Maintenance Phase (12 Weeks)||23
74454|NCT01648101|177902|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
74455|NCT01648101|177903|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
74456|NCT01648101|177904|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
74457|NCT01648101|177902|P3|COMPLETED|Titration Phase (4 Weeks)||18
74458|NCT01648101|177903|P2|COMPLETED|Titration Phase (4 Weeks)||23
74459|NCT01648101|177904|P1|COMPLETED|Titration Phase (4 Weeks)||23
74460|NCT01648101|177902|P3|STARTED|Titration Phase (4 Weeks)||24
74461|NCT01648101|177903|P2|STARTED|Titration Phase (4 Weeks)||26
74462|NCT01648101|177904|P1|STARTED|Titration Phase (4 Weeks)||25
74463|NCT01647945|177956|P4|NOT COMPLETED|Overall Study||1
74464|NCT01647945|177957|P3|NOT COMPLETED|Overall Study||2
74465|NCT01647945|177958|P2|NOT COMPLETED|Overall Study||0
74466|NCT01647945|177959|P1|NOT COMPLETED|Overall Study||0
74467|NCT01647945|177956|P4|COMPLETED|Overall Study||5
74468|NCT01647945|177957|P3|COMPLETED|Overall Study||3
74469|NCT01647945|177958|P2|COMPLETED|Overall Study||6
74470|NCT01647945|177959|P1|COMPLETED|Overall Study||6
74471|NCT01647945|177956|P4|STARTED|Overall Study||6
74472|NCT01647945|177957|P3|STARTED|Overall Study||5
74473|NCT01647945|177958|P2|STARTED|Overall Study||6
74474|NCT01647945|177959|P1|STARTED|Overall Study||6
74475|NCT01647737|177979|P2|NOT COMPLETED|Overall Study||5
74476|NCT01647737|177980|P1|NOT COMPLETED|Overall Study||4
74477|NCT01647737|177979|P2|COMPLETED|Overall Study||25
74478|NCT01647737|177980|P1|COMPLETED|Overall Study||26
74479|NCT01647737|177979|P2|STARTED|Overall Study||30
74480|NCT01647737|177980|P1|STARTED|Overall Study||30
74481|NCT01647711|177991|P5|NOT COMPLETED|Overall Study||6
74482|NCT01647711|177992|P4|NOT COMPLETED|Overall Study||11
74483|NCT01647711|177993|P3|NOT COMPLETED|Overall Study||9
74484|NCT01647711|177994|P2|NOT COMPLETED|Overall Study||3
74485|NCT01647711|177995|P1|NOT COMPLETED|Overall Study||6
74486|NCT01647711|177991|P5|COMPLETED|Overall Study||0
74487|NCT01647711|177992|P4|COMPLETED|Overall Study||0
74488|NCT01647711|177993|P3|COMPLETED|Overall Study||0
74489|NCT01647711|177994|P2|COMPLETED|Overall Study||0
74490|NCT01647711|177995|P1|COMPLETED|Overall Study||0
74491|NCT01647711|177991|P5|STARTED|Overall Study||6
74492|NCT01647711|177992|P4|STARTED|Overall Study||11
74493|NCT01647711|177993|P3|STARTED|Overall Study||9
74494|NCT01647711|177994|P2|STARTED|Overall Study||3
74495|NCT01647711|177995|P1|STARTED|Overall Study||6
74496|NCT01647542|178023|P3|NOT COMPLETED|Overall Study||72
74497|NCT01647542|178024|P2|NOT COMPLETED|Overall Study||73
74498|NCT01647542|178025|P1|NOT COMPLETED|Overall Study||76
74499|NCT01647542|178023|P3|COMPLETED|Overall Study||59
74500|NCT01647542|178024|P2|COMPLETED|Overall Study||58
74501|NCT01647542|178025|P1|COMPLETED|Overall Study||55
74502|NCT01647542|178023|P3|STARTED|Overall Study||131
74503|NCT01647542|178024|P2|STARTED|Overall Study||131
74504|NCT01647542|178025|P1|STARTED|Overall Study||131
74505|NCT01647464|178042|P1|NOT COMPLETED|Overall Study||0
74506|NCT01647464|178042|P1|COMPLETED|Overall Study||10
74507|NCT01647464|178042|P1|STARTED|Overall Study||10
74508|NCT01647438|178048|P2|NOT COMPLETED|Overall Study||0
74509|NCT01647438|178049|P1|NOT COMPLETED|Overall Study||0
74510|NCT01647438|178048|P2|COMPLETED|Overall Study||31
74511|NCT01647438|178049|P1|COMPLETED|Overall Study||32
74512|NCT01647438|178048|P2|STARTED|Overall Study||31
74513|NCT01647438|178049|P1|STARTED|Overall Study||32
74514|NCT01647282|178059|P2|NOT COMPLETED|Overall Study||5
74515|NCT01647282|178060|P1|NOT COMPLETED|Overall Study||7
74516|NCT01647282|178059|P2|COMPLETED|Overall Study||25
74517|NCT01647282|178060|P1|COMPLETED|Overall Study||23
74518|NCT01647282|178059|P2|STARTED|Overall Study||30
74519|NCT01647282|178060|P1|STARTED|Overall Study||30
74520|NCT01647217|178070|P2|NOT COMPLETED|Overall Study||1
74521|NCT01647217|178071|P1|NOT COMPLETED|Overall Study||1
74522|NCT01647217|178070|P2|COMPLETED|Overall Study||8
74523|NCT01647217|178071|P1|COMPLETED|Overall Study||7
74524|NCT01647217|178070|P2|STARTED|Overall Study||9
74525|NCT01647217|178071|P1|STARTED|Overall Study||8
74526|NCT01646827|178081|P2|NOT COMPLETED|Overall Study||5
74527|NCT01646827|178082|P1|NOT COMPLETED|Overall Study||2
74528|NCT01646827|178081|P2|COMPLETED|Overall Study||14
74529|NCT01646827|178082|P1|COMPLETED|Overall Study||16
74530|NCT01646827|178081|P2|STARTED|Overall Study||19
74531|NCT01646827|178082|P1|STARTED|Overall Study||18
74532|NCT01646814|178112|P2|NOT COMPLETED|Overall Study||6
74533|NCT01646814|178113|P1|NOT COMPLETED|Overall Study||11
74534|NCT01646814|178112|P2|COMPLETED|Overall Study||120
74535|NCT01646814|178113|P1|COMPLETED|Overall Study||110
74536|NCT01646814|178112|P2|STARTED|Overall Study||126
74537|NCT01646814|178113|P1|STARTED|Overall Study||121
74538|NCT01646762|178119|P1|NOT COMPLETED|Overall Study||0
74539|NCT01646762|178119|P1|COMPLETED|Overall Study||13
74540|NCT01646762|178119|P1|STARTED|Overall Study||13
74541|NCT01646671|178131|P3|NOT COMPLETED|Overall Study||0
74542|NCT01646671|178132|P2|NOT COMPLETED|Overall Study||0
74543|NCT01646671|178133|P1|NOT COMPLETED|Overall Study||0
74544|NCT01646671|178131|P3|COMPLETED|Overall Study||21
74545|NCT01646671|178132|P2|COMPLETED|Overall Study||11
74546|NCT01646671|178133|P1|COMPLETED|Overall Study||3
74547|NCT01646671|178131|P3|STARTED|Overall Study||21
74548|NCT01646671|178132|P2|STARTED|Overall Study||11
74549|NCT01646671|178133|P1|STARTED|Overall Study||3
74550|NCT01646398|178169|P2|NOT COMPLETED|Overall Study||0
74551|NCT01646398|178170|P1|NOT COMPLETED|Overall Study||1
74552|NCT01646398|178169|P2|COMPLETED|Overall Study||382
74553|NCT01646398|178170|P1|COMPLETED|Overall Study||381
74554|NCT01646398|178169|P2|STARTED|Overall Study||382
74555|NCT01646398|178170|P1|STARTED|Overall Study||382
74556|NCT01646385|178186|P2|NOT COMPLETED|Overall Study||871
74557|NCT01646385|178187|P1|NOT COMPLETED|Overall Study||838
74558|NCT01646385|178186|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
74559|NCT01646385|178187|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
74560|NCT01646385|178186|P2|STARTED|Overall Study||2864
74561|NCT01646385|178187|P1|STARTED|Overall Study||3529
74562|NCT01646320|178220|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
74563|NCT01646320|178221|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
74564|NCT01646320|178220|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
74565|NCT01646320|178221|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
74566|NCT01646320|178220|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
74567|NCT01646320|178221|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
74568|NCT01646320|178220|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
74569|NCT01646320|178221|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
74570|NCT01646320|178220|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
74571|NCT01646320|178221|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
74572|NCT01646320|178220|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
74573|NCT01646320|178221|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
74574|NCT01646268|178237|P2|NOT COMPLETED|Overall Study||16
74575|NCT01646268|178238|P1|NOT COMPLETED|Overall Study||11
74576|NCT01646268|178237|P2|COMPLETED|Overall Study||107
74577|NCT01646268|178238|P1|COMPLETED|Overall Study||113
74578|NCT01646268|178237|P2|STARTED|Overall Study||123
74579|NCT01646268|178238|P1|STARTED|Overall Study||124
74580|NCT01646255|178252|P2|NOT COMPLETED|Overall Study||14
74581|NCT01646255|178253|P1|NOT COMPLETED|Overall Study||21
74582|NCT01646255|178252|P2|COMPLETED|Overall Study||160
74583|NCT01646255|178253|P1|COMPLETED|Overall Study||151
74584|NCT01646255|178252|P2|STARTED|Overall Study||174
74585|NCT01646255|178253|P1|STARTED|Overall Study||172
74586|NCT01646216|178285|P2|NOT COMPLETED|Overall Study||13
74587|NCT01646216|178286|P1|NOT COMPLETED|Overall Study||11
74588|NCT01646216|178285|P2|COMPLETED|Overall Study||4
74589|NCT01646216|178286|P1|COMPLETED|Overall Study||6
74590|NCT01646216|178285|P2|STARTED|Overall Study||17
74591|NCT01646216|178286|P1|STARTED|Overall Study||17
74592|NCT01646177|178309|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
74593|NCT01646177|178310|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
74594|NCT01646177|178311|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
74595|NCT01646177|178312|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
74596|NCT01646177|178309|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74597|NCT01646177|178310|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74598|NCT01646177|178311|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74599|NCT01646177|178312|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74600|NCT01646177|178309|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74601|NCT01646177|178310|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74602|NCT01646177|178311|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74603|NCT01646177|178312|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
74604|NCT01646177|178309|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
74605|NCT01646177|178310|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
74606|NCT01646177|178311|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
74607|NCT01646177|178312|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
74608|NCT01646177|178309|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
74609|NCT01646177|178310|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
74610|NCT01646177|178311|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
74611|NCT01646177|178312|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
74612|NCT01646177|178309|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
74613|NCT01646177|178310|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
74614|NCT01646177|178311|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
74615|NCT01646177|178312|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
74616|NCT01646151|178390|P1|NOT COMPLETED|Overall Study||170
74617|NCT01646151|178390|P1|COMPLETED|Overall Study||2410
74618|NCT01646151|178390|P1|STARTED|Overall Study||2580
74619|NCT01646138|178406|P5|NOT COMPLETED|Overall Study||2
74620|NCT01646138|178407|P4|NOT COMPLETED|Overall Study||0
74621|NCT01646138|178408|P3|NOT COMPLETED|Overall Study||0
74622|NCT01646138|178409|P2|NOT COMPLETED|Overall Study||0
74623|NCT01646138|178410|P1|NOT COMPLETED|Overall Study||0
74624|NCT01646138|178406|P5|COMPLETED|Overall Study||13
74625|NCT01646138|178407|P4|COMPLETED|Overall Study||19
74626|NCT01646138|178408|P3|COMPLETED|Overall Study||5
74627|NCT01646138|178409|P2|COMPLETED|Overall Study||4
74628|NCT01646138|178410|P1|COMPLETED|Overall Study||5
74629|NCT01646138|178406|P5|STARTED|Overall Study||15
74630|NCT01646138|178407|P4|STARTED|Overall Study||19
74631|NCT01646138|178408|P3|STARTED|Overall Study||5
74632|NCT01646138|178409|P2|STARTED|Overall Study||4
74633|NCT01646138|178410|P1|STARTED|Overall Study||5
74634|NCT01646125|178424|P2|NOT COMPLETED|Overall Study||28
74635|NCT01646125|178425|P1|NOT COMPLETED|Overall Study||31
74636|NCT01646125|178424|P2|COMPLETED|Overall Study||0
74637|NCT01646125|178425|P1|COMPLETED|Overall Study||0
74638|NCT01646125|178424|P2|STARTED|Overall Study||28
74639|NCT01646125|178425|P1|STARTED|Overall Study||31
74640|NCT01646073|178450|P2|NOT COMPLETED|Period B (12 Weeks)||13
74641|NCT01646073|178451|P1|NOT COMPLETED|Period B (12 Weeks)||1
74642|NCT01646073|178450|P2|COMPLETED|Period B (12 Weeks)||320
74643|NCT01646073|178451|P1|COMPLETED|Period B (12 Weeks)||84
74644|NCT01646073|178450|P2|STARTED|Period B (12 Weeks)||333
74645|NCT01646073|178451|P1|STARTED|Period B (12 Weeks)||85
74646|NCT01646073|178450|P2|NOT COMPLETED|Period A (12 Weeks)||5
74647|NCT01646073|178451|P1|NOT COMPLETED|Period A (12 Weeks)||2
74648|NCT01646073|178450|P2|COMPLETED|Period A (12 Weeks)||333
74649|NCT01646073|178451|P1|COMPLETED|Period A (12 Weeks)||85
74650|NCT01646073|178450|P2|STARTED|Period A (12 Weeks)||338
74651|NCT01646073|178451|P1|STARTED|Period A (12 Weeks)||87
74652|NCT01646021|178492|P2|NOT COMPLETED|Overall Study||141
74653|NCT01646021|178493|P1|NOT COMPLETED|Overall Study||139
74654|NCT01646021|178492|P2|COMPLETED|Overall Study||0
74655|NCT01646021|178493|P1|COMPLETED|Overall Study||0
74656|NCT01646021|178492|P2|Treated|Overall Study||139
74657|NCT01646021|178493|P1|Treated|Overall Study||139
74658|NCT01646021|178492|P2|STARTED|Overall Study||141
74659|NCT01646021|178493|P1|STARTED|Overall Study||139
74660|NCT01645735|178532|P2|NOT COMPLETED|Overall Study||1
74661|NCT01645735|178533|P1|NOT COMPLETED|Overall Study||4
74662|NCT01645735|178532|P2|COMPLETED|Overall Study||16
74663|NCT01645735|178533|P1|COMPLETED|Overall Study||28
74664|NCT01645735|178532|P2|STARTED|Overall Study||17
74665|NCT01645735|178533|P1|STARTED|Overall Study||32
74666|NCT01645709|178547|P2|NOT COMPLETED|Overall Study||0
74667|NCT01645709|178548|P1|NOT COMPLETED|Overall Study||0
74668|NCT01645709|178547|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
74669|NCT01645709|178548|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
74670|NCT01645709|178547|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
74671|NCT01645709|178548|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
74672|NCT01645280|178575|P5|NOT COMPLETED|Overall Study||8
74673|NCT01645280|178576|P4|NOT COMPLETED|Overall Study||6
74674|NCT01645280|178577|P3|NOT COMPLETED|Overall Study||6
74675|NCT01645280|178578|P2|NOT COMPLETED|Overall Study||3
74676|NCT01645280|178579|P1|NOT COMPLETED|Overall Study||6
74677|NCT01645280|178575|P5|COMPLETED|Overall Study||47
74678|NCT01645280|178576|P4|COMPLETED|Overall Study||48
74679|NCT01645280|178577|P3|COMPLETED|Overall Study||49
74680|NCT01645280|178578|P2|COMPLETED|Overall Study||51
74681|NCT01645280|178579|P1|COMPLETED|Overall Study||49
74682|NCT01645280|178575|P5|STARTED|Overall Study||55
74683|NCT01645280|178576|P4|STARTED|Overall Study||54
74684|NCT01645280|178577|P3|STARTED|Overall Study||55
74685|NCT01645280|178578|P2|STARTED|Overall Study||54
74686|NCT01645280|178579|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
74687|NCT01645176|178607|P1|NOT COMPLETED|Overall Study||5
74688|NCT01645176|178607|P1|COMPLETED|Overall Study||16
74689|NCT01645176|178607|P1|STARTED|Overall Study||21
74690|NCT01645111|178611|P1|NOT COMPLETED|Overall Study||15
74691|NCT01645111|178611|P1|COMPLETED|Overall Study||35
74692|NCT01645111|178611|P1|STARTED|Overall Study||50
74693|NCT01645098|178617|P2|NOT COMPLETED|Overall Study||0
74694|NCT01645098|178618|P1|NOT COMPLETED|Overall Study||0
74695|NCT01645098|178617|P2|COMPLETED|Overall Study||29
74696|NCT01645098|178618|P1|COMPLETED|Overall Study||24
74697|NCT01645098|178617|P2|STARTED|Overall Study||29
74698|NCT01645098|178618|P1|STARTED|Overall Study||24
74699|NCT01645059|178632|P1|NOT COMPLETED|Overall Study||0
74700|NCT01645059|178632|P1|COMPLETED|Overall Study||129
74701|NCT01645059|178632|P1|STARTED|Overall Study||129
74702|NCT01644734|178650|P1|NOT COMPLETED|Overall Study||266
74703|NCT01644734|178650|P1|COMPLETED|Overall Study||1016
74704|NCT01644734|178650|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
74705|NCT01644695|178655|P1|NOT COMPLETED|Overall Study||0
74706|NCT01644695|178655|P1|COMPLETED|Overall Study||85
74707|NCT01644695|178655|P1|STARTED|Overall Study||85
74708|NCT01644643|178664|P4|NOT COMPLETED|Overall Study||10
74709|NCT01644643|178665|P3|NOT COMPLETED|Overall Study||5
74710|NCT01644643|178666|P2|NOT COMPLETED|Overall Study||0
74711|NCT01644643|178667|P1|NOT COMPLETED|Overall Study||2
74712|NCT01644643|178664|P4|COMPLETED|Overall Study||143
74713|NCT01644643|178665|P3|COMPLETED|Overall Study||148
74714|NCT01644643|178666|P2|COMPLETED|Overall Study||12
74715|NCT01644643|178667|P1|COMPLETED|Overall Study||13
74716|NCT01644643|178664|P4|STARTED|Overall Study||153
74717|NCT01644643|178665|P3|STARTED|Overall Study||153
74718|NCT01644643|178666|P2|STARTED|Overall Study||12
74719|NCT01644643|178667|P1|STARTED|Overall Study||15
74720|NCT01644617|178832|P3|NOT COMPLETED|Overall Study||7
74721|NCT01644617|178833|P2|NOT COMPLETED|Overall Study||5
74722|NCT01644617|178834|P1|NOT COMPLETED|Overall Study||6
74723|NCT01644617|178832|P3|COMPLETED|Overall Study||34
74724|NCT01644617|178833|P2|COMPLETED|Overall Study||36
74725|NCT01644617|178834|P1|COMPLETED|Overall Study||36
74726|NCT01644617|178832|P3|STARTED|Overall Study||41
74727|NCT01644617|178833|P2|STARTED|Overall Study||41
74728|NCT01644617|178834|P1|STARTED|Overall Study||42
74729|NCT01644500|178887|P3|NOT COMPLETED|Overall Study||15
74730|NCT01644500|178888|P2|NOT COMPLETED|Overall Study||24
74731|NCT01644500|178889|P1|NOT COMPLETED|Overall Study||22
74732|NCT01644500|178887|P3|COMPLETED|Overall Study||230
74733|NCT01644500|178888|P2|COMPLETED|Overall Study||224
74734|NCT01644500|178889|P1|COMPLETED|Overall Study||222
74735|NCT01644500|178887|P3|Modified Intent-to-treat Population|Overall Study||242
74736|NCT01644500|178888|P2|Modified Intent-to-treat Population|Overall Study||239
74737|NCT01644500|178889|P1|Modified Intent-to-treat Population|Overall Study||239
74738|NCT01644500|178887|P3|Received at Least One Dose of Study Drug|Overall Study||243
74739|NCT01644500|178888|P2|Received at Least One Dose of Study Drug|Overall Study||248
74740|NCT01644500|178889|P1|Received at Least One Dose of Study Drug|Overall Study||244
74741|NCT01644500|178887|P3|STARTED|Overall Study||245
74742|NCT01644500|178888|P2|STARTED|Overall Study||248
74743|NCT01644500|178889|P1|STARTED|Overall Study||244
74744|NCT01644474|178959|P2|NOT COMPLETED|Overall Study||8
74745|NCT01644474|178960|P1|NOT COMPLETED|Overall Study||7
74746|NCT01644474|178959|P2|COMPLETED|Overall Study||44
74747|NCT01644474|178960|P1|COMPLETED|Overall Study||44
74748|NCT01644474|178959|P2|Treated|Overall Study||52
74749|NCT01644474|178960|P1|Treated|Overall Study||51
74750|NCT01644474|178959|P2|STARTED|Overall Study|Randomized|52
74751|NCT01644474|178960|P1|STARTED|Overall Study|Randomized|51
74752|NCT01644396|179000|P1|NOT COMPLETED|Overall Study||0
74753|NCT01644396|179000|P1|COMPLETED|Overall Study||50
74754|NCT01644396|179000|P1|STARTED|Overall Study||50
74755|NCT01644331|179044|P2|NOT COMPLETED|Overall Study||10
74756|NCT01644331|179045|P1|NOT COMPLETED|Overall Study||11
74757|NCT01644331|179044|P2|COMPLETED|Overall Study||118
74758|NCT01644331|179045|P1|COMPLETED|Overall Study||118
74759|NCT01644331|179044|P2|STARTED|Overall Study||128
74760|NCT01644331|179045|P1|STARTED|Overall Study||129
74761|NCT01644292|179077|P1|NOT COMPLETED|Overall Study||0
74762|NCT01644292|179077|P1|COMPLETED|Overall Study||2
74763|NCT01644292|179077|P1|STARTED|Overall Study||2
74764|NCT01644240|179084|P3|NOT COMPLETED|Overall Study||0
74765|NCT01644240|179085|P2|NOT COMPLETED|Overall Study||0
74766|NCT01644240|179086|P1|NOT COMPLETED|Overall Study||0
74767|NCT01644240|179084|P3|COMPLETED|Overall Study||6
74768|NCT01644240|179085|P2|COMPLETED|Overall Study||4
74769|NCT01644240|179086|P1|COMPLETED|Overall Study||6
74770|NCT01644240|179084|P3|STARTED|Overall Study||6
74771|NCT01644240|179085|P2|STARTED|Overall Study||4
74772|NCT01644240|179086|P1|STARTED|Overall Study||6
74773|NCT01644188|179144|P2|NOT COMPLETED|Overall Study||75
74774|NCT01644188|179145|P1|NOT COMPLETED|Overall Study||122
74775|NCT01644188|179144|P2|COMPLETED|Overall Study||166
74776|NCT01644188|179145|P1|COMPLETED|Overall Study||357
74777|NCT01644188|179144|P2|Treated|Overall Study||241
74778|NCT01644188|179145|P1|Treated|Overall Study||479
74779|NCT01644188|179144|P2|STARTED|Overall Study|Randomized|241
74780|NCT01644188|179145|P1|STARTED|Overall Study|Randomized|479
74781|NCT01644175|179203|P2|NOT COMPLETED|Overall Study||53
74782|NCT01644175|179204|P1|NOT COMPLETED|Overall Study||32
74783|NCT01644175|179203|P2|COMPLETED|Overall Study||156
74784|NCT01644175|179204|P1|COMPLETED|Overall Study||75
74785|NCT01644175|179203|P2|Treated|Overall Study||207
74786|NCT01644175|179204|P1|Treated|Overall Study||107
74787|NCT01644175|179203|P2|STARTED|Overall Study|Randomized|209
74788|NCT01644175|179204|P1|STARTED|Overall Study|Randomized|107
74789|NCT01644058|179254|P1|NOT COMPLETED|Overall Study||0
74790|NCT01644058|179254|P1|COMPLETED|Overall Study||18
74791|NCT01644058|179254|P1|STARTED|Overall Study||18
74792|NCT01643928|179264|P5|NOT COMPLETED|Overall Study||2
74793|NCT01643928|179265|P4|NOT COMPLETED|Overall Study||3
74794|NCT01643928|179266|P3|NOT COMPLETED|Overall Study||3
74795|NCT01643928|179267|P2|NOT COMPLETED|Overall Study||2
74796|NCT01643928|179268|P1|NOT COMPLETED|Overall Study||10
74797|NCT01643928|179264|P5|COMPLETED|Overall Study||28
74798|NCT01643928|179265|P4|COMPLETED|Overall Study||27
74799|NCT01643928|179266|P3|COMPLETED|Overall Study||30
74800|NCT01643928|179267|P2|COMPLETED|Overall Study||30
74801|NCT01643928|179268|P1|COMPLETED|Overall Study||48
74802|NCT01643928|179264|P5|STARTED|Overall Study||30
74803|NCT01643928|179265|P4|STARTED|Overall Study||30
74804|NCT01643928|179266|P3|STARTED|Overall Study||33
74805|NCT01643928|179267|P2|STARTED|Overall Study||32
74806|NCT01643928|179268|P1|STARTED|Overall Study||58
74807|NCT01643902|179553|P1|NOT COMPLETED|Overall Study||0
74808|NCT01643902|179553|P1|COMPLETED|Overall Study||20
74809|NCT01643902|179553|P1|STARTED|Overall Study||20
74810|NCT01643876|179558|P1|NOT COMPLETED|Overall Study||0
74811|NCT01643876|179558|P1|COMPLETED|Overall Study||48
74812|NCT01643876|179558|P1|STARTED|Overall Study||48
74813|NCT01643798|179563|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
74814|NCT01643798|179564|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
74815|NCT01643798|179563|P2|COMPLETED|Pretreatment 2 and Stimulation||8
74816|NCT01643798|179564|P1|COMPLETED|Pretreatment 2 and Stimulation||6
74817|NCT01643798|179563|P2|STARTED|Pretreatment 2 and Stimulation||8
74818|NCT01643798|179564|P1|STARTED|Pretreatment 2 and Stimulation||6
74819|NCT01643798|179563|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
74820|NCT01643798|179564|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
74821|NCT01643798|179563|P2|COMPLETED|Pretreatment 1 and Stimulation||8
74822|NCT01643798|179564|P1|COMPLETED|Pretreatment 1 and Stimulation||6
74823|NCT01643798|179563|P2|STARTED|Pretreatment 1 and Stimulation||8
74824|NCT01643798|179564|P1|STARTED|Pretreatment 1 and Stimulation||7
74825|NCT01643668|179575|P1|NOT COMPLETED|Overall Study||1
74826|NCT01643668|179575|P1|COMPLETED|Overall Study||33
74827|NCT01643668|179575|P1|STARTED|Overall Study||34
74828|NCT01643616|179589|P2|NOT COMPLETED|Overall Study||0
74829|NCT01643616|179590|P1|NOT COMPLETED|Overall Study||0
74830|NCT01643616|179589|P2|COMPLETED|Overall Study||125
74831|NCT01643616|179590|P1|COMPLETED|Overall Study||125
74832|NCT01643616|179589|P2|STARTED|Overall Study||125
74833|NCT01643616|179590|P1|STARTED|Overall Study||125
74834|NCT01643525|179600|P1|NOT COMPLETED|Overall Study||0
74835|NCT01643525|179600|P1|COMPLETED|Overall Study||29
74836|NCT01643525|179600|P1|STARTED|Overall Study||29
74837|NCT01643213|179606|P2|NOT COMPLETED|Overall Study||0
74838|NCT01643213|179607|P1|NOT COMPLETED|Overall Study||1
74839|NCT01643213|179606|P2|COMPLETED|Overall Study||14
74840|NCT01643213|179607|P1|COMPLETED|Overall Study||12
74841|NCT01643213|179606|P2|STARTED|Overall Study||14
74842|NCT01643213|179607|P1|STARTED|Overall Study||13
74843|NCT01643044|179615|P2|NOT COMPLETED|Overall Study||5
74844|NCT01643044|179616|P1|NOT COMPLETED|Overall Study||4
74845|NCT01643044|179615|P2|COMPLETED|Overall Study||19
74846|NCT01643044|179616|P1|COMPLETED|Overall Study||20
74847|NCT01643044|179615|P2|STARTED|Overall Study||24
74848|NCT01643044|179616|P1|STARTED|Overall Study||24
74849|NCT01642914|179625|P3|NOT COMPLETED|Overall Study||40
74850|NCT01642914|179626|P2|NOT COMPLETED|Overall Study||32
74851|NCT01642914|179627|P1|NOT COMPLETED|Overall Study||46
74852|NCT01642914|179625|P3|COMPLETED|Overall Study||120
74853|NCT01642914|179626|P2|COMPLETED|Overall Study||122
74854|NCT01642914|179627|P1|COMPLETED|Overall Study||127
74855|NCT01642914|179625|P3|STARTED|Overall Study||160
74856|NCT01642914|179626|P2|STARTED|Overall Study||154
74857|NCT01642914|179627|P1|STARTED|Overall Study||173
74858|NCT01642732|179702|P1|NOT COMPLETED|Overall Study||1
74859|NCT01642732|179702|P1|COMPLETED|Overall Study||0
74860|NCT01642732|179702|P1|STARTED|Overall Study||1
74861|NCT01642615|179707|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
74862|NCT01642615|179708|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
74863|NCT01642615|179709|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
74864|NCT01642615|179707|P3|COMPLETED|Double Blind Maintenance Phase||20
74865|NCT01642615|179708|P2|COMPLETED|Double Blind Maintenance Phase||18
74866|NCT01642615|179709|P1|COMPLETED|Double Blind Maintenance Phase||0
74867|NCT01642615|179707|P3|STARTED|Double Blind Maintenance Phase||26
74868|NCT01642615|179708|P2|STARTED|Double Blind Maintenance Phase||25
74869|NCT01642615|179709|P1|STARTED|Double Blind Maintenance Phase||0
74870|NCT01642615|179707|P3|NOT COMPLETED|Open Label Maintenance Phase||0
74871|NCT01642615|179708|P2|NOT COMPLETED|Open Label Maintenance Phase||0
74872|NCT01642615|179709|P1|NOT COMPLETED|Open Label Maintenance Phase||5
74873|NCT01642615|179707|P3|COMPLETED|Open Label Maintenance Phase||0
74874|NCT01642615|179708|P2|COMPLETED|Open Label Maintenance Phase||0
74875|NCT01642615|179709|P1|COMPLETED|Open Label Maintenance Phase||58
74876|NCT01642615|179707|P3|Safety Analysis Set|Open Label Maintenance Phase||0
74877|NCT01642615|179708|P2|Safety Analysis Set|Open Label Maintenance Phase||0
74878|NCT01642615|179709|P1|Safety Analysis Set|Open Label Maintenance Phase||62
74879|NCT01642615|179707|P3|STARTED|Open Label Maintenance Phase||0
74880|NCT01642615|179708|P2|STARTED|Open Label Maintenance Phase||0
74881|NCT01642615|179709|P1|STARTED|Open Label Maintenance Phase||63
74882|NCT01642602|179723|P1|NOT COMPLETED|Overall Study||2
74883|NCT01642602|179723|P1|COMPLETED|Overall Study||102
74884|NCT01642602|179723|P1|STARTED|Overall Study||104
74885|NCT01642589|179730|P2|NOT COMPLETED|Overall Study||1
74886|NCT01642589|179731|P1|NOT COMPLETED|Overall Study||1
74887|NCT01642589|179730|P2|COMPLETED|Overall Study||99
74888|NCT01642589|179731|P1|COMPLETED|Overall Study||199
74889|NCT01642589|179730|P2|STARTED|Overall Study||100
74890|NCT01642589|179731|P1|STARTED|Overall Study||200
74891|NCT01642485|179745|P8|NOT COMPLETED|Period 2, Day 3||0
74892|NCT01642485|179746|P7|NOT COMPLETED|Period 2, Day 3||0
74893|NCT01642485|179747|P6|NOT COMPLETED|Period 2, Day 3||0
74894|NCT01642485|179748|P5|NOT COMPLETED|Period 2, Day 3||0
74895|NCT01642485|179749|P4|NOT COMPLETED|Period 2, Day 3||0
74896|NCT01642485|179750|P3|NOT COMPLETED|Period 2, Day 3||0
74897|NCT01642485|179751|P2|NOT COMPLETED|Period 2, Day 3||0
74898|NCT01642485|179752|P1|NOT COMPLETED|Period 2, Day 3||0
74899|NCT01642485|179745|P8|COMPLETED|Period 2, Day 3||4
74900|NCT01642485|179746|P7|COMPLETED|Period 2, Day 3||4
74901|NCT01642485|179747|P6|COMPLETED|Period 2, Day 3||4
74902|NCT01642485|179748|P5|COMPLETED|Period 2, Day 3||4
74903|NCT01642485|179749|P4|COMPLETED|Period 2, Day 3||4
74904|NCT01642485|179750|P3|COMPLETED|Period 2, Day 3||4
74905|NCT01642485|179751|P2|COMPLETED|Period 2, Day 3||4
74906|NCT01642485|179752|P1|COMPLETED|Period 2, Day 3||4
74907|NCT01642485|179745|P8|STARTED|Period 2, Day 3||4
74908|NCT01642485|179746|P7|STARTED|Period 2, Day 3||4
74909|NCT01642485|179747|P6|STARTED|Period 2, Day 3||4
74910|NCT01642485|179748|P5|STARTED|Period 2, Day 3||4
74911|NCT01642485|179749|P4|STARTED|Period 2, Day 3||4
74912|NCT01642485|179750|P3|STARTED|Period 2, Day 3||4
74913|NCT01642485|179751|P2|STARTED|Period 2, Day 3||4
74914|NCT01642485|179752|P1|STARTED|Period 2, Day 3||4
74915|NCT01642485|179745|P8|NOT COMPLETED|Period 2, Day 2||0
74916|NCT01642485|179746|P7|NOT COMPLETED|Period 2, Day 2||0
74917|NCT01642485|179747|P6|NOT COMPLETED|Period 2, Day 2||0
74918|NCT01642485|179748|P5|NOT COMPLETED|Period 2, Day 2||0
74919|NCT01642485|179749|P4|NOT COMPLETED|Period 2, Day 2||0
74920|NCT01642485|179750|P3|NOT COMPLETED|Period 2, Day 2||0
74921|NCT01642485|179751|P2|NOT COMPLETED|Period 2, Day 2||0
74922|NCT01642485|179752|P1|NOT COMPLETED|Period 2, Day 2||0
74923|NCT01642485|179745|P8|COMPLETED|Period 2, Day 2||4
74924|NCT01642485|179746|P7|COMPLETED|Period 2, Day 2||4
74925|NCT01642485|179747|P6|COMPLETED|Period 2, Day 2||4
74926|NCT01642485|179748|P5|COMPLETED|Period 2, Day 2||4
74927|NCT01642485|179749|P4|COMPLETED|Period 2, Day 2||4
74928|NCT01642485|179750|P3|COMPLETED|Period 2, Day 2||4
74929|NCT01642485|179751|P2|COMPLETED|Period 2, Day 2||4
74930|NCT01642485|179752|P1|COMPLETED|Period 2, Day 2||4
74931|NCT01642485|179745|P8|STARTED|Period 2, Day 2||4
74932|NCT01642485|179746|P7|STARTED|Period 2, Day 2||4
74933|NCT01642485|179747|P6|STARTED|Period 2, Day 2||4
74934|NCT01642485|179748|P5|STARTED|Period 2, Day 2||4
74935|NCT01642485|179749|P4|STARTED|Period 2, Day 2||4
74936|NCT01642485|179750|P3|STARTED|Period 2, Day 2||4
74937|NCT01642485|179751|P2|STARTED|Period 2, Day 2||4
74938|NCT01642485|179752|P1|STARTED|Period 2, Day 2||4
74939|NCT01642485|179745|P8|NOT COMPLETED|Period 2, Day 1||0
74940|NCT01642485|179746|P7|NOT COMPLETED|Period 2, Day 1||0
74941|NCT01642485|179747|P6|NOT COMPLETED|Period 2, Day 1||0
74942|NCT01642485|179748|P5|NOT COMPLETED|Period 2, Day 1||0
74943|NCT01642485|179749|P4|NOT COMPLETED|Period 2, Day 1||0
74944|NCT01642485|179750|P3|NOT COMPLETED|Period 2, Day 1||0
74945|NCT01642485|179751|P2|NOT COMPLETED|Period 2, Day 1||0
74946|NCT01642485|179752|P1|NOT COMPLETED|Period 2, Day 1||0
74947|NCT01642485|179745|P8|COMPLETED|Period 2, Day 1||4
74948|NCT01642485|179746|P7|COMPLETED|Period 2, Day 1||4
74949|NCT01642485|179747|P6|COMPLETED|Period 2, Day 1||4
74950|NCT01642485|179748|P5|COMPLETED|Period 2, Day 1||4
74951|NCT01642485|179749|P4|COMPLETED|Period 2, Day 1||4
74952|NCT01642485|179750|P3|COMPLETED|Period 2, Day 1||4
74953|NCT01642485|179751|P2|COMPLETED|Period 2, Day 1||4
74954|NCT01642485|179752|P1|COMPLETED|Period 2, Day 1||4
74955|NCT01642485|179745|P8|STARTED|Period 2, Day 1||4
74956|NCT01642485|179746|P7|STARTED|Period 2, Day 1||4
74957|NCT01642485|179747|P6|STARTED|Period 2, Day 1||4
74958|NCT01642485|179748|P5|STARTED|Period 2, Day 1||4
74959|NCT01642485|179749|P4|STARTED|Period 2, Day 1||4
74960|NCT01642485|179750|P3|STARTED|Period 2, Day 1||4
74961|NCT01642485|179751|P2|STARTED|Period 2, Day 1||4
74962|NCT01642485|179752|P1|STARTED|Period 2, Day 1||4
74963|NCT01642485|179745|P8|NOT COMPLETED|Period 1, Day 3||0
74964|NCT01642485|179746|P7|NOT COMPLETED|Period 1, Day 3||0
74965|NCT01642485|179747|P6|NOT COMPLETED|Period 1, Day 3||0
74966|NCT01642485|179748|P5|NOT COMPLETED|Period 1, Day 3||0
74967|NCT01642485|179749|P4|NOT COMPLETED|Period 1, Day 3||0
74968|NCT01642485|179750|P3|NOT COMPLETED|Period 1, Day 3||0
74969|NCT01642485|179751|P2|NOT COMPLETED|Period 1, Day 3||0
74970|NCT01642485|179752|P1|NOT COMPLETED|Period 1, Day 3||0
74971|NCT01642485|179745|P8|COMPLETED|Period 1, Day 3||4
74972|NCT01642485|179746|P7|COMPLETED|Period 1, Day 3||4
74973|NCT01642485|179747|P6|COMPLETED|Period 1, Day 3||4
74974|NCT01642485|179748|P5|COMPLETED|Period 1, Day 3||4
74975|NCT01642485|179749|P4|COMPLETED|Period 1, Day 3||4
74976|NCT01642485|179750|P3|COMPLETED|Period 1, Day 3||4
74977|NCT01642485|179751|P2|COMPLETED|Period 1, Day 3||4
74978|NCT01642485|179752|P1|COMPLETED|Period 1, Day 3||4
74979|NCT01642485|179745|P8|STARTED|Period 1, Day 3||4
74980|NCT01642485|179746|P7|STARTED|Period 1, Day 3||4
74981|NCT01642485|179747|P6|STARTED|Period 1, Day 3||4
74982|NCT01642485|179748|P5|STARTED|Period 1, Day 3||4
74983|NCT01642485|179749|P4|STARTED|Period 1, Day 3||4
74984|NCT01642485|179750|P3|STARTED|Period 1, Day 3||4
74985|NCT01642485|179751|P2|STARTED|Period 1, Day 3||4
74986|NCT01642485|179752|P1|STARTED|Period 1, Day 3||4
74987|NCT01642485|179745|P8|NOT COMPLETED|Period 1, Day 2||0
74988|NCT01642485|179746|P7|NOT COMPLETED|Period 1, Day 2||0
74989|NCT01642485|179747|P6|NOT COMPLETED|Period 1, Day 2||0
74990|NCT01642485|179748|P5|NOT COMPLETED|Period 1, Day 2||0
74991|NCT01642485|179749|P4|NOT COMPLETED|Period 1, Day 2||0
74992|NCT01642485|179750|P3|NOT COMPLETED|Period 1, Day 2||0
74993|NCT01642485|179751|P2|NOT COMPLETED|Period 1, Day 2||0
74994|NCT01642485|179752|P1|NOT COMPLETED|Period 1, Day 2||0
74995|NCT01642485|179745|P8|COMPLETED|Period 1, Day 2||4
74996|NCT01642485|179746|P7|COMPLETED|Period 1, Day 2||4
74997|NCT01642485|179747|P6|COMPLETED|Period 1, Day 2||4
74998|NCT01642485|179748|P5|COMPLETED|Period 1, Day 2||4
74999|NCT01642485|179749|P4|COMPLETED|Period 1, Day 2||4
75000|NCT01642485|179750|P3|COMPLETED|Period 1, Day 2||4
75001|NCT01642485|179751|P2|COMPLETED|Period 1, Day 2||4
75002|NCT01642485|179752|P1|COMPLETED|Period 1, Day 2||4
75003|NCT01642485|179745|P8|STARTED|Period 1, Day 2||4
75004|NCT01642485|179746|P7|STARTED|Period 1, Day 2||4
75005|NCT01642485|179747|P6|STARTED|Period 1, Day 2||4
75006|NCT01642485|179748|P5|STARTED|Period 1, Day 2||4
75007|NCT01642485|179749|P4|STARTED|Period 1, Day 2||4
75008|NCT01642485|179750|P3|STARTED|Period 1, Day 2||4
75009|NCT01642485|179751|P2|STARTED|Period 1, Day 2||4
75010|NCT01642485|179752|P1|STARTED|Period 1, Day 2||4
75011|NCT01642485|179745|P8|NOT COMPLETED|Period 1, Day 1||0
75012|NCT01642485|179746|P7|NOT COMPLETED|Period 1, Day 1||0
75013|NCT01642485|179747|P6|NOT COMPLETED|Period 1, Day 1||0
75014|NCT01642485|179748|P5|NOT COMPLETED|Period 1, Day 1||0
75015|NCT01642485|179749|P4|NOT COMPLETED|Period 1, Day 1||0
75016|NCT01642485|179750|P3|NOT COMPLETED|Period 1, Day 1||0
75017|NCT01642485|179751|P2|NOT COMPLETED|Period 1, Day 1||0
75018|NCT01642485|179752|P1|NOT COMPLETED|Period 1, Day 1||0
75019|NCT01642485|179745|P8|COMPLETED|Period 1, Day 1||4
75020|NCT01642485|179746|P7|COMPLETED|Period 1, Day 1||4
75021|NCT01642485|179747|P6|COMPLETED|Period 1, Day 1||4
75022|NCT01642485|179748|P5|COMPLETED|Period 1, Day 1||4
75023|NCT01642485|179749|P4|COMPLETED|Period 1, Day 1||4
75024|NCT01642485|179750|P3|COMPLETED|Period 1, Day 1||4
75025|NCT01642485|179751|P2|COMPLETED|Period 1, Day 1||4
75026|NCT01642485|179752|P1|COMPLETED|Period 1, Day 1||4
75027|NCT01642485|179745|P8|STARTED|Period 1, Day 1||4
75028|NCT01642485|179746|P7|STARTED|Period 1, Day 1||4
75029|NCT01642485|179747|P6|STARTED|Period 1, Day 1||4
75030|NCT01642485|179748|P5|STARTED|Period 1, Day 1||4
75031|NCT01642485|179749|P4|STARTED|Period 1, Day 1||4
75032|NCT01642485|179750|P3|STARTED|Period 1, Day 1||4
75033|NCT01642485|179751|P2|STARTED|Period 1, Day 1||4
75034|NCT01642485|179752|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
75035|NCT01642407|179770|P1|NOT COMPLETED|Overall Study||2
75036|NCT01642407|179770|P1|COMPLETED|Overall Study||4
75037|NCT01642407|179770|P1|STARTED|Overall Study||6
75038|NCT01642277|179814|P2|NOT COMPLETED|Overall Study||0
75039|NCT01642277|179815|P1|NOT COMPLETED|Overall Study||24
75040|NCT01642277|179814|P2|COMPLETED|Overall Study||60
75041|NCT01642277|179815|P1|COMPLETED|Overall Study||50
75042|NCT01642277|179814|P2|STARTED|Overall Study||60
75043|NCT01642277|179815|P1|STARTED|Overall Study||74
75044|NCT01642238|179824|P2|NOT COMPLETED|Second Intervention (1 Day)||0
75045|NCT01642238|179825|P1|NOT COMPLETED|Second Intervention (1 Day)||0
75046|NCT01642238|179824|P2|COMPLETED|Second Intervention (1 Day)||8
75047|NCT01642238|179825|P1|COMPLETED|Second Intervention (1 Day)||7
75048|NCT01642238|179824|P2|STARTED|Second Intervention (1 Day)||8
75049|NCT01642238|179825|P1|STARTED|Second Intervention (1 Day)||7
75050|NCT01642238|179824|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
75051|NCT01642238|179825|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
75052|NCT01642238|179824|P2|COMPLETED|Washout (1-2 Weeks)||8
75053|NCT01642238|179825|P1|COMPLETED|Washout (1-2 Weeks)||7
75054|NCT01642238|179824|P2|STARTED|Washout (1-2 Weeks)||8
75055|NCT01642238|179825|P1|STARTED|Washout (1-2 Weeks)||7
75056|NCT01642238|179824|P2|NOT COMPLETED|First Intervention (1 Day)||0
75057|NCT01642238|179825|P1|NOT COMPLETED|First Intervention (1 Day)||0
75058|NCT01642238|179824|P2|COMPLETED|First Intervention (1 Day)||8
75059|NCT01642238|179825|P1|COMPLETED|First Intervention (1 Day)||7
75060|NCT01642238|179824|P2|STARTED|First Intervention (1 Day)||8
75061|NCT01642238|179825|P1|STARTED|First Intervention (1 Day)||7
75062|NCT01642212|179847|P5|NOT COMPLETED|Open-label Extension||8
75063|NCT01642212|179848|P4|NOT COMPLETED|Open-label Extension||10
75064|NCT01642212|179849|P3|NOT COMPLETED|Open-label Extension||0
75065|NCT01642212|179850|P2|NOT COMPLETED|Open-label Extension||0
75066|NCT01642212|179851|P1|NOT COMPLETED|Open-label Extension||0
75067|NCT01642212|179847|P5|COMPLETED|Open-label Extension||37
75068|NCT01642212|179848|P4|COMPLETED|Open-label Extension||27
75069|NCT01642212|179849|P3|COMPLETED|Open-label Extension||0
75070|NCT01642212|179850|P2|COMPLETED|Open-label Extension||0
75071|NCT01642212|179851|P1|COMPLETED|Open-label Extension||0
75072|NCT01642212|179847|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
75073|NCT01642212|179848|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
75074|NCT01642212|179849|P3|STARTED|Open-label Extension||0
75075|NCT01642212|179850|P2|STARTED|Open-label Extension||0
75076|NCT01642212|179851|P1|STARTED|Open-label Extension||0
75077|NCT01642212|179847|P5|NOT COMPLETED|Double-blind Treatment||0
75078|NCT01642212|179848|P4|NOT COMPLETED|Double-blind Treatment||0
75079|NCT01642212|179849|P3|NOT COMPLETED|Double-blind Treatment||2
75080|NCT01642212|179850|P2|NOT COMPLETED|Double-blind Treatment||3
75081|NCT01642212|179851|P1|NOT COMPLETED|Double-blind Treatment||0
75082|NCT01642212|179847|P5|COMPLETED|Double-blind Treatment||0
75083|NCT01642212|179848|P4|COMPLETED|Double-blind Treatment||0
75084|NCT01642212|179849|P3|COMPLETED|Double-blind Treatment||49
75085|NCT01642212|179850|P2|COMPLETED|Double-blind Treatment||39
75086|NCT01642212|179851|P1|COMPLETED|Double-blind Treatment||0
75087|NCT01642212|179847|P5|STARTED|Double-blind Treatment||0
75088|NCT01642212|179848|P4|STARTED|Double-blind Treatment||0
75089|NCT01642212|179849|P3|STARTED|Double-blind Treatment||51
75090|NCT01642212|179850|P2|STARTED|Double-blind Treatment||42
75091|NCT01642212|179851|P1|STARTED|Double-blind Treatment||0
75092|NCT01642212|179847|P5|NOT COMPLETED|Single-blind Baseline||0
75093|NCT01642212|179848|P4|NOT COMPLETED|Single-blind Baseline||0
75094|NCT01642212|179849|P3|NOT COMPLETED|Single-blind Baseline||0
75095|NCT01642212|179850|P2|NOT COMPLETED|Single-blind Baseline||0
75096|NCT01642212|179851|P1|NOT COMPLETED|Single-blind Baseline||26
75097|NCT01642212|179847|P5|COMPLETED|Single-blind Baseline||0
75098|NCT01642212|179848|P4|COMPLETED|Single-blind Baseline||0
75099|NCT01642212|179849|P3|COMPLETED|Single-blind Baseline||0
75100|NCT01642212|179850|P2|COMPLETED|Single-blind Baseline||0
75101|NCT01642212|179851|P1|COMPLETED|Single-blind Baseline||93
75102|NCT01642212|179847|P5|STARTED|Single-blind Baseline||0
75103|NCT01642212|179848|P4|STARTED|Single-blind Baseline||0
75104|NCT01642212|179849|P3|STARTED|Single-blind Baseline||0
75105|NCT01642212|179850|P2|STARTED|Single-blind Baseline||0
75106|NCT01642212|179851|P1|STARTED|Single-blind Baseline||119
75107|NCT01642147|179901|P2|NOT COMPLETED|Overall Study||0
75108|NCT01642147|179902|P1|NOT COMPLETED|Overall Study||0
75109|NCT01642147|179901|P2|COMPLETED|Overall Study||30
75110|NCT01642147|179902|P1|COMPLETED|Overall Study||30
75111|NCT01642147|179901|P2|STARTED|Overall Study||30
75112|NCT01642147|179902|P1|STARTED|Overall Study||30
75113|NCT01642082|179930|P1|NOT COMPLETED|Overall Study||0
75114|NCT01642082|179930|P1|COMPLETED|Overall Study||28
75115|NCT01642082|179930|P1|STARTED|Overall Study||28
75116|NCT01642004|179946|P2|NOT COMPLETED|Treatment||127
75117|NCT01642004|179947|P1|NOT COMPLETED|Treatment||110
75118|NCT01642004|179946|P2|COMPLETED|Treatment||2
75119|NCT01642004|179947|P1|COMPLETED|Treatment||21
75120|NCT01642004|179946|P2|STARTED|Treatment||129
75121|NCT01642004|179947|P1|STARTED|Treatment||131
75122|NCT01642004|179946|P2|NOT COMPLETED|Randomization||8
75123|NCT01642004|179947|P1|NOT COMPLETED|Randomization||4
75124|NCT01642004|179946|P2|COMPLETED|Randomization||129
75125|NCT01642004|179947|P1|COMPLETED|Randomization||131
75126|NCT01642004|179946|P2|STARTED|Randomization||137
75127|NCT01642004|179947|P1|STARTED|Randomization||135
75128|NCT01641991|179981|P4|NOT COMPLETED|Overall Study||16
75129|NCT01641991|179982|P3|NOT COMPLETED|Overall Study||17
75130|NCT01641991|179983|P2|NOT COMPLETED|Overall Study||8
75131|NCT01641991|179984|P1|NOT COMPLETED|Overall Study||9
75132|NCT01641991|179981|P4|COMPLETED|Overall Study||66
75133|NCT01641991|179982|P3|COMPLETED|Overall Study||65
75134|NCT01641991|179983|P2|COMPLETED|Overall Study||74
75135|NCT01641991|179984|P1|COMPLETED|Overall Study||73
75136|NCT01641991|179981|P4|STARTED|Overall Study||82
75137|NCT01641991|179982|P3|STARTED|Overall Study||82
75138|NCT01641991|179983|P2|STARTED|Overall Study||82
75139|NCT01641991|179984|P1|STARTED|Overall Study||82
75140|NCT01641978|180060|P1|NOT COMPLETED|Overall Study||0
75141|NCT01641978|180060|P1|COMPLETED|Overall Study||125
75142|NCT01641978|180060|P1|STARTED|Overall Study||125
75143|NCT01641952|180068|P1|NOT COMPLETED|Overall Study||34
75144|NCT01641952|180068|P1|COMPLETED|Overall Study||471
75145|NCT01641952|180068|P1|Treated|Overall Study||504
75146|NCT01641952|180068|P1|STARTED|Overall Study||505
75147|NCT01641939|180084|P3|NOT COMPLETED|Overall Study||70
75148|NCT01641939|180085|P2|NOT COMPLETED|Overall Study||228
75149|NCT01641939|180086|P1|NOT COMPLETED|Overall Study||117
75150|NCT01641939|180084|P3|COMPLETED|Overall Study||0
75151|NCT01641939|180085|P2|COMPLETED|Overall Study||0
75152|NCT01641939|180086|P1|COMPLETED|Overall Study||0
75153|NCT01641939|180084|P3|Stage 2|Overall Study||0
75154|NCT01641939|180085|P2|Stage 2|Overall Study||153
75155|NCT01641939|180086|P1|Stage 2|Overall Study||80
75156|NCT01641939|180084|P3|Stage 1|Overall Study||70
75157|NCT01641939|180085|P2|Stage 1|Overall Study||75
75158|NCT01641939|180086|P1|Stage 1|Overall Study||37
75159|NCT01641939|180084|P3|STARTED|Overall Study||70
75160|NCT01641939|180085|P2|STARTED|Overall Study||228
75161|NCT01641939|180086|P1|STARTED|Overall Study||117
75162|NCT01641926|180129|P4|NOT COMPLETED|Overall Study||4
75163|NCT01641926|180130|P3|NOT COMPLETED|Overall Study||11
75164|NCT01641926|180131|P2|NOT COMPLETED|Overall Study||15
75165|NCT01641926|180132|P1|NOT COMPLETED|Overall Study||28
75166|NCT01641926|180129|P4|COMPLETED|Overall Study||53
75167|NCT01641926|180130|P3|COMPLETED|Overall Study||46
75168|NCT01641926|180131|P2|COMPLETED|Overall Study||130
75169|NCT01641926|180132|P1|COMPLETED|Overall Study||115
75170|NCT01641926|180129|P4|Treated (All Participants as Treated)|Overall Study||57
75171|NCT01641926|180130|P3|Treated (All Participants as Treated)|Overall Study||56
75172|NCT01641926|180131|P2|Treated (All Participants as Treated)|Overall Study||144
75173|NCT01641926|180132|P1|Treated (All Participants as Treated)|Overall Study||142
75174|NCT01641926|180129|P4|STARTED|Overall Study||57
75175|NCT01641926|180130|P3|STARTED|Overall Study||57
75176|NCT01641926|180131|P2|STARTED|Overall Study||145
75177|NCT01641926|180132|P1|STARTED|Overall Study||143
75178|NCT01641900|180160|P2|NOT COMPLETED|Overall Study||2
75179|NCT01641900|180161|P1|NOT COMPLETED|Overall Study||2
75180|NCT01641900|180160|P2|COMPLETED|Overall Study||29
75181|NCT01641900|180161|P1|COMPLETED|Overall Study||26
75182|NCT01641900|180160|P2|Completed Drug Intervention|Overall Study||29
75183|NCT01641900|180161|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
75184|NCT01641900|180160|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
75185|NCT01641900|180161|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
75186|NCT01641900|180160|P2|STARTED|Overall Study||31
75187|NCT01641900|180161|P1|STARTED|Overall Study||28
75188|NCT01641861|180173|P2|NOT COMPLETED|Overall Study||25
75189|NCT01641861|180174|P1|NOT COMPLETED|Overall Study||35
75190|NCT01641861|180173|P2|COMPLETED|Overall Study||217
75191|NCT01641861|180174|P1|COMPLETED|Overall Study||211
75192|NCT01641861|180173|P2|STARTED|Overall Study||242
75193|NCT01641861|180174|P1|STARTED|Overall Study||246
75194|NCT01641835|180188|P1|NOT COMPLETED|Overall Study||0
75195|NCT01641835|180188|P1|COMPLETED|Overall Study||303
75196|NCT01641835|180188|P1|STARTED|Overall Study||303
75197|NCT01641822|180195|P3|NOT COMPLETED|Comparative Phase||10
75198|NCT01641822|180196|P2|NOT COMPLETED|Comparative Phase||6
75199|NCT01641822|180197|P1|NOT COMPLETED|Comparative Phase||0
75200|NCT01641822|180195|P3|COMPLETED|Comparative Phase||37
75201|NCT01641822|180196|P2|COMPLETED|Comparative Phase||37
75202|NCT01641822|180197|P1|COMPLETED|Comparative Phase||0
75203|NCT01641822|180195|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
75204|NCT01641822|180196|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
75205|NCT01641822|180197|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
75206|NCT01641822|180195|P3|STARTED|Comparative Phase||47
75207|NCT01641822|180196|P2|STARTED|Comparative Phase||43
75208|NCT01641822|180197|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
75209|NCT01641822|180195|P3|NOT COMPLETED|Run-in Phase||0
75210|NCT01641822|180196|P2|NOT COMPLETED|Run-in Phase||0
75211|NCT01641822|180197|P1|NOT COMPLETED|Run-in Phase||14
75212|NCT01641822|180195|P3|COMPLETED|Run-in Phase||0
75213|NCT01641822|180196|P2|COMPLETED|Run-in Phase||0
75214|NCT01641822|180197|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
75215|NCT01641822|180195|P3|STARTED|Run-in Phase||0
75216|NCT01641822|180196|P2|STARTED|Run-in Phase||0
75217|NCT01641822|180197|P1|STARTED|Run-in Phase||107
75218|NCT01641692|180214|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
75219|NCT01641692|180215|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
75220|NCT01641692|180216|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
75221|NCT01641692|180217|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
75222|NCT01641692|180218|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
75223|NCT01641692|180219|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
75224|NCT01641692|180220|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
75225|NCT01641692|180221|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
75226|NCT01641692|180214|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
75227|NCT01641692|180215|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
75228|NCT01641692|180216|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
75229|NCT01641692|180217|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
75230|NCT01641692|180218|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
75231|NCT01641692|180219|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
75232|NCT01641692|180220|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
75233|NCT01641692|180221|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
75234|NCT01641692|180214|P8|STARTED|Washout Period 3 or Follow-up||38
75235|NCT01641692|180215|P7|STARTED|Washout Period 3 or Follow-up||33
75236|NCT01641692|180216|P6|STARTED|Washout Period 3 or Follow-up||39
75237|NCT01641692|180217|P5|STARTED|Washout Period 3 or Follow-up||40
75238|NCT01641692|180218|P4|STARTED|Washout Period 3 or Follow-up||42
75239|NCT01641692|180219|P3|STARTED|Washout Period 3 or Follow-up||37
75240|NCT01641692|180220|P2|STARTED|Washout Period 3 or Follow-up||32
75241|NCT01641692|180221|P1|STARTED|Washout Period 3 or Follow-up||43
75242|NCT01641692|180214|P8|NOT COMPLETED|Treatment Period 3||0
75243|NCT01641692|180215|P7|NOT COMPLETED|Treatment Period 3||2
75244|NCT01641692|180216|P6|NOT COMPLETED|Treatment Period 3||0
75245|NCT01641692|180217|P5|NOT COMPLETED|Treatment Period 3||0
75246|NCT01641692|180218|P4|NOT COMPLETED|Treatment Period 3||0
75247|NCT01641692|180219|P3|NOT COMPLETED|Treatment Period 3||1
75248|NCT01641692|180220|P2|NOT COMPLETED|Treatment Period 3||1
75249|NCT01641692|180221|P1|NOT COMPLETED|Treatment Period 3||0
75250|NCT01641692|180214|P8|COMPLETED|Treatment Period 3||38
75251|NCT01641692|180215|P7|COMPLETED|Treatment Period 3||33
75252|NCT01641692|180216|P6|COMPLETED|Treatment Period 3||39
75253|NCT01641692|180217|P5|COMPLETED|Treatment Period 3||40
75254|NCT01641692|180218|P4|COMPLETED|Treatment Period 3||42
75255|NCT01641692|180219|P3|COMPLETED|Treatment Period 3||37
75256|NCT01641692|180220|P2|COMPLETED|Treatment Period 3||32
75257|NCT01641692|180221|P1|COMPLETED|Treatment Period 3||43
75258|NCT01641692|180214|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
75259|NCT01641692|180215|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
75260|NCT01641692|180216|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
75261|NCT01641692|180217|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
75262|NCT01641692|180218|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
75263|NCT01641692|180219|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
75264|NCT01641692|180220|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
75265|NCT01641692|180221|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
75266|NCT01641692|180214|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
75267|NCT01641692|180215|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
75268|NCT01641692|180216|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
75269|NCT01641692|180217|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
75270|NCT01641692|180218|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
75271|NCT01641692|180219|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
75272|NCT01641692|180220|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
75273|NCT01641692|180221|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
75274|NCT01641692|180214|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
75275|NCT01641692|180215|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
75276|NCT01641692|180216|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
75277|NCT01641692|180217|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
75278|NCT01641692|180218|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
75279|NCT01641692|180219|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
75280|NCT01641692|180220|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
75281|NCT01641692|180221|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
75282|NCT01641692|180214|P8|STARTED|Washout Period 2 (12-14 Days)||35
75283|NCT01641692|180215|P7|STARTED|Washout Period 2 (12-14 Days)||43
75284|NCT01641692|180216|P6|STARTED|Washout Period 2 (12-14 Days)||43
75285|NCT01641692|180217|P5|STARTED|Washout Period 2 (12-14 Days)||37
75286|NCT01641692|180218|P4|STARTED|Washout Period 2 (12-14 Days)||41
75287|NCT01641692|180219|P3|STARTED|Washout Period 2 (12-14 Days)||40
75288|NCT01641692|180220|P2|STARTED|Washout Period 2 (12-14 Days)||46
75289|NCT01641692|180221|P1|STARTED|Washout Period 2 (12-14 Days)||30
75290|NCT01641692|180214|P8|NOT COMPLETED|Treatment Period 2||1
75291|NCT01641692|180215|P7|NOT COMPLETED|Treatment Period 2||0
75292|NCT01641692|180216|P6|NOT COMPLETED|Treatment Period 2||2
75293|NCT01641692|180217|P5|NOT COMPLETED|Treatment Period 2||0
75294|NCT01641692|180218|P4|NOT COMPLETED|Treatment Period 2||0
75295|NCT01641692|180219|P3|NOT COMPLETED|Treatment Period 2||0
75296|NCT01641692|180220|P2|NOT COMPLETED|Treatment Period 2||0
75297|NCT01641692|180221|P1|NOT COMPLETED|Treatment Period 2||3
75298|NCT01641692|180214|P8|COMPLETED|Treatment Period 2||35
75299|NCT01641692|180215|P7|COMPLETED|Treatment Period 2||43
75300|NCT01641692|180216|P6|COMPLETED|Treatment Period 2||43
75301|NCT01641692|180217|P5|COMPLETED|Treatment Period 2||37
75302|NCT01641692|180218|P4|COMPLETED|Treatment Period 2||41
75303|NCT01641692|180219|P3|COMPLETED|Treatment Period 2||40
75304|NCT01641692|180220|P2|COMPLETED|Treatment Period 2||46
75305|NCT01641692|180221|P1|COMPLETED|Treatment Period 2||30
75306|NCT01641692|180214|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
75307|NCT01641692|180215|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
75308|NCT01641692|180216|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
75309|NCT01641692|180217|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
75310|NCT01641692|180218|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
75311|NCT01641692|180219|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
75312|NCT01641692|180220|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
75313|NCT01641692|180221|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
75314|NCT01641692|180214|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
75315|NCT01641692|180215|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
75316|NCT01641692|180216|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
75317|NCT01641692|180217|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
75318|NCT01641692|180218|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
75319|NCT01641692|180219|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
75320|NCT01641692|180220|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
75321|NCT01641692|180221|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
75322|NCT01641692|180214|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
75323|NCT01641692|180215|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
75324|NCT01641692|180216|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
75325|NCT01641692|180217|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
75326|NCT01641692|180218|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
75327|NCT01641692|180219|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
75328|NCT01641692|180220|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
75329|NCT01641692|180221|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
75330|NCT01641692|180214|P8|STARTED|Washout Period 1 (12-14 Days)||48
75331|NCT01641692|180215|P7|STARTED|Washout Period 1 (12-14 Days)||38
75332|NCT01641692|180216|P6|STARTED|Washout Period 1 (12-14 Days)||37
75333|NCT01641692|180217|P5|STARTED|Washout Period 1 (12-14 Days)||39
75334|NCT01641692|180218|P4|STARTED|Washout Period 1 (12-14 Days)||41
75335|NCT01641692|180219|P3|STARTED|Washout Period 1 (12-14 Days)||50
75336|NCT01641692|180220|P2|STARTED|Washout Period 1 (12-14 Days)||45
75337|NCT01641692|180221|P1|STARTED|Washout Period 1 (12-14 Days)||40
75338|NCT01641692|180214|P8|NOT COMPLETED|Treatment Period 1||3
75339|NCT01641692|180215|P7|NOT COMPLETED|Treatment Period 1||0
75340|NCT01641692|180216|P6|NOT COMPLETED|Treatment Period 1||2
75341|NCT01641692|180217|P5|NOT COMPLETED|Treatment Period 1||4
75342|NCT01641692|180218|P4|NOT COMPLETED|Treatment Period 1||0
75343|NCT01641692|180219|P3|NOT COMPLETED|Treatment Period 1||1
75344|NCT01641692|180220|P2|NOT COMPLETED|Treatment Period 1||0
75345|NCT01641692|180221|P1|NOT COMPLETED|Treatment Period 1||2
75346|NCT01641692|180214|P8|COMPLETED|Treatment Period 1||48
75347|NCT01641692|180215|P7|COMPLETED|Treatment Period 1||38
75348|NCT01641692|180216|P6|COMPLETED|Treatment Period 1||37
75349|NCT01641692|180217|P5|COMPLETED|Treatment Period 1||39
75350|NCT01641692|180218|P4|COMPLETED|Treatment Period 1||41
75351|NCT01641692|180219|P3|COMPLETED|Treatment Period 1||50
75352|NCT01641692|180220|P2|COMPLETED|Treatment Period 1||45
75353|NCT01641692|180221|P1|COMPLETED|Treatment Period 1||40
75354|NCT01641692|180214|P8|STARTED|Treatment Period 1||51
75355|NCT01641692|180215|P7|STARTED|Treatment Period 1||38
75356|NCT01641692|180216|P6|STARTED|Treatment Period 1||39
75357|NCT01641692|180217|P5|STARTED|Treatment Period 1||43
75358|NCT01641692|180218|P4|STARTED|Treatment Period 1||41
75359|NCT01641692|180219|P3|STARTED|Treatment Period 1||51
75360|NCT01641692|180220|P2|STARTED|Treatment Period 1||45
75361|NCT01641692|180221|P1|STARTED|Treatment Period 1||42
75362|NCT01641653|180410|P2|NOT COMPLETED|Overall Study||0
75363|NCT01641653|180411|P1|NOT COMPLETED|Overall Study||0
75364|NCT01641653|180410|P2|COMPLETED|Overall Study||30
75365|NCT01641653|180411|P1|COMPLETED|Overall Study||30
75366|NCT01641653|180410|P2|STARTED|Overall Study||30
75367|NCT01641653|180411|P1|STARTED|Overall Study||30
75368|NCT01641640|180421|P1|NOT COMPLETED|Overall Study||36
75369|NCT01641640|180421|P1|COMPLETED|Overall Study||292
75370|NCT01641640|180421|P1|Enrolled and Treated|Overall Study||327
75371|NCT01641640|180421|P1|STARTED|Overall Study||328
75372|NCT01641471|180432|P2|NOT COMPLETED|Overall Study||27
75373|NCT01641471|180433|P1|NOT COMPLETED|Overall Study||23
75374|NCT01641471|180432|P2|COMPLETED|Overall Study||31
75375|NCT01641471|180433|P1|COMPLETED|Overall Study||35
75376|NCT01641471|180432|P2|STARTED|Overall Study||58
75377|NCT01641471|180433|P1|STARTED|Overall Study||58
75378|NCT01641367|180451|P6|NOT COMPLETED|Overall Study||1
75379|NCT01641367|180452|P5|NOT COMPLETED|Overall Study||3
75380|NCT01641367|180453|P4|NOT COMPLETED|Overall Study||0
75381|NCT01641367|180454|P3|NOT COMPLETED|Overall Study||4
75382|NCT01641367|180455|P2|NOT COMPLETED|Overall Study||1
75383|NCT01641367|180456|P1|NOT COMPLETED|Overall Study||34
75384|NCT01641367|180451|P6|COMPLETED|Overall Study||33
75385|NCT01641367|180452|P5|COMPLETED|Overall Study||67
75386|NCT01641367|180453|P4|COMPLETED|Overall Study||8
75387|NCT01641367|180454|P3|COMPLETED|Overall Study||68
75388|NCT01641367|180455|P2|COMPLETED|Overall Study||73
75389|NCT01641367|180456|P1|COMPLETED|Overall Study||253
75390|NCT01641367|180451|P6|STARTED|Overall Study||34
75391|NCT01641367|180452|P5|STARTED|Overall Study||70
75392|NCT01641367|180453|P4|STARTED|Overall Study||8
75393|NCT01641367|180454|P3|STARTED|Overall Study||72
75394|NCT01641367|180455|P2|STARTED|Overall Study||74
75395|NCT01641367|180456|P1|STARTED|Overall Study||287
75396|NCT01641237|180471|P4|NOT COMPLETED|Period IV||0
75397|NCT01641237|180472|P3|NOT COMPLETED|Period IV||0
75398|NCT01641237|180473|P2|NOT COMPLETED|Period IV||0
75399|NCT01641237|180474|P1|NOT COMPLETED|Period IV||0
75400|NCT01641237|180471|P4|COMPLETED|Period IV||15
75401|NCT01641237|180472|P3|COMPLETED|Period IV||15
75402|NCT01641237|180473|P2|COMPLETED|Period IV||15
75403|NCT01641237|180474|P1|COMPLETED|Period IV||15
75404|NCT01641237|180471|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
75405|NCT01641237|180472|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
75406|NCT01641237|180473|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
75407|NCT01641237|180474|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
75408|NCT01641237|180471|P4|NOT COMPLETED|Period III||0
75409|NCT01641237|180472|P3|NOT COMPLETED|Period III||0
75410|NCT01641237|180473|P2|NOT COMPLETED|Period III||0
75411|NCT01641237|180474|P1|NOT COMPLETED|Period III||1
75412|NCT01641237|180471|P4|COMPLETED|Period III||16
75413|NCT01641237|180472|P3|COMPLETED|Period III||15
75414|NCT01641237|180473|P2|COMPLETED|Period III||14
75415|NCT01641237|180474|P1|COMPLETED|Period III||15
75416|NCT01641237|180471|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
75417|NCT01641237|180472|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
75418|NCT01641237|180473|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
75419|NCT01641237|180474|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
75420|NCT01641237|180471|P4|NOT COMPLETED|Period II||0
75421|NCT01641237|180472|P3|NOT COMPLETED|Period II||0
75422|NCT01641237|180473|P2|NOT COMPLETED|Period II||0
75423|NCT01641237|180474|P1|NOT COMPLETED|Period II||1
75424|NCT01641237|180471|P4|COMPLETED|Period II||15
75425|NCT01641237|180472|P3|COMPLETED|Period II||16
75426|NCT01641237|180473|P2|COMPLETED|Period II||16
75427|NCT01641237|180474|P1|COMPLETED|Period II||14
75428|NCT01641237|180471|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
75429|NCT01641237|180472|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
75430|NCT01641237|180473|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
75431|NCT01641237|180474|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
75432|NCT01641237|180471|P4|NOT COMPLETED|Period I||0
75433|NCT01641237|180472|P3|NOT COMPLETED|Period I||0
75434|NCT01641237|180473|P2|NOT COMPLETED|Period I||0
75435|NCT01641237|180474|P1|NOT COMPLETED|Period I||0
75436|NCT01641237|180471|P4|COMPLETED|Period I||15
75437|NCT01641237|180472|P3|COMPLETED|Period I||15
75438|NCT01641237|180473|P2|COMPLETED|Period I||16
75439|NCT01641237|180474|P1|COMPLETED|Period I||16
75440|NCT01641237|180471|P4|STARTED|Period I||15
75441|NCT01641237|180472|P3|STARTED|Period I||15
75442|NCT01641237|180473|P2|STARTED|Period I||16
75443|NCT01641237|180474|P1|STARTED|Period I||16
75444|NCT01641159|180498|P2|NOT COMPLETED|Overall Study||2
75445|NCT01641159|180499|P1|NOT COMPLETED|Overall Study||2
75446|NCT01641159|180498|P2|COMPLETED|Overall Study||25
75447|NCT01641159|180499|P1|COMPLETED|Overall Study||33
75448|NCT01641159|180498|P2|STARTED|Overall Study||27
75449|NCT01641159|180499|P1|STARTED|Overall Study||35
75450|NCT01641133|180510|P3|NOT COMPLETED|Overall Study||8
75451|NCT01641133|180511|P2|NOT COMPLETED|Overall Study||9
75452|NCT01641133|180512|P1|NOT COMPLETED|Overall Study||10
75453|NCT01641133|180510|P3|COMPLETED|Overall Study||90
75454|NCT01641133|180511|P2|COMPLETED|Overall Study||90
75455|NCT01641133|180512|P1|COMPLETED|Overall Study||87
75456|NCT01641133|180510|P3|STARTED|Overall Study||98
75457|NCT01641133|180511|P2|STARTED|Overall Study||99
75458|NCT01641133|180512|P1|STARTED|Overall Study||97
75459|NCT01641120|180550|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
75460|NCT01641120|180550|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
75461|NCT01641120|180550|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
75462|NCT01641120|180550|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
75463|NCT01641120|180550|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
75464|NCT01641120|180550|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
75465|NCT01641081|180562|P10|NOT COMPLETED|Period 5||0
75466|NCT01641081|180563|P9|NOT COMPLETED|Period 5||0
75467|NCT01641081|180564|P8|NOT COMPLETED|Period 5||0
75468|NCT01641081|180565|P7|NOT COMPLETED|Period 5||0
75469|NCT01641081|180566|P6|NOT COMPLETED|Period 5||0
75470|NCT01641081|180567|P5|NOT COMPLETED|Period 5||0
75471|NCT01641081|180568|P4|NOT COMPLETED|Period 5||0
75472|NCT01641081|180569|P3|NOT COMPLETED|Period 5||2
75473|NCT01641081|180570|P2|NOT COMPLETED|Period 5||0
75474|NCT01641081|180571|P1|NOT COMPLETED|Period 5||0
75475|NCT01641081|180562|P10|COMPLETED|Period 5||14
75476|NCT01641081|180563|P9|COMPLETED|Period 5||14
75477|NCT01641081|180564|P8|COMPLETED|Period 5||14
75478|NCT01641081|180565|P7|COMPLETED|Period 5||16
75479|NCT01641081|180566|P6|COMPLETED|Period 5||18
75480|NCT01641081|180567|P5|COMPLETED|Period 5||16
75481|NCT01641081|180568|P4|COMPLETED|Period 5||20
75482|NCT01641081|180569|P3|COMPLETED|Period 5||12
75483|NCT01641081|180570|P2|COMPLETED|Period 5||17
75484|NCT01641081|180571|P1|COMPLETED|Period 5||16
75485|NCT01641081|180562|P10|STARTED|Period 5||14
75486|NCT01641081|180563|P9|STARTED|Period 5||14
75487|NCT01641081|180564|P8|STARTED|Period 5||14
75488|NCT01641081|180565|P7|STARTED|Period 5||16
75489|NCT01641081|180566|P6|STARTED|Period 5||18
75490|NCT01641081|180567|P5|STARTED|Period 5||16
75491|NCT01641081|180568|P4|STARTED|Period 5||20
75492|NCT01641081|180569|P3|STARTED|Period 5||14
75493|NCT01641081|180570|P2|STARTED|Period 5||17
75494|NCT01641081|180571|P1|STARTED|Period 5||16
75495|NCT01641081|180562|P10|NOT COMPLETED|Period 4||0
75496|NCT01641081|180563|P9|NOT COMPLETED|Period 4||0
75497|NCT01641081|180564|P8|NOT COMPLETED|Period 4||0
75498|NCT01641081|180565|P7|NOT COMPLETED|Period 4||0
75499|NCT01641081|180566|P6|NOT COMPLETED|Period 4||0
75500|NCT01641081|180567|P5|NOT COMPLETED|Period 4||0
75501|NCT01641081|180568|P4|NOT COMPLETED|Period 4||1
75502|NCT01641081|180569|P3|NOT COMPLETED|Period 4||0
75503|NCT01641081|180570|P2|NOT COMPLETED|Period 4||1
75504|NCT01641081|180571|P1|NOT COMPLETED|Period 4||0
75505|NCT01641081|180562|P10|COMPLETED|Period 4||14
75506|NCT01641081|180563|P9|COMPLETED|Period 4||14
75507|NCT01641081|180564|P8|COMPLETED|Period 4||14
75508|NCT01641081|180565|P7|COMPLETED|Period 4||16
75509|NCT01641081|180566|P6|COMPLETED|Period 4||18
75510|NCT01641081|180567|P5|COMPLETED|Period 4||16
75511|NCT01641081|180568|P4|COMPLETED|Period 4||20
75512|NCT01641081|180569|P3|COMPLETED|Period 4||14
75513|NCT01641081|180570|P2|COMPLETED|Period 4||17
75514|NCT01641081|180571|P1|COMPLETED|Period 4||16
75515|NCT01641081|180562|P10|STARTED|Period 4||14
75516|NCT01641081|180563|P9|STARTED|Period 4||14
75517|NCT01641081|180564|P8|STARTED|Period 4||14
75518|NCT01641081|180565|P7|STARTED|Period 4||16
75519|NCT01641081|180566|P6|STARTED|Period 4||18
75520|NCT01641081|180567|P5|STARTED|Period 4||16
75521|NCT01641081|180568|P4|STARTED|Period 4||21
75522|NCT01641081|180569|P3|STARTED|Period 4||14
75523|NCT01641081|180570|P2|STARTED|Period 4||18
75524|NCT01641081|180571|P1|STARTED|Period 4||16
75525|NCT01641081|180562|P10|NOT COMPLETED|Period 3||0
75526|NCT01641081|180563|P9|NOT COMPLETED|Period 3||1
75527|NCT01641081|180564|P8|NOT COMPLETED|Period 3||0
75528|NCT01641081|180565|P7|NOT COMPLETED|Period 3||0
75529|NCT01641081|180566|P6|NOT COMPLETED|Period 3||0
75530|NCT01641081|180567|P5|NOT COMPLETED|Period 3||0
75531|NCT01641081|180568|P4|NOT COMPLETED|Period 3||0
75532|NCT01641081|180569|P3|NOT COMPLETED|Period 3||1
75533|NCT01641081|180570|P2|NOT COMPLETED|Period 3||0
75534|NCT01641081|180571|P1|NOT COMPLETED|Period 3||0
75535|NCT01641081|180562|P10|COMPLETED|Period 3||14
75536|NCT01641081|180563|P9|COMPLETED|Period 3||14
75537|NCT01641081|180564|P8|COMPLETED|Period 3||14
75538|NCT01641081|180565|P7|COMPLETED|Period 3||16
75539|NCT01641081|180566|P6|COMPLETED|Period 3||18
75540|NCT01641081|180567|P5|COMPLETED|Period 3||16
75541|NCT01641081|180568|P4|COMPLETED|Period 3||21
75542|NCT01641081|180569|P3|COMPLETED|Period 3||14
75543|NCT01641081|180570|P2|COMPLETED|Period 3||18
75544|NCT01641081|180571|P1|COMPLETED|Period 3||16
75545|NCT01641081|180562|P10|STARTED|Period 3||14
75546|NCT01641081|180563|P9|STARTED|Period 3||15
75547|NCT01641081|180564|P8|STARTED|Period 3||14
75548|NCT01641081|180565|P7|STARTED|Period 3||16
75549|NCT01641081|180566|P6|STARTED|Period 3||18
75550|NCT01641081|180567|P5|STARTED|Period 3||16
75551|NCT01641081|180568|P4|STARTED|Period 3||21
75552|NCT01641081|180569|P3|STARTED|Period 3||15
75553|NCT01641081|180570|P2|STARTED|Period 3||18
75554|NCT01641081|180571|P1|STARTED|Period 3||16
75555|NCT01641081|180562|P10|NOT COMPLETED|Period 2||0
75556|NCT01641081|180563|P9|NOT COMPLETED|Period 2||0
75557|NCT01641081|180564|P8|NOT COMPLETED|Period 2||0
75558|NCT01641081|180565|P7|NOT COMPLETED|Period 2||2
75559|NCT01641081|180566|P6|NOT COMPLETED|Period 2||1
75560|NCT01641081|180567|P5|NOT COMPLETED|Period 2||0
75561|NCT01641081|180568|P4|NOT COMPLETED|Period 2||1
75562|NCT01641081|180569|P3|NOT COMPLETED|Period 2||0
75563|NCT01641081|180570|P2|NOT COMPLETED|Period 2||0
75564|NCT01641081|180571|P1|NOT COMPLETED|Period 2||1
75565|NCT01641081|180562|P10|COMPLETED|Period 2||14
75566|NCT01641081|180563|P9|COMPLETED|Period 2||15
75567|NCT01641081|180564|P8|COMPLETED|Period 2||14
75568|NCT01641081|180565|P7|COMPLETED|Period 2||16
75569|NCT01641081|180566|P6|COMPLETED|Period 2||18
75570|NCT01641081|180567|P5|COMPLETED|Period 2||16
75571|NCT01641081|180568|P4|COMPLETED|Period 2||21
75572|NCT01641081|180569|P3|COMPLETED|Period 2||15
75573|NCT01641081|180570|P2|COMPLETED|Period 2||18
75574|NCT01641081|180571|P1|COMPLETED|Period 2||16
75575|NCT01641081|180562|P10|STARTED|Period 2||14
75576|NCT01641081|180563|P9|STARTED|Period 2||15
75577|NCT01641081|180564|P8|STARTED|Period 2||14
75578|NCT01641081|180565|P7|STARTED|Period 2||18
75579|NCT01641081|180566|P6|STARTED|Period 2||19
75580|NCT01641081|180567|P5|STARTED|Period 2||16
75581|NCT01641081|180568|P4|STARTED|Period 2||22
75582|NCT01641081|180569|P3|STARTED|Period 2||15
75583|NCT01641081|180570|P2|STARTED|Period 2||18
75584|NCT01641081|180571|P1|STARTED|Period 2||17
75585|NCT01641081|180562|P10|NOT COMPLETED|Period 1||0
75586|NCT01641081|180563|P9|NOT COMPLETED|Period 1||0
75587|NCT01641081|180564|P8|NOT COMPLETED|Period 1||3
75588|NCT01641081|180565|P7|NOT COMPLETED|Period 1||1
75589|NCT01641081|180566|P6|NOT COMPLETED|Period 1||0
75590|NCT01641081|180567|P5|NOT COMPLETED|Period 1||1
75591|NCT01641081|180568|P4|NOT COMPLETED|Period 1||0
75592|NCT01641081|180569|P3|NOT COMPLETED|Period 1||0
75593|NCT01641081|180570|P2|NOT COMPLETED|Period 1||0
75594|NCT01641081|180571|P1|NOT COMPLETED|Period 1||1
75595|NCT01641081|180562|P10|COMPLETED|Period 1||14
75596|NCT01641081|180563|P9|COMPLETED|Period 1||15
75597|NCT01641081|180564|P8|COMPLETED|Period 1||14
75598|NCT01641081|180565|P7|COMPLETED|Period 1||18
75599|NCT01641081|180566|P6|COMPLETED|Period 1||19
75600|NCT01641081|180567|P5|COMPLETED|Period 1||16
75601|NCT01641081|180568|P4|COMPLETED|Period 1||22
75602|NCT01641081|180569|P3|COMPLETED|Period 1||15
75603|NCT01641081|180570|P2|COMPLETED|Period 1||18
75604|NCT01641081|180571|P1|COMPLETED|Period 1||17
75605|NCT01641081|180562|P10|STARTED|Period 1||14
75606|NCT01641081|180563|P9|STARTED|Period 1||15
75607|NCT01641081|180564|P8|STARTED|Period 1||17
75608|NCT01641081|180565|P7|STARTED|Period 1||19
75609|NCT01641081|180566|P6|STARTED|Period 1||19
75610|NCT01641081|180567|P5|STARTED|Period 1||17
75611|NCT01641081|180568|P4|STARTED|Period 1||22
75612|NCT01641081|180569|P3|STARTED|Period 1||15
75613|NCT01641081|180570|P2|STARTED|Period 1||18
75614|NCT01641081|180571|P1|STARTED|Period 1||18
75615|NCT01641042|180590|P2|NOT COMPLETED|Overall Study||0
75616|NCT01641042|180591|P1|NOT COMPLETED|Overall Study||0
75617|NCT01641042|180590|P2|COMPLETED|Overall Study||43
75618|NCT01641042|180591|P1|COMPLETED|Overall Study||43
75619|NCT01641042|180590|P2|STARTED|Overall Study||43
75620|NCT01641042|180591|P1|STARTED|Overall Study||43
75621|NCT01640964|180640|P3|NOT COMPLETED|Overall Study||3
75622|NCT01640964|180641|P2|NOT COMPLETED|Overall Study||1
75623|NCT01640964|180642|P1|NOT COMPLETED|Overall Study||1
75624|NCT01640964|180640|P3|COMPLETED|Overall Study||3
75625|NCT01640964|180641|P2|COMPLETED|Overall Study||19
75626|NCT01640964|180642|P1|COMPLETED|Overall Study||19
75627|NCT01640964|180640|P3|STARTED|Overall Study||6
75628|NCT01640964|180641|P2|STARTED|Overall Study||20
75629|NCT01640964|180642|P1|STARTED|Overall Study||20
75630|NCT01640951|180665|P8|NOT COMPLETED|Overall Study||16
75631|NCT01640951|180666|P7|NOT COMPLETED|Overall Study||18
75632|NCT01640951|180667|P6|NOT COMPLETED|Overall Study||47
75633|NCT01640951|180668|P5|NOT COMPLETED|Overall Study||13
75634|NCT01640951|180669|P4|NOT COMPLETED|Overall Study||45
75635|NCT01640951|180670|P3|NOT COMPLETED|Overall Study||42
75636|NCT01640951|180671|P2|NOT COMPLETED|Overall Study||15
75637|NCT01640951|180672|P1|NOT COMPLETED|Overall Study||46
75638|NCT01640951|180665|P8|COMPLETED|Overall Study||17
75639|NCT01640951|180666|P7|COMPLETED|Overall Study||94
75640|NCT01640951|180667|P6|COMPLETED|Overall Study||13
75641|NCT01640951|180668|P5|COMPLETED|Overall Study||82
75642|NCT01640951|180669|P4|COMPLETED|Overall Study||10
75643|NCT01640951|180670|P3|COMPLETED|Overall Study||126
75644|NCT01640951|180671|P2|COMPLETED|Overall Study||60
75645|NCT01640951|180672|P1|COMPLETED|Overall Study||31
75646|NCT01640951|180665|P8|STARTED|Overall Study||33
75647|NCT01640951|180666|P7|STARTED|Overall Study||112
75648|NCT01640951|180667|P6|STARTED|Overall Study||60
75649|NCT01640951|180668|P5|STARTED|Overall Study||95
75650|NCT01640951|180669|P4|STARTED|Overall Study||55
75651|NCT01640951|180670|P3|STARTED|Overall Study||168
75652|NCT01640951|180671|P2|STARTED|Overall Study||75
75653|NCT01640951|180672|P1|STARTED|Overall Study||77
75654|NCT01640925|180774|P2|NOT COMPLETED|Overall Study||11
75655|NCT01640925|180775|P1|NOT COMPLETED|Overall Study||14
75656|NCT01640925|180774|P2|COMPLETED|Overall Study||164
75657|NCT01640925|180775|P1|COMPLETED|Overall Study||161
75658|NCT01640925|180774|P2|STARTED|Overall Study||175
75659|NCT01640925|180775|P1|STARTED|Overall Study||175
75660|NCT01640548|180787|P1|NOT COMPLETED|Overall Study||0
75661|NCT01640548|180787|P1|COMPLETED|Overall Study||309
75662|NCT01640548|180787|P1|STARTED|Overall Study||309
75663|NCT01640379|180803|P2|NOT COMPLETED|Overall Study||12
75664|NCT01640379|180804|P1|NOT COMPLETED|Overall Study||14
75665|NCT01640379|180803|P2|COMPLETED|Overall Study||125
75666|NCT01640379|180804|P1|COMPLETED|Overall Study||135
75667|NCT01640379|180803|P2|STARTED|Overall Study||137
75668|NCT01640379|180804|P1|STARTED|Overall Study||149
75669|NCT01640353|180812|P1|NOT COMPLETED|Overall Study||45
75670|NCT01640353|180812|P1|COMPLETED|Overall Study||149
75671|NCT01640353|180812|P1|Month 18|Overall Study||150
75672|NCT01640353|180812|P1|Month 12|Overall Study||160
75673|NCT01640353|180812|P1|Month 6|Overall Study||168
75674|NCT01640353|180812|P1|Month 3|Overall Study||169
75675|NCT01640353|180812|P1|Month 1|Overall Study||171
75676|NCT01640353|180812|P1|Treated|Overall Study||172
75677|NCT01640353|180812|P1|STARTED|Overall Study||194
75678|NCT01640340|180824|P2|NOT COMPLETED|Overall Study||0
75679|NCT01640340|180825|P1|NOT COMPLETED|Overall Study||0
75680|NCT01640340|180824|P2|COMPLETED|Overall Study||20
75681|NCT01640340|180825|P1|COMPLETED|Overall Study||20
75682|NCT01640340|180824|P2|Overall Complete Response Rate|Overall Study||20
75683|NCT01640340|180825|P1|Overall Complete Response Rate|Overall Study||20
75684|NCT01640340|180824|P2|STARTED|Overall Study||20
75685|NCT01640340|180825|P1|STARTED|Overall Study||20
75686|NCT01640327|180845|P2|NOT COMPLETED|Overall Study||0
75687|NCT01640327|180846|P1|NOT COMPLETED|Overall Study||0
75688|NCT01640327|180845|P2|COMPLETED|Overall Study||63
75689|NCT01640327|180846|P1|COMPLETED|Overall Study||63
75690|NCT01640327|180845|P2|STARTED|Overall Study||63
75691|NCT01640327|180846|P1|STARTED|Overall Study||63
75692|NCT01640314|180860|P2|NOT COMPLETED|Overall Study||1
75693|NCT01640314|180861|P1|NOT COMPLETED|Overall Study||0
75694|NCT01640314|180860|P2|COMPLETED|Overall Study||62
75695|NCT01640314|180861|P1|COMPLETED|Overall Study||63
75696|NCT01640314|180860|P2|STARTED|Overall Study||63
75697|NCT01640314|180861|P1|STARTED|Overall Study||63
75698|NCT01640197|180877|P2|NOT COMPLETED|Overall Study||0
75699|NCT01640197|180878|P1|NOT COMPLETED|Overall Study||0
75700|NCT01640197|180877|P2|COMPLETED|Overall Study||30
75701|NCT01640197|180878|P1|COMPLETED|Overall Study||30
75702|NCT01640197|180877|P2|STARTED|Overall Study||30
75703|NCT01640197|180878|P1|STARTED|Overall Study||30
75704|NCT01640184|180899|P3|NOT COMPLETED|Overall Study||2
75705|NCT01640184|180900|P2|NOT COMPLETED|Overall Study||2
75706|NCT01640184|180901|P1|NOT COMPLETED|Overall Study||8
75707|NCT01640184|180899|P3|COMPLETED|Overall Study||20
75708|NCT01640184|180900|P2|COMPLETED|Overall Study||21
75709|NCT01640184|180901|P1|COMPLETED|Overall Study||26
75710|NCT01640184|180899|P3|STARTED|Overall Study||22
75711|NCT01640184|180900|P2|STARTED|Overall Study||23
75712|NCT01640184|180901|P1|STARTED|Overall Study||34
75713|NCT01640171|180923|P1|NOT COMPLETED|Overall Study||0
75714|NCT01640171|180923|P1|COMPLETED|Overall Study||57
75715|NCT01640171|180923|P1|STARTED|Overall Study||57
75716|NCT01640054|180930|P1|NOT COMPLETED|Overall Study||6
75717|NCT01640054|180930|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
75718|NCT01640054|180930|P1|Did Not Receive Treatment|Overall Study||0
75719|NCT01640054|180930|P1|STARTED|Overall Study|Patients who received treatment|115
75720|NCT01639833|180940|P2|NOT COMPLETED|Overall Study||4
75721|NCT01639833|180941|P1|NOT COMPLETED|Overall Study||6
75722|NCT01639833|180940|P2|COMPLETED|Overall Study||41
75723|NCT01639833|180941|P1|COMPLETED|Overall Study||39
75724|NCT01639833|180940|P2|STARTED|Overall Study||45
75725|NCT01639833|180941|P1|STARTED|Overall Study||45
75726|NCT01639755|180949|P1|NOT COMPLETED|Overall Study||19
75727|NCT01639755|180949|P1|COMPLETED|Overall Study||0
75728|NCT01639755|180949|P1|STARTED|Overall Study||19
75729|NCT01639742|180957|P1|NOT COMPLETED|Overall Study||18
75730|NCT01639742|180957|P1|COMPLETED|Overall Study||0
75731|NCT01639742|180957|P1|STARTED|Overall Study||18
75732|NCT01639729|180965|P6|NOT COMPLETED|Overall Study||0
75733|NCT01639729|180966|P5|NOT COMPLETED|Overall Study||0
75734|NCT01639729|180967|P4|NOT COMPLETED|Overall Study||1
75735|NCT01639729|180968|P3|NOT COMPLETED|Overall Study||1
75736|NCT01639729|180969|P2|NOT COMPLETED|Overall Study||0
75737|NCT01639729|180970|P1|NOT COMPLETED|Overall Study||1
75738|NCT01639729|180965|P6|COMPLETED|Overall Study||4
75739|NCT01639729|180966|P5|COMPLETED|Overall Study||4
75740|NCT01639729|180967|P4|COMPLETED|Overall Study||4
75741|NCT01639729|180968|P3|COMPLETED|Overall Study||3
75742|NCT01639729|180969|P2|COMPLETED|Overall Study||4
75743|NCT01639729|180970|P1|COMPLETED|Overall Study||3
75744|NCT01639729|180965|P6|STARTED|Overall Study||4
75745|NCT01639729|180966|P5|STARTED|Overall Study||4
75746|NCT01639729|180967|P4|STARTED|Overall Study||5
75747|NCT01639729|180968|P3|STARTED|Overall Study||4
75748|NCT01639729|180969|P2|STARTED|Overall Study||4
75749|NCT01639729|180970|P1|STARTED|Overall Study||4
75750|NCT01639703|180992|P1|NOT COMPLETED|Overall Study||12
75751|NCT01639703|180992|P1|COMPLETED|Overall Study||84
75752|NCT01639703|180992|P1|STARTED|Overall Study||96
75753|NCT01639560|181035|P2|NOT COMPLETED|Overall Study||29
75754|NCT01639560|181036|P1|NOT COMPLETED|Overall Study||19
75755|NCT01639560|181035|P2|COMPLETED|Overall Study||19
75756|NCT01639560|181036|P1|COMPLETED|Overall Study||26
75757|NCT01639560|181035|P2|End of Treatment|Overall Study||20
75758|NCT01639560|181036|P1|End of Treatment|Overall Study||28
75759|NCT01639560|181035|P2|STARTED|Overall Study||48
75760|NCT01639560|181036|P1|STARTED|Overall Study||45
75761|NCT01639495|181048|P1|NOT COMPLETED|Overall Study||16
75762|NCT01639495|181048|P1|COMPLETED|Overall Study||132
75763|NCT01639495|181048|P1|Primary Effectiveness Cohort|Overall Study||138
75764|NCT01639495|181048|P1|Safety Cohort|Overall Study||144
75765|NCT01639495|181048|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
75766|NCT01639469|181058|P2|NOT COMPLETED|Overall Study||3
75767|NCT01639469|181059|P1|NOT COMPLETED|Overall Study||5
75768|NCT01639469|181058|P2|COMPLETED|Overall Study||77
75769|NCT01639469|181059|P1|COMPLETED|Overall Study||84
75770|NCT01639469|181058|P2|STARTED|Overall Study||80
75771|NCT01639469|181059|P1|STARTED|Overall Study||89
75772|NCT01639443|181067|P2|NOT COMPLETED|Overall Study||0
75773|NCT01639443|181068|P1|NOT COMPLETED|Overall Study||0
75774|NCT01639443|181067|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
75775|NCT01639443|181068|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
75776|NCT01639443|181067|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
75777|NCT01639443|181068|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
75778|NCT01639352|181084|P1|NOT COMPLETED|Overall Study||0
75779|NCT01639352|181084|P1|COMPLETED|Overall Study||20
75780|NCT01639352|181084|P1|STARTED|Overall Study||20
75781|NCT01639222|181093|P1|NOT COMPLETED|Overall Study||0
75782|NCT01639222|181093|P1|COMPLETED|Overall Study||55
75783|NCT01639222|181093|P1|STARTED|Overall Study||55
75784|NCT01639157|181103|P2|NOT COMPLETED|Overall Study||0
75785|NCT01639157|181104|P1|NOT COMPLETED|Overall Study||0
75786|NCT01639157|181103|P2|COMPLETED|Overall Study||5
75787|NCT01639157|181104|P1|COMPLETED|Overall Study||4
75788|NCT01639157|181103|P2|STARTED|Overall Study||5
75789|NCT01639157|181104|P1|STARTED|Overall Study||4
75790|NCT01639144|181164|P2|NOT COMPLETED|Overall Study||5
75791|NCT01639144|181165|P1|NOT COMPLETED|Overall Study||10
75792|NCT01639144|181164|P2|COMPLETED|Overall Study||250
75793|NCT01639144|181165|P1|COMPLETED|Overall Study||250
75794|NCT01639144|181164|P2|STARTED|Overall Study||255
75795|NCT01639144|181165|P1|STARTED|Overall Study||260
75796|NCT01639040|181173|P2|NOT COMPLETED|Overall Study||0
75797|NCT01639040|181174|P1|NOT COMPLETED|Overall Study||1
75798|NCT01639040|181173|P2|COMPLETED|Overall Study||21
75799|NCT01639040|181174|P1|COMPLETED|Overall Study||9
75800|NCT01639040|181173|P2|STARTED|Overall Study||21
75801|NCT01639040|181174|P1|STARTED|Overall Study||10
75802|NCT01639001|181192|P2|NOT COMPLETED|Overall Study||103
75803|NCT01639001|181193|P1|NOT COMPLETED|Overall Study||104
75804|NCT01639001|181192|P2|COMPLETED|Overall Study||0
75805|NCT01639001|181193|P1|COMPLETED|Overall Study||0
75806|NCT01639001|181192|P2|Treated|Overall Study||101
75807|NCT01639001|181193|P1|Treated|Overall Study||104
75808|NCT01639001|181192|P2|STARTED|Overall Study||103
75809|NCT01639001|181193|P1|STARTED|Overall Study||104
75810|NCT01638559|181237|P1|NOT COMPLETED|Overall Study||0
75811|NCT01638559|181237|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint.|88
75812|NCT01638559|181237|P1|STARTED|Overall Study||88
75813|NCT01638546|181243|P2|NOT COMPLETED|Overall Study||3
75814|NCT01638546|181244|P1|NOT COMPLETED|Overall Study||1
75815|NCT01638546|181243|P2|COMPLETED|Overall Study||42
75816|NCT01638546|181244|P1|COMPLETED|Overall Study||51
75817|NCT01638546|181243|P2|STARTED|Overall Study||45
75818|NCT01638546|181244|P1|STARTED|Overall Study||52
75819|NCT01638507|181252|P1|NOT COMPLETED|Overall Study||6
75820|NCT01638507|181252|P1|COMPLETED|Overall Study||224
75821|NCT01638507|181252|P1|STARTED|Overall Study||230
75822|NCT01638468|181265|P1|NOT COMPLETED|Overall Study||0
75823|NCT01638468|181265|P1|COMPLETED|Overall Study||7
75824|NCT01638468|181265|P1|STARTED|Overall Study||7
75825|NCT01638312|181281|P2|NOT COMPLETED|Overall Study||0
75826|NCT01638312|181282|P1|NOT COMPLETED|Overall Study||0
75827|NCT01638312|181281|P2|COMPLETED|Overall Study||30
75828|NCT01638312|181282|P1|COMPLETED|Overall Study||20
75829|NCT01638312|181281|P2|STARTED|Overall Study||30
75830|NCT01638312|181282|P1|STARTED|Overall Study||20
75831|NCT01638000|181290|P2|NOT COMPLETED|Overall Study||71
75832|NCT01638000|181291|P1|NOT COMPLETED|Overall Study||60
75833|NCT01638000|181290|P2|COMPLETED|Overall Study||873
75834|NCT01638000|181291|P1|COMPLETED|Overall Study||883
75835|NCT01638000|181290|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
75836|NCT01638000|181291|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
75837|NCT01638000|181290|P2|STARTED|Overall Study||944
75838|NCT01638000|181291|P1|STARTED|Overall Study||943
75839|NCT01637961|181389|P1|NOT COMPLETED|Overall Study||2
75840|NCT01637961|181389|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
75841|NCT01637961|181389|P1|STARTED|Overall Study||23
75842|NCT01637935|181404|P2|NOT COMPLETED|Overall Study||0
75843|NCT01637935|181405|P1|NOT COMPLETED|Overall Study||0
75844|NCT01637935|181404|P2|COMPLETED|Overall Study||158918
75845|NCT01637935|181405|P1|COMPLETED|Overall Study||34181
75846|NCT01637935|181404|P2|STARTED|Overall Study||158918
75847|NCT01637935|181405|P1|STARTED|Overall Study||34181
75848|NCT01637922|181421|P2|NOT COMPLETED|Overall Study||5
75849|NCT01637922|181422|P1|NOT COMPLETED|Overall Study||2
75850|NCT01637922|181421|P2|COMPLETED|Overall Study||14
75851|NCT01637922|181422|P1|COMPLETED|Overall Study||13
75852|NCT01637922|181421|P2|STARTED|Overall Study||19
75853|NCT01637922|181422|P1|STARTED|Overall Study||15
75854|NCT01637870|181445|P1|NOT COMPLETED|Overall Study||0
75855|NCT01637870|181445|P1|COMPLETED|Overall Study||110
75856|NCT01637870|181445|P1|STARTED|Overall Study||110
75857|NCT01637584|181451|P2|NOT COMPLETED|Overall Study||3
75858|NCT01637584|181452|P1|NOT COMPLETED|Overall Study||1
75859|NCT01637584|181451|P2|COMPLETED|Overall Study||17
75860|NCT01637584|181452|P1|COMPLETED|Overall Study||19
75861|NCT01637584|181451|P2|STARTED|Overall Study||20
75862|NCT01637584|181452|P1|STARTED|Overall Study||20
75863|NCT01637272|181459|P1|NOT COMPLETED|Overall Study||20
75864|NCT01637272|181459|P1|COMPLETED|Overall Study||23
75865|NCT01637272|181459|P1|Completed Core But Did no Enter Ext..|Overall Study||4
75866|NCT01637272|181459|P1|Entered Extension Phase|Overall Study||27
75867|NCT01637272|181459|P1|Completed Core Phase (sc + LAR)|Overall Study||31
75868|NCT01637272|181459|P1|Completed sc Phase|Overall Study||33
75869|NCT01637272|181459|P1|STARTED|Overall Study||43
75870|NCT01637246|181521|P1|NOT COMPLETED|Overall Study||2139
75871|NCT01637246|181521|P1|COMPLETED|Overall Study||2246
75872|NCT01637246|181521|P1|STARTED|Overall Study||4385
75873|NCT01637090|181529|P1|NOT COMPLETED|Overall Study||3
75874|NCT01637090|181529|P1|COMPLETED|Overall Study||0
75875|NCT01637090|181529|P1|STARTED|Overall Study||3
75876|NCT01637077|181539|P2|NOT COMPLETED|Overall Study||1
75877|NCT01637077|181540|P1|NOT COMPLETED|Overall Study||4
75878|NCT01637077|181539|P2|COMPLETED|Overall Study||22
75879|NCT01637077|181540|P1|COMPLETED|Overall Study||19
75880|NCT01637077|181539|P2|STARTED|Overall Study||23
75881|NCT01637077|181540|P1|STARTED|Overall Study||23
75882|NCT01636986|181568|P2|NOT COMPLETED|Overall Study||2
75883|NCT01636986|181569|P1|NOT COMPLETED|Overall Study||0
75884|NCT01636986|181568|P2|COMPLETED|Overall Study||30
75885|NCT01636986|181569|P1|COMPLETED|Overall Study||30
75886|NCT01636986|181568|P2|STARTED|Overall Study||32
75887|NCT01636986|181569|P1|STARTED|Overall Study||30
75888|NCT01636960|181575|P1|NOT COMPLETED|Maintenance Phase||7
75889|NCT01636960|181575|P1|COMPLETED|Maintenance Phase||0
75890|NCT01636960|181575|P1|STARTED|Maintenance Phase||7
75891|NCT01636960|181575|P1|NOT COMPLETED|Induction Phase||2
75892|NCT01636960|181575|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
75893|NCT01636960|181575|P1|STARTED|Induction Phase||9
75894|NCT01636947|181583|P2|NOT COMPLETED|Overall Study||11
75895|NCT01636947|181584|P1|NOT COMPLETED|Overall Study||12
75896|NCT01636947|181583|P2|COMPLETED|Overall Study||239
75897|NCT01636947|181584|P1|COMPLETED|Overall Study||232
75898|NCT01636947|181583|P2|Treated|Overall Study||248
75899|NCT01636947|181584|P1|Treated|Overall Study||242
75900|NCT01636947|181583|P2|STARTED|Overall Study||250
75901|NCT01636947|181584|P1|STARTED|Overall Study||244
75902|NCT01636882|181604|P1|NOT COMPLETED|Overall Study||0
75903|NCT01636882|181604|P1|COMPLETED|Overall Study||16
75904|NCT01636882|181604|P1|STARTED|Overall Study||16
75905|NCT01636778|181608|P3|NOT COMPLETED|Follow-up Period After Part 2||4
75906|NCT01636778|181609|P2|NOT COMPLETED|Follow-up Period After Part 2||0
75907|NCT01636778|181610|P1|NOT COMPLETED|Follow-up Period After Part 2||0
75908|NCT01636778|181608|P3|COMPLETED|Follow-up Period After Part 2||37
75909|NCT01636778|181609|P2|COMPLETED|Follow-up Period After Part 2||0
75910|NCT01636778|181610|P1|COMPLETED|Follow-up Period After Part 2||0
75911|NCT01636778|181608|P3|STARTED|Follow-up Period After Part 2||41
75912|NCT01636778|181609|P2|STARTED|Follow-up Period After Part 2||0
75913|NCT01636778|181610|P1|STARTED|Follow-up Period After Part 2||0
75914|NCT01636778|181608|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
75915|NCT01636778|181609|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
75916|NCT01636778|181610|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
75917|NCT01636778|181608|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
75918|NCT01636778|181609|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
75919|NCT01636778|181610|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
75920|NCT01636778|181608|P3|STARTED|Antiviral Treatment Period (Part 2)||0
75921|NCT01636778|181609|P2|STARTED|Antiviral Treatment Period (Part 2)||41
75922|NCT01636778|181610|P1|STARTED|Antiviral Treatment Period (Part 2)||0
75923|NCT01636778|181608|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
75924|NCT01636778|181609|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
75925|NCT01636778|181610|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
75926|NCT01636778|181608|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
75927|NCT01636778|181609|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
75928|NCT01636778|181610|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
75929|NCT01636778|181608|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
75930|NCT01636778|181609|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
75931|NCT01636778|181610|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
75932|NCT01636765|181673|P1|NOT COMPLETED|Overall Study||0
75933|NCT01636765|181673|P1|COMPLETED|Overall Study||104
75934|NCT01636765|181673|P1|STARTED|Overall Study||104
75935|NCT01636713|181681|P3|NOT COMPLETED|Overall Study||23
75936|NCT01636713|181682|P2|NOT COMPLETED|Overall Study||28
75937|NCT01636713|181683|P1|NOT COMPLETED|Overall Study||32
75938|NCT01636713|181681|P3|COMPLETED|Overall Study||170
75939|NCT01636713|181682|P2|COMPLETED|Overall Study||166
75940|NCT01636713|181683|P1|COMPLETED|Overall Study||161
75941|NCT01636713|181681|P3|STARTED|Overall Study||193
75942|NCT01636713|181682|P2|STARTED|Overall Study||194
75943|NCT01636713|181683|P1|STARTED|Overall Study||193
75944|NCT01636661|181699|P2|NOT COMPLETED|Overall Study||0
75945|NCT01636661|181700|P1|NOT COMPLETED|Overall Study||0
75946|NCT01636661|181699|P2|COMPLETED|Overall Study||6
75947|NCT01636661|181700|P1|COMPLETED|Overall Study||5
75948|NCT01636661|181699|P2|STARTED|Overall Study||6
75949|NCT01636661|181700|P1|STARTED|Overall Study||5
75950|NCT01636466|181710|P2|NOT COMPLETED|Overall Study||0
75951|NCT01636466|181711|P1|NOT COMPLETED|Overall Study||1
75952|NCT01636466|181710|P2|COMPLETED|Overall Study||0
75953|NCT01636466|181711|P1|COMPLETED|Overall Study||0
75954|NCT01636466|181710|P2|STARTED|Overall Study||0
75955|NCT01636466|181711|P1|STARTED|Overall Study||1
75956|NCT01636414|181722|P3|NOT COMPLETED|Overall Study||9
75957|NCT01636414|181723|P2|NOT COMPLETED|Overall Study||6
75958|NCT01636414|181724|P1|NOT COMPLETED|Overall Study||3
75959|NCT01636414|181722|P3|COMPLETED|Overall Study||65
75960|NCT01636414|181723|P2|COMPLETED|Overall Study||60
75961|NCT01636414|181724|P1|COMPLETED|Overall Study||61
75962|NCT01636414|181722|P3|STARTED|Overall Study||74
75963|NCT01636414|181723|P2|STARTED|Overall Study||66
75964|NCT01636414|181724|P1|STARTED|Overall Study||64
75965|NCT01636362|181735|P1|NOT COMPLETED|Overall Study||8
75966|NCT01636362|181735|P1|COMPLETED|Overall Study||37
75967|NCT01636362|181735|P1|STARTED|Overall Study||45
75968|NCT01636258|181743|P2|NOT COMPLETED|Overall Study||0
75969|NCT01636258|181744|P1|NOT COMPLETED|Overall Study||1
75970|NCT01636258|181743|P2|COMPLETED|Overall Study||14
75971|NCT01636258|181744|P1|COMPLETED|Overall Study||12
75972|NCT01636258|181743|P2|STARTED|Overall Study||14
75973|NCT01636258|181744|P1|STARTED|Overall Study||13
75974|NCT01636206|181760|P2|NOT COMPLETED|Overall Study||51
75975|NCT01636206|181761|P1|NOT COMPLETED|Overall Study||19
75976|NCT01636206|181760|P2|COMPLETED|Overall Study||170
75977|NCT01636206|181761|P1|COMPLETED|Overall Study||92
75978|NCT01636206|181760|P2|STARTED|Overall Study||221
75979|NCT01636206|181761|P1|STARTED|Overall Study||111
75980|NCT01636102|181769|P2|NOT COMPLETED|Overall Study||0
75981|NCT01636102|181770|P1|NOT COMPLETED|Overall Study||0
75982|NCT01636102|181769|P2|COMPLETED|Overall Study||63
75983|NCT01636102|181770|P1|COMPLETED|Overall Study||63
75984|NCT01636102|181769|P2|STARTED|Overall Study||63
75985|NCT01636102|181770|P1|STARTED|Overall Study||63
75986|NCT01636076|181784|P2|NOT COMPLETED|Overall Study||25
75987|NCT01636076|181785|P1|NOT COMPLETED|Overall Study||17
75988|NCT01636076|181784|P2|COMPLETED|Overall Study||288
75989|NCT01636076|181785|P1|COMPLETED|Overall Study||299
75990|NCT01636076|181784|P2|STARTED|Overall Study||313
75991|NCT01636076|181785|P1|STARTED|Overall Study||316
75992|NCT01636063|181847|P2|NOT COMPLETED|Overall Study||0
75993|NCT01636063|181848|P1|NOT COMPLETED|Overall Study||0
75994|NCT01636063|181847|P2|COMPLETED|Overall Study||21
75995|NCT01636063|181848|P1|COMPLETED|Overall Study||21
75996|NCT01636063|181847|P2|STARTED|Overall Study||21
75997|NCT01636063|181848|P1|STARTED|Overall Study||21
75998|NCT01635933|181856|P2|NOT COMPLETED|Overall Study||8
75999|NCT01635933|181857|P1|NOT COMPLETED|Overall Study||2
76000|NCT01635933|181856|P2|COMPLETED|Overall Study||177
76001|NCT01635933|181857|P1|COMPLETED|Overall Study||176
76002|NCT01635933|181856|P2|STARTED|Overall Study||185
76003|NCT01635933|181857|P1|STARTED|Overall Study||178
76004|NCT01635920|181869|P2|NOT COMPLETED|Overall Study||1
76005|NCT01635920|181870|P1|NOT COMPLETED|Overall Study||3
76006|NCT01635920|181869|P2|COMPLETED|Overall Study||125
76007|NCT01635920|181870|P1|COMPLETED|Overall Study||122
76008|NCT01635920|181869|P2|STARTED|Overall Study||126
76009|NCT01635920|181870|P1|STARTED|Overall Study||125
76010|NCT01635881|181878|P1|NOT COMPLETED|Overall Study||0
76011|NCT01635881|181878|P1|COMPLETED|Overall Study||60
76012|NCT01635881|181878|P1|STARTED|Overall Study||60
76013|NCT01635855|181883|P1|NOT COMPLETED|Overall Study||4
76014|NCT01635855|181883|P1|COMPLETED|Overall Study||113
76015|NCT01635855|181883|P1|STARTED|Overall Study||117
76016|NCT01635764|181892|P1|NOT COMPLETED|Overall Study||273
76017|NCT01635764|181892|P1|COMPLETED|Overall Study||235
76018|NCT01635764|181892|P1|STARTED|Overall Study||508
76019|NCT01635504|181920|P1|NOT COMPLETED|Overall Study||0
76020|NCT01635504|181920|P1|COMPLETED|Overall Study||5
76021|NCT01635504|181920|P1|STARTED|Overall Study||5
76022|NCT01635439|181927|P2|NOT COMPLETED|Overall Study||0
76023|NCT01635439|181928|P1|NOT COMPLETED|Overall Study||0
76024|NCT01635439|181927|P2|COMPLETED|Overall Study||100
76025|NCT01635439|181928|P1|COMPLETED|Overall Study||100
76026|NCT01635439|181927|P2|STARTED|Overall Study||100
76027|NCT01635439|181928|P1|STARTED|Overall Study||100
76028|NCT01635244|181945|P3|NOT COMPLETED|Overall Study||2
76029|NCT01635244|181946|P2|NOT COMPLETED|Overall Study||1
76030|NCT01635244|181947|P1|NOT COMPLETED|Overall Study||1
76031|NCT01635244|181945|P3|COMPLETED|Overall Study||18
76032|NCT01635244|181946|P2|COMPLETED|Overall Study||21
76033|NCT01635244|181947|P1|COMPLETED|Overall Study||17
76034|NCT01635244|181945|P3|STARTED|Overall Study||20
76035|NCT01635244|181946|P2|STARTED|Overall Study||22
76036|NCT01635244|181947|P1|STARTED|Overall Study||18
76037|NCT01635218|181958|P3|NOT COMPLETED|Overall Study||6
76038|NCT01635218|181959|P2|NOT COMPLETED|Overall Study||7
76039|NCT01635218|181960|P1|NOT COMPLETED|Overall Study||3
76040|NCT01635218|181958|P3|COMPLETED|Overall Study||37
76041|NCT01635218|181959|P2|COMPLETED|Overall Study||39
76042|NCT01635218|181960|P1|COMPLETED|Overall Study||41
76043|NCT01635218|181958|P3|STARTED|Overall Study||43
76044|NCT01635218|181959|P2|STARTED|Overall Study||46
76045|NCT01635218|181960|P1|STARTED|Overall Study||44
76046|NCT01635062|181982|P2|NOT COMPLETED|Overall Study||0
76047|NCT01635062|181983|P1|NOT COMPLETED|Overall Study||0
76048|NCT01635062|181982|P2|COMPLETED|Overall Study||9
76049|NCT01635062|181983|P1|COMPLETED|Overall Study||9
76050|NCT01635062|181982|P2|Post-Randomization Sodium Loaded|Overall Study||9
76051|NCT01635062|181983|P1|Post-Randomization Sodium Loaded|Overall Study||9
76052|NCT01635062|181982|P2|Post-randomization Sodium Restriction|Overall Study||9
76053|NCT01635062|181983|P1|Post-randomization Sodium Restriction|Overall Study||9
76054|NCT01635062|181982|P2|Sodium Loading Baseline Visit|Overall Study||9
76055|NCT01635062|181983|P1|Sodium Loading Baseline Visit|Overall Study||9
76056|NCT01635062|181982|P2|Sodium Restriction Baseline Visit|Overall Study||9
76057|NCT01635062|181983|P1|Sodium Restriction Baseline Visit|Overall Study||9
76058|NCT01635062|181982|P2|STARTED|Overall Study||9
76059|NCT01635062|181983|P1|STARTED|Overall Study||9
76060|NCT01634854|181995|P2|NOT COMPLETED|Overall Study||7
76061|NCT01634854|181996|P1|NOT COMPLETED|Overall Study||2
76062|NCT01634854|181995|P2|COMPLETED|Overall Study||59
76063|NCT01634854|181996|P1|COMPLETED|Overall Study||62
76064|NCT01634854|181995|P2|STARTED|Overall Study||66
76065|NCT01634854|181996|P1|STARTED|Overall Study||64
76066|NCT01634659|182016|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
76067|NCT01634659|182017|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
76068|NCT01634659|182016|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
76069|NCT01634659|182017|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
76070|NCT01634659|182016|P2|STARTED|Period 2 - Second 8 Days of Wear||158
76071|NCT01634659|182017|P1|STARTED|Period 2 - Second 8 Days of Wear||155
76072|NCT01634659|182016|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
76073|NCT01634659|182017|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
76074|NCT01634659|182016|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
76075|NCT01634659|182017|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
76076|NCT01634659|182016|P2|STARTED|Period 1 - First 8 Days of Wear||158
76077|NCT01634659|182017|P1|STARTED|Period 1 - First 8 Days of Wear||155
76078|NCT01634620|182027|P1|NOT COMPLETED|Overall Study||0
76079|NCT01634620|182027|P1|COMPLETED|Overall Study||200
76080|NCT01634620|182027|P1|STARTED|Overall Study||200
76081|NCT01634555|182047|P1|NOT COMPLETED|Overall Study||17
76082|NCT01634555|182047|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|12
76083|NCT01634555|182047|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
76084|NCT01634555|182047|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
76085|NCT01634555|182047|P1|STARTED|Overall Study||29
76086|NCT01634360|182057|P2|NOT COMPLETED|Overall Study||136
76087|NCT01634360|182058|P1|NOT COMPLETED|Overall Study||49
76088|NCT01634360|182057|P2|COMPLETED|Overall Study||0
76089|NCT01634360|182058|P1|COMPLETED|Overall Study||0
76090|NCT01634360|182057|P2|STARTED|Overall Study||136
76091|NCT01634360|182058|P1|STARTED|Overall Study||49
76092|NCT01634256|182070|P2|NOT COMPLETED|Overall Study||8
76093|NCT01634256|182071|P1|NOT COMPLETED|Overall Study||4
76094|NCT01634256|182070|P2|COMPLETED|Overall Study||22
76095|NCT01634256|182071|P1|COMPLETED|Overall Study||26
76096|NCT01634256|182070|P2|STARTED|Overall Study||30
76097|NCT01634256|182071|P1|STARTED|Overall Study||30
76098|NCT01634243|182087|P2|NOT COMPLETED|Overall Study||5
76099|NCT01634243|182088|P1|NOT COMPLETED|Overall Study||6
76100|NCT01634243|182087|P2|COMPLETED|Overall Study||38
76101|NCT01634243|182088|P1|COMPLETED|Overall Study||15
76102|NCT01634243|182087|P2|STARTED|Overall Study||43
76103|NCT01634243|182088|P1|STARTED|Overall Study||21
76104|NCT01634165|182114|P4|NOT COMPLETED|Period 4||0
76105|NCT01634165|182115|P3|NOT COMPLETED|Period 4||0
76106|NCT01634165|182116|P2|NOT COMPLETED|Period 4||0
76107|NCT01634165|182117|P1|NOT COMPLETED|Period 4||0
76108|NCT01634165|182114|P4|COMPLETED|Period 4||6
76109|NCT01634165|182115|P3|COMPLETED|Period 4||6
76110|NCT01634165|182116|P2|COMPLETED|Period 4||5
76111|NCT01634165|182117|P1|COMPLETED|Period 4||6
76112|NCT01634165|182114|P4|STARTED|Period 4||6
76113|NCT01634165|182115|P3|STARTED|Period 4||6
76114|NCT01634165|182116|P2|STARTED|Period 4||5
76115|NCT01634165|182117|P1|STARTED|Period 4||6
76116|NCT01634165|182114|P4|NOT COMPLETED|Period 3||0
76117|NCT01634165|182115|P3|NOT COMPLETED|Period 3||0
76118|NCT01634165|182116|P2|NOT COMPLETED|Period 3||0
76119|NCT01634165|182117|P1|NOT COMPLETED|Period 3||0
76120|NCT01634165|182114|P4|COMPLETED|Period 3||6
76121|NCT01634165|182115|P3|COMPLETED|Period 3||6
76122|NCT01634165|182116|P2|COMPLETED|Period 3||5
76123|NCT01634165|182117|P1|COMPLETED|Period 3||6
76124|NCT01634165|182114|P4|STARTED|Period 3||6
76125|NCT01634165|182115|P3|STARTED|Period 3||6
76126|NCT01634165|182116|P2|STARTED|Period 3||5
76127|NCT01634165|182117|P1|STARTED|Period 3||6
76128|NCT01634165|182114|P4|NOT COMPLETED|Period 2||0
76129|NCT01634165|182115|P3|NOT COMPLETED|Period 2||0
76130|NCT01634165|182116|P2|NOT COMPLETED|Period 2||1
76131|NCT01634165|182117|P1|NOT COMPLETED|Period 2||0
76132|NCT01634165|182114|P4|COMPLETED|Period 2||6
76133|NCT01634165|182115|P3|COMPLETED|Period 2||6
76134|NCT01634165|182116|P2|COMPLETED|Period 2||5
76135|NCT01634165|182117|P1|COMPLETED|Period 2||6
76136|NCT01634165|182114|P4|STARTED|Period 2||6
76137|NCT01634165|182115|P3|STARTED|Period 2||6
76138|NCT01634165|182116|P2|STARTED|Period 2||6
76139|NCT01634165|182117|P1|STARTED|Period 2||6
76140|NCT01634165|182114|P4|NOT COMPLETED|Period 1||0
76141|NCT01634165|182115|P3|NOT COMPLETED|Period 1||0
76142|NCT01634165|182116|P2|NOT COMPLETED|Period 1||0
76143|NCT01634165|182117|P1|NOT COMPLETED|Period 1||0
76144|NCT01634165|182114|P4|COMPLETED|Period 1||6
76145|NCT01634165|182115|P3|COMPLETED|Period 1||6
76146|NCT01634165|182116|P2|COMPLETED|Period 1||6
76147|NCT01634165|182117|P1|COMPLETED|Period 1||6
76148|NCT01634165|182114|P4|Received at Least 1 Dose of Study Drug|Period 1||6
76149|NCT01634165|182115|P3|Received at Least 1 Dose of Study Drug|Period 1||6
76150|NCT01634165|182116|P2|Received at Least 1 Dose of Study Drug|Period 1||6
76151|NCT01634165|182117|P1|Received at Least 1 Dose of Study Drug|Period 1||6
76152|NCT01634165|182114|P4|STARTED|Period 1||6
76153|NCT01634165|182115|P3|STARTED|Period 1||6
76154|NCT01634165|182116|P2|STARTED|Period 1||6
76155|NCT01634165|182117|P1|STARTED|Period 1||6
76156|NCT01634152|182150|P3|NOT COMPLETED|Overall Study||4
76157|NCT01634152|182151|P2|NOT COMPLETED|Overall Study||1
76158|NCT01634152|182152|P1|NOT COMPLETED|Overall Study||4
76159|NCT01634152|182150|P3|COMPLETED|Overall Study||126
76160|NCT01634152|182151|P2|COMPLETED|Overall Study||136
76161|NCT01634152|182152|P1|COMPLETED|Overall Study||130
76162|NCT01634152|182150|P3|STARTED|Overall Study||130
76163|NCT01634152|182151|P2|STARTED|Overall Study||137
76164|NCT01634152|182152|P1|STARTED|Overall Study||134
76165|NCT01634139|182235|P3|NOT COMPLETED|Overall Study||5
76166|NCT01634139|182236|P2|NOT COMPLETED|Overall Study||6
76167|NCT01634139|182237|P1|NOT COMPLETED|Overall Study||10
76168|NCT01634139|182235|P3|COMPLETED|Overall Study||130
76169|NCT01634139|182236|P2|COMPLETED|Overall Study||130
76170|NCT01634139|182237|P1|COMPLETED|Overall Study||122
76171|NCT01634139|182235|P3|STARTED|Overall Study||135
76172|NCT01634139|182236|P2|STARTED|Overall Study||136
76173|NCT01634139|182237|P1|STARTED|Overall Study||132
76174|NCT01634113|182338|P3|NOT COMPLETED|Overall Study||1
76175|NCT01634113|182339|P2|NOT COMPLETED|Overall Study||0
76176|NCT01634113|182340|P1|NOT COMPLETED|Overall Study||0
76177|NCT01634113|182338|P3|COMPLETED|Overall Study||31
76178|NCT01634113|182339|P2|COMPLETED|Overall Study||36
76179|NCT01634113|182340|P1|COMPLETED|Overall Study||34
76180|NCT01634113|182338|P3|STARTED|Overall Study||32
76181|NCT01634113|182339|P2|STARTED|Overall Study||36
76182|NCT01634113|182340|P1|STARTED|Overall Study||34
76183|NCT01634100|182384|P6|NOT COMPLETED|Overall Study||0
76184|NCT01634100|182385|P5|NOT COMPLETED|Overall Study||0
76185|NCT01634100|182386|P4|NOT COMPLETED|Overall Study||0
76186|NCT01634100|182387|P3|NOT COMPLETED|Overall Study||1
76187|NCT01634100|182388|P2|NOT COMPLETED|Overall Study||0
76188|NCT01634100|182389|P1|NOT COMPLETED|Overall Study||1
76189|NCT01634100|182384|P6|COMPLETED|Overall Study||3
76190|NCT01634100|182385|P5|COMPLETED|Overall Study||3
76191|NCT01634100|182386|P4|COMPLETED|Overall Study||3
76192|NCT01634100|182387|P3|COMPLETED|Overall Study||2
76193|NCT01634100|182388|P2|COMPLETED|Overall Study||3
76194|NCT01634100|182389|P1|COMPLETED|Overall Study||2
76195|NCT01634100|182384|P6|Received Empa + Probenecid|Overall Study||3
76196|NCT01634100|182385|P5|Received Empa + Probenecid|Overall Study||3
76197|NCT01634100|182386|P4|Received Empa + Probenecid|Overall Study||3
76198|NCT01634100|182387|P3|Received Empa + Probenecid|Overall Study||2
76199|NCT01634100|182388|P2|Received Empa + Probenecid|Overall Study||3
76200|NCT01634100|182389|P1|Received Empa + Probenecid|Overall Study||2
76201|NCT01634100|182384|P6|Received Empa + Rifampicin|Overall Study||3
76202|NCT01634100|182385|P5|Received Empa + Rifampicin|Overall Study||3
76203|NCT01634100|182386|P4|Received Empa + Rifampicin|Overall Study||3
76204|NCT01634100|182387|P3|Received Empa + Rifampicin|Overall Study||3
76205|NCT01634100|182388|P2|Received Empa + Rifampicin|Overall Study||3
76206|NCT01634100|182389|P1|Received Empa + Rifampicin|Overall Study||3
76207|NCT01634100|182384|P6|Received Empa Alone|Overall Study||3
76208|NCT01634100|182385|P5|Received Empa Alone|Overall Study||3
76209|NCT01634100|182386|P4|Received Empa Alone|Overall Study||3
76210|NCT01634100|182387|P3|Received Empa Alone|Overall Study||3
76211|NCT01634100|182388|P2|Received Empa Alone|Overall Study||3
76212|NCT01634100|182389|P1|Received Empa Alone|Overall Study||3
76213|NCT01634100|182384|P6|STARTED|Overall Study||3
76214|NCT01634100|182385|P5|STARTED|Overall Study||3
76215|NCT01634100|182386|P4|STARTED|Overall Study||3
76216|NCT01634100|182387|P3|STARTED|Overall Study||3
76217|NCT01634100|182388|P2|STARTED|Overall Study||3
76218|NCT01634100|182389|P1|STARTED|Overall Study||3
76219|NCT01633944|182405|P3|NOT COMPLETED|Double-blind Treatment Phase||58
76220|NCT01633944|182406|P2|NOT COMPLETED|Double-blind Treatment Phase||54
76221|NCT01633944|182407|P1|NOT COMPLETED|Double-blind Treatment Phase||0
76222|NCT01633944|182405|P3|COMPLETED|Double-blind Treatment Phase||174
76223|NCT01633944|182406|P2|COMPLETED|Double-blind Treatment Phase||176
76224|NCT01633944|182407|P1|COMPLETED|Double-blind Treatment Phase||0
76225|NCT01633944|182405|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
76226|NCT01633944|182406|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
76227|NCT01633944|182407|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
76228|NCT01633944|182405|P3|NOT COMPLETED|Open-label Titration Phase||0
76229|NCT01633944|182406|P2|NOT COMPLETED|Open-label Titration Phase||0
76230|NCT01633944|182407|P1|NOT COMPLETED|Open-label Titration Phase||290
76231|NCT01633944|182405|P3|COMPLETED|Open-label Titration Phase||0
76232|NCT01633944|182406|P2|COMPLETED|Open-label Titration Phase||0
76233|NCT01633944|182407|P1|COMPLETED|Open-label Titration Phase||462
76234|NCT01633944|182405|P3|STARTED|Open-label Titration Phase||0
76235|NCT01633944|182406|P2|STARTED|Open-label Titration Phase||0
76236|NCT01633944|182407|P1|STARTED|Open-label Titration Phase||752
76237|NCT01633892|182427|P1|NOT COMPLETED|Overall Study||0
76238|NCT01633892|182427|P1|COMPLETED|Overall Study||5
76239|NCT01633892|182427|P1|STARTED|Overall Study||5
76240|NCT01633853|182437|P2|NOT COMPLETED|Overall Study||0
76241|NCT01633853|182438|P1|NOT COMPLETED|Overall Study||0
76242|NCT01633853|182437|P2|COMPLETED|Overall Study||100
76243|NCT01633853|182438|P1|COMPLETED|Overall Study||104
76244|NCT01633853|182437|P2|STARTED|Overall Study||100
76245|NCT01633853|182438|P1|STARTED|Overall Study||104
76246|NCT01633827|182452|P2|NOT COMPLETED|Second Intervention||0
76247|NCT01633827|182453|P1|NOT COMPLETED|Second Intervention||0
76248|NCT01633827|182452|P2|COMPLETED|Second Intervention||11
76249|NCT01633827|182453|P1|COMPLETED|Second Intervention||11
76250|NCT01633827|182452|P2|STARTED|Second Intervention||11
76251|NCT01633827|182453|P1|STARTED|Second Intervention||11
76252|NCT01633827|182452|P2|NOT COMPLETED|Washout Period||0
76253|NCT01633827|182453|P1|NOT COMPLETED|Washout Period||0
76254|NCT01633827|182452|P2|COMPLETED|Washout Period||11
76255|NCT01633827|182453|P1|COMPLETED|Washout Period||11
76256|NCT01633827|182452|P2|STARTED|Washout Period||11
76257|NCT01633827|182453|P1|STARTED|Washout Period||11
76258|NCT01633827|182452|P2|NOT COMPLETED|First Intervention||0
76259|NCT01633827|182453|P1|NOT COMPLETED|First Intervention||0
76260|NCT01633827|182452|P2|COMPLETED|First Intervention||11
76261|NCT01633827|182453|P1|COMPLETED|First Intervention||11
76262|NCT01633827|182452|P2|STARTED|First Intervention||11
76263|NCT01633827|182453|P1|STARTED|First Intervention||11
76264|NCT01633814|182466|P1|NOT COMPLETED|Overall Study||0
76265|NCT01633814|182466|P1|COMPLETED|Overall Study||4
76266|NCT01633814|182466|P1|STARTED|Overall Study||4
76267|NCT01633788|182475|P4|NOT COMPLETED|Overall Study||13
76268|NCT01633788|182476|P3|NOT COMPLETED|Overall Study||10
76269|NCT01633788|182477|P2|NOT COMPLETED|Overall Study||8
76270|NCT01633788|182478|P1|NOT COMPLETED|Overall Study||7
76271|NCT01633788|182475|P4|COMPLETED|Overall Study||45
76272|NCT01633788|182476|P3|COMPLETED|Overall Study||49
76273|NCT01633788|182477|P2|COMPLETED|Overall Study||50
76274|NCT01633788|182478|P1|COMPLETED|Overall Study||50
76275|NCT01633788|182475|P4|STARTED|Overall Study||58
76276|NCT01633788|182476|P3|STARTED|Overall Study||59
76277|NCT01633788|182477|P2|STARTED|Overall Study||58
76278|NCT01633788|182478|P1|STARTED|Overall Study||57
76279|NCT01633320|182498|P2|NOT COMPLETED|Overall Study||0
76280|NCT01633320|182499|P1|NOT COMPLETED|Overall Study||0
76281|NCT01633320|182498|P2|COMPLETED|Overall Study||68
76282|NCT01633320|182499|P1|COMPLETED|Overall Study||132
76283|NCT01633320|182498|P2|STARTED|Overall Study||68
76284|NCT01633320|182499|P1|STARTED|Overall Study||132
76285|NCT01632995|182507|P1|NOT COMPLETED|Main Study Follow-up Period||120
76286|NCT01632995|182507|P1|COMPLETED|Main Study Follow-up Period||437
76287|NCT01632995|182507|P1|STARTED|Main Study Follow-up Period||557
76288|NCT01632995|182507|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
76289|NCT01632995|182507|P1|COMPLETED|Pre-screening to Enrollment Period||557
76290|NCT01632995|182507|P1|STARTED|Pre-screening to Enrollment Period||1069
76291|NCT01632904|182522|P2|NOT COMPLETED|Overall Study||6
76292|NCT01632904|182523|P1|NOT COMPLETED|Overall Study||7
76293|NCT01632904|182522|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
76294|NCT01632904|182523|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
76295|NCT01632904|182522|P2|STARTED|Overall Study||56
76296|NCT01632904|182523|P1|STARTED|Overall Study||54
76297|NCT01632878|182534|P1|NOT COMPLETED|Treatment||158
76298|NCT01632878|182534|P1|COMPLETED|Treatment||1105
76299|NCT01632878|182534|P1|STARTED|Treatment||1263
76300|NCT01632878|182534|P1|NOT COMPLETED|Screening||268
76301|NCT01632878|182534|P1|COMPLETED|Screening||1263
76302|NCT01632878|182534|P1|STARTED|Screening||1531
76303|NCT01632800|182538|P1|NOT COMPLETED|Overall Study||1
76304|NCT01632800|182538|P1|COMPLETED|Overall Study||25
76305|NCT01632800|182538|P1|STARTED|Overall Study||26
76306|NCT01632735|182544|P2|NOT COMPLETED|Overall Study||3
76307|NCT01632735|182545|P1|NOT COMPLETED|Overall Study||4
76308|NCT01632735|182544|P2|COMPLETED|Overall Study||37
76309|NCT01632735|182545|P1|COMPLETED|Overall Study||36
76310|NCT01632735|182544|P2|STARTED|Overall Study||40
76311|NCT01632735|182545|P1|STARTED|Overall Study||40
76312|NCT01632709|182561|P4|NOT COMPLETED|Overall Study||1
76313|NCT01632709|182562|P3|NOT COMPLETED|Overall Study||0
76314|NCT01632709|182563|P2|NOT COMPLETED|Overall Study||1
76315|NCT01632709|182564|P1|NOT COMPLETED|Overall Study||2
76316|NCT01632709|182561|P4|COMPLETED|Overall Study||3
76317|NCT01632709|182562|P3|COMPLETED|Overall Study||5
76318|NCT01632709|182563|P2|COMPLETED|Overall Study||2
76319|NCT01632709|182564|P1|COMPLETED|Overall Study||2
76320|NCT01632709|182561|P4|Completed Visit 2 (Received Injection)|Overall Study||3
76321|NCT01632709|182562|P3|Completed Visit 2 (Received Injection)|Overall Study||5
76322|NCT01632709|182563|P2|Completed Visit 2 (Received Injection)|Overall Study||2
76323|NCT01632709|182564|P1|Completed Visit 2 (Received Injection)|Overall Study||4
76324|NCT01632709|182561|P4|STARTED|Overall Study||4
76325|NCT01632709|182562|P3|STARTED|Overall Study||5
76326|NCT01632709|182563|P2|STARTED|Overall Study||3
76327|NCT01632709|182564|P1|STARTED|Overall Study||4
76328|NCT01632683|182590|P2|NOT COMPLETED|Overall Study||0
76329|NCT01632683|182591|P1|NOT COMPLETED|Overall Study||0
76330|NCT01632683|182590|P2|COMPLETED|Overall Study||552
76331|NCT01632683|182591|P1|COMPLETED|Overall Study||548
76332|NCT01632683|182590|P2|STARTED|Overall Study||552
76333|NCT01632683|182591|P1|STARTED|Overall Study||548
76334|NCT01632423|182605|P1|NOT COMPLETED|Overall Study||246
76335|NCT01632423|182605|P1|COMPLETED|Overall Study||10091
76336|NCT01632423|182605|P1|STARTED|Overall Study||10337
76337|NCT01632345|182618|P7|NOT COMPLETED|Treatment: Part II||11
76338|NCT01632345|182619|P6|NOT COMPLETED|Treatment: Part II||11
76339|NCT01632345|182620|P5|NOT COMPLETED|Treatment: Part II||0
76340|NCT01632345|182621|P4|NOT COMPLETED|Treatment: Part II||0
76341|NCT01632345|182622|P3|NOT COMPLETED|Treatment: Part II||0
76342|NCT01632345|182623|P2|NOT COMPLETED|Treatment: Part II||0
76343|NCT01632345|182624|P1|NOT COMPLETED|Treatment: Part II||0
76344|NCT01632345|182618|P7|COMPLETED|Treatment: Part II||55
76345|NCT01632345|182619|P6|COMPLETED|Treatment: Part II||55
76346|NCT01632345|182620|P5|COMPLETED|Treatment: Part II||0
76347|NCT01632345|182621|P4|COMPLETED|Treatment: Part II||0
76348|NCT01632345|182622|P3|COMPLETED|Treatment: Part II||0
76349|NCT01632345|182623|P2|COMPLETED|Treatment: Part II||0
76350|NCT01632345|182624|P1|COMPLETED|Treatment: Part II||0
76351|NCT01632345|182618|P7|Treated|Treatment: Part II||66
76352|NCT01632345|182619|P6|Treated|Treatment: Part II||66
76353|NCT01632345|182620|P5|Treated|Treatment: Part II||0
76354|NCT01632345|182621|P4|Treated|Treatment: Part II||0
76355|NCT01632345|182622|P3|Treated|Treatment: Part II||0
76356|NCT01632345|182623|P2|Treated|Treatment: Part II||0
76357|NCT01632345|182624|P1|Treated|Treatment: Part II||0
76358|NCT01632345|182618|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
76359|NCT01632345|182619|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
76360|NCT01632345|182620|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
76361|NCT01632345|182621|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
76362|NCT01632345|182622|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
76363|NCT01632345|182623|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
76364|NCT01632345|182624|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
76365|NCT01632345|182618|P7|NOT COMPLETED|Treatment: Part I||0
76366|NCT01632345|182619|P6|NOT COMPLETED|Treatment: Part I||0
76367|NCT01632345|182620|P5|NOT COMPLETED|Treatment: Part I||13
76368|NCT01632345|182621|P4|NOT COMPLETED|Treatment: Part I||8
76369|NCT01632345|182622|P3|NOT COMPLETED|Treatment: Part I||10
76370|NCT01632345|182623|P2|NOT COMPLETED|Treatment: Part I||15
76371|NCT01632345|182624|P1|NOT COMPLETED|Treatment: Part I||12
76372|NCT01632345|182618|P7|COMPLETED|Treatment: Part I||0
76373|NCT01632345|182619|P6|COMPLETED|Treatment: Part I||0
76374|NCT01632345|182620|P5|COMPLETED|Treatment: Part I||30
76375|NCT01632345|182621|P4|COMPLETED|Treatment: Part I||33
76376|NCT01632345|182622|P3|COMPLETED|Treatment: Part I||32
76377|NCT01632345|182623|P2|COMPLETED|Treatment: Part I||28
76378|NCT01632345|182624|P1|COMPLETED|Treatment: Part I||29
76379|NCT01632345|182618|P7|Treated|Treatment: Part I||0
76380|NCT01632345|182619|P6|Treated|Treatment: Part I||0
76381|NCT01632345|182620|P5|Treated|Treatment: Part I||43
76382|NCT01632345|182621|P4|Treated|Treatment: Part I||41
76383|NCT01632345|182622|P3|Treated|Treatment: Part I||42
76384|NCT01632345|182623|P2|Treated|Treatment: Part I||43
76385|NCT01632345|182624|P1|Treated|Treatment: Part I||40
76386|NCT01632345|182618|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
76387|NCT01632345|182619|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
76388|NCT01632345|182620|P5|STARTED|Treatment: Part I||43
76389|NCT01632345|182621|P4|STARTED|Treatment: Part I||41
76390|NCT01632345|182622|P3|STARTED|Treatment: Part I||42
76391|NCT01632345|182623|P2|STARTED|Treatment: Part I||43
76392|NCT01632345|182624|P1|STARTED|Treatment: Part I||41
76393|NCT01632345|182618|P7|NOT COMPLETED|Randomized Participants||0
76394|NCT01632345|182619|P6|NOT COMPLETED|Randomized Participants||0
76395|NCT01632345|182620|P5|NOT COMPLETED|Randomized Participants||0
76396|NCT01632345|182621|P4|NOT COMPLETED|Randomized Participants||0
76397|NCT01632345|182622|P3|NOT COMPLETED|Randomized Participants||0
76398|NCT01632345|182623|P2|NOT COMPLETED|Randomized Participants||0
76399|NCT01632345|182624|P1|NOT COMPLETED|Randomized Participants||0
76400|NCT01632345|182618|P7|COMPLETED|Randomized Participants||66
76401|NCT01632345|182619|P6|COMPLETED|Randomized Participants||66
76402|NCT01632345|182620|P5|COMPLETED|Randomized Participants||43
76403|NCT01632345|182621|P4|COMPLETED|Randomized Participants||41
76404|NCT01632345|182622|P3|COMPLETED|Randomized Participants||42
76405|NCT01632345|182623|P2|COMPLETED|Randomized Participants||43
76406|NCT01632345|182624|P1|COMPLETED|Randomized Participants||41
76407|NCT01632345|182618|P7|STARTED|Randomized Participants||66
76408|NCT01632345|182619|P6|STARTED|Randomized Participants||66
76409|NCT01632345|182620|P5|STARTED|Randomized Participants||43
76410|NCT01632345|182621|P4|STARTED|Randomized Participants||41
76411|NCT01632345|182622|P3|STARTED|Randomized Participants||42
76412|NCT01632345|182623|P2|STARTED|Randomized Participants||43
76413|NCT01632345|182624|P1|STARTED|Randomized Participants||41
76414|NCT01632280|182686|P2|NOT COMPLETED|Overall Study||0
76415|NCT01632280|182687|P1|NOT COMPLETED|Overall Study||1
76416|NCT01632280|182686|P2|COMPLETED|Overall Study||6
76417|NCT01632280|182687|P1|COMPLETED|Overall Study||5
76418|NCT01632280|182686|P2|STARTED|Overall Study||6
76419|NCT01632280|182687|P1|STARTED|Overall Study||6
76420|NCT01632267|182697|P1|NOT COMPLETED|Overall Study||7
76421|NCT01632267|182697|P1|COMPLETED|Overall Study||97
76422|NCT01632267|182697|P1|STARTED|Overall Study||104
76423|NCT01632215|182703|P2|NOT COMPLETED|Overall Study||1
76424|NCT01632215|182704|P1|NOT COMPLETED|Overall Study||2
76425|NCT01632215|182703|P2|COMPLETED|Overall Study||19
76426|NCT01632215|182704|P1|COMPLETED|Overall Study||18
76427|NCT01632215|182703|P2|STARTED|Overall Study||20
76428|NCT01632215|182704|P1|STARTED|Overall Study||20
76429|NCT01632150|182710|P1|NOT COMPLETED|Overall Study||40
76430|NCT01632150|182710|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
76431|NCT01632150|182710|P1|Received Cyclophosphamide|Overall Study||11
76432|NCT01632150|182710|P1|STARTED|Overall Study||40
76433|NCT01632020|182719|P2|NOT COMPLETED|Overall Study||0
76434|NCT01632020|182720|P1|NOT COMPLETED|Overall Study||2
76435|NCT01632020|182719|P2|COMPLETED|Overall Study||3
76436|NCT01632020|182720|P1|COMPLETED|Overall Study||2
76437|NCT01632020|182719|P2|STARTED|Overall Study||3
76438|NCT01632020|182720|P1|STARTED|Overall Study||4
76439|NCT01631929|182730|P2|NOT COMPLETED|Overall Study||0
76440|NCT01631929|182731|P1|NOT COMPLETED|Overall Study||0
76441|NCT01631929|182730|P2|COMPLETED|Overall Study||6
76442|NCT01631929|182731|P1|COMPLETED|Overall Study||6
76443|NCT01631929|182730|P2|STARTED|Overall Study||6
76444|NCT01631929|182731|P1|STARTED|Overall Study||6
76445|NCT01631864|182739|P2|NOT COMPLETED|Overall Study||4
76446|NCT01631864|182740|P1|NOT COMPLETED|Overall Study||2
76447|NCT01631864|182739|P2|COMPLETED|Overall Study||44
76448|NCT01631864|182740|P1|COMPLETED|Overall Study||48
76449|NCT01631864|182739|P2|STARTED|Overall Study||48
76450|NCT01631864|182740|P1|STARTED|Overall Study||50
76451|NCT01631825|182752|P1|NOT COMPLETED|Overall Study||65
76452|NCT01631825|182752|P1|COMPLETED|Overall Study||256
76453|NCT01631825|182752|P1|STARTED|Overall Study||321
76454|NCT01631812|182772|P1|NOT COMPLETED|Overall Study||37
76455|NCT01631812|182772|P1|COMPLETED|Overall Study||93
76456|NCT01631812|182772|P1|STARTED|Overall Study||130
76457|NCT01631682|182784|P4|NOT COMPLETED|Overall Study||2
76458|NCT01631682|182785|P3|NOT COMPLETED|Overall Study||31
76459|NCT01631682|182786|P2|NOT COMPLETED|Overall Study||45
76460|NCT01631682|182787|P1|NOT COMPLETED|Overall Study||31
76461|NCT01631682|182784|P4|COMPLETED|Overall Study||5
76462|NCT01631682|182785|P3|COMPLETED|Overall Study||13
76463|NCT01631682|182786|P2|COMPLETED|Overall Study||21
76464|NCT01631682|182787|P1|COMPLETED|Overall Study||24
76465|NCT01631682|182784|P4|STARTED|Overall Study||7
76466|NCT01631682|182785|P3|STARTED|Overall Study||44
76467|NCT01631682|182786|P2|STARTED|Overall Study||66
76468|NCT01631682|182787|P1|STARTED|Overall Study||55
76469|NCT01631656|182799|P2|NOT COMPLETED|Overall Study||0
76470|NCT01631656|182800|P1|NOT COMPLETED|Overall Study||0
76471|NCT01631656|182799|P2|COMPLETED|Overall Study||5
76472|NCT01631656|182800|P1|COMPLETED|Overall Study||5
76473|NCT01631656|182799|P2|STARTED|Overall Study||5
76474|NCT01631656|182800|P1|STARTED|Overall Study||5
76475|NCT01631630|182808|P2|NOT COMPLETED|Overall Study||0
76476|NCT01631630|182809|P1|NOT COMPLETED|Overall Study||3
76477|NCT01631630|182808|P2|COMPLETED|Overall Study||8
76478|NCT01631630|182809|P1|COMPLETED|Overall Study||5
76479|NCT01631630|182808|P2|STARTED|Overall Study||8
76480|NCT01631630|182809|P1|STARTED|Overall Study||8
76481|NCT01631435|182919|P1|NOT COMPLETED|Overall Study||9
76482|NCT01631435|182919|P1|COMPLETED|Overall Study||66
76483|NCT01631435|182919|P1|STARTED|Overall Study||75
76484|NCT01631331|182924|P1|NOT COMPLETED|Overall Study||4
76485|NCT01631331|182924|P1|COMPLETED|Overall Study||11
76486|NCT01631331|182924|P1|STARTED|Overall Study||15
76487|NCT01631227|182933|P2|NOT COMPLETED|Overall Study||22
76488|NCT01631227|182934|P1|NOT COMPLETED|Overall Study||30
76489|NCT01631227|182933|P2|COMPLETED|Overall Study||310
76490|NCT01631227|182934|P1|COMPLETED|Overall Study||303
76491|NCT01631227|182933|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
76492|NCT01631227|182934|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
76493|NCT01631227|182933|P2|Safety Subject Sample|Overall Study||332
76494|NCT01631227|182934|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
76495|NCT01631227|182933|P2|STARTED|Overall Study||332
76496|NCT01631227|182934|P1|STARTED|Overall Study||333
76497|NCT01631149|182942|P2|NOT COMPLETED|Overall Study||0
76498|NCT01631149|182943|P1|NOT COMPLETED|Overall Study||0
76499|NCT01631149|182942|P2|COMPLETED|Overall Study||12
76500|NCT01631149|182943|P1|COMPLETED|Overall Study||12
76501|NCT01631149|182942|P2|STARTED|Overall Study||12
76502|NCT01631149|182943|P1|STARTED|Overall Study||12
76503|NCT01631110|182959|P2|NOT COMPLETED|Overall Study||0
76504|NCT01631110|182960|P1|NOT COMPLETED|Overall Study||0
76505|NCT01631110|182959|P2|COMPLETED|Overall Study||55
76506|NCT01631110|182960|P1|COMPLETED|Overall Study||55
76507|NCT01631110|182959|P2|STARTED|Overall Study||55
76508|NCT01631110|182960|P1|STARTED|Overall Study||55
76509|NCT01631071|182974|P2|NOT COMPLETED|Overall Study||0
76510|NCT01631071|182975|P1|NOT COMPLETED|Overall Study||0
76511|NCT01631071|182974|P2|COMPLETED|Overall Study||55
76512|NCT01631071|182975|P1|COMPLETED|Overall Study||55
76513|NCT01631071|182974|P2|STARTED|Overall Study||55
76514|NCT01631071|182975|P1|STARTED|Overall Study||55
76515|NCT01630811|182987|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
76516|NCT01630811|182988|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
76517|NCT01630811|182987|P2|COMPLETED|Second Washout (4 Weeks)||6
76518|NCT01630811|182988|P1|COMPLETED|Second Washout (4 Weeks)||6
76519|NCT01630811|182987|P2|STARTED|Second Washout (4 Weeks)||6
76520|NCT01630811|182988|P1|STARTED|Second Washout (4 Weeks)||6
76521|NCT01630811|182987|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
76522|NCT01630811|182988|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
76523|NCT01630811|182987|P2|COMPLETED|Second Intervention (8 Weeks)||6
76524|NCT01630811|182988|P1|COMPLETED|Second Intervention (8 Weeks)||6
76525|NCT01630811|182987|P2|STARTED|Second Intervention (8 Weeks)||6
76526|NCT01630811|182988|P1|STARTED|Second Intervention (8 Weeks)||7
76527|NCT01630811|182987|P2|NOT COMPLETED|Washout (4 Weeks)||0
76528|NCT01630811|182988|P1|NOT COMPLETED|Washout (4 Weeks)||0
76529|NCT01630811|182987|P2|COMPLETED|Washout (4 Weeks)||6
76530|NCT01630811|182988|P1|COMPLETED|Washout (4 Weeks)||7
76531|NCT01630811|182987|P2|STARTED|Washout (4 Weeks)||6
76532|NCT01630811|182988|P1|STARTED|Washout (4 Weeks)||7
76533|NCT01630811|182987|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
76534|NCT01630811|182988|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
76535|NCT01630811|182987|P2|COMPLETED|First Intervention (8 Weeks)||6
76536|NCT01630811|182988|P1|COMPLETED|First Intervention (8 Weeks)||7
76537|NCT01630811|182987|P2|STARTED|First Intervention (8 Weeks)||6
76538|NCT01630811|182988|P1|STARTED|First Intervention (8 Weeks)||7
76539|NCT01630694|183000|P2|NOT COMPLETED|Overall Study||0
76540|NCT01630694|183001|P1|NOT COMPLETED|Overall Study||0
76541|NCT01630694|183000|P2|COMPLETED|Overall Study||16
76542|NCT01630694|183001|P1|COMPLETED|Overall Study||12
76543|NCT01630694|183000|P2|STARTED|Overall Study||16
76544|NCT01630694|183001|P1|STARTED|Overall Study||12
76545|NCT01630616|183015|P6|NOT COMPLETED|Overall Study||0
76546|NCT01630616|183016|P5|NOT COMPLETED|Overall Study||0
76547|NCT01630616|183017|P4|NOT COMPLETED|Overall Study||3
76548|NCT01630616|183018|P3|NOT COMPLETED|Overall Study||0
76549|NCT01630616|183019|P2|NOT COMPLETED|Overall Study||0
76550|NCT01630616|183020|P1|NOT COMPLETED|Overall Study||0
76551|NCT01630616|183015|P6|COMPLETED|Overall Study||2
76552|NCT01630616|183016|P5|COMPLETED|Overall Study||6
76553|NCT01630616|183017|P4|COMPLETED|Overall Study||9
76554|NCT01630616|183018|P3|COMPLETED|Overall Study||3
76555|NCT01630616|183019|P2|COMPLETED|Overall Study||3
76556|NCT01630616|183020|P1|COMPLETED|Overall Study||5
76557|NCT01630616|183015|P6|STARTED|Overall Study||2
76558|NCT01630616|183016|P5|STARTED|Overall Study||6
76559|NCT01630616|183017|P4|STARTED|Overall Study||12
76560|NCT01630616|183018|P3|STARTED|Overall Study||3
76561|NCT01630616|183019|P2|STARTED|Overall Study||3
76562|NCT01630616|183020|P1|STARTED|Overall Study||5
76563|NCT01630135|183095|P2|NOT COMPLETED|Overall Study||2
76564|NCT01630135|183096|P1|NOT COMPLETED|Overall Study||0
76565|NCT01630135|183095|P2|COMPLETED|Overall Study||128
76566|NCT01630135|183096|P1|COMPLETED|Overall Study||131
76567|NCT01630135|183095|P2|STARTED|Overall Study||130
76568|NCT01630135|183096|P1|STARTED|Overall Study||131
76569|NCT01630109|183135|P3|NOT COMPLETED|Overall Study||0
76570|NCT01630109|183136|P2|NOT COMPLETED|Overall Study||0
76571|NCT01630109|183137|P1|NOT COMPLETED|Overall Study||0
76572|NCT01630109|183135|P3|COMPLETED|Overall Study||3
76573|NCT01630109|183136|P2|COMPLETED|Overall Study||1
76574|NCT01630109|183137|P1|COMPLETED|Overall Study||1
76575|NCT01630109|183135|P3|STARTED|Overall Study||3
76576|NCT01630109|183136|P2|STARTED|Overall Study||1
76577|NCT01630109|183137|P1|STARTED|Overall Study||1
76578|NCT01629953|183159|P2|NOT COMPLETED|Overall Study||15
76579|NCT01629953|183160|P1|NOT COMPLETED|Overall Study||13
76580|NCT01629953|183159|P2|COMPLETED|Overall Study||60
76581|NCT01629953|183160|P1|COMPLETED|Overall Study||52
76582|NCT01629953|183159|P2|STARTED|Overall Study||75
76583|NCT01629953|183160|P1|STARTED|Overall Study||65
76584|NCT01629862|183170|P2|NOT COMPLETED|Overall Study||2
76585|NCT01629862|183171|P1|NOT COMPLETED|Overall Study||2
76586|NCT01629862|183170|P2|COMPLETED|Overall Study||23
76587|NCT01629862|183171|P1|COMPLETED|Overall Study||26
76588|NCT01629862|183170|P2|STARTED|Overall Study||25
76589|NCT01629862|183171|P1|STARTED|Overall Study||28
76590|NCT01629823|183180|P3|NOT COMPLETED|Washout Period||0
76591|NCT01629823|183181|P2|NOT COMPLETED|Washout Period||6
76592|NCT01629823|183182|P1|NOT COMPLETED|Washout Period||3
76593|NCT01629823|183180|P3|COMPLETED|Washout Period||50
76594|NCT01629823|183181|P2|COMPLETED|Washout Period||51
76595|NCT01629823|183182|P1|COMPLETED|Washout Period||51
76596|NCT01629823|183180|P3|STARTED|Washout Period||50
76597|NCT01629823|183181|P2|STARTED|Washout Period||57
76598|NCT01629823|183182|P1|STARTED|Washout Period||54
76599|NCT01629823|183180|P3|NOT COMPLETED|Trial Period||10
76600|NCT01629823|183181|P2|NOT COMPLETED|Trial Period||13
76601|NCT01629823|183182|P1|NOT COMPLETED|Trial Period||13
76602|NCT01629823|183180|P3|COMPLETED|Trial Period||49
76603|NCT01629823|183181|P2|COMPLETED|Trial Period||56
76604|NCT01629823|183182|P1|COMPLETED|Trial Period||53
76605|NCT01629823|183180|P3|STARTED|Trial Period||59
76606|NCT01629823|183181|P2|STARTED|Trial Period||69
76607|NCT01629823|183182|P1|STARTED|Trial Period||66
76608|NCT01629797|183190|P1|NOT COMPLETED|Overall Study||18
76609|NCT01629797|183190|P1|COMPLETED|Overall Study||82
76610|NCT01629797|183190|P1|STARTED|Overall Study||100
76611|NCT01629784|183197|P1|NOT COMPLETED|Overall Study||6
76612|NCT01629784|183197|P1|COMPLETED|Overall Study||25
76613|NCT01629784|183197|P1|STARTED|Overall Study||31
76614|NCT01629771|183206|P2|NOT COMPLETED|Overall Study||0
76615|NCT01629771|183207|P1|NOT COMPLETED|Overall Study||0
76616|NCT01629771|183206|P2|COMPLETED|Overall Study||36
76617|NCT01629771|183207|P1|COMPLETED|Overall Study||36
76618|NCT01629771|183206|P2|STARTED|Overall Study||36
76619|NCT01629771|183207|P1|STARTED|Overall Study||36
76620|NCT01629706|183217|P1|NOT COMPLETED|Phase 2 Habitual||10
76621|NCT01629706|183217|P1|COMPLETED|Phase 2 Habitual||48
76622|NCT01629706|183217|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
76623|NCT01629706|183217|P1|NOT COMPLETED|Phase 1 PureVision||9
76624|NCT01629706|183217|P1|COMPLETED|Phase 1 PureVision||35
76625|NCT01629706|183217|P1|STARTED|Phase 1 PureVision||44
76626|NCT01629693|183245|P2|NOT COMPLETED|Overall Study||10
76627|NCT01629693|183246|P1|NOT COMPLETED|Overall Study||5
76628|NCT01629693|183245|P2|COMPLETED|Overall Study||178
76629|NCT01629693|183246|P1|COMPLETED|Overall Study||188
76630|NCT01629693|183245|P2|STARTED|Overall Study||188
76631|NCT01629693|183246|P1|STARTED|Overall Study||193
76632|NCT01629667|183255|P3|NOT COMPLETED|Overall Study||45
76633|NCT01629667|183256|P2|NOT COMPLETED|Overall Study||41
76634|NCT01629667|183257|P1|NOT COMPLETED|Overall Study||47
76635|NCT01629667|183255|P3|COMPLETED|Overall Study||14
76636|NCT01629667|183256|P2|COMPLETED|Overall Study||17
76637|NCT01629667|183257|P1|COMPLETED|Overall Study||12
76638|NCT01629667|183255|P3|Randomized and Treated|Overall Study||59
76639|NCT01629667|183256|P2|Randomized and Treated|Overall Study||57
76640|NCT01629667|183257|P1|Randomized and Treated|Overall Study||57
76641|NCT01629667|183255|P3|STARTED|Overall Study||59
76642|NCT01629667|183256|P2|STARTED|Overall Study||58
76643|NCT01629667|183257|P1|STARTED|Overall Study||59
76644|NCT01629589|183341|P2|NOT COMPLETED|Overall Study||7
76645|NCT01629589|183342|P1|NOT COMPLETED|Overall Study||8
76646|NCT01629589|183341|P2|COMPLETED|Overall Study||204
76647|NCT01629589|183342|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
76648|NCT01629589|183341|P2|STARTED|Overall Study||211
76649|NCT01629589|183342|P1|STARTED|Overall Study||212
76650|NCT01629290|183358|P1|NOT COMPLETED|Overall Study||0
76651|NCT01629290|183358|P1|COMPLETED|Overall Study||15
76652|NCT01629290|183358|P1|STARTED|Overall Study||15
76653|NCT01629134|183368|P1|NOT COMPLETED|Overall Study||0
76654|NCT01629134|183368|P1|COMPLETED|Overall Study||62
76655|NCT01629134|183368|P1|STARTED|Overall Study||62
76656|NCT01628965|183381|P1|NOT COMPLETED|Overall Study||49
76657|NCT01628965|183381|P1|COMPLETED|Overall Study||94
76658|NCT01628965|183381|P1|STARTED|Overall Study||143
76659|NCT01628926|183390|P3|NOT COMPLETED|Overall Study||17
76660|NCT01628926|183391|P2|NOT COMPLETED|Overall Study||23
76661|NCT01628926|183392|P1|NOT COMPLETED|Overall Study||26
76662|NCT01628926|183390|P3|COMPLETED|Overall Study||68
76663|NCT01628926|183391|P2|COMPLETED|Overall Study||144
76664|NCT01628926|183392|P1|COMPLETED|Overall Study||142
76665|NCT01628926|183390|P3|STARTED|Overall Study||85
76666|NCT01628926|183391|P2|STARTED|Overall Study||167
76667|NCT01628926|183392|P1|STARTED|Overall Study||168
76668|NCT01628913|183441|P2|NOT COMPLETED|Overall Study||31
76669|NCT01628913|183442|P1|NOT COMPLETED|Overall Study||31
76670|NCT01628913|183441|P2|COMPLETED|Overall Study||0
76671|NCT01628913|183442|P1|COMPLETED|Overall Study||0
76672|NCT01628913|183441|P2|STARTED|Overall Study||31
76673|NCT01628913|183442|P1|STARTED|Overall Study||31
76674|NCT01628848|183456|P2|NOT COMPLETED|Overall Study||14
76675|NCT01628848|183457|P1|NOT COMPLETED|Overall Study||12
76676|NCT01628848|183456|P2|COMPLETED|Overall Study||73
76677|NCT01628848|183457|P1|COMPLETED|Overall Study||75
76678|NCT01628848|183456|P2|STARTED|Overall Study||87
76679|NCT01628848|183457|P1|STARTED|Overall Study||87
76680|NCT01628692|183491|P6|NOT COMPLETED|Overall Study||9
76681|NCT01628692|183492|P5|NOT COMPLETED|Overall Study||4
76682|NCT01628692|183493|P4|NOT COMPLETED|Overall Study||1
76683|NCT01628692|183494|P3|NOT COMPLETED|Overall Study||8
76684|NCT01628692|183495|P2|NOT COMPLETED|Overall Study||6
76685|NCT01628692|183496|P1|NOT COMPLETED|Overall Study||7
76686|NCT01628692|183491|P6|COMPLETED|Overall Study||0
76687|NCT01628692|183492|P5|COMPLETED|Overall Study||8
76688|NCT01628692|183493|P4|COMPLETED|Overall Study||19
76689|NCT01628692|183494|P3|COMPLETED|Overall Study||43
76690|NCT01628692|183495|P2|COMPLETED|Overall Study||17
76691|NCT01628692|183496|P1|COMPLETED|Overall Study||46
76692|NCT01628692|183491|P6|STARTED|Overall Study||9
76693|NCT01628692|183492|P5|STARTED|Overall Study||12
76694|NCT01628692|183493|P4|STARTED|Overall Study||20
76695|NCT01628692|183494|P3|STARTED|Overall Study||51
76696|NCT01628692|183495|P2|STARTED|Overall Study||23
76697|NCT01628692|183496|P1|STARTED|Overall Study||53
76698|NCT01628614|183540|P1|NOT COMPLETED|Overall Study||1775
76699|NCT01628614|183540|P1|COMPLETED|Overall Study||3037
76700|NCT01628614|183540|P1|STARTED|Overall Study||4812
76701|NCT01628601|183546|P1|NOT COMPLETED|Overall Study||41
76702|NCT01628601|183546|P1|COMPLETED|Overall Study||351
76703|NCT01628601|183546|P1|STARTED|Overall Study||392
76704|NCT01628588|183554|P1|NOT COMPLETED|Overall Study||16
76705|NCT01628588|183554|P1|COMPLETED|Overall Study||838
76706|NCT01628588|183554|P1|STARTED|Overall Study||854
76707|NCT01628510|183564|P2|NOT COMPLETED|Overall Study||5
76708|NCT01628510|183565|P1|NOT COMPLETED|Overall Study||3
76709|NCT01628510|183564|P2|COMPLETED|Overall Study||44
76710|NCT01628510|183565|P1|COMPLETED|Overall Study||48
76711|NCT01628510|183564|P2|STARTED|Overall Study||49
76712|NCT01628510|183565|P1|STARTED|Overall Study||51
76713|NCT01628367|183575|P2|NOT COMPLETED|Overall Study||0
76714|NCT01628367|183576|P1|NOT COMPLETED|Overall Study||1
76715|NCT01628367|183575|P2|COMPLETED|Overall Study||16
76716|NCT01628367|183576|P1|COMPLETED|Overall Study||15
76717|NCT01628367|183575|P2|STARTED|Overall Study||16
76718|NCT01628367|183576|P1|STARTED|Overall Study||16
76719|NCT01628250|183588|P2|NOT COMPLETED|Overall Study||0
76720|NCT01628250|183589|P1|NOT COMPLETED|Overall Study||0
76721|NCT01628250|183588|P2|COMPLETED|Overall Study||50
76722|NCT01628250|183589|P1|COMPLETED|Overall Study||49
76723|NCT01628250|183588|P2|STARTED|Overall Study||50
76724|NCT01628250|183589|P1|STARTED|Overall Study||49
76725|NCT01628198|183595|P1|NOT COMPLETED|Overall Study||18
76726|NCT01628198|183595|P1|COMPLETED|Overall Study||20
76727|NCT01628198|183595|P1|STARTED|Overall Study||38
76728|NCT01628042|183612|P4|NOT COMPLETED|Overall Study||0
76729|NCT01628042|183613|P3|NOT COMPLETED|Overall Study||0
76730|NCT01628042|183614|P2|NOT COMPLETED|Overall Study||0
76731|NCT01628042|183615|P1|NOT COMPLETED|Overall Study||0
76732|NCT01628042|183612|P4|COMPLETED|Overall Study||8
76733|NCT01628042|183613|P3|COMPLETED|Overall Study||8
76734|NCT01628042|183614|P2|COMPLETED|Overall Study||8
76735|NCT01628042|183615|P1|COMPLETED|Overall Study||8
76736|NCT01628042|183612|P4|STARTED|Overall Study||8
76737|NCT01628042|183613|P3|STARTED|Overall Study||8
76738|NCT01628042|183614|P2|STARTED|Overall Study||8
76739|NCT01628042|183615|P1|STARTED|Overall Study||8
76740|NCT01627860|183635|P2|NOT COMPLETED|Overall Study||6
76741|NCT01627860|183636|P1|NOT COMPLETED|Overall Study||12
76742|NCT01627860|183635|P2|COMPLETED|Overall Study||14
76743|NCT01627860|183636|P1|COMPLETED|Overall Study||23
76744|NCT01627860|183635|P2|STARTED|Overall Study||20
76745|NCT01627860|183636|P1|STARTED|Overall Study||35
76746|NCT01627782|183650|P4|NOT COMPLETED|Overall Study||6
76747|NCT01627782|183651|P3|NOT COMPLETED|Overall Study||15
76748|NCT01627782|183652|P2|NOT COMPLETED|Overall Study||6
76749|NCT01627782|183653|P1|NOT COMPLETED|Overall Study||16
76750|NCT01627782|183650|P4|COMPLETED|Overall Study||11
76751|NCT01627782|183651|P3|COMPLETED|Overall Study||1
76752|NCT01627782|183652|P2|COMPLETED|Overall Study||12
76753|NCT01627782|183653|P1|COMPLETED|Overall Study||1
76754|NCT01627782|183650|P4|Treated|Overall Study||17
76755|NCT01627782|183651|P3|Treated|Overall Study||16
76756|NCT01627782|183652|P2|Treated|Overall Study||18
76757|NCT01627782|183653|P1|Treated|Overall Study||16
76758|NCT01627782|183650|P4|STARTED|Overall Study||17
76759|NCT01627782|183651|P3|STARTED|Overall Study||16
76760|NCT01627782|183652|P2|STARTED|Overall Study||18
76761|NCT01627782|183653|P1|STARTED|Overall Study||17
76762|NCT01627561|183711|P2|NOT COMPLETED|Overall Study||3
76763|NCT01627561|183712|P1|NOT COMPLETED|Overall Study||0
76764|NCT01627561|183711|P2|COMPLETED|Overall Study||71
76765|NCT01627561|183712|P1|COMPLETED|Overall Study||74
76766|NCT01627561|183711|P2|STARTED|Overall Study||74
76767|NCT01627561|183712|P1|STARTED|Overall Study||74
76768|NCT01627340|183760|P2|NOT COMPLETED|Overall Study||4
76769|NCT01627340|183761|P1|NOT COMPLETED|Overall Study||12
76770|NCT01627340|183760|P2|COMPLETED|Overall Study||254
76771|NCT01627340|183761|P1|COMPLETED|Overall Study||404
76772|NCT01627340|183760|P2|STARTED|Overall Study||258
76773|NCT01627340|183761|P1|STARTED|Overall Study||416
76774|NCT01627327|183779|P2|NOT COMPLETED|Overall Study||39
76775|NCT01627327|183780|P1|NOT COMPLETED|Overall Study||19
76776|NCT01627327|183779|P2|COMPLETED|Overall Study||274
76777|NCT01627327|183780|P1|COMPLETED|Overall Study||291
76778|NCT01627327|183779|P2|STARTED|Overall Study||313
76779|NCT01627327|183780|P1|STARTED|Overall Study||310
76780|NCT01627249|183793|P3|NOT COMPLETED|Overall Study||12
76781|NCT01627249|183794|P2|NOT COMPLETED|Overall Study||12
76782|NCT01627249|183795|P1|NOT COMPLETED|Overall Study||16
76783|NCT01627249|183793|P3|COMPLETED|Overall Study||206
76784|NCT01627249|183794|P2|COMPLETED|Overall Study||206
76785|NCT01627249|183795|P1|COMPLETED|Overall Study||208
76786|NCT01627249|183793|P3|STARTED|Overall Study||218
76787|NCT01627249|183794|P2|STARTED|Overall Study||218
76788|NCT01627249|183795|P1|STARTED|Overall Study||224
76789|NCT01627002|183832|P9|NOT COMPLETED|Overall Study||0
76790|NCT01627002|183833|P8|NOT COMPLETED|Overall Study||0
76791|NCT01627002|183834|P7|NOT COMPLETED|Overall Study||0
76792|NCT01627002|183835|P6|NOT COMPLETED|Overall Study||0
76793|NCT01627002|183836|P5|NOT COMPLETED|Overall Study||0
76794|NCT01627002|183837|P4|NOT COMPLETED|Overall Study||0
76795|NCT01627002|183838|P3|NOT COMPLETED|Overall Study||0
76796|NCT01627002|183839|P2|NOT COMPLETED|Overall Study||0
76797|NCT01627002|183840|P1|NOT COMPLETED|Overall Study||0
76798|NCT01627002|183832|P9|COMPLETED|Overall Study||7
76799|NCT01627002|183833|P8|COMPLETED|Overall Study||5
76800|NCT01627002|183834|P7|COMPLETED|Overall Study||10
76801|NCT01627002|183835|P6|COMPLETED|Overall Study||9
76802|NCT01627002|183836|P5|COMPLETED|Overall Study||2
76803|NCT01627002|183837|P4|COMPLETED|Overall Study||4
76804|NCT01627002|183838|P3|COMPLETED|Overall Study||4
76805|NCT01627002|183839|P2|COMPLETED|Overall Study||4
76806|NCT01627002|183840|P1|COMPLETED|Overall Study||4
76807|NCT01627002|183832|P9|STARTED|Overall Study||7
76808|NCT01627002|183833|P8|STARTED|Overall Study||5
76809|NCT01627002|183834|P7|STARTED|Overall Study||10
76810|NCT01627002|183835|P6|STARTED|Overall Study||9
76811|NCT01627002|183836|P5|STARTED|Overall Study||2
76812|NCT01627002|183837|P4|STARTED|Overall Study||4
76813|NCT01627002|183838|P3|STARTED|Overall Study||4
76814|NCT01627002|183839|P2|STARTED|Overall Study||4
76815|NCT01627002|183840|P1|STARTED|Overall Study||4
76816|NCT01626820|183893|P2|NOT COMPLETED|Overall Study||0
76817|NCT01626820|183894|P1|NOT COMPLETED|Overall Study||0
76818|NCT01626820|183893|P2|COMPLETED|Overall Study||57
76819|NCT01626820|183894|P1|COMPLETED|Overall Study||56
76820|NCT01626820|183893|P2|STARTED|Overall Study||57
76821|NCT01626820|183894|P1|STARTED|Overall Study||56
76822|NCT01626690|183916|P2|NOT COMPLETED|Overall Study||0
76823|NCT01626690|183917|P1|NOT COMPLETED|Overall Study||2
76824|NCT01626690|183916|P2|COMPLETED|Overall Study||51
76825|NCT01626690|183917|P1|COMPLETED|Overall Study||47
76826|NCT01626690|183916|P2|STARTED|Overall Study||51
76827|NCT01626690|183917|P1|STARTED|Overall Study||49
76828|NCT01626456|183939|P2|NOT COMPLETED|Overall Study||117
76829|NCT01626456|183940|P1|NOT COMPLETED|Overall Study||35
76830|NCT01626456|183939|P2|COMPLETED|Overall Study||251
76831|NCT01626456|183940|P1|COMPLETED|Overall Study||75
76832|NCT01626456|183939|P2|STARTED|Overall Study||368
76833|NCT01626456|183940|P1|STARTED|Overall Study||110
76834|NCT01626391|183970|P2|NOT COMPLETED|Overall Study||0
76835|NCT01626391|183971|P1|NOT COMPLETED|Overall Study||2
76836|NCT01626391|183970|P2|COMPLETED|Overall Study||4
76837|NCT01626391|183971|P1|COMPLETED|Overall Study||3
76838|NCT01626391|183970|P2|STARTED|Overall Study||4
76839|NCT01626391|183971|P1|STARTED|Overall Study||5
76840|NCT01626352|183977|P1|NOT COMPLETED|Overall Study||10
76841|NCT01626352|183977|P1|COMPLETED|Overall Study||12
76842|NCT01626352|183977|P1|STARTED|Overall Study||22
76843|NCT01626118|183991|P4|NOT COMPLETED|Overall Study||3
76844|NCT01626118|183992|P3|NOT COMPLETED|Overall Study||2
76845|NCT01626118|183993|P2|NOT COMPLETED|Overall Study||2
76846|NCT01626118|183994|P1|NOT COMPLETED|Overall Study||2
76847|NCT01626118|183991|P4|COMPLETED|Overall Study||91
76848|NCT01626118|183992|P3|COMPLETED|Overall Study||90
76849|NCT01626118|183993|P2|COMPLETED|Overall Study||91
76850|NCT01626118|183994|P1|COMPLETED|Overall Study||92
76851|NCT01626118|183991|P4|STARTED|Overall Study||94
76852|NCT01626118|183992|P3|STARTED|Overall Study||92
76853|NCT01626118|183993|P2|STARTED|Overall Study||93
76854|NCT01626118|183994|P1|STARTED|Overall Study||94
76855|NCT01626092|184032|P1|NOT COMPLETED|Overall Study||0
76856|NCT01626092|184032|P1|COMPLETED|Overall Study||3
76857|NCT01626092|184032|P1|STARTED|Overall Study||3
76858|NCT01625910|184040|P2|NOT COMPLETED|Overall Study||4
76859|NCT01625910|184041|P1|NOT COMPLETED|Overall Study||3
76860|NCT01625910|184040|P2|COMPLETED|Overall Study||33
76861|NCT01625910|184041|P1|COMPLETED|Overall Study||32
76862|NCT01625910|184040|P2|STARTED|Overall Study||37
76863|NCT01625910|184041|P1|STARTED|Overall Study||35
76864|NCT01625845|184051|P2|NOT COMPLETED|Overall Study||3
76865|NCT01625845|184052|P1|NOT COMPLETED|Overall Study||5
76866|NCT01625845|184051|P2|COMPLETED|Overall Study||3
76867|NCT01625845|184052|P1|COMPLETED|Overall Study||5
76868|NCT01625845|184051|P2|STARTED|Overall Study||6
76869|NCT01625845|184052|P1|STARTED|Overall Study||10
76870|NCT01625689|184072|P2|NOT COMPLETED|Overall Study||1
76871|NCT01625689|184073|P1|NOT COMPLETED|Overall Study||2
76872|NCT01625689|184072|P2|COMPLETED|Overall Study||149
76873|NCT01625689|184073|P1|COMPLETED|Overall Study||148
76874|NCT01625689|184072|P2|STARTED|Overall Study||150
76875|NCT01625689|184073|P1|STARTED|Overall Study||150
76876|NCT01625507|184083|P1|NOT COMPLETED|Overall Study||10
76877|NCT01625507|184083|P1|COMPLETED|Overall Study||63
76878|NCT01625507|184083|P1|STARTED|Overall Study||73
76879|NCT01625455|184098|P2|NOT COMPLETED|Overall Study||0
76880|NCT01625455|184099|P1|NOT COMPLETED|Overall Study||0
76881|NCT01625455|184098|P2|COMPLETED|Overall Study||3
76882|NCT01625455|184099|P1|COMPLETED|Overall Study||2
76883|NCT01625455|184098|P2|STARTED|Overall Study||3
76884|NCT01625455|184099|P1|STARTED|Overall Study||2
76885|NCT01625416|184109|P2|NOT COMPLETED|Overall Study||7
76886|NCT01625416|184110|P1|NOT COMPLETED|Overall Study||9
76887|NCT01625416|184109|P2|COMPLETED|Overall Study||54
76888|NCT01625416|184110|P1|COMPLETED|Overall Study||51
76889|NCT01625416|184109|P2|STARTED|Overall Study||61
76890|NCT01625416|184110|P1|STARTED|Overall Study||60
76891|NCT01625377|184128|P2|NOT COMPLETED|Overall Study||22
76892|NCT01625377|184129|P1|NOT COMPLETED|Overall Study||7
76893|NCT01625377|184128|P2|COMPLETED|Overall Study||71
76894|NCT01625377|184129|P1|COMPLETED|Overall Study||88
76895|NCT01625377|184128|P2|Intent to Treat Population|Overall Study||90
76896|NCT01625377|184129|P1|Intent to Treat Population|Overall Study||93
76897|NCT01625377|184128|P2|Safety Set of Population|Overall Study||90
76898|NCT01625377|184129|P1|Safety Set of Population|Overall Study||94
76899|NCT01625377|184128|P2|STARTED|Overall Study||93
76900|NCT01625377|184129|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
76901|NCT01625338|184162|P3|NOT COMPLETED|Overall Study||39
76902|NCT01625338|184163|P2|NOT COMPLETED|Overall Study||44
76903|NCT01625338|184164|P1|NOT COMPLETED|Overall Study||32
76904|NCT01625338|184162|P3|COMPLETED|Overall Study||181
76905|NCT01625338|184163|P2|COMPLETED|Overall Study||156
76906|NCT01625338|184164|P1|COMPLETED|Overall Study||82
76907|NCT01625338|184162|P3|STARTED|Overall Study||220
76908|NCT01625338|184163|P2|STARTED|Overall Study||200
76909|NCT01625338|184164|P1|STARTED|Overall Study||114
76910|NCT01625221|184184|P1|NOT COMPLETED|Overall Study||7
76911|NCT01625221|184184|P1|COMPLETED|Overall Study||28
76912|NCT01625221|184184|P1|STARTED|Overall Study||35
76913|NCT01625182|184191|P2|NOT COMPLETED|Overall Study||11
76914|NCT01625182|184192|P1|NOT COMPLETED|Overall Study||20
76915|NCT01625182|184191|P2|COMPLETED|Overall Study||41
76916|NCT01625182|184192|P1|COMPLETED|Overall Study||34
76917|NCT01625182|184191|P2|STARTED|Overall Study||52
76918|NCT01625182|184192|P1|STARTED|Overall Study||54
76919|NCT01625169|184205|P1|NOT COMPLETED|Overall Study||0
76920|NCT01625169|184205|P1|COMPLETED|Overall Study||9
76921|NCT01625169|184205|P1|STARTED|Overall Study||9
76922|NCT01625104|184220|P2|NOT COMPLETED|Overall Study||0
76923|NCT01625104|184221|P1|NOT COMPLETED|Overall Study||0
76924|NCT01625104|184220|P2|COMPLETED|Overall Study||434
76925|NCT01625104|184221|P1|COMPLETED|Overall Study||448
76926|NCT01625104|184220|P2|STARTED|Overall Study||434
76927|NCT01625104|184221|P1|STARTED|Overall Study||448
76928|NCT01625091|184229|P2|NOT COMPLETED|Post-intervention||2
76929|NCT01625091|184230|P1|NOT COMPLETED|Post-intervention||4
76930|NCT01625091|184229|P2|COMPLETED|Post-intervention||85
76931|NCT01625091|184230|P1|COMPLETED|Post-intervention||81
76932|NCT01625091|184229|P2|7 Months|Post-intervention||85
76933|NCT01625091|184230|P1|7 Months|Post-intervention||81
76934|NCT01625091|184229|P2|STARTED|Post-intervention||87
76935|NCT01625091|184230|P1|STARTED|Post-intervention||85
76936|NCT01625091|184229|P2|NOT COMPLETED|Intervention||11
76937|NCT01625091|184230|P1|NOT COMPLETED|Intervention||11
76938|NCT01625091|184229|P2|COMPLETED|Intervention||87
76939|NCT01625091|184230|P1|COMPLETED|Intervention||85
76940|NCT01625091|184229|P2|4 Months|Intervention||87
76941|NCT01625091|184230|P1|4 Months|Intervention||85
76942|NCT01625091|184229|P2|2 Months|Intervention||93
76943|NCT01625091|184230|P1|2 Months|Intervention||90
76944|NCT01625091|184229|P2|STARTED|Intervention||98
76945|NCT01625091|184230|P1|STARTED|Intervention||96
76946|NCT01624948|184244|P2|NOT COMPLETED|Overall Study||0
76947|NCT01624948|184245|P1|NOT COMPLETED|Overall Study||0
76948|NCT01624948|184244|P2|COMPLETED|Overall Study||20
76949|NCT01624948|184245|P1|COMPLETED|Overall Study||20
76950|NCT01624948|184244|P2|STARTED|Overall Study||20
76951|NCT01624948|184245|P1|STARTED|Overall Study||20
76952|NCT01624740|184263|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
76953|NCT01624740|184264|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
76954|NCT01624740|184263|P2|COMPLETED|Second Intervention (3-4 Days)||9
76955|NCT01624740|184264|P1|COMPLETED|Second Intervention (3-4 Days)||8
76956|NCT01624740|184263|P2|STARTED|Second Intervention (3-4 Days)||9
76957|NCT01624740|184264|P1|STARTED|Second Intervention (3-4 Days)||9
76958|NCT01624740|184263|P2|NOT COMPLETED|Washout (1 Hour)||0
76959|NCT01624740|184264|P1|NOT COMPLETED|Washout (1 Hour)||0
76960|NCT01624740|184263|P2|COMPLETED|Washout (1 Hour)||9
76961|NCT01624740|184264|P1|COMPLETED|Washout (1 Hour)||9
76962|NCT01624740|184263|P2|STARTED|Washout (1 Hour)||9
76963|NCT01624740|184264|P1|STARTED|Washout (1 Hour)||9
76964|NCT01624740|184263|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
76965|NCT01624740|184264|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
76966|NCT01624740|184263|P2|COMPLETED|First Intervention (3-4 Days)||9
76967|NCT01624740|184264|P1|COMPLETED|First Intervention (3-4 Days)||9
76968|NCT01624740|184263|P2|STARTED|First Intervention (3-4 Days)||9
76969|NCT01624740|184264|P1|STARTED|First Intervention (3-4 Days)||9
76970|NCT01624467|184271|P1|NOT COMPLETED|Overall Study||31
76971|NCT01624467|184271|P1|COMPLETED|Overall Study||44
76972|NCT01624467|184271|P1|Received at Least One Dose of Study Drug|Overall Study||75
76973|NCT01624467|184271|P1|STARTED|Overall Study||75
76974|NCT01624363|184284|P1|NOT COMPLETED|Overall Study||0
76975|NCT01624363|184284|P1|COMPLETED|Overall Study||341
76976|NCT01624363|184284|P1|STARTED|Overall Study||341
76977|NCT01624350|184288|P1|NOT COMPLETED|Overall Study||25
76978|NCT01624350|184288|P1|COMPLETED|Overall Study||75
76979|NCT01624350|184288|P1|STARTED|Overall Study||100
76980|NCT01624259|184310|P2|NOT COMPLETED|Overall Study||31
76981|NCT01624259|184311|P1|NOT COMPLETED|Overall Study||30
76982|NCT01624259|184310|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
76983|NCT01624259|184311|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
76984|NCT01624259|184310|P2|Received at Least One Dose of Study Drug|Overall Study||300
76985|NCT01624259|184311|P1|Received at Least One Dose of Study Drug|Overall Study||299
76986|NCT01624259|184310|P2|STARTED|Overall Study||300
76987|NCT01624259|184311|P1|STARTED|Overall Study||299
76988|NCT01624233|184360|P1|NOT COMPLETED|Period 3 - Maintenance||7
76989|NCT01624233|184360|P1|COMPLETED|Period 3 - Maintenance||83
76990|NCT01624233|184360|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
76991|NCT01624233|184360|P1|STARTED|Period 3 - Maintenance||90
76992|NCT01624233|184360|P1|NOT COMPLETED|Period 2 - Induction||1
76993|NCT01624233|184360|P1|COMPLETED|Period 2 - Induction||90
76994|NCT01624233|184360|P1|Plaque Ps|Period 2 - Induction||78
76995|NCT01624233|184360|P1|Pustular Ps|Period 2 - Induction||5
76996|NCT01624233|184360|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
76997|NCT01624233|184360|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
76998|NCT01624233|184360|P1|STARTED|Period 2 - Induction||91
76999|NCT01624168|184380|P3|NOT COMPLETED|Overall Study||6
77000|NCT01624168|184381|P2|NOT COMPLETED|Overall Study||12
77001|NCT01624168|184382|P1|NOT COMPLETED|Overall Study||4
77002|NCT01624168|184380|P3|COMPLETED|Overall Study||22
77003|NCT01624168|184381|P2|COMPLETED|Overall Study||16
77004|NCT01624168|184382|P1|COMPLETED|Overall Study||15
77005|NCT01624168|184380|P3|STARTED|Overall Study||28
77006|NCT01624168|184381|P2|STARTED|Overall Study||28
77007|NCT01624168|184382|P1|STARTED|Overall Study||19
77008|NCT01623869|184405|P1|NOT COMPLETED|Overall Study||0
77009|NCT01623869|184405|P1|COMPLETED|Overall Study||16
77010|NCT01623869|184405|P1|STARTED|Overall Study||16
77011|NCT01623830|184413|P2|NOT COMPLETED|Overall Study||9
77012|NCT01623830|184414|P1|NOT COMPLETED|Overall Study||7
77013|NCT01623830|184413|P2|COMPLETED|Overall Study||35
77014|NCT01623830|184414|P1|COMPLETED|Overall Study||38
77015|NCT01623830|184413|P2|STARTED|Overall Study||44
77016|NCT01623830|184414|P1|STARTED|Overall Study||45
77017|NCT01623739|184430|P2|NOT COMPLETED|Overall Study||4
77018|NCT01623739|184431|P1|NOT COMPLETED|Overall Study||2
77019|NCT01623739|184430|P2|COMPLETED|Overall Study||15
77020|NCT01623739|184431|P1|COMPLETED|Overall Study||17
77021|NCT01623739|184430|P2|STARTED|Overall Study||19
77022|NCT01623739|184431|P1|STARTED|Overall Study||19
77023|NCT01623596|184439|P2|NOT COMPLETED|Overall Study||100
77024|NCT01623596|184440|P1|NOT COMPLETED|Overall Study||62
77025|NCT01623596|184439|P2|COMPLETED|Overall Study||339
77026|NCT01623596|184440|P1|COMPLETED|Overall Study||374
77027|NCT01623596|184439|P2|On Switched Treatment|Overall Study||214
77028|NCT01623596|184440|P1|On Switched Treatment|Overall Study||22
77029|NCT01623596|184439|P2|On Randomized Treatment|Overall Study||125
77030|NCT01623596|184440|P1|On Randomized Treatment|Overall Study||352
77031|NCT01623596|184439|P2|STARTED|Overall Study||439
77032|NCT01623596|184440|P1|STARTED|Overall Study||436
77033|NCT01623479|184456|P1|NOT COMPLETED|Overall Study||0
77034|NCT01623479|184456|P1|COMPLETED|Overall Study||585
77035|NCT01623479|184456|P1|STARTED|Overall Study||585
77036|NCT01623466|184464|P2|NOT COMPLETED|Overall Study||0
77037|NCT01623466|184465|P1|NOT COMPLETED|Overall Study||1
77038|NCT01623466|184464|P2|COMPLETED|Overall Study||18
77039|NCT01623466|184465|P1|COMPLETED|Overall Study||17
77040|NCT01623466|184464|P2|STARTED|Overall Study||18
77041|NCT01623466|184465|P1|STARTED|Overall Study||18
77042|NCT01623323|184479|P1|NOT COMPLETED|Overall Study||104
77043|NCT01623323|184479|P1|COMPLETED|Overall Study||601
77044|NCT01623323|184479|P1|STARTED|Overall Study||705
77045|NCT01623310|184483|P1|NOT COMPLETED|Overall Study||79
77046|NCT01623310|184483|P1|COMPLETED|Overall Study||144
77047|NCT01623310|184483|P1|STARTED|Overall Study||223
77048|NCT01623271|184492|P1|NOT COMPLETED|Overall Study||2
77049|NCT01623271|184492|P1|COMPLETED|Overall Study||3
77050|NCT01623271|184492|P1|STARTED|Overall Study||5
77051|NCT01623154|184496|P1|NOT COMPLETED|Overall Study||4
77052|NCT01623154|184496|P1|COMPLETED|Overall Study||95
77053|NCT01623154|184496|P1|Available for Analysis|Overall Study||95
77054|NCT01623154|184496|P1|STARTED|Overall Study||99
77055|NCT01623115|184504|P2|NOT COMPLETED|Overall Study||77
77056|NCT01623115|184505|P1|NOT COMPLETED|Overall Study||33
77057|NCT01623115|184504|P2|COMPLETED|Overall Study||246
77058|NCT01623115|184505|P1|COMPLETED|Overall Study||130
77059|NCT01623115|184504|P2|Treated|Overall Study||322
77060|NCT01623115|184505|P1|Treated|Overall Study||163
77061|NCT01623115|184504|P2|STARTED|Overall Study|Randomized|323
77062|NCT01623115|184505|P1|STARTED|Overall Study|Randomized|163
77063|NCT01623050|184565|P1|NOT COMPLETED|Overall Study||9
77064|NCT01623050|184565|P1|COMPLETED|Overall Study||27
77065|NCT01623050|184565|P1|Treated|Overall Study||34
77066|NCT01623050|184565|P1|STARTED|Overall Study||36
77067|NCT01622673|184579|P6|NOT COMPLETED|Treatment Period 5||0
77068|NCT01622673|184580|P5|NOT COMPLETED|Treatment Period 5||0
77069|NCT01622673|184581|P4|NOT COMPLETED|Treatment Period 5||0
77070|NCT01622673|184582|P3|NOT COMPLETED|Treatment Period 5||0
77071|NCT01622673|184583|P2|NOT COMPLETED|Treatment Period 5||0
77072|NCT01622673|184584|P1|NOT COMPLETED|Treatment Period 5||0
77073|NCT01622673|184579|P6|COMPLETED|Treatment Period 5||4
77074|NCT01622673|184580|P5|COMPLETED|Treatment Period 5||4
77075|NCT01622673|184581|P4|COMPLETED|Treatment Period 5||4
77076|NCT01622673|184582|P3|COMPLETED|Treatment Period 5||4
77077|NCT01622673|184583|P2|COMPLETED|Treatment Period 5||3
77078|NCT01622673|184584|P1|COMPLETED|Treatment Period 5||4
77079|NCT01622673|184579|P6|STARTED|Treatment Period 5||4
77080|NCT01622673|184580|P5|STARTED|Treatment Period 5||4
77081|NCT01622673|184581|P4|STARTED|Treatment Period 5||4
77082|NCT01622673|184582|P3|STARTED|Treatment Period 5||4
77083|NCT01622673|184583|P2|STARTED|Treatment Period 5||3
77084|NCT01622673|184584|P1|STARTED|Treatment Period 5||4
77085|NCT01622673|184579|P6|NOT COMPLETED|Treatment Period 4||0
77086|NCT01622673|184580|P5|NOT COMPLETED|Treatment Period 4||0
77087|NCT01622673|184581|P4|NOT COMPLETED|Treatment Period 4||0
77088|NCT01622673|184582|P3|NOT COMPLETED|Treatment Period 4||0
77089|NCT01622673|184583|P2|NOT COMPLETED|Treatment Period 4||0
77090|NCT01622673|184584|P1|NOT COMPLETED|Treatment Period 4||0
77091|NCT01622673|184579|P6|COMPLETED|Treatment Period 4||4
77092|NCT01622673|184580|P5|COMPLETED|Treatment Period 4||4
77093|NCT01622673|184581|P4|COMPLETED|Treatment Period 4||4
77094|NCT01622673|184582|P3|COMPLETED|Treatment Period 4||4
77095|NCT01622673|184583|P2|COMPLETED|Treatment Period 4||3
77096|NCT01622673|184584|P1|COMPLETED|Treatment Period 4||4
77097|NCT01622673|184579|P6|STARTED|Treatment Period 4||4
77098|NCT01622673|184580|P5|STARTED|Treatment Period 4||4
77099|NCT01622673|184581|P4|STARTED|Treatment Period 4||4
77100|NCT01622673|184582|P3|STARTED|Treatment Period 4||4
77101|NCT01622673|184583|P2|STARTED|Treatment Period 4||3
77102|NCT01622673|184584|P1|STARTED|Treatment Period 4||4
77103|NCT01622673|184579|P6|NOT COMPLETED|Treatment Period 3||0
77104|NCT01622673|184580|P5|NOT COMPLETED|Treatment Period 3||0
77105|NCT01622673|184581|P4|NOT COMPLETED|Treatment Period 3||0
77106|NCT01622673|184582|P3|NOT COMPLETED|Treatment Period 3||0
77107|NCT01622673|184583|P2|NOT COMPLETED|Treatment Period 3||1
77108|NCT01622673|184584|P1|NOT COMPLETED|Treatment Period 3||0
77109|NCT01622673|184579|P6|COMPLETED|Treatment Period 3||4
77110|NCT01622673|184580|P5|COMPLETED|Treatment Period 3||4
77111|NCT01622673|184581|P4|COMPLETED|Treatment Period 3||4
77112|NCT01622673|184582|P3|COMPLETED|Treatment Period 3||4
77113|NCT01622673|184583|P2|COMPLETED|Treatment Period 3||3
77114|NCT01622673|184584|P1|COMPLETED|Treatment Period 3||4
77115|NCT01622673|184579|P6|STARTED|Treatment Period 3||4
77116|NCT01622673|184580|P5|STARTED|Treatment Period 3||4
77117|NCT01622673|184581|P4|STARTED|Treatment Period 3||4
77118|NCT01622673|184582|P3|STARTED|Treatment Period 3||4
77119|NCT01622673|184583|P2|STARTED|Treatment Period 3||4
77120|NCT01622673|184584|P1|STARTED|Treatment Period 3||4
77121|NCT01622673|184579|P6|NOT COMPLETED|Treatment Period 2||0
77122|NCT01622673|184580|P5|NOT COMPLETED|Treatment Period 2||0
77123|NCT01622673|184581|P4|NOT COMPLETED|Treatment Period 2||1
77124|NCT01622673|184582|P3|NOT COMPLETED|Treatment Period 2||0
77125|NCT01622673|184583|P2|NOT COMPLETED|Treatment Period 2||0
77126|NCT01622673|184584|P1|NOT COMPLETED|Treatment Period 2||0
77127|NCT01622673|184579|P6|COMPLETED|Treatment Period 2||4
77128|NCT01622673|184580|P5|COMPLETED|Treatment Period 2||4
77129|NCT01622673|184581|P4|COMPLETED|Treatment Period 2||4
77130|NCT01622673|184582|P3|COMPLETED|Treatment Period 2||4
77131|NCT01622673|184583|P2|COMPLETED|Treatment Period 2||4
77132|NCT01622673|184584|P1|COMPLETED|Treatment Period 2||4
77133|NCT01622673|184579|P6|STARTED|Treatment Period 2||4
77134|NCT01622673|184580|P5|STARTED|Treatment Period 2||4
77135|NCT01622673|184581|P4|STARTED|Treatment Period 2||5
77136|NCT01622673|184582|P3|STARTED|Treatment Period 2||4
77137|NCT01622673|184583|P2|STARTED|Treatment Period 2||4
77138|NCT01622673|184584|P1|STARTED|Treatment Period 2||4
77139|NCT01622673|184579|P6|NOT COMPLETED|Treatment Period 1||0
77140|NCT01622673|184580|P5|NOT COMPLETED|Treatment Period 1||0
77141|NCT01622673|184581|P4|NOT COMPLETED|Treatment Period 1||1
77142|NCT01622673|184582|P3|NOT COMPLETED|Treatment Period 1||0
77143|NCT01622673|184583|P2|NOT COMPLETED|Treatment Period 1||1
77144|NCT01622673|184584|P1|NOT COMPLETED|Treatment Period 1||0
77145|NCT01622673|184579|P6|COMPLETED|Treatment Period 1||4
77146|NCT01622673|184580|P5|COMPLETED|Treatment Period 1||4
77147|NCT01622673|184581|P4|COMPLETED|Treatment Period 1||5
77148|NCT01622673|184582|P3|COMPLETED|Treatment Period 1||4
77149|NCT01622673|184583|P2|COMPLETED|Treatment Period 1||4
77150|NCT01622673|184584|P1|COMPLETED|Treatment Period 1||4
77151|NCT01622673|184579|P6|STARTED|Treatment Period 1||4
77152|NCT01622673|184580|P5|STARTED|Treatment Period 1||4
77153|NCT01622673|184581|P4|STARTED|Treatment Period 1||6
77154|NCT01622673|184582|P3|STARTED|Treatment Period 1||4
77155|NCT01622673|184583|P2|STARTED|Treatment Period 1||5
77156|NCT01622673|184584|P1|STARTED|Treatment Period 1||4
77157|NCT01622660|184619|P1|NOT COMPLETED|Overall Study||1
77158|NCT01622660|184619|P1|COMPLETED|Overall Study||1
77159|NCT01622660|184619|P1|STARTED|Overall Study||2
77160|NCT01622348|184626|P3|NOT COMPLETED|Overall Study||1
77161|NCT01622348|184627|P2|NOT COMPLETED|Overall Study||0
77162|NCT01622348|184628|P1|NOT COMPLETED|Overall Study||1
77163|NCT01622348|184626|P3|COMPLETED|Overall Study||14
77164|NCT01622348|184627|P2|COMPLETED|Overall Study||14
77165|NCT01622348|184628|P1|COMPLETED|Overall Study||14
77166|NCT01622348|184626|P3|STARTED|Overall Study||15
77167|NCT01622348|184627|P2|STARTED|Overall Study||14
77168|NCT01622348|184628|P1|STARTED|Overall Study||15
77169|NCT01622296|184636|P2|NOT COMPLETED|Second Intervention||0
77170|NCT01622296|184637|P1|NOT COMPLETED|Second Intervention||0
77171|NCT01622296|184636|P2|COMPLETED|Second Intervention||10
77172|NCT01622296|184637|P1|COMPLETED|Second Intervention||10
77173|NCT01622296|184636|P2|STARTED|Second Intervention||10
77174|NCT01622296|184637|P1|STARTED|Second Intervention||10
77175|NCT01622296|184636|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
77176|NCT01622296|184637|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
77177|NCT01622296|184636|P2|COMPLETED|Washout Period of at Least 1 Week||10
77178|NCT01622296|184637|P1|COMPLETED|Washout Period of at Least 1 Week||10
77179|NCT01622296|184636|P2|STARTED|Washout Period of at Least 1 Week||10
77180|NCT01622296|184637|P1|STARTED|Washout Period of at Least 1 Week||10
77181|NCT01622296|184636|P2|NOT COMPLETED|First Intervention||0
77182|NCT01622296|184637|P1|NOT COMPLETED|First Intervention||0
77183|NCT01622296|184636|P2|COMPLETED|First Intervention||10
77184|NCT01622296|184637|P1|COMPLETED|First Intervention||10
77185|NCT01622296|184636|P2|STARTED|First Intervention||10
77186|NCT01622296|184637|P1|STARTED|First Intervention||10
77187|NCT01622257|184645|P3|NOT COMPLETED|Overall Study||0
77188|NCT01622257|184646|P2|NOT COMPLETED|Overall Study||0
77189|NCT01622257|184647|P1|NOT COMPLETED|Overall Study||0
77190|NCT01622257|184645|P3|COMPLETED|Overall Study||66
77191|NCT01622257|184646|P2|COMPLETED|Overall Study||66
77192|NCT01622257|184647|P1|COMPLETED|Overall Study||66
77193|NCT01622257|184645|P3|STARTED|Overall Study||66
77194|NCT01622257|184646|P2|STARTED|Overall Study||66
77195|NCT01622257|184647|P1|STARTED|Overall Study||66
77196|NCT01622231|184667|P1|NOT COMPLETED|Overall Study||2
77197|NCT01622231|184667|P1|COMPLETED|Overall Study||59
77198|NCT01622231|184667|P1|STARTED|Overall Study||61
77199|NCT01621802|184701|P6|NOT COMPLETED|Overall Study||12
77200|NCT01621802|184702|P5|NOT COMPLETED|Overall Study||35
77201|NCT01621802|184703|P4|NOT COMPLETED|Overall Study||11
77202|NCT01621802|184704|P3|NOT COMPLETED|Overall Study||33
77203|NCT01621802|184705|P2|NOT COMPLETED|Overall Study||23
77204|NCT01621802|184706|P1|NOT COMPLETED|Overall Study||47
77205|NCT01621802|184701|P6|COMPLETED|Overall Study||477
77206|NCT01621802|184702|P5|COMPLETED|Overall Study||1284
77207|NCT01621802|184703|P4|COMPLETED|Overall Study||292
77208|NCT01621802|184704|P3|COMPLETED|Overall Study||763
77209|NCT01621802|184705|P2|COMPLETED|Overall Study||275
77210|NCT01621802|184706|P1|COMPLETED|Overall Study||755
77211|NCT01621802|184701|P6|STARTED|Overall Study||489
77212|NCT01621802|184702|P5|STARTED|Overall Study||1319
77213|NCT01621802|184703|P4|STARTED|Overall Study||303
77214|NCT01621802|184704|P3|STARTED|Overall Study||796
77215|NCT01621802|184705|P2|STARTED|Overall Study||298
77216|NCT01621802|184706|P1|STARTED|Overall Study||802
77217|NCT01621776|184813|P3|NOT COMPLETED|Overall Study||0
77218|NCT01621776|184814|P2|NOT COMPLETED|Overall Study||0
77219|NCT01621776|184815|P1|NOT COMPLETED|Overall Study||0
77220|NCT01621776|184813|P3|COMPLETED|Overall Study||18
77221|NCT01621776|184814|P2|COMPLETED|Overall Study||40
77222|NCT01621776|184815|P1|COMPLETED|Overall Study||41
77223|NCT01621776|184813|P3|STARTED|Overall Study||18
77224|NCT01621776|184814|P2|STARTED|Overall Study||40
77225|NCT01621776|184815|P1|STARTED|Overall Study||41
77226|NCT01621672|184831|P2|NOT COMPLETED|Overall Study||0
77227|NCT01621672|184832|P1|NOT COMPLETED|Overall Study||0
77228|NCT01621672|184831|P2|COMPLETED|Overall Study||17
77229|NCT01621672|184832|P1|COMPLETED|Overall Study||25
77230|NCT01621672|184831|P2|STARTED|Overall Study||17
77231|NCT01621672|184832|P1|STARTED|Overall Study||25
77232|NCT01621633|184842|P4|NOT COMPLETED|Overall Study||0
77233|NCT01621633|184843|P3|NOT COMPLETED|Overall Study||0
77234|NCT01621633|184844|P2|NOT COMPLETED|Overall Study||0
77235|NCT01621633|184845|P1|NOT COMPLETED|Overall Study||0
77236|NCT01621633|184842|P4|COMPLETED|Overall Study||8
77237|NCT01621633|184843|P3|COMPLETED|Overall Study||8
77238|NCT01621633|184844|P2|COMPLETED|Overall Study||8
77239|NCT01621633|184845|P1|COMPLETED|Overall Study||8
77240|NCT01621633|184842|P4|STARTED|Overall Study||8
77241|NCT01621633|184843|P3|STARTED|Overall Study||8
77242|NCT01621633|184844|P2|STARTED|Overall Study||8
77243|NCT01621633|184845|P1|STARTED|Overall Study||8
77244|NCT01621477|184867|P1|NOT COMPLETED|Overall Study||0
77245|NCT01621477|184867|P1|COMPLETED|Overall Study||17
77246|NCT01621477|184867|P1|STARTED|Overall Study||17
77247|NCT01621191|184877|P1|NOT COMPLETED|Overall Study||25
77248|NCT01621191|184877|P1|COMPLETED|Overall Study||124
77249|NCT01621191|184877|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
77250|NCT01621191|184877|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
77251|NCT01621191|184877|P1|STARTED|Overall Study||149
77252|NCT01621178|184891|P3|NOT COMPLETED|Overall Study||36
77253|NCT01621178|184892|P2|NOT COMPLETED|Overall Study||30
77254|NCT01621178|184893|P1|NOT COMPLETED|Overall Study||31
77255|NCT01621178|184891|P3|COMPLETED|Overall Study||157
77256|NCT01621178|184892|P2|COMPLETED|Overall Study||160
77257|NCT01621178|184893|P1|COMPLETED|Overall Study||163
77258|NCT01621178|184891|P3|Modified Intent to Treat Population|Overall Study||183
77259|NCT01621178|184892|P2|Modified Intent to Treat Population|Overall Study||180
77260|NCT01621178|184893|P1|Modified Intent to Treat Population|Overall Study||186
77261|NCT01621178|184891|P3|Received at Least One Dose of Study Drug|Overall Study||192
77262|NCT01621178|184892|P2|Received at Least One Dose of Study Drug|Overall Study||190
77263|NCT01621178|184893|P1|Received at Least One Dose of Study Drug|Overall Study||194
77264|NCT01621178|184891|P3|STARTED|Overall Study||193
77265|NCT01621178|184892|P2|STARTED|Overall Study||190
77266|NCT01621178|184893|P1|STARTED|Overall Study||194
77267|NCT01621126|184985|P1|NOT COMPLETED|Overall Study||6
77268|NCT01621126|184985|P1|COMPLETED|Overall Study||34
77269|NCT01621126|184985|P1|STARTED|Overall Study||40
77270|NCT01621009|184993|P4|NOT COMPLETED|Overall Study||53
77271|NCT01621009|184994|P3|NOT COMPLETED|Overall Study||63
77272|NCT01621009|184995|P2|NOT COMPLETED|Overall Study||51
77273|NCT01621009|184996|P1|NOT COMPLETED|Overall Study||43
77274|NCT01621009|184993|P4|COMPLETED|Overall Study||60
77275|NCT01621009|184994|P3|COMPLETED|Overall Study||58
77276|NCT01621009|184995|P2|COMPLETED|Overall Study||65
77277|NCT01621009|184996|P1|COMPLETED|Overall Study||70
77278|NCT01621009|184993|P4|STARTED|Overall Study||113
77279|NCT01621009|184994|P3|STARTED|Overall Study||121
77280|NCT01621009|184995|P2|STARTED|Overall Study||116
77281|NCT01621009|184996|P1|STARTED|Overall Study||113
77282|NCT01620762|185007|P3|NOT COMPLETED|Overall Study||53
77283|NCT01620762|185008|P2|NOT COMPLETED|Overall Study||58
77284|NCT01620762|185009|P1|NOT COMPLETED|Overall Study||48
77285|NCT01620762|185007|P3|COMPLETED|Overall Study||417
77286|NCT01620762|185008|P2|COMPLETED|Overall Study||412
77287|NCT01620762|185009|P1|COMPLETED|Overall Study||420
77288|NCT01620762|185007|P3|STARTED|Overall Study||470
77289|NCT01620762|185008|P2|STARTED|Overall Study||470
77290|NCT01620762|185009|P1|STARTED|Overall Study||468
77291|NCT01620593|185037|P2|NOT COMPLETED|Overall Study||1
77292|NCT01620593|185038|P1|NOT COMPLETED|Overall Study||4
77293|NCT01620593|185037|P2|COMPLETED|Overall Study||19
77294|NCT01620593|185038|P1|COMPLETED|Overall Study||17
77295|NCT01620593|185037|P2|STARTED|Overall Study||20
77296|NCT01620593|185038|P1|STARTED|Overall Study||21
77297|NCT01620489|185054|P2|NOT COMPLETED|Overall Study||34
77298|NCT01620489|185055|P1|NOT COMPLETED|Overall Study||35
77299|NCT01620489|185054|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
77300|NCT01620489|185055|P1|COMPLETED|Overall Study||105
77301|NCT01620489|185054|P2|Exposed|Overall Study|2 subjects did not take trial product|137
77302|NCT01620489|185055|P1|Exposed|Overall Study||140
77303|NCT01620489|185054|P2|STARTED|Overall Study||139
77304|NCT01620489|185055|P1|STARTED|Overall Study||140
77305|NCT01620255|185076|P5|NOT COMPLETED|Overall Study||6
77306|NCT01620255|185077|P4|NOT COMPLETED|Overall Study||3
77307|NCT01620255|185078|P3|NOT COMPLETED|Overall Study||2
77308|NCT01620255|185079|P2|NOT COMPLETED|Overall Study||6
77309|NCT01620255|185080|P1|NOT COMPLETED|Overall Study||4
77310|NCT01620255|185076|P5|COMPLETED|Overall Study||64
77311|NCT01620255|185077|P4|COMPLETED|Overall Study||70
77312|NCT01620255|185078|P3|COMPLETED|Overall Study||68
77313|NCT01620255|185079|P2|COMPLETED|Overall Study||65
77314|NCT01620255|185080|P1|COMPLETED|Overall Study||69
77315|NCT01620255|185076|P5|Treated|Overall Study||70
77316|NCT01620255|185077|P4|Treated|Overall Study||73
77317|NCT01620255|185078|P3|Treated|Overall Study||70
77318|NCT01620255|185079|P2|Treated|Overall Study||71
77319|NCT01620255|185080|P1|Treated|Overall Study||73
77320|NCT01620255|185076|P5|STARTED|Overall Study||70
77321|NCT01620255|185077|P4|STARTED|Overall Study||73
77322|NCT01620255|185078|P3|STARTED|Overall Study||70
77323|NCT01620255|185079|P2|STARTED|Overall Study||71
77324|NCT01620255|185080|P1|STARTED|Overall Study||73
77325|NCT01620177|185157|P1|NOT COMPLETED|Overall Study||79
77326|NCT01620177|185157|P1|COMPLETED|Overall Study||19
77327|NCT01620177|185157|P1|STARTED|Overall Study||98
77328|NCT01620138|185182|P2|NOT COMPLETED|Overall Study||0
77329|NCT01620138|185183|P1|NOT COMPLETED|Overall Study||6
77330|NCT01620138|185182|P2|COMPLETED|Overall Study||9
77331|NCT01620138|185183|P1|COMPLETED|Overall Study||6
77332|NCT01620138|185182|P2|STARTED|Overall Study||9
77333|NCT01620138|185183|P1|STARTED|Overall Study||12
77334|NCT01620086|185191|P3|NOT COMPLETED|Overall Study||0
77335|NCT01620086|185192|P2|NOT COMPLETED|Overall Study||7
77336|NCT01620086|185193|P1|NOT COMPLETED|Overall Study||5
77337|NCT01620086|185191|P3|COMPLETED|Overall Study||2
77338|NCT01620086|185192|P2|COMPLETED|Overall Study||4
77339|NCT01620086|185193|P1|COMPLETED|Overall Study||8
77340|NCT01620086|185191|P3|STARTED|Overall Study||2
77341|NCT01620086|185192|P2|STARTED|Overall Study||11
77342|NCT01620086|185193|P1|STARTED|Overall Study||13
77343|NCT01620060|185212|P1|NOT COMPLETED|Overall Study||15
77344|NCT01620060|185212|P1|COMPLETED|Overall Study||90
77345|NCT01620060|185212|P1|STARTED|Overall Study||105
77346|NCT01620047|185221|P3|NOT COMPLETED|Overall Study||0
77347|NCT01620047|185222|P2|NOT COMPLETED|Overall Study||0
77348|NCT01620047|185223|P1|NOT COMPLETED|Overall Study||0
77349|NCT01620047|185221|P3|COMPLETED|Overall Study||20
77350|NCT01620047|185222|P2|COMPLETED|Overall Study||20
77351|NCT01620047|185223|P1|COMPLETED|Overall Study||20
77352|NCT01620047|185221|P3|STARTED|Overall Study||20
77353|NCT01620047|185222|P2|STARTED|Overall Study||20
77354|NCT01620047|185223|P1|STARTED|Overall Study||20
77355|NCT01619982|185233|P2|NOT COMPLETED|Overall Study||0
77356|NCT01619982|185234|P1|NOT COMPLETED|Overall Study||0
77357|NCT01619982|185233|P2|COMPLETED|Overall Study||12
77358|NCT01619982|185234|P1|COMPLETED|Overall Study||20
77359|NCT01619982|185233|P2|STARTED|Overall Study||12
77360|NCT01619982|185234|P1|STARTED|Overall Study||20
77361|NCT01619878|185250|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
77362|NCT01619878|185250|P1|COMPLETED|Follow-up at 12 Months of Age||17
77363|NCT01619878|185250|P1|STARTED|Follow-up at 12 Months of Age||20
77364|NCT01619878|185250|P1|NOT COMPLETED|6 Week Follow-up Phase||1
77365|NCT01619878|185250|P1|COMPLETED|6 Week Follow-up Phase||19
77366|NCT01619878|185250|P1|STARTED|6 Week Follow-up Phase||20
77367|NCT01619800|185264|P2|NOT COMPLETED|Overall Study||0
77368|NCT01619800|185265|P1|NOT COMPLETED|Overall Study||2
77369|NCT01619800|185264|P2|COMPLETED|Overall Study||0
77370|NCT01619800|185265|P1|COMPLETED|Overall Study||0
77371|NCT01619800|185264|P2|STARTED|Overall Study||0
77372|NCT01619800|185265|P1|STARTED|Overall Study||2
77373|NCT01619787|185273|P1|NOT COMPLETED|Overall Study||5
77374|NCT01619787|185273|P1|COMPLETED|Overall Study||212
77375|NCT01619787|185273|P1|STARTED|Overall Study||217
77376|NCT01619774|185282|P1|NOT COMPLETED|Overall Study||0
77377|NCT01619774|185282|P1|COMPLETED|Overall Study||23
77378|NCT01619774|185282|P1|STARTED|Overall Study||23
77379|NCT01619579|185290|P2|NOT COMPLETED|Overall Study||3
77380|NCT01619579|185291|P1|NOT COMPLETED|Overall Study||0
77381|NCT01619579|185290|P2|COMPLETED|Overall Study||14
77382|NCT01619579|185291|P1|COMPLETED|Overall Study||5
77383|NCT01619579|185290|P2|STARTED|Overall Study||17
77384|NCT01619579|185291|P1|STARTED|Overall Study||5
77385|NCT01619059|185303|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
77386|NCT01619059|185304|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
77387|NCT01619059|185303|P2|COMPLETED|Long-Term (LT) Treatment Period||133
77388|NCT01619059|185304|P1|COMPLETED|Long-Term (LT) Treatment Period||147
77389|NCT01619059|185303|P2|STARTED|Long-Term (LT) Treatment Period||142
77390|NCT01619059|185304|P1|STARTED|Long-Term (LT) Treatment Period||155
77391|NCT01619059|185303|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
77392|NCT01619059|185304|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
77393|NCT01619059|185303|P2|COMPLETED|Short-Term (ST) Treatment Period||142
77394|NCT01619059|185304|P1|COMPLETED|Short-Term (ST) Treatment Period||156
77395|NCT01619059|185303|P2|STARTED|Short-Term (ST) Treatment Period||153
77396|NCT01619059|185304|P1|STARTED|Short-Term (ST) Treatment Period||162
77397|NCT01618968|185320|P4|NOT COMPLETED|Overall Study||1
77398|NCT01618968|185321|P3|NOT COMPLETED|Overall Study||0
77399|NCT01618968|185322|P2|NOT COMPLETED|Overall Study||0
77400|NCT01618968|185323|P1|NOT COMPLETED|Overall Study||1
77401|NCT01618968|185320|P4|COMPLETED|Overall Study||11
77402|NCT01618968|185321|P3|COMPLETED|Overall Study||12
77403|NCT01618968|185322|P2|COMPLETED|Overall Study||12
77404|NCT01618968|185323|P1|COMPLETED|Overall Study||12
77405|NCT01618968|185320|P4|Received Treatment C|Overall Study||11
77406|NCT01618968|185321|P3|Received Treatment C|Overall Study||12
77407|NCT01618968|185322|P2|Received Treatment C|Overall Study||12
77408|NCT01618968|185323|P1|Received Treatment C|Overall Study||12
77409|NCT01618968|185320|P4|Received Treatment B|Overall Study||12
77410|NCT01618968|185321|P3|Received Treatment B|Overall Study||12
77411|NCT01618968|185322|P2|Received Treatment B|Overall Study||12
77412|NCT01618968|185323|P1|Received Treatment B|Overall Study||13
77413|NCT01618968|185320|P4|Received Treatment A|Overall Study||11
77414|NCT01618968|185321|P3|Received Treatment A|Overall Study||12
77415|NCT01618968|185322|P2|Received Treatment A|Overall Study||12
77416|NCT01618968|185323|P1|Received Treatment A|Overall Study||12
77417|NCT01618968|185320|P4|STARTED|Overall Study||12
77418|NCT01618968|185321|P3|STARTED|Overall Study||12
77419|NCT01618968|185322|P2|STARTED|Overall Study||12
77420|NCT01618968|185323|P1|STARTED|Overall Study||13
77421|NCT01618955|185342|P4|NOT COMPLETED|Overall Study||0
77422|NCT01618955|185343|P3|NOT COMPLETED|Overall Study||0
77423|NCT01618955|185344|P2|NOT COMPLETED|Overall Study||0
77424|NCT01618955|185345|P1|NOT COMPLETED|Overall Study||0
77425|NCT01618955|185342|P4|COMPLETED|Overall Study||20
77426|NCT01618955|185343|P3|COMPLETED|Overall Study||31
77427|NCT01618955|185344|P2|COMPLETED|Overall Study||30
77428|NCT01618955|185345|P1|COMPLETED|Overall Study||20
77429|NCT01618955|185342|P4|STARTED|Overall Study||20
77430|NCT01618955|185343|P3|STARTED|Overall Study||31
77431|NCT01618955|185344|P2|STARTED|Overall Study||30
77432|NCT01618955|185345|P1|STARTED|Overall Study||20
77433|NCT01618942|185369|P2|NOT COMPLETED|Overall Study||0
77434|NCT01618942|185370|P1|NOT COMPLETED|Overall Study||0
77435|NCT01618942|185369|P2|COMPLETED|Overall Study||50
77436|NCT01618942|185370|P1|COMPLETED|Overall Study||50
77437|NCT01618942|185369|P2|STARTED|Overall Study||50
77438|NCT01618942|185370|P1|STARTED|Overall Study||50
77439|NCT01618864|185390|P1|NOT COMPLETED|Overall Study||4
77440|NCT01618864|185390|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
77441|NCT01618864|185390|P1|Completed 2 Weeks|Overall Study||19
77442|NCT01618864|185390|P1|STARTED|Overall Study||23
77443|NCT01618838|185399|P1|NOT COMPLETED|Overall Study||4
77444|NCT01618838|185399|P1|COMPLETED|Overall Study||0
77445|NCT01618838|185399|P1|STARTED|Overall Study||4
77446|NCT01618708|185405|P2|NOT COMPLETED|Overall Study||46
77447|NCT01618708|185406|P1|NOT COMPLETED|Overall Study||44
77448|NCT01618708|185405|P2|COMPLETED|Overall Study||136
77449|NCT01618708|185406|P1|COMPLETED|Overall Study||131
77450|NCT01618708|185405|P2|Treated|Overall Study||180
77451|NCT01618708|185406|P1|Treated|Overall Study||172
77452|NCT01618708|185405|P2|STARTED|Overall Study||182
77453|NCT01618708|185406|P1|STARTED|Overall Study||175
77454|NCT01618669|185420|P2|NOT COMPLETED|Overall Study||23
77455|NCT01618669|185421|P1|NOT COMPLETED|Overall Study||34
77456|NCT01618669|185420|P2|COMPLETED|Overall Study||546
77457|NCT01618669|185421|P1|COMPLETED|Overall Study||544
77458|NCT01618669|185420|P2|Received Treatment|Overall Study||567
77459|NCT01618669|185421|P1|Received Treatment|Overall Study||575
77460|NCT01618669|185420|P2|STARTED|Overall Study||569
77461|NCT01618669|185421|P1|STARTED|Overall Study||578
77462|NCT01618422|185467|P2|NOT COMPLETED|Overall Study||0
77463|NCT01618422|185468|P1|NOT COMPLETED|Overall Study||0
77464|NCT01618422|185467|P2|COMPLETED|Overall Study||111
77465|NCT01618422|185468|P1|COMPLETED|Overall Study||114
77466|NCT01618422|185467|P2|STARTED|Overall Study||111
77467|NCT01618422|185468|P1|STARTED|Overall Study||114
77468|NCT01618344|185474|P1|NOT COMPLETED|Overall Study||9
77469|NCT01618344|185474|P1|COMPLETED|Overall Study||23
77470|NCT01618344|185474|P1|STARTED|Overall Study||32
77471|NCT01618266|185478|P1|NOT COMPLETED|Overall Study||96
77472|NCT01618266|185478|P1|COMPLETED|Overall Study||279
77473|NCT01618266|185478|P1|STARTED|Overall Study||375
77474|NCT01618240|185493|P1|NOT COMPLETED|Overall Study||0
77475|NCT01618240|185493|P1|COMPLETED|Overall Study||30
77476|NCT01618240|185493|P1|STARTED|Overall Study||30
77477|NCT01618227|185500|P2|NOT COMPLETED|Overall Study||2
77478|NCT01618227|185501|P1|NOT COMPLETED|Overall Study||0
77479|NCT01618227|185500|P2|COMPLETED|Overall Study||0
77480|NCT01618227|185501|P1|COMPLETED|Overall Study||2
77481|NCT01618227|185500|P2|STARTED|Overall Study||2
77482|NCT01618227|185501|P1|STARTED|Overall Study||2
77483|NCT01618214|185515|P2|NOT COMPLETED|Overall Study||13
77484|NCT01618214|185516|P1|NOT COMPLETED|Overall Study||10
77485|NCT01618214|185515|P2|COMPLETED|Overall Study||159
77486|NCT01618214|185516|P1|COMPLETED|Overall Study||162
77487|NCT01618214|185515|P2|Exposed|Overall Study||172
77488|NCT01618214|185516|P1|Exposed|Overall Study||172
77489|NCT01618214|185515|P2|STARTED|Overall Study||172
77490|NCT01618214|185516|P1|STARTED|Overall Study||172
77491|NCT01618162|185532|P2|NOT COMPLETED|Overall Study||35
77492|NCT01618162|185533|P1|NOT COMPLETED|Overall Study||38
77493|NCT01618162|185532|P2|COMPLETED|Overall Study||111
77494|NCT01618162|185533|P1|COMPLETED|Overall Study||251
77495|NCT01618162|185532|P2|Exposed|Overall Study||146
77496|NCT01618162|185533|P1|Exposed|Overall Study||288
77497|NCT01618162|185532|P2|STARTED|Overall Study||146
77498|NCT01618162|185533|P1|STARTED|Overall Study||289
77499|NCT01618019|185553|P2|NOT COMPLETED|Overall Study||14
77500|NCT01618019|185554|P1|NOT COMPLETED|Overall Study||14
77501|NCT01618019|185553|P2|COMPLETED|Overall Study||40
77502|NCT01618019|185554|P1|COMPLETED|Overall Study||41
77503|NCT01618019|185553|P2|STARTED|Overall Study||54
77504|NCT01618019|185554|P1|STARTED|Overall Study||55
77505|NCT01617681|185578|P5|NOT COMPLETED|Period 2 Open Label||6
77506|NCT01617681|185579|P4|NOT COMPLETED|Period 2 Open Label||0
77507|NCT01617681|185580|P3|NOT COMPLETED|Period 2 Open Label||0
77508|NCT01617681|185581|P2|NOT COMPLETED|Period 2 Open Label||0
77509|NCT01617681|185582|P1|NOT COMPLETED|Period 2 Open Label||0
77510|NCT01617681|185578|P5|COMPLETED|Period 2 Open Label||114
77511|NCT01617681|185579|P4|COMPLETED|Period 2 Open Label||0
77512|NCT01617681|185580|P3|COMPLETED|Period 2 Open Label||0
77513|NCT01617681|185581|P2|COMPLETED|Period 2 Open Label||0
77514|NCT01617681|185582|P1|COMPLETED|Period 2 Open Label||0
77515|NCT01617681|185578|P5|STARTED|Period 2 Open Label||120
77516|NCT01617681|185579|P4|STARTED|Period 2 Open Label||0
77517|NCT01617681|185580|P3|STARTED|Period 2 Open Label||0
77518|NCT01617681|185581|P2|STARTED|Period 2 Open Label||0
77519|NCT01617681|185582|P1|STARTED|Period 2 Open Label||0
77520|NCT01617681|185578|P5|NOT COMPLETED|Period 1 Double Blind||0
77521|NCT01617681|185579|P4|NOT COMPLETED|Period 1 Double Blind||2
77522|NCT01617681|185580|P3|NOT COMPLETED|Period 1 Double Blind||1
77523|NCT01617681|185581|P2|NOT COMPLETED|Period 1 Double Blind||1
77524|NCT01617681|185582|P1|NOT COMPLETED|Period 1 Double Blind||3
77525|NCT01617681|185578|P5|COMPLETED|Period 1 Double Blind||0
77526|NCT01617681|185579|P4|COMPLETED|Period 1 Double Blind||29
77527|NCT01617681|185580|P3|COMPLETED|Period 1 Double Blind||32
77528|NCT01617681|185581|P2|COMPLETED|Period 1 Double Blind||30
77529|NCT01617681|185582|P1|COMPLETED|Period 1 Double Blind||29
77530|NCT01617681|185578|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
77531|NCT01617681|185579|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
77532|NCT01617681|185580|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
77533|NCT01617681|185581|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
77534|NCT01617681|185582|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
77535|NCT01617681|185578|P5|STARTED|Period 1 Double Blind||0
77536|NCT01617681|185579|P4|STARTED|Period 1 Double Blind||31
77537|NCT01617681|185580|P3|STARTED|Period 1 Double Blind||33
77538|NCT01617681|185581|P2|STARTED|Period 1 Double Blind||31
77539|NCT01617681|185582|P1|STARTED|Period 1 Double Blind||32
77540|NCT01617668|185603|P4|NOT COMPLETED|Overall Study||15
77541|NCT01617668|185604|P3|NOT COMPLETED|Overall Study||23
77542|NCT01617668|185605|P2|NOT COMPLETED|Overall Study||9
77543|NCT01617668|185606|P1|NOT COMPLETED|Overall Study||13
77544|NCT01617668|185603|P4|COMPLETED|Overall Study||38
77545|NCT01617668|185604|P3|COMPLETED|Overall Study||32
77546|NCT01617668|185605|P2|COMPLETED|Overall Study||41
77547|NCT01617668|185606|P1|COMPLETED|Overall Study||38
77548|NCT01617668|185603|P4|Randomized Patients|Overall Study||55
77549|NCT01617668|185604|P3|Randomized Patients|Overall Study||55
77550|NCT01617668|185605|P2|Randomized Patients|Overall Study||54
77551|NCT01617668|185606|P1|Randomized Patients|Overall Study||51
77552|NCT01617668|185603|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
77553|NCT01617668|185604|P3|STARTED|Overall Study||55
77554|NCT01617668|185605|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
77555|NCT01617668|185606|P1|STARTED|Overall Study||51
77556|NCT01617655|185647|P2|NOT COMPLETED|Overall Study||29
77557|NCT01617655|185648|P1|NOT COMPLETED|Overall Study||9
77558|NCT01617655|185647|P2|COMPLETED|Overall Study||43
77559|NCT01617655|185648|P1|COMPLETED|Overall Study||26
77560|NCT01617655|185647|P2|Treated|Overall Study||72
77561|NCT01617655|185648|P1|Treated|Overall Study||35
77562|NCT01617655|185647|P2|STARTED|Overall Study|Randomized|72
77563|NCT01617655|185648|P1|STARTED|Overall Study|Randomized|35
77564|NCT01617629|185708|P1|NOT COMPLETED|Overall Study||6
77565|NCT01617629|185708|P1|COMPLETED|Overall Study||3
77566|NCT01617629|185708|P1|STARTED|Overall Study||9
77567|NCT01617603|185716|P3|NOT COMPLETED|Overall Study||1
77568|NCT01617603|185717|P2|NOT COMPLETED|Overall Study||2
77569|NCT01617603|185718|P1|NOT COMPLETED|Overall Study||3
77570|NCT01617603|185716|P3|COMPLETED|Overall Study||20
77571|NCT01617603|185717|P2|COMPLETED|Overall Study||19
77572|NCT01617603|185718|P1|COMPLETED|Overall Study||17
77573|NCT01617603|185716|P3|STARTED|Overall Study||21
77574|NCT01617603|185717|P2|STARTED|Overall Study||21
77575|NCT01617603|185718|P1|STARTED|Overall Study||20
77576|NCT01617577|185728|P2|NOT COMPLETED|Overall Study||0
77577|NCT01617577|185729|P1|NOT COMPLETED|Overall Study||0
77578|NCT01617577|185728|P2|COMPLETED|Overall Study||3
77579|NCT01617577|185729|P1|COMPLETED|Overall Study||5
77580|NCT01617577|185728|P2|STARTED|Overall Study||3
77581|NCT01617577|185729|P1|STARTED|Overall Study||5
77582|NCT01617460|185736|P1|NOT COMPLETED|Overall Study||40
77583|NCT01617460|185736|P1|COMPLETED|Overall Study||46
77584|NCT01617460|185736|P1|STARTED|Overall Study||86
77585|NCT01617447|185742|P2|NOT COMPLETED|Overall Study||3
77586|NCT01617447|185743|P1|NOT COMPLETED|Overall Study||0
77587|NCT01617447|185742|P2|COMPLETED|Overall Study||42
77588|NCT01617447|185743|P1|COMPLETED|Overall Study||47
77589|NCT01617447|185742|P2|STARTED|Overall Study||45
77590|NCT01617447|185743|P1|STARTED|Overall Study||47
77591|NCT01617434|185751|P2|NOT COMPLETED|Overall Study||51
77592|NCT01617434|185752|P1|NOT COMPLETED|Overall Study||35
77593|NCT01617434|185751|P2|COMPLETED|Overall Study||174
77594|NCT01617434|185752|P1|COMPLETED|Overall Study||191
77595|NCT01617434|185751|P2|Exposed|Overall Study||225
77596|NCT01617434|185752|P1|Exposed|Overall Study||225
77597|NCT01617434|185751|P2|STARTED|Overall Study||225
77598|NCT01617434|185752|P1|STARTED|Overall Study||226
77599|NCT01617369|185774|P1|NOT COMPLETED|Overall Study||0
77600|NCT01617369|185774|P1|COMPLETED|Overall Study||12
77601|NCT01617369|185774|P1|STARTED|Overall Study||12
77602|NCT01617187|185784|P4|NOT COMPLETED|Treatment Through Study Completion||10
77603|NCT01617187|185785|P3|NOT COMPLETED|Treatment Through Study Completion||5
77604|NCT01617187|185786|P2|NOT COMPLETED|Treatment Through Study Completion||11
77605|NCT01617187|185787|P1|NOT COMPLETED|Treatment Through Study Completion||11
77606|NCT01617187|185784|P4|COMPLETED|Treatment Through Study Completion||91
77607|NCT01617187|185785|P3|COMPLETED|Treatment Through Study Completion||41
77608|NCT01617187|185786|P2|COMPLETED|Treatment Through Study Completion||102
77609|NCT01617187|185787|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
77610|NCT01617187|185784|P4|STARTED|Treatment Through Study Completion|Treated|101
77611|NCT01617187|185785|P3|STARTED|Treatment Through Study Completion|Treated|46
77612|NCT01617187|185786|P2|STARTED|Treatment Through Study Completion|Treated|113
77613|NCT01617187|185787|P1|STARTED|Treatment Through Study Completion|Treated|97
77614|NCT01617187|185784|P4|NOT COMPLETED|Randomization Through Start Treatment||2
77615|NCT01617187|185785|P3|NOT COMPLETED|Randomization Through Start Treatment||0
77616|NCT01617187|185786|P2|NOT COMPLETED|Randomization Through Start Treatment||0
77617|NCT01617187|185787|P1|NOT COMPLETED|Randomization Through Start Treatment||1
77618|NCT01617187|185784|P4|COMPLETED|Randomization Through Start Treatment||101
77619|NCT01617187|185785|P3|COMPLETED|Randomization Through Start Treatment||46
77620|NCT01617187|185786|P2|COMPLETED|Randomization Through Start Treatment||113
77621|NCT01617187|185787|P1|COMPLETED|Randomization Through Start Treatment||97
77622|NCT01617187|185784|P4|STARTED|Randomization Through Start Treatment|Randomized|103
77623|NCT01617187|185785|P3|STARTED|Randomization Through Start Treatment|Randomized|46
77624|NCT01617187|185786|P2|STARTED|Randomization Through Start Treatment|Randomized|113
77625|NCT01617187|185787|P1|STARTED|Randomization Through Start Treatment|Randomized|98
77626|NCT01617083|185860|P3|NOT COMPLETED|Overall Study||0
77627|NCT01617083|185861|P2|NOT COMPLETED|Overall Study||0
77628|NCT01617083|185862|P1|NOT COMPLETED|Overall Study||0
77629|NCT01617083|185860|P3|COMPLETED|Overall Study||15
77630|NCT01617083|185861|P2|COMPLETED|Overall Study||14
77631|NCT01617083|185862|P1|COMPLETED|Overall Study||18
77632|NCT01617083|185860|P3|STARTED|Overall Study||15
77633|NCT01617083|185861|P2|STARTED|Overall Study||14
77634|NCT01617083|185862|P1|STARTED|Overall Study||18
77635|NCT01617070|185873|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
77636|NCT01617070|185873|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
77637|NCT01617070|185873|P1|STARTED|BH4 and LNAA (4 Weeks)||10
77638|NCT01617070|185873|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
77639|NCT01617070|185873|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
77640|NCT01617070|185873|P1|STARTED|BH4 Therapy (4 Weeks)||10
77641|NCT01617070|185873|P1|NOT COMPLETED|Washout (4 Weeks)||0
77642|NCT01617070|185873|P1|COMPLETED|Washout (4 Weeks)||10
77643|NCT01617070|185873|P1|STARTED|Washout (4 Weeks)||10
77644|NCT01617070|185873|P1|NOT COMPLETED|LNAA (4 Weeks)||0
77645|NCT01617070|185873|P1|COMPLETED|LNAA (4 Weeks)||10
77646|NCT01617070|185873|P1|STARTED|LNAA (4 Weeks)||10
77647|NCT01617005|185891|P1|NOT COMPLETED|Overall Study||2
77648|NCT01617005|185891|P1|COMPLETED|Overall Study||48
77649|NCT01617005|185891|P1|STARTED|Overall Study||50
77650|NCT01616953|185900|P2|NOT COMPLETED|Overall Study||0
77651|NCT01616953|185901|P1|NOT COMPLETED|Overall Study||2
77652|NCT01616953|185900|P2|COMPLETED|Overall Study||8
77653|NCT01616953|185901|P1|COMPLETED|Overall Study||8
77654|NCT01616953|185900|P2|6 Months Post-loading|Overall Study||8
77655|NCT01616953|185901|P1|6 Months Post-loading|Overall Study||8
77656|NCT01616953|185900|P2|Implant Uncovery|Overall Study||8
77657|NCT01616953|185901|P1|Implant Uncovery|Overall Study||8
77658|NCT01616953|185900|P2|Implant Placement Surgery|Overall Study||8
77659|NCT01616953|185901|P1|Implant Placement Surgery|Overall Study||9
77660|NCT01616953|185900|P2|STARTED|Overall Study||8
77661|NCT01616953|185901|P1|STARTED|Overall Study||10
77662|NCT01616771|185909|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
77663|NCT01616771|185909|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
77664|NCT01616771|185909|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
77665|NCT01616771|185909|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
77666|NCT01616771|185909|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
77667|NCT01616771|185909|P1|STARTED|GVL Selected by Weight for 5 Sec||23
77668|NCT01616771|185909|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
77669|NCT01616771|185909|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
77670|NCT01616771|185909|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
77671|NCT01616576|185920|P2|NOT COMPLETED|Overall Study||0
77672|NCT01616576|185921|P1|NOT COMPLETED|Overall Study||0
77673|NCT01616576|185920|P2|COMPLETED|Overall Study||18
77674|NCT01616576|185921|P1|COMPLETED|Overall Study||18
77675|NCT01616576|185920|P2|STARTED|Overall Study||18
77676|NCT01616576|185921|P1|STARTED|Overall Study||18
77677|NCT01616459|185934|P4|NOT COMPLETED|Overall Study||8
77678|NCT01616459|185935|P3|NOT COMPLETED|Overall Study||10
77679|NCT01616459|185936|P2|NOT COMPLETED|Overall Study||17
77680|NCT01616459|185937|P1|NOT COMPLETED|Overall Study||4
77681|NCT01616459|185934|P4|COMPLETED|Overall Study||233
77682|NCT01616459|185935|P3|COMPLETED|Overall Study||220
77683|NCT01616459|185936|P2|COMPLETED|Overall Study||223
77684|NCT01616459|185937|P1|COMPLETED|Overall Study||236
77685|NCT01616459|185934|P4|STARTED|Overall Study||241
77686|NCT01616459|185935|P3|STARTED|Overall Study||230
77687|NCT01616459|185936|P2|STARTED|Overall Study||240
77688|NCT01616459|185937|P1|STARTED|Overall Study||240
77689|NCT01616173|186026|P3|NOT COMPLETED|Overall Study||0
77690|NCT01616173|186027|P2|NOT COMPLETED|Overall Study||2
77691|NCT01616173|186028|P1|NOT COMPLETED|Overall Study||0
77692|NCT01616173|186026|P3|COMPLETED|Overall Study||27
77693|NCT01616173|186027|P2|COMPLETED|Overall Study||24
77694|NCT01616173|186028|P1|COMPLETED|Overall Study||27
77695|NCT01616173|186026|P3|STARTED|Overall Study||27
77696|NCT01616173|186027|P2|STARTED|Overall Study||26
77697|NCT01616173|186028|P1|STARTED|Overall Study||27
77698|NCT01616056|186042|P1|NOT COMPLETED|Overall Study||1
77699|NCT01616056|186042|P1|COMPLETED|Overall Study||19
77700|NCT01616056|186042|P1|STARTED|Overall Study||20
77701|NCT01615939|186056|P2|NOT COMPLETED|Overall Study||0
77702|NCT01615939|186057|P1|NOT COMPLETED|Overall Study||5
77703|NCT01615939|186056|P2|COMPLETED|Overall Study||4
77704|NCT01615939|186057|P1|COMPLETED|Overall Study||8
77705|NCT01615939|186056|P2|STARTED|Overall Study||4
77706|NCT01615939|186057|P1|STARTED|Overall Study||13
77707|NCT01615822|186070|P3|NOT COMPLETED|Period 2||2
77708|NCT01615822|186071|P2|NOT COMPLETED|Period 2||1
77709|NCT01615822|186072|P1|NOT COMPLETED|Period 2||0
77710|NCT01615822|186070|P3|COMPLETED|Period 2||4
77711|NCT01615822|186071|P2|COMPLETED|Period 2||8
77712|NCT01615822|186072|P1|COMPLETED|Period 2||7
77713|NCT01615822|186070|P3|STARTED|Period 2||6
77714|NCT01615822|186071|P2|STARTED|Period 2||9
77715|NCT01615822|186072|P1|STARTED|Period 2||7
77716|NCT01615822|186070|P3|NOT COMPLETED|Period 1||0
77717|NCT01615822|186071|P2|NOT COMPLETED|Period 1||2
77718|NCT01615822|186072|P1|NOT COMPLETED|Period 1||1
77719|NCT01615822|186070|P3|COMPLETED|Period 1||6
77720|NCT01615822|186071|P2|COMPLETED|Period 1||9
77721|NCT01615822|186072|P1|COMPLETED|Period 1||7
77722|NCT01615822|186070|P3|STARTED|Period 1||6
77723|NCT01615822|186071|P2|STARTED|Period 1||11
77724|NCT01615822|186072|P1|STARTED|Period 1||8
77725|NCT01615809|186089|P1|NOT COMPLETED|Overall Study||10
77726|NCT01615809|186089|P1|COMPLETED|Overall Study||22
77727|NCT01615809|186089|P1|STARTED|Overall Study|basal visit|32
77728|NCT01615731|186097|P2|NOT COMPLETED|Overall Study||2
77729|NCT01615731|186098|P1|NOT COMPLETED|Overall Study||3
77730|NCT01615731|186097|P2|COMPLETED|Overall Study||24
77731|NCT01615731|186098|P1|COMPLETED|Overall Study||21
77732|NCT01615731|186097|P2|STARTED|Overall Study||26
77733|NCT01615731|186098|P1|STARTED|Overall Study||24
77734|NCT01615484|186120|P2|NOT COMPLETED|Overall Study||0
77735|NCT01615484|186121|P1|NOT COMPLETED|Overall Study||0
77736|NCT01615484|186120|P2|COMPLETED|Overall Study||24
77737|NCT01615484|186121|P1|COMPLETED|Overall Study||0
77738|NCT01615484|186120|P2|STARTED|Overall Study||24
77739|NCT01615484|186121|P1|STARTED|Overall Study||0
77740|NCT01615367|186139|P2|NOT COMPLETED|Overall Study||6
77741|NCT01615367|186140|P1|NOT COMPLETED|Overall Study||5
77742|NCT01615367|186139|P2|COMPLETED|Overall Study||13
77743|NCT01615367|186140|P1|COMPLETED|Overall Study||14
77744|NCT01615367|186139|P2|STARTED|Overall Study||19
77745|NCT01615367|186140|P1|STARTED|Overall Study||19
77746|NCT01615328|186160|P2|NOT COMPLETED|Overall Study||5
77747|NCT01615328|186161|P1|NOT COMPLETED|Overall Study||3
77748|NCT01615328|186160|P2|COMPLETED|Overall Study||38
77749|NCT01615328|186161|P1|COMPLETED|Overall Study||39
77750|NCT01615328|186160|P2|STARTED|Overall Study||43
77751|NCT01615328|186161|P1|STARTED|Overall Study||42
77752|NCT01615263|186173|P2|NOT COMPLETED|Overall Study||2
77753|NCT01615263|186174|P1|NOT COMPLETED|Overall Study||0
77754|NCT01615263|186173|P2|COMPLETED|Overall Study||18
77755|NCT01615263|186174|P1|COMPLETED|Overall Study||20
77756|NCT01615263|186173|P2|STARTED|Overall Study||20
77757|NCT01615263|186174|P1|STARTED|Overall Study||20
77758|NCT01615198|186188|P2|NOT COMPLETED|Overall Study||19
77759|NCT01615198|186189|P1|NOT COMPLETED|Overall Study||24
77760|NCT01615198|186188|P2|COMPLETED|Overall Study||273
77761|NCT01615198|186189|P1|COMPLETED|Overall Study||272
77762|NCT01615198|186188|P2|ABPM Dipper Status Subset|Overall Study||84
77763|NCT01615198|186189|P1|ABPM Dipper Status Subset|Overall Study||82
77764|NCT01615198|186188|P2|Safety Set|Overall Study||292
77765|NCT01615198|186189|P1|Safety Set|Overall Study||296
77766|NCT01615198|186188|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
77767|NCT01615198|186189|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
77768|NCT01615198|186188|P2|Full Analysis Set|Overall Study||292
77769|NCT01615198|186189|P1|Full Analysis Set|Overall Study||296
77770|NCT01615198|186188|P2|STARTED|Overall Study||292
77771|NCT01615198|186189|P1|STARTED|Overall Study||296
77772|NCT01615029|186222|P5|NOT COMPLETED|Overall Study||32
77773|NCT01615029|186223|P4|NOT COMPLETED|Overall Study||3
77774|NCT01615029|186224|P3|NOT COMPLETED|Overall Study||4
77775|NCT01615029|186225|P2|NOT COMPLETED|Overall Study||3
77776|NCT01615029|186226|P1|NOT COMPLETED|Overall Study||3
77777|NCT01615029|186222|P5|COMPLETED|Overall Study||0
77778|NCT01615029|186223|P4|COMPLETED|Overall Study||0
77779|NCT01615029|186224|P3|COMPLETED|Overall Study||0
77780|NCT01615029|186225|P2|COMPLETED|Overall Study||0
77781|NCT01615029|186226|P1|COMPLETED|Overall Study||0
77782|NCT01615029|186222|P5|STARTED|Overall Study||32
77783|NCT01615029|186223|P4|STARTED|Overall Study||3
77784|NCT01615029|186224|P3|STARTED|Overall Study||4
77785|NCT01615029|186225|P2|STARTED|Overall Study||3
77786|NCT01615029|186226|P1|STARTED|Overall Study||3
77787|NCT01614886|186249|P2|NOT COMPLETED|Overall Study||26
77788|NCT01614886|186250|P1|NOT COMPLETED|Overall Study||20
77789|NCT01614886|186249|P2|COMPLETED|Overall Study||83
77790|NCT01614886|186250|P1|COMPLETED|Overall Study||87
77791|NCT01614886|186249|P2|Full Analysis Set (FAS)|Overall Study||105
77792|NCT01614886|186250|P1|Full Analysis Set (FAS)|Overall Study||104
77793|NCT01614886|186249|P2|Safety Population (SAF)|Overall Study||108
77794|NCT01614886|186250|P1|Safety Population (SAF)|Overall Study||107
77795|NCT01614886|186249|P2|STARTED|Overall Study||109
77796|NCT01614886|186250|P1|STARTED|Overall Study||107
77797|NCT01614795|186268|P4|NOT COMPLETED|Overall Study||12
77798|NCT01614795|186269|P3|NOT COMPLETED|Overall Study||11
77799|NCT01614795|186270|P2|NOT COMPLETED|Overall Study||12
77800|NCT01614795|186271|P1|NOT COMPLETED|Overall Study||11
77801|NCT01614795|186268|P4|COMPLETED|Overall Study||0
77802|NCT01614795|186269|P3|COMPLETED|Overall Study||0
77803|NCT01614795|186270|P2|COMPLETED|Overall Study||0
77804|NCT01614795|186271|P1|COMPLETED|Overall Study||0
77805|NCT01614795|186268|P4|STARTED|Overall Study||12
77806|NCT01614795|186269|P3|STARTED|Overall Study||11
77807|NCT01614795|186270|P2|STARTED|Overall Study||12
77808|NCT01614795|186271|P1|STARTED|Overall Study||11
77809|NCT01614769|186281|P6|NOT COMPLETED|Period 3||0
77810|NCT01614769|186282|P5|NOT COMPLETED|Period 3||0
77811|NCT01614769|186283|P4|NOT COMPLETED|Period 3||0
77812|NCT01614769|186284|P3|NOT COMPLETED|Period 3||1
77813|NCT01614769|186285|P2|NOT COMPLETED|Period 3||0
77814|NCT01614769|186286|P1|NOT COMPLETED|Period 3||0
77815|NCT01614769|186281|P6|COMPLETED|Period 3||1
77816|NCT01614769|186282|P5|COMPLETED|Period 3||1
77817|NCT01614769|186283|P4|COMPLETED|Period 3||0
77818|NCT01614769|186284|P3|COMPLETED|Period 3||1
77819|NCT01614769|186285|P2|COMPLETED|Period 3||1
77820|NCT01614769|186286|P1|COMPLETED|Period 3||1
77821|NCT01614769|186281|P6|STARTED|Period 3||1
77822|NCT01614769|186282|P5|STARTED|Period 3||1
77823|NCT01614769|186283|P4|STARTED|Period 3||0
77824|NCT01614769|186284|P3|STARTED|Period 3||2
77825|NCT01614769|186285|P2|STARTED|Period 3||1
77826|NCT01614769|186286|P1|STARTED|Period 3||1
77827|NCT01614769|186281|P6|NOT COMPLETED|7-Day Washout||0
77828|NCT01614769|186282|P5|NOT COMPLETED|7-Day Washout||0
77829|NCT01614769|186283|P4|NOT COMPLETED|7-Day Washout||0
77830|NCT01614769|186284|P3|NOT COMPLETED|7-Day Washout||0
77831|NCT01614769|186285|P2|NOT COMPLETED|7-Day Washout||0
77832|NCT01614769|186286|P1|NOT COMPLETED|7-Day Washout||0
77833|NCT01614769|186281|P6|COMPLETED|7-Day Washout||1
77834|NCT01614769|186282|P5|COMPLETED|7-Day Washout||1
77835|NCT01614769|186283|P4|COMPLETED|7-Day Washout||0
77836|NCT01614769|186284|P3|COMPLETED|7-Day Washout||2
77837|NCT01614769|186285|P2|COMPLETED|7-Day Washout||1
77838|NCT01614769|186286|P1|COMPLETED|7-Day Washout||1
77839|NCT01614769|186281|P6|STARTED|7-Day Washout||1
77840|NCT01614769|186282|P5|STARTED|7-Day Washout||1
77841|NCT01614769|186283|P4|STARTED|7-Day Washout||0
77842|NCT01614769|186284|P3|STARTED|7-Day Washout||2
77843|NCT01614769|186285|P2|STARTED|7-Day Washout||1
77844|NCT01614769|186286|P1|STARTED|7-Day Washout||1
77845|NCT01614769|186281|P6|NOT COMPLETED|Period 2||0
77846|NCT01614769|186282|P5|NOT COMPLETED|Period 2||0
77847|NCT01614769|186283|P4|NOT COMPLETED|Period 2||0
77848|NCT01614769|186284|P3|NOT COMPLETED|Period 2||0
77849|NCT01614769|186285|P2|NOT COMPLETED|Period 2||0
77850|NCT01614769|186286|P1|NOT COMPLETED|Period 2||0
77851|NCT01614769|186281|P6|COMPLETED|Period 2||1
77852|NCT01614769|186282|P5|COMPLETED|Period 2||1
77853|NCT01614769|186283|P4|COMPLETED|Period 2||0
77854|NCT01614769|186284|P3|COMPLETED|Period 2||2
77855|NCT01614769|186285|P2|COMPLETED|Period 2||1
77856|NCT01614769|186286|P1|COMPLETED|Period 2||1
77857|NCT01614769|186281|P6|STARTED|Period 2||1
77858|NCT01614769|186282|P5|STARTED|Period 2||1
77859|NCT01614769|186283|P4|STARTED|Period 2||0
77860|NCT01614769|186284|P3|STARTED|Period 2||2
77861|NCT01614769|186285|P2|STARTED|Period 2||1
77862|NCT01614769|186286|P1|STARTED|Period 2||1
77863|NCT01614769|186281|P6|NOT COMPLETED|7-Day Washout||0
77864|NCT01614769|186282|P5|NOT COMPLETED|7-Day Washout||0
77865|NCT01614769|186283|P4|NOT COMPLETED|7-Day Washout||0
77866|NCT01614769|186284|P3|NOT COMPLETED|7-Day Washout||0
77867|NCT01614769|186285|P2|NOT COMPLETED|7-Day Washout||0
77868|NCT01614769|186286|P1|NOT COMPLETED|7-Day Washout||0
77869|NCT01614769|186281|P6|COMPLETED|7-Day Washout||1
77870|NCT01614769|186282|P5|COMPLETED|7-Day Washout||1
77871|NCT01614769|186283|P4|COMPLETED|7-Day Washout||0
77872|NCT01614769|186284|P3|COMPLETED|7-Day Washout||2
77873|NCT01614769|186285|P2|COMPLETED|7-Day Washout||1
77874|NCT01614769|186286|P1|COMPLETED|7-Day Washout||1
77875|NCT01614769|186281|P6|STARTED|7-Day Washout||1
77876|NCT01614769|186282|P5|STARTED|7-Day Washout||1
77877|NCT01614769|186283|P4|STARTED|7-Day Washout||0
77878|NCT01614769|186284|P3|STARTED|7-Day Washout||2
77879|NCT01614769|186285|P2|STARTED|7-Day Washout||1
77880|NCT01614769|186286|P1|STARTED|7-Day Washout||1
77881|NCT01614769|186281|P6|NOT COMPLETED|Period 1||1
77882|NCT01614769|186282|P5|NOT COMPLETED|Period 1||0
77883|NCT01614769|186283|P4|NOT COMPLETED|Period 1||2
77884|NCT01614769|186284|P3|NOT COMPLETED|Period 1||0
77885|NCT01614769|186285|P2|NOT COMPLETED|Period 1||0
77886|NCT01614769|186286|P1|NOT COMPLETED|Period 1||1
77887|NCT01614769|186281|P6|COMPLETED|Period 1||1
77888|NCT01614769|186282|P5|COMPLETED|Period 1||1
77889|NCT01614769|186283|P4|COMPLETED|Period 1||0
77890|NCT01614769|186284|P3|COMPLETED|Period 1||2
77891|NCT01614769|186285|P2|COMPLETED|Period 1||1
77892|NCT01614769|186286|P1|COMPLETED|Period 1||1
77893|NCT01614769|186281|P6|STARTED|Period 1||2
77894|NCT01614769|186282|P5|STARTED|Period 1||1
77895|NCT01614769|186283|P4|STARTED|Period 1||2
77896|NCT01614769|186284|P3|STARTED|Period 1||2
77897|NCT01614769|186285|P2|STARTED|Period 1||1
77898|NCT01614769|186286|P1|STARTED|Period 1||2
77899|NCT01614613|186300|P1|NOT COMPLETED|Overall Study||0
77900|NCT01614613|186300|P1|COMPLETED|Overall Study||146
77901|NCT01614613|186300|P1|STARTED|Overall Study||146
77902|NCT01614600|186308|P1|NOT COMPLETED|Overall Study||4
77903|NCT01614600|186308|P1|COMPLETED|Overall Study||84
77904|NCT01614600|186308|P1|STARTED|Overall Study||88
77905|NCT01614574|186312|P1|NOT COMPLETED|Overall Study||0
77906|NCT01614574|186312|P1|COMPLETED|Overall Study||6
77907|NCT01614574|186312|P1|STARTED|Overall Study||6
77908|NCT01614509|186328|P2|NOT COMPLETED|Overall Study||3
77909|NCT01614509|186329|P1|NOT COMPLETED|Overall Study||1
77910|NCT01614509|186328|P2|COMPLETED|Overall Study||18
77911|NCT01614509|186329|P1|COMPLETED|Overall Study||23
77912|NCT01614509|186328|P2|STARTED|Overall Study||21
77913|NCT01614509|186329|P1|STARTED|Overall Study||24
77914|NCT01614470|186339|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
77915|NCT01614470|186340|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
77916|NCT01614470|186341|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
77917|NCT01614470|186339|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
77918|NCT01614470|186340|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
77919|NCT01614470|186341|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
77920|NCT01614470|186339|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
77921|NCT01614470|186340|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
77922|NCT01614470|186341|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
77923|NCT01614470|186339|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
77924|NCT01614470|186340|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
77925|NCT01614470|186341|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
77926|NCT01614470|186339|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
77927|NCT01614470|186340|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
77928|NCT01614470|186341|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
77929|NCT01614470|186339|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
77930|NCT01614470|186340|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
77931|NCT01614470|186341|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
77932|NCT01614470|186339|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
77933|NCT01614470|186340|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
77934|NCT01614470|186341|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
77935|NCT01614470|186339|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
77936|NCT01614470|186340|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
77937|NCT01614470|186341|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
77938|NCT01614470|186339|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
77939|NCT01614470|186340|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
77940|NCT01614470|186341|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
77941|NCT01614470|186339|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
77942|NCT01614470|186340|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
77943|NCT01614470|186341|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
77944|NCT01614470|186339|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
77945|NCT01614470|186340|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
77946|NCT01614470|186341|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
77947|NCT01614470|186339|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
77948|NCT01614470|186340|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
77949|NCT01614470|186341|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
77950|NCT01614457|186363|P2|NOT COMPLETED|Overall Study||0
77951|NCT01614457|186364|P1|NOT COMPLETED|Overall Study||2
77952|NCT01614457|186363|P2|COMPLETED|Overall Study||35
77953|NCT01614457|186364|P1|COMPLETED|Overall Study||32
77954|NCT01614457|186363|P2|STARTED|Overall Study||35
77955|NCT01614457|186364|P1|STARTED|Overall Study||34
77956|NCT01614249|186382|P2|NOT COMPLETED|Overall Study||23
77957|NCT01614249|186383|P1|NOT COMPLETED|Overall Study||11
77958|NCT01614249|186382|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
77959|NCT01614249|186383|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
77960|NCT01614249|186382|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
77961|NCT01614249|186383|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
77962|NCT01614249|186382|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
77963|NCT01614249|186383|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
77964|NCT01614249|186382|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
77965|NCT01614249|186383|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
77966|NCT01614210|186389|P1|NOT COMPLETED|Overall Study||0
77967|NCT01614210|186389|P1|COMPLETED|Overall Study||52
77968|NCT01614210|186389|P1|STARTED|Overall Study||52
77969|NCT01614093|186395|P1|NOT COMPLETED|Overall Study||1
77970|NCT01614093|186395|P1|COMPLETED|Overall Study||16
77971|NCT01614093|186395|P1|STARTED|Overall Study||17
77972|NCT01613716|186400|P1|NOT COMPLETED|Overall Study||7
77973|NCT01613716|186400|P1|COMPLETED|Overall Study||23
77974|NCT01613716|186400|P1|STARTED|Overall Study||30
77975|NCT01613599|186405|P1|NOT COMPLETED|Overall Study||97
77976|NCT01613599|186405|P1|COMPLETED|Overall Study||0
77977|NCT01613599|186405|P1|STARTED|Overall Study||97
77978|NCT01613417|186420|P2|NOT COMPLETED|Second Injection||0
77979|NCT01613417|186421|P1|NOT COMPLETED|Second Injection||0
77980|NCT01613417|186420|P2|COMPLETED|Second Injection||109
77981|NCT01613417|186421|P1|COMPLETED|Second Injection||100
77982|NCT01613417|186420|P2|STARTED|Second Injection||109
77983|NCT01613417|186421|P1|STARTED|Second Injection||100
77984|NCT01613417|186420|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
77985|NCT01613417|186421|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
77986|NCT01613417|186420|P2|COMPLETED|Washout (no Second Injection/MRI)||109
77987|NCT01613417|186421|P1|COMPLETED|Washout (no Second Injection/MRI)||100
77988|NCT01613417|186420|P2|STARTED|Washout (no Second Injection/MRI)||116
77989|NCT01613417|186421|P1|STARTED|Washout (no Second Injection/MRI)||113
77990|NCT01613417|186420|P2|NOT COMPLETED|First Injection||0
77991|NCT01613417|186421|P1|NOT COMPLETED|First Injection||0
77992|NCT01613417|186420|P2|COMPLETED|First Injection||116
77993|NCT01613417|186421|P1|COMPLETED|First Injection||113
77994|NCT01613417|186420|P2|STARTED|First Injection||116
77995|NCT01613417|186421|P1|STARTED|First Injection||113
77996|NCT01613378|186458|P1|NOT COMPLETED|Overall Study||39
77997|NCT01613378|186458|P1|COMPLETED|Overall Study||161
77998|NCT01613378|186458|P1|STARTED|Overall Study||200
77999|NCT01613339|186476|P2|NOT COMPLETED|Overall Study||1
78000|NCT01613339|186477|P1|NOT COMPLETED|Overall Study||3
78001|NCT01613339|186476|P2|COMPLETED|Overall Study||21
78002|NCT01613339|186477|P1|COMPLETED|Overall Study||21
78003|NCT01613339|186476|P2|STARTED|Overall Study||22
78004|NCT01613339|186477|P1|STARTED|Overall Study||24
78005|NCT01613326|186488|P2|NOT COMPLETED|Overall Study||14
78006|NCT01613326|186489|P1|NOT COMPLETED|Overall Study||13
78007|NCT01613326|186488|P2|COMPLETED|Overall Study||316
78008|NCT01613326|186489|P1|COMPLETED|Overall Study||314
78009|NCT01613326|186488|P2|STARTED|Overall Study||330
78010|NCT01613326|186489|P1|STARTED|Overall Study||327
78011|NCT01613313|186523|P4|NOT COMPLETED|Overall Study||0
78012|NCT01613313|186524|P3|NOT COMPLETED|Overall Study||0
78013|NCT01613313|186525|P2|NOT COMPLETED|Overall Study||0
78014|NCT01613313|186526|P1|NOT COMPLETED|Overall Study||0
78015|NCT01613313|186523|P4|COMPLETED|Overall Study||4
78016|NCT01613313|186524|P3|COMPLETED|Overall Study||4
78017|NCT01613313|186525|P2|COMPLETED|Overall Study||4
78018|NCT01613313|186526|P1|COMPLETED|Overall Study||2
78019|NCT01613313|186523|P4|STARTED|Overall Study||4
78020|NCT01613313|186524|P3|STARTED|Overall Study||4
78021|NCT01613313|186525|P2|STARTED|Overall Study||4
78022|NCT01613313|186526|P1|STARTED|Overall Study||2
78023|NCT01613248|186546|P6|NOT COMPLETED|Overall Study||38
78024|NCT01613248|186547|P5|NOT COMPLETED|Overall Study||35
78025|NCT01613248|186548|P4|NOT COMPLETED|Overall Study||38
78026|NCT01613248|186549|P3|NOT COMPLETED|Overall Study||33
78027|NCT01613248|186550|P2|NOT COMPLETED|Overall Study||34
78028|NCT01613248|186551|P1|NOT COMPLETED|Overall Study||29
78029|NCT01613248|186546|P6|COMPLETED|Overall Study||102
78030|NCT01613248|186547|P5|COMPLETED|Overall Study||104
78031|NCT01613248|186548|P4|COMPLETED|Overall Study||101
78032|NCT01613248|186549|P3|COMPLETED|Overall Study||106
78033|NCT01613248|186550|P2|COMPLETED|Overall Study||104
78034|NCT01613248|186551|P1|COMPLETED|Overall Study||110
78035|NCT01613248|186546|P6|STARTED|Overall Study||140
78036|NCT01613248|186547|P5|STARTED|Overall Study||139
78037|NCT01613248|186548|P4|STARTED|Overall Study||139
78038|NCT01613248|186549|P3|STARTED|Overall Study||139
78039|NCT01613248|186550|P2|STARTED|Overall Study||138
78040|NCT01613248|186551|P1|STARTED|Overall Study||139
78041|NCT01613131|186651|P2|NOT COMPLETED|Overall Study||5
78042|NCT01613131|186652|P1|NOT COMPLETED|Overall Study||3
78043|NCT01613131|186651|P2|COMPLETED|Overall Study||13
78044|NCT01613131|186652|P1|COMPLETED|Overall Study||17
78045|NCT01613131|186651|P2|STARTED|Overall Study||18
78046|NCT01613131|186652|P1|STARTED|Overall Study||20
78047|NCT01613027|186680|P1|NOT COMPLETED|Overall Study||8
78048|NCT01613027|186680|P1|COMPLETED|Overall Study||127
78049|NCT01613027|186680|P1|STARTED|Overall Study||135
78050|NCT01613014|186701|P2|NOT COMPLETED|Overall Study||12
78051|NCT01613014|186702|P1|NOT COMPLETED|Overall Study||18
78052|NCT01613014|186701|P2|COMPLETED|Overall Study||63
78053|NCT01613014|186702|P1|COMPLETED|Overall Study||57
78054|NCT01613014|186701|P2|STARTED|Overall Study||75
78055|NCT01613014|186702|P1|STARTED|Overall Study||75
78056|NCT01612884|186710|P2|NOT COMPLETED|Overall Study||0
78057|NCT01612884|186711|P1|NOT COMPLETED|Overall Study||0
78058|NCT01612884|186710|P2|COMPLETED|Overall Study||18
78059|NCT01612884|186711|P1|COMPLETED|Overall Study||19
78060|NCT01612884|186710|P2|STARTED|Overall Study||18
78061|NCT01612884|186711|P1|STARTED|Overall Study||19
78062|NCT01612858|186723|P2|NOT COMPLETED|Overall Study||1
78063|NCT01612858|186724|P1|NOT COMPLETED|Overall Study||5
78064|NCT01612858|186723|P2|COMPLETED|Overall Study||3
78065|NCT01612858|186724|P1|COMPLETED|Overall Study||11
78066|NCT01612858|186723|P2|STARTED|Overall Study||4
78067|NCT01612858|186724|P1|STARTED|Overall Study||16
78068|NCT01612767|186732|P1|NOT COMPLETED|Overall Study||9
78069|NCT01612767|186732|P1|COMPLETED|Overall Study||320
78070|NCT01612767|186732|P1|STARTED|Overall Study||329
78071|NCT01612702|186761|P2|NOT COMPLETED|Overall Study||11
78072|NCT01612702|186762|P1|NOT COMPLETED|Overall Study||11
78073|NCT01612702|186761|P2|COMPLETED|Overall Study||134
78074|NCT01612702|186762|P1|COMPLETED|Overall Study||135
78075|NCT01612702|186761|P2|STARTED|Overall Study||145
78076|NCT01612702|186762|P1|STARTED|Overall Study||146
78077|NCT01612676|186776|P4|NOT COMPLETED|Overall Study||3
78078|NCT01612676|186777|P3|NOT COMPLETED|Overall Study||1
78079|NCT01612676|186778|P2|NOT COMPLETED|Overall Study||4
78080|NCT01612676|186779|P1|NOT COMPLETED|Overall Study||2
78081|NCT01612676|186776|P4|COMPLETED|Overall Study||10
78082|NCT01612676|186777|P3|COMPLETED|Overall Study||4
78083|NCT01612676|186778|P2|COMPLETED|Overall Study||3
78084|NCT01612676|186779|P1|COMPLETED|Overall Study||4
78085|NCT01612676|186776|P4|Dosed|Overall Study||13
78086|NCT01612676|186777|P3|Dosed|Overall Study||5
78087|NCT01612676|186778|P2|Dosed|Overall Study||7
78088|NCT01612676|186779|P1|Dosed|Overall Study||5
78089|NCT01612676|186776|P4|STARTED|Overall Study||13
78090|NCT01612676|186777|P3|STARTED|Overall Study||5
78091|NCT01612676|186778|P2|STARTED|Overall Study||7
78092|NCT01612676|186779|P1|STARTED|Overall Study||6
78093|NCT01612546|186835|P1|NOT COMPLETED|Overall Study||0
78094|NCT01612546|186835|P1|COMPLETED|Overall Study||10
78095|NCT01612546|186835|P1|STARTED|Overall Study||10
78096|NCT01612494|186845|P2|NOT COMPLETED|Overall Study||0
78097|NCT01612494|186846|P1|NOT COMPLETED|Overall Study||0
78098|NCT01612494|186845|P2|COMPLETED|Overall Study||23
78099|NCT01612494|186846|P1|COMPLETED|Overall Study||21
78100|NCT01612494|186845|P2|STARTED|Overall Study||23
78101|NCT01612494|186846|P1|STARTED|Overall Study||21
78102|NCT01612351|186852|P1|NOT COMPLETED|Post-Operative Treatment||0
78103|NCT01612351|186852|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
78104|NCT01612351|186852|P1|STARTED|Post-Operative Treatment||39
78105|NCT01612351|186852|P1|NOT COMPLETED|Transoral Surgery||0
78106|NCT01612351|186852|P1|COMPLETED|Transoral Surgery||39
78107|NCT01612351|186852|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
78108|NCT01612351|186852|P1|NOT COMPLETED|Chemotherapy||0
78109|NCT01612351|186852|P1|COMPLETED|Chemotherapy||40
78110|NCT01612351|186852|P1|STARTED|Chemotherapy||40
78111|NCT01612221|186866|P2|NOT COMPLETED|Overall Study||0
78112|NCT01612221|186867|P1|NOT COMPLETED|Overall Study||0
78113|NCT01612221|186866|P2|COMPLETED|Overall Study||50
78114|NCT01612221|186867|P1|COMPLETED|Overall Study||50
78115|NCT01612221|186866|P2|STARTED|Overall Study||50
78116|NCT01612221|186867|P1|STARTED|Overall Study||50
78117|NCT01612156|186877|P2|NOT COMPLETED|Overall Study||0
78118|NCT01612156|186878|P1|NOT COMPLETED|Overall Study||2
78119|NCT01612156|186877|P2|COMPLETED|Overall Study||48
78120|NCT01612156|186878|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
78121|NCT01612156|186877|P2|STARTED|Overall Study||48
78122|NCT01612156|186878|P1|STARTED|Overall Study||42
78123|NCT01612000|186890|P4|NOT COMPLETED|Overall Study||10
78124|NCT01612000|186891|P3|NOT COMPLETED|Overall Study||7
78125|NCT01612000|186892|P2|NOT COMPLETED|Overall Study||5
78126|NCT01612000|186893|P1|NOT COMPLETED|Overall Study||9
78127|NCT01612000|186890|P4|COMPLETED|Overall Study||76
78128|NCT01612000|186891|P3|COMPLETED|Overall Study||78
78129|NCT01612000|186892|P2|COMPLETED|Overall Study||81
78130|NCT01612000|186893|P1|COMPLETED|Overall Study||75
78131|NCT01612000|186890|P4|STARTED|Overall Study||86
78132|NCT01612000|186891|P3|STARTED|Overall Study||85
78133|NCT01612000|186892|P2|STARTED|Overall Study||86
78134|NCT01612000|186893|P1|STARTED|Overall Study||84
78135|NCT01611974|186918|P3|NOT COMPLETED|Overall Study||16
78136|NCT01611974|186919|P2|NOT COMPLETED|Overall Study||15
78137|NCT01611974|186920|P1|NOT COMPLETED|Overall Study||15
78138|NCT01611974|186918|P3|COMPLETED|Overall Study||24
78139|NCT01611974|186919|P2|COMPLETED|Overall Study||25
78140|NCT01611974|186920|P1|COMPLETED|Overall Study||25
78141|NCT01611974|186918|P3|STARTED|Overall Study||40
78142|NCT01611974|186919|P2|STARTED|Overall Study||40
78143|NCT01611974|186920|P1|STARTED|Overall Study||40
78144|NCT01611948|186957|P2|NOT COMPLETED|Overall Study||12
78145|NCT01611948|186958|P1|NOT COMPLETED|Overall Study||14
78146|NCT01611948|186957|P2|COMPLETED|Overall Study||26
78147|NCT01611948|186958|P1|COMPLETED|Overall Study||18
78148|NCT01611948|186957|P2|STARTED|Overall Study||38
78149|NCT01611948|186958|P1|STARTED|Overall Study||32
78150|NCT01611883|186966|P2|NOT COMPLETED|Overall Study||1
78151|NCT01611883|186967|P1|NOT COMPLETED|Overall Study||1
78152|NCT01611883|186966|P2|COMPLETED|Overall Study||76
78153|NCT01611883|186967|P1|COMPLETED|Overall Study||74
78154|NCT01611883|186966|P2|STARTED|Overall Study||77
78155|NCT01611883|186967|P1|STARTED|Overall Study||75
78156|NCT01611857|186993|P2|NOT COMPLETED|Overall Study||2
78157|NCT01611857|186994|P1|NOT COMPLETED|Overall Study||0
78158|NCT01611857|186993|P2|COMPLETED|Overall Study||32
78159|NCT01611857|186994|P1|COMPLETED|Overall Study||15
78160|NCT01611857|186993|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
78161|NCT01611857|186994|P1|Tivantinib 360 mg|Overall Study||7
78162|NCT01611857|186993|P2|Tivantinib 240 mg|Overall Study||0
78163|NCT01611857|186994|P1|Tivantinib 240 mg|Overall Study||3
78164|NCT01611857|186993|P2|Tivantinib 120 mg|Overall Study||0
78165|NCT01611857|186994|P1|Tivantinib 120 mg|Overall Study||5
78166|NCT01611857|186993|P2|STARTED|Overall Study||34
78167|NCT01611857|186994|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
78168|NCT01611792|187006|P2|NOT COMPLETED|Followup: at 6 Months||13
78169|NCT01611792|187007|P1|NOT COMPLETED|Followup: at 6 Months||6
78170|NCT01611792|187006|P2|COMPLETED|Followup: at 6 Months||7
78171|NCT01611792|187007|P1|COMPLETED|Followup: at 6 Months||11
78172|NCT01611792|187006|P2|STARTED|Followup: at 6 Months||20
78173|NCT01611792|187007|P1|STARTED|Followup: at 6 Months||17
78174|NCT01611792|187006|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
78175|NCT01611792|187007|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
78176|NCT01611792|187006|P2|COMPLETED|Follow-up: at 11 Weeks||20
78177|NCT01611792|187007|P1|COMPLETED|Follow-up: at 11 Weeks||17
78178|NCT01611792|187006|P2|STARTED|Follow-up: at 11 Weeks||20
78179|NCT01611792|187007|P1|STARTED|Follow-up: at 11 Weeks||17
78180|NCT01611792|187006|P2|NOT COMPLETED|Initial Period: Time 0||9
78181|NCT01611792|187007|P1|NOT COMPLETED|Initial Period: Time 0||12
78182|NCT01611792|187006|P2|COMPLETED|Initial Period: Time 0||20
78183|NCT01611792|187007|P1|COMPLETED|Initial Period: Time 0||17
78184|NCT01611792|187006|P2|STARTED|Initial Period: Time 0||29
78185|NCT01611792|187007|P1|STARTED|Initial Period: Time 0||29
78186|NCT01611779|187023|P1|NOT COMPLETED|Overall Study||0
78187|NCT01611779|187023|P1|COMPLETED|Overall Study||5
78188|NCT01611779|187023|P1|STARTED|Overall Study||5
78189|NCT01611662|187032|P1|NOT COMPLETED|Overall Study||1
78190|NCT01611662|187032|P1|COMPLETED|Overall Study||31
78191|NCT01611662|187032|P1|STARTED|Overall Study||32
78192|NCT01611571|187039|P3|NOT COMPLETED|Overall Study||1
78193|NCT01611571|187040|P2|NOT COMPLETED|Overall Study||0
78194|NCT01611571|187041|P1|NOT COMPLETED|Overall Study||1
78195|NCT01611571|187039|P3|COMPLETED|Overall Study||9
78196|NCT01611571|187040|P2|COMPLETED|Overall Study||10
78197|NCT01611571|187041|P1|COMPLETED|Overall Study||10
78198|NCT01611571|187039|P3|STARTED|Overall Study||10
78199|NCT01611571|187040|P2|STARTED|Overall Study||10
78200|NCT01611571|187041|P1|STARTED|Overall Study||11
78201|NCT01611558|187061|P1|NOT COMPLETED|Maintenance Phase||2
78202|NCT01611558|187061|P1|COMPLETED|Maintenance Phase||0
78203|NCT01611558|187061|P1|STARTED|Maintenance Phase||2
78204|NCT01611558|187061|P1|NOT COMPLETED|Induction Phase||38
78205|NCT01611558|187061|P1|COMPLETED|Induction Phase||2
78206|NCT01611558|187061|P1|STARTED|Induction Phase||40
78207|NCT01611259|187067|P1|NOT COMPLETED|Overall Study||14
78208|NCT01611259|187067|P1|COMPLETED|Overall Study||34
78209|NCT01611259|187067|P1|STARTED|Overall Study||48
78210|NCT01610791|187071|P1|NOT COMPLETED|Overall Study||21
78211|NCT01610791|187071|P1|COMPLETED|Overall Study||100
78212|NCT01610791|187071|P1|STARTED|Overall Study||121
78213|NCT01610713|187094|P2|NOT COMPLETED|Overall Study||1
78214|NCT01610713|187095|P1|NOT COMPLETED|Overall Study||6
78215|NCT01610713|187094|P2|COMPLETED|Overall Study||76
78216|NCT01610713|187095|P1|COMPLETED|Overall Study||71
78217|NCT01610713|187094|P2|STARTED|Overall Study||77
78218|NCT01610713|187095|P1|STARTED|Overall Study||77
78219|NCT01610700|187153|P2|NOT COMPLETED|Overall Study||3
78220|NCT01610700|187154|P1|NOT COMPLETED|Overall Study||3
78221|NCT01610700|187153|P2|COMPLETED|Overall Study||77
78222|NCT01610700|187154|P1|COMPLETED|Overall Study||77
78223|NCT01610700|187153|P2|STARTED|Overall Study||80
78224|NCT01610700|187154|P1|STARTED|Overall Study||80
78225|NCT01610687|187208|P1|NOT COMPLETED|Overall Study||67
78226|NCT01610687|187208|P1|COMPLETED|Overall Study||70
78227|NCT01610687|187208|P1|STARTED|Overall Study||137
78228|NCT01610596|187221|P2|NOT COMPLETED|Overall Study||1
78229|NCT01610596|187222|P1|NOT COMPLETED|Overall Study||0
78230|NCT01610596|187221|P2|COMPLETED|Overall Study||35
78231|NCT01610596|187222|P1|COMPLETED|Overall Study||36
78232|NCT01610596|187221|P2|STARTED|Overall Study||36
78233|NCT01610596|187222|P1|STARTED|Overall Study||36
78234|NCT01610570|187238|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78235|NCT01610570|187239|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78236|NCT01610570|187240|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78237|NCT01610570|187241|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78238|NCT01610570|187238|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78239|NCT01610570|187239|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78240|NCT01610570|187240|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78241|NCT01610570|187241|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
78242|NCT01610570|187238|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
78243|NCT01610570|187239|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
78244|NCT01610570|187240|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
78245|NCT01610570|187241|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
78246|NCT01610570|187238|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
78247|NCT01610570|187239|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
78248|NCT01610570|187240|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
78249|NCT01610570|187241|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
78250|NCT01610570|187238|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
78251|NCT01610570|187239|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
78252|NCT01610570|187240|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
78253|NCT01610570|187241|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
78254|NCT01610570|187238|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
78255|NCT01610570|187239|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
78256|NCT01610570|187240|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
78257|NCT01610570|187241|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
78258|NCT01610570|187238|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
78259|NCT01610570|187239|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
78260|NCT01610570|187240|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
78261|NCT01610570|187241|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
78262|NCT01610570|187238|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
78263|NCT01610570|187239|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
78264|NCT01610570|187240|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
78265|NCT01610570|187241|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
78266|NCT01610570|187238|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
78267|NCT01610570|187239|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
78268|NCT01610570|187240|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
78269|NCT01610570|187241|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
78270|NCT01610557|187280|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
78271|NCT01610557|187281|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
78272|NCT01610557|187282|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
78273|NCT01610557|187283|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
78274|NCT01610557|187284|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
78275|NCT01610557|187280|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
78276|NCT01610557|187281|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78277|NCT01610557|187282|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78278|NCT01610557|187283|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78279|NCT01610557|187284|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78280|NCT01610557|187280|P5|STARTED|Post-36-Week Extension Phase||55
78281|NCT01610557|187281|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78282|NCT01610557|187282|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78283|NCT01610557|187283|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78284|NCT01610557|187284|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
78285|NCT01610557|187280|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
78286|NCT01610557|187281|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
78287|NCT01610557|187282|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
78288|NCT01610557|187283|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
78289|NCT01610557|187284|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
78290|NCT01610557|187280|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
78291|NCT01610557|187281|P4|COMPLETED|36-Week Randomized Crossover Phase||13
78292|NCT01610557|187282|P3|COMPLETED|36-Week Randomized Crossover Phase||14
78293|NCT01610557|187283|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
78294|NCT01610557|187284|P1|COMPLETED|36-Week Randomized Crossover Phase||16
78295|NCT01610557|187280|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
78296|NCT01610557|187281|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
78297|NCT01610557|187282|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
78298|NCT01610557|187283|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
78299|NCT01610557|187284|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
78300|NCT01610492|187297|P1|NOT COMPLETED|Overall Study||6
78301|NCT01610492|187297|P1|COMPLETED|Overall Study||8
78302|NCT01610492|187297|P1|STARTED|Overall Study||14
78303|NCT01610453|187341|P1|NOT COMPLETED|Overall Study||0
78304|NCT01610453|187341|P1|COMPLETED|Overall Study||150
78305|NCT01610453|187341|P1|STARTED|Overall Study||150
78306|NCT01610414|187348|P2|NOT COMPLETED|After Month 25||53
78307|NCT01610414|187349|P1|NOT COMPLETED|After Month 25||48
78308|NCT01610414|187348|P2|COMPLETED|After Month 25||871
78309|NCT01610414|187349|P1|COMPLETED|After Month 25||874
78310|NCT01610414|187348|P2|STARTED|After Month 25||924
78311|NCT01610414|187349|P1|STARTED|After Month 25||922
78312|NCT01610414|187348|P2|NOT COMPLETED|Month 13 - Month 25||70
78313|NCT01610414|187349|P1|NOT COMPLETED|Month 13 - Month 25||65
78314|NCT01610414|187348|P2|COMPLETED|Month 13 - Month 25||854
78315|NCT01610414|187349|P1|COMPLETED|Month 13 - Month 25||857
78316|NCT01610414|187348|P2|STARTED|Month 13 - Month 25||924
78317|NCT01610414|187349|P1|STARTED|Month 13 - Month 25||922
78318|NCT01610414|187348|P2|NOT COMPLETED|Study Start - Month 13||129
78319|NCT01610414|187349|P1|NOT COMPLETED|Study Start - Month 13||115
78320|NCT01610414|187348|P2|COMPLETED|Study Start - Month 13||795
78321|NCT01610414|187349|P1|COMPLETED|Study Start - Month 13||807
78322|NCT01610414|187348|P2|STARTED|Study Start - Month 13||924
78323|NCT01610414|187349|P1|STARTED|Study Start - Month 13||922
78324|NCT01610297|187378|P1|NOT COMPLETED|Overall Study||1
78325|NCT01610297|187378|P1|COMPLETED|Overall Study||26
78326|NCT01610297|187378|P1|STARTED|Overall Study||27
78327|NCT01610167|187389|P3|NOT COMPLETED|Overall Study||2
78328|NCT01610167|187390|P2|NOT COMPLETED|Overall Study||0
78329|NCT01610167|187391|P1|NOT COMPLETED|Overall Study||0
78330|NCT01610167|187389|P3|COMPLETED|Overall Study||48
78331|NCT01610167|187390|P2|COMPLETED|Overall Study||49
78332|NCT01610167|187391|P1|COMPLETED|Overall Study||52
78333|NCT01610167|187389|P3|STARTED|Overall Study||50
78334|NCT01610167|187390|P2|STARTED|Overall Study||49
78335|NCT01610167|187391|P1|STARTED|Overall Study||52
78336|NCT01610154|187411|P1|NOT COMPLETED|Overall Study||1
78337|NCT01610154|187411|P1|COMPLETED|Overall Study||84
78338|NCT01610154|187411|P1|STARTED|Overall Study||85
78339|NCT01610076|187428|P2|NOT COMPLETED|Overall Study||5
78340|NCT01610076|187429|P1|NOT COMPLETED|Overall Study||3
78341|NCT01610076|187428|P2|COMPLETED|Overall Study||100
78342|NCT01610076|187429|P1|COMPLETED|Overall Study||100
78343|NCT01610076|187428|P2|STARTED|Overall Study||105
78344|NCT01610076|187429|P1|STARTED|Overall Study||103
78345|NCT01610063|187440|P2|NOT COMPLETED|Overall Study||20
78346|NCT01610063|187441|P1|NOT COMPLETED|Overall Study||42
78347|NCT01610063|187440|P2|COMPLETED|Overall Study||93
78348|NCT01610063|187441|P1|COMPLETED|Overall Study||72
78349|NCT01610063|187440|P2|Completed 8-week|Overall Study||93
78350|NCT01610063|187441|P1|Completed 8-week|Overall Study||72
78351|NCT01610063|187440|P2|Completed 4-week|Overall Study||98
78352|NCT01610063|187441|P1|Completed 4-week|Overall Study||86
78353|NCT01610063|187440|P2|Completed 2-week|Overall Study||105
78354|NCT01610063|187441|P1|Completed 2-week|Overall Study||97
78355|NCT01610063|187440|P2|Baseline|Overall Study||113
78356|NCT01610063|187441|P1|Baseline|Overall Study||114
78357|NCT01610063|187440|P2|STARTED|Overall Study||113
78358|NCT01610063|187441|P1|STARTED|Overall Study||114
78359|NCT01610037|187464|P3|NOT COMPLETED|Treatment and Follow up Period||26
78360|NCT01610037|187465|P2|NOT COMPLETED|Treatment and Follow up Period||28
78361|NCT01610037|187466|P1|NOT COMPLETED|Treatment and Follow up Period||25
78362|NCT01610037|187464|P3|COMPLETED|Treatment and Follow up Period||378
78363|NCT01610037|187465|P2|COMPLETED|Treatment and Follow up Period||377
78364|NCT01610037|187466|P1|COMPLETED|Treatment and Follow up Period||382
78365|NCT01610037|187464|P3|STARTED|Treatment and Follow up Period||404
78366|NCT01610037|187465|P2|STARTED|Treatment and Follow up Period||405
78367|NCT01610037|187466|P1|STARTED|Treatment and Follow up Period||407
78368|NCT01610037|187464|P3|NOT COMPLETED|All Patients||84
78369|NCT01610037|187465|P2|NOT COMPLETED|All Patients||51
78370|NCT01610037|187466|P1|NOT COMPLETED|All Patients||59
78371|NCT01610037|187464|P3|COMPLETED|All Patients||320
78372|NCT01610037|187465|P2|COMPLETED|All Patients||354
78373|NCT01610037|187466|P1|COMPLETED|All Patients||348
78374|NCT01610037|187464|P3|Full Analysis Set (FAS)|All Patients||403
78375|NCT01610037|187465|P2|Full Analysis Set (FAS)|All Patients||405
78376|NCT01610037|187466|P1|Full Analysis Set (FAS)|All Patients||407
78377|NCT01610037|187464|P3|Randomized Set (RAN)|All Patients||404
78378|NCT01610037|187465|P2|Randomized Set (RAN)|All Patients||405
78379|NCT01610037|187466|P1|Randomized Set (RAN)|All Patients||407
78380|NCT01610037|187464|P3|STARTED|All Patients||404
78381|NCT01610037|187465|P2|STARTED|All Patients||405
78382|NCT01610037|187466|P1|STARTED|All Patients||407
78383|NCT01610011|187509|P2|NOT COMPLETED|Overall Study||0
78384|NCT01610011|187510|P1|NOT COMPLETED|Overall Study||10
78385|NCT01610011|187509|P2|COMPLETED|Overall Study||2
78386|NCT01610011|187510|P1|COMPLETED|Overall Study||9
78387|NCT01610011|187509|P2|STARTED|Overall Study||2
78388|NCT01610011|187510|P1|STARTED|Overall Study||19
78389|NCT01609790|187519|P3|NOT COMPLETED|Overall Study||8
78390|NCT01609790|187520|P2|NOT COMPLETED|Overall Study||7
78391|NCT01609790|187521|P1|NOT COMPLETED|Overall Study||1
78392|NCT01609790|187519|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
78393|NCT01609790|187520|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
78394|NCT01609790|187521|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
78395|NCT01609790|187519|P3|STARTED|Overall Study||65
78396|NCT01609790|187520|P2|STARTED|Overall Study||65
78397|NCT01609790|187521|P1|STARTED|Overall Study||7
78398|NCT01609582|187540|P2|NOT COMPLETED|Overall Study||1604
78399|NCT01609582|187541|P1|NOT COMPLETED|Overall Study||1603
78400|NCT01609582|187540|P2|COMPLETED|Overall Study||0
78401|NCT01609582|187541|P1|COMPLETED|Overall Study||0
78402|NCT01609582|187540|P2|Treated|Overall Study||1601
78403|NCT01609582|187541|P1|Treated|Overall Study||1603
78404|NCT01609582|187540|P2|STARTED|Overall Study||1604
78405|NCT01609582|187541|P1|STARTED|Overall Study||1603
78406|NCT01609543|187549|P1|NOT COMPLETED|Overall Study||42
78407|NCT01609543|187549|P1|COMPLETED|Overall Study||20
78408|NCT01609543|187549|P1|STARTED|Overall Study||62
78409|NCT01609478|187558|P3|NOT COMPLETED|Overall Study||9
78410|NCT01609478|187559|P2|NOT COMPLETED|Overall Study||2
78411|NCT01609478|187560|P1|NOT COMPLETED|Overall Study||7
78412|NCT01609478|187558|P3|COMPLETED|Overall Study||107
78413|NCT01609478|187559|P2|COMPLETED|Overall Study||106
78414|NCT01609478|187560|P1|COMPLETED|Overall Study||104
78415|NCT01609478|187558|P3|Full Analysis Set (FAS)|Overall Study||115
78416|NCT01609478|187559|P2|Full Analysis Set (FAS)|Overall Study||108
78417|NCT01609478|187560|P1|Full Analysis Set (FAS)|Overall Study||110
78418|NCT01609478|187558|P3|STARTED|Overall Study||116
78419|NCT01609478|187559|P2|STARTED|Overall Study||108
78420|NCT01609478|187560|P1|STARTED|Overall Study||111
78421|NCT01609348|187626|P2|NOT COMPLETED|Overall Study||0
78422|NCT01609348|187627|P1|NOT COMPLETED|Overall Study||0
78423|NCT01609348|187626|P2|COMPLETED|Overall Study||2
78424|NCT01609348|187627|P1|COMPLETED|Overall Study||3
78425|NCT01609348|187626|P2|STARTED|Overall Study||2
78426|NCT01609348|187627|P1|STARTED|Overall Study||3
78427|NCT01609257|187635|P2|NOT COMPLETED|Overall Study||8
78428|NCT01609257|187636|P1|NOT COMPLETED|Overall Study||6
78429|NCT01609257|187635|P2|COMPLETED|Overall Study||57
78430|NCT01609257|187636|P1|COMPLETED|Overall Study||61
78431|NCT01609257|187635|P2|Received Challenge Product|Overall Study||53
78432|NCT01609257|187636|P1|Received Challenge Product|Overall Study||56
78433|NCT01609257|187635|P2|Received 2 Doses|Overall Study||64
78434|NCT01609257|187636|P1|Received 2 Doses|Overall Study||63
78435|NCT01609257|187635|P2|STARTED|Overall Study||65
78436|NCT01609257|187636|P1|STARTED|Overall Study||67
78437|NCT01609062|187708|P2|NOT COMPLETED|Extension Phase||10
78438|NCT01609062|187709|P1|NOT COMPLETED|Extension Phase||15
78439|NCT01609062|187708|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
78440|NCT01609062|187709|P1|COMPLETED|Extension Phase||0
78441|NCT01609062|187708|P2|STARTED|Extension Phase||10
78442|NCT01609062|187709|P1|STARTED|Extension Phase||15
78443|NCT01609062|187708|P2|NOT COMPLETED|Primary Phase||0
78444|NCT01609062|187709|P1|NOT COMPLETED|Primary Phase||0
78445|NCT01609062|187708|P2|COMPLETED|Primary Phase||10
78446|NCT01609062|187709|P1|COMPLETED|Primary Phase||15
78447|NCT01609062|187708|P2|STARTED|Primary Phase||10
78448|NCT01609062|187709|P1|STARTED|Primary Phase||15
78449|NCT01609023|187752|P1|NOT COMPLETED|Overall Study||33
78450|NCT01609023|187752|P1|COMPLETED|Overall Study||34
78451|NCT01609023|187752|P1|STARTED|Overall Study||67
78452|NCT01609010|187764|P2|NOT COMPLETED|Overall Study||37
78453|NCT01609010|187765|P1|NOT COMPLETED|Overall Study||43
78454|NCT01609010|187764|P2|COMPLETED|Overall Study||120
78455|NCT01609010|187765|P1|COMPLETED|Overall Study||113
78456|NCT01609010|187764|P2|Entering Cycle 2|Overall Study||124
78457|NCT01609010|187765|P1|Entering Cycle 2|Overall Study||120
78458|NCT01609010|187764|P2|STARTED|Overall Study||157
78459|NCT01609010|187765|P1|STARTED|Overall Study||156
78460|NCT01608971|187791|P2|NOT COMPLETED|Overall Study||0
78461|NCT01608971|187792|P1|NOT COMPLETED|Overall Study||0
78462|NCT01608971|187791|P2|COMPLETED|Overall Study||15
78463|NCT01608971|187792|P1|COMPLETED|Overall Study||15
78464|NCT01608971|187791|P2|STARTED|Overall Study||15
78465|NCT01608971|187792|P1|STARTED|Overall Study||15
78466|NCT01608815|187807|P3|NOT COMPLETED|Overall Study||0
78467|NCT01608815|187808|P2|NOT COMPLETED|Overall Study||0
78468|NCT01608815|187809|P1|NOT COMPLETED|Overall Study||0
78469|NCT01608815|187807|P3|COMPLETED|Overall Study||5
78470|NCT01608815|187808|P2|COMPLETED|Overall Study||7
78471|NCT01608815|187809|P1|COMPLETED|Overall Study||188
78472|NCT01608815|187807|P3|STARTED|Overall Study||5
78473|NCT01608815|187808|P2|STARTED|Overall Study||7
78474|NCT01608815|187809|P1|STARTED|Overall Study||188
78475|NCT01608724|187826|P1|NOT COMPLETED|Overall Study||243
78476|NCT01608724|187826|P1|COMPLETED|Overall Study||1180
78477|NCT01608724|187826|P1|Treated|Overall Study||1361
78478|NCT01608724|187826|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
78479|NCT01608672|187833|P1|NOT COMPLETED|Overall Study||0
78480|NCT01608672|187833|P1|COMPLETED|Overall Study||207
78481|NCT01608672|187833|P1|STARTED|Overall Study||207
78482|NCT01608659|187839|P1|NOT COMPLETED|Overall Study||16
78483|NCT01608659|187839|P1|COMPLETED|Overall Study||94
78484|NCT01608659|187839|P1|STARTED|Overall Study||110
78485|NCT01608490|187847|P2|NOT COMPLETED|Overall Study||0
78486|NCT01608490|187848|P1|NOT COMPLETED|Overall Study||0
78487|NCT01608490|187847|P2|COMPLETED|Overall Study||157
78488|NCT01608490|187848|P1|COMPLETED|Overall Study||158
78489|NCT01608490|187847|P2|STARTED|Overall Study||157
78490|NCT01608490|187848|P1|STARTED|Overall Study||158
78491|NCT01608321|187858|P2|NOT COMPLETED|Overall Study||0
78492|NCT01608321|187859|P1|NOT COMPLETED|Overall Study||1
78493|NCT01608321|187858|P2|COMPLETED|Overall Study||4
78494|NCT01608321|187859|P1|COMPLETED|Overall Study||12
78495|NCT01608321|187858|P2|STARTED|Overall Study||4
78496|NCT01608321|187859|P1|STARTED|Overall Study||13
78497|NCT01608308|187867|P2|NOT COMPLETED|Overall Study||2
78498|NCT01608308|187868|P1|NOT COMPLETED|Overall Study||0
78499|NCT01608308|187867|P2|COMPLETED|Overall Study||29
78500|NCT01608308|187868|P1|COMPLETED|Overall Study||31
78501|NCT01608308|187867|P2|STARTED|Overall Study||31
78502|NCT01608308|187868|P1|STARTED|Overall Study||31
78503|NCT01608295|187892|P2|NOT COMPLETED|Overall Study||5
78504|NCT01608295|187893|P1|NOT COMPLETED|Overall Study||6
78505|NCT01608295|187892|P2|COMPLETED|Overall Study||25
78506|NCT01608295|187893|P1|COMPLETED|Overall Study||20
78507|NCT01608295|187892|P2|STARTED|Overall Study||30
78508|NCT01608295|187893|P1|STARTED|Overall Study||26
78509|NCT01608100|187904|P1|NOT COMPLETED|Overall Study||0
78510|NCT01608100|187904|P1|COMPLETED|Overall Study||1101
78511|NCT01608100|187904|P1|STARTED|Overall Study||1101
78512|NCT01607853|187928|P1|NOT COMPLETED|Overall Study||0
78513|NCT01607853|187928|P1|COMPLETED|Overall Study||24
78514|NCT01607853|187928|P1|STARTED|Overall Study||24
78515|NCT01607645|188037|P2|NOT COMPLETED|Overall Study||0
78516|NCT01607645|188038|P1|NOT COMPLETED|Overall Study||0
78517|NCT01607645|188037|P2|COMPLETED|Overall Study||3
78518|NCT01607645|188038|P1|COMPLETED|Overall Study||4
78519|NCT01607645|188037|P2|STARTED|Overall Study||3
78520|NCT01607645|188038|P1|STARTED|Overall Study||4
78521|NCT01607593|188068|P1|NOT COMPLETED|Overall Study||93
78522|NCT01607593|188068|P1|COMPLETED|Overall Study||29
78523|NCT01607593|188068|P1|STARTED|Overall Study||122
78524|NCT01607554|188074|P1|NOT COMPLETED|Overall Study||2
78525|NCT01607554|188074|P1|COMPLETED|Overall Study||0
78526|NCT01607554|188074|P1|STARTED|Overall Study||2
78527|NCT01607476|188087|P3|NOT COMPLETED|Overall Study||3
78528|NCT01607476|188088|P2|NOT COMPLETED|Overall Study||0
78529|NCT01607476|188089|P1|NOT COMPLETED|Overall Study||1
78530|NCT01607476|188087|P3|COMPLETED|Overall Study||30
78531|NCT01607476|188088|P2|COMPLETED|Overall Study||30
78532|NCT01607476|188089|P1|COMPLETED|Overall Study||24
78533|NCT01607476|188087|P3|STARTED|Overall Study||33
78534|NCT01607476|188088|P2|STARTED|Overall Study||30
78535|NCT01607476|188089|P1|STARTED|Overall Study||25
78536|NCT01607450|188107|P7|NOT COMPLETED|Overall Study||0
78537|NCT01607450|188108|P6|NOT COMPLETED|Overall Study||0
78538|NCT01607450|188109|P5|NOT COMPLETED|Overall Study||0
78539|NCT01607450|188110|P4|NOT COMPLETED|Overall Study||0
78540|NCT01607450|188111|P3|NOT COMPLETED|Overall Study||0
78541|NCT01607450|188112|P2|NOT COMPLETED|Overall Study||0
78542|NCT01607450|188113|P1|NOT COMPLETED|Overall Study||0
78543|NCT01607450|188107|P7|COMPLETED|Overall Study||0
78544|NCT01607450|188108|P6|COMPLETED|Overall Study||0
78545|NCT01607450|188109|P5|COMPLETED|Overall Study||1
78546|NCT01607450|188110|P4|COMPLETED|Overall Study||11
78547|NCT01607450|188111|P3|COMPLETED|Overall Study||7
78548|NCT01607450|188112|P2|COMPLETED|Overall Study||8
78549|NCT01607450|188113|P1|COMPLETED|Overall Study||6
78550|NCT01607450|188107|P7|STARTED|Overall Study||0
78551|NCT01607450|188108|P6|STARTED|Overall Study||0
78552|NCT01607450|188109|P5|STARTED|Overall Study||1
78553|NCT01607450|188110|P4|STARTED|Overall Study||11
78554|NCT01607450|188111|P3|STARTED|Overall Study||7
78555|NCT01607450|188112|P2|STARTED|Overall Study||8
78556|NCT01607450|188113|P1|STARTED|Overall Study||6
78557|NCT01607411|188157|P4|NOT COMPLETED|Period IV||0
78558|NCT01607411|188158|P3|NOT COMPLETED|Period IV||0
78559|NCT01607411|188159|P2|NOT COMPLETED|Period IV||0
78560|NCT01607411|188160|P1|NOT COMPLETED|Period IV||0
78561|NCT01607411|188157|P4|COMPLETED|Period IV||14
78562|NCT01607411|188158|P3|COMPLETED|Period IV||14
78563|NCT01607411|188159|P2|COMPLETED|Period IV||14
78564|NCT01607411|188160|P1|COMPLETED|Period IV||13
78565|NCT01607411|188157|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
78566|NCT01607411|188158|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
78567|NCT01607411|188159|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
78568|NCT01607411|188160|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
78569|NCT01607411|188157|P4|NOT COMPLETED|Period III||0
78570|NCT01607411|188158|P3|NOT COMPLETED|Period III||0
78571|NCT01607411|188159|P2|NOT COMPLETED|Period III||0
78572|NCT01607411|188160|P1|NOT COMPLETED|Period III||0
78573|NCT01607411|188157|P4|COMPLETED|Period III||13
78574|NCT01607411|188158|P3|COMPLETED|Period III||14
78575|NCT01607411|188159|P2|COMPLETED|Period III||14
78576|NCT01607411|188160|P1|COMPLETED|Period III||14
78577|NCT01607411|188157|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
78578|NCT01607411|188158|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
78579|NCT01607411|188159|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
78580|NCT01607411|188160|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
78581|NCT01607411|188157|P4|NOT COMPLETED|Period II||0
78582|NCT01607411|188158|P3|NOT COMPLETED|Period II||0
78583|NCT01607411|188159|P2|NOT COMPLETED|Period II||0
78584|NCT01607411|188160|P1|NOT COMPLETED|Period II||0
78585|NCT01607411|188157|P4|COMPLETED|Period II||14
78586|NCT01607411|188158|P3|COMPLETED|Period II||13
78587|NCT01607411|188159|P2|COMPLETED|Period II||14
78588|NCT01607411|188160|P1|COMPLETED|Period II||14
78589|NCT01607411|188157|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
78590|NCT01607411|188158|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
78591|NCT01607411|188159|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
78592|NCT01607411|188160|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
78593|NCT01607411|188157|P4|NOT COMPLETED|Period I||0
78594|NCT01607411|188158|P3|NOT COMPLETED|Period I||0
78595|NCT01607411|188159|P2|NOT COMPLETED|Period I||0
78596|NCT01607411|188160|P1|NOT COMPLETED|Period I||0
78597|NCT01607411|188157|P4|COMPLETED|Period I||14
78598|NCT01607411|188158|P3|COMPLETED|Period I||14
78599|NCT01607411|188159|P2|COMPLETED|Period I||13
78600|NCT01607411|188160|P1|COMPLETED|Period I||14
78601|NCT01607411|188157|P4|STARTED|Period I||14
78602|NCT01607411|188158|P3|STARTED|Period I||14
78603|NCT01607411|188159|P2|STARTED|Period I||13
78604|NCT01607411|188160|P1|STARTED|Period I||14
78605|NCT01607398|188183|P2|NOT COMPLETED|Overall Study||2
78606|NCT01607398|188184|P1|NOT COMPLETED|Overall Study||2
78607|NCT01607398|188183|P2|COMPLETED|Overall Study||26
78608|NCT01607398|188184|P1|COMPLETED|Overall Study||26
78609|NCT01607398|188183|P2|STARTED|Overall Study||28
78610|NCT01607398|188184|P1|STARTED|Overall Study||28
78611|NCT01607346|188228|P1|NOT COMPLETED|Overall Study||3
78612|NCT01607346|188228|P1|COMPLETED|Overall Study||7
78613|NCT01607346|188228|P1|STARTED|Overall Study||10
78614|NCT01607320|188244|P2|NOT COMPLETED|Overall Study||0
78615|NCT01607320|188245|P1|NOT COMPLETED|Overall Study||0
78616|NCT01607320|188244|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
78617|NCT01607320|188245|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
78618|NCT01607320|188244|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
78619|NCT01607320|188245|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
78620|NCT01607203|188251|P2|NOT COMPLETED|Overall Study||0
78621|NCT01607203|188252|P1|NOT COMPLETED|Overall Study||0
78622|NCT01607203|188251|P2|COMPLETED|Overall Study||61
78623|NCT01607203|188252|P1|COMPLETED|Overall Study||59
78624|NCT01607203|188251|P2|STARTED|Overall Study||61
78625|NCT01607203|188252|P1|STARTED|Overall Study||59
78626|NCT01607112|188264|P2|NOT COMPLETED|Overall Study||0
78627|NCT01607112|188265|P1|NOT COMPLETED|Overall Study||0
78628|NCT01607112|188264|P2|COMPLETED|Overall Study||59
78629|NCT01607112|188265|P1|COMPLETED|Overall Study||60
78630|NCT01607112|188264|P2|STARTED|Overall Study||59
78631|NCT01607112|188265|P1|STARTED|Overall Study||60
78632|NCT01606852|188301|P2|NOT COMPLETED|Overall Study||0
78633|NCT01606852|188302|P1|NOT COMPLETED|Overall Study||0
78634|NCT01606852|188301|P2|COMPLETED|Overall Study||8
78635|NCT01606852|188302|P1|COMPLETED|Overall Study||7
78636|NCT01606852|188301|P2|STARTED|Overall Study||8
78637|NCT01606852|188302|P1|STARTED|Overall Study||7
78638|NCT01606800|188312|P2|NOT COMPLETED|Overall Study||2
78639|NCT01606800|188313|P1|NOT COMPLETED|Overall Study||5
78640|NCT01606800|188312|P2|COMPLETED|Overall Study||21
78641|NCT01606800|188313|P1|COMPLETED|Overall Study||17
78642|NCT01606800|188312|P2|Treated|Overall Study||23
78643|NCT01606800|188313|P1|Treated|Overall Study||22
78644|NCT01606800|188312|P2|STARTED|Overall Study||23
78645|NCT01606800|188313|P1|STARTED|Overall Study||22
78646|NCT01606761|188322|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
78647|NCT01606761|188323|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
78648|NCT01606761|188324|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
78649|NCT01606761|188325|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
78650|NCT01606761|188326|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
78651|NCT01606761|188322|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
78652|NCT01606761|188323|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
78653|NCT01606761|188324|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
78654|NCT01606761|188325|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
78655|NCT01606761|188326|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
78656|NCT01606761|188322|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
78657|NCT01606761|188323|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
78658|NCT01606761|188324|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
78659|NCT01606761|188325|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
78660|NCT01606761|188326|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
78661|NCT01606761|188322|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
78662|NCT01606761|188323|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
78663|NCT01606761|188324|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
78664|NCT01606761|188325|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
78665|NCT01606761|188326|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
78666|NCT01606761|188322|P5|NOT COMPLETED|Week 24 to Week 52||20
78667|NCT01606761|188323|P4|NOT COMPLETED|Week 24 to Week 52||17
78668|NCT01606761|188324|P3|NOT COMPLETED|Week 24 to Week 52||33
78669|NCT01606761|188325|P2|NOT COMPLETED|Week 24 to Week 52||33
78670|NCT01606761|188326|P1|NOT COMPLETED|Week 24 to Week 52||0
78671|NCT01606761|188322|P5|COMPLETED|Week 24 to Week 52||106
78672|NCT01606761|188323|P4|COMPLETED|Week 24 to Week 52||109
78673|NCT01606761|188324|P3|COMPLETED|Week 24 to Week 52||212
78674|NCT01606761|188325|P2|COMPLETED|Week 24 to Week 52||204
78675|NCT01606761|188326|P1|COMPLETED|Week 24 to Week 52||0
78676|NCT01606761|188322|P5|Treated|Week 24 to Week 52||126
78677|NCT01606761|188323|P4|Treated|Week 24 to Week 52||124
78678|NCT01606761|188324|P3|Treated|Week 24 to Week 52||245
78679|NCT01606761|188325|P2|Treated|Week 24 to Week 52||237
78680|NCT01606761|188326|P1|Treated|Week 24 to Week 52||0
78681|NCT01606761|188322|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
78682|NCT01606761|188323|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
78683|NCT01606761|188324|P3|STARTED|Week 24 to Week 52||245
78684|NCT01606761|188325|P2|STARTED|Week 24 to Week 52||237
78685|NCT01606761|188326|P1|STARTED|Week 24 to Week 52||0
78686|NCT01606761|188322|P5|NOT COMPLETED|Prior to Week 24||0
78687|NCT01606761|188323|P4|NOT COMPLETED|Prior to Week 24||0
78688|NCT01606761|188324|P3|NOT COMPLETED|Prior to Week 24||47
78689|NCT01606761|188325|P2|NOT COMPLETED|Prior to Week 24||55
78690|NCT01606761|188326|P1|NOT COMPLETED|Prior to Week 24||42
78691|NCT01606761|188322|P5|COMPLETED|Prior to Week 24||0
78692|NCT01606761|188323|P4|COMPLETED|Prior to Week 24||0
78693|NCT01606761|188324|P3|COMPLETED|Prior to Week 24||245
78694|NCT01606761|188325|P2|COMPLETED|Prior to Week 24||237
78695|NCT01606761|188326|P1|COMPLETED|Prior to Week 24||252
78696|NCT01606761|188322|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
78697|NCT01606761|188323|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
78698|NCT01606761|188324|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
78699|NCT01606761|188325|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
78700|NCT01606761|188326|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
78701|NCT01606761|188322|P5|STARTED|Prior to Week 24||0
78702|NCT01606761|188323|P4|STARTED|Prior to Week 24||0
78703|NCT01606761|188324|P3|STARTED|Prior to Week 24||292
78704|NCT01606761|188325|P2|STARTED|Prior to Week 24||292
78705|NCT01606761|188326|P1|STARTED|Prior to Week 24||294
78706|NCT01606748|188352|P2|NOT COMPLETED|Overall Study||0
78707|NCT01606748|188353|P1|NOT COMPLETED|Overall Study||3
78708|NCT01606748|188352|P2|COMPLETED|Overall Study||17
78709|NCT01606748|188353|P1|COMPLETED|Overall Study||15
78710|NCT01606748|188352|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
78711|NCT01606748|188353|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
78712|NCT01606748|188352|P2|STARTED|Overall Study||17
78713|NCT01606748|188353|P1|STARTED|Overall Study||18
78714|NCT01606735|188384|P3|NOT COMPLETED|Overall Study||0
78715|NCT01606735|188385|P2|NOT COMPLETED|Overall Study||0
78716|NCT01606735|188386|P1|NOT COMPLETED|Overall Study||0
78717|NCT01606735|188384|P3|COMPLETED|Overall Study||58
78718|NCT01606735|188385|P2|COMPLETED|Overall Study||56
78719|NCT01606735|188386|P1|COMPLETED|Overall Study||58
78720|NCT01606735|188384|P3|STARTED|Overall Study||58
78721|NCT01606735|188385|P2|STARTED|Overall Study||56
78722|NCT01606735|188386|P1|STARTED|Overall Study||58
78723|NCT01606670|188394|P1|NOT COMPLETED|Overall Study||16
78724|NCT01606670|188394|P1|COMPLETED|Overall Study||77
78725|NCT01606670|188394|P1|Full Analysis Set|Overall Study||70
78726|NCT01606670|188394|P1|Safety Set|Overall Study||93
78727|NCT01606670|188394|P1|STARTED|Overall Study||93
78728|NCT01606319|188404|P2|NOT COMPLETED|Overall Study||40
78729|NCT01606319|188405|P1|NOT COMPLETED|Overall Study||34
78730|NCT01606319|188404|P2|COMPLETED|Overall Study||110
78731|NCT01606319|188405|P1|COMPLETED|Overall Study||116
78732|NCT01606319|188404|P2|STARTED|Overall Study||150
78733|NCT01606319|188405|P1|STARTED|Overall Study||150
78734|NCT01606306|188423|P6|NOT COMPLETED|Overall Study||11
78735|NCT01606306|188424|P5|NOT COMPLETED|Overall Study||11
78736|NCT01606306|188425|P4|NOT COMPLETED|Overall Study||13
78737|NCT01606306|188426|P3|NOT COMPLETED|Overall Study||14
78738|NCT01606306|188427|P2|NOT COMPLETED|Overall Study||10
78739|NCT01606306|188428|P1|NOT COMPLETED|Overall Study||15
78740|NCT01606306|188423|P6|COMPLETED|Overall Study||36
78741|NCT01606306|188424|P5|COMPLETED|Overall Study||41
78742|NCT01606306|188425|P4|COMPLETED|Overall Study||38
78743|NCT01606306|188426|P3|COMPLETED|Overall Study||37
78744|NCT01606306|188427|P2|COMPLETED|Overall Study||39
78745|NCT01606306|188428|P1|COMPLETED|Overall Study||35
78746|NCT01606306|188423|P6|Completed Third Treatment Period|Overall Study||36
78747|NCT01606306|188424|P5|Completed Third Treatment Period|Overall Study||41
78748|NCT01606306|188425|P4|Completed Third Treatment Period|Overall Study||38
78749|NCT01606306|188426|P3|Completed Third Treatment Period|Overall Study||37
78750|NCT01606306|188427|P2|Completed Third Treatment Period|Overall Study||39
78751|NCT01606306|188428|P1|Completed Third Treatment Period|Overall Study||35
78752|NCT01606306|188423|P6|Completed Second Treatment Period|Overall Study||41
78753|NCT01606306|188424|P5|Completed Second Treatment Period|Overall Study||46
78754|NCT01606306|188425|P4|Completed Second Treatment Period|Overall Study||44
78755|NCT01606306|188426|P3|Completed Second Treatment Period|Overall Study||43
78756|NCT01606306|188427|P2|Completed Second Treatment Period|Overall Study||38
78757|NCT01606306|188428|P1|Completed Second Treatment Period|Overall Study||41
78758|NCT01606306|188423|P6|Completed First Treatment Period|Overall Study||44
78759|NCT01606306|188424|P5|Completed First Treatment Period|Overall Study||47
78760|NCT01606306|188425|P4|Completed First Treatment Period|Overall Study||45
78761|NCT01606306|188426|P3|Completed First Treatment Period|Overall Study||47
78762|NCT01606306|188427|P2|Completed First Treatment Period|Overall Study||47
78763|NCT01606306|188428|P1|Completed First Treatment Period|Overall Study||43
78764|NCT01606306|188423|P6|STARTED|Overall Study||47
78765|NCT01606306|188424|P5|STARTED|Overall Study||52
78766|NCT01606306|188425|P4|STARTED|Overall Study||51
78767|NCT01606306|188426|P3|STARTED|Overall Study||51
78768|NCT01606306|188427|P2|STARTED|Overall Study||49
78769|NCT01606306|188428|P1|STARTED|Overall Study||50
78770|NCT01606254|188438|P4|NOT COMPLETED|Overall Study||3
78771|NCT01606254|188439|P3|NOT COMPLETED|Overall Study||0
78772|NCT01606254|188440|P2|NOT COMPLETED|Overall Study||4
78773|NCT01606254|188441|P1|NOT COMPLETED|Overall Study||2
78774|NCT01606254|188438|P4|COMPLETED|Overall Study||11
78775|NCT01606254|188439|P3|COMPLETED|Overall Study||14
78776|NCT01606254|188440|P2|COMPLETED|Overall Study||10
78777|NCT01606254|188441|P1|COMPLETED|Overall Study||12
78778|NCT01606254|188438|P4|STARTED|Overall Study||14
78779|NCT01606254|188439|P3|STARTED|Overall Study||14
78780|NCT01606254|188440|P2|STARTED|Overall Study||14
78781|NCT01606254|188441|P1|STARTED|Overall Study||14
78782|NCT01606228|188523|P1|NOT COMPLETED|Overall Study||29
78783|NCT01606228|188523|P1|COMPLETED|Overall Study||159
78784|NCT01606228|188523|P1|STARTED|Overall Study||188
78785|NCT01606202|188540|P2|NOT COMPLETED|Overall Study||3
78786|NCT01606202|188541|P1|NOT COMPLETED|Overall Study||7
78787|NCT01606202|188540|P2|COMPLETED|Overall Study||57
78788|NCT01606202|188541|P1|COMPLETED|Overall Study||49
78789|NCT01606202|188540|P2|STARTED|Overall Study||60
78790|NCT01606202|188541|P1|STARTED|Overall Study||56
78791|NCT01606189|188573|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
78792|NCT01606189|188574|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
78793|NCT01606189|188575|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
78794|NCT01606189|188576|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
78795|NCT01606189|188577|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
78796|NCT01606189|188578|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
78797|NCT01606189|188573|P6|COMPLETED|Third Intenvention (14-20 Days)||6
78798|NCT01606189|188574|P5|COMPLETED|Third Intenvention (14-20 Days)||8
78799|NCT01606189|188575|P4|COMPLETED|Third Intenvention (14-20 Days)||8
78800|NCT01606189|188576|P3|COMPLETED|Third Intenvention (14-20 Days)||8
78801|NCT01606189|188577|P2|COMPLETED|Third Intenvention (14-20 Days)||8
78802|NCT01606189|188578|P1|COMPLETED|Third Intenvention (14-20 Days)||8
78803|NCT01606189|188573|P6|STARTED|Third Intenvention (14-20 Days)||7
78804|NCT01606189|188574|P5|STARTED|Third Intenvention (14-20 Days)||8
78805|NCT01606189|188575|P4|STARTED|Third Intenvention (14-20 Days)||8
78806|NCT01606189|188576|P3|STARTED|Third Intenvention (14-20 Days)||8
78807|NCT01606189|188577|P2|STARTED|Third Intenvention (14-20 Days)||8
78808|NCT01606189|188578|P1|STARTED|Third Intenvention (14-20 Days)||8
78809|NCT01606189|188573|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
78810|NCT01606189|188574|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
78811|NCT01606189|188575|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
78812|NCT01606189|188576|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
78813|NCT01606189|188577|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
78814|NCT01606189|188578|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
78815|NCT01606189|188573|P6|COMPLETED|Second Intenvention (14-20 Days)||7
78816|NCT01606189|188574|P5|COMPLETED|Second Intenvention (14-20 Days)||8
78817|NCT01606189|188575|P4|COMPLETED|Second Intenvention (14-20 Days)||8
78818|NCT01606189|188576|P3|COMPLETED|Second Intenvention (14-20 Days)||8
78819|NCT01606189|188577|P2|COMPLETED|Second Intenvention (14-20 Days)||8
78820|NCT01606189|188578|P1|COMPLETED|Second Intenvention (14-20 Days)||8
78821|NCT01606189|188573|P6|STARTED|Second Intenvention (14-20 Days)||8
78822|NCT01606189|188574|P5|STARTED|Second Intenvention (14-20 Days)||8
78823|NCT01606189|188575|P4|STARTED|Second Intenvention (14-20 Days)||8
78824|NCT01606189|188576|P3|STARTED|Second Intenvention (14-20 Days)||8
78825|NCT01606189|188577|P2|STARTED|Second Intenvention (14-20 Days)||8
78826|NCT01606189|188578|P1|STARTED|Second Intenvention (14-20 Days)||8
78827|NCT01606189|188573|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
78828|NCT01606189|188574|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
78829|NCT01606189|188575|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
78830|NCT01606189|188576|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
78831|NCT01606189|188577|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
78832|NCT01606189|188578|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
78833|NCT01606189|188573|P6|COMPLETED|First Intenvention (14-20 Days)||8
78834|NCT01606189|188574|P5|COMPLETED|First Intenvention (14-20 Days)||8
78835|NCT01606189|188575|P4|COMPLETED|First Intenvention (14-20 Days)||8
78836|NCT01606189|188576|P3|COMPLETED|First Intenvention (14-20 Days)||8
78837|NCT01606189|188577|P2|COMPLETED|First Intenvention (14-20 Days)||8
78838|NCT01606189|188578|P1|COMPLETED|First Intenvention (14-20 Days)||8
78839|NCT01606189|188573|P6|STARTED|First Intenvention (14-20 Days)||8
78840|NCT01606189|188574|P5|STARTED|First Intenvention (14-20 Days)||8
78841|NCT01606189|188575|P4|STARTED|First Intenvention (14-20 Days)||8
78842|NCT01606189|188576|P3|STARTED|First Intenvention (14-20 Days)||8
78843|NCT01606189|188577|P2|STARTED|First Intenvention (14-20 Days)||8
78844|NCT01606189|188578|P1|STARTED|First Intenvention (14-20 Days)||8
78845|NCT01606176|188612|P2|NOT COMPLETED|Overall Study||3
78846|NCT01606176|188613|P1|NOT COMPLETED|Overall Study||4
78847|NCT01606176|188612|P2|COMPLETED|Overall Study||31
78848|NCT01606176|188613|P1|COMPLETED|Overall Study||32
78849|NCT01606176|188612|P2|STARTED|Overall Study||34
78850|NCT01606176|188613|P1|STARTED|Overall Study||36
78851|NCT01606150|188649|P2|NOT COMPLETED|Overall Study||0
78852|NCT01606150|188650|P1|NOT COMPLETED|Overall Study||0
78853|NCT01606150|188649|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
78854|NCT01606150|188650|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
78855|NCT01606150|188649|P2|STARTED|Overall Study||0
78856|NCT01606150|188650|P1|STARTED|Overall Study||0
78857|NCT01606137|188658|P1|NOT COMPLETED|Overall Study||262
78858|NCT01606137|188658|P1|COMPLETED|Overall Study||245
78859|NCT01606137|188658|P1|STARTED|Overall Study||507
78860|NCT01606124|188680|P2|NOT COMPLETED|Overall Study||0
78861|NCT01606124|188681|P1|NOT COMPLETED|Overall Study||0
78862|NCT01606124|188680|P2|COMPLETED|Overall Study||20
78863|NCT01606124|188681|P1|COMPLETED|Overall Study||19
78864|NCT01606124|188680|P2|STARTED|Overall Study||20
78865|NCT01606124|188681|P1|STARTED|Overall Study||19
78866|NCT01606007|188692|P3|NOT COMPLETED|Overall Study||10
78867|NCT01606007|188693|P2|NOT COMPLETED|Overall Study||19
78868|NCT01606007|188694|P1|NOT COMPLETED|Overall Study||15
78869|NCT01606007|188692|P3|COMPLETED|Overall Study||169
78870|NCT01606007|188693|P2|COMPLETED|Overall Study||160
78871|NCT01606007|188694|P1|COMPLETED|Overall Study||161
78872|NCT01606007|188692|P3|STARTED|Overall Study||179
78873|NCT01606007|188693|P2|STARTED|Overall Study||179
78874|NCT01606007|188694|P1|STARTED|Overall Study||176
78875|NCT01605942|188716|P2|NOT COMPLETED|Overall Study||0
78876|NCT01605942|188717|P1|NOT COMPLETED|Overall Study||0
78877|NCT01605942|188716|P2|COMPLETED|Overall Study||2
78878|NCT01605942|188717|P1|COMPLETED|Overall Study||6
78879|NCT01605942|188716|P2|STARTED|Overall Study||2
78880|NCT01605942|188717|P1|STARTED|Overall Study||6
78881|NCT01605916|188729|P5|NOT COMPLETED|Overall Study||6
78882|NCT01605916|188730|P4|NOT COMPLETED|Overall Study||6
78883|NCT01605916|188731|P3|NOT COMPLETED|Overall Study||3
78884|NCT01605916|188732|P2|NOT COMPLETED|Overall Study||4
78885|NCT01605916|188733|P1|NOT COMPLETED|Overall Study||4
78886|NCT01605916|188729|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
78887|NCT01605916|188730|P4|COMPLETED|Overall Study||0
78888|NCT01605916|188731|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
78889|NCT01605916|188732|P2|COMPLETED|Overall Study||0
78890|NCT01605916|188733|P1|COMPLETED|Overall Study||0
78891|NCT01605916|188729|P5|STARTED|Overall Study||7
78892|NCT01605916|188730|P4|STARTED|Overall Study||6
78893|NCT01605916|188731|P3|STARTED|Overall Study||4
78894|NCT01605916|188732|P2|STARTED|Overall Study||4
78895|NCT01605916|188733|P1|STARTED|Overall Study||4
78896|NCT01605903|188808|P2|NOT COMPLETED|Overall Study||0
78897|NCT01605903|188809|P1|NOT COMPLETED|Overall Study||0
78898|NCT01605903|188808|P2|COMPLETED|Overall Study||343
78899|NCT01605903|188809|P1|COMPLETED|Overall Study||345
78900|NCT01605903|188808|P2|STARTED|Overall Study||343
78901|NCT01605903|188809|P1|STARTED|Overall Study||345
78902|NCT01605877|188815|P1|NOT COMPLETED|Overall Study||1
78903|NCT01605877|188815|P1|COMPLETED|Overall Study||63
78904|NCT01605877|188815|P1|STARTED|Overall Study||64
78905|NCT01605825|188879|P2|NOT COMPLETED|Overall Study||3
78906|NCT01605825|188880|P1|NOT COMPLETED|Overall Study||10
78907|NCT01605825|188879|P2|COMPLETED|Overall Study||25
78908|NCT01605825|188880|P1|COMPLETED|Overall Study||45
78909|NCT01605825|188879|P2|STARTED|Overall Study||28
78910|NCT01605825|188880|P1|STARTED|Overall Study||55
78911|NCT01605799|188888|P2|NOT COMPLETED|Overall Study||1
78912|NCT01605799|188889|P1|NOT COMPLETED|Overall Study||2
78913|NCT01605799|188888|P2|COMPLETED|Overall Study||15
78914|NCT01605799|188889|P1|COMPLETED|Overall Study||15
78915|NCT01605799|188888|P2|STARTED|Overall Study||16
78916|NCT01605799|188889|P1|STARTED|Overall Study||17
78917|NCT01605669|188897|P1|NOT COMPLETED|Overall Study||0
78918|NCT01605669|188897|P1|COMPLETED|Overall Study||50
78919|NCT01605669|188897|P1|STARTED|Overall Study||50
78920|NCT01605617|188904|P2|NOT COMPLETED|Second Intervention||0
78921|NCT01605617|188905|P1|NOT COMPLETED|Second Intervention||0
78922|NCT01605617|188904|P2|COMPLETED|Second Intervention||0
78923|NCT01605617|188905|P1|COMPLETED|Second Intervention||0
78924|NCT01605617|188904|P2|STARTED|Second Intervention||0
78925|NCT01605617|188905|P1|STARTED|Second Intervention||0
78926|NCT01605617|188904|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
78927|NCT01605617|188905|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
78928|NCT01605617|188904|P2|COMPLETED|Washout Period of 4 Weeks||0
78929|NCT01605617|188905|P1|COMPLETED|Washout Period of 4 Weeks||0
78930|NCT01605617|188904|P2|STARTED|Washout Period of 4 Weeks||1
78931|NCT01605617|188905|P1|STARTED|Washout Period of 4 Weeks||2
78932|NCT01605617|188904|P2|NOT COMPLETED|First Intervention||1
78933|NCT01605617|188905|P1|NOT COMPLETED|First Intervention||0
78934|NCT01605617|188904|P2|COMPLETED|First Intervention||1
78935|NCT01605617|188905|P1|COMPLETED|First Intervention||2
78936|NCT01605617|188904|P2|STARTED|First Intervention||2
78937|NCT01605617|188905|P1|STARTED|First Intervention||2
78938|NCT01605552|188925|P2|NOT COMPLETED|Overall Study||2
78939|NCT01605552|188926|P1|NOT COMPLETED|Overall Study||6
78940|NCT01605552|188925|P2|COMPLETED|Overall Study||14
78941|NCT01605552|188926|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
78942|NCT01605552|188925|P2|STARTED|Overall Study||16
78943|NCT01605552|188926|P1|STARTED|Overall Study||13
78944|NCT01605539|188940|P3|NOT COMPLETED|Overall Study||0
78945|NCT01605539|188941|P2|NOT COMPLETED|Overall Study||1
78946|NCT01605539|188942|P1|NOT COMPLETED|Overall Study||0
78947|NCT01605539|188940|P3|COMPLETED|Overall Study||4
78948|NCT01605539|188941|P2|COMPLETED|Overall Study||2
78949|NCT01605539|188942|P1|COMPLETED|Overall Study||3
78950|NCT01605539|188940|P3|STARTED|Overall Study||4
78951|NCT01605539|188941|P2|STARTED|Overall Study||3
78952|NCT01605539|188942|P1|STARTED|Overall Study||3
78953|NCT01605461|188964|P1|NOT COMPLETED|Overall Study||4
78954|NCT01605461|188964|P1|COMPLETED|Overall Study||8
78955|NCT01605461|188964|P1|STARTED|Overall Study||12
78956|NCT01605370|188975|P2|NOT COMPLETED|Overall Study||0
78957|NCT01605370|188976|P1|NOT COMPLETED|Overall Study||1
78958|NCT01605370|188975|P2|COMPLETED|Overall Study||0
78959|NCT01605370|188976|P1|COMPLETED|Overall Study||0
78960|NCT01605370|188975|P2|STARTED|Overall Study||0
78961|NCT01605370|188976|P1|STARTED|Overall Study||1
78962|NCT01605292|188984|P2|NOT COMPLETED|Overall Study||0
78963|NCT01605292|188985|P1|NOT COMPLETED|Overall Study||0
78964|NCT01605292|188984|P2|COMPLETED|Overall Study||347
78965|NCT01605292|188985|P1|COMPLETED|Overall Study||351
78966|NCT01605292|188984|P2|STARTED|Overall Study||347
78967|NCT01605292|188985|P1|STARTED|Overall Study||351
78968|NCT01605227|189011|P2|NOT COMPLETED|Overall Study||329
78969|NCT01605227|189012|P1|NOT COMPLETED|Overall Study||621
78970|NCT01605227|189011|P2|COMPLETED|Overall Study||17
78971|NCT01605227|189012|P1|COMPLETED|Overall Study||61
78972|NCT01605227|189011|P2|STARTED|Overall Study||346
78973|NCT01605227|189012|P1|STARTED|Overall Study||682
78974|NCT01604941|189024|P6|NOT COMPLETED|Overall Study||7
78975|NCT01604941|189025|P5|NOT COMPLETED|Overall Study||1
78976|NCT01604941|189026|P4|NOT COMPLETED|Overall Study||3
78977|NCT01604941|189027|P3|NOT COMPLETED|Overall Study||3
78978|NCT01604941|189028|P2|NOT COMPLETED|Overall Study||4
78979|NCT01604941|189029|P1|NOT COMPLETED|Overall Study||11
78980|NCT01604941|189024|P6|COMPLETED|Overall Study||0
78981|NCT01604941|189025|P5|COMPLETED|Overall Study||3
78982|NCT01604941|189026|P4|COMPLETED|Overall Study||0
78983|NCT01604941|189027|P3|COMPLETED|Overall Study||0
78984|NCT01604941|189028|P2|COMPLETED|Overall Study||0
78985|NCT01604941|189029|P1|COMPLETED|Overall Study||0
78986|NCT01604941|189024|P6|STARTED|Overall Study||7
78987|NCT01604941|189025|P5|STARTED|Overall Study||4
78988|NCT01604941|189026|P4|STARTED|Overall Study||3
78989|NCT01604941|189027|P3|STARTED|Overall Study||3
78990|NCT01604941|189028|P2|STARTED|Overall Study||4
78991|NCT01604941|189029|P1|STARTED|Overall Study||11
78992|NCT01604850|189057|P2|NOT COMPLETED|Overall Study||30
78993|NCT01604850|189058|P1|NOT COMPLETED|Overall Study||52
78994|NCT01604850|189057|P2|COMPLETED|Overall Study||69
78995|NCT01604850|189058|P1|COMPLETED|Overall Study||51
78996|NCT01604850|189057|P2|Enrolled and Treated|Overall Study||98
78997|NCT01604850|189058|P1|Enrolled and Treated|Overall Study||103
78998|NCT01604850|189057|P2|STARTED|Overall Study||99
78999|NCT01604850|189058|P1|STARTED|Overall Study||103
79000|NCT01604772|189074|P1|NOT COMPLETED|Overall Study||0
79001|NCT01604772|189074|P1|COMPLETED|Overall Study||16
79002|NCT01604772|189074|P1|STARTED|Overall Study||16
79003|NCT01604408|189082|P2|NOT COMPLETED|Observation Period||3
79004|NCT01604408|189083|P1|NOT COMPLETED|Observation Period||1
79005|NCT01604408|189082|P2|COMPLETED|Observation Period||84
79006|NCT01604408|189083|P1|COMPLETED|Observation Period||85
79007|NCT01604408|189082|P2|STARTED|Observation Period||87
79008|NCT01604408|189083|P1|STARTED|Observation Period||86
79009|NCT01604408|189082|P2|NOT COMPLETED|Treatment Period 6||2
79010|NCT01604408|189083|P1|NOT COMPLETED|Treatment Period 6||2
79011|NCT01604408|189082|P2|COMPLETED|Treatment Period 6||87
79012|NCT01604408|189083|P1|COMPLETED|Treatment Period 6||86
79013|NCT01604408|189082|P2|STARTED|Treatment Period 6||89
79014|NCT01604408|189083|P1|STARTED|Treatment Period 6||88
79015|NCT01604408|189082|P2|NOT COMPLETED|Treatment Period 5||0
79016|NCT01604408|189083|P1|NOT COMPLETED|Treatment Period 5||4
79017|NCT01604408|189082|P2|COMPLETED|Treatment Period 5||89
79018|NCT01604408|189083|P1|COMPLETED|Treatment Period 5||88
79019|NCT01604408|189082|P2|STARTED|Treatment Period 5||89
79020|NCT01604408|189083|P1|STARTED|Treatment Period 5||92
79021|NCT01604408|189082|P2|NOT COMPLETED|Treatment Period 4||2
79022|NCT01604408|189083|P1|NOT COMPLETED|Treatment Period 4||3
79023|NCT01604408|189082|P2|COMPLETED|Treatment Period 4||89
79024|NCT01604408|189083|P1|COMPLETED|Treatment Period 4||92
79025|NCT01604408|189082|P2|STARTED|Treatment Period 4||91
79026|NCT01604408|189083|P1|STARTED|Treatment Period 4||95
79027|NCT01604408|189082|P2|NOT COMPLETED|Treatment Period 3||5
79028|NCT01604408|189083|P1|NOT COMPLETED|Treatment Period 3||5
79029|NCT01604408|189082|P2|COMPLETED|Treatment Period 3||91
79030|NCT01604408|189083|P1|COMPLETED|Treatment Period 3||95
79031|NCT01604408|189082|P2|STARTED|Treatment Period 3||96
79032|NCT01604408|189083|P1|STARTED|Treatment Period 3||100
79033|NCT01604408|189082|P2|NOT COMPLETED|Treatment Period 2||2
79034|NCT01604408|189083|P1|NOT COMPLETED|Treatment Period 2||2
79035|NCT01604408|189082|P2|COMPLETED|Treatment Period 2||96
79036|NCT01604408|189083|P1|COMPLETED|Treatment Period 2||100
79037|NCT01604408|189082|P2|STARTED|Treatment Period 2||98
79038|NCT01604408|189083|P1|STARTED|Treatment Period 2||102
79039|NCT01604408|189082|P2|NOT COMPLETED|Treatment Period 1||1
79040|NCT01604408|189083|P1|NOT COMPLETED|Treatment Period 1||0
79041|NCT01604408|189082|P2|COMPLETED|Treatment Period 1||98
79042|NCT01604408|189083|P1|COMPLETED|Treatment Period 1||102
79043|NCT01604408|189082|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
79044|NCT01604408|189083|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
79045|NCT01604408|189082|P2|STARTED|Treatment Period 1||99
79046|NCT01604408|189083|P1|STARTED|Treatment Period 1||102
79047|NCT01604343|189098|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
79048|NCT01604343|189099|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
79049|NCT01604343|189100|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
79050|NCT01604343|189101|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
79051|NCT01604343|189102|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
79052|NCT01604343|189098|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
79053|NCT01604343|189099|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
79054|NCT01604343|189100|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
79055|NCT01604343|189101|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
79056|NCT01604343|189102|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
79057|NCT01604343|189098|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
79058|NCT01604343|189099|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
79059|NCT01604343|189100|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
79060|NCT01604343|189101|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
79061|NCT01604343|189102|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
79062|NCT01604343|189098|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
79063|NCT01604343|189099|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
79064|NCT01604343|189100|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
79065|NCT01604343|189101|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
79066|NCT01604343|189102|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
79067|NCT01604343|189098|P5|NOT COMPLETED|Week 52 to Week 104||41
79068|NCT01604343|189099|P4|NOT COMPLETED|Week 52 to Week 104||46
79069|NCT01604343|189100|P3|NOT COMPLETED|Week 52 to Week 104||67
79070|NCT01604343|189101|P2|NOT COMPLETED|Week 52 to Week 104||43
79071|NCT01604343|189102|P1|NOT COMPLETED|Week 52 to Week 104||0
79072|NCT01604343|189098|P5|COMPLETED|Week 52 to Week 104||429
79073|NCT01604343|189099|P4|COMPLETED|Week 52 to Week 104||195
79074|NCT01604343|189100|P3|COMPLETED|Week 52 to Week 104||414
79075|NCT01604343|189101|P2|COMPLETED|Week 52 to Week 104||200
79076|NCT01604343|189102|P1|COMPLETED|Week 52 to Week 104||0
79077|NCT01604343|189098|P5|Treated|Week 52 to Week 104||470
79078|NCT01604343|189099|P4|Treated|Week 52 to Week 104||241
79079|NCT01604343|189100|P3|Treated|Week 52 to Week 104||481
79080|NCT01604343|189101|P2|Treated|Week 52 to Week 104||242
79081|NCT01604343|189102|P1|Treated|Week 52 to Week 104||0
79082|NCT01604343|189098|P5|STARTED|Week 52 to Week 104||470
79083|NCT01604343|189099|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
79084|NCT01604343|189100|P3|STARTED|Week 52 to Week 104||481
79085|NCT01604343|189101|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
79086|NCT01604343|189102|P1|STARTED|Week 52 to Week 104||0
79087|NCT01604343|189098|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
79088|NCT01604343|189099|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
79089|NCT01604343|189100|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
79090|NCT01604343|189101|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
79091|NCT01604343|189102|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
79092|NCT01604343|189098|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
79093|NCT01604343|189099|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
79094|NCT01604343|189100|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
79095|NCT01604343|189101|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
79096|NCT01604343|189102|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
79097|NCT01604343|189098|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
79098|NCT01604343|189099|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
79099|NCT01604343|189100|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
79100|NCT01604343|189101|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
79101|NCT01604343|189102|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
79102|NCT01604343|189098|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
79103|NCT01604343|189099|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
79104|NCT01604343|189100|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
79105|NCT01604343|189101|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
79106|NCT01604343|189102|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
79107|NCT01604343|189098|P5|STARTED|Prior to W52 Administration(Through W52)||557
79108|NCT01604343|189099|P4|STARTED|Prior to W52 Administration(Through W52)||0
79109|NCT01604343|189100|P3|STARTED|Prior to W52 Administration(Through W52)||557
79110|NCT01604343|189101|P2|STARTED|Prior to W52 Administration(Through W52)||0
79111|NCT01604343|189102|P1|STARTED|Prior to W52 Administration(Through W52)||556
79112|NCT01604278|189213|P2|NOT COMPLETED|Overall Study||13
79113|NCT01604278|189214|P1|NOT COMPLETED|Overall Study||14
79114|NCT01604278|189213|P2|COMPLETED|Overall Study||210
79115|NCT01604278|189214|P1|COMPLETED|Overall Study||212
79116|NCT01604278|189213|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
79117|NCT01604278|189214|P1|Full Analysis Set|Overall Study||226
79118|NCT01604278|189213|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
79119|NCT01604278|189214|P1|Safety Set|Overall Study||226
79120|NCT01604278|189213|P2|STARTED|Overall Study||223
79121|NCT01604278|189214|P1|STARTED|Overall Study||226
79122|NCT01604265|189240|P2|NOT COMPLETED|Overall Study||0
79123|NCT01604265|189241|P1|NOT COMPLETED|Overall Study||2
79124|NCT01604265|189240|P2|COMPLETED|Overall Study||32
79125|NCT01604265|189241|P1|COMPLETED|Overall Study||32
79126|NCT01604265|189240|P2|STARTED|Overall Study||32
79127|NCT01604265|189241|P1|STARTED|Overall Study||34
79128|NCT01604122|189277|P2|NOT COMPLETED|Overall Study||0
79129|NCT01604122|189278|P1|NOT COMPLETED|Overall Study||0
79130|NCT01604122|189277|P2|COMPLETED|Overall Study||32
79131|NCT01604122|189278|P1|COMPLETED|Overall Study||60
79132|NCT01604122|189277|P2|STARTED|Overall Study||32
79133|NCT01604122|189278|P1|STARTED|Overall Study||60
79134|NCT01604109|189325|P2|NOT COMPLETED|Overall Study||34
79135|NCT01604109|189326|P1|NOT COMPLETED|Overall Study||33
79136|NCT01604109|189325|P2|COMPLETED|Overall Study||112
79137|NCT01604109|189326|P1|COMPLETED|Overall Study||117
79138|NCT01604109|189325|P2|STARTED|Overall Study||146
79139|NCT01604109|189326|P1|STARTED|Overall Study||150
79140|NCT01603940|189334|P2|NOT COMPLETED|Overall Study||0
79141|NCT01603940|189335|P1|NOT COMPLETED|Overall Study||0
79142|NCT01603940|189334|P2|COMPLETED|Overall Study||14
79143|NCT01603940|189335|P1|COMPLETED|Overall Study||16
79144|NCT01603940|189334|P2|STARTED|Overall Study||14
79145|NCT01603940|189335|P1|STARTED|Overall Study||16
79146|NCT01603875|189352|P3|NOT COMPLETED|Overall Study||9
79147|NCT01603875|189353|P2|NOT COMPLETED|Overall Study||8
79148|NCT01603875|189354|P1|NOT COMPLETED|Overall Study||7
79149|NCT01603875|189352|P3|COMPLETED|Overall Study||26
79150|NCT01603875|189353|P2|COMPLETED|Overall Study||27
79151|NCT01603875|189354|P1|COMPLETED|Overall Study||28
79152|NCT01603875|189352|P3|STARTED|Overall Study||35
79153|NCT01603875|189353|P2|STARTED|Overall Study||35
79154|NCT01603875|189354|P1|STARTED|Overall Study||35
79155|NCT01603459|189374|P1|NOT COMPLETED|Overall Study||18
79156|NCT01603459|189374|P1|COMPLETED|Overall Study||137
79157|NCT01603459|189374|P1|STARTED|Overall Study||155
79158|NCT01603420|189496|P2|NOT COMPLETED|Overall Study||0
79159|NCT01603420|189497|P1|NOT COMPLETED|Overall Study||0
79160|NCT01603420|189496|P2|COMPLETED|Overall Study||1
79161|NCT01603420|189497|P1|COMPLETED|Overall Study||1
79162|NCT01603420|189496|P2|STARTED|Overall Study||1
79163|NCT01603420|189497|P1|STARTED|Overall Study||1
79164|NCT01603394|189525|P1|NOT COMPLETED|Overall Study||1
79165|NCT01603394|189525|P1|COMPLETED|Overall Study||8
79166|NCT01603394|189525|P1|STARTED|Overall Study||9
79167|NCT01603277|189542|P2|NOT COMPLETED|Overall Study||18
79168|NCT01603277|189543|P1|NOT COMPLETED|Overall Study||14
79169|NCT01603277|189542|P2|COMPLETED|Overall Study||64
79170|NCT01603277|189543|P1|COMPLETED|Overall Study||64
79171|NCT01603277|189542|P2|STARTED|Overall Study||82
79172|NCT01603277|189543|P1|STARTED|Overall Study||78
79173|NCT01603121|189549|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
79174|NCT01603121|189550|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
79175|NCT01603121|189549|P2|COMPLETED|Second Intervention, 10 Hours||0
79176|NCT01603121|189550|P1|COMPLETED|Second Intervention, 10 Hours||0
79177|NCT01603121|189549|P2|STARTED|Second Intervention, 10 Hours||0
79178|NCT01603121|189550|P1|STARTED|Second Intervention, 10 Hours||1
79179|NCT01603121|189549|P2|NOT COMPLETED|First Intervention, 10 Hours||0
79180|NCT01603121|189550|P1|NOT COMPLETED|First Intervention, 10 Hours||0
79181|NCT01603121|189549|P2|COMPLETED|First Intervention, 10 Hours||0
79182|NCT01603121|189550|P1|COMPLETED|First Intervention, 10 Hours||1
79183|NCT01603121|189549|P2|STARTED|First Intervention, 10 Hours||0
79184|NCT01603121|189550|P1|STARTED|First Intervention, 10 Hours||1
79185|NCT01603082|189562|P2|NOT COMPLETED|Overall Study||1
79186|NCT01603082|189563|P1|NOT COMPLETED|Overall Study||2
79187|NCT01603082|189562|P2|COMPLETED|Overall Study|Completed the study|48
79188|NCT01603082|189563|P1|COMPLETED|Overall Study|Completed the study.|49
79189|NCT01603082|189562|P2|STARTED|Overall Study|Randomized|49
79190|NCT01603082|189563|P1|STARTED|Overall Study|Randomized|51
79191|NCT01603056|189573|P2|NOT COMPLETED|Overall Study||14
79192|NCT01603056|189574|P1|NOT COMPLETED|Overall Study||34
79193|NCT01603056|189573|P2|COMPLETED|Overall Study||190
79194|NCT01603056|189574|P1|COMPLETED|Overall Study||379
79195|NCT01603056|189573|P2|STARTED|Overall Study||204
79196|NCT01603056|189574|P1|STARTED|Overall Study||413
79197|NCT01603043|189604|P2|NOT COMPLETED|Overall Study||3
79198|NCT01603043|189605|P1|NOT COMPLETED|Overall Study||7
79199|NCT01603043|189604|P2|COMPLETED|Overall Study||0
79200|NCT01603043|189605|P1|COMPLETED|Overall Study||0
79201|NCT01603043|189604|P2|STARTED|Overall Study||3
79202|NCT01603043|189605|P1|STARTED|Overall Study||7
79203|NCT01602965|189617|P2|NOT COMPLETED|Overall Study||2
79204|NCT01602965|189618|P1|NOT COMPLETED|Overall Study||4
79205|NCT01602965|189617|P2|COMPLETED|Overall Study||18
79206|NCT01602965|189618|P1|COMPLETED|Overall Study||16
79207|NCT01602965|189617|P2|STARTED|Overall Study||20
79208|NCT01602965|189618|P1|STARTED|Overall Study||20
79209|NCT01602744|189626|P2|NOT COMPLETED|Overall Study||23
79210|NCT01602744|189627|P1|NOT COMPLETED|Overall Study||30
79211|NCT01602744|189626|P2|COMPLETED|Overall Study||160
79212|NCT01602744|189627|P1|COMPLETED|Overall Study||146
79213|NCT01602744|189626|P2|STARTED|Overall Study||183
79214|NCT01602744|189627|P1|STARTED|Overall Study||176
79215|NCT01602731|189643|P1|NOT COMPLETED|Overall Study||30
79216|NCT01602731|189643|P1|COMPLETED|Overall Study||15
79217|NCT01602731|189643|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
79218|NCT01602731|189643|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
79219|NCT01602731|189643|P1|STARTED|Overall Study||45
79220|NCT01602562|189651|P2|NOT COMPLETED|Overall Study||3
79221|NCT01602562|189652|P1|NOT COMPLETED|Overall Study||5
79222|NCT01602562|189651|P2|COMPLETED|Overall Study||16
79223|NCT01602562|189652|P1|COMPLETED|Overall Study||16
79224|NCT01602562|189651|P2|STARTED|Overall Study||19
79225|NCT01602562|189652|P1|STARTED|Overall Study||21
79226|NCT01602549|189688|P2|NOT COMPLETED|Overall Study||1
79227|NCT01602549|189689|P1|NOT COMPLETED|Overall Study||1
79228|NCT01602549|189688|P2|COMPLETED|Overall Study||37
79229|NCT01602549|189689|P1|COMPLETED|Overall Study||18
79230|NCT01602549|189688|P2|STARTED|Overall Study||38
79231|NCT01602549|189689|P1|STARTED|Overall Study||19
79232|NCT01602510|189768|P3|NOT COMPLETED|Randomized Phase||73
79233|NCT01602510|189769|P2|NOT COMPLETED|Randomized Phase||74
79234|NCT01602510|189770|P1|NOT COMPLETED|Randomized Phase||0
79235|NCT01602510|189768|P3|COMPLETED|Randomized Phase||58
79236|NCT01602510|189769|P2|COMPLETED|Randomized Phase||59
79237|NCT01602510|189770|P1|COMPLETED|Randomized Phase||0
79238|NCT01602510|189768|P3|STARTED|Randomized Phase||131
79239|NCT01602510|189769|P2|STARTED|Randomized Phase||133
79240|NCT01602510|189770|P1|STARTED|Randomized Phase||0
79241|NCT01602510|189768|P3|NOT COMPLETED|Open Label Phase||0
79242|NCT01602510|189769|P2|NOT COMPLETED|Open Label Phase||0
79243|NCT01602510|189770|P1|NOT COMPLETED|Open Label Phase||303
79244|NCT01602510|189768|P3|COMPLETED|Open Label Phase||0
79245|NCT01602510|189769|P2|COMPLETED|Open Label Phase||0
79246|NCT01602510|189770|P1|COMPLETED|Open Label Phase||117
79247|NCT01602510|189768|P3|STARTED|Open Label Phase||0
79248|NCT01602510|189769|P2|STARTED|Open Label Phase||0
79249|NCT01602510|189770|P1|STARTED|Open Label Phase||420
79250|NCT01602484|189796|P2|NOT COMPLETED|Overall Study||1
79251|NCT01602484|189797|P1|NOT COMPLETED|Overall Study||0
79252|NCT01602484|189796|P2|COMPLETED|Overall Study||24
79253|NCT01602484|189797|P1|COMPLETED|Overall Study||25
79254|NCT01602484|189796|P2|STARTED|Overall Study||25
79255|NCT01602484|189797|P1|STARTED|Overall Study||25
79256|NCT01602471|189809|P1|NOT COMPLETED|Overall Study||0
79257|NCT01602471|189809|P1|COMPLETED|Overall Study||4
79258|NCT01602471|189809|P1|STARTED|Overall Study||4
79259|NCT01602380|189815|P2|NOT COMPLETED|Overall Study||101
79260|NCT01602380|189816|P1|NOT COMPLETED|Overall Study||93
79261|NCT01602380|189815|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
79262|NCT01602380|189816|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
79263|NCT01602380|189815|P2|STARTED|Overall Study||232
79264|NCT01602380|189816|P1|STARTED|Overall Study||230
79265|NCT01602341|189840|P2|NOT COMPLETED|Overall Study||1
79266|NCT01602341|189841|P1|NOT COMPLETED|Overall Study||0
79267|NCT01602341|189840|P2|COMPLETED|Overall Study||41
79268|NCT01602341|189841|P1|COMPLETED|Overall Study||44
79269|NCT01602341|189840|P2|STARTED|Overall Study||42
79270|NCT01602341|189841|P1|STARTED|Overall Study||44
79271|NCT01602315|189882|P7|NOT COMPLETED|Overall Study||29
79272|NCT01602315|189883|P6|NOT COMPLETED|Overall Study||35
79273|NCT01602315|189884|P5|NOT COMPLETED|Overall Study||71
79274|NCT01602315|189885|P4|NOT COMPLETED|Overall Study||6
79275|NCT01602315|189886|P3|NOT COMPLETED|Overall Study||18
79276|NCT01602315|189887|P2|NOT COMPLETED|Overall Study||5
79277|NCT01602315|189888|P1|NOT COMPLETED|Overall Study||16
79278|NCT01602315|189882|P7|COMPLETED|Overall Study||0
79279|NCT01602315|189883|P6|COMPLETED|Overall Study||0
79280|NCT01602315|189884|P5|COMPLETED|Overall Study||0
79281|NCT01602315|189885|P4|COMPLETED|Overall Study||0
79282|NCT01602315|189886|P3|COMPLETED|Overall Study||0
79283|NCT01602315|189887|P2|COMPLETED|Overall Study||0
79284|NCT01602315|189888|P1|COMPLETED|Overall Study||0
79285|NCT01602315|189882|P7|STARTED|Overall Study||29
79286|NCT01602315|189883|P6|STARTED|Overall Study||35
79287|NCT01602315|189884|P5|STARTED|Overall Study||71
79288|NCT01602315|189885|P4|STARTED|Overall Study||6
79289|NCT01602315|189886|P3|STARTED|Overall Study||18
79290|NCT01602315|189887|P2|STARTED|Overall Study||5
79291|NCT01602315|189888|P1|STARTED|Overall Study||16
79292|NCT01602198|189976|P2|NOT COMPLETED|Overall Study||0
79293|NCT01602198|189977|P1|NOT COMPLETED|Overall Study||0
79294|NCT01602198|189976|P2|COMPLETED|Overall Study||1
79295|NCT01602198|189977|P1|COMPLETED|Overall Study||0
79296|NCT01602198|189976|P2|STARTED|Overall Study||1
79297|NCT01602198|189977|P1|STARTED|Overall Study||0
79298|NCT01602068|189985|P2|NOT COMPLETED|Overall Study||0
79299|NCT01602068|189986|P1|NOT COMPLETED|Overall Study||0
79300|NCT01602068|189985|P2|COMPLETED|Overall Study||22
79301|NCT01602068|189986|P1|COMPLETED|Overall Study||23
79302|NCT01602068|189985|P2|STARTED|Overall Study|Day before surgery|22
79303|NCT01602068|189986|P1|STARTED|Overall Study|Day before surgery|23
79304|NCT01602016|189992|P1|NOT COMPLETED|Overall Study||0
79305|NCT01602016|189992|P1|COMPLETED|Overall Study||0
79306|NCT01602016|189992|P1|STARTED|Overall Study||0
79307|NCT01601977|189999|P1|NOT COMPLETED|Overall Study||0
79308|NCT01601977|189999|P1|COMPLETED|Overall Study||10
79309|NCT01601977|189999|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
79310|NCT01601821|190019|P2|NOT COMPLETED|Overall Study||29
79311|NCT01601821|190020|P1|NOT COMPLETED|Overall Study||29
79312|NCT01601821|190019|P2|COMPLETED|Overall Study||91
79313|NCT01601821|190020|P1|COMPLETED|Overall Study||96
79314|NCT01601821|190019|P2|STARTED|Overall Study||120
79315|NCT01601821|190020|P1|STARTED|Overall Study||125
79316|NCT01601782|190050|P1|NOT COMPLETED|Overall Study||0
79317|NCT01601782|190050|P1|COMPLETED|Overall Study||16
79318|NCT01601782|190050|P1|STARTED|Overall Study||16
79319|NCT01601704|190056|P2|NOT COMPLETED|Overall Study||4
79320|NCT01601704|190057|P1|NOT COMPLETED|Overall Study||1
79321|NCT01601704|190056|P2|COMPLETED|Overall Study||4450
79322|NCT01601704|190057|P1|COMPLETED|Overall Study||4455
79323|NCT01601704|190056|P2|Treated|Overall Study||4450
79324|NCT01601704|190057|P1|Treated|Overall Study||4455
79325|NCT01601704|190056|P2|STARTED|Overall Study||4454
79326|NCT01601704|190057|P1|STARTED|Overall Study||4456
79327|NCT01601691|190071|P1|NOT COMPLETED|Overall Study||0
79328|NCT01601691|190071|P1|COMPLETED|Overall Study||10
79329|NCT01601691|190071|P1|STARTED|Overall Study||10
79330|NCT01601626|190078|P3|NOT COMPLETED|Overall Study||2
79331|NCT01601626|190079|P2|NOT COMPLETED|Overall Study||5
79332|NCT01601626|190080|P1|NOT COMPLETED|Overall Study||3
79333|NCT01601626|190078|P3|COMPLETED|Overall Study||21
79334|NCT01601626|190079|P2|COMPLETED|Overall Study||19
79335|NCT01601626|190080|P1|COMPLETED|Overall Study||21
79336|NCT01601626|190078|P3|STARTED|Overall Study||23
79337|NCT01601626|190079|P2|STARTED|Overall Study||24
79338|NCT01601626|190080|P1|STARTED|Overall Study||24
79339|NCT01601470|190163|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
79340|NCT01601470|190163|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
79341|NCT01601470|190163|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
79342|NCT01601470|190163|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
79343|NCT01601470|190163|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
79344|NCT01601470|190163|P1|NOT COMPLETED|Period 2 - LCZ696||1
79345|NCT01601470|190163|P1|COMPLETED|Period 2 - LCZ696||27
79346|NCT01601470|190163|P1|Safety Set|Period 2 - LCZ696||27
79347|NCT01601470|190163|P1|PK Analysis Set|Period 2 - LCZ696||27
79348|NCT01601470|190163|P1|STARTED|Period 2 - LCZ696||28
79349|NCT01601470|190163|P1|NOT COMPLETED|Period 1 - Sildenafil||0
79350|NCT01601470|190163|P1|COMPLETED|Period 1 - Sildenafil||28
79351|NCT01601470|190163|P1|Safety Set|Period 1 - Sildenafil||28
79352|NCT01601470|190163|P1|PK Analysis Set|Period 1 - Sildenafil||28
79353|NCT01601470|190163|P1|STARTED|Period 1 - Sildenafil||28
79354|NCT01601236|190184|P6|NOT COMPLETED|Overall Study||1
79355|NCT01601236|190185|P5|NOT COMPLETED|Overall Study||3
79356|NCT01601236|190186|P4|NOT COMPLETED|Overall Study||2
79357|NCT01601236|190187|P3|NOT COMPLETED|Overall Study||6
79358|NCT01601236|190188|P2|NOT COMPLETED|Overall Study||1
79359|NCT01601236|190189|P1|NOT COMPLETED|Overall Study||5
79360|NCT01601236|190184|P6|COMPLETED|Overall Study||0
79361|NCT01601236|190185|P5|COMPLETED|Overall Study||0
79362|NCT01601236|190186|P4|COMPLETED|Overall Study||4
79363|NCT01601236|190187|P3|COMPLETED|Overall Study||8
79364|NCT01601236|190188|P2|COMPLETED|Overall Study||2
79365|NCT01601236|190189|P1|COMPLETED|Overall Study||2
79366|NCT01601236|190184|P6|STARTED|Overall Study||1
79367|NCT01601236|190185|P5|STARTED|Overall Study||3
79368|NCT01601236|190186|P4|STARTED|Overall Study||6
79369|NCT01601236|190187|P3|STARTED|Overall Study||14
79370|NCT01601236|190188|P2|STARTED|Overall Study||3
79371|NCT01601236|190189|P1|STARTED|Overall Study||7
79372|NCT01601132|190225|P1|NOT COMPLETED|Overall Study||2
79373|NCT01601132|190225|P1|COMPLETED|Overall Study||28
79374|NCT01601132|190225|P1|STARTED|Overall Study||30
79375|NCT01600950|190242|P2|NOT COMPLETED|Period 2||0
79376|NCT01600950|190243|P1|NOT COMPLETED|Period 2||0
79377|NCT01600950|190242|P2|COMPLETED|Period 2||10
79378|NCT01600950|190243|P1|COMPLETED|Period 2||10
79379|NCT01600950|190242|P2|STARTED|Period 2||10
79380|NCT01600950|190243|P1|STARTED|Period 2||10
79381|NCT01600950|190242|P2|NOT COMPLETED|Period 1||0
79382|NCT01600950|190243|P1|NOT COMPLETED|Period 1||0
79383|NCT01600950|190242|P2|COMPLETED|Period 1||10
79384|NCT01600950|190243|P1|COMPLETED|Period 1||10
79385|NCT01600950|190242|P2|STARTED|Period 1||10
79386|NCT01600950|190243|P1|STARTED|Period 1||10
79387|NCT01600885|190259|P2|NOT COMPLETED|Second Period||0
79388|NCT01600885|190260|P1|NOT COMPLETED|Second Period||0
79389|NCT01600885|190259|P2|COMPLETED|Second Period||8
79390|NCT01600885|190260|P1|COMPLETED|Second Period||8
79391|NCT01600885|190259|P2|STARTED|Second Period||8
79392|NCT01600885|190260|P1|STARTED|Second Period||8
79393|NCT01600885|190259|P2|NOT COMPLETED|Wash Out Period||0
79394|NCT01600885|190260|P1|NOT COMPLETED|Wash Out Period||0
79395|NCT01600885|190259|P2|COMPLETED|Wash Out Period||8
79396|NCT01600885|190260|P1|COMPLETED|Wash Out Period||8
79397|NCT01600885|190259|P2|STARTED|Wash Out Period||8
79398|NCT01600885|190260|P1|STARTED|Wash Out Period||8
79399|NCT01600885|190259|P2|NOT COMPLETED|First Period||1
79400|NCT01600885|190260|P1|NOT COMPLETED|First Period||2
79401|NCT01600885|190259|P2|COMPLETED|First Period||8
79402|NCT01600885|190260|P1|COMPLETED|First Period||8
79403|NCT01600885|190259|P2|STARTED|First Period||9
79404|NCT01600885|190260|P1|STARTED|First Period||10
79405|NCT01600729|190270|P1|NOT COMPLETED|Overall Study||1
79406|NCT01600729|190270|P1|COMPLETED|Overall Study||65
79407|NCT01600729|190270|P1|STARTED|Overall Study||66
79408|NCT01600716|190277|P2|NOT COMPLETED|Overall Study||7
79409|NCT01600716|190278|P1|NOT COMPLETED|Overall Study||7
79410|NCT01600716|190277|P2|COMPLETED|Overall Study||71
79411|NCT01600716|190278|P1|COMPLETED|Overall Study||59
79412|NCT01600716|190277|P2|STARTED|Overall Study||78
79413|NCT01600716|190278|P1|STARTED|Overall Study||66
79414|NCT01600703|190294|P2|NOT COMPLETED|Second Intervention||0
79415|NCT01600703|190295|P1|NOT COMPLETED|Second Intervention||0
79416|NCT01600703|190294|P2|COMPLETED|Second Intervention||8
79417|NCT01600703|190295|P1|COMPLETED|Second Intervention||7
79418|NCT01600703|190294|P2|STARTED|Second Intervention||8
79419|NCT01600703|190295|P1|STARTED|Second Intervention||7
79420|NCT01600703|190294|P2|NOT COMPLETED|First Intervention||0
79421|NCT01600703|190295|P1|NOT COMPLETED|First Intervention||0
79422|NCT01600703|190294|P2|COMPLETED|First Intervention||8
79423|NCT01600703|190295|P1|COMPLETED|First Intervention||7
79424|NCT01600703|190294|P2|STARTED|First Intervention||8
79425|NCT01600703|190295|P1|STARTED|First Intervention||7
79426|NCT01600677|190305|P2|NOT COMPLETED|Overall Study||0
79427|NCT01600677|190306|P1|NOT COMPLETED|Overall Study||0
79428|NCT01600677|190305|P2|COMPLETED|Overall Study||4
79429|NCT01600677|190306|P1|COMPLETED|Overall Study||7
79430|NCT01600677|190305|P2|STARTED|Overall Study||4
79431|NCT01600677|190306|P1|STARTED|Overall Study||7
79432|NCT01600586|190318|P2|NOT COMPLETED|Overall Study||3
79433|NCT01600586|190319|P1|NOT COMPLETED|Overall Study||3
79434|NCT01600586|190318|P2|COMPLETED|Overall Study||48
79435|NCT01600586|190319|P1|COMPLETED|Overall Study||46
79436|NCT01600586|190318|P2|STARTED|Overall Study||51
79437|NCT01600586|190319|P1|STARTED|Overall Study||49
79438|NCT01600495|190335|P2|NOT COMPLETED|Overall Study||0
79439|NCT01600495|190336|P1|NOT COMPLETED|Overall Study||0
79440|NCT01600495|190335|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
79441|NCT01600495|190336|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
79442|NCT01600495|190335|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
79443|NCT01600495|190336|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
79444|NCT01600482|190350|P2|NOT COMPLETED|Overall Study||0
79445|NCT01600482|190351|P1|NOT COMPLETED|Overall Study||0
79446|NCT01600482|190350|P2|COMPLETED|Overall Study||59
79447|NCT01600482|190351|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
79448|NCT01600482|190350|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
79449|NCT01600482|190351|P1|STARTED|Overall Study||148
79450|NCT01600326|190371|P2|NOT COMPLETED|Overall Study||1
79451|NCT01600326|190372|P1|NOT COMPLETED|Overall Study||1
79452|NCT01600326|190371|P2|COMPLETED|Overall Study||14
79453|NCT01600326|190372|P1|COMPLETED|Overall Study||14
79454|NCT01600326|190371|P2|Primary Outcome Measure Data Collection|Overall Study||15
79455|NCT01600326|190372|P1|Primary Outcome Measure Data Collection|Overall Study||15
79456|NCT01600326|190371|P2|STARTED|Overall Study||15
79457|NCT01600326|190372|P1|STARTED|Overall Study||15
79458|NCT01600287|190382|P2|NOT COMPLETED|Overall Study||0
79459|NCT01600287|190383|P1|NOT COMPLETED|Overall Study||0
79460|NCT01600287|190382|P2|COMPLETED|Overall Study||20
79461|NCT01600287|190383|P1|COMPLETED|Overall Study||20
79462|NCT01600287|190382|P2|STARTED|Overall Study||20
79463|NCT01600287|190383|P1|STARTED|Overall Study||20
79464|NCT01600222|190423|P1|NOT COMPLETED|Overall Study||2
79465|NCT01600222|190423|P1|COMPLETED|Overall Study||35
79466|NCT01600222|190423|P1|STARTED|Overall Study||37
79467|NCT01600092|190448|P2|NOT COMPLETED|Overall Study||16
79468|NCT01600092|190449|P1|NOT COMPLETED|Overall Study||18
79469|NCT01600092|190448|P2|COMPLETED|Overall Study||491
79470|NCT01600092|190449|P1|COMPLETED|Overall Study||495
79471|NCT01600092|190448|P2|Received All 3 Vaccinations|Overall Study||494
79472|NCT01600092|190449|P1|Received All 3 Vaccinations|Overall Study||500
79473|NCT01600092|190448|P2|Received at Least 1 Vaccination|Overall Study||504
79474|NCT01600092|190449|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
79475|NCT01600092|190448|P2|STARTED|Overall Study||507
79476|NCT01600092|190449|P1|STARTED|Overall Study||513
79477|NCT01600053|190463|P1|NOT COMPLETED|Overall Study||11
79478|NCT01600053|190463|P1|COMPLETED|Overall Study||0
79479|NCT01600053|190463|P1|STARTED|Overall Study||11
79480|NCT01600014|190468|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
79481|NCT01600014|190469|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
79482|NCT01600014|190468|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
79483|NCT01600014|190469|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
79484|NCT01600014|190468|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
79485|NCT01600014|190469|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
79486|NCT01600014|190468|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
79487|NCT01600014|190469|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
79488|NCT01600014|190468|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
79489|NCT01600014|190469|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
79490|NCT01600014|190468|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
79491|NCT01600014|190469|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
79492|NCT01600014|190468|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
79493|NCT01600014|190469|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
79494|NCT01600014|190468|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
79495|NCT01600014|190469|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
79496|NCT01600014|190468|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
79497|NCT01600014|190469|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
79498|NCT01599832|190487|P1|NOT COMPLETED|Overall Study||0
79499|NCT01599832|190487|P1|COMPLETED|Overall Study||20
79500|NCT01599832|190487|P1|STARTED|Overall Study||20
79501|NCT01599806|190497|P2|NOT COMPLETED|Overall Study||41
79502|NCT01599806|190498|P1|NOT COMPLETED|Overall Study||43
79503|NCT01599806|190497|P2|COMPLETED|Overall Study||476
79504|NCT01599806|190498|P1|COMPLETED|Overall Study||473
79505|NCT01599806|190497|P2|STARTED|Overall Study||517
79506|NCT01599806|190498|P1|STARTED|Overall Study||516
79507|NCT01599741|190622|P1|NOT COMPLETED|Overall Study||3
79508|NCT01599741|190622|P1|COMPLETED|Overall Study||48
79509|NCT01599741|190622|P1|Collected Dose and Image Information|Overall Study||48
79510|NCT01599741|190622|P1|STARTED|Overall Study||51
79511|NCT01599650|190631|P3|NOT COMPLETED|Overall Study||27
79512|NCT01599650|190632|P2|NOT COMPLETED|Overall Study||26
79513|NCT01599650|190633|P1|NOT COMPLETED|Overall Study||22
79514|NCT01599650|190631|P3|COMPLETED|Overall Study||65
79515|NCT01599650|190632|P2|COMPLETED|Overall Study||154
79516|NCT01599650|190633|P1|COMPLETED|Overall Study||161
79517|NCT01599650|190631|P3|Completed 6 Mos|Overall Study||80
79518|NCT01599650|190632|P2|Completed 6 Mos|Overall Study||170
79519|NCT01599650|190633|P1|Completed 6 Mos|Overall Study||174
79520|NCT01599650|190631|P3|STARTED|Overall Study||92
79521|NCT01599650|190632|P2|STARTED|Overall Study||180
79522|NCT01599650|190633|P1|STARTED|Overall Study||183
79523|NCT01599637|190672|P3|NOT COMPLETED|Overall Study||0
79524|NCT01599637|190673|P2|NOT COMPLETED|Overall Study||2
79525|NCT01599637|190674|P1|NOT COMPLETED|Overall Study||1
79526|NCT01599637|190672|P3|COMPLETED|Overall Study||10
79527|NCT01599637|190673|P2|COMPLETED|Overall Study||8
79528|NCT01599637|190674|P1|COMPLETED|Overall Study||19
79529|NCT01599637|190672|P3|STARTED|Overall Study||10
79530|NCT01599637|190673|P2|STARTED|Overall Study||10
79531|NCT01599637|190674|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
79532|NCT01599585|190721|P2|NOT COMPLETED|Overall Study||17
79533|NCT01599585|190722|P1|NOT COMPLETED|Overall Study||22
79534|NCT01599585|190721|P2|COMPLETED|Overall Study||42
79535|NCT01599585|190722|P1|COMPLETED|Overall Study||40
79536|NCT01599585|190721|P2|STARTED|Overall Study||59
79537|NCT01599585|190722|P1|STARTED|Overall Study||62
79538|NCT01599325|190760|P1|NOT COMPLETED|Overall Study||57
79539|NCT01599325|190760|P1|COMPLETED|Overall Study|Participants still on study treatment at time of study closure|15
79540|NCT01599325|190760|P1|Pharmacokinetic (PK) Population|Overall Study|Includes all participants with evaluable azacitidine plasma PK profiles.|12
79541|NCT01599325|190760|P1|Intent to Treat (ITT) Population|Overall Study|Includes all participants who were enrolled into the study|72
79542|NCT01599325|190760|P1|STARTED|Overall Study||72
79543|NCT01599234|190782|P2|NOT COMPLETED|Overall Study||15
79544|NCT01599234|190783|P1|NOT COMPLETED|Overall Study||17
79545|NCT01599234|190782|P2|COMPLETED|Overall Study||155
79546|NCT01599234|190783|P1|COMPLETED|Overall Study||150
79547|NCT01599234|190782|P2|STARTED|Overall Study||170
79548|NCT01599234|190783|P1|STARTED|Overall Study||167
79549|NCT01599104|190808|P3|NOT COMPLETED|Overall Study||26
79550|NCT01599104|190809|P2|NOT COMPLETED|Overall Study||14
79551|NCT01599104|190810|P1|NOT COMPLETED|Overall Study||16
79552|NCT01599104|190808|P3|COMPLETED|Overall Study||363
79553|NCT01599104|190809|P2|COMPLETED|Overall Study||371
79554|NCT01599104|190810|P1|COMPLETED|Overall Study||371
79555|NCT01599104|190808|P3|STARTED|Overall Study||389
79556|NCT01599104|190809|P2|STARTED|Overall Study||385
79557|NCT01599104|190810|P1|STARTED|Overall Study||387
79558|NCT01598987|190848|P1|NOT COMPLETED|Baseline to 24 Month||8
79559|NCT01598987|190848|P1|COMPLETED|Baseline to 24 Month||48
79560|NCT01598987|190848|P1|STARTED|Baseline to 24 Month||56
79561|NCT01598987|190848|P1|NOT COMPLETED|Baseline to Month 12||6
79562|NCT01598987|190848|P1|COMPLETED|Baseline to Month 12||50
79563|NCT01598987|190848|P1|STARTED|Baseline to Month 12||56
79564|NCT01598779|190882|P1|NOT COMPLETED|Overall Study||0
79565|NCT01598779|190882|P1|COMPLETED|Overall Study||150
79566|NCT01598779|190882|P1|STARTED|Overall Study||150
79567|NCT01598740|190888|P2|NOT COMPLETED|Period 2||0
79568|NCT01598740|190889|P1|NOT COMPLETED|Period 2||1
79569|NCT01598740|190888|P2|COMPLETED|Period 2||9
79570|NCT01598740|190889|P1|COMPLETED|Period 2||7
79571|NCT01598740|190888|P2|STARTED|Period 2||9
79572|NCT01598740|190889|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
79573|NCT01598740|190888|P2|NOT COMPLETED|Period 1||0
79574|NCT01598740|190889|P1|NOT COMPLETED|Period 1||0
79575|NCT01598740|190888|P2|COMPLETED|Period 1||9
79576|NCT01598740|190889|P1|COMPLETED|Period 1||9
79577|NCT01598740|190888|P2|STARTED|Period 1||9
79578|NCT01598740|190889|P1|STARTED|Period 1||9
79579|NCT01598610|190897|P1|NOT COMPLETED|Overall Study||1
79580|NCT01598610|190897|P1|COMPLETED|Overall Study||219
79581|NCT01598610|190897|P1|STARTED|Overall Study||220
79582|NCT01598545|190906|P1|NOT COMPLETED|Overall Study||0
79583|NCT01598545|190906|P1|COMPLETED|Overall Study||20
79584|NCT01598545|190906|P1|STARTED|Overall Study||20
79585|NCT01598532|190914|P1|NOT COMPLETED|Overall Study||11
79586|NCT01598532|190914|P1|COMPLETED|Overall Study||11
79587|NCT01598532|190914|P1|STARTED|Overall Study||22
79588|NCT01598506|190923|P1|NOT COMPLETED|Overall Study||2
79589|NCT01598506|190923|P1|COMPLETED|Overall Study||20
79590|NCT01598506|190923|P1|STARTED|Overall Study||22
79591|NCT01598428|190928|P1|NOT COMPLETED|Overall Study||0
79592|NCT01598428|190928|P1|COMPLETED|Overall Study||20
79593|NCT01598428|190928|P1|STARTED|Overall Study||20
79594|NCT01598350|190937|P1|NOT COMPLETED|Overall Study||0
79595|NCT01598350|190937|P1|COMPLETED|Overall Study||6
79596|NCT01598350|190937|P1|STARTED|Overall Study||6
79597|NCT01598311|190943|P2|NOT COMPLETED|Overall Study||61
79598|NCT01598311|190944|P1|NOT COMPLETED|Overall Study||47
79599|NCT01598311|190943|P2|COMPLETED|Overall Study||244
79600|NCT01598311|190944|P1|COMPLETED|Overall Study||256
79601|NCT01598311|190943|P2|Treated and Confirmed CDAD|Overall Study||292
79602|NCT01598311|190944|P1|Treated and Confirmed CDAD|Overall Study||285
79603|NCT01598311|190943|P2|Treated|Overall Study||301
79604|NCT01598311|190944|P1|Treated|Overall Study||294
79605|NCT01598311|190943|P2|STARTED|Overall Study||305
79606|NCT01598311|190944|P1|STARTED|Overall Study||303
79607|NCT01598298|190960|P2|NOT COMPLETED|Overall Study||41
79608|NCT01598298|190961|P1|NOT COMPLETED|Overall Study||40
79609|NCT01598298|190960|P2|COMPLETED|Overall Study||108
79610|NCT01598298|190961|P1|COMPLETED|Overall Study||110
79611|NCT01598298|190960|P2|Patients Evaluable for Adverse Events|Overall Study||141
79612|NCT01598298|190961|P1|Patients Evaluable for Adverse Events|Overall Study||138
79613|NCT01598298|190960|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
79614|NCT01598298|190961|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
79615|NCT01598298|190960|P2|STARTED|Overall Study||149
79616|NCT01598298|190961|P1|STARTED|Overall Study||150
79617|NCT01598207|190973|P2|NOT COMPLETED|Overall Study||0
79618|NCT01598207|190974|P1|NOT COMPLETED|Overall Study||1
79619|NCT01598207|190973|P2|COMPLETED|Overall Study||6
79620|NCT01598207|190974|P1|COMPLETED|Overall Study||6
79621|NCT01598207|190973|P2|STARTED|Overall Study||6
79622|NCT01598207|190974|P1|STARTED|Overall Study||7
79623|NCT01598129|190992|P1|NOT COMPLETED|Overall Study||9
79624|NCT01598129|190992|P1|COMPLETED|Overall Study||3
79625|NCT01598129|190992|P1|STARTED|Overall Study||12
79626|NCT01598064|191003|P2|NOT COMPLETED|Overall Study||0
79627|NCT01598064|191004|P1|NOT COMPLETED|Overall Study||0
79628|NCT01598064|191003|P2|COMPLETED|Overall Study||24
79629|NCT01598064|191004|P1|COMPLETED|Overall Study||25
79630|NCT01598064|191003|P2|STARTED|Overall Study||24
79631|NCT01598064|191004|P1|STARTED|Overall Study||25
79632|NCT01598025|191014|P2|NOT COMPLETED|Overall Study||3
79633|NCT01598025|191015|P1|NOT COMPLETED|Overall Study||0
79634|NCT01598025|191014|P2|COMPLETED|Overall Study||0
79635|NCT01598025|191015|P1|COMPLETED|Overall Study||0
79636|NCT01598025|191014|P2|STARTED|Overall Study||3
79637|NCT01598025|191015|P1|STARTED|Overall Study||0
79638|NCT01597908|191025|P2|NOT COMPLETED|Overall Study||352
79639|NCT01597908|191026|P1|NOT COMPLETED|Overall Study||352
79640|NCT01597908|191025|P2|COMPLETED|Overall Study||0
79641|NCT01597908|191026|P1|COMPLETED|Overall Study||0
79642|NCT01597908|191025|P2|Ongoing|Overall Study||202
79643|NCT01597908|191026|P1|Ongoing|Overall Study||236
79644|NCT01597908|191025|P2|STARTED|Overall Study||352
79645|NCT01597908|191026|P1|STARTED|Overall Study||352
79646|NCT01597843|191041|P3|NOT COMPLETED|Overall Study||0
79647|NCT01597843|191042|P2|NOT COMPLETED|Overall Study||0
79648|NCT01597843|191043|P1|NOT COMPLETED|Overall Study||0
79649|NCT01597843|191041|P3|COMPLETED|Overall Study||81
79650|NCT01597843|191042|P2|COMPLETED|Overall Study||122
79651|NCT01597843|191043|P1|COMPLETED|Overall Study||79
79652|NCT01597843|191041|P3|Survey 3 Responses|Overall Study||76
79653|NCT01597843|191042|P2|Survey 3 Responses|Overall Study||56
79654|NCT01597843|191043|P1|Survey 3 Responses|Overall Study||65
79655|NCT01597843|191041|P3|Survey 2 Responses|Overall Study||58
79656|NCT01597843|191042|P2|Survey 2 Responses|Overall Study||42
79657|NCT01597843|191043|P1|Survey 2 Responses|Overall Study||52
79658|NCT01597843|191041|P3|Survey 1 Responses|Overall Study||59
79659|NCT01597843|191042|P2|Survey 1 Responses|Overall Study||71
79660|NCT01597843|191043|P1|Survey 1 Responses|Overall Study||45
79661|NCT01597843|191041|P3|STARTED|Overall Study||81
79662|NCT01597843|191042|P2|STARTED|Overall Study||122
79663|NCT01597843|191043|P1|STARTED|Overall Study||79
79664|NCT01597791|191053|P2|NOT COMPLETED|Overall Study||10
79665|NCT01597791|191054|P1|NOT COMPLETED|Overall Study||8
79666|NCT01597791|191053|P2|COMPLETED|Overall Study||18
79667|NCT01597791|191054|P1|COMPLETED|Overall Study||20
79668|NCT01597791|191053|P2|STARTED|Overall Study||28
79669|NCT01597791|191054|P1|STARTED|Overall Study||28
79670|NCT01597635|191063|P3|NOT COMPLETED|Part B||4
79671|NCT01597635|191064|P2|NOT COMPLETED|Part B||6
79672|NCT01597635|191065|P1|NOT COMPLETED|Part B||0
79673|NCT01597635|191063|P3|COMPLETED|Part B||15
79674|NCT01597635|191064|P2|COMPLETED|Part B||14
79675|NCT01597635|191065|P1|COMPLETED|Part B||0
79676|NCT01597635|191063|P3|STARTED|Part B||19
79677|NCT01597635|191064|P2|STARTED|Part B||20
79678|NCT01597635|191065|P1|STARTED|Part B||0
79679|NCT01597635|191063|P3|NOT COMPLETED|Part A||0
79680|NCT01597635|191064|P2|NOT COMPLETED|Part A||0
79681|NCT01597635|191065|P1|NOT COMPLETED|Part A||3
79682|NCT01597635|191063|P3|COMPLETED|Part A||0
79683|NCT01597635|191064|P2|COMPLETED|Part A||0
79684|NCT01597635|191065|P1|COMPLETED|Part A||2
79685|NCT01597635|191063|P3|STARTED|Part A||0
79686|NCT01597635|191064|P2|STARTED|Part A||0
79687|NCT01597635|191065|P1|STARTED|Part A||5
79688|NCT01597596|191130|P2|NOT COMPLETED|Overall Study||1
79689|NCT01597596|191131|P1|NOT COMPLETED|Overall Study||1
79690|NCT01597596|191130|P2|COMPLETED|Overall Study||2
79691|NCT01597596|191131|P1|COMPLETED|Overall Study||0
79692|NCT01597596|191130|P2|STARTED|Overall Study||3
79693|NCT01597596|191131|P1|STARTED|Overall Study||1
79694|NCT01597505|191145|P2|NOT COMPLETED|Overall Study||33
79695|NCT01597505|191146|P1|NOT COMPLETED|Overall Study||44
79696|NCT01597505|191145|P2|COMPLETED|Overall Study||265
79697|NCT01597505|191146|P1|COMPLETED|Overall Study||264
79698|NCT01597505|191145|P2|Treated|Overall Study||286
79699|NCT01597505|191146|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
79700|NCT01597505|191145|P2|STARTED|Overall Study|Randomized participants|298
79701|NCT01597505|191146|P1|STARTED|Overall Study|Randomized participants|308
79702|NCT01597492|191180|P2|NOT COMPLETED|Overall Study||4
79703|NCT01597492|191181|P1|NOT COMPLETED|Overall Study||6
79704|NCT01597492|191180|P2|COMPLETED|Overall Study||41
79705|NCT01597492|191181|P1|COMPLETED|Overall Study||28
79706|NCT01597492|191180|P2|STARTED|Overall Study||45
79707|NCT01597492|191181|P1|STARTED|Overall Study||34
79708|NCT01597479|191189|P2|NOT COMPLETED|Overall Study||0
79709|NCT01597479|191190|P1|NOT COMPLETED|Overall Study||2
79710|NCT01597479|191189|P2|COMPLETED|Overall Study||26
79711|NCT01597479|191190|P1|COMPLETED|Overall Study||24
79712|NCT01597479|191189|P2|STARTED|Overall Study||26
79713|NCT01597479|191190|P1|STARTED|Overall Study||26
79714|NCT01597440|191199|P2|NOT COMPLETED|Overall Study||0
79715|NCT01597440|191200|P1|NOT COMPLETED|Overall Study||0
79716|NCT01597440|191199|P2|COMPLETED|Overall Study||0
79717|NCT01597440|191200|P1|COMPLETED|Overall Study||1
79718|NCT01597440|191199|P2|STARTED|Overall Study||0
79719|NCT01597440|191200|P1|STARTED|Overall Study||1
79720|NCT01597245|191212|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
79721|NCT01597245|191213|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
79722|NCT01597245|191214|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
79723|NCT01597245|191215|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
79724|NCT01597245|191216|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
79725|NCT01597245|191217|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
79726|NCT01597245|191218|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
79727|NCT01597245|191219|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
79728|NCT01597245|191220|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
79729|NCT01597245|191221|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79730|NCT01597245|191222|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79731|NCT01597245|191223|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79732|NCT01597245|191224|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79733|NCT01597245|191212|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
79734|NCT01597245|191213|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
79735|NCT01597245|191214|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
79736|NCT01597245|191215|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
79737|NCT01597245|191216|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
79738|NCT01597245|191217|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79739|NCT01597245|191218|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
79740|NCT01597245|191219|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
79741|NCT01597245|191220|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
79742|NCT01597245|191221|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79743|NCT01597245|191222|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79744|NCT01597245|191223|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79745|NCT01597245|191224|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
79746|NCT01597245|191212|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
79747|NCT01597245|191213|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
79748|NCT01597245|191214|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
79749|NCT01597245|191215|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
79750|NCT01597245|191216|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
79751|NCT01597245|191217|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
79752|NCT01597245|191218|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
79753|NCT01597245|191219|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
79754|NCT01597245|191220|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
79755|NCT01597245|191221|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
79756|NCT01597245|191222|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
79757|NCT01597245|191223|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
79758|NCT01597245|191224|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
79759|NCT01597245|191212|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
79760|NCT01597245|191213|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
79761|NCT01597245|191214|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
79762|NCT01597245|191215|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
79763|NCT01597245|191216|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
79764|NCT01597245|191217|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
79765|NCT01597245|191218|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
79766|NCT01597245|191219|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
79767|NCT01597245|191220|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
79768|NCT01597245|191221|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
79769|NCT01597245|191222|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
79770|NCT01597245|191223|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
79771|NCT01597245|191224|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
79772|NCT01597245|191212|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79773|NCT01597245|191213|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79774|NCT01597245|191214|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79775|NCT01597245|191215|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79776|NCT01597245|191216|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79777|NCT01597245|191217|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79778|NCT01597245|191218|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79779|NCT01597245|191219|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79780|NCT01597245|191220|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
79781|NCT01597245|191221|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
79782|NCT01597245|191222|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
79783|NCT01597245|191223|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
79784|NCT01597245|191224|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
79785|NCT01597245|191212|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
79786|NCT01597245|191213|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
79787|NCT01597245|191214|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
79788|NCT01597245|191215|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
79789|NCT01597245|191216|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
79790|NCT01597245|191217|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
79791|NCT01597245|191218|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
79792|NCT01597245|191219|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
79793|NCT01597245|191220|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
79794|NCT01597245|191221|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
79795|NCT01597245|191222|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
79796|NCT01597245|191223|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
79797|NCT01597245|191224|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
79798|NCT01597245|191212|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79799|NCT01597245|191213|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79800|NCT01597245|191214|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79801|NCT01597245|191215|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79802|NCT01597245|191216|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79803|NCT01597245|191217|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79804|NCT01597245|191218|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79805|NCT01597245|191219|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79806|NCT01597245|191220|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
79807|NCT01597245|191221|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
79808|NCT01597245|191222|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
79809|NCT01597245|191223|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
79810|NCT01597245|191224|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
79811|NCT01597245|191212|P13|STARTED|Induction Period (Week 0 - Week 12)||0
79812|NCT01597245|191213|P12|STARTED|Induction Period (Week 0 - Week 12)||0
79813|NCT01597245|191214|P11|STARTED|Induction Period (Week 0 - Week 12)||0
79814|NCT01597245|191215|P10|STARTED|Induction Period (Week 0 - Week 12)||0
79815|NCT01597245|191216|P9|STARTED|Induction Period (Week 0 - Week 12)||0
79816|NCT01597245|191217|P8|STARTED|Induction Period (Week 0 - Week 12)||0
79817|NCT01597245|191218|P7|STARTED|Induction Period (Week 0 - Week 12)||0
79818|NCT01597245|191219|P6|STARTED|Induction Period (Week 0 - Week 12)||0
79819|NCT01597245|191220|P5|STARTED|Induction Period (Week 0 - Week 12)||0
79820|NCT01597245|191221|P4|STARTED|Induction Period (Week 0 - Week 12)||351
79821|NCT01597245|191222|P3|STARTED|Induction Period (Week 0 - Week 12)||347
79822|NCT01597245|191223|P2|STARTED|Induction Period (Week 0 - Week 12)||358
79823|NCT01597245|191224|P1|STARTED|Induction Period (Week 0 - Week 12)||168
79824|NCT01597141|191309|P2|NOT COMPLETED|Overall Study||0
79825|NCT01597141|191310|P1|NOT COMPLETED|Overall Study||0
79826|NCT01597141|191309|P2|COMPLETED|Overall Study||50
79827|NCT01597141|191310|P1|COMPLETED|Overall Study||50
79828|NCT01597141|191309|P2|STARTED|Overall Study||50
79829|NCT01597141|191310|P1|STARTED|Overall Study||50
79830|NCT01597128|191320|P2|NOT COMPLETED|Overall Study||0
79831|NCT01597128|191321|P1|NOT COMPLETED|Overall Study||0
79832|NCT01597128|191320|P2|COMPLETED|Overall Study||17
79833|NCT01597128|191321|P1|COMPLETED|Overall Study||18
79834|NCT01597128|191320|P2|STARTED|Overall Study||17
79835|NCT01597128|191321|P1|STARTED|Overall Study||18
79836|NCT01597050|191347|P2|NOT COMPLETED|Overall Study||0
79837|NCT01597050|191348|P1|NOT COMPLETED|Overall Study||1
79838|NCT01597050|191347|P2|COMPLETED|Overall Study||18
79839|NCT01597050|191348|P1|COMPLETED|Overall Study||35
79840|NCT01597050|191347|P2|STARTED|Overall Study||18
79841|NCT01597050|191348|P1|STARTED|Overall Study||36
79842|NCT01596972|191356|P2|NOT COMPLETED|Overall Study||14
79843|NCT01596972|191357|P1|NOT COMPLETED|Overall Study||1
79844|NCT01596972|191356|P2|COMPLETED|Overall Study||12
79845|NCT01596972|191357|P1|COMPLETED|Overall Study||24
79846|NCT01596972|191356|P2|STARTED|Overall Study||26
79847|NCT01596972|191357|P1|STARTED|Overall Study||25
79848|NCT01596842|191369|P2|NOT COMPLETED|Overall Study||0
79849|NCT01596842|191370|P1|NOT COMPLETED|Overall Study||2
79850|NCT01596842|191369|P2|COMPLETED|Overall Study||7
79851|NCT01596842|191370|P1|COMPLETED|Overall Study||8
79852|NCT01596842|191369|P2|STARTED|Overall Study||7
79853|NCT01596842|191370|P1|STARTED|Overall Study||10
79854|NCT01596582|191380|P2|NOT COMPLETED|Overall Study||7
79855|NCT01596582|191381|P1|NOT COMPLETED|Overall Study||4
79856|NCT01596582|191380|P2|COMPLETED|Overall Study||173
79857|NCT01596582|191381|P1|COMPLETED|Overall Study||168
79858|NCT01596582|191380|P2|STARTED|Overall Study||180
79859|NCT01596582|191381|P1|STARTED|Overall Study||172
79860|NCT01596504|191408|P3|NOT COMPLETED|Overall Study||1
79861|NCT01596504|191409|P2|NOT COMPLETED|Overall Study||3
79862|NCT01596504|191410|P1|NOT COMPLETED|Overall Study||2
79863|NCT01596504|191408|P3|COMPLETED|Overall Study||46
79864|NCT01596504|191409|P2|COMPLETED|Overall Study||44
79865|NCT01596504|191410|P1|COMPLETED|Overall Study||46
79866|NCT01596504|191408|P3|STARTED|Overall Study||47
79867|NCT01596504|191409|P2|STARTED|Overall Study||47
79868|NCT01596504|191410|P1|STARTED|Overall Study||48
79869|NCT01596283|191468|P2|NOT COMPLETED|Overall Study||0
79870|NCT01596283|191469|P1|NOT COMPLETED|Overall Study||0
79871|NCT01596283|191468|P2|COMPLETED|Overall Study||66
79872|NCT01596283|191469|P1|COMPLETED|Overall Study||69
79873|NCT01596283|191468|P2|STARTED|Overall Study||66
79874|NCT01596283|191469|P1|STARTED|Overall Study||69
79875|NCT01596231|191485|P2|NOT COMPLETED|Overall Study||0
79876|NCT01596231|191486|P1|NOT COMPLETED|Overall Study||0
79877|NCT01596231|191485|P2|COMPLETED|Overall Study||10
79878|NCT01596231|191486|P1|COMPLETED|Overall Study||10
79879|NCT01596231|191485|P2|STARTED|Overall Study||10
79880|NCT01596231|191486|P1|STARTED|Overall Study||10
79881|NCT01596127|191492|P1|NOT COMPLETED|Overall Study||1
79882|NCT01596127|191492|P1|COMPLETED|Overall Study||3
79883|NCT01596127|191492|P1|STARTED|Overall Study||4
79884|NCT01596088|191497|P1|NOT COMPLETED|Overall Study||0
79885|NCT01596088|191497|P1|COMPLETED|Overall Study||2
79886|NCT01596088|191497|P1|STARTED|Overall Study||2
79887|NCT01596062|191504|P3|NOT COMPLETED|Overall Study||3
79888|NCT01596062|191505|P2|NOT COMPLETED|Overall Study||0
79889|NCT01596062|191506|P1|NOT COMPLETED|Overall Study||1
79890|NCT01596062|191504|P3|COMPLETED|Overall Study||4
79891|NCT01596062|191505|P2|COMPLETED|Overall Study||6
79892|NCT01596062|191506|P1|COMPLETED|Overall Study||2
79893|NCT01596062|191504|P3|STARTED|Overall Study||7
79894|NCT01596062|191505|P2|STARTED|Overall Study||6
79895|NCT01596062|191506|P1|STARTED|Overall Study||3
79896|NCT01595854|191543|P5|NOT COMPLETED|Overall Study||0
79897|NCT01595854|191544|P4|NOT COMPLETED|Overall Study||0
79898|NCT01595854|191545|P3|NOT COMPLETED|Overall Study||0
79899|NCT01595854|191546|P2|NOT COMPLETED|Overall Study||0
79900|NCT01595854|191547|P1|NOT COMPLETED|Overall Study||0
79901|NCT01595854|191543|P5|COMPLETED|Overall Study||12
79902|NCT01595854|191544|P4|COMPLETED|Overall Study||4
79903|NCT01595854|191545|P3|COMPLETED|Overall Study||8
79904|NCT01595854|191546|P2|COMPLETED|Overall Study||4
79905|NCT01595854|191547|P1|COMPLETED|Overall Study||8
79906|NCT01595854|191543|P5|STARTED|Overall Study||12
79907|NCT01595854|191544|P4|STARTED|Overall Study||4
79908|NCT01595854|191545|P3|STARTED|Overall Study||8
79909|NCT01595854|191546|P2|STARTED|Overall Study||4
79910|NCT01595854|191547|P1|STARTED|Overall Study||8
79911|NCT01595646|191570|P3|NOT COMPLETED|Overall Study||0
79912|NCT01595646|191571|P2|NOT COMPLETED|Overall Study||0
79913|NCT01595646|191572|P1|NOT COMPLETED|Overall Study||1
79914|NCT01595646|191570|P3|COMPLETED|Overall Study||12
79915|NCT01595646|191571|P2|COMPLETED|Overall Study||12
79916|NCT01595646|191572|P1|COMPLETED|Overall Study||12
79917|NCT01595646|191570|P3|STARTED|Overall Study||12
79918|NCT01595646|191571|P2|STARTED|Overall Study||12
79919|NCT01595646|191572|P1|STARTED|Overall Study||13
79920|NCT01595438|191594|P2|NOT COMPLETED|Overall Study||41
79921|NCT01595438|191595|P1|NOT COMPLETED|Overall Study||43
79922|NCT01595438|191594|P2|COMPLETED|Overall Study||476
79923|NCT01595438|191595|P1|COMPLETED|Overall Study||473
79924|NCT01595438|191594|P2|STARTED|Overall Study||517
79925|NCT01595438|191595|P1|STARTED|Overall Study||516
79926|NCT01595386|191721|P2|NOT COMPLETED|Overall Study||0
79927|NCT01595386|191722|P1|NOT COMPLETED|Overall Study||0
79928|NCT01595386|191721|P2|COMPLETED|Overall Study||19
79929|NCT01595386|191722|P1|COMPLETED|Overall Study||21
79930|NCT01595386|191721|P2|STARTED|Overall Study||19
79931|NCT01595386|191722|P1|STARTED|Overall Study||21
79932|NCT01595282|191750|P2|NOT COMPLETED|Overall Study||0
79933|NCT01595282|191751|P1|NOT COMPLETED|Overall Study||0
79934|NCT01595282|191750|P2|COMPLETED|Overall Study||47
79935|NCT01595282|191751|P1|COMPLETED|Overall Study||47
79936|NCT01595282|191750|P2|STARTED|Overall Study||47
79937|NCT01595282|191751|P1|STARTED|Overall Study||47
79938|NCT01594970|191764|P3|NOT COMPLETED|Overall Study||66
79939|NCT01594970|191765|P2|NOT COMPLETED|Overall Study||82
79940|NCT01594970|191766|P1|NOT COMPLETED|Overall Study||75
79941|NCT01594970|191764|P3|COMPLETED|Overall Study||191
79942|NCT01594970|191765|P2|COMPLETED|Overall Study||166
79943|NCT01594970|191766|P1|COMPLETED|Overall Study||220
79944|NCT01594970|191764|P3|STARTED|Overall Study||257
79945|NCT01594970|191765|P2|STARTED|Overall Study||248
79946|NCT01594970|191766|P1|STARTED|Overall Study||295
79947|NCT01594762|191785|P2|NOT COMPLETED|Overall Study||10
79948|NCT01594762|191786|P1|NOT COMPLETED|Overall Study||11
79949|NCT01594762|191785|P2|COMPLETED|Overall Study||93
79950|NCT01594762|191786|P1|COMPLETED|Overall Study||86
79951|NCT01594762|191785|P2|STARTED|Overall Study||103
79952|NCT01594762|191786|P1|STARTED|Overall Study||97
79953|NCT01594749|191798|P2|NOT COMPLETED|Overall Study||18
79954|NCT01594749|191799|P1|NOT COMPLETED|Overall Study||22
79955|NCT01594749|191798|P2|COMPLETED|Overall Study||490
79956|NCT01594749|191799|P1|COMPLETED|Overall Study||485
79957|NCT01594749|191798|P2|Treated|Overall Study||498
79958|NCT01594749|191799|P1|Treated|Overall Study||503
79959|NCT01594749|191798|P2|STARTED|Overall Study||508
79960|NCT01594749|191799|P1|STARTED|Overall Study||507
79961|NCT01594515|191825|P10|NOT COMPLETED|Overall Study||0
79962|NCT01594515|191826|P9|NOT COMPLETED|Overall Study||0
79963|NCT01594515|191827|P8|NOT COMPLETED|Overall Study||0
79964|NCT01594515|191828|P7|NOT COMPLETED|Overall Study||0
79965|NCT01594515|191829|P6|NOT COMPLETED|Overall Study||0
79966|NCT01594515|191830|P5|NOT COMPLETED|Overall Study||0
79967|NCT01594515|191831|P4|NOT COMPLETED|Overall Study||0
79968|NCT01594515|191832|P3|NOT COMPLETED|Overall Study||0
79969|NCT01594515|191833|P2|NOT COMPLETED|Overall Study||0
79970|NCT01594515|191834|P1|NOT COMPLETED|Overall Study||0
79971|NCT01594515|191825|P10|COMPLETED|Overall Study||16
79972|NCT01594515|191826|P9|COMPLETED|Overall Study||6
79973|NCT01594515|191827|P8|COMPLETED|Overall Study||6
79974|NCT01594515|191828|P7|COMPLETED|Overall Study||6
79975|NCT01594515|191829|P6|COMPLETED|Overall Study||6
79976|NCT01594515|191830|P5|COMPLETED|Overall Study||6
79977|NCT01594515|191831|P4|COMPLETED|Overall Study||6
79978|NCT01594515|191832|P3|COMPLETED|Overall Study||6
79979|NCT01594515|191833|P2|COMPLETED|Overall Study||6
79980|NCT01594515|191834|P1|COMPLETED|Overall Study||6
79981|NCT01594515|191825|P10|STARTED|Overall Study||16
79982|NCT01594515|191826|P9|STARTED|Overall Study||6
79983|NCT01594515|191827|P8|STARTED|Overall Study||6
79984|NCT01594515|191828|P7|STARTED|Overall Study||6
79985|NCT01594515|191829|P6|STARTED|Overall Study||6
79986|NCT01594515|191830|P5|STARTED|Overall Study||6
79987|NCT01594515|191831|P4|STARTED|Overall Study||6
79988|NCT01594515|191832|P3|STARTED|Overall Study||6
79989|NCT01594515|191833|P2|STARTED|Overall Study||6
79990|NCT01594515|191834|P1|STARTED|Overall Study||6
79991|NCT01594424|191924|P1|NOT COMPLETED|Overall Study||2
79992|NCT01594424|191924|P1|COMPLETED|Overall Study||8
79993|NCT01594424|191924|P1|STARTED|Overall Study||10
79994|NCT01594411|191928|P1|NOT COMPLETED|Overall Study||2
79995|NCT01594411|191928|P1|COMPLETED|Overall Study||249
79996|NCT01594411|191928|P1|STARTED|Overall Study||251
79997|NCT01594385|191937|P2|NOT COMPLETED|Overall Study||0
79998|NCT01594385|191938|P1|NOT COMPLETED|Overall Study||0
79999|NCT01594385|191937|P2|COMPLETED|Overall Study||13
80000|NCT01594385|191938|P1|COMPLETED|Overall Study||17
80001|NCT01594385|191937|P2|STARTED|Overall Study||13
80002|NCT01594385|191938|P1|STARTED|Overall Study||17
80003|NCT01594294|191962|P2|NOT COMPLETED|Overall Study||4
80004|NCT01594294|191963|P1|NOT COMPLETED|Overall Study||3
80005|NCT01594294|191962|P2|COMPLETED|Overall Study||36
80006|NCT01594294|191963|P1|COMPLETED|Overall Study||36
80007|NCT01594294|191962|P2|STARTED|Overall Study||40
80008|NCT01594294|191963|P1|STARTED|Overall Study||39
80009|NCT01594125|191982|P5|NOT COMPLETED|Overall Study||7
80010|NCT01594125|191983|P4|NOT COMPLETED|Overall Study||4
80011|NCT01594125|191984|P3|NOT COMPLETED|Overall Study||3
80012|NCT01594125|191985|P2|NOT COMPLETED|Overall Study||12
80013|NCT01594125|191986|P1|NOT COMPLETED|Overall Study||4
80014|NCT01594125|191982|P5|COMPLETED|Overall Study||0
80015|NCT01594125|191983|P4|COMPLETED|Overall Study||0
80016|NCT01594125|191984|P3|COMPLETED|Overall Study||0
80017|NCT01594125|191985|P2|COMPLETED|Overall Study||0
80018|NCT01594125|191986|P1|COMPLETED|Overall Study||0
80019|NCT01594125|191982|P5|STARTED|Overall Study||7
80020|NCT01594125|191983|P4|STARTED|Overall Study||4
80021|NCT01594125|191984|P3|STARTED|Overall Study||3
80022|NCT01594125|191985|P2|STARTED|Overall Study||12
80023|NCT01594125|191986|P1|STARTED|Overall Study||4
80024|NCT01593852|192020|P2|NOT COMPLETED|Overall Study||0
80025|NCT01593852|192021|P1|NOT COMPLETED|Overall Study||0
80026|NCT01593852|192020|P2|COMPLETED|Overall Study||68
80027|NCT01593852|192021|P1|COMPLETED|Overall Study||68
80028|NCT01593852|192020|P2|STARTED|Overall Study||68
80029|NCT01593852|192021|P1|STARTED|Overall Study||68
80030|NCT01593787|192046|P3|NOT COMPLETED|Overall Study||0
80031|NCT01593787|192047|P2|NOT COMPLETED|Overall Study||0
80032|NCT01593787|192048|P1|NOT COMPLETED|Overall Study||1
80033|NCT01593787|192046|P3|COMPLETED|Overall Study||18
80034|NCT01593787|192047|P2|COMPLETED|Overall Study||8
80035|NCT01593787|192048|P1|COMPLETED|Overall Study||5
80036|NCT01593787|192046|P3|STARTED|Overall Study||18
80037|NCT01593787|192047|P2|STARTED|Overall Study||8
80038|NCT01593787|192048|P1|STARTED|Overall Study||6
80039|NCT01593722|192088|P2|NOT COMPLETED|Overall Study||0
80040|NCT01593722|192089|P1|NOT COMPLETED|Overall Study||0
80041|NCT01593722|192088|P2|COMPLETED|Overall Study||6
80042|NCT01593722|192089|P1|COMPLETED|Overall Study||6
80043|NCT01593722|192088|P2|STARTED|Overall Study||6
80044|NCT01593722|192089|P1|STARTED|Overall Study||6
80045|NCT01593670|192103|P1|NOT COMPLETED|Overall Study||0
80046|NCT01593670|192103|P1|COMPLETED|Overall Study||9
80047|NCT01593670|192103|P1|STARTED|Overall Study||9
80048|NCT01593592|192113|P2|NOT COMPLETED|Overall Study||0
80049|NCT01593592|192114|P1|NOT COMPLETED|Overall Study||0
80050|NCT01593592|192113|P2|COMPLETED|Overall Study||35
80051|NCT01593592|192114|P1|COMPLETED|Overall Study||35
80052|NCT01593592|192113|P2|STARTED|Overall Study||35
80053|NCT01593592|192114|P1|STARTED|Overall Study||35
80054|NCT01593215|192126|P2|NOT COMPLETED|Overall Study||0
80055|NCT01593215|192127|P1|NOT COMPLETED|Overall Study||1
80056|NCT01593215|192126|P2|COMPLETED|Overall Study||25
80057|NCT01593215|192127|P1|COMPLETED|Overall Study||24
80058|NCT01593215|192126|P2|STARTED|Overall Study||25
80059|NCT01593215|192127|P1|STARTED|Overall Study||25
80060|NCT01592864|192135|P2|NOT COMPLETED|Overall Study||1
80061|NCT01592864|192136|P1|NOT COMPLETED|Overall Study||0
80062|NCT01592864|192135|P2|COMPLETED|Overall Study||57
80063|NCT01592864|192136|P1|COMPLETED|Overall Study||60
80064|NCT01592864|192135|P2|STARTED|Overall Study||58
80065|NCT01592864|192136|P1|STARTED|Overall Study||60
80066|NCT01592851|192150|P2|NOT COMPLETED|Overall Study||0
80067|NCT01592851|192151|P1|NOT COMPLETED|Overall Study||0
80068|NCT01592851|192150|P2|COMPLETED|Overall Study||57
80069|NCT01592851|192151|P1|COMPLETED|Overall Study||56
80070|NCT01592851|192150|P2|STARTED|Overall Study||57
80071|NCT01592851|192151|P1|STARTED|Overall Study||56
80072|NCT01592786|192167|P1|NOT COMPLETED|Overall Study||138
80073|NCT01592786|192167|P1|COMPLETED|Overall Study||765
80074|NCT01592786|192167|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
80075|NCT01592773|192171|P1|NOT COMPLETED|Overall Study||666
80076|NCT01592773|192171|P1|COMPLETED|Overall Study||81
80077|NCT01592773|192171|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
80078|NCT01592760|192178|P3|NOT COMPLETED|24-hour Follow-Up||2
80079|NCT01592760|192179|P2|NOT COMPLETED|24-hour Follow-Up||3
80080|NCT01592760|192180|P1|NOT COMPLETED|24-hour Follow-Up||4
80081|NCT01592760|192178|P3|COMPLETED|24-hour Follow-Up||43
80082|NCT01592760|192179|P2|COMPLETED|24-hour Follow-Up||87
80083|NCT01592760|192180|P1|COMPLETED|24-hour Follow-Up||86
80084|NCT01592760|192178|P3|STARTED|24-hour Follow-Up||45
80085|NCT01592760|192179|P2|STARTED|24-hour Follow-Up||90
80086|NCT01592760|192180|P1|STARTED|24-hour Follow-Up||90
80087|NCT01592760|192178|P3|NOT COMPLETED|Perioperative to Discharge||0
80088|NCT01592760|192179|P2|NOT COMPLETED|Perioperative to Discharge||0
80089|NCT01592760|192180|P1|NOT COMPLETED|Perioperative to Discharge||0
80090|NCT01592760|192178|P3|COMPLETED|Perioperative to Discharge||45
80091|NCT01592760|192179|P2|COMPLETED|Perioperative to Discharge||90
80092|NCT01592760|192180|P1|COMPLETED|Perioperative to Discharge||90
80093|NCT01592760|192178|P3|STARTED|Perioperative to Discharge||45
80094|NCT01592760|192179|P2|STARTED|Perioperative to Discharge||90
80095|NCT01592760|192180|P1|STARTED|Perioperative to Discharge||90
80096|NCT01592708|192223|P2|NOT COMPLETED|Overall Study||0
80097|NCT01592708|192224|P1|NOT COMPLETED|Overall Study||3
80098|NCT01592708|192223|P2|COMPLETED|Overall Study||137
80099|NCT01592708|192224|P1|COMPLETED|Overall Study||93
80100|NCT01592708|192223|P2|STARTED|Overall Study||137
80101|NCT01592708|192224|P1|STARTED|Overall Study||96
80102|NCT01592695|192240|P2|NOT COMPLETED|Overall Study||4
80103|NCT01592695|192241|P1|NOT COMPLETED|Overall Study||8
80104|NCT01592695|192240|P2|COMPLETED|Overall Study||28
80105|NCT01592695|192241|P1|COMPLETED|Overall Study||23
80106|NCT01592695|192240|P2|STARTED|Overall Study||32
80107|NCT01592695|192241|P1|STARTED|Overall Study||31
80108|NCT01592435|192259|P1|NOT COMPLETED|Overall Study||0
80109|NCT01592435|192259|P1|COMPLETED|Overall Study||76
80110|NCT01592435|192259|P1|STARTED|Overall Study||76
80111|NCT01592396|192267|P2|NOT COMPLETED|Overall Study||0
80112|NCT01592396|192268|P1|NOT COMPLETED|Overall Study||0
80113|NCT01592396|192267|P2|COMPLETED|Overall Study||10
80114|NCT01592396|192268|P1|COMPLETED|Overall Study||10
80115|NCT01592396|192267|P2|STARTED|Overall Study||10
80116|NCT01592396|192268|P1|STARTED|Overall Study||10
80117|NCT01592344|192285|P2|NOT COMPLETED|Overall Study||5
80118|NCT01592344|192286|P1|NOT COMPLETED|Overall Study||4
80119|NCT01592344|192285|P2|COMPLETED|Overall Study||44
80120|NCT01592344|192286|P1|COMPLETED|Overall Study||41
80121|NCT01592344|192285|P2|STARTED|Overall Study||49
80122|NCT01592344|192286|P1|STARTED|Overall Study||45
80123|NCT01592292|192300|P4|NOT COMPLETED|Overall Study||1
80124|NCT01592292|192301|P3|NOT COMPLETED|Overall Study||3
80125|NCT01592292|192302|P2|NOT COMPLETED|Overall Study||5
80126|NCT01592292|192303|P1|NOT COMPLETED|Overall Study||6
80127|NCT01592292|192300|P4|COMPLETED|Overall Study||10
80128|NCT01592292|192301|P3|COMPLETED|Overall Study||10
80129|NCT01592292|192302|P2|COMPLETED|Overall Study||15
80130|NCT01592292|192303|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
80131|NCT01592292|192300|P4|Standard Population Set (SPS)|Overall Study||7
80132|NCT01592292|192301|P3|Standard Population Set (SPS)|Overall Study||7
80133|NCT01592292|192302|P2|Standard Population Set (SPS)|Overall Study||10
80134|NCT01592292|192303|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
80135|NCT01592292|192300|P4|Intention to Treat (ITT) Set|Overall Study||8
80136|NCT01592292|192301|P3|Intention to Treat (ITT) Set|Overall Study||10
80137|NCT01592292|192302|P2|Intention to Treat (ITT) Set|Overall Study||13
80138|NCT01592292|192303|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
80139|NCT01592292|192300|P4|STARTED|Overall Study||11
80140|NCT01592292|192301|P3|STARTED|Overall Study||13
80141|NCT01592292|192302|P2|STARTED|Overall Study||20
80142|NCT01592292|192303|P1|STARTED|Overall Study||46
80143|NCT01592240|192342|P7|NOT COMPLETED|Overall Study||3
80144|NCT01592240|192343|P6|NOT COMPLETED|Overall Study||3
80145|NCT01592240|192344|P5|NOT COMPLETED|Overall Study||7
80146|NCT01592240|192345|P4|NOT COMPLETED|Overall Study||3
80147|NCT01592240|192346|P3|NOT COMPLETED|Overall Study||7
80148|NCT01592240|192347|P2|NOT COMPLETED|Overall Study||11
80149|NCT01592240|192348|P1|NOT COMPLETED|Overall Study||3
80150|NCT01592240|192342|P7|COMPLETED|Overall Study||48
80151|NCT01592240|192343|P6|COMPLETED|Overall Study||47
80152|NCT01592240|192344|P5|COMPLETED|Overall Study||44
80153|NCT01592240|192345|P4|COMPLETED|Overall Study||47
80154|NCT01592240|192346|P3|COMPLETED|Overall Study||45
80155|NCT01592240|192347|P2|COMPLETED|Overall Study||39
80156|NCT01592240|192348|P1|COMPLETED|Overall Study||47
80157|NCT01592240|192342|P7|STARTED|Overall Study||51
80158|NCT01592240|192343|P6|STARTED|Overall Study||50
80159|NCT01592240|192344|P5|STARTED|Overall Study||51
80160|NCT01592240|192345|P4|STARTED|Overall Study||50
80161|NCT01592240|192346|P3|STARTED|Overall Study||52
80162|NCT01592240|192347|P2|STARTED|Overall Study||50
80163|NCT01592240|192348|P1|STARTED|Overall Study||50
80164|NCT01592071|192528|P1|NOT COMPLETED|Overall Study||0
80165|NCT01592071|192528|P1|COMPLETED|Overall Study||120
80166|NCT01592071|192528|P1|STARTED|Overall Study||120
80167|NCT01592045|192541|P2|NOT COMPLETED|Overall Study||2
80168|NCT01592045|192542|P1|NOT COMPLETED|Overall Study||5
80169|NCT01592045|192541|P2|COMPLETED|Overall Study||12
80170|NCT01592045|192542|P1|COMPLETED|Overall Study||9
80171|NCT01592045|192541|P2|Completed Course 5|Overall Study||12
80172|NCT01592045|192542|P1|Completed Course 5|Overall Study||9
80173|NCT01592045|192541|P2|Completed Course 4|Overall Study||12
80174|NCT01592045|192542|P1|Completed Course 4|Overall Study||11
80175|NCT01592045|192541|P2|Completed Course 3|Overall Study||13
80176|NCT01592045|192542|P1|Completed Course 3|Overall Study||11
80177|NCT01592045|192541|P2|Completed Course 2|Overall Study||13
80178|NCT01592045|192542|P1|Completed Course 2|Overall Study||13
80179|NCT01592045|192541|P2|Completed Course 1|Overall Study||14
80180|NCT01592045|192542|P1|Completed Course 1|Overall Study||13
80181|NCT01592045|192541|P2|STARTED|Overall Study||14
80182|NCT01592045|192542|P1|STARTED|Overall Study||14
80183|NCT01592006|192550|P1|NOT COMPLETED|Overall Study||0
80184|NCT01592006|192550|P1|COMPLETED|Overall Study||3
80185|NCT01592006|192550|P1|STARTED|Overall Study||3
80186|NCT01591954|192555|P1|NOT COMPLETED|Overall Study||0
80187|NCT01591954|192555|P1|COMPLETED|Overall Study||1
80188|NCT01591954|192555|P1|STARTED|Overall Study||1
80189|NCT01591863|192560|P1|NOT COMPLETED|Overall Study||14
80190|NCT01591863|192560|P1|COMPLETED|Overall Study||24
80191|NCT01591863|192560|P1|STARTED|Overall Study||38
80192|NCT01591837|192572|P2|NOT COMPLETED|Overall Study||0
80193|NCT01591837|192573|P1|NOT COMPLETED|Overall Study||0
80194|NCT01591837|192572|P2|COMPLETED|Overall Study||60
80195|NCT01591837|192573|P1|COMPLETED|Overall Study||60
80196|NCT01591837|192572|P2|STARTED|Overall Study||60
80197|NCT01591837|192573|P1|STARTED|Overall Study||60
80198|NCT01591733|192587|P1|NOT COMPLETED|Overall Study||0
80199|NCT01591733|192587|P1|COMPLETED|Overall Study||48
80200|NCT01591733|192587|P1|STARTED|Overall Study||48
80201|NCT01591681|192598|P1|NOT COMPLETED|Overall Study||4
80202|NCT01591681|192598|P1|COMPLETED|Overall Study||45
80203|NCT01591681|192598|P1|STARTED|Overall Study||49
80204|NCT01591616|192624|P1|NOT COMPLETED|Overall Study||1
80205|NCT01591616|192624|P1|COMPLETED|Overall Study||15
80206|NCT01591616|192624|P1|STARTED|Overall Study||16
80207|NCT01591499|192765|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
80208|NCT01591499|192766|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
80209|NCT01591499|192767|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
80210|NCT01591499|192768|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
80211|NCT01591499|192765|P4|COMPLETED|Second Intervention (up to 24 Days)||34
80212|NCT01591499|192766|P3|COMPLETED|Second Intervention (up to 24 Days)||28
80213|NCT01591499|192767|P2|COMPLETED|Second Intervention (up to 24 Days)||34
80214|NCT01591499|192768|P1|COMPLETED|Second Intervention (up to 24 Days)||27
80215|NCT01591499|192765|P4|STARTED|Second Intervention (up to 24 Days)||37
80216|NCT01591499|192766|P3|STARTED|Second Intervention (up to 24 Days)||31
80217|NCT01591499|192767|P2|STARTED|Second Intervention (up to 24 Days)||37
80218|NCT01591499|192768|P1|STARTED|Second Intervention (up to 24 Days)||33
80219|NCT01591499|192765|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
80220|NCT01591499|192766|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
80221|NCT01591499|192767|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
80222|NCT01591499|192768|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
80223|NCT01591499|192765|P4|COMPLETED|First Intervention (up to 24 Days)||37
80224|NCT01591499|192766|P3|COMPLETED|First Intervention (up to 24 Days)||31
80225|NCT01591499|192767|P2|COMPLETED|First Intervention (up to 24 Days)||37
80226|NCT01591499|192768|P1|COMPLETED|First Intervention (up to 24 Days)||33
80227|NCT01591499|192765|P4|STARTED|First Intervention (up to 24 Days)||37
80228|NCT01591499|192766|P3|STARTED|First Intervention (up to 24 Days)||31
80229|NCT01591499|192767|P2|STARTED|First Intervention (up to 24 Days)||37
80230|NCT01591499|192768|P1|STARTED|First Intervention (up to 24 Days)||33
80231|NCT01591499|192765|P4|NOT COMPLETED|Baseline Visit||2
80232|NCT01591499|192766|P3|NOT COMPLETED|Baseline Visit||0
80233|NCT01591499|192767|P2|NOT COMPLETED|Baseline Visit||2
80234|NCT01591499|192768|P1|NOT COMPLETED|Baseline Visit||0
80235|NCT01591499|192765|P4|COMPLETED|Baseline Visit||37
80236|NCT01591499|192766|P3|COMPLETED|Baseline Visit||31
80237|NCT01591499|192767|P2|COMPLETED|Baseline Visit||37
80238|NCT01591499|192768|P1|COMPLETED|Baseline Visit||33
80239|NCT01591499|192765|P4|STARTED|Baseline Visit||39
80240|NCT01591499|192766|P3|STARTED|Baseline Visit||31
80241|NCT01591499|192767|P2|STARTED|Baseline Visit||39
80242|NCT01591499|192768|P1|STARTED|Baseline Visit||33
80243|NCT01591460|192834|P1|NOT COMPLETED|Overall Study||26
80244|NCT01591460|192834|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
80245|NCT01591460|192834|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
80246|NCT01591408|192916|P2|NOT COMPLETED|Overall Study||8
80247|NCT01591408|192917|P1|NOT COMPLETED|Overall Study||12
80248|NCT01591408|192916|P2|COMPLETED|Overall Study||24
80249|NCT01591408|192917|P1|COMPLETED|Overall Study||24
80250|NCT01591408|192916|P2|STARTED|Overall Study||32
80251|NCT01591408|192917|P1|STARTED|Overall Study||36
80252|NCT01591382|192925|P2|NOT COMPLETED|Overall Study||2
80253|NCT01591382|192926|P1|NOT COMPLETED|Overall Study||3
80254|NCT01591382|192925|P2|COMPLETED|Overall Study||30
80255|NCT01591382|192926|P1|COMPLETED|Overall Study||29
80256|NCT01591382|192925|P2|STARTED|Overall Study||32
80257|NCT01591382|192926|P1|STARTED|Overall Study||32
80258|NCT01591317|192943|P3|NOT COMPLETED|Overall Study||0
80259|NCT01591317|192944|P2|NOT COMPLETED|Overall Study||0
80260|NCT01591317|192945|P1|NOT COMPLETED|Overall Study||0
80261|NCT01591317|192943|P3|COMPLETED|Overall Study||10
80262|NCT01591317|192944|P2|COMPLETED|Overall Study||10
80263|NCT01591317|192945|P1|COMPLETED|Overall Study||10
80264|NCT01591317|192943|P3|STARTED|Overall Study||10
80265|NCT01591317|192944|P2|STARTED|Overall Study||10
80266|NCT01591317|192945|P1|STARTED|Overall Study||10
80267|NCT01591096|192971|P1|NOT COMPLETED|Overall Study||1
80268|NCT01591096|192971|P1|COMPLETED|Overall Study||0
80269|NCT01591096|192971|P1|STARTED|Overall Study||1
80270|NCT01591044|192980|P3|NOT COMPLETED|Overall Study||4
80271|NCT01591044|192981|P2|NOT COMPLETED|Overall Study||9
80272|NCT01591044|192982|P1|NOT COMPLETED|Overall Study||7
80273|NCT01591044|192980|P3|COMPLETED|Overall Study||96
80274|NCT01591044|192981|P2|COMPLETED|Overall Study||91
80275|NCT01591044|192982|P1|COMPLETED|Overall Study||94
80276|NCT01591044|192980|P3|STARTED|Overall Study||100
80277|NCT01591044|192981|P2|STARTED|Overall Study||100
80278|NCT01591044|192982|P1|STARTED|Overall Study||101
80279|NCT01591018|192992|P2|NOT COMPLETED|Overall Study||0
80280|NCT01591018|192993|P1|NOT COMPLETED|Overall Study||0
80281|NCT01591018|192992|P2|COMPLETED|Overall Study||60
80282|NCT01591018|192993|P1|COMPLETED|Overall Study||60
80283|NCT01591018|192992|P2|STARTED|Overall Study||60
80284|NCT01591018|192993|P1|STARTED|Overall Study||60
80285|NCT01591005|193007|P4|NOT COMPLETED|Overall Study||0
80286|NCT01591005|193008|P3|NOT COMPLETED|Overall Study||0
80287|NCT01591005|193009|P2|NOT COMPLETED|Overall Study||0
80288|NCT01591005|193010|P1|NOT COMPLETED|Overall Study||0
80289|NCT01591005|193007|P4|COMPLETED|Overall Study||68
80290|NCT01591005|193008|P3|COMPLETED|Overall Study||68
80291|NCT01591005|193009|P2|COMPLETED|Overall Study||53
80292|NCT01591005|193010|P1|COMPLETED|Overall Study||53
80293|NCT01591005|193007|P4|STARTED|Overall Study||68
80294|NCT01591005|193008|P3|STARTED|Overall Study||68
80295|NCT01591005|193009|P2|STARTED|Overall Study||53
80296|NCT01591005|193010|P1|STARTED|Overall Study||53
80297|NCT01590979|193046|P2|NOT COMPLETED|Overall Study||0
80298|NCT01590979|193047|P1|NOT COMPLETED|Overall Study||0
80299|NCT01590979|193046|P2|COMPLETED|Overall Study||27
80300|NCT01590979|193047|P1|COMPLETED|Overall Study||27
80301|NCT01590979|193046|P2|STARTED|Overall Study||27
80302|NCT01590979|193047|P1|STARTED|Overall Study||27
80303|NCT01590888|193056|P3|NOT COMPLETED|Overall Study||1
80304|NCT01590888|193057|P2|NOT COMPLETED|Overall Study||0
80305|NCT01590888|193058|P1|NOT COMPLETED|Overall Study||4
80306|NCT01590888|193056|P3|COMPLETED|Overall Study||34
80307|NCT01590888|193057|P2|COMPLETED|Overall Study||38
80308|NCT01590888|193058|P1|COMPLETED|Overall Study||32
80309|NCT01590888|193056|P3|STARTED|Overall Study||35
80310|NCT01590888|193057|P2|STARTED|Overall Study||38
80311|NCT01590888|193058|P1|STARTED|Overall Study||36
80312|NCT01590875|193104|P2|NOT COMPLETED|Overall Study||0
80313|NCT01590875|193105|P1|NOT COMPLETED|Overall Study||0
80314|NCT01590875|193104|P2|COMPLETED|Overall Study||10
80315|NCT01590875|193105|P1|COMPLETED|Overall Study||10
80316|NCT01590875|193104|P2|STARTED|Overall Study||10
80317|NCT01590875|193105|P1|STARTED|Overall Study||10
80318|NCT01590810|193118|P5|NOT COMPLETED|Overall Study||0
80319|NCT01590810|193119|P4|NOT COMPLETED|Overall Study||0
80320|NCT01590810|193120|P3|NOT COMPLETED|Overall Study||1
80321|NCT01590810|193121|P2|NOT COMPLETED|Overall Study||1
80322|NCT01590810|193122|P1|NOT COMPLETED|Overall Study||0
80323|NCT01590810|193118|P5|COMPLETED|Overall Study||2
80324|NCT01590810|193119|P4|COMPLETED|Overall Study||8
80325|NCT01590810|193120|P3|COMPLETED|Overall Study||7
80326|NCT01590810|193121|P2|COMPLETED|Overall Study||7
80327|NCT01590810|193122|P1|COMPLETED|Overall Study||8
80328|NCT01590810|193118|P5|STARTED|Overall Study||2
80329|NCT01590810|193119|P4|STARTED|Overall Study||8
80330|NCT01590810|193120|P3|STARTED|Overall Study||8
80331|NCT01590810|193121|P2|STARTED|Overall Study||8
80332|NCT01590810|193122|P1|STARTED|Overall Study||8
80333|NCT01590797|193267|P2|NOT COMPLETED|Overall Study||16
80334|NCT01590797|193268|P1|NOT COMPLETED|Overall Study||17
80335|NCT01590797|193267|P2|COMPLETED|Overall Study||217
80336|NCT01590797|193268|P1|COMPLETED|Overall Study||217
80337|NCT01590797|193267|P2|STARTED|Overall Study||233
80338|NCT01590797|193268|P1|STARTED|Overall Study||234
80339|NCT01590771|193284|P2|NOT COMPLETED|Overall Study||39
80340|NCT01590771|193285|P1|NOT COMPLETED|Overall Study||19
80341|NCT01590771|193284|P2|COMPLETED|Overall Study||210
80342|NCT01590771|193285|P1|COMPLETED|Overall Study||230
80343|NCT01590771|193284|P2|STARTED|Overall Study||249
80344|NCT01590771|193285|P1|STARTED|Overall Study||249
80345|NCT01590758|193313|P2|NOT COMPLETED|Overall Study||7
80346|NCT01590758|193314|P1|NOT COMPLETED|Overall Study||5
80347|NCT01590758|193313|P2|COMPLETED|Overall Study||97
80348|NCT01590758|193314|P1|COMPLETED|Overall Study||80
80349|NCT01590758|193313|P2|STARTED|Overall Study||104
80350|NCT01590758|193314|P1|STARTED|Overall Study||85
80351|NCT01590563|193324|P1|NOT COMPLETED|Overall Study||1
80352|NCT01590563|193324|P1|COMPLETED|Overall Study||14
80353|NCT01590563|193324|P1|STARTED|Overall Study||15
80354|NCT01590550|193330|P1|NOT COMPLETED|Overall Study||0
80355|NCT01590550|193330|P1|COMPLETED|Overall Study||18
80356|NCT01590550|193330|P1|STARTED|Overall Study||18
80357|NCT01590394|193336|P1|NOT COMPLETED|Overall Study||0
80358|NCT01590394|193336|P1|COMPLETED|Overall Study||3
80359|NCT01590394|193336|P1|STARTED|Overall Study||3
80360|NCT01590264|193340|P1|NOT COMPLETED|Overall Study||0
80361|NCT01590264|193340|P1|COMPLETED|Overall Study||5
80362|NCT01590264|193340|P1|STARTED|Overall Study||5
80363|NCT01590238|193345|P1|NOT COMPLETED|Overall Study||2
80364|NCT01590238|193345|P1|COMPLETED|Overall Study||13
80365|NCT01590238|193345|P1|STARTED|Overall Study||15
80366|NCT01590212|193352|P3|NOT COMPLETED|Overall Study||5
80367|NCT01590212|193353|P2|NOT COMPLETED|Overall Study||4
80368|NCT01590212|193354|P1|NOT COMPLETED|Overall Study||3
80369|NCT01590212|193352|P3|COMPLETED|Overall Study||9
80370|NCT01590212|193353|P2|COMPLETED|Overall Study||5
80371|NCT01590212|193354|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
80372|NCT01590212|193352|P3|Post-intervention|Overall Study|failed contact=1|10
80373|NCT01590212|193353|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
80374|NCT01590212|193354|P1|Post-intervention|Overall Study|failed contact=3|7
80375|NCT01590212|193352|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
80376|NCT01590212|193353|P2|Baseline (Pre-intervention)|Overall Study||9
80377|NCT01590212|193354|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
80378|NCT01590212|193352|P3|STARTED|Overall Study||14
80379|NCT01590212|193353|P2|STARTED|Overall Study||9
80380|NCT01590212|193354|P1|STARTED|Overall Study||12
80381|NCT01589978|193371|P1|NOT COMPLETED|Overall Study||0
80382|NCT01589978|193371|P1|COMPLETED|Overall Study||2681
80383|NCT01589978|193371|P1|STARTED|Overall Study||2681
80384|NCT01589822|193398|P3|NOT COMPLETED|Overall Study||1
80385|NCT01589822|193399|P2|NOT COMPLETED|Overall Study||3
80386|NCT01589822|193400|P1|NOT COMPLETED|Overall Study||4
80387|NCT01589822|193398|P3|COMPLETED|Overall Study||40
80388|NCT01589822|193399|P2|COMPLETED|Overall Study||86
80389|NCT01589822|193400|P1|COMPLETED|Overall Study||80
80390|NCT01589822|193398|P3|STARTED|Overall Study||41
80391|NCT01589822|193399|P2|STARTED|Overall Study||89
80392|NCT01589822|193400|P1|STARTED|Overall Study||84
80393|NCT01589653|193419|P2|NOT COMPLETED|Overall Study||11
80394|NCT01589653|193420|P1|NOT COMPLETED|Overall Study||7
80395|NCT01589653|193419|P2|COMPLETED|Overall Study||68
80396|NCT01589653|193420|P1|COMPLETED|Overall Study||69
80397|NCT01589653|193419|P2|Exposed|Overall Study||78
80398|NCT01589653|193420|P1|Exposed|Overall Study||76
80399|NCT01589653|193419|P2|STARTED|Overall Study||79
80400|NCT01589653|193420|P1|STARTED|Overall Study||76
80401|NCT01589601|193436|P2|NOT COMPLETED|Overall Study||49
80402|NCT01589601|193437|P1|NOT COMPLETED|Overall Study||47
80403|NCT01589601|193436|P2|COMPLETED|Overall Study||26
80404|NCT01589601|193437|P1|COMPLETED|Overall Study||28
80405|NCT01589601|193436|P2|STARTED|Overall Study||75
80406|NCT01589601|193437|P1|STARTED|Overall Study||75
80407|NCT01589510|193453|P1|NOT COMPLETED|Overall Study||33
80408|NCT01589510|193453|P1|COMPLETED|Overall Study||386
80409|NCT01589510|193453|P1|STARTED|Overall Study||419
80410|NCT01589497|193468|P4|NOT COMPLETED|Overall Study||1
80411|NCT01589497|193469|P3|NOT COMPLETED|Overall Study||1
80412|NCT01589497|193470|P2|NOT COMPLETED|Overall Study||1
80413|NCT01589497|193471|P1|NOT COMPLETED|Overall Study||1
80414|NCT01589497|193468|P4|COMPLETED|Overall Study||17
80415|NCT01589497|193469|P3|COMPLETED|Overall Study||15
80416|NCT01589497|193470|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
80417|NCT01589497|193471|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
80418|NCT01589497|193468|P4|STARTED|Overall Study||18
80419|NCT01589497|193469|P3|STARTED|Overall Study||16
80420|NCT01589497|193470|P2|STARTED|Overall Study||17
80421|NCT01589497|193471|P1|STARTED|Overall Study||18
80422|NCT01589484|193572|P1|NOT COMPLETED|Overall Study||4
80423|NCT01589484|193572|P1|COMPLETED|Overall Study||100
80424|NCT01589484|193572|P1|STARTED|Overall Study||104
80425|NCT01589445|193577|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
80426|NCT01589445|193577|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
80427|NCT01589445|193577|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
80428|NCT01589445|193577|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
80429|NCT01589445|193577|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
80430|NCT01589445|193577|P1|STARTED|001 (Pioglitazone) -3 Months||77
80431|NCT01589237|193597|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
80432|NCT01589237|193598|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
80433|NCT01589237|193599|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
80434|NCT01589237|193600|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
80435|NCT01589237|193597|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
80436|NCT01589237|193598|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
80437|NCT01589237|193599|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
80438|NCT01589237|193600|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
80439|NCT01589237|193597|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
80440|NCT01589237|193598|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
80441|NCT01589237|193599|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
80442|NCT01589237|193600|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
80443|NCT01589237|193597|P4|NOT COMPLETED|Part A (52 Weeks)||0
80444|NCT01589237|193598|P3|NOT COMPLETED|Part A (52 Weeks)||2
80445|NCT01589237|193599|P2|NOT COMPLETED|Part A (52 Weeks)||3
80446|NCT01589237|193600|P1|NOT COMPLETED|Part A (52 Weeks)||2
80447|NCT01589237|193597|P4|COMPLETED|Part A (52 Weeks)||5
80448|NCT01589237|193598|P3|COMPLETED|Part A (52 Weeks)||8
80449|NCT01589237|193599|P2|COMPLETED|Part A (52 Weeks)||9
80450|NCT01589237|193600|P1|COMPLETED|Part A (52 Weeks)||9
80451|NCT01589237|193597|P4|STARTED|Part A (52 Weeks)||5
80452|NCT01589237|193598|P3|STARTED|Part A (52 Weeks)||10
80453|NCT01589237|193599|P2|STARTED|Part A (52 Weeks)||12
80454|NCT01589237|193600|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
80455|NCT01588951|193649|P3|NOT COMPLETED|Overall Study||1
80456|NCT01588951|193650|P2|NOT COMPLETED|Overall Study||0
80457|NCT01588951|193651|P1|NOT COMPLETED|Overall Study||0
80458|NCT01588951|193649|P3|COMPLETED|Overall Study||5
80459|NCT01588951|193650|P2|COMPLETED|Overall Study||2
80460|NCT01588951|193651|P1|COMPLETED|Overall Study||2
80461|NCT01588951|193649|P3|STARTED|Overall Study||6
80462|NCT01588951|193650|P2|STARTED|Overall Study||2
80463|NCT01588951|193651|P1|STARTED|Overall Study||2
80464|NCT01588821|193659|P1|NOT COMPLETED|Overall Study||0
80465|NCT01588821|193659|P1|COMPLETED|Overall Study||37
80466|NCT01588821|193659|P1|STARTED|Overall Study||37
80467|NCT01588561|193664|P2|NOT COMPLETED|Overall Study||0
80468|NCT01588561|193665|P1|NOT COMPLETED|Overall Study||0
80469|NCT01588561|193664|P2|COMPLETED|Overall Study||1
80470|NCT01588561|193665|P1|COMPLETED|Overall Study||14
80471|NCT01588561|193664|P2|Second Injection (Visit 2)|Overall Study||1
80472|NCT01588561|193665|P1|Second Injection (Visit 2)|Overall Study||14
80473|NCT01588561|193664|P2|Rest Period|Overall Study||1
80474|NCT01588561|193665|P1|Rest Period|Overall Study||14
80475|NCT01588561|193664|P2|First Injection (Visit 1)|Overall Study||1
80476|NCT01588561|193665|P1|First Injection (Visit 1)|Overall Study||14
80477|NCT01588561|193664|P2|STARTED|Overall Study||1
80478|NCT01588561|193665|P1|STARTED|Overall Study||14
80479|NCT01588548|193682|P6|NOT COMPLETED|Overall Study||6
80480|NCT01588548|193683|P5|NOT COMPLETED|Overall Study||6
80481|NCT01588548|193684|P4|NOT COMPLETED|Overall Study||7
80482|NCT01588548|193685|P3|NOT COMPLETED|Overall Study||6
80483|NCT01588548|193686|P2|NOT COMPLETED|Overall Study||7
80484|NCT01588548|193687|P1|NOT COMPLETED|Overall Study||3
80485|NCT01588548|193682|P6|COMPLETED|Overall Study||0
80486|NCT01588548|193683|P5|COMPLETED|Overall Study||0
80487|NCT01588548|193684|P4|COMPLETED|Overall Study||0
80488|NCT01588548|193685|P3|COMPLETED|Overall Study||0
80489|NCT01588548|193686|P2|COMPLETED|Overall Study||0
80490|NCT01588548|193687|P1|COMPLETED|Overall Study||0
80491|NCT01588548|193682|P6|Cycle 1 Day 21|Overall Study||3
80492|NCT01588548|193683|P5|Cycle 1 Day 21|Overall Study||3
80493|NCT01588548|193684|P4|Cycle 1 Day 21|Overall Study||5
80494|NCT01588548|193685|P3|Cycle 1 Day 21|Overall Study||2
80495|NCT01588548|193686|P2|Cycle 1 Day 21|Overall Study||5
80496|NCT01588548|193687|P1|Cycle 1 Day 21|Overall Study||3
80497|NCT01588548|193682|P6|STARTED|Overall Study||6
80498|NCT01588548|193683|P5|STARTED|Overall Study||6
80499|NCT01588548|193684|P4|STARTED|Overall Study||7
80500|NCT01588548|193685|P3|STARTED|Overall Study||6
80501|NCT01588548|193686|P2|STARTED|Overall Study||7
80502|NCT01588548|193687|P1|STARTED|Overall Study||3
80503|NCT01588496|193704|P3|NOT COMPLETED|Overall Study||0
80504|NCT01588496|193705|P2|NOT COMPLETED|Overall Study||1
80505|NCT01588496|193706|P1|NOT COMPLETED|Overall Study||0
80506|NCT01588496|193704|P3|COMPLETED|Overall Study||33
80507|NCT01588496|193705|P2|COMPLETED|Overall Study||16
80508|NCT01588496|193706|P1|COMPLETED|Overall Study||8
80509|NCT01588496|193704|P3|Received Treatment|Overall Study||33
80510|NCT01588496|193705|P2|Received Treatment|Overall Study||16
80511|NCT01588496|193706|P1|Received Treatment|Overall Study||8
80512|NCT01588496|193704|P3|STARTED|Overall Study||33
80513|NCT01588496|193705|P2|STARTED|Overall Study||17
80514|NCT01588496|193706|P1|STARTED|Overall Study||8
80515|NCT01588470|193731|P1|NOT COMPLETED|Overall Study||80
80516|NCT01588470|193731|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
80517|NCT01588470|193731|P1|STARTED|Overall Study|First enrolled April 2007|130
80518|NCT01588444|193742|P2|NOT COMPLETED|Overall Study||0
80519|NCT01588444|193743|P1|NOT COMPLETED|Overall Study||0
80520|NCT01588444|193742|P2|COMPLETED|Overall Study||20
80521|NCT01588444|193743|P1|COMPLETED|Overall Study||20
80522|NCT01588444|193742|P2|STARTED|Overall Study||20
80523|NCT01588444|193743|P1|STARTED|Overall Study||20
80524|NCT01588418|193749|P2|NOT COMPLETED|Overall Study||0
80525|NCT01588418|193750|P1|NOT COMPLETED|Overall Study||0
80526|NCT01588418|193749|P2|COMPLETED|Overall Study||4
80527|NCT01588418|193750|P1|COMPLETED|Overall Study||11
80528|NCT01588418|193749|P2|STARTED|Overall Study||4
80529|NCT01588418|193750|P1|STARTED|Overall Study||11
80530|NCT01588405|193756|P1|NOT COMPLETED|Overall Study||2
80531|NCT01588405|193756|P1|COMPLETED|Overall Study||31
80532|NCT01588405|193756|P1|STARTED|Overall Study||33
80533|NCT01588353|193783|P3|NOT COMPLETED|Step3||2
80534|NCT01588353|193784|P2|NOT COMPLETED|Step3||0
80535|NCT01588353|193785|P1|NOT COMPLETED|Step3||0
80536|NCT01588353|193783|P3|COMPLETED|Step3||23
80537|NCT01588353|193784|P2|COMPLETED|Step3||0
80538|NCT01588353|193785|P1|COMPLETED|Step3||0
80539|NCT01588353|193783|P3|STARTED|Step3||25
80540|NCT01588353|193784|P2|STARTED|Step3||0
80541|NCT01588353|193785|P1|STARTED|Step3||0
80542|NCT01588353|193783|P3|NOT COMPLETED|Step2||0
80543|NCT01588353|193784|P2|NOT COMPLETED|Step2||1
80544|NCT01588353|193785|P1|NOT COMPLETED|Step2||0
80545|NCT01588353|193783|P3|COMPLETED|Step2||0
80546|NCT01588353|193784|P2|COMPLETED|Step2||70
80547|NCT01588353|193785|P1|COMPLETED|Step2||0
80548|NCT01588353|193783|P3|STARTED|Step2||0
80549|NCT01588353|193784|P2|STARTED|Step2||71
80550|NCT01588353|193785|P1|STARTED|Step2||0
80551|NCT01588353|193783|P3|NOT COMPLETED|Step1||0
80552|NCT01588353|193784|P2|NOT COMPLETED|Step1||0
80553|NCT01588353|193785|P1|NOT COMPLETED|Step1||0
80554|NCT01588353|193783|P3|COMPLETED|Step1||0
80555|NCT01588353|193784|P2|COMPLETED|Step1||0
80556|NCT01588353|193785|P1|COMPLETED|Step1||6
80557|NCT01588353|193783|P3|STARTED|Step1||0
80558|NCT01588353|193784|P2|STARTED|Step1||0
80559|NCT01588353|193785|P1|STARTED|Step1||6
80560|NCT01588158|193803|P2|NOT COMPLETED|Overall Study||0
80561|NCT01588158|193804|P1|NOT COMPLETED|Overall Study||0
80562|NCT01588158|193803|P2|COMPLETED|Overall Study||3
80563|NCT01588158|193804|P1|COMPLETED|Overall Study||4
80564|NCT01588158|193803|P2|STARTED|Overall Study||3
80565|NCT01588158|193804|P1|STARTED|Overall Study||4
80566|NCT01588106|193828|P2|NOT COMPLETED|Overall Study||4
80567|NCT01588106|193829|P1|NOT COMPLETED|Overall Study||5
80568|NCT01588106|193828|P2|COMPLETED|Overall Study||72
80569|NCT01588106|193829|P1|COMPLETED|Overall Study||73
80570|NCT01588106|193828|P2|STARTED|Overall Study||76
80571|NCT01588106|193829|P1|STARTED|Overall Study||78
80572|NCT01587989|193837|P3|NOT COMPLETED|Randomized Study Treatment||1
80573|NCT01587989|193838|P2|NOT COMPLETED|Randomized Study Treatment||2
80574|NCT01587989|193839|P1|NOT COMPLETED|Randomized Study Treatment||0
80575|NCT01587989|193837|P3|COMPLETED|Randomized Study Treatment||32
80576|NCT01587989|193838|P2|COMPLETED|Randomized Study Treatment||30
80577|NCT01587989|193839|P1|COMPLETED|Randomized Study Treatment||0
80578|NCT01587989|193837|P3|STARTED|Randomized Study Treatment||33
80579|NCT01587989|193838|P2|STARTED|Randomized Study Treatment||32
80580|NCT01587989|193839|P1|STARTED|Randomized Study Treatment||0
80581|NCT01587989|193837|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
80582|NCT01587989|193838|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
80583|NCT01587989|193839|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
80584|NCT01587989|193837|P3|COMPLETED|12-Week Open-Label Run-In Period||0
80585|NCT01587989|193838|P2|COMPLETED|12-Week Open-Label Run-In Period||0
80586|NCT01587989|193839|P1|COMPLETED|12-Week Open-Label Run-In Period||65
80587|NCT01587989|193837|P3|STARTED|12-Week Open-Label Run-In Period||0
80588|NCT01587989|193838|P2|STARTED|12-Week Open-Label Run-In Period||0
80589|NCT01587989|193839|P1|STARTED|12-Week Open-Label Run-In Period||77
80590|NCT01587963|193863|P2|NOT COMPLETED|Overall Study||0
80591|NCT01587963|193864|P1|NOT COMPLETED|Overall Study||1
80592|NCT01587963|193863|P2|COMPLETED|Overall Study||4
80593|NCT01587963|193864|P1|COMPLETED|Overall Study||6
80594|NCT01587963|193863|P2|STARTED|Overall Study||4
80595|NCT01587963|193864|P1|STARTED|Overall Study||7
80596|NCT01587950|193870|P1|NOT COMPLETED|Period 3||0
80597|NCT01587950|193870|P1|COMPLETED|Period 3||12
80598|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
80599|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
80600|NCT01587950|193870|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
80601|NCT01587950|193870|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
80602|NCT01587950|193870|P1|Received Sterile Water (5 Minutes)|Period 3||5
80603|NCT01587950|193870|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
80604|NCT01587950|193870|P1|Received Sterile Water (2 Minutes)|Period 3||2
80605|NCT01587950|193870|P1|Received Sterile Water (10 Minutes)|Period 3||5
80606|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
80607|NCT01587950|193870|P1|STARTED|Period 3||12
80608|NCT01587950|193870|P1|NOT COMPLETED|Washout 2||0
80609|NCT01587950|193870|P1|COMPLETED|Washout 2||12
80610|NCT01587950|193870|P1|STARTED|Washout 2||12
80611|NCT01587950|193870|P1|NOT COMPLETED|Period 2||0
80612|NCT01587950|193870|P1|COMPLETED|Period 2||12
80613|NCT01587950|193870|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
80614|NCT01587950|193870|P1|Received Sterile Water (10 Minutes)|Period 2||2
80615|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
80616|NCT01587950|193870|P1|Received Sterile Water (5 Minutes)|Period 2||2
80617|NCT01587950|193870|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
80618|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
80619|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
80620|NCT01587950|193870|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
80621|NCT01587950|193870|P1|Received Sterile Water (2 Minutes)|Period 2||8
80622|NCT01587950|193870|P1|STARTED|Period 2||12
80623|NCT01587950|193870|P1|NOT COMPLETED|Washout 1||0
80624|NCT01587950|193870|P1|COMPLETED|Washout 1||12
80625|NCT01587950|193870|P1|STARTED|Washout 1||12
80626|NCT01587950|193870|P1|NOT COMPLETED|Period 1||0
80627|NCT01587950|193870|P1|COMPLETED|Period 1||12
80628|NCT01587950|193870|P1|Received Sterile Water (5 Minutes)|Period 1||5
80629|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
80630|NCT01587950|193870|P1|Received Sterile Water (10 Minutes)|Period 1||5
80631|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
80632|NCT01587950|193870|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
80633|NCT01587950|193870|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
80634|NCT01587950|193870|P1|Received Sterile Water (2 Minutes)|Period 1||2
80635|NCT01587950|193870|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
80636|NCT01587950|193870|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
80637|NCT01587950|193870|P1|STARTED|Period 1||12
80638|NCT01587924|193904|P4|NOT COMPLETED|Overall Study||1
80639|NCT01587924|193905|P3|NOT COMPLETED|Overall Study||4
80640|NCT01587924|193906|P2|NOT COMPLETED|Overall Study||4
80641|NCT01587924|193907|P1|NOT COMPLETED|Overall Study||4
80642|NCT01587924|193904|P4|COMPLETED|Overall Study||19
80643|NCT01587924|193905|P3|COMPLETED|Overall Study||17
80644|NCT01587924|193906|P2|COMPLETED|Overall Study||17
80645|NCT01587924|193907|P1|COMPLETED|Overall Study||17
80646|NCT01587924|193904|P4|STARTED|Overall Study||20
80647|NCT01587924|193905|P3|STARTED|Overall Study||21
80648|NCT01587924|193906|P2|STARTED|Overall Study||21
80649|NCT01587924|193907|P1|STARTED|Overall Study||21
80650|NCT01587898|194008|P4|NOT COMPLETED|Overall Study||2
80651|NCT01587898|194009|P3|NOT COMPLETED|Overall Study||2
80652|NCT01587898|194010|P2|NOT COMPLETED|Overall Study||5
80653|NCT01587898|194011|P1|NOT COMPLETED|Overall Study||4
80654|NCT01587898|194008|P4|COMPLETED|Overall Study||17
80655|NCT01587898|194009|P3|COMPLETED|Overall Study||16
80656|NCT01587898|194010|P2|COMPLETED|Overall Study||12
80657|NCT01587898|194011|P1|COMPLETED|Overall Study||14
80658|NCT01587898|194008|P4|STARTED|Overall Study||19
80659|NCT01587898|194009|P3|STARTED|Overall Study||18
80660|NCT01587898|194010|P2|STARTED|Overall Study||17
80661|NCT01587898|194011|P1|STARTED|Overall Study||18
80662|NCT01587885|194187|P2|NOT COMPLETED|Treatment Period 2||0
80663|NCT01587885|194188|P1|NOT COMPLETED|Treatment Period 2||0
80664|NCT01587885|194187|P2|COMPLETED|Treatment Period 2||19
80665|NCT01587885|194188|P1|COMPLETED|Treatment Period 2||26
80666|NCT01587885|194187|P2|STARTED|Treatment Period 2||19
80667|NCT01587885|194188|P1|STARTED|Treatment Period 2||26
80668|NCT01587885|194187|P2|NOT COMPLETED|Treatment Period 1||3
80669|NCT01587885|194188|P1|NOT COMPLETED|Treatment Period 1||0
80670|NCT01587885|194187|P2|COMPLETED|Treatment Period 1||19
80671|NCT01587885|194188|P1|COMPLETED|Treatment Period 1||26
80672|NCT01587885|194187|P2|STARTED|Treatment Period 1||22
80673|NCT01587885|194188|P1|STARTED|Treatment Period 1||26
80674|NCT01587651|194204|P3|NOT COMPLETED|Overall Study||1
80675|NCT01587651|194205|P2|NOT COMPLETED|Overall Study||3
80676|NCT01587651|194206|P1|NOT COMPLETED|Overall Study||0
80677|NCT01587651|194204|P3|COMPLETED|Overall Study||34
80678|NCT01587651|194205|P2|COMPLETED|Overall Study||38
80679|NCT01587651|194206|P1|COMPLETED|Overall Study||34
80680|NCT01587651|194204|P3|STARTED|Overall Study||35
80681|NCT01587651|194205|P2|STARTED|Overall Study||41
80682|NCT01587651|194206|P1|STARTED|Overall Study||34
80683|NCT01587118|194233|P1|NOT COMPLETED|Overall Study||7
80684|NCT01587118|194233|P1|COMPLETED|Overall Study||11
80685|NCT01587118|194233|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
80686|NCT01587105|194240|P2|NOT COMPLETED|Overall Study||43
80687|NCT01587105|194241|P1|NOT COMPLETED|Overall Study||6
80688|NCT01587105|194240|P2|COMPLETED|Overall Study||138
80689|NCT01587105|194241|P1|COMPLETED|Overall Study||144
80690|NCT01587105|194240|P2|STARTED|Overall Study||181
80691|NCT01587105|194241|P1|STARTED|Overall Study||150
80692|NCT01587079|194257|P1|NOT COMPLETED|Overall Study||39
80693|NCT01587079|194257|P1|COMPLETED|Overall Study||120
80694|NCT01587079|194257|P1|STARTED|Overall Study||159
80695|NCT01587027|194381|P2|NOT COMPLETED|Discharge (1 Day)||0
80696|NCT01587027|194382|P1|NOT COMPLETED|Discharge (1 Day)||0
80697|NCT01587027|194381|P2|COMPLETED|Discharge (1 Day)||8
80698|NCT01587027|194382|P1|COMPLETED|Discharge (1 Day)||8
80699|NCT01587027|194381|P2|STARTED|Discharge (1 Day)||8
80700|NCT01587027|194382|P1|STARTED|Discharge (1 Day)||8
80701|NCT01587027|194381|P2|NOT COMPLETED|Third Intervention (1 Day)||0
80702|NCT01587027|194382|P1|NOT COMPLETED|Third Intervention (1 Day)||0
80703|NCT01587027|194381|P2|COMPLETED|Third Intervention (1 Day)||8
80704|NCT01587027|194382|P1|COMPLETED|Third Intervention (1 Day)||8
80705|NCT01587027|194381|P2|STARTED|Third Intervention (1 Day)||8
80706|NCT01587027|194382|P1|STARTED|Third Intervention (1 Day)||8
80707|NCT01587027|194381|P2|NOT COMPLETED|Washout (1 Day)||0
80708|NCT01587027|194382|P1|NOT COMPLETED|Washout (1 Day)||0
80709|NCT01587027|194381|P2|COMPLETED|Washout (1 Day)||8
80710|NCT01587027|194382|P1|COMPLETED|Washout (1 Day)||8
80711|NCT01587027|194381|P2|STARTED|Washout (1 Day)||8
80712|NCT01587027|194382|P1|STARTED|Washout (1 Day)||8
80713|NCT01587027|194381|P2|NOT COMPLETED|Second Intervention (1 Day)||0
80714|NCT01587027|194382|P1|NOT COMPLETED|Second Intervention (1 Day)||0
80715|NCT01587027|194381|P2|COMPLETED|Second Intervention (1 Day)||8
80716|NCT01587027|194382|P1|COMPLETED|Second Intervention (1 Day)||8
80717|NCT01587027|194381|P2|STARTED|Second Intervention (1 Day)||8
80718|NCT01587027|194382|P1|STARTED|Second Intervention (1 Day)||8
80719|NCT01587027|194381|P2|NOT COMPLETED|Washout (1 Day)||0
80720|NCT01587027|194382|P1|NOT COMPLETED|Washout (1 Day)||0
80721|NCT01587027|194381|P2|COMPLETED|Washout (1 Day)||8
80722|NCT01587027|194382|P1|COMPLETED|Washout (1 Day)||8
80723|NCT01587027|194381|P2|STARTED|Washout (1 Day)||8
80724|NCT01587027|194382|P1|STARTED|Washout (1 Day)||8
80725|NCT01587027|194381|P2|NOT COMPLETED|First Intervention (1 Day)||0
80726|NCT01587027|194382|P1|NOT COMPLETED|First Intervention (1 Day)||0
80727|NCT01587027|194381|P2|COMPLETED|First Intervention (1 Day)||8
80728|NCT01587027|194382|P1|COMPLETED|First Intervention (1 Day)||8
80729|NCT01587027|194381|P2|STARTED|First Intervention (1 Day)||8
80730|NCT01587027|194382|P1|STARTED|First Intervention (1 Day)||8
80731|NCT01587014|194388|P1|NOT COMPLETED|Overall Study||2
80732|NCT01587014|194388|P1|COMPLETED|Overall Study||24
80733|NCT01587014|194388|P1|STARTED|Overall Study||26
80734|NCT01587001|194395|P2|NOT COMPLETED|Overall Study||1
80735|NCT01587001|194396|P1|NOT COMPLETED|Overall Study||6
80736|NCT01587001|194395|P2|COMPLETED|Overall Study||2
80737|NCT01587001|194396|P1|COMPLETED|Overall Study||8
80738|NCT01587001|194395|P2|STARTED|Overall Study||3
80739|NCT01587001|194396|P1|STARTED|Overall Study||14
80740|NCT01586975|194407|P3|NOT COMPLETED|Overall Study||0
80741|NCT01586975|194408|P2|NOT COMPLETED|Overall Study||0
80742|NCT01586975|194409|P1|NOT COMPLETED|Overall Study||0
80743|NCT01586975|194407|P3|COMPLETED|Overall Study||46
80744|NCT01586975|194408|P2|COMPLETED|Overall Study||32
80745|NCT01586975|194409|P1|COMPLETED|Overall Study||15
80746|NCT01586975|194407|P3|STARTED|Overall Study||46
80747|NCT01586975|194408|P2|STARTED|Overall Study||32
80748|NCT01586975|194409|P1|STARTED|Overall Study||15
80749|NCT01586962|194417|P1|NOT COMPLETED|Overall Study||0
80750|NCT01586962|194417|P1|COMPLETED|Overall Study||56
80751|NCT01586962|194417|P1|STARTED|Overall Study||56
80752|NCT01586897|194425|P2|NOT COMPLETED|Overall Study||0
80753|NCT01586897|194426|P1|NOT COMPLETED|Overall Study||0
80754|NCT01586897|194425|P2|COMPLETED|Overall Study||26
80755|NCT01586897|194426|P1|COMPLETED|Overall Study||26
80756|NCT01586897|194425|P2|STARTED|Overall Study||26
80757|NCT01586897|194426|P1|STARTED|Overall Study||26
80758|NCT01586819|194444|P2|NOT COMPLETED|Overall Study||0
80759|NCT01586819|194445|P1|NOT COMPLETED|Overall Study||1
80760|NCT01586819|194444|P2|COMPLETED|Overall Study||14
80761|NCT01586819|194445|P1|COMPLETED|Overall Study||11
80762|NCT01586819|194444|P2|STARTED|Overall Study||14
80763|NCT01586819|194445|P1|STARTED|Overall Study||12
80764|NCT01586806|194456|P3|NOT COMPLETED|Overall Study||2
80765|NCT01586806|194457|P2|NOT COMPLETED|Overall Study||4
80766|NCT01586806|194458|P1|NOT COMPLETED|Overall Study||3
80767|NCT01586806|194456|P3|COMPLETED|Overall Study||63
80768|NCT01586806|194457|P2|COMPLETED|Overall Study||61
80769|NCT01586806|194458|P1|COMPLETED|Overall Study||62
80770|NCT01586806|194456|P3|STARTED|Overall Study||65
80771|NCT01586806|194457|P2|STARTED|Overall Study||65
80772|NCT01586806|194458|P1|STARTED|Overall Study||65
80773|NCT01586364|194478|P1|NOT COMPLETED|Overall Study||117
80774|NCT01586364|194478|P1|COMPLETED|Overall Study||184
80775|NCT01586364|194478|P1|STARTED|Overall Study||301
80776|NCT01586338|194531|P1|NOT COMPLETED|Overall Study||8
80777|NCT01586338|194531|P1|COMPLETED|Overall Study||229
80778|NCT01586338|194531|P1|STARTED|Overall Study||237
80779|NCT01586312|194543|P2|NOT COMPLETED|Overall Study||0
80780|NCT01586312|194544|P1|NOT COMPLETED|Overall Study||0
80781|NCT01586312|194543|P2|COMPLETED|Overall Study||15
80782|NCT01586312|194544|P1|COMPLETED|Overall Study||15
80783|NCT01586312|194543|P2|STARTED|Overall Study||15
80784|NCT01586312|194544|P1|STARTED|Overall Study||15
80785|NCT01586195|194554|P1|NOT COMPLETED|Overall Study||26
80786|NCT01586195|194554|P1|COMPLETED|Overall Study||5
80787|NCT01586195|194554|P1|STARTED|Overall Study||31
80788|NCT01586156|194568|P3|NOT COMPLETED|Overall Study||0
80789|NCT01586156|194569|P2|NOT COMPLETED|Overall Study||1
80790|NCT01586156|194570|P1|NOT COMPLETED|Overall Study||0
80791|NCT01586156|194568|P3|COMPLETED|Overall Study||10
80792|NCT01586156|194569|P2|COMPLETED|Overall Study||9
80793|NCT01586156|194570|P1|COMPLETED|Overall Study||10
80794|NCT01586156|194568|P3|STARTED|Overall Study||10
80795|NCT01586156|194569|P2|STARTED|Overall Study||10
80796|NCT01586156|194570|P1|STARTED|Overall Study||10
80797|NCT01586026|194596|P3|NOT COMPLETED|Overall Study||0
80798|NCT01586026|194597|P2|NOT COMPLETED|Overall Study||0
80799|NCT01586026|194598|P1|NOT COMPLETED|Overall Study||0
80800|NCT01586026|194596|P3|COMPLETED|Overall Study||271
80801|NCT01586026|194597|P2|COMPLETED|Overall Study||414
80802|NCT01586026|194598|P1|COMPLETED|Overall Study||350
80803|NCT01586026|194596|P3|STARTED|Overall Study||271
80804|NCT01586026|194597|P2|STARTED|Overall Study||414
80805|NCT01586026|194598|P1|STARTED|Overall Study||350
80806|NCT01585987|194608|P2|NOT COMPLETED|Treated||49
80807|NCT01585987|194609|P1|NOT COMPLETED|Treated||54
80808|NCT01585987|194608|P2|COMPLETED|Treated||2
80809|NCT01585987|194609|P1|COMPLETED|Treated||3
80810|NCT01585987|194608|P2|STARTED|Treated||51
80811|NCT01585987|194609|P1|STARTED|Treated||57
80812|NCT01585987|194608|P2|NOT COMPLETED|Randomized||6
80813|NCT01585987|194609|P1|NOT COMPLETED|Randomized||0
80814|NCT01585987|194608|P2|COMPLETED|Randomized||51
80815|NCT01585987|194609|P1|COMPLETED|Randomized||57
80816|NCT01585987|194608|P2|STARTED|Randomized||57
80817|NCT01585987|194609|P1|STARTED|Randomized||57
80818|NCT01585961|194624|P1|NOT COMPLETED|Overall Study||33
80819|NCT01585961|194624|P1|COMPLETED|Overall Study||478
80820|NCT01585961|194624|P1|Safety|Overall Study|Patients ablated with study catheter|508
80821|NCT01585961|194624|P1|STARTED|Overall Study||511
80822|NCT01585779|194641|P2|NOT COMPLETED|Overall Study||7
80823|NCT01585779|194642|P1|NOT COMPLETED|Overall Study||10
80824|NCT01585779|194641|P2|COMPLETED|Overall Study||21
80825|NCT01585779|194642|P1|COMPLETED|Overall Study||26
80826|NCT01585779|194641|P2|STARTED|Overall Study||28
80827|NCT01585779|194642|P1|STARTED|Overall Study||36
80828|NCT01585597|194696|P1|NOT COMPLETED|Overall Study||0
80829|NCT01585597|194696|P1|COMPLETED|Overall Study||20
80830|NCT01585597|194696|P1|STARTED|Overall Study||20
80831|NCT01585584|194701|P1|NOT COMPLETED|Overall Study||4
80832|NCT01585584|194701|P1|COMPLETED|Overall Study||6
80833|NCT01585584|194701|P1|STARTED|Overall Study||10
80834|NCT01585558|194708|P3|NOT COMPLETED|Overall Study||15
80835|NCT01585558|194709|P2|NOT COMPLETED|Overall Study||12
80836|NCT01585558|194710|P1|NOT COMPLETED|Overall Study||13
80837|NCT01585558|194708|P3|COMPLETED|Overall Study||34
80838|NCT01585558|194709|P2|COMPLETED|Overall Study||57
80839|NCT01585558|194710|P1|COMPLETED|Overall Study||49
80840|NCT01585558|194708|P3|STARTED|Overall Study||49
80841|NCT01585558|194709|P2|STARTED|Overall Study||69
80842|NCT01585558|194710|P1|STARTED|Overall Study||62
80843|NCT01585441|194891|P2|NOT COMPLETED|Overall Study||0
80844|NCT01585441|194892|P1|NOT COMPLETED|Overall Study||0
80845|NCT01585441|194891|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
80846|NCT01585441|194892|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
80847|NCT01585441|194891|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
80848|NCT01585441|194892|P1|Final Study Safety Visit|Overall Study||3
80849|NCT01585441|194891|P2|Received Finasteride at Month 3|Overall Study||2
80850|NCT01585441|194892|P1|Received Finasteride at Month 3|Overall Study||2
80851|NCT01585441|194891|P2|Month 3|Overall Study||3
80852|NCT01585441|194892|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
80853|NCT01585441|194891|P2|STARTED|Overall Study||3
80854|NCT01585441|194892|P1|STARTED|Overall Study||3
80855|NCT01585428|194944|P2|NOT COMPLETED|Overall Study||0
80856|NCT01585428|194945|P1|NOT COMPLETED|Overall Study||1
80857|NCT01585428|194944|P2|COMPLETED|Overall Study||11
80858|NCT01585428|194945|P1|COMPLETED|Overall Study||17
80859|NCT01585428|194944|P2|STARTED|Overall Study||11
80860|NCT01585428|194945|P1|STARTED|Overall Study||18
80861|NCT01585324|194953|P1|NOT COMPLETED|Overall Study||0
80862|NCT01585324|194953|P1|COMPLETED|Overall Study||30
80863|NCT01585324|194953|P1|STARTED|Overall Study||30
80864|NCT01585272|194969|P1|NOT COMPLETED|Overall Study||39
80865|NCT01585272|194969|P1|COMPLETED|Overall Study||82
80866|NCT01585272|194969|P1|Exelon Patch 10 cm2|Overall Study||96
80867|NCT01585272|194969|P1|Exelon Patch 5 cm2|Overall Study||114
80868|NCT01585272|194969|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
80869|NCT01585272|194969|P1|STARTED|Overall Study||121
80870|NCT01585246|194982|P5|NOT COMPLETED|Overall Study||2
80871|NCT01585246|194983|P4|NOT COMPLETED|Overall Study||4
80872|NCT01585246|194984|P3|NOT COMPLETED|Overall Study||4
80873|NCT01585246|194985|P2|NOT COMPLETED|Overall Study||1
80874|NCT01585246|194986|P1|NOT COMPLETED|Overall Study||0
80875|NCT01585246|194982|P5|COMPLETED|Overall Study||9
80876|NCT01585246|194983|P4|COMPLETED|Overall Study||6
80877|NCT01585246|194984|P3|COMPLETED|Overall Study||16
80878|NCT01585246|194985|P2|COMPLETED|Overall Study||3
80879|NCT01585246|194986|P1|COMPLETED|Overall Study||3
80880|NCT01585246|194982|P5|STARTED|Overall Study||11
80881|NCT01585246|194983|P4|STARTED|Overall Study||10
80882|NCT01585246|194984|P3|STARTED|Overall Study||20
80883|NCT01585246|194985|P2|STARTED|Overall Study||4
80884|NCT01585246|194986|P1|STARTED|Overall Study||3
80885|NCT01585207|195001|P1|NOT COMPLETED|Overall Study||0
80886|NCT01585207|195001|P1|COMPLETED|Overall Study||4
80887|NCT01585207|195001|P1|STARTED|Overall Study||4
80888|NCT01585168|195007|P4|NOT COMPLETED|Overall Study||1
80889|NCT01585168|195008|P3|NOT COMPLETED|Overall Study||1
80890|NCT01585168|195009|P2|NOT COMPLETED|Overall Study||1
80891|NCT01585168|195010|P1|NOT COMPLETED|Overall Study||3
80892|NCT01585168|195007|P4|COMPLETED|Overall Study||18
80893|NCT01585168|195008|P3|COMPLETED|Overall Study||15
80894|NCT01585168|195009|P2|COMPLETED|Overall Study||17
80895|NCT01585168|195010|P1|COMPLETED|Overall Study||15
80896|NCT01585168|195007|P4|STARTED|Overall Study||19
80897|NCT01585168|195008|P3|STARTED|Overall Study||16
80898|NCT01585168|195009|P2|STARTED|Overall Study||18
80899|NCT01585168|195010|P1|STARTED|Overall Study||18
80900|NCT01585129|195032|P2|NOT COMPLETED|Overall Study||0
80901|NCT01585129|195033|P1|NOT COMPLETED|Overall Study||0
80902|NCT01585129|195032|P2|COMPLETED|Overall Study||39
80903|NCT01585129|195033|P1|COMPLETED|Overall Study||41
80904|NCT01585129|195032|P2|STARTED|Overall Study||39
80905|NCT01585129|195033|P1|STARTED|Overall Study||41
80906|NCT01585038|195045|P2|NOT COMPLETED|Overall Study||2
80907|NCT01585038|195046|P1|NOT COMPLETED|Overall Study||2
80908|NCT01585038|195045|P2|COMPLETED|Overall Study||18
80909|NCT01585038|195046|P1|COMPLETED|Overall Study||18
80910|NCT01585038|195045|P2|STARTED|Overall Study||20
80911|NCT01585038|195046|P1|STARTED|Overall Study||20
80912|NCT01584843|195062|P6|NOT COMPLETED|Second Treatment Period||1
80913|NCT01584843|195063|P5|NOT COMPLETED|Second Treatment Period||0
80914|NCT01584843|195064|P4|NOT COMPLETED|Second Treatment Period||0
80915|NCT01584843|195065|P3|NOT COMPLETED|Second Treatment Period||0
80916|NCT01584843|195066|P2|NOT COMPLETED|Second Treatment Period||0
80917|NCT01584843|195067|P1|NOT COMPLETED|Second Treatment Period||0
80918|NCT01584843|195062|P6|COMPLETED|Second Treatment Period||0
80919|NCT01584843|195063|P5|COMPLETED|Second Treatment Period||3
80920|NCT01584843|195064|P4|COMPLETED|Second Treatment Period||6
80921|NCT01584843|195065|P3|COMPLETED|Second Treatment Period||2
80922|NCT01584843|195066|P2|COMPLETED|Second Treatment Period||1
80923|NCT01584843|195067|P1|COMPLETED|Second Treatment Period||2
80924|NCT01584843|195062|P6|STARTED|Second Treatment Period||1
80925|NCT01584843|195063|P5|STARTED|Second Treatment Period||3
80926|NCT01584843|195064|P4|STARTED|Second Treatment Period||6
80927|NCT01584843|195065|P3|STARTED|Second Treatment Period||2
80928|NCT01584843|195066|P2|STARTED|Second Treatment Period||1
80929|NCT01584843|195067|P1|STARTED|Second Treatment Period||2
80930|NCT01584843|195062|P6|NOT COMPLETED|First Treatment Period||2
80931|NCT01584843|195063|P5|NOT COMPLETED|First Treatment Period||0
80932|NCT01584843|195064|P4|NOT COMPLETED|First Treatment Period||0
80933|NCT01584843|195065|P3|NOT COMPLETED|First Treatment Period||1
80934|NCT01584843|195066|P2|NOT COMPLETED|First Treatment Period||0
80935|NCT01584843|195067|P1|NOT COMPLETED|First Treatment Period||0
80936|NCT01584843|195062|P6|COMPLETED|First Treatment Period||9
80937|NCT01584843|195063|P5|COMPLETED|First Treatment Period||10
80938|NCT01584843|195064|P4|COMPLETED|First Treatment Period||10
80939|NCT01584843|195065|P3|COMPLETED|First Treatment Period||2
80940|NCT01584843|195066|P2|COMPLETED|First Treatment Period||4
80941|NCT01584843|195067|P1|COMPLETED|First Treatment Period||3
80942|NCT01584843|195062|P6|STARTED|First Treatment Period||11
80943|NCT01584843|195063|P5|STARTED|First Treatment Period||10
80944|NCT01584843|195064|P4|STARTED|First Treatment Period||10
80945|NCT01584843|195065|P3|STARTED|First Treatment Period||3
80946|NCT01584843|195066|P2|STARTED|First Treatment Period||4
80947|NCT01584843|195067|P1|STARTED|First Treatment Period||3
80948|NCT01584648|195178|P2|NOT COMPLETED|Overall Study||212
80949|NCT01584648|195179|P1|NOT COMPLETED|Overall Study||211
80950|NCT01584648|195178|P2|COMPLETED|Overall Study||0
80951|NCT01584648|195179|P1|COMPLETED|Overall Study||0
80952|NCT01584648|195178|P2|Ongoing|Overall Study||147
80953|NCT01584648|195179|P1|Ongoing|Overall Study||154
80954|NCT01584648|195178|P2|STARTED|Overall Study||212
80955|NCT01584648|195179|P1|STARTED|Overall Study||211
80956|NCT01584544|195222|P5|NOT COMPLETED|Overall Study||0
80957|NCT01584544|195223|P4|NOT COMPLETED|Overall Study||0
80958|NCT01584544|195224|P3|NOT COMPLETED|Overall Study||0
80959|NCT01584544|195225|P2|NOT COMPLETED|Overall Study||0
80960|NCT01584544|195226|P1|NOT COMPLETED|Overall Study||0
80961|NCT01584544|195222|P5|COMPLETED|Overall Study||6
80962|NCT01584544|195223|P4|COMPLETED|Overall Study||3
80963|NCT01584544|195224|P3|COMPLETED|Overall Study||6
80964|NCT01584544|195225|P2|COMPLETED|Overall Study||6
80965|NCT01584544|195226|P1|COMPLETED|Overall Study||3
80966|NCT01584544|195222|P5|STARTED|Overall Study||6
80967|NCT01584544|195223|P4|STARTED|Overall Study||3
80968|NCT01584544|195224|P3|STARTED|Overall Study||6
80969|NCT01584544|195225|P2|STARTED|Overall Study||6
80970|NCT01584544|195226|P1|STARTED|Overall Study||3
80971|NCT01584518|195240|P2|NOT COMPLETED|Overall Study||0
80972|NCT01584518|195241|P1|NOT COMPLETED|Overall Study||0
80973|NCT01584518|195240|P2|COMPLETED|Overall Study||25
80974|NCT01584518|195241|P1|COMPLETED|Overall Study||25
80975|NCT01584518|195240|P2|STARTED|Overall Study||25
80976|NCT01584518|195241|P1|STARTED|Overall Study||25
80977|NCT01584479|195251|P4|NOT COMPLETED|Overall Study||0
80978|NCT01584479|195252|P3|NOT COMPLETED|Overall Study||0
80979|NCT01584479|195253|P2|NOT COMPLETED|Overall Study||0
80980|NCT01584479|195254|P1|NOT COMPLETED|Overall Study||0
80981|NCT01584479|195251|P4|COMPLETED|Overall Study||1847
80982|NCT01584479|195252|P3|COMPLETED|Overall Study||852
80983|NCT01584479|195253|P2|COMPLETED|Overall Study||1686
80984|NCT01584479|195254|P1|COMPLETED|Overall Study||732
80985|NCT01584479|195251|P4|STARTED|Overall Study||1847
80986|NCT01584479|195252|P3|STARTED|Overall Study||852
80987|NCT01584479|195253|P2|STARTED|Overall Study||1686
80988|NCT01584479|195254|P1|STARTED|Overall Study||732
80989|NCT01584388|195264|P1|NOT COMPLETED|Overall Study||0
80990|NCT01584388|195264|P1|COMPLETED|Overall Study||30
80991|NCT01584388|195264|P1|STARTED|Overall Study||30
80992|NCT01584232|195284|P2|NOT COMPLETED|Overall Study||3
80993|NCT01584232|195285|P1|NOT COMPLETED|Overall Study||8
80994|NCT01584232|195284|P2|COMPLETED|Overall Study||177
80995|NCT01584232|195285|P1|COMPLETED|Overall Study||173
80996|NCT01584232|195284|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
80997|NCT01584232|195285|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
80998|NCT01584232|195284|P2|STARTED|Overall Study||180
80999|NCT01584232|195285|P1|STARTED|Overall Study||181
81000|NCT01583894|195301|P1|NOT COMPLETED|Overall Study||15
81001|NCT01583894|195301|P1|COMPLETED|Overall Study||813
81002|NCT01583894|195301|P1|STARTED|Overall Study||828
81003|NCT01583647|195305|P2|NOT COMPLETED|Overall Study||0
81004|NCT01583647|195306|P1|NOT COMPLETED|Overall Study||0
81005|NCT01583647|195305|P2|COMPLETED|Overall Study||0
81006|NCT01583647|195306|P1|COMPLETED|Overall Study||10
81007|NCT01583647|195305|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
81008|NCT01583647|195306|P1|STARTED|Overall Study||10
81009|NCT01583543|195318|P1|NOT COMPLETED|Overall Study||0
81010|NCT01583543|195318|P1|COMPLETED|Overall Study||12
81011|NCT01583543|195318|P1|STARTED|Overall Study||12
81012|NCT01583530|195331|P6|NOT COMPLETED|Overall Study||3
81013|NCT01583530|195332|P5|NOT COMPLETED|Overall Study||5
81014|NCT01583530|195333|P4|NOT COMPLETED|Overall Study||1
81015|NCT01583530|195334|P3|NOT COMPLETED|Overall Study||0
81016|NCT01583530|195335|P2|NOT COMPLETED|Overall Study||3
81017|NCT01583530|195336|P1|NOT COMPLETED|Overall Study||0
81018|NCT01583530|195331|P6|COMPLETED|Overall Study||17
81019|NCT01583530|195332|P5|COMPLETED|Overall Study||15
81020|NCT01583530|195333|P4|COMPLETED|Overall Study||18
81021|NCT01583530|195334|P3|COMPLETED|Overall Study||20
81022|NCT01583530|195335|P2|COMPLETED|Overall Study||17
81023|NCT01583530|195336|P1|COMPLETED|Overall Study||19
81024|NCT01583530|195331|P6|STARTED|Overall Study||20
81025|NCT01583530|195332|P5|STARTED|Overall Study||20
81026|NCT01583530|195333|P4|STARTED|Overall Study||19
81027|NCT01583530|195334|P3|STARTED|Overall Study||20
81028|NCT01583530|195335|P2|STARTED|Overall Study||20
81029|NCT01583530|195336|P1|STARTED|Overall Study||19
81030|NCT01583452|195382|P2|NOT COMPLETED|Overall Study||0
81031|NCT01583452|195383|P1|NOT COMPLETED|Overall Study||0
81032|NCT01583452|195382|P2|COMPLETED|Overall Study||20
81033|NCT01583452|195383|P1|COMPLETED|Overall Study||21
81034|NCT01583452|195382|P2|STARTED|Overall Study||20
81035|NCT01583452|195383|P1|STARTED|Overall Study||21
81036|NCT01583374|195398|P3|NOT COMPLETED|Overall Study||25
81037|NCT01583374|195399|P2|NOT COMPLETED|Overall Study||16
81038|NCT01583374|195400|P1|NOT COMPLETED|Overall Study||19
81039|NCT01583374|195398|P3|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|138
81040|NCT01583374|195399|P2|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|147
81041|NCT01583374|195400|P1|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|145
81042|NCT01583374|195398|P3|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|49
81043|NCT01583374|195399|P2|Early Escape at Week 16|Overall Study||49
81044|NCT01583374|195400|P1|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|51
81045|NCT01583374|195398|P3|Completed Week 16|Overall Study||144
81046|NCT01583374|195399|P2|Completed Week 16|Overall Study||151
81047|NCT01583374|195400|P1|Completed Week 16|Overall Study||150
81048|NCT01583374|195398|P3|Received Treatment|Overall Study||163
81049|NCT01583374|195399|P2|Received Treatment|Overall Study||163
81050|NCT01583374|195400|P1|Received Treatment|Overall Study||164
81051|NCT01583374|195398|P3|STARTED|Overall Study||163
81052|NCT01583374|195399|P2|STARTED|Overall Study||163
81053|NCT01583374|195400|P1|STARTED|Overall Study||164
81054|NCT01583218|195412|P2|NOT COMPLETED|Overall Study||283
81055|NCT01583218|195413|P1|NOT COMPLETED|Overall Study||289
81056|NCT01583218|195412|P2|COMPLETED|Overall Study||3471
81057|NCT01583218|195413|P1|COMPLETED|Overall Study||3470
81058|NCT01583218|195412|P2|STARTED|Overall Study||3754
81059|NCT01583218|195413|P1|STARTED|Overall Study||3759
81060|NCT01583101|195433|P2|NOT COMPLETED|Overall Study||0
81061|NCT01583101|195434|P1|NOT COMPLETED|Overall Study||0
81062|NCT01583101|195433|P2|COMPLETED|Overall Study||1161
81063|NCT01583101|195434|P1|COMPLETED|Overall Study||1076
81064|NCT01583101|195433|P2|STARTED|Overall Study||1161
81065|NCT01583101|195434|P1|STARTED|Overall Study||1076
81066|NCT01582971|195442|P2|NOT COMPLETED|Overall Study||37
81067|NCT01582971|195443|P1|NOT COMPLETED|Overall Study||39
81068|NCT01582971|195442|P2|COMPLETED|Overall Study||91
81069|NCT01582971|195443|P1|COMPLETED|Overall Study||89
81070|NCT01582971|195442|P2|STARTED|Overall Study||128
81071|NCT01582971|195443|P1|STARTED|Overall Study||128
81072|NCT01582945|195461|P1|NOT COMPLETED|Overall Study||2
81073|NCT01582945|195461|P1|COMPLETED|Overall Study||12
81074|NCT01582945|195461|P1|STARTED|Overall Study||14
81075|NCT01582880|195465|P1|NOT COMPLETED|Overall Study||0
81076|NCT01582880|195465|P1|COMPLETED|Overall Study||1
81077|NCT01582880|195465|P1|STARTED|Overall Study||1
81078|NCT01582854|195475|P2|NOT COMPLETED|Overall Study||34
81079|NCT01582854|195476|P1|NOT COMPLETED|Overall Study||36
81080|NCT01582854|195475|P2|COMPLETED|Overall Study||221
81081|NCT01582854|195476|P1|COMPLETED|Overall Study||212
81082|NCT01582854|195475|P2|STARTED|Overall Study||255
81083|NCT01582854|195476|P1|STARTED|Overall Study||248
81084|NCT01582789|195504|P2|NOT COMPLETED|Second Intervention (14 Days)||0
81085|NCT01582789|195505|P1|NOT COMPLETED|Second Intervention (14 Days)||1
81086|NCT01582789|195504|P2|COMPLETED|Second Intervention (14 Days)||27
81087|NCT01582789|195505|P1|COMPLETED|Second Intervention (14 Days)||33
81088|NCT01582789|195504|P2|STARTED|Second Intervention (14 Days)||27
81089|NCT01582789|195505|P1|STARTED|Second Intervention (14 Days)||34
81090|NCT01582789|195504|P2|NOT COMPLETED|First Intervention (14 Days)||0
81091|NCT01582789|195505|P1|NOT COMPLETED|First Intervention (14 Days)||0
81092|NCT01582789|195504|P2|COMPLETED|First Intervention (14 Days)||27
81093|NCT01582789|195505|P1|COMPLETED|First Intervention (14 Days)||34
81094|NCT01582789|195504|P2|STARTED|First Intervention (14 Days)||27
81095|NCT01582789|195505|P1|STARTED|First Intervention (14 Days)||34
81096|NCT01582490|195523|P2|NOT COMPLETED|Overall Study||1
81097|NCT01582490|195524|P1|NOT COMPLETED|Overall Study||1
81098|NCT01582490|195523|P2|COMPLETED|Overall Study||9
81099|NCT01582490|195524|P1|COMPLETED|Overall Study||8
81100|NCT01582490|195523|P2|STARTED|Overall Study||10
81101|NCT01582490|195524|P1|STARTED|Overall Study||9
81102|NCT01582477|195546|P2|NOT COMPLETED|Overall Study||0
81103|NCT01582477|195547|P1|NOT COMPLETED|Overall Study||0
81104|NCT01582477|195546|P2|COMPLETED|Overall Study||12
81105|NCT01582477|195547|P1|COMPLETED|Overall Study||12
81106|NCT01582477|195546|P2|STARTED|Overall Study||12
81107|NCT01582477|195547|P1|STARTED|Overall Study||12
81108|NCT01582451|195565|P2|NOT COMPLETED|Overall Study||20
81109|NCT01582451|195566|P1|NOT COMPLETED|Overall Study||32
81110|NCT01582451|195565|P2|COMPLETED|Overall Study||139
81111|NCT01582451|195566|P1|COMPLETED|Overall Study||275
81205|NCT01582308|195617|P1|STARTED|Period 4||2
81112|NCT01582451|195565|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
81113|NCT01582451|195566|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
81114|NCT01582451|195565|P2|STARTED|Overall Study||159
81115|NCT01582451|195566|P1|STARTED|Overall Study||307
81116|NCT01582308|195608|P10|NOT COMPLETED|Period 5||0
81117|NCT01582308|195609|P9|NOT COMPLETED|Period 5||0
81118|NCT01582308|195610|P8|NOT COMPLETED|Period 5||0
81119|NCT01582308|195611|P7|NOT COMPLETED|Period 5||0
81120|NCT01582308|195612|P6|NOT COMPLETED|Period 5||0
81121|NCT01582308|195613|P5|NOT COMPLETED|Period 5||0
81122|NCT01582308|195614|P4|NOT COMPLETED|Period 5||0
81123|NCT01582308|195615|P3|NOT COMPLETED|Period 5||0
81124|NCT01582308|195616|P2|NOT COMPLETED|Period 5||0
81125|NCT01582308|195617|P1|NOT COMPLETED|Period 5||0
81126|NCT01582308|195608|P10|COMPLETED|Period 5||1
81127|NCT01582308|195609|P9|COMPLETED|Period 5||2
81128|NCT01582308|195610|P8|COMPLETED|Period 5||2
81129|NCT01582308|195611|P7|COMPLETED|Period 5||2
81130|NCT01582308|195612|P6|COMPLETED|Period 5||1
81131|NCT01582308|195613|P5|COMPLETED|Period 5||2
81132|NCT01582308|195614|P4|COMPLETED|Period 5||2
81133|NCT01582308|195615|P3|COMPLETED|Period 5||2
81134|NCT01582308|195616|P2|COMPLETED|Period 5||2
81135|NCT01582308|195617|P1|COMPLETED|Period 5||1
81136|NCT01582308|195608|P10|STARTED|Period 5||1
81137|NCT01582308|195609|P9|STARTED|Period 5||2
81138|NCT01582308|195610|P8|STARTED|Period 5||2
81139|NCT01582308|195611|P7|STARTED|Period 5||2
81140|NCT01582308|195612|P6|STARTED|Period 5||1
81141|NCT01582308|195613|P5|STARTED|Period 5||2
81142|NCT01582308|195614|P4|STARTED|Period 5||2
81143|NCT01582308|195615|P3|STARTED|Period 5||2
81144|NCT01582308|195616|P2|STARTED|Period 5||2
81145|NCT01582308|195617|P1|STARTED|Period 5||1
81146|NCT01582308|195608|P10|NOT COMPLETED|10-day Washout Following Period 4||0
81147|NCT01582308|195609|P9|NOT COMPLETED|10-day Washout Following Period 4||0
81148|NCT01582308|195610|P8|NOT COMPLETED|10-day Washout Following Period 4||0
81149|NCT01582308|195611|P7|NOT COMPLETED|10-day Washout Following Period 4||0
81150|NCT01582308|195612|P6|NOT COMPLETED|10-day Washout Following Period 4||0
81151|NCT01582308|195613|P5|NOT COMPLETED|10-day Washout Following Period 4||0
81152|NCT01582308|195614|P4|NOT COMPLETED|10-day Washout Following Period 4||0
81153|NCT01582308|195615|P3|NOT COMPLETED|10-day Washout Following Period 4||0
81154|NCT01582308|195616|P2|NOT COMPLETED|10-day Washout Following Period 4||0
81155|NCT01582308|195617|P1|NOT COMPLETED|10-day Washout Following Period 4||0
81156|NCT01582308|195608|P10|COMPLETED|10-day Washout Following Period 4||1
81157|NCT01582308|195609|P9|COMPLETED|10-day Washout Following Period 4||2
81158|NCT01582308|195610|P8|COMPLETED|10-day Washout Following Period 4||2
81159|NCT01582308|195611|P7|COMPLETED|10-day Washout Following Period 4||2
81160|NCT01582308|195612|P6|COMPLETED|10-day Washout Following Period 4||1
81161|NCT01582308|195613|P5|COMPLETED|10-day Washout Following Period 4||2
81162|NCT01582308|195614|P4|COMPLETED|10-day Washout Following Period 4||2
81163|NCT01582308|195615|P3|COMPLETED|10-day Washout Following Period 4||2
81164|NCT01582308|195616|P2|COMPLETED|10-day Washout Following Period 4||2
81165|NCT01582308|195617|P1|COMPLETED|10-day Washout Following Period 4||1
81166|NCT01582308|195608|P10|STARTED|10-day Washout Following Period 4||1
81167|NCT01582308|195609|P9|STARTED|10-day Washout Following Period 4||2
81168|NCT01582308|195610|P8|STARTED|10-day Washout Following Period 4||2
81169|NCT01582308|195611|P7|STARTED|10-day Washout Following Period 4||2
81170|NCT01582308|195612|P6|STARTED|10-day Washout Following Period 4||1
81171|NCT01582308|195613|P5|STARTED|10-day Washout Following Period 4||2
81172|NCT01582308|195614|P4|STARTED|10-day Washout Following Period 4||2
81173|NCT01582308|195615|P3|STARTED|10-day Washout Following Period 4||2
81174|NCT01582308|195616|P2|STARTED|10-day Washout Following Period 4||2
81175|NCT01582308|195617|P1|STARTED|10-day Washout Following Period 4||1
81176|NCT01582308|195608|P10|NOT COMPLETED|Period 4||1
81177|NCT01582308|195609|P9|NOT COMPLETED|Period 4||0
81178|NCT01582308|195610|P8|NOT COMPLETED|Period 4||0
81179|NCT01582308|195611|P7|NOT COMPLETED|Period 4||0
81180|NCT01582308|195612|P6|NOT COMPLETED|Period 4||1
81181|NCT01582308|195613|P5|NOT COMPLETED|Period 4||0
81182|NCT01582308|195614|P4|NOT COMPLETED|Period 4||0
81183|NCT01582308|195615|P3|NOT COMPLETED|Period 4||0
81184|NCT01582308|195616|P2|NOT COMPLETED|Period 4||0
81185|NCT01582308|195617|P1|NOT COMPLETED|Period 4||1
81186|NCT01582308|195608|P10|COMPLETED|Period 4||1
81187|NCT01582308|195609|P9|COMPLETED|Period 4||2
81188|NCT01582308|195610|P8|COMPLETED|Period 4||2
81189|NCT01582308|195611|P7|COMPLETED|Period 4||2
81190|NCT01582308|195612|P6|COMPLETED|Period 4||1
81191|NCT01582308|195613|P5|COMPLETED|Period 4||2
81192|NCT01582308|195614|P4|COMPLETED|Period 4||2
81193|NCT01582308|195615|P3|COMPLETED|Period 4||2
81194|NCT01582308|195616|P2|COMPLETED|Period 4||2
81195|NCT01582308|195617|P1|COMPLETED|Period 4||1
81196|NCT01582308|195608|P10|STARTED|Period 4||2
81197|NCT01582308|195609|P9|STARTED|Period 4||2
81198|NCT01582308|195610|P8|STARTED|Period 4||2
81199|NCT01582308|195611|P7|STARTED|Period 4||2
81200|NCT01582308|195612|P6|STARTED|Period 4||2
81201|NCT01582308|195613|P5|STARTED|Period 4||2
81202|NCT01582308|195614|P4|STARTED|Period 4||2
81203|NCT01582308|195615|P3|STARTED|Period 4||2
81204|NCT01582308|195616|P2|STARTED|Period 4||2
81206|NCT01582308|195608|P10|NOT COMPLETED|10-day Washout Following Period 3||0
81207|NCT01582308|195609|P9|NOT COMPLETED|10-day Washout Following Period 3||0
81208|NCT01582308|195610|P8|NOT COMPLETED|10-day Washout Following Period 3||0
81209|NCT01582308|195611|P7|NOT COMPLETED|10-day Washout Following Period 3||0
81210|NCT01582308|195612|P6|NOT COMPLETED|10-day Washout Following Period 3||0
81211|NCT01582308|195613|P5|NOT COMPLETED|10-day Washout Following Period 3||0
81212|NCT01582308|195614|P4|NOT COMPLETED|10-day Washout Following Period 3||0
81213|NCT01582308|195615|P3|NOT COMPLETED|10-day Washout Following Period 3||0
81214|NCT01582308|195616|P2|NOT COMPLETED|10-day Washout Following Period 3||0
81215|NCT01582308|195617|P1|NOT COMPLETED|10-day Washout Following Period 3||0
81216|NCT01582308|195608|P10|COMPLETED|10-day Washout Following Period 3||2
81217|NCT01582308|195609|P9|COMPLETED|10-day Washout Following Period 3||2
81218|NCT01582308|195610|P8|COMPLETED|10-day Washout Following Period 3||2
81219|NCT01582308|195611|P7|COMPLETED|10-day Washout Following Period 3||2
81220|NCT01582308|195612|P6|COMPLETED|10-day Washout Following Period 3||2
81221|NCT01582308|195613|P5|COMPLETED|10-day Washout Following Period 3||2
81222|NCT01582308|195614|P4|COMPLETED|10-day Washout Following Period 3||2
81223|NCT01582308|195615|P3|COMPLETED|10-day Washout Following Period 3||2
81224|NCT01582308|195616|P2|COMPLETED|10-day Washout Following Period 3||2
81225|NCT01582308|195617|P1|COMPLETED|10-day Washout Following Period 3||2
81226|NCT01582308|195608|P10|STARTED|10-day Washout Following Period 3||2
81227|NCT01582308|195609|P9|STARTED|10-day Washout Following Period 3||2
81228|NCT01582308|195610|P8|STARTED|10-day Washout Following Period 3||2
81229|NCT01582308|195611|P7|STARTED|10-day Washout Following Period 3||2
81230|NCT01582308|195612|P6|STARTED|10-day Washout Following Period 3||2
81231|NCT01582308|195613|P5|STARTED|10-day Washout Following Period 3||2
81232|NCT01582308|195614|P4|STARTED|10-day Washout Following Period 3||2
81233|NCT01582308|195615|P3|STARTED|10-day Washout Following Period 3||2
81234|NCT01582308|195616|P2|STARTED|10-day Washout Following Period 3||2
81235|NCT01582308|195617|P1|STARTED|10-day Washout Following Period 3||2
81236|NCT01582308|195608|P10|NOT COMPLETED|Period 3||0
81237|NCT01582308|195609|P9|NOT COMPLETED|Period 3||0
81238|NCT01582308|195610|P8|NOT COMPLETED|Period 3||0
81239|NCT01582308|195611|P7|NOT COMPLETED|Period 3||0
81240|NCT01582308|195612|P6|NOT COMPLETED|Period 3||0
81241|NCT01582308|195613|P5|NOT COMPLETED|Period 3||0
81242|NCT01582308|195614|P4|NOT COMPLETED|Period 3||0
81243|NCT01582308|195615|P3|NOT COMPLETED|Period 3||0
81244|NCT01582308|195616|P2|NOT COMPLETED|Period 3||0
81245|NCT01582308|195617|P1|NOT COMPLETED|Period 3||0
81246|NCT01582308|195608|P10|COMPLETED|Period 3||2
81247|NCT01582308|195609|P9|COMPLETED|Period 3||2
81248|NCT01582308|195610|P8|COMPLETED|Period 3||2
81249|NCT01582308|195611|P7|COMPLETED|Period 3||2
81250|NCT01582308|195612|P6|COMPLETED|Period 3||2
81251|NCT01582308|195613|P5|COMPLETED|Period 3||2
81252|NCT01582308|195614|P4|COMPLETED|Period 3||2
81253|NCT01582308|195615|P3|COMPLETED|Period 3||2
81254|NCT01582308|195616|P2|COMPLETED|Period 3||2
81255|NCT01582308|195617|P1|COMPLETED|Period 3||2
81256|NCT01582308|195608|P10|STARTED|Period 3||2
81257|NCT01582308|195609|P9|STARTED|Period 3||2
81258|NCT01582308|195610|P8|STARTED|Period 3||2
81259|NCT01582308|195611|P7|STARTED|Period 3||2
81260|NCT01582308|195612|P6|STARTED|Period 3||2
81261|NCT01582308|195613|P5|STARTED|Period 3||2
81262|NCT01582308|195614|P4|STARTED|Period 3||2
81263|NCT01582308|195615|P3|STARTED|Period 3||2
81264|NCT01582308|195616|P2|STARTED|Period 3||2
81265|NCT01582308|195617|P1|STARTED|Period 3||2
81266|NCT01582308|195608|P10|NOT COMPLETED|10-day Washout Following Period 2||0
81267|NCT01582308|195609|P9|NOT COMPLETED|10-day Washout Following Period 2||0
81268|NCT01582308|195610|P8|NOT COMPLETED|10-day Washout Following Period 2||0
81269|NCT01582308|195611|P7|NOT COMPLETED|10-day Washout Following Period 2||0
81270|NCT01582308|195612|P6|NOT COMPLETED|10-day Washout Following Period 2||0
81271|NCT01582308|195613|P5|NOT COMPLETED|10-day Washout Following Period 2||0
81272|NCT01582308|195614|P4|NOT COMPLETED|10-day Washout Following Period 2||0
81273|NCT01582308|195615|P3|NOT COMPLETED|10-day Washout Following Period 2||0
81274|NCT01582308|195616|P2|NOT COMPLETED|10-day Washout Following Period 2||0
81275|NCT01582308|195617|P1|NOT COMPLETED|10-day Washout Following Period 2||0
81276|NCT01582308|195608|P10|COMPLETED|10-day Washout Following Period 2||2
81277|NCT01582308|195609|P9|COMPLETED|10-day Washout Following Period 2||2
81278|NCT01582308|195610|P8|COMPLETED|10-day Washout Following Period 2||2
81279|NCT01582308|195611|P7|COMPLETED|10-day Washout Following Period 2||2
81280|NCT01582308|195612|P6|COMPLETED|10-day Washout Following Period 2||2
81281|NCT01582308|195613|P5|COMPLETED|10-day Washout Following Period 2||2
81282|NCT01582308|195614|P4|COMPLETED|10-day Washout Following Period 2||2
81283|NCT01582308|195615|P3|COMPLETED|10-day Washout Following Period 2||2
81284|NCT01582308|195616|P2|COMPLETED|10-day Washout Following Period 2||2
81285|NCT01582308|195617|P1|COMPLETED|10-day Washout Following Period 2||2
81286|NCT01582308|195608|P10|STARTED|10-day Washout Following Period 2||2
81287|NCT01582308|195609|P9|STARTED|10-day Washout Following Period 2||2
81288|NCT01582308|195610|P8|STARTED|10-day Washout Following Period 2||2
81289|NCT01582308|195611|P7|STARTED|10-day Washout Following Period 2||2
81290|NCT01582308|195612|P6|STARTED|10-day Washout Following Period 2||2
81291|NCT01582308|195613|P5|STARTED|10-day Washout Following Period 2||2
81292|NCT01582308|195614|P4|STARTED|10-day Washout Following Period 2||2
81293|NCT01582308|195615|P3|STARTED|10-day Washout Following Period 2||2
81294|NCT01582308|195616|P2|STARTED|10-day Washout Following Period 2||2
81295|NCT01582308|195617|P1|STARTED|10-day Washout Following Period 2||2
81296|NCT01582308|195608|P10|NOT COMPLETED|Period 2||0
81297|NCT01582308|195609|P9|NOT COMPLETED|Period 2||0
81298|NCT01582308|195610|P8|NOT COMPLETED|Period 2||0
81299|NCT01582308|195611|P7|NOT COMPLETED|Period 2||0
81300|NCT01582308|195612|P6|NOT COMPLETED|Period 2||0
81301|NCT01582308|195613|P5|NOT COMPLETED|Period 2||0
81302|NCT01582308|195614|P4|NOT COMPLETED|Period 2||0
81303|NCT01582308|195615|P3|NOT COMPLETED|Period 2||0
81304|NCT01582308|195616|P2|NOT COMPLETED|Period 2||0
81305|NCT01582308|195617|P1|NOT COMPLETED|Period 2||0
81306|NCT01582308|195608|P10|COMPLETED|Period 2||2
81307|NCT01582308|195609|P9|COMPLETED|Period 2||2
81308|NCT01582308|195610|P8|COMPLETED|Period 2||2
81309|NCT01582308|195611|P7|COMPLETED|Period 2||2
81310|NCT01582308|195612|P6|COMPLETED|Period 2||2
81311|NCT01582308|195613|P5|COMPLETED|Period 2||2
81312|NCT01582308|195614|P4|COMPLETED|Period 2||2
81313|NCT01582308|195615|P3|COMPLETED|Period 2||2
81314|NCT01582308|195616|P2|COMPLETED|Period 2||2
81315|NCT01582308|195617|P1|COMPLETED|Period 2||2
81316|NCT01582308|195608|P10|STARTED|Period 2||2
81317|NCT01582308|195609|P9|STARTED|Period 2||2
81318|NCT01582308|195610|P8|STARTED|Period 2||2
81319|NCT01582308|195611|P7|STARTED|Period 2||2
81320|NCT01582308|195612|P6|STARTED|Period 2||2
81321|NCT01582308|195613|P5|STARTED|Period 2||2
81322|NCT01582308|195614|P4|STARTED|Period 2||2
81323|NCT01582308|195615|P3|STARTED|Period 2||2
81324|NCT01582308|195616|P2|STARTED|Period 2||2
81325|NCT01582308|195617|P1|STARTED|Period 2||2
81326|NCT01582308|195608|P10|NOT COMPLETED|10-day Washout Following Period 1||0
81327|NCT01582308|195609|P9|NOT COMPLETED|10-day Washout Following Period 1||0
81328|NCT01582308|195610|P8|NOT COMPLETED|10-day Washout Following Period 1||0
81329|NCT01582308|195611|P7|NOT COMPLETED|10-day Washout Following Period 1||0
81330|NCT01582308|195612|P6|NOT COMPLETED|10-day Washout Following Period 1||0
81331|NCT01582308|195613|P5|NOT COMPLETED|10-day Washout Following Period 1||1
81332|NCT01582308|195614|P4|NOT COMPLETED|10-day Washout Following Period 1||0
81333|NCT01582308|195615|P3|NOT COMPLETED|10-day Washout Following Period 1||0
81334|NCT01582308|195616|P2|NOT COMPLETED|10-day Washout Following Period 1||0
81335|NCT01582308|195617|P1|NOT COMPLETED|10-day Washout Following Period 1||0
81336|NCT01582308|195608|P10|COMPLETED|10-day Washout Following Period 1||2
81337|NCT01582308|195609|P9|COMPLETED|10-day Washout Following Period 1||2
81338|NCT01582308|195610|P8|COMPLETED|10-day Washout Following Period 1||2
81339|NCT01582308|195611|P7|COMPLETED|10-day Washout Following Period 1||2
81340|NCT01582308|195612|P6|COMPLETED|10-day Washout Following Period 1||2
81341|NCT01582308|195613|P5|COMPLETED|10-day Washout Following Period 1||2
81342|NCT01582308|195614|P4|COMPLETED|10-day Washout Following Period 1||2
81343|NCT01582308|195615|P3|COMPLETED|10-day Washout Following Period 1||2
81344|NCT01582308|195616|P2|COMPLETED|10-day Washout Following Period 1||2
81345|NCT01582308|195617|P1|COMPLETED|10-day Washout Following Period 1||2
81346|NCT01582308|195608|P10|STARTED|10-day Washout Following Period 1||2
81347|NCT01582308|195609|P9|STARTED|10-day Washout Following Period 1||2
81348|NCT01582308|195610|P8|STARTED|10-day Washout Following Period 1||2
81349|NCT01582308|195611|P7|STARTED|10-day Washout Following Period 1||2
81350|NCT01582308|195612|P6|STARTED|10-day Washout Following Period 1||2
81351|NCT01582308|195613|P5|STARTED|10-day Washout Following Period 1||3
81352|NCT01582308|195614|P4|STARTED|10-day Washout Following Period 1||2
81353|NCT01582308|195615|P3|STARTED|10-day Washout Following Period 1||2
81354|NCT01582308|195616|P2|STARTED|10-day Washout Following Period 1||2
81355|NCT01582308|195617|P1|STARTED|10-day Washout Following Period 1||2
81356|NCT01582308|195608|P10|NOT COMPLETED|Period 1||0
81357|NCT01582308|195609|P9|NOT COMPLETED|Period 1||0
81358|NCT01582308|195610|P8|NOT COMPLETED|Period 1||0
81359|NCT01582308|195611|P7|NOT COMPLETED|Period 1||1
81360|NCT01582308|195612|P6|NOT COMPLETED|Period 1||0
81361|NCT01582308|195613|P5|NOT COMPLETED|Period 1||0
81362|NCT01582308|195614|P4|NOT COMPLETED|Period 1||0
81363|NCT01582308|195615|P3|NOT COMPLETED|Period 1||0
81364|NCT01582308|195616|P2|NOT COMPLETED|Period 1||0
81365|NCT01582308|195617|P1|NOT COMPLETED|Period 1||0
81366|NCT01582308|195608|P10|COMPLETED|Period 1||2
81367|NCT01582308|195609|P9|COMPLETED|Period 1||2
81368|NCT01582308|195610|P8|COMPLETED|Period 1||2
81369|NCT01582308|195611|P7|COMPLETED|Period 1||2
81370|NCT01582308|195612|P6|COMPLETED|Period 1||2
81371|NCT01582308|195613|P5|COMPLETED|Period 1||3
81372|NCT01582308|195614|P4|COMPLETED|Period 1||2
81373|NCT01582308|195615|P3|COMPLETED|Period 1||2
81374|NCT01582308|195616|P2|COMPLETED|Period 1||2
81375|NCT01582308|195617|P1|COMPLETED|Period 1||2
81376|NCT01582308|195608|P10|STARTED|Period 1||2
81377|NCT01582308|195609|P9|STARTED|Period 1||2
81378|NCT01582308|195610|P8|STARTED|Period 1||2
81379|NCT01582308|195611|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
81380|NCT01582308|195612|P6|STARTED|Period 1||2
81381|NCT01582308|195613|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
81382|NCT01582308|195614|P4|STARTED|Period 1||2
81383|NCT01582308|195615|P3|STARTED|Period 1||2
81384|NCT01582308|195616|P2|STARTED|Period 1||2
81385|NCT01582308|195617|P1|STARTED|Period 1||2
81386|NCT01582282|195645|P3|NOT COMPLETED|Overall Study||0
81387|NCT01582282|195646|P2|NOT COMPLETED|Overall Study||2
81388|NCT01582282|195647|P1|NOT COMPLETED|Overall Study||2
81389|NCT01582282|195645|P3|COMPLETED|Overall Study||8
81390|NCT01582282|195646|P2|COMPLETED|Overall Study||12
81391|NCT01582282|195647|P1|COMPLETED|Overall Study||13
81392|NCT01582282|195645|P3|STARTED|Overall Study||8
81393|NCT01582282|195646|P2|STARTED|Overall Study||14
81394|NCT01582282|195647|P1|STARTED|Overall Study||15
81395|NCT01582243|195670|P1|NOT COMPLETED|Overall Study||3
81396|NCT01582243|195670|P1|COMPLETED|Overall Study||37
81397|NCT01582243|195670|P1|STARTED|Overall Study||40
81398|NCT01582178|195681|P2|NOT COMPLETED|Overall Study||5
81399|NCT01582178|195682|P1|NOT COMPLETED|Overall Study||6
81400|NCT01582178|195681|P2|COMPLETED|Overall Study||101
81401|NCT01582178|195682|P1|COMPLETED|Overall Study||100
81402|NCT01582178|195681|P2|STARTED|Overall Study||106
81403|NCT01582178|195682|P1|STARTED|Overall Study||106
81404|NCT01582139|195690|P2|NOT COMPLETED|Overall Study||0
81405|NCT01582139|195691|P1|NOT COMPLETED|Overall Study||0
81406|NCT01582139|195690|P2|COMPLETED|Overall Study||6
81407|NCT01582139|195691|P1|COMPLETED|Overall Study||6
81408|NCT01582139|195690|P2|STARTED|Overall Study||6
81409|NCT01582139|195691|P1|STARTED|Overall Study||6
81410|NCT01582100|195703|P1|NOT COMPLETED|Overall Study||2
81411|NCT01582100|195703|P1|COMPLETED|Overall Study||0
81412|NCT01582100|195703|P1|STARTED|Overall Study||2
81413|NCT01582009|195707|P1|NOT COMPLETED|Overall Study||2
81414|NCT01582009|195707|P1|COMPLETED|Overall Study||24
81415|NCT01582009|195707|P1|STARTED|Overall Study||26
81416|NCT01581931|195715|P2|NOT COMPLETED|Second Period||0
81417|NCT01581931|195716|P1|NOT COMPLETED|Second Period||0
81418|NCT01581931|195715|P2|COMPLETED|Second Period||15
81419|NCT01581931|195716|P1|COMPLETED|Second Period||16
81420|NCT01581931|195715|P2|STARTED|Second Period||15
81421|NCT01581931|195716|P1|STARTED|Second Period||16
81422|NCT01581931|195715|P2|NOT COMPLETED|Washout||1
81423|NCT01581931|195716|P1|NOT COMPLETED|Washout||0
81424|NCT01581931|195715|P2|COMPLETED|Washout||15
81425|NCT01581931|195716|P1|COMPLETED|Washout||16
81426|NCT01581931|195715|P2|STARTED|Washout||16
81427|NCT01581931|195716|P1|STARTED|Washout||16
81428|NCT01581931|195715|P2|NOT COMPLETED|First Period||0
81429|NCT01581931|195716|P1|NOT COMPLETED|First Period||0
81430|NCT01581931|195715|P2|COMPLETED|First Period||16
81431|NCT01581931|195716|P1|COMPLETED|First Period||16
81432|NCT01581931|195715|P2|STARTED|First Period||16
81433|NCT01581931|195716|P1|STARTED|First Period||16
81434|NCT01581710|195730|P2|NOT COMPLETED|Second Intervention (14days)||2
81435|NCT01581710|195731|P1|NOT COMPLETED|Second Intervention (14days)||0
81436|NCT01581710|195730|P2|COMPLETED|Second Intervention (14days)||12
81437|NCT01581710|195731|P1|COMPLETED|Second Intervention (14days)||18
81438|NCT01581710|195730|P2|STARTED|Second Intervention (14days)||14
81439|NCT01581710|195731|P1|STARTED|Second Intervention (14days)||18
81440|NCT01581710|195730|P2|NOT COMPLETED|Washout Period (14days)||0
81441|NCT01581710|195731|P1|NOT COMPLETED|Washout Period (14days)||0
81442|NCT01581710|195730|P2|COMPLETED|Washout Period (14days)||14
81443|NCT01581710|195731|P1|COMPLETED|Washout Period (14days)||18
81444|NCT01581710|195730|P2|STARTED|Washout Period (14days)||14
81445|NCT01581710|195731|P1|STARTED|Washout Period (14days)||18
81446|NCT01581710|195730|P2|NOT COMPLETED|First Intervention (14days)||0
81447|NCT01581710|195731|P1|NOT COMPLETED|First Intervention (14days)||0
81448|NCT01581710|195730|P2|COMPLETED|First Intervention (14days)||14
81449|NCT01581710|195731|P1|COMPLETED|First Intervention (14days)||18
81450|NCT01581710|195730|P2|STARTED|First Intervention (14days)||14
81451|NCT01581710|195731|P1|STARTED|First Intervention (14days)||18
81452|NCT01581684|195769|P10|NOT COMPLETED|Overall Study||0
81453|NCT01581684|195770|P9|NOT COMPLETED|Overall Study||1
81454|NCT01581684|195771|P8|NOT COMPLETED|Overall Study||0
81455|NCT01581684|195772|P7|NOT COMPLETED|Overall Study||0
81456|NCT01581684|195773|P6|NOT COMPLETED|Overall Study||0
81457|NCT01581684|195774|P5|NOT COMPLETED|Overall Study||0
81458|NCT01581684|195775|P4|NOT COMPLETED|Overall Study||0
81459|NCT01581684|195776|P3|NOT COMPLETED|Overall Study||0
81460|NCT01581684|195777|P2|NOT COMPLETED|Overall Study||0
81461|NCT01581684|195778|P1|NOT COMPLETED|Overall Study||0
81462|NCT01581684|195769|P10|COMPLETED|Overall Study||5
81463|NCT01581684|195770|P9|COMPLETED|Overall Study||0
81464|NCT01581684|195771|P8|COMPLETED|Overall Study||6
81465|NCT01581684|195772|P7|COMPLETED|Overall Study||6
81466|NCT01581684|195773|P6|COMPLETED|Overall Study||6
81467|NCT01581684|195774|P5|COMPLETED|Overall Study||6
81468|NCT01581684|195775|P4|COMPLETED|Overall Study||6
81469|NCT01581684|195776|P3|COMPLETED|Overall Study||6
81470|NCT01581684|195777|P2|COMPLETED|Overall Study||6
81471|NCT01581684|195778|P1|COMPLETED|Overall Study||14
81472|NCT01581684|195769|P10|STARTED|Overall Study||5
81473|NCT01581684|195770|P9|STARTED|Overall Study||1
81474|NCT01581684|195771|P8|STARTED|Overall Study||6
81475|NCT01581684|195772|P7|STARTED|Overall Study||6
81476|NCT01581684|195773|P6|STARTED|Overall Study||6
81477|NCT01581684|195774|P5|STARTED|Overall Study||6
81478|NCT01581684|195775|P4|STARTED|Overall Study||6
81479|NCT01581684|195776|P3|STARTED|Overall Study||6
81480|NCT01581684|195777|P2|STARTED|Overall Study||6
81481|NCT01581684|195778|P1|STARTED|Overall Study||14
81482|NCT01581658|195853|P4|NOT COMPLETED|Overall Study||0
81483|NCT01581658|195854|P3|NOT COMPLETED|Overall Study||0
81484|NCT01581658|195855|P2|NOT COMPLETED|Overall Study||0
81485|NCT01581658|195856|P1|NOT COMPLETED|Overall Study||0
81486|NCT01581658|195853|P4|COMPLETED|Overall Study||8
81487|NCT01581658|195854|P3|COMPLETED|Overall Study||8
81488|NCT01581658|195855|P2|COMPLETED|Overall Study||8
81489|NCT01581658|195856|P1|COMPLETED|Overall Study||8
81490|NCT01581658|195853|P4|STARTED|Overall Study||8
81491|NCT01581658|195854|P3|STARTED|Overall Study||8
81492|NCT01581658|195855|P2|STARTED|Overall Study||8
81493|NCT01581658|195856|P1|STARTED|Overall Study||8
81494|NCT01581619|195874|P1|NOT COMPLETED|Overall Study||2
81495|NCT01581619|195874|P1|COMPLETED|Overall Study||52
81496|NCT01581619|195874|P1|STARTED|Overall Study||54
81497|NCT01581541|195882|P11|NOT COMPLETED|Overall Study||0
81498|NCT01581541|195883|P10|NOT COMPLETED|Overall Study||0
81499|NCT01581541|195884|P9|NOT COMPLETED|Overall Study||0
81500|NCT01581541|195885|P8|NOT COMPLETED|Overall Study||0
81501|NCT01581541|195886|P7|NOT COMPLETED|Overall Study||0
81502|NCT01581541|195887|P6|NOT COMPLETED|Overall Study||0
81503|NCT01581541|195888|P5|NOT COMPLETED|Overall Study||0
81504|NCT01581541|195889|P4|NOT COMPLETED|Overall Study||0
81505|NCT01581541|195890|P3|NOT COMPLETED|Overall Study||0
81506|NCT01581541|195891|P2|NOT COMPLETED|Overall Study||0
81507|NCT01581541|195892|P1|NOT COMPLETED|Overall Study||0
81508|NCT01581541|195882|P11|COMPLETED|Overall Study||1
81509|NCT01581541|195883|P10|COMPLETED|Overall Study||3
81510|NCT01581541|195884|P9|COMPLETED|Overall Study||1
81511|NCT01581541|195885|P8|COMPLETED|Overall Study||2
81512|NCT01581541|195886|P7|COMPLETED|Overall Study||1
81513|NCT01581541|195887|P6|COMPLETED|Overall Study||3
81514|NCT01581541|195888|P5|COMPLETED|Overall Study||2
81515|NCT01581541|195889|P4|COMPLETED|Overall Study||1
81516|NCT01581541|195890|P3|COMPLETED|Overall Study||1
81517|NCT01581541|195891|P2|COMPLETED|Overall Study||1
81518|NCT01581541|195892|P1|COMPLETED|Overall Study||1
81519|NCT01581541|195882|P11|STARTED|Overall Study||1
81520|NCT01581541|195883|P10|STARTED|Overall Study||3
81521|NCT01581541|195884|P9|STARTED|Overall Study||1
81522|NCT01581541|195885|P8|STARTED|Overall Study||2
81523|NCT01581541|195886|P7|STARTED|Overall Study||1
81524|NCT01581541|195887|P6|STARTED|Overall Study||3
81525|NCT01581541|195888|P5|STARTED|Overall Study||2
81526|NCT01581541|195889|P4|STARTED|Overall Study||1
81527|NCT01581541|195890|P3|STARTED|Overall Study||1
81528|NCT01581541|195891|P2|STARTED|Overall Study||1
81529|NCT01581541|195892|P1|STARTED|Overall Study||1
81530|NCT01581437|196016|P1|NOT COMPLETED|Overall Study||0
81531|NCT01581437|196016|P1|COMPLETED|Overall Study||78
81532|NCT01581437|196016|P1|STARTED|Overall Study||78
81533|NCT01581307|196027|P1|NOT COMPLETED|Overall Study||1
81534|NCT01581307|196027|P1|COMPLETED|Overall Study||8
81535|NCT01581307|196027|P1|STARTED|Overall Study||9
81536|NCT01581281|196036|P3|NOT COMPLETED|Overall Study||12
81537|NCT01581281|196037|P2|NOT COMPLETED|Overall Study||6
81538|NCT01581281|196038|P1|NOT COMPLETED|Overall Study||15
81539|NCT01581281|196036|P3|COMPLETED|Overall Study||132
81540|NCT01581281|196037|P2|COMPLETED|Overall Study||66
81541|NCT01581281|196038|P1|COMPLETED|Overall Study||130
81542|NCT01581281|196036|P3|STARTED|Overall Study||144
81543|NCT01581281|196037|P2|STARTED|Overall Study||72
81544|NCT01581281|196038|P1|STARTED|Overall Study||145
81545|NCT01581021|196060|P2|NOT COMPLETED|Overall Study||11
81546|NCT01581021|196061|P1|NOT COMPLETED|Overall Study||10
81547|NCT01581021|196060|P2|COMPLETED|Overall Study||18
81548|NCT01581021|196061|P1|COMPLETED|Overall Study||19
81549|NCT01581021|196060|P2|STARTED|Overall Study||29
81550|NCT01581021|196061|P1|STARTED|Overall Study||29
81551|NCT01581008|196075|P2|NOT COMPLETED|Overall Study||6
81552|NCT01581008|196076|P1|NOT COMPLETED|Overall Study||1
81553|NCT01581008|196075|P2|COMPLETED|Overall Study||7
81554|NCT01581008|196076|P1|COMPLETED|Overall Study||16
81555|NCT01581008|196075|P2|STARTED|Overall Study||13
81556|NCT01581008|196076|P1|STARTED|Overall Study||17
81557|NCT01580995|196087|P2|NOT COMPLETED|Overall Study||2
81558|NCT01580995|196088|P1|NOT COMPLETED|Overall Study||2
81559|NCT01580995|196087|P2|COMPLETED|Overall Study||7
81560|NCT01580995|196088|P1|COMPLETED|Overall Study||8
81561|NCT01580995|196087|P2|STARTED|Overall Study||9
81562|NCT01580995|196088|P1|STARTED|Overall Study||10
81563|NCT01580904|196096|P2|NOT COMPLETED|Overall Study||7
81564|NCT01580904|196097|P1|NOT COMPLETED|Overall Study||4
81565|NCT01580904|196096|P2|COMPLETED|Overall Study||42
81566|NCT01580904|196097|P1|COMPLETED|Overall Study||47
81567|NCT01580904|196096|P2|STARTED|Overall Study||49
81568|NCT01580904|196097|P1|STARTED|Overall Study||51
81569|NCT01580618|196111|P2|NOT COMPLETED|Overall Study||0
81570|NCT01580618|196112|P1|NOT COMPLETED|Overall Study||1
81571|NCT01580618|196111|P2|COMPLETED|Overall Study||12
81666|NCT01579669|196392|P2|STARTED|Overall Study||41
81667|NCT01579669|196393|P1|STARTED|Overall Study||170
81572|NCT01580618|196112|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
81573|NCT01580618|196111|P2|STARTED|Overall Study||12
81574|NCT01580618|196112|P1|STARTED|Overall Study||8
81575|NCT01580592|196128|P3|NOT COMPLETED|Overall Study||0
81576|NCT01580592|196129|P2|NOT COMPLETED|Overall Study||0
81577|NCT01580592|196130|P1|NOT COMPLETED|Overall Study||0
81578|NCT01580592|196128|P3|COMPLETED|Overall Study||12
81579|NCT01580592|196129|P2|COMPLETED|Overall Study||9
81580|NCT01580592|196130|P1|COMPLETED|Overall Study||10
81581|NCT01580592|196128|P3|STARTED|Overall Study||12
81582|NCT01580592|196129|P2|STARTED|Overall Study||9
81583|NCT01580592|196130|P1|STARTED|Overall Study||10
81584|NCT01580488|196141|P1|NOT COMPLETED|Overall Study||1
81585|NCT01580488|196141|P1|COMPLETED|Overall Study||23
81586|NCT01580488|196141|P1|STARTED|Overall Study||24
81587|NCT01580423|196185|P2|NOT COMPLETED|Second Intervention||0
81588|NCT01580423|196186|P1|NOT COMPLETED|Second Intervention||0
81589|NCT01580423|196185|P2|COMPLETED|Second Intervention||8
81590|NCT01580423|196186|P1|COMPLETED|Second Intervention||8
81591|NCT01580423|196185|P2|STARTED|Second Intervention||8
81592|NCT01580423|196186|P1|STARTED|Second Intervention||8
81593|NCT01580423|196185|P2|NOT COMPLETED|First Intervention||0
81594|NCT01580423|196186|P1|NOT COMPLETED|First Intervention||0
81595|NCT01580423|196185|P2|COMPLETED|First Intervention||8
81596|NCT01580423|196186|P1|COMPLETED|First Intervention||8
81597|NCT01580423|196185|P2|STARTED|First Intervention||8
81598|NCT01580423|196186|P1|STARTED|First Intervention||8
81599|NCT01580410|196198|P2|NOT COMPLETED|Overall Study||8
81600|NCT01580410|196199|P1|NOT COMPLETED|Overall Study||11
81601|NCT01580410|196198|P2|COMPLETED|Overall Study||60
81602|NCT01580410|196199|P1|COMPLETED|Overall Study||57
81603|NCT01580410|196198|P2|STARTED|Overall Study||68
81604|NCT01580410|196199|P1|STARTED|Overall Study||68
81605|NCT01580306|196215|P4|NOT COMPLETED|Overall Study||0
81606|NCT01580306|196216|P3|NOT COMPLETED|Overall Study||0
81607|NCT01580306|196217|P2|NOT COMPLETED|Overall Study||0
81608|NCT01580306|196218|P1|NOT COMPLETED|Overall Study||0
81609|NCT01580306|196215|P4|COMPLETED|Overall Study||8
81610|NCT01580306|196216|P3|COMPLETED|Overall Study||8
81611|NCT01580306|196217|P2|COMPLETED|Overall Study||8
81612|NCT01580306|196218|P1|COMPLETED|Overall Study||8
81613|NCT01580306|196215|P4|STARTED|Overall Study||8
81614|NCT01580306|196216|P3|STARTED|Overall Study||8
81615|NCT01580306|196217|P2|STARTED|Overall Study||8
81616|NCT01580306|196218|P1|STARTED|Overall Study||8
81617|NCT01580098|196242|P3|NOT COMPLETED|Overall Study||3
81618|NCT01580098|196243|P2|NOT COMPLETED|Overall Study||13
81619|NCT01580098|196244|P1|NOT COMPLETED|Overall Study||15
81620|NCT01580098|196242|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
81621|NCT01580098|196243|P2|COMPLETED|Overall Study||101
81622|NCT01580098|196244|P1|COMPLETED|Overall Study||61
81623|NCT01580098|196242|P3|STARTED|Overall Study||3
81624|NCT01580098|196243|P2|STARTED|Overall Study||114
81625|NCT01580098|196244|P1|STARTED|Overall Study||76
81626|NCT01580072|196267|P3|NOT COMPLETED|Overall Study||0
81627|NCT01580072|196268|P2|NOT COMPLETED|Overall Study||9
81628|NCT01580072|196269|P1|NOT COMPLETED|Overall Study||12
81629|NCT01580072|196267|P3|COMPLETED|Overall Study||0
81630|NCT01580072|196268|P2|COMPLETED|Overall Study||28
81631|NCT01580072|196269|P1|COMPLETED|Overall Study||16
81632|NCT01580072|196267|P3|STARTED|Overall Study||0
81633|NCT01580072|196268|P2|STARTED|Overall Study||37
81634|NCT01580072|196269|P1|STARTED|Overall Study||28
81635|NCT01580020|196297|P4|NOT COMPLETED|Overall Study||2
81636|NCT01580020|196298|P3|NOT COMPLETED|Overall Study||4
81637|NCT01580020|196299|P2|NOT COMPLETED|Overall Study||7
81638|NCT01580020|196300|P1|NOT COMPLETED|Overall Study||1
81639|NCT01580020|196297|P4|COMPLETED|Overall Study||20
81640|NCT01580020|196298|P3|COMPLETED|Overall Study||57
81641|NCT01580020|196299|P2|COMPLETED|Overall Study||33
81642|NCT01580020|196300|P1|COMPLETED|Overall Study||51
81643|NCT01580020|196297|P4|STARTED|Overall Study||22
81644|NCT01580020|196298|P3|STARTED|Overall Study||61
81645|NCT01580020|196299|P2|STARTED|Overall Study||40
81646|NCT01580020|196300|P1|STARTED|Overall Study||52
81647|NCT01579916|196344|P2|NOT COMPLETED|Overall Study||2
81648|NCT01579916|196345|P1|NOT COMPLETED|Overall Study||8
81649|NCT01579916|196344|P2|COMPLETED|Overall Study||59
81650|NCT01579916|196345|P1|COMPLETED|Overall Study||234
81651|NCT01579916|196344|P2|STARTED|Overall Study||61
81652|NCT01579916|196345|P1|STARTED|Overall Study||242
81653|NCT01579812|196371|P1|NOT COMPLETED|Overall Study||52
81654|NCT01579812|196371|P1|COMPLETED|Overall Study||38
81655|NCT01579812|196371|P1|STARTED|Overall Study||90
81656|NCT01579747|196381|P2|NOT COMPLETED|Overall Study||0
81657|NCT01579747|196382|P1|NOT COMPLETED|Overall Study||0
81658|NCT01579747|196381|P2|COMPLETED|Overall Study||12
81659|NCT01579747|196382|P1|COMPLETED|Overall Study||12
81660|NCT01579747|196381|P2|STARTED|Overall Study||12
81661|NCT01579747|196382|P1|STARTED|Overall Study||12
81662|NCT01579669|196392|P2|NOT COMPLETED|Overall Study||0
81663|NCT01579669|196393|P1|NOT COMPLETED|Overall Study||36
81664|NCT01579669|196392|P2|COMPLETED|Overall Study||41
81665|NCT01579669|196393|P1|COMPLETED|Overall Study||134
81668|NCT01579578|196405|P2|NOT COMPLETED|Overall Study||12
81669|NCT01579578|196406|P1|NOT COMPLETED|Overall Study||13
81670|NCT01579578|196405|P2|COMPLETED|Overall Study||0
81671|NCT01579578|196406|P1|COMPLETED|Overall Study||0
81672|NCT01579578|196405|P2|Ongoing|Overall Study||0
81673|NCT01579578|196406|P1|Ongoing|Overall Study||3
81674|NCT01579578|196405|P2|STARTED|Overall Study||12
81675|NCT01579578|196406|P1|STARTED|Overall Study||13
81676|NCT01579565|196418|P2|NOT COMPLETED|Treated||3
81677|NCT01579565|196419|P1|NOT COMPLETED|Treated||2
81678|NCT01579565|196418|P2|COMPLETED|Treated||201
81679|NCT01579565|196419|P1|COMPLETED|Treated||200
81680|NCT01579565|196418|P2|STARTED|Treated||204
81681|NCT01579565|196419|P1|STARTED|Treated||202
81682|NCT01579565|196418|P2|NOT COMPLETED|Randomized||5
81683|NCT01579565|196419|P1|NOT COMPLETED|Randomized||5
81684|NCT01579565|196418|P2|COMPLETED|Randomized||204
81685|NCT01579565|196419|P1|COMPLETED|Randomized||202
81686|NCT01579565|196418|P2|STARTED|Randomized||209
81687|NCT01579565|196419|P1|STARTED|Randomized||207
81688|NCT01579474|196453|P6|NOT COMPLETED|Overall Study||1
81689|NCT01579474|196454|P5|NOT COMPLETED|Overall Study||1
81690|NCT01579474|196455|P4|NOT COMPLETED|Overall Study||0
81691|NCT01579474|196456|P3|NOT COMPLETED|Overall Study||2
81692|NCT01579474|196457|P2|NOT COMPLETED|Overall Study||13
81693|NCT01579474|196458|P1|NOT COMPLETED|Overall Study||3
81694|NCT01579474|196453|P6|COMPLETED|Overall Study||1
81695|NCT01579474|196454|P5|COMPLETED|Overall Study||9
81696|NCT01579474|196455|P4|COMPLETED|Overall Study||3
81697|NCT01579474|196456|P3|COMPLETED|Overall Study||27
81698|NCT01579474|196457|P2|COMPLETED|Overall Study||30
81699|NCT01579474|196458|P1|COMPLETED|Overall Study||41
81700|NCT01579474|196453|P6|STARTED|Overall Study||2
81701|NCT01579474|196454|P5|STARTED|Overall Study||10
81702|NCT01579474|196455|P4|STARTED|Overall Study||3
81703|NCT01579474|196456|P3|STARTED|Overall Study||29
81704|NCT01579474|196457|P2|STARTED|Overall Study||43
81705|NCT01579474|196458|P1|STARTED|Overall Study||44
81706|NCT01579318|196532|P1|NOT COMPLETED|Overall Study||1
81707|NCT01579318|196532|P1|COMPLETED|Overall Study||1
81708|NCT01579318|196532|P1|STARTED|Overall Study||2
81709|NCT01579305|196545|P2|NOT COMPLETED|Overall Study||27
81710|NCT01579305|196546|P1|NOT COMPLETED|Overall Study||21
81711|NCT01579305|196545|P2|COMPLETED|Overall Study||115
81712|NCT01579305|196546|P1|COMPLETED|Overall Study||118
81713|NCT01579305|196545|P2|Continued After Treatment|Overall Study||141
81714|NCT01579305|196546|P1|Continued After Treatment|Overall Study||139
81715|NCT01579305|196545|P2|Discontinued Before Treatment|Overall Study||1
81716|NCT01579305|196546|P1|Discontinued Before Treatment|Overall Study||0
81717|NCT01579305|196545|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
81718|NCT01579305|196546|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
81719|NCT01579214|196554|P2|NOT COMPLETED|Overall Study||0
81720|NCT01579214|196555|P1|NOT COMPLETED|Overall Study||0
81721|NCT01579214|196554|P2|COMPLETED|Overall Study||138
81722|NCT01579214|196555|P1|COMPLETED|Overall Study||45
81723|NCT01579214|196554|P2|STARTED|Overall Study||138
81724|NCT01579214|196555|P1|STARTED|Overall Study||45
81725|NCT01579084|196573|P10|NOT COMPLETED|Overall Study||0
81726|NCT01579084|196574|P9|NOT COMPLETED|Overall Study||0
81727|NCT01579084|196575|P8|NOT COMPLETED|Overall Study||0
81728|NCT01579084|196576|P7|NOT COMPLETED|Overall Study||0
81729|NCT01579084|196577|P6|NOT COMPLETED|Overall Study||0
81730|NCT01579084|196578|P5|NOT COMPLETED|Overall Study||0
81731|NCT01579084|196579|P4|NOT COMPLETED|Overall Study||0
81732|NCT01579084|196580|P3|NOT COMPLETED|Overall Study||0
81733|NCT01579084|196581|P2|NOT COMPLETED|Overall Study||0
81734|NCT01579084|196582|P1|NOT COMPLETED|Overall Study||0
81735|NCT01579084|196573|P10|COMPLETED|Overall Study||4
81736|NCT01579084|196574|P9|COMPLETED|Overall Study||4
81737|NCT01579084|196575|P8|COMPLETED|Overall Study||4
81738|NCT01579084|196576|P7|COMPLETED|Overall Study||4
81739|NCT01579084|196577|P6|COMPLETED|Overall Study||8
81740|NCT01579084|196578|P5|COMPLETED|Overall Study||8
81741|NCT01579084|196579|P4|COMPLETED|Overall Study||8
81742|NCT01579084|196580|P3|COMPLETED|Overall Study||8
81743|NCT01579084|196581|P2|COMPLETED|Overall Study||8
81744|NCT01579084|196582|P1|COMPLETED|Overall Study||8
81745|NCT01579084|196573|P10|STARTED|Overall Study||4
81746|NCT01579084|196574|P9|STARTED|Overall Study||4
81747|NCT01579084|196575|P8|STARTED|Overall Study||4
81748|NCT01579084|196576|P7|STARTED|Overall Study||4
81749|NCT01579084|196577|P6|STARTED|Overall Study||8
81750|NCT01579084|196578|P5|STARTED|Overall Study||8
81751|NCT01579084|196579|P4|STARTED|Overall Study||8
81752|NCT01579084|196580|P3|STARTED|Overall Study||8
81753|NCT01579084|196581|P2|STARTED|Overall Study||8
81754|NCT01579084|196582|P1|STARTED|Overall Study||8
81755|NCT01579045|196610|P1|NOT COMPLETED|Overall Study||0
81756|NCT01579045|196610|P1|COMPLETED|Overall Study||24
81757|NCT01579045|196610|P1|STARTED|Overall Study||24
81758|NCT01579006|196627|P1|NOT COMPLETED|Overall Study||33
81759|NCT01579006|196627|P1|COMPLETED|Overall Study||151
81760|NCT01579006|196627|P1|STARTED|Overall Study||184
81761|NCT01578993|196666|P1|NOT COMPLETED|Overall Study||0
81762|NCT01578993|196666|P1|COMPLETED|Overall Study||101
81763|NCT01578993|196666|P1|STARTED|Overall Study||101
81764|NCT01578980|196670|P1|NOT COMPLETED|Overall Study||0
81765|NCT01578980|196670|P1|COMPLETED|Overall Study||20
81766|NCT01578980|196670|P1|STARTED|Overall Study||20
81767|NCT01578967|196675|P1|NOT COMPLETED|Overall Study||0
81768|NCT01578967|196675|P1|COMPLETED|Overall Study||41
81769|NCT01578967|196675|P1|STARTED|Overall Study||41
81770|NCT01578850|196686|P3|NOT COMPLETED|Period 2||14
81771|NCT01578850|196687|P2|NOT COMPLETED|Period 2||13
81772|NCT01578850|196688|P1|NOT COMPLETED|Period 2||0
81773|NCT01578850|196686|P3|COMPLETED|Period 2||162
81774|NCT01578850|196687|P2|COMPLETED|Period 2||154
81775|NCT01578850|196688|P1|COMPLETED|Period 2||0
81776|NCT01578850|196686|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
81777|NCT01578850|196687|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
81778|NCT01578850|196688|P1|STARTED|Period 2||0
81779|NCT01578850|196686|P3|NOT COMPLETED|Period 1||0
81780|NCT01578850|196687|P2|NOT COMPLETED|Period 1||0
81781|NCT01578850|196688|P1|NOT COMPLETED|Period 1||37
81782|NCT01578850|196686|P3|COMPLETED|Period 1||0
81783|NCT01578850|196687|P2|COMPLETED|Period 1||0
81784|NCT01578850|196688|P1|COMPLETED|Period 1||452
81785|NCT01578850|196686|P3|STARTED|Period 1||0
81786|NCT01578850|196687|P2|STARTED|Period 1||0
81787|NCT01578850|196688|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
81788|NCT01578785|196740|P2|NOT COMPLETED|Overall Study||119
81789|NCT01578785|196741|P1|NOT COMPLETED|Overall Study||59
81790|NCT01578785|196740|P2|COMPLETED|Overall Study||0
81791|NCT01578785|196741|P1|COMPLETED|Overall Study||0
81792|NCT01578785|196740|P2|STARTED|Overall Study||119
81793|NCT01578785|196741|P1|STARTED|Overall Study||59
81794|NCT01578772|196753|P1|NOT COMPLETED|Overall Study||0
81795|NCT01578772|196753|P1|COMPLETED|Overall Study||17
81796|NCT01578772|196753|P1|STARTED|Overall Study||17
81797|NCT01578707|196762|P2|NOT COMPLETED|Overall Study||0
81798|NCT01578707|196763|P1|NOT COMPLETED|Overall Study||0
81799|NCT01578707|196762|P2|COMPLETED|Overall Study||195
81800|NCT01578707|196763|P1|COMPLETED|Overall Study||196
81801|NCT01578707|196762|P2|STARTED|Overall Study||195
81802|NCT01578707|196763|P1|STARTED|Overall Study||196
81803|NCT01578499|196773|P2|NOT COMPLETED|Overall Study||65
81804|NCT01578499|196774|P1|NOT COMPLETED|Overall Study||66
81805|NCT01578499|196773|P2|COMPLETED|Overall Study||0
81806|NCT01578499|196774|P1|COMPLETED|Overall Study||0
81807|NCT01578499|196773|P2|Intent to Treat Population: CD30+|Overall Study||64
81808|NCT01578499|196774|P1|Intent to Treat Population: CD30+|Overall Study||64
81809|NCT01578499|196773|P2|Safety Population: Treated|Overall Study||62
81810|NCT01578499|196774|P1|Safety Population: Treated|Overall Study||66
81811|NCT01578499|196773|P2|STARTED|Overall Study||65
81812|NCT01578499|196774|P1|STARTED|Overall Study||66
81813|NCT01578486|196808|P1|NOT COMPLETED|Overall Study||5
81814|NCT01578486|196808|P1|COMPLETED|Overall Study||8
81815|NCT01578486|196808|P1|STARTED|Overall Study||13
81816|NCT01578330|196819|P1|NOT COMPLETED|Overall Study||7
81817|NCT01578330|196819|P1|COMPLETED|Overall Study||35
81818|NCT01578330|196819|P1|Per Protocol Population|Overall Study||35
81819|NCT01578330|196819|P1|STARTED|Overall Study||42
81820|NCT01578239|196828|P2|NOT COMPLETED|Overall Study||25
81821|NCT01578239|196829|P1|NOT COMPLETED|Overall Study||22
81822|NCT01578239|196828|P2|COMPLETED|Overall Study||88
81823|NCT01578239|196829|P1|COMPLETED|Overall Study||94
81824|NCT01578239|196828|P2|STARTED|Overall Study||113
81825|NCT01578239|196829|P1|STARTED|Overall Study||116
81826|NCT01578187|196835|P1|NOT COMPLETED|Usability Phase||1
81827|NCT01578187|196835|P1|COMPLETED|Usability Phase||47
81828|NCT01578187|196835|P1|STARTED|Usability Phase||48
81829|NCT01578187|196835|P1|NOT COMPLETED|Label Comprehension Phase||0
81830|NCT01578187|196835|P1|COMPLETED|Label Comprehension Phase||63
81831|NCT01578187|196835|P1|STARTED|Label Comprehension Phase||63
81832|NCT01578044|196843|P2|NOT COMPLETED|Overall Study||0
81833|NCT01578044|196844|P1|NOT COMPLETED|Overall Study||0
81834|NCT01578044|196843|P2|COMPLETED|Overall Study||6
81835|NCT01578044|196844|P1|COMPLETED|Overall Study||6
81836|NCT01578044|196843|P2|STARTED|Overall Study||6
81837|NCT01578044|196844|P1|STARTED|Overall Study||6
81838|NCT01578031|196854|P4|NOT COMPLETED|Overall Study||0
81839|NCT01578031|196855|P3|NOT COMPLETED|Overall Study||0
81840|NCT01578031|196856|P2|NOT COMPLETED|Overall Study||34
81841|NCT01578031|196857|P1|NOT COMPLETED|Overall Study||62
81842|NCT01578031|196854|P4|COMPLETED|Overall Study|Only baseline data collected|30
81843|NCT01578031|196855|P3|COMPLETED|Overall Study|Only baseline data collected|12
81844|NCT01578031|196856|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
81845|NCT01578031|196857|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
81846|NCT01578031|196854|P4|STARTED|Overall Study||30
81847|NCT01578031|196855|P3|STARTED|Overall Study||12
81848|NCT01578031|196856|P2|STARTED|Overall Study||69
81849|NCT01578031|196857|P1|STARTED|Overall Study||129
81850|NCT01577966|196865|P1|NOT COMPLETED|Overall Study||0
81851|NCT01577966|196865|P1|COMPLETED|Overall Study||9
81852|NCT01577966|196865|P1|STARTED|Overall Study||9
81853|NCT01577758|196869|P8|NOT COMPLETED|mCRC Expansion Phase||25
81854|NCT01577758|196870|P7|NOT COMPLETED|mCRC Expansion Phase||0
81855|NCT01577758|196871|P6|NOT COMPLETED|mCRC Expansion Phase||0
81856|NCT01577758|196872|P5|NOT COMPLETED|mCRC Expansion Phase||0
81857|NCT01577758|196873|P4|NOT COMPLETED|mCRC Expansion Phase||0
81858|NCT01577758|196874|P3|NOT COMPLETED|mCRC Expansion Phase||0
81859|NCT01577758|196875|P2|NOT COMPLETED|mCRC Expansion Phase||0
81860|NCT01577758|196876|P1|NOT COMPLETED|mCRC Expansion Phase||0
81861|NCT01577758|196869|P8|COMPLETED|mCRC Expansion Phase||0
81862|NCT01577758|196870|P7|COMPLETED|mCRC Expansion Phase||0
81863|NCT01577758|196871|P6|COMPLETED|mCRC Expansion Phase||0
81864|NCT01577758|196872|P5|COMPLETED|mCRC Expansion Phase||0
81865|NCT01577758|196873|P4|COMPLETED|mCRC Expansion Phase||0
81866|NCT01577758|196874|P3|COMPLETED|mCRC Expansion Phase||0
81867|NCT01577758|196875|P2|COMPLETED|mCRC Expansion Phase||0
81868|NCT01577758|196876|P1|COMPLETED|mCRC Expansion Phase||0
81869|NCT01577758|196869|P8|STARTED|mCRC Expansion Phase||25
81870|NCT01577758|196870|P7|STARTED|mCRC Expansion Phase||0
81871|NCT01577758|196871|P6|STARTED|mCRC Expansion Phase||0
81872|NCT01577758|196872|P5|STARTED|mCRC Expansion Phase||0
81873|NCT01577758|196873|P4|STARTED|mCRC Expansion Phase||0
81874|NCT01577758|196874|P3|STARTED|mCRC Expansion Phase||0
81875|NCT01577758|196875|P2|STARTED|mCRC Expansion Phase||0
81876|NCT01577758|196876|P1|STARTED|mCRC Expansion Phase||0
81877|NCT01577758|196869|P8|NOT COMPLETED|Dose Escalation Phase||0
81878|NCT01577758|196870|P7|NOT COMPLETED|Dose Escalation Phase||1
81879|NCT01577758|196871|P6|NOT COMPLETED|Dose Escalation Phase||4
81880|NCT01577758|196872|P5|NOT COMPLETED|Dose Escalation Phase||6
81881|NCT01577758|196873|P4|NOT COMPLETED|Dose Escalation Phase||2
81882|NCT01577758|196874|P3|NOT COMPLETED|Dose Escalation Phase||2
81883|NCT01577758|196875|P2|NOT COMPLETED|Dose Escalation Phase||2
81884|NCT01577758|196876|P1|NOT COMPLETED|Dose Escalation Phase||2
81885|NCT01577758|196869|P8|COMPLETED|Dose Escalation Phase||0
81886|NCT01577758|196870|P7|COMPLETED|Dose Escalation Phase||0
81887|NCT01577758|196871|P6|COMPLETED|Dose Escalation Phase||0
81888|NCT01577758|196872|P5|COMPLETED|Dose Escalation Phase||0
81889|NCT01577758|196873|P4|COMPLETED|Dose Escalation Phase||0
81890|NCT01577758|196874|P3|COMPLETED|Dose Escalation Phase||0
81891|NCT01577758|196875|P2|COMPLETED|Dose Escalation Phase||0
81892|NCT01577758|196876|P1|COMPLETED|Dose Escalation Phase||0
81893|NCT01577758|196869|P8|STARTED|Dose Escalation Phase||0
81894|NCT01577758|196870|P7|STARTED|Dose Escalation Phase||1
81895|NCT01577758|196871|P6|STARTED|Dose Escalation Phase||4
81896|NCT01577758|196872|P5|STARTED|Dose Escalation Phase||6
81897|NCT01577758|196873|P4|STARTED|Dose Escalation Phase||2
81898|NCT01577758|196874|P3|STARTED|Dose Escalation Phase||2
81899|NCT01577758|196875|P2|STARTED|Dose Escalation Phase||2
81900|NCT01577758|196876|P1|STARTED|Dose Escalation Phase||2
81901|NCT01577745|196915|P6|NOT COMPLETED|Overall Study||4
81902|NCT01577745|196916|P5|NOT COMPLETED|Overall Study||5
81903|NCT01577745|196917|P4|NOT COMPLETED|Overall Study||6
81904|NCT01577745|196918|P3|NOT COMPLETED|Overall Study||2
81905|NCT01577745|196919|P2|NOT COMPLETED|Overall Study||3
81906|NCT01577745|196920|P1|NOT COMPLETED|Overall Study||3
81907|NCT01577745|196915|P6|COMPLETED|Overall Study||1
81908|NCT01577745|196916|P5|COMPLETED|Overall Study||0
81909|NCT01577745|196917|P4|COMPLETED|Overall Study||0
81910|NCT01577745|196918|P3|COMPLETED|Overall Study||1
81911|NCT01577745|196919|P2|COMPLETED|Overall Study||0
81912|NCT01577745|196920|P1|COMPLETED|Overall Study||0
81913|NCT01577745|196915|P6|STARTED|Overall Study||5
81914|NCT01577745|196916|P5|STARTED|Overall Study||5
81915|NCT01577745|196917|P4|STARTED|Overall Study||6
81916|NCT01577745|196918|P3|STARTED|Overall Study||3
81917|NCT01577745|196919|P2|STARTED|Overall Study||3
81918|NCT01577745|196920|P1|STARTED|Overall Study||3
81919|NCT01577732|197037|P1|NOT COMPLETED|Overall Study||0
81920|NCT01577732|197037|P1|COMPLETED|Overall Study||300
81921|NCT01577732|197037|P1|STARTED|Overall Study||300
81922|NCT01577706|197044|P3|NOT COMPLETED|Third Intervention (1 Day)||0
81923|NCT01577706|197045|P2|NOT COMPLETED|Third Intervention (1 Day)||0
81924|NCT01577706|197046|P1|NOT COMPLETED|Third Intervention (1 Day)||0
81925|NCT01577706|197044|P3|COMPLETED|Third Intervention (1 Day)||3
81926|NCT01577706|197045|P2|COMPLETED|Third Intervention (1 Day)||1
81927|NCT01577706|197046|P1|COMPLETED|Third Intervention (1 Day)||3
81928|NCT01577706|197044|P3|STARTED|Third Intervention (1 Day)||3
81929|NCT01577706|197045|P2|STARTED|Third Intervention (1 Day)||1
81930|NCT01577706|197046|P1|STARTED|Third Intervention (1 Day)||3
81931|NCT01577706|197044|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
81932|NCT01577706|197045|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
81933|NCT01577706|197046|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
81934|NCT01577706|197044|P3|COMPLETED|Washout (at Least 1 Week)||3
81935|NCT01577706|197045|P2|COMPLETED|Washout (at Least 1 Week)||1
81936|NCT01577706|197046|P1|COMPLETED|Washout (at Least 1 Week)||3
81937|NCT01577706|197044|P3|STARTED|Washout (at Least 1 Week)||3
81938|NCT01577706|197045|P2|STARTED|Washout (at Least 1 Week)||1
81939|NCT01577706|197046|P1|STARTED|Washout (at Least 1 Week)||3
81940|NCT01577706|197044|P3|NOT COMPLETED|Second Intervention (1 Day)||0
81941|NCT01577706|197045|P2|NOT COMPLETED|Second Intervention (1 Day)||0
81942|NCT01577706|197046|P1|NOT COMPLETED|Second Intervention (1 Day)||0
81943|NCT01577706|197044|P3|COMPLETED|Second Intervention (1 Day)||3
81944|NCT01577706|197045|P2|COMPLETED|Second Intervention (1 Day)||1
81945|NCT01577706|197046|P1|COMPLETED|Second Intervention (1 Day)||3
81946|NCT01577706|197044|P3|STARTED|Second Intervention (1 Day)||3
81947|NCT01577706|197045|P2|STARTED|Second Intervention (1 Day)||1
81948|NCT01577706|197046|P1|STARTED|Second Intervention (1 Day)||3
81949|NCT01577706|197044|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
81950|NCT01577706|197045|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
81951|NCT01577706|197046|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
81952|NCT01577706|197044|P3|COMPLETED|Washout (at Least 1 Week)||3
81953|NCT01577706|197045|P2|COMPLETED|Washout (at Least 1 Week)||1
81954|NCT01577706|197046|P1|COMPLETED|Washout (at Least 1 Week)||3
81955|NCT01577706|197044|P3|STARTED|Washout (at Least 1 Week)||3
81956|NCT01577706|197045|P2|STARTED|Washout (at Least 1 Week)||1
81957|NCT01577706|197046|P1|STARTED|Washout (at Least 1 Week)||3
81958|NCT01577706|197044|P3|NOT COMPLETED|First Intervention (1 Day)||0
81959|NCT01577706|197045|P2|NOT COMPLETED|First Intervention (1 Day)||0
81960|NCT01577706|197046|P1|NOT COMPLETED|First Intervention (1 Day)||0
81961|NCT01577706|197044|P3|COMPLETED|First Intervention (1 Day)||3
81962|NCT01577706|197045|P2|COMPLETED|First Intervention (1 Day)||1
81963|NCT01577706|197046|P1|COMPLETED|First Intervention (1 Day)||3
81964|NCT01577706|197044|P3|STARTED|First Intervention (1 Day)||3
81965|NCT01577706|197045|P2|STARTED|First Intervention (1 Day)||1
81966|NCT01577706|197046|P1|STARTED|First Intervention (1 Day)||3
81967|NCT01577628|197074|P3|NOT COMPLETED|Overall Study||2
81968|NCT01577628|197075|P2|NOT COMPLETED|Overall Study||0
81969|NCT01577628|197076|P1|NOT COMPLETED|Overall Study||0
81970|NCT01577628|197074|P3|COMPLETED|Overall Study||0
81971|NCT01577628|197075|P2|COMPLETED|Overall Study||0
81972|NCT01577628|197076|P1|COMPLETED|Overall Study||0
81973|NCT01577628|197074|P3|STARTED|Overall Study||2
81974|NCT01577628|197075|P2|STARTED|Overall Study||0
81975|NCT01577628|197076|P1|STARTED|Overall Study||0
81976|NCT01577381|197104|P4|NOT COMPLETED|Overall Study||2
81977|NCT01577381|197105|P3|NOT COMPLETED|Overall Study||3
81978|NCT01577381|197106|P2|NOT COMPLETED|Overall Study||3
81979|NCT01577381|197107|P1|NOT COMPLETED|Overall Study||2
81980|NCT01577381|197104|P4|COMPLETED|Overall Study||0
81981|NCT01577381|197105|P3|COMPLETED|Overall Study||0
81982|NCT01577381|197106|P2|COMPLETED|Overall Study||0
81983|NCT01577381|197107|P1|COMPLETED|Overall Study||0
81984|NCT01577381|197104|P4|STARTED|Overall Study||2
81985|NCT01577381|197105|P3|STARTED|Overall Study||3
81986|NCT01577381|197106|P2|STARTED|Overall Study||3
81987|NCT01577381|197107|P1|STARTED|Overall Study||2
81988|NCT01577329|197238|P2|NOT COMPLETED|Overall Study||0
81989|NCT01577329|197239|P1|NOT COMPLETED|Overall Study||3
81990|NCT01577329|197238|P2|COMPLETED|Overall Study||22
81991|NCT01577329|197239|P1|COMPLETED|Overall Study||16
81992|NCT01577329|197238|P2|STARTED|Overall Study||22
81993|NCT01577329|197239|P1|STARTED|Overall Study||19
81994|NCT01577186|197245|P1|NOT COMPLETED|Overall Study||130
81995|NCT01577186|197245|P1|COMPLETED|Overall Study||350
81996|NCT01577186|197245|P1|STARTED|Overall Study||480
81997|NCT01577160|197253|P1|NOT COMPLETED|Overall Study||98
81998|NCT01577160|197253|P1|COMPLETED|Overall Study||255
81999|NCT01577160|197253|P1|STARTED|Overall Study||353
82000|NCT01577108|197263|P2|NOT COMPLETED|Overall Study||6
82001|NCT01577108|197264|P1|NOT COMPLETED|Overall Study||5
82002|NCT01577108|197263|P2|COMPLETED|Overall Study||50
82003|NCT01577108|197264|P1|COMPLETED|Overall Study||49
82004|NCT01577108|197263|P2|STARTED|Overall Study||56
82005|NCT01577108|197264|P1|STARTED|Overall Study||54
82006|NCT01576952|197272|P2|NOT COMPLETED|Overall Study||55
82007|NCT01576952|197273|P1|NOT COMPLETED|Overall Study||41
82008|NCT01576952|197272|P2|COMPLETED|Overall Study||33
82009|NCT01576952|197273|P1|COMPLETED|Overall Study||139
82010|NCT01576952|197272|P2|mITT Population|Overall Study||85
82011|NCT01576952|197273|P1|mITT Population|Overall Study||168
82012|NCT01576952|197272|P2|Safety Population|Overall Study||85
82013|NCT01576952|197273|P1|Safety Population|Overall Study||169
82014|NCT01576952|197272|P2|STARTED|Overall Study||88
82015|NCT01576952|197273|P1|STARTED|Overall Study||180
82016|NCT01576939|197279|P1|NOT COMPLETED|Overall Study||0
82017|NCT01576939|197279|P1|COMPLETED|Overall Study||30
82018|NCT01576939|197279|P1|STARTED|Overall Study||30
82019|NCT01576809|197287|P1|NOT COMPLETED|Overall Study||0
82020|NCT01576809|197287|P1|COMPLETED|Overall Study||51
82021|NCT01576809|197287|P1|STARTED|Overall Study||51
82022|NCT01576718|197299|P7|NOT COMPLETED|Treatment Period||30
82023|NCT01576718|197300|P6|NOT COMPLETED|Treatment Period||48
82024|NCT01576718|197301|P5|NOT COMPLETED|Treatment Period||27
82025|NCT01576718|197302|P4|NOT COMPLETED|Treatment Period||31
82026|NCT01576718|197303|P3|NOT COMPLETED|Treatment Period||20
82027|NCT01576718|197304|P2|NOT COMPLETED|Treatment Period||25
82028|NCT01576718|197305|P1|NOT COMPLETED|Treatment Period||0
82029|NCT01576718|197299|P7|COMPLETED|Treatment Period||77
82030|NCT01576718|197300|P6|COMPLETED|Treatment Period||58
82031|NCT01576718|197301|P5|COMPLETED|Treatment Period||80
82032|NCT01576718|197302|P4|COMPLETED|Treatment Period||75
82033|NCT01576718|197303|P3|COMPLETED|Treatment Period||87
82034|NCT01576718|197304|P2|COMPLETED|Treatment Period||82
82035|NCT01576718|197305|P1|COMPLETED|Treatment Period||0
82036|NCT01576718|197299|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
82037|NCT01576718|197300|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
82038|NCT01576718|197301|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
82039|NCT01576718|197302|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
82040|NCT01576718|197303|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
82041|NCT01576718|197304|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
82042|NCT01576718|197305|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
82043|NCT01576718|197299|P7|Safety Population|Treatment Period||106
82044|NCT01576718|197300|P6|Safety Population|Treatment Period||106
82045|NCT01576718|197301|P5|Safety Population|Treatment Period||107
82046|NCT01576718|197302|P4|Safety Population|Treatment Period||106
82047|NCT01576718|197303|P3|Safety Population|Treatment Period||107
82048|NCT01576718|197304|P2|Safety Population|Treatment Period||107
82049|NCT01576718|197305|P1|Safety Population|Treatment Period||0
82050|NCT01576718|197299|P7|STARTED|Treatment Period||107
82051|NCT01576718|197300|P6|STARTED|Treatment Period||106
82052|NCT01576718|197301|P5|STARTED|Treatment Period||107
82053|NCT01576718|197302|P4|STARTED|Treatment Period||106
82054|NCT01576718|197303|P3|STARTED|Treatment Period||107
82055|NCT01576718|197304|P2|STARTED|Treatment Period||107
82056|NCT01576718|197305|P1|STARTED|Treatment Period||0
82057|NCT01576718|197299|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82058|NCT01576718|197300|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82059|NCT01576718|197301|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82060|NCT01576718|197302|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82061|NCT01576718|197303|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82062|NCT01576718|197304|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82063|NCT01576718|197305|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
82064|NCT01576718|197299|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82065|NCT01576718|197300|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82066|NCT01576718|197301|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82067|NCT01576718|197302|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82068|NCT01576718|197303|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82069|NCT01576718|197304|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
82070|NCT01576718|197305|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
82071|NCT01576718|197299|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
82072|NCT01576718|197300|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
82073|NCT01576718|197301|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
82074|NCT01576718|197302|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
82075|NCT01576718|197303|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
82076|NCT01576718|197304|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
82077|NCT01576718|197305|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
82078|NCT01576549|197397|P1|NOT COMPLETED|Overall Study||2
82079|NCT01576549|197397|P1|COMPLETED|Overall Study||0
82080|NCT01576549|197397|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
82081|NCT01576549|197397|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
82082|NCT01576549|197397|P1|STARTED|Overall Study||2
82083|NCT01576471|197407|P2|NOT COMPLETED|Overall Study||9
82084|NCT01576471|197408|P1|NOT COMPLETED|Overall Study||8
82085|NCT01576471|197407|P2|COMPLETED|Overall Study||116
82086|NCT01576471|197408|P1|COMPLETED|Overall Study||117
82087|NCT01576471|197407|P2|STARTED|Overall Study||125
82088|NCT01576471|197408|P1|STARTED|Overall Study||125
82089|NCT01576367|197414|P1|NOT COMPLETED|Overall Study||3
82090|NCT01576367|197414|P1|COMPLETED|Overall Study||14
82091|NCT01576367|197414|P1|STARTED|Overall Study||17
82092|NCT01576341|197422|P1|NOT COMPLETED|Overall Study||93
82093|NCT01576341|197422|P1|COMPLETED|Overall Study||324
82094|NCT01576341|197422|P1|STARTED|Overall Study||417
82095|NCT01576276|197431|P2|NOT COMPLETED|Overall Study||11
82096|NCT01576276|197432|P1|NOT COMPLETED|Overall Study||8
82097|NCT01576276|197431|P2|COMPLETED|Overall Study||18
82098|NCT01576276|197432|P1|COMPLETED|Overall Study||14
82099|NCT01576276|197431|P2|STARTED|Overall Study||29
82100|NCT01576276|197432|P1|STARTED|Overall Study||22
82101|NCT01576159|197443|P4|NOT COMPLETED|Overall Study||1
82102|NCT01576159|197444|P3|NOT COMPLETED|Overall Study||1
82103|NCT01576159|197445|P2|NOT COMPLETED|Overall Study||1
82104|NCT01576159|197446|P1|NOT COMPLETED|Overall Study||1
82105|NCT01576159|197443|P4|COMPLETED|Overall Study||11
82106|NCT01576159|197444|P3|COMPLETED|Overall Study||11
82107|NCT01576159|197445|P2|COMPLETED|Overall Study||11
82108|NCT01576159|197446|P1|COMPLETED|Overall Study||11
82109|NCT01576159|197443|P4|STARTED|Overall Study||12
82110|NCT01576159|197444|P3|STARTED|Overall Study||12
82111|NCT01576159|197445|P2|STARTED|Overall Study||12
82112|NCT01576159|197446|P1|STARTED|Overall Study||12
82113|NCT01576146|197464|P1|NOT COMPLETED|Extension Period 2||17
82114|NCT01576146|197464|P1|COMPLETED|Extension Period 2||0
82115|NCT01576146|197464|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
82116|NCT01576146|197464|P1|NOT COMPLETED|Extension Period 1||10
82117|NCT01576146|197464|P1|COMPLETED|Extension Period 1||20
82118|NCT01576146|197464|P1|STARTED|Extension Period 1||30
82119|NCT01576120|197473|P2|NOT COMPLETED|Overall Study||0
82120|NCT01576120|197474|P1|NOT COMPLETED|Overall Study||0
82121|NCT01576120|197473|P2|COMPLETED|Overall Study||19
82122|NCT01576120|197474|P1|COMPLETED|Overall Study||21
82123|NCT01576120|197473|P2|STARTED|Overall Study||19
82124|NCT01576120|197474|P1|STARTED|Overall Study||21
82125|NCT01576055|197482|P2|NOT COMPLETED|Overall Study||6
82126|NCT01576055|197483|P1|NOT COMPLETED|Overall Study||19
82127|NCT01576055|197482|P2|COMPLETED|Overall Study||64
82128|NCT01576055|197483|P1|COMPLETED|Overall Study||178
82129|NCT01576055|197482|P2|STARTED|Overall Study||70
82130|NCT01576055|197483|P1|STARTED|Overall Study||197
82131|NCT01576042|197497|P2|NOT COMPLETED|Overall Study||0
82132|NCT01576042|197498|P1|NOT COMPLETED|Overall Study||2
82133|NCT01576042|197497|P2|COMPLETED|Overall Study||14
82134|NCT01576042|197498|P1|COMPLETED|Overall Study||11
82135|NCT01576042|197497|P2|Switched to the Other Arm|Overall Study||1
82136|NCT01576042|197498|P1|Switched to the Other Arm|Overall Study||5
82137|NCT01576042|197497|P2|STARTED|Overall Study||14
82138|NCT01576042|197498|P1|STARTED|Overall Study||13
82139|NCT01575912|197521|P3|NOT COMPLETED|Overall Study||0
82140|NCT01575912|197522|P2|NOT COMPLETED|Overall Study||0
82141|NCT01575912|197523|P1|NOT COMPLETED|Overall Study||0
82142|NCT01575912|197521|P3|COMPLETED|Overall Study||30
82143|NCT01575912|197522|P2|COMPLETED|Overall Study||32
82144|NCT01575912|197523|P1|COMPLETED|Overall Study||30
82145|NCT01575912|197521|P3|STARTED|Overall Study||30
82146|NCT01575912|197522|P2|STARTED|Overall Study||32
82147|NCT01575912|197523|P1|STARTED|Overall Study||30
82148|NCT01575899|197534|P3|NOT COMPLETED|Overall Study||2
82149|NCT01575899|197535|P2|NOT COMPLETED|Overall Study||5
82150|NCT01575899|197536|P1|NOT COMPLETED|Overall Study||5
82151|NCT01575899|197534|P3|COMPLETED|Overall Study||60
82152|NCT01575899|197535|P2|COMPLETED|Overall Study||68
82153|NCT01575899|197536|P1|COMPLETED|Overall Study||68
82154|NCT01575899|197534|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
82155|NCT01575899|197535|P2|STARTED|Overall Study||73
82156|NCT01575899|197536|P1|STARTED|Overall Study||73
82157|NCT01575808|197548|P2|NOT COMPLETED|Overall Study||0
82158|NCT01575808|197549|P1|NOT COMPLETED|Overall Study||3
82159|NCT01575808|197548|P2|COMPLETED|Overall Study||68
82160|NCT01575808|197549|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
82161|NCT01575808|197548|P2|STARTED|Overall Study||68
82162|NCT01575808|197549|P1|STARTED|Overall Study||103
82163|NCT01575769|197596|P1|NOT COMPLETED|Overall Study||41
82164|NCT01575769|197596|P1|COMPLETED|Overall Study||0
82165|NCT01575769|197596|P1|STARTED|Overall Study||41
82166|NCT01575756|197622|P2|NOT COMPLETED|Treatment Period 2||0
82167|NCT01575756|197623|P1|NOT COMPLETED|Treatment Period 2||0
82168|NCT01575756|197622|P2|COMPLETED|Treatment Period 2||11
82169|NCT01575756|197623|P1|COMPLETED|Treatment Period 2||11
82170|NCT01575756|197622|P2|STARTED|Treatment Period 2||11
82171|NCT01575756|197623|P1|STARTED|Treatment Period 2||11
82172|NCT01575756|197622|P2|NOT COMPLETED|Treatment Period 1||0
82173|NCT01575756|197623|P1|NOT COMPLETED|Treatment Period 1||0
82174|NCT01575756|197622|P2|COMPLETED|Treatment Period 1||11
82175|NCT01575756|197623|P1|COMPLETED|Treatment Period 1||11
82176|NCT01575756|197622|P2|STARTED|Treatment Period 1||11
82177|NCT01575756|197623|P1|STARTED|Treatment Period 1||11
82178|NCT01575561|197654|P1|NOT COMPLETED|Overall Study||39
82179|NCT01575561|197654|P1|COMPLETED|Overall Study||338
82180|NCT01575561|197654|P1|STARTED|Overall Study||377
82181|NCT01575522|197666|P1|NOT COMPLETED|Overall Study||0
82182|NCT01575522|197666|P1|COMPLETED|Overall Study||22
82183|NCT01575522|197666|P1|STARTED|Overall Study||22
82184|NCT01575197|197677|P3|NOT COMPLETED|Overall Study||6
82185|NCT01575197|197678|P2|NOT COMPLETED|Overall Study||9
82186|NCT01575197|197679|P1|NOT COMPLETED|Overall Study||3
82187|NCT01575197|197677|P3|COMPLETED|Overall Study||146
82188|NCT01575197|197678|P2|COMPLETED|Overall Study||143
82189|NCT01575197|197679|P1|COMPLETED|Overall Study||149
82190|NCT01575197|197677|P3|STARTED|Overall Study||152
82191|NCT01575197|197678|P2|STARTED|Overall Study||152
82192|NCT01575197|197679|P1|STARTED|Overall Study||152
82193|NCT01575106|197692|P1|NOT COMPLETED|Overall Study||14
82194|NCT01575106|197692|P1|COMPLETED|Overall Study||24
82195|NCT01575106|197692|P1|STARTED|Overall Study||38
82196|NCT01575080|197698|P1|NOT COMPLETED|Overall Study||0
82197|NCT01575080|197698|P1|COMPLETED|Overall Study||102
82198|NCT01575080|197698|P1|STARTED|Overall Study||102
82199|NCT01575054|197707|P2|NOT COMPLETED|Overall Study||26
82200|NCT01575054|197708|P1|NOT COMPLETED|Overall Study||29
82201|NCT01575054|197707|P2|COMPLETED|Overall Study||209
82202|NCT01575054|197708|P1|COMPLETED|Overall Study||204
82203|NCT01575054|197707|P2|STARTED|Overall Study||235
82204|NCT01575054|197708|P1|STARTED|Overall Study||233
82205|NCT01575028|197724|P2|NOT COMPLETED|Overall Study||1
82206|NCT01575028|197725|P1|NOT COMPLETED|Overall Study||0
82207|NCT01575028|197724|P2|COMPLETED|Overall Study||0
82208|NCT01575028|197725|P1|COMPLETED|Overall Study||2
82209|NCT01575028|197724|P2|STARTED|Overall Study||1
82210|NCT01575028|197725|P1|STARTED|Overall Study||2
82211|NCT01574703|197735|P4|NOT COMPLETED|Overall Study||114
82212|NCT01574703|197736|P3|NOT COMPLETED|Overall Study||105
82213|NCT01574703|197737|P2|NOT COMPLETED|Overall Study||112
82214|NCT01574703|197738|P1|NOT COMPLETED|Overall Study||125
82215|NCT01574703|197735|P4|COMPLETED|Overall Study||1007
82216|NCT01574703|197736|P3|COMPLETED|Overall Study||1011
82217|NCT01574703|197737|P2|COMPLETED|Overall Study||1054
82218|NCT01574703|197738|P1|COMPLETED|Overall Study||1067
82219|NCT01574703|197735|P4|STARTED|Overall Study||1121
82220|NCT01574703|197736|P3|STARTED|Overall Study||1116
82221|NCT01574703|197737|P2|STARTED|Overall Study||1166
82222|NCT01574703|197738|P1|STARTED|Overall Study||1192
82223|NCT01574651|197782|P2|NOT COMPLETED|Overall Study||52
82224|NCT01574651|197783|P1|NOT COMPLETED|Overall Study||61
82225|NCT01574651|197782|P2|COMPLETED|Overall Study||406
82226|NCT01574651|197783|P1|COMPLETED|Overall Study||415
82227|NCT01574651|197782|P2|Per Protocol Set (PPS)|Overall Study||374
82228|NCT01574651|197783|P1|Per Protocol Set (PPS)|Overall Study||373
82229|NCT01574651|197782|P2|Full Analysis Set (FAS)|Overall Study||458
82230|NCT01574651|197783|P1|Full Analysis Set (FAS)|Overall Study||476
82231|NCT01574651|197782|P2|STARTED|Overall Study||458
82232|NCT01574651|197783|P1|STARTED|Overall Study||476
82233|NCT01574612|197805|P1|NOT COMPLETED|Overall Study||8
82234|NCT01574612|197805|P1|COMPLETED|Overall Study||46
82235|NCT01574612|197805|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
82236|NCT01574326|197811|P2|NOT COMPLETED|Overall Study||19
82237|NCT01574326|197812|P1|NOT COMPLETED|Overall Study||16
82238|NCT01574326|197811|P2|COMPLETED|Overall Study||31
82239|NCT01574326|197812|P1|COMPLETED|Overall Study||35
82240|NCT01574326|197811|P2|Treated|Overall Study||49
82241|NCT01574326|197812|P1|Treated|Overall Study||51
82242|NCT01574326|197811|P2|STARTED|Overall Study||50
82243|NCT01574326|197812|P1|STARTED|Overall Study||51
82244|NCT01574248|197825|P2|NOT COMPLETED|Overall Study||0
82245|NCT01574248|197826|P1|NOT COMPLETED|Overall Study||3
82246|NCT01574248|197825|P2|COMPLETED|Overall Study||18
82247|NCT01574248|197826|P1|COMPLETED|Overall Study||12
82248|NCT01574248|197825|P2|STARTED|Overall Study||18
82249|NCT01574248|197826|P1|STARTED|Overall Study||15
82250|NCT01574183|197846|P2|NOT COMPLETED|Overall Study||18
82251|NCT01574183|197847|P1|NOT COMPLETED|Overall Study||27
82252|NCT01574183|197846|P2|COMPLETED|Overall Study||17
82253|NCT01574183|197847|P1|COMPLETED|Overall Study||14
82254|NCT01574183|197846|P2|STARTED|Overall Study||35
82255|NCT01574183|197847|P1|STARTED|Overall Study||41
82256|NCT01574105|197859|P2|NOT COMPLETED|Overall Study||0
82257|NCT01574105|197860|P1|NOT COMPLETED|Overall Study||0
82258|NCT01574105|197859|P2|COMPLETED|Overall Study||37
82259|NCT01574105|197860|P1|COMPLETED|Overall Study||29
82260|NCT01574105|197859|P2|STARTED|Overall Study||37
82261|NCT01574105|197860|P1|STARTED|Overall Study||29
82262|NCT01574079|197870|P2|NOT COMPLETED|Overall Study||2
82263|NCT01574079|197871|P1|NOT COMPLETED|Overall Study||1
82264|NCT01574079|197870|P2|COMPLETED|Overall Study||13
82265|NCT01574079|197871|P1|COMPLETED|Overall Study||17
82266|NCT01574079|197870|P2|STARTED|Overall Study||15
82267|NCT01574079|197871|P1|STARTED|Overall Study||18
82268|NCT01573910|197883|P2|NOT COMPLETED|Overall Study||17
82269|NCT01573910|197884|P1|NOT COMPLETED|Overall Study||20
82270|NCT01573910|197883|P2|COMPLETED|Overall Study||476
82271|NCT01573910|197884|P1|COMPLETED|Overall Study||469
82272|NCT01573910|197883|P2|STARTED|Overall Study||493
82273|NCT01573910|197884|P1|STARTED|Overall Study||489
82274|NCT01573767|197896|P4|NOT COMPLETED|Overall Study||24
82275|NCT01573767|197897|P3|NOT COMPLETED|Overall Study||14
82276|NCT01573767|197898|P2|NOT COMPLETED|Overall Study||21
82277|NCT01573767|197899|P1|NOT COMPLETED|Overall Study||22
82278|NCT01573767|197896|P4|COMPLETED|Overall Study||90
82279|NCT01573767|197897|P3|COMPLETED|Overall Study||99
82280|NCT01573767|197898|P2|COMPLETED|Overall Study||93
82281|NCT01573767|197899|P1|COMPLETED|Overall Study||93
82282|NCT01573767|197896|P4|STARTED|Overall Study||114
82283|NCT01573767|197897|P3|STARTED|Overall Study||113
82284|NCT01573767|197898|P2|STARTED|Overall Study||114
82285|NCT01573767|197899|P1|STARTED|Overall Study||115
82286|NCT01573624|197933|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
82287|NCT01573624|197934|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
82288|NCT01573624|197935|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
82289|NCT01573624|197936|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
82290|NCT01573624|197937|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
82291|NCT01573624|197938|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
82292|NCT01573624|197939|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
82293|NCT01573624|197933|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
82294|NCT01573624|197934|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
82295|NCT01573624|197935|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
82296|NCT01573624|197936|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
82297|NCT01573624|197937|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
82298|NCT01573624|197938|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
82299|NCT01573624|197939|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
82300|NCT01573624|197933|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
82301|NCT01573624|197934|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
82302|NCT01573624|197935|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
82303|NCT01573624|197936|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
82304|NCT01573624|197937|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
82305|NCT01573624|197938|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
82306|NCT01573624|197939|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
82307|NCT01573624|197933|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
82308|NCT01573624|197934|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
82309|NCT01573624|197935|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
82310|NCT01573624|197936|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
82311|NCT01573624|197937|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
82312|NCT01573624|197938|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
82313|NCT01573624|197939|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
82314|NCT01573624|197933|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
82315|NCT01573624|197934|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
82316|NCT01573624|197935|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
82317|NCT01573624|197936|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
82318|NCT01573624|197937|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
82319|NCT01573624|197938|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
82320|NCT01573624|197939|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
82321|NCT01573624|197933|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
82322|NCT01573624|197934|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
82323|NCT01573624|197935|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
82324|NCT01573624|197936|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
82325|NCT01573624|197937|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
82326|NCT01573624|197938|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
82327|NCT01573624|197939|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
82328|NCT01573624|197933|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
82329|NCT01573624|197934|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
82330|NCT01573624|197935|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
82331|NCT01573624|197936|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
82332|NCT01573624|197937|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
82333|NCT01573624|197938|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
82334|NCT01573624|197939|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
82335|NCT01573624|197933|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
82336|NCT01573624|197934|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
82337|NCT01573624|197935|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
82338|NCT01573624|197936|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
82339|NCT01573624|197937|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
82340|NCT01573624|197938|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
82341|NCT01573624|197939|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
82342|NCT01573624|197933|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
82343|NCT01573624|197934|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
82344|NCT01573624|197935|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
82345|NCT01573624|197936|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
82346|NCT01573624|197937|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
82347|NCT01573624|197938|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
82348|NCT01573624|197939|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
82349|NCT01573624|197933|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
82350|NCT01573624|197934|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
82351|NCT01573624|197935|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
82352|NCT01573624|197936|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
82353|NCT01573624|197937|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
82354|NCT01573624|197938|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
82355|NCT01573624|197939|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
82356|NCT01573624|197933|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
82357|NCT01573624|197934|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
82358|NCT01573624|197935|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
82359|NCT01573624|197936|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
82360|NCT01573624|197937|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
82361|NCT01573624|197938|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
82362|NCT01573624|197939|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
82363|NCT01573624|197933|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
82364|NCT01573624|197934|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
82365|NCT01573624|197935|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
82366|NCT01573624|197936|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
82367|NCT01573624|197937|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
82368|NCT01573624|197938|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
82369|NCT01573624|197939|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
82370|NCT01573624|197933|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
82371|NCT01573624|197934|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
82372|NCT01573624|197935|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
82373|NCT01573624|197936|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
82374|NCT01573624|197937|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
82375|NCT01573624|197938|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
82376|NCT01573624|197939|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
82377|NCT01573624|197933|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
82378|NCT01573624|197934|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
82379|NCT01573624|197935|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
82380|NCT01573624|197936|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
82381|NCT01573624|197937|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
82382|NCT01573624|197938|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
82383|NCT01573624|197939|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
82384|NCT01573624|197933|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
82385|NCT01573624|197934|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
82386|NCT01573624|197935|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
82387|NCT01573624|197936|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
82388|NCT01573624|197937|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
82389|NCT01573624|197938|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
82390|NCT01573624|197939|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
82391|NCT01573624|197933|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
82392|NCT01573624|197934|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
82393|NCT01573624|197935|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
82394|NCT01573624|197936|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
82395|NCT01573624|197937|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
82396|NCT01573624|197938|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
82397|NCT01573624|197939|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
82398|NCT01573624|197933|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
82399|NCT01573624|197934|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
82400|NCT01573624|197935|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
82401|NCT01573624|197936|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
82402|NCT01573624|197937|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
82403|NCT01573624|197938|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
82404|NCT01573624|197939|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
82405|NCT01573624|197933|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
82406|NCT01573624|197934|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
82407|NCT01573624|197935|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
82408|NCT01573624|197936|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
82409|NCT01573624|197937|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
82410|NCT01573624|197938|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
82411|NCT01573624|197939|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
82412|NCT01573325|197986|P1|NOT COMPLETED|Overall Study||0
82413|NCT01573325|197986|P1|COMPLETED|Overall Study||50
82414|NCT01573325|197986|P1|STARTED|Overall Study||50
82415|NCT01573260|197993|P2|NOT COMPLETED|Overall Study||0
82416|NCT01573260|197994|P1|NOT COMPLETED|Overall Study||0
82417|NCT01573260|197993|P2|COMPLETED|Overall Study||15
82418|NCT01573260|197994|P1|COMPLETED|Overall Study||18
82419|NCT01573260|197993|P2|STARTED|Overall Study||15
82420|NCT01573260|197994|P1|STARTED|Overall Study||18
82421|NCT01573000|198028|P2|NOT COMPLETED|Long-Term Follow-Up||1
82422|NCT01573000|198029|P1|NOT COMPLETED|Long-Term Follow-Up||3
82423|NCT01573000|198028|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
82424|NCT01573000|198029|P1|COMPLETED|Long-Term Follow-Up||11
82425|NCT01573000|198028|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
82426|NCT01573000|198029|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
82427|NCT01573000|198028|P2|NOT COMPLETED|Crossover Phase||18
82428|NCT01573000|198029|P1|NOT COMPLETED|Crossover Phase||0
82429|NCT01573000|198028|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
82430|NCT01573000|198029|P1|COMPLETED|Crossover Phase||0
82431|NCT01573000|198028|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
82432|NCT01573000|198029|P1|STARTED|Crossover Phase||0
82433|NCT01573000|198028|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
82434|NCT01573000|198029|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
82435|NCT01573000|198028|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
82436|NCT01573000|198029|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
82437|NCT01573000|198028|P2|STARTED|Dosimetric and Therapeutic Treatment||36
82438|NCT01573000|198029|P1|STARTED|Dosimetric and Therapeutic Treatment||42
82439|NCT01572948|198125|P2|NOT COMPLETED|Overall Study||1
82440|NCT01572948|198126|P1|NOT COMPLETED|Overall Study||1
82441|NCT01572948|198125|P2|COMPLETED|Overall Study||15
82442|NCT01572948|198126|P1|COMPLETED|Overall Study||10
82443|NCT01572948|198125|P2|STARTED|Overall Study||16
82444|NCT01572948|198126|P1|STARTED|Overall Study||11
82445|NCT01572844|198142|P2|NOT COMPLETED|Overall Study||1
82446|NCT01572844|198143|P1|NOT COMPLETED|Overall Study||1
82447|NCT01572844|198142|P2|COMPLETED|Overall Study||2
82448|NCT01572844|198143|P1|COMPLETED|Overall Study||2
82449|NCT01572844|198142|P2|STARTED|Overall Study||3
82450|NCT01572844|198143|P1|STARTED|Overall Study||3
82451|NCT01572792|198161|P5|NOT COMPLETED|Extension Study||32
82452|NCT01572792|198162|P4|NOT COMPLETED|Extension Study||29
82453|NCT01572792|198163|P3|NOT COMPLETED|Extension Study||26
82454|NCT01572792|198164|P2|NOT COMPLETED|Extension Study||29
82455|NCT01572792|198165|P1|NOT COMPLETED|Extension Study||25
82456|NCT01572792|198161|P5|COMPLETED|Extension Study||160
82457|NCT01572792|198162|P4|COMPLETED|Extension Study||165
82458|NCT01572792|198163|P3|COMPLETED|Extension Study||179
82459|NCT01572792|198164|P2|COMPLETED|Extension Study||155
82460|NCT01572792|198165|P1|COMPLETED|Extension Study||121
82461|NCT01572792|198161|P5|STARTED|Extension Study||192
82462|NCT01572792|198162|P4|STARTED|Extension Study||194
82463|NCT01572792|198163|P3|STARTED|Extension Study||205
82464|NCT01572792|198164|P2|STARTED|Extension Study||184
82465|NCT01572792|198165|P1|STARTED|Extension Study||146
82466|NCT01572792|198161|P5|NOT COMPLETED|Lead-in Study||69
82467|NCT01572792|198162|P4|NOT COMPLETED|Lead-in Study||72
82468|NCT01572792|198163|P3|NOT COMPLETED|Lead-in Study||62
82469|NCT01572792|198164|P2|NOT COMPLETED|Lead-in Study||66
82470|NCT01572792|198165|P1|NOT COMPLETED|Lead-in Study||101
82471|NCT01572792|198161|P5|COMPLETED|Lead-in Study||270
82472|NCT01572792|198162|P4|COMPLETED|Lead-in Study||268
82473|NCT01572792|198163|P3|COMPLETED|Lead-in Study||276
82474|NCT01572792|198164|P2|COMPLETED|Lead-in Study||272
82475|NCT01572792|198165|P1|COMPLETED|Lead-in Study||236
82476|NCT01572792|198161|P5|STARTED|Lead-in Study||339
82477|NCT01572792|198162|P4|STARTED|Lead-in Study||340
82478|NCT01572792|198163|P3|STARTED|Lead-in Study||338
82479|NCT01572792|198164|P2|STARTED|Lead-in Study||338
82480|NCT01572792|198165|P1|STARTED|Lead-in Study||337
82481|NCT01572740|198214|P2|NOT COMPLETED|Overall Study||5
82482|NCT01572740|198215|P1|NOT COMPLETED|Overall Study||6
82483|NCT01572740|198214|P2|COMPLETED|Overall Study||125
82484|NCT01572740|198215|P1|COMPLETED|Overall Study||121
82485|NCT01572740|198214|P2|STARTED|Overall Study||130
82486|NCT01572740|198215|P1|STARTED|Overall Study||127
82487|NCT01572727|198245|P2|NOT COMPLETED|Overall Study||209
82488|NCT01572727|198246|P1|NOT COMPLETED|Overall Study||207
82489|NCT01572727|198245|P2|COMPLETED|Overall Study||0
82490|NCT01572727|198246|P1|COMPLETED|Overall Study||0
82491|NCT01572727|198245|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
82492|NCT01572727|198246|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
82493|NCT01572727|198245|P2|STARTED|Overall Study||209
82494|NCT01572727|198246|P1|STARTED|Overall Study||207
82495|NCT01572675|198268|P2|NOT COMPLETED|Overall Study||223
82496|NCT01572675|198269|P1|NOT COMPLETED|Overall Study||237
82497|NCT01572675|198268|P2|COMPLETED|Overall Study||56
82498|NCT01572675|198269|P1|COMPLETED|Overall Study||31
82499|NCT01572675|198268|P2|STARTED|Overall Study||279
82500|NCT01572675|198269|P1|STARTED|Overall Study||268
82501|NCT01572389|198368|P2|NOT COMPLETED|Overall Study||21
82502|NCT01572389|198369|P1|NOT COMPLETED|Overall Study||46
82503|NCT01572389|198368|P2|COMPLETED|Overall Study||68
82504|NCT01572389|198369|P1|COMPLETED|Overall Study||90
82505|NCT01572389|198368|P2|STARTED|Overall Study||89
82506|NCT01572389|198369|P1|STARTED|Overall Study||136
82507|NCT01572298|198379|P2|NOT COMPLETED|Overall Study||1
82508|NCT01572298|198380|P1|NOT COMPLETED|Overall Study||2
82509|NCT01572298|198379|P2|COMPLETED|Overall Study||12
82510|NCT01572298|198380|P1|COMPLETED|Overall Study||12
82511|NCT01572298|198379|P2|STARTED|Overall Study||13
82512|NCT01572298|198380|P1|STARTED|Overall Study||14
82513|NCT01572207|198390|P2|NOT COMPLETED|Overall Study||3
82514|NCT01572207|198391|P1|NOT COMPLETED|Overall Study||2
82515|NCT01572207|198390|P2|COMPLETED|Overall Study||13
82516|NCT01572207|198391|P1|COMPLETED|Overall Study||12
82517|NCT01572207|198390|P2|STARTED|Overall Study||16
82518|NCT01572207|198391|P1|STARTED|Overall Study||14
82519|NCT01571557|198401|P1|NOT COMPLETED|Overall Study||0
82520|NCT01571557|198401|P1|COMPLETED|Overall Study||573
82521|NCT01571557|198401|P1|STARTED|Overall Study||573
82522|NCT01571453|198410|P2|NOT COMPLETED|Overall Study||62
82523|NCT01571453|198411|P1|NOT COMPLETED|Overall Study||38
82524|NCT01571453|198410|P2|COMPLETED|Overall Study||164
82525|NCT01571453|198411|P1|COMPLETED|Overall Study||173
82526|NCT01571453|198410|P2|STARTED|Overall Study||226
82527|NCT01571453|198411|P1|STARTED|Overall Study||211
82528|NCT01571362|198427|P3|NOT COMPLETED|Double-Blind Treatment Period||39
82529|NCT01571362|198428|P2|NOT COMPLETED|Double-Blind Treatment Period||53
82530|NCT01571362|198429|P1|NOT COMPLETED|Double-Blind Treatment Period||0
82531|NCT01571362|198427|P3|COMPLETED|Double-Blind Treatment Period||107
82532|NCT01571362|198428|P2|COMPLETED|Double-Blind Treatment Period||81
82533|NCT01571362|198429|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
82534|NCT01571362|198427|P3|STARTED|Double-Blind Treatment Period||146
82535|NCT01571362|198428|P2|STARTED|Double-Blind Treatment Period||134
82536|NCT01571362|198429|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
82537|NCT01571362|198427|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
82538|NCT01571362|198428|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
82539|NCT01571362|198429|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
82540|NCT01571362|198427|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
82541|NCT01571362|198428|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
82542|NCT01571362|198429|P1|COMPLETED|Open-Label Conversion + Titration Period||281
82543|NCT01571362|198427|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
82544|NCT01571362|198428|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
82545|NCT01571362|198429|P1|STARTED|Open-Label Conversion + Titration Period||410
82546|NCT01571284|198599|P1|NOT COMPLETED|Overall Study||169
82547|NCT01571284|198599|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
82548|NCT01571284|198599|P1|Safety Population|Overall Study||779
82549|NCT01571284|198599|P1|STARTED|Overall Study||781
82550|NCT01571232|198622|P2|NOT COMPLETED|Overall Study||1
82551|NCT01571232|198623|P1|NOT COMPLETED|Overall Study||1
82552|NCT01571232|198622|P2|COMPLETED|Overall Study||9
82553|NCT01571232|198623|P1|COMPLETED|Overall Study||9
82554|NCT01571232|198622|P2|STARTED|Overall Study||10
82555|NCT01571232|198623|P1|STARTED|Overall Study||10
82556|NCT01570751|198635|P2|NOT COMPLETED|Period B (16 Weeks)||1
82557|NCT01570751|198636|P1|NOT COMPLETED|Period B (16 Weeks)||1
82558|NCT01570751|198635|P2|COMPLETED|Period B (16 Weeks)||66
82559|NCT01570751|198636|P1|COMPLETED|Period B (16 Weeks)||69
82560|NCT01570751|198635|P2|Exposed|Period B (16 Weeks)||67
82561|NCT01570751|198636|P1|Exposed|Period B (16 Weeks)||70
82562|NCT01570751|198635|P2|STARTED|Period B (16 Weeks)||67
82563|NCT01570751|198636|P1|STARTED|Period B (16 Weeks)||70
82564|NCT01570751|198635|P2|NOT COMPLETED|Period A (16 Weeks)||5
82565|NCT01570751|198636|P1|NOT COMPLETED|Period A (16 Weeks)||3
82566|NCT01570751|198635|P2|COMPLETED|Period A (16 Weeks)||67
82567|NCT01570751|198636|P1|COMPLETED|Period A (16 Weeks)||70
82568|NCT01570751|198635|P2|Exposed|Period A (16 Weeks)||72
82569|NCT01570751|198636|P1|Exposed|Period A (16 Weeks)||73
82570|NCT01570751|198635|P2|STARTED|Period A (16 Weeks)||72
82571|NCT01570751|198636|P1|STARTED|Period A (16 Weeks)||73
82572|NCT01570686|198654|P2|NOT COMPLETED|Overall Study||16
82573|NCT01570686|198655|P1|NOT COMPLETED|Overall Study||22
82574|NCT01570686|198654|P2|COMPLETED|Overall Study||278
82575|NCT01570686|198655|P1|COMPLETED|Overall Study||274
82576|NCT01570686|198654|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
82577|NCT01570686|198655|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
82578|NCT01570686|198654|P2|STARTED|Overall Study||294
82579|NCT01570686|198655|P1|STARTED|Overall Study||296
82580|NCT01570634|198681|P1|NOT COMPLETED|Overall Study||0
82581|NCT01570634|198681|P1|COMPLETED|Overall Study||2
82582|NCT01570634|198681|P1|STARTED|Overall Study||2
82583|NCT01570309|198691|P2|NOT COMPLETED|Overall Study||3
82584|NCT01570309|198692|P1|NOT COMPLETED|Overall Study||3
82585|NCT01570309|198691|P2|COMPLETED|Overall Study||45
82586|NCT01570309|198692|P1|COMPLETED|Overall Study||45
82587|NCT01570309|198691|P2|STARTED|Overall Study||48
82588|NCT01570309|198692|P1|STARTED|Overall Study||48
82589|NCT01570244|198706|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
82590|NCT01570244|198706|P1|COMPLETED|Microgynon+Faldaprevir||15
82591|NCT01570244|198706|P1|STARTED|Microgynon+Faldaprevir||16
82592|NCT01570244|198706|P1|NOT COMPLETED|Microgynon||0
82593|NCT01570244|198706|P1|COMPLETED|Microgynon||16
82594|NCT01570244|198706|P1|STARTED|Microgynon||16
82595|NCT01570192|198728|P2|NOT COMPLETED|Overall Study||13
82596|NCT01570192|198729|P1|NOT COMPLETED|Overall Study||7
82597|NCT01570192|198728|P2|COMPLETED|Overall Study||17
82598|NCT01570192|198729|P1|COMPLETED|Overall Study||6
82599|NCT01570192|198728|P2|STARTED|Overall Study||30
82600|NCT01570192|198729|P1|STARTED|Overall Study||13
82601|NCT01569841|198767|P2|NOT COMPLETED|Period B (6 Weeks)||0
82602|NCT01569841|198768|P1|NOT COMPLETED|Period B (6 Weeks)||0
82603|NCT01569841|198767|P2|COMPLETED|Period B (6 Weeks)||11
82604|NCT01569841|198768|P1|COMPLETED|Period B (6 Weeks)||12
82605|NCT01569841|198767|P2|Exposed|Period B (6 Weeks)||11
82606|NCT01569841|198768|P1|Exposed|Period B (6 Weeks)||12
82607|NCT01569841|198767|P2|STARTED|Period B (6 Weeks)||11
82608|NCT01569841|198768|P1|STARTED|Period B (6 Weeks)||12
82609|NCT01569841|198767|P2|NOT COMPLETED|Period A (6 Weeks)||1
82610|NCT01569841|198768|P1|NOT COMPLETED|Period A (6 Weeks)||0
82611|NCT01569841|198767|P2|COMPLETED|Period A (6 Weeks)||11
82612|NCT01569841|198768|P1|COMPLETED|Period A (6 Weeks)||12
82613|NCT01569841|198767|P2|Exposed|Period A (6 Weeks)||12
82614|NCT01569841|198768|P1|Exposed|Period A (6 Weeks)||12
82615|NCT01569841|198767|P2|STARTED|Period A (6 Weeks)||12
82616|NCT01569841|198768|P1|STARTED|Period A (6 Weeks)||12
82617|NCT01569828|198786|P2|NOT COMPLETED|Overall Study||0
82618|NCT01569828|198787|P1|NOT COMPLETED|Overall Study||0
82619|NCT01569828|198786|P2|COMPLETED|Overall Study||6
82620|NCT01569828|198787|P1|COMPLETED|Overall Study||6
82621|NCT01569828|198786|P2|STARTED|Overall Study||6
82622|NCT01569828|198787|P1|STARTED|Overall Study||6
82623|NCT01569815|198809|P4|NOT COMPLETED|Overall Study||0
82624|NCT01569815|198810|P3|NOT COMPLETED|Overall Study||0
82625|NCT01569815|198811|P2|NOT COMPLETED|Overall Study||0
82626|NCT01569815|198812|P1|NOT COMPLETED|Overall Study||0
82627|NCT01569815|198809|P4|COMPLETED|Overall Study||8
82628|NCT01569815|198810|P3|COMPLETED|Overall Study||8
82629|NCT01569815|198811|P2|COMPLETED|Overall Study||8
82630|NCT01569815|198812|P1|COMPLETED|Overall Study||8
82631|NCT01569815|198809|P4|STARTED|Overall Study||8
82632|NCT01569815|198810|P3|STARTED|Overall Study||8
82633|NCT01569815|198811|P2|STARTED|Overall Study||8
82634|NCT01569815|198812|P1|STARTED|Overall Study||8
82635|NCT01569763|198857|P2|NOT COMPLETED|Overall Study||7
82636|NCT01569763|198858|P1|NOT COMPLETED|Overall Study||3
82637|NCT01569763|198857|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
82638|NCT01569763|198858|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
82639|NCT01569763|198857|P2|Treated|Overall Study||51
82640|NCT01569763|198858|P1|Treated|Overall Study||102
82641|NCT01569763|198857|P2|STARTED|Overall Study||51
82642|NCT01569763|198858|P1|STARTED|Overall Study||102
82643|NCT01569607|198870|P2|NOT COMPLETED|Overall Study||1
82644|NCT01569607|198871|P1|NOT COMPLETED|Overall Study||1
82645|NCT01569607|198870|P2|COMPLETED|Overall Study||10
82646|NCT01569607|198871|P1|COMPLETED|Overall Study||10
82647|NCT01569607|198870|P2|STARTED|Overall Study||11
82648|NCT01569607|198871|P1|STARTED|Overall Study||11
82649|NCT01569568|198895|P2|NOT COMPLETED|Overall Study||2
82650|NCT01569568|198896|P1|NOT COMPLETED|Overall Study||0
82651|NCT01569568|198895|P2|COMPLETED|Overall Study||27
82652|NCT01569568|198896|P1|COMPLETED|Overall Study||20
82653|NCT01569568|198895|P2|STARTED|Overall Study||29
82654|NCT01569568|198896|P1|STARTED|Overall Study||20
82655|NCT01569529|198910|P2|NOT COMPLETED|Overall Study||0
82656|NCT01569529|198911|P1|NOT COMPLETED|Overall Study||0
82657|NCT01569529|198910|P2|COMPLETED|Overall Study||394
82658|NCT01569529|198911|P1|COMPLETED|Overall Study||2676
82659|NCT01569529|198910|P2|STARTED|Overall Study||394
82660|NCT01569529|198911|P1|STARTED|Overall Study||2676
82661|NCT01569464|198919|P2|NOT COMPLETED|Overall Study||5
82662|NCT01569464|198920|P1|NOT COMPLETED|Overall Study||10
82663|NCT01569464|198919|P2|COMPLETED|Overall Study||44
82664|NCT01569464|198920|P1|COMPLETED|Overall Study||91
82665|NCT01569464|198919|P2|STARTED|Overall Study||49
82666|NCT01569464|198920|P1|STARTED|Overall Study||101
82667|NCT01569438|198958|P2|NOT COMPLETED|Overall Study||9
82668|NCT01569438|198959|P1|NOT COMPLETED|Overall Study||2
82669|NCT01569438|198958|P2|COMPLETED|Overall Study||27
82670|NCT01569438|198959|P1|COMPLETED|Overall Study||36
82671|NCT01569438|198958|P2|STARTED|Overall Study||36
82672|NCT01569438|198959|P1|STARTED|Overall Study||38
82673|NCT01569295|198973|P2|NOT COMPLETED|Overall Study||67
82674|NCT01569295|198974|P1|NOT COMPLETED|Overall Study||134
82675|NCT01569295|198973|P2|COMPLETED|Overall Study||142
82676|NCT01569295|198974|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint (progressive disease or death)|73
82677|NCT01569295|198973|P2|STARTED|Overall Study||209
82678|NCT01569295|198974|P1|STARTED|Overall Study||207
82679|NCT01569191|198990|P2|NOT COMPLETED|Overall Study||0
82680|NCT01569191|198991|P1|NOT COMPLETED|Overall Study||0
82681|NCT01569191|198990|P2|COMPLETED|Overall Study||7
82682|NCT01569191|198991|P1|COMPLETED|Overall Study||11
82683|NCT01569191|198990|P2|STARTED|Overall Study||7
82684|NCT01569191|198991|P1|STARTED|Overall Study||11
82685|NCT01569152|199011|P3|NOT COMPLETED|Safety Extension, Period 3||55
82686|NCT01569152|199012|P2|NOT COMPLETED|Safety Extension, Period 3||0
82687|NCT01569152|199013|P1|NOT COMPLETED|Safety Extension, Period 3||0
82688|NCT01569152|199011|P3|COMPLETED|Safety Extension, Period 3||0
82689|NCT01569152|199012|P2|COMPLETED|Safety Extension, Period 3||0
82690|NCT01569152|199013|P1|COMPLETED|Safety Extension, Period 3||0
82691|NCT01569152|199011|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
82692|NCT01569152|199012|P2|STARTED|Safety Extension, Period 3||0
82693|NCT01569152|199013|P1|STARTED|Safety Extension, Period 3||0
82694|NCT01569152|199011|P3|NOT COMPLETED|Phase IIa, Period 1||0
82695|NCT01569152|199012|P2|NOT COMPLETED|Phase IIa, Period 1||32
82696|NCT01569152|199013|P1|NOT COMPLETED|Phase IIa, Period 1||21
82697|NCT01569152|199011|P3|COMPLETED|Phase IIa, Period 1||0
82698|NCT01569152|199012|P2|COMPLETED|Phase IIa, Period 1||9
82699|NCT01569152|199013|P1|COMPLETED|Phase IIa, Period 1||20
82700|NCT01569152|199011|P3|STARTED|Phase IIa, Period 1||0
82701|NCT01569152|199012|P2|STARTED|Phase IIa, Period 1||41
82702|NCT01569152|199013|P1|STARTED|Phase IIa, Period 1||41
82703|NCT01569126|199076|P6|NOT COMPLETED|Overall Study||0
82704|NCT01569126|199077|P5|NOT COMPLETED|Overall Study||0
82705|NCT01569126|199078|P4|NOT COMPLETED|Overall Study||0
82706|NCT01569126|199079|P3|NOT COMPLETED|Overall Study||0
82707|NCT01569126|199080|P2|NOT COMPLETED|Overall Study||0
82708|NCT01569126|199081|P1|NOT COMPLETED|Overall Study||0
82709|NCT01569126|199076|P6|COMPLETED|Overall Study||12
82710|NCT01569126|199077|P5|COMPLETED|Overall Study||12
82711|NCT01569126|199078|P4|COMPLETED|Overall Study||8
82712|NCT01569126|199079|P3|COMPLETED|Overall Study||8
82713|NCT01569126|199080|P2|COMPLETED|Overall Study||8
82714|NCT01569126|199081|P1|COMPLETED|Overall Study||8
82715|NCT01569126|199076|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
82716|NCT01569126|199077|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
82717|NCT01569126|199078|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
82718|NCT01569126|199079|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
82719|NCT01569126|199080|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
82720|NCT01569126|199081|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
82721|NCT01569126|199076|P6|STARTED|Overall Study||12
82722|NCT01569126|199077|P5|STARTED|Overall Study||12
82723|NCT01569126|199078|P4|STARTED|Overall Study||8
82724|NCT01569126|199079|P3|STARTED|Overall Study||8
82725|NCT01569126|199080|P2|STARTED|Overall Study||8
82726|NCT01569126|199081|P1|STARTED|Overall Study||8
82727|NCT01569087|199119|P3|NOT COMPLETED|Overall Study||1
82728|NCT01569087|199120|P2|NOT COMPLETED|Overall Study||0
82729|NCT01569087|199121|P1|NOT COMPLETED|Overall Study||1
82730|NCT01569087|199119|P3|COMPLETED|Overall Study||18
82731|NCT01569087|199120|P2|COMPLETED|Overall Study||20
82732|NCT01569087|199121|P1|COMPLETED|Overall Study||20
82733|NCT01569087|199119|P3|STARTED|Overall Study||19
82734|NCT01569087|199120|P2|STARTED|Overall Study||20
82735|NCT01569087|199121|P1|STARTED|Overall Study||21
82736|NCT01569074|199149|P5|NOT COMPLETED|Overall Study||8
82737|NCT01569074|199150|P4|NOT COMPLETED|Overall Study||8
82738|NCT01569074|199151|P3|NOT COMPLETED|Overall Study||12
82739|NCT01569074|199152|P2|NOT COMPLETED|Overall Study||9
82740|NCT01569074|199153|P1|NOT COMPLETED|Overall Study||7
82741|NCT01569074|199149|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
82742|NCT01569074|199150|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
82743|NCT01569074|199151|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
82744|NCT01569074|199152|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
82745|NCT01569074|199153|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
82746|NCT01569074|199149|P5|Randomised But Did Not Receive Treatment|Overall Study||0
82747|NCT01569074|199150|P4|Randomised But Did Not Receive Treatment|Overall Study||0
82748|NCT01569074|199151|P3|Randomised But Did Not Receive Treatment|Overall Study||0
82749|NCT01569074|199152|P2|Randomised But Did Not Receive Treatment|Overall Study||0
82750|NCT01569074|199153|P1|Randomised But Did Not Receive Treatment|Overall Study||0
82751|NCT01569074|199149|P5|STARTED|Overall Study|Patients who received treatment|33
82752|NCT01569074|199150|P4|STARTED|Overall Study|Patients who received treatment|33
82753|NCT01569074|199151|P3|STARTED|Overall Study|Patients who received treatment|33
82754|NCT01569074|199152|P2|STARTED|Overall Study|Patients who received treatment|33
82755|NCT01569074|199153|P1|STARTED|Overall Study|Patients who received treatment|31
82756|NCT01569022|199209|P2|NOT COMPLETED|Second Intervention||2
82757|NCT01569022|199210|P1|NOT COMPLETED|Second Intervention||2
82758|NCT01569022|199209|P2|COMPLETED|Second Intervention||18
82759|NCT01569022|199210|P1|COMPLETED|Second Intervention||17
82760|NCT01569022|199209|P2|STARTED|Second Intervention||20
82761|NCT01569022|199210|P1|STARTED|Second Intervention||19
82762|NCT01569022|199209|P2|NOT COMPLETED|First Intervention||1
82763|NCT01569022|199210|P1|NOT COMPLETED|First Intervention||2
82764|NCT01569022|199209|P2|COMPLETED|First Intervention||20
82765|NCT01569022|199210|P1|COMPLETED|First Intervention||19
82766|NCT01569022|199209|P2|STARTED|First Intervention||21
82767|NCT01569022|199210|P1|STARTED|First Intervention||21
82768|NCT01568905|199225|P3|NOT COMPLETED|Overall Study||0
82769|NCT01568905|199226|P2|NOT COMPLETED|Overall Study||0
82770|NCT01568905|199227|P1|NOT COMPLETED|Overall Study||1
82771|NCT01568905|199225|P3|COMPLETED|Overall Study||12
82772|NCT01568905|199226|P2|COMPLETED|Overall Study||11
82773|NCT01568905|199227|P1|COMPLETED|Overall Study||12
82774|NCT01568905|199225|P3|STARTED|Overall Study||12
82775|NCT01568905|199226|P2|STARTED|Overall Study||11
82776|NCT01568905|199227|P1|STARTED|Overall Study||13
82777|NCT01568892|199246|P2|NOT COMPLETED|Open-label Phase||16
82778|NCT01568892|199247|P1|NOT COMPLETED|Open-label Phase||13
82779|NCT01568892|199246|P2|COMPLETED|Open-label Phase||0
82780|NCT01568892|199247|P1|COMPLETED|Open-label Phase||0
82781|NCT01568892|199246|P2|Ongoing|Open-label Phase||15
82782|NCT01568892|199247|P1|Ongoing|Open-label Phase||12
82783|NCT01568892|199246|P2|STARTED|Open-label Phase||16
82784|NCT01568892|199247|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
82785|NCT01568892|199246|P2|NOT COMPLETED|Double-blind Phase||0
82786|NCT01568892|199247|P1|NOT COMPLETED|Double-blind Phase||0
82787|NCT01568892|199246|P2|COMPLETED|Double-blind Phase||16
82788|NCT01568892|199247|P1|COMPLETED|Double-blind Phase||14
82789|NCT01568892|199246|P2|STARTED|Double-blind Phase||16
82790|NCT01568892|199247|P1|STARTED|Double-blind Phase||14
82791|NCT01568866|199285|P2|NOT COMPLETED|Overall Study||264
82792|NCT01568866|199286|P1|NOT COMPLETED|Overall Study||360
82793|NCT01568866|199285|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|200
82794|NCT01568866|199286|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|105
82795|NCT01568866|199285|P2|Received Treatment|Overall Study||463
82796|NCT01568866|199286|P1|Received Treatment|Overall Study||456
82797|NCT01568866|199285|P2|STARTED|Overall Study||464
82798|NCT01568866|199286|P1|STARTED|Overall Study||465
82799|NCT01568827|199308|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
82800|NCT01568827|199309|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
82801|NCT01568827|199308|P2|COMPLETED|Intervention 2 (5 Days)||5
82802|NCT01568827|199309|P1|COMPLETED|Intervention 2 (5 Days)||5
82803|NCT01568827|199308|P2|STARTED|Intervention 2 (5 Days)||5
82804|NCT01568827|199309|P1|STARTED|Intervention 2 (5 Days)||5
82805|NCT01568827|199308|P2|NOT COMPLETED|Washout (2 Days)||0
82806|NCT01568827|199309|P1|NOT COMPLETED|Washout (2 Days)||0
82807|NCT01568827|199308|P2|COMPLETED|Washout (2 Days)||5
82808|NCT01568827|199309|P1|COMPLETED|Washout (2 Days)||5
82809|NCT01568827|199308|P2|STARTED|Washout (2 Days)||5
82810|NCT01568827|199309|P1|STARTED|Washout (2 Days)||5
82811|NCT01568827|199308|P2|NOT COMPLETED|First Intervention (6 Days)||0
82812|NCT01568827|199309|P1|NOT COMPLETED|First Intervention (6 Days)||0
82813|NCT01568827|199308|P2|COMPLETED|First Intervention (6 Days)||5
82814|NCT01568827|199309|P1|COMPLETED|First Intervention (6 Days)||5
82815|NCT01568827|199308|P2|STARTED|First Intervention (6 Days)||5
82816|NCT01568827|199309|P1|STARTED|First Intervention (6 Days)||5
82817|NCT01568593|199317|P2|NOT COMPLETED|Overall Study||3
82818|NCT01568593|199318|P1|NOT COMPLETED|Overall Study||7
82819|NCT01568593|199317|P2|COMPLETED|Overall Study||42
82820|NCT01568593|199318|P1|COMPLETED|Overall Study||41
82821|NCT01568593|199317|P2|STARTED|Overall Study||45
82822|NCT01568593|199318|P1|STARTED|Overall Study||48
82823|NCT01568424|199324|P1|NOT COMPLETED|Overall Study||0
82824|NCT01568424|199324|P1|COMPLETED|Overall Study||25
82825|NCT01568424|199324|P1|STARTED|Overall Study||25
82826|NCT01568112|199338|P4|NOT COMPLETED|Overall Study||12
82827|NCT01568112|199339|P3|NOT COMPLETED|Overall Study||7
82828|NCT01568112|199340|P2|NOT COMPLETED|Overall Study||8
82829|NCT01568112|199341|P1|NOT COMPLETED|Overall Study||5
82830|NCT01568112|199338|P4|COMPLETED|Overall Study||30
82831|NCT01568112|199339|P3|COMPLETED|Overall Study||36
82832|NCT01568112|199340|P2|COMPLETED|Overall Study||36
82833|NCT01568112|199341|P1|COMPLETED|Overall Study||39
82834|NCT01568112|199338|P4|STARTED|Overall Study||42
82835|NCT01568112|199339|P3|STARTED|Overall Study||43
82836|NCT01568112|199340|P2|STARTED|Overall Study||44
82837|NCT01568112|199341|P1|STARTED|Overall Study||44
82838|NCT01568073|199464|P5|NOT COMPLETED|Overall Study||9
82839|NCT01568073|199465|P4|NOT COMPLETED|Overall Study||11
82840|NCT01568073|199466|P3|NOT COMPLETED|Overall Study||12
82841|NCT01568073|199467|P2|NOT COMPLETED|Overall Study||15
82842|NCT01568073|199468|P1|NOT COMPLETED|Overall Study||11
82843|NCT01568073|199464|P5|COMPLETED|Overall Study||107
82844|NCT01568073|199465|P4|COMPLETED|Overall Study||108
82845|NCT01568073|199466|P3|COMPLETED|Overall Study||110
82846|NCT01568073|199467|P2|COMPLETED|Overall Study||107
82847|NCT01568073|199468|P1|COMPLETED|Overall Study||110
82848|NCT01568073|199464|P5|STARTED|Overall Study||116
82849|NCT01568073|199465|P4|STARTED|Overall Study||119
82850|NCT01568073|199466|P3|STARTED|Overall Study||122
82851|NCT01568073|199467|P2|STARTED|Overall Study||122
82852|NCT01568073|199468|P1|STARTED|Overall Study||121
82853|NCT01568047|199499|P4|NOT COMPLETED|Overall Study||1
82854|NCT01568047|199500|P3|NOT COMPLETED|Overall Study||1
82855|NCT01568047|199501|P2|NOT COMPLETED|Overall Study||1
82856|NCT01568047|199502|P1|NOT COMPLETED|Overall Study||1
82857|NCT01568047|199499|P4|COMPLETED|Overall Study||9
82858|NCT01568047|199500|P3|COMPLETED|Overall Study||9
82859|NCT01568047|199501|P2|COMPLETED|Overall Study||9
82860|NCT01568047|199502|P1|COMPLETED|Overall Study||9
82861|NCT01568047|199499|P4|STARTED|Overall Study||10
82862|NCT01568047|199500|P3|STARTED|Overall Study||10
82863|NCT01568047|199501|P2|STARTED|Overall Study||10
82864|NCT01568047|199502|P1|STARTED|Overall Study||10
82865|NCT01568034|199520|P4|NOT COMPLETED|Overall Study||0
82866|NCT01568034|199521|P3|NOT COMPLETED|Overall Study||0
82867|NCT01568034|199522|P2|NOT COMPLETED|Overall Study||0
82868|NCT01568034|199523|P1|NOT COMPLETED|Overall Study||1
82869|NCT01568034|199520|P4|COMPLETED|Overall Study||3
82870|NCT01568034|199521|P3|COMPLETED|Overall Study||3
82871|NCT01568034|199522|P2|COMPLETED|Overall Study||2
82872|NCT01568034|199523|P1|COMPLETED|Overall Study||1
82873|NCT01568034|199520|P4|Placebo|Overall Study||3
82874|NCT01568034|199521|P3|Placebo|Overall Study||3
82875|NCT01568034|199522|P2|Placebo|Overall Study||2
82876|NCT01568034|199523|P1|Placebo|Overall Study||1
82877|NCT01568034|199520|P4|100 mg BIA 9-1067|Overall Study||3
82878|NCT01568034|199521|P3|100 mg BIA 9-1067|Overall Study||3
82879|NCT01568034|199522|P2|100 mg BIA 9-1067|Overall Study||2
82880|NCT01568034|199523|P1|100 mg BIA 9-1067|Overall Study||2
82881|NCT01568034|199520|P4|50 mg BIA 9-1067|Overall Study||3
82882|NCT01568034|199521|P3|50 mg BIA 9-1067|Overall Study||3
82883|NCT01568034|199522|P2|50 mg BIA 9-1067|Overall Study||2
82884|NCT01568034|199523|P1|50 mg BIA 9-1067|Overall Study||2
82885|NCT01568034|199520|P4|25 mg BIA 9-1067|Overall Study||3
82886|NCT01568034|199521|P3|25 mg BIA 9-1067|Overall Study||3
82887|NCT01568034|199522|P2|25 mg BIA 9-1067|Overall Study||2
82888|NCT01568034|199523|P1|25 mg BIA 9-1067|Overall Study||2
82889|NCT01568034|199520|P4|STARTED|Overall Study||3
82890|NCT01568034|199521|P3|STARTED|Overall Study||3
82891|NCT01568034|199522|P2|STARTED|Overall Study||2
82892|NCT01568034|199523|P1|STARTED|Overall Study||2
82893|NCT01568021|199541|P1|NOT COMPLETED|Overall Study||16
82894|NCT01568021|199541|P1|COMPLETED|Overall Study||83
82895|NCT01568021|199541|P1|STARTED|Overall Study||99
82896|NCT01568008|199547|P1|NOT COMPLETED|Overall Study||234
82897|NCT01568008|199547|P1|COMPLETED|Overall Study||699
82898|NCT01568008|199547|P1|STARTED|Overall Study||933
82899|NCT01567943|199558|P3|NOT COMPLETED|Overall Study||0
82900|NCT01567943|199559|P2|NOT COMPLETED|Overall Study||10
82901|NCT01567943|199560|P1|NOT COMPLETED|Overall Study||14
82902|NCT01567943|199558|P3|COMPLETED|Overall Study||44
82903|NCT01567943|199559|P2|COMPLETED|Overall Study||29
82904|NCT01567943|199560|P1|COMPLETED|Overall Study||26
82905|NCT01567943|199558|P3|STARTED|Overall Study||44
82906|NCT01567943|199559|P2|STARTED|Overall Study||39
82907|NCT01567943|199560|P1|STARTED|Overall Study||40
82908|NCT01567852|199570|P2|NOT COMPLETED|Overall Study||7
82909|NCT01567852|199571|P1|NOT COMPLETED|Overall Study||4
82910|NCT01567852|199570|P2|COMPLETED|Overall Study||5
82911|NCT01567852|199571|P1|COMPLETED|Overall Study||4
82912|NCT01567852|199570|P2|STARTED|Overall Study||12
82913|NCT01567852|199571|P1|STARTED|Overall Study||8
82914|NCT01567839|199579|P1|NOT COMPLETED|Overall Study||0
82915|NCT01567839|199579|P1|COMPLETED|Overall Study||60
82916|NCT01567839|199579|P1|STARTED|Overall Study||60
82917|NCT01567826|199589|P2|NOT COMPLETED|Overall Study||2
82918|NCT01567826|199590|P1|NOT COMPLETED|Overall Study||3
82919|NCT01567826|199589|P2|COMPLETED|Overall Study||42
82920|NCT01567826|199590|P1|COMPLETED|Overall Study||40
82921|NCT01567826|199589|P2|STARTED|Overall Study||44
82922|NCT01567826|199590|P1|STARTED|Overall Study||43
82923|NCT01567462|199616|P2|NOT COMPLETED|Overall Study||7
82924|NCT01567462|199617|P1|NOT COMPLETED|Overall Study||4
82925|NCT01567462|199616|P2|COMPLETED|Overall Study||38
82926|NCT01567462|199617|P1|COMPLETED|Overall Study||41
82927|NCT01567462|199616|P2|STARTED|Overall Study||45
82928|NCT01567462|199617|P1|STARTED|Overall Study||45
82929|NCT01567371|199629|P1|NOT COMPLETED|Overall Study||0
82930|NCT01567371|199629|P1|COMPLETED|Overall Study||30
82931|NCT01567371|199629|P1|STARTED|Overall Study||30
82932|NCT01567163|199634|P1|NOT COMPLETED|Overall Study||4
82933|NCT01567163|199634|P1|COMPLETED|Overall Study||18
82934|NCT01567163|199634|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
82935|NCT01567163|199634|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
82936|NCT01567163|199634|P1|STARTED|Overall Study||22
82937|NCT01567150|199646|P2|NOT COMPLETED|Overall Study||2
82938|NCT01567150|199647|P1|NOT COMPLETED|Overall Study||2
82939|NCT01567150|199646|P2|COMPLETED|Overall Study||16
82940|NCT01567150|199647|P1|COMPLETED|Overall Study||19
82941|NCT01567150|199646|P2|STARTED|Overall Study||18
82942|NCT01567150|199647|P1|STARTED|Overall Study||21
82943|NCT01567020|199659|P4|NOT COMPLETED|Overall Study||1
82944|NCT01567020|199660|P3|NOT COMPLETED|Overall Study||2
82945|NCT01567020|199661|P2|NOT COMPLETED|Overall Study||5
82946|NCT01567020|199662|P1|NOT COMPLETED|Overall Study||7
82947|NCT01567020|199659|P4|COMPLETED|Overall Study||10
82948|NCT01567020|199660|P3|COMPLETED|Overall Study||18
82949|NCT01567020|199661|P2|COMPLETED|Overall Study||41
82950|NCT01567020|199662|P1|COMPLETED|Overall Study||21
82951|NCT01567020|199659|P4|STARTED|Overall Study||11
82952|NCT01567020|199660|P3|STARTED|Overall Study||20
82953|NCT01567020|199661|P2|STARTED|Overall Study||46
82954|NCT01567020|199662|P1|STARTED|Overall Study||28
82955|NCT01566981|199674|P2|NOT COMPLETED|Overall Study||8
82956|NCT01566981|199675|P1|NOT COMPLETED|Overall Study||5
82957|NCT01566981|199674|P2|COMPLETED|Overall Study||54
82958|NCT01566981|199675|P1|COMPLETED|Overall Study||53
82959|NCT01566981|199674|P2|STARTED|Overall Study||62
82960|NCT01566981|199675|P1|STARTED|Overall Study||58
82961|NCT01566838|199687|P2|NOT COMPLETED|Overall Study||0
82962|NCT01566838|199688|P1|NOT COMPLETED|Overall Study||3
82963|NCT01566838|199687|P2|COMPLETED|Overall Study||42
82964|NCT01566838|199688|P1|COMPLETED|Overall Study||38
82965|NCT01566838|199687|P2|STARTED|Overall Study||42
82966|NCT01566838|199688|P1|STARTED|Overall Study||41
82967|NCT01566773|199704|P1|NOT COMPLETED|Overall Study||30
82968|NCT01566773|199704|P1|COMPLETED|Overall Study||110
82969|NCT01566773|199704|P1|Spiriva® Handihaler®|Overall Study||62
82970|NCT01566773|199704|P1|Placebo MDI|Overall Study||62
82971|NCT01566773|199704|P1|GP MDI 0.6 µg BID|Overall Study||59
82972|NCT01566773|199704|P1|GP MDI 1.2 µg BID|Overall Study||57
82973|NCT01566773|199704|P1|GP MDI 2.4 µg BID|Overall Study||64
82974|NCT01566773|199704|P1|GP MDI 4.6 µg BID|Overall Study||62
82975|NCT01566773|199704|P1|GP MDI 9 µg BID|Overall Study||64
82976|NCT01566773|199704|P1|GP MDI 18 µg BID|Overall Study||64
82977|NCT01566773|199704|P1|STARTED|Overall Study||140
82978|NCT01566721|199913|P2|NOT COMPLETED|Overall Study||710
82979|NCT01566721|199914|P1|NOT COMPLETED|Overall Study||1867
82980|NCT01566721|199913|P2|COMPLETED|Overall Study||0
82981|NCT01566721|199914|P1|COMPLETED|Overall Study||0
82982|NCT01566721|199913|P2|Received Treatment|Overall Study||709
82983|NCT01566721|199914|P1|Received Treatment|Overall Study||1864
82984|NCT01566721|199913|P2|STARTED|Overall Study||710
82985|NCT01566721|199914|P1|STARTED|Overall Study||1867
82986|NCT01566630|199939|P2|NOT COMPLETED|Overall Study||0
82987|NCT01566630|199940|P1|NOT COMPLETED|Overall Study||0
82988|NCT01566630|199939|P2|COMPLETED|Overall Study||1
82989|NCT01566630|199940|P1|COMPLETED|Overall Study||2
82990|NCT01566630|199939|P2|STARTED|Overall Study||1
82991|NCT01566630|199940|P1|STARTED|Overall Study||2
82992|NCT01566604|199996|P2|NOT COMPLETED|Overall Study||11
82993|NCT01566604|199997|P1|NOT COMPLETED|Overall Study||24
82994|NCT01566604|199996|P2|COMPLETED|Overall Study||143
82995|NCT01566604|199997|P1|COMPLETED|Overall Study||282
82996|NCT01566604|199996|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
82997|NCT01566604|199997|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
82998|NCT01566604|199996|P2|Full Analysis Set (FAS)|Overall Study||154
82999|NCT01566604|199997|P1|Full Analysis Set (FAS)|Overall Study||305
83000|NCT01566604|199996|P2|Safety Set|Overall Study||154
83001|NCT01566604|199997|P1|Safety Set|Overall Study||305
83002|NCT01566604|199996|P2|STARTED|Overall Study||154
83003|NCT01566604|199997|P1|STARTED|Overall Study||306
83004|NCT01566539|200031|P9|NOT COMPLETED|Within Subject Group||0
83005|NCT01566539|200032|P8|NOT COMPLETED|Within Subject Group||0
83006|NCT01566539|200033|P7|NOT COMPLETED|Within Subject Group||0
83007|NCT01566539|200034|P6|NOT COMPLETED|Within Subject Group||0
83008|NCT01566539|200035|P5|NOT COMPLETED|Within Subject Group||0
83009|NCT01566539|200036|P4|NOT COMPLETED|Within Subject Group||3
83010|NCT01566539|200037|P3|NOT COMPLETED|Within Subject Group||0
83011|NCT01566539|200038|P2|NOT COMPLETED|Within Subject Group||0
83012|NCT01566539|200039|P1|NOT COMPLETED|Within Subject Group||0
83013|NCT01566539|200031|P9|COMPLETED|Within Subject Group||0
83014|NCT01566539|200032|P8|COMPLETED|Within Subject Group||0
83015|NCT01566539|200033|P7|COMPLETED|Within Subject Group||0
83016|NCT01566539|200034|P6|COMPLETED|Within Subject Group||0
83017|NCT01566539|200035|P5|COMPLETED|Within Subject Group||0
83018|NCT01566539|200036|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
83019|NCT01566539|200037|P3|COMPLETED|Within Subject Group||0
83020|NCT01566539|200038|P2|COMPLETED|Within Subject Group||0
83021|NCT01566539|200039|P1|COMPLETED|Within Subject Group||0
83022|NCT01566539|200031|P9|STARTED|Within Subject Group||0
83023|NCT01566539|200032|P8|STARTED|Within Subject Group||0
83024|NCT01566539|200033|P7|STARTED|Within Subject Group||0
83025|NCT01566539|200034|P6|STARTED|Within Subject Group||0
83026|NCT01566539|200035|P5|STARTED|Within Subject Group||0
83027|NCT01566539|200036|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
83028|NCT01566539|200037|P3|STARTED|Within Subject Group||0
83029|NCT01566539|200038|P2|STARTED|Within Subject Group||0
83030|NCT01566539|200039|P1|STARTED|Within Subject Group||0
83031|NCT01566539|200031|P9|NOT COMPLETED|Main Study Period||0
83032|NCT01566539|200032|P8|NOT COMPLETED|Main Study Period||0
83033|NCT01566539|200033|P7|NOT COMPLETED|Main Study Period||0
83034|NCT01566539|200034|P6|NOT COMPLETED|Main Study Period||3
83035|NCT01566539|200035|P5|NOT COMPLETED|Main Study Period||0
83036|NCT01566539|200036|P4|NOT COMPLETED|Main Study Period||0
83037|NCT01566539|200037|P3|NOT COMPLETED|Main Study Period||0
83038|NCT01566539|200038|P2|NOT COMPLETED|Main Study Period||0
83039|NCT01566539|200039|P1|NOT COMPLETED|Main Study Period||1
83040|NCT01566539|200031|P9|COMPLETED|Main Study Period||1
83041|NCT01566539|200032|P8|COMPLETED|Main Study Period||30
83042|NCT01566539|200033|P7|COMPLETED|Main Study Period||30
83043|NCT01566539|200034|P6|COMPLETED|Main Study Period||40
83044|NCT01566539|200035|P5|COMPLETED|Main Study Period||40
83045|NCT01566539|200036|P4|COMPLETED|Main Study Period||0
83046|NCT01566539|200037|P3|COMPLETED|Main Study Period||104
83047|NCT01566539|200038|P2|COMPLETED|Main Study Period||100
83048|NCT01566539|200039|P1|COMPLETED|Main Study Period||100
83049|NCT01566539|200031|P9|STARTED|Main Study Period||1
83050|NCT01566539|200032|P8|STARTED|Main Study Period||30
83051|NCT01566539|200033|P7|STARTED|Main Study Period||30
83052|NCT01566539|200034|P6|STARTED|Main Study Period||43
83053|NCT01566539|200035|P5|STARTED|Main Study Period||40
83054|NCT01566539|200036|P4|STARTED|Main Study Period||0
83055|NCT01566539|200037|P3|STARTED|Main Study Period||104
83056|NCT01566539|200038|P2|STARTED|Main Study Period||100
83057|NCT01566539|200039|P1|STARTED|Main Study Period||101
83058|NCT01566526|200092|P1|NOT COMPLETED|Overall Study||0
83059|NCT01566526|200092|P1|COMPLETED|Overall Study||26
83060|NCT01566526|200092|P1|STARTED|Overall Study||26
83061|NCT01566500|200102|P1|NOT COMPLETED|Overall Study||0
83062|NCT01566500|200102|P1|COMPLETED|Overall Study||140
83063|NCT01566500|200102|P1|STARTED|Overall Study||140
83064|NCT01566461|200108|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
83065|NCT01566461|200109|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
83066|NCT01566461|200108|P2|COMPLETED|IN.PACT SFA II Phase||55
83067|NCT01566461|200109|P1|COMPLETED|IN.PACT SFA II Phase||109
83068|NCT01566461|200108|P2|STARTED|IN.PACT SFA II Phase||60
83069|NCT01566461|200109|P1|STARTED|IN.PACT SFA II Phase||121
83070|NCT01566461|200108|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
83071|NCT01566461|200109|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
83072|NCT01566461|200108|P2|COMPLETED|IN.PACT SFA I Phase||49
83073|NCT01566461|200109|P1|COMPLETED|IN.PACT SFA I Phase||88
83074|NCT01566461|200108|P2|STARTED|IN.PACT SFA I Phase||51
83075|NCT01566461|200109|P1|STARTED|IN.PACT SFA I Phase||99
83076|NCT01566435|200153|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
83077|NCT01566435|200153|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
83078|NCT01566435|200153|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
83079|NCT01566435|200153|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
83080|NCT01566435|200153|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
83081|NCT01566435|200153|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
83082|NCT01566435|200153|P1|NOT COMPLETED|ACF Induction Therapy||0
83083|NCT01566435|200153|P1|COMPLETED|ACF Induction Therapy||30
83084|NCT01566435|200153|P1|STARTED|ACF Induction Therapy||30
83085|NCT01566409|200169|P2|NOT COMPLETED|Overall Study||5
83086|NCT01566409|200170|P1|NOT COMPLETED|Overall Study||2
83087|NCT01566409|200169|P2|COMPLETED|Overall Study||48
83088|NCT01566409|200170|P1|COMPLETED|Overall Study||47
83089|NCT01566409|200169|P2|STARTED|Overall Study||53
83090|NCT01566409|200170|P1|STARTED|Overall Study||49
83091|NCT01566370|200178|P2|NOT COMPLETED|Overall Study||1
83092|NCT01566370|200179|P1|NOT COMPLETED|Overall Study||2
83093|NCT01566370|200178|P2|COMPLETED|Overall Study||0
83094|NCT01566370|200179|P1|COMPLETED|Overall Study||0
83095|NCT01566370|200178|P2|STARTED|Overall Study||1
83096|NCT01566370|200179|P1|STARTED|Overall Study||2
83097|NCT01566331|200205|P2|NOT COMPLETED|Overall Study||0
83098|NCT01566331|200206|P1|NOT COMPLETED|Overall Study||0
83099|NCT01566331|200205|P2|COMPLETED|Overall Study||40
83100|NCT01566331|200206|P1|COMPLETED|Overall Study||40
83101|NCT01566331|200205|P2|STARTED|Overall Study||40
83102|NCT01566331|200206|P1|STARTED|Overall Study||40
83103|NCT01566162|200212|P1|NOT COMPLETED|Overall Study||36
83104|NCT01566162|200212|P1|COMPLETED|Overall Study||155
83105|NCT01566162|200212|P1|STARTED|Overall Study||191
83106|NCT01566149|200226|P2|NOT COMPLETED|Overall Study||2
83107|NCT01566149|200227|P1|NOT COMPLETED|Overall Study||3
83108|NCT01566149|200226|P2|COMPLETED|Overall Study||23
83109|NCT01566149|200227|P1|COMPLETED|Overall Study||21
83110|NCT01566149|200226|P2|STARTED|Overall Study||25
83111|NCT01566149|200227|P1|STARTED|Overall Study||24
83112|NCT01566084|200243|P2|NOT COMPLETED|Overall Study||0
83113|NCT01566084|200244|P1|NOT COMPLETED|Overall Study||0
83114|NCT01566084|200243|P2|COMPLETED|Overall Study||10
83115|NCT01566084|200244|P1|COMPLETED|Overall Study||7
83116|NCT01566084|200243|P2|STARTED|Overall Study||10
83117|NCT01566084|200244|P1|STARTED|Overall Study||7
83118|NCT01565993|200260|P2|NOT COMPLETED|Overall Study||3
83119|NCT01565993|200261|P1|NOT COMPLETED|Overall Study||0
83120|NCT01565993|200260|P2|COMPLETED|Overall Study||39
83121|NCT01565993|200261|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
83122|NCT01565993|200260|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
83123|NCT01565993|200261|P1|STARTED|Overall Study||66
83124|NCT01565980|200269|P2|NOT COMPLETED|Overall Study||4
83125|NCT01565980|200270|P1|NOT COMPLETED|Overall Study||4
83126|NCT01565980|200269|P2|COMPLETED|Overall Study||16
83127|NCT01565980|200270|P1|COMPLETED|Overall Study||16
83128|NCT01565980|200269|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
83129|NCT01565980|200270|P1|STARTED|Overall Study||20
83130|NCT01565941|200290|P2|NOT COMPLETED|Overall Study||4
83131|NCT01565941|200291|P1|NOT COMPLETED|Overall Study||11
83132|NCT01565941|200290|P2|COMPLETED|Overall Study||349
83133|NCT01565941|200291|P1|COMPLETED|Overall Study||349
83134|NCT01565941|200290|P2|STARTED|Overall Study||353
83135|NCT01565941|200291|P1|STARTED|Overall Study||360
83136|NCT01565902|200333|P4|NOT COMPLETED|Overall Study||0
83137|NCT01565902|200334|P3|NOT COMPLETED|Overall Study||0
83138|NCT01565902|200335|P2|NOT COMPLETED|Overall Study||0
83139|NCT01565902|200336|P1|NOT COMPLETED|Overall Study||0
83140|NCT01565902|200333|P4|COMPLETED|Overall Study||16
83141|NCT01565902|200334|P3|COMPLETED|Overall Study||8
83142|NCT01565902|200335|P2|COMPLETED|Overall Study||8
83143|NCT01565902|200336|P1|COMPLETED|Overall Study||8
83144|NCT01565902|200333|P4|STARTED|Overall Study||16
83145|NCT01565902|200334|P3|STARTED|Overall Study||8
83146|NCT01565902|200335|P2|STARTED|Overall Study||8
83147|NCT01565902|200336|P1|STARTED|Overall Study||8
83148|NCT01565889|200370|P6|NOT COMPLETED|Part B||4
83149|NCT01565889|200371|P5|NOT COMPLETED|Part B||0
83150|NCT01565889|200372|P4|NOT COMPLETED|Part B||0
83151|NCT01565889|200373|P3|NOT COMPLETED|Part B||0
83152|NCT01565889|200374|P2|NOT COMPLETED|Part B||0
83153|NCT01565889|200375|P1|NOT COMPLETED|Part B||0
83154|NCT01565889|200370|P6|COMPLETED|Part B||19
83155|NCT01565889|200371|P5|COMPLETED|Part B||0
83156|NCT01565889|200372|P4|COMPLETED|Part B||0
83157|NCT01565889|200373|P3|COMPLETED|Part B||0
83158|NCT01565889|200374|P2|COMPLETED|Part B||0
83159|NCT01565889|200375|P1|COMPLETED|Part B||0
83160|NCT01565889|200370|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
83161|NCT01565889|200371|P5|STARTED|Part B||0
83162|NCT01565889|200372|P4|STARTED|Part B||0
83163|NCT01565889|200373|P3|STARTED|Part B||0
83164|NCT01565889|200374|P2|STARTED|Part B||0
83165|NCT01565889|200375|P1|STARTED|Part B||0
83166|NCT01565889|200370|P6|NOT COMPLETED|Part A||0
83167|NCT01565889|200371|P5|NOT COMPLETED|Part A||0
83168|NCT01565889|200372|P4|NOT COMPLETED|Part A||0
83169|NCT01565889|200373|P3|NOT COMPLETED|Part A||0
83170|NCT01565889|200374|P2|NOT COMPLETED|Part A||0
83171|NCT01565889|200375|P1|NOT COMPLETED|Part A||1
83172|NCT01565889|200370|P6|COMPLETED|Part A||0
83173|NCT01565889|200371|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
83174|NCT01565889|200372|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
83175|NCT01565889|200373|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
83176|NCT01565889|200374|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
83177|NCT01565889|200375|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
83178|NCT01565889|200370|P6|STARTED|Part A||0
83179|NCT01565889|200371|P5|STARTED|Part A||7
83180|NCT01565889|200372|P4|STARTED|Part A||7
83181|NCT01565889|200373|P3|STARTED|Part A||8
83182|NCT01565889|200374|P2|STARTED|Part A||4
83183|NCT01565889|200375|P1|STARTED|Part A||12
83184|NCT01565850|200406|P2|NOT COMPLETED|Overall Study||8
83185|NCT01565850|200407|P1|NOT COMPLETED|Overall Study||20
83186|NCT01565850|200406|P2|COMPLETED|Overall Study||42
83187|NCT01565850|200407|P1|COMPLETED|Overall Study||83
83188|NCT01565850|200406|P2|STARTED|Overall Study||50
83189|NCT01565850|200407|P1|STARTED|Overall Study||103
83190|NCT01565707|200427|P4|NOT COMPLETED|Overall Study||5
83191|NCT01565707|200428|P3|NOT COMPLETED|Overall Study||3
83192|NCT01565707|200429|P2|NOT COMPLETED|Overall Study||8
83193|NCT01565707|200430|P1|NOT COMPLETED|Overall Study||9
83194|NCT01565707|200427|P4|COMPLETED|Overall Study||17
83195|NCT01565707|200428|P3|COMPLETED|Overall Study||16
83196|NCT01565707|200429|P2|COMPLETED|Overall Study||65
83197|NCT01565707|200430|P1|COMPLETED|Overall Study||66
83198|NCT01565707|200427|P4|Treated|Overall Study||22
83199|NCT01565707|200428|P3|Treated|Overall Study||19
83200|NCT01565707|200429|P2|Treated|Overall Study||73
83201|NCT01565707|200430|P1|Treated|Overall Study||73
83202|NCT01565707|200427|P4|STARTED|Overall Study||22
83203|NCT01565707|200428|P3|STARTED|Overall Study||19
83204|NCT01565707|200429|P2|STARTED|Overall Study||73
83205|NCT01565707|200430|P1|STARTED|Overall Study||75
83206|NCT01565616|200521|P1|NOT COMPLETED|Overall Study||0
83207|NCT01565616|200521|P1|COMPLETED|Overall Study||22
83208|NCT01565616|200521|P1|Second Component: Related or Unrelated|Overall Study||17
83209|NCT01565616|200521|P1|First Component: 5 Related Donors|Overall Study||5
83210|NCT01565616|200521|P1|STARTED|Overall Study||22
83211|NCT01565564|200534|P2|NOT COMPLETED|Overall Study||1
83212|NCT01565564|200535|P1|NOT COMPLETED|Overall Study||5
83213|NCT01565564|200534|P2|COMPLETED|Overall Study||361
83214|NCT01565564|200535|P1|COMPLETED|Overall Study||339
83215|NCT01565564|200534|P2|STARTED|Overall Study||362
83216|NCT01565564|200535|P1|STARTED|Overall Study||344
83217|NCT01565551|200545|P2|NOT COMPLETED|Overall Study||0
83218|NCT01565551|200546|P1|NOT COMPLETED|Overall Study||0
83219|NCT01565551|200545|P2|COMPLETED|Overall Study||51
83220|NCT01565551|200546|P1|COMPLETED|Overall Study||586
83221|NCT01565551|200545|P2|6-Month Outcomes|Overall Study||30
83222|NCT01565551|200546|P1|6-Month Outcomes|Overall Study||412
83223|NCT01565551|200545|P2|Neuroimaging|Overall Study||25
83224|NCT01565551|200546|P1|Neuroimaging|Overall Study||233
83225|NCT01565551|200545|P2|Biospecimens/Biomarkers|Overall Study||22
83226|NCT01565551|200546|P1|Biospecimens/Biomarkers|Overall Study||479
83227|NCT01565551|200545|P2|Clinical/Demographics|Overall Study||51
83228|NCT01565551|200546|P1|Clinical/Demographics|Overall Study||586
83229|NCT01565551|200545|P2|STARTED|Overall Study||51
83230|NCT01565551|200546|P1|STARTED|Overall Study||586
83231|NCT01565538|200554|P2|NOT COMPLETED|Overall Study||0
83232|NCT01565538|200555|P1|NOT COMPLETED|Overall Study||0
83233|NCT01565538|200554|P2|COMPLETED|Overall Study||62
83234|NCT01565538|200555|P1|COMPLETED|Overall Study||61
83235|NCT01565538|200554|P2|STARTED|Overall Study||62
83236|NCT01565538|200555|P1|STARTED|Overall Study||61
83237|NCT01565382|200565|P2|NOT COMPLETED|Overall Study||0
83238|NCT01565382|200566|P1|NOT COMPLETED|Overall Study||0
83239|NCT01565382|200565|P2|COMPLETED|Overall Study||7
83240|NCT01565382|200566|P1|COMPLETED|Overall Study||40
83241|NCT01565382|200565|P2|STARTED|Overall Study||7
83242|NCT01565382|200566|P1|STARTED|Overall Study||40
83243|NCT01565369|200571|P1|NOT COMPLETED|Overall Study||0
83244|NCT01565369|200571|P1|COMPLETED|Overall Study||35
83245|NCT01565369|200571|P1|STARTED|Overall Study||35
83246|NCT01565356|200577|P1|NOT COMPLETED|Overall Study||0
83247|NCT01565356|200577|P1|COMPLETED|Overall Study||41
83248|NCT01565356|200577|P1|STARTED|Overall Study||41
83249|NCT01565343|200585|P3|NOT COMPLETED|Overall Study||0
83250|NCT01565343|200586|P2|NOT COMPLETED|Overall Study||0
83251|NCT01565343|200587|P1|NOT COMPLETED|Overall Study||1
83252|NCT01565343|200585|P3|COMPLETED|Overall Study||10
83253|NCT01565343|200586|P2|COMPLETED|Overall Study||4
83254|NCT01565343|200587|P1|COMPLETED|Overall Study||10
83255|NCT01565343|200585|P3|STARTED|Overall Study||10
83256|NCT01565343|200586|P2|STARTED|Overall Study||4
83257|NCT01565343|200587|P1|STARTED|Overall Study||11
83258|NCT01565330|200598|P4|NOT COMPLETED|Overall Study||0
83259|NCT01565330|200599|P3|NOT COMPLETED|Overall Study||0
83260|NCT01565330|200600|P2|NOT COMPLETED|Overall Study||0
83261|NCT01565330|200601|P1|NOT COMPLETED|Overall Study||0
83262|NCT01565330|200598|P4|COMPLETED|Overall Study||7
83263|NCT01565330|200599|P3|COMPLETED|Overall Study||4
83264|NCT01565330|200600|P2|COMPLETED|Overall Study||4
83265|NCT01565330|200601|P1|COMPLETED|Overall Study||5
83266|NCT01565330|200598|P4|STARTED|Overall Study||7
83267|NCT01565330|200599|P3|STARTED|Overall Study||4
83268|NCT01565330|200600|P2|STARTED|Overall Study||4
83269|NCT01565330|200601|P1|STARTED|Overall Study||5
83270|NCT01565291|200617|P2|NOT COMPLETED|Overall Study||0
83271|NCT01565291|200618|P1|NOT COMPLETED|Overall Study||1
83272|NCT01565291|200617|P2|COMPLETED|Overall Study||16
83273|NCT01565291|200618|P1|COMPLETED|Overall Study||15
83274|NCT01565291|200617|P2|STARTED|Overall Study||16
83275|NCT01565291|200618|P1|STARTED|Overall Study||16
83276|NCT01565148|200630|P4|NOT COMPLETED|Overall Study||13
83277|NCT01565148|200631|P3|NOT COMPLETED|Overall Study||7
83278|NCT01565148|200632|P2|NOT COMPLETED|Overall Study||15
83279|NCT01565148|200633|P1|NOT COMPLETED|Overall Study||15
83280|NCT01565148|200630|P4|COMPLETED|Overall Study||32
83281|NCT01565148|200631|P3|COMPLETED|Overall Study||40
83282|NCT01565148|200632|P2|COMPLETED|Overall Study||31
83283|NCT01565148|200633|P1|COMPLETED|Overall Study||32
83284|NCT01565148|200630|P4|STARTED|Overall Study||45
83285|NCT01565148|200631|P3|STARTED|Overall Study||47
83286|NCT01565148|200632|P2|STARTED|Overall Study||46
83287|NCT01565148|200633|P1|STARTED|Overall Study||47
83288|NCT01565083|200669|P2|NOT COMPLETED|Overall Study||39
83289|NCT01565083|200670|P1|NOT COMPLETED|Overall Study||33
83290|NCT01565083|200669|P2|COMPLETED|Overall Study||68
83291|NCT01565083|200670|P1|COMPLETED|Overall Study||73
83292|NCT01565083|200669|P2|STARTED|Overall Study||107
83293|NCT01565083|200670|P1|STARTED|Overall Study||106
83294|NCT01564953|200696|P1|NOT COMPLETED|Overall Study||0
83295|NCT01564953|200696|P1|COMPLETED|Overall Study||143
83296|NCT01564953|200696|P1|STARTED|Overall Study||143
83297|NCT01564862|200707|P3|NOT COMPLETED|Overall Study||30
83298|NCT01564862|200708|P2|NOT COMPLETED|Overall Study||34
83299|NCT01564862|200709|P1|NOT COMPLETED|Overall Study||30
83300|NCT01564862|200707|P3|COMPLETED|Overall Study||164
83301|NCT01564862|200708|P2|COMPLETED|Overall Study||176
83302|NCT01564862|200709|P1|COMPLETED|Overall Study||168
83303|NCT01564862|200707|P3|Received Treatment|Overall Study||191
83304|NCT01564862|200708|P2|Received Treatment|Overall Study||207
83305|NCT01564862|200709|P1|Received Treatment|Overall Study||196
83306|NCT01564862|200707|P3|STARTED|Overall Study||194
83307|NCT01564862|200708|P2|STARTED|Overall Study||210
83308|NCT01564862|200709|P1|STARTED|Overall Study||198
83309|NCT01564784|200760|P2|NOT COMPLETED|Overall Study||133
83310|NCT01564784|200761|P1|NOT COMPLETED|Overall Study||134
83311|NCT01564784|200760|P2|COMPLETED|Overall Study||10
83312|NCT01564784|200761|P1|COMPLETED|Overall Study||30
83313|NCT01564784|200760|P2|STARTED|Overall Study|Treated (162 randomized)|143
83314|NCT01564784|200761|P1|STARTED|Overall Study|Treated (164 randomized)|164
83315|NCT01564758|200788|P1|NOT COMPLETED|Overall Study||14
83316|NCT01564758|200788|P1|COMPLETED|Overall Study||85
83317|NCT01564758|200788|P1|STARTED|Overall Study||99
83318|NCT01564732|200795|P2|NOT COMPLETED|Overall Study||5
83319|NCT01564732|200796|P1|NOT COMPLETED|Overall Study||6
83320|NCT01564732|200795|P2|COMPLETED|Overall Study||0
83321|NCT01564732|200796|P1|COMPLETED|Overall Study||0
83322|NCT01564732|200795|P2|STARTED|Overall Study||5
83323|NCT01564732|200796|P1|STARTED|Overall Study||6
83324|NCT01564706|200812|P1|NOT COMPLETED|Overall Study||0
83325|NCT01564706|200812|P1|COMPLETED|Overall Study||9
83326|NCT01564706|200812|P1|STARTED|Overall Study||9
83327|NCT01564693|200819|P3|NOT COMPLETED|Overall Study||0
83328|NCT01564693|200820|P2|NOT COMPLETED|Overall Study||0
83329|NCT01564693|200821|P1|NOT COMPLETED|Overall Study||0
83330|NCT01564693|200819|P3|COMPLETED|Overall Study||2
83331|NCT01564693|200820|P2|COMPLETED|Overall Study||4
83332|NCT01564693|200821|P1|COMPLETED|Overall Study||9
83333|NCT01564693|200819|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
83334|NCT01564693|200820|P2|STARTED|Overall Study||4
83335|NCT01564693|200821|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
83336|NCT01564537|200831|P2|NOT COMPLETED|Overall Study||6
83337|NCT01564537|200832|P1|NOT COMPLETED|Overall Study||6
83338|NCT01564537|200831|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
83339|NCT01564537|200832|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
83340|NCT01564537|200831|P2|Safety Population: Received Study Drug|Overall Study||360
83341|NCT01564537|200832|P1|Safety Population: Received Study Drug|Overall Study||360
83342|NCT01564537|200831|P2|STARTED|Overall Study||362
83343|NCT01564537|200832|P1|STARTED|Overall Study||360
83344|NCT01564459|200855|P3|NOT COMPLETED|Double-blind Treatment||1
83345|NCT01564459|200856|P2|NOT COMPLETED|Double-blind Treatment||0
83346|NCT01564459|200857|P1|NOT COMPLETED|Double-blind Treatment||0
83347|NCT01564459|200855|P3|COMPLETED|Double-blind Treatment||82
83348|NCT01564459|200856|P2|COMPLETED|Double-blind Treatment||87
83349|NCT01564459|200857|P1|COMPLETED|Double-blind Treatment||0
83350|NCT01564459|200855|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
83440|NCT01563081|201103|P2|COMPLETED|Overall Study||30
83351|NCT01564459|200856|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
83352|NCT01564459|200857|P1|STARTED|Double-blind Treatment||0
83353|NCT01564459|200855|P3|NOT COMPLETED|Run-In||0
83354|NCT01564459|200856|P2|NOT COMPLETED|Run-In||0
83355|NCT01564459|200857|P1|NOT COMPLETED|Run-In||12
83356|NCT01564459|200855|P3|COMPLETED|Run-In||83
83357|NCT01564459|200856|P2|COMPLETED|Run-In||87
83358|NCT01564459|200857|P1|COMPLETED|Run-In||0
83359|NCT01564459|200855|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
83360|NCT01564459|200856|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
83361|NCT01564459|200857|P1|STARTED|Run-In||12
83362|NCT01564407|200881|P5|NOT COMPLETED|Overall Study||0
83363|NCT01564407|200882|P4|NOT COMPLETED|Overall Study||1
83364|NCT01564407|200883|P3|NOT COMPLETED|Overall Study||0
83365|NCT01564407|200884|P2|NOT COMPLETED|Overall Study||2
83366|NCT01564407|200885|P1|NOT COMPLETED|Overall Study||0
83367|NCT01564407|200881|P5|COMPLETED|Overall Study||0
83368|NCT01564407|200882|P4|COMPLETED|Overall Study||1
83369|NCT01564407|200883|P3|COMPLETED|Overall Study||4
83370|NCT01564407|200884|P2|COMPLETED|Overall Study||3
83371|NCT01564407|200885|P1|COMPLETED|Overall Study||4
83372|NCT01564407|200881|P5|STARTED|Overall Study||0
83373|NCT01564407|200882|P4|STARTED|Overall Study||2
83374|NCT01564407|200883|P3|STARTED|Overall Study||4
83375|NCT01564407|200884|P2|STARTED|Overall Study||5
83376|NCT01564407|200885|P1|STARTED|Overall Study||4
83377|NCT01564394|200926|P2|NOT COMPLETED|Overall Study||10
83378|NCT01564394|200927|P1|NOT COMPLETED|Overall Study||6
83379|NCT01564394|200926|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
83380|NCT01564394|200927|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
83381|NCT01564394|200926|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
83382|NCT01564394|200927|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
83383|NCT01564277|200941|P2|NOT COMPLETED|Overall Study||1
83384|NCT01564277|200942|P1|NOT COMPLETED|Overall Study||1
83385|NCT01564277|200941|P2|COMPLETED|Overall Study||11
83386|NCT01564277|200942|P1|COMPLETED|Overall Study||11
83387|NCT01564277|200941|P2|STARTED|Overall Study||12
83388|NCT01564277|200942|P1|STARTED|Overall Study||12
83389|NCT01563978|200960|P2|NOT COMPLETED|Overall Study||2
83390|NCT01563978|200961|P1|NOT COMPLETED|Overall Study||4
83391|NCT01563978|200960|P2|COMPLETED|Overall Study||65
83392|NCT01563978|200961|P1|COMPLETED|Overall Study||64
83393|NCT01563978|200960|P2|Randomised But Did Not Receive Treatment|Overall Study||0
83394|NCT01563978|200961|P1|Randomised But Did Not Receive Treatment|Overall Study||0
83395|NCT01563978|200960|P2|STARTED|Overall Study|Patients who received treatment.|67
83396|NCT01563978|200961|P1|STARTED|Overall Study|Patients who received treatment.|68
83397|NCT01563913|200987|P2|NOT COMPLETED|Overall Study||0
83398|NCT01563913|200988|P1|NOT COMPLETED|Overall Study||2
83399|NCT01563913|200987|P2|COMPLETED|Overall Study||15
83400|NCT01563913|200988|P1|COMPLETED|Overall Study||13
83401|NCT01563913|200987|P2|STARTED|Overall Study||15
83402|NCT01563913|200988|P1|STARTED|Overall Study||15
83403|NCT01563536|201000|P2|NOT COMPLETED|Overall Study||2
83404|NCT01563536|201001|P1|NOT COMPLETED|Overall Study||1
83405|NCT01563536|201000|P2|COMPLETED|Overall Study||4
83406|NCT01563536|201001|P1|COMPLETED|Overall Study||5
83407|NCT01563536|201000|P2|STARTED|Overall Study||6
83408|NCT01563536|201001|P1|STARTED|Overall Study||6
83409|NCT01563406|201033|P4|NOT COMPLETED|Overall Study||0
83410|NCT01563406|201034|P3|NOT COMPLETED|Overall Study||0
83411|NCT01563406|201035|P2|NOT COMPLETED|Overall Study||0
83412|NCT01563406|201036|P1|NOT COMPLETED|Overall Study||0
83413|NCT01563406|201033|P4|COMPLETED|Overall Study|112 hubs|29
83414|NCT01563406|201034|P3|COMPLETED|Overall Study|101 hubs|30
83415|NCT01563406|201035|P2|COMPLETED|Overall Study|102 hubs|30
83416|NCT01563406|201036|P1|COMPLETED|Overall Study|194 hubs|60
83417|NCT01563406|201033|P4|STARTED|Overall Study|112 hubs|29
83418|NCT01563406|201034|P3|STARTED|Overall Study|101 hubs|30
83419|NCT01563406|201035|P2|STARTED|Overall Study|102 hubs|30
83420|NCT01563406|201036|P1|STARTED|Overall Study|194 hubs|60
83421|NCT01563198|201054|P1|NOT COMPLETED|After Training||0
83422|NCT01563198|201054|P1|COMPLETED|After Training||47979
83423|NCT01563198|201054|P1|STARTED|After Training||47979
83424|NCT01563198|201054|P1|NOT COMPLETED|Baseline||0
83425|NCT01563198|201054|P1|COMPLETED|Baseline||49733
83426|NCT01563198|201054|P1|STARTED|Baseline||49733
83427|NCT01563185|201060|P1|NOT COMPLETED|Overall Study||2
83428|NCT01563185|201060|P1|COMPLETED|Overall Study||10
83429|NCT01563185|201060|P1|STARTED|Overall Study||12
83430|NCT01563172|201074|P1|NOT COMPLETED|Overall Study||13
83431|NCT01563172|201074|P1|COMPLETED|Overall Study||52
83432|NCT01563172|201074|P1|Control Dentifrice|Overall Study||60
83433|NCT01563172|201074|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
83434|NCT01563172|201074|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
83435|NCT01563172|201074|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
83436|NCT01563172|201074|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
83437|NCT01563172|201074|P1|STARTED|Overall Study||65
83438|NCT01563081|201103|P2|NOT COMPLETED|Overall Study||0
83439|NCT01563081|201104|P1|NOT COMPLETED|Overall Study||0
83441|NCT01563081|201104|P1|COMPLETED|Overall Study||30
83442|NCT01563081|201103|P2|STARTED|Overall Study||30
83443|NCT01563081|201104|P1|STARTED|Overall Study||30
83444|NCT01563055|201117|P1|NOT COMPLETED|Overall Study||0
83445|NCT01563055|201117|P1|COMPLETED|Overall Study||10
83446|NCT01563055|201117|P1|STARTED|Overall Study||10
83447|NCT01563029|201180|P5|NOT COMPLETED|Overall Study||29
83448|NCT01563029|201181|P4|NOT COMPLETED|Overall Study||33
83449|NCT01563029|201182|P3|NOT COMPLETED|Overall Study||33
83450|NCT01563029|201183|P2|NOT COMPLETED|Overall Study||24
83451|NCT01563029|201184|P1|NOT COMPLETED|Overall Study||53
83452|NCT01563029|201180|P5|COMPLETED|Overall Study||89
83453|NCT01563029|201181|P4|COMPLETED|Overall Study||85
83454|NCT01563029|201182|P3|COMPLETED|Overall Study||87
83455|NCT01563029|201183|P2|COMPLETED|Overall Study||94
83456|NCT01563029|201184|P1|COMPLETED|Overall Study||66
83457|NCT01563029|201180|P5|STARTED|Overall Study||118
83458|NCT01563029|201181|P4|STARTED|Overall Study||118
83459|NCT01563029|201182|P3|STARTED|Overall Study||120
83460|NCT01563029|201183|P2|STARTED|Overall Study||118
83461|NCT01563029|201184|P1|STARTED|Overall Study||119
83462|NCT01563003|201234|P2|NOT COMPLETED|Overall Study||0
83463|NCT01563003|201235|P1|NOT COMPLETED|Overall Study||0
83464|NCT01563003|201234|P2|COMPLETED|Overall Study||15
83465|NCT01563003|201235|P1|COMPLETED|Overall Study||16
83466|NCT01563003|201234|P2|STARTED|Overall Study||15
83467|NCT01563003|201235|P1|STARTED|Overall Study||16
83468|NCT01562886|201245|P1|NOT COMPLETED|Overall Study||1
83469|NCT01562886|201245|P1|COMPLETED|Overall Study||13
83470|NCT01562886|201245|P1|STARTED|Overall Study||14
83471|NCT01562873|201250|P2|NOT COMPLETED|Overall Study||0
83472|NCT01562873|201251|P1|NOT COMPLETED|Overall Study||21
83473|NCT01562873|201250|P2|COMPLETED|Overall Study||0
83474|NCT01562873|201251|P1|COMPLETED|Overall Study||0
83475|NCT01562873|201250|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
83476|NCT01562873|201251|P1|STARTED|Overall Study||21
83477|NCT01562756|201258|P1|NOT COMPLETED|Overall Study||0
83478|NCT01562756|201258|P1|COMPLETED|Overall Study||6
83479|NCT01562756|201258|P1|STARTED|Overall Study||6
83480|NCT01562743|201263|P1|NOT COMPLETED|Overall Study||52
83481|NCT01562743|201263|P1|COMPLETED|Overall Study||133
83482|NCT01562743|201263|P1|STARTED|Overall Study||185
83483|NCT01562678|201275|P2|NOT COMPLETED|Overall Study||2
83484|NCT01562678|201276|P1|NOT COMPLETED|Overall Study||6
83485|NCT01562678|201275|P2|COMPLETED|Overall Study||12
83486|NCT01562678|201276|P1|COMPLETED|Overall Study||8
83487|NCT01562678|201275|P2|STARTED|Overall Study||14
83488|NCT01562678|201276|P1|STARTED|Overall Study||14
83489|NCT01562613|201282|P1|NOT COMPLETED|Overall Study||4
83490|NCT01562613|201282|P1|COMPLETED|Overall Study||529
83491|NCT01562613|201282|P1|STARTED|Overall Study||533
83492|NCT01562548|201292|P4|NOT COMPLETED|Overall Study||0
83493|NCT01562548|201293|P3|NOT COMPLETED|Overall Study||1
83494|NCT01562548|201294|P2|NOT COMPLETED|Overall Study||0
83495|NCT01562548|201295|P1|NOT COMPLETED|Overall Study||0
83496|NCT01562548|201292|P4|COMPLETED|Overall Study||14
83497|NCT01562548|201293|P3|COMPLETED|Overall Study||24
83498|NCT01562548|201294|P2|COMPLETED|Overall Study||15
83499|NCT01562548|201295|P1|COMPLETED|Overall Study||25
83500|NCT01562548|201292|P4|STARTED|Overall Study||14
83501|NCT01562548|201293|P3|STARTED|Overall Study||25
83502|NCT01562548|201294|P2|STARTED|Overall Study||15
83503|NCT01562548|201295|P1|STARTED|Overall Study||25
83504|NCT01562327|201345|P1|NOT COMPLETED|Overall Study||8
83505|NCT01562327|201345|P1|COMPLETED|Overall Study||42
83506|NCT01562327|201345|P1|STARTED|Overall Study||50
83507|NCT01562314|201375|P2|NOT COMPLETED|Overall Study||8
83508|NCT01562314|201376|P1|NOT COMPLETED|Overall Study||13
83509|NCT01562314|201375|P2|COMPLETED|Overall Study||23
83510|NCT01562314|201376|P1|COMPLETED|Overall Study||16
83511|NCT01562314|201375|P2|STARTED|Overall Study||31
83512|NCT01562314|201376|P1|STARTED|Overall Study||29
83513|NCT01562275|201463|P13|NOT COMPLETED|Stage 2||5
83514|NCT01562275|201464|P12|NOT COMPLETED|Stage 2||14
83515|NCT01562275|201465|P11|NOT COMPLETED|Stage 2||0
83516|NCT01562275|201466|P10|NOT COMPLETED|Stage 2||0
83517|NCT01562275|201467|P9|NOT COMPLETED|Stage 2||0
83518|NCT01562275|201468|P8|NOT COMPLETED|Stage 2||0
83519|NCT01562275|201469|P7|NOT COMPLETED|Stage 2||0
83520|NCT01562275|201470|P6|NOT COMPLETED|Stage 2||0
83521|NCT01562275|201471|P5|NOT COMPLETED|Stage 2||0
83522|NCT01562275|201472|P4|NOT COMPLETED|Stage 2||0
83523|NCT01562275|201473|P3|NOT COMPLETED|Stage 2||0
83524|NCT01562275|201474|P2|NOT COMPLETED|Stage 2||0
83525|NCT01562275|201475|P1|NOT COMPLETED|Stage 2||0
83526|NCT01562275|201463|P13|COMPLETED|Stage 2||0
83527|NCT01562275|201464|P12|COMPLETED|Stage 2||0
83528|NCT01562275|201465|P11|COMPLETED|Stage 2||0
83529|NCT01562275|201466|P10|COMPLETED|Stage 2||0
83530|NCT01562275|201467|P9|COMPLETED|Stage 2||0
83531|NCT01562275|201468|P8|COMPLETED|Stage 2||0
83532|NCT01562275|201469|P7|COMPLETED|Stage 2||0
83533|NCT01562275|201470|P6|COMPLETED|Stage 2||0
83534|NCT01562275|201471|P5|COMPLETED|Stage 2||0
83535|NCT01562275|201472|P4|COMPLETED|Stage 2||0
83536|NCT01562275|201473|P3|COMPLETED|Stage 2||0
83537|NCT01562275|201474|P2|COMPLETED|Stage 2||0
83538|NCT01562275|201475|P1|COMPLETED|Stage 2||0
83539|NCT01562275|201463|P13|STARTED|Stage 2||5
83540|NCT01562275|201464|P12|STARTED|Stage 2||14
83541|NCT01562275|201465|P11|STARTED|Stage 2||0
83542|NCT01562275|201466|P10|STARTED|Stage 2||0
83543|NCT01562275|201467|P9|STARTED|Stage 2||0
83544|NCT01562275|201468|P8|STARTED|Stage 2||0
83545|NCT01562275|201469|P7|STARTED|Stage 2||0
83546|NCT01562275|201470|P6|STARTED|Stage 2||0
83547|NCT01562275|201471|P5|STARTED|Stage 2||0
83548|NCT01562275|201472|P4|STARTED|Stage 2||0
83549|NCT01562275|201473|P3|STARTED|Stage 2||0
83550|NCT01562275|201474|P2|STARTED|Stage 2||0
83551|NCT01562275|201475|P1|STARTED|Stage 2||0
83552|NCT01562275|201463|P13|NOT COMPLETED|Stage 1||0
83553|NCT01562275|201464|P12|NOT COMPLETED|Stage 1||0
83554|NCT01562275|201465|P11|NOT COMPLETED|Stage 1||3
83555|NCT01562275|201466|P10|NOT COMPLETED|Stage 1||7
83556|NCT01562275|201467|P9|NOT COMPLETED|Stage 1||3
83557|NCT01562275|201468|P8|NOT COMPLETED|Stage 1||7
83558|NCT01562275|201469|P7|NOT COMPLETED|Stage 1||3
83559|NCT01562275|201470|P6|NOT COMPLETED|Stage 1||4
83560|NCT01562275|201471|P5|NOT COMPLETED|Stage 1||4
83561|NCT01562275|201472|P4|NOT COMPLETED|Stage 1||4
83562|NCT01562275|201473|P3|NOT COMPLETED|Stage 1||3
83563|NCT01562275|201474|P2|NOT COMPLETED|Stage 1||7
83564|NCT01562275|201475|P1|NOT COMPLETED|Stage 1||3
83565|NCT01562275|201463|P13|COMPLETED|Stage 1||0
83566|NCT01562275|201464|P12|COMPLETED|Stage 1||0
83567|NCT01562275|201465|P11|COMPLETED|Stage 1||0
83568|NCT01562275|201466|P10|COMPLETED|Stage 1||0
83569|NCT01562275|201467|P9|COMPLETED|Stage 1||0
83570|NCT01562275|201468|P8|COMPLETED|Stage 1||0
83571|NCT01562275|201469|P7|COMPLETED|Stage 1||0
83572|NCT01562275|201470|P6|COMPLETED|Stage 1||0
83573|NCT01562275|201471|P5|COMPLETED|Stage 1||0
83574|NCT01562275|201472|P4|COMPLETED|Stage 1||0
83575|NCT01562275|201473|P3|COMPLETED|Stage 1||0
83576|NCT01562275|201474|P2|COMPLETED|Stage 1||0
83577|NCT01562275|201475|P1|COMPLETED|Stage 1||0
83578|NCT01562275|201463|P13|STARTED|Stage 1||0
83579|NCT01562275|201464|P12|STARTED|Stage 1||0
83580|NCT01562275|201465|P11|STARTED|Stage 1||3
83581|NCT01562275|201466|P10|STARTED|Stage 1||7
83582|NCT01562275|201467|P9|STARTED|Stage 1||3
83583|NCT01562275|201468|P8|STARTED|Stage 1||7
83584|NCT01562275|201469|P7|STARTED|Stage 1||3
83585|NCT01562275|201470|P6|STARTED|Stage 1||4
83586|NCT01562275|201471|P5|STARTED|Stage 1||4
83587|NCT01562275|201472|P4|STARTED|Stage 1||4
83588|NCT01562275|201473|P3|STARTED|Stage 1||3
83589|NCT01562275|201474|P2|STARTED|Stage 1||7
83590|NCT01562275|201475|P1|STARTED|Stage 1||3
83591|NCT01562132|201607|P2|NOT COMPLETED|Overall Study||0
83592|NCT01562132|201608|P1|NOT COMPLETED|Overall Study||0
83593|NCT01562132|201607|P2|COMPLETED|Overall Study||3
83594|NCT01562132|201608|P1|COMPLETED|Overall Study||3
83595|NCT01562132|201607|P2|STARTED|Overall Study||3
83596|NCT01562132|201608|P1|STARTED|Overall Study||3
83597|NCT01561976|201620|P6|NOT COMPLETED|Period 3||0
83598|NCT01561976|201621|P5|NOT COMPLETED|Period 3||0
83599|NCT01561976|201622|P4|NOT COMPLETED|Period 3||0
83600|NCT01561976|201623|P3|NOT COMPLETED|Period 3||0
83601|NCT01561976|201624|P2|NOT COMPLETED|Period 3||0
83602|NCT01561976|201625|P1|NOT COMPLETED|Period 3||0
83603|NCT01561976|201620|P6|COMPLETED|Period 3||4
83604|NCT01561976|201621|P5|COMPLETED|Period 3||5
83605|NCT01561976|201622|P4|COMPLETED|Period 3||4
83606|NCT01561976|201623|P3|COMPLETED|Period 3||3
83607|NCT01561976|201624|P2|COMPLETED|Period 3||5
83608|NCT01561976|201625|P1|COMPLETED|Period 3||4
83609|NCT01561976|201620|P6|STARTED|Period 3||4
83610|NCT01561976|201621|P5|STARTED|Period 3||5
83611|NCT01561976|201622|P4|STARTED|Period 3||4
83612|NCT01561976|201623|P3|STARTED|Period 3||3
83613|NCT01561976|201624|P2|STARTED|Period 3||5
83614|NCT01561976|201625|P1|STARTED|Period 3||4
83615|NCT01561976|201620|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
83616|NCT01561976|201621|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
83617|NCT01561976|201622|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
83618|NCT01561976|201623|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
83619|NCT01561976|201624|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
83620|NCT01561976|201625|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
83621|NCT01561976|201620|P6|COMPLETED|Washout Period 2 (7 Days)||4
83622|NCT01561976|201621|P5|COMPLETED|Washout Period 2 (7 Days)||5
83623|NCT01561976|201622|P4|COMPLETED|Washout Period 2 (7 Days)||4
83624|NCT01561976|201623|P3|COMPLETED|Washout Period 2 (7 Days)||3
83625|NCT01561976|201624|P2|COMPLETED|Washout Period 2 (7 Days)||5
83626|NCT01561976|201625|P1|COMPLETED|Washout Period 2 (7 Days)||4
83627|NCT01561976|201620|P6|STARTED|Washout Period 2 (7 Days)||4
83628|NCT01561976|201621|P5|STARTED|Washout Period 2 (7 Days)||5
83629|NCT01561976|201622|P4|STARTED|Washout Period 2 (7 Days)||4
83630|NCT01561976|201623|P3|STARTED|Washout Period 2 (7 Days)||4
83631|NCT01561976|201624|P2|STARTED|Washout Period 2 (7 Days)||5
83632|NCT01561976|201625|P1|STARTED|Washout Period 2 (7 Days)||5
83633|NCT01561976|201620|P6|NOT COMPLETED|Period 2||0
83634|NCT01561976|201621|P5|NOT COMPLETED|Period 2||0
83635|NCT01561976|201622|P4|NOT COMPLETED|Period 2||0
83636|NCT01561976|201623|P3|NOT COMPLETED|Period 2||0
83637|NCT01561976|201624|P2|NOT COMPLETED|Period 2||0
83638|NCT01561976|201625|P1|NOT COMPLETED|Period 2||0
83639|NCT01561976|201620|P6|COMPLETED|Period 2||4
83640|NCT01561976|201621|P5|COMPLETED|Period 2||5
83641|NCT01561976|201622|P4|COMPLETED|Period 2||4
83642|NCT01561976|201623|P3|COMPLETED|Period 2||4
83643|NCT01561976|201624|P2|COMPLETED|Period 2||5
83644|NCT01561976|201625|P1|COMPLETED|Period 2||5
83645|NCT01561976|201620|P6|STARTED|Period 2||4
83646|NCT01561976|201621|P5|STARTED|Period 2||5
83647|NCT01561976|201622|P4|STARTED|Period 2||4
83648|NCT01561976|201623|P3|STARTED|Period 2||4
83649|NCT01561976|201624|P2|STARTED|Period 2||5
83650|NCT01561976|201625|P1|STARTED|Period 2||5
83651|NCT01561976|201620|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
83652|NCT01561976|201621|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
83653|NCT01561976|201622|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
83654|NCT01561976|201623|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
83655|NCT01561976|201624|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
83656|NCT01561976|201625|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
83657|NCT01561976|201620|P6|COMPLETED|Washout Period 1 (7 Days)||4
83658|NCT01561976|201621|P5|COMPLETED|Washout Period 1 (7 Days)||5
83659|NCT01561976|201622|P4|COMPLETED|Washout Period 1 (7 Days)||4
83660|NCT01561976|201623|P3|COMPLETED|Washout Period 1 (7 Days)||4
83661|NCT01561976|201624|P2|COMPLETED|Washout Period 1 (7 Days)||5
83662|NCT01561976|201625|P1|COMPLETED|Washout Period 1 (7 Days)||5
83663|NCT01561976|201620|P6|STARTED|Washout Period 1 (7 Days)||5
83664|NCT01561976|201621|P5|STARTED|Washout Period 1 (7 Days)||5
83665|NCT01561976|201622|P4|STARTED|Washout Period 1 (7 Days)||5
83666|NCT01561976|201623|P3|STARTED|Washout Period 1 (7 Days)||4
83667|NCT01561976|201624|P2|STARTED|Washout Period 1 (7 Days)||5
83668|NCT01561976|201625|P1|STARTED|Washout Period 1 (7 Days)||5
83669|NCT01561976|201620|P6|NOT COMPLETED|Period 1||0
83670|NCT01561976|201621|P5|NOT COMPLETED|Period 1||0
83671|NCT01561976|201622|P4|NOT COMPLETED|Period 1||0
83672|NCT01561976|201623|P3|NOT COMPLETED|Period 1||1
83673|NCT01561976|201624|P2|NOT COMPLETED|Period 1||0
83674|NCT01561976|201625|P1|NOT COMPLETED|Period 1||0
83675|NCT01561976|201620|P6|COMPLETED|Period 1||5
83676|NCT01561976|201621|P5|COMPLETED|Period 1||5
83677|NCT01561976|201622|P4|COMPLETED|Period 1||5
83678|NCT01561976|201623|P3|COMPLETED|Period 1||4
83679|NCT01561976|201624|P2|COMPLETED|Period 1||5
83680|NCT01561976|201625|P1|COMPLETED|Period 1||5
83681|NCT01561976|201620|P6|STARTED|Period 1||5
83682|NCT01561976|201621|P5|STARTED|Period 1||5
83683|NCT01561976|201622|P4|STARTED|Period 1||5
83684|NCT01561976|201623|P3|STARTED|Period 1||5
83685|NCT01561976|201624|P2|STARTED|Period 1||5
83686|NCT01561976|201625|P1|STARTED|Period 1||5
83687|NCT01561898|201658|P4|NOT COMPLETED|Overall Study||20
83688|NCT01561898|201659|P3|NOT COMPLETED|Overall Study||44
83689|NCT01561898|201660|P2|NOT COMPLETED|Overall Study||41
83690|NCT01561898|201661|P1|NOT COMPLETED|Overall Study||2
83691|NCT01561898|201658|P4|COMPLETED|Overall Study||12
83692|NCT01561898|201659|P3|COMPLETED|Overall Study||53
83693|NCT01561898|201660|P2|COMPLETED|Overall Study||51
83694|NCT01561898|201661|P1|COMPLETED|Overall Study||5
83695|NCT01561898|201658|P4|STARTED|Overall Study||32
83696|NCT01561898|201659|P3|STARTED|Overall Study||97
83697|NCT01561898|201660|P2|STARTED|Overall Study||92
83698|NCT01561898|201661|P1|STARTED|Overall Study||7
83699|NCT01561755|201675|P2|NOT COMPLETED|Overall Study||1
83700|NCT01561755|201676|P1|NOT COMPLETED|Overall Study||0
83701|NCT01561755|201675|P2|COMPLETED|Overall Study||5
83702|NCT01561755|201676|P1|COMPLETED|Overall Study||6
83703|NCT01561755|201675|P2|STARTED|Overall Study||6
83704|NCT01561755|201676|P1|STARTED|Overall Study||6
83705|NCT01561716|201700|P6|NOT COMPLETED|Overall Study||0
83706|NCT01561716|201701|P5|NOT COMPLETED|Overall Study||0
83707|NCT01561716|201702|P4|NOT COMPLETED|Overall Study||0
83708|NCT01561716|201703|P3|NOT COMPLETED|Overall Study||0
83709|NCT01561716|201704|P2|NOT COMPLETED|Overall Study||0
83710|NCT01561716|201705|P1|NOT COMPLETED|Overall Study||0
83711|NCT01561716|201700|P6|COMPLETED|Overall Study||5
83712|NCT01561716|201701|P5|COMPLETED|Overall Study||5
83713|NCT01561716|201702|P4|COMPLETED|Overall Study||5
83714|NCT01561716|201703|P3|COMPLETED|Overall Study||5
83715|NCT01561716|201704|P2|COMPLETED|Overall Study||5
83716|NCT01561716|201705|P1|COMPLETED|Overall Study||5
83717|NCT01561716|201700|P6|STARTED|Overall Study||5
83718|NCT01561716|201701|P5|STARTED|Overall Study||5
83719|NCT01561716|201702|P4|STARTED|Overall Study||5
83720|NCT01561716|201703|P3|STARTED|Overall Study||5
83721|NCT01561716|201704|P2|STARTED|Overall Study||5
83722|NCT01561716|201705|P1|STARTED|Overall Study||5
83723|NCT01561703|201721|P2|NOT COMPLETED|Overall Study||6
83724|NCT01561703|201722|P1|NOT COMPLETED|Overall Study||8
83725|NCT01561703|201721|P2|COMPLETED|Overall Study||24
83726|NCT01561703|201722|P1|COMPLETED|Overall Study||20
83727|NCT01561703|201721|P2|STARTED|Overall Study||30
83728|NCT01561703|201722|P1|STARTED|Overall Study||28
83729|NCT01561560|201728|P2|NOT COMPLETED|Second Two Weeks of Wear||1
83730|NCT01561560|201729|P1|NOT COMPLETED|Second Two Weeks of Wear||0
83731|NCT01561560|201728|P2|COMPLETED|Second Two Weeks of Wear||58
83732|NCT01561560|201729|P1|COMPLETED|Second Two Weeks of Wear||60
83733|NCT01561560|201728|P2|STARTED|Second Two Weeks of Wear||59
83734|NCT01561560|201729|P1|STARTED|Second Two Weeks of Wear||60
83735|NCT01561560|201728|P2|NOT COMPLETED|First Two Weeks of Wear||2
83736|NCT01561560|201729|P1|NOT COMPLETED|First Two Weeks of Wear||0
83737|NCT01561560|201728|P2|COMPLETED|First Two Weeks of Wear||59
83738|NCT01561560|201729|P1|COMPLETED|First Two Weeks of Wear||60
83739|NCT01561560|201728|P2|STARTED|First Two Weeks of Wear||61
83740|NCT01561560|201729|P1|STARTED|First Two Weeks of Wear||60
83741|NCT01561469|201737|P2|NOT COMPLETED|Overall Study||0
83742|NCT01561469|201738|P1|NOT COMPLETED|Overall Study||0
83743|NCT01561469|201737|P2|COMPLETED|Overall Study||87
83744|NCT01561469|201738|P1|COMPLETED|Overall Study||101
83745|NCT01561469|201737|P2|STARTED|Overall Study||87
83746|NCT01561469|201738|P1|STARTED|Overall Study||101
83747|NCT01561430|201760|P4|NOT COMPLETED|Overall Study||13
83748|NCT01561430|201761|P3|NOT COMPLETED|Overall Study||17
83749|NCT01561430|201762|P2|NOT COMPLETED|Overall Study||15
83750|NCT01561430|201763|P1|NOT COMPLETED|Overall Study||1
83751|NCT01561430|201760|P4|COMPLETED|Overall Study||7
83752|NCT01561430|201761|P3|COMPLETED|Overall Study||1
83753|NCT01561430|201762|P2|COMPLETED|Overall Study||8
83754|NCT01561430|201763|P1|COMPLETED|Overall Study||8
83755|NCT01561430|201760|P4|Received at Least One Dose of Study Drug|Overall Study||20
83756|NCT01561430|201761|P3|Received at Least One Dose of Study Drug|Overall Study||18
83757|NCT01561430|201762|P2|Received at Least One Dose of Study Drug|Overall Study||23
83758|NCT01561430|201763|P1|Received at Least One Dose of Study Drug|Overall Study||9
83759|NCT01561430|201760|P4|STARTED|Overall Study||20
83760|NCT01561430|201761|P3|STARTED|Overall Study||18
83761|NCT01561430|201762|P2|STARTED|Overall Study||23
83762|NCT01561430|201763|P1|STARTED|Overall Study||9
83763|NCT01561313|201803|P2|NOT COMPLETED|Overall Study||0
83764|NCT01561313|201804|P1|NOT COMPLETED|Overall Study||2
83765|NCT01561313|201803|P2|COMPLETED|Overall Study||31
83766|NCT01561313|201804|P1|COMPLETED|Overall Study||31
83767|NCT01561313|201803|P2|STARTED|Overall Study||31
83768|NCT01561313|201804|P1|STARTED|Overall Study||33
83769|NCT01561300|201822|P2|NOT COMPLETED|Second Intervention||0
83770|NCT01561300|201823|P1|NOT COMPLETED|Second Intervention||0
83771|NCT01561300|201822|P2|COMPLETED|Second Intervention||15
83772|NCT01561300|201823|P1|COMPLETED|Second Intervention||14
83773|NCT01561300|201822|P2|STARTED|Second Intervention||15
83774|NCT01561300|201823|P1|STARTED|Second Intervention||14
83775|NCT01561300|201822|P2|NOT COMPLETED|Washout on Placebo||0
83776|NCT01561300|201823|P1|NOT COMPLETED|Washout on Placebo||0
83777|NCT01561300|201822|P2|COMPLETED|Washout on Placebo||15
83778|NCT01561300|201823|P1|COMPLETED|Washout on Placebo||14
83779|NCT01561300|201822|P2|STARTED|Washout on Placebo||15
83780|NCT01561300|201823|P1|STARTED|Washout on Placebo||14
83781|NCT01561300|201822|P2|NOT COMPLETED|First Intervention||0
83782|NCT01561300|201823|P1|NOT COMPLETED|First Intervention||0
83783|NCT01561300|201822|P2|COMPLETED|First Intervention||15
83784|NCT01561300|201823|P1|COMPLETED|First Intervention||14
83785|NCT01561300|201822|P2|STARTED|First Intervention||15
83786|NCT01561300|201823|P1|STARTED|First Intervention||14
83787|NCT01561300|201822|P2|NOT COMPLETED|Run in on Placebo||0
83788|NCT01561300|201823|P1|NOT COMPLETED|Run in on Placebo||1
83789|NCT01561300|201822|P2|COMPLETED|Run in on Placebo||15
83790|NCT01561300|201823|P1|COMPLETED|Run in on Placebo||14
83791|NCT01561300|201822|P2|STARTED|Run in on Placebo||15
83792|NCT01561300|201823|P1|STARTED|Run in on Placebo||15
83793|NCT01561079|201834|P1|NOT COMPLETED|Overall Study||78
83794|NCT01561079|201834|P1|COMPLETED|Overall Study||49
83795|NCT01561079|201834|P1|STARTED|Overall Study||127
83796|NCT01560988|201877|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
83797|NCT01560988|201878|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
83798|NCT01560988|201877|P2|COMPLETED|Second Intervention (Six Weeks)||22
83799|NCT01560988|201878|P1|COMPLETED|Second Intervention (Six Weeks)||18
83800|NCT01560988|201877|P2|STARTED|Second Intervention (Six Weeks)||24
83801|NCT01560988|201878|P1|STARTED|Second Intervention (Six Weeks)||20
83802|NCT01560988|201877|P2|NOT COMPLETED|Washout (Six Weeks)||2
83803|NCT01560988|201878|P1|NOT COMPLETED|Washout (Six Weeks)||2
83804|NCT01560988|201877|P2|COMPLETED|Washout (Six Weeks)||24
83805|NCT01560988|201878|P1|COMPLETED|Washout (Six Weeks)||20
83806|NCT01560988|201877|P2|STARTED|Washout (Six Weeks)||26
83807|NCT01560988|201878|P1|STARTED|Washout (Six Weeks)||22
83808|NCT01560988|201877|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
83809|NCT01560988|201878|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
83810|NCT01560988|201877|P2|COMPLETED|First Intervention (Six Weeks)||26
83811|NCT01560988|201878|P1|COMPLETED|First Intervention (Six Weeks)||22
83812|NCT01560988|201877|P2|STARTED|First Intervention (Six Weeks)||30
83813|NCT01560988|201878|P1|STARTED|First Intervention (Six Weeks)||32
83814|NCT01560975|201901|P1|NOT COMPLETED|Overall Study||0
83815|NCT01560975|201901|P1|COMPLETED|Overall Study||10
83816|NCT01560975|201901|P1|STARTED|Overall Study||10
83817|NCT01560819|201916|P2|NOT COMPLETED|Overall Study||0
83818|NCT01560819|201917|P1|NOT COMPLETED|Overall Study||1
83819|NCT01560819|201916|P2|COMPLETED|Overall Study||10
83820|NCT01560819|201917|P1|COMPLETED|Overall Study||9
83821|NCT01560819|201916|P2|STARTED|Overall Study||10
83822|NCT01560819|201917|P1|STARTED|Overall Study||10
83823|NCT01560507|201924|P3|NOT COMPLETED|Overall Study||2
83824|NCT01560507|201925|P2|NOT COMPLETED|Overall Study||2
83825|NCT01560507|201926|P1|NOT COMPLETED|Overall Study||4
83826|NCT01560507|201924|P3|COMPLETED|Overall Study||0
83827|NCT01560507|201925|P2|COMPLETED|Overall Study||0
83828|NCT01560507|201926|P1|COMPLETED|Overall Study||1
83829|NCT01560507|201924|P3|STARTED|Overall Study||2
83830|NCT01560507|201925|P2|STARTED|Overall Study||2
83831|NCT01560507|201926|P1|STARTED|Overall Study||5
83832|NCT01560429|201939|P2|NOT COMPLETED|Overall Study||6
83833|NCT01560429|201940|P1|NOT COMPLETED|Overall Study||3
83834|NCT01560429|201939|P2|COMPLETED|Overall Study||20
83835|NCT01560429|201940|P1|COMPLETED|Overall Study||23
83836|NCT01560429|201939|P2|STARTED|Overall Study||26
83837|NCT01560429|201940|P1|STARTED|Overall Study||26
83838|NCT01560403|201950|P2|NOT COMPLETED|Overall Study||1
83839|NCT01560403|201951|P1|NOT COMPLETED|Overall Study||0
83840|NCT01560403|201950|P2|COMPLETED|Overall Study||8
83841|NCT01560403|201951|P1|COMPLETED|Overall Study||5
83842|NCT01560403|201950|P2|STARTED|Overall Study||9
83843|NCT01560403|201951|P1|STARTED|Overall Study||5
83844|NCT01560260|201957|P1|NOT COMPLETED|Overall Study||0
83845|NCT01560260|201957|P1|COMPLETED|Overall Study||20
83846|NCT01560260|201957|P1|STARTED|Overall Study||20
83847|NCT01560234|201969|P8|NOT COMPLETED|Overall Study||2
83848|NCT01560234|201970|P7|NOT COMPLETED|Overall Study||0
83849|NCT01560234|201971|P6|NOT COMPLETED|Overall Study||2
83850|NCT01560234|201972|P5|NOT COMPLETED|Overall Study||0
83851|NCT01560234|201973|P4|NOT COMPLETED|Overall Study||0
83852|NCT01560234|201974|P3|NOT COMPLETED|Overall Study||1
83853|NCT01560234|201975|P2|NOT COMPLETED|Overall Study||0
83854|NCT01560234|201976|P1|NOT COMPLETED|Overall Study||3
83855|NCT01560234|201969|P8|COMPLETED|Overall Study||6
83856|NCT01560234|201970|P7|COMPLETED|Overall Study||4
83857|NCT01560234|201971|P6|COMPLETED|Overall Study||2
83858|NCT01560234|201972|P5|COMPLETED|Overall Study||4
83859|NCT01560234|201973|P4|COMPLETED|Overall Study||3
83860|NCT01560234|201974|P3|COMPLETED|Overall Study||3
83861|NCT01560234|201975|P2|COMPLETED|Overall Study||4
83862|NCT01560234|201976|P1|COMPLETED|Overall Study||13
83863|NCT01560234|201969|P8|STARTED|Overall Study||8
83864|NCT01560234|201970|P7|STARTED|Overall Study||4
83865|NCT01560234|201971|P6|STARTED|Overall Study||4
83866|NCT01560234|201972|P5|STARTED|Overall Study||4
83867|NCT01560234|201973|P4|STARTED|Overall Study||3
83868|NCT01560234|201974|P3|STARTED|Overall Study||4
83869|NCT01560234|201975|P2|STARTED|Overall Study||4
83870|NCT01560234|201976|P1|STARTED|Overall Study||16
83871|NCT01560143|202050|P1|NOT COMPLETED|Overall Study||0
83872|NCT01560143|202050|P1|COMPLETED|Overall Study||12
83873|NCT01560143|202050|P1|STARTED|Overall Study||12
83874|NCT01559935|202054|P1|NOT COMPLETED|Maintenance Phase||54
83875|NCT01559935|202054|P1|COMPLETED|Maintenance Phase||0
83876|NCT01559935|202054|P1|STARTED|Maintenance Phase||54
83877|NCT01559935|202054|P1|NOT COMPLETED|BiRD Phase||4
83878|NCT01559935|202054|P1|COMPLETED|BiRD Phase||54
83879|NCT01559935|202054|P1|STARTED|BiRD Phase||58
83880|NCT01559935|202054|P1|NOT COMPLETED|Car Phase||14
83881|NCT01559935|202054|P1|COMPLETED|Car Phase||58
83882|NCT01559935|202054|P1|STARTED|Car Phase||72
83883|NCT01559922|202064|P2|NOT COMPLETED|Overall Study||10
83884|NCT01559922|202065|P1|NOT COMPLETED|Overall Study||4
83885|NCT01559922|202064|P2|COMPLETED|Overall Study||87
83886|NCT01559922|202065|P1|COMPLETED|Overall Study||46
83887|NCT01559922|202064|P2|STARTED|Overall Study||97
83888|NCT01559922|202065|P1|STARTED|Overall Study||50
83889|NCT01559857|202073|P2|NOT COMPLETED|Overall Study||0
83890|NCT01559857|202074|P1|NOT COMPLETED|Overall Study||0
83891|NCT01559857|202073|P2|COMPLETED|Overall Study||18
83892|NCT01559857|202074|P1|COMPLETED|Overall Study||19
83893|NCT01559857|202073|P2|STARTED|Overall Study||18
83894|NCT01559857|202074|P1|STARTED|Overall Study||19
83895|NCT01559844|202090|P1|NOT COMPLETED|Overall Study||25
83896|NCT01559844|202090|P1|COMPLETED|Overall Study||36
83897|NCT01559844|202090|P1|STARTED|Overall Study||61
83898|NCT01559675|202103|P2|NOT COMPLETED|Overall Study||14
83899|NCT01559675|202104|P1|NOT COMPLETED|Overall Study||15
83900|NCT01559675|202103|P2|COMPLETED|Overall Study||49
83901|NCT01559675|202104|P1|COMPLETED|Overall Study||43
83902|NCT01559675|202103|P2|STARTED|Overall Study||63
83903|NCT01559675|202104|P1|STARTED|Overall Study||58
83904|NCT01559649|202112|P2|NOT COMPLETED|Overall Study||6
83905|NCT01559649|202113|P1|NOT COMPLETED|Overall Study||19
83906|NCT01559649|202112|P2|COMPLETED|Overall Study||9
83907|NCT01559649|202113|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
83908|NCT01559649|202112|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
83909|NCT01559649|202113|P1|STARTED|Overall Study||269
83910|NCT01559506|202126|P2|NOT COMPLETED|Overall Study||3
83911|NCT01559506|202127|P1|NOT COMPLETED|Overall Study||0
83912|NCT01559506|202126|P2|COMPLETED|Overall Study||18
83913|NCT01559506|202127|P1|COMPLETED|Overall Study||20
83914|NCT01559506|202126|P2|STARTED|Overall Study||21
83915|NCT01559506|202127|P1|STARTED|Overall Study||20
83916|NCT01559454|202135|P2|NOT COMPLETED|Overall Study||6
83917|NCT01559454|202136|P1|NOT COMPLETED|Overall Study||3
83918|NCT01559454|202135|P2|COMPLETED|Overall Study||4
83919|NCT01559454|202136|P1|COMPLETED|Overall Study||6
83920|NCT01559454|202135|P2|STARTED|Overall Study||10
83921|NCT01559454|202136|P1|STARTED|Overall Study||9
83922|NCT01559311|202155|P3|NOT COMPLETED|Overall Study||8
83923|NCT01559311|202156|P2|NOT COMPLETED|Overall Study||6
83924|NCT01559311|202157|P1|NOT COMPLETED|Overall Study||3
83925|NCT01559311|202155|P3|COMPLETED|Overall Study|12-Month|26
83926|NCT01559311|202156|P2|COMPLETED|Overall Study|12-Month|28
83927|NCT01559311|202157|P1|COMPLETED|Overall Study|12-Month|27
83928|NCT01559311|202155|P3|6-Month|Overall Study||28
83929|NCT01559311|202156|P2|6-Month|Overall Study||33
83930|NCT01559311|202157|P1|6-Month|Overall Study||27
83931|NCT01559311|202155|P3|3-Month|Overall Study||29
83932|NCT01559311|202156|P2|3-Month|Overall Study||34
83933|NCT01559311|202157|P1|3-Month|Overall Study||27
83934|NCT01559311|202155|P3|1-Month|Overall Study||29
83935|NCT01559311|202156|P2|1-Month|Overall Study||34
83936|NCT01559311|202157|P1|1-Month|Overall Study||27
83937|NCT01559311|202155|P3|Implant|Overall Study||32
83938|NCT01559311|202156|P2|Implant|Overall Study||34
83939|NCT01559311|202157|P1|Implant|Overall Study||28
83940|NCT01559311|202155|P3|STARTED|Overall Study|Enrollment & Baseline|34
83941|NCT01559311|202156|P2|STARTED|Overall Study|Enrollment & Baseline|34
83942|NCT01559311|202157|P1|STARTED|Overall Study|Enrollment & Baseline|30
83943|NCT01559116|202168|P1|NOT COMPLETED|Overall Study||26
83944|NCT01559116|202168|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
83945|NCT01559116|202168|P1|STARTED|Overall Study|Randomised|219
83946|NCT01559064|202239|P3|NOT COMPLETED|Overall Study||2
83947|NCT01559064|202240|P2|NOT COMPLETED|Overall Study||1
83948|NCT01559064|202241|P1|NOT COMPLETED|Overall Study||1
83949|NCT01559064|202239|P3|COMPLETED|Overall Study||57
83950|NCT01559064|202240|P2|COMPLETED|Overall Study||39
83951|NCT01559064|202241|P1|COMPLETED|Overall Study||15
83952|NCT01559064|202239|P3|STARTED|Overall Study||59
83953|NCT01559064|202240|P2|STARTED|Overall Study||40
83954|NCT01559064|202241|P1|STARTED|Overall Study||16
83955|NCT01559012|202251|P2|NOT COMPLETED|Overall Study||1
83956|NCT01559012|202252|P1|NOT COMPLETED|Overall Study||0
83957|NCT01559012|202251|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
83958|NCT01559012|202252|P1|COMPLETED|Overall Study||6
83959|NCT01559012|202251|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
83960|NCT01559012|202252|P1|STARTED|Overall Study||6
83961|NCT01558791|202277|P2|NOT COMPLETED|Overall Study||0
83962|NCT01558791|202278|P1|NOT COMPLETED|Overall Study||0
83963|NCT01558791|202277|P2|COMPLETED|Overall Study||629
83964|NCT01558791|202278|P1|COMPLETED|Overall Study||607
83965|NCT01558791|202277|P2|STARTED|Overall Study||629
83966|NCT01558791|202278|P1|STARTED|Overall Study||607
83967|NCT01558739|202288|P1|NOT COMPLETED|Overall Study||17
83968|NCT01558739|202288|P1|COMPLETED|Overall Study||31
83969|NCT01558739|202288|P1|STARTED|Overall Study||48
83970|NCT01558700|202302|P2|NOT COMPLETED|Overall Study||0
83971|NCT01558700|202303|P1|NOT COMPLETED|Overall Study||0
83972|NCT01558700|202302|P2|COMPLETED|Overall Study||21
83973|NCT01558700|202303|P1|COMPLETED|Overall Study||19
83974|NCT01558700|202302|P2|STARTED|Overall Study||21
83975|NCT01558700|202303|P1|STARTED|Overall Study||19
83976|NCT01558674|202313|P2|NOT COMPLETED|Part 2||0
83977|NCT01558674|202314|P1|NOT COMPLETED|Part 2||0
83978|NCT01558674|202313|P2|COMPLETED|Part 2||0
83979|NCT01558674|202314|P1|COMPLETED|Part 2||0
83980|NCT01558674|202313|P2|STARTED|Part 2||0
83981|NCT01558674|202314|P1|STARTED|Part 2||0
83982|NCT01558674|202313|P2|NOT COMPLETED|Part 1||0
83983|NCT01558674|202314|P1|NOT COMPLETED|Part 1||11
83984|NCT01558674|202313|P2|COMPLETED|Part 1||0
83985|NCT01558674|202314|P1|COMPLETED|Part 1||0
83986|NCT01558674|202313|P2|STARTED|Part 1||0
83987|NCT01558674|202314|P1|STARTED|Part 1||11
83988|NCT01558661|202358|P1|NOT COMPLETED|Overall Study||0
83989|NCT01558661|202358|P1|COMPLETED|Overall Study||33
83990|NCT01558661|202358|P1|Second Stage|Overall Study||15
83991|NCT01558661|202358|P1|First Stage|Overall Study||18
83992|NCT01558661|202358|P1|STARTED|Overall Study||33
83993|NCT01558596|202367|P2|NOT COMPLETED|Overall Study||1
83994|NCT01558596|202368|P1|NOT COMPLETED|Overall Study||3
83995|NCT01558596|202367|P2|COMPLETED|Overall Study||100
83996|NCT01558596|202368|P1|COMPLETED|Overall Study||101
83997|NCT01558596|202367|P2|STARTED|Overall Study||101
83998|NCT01558596|202368|P1|STARTED|Overall Study||104
83999|NCT01558492|202374|P1|NOT COMPLETED|Overall Study||0
84000|NCT01558492|202374|P1|COMPLETED|Overall Study||3
84001|NCT01558492|202374|P1|STARTED|Overall Study||3
84002|NCT01558297|202383|P3|NOT COMPLETED|Overall Study||1
84003|NCT01558297|202384|P2|NOT COMPLETED|Overall Study||2
84004|NCT01558297|202385|P1|NOT COMPLETED|Overall Study||2
84005|NCT01558297|202383|P3|COMPLETED|Overall Study||29
84006|NCT01558297|202384|P2|COMPLETED|Overall Study||27
84007|NCT01558297|202385|P1|COMPLETED|Overall Study||28
84008|NCT01558297|202383|P3|STARTED|Overall Study||30
84009|NCT01558297|202384|P2|STARTED|Overall Study||29
84010|NCT01558297|202385|P1|STARTED|Overall Study||30
84011|NCT01558271|202402|P3|NOT COMPLETED|Overall Study||17
84012|NCT01558271|202403|P2|NOT COMPLETED|Overall Study||11
84013|NCT01558271|202404|P1|NOT COMPLETED|Overall Study||18
84014|NCT01558271|202402|P3|COMPLETED|Overall Study||124
84015|NCT01558271|202403|P2|COMPLETED|Overall Study||59
84016|NCT01558271|202404|P1|COMPLETED|Overall Study||263
84017|NCT01558271|202402|P3|Completed 26 Weeks|Overall Study||128
84018|NCT01558271|202403|P2|Completed 26 Weeks|Overall Study||63
84019|NCT01558271|202404|P1|Completed 26 Weeks|Overall Study||271
84020|NCT01558271|202402|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
84021|NCT01558271|202403|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
84022|NCT01558271|202404|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
84023|NCT01558271|202402|P3|STARTED|Overall Study||141
84024|NCT01558271|202403|P2|STARTED|Overall Study||70
84025|NCT01558271|202404|P1|STARTED|Overall Study||281
84026|NCT01558128|202466|P1|NOT COMPLETED|Overall Study||0
84027|NCT01558128|202466|P1|COMPLETED|Overall Study||1
84028|NCT01558128|202466|P1|STARTED|Overall Study||1
84029|NCT01558089|202470|P1|NOT COMPLETED|Overall Study||13
84030|NCT01558089|202470|P1|COMPLETED|Overall Study||63
84031|NCT01558089|202470|P1|STARTED|Overall Study||76
84032|NCT01557959|202481|P1|NOT COMPLETED|Overall Study||0
84033|NCT01557959|202481|P1|COMPLETED|Overall Study||45
84034|NCT01557959|202481|P1|STARTED|Overall Study||45
84035|NCT01557946|202491|P2|NOT COMPLETED|Overall Study||0
84036|NCT01557946|202492|P1|NOT COMPLETED|Overall Study||3
84037|NCT01557946|202491|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
84038|NCT01557946|202492|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
84039|NCT01557946|202491|P2|STARTED|Overall Study||12
84040|NCT01557946|202492|P1|STARTED|Overall Study||20
84041|NCT01557920|202498|P2|NOT COMPLETED|Overall Study||3
84042|NCT01557920|202499|P1|NOT COMPLETED|Overall Study||3
84043|NCT01557920|202498|P2|COMPLETED|Overall Study||6
84044|NCT01557920|202499|P1|COMPLETED|Overall Study||6
84045|NCT01557920|202498|P2|STARTED|Overall Study||9
84046|NCT01557920|202499|P1|STARTED|Overall Study||9
84047|NCT01557894|202534|P2|NOT COMPLETED|Overall Study||5
84048|NCT01557894|202535|P1|NOT COMPLETED|Overall Study||3
84049|NCT01557894|202534|P2|COMPLETED|Overall Study||33
84050|NCT01557894|202535|P1|COMPLETED|Overall Study||35
84051|NCT01557894|202534|P2|STARTED|Overall Study||38
84052|NCT01557894|202535|P1|STARTED|Overall Study||38
84053|NCT01557868|202551|P2|NOT COMPLETED|Overall Study||30
84054|NCT01557868|202552|P1|NOT COMPLETED|Overall Study||27
84055|NCT01557868|202551|P2|COMPLETED|Overall Study||65
84056|NCT01557868|202552|P1|COMPLETED|Overall Study||76
84057|NCT01557868|202551|P2|STARTED|Overall Study||95
84058|NCT01557868|202552|P1|STARTED|Overall Study||103
84059|NCT01557842|202562|P2|NOT COMPLETED|Overall Study||6
84060|NCT01557842|202563|P1|NOT COMPLETED|Overall Study||9
84061|NCT01557842|202562|P2|COMPLETED|Overall Study||0
84062|NCT01557842|202563|P1|COMPLETED|Overall Study||0
84063|NCT01557842|202562|P2|STARTED|Overall Study||6
84064|NCT01557842|202563|P1|STARTED|Overall Study||9
84065|NCT01557751|202571|P1|NOT COMPLETED|Overall Study||3
84066|NCT01557751|202571|P1|COMPLETED|Overall Study||153
84067|NCT01557751|202571|P1|STARTED|Overall Study||156
84068|NCT01557699|202578|P3|NOT COMPLETED|Overall Study||0
84069|NCT01557699|202579|P2|NOT COMPLETED|Overall Study||0
84070|NCT01557699|202580|P1|NOT COMPLETED|Overall Study||0
84071|NCT01557699|202578|P3|COMPLETED|Overall Study||20
84072|NCT01557699|202579|P2|COMPLETED|Overall Study||20
84073|NCT01557699|202580|P1|COMPLETED|Overall Study||20
84074|NCT01557699|202578|P3|STARTED|Overall Study||20
84075|NCT01557699|202579|P2|STARTED|Overall Study||20
84076|NCT01557699|202580|P1|STARTED|Overall Study||20
84077|NCT01557595|202612|P1|NOT COMPLETED|Overall Study||8
84078|NCT01557595|202612|P1|COMPLETED|Overall Study||14
84079|NCT01557595|202612|P1|STARTED|Overall Study||22
84080|NCT01557582|202616|P1|NOT COMPLETED|Overall Study||6
84081|NCT01557582|202616|P1|COMPLETED|Overall Study||97
84082|NCT01557582|202616|P1|STARTED|Overall Study||103
84083|NCT01557569|202624|P2|NOT COMPLETED|Overall Study||7
84084|NCT01557569|202625|P1|NOT COMPLETED|Overall Study||5
84085|NCT01557569|202624|P2|COMPLETED|Overall Study||0
84086|NCT01557569|202625|P1|COMPLETED|Overall Study||1
84087|NCT01557569|202624|P2|Completed 2-wk Residential Stay|Overall Study||1
84088|NCT01557569|202625|P1|Completed 2-wk Residential Stay|Overall Study||3
84089|NCT01557569|202624|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
84090|NCT01557569|202625|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
84091|NCT01557504|202633|P2|NOT COMPLETED|Overall Study||0
84092|NCT01557504|202634|P1|NOT COMPLETED|Overall Study||1
84093|NCT01557504|202633|P2|COMPLETED|Overall Study||12
84094|NCT01557504|202634|P1|COMPLETED|Overall Study||12
84095|NCT01557504|202633|P2|STARTED|Overall Study||12
84096|NCT01557504|202634|P1|STARTED|Overall Study||13
84097|NCT01557348|202659|P2|NOT COMPLETED|Overall Study||90
84098|NCT01557348|202660|P1|NOT COMPLETED|Overall Study||80
84099|NCT01557348|202659|P2|COMPLETED|Overall Study||417
84100|NCT01557348|202660|P1|COMPLETED|Overall Study||524
84101|NCT01557348|202659|P2|Safety Population|Overall Study||507
84102|NCT01557348|202660|P1|Safety Population|Overall Study||604
84103|NCT01557348|202659|P2|STARTED|Overall Study||507
84104|NCT01557348|202660|P1|STARTED|Overall Study||604
84105|NCT01557322|202702|P2|NOT COMPLETED|Overall Study||0
84106|NCT01557322|202703|P1|NOT COMPLETED|Overall Study||0
84107|NCT01557322|202702|P2|COMPLETED|Overall Study||1543
84108|NCT01557322|202703|P1|COMPLETED|Overall Study||211
84109|NCT01557322|202702|P2|STARTED|Overall Study||1543
84110|NCT01557322|202703|P1|STARTED|Overall Study||211
84111|NCT01557283|202777|P1|NOT COMPLETED|Overall Study||44
84112|NCT01557283|202777|P1|COMPLETED|Overall Study||96
84113|NCT01557283|202777|P1|STARTED|Overall Study||140
84114|NCT01557166|202789|P2|NOT COMPLETED|Overall Study||37
84115|NCT01557166|202790|P1|NOT COMPLETED|Overall Study||46
84116|NCT01557166|202789|P2|COMPLETED|Overall Study||142
84117|NCT01557166|202790|P1|COMPLETED|Overall Study||134
84118|NCT01557166|202789|P2|Exposed|Overall Study||179
84119|NCT01557166|202790|P1|Exposed|Overall Study||176
84120|NCT01557166|202789|P2|STARTED|Overall Study||179
84121|NCT01557166|202790|P1|STARTED|Overall Study||180
84122|NCT01556997|202805|P3|NOT COMPLETED|Overall Study||32
84123|NCT01556997|202806|P2|NOT COMPLETED|Overall Study||28
84124|NCT01556997|202807|P1|NOT COMPLETED|Overall Study||26
84125|NCT01556997|202805|P3|COMPLETED|Overall Study||246
84126|NCT01556997|202806|P2|COMPLETED|Overall Study||252
84127|NCT01556997|202807|P1|COMPLETED|Overall Study||253
84128|NCT01556997|202805|P3|STARTED|Overall Study||278
84129|NCT01556997|202806|P2|STARTED|Overall Study||280
84130|NCT01556997|202807|P1|STARTED|Overall Study||279
84131|NCT01556932|202818|P2|NOT COMPLETED|Second Treament||0
84132|NCT01556932|202819|P1|NOT COMPLETED|Second Treament||0
84133|NCT01556932|202818|P2|COMPLETED|Second Treament||8
84134|NCT01556932|202819|P1|COMPLETED|Second Treament||12
84135|NCT01556932|202818|P2|Recieved|Second Treament||8
84136|NCT01556932|202819|P1|Recieved|Second Treament||12
84137|NCT01556932|202818|P2|STARTED|Second Treament||8
84138|NCT01556932|202819|P1|STARTED|Second Treament||12
84139|NCT01556932|202818|P2|NOT COMPLETED|Time Point 60 Minutes||1
84140|NCT01556932|202819|P1|NOT COMPLETED|Time Point 60 Minutes||1
84141|NCT01556932|202818|P2|COMPLETED|Time Point 60 Minutes||8
84142|NCT01556932|202819|P1|COMPLETED|Time Point 60 Minutes||12
84143|NCT01556932|202818|P2|Recieved|Time Point 60 Minutes||8
84144|NCT01556932|202819|P1|Recieved|Time Point 60 Minutes||12
84145|NCT01556932|202818|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
84146|NCT01556932|202819|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
84147|NCT01556932|202818|P2|NOT COMPLETED|Baseline First Treatment||0
84148|NCT01556932|202819|P1|NOT COMPLETED|Baseline First Treatment||0
84149|NCT01556932|202818|P2|COMPLETED|Baseline First Treatment||9
84150|NCT01556932|202819|P1|COMPLETED|Baseline First Treatment||13
84151|NCT01556932|202818|P2|Recieved|Baseline First Treatment||9
84152|NCT01556932|202819|P1|Recieved|Baseline First Treatment||13
84153|NCT01556932|202818|P2|STARTED|Baseline First Treatment||9
84154|NCT01556932|202819|P1|STARTED|Baseline First Treatment||13
84155|NCT01556906|202824|P1|NOT COMPLETED|Overall Study||0
84156|NCT01556906|202824|P1|COMPLETED|Overall Study||6
84157|NCT01556906|202824|P1|STARTED|Overall Study||6
84158|NCT01556763|202845|P3|NOT COMPLETED|Overall Study||0
84159|NCT01556763|202846|P2|NOT COMPLETED|Overall Study||1
84160|NCT01556763|202847|P1|NOT COMPLETED|Overall Study||0
84161|NCT01556763|202845|P3|COMPLETED|Overall Study||8
84162|NCT01556763|202846|P2|COMPLETED|Overall Study||8
84163|NCT01556763|202847|P1|COMPLETED|Overall Study||4
84164|NCT01556763|202845|P3|STARTED|Overall Study||8
84165|NCT01556763|202846|P2|STARTED|Overall Study||9
84166|NCT01556763|202847|P1|STARTED|Overall Study||4
84167|NCT01556724|202885|P2|NOT COMPLETED|Overall Study||0
84168|NCT01556724|202886|P1|NOT COMPLETED|Overall Study||0
84169|NCT01556724|202885|P2|COMPLETED|Overall Study||14
84170|NCT01556724|202886|P1|COMPLETED|Overall Study||16
84171|NCT01556724|202885|P2|STARTED|Overall Study||14
84172|NCT01556724|202886|P1|STARTED|Overall Study||16
84173|NCT01556633|202902|P2|NOT COMPLETED|Overall Study||0
84174|NCT01556633|202903|P1|NOT COMPLETED|Overall Study||0
84175|NCT01556633|202902|P2|COMPLETED|Overall Study||6
84176|NCT01556633|202903|P1|COMPLETED|Overall Study||10
84177|NCT01556633|202902|P2|STARTED|Overall Study||6
84178|NCT01556633|202903|P1|STARTED|Overall Study||10
84179|NCT01556594|202928|P3|NOT COMPLETED|Overall Study||0
84180|NCT01556594|202929|P2|NOT COMPLETED|Overall Study||0
84181|NCT01556594|202930|P1|NOT COMPLETED|Overall Study||0
84182|NCT01556594|202928|P3|COMPLETED|Overall Study||6
84183|NCT01556594|202929|P2|COMPLETED|Overall Study||2
84184|NCT01556594|202930|P1|COMPLETED|Overall Study||10
84185|NCT01556594|202928|P3|STARTED|Overall Study||6
84186|NCT01556594|202929|P2|STARTED|Overall Study||2
84187|NCT01556594|202930|P1|STARTED|Overall Study||10
84188|NCT01556451|202948|P1|NOT COMPLETED|Overall Study||0
84189|NCT01556451|202948|P1|COMPLETED|Overall Study||180
84190|NCT01556451|202948|P1|STARTED|Overall Study||180
84191|NCT01556425|202959|P4|NOT COMPLETED|Overall Study||0
84192|NCT01556425|202960|P3|NOT COMPLETED|Overall Study||0
84193|NCT01556425|202961|P2|NOT COMPLETED|Overall Study||0
84194|NCT01556425|202962|P1|NOT COMPLETED|Overall Study||0
84195|NCT01556425|202959|P4|COMPLETED|Overall Study||18
84196|NCT01556425|202960|P3|COMPLETED|Overall Study||18
84197|NCT01556425|202961|P2|COMPLETED|Overall Study||23
84198|NCT01556425|202962|P1|COMPLETED|Overall Study||25
84199|NCT01556425|202959|P4|STARTED|Overall Study||18
84200|NCT01556425|202960|P3|STARTED|Overall Study||18
84201|NCT01556425|202961|P2|STARTED|Overall Study||23
84202|NCT01556425|202962|P1|STARTED|Overall Study||25
84203|NCT01556204|202978|P2|NOT COMPLETED|Overall Study||0
84204|NCT01556204|202979|P1|NOT COMPLETED|Overall Study||0
84205|NCT01556204|202978|P2|COMPLETED|Overall Study||38
84206|NCT01556204|202979|P1|COMPLETED|Overall Study||35
84207|NCT01556204|202978|P2|STARTED|Overall Study||38
84208|NCT01556204|202979|P1|STARTED|Overall Study||35
84209|NCT01556165|202989|P2|NOT COMPLETED|Overall Study||7
84210|NCT01556165|202990|P1|NOT COMPLETED|Overall Study||12
84211|NCT01556165|202989|P2|COMPLETED|Overall Study||58
84212|NCT01556165|202990|P1|COMPLETED|Overall Study||53
84213|NCT01556165|202989|P2|STARTED|Overall Study||65
84214|NCT01556165|202990|P1|STARTED|Overall Study||65
84215|NCT01556100|203002|P1|NOT COMPLETED|Overall Study||6
84216|NCT01556100|203002|P1|COMPLETED|Overall Study||34
84217|NCT01556100|203002|P1|STARTED|Overall Study||40
84218|NCT01556061|203009|P2|NOT COMPLETED|Overall Study||0
84219|NCT01556061|203010|P1|NOT COMPLETED|Overall Study||0
84220|NCT01556061|203009|P2|COMPLETED|Overall Study||25
84221|NCT01556061|203010|P1|COMPLETED|Overall Study||25
84222|NCT01556061|203009|P2|STARTED|Overall Study||25
84223|NCT01556061|203010|P1|STARTED|Overall Study||25
84224|NCT01555983|203020|P6|NOT COMPLETED|Overall Study||1
84225|NCT01555983|203021|P5|NOT COMPLETED|Overall Study||1
84226|NCT01555983|203022|P4|NOT COMPLETED|Overall Study||0
84227|NCT01555983|203023|P3|NOT COMPLETED|Overall Study||0
84228|NCT01555983|203024|P2|NOT COMPLETED|Overall Study||0
84229|NCT01555983|203025|P1|NOT COMPLETED|Overall Study||1
84230|NCT01555983|203020|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
84231|NCT01555983|203021|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
84232|NCT01555983|203022|P4|COMPLETED|Overall Study||7
84233|NCT01555983|203023|P3|COMPLETED|Overall Study||7
84234|NCT01555983|203024|P2|COMPLETED|Overall Study||7
84235|NCT01555983|203025|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
84236|NCT01555983|203020|P6|STARTED|Overall Study||7
84237|NCT01555983|203021|P5|STARTED|Overall Study||5
84238|NCT01555983|203022|P4|STARTED|Overall Study||7
84239|NCT01555983|203023|P3|STARTED|Overall Study||7
84240|NCT01555983|203024|P2|STARTED|Overall Study||7
84241|NCT01555983|203025|P1|STARTED|Overall Study||9
84242|NCT01555931|203035|P2|NOT COMPLETED|Overall Study||5
84243|NCT01555931|203036|P1|NOT COMPLETED|Overall Study||2
84244|NCT01555931|203035|P2|COMPLETED|Overall Study||13
84245|NCT01555931|203036|P1|COMPLETED|Overall Study||15
84246|NCT01555931|203035|P2|STARTED|Overall Study||18
84247|NCT01555931|203036|P1|STARTED|Overall Study||17
84248|NCT01555567|203048|P4|NOT COMPLETED|Return to Activity||1
84249|NCT01555567|203049|P3|NOT COMPLETED|Return to Activity||0
84250|NCT01555567|203050|P2|NOT COMPLETED|Return to Activity||2
84251|NCT01555567|203051|P1|NOT COMPLETED|Return to Activity||1
84252|NCT01555567|203048|P4|COMPLETED|Return to Activity||8
84253|NCT01555567|203049|P3|COMPLETED|Return to Activity||8
84254|NCT01555567|203050|P2|COMPLETED|Return to Activity||10
84255|NCT01555567|203051|P1|COMPLETED|Return to Activity||10
84256|NCT01555567|203048|P4|STARTED|Return to Activity||9
84257|NCT01555567|203049|P3|STARTED|Return to Activity||8
84258|NCT01555567|203050|P2|STARTED|Return to Activity||12
84259|NCT01555567|203051|P1|STARTED|Return to Activity||11
84260|NCT01555567|203048|P4|NOT COMPLETED|12 Week||0
84261|NCT01555567|203049|P3|NOT COMPLETED|12 Week||1
84262|NCT01555567|203050|P2|NOT COMPLETED|12 Week||1
84263|NCT01555567|203051|P1|NOT COMPLETED|12 Week||1
84264|NCT01555567|203048|P4|COMPLETED|12 Week||9
84265|NCT01555567|203049|P3|COMPLETED|12 Week||8
84266|NCT01555567|203050|P2|COMPLETED|12 Week||12
84267|NCT01555567|203051|P1|COMPLETED|12 Week||11
84268|NCT01555567|203048|P4|STARTED|12 Week||9
84269|NCT01555567|203049|P3|STARTED|12 Week||9
84270|NCT01555567|203050|P2|STARTED|12 Week||13
84271|NCT01555567|203051|P1|STARTED|12 Week||12
84272|NCT01555463|203067|P2|NOT COMPLETED|Follow up||45
84273|NCT01555463|203068|P1|NOT COMPLETED|Follow up||38
84274|NCT01555463|203067|P2|COMPLETED|Follow up||394
84275|NCT01555463|203068|P1|COMPLETED|Follow up||409
84276|NCT01555463|203067|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
84277|NCT01555463|203068|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
84278|NCT01555463|203067|P2|NOT COMPLETED|Treatment||79
84279|NCT01555463|203068|P1|NOT COMPLETED|Treatment||64
84280|NCT01555463|203067|P2|COMPLETED|Treatment||399
84281|NCT01555463|203068|P1|COMPLETED|Treatment||419
84282|NCT01555463|203067|P2|STARTED|Treatment||478
84283|NCT01555463|203068|P1|STARTED|Treatment||483
84284|NCT01555164|203110|P2|NOT COMPLETED|Overall Study||35
84285|NCT01555164|203111|P1|NOT COMPLETED|Overall Study||40
84286|NCT01555164|203110|P2|COMPLETED|Overall Study||185
84287|NCT01555164|203111|P1|COMPLETED|Overall Study||182
84288|NCT01555164|203110|P2|STARTED|Overall Study||220
84289|NCT01555164|203111|P1|STARTED|Overall Study||222
84290|NCT01555151|203125|P4|NOT COMPLETED|Overall Study||10
84291|NCT01555151|203126|P3|NOT COMPLETED|Overall Study||6
84292|NCT01555151|203127|P2|NOT COMPLETED|Overall Study||8
84293|NCT01555151|203128|P1|NOT COMPLETED|Overall Study||13
84294|NCT01555151|203125|P4|COMPLETED|Overall Study||176
84295|NCT01555151|203126|P3|COMPLETED|Overall Study||178
84296|NCT01555151|203127|P2|COMPLETED|Overall Study||173
84297|NCT01555151|203128|P1|COMPLETED|Overall Study||175
84298|NCT01555151|203125|P4|Safety Set (SAF)|Overall Study||186
84299|NCT01555151|203126|P3|Safety Set (SAF)|Overall Study||183
84300|NCT01555151|203127|P2|Safety Set (SAF)|Overall Study||180
84301|NCT01555151|203128|P1|Safety Set (SAF)|Overall Study||186
84302|NCT01555151|203125|P4|STARTED|Overall Study||186
84303|NCT01555151|203126|P3|STARTED|Overall Study||184
84304|NCT01555151|203127|P2|STARTED|Overall Study||181
84305|NCT01555151|203128|P1|STARTED|Overall Study||188
84306|NCT01555138|203181|P2|NOT COMPLETED|Overall Study||38
84307|NCT01555138|203182|P1|NOT COMPLETED|Overall Study||47
84308|NCT01555138|203181|P2|COMPLETED|Overall Study||250
84309|NCT01555138|203182|P1|COMPLETED|Overall Study||246
84310|NCT01555138|203181|P2|STARTED|Overall Study||288
84311|NCT01555138|203182|P1|STARTED|Overall Study||293
84312|NCT01555073|203212|P4|NOT COMPLETED|Overall Study||5
84313|NCT01555073|203213|P3|NOT COMPLETED|Overall Study||0
84314|NCT01555073|203214|P2|NOT COMPLETED|Overall Study||2
84315|NCT01555073|203215|P1|NOT COMPLETED|Overall Study||1
84316|NCT01555073|203212|P4|COMPLETED|Overall Study||1
84317|NCT01555073|203213|P3|COMPLETED|Overall Study||7
84318|NCT01555073|203214|P2|COMPLETED|Overall Study||1
84319|NCT01555073|203215|P1|COMPLETED|Overall Study||6
84320|NCT01555073|203212|P4|STARTED|Overall Study||6
84321|NCT01555073|203213|P3|STARTED|Overall Study||7
84322|NCT01555073|203214|P2|STARTED|Overall Study||3
84323|NCT01555073|203215|P1|STARTED|Overall Study||7
84324|NCT01554982|203229|P1|NOT COMPLETED|Overall Study||43
84325|NCT01554982|203229|P1|COMPLETED|Overall Study||125
84326|NCT01554982|203229|P1|Received Drug|Overall Study||166
84327|NCT01554982|203229|P1|STARTED|Overall Study||168
84328|NCT01554904|203242|P1|NOT COMPLETED|Overall Study||4
84329|NCT01554904|203242|P1|COMPLETED|Overall Study||14
84330|NCT01554904|203242|P1|Home Sleep Study 2|Overall Study||14
84331|NCT01554904|203242|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
84332|NCT01554904|203242|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
84333|NCT01554904|203242|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
84334|NCT01554904|203242|P1|STARTED|Overall Study||18
84335|NCT01554891|203250|P3|NOT COMPLETED|Overall Study||2
84336|NCT01554891|203251|P2|NOT COMPLETED|Overall Study||5
84337|NCT01554891|203252|P1|NOT COMPLETED|Overall Study||7
84338|NCT01554891|203250|P3|COMPLETED|Overall Study||55
84339|NCT01554891|203251|P2|COMPLETED|Overall Study||115
84340|NCT01554891|203252|P1|COMPLETED|Overall Study||98
84341|NCT01554891|203250|P3|STARTED|Overall Study||57
84342|NCT01554891|203251|P2|STARTED|Overall Study||120
84343|NCT01554891|203252|P1|STARTED|Overall Study||105
84344|NCT01554579|203262|P2|NOT COMPLETED|Overall Study||27
84345|NCT01554579|203263|P1|NOT COMPLETED|Overall Study||10
84346|NCT01554579|203262|P2|COMPLETED|Overall Study||58
84347|NCT01554579|203263|P1|COMPLETED|Overall Study||76
84348|NCT01554579|203262|P2|STARTED|Overall Study||85
84349|NCT01554579|203263|P1|STARTED|Overall Study||86
84350|NCT01554241|203277|P4|NOT COMPLETED|Overall Study||1
84351|NCT01554241|203278|P3|NOT COMPLETED|Overall Study||4
84352|NCT01554241|203279|P2|NOT COMPLETED|Overall Study||1
84353|NCT01554241|203280|P1|NOT COMPLETED|Overall Study||3
84354|NCT01554241|203277|P4|COMPLETED|Overall Study||13
84355|NCT01554241|203278|P3|COMPLETED|Overall Study||20
84356|NCT01554241|203279|P2|COMPLETED|Overall Study||19
84357|NCT01554241|203280|P1|COMPLETED|Overall Study||20
84358|NCT01554241|203277|P4|STARTED|Overall Study||14
84359|NCT01554241|203278|P3|STARTED|Overall Study||24
84360|NCT01554241|203279|P2|STARTED|Overall Study||20
84361|NCT01554241|203280|P1|STARTED|Overall Study||23
84362|NCT01554176|203296|P5|NOT COMPLETED|Run-out Phase||0
84363|NCT01554176|203297|P4|NOT COMPLETED|Run-out Phase||1
84364|NCT01554176|203298|P3|NOT COMPLETED|Run-out Phase||0
84365|NCT01554176|203299|P2|NOT COMPLETED|Run-out Phase||0
84366|NCT01554176|203300|P1|NOT COMPLETED|Run-out Phase||0
84367|NCT01554176|203296|P5|COMPLETED|Run-out Phase||59
84368|NCT01554176|203297|P4|COMPLETED|Run-out Phase||27
84369|NCT01554176|203298|P3|COMPLETED|Run-out Phase||29
84370|NCT01554176|203299|P2|COMPLETED|Run-out Phase||0
84371|NCT01554176|203300|P1|COMPLETED|Run-out Phase||0
84372|NCT01554176|203296|P5|Treated|Run-out Phase||59
84373|NCT01554176|203297|P4|Treated|Run-out Phase||28
84374|NCT01554176|203298|P3|Treated|Run-out Phase||29
84375|NCT01554176|203299|P2|Treated|Run-out Phase||0
84376|NCT01554176|203300|P1|Treated|Run-out Phase||0
84377|NCT01554176|203296|P5|STARTED|Run-out Phase||59
84378|NCT01554176|203297|P4|STARTED|Run-out Phase||28
84379|NCT01554176|203298|P3|STARTED|Run-out Phase||29
84380|NCT01554176|203299|P2|STARTED|Run-out Phase||0
84381|NCT01554176|203300|P1|STARTED|Run-out Phase||0
84382|NCT01554176|203296|P5|NOT COMPLETED|Treatment Phase||0
84383|NCT01554176|203297|P4|NOT COMPLETED|Treatment Phase||0
84384|NCT01554176|203298|P3|NOT COMPLETED|Treatment Phase||0
84385|NCT01554176|203299|P2|NOT COMPLETED|Treatment Phase||5
84386|NCT01554176|203300|P1|NOT COMPLETED|Treatment Phase||8
84387|NCT01554176|203296|P5|COMPLETED|Treatment Phase||0
84388|NCT01554176|203297|P4|COMPLETED|Treatment Phase||0
84389|NCT01554176|203298|P3|COMPLETED|Treatment Phase||0
84390|NCT01554176|203299|P2|COMPLETED|Treatment Phase||59
84391|NCT01554176|203300|P1|COMPLETED|Treatment Phase||57
84392|NCT01554176|203296|P5|Treated|Treatment Phase||0
84393|NCT01554176|203297|P4|Treated|Treatment Phase||0
84394|NCT01554176|203298|P3|Treated|Treatment Phase||0
84395|NCT01554176|203299|P2|Treated|Treatment Phase||64
84396|NCT01554176|203300|P1|Treated|Treatment Phase||64
84397|NCT01554176|203296|P5|STARTED|Treatment Phase||0
84398|NCT01554176|203297|P4|STARTED|Treatment Phase||0
84399|NCT01554176|203298|P3|STARTED|Treatment Phase||0
84400|NCT01554176|203299|P2|STARTED|Treatment Phase||64
84401|NCT01554176|203300|P1|STARTED|Treatment Phase||65
84402|NCT01554163|203327|P2|NOT COMPLETED|Overall Study||10
84403|NCT01554163|203328|P1|NOT COMPLETED|Overall Study||8
84404|NCT01554163|203327|P2|COMPLETED|Overall Study||109
84405|NCT01554163|203328|P1|COMPLETED|Overall Study||112
84406|NCT01554163|203327|P2|Number Treated|Overall Study||119
84407|NCT01554163|203328|P1|Number Treated|Overall Study||119
84408|NCT01554163|203327|P2|STARTED|Overall Study||119
84409|NCT01554163|203328|P1|STARTED|Overall Study||120
84410|NCT01553916|203346|P1|NOT COMPLETED|Overall Study||3
84411|NCT01553916|203346|P1|COMPLETED|Overall Study||16
84412|NCT01553916|203346|P1|STARTED|Overall Study||19
84413|NCT01553851|203359|P1|NOT COMPLETED|Overall Study||3
84414|NCT01553851|203359|P1|COMPLETED|Overall Study||17
84415|NCT01553851|203359|P1|STARTED|Overall Study||20
84416|NCT01553708|203373|P2|NOT COMPLETED|Overall Study||0
84417|NCT01553708|203374|P1|NOT COMPLETED|Overall Study||0
84418|NCT01553708|203373|P2|COMPLETED|Overall Study||17
84419|NCT01553708|203374|P1|COMPLETED|Overall Study||17
84420|NCT01553708|203373|P2|STARTED|Overall Study||17
84421|NCT01553708|203374|P1|STARTED|Overall Study||17
84422|NCT01553539|203380|P1|NOT COMPLETED|Overall Study||0
84423|NCT01553539|203380|P1|COMPLETED|Overall Study||20
84424|NCT01553539|203380|P1|STARTED|Overall Study||20
84425|NCT01553318|203390|P2|NOT COMPLETED|Overall Study||2
84426|NCT01553318|203391|P1|NOT COMPLETED|Overall Study||3
84427|NCT01553318|203390|P2|COMPLETED|Overall Study||25
84428|NCT01553318|203391|P1|COMPLETED|Overall Study||21
84429|NCT01553318|203390|P2|STARTED|Overall Study||27
84430|NCT01553318|203391|P1|STARTED|Overall Study||24
84431|NCT01553292|203403|P1|NOT COMPLETED|Overall Study||0
84432|NCT01553292|203403|P1|COMPLETED|Overall Study||21
84433|NCT01553292|203403|P1|STARTED|Overall Study||21
84434|NCT01553240|203419|P1|NOT COMPLETED|Overall Study||0
84435|NCT01553240|203419|P1|COMPLETED|Overall Study||0
84436|NCT01553240|203419|P1|STARTED|Overall Study||0
84437|NCT01553136|203426|P2|NOT COMPLETED|Overall Study||22
84438|NCT01553136|203427|P1|NOT COMPLETED|Overall Study||16
84439|NCT01553136|203426|P2|COMPLETED|Overall Study||45
84440|NCT01553136|203427|P1|COMPLETED|Overall Study||48
84441|NCT01553136|203426|P2|Completed Treatment|Overall Study||50
84442|NCT01553136|203427|P1|Completed Treatment|Overall Study||55
84443|NCT01553136|203426|P2|STARTED|Overall Study||67
84444|NCT01553136|203427|P1|STARTED|Overall Study||64
84445|NCT01553058|203444|P3|NOT COMPLETED|Overall Study||3
84446|NCT01553058|203445|P2|NOT COMPLETED|Overall Study||1
84447|NCT01553058|203446|P1|NOT COMPLETED|Overall Study||1
84448|NCT01553058|203444|P3|COMPLETED|Overall Study||30
84449|NCT01553058|203445|P2|COMPLETED|Overall Study||30
84450|NCT01553058|203446|P1|COMPLETED|Overall Study||32
84451|NCT01553058|203444|P3|STARTED|Overall Study||33
84452|NCT01553058|203445|P2|STARTED|Overall Study||31
84453|NCT01553058|203446|P1|STARTED|Overall Study||33
84454|NCT01552954|203507|P2|NOT COMPLETED|Overall Study||6
84455|NCT01552954|203508|P1|NOT COMPLETED|Overall Study||5
84456|NCT01552954|203507|P2|COMPLETED|Overall Study||119
84457|NCT01552954|203508|P1|COMPLETED|Overall Study||126
84458|NCT01552954|203507|P2|STARTED|Overall Study||125
84459|NCT01552954|203508|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
84460|NCT01552928|203524|P4|NOT COMPLETED|Period 4||0
84461|NCT01552928|203525|P3|NOT COMPLETED|Period 4||0
84462|NCT01552928|203526|P2|NOT COMPLETED|Period 4||0
84463|NCT01552928|203527|P1|NOT COMPLETED|Period 4||0
84464|NCT01552928|203524|P4|COMPLETED|Period 4||16
84465|NCT01552928|203525|P3|COMPLETED|Period 4||14
84466|NCT01552928|203526|P2|COMPLETED|Period 4||15
84467|NCT01552928|203527|P1|COMPLETED|Period 4||14
84468|NCT01552928|203524|P4|STARTED|Period 4||16
84469|NCT01552928|203525|P3|STARTED|Period 4||14
84470|NCT01552928|203526|P2|STARTED|Period 4||15
84471|NCT01552928|203527|P1|STARTED|Period 4||14
84472|NCT01552928|203524|P4|NOT COMPLETED|Period 3||0
84473|NCT01552928|203525|P3|NOT COMPLETED|Period 3||1
84474|NCT01552928|203526|P2|NOT COMPLETED|Period 3||0
84475|NCT01552928|203527|P1|NOT COMPLETED|Period 3||0
84476|NCT01552928|203524|P4|COMPLETED|Period 3||16
84477|NCT01552928|203525|P3|COMPLETED|Period 3||14
84478|NCT01552928|203526|P2|COMPLETED|Period 3||15
84479|NCT01552928|203527|P1|COMPLETED|Period 3||14
84480|NCT01552928|203524|P4|STARTED|Period 3||16
84481|NCT01552928|203525|P3|STARTED|Period 3||15
84482|NCT01552928|203526|P2|STARTED|Period 3||15
84483|NCT01552928|203527|P1|STARTED|Period 3||14
84484|NCT01552928|203524|P4|NOT COMPLETED|Period 2||0
84485|NCT01552928|203525|P3|NOT COMPLETED|Period 2||0
84486|NCT01552928|203526|P2|NOT COMPLETED|Period 2||0
84487|NCT01552928|203527|P1|NOT COMPLETED|Period 2||0
84488|NCT01552928|203524|P4|COMPLETED|Period 2||16
84489|NCT01552928|203525|P3|COMPLETED|Period 2||15
84490|NCT01552928|203526|P2|COMPLETED|Period 2||15
84491|NCT01552928|203527|P1|COMPLETED|Period 2||14
84492|NCT01552928|203524|P4|STARTED|Period 2||16
84493|NCT01552928|203525|P3|STARTED|Period 2||15
84494|NCT01552928|203526|P2|STARTED|Period 2||15
84495|NCT01552928|203527|P1|STARTED|Period 2||14
84496|NCT01552928|203524|P4|NOT COMPLETED|Period 1||0
84497|NCT01552928|203525|P3|NOT COMPLETED|Period 1||0
84498|NCT01552928|203526|P2|NOT COMPLETED|Period 1||0
84499|NCT01552928|203527|P1|NOT COMPLETED|Period 1||0
84500|NCT01552928|203524|P4|COMPLETED|Period 1||16
84501|NCT01552928|203525|P3|COMPLETED|Period 1||15
84502|NCT01552928|203526|P2|COMPLETED|Period 1||15
84503|NCT01552928|203527|P1|COMPLETED|Period 1||14
84504|NCT01552928|203524|P4|STARTED|Period 1||16
84505|NCT01552928|203525|P3|STARTED|Period 1||15
84506|NCT01552928|203526|P2|STARTED|Period 1||15
84507|NCT01552928|203527|P1|STARTED|Period 1||14
84508|NCT01552915|203574|P3|NOT COMPLETED|Overall Study||27
84509|NCT01552915|203575|P2|NOT COMPLETED|Overall Study||29
84510|NCT01552915|203576|P1|NOT COMPLETED|Overall Study||23
84511|NCT01552915|203574|P3|COMPLETED|Overall Study||157
84512|NCT01552915|203575|P2|COMPLETED|Overall Study||155
84513|NCT01552915|203576|P1|COMPLETED|Overall Study||68
84514|NCT01552915|203574|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
84515|NCT01552915|203575|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
84516|NCT01552915|203576|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
84517|NCT01552902|203599|P3|NOT COMPLETED|Overall Study||33
84518|NCT01552902|203600|P2|NOT COMPLETED|Overall Study||37
84519|NCT01552902|203601|P1|NOT COMPLETED|Overall Study||13
84520|NCT01552902|203599|P3|COMPLETED|Overall Study||186
84521|NCT01552902|203600|P2|COMPLETED|Overall Study||181
84522|NCT01552902|203601|P1|COMPLETED|Overall Study||97
84523|NCT01552902|203599|P3|STARTED|Overall Study||219
84524|NCT01552902|203600|P2|STARTED|Overall Study||218
84525|NCT01552902|203601|P1|STARTED|Overall Study||110
84526|NCT01552889|203623|P2|NOT COMPLETED|Overall Study||5
84527|NCT01552889|203624|P1|NOT COMPLETED|Overall Study||11
84528|NCT01552889|203623|P2|COMPLETED|Overall Study||95
84529|NCT01552889|203624|P1|COMPLETED|Overall Study||90
84530|NCT01552889|203623|P2|STARTED|Overall Study||100
84531|NCT01552889|203624|P1|STARTED|Overall Study||101
84532|NCT01552876|203634|P2|NOT COMPLETED|Overall Study||0
84533|NCT01552876|203635|P1|NOT COMPLETED|Overall Study||0
84534|NCT01552876|203634|P2|COMPLETED|Overall Study||20
84535|NCT01552876|203635|P1|COMPLETED|Overall Study||20
84536|NCT01552876|203634|P2|STARTED|Overall Study||20
84537|NCT01552876|203635|P1|STARTED|Overall Study||20
84538|NCT01552772|203651|P1|NOT COMPLETED|Overall Study||4
84539|NCT01552772|203651|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
84540|NCT01552772|203651|P1|STARTED|Overall Study||60
84541|NCT01552694|203667|P2|NOT COMPLETED|Overall Study||2
84542|NCT01552694|203668|P1|NOT COMPLETED|Overall Study||0
84543|NCT01552694|203667|P2|COMPLETED|Overall Study||18
84544|NCT01552694|203668|P1|COMPLETED|Overall Study||18
84545|NCT01552694|203667|P2|STARTED|Overall Study||20
84546|NCT01552694|203668|P1|STARTED|Overall Study||18
84547|NCT01552681|203684|P2|NOT COMPLETED|Overall Study||1
84548|NCT01552681|203685|P1|NOT COMPLETED|Overall Study||5
84549|NCT01552681|203684|P2|COMPLETED|Overall Study||18
84550|NCT01552681|203685|P1|COMPLETED|Overall Study||28
84551|NCT01552681|203684|P2|STARTED|Overall Study||19
84552|NCT01552681|203685|P1|STARTED|Overall Study||33
84553|NCT01552603|203733|P1|NOT COMPLETED|Overall Study||1
84554|NCT01552603|203733|P1|COMPLETED|Overall Study||13
84555|NCT01552603|203733|P1|STARTED|Overall Study||14
84556|NCT01552343|203740|P2|NOT COMPLETED|Overall Study||0
84557|NCT01552343|203741|P1|NOT COMPLETED|Overall Study||0
84558|NCT01552343|203740|P2|COMPLETED|Overall Study||27
84559|NCT01552343|203741|P1|COMPLETED|Overall Study||29
84560|NCT01552343|203740|P2|STARTED|Overall Study||27
84561|NCT01552343|203741|P1|STARTED|Overall Study||29
84562|NCT01552057|203764|P2|NOT COMPLETED|Overall Study||48
84563|NCT01552057|203765|P1|NOT COMPLETED|Overall Study||30
84564|NCT01552057|203764|P2|COMPLETED|Overall Study||149
84565|NCT01552057|203765|P1|COMPLETED|Overall Study||166
84566|NCT01552057|203764|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
84567|NCT01552057|203765|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
84568|NCT01552057|203764|P2|STARTED|Overall Study||197
84569|NCT01552057|203765|P1|STARTED|Overall Study||196
84570|NCT01551979|203799|P2|NOT COMPLETED|Overall Study||2
84571|NCT01551979|203800|P1|NOT COMPLETED|Overall Study||2
84572|NCT01551979|203799|P2|COMPLETED|Overall Study||5
84573|NCT01551979|203800|P1|COMPLETED|Overall Study||8
84574|NCT01551979|203799|P2|1 Week Post Treatment|Overall Study||6
84575|NCT01551979|203800|P1|1 Week Post Treatment|Overall Study||10
84576|NCT01551979|203799|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
84577|NCT01551979|203800|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
84578|NCT01551979|203799|P2|STARTED|Overall Study||7
84579|NCT01551979|203800|P1|STARTED|Overall Study||10
84580|NCT01551888|203816|P2|NOT COMPLETED|Period 2||0
84581|NCT01551888|203817|P1|NOT COMPLETED|Period 2||0
84582|NCT01551888|203816|P2|COMPLETED|Period 2||12
84583|NCT01551888|203817|P1|COMPLETED|Period 2||12
84584|NCT01551888|203816|P2|STARTED|Period 2||12
84585|NCT01551888|203817|P1|STARTED|Period 2||12
84586|NCT01551888|203816|P2|NOT COMPLETED|Period 1||0
84587|NCT01551888|203817|P1|NOT COMPLETED|Period 1||0
84588|NCT01551888|203816|P2|COMPLETED|Period 1||12
84589|NCT01551888|203817|P1|COMPLETED|Period 1||12
84590|NCT01551888|203816|P2|STARTED|Period 1||12
84591|NCT01551888|203817|P1|STARTED|Period 1||12
84592|NCT01551758|203831|P2|NOT COMPLETED|Overall Study||105
84593|NCT01551758|203832|P1|NOT COMPLETED|Overall Study||94
84594|NCT01551758|203831|P2|COMPLETED|Overall Study||1291
84595|NCT01551758|203832|P1|COMPLETED|Overall Study||1309
84596|NCT01551758|203831|P2|STARTED|Overall Study||1396
84597|NCT01551758|203832|P1|STARTED|Overall Study||1403
84598|NCT01551745|203870|P1|NOT COMPLETED|Overall Study||3
84599|NCT01551745|203870|P1|COMPLETED|Overall Study||2
84600|NCT01551745|203870|P1|STARTED|Overall Study||5
84601|NCT01551693|203879|P2|NOT COMPLETED|Overall Study||2
84602|NCT01551693|203880|P1|NOT COMPLETED|Overall Study||1
84603|NCT01551693|203879|P2|COMPLETED|Overall Study||0
84604|NCT01551693|203880|P1|COMPLETED|Overall Study||0
84605|NCT01551693|203879|P2|STARTED|Overall Study||2
84606|NCT01551693|203880|P1|STARTED|Overall Study||1
84607|NCT01551355|203896|P6|NOT COMPLETED|Overall Study||6
84608|NCT01551355|203897|P5|NOT COMPLETED|Overall Study||9
84609|NCT01551355|203898|P4|NOT COMPLETED|Overall Study||24
84610|NCT01551355|203899|P3|NOT COMPLETED|Overall Study||34
84611|NCT01551355|203900|P2|NOT COMPLETED|Overall Study||49
84612|NCT01551355|203901|P1|NOT COMPLETED|Overall Study||51
84613|NCT01551355|203896|P6|COMPLETED|Overall Study||65
84614|NCT01551355|203897|P5|COMPLETED|Overall Study||55
84615|NCT01551355|203898|P4|COMPLETED|Overall Study||411
84616|NCT01551355|203899|P3|COMPLETED|Overall Study||459
84617|NCT01551355|203900|P2|COMPLETED|Overall Study||545
84618|NCT01551355|203901|P1|COMPLETED|Overall Study||571
84619|NCT01551355|203896|P6|STARTED|Overall Study||71
84620|NCT01551355|203897|P5|STARTED|Overall Study||64
84621|NCT01551355|203898|P4|STARTED|Overall Study||435
84622|NCT01551355|203899|P3|STARTED|Overall Study||493
84623|NCT01551355|203900|P2|STARTED|Overall Study||594
84624|NCT01551355|203901|P1|STARTED|Overall Study||622
84625|NCT01551303|203915|P2|NOT COMPLETED|Overall Study||7
84626|NCT01551303|203916|P1|NOT COMPLETED|Overall Study||4
84627|NCT01551303|203915|P2|COMPLETED|Overall Study||15
84628|NCT01551303|203916|P1|COMPLETED|Overall Study||21
84629|NCT01551303|203915|P2|STARTED|Overall Study||22
84630|NCT01551303|203916|P1|STARTED|Overall Study||25
84631|NCT01551199|203922|P1|NOT COMPLETED|Overall Study||5
84632|NCT01551199|203922|P1|COMPLETED|Overall Study||2
84633|NCT01551199|203922|P1|STARTED|Overall Study||7
84634|NCT01551173|203930|P2|NOT COMPLETED|Overall Study||32
84635|NCT01551173|203931|P1|NOT COMPLETED|Overall Study||28
84636|NCT01551173|203930|P2|COMPLETED|Overall Study||186
84637|NCT01551173|203931|P1|COMPLETED|Overall Study||190
84638|NCT01551173|203930|P2|Full Analysis Set (FAS)|Overall Study||214
84639|NCT01551173|203931|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
84640|NCT01551173|203930|P2|STARTED|Overall Study||218
84641|NCT01551173|203931|P1|STARTED|Overall Study|"Started indicates randomized"|218
84642|NCT01551095|203942|P1|NOT COMPLETED|Overall Study||0
84643|NCT01551095|203942|P1|COMPLETED|Overall Study||7
84644|NCT01551095|203942|P1|STARTED|Overall Study||7
84645|NCT01551082|203947|P1|NOT COMPLETED|Overall Study||0
84646|NCT01551082|203947|P1|COMPLETED|Overall Study||12
84647|NCT01551082|203947|P1|STARTED|Overall Study||12
84648|NCT01551056|203953|P2|NOT COMPLETED|Overall Study||0
84649|NCT01551056|203954|P1|NOT COMPLETED|Overall Study||2
84650|NCT01551056|203953|P2|COMPLETED|Overall Study||45
84651|NCT01551056|203954|P1|COMPLETED|Overall Study||44
84652|NCT01551056|203953|P2|STARTED|Overall Study||45
84653|NCT01551056|203954|P1|STARTED|Overall Study||46
84654|NCT01550965|204008|P1|NOT COMPLETED|Overall Study||110
84655|NCT01550965|204008|P1|COMPLETED|Overall Study||353
84656|NCT01550965|204008|P1|STARTED|Overall Study||463
84657|NCT01550952|204027|P1|NOT COMPLETED|Overall Study||0
84658|NCT01550952|204027|P1|COMPLETED|Overall Study||10
84659|NCT01550952|204027|P1|STARTED|Overall Study||10
84660|NCT01550809|204037|P2|NOT COMPLETED|Overall Study||0
84661|NCT01550809|204038|P1|NOT COMPLETED|Overall Study||0
84662|NCT01550809|204037|P2|COMPLETED|Overall Study||6
84663|NCT01550809|204038|P1|COMPLETED|Overall Study||6
84664|NCT01550809|204037|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
84665|NCT01550809|204038|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
84666|NCT01550757|204052|P4|NOT COMPLETED|Overall Study||54
84667|NCT01550757|204053|P3|NOT COMPLETED|Overall Study||45
84668|NCT01550757|204054|P2|NOT COMPLETED|Overall Study||14
84669|NCT01550757|204055|P1|NOT COMPLETED|Overall Study||23
84670|NCT01550757|204052|P4|COMPLETED|Overall Study||90
84671|NCT01550757|204053|P3|COMPLETED|Overall Study||85
84672|NCT01550757|204054|P2|COMPLETED|Overall Study||38
84673|NCT01550757|204055|P1|COMPLETED|Overall Study||33
84674|NCT01550757|204052|P4|STARTED|Overall Study||144
84675|NCT01550757|204053|P3|STARTED|Overall Study||130
84676|NCT01550757|204054|P2|STARTED|Overall Study||52
84677|NCT01550757|204055|P1|STARTED|Overall Study||56
84678|NCT01550744|204065|P3|NOT COMPLETED|Double-Blind||67
84679|NCT01550744|204066|P2|NOT COMPLETED|Double-Blind||17
84680|NCT01550744|204067|P1|NOT COMPLETED|Double-Blind||0
84681|NCT01550744|204065|P3|COMPLETED|Double-Blind||235
84682|NCT01550744|204066|P2|COMPLETED|Double-Blind||59
84683|NCT01550744|204067|P1|COMPLETED|Double-Blind||0
84684|NCT01550744|204065|P3|STARTED|Double-Blind||302
84685|NCT01550744|204066|P2|STARTED|Double-Blind||76
84686|NCT01550744|204067|P1|STARTED|Double-Blind||0
84687|NCT01550744|204065|P3|NOT COMPLETED|Open-Label||0
84688|NCT01550744|204066|P2|NOT COMPLETED|Open-Label||0
84689|NCT01550744|204067|P1|NOT COMPLETED|Open-Label||100
84690|NCT01550744|204065|P3|COMPLETED|Open-Label||0
84691|NCT01550744|204066|P2|COMPLETED|Open-Label||0
84692|NCT01550744|204067|P1|COMPLETED|Open-Label||378
84693|NCT01550744|204065|P3|STARTED|Open-Label||0
84694|NCT01550744|204066|P2|STARTED|Open-Label||0
84695|NCT01550744|204067|P1|STARTED|Open-Label||478
84696|NCT01550705|204080|P1|NOT COMPLETED|Overall Study||1
84697|NCT01550705|204080|P1|COMPLETED|Overall Study||10
84698|NCT01550705|204080|P1|STARTED|Overall Study||11
84699|NCT01550549|204085|P1|NOT COMPLETED|Overall Study||0
84700|NCT01550549|204085|P1|COMPLETED|Overall Study||151
84701|NCT01550549|204085|P1|STARTED|Overall Study||151
84702|NCT01550302|204099|P2|NOT COMPLETED|Overall Study||0
84703|NCT01550302|204100|P1|NOT COMPLETED|Overall Study||0
84704|NCT01550302|204099|P2|COMPLETED|Overall Study||5
84705|NCT01550302|204100|P1|COMPLETED|Overall Study||5
84706|NCT01550302|204099|P2|STARTED|Overall Study||5
84707|NCT01550302|204100|P1|STARTED|Overall Study||5
84708|NCT01550289|204120|P2|NOT COMPLETED|Overall Study||4
84709|NCT01550289|204121|P1|NOT COMPLETED|Overall Study||13
84710|NCT01550289|204120|P2|COMPLETED|Overall Study||57
84711|NCT01550289|204121|P1|COMPLETED|Overall Study||115
84712|NCT01550289|204120|P2|STARTED|Overall Study||61
84713|NCT01550289|204121|P1|STARTED|Overall Study||128
84714|NCT01549977|204153|P2|NOT COMPLETED|Overall Study||0
84715|NCT01549977|204154|P1|NOT COMPLETED|Overall Study||0
84716|NCT01549977|204153|P2|COMPLETED|Overall Study||0
84717|NCT01549977|204154|P1|COMPLETED|Overall Study||1
84718|NCT01549977|204153|P2|STARTED|Overall Study||0
84719|NCT01549977|204154|P1|STARTED|Overall Study||1
84720|NCT01549964|204172|P4|NOT COMPLETED|80-Week Extension Period||137
84721|NCT01549964|204173|P3|NOT COMPLETED|80-Week Extension Period||140
84722|NCT01549964|204174|P2|NOT COMPLETED|80-Week Extension Period||138
84723|NCT01549964|204175|P1|NOT COMPLETED|80-Week Extension Period||66
84724|NCT01549964|204172|P4|COMPLETED|80-Week Extension Period||0
84725|NCT01549964|204173|P3|COMPLETED|80-Week Extension Period||0
84726|NCT01549964|204174|P2|COMPLETED|80-Week Extension Period||0
84727|NCT01549964|204175|P1|COMPLETED|80-Week Extension Period||0
84728|NCT01549964|204172|P4|STARTED|80-Week Extension Period||137
84729|NCT01549964|204173|P3|STARTED|80-Week Extension Period||140
84730|NCT01549964|204174|P2|STARTED|80-Week Extension Period||138
84731|NCT01549964|204175|P1|STARTED|80-Week Extension Period||66
84732|NCT01549964|204172|P4|NOT COMPLETED|24-Week Treatment Period||121
84733|NCT01549964|204173|P3|NOT COMPLETED|24-Week Treatment Period||116
84734|NCT01549964|204174|P2|NOT COMPLETED|24-Week Treatment Period||111
84735|NCT01549964|204175|P1|NOT COMPLETED|24-Week Treatment Period||61
84736|NCT01549964|204172|P4|COMPLETED|24-Week Treatment Period||140
84737|NCT01549964|204173|P3|COMPLETED|24-Week Treatment Period||147
84738|NCT01549964|204174|P2|COMPLETED|24-Week Treatment Period||149
84739|NCT01549964|204175|P1|COMPLETED|24-Week Treatment Period||71
84740|NCT01549964|204172|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
84741|NCT01549964|204173|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
84742|NCT01549964|204174|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
84743|NCT01549964|204175|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
84744|NCT01549964|204172|P4|STARTED|24-Week Treatment Period||261
84745|NCT01549964|204173|P3|STARTED|24-Week Treatment Period||263
84746|NCT01549964|204174|P2|STARTED|24-Week Treatment Period||260
84747|NCT01549964|204175|P1|STARTED|24-Week Treatment Period||132
84748|NCT01549951|204193|P1|NOT COMPLETED|Overall Study||50
84749|NCT01549951|204193|P1|COMPLETED|Overall Study||0
84750|NCT01549951|204193|P1|Primary Reason Off Study Treatment|Overall Study||50
84751|NCT01549951|204193|P1|STARTED|Overall Study||50
84752|NCT01549925|204211|P2|NOT COMPLETED|Overall Study||0
84753|NCT01549925|204212|P1|NOT COMPLETED|Overall Study||0
84754|NCT01549925|204211|P2|COMPLETED|Overall Study||25
84755|NCT01549925|204212|P1|COMPLETED|Overall Study||25
84756|NCT01549925|204211|P2|STARTED|Overall Study||25
84757|NCT01549925|204212|P1|STARTED|Overall Study||25
84758|NCT01549873|204220|P2|NOT COMPLETED|Overall Study||1
84759|NCT01549873|204221|P1|NOT COMPLETED|Overall Study||0
84760|NCT01549873|204220|P2|COMPLETED|Overall Study||14
84761|NCT01549873|204221|P1|COMPLETED|Overall Study||15
84762|NCT01549873|204220|P2|STARTED|Overall Study||15
84763|NCT01549873|204221|P1|STARTED|Overall Study||15
84764|NCT01549860|204233|P2|NOT COMPLETED|Overall Study||1
84765|NCT01549860|204234|P1|NOT COMPLETED|Overall Study||2
84766|NCT01549860|204233|P2|COMPLETED|Overall Study||40
84767|NCT01549860|204234|P1|COMPLETED|Overall Study||38
84768|NCT01549860|204233|P2|STARTED|Overall Study||41
84769|NCT01549860|204234|P1|STARTED|Overall Study||40
84770|NCT01549613|204246|P2|NOT COMPLETED|Overall Study||11
84771|NCT01549613|204247|P1|NOT COMPLETED|Overall Study||11
84772|NCT01549613|204246|P2|COMPLETED|Overall Study||39
84773|NCT01549613|204247|P1|COMPLETED|Overall Study||39
84774|NCT01549613|204246|P2|STARTED|Overall Study||50
84775|NCT01549613|204247|P1|STARTED|Overall Study||50
84776|NCT01549405|204255|P2|NOT COMPLETED|Overall Study||0
84777|NCT01549405|204256|P1|NOT COMPLETED|Overall Study||0
84778|NCT01549405|204255|P2|COMPLETED|Overall Study||20
84779|NCT01549405|204256|P1|COMPLETED|Overall Study||20
84780|NCT01549405|204255|P2|STARTED|Overall Study||20
84781|NCT01549405|204256|P1|STARTED|Overall Study||20
84782|NCT01549392|204266|P2|NOT COMPLETED|Overall Study||0
84783|NCT01549392|204267|P1|NOT COMPLETED|Overall Study||1
84784|NCT01549392|204266|P2|COMPLETED|Overall Study||0
84785|NCT01549392|204267|P1|COMPLETED|Overall Study||2
84786|NCT01549392|204266|P2|STARTED|Overall Study||0
84787|NCT01549392|204267|P1|STARTED|Overall Study||3
84788|NCT01549340|204273|P1|NOT COMPLETED|Overall Study||8405
84789|NCT01549340|204273|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
84790|NCT01549340|204273|P1|Started AIT|Overall Study||3182
84791|NCT01549340|204273|P1|STARTED|Overall Study|Advised to receive AIT|8790
84792|NCT01549275|204286|P2|NOT COMPLETED|Overall Study||0
84793|NCT01549275|204287|P1|NOT COMPLETED|Overall Study||1
84794|NCT01549275|204286|P2|COMPLETED|Overall Study||29
84795|NCT01549275|204287|P1|COMPLETED|Overall Study||75
84796|NCT01549275|204286|P2|STARTED|Overall Study||29
84797|NCT01549275|204287|P1|STARTED|Overall Study||76
84798|NCT01549223|204299|P2|NOT COMPLETED|Overall Study||0
84799|NCT01549223|204300|P1|NOT COMPLETED|Overall Study||0
84800|NCT01549223|204299|P2|COMPLETED|Overall Study||30
84801|NCT01549223|204300|P1|COMPLETED|Overall Study||30
84802|NCT01549223|204299|P2|STARTED|Overall Study||30
84803|NCT01549223|204300|P1|STARTED|Overall Study||30
84804|NCT01549041|204310|P2|NOT COMPLETED|Overall Study||8
84805|NCT01549041|204311|P1|NOT COMPLETED|Overall Study||2
84806|NCT01549041|204310|P2|COMPLETED|Overall Study||10
84807|NCT01549041|204311|P1|COMPLETED|Overall Study||10
84808|NCT01549041|204310|P2|STARTED|Overall Study||18
84809|NCT01549041|204311|P1|STARTED|Overall Study||12
84810|NCT01549002|204321|P2|NOT COMPLETED|Overall Study||4
84811|NCT01549002|204322|P1|NOT COMPLETED|Overall Study||0
84812|NCT01549002|204321|P2|COMPLETED|Overall Study||6
84813|NCT01549002|204322|P1|COMPLETED|Overall Study||10
84814|NCT01549002|204321|P2|STARTED|Overall Study||10
84815|NCT01549002|204322|P1|STARTED|Overall Study||10
84816|NCT01548885|204328|P1|NOT COMPLETED|Overall Study||0
84817|NCT01548885|204328|P1|COMPLETED|Overall Study||146
84818|NCT01548885|204328|P1|STARTED|Overall Study||146
84819|NCT01548833|204333|P1|NOT COMPLETED|Overall Study||0
84820|NCT01548833|204333|P1|COMPLETED|Overall Study||39
84821|NCT01548833|204333|P1|STARTED|Overall Study||39
84822|NCT01548742|204343|P2|NOT COMPLETED|Overall Study||4
84823|NCT01548742|204344|P1|NOT COMPLETED|Overall Study||13
84824|NCT01548742|204343|P2|COMPLETED|Overall Study||54
84825|NCT01548742|204344|P1|COMPLETED|Overall Study||45
84826|NCT01548742|204343|P2|STARTED|Overall Study||58
84827|NCT01548742|204344|P1|STARTED|Overall Study||58
84828|NCT01548638|204358|P1|NOT COMPLETED|Overall Study||4
84829|NCT01548638|204358|P1|COMPLETED|Overall Study||9
84830|NCT01548638|204358|P1|STARTED|Overall Study||13
84831|NCT01548573|204368|P1|NOT COMPLETED|Overall Study||5
84832|NCT01548573|204368|P1|COMPLETED|Overall Study||14
84833|NCT01548573|204368|P1|STARTED|Overall Study||19
84834|NCT01548417|204377|P2|NOT COMPLETED|Overall Study||2
84835|NCT01548417|204378|P1|NOT COMPLETED|Overall Study||0
84836|NCT01548417|204377|P2|COMPLETED|Overall Study||26
84837|NCT01548417|204378|P1|COMPLETED|Overall Study||28
84838|NCT01548417|204377|P2|STARTED|Overall Study||28
84839|NCT01548417|204378|P1|STARTED|Overall Study||28
84840|NCT01548287|204390|P5|NOT COMPLETED|Randomized Period||0
84841|NCT01548287|204391|P4|NOT COMPLETED|Randomized Period||0
84842|NCT01548287|204392|P3|NOT COMPLETED|Randomized Period||7
84843|NCT01548287|204393|P2|NOT COMPLETED|Randomized Period||2
84844|NCT01548287|204394|P1|NOT COMPLETED|Randomized Period||0
84845|NCT01548287|204390|P5|COMPLETED|Randomized Period||0
84846|NCT01548287|204391|P4|COMPLETED|Randomized Period||20
84847|NCT01548287|204392|P3|COMPLETED|Randomized Period||13
84848|NCT01548287|204393|P2|COMPLETED|Randomized Period||20
84849|NCT01548287|204394|P1|COMPLETED|Randomized Period||19
84850|NCT01548287|204390|P5|STARTED|Randomized Period||0
84851|NCT01548287|204391|P4|STARTED|Randomized Period||20
84852|NCT01548287|204392|P3|STARTED|Randomized Period||20
84853|NCT01548287|204393|P2|STARTED|Randomized Period||22
84854|NCT01548287|204394|P1|STARTED|Randomized Period||19
84855|NCT01548287|204390|P5|NOT COMPLETED|Screening||83
84856|NCT01548287|204391|P4|NOT COMPLETED|Screening||0
84857|NCT01548287|204392|P3|NOT COMPLETED|Screening||0
84858|NCT01548287|204393|P2|NOT COMPLETED|Screening||0
84859|NCT01548287|204394|P1|NOT COMPLETED|Screening||0
84860|NCT01548287|204390|P5|COMPLETED|Screening||0
84861|NCT01548287|204391|P4|COMPLETED|Screening||20
84862|NCT01548287|204392|P3|COMPLETED|Screening||20
84863|NCT01548287|204393|P2|COMPLETED|Screening||22
84864|NCT01548287|204394|P1|COMPLETED|Screening||19
84865|NCT01548287|204390|P5|STARTED|Screening||83
84866|NCT01548287|204391|P4|STARTED|Screening||20
84867|NCT01548287|204392|P3|STARTED|Screening||20
84868|NCT01548287|204393|P2|STARTED|Screening||22
84869|NCT01548287|204394|P1|STARTED|Screening||19
84870|NCT01548040|204426|P2|NOT COMPLETED|Overall Study||10
84871|NCT01548040|204427|P1|NOT COMPLETED|Overall Study||13
84872|NCT01548040|204426|P2|COMPLETED|Overall Study||45
84873|NCT01548040|204427|P1|COMPLETED|Overall Study||43
84874|NCT01548040|204426|P2|STARTED|Overall Study||55
84875|NCT01548040|204427|P1|STARTED|Overall Study||56
84876|NCT01547806|204435|P1|NOT COMPLETED|Overall Study||0
84877|NCT01547806|204435|P1|COMPLETED|Overall Study||49
84878|NCT01547806|204435|P1|STARTED|Overall Study||49
84879|NCT01547728|204451|P1|NOT COMPLETED|Overall Study||41
84880|NCT01547728|204451|P1|COMPLETED|Overall Study||1
84881|NCT01547728|204451|P1|STARTED|Overall Study||42
84882|NCT01547715|204458|P3|NOT COMPLETED|Overall Study||0
84883|NCT01547715|204459|P2|NOT COMPLETED|Overall Study||0
84884|NCT01547715|204460|P1|NOT COMPLETED|Overall Study||0
84885|NCT01547715|204458|P3|COMPLETED|Overall Study||60
84886|NCT01547715|204459|P2|COMPLETED|Overall Study||60
84887|NCT01547715|204460|P1|COMPLETED|Overall Study||60
84888|NCT01547715|204458|P3|STARTED|Overall Study||60
84889|NCT01547715|204459|P2|STARTED|Overall Study||60
84890|NCT01547715|204460|P1|STARTED|Overall Study||60
84891|NCT01547598|204560|P2|NOT COMPLETED|Overall Study||5
84892|NCT01547598|204561|P1|NOT COMPLETED|Overall Study||6
84893|NCT01547598|204560|P2|COMPLETED|Overall Study||63
84894|NCT01547598|204561|P1|COMPLETED|Overall Study||61
84895|NCT01547598|204560|P2|STARTED|Overall Study||68
84896|NCT01547598|204561|P1|STARTED|Overall Study||67
84897|NCT01547390|204578|P2|NOT COMPLETED|Overall Study||10
84898|NCT01547390|204579|P1|NOT COMPLETED|Overall Study||13
84899|NCT01547390|204578|P2|COMPLETED|Overall Study||16
84900|NCT01547390|204579|P1|COMPLETED|Overall Study||14
84901|NCT01547390|204578|P2|STARTED|Overall Study||26
84902|NCT01547390|204579|P1|STARTED|Overall Study||27
84903|NCT01547299|204589|P2|NOT COMPLETED|Overall Study||2
84904|NCT01547299|204590|P1|NOT COMPLETED|Overall Study||2
84905|NCT01547299|204589|P2|COMPLETED|Overall Study||25
84906|NCT01547299|204590|P1|COMPLETED|Overall Study||23
84907|NCT01547299|204589|P2|STARTED|Overall Study||27
84908|NCT01547299|204590|P1|STARTED|Overall Study||25
84909|NCT01547286|204656|P1|NOT COMPLETED|Overall Study||2
84910|NCT01547286|204656|P1|COMPLETED|Overall Study||5
84911|NCT01547286|204656|P1|STARTED|Overall Study||7
84912|NCT01547247|204665|P2|NOT COMPLETED|Overall Study||6
84913|NCT01547247|204666|P1|NOT COMPLETED|Overall Study||6
84914|NCT01547247|204665|P2|COMPLETED|Overall Study||98
84915|NCT01547247|204666|P1|COMPLETED|Overall Study||98
84916|NCT01547247|204665|P2|STARTED|Overall Study||104
84917|NCT01547247|204666|P1|STARTED|Overall Study||104
84918|NCT01547130|204676|P2|NOT COMPLETED|Overall Study||5
84919|NCT01547130|204677|P1|NOT COMPLETED|Overall Study||9
84920|NCT01547130|204676|P2|COMPLETED|Overall Study||68
84921|NCT01547130|204677|P1|COMPLETED|Overall Study||65
84922|NCT01547130|204676|P2|STARTED|Overall Study||73
84923|NCT01547130|204677|P1|STARTED|Overall Study||74
84924|NCT01546922|204691|P2|NOT COMPLETED|Second Period of 10 Weeks||3
84925|NCT01546922|204692|P1|NOT COMPLETED|Second Period of 10 Weeks||3
84926|NCT01546922|204691|P2|COMPLETED|Second Period of 10 Weeks||25
84927|NCT01546922|204692|P1|COMPLETED|Second Period of 10 Weeks||22
84928|NCT01546922|204691|P2|STARTED|Second Period of 10 Weeks||28
84929|NCT01546922|204692|P1|STARTED|Second Period of 10 Weeks||25
84930|NCT01546922|204691|P2|NOT COMPLETED|First Period of 10 Weeks||2
84931|NCT01546922|204692|P1|NOT COMPLETED|First Period of 10 Weeks||5
84932|NCT01546922|204691|P2|COMPLETED|First Period of 10 Weeks||28
84933|NCT01546922|204692|P1|COMPLETED|First Period of 10 Weeks||25
84934|NCT01546922|204691|P2|STARTED|First Period of 10 Weeks||30
84935|NCT01546922|204692|P1|STARTED|First Period of 10 Weeks||30
84936|NCT01546883|204698|P1|NOT COMPLETED|Overall Study||12
84937|NCT01546883|204698|P1|COMPLETED|Overall Study||2
84938|NCT01546883|204698|P1|STARTED|Overall Study||14
84939|NCT01546688|204704|P2|NOT COMPLETED|Overall Study||5
84940|NCT01546688|204705|P1|NOT COMPLETED|Overall Study||3
84941|NCT01546688|204704|P2|COMPLETED|Overall Study||28
84942|NCT01546688|204705|P1|COMPLETED|Overall Study||15
84943|NCT01546688|204704|P2|STARTED|Overall Study||33
84944|NCT01546688|204705|P1|STARTED|Overall Study||18
84945|NCT01546675|204719|P2|NOT COMPLETED|Overall Study||0
84946|NCT01546675|204720|P1|NOT COMPLETED|Overall Study||0
84947|NCT01546675|204719|P2|COMPLETED|Overall Study||1
84948|NCT01546675|204720|P1|COMPLETED|Overall Study||1
84949|NCT01546675|204719|P2|STARTED|Overall Study||1
84950|NCT01546675|204720|P1|STARTED|Overall Study||1
84951|NCT01546649|204737|P2|NOT COMPLETED|Overall Study||9
84952|NCT01546649|204738|P1|NOT COMPLETED|Overall Study||8
84953|NCT01546649|204737|P2|COMPLETED|Overall Study||75
84954|NCT01546649|204738|P1|COMPLETED|Overall Study||75
84955|NCT01546649|204737|P2|STARTED|Overall Study||84
84956|NCT01546649|204738|P1|STARTED|Overall Study||83
84957|NCT01546636|204760|P2|NOT COMPLETED|Overall Study||0
84958|NCT01546636|204761|P1|NOT COMPLETED|Overall Study||0
84959|NCT01546636|204760|P2|COMPLETED|Overall Study||34
84960|NCT01546636|204761|P1|COMPLETED|Overall Study||36
84961|NCT01546636|204760|P2|STARTED|Overall Study||34
84962|NCT01546636|204761|P1|STARTED|Overall Study||36
84963|NCT01546623|204773|P2|NOT COMPLETED|Overall Study||6
84964|NCT01546623|204774|P1|NOT COMPLETED|Overall Study||6
84965|NCT01546623|204773|P2|COMPLETED|Overall Study||74
84966|NCT01546623|204774|P1|COMPLETED|Overall Study||76
84967|NCT01546623|204773|P2|Received Study Drug|Overall Study||79
84968|NCT01546623|204774|P1|Received Study Drug|Overall Study||81
84969|NCT01546623|204773|P2|STARTED|Overall Study||80
84970|NCT01546623|204774|P1|STARTED|Overall Study||82
84971|NCT01546519|204804|P4|NOT COMPLETED|Overall Study||6
84972|NCT01546519|204805|P3|NOT COMPLETED|Overall Study||8
84973|NCT01546519|204806|P2|NOT COMPLETED|Overall Study||8
84974|NCT01546519|204807|P1|NOT COMPLETED|Overall Study||9
84975|NCT01546519|204804|P4|COMPLETED|Overall Study||0
84976|NCT01546519|204805|P3|COMPLETED|Overall Study||0
84977|NCT01546519|204806|P2|COMPLETED|Overall Study||0
84978|NCT01546519|204807|P1|COMPLETED|Overall Study||0
84979|NCT01546519|204804|P4|Safety-Evaluable Participants|Overall Study||6
84980|NCT01546519|204805|P3|Safety-Evaluable Participants|Overall Study||8
84981|NCT01546519|204806|P2|Safety-Evaluable Participants|Overall Study||8
84982|NCT01546519|204807|P1|Safety-Evaluable Participants|Overall Study||9
84983|NCT01546519|204804|P4|STARTED|Overall Study||6
84984|NCT01546519|204805|P3|STARTED|Overall Study||8
84985|NCT01546519|204806|P2|STARTED|Overall Study||8
84986|NCT01546519|204807|P1|STARTED|Overall Study||9
84987|NCT01546454|204849|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
84988|NCT01546454|204849|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
84989|NCT01546454|204849|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
84990|NCT01546454|204849|P1|NOT COMPLETED|Eligard Treatment||0
84991|NCT01546454|204849|P1|COMPLETED|Eligard Treatment||4
84992|NCT01546454|204849|P1|STARTED|Eligard Treatment||4
84993|NCT01546454|204849|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
84994|NCT01546454|204849|P1|COMPLETED|Oral Contraceptive Cycle||4
84995|NCT01546454|204849|P1|STARTED|Oral Contraceptive Cycle||4
84996|NCT01546454|204849|P1|NOT COMPLETED|Natural Menstrual Cycle||0
84997|NCT01546454|204849|P1|COMPLETED|Natural Menstrual Cycle||4
84998|NCT01546454|204849|P1|STARTED|Natural Menstrual Cycle||4
84999|NCT01546402|204857|P2|NOT COMPLETED|Overall Study||0
85000|NCT01546402|204858|P1|NOT COMPLETED|Overall Study||0
85001|NCT01546402|204857|P2|COMPLETED|Overall Study||10
85002|NCT01546402|204858|P1|COMPLETED|Overall Study||10
85003|NCT01546402|204857|P2|STARTED|Overall Study||10
85004|NCT01546402|204858|P1|STARTED|Overall Study||10
85005|NCT01546285|204866|P1|NOT COMPLETED|Overall Study||0
85006|NCT01546285|204866|P1|COMPLETED|Overall Study||66
85007|NCT01546285|204866|P1|STARTED|Overall Study||66
85008|NCT01546207|204872|P1|NOT COMPLETED|Overall Study||1
85009|NCT01546207|204872|P1|COMPLETED|Overall Study||3
85010|NCT01546207|204872|P1|STARTED|Overall Study||4
85011|NCT01546194|204878|P2|NOT COMPLETED|Overall Study||35
85012|NCT01546194|204879|P1|NOT COMPLETED|Overall Study||36
85013|NCT01546194|204878|P2|COMPLETED|Overall Study||65
85014|NCT01546194|204879|P1|COMPLETED|Overall Study||64
85015|NCT01546194|204878|P2|STARTED|Overall Study||100
85016|NCT01546194|204879|P1|STARTED|Overall Study||100
85017|NCT01546168|204887|P2|NOT COMPLETED|Overall Study||0
85018|NCT01546168|204888|P1|NOT COMPLETED|Overall Study||4
85019|NCT01546168|204887|P2|COMPLETED|Overall Study||33
85020|NCT01546168|204888|P1|COMPLETED|Overall Study||51
85021|NCT01546168|204887|P2|STARTED|Overall Study||33
85022|NCT01546168|204888|P1|STARTED|Overall Study||55
85023|NCT01546155|204900|P1|NOT COMPLETED|Overall Study||3
85024|NCT01546155|204900|P1|COMPLETED|Overall Study||8
85025|NCT01546155|204900|P1|STARTED|Overall Study||11
85026|NCT01546142|204906|P2|NOT COMPLETED|Overall Study||34
85027|NCT01546142|204907|P1|NOT COMPLETED|Overall Study||44
85028|NCT01546142|204906|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
85029|NCT01546142|204907|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
85030|NCT01546142|204906|P2|Received Treatment|Overall Study||257
85031|NCT01546142|204907|P1|Received Treatment|Overall Study||257
85032|NCT01546142|204906|P2|STARTED|Overall Study||258
85033|NCT01546142|204907|P1|STARTED|Overall Study||258
85034|NCT01546038|204925|P9|NOT COMPLETED|Overall Study||44
85035|NCT01546038|204926|P8|NOT COMPLETED|Overall Study||88
85036|NCT01546038|204927|P7|NOT COMPLETED|Overall Study||71
85037|NCT01546038|204928|P6|NOT COMPLETED|Overall Study||6
85038|NCT01546038|204929|P5|NOT COMPLETED|Overall Study||16
85039|NCT01546038|204930|P4|NOT COMPLETED|Overall Study||3
85040|NCT01546038|204931|P3|NOT COMPLETED|Overall Study||4
85041|NCT01546038|204932|P2|NOT COMPLETED|Overall Study||6
85042|NCT01546038|204933|P1|NOT COMPLETED|Overall Study||17
85043|NCT01546038|204925|P9|COMPLETED|Overall Study||0
85044|NCT01546038|204926|P8|COMPLETED|Overall Study||0
85045|NCT01546038|204927|P7|COMPLETED|Overall Study||0
85046|NCT01546038|204928|P6|COMPLETED|Overall Study||0
85047|NCT01546038|204929|P5|COMPLETED|Overall Study||0
85048|NCT01546038|204930|P4|COMPLETED|Overall Study||0
85049|NCT01546038|204931|P3|COMPLETED|Overall Study||0
85050|NCT01546038|204932|P2|COMPLETED|Overall Study||0
85051|NCT01546038|204933|P1|COMPLETED|Overall Study||0
85052|NCT01546038|204925|P9|Received Treatment|Overall Study||41
85053|NCT01546038|204926|P8|Received Treatment|Overall Study||84
85054|NCT01546038|204927|P7|Received Treatment|Overall Study||69
85055|NCT01546038|204928|P6|Received Treatment|Overall Study||6
85056|NCT01546038|204929|P5|Received Treatment|Overall Study||16
85057|NCT01546038|204930|P4|Received Treatment|Overall Study||3
85058|NCT01546038|204931|P3|Received Treatment|Overall Study||4
85059|NCT01546038|204932|P2|Received Treatment|Overall Study||6
85060|NCT01546038|204933|P1|Received Treatment|Overall Study||17
85061|NCT01546038|204925|P9|STARTED|Overall Study||44
85062|NCT01546038|204926|P8|STARTED|Overall Study||88
85063|NCT01546038|204927|P7|STARTED|Overall Study||71
85064|NCT01546038|204928|P6|STARTED|Overall Study||6
85065|NCT01546038|204929|P5|STARTED|Overall Study||16
85066|NCT01546038|204930|P4|STARTED|Overall Study||3
85067|NCT01546038|204931|P3|STARTED|Overall Study||4
85068|NCT01546038|204932|P2|STARTED|Overall Study||6
85069|NCT01546038|204933|P1|STARTED|Overall Study||17
85070|NCT01545843|205096|P3|NOT COMPLETED|Overall Study||4
85071|NCT01545843|205097|P2|NOT COMPLETED|Overall Study||7
85072|NCT01545843|205098|P1|NOT COMPLETED|Overall Study||3
85073|NCT01545843|205096|P3|COMPLETED|Overall Study||21
85074|NCT01545843|205097|P2|COMPLETED|Overall Study||17
85075|NCT01545843|205098|P1|COMPLETED|Overall Study||16
85076|NCT01545843|205096|P3|STARTED|Overall Study||25
85077|NCT01545843|205097|P2|STARTED|Overall Study||24
85078|NCT01545843|205098|P1|STARTED|Overall Study||19
85079|NCT01545765|205127|P1|NOT COMPLETED|Overall Study||0
85080|NCT01545765|205127|P1|COMPLETED|Overall Study||31
85081|NCT01545765|205127|P1|STARTED|Overall Study||31
85082|NCT01545700|205144|P6|NOT COMPLETED|Overall Study||0
85083|NCT01545700|205145|P5|NOT COMPLETED|Overall Study||1
85084|NCT01545700|205146|P4|NOT COMPLETED|Overall Study||0
85085|NCT01545700|205147|P3|NOT COMPLETED|Overall Study||2
85086|NCT01545700|205148|P2|NOT COMPLETED|Overall Study||1
85087|NCT01545700|205149|P1|NOT COMPLETED|Overall Study||1
85088|NCT01545700|205144|P6|COMPLETED|Overall Study||33
85089|NCT01545700|205145|P5|COMPLETED|Overall Study||32
85090|NCT01545700|205146|P4|COMPLETED|Overall Study||34
85091|NCT01545700|205147|P3|COMPLETED|Overall Study||31
85092|NCT01545700|205148|P2|COMPLETED|Overall Study||32
85093|NCT01545700|205149|P1|COMPLETED|Overall Study||33
85094|NCT01545700|205144|P6|STARTED|Overall Study||33
85095|NCT01545700|205145|P5|STARTED|Overall Study||33
85096|NCT01545700|205146|P4|STARTED|Overall Study||34
85097|NCT01545700|205147|P3|STARTED|Overall Study||33
85098|NCT01545700|205148|P2|STARTED|Overall Study||33
85099|NCT01545700|205149|P1|STARTED|Overall Study||34
85100|NCT01545518|205183|P1|NOT COMPLETED|Overall Study||0
85101|NCT01545518|205183|P1|COMPLETED|Overall Study||20
85102|NCT01545518|205183|P1|STARTED|Overall Study||20
85103|NCT01545388|205190|P3|NOT COMPLETED|Overall Study||8
85104|NCT01545388|205191|P2|NOT COMPLETED|Overall Study||11
85105|NCT01545388|205192|P1|NOT COMPLETED|Overall Study||8
85106|NCT01545388|205190|P3|COMPLETED|Overall Study||58
85107|NCT01545388|205191|P2|COMPLETED|Overall Study||122
85108|NCT01545388|205192|P1|COMPLETED|Overall Study||130
85109|NCT01545388|205190|P3|STARTED|Overall Study||66
85110|NCT01545388|205191|P2|STARTED|Overall Study||133
85111|NCT01545388|205192|P1|STARTED|Overall Study||138
85112|NCT01545375|205211|P2|NOT COMPLETED|Overall Study||90
85113|NCT01545375|205212|P1|NOT COMPLETED|Overall Study||97
85114|NCT01545375|205211|P2|COMPLETED|Overall Study||813
85115|NCT01545375|205212|P1|COMPLETED|Overall Study||803
85116|NCT01545375|205211|P2|STARTED|Overall Study||903
85117|NCT01545375|205212|P1|STARTED|Overall Study||900
85118|NCT01545336|205262|P2|NOT COMPLETED|Overall Study||0
85119|NCT01545336|205263|P1|NOT COMPLETED|Overall Study||0
85120|NCT01545336|205262|P2|COMPLETED|Overall Study||6
85121|NCT01545336|205263|P1|COMPLETED|Overall Study||12
85122|NCT01545336|205262|P2|STARTED|Overall Study||6
85123|NCT01545336|205263|P1|STARTED|Overall Study||12
85124|NCT01545232|205275|P2|NOT COMPLETED|Overall Study||0
85125|NCT01545232|205276|P1|NOT COMPLETED|Overall Study||0
85126|NCT01545232|205275|P2|COMPLETED|Overall Study||342
85127|NCT01545232|205276|P1|COMPLETED|Overall Study||338
85128|NCT01545232|205275|P2|STARTED|Overall Study||342
85129|NCT01545232|205276|P1|STARTED|Overall Study||338
85130|NCT01545193|205306|P2|NOT COMPLETED|Overall Study||1
85131|NCT01545193|205307|P1|NOT COMPLETED|Overall Study||0
85132|NCT01545193|205306|P2|COMPLETED|Overall Study||149
85133|NCT01545193|205307|P1|COMPLETED|Overall Study||150
85134|NCT01545193|205306|P2|STARTED|Overall Study||150
85135|NCT01545193|205307|P1|STARTED|Overall Study||150
85136|NCT01544998|205319|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
85137|NCT01544998|205320|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
85138|NCT01544998|205319|P2|COMPLETED|Second Intervention (3 Hours)||15
85139|NCT01544998|205320|P1|COMPLETED|Second Intervention (3 Hours)||26
85140|NCT01544998|205319|P2|STARTED|Second Intervention (3 Hours)||15
85141|NCT01544998|205320|P1|STARTED|Second Intervention (3 Hours)||26
85142|NCT01544998|205319|P2|NOT COMPLETED|Washout (1 Week)||0
85143|NCT01544998|205320|P1|NOT COMPLETED|Washout (1 Week)||0
85144|NCT01544998|205319|P2|COMPLETED|Washout (1 Week)||15
85145|NCT01544998|205320|P1|COMPLETED|Washout (1 Week)||26
85146|NCT01544998|205319|P2|STARTED|Washout (1 Week)||15
85147|NCT01544998|205320|P1|STARTED|Washout (1 Week)||26
85148|NCT01544998|205319|P2|NOT COMPLETED|First Intervention (3 Hours)||0
85149|NCT01544998|205320|P1|NOT COMPLETED|First Intervention (3 Hours)||0
85150|NCT01544998|205319|P2|COMPLETED|First Intervention (3 Hours)||15
85151|NCT01544998|205320|P1|COMPLETED|First Intervention (3 Hours)||26
85152|NCT01544998|205319|P2|STARTED|First Intervention (3 Hours)||15
85153|NCT01544998|205320|P1|STARTED|First Intervention (3 Hours)||26
85154|NCT01544920|205340|P2|NOT COMPLETED|Overall Study||23
85155|NCT01544920|205341|P1|NOT COMPLETED|Overall Study||19
85156|NCT01544920|205340|P2|COMPLETED|Overall Study||346
85157|NCT01544920|205341|P1|COMPLETED|Overall Study||349
85158|NCT01544920|205340|P2|STARTED|Overall Study||369
85159|NCT01544920|205341|P1|STARTED|Overall Study||368
85160|NCT01544582|205352|P4|NOT COMPLETED|Analysis Population||39
85161|NCT01544582|205353|P3|NOT COMPLETED|Analysis Population||102
85162|NCT01544582|205354|P2|NOT COMPLETED|Analysis Population||118
85163|NCT01544582|205355|P1|NOT COMPLETED|Analysis Population||0
85164|NCT01544582|205352|P4|COMPLETED|Analysis Population||35
85165|NCT01544582|205353|P3|COMPLETED|Analysis Population||205
85166|NCT01544582|205354|P2|COMPLETED|Analysis Population||180
85167|NCT01544582|205355|P1|COMPLETED|Analysis Population||0
85168|NCT01544582|205352|P4|STARTED|Analysis Population||74
85169|NCT01544582|205353|P3|STARTED|Analysis Population||307
85170|NCT01544582|205354|P2|STARTED|Analysis Population||298
85171|NCT01544582|205355|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
85172|NCT01544582|205352|P4|NOT COMPLETED|Screening/Eligibility||0
85173|NCT01544582|205353|P3|NOT COMPLETED|Screening/Eligibility||0
85174|NCT01544582|205354|P2|NOT COMPLETED|Screening/Eligibility||0
85175|NCT01544582|205355|P1|NOT COMPLETED|Screening/Eligibility||34
85176|NCT01544582|205352|P4|COMPLETED|Screening/Eligibility||0
85177|NCT01544582|205353|P3|COMPLETED|Screening/Eligibility||0
85178|NCT01544582|205354|P2|COMPLETED|Screening/Eligibility||0
85179|NCT01544582|205355|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
85180|NCT01544582|205352|P4|Analysis Population|Screening/Eligibility||0
85181|NCT01544582|205353|P3|Analysis Population|Screening/Eligibility||0
85182|NCT01544582|205354|P2|Analysis Population|Screening/Eligibility||0
85183|NCT01544582|205355|P1|Analysis Population|Screening/Eligibility||679
85184|NCT01544582|205352|P4|STARTED|Screening/Eligibility||0
85185|NCT01544582|205353|P3|STARTED|Screening/Eligibility||0
85186|NCT01544582|205354|P2|STARTED|Screening/Eligibility||0
85187|NCT01544582|205355|P1|STARTED|Screening/Eligibility||713
85188|NCT01544478|205413|P1|NOT COMPLETED|Overall Study||118
85189|NCT01544478|205413|P1|COMPLETED|Overall Study||912
85190|NCT01544478|205413|P1|Vaccination 3|Overall Study||1019
85191|NCT01544478|205413|P1|Vaccination 2|Overall Study||1026
85192|NCT01544478|205413|P1|Vaccination 1|Overall Study||1030
85193|NCT01544478|205413|P1|STARTED|Overall Study||1030
85194|NCT01544361|205422|P5|NOT COMPLETED|Overall Study||0
85195|NCT01544361|205423|P4|NOT COMPLETED|Overall Study||0
85196|NCT01544361|205424|P3|NOT COMPLETED|Overall Study||0
85197|NCT01544361|205425|P2|NOT COMPLETED|Overall Study||0
85198|NCT01544361|205426|P1|NOT COMPLETED|Overall Study||0
85199|NCT01544361|205422|P5|COMPLETED|Overall Study||6
85200|NCT01544361|205423|P4|COMPLETED|Overall Study||6
85201|NCT01544361|205424|P3|COMPLETED|Overall Study||6
85202|NCT01544361|205425|P2|COMPLETED|Overall Study||6
85203|NCT01544361|205426|P1|COMPLETED|Overall Study||8
85204|NCT01544361|205422|P5|STARTED|Overall Study||6
85205|NCT01544361|205423|P4|STARTED|Overall Study||6
85206|NCT01544361|205424|P3|STARTED|Overall Study||6
85207|NCT01544361|205425|P2|STARTED|Overall Study||6
85208|NCT01544361|205426|P1|STARTED|Overall Study||8
85209|NCT01544348|205456|P8|NOT COMPLETED|Overall Study||0
85210|NCT01544348|205457|P7|NOT COMPLETED|Overall Study||2
85211|NCT01544348|205458|P6|NOT COMPLETED|Overall Study||3
85212|NCT01544348|205459|P5|NOT COMPLETED|Overall Study||1
85213|NCT01544348|205460|P4|NOT COMPLETED|Overall Study||0
85214|NCT01544348|205461|P3|NOT COMPLETED|Overall Study||0
85215|NCT01544348|205462|P2|NOT COMPLETED|Overall Study||0
85216|NCT01544348|205463|P1|NOT COMPLETED|Overall Study||2
85217|NCT01544348|205456|P8|COMPLETED|Overall Study||8
85218|NCT01544348|205457|P7|COMPLETED|Overall Study||12
85219|NCT01544348|205458|P6|COMPLETED|Overall Study||16
85220|NCT01544348|205459|P5|COMPLETED|Overall Study||15
85221|NCT01544348|205460|P4|COMPLETED|Overall Study||3
85222|NCT01544348|205461|P3|COMPLETED|Overall Study||3
85223|NCT01544348|205462|P2|COMPLETED|Overall Study||6
85224|NCT01544348|205463|P1|COMPLETED|Overall Study||15
85225|NCT01544348|205456|P8|Treated|Overall Study||8
85226|NCT01544348|205457|P7|Treated|Overall Study||14
85227|NCT01544348|205458|P6|Treated|Overall Study||18
85228|NCT01544348|205459|P5|Treated|Overall Study||15
85229|NCT01544348|205460|P4|Treated|Overall Study||3
85230|NCT01544348|205461|P3|Treated|Overall Study||3
85231|NCT01544348|205462|P2|Treated|Overall Study||6
85232|NCT01544348|205463|P1|Treated|Overall Study||17
85233|NCT01544348|205456|P8|STARTED|Overall Study||8
85234|NCT01544348|205457|P7|STARTED|Overall Study||14
85235|NCT01544348|205458|P6|STARTED|Overall Study||19
85236|NCT01544348|205459|P5|STARTED|Overall Study||16
85237|NCT01544348|205460|P4|STARTED|Overall Study||3
85238|NCT01544348|205461|P3|STARTED|Overall Study||3
85239|NCT01544348|205462|P2|STARTED|Overall Study||6
85240|NCT01544348|205463|P1|STARTED|Overall Study||17
85241|NCT01544309|205505|P2|NOT COMPLETED|Overall Study||11
85242|NCT01544309|205506|P1|NOT COMPLETED|Overall Study||20
85243|NCT01544309|205505|P2|COMPLETED|Overall Study||514
85244|NCT01544309|205506|P1|COMPLETED|Overall Study||504
85245|NCT01544309|205505|P2|STARTED|Overall Study||525
85246|NCT01544309|205506|P1|STARTED|Overall Study||524
85247|NCT01544179|205544|P2|NOT COMPLETED|Overall Study||46
85248|NCT01544179|205545|P1|NOT COMPLETED|Overall Study||63
85249|NCT01544179|205544|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
85250|NCT01544179|205545|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
85251|NCT01544179|205544|P2|Did Not Receive Treatment|Overall Study||0
85252|NCT01544179|205545|P1|Did Not Receive Treatment|Overall Study||1
85253|NCT01544179|205544|P2|Received Treatment|Overall Study||132
85254|NCT01544179|205545|P1|Received Treatment|Overall Study||132
85255|NCT01544179|205544|P2|STARTED|Overall Study||132
85256|NCT01544179|205545|P1|STARTED|Overall Study||133
85257|NCT01544166|205573|P1|NOT COMPLETED|Overall Study||0
85258|NCT01544166|205573|P1|COMPLETED|Overall Study||44
85259|NCT01544166|205573|P1|STARTED|Overall Study||44
85260|NCT01544153|205638|P4|NOT COMPLETED|Overall Study||0
85261|NCT01544153|205639|P3|NOT COMPLETED|Overall Study||1
85262|NCT01544153|205640|P2|NOT COMPLETED|Overall Study||1
85263|NCT01544153|205641|P1|NOT COMPLETED|Overall Study||0
85264|NCT01544153|205638|P4|COMPLETED|Overall Study||1317
85265|NCT01544153|205639|P3|COMPLETED|Overall Study||1313
85266|NCT01544153|205640|P2|COMPLETED|Overall Study||1323
85267|NCT01544153|205641|P1|COMPLETED|Overall Study||1337
85268|NCT01544153|205638|P4|STARTED|Overall Study||1317
85269|NCT01544153|205639|P3|STARTED|Overall Study||1314
85270|NCT01544153|205640|P2|STARTED|Overall Study||1324
85271|NCT01544153|205641|P1|STARTED|Overall Study||1337
85272|NCT01544114|205658|P3|NOT COMPLETED|Overall Study||5
85273|NCT01544114|205659|P2|NOT COMPLETED|Overall Study||4
85274|NCT01544114|205660|P1|NOT COMPLETED|Overall Study||1
85275|NCT01544114|205658|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
85276|NCT01544114|205659|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
85277|NCT01544114|205660|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
85278|NCT01544114|205658|P3|STARTED|Overall Study||22
85279|NCT01544114|205659|P2|STARTED|Overall Study||20
85280|NCT01544114|205660|P1|STARTED|Overall Study||4
85281|NCT01544062|205691|P2|NOT COMPLETED|Overall Study||0
85282|NCT01544062|205692|P1|NOT COMPLETED|Overall Study||0
85283|NCT01544062|205691|P2|COMPLETED|Overall Study||35
85284|NCT01544062|205692|P1|COMPLETED|Overall Study||33
85285|NCT01544062|205691|P2|STARTED|Overall Study||35
85286|NCT01544062|205692|P1|STARTED|Overall Study||33
85287|NCT01544023|205738|P1|NOT COMPLETED|Overall Study||0
85288|NCT01544023|205738|P1|COMPLETED|Overall Study||207
85289|NCT01544023|205738|P1|STARTED|Overall Study|retrospective|207
85290|NCT01543958|205743|P1|NOT COMPLETED|Overall Study||4
85291|NCT01543958|205743|P1|COMPLETED|Overall Study||36
85292|NCT01543958|205743|P1|STARTED|Overall Study||40
85293|NCT01543828|205798|P2|NOT COMPLETED|Treatment 2||0
85294|NCT01543828|205799|P1|NOT COMPLETED|Treatment 2||1
85295|NCT01543828|205798|P2|COMPLETED|Treatment 2||19
85296|NCT01543828|205799|P1|COMPLETED|Treatment 2||19
85297|NCT01543828|205798|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
85298|NCT01543828|205799|P1|STARTED|Treatment 2||20
85299|NCT01543828|205798|P2|NOT COMPLETED|Treatment 1||0
85300|NCT01543828|205799|P1|NOT COMPLETED|Treatment 1||0
85301|NCT01543828|205798|P2|COMPLETED|Treatment 1||20
85302|NCT01543828|205799|P1|COMPLETED|Treatment 1||20
85303|NCT01543828|205798|P2|STARTED|Treatment 1||20
85304|NCT01543828|205799|P1|STARTED|Treatment 1||20
85305|NCT01543685|205812|P5|NOT COMPLETED|Overall Study||4
85306|NCT01543685|205813|P4|NOT COMPLETED|Overall Study||0
85307|NCT01543685|205814|P3|NOT COMPLETED|Overall Study||2
85308|NCT01543685|205815|P2|NOT COMPLETED|Overall Study||3
85309|NCT01543685|205816|P1|NOT COMPLETED|Overall Study||3
85310|NCT01543685|205812|P5|COMPLETED|Overall Study||90
85311|NCT01543685|205813|P4|COMPLETED|Overall Study||93
85312|NCT01543685|205814|P3|COMPLETED|Overall Study||89
85313|NCT01543685|205815|P2|COMPLETED|Overall Study||88
85314|NCT01543685|205816|P1|COMPLETED|Overall Study||90
85315|NCT01543685|205812|P5|STARTED|Overall Study||94
85316|NCT01543685|205813|P4|STARTED|Overall Study||93
85317|NCT01543685|205814|P3|STARTED|Overall Study||91
85318|NCT01543685|205815|P2|STARTED|Overall Study||91
85319|NCT01543685|205816|P1|STARTED|Overall Study||93
85320|NCT01543607|205863|P1|NOT COMPLETED|Overall Study||0
85321|NCT01543607|205863|P1|COMPLETED|Overall Study||1
85322|NCT01543607|205863|P1|STARTED|Overall Study||1
85323|NCT01543581|205869|P2|NOT COMPLETED|Overall Study||0
85324|NCT01543581|205870|P1|NOT COMPLETED|Overall Study||0
85325|NCT01543581|205869|P2|COMPLETED|Overall Study||0
85326|NCT01543581|205870|P1|COMPLETED|Overall Study||1
85327|NCT01543581|205869|P2|STARTED|Overall Study||0
85328|NCT01543581|205870|P1|STARTED|Overall Study||1
85329|NCT01543568|205876|P1|NOT COMPLETED|Overall Study||1
85330|NCT01543568|205876|P1|COMPLETED|Overall Study||45
85331|NCT01543568|205876|P1|STARTED|Overall Study||46
85332|NCT01543503|205888|P2|NOT COMPLETED|Overall Study||87
85333|NCT01543503|205889|P1|NOT COMPLETED|Overall Study||76
85334|NCT01543503|205888|P2|COMPLETED|Overall Study||711
85335|NCT01543503|205889|P1|COMPLETED|Overall Study||350
85336|NCT01543503|205888|P2|STARTED|Overall Study||798
85337|NCT01543503|205889|P1|STARTED|Overall Study||426
85338|NCT01543204|205933|P1|NOT COMPLETED|Overall Study||8
85339|NCT01543204|205933|P1|COMPLETED|Overall Study||56
85340|NCT01543204|205933|P1|STARTED|Overall Study||64
85341|NCT01543178|205980|P3|NOT COMPLETED|Double-blind Period||37
85342|NCT01543178|205981|P2|NOT COMPLETED|Double-blind Period||44
85343|NCT01543178|205982|P1|NOT COMPLETED|Double-blind Period||0
85344|NCT01543178|205980|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
85345|NCT01543178|205981|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
85346|NCT01543178|205982|P1|COMPLETED|Double-blind Period||0
85347|NCT01543178|205980|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
85348|NCT01543178|205981|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
85349|NCT01543178|205982|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
85350|NCT01543178|205980|P3|NOT COMPLETED|Open-label Period||0
85351|NCT01543178|205981|P2|NOT COMPLETED|Open-label Period||0
85352|NCT01543178|205982|P1|NOT COMPLETED|Open-label Period||1947
85353|NCT01543178|205980|P3|COMPLETED|Open-label Period||0
85354|NCT01543178|205981|P2|COMPLETED|Open-label Period||0
85355|NCT01543178|205982|P1|COMPLETED|Open-label Period||636
85356|NCT01543178|205980|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
85357|NCT01543178|205981|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
85358|NCT01543178|205982|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
85359|NCT01543074|205993|P4|NOT COMPLETED|Overall Study||0
85360|NCT01543074|205994|P3|NOT COMPLETED|Overall Study||0
85361|NCT01543074|205995|P2|NOT COMPLETED|Overall Study||0
85362|NCT01543074|205996|P1|NOT COMPLETED|Overall Study||0
85363|NCT01543074|205993|P4|COMPLETED|Overall Study||6
85364|NCT01543074|205994|P3|COMPLETED|Overall Study||5
85365|NCT01543074|205995|P2|COMPLETED|Overall Study||7
85366|NCT01543074|205996|P1|COMPLETED|Overall Study||5
85367|NCT01543074|205993|P4|STARTED|Overall Study||6
85368|NCT01543074|205994|P3|STARTED|Overall Study||5
85369|NCT01543074|205995|P2|STARTED|Overall Study||7
85370|NCT01543074|205996|P1|STARTED|Overall Study||5
85371|NCT01542957|206012|P2|NOT COMPLETED|12-month Follow-up||13
85372|NCT01542957|206013|P1|NOT COMPLETED|12-month Follow-up||16
85373|NCT01542957|206012|P2|COMPLETED|12-month Follow-up||40
85374|NCT01542957|206013|P1|COMPLETED|12-month Follow-up||37
85375|NCT01542957|206012|P2|STARTED|12-month Follow-up||53
85376|NCT01542957|206013|P1|STARTED|12-month Follow-up||53
85377|NCT01542957|206012|P2|NOT COMPLETED|3-month Follow-up||8
85378|NCT01542957|206013|P1|NOT COMPLETED|3-month Follow-up||3
85379|NCT01542957|206012|P2|COMPLETED|3-month Follow-up||45
85380|NCT01542957|206013|P1|COMPLETED|3-month Follow-up||50
85381|NCT01542957|206012|P2|STARTED|3-month Follow-up||53
85382|NCT01542957|206013|P1|STARTED|3-month Follow-up||53
85383|NCT01542957|206012|P2|NOT COMPLETED|End of Therapy||10
85384|NCT01542957|206013|P1|NOT COMPLETED|End of Therapy||12
85385|NCT01542957|206012|P2|COMPLETED|End of Therapy||53
85386|NCT01542957|206013|P1|COMPLETED|End of Therapy||53
85387|NCT01542957|206012|P2|STARTED|End of Therapy||63
85388|NCT01542957|206013|P1|STARTED|End of Therapy||65
85389|NCT01542788|206025|P2|NOT COMPLETED|Overall Study||71
85390|NCT01542788|206026|P1|NOT COMPLETED|Overall Study||55
85391|NCT01542788|206025|P2|COMPLETED|Overall Study||0
85392|NCT01542788|206026|P1|COMPLETED|Overall Study||154
85393|NCT01542788|206025|P2|Randomized and Treated|Overall Study||71
85394|NCT01542788|206026|P1|Randomized and Treated|Overall Study||207
85395|NCT01542788|206025|P2|STARTED|Overall Study||71
85396|NCT01542788|206026|P1|STARTED|Overall Study||209
85397|NCT01542684|206042|P1|NOT COMPLETED|Overall Study||0
85398|NCT01542684|206042|P1|COMPLETED|Overall Study||8
85399|NCT01542684|206042|P1|STARTED|Overall Study||8
85400|NCT01542645|206048|P2|NOT COMPLETED|Overall Study||3
85401|NCT01542645|206049|P1|NOT COMPLETED|Overall Study||5
85402|NCT01542645|206048|P2|COMPLETED|Overall Study||79
85403|NCT01542645|206049|P1|COMPLETED|Overall Study||77
85404|NCT01542645|206048|P2|STARTED|Overall Study||82
85405|NCT01542645|206049|P1|STARTED|Overall Study||82
85406|NCT01542632|206065|P6|NOT COMPLETED|Overall Study||0
85407|NCT01542632|206066|P5|NOT COMPLETED|Overall Study||4
85408|NCT01542632|206067|P4|NOT COMPLETED|Overall Study||2
85409|NCT01542632|206068|P3|NOT COMPLETED|Overall Study||1
85410|NCT01542632|206069|P2|NOT COMPLETED|Overall Study||1
85411|NCT01542632|206070|P1|NOT COMPLETED|Overall Study||0
85412|NCT01542632|206065|P6|COMPLETED|Overall Study||24
85413|NCT01542632|206066|P5|COMPLETED|Overall Study||17
85414|NCT01542632|206067|P4|COMPLETED|Overall Study||19
85415|NCT01542632|206068|P3|COMPLETED|Overall Study||23
85416|NCT01542632|206069|P2|COMPLETED|Overall Study||24
85417|NCT01542632|206070|P1|COMPLETED|Overall Study||25
85418|NCT01542632|206065|P6|STARTED|Overall Study||24
85419|NCT01542632|206066|P5|STARTED|Overall Study||21
85420|NCT01542632|206067|P4|STARTED|Overall Study||21
85421|NCT01542632|206068|P3|STARTED|Overall Study||24
85422|NCT01542632|206069|P2|STARTED|Overall Study||25
85423|NCT01542632|206070|P1|STARTED|Overall Study||25
85424|NCT01542541|206116|P2|NOT COMPLETED|Overall Study||0
85425|NCT01542541|206117|P1|NOT COMPLETED|Overall Study||8
85426|NCT01542541|206116|P2|COMPLETED|Overall Study||30
85427|NCT01542541|206117|P1|COMPLETED|Overall Study||30
85428|NCT01542541|206116|P2|STARTED|Overall Study||30
85429|NCT01542541|206117|P1|STARTED|Overall Study||38
85430|NCT01542528|206127|P2|NOT COMPLETED|Overall Study||7
85431|NCT01542528|206128|P1|NOT COMPLETED|Overall Study||12
85432|NCT01542528|206127|P2|COMPLETED|Overall Study||49
85433|NCT01542528|206128|P1|COMPLETED|Overall Study||49
85434|NCT01542528|206127|P2|STARTED|Overall Study||56
85435|NCT01542528|206128|P1|STARTED|Overall Study||61
85436|NCT01542502|206136|P2|NOT COMPLETED|Overall Study||0
85437|NCT01542502|206137|P1|NOT COMPLETED|Overall Study||0
85438|NCT01542502|206136|P2|COMPLETED|Overall Study||6
85439|NCT01542502|206137|P1|COMPLETED|Overall Study||6
85440|NCT01542502|206136|P2|STARTED|Overall Study||6
85441|NCT01542502|206137|P1|STARTED|Overall Study||6
85442|NCT01542372|206145|P2|NOT COMPLETED|Overall Study||0
85443|NCT01542372|206146|P1|NOT COMPLETED|Overall Study||0
85444|NCT01542372|206145|P2|COMPLETED|Overall Study||11
85445|NCT01542372|206146|P1|COMPLETED|Overall Study||11
85446|NCT01542372|206145|P2|STARTED|Overall Study||11
85447|NCT01542372|206146|P1|STARTED|Overall Study||11
85448|NCT01542307|206161|P2|NOT COMPLETED|Overall Study||0
85449|NCT01542307|206162|P1|NOT COMPLETED|Overall Study||0
85450|NCT01542307|206161|P2|COMPLETED|Overall Study||22
85451|NCT01542307|206162|P1|COMPLETED|Overall Study||22
85452|NCT01542307|206161|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
85453|NCT01542307|206162|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
85454|NCT01542255|206182|P1|NOT COMPLETED|Overall Study||0
85455|NCT01542255|206182|P1|COMPLETED|Overall Study||7
85456|NCT01542255|206182|P1|Analyzed for Time to Progression|Overall Study||7
85457|NCT01542255|206182|P1|STARTED|Overall Study||7
85458|NCT01542125|206188|P2|NOT COMPLETED|Overall Study||0
85459|NCT01542125|206189|P1|NOT COMPLETED|Overall Study||0
85460|NCT01542125|206188|P2|COMPLETED|Overall Study||141
85461|NCT01542125|206189|P1|COMPLETED|Overall Study||140
85462|NCT01542125|206188|P2|STARTED|Overall Study||141
85463|NCT01542125|206189|P1|STARTED|Overall Study||140
85464|NCT01542034|206197|P2|NOT COMPLETED|Overall Study||23
85465|NCT01542034|206198|P1|NOT COMPLETED|Overall Study||30
85466|NCT01542034|206197|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
85467|NCT01542034|206198|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
85468|NCT01542034|206197|P2|Received Treatment|Overall Study||249
85469|NCT01542034|206198|P1|Received Treatment|Overall Study||256
85470|NCT01542034|206197|P2|STARTED|Overall Study||250
85471|NCT01542034|206198|P1|STARTED|Overall Study||256
85472|NCT01541969|206212|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
85473|NCT01541969|206213|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
85474|NCT01541969|206212|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
85475|NCT01541969|206213|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
85476|NCT01541969|206212|P2|STARTED|Open Label Extension (12-36 Weeks)||48
85477|NCT01541969|206213|P1|STARTED|Open Label Extension (12-36 Weeks)||44
85478|NCT01541969|206212|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
85479|NCT01541969|206213|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
85480|NCT01541969|206212|P2|COMPLETED|Double-blind (0-12 Weeks)||48
85481|NCT01541969|206213|P1|COMPLETED|Double-blind (0-12 Weeks)||44
85482|NCT01541969|206212|P2|STARTED|Double-blind (0-12 Weeks)||50
85483|NCT01541969|206213|P1|STARTED|Double-blind (0-12 Weeks)||50
85484|NCT01541930|206229|P1|NOT COMPLETED|Overall Study||1
85485|NCT01541930|206229|P1|COMPLETED|Overall Study||20
85486|NCT01541930|206229|P1|STARTED|Overall Study||21
85487|NCT01541917|206251|P2|NOT COMPLETED|Overall Study||9
85488|NCT01541917|206252|P1|NOT COMPLETED|Overall Study||15
85489|NCT01541917|206251|P2|COMPLETED|Overall Study||136
85490|NCT01541917|206252|P1|COMPLETED|Overall Study||129
85491|NCT01541917|206251|P2|STARTED|Overall Study||145
85492|NCT01541917|206252|P1|STARTED|Overall Study||144
85493|NCT01541865|206268|P1|NOT COMPLETED|Overall Study||22
85494|NCT01541865|206268|P1|COMPLETED|Overall Study||124
85495|NCT01541865|206268|P1|STARTED|Overall Study||146
85496|NCT01541826|206286|P3|NOT COMPLETED|Overall Study||0
85497|NCT01541826|206287|P2|NOT COMPLETED|Overall Study||3
85498|NCT01541826|206288|P1|NOT COMPLETED|Overall Study||4
85499|NCT01541826|206286|P3|COMPLETED|Overall Study||6
85500|NCT01541826|206287|P2|COMPLETED|Overall Study||25
85501|NCT01541826|206288|P1|COMPLETED|Overall Study||24
85502|NCT01541826|206286|P3|STARTED|Overall Study||6
85503|NCT01541826|206287|P2|STARTED|Overall Study||28
85504|NCT01541826|206288|P1|STARTED|Overall Study||28
85505|NCT01541735|206357|P2|NOT COMPLETED|Overall Study||0
85506|NCT01541735|206358|P1|NOT COMPLETED|Overall Study||0
85507|NCT01541735|206357|P2|COMPLETED|Overall Study||7
85508|NCT01541735|206358|P1|COMPLETED|Overall Study||7
85509|NCT01541735|206357|P2|STARTED|Overall Study||7
85510|NCT01541735|206358|P1|STARTED|Overall Study||7
85511|NCT01541644|206370|P1|NOT COMPLETED|Overall Study||3
85512|NCT01541644|206370|P1|COMPLETED|Overall Study||24
85513|NCT01541644|206370|P1|STARTED|Overall Study||27
85514|NCT01541553|206376|P2|NOT COMPLETED|Overall Study||14
85515|NCT01541553|206377|P1|NOT COMPLETED|Overall Study||12
85516|NCT01541553|206376|P2|COMPLETED|Overall Study||148
85517|NCT01541553|206377|P1|COMPLETED|Overall Study||155
85518|NCT01541553|206376|P2|STARTED|Overall Study||162
85519|NCT01541553|206377|P1|STARTED|Overall Study||167
85520|NCT01541397|206389|P2|NOT COMPLETED|Overall Study||2
85521|NCT01541397|206390|P1|NOT COMPLETED|Overall Study||4
85522|NCT01541397|206389|P2|COMPLETED|Overall Study||0
85523|NCT01541397|206390|P1|COMPLETED|Overall Study||0
85524|NCT01541397|206389|P2|STARTED|Overall Study||2
85525|NCT01541397|206390|P1|STARTED|Overall Study||4
85526|NCT01541384|206405|P3|NOT COMPLETED|Overall Study||2
85527|NCT01541384|206406|P2|NOT COMPLETED|Overall Study||1
85528|NCT01541384|206407|P1|NOT COMPLETED|Overall Study||0
85529|NCT01541384|206405|P3|COMPLETED|Overall Study||38
85530|NCT01541384|206406|P2|COMPLETED|Overall Study||39
85531|NCT01541384|206407|P1|COMPLETED|Overall Study||40
85532|NCT01541384|206405|P3|STARTED|Overall Study||40
85533|NCT01541384|206406|P2|STARTED|Overall Study||40
85534|NCT01541384|206407|P1|STARTED|Overall Study||40
85535|NCT01541371|206415|P1|NOT COMPLETED|Overall Study||77
85536|NCT01541371|206415|P1|COMPLETED|Overall Study||326
85537|NCT01541371|206415|P1|Full Analysis Set|Overall Study||394
85538|NCT01541371|206415|P1|STARTED|Overall Study||403
85539|NCT01541358|206438|P1|NOT COMPLETED|Overall Study||0
85540|NCT01541358|206438|P1|COMPLETED|Overall Study||2
85541|NCT01541358|206438|P1|STARTED|Overall Study||2
85542|NCT01541254|206444|P1|NOT COMPLETED|Overall Study||6
85543|NCT01541254|206444|P1|COMPLETED|Overall Study||30
85544|NCT01541254|206444|P1|STARTED|Overall Study||36
85545|NCT01540981|206451|P2|NOT COMPLETED|Overall Study||0
85546|NCT01540981|206452|P1|NOT COMPLETED|Overall Study||1
85547|NCT01540981|206451|P2|COMPLETED|Overall Study||6
85548|NCT01540981|206452|P1|COMPLETED|Overall Study||5
85549|NCT01540981|206451|P2|STARTED|Overall Study||6
85550|NCT01540981|206452|P1|STARTED|Overall Study||6
85551|NCT01540851|206462|P2|NOT COMPLETED|Overall Study||18
85552|NCT01540851|206463|P1|NOT COMPLETED|Overall Study||21
85553|NCT01540851|206462|P2|COMPLETED|Overall Study||136
85554|NCT01540851|206463|P1|COMPLETED|Overall Study||133
85555|NCT01540851|206462|P2|STARTED|Overall Study||154
85556|NCT01540851|206463|P1|STARTED|Overall Study||154
85557|NCT01540825|206484|P11|NOT COMPLETED|Overall Study||0
85558|NCT01540825|206485|P10|NOT COMPLETED|Overall Study||0
85559|NCT01540825|206486|P9|NOT COMPLETED|Overall Study||0
85560|NCT01540825|206487|P8|NOT COMPLETED|Overall Study||0
85561|NCT01540825|206488|P7|NOT COMPLETED|Overall Study||0
85562|NCT01540825|206489|P6|NOT COMPLETED|Overall Study||0
85563|NCT01540825|206490|P5|NOT COMPLETED|Overall Study||0
85564|NCT01540825|206491|P4|NOT COMPLETED|Overall Study||0
85565|NCT01540825|206492|P3|NOT COMPLETED|Overall Study||0
85566|NCT01540825|206493|P2|NOT COMPLETED|Overall Study||0
85567|NCT01540825|206494|P1|NOT COMPLETED|Overall Study||0
85568|NCT01540825|206484|P11|COMPLETED|Overall Study||6
85569|NCT01540825|206485|P10|COMPLETED|Overall Study||6
85570|NCT01540825|206486|P9|COMPLETED|Overall Study||6
85571|NCT01540825|206487|P8|COMPLETED|Overall Study||6
85572|NCT01540825|206488|P7|COMPLETED|Overall Study||6
85573|NCT01540825|206489|P6|COMPLETED|Overall Study||6
85574|NCT01540825|206490|P5|COMPLETED|Overall Study||6
85575|NCT01540825|206491|P4|COMPLETED|Overall Study||6
85576|NCT01540825|206492|P3|COMPLETED|Overall Study||6
85577|NCT01540825|206493|P2|COMPLETED|Overall Study||6
85578|NCT01540825|206494|P1|COMPLETED|Overall Study||20
85579|NCT01540825|206484|P11|STARTED|Overall Study||6
85580|NCT01540825|206485|P10|STARTED|Overall Study||6
85581|NCT01540825|206486|P9|STARTED|Overall Study||6
85582|NCT01540825|206487|P8|STARTED|Overall Study||6
85583|NCT01540825|206488|P7|STARTED|Overall Study||6
85584|NCT01540825|206489|P6|STARTED|Overall Study||6
85585|NCT01540825|206490|P5|STARTED|Overall Study||6
85586|NCT01540825|206491|P4|STARTED|Overall Study||6
85587|NCT01540825|206492|P3|STARTED|Overall Study||6
85588|NCT01540825|206493|P2|STARTED|Overall Study||6
85589|NCT01540825|206494|P1|STARTED|Overall Study||20
85590|NCT01540773|206590|P2|NOT COMPLETED|Second Intervention||0
85591|NCT01540773|206591|P1|NOT COMPLETED|Second Intervention||0
85592|NCT01540773|206590|P2|COMPLETED|Second Intervention||8
85593|NCT01540773|206591|P1|COMPLETED|Second Intervention||8
85594|NCT01540773|206590|P2|STARTED|Second Intervention||8
85595|NCT01540773|206591|P1|STARTED|Second Intervention||8
85596|NCT01540773|206590|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
85597|NCT01540773|206591|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
85598|NCT01540773|206590|P2|COMPLETED|Wash Out Period of 1 Week||8
85599|NCT01540773|206591|P1|COMPLETED|Wash Out Period of 1 Week||8
85600|NCT01540773|206590|P2|STARTED|Wash Out Period of 1 Week||8
85601|NCT01540773|206591|P1|STARTED|Wash Out Period of 1 Week||8
85602|NCT01540773|206590|P2|NOT COMPLETED|First Intervention||0
85603|NCT01540773|206591|P1|NOT COMPLETED|First Intervention||0
85604|NCT01540773|206590|P2|COMPLETED|First Intervention||8
85605|NCT01540773|206591|P1|COMPLETED|First Intervention||8
85606|NCT01540773|206590|P2|STARTED|First Intervention||8
85607|NCT01540773|206591|P1|STARTED|First Intervention||8
85608|NCT01540513|206599|P1|NOT COMPLETED|Overall Study||0
85609|NCT01540513|206599|P1|COMPLETED|Overall Study||12
85610|NCT01540513|206599|P1|STARTED|Overall Study||12
85611|NCT01540487|206608|P2|NOT COMPLETED|Overall Study||0
85612|NCT01540487|206609|P1|NOT COMPLETED|Overall Study||1
85613|NCT01540487|206608|P2|COMPLETED|Overall Study||24
85614|NCT01540487|206609|P1|COMPLETED|Overall Study||23
85615|NCT01540487|206608|P2|STARTED|Overall Study||24
85616|NCT01540487|206609|P1|STARTED|Overall Study||24
85617|NCT01540370|206643|P1|NOT COMPLETED|Overall Study||2
85618|NCT01540370|206643|P1|COMPLETED|Overall Study||100
85619|NCT01540370|206643|P1|STARTED|Overall Study||102
85620|NCT01540266|206654|P6|NOT COMPLETED|Overall Study||0
85621|NCT01540266|206655|P5|NOT COMPLETED|Overall Study||0
85622|NCT01540266|206656|P4|NOT COMPLETED|Overall Study||0
85623|NCT01540266|206657|P3|NOT COMPLETED|Overall Study||1
85624|NCT01540266|206658|P2|NOT COMPLETED|Overall Study||1
85625|NCT01540266|206659|P1|NOT COMPLETED|Overall Study||6
85626|NCT01540266|206654|P6|COMPLETED|Overall Study||19
85627|NCT01540266|206655|P5|COMPLETED|Overall Study||20
85628|NCT01540266|206656|P4|COMPLETED|Overall Study||38
85629|NCT01540266|206657|P3|COMPLETED|Overall Study||59
85630|NCT01540266|206658|P2|COMPLETED|Overall Study||41
85631|NCT01540266|206659|P1|COMPLETED|Overall Study||57
85632|NCT01540266|206654|P6|STARTED|Overall Study||19
85633|NCT01540266|206655|P5|STARTED|Overall Study||20
85634|NCT01540266|206656|P4|STARTED|Overall Study||38
85635|NCT01540266|206657|P3|STARTED|Overall Study||60
85636|NCT01540266|206658|P2|STARTED|Overall Study||42
85637|NCT01540266|206659|P1|STARTED|Overall Study||63
85638|NCT01540162|206675|P2|NOT COMPLETED|Overall Study||0
85639|NCT01540162|206676|P1|NOT COMPLETED|Overall Study||0
85640|NCT01540162|206675|P2|COMPLETED|Overall Study||32
85641|NCT01540162|206676|P1|COMPLETED|Overall Study||30
85642|NCT01540162|206675|P2|STARTED|Overall Study||32
85643|NCT01540162|206676|P1|STARTED|Overall Study||30
85644|NCT01540045|206686|P1|NOT COMPLETED|Overall Study||0
85645|NCT01540045|206686|P1|COMPLETED|Overall Study||40
85646|NCT01540045|206686|P1|STARTED|Overall Study||40
85647|NCT01539980|206725|P1|NOT COMPLETED|Overall Study||0
85648|NCT01539980|206725|P1|COMPLETED|Overall Study||30
85649|NCT01539980|206725|P1|STARTED|Overall Study||30
85650|NCT01539811|206735|P2|NOT COMPLETED|Overall Study||0
85651|NCT01539811|206736|P1|NOT COMPLETED|Overall Study||0
85652|NCT01539811|206735|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
85653|NCT01539811|206736|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
85654|NCT01539811|206735|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
85655|NCT01539811|206736|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
85656|NCT01539759|206744|P2|NOT COMPLETED|Overall Study||8
85657|NCT01539759|206745|P1|NOT COMPLETED|Overall Study||6
85658|NCT01539759|206744|P2|COMPLETED|Overall Study||48
85659|NCT01539759|206745|P1|COMPLETED|Overall Study||50
85660|NCT01539759|206744|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
85661|NCT01539759|206745|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
85662|NCT01539759|206744|P2|IUD Removal|Overall Study||7
85663|NCT01539759|206745|P1|IUD Removal|Overall Study||2
85664|NCT01539759|206744|P2|IUD Expulsion|Overall Study||4
85665|NCT01539759|206745|P1|IUD Expulsion|Overall Study||1
85666|NCT01539759|206744|P2|Had Successful IUD Placement|Overall Study||53
85667|NCT01539759|206745|P1|Had Successful IUD Placement|Overall Study||34
85668|NCT01539759|206744|P2|STARTED|Overall Study||56
85669|NCT01539759|206745|P1|STARTED|Overall Study||56
85670|NCT01539642|206757|P2|NOT COMPLETED|Overall Study||31
85671|NCT01539642|206758|P1|NOT COMPLETED|Overall Study||36
85672|NCT01539642|206757|P2|COMPLETED|Overall Study||27
85673|NCT01539642|206758|P1|COMPLETED|Overall Study||78
85674|NCT01539642|206757|P2|STARTED|Overall Study||58
85675|NCT01539642|206758|P1|STARTED|Overall Study||114
85676|NCT01539590|206766|P2|NOT COMPLETED|Overall Study||0
85677|NCT01539590|206767|P1|NOT COMPLETED|Overall Study||3
85678|NCT01539590|206766|P2|COMPLETED|Overall Study||2
85679|NCT01539590|206767|P1|COMPLETED|Overall Study||0
85680|NCT01539590|206766|P2|Complete Study Treatment|Overall Study||2
85681|NCT01539590|206767|P1|Complete Study Treatment|Overall Study||1
85682|NCT01539590|206766|P2|STARTED|Overall Study||2
85683|NCT01539590|206767|P1|STARTED|Overall Study||3
85684|NCT01539538|206775|P2|NOT COMPLETED|Overall Study||44
85685|NCT01539538|206776|P1|NOT COMPLETED|Overall Study||31
85686|NCT01539538|206775|P2|COMPLETED|Overall Study||136
85687|NCT01539538|206776|P1|COMPLETED|Overall Study||146
85688|NCT01539538|206775|P2|STARTED|Overall Study||180
85689|NCT01539538|206776|P1|STARTED|Overall Study||177
85690|NCT01539525|206785|P3|NOT COMPLETED|Overall Study||17
85691|NCT01539525|206786|P2|NOT COMPLETED|Overall Study||16
85692|NCT01539525|206787|P1|NOT COMPLETED|Overall Study||20
85693|NCT01539525|206785|P3|COMPLETED|Overall Study||134
85694|NCT01539525|206786|P2|COMPLETED|Overall Study||127
85695|NCT01539525|206787|P1|COMPLETED|Overall Study||125
85696|NCT01539525|206785|P3|STARTED|Overall Study||151
85697|NCT01539525|206786|P2|STARTED|Overall Study||143
85698|NCT01539525|206787|P1|STARTED|Overall Study||145
85699|NCT01539512|206806|P2|NOT COMPLETED|Overall Study||13
85700|NCT01539512|206807|P1|NOT COMPLETED|Overall Study||23
85701|NCT01539512|206806|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
85702|NCT01539512|206807|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
85703|NCT01539512|206806|P2|STARTED|Overall Study||110
85704|NCT01539512|206807|P1|STARTED|Overall Study||110
85705|NCT01539317|206823|P2|NOT COMPLETED|Overall Study||0
85706|NCT01539317|206824|P1|NOT COMPLETED|Overall Study||1
85707|NCT01539317|206823|P2|COMPLETED|Overall Study||25
85708|NCT01539317|206824|P1|COMPLETED|Overall Study||24
85709|NCT01539317|206823|P2|STARTED|Overall Study||25
85710|NCT01539317|206824|P1|STARTED|Overall Study||25
85711|NCT01539135|206841|P2|NOT COMPLETED|Overall Study||0
85712|NCT01539135|206842|P1|NOT COMPLETED|Overall Study||0
85713|NCT01539135|206841|P2|COMPLETED|Overall Study||37
85714|NCT01539135|206842|P1|COMPLETED|Overall Study||43
85715|NCT01539135|206841|P2|STARTED|Overall Study||37
85716|NCT01539135|206842|P1|STARTED|Overall Study||43
85717|NCT01539083|206854|P3|NOT COMPLETED|After Randomization (TP and VTP)||11
85718|NCT01539083|206855|P2|NOT COMPLETED|After Randomization (TP and VTP)||13
85719|NCT01539083|206856|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
85720|NCT01539083|206854|P3|COMPLETED|After Randomization (TP and VTP)||92
85721|NCT01539083|206855|P2|COMPLETED|After Randomization (TP and VTP)||87
85722|NCT01539083|206856|P1|COMPLETED|After Randomization (TP and VTP)||0
85723|NCT01539083|206854|P3|Safety Population|After Randomization (TP and VTP)||103
85724|NCT01539083|206855|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
85725|NCT01539083|206856|P1|Safety Population|After Randomization (TP and VTP)||0
85726|NCT01539083|206854|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|103
85727|NCT01539083|206855|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
85728|NCT01539083|206856|P1|STARTED|After Randomization (TP and VTP)||0
85729|NCT01539083|206854|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
85730|NCT01539083|206855|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
85731|NCT01539083|206856|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
85732|NCT01539083|206854|P3|COMPLETED|Before Randomization (VCD Induction)||0
85733|NCT01539083|206855|P2|COMPLETED|Before Randomization (VCD Induction)||0
85734|NCT01539083|206856|P1|COMPLETED|Before Randomization (VCD Induction)||203
85735|NCT01539083|206854|P3|Treated|Before Randomization (VCD Induction)||0
85736|NCT01539083|206855|P2|Treated|Before Randomization (VCD Induction)||0
85737|NCT01539083|206856|P1|Treated|Before Randomization (VCD Induction)||254
85738|NCT01539083|206854|P3|STARTED|Before Randomization (VCD Induction)||0
85739|NCT01539083|206855|P2|STARTED|Before Randomization (VCD Induction)||0
85740|NCT01539083|206856|P1|STARTED|Before Randomization (VCD Induction)||256
85741|NCT01539070|206879|P2|NOT COMPLETED|Overall Study||39
85742|NCT01539070|206880|P1|NOT COMPLETED|Overall Study||59
85743|NCT01539070|206879|P2|COMPLETED|Overall Study||99
85744|NCT01539070|206880|P1|COMPLETED|Overall Study||109
85745|NCT01539070|206879|P2|STARTED|Overall Study||138
85746|NCT01539070|206880|P1|STARTED|Overall Study||168
85747|NCT01538862|206892|P1|NOT COMPLETED|Overall Study||0
85748|NCT01538862|206892|P1|COMPLETED|Overall Study||7
85749|NCT01538862|206892|P1|STARTED|Overall Study||7
85750|NCT01538719|206900|P2|NOT COMPLETED|Overall Study||0
85751|NCT01538719|206901|P1|NOT COMPLETED|Overall Study||2
85752|NCT01538719|206900|P2|COMPLETED|Overall Study||12
85753|NCT01538719|206901|P1|COMPLETED|Overall Study||5
85754|NCT01538719|206900|P2|STARTED|Overall Study||12
85755|NCT01538719|206901|P1|STARTED|Overall Study||7
85756|NCT01538615|206911|P2|NOT COMPLETED|Overall Study||12
85757|NCT01538615|206912|P1|NOT COMPLETED|Overall Study||22
85758|NCT01538615|206911|P2|COMPLETED|Overall Study||146
85759|NCT01538615|206912|P1|COMPLETED|Overall Study||140
85760|NCT01538615|206911|P2|STARTED|Overall Study||158
85761|NCT01538615|206912|P1|STARTED|Overall Study||162
85762|NCT01538472|206924|P1|NOT COMPLETED|Overall Study||4
85763|NCT01538472|206924|P1|COMPLETED|Overall Study||36
85764|NCT01538472|206924|P1|STARTED|Overall Study||40
85765|NCT01538199|206935|P4|NOT COMPLETED|Overall Study||2
85766|NCT01538199|206936|P3|NOT COMPLETED|Overall Study||1
85767|NCT01538199|206937|P2|NOT COMPLETED|Overall Study||3
85768|NCT01538199|206938|P1|NOT COMPLETED|Overall Study||2
85852|NCT01537185|207129|P1|NOT COMPLETED|Overall Study||3
85769|NCT01538199|206935|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
85770|NCT01538199|206936|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
85771|NCT01538199|206937|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
85772|NCT01538199|206938|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
85773|NCT01538199|206935|P4|STARTED|Overall Study||3
85774|NCT01538199|206936|P3|STARTED|Overall Study||4
85775|NCT01538199|206937|P2|STARTED|Overall Study||11
85776|NCT01538199|206938|P1|STARTED|Overall Study||10
85777|NCT01537900|206961|P1|NOT COMPLETED|Overall Study||0
85778|NCT01537900|206961|P1|COMPLETED|Overall Study||4
85779|NCT01537900|206961|P1|STARTED|Overall Study||4
85780|NCT01537835|206975|P3|NOT COMPLETED|Overall Study||0
85781|NCT01537835|206976|P2|NOT COMPLETED|Overall Study||0
85782|NCT01537835|206977|P1|NOT COMPLETED|Overall Study||0
85783|NCT01537835|206975|P3|COMPLETED|Overall Study||35
85784|NCT01537835|206976|P2|COMPLETED|Overall Study||37
85785|NCT01537835|206977|P1|COMPLETED|Overall Study||37
85786|NCT01537835|206975|P3|STARTED|Overall Study||35
85787|NCT01537835|206976|P2|STARTED|Overall Study||37
85788|NCT01537835|206977|P1|STARTED|Overall Study||37
85789|NCT01537783|206990|P2|NOT COMPLETED|Overall Study||2
85790|NCT01537783|206991|P1|NOT COMPLETED|Overall Study||11
85791|NCT01537783|206990|P2|COMPLETED|Overall Study||23
85792|NCT01537783|206991|P1|COMPLETED|Overall Study||14
85793|NCT01537783|206990|P2|STARTED|Overall Study||25
85794|NCT01537783|206991|P1|STARTED|Overall Study||25
85795|NCT01537666|207001|P4|NOT COMPLETED|Overall Study||0
85796|NCT01537666|207002|P3|NOT COMPLETED|Overall Study||0
85797|NCT01537666|207003|P2|NOT COMPLETED|Overall Study||0
85798|NCT01537666|207004|P1|NOT COMPLETED|Overall Study||0
85799|NCT01537666|207001|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
85800|NCT01537666|207002|P3|COMPLETED|Overall Study||6
85801|NCT01537666|207003|P2|COMPLETED|Overall Study||6
85802|NCT01537666|207004|P1|COMPLETED|Overall Study||6
85803|NCT01537666|207001|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
85804|NCT01537666|207002|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
85805|NCT01537666|207003|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
85806|NCT01537666|207004|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
85807|NCT01537549|207042|P1|NOT COMPLETED|Overall Study||3
85808|NCT01537549|207042|P1|COMPLETED|Overall Study||8
85809|NCT01537549|207042|P1|STARTED|Overall Study||11
85810|NCT01537432|207050|P2|NOT COMPLETED|Overall Study||2
85811|NCT01537432|207051|P1|NOT COMPLETED|Overall Study||6
85812|NCT01537432|207050|P2|COMPLETED|Overall Study||10
85813|NCT01537432|207051|P1|COMPLETED|Overall Study||18
85814|NCT01537432|207050|P2|STARTED|Overall Study||12
85815|NCT01537432|207051|P1|STARTED|Overall Study||24
85816|NCT01537419|207061|P2|NOT COMPLETED|Overall Study||12
85817|NCT01537419|207062|P1|NOT COMPLETED|Overall Study||11
85818|NCT01537419|207061|P2|COMPLETED|Overall Study||54
85819|NCT01537419|207062|P1|COMPLETED|Overall Study||52
85820|NCT01537419|207061|P2|STARTED|Overall Study||66
85821|NCT01537419|207062|P1|STARTED|Overall Study||63
85822|NCT01537393|207074|P2|NOT COMPLETED|Overall Study||191
85823|NCT01537393|207075|P1|NOT COMPLETED|Overall Study||154
85824|NCT01537393|207074|P2|COMPLETED|Overall Study||507
85825|NCT01537393|207075|P1|COMPLETED|Overall Study||553
85826|NCT01537393|207074|P2|STARTED|Overall Study||698
85827|NCT01537393|207075|P1|STARTED|Overall Study||707
85828|NCT01537367|207086|P3|NOT COMPLETED|Overall Study||0
85829|NCT01537367|207087|P2|NOT COMPLETED|Overall Study||0
85830|NCT01537367|207088|P1|NOT COMPLETED|Overall Study||0
85831|NCT01537367|207086|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
85832|NCT01537367|207087|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
85833|NCT01537367|207088|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
85834|NCT01537367|207086|P3|STARTED|Overall Study||613
85835|NCT01537367|207087|P2|STARTED|Overall Study||610
85836|NCT01537367|207088|P1|STARTED|Overall Study||615
85837|NCT01537315|207104|P2|NOT COMPLETED|Overall Study||0
85838|NCT01537315|207105|P1|NOT COMPLETED|Overall Study||0
85839|NCT01537315|207104|P2|COMPLETED|Overall Study||7
85840|NCT01537315|207105|P1|COMPLETED|Overall Study||1
85841|NCT01537315|207104|P2|STARTED|Overall Study||7
85842|NCT01537315|207105|P1|STARTED|Overall Study||1
85843|NCT01537302|207111|P1|NOT COMPLETED|Overall Study||2
85844|NCT01537302|207111|P1|COMPLETED|Overall Study||199
85845|NCT01537302|207111|P1|STARTED|Overall Study||201
85846|NCT01537198|207118|P1|NOT COMPLETED|Overall Study||154
85847|NCT01537198|207118|P1|COMPLETED|Overall Study||463
85848|NCT01537198|207118|P1|STARTED|Overall Study||617
85849|NCT01537185|207126|P4|NOT COMPLETED|Overall Study||2
85850|NCT01537185|207127|P3|NOT COMPLETED|Overall Study||6
85851|NCT01537185|207128|P2|NOT COMPLETED|Overall Study||6
85853|NCT01537185|207126|P4|COMPLETED|Overall Study||8
85854|NCT01537185|207127|P3|COMPLETED|Overall Study||4
85855|NCT01537185|207128|P2|COMPLETED|Overall Study||6
85856|NCT01537185|207129|P1|COMPLETED|Overall Study||7
85857|NCT01537185|207126|P4|STARTED|Overall Study||10
85858|NCT01537185|207127|P3|STARTED|Overall Study||10
85859|NCT01537185|207128|P2|STARTED|Overall Study||12
85860|NCT01537185|207129|P1|STARTED|Overall Study||10
85861|NCT01537133|207147|P4|NOT COMPLETED|Overall Study||0
85862|NCT01537133|207148|P3|NOT COMPLETED|Overall Study||0
85863|NCT01537133|207149|P2|NOT COMPLETED|Overall Study||0
85864|NCT01537133|207150|P1|NOT COMPLETED|Overall Study||3
85865|NCT01537133|207147|P4|COMPLETED|Overall Study||21
85866|NCT01537133|207148|P3|COMPLETED|Overall Study||21
85867|NCT01537133|207149|P2|COMPLETED|Overall Study||14
85868|NCT01537133|207150|P1|COMPLETED|Overall Study||25
85869|NCT01537133|207147|P4|STARTED|Overall Study||21
85870|NCT01537133|207148|P3|STARTED|Overall Study||21
85871|NCT01537133|207149|P2|STARTED|Overall Study||14
85872|NCT01537133|207150|P1|STARTED|Overall Study||28
85873|NCT01537120|207166|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
85874|NCT01537120|207166|P1|COMPLETED|12 Weeks Vildagliptin||23
85875|NCT01537120|207166|P1|STARTED|12 Weeks Vildagliptin||23
85876|NCT01537120|207166|P1|NOT COMPLETED|3 Weeks Placebo||1
85877|NCT01537120|207166|P1|COMPLETED|3 Weeks Placebo||23
85878|NCT01537120|207166|P1|STARTED|3 Weeks Placebo||24
85879|NCT01537120|207166|P1|NOT COMPLETED|8 Weeks Washout||1
85880|NCT01537120|207166|P1|COMPLETED|8 Weeks Washout||24
85881|NCT01537120|207166|P1|STARTED|8 Weeks Washout||25
85882|NCT01537120|207166|P1|NOT COMPLETED|Enrolled||0
85883|NCT01537120|207166|P1|COMPLETED|Enrolled||25
85884|NCT01537120|207166|P1|STARTED|Enrolled||25
85885|NCT01537081|207179|P3|NOT COMPLETED|Overall Study||16
85886|NCT01537081|207180|P2|NOT COMPLETED|Overall Study||38
85887|NCT01537081|207181|P1|NOT COMPLETED|Overall Study||39
85888|NCT01537081|207179|P3|COMPLETED|Overall Study||547
85889|NCT01537081|207180|P2|COMPLETED|Overall Study||1086
85890|NCT01537081|207181|P1|COMPLETED|Overall Study||1084
85891|NCT01537081|207179|P3|Modified Intent to Treat Population|Overall Study||556
85892|NCT01537081|207180|P2|Modified Intent to Treat Population|Overall Study||1109
85893|NCT01537081|207181|P1|Modified Intent to Treat Population|Overall Study||1106
85894|NCT01537081|207179|P3|Safety Population|Overall Study||561
85895|NCT01537081|207180|P2|Safety Population|Overall Study||1122
85896|NCT01537081|207181|P1|Safety Population|Overall Study||1122
85897|NCT01537081|207179|P3|STARTED|Overall Study||563
85898|NCT01537081|207180|P2|STARTED|Overall Study||1124
85899|NCT01537081|207181|P1|STARTED|Overall Study||1123
85900|NCT01537068|207194|P2|NOT COMPLETED|Overall Study||3
85901|NCT01537068|207195|P1|NOT COMPLETED|Overall Study||4
85902|NCT01537068|207194|P2|COMPLETED|Overall Study||26
85903|NCT01537068|207195|P1|COMPLETED|Overall Study||26
85904|NCT01537068|207194|P2|STARTED|Overall Study||29
85905|NCT01537068|207195|P1|STARTED|Overall Study||30
85906|NCT01537042|207207|P2|NOT COMPLETED|Overall Study||5
85907|NCT01537042|207208|P1|NOT COMPLETED|Overall Study||0
85908|NCT01537042|207207|P2|COMPLETED|Overall Study||15
85909|NCT01537042|207208|P1|COMPLETED|Overall Study||10
85910|NCT01537042|207207|P2|STARTED|Overall Study||20
85911|NCT01537042|207208|P1|STARTED|Overall Study||10
85912|NCT01536951|207246|P9|NOT COMPLETED|Third Intervention||0
85913|NCT01536951|207247|P8|NOT COMPLETED|Third Intervention||0
85914|NCT01536951|207248|P7|NOT COMPLETED|Third Intervention||0
85915|NCT01536951|207249|P6|NOT COMPLETED|Third Intervention||0
85916|NCT01536951|207250|P5|NOT COMPLETED|Third Intervention||0
85917|NCT01536951|207251|P4|NOT COMPLETED|Third Intervention||0
85918|NCT01536951|207252|P3|NOT COMPLETED|Third Intervention||0
85919|NCT01536951|207253|P2|NOT COMPLETED|Third Intervention||0
85920|NCT01536951|207254|P1|NOT COMPLETED|Third Intervention||0
85921|NCT01536951|207246|P9|COMPLETED|Third Intervention||9
85922|NCT01536951|207247|P8|COMPLETED|Third Intervention||8
85923|NCT01536951|207248|P7|COMPLETED|Third Intervention||9
85924|NCT01536951|207249|P6|COMPLETED|Third Intervention||9
85925|NCT01536951|207250|P5|COMPLETED|Third Intervention||9
85926|NCT01536951|207251|P4|COMPLETED|Third Intervention||8
85927|NCT01536951|207252|P3|COMPLETED|Third Intervention||2
85928|NCT01536951|207253|P2|COMPLETED|Third Intervention||3
85929|NCT01536951|207254|P1|COMPLETED|Third Intervention||3
85930|NCT01536951|207246|P9|STARTED|Third Intervention||9
85931|NCT01536951|207247|P8|STARTED|Third Intervention||8
85932|NCT01536951|207248|P7|STARTED|Third Intervention||9
85933|NCT01536951|207249|P6|STARTED|Third Intervention||9
85934|NCT01536951|207250|P5|STARTED|Third Intervention||9
85935|NCT01536951|207251|P4|STARTED|Third Intervention||8
85936|NCT01536951|207252|P3|STARTED|Third Intervention||2
85937|NCT01536951|207253|P2|STARTED|Third Intervention||3
85938|NCT01536951|207254|P1|STARTED|Third Intervention||3
85939|NCT01536951|207246|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
85940|NCT01536951|207247|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
85941|NCT01536951|207248|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
85942|NCT01536951|207249|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
85943|NCT01536951|207250|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
86019|NCT01536886|207298|P4|STARTED|Overall Study||51
85944|NCT01536951|207251|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
85945|NCT01536951|207252|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
85946|NCT01536951|207253|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
85947|NCT01536951|207254|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
85948|NCT01536951|207246|P9|COMPLETED|Second Intervention and Washout Period 2||9
85949|NCT01536951|207247|P8|COMPLETED|Second Intervention and Washout Period 2||8
85950|NCT01536951|207248|P7|COMPLETED|Second Intervention and Washout Period 2||9
85951|NCT01536951|207249|P6|COMPLETED|Second Intervention and Washout Period 2||9
85952|NCT01536951|207250|P5|COMPLETED|Second Intervention and Washout Period 2||9
85953|NCT01536951|207251|P4|COMPLETED|Second Intervention and Washout Period 2||8
85954|NCT01536951|207252|P3|COMPLETED|Second Intervention and Washout Period 2||2
85955|NCT01536951|207253|P2|COMPLETED|Second Intervention and Washout Period 2||3
85956|NCT01536951|207254|P1|COMPLETED|Second Intervention and Washout Period 2||3
85957|NCT01536951|207246|P9|STARTED|Second Intervention and Washout Period 2||9
85958|NCT01536951|207247|P8|STARTED|Second Intervention and Washout Period 2||9
85959|NCT01536951|207248|P7|STARTED|Second Intervention and Washout Period 2||9
85960|NCT01536951|207249|P6|STARTED|Second Intervention and Washout Period 2||9
85961|NCT01536951|207250|P5|STARTED|Second Intervention and Washout Period 2||9
85962|NCT01536951|207251|P4|STARTED|Second Intervention and Washout Period 2||8
85963|NCT01536951|207252|P3|STARTED|Second Intervention and Washout Period 2||2
85964|NCT01536951|207253|P2|STARTED|Second Intervention and Washout Period 2||3
85965|NCT01536951|207254|P1|STARTED|Second Intervention and Washout Period 2||3
85966|NCT01536951|207246|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
85967|NCT01536951|207247|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
85968|NCT01536951|207248|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
85969|NCT01536951|207249|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
85970|NCT01536951|207250|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
85971|NCT01536951|207251|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
85972|NCT01536951|207252|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
85973|NCT01536951|207253|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
85974|NCT01536951|207254|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
85975|NCT01536951|207246|P9|COMPLETED|First Intervention and Washout Period 1||9
85976|NCT01536951|207247|P8|COMPLETED|First Intervention and Washout Period 1||9
85977|NCT01536951|207248|P7|COMPLETED|First Intervention and Washout Period 1||9
85978|NCT01536951|207249|P6|COMPLETED|First Intervention and Washout Period 1||9
85979|NCT01536951|207250|P5|COMPLETED|First Intervention and Washout Period 1||9
85980|NCT01536951|207251|P4|COMPLETED|First Intervention and Washout Period 1||8
85981|NCT01536951|207252|P3|COMPLETED|First Intervention and Washout Period 1||2
85982|NCT01536951|207253|P2|COMPLETED|First Intervention and Washout Period 1||3
85983|NCT01536951|207254|P1|COMPLETED|First Intervention and Washout Period 1||3
85984|NCT01536951|207246|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
85985|NCT01536951|207247|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
85986|NCT01536951|207248|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
85987|NCT01536951|207249|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
85988|NCT01536951|207250|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
85989|NCT01536951|207251|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
85990|NCT01536951|207252|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
85991|NCT01536951|207253|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
85992|NCT01536951|207254|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
85993|NCT01536951|207246|P9|STARTED|First Intervention and Washout Period 1||9
85994|NCT01536951|207247|P8|STARTED|First Intervention and Washout Period 1||9
85995|NCT01536951|207248|P7|STARTED|First Intervention and Washout Period 1||9
85996|NCT01536951|207249|P6|STARTED|First Intervention and Washout Period 1||9
85997|NCT01536951|207250|P5|STARTED|First Intervention and Washout Period 1||9
85998|NCT01536951|207251|P4|STARTED|First Intervention and Washout Period 1||8
85999|NCT01536951|207252|P3|STARTED|First Intervention and Washout Period 1||3
86000|NCT01536951|207253|P2|STARTED|First Intervention and Washout Period 1||3
86001|NCT01536951|207254|P1|STARTED|First Intervention and Washout Period 1||3
86002|NCT01536938|207284|P3|NOT COMPLETED|Overall Study||8
86003|NCT01536938|207285|P2|NOT COMPLETED|Overall Study||7
86004|NCT01536938|207286|P1|NOT COMPLETED|Overall Study||6
86005|NCT01536938|207284|P3|COMPLETED|Overall Study||93
86006|NCT01536938|207285|P2|COMPLETED|Overall Study||94
86007|NCT01536938|207286|P1|COMPLETED|Overall Study||94
86008|NCT01536938|207284|P3|STARTED|Overall Study||101
86009|NCT01536938|207285|P2|STARTED|Overall Study||101
86010|NCT01536938|207286|P1|STARTED|Overall Study||100
86011|NCT01536886|207298|P4|NOT COMPLETED|Overall Study||3
86012|NCT01536886|207299|P3|NOT COMPLETED|Overall Study||2
86013|NCT01536886|207300|P2|NOT COMPLETED|Overall Study||8
86014|NCT01536886|207301|P1|NOT COMPLETED|Overall Study||5
86015|NCT01536886|207298|P4|COMPLETED|Overall Study||48
86016|NCT01536886|207299|P3|COMPLETED|Overall Study||47
86017|NCT01536886|207300|P2|COMPLETED|Overall Study||127
86018|NCT01536886|207301|P1|COMPLETED|Overall Study||136
86020|NCT01536886|207299|P3|STARTED|Overall Study||49
86021|NCT01536886|207300|P2|STARTED|Overall Study||135
86022|NCT01536886|207301|P1|STARTED|Overall Study||141
86023|NCT01536860|207311|P3|NOT COMPLETED|Third Intervention (1 Day)||0
86024|NCT01536860|207312|P2|NOT COMPLETED|Third Intervention (1 Day)||0
86025|NCT01536860|207313|P1|NOT COMPLETED|Third Intervention (1 Day)||0
86026|NCT01536860|207311|P3|COMPLETED|Third Intervention (1 Day)||4
86027|NCT01536860|207312|P2|COMPLETED|Third Intervention (1 Day)||4
86028|NCT01536860|207313|P1|COMPLETED|Third Intervention (1 Day)||3
86029|NCT01536860|207311|P3|STARTED|Third Intervention (1 Day)||4
86030|NCT01536860|207312|P2|STARTED|Third Intervention (1 Day)||4
86031|NCT01536860|207313|P1|STARTED|Third Intervention (1 Day)||3
86032|NCT01536860|207311|P3|NOT COMPLETED|Washout Period (3 Days)||0
86033|NCT01536860|207312|P2|NOT COMPLETED|Washout Period (3 Days)||0
86034|NCT01536860|207313|P1|NOT COMPLETED|Washout Period (3 Days)||1
86035|NCT01536860|207311|P3|COMPLETED|Washout Period (3 Days)||4
86036|NCT01536860|207312|P2|COMPLETED|Washout Period (3 Days)||4
86037|NCT01536860|207313|P1|COMPLETED|Washout Period (3 Days)||3
86038|NCT01536860|207311|P3|STARTED|Washout Period (3 Days)||4
86039|NCT01536860|207312|P2|STARTED|Washout Period (3 Days)||4
86040|NCT01536860|207313|P1|STARTED|Washout Period (3 Days)||4
86041|NCT01536860|207311|P3|NOT COMPLETED|Second Intervention (1 Day)||0
86042|NCT01536860|207312|P2|NOT COMPLETED|Second Intervention (1 Day)||0
86043|NCT01536860|207313|P1|NOT COMPLETED|Second Intervention (1 Day)||0
86044|NCT01536860|207311|P3|COMPLETED|Second Intervention (1 Day)||4
86045|NCT01536860|207312|P2|COMPLETED|Second Intervention (1 Day)||4
86046|NCT01536860|207313|P1|COMPLETED|Second Intervention (1 Day)||4
86047|NCT01536860|207311|P3|STARTED|Second Intervention (1 Day)||4
86048|NCT01536860|207312|P2|STARTED|Second Intervention (1 Day)||4
86049|NCT01536860|207313|P1|STARTED|Second Intervention (1 Day)||4
86050|NCT01536860|207311|P3|NOT COMPLETED|Washout Period (3 Days)||0
86051|NCT01536860|207312|P2|NOT COMPLETED|Washout Period (3 Days)||0
86052|NCT01536860|207313|P1|NOT COMPLETED|Washout Period (3 Days)||0
86053|NCT01536860|207311|P3|COMPLETED|Washout Period (3 Days)||4
86054|NCT01536860|207312|P2|COMPLETED|Washout Period (3 Days)||4
86055|NCT01536860|207313|P1|COMPLETED|Washout Period (3 Days)||4
86056|NCT01536860|207311|P3|STARTED|Washout Period (3 Days)||4
86057|NCT01536860|207312|P2|STARTED|Washout Period (3 Days)||4
86058|NCT01536860|207313|P1|STARTED|Washout Period (3 Days)||4
86059|NCT01536860|207311|P3|NOT COMPLETED|First Intervention (1 Day)||0
86060|NCT01536860|207312|P2|NOT COMPLETED|First Intervention (1 Day)||0
86061|NCT01536860|207313|P1|NOT COMPLETED|First Intervention (1 Day)||0
86062|NCT01536860|207311|P3|COMPLETED|First Intervention (1 Day)||4
86063|NCT01536860|207312|P2|COMPLETED|First Intervention (1 Day)||4
86064|NCT01536860|207313|P1|COMPLETED|First Intervention (1 Day)||4
86065|NCT01536860|207311|P3|STARTED|First Intervention (1 Day)||4
86066|NCT01536860|207312|P2|STARTED|First Intervention (1 Day)||4
86067|NCT01536860|207313|P1|STARTED|First Intervention (1 Day)||4
86068|NCT01536704|207321|P4|NOT COMPLETED|Period 4||0
86069|NCT01536704|207322|P3|NOT COMPLETED|Period 4||0
86070|NCT01536704|207323|P2|NOT COMPLETED|Period 4||0
86071|NCT01536704|207324|P1|NOT COMPLETED|Period 4||0
86072|NCT01536704|207321|P4|COMPLETED|Period 4||10
86073|NCT01536704|207322|P3|COMPLETED|Period 4||10
86074|NCT01536704|207323|P2|COMPLETED|Period 4||11
86075|NCT01536704|207324|P1|COMPLETED|Period 4||12
86076|NCT01536704|207321|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
86077|NCT01536704|207322|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
86078|NCT01536704|207323|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
86079|NCT01536704|207324|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
86080|NCT01536704|207321|P4|NOT COMPLETED|Washout Period 3||0
86081|NCT01536704|207322|P3|NOT COMPLETED|Washout Period 3||1
86082|NCT01536704|207323|P2|NOT COMPLETED|Washout Period 3||0
86083|NCT01536704|207324|P1|NOT COMPLETED|Washout Period 3||0
86084|NCT01536704|207321|P4|COMPLETED|Washout Period 3||10
86085|NCT01536704|207322|P3|COMPLETED|Washout Period 3||11
86086|NCT01536704|207323|P2|COMPLETED|Washout Period 3||12
86087|NCT01536704|207324|P1|COMPLETED|Washout Period 3||10
86088|NCT01536704|207321|P4|STARTED|Washout Period 3||10
86089|NCT01536704|207322|P3|STARTED|Washout Period 3||12
86090|NCT01536704|207323|P2|STARTED|Washout Period 3||12
86091|NCT01536704|207324|P1|STARTED|Washout Period 3||10
86092|NCT01536704|207321|P4|NOT COMPLETED|Period 3||1
86093|NCT01536704|207322|P3|NOT COMPLETED|Period 3||0
86094|NCT01536704|207323|P2|NOT COMPLETED|Period 3||0
86095|NCT01536704|207324|P1|NOT COMPLETED|Period 3||0
86096|NCT01536704|207321|P4|COMPLETED|Period 3||10
86097|NCT01536704|207322|P3|COMPLETED|Period 3||12
86098|NCT01536704|207323|P2|COMPLETED|Period 3||12
86099|NCT01536704|207324|P1|COMPLETED|Period 3||10
86100|NCT01536704|207321|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
86101|NCT01536704|207322|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
86102|NCT01536704|207323|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
86103|NCT01536704|207324|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
86104|NCT01536704|207321|P4|NOT COMPLETED|Washout Period 2||1
86105|NCT01536704|207322|P3|NOT COMPLETED|Washout Period 2||0
86106|NCT01536704|207323|P2|NOT COMPLETED|Washout Period 2||0
86107|NCT01536704|207324|P1|NOT COMPLETED|Washout Period 2||1
86108|NCT01536704|207321|P4|COMPLETED|Washout Period 2||12
86109|NCT01536704|207322|P3|COMPLETED|Washout Period 2||10
86110|NCT01536704|207323|P2|COMPLETED|Washout Period 2||11
86111|NCT01536704|207324|P1|COMPLETED|Washout Period 2||12
86112|NCT01536704|207321|P4|STARTED|Washout Period 2||13
86113|NCT01536704|207322|P3|STARTED|Washout Period 2||10
86114|NCT01536704|207323|P2|STARTED|Washout Period 2||11
86115|NCT01536704|207324|P1|STARTED|Washout Period 2||13
86116|NCT01536704|207321|P4|NOT COMPLETED|Period 2||0
86117|NCT01536704|207322|P3|NOT COMPLETED|Period 2||0
86118|NCT01536704|207323|P2|NOT COMPLETED|Period 2||0
86119|NCT01536704|207324|P1|NOT COMPLETED|Period 2||0
86120|NCT01536704|207321|P4|COMPLETED|Period 2||13
86121|NCT01536704|207322|P3|COMPLETED|Period 2||10
86122|NCT01536704|207323|P2|COMPLETED|Period 2||11
86123|NCT01536704|207324|P1|COMPLETED|Period 2||13
86124|NCT01536704|207321|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
86125|NCT01536704|207322|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
86126|NCT01536704|207323|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
86127|NCT01536704|207324|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
86128|NCT01536704|207321|P4|NOT COMPLETED|Washout Period 1||0
86129|NCT01536704|207322|P3|NOT COMPLETED|Washout Period 1||0
86130|NCT01536704|207323|P2|NOT COMPLETED|Washout Period 1||2
86131|NCT01536704|207324|P1|NOT COMPLETED|Washout Period 1||1
86132|NCT01536704|207321|P4|COMPLETED|Washout Period 1||13
86133|NCT01536704|207322|P3|COMPLETED|Washout Period 1||13
86134|NCT01536704|207323|P2|COMPLETED|Washout Period 1||10
86135|NCT01536704|207324|P1|COMPLETED|Washout Period 1||11
86136|NCT01536704|207321|P4|STARTED|Washout Period 1||13
86137|NCT01536704|207322|P3|STARTED|Washout Period 1||13
86138|NCT01536704|207323|P2|STARTED|Washout Period 1||12
86139|NCT01536704|207324|P1|STARTED|Washout Period 1||12
86140|NCT01536704|207321|P4|NOT COMPLETED|Period 1||0
86141|NCT01536704|207322|P3|NOT COMPLETED|Period 1||0
86142|NCT01536704|207323|P2|NOT COMPLETED|Period 1||0
86143|NCT01536704|207324|P1|NOT COMPLETED|Period 1||0
86144|NCT01536704|207321|P4|COMPLETED|Period 1||13
86145|NCT01536704|207322|P3|COMPLETED|Period 1||13
86146|NCT01536704|207323|P2|COMPLETED|Period 1||12
86147|NCT01536704|207324|P1|COMPLETED|Period 1||12
86148|NCT01536704|207321|P4|STARTED|Period 1||13
86149|NCT01536704|207322|P3|STARTED|Period 1||13
86150|NCT01536704|207323|P2|STARTED|Period 1||12
86151|NCT01536704|207324|P1|STARTED|Period 1||12
86152|NCT01536587|207354|P1|NOT COMPLETED|Overall Study||2
86153|NCT01536587|207354|P1|COMPLETED|Overall Study||30
86154|NCT01536587|207354|P1|STARTED|Overall Study||32
86155|NCT01536574|207393|P2|NOT COMPLETED|Overall Study||7
86156|NCT01536574|207394|P1|NOT COMPLETED|Overall Study||6
86157|NCT01536574|207393|P2|COMPLETED|Overall Study||126
86158|NCT01536574|207394|P1|COMPLETED|Overall Study||156
86159|NCT01536574|207393|P2|STARTED|Overall Study||133
86160|NCT01536574|207394|P1|STARTED|Overall Study||162
86161|NCT01536561|207412|P1|NOT COMPLETED|Long-Term Follow-Up||0
86162|NCT01536561|207412|P1|COMPLETED|Long-Term Follow-Up||13
86163|NCT01536561|207412|P1|STARTED|Long-Term Follow-Up||13
86164|NCT01536561|207412|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
86165|NCT01536561|207412|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
86166|NCT01536561|207412|P1|STARTED|Dosimetric and Therapeutic Treatment||59
86167|NCT01536496|207452|P2|NOT COMPLETED|Overall Study||1
86168|NCT01536496|207453|P1|NOT COMPLETED|Overall Study||2
86169|NCT01536496|207452|P2|COMPLETED|Overall Study||56
86170|NCT01536496|207453|P1|COMPLETED|Overall Study||55
86171|NCT01536496|207452|P2|STARTED|Overall Study||57
86172|NCT01536496|207453|P1|STARTED|Overall Study||57
86173|NCT01536418|207489|P2|NOT COMPLETED|Overall Study||66
86174|NCT01536418|207490|P1|NOT COMPLETED|Overall Study||69
86175|NCT01536418|207489|P2|COMPLETED|Overall Study||60
86176|NCT01536418|207490|P1|COMPLETED|Overall Study||58
86177|NCT01536418|207489|P2|STARTED|Overall Study||126
86178|NCT01536418|207490|P1|STARTED|Overall Study||127
86179|NCT01536405|207510|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
86180|NCT01536405|207511|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
86181|NCT01536405|207510|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
86182|NCT01536405|207511|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
86183|NCT01536405|207510|P2|STARTED|Visit 4 to Extended Study Follow-up||618
86184|NCT01536405|207511|P1|STARTED|Visit 4 to Extended Study Follow-up||615
86185|NCT01536405|207510|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
86186|NCT01536405|207511|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
86187|NCT01536405|207510|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
86188|NCT01536405|207511|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
86189|NCT01536405|207510|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
86280|NCT01536145|207694|P8|STARTED|Overall Study||4
86190|NCT01536405|207511|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
86191|NCT01536405|207510|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
86192|NCT01536405|207511|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
86193|NCT01536405|207510|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
86194|NCT01536405|207511|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
86195|NCT01536405|207510|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
86196|NCT01536405|207511|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
86197|NCT01536405|207510|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
86198|NCT01536405|207511|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
86199|NCT01536405|207510|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
86200|NCT01536405|207511|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
86201|NCT01536405|207510|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
86202|NCT01536405|207511|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
86203|NCT01536405|207510|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
86204|NCT01536405|207511|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
86205|NCT01536405|207510|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
86206|NCT01536405|207511|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
86207|NCT01536405|207510|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
86208|NCT01536405|207511|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
86209|NCT01536405|207510|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
86210|NCT01536405|207511|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
86211|NCT01536405|207510|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
86212|NCT01536405|207511|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
86213|NCT01536379|207549|P2|NOT COMPLETED|Overall Study||3
86214|NCT01536379|207550|P1|NOT COMPLETED|Overall Study||2
86215|NCT01536379|207549|P2|COMPLETED|Overall Study||9
86216|NCT01536379|207550|P1|COMPLETED|Overall Study||11
86217|NCT01536379|207549|P2|STARTED|Overall Study||12
86218|NCT01536379|207550|P1|STARTED|Overall Study||13
86219|NCT01536366|207626|P2|NOT COMPLETED|Overall Study||4
86220|NCT01536366|207627|P1|NOT COMPLETED|Overall Study||13
86221|NCT01536366|207626|P2|COMPLETED|Overall Study||9
86222|NCT01536366|207627|P1|COMPLETED|Overall Study||1
86223|NCT01536366|207626|P2|Follow-up|Overall Study||9
86224|NCT01536366|207627|P1|Follow-up|Overall Study||13
86225|NCT01536366|207626|P2|Repaglinide|Overall Study||13
86226|NCT01536366|207627|P1|Repaglinide|Overall Study||14
86227|NCT01536366|207626|P2|BIA 9-1067 + Repaglinide|Overall Study||10
86228|NCT01536366|207627|P1|BIA 9-1067 + Repaglinide|Overall Study||14
86229|NCT01536366|207626|P2|STARTED|Overall Study||13
86230|NCT01536366|207627|P1|STARTED|Overall Study||14
86231|NCT01536262|207642|P3|NOT COMPLETED|Overall Study||2
86232|NCT01536262|207643|P2|NOT COMPLETED|Overall Study||2
86233|NCT01536262|207644|P1|NOT COMPLETED|Overall Study||8
86234|NCT01536262|207642|P3|COMPLETED|Overall Study||39
86235|NCT01536262|207643|P2|COMPLETED|Overall Study||38
86236|NCT01536262|207644|P1|COMPLETED|Overall Study||33
86237|NCT01536262|207642|P3|STARTED|Overall Study||41
86238|NCT01536262|207643|P2|STARTED|Overall Study||40
86239|NCT01536262|207644|P1|STARTED|Overall Study||41
86240|NCT01536197|207660|P2|NOT COMPLETED|Overall Study||0
86241|NCT01536197|207661|P1|NOT COMPLETED|Overall Study||0
86242|NCT01536197|207660|P2|COMPLETED|Overall Study||10
86243|NCT01536197|207661|P1|COMPLETED|Overall Study||23
86244|NCT01536197|207660|P2|STARTED|Overall Study||10
86245|NCT01536197|207661|P1|STARTED|Overall Study||23
86246|NCT01536184|207671|P2|NOT COMPLETED|Overall Study||0
86247|NCT01536184|207672|P1|NOT COMPLETED|Overall Study||0
86248|NCT01536184|207671|P2|COMPLETED|Overall Study||4
86249|NCT01536184|207672|P1|COMPLETED|Overall Study||8
86250|NCT01536184|207671|P2|STARTED|Overall Study||4
86251|NCT01536184|207672|P1|STARTED|Overall Study||8
86252|NCT01536171|207686|P1|NOT COMPLETED|Overall Study||1
86253|NCT01536171|207686|P1|COMPLETED|Overall Study||21
86254|NCT01536171|207686|P1|STARTED|Overall Study||22
86255|NCT01536145|207691|P11|NOT COMPLETED|Overall Study||10
86256|NCT01536145|207692|P10|NOT COMPLETED|Overall Study||6
86257|NCT01536145|207693|P9|NOT COMPLETED|Overall Study||3
86258|NCT01536145|207694|P8|NOT COMPLETED|Overall Study||4
86259|NCT01536145|207695|P7|NOT COMPLETED|Overall Study||2
86260|NCT01536145|207696|P6|NOT COMPLETED|Overall Study||3
86261|NCT01536145|207697|P5|NOT COMPLETED|Overall Study||2
86262|NCT01536145|207698|P4|NOT COMPLETED|Overall Study||2
86263|NCT01536145|207699|P3|NOT COMPLETED|Overall Study||2
86264|NCT01536145|207700|P2|NOT COMPLETED|Overall Study||4
86265|NCT01536145|207701|P1|NOT COMPLETED|Overall Study||3
86266|NCT01536145|207691|P11|COMPLETED|Overall Study||0
86267|NCT01536145|207692|P10|COMPLETED|Overall Study||1
86268|NCT01536145|207693|P9|COMPLETED|Overall Study||0
86269|NCT01536145|207694|P8|COMPLETED|Overall Study||0
86270|NCT01536145|207695|P7|COMPLETED|Overall Study||1
86271|NCT01536145|207696|P6|COMPLETED|Overall Study||0
86272|NCT01536145|207697|P5|COMPLETED|Overall Study||2
86273|NCT01536145|207698|P4|COMPLETED|Overall Study||1
86274|NCT01536145|207699|P3|COMPLETED|Overall Study||1
86275|NCT01536145|207700|P2|COMPLETED|Overall Study||0
86276|NCT01536145|207701|P1|COMPLETED|Overall Study||0
86277|NCT01536145|207691|P11|STARTED|Overall Study||10
86278|NCT01536145|207692|P10|STARTED|Overall Study||7
86279|NCT01536145|207693|P9|STARTED|Overall Study||3
86281|NCT01536145|207695|P7|STARTED|Overall Study||3
86282|NCT01536145|207696|P6|STARTED|Overall Study||3
86283|NCT01536145|207697|P5|STARTED|Overall Study||4
86284|NCT01536145|207698|P4|STARTED|Overall Study||3
86285|NCT01536145|207699|P3|STARTED|Overall Study||3
86286|NCT01536145|207700|P2|STARTED|Overall Study||4
86287|NCT01536145|207701|P1|STARTED|Overall Study||3
86288|NCT01536119|207808|P2|NOT COMPLETED|Overall Study||14
86289|NCT01536119|207809|P1|NOT COMPLETED|Overall Study||17
86290|NCT01536119|207808|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
86291|NCT01536119|207809|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
86292|NCT01536119|207808|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
86293|NCT01536119|207809|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
86294|NCT01536093|207835|P2|NOT COMPLETED|Overall Study||3
86295|NCT01536093|207836|P1|NOT COMPLETED|Overall Study||3
86296|NCT01536093|207835|P2|COMPLETED|Overall Study||21
86297|NCT01536093|207836|P1|COMPLETED|Overall Study||21
86298|NCT01536093|207835|P2|STARTED|Overall Study||24
86299|NCT01536093|207836|P1|STARTED|Overall Study||24
86300|NCT01536067|207852|P1|NOT COMPLETED|Overall Study||1
86301|NCT01536067|207852|P1|COMPLETED|Overall Study||2
86302|NCT01536067|207852|P1|STARTED|Overall Study||3
86303|NCT01536015|207865|P2|NOT COMPLETED|Overall Study||10
86304|NCT01536015|207866|P1|NOT COMPLETED|Overall Study||8
86305|NCT01536015|207865|P2|COMPLETED|Overall Study||3
86306|NCT01536015|207866|P1|COMPLETED|Overall Study||4
86307|NCT01536015|207865|P2|STARTED|Overall Study||13
86308|NCT01536015|207866|P1|STARTED|Overall Study||12
86309|NCT01535976|207884|P2|NOT COMPLETED|Overall Study||1
86310|NCT01535976|207885|P1|NOT COMPLETED|Overall Study||1
86311|NCT01535976|207884|P2|COMPLETED|Overall Study||26
86312|NCT01535976|207885|P1|COMPLETED|Overall Study||26
86313|NCT01535976|207884|P2|STARTED|Overall Study||27
86314|NCT01535976|207885|P1|STARTED|Overall Study||27
86315|NCT01535807|207893|P2|NOT COMPLETED|Overall Study||2
86316|NCT01535807|207894|P1|NOT COMPLETED|Overall Study||2
86317|NCT01535807|207893|P2|COMPLETED|Overall Study||20
86318|NCT01535807|207894|P1|COMPLETED|Overall Study||20
86319|NCT01535807|207893|P2|STARTED|Overall Study||22
86320|NCT01535807|207894|P1|STARTED|Overall Study||22
86321|NCT01535729|207900|P1|NOT COMPLETED|Overall Study||416
86322|NCT01535729|207900|P1|COMPLETED|Overall Study||49
86323|NCT01535729|207900|P1|Treated|Overall Study||385
86324|NCT01535729|207900|P1|STARTED|Overall Study||465
86325|NCT01535664|207927|P1|NOT COMPLETED|Overall Study||0
86326|NCT01535664|207927|P1|COMPLETED|Overall Study||20
86327|NCT01535664|207927|P1|STARTED|Overall Study||20
86328|NCT01535638|207941|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
86329|NCT01535638|207942|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
86330|NCT01535638|207943|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
86331|NCT01535638|207944|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
86332|NCT01535638|207945|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
86333|NCT01535638|207946|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
86334|NCT01535638|207941|P6|COMPLETED|Treatment 3 (Single Dose)||2
86335|NCT01535638|207942|P5|COMPLETED|Treatment 3 (Single Dose)||3
86336|NCT01535638|207943|P4|COMPLETED|Treatment 3 (Single Dose)||2
86337|NCT01535638|207944|P3|COMPLETED|Treatment 3 (Single Dose)||3
86338|NCT01535638|207945|P2|COMPLETED|Treatment 3 (Single Dose)||3
86339|NCT01535638|207946|P1|COMPLETED|Treatment 3 (Single Dose)||3
86340|NCT01535638|207941|P6|STARTED|Treatment 3 (Single Dose)||2
86341|NCT01535638|207942|P5|STARTED|Treatment 3 (Single Dose)||3
86342|NCT01535638|207943|P4|STARTED|Treatment 3 (Single Dose)||3
86343|NCT01535638|207944|P3|STARTED|Treatment 3 (Single Dose)||3
86344|NCT01535638|207945|P2|STARTED|Treatment 3 (Single Dose)||3
86345|NCT01535638|207946|P1|STARTED|Treatment 3 (Single Dose)||3
86346|NCT01535638|207941|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
86347|NCT01535638|207942|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
86348|NCT01535638|207943|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
86349|NCT01535638|207944|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
86350|NCT01535638|207945|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
86351|NCT01535638|207946|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
86352|NCT01535638|207941|P6|COMPLETED|Treatment 2 (Single Dose)||2
86353|NCT01535638|207942|P5|COMPLETED|Treatment 2 (Single Dose)||3
86354|NCT01535638|207943|P4|COMPLETED|Treatment 2 (Single Dose)||3
86355|NCT01535638|207944|P3|COMPLETED|Treatment 2 (Single Dose)||3
86356|NCT01535638|207945|P2|COMPLETED|Treatment 2 (Single Dose)||3
86357|NCT01535638|207946|P1|COMPLETED|Treatment 2 (Single Dose)||3
86358|NCT01535638|207941|P6|STARTED|Treatment 2 (Single Dose)||2
86359|NCT01535638|207942|P5|STARTED|Treatment 2 (Single Dose)||3
86360|NCT01535638|207943|P4|STARTED|Treatment 2 (Single Dose)||3
86361|NCT01535638|207944|P3|STARTED|Treatment 2 (Single Dose)||3
86362|NCT01535638|207945|P2|STARTED|Treatment 2 (Single Dose)||3
86363|NCT01535638|207946|P1|STARTED|Treatment 2 (Single Dose)||3
86364|NCT01535638|207941|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
86365|NCT01535638|207942|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
86366|NCT01535638|207943|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
86367|NCT01535638|207944|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
86368|NCT01535638|207945|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
86369|NCT01535638|207946|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
86370|NCT01535638|207941|P6|COMPLETED|Treatment 1 (Single Dose)||2
86371|NCT01535638|207942|P5|COMPLETED|Treatment 1 (Single Dose)||3
86372|NCT01535638|207943|P4|COMPLETED|Treatment 1 (Single Dose)||3
86373|NCT01535638|207944|P3|COMPLETED|Treatment 1 (Single Dose)||3
86374|NCT01535638|207945|P2|COMPLETED|Treatment 1 (Single Dose)||3
86375|NCT01535638|207946|P1|COMPLETED|Treatment 1 (Single Dose)||3
86376|NCT01535638|207941|P6|STARTED|Treatment 1 (Single Dose)||3
86377|NCT01535638|207942|P5|STARTED|Treatment 1 (Single Dose)||3
86378|NCT01535638|207943|P4|STARTED|Treatment 1 (Single Dose)||3
86379|NCT01535638|207944|P3|STARTED|Treatment 1 (Single Dose)||3
86380|NCT01535638|207945|P2|STARTED|Treatment 1 (Single Dose)||3
86381|NCT01535638|207946|P1|STARTED|Treatment 1 (Single Dose)||3
86382|NCT01535599|207960|P2|NOT COMPLETED|Overall Study||96
86383|NCT01535599|207961|P1|NOT COMPLETED|Overall Study||50
86384|NCT01535599|207960|P2|COMPLETED|Overall Study||250
86385|NCT01535599|207961|P1|COMPLETED|Overall Study||297
86386|NCT01535599|207960|P2|STARTED|Overall Study||346
86387|NCT01535599|207961|P1|STARTED|Overall Study||347
86388|NCT01535560|207973|P2|NOT COMPLETED|Overall Study||96
86389|NCT01535560|207974|P1|NOT COMPLETED|Overall Study||37
86390|NCT01535560|207973|P2|COMPLETED|Overall Study||179
86391|NCT01535560|207974|P1|COMPLETED|Overall Study||237
86392|NCT01535560|207973|P2|STARTED|Overall Study||275
86393|NCT01535560|207974|P1|STARTED|Overall Study||274
86394|NCT01535365|207986|P2|NOT COMPLETED|Overall Study||0
86395|NCT01535365|207987|P1|NOT COMPLETED|Overall Study||0
86396|NCT01535365|207986|P2|COMPLETED|Overall Study||29
86397|NCT01535365|207987|P1|COMPLETED|Overall Study||31
86398|NCT01535365|207986|P2|STARTED|Overall Study||29
86399|NCT01535365|207987|P1|STARTED|Overall Study||31
86400|NCT01535326|207998|P3|NOT COMPLETED|Overall Study||0
86401|NCT01535326|207999|P2|NOT COMPLETED|Overall Study||0
86402|NCT01535326|208000|P1|NOT COMPLETED|Overall Study||0
86403|NCT01535326|207998|P3|COMPLETED|Overall Study||90
86404|NCT01535326|207999|P2|COMPLETED|Overall Study||90
86405|NCT01535326|208000|P1|COMPLETED|Overall Study||90
86406|NCT01535326|207998|P3|STARTED|Overall Study||90
86407|NCT01535326|207999|P2|STARTED|Overall Study||90
86408|NCT01535326|208000|P1|STARTED|Overall Study||90
86409|NCT01535261|208017|P1|NOT COMPLETED|Overall Study||50
86410|NCT01535261|208017|P1|COMPLETED|Overall Study||307
86411|NCT01535261|208017|P1|STARTED|Overall Study||357
86412|NCT01535235|208030|P2|NOT COMPLETED|Overall Study||0
86413|NCT01535235|208031|P1|NOT COMPLETED|Overall Study||1
86414|NCT01535235|208030|P2|COMPLETED|Overall Study||15
86415|NCT01535235|208031|P1|COMPLETED|Overall Study||15
86416|NCT01535235|208030|P2|STARTED|Overall Study||15
86417|NCT01535235|208031|P1|STARTED|Overall Study||16
86418|NCT01535222|208045|P6|NOT COMPLETED|Overall Study||0
86419|NCT01535222|208046|P5|NOT COMPLETED|Overall Study||0
86420|NCT01535222|208047|P4|NOT COMPLETED|Overall Study||0
86421|NCT01535222|208048|P3|NOT COMPLETED|Overall Study||1
86422|NCT01535222|208049|P2|NOT COMPLETED|Overall Study||0
86423|NCT01535222|208050|P1|NOT COMPLETED|Overall Study||0
86424|NCT01535222|208045|P6|COMPLETED|Overall Study||8
86425|NCT01535222|208046|P5|COMPLETED|Overall Study||6
86426|NCT01535222|208047|P4|COMPLETED|Overall Study||6
86427|NCT01535222|208048|P3|COMPLETED|Overall Study||6
86428|NCT01535222|208049|P2|COMPLETED|Overall Study||3
86429|NCT01535222|208050|P1|COMPLETED|Overall Study||3
86430|NCT01535222|208045|P6|STARTED|Overall Study||8
86431|NCT01535222|208046|P5|STARTED|Overall Study||6
86432|NCT01535222|208047|P4|STARTED|Overall Study||6
86433|NCT01535222|208048|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
86434|NCT01535222|208049|P2|STARTED|Overall Study||3
86435|NCT01535222|208050|P1|STARTED|Overall Study||3
86436|NCT01535118|208070|P1|NOT COMPLETED|Overall Study||0
86437|NCT01535118|208070|P1|COMPLETED|Overall Study||2765
86438|NCT01535118|208070|P1|STARTED|Overall Study||2765
86439|NCT01535040|208081|P2|NOT COMPLETED|Overall Study||21
86440|NCT01535040|208082|P1|NOT COMPLETED|Overall Study||30
86441|NCT01535040|208081|P2|COMPLETED|Overall Study||44
86442|NCT01535040|208082|P1|COMPLETED|Overall Study||35
86443|NCT01535040|208081|P2|STARTED|Overall Study||65
86444|NCT01535040|208082|P1|STARTED|Overall Study||65
86445|NCT01535001|208096|P2|NOT COMPLETED|Overall Study||6
86446|NCT01535001|208097|P1|NOT COMPLETED|Overall Study||3
86447|NCT01535001|208096|P2|COMPLETED|Overall Study||44
86448|NCT01535001|208097|P1|COMPLETED|Overall Study||47
86449|NCT01535001|208096|P2|STARTED|Overall Study||50
86450|NCT01535001|208097|P1|STARTED|Overall Study||50
86451|NCT01534975|208123|P4|NOT COMPLETED|Overall Study||0
86452|NCT01534975|208124|P3|NOT COMPLETED|Overall Study||0
86453|NCT01534975|208125|P2|NOT COMPLETED|Overall Study||0
86454|NCT01534975|208126|P1|NOT COMPLETED|Overall Study||0
86455|NCT01534975|208123|P4|COMPLETED|Overall Study||84
86456|NCT01534975|208124|P3|COMPLETED|Overall Study||160
86457|NCT01534975|208125|P2|COMPLETED|Overall Study||133
86458|NCT01534975|208126|P1|COMPLETED|Overall Study||136
86459|NCT01534975|208123|P4|STARTED|Overall Study||84
86460|NCT01534975|208124|P3|STARTED|Overall Study||160
86461|NCT01534975|208125|P2|STARTED|Overall Study||133
86462|NCT01534975|208126|P1|STARTED|Overall Study||136
86463|NCT01534962|208140|P4|NOT COMPLETED|Overall Study||32
86464|NCT01534962|208141|P3|NOT COMPLETED|Overall Study||24
86465|NCT01534962|208142|P2|NOT COMPLETED|Overall Study||26
86466|NCT01534962|208143|P1|NOT COMPLETED|Overall Study||37
86467|NCT01534962|208140|P4|COMPLETED|Overall Study||24
86468|NCT01534962|208141|P3|COMPLETED|Overall Study||34
86469|NCT01534962|208142|P2|COMPLETED|Overall Study||34
86470|NCT01534962|208143|P1|COMPLETED|Overall Study||30
86471|NCT01534962|208140|P4|STARTED|Overall Study||56
86472|NCT01534962|208141|P3|STARTED|Overall Study||58
86473|NCT01534962|208142|P2|STARTED|Overall Study||60
86474|NCT01534962|208143|P1|STARTED|Overall Study||67
86475|NCT01534910|208175|P2|NOT COMPLETED|Overall Study||4
86476|NCT01534910|208176|P1|NOT COMPLETED|Overall Study||4
86477|NCT01534910|208175|P2|COMPLETED|Overall Study||28
86478|NCT01534910|208176|P1|COMPLETED|Overall Study||29
86479|NCT01534910|208175|P2|STARTED|Overall Study||32
86480|NCT01534910|208176|P1|STARTED|Overall Study||33
86481|NCT01534897|208184|P1|NOT COMPLETED|Overall Study||0
86482|NCT01534897|208184|P1|COMPLETED|Overall Study||10
86483|NCT01534897|208184|P1|Day 37 Iodine-131 Treatment|Overall Study||6
86484|NCT01534897|208184|P1|Day 25 Iodine-131 Scan|Overall Study||10
86485|NCT01534897|208184|P1|STARTED|Overall Study||10
86486|NCT01534689|208192|P1|NOT COMPLETED|Overall Study||0
86487|NCT01534689|208192|P1|COMPLETED|Overall Study||105
86488|NCT01534689|208192|P1|STARTED|Overall Study||105
86489|NCT01534676|208200|P2|NOT COMPLETED|Overall Study||1
86490|NCT01534676|208201|P1|NOT COMPLETED|Overall Study||2
86491|NCT01534676|208200|P2|COMPLETED|Overall Study||0
86492|NCT01534676|208201|P1|COMPLETED|Overall Study||0
86493|NCT01534676|208200|P2|STARTED|Overall Study||1
86494|NCT01534676|208201|P1|STARTED|Overall Study||2
86495|NCT01534637|208207|P1|NOT COMPLETED|Overall Study||9
86496|NCT01534637|208207|P1|COMPLETED|Overall Study||13
86497|NCT01534637|208207|P1|STARTED|Overall Study||22
86498|NCT01534533|208217|P4|NOT COMPLETED|Overall Study||4
86499|NCT01534533|208218|P3|NOT COMPLETED|Overall Study||8
86500|NCT01534533|208219|P2|NOT COMPLETED|Overall Study||3
86501|NCT01534533|208220|P1|NOT COMPLETED|Overall Study||8
86502|NCT01534533|208217|P4|COMPLETED|Overall Study||44
86503|NCT01534533|208218|P3|COMPLETED|Overall Study||40
86504|NCT01534533|208219|P2|COMPLETED|Overall Study||45
86505|NCT01534533|208220|P1|COMPLETED|Overall Study||40
86506|NCT01534533|208217|P4|STARTED|Overall Study||48
86507|NCT01534533|208218|P3|STARTED|Overall Study||48
86508|NCT01534533|208219|P2|STARTED|Overall Study||48
86509|NCT01534533|208220|P1|STARTED|Overall Study||48
86510|NCT01534520|208248|P2|NOT COMPLETED|Overall Study||1
86511|NCT01534520|208249|P1|NOT COMPLETED|Overall Study||0
86512|NCT01534520|208248|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
86513|NCT01534520|208249|P1|COMPLETED|Overall Study||30
86514|NCT01534520|208248|P2|STARTED|Overall Study||29
86515|NCT01534520|208249|P1|STARTED|Overall Study||30
86516|NCT01534416|208263|P2|NOT COMPLETED|Overall Study||0
86517|NCT01534416|208264|P1|NOT COMPLETED|Overall Study||0
86518|NCT01534416|208263|P2|COMPLETED|Overall Study||64
86519|NCT01534416|208264|P1|COMPLETED|Overall Study||68
86520|NCT01534416|208263|P2|STARTED|Overall Study||64
86521|NCT01534416|208264|P1|STARTED|Overall Study||68
86522|NCT01534351|208283|P3|NOT COMPLETED|Overall Study||0
86523|NCT01534351|208284|P2|NOT COMPLETED|Overall Study||0
86524|NCT01534351|208285|P1|NOT COMPLETED|Overall Study||1
86525|NCT01534351|208283|P3|COMPLETED|Overall Study||0
86526|NCT01534351|208284|P2|COMPLETED|Overall Study||0
86527|NCT01534351|208285|P1|COMPLETED|Overall Study||0
86528|NCT01534351|208283|P3|STARTED|Overall Study||0
86529|NCT01534351|208284|P2|STARTED|Overall Study||0
86530|NCT01534351|208285|P1|STARTED|Overall Study||1
86531|NCT01534208|208304|P2|NOT COMPLETED|Overall Study||49
86532|NCT01534208|208305|P1|NOT COMPLETED|Overall Study||57
86533|NCT01534208|208304|P2|COMPLETED|Overall Study||234
86534|NCT01534208|208305|P1|COMPLETED|Overall Study||159
86535|NCT01534208|208304|P2|STARTED|Overall Study||283
86536|NCT01534208|208305|P1|STARTED|Overall Study||216
86537|NCT01534182|208323|P2|NOT COMPLETED|Overall Study||10
86538|NCT01534182|208324|P1|NOT COMPLETED|Overall Study||12
86539|NCT01534182|208323|P2|COMPLETED|Overall Study||58
86540|NCT01534182|208324|P1|COMPLETED|Overall Study||218
86541|NCT01534182|208323|P2|Full Analysis Set|Overall Study||62
86542|NCT01534182|208324|P1|Full Analysis Set|Overall Study||229
86543|NCT01534182|208323|P2|Safety Set|Overall Study||64
86544|NCT01534182|208324|P1|Safety Set|Overall Study||230
86545|NCT01534182|208323|P2|STARTED|Overall Study||68
86546|NCT01534182|208324|P1|STARTED|Overall Study||230
86547|NCT01534143|208339|P1|NOT COMPLETED|Overall Study||0
86548|NCT01534143|208339|P1|COMPLETED|Overall Study||1
86549|NCT01534143|208339|P1|STARTED|Overall Study||1
86550|NCT01534078|208355|P1|NOT COMPLETED|Overall Study||2
86551|NCT01534078|208355|P1|COMPLETED|Overall Study||32
86552|NCT01534078|208355|P1|STARTED|Overall Study||34
86553|NCT01534052|208362|P1|NOT COMPLETED|Overall Study||0
86554|NCT01534052|208362|P1|COMPLETED|Overall Study||52
86555|NCT01534052|208362|P1|Treatment Received|Overall Study||52
86556|NCT01534052|208362|P1|STARTED|Overall Study||52
86557|NCT01533974|208368|P2|NOT COMPLETED|Overall Study||50
86558|NCT01533974|208369|P1|NOT COMPLETED|Overall Study||51
86559|NCT01533974|208368|P2|COMPLETED|Overall Study||176
86560|NCT01533974|208369|P1|COMPLETED|Overall Study||173
86561|NCT01533974|208368|P2|STARTED|Overall Study||226
86562|NCT01533974|208369|P1|STARTED|Overall Study||224
86563|NCT01533948|208375|P1|NOT COMPLETED|Overall Study||0
86564|NCT01533948|208375|P1|COMPLETED|Overall Study||25
86565|NCT01533948|208375|P1|STARTED|Overall Study||25
86566|NCT01533935|208383|P5|NOT COMPLETED|Overall Study||8
86567|NCT01533935|208384|P4|NOT COMPLETED|Overall Study||7
86568|NCT01533935|208385|P3|NOT COMPLETED|Overall Study||8
86569|NCT01533935|208386|P2|NOT COMPLETED|Overall Study||13
86570|NCT01533935|208387|P1|NOT COMPLETED|Overall Study||6
86571|NCT01533935|208383|P5|COMPLETED|Overall Study|All treatment periods|50
86572|NCT01533935|208384|P4|COMPLETED|Overall Study|All treatment periods|52
86573|NCT01533935|208385|P3|COMPLETED|Overall Study|All treatment periods|50
86574|NCT01533935|208386|P2|COMPLETED|Overall Study|All treatment periods|45
86575|NCT01533935|208387|P1|COMPLETED|Overall Study|All treatment periods|52
86576|NCT01533935|208383|P5|Received Tio+Olo 5/5|Overall Study||55
86577|NCT01533935|208384|P4|Received Tio+Olo 5/5|Overall Study||54
86578|NCT01533935|208385|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
86579|NCT01533935|208386|P2|Received Tio+Olo 5/5|Overall Study||58
86580|NCT01533935|208387|P1|Received Tio+Olo 5/5|Overall Study||56
86581|NCT01533935|208383|P5|Received Tio+Olo 2.5/5|Overall Study||56
86582|NCT01533935|208384|P4|Received Tio+Olo 2.5/5|Overall Study||56
86583|NCT01533935|208385|P3|Received Tio+Olo 2.5/5|Overall Study||49
86584|NCT01533935|208386|P2|Received Tio+Olo 2.5/5|Overall Study||0
86585|NCT01533935|208387|P1|Received Tio+Olo 2.5/5|Overall Study||58
86586|NCT01533935|208383|P5|Received Tio 5|Overall Study||52
86587|NCT01533935|208384|P4|Received Tio 5|Overall Study||0
86588|NCT01533935|208385|P3|Received Tio 5|Overall Study||58
86589|NCT01533935|208386|P2|Received Tio 5|Overall Study||54
86590|NCT01533935|208387|P1|Received Tio 5|Overall Study||54
86591|NCT01533935|208383|P5|Received Olo 5|Overall Study||0
86592|NCT01533935|208384|P4|Received Olo 5|Overall Study||59
86593|NCT01533935|208385|P3|Received Olo 5|Overall Study||55
86594|NCT01533935|208386|P2|Received Olo 5|Overall Study||52
86595|NCT01533935|208387|P1|Received Olo 5|Overall Study||52
86596|NCT01533935|208383|P5|Received Placebo|Overall Study||58
86597|NCT01533935|208384|P4|Received Placebo|Overall Study||57
86598|NCT01533935|208385|P3|Received Placebo|Overall Study||52
86599|NCT01533935|208386|P2|Received Placebo|Overall Study||47
86600|NCT01533935|208387|P1|Received Placebo|Overall Study||0
86601|NCT01533935|208383|P5|STARTED|Overall Study||58
86602|NCT01533935|208384|P4|STARTED|Overall Study||59
86603|NCT01533935|208385|P3|STARTED|Overall Study||58
86604|NCT01533935|208386|P2|STARTED|Overall Study||58
86605|NCT01533935|208387|P1|STARTED|Overall Study||58
86606|NCT01533922|208414|P5|NOT COMPLETED|Overall Study||6
86607|NCT01533922|208415|P4|NOT COMPLETED|Overall Study||5
86608|NCT01533922|208416|P3|NOT COMPLETED|Overall Study||10
86609|NCT01533922|208417|P2|NOT COMPLETED|Overall Study||12
86610|NCT01533922|208418|P1|NOT COMPLETED|Overall Study||10
86611|NCT01533922|208414|P5|COMPLETED|Overall Study|Completed all treatment arms|53
86612|NCT01533922|208415|P4|COMPLETED|Overall Study|Completed all treatment arms|53
86613|NCT01533922|208416|P3|COMPLETED|Overall Study|Completed all treatment arms|50
86614|NCT01533922|208417|P2|COMPLETED|Overall Study|Completed all treatment arms|47
86615|NCT01533922|208418|P1|COMPLETED|Overall Study|Completed all treatment arms|49
86616|NCT01533922|208414|P5|Received Tio+Olo 5/5|Overall Study||56
86617|NCT01533922|208415|P4|Received Tio+Olo 5/5|Overall Study||53
86618|NCT01533922|208416|P3|Received Tio+Olo 5/5|Overall Study||0
86619|NCT01533922|208417|P2|Received Tio+Olo 5/5|Overall Study||59
86620|NCT01533922|208418|P1|Received Tio+Olo 5/5|Overall Study||58
86621|NCT01533922|208414|P5|Received Tio+Olo 2.5/5|Overall Study||56
86622|NCT01533922|208415|P4|Received Tio+Olo 2.5/5|Overall Study||55
86623|NCT01533922|208416|P3|Received Tio+Olo 2.5/5|Overall Study||52
86624|NCT01533922|208417|P2|Received Tio+Olo 2.5/5|Overall Study||0
86625|NCT01533922|208418|P1|Received Tio+Olo 2.5/5|Overall Study||59
86626|NCT01533922|208414|P5|Received Tio 5|Overall Study||54
86627|NCT01533922|208415|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
86628|NCT01533922|208416|P3|Received Tio 5|Overall Study||59
86629|NCT01533922|208417|P2|Received Tio 5|Overall Study||58
86630|NCT01533922|208418|P1|Received Tio 5|Overall Study||54
86631|NCT01533922|208414|P5|Received Olo 5|Overall Study||0
86632|NCT01533922|208415|P4|Received Olo 5|Overall Study||57
86633|NCT01533922|208416|P3|Received Olo 5|Overall Study||57
86634|NCT01533922|208417|P2|Received Olo 5|Overall Study||52
86635|NCT01533922|208418|P1|Received Olo 5|Overall Study||51
86636|NCT01533922|208414|P5|Received Placebo|Overall Study||59
86637|NCT01533922|208415|P4|Received Placebo|Overall Study||57
86638|NCT01533922|208416|P3|Received Placebo|Overall Study||57
86639|NCT01533922|208417|P2|Received Placebo|Overall Study||49
86640|NCT01533922|208418|P1|Received Placebo|Overall Study||0
86641|NCT01533922|208414|P5|STARTED|Overall Study||59
86642|NCT01533922|208415|P4|STARTED|Overall Study||58
86643|NCT01533922|208416|P3|STARTED|Overall Study||60
86644|NCT01533922|208417|P2|STARTED|Overall Study||59
86645|NCT01533922|208418|P1|STARTED|Overall Study||59
86646|NCT01533753|208447|P2|NOT COMPLETED|Overall Study||0
86647|NCT01533753|208448|P1|NOT COMPLETED|Overall Study||0
86648|NCT01533753|208447|P2|COMPLETED|Overall Study||3
86649|NCT01533753|208448|P1|COMPLETED|Overall Study||2
86650|NCT01533753|208447|P2|STARTED|Overall Study||3
86651|NCT01533753|208448|P1|STARTED|Overall Study||2
86652|NCT01533597|208462|P2|NOT COMPLETED|Overall Study||10
86653|NCT01533597|208463|P1|NOT COMPLETED|Overall Study||6
86654|NCT01533597|208462|P2|COMPLETED|Overall Study||25
86655|NCT01533597|208463|P1|COMPLETED|Overall Study||29
86656|NCT01533597|208462|P2|STARTED|Overall Study||35
86657|NCT01533597|208463|P1|STARTED|Overall Study||35
86658|NCT01533493|208481|P2|NOT COMPLETED|Overall Study||3
86659|NCT01533493|208482|P1|NOT COMPLETED|Overall Study||5
86660|NCT01533493|208481|P2|COMPLETED|Overall Study||11
86661|NCT01533493|208482|P1|COMPLETED|Overall Study||7
86662|NCT01533493|208481|P2|STARTED|Overall Study||14
86663|NCT01533493|208482|P1|STARTED|Overall Study||12
86664|NCT01533428|208490|P2|NOT COMPLETED|Overall Study||8
86665|NCT01533428|208491|P1|NOT COMPLETED|Overall Study||9
86666|NCT01533428|208490|P2|COMPLETED|Overall Study||175
86667|NCT01533428|208491|P1|COMPLETED|Overall Study||177
86668|NCT01533428|208490|P2|STARTED|Overall Study||183
86669|NCT01533428|208491|P1|STARTED|Overall Study||186
86670|NCT01533259|208531|P1|NOT COMPLETED|Overall Study||0
86671|NCT01533259|208531|P1|COMPLETED|Overall Study||48
86672|NCT01533259|208531|P1|STARTED|Overall Study||48
86673|NCT01533246|208537|P1|NOT COMPLETED|Overall Study||2
86674|NCT01533246|208537|P1|COMPLETED|Overall Study||15
86675|NCT01533246|208537|P1|STARTED|Overall Study||17
86676|NCT01533181|208548|P2|NOT COMPLETED|Overall Study||1
86677|NCT01533181|208549|P1|NOT COMPLETED|Overall Study||1
86678|NCT01533181|208548|P2|COMPLETED|Overall Study||28
86679|NCT01533181|208549|P1|COMPLETED|Overall Study||14
86680|NCT01533181|208548|P2|STARTED|Overall Study||29
86681|NCT01533181|208549|P1|STARTED|Overall Study||15
86682|NCT01533116|208565|P4|NOT COMPLETED|Overall Study||0
86683|NCT01533116|208566|P3|NOT COMPLETED|Overall Study||1
86684|NCT01533116|208567|P2|NOT COMPLETED|Overall Study||1
86685|NCT01533116|208568|P1|NOT COMPLETED|Overall Study||2
86686|NCT01533116|208565|P4|COMPLETED|Overall Study||12
86687|NCT01533116|208566|P3|COMPLETED|Overall Study||12
86688|NCT01533116|208567|P2|COMPLETED|Overall Study||12
86689|NCT01533116|208568|P1|COMPLETED|Overall Study||12
86690|NCT01533116|208565|P4|STARTED|Overall Study||12
86691|NCT01533116|208566|P3|STARTED|Overall Study||13
86692|NCT01533116|208567|P2|STARTED|Overall Study||13
86693|NCT01533116|208568|P1|STARTED|Overall Study||14
86694|NCT01533077|208598|P4|NOT COMPLETED|Overall Study||0
86695|NCT01533077|208599|P3|NOT COMPLETED|Overall Study||0
86696|NCT01533077|208600|P2|NOT COMPLETED|Overall Study||1
86697|NCT01533077|208601|P1|NOT COMPLETED|Overall Study||1
86698|NCT01533077|208598|P4|COMPLETED|Overall Study||4
86699|NCT01533077|208599|P3|COMPLETED|Overall Study||4
86700|NCT01533077|208600|P2|COMPLETED|Overall Study||4
86701|NCT01533077|208601|P1|COMPLETED|Overall Study||4
86702|NCT01533077|208598|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
86703|NCT01533077|208599|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
86704|NCT01533077|208600|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
86705|NCT01533077|208601|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
86706|NCT01533077|208598|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
86707|NCT01533077|208599|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
86708|NCT01533077|208600|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
86709|NCT01533077|208601|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
86710|NCT01533077|208598|P4|Sinemet® 100/25|Overall Study||4
86711|NCT01533077|208599|P3|Sinemet® 100/25|Overall Study||4
86712|NCT01533077|208600|P2|Sinemet® 100/25|Overall Study||5
86713|NCT01533077|208601|P1|Sinemet® 100/25|Overall Study||4
86714|NCT01533077|208598|P4|BIA 9-1067 50 mg|Overall Study||4
86715|NCT01533077|208599|P3|BIA 9-1067 50 mg|Overall Study||4
86716|NCT01533077|208600|P2|BIA 9-1067 50 mg|Overall Study||5
86717|NCT01533077|208601|P1|BIA 9-1067 50 mg|Overall Study||5
86718|NCT01533077|208598|P4|STARTED|Overall Study||4
86719|NCT01533077|208599|P3|STARTED|Overall Study||4
86720|NCT01533077|208600|P2|STARTED|Overall Study||5
86721|NCT01533077|208601|P1|STARTED|Overall Study||5
86722|NCT01533038|208657|P2|NOT COMPLETED|Overall Study||1
86723|NCT01533038|208658|P1|NOT COMPLETED|Overall Study||0
86724|NCT01533038|208657|P2|COMPLETED|Overall Study||34
86725|NCT01533038|208658|P1|COMPLETED|Overall Study||45
86726|NCT01533038|208657|P2|STARTED|Overall Study||35
86727|NCT01533038|208658|P1|STARTED|Overall Study||45
86728|NCT01532999|208666|P2|NOT COMPLETED|Overall Study||18
86729|NCT01532999|208667|P1|NOT COMPLETED|Overall Study||31
86730|NCT01532999|208666|P2|COMPLETED|Overall Study||77
86731|NCT01532999|208667|P1|COMPLETED|Overall Study||65
86732|NCT01532999|208666|P2|STARTED|Overall Study||95
86733|NCT01532999|208667|P1|STARTED|Overall Study||96
86734|NCT01532973|208698|P10|NOT COMPLETED|Part 3||0
86735|NCT01532973|208699|P9|NOT COMPLETED|Part 3||0
86736|NCT01532973|208700|P8|NOT COMPLETED|Part 3||0
86737|NCT01532973|208701|P7|NOT COMPLETED|Part 3||0
86738|NCT01532973|208702|P6|NOT COMPLETED|Part 3||0
86739|NCT01532973|208703|P5|NOT COMPLETED|Part 3||0
86740|NCT01532973|208704|P4|NOT COMPLETED|Part 3||0
86741|NCT01532973|208705|P3|NOT COMPLETED|Part 3||0
86742|NCT01532973|208706|P2|NOT COMPLETED|Part 3||0
86743|NCT01532973|208707|P1|NOT COMPLETED|Part 3||0
86744|NCT01532973|208698|P10|COMPLETED|Part 3||6
86745|NCT01532973|208699|P9|COMPLETED|Part 3||6
86746|NCT01532973|208700|P8|COMPLETED|Part 3||0
86747|NCT01532973|208701|P7|COMPLETED|Part 3||0
86748|NCT01532973|208702|P6|COMPLETED|Part 3||0
86749|NCT01532973|208703|P5|COMPLETED|Part 3||0
86750|NCT01532973|208704|P4|COMPLETED|Part 3||0
86751|NCT01532973|208705|P3|COMPLETED|Part 3||0
86752|NCT01532973|208706|P2|COMPLETED|Part 3||0
86753|NCT01532973|208707|P1|COMPLETED|Part 3||0
86754|NCT01532973|208698|P10|STARTED|Part 3||6
86755|NCT01532973|208699|P9|STARTED|Part 3||6
86756|NCT01532973|208700|P8|STARTED|Part 3||0
86757|NCT01532973|208701|P7|STARTED|Part 3||0
86758|NCT01532973|208702|P6|STARTED|Part 3||0
86759|NCT01532973|208703|P5|STARTED|Part 3||0
86760|NCT01532973|208704|P4|STARTED|Part 3||0
86761|NCT01532973|208705|P3|STARTED|Part 3||0
86762|NCT01532973|208706|P2|STARTED|Part 3||0
86763|NCT01532973|208707|P1|STARTED|Part 3||0
86764|NCT01532973|208698|P10|NOT COMPLETED|Part 2||0
86765|NCT01532973|208699|P9|NOT COMPLETED|Part 2||0
86766|NCT01532973|208700|P8|NOT COMPLETED|Part 2||0
86767|NCT01532973|208701|P7|NOT COMPLETED|Part 2||0
86768|NCT01532973|208702|P6|NOT COMPLETED|Part 2||0
86769|NCT01532973|208703|P5|NOT COMPLETED|Part 2||0
86770|NCT01532973|208704|P4|NOT COMPLETED|Part 2||0
86771|NCT01532973|208705|P3|NOT COMPLETED|Part 2||0
86772|NCT01532973|208706|P2|NOT COMPLETED|Part 2||0
86773|NCT01532973|208707|P1|NOT COMPLETED|Part 2||0
86774|NCT01532973|208698|P10|COMPLETED|Part 2||0
86775|NCT01532973|208699|P9|COMPLETED|Part 2||0
86776|NCT01532973|208700|P8|COMPLETED|Part 2||0
86777|NCT01532973|208701|P7|COMPLETED|Part 2||6
86778|NCT01532973|208702|P6|COMPLETED|Part 2||6
86779|NCT01532973|208703|P5|COMPLETED|Part 2||6
86780|NCT01532973|208704|P4|COMPLETED|Part 2||0
86781|NCT01532973|208705|P3|COMPLETED|Part 2||0
86782|NCT01532973|208706|P2|COMPLETED|Part 2||0
86783|NCT01532973|208707|P1|COMPLETED|Part 2||0
86784|NCT01532973|208698|P10|STARTED|Part 2||0
86785|NCT01532973|208699|P9|STARTED|Part 2||0
86786|NCT01532973|208700|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
86787|NCT01532973|208701|P7|STARTED|Part 2||6
86788|NCT01532973|208702|P6|STARTED|Part 2||6
86789|NCT01532973|208703|P5|STARTED|Part 2||6
86790|NCT01532973|208704|P4|STARTED|Part 2||0
86791|NCT01532973|208705|P3|STARTED|Part 2||0
86792|NCT01532973|208706|P2|STARTED|Part 2||0
86793|NCT01532973|208707|P1|STARTED|Part 2||0
86794|NCT01532973|208698|P10|NOT COMPLETED|Part 1||0
86795|NCT01532973|208699|P9|NOT COMPLETED|Part 1||0
86796|NCT01532973|208700|P8|NOT COMPLETED|Part 1||0
86797|NCT01532973|208701|P7|NOT COMPLETED|Part 1||0
86798|NCT01532973|208702|P6|NOT COMPLETED|Part 1||0
86799|NCT01532973|208703|P5|NOT COMPLETED|Part 1||0
86800|NCT01532973|208704|P4|NOT COMPLETED|Part 1||0
86801|NCT01532973|208705|P3|NOT COMPLETED|Part 1||0
86802|NCT01532973|208706|P2|NOT COMPLETED|Part 1||0
86803|NCT01532973|208707|P1|NOT COMPLETED|Part 1||0
86804|NCT01532973|208698|P10|COMPLETED|Part 1||0
86805|NCT01532973|208699|P9|COMPLETED|Part 1||0
86806|NCT01532973|208700|P8|COMPLETED|Part 1||0
86807|NCT01532973|208701|P7|COMPLETED|Part 1||0
86808|NCT01532973|208702|P6|COMPLETED|Part 1||0
86809|NCT01532973|208703|P5|COMPLETED|Part 1||0
86810|NCT01532973|208704|P4|COMPLETED|Part 1||0
86811|NCT01532973|208705|P3|COMPLETED|Part 1||6
86812|NCT01532973|208706|P2|COMPLETED|Part 1||6
86813|NCT01532973|208707|P1|COMPLETED|Part 1||6
86814|NCT01532973|208698|P10|STARTED|Part 1||0
86815|NCT01532973|208699|P9|STARTED|Part 1||0
86816|NCT01532973|208700|P8|STARTED|Part 1||0
86817|NCT01532973|208701|P7|STARTED|Part 1||0
86818|NCT01532973|208702|P6|STARTED|Part 1||0
86819|NCT01532973|208703|P5|STARTED|Part 1||0
86820|NCT01532973|208704|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
86821|NCT01532973|208705|P3|STARTED|Part 1||6
86822|NCT01532973|208706|P2|STARTED|Part 1||6
86823|NCT01532973|208707|P1|STARTED|Part 1||6
86824|NCT01532934|208749|P2|NOT COMPLETED|Overall Study||13
86825|NCT01532934|208750|P1|NOT COMPLETED|Overall Study||14
86826|NCT01532934|208749|P2|COMPLETED|Overall Study||39
86827|NCT01532934|208750|P1|COMPLETED|Overall Study||39
86828|NCT01532934|208749|P2|STARTED|Overall Study||52
86829|NCT01532934|208750|P1|STARTED|Overall Study||53
86830|NCT01532869|208762|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
86831|NCT01532869|208763|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
86832|NCT01532869|208762|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
86833|NCT01532869|208763|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
86834|NCT01532869|208762|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
86921|NCT01532128|208929|P2|STARTED|Overall Study||8
86835|NCT01532869|208763|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
86836|NCT01532869|208762|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
86837|NCT01532869|208763|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
86838|NCT01532869|208762|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
86839|NCT01532869|208763|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
86840|NCT01532869|208762|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
86841|NCT01532869|208763|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
86842|NCT01532869|208762|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
86843|NCT01532869|208763|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
86844|NCT01532869|208762|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
86845|NCT01532869|208763|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
86846|NCT01532869|208762|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
86847|NCT01532869|208763|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
86848|NCT01532830|208800|P1|NOT COMPLETED|Overall Study||4
86849|NCT01532830|208800|P1|COMPLETED|Overall Study||26
86850|NCT01532830|208800|P1|STARTED|Overall Study||30
86851|NCT01532817|208809|P1|NOT COMPLETED|Overall Study||0
86852|NCT01532817|208809|P1|COMPLETED|Overall Study||30
86853|NCT01532817|208809|P1|STARTED|Overall Study||30
86854|NCT01532635|208813|P1|NOT COMPLETED|Overall Study||0
86855|NCT01532635|208813|P1|COMPLETED|Overall Study||4
86856|NCT01532635|208813|P1|STARTED|Overall Study||4
86857|NCT01532570|208829|P4|NOT COMPLETED|Overall Study||0
86858|NCT01532570|208830|P3|NOT COMPLETED|Overall Study||0
86859|NCT01532570|208831|P2|NOT COMPLETED|Overall Study||1
86860|NCT01532570|208832|P1|NOT COMPLETED|Overall Study||1
86861|NCT01532570|208829|P4|COMPLETED|Overall Study||4
86862|NCT01532570|208830|P3|COMPLETED|Overall Study||1
86863|NCT01532570|208831|P2|COMPLETED|Overall Study||1
86864|NCT01532570|208832|P1|COMPLETED|Overall Study||10
86865|NCT01532570|208829|P4|STARTED|Overall Study||4
86866|NCT01532570|208830|P3|STARTED|Overall Study||1
86867|NCT01532570|208831|P2|STARTED|Overall Study||2
86868|NCT01532570|208832|P1|STARTED|Overall Study||11
86869|NCT01532453|208865|P2|NOT COMPLETED|Overall Study||70
86870|NCT01532453|208866|P1|NOT COMPLETED|Overall Study||27
86871|NCT01532453|208865|P2|COMPLETED|Overall Study||90
86872|NCT01532453|208866|P1|COMPLETED|Overall Study||54
86873|NCT01532453|208865|P2|STARTED|Overall Study||160
86874|NCT01532453|208866|P1|STARTED|Overall Study||81
86875|NCT01532414|208877|P3|NOT COMPLETED|Overall Study||3
86876|NCT01532414|208878|P2|NOT COMPLETED|Overall Study||2
86877|NCT01532414|208879|P1|NOT COMPLETED|Overall Study||7
86878|NCT01532414|208877|P3|COMPLETED|Overall Study||35
86879|NCT01532414|208878|P2|COMPLETED|Overall Study||19
86880|NCT01532414|208879|P1|COMPLETED|Overall Study||85
86881|NCT01532414|208877|P3|STARTED|Overall Study||38
86882|NCT01532414|208878|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
86883|NCT01532414|208879|P1|STARTED|Overall Study||92
86884|NCT01532362|208889|P2|NOT COMPLETED|Overall Study||0
86885|NCT01532362|208890|P1|NOT COMPLETED|Overall Study||0
86886|NCT01532362|208889|P2|COMPLETED|Overall Study||0
86887|NCT01532362|208890|P1|COMPLETED|Overall Study||1
86888|NCT01532362|208889|P2|STARTED|Overall Study||0
86889|NCT01532362|208890|P1|STARTED|Overall Study||1
86890|NCT01532349|208898|P2|NOT COMPLETED|Overall Study||5
86891|NCT01532349|208899|P1|NOT COMPLETED|Overall Study||2
86892|NCT01532349|208898|P2|COMPLETED|Overall Study||12
86893|NCT01532349|208899|P1|COMPLETED|Overall Study||15
86894|NCT01532349|208898|P2|STARTED|Overall Study||17
86895|NCT01532349|208899|P1|STARTED|Overall Study||17
86896|NCT01532141|208908|P3|NOT COMPLETED|Overall Study||0
86897|NCT01532141|208909|P2|NOT COMPLETED|Overall Study||0
86898|NCT01532141|208910|P1|NOT COMPLETED|Overall Study||1
86899|NCT01532141|208908|P3|COMPLETED|Overall Study||8
86900|NCT01532141|208909|P2|COMPLETED|Overall Study||8
86901|NCT01532141|208910|P1|COMPLETED|Overall Study||8
86902|NCT01532141|208908|P3|Period 3|Overall Study||8
86903|NCT01532141|208909|P2|Period 3|Overall Study||8
86904|NCT01532141|208910|P1|Period 3|Overall Study||8
86905|NCT01532141|208908|P3|Period 2|Overall Study||8
86906|NCT01532141|208909|P2|Period 2|Overall Study||8
86907|NCT01532141|208910|P1|Period 2|Overall Study||8
86908|NCT01532141|208908|P3|Period 1|Overall Study||8
86909|NCT01532141|208909|P2|Period 1|Overall Study||8
86910|NCT01532141|208910|P1|Period 1|Overall Study||9
86911|NCT01532141|208908|P3|STARTED|Overall Study||8
86912|NCT01532141|208909|P2|STARTED|Overall Study||8
86913|NCT01532141|208910|P1|STARTED|Overall Study||9
86914|NCT01532128|208928|P3|NOT COMPLETED|Overall Study||0
86915|NCT01532128|208929|P2|NOT COMPLETED|Overall Study||0
86916|NCT01532128|208930|P1|NOT COMPLETED|Overall Study||0
86917|NCT01532128|208928|P3|COMPLETED|Overall Study||8
86918|NCT01532128|208929|P2|COMPLETED|Overall Study||8
86919|NCT01532128|208930|P1|COMPLETED|Overall Study||8
86920|NCT01532128|208928|P3|STARTED|Overall Study||8
86922|NCT01532128|208930|P1|STARTED|Overall Study||8
86923|NCT01531998|208945|P1|NOT COMPLETED|Overall Study||3
86924|NCT01531998|208945|P1|COMPLETED|Overall Study||8
86925|NCT01531998|208945|P1|STARTED|Overall Study||11
86926|NCT01531725|208950|P1|NOT COMPLETED|Overall Study||5
86927|NCT01531725|208950|P1|COMPLETED|Overall Study||197
86928|NCT01531725|208950|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
86929|NCT01531673|208968|P13|NOT COMPLETED|Overall Study||0
86930|NCT01531673|208969|P12|NOT COMPLETED|Overall Study||0
86931|NCT01531673|208970|P11|NOT COMPLETED|Overall Study||0
86932|NCT01531673|208971|P10|NOT COMPLETED|Overall Study||1
86933|NCT01531673|208972|P9|NOT COMPLETED|Overall Study||0
86934|NCT01531673|208973|P8|NOT COMPLETED|Overall Study||0
86935|NCT01531673|208974|P7|NOT COMPLETED|Overall Study||0
86936|NCT01531673|208975|P6|NOT COMPLETED|Overall Study||1
86937|NCT01531673|208976|P5|NOT COMPLETED|Overall Study||1
86938|NCT01531673|208977|P4|NOT COMPLETED|Overall Study||1
86939|NCT01531673|208978|P3|NOT COMPLETED|Overall Study||0
86940|NCT01531673|208979|P2|NOT COMPLETED|Overall Study||1
86941|NCT01531673|208980|P1|NOT COMPLETED|Overall Study||0
86942|NCT01531673|208968|P13|COMPLETED|Overall Study||14
86943|NCT01531673|208969|P12|COMPLETED|Overall Study||4
86944|NCT01531673|208970|P11|COMPLETED|Overall Study||16
86945|NCT01531673|208971|P10|COMPLETED|Overall Study||18
86946|NCT01531673|208972|P9|COMPLETED|Overall Study||17
86947|NCT01531673|208973|P8|COMPLETED|Overall Study||9
86948|NCT01531673|208974|P7|COMPLETED|Overall Study||17
86949|NCT01531673|208975|P6|COMPLETED|Overall Study||18
86950|NCT01531673|208976|P5|COMPLETED|Overall Study||7
86951|NCT01531673|208977|P4|COMPLETED|Overall Study||17
86952|NCT01531673|208978|P3|COMPLETED|Overall Study||8
86953|NCT01531673|208979|P2|COMPLETED|Overall Study||7
86954|NCT01531673|208980|P1|COMPLETED|Overall Study||33
86955|NCT01531673|208968|P13|STARTED|Overall Study||14
86956|NCT01531673|208969|P12|STARTED|Overall Study||4
86957|NCT01531673|208970|P11|STARTED|Overall Study||16
86958|NCT01531673|208971|P10|STARTED|Overall Study||19
86959|NCT01531673|208972|P9|STARTED|Overall Study||17
86960|NCT01531673|208973|P8|STARTED|Overall Study||9
86961|NCT01531673|208974|P7|STARTED|Overall Study||17
86962|NCT01531673|208975|P6|STARTED|Overall Study||19
86963|NCT01531673|208976|P5|STARTED|Overall Study||8
86964|NCT01531673|208977|P4|STARTED|Overall Study||18
86965|NCT01531673|208978|P3|STARTED|Overall Study||8
86966|NCT01531673|208979|P2|STARTED|Overall Study||8
86967|NCT01531673|208980|P1|STARTED|Overall Study||33
86968|NCT01531387|209091|P2|NOT COMPLETED|Overall Study||11
86969|NCT01531387|209092|P1|NOT COMPLETED|Overall Study||11
86970|NCT01531387|209091|P2|COMPLETED|Overall Study||0
86971|NCT01531387|209092|P1|COMPLETED|Overall Study||0
86972|NCT01531387|209091|P2|STARTED|Overall Study||11
86973|NCT01531387|209092|P1|STARTED|Overall Study||11
86974|NCT01531374|209109|P3|NOT COMPLETED|Overall Study||283
86975|NCT01531374|209110|P2|NOT COMPLETED|Overall Study||142
86976|NCT01531374|209111|P1|NOT COMPLETED|Overall Study||364
86977|NCT01531374|209109|P3|COMPLETED|Overall Study||836
86978|NCT01531374|209110|P2|COMPLETED|Overall Study||231
86979|NCT01531374|209111|P1|COMPLETED|Overall Study||921
86980|NCT01531374|209109|P3|STARTED|Overall Study||1119
86981|NCT01531374|209110|P2|STARTED|Overall Study||373
86982|NCT01531374|209111|P1|STARTED|Overall Study||1285
86983|NCT01531335|209175|P2|NOT COMPLETED|Overall Study||0
86984|NCT01531335|209176|P1|NOT COMPLETED|Overall Study||0
86985|NCT01531335|209175|P2|COMPLETED|Overall Study||40
86986|NCT01531335|209176|P1|COMPLETED|Overall Study||40
86987|NCT01531335|209175|P2|STARTED|Overall Study||40
86988|NCT01531335|209176|P1|STARTED|Overall Study||40
86989|NCT01531205|209184|P1|NOT COMPLETED|Overall Study||1
86990|NCT01531205|209184|P1|COMPLETED|Overall Study||1
86991|NCT01531205|209184|P1|STARTED|Overall Study||2
86992|NCT01530997|209193|P1|NOT COMPLETED|Overall Study||2
86993|NCT01530997|209193|P1|COMPLETED|Overall Study||43
86994|NCT01530997|209193|P1|STARTED|Overall Study||45
86995|NCT01530880|209213|P1|NOT COMPLETED|Overall Study||0
86996|NCT01530880|209213|P1|COMPLETED|Overall Study||35
86997|NCT01530880|209213|P1|STARTED|Overall Study||35
86998|NCT01530477|209227|P3|NOT COMPLETED|Overall Study||0
86999|NCT01530477|209228|P2|NOT COMPLETED|Overall Study||0
87000|NCT01530477|209229|P1|NOT COMPLETED|Overall Study||0
87001|NCT01530477|209227|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
87002|NCT01530477|209228|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
87003|NCT01530477|209229|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
87004|NCT01530477|209227|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
87005|NCT01530477|209228|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
87006|NCT01530477|209229|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
87007|NCT01530464|209237|P2|NOT COMPLETED|Washout (24h)||1
87008|NCT01530464|209238|P1|NOT COMPLETED|Washout (24h)||0
87009|NCT01530464|209237|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
87010|NCT01530464|209238|P1|COMPLETED|Washout (24h)||9
87011|NCT01530464|209237|P2|STARTED|Washout (24h)||8
87012|NCT01530464|209238|P1|STARTED|Washout (24h)||9
87013|NCT01530464|209237|P2|NOT COMPLETED|Third Intervention (24h)||0
87014|NCT01530464|209238|P1|NOT COMPLETED|Third Intervention (24h)||0
87015|NCT01530464|209237|P2|COMPLETED|Third Intervention (24h)||8
87016|NCT01530464|209238|P1|COMPLETED|Third Intervention (24h)||9
87017|NCT01530464|209237|P2|STARTED|Third Intervention (24h)||8
87018|NCT01530464|209238|P1|STARTED|Third Intervention (24h)||9
87019|NCT01530464|209237|P2|NOT COMPLETED|Washout (24h)||0
87020|NCT01530464|209238|P1|NOT COMPLETED|Washout (24h)||1
87021|NCT01530464|209237|P2|COMPLETED|Washout (24h)||8
87022|NCT01530464|209238|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
87023|NCT01530464|209237|P2|STARTED|Washout (24h)||8
87024|NCT01530464|209238|P1|STARTED|Washout (24h)||10
87025|NCT01530464|209237|P2|NOT COMPLETED|Second Intervention (24h)||0
87026|NCT01530464|209238|P1|NOT COMPLETED|Second Intervention (24h)||0
87027|NCT01530464|209237|P2|COMPLETED|Second Intervention (24h)||8
87028|NCT01530464|209238|P1|COMPLETED|Second Intervention (24h)||10
87029|NCT01530464|209237|P2|STARTED|Second Intervention (24h)||8
87030|NCT01530464|209238|P1|STARTED|Second Intervention (24h)||10
87031|NCT01530464|209237|P2|NOT COMPLETED|Washout (24h)||0
87032|NCT01530464|209238|P1|NOT COMPLETED|Washout (24h)||0
87033|NCT01530464|209237|P2|COMPLETED|Washout (24h)||8
87034|NCT01530464|209238|P1|COMPLETED|Washout (24h)||10
87035|NCT01530464|209237|P2|STARTED|Washout (24h)||8
87036|NCT01530464|209238|P1|STARTED|Washout (24h)||10
87037|NCT01530464|209237|P2|NOT COMPLETED|First Intervention (24h)||0
87038|NCT01530464|209238|P1|NOT COMPLETED|First Intervention (24h)||0
87039|NCT01530464|209237|P2|COMPLETED|First Intervention (24h)||8
87040|NCT01530464|209238|P1|COMPLETED|First Intervention (24h)||10
87041|NCT01530464|209237|P2|STARTED|First Intervention (24h)||8
87042|NCT01530464|209238|P1|STARTED|First Intervention (24h)||10
87043|NCT01530399|209271|P6|NOT COMPLETED|Overall Study||1
87044|NCT01530399|209272|P5|NOT COMPLETED|Overall Study||0
87045|NCT01530399|209273|P4|NOT COMPLETED|Overall Study||0
87046|NCT01530399|209274|P3|NOT COMPLETED|Overall Study||1
87047|NCT01530399|209275|P2|NOT COMPLETED|Overall Study||2
87048|NCT01530399|209276|P1|NOT COMPLETED|Overall Study||1
87049|NCT01530399|209271|P6|COMPLETED|Overall Study||6
87050|NCT01530399|209272|P5|COMPLETED|Overall Study||6
87051|NCT01530399|209273|P4|COMPLETED|Overall Study||10
87052|NCT01530399|209274|P3|COMPLETED|Overall Study||7
87053|NCT01530399|209275|P2|COMPLETED|Overall Study||8
87054|NCT01530399|209276|P1|COMPLETED|Overall Study||7
87055|NCT01530399|209271|P6|STARTED|Overall Study||7
87056|NCT01530399|209272|P5|STARTED|Overall Study||6
87057|NCT01530399|209273|P4|STARTED|Overall Study||10
87058|NCT01530399|209274|P3|STARTED|Overall Study||8
87059|NCT01530399|209275|P2|STARTED|Overall Study||10
87060|NCT01530399|209276|P1|STARTED|Overall Study||8
87061|NCT01530334|209290|P1|NOT COMPLETED|Overall Study||51
87062|NCT01530334|209290|P1|COMPLETED|Overall Study||10
87063|NCT01530334|209290|P1|STARTED|Overall Study||61
87064|NCT01530243|209303|P4|NOT COMPLETED|Overall Study||2
87065|NCT01530243|209304|P3|NOT COMPLETED|Overall Study||3
87066|NCT01530243|209305|P2|NOT COMPLETED|Overall Study||3
87067|NCT01530243|209306|P1|NOT COMPLETED|Overall Study||2
87068|NCT01530243|209303|P4|COMPLETED|Overall Study||24
87069|NCT01530243|209304|P3|COMPLETED|Overall Study||23
87070|NCT01530243|209305|P2|COMPLETED|Overall Study||23
87071|NCT01530243|209306|P1|COMPLETED|Overall Study||24
87072|NCT01530243|209303|P4|STARTED|Overall Study||26
87073|NCT01530243|209304|P3|STARTED|Overall Study||26
87074|NCT01530243|209305|P2|STARTED|Overall Study||26
87075|NCT01530243|209306|P1|STARTED|Overall Study||26
87076|NCT01530087|209324|P1|NOT COMPLETED|Overall Study||2
87077|NCT01530087|209324|P1|COMPLETED|Overall Study||1
87078|NCT01530087|209324|P1|STARTED|Overall Study||3
87079|NCT01529827|209329|P1|NOT COMPLETED|Overall Study||0
87080|NCT01529827|209329|P1|COMPLETED|Overall Study||94
87081|NCT01529827|209329|P1|STARTED|Overall Study||94
87082|NCT01529645|209346|P10|NOT COMPLETED|Overall Study||0
87083|NCT01529645|209347|P9|NOT COMPLETED|Overall Study||1
87084|NCT01529645|209348|P8|NOT COMPLETED|Overall Study||0
87085|NCT01529645|209349|P7|NOT COMPLETED|Overall Study||2
87086|NCT01529645|209350|P6|NOT COMPLETED|Overall Study||1
87087|NCT01529645|209351|P5|NOT COMPLETED|Overall Study||2
87088|NCT01529645|209352|P4|NOT COMPLETED|Overall Study||2
87089|NCT01529645|209353|P3|NOT COMPLETED|Overall Study||2
87090|NCT01529645|209354|P2|NOT COMPLETED|Overall Study||1
87091|NCT01529645|209355|P1|NOT COMPLETED|Overall Study||2
87092|NCT01529645|209346|P10|COMPLETED|Overall Study||42
87093|NCT01529645|209347|P9|COMPLETED|Overall Study||41
87094|NCT01529645|209348|P8|COMPLETED|Overall Study||42
87095|NCT01529645|209349|P7|COMPLETED|Overall Study||40
87096|NCT01529645|209350|P6|COMPLETED|Overall Study||41
87097|NCT01529645|209351|P5|COMPLETED|Overall Study||40
87098|NCT01529645|209352|P4|COMPLETED|Overall Study||40
87099|NCT01529645|209353|P3|COMPLETED|Overall Study||40
87100|NCT01529645|209354|P2|COMPLETED|Overall Study||41
87101|NCT01529645|209355|P1|COMPLETED|Overall Study||40
87102|NCT01529645|209346|P10|STARTED|Overall Study||42
87103|NCT01529645|209347|P9|STARTED|Overall Study||42
87104|NCT01529645|209348|P8|STARTED|Overall Study||42
87105|NCT01529645|209349|P7|STARTED|Overall Study||42
87106|NCT01529645|209350|P6|STARTED|Overall Study||42
87107|NCT01529645|209351|P5|STARTED|Overall Study||42
87108|NCT01529645|209352|P4|STARTED|Overall Study||42
87109|NCT01529645|209353|P3|STARTED|Overall Study||42
87110|NCT01529645|209354|P2|STARTED|Overall Study||42
87111|NCT01529645|209355|P1|STARTED|Overall Study||42
87112|NCT01529632|209453|P2|NOT COMPLETED|Overall Study||3
87113|NCT01529632|209454|P1|NOT COMPLETED|Overall Study||3
87114|NCT01529632|209453|P2|COMPLETED|Overall Study||100
87115|NCT01529632|209454|P1|COMPLETED|Overall Study||87
87116|NCT01529632|209453|P2|STARTED|Overall Study||103
87117|NCT01529632|209454|P1|STARTED|Overall Study||90
87118|NCT01529515|209474|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
87119|NCT01529515|209475|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
87120|NCT01529515|209476|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
87121|NCT01529515|209477|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
87122|NCT01529515|209474|P4|COMPLETED|DOUBLE BLIND PHASE||148
87123|NCT01529515|209475|P3|COMPLETED|DOUBLE BLIND PHASE||122
87124|NCT01529515|209476|P2|COMPLETED|DOUBLE BLIND PHASE||0
87125|NCT01529515|209477|P1|COMPLETED|DOUBLE BLIND PHASE||0
87126|NCT01529515|209474|P4|STARTED|DOUBLE BLIND PHASE||160
87127|NCT01529515|209475|P3|STARTED|DOUBLE BLIND PHASE||145
87128|NCT01529515|209476|P2|STARTED|DOUBLE BLIND PHASE||0
87129|NCT01529515|209477|P1|STARTED|DOUBLE BLIND PHASE||0
87130|NCT01529515|209474|P4|NOT COMPLETED|MAINTENANCE PHASE||0
87131|NCT01529515|209475|P3|NOT COMPLETED|MAINTENANCE PHASE||0
87132|NCT01529515|209476|P2|NOT COMPLETED|MAINTENANCE PHASE||74
87133|NCT01529515|209477|P1|NOT COMPLETED|MAINTENANCE PHASE||0
87134|NCT01529515|209474|P4|COMPLETED|MAINTENANCE PHASE||0
87135|NCT01529515|209475|P3|COMPLETED|MAINTENANCE PHASE||0
87136|NCT01529515|209476|P2|COMPLETED|MAINTENANCE PHASE||305
87137|NCT01529515|209477|P1|COMPLETED|MAINTENANCE PHASE||0
87138|NCT01529515|209474|P4|STARTED|MAINTENANCE PHASE||0
87139|NCT01529515|209475|P3|STARTED|MAINTENANCE PHASE||0
87140|NCT01529515|209476|P2|STARTED|MAINTENANCE PHASE||379
87141|NCT01529515|209477|P1|STARTED|MAINTENANCE PHASE||0
87142|NCT01529515|209474|P4|NOT COMPLETED|TRANSITION PHASE||0
87143|NCT01529515|209475|P3|NOT COMPLETED|TRANSITION PHASE||0
87144|NCT01529515|209476|P2|NOT COMPLETED|TRANSITION PHASE||0
87145|NCT01529515|209477|P1|NOT COMPLETED|TRANSITION PHASE||127
87146|NCT01529515|209474|P4|COMPLETED|TRANSITION PHASE||0
87147|NCT01529515|209475|P3|COMPLETED|TRANSITION PHASE||0
87148|NCT01529515|209476|P2|COMPLETED|TRANSITION PHASE||0
87149|NCT01529515|209477|P1|COMPLETED|TRANSITION PHASE||379
87150|NCT01529515|209474|P4|STARTED|TRANSITION PHASE||0
87151|NCT01529515|209475|P3|STARTED|TRANSITION PHASE||0
87152|NCT01529515|209476|P2|STARTED|TRANSITION PHASE||0
87153|NCT01529515|209477|P1|STARTED|TRANSITION PHASE||506
87154|NCT01529502|209496|P6|NOT COMPLETED|Overall Study||0
87155|NCT01529502|209497|P5|NOT COMPLETED|Overall Study||0
87156|NCT01529502|209498|P4|NOT COMPLETED|Overall Study||2
87157|NCT01529502|209499|P3|NOT COMPLETED|Overall Study||0
87158|NCT01529502|209500|P2|NOT COMPLETED|Overall Study||0
87159|NCT01529502|209501|P1|NOT COMPLETED|Overall Study||0
87160|NCT01529502|209496|P6|COMPLETED|Overall Study||2
87161|NCT01529502|209497|P5|COMPLETED|Overall Study||2
87162|NCT01529502|209498|P4|COMPLETED|Overall Study||1
87163|NCT01529502|209499|P3|COMPLETED|Overall Study||2
87164|NCT01529502|209500|P2|COMPLETED|Overall Study||3
87165|NCT01529502|209501|P1|COMPLETED|Overall Study||2
87166|NCT01529502|209496|P6|STARTED|Overall Study||2
87167|NCT01529502|209497|P5|STARTED|Overall Study||2
87168|NCT01529502|209498|P4|STARTED|Overall Study||3
87169|NCT01529502|209499|P3|STARTED|Overall Study||2
87170|NCT01529502|209500|P2|STARTED|Overall Study||3
87171|NCT01529502|209501|P1|STARTED|Overall Study||2
87172|NCT01529450|209514|P2|NOT COMPLETED|Overall Study||2
87173|NCT01529450|209515|P1|NOT COMPLETED|Overall Study||0
87174|NCT01529450|209514|P2|COMPLETED|Overall Study||6
87175|NCT01529450|209515|P1|COMPLETED|Overall Study||3
87176|NCT01529450|209514|P2|STARTED|Overall Study||8
87177|NCT01529450|209515|P1|STARTED|Overall Study||3
87178|NCT01529385|209524|P2|NOT COMPLETED|Overall Study||1
87179|NCT01529385|209525|P1|NOT COMPLETED|Overall Study||2
87180|NCT01529385|209524|P2|COMPLETED|Overall Study||39
87181|NCT01529385|209525|P1|COMPLETED|Overall Study||38
87182|NCT01529385|209524|P2|Received Intervention|Overall Study||40
87183|NCT01529385|209525|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
87184|NCT01529385|209524|P2|STARTED|Overall Study||40
87185|NCT01529385|209525|P1|STARTED|Overall Study||40
87186|NCT01529268|209551|P2|NOT COMPLETED|Overall Study||3
87187|NCT01529268|209552|P1|NOT COMPLETED|Overall Study||12
87188|NCT01529268|209551|P2|COMPLETED|Overall Study||78
87189|NCT01529268|209552|P1|COMPLETED|Overall Study||76
87190|NCT01529268|209551|P2|Completed 52-week Biopsy|Overall Study||75
87191|NCT01529268|209552|P1|Completed 52-week Biopsy|Overall Study||71
87192|NCT01529268|209551|P2|STARTED|Overall Study||81
87193|NCT01529268|209552|P1|STARTED|Overall Study||88
87194|NCT01529203|209606|P1|NOT COMPLETED|Overall Study||3
87195|NCT01529203|209606|P1|COMPLETED|Overall Study||57
87196|NCT01529203|209606|P1|STARTED|Overall Study||60
87197|NCT01529112|209614|P2|NOT COMPLETED|Overall Study||41
87198|NCT01529112|209615|P1|NOT COMPLETED|Overall Study||69
87289|NCT01528293|209886|P2|COMPLETED|Overall Study||1
87199|NCT01529112|209614|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
87200|NCT01529112|209615|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
87201|NCT01529112|209614|P2|STARTED|Overall Study||46
87202|NCT01529112|209615|P1|STARTED|Overall Study||89
87203|NCT01528969|209642|P2|NOT COMPLETED|Overall Study||0
87204|NCT01528969|209643|P1|NOT COMPLETED|Overall Study||2
87205|NCT01528969|209642|P2|COMPLETED|Overall Study||38
87206|NCT01528969|209643|P1|COMPLETED|Overall Study||35
87207|NCT01528969|209642|P2|STARTED|Overall Study||38
87208|NCT01528969|209643|P1|STARTED|Overall Study||37
87209|NCT01528891|209651|P2|NOT COMPLETED|Overall Study||0
87210|NCT01528891|209652|P1|NOT COMPLETED|Overall Study||0
87211|NCT01528891|209651|P2|COMPLETED|Overall Study||200
87212|NCT01528891|209652|P1|COMPLETED|Overall Study||200
87213|NCT01528891|209651|P2|STARTED|Overall Study||200
87214|NCT01528891|209652|P1|STARTED|Overall Study||200
87215|NCT01528878|209664|P1|NOT COMPLETED|Overall Study||0
87216|NCT01528878|209664|P1|COMPLETED|Overall Study||30
87217|NCT01528878|209664|P1|STARTED|Overall Study||30
87218|NCT01528787|209679|P4|NOT COMPLETED|Overall Study||1
87219|NCT01528787|209680|P3|NOT COMPLETED|Overall Study||1
87220|NCT01528787|209681|P2|NOT COMPLETED|Overall Study||0
87221|NCT01528787|209682|P1|NOT COMPLETED|Overall Study||0
87222|NCT01528787|209679|P4|COMPLETED|Overall Study||22
87223|NCT01528787|209680|P3|COMPLETED|Overall Study||18
87224|NCT01528787|209681|P2|COMPLETED|Overall Study||21
87225|NCT01528787|209682|P1|COMPLETED|Overall Study||22
87226|NCT01528787|209679|P4|STARTED|Overall Study||23
87227|NCT01528787|209680|P3|STARTED|Overall Study||19
87228|NCT01528787|209681|P2|STARTED|Overall Study||21
87229|NCT01528787|209682|P1|STARTED|Overall Study||22
87230|NCT01528735|209694|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
87231|NCT01528735|209695|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
87232|NCT01528735|209694|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
87233|NCT01528735|209695|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
87234|NCT01528735|209694|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
87235|NCT01528735|209695|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
87236|NCT01528735|209694|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
87237|NCT01528735|209695|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
87238|NCT01528735|209694|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
87239|NCT01528735|209695|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
87240|NCT01528735|209694|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
87241|NCT01528735|209695|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
87242|NCT01528696|209797|P2|NOT COMPLETED|Overall Study||19
87243|NCT01528696|209798|P1|NOT COMPLETED|Overall Study||18
87244|NCT01528696|209797|P2|COMPLETED|Overall Study||0
87245|NCT01528696|209798|P1|COMPLETED|Overall Study||0
87246|NCT01528696|209797|P2|Hospital Stay (2-5 Days)|Overall Study||19
87247|NCT01528696|209798|P1|Hospital Stay (2-5 Days)|Overall Study||18
87248|NCT01528696|209797|P2|STARTED|Overall Study||19
87249|NCT01528696|209798|P1|STARTED|Overall Study||18
87250|NCT01528605|209814|P6|NOT COMPLETED|Overall Study||0
87251|NCT01528605|209815|P5|NOT COMPLETED|Overall Study||0
87252|NCT01528605|209816|P4|NOT COMPLETED|Overall Study||1
87253|NCT01528605|209817|P3|NOT COMPLETED|Overall Study||1
87254|NCT01528605|209818|P2|NOT COMPLETED|Overall Study||0
87255|NCT01528605|209819|P1|NOT COMPLETED|Overall Study||2
87256|NCT01528605|209814|P6|COMPLETED|Overall Study||28
87257|NCT01528605|209815|P5|COMPLETED|Overall Study||28
87258|NCT01528605|209816|P4|COMPLETED|Overall Study||27
87259|NCT01528605|209817|P3|COMPLETED|Overall Study||27
87260|NCT01528605|209818|P2|COMPLETED|Overall Study||28
87261|NCT01528605|209819|P1|COMPLETED|Overall Study||26
87262|NCT01528605|209814|P6|STARTED|Overall Study||28
87263|NCT01528605|209815|P5|STARTED|Overall Study||28
87264|NCT01528605|209816|P4|STARTED|Overall Study||28
87265|NCT01528605|209817|P3|STARTED|Overall Study||28
87266|NCT01528605|209818|P2|STARTED|Overall Study||28
87267|NCT01528605|209819|P1|STARTED|Overall Study||28
87268|NCT01528592|209843|P1|NOT COMPLETED|Overall Study||0
87269|NCT01528592|209843|P1|COMPLETED|Overall Study||18
87270|NCT01528592|209843|P1|STARTED|Overall Study||18
87271|NCT01528345|209849|P2|NOT COMPLETED|Overall Study||50
87272|NCT01528345|209850|P1|NOT COMPLETED|Overall Study||47
87273|NCT01528345|209849|P2|COMPLETED|Overall Study||0
87274|NCT01528345|209850|P1|COMPLETED|Overall Study||0
87275|NCT01528345|209849|P2|STARTED|Overall Study||50
87276|NCT01528345|209850|P1|STARTED|Overall Study||47
87277|NCT01528332|209868|P2|NOT COMPLETED|Overall Study||2
87278|NCT01528332|209869|P1|NOT COMPLETED|Overall Study||4
87279|NCT01528332|209868|P2|COMPLETED|Overall Study||84
87280|NCT01528332|209869|P1|COMPLETED|Overall Study||81
87281|NCT01528332|209868|P2|STARTED|Overall Study||86
87282|NCT01528332|209869|P1|STARTED|Overall Study||85
87283|NCT01528319|209875|P1|NOT COMPLETED|Overall Study||1
87284|NCT01528319|209875|P1|COMPLETED|Overall Study||23
87285|NCT01528319|209875|P1|12 Weeks After Surgery|Overall Study||24
87286|NCT01528319|209875|P1|STARTED|Overall Study||24
87287|NCT01528293|209886|P2|NOT COMPLETED|Overall Study||0
87288|NCT01528293|209887|P1|NOT COMPLETED|Overall Study||1
87290|NCT01528293|209887|P1|COMPLETED|Overall Study||0
87291|NCT01528293|209886|P2|STARTED|Overall Study||1
87292|NCT01528293|209887|P1|STARTED|Overall Study||1
87293|NCT01528215|209901|P2|NOT COMPLETED|Overall Study||1
87294|NCT01528215|209902|P1|NOT COMPLETED|Overall Study||4
87295|NCT01528215|209901|P2|COMPLETED|Overall Study||60
87296|NCT01528215|209902|P1|COMPLETED|Overall Study||55
87297|NCT01528215|209901|P2|STARTED|Overall Study||61
87298|NCT01528215|209902|P1|STARTED|Overall Study||59
87299|NCT01528150|209908|P1|NOT COMPLETED|Overall Study||44
87300|NCT01528150|209908|P1|COMPLETED|Overall Study||422
87301|NCT01528150|209908|P1|STARTED|Overall Study||466
87302|NCT01527942|209914|P2|NOT COMPLETED|Overall Study||0
87303|NCT01527942|209915|P1|NOT COMPLETED|Overall Study||0
87304|NCT01527942|209914|P2|COMPLETED|Overall Study||18
87305|NCT01527942|209915|P1|COMPLETED|Overall Study||16
87306|NCT01527942|209914|P2|STARTED|Overall Study||18
87307|NCT01527942|209915|P1|STARTED|Overall Study||16
87308|NCT01527513|209927|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
87309|NCT01527513|209928|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
87310|NCT01527513|209927|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
87311|NCT01527513|209928|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
87312|NCT01527513|209927|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
87313|NCT01527513|209928|P1|STARTED|Eligible for 1-Year Open Label Period||0
87314|NCT01527513|209927|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
87315|NCT01527513|209928|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
87316|NCT01527513|209927|P2|COMPLETED|Double Blind Period (DB) - Part I||75
87317|NCT01527513|209928|P1|COMPLETED|Double Blind Period (DB) - Part I||37
87318|NCT01527513|209927|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
87319|NCT01527513|209928|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
87320|NCT01527513|209927|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
87321|NCT01527513|209928|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
87322|NCT01527513|209927|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
87323|NCT01527513|209928|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
87324|NCT01527513|209927|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
87325|NCT01527513|209928|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
87326|NCT01527513|209927|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
87327|NCT01527513|209928|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
87328|NCT01527513|209927|P2|Safety Population|Double Blind Period (DB) - Part I||83
87329|NCT01527513|209928|P1|Safety Population|Double Blind Period (DB) - Part I||40
87330|NCT01527513|209927|P2|Randomized|Double Blind Period (DB) - Part I||83
87331|NCT01527513|209928|P1|Randomized|Double Blind Period (DB) - Part I||40
87332|NCT01527513|209927|P2|STARTED|Double Blind Period (DB) - Part I||83
87333|NCT01527513|209928|P1|STARTED|Double Blind Period (DB) - Part I||40
87334|NCT01527487|209940|P2|NOT COMPLETED|Overall Study||7
87335|NCT01527487|209941|P1|NOT COMPLETED|Overall Study||8
87336|NCT01527487|209940|P2|COMPLETED|Overall Study||15
87337|NCT01527487|209941|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
87338|NCT01527487|209940|P2|STARTED|Overall Study||22
87339|NCT01527487|209941|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
87340|NCT01527370|209953|P1|NOT COMPLETED|Overall Study||6
87341|NCT01527370|209953|P1|COMPLETED|Overall Study||244
87342|NCT01527370|209953|P1|STARTED|Overall Study||250
87343|NCT01527162|209959|P2|NOT COMPLETED|Overall Study||0
87344|NCT01527162|209960|P1|NOT COMPLETED|Overall Study||0
87345|NCT01527162|209959|P2|COMPLETED|Overall Study||5
87346|NCT01527162|209960|P1|COMPLETED|Overall Study||6
87347|NCT01527162|209959|P2|STARTED|Overall Study||5
87348|NCT01527162|209960|P1|STARTED|Overall Study||6
87349|NCT01527110|209970|P1|NOT COMPLETED|Overall Study||1
87350|NCT01527110|209970|P1|COMPLETED|Overall Study||20
87351|NCT01527110|209970|P1|STARTED|Overall Study||21
87352|NCT01527006|210017|P2|NOT COMPLETED|Extension Phase||8
87353|NCT01527006|210018|P1|NOT COMPLETED|Extension Phase||6
87354|NCT01527006|210017|P2|COMPLETED|Extension Phase||14
87355|NCT01527006|210018|P1|COMPLETED|Extension Phase||13
87356|NCT01527006|210017|P2|STARTED|Extension Phase||22
87357|NCT01527006|210018|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
87358|NCT01527006|210017|P2|NOT COMPLETED|Core Study||6
87359|NCT01527006|210018|P1|NOT COMPLETED|Core Study||2
87360|NCT01527006|210017|P2|COMPLETED|Core Study||22
87361|NCT01527006|210018|P1|COMPLETED|Core Study||20
87362|NCT01527006|210017|P2|STARTED|Core Study||28
87363|NCT01527006|210018|P1|STARTED|Core Study||22
87364|NCT01526902|210068|P2|NOT COMPLETED|Overall Study||0
87365|NCT01526902|210069|P1|NOT COMPLETED|Overall Study||0
87366|NCT01526902|210068|P2|COMPLETED|Overall Study||24
87367|NCT01526902|210069|P1|COMPLETED|Overall Study||25
87368|NCT01526902|210068|P2|STARTED|Overall Study||24
87369|NCT01526902|210069|P1|STARTED|Overall Study||25
87370|NCT01526785|210085|P1|NOT COMPLETED|Overall Study||13
87371|NCT01526785|210085|P1|COMPLETED|Overall Study||100
87372|NCT01526785|210085|P1|STARTED|Overall Study||113
87373|NCT01526733|210095|P2|NOT COMPLETED|Phase 2||0
87374|NCT01526733|210096|P1|NOT COMPLETED|Phase 2||0
87375|NCT01526733|210095|P2|COMPLETED|Phase 2||12
87376|NCT01526733|210096|P1|COMPLETED|Phase 2||10
87377|NCT01526733|210095|P2|STARTED|Phase 2||12
87378|NCT01526733|210096|P1|STARTED|Phase 2||10
87379|NCT01526733|210095|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
87380|NCT01526733|210096|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
87381|NCT01526733|210095|P2|COMPLETED|Washout Period of 5 to 21 Days||12
87382|NCT01526733|210096|P1|COMPLETED|Washout Period of 5 to 21 Days||10
87383|NCT01526733|210095|P2|STARTED|Washout Period of 5 to 21 Days||12
87384|NCT01526733|210096|P1|STARTED|Washout Period of 5 to 21 Days||10
87385|NCT01526733|210095|P2|NOT COMPLETED|Phase 1||1
87386|NCT01526733|210096|P1|NOT COMPLETED|Phase 1||2
87387|NCT01526733|210095|P2|COMPLETED|Phase 1||12
87388|NCT01526733|210096|P1|COMPLETED|Phase 1||10
87389|NCT01526733|210095|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
87390|NCT01526733|210096|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
87391|NCT01526733|210095|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
87392|NCT01526733|210096|P1|STARTED|Phase 1||12
87393|NCT01526629|210114|P1|NOT COMPLETED|Overall Study||46
87394|NCT01526629|210114|P1|COMPLETED|Overall Study||308
87395|NCT01526629|210114|P1|STARTED|Overall Study||354
87396|NCT01526551|210118|P1|NOT COMPLETED|Overall Study||424
87397|NCT01526551|210118|P1|COMPLETED|Overall Study||511
87398|NCT01526551|210118|P1|STARTED|Overall Study||935
87399|NCT01526538|210125|P2|NOT COMPLETED|Overall Study||4
87400|NCT01526538|210126|P1|NOT COMPLETED|Overall Study||9
87401|NCT01526538|210125|P2|COMPLETED|Overall Study||18
87402|NCT01526538|210126|P1|COMPLETED|Overall Study||21
87403|NCT01526538|210125|P2|STARTED|Overall Study||22
87404|NCT01526538|210126|P1|STARTED|Overall Study||30
87405|NCT01526343|210136|P1|NOT COMPLETED|Overall Study||0
87406|NCT01526343|210136|P1|COMPLETED|Overall Study||47
87407|NCT01526343|210136|P1|STARTED|Overall Study||47
87408|NCT01526213|210147|P6|NOT COMPLETED|Period 3 (5 Days)||0
87409|NCT01526213|210148|P5|NOT COMPLETED|Period 3 (5 Days)||0
87410|NCT01526213|210149|P4|NOT COMPLETED|Period 3 (5 Days)||0
87411|NCT01526213|210150|P3|NOT COMPLETED|Period 3 (5 Days)||0
87412|NCT01526213|210151|P2|NOT COMPLETED|Period 3 (5 Days)||0
87413|NCT01526213|210152|P1|NOT COMPLETED|Period 3 (5 Days)||0
87414|NCT01526213|210147|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87415|NCT01526213|210148|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87416|NCT01526213|210149|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87417|NCT01526213|210150|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87418|NCT01526213|210151|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87419|NCT01526213|210152|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87420|NCT01526213|210147|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87421|NCT01526213|210148|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87422|NCT01526213|210149|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87423|NCT01526213|210150|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87424|NCT01526213|210151|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87425|NCT01526213|210152|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87426|NCT01526213|210147|P6|NOT COMPLETED|Washout 2 (10 Days)||0
87427|NCT01526213|210148|P5|NOT COMPLETED|Washout 2 (10 Days)||0
87428|NCT01526213|210149|P4|NOT COMPLETED|Washout 2 (10 Days)||0
87429|NCT01526213|210150|P3|NOT COMPLETED|Washout 2 (10 Days)||0
87430|NCT01526213|210151|P2|NOT COMPLETED|Washout 2 (10 Days)||0
87431|NCT01526213|210152|P1|NOT COMPLETED|Washout 2 (10 Days)||0
87432|NCT01526213|210147|P6|COMPLETED|Washout 2 (10 Days)||3
87433|NCT01526213|210148|P5|COMPLETED|Washout 2 (10 Days)||3
87434|NCT01526213|210149|P4|COMPLETED|Washout 2 (10 Days)||3
87435|NCT01526213|210150|P3|COMPLETED|Washout 2 (10 Days)||3
87436|NCT01526213|210151|P2|COMPLETED|Washout 2 (10 Days)||3
87437|NCT01526213|210152|P1|COMPLETED|Washout 2 (10 Days)||3
87438|NCT01526213|210147|P6|STARTED|Washout 2 (10 Days)||3
87439|NCT01526213|210148|P5|STARTED|Washout 2 (10 Days)||3
87440|NCT01526213|210149|P4|STARTED|Washout 2 (10 Days)||3
87441|NCT01526213|210150|P3|STARTED|Washout 2 (10 Days)||3
87442|NCT01526213|210151|P2|STARTED|Washout 2 (10 Days)||3
87443|NCT01526213|210152|P1|STARTED|Washout 2 (10 Days)||3
87444|NCT01526213|210147|P6|NOT COMPLETED|Period 2 (5 Days)||0
87445|NCT01526213|210148|P5|NOT COMPLETED|Period 2 (5 Days)||0
87446|NCT01526213|210149|P4|NOT COMPLETED|Period 2 (5 Days)||0
87447|NCT01526213|210150|P3|NOT COMPLETED|Period 2 (5 Days)||0
87448|NCT01526213|210151|P2|NOT COMPLETED|Period 2 (5 Days)||0
87449|NCT01526213|210152|P1|NOT COMPLETED|Period 2 (5 Days)||0
87450|NCT01526213|210147|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
87451|NCT01526213|210148|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
87524|NCT01525667|210226|P2|NOT COMPLETED|Overall Study||0
87452|NCT01526213|210149|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
87453|NCT01526213|210150|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
87454|NCT01526213|210151|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87455|NCT01526213|210152|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87456|NCT01526213|210147|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87457|NCT01526213|210148|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87458|NCT01526213|210149|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87459|NCT01526213|210150|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87460|NCT01526213|210151|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87461|NCT01526213|210152|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87462|NCT01526213|210147|P6|NOT COMPLETED|Washout 1 (10 Days)||0
87463|NCT01526213|210148|P5|NOT COMPLETED|Washout 1 (10 Days)||0
87464|NCT01526213|210149|P4|NOT COMPLETED|Washout 1 (10 Days)||0
87465|NCT01526213|210150|P3|NOT COMPLETED|Washout 1 (10 Days)||0
87466|NCT01526213|210151|P2|NOT COMPLETED|Washout 1 (10 Days)||0
87467|NCT01526213|210152|P1|NOT COMPLETED|Washout 1 (10 Days)||0
87468|NCT01526213|210147|P6|COMPLETED|Washout 1 (10 Days)||3
87469|NCT01526213|210148|P5|COMPLETED|Washout 1 (10 Days)||3
87470|NCT01526213|210149|P4|COMPLETED|Washout 1 (10 Days)||3
87471|NCT01526213|210150|P3|COMPLETED|Washout 1 (10 Days)||3
87472|NCT01526213|210151|P2|COMPLETED|Washout 1 (10 Days)||3
87473|NCT01526213|210152|P1|COMPLETED|Washout 1 (10 Days)||3
87474|NCT01526213|210147|P6|STARTED|Washout 1 (10 Days)||3
87475|NCT01526213|210148|P5|STARTED|Washout 1 (10 Days)||3
87476|NCT01526213|210149|P4|STARTED|Washout 1 (10 Days)||3
87477|NCT01526213|210150|P3|STARTED|Washout 1 (10 Days)||3
87478|NCT01526213|210151|P2|STARTED|Washout 1 (10 Days)||3
87479|NCT01526213|210152|P1|STARTED|Washout 1 (10 Days)||3
87480|NCT01526213|210147|P6|NOT COMPLETED|Period 1 (5 Days)||0
87481|NCT01526213|210148|P5|NOT COMPLETED|Period 1 (5 Days)||0
87482|NCT01526213|210149|P4|NOT COMPLETED|Period 1 (5 Days)||0
87483|NCT01526213|210150|P3|NOT COMPLETED|Period 1 (5 Days)||0
87484|NCT01526213|210151|P2|NOT COMPLETED|Period 1 (5 Days)||0
87485|NCT01526213|210152|P1|NOT COMPLETED|Period 1 (5 Days)||0
87486|NCT01526213|210147|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87487|NCT01526213|210148|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87488|NCT01526213|210149|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87489|NCT01526213|210150|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87490|NCT01526213|210151|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87491|NCT01526213|210152|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
87492|NCT01526213|210147|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
87493|NCT01526213|210148|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87494|NCT01526213|210149|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87495|NCT01526213|210150|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87496|NCT01526213|210151|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87497|NCT01526213|210152|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
87498|NCT01526148|210165|P2|NOT COMPLETED|Overall Study||13
87499|NCT01526148|210166|P1|NOT COMPLETED|Overall Study||14
87500|NCT01526148|210165|P2|COMPLETED|Overall Study||11
87501|NCT01526148|210166|P1|COMPLETED|Overall Study||4
87502|NCT01526148|210165|P2|STARTED|Overall Study||24
87503|NCT01526148|210166|P1|STARTED|Overall Study||18
87504|NCT01525927|210176|P1|NOT COMPLETED|Overall Study||0
87505|NCT01525927|210176|P1|COMPLETED|Overall Study||0
87506|NCT01525927|210176|P1|STARTED|Overall Study||0
87507|NCT01525849|210190|P2|NOT COMPLETED|Overall Study||16
87508|NCT01525849|210191|P1|NOT COMPLETED|Overall Study||5
87509|NCT01525849|210190|P2|COMPLETED|Overall Study||59
87510|NCT01525849|210191|P1|COMPLETED|Overall Study||71
87511|NCT01525849|210190|P2|6-Months|Overall Study||60
87512|NCT01525849|210191|P1|6-Months|Overall Study||73
87513|NCT01525849|210190|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
87514|NCT01525849|210191|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
87515|NCT01525849|210190|P2|STARTED|Overall Study||75
87516|NCT01525849|210191|P1|STARTED|Overall Study||76
87517|NCT01525745|210207|P2|NOT COMPLETED|Overall Study||1
87518|NCT01525745|210208|P1|NOT COMPLETED|Overall Study||1
87519|NCT01525745|210207|P2|COMPLETED|Overall Study||1
87520|NCT01525745|210208|P1|COMPLETED|Overall Study||3
87521|NCT01525745|210207|P2|STARTED|Overall Study||2
87522|NCT01525745|210208|P1|STARTED|Overall Study||4
87523|NCT01525667|210225|P3|NOT COMPLETED|Overall Study||0
87525|NCT01525667|210227|P1|NOT COMPLETED|Overall Study||0
87526|NCT01525667|210225|P3|COMPLETED|Overall Study||7
87527|NCT01525667|210226|P2|COMPLETED|Overall Study||6
87528|NCT01525667|210227|P1|COMPLETED|Overall Study||7
87529|NCT01525667|210225|P3|STARTED|Overall Study||7
87530|NCT01525667|210226|P2|STARTED|Overall Study||6
87531|NCT01525667|210227|P1|STARTED|Overall Study||7
87532|NCT01525641|210247|P1|NOT COMPLETED|Overall Study||180
87533|NCT01525641|210247|P1|COMPLETED|Overall Study||435
87534|NCT01525641|210247|P1|STARTED|Overall Study||615
87535|NCT01525628|210261|P5|NOT COMPLETED|Overall Study||3
87536|NCT01525628|210262|P4|NOT COMPLETED|Overall Study||4
87537|NCT01525628|210263|P3|NOT COMPLETED|Overall Study||5
87538|NCT01525628|210264|P2|NOT COMPLETED|Overall Study||5
87539|NCT01525628|210265|P1|NOT COMPLETED|Overall Study||2
87540|NCT01525628|210261|P5|COMPLETED|Overall Study||4
87541|NCT01525628|210262|P4|COMPLETED|Overall Study||10
87542|NCT01525628|210263|P3|COMPLETED|Overall Study||11
87543|NCT01525628|210264|P2|COMPLETED|Overall Study||14
87544|NCT01525628|210265|P1|COMPLETED|Overall Study||14
87545|NCT01525628|210261|P5|STARTED|Overall Study||7
87546|NCT01525628|210262|P4|STARTED|Overall Study||14
87547|NCT01525628|210263|P3|STARTED|Overall Study||16
87548|NCT01525628|210264|P2|STARTED|Overall Study||19
87549|NCT01525628|210265|P1|STARTED|Overall Study||16
87550|NCT01525615|210332|P3|NOT COMPLETED|Overall Study||6
87551|NCT01525615|210333|P2|NOT COMPLETED|Overall Study||7
87552|NCT01525615|210334|P1|NOT COMPLETED|Overall Study||14
87553|NCT01525615|210332|P3|COMPLETED|Overall Study||133
87554|NCT01525615|210333|P2|COMPLETED|Overall Study||126
87555|NCT01525615|210334|P1|COMPLETED|Overall Study||118
87556|NCT01525615|210332|P3|STARTED|Overall Study||139
87557|NCT01525615|210333|P2|STARTED|Overall Study||133
87558|NCT01525615|210334|P1|STARTED|Overall Study||132
87559|NCT01525563|210378|P1|NOT COMPLETED|Overall Study||212
87560|NCT01525563|210378|P1|COMPLETED|Overall Study|6 Months Follow-up|788
87561|NCT01525563|210378|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
87562|NCT01525563|210378|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
87563|NCT01525563|210378|P1|STARTED|Overall Study||1000
87564|NCT01525550|210390|P2|NOT COMPLETED|Overall Study||45
87565|NCT01525550|210391|P1|NOT COMPLETED|Overall Study||61
87566|NCT01525550|210390|P2|COMPLETED|Overall Study||0
87567|NCT01525550|210391|P1|COMPLETED|Overall Study||0
87568|NCT01525550|210390|P2|STARTED|Overall Study||45
87569|NCT01525550|210391|P1|STARTED|Overall Study||61
87570|NCT01525420|210453|P2|NOT COMPLETED|Overall Study||24
87571|NCT01525420|210454|P1|NOT COMPLETED|Overall Study||16
87572|NCT01525420|210453|P2|COMPLETED|Overall Study||38
87573|NCT01525420|210454|P1|COMPLETED|Overall Study||43
87574|NCT01525420|210453|P2|STARTED|Overall Study||62
87575|NCT01525420|210454|P1|STARTED|Overall Study||59
87576|NCT01525407|210462|P2|NOT COMPLETED|Overall Study||4
87577|NCT01525407|210463|P1|NOT COMPLETED|Overall Study||3
87578|NCT01525407|210462|P2|COMPLETED|Overall Study||38
87579|NCT01525407|210463|P1|COMPLETED|Overall Study||38
87580|NCT01525407|210462|P2|STARTED|Overall Study||42
87581|NCT01525407|210463|P1|STARTED|Overall Study||41
87582|NCT01525238|210480|P3|NOT COMPLETED|Overall Study||0
87583|NCT01525238|210481|P2|NOT COMPLETED|Overall Study||0
87584|NCT01525238|210482|P1|NOT COMPLETED|Overall Study||1
87585|NCT01525238|210480|P3|COMPLETED|Overall Study||8
87586|NCT01525238|210481|P2|COMPLETED|Overall Study||8
87587|NCT01525238|210482|P1|COMPLETED|Overall Study||7
87588|NCT01525238|210480|P3|STARTED|Overall Study||8
87589|NCT01525238|210481|P2|STARTED|Overall Study||8
87590|NCT01525238|210482|P1|STARTED|Overall Study||8
87591|NCT01525225|210547|P1|NOT COMPLETED|Treated||0
87592|NCT01525225|210547|P1|COMPLETED|Treated||2
87593|NCT01525225|210547|P1|STARTED|Treated||2
87594|NCT01525225|210547|P1|NOT COMPLETED|Enrollment||2
87595|NCT01525225|210547|P1|COMPLETED|Enrollment||2
87596|NCT01525225|210547|P1|STARTED|Enrollment||4
87597|NCT01525173|210554|P2|NOT COMPLETED|Overall Study||5
87598|NCT01525173|210555|P1|NOT COMPLETED|Overall Study||7
87599|NCT01525173|210554|P2|COMPLETED|Overall Study||62
87600|NCT01525173|210555|P1|COMPLETED|Overall Study||63
87601|NCT01525173|210554|P2|STARTED|Overall Study||67
87602|NCT01525173|210555|P1|STARTED|Overall Study||70
87603|NCT01524978|210572|P11|NOT COMPLETED|Overall Study||28
87604|NCT01524978|210573|P10|NOT COMPLETED|Overall Study||9
87605|NCT01524978|210574|P9|NOT COMPLETED|Overall Study||12
87606|NCT01524978|210575|P8|NOT COMPLETED|Overall Study||12
87607|NCT01524978|210576|P7|NOT COMPLETED|Overall Study||26
87608|NCT01524978|210577|P6|NOT COMPLETED|Overall Study||9
87609|NCT01524978|210578|P5|NOT COMPLETED|Overall Study||9
87610|NCT01524978|210579|P4|NOT COMPLETED|Overall Study||27
87611|NCT01524978|210580|P3|NOT COMPLETED|Overall Study||10
87612|NCT01524978|210581|P2|NOT COMPLETED|Overall Study||4
87613|NCT01524978|210582|P1|NOT COMPLETED|Overall Study||62
87614|NCT01524978|210572|P11|COMPLETED|Overall Study||0
87615|NCT01524978|210573|P10|COMPLETED|Overall Study||0
87616|NCT01524978|210574|P9|COMPLETED|Overall Study||0
87617|NCT01524978|210575|P8|COMPLETED|Overall Study||0
87618|NCT01524978|210576|P7|COMPLETED|Overall Study||0
87619|NCT01524978|210577|P6|COMPLETED|Overall Study||0
87620|NCT01524978|210578|P5|COMPLETED|Overall Study||0
87621|NCT01524978|210579|P4|COMPLETED|Overall Study||0
87622|NCT01524978|210580|P3|COMPLETED|Overall Study||0
87623|NCT01524978|210581|P2|COMPLETED|Overall Study||0
87624|NCT01524978|210582|P1|COMPLETED|Overall Study||0
87625|NCT01524978|210572|P11|STARTED|Overall Study||28
87626|NCT01524978|210573|P10|STARTED|Overall Study||9
87627|NCT01524978|210574|P9|STARTED|Overall Study||12
87628|NCT01524978|210575|P8|STARTED|Overall Study||12
87629|NCT01524978|210576|P7|STARTED|Overall Study||26
87630|NCT01524978|210577|P6|STARTED|Overall Study||9
87631|NCT01524978|210578|P5|STARTED|Overall Study||9
87632|NCT01524978|210579|P4|STARTED|Overall Study||27
87633|NCT01524978|210580|P3|STARTED|Overall Study||10
87634|NCT01524978|210581|P2|STARTED|Overall Study||4
87635|NCT01524978|210582|P1|STARTED|Overall Study||62
87636|NCT01524913|210710|P3|NOT COMPLETED|Overall Study||0
87637|NCT01524913|210711|P2|NOT COMPLETED|Overall Study||0
87638|NCT01524913|210712|P1|NOT COMPLETED|Overall Study||4
87639|NCT01524913|210710|P3|COMPLETED|Overall Study||31
87640|NCT01524913|210711|P2|COMPLETED|Overall Study||36
87641|NCT01524913|210712|P1|COMPLETED|Overall Study||31
87642|NCT01524913|210710|P3|STARTED|Overall Study||31
87643|NCT01524913|210711|P2|STARTED|Overall Study||36
87644|NCT01524913|210712|P1|STARTED|Overall Study||35
87645|NCT01524900|210734|P5|NOT COMPLETED|Overall Study||0
87646|NCT01524900|210735|P4|NOT COMPLETED|Overall Study||1
87647|NCT01524900|210736|P3|NOT COMPLETED|Overall Study||1
87648|NCT01524900|210737|P2|NOT COMPLETED|Overall Study||14
87649|NCT01524900|210738|P1|NOT COMPLETED|Overall Study||6
87650|NCT01524900|210734|P5|COMPLETED|Overall Study||40
87651|NCT01524900|210735|P4|COMPLETED|Overall Study||21
87652|NCT01524900|210736|P3|COMPLETED|Overall Study||29
87653|NCT01524900|210737|P2|COMPLETED|Overall Study||232
87654|NCT01524900|210738|P1|COMPLETED|Overall Study||43
87655|NCT01524900|210734|P5|STARTED|Overall Study||40
87656|NCT01524900|210735|P4|STARTED|Overall Study||22
87657|NCT01524900|210736|P3|STARTED|Overall Study||30
87658|NCT01524900|210737|P2|STARTED|Overall Study||246
87659|NCT01524900|210738|P1|STARTED|Overall Study||49
87660|NCT01524887|210783|P3|NOT COMPLETED|Overall Study||86
87661|NCT01524887|210784|P2|NOT COMPLETED|Overall Study||90
87662|NCT01524887|210785|P1|NOT COMPLETED|Overall Study||85
87663|NCT01524887|210783|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
87664|NCT01524887|210784|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
87665|NCT01524887|210785|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
87666|NCT01524887|210783|P3|Received Treatment|Overall Study||83
87667|NCT01524887|210784|P2|Received Treatment|Overall Study||85
87668|NCT01524887|210785|P1|Received Treatment|Overall Study||83
87669|NCT01524887|210783|P3|STARTED|Overall Study||86
87670|NCT01524887|210784|P2|STARTED|Overall Study||90
87671|NCT01524887|210785|P1|STARTED|Overall Study||85
87672|NCT01524796|210829|P1|NOT COMPLETED|Overall Study||28
87673|NCT01524796|210829|P1|COMPLETED|Overall Study||100
87674|NCT01524796|210829|P1|STARTED|Overall Study||128
87675|NCT01524783|210844|P2|NOT COMPLETED|Randomized and Treated||84
87676|NCT01524783|210845|P1|NOT COMPLETED|Randomized and Treated||155
87677|NCT01524783|210844|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
87678|NCT01524783|210845|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
87679|NCT01524783|210844|P2|STARTED|Randomized and Treated||97
87680|NCT01524783|210845|P1|STARTED|Randomized and Treated||203
87681|NCT01524783|210844|P2|NOT COMPLETED|Randomized But Not Treated||0
87682|NCT01524783|210845|P1|NOT COMPLETED|Randomized But Not Treated||2
87683|NCT01524783|210844|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
87684|NCT01524783|210845|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
87685|NCT01524783|210844|P2|STARTED|Randomized But Not Treated||97
87686|NCT01524783|210845|P1|STARTED|Randomized But Not Treated||205
87687|NCT01524770|210867|P2|NOT COMPLETED|Second Intervention||0
87688|NCT01524770|210868|P1|NOT COMPLETED|Second Intervention||0
87689|NCT01524770|210867|P2|COMPLETED|Second Intervention||23
87690|NCT01524770|210868|P1|COMPLETED|Second Intervention||23
87691|NCT01524770|210867|P2|STARTED|Second Intervention||23
87692|NCT01524770|210868|P1|STARTED|Second Intervention||23
87693|NCT01524770|210867|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
87694|NCT01524770|210868|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
87695|NCT01524770|210867|P2|COMPLETED|Washout Period of at Least 28 Days||23
87696|NCT01524770|210868|P1|COMPLETED|Washout Period of at Least 28 Days||23
87697|NCT01524770|210867|P2|STARTED|Washout Period of at Least 28 Days||23
87698|NCT01524770|210868|P1|STARTED|Washout Period of at Least 28 Days||23
87699|NCT01524770|210867|P2|NOT COMPLETED|First Intervention||1
87700|NCT01524770|210868|P1|NOT COMPLETED|First Intervention||3
87701|NCT01524770|210867|P2|COMPLETED|First Intervention||23
87702|NCT01524770|210868|P1|COMPLETED|First Intervention||23
87703|NCT01524770|210867|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
87798|NCT01523743|210996|P2|NOT COMPLETED|Period 1||2
87704|NCT01524770|210868|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
87705|NCT01524770|210867|P2|STARTED|First Intervention||24
87706|NCT01524770|210868|P1|STARTED|First Intervention||26
87707|NCT01524692|210878|P1|NOT COMPLETED|Overall Study||3
87708|NCT01524692|210878|P1|COMPLETED|Overall Study||32
87709|NCT01524692|210878|P1|STARTED|Overall Study||35
87710|NCT01524627|210888|P2|NOT COMPLETED|Overall Study||2
87711|NCT01524627|210889|P1|NOT COMPLETED|Overall Study||1
87712|NCT01524627|210888|P2|COMPLETED|Overall Study||19
87713|NCT01524627|210889|P1|COMPLETED|Overall Study||21
87714|NCT01524627|210888|P2|STARTED|Overall Study||21
87715|NCT01524627|210889|P1|STARTED|Overall Study||22
87716|NCT01524302|210897|P2|NOT COMPLETED|Overall Study||0
87717|NCT01524302|210898|P1|NOT COMPLETED|Overall Study||0
87718|NCT01524302|210897|P2|COMPLETED|Overall Study||6
87719|NCT01524302|210898|P1|COMPLETED|Overall Study||6
87720|NCT01524302|210897|P2|STARTED|Overall Study||6
87721|NCT01524302|210898|P1|STARTED|Overall Study||6
87722|NCT01524198|210916|P2|NOT COMPLETED|Overall Study||16
87723|NCT01524198|210917|P1|NOT COMPLETED|Overall Study||23
87724|NCT01524198|210916|P2|COMPLETED|Overall Study||458
87725|NCT01524198|210917|P1|COMPLETED|Overall Study||448
87726|NCT01524198|210916|P2|STARTED|Overall Study||474
87727|NCT01524198|210917|P1|STARTED|Overall Study||471
87728|NCT01524133|210928|P3|NOT COMPLETED|Overall Study 52 Weeks||27
87729|NCT01524133|210929|P2|NOT COMPLETED|Overall Study 52 Weeks||20
87730|NCT01524133|210930|P1|NOT COMPLETED|Overall Study 52 Weeks||21
87731|NCT01524133|210928|P3|COMPLETED|Overall Study 52 Weeks||40
87732|NCT01524133|210929|P2|COMPLETED|Overall Study 52 Weeks||49
87733|NCT01524133|210930|P1|COMPLETED|Overall Study 52 Weeks||50
87734|NCT01524133|210928|P3|STARTED|Overall Study 52 Weeks||67
87735|NCT01524133|210929|P2|STARTED|Overall Study 52 Weeks||69
87736|NCT01524133|210930|P1|STARTED|Overall Study 52 Weeks||71
87737|NCT01524133|210928|P3|NOT COMPLETED|Treatment Phase||36
87738|NCT01524133|210929|P2|NOT COMPLETED|Treatment Phase||32
87739|NCT01524133|210930|P1|NOT COMPLETED|Treatment Phase||19
87740|NCT01524133|210928|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
87741|NCT01524133|210929|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
87742|NCT01524133|210930|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
87743|NCT01524133|210928|P3|STARTED|Treatment Phase||67
87744|NCT01524133|210929|P2|STARTED|Treatment Phase||69
87745|NCT01524133|210930|P1|STARTED|Treatment Phase||71
87746|NCT01523964|210945|P4|NOT COMPLETED|Overall Study||0
87747|NCT01523964|210946|P3|NOT COMPLETED|Overall Study||0
87748|NCT01523964|210947|P2|NOT COMPLETED|Overall Study||0
87749|NCT01523964|210948|P1|NOT COMPLETED|Overall Study||0
87750|NCT01523964|210945|P4|COMPLETED|Overall Study||15
87751|NCT01523964|210946|P3|COMPLETED|Overall Study||16
87752|NCT01523964|210947|P2|COMPLETED|Overall Study||30
87753|NCT01523964|210948|P1|COMPLETED|Overall Study||31
87754|NCT01523964|210945|P4|STARTED|Overall Study||15
87755|NCT01523964|210946|P3|STARTED|Overall Study||16
87756|NCT01523964|210947|P2|STARTED|Overall Study||30
87757|NCT01523964|210948|P1|STARTED|Overall Study||31
87758|NCT01523899|210960|P2|NOT COMPLETED|Overall Study||0
87759|NCT01523899|210961|P1|NOT COMPLETED|Overall Study||0
87760|NCT01523899|210960|P2|COMPLETED|Overall Study||126
87761|NCT01523899|210961|P1|COMPLETED|Overall Study||126
87762|NCT01523899|210960|P2|STARTED|Overall Study||126
87763|NCT01523899|210961|P1|STARTED|Overall Study||126
87764|NCT01523886|210973|P2|NOT COMPLETED|Overall Study||1
87765|NCT01523886|210974|P1|NOT COMPLETED|Overall Study||0
87766|NCT01523886|210973|P2|COMPLETED|Overall Study||23
87767|NCT01523886|210974|P1|COMPLETED|Overall Study||25
87768|NCT01523886|210973|P2|STARTED|Overall Study||24
87769|NCT01523886|210974|P1|STARTED|Overall Study||25
87770|NCT01523873|210980|P1|NOT COMPLETED|Overall Study||422
87771|NCT01523873|210980|P1|COMPLETED|Overall Study||35499
87772|NCT01523873|210980|P1|Administered With Dotarem|Overall Study||35474
87773|NCT01523873|210980|P1|STARTED|Overall Study||35921
87774|NCT01523756|210987|P2|NOT COMPLETED|Test Period 2||1
87775|NCT01523756|210988|P1|NOT COMPLETED|Test Period 2||0
87776|NCT01523756|210987|P2|COMPLETED|Test Period 2||7
87777|NCT01523756|210988|P1|COMPLETED|Test Period 2||10
87778|NCT01523756|210987|P2|STARTED|Test Period 2||8
87779|NCT01523756|210988|P1|STARTED|Test Period 2||10
87780|NCT01523756|210987|P2|NOT COMPLETED|Test Period 1||0
87781|NCT01523756|210988|P1|NOT COMPLETED|Test Period 1||1
87782|NCT01523756|210987|P2|COMPLETED|Test Period 1||8
87783|NCT01523756|210988|P1|COMPLETED|Test Period 1||10
87784|NCT01523756|210987|P2|STARTED|Test Period 1||8
87785|NCT01523756|210988|P1|STARTED|Test Period 1||11
87786|NCT01523756|210987|P2|NOT COMPLETED|Baseline Period||1
87787|NCT01523756|210988|P1|NOT COMPLETED|Baseline Period||0
87788|NCT01523756|210987|P2|COMPLETED|Baseline Period||8
87789|NCT01523756|210988|P1|COMPLETED|Baseline Period||11
87790|NCT01523756|210987|P2|STARTED|Baseline Period||9
87791|NCT01523756|210988|P1|STARTED|Baseline Period||11
87792|NCT01523743|210996|P2|NOT COMPLETED|Period 2||2
87793|NCT01523743|210997|P1|NOT COMPLETED|Period 2||1
87794|NCT01523743|210996|P2|COMPLETED|Period 2||58
87795|NCT01523743|210997|P1|COMPLETED|Period 2||52
87796|NCT01523743|210996|P2|STARTED|Period 2||60
87797|NCT01523743|210997|P1|STARTED|Period 2||53
87799|NCT01523743|210997|P1|NOT COMPLETED|Period 1||10
87800|NCT01523743|210996|P2|COMPLETED|Period 1||60
87801|NCT01523743|210997|P1|COMPLETED|Period 1||53
87802|NCT01523743|210996|P2|STARTED|Period 1||62
87803|NCT01523743|210997|P1|STARTED|Period 1||63
87804|NCT01523613|211006|P3|NOT COMPLETED|Overall Study||12
87805|NCT01523613|211007|P2|NOT COMPLETED|Overall Study||5
87806|NCT01523613|211008|P1|NOT COMPLETED|Overall Study||7
87807|NCT01523613|211006|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
87808|NCT01523613|211007|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
87809|NCT01523613|211008|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
87810|NCT01523613|211006|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
87811|NCT01523613|211007|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
87812|NCT01523613|211008|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
87813|NCT01523587|211020|P2|NOT COMPLETED|Overall Study||54
87814|NCT01523587|211021|P1|NOT COMPLETED|Overall Study||87
87815|NCT01523587|211020|P2|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|280
87816|NCT01523587|211021|P1|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|248
87817|NCT01523587|211020|P2|STARTED|Overall Study||334
87818|NCT01523587|211021|P1|STARTED|Overall Study||335
87819|NCT01523496|211043|P4|NOT COMPLETED|Overall Study||3
87820|NCT01523496|211044|P3|NOT COMPLETED|Overall Study||12
87821|NCT01523496|211045|P2|NOT COMPLETED|Overall Study||4
87822|NCT01523496|211046|P1|NOT COMPLETED|Overall Study||10
87823|NCT01523496|211043|P4|COMPLETED|Overall Study||27
87824|NCT01523496|211044|P3|COMPLETED|Overall Study||46
87825|NCT01523496|211045|P2|COMPLETED|Overall Study||32
87826|NCT01523496|211046|P1|COMPLETED|Overall Study||56
87827|NCT01523496|211043|P4|STARTED|Overall Study||30
87828|NCT01523496|211044|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
87829|NCT01523496|211045|P2|STARTED|Overall Study||36
87830|NCT01523496|211046|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
87831|NCT01523457|211062|P2|NOT COMPLETED|Overall Study||2
87832|NCT01523457|211063|P1|NOT COMPLETED|Overall Study||7
87833|NCT01523457|211062|P2|COMPLETED|Overall Study||29
87834|NCT01523457|211063|P1|COMPLETED|Overall Study||37
87835|NCT01523457|211062|P2|STARTED|Overall Study||31
87836|NCT01523457|211063|P1|STARTED|Overall Study||44
87837|NCT01523392|211081|P2|NOT COMPLETED|Treatment Period 2||0
87838|NCT01523392|211082|P1|NOT COMPLETED|Treatment Period 2||0
87839|NCT01523392|211081|P2|COMPLETED|Treatment Period 2||14
87840|NCT01523392|211082|P1|COMPLETED|Treatment Period 2||17
87841|NCT01523392|211081|P2|STARTED|Treatment Period 2||14
87842|NCT01523392|211082|P1|STARTED|Treatment Period 2||17
87843|NCT01523392|211081|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
87844|NCT01523392|211082|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
87845|NCT01523392|211081|P2|COMPLETED|Washout Period - 10 to 14 Days||14
87846|NCT01523392|211082|P1|COMPLETED|Washout Period - 10 to 14 Days||17
87847|NCT01523392|211081|P2|STARTED|Washout Period - 10 to 14 Days||14
87848|NCT01523392|211082|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
87849|NCT01523392|211081|P2|NOT COMPLETED|Treatment Period 1||0
87850|NCT01523392|211082|P1|NOT COMPLETED|Treatment Period 1||3
87851|NCT01523392|211081|P2|COMPLETED|Treatment Period 1||14
87852|NCT01523392|211082|P1|COMPLETED|Treatment Period 1||17
87853|NCT01523392|211081|P2|STARTED|Treatment Period 1||14
87854|NCT01523392|211082|P1|STARTED|Treatment Period 1||20
87855|NCT01523366|211098|P2|NOT COMPLETED|Treatment Period 2||0
87856|NCT01523366|211099|P1|NOT COMPLETED|Treatment Period 2||1
87857|NCT01523366|211098|P2|COMPLETED|Treatment Period 2||20
87858|NCT01523366|211099|P1|COMPLETED|Treatment Period 2||18
87859|NCT01523366|211098|P2|STARTED|Treatment Period 2||20
87860|NCT01523366|211099|P1|STARTED|Treatment Period 2||19
87861|NCT01523366|211098|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
87862|NCT01523366|211099|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
87863|NCT01523366|211098|P2|COMPLETED|Washout Period - 10-14 Days||20
87864|NCT01523366|211099|P1|COMPLETED|Washout Period - 10-14 Days||19
87865|NCT01523366|211098|P2|STARTED|Washout Period - 10-14 Days||20
87866|NCT01523366|211099|P1|STARTED|Washout Period - 10-14 Days||19
87867|NCT01523366|211098|P2|NOT COMPLETED|Treatment Period 1||0
87868|NCT01523366|211099|P1|NOT COMPLETED|Treatment Period 1||1
87869|NCT01523366|211098|P2|COMPLETED|Treatment Period 1||20
87870|NCT01523366|211099|P1|COMPLETED|Treatment Period 1||19
87871|NCT01523366|211098|P2|STARTED|Treatment Period 1||20
87872|NCT01523366|211099|P1|STARTED|Treatment Period 1||20
87873|NCT01523301|211115|P2|NOT COMPLETED|Overall Study||32
87874|NCT01523301|211116|P1|NOT COMPLETED|Overall Study||35
87875|NCT01523301|211115|P2|COMPLETED|Overall Study||164
87876|NCT01523301|211116|P1|COMPLETED|Overall Study||149
87877|NCT01523301|211115|P2|STARTED|Overall Study||196
87878|NCT01523301|211116|P1|STARTED|Overall Study||184
87879|NCT01522976|211137|P3|NOT COMPLETED|Overall Study||93
87880|NCT01522976|211138|P2|NOT COMPLETED|Overall Study||92
87881|NCT01522976|211139|P1|NOT COMPLETED|Overall Study||97
87882|NCT01522976|211137|P3|COMPLETED|Overall Study||0
87883|NCT01522976|211138|P2|COMPLETED|Overall Study||0
87884|NCT01522976|211139|P1|COMPLETED|Overall Study||0
87885|NCT01522976|211137|P3|STARTED|Overall Study||93
87886|NCT01522976|211138|P2|STARTED|Overall Study||92
87887|NCT01522976|211139|P1|STARTED|Overall Study||97
87888|NCT01522963|211166|P4|NOT COMPLETED|Overall Study||6
87889|NCT01522963|211167|P3|NOT COMPLETED|Overall Study||3
87890|NCT01522963|211168|P2|NOT COMPLETED|Overall Study||3
87891|NCT01522963|211169|P1|NOT COMPLETED|Overall Study||2
87892|NCT01522963|211166|P4|COMPLETED|Overall Study||18
87893|NCT01522963|211167|P3|COMPLETED|Overall Study||22
87894|NCT01522963|211168|P2|COMPLETED|Overall Study||22
87895|NCT01522963|211169|P1|COMPLETED|Overall Study||22
87896|NCT01522963|211166|P4|STARTED|Overall Study||24
87897|NCT01522963|211167|P3|STARTED|Overall Study||25
87898|NCT01522963|211168|P2|STARTED|Overall Study||25
87899|NCT01522963|211169|P1|STARTED|Overall Study||24
87900|NCT01522937|211181|P1|NOT COMPLETED|Overall Study||0
87901|NCT01522937|211181|P1|COMPLETED|Overall Study||146
87902|NCT01522937|211181|P1|STARTED|Overall Study||146
87903|NCT01522924|211191|P2|NOT COMPLETED|Overall Study||0
87904|NCT01522924|211192|P1|NOT COMPLETED|Overall Study||0
87905|NCT01522924|211191|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
87906|NCT01522924|211192|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
87907|NCT01522924|211191|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
87908|NCT01522924|211192|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
87909|NCT01522703|211212|P2|NOT COMPLETED|Overall Study||6
87910|NCT01522703|211213|P1|NOT COMPLETED|Overall Study||5
87911|NCT01522703|211212|P2|COMPLETED|Overall Study||20
87912|NCT01522703|211213|P1|COMPLETED|Overall Study||20
87913|NCT01522703|211212|P2|STARTED|Overall Study||26
87914|NCT01522703|211213|P1|STARTED|Overall Study||25
87915|NCT01522456|211219|P1|NOT COMPLETED|Overall Study||8
87916|NCT01522456|211219|P1|COMPLETED|Overall Study||65
87917|NCT01522456|211219|P1|STARTED|Overall Study||73
87918|NCT01522443|211282|P2|NOT COMPLETED|Overall Study||55
87919|NCT01522443|211283|P1|NOT COMPLETED|Overall Study||53
87920|NCT01522443|211282|P2|COMPLETED|Overall Study||3
87921|NCT01522443|211283|P1|COMPLETED|Overall Study||8
87922|NCT01522443|211282|P2|STARTED|Overall Study||58
87923|NCT01522443|211283|P1|STARTED|Overall Study||61
87924|NCT01522339|211293|P1|NOT COMPLETED|Overall Study||0
87925|NCT01522339|211293|P1|COMPLETED|Overall Study||15
87926|NCT01522339|211293|P1|STARTED|Overall Study||15
87927|NCT01522235|211300|P2|NOT COMPLETED|Overall Study||1
87928|NCT01522235|211301|P1|NOT COMPLETED|Overall Study||1
87929|NCT01522235|211300|P2|COMPLETED|Overall Study||2
87930|NCT01522235|211301|P1|COMPLETED|Overall Study||2
87931|NCT01522235|211300|P2|Randomized|Overall Study||3
87932|NCT01522235|211301|P1|Randomized|Overall Study||2
87933|NCT01522235|211300|P2|STARTED|Overall Study||3
87934|NCT01522235|211301|P1|STARTED|Overall Study||3
87935|NCT01522131|211319|P2|NOT COMPLETED|Overall Study||0
87936|NCT01522131|211320|P1|NOT COMPLETED|Overall Study||2
87937|NCT01522131|211319|P2|COMPLETED|Overall Study||17
87938|NCT01522131|211320|P1|COMPLETED|Overall Study||14
87939|NCT01522131|211319|P2|STARTED|Overall Study||17
87940|NCT01522131|211320|P1|STARTED|Overall Study||16
87941|NCT01521923|211332|P4|NOT COMPLETED|Overall Study||13
87942|NCT01521923|211333|P3|NOT COMPLETED|Overall Study||15
87943|NCT01521923|211334|P2|NOT COMPLETED|Overall Study||9
87944|NCT01521923|211335|P1|NOT COMPLETED|Overall Study||7
87945|NCT01521923|211332|P4|COMPLETED|Overall Study||70
87946|NCT01521923|211333|P3|COMPLETED|Overall Study||112
87947|NCT01521923|211334|P2|COMPLETED|Overall Study||72
87948|NCT01521923|211335|P1|COMPLETED|Overall Study||59
87949|NCT01521923|211332|P4|STARTED|Overall Study||83
87950|NCT01521923|211333|P3|STARTED|Overall Study||127
87951|NCT01521923|211334|P2|STARTED|Overall Study||81
87952|NCT01521923|211335|P1|STARTED|Overall Study||66
87953|NCT01521897|211455|P1|NOT COMPLETED|Overall Study||23
87954|NCT01521897|211455|P1|COMPLETED|Overall Study||1120
87955|NCT01521897|211455|P1|STARTED|Overall Study||1143
87956|NCT01521884|211467|P1|NOT COMPLETED|Overall Study||27
87957|NCT01521884|211467|P1|COMPLETED|Overall Study||35
87958|NCT01521884|211467|P1|STARTED|Overall Study||62
87959|NCT01521871|211486|P2|NOT COMPLETED|Overall Study||0
87960|NCT01521871|211487|P1|NOT COMPLETED|Overall Study||0
87961|NCT01521871|211486|P2|COMPLETED|Overall Study||32
87962|NCT01521871|211487|P1|COMPLETED|Overall Study||32
87963|NCT01521871|211486|P2|STARTED|Overall Study||32
87964|NCT01521871|211487|P1|STARTED|Overall Study||32
87965|NCT01521845|211527|P2|NOT COMPLETED|Overall Study||5
87966|NCT01521845|211528|P1|NOT COMPLETED|Overall Study||9
87967|NCT01521845|211527|P2|COMPLETED|Overall Study||47
87968|NCT01521845|211528|P1|COMPLETED|Overall Study||43
87969|NCT01521845|211527|P2|STARTED|Overall Study||52
87970|NCT01521845|211528|P1|STARTED|Overall Study||52
87971|NCT01521780|211538|P3|NOT COMPLETED|Overall Study||0
87972|NCT01521780|211539|P2|NOT COMPLETED|Overall Study||0
87973|NCT01521780|211540|P1|NOT COMPLETED|Overall Study||0
87974|NCT01521780|211538|P3|COMPLETED|Overall Study||2
87975|NCT01521780|211539|P2|COMPLETED|Overall Study||1
87976|NCT01521780|211540|P1|COMPLETED|Overall Study||9
87977|NCT01521780|211538|P3|STARTED|Overall Study||2
87978|NCT01521780|211539|P2|STARTED|Overall Study||1
87979|NCT01521780|211540|P1|STARTED|Overall Study||9
87980|NCT01521559|211564|P2|NOT COMPLETED|Overall Study||18
87981|NCT01521559|211565|P1|NOT COMPLETED|Overall Study||15
87982|NCT01521559|211564|P2|COMPLETED|Overall Study||73
87983|NCT01521559|211565|P1|COMPLETED|Overall Study||77
87984|NCT01521559|211564|P2|Completed Week 52|Overall Study||73
87985|NCT01521559|211565|P1|Completed Week 52|Overall Study||77
87986|NCT01521559|211564|P2|Completed Week 24|Overall Study||85
87987|NCT01521559|211565|P1|Completed Week 24|Overall Study||83
87988|NCT01521559|211564|P2|STARTED|Overall Study||91
87989|NCT01521559|211565|P1|STARTED|Overall Study||92
87990|NCT01521546|211579|P2|NOT COMPLETED|Overall Study||0
87991|NCT01521546|211580|P1|NOT COMPLETED|Overall Study||2
87992|NCT01521546|211579|P2|COMPLETED|Overall Study||20
87993|NCT01521546|211580|P1|COMPLETED|Overall Study||20
87994|NCT01521546|211579|P2|STARTED|Overall Study||20
87995|NCT01521546|211580|P1|STARTED|Overall Study||22
87996|NCT01521507|211588|P2|NOT COMPLETED|Stage 2: Observational Design||2
87997|NCT01521507|211589|P1|NOT COMPLETED|Stage 2: Observational Design||4
87998|NCT01521507|211588|P2|COMPLETED|Stage 2: Observational Design||92
87999|NCT01521507|211589|P1|COMPLETED|Stage 2: Observational Design||94
88000|NCT01521507|211588|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
88001|NCT01521507|211589|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
88002|NCT01521507|211588|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
88003|NCT01521507|211589|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
88004|NCT01521507|211588|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
88005|NCT01521507|211589|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
88006|NCT01521507|211588|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
88007|NCT01521507|211589|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
88008|NCT01521507|211588|P2|STARTED|Stage 2: Observational Design||94
88009|NCT01521507|211589|P1|STARTED|Stage 2: Observational Design||98
88010|NCT01521507|211588|P2|NOT COMPLETED|Stage 1: Randomized Design||5
88011|NCT01521507|211589|P1|NOT COMPLETED|Stage 1: Randomized Design||3
88012|NCT01521507|211588|P2|COMPLETED|Stage 1: Randomized Design||94
88013|NCT01521507|211589|P1|COMPLETED|Stage 1: Randomized Design||98
88014|NCT01521507|211588|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
88015|NCT01521507|211589|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
88016|NCT01521507|211588|P2|STARTED|Stage 1: Randomized Design||99
88017|NCT01521507|211589|P1|STARTED|Stage 1: Randomized Design||101
88018|NCT01521364|211606|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
88019|NCT01521364|211606|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
88020|NCT01521364|211606|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
88021|NCT01521364|211606|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
88022|NCT01521364|211606|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
88023|NCT01521364|211606|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
88024|NCT01521364|211606|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
88025|NCT01521364|211606|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
88026|NCT01521364|211606|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
88027|NCT01521260|211619|P2|NOT COMPLETED|Overall Study||0
88028|NCT01521260|211620|P1|NOT COMPLETED|Overall Study||0
88029|NCT01521260|211619|P2|COMPLETED|Overall Study||15
88030|NCT01521260|211620|P1|COMPLETED|Overall Study||15
88031|NCT01521260|211619|P2|STARTED|Overall Study||15
88032|NCT01521260|211620|P1|STARTED|Overall Study||15
88033|NCT01521143|211630|P4|NOT COMPLETED|Overall Study||7
88034|NCT01521143|211631|P3|NOT COMPLETED|Overall Study||8
88035|NCT01521143|211632|P2|NOT COMPLETED|Overall Study||26
88036|NCT01521143|211633|P1|NOT COMPLETED|Overall Study||29
88037|NCT01521143|211630|P4|COMPLETED|Overall Study||0
88038|NCT01521143|211631|P3|COMPLETED|Overall Study||0
88039|NCT01521143|211632|P2|COMPLETED|Overall Study||10
88040|NCT01521143|211633|P1|COMPLETED|Overall Study||11
88041|NCT01521143|211630|P4|Received Treatment|Overall Study||4
88042|NCT01521143|211631|P3|Received Treatment|Overall Study||3
88043|NCT01521143|211632|P2|Received Treatment|Overall Study||20
88044|NCT01521143|211633|P1|Received Treatment|Overall Study||20
88045|NCT01521143|211630|P4|STARTED|Overall Study||7
88046|NCT01521143|211631|P3|STARTED|Overall Study||8
88047|NCT01521143|211632|P2|STARTED|Overall Study||36
88048|NCT01521143|211633|P1|STARTED|Overall Study||40
88049|NCT01521026|211665|P2|NOT COMPLETED|Overall Study||3
88050|NCT01521026|211666|P1|NOT COMPLETED|Overall Study||15
88051|NCT01521026|211665|P2|COMPLETED|Overall Study||28
88052|NCT01521026|211666|P1|COMPLETED|Overall Study||23
88053|NCT01521026|211665|P2|STARTED|Overall Study||31
88054|NCT01521026|211666|P1|STARTED|Overall Study||38
88055|NCT01520987|211682|P8|NOT COMPLETED|Overall Study||0
88056|NCT01520987|211683|P7|NOT COMPLETED|Overall Study||0
88057|NCT01520987|211684|P6|NOT COMPLETED|Overall Study||1
88058|NCT01520987|211685|P5|NOT COMPLETED|Overall Study||0
88059|NCT01520987|211686|P4|NOT COMPLETED|Overall Study||0
88060|NCT01520987|211687|P3|NOT COMPLETED|Overall Study||0
88061|NCT01520987|211688|P2|NOT COMPLETED|Overall Study||0
88062|NCT01520987|211689|P1|NOT COMPLETED|Overall Study||1
88063|NCT01520987|211682|P8|COMPLETED|Overall Study||14
88064|NCT01520987|211683|P7|COMPLETED|Overall Study||12
88065|NCT01520987|211684|P6|COMPLETED|Overall Study||13
88066|NCT01520987|211685|P5|COMPLETED|Overall Study||14
88067|NCT01520987|211686|P4|COMPLETED|Overall Study||15
88068|NCT01520987|211687|P3|COMPLETED|Overall Study||11
88069|NCT01520987|211688|P2|COMPLETED|Overall Study||12
88070|NCT01520987|211689|P1|COMPLETED|Overall Study||12
88071|NCT01520987|211682|P8|Dosed|Overall Study||14
88072|NCT01520987|211683|P7|Dosed|Overall Study||12
88073|NCT01520987|211684|P6|Dosed|Overall Study||14
88074|NCT01520987|211685|P5|Dosed|Overall Study||14
88075|NCT01520987|211686|P4|Dosed|Overall Study||15
88076|NCT01520987|211687|P3|Dosed|Overall Study||11
88077|NCT01520987|211688|P2|Dosed|Overall Study||12
88078|NCT01520987|211689|P1|Dosed|Overall Study||13
88079|NCT01520987|211682|P8|STARTED|Overall Study||14
88080|NCT01520987|211683|P7|STARTED|Overall Study||12
88081|NCT01520987|211684|P6|STARTED|Overall Study||14
88082|NCT01520987|211685|P5|STARTED|Overall Study||14
88083|NCT01520987|211686|P4|STARTED|Overall Study||15
88084|NCT01520987|211687|P3|STARTED|Overall Study||11
88085|NCT01520987|211688|P2|STARTED|Overall Study||12
88086|NCT01520987|211689|P1|STARTED|Overall Study||13
88087|NCT01520922|211749|P2|NOT COMPLETED|Survival Follow-up||0
88088|NCT01520922|211750|P1|NOT COMPLETED|Survival Follow-up||1
88089|NCT01520922|211749|P2|COMPLETED|Survival Follow-up||40
88090|NCT01520922|211750|P1|COMPLETED|Survival Follow-up||20
88091|NCT01520922|211749|P2|STARTED|Survival Follow-up||40
88092|NCT01520922|211750|P1|STARTED|Survival Follow-up||21
88093|NCT01520922|211749|P2|NOT COMPLETED|Follow up||1
88094|NCT01520922|211750|P1|NOT COMPLETED|Follow up||0
88095|NCT01520922|211749|P2|COMPLETED|Follow up||44
88096|NCT01520922|211750|P1|COMPLETED|Follow up||44
88097|NCT01520922|211749|P2|STARTED|Follow up||45
88098|NCT01520922|211750|P1|STARTED|Follow up||44
88099|NCT01520922|211749|P2|NOT COMPLETED|Treatment Phase||8
88100|NCT01520922|211750|P1|NOT COMPLETED|Treatment Phase||5
88101|NCT01520922|211749|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
88102|NCT01520922|211750|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
88103|NCT01520922|211749|P2|STARTED|Treatment Phase||53
88104|NCT01520922|211750|P1|STARTED|Treatment Phase||44
88105|NCT01520909|211812|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
88106|NCT01520909|211813|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
88107|NCT01520909|211814|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
88108|NCT01520909|211812|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
88109|NCT01520909|211813|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
88110|NCT01520909|211814|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
88111|NCT01520909|211812|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
88112|NCT01520909|211813|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
88113|NCT01520909|211814|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
88114|NCT01520909|211812|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
88115|NCT01520909|211813|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
88116|NCT01520909|211814|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
88117|NCT01520909|211812|P3|COMPLETED|Part 1 (Randomized Period)||0
88118|NCT01520909|211813|P2|COMPLETED|Part 1 (Randomized Period)||61
88119|NCT01520909|211814|P1|COMPLETED|Part 1 (Randomized Period)||28
88120|NCT01520909|211812|P3|STARTED|Part 1 (Randomized Period)||0
88121|NCT01520909|211813|P2|STARTED|Part 1 (Randomized Period)||63
88122|NCT01520909|211814|P1|STARTED|Part 1 (Randomized Period)||29
88123|NCT01520727|211885|P9|NOT COMPLETED|Overall Study||0
88124|NCT01520727|211886|P8|NOT COMPLETED|Overall Study||0
88125|NCT01520727|211887|P7|NOT COMPLETED|Overall Study||0
88126|NCT01520727|211888|P6|NOT COMPLETED|Overall Study||0
88127|NCT01520727|211889|P5|NOT COMPLETED|Overall Study||0
88128|NCT01520727|211890|P4|NOT COMPLETED|Overall Study||0
88129|NCT01520727|211891|P3|NOT COMPLETED|Overall Study||0
88130|NCT01520727|211892|P2|NOT COMPLETED|Overall Study||0
88131|NCT01520727|211893|P1|NOT COMPLETED|Overall Study||0
88132|NCT01520727|211885|P9|COMPLETED|Overall Study||16
88133|NCT01520727|211886|P8|COMPLETED|Overall Study||6
88134|NCT01520727|211887|P7|COMPLETED|Overall Study||6
88135|NCT01520727|211888|P6|COMPLETED|Overall Study||6
88136|NCT01520727|211889|P5|COMPLETED|Overall Study||6
88137|NCT01520727|211890|P4|COMPLETED|Overall Study||6
88138|NCT01520727|211891|P3|COMPLETED|Overall Study||6
88139|NCT01520727|211892|P2|COMPLETED|Overall Study||6
88140|NCT01520727|211893|P1|COMPLETED|Overall Study||6
88141|NCT01520727|211885|P9|STARTED|Overall Study||16
88142|NCT01520727|211886|P8|STARTED|Overall Study||6
88143|NCT01520727|211887|P7|STARTED|Overall Study||6
88144|NCT01520727|211888|P6|STARTED|Overall Study||6
88145|NCT01520727|211889|P5|STARTED|Overall Study||6
88146|NCT01520727|211890|P4|STARTED|Overall Study||6
88147|NCT01520727|211891|P3|STARTED|Overall Study||6
88148|NCT01520727|211892|P2|STARTED|Overall Study||6
88149|NCT01520727|211893|P1|STARTED|Overall Study||6
88150|NCT01520714|211931|P2|NOT COMPLETED|Overall Study||6
88151|NCT01520714|211932|P1|NOT COMPLETED|Overall Study||0
88152|NCT01520714|211931|P2|COMPLETED|Overall Study||5
88153|NCT01520714|211932|P1|COMPLETED|Overall Study||0
88154|NCT01520714|211931|P2|STARTED|Overall Study||11
88155|NCT01520714|211932|P1|STARTED|Overall Study||0
88156|NCT01520558|211941|P3|NOT COMPLETED|Overall Study||3
88157|NCT01520558|211942|P2|NOT COMPLETED|Overall Study||2
88158|NCT01520558|211943|P1|NOT COMPLETED|Overall Study||2
88159|NCT01520558|211941|P3|COMPLETED|Overall Study||3
88160|NCT01520558|211942|P2|COMPLETED|Overall Study||1
88161|NCT01520558|211943|P1|COMPLETED|Overall Study||1
88162|NCT01520558|211941|P3|STARTED|Overall Study||6
88163|NCT01520558|211942|P2|STARTED|Overall Study||3
88164|NCT01520558|211943|P1|STARTED|Overall Study||3
88165|NCT01520532|211951|P1|NOT COMPLETED|Overall Study||0
88166|NCT01520532|211951|P1|COMPLETED|Overall Study||60
88167|NCT01520532|211951|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
88168|NCT01520506|211957|P1|NOT COMPLETED|Overall Study||6
88169|NCT01520506|211957|P1|COMPLETED|Overall Study||44
88170|NCT01520506|211957|P1|STARTED|Overall Study||50
88171|NCT01520454|211967|P4|NOT COMPLETED|Overall Study||0
88172|NCT01520454|211968|P3|NOT COMPLETED|Overall Study||0
88173|NCT01520454|211969|P2|NOT COMPLETED|Overall Study||0
88174|NCT01520454|211970|P1|NOT COMPLETED|Overall Study||0
88175|NCT01520454|211967|P4|COMPLETED|Overall Study||6
88176|NCT01520454|211968|P3|COMPLETED|Overall Study||5
88177|NCT01520454|211969|P2|COMPLETED|Overall Study||6
88178|NCT01520454|211970|P1|COMPLETED|Overall Study||9
88179|NCT01520454|211967|P4|STARTED|Overall Study||6
88180|NCT01520454|211968|P3|STARTED|Overall Study||5
88181|NCT01520454|211969|P2|STARTED|Overall Study||6
88182|NCT01520454|211970|P1|STARTED|Overall Study||9
88183|NCT01520402|212012|P1|NOT COMPLETED|Overall Study||5
88184|NCT01520402|212012|P1|COMPLETED|Overall Study||30
88185|NCT01520402|212012|P1|STARTED|Overall Study||35
88186|NCT01520207|212025|P2|NOT COMPLETED|Overall Study||0
88187|NCT01520207|212026|P1|NOT COMPLETED|Overall Study||2
88188|NCT01520207|212025|P2|COMPLETED|Overall Study||25
88189|NCT01520207|212026|P1|COMPLETED|Overall Study||25
88190|NCT01520207|212025|P2|STARTED|Overall Study||25
88191|NCT01520207|212026|P1|STARTED|Overall Study||27
88192|NCT01519960|212035|P3|NOT COMPLETED|Overall Study||10
88193|NCT01519960|212036|P2|NOT COMPLETED|Overall Study||50
88194|NCT01519960|212037|P1|NOT COMPLETED|Overall Study||101
88195|NCT01519960|212035|P3|COMPLETED|Overall Study||0
88196|NCT01519960|212036|P2|COMPLETED|Overall Study||0
88197|NCT01519960|212037|P1|COMPLETED|Overall Study||0
88198|NCT01519960|212035|P3|Completed FU Week 24|Overall Study||10
88199|NCT01519960|212036|P2|Completed FU Week 24|Overall Study||15
88200|NCT01519960|212037|P1|Completed FU Week 24|Overall Study||101
88201|NCT01519960|212035|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
88202|NCT01519960|212036|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
88203|NCT01519960|212037|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
88204|NCT01519960|212035|P3|Completed Week 48|Overall Study||10
88205|NCT01519960|212036|P2|Completed Week 48|Overall Study||47
88206|NCT01519960|212037|P1|Completed Week 48|Overall Study||99
88207|NCT01519960|212035|P3|STARTED|Overall Study||10
88208|NCT01519960|212036|P2|STARTED|Overall Study||50
88209|NCT01519960|212037|P1|STARTED|Overall Study||101
88210|NCT01519934|212143|P1|NOT COMPLETED|Overall Study||3
88211|NCT01519934|212143|P1|COMPLETED|Overall Study||45
88212|NCT01519934|212143|P1|STARTED|Overall Study||48
88213|NCT01519921|212152|P2|NOT COMPLETED|Overall Study||15
88214|NCT01519921|212153|P1|NOT COMPLETED|Overall Study||21
88215|NCT01519921|212152|P2|COMPLETED|Overall Study||49
88216|NCT01519921|212153|P1|COMPLETED|Overall Study||65
88217|NCT01519921|212152|P2|STARTED|Overall Study||64
88218|NCT01519921|212153|P1|STARTED|Overall Study||86
88219|NCT01519882|212177|P2|NOT COMPLETED|Overall Study||0
88220|NCT01519882|212178|P1|NOT COMPLETED|Overall Study||0
88221|NCT01519882|212177|P2|COMPLETED|Overall Study||0
88222|NCT01519882|212178|P1|COMPLETED|Overall Study||1
88223|NCT01519882|212177|P2|STARTED|Overall Study||0
88224|NCT01519882|212178|P1|STARTED|Overall Study||1
88225|NCT01519817|212202|P4|NOT COMPLETED|Overall Study||1
88226|NCT01519817|212203|P3|NOT COMPLETED|Overall Study||0
88227|NCT01519817|212204|P2|NOT COMPLETED|Overall Study||0
88228|NCT01519817|212205|P1|NOT COMPLETED|Overall Study||1
88229|NCT01519817|212202|P4|COMPLETED|Overall Study||10
88230|NCT01519817|212203|P3|COMPLETED|Overall Study||16
88231|NCT01519817|212204|P2|COMPLETED|Overall Study||3
88232|NCT01519817|212205|P1|COMPLETED|Overall Study||3
88233|NCT01519817|212202|P4|STARTED|Overall Study||11
88234|NCT01519817|212203|P3|STARTED|Overall Study||16
88235|NCT01519817|212204|P2|STARTED|Overall Study||3
88236|NCT01519817|212205|P1|STARTED|Overall Study||4
88237|NCT01519791|212245|P2|NOT COMPLETED|Overall Study||368
88238|NCT01519791|212246|P1|NOT COMPLETED|Overall Study||152
88239|NCT01519791|212245|P2|COMPLETED|Overall Study||292
88240|NCT01519791|212246|P1|COMPLETED|Overall Study||67
88241|NCT01519791|212245|P2|Completed Week 52|Overall Study||500
88242|NCT01519791|212246|P1|Completed Week 52|Overall Study||143
88243|NCT01519791|212245|P2|STARTED|Overall Study||660
88244|NCT01519791|212246|P1|STARTED|Overall Study||219
88245|NCT01519778|212310|P1|NOT COMPLETED|Overall Study||14
88246|NCT01519778|212310|P1|COMPLETED|Overall Study||186
88247|NCT01519778|212310|P1|STARTED|Overall Study||200
88248|NCT01519765|212316|P2|NOT COMPLETED|Overall Study||2
88249|NCT01519765|212317|P1|NOT COMPLETED|Overall Study||3
88250|NCT01519765|212316|P2|COMPLETED|Overall Study||34
88251|NCT01519765|212317|P1|COMPLETED|Overall Study||34
88252|NCT01519765|212316|P2|STARTED|Overall Study||36
88253|NCT01519765|212317|P1|STARTED|Overall Study||37
88254|NCT01519713|212366|P3|NOT COMPLETED|Overall Study||0
88255|NCT01519713|212367|P2|NOT COMPLETED|Overall Study||0
88256|NCT01519713|212368|P1|NOT COMPLETED|Overall Study||0
88257|NCT01519713|212366|P3|COMPLETED|Overall Study||4
88258|NCT01519713|212367|P2|COMPLETED|Overall Study||2
88259|NCT01519713|212368|P1|COMPLETED|Overall Study||194
88260|NCT01519713|212366|P3|STARTED|Overall Study||4
88261|NCT01519713|212367|P2|STARTED|Overall Study||2
88262|NCT01519713|212368|P1|STARTED|Overall Study||194
88263|NCT01519700|212395|P4|NOT COMPLETED|Overall Study||7
88264|NCT01519700|212396|P3|NOT COMPLETED|Overall Study||7
88265|NCT01519700|212397|P2|NOT COMPLETED|Overall Study||6
88266|NCT01519700|212398|P1|NOT COMPLETED|Overall Study||9
88267|NCT01519700|212395|P4|COMPLETED|Overall Study||47
88268|NCT01519700|212396|P3|COMPLETED|Overall Study||48
88269|NCT01519700|212397|P2|COMPLETED|Overall Study||49
88270|NCT01519700|212398|P1|COMPLETED|Overall Study||45
88271|NCT01519700|212395|P4|Treated Cycle 6 Neupogen|Overall Study||49
88272|NCT01519700|212396|P3|Treated Cycle 6 Neupogen|Overall Study||0
88273|NCT01519700|212397|P2|Treated Cycle 6 Neupogen|Overall Study||49
88274|NCT01519700|212398|P1|Treated Cycle 6 Neupogen|Overall Study||0
88275|NCT01519700|212395|P4|Treated Cycle 6 EP2006|Overall Study||0
88276|NCT01519700|212396|P3|Treated Cycle 6 EP2006|Overall Study||48
88277|NCT01519700|212397|P2|Treated Cycle 6 EP2006|Overall Study||0
88278|NCT01519700|212398|P1|Treated Cycle 6 EP2006|Overall Study||45
88279|NCT01519700|212395|P4|Treated Cycle 5 Neupogen|Overall Study||50
88280|NCT01519700|212396|P3|Treated Cycle 5 Neupogen|Overall Study||48
88281|NCT01519700|212397|P2|Treated Cycle 5 Neupogen|Overall Study||0
88282|NCT01519700|212398|P1|Treated Cycle 5 Neupogen|Overall Study||0
88283|NCT01519700|212395|P4|Treated Cycle 5 EP2006|Overall Study||0
88284|NCT01519700|212396|P3|Treated Cycle 5 EP2006|Overall Study||0
88285|NCT01519700|212397|P2|Treated Cycle 5 EP2006|Overall Study||49
88286|NCT01519700|212398|P1|Treated Cycle 5 EP2006|Overall Study||46
88287|NCT01519700|212395|P4|Treated Cycle 4 Neupogen|Overall Study||50
88288|NCT01519700|212396|P3|Treated Cycle 4 Neupogen|Overall Study||0
88289|NCT01519700|212397|P2|Treated Cycle 4 Neupogen|Overall Study||51
88290|NCT01519700|212398|P1|Treated Cycle 4 Neupogen|Overall Study||0
88291|NCT01519700|212395|P4|Treated Cycle 4 EP2006|Overall Study||0
88292|NCT01519700|212396|P3|Treated Cycle 4 EP2006|Overall Study||50
88293|NCT01519700|212397|P2|Treated Cycle 4 EP2006|Overall Study||0
88294|NCT01519700|212398|P1|Treated Cycle 4 EP2006|Overall Study||51
88295|NCT01519700|212395|P4|Treated Cycle 3 Neupogen|Overall Study||51
88296|NCT01519700|212396|P3|Treated Cycle 3 Neupogen|Overall Study||54
88297|NCT01519700|212397|P2|Treated Cycle 3 Neupogen|Overall Study||0
88298|NCT01519700|212398|P1|Treated Cycle 3 Neupogen|Overall Study||0
88299|NCT01519700|212395|P4|Treated Cycle 3 EP2006|Overall Study||0
88300|NCT01519700|212396|P3|Treated Cycle 3 EP2006|Overall Study||0
88301|NCT01519700|212397|P2|Treated Cycle 3 EP2006|Overall Study||51
88302|NCT01519700|212398|P1|Treated Cycle 3 EP2006|Overall Study||51
88303|NCT01519700|212395|P4|Treated Cycle 2 Neupogen|Overall Study||51
88304|NCT01519700|212396|P3|Treated Cycle 2 Neupogen|Overall Study||0
88305|NCT01519700|212397|P2|Treated Cycle 2 Neupogen|Overall Study||52
88306|NCT01519700|212398|P1|Treated Cycle 2 Neupogen|Overall Study||0
88307|NCT01519700|212395|P4|Treated Cycle 2 EP2006|Overall Study||0
88308|NCT01519700|212396|P3|Treated Cycle 2 EP2006|Overall Study||55
88309|NCT01519700|212397|P2|Treated Cycle 2 EP2006|Overall Study||0
88310|NCT01519700|212398|P1|Treated Cycle 2 EP2006|Overall Study||52
88311|NCT01519700|212395|P4|Treated Cycle 1 Neupogen|Overall Study||52
88312|NCT01519700|212396|P3|Treated Cycle 1 Neupogen|Overall Study||55
88313|NCT01519700|212397|P2|Treated Cycle 1 Neupogen|Overall Study||0
88314|NCT01519700|212398|P1|Treated Cycle 1 Neupogen|Overall Study||0
88315|NCT01519700|212395|P4|Treated Cycle 1 EP2006|Overall Study||0
88316|NCT01519700|212396|P3|Treated Cycle 1 EP2006|Overall Study||0
88317|NCT01519700|212397|P2|Treated Cycle 1 EP2006|Overall Study||54
88318|NCT01519700|212398|P1|Treated Cycle 1 EP2006|Overall Study||53
88319|NCT01519700|212395|P4|STARTED|Overall Study||54
88320|NCT01519700|212396|P3|STARTED|Overall Study||55
88321|NCT01519700|212397|P2|STARTED|Overall Study||55
88322|NCT01519700|212398|P1|STARTED|Overall Study||54
88323|NCT01519674|212433|P3|NOT COMPLETED|Overall Study||12
88324|NCT01519674|212434|P2|NOT COMPLETED|Overall Study||13
88325|NCT01519674|212435|P1|NOT COMPLETED|Overall Study||21
88326|NCT01519674|212433|P3|COMPLETED|Overall Study||181
88327|NCT01519674|212434|P2|COMPLETED|Overall Study||182
88328|NCT01519674|212435|P1|COMPLETED|Overall Study||173
88329|NCT01519674|212433|P3|Exposed|Overall Study||190
88330|NCT01519674|212434|P2|Exposed|Overall Study||193
88331|NCT01519674|212435|P1|Exposed|Overall Study||192
88332|NCT01519674|212433|P3|STARTED|Overall Study||193
88333|NCT01519674|212434|P2|STARTED|Overall Study||195
88334|NCT01519674|212435|P1|STARTED|Overall Study||194
88335|NCT01519661|212473|P1|NOT COMPLETED|Overall Study||61
88336|NCT01519661|212473|P1|COMPLETED|Overall Study||96
88337|NCT01519661|212473|P1|STARTED|Overall Study||157
88338|NCT01519648|212490|P2|NOT COMPLETED|Overall Study||0
88339|NCT01519648|212491|P1|NOT COMPLETED|Overall Study||0
88340|NCT01519648|212490|P2|COMPLETED|Overall Study||306
88341|NCT01519648|212491|P1|COMPLETED|Overall Study||502
88342|NCT01519648|212490|P2|STARTED|Overall Study||306
88343|NCT01519648|212491|P1|STARTED|Overall Study||502
88344|NCT01519518|212499|P2|NOT COMPLETED|Overall Study||10
88345|NCT01519518|212500|P1|NOT COMPLETED|Overall Study||7
88346|NCT01519518|212499|P2|COMPLETED|Overall Study||905
88347|NCT01519518|212500|P1|COMPLETED|Overall Study||907
88348|NCT01519518|212499|P2|STARTED|Overall Study||915
88349|NCT01519518|212500|P1|STARTED|Overall Study||914
88350|NCT01519466|212514|P2|NOT COMPLETED|Overall Study||0
88351|NCT01519466|212515|P1|NOT COMPLETED|Overall Study||0
88352|NCT01519466|212514|P2|COMPLETED|Overall Study||16
88353|NCT01519466|212515|P1|COMPLETED|Overall Study||33
88354|NCT01519466|212514|P2|STARTED|Overall Study||16
88355|NCT01519466|212515|P1|STARTED|Overall Study||33
88356|NCT01519427|212525|P1|NOT COMPLETED|Overall Study||2
88357|NCT01519427|212525|P1|COMPLETED|Overall Study||0
88358|NCT01519427|212525|P1|STARTED|Overall Study||2
88359|NCT01519323|212532|P2|NOT COMPLETED|Overall Study||3
88360|NCT01519323|212533|P1|NOT COMPLETED|Overall Study||3
88361|NCT01519323|212532|P2|COMPLETED|Overall Study||0
88362|NCT01519323|212533|P1|COMPLETED|Overall Study||0
88363|NCT01519323|212532|P2|STARTED|Overall Study||3
88364|NCT01519323|212533|P1|STARTED|Overall Study||3
88365|NCT01519284|212549|P5|NOT COMPLETED|Overall Study||0
88366|NCT01519284|212550|P4|NOT COMPLETED|Overall Study||0
88367|NCT01519284|212551|P3|NOT COMPLETED|Overall Study||2
88368|NCT01519284|212552|P2|NOT COMPLETED|Overall Study||0
88369|NCT01519284|212553|P1|NOT COMPLETED|Overall Study||0
88370|NCT01519284|212549|P5|COMPLETED|Overall Study||16
88371|NCT01519284|212550|P4|COMPLETED|Overall Study||16
88372|NCT01519284|212551|P3|COMPLETED|Overall Study||16
88373|NCT01519284|212552|P2|COMPLETED|Overall Study||16
88374|NCT01519284|212553|P1|COMPLETED|Overall Study||16
88375|NCT01519284|212549|P5|STARTED|Overall Study||16
88376|NCT01519284|212550|P4|STARTED|Overall Study||16
88377|NCT01519284|212551|P3|STARTED|Overall Study||18
88378|NCT01519284|212552|P2|STARTED|Overall Study||16
88379|NCT01519284|212553|P1|STARTED|Overall Study||16
88380|NCT01519271|212582|P2|NOT COMPLETED|Phase 2||0
88381|NCT01519271|212583|P1|NOT COMPLETED|Phase 2||0
88382|NCT01519271|212582|P2|COMPLETED|Phase 2||14
88383|NCT01519271|212583|P1|COMPLETED|Phase 2||12
88384|NCT01519271|212582|P2|STARTED|Phase 2||14
88385|NCT01519271|212583|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
88386|NCT01519271|212582|P2|NOT COMPLETED|Phase 1||1
88387|NCT01519271|212583|P1|NOT COMPLETED|Phase 1||0
88388|NCT01519271|212582|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
88389|NCT01519271|212583|P1|COMPLETED|Phase 1||14
88390|NCT01519271|212582|P2|STARTED|Phase 1||14
88391|NCT01519271|212583|P1|STARTED|Phase 1||14
88392|NCT01519245|212593|P2|NOT COMPLETED|Overall Study||2
88393|NCT01519245|212594|P1|NOT COMPLETED|Overall Study||1
88394|NCT01519245|212593|P2|COMPLETED|Overall Study||18
88395|NCT01519245|212594|P1|COMPLETED|Overall Study||23
88396|NCT01519245|212593|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
88397|NCT01519245|212594|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
88398|NCT01519245|212593|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
88399|NCT01519245|212594|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
88400|NCT01519245|212593|P2|STARTED|Overall Study||20
88401|NCT01519245|212594|P1|STARTED|Overall Study||24
88402|NCT01519206|212606|P1|NOT COMPLETED|Overall Study||5
88403|NCT01519206|212606|P1|COMPLETED|Overall Study||27
88404|NCT01519206|212606|P1|STARTED|Overall Study||32
88405|NCT01519167|212620|P2|NOT COMPLETED|Overall Study||8
88406|NCT01519167|212621|P1|NOT COMPLETED|Overall Study||0
88407|NCT01519167|212620|P2|COMPLETED|Overall Study||81
88408|NCT01519167|212621|P1|COMPLETED|Overall Study||1
88409|NCT01519167|212620|P2|STARTED|Overall Study||89
88410|NCT01519167|212621|P1|STARTED|Overall Study||1
88411|NCT01519089|212647|P2|NOT COMPLETED|Overall Study||15
88412|NCT01519089|212648|P1|NOT COMPLETED|Overall Study||7
88413|NCT01519089|212647|P2|COMPLETED|Overall Study||33
88414|NCT01519089|212648|P1|COMPLETED|Overall Study||40
88415|NCT01519089|212647|P2|Received Treatment|Overall Study||47
88416|NCT01519089|212648|P1|Received Treatment|Overall Study||47
88417|NCT01519089|212647|P2|STARTED|Overall Study||48
88418|NCT01519089|212648|P1|STARTED|Overall Study||47
88419|NCT01518946|212769|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
88420|NCT01518946|212770|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
88421|NCT01518946|212771|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
88422|NCT01518946|212769|P3|COMPLETED|Randomized Phase (Second Intervention)||10
88423|NCT01518946|212770|P2|COMPLETED|Randomized Phase (Second Intervention)||9
88424|NCT01518946|212771|P1|COMPLETED|Randomized Phase (Second Intervention)||0
88425|NCT01518946|212769|P3|STARTED|Randomized Phase (Second Intervention)||10
88426|NCT01518946|212770|P2|STARTED|Randomized Phase (Second Intervention)||9
88427|NCT01518946|212771|P1|STARTED|Randomized Phase (Second Intervention)||0
88428|NCT01518946|212769|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
88429|NCT01518946|212770|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
88430|NCT01518946|212771|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
88431|NCT01518946|212769|P3|COMPLETED|Randomized Phase (First Intervention)||10
88432|NCT01518946|212770|P2|COMPLETED|Randomized Phase (First Intervention)||9
88433|NCT01518946|212771|P1|COMPLETED|Randomized Phase (First Intervention)||0
88434|NCT01518946|212769|P3|STARTED|Randomized Phase (First Intervention)||10
88435|NCT01518946|212770|P2|STARTED|Randomized Phase (First Intervention)||10
88436|NCT01518946|212771|P1|STARTED|Randomized Phase (First Intervention)||0
88437|NCT01518946|212769|P3|NOT COMPLETED|Open-label Phase||0
88438|NCT01518946|212770|P2|NOT COMPLETED|Open-label Phase||0
88439|NCT01518946|212771|P1|NOT COMPLETED|Open-label Phase||4
88440|NCT01518946|212769|P3|COMPLETED|Open-label Phase||0
88441|NCT01518946|212770|P2|COMPLETED|Open-label Phase||0
88442|NCT01518946|212771|P1|COMPLETED|Open-label Phase||20
88443|NCT01518946|212769|P3|STARTED|Open-label Phase||0
88444|NCT01518946|212770|P2|STARTED|Open-label Phase||0
88445|NCT01518946|212771|P1|STARTED|Open-label Phase||24
88446|NCT01518530|212778|P1|NOT COMPLETED|Post-Treatment Follow-up||0
88447|NCT01518530|212778|P1|COMPLETED|Post-Treatment Follow-up||9
88448|NCT01518530|212778|P1|STARTED|Post-Treatment Follow-up||9
88449|NCT01518530|212778|P1|NOT COMPLETED|Active Treatment Period||1
88450|NCT01518530|212778|P1|COMPLETED|Active Treatment Period||9
88451|NCT01518530|212778|P1|STARTED|Active Treatment Period||10
88452|NCT01518322|212782|P1|NOT COMPLETED|Overall Study||13
88453|NCT01518322|212782|P1|COMPLETED|Overall Study||222
88454|NCT01518322|212782|P1|STARTED|Overall Study||235
88455|NCT01518270|212795|P1|NOT COMPLETED|Overall Study||0
88456|NCT01518270|212795|P1|COMPLETED|Overall Study||179
88457|NCT01518270|212795|P1|STARTED|Overall Study||179
88458|NCT01518257|212803|P2|NOT COMPLETED|Overall Study||0
88459|NCT01518257|212804|P1|NOT COMPLETED|Overall Study||2
88460|NCT01518257|212803|P2|COMPLETED|Overall Study||60
88461|NCT01518257|212804|P1|COMPLETED|Overall Study||59
88462|NCT01518257|212803|P2|STARTED|Overall Study||60
88463|NCT01518257|212804|P1|STARTED|Overall Study||61
88464|NCT01518244|212826|P1|NOT COMPLETED|Overall Study||3
88465|NCT01518244|212826|P1|COMPLETED|Overall Study||47
88466|NCT01518244|212826|P1|STARTED|Overall Study||50
88467|NCT01518192|212834|P3|NOT COMPLETED|Overall Study||35
88468|NCT01518192|212835|P2|NOT COMPLETED|Overall Study||26
88469|NCT01518192|212836|P1|NOT COMPLETED|Overall Study||29
88470|NCT01518192|212834|P3|COMPLETED|Overall Study||224
88471|NCT01518192|212835|P2|COMPLETED|Overall Study||114
88472|NCT01518192|212836|P1|COMPLETED|Overall Study||116
88473|NCT01518192|212834|P3|STARTED|Overall Study||259
88474|NCT01518192|212835|P2|STARTED|Overall Study||140
88475|NCT01518192|212836|P1|STARTED|Overall Study||145
88476|NCT01518153|212857|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
88477|NCT01518153|212858|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
88478|NCT01518153|212859|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
88479|NCT01518153|212857|P3|COMPLETED|Donor Lymphocyte Infusion||3
88480|NCT01518153|212858|P2|COMPLETED|Donor Lymphocyte Infusion||1
88481|NCT01518153|212859|P1|COMPLETED|Donor Lymphocyte Infusion||0
88482|NCT01518153|212857|P3|STARTED|Donor Lymphocyte Infusion||4
88483|NCT01518153|212858|P2|STARTED|Donor Lymphocyte Infusion||3
88484|NCT01518153|212859|P1|STARTED|Donor Lymphocyte Infusion||0
88485|NCT01518153|212857|P3|NOT COMPLETED|Stem Cell Transplant||0
88486|NCT01518153|212858|P2|NOT COMPLETED|Stem Cell Transplant||0
88487|NCT01518153|212859|P1|NOT COMPLETED|Stem Cell Transplant||9
88488|NCT01518153|212857|P3|COMPLETED|Stem Cell Transplant||0
88489|NCT01518153|212858|P2|COMPLETED|Stem Cell Transplant||0
88490|NCT01518153|212859|P1|COMPLETED|Stem Cell Transplant||7
88491|NCT01518153|212857|P3|STARTED|Stem Cell Transplant||0
88492|NCT01518153|212858|P2|STARTED|Stem Cell Transplant||0
88493|NCT01518153|212859|P1|STARTED|Stem Cell Transplant||16
88494|NCT01517984|212870|P4|NOT COMPLETED|Overall Study||1
88495|NCT01517984|212871|P3|NOT COMPLETED|Overall Study||4
88496|NCT01517984|212872|P2|NOT COMPLETED|Overall Study||23
88497|NCT01517984|212873|P1|NOT COMPLETED|Overall Study||5
88498|NCT01517984|212870|P4|COMPLETED|Overall Study||6
88499|NCT01517984|212871|P3|COMPLETED|Overall Study||10
88500|NCT01517984|212872|P2|COMPLETED|Overall Study||3
88501|NCT01517984|212873|P1|COMPLETED|Overall Study||0
88502|NCT01517984|212870|P4|STARTED|Overall Study||7
88503|NCT01517984|212871|P3|STARTED|Overall Study||14
88504|NCT01517984|212872|P2|STARTED|Overall Study||26
88505|NCT01517984|212873|P1|STARTED|Overall Study||5
88506|NCT01517893|212899|P2|NOT COMPLETED|Overall Study||1
88507|NCT01517893|212900|P1|NOT COMPLETED|Overall Study||2
88508|NCT01517893|212899|P2|COMPLETED|Overall Study||6
88509|NCT01517893|212900|P1|COMPLETED|Overall Study||6
88510|NCT01517893|212899|P2|STARTED|Overall Study||7
88511|NCT01517893|212900|P1|STARTED|Overall Study||8
88512|NCT01517867|212908|P2|NOT COMPLETED|Overall Study||65
88513|NCT01517867|212909|P1|NOT COMPLETED|Overall Study||63
88514|NCT01517867|212908|P2|COMPLETED|Overall Study||15
88515|NCT01517867|212909|P1|COMPLETED|Overall Study||18
88516|NCT01517867|212908|P2|STARTED|Overall Study||80
88517|NCT01517867|212909|P1|STARTED|Overall Study||81
88518|NCT01517750|212921|P4|NOT COMPLETED|Overall Study||1
88519|NCT01517750|212922|P3|NOT COMPLETED|Overall Study||4
88520|NCT01517750|212923|P2|NOT COMPLETED|Overall Study||2
88521|NCT01517750|212924|P1|NOT COMPLETED|Overall Study||1
88522|NCT01517750|212921|P4|COMPLETED|Overall Study||18
88523|NCT01517750|212922|P3|COMPLETED|Overall Study||17
88524|NCT01517750|212923|P2|COMPLETED|Overall Study||17
88525|NCT01517750|212924|P1|COMPLETED|Overall Study||20
88526|NCT01517750|212921|P4|STARTED|Overall Study||19
88527|NCT01517750|212922|P3|STARTED|Overall Study||21
88528|NCT01517750|212923|P2|STARTED|Overall Study||19
88529|NCT01517750|212924|P1|STARTED|Overall Study||21
88530|NCT01517529|212954|P1|NOT COMPLETED|Overall Study||0
88531|NCT01517529|212954|P1|COMPLETED|Overall Study||10
88532|NCT01517529|212954|P1|STARTED|Overall Study||10
88533|NCT01517412|212961|P2|NOT COMPLETED|Overall Study||24
88534|NCT01517412|212962|P1|NOT COMPLETED|Overall Study||36
88535|NCT01517412|212961|P2|COMPLETED|Overall Study||202
88536|NCT01517412|212962|P1|COMPLETED|Overall Study||189
88537|NCT01517412|212961|P2|STARTED|Overall Study||226
88538|NCT01517412|212962|P1|STARTED|Overall Study||225
88539|NCT01517373|212991|P6|NOT COMPLETED|Treatment Period||7
88540|NCT01517373|212992|P5|NOT COMPLETED|Treatment Period||6
88541|NCT01517373|212993|P4|NOT COMPLETED|Treatment Period||7
88542|NCT01517373|212994|P3|NOT COMPLETED|Treatment Period||6
88543|NCT01517373|212995|P2|NOT COMPLETED|Treatment Period||4
88544|NCT01517373|212996|P1|NOT COMPLETED|Treatment Period||0
88545|NCT01517373|212991|P6|COMPLETED|Treatment Period||54
88546|NCT01517373|212992|P5|COMPLETED|Treatment Period||55
88547|NCT01517373|212993|P4|COMPLETED|Treatment Period||54
88548|NCT01517373|212994|P3|COMPLETED|Treatment Period||54
88549|NCT01517373|212995|P2|COMPLETED|Treatment Period||57
88550|NCT01517373|212996|P1|COMPLETED|Treatment Period||0
88551|NCT01517373|212991|P6|STARTED|Treatment Period||61
88552|NCT01517373|212992|P5|STARTED|Treatment Period||61
88553|NCT01517373|212993|P4|STARTED|Treatment Period||61
88554|NCT01517373|212994|P3|STARTED|Treatment Period||60
88555|NCT01517373|212995|P2|STARTED|Treatment Period||61
88556|NCT01517373|212996|P1|STARTED|Treatment Period||0
88557|NCT01517373|212991|P6|NOT COMPLETED|Run-in Period||0
88558|NCT01517373|212992|P5|NOT COMPLETED|Run-in Period||0
88559|NCT01517373|212993|P4|NOT COMPLETED|Run-in Period||0
88560|NCT01517373|212994|P3|NOT COMPLETED|Run-in Period||0
88561|NCT01517373|212995|P2|NOT COMPLETED|Run-in Period||0
88562|NCT01517373|212996|P1|NOT COMPLETED|Run-in Period||57
88563|NCT01517373|212991|P6|COMPLETED|Run-in Period||0
88564|NCT01517373|212992|P5|COMPLETED|Run-in Period||0
88565|NCT01517373|212993|P4|COMPLETED|Run-in Period||0
88566|NCT01517373|212994|P3|COMPLETED|Run-in Period||0
88567|NCT01517373|212995|P2|COMPLETED|Run-in Period||0
88568|NCT01517373|212996|P1|COMPLETED|Run-in Period||304
88569|NCT01517373|212991|P6|STARTED|Run-in Period||0
88570|NCT01517373|212992|P5|STARTED|Run-in Period||0
88571|NCT01517373|212993|P4|STARTED|Run-in Period||0
88572|NCT01517373|212994|P3|STARTED|Run-in Period||0
88573|NCT01517373|212995|P2|STARTED|Run-in Period||0
88574|NCT01517373|212996|P1|STARTED|Run-in Period||361
88575|NCT01517295|213066|P2|NOT COMPLETED|Overall Study||0
88576|NCT01517295|213067|P1|NOT COMPLETED|Overall Study||1
88577|NCT01517295|213066|P2|COMPLETED|Overall Study||14
88578|NCT01517295|213067|P1|COMPLETED|Overall Study||15
88579|NCT01517295|213066|P2|STARTED|Overall Study||14
88580|NCT01517295|213067|P1|STARTED|Overall Study||16
88581|NCT01517282|213081|P4|NOT COMPLETED|Overall Study||1
88582|NCT01517282|213082|P3|NOT COMPLETED|Overall Study||1
88583|NCT01517282|213083|P2|NOT COMPLETED|Overall Study||1
88584|NCT01517282|213084|P1|NOT COMPLETED|Overall Study||1
88585|NCT01517282|213081|P4|COMPLETED|Overall Study||5
88586|NCT01517282|213082|P3|COMPLETED|Overall Study||8
88587|NCT01517282|213083|P2|COMPLETED|Overall Study||7
88588|NCT01517282|213084|P1|COMPLETED|Overall Study||8
88589|NCT01517282|213081|P4|STARTED|Overall Study||6
88590|NCT01517282|213082|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
88591|NCT01517282|213083|P2|STARTED|Overall Study||8
88592|NCT01517282|213084|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
88593|NCT01517178|213118|P2|NOT COMPLETED|Period 2||2
88594|NCT01517178|213119|P1|NOT COMPLETED|Period 2||6
88595|NCT01517178|213118|P2|COMPLETED|Period 2||4
88596|NCT01517178|213119|P1|COMPLETED|Period 2||5
88597|NCT01517178|213118|P2|STARTED|Period 2||6
88598|NCT01517178|213119|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
88599|NCT01517178|213118|P2|NOT COMPLETED|Period 1||5
88600|NCT01517178|213119|P1|NOT COMPLETED|Period 1||4
88601|NCT01517178|213118|P2|COMPLETED|Period 1||6
88602|NCT01517178|213119|P1|COMPLETED|Period 1||12
88603|NCT01517178|213118|P2|STARTED|Period 1||11
88604|NCT01517178|213119|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
88605|NCT01517074|213125|P1|NOT COMPLETED|Overall Study||0
88606|NCT01517074|213125|P1|COMPLETED|Overall Study||5
88607|NCT01517074|213125|P1|STARTED|Overall Study||5
88608|NCT01516970|213138|P2|NOT COMPLETED|Overall Study||21
88609|NCT01516970|213139|P1|NOT COMPLETED|Overall Study||18
88610|NCT01516970|213138|P2|COMPLETED|Overall Study||132
88611|NCT01516970|213139|P1|COMPLETED|Overall Study||141
88612|NCT01516970|213138|P2|STARTED|Overall Study||153
88613|NCT01516970|213139|P1|STARTED|Overall Study||159
88614|NCT01516892|213151|P1|NOT COMPLETED|Overall Study||343
88615|NCT01516892|213151|P1|COMPLETED|Overall Study||373
88616|NCT01516892|213151|P1|STARTED|Overall Study||716
88617|NCT01516879|213159|P2|NOT COMPLETED|Overall Study||34
88618|NCT01516879|213160|P1|NOT COMPLETED|Overall Study||16
88619|NCT01516879|213159|P2|COMPLETED|Overall Study||568
88620|NCT01516879|213160|P1|COMPLETED|Overall Study||287
88621|NCT01516879|213159|P2|Received Treatment|Overall Study||599
88622|NCT01516879|213160|P1|Received Treatment|Overall Study||302
88623|NCT01516879|213159|P2|STARTED|Overall Study||602
88624|NCT01516879|213160|P1|STARTED|Overall Study||303
88625|NCT01516749|213194|P1|NOT COMPLETED|Follow-up Off Therapy||1
88626|NCT01516749|213194|P1|COMPLETED|Follow-up Off Therapy||4
88627|NCT01516749|213194|P1|STARTED|Follow-up Off Therapy||5
88628|NCT01516749|213194|P1|NOT COMPLETED|Active Therapy||1
88629|NCT01516749|213194|P1|COMPLETED|Active Therapy||5
88630|NCT01516749|213194|P1|STARTED|Active Therapy||6
88631|NCT01516736|213203|P2|NOT COMPLETED|Overall Study||13
88632|NCT01516736|213204|P1|NOT COMPLETED|Overall Study||20
88633|NCT01516736|213203|P2|COMPLETED|Overall Study||140
88634|NCT01516736|213204|P1|COMPLETED|Overall Study||135
88635|NCT01516736|213203|P2|STARTED|Overall Study||153
88636|NCT01516736|213204|P1|STARTED|Overall Study||155
88637|NCT01516632|213226|P2|NOT COMPLETED|Overall Study||15
88638|NCT01516632|213227|P1|NOT COMPLETED|Overall Study||24
88639|NCT01516632|213226|P2|COMPLETED|Overall Study||48
88640|NCT01516632|213227|P1|COMPLETED|Overall Study||77
88641|NCT01516632|213226|P2|STARTED|Overall Study||63
88642|NCT01516632|213227|P1|STARTED|Overall Study||101
88643|NCT01516437|213241|P4|NOT COMPLETED|Overall Study||1
88644|NCT01516437|213242|P3|NOT COMPLETED|Overall Study||1
88645|NCT01516437|213243|P2|NOT COMPLETED|Overall Study||0
88646|NCT01516437|213244|P1|NOT COMPLETED|Overall Study||0
88647|NCT01516437|213241|P4|COMPLETED|Overall Study||6
88648|NCT01516437|213242|P3|COMPLETED|Overall Study||14
88649|NCT01516437|213243|P2|COMPLETED|Overall Study||24
88650|NCT01516437|213244|P1|COMPLETED|Overall Study||24
88651|NCT01516437|213241|P4|STARTED|Overall Study||7
88652|NCT01516437|213242|P3|STARTED|Overall Study||15
88653|NCT01516437|213243|P2|STARTED|Overall Study||24
88654|NCT01516437|213244|P1|STARTED|Overall Study||24
88655|NCT01516268|213300|P2|NOT COMPLETED|Overall Study||0
88656|NCT01516268|213301|P1|NOT COMPLETED|Overall Study||0
88657|NCT01516268|213300|P2|COMPLETED|Overall Study||25
88658|NCT01516268|213301|P1|COMPLETED|Overall Study||25
88659|NCT01516268|213300|P2|STARTED|Overall Study||25
88660|NCT01516268|213301|P1|STARTED|Overall Study||25
88661|NCT01516034|213307|P1|NOT COMPLETED|Overall Study||8
88662|NCT01516034|213307|P1|COMPLETED|Overall Study||0
88663|NCT01516034|213307|P1|STARTED|Overall Study||8
88664|NCT01516008|213314|P3|NOT COMPLETED|Overall Study||18
88665|NCT01516008|213315|P2|NOT COMPLETED|Overall Study||16
88666|NCT01516008|213316|P1|NOT COMPLETED|Overall Study||45
88667|NCT01516008|213314|P3|COMPLETED|Overall Study||99
88668|NCT01516008|213315|P2|COMPLETED|Overall Study||105
88669|NCT01516008|213316|P1|COMPLETED|Overall Study||69
88670|NCT01516008|213314|P3|STARTED|Overall Study||117
88671|NCT01516008|213315|P2|STARTED|Overall Study||121
88672|NCT01516008|213316|P1|STARTED|Overall Study||114
88673|NCT01515956|213348|P1|NOT COMPLETED|Overall Study||0
88674|NCT01515956|213348|P1|COMPLETED|Overall Study||15
88675|NCT01515956|213348|P1|STARTED|Overall Study||15
88676|NCT01515943|213357|P3|NOT COMPLETED|Overall Study||13
88677|NCT01515943|213358|P2|NOT COMPLETED|Overall Study||16
88678|NCT01515943|213359|P1|NOT COMPLETED|Overall Study||6
88679|NCT01515943|213357|P3|COMPLETED|Overall Study||31
88680|NCT01515943|213358|P2|COMPLETED|Overall Study||69
88681|NCT01515943|213359|P1|COMPLETED|Overall Study||69
88682|NCT01515943|213357|P3|STARTED|Overall Study||44
88683|NCT01515943|213358|P2|STARTED|Overall Study||85
88684|NCT01515943|213359|P1|STARTED|Overall Study||75
88685|NCT01515891|213405|P1|NOT COMPLETED|Overall Study||0
88686|NCT01515891|213405|P1|COMPLETED|Overall Study||4
88687|NCT01515891|213405|P1|STARTED|Overall Study||4
88688|NCT01515865|213412|P3|NOT COMPLETED|Part C (Randomized)||0
88689|NCT01515865|213413|P2|NOT COMPLETED|Part C (Randomized)||0
88690|NCT01515865|213414|P1|NOT COMPLETED|Part C (Randomized)||0
88691|NCT01515865|213412|P3|COMPLETED|Part C (Randomized)||34
88692|NCT01515865|213413|P2|COMPLETED|Part C (Randomized)||33
88693|NCT01515865|213414|P1|COMPLETED|Part C (Randomized)||0
88694|NCT01515865|213412|P3|STARTED|Part C (Randomized)||34
88695|NCT01515865|213413|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
88696|NCT01515865|213414|P1|STARTED|Part C (Randomized)||0
88697|NCT01515865|213412|P3|NOT COMPLETED|Part B (Open-label)||0
88698|NCT01515865|213413|P2|NOT COMPLETED|Part B (Open-label)||0
88699|NCT01515865|213414|P1|NOT COMPLETED|Part B (Open-label)||2
88700|NCT01515865|213412|P3|COMPLETED|Part B (Open-label)||0
88701|NCT01515865|213413|P2|COMPLETED|Part B (Open-label)||0
88702|NCT01515865|213414|P1|COMPLETED|Part B (Open-label)||69
88703|NCT01515865|213412|P3|STARTED|Part B (Open-label)||0
88704|NCT01515865|213413|P2|STARTED|Part B (Open-label)||0
88705|NCT01515865|213414|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
88706|NCT01515865|213412|P3|NOT COMPLETED|Part A (Open-label)||0
88707|NCT01515865|213413|P2|NOT COMPLETED|Part A (Open-label)||0
88708|NCT01515865|213414|P1|NOT COMPLETED|Part A (Open-label)||3
88709|NCT01515865|213412|P3|COMPLETED|Part A (Open-label)||0
88710|NCT01515865|213413|P2|COMPLETED|Part A (Open-label)||0
88711|NCT01515865|213414|P1|COMPLETED|Part A (Open-label)||95
88712|NCT01515865|213412|P3|STARTED|Part A (Open-label)||0
88713|NCT01515865|213413|P2|STARTED|Part A (Open-label)||0
88714|NCT01515865|213414|P1|STARTED|Part A (Open-label)||98
88715|NCT01515696|213424|P2|NOT COMPLETED|Overall Study||10
88716|NCT01515696|213425|P1|NOT COMPLETED|Overall Study||8
88717|NCT01515696|213424|P2|COMPLETED|Overall Study||39
88718|NCT01515696|213425|P1|COMPLETED|Overall Study||39
88719|NCT01515696|213424|P2|STARTED|Overall Study||49
88720|NCT01515696|213425|P1|STARTED|Overall Study||47
88721|NCT01515657|213435|P3|NOT COMPLETED|Third Intervention||0
88722|NCT01515657|213436|P2|NOT COMPLETED|Third Intervention||0
88723|NCT01515657|213437|P1|NOT COMPLETED|Third Intervention||1
88724|NCT01515657|213435|P3|COMPLETED|Third Intervention||13
88725|NCT01515657|213436|P2|COMPLETED|Third Intervention||11
88726|NCT01515657|213437|P1|COMPLETED|Third Intervention||13
88727|NCT01515657|213435|P3|STARTED|Third Intervention||13
88728|NCT01515657|213436|P2|STARTED|Third Intervention||11
88729|NCT01515657|213437|P1|STARTED|Third Intervention||14
88730|NCT01515657|213435|P3|NOT COMPLETED|Second Intervention||0
88731|NCT01515657|213436|P2|NOT COMPLETED|Second Intervention||1
88732|NCT01515657|213437|P1|NOT COMPLETED|Second Intervention||0
88733|NCT01515657|213435|P3|COMPLETED|Second Intervention||13
88734|NCT01515657|213436|P2|COMPLETED|Second Intervention||11
88735|NCT01515657|213437|P1|COMPLETED|Second Intervention||14
88736|NCT01515657|213435|P3|STARTED|Second Intervention||13
88737|NCT01515657|213436|P2|STARTED|Second Intervention||12
88738|NCT01515657|213437|P1|STARTED|Second Intervention||14
88739|NCT01515657|213435|P3|NOT COMPLETED|First Intervention||0
88740|NCT01515657|213436|P2|NOT COMPLETED|First Intervention||1
88741|NCT01515657|213437|P1|NOT COMPLETED|First Intervention||0
88742|NCT01515657|213435|P3|COMPLETED|First Intervention||13
88743|NCT01515657|213436|P2|COMPLETED|First Intervention||12
88744|NCT01515657|213437|P1|COMPLETED|First Intervention||14
88745|NCT01515657|213435|P3|STARTED|First Intervention||13
88746|NCT01515657|213436|P2|STARTED|First Intervention||13
88747|NCT01515657|213437|P1|STARTED|First Intervention||14
88748|NCT01515566|213447|P2|NOT COMPLETED|Overall Study||0
88749|NCT01515566|213448|P1|NOT COMPLETED|Overall Study||0
88750|NCT01515566|213447|P2|COMPLETED|Overall Study||10
88751|NCT01515566|213448|P1|COMPLETED|Overall Study||10
88752|NCT01515566|213447|P2|STARTED|Overall Study||10
88753|NCT01515566|213448|P1|STARTED|Overall Study||10
88754|NCT01515540|213460|P2|NOT COMPLETED|Overall Study||3
88755|NCT01515540|213461|P1|NOT COMPLETED|Overall Study||5
88756|NCT01515540|213460|P2|COMPLETED|Overall Study||15
88757|NCT01515540|213461|P1|COMPLETED|Overall Study||15
88758|NCT01515540|213460|P2|STARTED|Overall Study||18
88759|NCT01515540|213461|P1|STARTED|Overall Study||20
88760|NCT01515488|213469|P2|NOT COMPLETED|Overall Study||0
88761|NCT01515488|213470|P1|NOT COMPLETED|Overall Study||0
88762|NCT01515488|213469|P2|COMPLETED|Overall Study||200
88763|NCT01515488|213470|P1|COMPLETED|Overall Study||200
88764|NCT01515488|213469|P2|STARTED|Overall Study||200
88765|NCT01515488|213470|P1|STARTED|Overall Study||200
88766|NCT01515423|213482|P3|NOT COMPLETED|DOUBLE BLIND||92
88767|NCT01515423|213483|P2|NOT COMPLETED|DOUBLE BLIND||82
88768|NCT01515423|213484|P1|NOT COMPLETED|DOUBLE BLIND||0
88769|NCT01515423|213482|P3|COMPLETED|DOUBLE BLIND||420
88770|NCT01515423|213483|P2|COMPLETED|DOUBLE BLIND||422
88771|NCT01515423|213484|P1|COMPLETED|DOUBLE BLIND||0
88772|NCT01515423|213482|P3|STARTED|DOUBLE BLIND||512
88773|NCT01515423|213483|P2|STARTED|DOUBLE BLIND||504
88774|NCT01515423|213484|P1|STARTED|DOUBLE BLIND||0
88775|NCT01515423|213482|P3|NOT COMPLETED|Open Label Phase||0
88776|NCT01515423|213483|P2|NOT COMPLETED|Open Label Phase||0
88777|NCT01515423|213484|P1|NOT COMPLETED|Open Label Phase||413
88778|NCT01515423|213482|P3|COMPLETED|Open Label Phase||0
88779|NCT01515423|213483|P2|COMPLETED|Open Label Phase||0
88780|NCT01515423|213484|P1|COMPLETED|Open Label Phase||1016
88781|NCT01515423|213482|P3|STARTED|Open Label Phase||0
88782|NCT01515423|213483|P2|STARTED|Open Label Phase||0
88783|NCT01515423|213484|P1|STARTED|Open Label Phase||1429
88784|NCT01515410|213503|P2|NOT COMPLETED|Overall Study||0
88785|NCT01515410|213504|P1|NOT COMPLETED|Overall Study||0
88786|NCT01515410|213503|P2|COMPLETED|Overall Study||15
88787|NCT01515410|213504|P1|COMPLETED|Overall Study||19
88788|NCT01515410|213503|P2|STARTED|Overall Study||15
88789|NCT01515410|213504|P1|STARTED|Overall Study||19
88790|NCT01515345|213512|P2|NOT COMPLETED|Overall Study||0
88791|NCT01515345|213513|P1|NOT COMPLETED|Overall Study||1
88792|NCT01515345|213512|P2|COMPLETED|Overall Study||343
88793|NCT01515345|213513|P1|COMPLETED|Overall Study||664
88794|NCT01515345|213512|P2|STARTED|Overall Study||343
88795|NCT01515345|213513|P1|STARTED|Overall Study||665
88796|NCT01515306|213525|P2|NOT COMPLETED|Overall Study||14
88797|NCT01515306|213526|P1|NOT COMPLETED|Overall Study||12
88798|NCT01515306|213525|P2|COMPLETED|Overall Study||2
88799|NCT01515306|213526|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
88800|NCT01515306|213525|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
88801|NCT01515306|213526|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
88802|NCT01515306|213525|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
88803|NCT01515306|213526|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
88804|NCT01515306|213525|P2|STARTED|Overall Study||16
88805|NCT01515306|213526|P1|STARTED|Overall Study||24
88806|NCT01515189|213539|P2|NOT COMPLETED|First Re-Induction Phase||15
88807|NCT01515189|213540|P1|NOT COMPLETED|First Re-Induction Phase||14
88808|NCT01515189|213539|P2|COMPLETED|First Re-Induction Phase||17
88809|NCT01515189|213540|P1|COMPLETED|First Re-Induction Phase||9
88810|NCT01515189|213539|P2|STARTED|First Re-Induction Phase||32
88811|NCT01515189|213540|P1|STARTED|First Re-Induction Phase||23
88812|NCT01515189|213539|P2|NOT COMPLETED|Induction||232
88813|NCT01515189|213540|P1|NOT COMPLETED|Induction||237
88814|NCT01515189|213539|P2|COMPLETED|Induction||130
88815|NCT01515189|213540|P1|COMPLETED|Induction||128
88816|NCT01515189|213539|P2|STARTED|Induction||362
88817|NCT01515189|213540|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
88818|NCT01515176|213562|P2|NOT COMPLETED|Overall Study||0
88819|NCT01515176|213563|P1|NOT COMPLETED|Overall Study||0
88820|NCT01515176|213562|P2|COMPLETED|Overall Study||32
88821|NCT01515176|213563|P1|COMPLETED|Overall Study||4
88822|NCT01515176|213562|P2|STARTED|Overall Study||32
88823|NCT01515176|213563|P1|STARTED|Overall Study||4
88824|NCT01515072|213577|P2|NOT COMPLETED|Overall Study||0
88825|NCT01515072|213578|P1|NOT COMPLETED|Overall Study||0
88826|NCT01515072|213577|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
88827|NCT01515072|213578|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
88828|NCT01515072|213577|P2|STARTED|Overall Study||155
88829|NCT01515072|213578|P1|STARTED|Overall Study||166
88830|NCT01515046|213618|P1|NOT COMPLETED|Overall Study||0
88831|NCT01515046|213618|P1|COMPLETED|Overall Study||1
88832|NCT01515046|213618|P1|STARTED|Overall Study||1
88833|NCT01514864|213628|P2|NOT COMPLETED|Overall Study||5
88834|NCT01514864|213629|P1|NOT COMPLETED|Overall Study||9
88835|NCT01514864|213628|P2|COMPLETED|Overall Study||0
88836|NCT01514864|213629|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
88837|NCT01514864|213628|P2|STARTED|Overall Study||5
88838|NCT01514864|213629|P1|STARTED|Overall Study||9
88839|NCT01514786|213647|P2|NOT COMPLETED|Overall Study||0
88840|NCT01514786|213648|P1|NOT COMPLETED|Overall Study||0
88841|NCT01514786|213647|P2|COMPLETED|Overall Study||284
88842|NCT01514786|213648|P1|COMPLETED|Overall Study||286
88843|NCT01514786|213647|P2|STARTED|Overall Study||284
88844|NCT01514786|213648|P1|STARTED|Overall Study||286
88845|NCT01514760|213654|P1|NOT COMPLETED|Overall Study||2
88846|NCT01514760|213654|P1|COMPLETED|Overall Study||20
88847|NCT01514760|213654|P1|STARTED|Overall Study||22
88848|NCT01514734|213661|P1|NOT COMPLETED|Overall Study||0
88849|NCT01514734|213661|P1|COMPLETED|Overall Study||9
88850|NCT01514734|213661|P1|STARTED|Overall Study||9
88851|NCT01514682|213667|P2|NOT COMPLETED|Overall Study||6
88852|NCT01514682|213668|P1|NOT COMPLETED|Overall Study||6
88853|NCT01514682|213667|P2|COMPLETED|Overall Study||14
88854|NCT01514682|213668|P1|COMPLETED|Overall Study||13
88855|NCT01514682|213667|P2|STARTED|Overall Study||20
88856|NCT01514682|213668|P1|STARTED|Overall Study||19
88857|NCT01514630|213684|P1|NOT COMPLETED|Overall Study||3
88858|NCT01514630|213684|P1|COMPLETED|Overall Study||11
88859|NCT01514630|213684|P1|STARTED|Overall Study||14
88860|NCT01514513|213690|P2|NOT COMPLETED|Overall Study||1
88861|NCT01514513|213691|P1|NOT COMPLETED|Overall Study||1
88862|NCT01514513|213690|P2|COMPLETED|Overall Study||20
88863|NCT01514513|213691|P1|COMPLETED|Overall Study||20
88864|NCT01514513|213690|P2|STARTED|Overall Study||21
88865|NCT01514513|213691|P1|STARTED|Overall Study||21
88866|NCT01514461|213702|P3|NOT COMPLETED|Overall Study||4
88867|NCT01514461|213703|P2|NOT COMPLETED|Overall Study||3
88868|NCT01514461|213704|P1|NOT COMPLETED|Overall Study||5
88869|NCT01514461|213702|P3|COMPLETED|Overall Study||11
88870|NCT01514461|213703|P2|COMPLETED|Overall Study||12
88871|NCT01514461|213704|P1|COMPLETED|Overall Study||10
88872|NCT01514461|213702|P3|STARTED|Overall Study||15
88873|NCT01514461|213703|P2|STARTED|Overall Study||15
88874|NCT01514461|213704|P1|STARTED|Overall Study||15
88875|NCT01514448|213743|P2|NOT COMPLETED|Overall Study||8
88876|NCT01514448|213744|P1|NOT COMPLETED|Overall Study||12
88877|NCT01514448|213743|P2|COMPLETED|Overall Study||5
88878|NCT01514448|213744|P1|COMPLETED|Overall Study||4
88879|NCT01514448|213743|P2|Full Analysis Set (FAS)|Overall Study||13
88880|NCT01514448|213744|P1|Full Analysis Set (FAS)|Overall Study||12
88881|NCT01514448|213743|P2|STARTED|Overall Study||13
88882|NCT01514448|213744|P1|STARTED|Overall Study||16
88883|NCT01514422|213759|P1|NOT COMPLETED|Overall Study||1
88884|NCT01514422|213759|P1|COMPLETED|Overall Study||19
88885|NCT01514422|213759|P1|STARTED|Overall Study||20
88886|NCT01514357|213767|P2|NOT COMPLETED|Overall Study||0
88887|NCT01514357|213768|P1|NOT COMPLETED|Overall Study||4
88888|NCT01514357|213767|P2|COMPLETED|Overall Study||0
88889|NCT01514357|213768|P1|COMPLETED|Overall Study||8
88890|NCT01514357|213767|P2|STARTED|Overall Study||0
88891|NCT01514357|213768|P1|STARTED|Overall Study||12
88892|NCT01514318|213774|P1|NOT COMPLETED|Overall Study||0
88893|NCT01514318|213774|P1|COMPLETED|Overall Study||8
88894|NCT01514318|213774|P1|STARTED|Overall Study||8
88895|NCT01514292|213780|P1|NOT COMPLETED|Overall Study||0
88896|NCT01514292|213780|P1|COMPLETED|Overall Study||72
88897|NCT01514292|213780|P1|STARTED|Overall Study||72
88898|NCT01514240|213786|P2|NOT COMPLETED|Overall Study||11
88899|NCT01514240|213787|P1|NOT COMPLETED|Overall Study||6
88900|NCT01514240|213786|P2|COMPLETED|Overall Study||45
88901|NCT01514240|213787|P1|COMPLETED|Overall Study||50
88902|NCT01514240|213786|P2|STARTED|Overall Study||56
88903|NCT01514240|213787|P1|STARTED|Overall Study||56
88904|NCT01514162|213861|P1|NOT COMPLETED|Overall Study||85
88905|NCT01514162|213861|P1|COMPLETED|Overall Study||160
88906|NCT01514162|213861|P1|STARTED|Overall Study||245
88907|NCT01514149|213872|P5|NOT COMPLETED|Overall Study||1
88908|NCT01514149|213873|P4|NOT COMPLETED|Overall Study||1
88909|NCT01514149|213874|P3|NOT COMPLETED|Overall Study||3
88910|NCT01514149|213875|P2|NOT COMPLETED|Overall Study||1
88911|NCT01514149|213876|P1|NOT COMPLETED|Overall Study||3
88912|NCT01514149|213872|P5|COMPLETED|Overall Study||14
88913|NCT01514149|213873|P4|COMPLETED|Overall Study||13
88914|NCT01514149|213874|P3|COMPLETED|Overall Study||11
88915|NCT01514149|213875|P2|COMPLETED|Overall Study||14
88916|NCT01514149|213876|P1|COMPLETED|Overall Study||12
88917|NCT01514149|213872|P5|STARTED|Overall Study||15
88918|NCT01514149|213873|P4|STARTED|Overall Study||14
88919|NCT01514149|213874|P3|STARTED|Overall Study||14
88920|NCT01514149|213875|P2|STARTED|Overall Study||15
88921|NCT01514149|213876|P1|STARTED|Overall Study||15
88922|NCT01514136|213900|P8|NOT COMPLETED|Test Period; Test D*||0
88923|NCT01514136|213901|P7|NOT COMPLETED|Test Period; Test D*||0
88924|NCT01514136|213902|P6|NOT COMPLETED|Test Period; Test D*||0
88925|NCT01514136|213903|P5|NOT COMPLETED|Test Period; Test D*||0
88926|NCT01514136|213904|P4|NOT COMPLETED|Test Period; Test D*||0
88927|NCT01514136|213905|P3|NOT COMPLETED|Test Period; Test D*||0
88928|NCT01514136|213906|P2|NOT COMPLETED|Test Period; Test D*||0
88929|NCT01514136|213907|P1|NOT COMPLETED|Test Period; Test D*||0
88930|NCT01514136|213900|P8|COMPLETED|Test Period; Test D*||23
88931|NCT01514136|213901|P7|COMPLETED|Test Period; Test D*||0
88932|NCT01514136|213902|P6|COMPLETED|Test Period; Test D*||0
88933|NCT01514136|213903|P5|COMPLETED|Test Period; Test D*||0
88934|NCT01514136|213904|P4|COMPLETED|Test Period; Test D*||0
88935|NCT01514136|213905|P3|COMPLETED|Test Period; Test D*||0
88936|NCT01514136|213906|P2|COMPLETED|Test Period; Test D*||0
88937|NCT01514136|213907|P1|COMPLETED|Test Period; Test D*||0
88938|NCT01514136|213900|P8|STARTED|Test Period; Test D*||23
88939|NCT01514136|213901|P7|STARTED|Test Period; Test D*||0
88940|NCT01514136|213902|P6|STARTED|Test Period; Test D*||0
88941|NCT01514136|213903|P5|STARTED|Test Period; Test D*||0
88942|NCT01514136|213904|P4|STARTED|Test Period; Test D*||0
88943|NCT01514136|213905|P3|STARTED|Test Period; Test D*||0
88944|NCT01514136|213906|P2|STARTED|Test Period; Test D*||0
88945|NCT01514136|213907|P1|STARTED|Test Period; Test D*||0
88946|NCT01514136|213900|P8|NOT COMPLETED|Test Period 2; Test C*||0
88947|NCT01514136|213901|P7|NOT COMPLETED|Test Period 2; Test C*||3
88948|NCT01514136|213902|P6|NOT COMPLETED|Test Period 2; Test C*||0
88949|NCT01514136|213903|P5|NOT COMPLETED|Test Period 2; Test C*||0
88950|NCT01514136|213904|P4|NOT COMPLETED|Test Period 2; Test C*||0
88951|NCT01514136|213905|P3|NOT COMPLETED|Test Period 2; Test C*||0
88952|NCT01514136|213906|P2|NOT COMPLETED|Test Period 2; Test C*||0
88953|NCT01514136|213907|P1|NOT COMPLETED|Test Period 2; Test C*||0
88954|NCT01514136|213900|P8|COMPLETED|Test Period 2; Test C*||0
88955|NCT01514136|213901|P7|COMPLETED|Test Period 2; Test C*||23
88956|NCT01514136|213902|P6|COMPLETED|Test Period 2; Test C*||0
88957|NCT01514136|213903|P5|COMPLETED|Test Period 2; Test C*||0
88958|NCT01514136|213904|P4|COMPLETED|Test Period 2; Test C*||0
88959|NCT01514136|213905|P3|COMPLETED|Test Period 2; Test C*||0
88960|NCT01514136|213906|P2|COMPLETED|Test Period 2; Test C*||0
88961|NCT01514136|213907|P1|COMPLETED|Test Period 2; Test C*||0
88962|NCT01514136|213900|P8|STARTED|Test Period 2; Test C*||0
88963|NCT01514136|213901|P7|STARTED|Test Period 2; Test C*||26
88964|NCT01514136|213902|P6|STARTED|Test Period 2; Test C*||0
88965|NCT01514136|213903|P5|STARTED|Test Period 2; Test C*||0
88966|NCT01514136|213904|P4|STARTED|Test Period 2; Test C*||0
88967|NCT01514136|213905|P3|STARTED|Test Period 2; Test C*||0
88968|NCT01514136|213906|P2|STARTED|Test Period 2; Test C*||0
88969|NCT01514136|213907|P1|STARTED|Test Period 2; Test C*||0
88970|NCT01514136|213900|P8|NOT COMPLETED|Test Period 2; Test B*||0
88971|NCT01514136|213901|P7|NOT COMPLETED|Test Period 2; Test B*||0
88972|NCT01514136|213902|P6|NOT COMPLETED|Test Period 2; Test B*||2
88973|NCT01514136|213903|P5|NOT COMPLETED|Test Period 2; Test B*||0
88974|NCT01514136|213904|P4|NOT COMPLETED|Test Period 2; Test B*||0
88975|NCT01514136|213905|P3|NOT COMPLETED|Test Period 2; Test B*||0
88976|NCT01514136|213906|P2|NOT COMPLETED|Test Period 2; Test B*||0
88977|NCT01514136|213907|P1|NOT COMPLETED|Test Period 2; Test B*||0
88978|NCT01514136|213900|P8|COMPLETED|Test Period 2; Test B*||0
88979|NCT01514136|213901|P7|COMPLETED|Test Period 2; Test B*||0
88980|NCT01514136|213902|P6|COMPLETED|Test Period 2; Test B*||26
88981|NCT01514136|213903|P5|COMPLETED|Test Period 2; Test B*||0
88982|NCT01514136|213904|P4|COMPLETED|Test Period 2; Test B*||0
88983|NCT01514136|213905|P3|COMPLETED|Test Period 2; Test B*||0
88984|NCT01514136|213906|P2|COMPLETED|Test Period 2; Test B*||0
88985|NCT01514136|213907|P1|COMPLETED|Test Period 2; Test B*||0
88986|NCT01514136|213900|P8|STARTED|Test Period 2; Test B*||0
88987|NCT01514136|213901|P7|STARTED|Test Period 2; Test B*||0
88988|NCT01514136|213902|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
88989|NCT01514136|213903|P5|STARTED|Test Period 2; Test B*||0
88990|NCT01514136|213904|P4|STARTED|Test Period 2; Test B*||0
88991|NCT01514136|213905|P3|STARTED|Test Period 2; Test B*||0
88992|NCT01514136|213906|P2|STARTED|Test Period 2; Test B*||0
88993|NCT01514136|213907|P1|STARTED|Test Period 2; Test B*||0
88994|NCT01514136|213900|P8|NOT COMPLETED|Test Period 2; Test A*||0
88995|NCT01514136|213901|P7|NOT COMPLETED|Test Period 2; Test A*||0
88996|NCT01514136|213902|P6|NOT COMPLETED|Test Period 2; Test A*||0
88997|NCT01514136|213903|P5|NOT COMPLETED|Test Period 2; Test A*||2
88998|NCT01514136|213904|P4|NOT COMPLETED|Test Period 2; Test A*||0
88999|NCT01514136|213905|P3|NOT COMPLETED|Test Period 2; Test A*||0
89000|NCT01514136|213906|P2|NOT COMPLETED|Test Period 2; Test A*||0
89001|NCT01514136|213907|P1|NOT COMPLETED|Test Period 2; Test A*||0
89002|NCT01514136|213900|P8|COMPLETED|Test Period 2; Test A*||0
89003|NCT01514136|213901|P7|COMPLETED|Test Period 2; Test A*||0
89004|NCT01514136|213902|P6|COMPLETED|Test Period 2; Test A*||0
89005|NCT01514136|213903|P5|COMPLETED|Test Period 2; Test A*||26
89006|NCT01514136|213904|P4|COMPLETED|Test Period 2; Test A*||0
89007|NCT01514136|213905|P3|COMPLETED|Test Period 2; Test A*||0
89008|NCT01514136|213906|P2|COMPLETED|Test Period 2; Test A*||0
89009|NCT01514136|213907|P1|COMPLETED|Test Period 2; Test A*||0
89010|NCT01514136|213900|P8|STARTED|Test Period 2; Test A*||0
89011|NCT01514136|213901|P7|STARTED|Test Period 2; Test A*||0
89012|NCT01514136|213902|P6|STARTED|Test Period 2; Test A*||0
89013|NCT01514136|213903|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
89014|NCT01514136|213904|P4|STARTED|Test Period 2; Test A*||0
89015|NCT01514136|213905|P3|STARTED|Test Period 2; Test A*||0
89016|NCT01514136|213906|P2|STARTED|Test Period 2; Test A*||0
89017|NCT01514136|213907|P1|STARTED|Test Period 2; Test A*||0
89018|NCT01514136|213900|P8|NOT COMPLETED|Test Period 1; Test D||0
89019|NCT01514136|213901|P7|NOT COMPLETED|Test Period 1; Test D||0
89020|NCT01514136|213902|P6|NOT COMPLETED|Test Period 1; Test D||0
89021|NCT01514136|213903|P5|NOT COMPLETED|Test Period 1; Test D||0
89022|NCT01514136|213904|P4|NOT COMPLETED|Test Period 1; Test D||2
89023|NCT01514136|213905|P3|NOT COMPLETED|Test Period 1; Test D||0
89024|NCT01514136|213906|P2|NOT COMPLETED|Test Period 1; Test D||0
89025|NCT01514136|213907|P1|NOT COMPLETED|Test Period 1; Test D||0
89026|NCT01514136|213900|P8|COMPLETED|Test Period 1; Test D||0
89027|NCT01514136|213901|P7|COMPLETED|Test Period 1; Test D||0
89028|NCT01514136|213902|P6|COMPLETED|Test Period 1; Test D||0
89029|NCT01514136|213903|P5|COMPLETED|Test Period 1; Test D||0
89030|NCT01514136|213904|P4|COMPLETED|Test Period 1; Test D||24
89031|NCT01514136|213905|P3|COMPLETED|Test Period 1; Test D||0
89032|NCT01514136|213906|P2|COMPLETED|Test Period 1; Test D||0
89033|NCT01514136|213907|P1|COMPLETED|Test Period 1; Test D||0
89034|NCT01514136|213900|P8|STARTED|Test Period 1; Test D||0
89035|NCT01514136|213901|P7|STARTED|Test Period 1; Test D||0
89036|NCT01514136|213902|P6|STARTED|Test Period 1; Test D||0
89037|NCT01514136|213903|P5|STARTED|Test Period 1; Test D||0
89038|NCT01514136|213904|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
89039|NCT01514136|213905|P3|STARTED|Test Period 1; Test D||0
89040|NCT01514136|213906|P2|STARTED|Test Period 1; Test D||0
89041|NCT01514136|213907|P1|STARTED|Test Period 1; Test D||0
89042|NCT01514136|213900|P8|NOT COMPLETED|Test Period 1; Test C||0
89043|NCT01514136|213901|P7|NOT COMPLETED|Test Period 1; Test C||0
89044|NCT01514136|213902|P6|NOT COMPLETED|Test Period 1; Test C||0
89045|NCT01514136|213903|P5|NOT COMPLETED|Test Period 1; Test C||0
89046|NCT01514136|213904|P4|NOT COMPLETED|Test Period 1; Test C||0
89047|NCT01514136|213905|P3|NOT COMPLETED|Test Period 1; Test C||0
89048|NCT01514136|213906|P2|NOT COMPLETED|Test Period 1; Test C||0
89049|NCT01514136|213907|P1|NOT COMPLETED|Test Period 1; Test C||0
89050|NCT01514136|213900|P8|COMPLETED|Test Period 1; Test C||0
89051|NCT01514136|213901|P7|COMPLETED|Test Period 1; Test C||0
89052|NCT01514136|213902|P6|COMPLETED|Test Period 1; Test C||0
89053|NCT01514136|213903|P5|COMPLETED|Test Period 1; Test C||0
89054|NCT01514136|213904|P4|COMPLETED|Test Period 1; Test C||0
89055|NCT01514136|213905|P3|COMPLETED|Test Period 1; Test C||24
89056|NCT01514136|213906|P2|COMPLETED|Test Period 1; Test C||0
89057|NCT01514136|213907|P1|COMPLETED|Test Period 1; Test C||0
89058|NCT01514136|213900|P8|STARTED|Test Period 1; Test C||0
89059|NCT01514136|213901|P7|STARTED|Test Period 1; Test C||0
89060|NCT01514136|213902|P6|STARTED|Test Period 1; Test C||0
89061|NCT01514136|213903|P5|STARTED|Test Period 1; Test C||0
89062|NCT01514136|213904|P4|STARTED|Test Period 1; Test C||0
89063|NCT01514136|213905|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
89064|NCT01514136|213906|P2|STARTED|Test Period 1; Test C||0
89065|NCT01514136|213907|P1|STARTED|Test Period 1; Test C||0
89066|NCT01514136|213900|P8|NOT COMPLETED|Test Period 1; Test B||0
89067|NCT01514136|213901|P7|NOT COMPLETED|Test Period 1; Test B||0
89068|NCT01514136|213902|P6|NOT COMPLETED|Test Period 1; Test B||0
89069|NCT01514136|213903|P5|NOT COMPLETED|Test Period 1; Test B||0
89070|NCT01514136|213904|P4|NOT COMPLETED|Test Period 1; Test B||0
89071|NCT01514136|213905|P3|NOT COMPLETED|Test Period 1; Test B||0
89072|NCT01514136|213906|P2|NOT COMPLETED|Test Period 1; Test B||1
89073|NCT01514136|213907|P1|NOT COMPLETED|Test Period 1; Test B||0
89074|NCT01514136|213900|P8|COMPLETED|Test Period 1; Test B||0
89075|NCT01514136|213901|P7|COMPLETED|Test Period 1; Test B||0
89076|NCT01514136|213902|P6|COMPLETED|Test Period 1; Test B||0
89077|NCT01514136|213903|P5|COMPLETED|Test Period 1; Test B||0
89078|NCT01514136|213904|P4|COMPLETED|Test Period 1; Test B||0
89079|NCT01514136|213905|P3|COMPLETED|Test Period 1; Test B||0
89080|NCT01514136|213906|P2|COMPLETED|Test Period 1; Test B||23
89081|NCT01514136|213907|P1|COMPLETED|Test Period 1; Test B||0
89082|NCT01514136|213900|P8|STARTED|Test Period 1; Test B||0
89083|NCT01514136|213901|P7|STARTED|Test Period 1; Test B||0
89084|NCT01514136|213902|P6|STARTED|Test Period 1; Test B||0
89085|NCT01514136|213903|P5|STARTED|Test Period 1; Test B||0
89086|NCT01514136|213904|P4|STARTED|Test Period 1; Test B||0
89087|NCT01514136|213905|P3|STARTED|Test Period 1; Test B||0
89088|NCT01514136|213906|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
89089|NCT01514136|213907|P1|STARTED|Test Period 1; Test B||0
89090|NCT01514136|213900|P8|NOT COMPLETED|Test Period 1; Test A||0
89091|NCT01514136|213901|P7|NOT COMPLETED|Test Period 1; Test A||0
89092|NCT01514136|213902|P6|NOT COMPLETED|Test Period 1; Test A||0
89093|NCT01514136|213903|P5|NOT COMPLETED|Test Period 1; Test A||0
89094|NCT01514136|213904|P4|NOT COMPLETED|Test Period 1; Test A||0
89095|NCT01514136|213905|P3|NOT COMPLETED|Test Period 1; Test A||0
89096|NCT01514136|213906|P2|NOT COMPLETED|Test Period 1; Test A||0
89097|NCT01514136|213907|P1|NOT COMPLETED|Test Period 1; Test A||3
89098|NCT01514136|213900|P8|COMPLETED|Test Period 1; Test A||0
89099|NCT01514136|213901|P7|COMPLETED|Test Period 1; Test A||0
89100|NCT01514136|213902|P6|COMPLETED|Test Period 1; Test A||0
89101|NCT01514136|213903|P5|COMPLETED|Test Period 1; Test A||0
89102|NCT01514136|213904|P4|COMPLETED|Test Period 1; Test A||0
89103|NCT01514136|213905|P3|COMPLETED|Test Period 1; Test A||0
89104|NCT01514136|213906|P2|COMPLETED|Test Period 1; Test A||0
89105|NCT01514136|213907|P1|COMPLETED|Test Period 1; Test A||22
89106|NCT01514136|213900|P8|STARTED|Test Period 1; Test A||0
89107|NCT01514136|213901|P7|STARTED|Test Period 1; Test A||0
89108|NCT01514136|213902|P6|STARTED|Test Period 1; Test A||0
89109|NCT01514136|213903|P5|STARTED|Test Period 1; Test A||0
89110|NCT01514136|213904|P4|STARTED|Test Period 1; Test A||0
89111|NCT01514136|213905|P3|STARTED|Test Period 1; Test A||0
89112|NCT01514136|213906|P2|STARTED|Test Period 1; Test A||0
89113|NCT01514136|213907|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
89114|NCT01513902|213936|P3|NOT COMPLETED|Overall Study||0
89115|NCT01513902|213937|P2|NOT COMPLETED|Overall Study||0
89116|NCT01513902|213938|P1|NOT COMPLETED|Overall Study||0
89117|NCT01513902|213936|P3|COMPLETED|Overall Study||9
89118|NCT01513902|213937|P2|COMPLETED|Overall Study||9
89119|NCT01513902|213938|P1|COMPLETED|Overall Study||8
89120|NCT01513902|213936|P3|STARTED|Overall Study||9
89121|NCT01513902|213937|P2|STARTED|Overall Study||9
89122|NCT01513902|213938|P1|STARTED|Overall Study||8
89123|NCT01513590|213975|P2|NOT COMPLETED|Overall Study||13
89124|NCT01513590|213976|P1|NOT COMPLETED|Overall Study||10
89125|NCT01513590|213975|P2|COMPLETED|Overall Study||184
89126|NCT01513590|213976|P1|COMPLETED|Overall Study||187
89127|NCT01513590|213975|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
89128|NCT01513590|213976|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
89129|NCT01513590|213975|P2|STARTED|Overall Study||197
89130|NCT01513590|213976|P1|STARTED|Overall Study||197
89131|NCT01513538|213994|P1|NOT COMPLETED|Overall Study||5
89132|NCT01513538|213994|P1|COMPLETED|Overall Study||573
89133|NCT01513538|213994|P1|STARTED|Overall Study||578
89134|NCT01513473|214000|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
89135|NCT01513473|214001|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
89136|NCT01513473|214000|P2|COMPLETED|Extension Trial (26 Weeks)||122
89137|NCT01513473|214001|P1|COMPLETED|Extension Trial (26 Weeks)||151
89138|NCT01513473|214000|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
89139|NCT01513473|214001|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
89140|NCT01513473|214000|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
89141|NCT01513473|214001|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
89142|NCT01513473|214000|P2|COMPLETED|Main Trial (26 Weeks)||165
89143|NCT01513473|214001|P1|COMPLETED|Main Trial (26 Weeks)||170
89144|NCT01513473|214000|P2|Exposed|Main Trial (26 Weeks)||175
89145|NCT01513473|214001|P1|Exposed|Main Trial (26 Weeks)||174
89233|NCT01513239|214130|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
89146|NCT01513473|214000|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
89147|NCT01513473|214001|P1|STARTED|Main Trial (26 Weeks)||174
89148|NCT01513460|214028|P3|NOT COMPLETED|Overall Study||56
89149|NCT01513460|214029|P2|NOT COMPLETED|Overall Study||32
89150|NCT01513460|214030|P1|NOT COMPLETED|Overall Study||29
89151|NCT01513460|214028|P3|COMPLETED|Overall Study||201
89152|NCT01513460|214029|P2|COMPLETED|Overall Study||226
89153|NCT01513460|214030|P1|COMPLETED|Overall Study||229
89154|NCT01513460|214028|P3|Per-protocol Set|Overall Study||166
89155|NCT01513460|214029|P2|Per-protocol Set|Overall Study||186
89156|NCT01513460|214030|P1|Per-protocol Set|Overall Study||196
89157|NCT01513460|214028|P3|Full Analysis Set|Overall Study||257
89158|NCT01513460|214029|P2|Full Analysis Set|Overall Study||258
89159|NCT01513460|214030|P1|Full Analysis Set|Overall Study||257
89160|NCT01513460|214028|P3|STARTED|Overall Study||257
89161|NCT01513460|214029|P2|STARTED|Overall Study||258
89162|NCT01513460|214030|P1|STARTED|Overall Study||258
89163|NCT01513447|214056|P2|NOT COMPLETED|Overall Study||0
89164|NCT01513447|214057|P1|NOT COMPLETED|Overall Study||0
89165|NCT01513447|214056|P2|COMPLETED|Overall Study||5
89166|NCT01513447|214057|P1|COMPLETED|Overall Study||3
89167|NCT01513447|214056|P2|STARTED|Overall Study||5
89168|NCT01513447|214057|P1|STARTED|Overall Study||3
89169|NCT01513330|214065|P2|NOT COMPLETED|Standard Care First,||4
89170|NCT01513330|214066|P1|NOT COMPLETED|Standard Care First,||4
89171|NCT01513330|214065|P2|COMPLETED|Standard Care First,||52
89172|NCT01513330|214066|P1|COMPLETED|Standard Care First,||56
89173|NCT01513330|214065|P2|STARTED|Standard Care First,||56
89174|NCT01513330|214066|P1|STARTED|Standard Care First,||60
89175|NCT01513330|214065|P2|NOT COMPLETED|SenSura Mio First,||2
89176|NCT01513330|214066|P1|NOT COMPLETED|SenSura Mio First,||4
89177|NCT01513330|214065|P2|COMPLETED|SenSura Mio First,||56
89178|NCT01513330|214066|P1|COMPLETED|SenSura Mio First,||60
89179|NCT01513330|214065|P2|STARTED|SenSura Mio First,||58
89180|NCT01513330|214066|P1|STARTED|SenSura Mio First,||64
89181|NCT01513317|214074|P2|NOT COMPLETED|Overall Study||24
89182|NCT01513317|214075|P1|NOT COMPLETED|Overall Study||34
89183|NCT01513317|214074|P2|COMPLETED|Overall Study||2
89184|NCT01513317|214075|P1|COMPLETED|Overall Study||16
89185|NCT01513317|214074|P2|STARTED|Overall Study||26
89186|NCT01513317|214075|P1|STARTED|Overall Study||50
89187|NCT01513291|214093|P5|NOT COMPLETED|Run-out Period||0
89188|NCT01513291|214094|P4|NOT COMPLETED|Run-out Period||2
89189|NCT01513291|214095|P3|NOT COMPLETED|Run-out Period||0
89190|NCT01513291|214096|P2|NOT COMPLETED|Run-out Period||0
89191|NCT01513291|214097|P1|NOT COMPLETED|Run-out Period||0
89192|NCT01513291|214093|P5|COMPLETED|Run-out Period||101
89193|NCT01513291|214094|P4|COMPLETED|Run-out Period||45
89194|NCT01513291|214095|P3|COMPLETED|Run-out Period||50
89195|NCT01513291|214096|P2|COMPLETED|Run-out Period||0
89196|NCT01513291|214097|P1|COMPLETED|Run-out Period||0
89197|NCT01513291|214093|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
89198|NCT01513291|214094|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
89199|NCT01513291|214095|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
89200|NCT01513291|214096|P2|STARTED|Run-out Period||0
89201|NCT01513291|214097|P1|STARTED|Run-out Period||0
89202|NCT01513291|214093|P5|NOT COMPLETED|Treatment Period||0
89203|NCT01513291|214094|P4|NOT COMPLETED|Treatment Period||0
89204|NCT01513291|214095|P3|NOT COMPLETED|Treatment Period||0
89205|NCT01513291|214096|P2|NOT COMPLETED|Treatment Period||16
89206|NCT01513291|214097|P1|NOT COMPLETED|Treatment Period||23
89207|NCT01513291|214093|P5|COMPLETED|Treatment Period||0
89208|NCT01513291|214094|P4|COMPLETED|Treatment Period||0
89209|NCT01513291|214095|P3|COMPLETED|Treatment Period||0
89210|NCT01513291|214096|P2|COMPLETED|Treatment Period||101
89211|NCT01513291|214097|P1|COMPLETED|Treatment Period||97
89212|NCT01513291|214093|P5|Treated|Treatment Period||0
89213|NCT01513291|214094|P4|Treated|Treatment Period||0
89214|NCT01513291|214095|P3|Treated|Treatment Period||0
89215|NCT01513291|214096|P2|Treated|Treatment Period||115
89216|NCT01513291|214097|P1|Treated|Treatment Period||120
89217|NCT01513291|214093|P5|STARTED|Treatment Period||0
89218|NCT01513291|214094|P4|STARTED|Treatment Period||0
89219|NCT01513291|214095|P3|STARTED|Treatment Period||0
89220|NCT01513291|214096|P2|STARTED|Treatment Period||117
89221|NCT01513291|214097|P1|STARTED|Treatment Period||120
89222|NCT01513239|214125|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
89223|NCT01513239|214126|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
89224|NCT01513239|214127|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
89225|NCT01513239|214128|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
89226|NCT01513239|214129|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
89227|NCT01513239|214130|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
89228|NCT01513239|214125|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
89229|NCT01513239|214126|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
89230|NCT01513239|214127|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
89231|NCT01513239|214128|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
89232|NCT01513239|214129|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
89234|NCT01513239|214125|P6|STARTED|Period 2: 9 Month Extension Phase||83
89235|NCT01513239|214126|P5|STARTED|Period 2: 9 Month Extension Phase||100
89236|NCT01513239|214127|P4|STARTED|Period 2: 9 Month Extension Phase||112
89237|NCT01513239|214128|P3|STARTED|Period 2: 9 Month Extension Phase||0
89238|NCT01513239|214129|P2|STARTED|Period 2: 9 Month Extension Phase||0
89239|NCT01513239|214130|P1|STARTED|Period 2: 9 Month Extension Phase||0
89240|NCT01513239|214125|P6|NOT COMPLETED|Period 1: Main Phase||0
89241|NCT01513239|214126|P5|NOT COMPLETED|Period 1: Main Phase||0
89242|NCT01513239|214127|P4|NOT COMPLETED|Period 1: Main Phase||0
89243|NCT01513239|214128|P3|NOT COMPLETED|Period 1: Main Phase||88
89244|NCT01513239|214129|P2|NOT COMPLETED|Period 1: Main Phase||70
89245|NCT01513239|214130|P1|NOT COMPLETED|Period 1: Main Phase||75
89246|NCT01513239|214125|P6|COMPLETED|Period 1: Main Phase||0
89247|NCT01513239|214126|P5|COMPLETED|Period 1: Main Phase||0
89248|NCT01513239|214127|P4|COMPLETED|Period 1: Main Phase||0
89249|NCT01513239|214128|P3|COMPLETED|Period 1: Main Phase||311
89250|NCT01513239|214129|P2|COMPLETED|Period 1: Main Phase||337
89251|NCT01513239|214130|P1|COMPLETED|Period 1: Main Phase||322
89252|NCT01513239|214125|P6|All Participants as Treated|Period 1: Main Phase||0
89253|NCT01513239|214126|P5|All Participants as Treated|Period 1: Main Phase||0
89254|NCT01513239|214127|P4|All Participants as Treated|Period 1: Main Phase||0
89255|NCT01513239|214128|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
89256|NCT01513239|214129|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
89257|NCT01513239|214130|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
89258|NCT01513239|214125|P6|Treated|Period 1: Main Phase||0
89259|NCT01513239|214126|P5|Treated|Period 1: Main Phase||0
89260|NCT01513239|214127|P4|Treated|Period 1: Main Phase||0
89261|NCT01513239|214128|P3|Treated|Period 1: Main Phase|Treated participants|381
89262|NCT01513239|214129|P2|Treated|Period 1: Main Phase|Treated participants|396
89263|NCT01513239|214130|P1|Treated|Period 1: Main Phase|Treated participants|391
89264|NCT01513239|214125|P6|STARTED|Period 1: Main Phase||0
89265|NCT01513239|214126|P5|STARTED|Period 1: Main Phase||0
89266|NCT01513239|214127|P4|STARTED|Period 1: Main Phase||0
89267|NCT01513239|214128|P3|STARTED|Period 1: Main Phase|Randomized participants|399
89268|NCT01513239|214129|P2|STARTED|Period 1: Main Phase|Randomized participants|407
89269|NCT01513239|214130|P1|STARTED|Period 1: Main Phase|Randomized participants|397
89270|NCT01513148|214183|P2|NOT COMPLETED|Overall Study||2
89271|NCT01513148|214184|P1|NOT COMPLETED|Overall Study||2
89272|NCT01513148|214183|P2|COMPLETED|Overall Study||14
89273|NCT01513148|214184|P1|COMPLETED|Overall Study||14
89274|NCT01513148|214183|P2|STARTED|Overall Study||16
89275|NCT01513148|214184|P1|STARTED|Overall Study||16
89276|NCT01513122|214232|P2|NOT COMPLETED|Overall Study||3
89277|NCT01513122|214233|P1|NOT COMPLETED|Overall Study||11
89278|NCT01513122|214232|P2|COMPLETED|Overall Study||105
89279|NCT01513122|214233|P1|COMPLETED|Overall Study||91
89280|NCT01513122|214232|P2|STARTED|Overall Study||108
89281|NCT01513122|214233|P1|STARTED|Overall Study||102
89282|NCT01512979|214251|P2|NOT COMPLETED|Overall Study||22
89283|NCT01512979|214252|P1|NOT COMPLETED|Overall Study||19
89284|NCT01512979|214251|P2|COMPLETED|Overall Study||135
89285|NCT01512979|214252|P1|COMPLETED|Overall Study||140
89286|NCT01512979|214251|P2|STARTED|Overall Study|Randomised and treated|157
89287|NCT01512979|214252|P1|STARTED|Overall Study|Randomised and treated|159
89288|NCT01512849|214272|P4|NOT COMPLETED|Crossover Period 2||0
89289|NCT01512849|214273|P3|NOT COMPLETED|Crossover Period 2||0
89290|NCT01512849|214274|P2|NOT COMPLETED|Crossover Period 2||0
89291|NCT01512849|214275|P1|NOT COMPLETED|Crossover Period 2||0
89292|NCT01512849|214272|P4|COMPLETED|Crossover Period 2||6
89293|NCT01512849|214273|P3|COMPLETED|Crossover Period 2||6
89294|NCT01512849|214274|P2|COMPLETED|Crossover Period 2||6
89295|NCT01512849|214275|P1|COMPLETED|Crossover Period 2||6
89296|NCT01512849|214272|P4|STARTED|Crossover Period 2||6
89297|NCT01512849|214273|P3|STARTED|Crossover Period 2||6
89298|NCT01512849|214274|P2|STARTED|Crossover Period 2||6
89299|NCT01512849|214275|P1|STARTED|Crossover Period 2||6
89300|NCT01512849|214272|P4|NOT COMPLETED|Crossover Period 1||0
89301|NCT01512849|214273|P3|NOT COMPLETED|Crossover Period 1||0
89302|NCT01512849|214274|P2|NOT COMPLETED|Crossover Period 1||0
89303|NCT01512849|214275|P1|NOT COMPLETED|Crossover Period 1||0
89304|NCT01512849|214272|P4|COMPLETED|Crossover Period 1||6
89305|NCT01512849|214273|P3|COMPLETED|Crossover Period 1||6
89306|NCT01512849|214274|P2|COMPLETED|Crossover Period 1||6
89307|NCT01512849|214275|P1|COMPLETED|Crossover Period 1||6
89308|NCT01512849|214272|P4|STARTED|Crossover Period 1||6
89309|NCT01512849|214273|P3|STARTED|Crossover Period 1||6
89310|NCT01512849|214274|P2|STARTED|Crossover Period 1||6
89311|NCT01512849|214275|P1|STARTED|Crossover Period 1||6
89312|NCT01512797|214299|P2|NOT COMPLETED|Overall Study||0
89313|NCT01512797|214300|P1|NOT COMPLETED|Overall Study||0
89314|NCT01512797|214299|P2|COMPLETED|Overall Study||16
89315|NCT01512797|214300|P1|COMPLETED|Overall Study||16
89316|NCT01512797|214299|P2|STARTED|Overall Study||16
89317|NCT01512797|214300|P1|STARTED|Overall Study||16
89318|NCT01512745|214316|P2|NOT COMPLETED|Overall Study||20
89319|NCT01512745|214317|P1|NOT COMPLETED|Overall Study||40
89320|NCT01512745|214316|P2|COMPLETED|Overall Study||71
89321|NCT01512745|214317|P1|COMPLETED|Overall Study||136
89322|NCT01512745|214316|P2|STARTED|Overall Study||91
89323|NCT01512745|214317|P1|STARTED|Overall Study||176
89324|NCT01512693|214333|P2|NOT COMPLETED|Overall Study||1
89325|NCT01512693|214334|P1|NOT COMPLETED|Overall Study||0
89326|NCT01512693|214333|P2|COMPLETED|Overall Study||8
89327|NCT01512693|214334|P1|COMPLETED|Overall Study||8
89328|NCT01512693|214333|P2|STARTED|Overall Study||9
89329|NCT01512693|214334|P1|STARTED|Overall Study||8
89330|NCT01512667|214348|P2|NOT COMPLETED|Overall Study||0
89331|NCT01512667|214349|P1|NOT COMPLETED|Overall Study||0
89332|NCT01512667|214348|P2|COMPLETED|Overall Study||12
89333|NCT01512667|214349|P1|COMPLETED|Overall Study||13
89334|NCT01512667|214348|P2|STARTED|Overall Study||12
89335|NCT01512667|214349|P1|STARTED|Overall Study|1 participant enrolled prior to relevant amendment was not matched to a healthy control participant|13
89336|NCT01512368|214361|P1|NOT COMPLETED|Overall Study||3
89337|NCT01512368|214361|P1|COMPLETED|Overall Study||60
89338|NCT01512368|214361|P1|STARTED|Overall Study||63
89339|NCT01512251|214372|P2|NOT COMPLETED|Phase II||0
89340|NCT01512251|214373|P1|NOT COMPLETED|Phase II||0
89341|NCT01512251|214372|P2|COMPLETED|Phase II||0
89342|NCT01512251|214373|P1|COMPLETED|Phase II||0
89343|NCT01512251|214372|P2|STARTED|Phase II||0
89344|NCT01512251|214373|P1|STARTED|Phase II||0
89345|NCT01512251|214372|P2|NOT COMPLETED|Phase I, Dose 4||0
89346|NCT01512251|214373|P1|NOT COMPLETED|Phase I, Dose 4||0
89347|NCT01512251|214372|P2|COMPLETED|Phase I, Dose 4||0
89348|NCT01512251|214373|P1|COMPLETED|Phase I, Dose 4||0
89349|NCT01512251|214372|P2|STARTED|Phase I, Dose 4||0
89350|NCT01512251|214373|P1|STARTED|Phase I, Dose 4||0
89351|NCT01512251|214372|P2|NOT COMPLETED|Phase I, Dose 3||0
89352|NCT01512251|214373|P1|NOT COMPLETED|Phase I, Dose 3||0
89353|NCT01512251|214372|P2|COMPLETED|Phase I, Dose 3||0
89354|NCT01512251|214373|P1|COMPLETED|Phase I, Dose 3||0
89355|NCT01512251|214372|P2|STARTED|Phase I, Dose 3||0
89356|NCT01512251|214373|P1|STARTED|Phase I, Dose 3||0
89357|NCT01512251|214372|P2|NOT COMPLETED|Phase I, Dose 2||0
89358|NCT01512251|214373|P1|NOT COMPLETED|Phase I, Dose 2||0
89359|NCT01512251|214372|P2|COMPLETED|Phase I, Dose 2||0
89360|NCT01512251|214373|P1|COMPLETED|Phase I, Dose 2||0
89361|NCT01512251|214372|P2|STARTED|Phase I, Dose 2||0
89362|NCT01512251|214373|P1|STARTED|Phase I, Dose 2||0
89363|NCT01512251|214372|P2|NOT COMPLETED|Phase I, Dose 1||5
89364|NCT01512251|214373|P1|NOT COMPLETED|Phase I, Dose 1||3
89365|NCT01512251|214372|P2|COMPLETED|Phase I, Dose 1||0
89366|NCT01512251|214373|P1|COMPLETED|Phase I, Dose 1||0
89367|NCT01512251|214372|P2|STARTED|Phase I, Dose 1||5
89368|NCT01512251|214373|P1|STARTED|Phase I, Dose 1||3
89369|NCT01512251|214372|P2|NOT COMPLETED|Dose Level -1||0
89370|NCT01512251|214373|P1|NOT COMPLETED|Dose Level -1||0
89371|NCT01512251|214372|P2|COMPLETED|Dose Level -1||5
89372|NCT01512251|214373|P1|COMPLETED|Dose Level -1||3
89373|NCT01512251|214372|P2|STARTED|Dose Level -1||5
89374|NCT01512251|214373|P1|STARTED|Dose Level -1||3
89375|NCT01512225|214394|P2|NOT COMPLETED|Overall Study||0
89376|NCT01512225|214395|P1|NOT COMPLETED|Overall Study||0
89377|NCT01512225|214394|P2|COMPLETED|Overall Study||45
89378|NCT01512225|214395|P1|COMPLETED|Overall Study||45
89379|NCT01512225|214394|P2|Provided Day 14 Volume|Overall Study||40
89380|NCT01512225|214395|P1|Provided Day 14 Volume|Overall Study||45
89381|NCT01512225|214394|P2|STARTED|Overall Study||45
89382|NCT01512225|214395|P1|STARTED|Overall Study||45
89383|NCT01512160|214419|P4|NOT COMPLETED|Overall Study||1
89384|NCT01512160|214420|P3|NOT COMPLETED|Overall Study||0
89385|NCT01512160|214421|P2|NOT COMPLETED|Overall Study||0
89386|NCT01512160|214422|P1|NOT COMPLETED|Overall Study||2
89387|NCT01512160|214419|P4|COMPLETED|Overall Study||22
89388|NCT01512160|214420|P3|COMPLETED|Overall Study||22
89389|NCT01512160|214421|P2|COMPLETED|Overall Study||23
89390|NCT01512160|214422|P1|COMPLETED|Overall Study||20
89391|NCT01512160|214419|P4|STARTED|Overall Study||23
89392|NCT01512160|214420|P3|STARTED|Overall Study||22
89393|NCT01512160|214421|P2|STARTED|Overall Study||23
89394|NCT01512160|214422|P1|STARTED|Overall Study||22
89395|NCT01512108|214514|P2|NOT COMPLETED|Overall Study||9
89396|NCT01512108|214515|P1|NOT COMPLETED|Overall Study||22
89397|NCT01512108|214514|P2|COMPLETED|Overall Study||111
89398|NCT01512108|214515|P1|COMPLETED|Overall Study||221
89399|NCT01512108|214514|P2|Exposed|Overall Study||120
89400|NCT01512108|214515|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
89401|NCT01512108|214514|P2|STARTED|Overall Study||120
89402|NCT01512108|214515|P1|STARTED|Overall Study||243
89403|NCT01511978|214529|P2|NOT COMPLETED|Overall Study||0
89404|NCT01511978|214530|P1|NOT COMPLETED|Overall Study||0
89405|NCT01511978|214529|P2|COMPLETED|Overall Study||18
89406|NCT01511978|214530|P1|COMPLETED|Overall Study||14
89407|NCT01511978|214529|P2|STARTED|Overall Study||18
89408|NCT01511978|214530|P1|STARTED|Overall Study||14
89409|NCT01511939|214541|P3|NOT COMPLETED|Overall Study||0
89410|NCT01511939|214542|P2|NOT COMPLETED|Overall Study||1
89411|NCT01511939|214543|P1|NOT COMPLETED|Overall Study||2
89412|NCT01511939|214541|P3|COMPLETED|Overall Study||8
89413|NCT01511939|214542|P2|COMPLETED|Overall Study||4
89414|NCT01511939|214543|P1|COMPLETED|Overall Study||7
89415|NCT01511939|214541|P3|STARTED|Overall Study||8
89416|NCT01511939|214542|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
89417|NCT01511939|214543|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
89418|NCT01511809|214562|P2|NOT COMPLETED|Overall Study||7
89419|NCT01511809|214563|P1|NOT COMPLETED|Overall Study||7
89420|NCT01511809|214562|P2|COMPLETED|Overall Study||52
89421|NCT01511809|214563|P1|COMPLETED|Overall Study||51
89422|NCT01511809|214562|P2|STARTED|Overall Study||59
89423|NCT01511809|214563|P1|STARTED|Overall Study||58
89424|NCT01511536|214572|P3|NOT COMPLETED|Phase 2||9
89425|NCT01511536|214573|P2|NOT COMPLETED|Phase 2||0
89426|NCT01511536|214574|P1|NOT COMPLETED|Phase 2||0
89427|NCT01511536|214572|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
89428|NCT01511536|214573|P2|COMPLETED|Phase 2||0
89429|NCT01511536|214574|P1|COMPLETED|Phase 2||0
89430|NCT01511536|214572|P3|STARTED|Phase 2||27
89431|NCT01511536|214573|P2|STARTED|Phase 2||0
89432|NCT01511536|214574|P1|STARTED|Phase 2||0
89433|NCT01511536|214572|P3|NOT COMPLETED|Phase 1||0
89434|NCT01511536|214573|P2|NOT COMPLETED|Phase 1||1
89435|NCT01511536|214574|P1|NOT COMPLETED|Phase 1||0
89436|NCT01511536|214572|P3|COMPLETED|Phase 1||0
89437|NCT01511536|214573|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
89438|NCT01511536|214574|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
89439|NCT01511536|214572|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
89440|NCT01511536|214573|P2|STARTED|Phase 1||7
89441|NCT01511536|214574|P1|STARTED|Phase 1||3
89442|NCT01511445|214596|P2|NOT COMPLETED|Overall Study||4
89443|NCT01511445|214597|P1|NOT COMPLETED|Overall Study||5
89444|NCT01511445|214596|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
89445|NCT01511445|214597|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
89446|NCT01511445|214596|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
89447|NCT01511445|214597|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
89448|NCT01511445|214596|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
89449|NCT01511445|214597|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
89450|NCT01511445|214596|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
89451|NCT01511445|214597|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
89452|NCT01511445|214596|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
89453|NCT01511445|214597|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
89454|NCT01511315|214605|P1|NOT COMPLETED|Overall Study||4
89455|NCT01511315|214605|P1|COMPLETED|Overall Study||32
89456|NCT01511315|214605|P1|STARTED|Overall Study||36
89457|NCT01511250|214625|P10|NOT COMPLETED|Overall Study||5
89458|NCT01511250|214626|P9|NOT COMPLETED|Overall Study||14
89459|NCT01511250|214627|P8|NOT COMPLETED|Overall Study||4
89460|NCT01511250|214628|P7|NOT COMPLETED|Overall Study||2
89461|NCT01511250|214629|P6|NOT COMPLETED|Overall Study||0
89462|NCT01511250|214630|P5|NOT COMPLETED|Overall Study||0
89463|NCT01511250|214631|P4|NOT COMPLETED|Overall Study||3
89464|NCT01511250|214632|P3|NOT COMPLETED|Overall Study||4
89465|NCT01511250|214633|P2|NOT COMPLETED|Overall Study||5
89466|NCT01511250|214634|P1|NOT COMPLETED|Overall Study||9
89467|NCT01511250|214625|P10|COMPLETED|Overall Study||48
89468|NCT01511250|214626|P9|COMPLETED|Overall Study||145
89469|NCT01511250|214627|P8|COMPLETED|Overall Study||9
89470|NCT01511250|214628|P7|COMPLETED|Overall Study||21
89471|NCT01511250|214629|P6|COMPLETED|Overall Study||17
89472|NCT01511250|214630|P5|COMPLETED|Overall Study||21
89473|NCT01511250|214631|P4|COMPLETED|Overall Study||11
89474|NCT01511250|214632|P3|COMPLETED|Overall Study||18
89475|NCT01511250|214633|P2|COMPLETED|Overall Study||9
89476|NCT01511250|214634|P1|COMPLETED|Overall Study||15
89477|NCT01511250|214625|P10|STARTED|Overall Study||53
89478|NCT01511250|214626|P9|STARTED|Overall Study||159
89479|NCT01511250|214627|P8|STARTED|Overall Study||13
89480|NCT01511250|214628|P7|STARTED|Overall Study||23
89481|NCT01511250|214629|P6|STARTED|Overall Study||17
89482|NCT01511250|214630|P5|STARTED|Overall Study||21
89483|NCT01511250|214631|P4|STARTED|Overall Study||14
89484|NCT01511250|214632|P3|STARTED|Overall Study||22
89485|NCT01511250|214633|P2|STARTED|Overall Study||14
89486|NCT01511250|214634|P1|STARTED|Overall Study||24
89487|NCT01511107|214782|P2|NOT COMPLETED|Overall Study||41
89488|NCT01511107|214783|P1|NOT COMPLETED|Overall Study||22
89489|NCT01511107|214782|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
89490|NCT01511107|214783|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
89491|NCT01511107|214782|P2|STARTED|Overall Study|Randomized to the treatment group.|260
89492|NCT01511107|214783|P1|STARTED|Overall Study|Randomized to the treatment group.|260
89493|NCT01511081|214833|P2|NOT COMPLETED|Overall Study||0
89494|NCT01511081|214834|P1|NOT COMPLETED|Overall Study||0
89495|NCT01511081|214833|P2|COMPLETED|Overall Study||9
89496|NCT01511081|214834|P1|COMPLETED|Overall Study||8
89497|NCT01511081|214833|P2|STARTED|Overall Study||9
89498|NCT01511081|214834|P1|STARTED|Overall Study||8
89499|NCT01511016|214844|P2|NOT COMPLETED|Overall Study||2
89500|NCT01511016|214845|P1|NOT COMPLETED|Overall Study||2
89501|NCT01511016|214844|P2|COMPLETED|Overall Study||7
89502|NCT01511016|214845|P1|COMPLETED|Overall Study||6
89503|NCT01511016|214844|P2|STARTED|Overall Study||9
89504|NCT01511016|214845|P1|STARTED|Overall Study||8
89505|NCT01510912|214861|P1|NOT COMPLETED|Overall Study||242
89506|NCT01510912|214861|P1|COMPLETED|Overall Study||360
89507|NCT01510912|214861|P1|STARTED|Overall Study||602
89508|NCT01510834|214867|P1|NOT COMPLETED|Overall Study||33
89509|NCT01510834|214867|P1|COMPLETED|Overall Study||57
89510|NCT01510834|214867|P1|STARTED|Overall Study||90
89511|NCT01510769|214877|P3|NOT COMPLETED|Overall Study||22
89512|NCT01510769|214878|P2|NOT COMPLETED|Overall Study||25
89513|NCT01510769|214879|P1|NOT COMPLETED|Overall Study||27
89514|NCT01510769|214877|P3|COMPLETED|Overall Study||87
89515|NCT01510769|214878|P2|COMPLETED|Overall Study||84
89516|NCT01510769|214879|P1|COMPLETED|Overall Study||79
89517|NCT01510769|214877|P3|STARTED|Overall Study||109
89518|NCT01510769|214878|P2|STARTED|Overall Study||109
89519|NCT01510769|214879|P1|STARTED|Overall Study||106
89520|NCT01510756|214896|P1|NOT COMPLETED|Overall Study||4
89521|NCT01510756|214896|P1|COMPLETED|Overall Study||0
89522|NCT01510756|214896|P1|STARTED|Overall Study||4
89523|NCT01510717|214904|P2|NOT COMPLETED|Overall Study||5
89524|NCT01510717|214905|P1|NOT COMPLETED|Overall Study||2
89525|NCT01510717|214904|P2|COMPLETED|Overall Study||160
89526|NCT01510717|214905|P1|COMPLETED|Overall Study||153
89527|NCT01510717|214904|P2|STARTED|Overall Study||165
89528|NCT01510717|214905|P1|STARTED|Overall Study||155
89529|NCT01510704|214933|P4|NOT COMPLETED|Overall Study||0
89530|NCT01510704|214934|P3|NOT COMPLETED|Overall Study||0
89531|NCT01510704|214935|P2|NOT COMPLETED|Overall Study||0
89532|NCT01510704|214936|P1|NOT COMPLETED|Overall Study||0
89533|NCT01510704|214933|P4|COMPLETED|Overall Study||53
89534|NCT01510704|214934|P3|COMPLETED|Overall Study||50
89535|NCT01510704|214935|P2|COMPLETED|Overall Study||58
89536|NCT01510704|214936|P1|COMPLETED|Overall Study||54
89537|NCT01510704|214933|P4|STARTED|Overall Study||53
89538|NCT01510704|214934|P3|STARTED|Overall Study||50
89539|NCT01510704|214935|P2|STARTED|Overall Study||58
89540|NCT01510704|214936|P1|STARTED|Overall Study||54
89541|NCT01510652|214948|P2|NOT COMPLETED|Overall Study||67
89542|NCT01510652|214949|P1|NOT COMPLETED|Overall Study||92
89543|NCT01510652|214948|P2|COMPLETED|Overall Study||288
89544|NCT01510652|214949|P1|COMPLETED|Overall Study||627
89545|NCT01510652|214948|P2|Baseline|Overall Study||348
89546|NCT01510652|214949|P1|Baseline|Overall Study||718
89547|NCT01510652|214948|P2|STARTED|Overall Study||355
89548|NCT01510652|214949|P1|STARTED|Overall Study||719
89549|NCT01510457|214961|P2|NOT COMPLETED|Overall Study||3
89550|NCT01510457|214962|P1|NOT COMPLETED|Overall Study||5
89551|NCT01510457|214961|P2|COMPLETED|Overall Study||26
89552|NCT01510457|214962|P1|COMPLETED|Overall Study||12
89553|NCT01510457|214961|P2|STARTED|Overall Study||29
89554|NCT01510457|214962|P1|STARTED|Overall Study||17
89555|NCT01510379|214982|P2|NOT COMPLETED|Overall Study||0
89556|NCT01510379|214983|P1|NOT COMPLETED|Overall Study||0
89557|NCT01510379|214982|P2|COMPLETED|Overall Study||51
89558|NCT01510379|214983|P1|COMPLETED|Overall Study||49
89559|NCT01510379|214982|P2|STARTED|Overall Study||51
89560|NCT01510379|214983|P1|STARTED|Overall Study||49
89561|NCT01510327|214991|P1|NOT COMPLETED|Overall Study||0
89562|NCT01510327|214991|P1|COMPLETED|Overall Study||22
89563|NCT01510327|214991|P1|STARTED|Overall Study||22
89564|NCT01510158|215025|P3|NOT COMPLETED|Overall Study||50
89565|NCT01510158|215026|P2|NOT COMPLETED|Overall Study||53
89566|NCT01510158|215027|P1|NOT COMPLETED|Overall Study||51
89567|NCT01510158|215025|P3|COMPLETED|Overall Study||152
89568|NCT01510158|215026|P2|COMPLETED|Overall Study||150
89569|NCT01510158|215027|P1|COMPLETED|Overall Study||151
89570|NCT01510158|215025|P3|STARTED|Overall Study||202
89571|NCT01510158|215026|P2|STARTED|Overall Study||203
89572|NCT01510158|215027|P1|STARTED|Overall Study||202
89573|NCT01510145|215041|P1|NOT COMPLETED|Overall Study||18
89574|NCT01510145|215041|P1|COMPLETED|Overall Study||173
89575|NCT01510145|215041|P1|STARTED|Overall Study||191
89576|NCT01509807|215048|P2|NOT COMPLETED|Overall Study||1
89577|NCT01509807|215049|P1|NOT COMPLETED|Overall Study||1
89578|NCT01509807|215048|P2|COMPLETED|Overall Study||16
89579|NCT01509807|215049|P1|COMPLETED|Overall Study||15
89580|NCT01509807|215048|P2|STARTED|Overall Study||17
89581|NCT01509807|215049|P1|STARTED|Overall Study||16
89582|NCT01509664|215075|P2|NOT COMPLETED|Overall Study||21
89583|NCT01509664|215076|P1|NOT COMPLETED|Overall Study||15
89584|NCT01509664|215075|P2|COMPLETED|Overall Study||28
89585|NCT01509664|215076|P1|COMPLETED|Overall Study||34
89586|NCT01509664|215075|P2|T3 Follow-up|Overall Study||33
89587|NCT01509664|215076|P1|T3 Follow-up|Overall Study||40
89588|NCT01509664|215075|P2|T2 Follow-up|Overall Study||38
89589|NCT01509664|215076|P1|T2 Follow-up|Overall Study||45
89590|NCT01509664|215075|P2|STARTED|Overall Study||49
89591|NCT01509664|215076|P1|STARTED|Overall Study||49
89592|NCT01509638|215084|P2|NOT COMPLETED|Overall Study||2
89593|NCT01509638|215085|P1|NOT COMPLETED|Overall Study||3
89594|NCT01509638|215084|P2|COMPLETED|Overall Study||24
89595|NCT01509638|215085|P1|COMPLETED|Overall Study||20
89596|NCT01509638|215084|P2|STARTED|Overall Study||26
89597|NCT01509638|215085|P1|STARTED|Overall Study||23
89598|NCT01509625|215109|P1|NOT COMPLETED|Overall Study||9
89599|NCT01509625|215109|P1|COMPLETED|Overall Study||263
89600|NCT01509625|215109|P1|STARTED|Overall Study||272
89601|NCT01509586|215127|P2|NOT COMPLETED|Overall Study||0
89602|NCT01509586|215128|P1|NOT COMPLETED|Overall Study||0
89603|NCT01509586|215127|P2|COMPLETED|Overall Study|final intent to treat sample|610
89604|NCT01509586|215128|P1|COMPLETED|Overall Study|final intent to treat sample|626
89605|NCT01509586|215127|P2|Week 58 (Month 12)|Overall Study||499
89606|NCT01509586|215128|P1|Week 58 (Month 12)|Overall Study||492
89607|NCT01509586|215127|P2|Week 46|Overall Study||494
89608|NCT01509586|215128|P1|Week 46|Overall Study||483
89609|NCT01509586|215127|P2|Week 32 (Month 6)|Overall Study||523
89610|NCT01509586|215128|P1|Week 32 (Month 6)|Overall Study||504
89611|NCT01509586|215127|P2|Week18|Overall Study||555
89612|NCT01509586|215128|P1|Week18|Overall Study||529
89613|NCT01509586|215127|P2|Week 14|Overall Study||566
89614|NCT01509586|215128|P1|Week 14|Overall Study||528
89615|NCT01509586|215127|P2|Week 10|Overall Study||574
89616|NCT01509586|215128|P1|Week 10|Overall Study||537
89617|NCT01509586|215127|P2|Week 6|Overall Study||585
89618|NCT01509586|215128|P1|Week 6|Overall Study||551
89619|NCT01509586|215127|P2|Week 3|Overall Study||585
89620|NCT01509586|215128|P1|Week 3|Overall Study||574
89621|NCT01509586|215127|P2|STARTED|Overall Study|Week 0|610
89622|NCT01509586|215128|P1|STARTED|Overall Study|Week 0|626
89623|NCT01509183|215136|P2|NOT COMPLETED|Overall Study||111
89624|NCT01509183|215137|P1|NOT COMPLETED|Overall Study||109
89625|NCT01509183|215136|P2|COMPLETED|Overall Study||134
89626|NCT01509183|215137|P1|COMPLETED|Overall Study||141
89627|NCT01509183|215136|P2|STARTED|Overall Study||245
89628|NCT01509183|215137|P1|STARTED|Overall Study||250
89629|NCT01509105|215145|P1|NOT COMPLETED|Overall Study||0
89630|NCT01509105|215145|P1|COMPLETED|Overall Study||649
89631|NCT01509105|215145|P1|STARTED|Overall Study||649
89632|NCT01509079|215162|P2|NOT COMPLETED|Overall Study||3
89633|NCT01509079|215163|P1|NOT COMPLETED|Overall Study||0
89634|NCT01509079|215162|P2|COMPLETED|Overall Study||56
89635|NCT01509079|215163|P1|COMPLETED|Overall Study||57
89636|NCT01509079|215162|P2|STARTED|Overall Study||59
89637|NCT01509079|215163|P1|STARTED|Overall Study||57
89638|NCT01509053|215179|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
89639|NCT01509053|215179|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
89640|NCT01509053|215179|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
89641|NCT01509053|215179|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
89642|NCT01509053|215179|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
89643|NCT01509053|215179|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
89644|NCT01509053|215179|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
89645|NCT01509053|215179|P1|COMPLETED|Oral Aripirazole (Phase A)||8
89646|NCT01509053|215179|P1|STARTED|Oral Aripirazole (Phase A)||19
89647|NCT01509040|215193|P3|NOT COMPLETED|Overall Study||0
89648|NCT01509040|215194|P2|NOT COMPLETED|Overall Study||1
89649|NCT01509040|215195|P1|NOT COMPLETED|Overall Study||0
89650|NCT01509040|215193|P3|COMPLETED|Overall Study||0
89651|NCT01509040|215194|P2|COMPLETED|Overall Study||1
89652|NCT01509040|215195|P1|COMPLETED|Overall Study||0
89653|NCT01509040|215193|P3|STARTED|Overall Study||0
89654|NCT01509040|215194|P2|STARTED|Overall Study||2
89655|NCT01509040|215195|P1|STARTED|Overall Study||0
89656|NCT01508936|215241|P2|NOT COMPLETED|Overall Study||79
89657|NCT01508936|215242|P1|NOT COMPLETED|Overall Study||23
89658|NCT01508936|215241|P2|COMPLETED|Overall Study||330
89659|NCT01508936|215242|P1|COMPLETED|Overall Study||79
89660|NCT01508936|215241|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
89661|NCT01508936|215242|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
89662|NCT01508936|215241|P2|Full Analysis Set|Overall Study||395
89663|NCT01508936|215242|P1|Full Analysis Set|Overall Study||97
89664|NCT01508936|215241|P2|Safety Analysis Set|Overall Study||395
89665|NCT01508936|215242|P1|Safety Analysis Set|Overall Study||97
89666|NCT01508936|215241|P2|Randomized, Not Treated|Overall Study||3
89667|NCT01508936|215242|P1|Randomized, Not Treated|Overall Study||1
89668|NCT01508936|215241|P2|Randomized|Overall Study||398
89669|NCT01508936|215242|P1|Randomized|Overall Study||98
89670|NCT01508936|215241|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
89671|NCT01508936|215242|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
89672|NCT01508936|215241|P2|STARTED|Overall Study||409
89673|NCT01508936|215242|P1|STARTED|Overall Study||102
89674|NCT01508910|215281|P4|NOT COMPLETED|Treatment||3
89675|NCT01508910|215282|P3|NOT COMPLETED|Treatment||10
89676|NCT01508910|215283|P2|NOT COMPLETED|Treatment||4
89677|NCT01508910|215284|P1|NOT COMPLETED|Treatment||2
89678|NCT01508910|215281|P4|COMPLETED|Treatment||3
89679|NCT01508910|215282|P3|COMPLETED|Treatment||18
89680|NCT01508910|215283|P2|COMPLETED|Treatment||24
89681|NCT01508910|215284|P1|COMPLETED|Treatment||48
89682|NCT01508910|215281|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
89683|NCT01508910|215282|P3|STARTED|Treatment||28
89684|NCT01508910|215283|P2|STARTED|Treatment||28
89685|NCT01508910|215284|P1|STARTED|Treatment||50
89686|NCT01508910|215281|P4|NOT COMPLETED|Randomization||0
89687|NCT01508910|215282|P3|NOT COMPLETED|Randomization||0
89688|NCT01508910|215283|P2|NOT COMPLETED|Randomization||0
89689|NCT01508910|215284|P1|NOT COMPLETED|Randomization||0
89690|NCT01508910|215281|P4|COMPLETED|Randomization||0
89691|NCT01508910|215282|P3|COMPLETED|Randomization||28
89692|NCT01508910|215283|P2|COMPLETED|Randomization||27
89693|NCT01508910|215284|P1|COMPLETED|Randomization||57
89694|NCT01508910|215281|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
89695|NCT01508910|215282|P3|STARTED|Randomization||28
89696|NCT01508910|215283|P2|STARTED|Randomization||27
89697|NCT01508910|215284|P1|STARTED|Randomization||57
89698|NCT01508832|215308|P2|NOT COMPLETED|Overall Study||0
89699|NCT01508832|215309|P1|NOT COMPLETED|Overall Study||0
89700|NCT01508832|215308|P2|COMPLETED|Overall Study||6
89701|NCT01508832|215309|P1|COMPLETED|Overall Study||6
89702|NCT01508832|215308|P2|STARTED|Overall Study||6
89703|NCT01508832|215309|P1|STARTED|Overall Study||6
89704|NCT01508702|215317|P2|NOT COMPLETED|Overall Study||13
89705|NCT01508702|215318|P1|NOT COMPLETED|Overall Study||23
89706|NCT01508702|215317|P2|COMPLETED|Overall Study||94
89707|NCT01508702|215318|P1|COMPLETED|Overall Study||84
89708|NCT01508702|215317|P2|STARTED|Overall Study||107
89709|NCT01508702|215318|P1|STARTED|Overall Study||107
89710|NCT01508676|215326|P2|NOT COMPLETED|Phase II (2 Weeks)||1
89711|NCT01508676|215327|P1|NOT COMPLETED|Phase II (2 Weeks)||1
89712|NCT01508676|215326|P2|COMPLETED|Phase II (2 Weeks)||13
89713|NCT01508676|215327|P1|COMPLETED|Phase II (2 Weeks)||15
89714|NCT01508676|215326|P2|STARTED|Phase II (2 Weeks)||14
89715|NCT01508676|215327|P1|STARTED|Phase II (2 Weeks)||16
89716|NCT01508676|215326|P2|NOT COMPLETED|Washout Period (1 Week)||0
89717|NCT01508676|215327|P1|NOT COMPLETED|Washout Period (1 Week)||0
89718|NCT01508676|215326|P2|COMPLETED|Washout Period (1 Week)||14
89719|NCT01508676|215327|P1|COMPLETED|Washout Period (1 Week)||16
89720|NCT01508676|215326|P2|STARTED|Washout Period (1 Week)||14
89721|NCT01508676|215327|P1|STARTED|Washout Period (1 Week)||16
89722|NCT01508676|215326|P2|NOT COMPLETED|Phase I (2 Weeks)||3
89723|NCT01508676|215327|P1|NOT COMPLETED|Phase I (2 Weeks)||2
89724|NCT01508676|215326|P2|COMPLETED|Phase I (2 Weeks)||14
89725|NCT01508676|215327|P1|COMPLETED|Phase I (2 Weeks)||16
89726|NCT01508676|215326|P2|STARTED|Phase I (2 Weeks)||17
89727|NCT01508676|215327|P1|STARTED|Phase I (2 Weeks)||18
89728|NCT01508455|215337|P1|NOT COMPLETED|Overall Study||0
89729|NCT01508455|215337|P1|COMPLETED|Overall Study||6
89730|NCT01508455|215337|P1|STARTED|Overall Study||6
89731|NCT01508325|215348|P2|NOT COMPLETED|Overall Study||21
89732|NCT01508325|215349|P1|NOT COMPLETED|Overall Study||18
89733|NCT01508325|215348|P2|COMPLETED|Overall Study||72
89734|NCT01508325|215349|P1|COMPLETED|Overall Study||75
89735|NCT01508325|215348|P2|STARTED|Overall Study||93
89736|NCT01508325|215349|P1|STARTED|Overall Study||93
89737|NCT01508169|215379|P2|NOT COMPLETED|Overall Study||2
89738|NCT01508169|215380|P1|NOT COMPLETED|Overall Study||3
89739|NCT01508169|215379|P2|COMPLETED|Overall Study||45
89740|NCT01508169|215380|P1|COMPLETED|Overall Study||44
89741|NCT01508169|215379|P2|STARTED|Overall Study||47
89742|NCT01508169|215380|P1|STARTED|Overall Study||47
89743|NCT01508130|215394|P2|NOT COMPLETED|Overall Study||69
89744|NCT01508130|215395|P1|NOT COMPLETED|Overall Study||227
89745|NCT01508130|215394|P2|COMPLETED|Overall Study||73
89746|NCT01508130|215395|P1|COMPLETED|Overall Study||266
89747|NCT01508130|215394|P2|mTRT|Overall Study||142
89748|NCT01508130|215395|P1|mTRT|Overall Study||493
89749|NCT01508130|215394|P2|STARTED|Overall Study||142
89750|NCT01508130|215395|P1|STARTED|Overall Study||493
89751|NCT01508117|215437|P1|NOT COMPLETED|Overall Study||0
89752|NCT01508117|215437|P1|COMPLETED|Overall Study||1
89753|NCT01508117|215437|P1|STARTED|Overall Study||1
89754|NCT01508052|215443|P2|NOT COMPLETED|Overall Study||0
89755|NCT01508052|215444|P1|NOT COMPLETED|Overall Study||0
89756|NCT01508052|215443|P2|COMPLETED|Overall Study||20
89757|NCT01508052|215444|P1|COMPLETED|Overall Study||20
89758|NCT01508052|215443|P2|STARTED|Overall Study||20
89759|NCT01508052|215444|P1|STARTED|Overall Study||20
89760|NCT01508013|215452|P2|NOT COMPLETED|Overall Study||23
89761|NCT01508013|215453|P1|NOT COMPLETED|Overall Study||32
89762|NCT01508013|215452|P2|COMPLETED|Overall Study||206
89763|NCT01508013|215453|P1|COMPLETED|Overall Study||182
89764|NCT01508013|215452|P2|STARTED|Overall Study||229
89765|NCT01508013|215453|P1|STARTED|Overall Study||214
89766|NCT01507896|215463|P1|NOT COMPLETED|Overall Study||2
89767|NCT01507896|215463|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
89768|NCT01507896|215463|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
89769|NCT01507831|215506|P2|NOT COMPLETED|Overall Study||440
89770|NCT01507831|215507|P1|NOT COMPLETED|Overall Study||193
89771|NCT01507831|215506|P2|COMPLETED|Overall Study||1113
89772|NCT01507831|215507|P1|COMPLETED|Overall Study||595
89773|NCT01507831|215506|P2|Treated|Overall Study||1550
89774|NCT01507831|215507|P1|Treated|Overall Study||788
89775|NCT01507831|215506|P2|STARTED|Overall Study|Randomized|1553
89776|NCT01507831|215507|P1|STARTED|Overall Study|Randomized|788
89777|NCT01507662|215577|P2|NOT COMPLETED|Overall Study||831
89778|NCT01507662|215578|P1|NOT COMPLETED|Overall Study||816
89779|NCT01507662|215577|P2|COMPLETED|Overall Study||3020
89780|NCT01507662|215578|P1|COMPLETED|Overall Study||3082
89781|NCT01507662|215577|P2|STARTED|Overall Study||3851
89782|NCT01507662|215578|P1|STARTED|Overall Study||3898
89783|NCT01507493|215586|P2|NOT COMPLETED|Overall Study||0
89784|NCT01507493|215587|P1|NOT COMPLETED|Overall Study||0
89785|NCT01507493|215586|P2|COMPLETED|Overall Study||178
89786|NCT01507493|215587|P1|COMPLETED|Overall Study||22
89787|NCT01507493|215586|P2|STARTED|Overall Study||178
89788|NCT01507493|215587|P1|STARTED|Overall Study||22
89789|NCT01507246|215603|P2|NOT COMPLETED|Overall Study||1
89790|NCT01507246|215604|P1|NOT COMPLETED|Overall Study||2
89791|NCT01507246|215603|P2|COMPLETED|Overall Study||21
89792|NCT01507246|215604|P1|COMPLETED|Overall Study||18
89793|NCT01507246|215603|P2|STARTED|Overall Study||22
89794|NCT01507246|215604|P1|STARTED|Overall Study||20
89795|NCT01507233|215618|P2|NOT COMPLETED|Overall Study||0
89796|NCT01507233|215619|P1|NOT COMPLETED|Overall Study||0
89797|NCT01507233|215618|P2|COMPLETED|Overall Study||0
89798|NCT01507233|215619|P1|COMPLETED|Overall Study||5
89799|NCT01507233|215618|P2|STARTED|Overall Study||0
89800|NCT01507233|215619|P1|STARTED|Overall Study||5
89801|NCT01507220|215631|P2|NOT COMPLETED|Overall Study||0
89802|NCT01507220|215632|P1|NOT COMPLETED|Overall Study||0
89803|NCT01507220|215631|P2|COMPLETED|Overall Study||0
89804|NCT01507220|215632|P1|COMPLETED|Overall Study||2
89805|NCT01507220|215631|P2|STARTED|Overall Study||0
89806|NCT01507220|215632|P1|STARTED|Overall Study||2
89807|NCT01507181|215646|P2|NOT COMPLETED|Overall Study||0
89808|NCT01507181|215647|P1|NOT COMPLETED|Overall Study||0
89809|NCT01507181|215646|P2|COMPLETED|Overall Study||12
89810|NCT01507181|215647|P1|COMPLETED|Overall Study||12
89811|NCT01507181|215646|P2|STARTED|Overall Study||12
89812|NCT01507181|215647|P1|STARTED|Overall Study||12
89813|NCT01507155|215667|P2|NOT COMPLETED|Overall Study||0
89814|NCT01507155|215668|P1|NOT COMPLETED|Overall Study||0
89815|NCT01507155|215667|P2|COMPLETED|Overall Study||60
89816|NCT01507155|215668|P1|COMPLETED|Overall Study||625
89817|NCT01507155|215667|P2|STARTED|Overall Study||60
89818|NCT01507155|215668|P1|STARTED|Overall Study||625
89819|NCT01507103|215677|P3|NOT COMPLETED|Overall Study||0
89820|NCT01507103|215678|P2|NOT COMPLETED|Overall Study||0
89821|NCT01507103|215679|P1|NOT COMPLETED|Overall Study||0
89822|NCT01507103|215677|P3|COMPLETED|Overall Study||42
89823|NCT01507103|215678|P2|COMPLETED|Overall Study||41
89824|NCT01507103|215679|P1|COMPLETED|Overall Study||41
89825|NCT01507103|215677|P3|STARTED|Overall Study||42
89826|NCT01507103|215678|P2|STARTED|Overall Study||41
89827|NCT01507103|215679|P1|STARTED|Overall Study||41
89828|NCT01507090|215702|P1|NOT COMPLETED|Overall Study||18
89829|NCT01507090|215702|P1|COMPLETED|Overall Study||624
89830|NCT01507090|215702|P1|STARTED|Overall Study||642
89831|NCT01507051|215741|P4|NOT COMPLETED|Overall Study||7
89832|NCT01507051|215742|P3|NOT COMPLETED|Overall Study||1
89833|NCT01507051|215743|P2|NOT COMPLETED|Overall Study||3
89834|NCT01507051|215744|P1|NOT COMPLETED|Overall Study||2
89835|NCT01507051|215741|P4|COMPLETED|Overall Study||0
89836|NCT01507051|215742|P3|COMPLETED|Overall Study||28
89837|NCT01507051|215743|P2|COMPLETED|Overall Study||28
89838|NCT01507051|215744|P1|COMPLETED|Overall Study||27
89839|NCT01507051|215741|P4|Received Placebo or Rivaroxaban|Overall Study||0
89840|NCT01507051|215742|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
89841|NCT01507051|215743|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
89842|NCT01507051|215744|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
89843|NCT01507051|215741|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
89844|NCT01507051|215742|P3|Warfarin run-in Phase|Overall Study||0
89845|NCT01507051|215743|P2|Warfarin run-in Phase|Overall Study||28
89846|NCT01507051|215744|P1|Warfarin run-in Phase|Overall Study||28
89847|NCT01507051|215741|P4|STARTED|Overall Study||7
89848|NCT01507051|215742|P3|STARTED|Overall Study||29
89849|NCT01507051|215743|P2|STARTED|Overall Study||31
89850|NCT01507051|215744|P1|STARTED|Overall Study||29
89851|NCT01506960|215862|P1|NOT COMPLETED|Overall Study||47
89852|NCT01506960|215862|P1|COMPLETED|Overall Study||17
89853|NCT01506960|215862|P1|STARTED|Overall Study||64
89854|NCT01506947|215868|P1|NOT COMPLETED|Overall Study||16
89855|NCT01506947|215868|P1|COMPLETED|Overall Study||49
89856|NCT01506947|215868|P1|STARTED|Overall Study||65
89857|NCT01506908|215886|P2|NOT COMPLETED|Overall Study||0
89858|NCT01506908|215887|P1|NOT COMPLETED|Overall Study||1
89859|NCT01506908|215886|P2|COMPLETED|Overall Study||161
89860|NCT01506908|215887|P1|COMPLETED|Overall Study||161
89861|NCT01506908|215886|P2|STARTED|Overall Study||161
89862|NCT01506908|215887|P1|STARTED|Overall Study||162
89863|NCT01506882|215905|P2|NOT COMPLETED|Overall Study||7
89864|NCT01506882|215906|P1|NOT COMPLETED|Overall Study||22
89865|NCT01506882|215905|P2|COMPLETED|Overall Study||3
89866|NCT01506882|215906|P1|COMPLETED|Overall Study||39
89867|NCT01506882|215905|P2|STARTED|Overall Study||10
89868|NCT01506882|215906|P1|STARTED|Overall Study||61
89869|NCT01506726|215920|P2|NOT COMPLETED|Overall Study||2
89870|NCT01506726|215921|P1|NOT COMPLETED|Overall Study||1
89871|NCT01506726|215920|P2|COMPLETED|Overall Study||3
89872|NCT01506726|215921|P1|COMPLETED|Overall Study||5
89873|NCT01506726|215920|P2|STARTED|Overall Study||5
89874|NCT01506726|215921|P1|STARTED|Overall Study||6
89875|NCT01506596|215961|P1|NOT COMPLETED|Overall Study||1
89876|NCT01506596|215961|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
89877|NCT01506596|215961|P1|STARTED|Overall Study||42
89878|NCT01506479|215972|P3|NOT COMPLETED|Overall Study||3
89879|NCT01506479|215973|P2|NOT COMPLETED|Overall Study||5
89880|NCT01506479|215974|P1|NOT COMPLETED|Overall Study||3
89881|NCT01506479|215972|P3|COMPLETED|Overall Study||42
89882|NCT01506479|215973|P2|COMPLETED|Overall Study||38
89883|NCT01506479|215974|P1|COMPLETED|Overall Study||37
89884|NCT01506479|215972|P3|STARTED|Overall Study||45
89885|NCT01506479|215973|P2|STARTED|Overall Study||43
89886|NCT01506479|215974|P1|STARTED|Overall Study||40
89887|NCT01506362|215986|P1|NOT COMPLETED|Overall Study||6
89888|NCT01506362|215986|P1|COMPLETED|Overall Study||16
89889|NCT01506362|215986|P1|STARTED|Overall Study||22
89890|NCT01506323|215992|P2|NOT COMPLETED|Overall Study||13
89891|NCT01506323|215993|P1|NOT COMPLETED|Overall Study||24
89892|NCT01506323|215992|P2|COMPLETED|Overall Study||71
89893|NCT01506323|215993|P1|COMPLETED|Overall Study||65
89894|NCT01506323|215992|P2|Post-treatment Completed CAPS|Overall Study||72
89895|NCT01506323|215993|P1|Post-treatment Completed CAPS|Overall Study||68
89896|NCT01506323|215992|P2|Post-treatment Completers|Overall Study||72
89897|NCT01506323|215993|P1|Post-treatment Completers|Overall Study||69
89898|NCT01506323|215992|P2|STARTED|Overall Study||84
89899|NCT01506323|215993|P1|STARTED|Overall Study||89
89900|NCT01506193|216022|P3|NOT COMPLETED|Overall Study||14
89901|NCT01506193|216023|P2|NOT COMPLETED|Overall Study||4
89902|NCT01506193|216024|P1|NOT COMPLETED|Overall Study||14
89903|NCT01506193|216022|P3|COMPLETED|Overall Study||168
89904|NCT01506193|216023|P2|COMPLETED|Overall Study||179
89905|NCT01506193|216024|P1|COMPLETED|Overall Study||337
89906|NCT01506193|216022|P3|STARTED|Overall Study||182
89907|NCT01506193|216023|P2|STARTED|Overall Study||183
89908|NCT01506193|216024|P1|STARTED|Overall Study||351
89909|NCT01505881|216057|P2|NOT COMPLETED|Overall Study||1
89910|NCT01505881|216058|P1|NOT COMPLETED|Overall Study||4
89911|NCT01505881|216057|P2|COMPLETED|Overall Study||58
89912|NCT01505881|216058|P1|COMPLETED|Overall Study||95
89913|NCT01505881|216057|P2|STARTED|Overall Study||59
89914|NCT01505881|216058|P1|STARTED|Overall Study||99
89915|NCT01505764|216072|P2|NOT COMPLETED|Overall Study||1
89916|NCT01505764|216073|P1|NOT COMPLETED|Overall Study||3
89917|NCT01505764|216072|P2|COMPLETED|Overall Study||2
89918|NCT01505764|216073|P1|COMPLETED|Overall Study||3
89919|NCT01505764|216072|P2|STARTED|Overall Study||3
89920|NCT01505764|216073|P1|STARTED|Overall Study||6
89921|NCT01505673|216081|P2|NOT COMPLETED|Overall Study||2
89922|NCT01505673|216082|P1|NOT COMPLETED|Overall Study||3
89923|NCT01505673|216081|P2|COMPLETED|Overall Study||34
89924|NCT01505673|216082|P1|COMPLETED|Overall Study||32
89925|NCT01505673|216081|P2|STARTED|Overall Study||36
89926|NCT01505673|216082|P1|STARTED|Overall Study||35
89927|NCT01505647|216142|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
89928|NCT01505647|216143|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
89929|NCT01505647|216142|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
89930|NCT01505647|216143|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
89931|NCT01505647|216142|P2|STARTED|Day 43 Through Day 182 Follow-up||166
89932|NCT01505647|216143|P1|STARTED|Day 43 Through Day 182 Follow-up||329
89933|NCT01505647|216142|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
89934|NCT01505647|216143|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
89935|NCT01505647|216142|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
89936|NCT01505647|216143|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
89937|NCT01505647|216142|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
89938|NCT01505647|216143|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
89939|NCT01505647|216142|P2|STARTED|Day 1 Through Day 42 Follow-up||166
89940|NCT01505647|216143|P1|STARTED|Day 1 Through Day 42 Follow-up||332
89941|NCT01505608|216159|P2|NOT COMPLETED|Phase II||2
89942|NCT01505608|216160|P1|NOT COMPLETED|Phase II||2
89943|NCT01505608|216159|P2|COMPLETED|Phase II||2
89944|NCT01505608|216160|P1|COMPLETED|Phase II||0
89945|NCT01505608|216159|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
89946|NCT01505608|216160|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
89947|NCT01505608|216159|P2|NOT COMPLETED|Phase I||6
89948|NCT01505608|216160|P1|NOT COMPLETED|Phase I||0
89949|NCT01505608|216159|P2|COMPLETED|Phase I||2
89950|NCT01505608|216160|P1|COMPLETED|Phase I||0
89951|NCT01505608|216159|P2|STARTED|Phase I||8
89952|NCT01505608|216160|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
89953|NCT01505465|216178|P2|NOT COMPLETED|Overall Study||7
89954|NCT01505465|216179|P1|NOT COMPLETED|Overall Study||6
89955|NCT01505465|216178|P2|COMPLETED|Overall Study||18
89956|NCT01505465|216179|P1|COMPLETED|Overall Study||19
89957|NCT01505465|216178|P2|STARTED|Overall Study||25
89958|NCT01505465|216179|P1|STARTED|Overall Study||25
89959|NCT01505387|216195|P2|NOT COMPLETED|Overall Study||1
89960|NCT01505387|216196|P1|NOT COMPLETED|Overall Study||2
89961|NCT01505387|216195|P2|COMPLETED|Overall Study||24
89962|NCT01505387|216196|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
89963|NCT01505387|216195|P2|Treated|Overall Study||24
89964|NCT01505387|216196|P1|Treated|Overall Study||24
89965|NCT01505387|216195|P2|STARTED|Overall Study||25
89966|NCT01505387|216196|P1|STARTED|Overall Study||25
89967|NCT01505374|216202|P2|NOT COMPLETED|Overall Study||0
89968|NCT01505374|216203|P1|NOT COMPLETED|Overall Study||1
89969|NCT01505374|216202|P2|COMPLETED|Overall Study||30
89970|NCT01505374|216203|P1|COMPLETED|Overall Study||29
89971|NCT01505374|216202|P2|STARTED|Overall Study||30
89972|NCT01505374|216203|P1|STARTED|Overall Study||30
89973|NCT01505166|216220|P3|NOT COMPLETED|Overall Study||0
89974|NCT01505166|216221|P2|NOT COMPLETED|Overall Study||0
89975|NCT01505166|216222|P1|NOT COMPLETED|Overall Study||0
89976|NCT01505166|216220|P3|COMPLETED|Overall Study||0
89977|NCT01505166|216221|P2|COMPLETED|Overall Study||0
89978|NCT01505166|216222|P1|COMPLETED|Overall Study||3
89979|NCT01505166|216220|P3|STARTED|Overall Study||0
89980|NCT01505166|216221|P2|STARTED|Overall Study||0
89981|NCT01505166|216222|P1|STARTED|Overall Study||3
89982|NCT01505114|216249|P4|NOT COMPLETED|Overall Study||23
89983|NCT01505114|216250|P3|NOT COMPLETED|Overall Study||18
89984|NCT01505114|216251|P2|NOT COMPLETED|Overall Study||13
89985|NCT01505114|216252|P1|NOT COMPLETED|Overall Study||25
89986|NCT01505114|216249|P4|COMPLETED|Overall Study||128
89987|NCT01505114|216250|P3|COMPLETED|Overall Study||129
89988|NCT01505114|216251|P2|COMPLETED|Overall Study||135
89989|NCT01505114|216252|P1|COMPLETED|Overall Study||123
89990|NCT01505114|216249|P4|STARTED|Overall Study||151
89991|NCT01505114|216250|P3|STARTED|Overall Study||147
89992|NCT01505114|216251|P2|STARTED|Overall Study||148
89993|NCT01505114|216252|P1|STARTED|Overall Study||148
89994|NCT01504997|216262|P1|NOT COMPLETED|Overall Study||0
89995|NCT01504997|216262|P1|COMPLETED|Overall Study||18
89996|NCT01504997|216262|P1|STARTED|Overall Study||18
89997|NCT01504971|216266|P1|NOT COMPLETED|Overall Study||13
89998|NCT01504971|216266|P1|COMPLETED|Overall Study||82
89999|NCT01504971|216266|P1|STARTED|Overall Study||95
90000|NCT01504958|216277|P3|NOT COMPLETED|Overall Study||0
90001|NCT01504958|216278|P2|NOT COMPLETED|Overall Study||0
90002|NCT01504958|216279|P1|NOT COMPLETED|Overall Study||0
90003|NCT01504958|216277|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
90004|NCT01504958|216278|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
90005|NCT01504958|216279|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
90006|NCT01504958|216277|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
90007|NCT01504958|216278|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
90008|NCT01504958|216279|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
90009|NCT01504867|216295|P2|NOT COMPLETED|Overall Study||3
90010|NCT01504867|216296|P1|NOT COMPLETED|Overall Study||7
90011|NCT01504867|216295|P2|COMPLETED|Overall Study||195
90012|NCT01504867|216296|P1|COMPLETED|Overall Study||195
90013|NCT01504867|216295|P2|STARTED|Overall Study||198
90014|NCT01504867|216296|P1|STARTED|Overall Study||202
90015|NCT01504854|216316|P2|NOT COMPLETED|Overall Study||7
90016|NCT01504854|216317|P1|NOT COMPLETED|Overall Study||8
90017|NCT01504854|216316|P2|COMPLETED|Overall Study||48
90018|NCT01504854|216317|P1|COMPLETED|Overall Study||56
90019|NCT01504854|216316|P2|STARTED|Overall Study||55
90020|NCT01504854|216317|P1|STARTED|Overall Study||64
90021|NCT01504204|216333|P2|NOT COMPLETED|Overall Study||1
90022|NCT01504204|216334|P1|NOT COMPLETED|Overall Study||1
90023|NCT01504204|216333|P2|COMPLETED|Overall Study||9
90024|NCT01504204|216334|P1|COMPLETED|Overall Study||9
90025|NCT01504204|216333|P2|STARTED|Overall Study||10
90026|NCT01504204|216334|P1|STARTED|Overall Study||10
90027|NCT01503749|216347|P3|NOT COMPLETED|Overall Study||0
90028|NCT01503749|216348|P2|NOT COMPLETED|Overall Study||0
90029|NCT01503749|216349|P1|NOT COMPLETED|Overall Study||0
90030|NCT01503749|216347|P3|COMPLETED|Overall Study||3
90031|NCT01503749|216348|P2|COMPLETED|Overall Study||3
90032|NCT01503749|216349|P1|COMPLETED|Overall Study||3
90033|NCT01503749|216347|P3|STARTED|Overall Study||3
90034|NCT01503749|216348|P2|STARTED|Overall Study||3
90035|NCT01503749|216349|P1|STARTED|Overall Study||3
90036|NCT01503164|216362|P2|NOT COMPLETED|Overall Study||1
90037|NCT01503164|216363|P1|NOT COMPLETED|Overall Study||2
90038|NCT01503164|216362|P2|COMPLETED|Overall Study||55
90039|NCT01503164|216363|P1|COMPLETED|Overall Study||53
90040|NCT01503164|216362|P2|STARTED|Overall Study||56
90041|NCT01503164|216363|P1|STARTED|Overall Study||55
90042|NCT01503021|216393|P2|NOT COMPLETED|Overall Study||26
90043|NCT01503021|216394|P1|NOT COMPLETED|Overall Study||27
90044|NCT01503021|216393|P2|COMPLETED|Overall Study||332
90045|NCT01503021|216394|P1|COMPLETED|Overall Study||333
90046|NCT01503021|216393|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
90047|NCT01503021|216394|P1|Completed Treatment|Overall Study||333
90048|NCT01503021|216393|P2|Dosed|Overall Study||352
90049|NCT01503021|216394|P1|Dosed|Overall Study||351
90050|NCT01503021|216393|P2|STARTED|Overall Study||358
90051|NCT01503021|216394|P1|STARTED|Overall Study||360
90052|NCT01502956|216443|P2|NOT COMPLETED|Overall Study||26
90053|NCT01502956|216444|P1|NOT COMPLETED|Overall Study||24
90054|NCT01502956|216443|P2|COMPLETED|Overall Study||168
90055|NCT01502956|216444|P1|COMPLETED|Overall Study||168
90056|NCT01502956|216443|P2|STARTED|Overall Study||194
90057|NCT01502956|216444|P1|STARTED|Overall Study||192
90058|NCT01502787|216468|P2|NOT COMPLETED|Overall Study||0
90059|NCT01502787|216469|P1|NOT COMPLETED|Overall Study||0
90060|NCT01502787|216468|P2|COMPLETED|Overall Study||10
90061|NCT01502787|216469|P1|COMPLETED|Overall Study||11
90062|NCT01502787|216468|P2|STARTED|Overall Study||10
90063|NCT01502787|216469|P1|STARTED|Overall Study||11
90064|NCT01502761|216479|P4|NOT COMPLETED|Overall Study||0
90065|NCT01502761|216480|P3|NOT COMPLETED|Overall Study||0
90066|NCT01502761|216481|P2|NOT COMPLETED|Overall Study||0
90067|NCT01502761|216482|P1|NOT COMPLETED|Overall Study||0
90068|NCT01502761|216479|P4|COMPLETED|Overall Study||0
90069|NCT01502761|216480|P3|COMPLETED|Overall Study||0
90070|NCT01502761|216481|P2|COMPLETED|Overall Study||0
90071|NCT01502761|216482|P1|COMPLETED|Overall Study||4
90072|NCT01502761|216479|P4|STARTED|Overall Study||0
90073|NCT01502761|216480|P3|STARTED|Overall Study||0
90074|NCT01502761|216481|P2|STARTED|Overall Study||0
90075|NCT01502761|216482|P1|STARTED|Overall Study||4
90076|NCT01502709|216498|P2|NOT COMPLETED|Overall Study||0
90077|NCT01502709|216499|P1|NOT COMPLETED|Overall Study||4
90078|NCT01502709|216498|P2|COMPLETED|Overall Study||0
90079|NCT01502709|216499|P1|COMPLETED|Overall Study||1
90080|NCT01502709|216498|P2|STARTED|Overall Study||0
90081|NCT01502709|216499|P1|STARTED|Overall Study||5
90082|NCT01502644|216512|P4|NOT COMPLETED|Assigned to NA Groups||8
90083|NCT01502644|216513|P3|NOT COMPLETED|Assigned to NA Groups||3
90084|NCT01502644|216514|P2|NOT COMPLETED|Assigned to NA Groups||6
90085|NCT01502644|216515|P1|NOT COMPLETED|Assigned to NA Groups||0
90086|NCT01502644|216512|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
90087|NCT01502644|216513|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
90088|NCT01502644|216514|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
90089|NCT01502644|216515|P1|COMPLETED|Assigned to NA Groups||0
90090|NCT01502644|216512|P4|STARTED|Assigned to NA Groups||32
90091|NCT01502644|216513|P3|STARTED|Assigned to NA Groups||10
90092|NCT01502644|216514|P2|STARTED|Assigned to NA Groups||30
90093|NCT01502644|216515|P1|STARTED|Assigned to NA Groups||0
90094|NCT01502644|216512|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
90095|NCT01502644|216513|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
90096|NCT01502644|216514|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
90097|NCT01502644|216515|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
90098|NCT01502644|216512|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
90099|NCT01502644|216513|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
90100|NCT01502644|216514|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
90101|NCT01502644|216515|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
90102|NCT01502644|216512|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
90103|NCT01502644|216513|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
90104|NCT01502644|216514|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
90105|NCT01502644|216515|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
90106|NCT01502423|216525|P2|NOT COMPLETED|Overall Study||1
90107|NCT01502423|216526|P1|NOT COMPLETED|Overall Study||0
90108|NCT01502423|216525|P2|COMPLETED|Overall Study||29
90109|NCT01502423|216526|P1|COMPLETED|Overall Study||31
90110|NCT01502423|216525|P2|STARTED|Overall Study||30
90111|NCT01502423|216526|P1|STARTED|Overall Study||31
90112|NCT01502410|216548|P4|NOT COMPLETED|Overall Study||0
90113|NCT01502410|216549|P3|NOT COMPLETED|Overall Study||0
90114|NCT01502410|216550|P2|NOT COMPLETED|Overall Study||10
90115|NCT01502410|216551|P1|NOT COMPLETED|Overall Study||10
90116|NCT01502410|216548|P4|COMPLETED|Overall Study||0
90117|NCT01502410|216549|P3|COMPLETED|Overall Study||0
90118|NCT01502410|216550|P2|COMPLETED|Overall Study||0
90119|NCT01502410|216551|P1|COMPLETED|Overall Study||0
90120|NCT01502410|216548|P4|STARTED|Overall Study||0
90121|NCT01502410|216549|P3|STARTED|Overall Study||0
90122|NCT01502410|216550|P2|STARTED|Overall Study||10
90123|NCT01502410|216551|P1|STARTED|Overall Study||10
90124|NCT01502371|216564|P5|NOT COMPLETED|Overall Study||52
90125|NCT01502371|216565|P4|NOT COMPLETED|Overall Study||37
90126|NCT01502371|216566|P3|NOT COMPLETED|Overall Study||25
90127|NCT01502371|216567|P2|NOT COMPLETED|Overall Study||32
90128|NCT01502371|216568|P1|NOT COMPLETED|Overall Study||41
90129|NCT01502371|216564|P5|COMPLETED|Overall Study||60
90130|NCT01502371|216565|P4|COMPLETED|Overall Study||88
90131|NCT01502371|216566|P3|COMPLETED|Overall Study||83
90132|NCT01502371|216567|P2|COMPLETED|Overall Study||81
90133|NCT01502371|216568|P1|COMPLETED|Overall Study||79
90134|NCT01502371|216564|P5|STARTED|Overall Study||112
90135|NCT01502371|216565|P4|STARTED|Overall Study||125
90136|NCT01502371|216566|P3|STARTED|Overall Study||108
90137|NCT01502371|216567|P2|STARTED|Overall Study||113
90138|NCT01502371|216568|P1|STARTED|Overall Study||120
90139|NCT01502332|216593|P2|NOT COMPLETED|Overall Study||0
90140|NCT01502332|216594|P1|NOT COMPLETED|Overall Study||0
90141|NCT01502332|216593|P2|COMPLETED|Overall Study||163
90142|NCT01502332|216594|P1|COMPLETED|Overall Study||157
90143|NCT01502332|216593|P2|STARTED|Overall Study||163
90144|NCT01502332|216594|P1|STARTED|Overall Study||157
90145|NCT01502228|216608|P1|NOT COMPLETED|Overall Study||1
90146|NCT01502228|216608|P1|COMPLETED|Overall Study||13
90147|NCT01502228|216608|P1|STARTED|Overall Study||14
90148|NCT01502033|216613|P1|NOT COMPLETED|Overall Study||3
90149|NCT01502033|216613|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
90150|NCT01502033|216613|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
90151|NCT01501162|216621|P2|NOT COMPLETED|Overall Study||5
90152|NCT01501162|216622|P1|NOT COMPLETED|Overall Study||8
90153|NCT01501162|216621|P2|COMPLETED|Overall Study||60
90154|NCT01501162|216622|P1|COMPLETED|Overall Study||57
90155|NCT01501162|216621|P2|STARTED|Overall Study||65
90156|NCT01501162|216622|P1|STARTED|Overall Study||65
90157|NCT01501110|216632|P2|NOT COMPLETED|Overall Study||1
90158|NCT01501110|216633|P1|NOT COMPLETED|Overall Study||0
90159|NCT01501110|216632|P2|COMPLETED|Overall Study||33
90160|NCT01501110|216633|P1|COMPLETED|Overall Study||34
90161|NCT01501110|216632|P2|STARTED|Overall Study||34
90162|NCT01501110|216633|P1|STARTED|Overall Study||34
90163|NCT01500772|216639|P1|NOT COMPLETED|Overall Study||6
90164|NCT01500772|216639|P1|COMPLETED|Overall Study||0
90165|NCT01500772|216639|P1|STARTED|Overall Study||6
90166|NCT01500746|216648|P2|NOT COMPLETED|Overall Study||0
90167|NCT01500746|216649|P1|NOT COMPLETED|Overall Study||0
90168|NCT01500746|216648|P2|COMPLETED|Overall Study||4
90169|NCT01500746|216649|P1|COMPLETED|Overall Study||4
90170|NCT01500746|216648|P2|STARTED|Overall Study||4
90171|NCT01500746|216649|P1|STARTED|Overall Study||4
90172|NCT01500720|216657|P2|NOT COMPLETED|Overall Study||9
90173|NCT01500720|216658|P1|NOT COMPLETED|Overall Study||5
90174|NCT01500720|216657|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
90175|NCT01500720|216658|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
90176|NCT01500720|216657|P2|Treated|Overall Study||88
90177|NCT01500720|216658|P1|Treated|Overall Study||89
90178|NCT01500720|216657|P2|STARTED|Overall Study|Randomized|89
90179|NCT01500720|216658|P1|STARTED|Overall Study|Randomized|90
90180|NCT01500694|216672|P2|NOT COMPLETED|Overall Study||29
90181|NCT01500694|216673|P1|NOT COMPLETED|Overall Study||52
90182|NCT01500694|216672|P2|COMPLETED|Overall Study||54
90183|NCT01500694|216673|P1|COMPLETED|Overall Study||79
90184|NCT01500694|216672|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
90185|NCT01500694|216673|P1|STARTED|Overall Study||131
90186|NCT01500629|216699|P2|NOT COMPLETED|Period 2 (Single Dose)||0
90187|NCT01500629|216700|P1|NOT COMPLETED|Period 2 (Single Dose)||0
90188|NCT01500629|216699|P2|COMPLETED|Period 2 (Single Dose)||10
90189|NCT01500629|216700|P1|COMPLETED|Period 2 (Single Dose)||10
90190|NCT01500629|216699|P2|STARTED|Period 2 (Single Dose)||10
90191|NCT01500629|216700|P1|STARTED|Period 2 (Single Dose)||10
90192|NCT01500629|216699|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
90193|NCT01500629|216700|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
90194|NCT01500629|216699|P2|COMPLETED|Washout Period of 14 to 30 Days||10
90195|NCT01500629|216700|P1|COMPLETED|Washout Period of 14 to 30 Days||10
90196|NCT01500629|216699|P2|STARTED|Washout Period of 14 to 30 Days||10
90197|NCT01500629|216700|P1|STARTED|Washout Period of 14 to 30 Days||11
90198|NCT01500629|216699|P2|NOT COMPLETED|Period 1 (Single Dose)||0
90199|NCT01500629|216700|P1|NOT COMPLETED|Period 1 (Single Dose)||0
90200|NCT01500629|216699|P2|COMPLETED|Period 1 (Single Dose)||10
90201|NCT01500629|216700|P1|COMPLETED|Period 1 (Single Dose)||11
90202|NCT01500629|216699|P2|STARTED|Period 1 (Single Dose)||10
90203|NCT01500629|216700|P1|STARTED|Period 1 (Single Dose)||11
90204|NCT01500434|216784|P1|NOT COMPLETED|Overall Study||7
90205|NCT01500434|216784|P1|COMPLETED|Overall Study||95
90206|NCT01500434|216784|P1|STARTED|Overall Study||102
90207|NCT01500382|216817|P4|NOT COMPLETED|Treatment Period 2||0
90208|NCT01500382|216818|P3|NOT COMPLETED|Treatment Period 2||0
90209|NCT01500382|216819|P2|NOT COMPLETED|Treatment Period 2||0
90210|NCT01500382|216820|P1|NOT COMPLETED|Treatment Period 2||0
90211|NCT01500382|216817|P4|COMPLETED|Treatment Period 2||1
90212|NCT01500382|216818|P3|COMPLETED|Treatment Period 2||0
90213|NCT01500382|216819|P2|COMPLETED|Treatment Period 2||1
90214|NCT01500382|216820|P1|COMPLETED|Treatment Period 2||1
90215|NCT01500382|216817|P4|STARTED|Treatment Period 2||1
90216|NCT01500382|216818|P3|STARTED|Treatment Period 2||0
90217|NCT01500382|216819|P2|STARTED|Treatment Period 2||1
90218|NCT01500382|216820|P1|STARTED|Treatment Period 2||1
90219|NCT01500382|216817|P4|NOT COMPLETED|Washout Period||0
90220|NCT01500382|216818|P3|NOT COMPLETED|Washout Period||1
90221|NCT01500382|216819|P2|NOT COMPLETED|Washout Period||0
90222|NCT01500382|216820|P1|NOT COMPLETED|Washout Period||0
90223|NCT01500382|216817|P4|COMPLETED|Washout Period||1
90224|NCT01500382|216818|P3|COMPLETED|Washout Period||0
90225|NCT01500382|216819|P2|COMPLETED|Washout Period||1
90226|NCT01500382|216820|P1|COMPLETED|Washout Period||1
90227|NCT01500382|216817|P4|STARTED|Washout Period||1
90228|NCT01500382|216818|P3|STARTED|Washout Period||1
90229|NCT01500382|216819|P2|STARTED|Washout Period||1
90230|NCT01500382|216820|P1|STARTED|Washout Period||1
90231|NCT01500382|216817|P4|NOT COMPLETED|Treatment Period 1||0
90232|NCT01500382|216818|P3|NOT COMPLETED|Treatment Period 1||0
90233|NCT01500382|216819|P2|NOT COMPLETED|Treatment Period 1||0
90234|NCT01500382|216820|P1|NOT COMPLETED|Treatment Period 1||0
90235|NCT01500382|216817|P4|COMPLETED|Treatment Period 1||1
90236|NCT01500382|216818|P3|COMPLETED|Treatment Period 1||1
90237|NCT01500382|216819|P2|COMPLETED|Treatment Period 1||1
90238|NCT01500382|216820|P1|COMPLETED|Treatment Period 1||1
90239|NCT01500382|216817|P4|STARTED|Treatment Period 1||1
90240|NCT01500382|216818|P3|STARTED|Treatment Period 1||1
90241|NCT01500382|216819|P2|STARTED|Treatment Period 1||1
90242|NCT01500382|216820|P1|STARTED|Treatment Period 1||1
90243|NCT01500317|216845|P3|NOT COMPLETED|Overall Study||0
90244|NCT01500317|216846|P2|NOT COMPLETED|Overall Study||2
90245|NCT01500317|216847|P1|NOT COMPLETED|Overall Study||3
90246|NCT01500317|216845|P3|COMPLETED|Overall Study||13
90247|NCT01500317|216846|P2|COMPLETED|Overall Study||10
90248|NCT01500317|216847|P1|COMPLETED|Overall Study||10
90249|NCT01500317|216845|P3|STARTED|Overall Study||13
90250|NCT01500317|216846|P2|STARTED|Overall Study||12
90251|NCT01500317|216847|P1|STARTED|Overall Study||13
90252|NCT01500278|216869|P2|NOT COMPLETED|Week 13 - Week 104||126
90253|NCT01500278|216870|P1|NOT COMPLETED|Week 13 - Week 104||139
90254|NCT01500278|216869|P2|COMPLETED|Week 13 - Week 104||302
90255|NCT01500278|216870|P1|COMPLETED|Week 13 - Week 104||287
90256|NCT01500278|216869|P2|STARTED|Week 13 - Week 104||428
90257|NCT01500278|216870|P1|STARTED|Week 13 - Week 104||426
90258|NCT01500278|216869|P2|NOT COMPLETED|Week 0 - Week 12||30
90259|NCT01500278|216870|P1|NOT COMPLETED|Week 0 - Week 12||31
90260|NCT01500278|216869|P2|COMPLETED|Week 0 - Week 12||428
90261|NCT01500278|216870|P1|COMPLETED|Week 0 - Week 12||426
90262|NCT01500278|216869|P2|STARTED|Week 0 - Week 12||458
90263|NCT01500278|216870|P1|STARTED|Week 0 - Week 12||457
90264|NCT01500252|216894|P2|NOT COMPLETED|Overall Study||6
90265|NCT01500252|216895|P1|NOT COMPLETED|Overall Study||9
90266|NCT01500252|216894|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
90267|NCT01500252|216895|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
90268|NCT01500252|216894|P2|Ten Years|Overall Study||11
90269|NCT01500252|216895|P1|Ten Years|Overall Study||12
90270|NCT01500252|216894|P2|Five Years|Overall Study||13
90271|NCT01500252|216895|P1|Five Years|Overall Study||17
90272|NCT01500252|216894|P2|One Years|Overall Study||16
90273|NCT01500252|216895|P1|One Years|Overall Study||20
90274|NCT01500252|216894|P2|STARTED|Overall Study||17
90275|NCT01500252|216895|P1|STARTED|Overall Study||21
90276|NCT01500226|216921|P2|NOT COMPLETED|Overall Study||494
90277|NCT01500226|216922|P1|NOT COMPLETED|Overall Study||499
90278|NCT01500226|216921|P2|COMPLETED|Overall Study||191
90279|NCT01500226|216922|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
90280|NCT01500226|216921|P2|STARTED|Overall Study||685
90281|NCT01500226|216922|P1|STARTED|Overall Study|Number of randomized patients|684
90282|NCT01500213|216934|P2|NOT COMPLETED|Overall Study||224
90283|NCT01500213|216935|P1|NOT COMPLETED|Overall Study||217
90284|NCT01500213|216934|P2|COMPLETED|Overall Study||53
90285|NCT01500213|216935|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
90286|NCT01500213|216934|P2|STARTED|Overall Study||277
90287|NCT01500213|216935|P1|STARTED|Overall Study|Number of randomized patients|278
90288|NCT01500135|216947|P2|NOT COMPLETED|Overall Study||11
90289|NCT01500135|216948|P1|NOT COMPLETED|Overall Study||17
90290|NCT01500135|216947|P2|COMPLETED|Overall Study||39
90291|NCT01500135|216948|P1|COMPLETED|Overall Study||83
90292|NCT01500135|216947|P2|STARTED|Overall Study||50
90293|NCT01500135|216948|P1|STARTED|Overall Study||100
90294|NCT01500109|216961|P3|NOT COMPLETED|Overall Study||0
90295|NCT01500109|216962|P2|NOT COMPLETED|Overall Study||0
90296|NCT01500109|216963|P1|NOT COMPLETED|Overall Study||0
90297|NCT01500109|216961|P3|COMPLETED|Overall Study||16
90298|NCT01500109|216962|P2|COMPLETED|Overall Study||14
90299|NCT01500109|216963|P1|COMPLETED|Overall Study||15
90300|NCT01500109|216961|P3|STARTED|Overall Study||16
90301|NCT01500109|216962|P2|STARTED|Overall Study||14
90302|NCT01500109|216963|P1|STARTED|Overall Study||15
90303|NCT01500083|216973|P2|NOT COMPLETED|Overall Study||43
90304|NCT01500083|216974|P1|NOT COMPLETED|Overall Study||12
90305|NCT01500083|216973|P2|COMPLETED|Overall Study||31
90306|NCT01500083|216974|P1|COMPLETED|Overall Study||4
90307|NCT01500083|216973|P2|STARTED|Overall Study||74
90308|NCT01500083|216974|P1|STARTED|Overall Study||16
90309|NCT01500057|216982|P2|NOT COMPLETED|Overall Study||4
90310|NCT01500057|216983|P1|NOT COMPLETED|Overall Study||6
90311|NCT01500057|216982|P2|COMPLETED|Overall Study||31
90312|NCT01500057|216983|P1|COMPLETED|Overall Study||25
90313|NCT01500057|216982|P2|STARTED|Overall Study||35
90314|NCT01500057|216983|P1|STARTED|Overall Study||31
90315|NCT01500031|216993|P1|NOT COMPLETED|Overall Study||5
90316|NCT01500031|216993|P1|COMPLETED|Overall Study||87
90317|NCT01500031|216993|P1|STARTED|Overall Study||92
90318|NCT01499862|217008|P1|NOT COMPLETED|Overall Study||0
90319|NCT01499862|217008|P1|COMPLETED|Overall Study||3
90320|NCT01499862|217008|P1|STARTED|Overall Study||3
90321|NCT01499849|217028|P2|NOT COMPLETED|Overall Study||226
90322|NCT01499849|217029|P1|NOT COMPLETED|Overall Study||224
90323|NCT01499849|217028|P2|COMPLETED|Overall Study||40
90324|NCT01499849|217029|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
90325|NCT01499849|217028|P2|STARTED|Overall Study||266
90326|NCT01499849|217029|P1|STARTED|Overall Study|Number of randomized patients|266
90327|NCT01499810|217039|P1|NOT COMPLETED|Overall Study||12
90328|NCT01499810|217039|P1|COMPLETED|Overall Study||41
90329|NCT01499810|217039|P1|STARTED|Overall Study||53
90330|NCT01499667|217089|P3|NOT COMPLETED|Overall Study||10
90331|NCT01499667|217090|P2|NOT COMPLETED|Overall Study||11
90332|NCT01499667|217091|P1|NOT COMPLETED|Overall Study||9
90333|NCT01499667|217089|P3|COMPLETED|Overall Study||40
90334|NCT01499667|217090|P2|COMPLETED|Overall Study||31
90335|NCT01499667|217091|P1|COMPLETED|Overall Study||41
90336|NCT01499667|217089|P3|Modified Full Analysis Set|Overall Study||39
90337|NCT01499667|217090|P2|Modified Full Analysis Set|Overall Study||29
90338|NCT01499667|217091|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
90339|NCT01499667|217089|P3|Full Analysis Set (FAS)|Overall Study||50
90340|NCT01499667|217090|P2|Full Analysis Set (FAS)|Overall Study||42
90341|NCT01499667|217091|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
90342|NCT01499667|217089|P3|STARTED|Overall Study||50
90343|NCT01499667|217090|P2|STARTED|Overall Study||42
90344|NCT01499667|217091|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
90345|NCT01499654|217120|P1|NOT COMPLETED|Overall Study||0
90346|NCT01499654|217120|P1|COMPLETED|Overall Study||64
90347|NCT01499654|217120|P1|STARTED|Overall Study||64
90348|NCT01499576|217139|P1|NOT COMPLETED|Overall Study||21
90349|NCT01499576|217139|P1|COMPLETED|Overall Study||105
90350|NCT01499576|217139|P1|STARTED|Overall Study||126
90351|NCT01499498|217145|P1|NOT COMPLETED|Overall Study||0
90352|NCT01499498|217145|P1|COMPLETED|Overall Study||13
90353|NCT01499498|217145|P1|STARTED|Overall Study||13
90354|NCT01499355|217153|P4|NOT COMPLETED|Double-Blind Period||23
90355|NCT01499355|217154|P3|NOT COMPLETED|Double-Blind Period||25
90356|NCT01499355|217155|P2|NOT COMPLETED|Double-Blind Period||23
90357|NCT01499355|217156|P1|NOT COMPLETED|Double-Blind Period||0
90358|NCT01499355|217153|P4|COMPLETED|Double-Blind Period||39
90359|NCT01499355|217154|P3|COMPLETED|Double-Blind Period||38
90360|NCT01499355|217155|P2|COMPLETED|Double-Blind Period||40
90361|NCT01499355|217156|P1|COMPLETED|Double-Blind Period||0
90362|NCT01499355|217153|P4|STARTED|Double-Blind Period||62
90363|NCT01499355|217154|P3|STARTED|Double-Blind Period||63
90364|NCT01499355|217155|P2|STARTED|Double-Blind Period||63
90365|NCT01499355|217156|P1|STARTED|Double-Blind Period||0
90366|NCT01499355|217153|P4|NOT COMPLETED|Run-In Period||0
90367|NCT01499355|217154|P3|NOT COMPLETED|Run-In Period||0
90368|NCT01499355|217155|P2|NOT COMPLETED|Run-In Period||0
90369|NCT01499355|217156|P1|NOT COMPLETED|Run-In Period||31
90370|NCT01499355|217153|P4|COMPLETED|Run-In Period||0
90371|NCT01499355|217154|P3|COMPLETED|Run-In Period||0
90372|NCT01499355|217155|P2|COMPLETED|Run-In Period||0
90373|NCT01499355|217156|P1|COMPLETED|Run-In Period||245
90374|NCT01499355|217153|P4|STARTED|Run-In Period||0
90375|NCT01499355|217154|P3|STARTED|Run-In Period||0
90376|NCT01499355|217155|P2|STARTED|Run-In Period||0
90377|NCT01499355|217156|P1|STARTED|Run-In Period||276
90378|NCT01499303|217189|P2|NOT COMPLETED|Overall Study||7
90379|NCT01499303|217190|P1|NOT COMPLETED|Overall Study||3
90380|NCT01499303|217189|P2|COMPLETED|Overall Study||40
90381|NCT01499303|217190|P1|COMPLETED|Overall Study||18
90382|NCT01499303|217189|P2|STARTED|Overall Study||47
90383|NCT01499303|217190|P1|STARTED|Overall Study||21
90384|NCT01499290|217198|P2|NOT COMPLETED|Overall Study||35
90385|NCT01499290|217199|P1|NOT COMPLETED|Overall Study||55
90386|NCT01499290|217198|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
90387|NCT01499290|217199|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
90388|NCT01499290|217198|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
90389|NCT01499290|217199|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
90390|NCT01499277|217249|P2|NOT COMPLETED|Overall Study||32
90391|NCT01499277|217250|P1|NOT COMPLETED|Overall Study||47
90392|NCT01499277|217249|P2|COMPLETED|Overall Study||223
90393|NCT01499277|217250|P1|COMPLETED|Overall Study||459
90394|NCT01499277|217249|P2|STARTED|Overall Study||255
90395|NCT01499277|217250|P1|STARTED|Overall Study||506
90396|NCT01499199|217272|P1|NOT COMPLETED|Overall Study||2
90397|NCT01499199|217272|P1|COMPLETED|Overall Study||11
90398|NCT01499199|217272|P1|STARTED|Overall Study||13
90399|NCT01499173|217291|P1|NOT COMPLETED|Overall Study||37
90400|NCT01499173|217291|P1|COMPLETED|Overall Study||64
90401|NCT01499173|217291|P1|STARTED|Overall Study||101
90402|NCT01499160|217301|P1|NOT COMPLETED|Overall Study||2
90403|NCT01499160|217301|P1|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
90404|NCT01499160|217301|P1|STARTED|Overall Study||7
90405|NCT01499147|217308|P2|NOT COMPLETED|Overall Study||5
90406|NCT01499147|217309|P1|NOT COMPLETED|Overall Study||15
90407|NCT01499147|217308|P2|COMPLETED|Overall Study||12
90408|NCT01499147|217309|P1|COMPLETED|Overall Study||18
90409|NCT01499147|217308|P2|STARTED|Overall Study||17
90410|NCT01499147|217309|P1|STARTED|Overall Study||33
90411|NCT01499134|217324|P2|NOT COMPLETED|Overall Study||1
90412|NCT01499134|217325|P1|NOT COMPLETED|Overall Study||0
90413|NCT01499134|217324|P2|COMPLETED|Overall Study||7
90414|NCT01499134|217325|P1|COMPLETED|Overall Study||9
90415|NCT01499134|217324|P2|STARTED|Overall Study||8
90416|NCT01499134|217325|P1|STARTED|Overall Study||9
90417|NCT01499095|217347|P2|NOT COMPLETED|Overall Study||93
90418|NCT01499095|217348|P1|NOT COMPLETED|Overall Study||89
90419|NCT01499095|217347|P2|COMPLETED|Overall Study||314
90420|NCT01499095|217348|P1|COMPLETED|Overall Study||315
90421|NCT01499095|217347|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
90422|NCT01499095|217348|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
90423|NCT01499095|217347|P2|Participated in Substudy|Overall Study||0
90424|NCT01499095|217348|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
90425|NCT01499095|217347|P2|Treated|Overall Study||406
90426|NCT01499095|217348|P1|Treated|Overall Study||403
90427|NCT01499095|217347|P2|STARTED|Overall Study||407
90428|NCT01499095|217348|P1|STARTED|Overall Study||404
90429|NCT01499082|217378|P2|NOT COMPLETED|Overall Study||48
90430|NCT01499082|217379|P1|NOT COMPLETED|Overall Study||45
90431|NCT01499082|217378|P2|COMPLETED|Overall Study||355
90432|NCT01499082|217379|P1|COMPLETED|Overall Study||359
90433|NCT01499082|217378|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
90434|NCT01499082|217379|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
90435|NCT01499082|217378|P2|Participated in Substudy|Overall Study||0
90436|NCT01499082|217379|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
90437|NCT01499082|217378|P2|Treated|Overall Study||402
90438|NCT01499082|217379|P1|Treated|Overall Study||404
90439|NCT01499082|217378|P2|STARTED|Overall Study||403
90440|NCT01499082|217379|P1|STARTED|Overall Study||404
90441|NCT01498978|217407|P1|NOT COMPLETED|Overall Study||2
90442|NCT01498978|217407|P1|COMPLETED|Overall Study||8
90443|NCT01498978|217407|P1|STARTED|Overall Study||10
90444|NCT01498822|217429|P2|NOT COMPLETED|Overall Study||56
90445|NCT01498822|217430|P1|NOT COMPLETED|Overall Study||54
90446|NCT01498822|217429|P2|COMPLETED|Overall Study||122
90447|NCT01498822|217430|P1|COMPLETED|Overall Study||121
90448|NCT01498822|217429|P2|STARTED|Overall Study||178
90449|NCT01498822|217430|P1|STARTED|Overall Study||175
90450|NCT01498744|217444|P2|NOT COMPLETED|Overall Study||0
90451|NCT01498744|217445|P1|NOT COMPLETED|Overall Study||0
90452|NCT01498744|217444|P2|COMPLETED|Overall Study||31
90453|NCT01498744|217445|P1|COMPLETED|Overall Study||22
90454|NCT01498744|217444|P2|STARTED|Overall Study||31
90455|NCT01498744|217445|P1|STARTED|Overall Study||22
90456|NCT01498692|217457|P1|NOT COMPLETED|Overall Study||8
90457|NCT01498692|217457|P1|COMPLETED|Overall Study||86
90458|NCT01498692|217457|P1|STARTED|Overall Study||94
90459|NCT01498679|217488|P2|NOT COMPLETED|Overall Study||22
90460|NCT01498679|217489|P1|NOT COMPLETED|Overall Study||89
90461|NCT01498679|217488|P2|COMPLETED|Overall Study||131
90462|NCT01498679|217489|P1|COMPLETED|Overall Study||65
90463|NCT01498679|217488|P2|STARTED|Overall Study||153
90464|NCT01498679|217489|P1|STARTED|Overall Study||154
90465|NCT01498653|217505|P2|NOT COMPLETED|Overall Study||35
90466|NCT01498653|217506|P1|NOT COMPLETED|Overall Study||19
90467|NCT01498653|217505|P2|COMPLETED|Overall Study||119
90468|NCT01498653|217506|P1|COMPLETED|Overall Study||136
90469|NCT01498653|217505|P2|STARTED|Overall Study||154
90470|NCT01498653|217506|P1|STARTED|Overall Study||155
90471|NCT01498640|217520|P1|NOT COMPLETED|Overall Study||5
90472|NCT01498640|217520|P1|COMPLETED|Overall Study||47
90473|NCT01498640|217520|P1|STARTED|Overall Study||52
90474|NCT01498601|217536|P2|NOT COMPLETED|Overall Study||0
90475|NCT01498601|217537|P1|NOT COMPLETED|Overall Study||0
90476|NCT01498601|217536|P2|COMPLETED|Overall Study||32
90477|NCT01498601|217537|P1|COMPLETED|Overall Study||51
90478|NCT01498601|217536|P2|STARTED|Overall Study||32
90479|NCT01498601|217537|P1|STARTED|Overall Study||51
90480|NCT01498588|217543|P1|NOT COMPLETED|Overall Study||0
90481|NCT01498588|217543|P1|COMPLETED|Overall Study||7
90482|NCT01498588|217543|P1|STARTED|Overall Study||7
90483|NCT01498575|217550|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
90484|NCT01498575|217551|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
90485|NCT01498575|217550|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
90486|NCT01498575|217551|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
90487|NCT01498575|217550|P2|STARTED|On the Road Driving Assessment (ODA)||89
90488|NCT01498575|217551|P1|STARTED|On the Road Driving Assessment (ODA)||128
90489|NCT01498575|217550|P2|NOT COMPLETED|Overall Sample||14
90490|NCT01498575|217551|P1|NOT COMPLETED|Overall Sample||60
90491|NCT01498575|217550|P2|COMPLETED|Overall Sample||400
90492|NCT01498575|217551|P1|COMPLETED|Overall Sample||550
90493|NCT01498575|217550|P2|STARTED|Overall Sample||414
90494|NCT01498575|217551|P1|STARTED|Overall Sample||610
90495|NCT01498549|217557|P1|NOT COMPLETED|Overall Study||4
90496|NCT01498549|217557|P1|COMPLETED|Overall Study||35
90497|NCT01498549|217557|P1|Sugar Pill 0 mg|Overall Study||36
90498|NCT01498549|217557|P1|Atomoxetine 80 mg|Overall Study||37
90499|NCT01498549|217557|P1|Atomoxetine 40 mg|Overall Study||39
90500|NCT01498549|217557|P1|STARTED|Overall Study||39
90501|NCT01498458|217568|P1|NOT COMPLETED|Overall Study||7
90502|NCT01498458|217568|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
90503|NCT01498458|217568|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
90504|NCT01498419|217581|P4|NOT COMPLETED|Overall Study||19
90505|NCT01498419|217582|P3|NOT COMPLETED|Overall Study||18
90506|NCT01498419|217583|P2|NOT COMPLETED|Overall Study||23
90507|NCT01498419|217584|P1|NOT COMPLETED|Overall Study||18
90508|NCT01498419|217581|P4|COMPLETED|Overall Study||7
90509|NCT01498419|217582|P3|COMPLETED|Overall Study||41
90510|NCT01498419|217583|P2|COMPLETED|Overall Study||39
90511|NCT01498419|217584|P1|COMPLETED|Overall Study||42
90512|NCT01498419|217581|P4|STARTED|Overall Study||26
90513|NCT01498419|217582|P3|STARTED|Overall Study||59
90514|NCT01498419|217583|P2|STARTED|Overall Study||62
90515|NCT01498419|217584|P1|STARTED|Overall Study||60
90516|NCT01498185|217623|P5|NOT COMPLETED|Overall Study||3
90517|NCT01498185|217624|P4|NOT COMPLETED|Overall Study||3
90518|NCT01498185|217625|P3|NOT COMPLETED|Overall Study||0
90519|NCT01498185|217626|P2|NOT COMPLETED|Overall Study||1
90520|NCT01498185|217627|P1|NOT COMPLETED|Overall Study||1
90521|NCT01498185|217623|P5|COMPLETED|Overall Study||12
90522|NCT01498185|217624|P4|COMPLETED|Overall Study||11
90523|NCT01498185|217625|P3|COMPLETED|Overall Study||15
90524|NCT01498185|217626|P2|COMPLETED|Overall Study||12
90525|NCT01498185|217627|P1|COMPLETED|Overall Study||12
90526|NCT01498185|217623|P5|STARTED|Overall Study||15
90527|NCT01498185|217624|P4|STARTED|Overall Study||14
90528|NCT01498185|217625|P3|STARTED|Overall Study||15
90529|NCT01498185|217626|P2|STARTED|Overall Study||13
90530|NCT01498185|217627|P1|STARTED|Overall Study||13
90531|NCT01498120|217667|P1|NOT COMPLETED|Overall Study||13
90532|NCT01498120|217667|P1|COMPLETED|Overall Study||1
90533|NCT01498120|217667|P1|STARTED|Overall Study||14
90534|NCT01498068|217674|P2|NOT COMPLETED|Overall Study||1
90535|NCT01498068|217675|P1|NOT COMPLETED|Overall Study||1
90536|NCT01498068|217674|P2|COMPLETED|Overall Study||19
90537|NCT01498068|217675|P1|COMPLETED|Overall Study||15
90538|NCT01498068|217674|P2|STARTED|Overall Study||20
90539|NCT01498068|217675|P1|STARTED|Overall Study||16
90540|NCT01497938|217693|P2|NOT COMPLETED|Overall Study||2
90541|NCT01497938|217694|P1|NOT COMPLETED|Overall Study||5
90542|NCT01497938|217693|P2|COMPLETED|Overall Study||124
90543|NCT01497938|217694|P1|COMPLETED|Overall Study||116
90544|NCT01497938|217693|P2|STARTED|Overall Study||126
90545|NCT01497938|217694|P1|STARTED|Overall Study||121
90546|NCT01497899|217706|P4|NOT COMPLETED|Open-Label Extension Phase||5
90547|NCT01497899|217707|P3|NOT COMPLETED|Open-Label Extension Phase||9
90548|NCT01497899|217708|P2|NOT COMPLETED|Open-Label Extension Phase||7
90549|NCT01497899|217709|P1|NOT COMPLETED|Open-Label Extension Phase||19
90550|NCT01497899|217706|P4|COMPLETED|Open-Label Extension Phase||33
90551|NCT01497899|217707|P3|COMPLETED|Open-Label Extension Phase||61
90552|NCT01497899|217708|P2|COMPLETED|Open-Label Extension Phase||46
90553|NCT01497899|217709|P1|COMPLETED|Open-Label Extension Phase||86
90554|NCT01497899|217706|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
90555|NCT01497899|217707|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
90556|NCT01497899|217708|P2|STARTED|Open-Label Extension Phase||53
90557|NCT01497899|217709|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
90558|NCT01497899|217706|P4|NOT COMPLETED|Double-Blind Phase||0
90559|NCT01497899|217707|P3|NOT COMPLETED|Double-Blind Phase||0
90560|NCT01497899|217708|P2|NOT COMPLETED|Double-Blind Phase||5
90561|NCT01497899|217709|P1|NOT COMPLETED|Double-Blind Phase||6
90562|NCT01497899|217706|P4|COMPLETED|Double-Blind Phase||0
90563|NCT01497899|217707|P3|COMPLETED|Double-Blind Phase||0
90564|NCT01497899|217708|P2|COMPLETED|Double-Blind Phase||53
90565|NCT01497899|217709|P1|COMPLETED|Double-Blind Phase||107
90566|NCT01497899|217706|P4|STARTED|Double-Blind Phase||0
90567|NCT01497899|217707|P3|STARTED|Double-Blind Phase||0
90568|NCT01497899|217708|P2|STARTED|Double-Blind Phase||58
90569|NCT01497899|217709|P1|STARTED|Double-Blind Phase||113
90570|NCT01497756|217722|P1|NOT COMPLETED|Overall Study||0
90571|NCT01497756|217722|P1|COMPLETED|Overall Study||10
90572|NCT01497756|217722|P1|STARTED|Overall Study||10
90573|NCT01497665|217727|P1|NOT COMPLETED|Overall Study||0
90574|NCT01497665|217727|P1|COMPLETED|Overall Study||16
90575|NCT01497665|217727|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
90576|NCT01497665|217727|P1|STARTED|Overall Study||16
90577|NCT01497613|217737|P2|NOT COMPLETED|Overall Study||19
90578|NCT01497613|217738|P1|NOT COMPLETED|Overall Study||37
90579|NCT01497613|217737|P2|COMPLETED|Overall Study||131
90580|NCT01497613|217738|P1|COMPLETED|Overall Study||113
90581|NCT01497613|217737|P2|STARTED|Overall Study||150
90582|NCT01497613|217738|P1|STARTED|Overall Study||150
90583|NCT01497366|217772|P2|NOT COMPLETED|Overall Study||88
90584|NCT01497366|217773|P1|NOT COMPLETED|Overall Study||39
90585|NCT01497366|217772|P2|COMPLETED|Overall Study||176
90586|NCT01497366|217773|P1|COMPLETED|Overall Study||224
90587|NCT01497366|217772|P2|Randomized But Not Treated|Overall Study||21
90588|NCT01497366|217773|P1|Randomized But Not Treated|Overall Study||7
90589|NCT01497366|217772|P2|STARTED|Overall Study||264
90590|NCT01497366|217773|P1|STARTED|Overall Study||263
90591|NCT01497275|217791|P1|NOT COMPLETED|Overall Study||2
90592|NCT01497275|217791|P1|COMPLETED|Overall Study||3
90593|NCT01497275|217791|P1|STARTED|Overall Study||5
90594|NCT01497262|217798|P1|NOT COMPLETED|Overall Study||11
90595|NCT01497262|217798|P1|COMPLETED|Overall Study||151
90596|NCT01497262|217798|P1|STARTED|Overall Study||162
90597|NCT01497197|217805|P2|NOT COMPLETED|Overall Study||15
90598|NCT01497197|217806|P1|NOT COMPLETED|Overall Study||17
90599|NCT01497197|217805|P2|COMPLETED|Overall Study||70
90600|NCT01497197|217806|P1|COMPLETED|Overall Study||72
90601|NCT01497197|217805|P2|STARTED|Overall Study||85
90602|NCT01497197|217806|P1|STARTED|Overall Study||89
90603|NCT01497171|217834|P2|NOT COMPLETED|Overall Study||0
90604|NCT01497171|217835|P1|NOT COMPLETED|Overall Study||0
90605|NCT01497171|217834|P2|COMPLETED|Overall Study||3
90606|NCT01497171|217835|P1|COMPLETED|Overall Study||2
90607|NCT01497171|217834|P2|STARTED|Overall Study||3
90608|NCT01497171|217835|P1|STARTED|Overall Study||2
90609|NCT01496846|217847|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
90610|NCT01496846|217848|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
90611|NCT01496846|217849|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
90612|NCT01496846|217850|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
90613|NCT01496846|217851|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
90614|NCT01496846|217852|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
90615|NCT01496846|217847|P6|COMPLETED|Supplemental Buccal Infiltration||38
90616|NCT01496846|217848|P5|COMPLETED|Supplemental Buccal Infiltration||35
90617|NCT01496846|217849|P4|COMPLETED|Supplemental Buccal Infiltration||40
90618|NCT01496846|217850|P3|COMPLETED|Supplemental Buccal Infiltration||36
90619|NCT01496846|217851|P2|COMPLETED|Supplemental Buccal Infiltration||0
90620|NCT01496846|217852|P1|COMPLETED|Supplemental Buccal Infiltration||0
90621|NCT01496846|217847|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
90622|NCT01496846|217848|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
90623|NCT01496846|217849|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
90624|NCT01496846|217850|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
90625|NCT01496846|217851|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
90626|NCT01496846|217852|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
90627|NCT01496846|217847|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
90628|NCT01496846|217848|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
90629|NCT01496846|217849|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
90630|NCT01496846|217850|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
90631|NCT01496846|217851|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
90632|NCT01496846|217852|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
90633|NCT01496846|217847|P6|COMPLETED|IANB Articaine (All Participants)||38
90634|NCT01496846|217848|P5|COMPLETED|IANB Articaine (All Participants)||35
90635|NCT01496846|217849|P4|COMPLETED|IANB Articaine (All Participants)||40
90636|NCT01496846|217850|P3|COMPLETED|IANB Articaine (All Participants)||36
90637|NCT01496846|217851|P2|COMPLETED|IANB Articaine (All Participants)||23
90638|NCT01496846|217852|P1|COMPLETED|IANB Articaine (All Participants)||27
90639|NCT01496846|217847|P6|STARTED|IANB Articaine (All Participants)||38
90640|NCT01496846|217848|P5|STARTED|IANB Articaine (All Participants)||35
90641|NCT01496846|217849|P4|STARTED|IANB Articaine (All Participants)||40
90642|NCT01496846|217850|P3|STARTED|IANB Articaine (All Participants)||36
90643|NCT01496846|217851|P2|STARTED|IANB Articaine (All Participants)||24
90644|NCT01496846|217852|P1|STARTED|IANB Articaine (All Participants)||28
90645|NCT01496807|217863|P1|NOT COMPLETED|Overall Study||30
90646|NCT01496807|217863|P1|COMPLETED|Overall Study||1
90647|NCT01496807|217863|P1|STARTED|Overall Study||31
90648|NCT01496469|217875|P2|NOT COMPLETED|Overall Study||8
90649|NCT01496469|217876|P1|NOT COMPLETED|Overall Study||10
90650|NCT01496469|217875|P2|COMPLETED|Overall Study||53
90651|NCT01496469|217876|P1|COMPLETED|Overall Study||50
90652|NCT01496469|217875|P2|STARTED|Overall Study||61
90653|NCT01496469|217876|P1|STARTED|Overall Study||60
90654|NCT01496456|217886|P1|NOT COMPLETED|Overall Study||8
90655|NCT01496456|217886|P1|COMPLETED|Overall Study||9
90656|NCT01496456|217886|P1|3-yr Final Recall|Overall Study||9
90657|NCT01496456|217886|P1|2-yr Recall|Overall Study||10
90658|NCT01496456|217886|P1|1-yr Recall|Overall Study||12
90659|NCT01496456|217886|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
90660|NCT01496456|217886|P1|STARTED|Overall Study||17
90661|NCT01496430|217899|P3|NOT COMPLETED|Overall Study||10
90662|NCT01496430|217900|P2|NOT COMPLETED|Overall Study||5
90663|NCT01496430|217901|P1|NOT COMPLETED|Overall Study||6
90664|NCT01496430|217899|P3|COMPLETED|Overall Study||25
90665|NCT01496430|217900|P2|COMPLETED|Overall Study||30
90666|NCT01496430|217901|P1|COMPLETED|Overall Study||29
90667|NCT01496430|217899|P3|STARTED|Overall Study||35
90668|NCT01496430|217900|P2|STARTED|Overall Study||35
90669|NCT01496430|217901|P1|STARTED|Overall Study||35
90670|NCT01496352|217977|P2|NOT COMPLETED|Overall Study||0
90671|NCT01496352|217978|P1|NOT COMPLETED|Overall Study||0
90672|NCT01496352|217977|P2|COMPLETED|Overall Study||6
90673|NCT01496352|217978|P1|COMPLETED|Overall Study||24
90674|NCT01496352|217977|P2|STARTED|Overall Study||6
90675|NCT01496352|217978|P1|STARTED|Overall Study||24
90676|NCT01496313|217996|P2|NOT COMPLETED|Overall Study||15
90677|NCT01496313|217997|P1|NOT COMPLETED|Overall Study||5
90678|NCT01496313|217996|P2|COMPLETED|Overall Study||26
90679|NCT01496313|217997|P1|COMPLETED|Overall Study||35
90680|NCT01496313|217996|P2|STARTED|Overall Study||41
90681|NCT01496313|217997|P1|STARTED|Overall Study||40
90682|NCT01496287|218013|P1|NOT COMPLETED|Overall Study||6
90683|NCT01496287|218013|P1|COMPLETED|Overall Study||64
90684|NCT01496287|218013|P1|STARTED|Overall Study||70
90685|NCT01496274|218023|P2|NOT COMPLETED|Overall Study||5
90686|NCT01496274|218024|P1|NOT COMPLETED|Overall Study||3
90687|NCT01496274|218023|P2|COMPLETED|Overall Study||18
90688|NCT01496274|218024|P1|COMPLETED|Overall Study||37
90689|NCT01496274|218023|P2|STARTED|Overall Study||23
90690|NCT01496274|218024|P1|STARTED|Overall Study||40
90691|NCT01496248|218056|P1|NOT COMPLETED|Overall Study||10
90692|NCT01496248|218056|P1|COMPLETED|Overall Study||25
90693|NCT01496248|218056|P1|STARTED|Overall Study||35
90694|NCT01496183|218069|P2|NOT COMPLETED|Overall Study||2
90695|NCT01496183|218070|P1|NOT COMPLETED|Overall Study||3
90696|NCT01496183|218069|P2|COMPLETED|Overall Study||13
90697|NCT01496183|218070|P1|COMPLETED|Overall Study||6
90698|NCT01496183|218069|P2|STARTED|Overall Study||15
90699|NCT01496183|218070|P1|STARTED|Overall Study||9
90700|NCT01496131|218078|P2|NOT COMPLETED|Overall Study||0
90701|NCT01496131|218079|P1|NOT COMPLETED|Overall Study||0
90702|NCT01496131|218078|P2|COMPLETED|Overall Study||14
90703|NCT01496131|218079|P1|COMPLETED|Overall Study||14
90704|NCT01496131|218078|P2|STARTED|Overall Study||14
90705|NCT01496131|218079|P1|STARTED|Overall Study||14
90706|NCT01496066|218093|P2|NOT COMPLETED|Overall Study||9
90707|NCT01496066|218094|P1|NOT COMPLETED|Overall Study||12
90708|NCT01496066|218093|P2|COMPLETED|Overall Study||188
90709|NCT01496066|218094|P1|COMPLETED|Overall Study||391
90710|NCT01496066|218093|P2|STARTED|Overall Study||197
90711|NCT01496066|218094|P1|STARTED|Overall Study||403
90712|NCT01495988|218117|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90713|NCT01495988|218118|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90714|NCT01495988|218119|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90715|NCT01495988|218120|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90716|NCT01495988|218117|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90717|NCT01495988|218118|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90718|NCT01495988|218119|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
90719|NCT01495988|218120|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90720|NCT01495988|218117|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90721|NCT01495988|218118|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90722|NCT01495988|218119|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
90723|NCT01495988|218120|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
90724|NCT01495988|218117|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
90725|NCT01495988|218118|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
90726|NCT01495988|218119|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
90727|NCT01495988|218120|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
90728|NCT01495988|218117|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
90729|NCT01495988|218118|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
90730|NCT01495988|218119|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
90731|NCT01495988|218120|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
90732|NCT01495988|218117|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
90733|NCT01495988|218118|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
90734|NCT01495988|218119|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
90735|NCT01495988|218120|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
90736|NCT01495975|218156|P2|NOT COMPLETED|Overall Study||0
90737|NCT01495975|218157|P1|NOT COMPLETED|Overall Study||1
90738|NCT01495975|218156|P2|COMPLETED|Overall Study||14
90739|NCT01495975|218157|P1|COMPLETED|Overall Study||14
90740|NCT01495975|218156|P2|STARTED|Overall Study||14
90741|NCT01495975|218157|P1|STARTED|Overall Study||15
90742|NCT01495923|218165|P2|NOT COMPLETED|Overall Study||0
90743|NCT01495923|218166|P1|NOT COMPLETED|Overall Study||0
90744|NCT01495923|218165|P2|COMPLETED|Overall Study||72
90745|NCT01495923|218166|P1|COMPLETED|Overall Study||73
90746|NCT01495923|218165|P2|STARTED|Overall Study||72
90747|NCT01495923|218166|P1|STARTED|Overall Study||73
90748|NCT01495858|218199|P3|NOT COMPLETED|Overall Study||0
90749|NCT01495858|218200|P2|NOT COMPLETED|Overall Study||0
90750|NCT01495858|218201|P1|NOT COMPLETED|Overall Study||0
90751|NCT01495858|218199|P3|COMPLETED|Overall Study||54
90752|NCT01495858|218200|P2|COMPLETED|Overall Study||106
90753|NCT01495858|218201|P1|COMPLETED|Overall Study||107
90754|NCT01495858|218199|P3|STARTED|Overall Study||54
90755|NCT01495858|218200|P2|STARTED|Overall Study||106
90756|NCT01495858|218201|P1|STARTED|Overall Study||107
90757|NCT01495793|218281|P1|NOT COMPLETED|Overall Study||2
90758|NCT01495793|218281|P1|COMPLETED|Overall Study||22
90759|NCT01495793|218281|P1|STARTED|Overall Study||24
90760|NCT01495702|218294|P2|NOT COMPLETED|Extension Phase||0
90761|NCT01495702|218295|P1|NOT COMPLETED|Extension Phase||0
90762|NCT01495702|218294|P2|COMPLETED|Extension Phase||2
90763|NCT01495702|218295|P1|COMPLETED|Extension Phase||26
90764|NCT01495702|218294|P2|STARTED|Extension Phase||2
90765|NCT01495702|218295|P1|STARTED|Extension Phase||26
90766|NCT01495702|218294|P2|NOT COMPLETED|Randomized Phase||28
90767|NCT01495702|218295|P1|NOT COMPLETED|Randomized Phase||26
90768|NCT01495702|218294|P2|COMPLETED|Randomized Phase||119
90769|NCT01495702|218295|P1|COMPLETED|Randomized Phase||266
90770|NCT01495702|218294|P2|STARTED|Randomized Phase||147
90771|NCT01495702|218295|P1|STARTED|Randomized Phase||292
90772|NCT01495689|218310|P2|NOT COMPLETED|Overall Study||7
90773|NCT01495689|218311|P1|NOT COMPLETED|Overall Study||10
90774|NCT01495689|218310|P2|COMPLETED|Overall Study||16
90775|NCT01495689|218311|P1|COMPLETED|Overall Study||16
90776|NCT01495689|218310|P2|STARTED|Overall Study||23
90777|NCT01495689|218311|P1|STARTED|Overall Study||26
90778|NCT01495585|218320|P3|NOT COMPLETED|Overall Study||0
90779|NCT01495585|218321|P2|NOT COMPLETED|Overall Study||0
90780|NCT01495585|218322|P1|NOT COMPLETED|Overall Study||0
90781|NCT01495585|218320|P3|COMPLETED|Overall Study||4
90782|NCT01495585|218321|P2|COMPLETED|Overall Study||6
90783|NCT01495585|218322|P1|COMPLETED|Overall Study||4
90784|NCT01495585|218320|P3|Open Label Lonafarnib 200 mg|Overall Study||0
90785|NCT01495585|218321|P2|Open Label Lonafarnib 200 mg|Overall Study||0
90786|NCT01495585|218322|P1|Open Label Lonafarnib 200 mg|Overall Study||2
90787|NCT01495585|218320|P3|STARTED|Overall Study||4
90788|NCT01495585|218321|P2|STARTED|Overall Study||6
90789|NCT01495585|218322|P1|STARTED|Overall Study||4
90790|NCT01495572|218335|P2|NOT COMPLETED|Overall Study||0
90791|NCT01495572|218336|P1|NOT COMPLETED|Overall Study||0
90792|NCT01495572|218335|P2|COMPLETED|Overall Study||5
90793|NCT01495572|218336|P1|COMPLETED|Overall Study||0
90794|NCT01495572|218335|P2|STARTED|Overall Study||5
90795|NCT01495572|218336|P1|STARTED|Overall Study||0
90796|NCT01495481|218344|P1|NOT COMPLETED|Dexmedetomidine||0
90797|NCT01495481|218344|P1|COMPLETED|Dexmedetomidine||22
90798|NCT01495481|218344|P1|STARTED|Dexmedetomidine||22
90799|NCT01495481|218344|P1|NOT COMPLETED|Washout||0
90800|NCT01495481|218344|P1|COMPLETED|Washout||22
90801|NCT01495481|218344|P1|STARTED|Washout||22
90802|NCT01495481|218344|P1|NOT COMPLETED|Adenosine||0
90803|NCT01495481|218344|P1|COMPLETED|Adenosine||22
90804|NCT01495481|218344|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
90805|NCT01495286|218356|P1|NOT COMPLETED|Overall Study||0
90806|NCT01495286|218356|P1|COMPLETED|Overall Study||30
90807|NCT01495286|218356|P1|STARTED|Overall Study||30
90808|NCT01495000|218366|P2|NOT COMPLETED|Overall Study||12
90809|NCT01495000|218367|P1|NOT COMPLETED|Overall Study||13
90810|NCT01495000|218366|P2|COMPLETED|Overall Study||114
90811|NCT01495000|218367|P1|COMPLETED|Overall Study||111
90812|NCT01495000|218366|P2|STARTED|Overall Study||126
90813|NCT01495000|218367|P1|STARTED|Overall Study||124
90814|NCT01494987|218409|P2|NOT COMPLETED|Overall Study||28
90815|NCT01494987|218410|P1|NOT COMPLETED|Overall Study||28
90816|NCT01494987|218409|P2|COMPLETED|Overall Study||187
90817|NCT01494987|218410|P1|COMPLETED|Overall Study||188
90818|NCT01494987|218409|P2|STARTED|Overall Study||215
90819|NCT01494987|218410|P1|STARTED|Overall Study||216
90820|NCT01494818|218424|P2|NOT COMPLETED|Overall Study||2
90821|NCT01494818|218425|P1|NOT COMPLETED|Overall Study||2
90822|NCT01494818|218424|P2|COMPLETED|Overall Study||37
90823|NCT01494818|218425|P1|COMPLETED|Overall Study||37
90824|NCT01494818|218424|P2|STARTED|Overall Study||39
90825|NCT01494818|218425|P1|STARTED|Overall Study||39
90826|NCT01494753|218447|P2|NOT COMPLETED|Day42-Day84||0
90827|NCT01494753|218448|P1|NOT COMPLETED|Day42-Day84||0
90828|NCT01494753|218447|P2|COMPLETED|Day42-Day84||15
90829|NCT01494753|218448|P1|COMPLETED|Day42-Day84||15
90830|NCT01494753|218447|P2|STARTED|Day42-Day84||15
90831|NCT01494753|218448|P1|STARTED|Day42-Day84||15
90832|NCT01494753|218447|P2|NOT COMPLETED|Day0-Day42||0
90833|NCT01494753|218448|P1|NOT COMPLETED|Day0-Day42||0
90834|NCT01494753|218447|P2|COMPLETED|Day0-Day42||15
90835|NCT01494753|218448|P1|COMPLETED|Day0-Day42||15
90836|NCT01494753|218447|P2|STARTED|Day0-Day42||15
90837|NCT01494753|218448|P1|STARTED|Day0-Day42||15
90838|NCT01494649|218456|P2|NOT COMPLETED|Overall Study||1
90839|NCT01494649|218457|P1|NOT COMPLETED|Overall Study||0
90840|NCT01494649|218456|P2|COMPLETED|Overall Study||58
90841|NCT01494649|218457|P1|COMPLETED|Overall Study||59
90842|NCT01494649|218456|P2|STARTED|Overall Study||59
90843|NCT01494649|218457|P1|STARTED|Overall Study||59
90844|NCT01494610|218473|P2|NOT COMPLETED|Period 4||0
90845|NCT01494610|218474|P1|NOT COMPLETED|Period 4||1
90846|NCT01494610|218473|P2|COMPLETED|Period 4||28
90847|NCT01494610|218474|P1|COMPLETED|Period 4||27
90848|NCT01494610|218473|P2|STARTED|Period 4||28
90849|NCT01494610|218474|P1|STARTED|Period 4||28
90850|NCT01494610|218473|P2|NOT COMPLETED|Period 3||0
90851|NCT01494610|218474|P1|NOT COMPLETED|Period 3||2
90852|NCT01494610|218473|P2|COMPLETED|Period 3||28
90853|NCT01494610|218474|P1|COMPLETED|Period 3||28
90854|NCT01494610|218473|P2|STARTED|Period 3||28
90855|NCT01494610|218474|P1|STARTED|Period 3||30
90856|NCT01494610|218473|P2|NOT COMPLETED|Period 2||0
90857|NCT01494610|218474|P1|NOT COMPLETED|Period 2||0
90858|NCT01494610|218473|P2|COMPLETED|Period 2||28
90859|NCT01494610|218474|P1|COMPLETED|Period 2||30
90860|NCT01494610|218473|P2|STARTED|Period 2||28
90861|NCT01494610|218474|P1|STARTED|Period 2||30
90862|NCT01494610|218473|P2|NOT COMPLETED|Period 1||1
90863|NCT01494610|218474|P1|NOT COMPLETED|Period 1||1
90864|NCT01494610|218473|P2|COMPLETED|Period 1||28
90865|NCT01494610|218474|P1|COMPLETED|Period 1||30
90866|NCT01494610|218473|P2|STARTED|Period 1||29
90867|NCT01494610|218474|P1|STARTED|Period 1||31
90868|NCT01494584|218542|P1|NOT COMPLETED|Overall Study||1
90869|NCT01494584|218542|P1|COMPLETED|Overall Study||4
90870|NCT01494584|218542|P1|STARTED|Overall Study||5
90871|NCT01494545|218631|P1|NOT COMPLETED|Overall Study||10
90872|NCT01494545|218631|P1|COMPLETED|Overall Study||92
90873|NCT01494545|218631|P1|STARTED|Overall Study||102
90874|NCT01494532|218674|P6|NOT COMPLETED|Overall Study||0
90875|NCT01494532|218675|P5|NOT COMPLETED|Overall Study||12
90876|NCT01494532|218676|P4|NOT COMPLETED|Overall Study||15
90877|NCT01494532|218677|P3|NOT COMPLETED|Overall Study||17
90878|NCT01494532|218678|P2|NOT COMPLETED|Overall Study||4
90879|NCT01494532|218679|P1|NOT COMPLETED|Overall Study||10
90880|NCT01494532|218674|P6|COMPLETED|Overall Study||25
90881|NCT01494532|218675|P5|COMPLETED|Overall Study||64
90882|NCT01494532|218676|P4|COMPLETED|Overall Study||60
90883|NCT01494532|218677|P3|COMPLETED|Overall Study||59
90884|NCT01494532|218678|P2|COMPLETED|Overall Study||21
90885|NCT01494532|218679|P1|COMPLETED|Overall Study||65
90886|NCT01494532|218674|P6|STARTED|Overall Study||25
90887|NCT01494532|218675|P5|STARTED|Overall Study||76
90888|NCT01494532|218676|P4|STARTED|Overall Study||75
90889|NCT01494532|218677|P3|STARTED|Overall Study||76
90890|NCT01494532|218678|P2|STARTED|Overall Study||25
90891|NCT01494532|218679|P1|STARTED|Overall Study||75
90892|NCT01494506|218834|P3|NOT COMPLETED|Overall Study||103
90893|NCT01494506|218835|P2|NOT COMPLETED|Overall Study||143
90894|NCT01494506|218836|P1|NOT COMPLETED|Overall Study||148
90895|NCT01494506|218834|P3|COMPLETED|Overall Study||14
90896|NCT01494506|218835|P2|COMPLETED|Overall Study||6
90897|NCT01494506|218836|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
90898|NCT01494506|218834|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
90899|NCT01494506|218835|P2|Treated Population|Overall Study||134
90900|NCT01494506|218836|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
90901|NCT01494506|218834|P3|STARTED|Overall Study||117
90902|NCT01494506|218835|P2|STARTED|Overall Study||149
90903|NCT01494506|218836|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
90904|NCT01494467|218873|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
90905|NCT01494467|218874|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
90906|NCT01494467|218873|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
90907|NCT01494467|218874|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
90908|NCT01494467|218873|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
90909|NCT01494467|218874|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
90910|NCT01494467|218873|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
90911|NCT01494467|218874|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
90912|NCT01494467|218873|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
90913|NCT01494467|218874|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
90914|NCT01494467|218873|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
90915|NCT01494467|218874|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
90916|NCT01494467|218873|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
90917|NCT01494467|218874|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
90918|NCT01494467|218873|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
90919|NCT01494467|218874|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
90920|NCT01494467|218873|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
90921|NCT01494467|218874|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
90922|NCT01494350|218890|P1|NOT COMPLETED|Overall Study||1
90923|NCT01494350|218890|P1|COMPLETED|Overall Study||49
90924|NCT01494350|218890|P1|STARTED|Overall Study||50
90925|NCT01494298|218900|P2|NOT COMPLETED|Overall Study||8
90926|NCT01494298|218901|P1|NOT COMPLETED|Overall Study||2
90927|NCT01494298|218900|P2|COMPLETED|Overall Study||47
90928|NCT01494298|218901|P1|COMPLETED|Overall Study||54
90929|NCT01494298|218900|P2|STARTED|Overall Study||55
90930|NCT01494298|218901|P1|STARTED|Overall Study||56
90931|NCT01493960|218913|P2|NOT COMPLETED|Overall Study||18
90932|NCT01493960|218914|P1|NOT COMPLETED|Overall Study||32
90933|NCT01493960|218913|P2|COMPLETED|Overall Study||26
90934|NCT01493960|218914|P1|COMPLETED|Overall Study||55
90935|NCT01493960|218913|P2|Received Study Drug|Overall Study||43
90936|NCT01493960|218914|P1|Received Study Drug|Overall Study||87
90937|NCT01493960|218913|P2|STARTED|Overall Study||44
90938|NCT01493960|218914|P1|STARTED|Overall Study||87
90939|NCT01493947|218934|P2|NOT COMPLETED|Period B Extension Period||32
90940|NCT01493947|218935|P1|NOT COMPLETED|Period B Extension Period||33
90941|NCT01493947|218934|P2|COMPLETED|Period B Extension Period||326
90942|NCT01493947|218935|P1|COMPLETED|Period B Extension Period||366
90943|NCT01493947|218934|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
90944|NCT01493947|218935|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
90945|NCT01493947|218934|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
90946|NCT01493947|218935|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
90947|NCT01493947|218934|P2|COMPLETED|Period A Efficacy and Safety Data||456
90948|NCT01493947|218935|P1|COMPLETED|Period A Efficacy and Safety Data||446
90949|NCT01493947|218934|P2|STARTED|Period A Efficacy and Safety Data||484
90950|NCT01493947|218935|P1|STARTED|Period A Efficacy and Safety Data||478
90951|NCT01493687|218947|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
90952|NCT01493687|218948|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
90953|NCT01493687|218947|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
90954|NCT01493687|218948|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
90955|NCT01493687|218947|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
90956|NCT01493687|218948|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
90957|NCT01493687|218947|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
90958|NCT01493687|218948|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
90959|NCT01493687|218947|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
90960|NCT01493687|218948|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
90961|NCT01493687|218947|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
90962|NCT01493687|218948|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
90963|NCT01493687|218947|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
90964|NCT01493687|218948|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
90965|NCT01493687|218947|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
90966|NCT01493687|218948|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
90967|NCT01493687|218947|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
90968|NCT01493687|218948|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
90969|NCT01493557|218967|P3|NOT COMPLETED|Adding the Second Strategy||0
90970|NCT01493557|218968|P2|NOT COMPLETED|Adding the Second Strategy||4
90971|NCT01493557|218969|P1|NOT COMPLETED|Adding the Second Strategy||2
90972|NCT01493557|218967|P3|COMPLETED|Adding the Second Strategy||0
90973|NCT01493557|218968|P2|COMPLETED|Adding the Second Strategy||11
90974|NCT01493557|218969|P1|COMPLETED|Adding the Second Strategy||12
90975|NCT01493557|218967|P3|STARTED|Adding the Second Strategy||0
90976|NCT01493557|218968|P2|STARTED|Adding the Second Strategy||15
90977|NCT01493557|218969|P1|STARTED|Adding the Second Strategy||14
90978|NCT01493557|218967|P3|NOT COMPLETED|Randomized to Management Strategies||0
90979|NCT01493557|218968|P2|NOT COMPLETED|Randomized to Management Strategies||11
90980|NCT01493557|218969|P1|NOT COMPLETED|Randomized to Management Strategies||15
90981|NCT01493557|218967|P3|COMPLETED|Randomized to Management Strategies||0
90982|NCT01493557|218968|P2|COMPLETED|Randomized to Management Strategies||47
90983|NCT01493557|218969|P1|COMPLETED|Randomized to Management Strategies||44
90984|NCT01493557|218967|P3|STARTED|Randomized to Management Strategies||0
90985|NCT01493557|218968|P2|STARTED|Randomized to Management Strategies||58
90986|NCT01493557|218969|P1|STARTED|Randomized to Management Strategies||59
90987|NCT01493557|218967|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
90988|NCT01493557|218968|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
90989|NCT01493557|218969|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
90990|NCT01493557|218967|P3|COMPLETED|Not Randomized to Management Strategies||816
90991|NCT01493557|218968|P2|COMPLETED|Not Randomized to Management Strategies||0
90992|NCT01493557|218969|P1|COMPLETED|Not Randomized to Management Strategies||0
90993|NCT01493557|218967|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
90994|NCT01493557|218968|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
90995|NCT01493557|218969|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
90996|NCT01493557|218967|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
90997|NCT01493557|218968|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
90998|NCT01493557|218969|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
90999|NCT01493557|218967|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
91000|NCT01493557|218968|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
91001|NCT01493557|218969|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
91002|NCT01493557|218967|P3|STARTED|Not Randomized to Management Strategies||950
91003|NCT01493557|218968|P2|STARTED|Not Randomized to Management Strategies||0
91004|NCT01493557|218969|P1|STARTED|Not Randomized to Management Strategies||0
91005|NCT01493531|218997|P3|NOT COMPLETED|Overall Study||48
91006|NCT01493531|218998|P2|NOT COMPLETED|Overall Study||50
91007|NCT01493531|218999|P1|NOT COMPLETED|Overall Study||41
91008|NCT01493531|218997|P3|COMPLETED|Overall Study||158
91009|NCT01493531|218998|P2|COMPLETED|Overall Study||150
91010|NCT01493531|218999|P1|COMPLETED|Overall Study||163
91011|NCT01493531|218997|P3|STARTED|Overall Study||206
91012|NCT01493531|218998|P2|STARTED|Overall Study||200
91013|NCT01493531|218999|P1|STARTED|Overall Study||204
91014|NCT01493427|219013|P1|NOT COMPLETED|Overall Study||20
91015|NCT01493427|219013|P1|COMPLETED|Overall Study||179
91016|NCT01493427|219013|P1|STARTED|Overall Study||199
91017|NCT01493284|219018|P1|NOT COMPLETED|Overall Study||61
91018|NCT01493284|219018|P1|COMPLETED|Overall Study||161
91019|NCT01493284|219018|P1|STARTED|Overall Study||222
91020|NCT01493180|219027|P2|NOT COMPLETED|Overall Study||2
91021|NCT01493180|219028|P1|NOT COMPLETED|Overall Study||3
91022|NCT01493180|219027|P2|COMPLETED|Overall Study||49
91023|NCT01493180|219028|P1|COMPLETED|Overall Study||48
91024|NCT01493180|219027|P2|STARTED|Overall Study||51
91025|NCT01493180|219028|P1|STARTED|Overall Study||51
91026|NCT01493167|219034|P1|NOT COMPLETED|Overall Study||0
91027|NCT01493167|219034|P1|COMPLETED|Overall Study||97
91028|NCT01493167|219034|P1|STARTED|Overall Study||97
91029|NCT01493089|219040|P2|NOT COMPLETED|Overall Study||3
91030|NCT01493089|219041|P1|NOT COMPLETED|Overall Study||3
91031|NCT01493089|219040|P2|COMPLETED|Overall Study||114
91032|NCT01493089|219041|P1|COMPLETED|Overall Study||119
91033|NCT01493089|219040|P2|STARTED|Overall Study||117
91034|NCT01493089|219041|P1|STARTED|Overall Study||122
91035|NCT01492439|219059|P2|NOT COMPLETED|Overall Study||9
91036|NCT01492439|219060|P1|NOT COMPLETED|Overall Study||4
91037|NCT01492439|219059|P2|COMPLETED|Overall Study||9
91038|NCT01492439|219060|P1|COMPLETED|Overall Study||15
91039|NCT01492439|219059|P2|Post-intervention|Overall Study||13
91040|NCT01492439|219060|P1|Post-intervention|Overall Study||18
91041|NCT01492439|219059|P2|STARTED|Overall Study||18
91042|NCT01492439|219060|P1|STARTED|Overall Study||19
91043|NCT01492426|219108|P2|NOT COMPLETED|Follow-Up||10
91044|NCT01492426|219109|P1|NOT COMPLETED|Follow-Up||25
91045|NCT01492426|219108|P2|COMPLETED|Follow-Up||181
91046|NCT01492426|219109|P1|COMPLETED|Follow-Up||359
91047|NCT01492426|219108|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
91048|NCT01492426|219109|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
91049|NCT01492426|219108|P2|NOT COMPLETED|Treatment||40
91050|NCT01492426|219109|P1|NOT COMPLETED|Treatment||83
91051|NCT01492426|219108|P2|COMPLETED|Treatment||160
91052|NCT01492426|219109|P1|COMPLETED|Treatment||319
91053|NCT01492426|219108|P2|STARTED|Treatment||200
91054|NCT01492426|219109|P1|STARTED|Treatment||402
91055|NCT01492400|219127|P2|NOT COMPLETED|Overall Study||16
91056|NCT01492400|219128|P1|NOT COMPLETED|Overall Study||16
91057|NCT01492400|219127|P2|COMPLETED|Overall Study||166
91058|NCT01492400|219128|P1|COMPLETED|Overall Study||165
91059|NCT01492400|219127|P2|STARTED|Overall Study||182
91060|NCT01492400|219128|P1|STARTED|Overall Study||181
91061|NCT01492309|219140|P2|NOT COMPLETED|Overall Study||0
91062|NCT01492309|219141|P1|NOT COMPLETED|Overall Study||0
91063|NCT01492309|219140|P2|COMPLETED|Overall Study||11
91064|NCT01492309|219141|P1|COMPLETED|Overall Study||11
91065|NCT01492309|219140|P2|STARTED|Overall Study||11
91066|NCT01492309|219141|P1|STARTED|Overall Study||11
91067|NCT01492088|219152|P3|NOT COMPLETED|Overall Study||13
91068|NCT01492088|219153|P2|NOT COMPLETED|Overall Study||14
91069|NCT01492088|219154|P1|NOT COMPLETED|Overall Study||3
91070|NCT01492088|219152|P3|COMPLETED|Overall Study||4
91071|NCT01492088|219153|P2|COMPLETED|Overall Study||2
91072|NCT01492088|219154|P1|COMPLETED|Overall Study||0
91073|NCT01492088|219152|P3|STARTED|Overall Study||17
91074|NCT01492088|219153|P2|STARTED|Overall Study||16
91075|NCT01492088|219154|P1|STARTED|Overall Study||3
91076|NCT01491984|219214|P2|NOT COMPLETED|Overall Study||1
91077|NCT01491984|219215|P1|NOT COMPLETED|Overall Study||2
91078|NCT01491984|219214|P2|COMPLETED|Overall Study||44
91079|NCT01491984|219215|P1|COMPLETED|Overall Study||47
91080|NCT01491984|219214|P2|STARTED|Overall Study||45
91081|NCT01491984|219215|P1|STARTED|Overall Study||49
91082|NCT01491958|219223|P2|NOT COMPLETED|Overall Study||0
91083|NCT01491958|219224|P1|NOT COMPLETED|Overall Study||0
91084|NCT01491958|219223|P2|COMPLETED|Overall Study||40
91085|NCT01491958|219224|P1|COMPLETED|Overall Study||40
91086|NCT01491958|219223|P2|STARTED|Overall Study||40
91087|NCT01491958|219224|P1|STARTED|Overall Study||40
91088|NCT01491919|219235|P3|NOT COMPLETED|Overall Study||1
91089|NCT01491919|219236|P2|NOT COMPLETED|Overall Study||2
91090|NCT01491919|219237|P1|NOT COMPLETED|Overall Study||1
91091|NCT01491919|219235|P3|COMPLETED|Overall Study||2
91092|NCT01491919|219236|P2|COMPLETED|Overall Study||8
91093|NCT01491919|219237|P1|COMPLETED|Overall Study||12
91094|NCT01491919|219235|P3|STARTED|Overall Study||3
91095|NCT01491919|219236|P2|STARTED|Overall Study||10
91096|NCT01491919|219237|P1|STARTED|Overall Study||13
91097|NCT01491802|219283|P2|NOT COMPLETED|Overall Study||2
91098|NCT01491802|219284|P1|NOT COMPLETED|Overall Study||1
91099|NCT01491802|219283|P2|COMPLETED|Overall Study||6
91100|NCT01491802|219284|P1|COMPLETED|Overall Study||8
91101|NCT01491802|219283|P2|STARTED|Overall Study||8
91102|NCT01491802|219284|P1|STARTED|Overall Study||9
91103|NCT01491737|219311|P2|NOT COMPLETED|Overall Study||50
91104|NCT01491737|219312|P1|NOT COMPLETED|Overall Study||49
91105|NCT01491737|219311|P2|COMPLETED|Overall Study||79
91106|NCT01491737|219312|P1|COMPLETED|Overall Study||80
91107|NCT01491737|219311|P2|STARTED|Overall Study||129
91108|NCT01491737|219312|P1|STARTED|Overall Study||129
91109|NCT01491672|219335|P3|NOT COMPLETED|Overall Study||11
91110|NCT01491672|219336|P2|NOT COMPLETED|Overall Study||60
91111|NCT01491672|219337|P1|NOT COMPLETED|Overall Study||56
91112|NCT01491672|219335|P3|COMPLETED|Overall Study||3
91113|NCT01491672|219336|P2|COMPLETED|Overall Study||2
91114|NCT01491672|219337|P1|COMPLETED|Overall Study||2
91115|NCT01491672|219335|P3|Safety Set|Overall Study||14
91116|NCT01491672|219336|P2|Safety Set|Overall Study||61
91117|NCT01491672|219337|P1|Safety Set|Overall Study||58
91118|NCT01491672|219335|P3|STARTED|Overall Study||14
91119|NCT01491672|219336|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
91120|NCT01491672|219337|P1|STARTED|Overall Study||58
91121|NCT01491633|219362|P1|NOT COMPLETED|Overall Study||5
91122|NCT01491633|219362|P1|COMPLETED|Overall Study||0
91123|NCT01491633|219362|P1|STARTED|Overall Study||5
91124|NCT01491607|219374|P1|NOT COMPLETED|Overall Study||10
91125|NCT01491607|219374|P1|COMPLETED|Overall Study||190
91126|NCT01491607|219374|P1|STARTED|Overall Study||200
91127|NCT01491490|219472|P2|NOT COMPLETED|Overall Study||0
91128|NCT01491490|219473|P1|NOT COMPLETED|Overall Study||0
91129|NCT01491490|219472|P2|COMPLETED|Overall Study||1
91130|NCT01491490|219473|P1|COMPLETED|Overall Study||1
91131|NCT01491490|219472|P2|STARTED|Overall Study||1
91132|NCT01491490|219473|P1|STARTED|Overall Study||1
91133|NCT01491178|219479|P1|NOT COMPLETED|Overall Study||2794
91134|NCT01491178|219479|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
91135|NCT01491178|219479|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
91136|NCT01491113|219489|P5|NOT COMPLETED|Overall Study||0
91137|NCT01491113|219490|P4|NOT COMPLETED|Overall Study||0
91138|NCT01491113|219491|P3|NOT COMPLETED|Overall Study||0
91139|NCT01491113|219492|P2|NOT COMPLETED|Overall Study||0
91140|NCT01491113|219493|P1|NOT COMPLETED|Overall Study||0
91141|NCT01491113|219489|P5|COMPLETED|Overall Study||6
91142|NCT01491113|219490|P4|COMPLETED|Overall Study||6
91143|NCT01491113|219491|P3|COMPLETED|Overall Study||6
91144|NCT01491113|219492|P2|COMPLETED|Overall Study||6
91145|NCT01491113|219493|P1|COMPLETED|Overall Study||6
91146|NCT01491113|219489|P5|STARTED|Overall Study||6
91147|NCT01491113|219490|P4|STARTED|Overall Study||6
91148|NCT01491113|219491|P3|STARTED|Overall Study||6
91149|NCT01491113|219492|P2|STARTED|Overall Study||6
91150|NCT01491113|219493|P1|STARTED|Overall Study||6
91151|NCT01491035|219588|P8|NOT COMPLETED|Overall Study||0
91152|NCT01491035|219589|P7|NOT COMPLETED|Overall Study||0
91153|NCT01491035|219590|P6|NOT COMPLETED|Overall Study||0
91154|NCT01491035|219591|P5|NOT COMPLETED|Overall Study||1
91155|NCT01491035|219592|P4|NOT COMPLETED|Overall Study||0
91156|NCT01491035|219593|P3|NOT COMPLETED|Overall Study||0
91157|NCT01491035|219594|P2|NOT COMPLETED|Overall Study||0
91158|NCT01491035|219595|P1|NOT COMPLETED|Overall Study||0
91159|NCT01491035|219588|P8|COMPLETED|Overall Study||6
91160|NCT01491035|219589|P7|COMPLETED|Overall Study||6
91161|NCT01491035|219590|P6|COMPLETED|Overall Study||6
91162|NCT01491035|219591|P5|COMPLETED|Overall Study||5
91163|NCT01491035|219592|P4|COMPLETED|Overall Study||6
91164|NCT01491035|219593|P3|COMPLETED|Overall Study||6
91165|NCT01491035|219594|P2|COMPLETED|Overall Study||6
91166|NCT01491035|219595|P1|COMPLETED|Overall Study||6
91167|NCT01491035|219588|P8|STARTED|Overall Study||6
91168|NCT01491035|219589|P7|STARTED|Overall Study||6
91169|NCT01491035|219590|P6|STARTED|Overall Study||6
91170|NCT01491035|219591|P5|STARTED|Overall Study||6
91171|NCT01491035|219592|P4|STARTED|Overall Study||6
91172|NCT01491035|219593|P3|STARTED|Overall Study||6
91173|NCT01491035|219594|P2|STARTED|Overall Study||6
91174|NCT01491035|219595|P1|STARTED|Overall Study||6
91175|NCT01491022|219663|P2|NOT COMPLETED|Intervention 2||0
91176|NCT01491022|219664|P1|NOT COMPLETED|Intervention 2||1
91177|NCT01491022|219663|P2|COMPLETED|Intervention 2||11
91178|NCT01491022|219664|P1|COMPLETED|Intervention 2||8
91179|NCT01491022|219663|P2|STARTED|Intervention 2||11
91180|NCT01491022|219664|P1|STARTED|Intervention 2||9
91181|NCT01491022|219663|P2|NOT COMPLETED|2 Week Washout||0
91182|NCT01491022|219664|P1|NOT COMPLETED|2 Week Washout||0
91183|NCT01491022|219663|P2|COMPLETED|2 Week Washout||11
91184|NCT01491022|219664|P1|COMPLETED|2 Week Washout||9
91185|NCT01491022|219663|P2|STARTED|2 Week Washout||11
91186|NCT01491022|219664|P1|STARTED|2 Week Washout||9
91187|NCT01491022|219663|P2|NOT COMPLETED|Intervention 1||1
91188|NCT01491022|219664|P1|NOT COMPLETED|Intervention 1||1
91189|NCT01491022|219663|P2|COMPLETED|Intervention 1||11
91190|NCT01491022|219664|P1|COMPLETED|Intervention 1||9
91191|NCT01491022|219663|P2|STARTED|Intervention 1||12
91192|NCT01491022|219664|P1|STARTED|Intervention 1||10
91193|NCT01490931|219680|P1|NOT COMPLETED|Overall Study||0
91194|NCT01490931|219680|P1|COMPLETED|Overall Study||25
91195|NCT01490931|219680|P1|STARTED|Overall Study||25
91196|NCT01490866|219696|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
91197|NCT01490866|219696|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
91198|NCT01490866|219696|P1|STARTED|Axitinib Maintenance Therapy||49
91199|NCT01490866|219696|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
91200|NCT01490866|219696|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
91201|NCT01490866|219696|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
91202|NCT01490840|219707|P2|NOT COMPLETED|Phase 2||6
91203|NCT01490840|219708|P1|NOT COMPLETED|Phase 2||6
91204|NCT01490840|219707|P2|COMPLETED|Phase 2||68
91205|NCT01490840|219708|P1|COMPLETED|Phase 2||75
91206|NCT01490840|219707|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
91207|NCT01490840|219708|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
91208|NCT01490840|219707|P2|NOT COMPLETED|Phase 1||6
91209|NCT01490840|219708|P1|NOT COMPLETED|Phase 1||10
91210|NCT01490840|219707|P2|COMPLETED|Phase 1||78
91211|NCT01490840|219708|P1|COMPLETED|Phase 1||84
91212|NCT01490840|219707|P2|Modified Full Analysis Set|Phase 1||83
91213|NCT01490840|219708|P1|Modified Full Analysis Set|Phase 1||56
91214|NCT01490840|219707|P2|STARTED|Phase 1||84
91215|NCT01490840|219708|P1|STARTED|Phase 1||94
91216|NCT01490697|219732|P2|NOT COMPLETED|Overall Study||2
91217|NCT01490697|219733|P1|NOT COMPLETED|Overall Study||1
91218|NCT01490697|219732|P2|COMPLETED|Overall Study||16
91219|NCT01490697|219733|P1|COMPLETED|Overall Study||15
91220|NCT01490697|219732|P2|STARTED|Overall Study||18
91221|NCT01490697|219733|P1|STARTED|Overall Study||16
91222|NCT01490632|219746|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
91223|NCT01490632|219747|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
91224|NCT01490632|219748|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
91225|NCT01490632|219749|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
91226|NCT01490632|219750|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
91227|NCT01490632|219751|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
91228|NCT01490632|219752|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
91229|NCT01490632|219753|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
91230|NCT01490632|219754|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
91231|NCT01490632|219755|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
91232|NCT01490632|219756|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
91233|NCT01490632|219757|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
91234|NCT01490632|219758|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
91235|NCT01490632|219759|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
91236|NCT01490632|219760|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
91237|NCT01490632|219761|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
91238|NCT01490632|219762|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
91239|NCT01490632|219763|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
91240|NCT01490632|219764|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
91241|NCT01490632|219765|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
91242|NCT01490632|219746|P20|COMPLETED|Part D: Re-Treatment Period||30
91243|NCT01490632|219747|P19|COMPLETED|Part D: Re-Treatment Period||12
91244|NCT01490632|219748|P18|COMPLETED|Part D: Re-Treatment Period||8
91245|NCT01490632|219749|P17|COMPLETED|Part D: Re-Treatment Period||3
91246|NCT01490632|219750|P16|COMPLETED|Part D: Re-Treatment Period||0
91247|NCT01490632|219751|P15|COMPLETED|Part D: Re-Treatment Period||0
91248|NCT01490632|219752|P14|COMPLETED|Part D: Re-Treatment Period||0
91249|NCT01490632|219753|P13|COMPLETED|Part D: Re-Treatment Period||0
91250|NCT01490632|219754|P12|COMPLETED|Part D: Re-Treatment Period||0
91251|NCT01490632|219755|P11|COMPLETED|Part D: Re-Treatment Period||0
91252|NCT01490632|219756|P10|COMPLETED|Part D: Re-Treatment Period||0
91253|NCT01490632|219757|P9|COMPLETED|Part D: Re-Treatment Period||0
91254|NCT01490632|219758|P8|COMPLETED|Part D: Re-Treatment Period||0
91255|NCT01490632|219759|P7|COMPLETED|Part D: Re-Treatment Period||0
91256|NCT01490632|219760|P6|COMPLETED|Part D: Re-Treatment Period||0
91257|NCT01490632|219761|P5|COMPLETED|Part D: Re-Treatment Period||0
91258|NCT01490632|219762|P4|COMPLETED|Part D: Re-Treatment Period||0
91259|NCT01490632|219763|P3|COMPLETED|Part D: Re-Treatment Period||0
91260|NCT01490632|219764|P2|COMPLETED|Part D: Re-Treatment Period||0
91261|NCT01490632|219765|P1|COMPLETED|Part D: Re-Treatment Period||0
91262|NCT01490632|219746|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
91263|NCT01490632|219747|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
91264|NCT01490632|219748|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
91265|NCT01490632|219749|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
91266|NCT01490632|219750|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
91267|NCT01490632|219751|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
91268|NCT01490632|219752|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
91269|NCT01490632|219753|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
91270|NCT01490632|219754|P12|STARTED|Part D: Re-Treatment Period||0
91271|NCT01490632|219755|P11|STARTED|Part D: Re-Treatment Period||0
91272|NCT01490632|219756|P10|STARTED|Part D: Re-Treatment Period||0
91273|NCT01490632|219757|P9|STARTED|Part D: Re-Treatment Period||0
91274|NCT01490632|219758|P8|STARTED|Part D: Re-Treatment Period||0
91275|NCT01490632|219759|P7|STARTED|Part D: Re-Treatment Period||0
91276|NCT01490632|219760|P6|STARTED|Part D: Re-Treatment Period||0
91277|NCT01490632|219761|P5|STARTED|Part D: Re-Treatment Period||0
91278|NCT01490632|219762|P4|STARTED|Part D: Re-Treatment Period||0
91279|NCT01490632|219763|P3|STARTED|Part D: Re-Treatment Period||0
91280|NCT01490632|219764|P2|STARTED|Part D: Re-Treatment Period||0
91281|NCT01490632|219765|P1|STARTED|Part D: Re-Treatment Period||0
91282|NCT01490632|219746|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91283|NCT01490632|219747|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91284|NCT01490632|219748|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91285|NCT01490632|219749|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91286|NCT01490632|219750|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
91287|NCT01490632|219751|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
91288|NCT01490632|219752|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
91289|NCT01490632|219753|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
91290|NCT01490632|219754|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91291|NCT01490632|219755|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91292|NCT01490632|219756|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91293|NCT01490632|219757|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91294|NCT01490632|219758|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91295|NCT01490632|219759|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91296|NCT01490632|219760|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91297|NCT01490632|219761|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91298|NCT01490632|219762|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91299|NCT01490632|219763|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91300|NCT01490632|219764|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91301|NCT01490632|219765|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
91302|NCT01490632|219746|P20|COMPLETED|Part C: Washout or Step-Down Period||0
91303|NCT01490632|219747|P19|COMPLETED|Part C: Washout or Step-Down Period||0
91304|NCT01490632|219748|P18|COMPLETED|Part C: Washout or Step-Down Period||0
91305|NCT01490632|219749|P17|COMPLETED|Part C: Washout or Step-Down Period||0
91306|NCT01490632|219750|P16|COMPLETED|Part C: Washout or Step-Down Period||18
91307|NCT01490632|219751|P15|COMPLETED|Part C: Washout or Step-Down Period||37
91308|NCT01490632|219752|P14|COMPLETED|Part C: Washout or Step-Down Period||6
91309|NCT01490632|219753|P13|COMPLETED|Part C: Washout or Step-Down Period||10
91310|NCT01490632|219754|P12|COMPLETED|Part C: Washout or Step-Down Period||0
91311|NCT01490632|219755|P11|COMPLETED|Part C: Washout or Step-Down Period||0
91312|NCT01490632|219756|P10|COMPLETED|Part C: Washout or Step-Down Period||0
91313|NCT01490632|219757|P9|COMPLETED|Part C: Washout or Step-Down Period||0
91314|NCT01490632|219758|P8|COMPLETED|Part C: Washout or Step-Down Period||0
91315|NCT01490632|219759|P7|COMPLETED|Part C: Washout or Step-Down Period||0
91316|NCT01490632|219760|P6|COMPLETED|Part C: Washout or Step-Down Period||0
91317|NCT01490632|219761|P5|COMPLETED|Part C: Washout or Step-Down Period||0
91318|NCT01490632|219762|P4|COMPLETED|Part C: Washout or Step-Down Period||0
91319|NCT01490632|219763|P3|COMPLETED|Part C: Washout or Step-Down Period||0
91320|NCT01490632|219764|P2|COMPLETED|Part C: Washout or Step-Down Period||0
91321|NCT01490632|219765|P1|COMPLETED|Part C: Washout or Step-Down Period||0
91322|NCT01490632|219746|P20|STARTED|Part C: Washout or Step-Down Period||0
91323|NCT01490632|219747|P19|STARTED|Part C: Washout or Step-Down Period||0
91324|NCT01490632|219748|P18|STARTED|Part C: Washout or Step-Down Period||0
91325|NCT01490632|219749|P17|STARTED|Part C: Washout or Step-Down Period||0
91326|NCT01490632|219750|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
91327|NCT01490632|219751|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
91328|NCT01490632|219752|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
91329|NCT01490632|219753|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
91330|NCT01490632|219754|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
91331|NCT01490632|219755|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
91332|NCT01490632|219756|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
91333|NCT01490632|219757|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
91334|NCT01490632|219758|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
91335|NCT01490632|219759|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
91336|NCT01490632|219760|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
91337|NCT01490632|219761|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
91338|NCT01490632|219762|P4|STARTED|Part C: Washout or Step-Down Period||0
91339|NCT01490632|219763|P3|STARTED|Part C: Washout or Step-Down Period||0
91340|NCT01490632|219764|P2|STARTED|Part C: Washout or Step-Down Period||0
91341|NCT01490632|219765|P1|STARTED|Part C: Washout or Step-Down Period||0
91342|NCT01490632|219746|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91343|NCT01490632|219747|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91344|NCT01490632|219748|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91345|NCT01490632|219749|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91346|NCT01490632|219750|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91347|NCT01490632|219751|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91348|NCT01490632|219752|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91349|NCT01490632|219753|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91350|NCT01490632|219754|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
91351|NCT01490632|219755|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
91352|NCT01490632|219756|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
91353|NCT01490632|219757|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
91354|NCT01490632|219758|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
91355|NCT01490632|219759|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
91356|NCT01490632|219760|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
91357|NCT01490632|219761|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91358|NCT01490632|219762|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91359|NCT01490632|219763|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91360|NCT01490632|219764|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91361|NCT01490632|219765|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
91362|NCT01490632|219746|P20|COMPLETED|Part B: Extension or Step-Up Period||0
91363|NCT01490632|219747|P19|COMPLETED|Part B: Extension or Step-Up Period||0
91364|NCT01490632|219748|P18|COMPLETED|Part B: Extension or Step-Up Period||0
91365|NCT01490632|219749|P17|COMPLETED|Part B: Extension or Step-Up Period||0
91366|NCT01490632|219750|P16|COMPLETED|Part B: Extension or Step-Up Period||0
91367|NCT01490632|219751|P15|COMPLETED|Part B: Extension or Step-Up Period||0
91368|NCT01490632|219752|P14|COMPLETED|Part B: Extension or Step-Up Period||0
91369|NCT01490632|219753|P13|COMPLETED|Part B: Extension or Step-Up Period||0
91370|NCT01490632|219754|P12|COMPLETED|Part B: Extension or Step-Up Period||0
91371|NCT01490632|219755|P11|COMPLETED|Part B: Extension or Step-Up Period||22
91372|NCT01490632|219756|P10|COMPLETED|Part B: Extension or Step-Up Period||25
91373|NCT01490632|219757|P9|COMPLETED|Part B: Extension or Step-Up Period||6
91374|NCT01490632|219758|P8|COMPLETED|Part B: Extension or Step-Up Period||13
91375|NCT01490632|219759|P7|COMPLETED|Part B: Extension or Step-Up Period||51
91376|NCT01490632|219760|P6|COMPLETED|Part B: Extension or Step-Up Period||25
91377|NCT01490632|219761|P5|COMPLETED|Part B: Extension or Step-Up Period||0
91378|NCT01490632|219762|P4|COMPLETED|Part B: Extension or Step-Up Period||0
91379|NCT01490632|219763|P3|COMPLETED|Part B: Extension or Step-Up Period||0
91380|NCT01490632|219764|P2|COMPLETED|Part B: Extension or Step-Up Period||0
91381|NCT01490632|219765|P1|COMPLETED|Part B: Extension or Step-Up Period||0
91382|NCT01490632|219746|P20|STARTED|Part B: Extension or Step-Up Period||0
91383|NCT01490632|219747|P19|STARTED|Part B: Extension or Step-Up Period||0
91384|NCT01490632|219748|P18|STARTED|Part B: Extension or Step-Up Period||0
91385|NCT01490632|219749|P17|STARTED|Part B: Extension or Step-Up Period||0
91386|NCT01490632|219750|P16|STARTED|Part B: Extension or Step-Up Period||0
91387|NCT01490632|219751|P15|STARTED|Part B: Extension or Step-Up Period||0
91388|NCT01490632|219752|P14|STARTED|Part B: Extension or Step-Up Period||0
91389|NCT01490632|219753|P13|STARTED|Part B: Extension or Step-Up Period||0
91390|NCT01490632|219754|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
91391|NCT01490632|219755|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
91392|NCT01490632|219756|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
91393|NCT01490632|219757|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
91394|NCT01490632|219758|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
91395|NCT01490632|219759|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
91396|NCT01490632|219760|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
91397|NCT01490632|219761|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
91398|NCT01490632|219762|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
91399|NCT01490632|219763|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
91400|NCT01490632|219764|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
91401|NCT01490632|219765|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
91402|NCT01490632|219746|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
91403|NCT01490632|219747|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
91404|NCT01490632|219748|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
91405|NCT01490632|219749|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
91406|NCT01490632|219750|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
91407|NCT01490632|219751|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
91408|NCT01490632|219752|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
91409|NCT01490632|219753|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
91410|NCT01490632|219754|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
91411|NCT01490632|219755|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
91412|NCT01490632|219756|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
91413|NCT01490632|219757|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
91414|NCT01490632|219758|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
91415|NCT01490632|219759|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
91416|NCT01490632|219760|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
91417|NCT01490632|219761|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
91418|NCT01490632|219762|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
91419|NCT01490632|219763|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
91420|NCT01490632|219764|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
91421|NCT01490632|219765|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
91422|NCT01490632|219746|P20|COMPLETED|Part A: Initial Treatment Period||0
91423|NCT01490632|219747|P19|COMPLETED|Part A: Initial Treatment Period||0
91424|NCT01490632|219748|P18|COMPLETED|Part A: Initial Treatment Period||0
91425|NCT01490632|219749|P17|COMPLETED|Part A: Initial Treatment Period||0
91426|NCT01490632|219750|P16|COMPLETED|Part A: Initial Treatment Period||0
91427|NCT01490632|219751|P15|COMPLETED|Part A: Initial Treatment Period||0
91428|NCT01490632|219752|P14|COMPLETED|Part A: Initial Treatment Period||0
91429|NCT01490632|219753|P13|COMPLETED|Part A: Initial Treatment Period||0
91430|NCT01490632|219754|P12|COMPLETED|Part A: Initial Treatment Period||0
91431|NCT01490632|219755|P11|COMPLETED|Part A: Initial Treatment Period||0
91432|NCT01490632|219756|P10|COMPLETED|Part A: Initial Treatment Period||0
91433|NCT01490632|219757|P9|COMPLETED|Part A: Initial Treatment Period||0
91434|NCT01490632|219758|P8|COMPLETED|Part A: Initial Treatment Period||0
91435|NCT01490632|219759|P7|COMPLETED|Part A: Initial Treatment Period||0
91436|NCT01490632|219760|P6|COMPLETED|Part A: Initial Treatment Period||0
91437|NCT01490632|219761|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
91438|NCT01490632|219762|P4|COMPLETED|Part A: Initial Treatment Period||55
91439|NCT01490632|219763|P3|COMPLETED|Part A: Initial Treatment Period||67
91440|NCT01490632|219764|P2|COMPLETED|Part A: Initial Treatment Period||28
91441|NCT01490632|219765|P1|COMPLETED|Part A: Initial Treatment Period||27
91442|NCT01490632|219746|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91443|NCT01490632|219747|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91444|NCT01490632|219748|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91445|NCT01490632|219749|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91446|NCT01490632|219750|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91447|NCT01490632|219751|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91448|NCT01490632|219752|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91449|NCT01490632|219753|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91450|NCT01490632|219754|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91451|NCT01490632|219755|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91452|NCT01490632|219756|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91453|NCT01490632|219757|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91454|NCT01490632|219758|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91455|NCT01490632|219759|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91456|NCT01490632|219760|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
91457|NCT01490632|219761|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
91458|NCT01490632|219762|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
91459|NCT01490632|219763|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
91460|NCT01490632|219764|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
91461|NCT01490632|219765|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
91462|NCT01490632|219746|P20|STARTED|Part A: Initial Treatment Period||0
91463|NCT01490632|219747|P19|STARTED|Part A: Initial Treatment Period||0
91464|NCT01490632|219748|P18|STARTED|Part A: Initial Treatment Period||0
91465|NCT01490632|219749|P17|STARTED|Part A: Initial Treatment Period||0
91466|NCT01490632|219750|P16|STARTED|Part A: Initial Treatment Period||0
91467|NCT01490632|219751|P15|STARTED|Part A: Initial Treatment Period||0
91468|NCT01490632|219752|P14|STARTED|Part A: Initial Treatment Period||0
91469|NCT01490632|219753|P13|STARTED|Part A: Initial Treatment Period||0
91470|NCT01490632|219754|P12|STARTED|Part A: Initial Treatment Period||0
91471|NCT01490632|219755|P11|STARTED|Part A: Initial Treatment Period||0
91472|NCT01490632|219756|P10|STARTED|Part A: Initial Treatment Period||0
91473|NCT01490632|219757|P9|STARTED|Part A: Initial Treatment Period||0
91474|NCT01490632|219758|P8|STARTED|Part A: Initial Treatment Period||0
91475|NCT01490632|219759|P7|STARTED|Part A: Initial Treatment Period||0
91476|NCT01490632|219760|P6|STARTED|Part A: Initial Treatment Period||0
91477|NCT01490632|219761|P5|STARTED|Part A: Initial Treatment Period||69
91478|NCT01490632|219762|P4|STARTED|Part A: Initial Treatment Period||64
91479|NCT01490632|219763|P3|STARTED|Part A: Initial Treatment Period||72
91480|NCT01490632|219764|P2|STARTED|Part A: Initial Treatment Period||32
91481|NCT01490632|219765|P1|STARTED|Part A: Initial Treatment Period||34
91482|NCT01490359|219895|P2|NOT COMPLETED|Overall Study||17
91483|NCT01490359|219896|P1|NOT COMPLETED|Overall Study||24
91484|NCT01490359|219895|P2|COMPLETED|Overall Study||555
91485|NCT01490359|219896|P1|COMPLETED|Overall Study||585
91486|NCT01490359|219895|P2|Followed-up at 12 mo|Overall Study||537
91487|NCT01490359|219896|P1|Followed-up at 12 mo|Overall Study||569
91488|NCT01490359|219895|P2|Followed-up at 6 mo|Overall Study||535
91489|NCT01490359|219896|P1|Followed-up at 6 mo|Overall Study||558
91490|NCT01490359|219895|P2|STARTED|Overall Study||572
91491|NCT01490359|219896|P1|STARTED|Overall Study||609
91492|NCT01490294|219920|P4|NOT COMPLETED|Overall Study||1
91493|NCT01490294|219921|P3|NOT COMPLETED|Overall Study||1
91494|NCT01490294|219922|P2|NOT COMPLETED|Overall Study||0
91495|NCT01490294|219923|P1|NOT COMPLETED|Overall Study||5
91496|NCT01490294|219920|P4|COMPLETED|Overall Study||54
91497|NCT01490294|219921|P3|COMPLETED|Overall Study||58
91498|NCT01490294|219922|P2|COMPLETED|Overall Study||60
91499|NCT01490294|219923|P1|COMPLETED|Overall Study||53
91500|NCT01490294|219920|P4|Participant Received Treatment|Overall Study||54
91501|NCT01490294|219921|P3|Participant Received Treatment|Overall Study||58
91502|NCT01490294|219922|P2|Participant Received Treatment|Overall Study||60
91503|NCT01490294|219923|P1|Participant Received Treatment|Overall Study||54
91504|NCT01490294|219920|P4|STARTED|Overall Study||55
91505|NCT01490294|219921|P3|STARTED|Overall Study||59
91506|NCT01490294|219922|P2|STARTED|Overall Study||60
91507|NCT01490294|219923|P1|STARTED|Overall Study||58
91508|NCT01490190|220157|P1|NOT COMPLETED|Overall Study||48
91509|NCT01490190|220157|P1|COMPLETED|Overall Study||204
91510|NCT01490190|220157|P1|STARTED|Overall Study||252
91511|NCT01490151|220178|P1|NOT COMPLETED|Overall Study||0
91512|NCT01490151|220178|P1|COMPLETED|Overall Study||22
91513|NCT01490151|220178|P1|STARTED|Overall Study||22
91514|NCT01490125|220184|P6|NOT COMPLETED|Period III||0
91515|NCT01490125|220185|P5|NOT COMPLETED|Period III||1
91516|NCT01490125|220186|P4|NOT COMPLETED|Period III||2
91517|NCT01490125|220187|P3|NOT COMPLETED|Period III||0
91518|NCT01490125|220188|P2|NOT COMPLETED|Period III||1
91519|NCT01490125|220189|P1|NOT COMPLETED|Period III||3
91520|NCT01490125|220184|P6|COMPLETED|Period III||35
91521|NCT01490125|220185|P5|COMPLETED|Period III||31
91522|NCT01490125|220186|P4|COMPLETED|Period III||28
91523|NCT01490125|220187|P3|COMPLETED|Period III||34
91524|NCT01490125|220188|P2|COMPLETED|Period III||32
91525|NCT01490125|220189|P1|COMPLETED|Period III||31
91526|NCT01490125|220184|P6|STARTED|Period III||35
91527|NCT01490125|220185|P5|STARTED|Period III||32
91528|NCT01490125|220186|P4|STARTED|Period III||30
91529|NCT01490125|220187|P3|STARTED|Period III||34
91530|NCT01490125|220188|P2|STARTED|Period III||33
91531|NCT01490125|220189|P1|STARTED|Period III||34
91532|NCT01490125|220184|P6|NOT COMPLETED|Period II||2
91533|NCT01490125|220185|P5|NOT COMPLETED|Period II||4
91534|NCT01490125|220186|P4|NOT COMPLETED|Period II||3
91535|NCT01490125|220187|P3|NOT COMPLETED|Period II||3
91536|NCT01490125|220188|P2|NOT COMPLETED|Period II||4
91537|NCT01490125|220189|P1|NOT COMPLETED|Period II||3
91538|NCT01490125|220184|P6|COMPLETED|Period II||35
91539|NCT01490125|220185|P5|COMPLETED|Period II||32
91540|NCT01490125|220186|P4|COMPLETED|Period II||30
91541|NCT01490125|220187|P3|COMPLETED|Period II||34
91542|NCT01490125|220188|P2|COMPLETED|Period II||33
91543|NCT01490125|220189|P1|COMPLETED|Period II||34
91544|NCT01490125|220184|P6|STARTED|Period II||37
91545|NCT01490125|220185|P5|STARTED|Period II||36
91546|NCT01490125|220186|P4|STARTED|Period II||33
91547|NCT01490125|220187|P3|STARTED|Period II||37
91548|NCT01490125|220188|P2|STARTED|Period II||37
91549|NCT01490125|220189|P1|STARTED|Period II||37
91550|NCT01490125|220184|P6|NOT COMPLETED|Period I||5
91551|NCT01490125|220185|P5|NOT COMPLETED|Period I||4
91552|NCT01490125|220186|P4|NOT COMPLETED|Period I||5
91553|NCT01490125|220187|P3|NOT COMPLETED|Period I||4
91554|NCT01490125|220188|P2|NOT COMPLETED|Period I||5
91555|NCT01490125|220189|P1|NOT COMPLETED|Period I||6
91556|NCT01490125|220184|P6|COMPLETED|Period I||37
91557|NCT01490125|220185|P5|COMPLETED|Period I||36
91558|NCT01490125|220186|P4|COMPLETED|Period I||33
91559|NCT01490125|220187|P3|COMPLETED|Period I||37
91560|NCT01490125|220188|P2|COMPLETED|Period I||37
91561|NCT01490125|220189|P1|COMPLETED|Period I||37
91562|NCT01490125|220184|P6|STARTED|Period I||42
91563|NCT01490125|220185|P5|STARTED|Period I||40
91564|NCT01490125|220186|P4|STARTED|Period I||38
91565|NCT01490125|220187|P3|STARTED|Period I||41
91566|NCT01490125|220188|P2|STARTED|Period I||42
91567|NCT01490125|220189|P1|STARTED|Period I||43
91568|NCT01490086|220217|P5|NOT COMPLETED|Overall Study||11
91569|NCT01490086|220218|P4|NOT COMPLETED|Overall Study||7
91570|NCT01490086|220219|P3|NOT COMPLETED|Overall Study||7
91571|NCT01490086|220220|P2|NOT COMPLETED|Overall Study||15
91572|NCT01490086|220221|P1|NOT COMPLETED|Overall Study||8
91573|NCT01490086|220217|P5|COMPLETED|Overall Study||28
91574|NCT01490086|220218|P4|COMPLETED|Overall Study||13
91575|NCT01490086|220219|P3|COMPLETED|Overall Study||51
91576|NCT01490086|220220|P2|COMPLETED|Overall Study||44
91577|NCT01490086|220221|P1|COMPLETED|Overall Study||50
91578|NCT01490086|220217|P5|STARTED|Overall Study||39
91579|NCT01490086|220218|P4|STARTED|Overall Study||20
91580|NCT01490086|220219|P3|STARTED|Overall Study||58
91581|NCT01490086|220220|P2|STARTED|Overall Study||59
91582|NCT01490086|220221|P1|STARTED|Overall Study||58
91583|NCT01490060|220255|P4|NOT COMPLETED|Cycle 2||0
91584|NCT01490060|220256|P3|NOT COMPLETED|Cycle 2||1
91585|NCT01490060|220257|P2|NOT COMPLETED|Cycle 2||1
91586|NCT01490060|220258|P1|NOT COMPLETED|Cycle 2||2
91587|NCT01490060|220255|P4|COMPLETED|Cycle 2||8
91588|NCT01490060|220256|P3|COMPLETED|Cycle 2||8
91589|NCT01490060|220257|P2|COMPLETED|Cycle 2||11
91590|NCT01490060|220258|P1|COMPLETED|Cycle 2||9
91591|NCT01490060|220255|P4|STARTED|Cycle 2||8
91592|NCT01490060|220256|P3|STARTED|Cycle 2||9
91593|NCT01490060|220257|P2|STARTED|Cycle 2||12
91594|NCT01490060|220258|P1|STARTED|Cycle 2||11
91595|NCT01490060|220255|P4|NOT COMPLETED|Cycle 1||3
91596|NCT01490060|220256|P3|NOT COMPLETED|Cycle 1||3
91597|NCT01490060|220257|P2|NOT COMPLETED|Cycle 1||1
91598|NCT01490060|220258|P1|NOT COMPLETED|Cycle 1||0
91599|NCT01490060|220255|P4|COMPLETED|Cycle 1||8
91600|NCT01490060|220256|P3|COMPLETED|Cycle 1||9
91601|NCT01490060|220257|P2|COMPLETED|Cycle 1||12
91602|NCT01490060|220258|P1|COMPLETED|Cycle 1||11
91603|NCT01490060|220255|P4|STARTED|Cycle 1||11
91604|NCT01490060|220256|P3|STARTED|Cycle 1||12
91605|NCT01490060|220257|P2|STARTED|Cycle 1||13
91606|NCT01490060|220258|P1|STARTED|Cycle 1||11
91607|NCT01489956|220268|P3|NOT COMPLETED|Overall Study||1
91608|NCT01489956|220269|P2|NOT COMPLETED|Overall Study||0
91609|NCT01489956|220270|P1|NOT COMPLETED|Overall Study||1
91610|NCT01489956|220268|P3|COMPLETED|Overall Study||5
91611|NCT01489956|220269|P2|COMPLETED|Overall Study||0
91612|NCT01489956|220270|P1|COMPLETED|Overall Study||12
91613|NCT01489956|220268|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
91614|NCT01489956|220269|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
91615|NCT01489956|220270|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
91616|NCT01489891|220307|P2|NOT COMPLETED|Overall Study||0
91617|NCT01489891|220308|P1|NOT COMPLETED|Overall Study||1
91618|NCT01489891|220307|P2|COMPLETED|Overall Study||60
91619|NCT01489891|220308|P1|COMPLETED|Overall Study||59
91620|NCT01489891|220307|P2|STARTED|Overall Study||60
91621|NCT01489891|220308|P1|STARTED|Overall Study||60
91622|NCT01489826|220329|P9|NOT COMPLETED|Overall Study||0
91623|NCT01489826|220330|P8|NOT COMPLETED|Overall Study||0
91624|NCT01489826|220331|P7|NOT COMPLETED|Overall Study||0
91625|NCT01489826|220332|P6|NOT COMPLETED|Overall Study||0
91626|NCT01489826|220333|P5|NOT COMPLETED|Overall Study||0
91627|NCT01489826|220334|P4|NOT COMPLETED|Overall Study||0
91628|NCT01489826|220335|P3|NOT COMPLETED|Overall Study||0
91629|NCT01489826|220336|P2|NOT COMPLETED|Overall Study||0
91630|NCT01489826|220337|P1|NOT COMPLETED|Overall Study||0
91631|NCT01489826|220329|P9|COMPLETED|Overall Study||6
91632|NCT01489826|220330|P8|COMPLETED|Overall Study||3
91633|NCT01489826|220331|P7|COMPLETED|Overall Study||9
91634|NCT01489826|220332|P6|COMPLETED|Overall Study||3
91635|NCT01489826|220333|P5|COMPLETED|Overall Study||3
91636|NCT01489826|220334|P4|COMPLETED|Overall Study||7
91637|NCT01489826|220335|P3|COMPLETED|Overall Study||3
91638|NCT01489826|220336|P2|COMPLETED|Overall Study||3
91639|NCT01489826|220337|P1|COMPLETED|Overall Study||3
91640|NCT01489826|220329|P9|STARTED|Overall Study||6
91641|NCT01489826|220330|P8|STARTED|Overall Study||3
91642|NCT01489826|220331|P7|STARTED|Overall Study||9
91643|NCT01489826|220332|P6|STARTED|Overall Study||3
91644|NCT01489826|220333|P5|STARTED|Overall Study||3
91645|NCT01489826|220334|P4|STARTED|Overall Study||7
91646|NCT01489826|220335|P3|STARTED|Overall Study||3
91647|NCT01489826|220336|P2|STARTED|Overall Study||3
91648|NCT01489826|220337|P1|STARTED|Overall Study||3
91649|NCT01489670|220434|P1|NOT COMPLETED|Overall Study||53
91650|NCT01489670|220434|P1|COMPLETED|Overall Study||334
91651|NCT01489670|220434|P1|STARTED|Overall Study||387
91652|NCT01489527|220446|P2|NOT COMPLETED|Overall Study||26
91653|NCT01489527|220447|P1|NOT COMPLETED|Overall Study||22
91654|NCT01489527|220446|P2|COMPLETED|Overall Study||175
91655|NCT01489527|220447|P1|COMPLETED|Overall Study||183
91656|NCT01489527|220446|P2|STARTED|Overall Study||201
91657|NCT01489527|220447|P1|STARTED|Overall Study||205
91658|NCT01489358|220464|P3|NOT COMPLETED|Overall Study||2
91659|NCT01489358|220465|P2|NOT COMPLETED|Overall Study||0
91660|NCT01489358|220466|P1|NOT COMPLETED|Overall Study||0
91661|NCT01489358|220464|P3|COMPLETED|Overall Study||8
91662|NCT01489358|220465|P2|COMPLETED|Overall Study||10
91663|NCT01489358|220466|P1|COMPLETED|Overall Study||5
91664|NCT01489358|220464|P3|STARTED|Overall Study||10
91665|NCT01489358|220465|P2|STARTED|Overall Study||10
91666|NCT01489358|220466|P1|STARTED|Overall Study||5
91667|NCT01489254|220516|P4|NOT COMPLETED|Open-label Extension Part||58
91668|NCT01489254|220517|P3|NOT COMPLETED|Open-label Extension Part||0
91669|NCT01489254|220518|P2|NOT COMPLETED|Open-label Extension Part||0
91670|NCT01489254|220519|P1|NOT COMPLETED|Open-label Extension Part||0
91671|NCT01489254|220516|P4|COMPLETED|Open-label Extension Part||670
91672|NCT01489254|220517|P3|COMPLETED|Open-label Extension Part||0
91673|NCT01489254|220518|P2|COMPLETED|Open-label Extension Part||0
91674|NCT01489254|220519|P1|COMPLETED|Open-label Extension Part||0
91766|NCT01488279|220803|P2|STARTED|Overall Study||5
91675|NCT01489254|220516|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
91676|NCT01489254|220517|P3|STARTED|Open-label Extension Part||0
91677|NCT01489254|220518|P2|STARTED|Open-label Extension Part||0
91678|NCT01489254|220519|P1|STARTED|Open-label Extension Part||0
91679|NCT01489254|220516|P4|NOT COMPLETED|Double-blind Part||0
91680|NCT01489254|220517|P3|NOT COMPLETED|Double-blind Part||3
91681|NCT01489254|220518|P2|NOT COMPLETED|Double-blind Part||33
91682|NCT01489254|220519|P1|NOT COMPLETED|Double-blind Part||25
91683|NCT01489254|220516|P4|COMPLETED|Double-blind Part||0
91684|NCT01489254|220517|P3|COMPLETED|Double-blind Part||81
91685|NCT01489254|220518|P2|COMPLETED|Double-blind Part||324
91686|NCT01489254|220519|P1|COMPLETED|Double-blind Part||330
91687|NCT01489254|220516|P4|STARTED|Double-blind Part||0
91688|NCT01489254|220517|P3|STARTED|Double-blind Part||84
91689|NCT01489254|220518|P2|STARTED|Double-blind Part||357
91690|NCT01489254|220519|P1|STARTED|Double-blind Part||355
91691|NCT01489189|220530|P2|NOT COMPLETED|Overall Study||35
91692|NCT01489189|220531|P1|NOT COMPLETED|Overall Study||31
91693|NCT01489189|220530|P2|COMPLETED|Overall Study|Number of Eyes|168
91694|NCT01489189|220531|P1|COMPLETED|Overall Study|Number of Eyes|160
91695|NCT01489189|220530|P2|STARTED|Overall Study|Number of Eyes|203
91696|NCT01489189|220531|P1|STARTED|Overall Study|Number of Eyes|191
91697|NCT01488994|220558|P2|NOT COMPLETED|Overall Study||1
91698|NCT01488994|220559|P1|NOT COMPLETED|Overall Study||0
91699|NCT01488994|220558|P2|COMPLETED|Overall Study||11
91700|NCT01488994|220559|P1|COMPLETED|Overall Study||11
91701|NCT01488994|220558|P2|STARTED|Overall Study||12
91702|NCT01488994|220559|P1|STARTED|Overall Study||11
91703|NCT01488877|220646|P3|NOT COMPLETED|Re-randomization||0
91704|NCT01488877|220647|P2|NOT COMPLETED|Re-randomization||0
91705|NCT01488877|220648|P1|NOT COMPLETED|Re-randomization||0
91706|NCT01488877|220646|P3|COMPLETED|Re-randomization||3
91707|NCT01488877|220647|P2|COMPLETED|Re-randomization||0
91708|NCT01488877|220648|P1|COMPLETED|Re-randomization||0
91709|NCT01488877|220646|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
91710|NCT01488877|220647|P2|STARTED|Re-randomization||0
91711|NCT01488877|220648|P1|STARTED|Re-randomization||0
91712|NCT01488877|220646|P3|NOT COMPLETED|Initial Randomization||0
91713|NCT01488877|220647|P2|NOT COMPLETED|Initial Randomization||0
91714|NCT01488877|220648|P1|NOT COMPLETED|Initial Randomization||0
91715|NCT01488877|220646|P3|COMPLETED|Initial Randomization||0
91716|NCT01488877|220647|P2|COMPLETED|Initial Randomization||5
91717|NCT01488877|220648|P1|COMPLETED|Initial Randomization||1
91718|NCT01488877|220646|P3|STARTED|Initial Randomization||0
91719|NCT01488877|220647|P2|STARTED|Initial Randomization||5
91720|NCT01488877|220648|P1|STARTED|Initial Randomization||1
91721|NCT01488708|220665|P2|NOT COMPLETED|Overall Study||578
91722|NCT01488708|220666|P1|NOT COMPLETED|Overall Study||940
91723|NCT01488708|220665|P2|COMPLETED|Overall Study||0
91724|NCT01488708|220666|P1|COMPLETED|Overall Study||0
91725|NCT01488708|220665|P2|Participated in Follow Up|Overall Study||526
91726|NCT01488708|220666|P1|Participated in Follow Up|Overall Study||810
91727|NCT01488708|220665|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
91728|NCT01488708|220666|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
91729|NCT01488708|220665|P2|STARTED|Overall Study||578
91730|NCT01488708|220666|P1|STARTED|Overall Study||940
91731|NCT01488578|220686|P1|NOT COMPLETED|Overall Study||1836
91732|NCT01488578|220686|P1|COMPLETED|Overall Study||9321
91733|NCT01488578|220686|P1|STARTED|Overall Study||11157
91734|NCT01488487|220720|P1|NOT COMPLETED|Overall Study||9
91735|NCT01488487|220720|P1|COMPLETED|Overall Study||15
91736|NCT01488487|220720|P1|Received Treatment|Overall Study||24
91737|NCT01488487|220720|P1|STARTED|Overall Study||24
91738|NCT01488448|220729|P2|NOT COMPLETED|Overall Study||17
91739|NCT01488448|220730|P1|NOT COMPLETED|Overall Study||20
91740|NCT01488448|220729|P2|COMPLETED|Overall Study||97
91741|NCT01488448|220730|P1|COMPLETED|Overall Study||93
91742|NCT01488448|220729|P2|STARTED|Overall Study||114
91743|NCT01488448|220730|P1|STARTED|Overall Study||113
91744|NCT01488409|220754|P2|NOT COMPLETED|Overall Study||4
91745|NCT01488409|220755|P1|NOT COMPLETED|Overall Study||4
91746|NCT01488409|220754|P2|COMPLETED|Overall Study||15
91747|NCT01488409|220755|P1|COMPLETED|Overall Study||16
91748|NCT01488409|220754|P2|STARTED|Overall Study||19
91749|NCT01488409|220755|P1|STARTED|Overall Study||20
91750|NCT01488370|220772|P3|NOT COMPLETED|Overall Study||1
91751|NCT01488370|220773|P2|NOT COMPLETED|Overall Study||1
91752|NCT01488370|220774|P1|NOT COMPLETED|Overall Study||0
91753|NCT01488370|220772|P3|COMPLETED|Overall Study||19
91754|NCT01488370|220773|P2|COMPLETED|Overall Study||22
91755|NCT01488370|220774|P1|COMPLETED|Overall Study||22
91756|NCT01488370|220772|P3|STARTED|Overall Study||20
91757|NCT01488370|220773|P2|STARTED|Overall Study||23
91758|NCT01488370|220774|P1|STARTED|Overall Study||22
91759|NCT01488318|220794|P1|NOT COMPLETED|Overall Study||0
91760|NCT01488318|220794|P1|COMPLETED|Overall Study||14
91761|NCT01488318|220794|P1|STARTED|Overall Study||14
91762|NCT01488279|220803|P2|NOT COMPLETED|Overall Study||0
91763|NCT01488279|220804|P1|NOT COMPLETED|Overall Study||0
91764|NCT01488279|220803|P2|COMPLETED|Overall Study||5
91765|NCT01488279|220804|P1|COMPLETED|Overall Study||5
91767|NCT01488279|220804|P1|STARTED|Overall Study||5
91768|NCT01488188|220820|P2|NOT COMPLETED|Overall Study||0
91769|NCT01488188|220821|P1|NOT COMPLETED|Overall Study||0
91770|NCT01488188|220820|P2|COMPLETED|Overall Study||20
91771|NCT01488188|220821|P1|COMPLETED|Overall Study||20
91772|NCT01488188|220820|P2|STARTED|Overall Study||20
91773|NCT01488188|220821|P1|STARTED|Overall Study||20
91774|NCT01488097|220833|P1|NOT COMPLETED|Long-term Treatment (Beyond Week 104)||6
91775|NCT01488097|220833|P1|COMPLETED|Long-term Treatment (Beyond Week 104)|This period is ongoing.|2
91776|NCT01488097|220833|P1|STARTED|Long-term Treatment (Beyond Week 104)||8
91777|NCT01488097|220833|P1|NOT COMPLETED|Long-term Treatment (up to Week 104)||0
91778|NCT01488097|220833|P1|COMPLETED|Long-term Treatment (up to Week 104)||8
91779|NCT01488097|220833|P1|STARTED|Long-term Treatment (up to Week 104)||8
91780|NCT01488071|220845|P2|NOT COMPLETED|Overall Study||63
91781|NCT01488071|220846|P1|NOT COMPLETED|Overall Study||53
91782|NCT01488071|220845|P2|COMPLETED|Overall Study||179
91783|NCT01488071|220846|P1|COMPLETED|Overall Study||200
91784|NCT01488071|220845|P2|STARTED|Overall Study|APTS|242
91785|NCT01488071|220846|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
91786|NCT01488019|220880|P2|NOT COMPLETED|Overall Study||304
91787|NCT01488019|220881|P1|NOT COMPLETED|Overall Study||247
91788|NCT01488019|220880|P2|COMPLETED|Overall Study||226
91789|NCT01488019|220881|P1|COMPLETED|Overall Study||294
91790|NCT01488019|220880|P2|STARTED|Overall Study||530
91791|NCT01488019|220881|P1|STARTED|Overall Study||541
91792|NCT01487954|220915|P2|NOT COMPLETED|Overall Study||0
91793|NCT01487954|220916|P1|NOT COMPLETED|Overall Study||0
91794|NCT01487954|220915|P2|COMPLETED|Overall Study||16
91795|NCT01487954|220916|P1|COMPLETED|Overall Study||29
91796|NCT01487954|220915|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
91797|NCT01487954|220916|P1|Safety lead-in|Overall Study||10
91798|NCT01487954|220915|P2|STARTED|Overall Study||16
91799|NCT01487954|220916|P1|STARTED|Overall Study||29
91800|NCT01487863|220926|P2|NOT COMPLETED|Overall Study||19
91801|NCT01487863|220927|P1|NOT COMPLETED|Overall Study||19
91802|NCT01487863|220926|P2|COMPLETED|Overall Study||15
91803|NCT01487863|220927|P1|COMPLETED|Overall Study||16
91804|NCT01487863|220926|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
91805|NCT01487863|220927|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
91806|NCT01487863|220926|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
91807|NCT01487863|220927|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
91808|NCT01487863|220926|P2|STARTED|Overall Study||34
91809|NCT01487863|220927|P1|STARTED|Overall Study||35
91810|NCT01487668|220935|P2|NOT COMPLETED|Overall Study||17
91811|NCT01487668|220936|P1|NOT COMPLETED|Overall Study||25
91812|NCT01487668|220935|P2|COMPLETED|Overall Study||124
91813|NCT01487668|220936|P1|COMPLETED|Overall Study||121
91814|NCT01487668|220935|P2|STARTED|Overall Study||141
91815|NCT01487668|220936|P1|STARTED|Overall Study||146
91816|NCT01487577|220944|P1|NOT COMPLETED|Overall Study||1
91817|NCT01487577|220944|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
91818|NCT01487577|220944|P1|STARTED|Overall Study||19
91819|NCT01487525|220958|P2|NOT COMPLETED|Overall Study||1
91820|NCT01487525|220959|P1|NOT COMPLETED|Overall Study||0
91821|NCT01487525|220958|P2|COMPLETED|Overall Study||19
91822|NCT01487525|220959|P1|COMPLETED|Overall Study||22
91823|NCT01487525|220958|P2|STARTED|Overall Study||20
91824|NCT01487525|220959|P1|STARTED|Overall Study||22
91825|NCT01487499|220969|P1|NOT COMPLETED|Overall Study||0
91826|NCT01487499|220969|P1|COMPLETED|Overall Study||4
91827|NCT01487499|220969|P1|STARTED|Overall Study||4
91828|NCT01487265|220975|P1|NOT COMPLETED|Overall Study||37
91829|NCT01487265|220975|P1|COMPLETED|Overall Study||0
91830|NCT01487265|220975|P1|STARTED|Overall Study||37
91831|NCT01487161|220987|P4|NOT COMPLETED|Overall Study||2
91832|NCT01487161|220988|P3|NOT COMPLETED|Overall Study||1
91833|NCT01487161|220989|P2|NOT COMPLETED|Overall Study||2
91834|NCT01487161|220990|P1|NOT COMPLETED|Overall Study||2
91835|NCT01487161|220987|P4|COMPLETED|Overall Study||50
91836|NCT01487161|220988|P3|COMPLETED|Overall Study||59
91837|NCT01487161|220989|P2|COMPLETED|Overall Study||57
91838|NCT01487161|220990|P1|COMPLETED|Overall Study||56
91839|NCT01487161|220987|P4|STARTED|Overall Study||52
91840|NCT01487161|220988|P3|STARTED|Overall Study||60
91841|NCT01487161|220989|P2|STARTED|Overall Study||59
91842|NCT01487161|220990|P1|STARTED|Overall Study||58
91843|NCT01486966|221055|P2|NOT COMPLETED|Overall Study||2
91844|NCT01486966|221056|P1|NOT COMPLETED|Overall Study||0
91845|NCT01486966|221055|P2|COMPLETED|Overall Study||27
91846|NCT01486966|221056|P1|COMPLETED|Overall Study||29
91847|NCT01486966|221055|P2|STARTED|Overall Study||29
91848|NCT01486966|221056|P1|STARTED|Overall Study||29
91849|NCT01486927|221080|P1|NOT COMPLETED|Overall Study||13
91850|NCT01486927|221080|P1|COMPLETED|Overall Study||161
91851|NCT01486927|221080|P1|STARTED|Overall Study||174
91852|NCT01486758|221113|P2|NOT COMPLETED|Overall Study||1
91853|NCT01486758|221114|P1|NOT COMPLETED|Overall Study||0
91854|NCT01486758|221113|P2|COMPLETED|Overall Study||19
91855|NCT01486758|221114|P1|COMPLETED|Overall Study||20
91856|NCT01486758|221113|P2|STARTED|Overall Study||20
91857|NCT01486758|221114|P1|STARTED|Overall Study||20
91858|NCT01486615|221138|P4|NOT COMPLETED|Overall Study||2
91859|NCT01486615|221139|P3|NOT COMPLETED|Overall Study||2
91860|NCT01486615|221140|P2|NOT COMPLETED|Overall Study||1
91861|NCT01486615|221141|P1|NOT COMPLETED|Overall Study||0
91862|NCT01486615|221138|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
91863|NCT01486615|221139|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
91864|NCT01486615|221140|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
91865|NCT01486615|221141|P1|COMPLETED|Overall Study||20
91866|NCT01486615|221138|P4|STARTED|Overall Study||20
91867|NCT01486615|221139|P3|STARTED|Overall Study||20
91868|NCT01486615|221140|P2|STARTED|Overall Study||20
91869|NCT01486615|221141|P1|STARTED|Overall Study||20
91870|NCT01486446|221181|P2|NOT COMPLETED|Overall Study||0
91871|NCT01486446|221182|P1|NOT COMPLETED|Overall Study||1
91872|NCT01486446|221181|P2|COMPLETED|Overall Study||1
91873|NCT01486446|221182|P1|COMPLETED|Overall Study||6
91874|NCT01486446|221181|P2|STARTED|Overall Study||1
91875|NCT01486446|221182|P1|STARTED|Overall Study||7
91876|NCT01486238|221204|P2|NOT COMPLETED|Overall Study||6
91877|NCT01486238|221205|P1|NOT COMPLETED|Overall Study||2
91878|NCT01486238|221204|P2|COMPLETED|Overall Study||43
91879|NCT01486238|221205|P1|COMPLETED|Overall Study||21
91880|NCT01486238|221204|P2|STARTED|Overall Study||49
91881|NCT01486238|221205|P1|STARTED|Overall Study||23
91882|NCT01486199|221213|P2|NOT COMPLETED|Study Day at t= 2 Years||0
91883|NCT01486199|221214|P1|NOT COMPLETED|Study Day at t= 2 Years||0
91884|NCT01486199|221213|P2|COMPLETED|Study Day at t= 2 Years||0
91885|NCT01486199|221214|P1|COMPLETED|Study Day at t= 2 Years||9
91886|NCT01486199|221213|P2|STARTED|Study Day at t= 2 Years||0
91887|NCT01486199|221214|P1|STARTED|Study Day at t= 2 Years||9
91888|NCT01486199|221213|P2|NOT COMPLETED|Two Year Period Between Study Days||0
91889|NCT01486199|221214|P1|NOT COMPLETED|Two Year Period Between Study Days||1
91890|NCT01486199|221213|P2|COMPLETED|Two Year Period Between Study Days||0
91891|NCT01486199|221214|P1|COMPLETED|Two Year Period Between Study Days||9
91892|NCT01486199|221213|P2|STARTED|Two Year Period Between Study Days||0
91893|NCT01486199|221214|P1|STARTED|Two Year Period Between Study Days||10
91894|NCT01486199|221213|P2|NOT COMPLETED|Baseline Study Day||1
91895|NCT01486199|221214|P1|NOT COMPLETED|Baseline Study Day||0
91896|NCT01486199|221213|P2|COMPLETED|Baseline Study Day||9
91897|NCT01486199|221214|P1|COMPLETED|Baseline Study Day||10
91898|NCT01486199|221213|P2|STARTED|Baseline Study Day||10
91899|NCT01486199|221214|P1|STARTED|Baseline Study Day||10
91900|NCT01486043|221226|P1|NOT COMPLETED|Overall Study||2
91901|NCT01486043|221226|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
91902|NCT01486043|221226|P1|STARTED|Overall Study||4
91903|NCT01485991|221234|P2|NOT COMPLETED|Overall Study||36
91904|NCT01485991|221235|P1|NOT COMPLETED|Overall Study||32
91905|NCT01485991|221234|P2|COMPLETED|Overall Study||350
91906|NCT01485991|221235|P1|COMPLETED|Overall Study||353
91907|NCT01485991|221234|P2|Treated|Overall Study||384
91908|NCT01485991|221235|P1|Treated|Overall Study||379
91909|NCT01485991|221234|P2|STARTED|Overall Study||386
91910|NCT01485991|221235|P1|STARTED|Overall Study||385
91911|NCT01485887|221245|P1|NOT COMPLETED|Overall Study||12
91912|NCT01485887|221245|P1|COMPLETED|Overall Study||38
91913|NCT01485887|221245|P1|STARTED|Overall Study||50
91914|NCT01485796|221257|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
91915|NCT01485796|221257|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
91916|NCT01485796|221257|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
91917|NCT01485796|221257|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
91918|NCT01485796|221257|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
91919|NCT01485796|221257|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
91920|NCT01485796|221257|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
91921|NCT01485796|221257|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
91922|NCT01485796|221257|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
91923|NCT01485796|221257|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
91924|NCT01485796|221257|P1|NOT COMPLETED|Period 2: Epoch 2||35
91925|NCT01485796|221257|P1|COMPLETED|Period 2: Epoch 2||1
91926|NCT01485796|221257|P1|Treated in Epoch 2|Period 2: Epoch 2||36
91927|NCT01485796|221257|P1|STARTED|Period 2: Epoch 2||36
91928|NCT01485796|221257|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
91929|NCT01485796|221257|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
91930|NCT01485796|221257|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
91931|NCT01485796|221257|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
91932|NCT01485640|221279|P1|NOT COMPLETED|Overall Study||122
91933|NCT01485640|221279|P1|COMPLETED|Overall Study||40
91934|NCT01485640|221279|P1|STARTED|Overall Study||162
91935|NCT01485536|221284|P1|NOT COMPLETED|Overall Study||4
91936|NCT01485536|221284|P1|COMPLETED|Overall Study||17
91937|NCT01485536|221284|P1|STARTED|Overall Study||21
91938|NCT01485380|221289|P1|NOT COMPLETED|Overall Study||3
91939|NCT01485380|221289|P1|COMPLETED|Overall Study||17
91940|NCT01485380|221289|P1|STARTED|Overall Study||20
91941|NCT01485354|221293|P1|NOT COMPLETED|Overall Study||5
91942|NCT01485354|221293|P1|COMPLETED|Overall Study||12
91943|NCT01485354|221293|P1|STARTED|Overall Study||17
91944|NCT01485172|221307|P6|NOT COMPLETED|Overall Study||4
91945|NCT01485172|221308|P5|NOT COMPLETED|Overall Study||5
91946|NCT01485172|221309|P4|NOT COMPLETED|Overall Study||8
91947|NCT01485172|221310|P3|NOT COMPLETED|Overall Study||7
91948|NCT01485172|221311|P2|NOT COMPLETED|Overall Study||1
91949|NCT01485172|221312|P1|NOT COMPLETED|Overall Study||7
91950|NCT01485172|221307|P6|COMPLETED|Overall Study||9
91951|NCT01485172|221308|P5|COMPLETED|Overall Study||34
91952|NCT01485172|221309|P4|COMPLETED|Overall Study||32
91953|NCT01485172|221310|P3|COMPLETED|Overall Study||34
91954|NCT01485172|221311|P2|COMPLETED|Overall Study||12
91955|NCT01485172|221312|P1|COMPLETED|Overall Study||33
91956|NCT01485172|221307|P6|STARTED|Overall Study||13
91957|NCT01485172|221308|P5|STARTED|Overall Study||39
91958|NCT01485172|221309|P4|STARTED|Overall Study||40
91959|NCT01485172|221310|P3|STARTED|Overall Study||41
91960|NCT01485172|221311|P2|STARTED|Overall Study||13
91961|NCT01485172|221312|P1|STARTED|Overall Study||40
91962|NCT01485094|221389|P3|NOT COMPLETED|Overall Study||1
91963|NCT01485094|221390|P2|NOT COMPLETED|Overall Study||2
91964|NCT01485094|221391|P1|NOT COMPLETED|Overall Study||3
91965|NCT01485094|221389|P3|COMPLETED|Overall Study||18
91966|NCT01485094|221390|P2|COMPLETED|Overall Study||18
91967|NCT01485094|221391|P1|COMPLETED|Overall Study||17
91968|NCT01485094|221389|P3|STARTED|Overall Study||19
91969|NCT01485094|221390|P2|STARTED|Overall Study||20
91970|NCT01485094|221391|P1|STARTED|Overall Study||20
91971|NCT01484977|221432|P1|NOT COMPLETED|Overall Study||27
91972|NCT01484977|221432|P1|COMPLETED|Overall Study||93
91973|NCT01484977|221432|P1|STARTED|Overall Study||120
91974|NCT01484951|221436|P1|NOT COMPLETED|Overall Study||5
91975|NCT01484951|221436|P1|COMPLETED|Overall Study||69
91976|NCT01484951|221436|P1|STARTED|Overall Study||74
91977|NCT01484938|221441|P1|NOT COMPLETED|Overall Study||4
91978|NCT01484938|221441|P1|COMPLETED|Overall Study||171
91979|NCT01484938|221441|P1|STARTED|Overall Study||175
91980|NCT01484912|221448|P2|NOT COMPLETED|Overall Study||1
91981|NCT01484912|221449|P1|NOT COMPLETED|Overall Study||1
91982|NCT01484912|221448|P2|COMPLETED|Overall Study||39
91983|NCT01484912|221449|P1|COMPLETED|Overall Study||38
91984|NCT01484912|221448|P2|STARTED|Overall Study||40
91985|NCT01484912|221449|P1|STARTED|Overall Study||39
91986|NCT01484873|221459|P1|NOT COMPLETED|Overall Study||2
91987|NCT01484873|221459|P1|COMPLETED|Overall Study||8
91988|NCT01484873|221459|P1|STARTED|Overall Study||10
91989|NCT01484834|221471|P4|NOT COMPLETED|Overall Study||4
91990|NCT01484834|221472|P3|NOT COMPLETED|Overall Study||1
91991|NCT01484834|221473|P2|NOT COMPLETED|Overall Study||8
91992|NCT01484834|221474|P1|NOT COMPLETED|Overall Study||5
91993|NCT01484834|221471|P4|COMPLETED|Overall Study||20
91994|NCT01484834|221472|P3|COMPLETED|Overall Study||38
91995|NCT01484834|221473|P2|COMPLETED|Overall Study||54
91996|NCT01484834|221474|P1|COMPLETED|Overall Study||60
91997|NCT01484834|221471|P4|STARTED|Overall Study||24
91998|NCT01484834|221472|P3|STARTED|Overall Study||39
91999|NCT01484834|221473|P2|STARTED|Overall Study||62
92000|NCT01484834|221474|P1|STARTED|Overall Study||65
92001|NCT01484652|221502|P2|NOT COMPLETED|Overall Study||21
92002|NCT01484652|221503|P1|NOT COMPLETED|Overall Study||15
92003|NCT01484652|221502|P2|COMPLETED|Overall Study||142
92004|NCT01484652|221503|P1|COMPLETED|Overall Study||151
92005|NCT01484652|221502|P2|STARTED|Overall Study||163
92006|NCT01484652|221503|P1|STARTED|Overall Study||166
92007|NCT01484561|221511|P2|NOT COMPLETED|Overall Study||6
92008|NCT01484561|221512|P1|NOT COMPLETED|Overall Study||9
92009|NCT01484561|221511|P2|COMPLETED|Overall Study||45
92010|NCT01484561|221512|P1|COMPLETED|Overall Study||88
92011|NCT01484561|221511|P2|STARTED|Overall Study||51
92012|NCT01484561|221512|P1|STARTED|Overall Study||97
92013|NCT01484496|221602|P4|NOT COMPLETED|Period 2||22
92014|NCT01484496|221603|P3|NOT COMPLETED|Period 2||15
92015|NCT01484496|221604|P2|NOT COMPLETED|Period 2||0
92016|NCT01484496|221605|P1|NOT COMPLETED|Period 2||0
92017|NCT01484496|221602|P4|COMPLETED|Period 2||434
92018|NCT01484496|221603|P3|COMPLETED|Period 2||191
92019|NCT01484496|221604|P2|COMPLETED|Period 2||0
92020|NCT01484496|221605|P1|COMPLETED|Period 2||0
92021|NCT01484496|221602|P4|STARTED|Period 2||456
92022|NCT01484496|221603|P3|STARTED|Period 2||206
92023|NCT01484496|221604|P2|STARTED|Period 2||0
92024|NCT01484496|221605|P1|STARTED|Period 2||0
92025|NCT01484496|221602|P4|NOT COMPLETED|Period 1||0
92026|NCT01484496|221603|P3|NOT COMPLETED|Period 1||0
92027|NCT01484496|221604|P2|NOT COMPLETED|Period 1||93
92028|NCT01484496|221605|P1|NOT COMPLETED|Period 1||66
92029|NCT01484496|221602|P4|COMPLETED|Period 1||0
92030|NCT01484496|221603|P3|COMPLETED|Period 1||0
92031|NCT01484496|221604|P2|COMPLETED|Period 1||463
92032|NCT01484496|221605|P1|COMPLETED|Period 1||214
92033|NCT01484496|221602|P4|STARTED|Period 1||0
92034|NCT01484496|221603|P3|STARTED|Period 1||0
92035|NCT01484496|221604|P2|STARTED|Period 1||556
92036|NCT01484496|221605|P1|STARTED|Period 1||280
92037|NCT01484314|221617|P1|NOT COMPLETED|Overall Study||0
92038|NCT01484314|221617|P1|COMPLETED|Overall Study||1
92039|NCT01484314|221617|P1|STARTED|Overall Study||1
92040|NCT01484197|221623|P4|NOT COMPLETED|Treatment Period 4||0
92041|NCT01484197|221624|P3|NOT COMPLETED|Treatment Period 4||0
92042|NCT01484197|221625|P2|NOT COMPLETED|Treatment Period 4||0
92043|NCT01484197|221626|P1|NOT COMPLETED|Treatment Period 4||0
92044|NCT01484197|221623|P4|COMPLETED|Treatment Period 4||6
92045|NCT01484197|221624|P3|COMPLETED|Treatment Period 4||9
92046|NCT01484197|221625|P2|COMPLETED|Treatment Period 4||8
92047|NCT01484197|221626|P1|COMPLETED|Treatment Period 4||7
92048|NCT01484197|221623|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
92049|NCT01484197|221624|P3|STARTED|Treatment Period 4||9
92050|NCT01484197|221625|P2|STARTED|Treatment Period 4||8
92051|NCT01484197|221626|P1|STARTED|Treatment Period 4||7
92052|NCT01484197|221623|P4|NOT COMPLETED|Treatment Period 3||0
92053|NCT01484197|221624|P3|NOT COMPLETED|Treatment Period 3||0
92054|NCT01484197|221625|P2|NOT COMPLETED|Treatment Period 3||0
92055|NCT01484197|221626|P1|NOT COMPLETED|Treatment Period 3||0
92056|NCT01484197|221623|P4|COMPLETED|Treatment Period 3||8
92057|NCT01484197|221624|P3|COMPLETED|Treatment Period 3||9
92058|NCT01484197|221625|P2|COMPLETED|Treatment Period 3||8
92059|NCT01484197|221626|P1|COMPLETED|Treatment Period 3||7
92060|NCT01484197|221623|P4|STARTED|Treatment Period 3||8
92061|NCT01484197|221624|P3|STARTED|Treatment Period 3||9
92062|NCT01484197|221625|P2|STARTED|Treatment Period 3||8
92063|NCT01484197|221626|P1|STARTED|Treatment Period 3||7
92064|NCT01484197|221623|P4|NOT COMPLETED|Treatment Period 2||1
92065|NCT01484197|221624|P3|NOT COMPLETED|Treatment Period 2||0
92066|NCT01484197|221625|P2|NOT COMPLETED|Treatment Period 2||0
92067|NCT01484197|221626|P1|NOT COMPLETED|Treatment Period 2||0
92068|NCT01484197|221623|P4|COMPLETED|Treatment Period 2||8
92069|NCT01484197|221624|P3|COMPLETED|Treatment Period 2||9
92070|NCT01484197|221625|P2|COMPLETED|Treatment Period 2||8
92071|NCT01484197|221626|P1|COMPLETED|Treatment Period 2||7
92072|NCT01484197|221623|P4|STARTED|Treatment Period 2||9
92073|NCT01484197|221624|P3|STARTED|Treatment Period 2||9
92074|NCT01484197|221625|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
92075|NCT01484197|221626|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
92076|NCT01484197|221623|P4|NOT COMPLETED|Treatment Period 1||0
92077|NCT01484197|221624|P3|NOT COMPLETED|Treatment Period 1||0
92078|NCT01484197|221625|P2|NOT COMPLETED|Treatment Period 1||0
92079|NCT01484197|221626|P1|NOT COMPLETED|Treatment Period 1||1
92080|NCT01484197|221623|P4|COMPLETED|Treatment Period 1||9
92081|NCT01484197|221624|P3|COMPLETED|Treatment Period 1||9
92082|NCT01484197|221625|P2|COMPLETED|Treatment Period 1||9
92083|NCT01484197|221626|P1|COMPLETED|Treatment Period 1||8
92084|NCT01484197|221623|P4|STARTED|Treatment Period 1||9
92085|NCT01484197|221624|P3|STARTED|Treatment Period 1||9
92086|NCT01484197|221625|P2|STARTED|Treatment Period 1||9
92087|NCT01484197|221626|P1|STARTED|Treatment Period 1||9
92088|NCT01484132|221709|P1|NOT COMPLETED|Overall Study||22
92089|NCT01484132|221709|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
92090|NCT01484132|221709|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
92091|NCT01484132|221709|P1|STARTED|Overall Study||113
92092|NCT01484054|221717|P2|NOT COMPLETED|Period 2||0
92093|NCT01484054|221718|P1|NOT COMPLETED|Period 2||0
92094|NCT01484054|221717|P2|COMPLETED|Period 2||49
92095|NCT01484054|221718|P1|COMPLETED|Period 2||50
92096|NCT01484054|221717|P2|STARTED|Period 2||49
92097|NCT01484054|221718|P1|STARTED|Period 2||50
92098|NCT01484054|221717|P2|NOT COMPLETED|Period 1||1
92099|NCT01484054|221718|P1|NOT COMPLETED|Period 1||0
92100|NCT01484054|221717|P2|COMPLETED|Period 1||49
92101|NCT01484054|221718|P1|COMPLETED|Period 1||50
92102|NCT01484054|221717|P2|STARTED|Period 1||50
92103|NCT01484054|221718|P1|STARTED|Period 1||50
92104|NCT01484041|221728|P1|NOT COMPLETED|Overall Study||0
92105|NCT01484041|221728|P1|COMPLETED|Overall Study||12
92106|NCT01484041|221728|P1|STARTED|Overall Study||12
92107|NCT01484028|221736|P4|NOT COMPLETED|Period 2||0
92108|NCT01484028|221737|P3|NOT COMPLETED|Period 2||0
92109|NCT01484028|221738|P2|NOT COMPLETED|Period 2||0
92110|NCT01484028|221739|P1|NOT COMPLETED|Period 2||0
92111|NCT01484028|221736|P4|COMPLETED|Period 2||66
92112|NCT01484028|221737|P3|COMPLETED|Period 2||64
92113|NCT01484028|221738|P2|COMPLETED|Period 2||67
92114|NCT01484028|221739|P1|COMPLETED|Period 2||66
92115|NCT01484028|221736|P4|STARTED|Period 2||66
92116|NCT01484028|221737|P3|STARTED|Period 2||64
92117|NCT01484028|221738|P2|STARTED|Period 2||67
92118|NCT01484028|221739|P1|STARTED|Period 2||66
92119|NCT01484028|221736|P4|NOT COMPLETED|Period 1||1
92120|NCT01484028|221737|P3|NOT COMPLETED|Period 1||0
92121|NCT01484028|221738|P2|NOT COMPLETED|Period 1||3
92122|NCT01484028|221739|P1|NOT COMPLETED|Period 1||0
92123|NCT01484028|221736|P4|COMPLETED|Period 1||66
92124|NCT01484028|221737|P3|COMPLETED|Period 1||64
92125|NCT01484028|221738|P2|COMPLETED|Period 1||67
92126|NCT01484028|221739|P1|COMPLETED|Period 1||66
92127|NCT01484028|221736|P4|STARTED|Period 1||67
92128|NCT01484028|221737|P3|STARTED|Period 1||64
92129|NCT01484028|221738|P2|STARTED|Period 1||70
92130|NCT01484028|221739|P1|STARTED|Period 1||66
92131|NCT01483963|221754|P5|NOT COMPLETED|Overall Study||0
92132|NCT01483963|221755|P4|NOT COMPLETED|Overall Study||0
92133|NCT01483963|221756|P3|NOT COMPLETED|Overall Study||0
92134|NCT01483963|221757|P2|NOT COMPLETED|Overall Study||0
92135|NCT01483963|221758|P1|NOT COMPLETED|Overall Study||0
92136|NCT01483963|221754|P5|COMPLETED|Overall Study||10
92137|NCT01483963|221755|P4|COMPLETED|Overall Study||10
92138|NCT01483963|221756|P3|COMPLETED|Overall Study||10
92139|NCT01483963|221757|P2|COMPLETED|Overall Study||10
92140|NCT01483963|221758|P1|COMPLETED|Overall Study||10
92141|NCT01483963|221754|P5|STARTED|Overall Study||10
92142|NCT01483963|221755|P4|STARTED|Overall Study||10
92143|NCT01483963|221756|P3|STARTED|Overall Study||10
92144|NCT01483963|221757|P2|STARTED|Overall Study||10
92145|NCT01483963|221758|P1|STARTED|Overall Study||10
92146|NCT01483937|221832|P2|NOT COMPLETED|Overall Study||3
92147|NCT01483937|221833|P1|NOT COMPLETED|Overall Study||4
92148|NCT01483937|221832|P2|COMPLETED|Overall Study||14
92149|NCT01483937|221833|P1|COMPLETED|Overall Study||11
92150|NCT01483937|221832|P2|STARTED|Overall Study||17
92151|NCT01483937|221833|P1|STARTED|Overall Study||15
92152|NCT01483924|221860|P5|NOT COMPLETED|Overall Study||2
92153|NCT01483924|221861|P4|NOT COMPLETED|Overall Study||4
92154|NCT01483924|221862|P3|NOT COMPLETED|Overall Study||1
92155|NCT01483924|221863|P2|NOT COMPLETED|Overall Study||0
92156|NCT01483924|221864|P1|NOT COMPLETED|Overall Study||2
92157|NCT01483924|221860|P5|COMPLETED|Overall Study||10
92158|NCT01483924|221861|P4|COMPLETED|Overall Study||8
92159|NCT01483924|221862|P3|COMPLETED|Overall Study||11
92160|NCT01483924|221863|P2|COMPLETED|Overall Study||12
92161|NCT01483924|221864|P1|COMPLETED|Overall Study||10
92162|NCT01483924|221860|P5|STARTED|Overall Study||12
92163|NCT01483924|221861|P4|STARTED|Overall Study||12
92164|NCT01483924|221862|P3|STARTED|Overall Study||12
92165|NCT01483924|221863|P2|STARTED|Overall Study||12
92166|NCT01483924|221864|P1|STARTED|Overall Study||12
92167|NCT01483820|221912|P1|NOT COMPLETED|Overall Study||8
92168|NCT01483820|221912|P1|COMPLETED|Overall Study||0
92169|NCT01483820|221912|P1|STARTED|Overall Study||8
92170|NCT01483651|221921|P6|NOT COMPLETED|Overall Study||1
92171|NCT01483651|221922|P5|NOT COMPLETED|Overall Study||0
92172|NCT01483651|221923|P4|NOT COMPLETED|Overall Study||0
92173|NCT01483651|221924|P3|NOT COMPLETED|Overall Study||1
92174|NCT01483651|221925|P2|NOT COMPLETED|Overall Study||1
92175|NCT01483651|221926|P1|NOT COMPLETED|Overall Study||0
92176|NCT01483651|221921|P6|COMPLETED|Overall Study||1
92177|NCT01483651|221922|P5|COMPLETED|Overall Study||2
92178|NCT01483651|221923|P4|COMPLETED|Overall Study||1
92179|NCT01483651|221924|P3|COMPLETED|Overall Study||1
92180|NCT01483651|221925|P2|COMPLETED|Overall Study||2
92181|NCT01483651|221926|P1|COMPLETED|Overall Study||1
92182|NCT01483651|221921|P6|STARTED|Overall Study||2
92183|NCT01483651|221922|P5|STARTED|Overall Study||2
92184|NCT01483651|221923|P4|STARTED|Overall Study||1
92185|NCT01483651|221924|P3|STARTED|Overall Study||2
92186|NCT01483651|221925|P2|STARTED|Overall Study||3
92187|NCT01483651|221926|P1|STARTED|Overall Study||1
92188|NCT01483625|221936|P2|NOT COMPLETED|Overall Study||2
92189|NCT01483625|221937|P1|NOT COMPLETED|Overall Study||4
92190|NCT01483625|221936|P2|COMPLETED|Overall Study||66
92191|NCT01483625|221937|P1|COMPLETED|Overall Study||68
92192|NCT01483625|221936|P2|STARTED|Overall Study||68
92193|NCT01483625|221937|P1|STARTED|Overall Study||72
92194|NCT01483599|221960|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
92195|NCT01483599|221961|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
92196|NCT01483599|221962|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
92197|NCT01483599|221963|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
92198|NCT01483599|221964|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
92199|NCT01483599|221965|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
92200|NCT01483599|221966|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
92201|NCT01483599|221967|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
92202|NCT01483599|221968|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
92203|NCT01483599|221969|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
92204|NCT01483599|221970|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
92205|NCT01483599|221971|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
92206|NCT01483599|221972|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
92207|NCT01483599|221973|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
92208|NCT01483599|221960|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
92209|NCT01483599|221961|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
92210|NCT01483599|221962|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
92211|NCT01483599|221963|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
92212|NCT01483599|221964|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
92213|NCT01483599|221965|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
92214|NCT01483599|221966|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
92215|NCT01483599|221967|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
92216|NCT01483599|221968|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
92217|NCT01483599|221969|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
92218|NCT01483599|221970|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
92219|NCT01483599|221971|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
92220|NCT01483599|221972|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
92221|NCT01483599|221973|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
92222|NCT01483599|221960|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
92223|NCT01483599|221961|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
92224|NCT01483599|221962|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
92225|NCT01483599|221963|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
92226|NCT01483599|221964|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
92227|NCT01483599|221965|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
92228|NCT01483599|221966|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
92229|NCT01483599|221967|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
92230|NCT01483599|221968|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
92231|NCT01483599|221969|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
92232|NCT01483599|221970|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
92233|NCT01483599|221971|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
92234|NCT01483599|221972|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
92235|NCT01483599|221973|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
92236|NCT01483599|221960|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92237|NCT01483599|221961|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92238|NCT01483599|221962|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92239|NCT01483599|221963|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92240|NCT01483599|221964|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92241|NCT01483599|221965|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92242|NCT01483599|221966|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92243|NCT01483599|221967|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
92244|NCT01483599|221968|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
92245|NCT01483599|221969|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
92246|NCT01483599|221970|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
92247|NCT01483599|221971|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
92248|NCT01483599|221972|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
92249|NCT01483599|221973|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
92250|NCT01483599|221960|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
92251|NCT01483599|221961|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
92252|NCT01483599|221962|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
92253|NCT01483599|221963|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
92254|NCT01483599|221964|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
92255|NCT01483599|221965|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
92256|NCT01483599|221966|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
92257|NCT01483599|221967|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
92258|NCT01483599|221968|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
92259|NCT01483599|221969|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
92260|NCT01483599|221970|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
92261|NCT01483599|221971|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
92262|NCT01483599|221972|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
92263|NCT01483599|221973|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
92264|NCT01483599|221960|P14|Treated|Controlled Period (CP) (up to Week 16)||0
92265|NCT01483599|221961|P13|Treated|Controlled Period (CP) (up to Week 16)||0
92266|NCT01483599|221962|P12|Treated|Controlled Period (CP) (up to Week 16)||0
92267|NCT01483599|221963|P11|Treated|Controlled Period (CP) (up to Week 16)||0
92268|NCT01483599|221964|P10|Treated|Controlled Period (CP) (up to Week 16)||0
92269|NCT01483599|221965|P9|Treated|Controlled Period (CP) (up to Week 16)||0
92270|NCT01483599|221966|P8|Treated|Controlled Period (CP) (up to Week 16)||0
92271|NCT01483599|221967|P7|Treated|Controlled Period (CP) (up to Week 16)||43
92272|NCT01483599|221968|P6|Treated|Controlled Period (CP) (up to Week 16)||41
92273|NCT01483599|221969|P5|Treated|Controlled Period (CP) (up to Week 16)||42
92274|NCT01483599|221970|P4|Treated|Controlled Period (CP) (up to Week 16)||42
92275|NCT01483599|221971|P3|Treated|Controlled Period (CP) (up to Week 16)||41
92276|NCT01483599|221972|P2|Treated|Controlled Period (CP) (up to Week 16)||41
92277|NCT01483599|221973|P1|Treated|Controlled Period (CP) (up to Week 16)||42
92278|NCT01483599|221960|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
92279|NCT01483599|221961|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
92280|NCT01483599|221962|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
92281|NCT01483599|221963|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
92282|NCT01483599|221964|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
92283|NCT01483599|221965|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
92284|NCT01483599|221966|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
92285|NCT01483599|221967|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
92286|NCT01483599|221968|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
92287|NCT01483599|221969|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
92288|NCT01483599|221970|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
92289|NCT01483599|221971|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
92290|NCT01483599|221972|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
92291|NCT01483599|221973|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
92292|NCT01483378|222022|P2|NOT COMPLETED|Overall Study||0
92293|NCT01483378|222023|P1|NOT COMPLETED|Overall Study||0
92294|NCT01483378|222022|P2|COMPLETED|Overall Study||66
92295|NCT01483378|222023|P1|COMPLETED|Overall Study||100
92296|NCT01483378|222022|P2|STARTED|Overall Study||66
92297|NCT01483378|222023|P1|STARTED|Overall Study||100
92298|NCT01483352|222029|P1|NOT COMPLETED|Overall Study||0
92299|NCT01483352|222029|P1|COMPLETED|Overall Study||12
92300|NCT01483352|222029|P1|STARTED|Overall Study||12
92301|NCT01483209|222048|P1|NOT COMPLETED|Overall Study||1
92302|NCT01483209|222048|P1|COMPLETED|Overall Study||1
92303|NCT01483209|222048|P1|STARTED|Overall Study||2
92304|NCT01483183|222063|P10|NOT COMPLETED|Overall Study||1
92305|NCT01483183|222064|P9|NOT COMPLETED|Overall Study||0
92306|NCT01483183|222065|P8|NOT COMPLETED|Overall Study||0
92307|NCT01483183|222066|P7|NOT COMPLETED|Overall Study||2
92308|NCT01483183|222067|P6|NOT COMPLETED|Overall Study||0
92309|NCT01483183|222068|P5|NOT COMPLETED|Overall Study||0
92310|NCT01483183|222069|P4|NOT COMPLETED|Overall Study||0
92311|NCT01483183|222070|P3|NOT COMPLETED|Overall Study||0
92312|NCT01483183|222071|P2|NOT COMPLETED|Overall Study||0
92313|NCT01483183|222072|P1|NOT COMPLETED|Overall Study||0
92314|NCT01483183|222063|P10|COMPLETED|Overall Study||4
92315|NCT01483183|222064|P9|COMPLETED|Overall Study||4
92316|NCT01483183|222065|P8|COMPLETED|Overall Study||4
92317|NCT01483183|222066|P7|COMPLETED|Overall Study||4
92318|NCT01483183|222067|P6|COMPLETED|Overall Study||4
92319|NCT01483183|222068|P5|COMPLETED|Overall Study||4
92320|NCT01483183|222069|P4|COMPLETED|Overall Study||3
92321|NCT01483183|222070|P3|COMPLETED|Overall Study||5
92322|NCT01483183|222071|P2|COMPLETED|Overall Study||1
92323|NCT01483183|222072|P1|COMPLETED|Overall Study||4
92324|NCT01483183|222063|P10|STARTED|Overall Study||5
92325|NCT01483183|222064|P9|STARTED|Overall Study||4
92326|NCT01483183|222065|P8|STARTED|Overall Study||4
92327|NCT01483183|222066|P7|STARTED|Overall Study||6
92328|NCT01483183|222067|P6|STARTED|Overall Study||4
92329|NCT01483183|222068|P5|STARTED|Overall Study||4
92330|NCT01483183|222069|P4|STARTED|Overall Study||3
92331|NCT01483183|222070|P3|STARTED|Overall Study||5
92332|NCT01483183|222071|P2|STARTED|Overall Study||1
92333|NCT01483183|222072|P1|STARTED|Overall Study||4
92334|NCT01483118|222142|P2|NOT COMPLETED|Overall Study||16
92335|NCT01483118|222143|P1|NOT COMPLETED|Overall Study||12
92336|NCT01483118|222142|P2|COMPLETED|Overall Study||6
92337|NCT01483118|222143|P1|COMPLETED|Overall Study||11
92338|NCT01483118|222142|P2|Completed 3 Months|Overall Study||11
92339|NCT01483118|222143|P1|Completed 3 Months|Overall Study||15
92340|NCT01483118|222142|P2|STARTED|Overall Study||22
92341|NCT01483118|222143|P1|STARTED|Overall Study||23
92342|NCT01482910|222155|P2|NOT COMPLETED|Overall Study||9
92343|NCT01482910|222156|P1|NOT COMPLETED|Overall Study||15
92344|NCT01482910|222155|P2|COMPLETED|Overall Study||67
92345|NCT01482910|222156|P1|COMPLETED|Overall Study||213
92346|NCT01482910|222155|P2|Completed Week 28|Overall Study||71
92347|NCT01482910|222156|P1|Completed Week 28|Overall Study||216
92348|NCT01482910|222155|P2|STARTED|Overall Study||76
92349|NCT01482910|222156|P1|STARTED|Overall Study||228
92350|NCT01482884|222168|P2|NOT COMPLETED|Overall Study||18
92351|NCT01482884|222169|P1|NOT COMPLETED|Overall Study||13
92352|NCT01482884|222168|P2|COMPLETED|Overall Study||37
92353|NCT01482884|222169|P1|COMPLETED|Overall Study||43
92354|NCT01482884|222168|P2|STARTED|Overall Study||55
92355|NCT01482884|222169|P1|STARTED|Overall Study|One participant did not receive study treatment|56
92356|NCT01482819|222195|P1|NOT COMPLETED|Overall Study||2
92357|NCT01482819|222195|P1|COMPLETED|Overall Study||19
92358|NCT01482819|222195|P1|STARTED|Overall Study||21
92359|NCT01482767|222215|P2|NOT COMPLETED|Overall Study||49
92360|NCT01482767|222216|P1|NOT COMPLETED|Overall Study||54
92361|NCT01482767|222215|P2|COMPLETED|Overall Study||78
92362|NCT01482767|222216|P1|COMPLETED|Overall Study||81
92363|NCT01482767|222215|P2|STARTED|Overall Study||127
92364|NCT01482767|222216|P1|STARTED|Overall Study||135
92365|NCT01482429|222238|P2|NOT COMPLETED|Protocol||0
92366|NCT01482429|222239|P1|NOT COMPLETED|Protocol||275
92367|NCT01482429|222238|P2|COMPLETED|Protocol||0
92368|NCT01482429|222239|P1|COMPLETED|Protocol||139
92369|NCT01482429|222238|P2|STARTED|Protocol||0
92370|NCT01482429|222239|P1|STARTED|Protocol||414
92371|NCT01482429|222238|P2|NOT COMPLETED|Care Usual||173
92372|NCT01482429|222239|P1|NOT COMPLETED|Care Usual||0
92373|NCT01482429|222238|P2|COMPLETED|Care Usual||96
92374|NCT01482429|222239|P1|COMPLETED|Care Usual||0
92375|NCT01482429|222238|P2|STARTED|Care Usual||269
92376|NCT01482429|222239|P1|STARTED|Care Usual||0
92377|NCT01482325|222247|P1|NOT COMPLETED|Overall Study||0
92378|NCT01482325|222247|P1|COMPLETED|Overall Study||31
92379|NCT01482325|222247|P1|STARTED|Overall Study||31
92380|NCT01482312|222251|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
92381|NCT01482312|222252|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
92382|NCT01482312|222253|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
92383|NCT01482312|222251|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
92384|NCT01482312|222252|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
92385|NCT01482312|222253|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
92386|NCT01482312|222251|P3|STARTED|Period 3, 90 Minutes of Wear||9
92387|NCT01482312|222252|P2|STARTED|Period 3, 90 Minutes of Wear||9
92388|NCT01482312|222253|P1|STARTED|Period 3, 90 Minutes of Wear||8
92389|NCT01482312|222251|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
92390|NCT01482312|222252|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
92391|NCT01482312|222253|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
92392|NCT01482312|222251|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
92393|NCT01482312|222252|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
92394|NCT01482312|222253|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
92395|NCT01482312|222251|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
92396|NCT01482312|222252|P2|STARTED|Period 2, 90 Minutes of Wear||9
92397|NCT01482312|222253|P1|STARTED|Period 2, 90 Minutes of Wear||9
92398|NCT01482312|222251|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
92399|NCT01482312|222252|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
92400|NCT01482312|222253|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
92401|NCT01482312|222251|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
92402|NCT01482312|222252|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
92403|NCT01482312|222253|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
92404|NCT01482312|222251|P3|STARTED|Period 1, 90 Minutes of Wear||10
92405|NCT01482312|222252|P2|STARTED|Period 1, 90 Minutes of Wear||9
92406|NCT01482312|222253|P1|STARTED|Period 1, 90 Minutes of Wear||10
92407|NCT01482221|222267|P3|NOT COMPLETED|Overall Study||23
92408|NCT01482221|222268|P2|NOT COMPLETED|Overall Study||20
92409|NCT01482221|222269|P1|NOT COMPLETED|Overall Study||21
92410|NCT01482221|222267|P3|COMPLETED|Overall Study||77
92411|NCT01482221|222268|P2|COMPLETED|Overall Study||81
92412|NCT01482221|222269|P1|COMPLETED|Overall Study||80
92413|NCT01482221|222267|P3|STARTED|Overall Study||100
92414|NCT01482221|222268|P2|STARTED|Overall Study||101
92415|NCT01482221|222269|P1|STARTED|Overall Study||101
92416|NCT01482169|222310|P1|NOT COMPLETED|Overall Study||2
92417|NCT01482169|222310|P1|COMPLETED|Overall Study||46
92418|NCT01482169|222310|P1|STARTED|Overall Study||48
92419|NCT01482091|222319|P2|NOT COMPLETED|Overall Study||0
92420|NCT01482091|222320|P1|NOT COMPLETED|Overall Study||0
92421|NCT01482091|222319|P2|COMPLETED|Overall Study||24
92422|NCT01482091|222320|P1|COMPLETED|Overall Study||25
92423|NCT01482091|222319|P2|STARTED|Overall Study||24
92424|NCT01482091|222320|P1|STARTED|Overall Study||25
92425|NCT01482065|222352|P2|NOT COMPLETED|Overall Study||1
92426|NCT01482065|222353|P1|NOT COMPLETED|Overall Study||0
92427|NCT01482065|222352|P2|COMPLETED|Overall Study||4
92428|NCT01482065|222353|P1|COMPLETED|Overall Study||4
92429|NCT01482065|222352|P2|STARTED|Overall Study||5
92430|NCT01482065|222353|P1|STARTED|Overall Study||4
92431|NCT01481935|222367|P2|NOT COMPLETED|Overall Study||0
92432|NCT01481935|222368|P1|NOT COMPLETED|Overall Study||0
92433|NCT01481935|222367|P2|COMPLETED|Overall Study||93
92434|NCT01481935|222368|P1|COMPLETED|Overall Study||97
92435|NCT01481935|222367|P2|STARTED|Overall Study||93
92436|NCT01481935|222368|P1|STARTED|Overall Study||97
92437|NCT01481896|222374|P1|NOT COMPLETED|Overall Study||12
92438|NCT01481896|222374|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
92439|NCT01481896|222374|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
92440|NCT01481896|222374|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
92441|NCT01481779|222390|P2|NOT COMPLETED|Overall Study||28
92442|NCT01481779|222391|P1|NOT COMPLETED|Overall Study||70
92443|NCT01481779|222390|P2|COMPLETED|Overall Study||132
92444|NCT01481779|222391|P1|COMPLETED|Overall Study||225
92445|NCT01481779|222390|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
92446|NCT01481779|222391|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
92447|NCT01481779|222390|P2|STARTED|Overall Study||160
92448|NCT01481779|222391|P1|STARTED|Overall Study||295
92449|NCT01481740|222439|P2|NOT COMPLETED|Overall Study||7
92450|NCT01481740|222440|P1|NOT COMPLETED|Overall Study||11
92451|NCT01481740|222439|P2|COMPLETED|Overall Study||81
92452|NCT01481740|222440|P1|COMPLETED|Overall Study||79
92453|NCT01481740|222439|P2|STARTED|Overall Study||88
92454|NCT01481740|222440|P1|STARTED|Overall Study||90
92455|NCT01481558|222458|P2|NOT COMPLETED|Overall Study||0
92456|NCT01481558|222459|P1|NOT COMPLETED|Overall Study||0
92457|NCT01481558|222458|P2|COMPLETED|Overall Study||20
92458|NCT01481558|222459|P1|COMPLETED|Overall Study||20
92459|NCT01481558|222458|P2|STARTED|Overall Study||20
92460|NCT01481558|222459|P1|STARTED|Overall Study||20
92461|NCT01481376|222465|P1|NOT COMPLETED|Overall Study||31
92462|NCT01481376|222465|P1|COMPLETED|Overall Study||169
92463|NCT01481376|222465|P1|STARTED|Overall Study||200
92464|NCT01481324|222476|P3|NOT COMPLETED|Overall Study||2
92465|NCT01481324|222477|P2|NOT COMPLETED|Overall Study||2
92466|NCT01481324|222478|P1|NOT COMPLETED|Overall Study||0
92467|NCT01481324|222476|P3|COMPLETED|Overall Study||20
92468|NCT01481324|222477|P2|COMPLETED|Overall Study||22
92469|NCT01481324|222478|P1|COMPLETED|Overall Study||21
92470|NCT01481324|222476|P3|Month 3-Wear Rate Data|Overall Study||6
92471|NCT01481324|222477|P2|Month 3-Wear Rate Data|Overall Study||11
92472|NCT01481324|222478|P1|Month 3-Wear Rate Data|Overall Study||7
92473|NCT01481324|222476|P3|Month 2-Wear Rate Data|Overall Study||7
92474|NCT01481324|222477|P2|Month 2-Wear Rate Data|Overall Study||13
92475|NCT01481324|222478|P1|Month 2-Wear Rate Data|Overall Study||9
92476|NCT01481324|222476|P3|Month 1-Wear Rate Data|Overall Study||8
92477|NCT01481324|222477|P2|Month 1-Wear Rate Data|Overall Study||16
92478|NCT01481324|222478|P1|Month 1-Wear Rate Data|Overall Study||15
92479|NCT01481324|222476|P3|STARTED|Overall Study||22
92480|NCT01481324|222477|P2|STARTED|Overall Study||24
92481|NCT01481324|222478|P1|STARTED|Overall Study||21
92482|NCT01481129|222486|P1|NOT COMPLETED|Overall Study||0
92483|NCT01481129|222486|P1|COMPLETED|Overall Study||22
92484|NCT01481129|222486|P1|STARTED|Overall Study||22
92485|NCT01481116|222497|P3|NOT COMPLETED|Overall Study||813
92486|NCT01481116|222498|P2|NOT COMPLETED|Overall Study||817
92487|NCT01481116|222499|P1|NOT COMPLETED|Overall Study||824
92488|NCT01481116|222497|P3|COMPLETED|Overall Study||0
92489|NCT01481116|222498|P2|COMPLETED|Overall Study||0
92490|NCT01481116|222499|P1|COMPLETED|Overall Study||0
92491|NCT01481116|222497|P3|Treated|Overall Study||813
92492|NCT01481116|222498|P2|Treated|Overall Study||816
92493|NCT01481116|222499|P1|Treated|Overall Study||822
92494|NCT01481116|222497|P3|STARTED|Overall Study||813
92495|NCT01481116|222498|P2|STARTED|Overall Study||817
92496|NCT01481116|222499|P1|STARTED|Overall Study||824
92497|NCT01480843|222525|P1|NOT COMPLETED|Overall Study||5
92498|NCT01480843|222525|P1|COMPLETED|Overall Study||60
92499|NCT01480843|222525|P1|STARTED|Overall Study||65
92500|NCT01480674|222530|P1|NOT COMPLETED|Overall Study||35
92501|NCT01480674|222530|P1|COMPLETED|Overall Study||125
92502|NCT01480674|222530|P1|Analysed Set|Overall Study||128
92503|NCT01480674|222530|P1|Safety Set|Overall Study||154
92504|NCT01480674|222530|P1|STARTED|Overall Study||160
92505|NCT01480596|222544|P2|NOT COMPLETED|Overall Study||2
92506|NCT01480596|222545|P1|NOT COMPLETED|Overall Study||5
92507|NCT01480596|222544|P2|COMPLETED|Overall Study||16
92508|NCT01480596|222545|P1|COMPLETED|Overall Study||17
92509|NCT01480596|222544|P2|STARTED|Overall Study||18
92510|NCT01480596|222545|P1|STARTED|Overall Study||22
92511|NCT01480297|222587|P1|NOT COMPLETED|Overall Study||0
92512|NCT01480297|222587|P1|COMPLETED|Overall Study||8
92513|NCT01480297|222587|P1|STARTED|Overall Study||8
92514|NCT01480284|222593|P2|NOT COMPLETED|Overall Study||0
92515|NCT01480284|222594|P1|NOT COMPLETED|Overall Study||8
92516|NCT01480284|222593|P2|COMPLETED|Overall Study||56
92517|NCT01480284|222594|P1|COMPLETED|Overall Study||102
92518|NCT01480284|222593|P2|STARTED|Overall Study||56
92519|NCT01480284|222594|P1|STARTED|Overall Study||110
92520|NCT01480232|222626|P4|NOT COMPLETED|Overall Study||19
92521|NCT01480232|222627|P3|NOT COMPLETED|Overall Study||17
92522|NCT01480232|222628|P2|NOT COMPLETED|Overall Study||22
92523|NCT01480232|222629|P1|NOT COMPLETED|Overall Study||18
92524|NCT01480232|222626|P4|COMPLETED|Overall Study||22
92525|NCT01480232|222627|P3|COMPLETED|Overall Study||21
92526|NCT01480232|222628|P2|COMPLETED|Overall Study||19
92527|NCT01480232|222629|P1|COMPLETED|Overall Study||22
92528|NCT01480232|222626|P4|STARTED|Overall Study||41
92529|NCT01480232|222627|P3|STARTED|Overall Study||38
92530|NCT01480232|222628|P2|STARTED|Overall Study||41
92531|NCT01480232|222629|P1|STARTED|Overall Study||40
92532|NCT01480219|222657|P2|NOT COMPLETED|Overall Study||0
92533|NCT01480219|222658|P1|NOT COMPLETED|Overall Study||0
92534|NCT01480219|222657|P2|COMPLETED|Overall Study||142
92535|NCT01480219|222658|P1|COMPLETED|Overall Study||325
92536|NCT01480219|222657|P2|STARTED|Overall Study||142
92537|NCT01480219|222658|P1|STARTED|Overall Study||325
92538|NCT01480089|222666|P2|NOT COMPLETED|Overall Study||0
92539|NCT01480089|222667|P1|NOT COMPLETED|Overall Study||0
92540|NCT01480089|222666|P2|COMPLETED|Overall Study||30
92541|NCT01480089|222667|P1|COMPLETED|Overall Study||25
92542|NCT01480089|222666|P2|STARTED|Overall Study||30
92543|NCT01480089|222667|P1|STARTED|Overall Study||25
92544|NCT01480076|222677|P1|NOT COMPLETED|Overall Study||290
92545|NCT01480076|222677|P1|COMPLETED|Overall Study||611
92546|NCT01480076|222677|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
92547|NCT01480076|222677|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
92548|NCT01479868|222796|P1|NOT COMPLETED|Overall Study||9
92549|NCT01479868|222796|P1|COMPLETED|Overall Study||97
92550|NCT01479868|222796|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
92551|NCT01479777|222811|P1|NOT COMPLETED|Overall Study||2
92552|NCT01479777|222811|P1|COMPLETED|Overall Study||10
92553|NCT01479777|222811|P1|STARTED|Overall Study||12
92554|NCT01479764|222823|P2|NOT COMPLETED|Treated||2
92555|NCT01479764|222824|P1|NOT COMPLETED|Treated||0
92556|NCT01479764|222823|P2|COMPLETED|Treated||75
92557|NCT01479764|222824|P1|COMPLETED|Treated||74
92558|NCT01479764|222823|P2|STARTED|Treated||77
92559|NCT01479764|222824|P1|STARTED|Treated||74
92560|NCT01479764|222823|P2|NOT COMPLETED|Randomized||1
92561|NCT01479764|222824|P1|NOT COMPLETED|Randomized||2
92562|NCT01479764|222823|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
92563|NCT01479764|222824|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
92564|NCT01479764|222823|P2|STARTED|Randomized||78
92565|NCT01479764|222824|P1|STARTED|Randomized||76
92566|NCT01479725|222834|P2|NOT COMPLETED|Overall Study||1
92567|NCT01479725|222835|P1|NOT COMPLETED|Overall Study||2
92568|NCT01479725|222834|P2|COMPLETED|Overall Study||1
92569|NCT01479725|222835|P1|COMPLETED|Overall Study||4
92570|NCT01479725|222834|P2|STARTED|Overall Study||2
92571|NCT01479725|222835|P1|STARTED|Overall Study||6
92572|NCT01479621|222847|P7|NOT COMPLETED|Treatment Period||20
92573|NCT01479621|222848|P6|NOT COMPLETED|Treatment Period||41
92574|NCT01479621|222849|P5|NOT COMPLETED|Treatment Period||21
92575|NCT01479621|222850|P4|NOT COMPLETED|Treatment Period||12
92576|NCT01479621|222851|P3|NOT COMPLETED|Treatment Period||21
92577|NCT01479621|222852|P2|NOT COMPLETED|Treatment Period||24
92578|NCT01479621|222853|P1|NOT COMPLETED|Treatment Period||0
92579|NCT01479621|222847|P7|COMPLETED|Treatment Period||84
92580|NCT01479621|222848|P6|COMPLETED|Treatment Period||63
92581|NCT01479621|222849|P5|COMPLETED|Treatment Period||82
92582|NCT01479621|222850|P4|COMPLETED|Treatment Period||92
92583|NCT01479621|222851|P3|COMPLETED|Treatment Period||83
92584|NCT01479621|222852|P2|COMPLETED|Treatment Period||79
92585|NCT01479621|222853|P1|COMPLETED|Treatment Period||0
92586|NCT01479621|222847|P7|Full Analysis Set|Treatment Period||102
92587|NCT01479621|222848|P6|Full Analysis Set|Treatment Period||102
92588|NCT01479621|222849|P5|Full Analysis Set|Treatment Period||102
92589|NCT01479621|222850|P4|Full Analysis Set|Treatment Period||102
92590|NCT01479621|222851|P3|Full Analysis Set|Treatment Period||101
92591|NCT01479621|222852|P2|Full Analysis Set|Treatment Period||102
92592|NCT01479621|222853|P1|Full Analysis Set|Treatment Period||0
92593|NCT01479621|222847|P7|Safety Population|Treatment Period||104
92594|NCT01479621|222848|P6|Safety Population|Treatment Period||104
92595|NCT01479621|222849|P5|Safety Population|Treatment Period||103
92596|NCT01479621|222850|P4|Safety Population|Treatment Period||104
92597|NCT01479621|222851|P3|Safety Population|Treatment Period||104
92598|NCT01479621|222852|P2|Safety Population|Treatment Period||103
92599|NCT01479621|222853|P1|Safety Population|Treatment Period||0
92600|NCT01479621|222847|P7|STARTED|Treatment Period||104
92601|NCT01479621|222848|P6|STARTED|Treatment Period||104
92602|NCT01479621|222849|P5|STARTED|Treatment Period||103
92603|NCT01479621|222850|P4|STARTED|Treatment Period||104
92604|NCT01479621|222851|P3|STARTED|Treatment Period||104
92605|NCT01479621|222852|P2|STARTED|Treatment Period||103
92606|NCT01479621|222853|P1|STARTED|Treatment Period||0
92607|NCT01479621|222847|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92608|NCT01479621|222848|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92609|NCT01479621|222849|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92610|NCT01479621|222850|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92611|NCT01479621|222851|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92612|NCT01479621|222852|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92613|NCT01479621|222853|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
92614|NCT01479621|222847|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92615|NCT01479621|222848|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92616|NCT01479621|222849|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92617|NCT01479621|222850|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92618|NCT01479621|222851|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92619|NCT01479621|222852|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
92620|NCT01479621|222853|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
92621|NCT01479621|222847|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
92622|NCT01479621|222848|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
92623|NCT01479621|222849|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
92624|NCT01479621|222850|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
92625|NCT01479621|222851|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
92626|NCT01479621|222852|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
92627|NCT01479621|222853|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
92628|NCT01479595|222941|P2|NOT COMPLETED|Overall Study||2
92629|NCT01479595|222942|P1|NOT COMPLETED|Overall Study||2
92630|NCT01479595|222941|P2|COMPLETED|Overall Study||19
92631|NCT01479595|222942|P1|COMPLETED|Overall Study||42
92632|NCT01479595|222941|P2|Per Protocol Analysis Set|Overall Study||20
92633|NCT01479595|222942|P1|Per Protocol Analysis Set|Overall Study||41
92634|NCT01479595|222941|P2|PK Analysis Set|Overall Study||0
92635|NCT01479595|222942|P1|PK Analysis Set|Overall Study||42
92636|NCT01479595|222941|P2|STARTED|Overall Study||21
92637|NCT01479595|222942|P1|STARTED|Overall Study||44
92638|NCT01479543|222969|P5|NOT COMPLETED|Overall Study||1
92639|NCT01479543|222970|P4|NOT COMPLETED|Overall Study||0
92640|NCT01479543|222971|P3|NOT COMPLETED|Overall Study||1
92641|NCT01479543|222972|P2|NOT COMPLETED|Overall Study||0
92642|NCT01479543|222973|P1|NOT COMPLETED|Overall Study||1
92643|NCT01479543|222969|P5|COMPLETED|Overall Study||20
92644|NCT01479543|222970|P4|COMPLETED|Overall Study||20
92645|NCT01479543|222971|P3|COMPLETED|Overall Study||20
92646|NCT01479543|222972|P2|COMPLETED|Overall Study||20
92647|NCT01479543|222973|P1|COMPLETED|Overall Study||20
92648|NCT01479543|222969|P5|STARTED|Overall Study||21
92649|NCT01479543|222970|P4|STARTED|Overall Study||20
92650|NCT01479543|222971|P3|STARTED|Overall Study||21
92651|NCT01479543|222972|P2|STARTED|Overall Study||20
92652|NCT01479543|222973|P1|STARTED|Overall Study||21
92653|NCT01479530|222987|P2|NOT COMPLETED|Overall Study||12
92654|NCT01479530|222988|P1|NOT COMPLETED|Overall Study||10
92655|NCT01479530|222987|P2|COMPLETED|Overall Study||151
92656|NCT01479530|222988|P1|COMPLETED|Overall Study||148
92657|NCT01479530|222987|P2|STARTED|Overall Study||163
92658|NCT01479530|222988|P1|STARTED|Overall Study||158
92659|NCT01479517|223003|P3|NOT COMPLETED|Overall Study||0
92660|NCT01479517|223004|P2|NOT COMPLETED|Overall Study||0
92661|NCT01479517|223005|P1|NOT COMPLETED|Overall Study||0
92662|NCT01479517|223003|P3|COMPLETED|Overall Study||10
92663|NCT01479517|223004|P2|COMPLETED|Overall Study||10
92664|NCT01479517|223005|P1|COMPLETED|Overall Study||10
92665|NCT01479517|223003|P3|STARTED|Overall Study||10
92666|NCT01479517|223004|P2|STARTED|Overall Study||10
92667|NCT01479517|223005|P1|STARTED|Overall Study||10
92668|NCT01479374|223025|P3|NOT COMPLETED|Overall Study||5
92669|NCT01479374|223026|P2|NOT COMPLETED|Overall Study||8
92670|NCT01479374|223027|P1|NOT COMPLETED|Overall Study||3
92671|NCT01479374|223025|P3|COMPLETED|Overall Study||63
92672|NCT01479374|223026|P2|COMPLETED|Overall Study||60
92673|NCT01479374|223027|P1|COMPLETED|Overall Study||63
92674|NCT01479374|223025|P3|STARTED|Overall Study||68
92675|NCT01479374|223026|P2|STARTED|Overall Study||68
92676|NCT01479374|223027|P1|STARTED|Overall Study||66
92677|NCT01479127|223053|P1|NOT COMPLETED|Overall Study||3
92678|NCT01479127|223053|P1|COMPLETED|Overall Study||5
92679|NCT01479127|223053|P1|Started LCIG|Overall Study||6
92680|NCT01479127|223053|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
92681|NCT01479010|223087|P1|NOT COMPLETED|Overall Study||1
92682|NCT01479010|223087|P1|COMPLETED|Overall Study||1
92683|NCT01479010|223087|P1|STARTED|Overall Study||2
92684|NCT01478971|223098|P1|NOT COMPLETED|Peginesatide Treatment Period||14
92685|NCT01478971|223098|P1|COMPLETED|Peginesatide Treatment Period||143
92686|NCT01478971|223098|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
92687|NCT01478971|223098|P1|NOT COMPLETED|Standard of Care Period||25
92688|NCT01478971|223098|P1|COMPLETED|Standard of Care Period||159
92689|NCT01478971|223098|P1|Received Treatment|Standard of Care Period||178
92690|NCT01478971|223098|P1|STARTED|Standard of Care Period||184
92691|NCT01478958|223115|P3|NOT COMPLETED|Overall Study||3
92692|NCT01478958|223116|P2|NOT COMPLETED|Overall Study||2
92693|NCT01478958|223117|P1|NOT COMPLETED|Overall Study||2
92694|NCT01478958|223115|P3|COMPLETED|Overall Study||66
92695|NCT01478958|223116|P2|COMPLETED|Overall Study||64
92696|NCT01478958|223117|P1|COMPLETED|Overall Study||65
92697|NCT01478958|223115|P3|STARTED|Overall Study||69
92698|NCT01478958|223116|P2|STARTED|Overall Study||66
92699|NCT01478958|223117|P1|STARTED|Overall Study||67
92700|NCT01478828|223125|P1|NOT COMPLETED|Overall Study||1
92701|NCT01478828|223125|P1|COMPLETED|Overall Study||1
92702|NCT01478828|223125|P1|STARTED|Overall Study||2
92703|NCT01478620|223130|P1|NOT COMPLETED|Overall Study||6
92704|NCT01478620|223130|P1|COMPLETED|Overall Study||119
92705|NCT01478620|223130|P1|STARTED|Overall Study||125
92706|NCT01478594|223136|P2|NOT COMPLETED|Overall Study||28
92707|NCT01478594|223137|P1|NOT COMPLETED|Overall Study||65
92708|NCT01478594|223136|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
92709|NCT01478594|223137|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
92710|NCT01478594|223136|P2|Treated|Overall Study||87
92711|NCT01478594|223137|P1|Treated|Overall Study||177
92712|NCT01478594|223136|P2|STARTED|Overall Study||88
92713|NCT01478594|223137|P1|STARTED|Overall Study||177
92714|NCT01478373|223209|P1|NOT COMPLETED|Survival Phase||38
92715|NCT01478373|223209|P1|COMPLETED|Survival Phase||0
92716|NCT01478373|223209|P1|STARTED|Survival Phase||38
92717|NCT01478373|223209|P1|NOT COMPLETED|Treatment Phase||1
92718|NCT01478373|223209|P1|COMPLETED|Treatment Phase||38
92719|NCT01478373|223209|P1|STARTED|Treatment Phase||39
92720|NCT01478360|223222|P2|NOT COMPLETED|Overall Study||3
92721|NCT01478360|223223|P1|NOT COMPLETED|Overall Study||2
92722|NCT01478360|223222|P2|COMPLETED|Overall Study||12
92723|NCT01478360|223223|P1|COMPLETED|Overall Study||29
92724|NCT01478360|223222|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
92725|NCT01478360|223223|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
92726|NCT01478360|223222|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
92727|NCT01478360|223223|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
92728|NCT01478360|223222|P2|STARTED|Overall Study||15
92729|NCT01478360|223223|P1|STARTED|Overall Study||31
92730|NCT01478347|223229|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
92731|NCT01478347|223229|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
92732|NCT01478347|223229|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
92733|NCT01478347|223229|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
92734|NCT01478347|223229|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
92735|NCT01478347|223229|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
92736|NCT01478256|223236|P2|NOT COMPLETED|Overall Study||0
92737|NCT01478256|223237|P1|NOT COMPLETED|Overall Study||0
92738|NCT01478256|223236|P2|COMPLETED|Overall Study||15
92739|NCT01478256|223237|P1|COMPLETED|Overall Study||15
92740|NCT01478256|223236|P2|STARTED|Overall Study||15
92741|NCT01478256|223237|P1|STARTED|Overall Study||15
92742|NCT01478113|223247|P2|NOT COMPLETED|Overall Study||1
92743|NCT01478113|223248|P1|NOT COMPLETED|Overall Study||1
92744|NCT01478113|223247|P2|COMPLETED|Overall Study||1
92745|NCT01478113|223248|P1|COMPLETED|Overall Study||1
92746|NCT01478113|223247|P2|STARTED|Overall Study||2
92747|NCT01478113|223248|P1|STARTED|Overall Study||2
92748|NCT01478087|223266|P1|NOT COMPLETED|Overall Study||1
92749|NCT01478087|223266|P1|COMPLETED|Overall Study||2
92750|NCT01478087|223266|P1|STARTED|Overall Study||3
92751|NCT01478048|223273|P2|NOT COMPLETED|Overall Study||75
92752|NCT01478048|223274|P1|NOT COMPLETED|Overall Study||77
92753|NCT01478048|223273|P2|COMPLETED|Overall Study||0
92754|NCT01478048|223274|P1|COMPLETED|Overall Study||0
92755|NCT01478048|223273|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
92756|NCT01478048|223274|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
92757|NCT01478048|223273|P2|STARTED|Overall Study||75
92758|NCT01478048|223274|P1|STARTED|Overall Study||77
92759|NCT01478009|223292|P2|NOT COMPLETED|Overall Study||1
92760|NCT01478009|223293|P1|NOT COMPLETED|Overall Study||1
92761|NCT01478009|223292|P2|COMPLETED|Overall Study||49
92762|NCT01478009|223293|P1|COMPLETED|Overall Study||49
92763|NCT01478009|223292|P2|STARTED|Overall Study||50
92764|NCT01478009|223293|P1|STARTED|Overall Study||50
92765|NCT01477892|223303|P2|NOT COMPLETED|Overall Study||2
92766|NCT01477892|223304|P1|NOT COMPLETED|Overall Study||0
92767|NCT01477892|223303|P2|COMPLETED|Overall Study||5
92768|NCT01477892|223304|P1|COMPLETED|Overall Study||7
92769|NCT01477892|223303|P2|STARTED|Overall Study||7
92770|NCT01477892|223304|P1|STARTED|Overall Study||7
92771|NCT01477853|223315|P3|NOT COMPLETED|Phase B||11
92772|NCT01477853|223316|P2|NOT COMPLETED|Phase B||11
92773|NCT01477853|223317|P1|NOT COMPLETED|Phase B||12
92774|NCT01477853|223315|P3|COMPLETED|Phase B||0
92775|NCT01477853|223316|P2|COMPLETED|Phase B||0
92776|NCT01477853|223317|P1|COMPLETED|Phase B||0
92777|NCT01477853|223315|P3|STARTED|Phase B||11
92778|NCT01477853|223316|P2|STARTED|Phase B||11
92779|NCT01477853|223317|P1|STARTED|Phase B||12
92780|NCT01477853|223315|P3|NOT COMPLETED|Phase A||44
92781|NCT01477853|223316|P2|NOT COMPLETED|Phase A||45
92782|NCT01477853|223317|P1|NOT COMPLETED|Phase A||43
92783|NCT01477853|223315|P3|COMPLETED|Phase A||11
92784|NCT01477853|223316|P2|COMPLETED|Phase A||11
92785|NCT01477853|223317|P1|COMPLETED|Phase A||12
92786|NCT01477853|223315|P3|STARTED|Phase A||55
92787|NCT01477853|223316|P2|STARTED|Phase A||56
92788|NCT01477853|223317|P1|STARTED|Phase A||55
92789|NCT01477762|223359|P4|NOT COMPLETED|Overall Study||2
92790|NCT01477762|223360|P3|NOT COMPLETED|Overall Study||4
92791|NCT01477762|223361|P2|NOT COMPLETED|Overall Study||13
92792|NCT01477762|223362|P1|NOT COMPLETED|Overall Study||9
92793|NCT01477762|223359|P4|COMPLETED|Overall Study||11
92794|NCT01477762|223360|P3|COMPLETED|Overall Study||16
92795|NCT01477762|223361|P2|COMPLETED|Overall Study||20
92796|NCT01477762|223362|P1|COMPLETED|Overall Study||16
92797|NCT01477762|223359|P4|STARTED|Overall Study||13
92798|NCT01477762|223360|P3|STARTED|Overall Study||20
92799|NCT01477762|223361|P2|STARTED|Overall Study||33
92800|NCT01477762|223362|P1|STARTED|Overall Study||25
92801|NCT01477749|223384|P1|NOT COMPLETED|Overall Study||4
92802|NCT01477749|223384|P1|COMPLETED|Overall Study||43
92803|NCT01477749|223384|P1|STARTED|Overall Study||47
92804|NCT01477710|223391|P1|NOT COMPLETED|Overall Study||0
92805|NCT01477710|223391|P1|COMPLETED|Overall Study||30
92806|NCT01477710|223391|P1|STARTED|Overall Study||30
92807|NCT01477567|223406|P7|NOT COMPLETED|Overall Study||0
92808|NCT01477567|223407|P6|NOT COMPLETED|Overall Study||0
92809|NCT01477567|223408|P5|NOT COMPLETED|Overall Study||0
92810|NCT01477567|223409|P4|NOT COMPLETED|Overall Study||0
92811|NCT01477567|223410|P3|NOT COMPLETED|Overall Study||0
92812|NCT01477567|223411|P2|NOT COMPLETED|Overall Study||0
92813|NCT01477567|223412|P1|NOT COMPLETED|Overall Study||0
92814|NCT01477567|223406|P7|COMPLETED|Overall Study||6
92815|NCT01477567|223407|P6|COMPLETED|Overall Study||5
92816|NCT01477567|223408|P5|COMPLETED|Overall Study||6
92817|NCT01477567|223409|P4|COMPLETED|Overall Study||6
92818|NCT01477567|223410|P3|COMPLETED|Overall Study||6
92819|NCT01477567|223411|P2|COMPLETED|Overall Study||6
92820|NCT01477567|223412|P1|COMPLETED|Overall Study||5
92821|NCT01477567|223406|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
92822|NCT01477567|223407|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
92823|NCT01477567|223408|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
92824|NCT01477567|223409|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
92825|NCT01477567|223410|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
92826|NCT01477567|223411|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
92827|NCT01477567|223412|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
92828|NCT01477567|223406|P7|STARTED|Overall Study||6
92829|NCT01477567|223407|P6|STARTED|Overall Study||5
92830|NCT01477567|223408|P5|STARTED|Overall Study||6
92831|NCT01477567|223409|P4|STARTED|Overall Study||6
92832|NCT01477567|223410|P3|STARTED|Overall Study||6
92833|NCT01477567|223411|P2|STARTED|Overall Study||6
92834|NCT01477567|223412|P1|STARTED|Overall Study||5
92835|NCT01477463|223468|P2|NOT COMPLETED|Overall Study||0
92836|NCT01477463|223469|P1|NOT COMPLETED|Overall Study||0
92837|NCT01477463|223468|P2|COMPLETED|Overall Study||6
92838|NCT01477463|223469|P1|COMPLETED|Overall Study||18
92839|NCT01477463|223468|P2|STARTED|Overall Study||6
92840|NCT01477463|223469|P1|STARTED|Overall Study||18
92841|NCT01477450|223482|P3|NOT COMPLETED|Overall Study||0
92842|NCT01477450|223483|P2|NOT COMPLETED|Overall Study||0
92843|NCT01477450|223484|P1|NOT COMPLETED|Overall Study||0
92844|NCT01477450|223482|P3|COMPLETED|Overall Study||10
92845|NCT01477450|223483|P2|COMPLETED|Overall Study||10
92846|NCT01477450|223484|P1|COMPLETED|Overall Study||10
92847|NCT01477450|223482|P3|STARTED|Overall Study||10
92848|NCT01477450|223483|P2|STARTED|Overall Study||10
92849|NCT01477450|223484|P1|STARTED|Overall Study||10
92850|NCT01477333|223492|P1|NOT COMPLETED|Overall Study||3
92851|NCT01477333|223492|P1|COMPLETED|Overall Study||15
92852|NCT01477333|223492|P1|STARTED|Overall Study||18
92853|NCT01477320|223510|P2|NOT COMPLETED|Overall Study||15
92854|NCT01477320|223511|P1|NOT COMPLETED|Overall Study||7
92855|NCT01477320|223510|P2|COMPLETED|Overall Study||47
92856|NCT01477320|223511|P1|COMPLETED|Overall Study||55
92857|NCT01477320|223510|P2|STARTED|Overall Study||62
92858|NCT01477320|223511|P1|STARTED|Overall Study||62
92859|NCT01476748|223522|P3|NOT COMPLETED|Overall Study||0
92860|NCT01476748|223523|P2|NOT COMPLETED|Overall Study||0
92861|NCT01476748|223524|P1|NOT COMPLETED|Overall Study||0
92862|NCT01476748|223522|P3|COMPLETED|Overall Study||5
92863|NCT01476748|223523|P2|COMPLETED|Overall Study||5
92864|NCT01476748|223524|P1|COMPLETED|Overall Study||5
92865|NCT01476748|223522|P3|STARTED|Overall Study||5
92866|NCT01476748|223523|P2|STARTED|Overall Study||5
92867|NCT01476748|223524|P1|STARTED|Overall Study||5
92868|NCT01476722|223535|P1|NOT COMPLETED|Overall Study||1
92869|NCT01476722|223535|P1|COMPLETED|Overall Study||124
92870|NCT01476722|223535|P1|STARTED|Overall Study||125
92871|NCT01476696|223542|P3|NOT COMPLETED|Overall Study||0
92872|NCT01476696|223543|P2|NOT COMPLETED|Overall Study||1
92873|NCT01476696|223544|P1|NOT COMPLETED|Overall Study||3
92874|NCT01476696|223542|P3|COMPLETED|Overall Study||9
92875|NCT01476696|223543|P2|COMPLETED|Overall Study||8
92876|NCT01476696|223544|P1|COMPLETED|Overall Study||12
92877|NCT01476696|223542|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
92878|NCT01476696|223543|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
92879|NCT01476696|223544|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
92880|NCT01476696|223542|P3|STARTED|Overall Study||9
92881|NCT01476696|223543|P2|STARTED|Overall Study||9
92882|NCT01476696|223544|P1|STARTED|Overall Study||15
92883|NCT01476475|223560|P2|NOT COMPLETED|Overall Study||3
92884|NCT01476475|223561|P1|NOT COMPLETED|Overall Study||11
92885|NCT01476475|223560|P2|COMPLETED|Overall Study||159
92886|NCT01476475|223561|P1|COMPLETED|Overall Study||150
92887|NCT01476475|223560|P2|STARTED|Overall Study||162
92888|NCT01476475|223561|P1|STARTED|Overall Study||161
92889|NCT01476345|223593|P2|NOT COMPLETED|Period 4||0
92890|NCT01476345|223594|P1|NOT COMPLETED|Period 4||0
92891|NCT01476345|223593|P2|COMPLETED|Period 4||39
92892|NCT01476345|223594|P1|COMPLETED|Period 4||39
92893|NCT01476345|223593|P2|STARTED|Period 4||39
92894|NCT01476345|223594|P1|STARTED|Period 4||39
92895|NCT01476345|223593|P2|NOT COMPLETED|Period 3||0
92896|NCT01476345|223594|P1|NOT COMPLETED|Period 3||0
92897|NCT01476345|223593|P2|COMPLETED|Period 3||39
92898|NCT01476345|223594|P1|COMPLETED|Period 3||39
92899|NCT01476345|223593|P2|STARTED|Period 3||39
92900|NCT01476345|223594|P1|STARTED|Period 3||39
92901|NCT01476345|223593|P2|NOT COMPLETED|Period 2||0
92902|NCT01476345|223594|P1|NOT COMPLETED|Period 2||0
92903|NCT01476345|223593|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
92904|NCT01476345|223594|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
92905|NCT01476345|223593|P2|STARTED|Period 2||40
92906|NCT01476345|223594|P1|STARTED|Period 2||40
92907|NCT01476345|223593|P2|NOT COMPLETED|Period 1||0
92908|NCT01476345|223594|P1|NOT COMPLETED|Period 1||0
92909|NCT01476345|223593|P2|COMPLETED|Period 1||40
92910|NCT01476345|223594|P1|COMPLETED|Period 1||40
92911|NCT01476345|223593|P2|Received at Least 1 Dose of Study Drug|Period 1||40
92912|NCT01476345|223594|P1|Received at Least 1 Dose of Study Drug|Period 1||40
92913|NCT01476345|223593|P2|STARTED|Period 1||40
92914|NCT01476345|223594|P1|STARTED|Period 1||40
92915|NCT01476202|223609|P3|NOT COMPLETED|Overall Study||0
92916|NCT01476202|223610|P2|NOT COMPLETED|Overall Study||0
92917|NCT01476202|223611|P1|NOT COMPLETED|Overall Study||0
92918|NCT01476202|223609|P3|COMPLETED|Overall Study||40
92919|NCT01476202|223610|P2|COMPLETED|Overall Study||40
92920|NCT01476202|223611|P1|COMPLETED|Overall Study||40
92921|NCT01476202|223609|P3|STARTED|Overall Study||40
92922|NCT01476202|223610|P2|STARTED|Overall Study||40
92923|NCT01476202|223611|P1|STARTED|Overall Study||40
92924|NCT01475955|223627|P5|NOT COMPLETED|Overall Study||0
92925|NCT01475955|223628|P4|NOT COMPLETED|Overall Study||0
92926|NCT01475955|223629|P3|NOT COMPLETED|Overall Study||3
92927|NCT01475955|223630|P2|NOT COMPLETED|Overall Study||0
92928|NCT01475955|223631|P1|NOT COMPLETED|Overall Study||1
92929|NCT01475955|223627|P5|COMPLETED|Overall Study||46
92930|NCT01475955|223628|P4|COMPLETED|Overall Study||46
92931|NCT01475955|223629|P3|COMPLETED|Overall Study||44
92932|NCT01475955|223630|P2|COMPLETED|Overall Study||48
92933|NCT01475955|223631|P1|COMPLETED|Overall Study||47
92934|NCT01475955|223627|P5|STARTED|Overall Study||46
92935|NCT01475955|223628|P4|STARTED|Overall Study||46
92936|NCT01475955|223629|P3|STARTED|Overall Study||47
92937|NCT01475955|223630|P2|STARTED|Overall Study||48
92938|NCT01475955|223631|P1|STARTED|Overall Study||48
92939|NCT01475851|223990|P2|NOT COMPLETED|Overall Study||0
92940|NCT01475851|223991|P1|NOT COMPLETED|Overall Study||1
92941|NCT01475851|223990|P2|COMPLETED|Overall Study||21
92942|NCT01475851|223991|P1|COMPLETED|Overall Study||12
92943|NCT01475851|223990|P2|STARTED|Overall Study||21
92944|NCT01475851|223991|P1|STARTED|Overall Study||13
92945|NCT01475838|224019|P2|NOT COMPLETED|Extension Phase||0
92946|NCT01475838|224020|P1|NOT COMPLETED|Extension Phase||1
92947|NCT01475838|224019|P2|COMPLETED|Extension Phase||20
92948|NCT01475838|224020|P1|COMPLETED|Extension Phase||41
92949|NCT01475838|224019|P2|STARTED|Extension Phase||20
92950|NCT01475838|224020|P1|STARTED|Extension Phase||42
92951|NCT01475838|224019|P2|NOT COMPLETED|Randomized Phase||36
92952|NCT01475838|224020|P1|NOT COMPLETED|Randomized Phase||30
92953|NCT01475838|224019|P2|COMPLETED|Randomized Phase||109
92954|NCT01475838|224020|P1|COMPLETED|Randomized Phase||263
92955|NCT01475838|224019|P2|STARTED|Randomized Phase||145
92956|NCT01475838|224020|P1|STARTED|Randomized Phase||293
92957|NCT01475734|224035|P2|NOT COMPLETED|Overall Study||1
92958|NCT01475734|224036|P1|NOT COMPLETED|Overall Study||2
92959|NCT01475734|224035|P2|COMPLETED|Overall Study||21
92960|NCT01475734|224036|P1|COMPLETED|Overall Study||20
92961|NCT01475734|224035|P2|STARTED|Overall Study||22
92962|NCT01475734|224036|P1|STARTED|Overall Study||22
92963|NCT01475721|224064|P2|NOT COMPLETED|Overall Study||14
92964|NCT01475721|224065|P1|NOT COMPLETED|Overall Study||11
92965|NCT01475721|224064|P2|COMPLETED|Overall Study||5831
92966|NCT01475721|224065|P1|COMPLETED|Overall Study||5823
92967|NCT01475721|224064|P2|STARTED|Overall Study||5845
92968|NCT01475721|224065|P1|STARTED|Overall Study||5834
92969|NCT01475487|224081|P2|NOT COMPLETED|Overall Study||1
92970|NCT01475487|224082|P1|NOT COMPLETED|Overall Study||2
92971|NCT01475487|224081|P2|COMPLETED|Overall Study||24
92972|NCT01475487|224082|P1|COMPLETED|Overall Study||23
92973|NCT01475487|224081|P2|STARTED|Overall Study||25
92974|NCT01475487|224082|P1|STARTED|Overall Study||25
92975|NCT01475474|224094|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
92976|NCT01475474|224094|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
92977|NCT01475474|224094|P1|STARTED|Return to Baseline Period - 4 Weeks||73
92978|NCT01475474|224094|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
92979|NCT01475474|224094|P1|COMPLETED|Treatment Period - 12 Weeks||73
92980|NCT01475474|224094|P1|STARTED|Treatment Period - 12 Weeks||91
92981|NCT01475474|224094|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
92982|NCT01475474|224094|P1|COMPLETED|Baseline Period - 4 Weeks||91
92983|NCT01475474|224094|P1|STARTED|Baseline Period - 4 Weeks||97
92984|NCT01475461|224105|P7|NOT COMPLETED|Treatment Period||2
92985|NCT01475461|224106|P6|NOT COMPLETED|Treatment Period||5
92986|NCT01475461|224107|P5|NOT COMPLETED|Treatment Period||4
92987|NCT01475461|224108|P4|NOT COMPLETED|Treatment Period||8
92988|NCT01475461|224109|P3|NOT COMPLETED|Treatment Period||4
92989|NCT01475461|224110|P2|NOT COMPLETED|Treatment Period||9
92990|NCT01475461|224111|P1|NOT COMPLETED|Treatment Period||0
92991|NCT01475461|224105|P7|COMPLETED|Treatment Period||53
92992|NCT01475461|224106|P6|COMPLETED|Treatment Period||51
92993|NCT01475461|224107|P5|COMPLETED|Treatment Period||52
92994|NCT01475461|224108|P4|COMPLETED|Treatment Period||46
92995|NCT01475461|224109|P3|COMPLETED|Treatment Period||53
92996|NCT01475461|224110|P2|COMPLETED|Treatment Period||48
92997|NCT01475461|224111|P1|COMPLETED|Treatment Period||0
92998|NCT01475461|224105|P7|STARTED|Treatment Period||55
92999|NCT01475461|224106|P6|STARTED|Treatment Period||56
93000|NCT01475461|224107|P5|STARTED|Treatment Period||56
93001|NCT01475461|224108|P4|STARTED|Treatment Period||54
93002|NCT01475461|224109|P3|STARTED|Treatment Period||57
93003|NCT01475461|224110|P2|STARTED|Treatment Period||57
93004|NCT01475461|224111|P1|STARTED|Treatment Period||0
93005|NCT01475461|224105|P7|NOT COMPLETED|Run-in Period||0
93006|NCT01475461|224106|P6|NOT COMPLETED|Run-in Period||0
93007|NCT01475461|224107|P5|NOT COMPLETED|Run-in Period||0
93008|NCT01475461|224108|P4|NOT COMPLETED|Run-in Period||0
93009|NCT01475461|224109|P3|NOT COMPLETED|Run-in Period||0
93010|NCT01475461|224110|P2|NOT COMPLETED|Run-in Period||0
93011|NCT01475461|224111|P1|NOT COMPLETED|Run-in Period||41
93012|NCT01475461|224105|P7|COMPLETED|Run-in Period||0
93013|NCT01475461|224106|P6|COMPLETED|Run-in Period||0
93014|NCT01475461|224107|P5|COMPLETED|Run-in Period||0
93015|NCT01475461|224108|P4|COMPLETED|Run-in Period||0
93016|NCT01475461|224109|P3|COMPLETED|Run-in Period||0
93017|NCT01475461|224110|P2|COMPLETED|Run-in Period||0
93018|NCT01475461|224111|P1|COMPLETED|Run-in Period||335
93019|NCT01475461|224105|P7|STARTED|Run-in Period||0
93020|NCT01475461|224106|P6|STARTED|Run-in Period||0
93021|NCT01475461|224107|P5|STARTED|Run-in Period||0
93022|NCT01475461|224108|P4|STARTED|Run-in Period||0
93023|NCT01475461|224109|P3|STARTED|Run-in Period||0
93024|NCT01475461|224110|P2|STARTED|Run-in Period||0
93025|NCT01475461|224111|P1|STARTED|Run-in Period||376
93026|NCT01475331|224191|P2|NOT COMPLETED|Overall Study||2
93027|NCT01475331|224192|P1|NOT COMPLETED|Overall Study||5
93028|NCT01475331|224191|P2|COMPLETED|Overall Study||21
93029|NCT01475331|224192|P1|COMPLETED|Overall Study||18
93030|NCT01475331|224191|P2|STARTED|Overall Study||23
93031|NCT01475331|224192|P1|STARTED|Overall Study||23
93032|NCT01475305|224200|P2|NOT COMPLETED|Overall Study||0
93033|NCT01475305|224201|P1|NOT COMPLETED|Overall Study||0
93034|NCT01475305|224200|P2|COMPLETED|Overall Study||3
93035|NCT01475305|224201|P1|COMPLETED|Overall Study||4
93036|NCT01475305|224200|P2|End of Quarantine, Day 15|Overall Study||3
93037|NCT01475305|224201|P1|End of Quarantine, Day 15|Overall Study||4
93038|NCT01475305|224200|P2|STARTED|Overall Study||3
93039|NCT01475305|224201|P1|STARTED|Overall Study||4
93040|NCT01475253|224244|P4|NOT COMPLETED|Open Label Extension||0
93041|NCT01475253|224245|P3|NOT COMPLETED|Open Label Extension||0
93042|NCT01475253|224246|P2|NOT COMPLETED|Open Label Extension||0
93043|NCT01475253|224247|P1|NOT COMPLETED|Open Label Extension||0
93044|NCT01475253|224244|P4|COMPLETED|Open Label Extension||56
93045|NCT01475253|224245|P3|COMPLETED|Open Label Extension||0
93046|NCT01475253|224246|P2|COMPLETED|Open Label Extension||0
93047|NCT01475253|224247|P1|COMPLETED|Open Label Extension||0
93048|NCT01475253|224244|P4|STARTED|Open Label Extension||56
93049|NCT01475253|224245|P3|STARTED|Open Label Extension||0
93050|NCT01475253|224246|P2|STARTED|Open Label Extension||0
93051|NCT01475253|224247|P1|STARTED|Open Label Extension||0
93052|NCT01475253|224244|P4|NOT COMPLETED|Randomized, Blinded Study||0
93053|NCT01475253|224245|P3|NOT COMPLETED|Randomized, Blinded Study||0
93054|NCT01475253|224246|P2|NOT COMPLETED|Randomized, Blinded Study||1
93055|NCT01475253|224247|P1|NOT COMPLETED|Randomized, Blinded Study||2
93056|NCT01475253|224244|P4|COMPLETED|Randomized, Blinded Study||0
93057|NCT01475253|224245|P3|COMPLETED|Randomized, Blinded Study||11
93058|NCT01475253|224246|P2|COMPLETED|Randomized, Blinded Study||45
93059|NCT01475253|224247|P1|COMPLETED|Randomized, Blinded Study||45
93060|NCT01475253|224244|P4|STARTED|Randomized, Blinded Study||0
93061|NCT01475253|224245|P3|STARTED|Randomized, Blinded Study||11
93062|NCT01475253|224246|P2|STARTED|Randomized, Blinded Study||46
93063|NCT01475253|224247|P1|STARTED|Randomized, Blinded Study||47
93064|NCT01475214|224276|P3|NOT COMPLETED|Overall Study||2
93065|NCT01475214|224277|P2|NOT COMPLETED|Overall Study||4
93066|NCT01475214|224278|P1|NOT COMPLETED|Overall Study||5
93067|NCT01475214|224276|P3|COMPLETED|Overall Study||79
93068|NCT01475214|224277|P2|COMPLETED|Overall Study||75
93069|NCT01475214|224278|P1|COMPLETED|Overall Study||79
93070|NCT01475214|224276|P3|STARTED|Overall Study||81
93071|NCT01475214|224277|P2|STARTED|Overall Study||79
93072|NCT01475214|224278|P1|STARTED|Overall Study||84
93073|NCT01475175|224289|P1|NOT COMPLETED|Overall Study||0
93074|NCT01475175|224289|P1|COMPLETED|Overall Study||12
93075|NCT01475175|224289|P1|STARTED|Overall Study||12
93076|NCT01475097|224303|P2|NOT COMPLETED|Overall Study||1
93077|NCT01475097|224304|P1|NOT COMPLETED|Overall Study||1
93078|NCT01475097|224303|P2|COMPLETED|Overall Study||126
93079|NCT01475097|224304|P1|COMPLETED|Overall Study||127
93080|NCT01475097|224303|P2|STARTED|Overall Study||127
93081|NCT01475097|224304|P1|STARTED|Overall Study||128
93082|NCT01475071|224312|P1|NOT COMPLETED|Overall Study||8
93083|NCT01475071|224312|P1|COMPLETED|Overall Study||92
93084|NCT01475071|224312|P1|STARTED|Overall Study||100
93085|NCT01474993|224322|P2|NOT COMPLETED|Overall Study||3
93086|NCT01474993|224323|P1|NOT COMPLETED|Overall Study||1
93087|NCT01474993|224322|P2|COMPLETED|Overall Study||26
93088|NCT01474993|224323|P1|COMPLETED|Overall Study||14
93089|NCT01474993|224322|P2|STARTED|Overall Study||29
93090|NCT01474993|224323|P1|STARTED|Overall Study||15
93091|NCT01474915|224349|P2|NOT COMPLETED|Overall Study||10
93092|NCT01474915|224350|P1|NOT COMPLETED|Overall Study||10
93093|NCT01474915|224349|P2|COMPLETED|Overall Study||51
93094|NCT01474915|224350|P1|COMPLETED|Overall Study||50
93095|NCT01474915|224349|P2|STARTED|Overall Study||61
93096|NCT01474915|224350|P1|STARTED|Overall Study||60
93097|NCT01474876|224361|P3|NOT COMPLETED|Overall Study||0
93098|NCT01474876|224362|P2|NOT COMPLETED|Overall Study||23
93099|NCT01474876|224363|P1|NOT COMPLETED|Overall Study||66
93100|NCT01474876|224361|P3|COMPLETED|Overall Study||1
93101|NCT01474876|224362|P2|COMPLETED|Overall Study||128
93102|NCT01474876|224363|P1|COMPLETED|Overall Study||337
93103|NCT01474876|224361|P3|STARTED|Overall Study||1
93104|NCT01474876|224362|P2|STARTED|Overall Study||151
93105|NCT01474876|224363|P1|STARTED|Overall Study||403
93106|NCT01474863|224397|P3|NOT COMPLETED|Overall Study||0
93107|NCT01474863|224398|P2|NOT COMPLETED|Overall Study||0
93108|NCT01474863|224399|P1|NOT COMPLETED|Overall Study||0
93109|NCT01474863|224397|P3|COMPLETED|Overall Study||24
93110|NCT01474863|224398|P2|COMPLETED|Overall Study||22
93111|NCT01474863|224399|P1|COMPLETED|Overall Study||26
93112|NCT01474863|224397|P3|STARTED|Overall Study||24
93113|NCT01474863|224398|P2|STARTED|Overall Study||22
93114|NCT01474863|224399|P1|STARTED|Overall Study||26
93115|NCT01474772|224409|P2|NOT COMPLETED|Follow-up||1
93116|NCT01474772|224410|P1|NOT COMPLETED|Follow-up||0
93117|NCT01474772|224409|P2|COMPLETED|Follow-up||86
93118|NCT01474772|224410|P1|COMPLETED|Follow-up||77
93119|NCT01474772|224409|P2|STARTED|Follow-up||87
93120|NCT01474772|224410|P1|STARTED|Follow-up||77
93121|NCT01474772|224409|P2|NOT COMPLETED|Period 2||10
93122|NCT01474772|224410|P1|NOT COMPLETED|Period 2||9
93123|NCT01474772|224409|P2|COMPLETED|Period 2||87
93124|NCT01474772|224410|P1|COMPLETED|Period 2||77
93125|NCT01474772|224409|P2|STARTED|Period 2||97
93126|NCT01474772|224410|P1|STARTED|Period 2||86
93127|NCT01474772|224409|P2|NOT COMPLETED|Washout||2
93128|NCT01474772|224410|P1|NOT COMPLETED|Washout||3
93129|NCT01474772|224409|P2|COMPLETED|Washout||97
93130|NCT01474772|224410|P1|COMPLETED|Washout||86
93131|NCT01474772|224409|P2|STARTED|Washout||99
93132|NCT01474772|224410|P1|STARTED|Washout||89
93133|NCT01474772|224409|P2|NOT COMPLETED|Period 1||3
93134|NCT01474772|224410|P1|NOT COMPLETED|Period 1||12
93135|NCT01474772|224409|P2|COMPLETED|Period 1||99
93136|NCT01474772|224410|P1|COMPLETED|Period 1||89
93137|NCT01474772|224409|P2|STARTED|Period 1|STARTED=treated|102
93138|NCT01474772|224410|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
93139|NCT01474746|224460|P2|NOT COMPLETED|Overall Study||2
93140|NCT01474746|224461|P1|NOT COMPLETED|Overall Study||3
93141|NCT01474746|224460|P2|COMPLETED|Overall Study||25
93142|NCT01474746|224461|P1|COMPLETED|Overall Study||27
93143|NCT01474746|224460|P2|STARTED|Overall Study||27
93144|NCT01474746|224461|P1|STARTED|Overall Study||30
93145|NCT01474681|224525|P4|NOT COMPLETED|Overall Study||6
93146|NCT01474681|224526|P3|NOT COMPLETED|Overall Study||2
93147|NCT01474681|224527|P2|NOT COMPLETED|Overall Study||3
93148|NCT01474681|224528|P1|NOT COMPLETED|Overall Study||0
93149|NCT01474681|224525|P4|COMPLETED|Overall Study||9
93150|NCT01474681|224526|P3|COMPLETED|Overall Study||1
93151|NCT01474681|224527|P2|COMPLETED|Overall Study||5
93152|NCT01474681|224528|P1|COMPLETED|Overall Study||1
93153|NCT01474681|224525|P4|STARTED|Overall Study||15
93154|NCT01474681|224526|P3|STARTED|Overall Study||3
93155|NCT01474681|224527|P2|STARTED|Overall Study||8
93156|NCT01474681|224528|P1|STARTED|Overall Study||1
93157|NCT01474590|224572|P2|NOT COMPLETED|Overall Study||17
93158|NCT01474590|224573|P1|NOT COMPLETED|Overall Study||28
93159|NCT01474590|224572|P2|COMPLETED|Overall Study||116
93160|NCT01474590|224573|P1|COMPLETED|Overall Study||105
93161|NCT01474590|224572|P2|STARTED|Overall Study||133
93162|NCT01474590|224573|P1|STARTED|Overall Study||133
93163|NCT01474551|224579|P1|NOT COMPLETED|Overall Study||1
93164|NCT01474551|224579|P1|COMPLETED|Overall Study||1
93165|NCT01474551|224579|P1|STARTED|Overall Study||2
93166|NCT01474538|224585|P2|NOT COMPLETED|Treatment Period 2||2
93167|NCT01474538|224586|P1|NOT COMPLETED|Treatment Period 2||6
93168|NCT01474538|224585|P2|COMPLETED|Treatment Period 2||56
93169|NCT01474538|224586|P1|COMPLETED|Treatment Period 2||51
93170|NCT01474538|224585|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
93171|NCT01474538|224586|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
93172|NCT01474538|224585|P2|STARTED|Treatment Period 2||58
93173|NCT01474538|224586|P1|STARTED|Treatment Period 2||57
93174|NCT01474538|224585|P2|NOT COMPLETED|Treatment Period 1||4
93175|NCT01474538|224586|P1|NOT COMPLETED|Treatment Period 1||3
93176|NCT01474538|224585|P2|COMPLETED|Treatment Period 1||58
93177|NCT01474538|224586|P1|COMPLETED|Treatment Period 1||57
93178|NCT01474538|224585|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
93179|NCT01474538|224586|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
93180|NCT01474538|224585|P2|STARTED|Treatment Period 1||62
93181|NCT01474538|224586|P1|STARTED|Treatment Period 1||60
93182|NCT01474512|224603|P10|NOT COMPLETED|Maintenance Period||18
93183|NCT01474512|224604|P9|NOT COMPLETED|Maintenance Period||16
93184|NCT01474512|224605|P8|NOT COMPLETED|Maintenance Period||41
93185|NCT01474512|224606|P7|NOT COMPLETED|Maintenance Period||10
93186|NCT01474512|224607|P6|NOT COMPLETED|Maintenance Period||52
93187|NCT01474512|224608|P5|NOT COMPLETED|Maintenance Period||119
93188|NCT01474512|224609|P4|NOT COMPLETED|Maintenance Period||202
93189|NCT01474512|224610|P3|NOT COMPLETED|Maintenance Period||0
93190|NCT01474512|224611|P2|NOT COMPLETED|Maintenance Period||0
93191|NCT01474512|224612|P1|NOT COMPLETED|Maintenance Period||0
93192|NCT01474512|224603|P10|COMPLETED|Maintenance Period||44
93193|NCT01474512|224604|P9|COMPLETED|Maintenance Period||62
93194|NCT01474512|224605|P8|COMPLETED|Maintenance Period||350
93195|NCT01474512|224606|P7|COMPLETED|Maintenance Period||6
93196|NCT01474512|224607|P6|COMPLETED|Maintenance Period||177
93197|NCT01474512|224608|P5|COMPLETED|Maintenance Period||108
93198|NCT01474512|224609|P4|COMPLETED|Maintenance Period||24
93199|NCT01474512|224610|P3|COMPLETED|Maintenance Period||0
93200|NCT01474512|224611|P2|COMPLETED|Maintenance Period||0
93201|NCT01474512|224612|P1|COMPLETED|Maintenance Period||0
93202|NCT01474512|224603|P10|Received Study Drug|Maintenance Period||62
93203|NCT01474512|224604|P9|Received Study Drug|Maintenance Period||78
93204|NCT01474512|224605|P8|Received Study Drug|Maintenance Period||391
93205|NCT01474512|224606|P7|Received Study Drug|Maintenance Period||16
93206|NCT01474512|224607|P6|Received Study Drug|Maintenance Period||229
93207|NCT01474512|224608|P5|Received Study Drug|Maintenance Period||227
93208|NCT01474512|224609|P4|Received Study Drug|Maintenance Period||226
93209|NCT01474512|224610|P3|Received Study Drug|Maintenance Period||0
93210|NCT01474512|224611|P2|Received Study Drug|Maintenance Period||0
93211|NCT01474512|224612|P1|Received Study Drug|Maintenance Period||0
93212|NCT01474512|224603|P10|STARTED|Maintenance Period||62
93213|NCT01474512|224604|P9|STARTED|Maintenance Period||78
93214|NCT01474512|224605|P8|STARTED|Maintenance Period||391
93215|NCT01474512|224606|P7|STARTED|Maintenance Period||16
93216|NCT01474512|224607|P6|STARTED|Maintenance Period||229
93217|NCT01474512|224608|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
93218|NCT01474512|224609|P4|STARTED|Maintenance Period||226
93219|NCT01474512|224610|P3|STARTED|Maintenance Period||0
93220|NCT01474512|224611|P2|STARTED|Maintenance Period||0
93221|NCT01474512|224612|P1|STARTED|Maintenance Period||0
93222|NCT01474512|224603|P10|NOT COMPLETED|Induction Period||0
93223|NCT01474512|224604|P9|NOT COMPLETED|Induction Period||0
93224|NCT01474512|224605|P8|NOT COMPLETED|Induction Period||0
93225|NCT01474512|224606|P7|NOT COMPLETED|Induction Period||0
93226|NCT01474512|224607|P6|NOT COMPLETED|Induction Period||0
93227|NCT01474512|224608|P5|NOT COMPLETED|Induction Period||0
93228|NCT01474512|224609|P4|NOT COMPLETED|Induction Period||0
93229|NCT01474512|224610|P3|NOT COMPLETED|Induction Period||18
93230|NCT01474512|224611|P2|NOT COMPLETED|Induction Period||24
93231|NCT01474512|224612|P1|NOT COMPLETED|Induction Period||24
93232|NCT01474512|224603|P10|COMPLETED|Induction Period||0
93233|NCT01474512|224604|P9|COMPLETED|Induction Period||0
93234|NCT01474512|224605|P8|COMPLETED|Induction Period||0
93235|NCT01474512|224606|P7|COMPLETED|Induction Period||0
93236|NCT01474512|224607|P6|COMPLETED|Induction Period||0
93237|NCT01474512|224608|P5|COMPLETED|Induction Period||0
93238|NCT01474512|224609|P4|COMPLETED|Induction Period||0
93239|NCT01474512|224610|P3|COMPLETED|Induction Period||415
93240|NCT01474512|224611|P2|COMPLETED|Induction Period||408
93241|NCT01474512|224612|P1|COMPLETED|Induction Period||407
93242|NCT01474512|224603|P10|Received Study Drug|Induction Period||0
93243|NCT01474512|224604|P9|Received Study Drug|Induction Period||0
93244|NCT01474512|224605|P8|Received Study Drug|Induction Period||0
93245|NCT01474512|224606|P7|Received Study Drug|Induction Period||0
93246|NCT01474512|224607|P6|Received Study Drug|Induction Period||0
93247|NCT01474512|224608|P5|Received Study Drug|Induction Period||0
93248|NCT01474512|224609|P4|Received Study Drug|Induction Period||0
93249|NCT01474512|224610|P3|Received Study Drug|Induction Period||433
93250|NCT01474512|224611|P2|Received Study Drug|Induction Period||432
93251|NCT01474512|224612|P1|Received Study Drug|Induction Period||431
93252|NCT01474512|224603|P10|STARTED|Induction Period||0
93253|NCT01474512|224604|P9|STARTED|Induction Period||0
93254|NCT01474512|224605|P8|STARTED|Induction Period||0
93255|NCT01474512|224606|P7|STARTED|Induction Period||0
93256|NCT01474512|224607|P6|STARTED|Induction Period||0
93257|NCT01474512|224608|P5|STARTED|Induction Period||0
93258|NCT01474512|224609|P4|STARTED|Induction Period||0
93259|NCT01474512|224610|P3|STARTED|Induction Period||433
93260|NCT01474512|224611|P2|STARTED|Induction Period||432
93261|NCT01474512|224612|P1|STARTED|Induction Period||431
93262|NCT01474434|224681|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
93263|NCT01474434|224682|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
93264|NCT01474434|224683|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
93265|NCT01474434|224684|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
93266|NCT01474434|224681|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
93267|NCT01474434|224682|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
93268|NCT01474434|224683|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
93269|NCT01474434|224684|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
93270|NCT01474434|224681|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
93271|NCT01474434|224682|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
93272|NCT01474434|224683|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
93273|NCT01474434|224684|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
93274|NCT01474434|224681|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
93275|NCT01474434|224682|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
93276|NCT01474434|224683|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
93277|NCT01474434|224684|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
93278|NCT01474434|224681|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
93279|NCT01474434|224682|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
93280|NCT01474434|224683|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
93281|NCT01474434|224684|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
93282|NCT01474434|224681|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
93283|NCT01474434|224682|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
93284|NCT01474434|224683|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
93285|NCT01474434|224684|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
93286|NCT01474317|224726|P1|NOT COMPLETED|Overall Study||2
93287|NCT01474317|224726|P1|COMPLETED|Overall Study||224
93288|NCT01474317|224726|P1|STARTED|Overall Study||226
93289|NCT01474291|224735|P1|NOT COMPLETED|Overall Study||220
93290|NCT01474291|224735|P1|COMPLETED|Overall Study||383
93291|NCT01474291|224735|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
93292|NCT01474291|224735|P1|STARTED|Overall Study||603
93293|NCT01474239|224779|P2|NOT COMPLETED|Overall Study||32
93294|NCT01474239|224780|P1|NOT COMPLETED|Overall Study||59
93295|NCT01474239|224779|P2|COMPLETED|Overall Study||0
93296|NCT01474239|224780|P1|COMPLETED|Overall Study||0
93297|NCT01474239|224779|P2|STARTED|Overall Study||32
93298|NCT01474239|224780|P1|STARTED|Overall Study||59
93299|NCT01474213|224818|P2|NOT COMPLETED|Overall Study||0
93300|NCT01474213|224819|P1|NOT COMPLETED|Overall Study||0
93301|NCT01474213|224818|P2|COMPLETED|Overall Study||20
93302|NCT01474213|224819|P1|COMPLETED|Overall Study||20
93303|NCT01474213|224818|P2|STARTED|Overall Study||20
93304|NCT01474213|224819|P1|STARTED|Overall Study||20
93305|NCT01474200|224843|P2|NOT COMPLETED|Overall Study||30
93306|NCT01474200|224844|P1|NOT COMPLETED|Overall Study||29
93307|NCT01474200|224843|P2|COMPLETED|Overall Study||84
93308|NCT01474200|224844|P1|COMPLETED|Overall Study||81
93309|NCT01474200|224843|P2|STARTED|Overall Study||114
93310|NCT01474200|224844|P1|STARTED|Overall Study||110
93311|NCT01474122|224897|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
93312|NCT01474122|224898|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
93313|NCT01474122|224899|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
93314|NCT01474122|224897|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
93315|NCT01474122|224898|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
93316|NCT01474122|224899|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
93317|NCT01474122|224897|P3|STARTED|Period 2: Week 16 to End of Study||88
93318|NCT01474122|224898|P2|STARTED|Period 2: Week 16 to End of Study||86
93319|NCT01474122|224899|P1|STARTED|Period 2: Week 16 to End of Study||87
93320|NCT01474122|224897|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
93321|NCT01474122|224898|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
93322|NCT01474122|224899|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
93323|NCT01474122|224897|P3|COMPLETED|Period 1: Baseline to Week 16||88
93324|NCT01474122|224898|P2|COMPLETED|Period 1: Baseline to Week 16||86
93325|NCT01474122|224899|P1|COMPLETED|Period 1: Baseline to Week 16||87
93326|NCT01474122|224897|P3|STARTED|Period 1: Baseline to Week 16||89
93327|NCT01474122|224898|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
93328|NCT01474122|224899|P1|STARTED|Period 1: Baseline to Week 16||88
93329|NCT01474109|224925|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
93330|NCT01474109|224926|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
93331|NCT01474109|224927|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
93332|NCT01474109|224925|P3|COMPLETED|Period 2: Week 16 to End of Study||83
93333|NCT01474109|224926|P2|COMPLETED|Period 2: Week 16 to End of Study||73
93334|NCT01474109|224927|P1|COMPLETED|Period 2: Week 16 to End of Study||70
93335|NCT01474109|224925|P3|STARTED|Period 2: Week 16 to End of Study||95
93336|NCT01474109|224926|P2|STARTED|Period 2: Week 16 to End of Study||91
93337|NCT01474109|224927|P1|STARTED|Period 2: Week 16 to End of Study||88
93338|NCT01474109|224925|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
93339|NCT01474109|224926|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
93340|NCT01474109|224927|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
93341|NCT01474109|224925|P3|COMPLETED|Period 1: Baseline to Week 16||95
93342|NCT01474109|224926|P2|COMPLETED|Period 1: Baseline to Week 16||91
93343|NCT01474109|224927|P1|COMPLETED|Period 1: Baseline to Week 16||88
93344|NCT01474109|224925|P3|STARTED|Period 1: Baseline to Week 16||97
93345|NCT01474109|224926|P2|STARTED|Period 1: Baseline to Week 16||97
93346|NCT01474109|224927|P1|STARTED|Period 1: Baseline to Week 16||95
93347|NCT01473992|224952|P3|NOT COMPLETED|Overall Study||0
93348|NCT01473992|224953|P2|NOT COMPLETED|Overall Study||0
93349|NCT01473992|224954|P1|NOT COMPLETED|Overall Study||0
93350|NCT01473992|224952|P3|COMPLETED|Overall Study||5
93351|NCT01473992|224953|P2|COMPLETED|Overall Study||10
93352|NCT01473992|224954|P1|COMPLETED|Overall Study||10
93353|NCT01473992|224952|P3|STARTED|Overall Study||5
93354|NCT01473992|224953|P2|STARTED|Overall Study||10
93355|NCT01473992|224954|P1|STARTED|Overall Study||10
93356|NCT01473953|224974|P5|NOT COMPLETED|Overall Study||0
93357|NCT01473953|224975|P4|NOT COMPLETED|Overall Study||0
93358|NCT01473953|224976|P3|NOT COMPLETED|Overall Study||0
93359|NCT01473953|224977|P2|NOT COMPLETED|Overall Study||0
93360|NCT01473953|224978|P1|NOT COMPLETED|Overall Study||1
93361|NCT01473953|224974|P5|COMPLETED|Overall Study||8
93362|NCT01473953|224975|P4|COMPLETED|Overall Study||5
93363|NCT01473953|224976|P3|COMPLETED|Overall Study||6
93364|NCT01473953|224977|P2|COMPLETED|Overall Study||6
93365|NCT01473953|224978|P1|COMPLETED|Overall Study||5
93366|NCT01473953|224974|P5|STARTED|Overall Study||8
93367|NCT01473953|224975|P4|STARTED|Overall Study||5
93368|NCT01473953|224976|P3|STARTED|Overall Study||6
93369|NCT01473953|224977|P2|STARTED|Overall Study||6
93370|NCT01473953|224978|P1|STARTED|Overall Study||6
93371|NCT01473836|225020|P1|NOT COMPLETED|Overall Study||6
93372|NCT01473836|225020|P1|COMPLETED|Overall Study||32
93373|NCT01473836|225020|P1|STARTED|Overall Study||38
93374|NCT01473758|225031|P4|NOT COMPLETED|Cycle 2||0
93375|NCT01473758|225032|P3|NOT COMPLETED|Cycle 2||5
93376|NCT01473758|225033|P2|NOT COMPLETED|Cycle 2||0
93377|NCT01473758|225034|P1|NOT COMPLETED|Cycle 2||0
93378|NCT01473758|225031|P4|COMPLETED|Cycle 2||4
93379|NCT01473758|225032|P3|COMPLETED|Cycle 2||5
93380|NCT01473758|225033|P2|COMPLETED|Cycle 2||0
93381|NCT01473758|225034|P1|COMPLETED|Cycle 2||0
93382|NCT01473758|225031|P4|STARTED|Cycle 2||4
93383|NCT01473758|225032|P3|STARTED|Cycle 2||10
93384|NCT01473758|225033|P2|STARTED|Cycle 2||0
93385|NCT01473758|225034|P1|STARTED|Cycle 2||0
93386|NCT01473758|225031|P4|NOT COMPLETED|Cycle 1||0
93387|NCT01473758|225032|P3|NOT COMPLETED|Cycle 1||0
93388|NCT01473758|225033|P2|NOT COMPLETED|Cycle 1||3
93389|NCT01473758|225034|P1|NOT COMPLETED|Cycle 1||11
93390|NCT01473758|225031|P4|COMPLETED|Cycle 1||0
93391|NCT01473758|225032|P3|COMPLETED|Cycle 1||0
93392|NCT01473758|225033|P2|COMPLETED|Cycle 1||40
93393|NCT01473758|225034|P1|COMPLETED|Cycle 1||27
93394|NCT01473758|225031|P4|STARTED|Cycle 1||0
93395|NCT01473758|225032|P3|STARTED|Cycle 1||0
93396|NCT01473758|225033|P2|STARTED|Cycle 1||43
93397|NCT01473758|225034|P1|STARTED|Cycle 1||38
93398|NCT01473745|225158|P2|NOT COMPLETED|Overall Study||0
93399|NCT01473745|225159|P1|NOT COMPLETED|Overall Study||0
93400|NCT01473745|225158|P2|COMPLETED|Overall Study||24
93401|NCT01473745|225159|P1|COMPLETED|Overall Study||24
93402|NCT01473745|225158|P2|STARTED|Overall Study||24
93403|NCT01473745|225159|P1|STARTED|Overall Study||24
93404|NCT01473602|225171|P2|NOT COMPLETED|Overall Study||8
93405|NCT01473602|225172|P1|NOT COMPLETED|Overall Study||8
93406|NCT01473602|225171|P2|COMPLETED|Overall Study||13
93407|NCT01473602|225172|P1|COMPLETED|Overall Study||10
93408|NCT01473602|225171|P2|Completed 12 Months|Overall Study||13
93409|NCT01473602|225172|P1|Completed 12 Months|Overall Study||10
93410|NCT01473602|225171|P2|Completed 6 Months|Overall Study||15
93411|NCT01473602|225172|P1|Completed 6 Months|Overall Study||12
93412|NCT01473602|225171|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
93413|NCT01473602|225172|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
93414|NCT01473602|225171|P2|STARTED|Overall Study||21
93415|NCT01473602|225172|P1|STARTED|Overall Study||18
93416|NCT01473589|225208|P2|NOT COMPLETED|Overall Study||16
93417|NCT01473589|225209|P1|NOT COMPLETED|Overall Study||11
93418|NCT01473589|225208|P2|COMPLETED|Overall Study||46
93419|NCT01473589|225209|P1|COMPLETED|Overall Study||49
93420|NCT01473589|225208|P2|Completed 12 Months|Overall Study||48
93421|NCT01473589|225209|P1|Completed 12 Months|Overall Study||49
93422|NCT01473589|225208|P2|Completed 6 Months|Overall Study||54
93423|NCT01473589|225209|P1|Completed 6 Months|Overall Study||51
93424|NCT01473589|225208|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
93425|NCT01473589|225209|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
93426|NCT01473589|225208|P2|STARTED|Overall Study||62
93427|NCT01473589|225209|P1|STARTED|Overall Study||60
93428|NCT01473563|225243|P1|NOT COMPLETED|Overall Study||1
93429|NCT01473563|225243|P1|COMPLETED|Overall Study||51
93430|NCT01473563|225243|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
93431|NCT01473563|225243|P1|STARTED|Overall Study||52
93432|NCT01473524|225265|P3|NOT COMPLETED|Overall Study||3
93433|NCT01473524|225266|P2|NOT COMPLETED|Overall Study||9
93434|NCT01473524|225267|P1|NOT COMPLETED|Overall Study||7
93435|NCT01473524|225265|P3|COMPLETED|Overall Study||70
93436|NCT01473524|225266|P2|COMPLETED|Overall Study||64
93437|NCT01473524|225267|P1|COMPLETED|Overall Study||64
93438|NCT01473524|225265|P3|STARTED|Overall Study||73
93439|NCT01473524|225266|P2|STARTED|Overall Study||73
93440|NCT01473524|225267|P1|STARTED|Overall Study||71
93441|NCT01473394|225300|P2|NOT COMPLETED|Overall Study||43
93442|NCT01473394|225301|P1|NOT COMPLETED|Overall Study||45
93443|NCT01473394|225300|P2|COMPLETED|Overall Study||212
93444|NCT01473394|225301|P1|COMPLETED|Overall Study||208
93445|NCT01473394|225300|P2|STARTED|Overall Study||255
93446|NCT01473394|225301|P1|STARTED|Overall Study||253
93447|NCT01473381|225315|P4|NOT COMPLETED|Overall Study||89
93448|NCT01473381|225316|P3|NOT COMPLETED|Overall Study||102
93449|NCT01473381|225317|P2|NOT COMPLETED|Overall Study||93
93450|NCT01473381|225318|P1|NOT COMPLETED|Overall Study||80
93451|NCT01473381|225315|P4|COMPLETED|Overall Study||200
93452|NCT01473381|225316|P3|COMPLETED|Overall Study||189
93453|NCT01473381|225317|P2|COMPLETED|Overall Study||199
93454|NCT01473381|225318|P1|COMPLETED|Overall Study||210
93455|NCT01473381|225315|P4|Safety Population|Overall Study||282
93456|NCT01473381|225316|P3|Safety Population|Overall Study||287
93457|NCT01473381|225317|P2|Safety Population|Overall Study||288
93458|NCT01473381|225318|P1|Safety Population|Overall Study||281
93459|NCT01473381|225315|P4|STARTED|Overall Study||289
93460|NCT01473381|225316|P3|STARTED|Overall Study||291
93461|NCT01473381|225317|P2|STARTED|Overall Study||292
93462|NCT01473381|225318|P1|STARTED|Overall Study||290
93463|NCT01473368|225340|P4|NOT COMPLETED|Overall Study||0
93464|NCT01473368|225341|P3|NOT COMPLETED|Overall Study||3
93465|NCT01473368|225342|P2|NOT COMPLETED|Overall Study||0
93466|NCT01473368|225343|P1|NOT COMPLETED|Overall Study||1
93467|NCT01473368|225340|P4|COMPLETED|Overall Study||12
93468|NCT01473368|225341|P3|COMPLETED|Overall Study||12
93469|NCT01473368|225342|P2|COMPLETED|Overall Study||12
93470|NCT01473368|225343|P1|COMPLETED|Overall Study||13
93471|NCT01473368|225340|P4|STARTED|Overall Study||12
93472|NCT01473368|225341|P3|STARTED|Overall Study||15
93473|NCT01473368|225342|P2|STARTED|Overall Study||12
93474|NCT01473368|225343|P1|STARTED|Overall Study||14
93475|NCT01473160|225380|P1|NOT COMPLETED|Overall Study||0
93476|NCT01473160|225380|P1|COMPLETED|Overall Study||9
93477|NCT01473160|225380|P1|STARTED|Overall Study||9
93478|NCT01472965|225400|P2|NOT COMPLETED|Overall Study||0
93479|NCT01472965|225401|P1|NOT COMPLETED|Overall Study||1
93480|NCT01472965|225400|P2|COMPLETED|Overall Study||46
93481|NCT01472965|225401|P1|COMPLETED|Overall Study||48
93482|NCT01472965|225400|P2|STARTED|Overall Study||46
93483|NCT01472965|225401|P1|STARTED|Overall Study||49
93484|NCT01472939|225421|P4|NOT COMPLETED|Overall Study||20
93485|NCT01472939|225422|P3|NOT COMPLETED|Overall Study||11
93486|NCT01472939|225423|P2|NOT COMPLETED|Overall Study||14
93487|NCT01472939|225424|P1|NOT COMPLETED|Overall Study||20
93488|NCT01472939|225421|P4|COMPLETED|Overall Study||99
93489|NCT01472939|225422|P3|COMPLETED|Overall Study||108
93490|NCT01472939|225423|P2|COMPLETED|Overall Study||105
93491|NCT01472939|225424|P1|COMPLETED|Overall Study||103
93492|NCT01472939|225421|P4|STARTED|Overall Study||119
93493|NCT01472939|225422|P3|STARTED|Overall Study||119
93494|NCT01472939|225423|P2|STARTED|Overall Study||119
93495|NCT01472939|225424|P1|STARTED|Overall Study||123
93496|NCT01472874|225451|P1|NOT COMPLETED|Overall Study||0
93497|NCT01472874|225451|P1|COMPLETED|Overall Study||8
93498|NCT01472874|225451|P1|STARTED|Overall Study||8
93499|NCT01472835|225468|P2|NOT COMPLETED|Overall Study||0
93500|NCT01472835|225469|P1|NOT COMPLETED|Overall Study||2
93501|NCT01472835|225468|P2|COMPLETED|Overall Study||36
93502|NCT01472835|225469|P1|COMPLETED|Overall Study||35
93503|NCT01472835|225468|P2|STARTED|Overall Study||36
93504|NCT01472835|225469|P1|STARTED|Overall Study||37
93505|NCT01472822|225485|P2|NOT COMPLETED|Overall Study||2
93506|NCT01472822|225486|P1|NOT COMPLETED|Overall Study||2
93507|NCT01472822|225485|P2|COMPLETED|Overall Study||28
93508|NCT01472822|225486|P1|COMPLETED|Overall Study||28
93509|NCT01472822|225485|P2|STARTED|Overall Study||30
93510|NCT01472822|225486|P1|STARTED|Overall Study||30
93511|NCT01472562|225500|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
93512|NCT01472562|225500|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
93513|NCT01472562|225500|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
93514|NCT01472562|225500|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
93515|NCT01472562|225500|P1|COMPLETED|Induction Phase (Week 1- 48)||27
93516|NCT01472562|225500|P1|STARTED|Induction Phase (Week 1- 48)||38
93517|NCT01472432|225507|P2|NOT COMPLETED|Overall Study||0
93518|NCT01472432|225508|P1|NOT COMPLETED|Overall Study||0
93519|NCT01472432|225507|P2|COMPLETED|Overall Study||53
93520|NCT01472432|225508|P1|COMPLETED|Overall Study||53
93521|NCT01472432|225507|P2|Ulcer Reduction|Overall Study||33
93522|NCT01472432|225508|P1|Ulcer Reduction|Overall Study||13
93523|NCT01472432|225507|P2|STARTED|Overall Study||53
93524|NCT01472432|225508|P1|STARTED|Overall Study||53
93525|NCT01472380|225524|P1|NOT COMPLETED|Efavirenz and FFA||0
93526|NCT01472380|225524|P1|COMPLETED|Efavirenz and FFA||28
93527|NCT01472380|225524|P1|STARTED|Efavirenz and FFA||28
93528|NCT01472380|225524|P1|NOT COMPLETED|1 Day Period Between Dosing||1
93529|NCT01472380|225524|P1|COMPLETED|1 Day Period Between Dosing||28
93530|NCT01472380|225524|P1|STARTED|1 Day Period Between Dosing||29
93531|NCT01472380|225524|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
93532|NCT01472380|225524|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
93533|NCT01472380|225524|P1|STARTED|Fenofibric Acid (FFA) Alone||29
93534|NCT01472380|225524|P1|NOT COMPLETED|Efavirenz Alone||1
93535|NCT01472380|225524|P1|COMPLETED|Efavirenz Alone||29
93536|NCT01472380|225524|P1|STARTED|Efavirenz Alone||30
93537|NCT01472341|225535|P1|NOT COMPLETED|Overall Study||272
93538|NCT01472341|225535|P1|COMPLETED|Overall Study||235
93539|NCT01472341|225535|P1|STARTED|Overall Study||507
93540|NCT01472289|225541|P1|NOT COMPLETED|Overall Study||2
93541|NCT01472289|225541|P1|COMPLETED|Overall Study||15
93542|NCT01472289|225541|P1|STARTED|Overall Study||17
93543|NCT01472185|225553|P2|NOT COMPLETED|Overall Study||34
93544|NCT01472185|225554|P1|NOT COMPLETED|Overall Study||34
93545|NCT01472185|225553|P2|COMPLETED|Overall Study||199
93546|NCT01472185|225554|P1|COMPLETED|Overall Study||198
93547|NCT01472185|225553|P2|STARTED|Overall Study||233
93548|NCT01472185|225554|P1|STARTED|Overall Study||232
93549|NCT01471782|225574|P6|NOT COMPLETED|Overall Study||41
93550|NCT01471782|225575|P5|NOT COMPLETED|Overall Study||26
93551|NCT01471782|225576|P4|NOT COMPLETED|Overall Study||5
93552|NCT01471782|225577|P3|NOT COMPLETED|Overall Study||5
93553|NCT01471782|225578|P2|NOT COMPLETED|Overall Study||6
93554|NCT01471782|225579|P1|NOT COMPLETED|Overall Study||5
93555|NCT01471782|225574|P6|COMPLETED|Overall Study|Completed 5 cycles|3
93556|NCT01471782|225575|P5|COMPLETED|Overall Study|Completed 5 cycles|0
93557|NCT01471782|225576|P4|COMPLETED|Overall Study|Completed 5 cycles|1
93558|NCT01471782|225577|P3|COMPLETED|Overall Study|Completed 5 cycles|0
93559|NCT01471782|225578|P2|COMPLETED|Overall Study|Completed 5 cycles|1
93560|NCT01471782|225579|P1|COMPLETED|Overall Study|Completed 5 cycles|0
93561|NCT01471782|225574|P6|STARTED|Overall Study||44
93562|NCT01471782|225575|P5|STARTED|Overall Study||26
93563|NCT01471782|225576|P4|STARTED|Overall Study||6
93564|NCT01471782|225577|P3|STARTED|Overall Study||5
93565|NCT01471782|225578|P2|STARTED|Overall Study||7
93566|NCT01471782|225579|P1|STARTED|Overall Study||5
93567|NCT01471691|225633|P2|NOT COMPLETED|Overall Study||1
93568|NCT01471691|225634|P1|NOT COMPLETED|Overall Study||0
93569|NCT01471691|225633|P2|COMPLETED|Overall Study||5
93570|NCT01471691|225634|P1|COMPLETED|Overall Study||8
93571|NCT01471691|225633|P2|STARTED|Overall Study||6
93572|NCT01471691|225634|P1|STARTED|Overall Study||8
93573|NCT01471379|225643|P3|NOT COMPLETED|Overall Study||0
93574|NCT01471379|225644|P2|NOT COMPLETED|Overall Study||1
93575|NCT01471379|225645|P1|NOT COMPLETED|Overall Study||1
93576|NCT01471379|225643|P3|COMPLETED|Overall Study||0
93577|NCT01471379|225644|P2|COMPLETED|Overall Study||0
93578|NCT01471379|225645|P1|COMPLETED|Overall Study||0
93579|NCT01471379|225643|P3|STARTED|Overall Study||0
93580|NCT01471379|225644|P2|STARTED|Overall Study||1
93581|NCT01471379|225645|P1|STARTED|Overall Study||1
93582|NCT01471353|225665|P1|NOT COMPLETED|Overall Study||3
93583|NCT01471353|225665|P1|COMPLETED|Overall Study||39
93584|NCT01471353|225665|P1|STARTED|Overall Study||42
93585|NCT01471340|225673|P2|NOT COMPLETED|Overall Study||6
93586|NCT01471340|225674|P1|NOT COMPLETED|Overall Study||6
93587|NCT01471340|225673|P2|COMPLETED|Overall Study||5855
93588|NCT01471340|225674|P1|COMPLETED|Overall Study||5862
93589|NCT01471340|225673|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
93590|NCT01471340|225674|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
93591|NCT01471639|225684|P1|NOT COMPLETED|Overall Study||0
93592|NCT01471639|225684|P1|COMPLETED|Overall Study||37
93593|NCT01471639|225684|P1|STARTED|Overall Study||37
93594|NCT01471626|225689|P1|NOT COMPLETED|Overall Study||0
93595|NCT01471626|225689|P1|COMPLETED|Overall Study||21
93596|NCT01471626|225689|P1|STARTED|Overall Study||21
93597|NCT01471574|225697|P4|NOT COMPLETED|Follow-up Period||3
93598|NCT01471574|225698|P3|NOT COMPLETED|Follow-up Period||7
93599|NCT01471574|225699|P2|NOT COMPLETED|Follow-up Period||2
93600|NCT01471574|225700|P1|NOT COMPLETED|Follow-up Period||7
93601|NCT01471574|225697|P4|COMPLETED|Follow-up Period||21
93602|NCT01471574|225698|P3|COMPLETED|Follow-up Period||95
93603|NCT01471574|225699|P2|COMPLETED|Follow-up Period||32
93604|NCT01471574|225700|P1|COMPLETED|Follow-up Period||114
93605|NCT01471574|225697|P4|STARTED|Follow-up Period||24
93606|NCT01471574|225698|P3|STARTED|Follow-up Period||102
93607|NCT01471574|225699|P2|STARTED|Follow-up Period||34
93608|NCT01471574|225700|P1|STARTED|Follow-up Period||121
93609|NCT01471574|225697|P4|NOT COMPLETED|Treatment Period||3
93610|NCT01471574|225698|P3|NOT COMPLETED|Treatment Period||24
93611|NCT01471574|225699|P2|NOT COMPLETED|Treatment Period||10
93612|NCT01471574|225700|P1|NOT COMPLETED|Treatment Period||31
93613|NCT01471574|225697|P4|COMPLETED|Treatment Period||21
93614|NCT01471574|225698|P3|COMPLETED|Treatment Period||82
93615|NCT01471574|225699|P2|COMPLETED|Treatment Period||29
93616|NCT01471574|225700|P1|COMPLETED|Treatment Period||101
93617|NCT01471574|225697|P4|STARTED|Treatment Period||24
93618|NCT01471574|225698|P3|STARTED|Treatment Period||106
93619|NCT01471574|225699|P2|STARTED|Treatment Period||39
93620|NCT01471574|225700|P1|STARTED|Treatment Period||132
93621|NCT01471197|225731|P2|NOT COMPLETED|Overall Study||2
93622|NCT01471197|225732|P1|NOT COMPLETED|Overall Study||6
93623|NCT01471197|225731|P2|COMPLETED|Overall Study||0
93624|NCT01471197|225732|P1|COMPLETED|Overall Study||0
93625|NCT01471197|225731|P2|STARTED|Overall Study||2
93626|NCT01471197|225732|P1|STARTED|Overall Study||6
93627|NCT01471171|225742|P2|NOT COMPLETED|Treatment Period 2||0
93628|NCT01471171|225743|P1|NOT COMPLETED|Treatment Period 2||1
93629|NCT01471171|225742|P2|COMPLETED|Treatment Period 2||54
93630|NCT01471171|225743|P1|COMPLETED|Treatment Period 2||52
93631|NCT01471171|225742|P2|STARTED|Treatment Period 2||54
93632|NCT01471171|225743|P1|STARTED|Treatment Period 2||53
93633|NCT01471171|225742|P2|NOT COMPLETED|Treatment Period 1||1
93634|NCT01471171|225743|P1|NOT COMPLETED|Treatment Period 1||4
93635|NCT01471171|225742|P2|COMPLETED|Treatment Period 1||54
93636|NCT01471171|225743|P1|COMPLETED|Treatment Period 1||53
93637|NCT01471171|225742|P2|STARTED|Treatment Period 1||55
93638|NCT01471171|225743|P1|STARTED|Treatment Period 1||57
93639|NCT01471041|225753|P1|NOT COMPLETED|Overall Study||7
93640|NCT01471041|225753|P1|COMPLETED|Overall Study||47
93641|NCT01471041|225753|P1|STARTED|Overall Study||54
93642|NCT01471015|225761|P3|NOT COMPLETED|Overall Study||1
93643|NCT01471015|225762|P2|NOT COMPLETED|Overall Study||1
93644|NCT01471015|225763|P1|NOT COMPLETED|Overall Study||0
93645|NCT01471015|225761|P3|COMPLETED|Overall Study||9
93646|NCT01471015|225762|P2|COMPLETED|Overall Study||9
93647|NCT01471015|225763|P1|COMPLETED|Overall Study||10
93648|NCT01471015|225761|P3|STARTED|Overall Study||10
93649|NCT01471015|225762|P2|STARTED|Overall Study||10
93650|NCT01471015|225763|P1|STARTED|Overall Study||10
93651|NCT01470859|225777|P2|NOT COMPLETED|Overall Study||0
93652|NCT01470859|225778|P1|NOT COMPLETED|Overall Study||1
93653|NCT01470859|225777|P2|COMPLETED|Overall Study||15
93654|NCT01470859|225778|P1|COMPLETED|Overall Study||14
93655|NCT01470859|225777|P2|STARTED|Overall Study||15
93656|NCT01470859|225778|P1|STARTED|Overall Study||15
93657|NCT01470651|225794|P2|NOT COMPLETED|Overall Study||3
93658|NCT01470651|225795|P1|NOT COMPLETED|Overall Study||7
93659|NCT01470651|225794|P2|COMPLETED|Overall Study||10
93660|NCT01470651|225795|P1|COMPLETED|Overall Study||6
93661|NCT01470651|225794|P2|STARTED|Overall Study||13
93662|NCT01470651|225795|P1|STARTED|Overall Study||13
93663|NCT01470599|225805|P2|NOT COMPLETED|Overall Study||43
93664|NCT01470599|225806|P1|NOT COMPLETED|Overall Study||19
93665|NCT01470599|225805|P2|COMPLETED|Overall Study||45
93666|NCT01470599|225806|P1|COMPLETED|Overall Study||43
93667|NCT01470599|225805|P2|STARTED|Overall Study||88
93668|NCT01470599|225806|P1|STARTED|Overall Study||62
93669|NCT01470469|225870|P2|NOT COMPLETED|Overall Study||24
93670|NCT01470469|225871|P1|NOT COMPLETED|Overall Study||10
93671|NCT01470469|225870|P2|COMPLETED|Overall Study||38
93672|NCT01470469|225871|P1|COMPLETED|Overall Study||11
93673|NCT01470469|225870|P2|STARTED|Overall Study||62
93674|NCT01470469|225871|P1|STARTED|Overall Study||21
93675|NCT01470417|225891|P2|NOT COMPLETED|Overall Study||2
93676|NCT01470417|225892|P1|NOT COMPLETED|Overall Study||0
93677|NCT01470417|225891|P2|COMPLETED|Overall Study||5
93678|NCT01470417|225892|P1|COMPLETED|Overall Study||3
93679|NCT01470417|225891|P2|STARTED|Overall Study||7
93680|NCT01470417|225892|P1|STARTED|Overall Study||3
93681|NCT01470248|225904|P1|NOT COMPLETED|Overall Study||1
93682|NCT01470248|225904|P1|COMPLETED|Overall Study||19
93683|NCT01470248|225904|P1|STARTED|Overall Study||20
93684|NCT01470196|225911|P1|NOT COMPLETED|Overall Study||0
93685|NCT01470196|225911|P1|COMPLETED|Overall Study||31
93686|NCT01470196|225911|P1|STARTED|Overall Study||31
93687|NCT01470170|225924|P5|NOT COMPLETED|Overall Study||0
93688|NCT01470170|225925|P4|NOT COMPLETED|Overall Study||0
93689|NCT01470170|225926|P3|NOT COMPLETED|Overall Study||0
93690|NCT01470170|225927|P2|NOT COMPLETED|Overall Study||0
93691|NCT01470170|225928|P1|NOT COMPLETED|Overall Study||0
93692|NCT01470170|225924|P5|COMPLETED|Overall Study||34
93693|NCT01470170|225925|P4|COMPLETED|Overall Study||36
93694|NCT01470170|225926|P3|COMPLETED|Overall Study||34
93695|NCT01470170|225927|P2|COMPLETED|Overall Study||35
93696|NCT01470170|225928|P1|COMPLETED|Overall Study||34
93697|NCT01470170|225924|P5|STARTED|Overall Study||34
93698|NCT01470170|225925|P4|STARTED|Overall Study||36
93699|NCT01470170|225926|P3|STARTED|Overall Study||34
93700|NCT01470170|225927|P2|STARTED|Overall Study||35
93701|NCT01470170|225928|P1|STARTED|Overall Study||34
93702|NCT01470144|225960|P1|NOT COMPLETED|Overall Study||10
93703|NCT01470144|225960|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
93704|NCT01470144|225960|P1|STARTED|Overall Study||41
93705|NCT01470118|225968|P3|NOT COMPLETED|Overall Study||2
93706|NCT01470118|225969|P2|NOT COMPLETED|Overall Study||5
93707|NCT01470118|225970|P1|NOT COMPLETED|Overall Study||5
93708|NCT01470118|225968|P3|COMPLETED|Overall Study||39
93709|NCT01470118|225969|P2|COMPLETED|Overall Study||38
93710|NCT01470118|225970|P1|COMPLETED|Overall Study||38
93711|NCT01470118|225968|P3|STARTED|Overall Study||41
93712|NCT01470118|225969|P2|STARTED|Overall Study||43
93713|NCT01470118|225970|P1|STARTED|Overall Study||43
93714|NCT01470027|226005|P3|NOT COMPLETED|Overall Study||1
93715|NCT01470027|226006|P2|NOT COMPLETED|Overall Study||1
93716|NCT01470027|226007|P1|NOT COMPLETED|Overall Study||1
93717|NCT01470027|226005|P3|COMPLETED|Overall Study||15
93718|NCT01470027|226006|P2|COMPLETED|Overall Study||14
93719|NCT01470027|226007|P1|COMPLETED|Overall Study||15
93720|NCT01470027|226005|P3|STARTED|Overall Study||16
93721|NCT01470027|226006|P2|STARTED|Overall Study||15
93722|NCT01470027|226007|P1|STARTED|Overall Study||16
93723|NCT01470001|226065|P2|NOT COMPLETED|Overall Study||2
93724|NCT01470001|226066|P1|NOT COMPLETED|Overall Study||5
93725|NCT01470001|226065|P2|COMPLETED|Overall Study||58
93726|NCT01470001|226066|P1|COMPLETED|Overall Study||53
93727|NCT01470001|226065|P2|STARTED|Overall Study||60
93728|NCT01470001|226066|P1|STARTED|Overall Study||58
93729|NCT01469819|226076|P1|NOT COMPLETED|Overall Study||8
93730|NCT01469819|226076|P1|COMPLETED|Overall Study||29
93731|NCT01469819|226076|P1|STARTED|Overall Study||37
93732|NCT01469767|226086|P1|NOT COMPLETED|Overall Study||0
93733|NCT01469767|226086|P1|COMPLETED|Overall Study||10
93734|NCT01469767|226086|P1|STARTED|Overall Study||10
93735|NCT01469715|226094|P1|NOT COMPLETED|Overall Study||0
93736|NCT01469715|226094|P1|COMPLETED|Overall Study||16
93737|NCT01469715|226094|P1|STARTED|Overall Study||16
93738|NCT01469637|226100|P2|NOT COMPLETED|Second Intervention||0
93739|NCT01469637|226101|P1|NOT COMPLETED|Second Intervention||1
93740|NCT01469637|226100|P2|COMPLETED|Second Intervention||21
93741|NCT01469637|226101|P1|COMPLETED|Second Intervention||21
93742|NCT01469637|226100|P2|STARTED|Second Intervention||21
93743|NCT01469637|226101|P1|STARTED|Second Intervention||22
93744|NCT01469637|226100|P2|NOT COMPLETED|First Intervention||1
93745|NCT01469637|226101|P1|NOT COMPLETED|First Intervention||0
93746|NCT01469637|226100|P2|COMPLETED|First Intervention||21
93747|NCT01469637|226101|P1|COMPLETED|First Intervention||22
93748|NCT01469637|226100|P2|STARTED|First Intervention||22
93749|NCT01469637|226101|P1|STARTED|First Intervention||22
93750|NCT01469546|226109|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
93751|NCT01469546|226109|P1|COMPLETED|Dose Escalation to 10 mg||19
93752|NCT01469546|226109|P1|STARTED|Dose Escalation to 10 mg||19
93753|NCT01469546|226109|P1|NOT COMPLETED|Received 5 mg Dose||23
93754|NCT01469546|226109|P1|COMPLETED|Received 5 mg Dose||19
93755|NCT01469546|226109|P1|Completed First Cycle|Received 5 mg Dose||30
93756|NCT01469546|226109|P1|STARTED|Received 5 mg Dose||42
93757|NCT01469377|226119|P3|NOT COMPLETED|Overall Study||66
93758|NCT01469377|226120|P2|NOT COMPLETED|Overall Study||48
93759|NCT01469377|226121|P1|NOT COMPLETED|Overall Study||35
93760|NCT01469377|226119|P3|COMPLETED|Overall Study||210
93761|NCT01469377|226120|P2|COMPLETED|Overall Study||226
93762|NCT01469377|226121|P1|COMPLETED|Overall Study||234
93763|NCT01469377|226119|P3|STARTED|Overall Study||276
93764|NCT01469377|226120|P2|STARTED|Overall Study||274
93765|NCT01469377|226121|P1|STARTED|Overall Study||269
93766|NCT01469364|226132|P1|NOT COMPLETED|Overall Study||2
93767|NCT01469364|226132|P1|COMPLETED|Overall Study||28
93768|NCT01469364|226132|P1|STARTED|Overall Study||30
93769|NCT01469234|226150|P3|NOT COMPLETED|Overall Study||0
93770|NCT01469234|226151|P2|NOT COMPLETED|Overall Study||0
93771|NCT01469234|226152|P1|NOT COMPLETED|Overall Study||0
93772|NCT01469234|226150|P3|COMPLETED|Overall Study||85
93773|NCT01469234|226151|P2|COMPLETED|Overall Study||85
93774|NCT01469234|226152|P1|COMPLETED|Overall Study||85
93775|NCT01469234|226150|P3|STARTED|Overall Study||85
93776|NCT01469234|226151|P2|STARTED|Overall Study||85
93777|NCT01469234|226152|P1|STARTED|Overall Study||85
93778|NCT01469221|226183|P3|NOT COMPLETED|Double Blind Phase||0
93779|NCT01469221|226184|P2|NOT COMPLETED|Double Blind Phase||17
93780|NCT01469221|226185|P1|NOT COMPLETED|Double Blind Phase||14
93781|NCT01469221|226183|P3|COMPLETED|Double Blind Phase||0
93782|NCT01469221|226184|P2|COMPLETED|Double Blind Phase||0
93783|NCT01469221|226185|P1|COMPLETED|Double Blind Phase||0
93784|NCT01469221|226183|P3|STARTED|Double Blind Phase||0
93785|NCT01469221|226184|P2|STARTED|Double Blind Phase||17
93786|NCT01469221|226185|P1|STARTED|Double Blind Phase||14
93787|NCT01469221|226183|P3|NOT COMPLETED|Open Label Phase||3
93788|NCT01469221|226184|P2|NOT COMPLETED|Open Label Phase||0
93789|NCT01469221|226185|P1|NOT COMPLETED|Open Label Phase||0
93790|NCT01469221|226183|P3|COMPLETED|Open Label Phase||44
93791|NCT01469221|226184|P2|COMPLETED|Open Label Phase||0
93792|NCT01469221|226185|P1|COMPLETED|Open Label Phase||0
93793|NCT01469221|226183|P3|STARTED|Open Label Phase||47
93794|NCT01469221|226184|P2|STARTED|Open Label Phase||0
93795|NCT01469221|226185|P1|STARTED|Open Label Phase||0
93796|NCT01469182|226196|P2|NOT COMPLETED|Overall Study||6
93797|NCT01469182|226197|P1|NOT COMPLETED|Overall Study||35
93798|NCT01469182|226196|P2|COMPLETED|Overall Study||298
93799|NCT01469182|226197|P1|COMPLETED|Overall Study||575
93800|NCT01469182|226196|P2|Treated|Overall Study||304
93801|NCT01469182|226197|P1|Treated|Overall Study||609
93802|NCT01469182|226196|P2|STARTED|Overall Study||304
93803|NCT01469182|226197|P1|STARTED|Overall Study||610
93804|NCT01469065|226224|P5|NOT COMPLETED|Overall Study||1
93805|NCT01469065|226225|P4|NOT COMPLETED|Overall Study||0
93806|NCT01469065|226226|P3|NOT COMPLETED|Overall Study||0
93807|NCT01469065|226227|P2|NOT COMPLETED|Overall Study||1
93808|NCT01469065|226228|P1|NOT COMPLETED|Overall Study||0
93809|NCT01469065|226224|P5|COMPLETED|Overall Study||16
93810|NCT01469065|226225|P4|COMPLETED|Overall Study||16
93811|NCT01469065|226226|P3|COMPLETED|Overall Study||16
93812|NCT01469065|226227|P2|COMPLETED|Overall Study||16
93813|NCT01469065|226228|P1|COMPLETED|Overall Study||16
93814|NCT01469065|226224|P5|STARTED|Overall Study||17
93815|NCT01469065|226225|P4|STARTED|Overall Study||16
93816|NCT01469065|226226|P3|STARTED|Overall Study||16
93817|NCT01469065|226227|P2|STARTED|Overall Study||17
93818|NCT01469065|226228|P1|STARTED|Overall Study||16
93819|NCT01469052|226324|P6|NOT COMPLETED|Overall Study||6
93820|NCT01469052|226325|P5|NOT COMPLETED|Overall Study||8
93821|NCT01469052|226326|P4|NOT COMPLETED|Overall Study||5
93822|NCT01469052|226327|P3|NOT COMPLETED|Overall Study||6
93823|NCT01469052|226328|P2|NOT COMPLETED|Overall Study||4
93824|NCT01469052|226329|P1|NOT COMPLETED|Overall Study||6
93825|NCT01469052|226324|P6|COMPLETED|Overall Study||0
93826|NCT01469052|226325|P5|COMPLETED|Overall Study||0
93827|NCT01469052|226326|P4|COMPLETED|Overall Study||1
93828|NCT01469052|226327|P3|COMPLETED|Overall Study||0
93829|NCT01469052|226328|P2|COMPLETED|Overall Study||0
93830|NCT01469052|226329|P1|COMPLETED|Overall Study||0
93831|NCT01469052|226324|P6|STARTED|Overall Study||6
93832|NCT01469052|226325|P5|STARTED|Overall Study||8
93833|NCT01469052|226326|P4|STARTED|Overall Study||6
93834|NCT01469052|226327|P3|STARTED|Overall Study||6
93835|NCT01469052|226328|P2|STARTED|Overall Study||4
93836|NCT01469052|226329|P1|STARTED|Overall Study||6
93837|NCT01469039|226376|P3|NOT COMPLETED|Overall Study||113
93838|NCT01469039|226377|P2|NOT COMPLETED|Overall Study||73
93839|NCT01469039|226378|P1|NOT COMPLETED|Overall Study||77
93840|NCT01469039|226376|P3|COMPLETED|Overall Study||95
93841|NCT01469039|226377|P2|COMPLETED|Overall Study||135
93842|NCT01469039|226378|P1|COMPLETED|Overall Study||130
93843|NCT01469039|226376|P3|STARTED|Overall Study||208
93844|NCT01469039|226377|P2|STARTED|Overall Study||208
93845|NCT01469039|226378|P1|STARTED|Overall Study||207
93846|NCT01469000|226391|P2|NOT COMPLETED|Overall Study||9
93847|NCT01469000|226392|P1|NOT COMPLETED|Overall Study||33
93848|NCT01469000|226391|P2|COMPLETED|Overall Study||57
93849|NCT01469000|226392|P1|COMPLETED|Overall Study||96
93850|NCT01469000|226391|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
93851|NCT01469000|226392|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
93852|NCT01469000|226391|P2|STARTED|Overall Study||66
93853|NCT01469000|226392|P1|STARTED|Overall Study||129
93854|NCT01468987|226408|P2|NOT COMPLETED|Overall Study||60
93855|NCT01468987|226409|P1|NOT COMPLETED|Overall Study||71
93856|NCT01468987|226408|P2|COMPLETED|Overall Study||618
93857|NCT01468987|226409|P1|COMPLETED|Overall Study||620
93858|NCT01468987|226408|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
93859|NCT01468987|226409|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
93860|NCT01468987|226408|P2|STARTED|Overall Study||678
93861|NCT01468987|226409|P1|STARTED|Overall Study||691
93862|NCT01468896|226455|P2|NOT COMPLETED|Overall Study||0
93863|NCT01468896|226456|P1|NOT COMPLETED|Overall Study||0
93864|NCT01468896|226455|P2|COMPLETED|Overall Study||17
93865|NCT01468896|226456|P1|COMPLETED|Overall Study||6
93866|NCT01468896|226455|P2|STARTED|Overall Study||17
93867|NCT01468896|226456|P1|STARTED|Overall Study||6
93868|NCT01468818|226472|P1|NOT COMPLETED|Overall Study||2
93869|NCT01468818|226472|P1|COMPLETED|Overall Study||16
93870|NCT01468818|226472|P1|STARTED|Overall Study||18
93871|NCT01468675|226479|P2|NOT COMPLETED|Overall Study||1372
93872|NCT01468675|226480|P1|NOT COMPLETED|Overall Study||1000
93873|NCT01468675|226479|P2|COMPLETED|Overall Study||2004
93874|NCT01468675|226480|P1|COMPLETED|Overall Study||1699
93875|NCT01468675|226479|P2|STARTED|Overall Study||3376
93876|NCT01468675|226480|P1|STARTED|Overall Study||2699
93877|NCT01468584|226486|P1|NOT COMPLETED|Overall Study||0
93878|NCT01468584|226486|P1|COMPLETED|Overall Study||10
93879|NCT01468584|226486|P1|STARTED|Overall Study||10
93880|NCT01468558|226490|P1|NOT COMPLETED|Overall Study||2
93881|NCT01468558|226490|P1|COMPLETED|Overall Study||22
93882|NCT01468558|226490|P1|STARTED|Overall Study||24
93883|NCT01468350|226505|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
93884|NCT01468350|226506|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
93885|NCT01468350|226507|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
93886|NCT01468350|226508|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
93887|NCT01468350|226505|P4|COMPLETED|(PART B) Day 1, Day 15||12
93888|NCT01468350|226506|P3|COMPLETED|(PART B) Day 1, Day 15||12
93889|NCT01468350|226507|P2|COMPLETED|(PART B) Day 1, Day 15||0
93890|NCT01468350|226508|P1|COMPLETED|(PART B) Day 1, Day 15||0
93891|NCT01468350|226505|P4|STARTED|(PART B) Day 1, Day 15||12
93892|NCT01468350|226506|P3|STARTED|(PART B) Day 1, Day 15||12
93893|NCT01468350|226507|P2|STARTED|(PART B) Day 1, Day 15||0
93894|NCT01468350|226508|P1|STARTED|(PART B) Day 1, Day 15||0
93895|NCT01468350|226505|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
93896|NCT01468350|226506|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
93897|NCT01468350|226507|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
93898|NCT01468350|226508|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
93899|NCT01468350|226505|P4|COMPLETED|(PART A) Day 1, Day 3||0
93900|NCT01468350|226506|P3|COMPLETED|(PART A) Day 1, Day 3||0
93901|NCT01468350|226507|P2|COMPLETED|(PART A) Day 1, Day 3||5
93902|NCT01468350|226508|P1|COMPLETED|(PART A) Day 1, Day 3||6
93903|NCT01468350|226505|P4|STARTED|(PART A) Day 1, Day 3||0
93904|NCT01468350|226506|P3|STARTED|(PART A) Day 1, Day 3||0
93905|NCT01468350|226507|P2|STARTED|(PART A) Day 1, Day 3||5
93906|NCT01468350|226508|P1|STARTED|(PART A) Day 1, Day 3||6
93907|NCT01468337|226518|P1|NOT COMPLETED|Overall Study||0
93908|NCT01468337|226518|P1|COMPLETED|Overall Study||5
93909|NCT01468337|226518|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
93910|NCT01468337|226518|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
93911|NCT01468337|226518|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
93912|NCT01468337|226518|P1|Week 2|Overall Study||5
93913|NCT01468337|226518|P1|STARTED|Overall Study||5
93914|NCT01468311|226530|P1|NOT COMPLETED|Overall Study||2
93915|NCT01468311|226530|P1|COMPLETED|Overall Study||4
93916|NCT01468311|226530|P1|STARTED|Overall Study||6
93917|NCT01468233|226542|P6|NOT COMPLETED|Treatment Period 2||23
93918|NCT01468233|226543|P5|NOT COMPLETED|Treatment Period 2||28
93919|NCT01468233|226544|P4|NOT COMPLETED|Treatment Period 2||28
93920|NCT01468233|226545|P3|NOT COMPLETED|Treatment Period 2||111
93921|NCT01468233|226546|P2|NOT COMPLETED|Treatment Period 2||0
93922|NCT01468233|226547|P1|NOT COMPLETED|Treatment Period 2||0
93923|NCT01468233|226542|P6|COMPLETED|Treatment Period 2||28
93924|NCT01468233|226543|P5|COMPLETED|Treatment Period 2||25
93925|NCT01468233|226544|P4|COMPLETED|Treatment Period 2||23
93926|NCT01468233|226545|P3|COMPLETED|Treatment Period 2||40
93927|NCT01468233|226546|P2|COMPLETED|Treatment Period 2||0
93928|NCT01468233|226547|P1|COMPLETED|Treatment Period 2||0
93929|NCT01468233|226542|P6|STARTED|Treatment Period 2||51
93930|NCT01468233|226543|P5|STARTED|Treatment Period 2||53
93931|NCT01468233|226544|P4|STARTED|Treatment Period 2||51
93932|NCT01468233|226545|P3|STARTED|Treatment Period 2||151
93933|NCT01468233|226546|P2|STARTED|Treatment Period 2||0
93934|NCT01468233|226547|P1|STARTED|Treatment Period 2||0
93935|NCT01468233|226542|P6|NOT COMPLETED|Treatment Period 1||0
93936|NCT01468233|226543|P5|NOT COMPLETED|Treatment Period 1||0
93937|NCT01468233|226544|P4|NOT COMPLETED|Treatment Period 1||0
93938|NCT01468233|226545|P3|NOT COMPLETED|Treatment Period 1||0
93939|NCT01468233|226546|P2|NOT COMPLETED|Treatment Period 1||8
93940|NCT01468233|226547|P1|NOT COMPLETED|Treatment Period 1||12
93941|NCT01468233|226542|P6|COMPLETED|Treatment Period 1||0
93942|NCT01468233|226543|P5|COMPLETED|Treatment Period 1||0
93943|NCT01468233|226544|P4|COMPLETED|Treatment Period 1||0
93944|NCT01468233|226545|P3|COMPLETED|Treatment Period 1||0
93945|NCT01468233|226546|P2|COMPLETED|Treatment Period 1||155
93946|NCT01468233|226547|P1|COMPLETED|Treatment Period 1||151
93947|NCT01468233|226542|P6|STARTED|Treatment Period 1||0
93948|NCT01468233|226543|P5|STARTED|Treatment Period 1||0
93949|NCT01468233|226544|P4|STARTED|Treatment Period 1||0
93950|NCT01468233|226545|P3|STARTED|Treatment Period 1||0
93951|NCT01468233|226546|P2|STARTED|Treatment Period 1||163
93952|NCT01468233|226547|P1|STARTED|Treatment Period 1||163
93953|NCT01468207|226569|P6|NOT COMPLETED|Treatment Period 2||20
93954|NCT01468207|226570|P5|NOT COMPLETED|Treatment Period 2||21
93955|NCT01468207|226571|P4|NOT COMPLETED|Treatment Period 2||27
93956|NCT01468207|226572|P3|NOT COMPLETED|Treatment Period 2||52
93957|NCT01468207|226573|P2|NOT COMPLETED|Treatment Period 2||0
93958|NCT01468207|226574|P1|NOT COMPLETED|Treatment Period 2||0
93959|NCT01468207|226569|P6|COMPLETED|Treatment Period 2||28
93960|NCT01468207|226570|P5|COMPLETED|Treatment Period 2||27
93961|NCT01468207|226571|P4|COMPLETED|Treatment Period 2||22
93962|NCT01468207|226572|P3|COMPLETED|Treatment Period 2||93
93963|NCT01468207|226573|P2|COMPLETED|Treatment Period 2||0
93964|NCT01468207|226574|P1|COMPLETED|Treatment Period 2||0
93965|NCT01468207|226569|P6|STARTED|Treatment Period 2||48
93966|NCT01468207|226570|P5|STARTED|Treatment Period 2||48
93967|NCT01468207|226571|P4|STARTED|Treatment Period 2||49
93968|NCT01468207|226572|P3|STARTED|Treatment Period 2||145
93969|NCT01468207|226573|P2|STARTED|Treatment Period 2||0
93970|NCT01468207|226574|P1|STARTED|Treatment Period 2||0
93971|NCT01468207|226569|P6|NOT COMPLETED|Treatment Period 1||0
93972|NCT01468207|226570|P5|NOT COMPLETED|Treatment Period 1||0
93973|NCT01468207|226571|P4|NOT COMPLETED|Treatment Period 1||0
93974|NCT01468207|226572|P3|NOT COMPLETED|Treatment Period 1||0
93975|NCT01468207|226573|P2|NOT COMPLETED|Treatment Period 1||8
93976|NCT01468207|226574|P1|NOT COMPLETED|Treatment Period 1||9
93977|NCT01468207|226569|P6|COMPLETED|Treatment Period 1||0
93978|NCT01468207|226570|P5|COMPLETED|Treatment Period 1||0
93979|NCT01468207|226571|P4|COMPLETED|Treatment Period 1||0
93980|NCT01468207|226572|P3|COMPLETED|Treatment Period 1||0
93981|NCT01468207|226573|P2|COMPLETED|Treatment Period 1||145
93982|NCT01468207|226574|P1|COMPLETED|Treatment Period 1||145
93983|NCT01468207|226569|P6|Received Study Drug|Treatment Period 1||0
93984|NCT01468207|226570|P5|Received Study Drug|Treatment Period 1||0
93985|NCT01468207|226571|P4|Received Study Drug|Treatment Period 1||0
93986|NCT01468207|226572|P3|Received Study Drug|Treatment Period 1||0
93987|NCT01468207|226573|P2|Received Study Drug|Treatment Period 1||153
93988|NCT01468207|226574|P1|Received Study Drug|Treatment Period 1||152
93989|NCT01468207|226569|P6|STARTED|Treatment Period 1||0
93990|NCT01468207|226570|P5|STARTED|Treatment Period 1||0
93991|NCT01468207|226571|P4|STARTED|Treatment Period 1||0
93992|NCT01468207|226572|P3|STARTED|Treatment Period 1||0
93993|NCT01468207|226573|P2|STARTED|Treatment Period 1||153
93994|NCT01468207|226574|P1|STARTED|Treatment Period 1||154
93995|NCT01468181|226599|P5|NOT COMPLETED|Overall Study||5
93996|NCT01468181|226600|P4|NOT COMPLETED|Overall Study||3
93997|NCT01468181|226601|P3|NOT COMPLETED|Overall Study||8
93998|NCT01468181|226602|P2|NOT COMPLETED|Overall Study||2
93999|NCT01468181|226603|P1|NOT COMPLETED|Overall Study||10
94000|NCT01468181|226599|P5|COMPLETED|Overall Study||66
94001|NCT01468181|226600|P4|COMPLETED|Overall Study||63
94002|NCT01468181|226601|P3|COMPLETED|Overall Study||57
94003|NCT01468181|226602|P2|COMPLETED|Overall Study||59
94004|NCT01468181|226603|P1|COMPLETED|Overall Study||121
94005|NCT01468181|226599|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
94006|NCT01468181|226600|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
94007|NCT01468181|226601|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
94008|NCT01468181|226602|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
94009|NCT01468181|226603|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
94010|NCT01468181|226599|P5|STARTED|Overall Study||71
94011|NCT01468181|226600|P4|STARTED|Overall Study||66
94012|NCT01468181|226601|P3|STARTED|Overall Study||65
94013|NCT01468181|226602|P2|STARTED|Overall Study||61
94014|NCT01468181|226603|P1|STARTED|Overall Study||131
94015|NCT01468077|226652|P2|NOT COMPLETED|Overall Study||3
94016|NCT01468077|226653|P1|NOT COMPLETED|Overall Study||4
94017|NCT01468077|226652|P2|COMPLETED|Overall Study||22
94018|NCT01468077|226653|P1|COMPLETED|Overall Study||18
94019|NCT01468077|226652|P2|STARTED|Overall Study||25
94020|NCT01468077|226653|P1|STARTED|Overall Study||22
94021|NCT01468012|226692|P3|NOT COMPLETED|Overall Study||4
94022|NCT01468012|226693|P2|NOT COMPLETED|Overall Study||1
94023|NCT01468012|226694|P1|NOT COMPLETED|Overall Study||2
94024|NCT01468012|226692|P3|COMPLETED|Overall Study||0
94025|NCT01468012|226693|P2|COMPLETED|Overall Study||9
94026|NCT01468012|226694|P1|COMPLETED|Overall Study||7
94027|NCT01468012|226692|P3|STARTED|Overall Study||4
94028|NCT01468012|226693|P2|STARTED|Overall Study||10
94029|NCT01468012|226694|P1|STARTED|Overall Study||9
94030|NCT01467960|226711|P6|NOT COMPLETED|Overall Study||30
94031|NCT01467960|226712|P5|NOT COMPLETED|Overall Study||30
94032|NCT01467960|226713|P4|NOT COMPLETED|Overall Study||30
94033|NCT01467960|226714|P3|NOT COMPLETED|Overall Study||0
94034|NCT01467960|226715|P2|NOT COMPLETED|Overall Study||0
94035|NCT01467960|226716|P1|NOT COMPLETED|Overall Study||0
94036|NCT01467960|226711|P6|COMPLETED|Overall Study||0
94037|NCT01467960|226712|P5|COMPLETED|Overall Study||0
94038|NCT01467960|226713|P4|COMPLETED|Overall Study||0
94039|NCT01467960|226714|P3|COMPLETED|Overall Study||30
94040|NCT01467960|226715|P2|COMPLETED|Overall Study||30
94041|NCT01467960|226716|P1|COMPLETED|Overall Study||30
94042|NCT01467960|226711|P6|STARTED|Overall Study||30
94043|NCT01467960|226712|P5|STARTED|Overall Study||30
94044|NCT01467960|226713|P4|STARTED|Overall Study||30
94045|NCT01467960|226714|P3|STARTED|Overall Study||30
94046|NCT01467960|226715|P2|STARTED|Overall Study||30
94047|NCT01467960|226716|P1|STARTED|Overall Study||30
94048|NCT01467947|226730|P1|NOT COMPLETED|Overall Study||0
94049|NCT01467947|226730|P1|COMPLETED|Overall Study||46
94050|NCT01467947|226730|P1|STARTED|Overall Study||46
94051|NCT01467934|226738|P3|NOT COMPLETED|Overall Study||0
94052|NCT01467934|226739|P2|NOT COMPLETED|Overall Study||0
94053|NCT01467934|226740|P1|NOT COMPLETED|Overall Study||0
94054|NCT01467934|226738|P3|COMPLETED|Overall Study||110
94055|NCT01467934|226739|P2|COMPLETED|Overall Study||212
94056|NCT01467934|226740|P1|COMPLETED|Overall Study||208
94057|NCT01467934|226738|P3|STARTED|Overall Study||110
94058|NCT01467934|226739|P2|STARTED|Overall Study||212
94059|NCT01467934|226740|P1|STARTED|Overall Study||208
94060|NCT01467882|226748|P1|NOT COMPLETED|Overall Study||0
94061|NCT01467882|226748|P1|COMPLETED|Overall Study||44
94062|NCT01467882|226748|P1|STARTED|Overall Study||44
94063|NCT01467713|226775|P4|NOT COMPLETED|Overall Study||109
94064|NCT01467713|226776|P3|NOT COMPLETED|Overall Study||102
94065|NCT01467713|226777|P2|NOT COMPLETED|Overall Study||104
94066|NCT01467713|226778|P1|NOT COMPLETED|Overall Study||102
94067|NCT01467713|226775|P4|COMPLETED|Overall Study||45
94068|NCT01467713|226776|P3|COMPLETED|Overall Study||58
94069|NCT01467713|226777|P2|COMPLETED|Overall Study||60
94070|NCT01467713|226778|P1|COMPLETED|Overall Study||62
94071|NCT01467713|226775|P4|Safety Analysis Set: Received Treatment|Overall Study||154
94072|NCT01467713|226776|P3|Safety Analysis Set: Received Treatment|Overall Study||159
94073|NCT01467713|226777|P2|Safety Analysis Set: Received Treatment|Overall Study||164
94074|NCT01467713|226778|P1|Safety Analysis Set: Received Treatment|Overall Study||163
94075|NCT01467713|226775|P4|STARTED|Overall Study||154
94076|NCT01467713|226776|P3|STARTED|Overall Study||160
94077|NCT01467713|226777|P2|STARTED|Overall Study||164
94078|NCT01467713|226778|P1|STARTED|Overall Study||164
94079|NCT01467700|226832|P4|NOT COMPLETED|Overall Study||27
94080|NCT01467700|226833|P3|NOT COMPLETED|Overall Study||27
94081|NCT01467700|226834|P2|NOT COMPLETED|Overall Study||28
94082|NCT01467700|226835|P1|NOT COMPLETED|Overall Study||29
94083|NCT01467700|226832|P4|COMPLETED|Overall Study||96
94084|NCT01467700|226833|P3|COMPLETED|Overall Study||97
94085|NCT01467700|226834|P2|COMPLETED|Overall Study||100
94086|NCT01467700|226835|P1|COMPLETED|Overall Study||86
94087|NCT01467700|226832|P4|Safety Set - Received Treatment|Overall Study||123
94088|NCT01467700|226833|P3|Safety Set - Received Treatment|Overall Study||124
94089|NCT01467700|226834|P2|Safety Set - Received Treatment|Overall Study||127
94090|NCT01467700|226835|P1|Safety Set - Received Treatment|Overall Study||115
94091|NCT01467700|226832|P4|STARTED|Overall Study||123
94092|NCT01467700|226833|P3|STARTED|Overall Study||124
94093|NCT01467700|226834|P2|STARTED|Overall Study||128
94094|NCT01467700|226835|P1|STARTED|Overall Study||115
94095|NCT01467661|226877|P1|NOT COMPLETED|Overall Study||21
94096|NCT01467661|226877|P1|COMPLETED|Overall Study|Completed study SPD422-309 (NCT01467661)|32
94097|NCT01467661|226877|P1|Started Post Marketing Trial|Overall Study||33
94098|NCT01467661|226877|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
94099|NCT01467661|226877|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
94100|NCT01467661|226877|P1|STARTED|Overall Study|Started Study SPD422-308 (NCT01214915)|53
94101|NCT01467583|226897|P3|NOT COMPLETED|Overall Study||2
94102|NCT01467583|226898|P2|NOT COMPLETED|Overall Study||1
94103|NCT01467583|226899|P1|NOT COMPLETED|Overall Study||2
94104|NCT01467583|226897|P3|COMPLETED|Overall Study||10
94105|NCT01467583|226898|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
94106|NCT01467583|226899|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
94107|NCT01467583|226897|P3|STARTED|Overall Study||12
94108|NCT01467583|226898|P2|STARTED|Overall Study||4
94109|NCT01467583|226899|P1|STARTED|Overall Study||16
94110|NCT01467570|226912|P2|NOT COMPLETED|Overall Study||9
94111|NCT01467570|226913|P1|NOT COMPLETED|Overall Study||8
94112|NCT01467570|226912|P2|COMPLETED|Overall Study||63
94113|NCT01467570|226913|P1|COMPLETED|Overall Study||67
94114|NCT01467570|226912|P2|STARTED|Overall Study||72
94115|NCT01467570|226913|P1|STARTED|Overall Study||75
94116|NCT01467557|226939|P2|NOT COMPLETED|Overall Study||107
94117|NCT01467557|226940|P1|NOT COMPLETED|Overall Study||99
94118|NCT01467557|226939|P2|COMPLETED|Overall Study||463
94119|NCT01467557|226940|P1|COMPLETED|Overall Study||502
94120|NCT01467557|226939|P2|12 Month Survey Completed|Overall Study||463
94121|NCT01467557|226940|P1|12 Month Survey Completed|Overall Study||502
94122|NCT01467557|226939|P2|4 Month Survey Completed|Overall Study||493
94123|NCT01467557|226940|P1|4 Month Survey Completed|Overall Study||533
94124|NCT01467557|226939|P2|2 Week Survey Completed|Overall Study||522
94125|NCT01467557|226940|P1|2 Week Survey Completed|Overall Study||551
94126|NCT01467557|226939|P2|STARTED|Overall Study||570
94127|NCT01467557|226940|P1|STARTED|Overall Study||601
94128|NCT01467505|226950|P2|NOT COMPLETED|Overall Study||3
94129|NCT01467505|226951|P1|NOT COMPLETED|Overall Study||33
94130|NCT01467505|226950|P2|COMPLETED|Overall Study||7
94131|NCT01467505|226951|P1|COMPLETED|Overall Study||18
94132|NCT01467505|226950|P2|STARTED|Overall Study||10
94133|NCT01467505|226951|P1|STARTED|Overall Study||51
94134|NCT01467492|226983|P2|NOT COMPLETED|Overall Study||13
94135|NCT01467492|226984|P1|NOT COMPLETED|Overall Study||22
94136|NCT01467492|226983|P2|COMPLETED|Overall Study||25
94137|NCT01467492|226984|P1|COMPLETED|Overall Study||61
94138|NCT01467492|226983|P2|STARTED|Overall Study||38
94139|NCT01467492|226984|P1|STARTED|Overall Study||83
94140|NCT01467479|227008|P3|NOT COMPLETED|Overall Study||16
94141|NCT01467479|227009|P2|NOT COMPLETED|Overall Study||17
94142|NCT01467479|227010|P1|NOT COMPLETED|Overall Study||9
94143|NCT01467479|227008|P3|COMPLETED|Overall Study||45
94144|NCT01467479|227009|P2|COMPLETED|Overall Study||52
94145|NCT01467479|227010|P1|COMPLETED|Overall Study||46
94146|NCT01467479|227008|P3|Treated|Overall Study||59
94147|NCT01467479|227009|P2|Treated|Overall Study||69
94148|NCT01467479|227010|P1|Treated|Overall Study||54
94149|NCT01467479|227008|P3|STARTED|Overall Study||61
94150|NCT01467479|227009|P2|STARTED|Overall Study||69
94151|NCT01467479|227010|P1|STARTED|Overall Study||55
94152|NCT01467427|227039|P2|NOT COMPLETED|Overall Study||13
94153|NCT01467427|227040|P1|NOT COMPLETED|Overall Study||12
94154|NCT01467427|227039|P2|COMPLETED|Overall Study||0
94155|NCT01467427|227040|P1|COMPLETED|Overall Study||0
94156|NCT01467427|227039|P2|Completed Main Phase|Overall Study||13
94157|NCT01467427|227040|P1|Completed Main Phase|Overall Study||11
94158|NCT01467427|227039|P2|STARTED|Overall Study||13
94159|NCT01467427|227040|P1|STARTED|Overall Study||12
94160|NCT01467076|227061|P3|NOT COMPLETED|Overall Study||0
94161|NCT01467076|227062|P2|NOT COMPLETED|Overall Study||0
94162|NCT01467076|227063|P1|NOT COMPLETED|Overall Study||1
94163|NCT01467076|227061|P3|COMPLETED|Overall Study||2
94164|NCT01467076|227062|P2|COMPLETED|Overall Study||2
94165|NCT01467076|227063|P1|COMPLETED|Overall Study||2
94166|NCT01467076|227061|P3|STARTED|Overall Study||2
94167|NCT01467076|227062|P2|STARTED|Overall Study||2
94168|NCT01467076|227063|P1|STARTED|Overall Study||3
94169|NCT01467037|227073|P1|NOT COMPLETED|Overall Study||0
94170|NCT01467037|227073|P1|COMPLETED|Overall Study||374
94171|NCT01467037|227073|P1|STARTED|Overall Study||374
94172|NCT01466881|227080|P1|NOT COMPLETED|Overall Study||40
94173|NCT01466881|227080|P1|COMPLETED|Overall Study||2
94174|NCT01466881|227080|P1|Eligible and Treated|Overall Study||37
94175|NCT01466881|227080|P1|STARTED|Overall Study||42
94176|NCT01466790|227097|P8|NOT COMPLETED|Overall Study||1
94177|NCT01466790|227098|P7|NOT COMPLETED|Overall Study||1
94178|NCT01466790|227099|P6|NOT COMPLETED|Overall Study||0
94179|NCT01466790|227100|P5|NOT COMPLETED|Overall Study||3
94180|NCT01466790|227101|P4|NOT COMPLETED|Overall Study||0
94181|NCT01466790|227102|P3|NOT COMPLETED|Overall Study||0
94182|NCT01466790|227103|P2|NOT COMPLETED|Overall Study||1
94183|NCT01466790|227104|P1|NOT COMPLETED|Overall Study||4
94184|NCT01466790|227097|P8|COMPLETED|Overall Study||13
94185|NCT01466790|227098|P7|COMPLETED|Overall Study||26
94186|NCT01466790|227099|P6|COMPLETED|Overall Study||16
94187|NCT01466790|227100|P5|COMPLETED|Overall Study||27
94188|NCT01466790|227101|P4|COMPLETED|Overall Study||14
94189|NCT01466790|227102|P3|COMPLETED|Overall Study||27
94190|NCT01466790|227103|P2|COMPLETED|Overall Study||14
94191|NCT01466790|227104|P1|COMPLETED|Overall Study||20
94192|NCT01466790|227097|P8|STARTED|Overall Study||14
94193|NCT01466790|227098|P7|STARTED|Overall Study||27
94194|NCT01466790|227099|P6|STARTED|Overall Study||16
94195|NCT01466790|227100|P5|STARTED|Overall Study||30
94196|NCT01466790|227101|P4|STARTED|Overall Study||14
94197|NCT01466790|227102|P3|STARTED|Overall Study||27
94198|NCT01466790|227103|P2|STARTED|Overall Study||15
94199|NCT01466790|227104|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
94200|NCT01466764|227168|P2|NOT COMPLETED|Overall Study||0
94201|NCT01466764|227169|P1|NOT COMPLETED|Overall Study||0
94202|NCT01466764|227168|P2|COMPLETED|Overall Study||5
94203|NCT01466764|227169|P1|COMPLETED|Overall Study||5
94204|NCT01466764|227168|P2|STARTED|Overall Study||5
94205|NCT01466764|227169|P1|STARTED|Overall Study||5
94206|NCT01466673|227189|P2|NOT COMPLETED|Overall Study||6
94207|NCT01466673|227190|P1|NOT COMPLETED|Overall Study||7
94208|NCT01466673|227189|P2|COMPLETED|Overall Study||95
94209|NCT01466673|227190|P1|COMPLETED|Overall Study||93
94210|NCT01466673|227189|P2|STARTED|Overall Study||101
94211|NCT01466673|227190|P1|STARTED|Overall Study||100
94212|NCT01466660|227216|P2|NOT COMPLETED|Overall Study||151
94213|NCT01466660|227217|P1|NOT COMPLETED|Overall Study||146
94214|NCT01466660|227216|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|8
94215|NCT01466660|227217|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|14
94216|NCT01466660|227216|P2|STARTED|Overall Study||159
94217|NCT01466660|227217|P1|STARTED|Overall Study||160
94218|NCT01466595|227243|P2|NOT COMPLETED|Overall Study||1
94219|NCT01466595|227244|P1|NOT COMPLETED|Overall Study||0
94220|NCT01466595|227243|P2|COMPLETED|Overall Study||23
94221|NCT01466595|227244|P1|COMPLETED|Overall Study||49
94222|NCT01466595|227243|P2|STARTED|Overall Study||24
94223|NCT01466595|227244|P1|STARTED|Overall Study||49
94224|NCT01466491|227338|P4|NOT COMPLETED|Overall Study||0
94225|NCT01466491|227339|P3|NOT COMPLETED|Overall Study||3
94226|NCT01466491|227340|P2|NOT COMPLETED|Overall Study||3
94227|NCT01466491|227341|P1|NOT COMPLETED|Overall Study||0
94228|NCT01466491|227338|P4|COMPLETED|Overall Study||83
94229|NCT01466491|227339|P3|COMPLETED|Overall Study||80
94230|NCT01466491|227340|P2|COMPLETED|Overall Study||80
94231|NCT01466491|227341|P1|COMPLETED|Overall Study||83
94232|NCT01466491|227338|P4|STARTED|Overall Study||83
94233|NCT01466491|227339|P3|STARTED|Overall Study||83
94234|NCT01466491|227340|P2|STARTED|Overall Study||83
94235|NCT01466491|227341|P1|STARTED|Overall Study||83
94236|NCT01466387|227361|P6|NOT COMPLETED|Overall Study||1
94237|NCT01466387|227362|P5|NOT COMPLETED|Overall Study||0
94238|NCT01466387|227363|P4|NOT COMPLETED|Overall Study||2
94239|NCT01466387|227364|P3|NOT COMPLETED|Overall Study||1
94240|NCT01466387|227365|P2|NOT COMPLETED|Overall Study||0
94241|NCT01466387|227366|P1|NOT COMPLETED|Overall Study||1
94242|NCT01466387|227361|P6|COMPLETED|Overall Study||99
94243|NCT01466387|227362|P5|COMPLETED|Overall Study||51
94244|NCT01466387|227363|P4|COMPLETED|Overall Study||99
94245|NCT01466387|227364|P3|COMPLETED|Overall Study||98
94246|NCT01466387|227365|P2|COMPLETED|Overall Study||100
94247|NCT01466387|227366|P1|COMPLETED|Overall Study||100
94248|NCT01466387|227361|P6|STARTED|Overall Study||100
94249|NCT01466387|227362|P5|STARTED|Overall Study||51
94250|NCT01466387|227363|P4|STARTED|Overall Study||101
94251|NCT01466387|227364|P3|STARTED|Overall Study||99
94252|NCT01466387|227365|P2|STARTED|Overall Study||100
94253|NCT01466387|227366|P1|STARTED|Overall Study||101
94254|NCT01466361|227408|P4|NOT COMPLETED|Overall Study||0
94255|NCT01466361|227409|P3|NOT COMPLETED|Overall Study||0
94256|NCT01466361|227410|P2|NOT COMPLETED|Overall Study||0
94257|NCT01466361|227411|P1|NOT COMPLETED|Overall Study||0
94258|NCT01466361|227408|P4|COMPLETED|Overall Study||41
94259|NCT01466361|227409|P3|COMPLETED|Overall Study||60
94260|NCT01466361|227410|P2|COMPLETED|Overall Study||34
94261|NCT01466361|227411|P1|COMPLETED|Overall Study||52
94262|NCT01466361|227408|P4|STARTED|Overall Study||41
94263|NCT01466361|227409|P3|STARTED|Overall Study||60
94264|NCT01466361|227410|P2|STARTED|Overall Study||34
94265|NCT01466361|227411|P1|STARTED|Overall Study||52
94266|NCT01466348|227427|P2|NOT COMPLETED|Period II - Second Intervention||0
94267|NCT01466348|227428|P1|NOT COMPLETED|Period II - Second Intervention||0
94268|NCT01466348|227427|P2|COMPLETED|Period II - Second Intervention||36
94269|NCT01466348|227428|P1|COMPLETED|Period II - Second Intervention||35
94270|NCT01466348|227427|P2|STARTED|Period II - Second Intervention||36
94271|NCT01466348|227428|P1|STARTED|Period II - Second Intervention||35
94272|NCT01466348|227427|P2|NOT COMPLETED|Period I - First Intervention||1
94273|NCT01466348|227428|P1|NOT COMPLETED|Period I - First Intervention||0
94274|NCT01466348|227427|P2|COMPLETED|Period I - First Intervention||35
94275|NCT01466348|227428|P1|COMPLETED|Period I - First Intervention||36
94276|NCT01466348|227427|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
94277|NCT01466348|227428|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
94278|NCT01466348|227427|P2|STARTED|Period I - First Intervention||36
94279|NCT01466348|227428|P1|STARTED|Period I - First Intervention||36
94280|NCT01466270|227456|P2|NOT COMPLETED|Overall Study||6
94281|NCT01466270|227457|P1|NOT COMPLETED|Overall Study||12
94282|NCT01466270|227456|P2|COMPLETED|Overall Study||25
94283|NCT01466270|227457|P1|COMPLETED|Overall Study||19
94284|NCT01466270|227456|P2|STARTED|Overall Study||31
94285|NCT01466270|227457|P1|STARTED|Overall Study||31
94286|NCT01466192|227469|P1|NOT COMPLETED|Overall Study||4
94287|NCT01466192|227469|P1|COMPLETED|Overall Study||104
94288|NCT01466192|227469|P1|STARTED|Overall Study||108
94289|NCT01466179|227473|P1|NOT COMPLETED|Overall Study||179
94290|NCT01466179|227473|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
94291|NCT01466179|227473|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
94292|NCT01466153|227496|P3|NOT COMPLETED|Overall Study||25
94293|NCT01466153|227497|P2|NOT COMPLETED|Overall Study||24
94294|NCT01466153|227498|P1|NOT COMPLETED|Overall Study||29
94295|NCT01466153|227496|P3|COMPLETED|Overall Study||36
94296|NCT01466153|227497|P2|COMPLETED|Overall Study||12
94297|NCT01466153|227498|P1|COMPLETED|Overall Study||33
94298|NCT01466153|227496|P3|STARTED|Overall Study||61
94299|NCT01466153|227497|P2|STARTED|Overall Study||36
94300|NCT01466153|227498|P1|STARTED|Overall Study||62
94301|NCT01466127|227539|P2|NOT COMPLETED|Overall Study||16
94302|NCT01466127|227540|P1|NOT COMPLETED|Overall Study||14
94303|NCT01466127|227539|P2|COMPLETED|Overall Study||14
94304|NCT01466127|227540|P1|COMPLETED|Overall Study||16
94305|NCT01466127|227539|P2|STARTED|Overall Study||30
94306|NCT01466127|227540|P1|STARTED|Overall Study||30
94307|NCT01466075|227546|P1|NOT COMPLETED|Overall Study||0
94308|NCT01466075|227546|P1|COMPLETED|Overall Study||207
94309|NCT01466075|227546|P1|STARTED|Overall Study||207
94310|NCT01466062|227553|P1|NOT COMPLETED|Overall Study||2
94311|NCT01466062|227553|P1|COMPLETED|Overall Study||26
94312|NCT01466062|227553|P1|STARTED|Overall Study||28
94313|NCT01465997|227576|P2|NOT COMPLETED|Overall Study||89
94314|NCT01465997|227577|P1|NOT COMPLETED|Overall Study||68
94315|NCT01465997|227576|P2|COMPLETED|Overall Study||180
94316|NCT01465997|227577|P1|COMPLETED|Overall Study||211
94317|NCT01465997|227576|P2|STARTED|Overall Study||269
94318|NCT01465997|227577|P1|STARTED|Overall Study||279
94319|NCT01465958|227587|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
94320|NCT01465958|227588|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
94321|NCT01465958|227587|P2|COMPLETED|Subcutaneous (SC) Phase||10
94322|NCT01465958|227588|P1|COMPLETED|Subcutaneous (SC) Phase||0
94323|NCT01465958|227587|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
94324|NCT01465958|227588|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
94325|NCT01465958|227587|P2|NOT COMPLETED|Intravenous (IV) Phase||0
94326|NCT01465958|227588|P1|NOT COMPLETED|Intravenous (IV) Phase||0
94327|NCT01465958|227587|P2|COMPLETED|Intravenous (IV) Phase||0
94328|NCT01465958|227588|P1|COMPLETED|Intravenous (IV) Phase||11
94329|NCT01465958|227587|P2|STARTED|Intravenous (IV) Phase||0
94330|NCT01465958|227588|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
94331|NCT01465958|227587|P2|NOT COMPLETED|Run-in Phase||0
94332|NCT01465958|227588|P1|NOT COMPLETED|Run-in Phase||1
94333|NCT01465958|227587|P2|COMPLETED|Run-in Phase||0
94334|NCT01465958|227588|P1|COMPLETED|Run-in Phase||10
94335|NCT01465958|227587|P2|STARTED|Run-in Phase||0
94336|NCT01465958|227588|P1|STARTED|Run-in Phase||11
94337|NCT01465802|227601|P5|NOT COMPLETED|Overall Study||12
94338|NCT01465802|227602|P4|NOT COMPLETED|Overall Study||29
94339|NCT01465802|227603|P3|NOT COMPLETED|Overall Study||0
94340|NCT01465802|227604|P2|NOT COMPLETED|Overall Study||24
94341|NCT01465802|227605|P1|NOT COMPLETED|Overall Study||33
94342|NCT01465802|227601|P5|COMPLETED|Overall Study||13
94343|NCT01465802|227602|P4|COMPLETED|Overall Study||38
94344|NCT01465802|227603|P3|COMPLETED|Overall Study||7
94345|NCT01465802|227604|P2|COMPLETED|Overall Study||42
94346|NCT01465802|227605|P1|COMPLETED|Overall Study||33
94347|NCT01465802|227601|P5|STARTED|Overall Study||25
94348|NCT01465802|227602|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
94349|NCT01465802|227603|P3|STARTED|Overall Study||7
94350|NCT01465802|227604|P2|STARTED|Overall Study||66
94351|NCT01465802|227605|P1|STARTED|Overall Study||66
94352|NCT01465763|227657|P3|NOT COMPLETED|Overall Study||4
94353|NCT01465763|227658|P2|NOT COMPLETED|Overall Study||1
94354|NCT01465763|227659|P1|NOT COMPLETED|Overall Study||31
94355|NCT01465763|227657|P3|COMPLETED|Overall Study||118
94356|NCT01465763|227658|P2|COMPLETED|Overall Study||15
94357|NCT01465763|227659|P1|COMPLETED|Overall Study||445
94358|NCT01465763|227657|P3|STARTED|Overall Study||122
94359|NCT01465763|227658|P2|STARTED|Overall Study||16
94360|NCT01465763|227659|P1|STARTED|Overall Study||476
94361|NCT01465412|227688|P4|NOT COMPLETED|Overall Study||0
94362|NCT01465412|227689|P3|NOT COMPLETED|Overall Study||0
94363|NCT01465412|227690|P2|NOT COMPLETED|Overall Study||0
94364|NCT01465412|227691|P1|NOT COMPLETED|Overall Study||0
94365|NCT01465412|227688|P4|COMPLETED|Overall Study||9
94366|NCT01465412|227689|P3|COMPLETED|Overall Study||9
94367|NCT01465412|227690|P2|COMPLETED|Overall Study||12
94368|NCT01465412|227691|P1|COMPLETED|Overall Study||12
94369|NCT01465412|227688|P4|STARTED|Overall Study||9
94370|NCT01465412|227689|P3|STARTED|Overall Study||9
94371|NCT01465412|227690|P2|STARTED|Overall Study||12
94372|NCT01465412|227691|P1|STARTED|Overall Study||12
94373|NCT01465386|227729|P1|NOT COMPLETED|Overall Study||4
94374|NCT01465386|227729|P1|COMPLETED|Overall Study||2
94375|NCT01465386|227729|P1|STARTED|Overall Study||6
94376|NCT01465347|227733|P2|NOT COMPLETED|Overall Study||3
94377|NCT01465347|227734|P1|NOT COMPLETED|Overall Study||1
94378|NCT01465347|227733|P2|COMPLETED|Overall Study||53
94379|NCT01465347|227734|P1|COMPLETED|Overall Study||2
94380|NCT01465347|227733|P2|STARTED|Overall Study||56
94381|NCT01465347|227734|P1|STARTED|Overall Study||3
94382|NCT01465230|227744|P1|NOT COMPLETED|Overall Study||2
94383|NCT01465230|227744|P1|COMPLETED|Overall Study||0
94384|NCT01465230|227744|P1|STARTED|Overall Study||2
94385|NCT01465178|227750|P2|NOT COMPLETED|Overall Study||0
94386|NCT01465178|227751|P1|NOT COMPLETED|Overall Study||1
94387|NCT01465178|227750|P2|COMPLETED|Overall Study||31
94388|NCT01465178|227751|P1|COMPLETED|Overall Study||30
94389|NCT01465178|227750|P2|STARTED|Overall Study||31
94390|NCT01465178|227751|P1|STARTED|Overall Study||31
94391|NCT01465048|227762|P3|NOT COMPLETED|Overall Study||0
94392|NCT01465048|227763|P2|NOT COMPLETED|Overall Study||0
94393|NCT01465048|227764|P1|NOT COMPLETED|Overall Study||0
94394|NCT01465048|227762|P3|COMPLETED|Overall Study||6
94395|NCT01465048|227763|P2|COMPLETED|Overall Study||6
94396|NCT01465048|227764|P1|COMPLETED|Overall Study||6
94397|NCT01465048|227762|P3|STARTED|Overall Study||6
94398|NCT01465048|227763|P2|STARTED|Overall Study||6
94399|NCT01465048|227764|P1|STARTED|Overall Study||6
94400|NCT01465022|227775|P3|NOT COMPLETED|Overall Study||70
94401|NCT01465022|227776|P2|NOT COMPLETED|Overall Study||23
94402|NCT01465022|227777|P1|NOT COMPLETED|Overall Study||23
94403|NCT01465022|227775|P3|COMPLETED|Overall Study||0
94404|NCT01465022|227776|P2|COMPLETED|Overall Study||40
94405|NCT01465022|227777|P1|COMPLETED|Overall Study||41
94406|NCT01465022|227775|P3|STARTED|Overall Study||70
94407|NCT01465022|227776|P2|STARTED|Overall Study||63
94408|NCT01465022|227777|P1|STARTED|Overall Study||64
94409|NCT01464996|227791|P1|NOT COMPLETED|Overall Study||0
94410|NCT01464996|227791|P1|COMPLETED|Overall Study||24
94411|NCT01464996|227791|P1|OptiBond FL|Overall Study||24
94412|NCT01464996|227791|P1|OptiBond XTR|Overall Study||23
94413|NCT01464996|227791|P1|STARTED|Overall Study||24
94414|NCT01464931|227811|P2|NOT COMPLETED|Overall Study||0
94415|NCT01464931|227812|P1|NOT COMPLETED|Overall Study||1
94416|NCT01464931|227811|P2|COMPLETED|Overall Study||16
94417|NCT01464931|227812|P1|COMPLETED|Overall Study||15
94418|NCT01464931|227811|P2|STARTED|Overall Study||16
94419|NCT01464931|227812|P1|STARTED|Overall Study||16
94420|NCT01464879|227849|P1|NOT COMPLETED|Overall Study||2
94421|NCT01464879|227849|P1|COMPLETED|Overall Study||18
94422|NCT01464879|227849|P1|Applicator Application (3.75 mL)|Overall Study||18
94423|NCT01464879|227849|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
94424|NCT01464879|227849|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
94425|NCT01464879|227849|P1|Washout Period|Overall Study||20
94426|NCT01464879|227849|P1|Hand Application (2.50 mL)|Overall Study||20
94427|NCT01464879|227849|P1|STARTED|Overall Study||20
94428|NCT01464840|227886|P3|NOT COMPLETED|Overall Study||0
94429|NCT01464840|227887|P2|NOT COMPLETED|Overall Study||0
94430|NCT01464840|227888|P1|NOT COMPLETED|Overall Study||0
94431|NCT01464840|227886|P3|COMPLETED|Overall Study||10
94432|NCT01464840|227887|P2|COMPLETED|Overall Study||10
94433|NCT01464840|227888|P1|COMPLETED|Overall Study||10
94434|NCT01464840|227886|P3|STARTED|Overall Study||10
94435|NCT01464840|227887|P2|STARTED|Overall Study||10
94436|NCT01464840|227888|P1|STARTED|Overall Study||10
94437|NCT01464827|227910|P14|NOT COMPLETED|Overall Study||3
94438|NCT01464827|227911|P13|NOT COMPLETED|Overall Study||2
94439|NCT01464827|227912|P12|NOT COMPLETED|Overall Study||2
94440|NCT01464827|227913|P11|NOT COMPLETED|Overall Study||2
94441|NCT01464827|227914|P10|NOT COMPLETED|Overall Study||3
94442|NCT01464827|227915|P9|NOT COMPLETED|Overall Study||3
94443|NCT01464827|227916|P8|NOT COMPLETED|Overall Study||3
94444|NCT01464827|227917|P7|NOT COMPLETED|Overall Study||4
94445|NCT01464827|227918|P6|NOT COMPLETED|Overall Study||1
94446|NCT01464827|227919|P5|NOT COMPLETED|Overall Study||8
94447|NCT01464827|227920|P4|NOT COMPLETED|Overall Study||4
94448|NCT01464827|227921|P3|NOT COMPLETED|Overall Study||0
94449|NCT01464827|227922|P2|NOT COMPLETED|Overall Study||7
94450|NCT01464827|227923|P1|NOT COMPLETED|Overall Study||3
94451|NCT01464827|227910|P14|COMPLETED|Overall Study||19
94452|NCT01464827|227911|P13|COMPLETED|Overall Study||21
94453|NCT01464827|227912|P12|COMPLETED|Overall Study||21
94454|NCT01464827|227913|P11|COMPLETED|Overall Study||21
94455|NCT01464827|227914|P10|COMPLETED|Overall Study||44
94456|NCT01464827|227915|P9|COMPLETED|Overall Study||37
94457|NCT01464827|227916|P8|COMPLETED|Overall Study||37
94458|NCT01464827|227917|P7|COMPLETED|Overall Study||37
94459|NCT01464827|227918|P6|COMPLETED|Overall Study||38
94460|NCT01464827|227919|P5|COMPLETED|Overall Study||72
94461|NCT01464827|227920|P4|COMPLETED|Overall Study||36
94462|NCT01464827|227921|P3|COMPLETED|Overall Study||39
94463|NCT01464827|227922|P2|COMPLETED|Overall Study||36
94464|NCT01464827|227923|P1|COMPLETED|Overall Study||77
94465|NCT01464827|227910|P14|Treated|Overall Study||20
94466|NCT01464827|227911|P13|Treated|Overall Study||23
94467|NCT01464827|227912|P12|Treated|Overall Study||22
94468|NCT01464827|227913|P11|Treated|Overall Study||23
94469|NCT01464827|227914|P10|Treated|Overall Study||45
94470|NCT01464827|227915|P9|Treated|Overall Study||40
94471|NCT01464827|227916|P8|Treated|Overall Study||40
94472|NCT01464827|227917|P7|Treated|Overall Study||40
94473|NCT01464827|227918|P6|Treated|Overall Study||39
94474|NCT01464827|227919|P5|Treated|Overall Study||79
94475|NCT01464827|227920|P4|Treated|Overall Study||40
94476|NCT01464827|227921|P3|Treated|Overall Study||39
94477|NCT01464827|227922|P2|Treated|Overall Study||41
94478|NCT01464827|227923|P1|Treated|Overall Study||80
94479|NCT01464827|227910|P14|STARTED|Overall Study||22
94480|NCT01464827|227911|P13|STARTED|Overall Study||23
94481|NCT01464827|227912|P12|STARTED|Overall Study||23
94482|NCT01464827|227913|P11|STARTED|Overall Study||23
94483|NCT01464827|227914|P10|STARTED|Overall Study||47
94484|NCT01464827|227915|P9|STARTED|Overall Study||40
94485|NCT01464827|227916|P8|STARTED|Overall Study||40
94486|NCT01464827|227917|P7|STARTED|Overall Study||41
94487|NCT01464827|227918|P6|STARTED|Overall Study||39
94488|NCT01464827|227919|P5|STARTED|Overall Study||80
94489|NCT01464827|227920|P4|STARTED|Overall Study||40
94490|NCT01464827|227921|P3|STARTED|Overall Study||39
94491|NCT01464827|227922|P2|STARTED|Overall Study||43
94492|NCT01464827|227923|P1|STARTED|Overall Study||80
94493|NCT01464788|227970|P3|NOT COMPLETED|Overall Study||0
94494|NCT01464788|227971|P2|NOT COMPLETED|Overall Study||2
94495|NCT01464788|227972|P1|NOT COMPLETED|Overall Study||0
94496|NCT01464788|227970|P3|COMPLETED|Overall Study||29
94497|NCT01464788|227971|P2|COMPLETED|Overall Study||29
94498|NCT01464788|227972|P1|COMPLETED|Overall Study||30
94499|NCT01464788|227970|P3|STARTED|Overall Study||29
94500|NCT01464788|227971|P2|STARTED|Overall Study||31
94501|NCT01464788|227972|P1|STARTED|Overall Study||30
94502|NCT01464619|227985|P2|NOT COMPLETED|Overall Study||4
94503|NCT01464619|227986|P1|NOT COMPLETED|Overall Study||3
94504|NCT01464619|227985|P2|COMPLETED|Overall Study||25
94505|NCT01464619|227986|P1|COMPLETED|Overall Study||29
94506|NCT01464619|227985|P2|STARTED|Overall Study||29
94507|NCT01464619|227986|P1|STARTED|Overall Study||32
94508|NCT01464424|228006|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
94509|NCT01464424|228007|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
94510|NCT01464424|228006|P2|COMPLETED|Period 2, Second 6 Weeks||41
94511|NCT01464424|228007|P1|COMPLETED|Period 2, Second 6 Weeks||42
94512|NCT01464424|228006|P2|STARTED|Period 2, Second 6 Weeks||41
94513|NCT01464424|228007|P1|STARTED|Period 2, Second 6 Weeks||42
94514|NCT01464424|228006|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
94515|NCT01464424|228007|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
94516|NCT01464424|228006|P2|COMPLETED|Period 1, First 6 Weeks||41
94517|NCT01464424|228007|P1|COMPLETED|Period 1, First 6 Weeks||42
94518|NCT01464424|228006|P2|STARTED|Period 1, First 6 Weeks||42
94519|NCT01464424|228007|P1|STARTED|Period 1, First 6 Weeks||42
94520|NCT01464359|228015|P1|NOT COMPLETED|Overall Study||0
94521|NCT01464359|228015|P1|COMPLETED|Overall Study||3
94522|NCT01464359|228015|P1|STARTED|Overall Study||3
94523|NCT01464346|228027|P3|NOT COMPLETED|Overall Study||1
94524|NCT01464346|228028|P2|NOT COMPLETED|Overall Study||0
94525|NCT01464346|228029|P1|NOT COMPLETED|Overall Study||0
94526|NCT01464346|228027|P3|COMPLETED|Overall Study||28
94527|NCT01464346|228028|P2|COMPLETED|Overall Study||32
94528|NCT01464346|228029|P1|COMPLETED|Overall Study||29
94529|NCT01464346|228027|P3|STARTED|Overall Study||29
94530|NCT01464346|228028|P2|STARTED|Overall Study||32
94531|NCT01464346|228029|P1|STARTED|Overall Study||29
94532|NCT01464307|228040|P2|NOT COMPLETED|Open-Label Extension Period||0
94533|NCT01464307|228041|P1|NOT COMPLETED|Open-Label Extension Period||51
94534|NCT01464307|228040|P2|COMPLETED|Open-Label Extension Period||0
94535|NCT01464307|228041|P1|COMPLETED|Open-Label Extension Period||218
94536|NCT01464307|228040|P2|Treated|Open-Label Extension Period||0
94537|NCT01464307|228041|P1|Treated|Open-Label Extension Period||269
94538|NCT01464307|228040|P2|STARTED|Open-Label Extension Period||0
94539|NCT01464307|228041|P1|STARTED|Open-Label Extension Period||269
94540|NCT01464307|228040|P2|NOT COMPLETED|Main Period||5
94541|NCT01464307|228041|P1|NOT COMPLETED|Main Period||15
94542|NCT01464307|228040|P2|COMPLETED|Main Period||140
94543|NCT01464307|228041|P1|COMPLETED|Main Period||129
94544|NCT01464307|228040|P2|Treated|Main Period||145
94545|NCT01464307|228041|P1|Treated|Main Period||144
94546|NCT01464307|228040|P2|STARTED|Main Period||145
94547|NCT01464307|228041|P1|STARTED|Main Period||144
94548|NCT01464255|228056|P2|NOT COMPLETED|Overall Study||1
94549|NCT01464255|228057|P1|NOT COMPLETED|Overall Study||0
94550|NCT01464255|228056|P2|COMPLETED|Overall Study||24
94551|NCT01464255|228057|P1|COMPLETED|Overall Study||25
94552|NCT01464255|228056|P2|STARTED|Overall Study||25
94553|NCT01464255|228057|P1|STARTED|Overall Study||25
94554|NCT01464229|228082|P2|NOT COMPLETED|Overall Study||2
94555|NCT01464229|228083|P1|NOT COMPLETED|Overall Study||5
94556|NCT01464229|228082|P2|COMPLETED|Overall Study||8
94557|NCT01464229|228083|P1|COMPLETED|Overall Study||5
94558|NCT01464229|228082|P2|STARTED|Overall Study||10
94559|NCT01464229|228083|P1|STARTED|Overall Study||10
94560|NCT01464190|228091|P2|NOT COMPLETED|Overall Study||41
94561|NCT01464190|228092|P1|NOT COMPLETED|Overall Study||69
94562|NCT01464190|228091|P2|COMPLETED|Overall Study||227
94563|NCT01464190|228092|P1|COMPLETED|Overall Study||322
94564|NCT01464190|228091|P2|STARTED|Overall Study||268
94565|NCT01464190|228092|P1|STARTED|Overall Study||391
94566|NCT01464021|228102|P1|NOT COMPLETED|Overall Study||26
94567|NCT01464021|228102|P1|COMPLETED|Overall Study||0
94568|NCT01464021|228102|P1|STARTED|Overall Study||26
94569|NCT01463982|228118|P4|NOT COMPLETED|Overall Study||0
94570|NCT01463982|228119|P3|NOT COMPLETED|Overall Study||2
94571|NCT01463982|228120|P2|NOT COMPLETED|Overall Study||1
94572|NCT01463982|228121|P1|NOT COMPLETED|Overall Study||0
94573|NCT01463982|228118|P4|COMPLETED|Overall Study||6
94574|NCT01463982|228119|P3|COMPLETED|Overall Study||2
94575|NCT01463982|228120|P2|COMPLETED|Overall Study||7
94576|NCT01463982|228121|P1|COMPLETED|Overall Study||3
94577|NCT01463982|228118|P4|STARTED|Overall Study||6
94578|NCT01463982|228119|P3|STARTED|Overall Study||4
94579|NCT01463982|228120|P2|STARTED|Overall Study||8
94580|NCT01463982|228121|P1|STARTED|Overall Study||3
94581|NCT01463878|228137|P2|NOT COMPLETED|Overall Study||2
94582|NCT01463878|228138|P1|NOT COMPLETED|Overall Study||2
94583|NCT01463878|228137|P2|COMPLETED|Overall Study||7
94584|NCT01463878|228138|P1|COMPLETED|Overall Study||7
94585|NCT01463878|228137|P2|STARTED|Overall Study||9
94586|NCT01463878|228138|P1|STARTED|Overall Study||9
94587|NCT01463696|228152|P8|NOT COMPLETED|Overall Study||4
94588|NCT01463696|228153|P7|NOT COMPLETED|Overall Study||10
94589|NCT01463696|228154|P6|NOT COMPLETED|Overall Study||3
94590|NCT01463696|228155|P5|NOT COMPLETED|Overall Study||1
94591|NCT01463696|228156|P4|NOT COMPLETED|Overall Study||4
94592|NCT01463696|228157|P3|NOT COMPLETED|Overall Study||1
94593|NCT01463696|228158|P2|NOT COMPLETED|Overall Study||2
94594|NCT01463696|228159|P1|NOT COMPLETED|Overall Study||0
94595|NCT01463696|228152|P8|COMPLETED|Overall Study||2
94596|NCT01463696|228153|P7|COMPLETED|Overall Study||6
94597|NCT01463696|228154|P6|COMPLETED|Overall Study||3
94598|NCT01463696|228155|P5|COMPLETED|Overall Study||2
94599|NCT01463696|228156|P4|COMPLETED|Overall Study||3
94600|NCT01463696|228157|P3|COMPLETED|Overall Study||2
94601|NCT01463696|228158|P2|COMPLETED|Overall Study||4
94602|NCT01463696|228159|P1|COMPLETED|Overall Study||1
94603|NCT01463696|228152|P8|Treated|Overall Study||6
94604|NCT01463696|228153|P7|Treated|Overall Study||15
94605|NCT01463696|228154|P6|Treated|Overall Study||6
94606|NCT01463696|228155|P5|Treated|Overall Study||3
94607|NCT01463696|228156|P4|Treated|Overall Study||7
94608|NCT01463696|228157|P3|Treated|Overall Study||3
94609|NCT01463696|228158|P2|Treated|Overall Study||6
94610|NCT01463696|228159|P1|Treated|Overall Study||1
94611|NCT01463696|228152|P8|STARTED|Overall Study||6
94612|NCT01463696|228153|P7|STARTED|Overall Study||16
94613|NCT01463696|228154|P6|STARTED|Overall Study||6
94614|NCT01463696|228155|P5|STARTED|Overall Study||3
94615|NCT01463696|228156|P4|STARTED|Overall Study||7
94616|NCT01463696|228157|P3|STARTED|Overall Study||3
94617|NCT01463696|228158|P2|STARTED|Overall Study||6
94618|NCT01463696|228159|P1|STARTED|Overall Study||1
94619|NCT01463683|228212|P3|NOT COMPLETED|Overall Study||11
94620|NCT01463683|228213|P2|NOT COMPLETED|Overall Study||31
94621|NCT01463683|228214|P1|NOT COMPLETED|Overall Study||19
94622|NCT01463683|228212|P3|COMPLETED|Overall Study||93
94623|NCT01463683|228213|P2|COMPLETED|Overall Study||278
94624|NCT01463683|228214|P1|COMPLETED|Overall Study||290
94625|NCT01463683|228212|P3|Received Vaccination 3 (Month 6)|Overall Study||93
94626|NCT01463683|228213|P2|Received Vaccination 3 (Month 6)|Overall Study||281
94627|NCT01463683|228214|P1|Received Vaccination 3 (Month 6)|Overall Study||290
94628|NCT01463683|228212|P3|Received Vaccination 2 (Month 1)|Overall Study||103
94629|NCT01463683|228213|P2|Received Vaccination 2 (Month 1)|Overall Study||300
94630|NCT01463683|228214|P1|Received Vaccination 2 (Month 1)|Overall Study||302
94631|NCT01463683|228212|P3|Received Vaccination 1 (Day 1)|Overall Study||104
94632|NCT01463683|228213|P2|Received Vaccination 1 (Day 1)|Overall Study||308
94633|NCT01463683|228214|P1|Received Vaccination 1 (Day 1)|Overall Study||309
94634|NCT01463683|228212|P3|STARTED|Overall Study||104
94635|NCT01463683|228213|P2|STARTED|Overall Study||309
94636|NCT01463683|228214|P1|STARTED|Overall Study||309
94637|NCT01463527|228229|P2|NOT COMPLETED|Overall Study||7
94638|NCT01463527|228230|P1|NOT COMPLETED|Overall Study||6
94639|NCT01463527|228229|P2|COMPLETED|Overall Study||77
94640|NCT01463527|228230|P1|COMPLETED|Overall Study||77
94641|NCT01463527|228229|P2|STARTED|Overall Study||84
94642|NCT01463527|228230|P1|STARTED|Overall Study||83
94643|NCT01463384|228238|P1|NOT COMPLETED|Overall Study||0
94644|NCT01463384|228238|P1|COMPLETED|Overall Study||13
94645|NCT01463384|228238|P1|STARTED|Overall Study||13
94646|NCT01463293|228253|P3|NOT COMPLETED|Overall Study||12
94647|NCT01463293|228254|P2|NOT COMPLETED|Overall Study||16
94648|NCT01463293|228255|P1|NOT COMPLETED|Overall Study||6
94649|NCT01463293|228253|P3|COMPLETED|Overall Study||59
94650|NCT01463293|228254|P2|COMPLETED|Overall Study||63
94651|NCT01463293|228255|P1|COMPLETED|Overall Study||68
94652|NCT01463293|228253|P3|STARTED|Overall Study||71
94653|NCT01463293|228254|P2|STARTED|Overall Study||79
94654|NCT01463293|228255|P1|STARTED|Overall Study||74
94655|NCT01463202|228265|P2|NOT COMPLETED|Overall Study||0
94656|NCT01463202|228266|P1|NOT COMPLETED|Overall Study||0
94657|NCT01463202|228265|P2|COMPLETED|Overall Study||78
94658|NCT01463202|228266|P1|COMPLETED|Overall Study||79
94659|NCT01463202|228265|P2|STARTED|Overall Study||78
94660|NCT01463202|228266|P1|STARTED|Overall Study||79
94661|NCT01463111|228274|P1|NOT COMPLETED|Overall Study||9
94662|NCT01463111|228274|P1|COMPLETED|Overall Study||17
94663|NCT01463111|228274|P1|STARTED|Overall Study||26
94664|NCT01463033|228284|P2|NOT COMPLETED|Overall Study||6
94665|NCT01463033|228285|P1|NOT COMPLETED|Overall Study||7
94666|NCT01463033|228284|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
94667|NCT01463033|228285|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
94668|NCT01463033|228284|P2|STARTED|Overall Study||60
94669|NCT01463033|228285|P1|STARTED|Overall Study||66
94670|NCT01463007|228292|P1|NOT COMPLETED|Overall Study||1
94671|NCT01463007|228292|P1|COMPLETED|Overall Study||40
94672|NCT01463007|228292|P1|STARTED|Overall Study||41
94673|NCT01462942|228303|P5|NOT COMPLETED|Overall Study||45
94674|NCT01462942|228304|P4|NOT COMPLETED|Overall Study||50
94675|NCT01462942|228305|P3|NOT COMPLETED|Overall Study||40
94676|NCT01462942|228306|P2|NOT COMPLETED|Overall Study||34
94677|NCT01462942|228307|P1|NOT COMPLETED|Overall Study||34
94678|NCT01462942|228303|P5|COMPLETED|Overall Study||339
94679|NCT01462942|228304|P4|COMPLETED|Overall Study||335
94680|NCT01462942|228305|P3|COMPLETED|Overall Study||341
94681|NCT01462942|228306|P2|COMPLETED|Overall Study||351
94682|NCT01462942|228307|P1|COMPLETED|Overall Study||160
94683|NCT01462942|228303|P5|STARTED|Overall Study||384
94684|NCT01462942|228304|P4|STARTED|Overall Study||385
94685|NCT01462942|228305|P3|STARTED|Overall Study||381
94686|NCT01462942|228306|P2|STARTED|Overall Study||385
94687|NCT01462942|228307|P1|STARTED|Overall Study||194
94688|NCT01462929|228337|P3|NOT COMPLETED|Overall Study||5
94689|NCT01462929|228338|P2|NOT COMPLETED|Overall Study||4
94690|NCT01462929|228339|P1|NOT COMPLETED|Overall Study||5
94691|NCT01462929|228337|P3|COMPLETED|Overall Study||80
94692|NCT01462929|228338|P2|COMPLETED|Overall Study||154
94693|NCT01462929|228339|P1|COMPLETED|Overall Study||166
94694|NCT01462929|228337|P3|STARTED|Overall Study||85
94695|NCT01462929|228338|P2|STARTED|Overall Study||158
94696|NCT01462929|228339|P1|STARTED|Overall Study||171
94697|NCT01462877|228350|P1|NOT COMPLETED|Overall Study||71
94698|NCT01462877|228350|P1|COMPLETED|Overall Study||435
94699|NCT01462877|228350|P1|Per-protocol Set|Overall Study||364
94700|NCT01462877|228350|P1|Full Analysis Set|Overall Study||468
94701|NCT01462877|228350|P1|Safety Set|Overall Study||492
94702|NCT01462877|228350|P1|STARTED|Overall Study||506
94703|NCT01462812|228366|P2|NOT COMPLETED|Overall Study||1
94704|NCT01462812|228367|P1|NOT COMPLETED|Overall Study||0
94705|NCT01462812|228366|P2|COMPLETED|Overall Study||111
94706|NCT01462812|228367|P1|COMPLETED|Overall Study||111
94707|NCT01462812|228366|P2|STARTED|Overall Study||112
94708|NCT01462812|228367|P1|STARTED|Overall Study||111
94709|NCT01462773|228373|P1|NOT COMPLETED|Overall Study||0
94710|NCT01462773|228373|P1|COMPLETED|Overall Study||16
94711|NCT01462773|228373|P1|STARTED|Overall Study||16
94712|NCT01462695|228380|P2|NOT COMPLETED|Overall Study||13
94713|NCT01462695|228381|P1|NOT COMPLETED|Overall Study||17
94714|NCT01462695|228380|P2|COMPLETED|Overall Study||0
94715|NCT01462695|228381|P1|COMPLETED|Overall Study||0
94716|NCT01462695|228380|P2|STARTED|Overall Study||13
94717|NCT01462695|228381|P1|STARTED|Overall Study||17
94718|NCT01462565|228387|P1|NOT COMPLETED|Overall Study||0
94719|NCT01462565|228387|P1|COMPLETED|Overall Study||16
94720|NCT01462565|228387|P1|STARTED|Overall Study||16
94721|NCT01462435|228409|P4|NOT COMPLETED|Overall Study||5
94722|NCT01462435|228410|P3|NOT COMPLETED|Overall Study||1
94723|NCT01462435|228411|P2|NOT COMPLETED|Overall Study||0
94724|NCT01462435|228412|P1|NOT COMPLETED|Overall Study||1
94725|NCT01462435|228409|P4|COMPLETED|Overall Study||101
94726|NCT01462435|228410|P3|COMPLETED|Overall Study||106
94727|NCT01462435|228411|P2|COMPLETED|Overall Study||109
94728|NCT01462435|228412|P1|COMPLETED|Overall Study||105
94729|NCT01462435|228409|P4|STARTED|Overall Study||106
94730|NCT01462435|228410|P3|STARTED|Overall Study||107
94731|NCT01462435|228411|P2|STARTED|Overall Study||109
94732|NCT01462435|228412|P1|STARTED|Overall Study||106
94733|NCT01462370|228450|P2|NOT COMPLETED|Overall Study||5
94734|NCT01462370|228451|P1|NOT COMPLETED|Overall Study||1
94735|NCT01462370|228450|P2|COMPLETED|Overall Study||65
94736|NCT01462370|228451|P1|COMPLETED|Overall Study||68
94737|NCT01462370|228450|P2|STARTED|Overall Study||70
94738|NCT01462370|228451|P1|STARTED|Overall Study||69
94739|NCT01462357|228486|P3|NOT COMPLETED|Month 36||0
94740|NCT01462357|228487|P2|NOT COMPLETED|Month 36||0
94741|NCT01462357|228488|P1|NOT COMPLETED|Month 36||0
94742|NCT01462357|228486|P3|COMPLETED|Month 36||346
94743|NCT01462357|228487|P2|COMPLETED|Month 36||339
94744|NCT01462357|228488|P1|COMPLETED|Month 36||351
94745|NCT01462357|228486|P3|STARTED|Month 36||346
94746|NCT01462357|228487|P2|STARTED|Month 36||339
94747|NCT01462357|228488|P1|STARTED|Month 36||351
94748|NCT01462357|228486|P3|NOT COMPLETED|Month 24||9
94749|NCT01462357|228487|P2|NOT COMPLETED|Month 24||14
94750|NCT01462357|228488|P1|NOT COMPLETED|Month 24||4
94751|NCT01462357|228486|P3|COMPLETED|Month 24||349
94752|NCT01462357|228487|P2|COMPLETED|Month 24||344
94753|NCT01462357|228488|P1|COMPLETED|Month 24||355
94754|NCT01462357|228486|P3|STARTED|Month 24||358
94755|NCT01462357|228487|P2|STARTED|Month 24||358
94756|NCT01462357|228488|P1|STARTED|Month 24||359
94757|NCT01462357|228486|P3|NOT COMPLETED|Month 18||9
94758|NCT01462357|228487|P2|NOT COMPLETED|Month 18||11
94759|NCT01462357|228488|P1|NOT COMPLETED|Month 18||3
94760|NCT01462357|228486|P3|COMPLETED|Month 18||349
94761|NCT01462357|228487|P2|COMPLETED|Month 18||347
94762|NCT01462357|228488|P1|COMPLETED|Month 18||356
94763|NCT01462357|228486|P3|STARTED|Month 18||358
94764|NCT01462357|228487|P2|STARTED|Month 18||358
94765|NCT01462357|228488|P1|STARTED|Month 18||359
94766|NCT01462357|228486|P3|NOT COMPLETED|Month 12||8
94767|NCT01462357|228487|P2|NOT COMPLETED|Month 12||10
94768|NCT01462357|228488|P1|NOT COMPLETED|Month 12||3
94769|NCT01462357|228486|P3|COMPLETED|Month 12||350
94770|NCT01462357|228487|P2|COMPLETED|Month 12||348
94771|NCT01462357|228488|P1|COMPLETED|Month 12||356
94772|NCT01462357|228486|P3|STARTED|Month 12||358
94773|NCT01462357|228487|P2|STARTED|Month 12||358
94774|NCT01462357|228488|P1|STARTED|Month 12||359
94775|NCT01462357|228486|P3|NOT COMPLETED|Month 7||6
94776|NCT01462357|228487|P2|NOT COMPLETED|Month 7||5
94777|NCT01462357|228488|P1|NOT COMPLETED|Month 7||1
94778|NCT01462357|228486|P3|COMPLETED|Month 7||352
94779|NCT01462357|228487|P2|COMPLETED|Month 7||353
94780|NCT01462357|228488|P1|COMPLETED|Month 7||358
94781|NCT01462357|228486|P3|STARTED|Month 7||358
94782|NCT01462357|228487|P2|STARTED|Month 7||358
94783|NCT01462357|228488|P1|STARTED|Month 7||359
94784|NCT01462344|228561|P2|NOT COMPLETED|Overall Study||350
94785|NCT01462344|228562|P1|NOT COMPLETED|Overall Study||383
94786|NCT01462344|228561|P2|COMPLETED|Overall Study||2751
94787|NCT01462344|228562|P1|COMPLETED|Overall Study||2724
94788|NCT01462344|228561|P2|STARTED|Overall Study||3101
94789|NCT01462344|228562|P1|STARTED|Overall Study||3107
94790|NCT01462318|228584|P3|NOT COMPLETED|Extension Phase||45
94791|NCT01462318|228585|P2|NOT COMPLETED|Extension Phase||0
94792|NCT01462318|228586|P1|NOT COMPLETED|Extension Phase||0
94793|NCT01462318|228584|P3|COMPLETED|Extension Phase||70
94794|NCT01462318|228585|P2|COMPLETED|Extension Phase||0
94795|NCT01462318|228586|P1|COMPLETED|Extension Phase||0
94796|NCT01462318|228584|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
94797|NCT01462318|228585|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
94798|NCT01462318|228586|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
94799|NCT01462318|228584|P3|NOT COMPLETED|Main Study / TP-DI Study||0
94800|NCT01462318|228585|P2|NOT COMPLETED|Main Study / TP-DI Study||0
94801|NCT01462318|228586|P1|NOT COMPLETED|Main Study / TP-DI Study||8
94802|NCT01462318|228584|P3|COMPLETED|Main Study / TP-DI Study||0
94803|NCT01462318|228585|P2|COMPLETED|Main Study / TP-DI Study||20
94804|NCT01462318|228586|P1|COMPLETED|Main Study / TP-DI Study||105
94805|NCT01462318|228584|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
94806|NCT01462318|228585|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
94807|NCT01462318|228586|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
94808|NCT01462318|228584|P3|STARTED|Main Study / TP-DI Study||0
94809|NCT01462318|228585|P2|STARTED|Main Study / TP-DI Study||20
94810|NCT01462318|228586|P1|STARTED|Main Study / TP-DI Study||113
94811|NCT01462292|228606|P3|NOT COMPLETED|Overall Study||0
94812|NCT01462292|228607|P2|NOT COMPLETED|Overall Study||0
94813|NCT01462292|228608|P1|NOT COMPLETED|Overall Study||0
94814|NCT01462292|228606|P3|COMPLETED|Overall Study||18
94815|NCT01462292|228607|P2|COMPLETED|Overall Study||17
94816|NCT01462292|228608|P1|COMPLETED|Overall Study||16
94817|NCT01462292|228606|P3|STARTED|Overall Study||18
94818|NCT01462292|228607|P2|STARTED|Overall Study||17
94819|NCT01462292|228608|P1|STARTED|Overall Study||16
94820|NCT01462279|228667|P1|NOT COMPLETED|Overall Study||3
94821|NCT01462279|228667|P1|COMPLETED|Overall Study||17
94822|NCT01462279|228667|P1|STARTED|Overall Study||20
94823|NCT01462266|228674|P2|NOT COMPLETED|Overall Study||27
94824|NCT01462266|228675|P1|NOT COMPLETED|Overall Study||35
94825|NCT01462266|228674|P2|COMPLETED|Overall Study||303
94826|NCT01462266|228675|P1|COMPLETED|Overall Study||295
94827|NCT01462266|228674|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
94828|NCT01462266|228675|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
94829|NCT01462266|228674|P2|STARTED|Overall Study||330
94830|NCT01462266|228675|P1|STARTED|Overall Study||330
94831|NCT01462227|228691|P4|NOT COMPLETED|Second Assignment||0
94832|NCT01462227|228692|P3|NOT COMPLETED|Second Assignment||1
94833|NCT01462227|228693|P2|NOT COMPLETED|Second Assignment||1
94834|NCT01462227|228694|P1|NOT COMPLETED|Second Assignment||1
94835|NCT01462227|228691|P4|COMPLETED|Second Assignment||5
94836|NCT01462227|228692|P3|COMPLETED|Second Assignment||5
94837|NCT01462227|228693|P2|COMPLETED|Second Assignment||1
94838|NCT01462227|228694|P1|COMPLETED|Second Assignment||3
94839|NCT01462227|228691|P4|STARTED|Second Assignment||5
94840|NCT01462227|228692|P3|STARTED|Second Assignment||6
94841|NCT01462227|228693|P2|STARTED|Second Assignment||2
94842|NCT01462227|228694|P1|STARTED|Second Assignment||4
94843|NCT01462227|228691|P4|NOT COMPLETED|First Assignment||0
94844|NCT01462227|228692|P3|NOT COMPLETED|First Assignment||0
94845|NCT01462227|228693|P2|NOT COMPLETED|First Assignment||0
94846|NCT01462227|228694|P1|NOT COMPLETED|First Assignment||0
94847|NCT01462227|228691|P4|COMPLETED|First Assignment||5
94848|NCT01462227|228692|P3|COMPLETED|First Assignment||6
94849|NCT01462227|228693|P2|COMPLETED|First Assignment||2
94850|NCT01462227|228694|P1|COMPLETED|First Assignment||4
94851|NCT01462227|228691|P4|STARTED|First Assignment||5
94852|NCT01462227|228692|P3|STARTED|First Assignment||6
94853|NCT01462227|228693|P2|STARTED|First Assignment||2
94854|NCT01462227|228694|P1|STARTED|First Assignment||4
94855|NCT01462162|228712|P1|NOT COMPLETED|Overall Study||12
94856|NCT01462162|228712|P1|COMPLETED|Overall Study||108
94857|NCT01462162|228712|P1|STARTED|Overall Study||120
94858|NCT01462084|228737|P2|NOT COMPLETED|Overall Study||1
94859|NCT01462084|228738|P1|NOT COMPLETED|Overall Study||2
94860|NCT01462084|228737|P2|COMPLETED|Overall Study||9
94861|NCT01462084|228738|P1|COMPLETED|Overall Study||9
94862|NCT01462084|228737|P2|Included for Analysis|Overall Study||9
94863|NCT01462084|228738|P1|Included for Analysis|Overall Study||9
94864|NCT01462084|228737|P2|STARTED|Overall Study||10
94865|NCT01462084|228738|P1|STARTED|Overall Study||11
94866|NCT01462045|228749|P3|NOT COMPLETED|Overall Study||0
94867|NCT01462045|228750|P2|NOT COMPLETED|Overall Study||1
94868|NCT01462045|228751|P1|NOT COMPLETED|Overall Study||0
94869|NCT01462045|228749|P3|COMPLETED|Overall Study||7
94870|NCT01462045|228750|P2|COMPLETED|Overall Study||10
94871|NCT01462045|228751|P1|COMPLETED|Overall Study||11
94872|NCT01462045|228749|P3|STARTED|Overall Study||7
94873|NCT01462045|228750|P2|STARTED|Overall Study||11
94874|NCT01462045|228751|P1|STARTED|Overall Study||11
94875|NCT01461993|228765|P3|NOT COMPLETED|Overall Study||64
94876|NCT01461993|228766|P2|NOT COMPLETED|Overall Study||157
94877|NCT01461993|228767|P1|NOT COMPLETED|Overall Study||151
94878|NCT01461993|228765|P3|COMPLETED|Overall Study||438
94879|NCT01461993|228766|P2|COMPLETED|Overall Study||841
94880|NCT01461993|228767|P1|COMPLETED|Overall Study||848
94881|NCT01461993|228765|P3|STARTED|Overall Study||502
94882|NCT01461993|228766|P2|STARTED|Overall Study||998
94883|NCT01461993|228767|P1|STARTED|Overall Study||999
94884|NCT01461980|228792|P3|NOT COMPLETED|Overall Study||165
94885|NCT01461980|228793|P2|NOT COMPLETED|Overall Study||145
94886|NCT01461980|228794|P1|NOT COMPLETED|Overall Study||166
94887|NCT01461980|228792|P3|COMPLETED|Overall Study||717
94888|NCT01461980|228793|P2|COMPLETED|Overall Study||733
94889|NCT01461980|228794|P1|COMPLETED|Overall Study||722
94890|NCT01461980|228792|P3|Vaccination 3|Overall Study||748
94891|NCT01461980|228793|P2|Vaccination 3|Overall Study||777
94892|NCT01461980|228794|P1|Vaccination 3|Overall Study||757
94893|NCT01461980|228792|P3|Vaccination 2|Overall Study||799
94894|NCT01461980|228793|P2|Vaccination 2|Overall Study||819
94895|NCT01461980|228794|P1|Vaccination 2|Overall Study||802
94896|NCT01461980|228792|P3|Vaccination 1|Overall Study||875
94897|NCT01461980|228793|P2|Vaccination 1|Overall Study||870
94898|NCT01461980|228794|P1|Vaccination 1|Overall Study||884
94899|NCT01461980|228792|P3|STARTED|Overall Study||882
94900|NCT01461980|228793|P2|STARTED|Overall Study||878
94901|NCT01461980|228794|P1|STARTED|Overall Study||888
94902|NCT01461824|228827|P3|NOT COMPLETED|Overall Study||3
94903|NCT01461824|228828|P2|NOT COMPLETED|Overall Study||4
94904|NCT01461824|228829|P1|NOT COMPLETED|Overall Study||2
94905|NCT01461824|228827|P3|COMPLETED|Overall Study||8
94906|NCT01461824|228828|P2|COMPLETED|Overall Study||7
94907|NCT01461824|228829|P1|COMPLETED|Overall Study||10
94908|NCT01461824|228827|P3|STARTED|Overall Study||11
94909|NCT01461824|228828|P2|STARTED|Overall Study||11
94910|NCT01461824|228829|P1|STARTED|Overall Study||12
94911|NCT01461811|228845|P2|NOT COMPLETED|Overall Study||3
94912|NCT01461811|228846|P1|NOT COMPLETED|Overall Study||4
94913|NCT01461811|228845|P2|COMPLETED|Overall Study||46
94914|NCT01461811|228846|P1|COMPLETED|Overall Study||91
94915|NCT01461811|228845|P2|STARTED|Overall Study||49
94916|NCT01461811|228846|P1|STARTED|Overall Study||95
94917|NCT01461733|228876|P2|NOT COMPLETED|Overall Study||4
94918|NCT01461733|228877|P1|NOT COMPLETED|Overall Study||4
94919|NCT01461733|228876|P2|COMPLETED|Overall Study||8
94920|NCT01461733|228877|P1|COMPLETED|Overall Study||8
94921|NCT01461733|228876|P2|STARTED|Overall Study||12
94922|NCT01461733|228877|P1|STARTED|Overall Study||12
94923|NCT01461707|228885|P2|NOT COMPLETED|Overall Study||0
94924|NCT01461707|228886|P1|NOT COMPLETED|Overall Study||1
94925|NCT01461707|228885|P2|COMPLETED|Overall Study||15
94926|NCT01461707|228886|P1|COMPLETED|Overall Study||14
94927|NCT01461707|228885|P2|STARTED|Overall Study||15
94928|NCT01461707|228886|P1|STARTED|Overall Study||15
94929|NCT01461668|228896|P2|NOT COMPLETED|Overall Study||1
94930|NCT01461668|228897|P1|NOT COMPLETED|Overall Study||2
94931|NCT01461668|228896|P2|COMPLETED|Overall Study||25
94932|NCT01461668|228897|P1|COMPLETED|Overall Study||25
94933|NCT01461668|228896|P2|STARTED|Overall Study||26
94934|NCT01461668|228897|P1|STARTED|Overall Study||27
94935|NCT01461655|228903|P1|NOT COMPLETED|Overall Study||0
94936|NCT01461655|228903|P1|COMPLETED|Overall Study||40
94937|NCT01461655|228903|P1|STARTED|Overall Study||40
94938|NCT01461551|228923|P3|NOT COMPLETED|Overall Study||2
94939|NCT01461551|228924|P2|NOT COMPLETED|Overall Study||1
94940|NCT01461551|228925|P1|NOT COMPLETED|Overall Study||2
94941|NCT01461551|228923|P3|COMPLETED|Overall Study||33
94942|NCT01461551|228924|P2|COMPLETED|Overall Study||34
94943|NCT01461551|228925|P1|COMPLETED|Overall Study||33
94944|NCT01461551|228923|P3|STARTED|Overall Study||35
94945|NCT01461551|228924|P2|STARTED|Overall Study||35
94946|NCT01461551|228925|P1|STARTED|Overall Study||35
94947|NCT01461538|228936|P3|NOT COMPLETED|Overall Study||2
94948|NCT01461538|228937|P2|NOT COMPLETED|Overall Study||8
94949|NCT01461538|228938|P1|NOT COMPLETED|Overall Study||18
94950|NCT01461538|228936|P3|COMPLETED|Overall Study||7
94951|NCT01461538|228937|P2|COMPLETED|Overall Study||20
94952|NCT01461538|228938|P1|COMPLETED|Overall Study||28
94953|NCT01461538|228936|P3|STARTED|Overall Study||9
94954|NCT01461538|228937|P2|STARTED|Overall Study||28
94955|NCT01461538|228938|P1|STARTED|Overall Study||46
94956|NCT01461499|228976|P2|NOT COMPLETED|Overall Study||4
94957|NCT01461499|228977|P1|NOT COMPLETED|Overall Study||8
94958|NCT01461499|228976|P2|COMPLETED|Overall Study||114
94959|NCT01461499|228977|P1|COMPLETED|Overall Study||111
94960|NCT01461499|228976|P2|STARTED|Overall Study||118
94961|NCT01461499|228977|P1|STARTED|Overall Study||119
94962|NCT01461473|228987|P2|NOT COMPLETED|Overall Study||4
94963|NCT01461473|228988|P1|NOT COMPLETED|Overall Study||5
94964|NCT01461473|228987|P2|COMPLETED|Overall Study||55
94965|NCT01461473|228988|P1|COMPLETED|Overall Study||67
94966|NCT01461473|228987|P2|STARTED|Overall Study||59
94967|NCT01461473|228988|P1|STARTED|Overall Study||72
94968|NCT01461369|229007|P3|NOT COMPLETED|Overall Study||17
94969|NCT01461369|229008|P2|NOT COMPLETED|Overall Study||17
94970|NCT01461369|229009|P1|NOT COMPLETED|Overall Study||13
94971|NCT01461369|229007|P3|COMPLETED|Overall Study||86
94972|NCT01461369|229008|P2|COMPLETED|Overall Study||81
94973|NCT01461369|229009|P1|COMPLETED|Overall Study||91
94974|NCT01461369|229007|P3|STARTED|Overall Study||103
94975|NCT01461369|229008|P2|STARTED|Overall Study||98
94976|NCT01461369|229009|P1|STARTED|Overall Study||104
94977|NCT01461096|229034|P2|NOT COMPLETED|Overall Study||61
94978|NCT01461096|229035|P1|NOT COMPLETED|Overall Study||62
94979|NCT01461096|229034|P2|COMPLETED|Overall Study||226
94980|NCT01461096|229035|P1|COMPLETED|Overall Study||226
94981|NCT01461096|229034|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
94982|NCT01461096|229035|P1|Did Not Start Treatment|Overall Study||0
94983|NCT01461096|229034|P2|STARTED|Overall Study||287
94984|NCT01461096|229035|P1|STARTED|Overall Study||288
94985|NCT01461057|229051|P2|NOT COMPLETED|Overall Study||15
94986|NCT01461057|229052|P1|NOT COMPLETED|Overall Study||15
94987|NCT01461057|229051|P2|COMPLETED|Overall Study||0
94988|NCT01461057|229052|P1|COMPLETED|Overall Study||0
94989|NCT01461057|229051|P2|STARTED|Overall Study||15
94990|NCT01461057|229052|P1|STARTED|Overall Study||15
94991|NCT01461044|229062|P2|NOT COMPLETED|Overall Study||40
94992|NCT01461044|229063|P1|NOT COMPLETED|Overall Study||70
94993|NCT01461044|229062|P2|COMPLETED|Overall Study||37
94994|NCT01461044|229063|P1|COMPLETED|Overall Study||80
94995|NCT01461044|229062|P2|Participants Alive at Inclusion|Overall Study||58
94996|NCT01461044|229063|P1|Participants Alive at Inclusion|Overall Study||127
94997|NCT01461044|229062|P2|STARTED|Overall Study||77
94998|NCT01461044|229063|P1|STARTED|Overall Study||150
94999|NCT01460940|229136|P1|NOT COMPLETED|Overall Study||0
95000|NCT01460940|229136|P1|COMPLETED|Overall Study||24
95001|NCT01460940|229136|P1|STARTED|Overall Study||24
95002|NCT01460927|229142|P1|NOT COMPLETED|Overall Study||0
95003|NCT01460927|229142|P1|COMPLETED|Overall Study||25
95004|NCT01460927|229142|P1|STARTED|Overall Study||25
95005|NCT01460732|229150|P1|NOT COMPLETED|Overall Study||0
95006|NCT01460732|229150|P1|COMPLETED|Overall Study||81
95007|NCT01460732|229150|P1|STARTED|Overall Study||81
95008|NCT01460628|229163|P1|NOT COMPLETED|Overall Study||5
95009|NCT01460628|229163|P1|COMPLETED|Overall Study||20
95010|NCT01460628|229163|P1|STARTED|Overall Study||25
95011|NCT01460446|229175|P2|NOT COMPLETED|Overall Study||20
95012|NCT01460446|229176|P1|NOT COMPLETED|Overall Study||5
95013|NCT01460446|229175|P2|COMPLETED|Overall Study||93
95014|NCT01460446|229176|P1|COMPLETED|Overall Study||100
95015|NCT01460446|229175|P2|STARTED|Overall Study||113
95016|NCT01460446|229176|P1|STARTED|Overall Study||105
95017|NCT01460342|229205|P2|NOT COMPLETED|Overall Study||14
95018|NCT01460342|229206|P1|NOT COMPLETED|Overall Study||11
95019|NCT01460342|229205|P2|COMPLETED|Overall Study||292
95020|NCT01460342|229206|P1|COMPLETED|Overall Study||293
95021|NCT01460342|229205|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
95022|NCT01460342|229206|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
95023|NCT01460342|229205|P2|STARTED|Overall Study||306
95024|NCT01460342|229206|P1|STARTED|Overall Study||304
95025|NCT01460303|229228|P2|NOT COMPLETED|Overall Study||0
95026|NCT01460303|229229|P1|NOT COMPLETED|Overall Study||0
95027|NCT01460303|229228|P2|COMPLETED|Overall Study||24
95028|NCT01460303|229229|P1|COMPLETED|Overall Study||25
95029|NCT01460303|229228|P2|STARTED|Overall Study||24
95030|NCT01460303|229229|P1|STARTED|Overall Study||25
95031|NCT01460290|229237|P1|NOT COMPLETED|Overall Study||4
95032|NCT01460290|229237|P1|COMPLETED|Overall Study||11
95033|NCT01460290|229237|P1|STARTED|Overall Study||15
95034|NCT01459913|229261|P4|NOT COMPLETED|Overall Study||33
95035|NCT01459913|229262|P3|NOT COMPLETED|Overall Study||13
95036|NCT01459913|229263|P2|NOT COMPLETED|Overall Study||20
95037|NCT01459913|229264|P1|NOT COMPLETED|Overall Study||41
95038|NCT01459913|229261|P4|COMPLETED|Overall Study||29
95039|NCT01459913|229262|P3|COMPLETED|Overall Study||6
95040|NCT01459913|229263|P2|COMPLETED|Overall Study||32
95041|NCT01459913|229264|P1|COMPLETED|Overall Study||65
95042|NCT01459913|229261|P4|STARTED|Overall Study||62
95043|NCT01459913|229262|P3|STARTED|Overall Study||19
95044|NCT01459913|229263|P2|STARTED|Overall Study||52
95045|NCT01459913|229264|P1|STARTED|Overall Study||106
95046|NCT01459796|229295|P2|NOT COMPLETED|Overall Study||126
95047|NCT01459796|229296|P1|NOT COMPLETED|Overall Study||94
95048|NCT01459796|229295|P2|COMPLETED|Overall Study||0
95049|NCT01459796|229296|P1|COMPLETED|Overall Study||0
95050|NCT01459796|229295|P2|STARTED|Overall Study||126
95051|NCT01459796|229296|P1|STARTED|Overall Study||94
95052|NCT01459783|229314|P2|NOT COMPLETED|6 Months to 12 Months||30
95053|NCT01459783|229315|P1|NOT COMPLETED|6 Months to 12 Months||19
95054|NCT01459783|229314|P2|COMPLETED|6 Months to 12 Months||23
95055|NCT01459783|229315|P1|COMPLETED|6 Months to 12 Months||20
95056|NCT01459783|229314|P2|STARTED|6 Months to 12 Months||53
95057|NCT01459783|229315|P1|STARTED|6 Months to 12 Months||39
95058|NCT01459783|229314|P2|NOT COMPLETED|Baseline to 6 Months||20
95059|NCT01459783|229315|P1|NOT COMPLETED|Baseline to 6 Months||32
95060|NCT01459783|229314|P2|COMPLETED|Baseline to 6 Months||53
95061|NCT01459783|229315|P1|COMPLETED|Baseline to 6 Months||39
95062|NCT01459783|229314|P2|STARTED|Baseline to 6 Months||73
95063|NCT01459783|229315|P1|STARTED|Baseline to 6 Months||71
95064|NCT01459705|229326|P3|NOT COMPLETED|Overall Study||7
95065|NCT01459705|229327|P2|NOT COMPLETED|Overall Study||24
95066|NCT01459705|229328|P1|NOT COMPLETED|Overall Study||22
95067|NCT01459705|229326|P3|COMPLETED|Overall Study||47
95068|NCT01459705|229327|P2|COMPLETED|Overall Study||30
95069|NCT01459705|229328|P1|COMPLETED|Overall Study||32
95070|NCT01459705|229326|P3|STARTED|Overall Study||54
95071|NCT01459705|229327|P2|STARTED|Overall Study||54
95072|NCT01459705|229328|P1|STARTED|Overall Study||54
95073|NCT01459653|229346|P1|NOT COMPLETED|Overall Study||668
95074|NCT01459653|229346|P1|COMPLETED|Overall Study||828
95075|NCT01459653|229346|P1|STARTED|Overall Study||1496
95076|NCT01459588|229496|P4|NOT COMPLETED|Overall Study||1
95077|NCT01459588|229497|P3|NOT COMPLETED|Overall Study||1
95078|NCT01459588|229498|P2|NOT COMPLETED|Overall Study||2
95079|NCT01459588|229499|P1|NOT COMPLETED|Overall Study||1
95080|NCT01459588|229496|P4|COMPLETED|Overall Study||55
95081|NCT01459588|229497|P3|COMPLETED|Overall Study||102
95082|NCT01459588|229498|P2|COMPLETED|Overall Study||49
95083|NCT01459588|229499|P1|COMPLETED|Overall Study||104
95084|NCT01459588|229496|P4|STARTED|Overall Study||56
95085|NCT01459588|229497|P3|STARTED|Overall Study||103
95086|NCT01459588|229498|P2|STARTED|Overall Study||51
95087|NCT01459588|229499|P1|STARTED|Overall Study||105
95088|NCT01459068|229527|P2|NOT COMPLETED|Overall Study||34
95089|NCT01459068|229528|P1|NOT COMPLETED|Overall Study||39
95090|NCT01459068|229527|P2|COMPLETED|Overall Study||148
95091|NCT01459068|229528|P1|COMPLETED|Overall Study||126
95092|NCT01459068|229527|P2|STARTED|Overall Study||182
95093|NCT01459068|229528|P1|STARTED|Overall Study||165
95094|NCT01459016|229544|P1|NOT COMPLETED|Overall Study||15
95095|NCT01459016|229544|P1|COMPLETED|Overall Study||41
95096|NCT01459016|229544|P1|STARTED|Overall Study||56
95097|NCT01458990|229560|P2|NOT COMPLETED|Overall Study||0
95098|NCT01458990|229561|P1|NOT COMPLETED|Overall Study||0
95099|NCT01458990|229560|P2|COMPLETED|Overall Study||15
95100|NCT01458990|229561|P1|COMPLETED|Overall Study||45
95101|NCT01458990|229560|P2|STARTED|Overall Study||15
95102|NCT01458990|229561|P1|STARTED|Overall Study||45
95103|NCT01458951|229572|P3|NOT COMPLETED|Overall Study||15
95104|NCT01458951|229573|P2|NOT COMPLETED|Overall Study||1
95105|NCT01458951|229574|P1|NOT COMPLETED|Overall Study||32
95106|NCT01458951|229572|P3|COMPLETED|Overall Study||97
95107|NCT01458951|229573|P2|COMPLETED|Overall Study||5
95108|NCT01458951|229574|P1|COMPLETED|Overall Study||397
95109|NCT01458951|229572|P3|STARTED|Overall Study||112
95110|NCT01458951|229573|P2|STARTED|Overall Study||6
95111|NCT01458951|229574|P1|STARTED|Overall Study||429
95112|NCT01458639|229599|P1|NOT COMPLETED|Overall Study||6
95113|NCT01458639|229599|P1|COMPLETED|Overall Study||12
95114|NCT01458639|229599|P1|STARTED|Overall Study||18
95115|NCT01458587|229611|P2|NOT COMPLETED|Overall Study||0
95116|NCT01458587|229612|P1|NOT COMPLETED|Overall Study||1
95117|NCT01458587|229611|P2|COMPLETED|Overall Study||35
95118|NCT01458587|229612|P1|COMPLETED|Overall Study||34
95119|NCT01458587|229611|P2|STARTED|Overall Study||35
95120|NCT01458587|229612|P1|STARTED|Overall Study||35
95121|NCT01458574|229775|P3|NOT COMPLETED|Overall Study||145
95122|NCT01458574|229776|P2|NOT COMPLETED|Overall Study||71
95123|NCT01458574|229777|P1|NOT COMPLETED|Overall Study||87
95124|NCT01458574|229775|P3|COMPLETED|Overall Study||53
95125|NCT01458574|229776|P2|COMPLETED|Overall Study||126
95126|NCT01458574|229777|P1|COMPLETED|Overall Study||111
95127|NCT01458574|229775|P3|Treated|Overall Study||198
95128|NCT01458574|229776|P2|Treated|Overall Study||196
95129|NCT01458574|229777|P1|Treated|Overall Study||198
95130|NCT01458574|229775|P3|STARTED|Overall Study||198
95131|NCT01458574|229776|P2|STARTED|Overall Study||197
95132|NCT01458574|229777|P1|STARTED|Overall Study||198
95133|NCT01458561|229862|P2|NOT COMPLETED|Overall Study||0
95134|NCT01458561|229863|P1|NOT COMPLETED|Overall Study||0
95135|NCT01458561|229862|P2|COMPLETED|Overall Study||1
95136|NCT01458561|229863|P1|COMPLETED|Overall Study||0
95137|NCT01458561|229862|P2|STARTED|Overall Study||1
95138|NCT01458561|229863|P1|STARTED|Overall Study||0
95139|NCT01458535|229907|P6|NOT COMPLETED|Overall Study||4
95140|NCT01458535|229908|P5|NOT COMPLETED|Overall Study||4
95141|NCT01458535|229909|P4|NOT COMPLETED|Overall Study||4
95142|NCT01458535|229910|P3|NOT COMPLETED|Overall Study||2
95143|NCT01458535|229911|P2|NOT COMPLETED|Overall Study||2
95144|NCT01458535|229912|P1|NOT COMPLETED|Overall Study||0
95145|NCT01458535|229907|P6|COMPLETED|Overall Study||7
95146|NCT01458535|229908|P5|COMPLETED|Overall Study||6
95147|NCT01458535|229909|P4|COMPLETED|Overall Study||6
95148|NCT01458535|229910|P3|COMPLETED|Overall Study||8
95149|NCT01458535|229911|P2|COMPLETED|Overall Study||8
95150|NCT01458535|229912|P1|COMPLETED|Overall Study||10
95151|NCT01458535|229907|P6|STARTED|Overall Study||11
95152|NCT01458535|229908|P5|STARTED|Overall Study||10
95153|NCT01458535|229909|P4|STARTED|Overall Study||10
95154|NCT01458535|229910|P3|STARTED|Overall Study||10
95155|NCT01458535|229911|P2|STARTED|Overall Study||10
95156|NCT01458535|229912|P1|STARTED|Overall Study||10
95157|NCT01458392|229965|P3|NOT COMPLETED|Overall Study||31
95158|NCT01458392|229966|P2|NOT COMPLETED|Overall Study||13
95159|NCT01458392|229967|P1|NOT COMPLETED|Overall Study||2
95160|NCT01458392|229965|P3|COMPLETED|Overall Study||0
95161|NCT01458392|229966|P2|COMPLETED|Overall Study||0
95162|NCT01458392|229967|P1|COMPLETED|Overall Study||0
95163|NCT01458392|229965|P3|STARTED|Overall Study||31
95164|NCT01458392|229966|P2|STARTED|Overall Study||13
95165|NCT01458392|229967|P1|STARTED|Overall Study||2
95166|NCT01458288|229987|P1|NOT COMPLETED|Overall Study||0
95167|NCT01458288|229987|P1|COMPLETED|Overall Study||12
95168|NCT01458288|229987|P1|STARTED|Overall Study||12
95169|NCT01458275|229999|P3|NOT COMPLETED|Overall Study||9
95170|NCT01458275|230000|P2|NOT COMPLETED|Overall Study||13
95171|NCT01458275|230001|P1|NOT COMPLETED|Overall Study||14
95172|NCT01458275|229999|P3|COMPLETED|Overall Study||273
95173|NCT01458275|230000|P2|COMPLETED|Overall Study||269
95174|NCT01458275|230001|P1|COMPLETED|Overall Study||269
95175|NCT01458275|229999|P3|STARTED|Overall Study||282
95176|NCT01458275|230000|P2|STARTED|Overall Study||282
95177|NCT01458275|230001|P1|STARTED|Overall Study||283
95178|NCT01458249|230043|P1|NOT COMPLETED|Overall Study||8
95179|NCT01458249|230043|P1|COMPLETED|Overall Study||44
95180|NCT01458249|230043|P1|Participants Treated|Overall Study||51
95181|NCT01458249|230043|P1|STARTED|Overall Study||52
95182|NCT01458210|230062|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
95183|NCT01458210|230062|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
95184|NCT01458210|230062|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
95185|NCT01458210|230062|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
95186|NCT01458210|230062|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
95187|NCT01458210|230062|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
95188|NCT01458210|230062|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
95189|NCT01458210|230062|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
95190|NCT01458210|230062|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
95191|NCT01458210|230062|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
95192|NCT01458171|230079|P1|NOT COMPLETED|Overall Study||1
95193|NCT01458171|230079|P1|COMPLETED|Overall Study||22
95194|NCT01458171|230079|P1|STARTED|Overall Study||23
95195|NCT01458106|230102|P2|NOT COMPLETED|Overall Study||1
95196|NCT01458106|230103|P1|NOT COMPLETED|Overall Study||3
95197|NCT01458106|230102|P2|COMPLETED|Overall Study||34
95198|NCT01458106|230103|P1|COMPLETED|Overall Study||33
95199|NCT01458106|230102|P2|Non-PK Subgroup|Overall Study||0
95200|NCT01458106|230103|P1|Non-PK Subgroup|Overall Study||11
95201|NCT01458106|230102|P2|PK Subgroup|Overall Study||35
95202|NCT01458106|230103|P1|PK Subgroup|Overall Study||25
95203|NCT01458106|230102|P2|STARTED|Overall Study||35
95204|NCT01458106|230103|P1|STARTED|Overall Study||36
95205|NCT01457950|230180|P4|NOT COMPLETED|Open-Label Phase||2
95206|NCT01457950|230181|P3|NOT COMPLETED|Open-Label Phase||2
95207|NCT01457950|230182|P2|NOT COMPLETED|Open-Label Phase||0
95208|NCT01457950|230183|P1|NOT COMPLETED|Open-Label Phase||0
95209|NCT01457950|230180|P4|COMPLETED|Open-Label Phase||61
95210|NCT01457950|230181|P3|COMPLETED|Open-Label Phase||58
95211|NCT01457950|230182|P2|COMPLETED|Open-Label Phase||0
95212|NCT01457950|230183|P1|COMPLETED|Open-Label Phase||0
95213|NCT01457950|230180|P4|STARTED|Open-Label Phase||63
95214|NCT01457950|230181|P3|STARTED|Open-Label Phase||60
95215|NCT01457950|230182|P2|STARTED|Open-Label Phase||0
95216|NCT01457950|230183|P1|STARTED|Open-Label Phase||0
95217|NCT01457950|230180|P4|NOT COMPLETED|Double-Blind Phase||0
95218|NCT01457950|230181|P3|NOT COMPLETED|Double-Blind Phase||0
95219|NCT01457950|230182|P2|NOT COMPLETED|Double-Blind Phase||3
95220|NCT01457950|230183|P1|NOT COMPLETED|Double-Blind Phase||9
95221|NCT01457950|230180|P4|COMPLETED|Double-Blind Phase||0
95222|NCT01457950|230181|P3|COMPLETED|Double-Blind Phase||0
95223|NCT01457950|230182|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
95224|NCT01457950|230183|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
95225|NCT01457950|230180|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
95226|NCT01457950|230181|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
95227|NCT01457950|230182|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
95228|NCT01457950|230183|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
95229|NCT01457950|230180|P4|STARTED|Double-Blind Phase||0
95230|NCT01457950|230181|P3|STARTED|Double-Blind Phase||0
95231|NCT01457950|230182|P2|STARTED|Double-Blind Phase||66
95232|NCT01457950|230183|P1|STARTED|Double-Blind Phase||69
95233|NCT01457924|230262|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
95234|NCT01457924|230263|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
95235|NCT01457924|230264|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
95236|NCT01457924|230265|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
95237|NCT01457924|230266|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
95238|NCT01457924|230262|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
95239|NCT01457924|230263|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
95240|NCT01457924|230264|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
95241|NCT01457924|230265|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
95242|NCT01457924|230266|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
95243|NCT01457924|230262|P5|STARTED|Individualized FUP (Weeks 48+)||42
95244|NCT01457924|230263|P4|STARTED|Individualized FUP (Weeks 48+)||20
95245|NCT01457924|230264|P3|STARTED|Individualized FUP (Weeks 48+)||16
95246|NCT01457924|230265|P2|STARTED|Individualized FUP (Weeks 48+)||18
95247|NCT01457924|230266|P1|STARTED|Individualized FUP (Weeks 48+)||16
95248|NCT01457924|230262|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
95249|NCT01457924|230263|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
95250|NCT01457924|230264|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
95251|NCT01457924|230265|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
95252|NCT01457924|230266|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
95253|NCT01457924|230262|P5|COMPLETED|FUP (Weeks 24-48)||57
95254|NCT01457924|230263|P4|COMPLETED|FUP (Weeks 24-48)||32
95255|NCT01457924|230264|P3|COMPLETED|FUP (Weeks 24-48)||30
95256|NCT01457924|230265|P2|COMPLETED|FUP (Weeks 24-48)||30
95257|NCT01457924|230266|P1|COMPLETED|FUP (Weeks 24-48)||63
95258|NCT01457924|230262|P5|STARTED|FUP (Weeks 24-48)||59
95259|NCT01457924|230263|P4|STARTED|FUP (Weeks 24-48)||33
95260|NCT01457924|230264|P3|STARTED|FUP (Weeks 24-48)||32
95261|NCT01457924|230265|P2|STARTED|FUP (Weeks 24-48)||31
95262|NCT01457924|230266|P1|STARTED|FUP (Weeks 24-48)||66
95263|NCT01457924|230262|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
95264|NCT01457924|230263|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
95265|NCT01457924|230264|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
95266|NCT01457924|230265|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
95267|NCT01457924|230266|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
95268|NCT01457924|230262|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
95269|NCT01457924|230263|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
95270|NCT01457924|230264|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
95271|NCT01457924|230265|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
95272|NCT01457924|230266|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
95273|NCT01457924|230262|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
95274|NCT01457924|230263|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
95275|NCT01457924|230264|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
95276|NCT01457924|230265|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
95277|NCT01457924|230266|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
95278|NCT01457924|230262|P5|STARTED|Treatment Phase (Weeks 0-24)||64
95279|NCT01457924|230263|P4|STARTED|Treatment Phase (Weeks 0-24)||34
95280|NCT01457924|230264|P3|STARTED|Treatment Phase (Weeks 0-24)||32
95281|NCT01457924|230265|P2|STARTED|Treatment Phase (Weeks 0-24)||34
95282|NCT01457924|230266|P1|STARTED|Treatment Phase (Weeks 0-24)||67
95283|NCT01457885|230328|P1|NOT COMPLETED|Overall Study||0
95284|NCT01457885|230328|P1|COMPLETED|Overall Study||74
95285|NCT01457885|230328|P1|STARTED|Overall Study||74
95286|NCT01457846|230336|P2|NOT COMPLETED|Overall Study||30
95287|NCT01457846|230337|P1|NOT COMPLETED|Overall Study||41
95288|NCT01457846|230336|P2|COMPLETED|Overall Study||0
95289|NCT01457846|230337|P1|COMPLETED|Overall Study||0
95290|NCT01457846|230336|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
95291|NCT01457846|230337|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
95292|NCT01457846|230336|P2|Did Not Receive Treatment|Overall Study||3
95293|NCT01457846|230337|P1|Did Not Receive Treatment|Overall Study||1
95294|NCT01457846|230336|P2|Received Treatment|Overall Study||27
95295|NCT01457846|230337|P1|Received Treatment|Overall Study||40
95296|NCT01457846|230336|P2|STARTED|Overall Study||30
95297|NCT01457846|230337|P1|STARTED|Overall Study||41
95298|NCT01457703|230353|P2|NOT COMPLETED|Overall Study||11
95299|NCT01457703|230354|P1|NOT COMPLETED|Overall Study||6
95300|NCT01457703|230353|P2|COMPLETED|Overall Study||22
95301|NCT01457703|230354|P1|COMPLETED|Overall Study||23
95302|NCT01457703|230353|P2|STARTED|Overall Study||33
95303|NCT01457703|230354|P1|STARTED|Overall Study||29
95304|NCT01457573|230368|P1|NOT COMPLETED|Overall Study||0
95305|NCT01457573|230368|P1|COMPLETED|Overall Study||10
95306|NCT01457573|230368|P1|STARTED|Overall Study||10
95307|NCT01457521|230384|P2|NOT COMPLETED|Overall Study||10
95308|NCT01457521|230385|P1|NOT COMPLETED|Overall Study||12
95309|NCT01457521|230384|P2|COMPLETED|Overall Study||117
95310|NCT01457521|230385|P1|COMPLETED|Overall Study||111
95311|NCT01457521|230384|P2|STARTED|Overall Study||127
95312|NCT01457521|230385|P1|STARTED|Overall Study||123
95313|NCT01457430|230391|P1|NOT COMPLETED|Overall Study||0
95314|NCT01457430|230391|P1|COMPLETED|Overall Study||19
95315|NCT01457430|230391|P1|STARTED|Overall Study||19
95316|NCT01457417|230403|P5|NOT COMPLETED|Overall Study||0
95317|NCT01457417|230404|P4|NOT COMPLETED|Overall Study||0
95318|NCT01457417|230405|P3|NOT COMPLETED|Overall Study||0
95319|NCT01457417|230406|P2|NOT COMPLETED|Overall Study||0
95320|NCT01457417|230407|P1|NOT COMPLETED|Overall Study||0
95321|NCT01457417|230403|P5|COMPLETED|Overall Study||19
95322|NCT01457417|230404|P4|COMPLETED|Overall Study||3
95323|NCT01457417|230405|P3|COMPLETED|Overall Study||4
95324|NCT01457417|230406|P2|COMPLETED|Overall Study||3
95325|NCT01457417|230407|P1|COMPLETED|Overall Study||3
95326|NCT01457417|230403|P5|STARTED|Overall Study||19
95327|NCT01457417|230404|P4|STARTED|Overall Study||3
95328|NCT01457417|230405|P3|STARTED|Overall Study||4
95329|NCT01457417|230406|P2|STARTED|Overall Study||3
95330|NCT01457417|230407|P1|STARTED|Overall Study||3
95331|NCT01457339|230465|P2|NOT COMPLETED|Period 6 (250 mg)||1
95332|NCT01457339|230466|P1|NOT COMPLETED|Period 6 (250 mg)||1
95333|NCT01457339|230465|P2|COMPLETED|Period 6 (250 mg)||21
95334|NCT01457339|230466|P1|COMPLETED|Period 6 (250 mg)||6
95335|NCT01457339|230465|P2|STARTED|Period 6 (250 mg)||22
95336|NCT01457339|230466|P1|STARTED|Period 6 (250 mg)||7
95337|NCT01457339|230465|P2|NOT COMPLETED|Period 5 (200 mg)||1
95338|NCT01457339|230466|P1|NOT COMPLETED|Period 5 (200 mg)||0
95339|NCT01457339|230465|P2|COMPLETED|Period 5 (200 mg)||22
95340|NCT01457339|230466|P1|COMPLETED|Period 5 (200 mg)||7
95341|NCT01457339|230465|P2|STARTED|Period 5 (200 mg)||23
95342|NCT01457339|230466|P1|STARTED|Period 5 (200 mg)||7
95343|NCT01457339|230465|P2|NOT COMPLETED|Period 4 (150 mg)||0
95344|NCT01457339|230466|P1|NOT COMPLETED|Period 4 (150 mg)||0
95345|NCT01457339|230465|P2|COMPLETED|Period 4 (150 mg)||23
95346|NCT01457339|230466|P1|COMPLETED|Period 4 (150 mg)||7
95347|NCT01457339|230465|P2|STARTED|Period 4 (150 mg)||23
95348|NCT01457339|230466|P1|STARTED|Period 4 (150 mg)||7
95349|NCT01457339|230465|P2|NOT COMPLETED|Period 3 (100 mg)||1
95350|NCT01457339|230466|P1|NOT COMPLETED|Period 3 (100 mg)||0
95351|NCT01457339|230465|P2|COMPLETED|Period 3 (100 mg)||23
95352|NCT01457339|230466|P1|COMPLETED|Period 3 (100 mg)||7
95353|NCT01457339|230465|P2|STARTED|Period 3 (100 mg)||24
95354|NCT01457339|230466|P1|STARTED|Period 3 (100 mg)||7
95355|NCT01457339|230465|P2|NOT COMPLETED|Period 2 (70 mg)||0
95356|NCT01457339|230466|P1|NOT COMPLETED|Period 2 (70 mg)||0
95357|NCT01457339|230465|P2|COMPLETED|Period 2 (70 mg)||24
95358|NCT01457339|230466|P1|COMPLETED|Period 2 (70 mg)||7
95359|NCT01457339|230465|P2|STARTED|Period 2 (70 mg)||24
95360|NCT01457339|230466|P1|STARTED|Period 2 (70 mg)||7
95361|NCT01457339|230465|P2|NOT COMPLETED|Period 1 (50 mg)||0
95362|NCT01457339|230466|P1|NOT COMPLETED|Period 1 (50 mg)||0
95363|NCT01457339|230465|P2|COMPLETED|Period 1 (50 mg)||24
95364|NCT01457339|230466|P1|COMPLETED|Period 1 (50 mg)||7
95365|NCT01457339|230465|P2|STARTED|Period 1 (50 mg)||24
95366|NCT01457339|230466|P1|STARTED|Period 1 (50 mg)||7
95367|NCT01457053|230632|P2|NOT COMPLETED|Overall Study||1
95368|NCT01457053|230633|P1|NOT COMPLETED|Overall Study||1
95369|NCT01457053|230632|P2|COMPLETED|Overall Study||1
95370|NCT01457053|230633|P1|COMPLETED|Overall Study||1
95371|NCT01457053|230632|P2|STARTED|Overall Study||2
95372|NCT01457053|230633|P1|STARTED|Overall Study||2
95373|NCT01457014|230639|P4|NOT COMPLETED|Fourth Night||0
95374|NCT01457014|230640|P3|NOT COMPLETED|Fourth Night||0
95375|NCT01457014|230641|P2|NOT COMPLETED|Fourth Night||0
95376|NCT01457014|230642|P1|NOT COMPLETED|Fourth Night||0
95377|NCT01457014|230639|P4|COMPLETED|Fourth Night||11
95378|NCT01457014|230640|P3|COMPLETED|Fourth Night||12
95379|NCT01457014|230641|P2|COMPLETED|Fourth Night||11
95380|NCT01457014|230642|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
95381|NCT01457014|230639|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
95382|NCT01457014|230640|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
95383|NCT01457014|230641|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
95384|NCT01457014|230642|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
95385|NCT01457014|230639|P4|NOT COMPLETED|Third Night||0
95386|NCT01457014|230640|P3|NOT COMPLETED|Third Night||0
95387|NCT01457014|230641|P2|NOT COMPLETED|Third Night||0
95388|NCT01457014|230642|P1|NOT COMPLETED|Third Night||0
95389|NCT01457014|230639|P4|COMPLETED|Third Night||12
95390|NCT01457014|230640|P3|COMPLETED|Third Night||11
95391|NCT01457014|230641|P2|COMPLETED|Third Night||11
95392|NCT01457014|230642|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
95393|NCT01457014|230639|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
95394|NCT01457014|230640|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
95395|NCT01457014|230641|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
95396|NCT01457014|230642|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
95397|NCT01457014|230639|P4|NOT COMPLETED|Second Night||0
95398|NCT01457014|230640|P3|NOT COMPLETED|Second Night||0
95399|NCT01457014|230641|P2|NOT COMPLETED|Second Night||0
95400|NCT01457014|230642|P1|NOT COMPLETED|Second Night||0
95401|NCT01457014|230639|P4|COMPLETED|Second Night||11
95402|NCT01457014|230640|P3|COMPLETED|Second Night||11
95403|NCT01457014|230641|P2|COMPLETED|Second Night||12
95404|NCT01457014|230642|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
95405|NCT01457014|230639|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
95406|NCT01457014|230640|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
95407|NCT01457014|230641|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
95408|NCT01457014|230642|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
95409|NCT01457014|230639|P4|NOT COMPLETED|First Night||0
95410|NCT01457014|230640|P3|NOT COMPLETED|First Night||0
95411|NCT01457014|230641|P2|NOT COMPLETED|First Night||0
95412|NCT01457014|230642|P1|NOT COMPLETED|First Night||40
95413|NCT01457014|230639|P4|COMPLETED|First Night||0
95414|NCT01457014|230640|P3|COMPLETED|First Night||0
95415|NCT01457014|230641|P2|COMPLETED|First Night||0
95416|NCT01457014|230642|P1|COMPLETED|First Night||34
95417|NCT01457014|230639|P4|STARTED|First Night||0
95418|NCT01457014|230640|P3|STARTED|First Night||0
95419|NCT01457014|230641|P2|STARTED|First Night||0
95420|NCT01457014|230642|P1|STARTED|First Night||74
95421|NCT01456962|230659|P2|NOT COMPLETED|Overall Study||1
95422|NCT01456962|230660|P1|NOT COMPLETED|Overall Study||2
95423|NCT01456962|230659|P2|COMPLETED|Overall Study||19
95424|NCT01456962|230660|P1|COMPLETED|Overall Study||14
95425|NCT01456962|230659|P2|STARTED|Overall Study||20
95426|NCT01456962|230660|P1|STARTED|Overall Study||16
95427|NCT01456936|230670|P4|NOT COMPLETED|Overall Study||483
95428|NCT01456936|230671|P3|NOT COMPLETED|Overall Study||481
95429|NCT01456936|230672|P2|NOT COMPLETED|Overall Study||448
95430|NCT01456936|230673|P1|NOT COMPLETED|Overall Study||439
95431|NCT01456936|230670|P4|COMPLETED|Overall Study||1552
95432|NCT01456936|230671|P3|COMPLETED|Overall Study||1557
95433|NCT01456936|230672|P2|COMPLETED|Overall Study||1586
95434|NCT01456936|230673|P1|COMPLETED|Overall Study||1598
95435|NCT01456936|230670|P4|Randomized and Treated|Overall Study||2014
95436|NCT01456936|230671|P3|Randomized and Treated|Overall Study||2022
95437|NCT01456936|230672|P2|Randomized and Treated|Overall Study||2006
95438|NCT01456936|230673|P1|Randomized and Treated|Overall Study||2016
95439|NCT01456936|230670|P4|STARTED|Overall Study||2035
95440|NCT01456936|230671|P3|STARTED|Overall Study||2038
95441|NCT01456936|230672|P2|STARTED|Overall Study||2034
95442|NCT01456936|230673|P1|STARTED|Overall Study||2037
95443|NCT01456780|230782|P3|NOT COMPLETED|Overall Study||0
95444|NCT01456780|230783|P2|NOT COMPLETED|Overall Study||3
95445|NCT01456780|230784|P1|NOT COMPLETED|Overall Study||3
95446|NCT01456780|230782|P3|COMPLETED|Overall Study||20
95447|NCT01456780|230783|P2|COMPLETED|Overall Study||17
95448|NCT01456780|230784|P1|COMPLETED|Overall Study||17
95449|NCT01456780|230782|P3|STARTED|Overall Study||20
95450|NCT01456780|230783|P2|STARTED|Overall Study||20
95451|NCT01456780|230784|P1|STARTED|Overall Study||20
95452|NCT01456299|230804|P3|NOT COMPLETED|Overall Study||1
95453|NCT01456299|230805|P2|NOT COMPLETED|Overall Study||1
95454|NCT01456299|230806|P1|NOT COMPLETED|Overall Study||0
95455|NCT01456299|230804|P3|COMPLETED|Overall Study||33
95456|NCT01456299|230805|P2|COMPLETED|Overall Study||33
95457|NCT01456299|230806|P1|COMPLETED|Overall Study||34
95458|NCT01456299|230804|P3|STARTED|Overall Study||34
95459|NCT01456299|230805|P2|STARTED|Overall Study||34
95460|NCT01456299|230806|P1|STARTED|Overall Study||34
95461|NCT01456195|230817|P3|NOT COMPLETED|Overall Study||14
95462|NCT01456195|230818|P2|NOT COMPLETED|Overall Study||10
95463|NCT01456195|230819|P1|NOT COMPLETED|Overall Study||11
95464|NCT01456195|230817|P3|COMPLETED|Overall Study||127
95465|NCT01456195|230818|P2|COMPLETED|Overall Study||127
95466|NCT01456195|230819|P1|COMPLETED|Overall Study||132
95467|NCT01456195|230817|P3|STARTED|Overall Study||141
95468|NCT01456195|230818|P2|STARTED|Overall Study||137
95469|NCT01456195|230819|P1|STARTED|Overall Study||143
95470|NCT01456169|230839|P3|NOT COMPLETED|Overall Study||12
95471|NCT01456169|230840|P2|NOT COMPLETED|Overall Study||5
95472|NCT01456169|230841|P1|NOT COMPLETED|Overall Study||10
95473|NCT01456169|230839|P3|COMPLETED|Overall Study||123
95474|NCT01456169|230840|P2|COMPLETED|Overall Study||122
95475|NCT01456169|230841|P1|COMPLETED|Overall Study||123
95476|NCT01456169|230839|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
95477|NCT01456169|230840|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
95478|NCT01456169|230841|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
95479|NCT01456143|230892|P1|NOT COMPLETED|Overall Study||0
95480|NCT01456143|230892|P1|COMPLETED|Overall Study||33
95481|NCT01456143|230892|P1|STARTED|Overall Study||33
95482|NCT01456130|230901|P1|NOT COMPLETED|Overall Study||10
95483|NCT01456130|230901|P1|COMPLETED|Overall Study||57
95484|NCT01456130|230901|P1|STARTED|Overall Study||67
95485|NCT01456052|230911|P3|NOT COMPLETED|Overall Study||5
95486|NCT01456052|230912|P2|NOT COMPLETED|Overall Study||5
95487|NCT01456052|230913|P1|NOT COMPLETED|Overall Study||2
95488|NCT01456052|230911|P3|COMPLETED|Overall Study||19
95489|NCT01456052|230912|P2|COMPLETED|Overall Study||20
95490|NCT01456052|230913|P1|COMPLETED|Overall Study||8
95491|NCT01456052|230911|P3|STARTED|Overall Study||24
95492|NCT01456052|230912|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
95493|NCT01456052|230913|P1|STARTED|Overall Study||10
95494|NCT01456039|230933|P3|NOT COMPLETED|Phase 2 (Second Step)||33
95495|NCT01456039|230934|P2|NOT COMPLETED|Phase 2 (Second Step)||0
95496|NCT01456039|230935|P1|NOT COMPLETED|Phase 2 (Second Step)||0
95497|NCT01456039|230933|P3|COMPLETED|Phase 2 (Second Step)||7
95498|NCT01456039|230934|P2|COMPLETED|Phase 2 (Second Step)||0
95499|NCT01456039|230935|P1|COMPLETED|Phase 2 (Second Step)||0
95500|NCT01456039|230933|P3|STARTED|Phase 2 (Second Step)||40
95501|NCT01456039|230934|P2|STARTED|Phase 2 (Second Step)||0
95502|NCT01456039|230935|P1|STARTED|Phase 2 (Second Step)||0
95503|NCT01456039|230933|P3|NOT COMPLETED|Phase 1 (First Step)||0
95504|NCT01456039|230934|P2|NOT COMPLETED|Phase 1 (First Step)||7
95505|NCT01456039|230935|P1|NOT COMPLETED|Phase 1 (First Step)||2
95506|NCT01456039|230933|P3|COMPLETED|Phase 1 (First Step)||0
95507|NCT01456039|230934|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
95508|NCT01456039|230935|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
95509|NCT01456039|230933|P3|STARTED|Phase 1 (First Step)||0
95510|NCT01456039|230934|P2|STARTED|Phase 1 (First Step)||8
95511|NCT01456039|230935|P1|STARTED|Phase 1 (First Step)||3
95512|NCT01456000|231007|P2|NOT COMPLETED|Overall Study||3
95513|NCT01456000|231008|P1|NOT COMPLETED|Overall Study||8
95514|NCT01456000|231007|P2|COMPLETED|Overall Study||172
95515|NCT01456000|231008|P1|COMPLETED|Overall Study||170
95516|NCT01456000|231007|P2|STARTED|Overall Study||175
95517|NCT01456000|231008|P1|STARTED|Overall Study||178
95518|NCT01455545|231014|P2|NOT COMPLETED|Overall Study||0
95519|NCT01455545|231015|P1|NOT COMPLETED|Overall Study||0
95520|NCT01455545|231014|P2|COMPLETED|Overall Study||45
95521|NCT01455545|231015|P1|COMPLETED|Overall Study||55
95522|NCT01455545|231014|P2|STARTED|Overall Study||45
95523|NCT01455545|231015|P1|STARTED|Overall Study||55
95524|NCT01455519|231045|P2|NOT COMPLETED|Overall Study||5
95525|NCT01455519|231046|P1|NOT COMPLETED|Overall Study||4
95526|NCT01455519|231045|P2|COMPLETED|Overall Study||18
95527|NCT01455519|231046|P1|COMPLETED|Overall Study||8
95528|NCT01455519|231045|P2|STARTED|Overall Study||23
95529|NCT01455519|231046|P1|STARTED|Overall Study||12
95530|NCT01455428|231078|P2|NOT COMPLETED|Overall Study||18
95531|NCT01455428|231079|P1|NOT COMPLETED|Overall Study||14
95532|NCT01455428|231078|P2|COMPLETED|Overall Study||92
95533|NCT01455428|231079|P1|COMPLETED|Overall Study||98
95534|NCT01455428|231078|P2|Treated|Overall Study||109
95535|NCT01455428|231079|P1|Treated|Overall Study||111
95536|NCT01455428|231078|P2|STARTED|Overall Study||110
95537|NCT01455428|231079|P1|STARTED|Overall Study||112
95538|NCT01455415|231135|P2|NOT COMPLETED|Follow-up||2
95539|NCT01455415|231136|P1|NOT COMPLETED|Follow-up||3
95540|NCT01455415|231135|P2|COMPLETED|Follow-up||104
95541|NCT01455415|231136|P1|COMPLETED|Follow-up||111
95542|NCT01455415|231135|P2|STARTED|Follow-up||106
95543|NCT01455415|231136|P1|STARTED|Follow-up||114
95544|NCT01455415|231135|P2|NOT COMPLETED|Period 2||10
95545|NCT01455415|231136|P1|NOT COMPLETED|Period 2||13
95546|NCT01455415|231135|P2|COMPLETED|Period 2||106
95547|NCT01455415|231136|P1|COMPLETED|Period 2||114
95548|NCT01455415|231135|P2|STARTED|Period 2||116
95549|NCT01455415|231136|P1|STARTED|Period 2||127
95550|NCT01455415|231135|P2|NOT COMPLETED|Washout||7
95551|NCT01455415|231136|P1|NOT COMPLETED|Washout||8
95552|NCT01455415|231135|P2|COMPLETED|Washout||116
95553|NCT01455415|231136|P1|COMPLETED|Washout||127
95554|NCT01455415|231135|P2|STARTED|Washout||123
95555|NCT01455415|231136|P1|STARTED|Washout||135
95556|NCT01455415|231135|P2|NOT COMPLETED|Period 1||24
95557|NCT01455415|231136|P1|NOT COMPLETED|Period 1||19
95558|NCT01455415|231135|P2|COMPLETED|Period 1||123
95559|NCT01455415|231136|P1|COMPLETED|Period 1||135
95560|NCT01455415|231135|P2|STARTED|Period 1|Started=Treated|147
95561|NCT01455415|231136|P1|STARTED|Period 1|Started=Treated|154
95562|NCT01455220|231186|P1|NOT COMPLETED|Overall Study||30
95563|NCT01455220|231186|P1|COMPLETED|Overall Study||15
95564|NCT01455220|231186|P1|STARTED|Overall Study||45
95565|NCT01455194|231196|P4|NOT COMPLETED|Overall Study||28
95566|NCT01455194|231197|P3|NOT COMPLETED|Overall Study||30
95567|NCT01455194|231198|P2|NOT COMPLETED|Overall Study||31
95568|NCT01455194|231199|P1|NOT COMPLETED|Overall Study||153
95569|NCT01455194|231196|P4|COMPLETED|Overall Study||97
95570|NCT01455194|231197|P3|COMPLETED|Overall Study||92
95571|NCT01455194|231198|P2|COMPLETED|Overall Study||89
95572|NCT01455194|231199|P1|COMPLETED|Overall Study||0
95573|NCT01455194|231196|P4|STARTED|Overall Study||125
95574|NCT01455194|231197|P3|STARTED|Overall Study||122
95575|NCT01455194|231198|P2|STARTED|Overall Study||120
95576|NCT01455194|231199|P1|STARTED|Overall Study||153
95577|NCT01455181|231248|P1|NOT COMPLETED|Overall Study||0
95578|NCT01455181|231248|P1|COMPLETED|Overall Study||24
95579|NCT01455181|231248|P1|STARTED|Overall Study||24
95580|NCT01455064|231256|P1|NOT COMPLETED|Overall Study||1
95581|NCT01455064|231256|P1|COMPLETED|Overall Study||30
95582|NCT01455064|231256|P1|STARTED|Overall Study||31
95583|NCT01455012|231262|P2|NOT COMPLETED|Overall Study||4
95584|NCT01455012|231263|P1|NOT COMPLETED|Overall Study||11
95585|NCT01455012|231262|P2|COMPLETED|Overall Study||36
95586|NCT01455012|231263|P1|COMPLETED|Overall Study||30
95587|NCT01455012|231262|P2|STARTED|Overall Study||40
95588|NCT01455012|231263|P1|STARTED|Overall Study||41
95589|NCT01454947|231303|P8|NOT COMPLETED|Overall Study||5
95590|NCT01454947|231304|P7|NOT COMPLETED|Overall Study||1
95591|NCT01454947|231305|P6|NOT COMPLETED|Overall Study||3
95592|NCT01454947|231306|P5|NOT COMPLETED|Overall Study||1
95593|NCT01454947|231307|P4|NOT COMPLETED|Overall Study||1
95594|NCT01454947|231308|P3|NOT COMPLETED|Overall Study||3
95595|NCT01454947|231309|P2|NOT COMPLETED|Overall Study||4
95596|NCT01454947|231310|P1|NOT COMPLETED|Overall Study||3
95597|NCT01454947|231303|P8|COMPLETED|Overall Study||23
95598|NCT01454947|231304|P7|COMPLETED|Overall Study||26
95599|NCT01454947|231305|P6|COMPLETED|Overall Study||32
95600|NCT01454947|231306|P5|COMPLETED|Overall Study||33
95601|NCT01454947|231307|P4|COMPLETED|Overall Study||19
95602|NCT01454947|231308|P3|COMPLETED|Overall Study||32
95603|NCT01454947|231309|P2|COMPLETED|Overall Study||38
95604|NCT01454947|231310|P1|COMPLETED|Overall Study||24
95605|NCT01454947|231303|P8|STARTED|Overall Study||28
95606|NCT01454947|231304|P7|STARTED|Overall Study||27
95607|NCT01454947|231305|P6|STARTED|Overall Study||35
95608|NCT01454947|231306|P5|STARTED|Overall Study||34
95609|NCT01454947|231307|P4|STARTED|Overall Study||20
95610|NCT01454947|231308|P3|STARTED|Overall Study||35
95611|NCT01454947|231309|P2|STARTED|Overall Study||42
95612|NCT01454947|231310|P1|STARTED|Overall Study||27
95613|NCT01454934|231330|P2|NOT COMPLETED|Overall Study||270
95614|NCT01454934|231331|P1|NOT COMPLETED|Overall Study||270
95615|NCT01454934|231330|P2|COMPLETED|Overall Study||0
95616|NCT01454934|231331|P1|COMPLETED|Overall Study||0
95617|NCT01454934|231330|P2|STARTED|Overall Study||270
95618|NCT01454934|231331|P1|STARTED|Overall Study||270
95619|NCT01454830|231343|P2|NOT COMPLETED|Overall Study||27
95620|NCT01454830|231344|P1|NOT COMPLETED|Overall Study||31
95621|NCT01454830|231343|P2|COMPLETED|Overall Study||30
95622|NCT01454830|231344|P1|COMPLETED|Overall Study||30
95623|NCT01454830|231343|P2|STARTED|Overall Study||57
95624|NCT01454830|231344|P1|STARTED|Overall Study||61
95625|NCT01454791|231364|P2|NOT COMPLETED|Overall Study||0
95626|NCT01454791|231365|P1|NOT COMPLETED|Overall Study||0
95627|NCT01454791|231364|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
95628|NCT01454791|231365|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
95629|NCT01454791|231364|P2|STARTED|Overall Study||20
95630|NCT01454791|231365|P1|STARTED|Overall Study||20
95631|NCT01454778|231375|P1|NOT COMPLETED|Overall Study||3
95632|NCT01454778|231375|P1|COMPLETED|Overall Study||47
95633|NCT01454778|231375|P1|STARTED|Overall Study||50
95634|NCT01454726|231386|P2|NOT COMPLETED|Overall Study||1
95635|NCT01454726|231387|P1|NOT COMPLETED|Overall Study||0
95636|NCT01454726|231386|P2|COMPLETED|Overall Study||10
95637|NCT01454726|231387|P1|COMPLETED|Overall Study||16
95638|NCT01454726|231386|P2|STARTED|Overall Study||11
95639|NCT01454726|231387|P1|STARTED|Overall Study||16
95640|NCT01454583|231396|P3|NOT COMPLETED|3rd Year||297
95641|NCT01454583|231397|P2|NOT COMPLETED|3rd Year||512
95642|NCT01454583|231398|P1|NOT COMPLETED|3rd Year||1959
95643|NCT01454583|231396|P3|COMPLETED|3rd Year||285
95644|NCT01454583|231397|P2|COMPLETED|3rd Year||470
95645|NCT01454583|231398|P1|COMPLETED|3rd Year||1832
95646|NCT01454583|231396|P3|STARTED|3rd Year||582
95647|NCT01454583|231397|P2|STARTED|3rd Year||982
95648|NCT01454583|231398|P1|STARTED|3rd Year||3791
95649|NCT01454583|231396|P3|NOT COMPLETED|2nd Year||737
95650|NCT01454583|231397|P2|NOT COMPLETED|2nd Year||1049
95651|NCT01454583|231398|P1|NOT COMPLETED|2nd Year||3965
95652|NCT01454583|231396|P3|COMPLETED|2nd Year||1376
95653|NCT01454583|231397|P2|COMPLETED|2nd Year||1647
95654|NCT01454583|231398|P1|COMPLETED|2nd Year||6212
95655|NCT01454583|231396|P3|STARTED|2nd Year||2113
95656|NCT01454583|231397|P2|STARTED|2nd Year||2696
95657|NCT01454583|231398|P1|STARTED|2nd Year||10177
95658|NCT01454583|231396|P3|NOT COMPLETED|1st Year||180
95659|NCT01454583|231397|P2|NOT COMPLETED|1st Year||318
95660|NCT01454583|231398|P1|NOT COMPLETED|1st Year||1057
95661|NCT01454583|231396|P3|COMPLETED|1st Year||1933
95662|NCT01454583|231397|P2|COMPLETED|1st Year||2378
95663|NCT01454583|231398|P1|COMPLETED|1st Year||9120
95664|NCT01454583|231396|P3|STARTED|1st Year||2113
95665|NCT01454583|231397|P2|STARTED|1st Year||2696
95666|NCT01454583|231398|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
95667|NCT01454531|231466|P1|NOT COMPLETED|Overall Study||23
95668|NCT01454531|231466|P1|COMPLETED|Overall Study||173
95669|NCT01454531|231466|P1|Subjects Treated|Overall Study||192
95670|NCT01454531|231466|P1|STARTED|Overall Study||196
95671|NCT01454505|231478|P4|NOT COMPLETED|Overall Study||0
95672|NCT01454505|231479|P3|NOT COMPLETED|Overall Study||0
95673|NCT01454505|231480|P2|NOT COMPLETED|Overall Study||0
95674|NCT01454505|231481|P1|NOT COMPLETED|Overall Study||0
95675|NCT01454505|231478|P4|COMPLETED|Overall Study||20
95676|NCT01454505|231479|P3|COMPLETED|Overall Study||40
95677|NCT01454505|231480|P2|COMPLETED|Overall Study||15
95678|NCT01454505|231481|P1|COMPLETED|Overall Study||35
95679|NCT01454505|231478|P4|STARTED|Overall Study||20
95680|NCT01454505|231479|P3|STARTED|Overall Study||40
95681|NCT01454505|231480|P2|STARTED|Overall Study||15
95682|NCT01454505|231481|P1|STARTED|Overall Study||35
95683|NCT01454414|231495|P2|NOT COMPLETED|Overall Study||16
95684|NCT01454414|231496|P1|NOT COMPLETED|Overall Study||13
95685|NCT01454414|231495|P2|COMPLETED|Overall Study||64
95686|NCT01454414|231496|P1|COMPLETED|Overall Study||66
95687|NCT01454414|231495|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
95688|NCT01454414|231496|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
95689|NCT01454414|231495|P2|STARTED|Overall Study||80
95690|NCT01454414|231496|P1|STARTED|Overall Study||79
95691|NCT01454401|231502|P1|NOT COMPLETED|Overall Study||5
95692|NCT01454401|231502|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
95693|NCT01454401|231502|P1|STARTED|Overall Study|ITT|44
95694|NCT01454284|231509|P2|NOT COMPLETED|Overall Study||73
95695|NCT01454284|231510|P1|NOT COMPLETED|Overall Study||116
95696|NCT01454284|231509|P2|COMPLETED|Overall Study||377
95697|NCT01454284|231510|P1|COMPLETED|Overall Study||548
95698|NCT01454284|231509|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
95699|NCT01454284|231510|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
95700|NCT01454284|231509|P2|STARTED|Overall Study||450
95701|NCT01454284|231510|P1|STARTED|Overall Study||664
95702|NCT01454258|231558|P1|NOT COMPLETED|Overall Study||997
95703|NCT01454258|231558|P1|COMPLETED|Overall Study||9103
95704|NCT01454258|231558|P1|STARTED|Overall Study||10100
95705|NCT01454076|231569|P5|NOT COMPLETED|Overall Study||6
95706|NCT01454076|231570|P4|NOT COMPLETED|Overall Study||2
95707|NCT01454076|231571|P3|NOT COMPLETED|Overall Study||9
95708|NCT01454076|231572|P2|NOT COMPLETED|Overall Study||6
95709|NCT01454076|231573|P1|NOT COMPLETED|Overall Study||13
95710|NCT01454076|231569|P5|COMPLETED|Overall Study||15
95711|NCT01454076|231570|P4|COMPLETED|Overall Study||16
95712|NCT01454076|231571|P3|COMPLETED|Overall Study||15
95713|NCT01454076|231572|P2|COMPLETED|Overall Study||14
95714|NCT01454076|231573|P1|COMPLETED|Overall Study||16
95715|NCT01454076|231569|P5|STARTED|Overall Study||21
95716|NCT01454076|231570|P4|STARTED|Overall Study||18
95717|NCT01454076|231571|P3|STARTED|Overall Study||24
95718|NCT01454076|231572|P2|STARTED|Overall Study||20
95719|NCT01454076|231573|P1|STARTED|Overall Study||29
95720|NCT01454063|231626|P2|NOT COMPLETED|Treated||0
95721|NCT01454063|231627|P1|NOT COMPLETED|Treated||2
95722|NCT01454063|231626|P2|COMPLETED|Treated||201
95723|NCT01454063|231627|P1|COMPLETED|Treated||199
95724|NCT01454063|231626|P2|STARTED|Treated||201
95725|NCT01454063|231627|P1|STARTED|Treated||201
95726|NCT01454063|231626|P2|NOT COMPLETED|Randomized||2
95727|NCT01454063|231627|P1|NOT COMPLETED|Randomized||1
95728|NCT01454063|231626|P2|COMPLETED|Randomized||201
95729|NCT01454063|231627|P1|COMPLETED|Randomized||201
95730|NCT01454063|231626|P2|STARTED|Randomized||203
95731|NCT01454063|231627|P1|STARTED|Randomized||202
95732|NCT01453998|231648|P3|NOT COMPLETED|After Protocol Amendment 2.||0
95733|NCT01453998|231649|P2|NOT COMPLETED|After Protocol Amendment 2.||0
95734|NCT01453998|231650|P1|NOT COMPLETED|After Protocol Amendment 2.||1
95735|NCT01453998|231648|P3|COMPLETED|After Protocol Amendment 2.||183
95736|NCT01453998|231649|P2|COMPLETED|After Protocol Amendment 2.||99
95737|NCT01453998|231650|P1|COMPLETED|After Protocol Amendment 2.||102
95738|NCT01453998|231648|P3|STARTED|After Protocol Amendment 2.||183
95739|NCT01453998|231649|P2|STARTED|After Protocol Amendment 2.||99
95740|NCT01453998|231650|P1|STARTED|After Protocol Amendment 2.||103
95741|NCT01453998|231648|P3|NOT COMPLETED|Before Protocol Amendment 2||0
95742|NCT01453998|231649|P2|NOT COMPLETED|Before Protocol Amendment 2||0
95743|NCT01453998|231650|P1|NOT COMPLETED|Before Protocol Amendment 2||0
95744|NCT01453998|231648|P3|COMPLETED|Before Protocol Amendment 2||99
95745|NCT01453998|231649|P2|COMPLETED|Before Protocol Amendment 2||88
95746|NCT01453998|231650|P1|COMPLETED|Before Protocol Amendment 2||85
95747|NCT01453998|231648|P3|STARTED|Before Protocol Amendment 2||99
95748|NCT01453998|231649|P2|STARTED|Before Protocol Amendment 2||88
95749|NCT01453998|231650|P1|STARTED|Before Protocol Amendment 2||85
95750|NCT01453946|231715|P1|NOT COMPLETED|Overall Study||9
95751|NCT01453946|231715|P1|COMPLETED|Overall Study||41
95752|NCT01453946|231715|P1|STARTED|Overall Study||50
95753|NCT01453894|231723|P2|NOT COMPLETED|Overall Study||0
95754|NCT01453894|231724|P1|NOT COMPLETED|Overall Study||0
95755|NCT01453894|231723|P2|COMPLETED|Overall Study||225
95756|NCT01453894|231724|P1|COMPLETED|Overall Study||225
95757|NCT01453894|231723|P2|STARTED|Overall Study||225
95758|NCT01453894|231724|P1|STARTED|Overall Study||225
95759|NCT01453855|231732|P2|NOT COMPLETED|Overall Study||14
95760|NCT01453855|231733|P1|NOT COMPLETED|Overall Study||10
95761|NCT01453855|231732|P2|COMPLETED|Overall Study||408
95762|NCT01453855|231733|P1|COMPLETED|Overall Study||432
95763|NCT01453855|231732|P2|STARTED|Overall Study||422
95764|NCT01453855|231733|P1|STARTED|Overall Study||442
95765|NCT01453725|231741|P2|NOT COMPLETED|Overall Study||11
95766|NCT01453725|231742|P1|NOT COMPLETED|Overall Study||13
95767|NCT01453725|231741|P2|COMPLETED|Overall Study||89
95768|NCT01453725|231742|P1|COMPLETED|Overall Study||85
95769|NCT01453725|231741|P2|STARTED|Overall Study||100
95770|NCT01453725|231742|P1|STARTED|Overall Study||98
95771|NCT01453595|231765|P3|NOT COMPLETED|Overall Study||2
95772|NCT01453595|231766|P2|NOT COMPLETED|Overall Study||1
95773|NCT01453595|231767|P1|NOT COMPLETED|Overall Study||2
95774|NCT01453595|231765|P3|COMPLETED|Overall Study||0
95775|NCT01453595|231766|P2|COMPLETED|Overall Study||5
95776|NCT01453595|231767|P1|COMPLETED|Overall Study||0
95777|NCT01453595|231765|P3|STARTED|Overall Study||2
95778|NCT01453595|231766|P2|STARTED|Overall Study||6
95779|NCT01453595|231767|P1|STARTED|Overall Study||2
95780|NCT01453569|231776|P3|NOT COMPLETED|Overall Study||7
95781|NCT01453569|231777|P2|NOT COMPLETED|Overall Study||14
95782|NCT01453569|231778|P1|NOT COMPLETED|Overall Study||11
95783|NCT01453569|231776|P3|COMPLETED|Overall Study||78
95784|NCT01453569|231777|P2|COMPLETED|Overall Study||70
95785|NCT01453569|231778|P1|COMPLETED|Overall Study||75
95786|NCT01453569|231776|P3|STARTED|Overall Study||85
95787|NCT01453569|231777|P2|STARTED|Overall Study||84
95788|NCT01453569|231778|P1|STARTED|Overall Study||86
95789|NCT01453413|231795|P1|NOT COMPLETED|Overall Study||0
95790|NCT01453413|231795|P1|COMPLETED|Overall Study||297
95791|NCT01453413|231795|P1|STARTED|Overall Study||297
95792|NCT01453387|231802|P2|NOT COMPLETED|Overall Study||0
95793|NCT01453387|231803|P1|NOT COMPLETED|Overall Study||0
95794|NCT01453387|231802|P2|COMPLETED|Overall Study||7
95795|NCT01453387|231803|P1|COMPLETED|Overall Study||21
95796|NCT01453387|231802|P2|STARTED|Overall Study||7
95797|NCT01453387|231803|P1|STARTED|Overall Study||21
95798|NCT01453374|231886|P1|NOT COMPLETED|Overall Study||18
95799|NCT01453374|231886|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
95800|NCT01453374|231886|P1|STARTED|Overall Study||27
95801|NCT01453361|231902|P1|NOT COMPLETED|Overall Study||16
95802|NCT01453361|231902|P1|COMPLETED|Overall Study||2
95803|NCT01453361|231902|P1|STARTED|Overall Study||18
95804|NCT01453348|231910|P3|NOT COMPLETED|Overall Study||1
95805|NCT01453348|231911|P2|NOT COMPLETED|Overall Study||1
95806|NCT01453348|231912|P1|NOT COMPLETED|Overall Study||1
95807|NCT01453348|231910|P3|COMPLETED|Overall Study||83
95808|NCT01453348|231911|P2|COMPLETED|Overall Study||83
95809|NCT01453348|231912|P1|COMPLETED|Overall Study||83
95810|NCT01453348|231910|P3|STARTED|Overall Study||84
95811|NCT01453348|231911|P2|STARTED|Overall Study||84
95812|NCT01453348|231912|P1|STARTED|Overall Study||84
95813|NCT01453296|231928|P2|NOT COMPLETED|Treatment Period 2||0
95814|NCT01453296|231929|P1|NOT COMPLETED|Treatment Period 2||2
95815|NCT01453296|231928|P2|COMPLETED|Treatment Period 2||13
95816|NCT01453296|231929|P1|COMPLETED|Treatment Period 2||11
95817|NCT01453296|231928|P2|STARTED|Treatment Period 2||13
95818|NCT01453296|231929|P1|STARTED|Treatment Period 2||13
95819|NCT01453296|231928|P2|NOT COMPLETED|Washout Period||0
95820|NCT01453296|231929|P1|NOT COMPLETED|Washout Period||0
95821|NCT01453296|231928|P2|COMPLETED|Washout Period||13
95822|NCT01453296|231929|P1|COMPLETED|Washout Period||13
95823|NCT01453296|231928|P2|STARTED|Washout Period||13
95824|NCT01453296|231929|P1|STARTED|Washout Period||13
95825|NCT01453296|231928|P2|NOT COMPLETED|Treatment Period 1||1
95826|NCT01453296|231929|P1|NOT COMPLETED|Treatment Period 1||1
95827|NCT01453296|231928|P2|COMPLETED|Treatment Period 1||13
95828|NCT01453296|231929|P1|COMPLETED|Treatment Period 1||13
95829|NCT01453296|231928|P2|STARTED|Treatment Period 1||14
95830|NCT01453296|231929|P1|STARTED|Treatment Period 1||14
95831|NCT01453205|231996|P3|NOT COMPLETED|Overall Study||54
95832|NCT01453205|231997|P2|NOT COMPLETED|Overall Study||52
95833|NCT01453205|231998|P1|NOT COMPLETED|Overall Study||80
95834|NCT01453205|231996|P3|COMPLETED|Overall Study||1
95835|NCT01453205|231997|P2|COMPLETED|Overall Study||0
95836|NCT01453205|231998|P1|COMPLETED|Overall Study||0
95837|NCT01453205|231996|P3|STARTED|Overall Study||55
95838|NCT01453205|231997|P2|STARTED|Overall Study||52
95839|NCT01453205|231998|P1|STARTED|Overall Study||80
95840|NCT01453166|232049|P3|NOT COMPLETED|Overall Study||1
95841|NCT01453166|232050|P2|NOT COMPLETED|Overall Study||2
95842|NCT01453166|232051|P1|NOT COMPLETED|Overall Study||2
95843|NCT01453166|232049|P3|COMPLETED|Overall Study||38
95844|NCT01453166|232050|P2|COMPLETED|Overall Study||39
95845|NCT01453166|232051|P1|COMPLETED|Overall Study||40
95846|NCT01453166|232049|P3|STARTED|Overall Study||39
95847|NCT01453166|232050|P2|STARTED|Overall Study||41
95848|NCT01453166|232051|P1|STARTED|Overall Study||42
95849|NCT01453075|232073|P2|NOT COMPLETED|Overall Study||1
95850|NCT01453075|232074|P1|NOT COMPLETED|Overall Study||5
95851|NCT01453075|232073|P2|COMPLETED|Overall Study||14
95852|NCT01453075|232074|P1|COMPLETED|Overall Study||11
95853|NCT01453075|232073|P2|STARTED|Overall Study||15
95854|NCT01453075|232074|P1|STARTED|Overall Study||16
95855|NCT01453049|232082|P2|NOT COMPLETED|Overall Study||42
95856|NCT01453049|232083|P1|NOT COMPLETED|Overall Study||41
95857|NCT01453049|232082|P2|COMPLETED|Overall Study||2
95858|NCT01453049|232083|P1|COMPLETED|Overall Study||1
95859|NCT01453049|232082|P2|STARTED|Overall Study||44
95860|NCT01453049|232083|P1|STARTED|Overall Study||42
95861|NCT01453036|232156|P3|NOT COMPLETED|Overall Study||31
95862|NCT01453036|232157|P2|NOT COMPLETED|Overall Study||115
95863|NCT01453036|232158|P1|NOT COMPLETED|Overall Study||26
95864|NCT01453036|232156|P3|COMPLETED|Overall Study||277
95865|NCT01453036|232157|P2|COMPLETED|Overall Study||193
95866|NCT01453036|232158|P1|COMPLETED|Overall Study||282
95867|NCT01453036|232156|P3|STARTED|Overall Study||308
95868|NCT01453036|232157|P2|STARTED|Overall Study||308
95869|NCT01453036|232158|P1|STARTED|Overall Study||308
95870|NCT01453023|232166|P2|NOT COMPLETED|Treatment Period 2||1
95871|NCT01453023|232167|P1|NOT COMPLETED|Treatment Period 2||0
95872|NCT01453023|232166|P2|COMPLETED|Treatment Period 2||11
95873|NCT01453023|232167|P1|COMPLETED|Treatment Period 2||12
95874|NCT01453023|232166|P2|STARTED|Treatment Period 2||12
95875|NCT01453023|232167|P1|STARTED|Treatment Period 2||12
95876|NCT01453023|232166|P2|NOT COMPLETED|Washout Period||0
95877|NCT01453023|232167|P1|NOT COMPLETED|Washout Period||0
95878|NCT01453023|232166|P2|COMPLETED|Washout Period||12
95879|NCT01453023|232167|P1|COMPLETED|Washout Period||12
95880|NCT01453023|232166|P2|STARTED|Washout Period||12
95881|NCT01453023|232167|P1|STARTED|Washout Period||12
95882|NCT01453023|232166|P2|NOT COMPLETED|Treatment Period (TP) 1||1
95883|NCT01453023|232167|P1|NOT COMPLETED|Treatment Period (TP) 1||1
95884|NCT01453023|232166|P2|COMPLETED|Treatment Period (TP) 1||12
95885|NCT01453023|232167|P1|COMPLETED|Treatment Period (TP) 1||12
95886|NCT01453023|232166|P2|STARTED|Treatment Period (TP) 1||13
95887|NCT01453023|232167|P1|STARTED|Treatment Period (TP) 1||13
95888|NCT01452854|232235|P1|NOT COMPLETED|Overall Study||0
95889|NCT01452854|232235|P1|COMPLETED|Overall Study||2
95890|NCT01452854|232235|P1|STARTED|Overall Study||2
95891|NCT01452529|232241|P3|NOT COMPLETED|Double-blind (DB) Period||82
95892|NCT01452529|232242|P2|NOT COMPLETED|Double-blind (DB) Period||67
95893|NCT01452529|232243|P1|NOT COMPLETED|Double-blind (DB) Period||0
95894|NCT01452529|232241|P3|COMPLETED|Double-blind (DB) Period||210
95895|NCT01452529|232242|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
95896|NCT01452529|232243|P1|COMPLETED|Double-blind (DB) Period||0
95897|NCT01452529|232241|P3|STARTED|Double-blind (DB) Period||292
95898|NCT01452529|232242|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
95899|NCT01452529|232243|P1|STARTED|Double-blind (DB) Period||0
95900|NCT01452529|232241|P3|NOT COMPLETED|Run-in Period||0
95901|NCT01452529|232242|P2|NOT COMPLETED|Run-in Period||0
95902|NCT01452529|232243|P1|NOT COMPLETED|Run-in Period||313
95903|NCT01452529|232241|P3|COMPLETED|Run-in Period||0
95904|NCT01452529|232242|P2|COMPLETED|Run-in Period||0
95905|NCT01452529|232243|P1|COMPLETED|Run-in Period||592
95906|NCT01452529|232241|P3|STARTED|Run-in Period||0
95907|NCT01452529|232242|P2|STARTED|Run-in Period||0
95908|NCT01452529|232243|P1|STARTED|Run-in Period||905
95909|NCT01452425|232258|P1|NOT COMPLETED|Overall Study||0
95910|NCT01452425|232258|P1|COMPLETED|Overall Study||10
95911|NCT01452425|232258|P1|STARTED|Overall Study||10
95912|NCT01452347|232265|P2|NOT COMPLETED|Overall Study||7
95913|NCT01452347|232266|P1|NOT COMPLETED|Overall Study||17
95914|NCT01452347|232265|P2|COMPLETED|Overall Study||77
95915|NCT01452347|232266|P1|COMPLETED|Overall Study||151
95916|NCT01452347|232265|P2|STARTED|Overall Study||84
95917|NCT01452347|232266|P1|STARTED|Overall Study||168
95918|NCT01452269|232284|P2|NOT COMPLETED|Overall Study||5
95919|NCT01452269|232285|P1|NOT COMPLETED|Overall Study||1
95920|NCT01452269|232284|P2|COMPLETED|Overall Study||51
95921|NCT01452269|232285|P1|COMPLETED|Overall Study||47
95922|NCT01452269|232284|P2|STARTED|Overall Study||56
95923|NCT01452269|232285|P1|STARTED|Overall Study||48
95924|NCT01452152|232298|P3|NOT COMPLETED|Overall Study||4
95925|NCT01452152|232299|P2|NOT COMPLETED|Overall Study||0
95926|NCT01452152|232300|P1|NOT COMPLETED|Overall Study||5
95927|NCT01452152|232298|P3|COMPLETED|Overall Study||0
95928|NCT01452152|232299|P2|COMPLETED|Overall Study||0
95929|NCT01452152|232300|P1|COMPLETED|Overall Study||0
95930|NCT01452152|232298|P3|STARTED|Overall Study||4
95931|NCT01452152|232299|P2|STARTED|Overall Study||0
95932|NCT01452152|232300|P1|STARTED|Overall Study||5
95933|NCT01452126|232323|P1|NOT COMPLETED|Overall Study||0
95934|NCT01452126|232323|P1|COMPLETED|Overall Study||49
95935|NCT01452126|232323|P1|STARTED|Overall Study||49
95936|NCT01451996|232335|P4|NOT COMPLETED|Overall Study||0
95937|NCT01451996|232336|P3|NOT COMPLETED|Overall Study||0
95938|NCT01451996|232337|P2|NOT COMPLETED|Overall Study||0
95939|NCT01451996|232338|P1|NOT COMPLETED|Overall Study||0
95940|NCT01451996|232335|P4|COMPLETED|Overall Study||85
95941|NCT01451996|232336|P3|COMPLETED|Overall Study||85
95942|NCT01451996|232337|P2|COMPLETED|Overall Study||87
95943|NCT01451996|232338|P1|COMPLETED|Overall Study||83
95944|NCT01451996|232335|P4|STARTED|Overall Study||85
95945|NCT01451996|232336|P3|STARTED|Overall Study||85
95946|NCT01451996|232337|P2|STARTED|Overall Study||87
95947|NCT01451996|232338|P1|STARTED|Overall Study||83
95948|NCT01451983|232356|P4|NOT COMPLETED|Overall Study||0
95949|NCT01451983|232357|P3|NOT COMPLETED|Overall Study||0
95950|NCT01451983|232358|P2|NOT COMPLETED|Overall Study||0
95951|NCT01451983|232359|P1|NOT COMPLETED|Overall Study||0
95952|NCT01451983|232356|P4|COMPLETED|Overall Study||24
95953|NCT01451983|232357|P3|COMPLETED|Overall Study||61
95954|NCT01451983|232358|P2|COMPLETED|Overall Study||27
95955|NCT01451983|232359|P1|COMPLETED|Overall Study||26
95956|NCT01451983|232356|P4|STARTED|Overall Study||24
95957|NCT01451983|232357|P3|STARTED|Overall Study||61
95958|NCT01451983|232358|P2|STARTED|Overall Study||27
95959|NCT01451983|232359|P1|STARTED|Overall Study||26
95960|NCT01451931|232372|P3|NOT COMPLETED|Overall Study||43
95961|NCT01451931|232373|P2|NOT COMPLETED|Overall Study||58
95962|NCT01451931|232374|P1|NOT COMPLETED|Overall Study||33
95963|NCT01451931|232372|P3|COMPLETED|Overall Study||923
95964|NCT01451931|232373|P2|COMPLETED|Overall Study||843
95965|NCT01451931|232374|P1|COMPLETED|Overall Study||876
95966|NCT01451931|232372|P3|6-month Follow up|Overall Study||923
95967|NCT01451931|232373|P2|6-month Follow up|Overall Study||843
95968|NCT01451931|232374|P1|6-month Follow up|Overall Study||876
95969|NCT01451931|232372|P3|Baseline Data Collection|Overall Study||958
95970|NCT01451931|232373|P2|Baseline Data Collection|Overall Study||893
95971|NCT01451931|232374|P1|Baseline Data Collection|Overall Study||908
95972|NCT01451931|232372|P3|STARTED|Overall Study||966
95973|NCT01451931|232373|P2|STARTED|Overall Study||901
95974|NCT01451931|232374|P1|STARTED|Overall Study||909
95975|NCT01451814|232396|P2|NOT COMPLETED|Overall Study||5
95976|NCT01451814|232397|P1|NOT COMPLETED|Overall Study||6
95977|NCT01451814|232396|P2|COMPLETED|Overall Study||26
95978|NCT01451814|232397|P1|COMPLETED|Overall Study||29
95979|NCT01451814|232396|P2|Attended a Session|Overall Study||31
95980|NCT01451814|232397|P1|Attended a Session|Overall Study||35
95981|NCT01451814|232396|P2|STARTED|Overall Study||31
95982|NCT01451814|232397|P1|STARTED|Overall Study||35
95983|NCT01451775|232407|P6|NOT COMPLETED|Overall Study||0
95984|NCT01451775|232408|P5|NOT COMPLETED|Overall Study||0
95985|NCT01451775|232409|P4|NOT COMPLETED|Overall Study||0
95986|NCT01451775|232410|P3|NOT COMPLETED|Overall Study||0
95987|NCT01451775|232411|P2|NOT COMPLETED|Overall Study||0
95988|NCT01451775|232412|P1|NOT COMPLETED|Overall Study||0
95989|NCT01451775|232407|P6|COMPLETED|Overall Study||3
95990|NCT01451775|232408|P5|COMPLETED|Overall Study||3
95991|NCT01451775|232409|P4|COMPLETED|Overall Study||3
95992|NCT01451775|232410|P3|COMPLETED|Overall Study||3
95993|NCT01451775|232411|P2|COMPLETED|Overall Study||3
95994|NCT01451775|232412|P1|COMPLETED|Overall Study||3
95995|NCT01451775|232407|P6|STARTED|Overall Study||3
95996|NCT01451775|232408|P5|STARTED|Overall Study||3
95997|NCT01451775|232409|P4|STARTED|Overall Study||3
95998|NCT01451775|232410|P3|STARTED|Overall Study||3
95999|NCT01451775|232411|P2|STARTED|Overall Study||3
96000|NCT01451775|232412|P1|STARTED|Overall Study||3
96001|NCT01451762|232429|P3|NOT COMPLETED|Overall Study||6
96002|NCT01451762|232430|P2|NOT COMPLETED|Overall Study||6
96003|NCT01451762|232431|P1|NOT COMPLETED|Overall Study||3
96004|NCT01451762|232429|P3|COMPLETED|Overall Study||24
96005|NCT01451762|232430|P2|COMPLETED|Overall Study||24
96006|NCT01451762|232431|P1|COMPLETED|Overall Study||27
96007|NCT01451762|232429|P3|STARTED|Overall Study||30
96008|NCT01451762|232430|P2|STARTED|Overall Study||30
96009|NCT01451762|232431|P1|STARTED|Overall Study||30
96010|NCT01451749|232441|P2|NOT COMPLETED|Overall Study||14
96011|NCT01451749|232442|P1|NOT COMPLETED|Overall Study||32
96012|NCT01451749|232441|P2|COMPLETED|Overall Study||94
96013|NCT01451749|232442|P1|COMPLETED|Overall Study||184
96014|NCT01451749|232441|P2|STARTED|Overall Study||108
96015|NCT01451749|232442|P1|STARTED|Overall Study||216
96016|NCT01451723|232454|P2|NOT COMPLETED|Overall Study||5
96017|NCT01451723|232455|P1|NOT COMPLETED|Overall Study||6
96018|NCT01451723|232454|P2|COMPLETED|Overall Study||0
96019|NCT01451723|232455|P1|COMPLETED|Overall Study||0
96020|NCT01451723|232454|P2|STARTED|Overall Study||5
96021|NCT01451723|232455|P1|STARTED|Overall Study||6
96022|NCT01451645|232465|P2|NOT COMPLETED|Overall Study||8
96023|NCT01451645|232466|P1|NOT COMPLETED|Overall Study||9
96024|NCT01451645|232465|P2|COMPLETED|Overall Study||33
96025|NCT01451645|232466|P1|COMPLETED|Overall Study||32
96026|NCT01451645|232465|P2|STARTED|Overall Study||41
96027|NCT01451645|232466|P1|STARTED|Overall Study||41
96028|NCT01451632|232480|P10|NOT COMPLETED|Overall Study||0
96029|NCT01451632|232481|P9|NOT COMPLETED|Overall Study||0
96030|NCT01451632|232482|P8|NOT COMPLETED|Overall Study||0
96031|NCT01451632|232483|P7|NOT COMPLETED|Overall Study||0
96032|NCT01451632|232484|P6|NOT COMPLETED|Overall Study||0
96033|NCT01451632|232485|P5|NOT COMPLETED|Overall Study||0
96034|NCT01451632|232486|P4|NOT COMPLETED|Overall Study||0
96035|NCT01451632|232487|P3|NOT COMPLETED|Overall Study||0
96036|NCT01451632|232488|P2|NOT COMPLETED|Overall Study||0
96037|NCT01451632|232489|P1|NOT COMPLETED|Overall Study||0
96038|NCT01451632|232480|P10|COMPLETED|Overall Study||4
96039|NCT01451632|232481|P9|COMPLETED|Overall Study||4
96040|NCT01451632|232482|P8|COMPLETED|Overall Study||6
96041|NCT01451632|232483|P7|COMPLETED|Overall Study||8
96042|NCT01451632|232484|P6|COMPLETED|Overall Study||4
96043|NCT01451632|232485|P5|COMPLETED|Overall Study||4
96044|NCT01451632|232486|P4|COMPLETED|Overall Study||3
96045|NCT01451632|232487|P3|COMPLETED|Overall Study||3
96046|NCT01451632|232488|P2|COMPLETED|Overall Study||4
96047|NCT01451632|232489|P1|COMPLETED|Overall Study||8
96048|NCT01451632|232480|P10|STARTED|Overall Study||4
96049|NCT01451632|232481|P9|STARTED|Overall Study||4
96050|NCT01451632|232482|P8|STARTED|Overall Study||6
96051|NCT01451632|232483|P7|STARTED|Overall Study||8
96052|NCT01451632|232484|P6|STARTED|Overall Study||4
96053|NCT01451632|232485|P5|STARTED|Overall Study||4
96054|NCT01451632|232486|P4|STARTED|Overall Study||3
96055|NCT01451632|232487|P3|STARTED|Overall Study||3
96056|NCT01451632|232488|P2|STARTED|Overall Study||4
96057|NCT01451632|232489|P1|STARTED|Overall Study||8
96058|NCT01451606|232537|P2|NOT COMPLETED|Overall Study||3
96059|NCT01451606|232538|P1|NOT COMPLETED|Overall Study||4
96060|NCT01451606|232537|P2|COMPLETED|Overall Study||15
96061|NCT01451606|232538|P1|COMPLETED|Overall Study||12
96062|NCT01451606|232537|P2|STARTED|Overall Study||18
96063|NCT01451606|232538|P1|STARTED|Overall Study||16
96064|NCT01451554|232548|P2|NOT COMPLETED|Overall Study||9
96065|NCT01451554|232549|P1|NOT COMPLETED|Overall Study||14
96066|NCT01451554|232548|P2|COMPLETED|Overall Study||23
96067|NCT01451554|232549|P1|COMPLETED|Overall Study||19
96068|NCT01451554|232548|P2|STARTED|Overall Study||32
96069|NCT01451554|232549|P1|STARTED|Overall Study||33
96070|NCT01451541|232560|P3|NOT COMPLETED|Overall Study||27
96071|NCT01451541|232561|P2|NOT COMPLETED|Overall Study||25
96072|NCT01451541|232562|P1|NOT COMPLETED|Overall Study||36
96073|NCT01451541|232560|P3|COMPLETED|Overall Study||254
96074|NCT01451541|232561|P2|COMPLETED|Overall Study||257
96075|NCT01451541|232562|P1|COMPLETED|Overall Study||247
96076|NCT01451541|232560|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
96077|NCT01451541|232561|P2|STARTED|Overall Study||282
96078|NCT01451541|232562|P1|STARTED|Overall Study||283
96079|NCT01451463|232602|P1|NOT COMPLETED|Overall Study||0
96080|NCT01451463|232602|P1|COMPLETED|Overall Study||11
96081|NCT01451463|232602|P1|STARTED|Overall Study||11
96082|NCT01451437|232620|P9|NOT COMPLETED|Overall Study||4
96083|NCT01451437|232621|P8|NOT COMPLETED|Overall Study||3
96084|NCT01451437|232622|P7|NOT COMPLETED|Overall Study||6
96085|NCT01451437|232623|P6|NOT COMPLETED|Overall Study||3
96086|NCT01451437|232624|P5|NOT COMPLETED|Overall Study||4
96087|NCT01451437|232625|P4|NOT COMPLETED|Overall Study||1
96088|NCT01451437|232626|P3|NOT COMPLETED|Overall Study||3
96089|NCT01451437|232627|P2|NOT COMPLETED|Overall Study||1
96090|NCT01451437|232628|P1|NOT COMPLETED|Overall Study||1
96091|NCT01451437|232620|P9|COMPLETED|Overall Study||0
96092|NCT01451437|232621|P8|COMPLETED|Overall Study||0
96093|NCT01451437|232622|P7|COMPLETED|Overall Study||0
96094|NCT01451437|232623|P6|COMPLETED|Overall Study||0
96095|NCT01451437|232624|P5|COMPLETED|Overall Study||0
96096|NCT01451437|232625|P4|COMPLETED|Overall Study||0
96097|NCT01451437|232626|P3|COMPLETED|Overall Study||0
96098|NCT01451437|232627|P2|COMPLETED|Overall Study||0
96099|NCT01451437|232628|P1|COMPLETED|Overall Study||0
96100|NCT01451437|232620|P9|STARTED|Overall Study||4
96101|NCT01451437|232621|P8|STARTED|Overall Study||3
96102|NCT01451437|232622|P7|STARTED|Overall Study||6
96103|NCT01451437|232623|P6|STARTED|Overall Study||3
96104|NCT01451437|232624|P5|STARTED|Overall Study||4
96105|NCT01451437|232625|P4|STARTED|Overall Study||1
96106|NCT01451437|232626|P3|STARTED|Overall Study||3
96107|NCT01451437|232627|P2|STARTED|Overall Study||1
96108|NCT01451437|232628|P1|STARTED|Overall Study||1
96109|NCT01451424|232760|P4|NOT COMPLETED|Overall Study||5
96110|NCT01451424|232761|P3|NOT COMPLETED|Overall Study||1
96111|NCT01451424|232762|P2|NOT COMPLETED|Overall Study||2
96112|NCT01451424|232763|P1|NOT COMPLETED|Overall Study||1
96113|NCT01451424|232760|P4|COMPLETED|Overall Study||5
96114|NCT01451424|232761|P3|COMPLETED|Overall Study||11
96115|NCT01451424|232762|P2|COMPLETED|Overall Study||7
96116|NCT01451424|232763|P1|COMPLETED|Overall Study||8
96117|NCT01451424|232760|P4|STARTED|Overall Study||10
96118|NCT01451424|232761|P3|STARTED|Overall Study||12
96119|NCT01451424|232762|P2|STARTED|Overall Study||9
96120|NCT01451424|232763|P1|STARTED|Overall Study||9
96121|NCT01451411|232796|P2|NOT COMPLETED|Overall Study||0
96122|NCT01451411|232797|P1|NOT COMPLETED|Overall Study||0
96123|NCT01451411|232796|P2|COMPLETED|Overall Study||1
96124|NCT01451411|232797|P1|COMPLETED|Overall Study||3
96125|NCT01451411|232796|P2|STARTED|Overall Study||1
96126|NCT01451411|232797|P1|STARTED|Overall Study||3
96127|NCT01451398|232821|P2|NOT COMPLETED|Overall Study||37
96128|NCT01451398|232822|P1|NOT COMPLETED|Overall Study||27
96129|NCT01451398|232821|P2|COMPLETED|Overall Study||139
96130|NCT01451398|232822|P1|COMPLETED|Overall Study||150
96131|NCT01451398|232821|P2|STARTED|Overall Study||176
96132|NCT01451398|232822|P1|STARTED|Overall Study||177
96133|NCT01451203|232856|P2|NOT COMPLETED|Post-treatment Period||34
96134|NCT01451203|232857|P1|NOT COMPLETED|Post-treatment Period||14
96135|NCT01451203|232856|P2|COMPLETED|Post-treatment Period||74
96136|NCT01451203|232857|P1|COMPLETED|Post-treatment Period||57
96137|NCT01451203|232856|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
96138|NCT01451203|232857|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
96139|NCT01451203|232856|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
96140|NCT01451203|232857|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
96141|NCT01451203|232856|P2|NOT COMPLETED|Double-blind Treatment Period||50
96142|NCT01451203|232857|P1|NOT COMPLETED|Double-blind Treatment Period||85
96143|NCT01451203|232856|P2|COMPLETED|Double-blind Treatment Period||111
96144|NCT01451203|232857|P1|COMPLETED|Double-blind Treatment Period||73
96145|NCT01451203|232856|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
96146|NCT01451203|232857|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
96147|NCT01451203|232856|P2|Received Treatment|Double-blind Treatment Period||159
96148|NCT01451203|232857|P1|Received Treatment|Double-blind Treatment Period||157
96149|NCT01451203|232856|P2|STARTED|Double-blind Treatment Period||161
96150|NCT01451203|232857|P1|STARTED|Double-blind Treatment Period||158
96151|NCT01450813|232875|P4|NOT COMPLETED|Overall Study||3
96152|NCT01450813|232876|P3|NOT COMPLETED|Overall Study||0
96153|NCT01450813|232877|P2|NOT COMPLETED|Overall Study||1
96154|NCT01450813|232878|P1|NOT COMPLETED|Overall Study||1
96155|NCT01450813|232875|P4|COMPLETED|Overall Study||17
96156|NCT01450813|232876|P3|COMPLETED|Overall Study||20
96157|NCT01450813|232877|P2|COMPLETED|Overall Study||19
96158|NCT01450813|232878|P1|COMPLETED|Overall Study||19
96159|NCT01450813|232875|P4|STARTED|Overall Study||20
96160|NCT01450813|232876|P3|STARTED|Overall Study||20
96161|NCT01450813|232877|P2|STARTED|Overall Study||20
96162|NCT01450813|232878|P1|STARTED|Overall Study||20
96163|NCT01450800|232892|P2|NOT COMPLETED|Overall Study||3
96164|NCT01450800|232893|P1|NOT COMPLETED|Overall Study||1
96165|NCT01450800|232892|P2|COMPLETED|Overall Study||78
96166|NCT01450800|232893|P1|COMPLETED|Overall Study||81
96167|NCT01450800|232892|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
96168|NCT01450800|232893|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
96169|NCT01450787|232909|P2|NOT COMPLETED|Overall Study||0
96170|NCT01450787|232910|P1|NOT COMPLETED|Overall Study||0
96171|NCT01450787|232909|P2|COMPLETED|Overall Study||25
96172|NCT01450787|232910|P1|COMPLETED|Overall Study||38
96173|NCT01450787|232909|P2|STARTED|Overall Study||25
96174|NCT01450787|232910|P1|STARTED|Overall Study||38
96175|NCT01450761|232928|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||466
96176|NCT01450761|232929|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||464
96177|NCT01450761|232928|P2|COMPLETED|Treatment With Blinded Study Therapy||10
96178|NCT01450761|232929|P1|COMPLETED|Treatment With Blinded Study Therapy||14
96179|NCT01450761|232928|P2|STARTED|Treatment With Blinded Study Therapy||476
96180|NCT01450761|232929|P1|STARTED|Treatment With Blinded Study Therapy||478
96181|NCT01450761|232928|P2|NOT COMPLETED|Lead-in Chemotherapy||85
96182|NCT01450761|232929|P1|NOT COMPLETED|Lead-in Chemotherapy||84
96183|NCT01450761|232928|P2|COMPLETED|Lead-in Chemotherapy||476
96184|NCT01450761|232929|P1|COMPLETED|Lead-in Chemotherapy||478
96185|NCT01450761|232928|P2|STARTED|Lead-in Chemotherapy||561
96186|NCT01450761|232929|P1|STARTED|Lead-in Chemotherapy||562
96187|NCT01450761|232928|P2|NOT COMPLETED|Randomization||5
96188|NCT01450761|232929|P1|NOT COMPLETED|Randomization||4
96189|NCT01450761|232928|P2|COMPLETED|Randomization||561
96190|NCT01450761|232929|P1|COMPLETED|Randomization||562
96191|NCT01450761|232928|P2|STARTED|Randomization||566
96192|NCT01450761|232929|P1|STARTED|Randomization||566
96193|NCT01450696|232941|P2|NOT COMPLETED|Overall Study||148
96194|NCT01450696|232942|P1|NOT COMPLETED|Overall Study||148
96195|NCT01450696|232941|P2|COMPLETED|Overall Study||0
96196|NCT01450696|232942|P1|COMPLETED|Overall Study||0
96197|NCT01450696|232941|P2|Treated (Safety Population)|Overall Study||147
96198|NCT01450696|232942|P1|Treated (Safety Population)|Overall Study||147
96199|NCT01450696|232941|P2|STARTED|Overall Study||148
96200|NCT01450696|232942|P1|STARTED|Overall Study||148
96201|NCT01450683|232964|P1|NOT COMPLETED|Overall Study||2
96202|NCT01450683|232964|P1|COMPLETED|Overall Study||2
96203|NCT01450683|232964|P1|STARTED|Overall Study||4
96204|NCT01450631|232970|P2|NOT COMPLETED|Overall Study||4
96205|NCT01450631|232971|P1|NOT COMPLETED|Overall Study||3
96206|NCT01450631|232970|P2|COMPLETED|Overall Study||42
96207|NCT01450631|232971|P1|COMPLETED|Overall Study||43
96208|NCT01450631|232970|P2|STARTED|Overall Study||46
96209|NCT01450631|232971|P1|STARTED|Overall Study||46
96210|NCT01450397|232979|P1|NOT COMPLETED|Overall Study||0
96211|NCT01450397|232979|P1|COMPLETED|Overall Study||5
96212|NCT01450397|232979|P1|STARTED|Overall Study||5
96213|NCT01450319|232983|P1|NOT COMPLETED|Overall Study||0
96214|NCT01450319|232983|P1|COMPLETED|Overall Study||70
96215|NCT01450319|232983|P1|STARTED|Overall Study||70
96216|NCT01450306|232996|P2|NOT COMPLETED|Overall Study||0
96217|NCT01450306|232997|P1|NOT COMPLETED|Overall Study||0
96218|NCT01450306|232996|P2|COMPLETED|Overall Study||10
96219|NCT01450306|232997|P1|COMPLETED|Overall Study||10
96220|NCT01450306|232996|P2|STARTED|Overall Study||10
96221|NCT01450306|232997|P1|STARTED|Overall Study||10
96222|NCT01450189|233010|P3|NOT COMPLETED|Overall Study||0
96223|NCT01450189|233011|P2|NOT COMPLETED|Overall Study||0
96224|NCT01450189|233012|P1|NOT COMPLETED|Overall Study||0
96225|NCT01450189|233010|P3|COMPLETED|Overall Study||19
96226|NCT01450189|233011|P2|COMPLETED|Overall Study||18
96227|NCT01450189|233012|P1|COMPLETED|Overall Study||9
96228|NCT01450189|233010|P3|STARTED|Overall Study||19
96229|NCT01450189|233011|P2|STARTED|Overall Study||18
96230|NCT01450189|233012|P1|STARTED|Overall Study||9
96231|NCT01450007|233102|P3|NOT COMPLETED|Overall Study||3
96232|NCT01450007|233103|P2|NOT COMPLETED|Overall Study||5
96233|NCT01450007|233104|P1|NOT COMPLETED|Overall Study||2
96234|NCT01450007|233102|P3|COMPLETED|Overall Study||41
96235|NCT01450007|233103|P2|COMPLETED|Overall Study||37
96236|NCT01450007|233104|P1|COMPLETED|Overall Study||42
96237|NCT01450007|233102|P3|STARTED|Overall Study||44
96238|NCT01450007|233103|P2|STARTED|Overall Study||42
96239|NCT01450007|233104|P1|STARTED|Overall Study||44
96240|NCT01449955|233123|P2|NOT COMPLETED|Overall Study||2
96241|NCT01449955|233124|P1|NOT COMPLETED|Overall Study||1
96242|NCT01449955|233123|P2|COMPLETED|Overall Study||24
96243|NCT01449955|233124|P1|COMPLETED|Overall Study||27
96244|NCT01449955|233123|P2|STARTED|Overall Study||26
96245|NCT01449955|233124|P1|STARTED|Overall Study||28
96246|NCT01449929|233132|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
96247|NCT01449929|233133|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
96248|NCT01449929|233134|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
96249|NCT01449929|233132|P3|COMPLETED|Extension Phase Approximately 3 Years||115
96250|NCT01449929|233133|P2|COMPLETED|Extension Phase Approximately 3 Years||0
96251|NCT01449929|233134|P1|COMPLETED|Extension Phase Approximately 3 Years||0
96252|NCT01449929|233132|P3|STARTED|Extension Phase Approximately 3 Years||123
96253|NCT01449929|233133|P2|STARTED|Extension Phase Approximately 3 Years||0
96254|NCT01449929|233134|P1|STARTED|Extension Phase Approximately 3 Years||0
96255|NCT01449929|233132|P3|NOT COMPLETED|Randomization Phase 96 Week||0
96256|NCT01449929|233133|P2|NOT COMPLETED|Randomization Phase 96 Week||53
96257|NCT01449929|233134|P1|NOT COMPLETED|Randomization Phase 96 Week||33
96258|NCT01449929|233132|P3|COMPLETED|Randomization Phase 96 Week||0
96259|NCT01449929|233133|P2|COMPLETED|Randomization Phase 96 Week||189
96260|NCT01449929|233134|P1|COMPLETED|Randomization Phase 96 Week||209
96261|NCT01449929|233132|P3|STARTED|Randomization Phase 96 Week||0
96262|NCT01449929|233133|P2|STARTED|Randomization Phase 96 Week||242
96263|NCT01449929|233134|P1|STARTED|Randomization Phase 96 Week||242
96264|NCT01449812|233174|P3|NOT COMPLETED|Overall Study||1
96265|NCT01449812|233175|P2|NOT COMPLETED|Overall Study||0
96266|NCT01449812|233176|P1|NOT COMPLETED|Overall Study||2
96267|NCT01449812|233174|P3|COMPLETED|Overall Study||279
96268|NCT01449812|233175|P2|COMPLETED|Overall Study||273
96269|NCT01449812|233176|P1|COMPLETED|Overall Study||270
96270|NCT01449812|233174|P3|STARTED|Overall Study||280
96271|NCT01449812|233175|P2|STARTED|Overall Study||273
96272|NCT01449812|233176|P1|STARTED|Overall Study||272
96273|NCT01449747|233270|P2|NOT COMPLETED|Overall Study||0
96274|NCT01449747|233271|P1|NOT COMPLETED|Overall Study||0
96275|NCT01449747|233270|P2|COMPLETED|Overall Study||12
96276|NCT01449747|233271|P1|COMPLETED|Overall Study||12
96277|NCT01449747|233270|P2|STARTED|Overall Study||12
96278|NCT01449747|233271|P1|STARTED|Overall Study||12
96279|NCT01449734|233285|P1|NOT COMPLETED|Overall Study||0
96280|NCT01449734|233285|P1|COMPLETED|Overall Study||215
96281|NCT01449734|233285|P1|STARTED|Overall Study||215
96282|NCT01449721|233291|P2|NOT COMPLETED|Overall Study||2
96283|NCT01449721|233292|P1|NOT COMPLETED|Overall Study||0
96284|NCT01449721|233291|P2|COMPLETED|Overall Study||28
96285|NCT01449721|233292|P1|COMPLETED|Overall Study||112
96286|NCT01449721|233291|P2|STARTED|Overall Study||30
96287|NCT01449721|233292|P1|STARTED|Overall Study||112
96288|NCT01449708|233304|P2|NOT COMPLETED|Overall Study||3
96289|NCT01449708|233305|P1|NOT COMPLETED|Overall Study||2
96290|NCT01449708|233304|P2|COMPLETED|Overall Study||60
96291|NCT01449708|233305|P1|COMPLETED|Overall Study||59
96292|NCT01449708|233304|P2|STARTED|Overall Study||63
96293|NCT01449708|233305|P1|STARTED|Overall Study||61
96294|NCT01449682|233316|P2|NOT COMPLETED|Overall Study||1
96295|NCT01449682|233317|P1|NOT COMPLETED|Overall Study||1
96296|NCT01449682|233316|P2|COMPLETED|Overall Study||4
96297|NCT01449682|233317|P1|COMPLETED|Overall Study||4
96298|NCT01449682|233316|P2|STARTED|Overall Study||5
96299|NCT01449682|233317|P1|STARTED|Overall Study||5
96300|NCT01449539|233329|P1|NOT COMPLETED|Overall Study||4
96301|NCT01449539|233329|P1|COMPLETED|Overall Study||4
96302|NCT01449539|233329|P1|STARTED|Overall Study||8
96303|NCT01449526|233335|P2|NOT COMPLETED|Overall Study||6
96304|NCT01449526|233336|P1|NOT COMPLETED|Overall Study||2
96305|NCT01449526|233335|P2|COMPLETED|Overall Study||77
96306|NCT01449526|233336|P1|COMPLETED|Overall Study||81
96307|NCT01449526|233335|P2|STARTED|Overall Study||83
96308|NCT01449526|233336|P1|STARTED|Overall Study||83
96309|NCT01449513|233346|P2|NOT COMPLETED|Overall Study||0
96310|NCT01449513|233347|P1|NOT COMPLETED|Overall Study||0
96311|NCT01449513|233346|P2|COMPLETED|Overall Study||8
96312|NCT01449513|233347|P1|COMPLETED|Overall Study||16
96313|NCT01449513|233346|P2|STARTED|Overall Study||8
96314|NCT01449513|233347|P1|STARTED|Overall Study||16
96315|NCT01449461|233405|P6|NOT COMPLETED|Overall Study||15
96316|NCT01449461|233406|P5|NOT COMPLETED|Overall Study||48
96317|NCT01449461|233407|P4|NOT COMPLETED|Overall Study||32
96318|NCT01449461|233408|P3|NOT COMPLETED|Overall Study||18
96319|NCT01449461|233409|P2|NOT COMPLETED|Overall Study||18
96320|NCT01449461|233410|P1|NOT COMPLETED|Overall Study||6
96321|NCT01449461|233405|P6|COMPLETED|Overall Study||0
96322|NCT01449461|233406|P5|COMPLETED|Overall Study||0
96323|NCT01449461|233407|P4|COMPLETED|Overall Study||0
96324|NCT01449461|233408|P3|COMPLETED|Overall Study||0
96325|NCT01449461|233409|P2|COMPLETED|Overall Study||0
96326|NCT01449461|233410|P1|COMPLETED|Overall Study||0
96327|NCT01449461|233405|P6|STARTED|Overall Study||15
96328|NCT01449461|233406|P5|STARTED|Overall Study||48
96329|NCT01449461|233407|P4|STARTED|Overall Study||32
96330|NCT01449461|233408|P3|STARTED|Overall Study||18
96331|NCT01449461|233409|P2|STARTED|Overall Study||18
96332|NCT01449461|233410|P1|STARTED|Overall Study||6
96333|NCT01449370|233547|P25|NOT COMPLETED|Overall Study||8
96334|NCT01449370|233548|P24|NOT COMPLETED|Overall Study||10
96335|NCT01449370|233549|P23|NOT COMPLETED|Overall Study||4
96336|NCT01449370|233550|P22|NOT COMPLETED|Overall Study||4
96337|NCT01449370|233551|P21|NOT COMPLETED|Overall Study||6
96338|NCT01449370|233552|P20|NOT COMPLETED|Overall Study||3
96339|NCT01449370|233553|P19|NOT COMPLETED|Overall Study||3
96340|NCT01449370|233554|P18|NOT COMPLETED|Overall Study||3
96341|NCT01449370|233555|P17|NOT COMPLETED|Overall Study||7
96342|NCT01449370|233556|P16|NOT COMPLETED|Overall Study||3
96343|NCT01449370|233557|P15|NOT COMPLETED|Overall Study||3
96344|NCT01449370|233558|P14|NOT COMPLETED|Overall Study||11
96345|NCT01449370|233559|P13|NOT COMPLETED|Overall Study||3
96346|NCT01449370|233560|P12|NOT COMPLETED|Overall Study||3
96347|NCT01449370|233561|P11|NOT COMPLETED|Overall Study||3
96348|NCT01449370|233562|P10|NOT COMPLETED|Overall Study||3
96349|NCT01449370|233563|P9|NOT COMPLETED|Overall Study||12
96350|NCT01449370|233564|P8|NOT COMPLETED|Overall Study||3
96351|NCT01449370|233565|P7|NOT COMPLETED|Overall Study||3
96352|NCT01449370|233566|P6|NOT COMPLETED|Overall Study||3
96353|NCT01449370|233567|P5|NOT COMPLETED|Overall Study||3
96354|NCT01449370|233568|P4|NOT COMPLETED|Overall Study||4
96355|NCT01449370|233569|P3|NOT COMPLETED|Overall Study||8
96356|NCT01449370|233570|P2|NOT COMPLETED|Overall Study||6
96357|NCT01449370|233571|P1|NOT COMPLETED|Overall Study||6
96358|NCT01449370|233547|P25|COMPLETED|Overall Study||0
96359|NCT01449370|233548|P24|COMPLETED|Overall Study||0
96360|NCT01449370|233549|P23|COMPLETED|Overall Study||0
96361|NCT01449370|233550|P22|COMPLETED|Overall Study||0
96362|NCT01449370|233551|P21|COMPLETED|Overall Study||0
96363|NCT01449370|233552|P20|COMPLETED|Overall Study||0
96364|NCT01449370|233553|P19|COMPLETED|Overall Study||0
96365|NCT01449370|233554|P18|COMPLETED|Overall Study||0
96366|NCT01449370|233555|P17|COMPLETED|Overall Study||0
96367|NCT01449370|233556|P16|COMPLETED|Overall Study||0
96368|NCT01449370|233557|P15|COMPLETED|Overall Study||0
96369|NCT01449370|233558|P14|COMPLETED|Overall Study||0
96370|NCT01449370|233559|P13|COMPLETED|Overall Study||0
96371|NCT01449370|233560|P12|COMPLETED|Overall Study||0
96372|NCT01449370|233561|P11|COMPLETED|Overall Study||0
96373|NCT01449370|233562|P10|COMPLETED|Overall Study||0
96374|NCT01449370|233563|P9|COMPLETED|Overall Study||0
96375|NCT01449370|233564|P8|COMPLETED|Overall Study||0
96376|NCT01449370|233565|P7|COMPLETED|Overall Study||0
96377|NCT01449370|233566|P6|COMPLETED|Overall Study||0
96378|NCT01449370|233567|P5|COMPLETED|Overall Study||0
96379|NCT01449370|233568|P4|COMPLETED|Overall Study||0
96380|NCT01449370|233569|P3|COMPLETED|Overall Study||0
96381|NCT01449370|233570|P2|COMPLETED|Overall Study||0
96382|NCT01449370|233571|P1|COMPLETED|Overall Study||0
96383|NCT01449370|233547|P25|STARTED|Overall Study||8
96384|NCT01449370|233548|P24|STARTED|Overall Study||10
96385|NCT01449370|233549|P23|STARTED|Overall Study||4
96386|NCT01449370|233550|P22|STARTED|Overall Study||4
96387|NCT01449370|233551|P21|STARTED|Overall Study||6
96388|NCT01449370|233552|P20|STARTED|Overall Study||3
96389|NCT01449370|233553|P19|STARTED|Overall Study||3
96390|NCT01449370|233554|P18|STARTED|Overall Study||3
96391|NCT01449370|233555|P17|STARTED|Overall Study||7
96392|NCT01449370|233556|P16|STARTED|Overall Study||3
96393|NCT01449370|233557|P15|STARTED|Overall Study||3
96394|NCT01449370|233558|P14|STARTED|Overall Study||11
96395|NCT01449370|233559|P13|STARTED|Overall Study||3
96396|NCT01449370|233560|P12|STARTED|Overall Study||3
96397|NCT01449370|233561|P11|STARTED|Overall Study||3
96398|NCT01449370|233562|P10|STARTED|Overall Study||3
96399|NCT01449370|233563|P9|STARTED|Overall Study||12
96400|NCT01449370|233564|P8|STARTED|Overall Study||3
96401|NCT01449370|233565|P7|STARTED|Overall Study||3
96402|NCT01449370|233566|P6|STARTED|Overall Study||3
96403|NCT01449370|233567|P5|STARTED|Overall Study||3
96404|NCT01449370|233568|P4|STARTED|Overall Study||4
96405|NCT01449370|233569|P3|STARTED|Overall Study||8
96406|NCT01449370|233570|P2|STARTED|Overall Study||6
96407|NCT01449370|233571|P1|STARTED|Overall Study||6
96408|NCT01449305|233944|P1|NOT COMPLETED|Overall Study||2
96409|NCT01449305|233944|P1|COMPLETED|Overall Study||42
96410|NCT01449305|233944|P1|STARTED|Overall Study||44
96411|NCT01449279|233949|P1|NOT COMPLETED|Overall Study||7
96412|NCT01449279|233949|P1|COMPLETED|Overall Study||15
96413|NCT01449279|233949|P1|STARTED|Overall Study||22
96414|NCT01449266|233960|P1|NOT COMPLETED|Overall Study||0
96415|NCT01449266|233960|P1|COMPLETED|Overall Study||10
96416|NCT01449266|233960|P1|STARTED|Overall Study||10
96417|NCT01449240|233967|P1|NOT COMPLETED|Overall Study||0
96418|NCT01449240|233967|P1|COMPLETED|Overall Study||10
96419|NCT01449240|233967|P1|STARTED|Overall Study||10
96420|NCT01449006|233974|P2|NOT COMPLETED|Overall Study||0
96421|NCT01449006|233975|P1|NOT COMPLETED|Overall Study||3
96422|NCT01449006|233974|P2|COMPLETED|Overall Study||9
96423|NCT01449006|233975|P1|COMPLETED|Overall Study||5
96424|NCT01449006|233974|P2|STARTED|Overall Study||9
96425|NCT01449006|233975|P1|STARTED|Overall Study||8
96426|NCT01448850|233989|P2|NOT COMPLETED|Overall Study||40
96427|NCT01448850|233990|P1|NOT COMPLETED|Overall Study||34
96428|NCT01448850|233989|P2|COMPLETED|Overall Study||120
96429|NCT01448850|233990|P1|COMPLETED|Overall Study||130
96430|NCT01448850|233989|P2|STARTED|Overall Study||160
96431|NCT01448850|233990|P1|STARTED|Overall Study||164
96432|NCT01448707|234015|P2|NOT COMPLETED|Overall Study||18
96433|NCT01448707|234016|P1|NOT COMPLETED|Overall Study||18
96434|NCT01448707|234015|P2|COMPLETED|Overall Study||118
96435|NCT01448707|234016|P1|COMPLETED|Overall Study||119
96436|NCT01448707|234015|P2|STARTED|Overall Study||136
96437|NCT01448707|234016|P1|STARTED|Overall Study||137
96438|NCT01448616|234037|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
96439|NCT01448616|234038|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
96440|NCT01448616|234039|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
96441|NCT01448616|234040|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
96442|NCT01448616|234037|P4|COMPLETED|Study Drug (Treatment Phase)||9
96443|NCT01448616|234038|P3|COMPLETED|Study Drug (Treatment Phase)||23
96444|NCT01448616|234039|P2|COMPLETED|Study Drug (Treatment Phase)||22
96445|NCT01448616|234040|P1|COMPLETED|Study Drug (Treatment Phase)||0
96446|NCT01448616|234037|P4|STARTED|Study Drug (Treatment Phase)||13
96447|NCT01448616|234038|P3|STARTED|Study Drug (Treatment Phase)||27
96448|NCT01448616|234039|P2|STARTED|Study Drug (Treatment Phase)||24
96449|NCT01448616|234040|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
96450|NCT01448616|234037|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
96451|NCT01448616|234038|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
96452|NCT01448616|234039|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
96453|NCT01448616|234040|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
96454|NCT01448616|234037|P4|COMPLETED|Lead-In (Observational Phase)||0
96455|NCT01448616|234038|P3|COMPLETED|Lead-In (Observational Phase)||0
96456|NCT01448616|234039|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
96457|NCT01448616|234040|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
96458|NCT01448616|234037|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
96459|NCT01448616|234038|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
96460|NCT01448616|234039|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
96461|NCT01448616|234040|P1|STARTED|Lead-In (Observational Phase)||73
96462|NCT01448525|234060|P2|NOT COMPLETED|Overall Study||2
96463|NCT01448525|234061|P1|NOT COMPLETED|Overall Study||1
96464|NCT01448525|234060|P2|COMPLETED|Overall Study||42
96465|NCT01448525|234061|P1|COMPLETED|Overall Study||43
96466|NCT01448525|234060|P2|STARTED|Overall Study||44
96467|NCT01448525|234061|P1|STARTED|Overall Study||44
96468|NCT01448486|234071|P2|NOT COMPLETED|Overall Study||0
96469|NCT01448486|234072|P1|NOT COMPLETED|Overall Study||0
96470|NCT01448486|234071|P2|COMPLETED|Overall Study||3
96471|NCT01448486|234072|P1|COMPLETED|Overall Study||3
96472|NCT01448486|234071|P2|STARTED|Overall Study||3
96473|NCT01448486|234072|P1|STARTED|Overall Study||3
96474|NCT01448356|234080|P1|NOT COMPLETED|Overall Study||0
96475|NCT01448356|234080|P1|COMPLETED|Overall Study|cross-over|10
96476|NCT01448356|234080|P1|STARTED|Overall Study||10
96477|NCT01448213|234087|P2|NOT COMPLETED|Overall Study||22
96478|NCT01448213|234088|P1|NOT COMPLETED|Overall Study||17
96479|NCT01448213|234087|P2|COMPLETED|Overall Study||112
96480|NCT01448213|234088|P1|COMPLETED|Overall Study||113
96481|NCT01448213|234087|P2|STARTED|Overall Study||134
96482|NCT01448213|234088|P1|STARTED|Overall Study||130
96483|NCT01448057|234098|P2|NOT COMPLETED|Overall Study||4
96484|NCT01448057|234099|P1|NOT COMPLETED|Overall Study||8
96485|NCT01448057|234098|P2|COMPLETED|Overall Study||167
96486|NCT01448057|234099|P1|COMPLETED|Overall Study||162
96487|NCT01448057|234098|P2|STARTED|Overall Study||171
96488|NCT01448057|234099|P1|STARTED|Overall Study||170
96489|NCT01448044|234109|P2|NOT COMPLETED|Follow Up Period||14
96490|NCT01448044|234110|P1|NOT COMPLETED|Follow Up Period||12
96491|NCT01448044|234109|P2|COMPLETED|Follow Up Period||26
96492|NCT01448044|234110|P1|COMPLETED|Follow Up Period||65
96493|NCT01448044|234109|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
96494|NCT01448044|234110|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
96495|NCT01448044|234109|P2|NOT COMPLETED|Treatment Period||16
96496|NCT01448044|234110|P1|NOT COMPLETED|Treatment Period||23
96497|NCT01448044|234109|P2|COMPLETED|Treatment Period||26
96498|NCT01448044|234110|P1|COMPLETED|Treatment Period||59
96499|NCT01448044|234109|P2|STARTED|Treatment Period||42
96500|NCT01448044|234110|P1|STARTED|Treatment Period||82
96501|NCT01447927|234126|P2|NOT COMPLETED|Overall Study||3
96502|NCT01447927|234127|P1|NOT COMPLETED|Overall Study||5
96503|NCT01447927|234126|P2|COMPLETED|Overall Study||33
96504|NCT01447927|234127|P1|COMPLETED|Overall Study||33
96505|NCT01447927|234126|P2|STARTED|Overall Study||36
96506|NCT01447927|234127|P1|STARTED|Overall Study||38
96507|NCT01447914|234135|P1|NOT COMPLETED|Overall Study||0
96508|NCT01447914|234135|P1|COMPLETED|Overall Study||16
96509|NCT01447914|234135|P1|STARTED|Overall Study||16
96510|NCT01447849|234144|P4|NOT COMPLETED|Second Intervention||0
96511|NCT01447849|234145|P3|NOT COMPLETED|Second Intervention||0
96512|NCT01447849|234146|P2|NOT COMPLETED|Second Intervention||0
96513|NCT01447849|234147|P1|NOT COMPLETED|Second Intervention||0
96514|NCT01447849|234144|P4|COMPLETED|Second Intervention||10
96515|NCT01447849|234145|P3|COMPLETED|Second Intervention||10
96516|NCT01447849|234146|P2|COMPLETED|Second Intervention||10
96517|NCT01447849|234147|P1|COMPLETED|Second Intervention||10
96518|NCT01447849|234144|P4|STARTED|Second Intervention||10
96519|NCT01447849|234145|P3|STARTED|Second Intervention||10
96520|NCT01447849|234146|P2|STARTED|Second Intervention||10
96521|NCT01447849|234147|P1|STARTED|Second Intervention||10
96522|NCT01447849|234144|P4|NOT COMPLETED|Washout Period for 1 Week||0
96523|NCT01447849|234145|P3|NOT COMPLETED|Washout Period for 1 Week||0
96524|NCT01447849|234146|P2|NOT COMPLETED|Washout Period for 1 Week||0
96525|NCT01447849|234147|P1|NOT COMPLETED|Washout Period for 1 Week||0
96526|NCT01447849|234144|P4|COMPLETED|Washout Period for 1 Week||10
96527|NCT01447849|234145|P3|COMPLETED|Washout Period for 1 Week||10
96528|NCT01447849|234146|P2|COMPLETED|Washout Period for 1 Week||10
96529|NCT01447849|234147|P1|COMPLETED|Washout Period for 1 Week||10
96530|NCT01447849|234144|P4|STARTED|Washout Period for 1 Week||10
96531|NCT01447849|234145|P3|STARTED|Washout Period for 1 Week||10
96532|NCT01447849|234146|P2|STARTED|Washout Period for 1 Week||10
96533|NCT01447849|234147|P1|STARTED|Washout Period for 1 Week||10
96534|NCT01447849|234144|P4|NOT COMPLETED|First Intervention||0
96535|NCT01447849|234145|P3|NOT COMPLETED|First Intervention||0
96536|NCT01447849|234146|P2|NOT COMPLETED|First Intervention||0
96537|NCT01447849|234147|P1|NOT COMPLETED|First Intervention||0
96538|NCT01447849|234144|P4|COMPLETED|First Intervention||10
96539|NCT01447849|234145|P3|COMPLETED|First Intervention||10
96540|NCT01447849|234146|P2|COMPLETED|First Intervention||10
96541|NCT01447849|234147|P1|COMPLETED|First Intervention||10
96542|NCT01447849|234144|P4|STARTED|First Intervention||10
96543|NCT01447849|234145|P3|STARTED|First Intervention||10
96544|NCT01447849|234146|P2|STARTED|First Intervention||10
96545|NCT01447849|234147|P1|STARTED|First Intervention||10
96546|NCT01447719|234157|P1|NOT COMPLETED|Overall Study||93
96547|NCT01447719|234157|P1|COMPLETED|Overall Study||59
96548|NCT01447719|234157|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
96549|NCT01447719|234157|P1|Valid AV-45 Scan Acquired|Overall Study||147
96550|NCT01447719|234157|P1|STARTED|Overall Study||152
96551|NCT01447706|234170|P2|NOT COMPLETED|Overall Study||3
96552|NCT01447706|234171|P1|NOT COMPLETED|Overall Study||0
96553|NCT01447706|234170|P2|COMPLETED|Overall Study||80
96554|NCT01447706|234171|P1|COMPLETED|Overall Study||140
96555|NCT01447706|234170|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
96556|NCT01447706|234171|P1|STARTED|Overall Study||140
96557|NCT01447576|234183|P1|NOT COMPLETED|Overall Study||476
96558|NCT01447576|234183|P1|COMPLETED|Overall Study||560
96559|NCT01447576|234183|P1|STARTED|Overall Study||1036
96560|NCT01447511|234194|P5|NOT COMPLETED|Rifampin Period||0
96561|NCT01447511|234195|P4|NOT COMPLETED|Rifampin Period||1
96562|NCT01447511|234196|P3|NOT COMPLETED|Rifampin Period||0
96563|NCT01447511|234197|P2|NOT COMPLETED|Rifampin Period||0
96564|NCT01447511|234198|P1|NOT COMPLETED|Rifampin Period||0
96565|NCT01447511|234194|P5|COMPLETED|Rifampin Period||4
96566|NCT01447511|234195|P4|COMPLETED|Rifampin Period||2
96567|NCT01447511|234196|P3|COMPLETED|Rifampin Period||8
96568|NCT01447511|234197|P2|COMPLETED|Rifampin Period||5
96569|NCT01447511|234198|P1|COMPLETED|Rifampin Period||8
96570|NCT01447511|234194|P5|STARTED|Rifampin Period||4
96571|NCT01447511|234195|P4|STARTED|Rifampin Period||3
96572|NCT01447511|234196|P3|STARTED|Rifampin Period||8
96573|NCT01447511|234197|P2|STARTED|Rifampin Period||5
96574|NCT01447511|234198|P1|STARTED|Rifampin Period||8
96575|NCT01447511|234194|P5|NOT COMPLETED|Fluconazole Period||0
96576|NCT01447511|234195|P4|NOT COMPLETED|Fluconazole Period||0
96577|NCT01447511|234196|P3|NOT COMPLETED|Fluconazole Period||1
96578|NCT01447511|234197|P2|NOT COMPLETED|Fluconazole Period||0
96579|NCT01447511|234198|P1|NOT COMPLETED|Fluconazole Period||0
96580|NCT01447511|234194|P5|COMPLETED|Fluconazole Period||4
96581|NCT01447511|234195|P4|COMPLETED|Fluconazole Period||3
96582|NCT01447511|234196|P3|COMPLETED|Fluconazole Period||8
96583|NCT01447511|234197|P2|COMPLETED|Fluconazole Period||0
96584|NCT01447511|234198|P1|COMPLETED|Fluconazole Period||8
96585|NCT01447511|234194|P5|STARTED|Fluconazole Period||4
96586|NCT01447511|234195|P4|STARTED|Fluconazole Period||3
96587|NCT01447511|234196|P3|STARTED|Fluconazole Period||9
96588|NCT01447511|234197|P2|STARTED|Fluconazole Period||0
96589|NCT01447511|234198|P1|STARTED|Fluconazole Period||8
96590|NCT01447511|234194|P5|NOT COMPLETED|Control Period||0
96591|NCT01447511|234195|P4|NOT COMPLETED|Control Period||0
96592|NCT01447511|234196|P3|NOT COMPLETED|Control Period||0
96593|NCT01447511|234197|P2|NOT COMPLETED|Control Period||0
96594|NCT01447511|234198|P1|NOT COMPLETED|Control Period||0
96595|NCT01447511|234194|P5|COMPLETED|Control Period||4
96596|NCT01447511|234195|P4|COMPLETED|Control Period||3
96597|NCT01447511|234196|P3|COMPLETED|Control Period||9
96598|NCT01447511|234197|P2|COMPLETED|Control Period||5
96599|NCT01447511|234198|P1|COMPLETED|Control Period||8
96600|NCT01447511|234194|P5|STARTED|Control Period||4
96601|NCT01447511|234195|P4|STARTED|Control Period||3
96602|NCT01447511|234196|P3|STARTED|Control Period||9
96603|NCT01447511|234197|P2|STARTED|Control Period||5
96604|NCT01447511|234198|P1|STARTED|Control Period||8
96605|NCT01447446|234216|P6|NOT COMPLETED|Overall Study||32
96606|NCT01447446|234217|P5|NOT COMPLETED|Overall Study||211
96607|NCT01447446|234218|P4|NOT COMPLETED|Overall Study||33
96608|NCT01447446|234219|P3|NOT COMPLETED|Overall Study||100
96609|NCT01447446|234220|P2|NOT COMPLETED|Overall Study||165
96610|NCT01447446|234221|P1|NOT COMPLETED|Overall Study||722
96611|NCT01447446|234216|P6|COMPLETED|Overall Study||54
96612|NCT01447446|234217|P5|COMPLETED|Overall Study||610
96613|NCT01447446|234218|P4|COMPLETED|Overall Study||60
96614|NCT01447446|234219|P3|COMPLETED|Overall Study||192
96615|NCT01447446|234220|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
96616|NCT01447446|234221|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
96617|NCT01447446|234216|P6|STARTED|Overall Study||86
96618|NCT01447446|234217|P5|STARTED|Overall Study||821
96619|NCT01447446|234218|P4|STARTED|Overall Study||93
96620|NCT01447446|234219|P3|STARTED|Overall Study||292
96621|NCT01447446|234220|P2|STARTED|Overall Study||496
96622|NCT01447446|234221|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
96623|NCT01447433|234311|P2|NOT COMPLETED|Overall Study||6
96624|NCT01447433|234312|P1|NOT COMPLETED|Overall Study||4
96625|NCT01447433|234311|P2|COMPLETED|Overall Study||21
96626|NCT01447433|234312|P1|COMPLETED|Overall Study||22
96627|NCT01447433|234311|P2|STARTED|Overall Study||27
96628|NCT01447433|234312|P1|STARTED|Overall Study||26
96629|NCT01447420|234339|P3|NOT COMPLETED|Overall Study||10
96630|NCT01447420|234340|P2|NOT COMPLETED|Overall Study||27
96631|NCT01447420|234341|P1|NOT COMPLETED|Overall Study||10
96632|NCT01447420|234339|P3|COMPLETED|Overall Study||8
96633|NCT01447420|234340|P2|COMPLETED|Overall Study||45
96634|NCT01447420|234341|P1|COMPLETED|Overall Study||29
96635|NCT01447420|234339|P3|STARTED|Overall Study||18
96636|NCT01447420|234340|P2|STARTED|Overall Study||72
96637|NCT01447420|234341|P1|STARTED|Overall Study||39
96638|NCT01447225|234361|P10|NOT COMPLETED|Overall Study||0
96639|NCT01447225|234362|P9|NOT COMPLETED|Overall Study||0
96640|NCT01447225|234363|P8|NOT COMPLETED|Overall Study||0
96641|NCT01447225|234364|P7|NOT COMPLETED|Overall Study||0
96642|NCT01447225|234365|P6|NOT COMPLETED|Overall Study||0
96643|NCT01447225|234366|P5|NOT COMPLETED|Overall Study||0
96644|NCT01447225|234367|P4|NOT COMPLETED|Overall Study||0
96645|NCT01447225|234368|P3|NOT COMPLETED|Overall Study||0
96646|NCT01447225|234369|P2|NOT COMPLETED|Overall Study||0
96647|NCT01447225|234370|P1|NOT COMPLETED|Overall Study||0
96648|NCT01447225|234361|P10|COMPLETED|Overall Study||4
96649|NCT01447225|234362|P9|COMPLETED|Overall Study||3
96650|NCT01447225|234363|P8|COMPLETED|Overall Study||4
96651|NCT01447225|234364|P7|COMPLETED|Overall Study||7
96652|NCT01447225|234365|P6|COMPLETED|Overall Study||3
96653|NCT01447225|234366|P5|COMPLETED|Overall Study||3
96654|NCT01447225|234367|P4|COMPLETED|Overall Study||3
96655|NCT01447225|234368|P3|COMPLETED|Overall Study||5
96656|NCT01447225|234369|P2|COMPLETED|Overall Study||8
96657|NCT01447225|234370|P1|COMPLETED|Overall Study||3
96658|NCT01447225|234361|P10|STARTED|Overall Study||4
96659|NCT01447225|234362|P9|STARTED|Overall Study||3
96660|NCT01447225|234363|P8|STARTED|Overall Study||4
96661|NCT01447225|234364|P7|STARTED|Overall Study||7
96662|NCT01447225|234365|P6|STARTED|Overall Study||3
96663|NCT01447225|234366|P5|STARTED|Overall Study||3
96664|NCT01447225|234367|P4|STARTED|Overall Study||3
96665|NCT01447225|234368|P3|STARTED|Overall Study||5
96666|NCT01447225|234369|P2|STARTED|Overall Study||8
96667|NCT01447225|234370|P1|STARTED|Overall Study||3
96668|NCT01447121|234440|P1|NOT COMPLETED|Overall Study||0
96669|NCT01447121|234440|P1|COMPLETED|Overall Study||118
96670|NCT01447121|234440|P1|STARTED|Overall Study||118
96671|NCT01447017|234447|P2|NOT COMPLETED|Overall Study||10
96672|NCT01447017|234448|P1|NOT COMPLETED|Overall Study||10
96673|NCT01447017|234447|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
96674|NCT01447017|234448|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
96675|NCT01447017|234447|P2|Performed Visit 2|Overall Study||24
96676|NCT01447017|234448|P1|Performed Visit 2|Overall Study||43
96677|NCT01447017|234447|P2|STARTED|Overall Study||24
96678|NCT01447017|234448|P1|STARTED|Overall Study||45
96679|NCT01446796|234454|P2|NOT COMPLETED|Overall Study||0
96680|NCT01446796|234455|P1|NOT COMPLETED|Overall Study||1
96681|NCT01446796|234454|P2|COMPLETED|Overall Study|Study terminated early|0
96682|NCT01446796|234455|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
96683|NCT01446796|234454|P2|STARTED|Overall Study||0
96684|NCT01446796|234455|P1|STARTED|Overall Study||3
96685|NCT01446705|234469|P2|NOT COMPLETED|Overall Study||0
96686|NCT01446705|234470|P1|NOT COMPLETED|Overall Study||0
96687|NCT01446705|234469|P2|COMPLETED|Overall Study||6627
96688|NCT01446705|234470|P1|COMPLETED|Overall Study||50446
96689|NCT01446705|234469|P2|STARTED|Overall Study||6627
96690|NCT01446705|234470|P1|STARTED|Overall Study||50446
96691|NCT01446419|234480|P2|NOT COMPLETED|Overall Study||1
96692|NCT01446419|234481|P1|NOT COMPLETED|Overall Study||5
96693|NCT01446419|234480|P2|COMPLETED|Overall Study||77
96694|NCT01446419|234481|P1|COMPLETED|Overall Study||142
96695|NCT01446419|234480|P2|12 Month Follow-up|Overall Study||77
96696|NCT01446419|234481|P1|12 Month Follow-up|Overall Study||142
96697|NCT01446419|234480|P2|6 Month Follow-up|Overall Study||77
96698|NCT01446419|234481|P1|6 Month Follow-up|Overall Study||144
96699|NCT01446419|234480|P2|3 Month Follow-up|Overall Study||77
96700|NCT01446419|234481|P1|3 Month Follow-up|Overall Study||146
96701|NCT01446419|234480|P2|STARTED|Overall Study||78
96702|NCT01446419|234481|P1|STARTED|Overall Study||147
96703|NCT01446289|234495|P4|NOT COMPLETED|Overall Study||0
96704|NCT01446289|234496|P3|NOT COMPLETED|Overall Study||1
96705|NCT01446289|234497|P2|NOT COMPLETED|Overall Study||0
96706|NCT01446289|234498|P1|NOT COMPLETED|Overall Study||1
96707|NCT01446289|234495|P4|COMPLETED|Overall Study||35
96708|NCT01446289|234496|P3|COMPLETED|Overall Study||50
96709|NCT01446289|234497|P2|COMPLETED|Overall Study||35
96710|NCT01446289|234498|P1|COMPLETED|Overall Study||50
96711|NCT01446289|234495|P4|STARTED|Overall Study||35
96712|NCT01446289|234496|P3|STARTED|Overall Study||51
96713|NCT01446289|234497|P2|STARTED|Overall Study||35
96714|NCT01446289|234498|P1|STARTED|Overall Study||51
96715|NCT01446250|234526|P4|NOT COMPLETED|Follow-up||6
96716|NCT01446250|234527|P3|NOT COMPLETED|Follow-up||0
96717|NCT01446250|234528|P2|NOT COMPLETED|Follow-up||0
96718|NCT01446250|234529|P1|NOT COMPLETED|Follow-up||0
96719|NCT01446250|234526|P4|COMPLETED|Follow-up||0
96720|NCT01446250|234527|P3|COMPLETED|Follow-up||0
96721|NCT01446250|234528|P2|COMPLETED|Follow-up||0
96722|NCT01446250|234529|P1|COMPLETED|Follow-up||0
96723|NCT01446250|234526|P4|STARTED|Follow-up||6
96724|NCT01446250|234527|P3|STARTED|Follow-up||0
96725|NCT01446250|234528|P2|STARTED|Follow-up||0
96726|NCT01446250|234529|P1|STARTED|Follow-up||0
96727|NCT01446250|234526|P4|NOT COMPLETED|Treatment Period 2||0
96728|NCT01446250|234527|P3|NOT COMPLETED|Treatment Period 2||0
96729|NCT01446250|234528|P2|NOT COMPLETED|Treatment Period 2||1
96730|NCT01446250|234529|P1|NOT COMPLETED|Treatment Period 2||0
96731|NCT01446250|234526|P4|COMPLETED|Treatment Period 2||0
96732|NCT01446250|234527|P3|COMPLETED|Treatment Period 2||0
96733|NCT01446250|234528|P2|COMPLETED|Treatment Period 2||6
96734|NCT01446250|234529|P1|COMPLETED|Treatment Period 2||0
96735|NCT01446250|234526|P4|STARTED|Treatment Period 2||0
96736|NCT01446250|234527|P3|STARTED|Treatment Period 2||0
96737|NCT01446250|234528|P2|STARTED|Treatment Period 2||7
96738|NCT01446250|234529|P1|STARTED|Treatment Period 2||0
96739|NCT01446250|234526|P4|NOT COMPLETED|Clinical Hold||0
96740|NCT01446250|234527|P3|NOT COMPLETED|Clinical Hold||0
96741|NCT01446250|234528|P2|NOT COMPLETED|Clinical Hold||0
96742|NCT01446250|234529|P1|NOT COMPLETED|Clinical Hold||0
96743|NCT01446250|234526|P4|COMPLETED|Clinical Hold||0
96744|NCT01446250|234527|P3|COMPLETED|Clinical Hold||5
96745|NCT01446250|234528|P2|COMPLETED|Clinical Hold||2
96746|NCT01446250|234529|P1|COMPLETED|Clinical Hold||0
96747|NCT01446250|234526|P4|STARTED|Clinical Hold||0
96748|NCT01446250|234527|P3|STARTED|Clinical Hold||5
96749|NCT01446250|234528|P2|STARTED|Clinical Hold||2
96750|NCT01446250|234529|P1|STARTED|Clinical Hold||0
96751|NCT01446250|234526|P4|NOT COMPLETED|Treatment Period 1||0
96752|NCT01446250|234527|P3|NOT COMPLETED|Treatment Period 1||0
96753|NCT01446250|234528|P2|NOT COMPLETED|Treatment Period 1||1
96754|NCT01446250|234529|P1|NOT COMPLETED|Treatment Period 1||0
96755|NCT01446250|234526|P4|COMPLETED|Treatment Period 1||0
96756|NCT01446250|234527|P3|COMPLETED|Treatment Period 1||0
96757|NCT01446250|234528|P2|COMPLETED|Treatment Period 1||2
96758|NCT01446250|234529|P1|COMPLETED|Treatment Period 1||5
96759|NCT01446250|234526|P4|STARTED|Treatment Period 1||0
96760|NCT01446250|234527|P3|STARTED|Treatment Period 1||0
96761|NCT01446250|234528|P2|STARTED|Treatment Period 1||3
96762|NCT01446250|234529|P1|STARTED|Treatment Period 1||5
96763|NCT01446237|234541|P1|NOT COMPLETED|Overall Study||10
96764|NCT01446237|234541|P1|COMPLETED|Overall Study||115
96765|NCT01446237|234541|P1|STARTED|Overall Study||125
96766|NCT01446003|234549|P2|NOT COMPLETED|Period 2||0
96767|NCT01446003|234550|P1|NOT COMPLETED|Period 2||1
96768|NCT01446003|234549|P2|COMPLETED|Period 2||15
96769|NCT01446003|234550|P1|COMPLETED|Period 2||13
96770|NCT01446003|234549|P2|STARTED|Period 2||15
96771|NCT01446003|234550|P1|STARTED|Period 2||14
96772|NCT01446003|234549|P2|NOT COMPLETED|Period 1||0
96773|NCT01446003|234550|P1|NOT COMPLETED|Period 1||2
96774|NCT01446003|234549|P2|COMPLETED|Period 1||15
96775|NCT01446003|234550|P1|COMPLETED|Period 1||14
96776|NCT01446003|234549|P2|STARTED|Period 1||15
96777|NCT01446003|234550|P1|STARTED|Period 1||16
96778|NCT01445951|234571|P3|NOT COMPLETED|Overall Study||19
96779|NCT01445951|234572|P2|NOT COMPLETED|Overall Study||36
96780|NCT01445951|234573|P1|NOT COMPLETED|Overall Study||44
96781|NCT01445951|234571|P3|COMPLETED|Overall Study||151
96782|NCT01445951|234572|P2|COMPLETED|Overall Study||138
96783|NCT01445951|234573|P1|COMPLETED|Overall Study||130
96784|NCT01445951|234571|P3|STARTED|Overall Study||170
96785|NCT01445951|234572|P2|STARTED|Overall Study||174
96786|NCT01445951|234573|P1|STARTED|Overall Study||174
96787|NCT01445873|234611|P1|NOT COMPLETED|Overall Study||0
96788|NCT01445873|234611|P1|COMPLETED|Overall Study||36
96789|NCT01445873|234611|P1|STARTED|Overall Study||36
96790|NCT01445847|234641|P2|NOT COMPLETED|Overall Study||14
96791|NCT01445847|234642|P1|NOT COMPLETED|Overall Study||14
96792|NCT01445847|234641|P2|COMPLETED|Overall Study||36
96793|NCT01445847|234642|P1|COMPLETED|Overall Study||36
96794|NCT01445847|234641|P2|STARTED|Overall Study||50
96795|NCT01445847|234642|P1|STARTED|Overall Study||50
96796|NCT01445769|234648|P1|NOT COMPLETED|Overall Study||8
96797|NCT01445769|234648|P1|COMPLETED|Overall Study||37
96798|NCT01445769|234648|P1|STARTED|Overall Study||45
96799|NCT01445678|234668|P2|NOT COMPLETED|Overall Study||21
96800|NCT01445678|234669|P1|NOT COMPLETED|Overall Study||30
96801|NCT01445678|234668|P2|COMPLETED|Overall Study||476
96802|NCT01445678|234669|P1|COMPLETED|Overall Study||452
96803|NCT01445678|234668|P2|STARTED|Overall Study||497
96804|NCT01445678|234669|P1|STARTED|Overall Study||482
96805|NCT01445652|234687|P2|NOT COMPLETED|Overall Study||3
96806|NCT01445652|234688|P1|NOT COMPLETED|Overall Study||10
96807|NCT01445652|234687|P2|COMPLETED|Overall Study||50
96808|NCT01445652|234688|P1|COMPLETED|Overall Study||47
96809|NCT01445652|234687|P2|STARTED|Overall Study||53
96810|NCT01445652|234688|P1|STARTED|Overall Study||57
96811|NCT01445626|234696|P1|NOT COMPLETED|Overall Study||0
96812|NCT01445626|234696|P1|COMPLETED|Overall Study||87
96813|NCT01445626|234696|P1|STARTED|Overall Study||87
96814|NCT01445613|234706|P1|NOT COMPLETED|1-year Follow-up||77
96815|NCT01445613|234706|P1|COMPLETED|1-year Follow-up||1088
96816|NCT01445613|234706|P1|STARTED|1-year Follow-up||1165
96817|NCT01445613|234706|P1|NOT COMPLETED|30-day Follow-up||35
96818|NCT01445613|234706|P1|COMPLETED|30-day Follow-up||1165
96819|NCT01445613|234706|P1|STARTED|30-day Follow-up||1200
96820|NCT01445548|234724|P1|NOT COMPLETED|Overall Study||1
96821|NCT01445548|234724|P1|COMPLETED|Overall Study||5
96822|NCT01445548|234724|P1|STARTED|Overall Study||6
96823|NCT01445301|234748|P3|NOT COMPLETED|Overall Study||9
96824|NCT01445301|234749|P2|NOT COMPLETED|Overall Study||35
96825|NCT01445301|234750|P1|NOT COMPLETED|Overall Study||21
96826|NCT01445301|234748|P3|COMPLETED|Overall Study||290
96827|NCT01445301|234749|P2|COMPLETED|Overall Study||262
96828|NCT01445301|234750|P1|COMPLETED|Overall Study||183
96829|NCT01445301|234748|P3|STARTED|Overall Study||299
96830|NCT01445301|234749|P2|STARTED|Overall Study||297
96831|NCT01445301|234750|P1|STARTED|Overall Study||204
96832|NCT01445028|234787|P2|NOT COMPLETED|Overall Study||3
96833|NCT01445028|234788|P1|NOT COMPLETED|Overall Study||0
96834|NCT01445028|234787|P2|COMPLETED|Overall Study||51
96835|NCT01445028|234788|P1|COMPLETED|Overall Study||58
96836|NCT01445028|234787|P2|STARTED|Overall Study||54
96837|NCT01445028|234788|P1|STARTED|Overall Study||58
96838|NCT01444924|234796|P2|NOT COMPLETED|Overall Study||0
96839|NCT01444924|234797|P1|NOT COMPLETED|Overall Study||0
96840|NCT01444924|234796|P2|COMPLETED|Overall Study||33
96841|NCT01444924|234797|P1|COMPLETED|Overall Study||31
96842|NCT01444924|234796|P2|STARTED|Overall Study||33
96843|NCT01444924|234797|P1|STARTED|Overall Study||31
96844|NCT01444911|234807|P2|NOT COMPLETED|Overall Study||0
96845|NCT01444911|234808|P1|NOT COMPLETED|Overall Study||8
96846|NCT01444911|234807|P2|COMPLETED|Overall Study||13
96847|NCT01444911|234808|P1|COMPLETED|Overall Study||8
96848|NCT01444911|234807|P2|STARTED|Overall Study||13
96849|NCT01444911|234808|P1|STARTED|Overall Study||16
96850|NCT01444898|234820|P1|NOT COMPLETED|Overall Study||1
96851|NCT01444898|234820|P1|COMPLETED|Overall Study||9
96852|NCT01444898|234820|P1|STARTED|Overall Study||10
96853|NCT01444781|234835|P3|NOT COMPLETED|Overall Study||3
96854|NCT01444781|234836|P2|NOT COMPLETED|Overall Study||4
96855|NCT01444781|234837|P1|NOT COMPLETED|Overall Study||3
96856|NCT01444781|234835|P3|COMPLETED|Overall Study||272
96857|NCT01444781|234836|P2|COMPLETED|Overall Study||411
96858|NCT01444781|234837|P1|COMPLETED|Overall Study||413
96859|NCT01444781|234835|P3|STARTED|Overall Study||275
96860|NCT01444781|234836|P2|STARTED|Overall Study||415
96861|NCT01444781|234837|P1|STARTED|Overall Study||416
96862|NCT01444742|234875|P1|NOT COMPLETED|Overall Study||1
96863|NCT01444742|234875|P1|COMPLETED|Overall Study||80
96864|NCT01444742|234875|P1|STARTED|Overall Study||81
96865|NCT01444651|234882|P2|NOT COMPLETED|Overall Study||9
96866|NCT01444651|234883|P1|NOT COMPLETED|Overall Study||11
96867|NCT01444651|234882|P2|COMPLETED|Overall Study||28
96868|NCT01444651|234883|P1|COMPLETED|Overall Study||25
96869|NCT01444651|234882|P2|STARTED|Overall Study||37
96870|NCT01444651|234883|P1|STARTED|Overall Study||36
96871|NCT01444456|234899|P1|NOT COMPLETED|Overall Study||285
96872|NCT01444456|234899|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
96873|NCT01444456|234899|P1|Received Darbepoetin Alfa|Overall Study||1134
96874|NCT01444456|234899|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
96875|NCT01444456|234899|P1|STARTED|Overall Study||1262
96876|NCT01444430|234910|P2|NOT COMPLETED|Overall Study||81
96877|NCT01444430|234911|P1|NOT COMPLETED|Overall Study||61
96878|NCT01444430|234910|P2|COMPLETED|Overall Study||5766
96879|NCT01444430|234911|P1|COMPLETED|Overall Study||5785
96880|NCT01444430|234910|P2|STARTED|Overall Study||5847
96881|NCT01444430|234911|P1|STARTED|Overall Study||5846
96882|NCT01444417|234933|P2|NOT COMPLETED|Overall Study||1
96883|NCT01444417|234934|P1|NOT COMPLETED|Overall Study||2
96884|NCT01444417|234933|P2|COMPLETED|Overall Study||41
96885|NCT01444417|234934|P1|COMPLETED|Overall Study||18
96886|NCT01444417|234933|P2|Received Treatment|Overall Study||42
96887|NCT01444417|234934|P1|Received Treatment|Overall Study||19
96888|NCT01444417|234933|P2|STARTED|Overall Study||42
96889|NCT01444417|234934|P1|STARTED|Overall Study||20
96890|NCT01444391|234950|P1|NOT COMPLETED|Overall Study||1
96891|NCT01444391|234950|P1|COMPLETED|Overall Study||41
96892|NCT01444391|234950|P1|STARTED|Overall Study||42
96893|NCT01444378|234958|P1|NOT COMPLETED|Overall Study||17
96894|NCT01444378|234958|P1|COMPLETED|Overall Study||124
96895|NCT01444378|234958|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
96896|NCT01444300|235070|P2|NOT COMPLETED|Overall Study||0
96897|NCT01444300|235071|P1|NOT COMPLETED|Overall Study||4
96898|NCT01444300|235070|P2|COMPLETED|Overall Study||12
96899|NCT01444300|235071|P1|COMPLETED|Overall Study||8
96900|NCT01444300|235070|P2|STARTED|Overall Study||12
96901|NCT01444300|235071|P1|STARTED|Overall Study||12
96902|NCT01444287|235081|P1|NOT COMPLETED|Period 4||0
96903|NCT01444287|235081|P1|COMPLETED|Period 4||22
96904|NCT01444287|235081|P1|STARTED|Period 4||22
96905|NCT01444287|235081|P1|NOT COMPLETED|Period 3||0
96906|NCT01444287|235081|P1|COMPLETED|Period 3||22
96907|NCT01444287|235081|P1|STARTED|Period 3||22
96908|NCT01444287|235081|P1|NOT COMPLETED|Period 2||0
96909|NCT01444287|235081|P1|COMPLETED|Period 2||22
96910|NCT01444287|235081|P1|STARTED|Period 2||22
96911|NCT01444287|235081|P1|NOT COMPLETED|Period 1||0
96912|NCT01444287|235081|P1|COMPLETED|Period 1||22
96913|NCT01444287|235081|P1|STARTED|Period 1||22
96914|NCT01444092|235103|P1|NOT COMPLETED|Overall Study||17
96915|NCT01444092|235103|P1|COMPLETED|Overall Study||91
96916|NCT01444092|235103|P1|INFORMED CONSENT OBTAINED|Overall Study||108
96917|NCT01444092|235103|P1|STARTED|Overall Study||108
96918|NCT01444027|235112|P3|NOT COMPLETED|Overall Study||38
96919|NCT01444027|235113|P2|NOT COMPLETED|Overall Study||30
96920|NCT01444027|235114|P1|NOT COMPLETED|Overall Study||30
96921|NCT01444027|235112|P3|COMPLETED|Overall Study||133
96922|NCT01444027|235113|P2|COMPLETED|Overall Study||141
96923|NCT01444027|235114|P1|COMPLETED|Overall Study||142
96924|NCT01444027|235112|P3|3 Month Follow-up|Overall Study||133
96925|NCT01444027|235113|P2|3 Month Follow-up|Overall Study||141
96926|NCT01444027|235114|P1|3 Month Follow-up|Overall Study||142
96927|NCT01444027|235112|P3|1 Month Follow-up|Overall Study||141
96928|NCT01444027|235113|P2|1 Month Follow-up|Overall Study||159
96929|NCT01444027|235114|P1|1 Month Follow-up|Overall Study||160
96930|NCT01444027|235112|P3|Received Intervention as Assigned|Overall Study||147
96931|NCT01444027|235113|P2|Received Intervention as Assigned|Overall Study||161
96932|NCT01444027|235114|P1|Received Intervention as Assigned|Overall Study||168
96933|NCT01444027|235112|P3|STARTED|Overall Study||171
96934|NCT01444027|235113|P2|STARTED|Overall Study||171
96935|NCT01444027|235114|P1|STARTED|Overall Study||172
96936|NCT01443923|235136|P2|NOT COMPLETED|Overall Study||0
96937|NCT01443923|235137|P1|NOT COMPLETED|Overall Study||1
96938|NCT01443923|235136|P2|COMPLETED|Overall Study||1
96939|NCT01443923|235137|P1|COMPLETED|Overall Study||2
96940|NCT01443923|235136|P2|STARTED|Overall Study||1
96941|NCT01443923|235137|P1|STARTED|Overall Study||3
96942|NCT01443858|235154|P3|NOT COMPLETED|Overall Study||7
96943|NCT01443858|235155|P2|NOT COMPLETED|Overall Study||13
96944|NCT01443858|235156|P1|NOT COMPLETED|Overall Study||15
96945|NCT01443858|235154|P3|COMPLETED|Overall Study||18
96946|NCT01443858|235155|P2|COMPLETED|Overall Study||12
96947|NCT01443858|235156|P1|COMPLETED|Overall Study||10
96948|NCT01443858|235154|P3|STARTED|Overall Study||25
96949|NCT01443858|235155|P2|STARTED|Overall Study||25
96950|NCT01443858|235156|P1|STARTED|Overall Study||25
96951|NCT01443845|235178|P2|NOT COMPLETED|Overall Study||337
96952|NCT01443845|235179|P1|NOT COMPLETED|Overall Study||254
96953|NCT01443845|235178|P2|COMPLETED|Overall Study||841
96954|NCT01443845|235179|P1|COMPLETED|Overall Study||922
96955|NCT01443845|235178|P2|STARTED|Overall Study||1178
96956|NCT01443845|235179|P1|STARTED|Overall Study||1176
96957|NCT01443494|235191|P1|NOT COMPLETED|Overall Study||0
96958|NCT01443494|235191|P1|COMPLETED|Overall Study||19
96959|NCT01443494|235191|P1|STARTED|Overall Study||19
96960|NCT01443403|235200|P4|NOT COMPLETED|Overall Study||9
96961|NCT01443403|235201|P3|NOT COMPLETED|Overall Study||7
96962|NCT01443403|235202|P2|NOT COMPLETED|Overall Study||6
96963|NCT01443403|235203|P1|NOT COMPLETED|Overall Study||6
96964|NCT01443403|235200|P4|COMPLETED|Overall Study||52
96965|NCT01443403|235201|P3|COMPLETED|Overall Study||54
96966|NCT01443403|235202|P2|COMPLETED|Overall Study||55
96967|NCT01443403|235203|P1|COMPLETED|Overall Study||55
96968|NCT01443403|235200|P4|Received Treatment|Overall Study||61
96969|NCT01443403|235201|P3|Received Treatment|Overall Study||60
96970|NCT01443403|235202|P2|Received Treatment|Overall Study||61
96971|NCT01443403|235203|P1|Received Treatment|Overall Study||61
96972|NCT01443403|235200|P4|STARTED|Overall Study||61
96973|NCT01443403|235201|P3|STARTED|Overall Study||61
96974|NCT01443403|235202|P2|STARTED|Overall Study||61
96975|NCT01443403|235203|P1|STARTED|Overall Study||61
96976|NCT01443364|235350|P1|NOT COMPLETED|Overall Study||41
96977|NCT01443364|235350|P1|COMPLETED|Overall Study||91
96978|NCT01443364|235350|P1|STARTED|Overall Study||132
96979|NCT01443130|235479|P6|NOT COMPLETED|Overall Study||34
96980|NCT01443130|235480|P5|NOT COMPLETED|Overall Study||44
96981|NCT01443130|235481|P4|NOT COMPLETED|Overall Study||39
96982|NCT01443130|235482|P3|NOT COMPLETED|Overall Study||77
96983|NCT01443130|235483|P2|NOT COMPLETED|Overall Study||69
96984|NCT01443130|235484|P1|NOT COMPLETED|Overall Study||68
96985|NCT01443130|235479|P6|COMPLETED|Overall Study||225
96986|NCT01443130|235480|P5|COMPLETED|Overall Study||230
96987|NCT01443130|235481|P4|COMPLETED|Overall Study||231
96988|NCT01443130|235482|P3|COMPLETED|Overall Study||223
96989|NCT01443130|235483|P2|COMPLETED|Overall Study||231
96990|NCT01443130|235484|P1|COMPLETED|Overall Study||232
96991|NCT01443130|235479|P6|STARTED|Overall Study||259
96992|NCT01443130|235480|P5|STARTED|Overall Study||274
96993|NCT01443130|235481|P4|STARTED|Overall Study||270
96994|NCT01443130|235482|P3|STARTED|Overall Study||300
96995|NCT01443130|235483|P2|STARTED|Overall Study||300
96996|NCT01443130|235484|P1|STARTED|Overall Study||300
96997|NCT01443078|235534|P1|NOT COMPLETED|Overall Study||29
96998|NCT01443078|235534|P1|COMPLETED|Overall Study||13
96999|NCT01443078|235534|P1|STARTED|Overall Study||42
97000|NCT01443026|235540|P2|NOT COMPLETED|Overall Study||5
97001|NCT01443026|235541|P1|NOT COMPLETED|Overall Study||3
97002|NCT01443026|235540|P2|COMPLETED|Overall Study||32
97003|NCT01443026|235541|P1|COMPLETED|Overall Study||26
97004|NCT01443026|235540|P2|STARTED|Overall Study||37
97005|NCT01443026|235541|P1|STARTED|Overall Study||29
97006|NCT01442844|235549|P2|NOT COMPLETED|Overall Study||0
97007|NCT01442844|235550|P1|NOT COMPLETED|Overall Study||0
97008|NCT01442844|235549|P2|COMPLETED|Overall Study||2
97009|NCT01442844|235550|P1|COMPLETED|Overall Study||1
97010|NCT01442844|235549|P2|STARTED|Overall Study||2
97011|NCT01442844|235550|P1|STARTED|Overall Study||1
97012|NCT01442779|235556|P1|NOT COMPLETED|Overall Study||7
97013|NCT01442779|235556|P1|COMPLETED|Overall Study||11
97014|NCT01442779|235556|P1|STARTED|Overall Study||18
97015|NCT01442714|235562|P1|NOT COMPLETED|Overall Study||12
97016|NCT01442714|235562|P1|COMPLETED|Overall Study||21
97017|NCT01442714|235562|P1|STARTED|Overall Study||33
97018|NCT01442688|235570|P2|NOT COMPLETED|Second Intervention||0
97019|NCT01442688|235571|P1|NOT COMPLETED|Second Intervention||1
97020|NCT01442688|235570|P2|COMPLETED|Second Intervention||31
97021|NCT01442688|235571|P1|COMPLETED|Second Intervention||28
97022|NCT01442688|235570|P2|STARTED|Second Intervention||31
97023|NCT01442688|235571|P1|STARTED|Second Intervention||29
97024|NCT01442688|235570|P2|NOT COMPLETED|First Intervention||0
97025|NCT01442688|235571|P1|NOT COMPLETED|First Intervention||2
97026|NCT01442688|235570|P2|COMPLETED|First Intervention||31
97027|NCT01442688|235571|P1|COMPLETED|First Intervention||29
97028|NCT01442688|235570|P2|STARTED|First Intervention||31
97029|NCT01442688|235571|P1|STARTED|First Intervention||31
97030|NCT01442675|235579|P1|NOT COMPLETED|Overall Study||12
97031|NCT01442675|235579|P1|COMPLETED|Overall Study||822
97032|NCT01442675|235579|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
97033|NCT01442675|235579|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
97034|NCT01442675|235579|P1|STARTED|Overall Study||834
97035|NCT01442493|235591|P2|NOT COMPLETED|Overall Study||2
97036|NCT01442493|235592|P1|NOT COMPLETED|Overall Study||3
97037|NCT01442493|235591|P2|COMPLETED|Overall Study||149
97038|NCT01442493|235592|P1|COMPLETED|Overall Study||146
97039|NCT01442493|235591|P2|STARTED|Overall Study||151
97040|NCT01442493|235592|P1|STARTED|Overall Study||149
97041|NCT01442376|235613|P3|NOT COMPLETED|Overall Study||5
97042|NCT01442376|235614|P2|NOT COMPLETED|Overall Study||9
97043|NCT01442376|235615|P1|NOT COMPLETED|Overall Study||3
97044|NCT01442376|235613|P3|COMPLETED|Overall Study||159
97045|NCT01442376|235614|P2|COMPLETED|Overall Study||160
97046|NCT01442376|235615|P1|COMPLETED|Overall Study||166
97047|NCT01442376|235613|P3|STARTED|Overall Study|Randomized patients|164
97048|NCT01442376|235614|P2|STARTED|Overall Study|Randomized patients|169
97049|NCT01442376|235615|P1|STARTED|Overall Study|Randomized patients|169
97050|NCT01442181|235628|P2|NOT COMPLETED|Overall Study||3
97051|NCT01442181|235629|P1|NOT COMPLETED|Overall Study||4
97052|NCT01442181|235628|P2|COMPLETED|Overall Study||8
97053|NCT01442181|235629|P1|COMPLETED|Overall Study||10
97054|NCT01442181|235628|P2|STARTED|Overall Study||11
97055|NCT01442181|235629|P1|STARTED|Overall Study||14
97056|NCT01442155|235653|P1|NOT COMPLETED|Overall Study||65
97057|NCT01442155|235653|P1|COMPLETED|Overall Study||9
97058|NCT01442155|235653|P1|STARTED|Overall Study||74
97059|NCT01442129|235660|P2|NOT COMPLETED|Overall Study||0
97060|NCT01442129|235661|P1|NOT COMPLETED|Overall Study||0
97061|NCT01442129|235660|P2|COMPLETED|Overall Study||10
97062|NCT01442129|235661|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
97063|NCT01442129|235660|P2|STARTED|Overall Study||10
97064|NCT01442129|235661|P1|STARTED|Overall Study||20
97065|NCT01442103|235669|P1|NOT COMPLETED|Overall Study||2
97066|NCT01442103|235669|P1|COMPLETED|Overall Study||8
97067|NCT01442103|235669|P1|STARTED|Overall Study||10
97068|NCT01442064|235679|P6|NOT COMPLETED|Overall Study||99
97069|NCT01442064|235680|P5|NOT COMPLETED|Overall Study||106
97070|NCT01442064|235681|P4|NOT COMPLETED|Overall Study||98
97071|NCT01442064|235682|P3|NOT COMPLETED|Overall Study||104
97072|NCT01442064|235683|P2|NOT COMPLETED|Overall Study||101
97073|NCT01442064|235684|P1|NOT COMPLETED|Overall Study||97
97074|NCT01442064|235679|P6|COMPLETED|Overall Study||0
97075|NCT01442064|235680|P5|COMPLETED|Overall Study||1
97076|NCT01442064|235681|P4|COMPLETED|Overall Study||0
97077|NCT01442064|235682|P3|COMPLETED|Overall Study||0
97078|NCT01442064|235683|P2|COMPLETED|Overall Study||2
97079|NCT01442064|235684|P1|COMPLETED|Overall Study||0
97080|NCT01442064|235679|P6|Received Study Drug in Extension Study|Overall Study||81
97081|NCT01442064|235680|P5|Received Study Drug in Extension Study|Overall Study||89
97082|NCT01442064|235681|P4|Received Study Drug in Extension Study|Overall Study||70
97083|NCT01442064|235682|P3|Received Study Drug in Extension Study|Overall Study||60
97084|NCT01442064|235683|P2|Received Study Drug in Extension Study|Overall Study||70
97085|NCT01442064|235684|P1|Received Study Drug in Extension Study|Overall Study||61
97086|NCT01442064|235679|P6|Ranibizumab-Treated Subjects|Overall Study||99
97087|NCT01442064|235680|P5|Ranibizumab-Treated Subjects|Overall Study||107
97088|NCT01442064|235681|P4|Ranibizumab-Treated Subjects|Overall Study||96
97089|NCT01442064|235682|P3|Ranibizumab-Treated Subjects|Overall Study||104
97090|NCT01442064|235683|P2|Ranibizumab-Treated Subjects|Overall Study||103
97091|NCT01442064|235684|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
97092|NCT01442064|235679|P6|STARTED|Overall Study||99
97093|NCT01442064|235680|P5|STARTED|Overall Study||107
97094|NCT01442064|235681|P4|STARTED|Overall Study||98
97095|NCT01442064|235682|P3|STARTED|Overall Study||104
97096|NCT01442064|235683|P2|STARTED|Overall Study||103
97097|NCT01442064|235684|P1|STARTED|Overall Study||97
97098|NCT01442038|235721|P2|NOT COMPLETED|Overall Study||279
97099|NCT01442038|235722|P1|NOT COMPLETED|Overall Study||303
97100|NCT01442038|235721|P2|COMPLETED|Overall Study||1040
97101|NCT01442038|235722|P1|COMPLETED|Overall Study||1029
97102|NCT01442038|235721|P2|STARTED|Overall Study||1319
97103|NCT01442038|235722|P1|STARTED|Overall Study||1332
97104|NCT01441973|235736|P2|NOT COMPLETED|Overall Study||16
97105|NCT01441973|235737|P1|NOT COMPLETED|Overall Study||15
97106|NCT01441973|235736|P2|COMPLETED|Overall Study|Still receiving treatment|0
97107|NCT01441973|235737|P1|COMPLETED|Overall Study|Still receiving treatment|0
97108|NCT01441973|235736|P2|STARTED|Overall Study||16
97109|NCT01441973|235737|P1|STARTED|Overall Study||15
97110|NCT01441960|235759|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
97111|NCT01441960|235760|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
97112|NCT01441960|235759|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
97113|NCT01441960|235760|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
97114|NCT01441960|235759|P2|STARTED|Second Neuromuscular Blocking Agent||13
97115|NCT01441960|235760|P1|STARTED|Second Neuromuscular Blocking Agent||18
97116|NCT01441960|235759|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
97117|NCT01441960|235760|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
97118|NCT01441960|235759|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
97119|NCT01441960|235760|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
97120|NCT01441960|235759|P2|STARTED|First Neuromuscular Blocking Agent:||19
97121|NCT01441960|235760|P1|STARTED|First Neuromuscular Blocking Agent:||26
97122|NCT01441882|235770|P1|NOT COMPLETED|Overall Study||6
97123|NCT01441882|235770|P1|COMPLETED|Overall Study||13
97124|NCT01441882|235770|P1|STARTED|Overall Study||19
97125|NCT01441843|235776|P2|NOT COMPLETED|Overall Study||5
97126|NCT01441843|235777|P1|NOT COMPLETED|Overall Study||12
97127|NCT01441843|235776|P2|COMPLETED|Overall Study||195
97128|NCT01441843|235777|P1|COMPLETED|Overall Study||188
97129|NCT01441843|235776|P2|STARTED|Overall Study||200
97130|NCT01441843|235777|P1|STARTED|Overall Study||200
97131|NCT01441765|235785|P2|NOT COMPLETED|Overall Study||0
97132|NCT01441765|235786|P1|NOT COMPLETED|Overall Study||1
97133|NCT01441765|235785|P2|COMPLETED|Overall Study|not opened|0
97134|NCT01441765|235786|P1|COMPLETED|Overall Study||10
97135|NCT01441765|235785|P2|STARTED|Overall Study|not opened|0
97136|NCT01441765|235786|P1|STARTED|Overall Study||11
97137|NCT01441596|235803|P3|NOT COMPLETED|Overall Study||4
97138|NCT01441596|235804|P2|NOT COMPLETED|Overall Study||3
97139|NCT01441596|235805|P1|NOT COMPLETED|Overall Study||4
97140|NCT01441596|235803|P3|COMPLETED|Overall Study||39
97141|NCT01441596|235804|P2|COMPLETED|Overall Study||35
97142|NCT01441596|235805|P1|COMPLETED|Overall Study||36
97143|NCT01441596|235803|P3|STARTED|Overall Study||43
97144|NCT01441596|235804|P2|STARTED|Overall Study||38
97145|NCT01441596|235805|P1|STARTED|Overall Study||40
97146|NCT01441570|235821|P2|NOT COMPLETED|Overall Study||0
97147|NCT01441570|235822|P1|NOT COMPLETED|Overall Study||0
97148|NCT01441570|235821|P2|COMPLETED|Overall Study||5
97149|NCT01441570|235822|P1|COMPLETED|Overall Study||6
97150|NCT01441570|235821|P2|STARTED|Overall Study||5
97151|NCT01441570|235822|P1|STARTED|Overall Study||6
97152|NCT01441466|235832|P2|NOT COMPLETED|Overall Study||0
97153|NCT01441466|235833|P1|NOT COMPLETED|Overall Study||0
97154|NCT01441466|235832|P2|COMPLETED|Overall Study||11
97155|NCT01441466|235833|P1|COMPLETED|Overall Study||37
97156|NCT01441466|235832|P2|STARTED|Overall Study||11
97157|NCT01441466|235833|P1|STARTED|Overall Study||37
97158|NCT01441440|235852|P3|NOT COMPLETED|Overall Study||22
97159|NCT01441440|235853|P2|NOT COMPLETED|Overall Study||23
97160|NCT01441440|235854|P1|NOT COMPLETED|Overall Study||17
97161|NCT01441440|235852|P3|COMPLETED|Overall Study||158
97162|NCT01441440|235853|P2|COMPLETED|Overall Study||151
97163|NCT01441440|235854|P1|COMPLETED|Overall Study||166
97164|NCT01441440|235852|P3|STARTED|Overall Study|Safety analysis set|180
97165|NCT01441440|235853|P2|STARTED|Overall Study|Safety analysis set|174
97166|NCT01441440|235854|P1|STARTED|Overall Study|Safety analysis set|183
97167|NCT01441414|235877|P1|NOT COMPLETED|Overall Study||15
97168|NCT01441414|235877|P1|COMPLETED|Overall Study||3
97169|NCT01441414|235877|P1|STARTED|Overall Study||18
97170|NCT01441401|235902|P1|NOT COMPLETED|Overall Study||0
97171|NCT01441401|235902|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
97172|NCT01441401|235902|P1|STARTED|Overall Study||82
97173|NCT01441245|235930|P2|NOT COMPLETED|Overall Study||0
97174|NCT01441245|235931|P1|NOT COMPLETED|Overall Study||0
97175|NCT01441245|235930|P2|COMPLETED|Overall Study||27
97176|NCT01441245|235931|P1|COMPLETED|Overall Study||30
97177|NCT01441245|235930|P2|STARTED|Overall Study||27
97178|NCT01441245|235931|P1|STARTED|Overall Study||30
97179|NCT01441180|235956|P3|NOT COMPLETED|Overall Study||3
97180|NCT01441180|235957|P2|NOT COMPLETED|Overall Study||1
97181|NCT01441180|235958|P1|NOT COMPLETED|Overall Study||1
97182|NCT01441180|235956|P3|COMPLETED|Overall Study||22
97183|NCT01441180|235957|P2|COMPLETED|Overall Study||24
97184|NCT01441180|235958|P1|COMPLETED|Overall Study||9
97185|NCT01441180|235956|P3|STARTED|Overall Study||25
97186|NCT01441180|235957|P2|STARTED|Overall Study||25
97187|NCT01441180|235958|P1|STARTED|Overall Study||10
97188|NCT01441102|235969|P1|NOT COMPLETED|Overall Study||3
97189|NCT01441102|235969|P1|COMPLETED|Overall Study||4
97190|NCT01441102|235969|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
97191|NCT01441076|235989|P1|NOT COMPLETED|Overall Study||2
97192|NCT01441076|235989|P1|COMPLETED|Overall Study||4
97193|NCT01441076|235989|P1|STARTED|Overall Study||6
97194|NCT01440972|236009|P2|NOT COMPLETED|Overall Study||2
97195|NCT01440972|236010|P1|NOT COMPLETED|Overall Study||3
97196|NCT01440972|236009|P2|COMPLETED|Overall Study||19
97197|NCT01440972|236010|P1|COMPLETED|Overall Study||21
97198|NCT01440972|236009|P2|STARTED|Overall Study||21
97199|NCT01440972|236010|P1|STARTED|Overall Study||24
97200|NCT01440959|236024|P1|NOT COMPLETED|Overall Study||0
97201|NCT01440959|236024|P1|COMPLETED|Overall Study||30
97202|NCT01440959|236024|P1|STARTED|Overall Study||30
97203|NCT01440946|236034|P2|NOT COMPLETED|Overall Study||1
97204|NCT01440946|236035|P1|NOT COMPLETED|Overall Study||2
97205|NCT01440946|236034|P2|COMPLETED|Overall Study||14
97206|NCT01440946|236035|P1|COMPLETED|Overall Study||13
97207|NCT01440946|236034|P2|STARTED|Overall Study||15
97208|NCT01440946|236035|P1|STARTED|Overall Study||15
97209|NCT01440881|236074|P2|NOT COMPLETED|Overall Study||1
97210|NCT01440881|236075|P1|NOT COMPLETED|Overall Study||0
97211|NCT01440881|236074|P2|COMPLETED|Overall Study||14
97212|NCT01440881|236075|P1|COMPLETED|Overall Study||14
97213|NCT01440881|236074|P2|STARTED|Overall Study||15
97214|NCT01440881|236075|P1|STARTED|Overall Study||14
97215|NCT01440816|236089|P2|NOT COMPLETED|Overall Study||11
97216|NCT01440816|236090|P1|NOT COMPLETED|Overall Study||1
97217|NCT01440816|236089|P2|COMPLETED|Overall Study||1
97218|NCT01440816|236090|P1|COMPLETED|Overall Study||2
97219|NCT01440816|236089|P2|STARTED|Overall Study||12
97220|NCT01440816|236090|P1|STARTED|Overall Study||3
97221|NCT01440764|236106|P7|NOT COMPLETED|Test Day 3||0
97222|NCT01440764|236107|P6|NOT COMPLETED|Test Day 3||0
97223|NCT01440764|236108|P5|NOT COMPLETED|Test Day 3||0
97224|NCT01440764|236109|P4|NOT COMPLETED|Test Day 3||0
97225|NCT01440764|236110|P3|NOT COMPLETED|Test Day 3||0
97226|NCT01440764|236111|P2|NOT COMPLETED|Test Day 3||0
97227|NCT01440764|236112|P1|NOT COMPLETED|Test Day 3||0
97228|NCT01440764|236106|P7|COMPLETED|Test Day 3||3
97229|NCT01440764|236107|P6|COMPLETED|Test Day 3||5
97230|NCT01440764|236108|P5|COMPLETED|Test Day 3||3
97231|NCT01440764|236109|P4|COMPLETED|Test Day 3||1
97232|NCT01440764|236110|P3|COMPLETED|Test Day 3||6
97233|NCT01440764|236111|P2|COMPLETED|Test Day 3||2
97234|NCT01440764|236112|P1|COMPLETED|Test Day 3||3
97235|NCT01440764|236106|P7|STARTED|Test Day 3||3
97236|NCT01440764|236107|P6|STARTED|Test Day 3||5
97237|NCT01440764|236108|P5|STARTED|Test Day 3||3
97238|NCT01440764|236109|P4|STARTED|Test Day 3||1
97239|NCT01440764|236110|P3|STARTED|Test Day 3||6
97240|NCT01440764|236111|P2|STARTED|Test Day 3||2
97241|NCT01440764|236112|P1|STARTED|Test Day 3||3
97242|NCT01440764|236106|P7|NOT COMPLETED|Test Day 2||0
97243|NCT01440764|236107|P6|NOT COMPLETED|Test Day 2||0
97244|NCT01440764|236108|P5|NOT COMPLETED|Test Day 2||0
97245|NCT01440764|236109|P4|NOT COMPLETED|Test Day 2||0
97246|NCT01440764|236110|P3|NOT COMPLETED|Test Day 2||0
97247|NCT01440764|236111|P2|NOT COMPLETED|Test Day 2||0
97248|NCT01440764|236112|P1|NOT COMPLETED|Test Day 2||0
97249|NCT01440764|236106|P7|COMPLETED|Test Day 2||3
97250|NCT01440764|236107|P6|COMPLETED|Test Day 2||5
97251|NCT01440764|236108|P5|COMPLETED|Test Day 2||3
97252|NCT01440764|236109|P4|COMPLETED|Test Day 2||1
97253|NCT01440764|236110|P3|COMPLETED|Test Day 2||6
97254|NCT01440764|236111|P2|COMPLETED|Test Day 2||2
97255|NCT01440764|236112|P1|COMPLETED|Test Day 2||3
97256|NCT01440764|236106|P7|STARTED|Test Day 2||3
97257|NCT01440764|236107|P6|STARTED|Test Day 2||5
97258|NCT01440764|236108|P5|STARTED|Test Day 2||3
97259|NCT01440764|236109|P4|STARTED|Test Day 2||1
97260|NCT01440764|236110|P3|STARTED|Test Day 2||6
97261|NCT01440764|236111|P2|STARTED|Test Day 2||2
97262|NCT01440764|236112|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
97263|NCT01440764|236106|P7|NOT COMPLETED|Test Day 1||0
97264|NCT01440764|236107|P6|NOT COMPLETED|Test Day 1||0
97265|NCT01440764|236108|P5|NOT COMPLETED|Test Day 1||0
97266|NCT01440764|236109|P4|NOT COMPLETED|Test Day 1||0
97267|NCT01440764|236110|P3|NOT COMPLETED|Test Day 1||0
97268|NCT01440764|236111|P2|NOT COMPLETED|Test Day 1||0
97269|NCT01440764|236112|P1|NOT COMPLETED|Test Day 1||0
97270|NCT01440764|236106|P7|COMPLETED|Test Day 1||3
97271|NCT01440764|236107|P6|COMPLETED|Test Day 1||5
97272|NCT01440764|236108|P5|COMPLETED|Test Day 1||3
97273|NCT01440764|236109|P4|COMPLETED|Test Day 1||1
97274|NCT01440764|236110|P3|COMPLETED|Test Day 1||6
97275|NCT01440764|236111|P2|COMPLETED|Test Day 1||2
97276|NCT01440764|236112|P1|COMPLETED|Test Day 1||4
97277|NCT01440764|236106|P7|STARTED|Test Day 1||3
97278|NCT01440764|236107|P6|STARTED|Test Day 1||5
97279|NCT01440764|236108|P5|STARTED|Test Day 1||3
97280|NCT01440764|236109|P4|STARTED|Test Day 1||1
97281|NCT01440764|236110|P3|STARTED|Test Day 1||6
97282|NCT01440764|236111|P2|STARTED|Test Day 1||2
97283|NCT01440764|236112|P1|STARTED|Test Day 1||4
97284|NCT01440647|236133|P2|NOT COMPLETED|Overall Study||3
97285|NCT01440647|236134|P1|NOT COMPLETED|Overall Study||2
97286|NCT01440647|236133|P2|COMPLETED|Overall Study||15
97287|NCT01440647|236134|P1|COMPLETED|Overall Study||14
97288|NCT01440647|236133|P2|STARTED|Overall Study||18
97289|NCT01440647|236134|P1|STARTED|Overall Study||16
97290|NCT01440634|236144|P2|NOT COMPLETED|Randomization Phase||10
97291|NCT01440634|236145|P1|NOT COMPLETED|Randomization Phase||6
97292|NCT01440634|236144|P2|COMPLETED|Randomization Phase||14
97293|NCT01440634|236145|P1|COMPLETED|Randomization Phase||24
97294|NCT01440634|236144|P2|STARTED|Randomization Phase||24
97295|NCT01440634|236145|P1|STARTED|Randomization Phase||30
97296|NCT01440634|236144|P2|NOT COMPLETED|Cross Sectional Phase||0
97297|NCT01440634|236145|P1|NOT COMPLETED|Cross Sectional Phase||0
97298|NCT01440634|236144|P2|COMPLETED|Cross Sectional Phase||347
97299|NCT01440634|236145|P1|COMPLETED|Cross Sectional Phase||0
97300|NCT01440634|236144|P2|STARTED|Cross Sectional Phase||347
97301|NCT01440634|236145|P1|STARTED|Cross Sectional Phase||0
97302|NCT01440595|236153|P3|NOT COMPLETED|Overall Study||1
97303|NCT01440595|236154|P2|NOT COMPLETED|Overall Study||3
97304|NCT01440595|236155|P1|NOT COMPLETED|Overall Study||1
97305|NCT01440595|236153|P3|COMPLETED|Overall Study||0
97306|NCT01440595|236154|P2|COMPLETED|Overall Study||0
97307|NCT01440595|236155|P1|COMPLETED|Overall Study||0
97308|NCT01440595|236153|P3|STARTED|Overall Study||1
97309|NCT01440595|236154|P2|STARTED|Overall Study||3
97310|NCT01440595|236155|P1|STARTED|Overall Study||1
97311|NCT01440569|236175|P2|NOT COMPLETED|Open-Label Rollover Phase||6
97312|NCT01440569|236176|P1|NOT COMPLETED|Open-Label Rollover Phase||47
97313|NCT01440569|236175|P2|COMPLETED|Open-Label Rollover Phase||7
97314|NCT01440569|236176|P1|COMPLETED|Open-Label Rollover Phase||204
97315|NCT01440569|236175|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
97316|NCT01440569|236176|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
97317|NCT01440569|236175|P2|NOT COMPLETED|Main Study||4
97318|NCT01440569|236176|P1|NOT COMPLETED|Main Study||36
97319|NCT01440569|236175|P2|COMPLETED|Main Study||14
97320|NCT01440569|236176|P1|COMPLETED|Main Study||260
97321|NCT01440569|236175|P2|Enrolled and Treated|Main Study||18
97322|NCT01440569|236176|P1|Enrolled and Treated|Main Study||295
97323|NCT01440569|236175|P2|STARTED|Main Study||18
97324|NCT01440569|236176|P1|STARTED|Main Study||296
97325|NCT01440543|236198|P4|NOT COMPLETED|Overall Study||6
97326|NCT01440543|236199|P3|NOT COMPLETED|Overall Study||2
97327|NCT01440543|236200|P2|NOT COMPLETED|Overall Study||4
97328|NCT01440543|236201|P1|NOT COMPLETED|Overall Study||4
97329|NCT01440543|236198|P4|COMPLETED|Overall Study||101
97330|NCT01440543|236199|P3|COMPLETED|Overall Study||100
97331|NCT01440543|236200|P2|COMPLETED|Overall Study||101
97332|NCT01440543|236201|P1|COMPLETED|Overall Study||102
97333|NCT01440543|236198|P4|STARTED|Overall Study||107
97334|NCT01440543|236199|P3|STARTED|Overall Study||102
97335|NCT01440543|236200|P2|STARTED|Overall Study||105
97336|NCT01440543|236201|P1|STARTED|Overall Study||106
97337|NCT01440517|236211|P1|NOT COMPLETED|Overall Study||1
97338|NCT01440517|236211|P1|COMPLETED|Overall Study||4
97339|NCT01440517|236211|P1|STARTED|Overall Study||5
97340|NCT01440387|236218|P2|NOT COMPLETED|Overall Study||0
97341|NCT01440387|236219|P1|NOT COMPLETED|Overall Study||0
97342|NCT01440387|236218|P2|COMPLETED|Overall Study||56
97343|NCT01440387|236219|P1|COMPLETED|Overall Study||56
97344|NCT01440387|236218|P2|STARTED|Overall Study||56
97345|NCT01440387|236219|P1|STARTED|Overall Study||56
97346|NCT01440374|236242|P4|NOT COMPLETED|Part 3: Extension||32
97347|NCT01440374|236243|P3|NOT COMPLETED|Part 3: Extension||0
97348|NCT01440374|236244|P2|NOT COMPLETED|Part 3: Extension||0
97349|NCT01440374|236245|P1|NOT COMPLETED|Part 3: Extension||0
97350|NCT01440374|236242|P4|COMPLETED|Part 3: Extension||27
97351|NCT01440374|236243|P3|COMPLETED|Part 3: Extension||0
97352|NCT01440374|236244|P2|COMPLETED|Part 3: Extension||0
97353|NCT01440374|236245|P1|COMPLETED|Part 3: Extension||0
97354|NCT01440374|236242|P4|STARTED|Part 3: Extension||59
97355|NCT01440374|236243|P3|STARTED|Part 3: Extension||0
97356|NCT01440374|236244|P2|STARTED|Part 3: Extension||0
97357|NCT01440374|236245|P1|STARTED|Part 3: Extension||0
97358|NCT01440374|236242|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
97359|NCT01440374|236243|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
97360|NCT01440374|236244|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
97361|NCT01440374|236245|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
97362|NCT01440374|236242|P4|COMPLETED|Part 2; Double-blind Phase||0
97363|NCT01440374|236243|P3|COMPLETED|Part 2; Double-blind Phase||43
97364|NCT01440374|236244|P2|COMPLETED|Part 2; Double-blind Phase||27
97365|NCT01440374|236245|P1|COMPLETED|Part 2; Double-blind Phase||0
97366|NCT01440374|236242|P4|STARTED|Part 2; Double-blind Phase||0
97367|NCT01440374|236243|P3|STARTED|Part 2; Double-blind Phase||98
97368|NCT01440374|236244|P2|STARTED|Part 2; Double-blind Phase||47
97369|NCT01440374|236245|P1|STARTED|Part 2; Double-blind Phase||0
97370|NCT01440374|236242|P4|NOT COMPLETED|Part 1: Open-label Phase||0
97371|NCT01440374|236243|P3|NOT COMPLETED|Part 1: Open-label Phase||0
97372|NCT01440374|236244|P2|NOT COMPLETED|Part 1: Open-label Phase||0
97373|NCT01440374|236245|P1|NOT COMPLETED|Part 1: Open-label Phase||6
97374|NCT01440374|236242|P4|COMPLETED|Part 1: Open-label Phase||0
97375|NCT01440374|236243|P3|COMPLETED|Part 1: Open-label Phase||0
97376|NCT01440374|236244|P2|COMPLETED|Part 1: Open-label Phase||0
97377|NCT01440374|236245|P1|COMPLETED|Part 1: Open-label Phase||11
97378|NCT01440374|236242|P4|STARTED|Part 1: Open-label Phase||0
97379|NCT01440374|236243|P3|STARTED|Part 1: Open-label Phase||0
97380|NCT01440374|236244|P2|STARTED|Part 1: Open-label Phase||0
97381|NCT01440374|236245|P1|STARTED|Part 1: Open-label Phase||17
97382|NCT01440322|236280|P2|NOT COMPLETED|Overall Study||1
97383|NCT01440322|236281|P1|NOT COMPLETED|Overall Study||7
97384|NCT01440322|236280|P2|COMPLETED|Overall Study||49
97385|NCT01440322|236281|P1|COMPLETED|Overall Study||90
97386|NCT01440322|236280|P2|STARTED|Overall Study||50
97387|NCT01440322|236281|P1|STARTED|Overall Study||97
97388|NCT01440283|236303|P1|NOT COMPLETED|Overall Study||10
97389|NCT01440283|236303|P1|COMPLETED|Overall Study||4
97390|NCT01440283|236303|P1|STARTED|Overall Study||14
97391|NCT01440101|236318|P3|NOT COMPLETED|Overall Study||1
97392|NCT01440101|236319|P2|NOT COMPLETED|Overall Study||4
97393|NCT01440101|236320|P1|NOT COMPLETED|Overall Study||2
97394|NCT01440101|236318|P3|COMPLETED|Overall Study||46
97395|NCT01440101|236319|P2|COMPLETED|Overall Study||43
97396|NCT01440101|236320|P1|COMPLETED|Overall Study||10
97397|NCT01440101|236318|P3|STARTED|Overall Study||47
97398|NCT01440101|236319|P2|STARTED|Overall Study||47
97399|NCT01440101|236320|P1|STARTED|Overall Study||12
97400|NCT01440049|236353|P1|NOT COMPLETED|Overall Study||5
97401|NCT01440049|236353|P1|COMPLETED|Overall Study||155
97402|NCT01440049|236353|P1|STARTED|Overall Study||160
97403|NCT01439971|236385|P5|NOT COMPLETED|Overall Study||1
97404|NCT01439971|236386|P4|NOT COMPLETED|Overall Study||0
97405|NCT01439971|236387|P3|NOT COMPLETED|Overall Study||2
97406|NCT01439971|236388|P2|NOT COMPLETED|Overall Study||1
97407|NCT01439971|236389|P1|NOT COMPLETED|Overall Study||0
97408|NCT01439971|236385|P5|COMPLETED|Overall Study||6
97409|NCT01439971|236386|P4|COMPLETED|Overall Study||6
97410|NCT01439971|236387|P3|COMPLETED|Overall Study||6
97411|NCT01439971|236388|P2|COMPLETED|Overall Study||6
97412|NCT01439971|236389|P1|COMPLETED|Overall Study||1
97413|NCT01439971|236385|P5|Received Treatment|Overall Study||6
97414|NCT01439971|236386|P4|Received Treatment|Overall Study||6
97415|NCT01439971|236387|P3|Received Treatment|Overall Study||6
97416|NCT01439971|236388|P2|Received Treatment|Overall Study||6
97417|NCT01439971|236389|P1|Received Treatment|Overall Study||1
97418|NCT01439971|236385|P5|STARTED|Overall Study||7
97419|NCT01439971|236386|P4|STARTED|Overall Study||6
97420|NCT01439971|236387|P3|STARTED|Overall Study||8
97421|NCT01439971|236388|P2|STARTED|Overall Study||7
97422|NCT01439971|236389|P1|STARTED|Overall Study||1
97423|NCT01439945|236569|P4|NOT COMPLETED|Optional Continuation Phase||0
97424|NCT01439945|236570|P3|NOT COMPLETED|Optional Continuation Phase||0
97425|NCT01439945|236571|P2|NOT COMPLETED|Optional Continuation Phase||0
97426|NCT01439945|236572|P1|NOT COMPLETED|Optional Continuation Phase||0
97427|NCT01439945|236569|P4|COMPLETED|Optional Continuation Phase||0
97428|NCT01439945|236570|P3|COMPLETED|Optional Continuation Phase||0
97429|NCT01439945|236571|P2|COMPLETED|Optional Continuation Phase||44
97430|NCT01439945|236572|P1|COMPLETED|Optional Continuation Phase||72
97431|NCT01439945|236569|P4|STARTED|Optional Continuation Phase||0
97432|NCT01439945|236570|P3|STARTED|Optional Continuation Phase||0
97433|NCT01439945|236571|P2|STARTED|Optional Continuation Phase||44
97434|NCT01439945|236572|P1|STARTED|Optional Continuation Phase||72
97435|NCT01439945|236569|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
97436|NCT01439945|236570|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
97437|NCT01439945|236571|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
97438|NCT01439945|236572|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
97439|NCT01439945|236569|P4|COMPLETED|Double-Blind Treatment Phase||46
97440|NCT01439945|236570|P3|COMPLETED|Double-Blind Treatment Phase||45
97441|NCT01439945|236571|P2|COMPLETED|Double-Blind Treatment Phase||91
97442|NCT01439945|236572|P1|COMPLETED|Double-Blind Treatment Phase||93
97443|NCT01439945|236569|P4|STARTED|Double-Blind Treatment Phase||48
97444|NCT01439945|236570|P3|STARTED|Double-Blind Treatment Phase||48
97445|NCT01439945|236571|P2|STARTED|Double-Blind Treatment Phase||96
97446|NCT01439945|236572|P1|STARTED|Double-Blind Treatment Phase||97
97447|NCT01439867|236597|P2|NOT COMPLETED|Overall Study||8
97448|NCT01439867|236598|P1|NOT COMPLETED|Overall Study||6
97449|NCT01439867|236597|P2|COMPLETED|Overall Study||2
97450|NCT01439867|236598|P1|COMPLETED|Overall Study||2
97451|NCT01439867|236597|P2|Received Treatment|Overall Study||10
97452|NCT01439867|236598|P1|Received Treatment|Overall Study||7
97453|NCT01439867|236597|P2|STARTED|Overall Study||10
97454|NCT01439867|236598|P1|STARTED|Overall Study||8
97455|NCT01439724|236639|P2|NOT COMPLETED|Overall Study||8
97456|NCT01439724|236640|P1|NOT COMPLETED|Overall Study||9
97457|NCT01439724|236639|P2|COMPLETED|Overall Study||39
97458|NCT01439724|236640|P1|COMPLETED|Overall Study||38
97459|NCT01439724|236639|P2|STARTED|Overall Study||47
97460|NCT01439724|236640|P1|STARTED|Overall Study||47
97461|NCT01439711|236646|P1|NOT COMPLETED|Overall Study||40
97462|NCT01439711|236646|P1|COMPLETED|Overall Study||68
97463|NCT01439711|236646|P1|STARTED|Overall Study||108
97464|NCT01439672|236657|P1|NOT COMPLETED|Overall Study||24
97465|NCT01439672|236657|P1|COMPLETED|Overall Study||11
97466|NCT01439672|236657|P1|STARTED|Overall Study||35
97467|NCT01439373|236663|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
97468|NCT01439373|236664|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
97469|NCT01439373|236663|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
97470|NCT01439373|236664|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
97471|NCT01439373|236663|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
97472|NCT01439373|236664|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
97473|NCT01439373|236663|P2|NOT COMPLETED|Monotherapy (Day 1)||1
97474|NCT01439373|236664|P1|NOT COMPLETED|Monotherapy (Day 1)||0
97475|NCT01439373|236663|P2|COMPLETED|Monotherapy (Day 1)||4
97476|NCT01439373|236664|P1|COMPLETED|Monotherapy (Day 1)||11
97477|NCT01439373|236663|P2|STARTED|Monotherapy (Day 1)||5
97478|NCT01439373|236664|P1|STARTED|Monotherapy (Day 1)||11
97479|NCT01439360|236707|P2|NOT COMPLETED|Overall Study||208
97480|NCT01439360|236708|P1|NOT COMPLETED|Overall Study||198
97481|NCT01439360|236707|P2|COMPLETED|Overall Study||5804
97482|NCT01439360|236708|P1|COMPLETED|Overall Study||5808
97483|NCT01439360|236707|P2|STARTED|Overall Study||6012
97484|NCT01439360|236708|P1|STARTED|Overall Study||6006
97485|NCT01439282|236758|P2|NOT COMPLETED|Overall Study||1
97486|NCT01439282|236759|P1|NOT COMPLETED|Overall Study||8
97487|NCT01439282|236758|P2|COMPLETED|Overall Study||9
97488|NCT01439282|236759|P1|COMPLETED|Overall Study||59
97489|NCT01439282|236758|P2|STARTED|Overall Study||10
97490|NCT01439282|236759|P1|STARTED|Overall Study||67
97491|NCT01439204|236769|P2|NOT COMPLETED|Overall Study||3
97492|NCT01439204|236770|P1|NOT COMPLETED|Overall Study||4
97493|NCT01439204|236769|P2|COMPLETED|Overall Study||33
97494|NCT01439204|236770|P1|COMPLETED|Overall Study||32
97495|NCT01439204|236769|P2|STARTED|Overall Study||36
97496|NCT01439204|236770|P1|STARTED|Overall Study||36
97497|NCT01439165|236804|P2|NOT COMPLETED|Overall Study||2
97498|NCT01439165|236805|P1|NOT COMPLETED|Overall Study||21
97499|NCT01439165|236804|P2|COMPLETED|Overall Study||326
97500|NCT01439165|236805|P1|COMPLETED|Overall Study||981
97501|NCT01439165|236804|P2|STARTED|Overall Study||328
97502|NCT01439165|236805|P1|STARTED|Overall Study||1002
97503|NCT01439126|236819|P2|NOT COMPLETED|Overall Study||42
97504|NCT01439126|236820|P1|NOT COMPLETED|Overall Study||31
97505|NCT01439126|236819|P2|COMPLETED|Overall Study||25
97506|NCT01439126|236820|P1|COMPLETED|Overall Study||37
97507|NCT01439126|236819|P2|STARTED|Overall Study||67
97508|NCT01439126|236820|P1|STARTED|Overall Study||68
97509|NCT01439074|236842|P2|NOT COMPLETED|Overall Study||13
97510|NCT01439074|236843|P1|NOT COMPLETED|Overall Study||9
97511|NCT01439074|236842|P2|COMPLETED|Overall Study||74
97512|NCT01439074|236843|P1|COMPLETED|Overall Study||66
97513|NCT01439074|236842|P2|STARTED|Overall Study||87
97514|NCT01439074|236843|P1|STARTED|Overall Study||75
97515|NCT01438996|236858|P3|NOT COMPLETED|Overall Study||0
97516|NCT01438996|236859|P2|NOT COMPLETED|Overall Study||1
97517|NCT01438996|236860|P1|NOT COMPLETED|Overall Study||4
97518|NCT01438996|236858|P3|COMPLETED|Overall Study||20
97519|NCT01438996|236859|P2|COMPLETED|Overall Study||12
97520|NCT01438996|236860|P1|COMPLETED|Overall Study||14
97521|NCT01438996|236858|P3|STARTED|Overall Study||20
97522|NCT01438996|236859|P2|STARTED|Overall Study||13
97523|NCT01438996|236860|P1|STARTED|Overall Study||18
97524|NCT01438840|236894|P3|NOT COMPLETED|Extension Phase||10
97525|NCT01438840|236895|P2|NOT COMPLETED|Extension Phase||0
97526|NCT01438840|236896|P1|NOT COMPLETED|Extension Phase||0
97527|NCT01438840|236894|P3|COMPLETED|Extension Phase||29
97528|NCT01438840|236895|P2|COMPLETED|Extension Phase||0
97529|NCT01438840|236896|P1|COMPLETED|Extension Phase||0
97530|NCT01438840|236894|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
97531|NCT01438840|236895|P2|STARTED|Extension Phase||0
97532|NCT01438840|236896|P1|STARTED|Extension Phase||0
97533|NCT01438840|236894|P3|NOT COMPLETED|Core Study||0
97534|NCT01438840|236895|P2|NOT COMPLETED|Core Study||10
97535|NCT01438840|236896|P1|NOT COMPLETED|Core Study||16
97536|NCT01438840|236894|P3|COMPLETED|Core Study||0
97537|NCT01438840|236895|P2|COMPLETED|Core Study||22
97538|NCT01438840|236896|P1|COMPLETED|Core Study||1
97539|NCT01438840|236894|P3|STARTED|Core Study||0
97540|NCT01438840|236895|P2|STARTED|Core Study||32
97541|NCT01438840|236896|P1|STARTED|Core Study||17
97542|NCT01438814|236909|P2|NOT COMPLETED|Overall Study||14
97543|NCT01438814|236910|P1|NOT COMPLETED|Overall Study||14
97544|NCT01438814|236909|P2|COMPLETED|Overall Study||331
97545|NCT01438814|236910|P1|COMPLETED|Overall Study||330
97546|NCT01438814|236909|P2|STARTED|Overall Study||345
97547|NCT01438814|236910|P1|STARTED|Overall Study||344
97548|NCT01438710|236940|P2|NOT COMPLETED|Second Week of Treatment||0
97549|NCT01438710|236941|P1|NOT COMPLETED|Second Week of Treatment||1
97550|NCT01438710|236940|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
97551|NCT01438710|236941|P1|COMPLETED|Second Week of Treatment||40
97552|NCT01438710|236940|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
97553|NCT01438710|236941|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
97554|NCT01438710|236940|P2|NOT COMPLETED|First Week of Treatment||3
97555|NCT01438710|236941|P1|NOT COMPLETED|First Week of Treatment||0
97556|NCT01438710|236940|P2|COMPLETED|First Week of Treatment||41
97557|NCT01438710|236941|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
97558|NCT01438710|236940|P2|STARTED|First Week of Treatment||44
97559|NCT01438710|236941|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
97560|NCT01438541|236946|P1|NOT COMPLETED|Overall Study||7
97561|NCT01438541|236946|P1|COMPLETED|Overall Study||22
97562|NCT01438541|236946|P1|STARTED|Overall Study||29
97563|NCT01438489|236955|P3|NOT COMPLETED|Overall Study||19
97564|NCT01438489|236956|P2|NOT COMPLETED|Overall Study||16
97565|NCT01438489|236957|P1|NOT COMPLETED|Overall Study||26
97566|NCT01438489|236955|P3|COMPLETED|Overall Study||85
97567|NCT01438489|236956|P2|COMPLETED|Overall Study||84
97568|NCT01438489|236957|P1|COMPLETED|Overall Study||77
97569|NCT01438489|236955|P3|STARTED|Overall Study||104
97570|NCT01438489|236956|P2|STARTED|Overall Study||100
97571|NCT01438489|236957|P1|STARTED|Overall Study||103
97572|NCT01438424|237000|P1|NOT COMPLETED|Overall Study||417
97573|NCT01438424|237000|P1|COMPLETED|Overall Study|Completed treatment|634
97574|NCT01438424|237000|P1|STARTED|Overall Study|Received treatment|1051
97575|NCT01438307|237038|P2|NOT COMPLETED|Overall Study||1
97576|NCT01438307|237039|P1|NOT COMPLETED|Overall Study||1
97577|NCT01438307|237038|P2|COMPLETED|Overall Study||13
97578|NCT01438307|237039|P1|COMPLETED|Overall Study||13
97579|NCT01438307|237038|P2|STARTED|Overall Study||14
97580|NCT01438307|237039|P1|STARTED|Overall Study||14
97581|NCT01438294|237053|P2|NOT COMPLETED|Overall Study||7
97582|NCT01438294|237054|P1|NOT COMPLETED|Overall Study||3
97583|NCT01438294|237053|P2|COMPLETED|Overall Study||13
97584|NCT01438294|237054|P1|COMPLETED|Overall Study||13
97585|NCT01438294|237053|P2|STARTED|Overall Study||20
97586|NCT01438294|237054|P1|STARTED|Overall Study||16
97587|NCT01438229|237064|P1|NOT COMPLETED|Overall Study||3
97588|NCT01438229|237064|P1|COMPLETED|Overall Study||44
97589|NCT01438229|237064|P1|Underwent Procedure|Overall Study||46
97590|NCT01438229|237064|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
97591|NCT01438229|237064|P1|STARTED|Overall Study||47
97592|NCT01438177|237097|P1|NOT COMPLETED|Overall Study||2
97593|NCT01438177|237097|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
97594|NCT01438177|237097|P1|STARTED|Overall Study||11
97595|NCT01438151|237103|P1|NOT COMPLETED|Overall Study||8
97596|NCT01438151|237103|P1|COMPLETED|Overall Study||3
97597|NCT01438151|237103|P1|STARTED|Overall Study||11
97598|NCT01438060|237109|P2|NOT COMPLETED|On Study Beyond Week 140||8
97599|NCT01438060|237110|P1|NOT COMPLETED|On Study Beyond Week 140||0
97600|NCT01438060|237109|P2|COMPLETED|On Study Beyond Week 140||1
97601|NCT01438060|237110|P1|COMPLETED|On Study Beyond Week 140||0
97602|NCT01438060|237109|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
97603|NCT01438060|237110|P1|STARTED|On Study Beyond Week 140||0
97604|NCT01438060|237109|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
97605|NCT01438060|237110|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
97606|NCT01438060|237109|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
97607|NCT01438060|237110|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
97608|NCT01438060|237109|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
97609|NCT01438060|237110|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
97610|NCT01438060|237109|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
97611|NCT01438060|237110|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
97612|NCT01438060|237109|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
97613|NCT01438060|237110|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
97614|NCT01438060|237109|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
97615|NCT01438060|237110|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
97616|NCT01437995|237191|P3|NOT COMPLETED|Overall Study||20
97617|NCT01437995|237192|P2|NOT COMPLETED|Overall Study||18
97618|NCT01437995|237193|P1|NOT COMPLETED|Overall Study||11
97619|NCT01437995|237191|P3|COMPLETED|Overall Study||135
97620|NCT01437995|237192|P2|COMPLETED|Overall Study||131
97621|NCT01437995|237193|P1|COMPLETED|Overall Study||140
97622|NCT01437995|237191|P3|Included in Treatment Failure Analysis|Overall Study||151
97623|NCT01437995|237192|P2|Included in Treatment Failure Analysis|Overall Study||146
97624|NCT01437995|237193|P1|Included in Treatment Failure Analysis|Overall Study||150
97625|NCT01437995|237191|P3|STARTED|Overall Study||155
97626|NCT01437995|237192|P2|STARTED|Overall Study||149
97627|NCT01437995|237193|P1|STARTED|Overall Study||151
97628|NCT01437943|237215|P2|NOT COMPLETED|Overall Study||2
97629|NCT01437943|237216|P1|NOT COMPLETED|Overall Study||7
97630|NCT01437943|237215|P2|COMPLETED|Overall Study||1
97631|NCT01437943|237216|P1|COMPLETED|Overall Study||0
97632|NCT01437943|237215|P2|STARTED|Overall Study||3
97633|NCT01437943|237216|P1|STARTED|Overall Study||7
97634|NCT01437878|237224|P2|NOT COMPLETED|Overall Study||0
97635|NCT01437878|237225|P1|NOT COMPLETED|Overall Study||1
97636|NCT01437878|237224|P2|COMPLETED|Overall Study||1
97637|NCT01437878|237225|P1|COMPLETED|Overall Study||0
97638|NCT01437878|237224|P2|STARTED|Overall Study||1
97639|NCT01437878|237225|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
97640|NCT01437540|237267|P2|NOT COMPLETED|Overall Study||65
97641|NCT01437540|237268|P1|NOT COMPLETED|Overall Study||127
97642|NCT01437540|237267|P2|COMPLETED|Overall Study||133
97643|NCT01437540|237268|P1|COMPLETED|Overall Study||265
97644|NCT01437540|237267|P2|STARTED|Overall Study||198
97645|NCT01437540|237268|P1|STARTED|Overall Study||392
97646|NCT01437501|237282|P2|NOT COMPLETED|Overall Study||11
97647|NCT01437501|237283|P1|NOT COMPLETED|Overall Study||13
97648|NCT01437501|237282|P2|COMPLETED|Overall Study||132
97649|NCT01437501|237283|P1|COMPLETED|Overall Study||135
97650|NCT01437501|237282|P2|STARTED|Overall Study||143
97651|NCT01437501|237283|P1|STARTED|Overall Study||148
97652|NCT01437488|237291|P1|NOT COMPLETED|Overall Study||0
97653|NCT01437488|237291|P1|COMPLETED|Overall Study||14
97654|NCT01437488|237291|P1|STARTED|Overall Study||14
97655|NCT01437423|237298|P1|NOT COMPLETED|Overall Study||15
97656|NCT01437423|237298|P1|COMPLETED|Overall Study||647
97657|NCT01437423|237298|P1|STARTED|Overall Study||662
97658|NCT01437397|237310|P5|NOT COMPLETED|Overall Study||101
97659|NCT01437397|237311|P4|NOT COMPLETED|Overall Study||69
97660|NCT01437397|237312|P3|NOT COMPLETED|Overall Study||72
97661|NCT01437397|237313|P2|NOT COMPLETED|Overall Study||62
97662|NCT01437397|237314|P1|NOT COMPLETED|Overall Study||66
97663|NCT01437397|237310|P5|COMPLETED|Overall Study||236
97664|NCT01437397|237311|P4|COMPLETED|Overall Study||270
97665|NCT01437397|237312|P3|COMPLETED|Overall Study||268
97666|NCT01437397|237313|P2|COMPLETED|Overall Study||276
97667|NCT01437397|237314|P1|COMPLETED|Overall Study||272
97668|NCT01437397|237310|P5|STARTED|Overall Study||337
97669|NCT01437397|237311|P4|STARTED|Overall Study||339
97670|NCT01437397|237312|P3|STARTED|Overall Study||340
97671|NCT01437397|237313|P2|STARTED|Overall Study||338
97672|NCT01437397|237314|P1|STARTED|Overall Study||338
97673|NCT01437319|237341|P3|NOT COMPLETED|Phase II||37
97674|NCT01437319|237342|P2|NOT COMPLETED|Phase II||44
97675|NCT01437319|237343|P1|NOT COMPLETED|Phase II||0
97676|NCT01437319|237341|P3|COMPLETED|Phase II||75
97677|NCT01437319|237342|P2|COMPLETED|Phase II||71
97678|NCT01437319|237343|P1|COMPLETED|Phase II||0
97679|NCT01437319|237341|P3|STARTED|Phase II||112
97680|NCT01437319|237342|P2|STARTED|Phase II||115
97681|NCT01437319|237343|P1|STARTED|Phase II||0
97682|NCT01437319|237341|P3|NOT COMPLETED|Phase I||0
97683|NCT01437319|237342|P2|NOT COMPLETED|Phase I||0
97684|NCT01437319|237343|P1|NOT COMPLETED|Phase I||55
97685|NCT01437319|237341|P3|COMPLETED|Phase I||0
97686|NCT01437319|237342|P2|COMPLETED|Phase I||0
97687|NCT01437319|237343|P1|COMPLETED|Phase I||227
97688|NCT01437319|237341|P3|STARTED|Phase I||0
97689|NCT01437319|237342|P2|STARTED|Phase I||0
97690|NCT01437319|237343|P1|STARTED|Phase I||282
97691|NCT01437267|237358|P6|NOT COMPLETED|Overall Study||0
97692|NCT01437267|237359|P5|NOT COMPLETED|Overall Study||0
97693|NCT01437267|237360|P4|NOT COMPLETED|Overall Study||1
97694|NCT01437267|237361|P3|NOT COMPLETED|Overall Study||0
97695|NCT01437267|237362|P2|NOT COMPLETED|Overall Study||1
97696|NCT01437267|237363|P1|NOT COMPLETED|Overall Study||0
97697|NCT01437267|237358|P6|COMPLETED|Overall Study||20
97698|NCT01437267|237359|P5|COMPLETED|Overall Study||20
97699|NCT01437267|237360|P4|COMPLETED|Overall Study||19
97700|NCT01437267|237361|P3|COMPLETED|Overall Study||20
97701|NCT01437267|237362|P2|COMPLETED|Overall Study||19
97702|NCT01437267|237363|P1|COMPLETED|Overall Study||20
97703|NCT01437267|237358|P6|STARTED|Overall Study||20
97704|NCT01437267|237359|P5|STARTED|Overall Study||20
97705|NCT01437267|237360|P4|STARTED|Overall Study||20
97706|NCT01437267|237361|P3|STARTED|Overall Study||20
97707|NCT01437267|237362|P2|STARTED|Overall Study||20
97708|NCT01437267|237363|P1|STARTED|Overall Study||20
97709|NCT01437124|237401|P1|NOT COMPLETED|Overall Study||0
97710|NCT01437124|237401|P1|COMPLETED|Overall Study||83
97711|NCT01437124|237401|P1|STARTED|Overall Study||83
97712|NCT01437111|237406|P1|NOT COMPLETED|Overall Study||18
97713|NCT01437111|237406|P1|COMPLETED|Overall Study||182
97714|NCT01437111|237406|P1|Treated Participants|Overall Study||198
97715|NCT01437111|237406|P1|STARTED|Overall Study||200
97716|NCT01437098|237417|P1|NOT COMPLETED|Overall Study||13
97717|NCT01437098|237417|P1|COMPLETED|Overall Study||42
97718|NCT01437098|237417|P1|36 Months|Overall Study||36
97719|NCT01437098|237417|P1|24 Months|Overall Study||42
97720|NCT01437098|237417|P1|12 Months|Overall Study||45
97721|NCT01437098|237417|P1|6 Months|Overall Study||47
97722|NCT01437098|237417|P1|30 Days|Overall Study||51
97723|NCT01437098|237417|P1|STARTED|Overall Study||55
97724|NCT01436799|237474|P2|NOT COMPLETED|Overall Study||0
97725|NCT01436799|237475|P1|NOT COMPLETED|Overall Study||0
97726|NCT01436799|237474|P2|COMPLETED|Overall Study||20
97727|NCT01436799|237475|P1|COMPLETED|Overall Study||20
97728|NCT01436799|237474|P2|STARTED|Overall Study||20
97729|NCT01436799|237475|P1|STARTED|Overall Study||20
97730|NCT01436643|237484|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
97731|NCT01436643|237485|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
97732|NCT01436643|237486|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
97733|NCT01436643|237487|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
97734|NCT01436643|237484|P4|COMPLETED|Core Phase (16 Weeks)||0
97735|NCT01436643|237485|P3|COMPLETED|Core Phase (16 Weeks)||17
97736|NCT01436643|237486|P2|COMPLETED|Core Phase (16 Weeks)||11
97737|NCT01436643|237487|P1|COMPLETED|Core Phase (16 Weeks)||16
97738|NCT01436643|237484|P4|STARTED|Core Phase (16 Weeks)||0
97739|NCT01436643|237485|P3|STARTED|Core Phase (16 Weeks)||20
97740|NCT01436643|237486|P2|STARTED|Core Phase (16 Weeks)||15
97741|NCT01436643|237487|P1|STARTED|Core Phase (16 Weeks)||17
97742|NCT01436643|237484|P4|NOT COMPLETED|2-week Pre-treatment||10
97743|NCT01436643|237485|P3|NOT COMPLETED|2-week Pre-treatment||0
97744|NCT01436643|237486|P2|NOT COMPLETED|2-week Pre-treatment||0
97745|NCT01436643|237487|P1|NOT COMPLETED|2-week Pre-treatment||0
97746|NCT01436643|237484|P4|COMPLETED|2-week Pre-treatment||44
97747|NCT01436643|237485|P3|COMPLETED|2-week Pre-treatment||0
97748|NCT01436643|237486|P2|COMPLETED|2-week Pre-treatment||0
97749|NCT01436643|237487|P1|COMPLETED|2-week Pre-treatment||0
97750|NCT01436643|237484|P4|STARTED|2-week Pre-treatment||54
97751|NCT01436643|237485|P3|STARTED|2-week Pre-treatment||0
97752|NCT01436643|237486|P2|STARTED|2-week Pre-treatment||0
97753|NCT01436643|237487|P1|STARTED|2-week Pre-treatment||0
97754|NCT01436526|237499|P2|NOT COMPLETED|Period 2||0
97755|NCT01436526|237500|P1|NOT COMPLETED|Period 2||0
97756|NCT01436526|237499|P2|COMPLETED|Period 2||13
97757|NCT01436526|237500|P1|COMPLETED|Period 2||13
97758|NCT01436526|237499|P2|Participants Received Treatment|Period 2||13
97759|NCT01436526|237500|P1|Participants Received Treatment|Period 2||13
97760|NCT01436526|237499|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
97761|NCT01436526|237500|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
97762|NCT01436526|237499|P2|NOT COMPLETED|Period 1||0
97763|NCT01436526|237500|P1|NOT COMPLETED|Period 1||0
97764|NCT01436526|237499|P2|COMPLETED|Period 1||14
97765|NCT01436526|237500|P1|COMPLETED|Period 1||14
97766|NCT01436526|237499|P2|Participants Received Treatment|Period 1||14
97767|NCT01436526|237500|P1|Participants Received Treatment|Period 1||14
97768|NCT01436526|237499|P2|STARTED|Period 1||14
97769|NCT01436526|237500|P1|STARTED|Period 1||14
97770|NCT01436500|237522|P5|NOT COMPLETED|Overall Study||4
97771|NCT01436500|237523|P4|NOT COMPLETED|Overall Study||1
97772|NCT01436500|237524|P3|NOT COMPLETED|Overall Study||5
97773|NCT01436500|237525|P2|NOT COMPLETED|Overall Study||3
97774|NCT01436500|237526|P1|NOT COMPLETED|Overall Study||3
97775|NCT01436500|237522|P5|COMPLETED|Overall Study||9
97776|NCT01436500|237523|P4|COMPLETED|Overall Study||5
97777|NCT01436500|237524|P3|COMPLETED|Overall Study||7
97778|NCT01436500|237525|P2|COMPLETED|Overall Study||9
97779|NCT01436500|237526|P1|COMPLETED|Overall Study||9
97780|NCT01436500|237522|P5|STARTED|Overall Study||13
97781|NCT01436500|237523|P4|STARTED|Overall Study||6
97782|NCT01436500|237524|P3|STARTED|Overall Study||12
97783|NCT01436500|237525|P2|STARTED|Overall Study||12
97784|NCT01436500|237526|P1|STARTED|Overall Study||12
97785|NCT01436435|237559|P1|NOT COMPLETED|Overall Study||64
97786|NCT01436435|237559|P1|COMPLETED|Overall Study||177
97787|NCT01436435|237559|P1|STARTED|Overall Study||241
97788|NCT01436370|237576|P8|NOT COMPLETED|Overall Study||0
97789|NCT01436370|237577|P7|NOT COMPLETED|Overall Study||0
97790|NCT01436370|237578|P6|NOT COMPLETED|Overall Study||0
97791|NCT01436370|237579|P5|NOT COMPLETED|Overall Study||1
97792|NCT01436370|237580|P4|NOT COMPLETED|Overall Study||0
97793|NCT01436370|237581|P3|NOT COMPLETED|Overall Study||0
97794|NCT01436370|237582|P2|NOT COMPLETED|Overall Study||0
97795|NCT01436370|237583|P1|NOT COMPLETED|Overall Study||0
97796|NCT01436370|237576|P8|COMPLETED|Overall Study||16
97797|NCT01436370|237577|P7|COMPLETED|Overall Study||16
97798|NCT01436370|237578|P6|COMPLETED|Overall Study||19
97799|NCT01436370|237579|P5|COMPLETED|Overall Study||18
97800|NCT01436370|237580|P4|COMPLETED|Overall Study||10
97801|NCT01436370|237581|P3|COMPLETED|Overall Study||10
97802|NCT01436370|237582|P2|COMPLETED|Overall Study||6
97803|NCT01436370|237583|P1|COMPLETED|Overall Study||6
97804|NCT01436370|237576|P8|STARTED|Overall Study||16
97805|NCT01436370|237577|P7|STARTED|Overall Study||16
97806|NCT01436370|237578|P6|STARTED|Overall Study||19
97807|NCT01436370|237579|P5|STARTED|Overall Study||19
97808|NCT01436370|237580|P4|STARTED|Overall Study||10
97809|NCT01436370|237581|P3|STARTED|Overall Study||10
97810|NCT01436370|237582|P2|STARTED|Overall Study||6
97811|NCT01436370|237583|P1|STARTED|Overall Study||6
97812|NCT01436305|237664|P3|NOT COMPLETED|Overall Study||0
97813|NCT01436305|237665|P2|NOT COMPLETED|Overall Study||4
97814|NCT01436305|237666|P1|NOT COMPLETED|Overall Study||2
97815|NCT01436305|237664|P3|COMPLETED|Overall Study||7
97816|NCT01436305|237665|P2|COMPLETED|Overall Study||2
97817|NCT01436305|237666|P1|COMPLETED|Overall Study||4
97818|NCT01436305|237664|P3|STARTED|Overall Study||7
97819|NCT01436305|237665|P2|STARTED|Overall Study||6
97820|NCT01436305|237666|P1|STARTED|Overall Study||6
97821|NCT01436279|237763|P2|NOT COMPLETED|Overall Study||0
97822|NCT01436279|237764|P1|NOT COMPLETED|Overall Study||0
97823|NCT01436279|237763|P2|COMPLETED|Overall Study||20
97824|NCT01436279|237764|P1|COMPLETED|Overall Study||30
97825|NCT01436279|237763|P2|STARTED|Overall Study||20
97826|NCT01436279|237764|P1|STARTED|Overall Study||30
97827|NCT01436266|237786|P2|NOT COMPLETED|Overall Study||0
97828|NCT01436266|237787|P1|NOT COMPLETED|Overall Study||0
97829|NCT01436266|237786|P2|COMPLETED|Overall Study||1
97830|NCT01436266|237787|P1|COMPLETED|Overall Study||1
97831|NCT01436266|237786|P2|STARTED|Overall Study||1
97832|NCT01436266|237787|P1|STARTED|Overall Study||1
97833|NCT01436253|237793|P1|NOT COMPLETED|Overall Study||299
97834|NCT01436253|237793|P1|COMPLETED|Overall Study||1897
97835|NCT01436253|237793|P1|STARTED|Overall Study||2196
97836|NCT01436201|237798|P1|NOT COMPLETED|Overall Study||4
97837|NCT01436201|237798|P1|COMPLETED|Overall Study||20
97838|NCT01436201|237798|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
97839|NCT01436201|237798|P1|STARTED|Overall Study||24
97840|NCT01436175|237808|P1|NOT COMPLETED|Overall Study||1270
97841|NCT01436175|237808|P1|COMPLETED|Overall Study||300
97842|NCT01436175|237808|P1|STARTED|Overall Study||1570
97843|NCT01436162|237835|P3|NOT COMPLETED|Randomized Phase||25
97844|NCT01436162|237836|P2|NOT COMPLETED|Randomized Phase||31
97845|NCT01436162|237837|P1|NOT COMPLETED|Randomized Phase||44
97846|NCT01436162|237835|P3|COMPLETED|Randomized Phase||189
97847|NCT01436162|237836|P2|COMPLETED|Randomized Phase||181
97848|NCT01436162|237837|P1|COMPLETED|Randomized Phase||353
97849|NCT01436162|237835|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
97850|NCT01436162|237836|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
97851|NCT01436162|237837|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
97852|NCT01436162|237835|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
97853|NCT01436162|237836|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
97854|NCT01436162|237837|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
97855|NCT01436162|237835|P3|COMPLETED|Single-blind Lead-in Phase||0
97856|NCT01436162|237836|P2|COMPLETED|Single-blind Lead-in Phase||0
97857|NCT01436162|237837|P1|COMPLETED|Single-blind Lead-in Phase||823
97858|NCT01436162|237835|P3|STARTED|Single-blind Lead-in Phase||0
97859|NCT01436162|237836|P2|STARTED|Single-blind Lead-in Phase||0
97860|NCT01436162|237837|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
97861|NCT01436149|237871|P3|NOT COMPLETED|Randomized Phase||42
97862|NCT01436149|237872|P2|NOT COMPLETED|Randomized Phase||38
97863|NCT01436149|237873|P1|NOT COMPLETED|Randomized Phase||77
97864|NCT01436149|237871|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
97865|NCT01436149|237872|P2|COMPLETED|Randomized Phase||164
97866|NCT01436149|237873|P1|COMPLETED|Randomized Phase||415
97867|NCT01436149|237871|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
97868|NCT01436149|237872|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
97869|NCT01436149|237873|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
97870|NCT01436149|237871|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
97871|NCT01436149|237872|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
97872|NCT01436149|237873|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
97873|NCT01436149|237871|P3|COMPLETED|Antidepressant Lead-in Phase||0
97874|NCT01436149|237872|P2|COMPLETED|Antidepressant Lead-in Phase||0
97875|NCT01436149|237873|P1|COMPLETED|Antidepressant Lead-in Phase||896
97876|NCT01436149|237871|P3|STARTED|Antidepressant Lead-in Phase||0
97877|NCT01436149|237872|P2|STARTED|Antidepressant Lead-in Phase||0
97878|NCT01436149|237873|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
97879|NCT01436110|237904|P3|NOT COMPLETED|Overall Study||23
97880|NCT01436110|237905|P2|NOT COMPLETED|Overall Study||26
97881|NCT01436110|237906|P1|NOT COMPLETED|Overall Study||39
97882|NCT01436110|237904|P3|COMPLETED|Overall Study||95
97883|NCT01436110|237905|P2|COMPLETED|Overall Study||91
97884|NCT01436110|237906|P1|COMPLETED|Overall Study||77
97885|NCT01436110|237904|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
97886|NCT01436110|237905|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
97887|NCT01436110|237906|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
97888|NCT01436110|237904|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
97889|NCT01436110|237905|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
97890|NCT01436110|237906|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
97891|NCT01436084|237929|P1|NOT COMPLETED|Overall Study||4
97892|NCT01436084|237929|P1|COMPLETED|Overall Study||0
97893|NCT01436084|237929|P1|STARTED|Overall Study||4
97894|NCT01436071|237935|P2|NOT COMPLETED|Overall Study||14
97895|NCT01436071|237936|P1|NOT COMPLETED|Overall Study||26
97896|NCT01436071|237935|P2|COMPLETED|Overall Study||110
97897|NCT01436071|237936|P1|COMPLETED|Overall Study||98
97898|NCT01436071|237935|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
97899|NCT01436071|237936|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
97900|NCT01436071|237935|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
97901|NCT01436071|237936|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
97902|NCT01436045|237952|P2|NOT COMPLETED|Overall Study||0
97903|NCT01436045|237953|P1|NOT COMPLETED|Overall Study||0
97904|NCT01436045|237952|P2|COMPLETED|Overall Study||6
97905|NCT01436045|237953|P1|COMPLETED|Overall Study||6
97906|NCT01436045|237952|P2|STARTED|Overall Study||6
97907|NCT01436045|237953|P1|STARTED|Overall Study||6
97908|NCT01436006|237964|P1|NOT COMPLETED|Overall Study||37
97909|NCT01436006|237964|P1|COMPLETED|Overall Study||6663
97910|NCT01436006|237964|P1|STARTED|Overall Study||6700
97911|NCT01435928|237978|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
97912|NCT01435928|237979|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
97913|NCT01435928|237980|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
97914|NCT01435928|237978|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
97915|NCT01435928|237979|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
97916|NCT01435928|237980|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
97917|NCT01435928|237978|P3|STARTED|Double Blind Phase - 28 Weeks||141
97918|NCT01435928|237979|P2|STARTED|Double Blind Phase - 28 Weeks||144
97919|NCT01435928|237980|P1|STARTED|Double Blind Phase - 28 Weeks||0
97920|NCT01435928|237978|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
97921|NCT01435928|237979|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
97922|NCT01435928|237980|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
97923|NCT01435928|237978|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
97924|NCT01435928|237979|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
97925|NCT01435928|237980|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
97926|NCT01435928|237978|P3|STARTED|Open Label Phase - up to 24 Weeks||0
97927|NCT01435928|237979|P2|STARTED|Open Label Phase - up to 24 Weeks||0
97928|NCT01435928|237980|P1|STARTED|Open Label Phase - up to 24 Weeks||676
97929|NCT01435798|238007|P1|NOT COMPLETED|Overall Study||1
97930|NCT01435798|238007|P1|COMPLETED|Overall Study|Crossover design|25
97931|NCT01435798|238007|P1|100% MTD|Overall Study||25
97932|NCT01435798|238007|P1|50% MTD|Overall Study||25
97933|NCT01435798|238007|P1|25% MTD|Overall Study||26
97934|NCT01435798|238007|P1|0% MTD|Overall Study||25
97935|NCT01435798|238007|P1|STARTED|Overall Study|Crossover design|26
97936|NCT01435772|238024|P3|NOT COMPLETED|Overall Study||15
97937|NCT01435772|238025|P2|NOT COMPLETED|Overall Study||3
97938|NCT01435772|238026|P1|NOT COMPLETED|Overall Study||3
97939|NCT01435772|238024|P3|COMPLETED|Overall Study||0
97940|NCT01435772|238025|P2|COMPLETED|Overall Study||0
97941|NCT01435772|238026|P1|COMPLETED|Overall Study||0
97942|NCT01435772|238024|P3|STARTED|Overall Study||15
97943|NCT01435772|238025|P2|STARTED|Overall Study||3
97944|NCT01435772|238026|P1|STARTED|Overall Study||3
97945|NCT01435759|238076|P6|NOT COMPLETED|Double-blind Phase||9
97946|NCT01435759|238077|P5|NOT COMPLETED|Double-blind Phase||9
97947|NCT01435759|238078|P4|NOT COMPLETED|Double-blind Phase||9
97948|NCT01435759|238079|P3|NOT COMPLETED|Double-blind Phase||7
97949|NCT01435759|238080|P2|NOT COMPLETED|Double-blind Phase||7
97950|NCT01435759|238081|P1|NOT COMPLETED|Double-blind Phase||66
97951|NCT01435759|238076|P6|COMPLETED|Double-blind Phase||71
97952|NCT01435759|238077|P5|COMPLETED|Double-blind Phase||69
97953|NCT01435759|238078|P4|COMPLETED|Double-blind Phase||69
97954|NCT01435759|238079|P3|COMPLETED|Double-blind Phase||71
97955|NCT01435759|238080|P2|COMPLETED|Double-blind Phase||71
97956|NCT01435759|238081|P1|COMPLETED|Double-blind Phase||397
97957|NCT01435759|238076|P6|STARTED|Double-blind Phase||80
97958|NCT01435759|238077|P5|STARTED|Double-blind Phase||78
97959|NCT01435759|238078|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
97960|NCT01435759|238079|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
97961|NCT01435759|238080|P2|STARTED|Double-blind Phase||78
97962|NCT01435759|238081|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
97963|NCT01435759|238076|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
97964|NCT01435759|238077|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
97965|NCT01435759|238078|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
97966|NCT01435759|238079|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
97967|NCT01435759|238080|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
97968|NCT01435759|238081|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
97969|NCT01435759|238076|P6|COMPLETED|Antidepressant Lead-in Phase||0
97970|NCT01435759|238077|P5|COMPLETED|Antidepressant Lead-in Phase||0
97971|NCT01435759|238078|P4|COMPLETED|Antidepressant Lead-in Phase||0
97972|NCT01435759|238079|P3|COMPLETED|Antidepressant Lead-in Phase||0
97973|NCT01435759|238080|P2|COMPLETED|Antidepressant Lead-in Phase||0
97974|NCT01435759|238081|P1|COMPLETED|Antidepressant Lead-in Phase||855
97975|NCT01435759|238076|P6|STARTED|Antidepressant Lead-in Phase||0
97976|NCT01435759|238077|P5|STARTED|Antidepressant Lead-in Phase||0
97977|NCT01435759|238078|P4|STARTED|Antidepressant Lead-in Phase||0
97978|NCT01435759|238079|P3|STARTED|Antidepressant Lead-in Phase||0
97979|NCT01435759|238080|P2|STARTED|Antidepressant Lead-in Phase||0
97980|NCT01435759|238081|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
97981|NCT01435655|238108|P1|NOT COMPLETED|Overall Study||3
97982|NCT01435655|238108|P1|COMPLETED|Overall Study||7
97983|NCT01435655|238108|P1|STARTED|Overall Study||10
97984|NCT01435616|238122|P2|NOT COMPLETED|Overall Study||80
97985|NCT01435616|238123|P1|NOT COMPLETED|Overall Study||171
97986|NCT01435616|238122|P2|COMPLETED|Overall Study||455
97987|NCT01435616|238123|P1|COMPLETED|Overall Study||832
97988|NCT01435616|238122|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
97989|NCT01435616|238123|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
97990|NCT01435616|238122|P2|STARTED|Overall Study||535
97991|NCT01435616|238123|P1|STARTED|Overall Study||1003
97992|NCT01435603|238169|P2|NOT COMPLETED|Overall Study||35
97993|NCT01435603|238170|P1|NOT COMPLETED|Overall Study||39
97994|NCT01435603|238169|P2|COMPLETED|Overall Study||129
97995|NCT01435603|238170|P1|COMPLETED|Overall Study||128
97996|NCT01435603|238169|P2|STARTED|Overall Study||164
97997|NCT01435603|238170|P1|STARTED|Overall Study||167
97998|NCT01435577|238178|P2|NOT COMPLETED|Overall Study||52
97999|NCT01435577|238179|P1|NOT COMPLETED|Overall Study||17
98000|NCT01435577|238178|P2|COMPLETED|Overall Study||13
98001|NCT01435577|238179|P1|COMPLETED|Overall Study||47
98002|NCT01435577|238178|P2|STARTED|Overall Study||65
98003|NCT01435577|238179|P1|STARTED|Overall Study||64
98004|NCT01435460|238229|P2|NOT COMPLETED|Overall Study||6
98005|NCT01435460|238230|P1|NOT COMPLETED|Overall Study||11
98006|NCT01435460|238229|P2|COMPLETED|Overall Study||143
98007|NCT01435460|238230|P1|COMPLETED|Overall Study||140
98008|NCT01435460|238229|P2|STARTED|Overall Study||149
98009|NCT01435460|238230|P1|STARTED|Overall Study||151
98010|NCT01435304|238244|P2|NOT COMPLETED|Overall Study||0
98011|NCT01435304|238245|P1|NOT COMPLETED|Overall Study||0
98012|NCT01435304|238244|P2|COMPLETED|Overall Study||50
98013|NCT01435304|238245|P1|COMPLETED|Overall Study||50
98014|NCT01435304|238244|P2|STARTED|Overall Study||50
98015|NCT01435304|238245|P1|STARTED|Overall Study||50
98016|NCT01435265|238263|P2|NOT COMPLETED|Overall Study||1
98017|NCT01435265|238264|P1|NOT COMPLETED|Overall Study||0
98018|NCT01435265|238263|P2|COMPLETED|Overall Study||3
98019|NCT01435265|238264|P1|COMPLETED|Overall Study||3
98020|NCT01435265|238263|P2|STARTED|Overall Study||4
98021|NCT01435265|238264|P1|STARTED|Overall Study||3
98022|NCT01435174|238274|P1|NOT COMPLETED|Overall Study||9
98023|NCT01435174|238274|P1|COMPLETED|Overall Study||8
98024|NCT01435174|238274|P1|STARTED|Overall Study||17
98025|NCT01435122|238278|P1|NOT COMPLETED|Overall Study||8
98026|NCT01435122|238278|P1|COMPLETED|Overall Study||22
98027|NCT01435122|238278|P1|STARTED|Overall Study||30
98028|NCT01435031|238287|P1|NOT COMPLETED|ITT at 4 Years||7
98029|NCT01435031|238287|P1|COMPLETED|ITT at 4 Years||171
98030|NCT01435031|238287|P1|STARTED|ITT at 4 Years||178
98031|NCT01435031|238287|P1|NOT COMPLETED|ITT at 3 Years||11
98032|NCT01435031|238287|P1|COMPLETED|ITT at 3 Years||178
98033|NCT01435031|238287|P1|STARTED|ITT at 3 Years||189
98034|NCT01435031|238287|P1|NOT COMPLETED|ITT at 2 Years||13
98035|NCT01435031|238287|P1|COMPLETED|ITT at 2 Years||189
98036|NCT01435031|238287|P1|STARTED|ITT at 2 Years||202
98037|NCT01435031|238287|P1|NOT COMPLETED|ITT at 1 Year||9
98038|NCT01435031|238287|P1|COMPLETED|ITT at 1 Year||202
98039|NCT01435031|238287|P1|STARTED|ITT at 1 Year||211
98040|NCT01435031|238287|P1|NOT COMPLETED|ITT at 6 Months||5
98041|NCT01435031|238287|P1|COMPLETED|ITT at 6 Months||211
98042|NCT01435031|238287|P1|STARTED|ITT at 6 Months||216
98043|NCT01435031|238287|P1|NOT COMPLETED|ITT at 1 Month||6
98044|NCT01435031|238287|P1|COMPLETED|ITT at 1 Month||216
98045|NCT01435031|238287|P1|STARTED|ITT at 1 Month|ITT population|222
98046|NCT01434823|238387|P2|NOT COMPLETED|Overall Study||7
98047|NCT01434823|238388|P1|NOT COMPLETED|Overall Study||4
98048|NCT01434823|238387|P2|COMPLETED|Overall Study||778
98049|NCT01434823|238388|P1|COMPLETED|Overall Study||820
98050|NCT01434823|238387|P2|STARTED|Overall Study||785
98051|NCT01434823|238388|P1|STARTED|Overall Study||824
98052|NCT01434693|238408|P4|NOT COMPLETED|Overall Study||1
98053|NCT01434693|238409|P3|NOT COMPLETED|Overall Study||1
98054|NCT01434693|238410|P2|NOT COMPLETED|Overall Study||0
98055|NCT01434693|238411|P1|NOT COMPLETED|Overall Study||3
98056|NCT01434693|238408|P4|COMPLETED|Overall Study||8
98057|NCT01434693|238409|P3|COMPLETED|Overall Study||8
98058|NCT01434693|238410|P2|COMPLETED|Overall Study||9
98059|NCT01434693|238411|P1|COMPLETED|Overall Study||6
98060|NCT01434693|238408|P4|STARTED|Overall Study||9
98061|NCT01434693|238409|P3|STARTED|Overall Study||9
98062|NCT01434693|238410|P2|STARTED|Overall Study||9
98063|NCT01434693|238411|P1|STARTED|Overall Study||9
98064|NCT01434680|238425|P4|NOT COMPLETED|Overall Study||0
98065|NCT01434680|238426|P3|NOT COMPLETED|Overall Study||2
98066|NCT01434680|238427|P2|NOT COMPLETED|Overall Study||2
98067|NCT01434680|238428|P1|NOT COMPLETED|Overall Study||3
98068|NCT01434680|238425|P4|COMPLETED|Overall Study||119
98069|NCT01434680|238426|P3|COMPLETED|Overall Study||304
98070|NCT01434680|238427|P2|COMPLETED|Overall Study||266
98071|NCT01434680|238428|P1|COMPLETED|Overall Study||296
98072|NCT01434680|238425|P4|STARTED|Overall Study||119
98073|NCT01434680|238426|P3|STARTED|Overall Study||306
98074|NCT01434680|238427|P2|STARTED|Overall Study||268
98075|NCT01434680|238428|P1|STARTED|Overall Study||299
98076|NCT01434654|238445|P2|NOT COMPLETED|Overall Study||0
98077|NCT01434654|238446|P1|NOT COMPLETED|Overall Study||2
98078|NCT01434654|238445|P2|COMPLETED|Overall Study||12
98079|NCT01434654|238446|P1|COMPLETED|Overall Study||5
98080|NCT01434654|238445|P2|STARTED|Overall Study||12
98081|NCT01434654|238446|P1|STARTED|Overall Study||7
98082|NCT01434641|238458|P1|NOT COMPLETED|Overall Study||0
98083|NCT01434641|238458|P1|COMPLETED|Overall Study||102
98084|NCT01434641|238458|P1|STARTED|Overall Study||102
98085|NCT01434511|238463|P1|NOT COMPLETED|Overall Study||0
98086|NCT01434511|238463|P1|COMPLETED|Overall Study||1
98087|NCT01434511|238463|P1|STARTED|Overall Study||1
98088|NCT01434342|238482|P2|NOT COMPLETED|Overall Study||17
98089|NCT01434342|238483|P1|NOT COMPLETED|Overall Study||48
98090|NCT01434342|238482|P2|COMPLETED|Overall Study||31
98091|NCT01434342|238483|P1|COMPLETED|Overall Study||50
98092|NCT01434342|238482|P2|STARTED|Overall Study||48
98093|NCT01434342|238483|P1|STARTED|Overall Study||98
98094|NCT01434290|238493|P2|NOT COMPLETED|Overall Study||7
98095|NCT01434290|238494|P1|NOT COMPLETED|Overall Study||8
98096|NCT01434290|238493|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
98097|NCT01434290|238494|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
98098|NCT01434290|238493|P2|STARTED|Overall Study||128
98099|NCT01434290|238494|P1|STARTED|Overall Study||127
98100|NCT01434186|238522|P2|NOT COMPLETED|Overall Study||0
98101|NCT01434186|238523|P1|NOT COMPLETED|Overall Study||0
98102|NCT01434186|238522|P2|COMPLETED|Overall Study||4
98103|NCT01434186|238523|P1|COMPLETED|Overall Study||2
98104|NCT01434186|238522|P2|STARTED|Overall Study||4
98105|NCT01434186|238523|P1|STARTED|Overall Study||2
98106|NCT01434121|238532|P3|NOT COMPLETED|Overall Study||0
98107|NCT01434121|238533|P2|NOT COMPLETED|Overall Study||0
98108|NCT01434121|238534|P1|NOT COMPLETED|Overall Study||0
98109|NCT01434121|238532|P3|COMPLETED|Overall Study||8
98110|NCT01434121|238533|P2|COMPLETED|Overall Study||8
98111|NCT01434121|238534|P1|COMPLETED|Overall Study||8
98112|NCT01434121|238532|P3|STARTED|Overall Study||8
98113|NCT01434121|238533|P2|STARTED|Overall Study||8
98114|NCT01434121|238534|P1|STARTED|Overall Study||8
98115|NCT01434030|238560|P1|NOT COMPLETED|Overall Study||1
98116|NCT01434030|238560|P1|COMPLETED|Overall Study||56
98117|NCT01434030|238560|P1|STARTED|Overall Study||57
98118|NCT01433978|238567|P3|NOT COMPLETED|Extension Phase||6
98119|NCT01433978|238568|P2|NOT COMPLETED|Extension Phase||0
98120|NCT01433978|238569|P1|NOT COMPLETED|Extension Phase||0
98121|NCT01433978|238567|P3|COMPLETED|Extension Phase||0
98122|NCT01433978|238568|P2|COMPLETED|Extension Phase||0
98123|NCT01433978|238569|P1|COMPLETED|Extension Phase||0
98124|NCT01433978|238567|P3|STARTED|Extension Phase||6
98125|NCT01433978|238568|P2|STARTED|Extension Phase||0
98126|NCT01433978|238569|P1|STARTED|Extension Phase||0
98127|NCT01433978|238567|P3|NOT COMPLETED|Core Study||0
98128|NCT01433978|238568|P2|NOT COMPLETED|Core Study||11
98129|NCT01433978|238569|P1|NOT COMPLETED|Core Study||11
98130|NCT01433978|238567|P3|COMPLETED|Core Study||0
98131|NCT01433978|238568|P2|COMPLETED|Core Study||1
98132|NCT01433978|238569|P1|COMPLETED|Core Study||0
98133|NCT01433978|238567|P3|STARTED|Core Study||0
98134|NCT01433978|238568|P2|STARTED|Core Study||12
98135|NCT01433978|238569|P1|STARTED|Core Study||11
98136|NCT01433913|238578|P2|NOT COMPLETED|Overall Study||0
98137|NCT01433913|238579|P1|NOT COMPLETED|Overall Study||1
98138|NCT01433913|238578|P2|COMPLETED|Overall Study||10
98139|NCT01433913|238579|P1|COMPLETED|Overall Study||9
98140|NCT01433913|238578|P2|STARTED|Overall Study||10
98141|NCT01433913|238579|P1|STARTED|Overall Study||10
98142|NCT01433731|238615|P4|NOT COMPLETED|Overall Study||0
98143|NCT01433731|238616|P3|NOT COMPLETED|Overall Study||0
98144|NCT01433731|238617|P2|NOT COMPLETED|Overall Study||0
98145|NCT01433731|238618|P1|NOT COMPLETED|Overall Study||0
98146|NCT01433731|238615|P4|COMPLETED|Overall Study||5
98147|NCT01433731|238616|P3|COMPLETED|Overall Study||5
98148|NCT01433731|238617|P2|COMPLETED|Overall Study||5
98149|NCT01433731|238618|P1|COMPLETED|Overall Study||3
98150|NCT01433731|238615|P4|STARTED|Overall Study||5
98151|NCT01433731|238616|P3|STARTED|Overall Study||5
98152|NCT01433731|238617|P2|STARTED|Overall Study||5
98153|NCT01433731|238618|P1|STARTED|Overall Study||3
98154|NCT01433549|238626|P2|NOT COMPLETED|Phase 2: Second Study Product||1
98155|NCT01433549|238627|P1|NOT COMPLETED|Phase 2: Second Study Product||0
98156|NCT01433549|238626|P2|COMPLETED|Phase 2: Second Study Product||12
98157|NCT01433549|238627|P1|COMPLETED|Phase 2: Second Study Product||12
98158|NCT01433549|238626|P2|STARTED|Phase 2: Second Study Product||13
98159|NCT01433549|238627|P1|STARTED|Phase 2: Second Study Product||12
98160|NCT01433549|238626|P2|NOT COMPLETED|Phase 1: First Study Product||0
98161|NCT01433549|238627|P1|NOT COMPLETED|Phase 1: First Study Product||0
98162|NCT01433549|238626|P2|COMPLETED|Phase 1: First Study Product||13
98163|NCT01433549|238627|P1|COMPLETED|Phase 1: First Study Product||12
98164|NCT01433549|238626|P2|STARTED|Phase 1: First Study Product||13
98165|NCT01433549|238627|P1|STARTED|Phase 1: First Study Product||12
98166|NCT01433471|238637|P2|NOT COMPLETED|Overall Study||1
98167|NCT01433471|238638|P1|NOT COMPLETED|Overall Study||0
98168|NCT01433471|238637|P2|COMPLETED|Overall Study||1
98169|NCT01433471|238638|P1|COMPLETED|Overall Study||2
98170|NCT01433471|238637|P2|STARTED|Overall Study||2
98171|NCT01433471|238638|P1|STARTED|Overall Study||2
98172|NCT01433354|238654|P1|NOT COMPLETED|Overall Study||119
98173|NCT01433354|238654|P1|COMPLETED|Overall Study||0
98174|NCT01433354|238654|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
98175|NCT01433263|238670|P2|NOT COMPLETED|Overall Study||12
98176|NCT01433263|238671|P1|NOT COMPLETED|Overall Study||19
98177|NCT01433263|238670|P2|COMPLETED|Overall Study||16
98178|NCT01433263|238671|P1|COMPLETED|Overall Study||10
98179|NCT01433263|238670|P2|STARTED|Overall Study||28
98180|NCT01433263|238671|P1|STARTED|Overall Study||29
98181|NCT01433250|238700|P2|NOT COMPLETED|Overall Study||3
98182|NCT01433250|238701|P1|NOT COMPLETED|Overall Study||3
98183|NCT01433250|238700|P2|COMPLETED|Overall Study||14
98184|NCT01433250|238701|P1|COMPLETED|Overall Study||19
98185|NCT01433250|238700|P2|STARTED|Overall Study||17
98186|NCT01433250|238701|P1|STARTED|Overall Study||22
98187|NCT01433172|238720|P3|NOT COMPLETED|Overall Study||1
98188|NCT01433172|238721|P2|NOT COMPLETED|Overall Study||3
98189|NCT01433172|238722|P1|NOT COMPLETED|Overall Study||0
98190|NCT01433172|238720|P3|COMPLETED|Overall Study||32
98191|NCT01433172|238721|P2|COMPLETED|Overall Study||34
98192|NCT01433172|238722|P1|COMPLETED|Overall Study||3
98193|NCT01433172|238720|P3|STARTED|Overall Study||33
98194|NCT01433172|238721|P2|STARTED|Overall Study||37
98195|NCT01433172|238722|P1|STARTED|Overall Study||3
98196|NCT01433159|238734|P2|NOT COMPLETED|Overall Study||1
98197|NCT01433159|238735|P1|NOT COMPLETED|Overall Study||2
98198|NCT01433159|238734|P2|COMPLETED|Overall Study||9
98199|NCT01433159|238735|P1|COMPLETED|Overall Study||7
98200|NCT01433159|238734|P2|STARTED|Overall Study||10
98201|NCT01433159|238735|P1|STARTED|Overall Study||9
98202|NCT01433107|238743|P2|NOT COMPLETED|Overall Study||17
98203|NCT01433107|238744|P1|NOT COMPLETED|Overall Study||27
98204|NCT01433107|238743|P2|COMPLETED|Overall Study||128
98205|NCT01433107|238744|P1|COMPLETED|Overall Study||118
98206|NCT01433107|238743|P2|STARTED|Overall Study||145
98207|NCT01433107|238744|P1|STARTED|Overall Study||145
98208|NCT01433081|238756|P2|NOT COMPLETED|Overall Study||2
98209|NCT01433081|238757|P1|NOT COMPLETED|Overall Study||2
98210|NCT01433081|238756|P2|COMPLETED|Overall Study||23
98211|NCT01433081|238757|P1|COMPLETED|Overall Study||23
98212|NCT01433081|238756|P2|STARTED|Overall Study||25
98213|NCT01433081|238757|P1|STARTED|Overall Study||25
98214|NCT01433055|238767|P2|NOT COMPLETED|Overall Study||0
98215|NCT01433055|238768|P1|NOT COMPLETED|Overall Study||2
98216|NCT01433055|238767|P2|COMPLETED|Overall Study||23
98217|NCT01433055|238768|P1|COMPLETED|Overall Study||27
98218|NCT01433055|238767|P2|STARTED|Overall Study||23
98219|NCT01433055|238768|P1|STARTED|Overall Study||29
98220|NCT01433042|238782|P1|NOT COMPLETED|Overall Study||1
98221|NCT01433042|238782|P1|COMPLETED|Overall Study||224
98222|NCT01433042|238782|P1|STARTED|Overall Study||225
98223|NCT01433016|238786|P1|NOT COMPLETED|Overall Study||0
98224|NCT01433016|238786|P1|COMPLETED|Overall Study||20
98225|NCT01433016|238786|P1|STARTED|Overall Study||20
98226|NCT01432938|238790|P2|NOT COMPLETED|Second Intervention||0
98227|NCT01432938|238791|P1|NOT COMPLETED|Second Intervention||1
98228|NCT01432938|238790|P2|COMPLETED|Second Intervention||14
98229|NCT01432938|238791|P1|COMPLETED|Second Intervention||11
98230|NCT01432938|238790|P2|STARTED|Second Intervention||14
98231|NCT01432938|238791|P1|STARTED|Second Intervention||12
98232|NCT01432938|238790|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
98233|NCT01432938|238791|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
98234|NCT01432938|238790|P2|COMPLETED|Washout Period of at Least 24 Days||14
98235|NCT01432938|238791|P1|COMPLETED|Washout Period of at Least 24 Days||12
98236|NCT01432938|238790|P2|STARTED|Washout Period of at Least 24 Days||14
98237|NCT01432938|238791|P1|STARTED|Washout Period of at Least 24 Days||12
98238|NCT01432938|238790|P2|NOT COMPLETED|First Intervention||0
98239|NCT01432938|238791|P1|NOT COMPLETED|First Intervention||2
98240|NCT01432938|238790|P2|COMPLETED|First Intervention||14
98241|NCT01432938|238791|P1|COMPLETED|First Intervention||12
98242|NCT01432938|238790|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
98243|NCT01432938|238791|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
98244|NCT01432938|238790|P2|STARTED|First Intervention||14
98245|NCT01432938|238791|P1|STARTED|First Intervention||14
98246|NCT01432886|238808|P2|NOT COMPLETED|Overall Study||0
98247|NCT01432886|238809|P1|NOT COMPLETED|Overall Study||0
98248|NCT01432886|238808|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
98249|NCT01432886|238809|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
98250|NCT01432886|238808|P2|STARTED|Overall Study||6
98251|NCT01432886|238809|P1|STARTED|Overall Study||6
98252|NCT01432756|238821|P4|NOT COMPLETED|Overall Study||1
98253|NCT01432756|238822|P3|NOT COMPLETED|Overall Study||2
98254|NCT01432756|238823|P2|NOT COMPLETED|Overall Study||0
98255|NCT01432756|238824|P1|NOT COMPLETED|Overall Study||1
98256|NCT01432756|238821|P4|COMPLETED|Overall Study||33
98257|NCT01432756|238822|P3|COMPLETED|Overall Study||30
98258|NCT01432756|238823|P2|COMPLETED|Overall Study||34
98259|NCT01432756|238824|P1|COMPLETED|Overall Study||31
98260|NCT01432756|238821|P4|STARTED|Overall Study||34
98261|NCT01432756|238822|P3|STARTED|Overall Study||32
98262|NCT01432756|238823|P2|STARTED|Overall Study||34
98263|NCT01432756|238824|P1|STARTED|Overall Study||32
98264|NCT01432626|238832|P1|NOT COMPLETED|Overall Study||7
98265|NCT01432626|238832|P1|COMPLETED|Overall Study|Completed both images|3
98266|NCT01432626|238832|P1|STARTED|Overall Study||10
98267|NCT01432600|238839|P3|NOT COMPLETED|Overall Study||1
98268|NCT01432600|238840|P2|NOT COMPLETED|Overall Study||1
98269|NCT01432600|238841|P1|NOT COMPLETED|Overall Study||0
98270|NCT01432600|238839|P3|COMPLETED|Overall Study||33
98271|NCT01432600|238840|P2|COMPLETED|Overall Study||35
98272|NCT01432600|238841|P1|COMPLETED|Overall Study||10
98273|NCT01432600|238839|P3|STARTED|Overall Study||34
98274|NCT01432600|238840|P2|STARTED|Overall Study||36
98275|NCT01432600|238841|P1|STARTED|Overall Study||10
98276|NCT01432574|238857|P1|NOT COMPLETED|Overall Study||3
98277|NCT01432574|238857|P1|COMPLETED|Overall Study||147
98278|NCT01432574|238857|P1|STARTED|Overall Study||150
98279|NCT01432561|238863|P1|NOT COMPLETED|Overall Study||0
98280|NCT01432561|238863|P1|COMPLETED|Overall Study||8
98281|NCT01432561|238863|P1|STARTED|Overall Study||8
98282|NCT01432535|238872|P3|NOT COMPLETED|Overall Study||0
98283|NCT01432535|238873|P2|NOT COMPLETED|Overall Study||0
98284|NCT01432535|238874|P1|NOT COMPLETED|Overall Study||0
98285|NCT01432535|238872|P3|COMPLETED|Overall Study||6
98286|NCT01432535|238873|P2|COMPLETED|Overall Study||7
98287|NCT01432535|238874|P1|COMPLETED|Overall Study||12
98288|NCT01432535|238872|P3|STARTED|Overall Study||6
98289|NCT01432535|238873|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
98290|NCT01432535|238874|P1|STARTED|Overall Study||12
98291|NCT01432457|238903|P3|NOT COMPLETED|Overall Study||59
98292|NCT01432457|238904|P2|NOT COMPLETED|Overall Study||48
98293|NCT01432457|238905|P1|NOT COMPLETED|Overall Study||37
98294|NCT01432457|238903|P3|COMPLETED|Overall Study||253
98295|NCT01432457|238904|P2|COMPLETED|Overall Study||258
98296|NCT01432457|238905|P1|COMPLETED|Overall Study||269
98297|NCT01432457|238903|P3|STARTED|Overall Study||312
98298|NCT01432457|238904|P2|STARTED|Overall Study||306
98299|NCT01432457|238905|P1|STARTED|Overall Study||306
98300|NCT01432444|238934|P3|NOT COMPLETED|Extension Phase||192
98301|NCT01432444|238935|P2|NOT COMPLETED|Extension Phase||0
98302|NCT01432444|238936|P1|NOT COMPLETED|Extension Phase||0
98303|NCT01432444|238934|P3|COMPLETED|Extension Phase||0
98304|NCT01432444|238935|P2|COMPLETED|Extension Phase||0
98305|NCT01432444|238936|P1|COMPLETED|Extension Phase||0
98306|NCT01432444|238934|P3|STARTED|Extension Phase||192
98307|NCT01432444|238935|P2|STARTED|Extension Phase||0
98308|NCT01432444|238936|P1|STARTED|Extension Phase||0
98309|NCT01432444|238934|P3|NOT COMPLETED|Treatment Phase||0
98310|NCT01432444|238935|P2|NOT COMPLETED|Treatment Phase||140
98311|NCT01432444|238936|P1|NOT COMPLETED|Treatment Phase||0
98312|NCT01432444|238934|P3|COMPLETED|Treatment Phase||0
98313|NCT01432444|238935|P2|COMPLETED|Treatment Phase||293
98314|NCT01432444|238936|P1|COMPLETED|Treatment Phase||0
98315|NCT01432444|238934|P3|STARTED|Treatment Phase||0
98316|NCT01432444|238935|P2|STARTED|Treatment Phase||433
98317|NCT01432444|238936|P1|STARTED|Treatment Phase||0
98318|NCT01432444|238934|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
98319|NCT01432444|238935|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
98320|NCT01432444|238936|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
98321|NCT01432444|238934|P3|COMPLETED|Tolerability/Cross-titration Phase||0
98322|NCT01432444|238935|P2|COMPLETED|Tolerability/Cross-titration Phase||0
98323|NCT01432444|238936|P1|COMPLETED|Tolerability/Cross-titration Phase||265
98324|NCT01432444|238934|P3|STARTED|Tolerability/Cross-titration Phase||0
98325|NCT01432444|238935|P2|STARTED|Tolerability/Cross-titration Phase||0
98326|NCT01432444|238936|P1|STARTED|Tolerability/Cross-titration Phase||325
98327|NCT01432405|238948|P2|NOT COMPLETED|Overall Study||2
98328|NCT01432405|238949|P1|NOT COMPLETED|Overall Study||1
98329|NCT01432405|238948|P2|COMPLETED|Overall Study||10
98330|NCT01432405|238949|P1|COMPLETED|Overall Study||11
98331|NCT01432405|238948|P2|STARTED|Overall Study||12
98332|NCT01432405|238949|P1|STARTED|Overall Study||12
98333|NCT01432379|238957|P1|NOT COMPLETED|Overall Study||385
98334|NCT01432379|238957|P1|COMPLETED|Overall Study||783
98335|NCT01432379|238957|P1|STARTED|Overall Study||1168
98336|NCT01432366|238962|P1|NOT COMPLETED|Overall Study||68
98337|NCT01432366|238962|P1|COMPLETED|Overall Study||392
98338|NCT01432366|238962|P1|STARTED|Overall Study||460
98339|NCT01432327|238984|P4|NOT COMPLETED|Posttest 1 Year||23
98340|NCT01432327|238985|P3|NOT COMPLETED|Posttest 1 Year||20
98341|NCT01432327|238986|P2|NOT COMPLETED|Posttest 1 Year||28
98342|NCT01432327|238987|P1|NOT COMPLETED|Posttest 1 Year||24
98343|NCT01432327|238984|P4|COMPLETED|Posttest 1 Year||31
98344|NCT01432327|238985|P3|COMPLETED|Posttest 1 Year||30
98345|NCT01432327|238986|P2|COMPLETED|Posttest 1 Year||27
98346|NCT01432327|238987|P1|COMPLETED|Posttest 1 Year||28
98347|NCT01432327|238984|P4|STARTED|Posttest 1 Year||54
98348|NCT01432327|238985|P3|STARTED|Posttest 1 Year||50
98349|NCT01432327|238986|P2|STARTED|Posttest 1 Year||55
98350|NCT01432327|238987|P1|STARTED|Posttest 1 Year||52
98351|NCT01432327|238984|P4|NOT COMPLETED|Posttest 6 Months||2
98352|NCT01432327|238985|P3|NOT COMPLETED|Posttest 6 Months||5
98353|NCT01432327|238986|P2|NOT COMPLETED|Posttest 6 Months||0
98354|NCT01432327|238987|P1|NOT COMPLETED|Posttest 6 Months||0
98355|NCT01432327|238984|P4|COMPLETED|Posttest 6 Months||54
98356|NCT01432327|238985|P3|COMPLETED|Posttest 6 Months||50
98357|NCT01432327|238986|P2|COMPLETED|Posttest 6 Months||55
98358|NCT01432327|238987|P1|COMPLETED|Posttest 6 Months||52
98359|NCT01432327|238984|P4|STARTED|Posttest 6 Months||56
98360|NCT01432327|238985|P3|STARTED|Posttest 6 Months||55
98361|NCT01432327|238986|P2|STARTED|Posttest 6 Months||55
98362|NCT01432327|238987|P1|STARTED|Posttest 6 Months||52
98363|NCT01432327|238984|P4|NOT COMPLETED|Posttest 3 Months||1
98364|NCT01432327|238985|P3|NOT COMPLETED|Posttest 3 Months||2
98365|NCT01432327|238986|P2|NOT COMPLETED|Posttest 3 Months||2
98366|NCT01432327|238987|P1|NOT COMPLETED|Posttest 3 Months||4
98367|NCT01432327|238984|P4|COMPLETED|Posttest 3 Months||56
98368|NCT01432327|238985|P3|COMPLETED|Posttest 3 Months||55
98369|NCT01432327|238986|P2|COMPLETED|Posttest 3 Months||55
98370|NCT01432327|238987|P1|COMPLETED|Posttest 3 Months||52
98371|NCT01432327|238984|P4|STARTED|Posttest 3 Months||57
98372|NCT01432327|238985|P3|STARTED|Posttest 3 Months||57
98373|NCT01432327|238986|P2|STARTED|Posttest 3 Months||57
98374|NCT01432327|238987|P1|STARTED|Posttest 3 Months||56
98375|NCT01432327|238984|P4|NOT COMPLETED|Baseline||0
98376|NCT01432327|238985|P3|NOT COMPLETED|Baseline||0
98377|NCT01432327|238986|P2|NOT COMPLETED|Baseline||0
98378|NCT01432327|238987|P1|NOT COMPLETED|Baseline||0
98379|NCT01432327|238984|P4|COMPLETED|Baseline||57
98380|NCT01432327|238985|P3|COMPLETED|Baseline||57
98381|NCT01432327|238986|P2|COMPLETED|Baseline||57
98382|NCT01432327|238987|P1|COMPLETED|Baseline||56
98383|NCT01432327|238984|P4|STARTED|Baseline||57
98384|NCT01432327|238985|P3|STARTED|Baseline||57
98385|NCT01432327|238986|P2|STARTED|Baseline||57
98386|NCT01432327|238987|P1|STARTED|Baseline||56
98387|NCT01432275|238997|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
98388|NCT01432275|238998|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
98389|NCT01432275|238997|P2|COMPLETED|ADC With Calculator (10 Days)||79
98390|NCT01432275|238998|P1|COMPLETED|ADC With Calculator (10 Days)||85
98391|NCT01432275|238997|P2|STARTED|ADC With Calculator (10 Days)||81
98392|NCT01432275|238998|P1|STARTED|ADC With Calculator (10 Days)||88
98393|NCT01432275|238997|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
98394|NCT01432275|238998|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
98395|NCT01432275|238997|P2|COMPLETED|Second BG Meter System (7 Days)||81
98396|NCT01432275|238998|P1|COMPLETED|Second BG Meter System (7 Days)||88
98397|NCT01432275|238997|P2|STARTED|Second BG Meter System (7 Days)||84
98398|NCT01432275|238998|P1|STARTED|Second BG Meter System (7 Days)||90
98399|NCT01432275|238997|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
98400|NCT01432275|238998|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
98401|NCT01432275|238997|P2|COMPLETED|First BG Meter System (7 Days)||84
98402|NCT01432275|238998|P1|COMPLETED|First BG Meter System (7 Days)||90
98403|NCT01432275|238997|P2|STARTED|First BG Meter System (7 Days)||87
98404|NCT01432275|238998|P1|STARTED|First BG Meter System (7 Days)||90
98405|NCT01432262|239007|P2|NOT COMPLETED|Overall Study||1
98406|NCT01432262|239008|P1|NOT COMPLETED|Overall Study||2
98407|NCT01432262|239007|P2|COMPLETED|Overall Study||161
98408|NCT01432262|239008|P1|COMPLETED|Overall Study||160
98409|NCT01432262|239007|P2|Vaccinated|Overall Study||161
98410|NCT01432262|239008|P1|Vaccinated|Overall Study||162
98411|NCT01432262|239007|P2|STARTED|Overall Study||162
98412|NCT01432262|239008|P1|STARTED|Overall Study||162
98413|NCT01432236|239026|P2|NOT COMPLETED|Overall Study||18
98414|NCT01432236|239027|P1|NOT COMPLETED|Overall Study||26
98415|NCT01432236|239026|P2|COMPLETED|Overall Study||79
98416|NCT01432236|239027|P1|COMPLETED|Overall Study||70
98417|NCT01432236|239026|P2|STARTED|Overall Study||97
98418|NCT01432236|239027|P1|STARTED|Overall Study||96
98419|NCT01432015|239074|P2|NOT COMPLETED|Overall Study||0
98420|NCT01432015|239075|P1|NOT COMPLETED|Overall Study||0
98421|NCT01432015|239074|P2|COMPLETED|Overall Study||10
98422|NCT01432015|239075|P1|COMPLETED|Overall Study||10
98423|NCT01432015|239074|P2|STARTED|Overall Study||10
98424|NCT01432015|239075|P1|STARTED|Overall Study||10
98425|NCT01431989|239083|P2|NOT COMPLETED|Period 2||0
98426|NCT01431989|239084|P1|NOT COMPLETED|Period 2||0
98427|NCT01431989|239083|P2|COMPLETED|Period 2||14
98428|NCT01431989|239084|P1|COMPLETED|Period 2||14
98429|NCT01431989|239083|P2|STARTED|Period 2||14
98430|NCT01431989|239084|P1|STARTED|Period 2||14
98431|NCT01431989|239083|P2|NOT COMPLETED|14-Day Washout Period||0
98432|NCT01431989|239084|P1|NOT COMPLETED|14-Day Washout Period||0
98433|NCT01431989|239083|P2|COMPLETED|14-Day Washout Period||14
98434|NCT01431989|239084|P1|COMPLETED|14-Day Washout Period||14
98435|NCT01431989|239083|P2|STARTED|14-Day Washout Period||14
98436|NCT01431989|239084|P1|STARTED|14-Day Washout Period||14
98437|NCT01431989|239083|P2|NOT COMPLETED|Period 1||0
98438|NCT01431989|239084|P1|NOT COMPLETED|Period 1||0
98439|NCT01431989|239083|P2|COMPLETED|Period 1||14
98440|NCT01431989|239084|P1|COMPLETED|Period 1||14
98441|NCT01431989|239083|P2|STARTED|Period 1||14
98442|NCT01431989|239084|P1|STARTED|Period 1||14
98443|NCT01431976|239102|P1|NOT COMPLETED|Overall Study||14
98444|NCT01431976|239102|P1|COMPLETED|Overall Study||6
98445|NCT01431976|239102|P1|STARTED|Overall Study||20
98446|NCT01431963|239113|P1|NOT COMPLETED|Overall Study||35
98447|NCT01431963|239113|P1|COMPLETED|Overall Study||32
98448|NCT01431963|239113|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
98449|NCT01431963|239113|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
98450|NCT01431963|239113|P1|Complete MP (24 Weeks)|Overall Study||42
98451|NCT01431963|239113|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
98452|NCT01431963|239113|P1|Complete EP (6 Weeks)|Overall Study||52
98453|NCT01431963|239113|P1|Received Treatment|Overall Study||65
98454|NCT01431963|239113|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
98455|NCT01431963|239113|P1|STARTED|Overall Study||67
98456|NCT01431950|239121|P2|NOT COMPLETED|Overall Study||15
98457|NCT01431950|239122|P1|NOT COMPLETED|Overall Study||19
98458|NCT01431950|239121|P2|COMPLETED|Overall Study||104
98459|NCT01431950|239122|P1|COMPLETED|Overall Study||100
98460|NCT01431950|239121|P2|STARTED|Overall Study||119
98461|NCT01431950|239122|P1|STARTED|Overall Study||119
98462|NCT01431846|239139|P3|NOT COMPLETED|Overall Study||0
98463|NCT01431846|239140|P2|NOT COMPLETED|Overall Study||0
98464|NCT01431846|239141|P1|NOT COMPLETED|Overall Study||0
98465|NCT01431846|239139|P3|COMPLETED|Overall Study||8
98466|NCT01431846|239140|P2|COMPLETED|Overall Study||3
98467|NCT01431846|239141|P1|COMPLETED|Overall Study||8
98468|NCT01431846|239139|P3|STARTED|Overall Study||8
98469|NCT01431846|239140|P2|STARTED|Overall Study||3
98470|NCT01431846|239141|P1|STARTED|Overall Study||8
98471|NCT01431755|239149|P1|NOT COMPLETED|Overall Study||5
98472|NCT01431755|239149|P1|COMPLETED|Overall Study||49
98473|NCT01431755|239149|P1|STARTED|Overall Study||54
98474|NCT01431716|239160|P1|NOT COMPLETED|Overall Study||1
98475|NCT01431716|239160|P1|COMPLETED|Overall Study||41
98476|NCT01431716|239160|P1|STARTED|Overall Study||42
98477|NCT01431703|239177|P1|NOT COMPLETED|Overall Study||0
98478|NCT01431703|239177|P1|COMPLETED|Overall Study||326
98479|NCT01431703|239177|P1|STARTED|Overall Study||326
98480|NCT01431521|239185|P4|NOT COMPLETED|Overall Study||0
98481|NCT01431521|239186|P3|NOT COMPLETED|Overall Study||1
98482|NCT01431521|239187|P2|NOT COMPLETED|Overall Study||0
98483|NCT01431521|239188|P1|NOT COMPLETED|Overall Study||0
98484|NCT01431521|239185|P4|COMPLETED|Overall Study||5
98485|NCT01431521|239186|P3|COMPLETED|Overall Study||10
98486|NCT01431521|239187|P2|COMPLETED|Overall Study||5
98487|NCT01431521|239188|P1|COMPLETED|Overall Study||10
98488|NCT01431521|239185|P4|Treated|Overall Study||5
98489|NCT01431521|239186|P3|Treated|Overall Study||10
98490|NCT01431521|239187|P2|Treated|Overall Study||5
98491|NCT01431521|239188|P1|Treated|Overall Study||10
98492|NCT01431521|239185|P4|STARTED|Overall Study||5
98493|NCT01431521|239186|P3|STARTED|Overall Study||11
98494|NCT01431521|239187|P2|STARTED|Overall Study||5
98495|NCT01431521|239188|P1|STARTED|Overall Study||10
98496|NCT01431508|239209|P1|NOT COMPLETED|Overall Study||2
98497|NCT01431508|239209|P1|COMPLETED|Overall Study||13
98498|NCT01431508|239209|P1|STARTED|Overall Study||15
98499|NCT01431391|239215|P2|NOT COMPLETED|Overall Study||4
98500|NCT01431391|239216|P1|NOT COMPLETED|Overall Study||8
98501|NCT01431391|239215|P2|COMPLETED|Overall Study||30
98502|NCT01431391|239216|P1|COMPLETED|Overall Study||26
98503|NCT01431391|239215|P2|Received ≥1 Leaukapheresis|Overall Study||34
98504|NCT01431391|239216|P1|Received ≥1 Leaukapheresis|Overall Study||34
98505|NCT01431391|239215|P2|STARTED|Overall Study||34
98506|NCT01431391|239216|P1|STARTED|Overall Study||34
98507|NCT01431339|239226|P2|NOT COMPLETED|Overall Study||35
98508|NCT01431339|239227|P1|NOT COMPLETED|Overall Study||39
98509|NCT01431339|239226|P2|COMPLETED|Overall Study||333
98510|NCT01431339|239227|P1|COMPLETED|Overall Study||332
98511|NCT01431339|239226|P2|Safety Population|Overall Study||367
98512|NCT01431339|239227|P1|Safety Population|Overall Study||368
98513|NCT01431339|239226|P2|STARTED|Overall Study||368
98514|NCT01431339|239227|P1|STARTED|Overall Study||371
98515|NCT01431300|239242|P3|NOT COMPLETED|Overall Study||0
98516|NCT01431300|239243|P2|NOT COMPLETED|Overall Study||0
98517|NCT01431300|239244|P1|NOT COMPLETED|Overall Study||1
98518|NCT01431300|239242|P3|COMPLETED|Overall Study||10
98519|NCT01431300|239243|P2|COMPLETED|Overall Study||10
98520|NCT01431300|239244|P1|COMPLETED|Overall Study||10
98521|NCT01431300|239242|P3|STARTED|Overall Study||10
98522|NCT01431300|239243|P2|STARTED|Overall Study||10
98523|NCT01431300|239244|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
98524|NCT01431287|239260|P5|NOT COMPLETED|Overall Study||77
98525|NCT01431287|239261|P4|NOT COMPLETED|Overall Study||63
98526|NCT01431287|239262|P3|NOT COMPLETED|Overall Study||97
98527|NCT01431287|239263|P2|NOT COMPLETED|Overall Study||98
98528|NCT01431287|239264|P1|NOT COMPLETED|Overall Study||98
98529|NCT01431287|239260|P5|COMPLETED|Overall Study||430
98530|NCT01431287|239261|P4|COMPLETED|Overall Study||445
98531|NCT01431287|239262|P3|COMPLETED|Overall Study||410
98532|NCT01431287|239263|P2|COMPLETED|Overall Study||409
98533|NCT01431287|239264|P1|COMPLETED|Overall Study||412
98534|NCT01431287|239260|P5|STARTED|Overall Study||507
98535|NCT01431287|239261|P4|STARTED|Overall Study||508
98536|NCT01431287|239262|P3|STARTED|Overall Study||507
98537|NCT01431287|239263|P2|STARTED|Overall Study||507
98538|NCT01431287|239264|P1|STARTED|Overall Study|started are actually the randomized|510
98539|NCT01431274|239426|P5|NOT COMPLETED|Overall Study||56
98540|NCT01431274|239427|P4|NOT COMPLETED|Overall Study||60
98541|NCT01431274|239428|P3|NOT COMPLETED|Overall Study||72
98542|NCT01431274|239429|P2|NOT COMPLETED|Overall Study||77
98543|NCT01431274|239430|P1|NOT COMPLETED|Overall Study||97
98544|NCT01431274|239426|P5|COMPLETED|Overall Study||466
98545|NCT01431274|239427|P4|COMPLETED|Overall Study||462
98546|NCT01431274|239428|P3|COMPLETED|Overall Study||455
98547|NCT01431274|239429|P2|COMPLETED|Overall Study||448
98548|NCT01431274|239430|P1|COMPLETED|Overall Study||431
98549|NCT01431274|239426|P5|STARTED|Overall Study||522
98550|NCT01431274|239427|P4|STARTED|Overall Study||522
98551|NCT01431274|239428|P3|STARTED|Overall Study||527
98552|NCT01431274|239429|P2|STARTED|Overall Study||525
98553|NCT01431274|239430|P1|STARTED|Overall Study||528
98554|NCT01431170|239589|P2|NOT COMPLETED|Overall Study||1
98555|NCT01431170|239590|P1|NOT COMPLETED|Overall Study||3
98556|NCT01431170|239589|P2|COMPLETED|Overall Study||11
98557|NCT01431170|239590|P1|COMPLETED|Overall Study||9
98558|NCT01431170|239589|P2|STARTED|Overall Study||12
98559|NCT01431170|239590|P1|STARTED|Overall Study||12
98560|NCT01431144|239608|P2|NOT COMPLETED|Overall Study||0
98561|NCT01431144|239609|P1|NOT COMPLETED|Overall Study||2
98562|NCT01431144|239608|P2|COMPLETED|Overall Study||14
98563|NCT01431144|239609|P1|COMPLETED|Overall Study||11
98564|NCT01431144|239608|P2|STARTED|Overall Study||14
98565|NCT01431144|239609|P1|STARTED|Overall Study||13
98566|NCT01431131|239617|P2|NOT COMPLETED|Overall Study||0
98567|NCT01431131|239618|P1|NOT COMPLETED|Overall Study||0
98568|NCT01431131|239617|P2|COMPLETED|Overall Study||12
98569|NCT01431131|239618|P1|COMPLETED|Overall Study||12
98570|NCT01431131|239617|P2|STARTED|Overall Study||12
98571|NCT01431131|239618|P1|STARTED|Overall Study||12
98572|NCT01431079|239628|P2|NOT COMPLETED|Overall Study||39
98573|NCT01431079|239629|P1|NOT COMPLETED|Overall Study||35
98574|NCT01431079|239628|P2|COMPLETED|Overall Study||6
98575|NCT01431079|239629|P1|COMPLETED|Overall Study||10
98576|NCT01431079|239628|P2|Post-test|Overall Study||45
98577|NCT01431079|239629|P1|Post-test|Overall Study||45
98578|NCT01431079|239628|P2|STARTED|Overall Study||45
98579|NCT01431079|239629|P1|STARTED|Overall Study||45
98580|NCT01431014|239683|P2|NOT COMPLETED|Overall Study||9
98581|NCT01431014|239684|P1|NOT COMPLETED|Overall Study||3
98582|NCT01431014|239683|P2|COMPLETED|Overall Study||25
98583|NCT01431014|239684|P1|COMPLETED|Overall Study||31
98584|NCT01431014|239683|P2|STARTED|Overall Study||34
98585|NCT01431014|239684|P1|STARTED|Overall Study||34
98586|NCT01430819|239692|P2|NOT COMPLETED|Overall Study||0
98587|NCT01430819|239693|P1|NOT COMPLETED|Overall Study||0
98588|NCT01430819|239692|P2|COMPLETED|Overall Study||150
98589|NCT01430819|239693|P1|COMPLETED|Overall Study||150
98590|NCT01430819|239692|P2|STARTED|Overall Study||150
98591|NCT01430819|239693|P1|STARTED|Overall Study||150
98592|NCT01430754|239708|P2|NOT COMPLETED|Randomized Phase||0
98593|NCT01430754|239709|P1|NOT COMPLETED|Randomized Phase||0
98594|NCT01430754|239708|P2|COMPLETED|Randomized Phase||10
98595|NCT01430754|239709|P1|COMPLETED|Randomized Phase||10
98596|NCT01430754|239708|P2|STARTED|Randomized Phase||10
98597|NCT01430754|239709|P1|STARTED|Randomized Phase||10
98598|NCT01430754|239708|P2|NOT COMPLETED|Run-In Phase||0
98599|NCT01430754|239709|P1|NOT COMPLETED|Run-In Phase||37
98600|NCT01430754|239708|P2|COMPLETED|Run-In Phase||0
98601|NCT01430754|239709|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
98602|NCT01430754|239708|P2|Entrained - After Run-In Phase|Run-In Phase||0
98603|NCT01430754|239709|P1|Entrained - After Run-In Phase|Run-In Phase||24
98604|NCT01430754|239708|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
98605|NCT01430754|239709|P1|STARTED|Run-In Phase||57
98606|NCT01430741|239731|P4|NOT COMPLETED|Overall Study||0
98607|NCT01430741|239732|P3|NOT COMPLETED|Overall Study||10
98608|NCT01430741|239733|P2|NOT COMPLETED|Overall Study||0
98609|NCT01430741|239734|P1|NOT COMPLETED|Overall Study||0
98610|NCT01430741|239731|P4|COMPLETED|Overall Study||81
98611|NCT01430741|239732|P3|COMPLETED|Overall Study||37
98612|NCT01430741|239733|P2|COMPLETED|Overall Study||87
98613|NCT01430741|239734|P1|COMPLETED|Overall Study||22
98614|NCT01430741|239731|P4|STARTED|Overall Study||81
98615|NCT01430741|239732|P3|STARTED|Overall Study||47
98616|NCT01430741|239733|P2|STARTED|Overall Study||87
98617|NCT01430741|239734|P1|STARTED|Overall Study||22
98618|NCT01430624|239767|P3|NOT COMPLETED|Overall Study||29
98619|NCT01430624|239768|P2|NOT COMPLETED|Overall Study||34
98620|NCT01430624|239769|P1|NOT COMPLETED|Overall Study||28
98621|NCT01430624|239767|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
98622|NCT01430624|239768|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
98623|NCT01430624|239769|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
98624|NCT01430624|239767|P3|Eligible Baseline Completes|Overall Study||79
98625|NCT01430624|239768|P2|Eligible Baseline Completes|Overall Study||77
98626|NCT01430624|239769|P1|Eligible Baseline Completes|Overall Study||77
98627|NCT01430624|239767|P3|STARTED|Overall Study||81
98628|NCT01430624|239768|P2|STARTED|Overall Study||82
98629|NCT01430624|239769|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
98630|NCT01430611|239800|P2|NOT COMPLETED|Overall Study||15
98631|NCT01430611|239801|P1|NOT COMPLETED|Overall Study||17
98632|NCT01430611|239800|P2|COMPLETED|Overall Study||318
98633|NCT01430611|239801|P1|COMPLETED|Overall Study||315
98634|NCT01430611|239800|P2|STARTED|Overall Study||333
98635|NCT01430611|239801|P1|STARTED|Overall Study||332
98636|NCT01430585|239819|P1|NOT COMPLETED|Overall Study||14
98637|NCT01430585|239819|P1|COMPLETED|Overall Study||0
98638|NCT01430585|239819|P1|STARTED|Overall Study||14
98639|NCT01430468|239854|P2|NOT COMPLETED|Overall Study||2
98640|NCT01430468|239855|P1|NOT COMPLETED|Overall Study||3
98641|NCT01430468|239854|P2|COMPLETED|Overall Study||16
98642|NCT01430468|239855|P1|COMPLETED|Overall Study||15
98643|NCT01430468|239854|P2|STARTED|Overall Study||18
98644|NCT01430468|239855|P1|STARTED|Overall Study||18
98645|NCT01430455|239861|P1|NOT COMPLETED|Overall Study||2
98646|NCT01430455|239861|P1|COMPLETED|Overall Study||5
98647|NCT01430455|239861|P1|STARTED|Overall Study||7
98648|NCT01430403|239868|P3|NOT COMPLETED|Overall Study||8
98649|NCT01430403|239869|P2|NOT COMPLETED|Overall Study||9
98650|NCT01430403|239870|P1|NOT COMPLETED|Overall Study||17
98651|NCT01430403|239868|P3|COMPLETED|Overall Study||81
98652|NCT01430403|239869|P2|COMPLETED|Overall Study||121
98653|NCT01430403|239870|P1|COMPLETED|Overall Study||242
98654|NCT01430403|239868|P3|STARTED|Overall Study|Intent-to-treat|89
98655|NCT01430403|239869|P2|STARTED|Overall Study|Intent-to-treat|130
98656|NCT01430403|239870|P1|STARTED|Overall Study|Intent-to-treat|259
98657|NCT01430325|239923|P4|NOT COMPLETED|Overall Study||0
98658|NCT01430325|239924|P3|NOT COMPLETED|Overall Study||0
98659|NCT01430325|239925|P2|NOT COMPLETED|Overall Study||0
98660|NCT01430325|239926|P1|NOT COMPLETED|Overall Study||0
98661|NCT01430325|239923|P4|COMPLETED|Overall Study||12
98662|NCT01430325|239924|P3|COMPLETED|Overall Study||8
98663|NCT01430325|239925|P2|COMPLETED|Overall Study||12
98664|NCT01430325|239926|P1|COMPLETED|Overall Study||10
98665|NCT01430325|239923|P4|STARTED|Overall Study||12
98666|NCT01430325|239924|P3|STARTED|Overall Study||8
98667|NCT01430325|239925|P2|STARTED|Overall Study||12
98668|NCT01430325|239926|P1|STARTED|Overall Study||10
98669|NCT01430299|239946|P2|NOT COMPLETED|Overall Study||2
98670|NCT01430299|239947|P1|NOT COMPLETED|Overall Study||4
98671|NCT01430299|239946|P2|COMPLETED|Overall Study||21
98672|NCT01430299|239947|P1|COMPLETED|Overall Study||16
98673|NCT01430299|239946|P2|STARTED|Overall Study||23
98674|NCT01430299|239947|P1|STARTED|Overall Study||20
98675|NCT01430182|239955|P2|NOT COMPLETED|Overall Study||0
98676|NCT01430182|239956|P1|NOT COMPLETED|Overall Study||0
98677|NCT01430182|239955|P2|COMPLETED|Overall Study||8
98678|NCT01430182|239956|P1|COMPLETED|Overall Study||9
98679|NCT01430182|239955|P2|STARTED|Overall Study||8
98680|NCT01430182|239956|P1|STARTED|Overall Study||9
98681|NCT01430169|239962|P1|NOT COMPLETED|Overall Study||0
98682|NCT01430169|239962|P1|COMPLETED|Overall Study||20
98683|NCT01430169|239962|P1|STARTED|Overall Study||20
98684|NCT01430130|239977|P1|NOT COMPLETED|Overall Study||2
98685|NCT01430130|239977|P1|COMPLETED|Overall Study||10
98686|NCT01430130|239977|P1|STARTED|Overall Study||12
98687|NCT01430104|239983|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
98688|NCT01430104|239983|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
98689|NCT01430104|239983|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
98690|NCT01430104|239983|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
98691|NCT01430104|239983|P1|NOT COMPLETED|14-Day Lead-In Period||0
98692|NCT01430104|239983|P1|COMPLETED|14-Day Lead-In Period||30
98693|NCT01430104|239983|P1|STARTED|14-Day Lead-In Period||30
98694|NCT01430091|239995|P1|NOT COMPLETED|Overall Study||0
98695|NCT01430091|239995|P1|COMPLETED|Overall Study||18
98696|NCT01430091|239995|P1|STARTED|Overall Study||18
98697|NCT01429987|240021|P4|NOT COMPLETED|Overall Study||66
98698|NCT01429987|240022|P3|NOT COMPLETED|Overall Study||36
98699|NCT01429987|240023|P2|NOT COMPLETED|Overall Study||62
98700|NCT01429987|240024|P1|NOT COMPLETED|Overall Study||49
98701|NCT01429987|240021|P4|COMPLETED|Overall Study||171
98702|NCT01429987|240022|P3|COMPLETED|Overall Study||202
98703|NCT01429987|240023|P2|COMPLETED|Overall Study||176
98704|NCT01429987|240024|P1|COMPLETED|Overall Study||189
98705|NCT01429987|240021|P4|STARTED|Overall Study||237
98706|NCT01429987|240022|P3|STARTED|Overall Study||238
98707|NCT01429987|240023|P2|STARTED|Overall Study||238
98708|NCT01429987|240024|P1|STARTED|Overall Study||238
98709|NCT01429623|240036|P2|NOT COMPLETED|Overall Study||59
98710|NCT01429623|240037|P1|NOT COMPLETED|Overall Study||51
98711|NCT01429623|240036|P2|COMPLETED|Overall Study||48
98712|NCT01429623|240037|P1|COMPLETED|Overall Study||51
98713|NCT01429623|240036|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
98714|NCT01429623|240037|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
98715|NCT01429623|240036|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
98716|NCT01429623|240037|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
98717|NCT01429584|240051|P2|NOT COMPLETED|Overall Study||1
98718|NCT01429584|240052|P1|NOT COMPLETED|Overall Study||1
98719|NCT01429584|240051|P2|COMPLETED|Overall Study||14
98720|NCT01429584|240052|P1|COMPLETED|Overall Study||14
98721|NCT01429584|240051|P2|STARTED|Overall Study||15
98722|NCT01429584|240052|P1|STARTED|Overall Study||15
98723|NCT01429532|240065|P3|NOT COMPLETED|Overall Study||0
98724|NCT01429532|240066|P2|NOT COMPLETED|Overall Study||0
98725|NCT01429532|240067|P1|NOT COMPLETED|Overall Study||0
98726|NCT01429532|240065|P3|COMPLETED|Overall Study||40
98727|NCT01429532|240066|P2|COMPLETED|Overall Study||40
98728|NCT01429532|240067|P1|COMPLETED|Overall Study||40
98729|NCT01429532|240065|P3|STARTED|Overall Study||40
98730|NCT01429532|240066|P2|STARTED|Overall Study||40
98731|NCT01429532|240067|P1|STARTED|Overall Study||40
98732|NCT01429441|240083|P2|NOT COMPLETED|Overall Study||23
98733|NCT01429441|240084|P1|NOT COMPLETED|Overall Study||38
98734|NCT01429441|240083|P2|COMPLETED|Overall Study||51
98735|NCT01429441|240084|P1|COMPLETED|Overall Study||108
98736|NCT01429441|240083|P2|STARTED|Overall Study||74
98737|NCT01429441|240084|P1|STARTED|Overall Study||146
98738|NCT01429298|240094|P2|NOT COMPLETED|Overall Study||6
98739|NCT01429298|240095|P1|NOT COMPLETED|Overall Study||4
98740|NCT01429298|240094|P2|COMPLETED|Overall Study||169
98741|NCT01429298|240095|P1|COMPLETED|Overall Study||171
98742|NCT01429298|240094|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
98743|NCT01429298|240095|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
98744|NCT01429298|240094|P2|STARTED|Overall Study||175
98745|NCT01429298|240095|P1|STARTED|Overall Study||175
98746|NCT01429285|240111|P2|NOT COMPLETED|Overall Study||9
98747|NCT01429285|240112|P1|NOT COMPLETED|Overall Study||22
98748|NCT01429285|240111|P2|COMPLETED|Overall Study||166
98749|NCT01429285|240112|P1|COMPLETED|Overall Study||153
98750|NCT01429285|240111|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
98751|NCT01429285|240112|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
98752|NCT01429285|240111|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
98753|NCT01429285|240112|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
98754|NCT01429285|240111|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
98755|NCT01429285|240112|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
98756|NCT01429285|240111|P2|STARTED|Overall Study||175
98757|NCT01429285|240112|P1|STARTED|Overall Study||175
98758|NCT01429272|240134|P4|NOT COMPLETED|Overall Study||5
98759|NCT01429272|240135|P3|NOT COMPLETED|Overall Study||4
98760|NCT01429272|240136|P2|NOT COMPLETED|Overall Study||9
98761|NCT01429272|240137|P1|NOT COMPLETED|Overall Study||6
98762|NCT01429272|240134|P4|COMPLETED|Overall Study||14
98763|NCT01429272|240135|P3|COMPLETED|Overall Study||15
98764|NCT01429272|240136|P2|COMPLETED|Overall Study||22
98765|NCT01429272|240137|P1|COMPLETED|Overall Study||24
98766|NCT01429272|240134|P4|STARTED|Overall Study||19
98767|NCT01429272|240135|P3|STARTED|Overall Study||19
98768|NCT01429272|240136|P2|STARTED|Overall Study||31
98769|NCT01429272|240137|P1|STARTED|Overall Study||30
98770|NCT01429259|240151|P1|NOT COMPLETED|Overall Study||0
98771|NCT01429259|240151|P1|COMPLETED|Overall Study||30
98772|NCT01429259|240151|P1|STARTED|Overall Study||30
98773|NCT01429077|240158|P2|NOT COMPLETED|Overall Study||3
98774|NCT01429077|240159|P1|NOT COMPLETED|Overall Study||0
98775|NCT01429077|240158|P2|COMPLETED|Overall Study||14
98776|NCT01429077|240159|P1|COMPLETED|Overall Study||19
98777|NCT01429077|240158|P2|Completed 6-week Intervention|Overall Study||17
98778|NCT01429077|240159|P1|Completed 6-week Intervention|Overall Study||19
98779|NCT01429077|240158|P2|STARTED|Overall Study||17
98780|NCT01429077|240159|P1|STARTED|Overall Study||19
98781|NCT01429064|240169|P4|NOT COMPLETED|Overall Study||0
98782|NCT01429064|240170|P3|NOT COMPLETED|Overall Study||0
98783|NCT01429064|240171|P2|NOT COMPLETED|Overall Study||0
98784|NCT01429064|240172|P1|NOT COMPLETED|Overall Study||0
98785|NCT01429064|240169|P4|COMPLETED|Overall Study||16
98786|NCT01429064|240170|P3|COMPLETED|Overall Study||19
98787|NCT01429064|240171|P2|COMPLETED|Overall Study||22
98788|NCT01429064|240172|P1|COMPLETED|Overall Study||19
98789|NCT01429064|240169|P4|STARTED|Overall Study||16
98790|NCT01429064|240170|P3|STARTED|Overall Study||19
98791|NCT01429064|240171|P2|STARTED|Overall Study||22
98792|NCT01429064|240172|P1|STARTED|Overall Study||19
98793|NCT01429051|240182|P1|NOT COMPLETED|Tolerability Phase||15
98794|NCT01429051|240182|P1|COMPLETED|Tolerability Phase||16
98795|NCT01429051|240182|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
98796|NCT01429051|240182|P1|NOT COMPLETED|Efficacy Phase||2
98797|NCT01429051|240182|P1|COMPLETED|Efficacy Phase||13
98798|NCT01429051|240182|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
98799|NCT01429051|240182|P1|NOT COMPLETED|Titration Phase||12
98800|NCT01429051|240182|P1|COMPLETED|Titration Phase||33
98801|NCT01429051|240182|P1|STARTED|Titration Phase||45
98802|NCT01428882|240205|P2|NOT COMPLETED|Overall Study||10
98803|NCT01428882|240206|P1|NOT COMPLETED|Overall Study||6
98804|NCT01428882|240205|P2|COMPLETED|Overall Study||58
98805|NCT01428882|240206|P1|COMPLETED|Overall Study||61
98806|NCT01428882|240205|P2|STARTED|Overall Study||68
98807|NCT01428882|240206|P1|STARTED|Overall Study||67
98808|NCT01428765|240218|P1|NOT COMPLETED|Overall Study||0
98809|NCT01428765|240218|P1|COMPLETED|Overall Study||1063
98810|NCT01428765|240218|P1|STARTED|Overall Study||1063
98811|NCT01428713|240229|P2|NOT COMPLETED|Overall Study||5
98812|NCT01428713|240230|P1|NOT COMPLETED|Overall Study||3
98813|NCT01428713|240229|P2|COMPLETED|Overall Study||3
98814|NCT01428713|240230|P1|COMPLETED|Overall Study||6
98815|NCT01428713|240229|P2|STARTED|Overall Study||8
98816|NCT01428713|240230|P1|STARTED|Overall Study||9
98817|NCT01428661|240239|P3|NOT COMPLETED|Open Label Extension||320
98818|NCT01428661|240240|P2|NOT COMPLETED|Open Label Extension||0
98819|NCT01428661|240241|P1|NOT COMPLETED|Open Label Extension||0
98820|NCT01428661|240239|P3|COMPLETED|Open Label Extension||19
98821|NCT01428661|240240|P2|COMPLETED|Open Label Extension|Does not apply.|0
98822|NCT01428661|240241|P1|COMPLETED|Open Label Extension|Does not apply.|0
98823|NCT01428661|240239|P3|STARTED|Open Label Extension||339
98824|NCT01428661|240240|P2|STARTED|Open Label Extension|Does not apply.|0
98825|NCT01428661|240241|P1|STARTED|Open Label Extension|Does not apply.|0
98826|NCT01428661|240239|P3|NOT COMPLETED|Double-Masked Phase||0
98827|NCT01428661|240240|P2|NOT COMPLETED|Double-Masked Phase||49
98828|NCT01428661|240241|P1|NOT COMPLETED|Double-Masked Phase||57
98829|NCT01428661|240239|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
98830|NCT01428661|240240|P2|COMPLETED|Double-Masked Phase||204
98831|NCT01428661|240241|P1|COMPLETED|Double-Masked Phase||197
98832|NCT01428661|240239|P3|STARTED|Double-Masked Phase|Does not apply.|0
98833|NCT01428661|240240|P2|STARTED|Double-Masked Phase||253
98834|NCT01428661|240241|P1|STARTED|Double-Masked Phase||254
98835|NCT01428583|240249|P1|NOT COMPLETED|Overall Study||237
98836|NCT01428583|240249|P1|COMPLETED|Overall Study||158
98837|NCT01428583|240249|P1|STARTED|Overall Study||395
98838|NCT01428336|240273|P2|NOT COMPLETED|Overall Study||0
98839|NCT01428336|240274|P1|NOT COMPLETED|Overall Study||0
98840|NCT01428336|240273|P2|COMPLETED|Overall Study||12
98841|NCT01428336|240274|P1|COMPLETED|Overall Study||10
98842|NCT01428336|240273|P2|STARTED|Overall Study||12
98843|NCT01428336|240274|P1|STARTED|Overall Study||10
98844|NCT01428258|240286|P2|NOT COMPLETED|Intervention 2||0
98845|NCT01428258|240287|P1|NOT COMPLETED|Intervention 2||0
98846|NCT01428258|240286|P2|COMPLETED|Intervention 2||15
98847|NCT01428258|240287|P1|COMPLETED|Intervention 2||15
98848|NCT01428258|240286|P2|STARTED|Intervention 2||15
98849|NCT01428258|240287|P1|STARTED|Intervention 2||15
98850|NCT01428258|240286|P2|NOT COMPLETED|Intervention 1||0
98851|NCT01428258|240287|P1|NOT COMPLETED|Intervention 1||2
98852|NCT01428258|240286|P2|COMPLETED|Intervention 1||15
98853|NCT01428258|240287|P1|COMPLETED|Intervention 1||15
98854|NCT01428258|240286|P2|STARTED|Intervention 1||15
98855|NCT01428258|240287|P1|STARTED|Intervention 1||17
98856|NCT01428219|240305|P1|NOT COMPLETED|Overall Study||3
98857|NCT01428219|240305|P1|COMPLETED|Overall Study||22
98858|NCT01428219|240305|P1|STARTED|Overall Study||25
98859|NCT01428128|240316|P1|NOT COMPLETED|Overall Study||17
98860|NCT01428128|240316|P1|COMPLETED|Overall Study||33
98861|NCT01428128|240316|P1|STARTED|Overall Study||50
98862|NCT01428115|240321|P1|NOT COMPLETED|Overall Study||21
98863|NCT01428115|240321|P1|COMPLETED|Overall Study||62
98864|NCT01428115|240321|P1|STARTED|Overall Study||83
98865|NCT01428076|240336|P2|NOT COMPLETED|Overall Study||1
98866|NCT01428076|240337|P1|NOT COMPLETED|Overall Study||0
98867|NCT01428076|240336|P2|COMPLETED|Overall Study||11
98868|NCT01428076|240337|P1|COMPLETED|Overall Study||9
98869|NCT01428076|240336|P2|STARTED|Overall Study||12
98870|NCT01428076|240337|P1|STARTED|Overall Study||9
98871|NCT01428063|240348|P3|NOT COMPLETED|Overall Study||1
98872|NCT01428063|240349|P2|NOT COMPLETED|Overall Study||10
98873|NCT01428063|240350|P1|NOT COMPLETED|Overall Study||10
98874|NCT01428063|240348|P3|COMPLETED|Overall Study||5
98875|NCT01428063|240349|P2|COMPLETED|Overall Study||112
98876|NCT01428063|240350|P1|COMPLETED|Overall Study||89
98877|NCT01428063|240348|P3|STARTED|Overall Study||6
98878|NCT01428063|240349|P2|STARTED|Overall Study||122
98879|NCT01428063|240350|P1|STARTED|Overall Study||99
98880|NCT01427933|240421|P2|NOT COMPLETED|Overall Study||13
98881|NCT01427933|240422|P1|NOT COMPLETED|Overall Study||8
98882|NCT01427933|240421|P2|COMPLETED|Overall Study||57
98883|NCT01427933|240422|P1|COMPLETED|Overall Study||63
98884|NCT01427933|240421|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
98885|NCT01427933|240422|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
98886|NCT01427933|240421|P2|STARTED|Overall Study||70
98887|NCT01427933|240422|P1|STARTED|Overall Study||71
98888|NCT01427920|240442|P2|NOT COMPLETED|Overall Study||17
98889|NCT01427920|240443|P1|NOT COMPLETED|Overall Study||9
98890|NCT01427920|240442|P2|COMPLETED|Overall Study||157
98891|NCT01427920|240443|P1|COMPLETED|Overall Study||165
98892|NCT01427920|240442|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
98893|NCT01427920|240443|P1|Exposed|Overall Study||174
98894|NCT01427920|240442|P2|STARTED|Overall Study||174
98895|NCT01427920|240443|P1|STARTED|Overall Study||174
98896|NCT01427907|240463|P2|NOT COMPLETED|Overall Study||4
98897|NCT01427907|240464|P1|NOT COMPLETED|Overall Study||3
98898|NCT01427907|240463|P2|COMPLETED|Overall Study|Completed study|14
98899|NCT01427907|240464|P1|COMPLETED|Overall Study|Completed study|17
98900|NCT01427907|240463|P2|STARTED|Overall Study|Randomized|18
98901|NCT01427907|240464|P1|STARTED|Overall Study|Randomized|20
98902|NCT01427881|240470|P1|NOT COMPLETED|Overall Study||0
98903|NCT01427881|240470|P1|COMPLETED|Overall Study||43
98904|NCT01427881|240470|P1|STARTED|Overall Study||43
98905|NCT01427803|240485|P2|NOT COMPLETED|Overall Study||26
98906|NCT01427803|240486|P1|NOT COMPLETED|Overall Study||63
98907|NCT01427803|240485|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
98908|NCT01427803|240486|P1|COMPLETED|Overall Study||463
98909|NCT01427803|240485|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
98910|NCT01427803|240486|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
98911|NCT01427803|240485|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
98912|NCT01427803|240486|P1|Baseline Assessment|Overall Study||516
98913|NCT01427803|240485|P2|Purchased Product|Overall Study||252
98914|NCT01427803|240486|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
98915|NCT01427803|240485|P2|STARTED|Overall Study||252
98916|NCT01427803|240486|P1|STARTED|Overall Study||526
98917|NCT01427751|240500|P2|NOT COMPLETED|Overall Study||14
98918|NCT01427751|240501|P1|NOT COMPLETED|Overall Study||42
98919|NCT01427751|240500|P2|COMPLETED|Overall Study||139
98920|NCT01427751|240501|P1|COMPLETED|Overall Study||112
98921|NCT01427751|240500|P2|STARTED|Overall Study||153
98922|NCT01427751|240501|P1|STARTED|Overall Study||154
98923|NCT01427738|240521|P2|NOT COMPLETED|Overall Study||21
98924|NCT01427738|240522|P1|NOT COMPLETED|Overall Study||19
98925|NCT01427738|240521|P2|COMPLETED|Overall Study||90
98926|NCT01427738|240522|P1|COMPLETED|Overall Study||91
98927|NCT01427738|240521|P2|STARTED|Overall Study||111
98928|NCT01427738|240522|P1|STARTED|Overall Study||110
98929|NCT01427517|240543|P3|NOT COMPLETED|Overall Study||0
98930|NCT01427517|240544|P2|NOT COMPLETED|Overall Study||0
98931|NCT01427517|240545|P1|NOT COMPLETED|Overall Study||0
98932|NCT01427517|240543|P3|COMPLETED|Overall Study||3
98933|NCT01427517|240544|P2|COMPLETED|Overall Study||3
98934|NCT01427517|240545|P1|COMPLETED|Overall Study||3
98935|NCT01427517|240543|P3|STARTED|Overall Study||3
98936|NCT01427517|240544|P2|STARTED|Overall Study||3
98937|NCT01427517|240545|P1|STARTED|Overall Study||3
98938|NCT01427504|240559|P6|NOT COMPLETED|Overall Study||2
98939|NCT01427504|240560|P5|NOT COMPLETED|Overall Study||1
98940|NCT01427504|240561|P4|NOT COMPLETED|Overall Study||1
98941|NCT01427504|240562|P3|NOT COMPLETED|Overall Study||1
98942|NCT01427504|240563|P2|NOT COMPLETED|Overall Study||1
98943|NCT01427504|240564|P1|NOT COMPLETED|Overall Study||0
98944|NCT01427504|240559|P6|COMPLETED|Overall Study||4
98945|NCT01427504|240560|P5|COMPLETED|Overall Study||2
98946|NCT01427504|240561|P4|COMPLETED|Overall Study||5
98947|NCT01427504|240562|P3|COMPLETED|Overall Study||3
98948|NCT01427504|240563|P2|COMPLETED|Overall Study||2
98949|NCT01427504|240564|P1|COMPLETED|Overall Study||4
98950|NCT01427504|240559|P6|Received Combination|Overall Study||6
98951|NCT01427504|240560|P5|Received Combination|Overall Study||3
98952|NCT01427504|240561|P4|Received Combination|Overall Study||6
98953|NCT01427504|240562|P3|Received Combination|Overall Study||3
98954|NCT01427504|240563|P2|Received Combination|Overall Study||3
98955|NCT01427504|240564|P1|Received Combination|Overall Study||4
98956|NCT01427504|240559|P6|Received Etravirine|Overall Study||4
98957|NCT01427504|240560|P5|Received Etravirine|Overall Study||2
98958|NCT01427504|240561|P4|Received Etravirine|Overall Study||6
98959|NCT01427504|240562|P3|Received Etravirine|Overall Study||4
98960|NCT01427504|240563|P2|Received Etravirine|Overall Study||2
98961|NCT01427504|240564|P1|Received Etravirine|Overall Study||4
98962|NCT01427504|240559|P6|Received Boceprevir|Overall Study||4
98963|NCT01427504|240560|P5|Received Boceprevir|Overall Study||2
98964|NCT01427504|240561|P4|Received Boceprevir|Overall Study||5
98965|NCT01427504|240562|P3|Received Boceprevir|Overall Study||3
98966|NCT01427504|240563|P2|Received Boceprevir|Overall Study||3
98967|NCT01427504|240564|P1|Received Boceprevir|Overall Study||4
98968|NCT01427504|240559|P6|STARTED|Overall Study||6
98969|NCT01427504|240560|P5|STARTED|Overall Study||3
98970|NCT01427504|240561|P4|STARTED|Overall Study||6
98971|NCT01427504|240562|P3|STARTED|Overall Study||4
98972|NCT01427504|240563|P2|STARTED|Overall Study||3
98973|NCT01427504|240564|P1|STARTED|Overall Study||4
98974|NCT01427309|240585|P4|NOT COMPLETED|Overall Study||376
98975|NCT01427309|240586|P3|NOT COMPLETED|Overall Study||361
98976|NCT01427309|240587|P2|NOT COMPLETED|Overall Study||407
98977|NCT01427309|240588|P1|NOT COMPLETED|Overall Study||372
98978|NCT01427309|240585|P4|COMPLETED|Overall Study||8373
98979|NCT01427309|240586|P3|COMPLETED|Overall Study||8376
98980|NCT01427309|240587|P2|COMPLETED|Overall Study||6837
98981|NCT01427309|240588|P1|COMPLETED|Overall Study||6881
98982|NCT01427309|240585|P4|STARTED|Overall Study||8749
98983|NCT01427309|240586|P3|STARTED|Overall Study||8737
98984|NCT01427309|240587|P2|STARTED|Overall Study||7244
98985|NCT01427309|240588|P1|STARTED|Overall Study||7253
98986|NCT01427296|240628|P2|NOT COMPLETED|Overall Study||0
98987|NCT01427296|240629|P1|NOT COMPLETED|Overall Study||0
98988|NCT01427296|240628|P2|COMPLETED|Overall Study||1051
98989|NCT01427296|240629|P1|COMPLETED|Overall Study||1041
98990|NCT01427296|240628|P2|STARTED|Overall Study||1051
98991|NCT01427296|240629|P1|STARTED|Overall Study||1041
98992|NCT01426958|240635|P1|NOT COMPLETED|Overall Study||2
98993|NCT01426958|240635|P1|COMPLETED|Overall Study||22
98994|NCT01426958|240635|P1|STARTED|Overall Study||24
98995|NCT01426867|240652|P3|NOT COMPLETED|Overall Study||0
98996|NCT01426867|240653|P2|NOT COMPLETED|Overall Study||0
98997|NCT01426867|240654|P1|NOT COMPLETED|Overall Study||0
98998|NCT01426867|240652|P3|COMPLETED|Overall Study||34
98999|NCT01426867|240653|P2|COMPLETED|Overall Study||34
99000|NCT01426867|240654|P1|COMPLETED|Overall Study||33
99001|NCT01426867|240652|P3|STARTED|Overall Study||34
99002|NCT01426867|240653|P2|STARTED|Overall Study||34
99003|NCT01426867|240654|P1|STARTED|Overall Study||33
99004|NCT01426854|240664|P2|NOT COMPLETED|Overall Study||31
99005|NCT01426854|240665|P1|NOT COMPLETED|Overall Study||12
99006|NCT01426854|240664|P2|COMPLETED|Overall Study||98
99007|NCT01426854|240665|P1|COMPLETED|Overall Study||119
99008|NCT01426854|240664|P2|STARTED|Overall Study||129
99009|NCT01426854|240665|P1|STARTED|Overall Study||131
99010|NCT01426789|240675|P6|NOT COMPLETED|Part 2||0
99011|NCT01426789|240676|P5|NOT COMPLETED|Part 2||8
99012|NCT01426789|240677|P4|NOT COMPLETED|Part 2||1
99013|NCT01426789|240678|P3|NOT COMPLETED|Part 2||15
99014|NCT01426789|240679|P2|NOT COMPLETED|Part 2||0
99015|NCT01426789|240680|P1|NOT COMPLETED|Part 2||0
99016|NCT01426789|240675|P6|COMPLETED|Part 2||1
99017|NCT01426789|240676|P5|COMPLETED|Part 2||19
99018|NCT01426789|240677|P4|COMPLETED|Part 2||12
99019|NCT01426789|240678|P3|COMPLETED|Part 2||34
99020|NCT01426789|240679|P2|COMPLETED|Part 2||0
99021|NCT01426789|240680|P1|COMPLETED|Part 2||0
99022|NCT01426789|240675|P6|STARTED|Part 2||1
99023|NCT01426789|240676|P5|STARTED|Part 2||27
99024|NCT01426789|240677|P4|STARTED|Part 2||13
99025|NCT01426789|240678|P3|STARTED|Part 2||49
99026|NCT01426789|240679|P2|STARTED|Part 2||0
99027|NCT01426789|240680|P1|STARTED|Part 2||0
99028|NCT01426789|240675|P6|NOT COMPLETED|Part 1||0
99029|NCT01426789|240676|P5|NOT COMPLETED|Part 1||0
99030|NCT01426789|240677|P4|NOT COMPLETED|Part 1||0
99031|NCT01426789|240678|P3|NOT COMPLETED|Part 1||0
99032|NCT01426789|240679|P2|NOT COMPLETED|Part 1||4
99033|NCT01426789|240680|P1|NOT COMPLETED|Part 1||6
99034|NCT01426789|240675|P6|COMPLETED|Part 1||0
99035|NCT01426789|240676|P5|COMPLETED|Part 1||0
99036|NCT01426789|240677|P4|COMPLETED|Part 1||0
99037|NCT01426789|240678|P3|COMPLETED|Part 1||0
99038|NCT01426789|240679|P2|COMPLETED|Part 1||28
99039|NCT01426789|240680|P1|COMPLETED|Part 1||62
99040|NCT01426789|240675|P6|STARTED|Part 1||0
99041|NCT01426789|240676|P5|STARTED|Part 1||0
99042|NCT01426789|240677|P4|STARTED|Part 1||0
99043|NCT01426789|240678|P3|STARTED|Part 1||0
99044|NCT01426789|240679|P2|STARTED|Part 1||32
99045|NCT01426789|240680|P1|STARTED|Part 1||68
99046|NCT01426763|240696|P2|NOT COMPLETED|Overall Study||0
99047|NCT01426763|240697|P1|NOT COMPLETED|Overall Study||0
99048|NCT01426763|240696|P2|COMPLETED|Overall Study||6
99049|NCT01426763|240697|P1|COMPLETED|Overall Study||6
99050|NCT01426763|240696|P2|STARTED|Overall Study||6
99051|NCT01426763|240697|P1|STARTED|Overall Study||6
99052|NCT01426555|240705|P2|NOT COMPLETED|Overall Study||15
99053|NCT01426555|240706|P1|NOT COMPLETED|Overall Study||18
99054|NCT01426555|240705|P2|COMPLETED|Overall Study||20
99055|NCT01426555|240706|P1|COMPLETED|Overall Study||17
99056|NCT01426555|240705|P2|STARTED|Overall Study||35
99057|NCT01426555|240706|P1|STARTED|Overall Study||35
99058|NCT01426516|240716|P2|NOT COMPLETED|Overall Study||0
99059|NCT01426516|240717|P1|NOT COMPLETED|Overall Study||0
99060|NCT01426516|240716|P2|COMPLETED|Overall Study||17
99061|NCT01426516|240717|P1|COMPLETED|Overall Study||12
99062|NCT01426516|240716|P2|STARTED|Overall Study||17
99063|NCT01426516|240717|P1|STARTED|Overall Study||12
99064|NCT01426438|240725|P2|NOT COMPLETED|Overall Study||10
99065|NCT01426438|240726|P1|NOT COMPLETED|Overall Study||15
99066|NCT01426438|240725|P2|COMPLETED|Overall Study||39
99067|NCT01426438|240726|P1|COMPLETED|Overall Study||35
99068|NCT01426438|240725|P2|STARTED|Overall Study||49
99069|NCT01426438|240726|P1|STARTED|Overall Study||50
99070|NCT01426425|240758|P1|NOT COMPLETED|Overall Study||175
99071|NCT01426425|240758|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
99156|NCT01426009|240850|P1|STARTED|Washout 2||130
99072|NCT01426425|240758|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
99073|NCT01426425|240758|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
99074|NCT01426425|240758|P1|STARTED|Overall Study||572
99075|NCT01426373|240764|P1|NOT COMPLETED|Overall Study||34
99076|NCT01426373|240764|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
99077|NCT01426373|240764|P1|STARTED|Overall Study||165
99078|NCT01426360|240782|P2|NOT COMPLETED|Overall Study||0
99079|NCT01426360|240783|P1|NOT COMPLETED|Overall Study||0
99080|NCT01426360|240782|P2|COMPLETED|Overall Study||41
99081|NCT01426360|240783|P1|COMPLETED|Overall Study||38
99082|NCT01426360|240782|P2|STARTED|Overall Study||41
99083|NCT01426360|240783|P1|STARTED|Overall Study||38
99084|NCT01426347|240797|P2|NOT COMPLETED|Overall Study||3
99085|NCT01426347|240798|P1|NOT COMPLETED|Overall Study||7
99086|NCT01426347|240797|P2|COMPLETED|Overall Study||39
99087|NCT01426347|240798|P1|COMPLETED|Overall Study||34
99088|NCT01426347|240797|P2|STARTED|Overall Study||42
99089|NCT01426347|240798|P1|STARTED|Overall Study||41
99090|NCT01426269|240806|P3|NOT COMPLETED|Period 2: 40 Weeks||47
99091|NCT01426269|240807|P2|NOT COMPLETED|Period 2: 40 Weeks||38
99092|NCT01426269|240808|P1|NOT COMPLETED|Period 2: 40 Weeks||0
99093|NCT01426269|240806|P3|COMPLETED|Period 2: 40 Weeks||18
99094|NCT01426269|240807|P2|COMPLETED|Period 2: 40 Weeks||27
99095|NCT01426269|240808|P1|COMPLETED|Period 2: 40 Weeks||0
99096|NCT01426269|240806|P3|STARTED|Period 2: 40 Weeks||65
99097|NCT01426269|240807|P2|STARTED|Period 2: 40 Weeks||65
99098|NCT01426269|240808|P1|STARTED|Period 2: 40 Weeks||0
99099|NCT01426269|240806|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
99100|NCT01426269|240807|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
99101|NCT01426269|240808|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
99102|NCT01426269|240806|P3|COMPLETED|Eligibility for Period 2, Randomization||0
99103|NCT01426269|240807|P2|COMPLETED|Eligibility for Period 2, Randomization||0
99104|NCT01426269|240808|P1|COMPLETED|Eligibility for Period 2, Randomization||130
99105|NCT01426269|240806|P3|STARTED|Eligibility for Period 2, Randomization||0
99106|NCT01426269|240807|P2|STARTED|Eligibility for Period 2, Randomization||0
99107|NCT01426269|240808|P1|STARTED|Eligibility for Period 2, Randomization||180
99108|NCT01426269|240806|P3|NOT COMPLETED|Period 1: 12 Weeks||0
99109|NCT01426269|240807|P2|NOT COMPLETED|Period 1: 12 Weeks||0
99110|NCT01426269|240808|P1|NOT COMPLETED|Period 1: 12 Weeks||55
99111|NCT01426269|240806|P3|COMPLETED|Period 1: 12 Weeks||0
99112|NCT01426269|240807|P2|COMPLETED|Period 1: 12 Weeks||0
99113|NCT01426269|240808|P1|COMPLETED|Period 1: 12 Weeks||180
99114|NCT01426269|240806|P3|STARTED|Period 1: 12 Weeks||0
99115|NCT01426269|240807|P2|STARTED|Period 1: 12 Weeks||0
99116|NCT01426269|240808|P1|STARTED|Period 1: 12 Weeks||235
99117|NCT01426230|240835|P2|NOT COMPLETED|Overall Study||27
99118|NCT01426230|240836|P1|NOT COMPLETED|Overall Study||31
99119|NCT01426230|240835|P2|COMPLETED|Overall Study||84
99120|NCT01426230|240836|P1|COMPLETED|Overall Study||55
99121|NCT01426230|240835|P2|STARTED|Overall Study||111
99122|NCT01426230|240836|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
99123|NCT01426113|240843|P2|NOT COMPLETED|Overall Study||2
99124|NCT01426113|240844|P1|NOT COMPLETED|Overall Study||1
99125|NCT01426113|240843|P2|COMPLETED|Overall Study||1
99126|NCT01426113|240844|P1|COMPLETED|Overall Study||2
99127|NCT01426113|240843|P2|STARTED|Overall Study||3
99128|NCT01426113|240844|P1|STARTED|Overall Study||3
99129|NCT01426009|240850|P1|NOT COMPLETED|Washout 4||1
99130|NCT01426009|240850|P1|COMPLETED|Washout 4||126
99131|NCT01426009|240850|P1|STARTED|Washout 4||127
99132|NCT01426009|240850|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
99133|NCT01426009|240850|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
99134|NCT01426009|240850|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
99135|NCT01426009|240850|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
99136|NCT01426009|240850|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
99137|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
99138|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
99139|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
99140|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
99141|NCT01426009|240850|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
99142|NCT01426009|240850|P1|NOT COMPLETED|Washout 3||1
99143|NCT01426009|240850|P1|COMPLETED|Washout 3||128
99144|NCT01426009|240850|P1|STARTED|Washout 3||129
99145|NCT01426009|240850|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
99146|NCT01426009|240850|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
99147|NCT01426009|240850|P1|Placebo|Period 3-Third Intervention (7 Days)||22
99148|NCT01426009|240850|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
99149|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
99150|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
99151|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
99152|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
99153|NCT01426009|240850|P1|STARTED|Period 3-Third Intervention (7 Days)||129
99154|NCT01426009|240850|P1|NOT COMPLETED|Washout 2||1
99155|NCT01426009|240850|P1|COMPLETED|Washout 2||129
99157|NCT01426009|240850|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
99158|NCT01426009|240850|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
99159|NCT01426009|240850|P1|Placebo|Period 2-Second Intervention (7 Days)||21
99160|NCT01426009|240850|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
99161|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
99162|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
99163|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
99164|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
99165|NCT01426009|240850|P1|STARTED|Period 2-Second Intervention (7 Days)||135
99166|NCT01426009|240850|P1|NOT COMPLETED|Washout 1||2
99167|NCT01426009|240850|P1|COMPLETED|Washout 1||135
99168|NCT01426009|240850|P1|STARTED|Washout 1||137
99169|NCT01426009|240850|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
99170|NCT01426009|240850|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
99171|NCT01426009|240850|P1|Placebo|Period 1-First Intervention (7 Days)||24
99172|NCT01426009|240850|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
99173|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
99174|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
99175|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
99176|NCT01426009|240850|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
99177|NCT01426009|240850|P1|STARTED|Period 1-First Intervention (7 Days)||139
99178|NCT01425879|240906|P1|NOT COMPLETED|Overall Study||0
99179|NCT01425879|240906|P1|COMPLETED|Overall Study||8
99180|NCT01425879|240906|P1|STARTED|Overall Study||8
99181|NCT01425853|240915|P2|NOT COMPLETED|Overall Study||77
99182|NCT01425853|240916|P1|NOT COMPLETED|Overall Study||64
99183|NCT01425853|240915|P2|COMPLETED|Overall Study||225
99184|NCT01425853|240916|P1|COMPLETED|Overall Study||240
99185|NCT01425853|240915|P2|Per Protocol (PP)|Overall Study||258
99186|NCT01425853|240916|P1|Per Protocol (PP)|Overall Study||264
99187|NCT01425853|240915|P2|Safety Population|Overall Study||299
99188|NCT01425853|240916|P1|Safety Population|Overall Study||304
99189|NCT01425853|240915|P2|STARTED|Overall Study||302
99190|NCT01425853|240916|P1|STARTED|Overall Study||304
99191|NCT01425814|240946|P6|NOT COMPLETED|Period 5||1
99192|NCT01425814|240947|P5|NOT COMPLETED|Period 5||0
99193|NCT01425814|240948|P4|NOT COMPLETED|Period 5||0
99194|NCT01425814|240949|P3|NOT COMPLETED|Period 5||1
99195|NCT01425814|240950|P2|NOT COMPLETED|Period 5||0
99196|NCT01425814|240951|P1|NOT COMPLETED|Period 5||0
99197|NCT01425814|240946|P6|COMPLETED|Period 5||11
99198|NCT01425814|240947|P5|COMPLETED|Period 5||12
99199|NCT01425814|240948|P4|COMPLETED|Period 5||10
99200|NCT01425814|240949|P3|COMPLETED|Period 5||10
99201|NCT01425814|240950|P2|COMPLETED|Period 5||9
99202|NCT01425814|240951|P1|COMPLETED|Period 5||11
99203|NCT01425814|240946|P6|STARTED|Period 5||12
99204|NCT01425814|240947|P5|STARTED|Period 5||12
99205|NCT01425814|240948|P4|STARTED|Period 5||10
99206|NCT01425814|240949|P3|STARTED|Period 5||11
99207|NCT01425814|240950|P2|STARTED|Period 5||9
99208|NCT01425814|240951|P1|STARTED|Period 5||11
99209|NCT01425814|240946|P6|NOT COMPLETED|Period 4||0
99210|NCT01425814|240947|P5|NOT COMPLETED|Period 4||0
99211|NCT01425814|240948|P4|NOT COMPLETED|Period 4||0
99212|NCT01425814|240949|P3|NOT COMPLETED|Period 4||1
99213|NCT01425814|240950|P2|NOT COMPLETED|Period 4||0
99214|NCT01425814|240951|P1|NOT COMPLETED|Period 4||1
99215|NCT01425814|240946|P6|COMPLETED|Period 4||12
99216|NCT01425814|240947|P5|COMPLETED|Period 4||12
99217|NCT01425814|240948|P4|COMPLETED|Period 4||10
99218|NCT01425814|240949|P3|COMPLETED|Period 4||11
99219|NCT01425814|240950|P2|COMPLETED|Period 4||9
99220|NCT01425814|240951|P1|COMPLETED|Period 4||11
99221|NCT01425814|240946|P6|STARTED|Period 4||12
99222|NCT01425814|240947|P5|STARTED|Period 4||12
99223|NCT01425814|240948|P4|STARTED|Period 4||10
99224|NCT01425814|240949|P3|STARTED|Period 4||12
99225|NCT01425814|240950|P2|STARTED|Period 4||9
99226|NCT01425814|240951|P1|STARTED|Period 4||12
99227|NCT01425814|240946|P6|NOT COMPLETED|Period 3||1
99228|NCT01425814|240947|P5|NOT COMPLETED|Period 3||0
99229|NCT01425814|240948|P4|NOT COMPLETED|Period 3||0
99230|NCT01425814|240949|P3|NOT COMPLETED|Period 3||0
99231|NCT01425814|240950|P2|NOT COMPLETED|Period 3||0
99232|NCT01425814|240951|P1|NOT COMPLETED|Period 3||0
99233|NCT01425814|240946|P6|COMPLETED|Period 3||12
99234|NCT01425814|240947|P5|COMPLETED|Period 3||12
99235|NCT01425814|240948|P4|COMPLETED|Period 3||10
99236|NCT01425814|240949|P3|COMPLETED|Period 3||12
99237|NCT01425814|240950|P2|COMPLETED|Period 3||9
99238|NCT01425814|240951|P1|COMPLETED|Period 3||12
99239|NCT01425814|240946|P6|STARTED|Period 3||13
99240|NCT01425814|240947|P5|STARTED|Period 3||12
99241|NCT01425814|240948|P4|STARTED|Period 3||10
99242|NCT01425814|240949|P3|STARTED|Period 3||12
99243|NCT01425814|240950|P2|STARTED|Period 3||9
99244|NCT01425814|240951|P1|STARTED|Period 3||12
99245|NCT01425814|240946|P6|NOT COMPLETED|Period 2||0
99246|NCT01425814|240947|P5|NOT COMPLETED|Period 2||0
99247|NCT01425814|240948|P4|NOT COMPLETED|Period 2||0
99248|NCT01425814|240949|P3|NOT COMPLETED|Period 2||0
99249|NCT01425814|240950|P2|NOT COMPLETED|Period 2||1
99250|NCT01425814|240951|P1|NOT COMPLETED|Period 2||0
99251|NCT01425814|240946|P6|COMPLETED|Period 2||13
99252|NCT01425814|240947|P5|COMPLETED|Period 2||12
99253|NCT01425814|240948|P4|COMPLETED|Period 2||10
99254|NCT01425814|240949|P3|COMPLETED|Period 2||12
99255|NCT01425814|240950|P2|COMPLETED|Period 2||9
99256|NCT01425814|240951|P1|COMPLETED|Period 2||12
99257|NCT01425814|240946|P6|STARTED|Period 2||13
99258|NCT01425814|240947|P5|STARTED|Period 2||12
99259|NCT01425814|240948|P4|STARTED|Period 2||10
99260|NCT01425814|240949|P3|STARTED|Period 2||12
99261|NCT01425814|240950|P2|STARTED|Period 2||10
99262|NCT01425814|240951|P1|STARTED|Period 2||12
99263|NCT01425814|240946|P6|NOT COMPLETED|Period 1||0
99264|NCT01425814|240947|P5|NOT COMPLETED|Period 1||0
99265|NCT01425814|240948|P4|NOT COMPLETED|Period 1||0
99266|NCT01425814|240949|P3|NOT COMPLETED|Period 1||0
99267|NCT01425814|240950|P2|NOT COMPLETED|Period 1||1
99268|NCT01425814|240951|P1|NOT COMPLETED|Period 1||0
99269|NCT01425814|240946|P6|COMPLETED|Period 1||13
99270|NCT01425814|240947|P5|COMPLETED|Period 1||12
99271|NCT01425814|240948|P4|COMPLETED|Period 1||10
99272|NCT01425814|240949|P3|COMPLETED|Period 1||12
99273|NCT01425814|240950|P2|COMPLETED|Period 1||10
99274|NCT01425814|240951|P1|COMPLETED|Period 1||12
99275|NCT01425814|240946|P6|STARTED|Period 1||13
99276|NCT01425814|240947|P5|STARTED|Period 1||12
99277|NCT01425814|240948|P4|STARTED|Period 1||10
99278|NCT01425814|240949|P3|STARTED|Period 1||12
99279|NCT01425814|240950|P2|STARTED|Period 1||11
99280|NCT01425814|240951|P1|STARTED|Period 1||12
99281|NCT01425801|241043|P6|NOT COMPLETED|Period 6||0
99282|NCT01425801|241044|P5|NOT COMPLETED|Period 6||0
99283|NCT01425801|241045|P4|NOT COMPLETED|Period 6||0
99284|NCT01425801|241046|P3|NOT COMPLETED|Period 6||0
99285|NCT01425801|241047|P2|NOT COMPLETED|Period 6||0
99286|NCT01425801|241048|P1|NOT COMPLETED|Period 6||0
99287|NCT01425801|241043|P6|COMPLETED|Period 6||10
99288|NCT01425801|241044|P5|COMPLETED|Period 6||11
99289|NCT01425801|241045|P4|COMPLETED|Period 6||12
99290|NCT01425801|241046|P3|COMPLETED|Period 6||7
99291|NCT01425801|241047|P2|COMPLETED|Period 6||9
99292|NCT01425801|241048|P1|COMPLETED|Period 6||9
99293|NCT01425801|241043|P6|STARTED|Period 6||10
99294|NCT01425801|241044|P5|STARTED|Period 6||11
99295|NCT01425801|241045|P4|STARTED|Period 6||12
99296|NCT01425801|241046|P3|STARTED|Period 6||7
99297|NCT01425801|241047|P2|STARTED|Period 6||9
99298|NCT01425801|241048|P1|STARTED|Period 6||9
99299|NCT01425801|241043|P6|NOT COMPLETED|Period 5||0
99300|NCT01425801|241044|P5|NOT COMPLETED|Period 5||0
99301|NCT01425801|241045|P4|NOT COMPLETED|Period 5||0
99302|NCT01425801|241046|P3|NOT COMPLETED|Period 5||0
99303|NCT01425801|241047|P2|NOT COMPLETED|Period 5||0
99304|NCT01425801|241048|P1|NOT COMPLETED|Period 5||0
99305|NCT01425801|241043|P6|COMPLETED|Period 5||10
99306|NCT01425801|241044|P5|COMPLETED|Period 5||11
99307|NCT01425801|241045|P4|COMPLETED|Period 5||12
99308|NCT01425801|241046|P3|COMPLETED|Period 5||7
99309|NCT01425801|241047|P2|COMPLETED|Period 5||9
99310|NCT01425801|241048|P1|COMPLETED|Period 5||9
99311|NCT01425801|241043|P6|STARTED|Period 5||10
99312|NCT01425801|241044|P5|STARTED|Period 5||11
99313|NCT01425801|241045|P4|STARTED|Period 5||12
99314|NCT01425801|241046|P3|STARTED|Period 5||7
99315|NCT01425801|241047|P2|STARTED|Period 5||9
99316|NCT01425801|241048|P1|STARTED|Period 5||9
99317|NCT01425801|241043|P6|NOT COMPLETED|Period 4||0
99318|NCT01425801|241044|P5|NOT COMPLETED|Period 4||0
99319|NCT01425801|241045|P4|NOT COMPLETED|Period 4||0
99320|NCT01425801|241046|P3|NOT COMPLETED|Period 4||1
99321|NCT01425801|241047|P2|NOT COMPLETED|Period 4||0
99322|NCT01425801|241048|P1|NOT COMPLETED|Period 4||0
99323|NCT01425801|241043|P6|COMPLETED|Period 4||10
99324|NCT01425801|241044|P5|COMPLETED|Period 4||11
99325|NCT01425801|241045|P4|COMPLETED|Period 4||12
99326|NCT01425801|241046|P3|COMPLETED|Period 4||7
99327|NCT01425801|241047|P2|COMPLETED|Period 4||9
99328|NCT01425801|241048|P1|COMPLETED|Period 4||9
99329|NCT01425801|241043|P6|STARTED|Period 4||10
99330|NCT01425801|241044|P5|STARTED|Period 4||11
99331|NCT01425801|241045|P4|STARTED|Period 4||12
99332|NCT01425801|241046|P3|STARTED|Period 4||8
99333|NCT01425801|241047|P2|STARTED|Period 4||9
99334|NCT01425801|241048|P1|STARTED|Period 4||9
99335|NCT01425801|241043|P6|NOT COMPLETED|Period 3||0
99336|NCT01425801|241044|P5|NOT COMPLETED|Period 3||0
99337|NCT01425801|241045|P4|NOT COMPLETED|Period 3||0
99338|NCT01425801|241046|P3|NOT COMPLETED|Period 3||1
99339|NCT01425801|241047|P2|NOT COMPLETED|Period 3||0
99340|NCT01425801|241048|P1|NOT COMPLETED|Period 3||0
99341|NCT01425801|241043|P6|COMPLETED|Period 3||10
99342|NCT01425801|241044|P5|COMPLETED|Period 3||11
99343|NCT01425801|241045|P4|COMPLETED|Period 3||12
99344|NCT01425801|241046|P3|COMPLETED|Period 3||8
99345|NCT01425801|241047|P2|COMPLETED|Period 3||9
99346|NCT01425801|241048|P1|COMPLETED|Period 3||9
99347|NCT01425801|241043|P6|STARTED|Period 3||10
99348|NCT01425801|241044|P5|STARTED|Period 3||11
99349|NCT01425801|241045|P4|STARTED|Period 3||12
99350|NCT01425801|241046|P3|STARTED|Period 3||9
99351|NCT01425801|241047|P2|STARTED|Period 3||9
99352|NCT01425801|241048|P1|STARTED|Period 3||9
99353|NCT01425801|241043|P6|NOT COMPLETED|Period 2||0
99354|NCT01425801|241044|P5|NOT COMPLETED|Period 2||1
99355|NCT01425801|241045|P4|NOT COMPLETED|Period 2||0
99356|NCT01425801|241046|P3|NOT COMPLETED|Period 2||0
99357|NCT01425801|241047|P2|NOT COMPLETED|Period 2||0
99358|NCT01425801|241048|P1|NOT COMPLETED|Period 2||0
99359|NCT01425801|241043|P6|COMPLETED|Period 2||10
99360|NCT01425801|241044|P5|COMPLETED|Period 2||11
99361|NCT01425801|241045|P4|COMPLETED|Period 2||12
99362|NCT01425801|241046|P3|COMPLETED|Period 2||9
99363|NCT01425801|241047|P2|COMPLETED|Period 2||9
99364|NCT01425801|241048|P1|COMPLETED|Period 2||9
99365|NCT01425801|241043|P6|STARTED|Period 2||10
99366|NCT01425801|241044|P5|STARTED|Period 2||12
99367|NCT01425801|241045|P4|STARTED|Period 2||12
99368|NCT01425801|241046|P3|STARTED|Period 2||9
99369|NCT01425801|241047|P2|STARTED|Period 2||9
99370|NCT01425801|241048|P1|STARTED|Period 2||9
99371|NCT01425801|241043|P6|NOT COMPLETED|Period 1||0
99372|NCT01425801|241044|P5|NOT COMPLETED|Period 1||1
99373|NCT01425801|241045|P4|NOT COMPLETED|Period 1||0
99374|NCT01425801|241046|P3|NOT COMPLETED|Period 1||0
99375|NCT01425801|241047|P2|NOT COMPLETED|Period 1||0
99376|NCT01425801|241048|P1|NOT COMPLETED|Period 1||0
99377|NCT01425801|241043|P6|COMPLETED|Period 1||10
99378|NCT01425801|241044|P5|COMPLETED|Period 1||12
99379|NCT01425801|241045|P4|COMPLETED|Period 1||12
99380|NCT01425801|241046|P3|COMPLETED|Period 1||9
99381|NCT01425801|241047|P2|COMPLETED|Period 1||9
99382|NCT01425801|241048|P1|COMPLETED|Period 1||9
99383|NCT01425801|241043|P6|STARTED|Period 1||10
99384|NCT01425801|241044|P5|STARTED|Period 1||13
99385|NCT01425801|241045|P4|STARTED|Period 1||12
99386|NCT01425801|241046|P3|STARTED|Period 1||9
99387|NCT01425801|241047|P2|STARTED|Period 1||9
99388|NCT01425801|241048|P1|STARTED|Period 1||9
99389|NCT01425749|241154|P2|NOT COMPLETED|Overall Study||1
99390|NCT01425749|241155|P1|NOT COMPLETED|Overall Study||0
99391|NCT01425749|241154|P2|COMPLETED|Overall Study||11
99392|NCT01425749|241155|P1|COMPLETED|Overall Study||13
99393|NCT01425749|241154|P2|STARTED|Overall Study||12
99394|NCT01425749|241155|P1|STARTED|Overall Study||13
99395|NCT01425632|241173|P3|NOT COMPLETED|Overall Study||4
99396|NCT01425632|241174|P2|NOT COMPLETED|Overall Study||1
99397|NCT01425632|241175|P1|NOT COMPLETED|Overall Study||1
99398|NCT01425632|241173|P3|COMPLETED|Overall Study||159
99399|NCT01425632|241174|P2|COMPLETED|Overall Study||165
99400|NCT01425632|241175|P1|COMPLETED|Overall Study||160
99401|NCT01425632|241173|P3|STARTED|Overall Study||163
99402|NCT01425632|241174|P2|STARTED|Overall Study||166
99403|NCT01425632|241175|P1|STARTED|Overall Study||161
99404|NCT01425528|241185|P2|NOT COMPLETED|Overall Study||1
99405|NCT01425528|241186|P1|NOT COMPLETED|Overall Study||1
99406|NCT01425528|241185|P2|COMPLETED|Overall Study||5
99407|NCT01425528|241186|P1|COMPLETED|Overall Study||5
99408|NCT01425528|241185|P2|STARTED|Overall Study||6
99409|NCT01425528|241186|P1|STARTED|Overall Study||6
99410|NCT01425463|241194|P2|NOT COMPLETED|Overall Study||24
99411|NCT01425463|241195|P1|NOT COMPLETED|Overall Study||24
99412|NCT01425463|241194|P2|COMPLETED|Overall Study||102
99413|NCT01425463|241195|P1|COMPLETED|Overall Study||106
99414|NCT01425463|241194|P2|Full Analysis Set|Overall Study||116
99415|NCT01425463|241195|P1|Full Analysis Set|Overall Study||122
99416|NCT01425463|241194|P2|Safety Set|Overall Study||122
99417|NCT01425463|241195|P1|Safety Set|Overall Study||126
99418|NCT01425463|241194|P2|STARTED|Overall Study||126
99419|NCT01425463|241195|P1|STARTED|Overall Study||130
99420|NCT01425359|241211|P2|NOT COMPLETED|Overall Study||22
99421|NCT01425359|241212|P1|NOT COMPLETED|Overall Study||19
99422|NCT01425359|241211|P2|COMPLETED|Overall Study||451
99423|NCT01425359|241212|P1|COMPLETED|Overall Study||457
99424|NCT01425359|241211|P2|STARTED|Overall Study||473
99425|NCT01425359|241212|P1|STARTED|Overall Study||476
99426|NCT01425307|241230|P2|NOT COMPLETED|Overall Study||19
99427|NCT01425307|241231|P1|NOT COMPLETED|Overall Study||19
99428|NCT01425307|241230|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
99429|NCT01425307|241231|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
99430|NCT01425307|241230|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
99431|NCT01425307|241231|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
99432|NCT01425268|241243|P2|NOT COMPLETED|Overall Study||0
99433|NCT01425268|241244|P1|NOT COMPLETED|Overall Study||8
99434|NCT01425268|241243|P2|COMPLETED|Overall Study||52
99435|NCT01425268|241244|P1|COMPLETED|Overall Study||98
99436|NCT01425268|241243|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
99437|NCT01425268|241244|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
99438|NCT01425229|241252|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
99439|NCT01425229|241252|P1|COMPLETED|Bosentan During Clarithromycin||16
99440|NCT01425229|241252|P1|STARTED|Bosentan During Clarithromycin||16
99441|NCT01425229|241252|P1|NOT COMPLETED|Bosentan Steady-state||0
99442|NCT01425229|241252|P1|COMPLETED|Bosentan Steady-state||16
99443|NCT01425229|241252|P1|STARTED|Bosentan Steady-state||16
99444|NCT01425229|241252|P1|NOT COMPLETED|Bosentan Single Dose||0
99445|NCT01425229|241252|P1|COMPLETED|Bosentan Single Dose||16
99446|NCT01425229|241252|P1|STARTED|Bosentan Single Dose||16
99447|NCT01425203|241265|P3|NOT COMPLETED|Follow-up Phase||0
99448|NCT01425203|241266|P2|NOT COMPLETED|Follow-up Phase||0
99449|NCT01425203|241267|P1|NOT COMPLETED|Follow-up Phase||0
99450|NCT01425203|241265|P3|COMPLETED|Follow-up Phase||27
99451|NCT01425203|241266|P2|COMPLETED|Follow-up Phase||49
99452|NCT01425203|241267|P1|COMPLETED|Follow-up Phase||153
99453|NCT01425203|241265|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
99454|NCT01425203|241266|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
99455|NCT01425203|241267|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
99456|NCT01425203|241265|P3|NOT COMPLETED|Crossover Phase||6
99457|NCT01425203|241266|P2|NOT COMPLETED|Crossover Phase||0
99458|NCT01425203|241267|P1|NOT COMPLETED|Crossover Phase||0
99459|NCT01425203|241265|P3|COMPLETED|Crossover Phase||21
99460|NCT01425203|241266|P2|COMPLETED|Crossover Phase||0
99461|NCT01425203|241267|P1|COMPLETED|Crossover Phase||0
99462|NCT01425203|241265|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
99463|NCT01425203|241266|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
99464|NCT01425203|241267|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
99465|NCT01425203|241265|P3|NOT COMPLETED|Treatment Phase||0
99466|NCT01425203|241266|P2|NOT COMPLETED|Treatment Phase||37
99467|NCT01425203|241267|P1|NOT COMPLETED|Treatment Phase||27
99468|NCT01425203|241265|P3|COMPLETED|Treatment Phase||0
99469|NCT01425203|241266|P2|COMPLETED|Treatment Phase||42
99470|NCT01425203|241267|P1|COMPLETED|Treatment Phase||132
99471|NCT01425203|241265|P3|Treated (FAS)|Treatment Phase||0
99472|NCT01425203|241266|P2|Treated (FAS)|Treatment Phase||78
99473|NCT01425203|241267|P1|Treated (FAS)|Treatment Phase||159
99474|NCT01425203|241265|P3|STARTED|Treatment Phase||0
99475|NCT01425203|241266|P2|STARTED|Treatment Phase||79
99476|NCT01425203|241267|P1|STARTED|Treatment Phase||159
99477|NCT01425190|241284|P3|NOT COMPLETED|Overall Study||0
99478|NCT01425190|241285|P2|NOT COMPLETED|Overall Study||0
99479|NCT01425190|241286|P1|NOT COMPLETED|Overall Study||1
99480|NCT01425190|241284|P3|COMPLETED|Overall Study||0
99481|NCT01425190|241285|P2|COMPLETED|Overall Study||0
99482|NCT01425190|241286|P1|COMPLETED|Overall Study||15
99483|NCT01425190|241284|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
99484|NCT01425190|241285|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
99485|NCT01425190|241286|P1|STARTED|Overall Study||16
99486|NCT01424943|241305|P2|NOT COMPLETED|Overall Study||1
99487|NCT01424943|241306|P1|NOT COMPLETED|Overall Study||13
99488|NCT01424943|241305|P2|COMPLETED|Overall Study||23
99489|NCT01424943|241306|P1|COMPLETED|Overall Study||12
99490|NCT01424943|241305|P2|STARTED|Overall Study||24
99491|NCT01424943|241306|P1|STARTED|Overall Study||25
99492|NCT01424930|241322|P2|NOT COMPLETED|Overall Study||14
99493|NCT01424930|241323|P1|NOT COMPLETED|Overall Study||4
99494|NCT01424930|241322|P2|COMPLETED|Overall Study||4
99495|NCT01424930|241323|P1|COMPLETED|Overall Study||3
99496|NCT01424930|241322|P2|Completed Food Safety Evaluation|Overall Study||18
99497|NCT01424930|241323|P1|Completed Food Safety Evaluation|Overall Study||6
99498|NCT01424930|241322|P2|STARTED|Overall Study||18
99499|NCT01424930|241323|P1|STARTED|Overall Study||7
99500|NCT01424813|241337|P2|NOT COMPLETED|Overall Study||2
99501|NCT01424813|241338|P1|NOT COMPLETED|Overall Study||5
99502|NCT01424813|241337|P2|COMPLETED|Overall Study||77
99503|NCT01424813|241338|P1|COMPLETED|Overall Study||74
99504|NCT01424813|241337|P2|Treated|Overall Study|Safety set and full analysis set|78
99505|NCT01424813|241338|P1|Treated|Overall Study|Safety set and full analysis set|79
99506|NCT01424813|241337|P2|STARTED|Overall Study||79
99507|NCT01424813|241338|P1|STARTED|Overall Study||79
99508|NCT01424644|241358|P2|NOT COMPLETED|Overall Study||27
99509|NCT01424644|241359|P1|NOT COMPLETED|Overall Study||33
99510|NCT01424644|241358|P2|COMPLETED|Overall Study||372
99511|NCT01424644|241359|P1|COMPLETED|Overall Study||369
99512|NCT01424644|241358|P2|STARTED|Overall Study||399
99513|NCT01424644|241359|P1|STARTED|Overall Study||402
99514|NCT01424566|241373|P3|NOT COMPLETED|Double-blind Treatment||15
99515|NCT01424566|241374|P2|NOT COMPLETED|Double-blind Treatment||25
99516|NCT01424566|241375|P1|NOT COMPLETED|Double-blind Treatment||0
99517|NCT01424566|241373|P3|COMPLETED|Double-blind Treatment||88
99518|NCT01424566|241374|P2|COMPLETED|Double-blind Treatment||78
99519|NCT01424566|241375|P1|COMPLETED|Double-blind Treatment||0
99520|NCT01424566|241373|P3|ITT Population|Double-blind Treatment||103
99521|NCT01424566|241374|P2|ITT Population|Double-blind Treatment||103
99522|NCT01424566|241375|P1|ITT Population|Double-blind Treatment||0
99523|NCT01424566|241373|P3|Randomized Safety Population|Double-blind Treatment||103
99524|NCT01424566|241374|P2|Randomized Safety Population|Double-blind Treatment||103
99525|NCT01424566|241375|P1|Randomized Safety Population|Double-blind Treatment||0
99526|NCT01424566|241373|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
99527|NCT01424566|241374|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
99528|NCT01424566|241375|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
99529|NCT01424566|241373|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
99613|NCT01424189|241713|P1|COMPLETED|Overall Study||373
99530|NCT01424566|241374|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
99531|NCT01424566|241375|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
99532|NCT01424566|241373|P3|NOT COMPLETED|Single-blind Treatment||0
99533|NCT01424566|241374|P2|NOT COMPLETED|Single-blind Treatment||0
99534|NCT01424566|241375|P1|NOT COMPLETED|Single-blind Treatment||200
99535|NCT01424566|241373|P3|COMPLETED|Single-blind Treatment||0
99536|NCT01424566|241374|P2|COMPLETED|Single-blind Treatment||0
99537|NCT01424566|241375|P1|COMPLETED|Single-blind Treatment||206
99538|NCT01424566|241373|P3|Met Randomization Criteria|Single-blind Treatment||0
99539|NCT01424566|241374|P2|Met Randomization Criteria|Single-blind Treatment||0
99540|NCT01424566|241375|P1|Met Randomization Criteria|Single-blind Treatment||206
99541|NCT01424566|241373|P3|Single-blind Safety Population|Single-blind Treatment||0
99542|NCT01424566|241374|P2|Single-blind Safety Population|Single-blind Treatment||0
99543|NCT01424566|241375|P1|Single-blind Safety Population|Single-blind Treatment||404
99544|NCT01424566|241373|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
99545|NCT01424566|241374|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
99546|NCT01424566|241375|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
99547|NCT01424566|241373|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
99548|NCT01424566|241374|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
99549|NCT01424566|241375|P1|STARTED|Single-blind Treatment||406
99550|NCT01424514|241402|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
99551|NCT01424514|241403|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
99552|NCT01424514|241402|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
99553|NCT01424514|241403|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
99554|NCT01424514|241402|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
99555|NCT01424514|241403|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
99556|NCT01424514|241402|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
99557|NCT01424514|241403|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
99558|NCT01424514|241402|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
99559|NCT01424514|241403|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
99560|NCT01424514|241402|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
99561|NCT01424514|241403|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
99562|NCT01424514|241402|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
99563|NCT01424514|241403|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
99564|NCT01424514|241402|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
99565|NCT01424514|241403|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
99566|NCT01424514|241402|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
99567|NCT01424514|241403|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
99568|NCT01424501|241448|P6|NOT COMPLETED|Overall Study||0
99569|NCT01424501|241449|P5|NOT COMPLETED|Overall Study||0
99570|NCT01424501|241450|P4|NOT COMPLETED|Overall Study||0
99571|NCT01424501|241451|P3|NOT COMPLETED|Overall Study||2
99572|NCT01424501|241452|P2|NOT COMPLETED|Overall Study||1
99573|NCT01424501|241453|P1|NOT COMPLETED|Overall Study||1
99574|NCT01424501|241448|P6|COMPLETED|Overall Study||40
99575|NCT01424501|241449|P5|COMPLETED|Overall Study||40
99576|NCT01424501|241450|P4|COMPLETED|Overall Study||25
99577|NCT01424501|241451|P3|COMPLETED|Overall Study||22
99578|NCT01424501|241452|P2|COMPLETED|Overall Study||5
99579|NCT01424501|241453|P1|COMPLETED|Overall Study||6
99580|NCT01424501|241448|P6|STARTED|Overall Study||40
99581|NCT01424501|241449|P5|STARTED|Overall Study||40
99582|NCT01424501|241450|P4|STARTED|Overall Study||25
99583|NCT01424501|241451|P3|STARTED|Overall Study||24
99584|NCT01424501|241452|P2|STARTED|Overall Study||6
99585|NCT01424501|241453|P1|STARTED|Overall Study||7
99586|NCT01424306|241617|P6|NOT COMPLETED|Overall Study||0
99587|NCT01424306|241618|P5|NOT COMPLETED|Overall Study||1
99588|NCT01424306|241619|P4|NOT COMPLETED|Overall Study||0
99589|NCT01424306|241620|P3|NOT COMPLETED|Overall Study||0
99590|NCT01424306|241621|P2|NOT COMPLETED|Overall Study||0
99591|NCT01424306|241622|P1|NOT COMPLETED|Overall Study||0
99592|NCT01424306|241617|P6|COMPLETED|Overall Study||6
99593|NCT01424306|241618|P5|COMPLETED|Overall Study||4
99594|NCT01424306|241619|P4|COMPLETED|Overall Study||3
99595|NCT01424306|241620|P3|COMPLETED|Overall Study||3
99596|NCT01424306|241621|P2|COMPLETED|Overall Study||4
99597|NCT01424306|241622|P1|COMPLETED|Overall Study||4
99598|NCT01424306|241617|P6|STARTED|Overall Study||6
99599|NCT01424306|241618|P5|STARTED|Overall Study||5
99600|NCT01424306|241619|P4|STARTED|Overall Study||3
99601|NCT01424306|241620|P3|STARTED|Overall Study||3
99602|NCT01424306|241621|P2|STARTED|Overall Study||4
99603|NCT01424306|241622|P1|STARTED|Overall Study||4
99604|NCT01424228|241671|P2|NOT COMPLETED|Overall Study||47
99605|NCT01424228|241672|P1|NOT COMPLETED|Overall Study||56
99606|NCT01424228|241671|P2|COMPLETED|Overall Study||135
99607|NCT01424228|241672|P1|COMPLETED|Overall Study||126
99608|NCT01424228|241671|P2|STARTED|Overall Study||182
99609|NCT01424228|241672|P1|STARTED|Overall Study||182
99610|NCT01424189|241712|P2|NOT COMPLETED|Overall Study||6
99611|NCT01424189|241713|P1|NOT COMPLETED|Overall Study||13
99612|NCT01424189|241712|P2|COMPLETED|Overall Study||182
99614|NCT01424189|241712|P2|STARTED|Overall Study||188
99615|NCT01424189|241713|P1|STARTED|Overall Study||386
99616|NCT01424072|241728|P3|NOT COMPLETED|Overall Study||0
99617|NCT01424072|241729|P2|NOT COMPLETED|Overall Study||0
99618|NCT01424072|241730|P1|NOT COMPLETED|Overall Study||0
99619|NCT01424072|241728|P3|COMPLETED|Overall Study||22
99620|NCT01424072|241729|P2|COMPLETED|Overall Study||26
99621|NCT01424072|241730|P1|COMPLETED|Overall Study||27
99622|NCT01424072|241728|P3|STARTED|Overall Study||22
99623|NCT01424072|241729|P2|STARTED|Overall Study||26
99624|NCT01424072|241730|P1|STARTED|Overall Study||27
99625|NCT01424033|241747|P1|NOT COMPLETED|Overall Study||5
99626|NCT01424033|241747|P1|COMPLETED|Overall Study||0
99627|NCT01424033|241747|P1|STARTED|Overall Study||5
99628|NCT01423916|241754|P3|NOT COMPLETED|Overall Study||7
99629|NCT01423916|241755|P2|NOT COMPLETED|Overall Study||20
99630|NCT01423916|241756|P1|NOT COMPLETED|Overall Study||11
99631|NCT01423916|241754|P3|COMPLETED|Overall Study||64
99632|NCT01423916|241755|P2|COMPLETED|Overall Study||53
99633|NCT01423916|241756|P1|COMPLETED|Overall Study||63
99634|NCT01423916|241754|P3|STARTED|Overall Study||71
99635|NCT01423916|241755|P2|STARTED|Overall Study||73
99636|NCT01423916|241756|P1|STARTED|Overall Study||74
99637|NCT01423812|241812|P2|NOT COMPLETED|Overall Study||4
99638|NCT01423812|241813|P1|NOT COMPLETED|Overall Study||3
99639|NCT01423812|241812|P2|COMPLETED|Overall Study||26
99640|NCT01423812|241813|P1|COMPLETED|Overall Study||27
99641|NCT01423812|241812|P2|STARTED|Overall Study||30
99642|NCT01423812|241813|P1|STARTED|Overall Study||30
99643|NCT01423773|241821|P2|NOT COMPLETED|Period 2, 2 Days||0
99644|NCT01423773|241822|P1|NOT COMPLETED|Period 2, 2 Days||0
99645|NCT01423773|241821|P2|COMPLETED|Period 2, 2 Days||10
99646|NCT01423773|241822|P1|COMPLETED|Period 2, 2 Days||10
99647|NCT01423773|241821|P2|STARTED|Period 2, 2 Days||10
99648|NCT01423773|241822|P1|STARTED|Period 2, 2 Days||10
99649|NCT01423773|241821|P2|NOT COMPLETED|Period One, 2 Days||0
99650|NCT01423773|241822|P1|NOT COMPLETED|Period One, 2 Days||0
99651|NCT01423773|241821|P2|COMPLETED|Period One, 2 Days||10
99652|NCT01423773|241822|P1|COMPLETED|Period One, 2 Days||10
99653|NCT01423773|241821|P2|STARTED|Period One, 2 Days||10
99654|NCT01423773|241822|P1|STARTED|Period One, 2 Days||10
99655|NCT01423760|241830|P2|NOT COMPLETED|Overall Study||0
99656|NCT01423760|241831|P1|NOT COMPLETED|Overall Study||0
99657|NCT01423760|241830|P2|COMPLETED|Overall Study||13
99658|NCT01423760|241831|P1|COMPLETED|Overall Study||14
99659|NCT01423760|241830|P2|Safety Analysis Set|Overall Study||8
99660|NCT01423760|241831|P1|Safety Analysis Set|Overall Study||12
99661|NCT01423760|241830|P2|Number of Non-treatment Subjects|Overall Study||5
99662|NCT01423760|241831|P1|Number of Non-treatment Subjects|Overall Study||2
99663|NCT01423760|241830|P2|Number of Tecemotide Subjects|Overall Study||8
99664|NCT01423760|241831|P1|Number of Tecemotide Subjects|Overall Study||12
99665|NCT01423760|241830|P2|STARTED|Overall Study||13
99666|NCT01423760|241831|P1|STARTED|Overall Study||14
99667|NCT01423617|241841|P2|NOT COMPLETED|Overall Study||1
99668|NCT01423617|241842|P1|NOT COMPLETED|Overall Study||0
99669|NCT01423617|241841|P2|COMPLETED|Overall Study||45
99670|NCT01423617|241842|P1|COMPLETED|Overall Study||46
99671|NCT01423617|241841|P2|STARTED|Overall Study||46
99672|NCT01423617|241842|P1|STARTED|Overall Study||46
99673|NCT01423604|241859|P2|NOT COMPLETED|Randomized||63
99674|NCT01423604|241860|P1|NOT COMPLETED|Randomized||63
99675|NCT01423604|241859|P2|COMPLETED|Randomized||0
99676|NCT01423604|241860|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
99677|NCT01423604|241859|P2|STARTED|Randomized||63
99678|NCT01423604|241860|P1|STARTED|Randomized||64
99679|NCT01423604|241859|P2|NOT COMPLETED|Safety Run-In||0
99680|NCT01423604|241860|P1|NOT COMPLETED|Safety Run-In||9
99681|NCT01423604|241859|P2|COMPLETED|Safety Run-In||0
99682|NCT01423604|241860|P1|COMPLETED|Safety Run-In||0
99683|NCT01423604|241859|P2|STARTED|Safety Run-In||0
99684|NCT01423604|241860|P1|STARTED|Safety Run-In||9
99685|NCT01423253|241875|P1|NOT COMPLETED|Overall Study||9
99686|NCT01423253|241875|P1|COMPLETED|Overall Study||39
99687|NCT01423253|241875|P1|STARTED|Overall Study||48
99688|NCT01423162|241888|P2|NOT COMPLETED|Overall Study||0
99689|NCT01423162|241889|P1|NOT COMPLETED|Overall Study||0
99690|NCT01423162|241888|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
99691|NCT01423162|241889|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
99692|NCT01423162|241888|P2|STARTED|Overall Study||9
99693|NCT01423162|241889|P1|STARTED|Overall Study||11
99694|NCT01423084|241897|P2|NOT COMPLETED|Overall Study||4
99695|NCT01423084|241898|P1|NOT COMPLETED|Overall Study||2
99696|NCT01423084|241897|P2|COMPLETED|Overall Study||170
99697|NCT01423084|241898|P1|COMPLETED|Overall Study||168
99698|NCT01423084|241897|P2|STARTED|Overall Study||174
99699|NCT01423084|241898|P1|STARTED|Overall Study||170
99700|NCT01422915|241928|P1|NOT COMPLETED|Overall Study||1
99701|NCT01422915|241928|P1|COMPLETED|Overall Study||3
99702|NCT01422915|241928|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
99703|NCT01422889|241933|P1|NOT COMPLETED|Overall Study||9
99704|NCT01422889|241933|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
99705|NCT01422889|241933|P1|STARTED|Overall Study||1120
99706|NCT01422876|241948|P10|NOT COMPLETED|Week 52||17
99707|NCT01422876|241949|P9|NOT COMPLETED|Week 52||21
99708|NCT01422876|241950|P8|NOT COMPLETED|Week 52||23
99709|NCT01422876|241951|P7|NOT COMPLETED|Week 52||16
99710|NCT01422876|241952|P6|NOT COMPLETED|Week 52||17
99711|NCT01422876|241953|P5|NOT COMPLETED|Week 52||15
99712|NCT01422876|241954|P4|NOT COMPLETED|Week 52||18
99713|NCT01422876|241955|P3|NOT COMPLETED|Week 52||13
99714|NCT01422876|241956|P2|NOT COMPLETED|Week 52||10
99715|NCT01422876|241957|P1|NOT COMPLETED|Week 52||12
99716|NCT01422876|241948|P10|COMPLETED|Week 52||118
99717|NCT01422876|241949|P9|COMPLETED|Week 52||113
99718|NCT01422876|241950|P8|COMPLETED|Week 52||112
99719|NCT01422876|241951|P7|COMPLETED|Week 52||120
99720|NCT01422876|241952|P6|COMPLETED|Week 52||120
99721|NCT01422876|241953|P5|COMPLETED|Week 52||117
99722|NCT01422876|241954|P4|COMPLETED|Week 52||122
99723|NCT01422876|241955|P3|COMPLETED|Week 52||128
99724|NCT01422876|241956|P2|COMPLETED|Week 52||126
99725|NCT01422876|241957|P1|COMPLETED|Week 52||125
99726|NCT01422876|241948|P10|STARTED|Week 52||135
99727|NCT01422876|241949|P9|STARTED|Week 52||134
99728|NCT01422876|241950|P8|STARTED|Week 52||135
99729|NCT01422876|241951|P7|STARTED|Week 52||136
99730|NCT01422876|241952|P6|STARTED|Week 52||137
99731|NCT01422876|241953|P5|STARTED|Week 52||132
99732|NCT01422876|241954|P4|STARTED|Week 52||140
99733|NCT01422876|241955|P3|STARTED|Week 52||141
99734|NCT01422876|241956|P2|STARTED|Week 52||136
99735|NCT01422876|241957|P1|STARTED|Week 52||137
99736|NCT01422876|241948|P10|NOT COMPLETED|Week 24||10
99737|NCT01422876|241949|P9|NOT COMPLETED|Week 24||6
99738|NCT01422876|241950|P8|NOT COMPLETED|Week 24||7
99739|NCT01422876|241951|P7|NOT COMPLETED|Week 24||6
99740|NCT01422876|241952|P6|NOT COMPLETED|Week 24||6
99741|NCT01422876|241953|P5|NOT COMPLETED|Week 24||7
99742|NCT01422876|241954|P4|NOT COMPLETED|Week 24||8
99743|NCT01422876|241955|P3|NOT COMPLETED|Week 24||5
99744|NCT01422876|241956|P2|NOT COMPLETED|Week 24||3
99745|NCT01422876|241957|P1|NOT COMPLETED|Week 24||6
99746|NCT01422876|241948|P10|COMPLETED|Week 24||125
99747|NCT01422876|241949|P9|COMPLETED|Week 24||128
99748|NCT01422876|241950|P8|COMPLETED|Week 24||128
99749|NCT01422876|241951|P7|COMPLETED|Week 24||130
99750|NCT01422876|241952|P6|COMPLETED|Week 24||131
99751|NCT01422876|241953|P5|COMPLETED|Week 24||125
99752|NCT01422876|241954|P4|COMPLETED|Week 24||132
99753|NCT01422876|241955|P3|COMPLETED|Week 24||136
99754|NCT01422876|241956|P2|COMPLETED|Week 24||133
99755|NCT01422876|241957|P1|COMPLETED|Week 24||131
99756|NCT01422876|241948|P10|STARTED|Week 24||135
99757|NCT01422876|241949|P9|STARTED|Week 24||134
99758|NCT01422876|241950|P8|STARTED|Week 24||135
99759|NCT01422876|241951|P7|STARTED|Week 24||136
99760|NCT01422876|241952|P6|STARTED|Week 24||137
99761|NCT01422876|241953|P5|STARTED|Week 24||132
99762|NCT01422876|241954|P4|STARTED|Week 24||140
99763|NCT01422876|241955|P3|STARTED|Week 24||141
99764|NCT01422876|241956|P2|STARTED|Week 24||136
99765|NCT01422876|241957|P1|STARTED|Week 24||137
99766|NCT01422850|242004|P1|NOT COMPLETED|Overall Study||3
99767|NCT01422850|242004|P1|COMPLETED|Overall Study||18
99768|NCT01422850|242004|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
99769|NCT01422850|242004|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
99770|NCT01422850|242004|P1|Week 9 - Second Treatment|Overall Study||20
99771|NCT01422850|242004|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
99772|NCT01422850|242004|P1|Week 4 - First Treatment|Overall Study||21
99773|NCT01422850|242004|P1|STARTED|Overall Study||21
99774|NCT01422824|242010|P1|NOT COMPLETED|Overall Study||38
99775|NCT01422824|242010|P1|COMPLETED|Overall Study||147
99776|NCT01422824|242010|P1|Treated|Overall Study||184
99777|NCT01422824|242010|P1|STARTED|Overall Study||185
99778|NCT01422720|242015|P1|NOT COMPLETED|Overall Study||22
99779|NCT01422720|242015|P1|COMPLETED|Overall Study||50
99780|NCT01422720|242015|P1|Per-Protocol Set (PPS)|Overall Study||55
99781|NCT01422720|242015|P1|Full Analysis Set (FAS)|Overall Study||71
99782|NCT01422720|242015|P1|Safety Set|Overall Study||72
99783|NCT01422720|242015|P1|STARTED|Overall Study||72
99784|NCT01422538|242026|P3|NOT COMPLETED|Overall Study||2
99785|NCT01422538|242027|P2|NOT COMPLETED|Overall Study||2
99786|NCT01422538|242028|P1|NOT COMPLETED|Overall Study||0
99787|NCT01422538|242026|P3|COMPLETED|Overall Study||8
99788|NCT01422538|242027|P2|COMPLETED|Overall Study||8
99789|NCT01422538|242028|P1|COMPLETED|Overall Study||10
99790|NCT01422538|242026|P3|STARTED|Overall Study||10
99791|NCT01422538|242027|P2|STARTED|Overall Study||10
99792|NCT01422538|242028|P1|STARTED|Overall Study||10
99793|NCT01422434|242053|P3|NOT COMPLETED|Overall Study||6
99794|NCT01422434|242054|P2|NOT COMPLETED|Overall Study||5
99795|NCT01422434|242055|P1|NOT COMPLETED|Overall Study||11
99796|NCT01422434|242053|P3|COMPLETED|Overall Study||217
99797|NCT01422434|242054|P2|COMPLETED|Overall Study||221
99798|NCT01422434|242055|P1|COMPLETED|Overall Study||216
99799|NCT01422434|242053|P3|STARTED|Overall Study||223
99800|NCT01422434|242054|P2|STARTED|Overall Study||226
99801|NCT01422434|242055|P1|STARTED|Overall Study||227
99802|NCT01422408|242072|P1|NOT COMPLETED|Overall Study||4
99803|NCT01422408|242072|P1|COMPLETED|Overall Study||30
99804|NCT01422408|242072|P1|STARTED|Overall Study||34
99805|NCT01422382|242101|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
99806|NCT01422382|242101|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
99807|NCT01422382|242101|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
99808|NCT01422382|242101|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
99809|NCT01422382|242101|P1|COMPLETED|Diltiazem 240 mg QD||28
99810|NCT01422382|242101|P1|STARTED|Diltiazem 240 mg QD||28
99811|NCT01422382|242101|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
99812|NCT01422382|242101|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
99813|NCT01422382|242101|P1|STARTED|NK-104 4mg Once Daily (QD)||28
99814|NCT01422369|242106|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
99815|NCT01422369|242106|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
99816|NCT01422369|242106|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
99817|NCT01422369|242106|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
99818|NCT01422369|242106|P1|COMPLETED|Prezista 800mg/100mg QD||28
99819|NCT01422369|242106|P1|STARTED|Prezista 800mg/100mg QD||28
99820|NCT01422369|242106|P1|NOT COMPLETED|NK-104 4mg QD||0
99821|NCT01422369|242106|P1|COMPLETED|NK-104 4mg QD||28
99822|NCT01422369|242106|P1|STARTED|NK-104 4mg QD||28
99823|NCT01422356|242111|P1|NOT COMPLETED|Overall Study||31
99824|NCT01422356|242111|P1|COMPLETED|Overall Study||169
99825|NCT01422356|242111|P1|STARTED|Overall Study||200
99826|NCT01422304|242117|P2|NOT COMPLETED|Overall Study||37
99827|NCT01422304|242118|P1|NOT COMPLETED|Overall Study||24
99828|NCT01422304|242117|P2|COMPLETED|Overall Study||563
99829|NCT01422304|242118|P1|COMPLETED|Overall Study||574
99830|NCT01422304|242117|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
99831|NCT01422304|242118|P1|Treated|Overall Study||595
99832|NCT01422304|242117|P2|STARTED|Overall Study|Randomized|600
99833|NCT01422304|242118|P1|STARTED|Overall Study|Randomized|598
99834|NCT01422239|242150|P2|NOT COMPLETED|Overall Study||3
99835|NCT01422239|242151|P1|NOT COMPLETED|Overall Study||4
99836|NCT01422239|242150|P2|COMPLETED|Overall Study||3
99837|NCT01422239|242151|P1|COMPLETED|Overall Study||10
99838|NCT01422239|242150|P2|STARTED|Overall Study||6
99839|NCT01422239|242151|P1|STARTED|Overall Study||14
99840|NCT01422226|242163|P2|NOT COMPLETED|Overall Study||0
99841|NCT01422226|242164|P1|NOT COMPLETED|Overall Study||0
99842|NCT01422226|242163|P2|COMPLETED|Overall Study||2
99843|NCT01422226|242164|P1|COMPLETED|Overall Study||1
99844|NCT01422226|242163|P2|STARTED|Overall Study||2
99845|NCT01422226|242164|P1|STARTED|Overall Study||1
99846|NCT01422213|242173|P3|NOT COMPLETED|Overall Study||29
99847|NCT01422213|242174|P2|NOT COMPLETED|Overall Study||22
99848|NCT01422213|242175|P1|NOT COMPLETED|Overall Study||33
99849|NCT01422213|242173|P3|COMPLETED|Overall Study||178
99850|NCT01422213|242174|P2|COMPLETED|Overall Study||173
99851|NCT01422213|242175|P1|COMPLETED|Overall Study||163
99852|NCT01422213|242173|P3|STARTED|Overall Study||207
99853|NCT01422213|242174|P2|STARTED|Overall Study||195
99854|NCT01422213|242175|P1|STARTED|Overall Study||196
99855|NCT01422187|242236|P3|NOT COMPLETED|Overall Study||0
99856|NCT01422187|242237|P2|NOT COMPLETED|Overall Study||1
99857|NCT01422187|242238|P1|NOT COMPLETED|Overall Study||1
99858|NCT01422187|242236|P3|COMPLETED|Overall Study||2
99859|NCT01422187|242237|P2|COMPLETED|Overall Study||8
99860|NCT01422187|242238|P1|COMPLETED|Overall Study||7
99861|NCT01422187|242236|P3|STARTED|Overall Study||2
99862|NCT01422187|242237|P2|STARTED|Overall Study||9
99863|NCT01422187|242238|P1|STARTED|Overall Study||8
99864|NCT01422070|242257|P2|NOT COMPLETED|Overall Study||0
99865|NCT01422070|242258|P1|NOT COMPLETED|Overall Study||0
99866|NCT01422070|242257|P2|COMPLETED|Overall Study||803
99867|NCT01422070|242258|P1|COMPLETED|Overall Study||5031
99868|NCT01422070|242257|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
99869|NCT01422070|242258|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
99870|NCT01421719|242269|P1|NOT COMPLETED|Overall Study||4
99871|NCT01421719|242269|P1|COMPLETED|Overall Study||16
99872|NCT01421719|242269|P1|STARTED|Overall Study||20
99873|NCT01421667|242278|P4|NOT COMPLETED|Overall Study||1
99874|NCT01421667|242279|P3|NOT COMPLETED|Overall Study||2
99875|NCT01421667|242280|P2|NOT COMPLETED|Overall Study||2
99876|NCT01421667|242281|P1|NOT COMPLETED|Overall Study||0
99877|NCT01421667|242278|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
99878|NCT01421667|242279|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
99879|NCT01421667|242280|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
99880|NCT01421667|242281|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
99881|NCT01421667|242278|P4|STARTED|Overall Study||16
99882|NCT01421667|242279|P3|STARTED|Overall Study||53
99883|NCT01421667|242280|P2|STARTED|Overall Study||68
99884|NCT01421667|242281|P1|STARTED|Overall Study||35
99885|NCT01421654|242333|P2|NOT COMPLETED|Overall Study||0
99886|NCT01421654|242334|P1|NOT COMPLETED|Overall Study||0
99887|NCT01421654|242333|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
99888|NCT01421654|242334|P1|COMPLETED|Overall Study||11
99889|NCT01421654|242333|P2|STARTED|Overall Study||9
99890|NCT01421654|242334|P1|STARTED|Overall Study||11
99891|NCT01421641|242342|P2|NOT COMPLETED|Overall Study||2
99892|NCT01421641|242343|P1|NOT COMPLETED|Overall Study||2
99893|NCT01421641|242342|P2|COMPLETED|Overall Study||35
99894|NCT01421641|242343|P1|COMPLETED|Overall Study||35
99895|NCT01421641|242342|P2|STARTED|Overall Study||37
99896|NCT01421641|242343|P1|STARTED|Overall Study||37
99897|NCT01421589|242353|P1|NOT COMPLETED|Overall Study||0
99898|NCT01421589|242353|P1|COMPLETED|Overall Study||15
99899|NCT01421589|242353|P1|STARTED|Overall Study||15
99900|NCT01421511|242365|P2|NOT COMPLETED|Overall Study||28
99901|NCT01421511|242366|P1|NOT COMPLETED|Overall Study||19
99902|NCT01421511|242365|P2|COMPLETED|Overall Study||306
99903|NCT01421511|242366|P1|COMPLETED|Overall Study||313
99904|NCT01421511|242365|P2|STARTED|Overall Study||334
99905|NCT01421511|242366|P1|STARTED|Overall Study||332
99906|NCT01421498|242388|P2|NOT COMPLETED|Overall Study||11
99907|NCT01421498|242389|P1|NOT COMPLETED|Overall Study||12
99908|NCT01421498|242388|P2|COMPLETED|Overall Study||284
99909|NCT01421498|242389|P1|COMPLETED|Overall Study||281
99910|NCT01421498|242388|P2|STARTED|Overall Study||295
99911|NCT01421498|242389|P1|STARTED|Overall Study||293
99912|NCT01421472|242401|P4|NOT COMPLETED|Overall Study||0
99913|NCT01421472|242402|P3|NOT COMPLETED|Overall Study||0
99914|NCT01421472|242403|P2|NOT COMPLETED|Overall Study||0
99915|NCT01421472|242404|P1|NOT COMPLETED|Overall Study||0
99916|NCT01421472|242401|P4|COMPLETED|Overall Study||32
99917|NCT01421472|242402|P3|COMPLETED|Overall Study||64
99918|NCT01421472|242403|P2|COMPLETED|Overall Study||33
99919|NCT01421472|242404|P1|COMPLETED|Overall Study||67
99920|NCT01421472|242401|P4|STARTED|Overall Study||32
99921|NCT01421472|242402|P3|STARTED|Overall Study||64
99922|NCT01421472|242403|P2|STARTED|Overall Study||33
99923|NCT01421472|242404|P1|STARTED|Overall Study||67
99924|NCT01421459|242416|P2|NOT COMPLETED|Overall Study||52
99925|NCT01421459|242417|P1|NOT COMPLETED|Overall Study||45
99926|NCT01421459|242416|P2|COMPLETED|Overall Study||328
99927|NCT01421459|242417|P1|COMPLETED|Overall Study||334
99928|NCT01421459|242416|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
99929|NCT01421459|242417|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
99930|NCT01421459|242416|P2|STARTED|Overall Study||380
99931|NCT01421459|242417|P1|STARTED|Overall Study||379
99932|NCT01421355|242451|P1|NOT COMPLETED|Overall Study||6
99933|NCT01421355|242451|P1|COMPLETED|Overall Study||15
99934|NCT01421355|242451|P1|STARTED|Overall Study||21
99935|NCT01421342|242458|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
99936|NCT01421342|242459|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
99937|NCT01421342|242460|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
99938|NCT01421342|242458|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
99939|NCT01421342|242459|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
99940|NCT01421342|242460|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
99941|NCT01421342|242458|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
99942|NCT01421342|242459|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
99943|NCT01421342|242460|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
99944|NCT01421342|242458|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
99945|NCT01421342|242459|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
99946|NCT01421342|242460|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
99947|NCT01421342|242458|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
99948|NCT01421342|242459|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
99949|NCT01421342|242460|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
99950|NCT01421342|242458|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
99951|NCT01421342|242459|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
99952|NCT01421342|242460|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
99953|NCT01421342|242458|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
99954|NCT01421342|242459|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
99955|NCT01421342|242460|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
99956|NCT01421342|242458|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
99957|NCT01421342|242459|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
99958|NCT01421342|242460|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
99959|NCT01421342|242458|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
99960|NCT01421342|242459|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
99961|NCT01421342|242460|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
99962|NCT01421303|242477|P1|NOT COMPLETED|Overall Study||22
99963|NCT01421303|242477|P1|COMPLETED|Overall Study||58
99964|NCT01421303|242477|P1|STARTED|Overall Study||80
99965|NCT01421277|242504|P2|NOT COMPLETED|Overall Study||92
99966|NCT01421277|242505|P1|NOT COMPLETED|Overall Study||0
99967|NCT01421277|242504|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
99968|NCT01421277|242505|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
99969|NCT01421277|242504|P2|STARTED|Overall Study||191
99970|NCT01421277|242505|P1|STARTED|Overall Study||25
99971|NCT01421147|242517|P2|NOT COMPLETED|Extension Period||11
99972|NCT01421147|242518|P1|NOT COMPLETED|Extension Period||8
99973|NCT01421147|242517|P2|COMPLETED|Extension Period||245
99974|NCT01421147|242518|P1|COMPLETED|Extension Period||245
99975|NCT01421147|242517|P2|STARTED|Extension Period||256
99976|NCT01421147|242518|P1|STARTED|Extension Period||253
99977|NCT01421147|242517|P2|NOT COMPLETED|Treatment Period||11
99978|NCT01421147|242518|P1|NOT COMPLETED|Treatment Period||16
99979|NCT01421147|242517|P2|COMPLETED|Treatment Period||256
99980|NCT01421147|242518|P1|COMPLETED|Treatment Period||253
99981|NCT01421147|242517|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
99982|NCT01421147|242518|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
99983|NCT01421147|242517|P2|STARTED|Treatment Period||267
99984|NCT01421147|242518|P1|STARTED|Treatment Period||269
99985|NCT01421134|242550|P2|NOT COMPLETED|Overall Study||15
99986|NCT01421134|242551|P1|NOT COMPLETED|Overall Study||7
99987|NCT01421134|242550|P2|COMPLETED|Overall Study||87
99988|NCT01421134|242551|P1|COMPLETED|Overall Study||102
99989|NCT01421134|242550|P2|STARTED|Overall Study||102
99990|NCT01421134|242551|P1|STARTED|Overall Study||109
99991|NCT01420926|242571|P2|NOT COMPLETED|Overall Study||65
99992|NCT01420926|242572|P1|NOT COMPLETED|Overall Study||60
99993|NCT01420926|242571|P2|COMPLETED|Overall Study||16
99994|NCT01420926|242572|P1|COMPLETED|Overall Study||22
99995|NCT01420926|242571|P2|STARTED|Overall Study||81
99996|NCT01420926|242572|P1|STARTED|Overall Study||82
99997|NCT01420848|242589|P3|NOT COMPLETED|Overall Study||0
99998|NCT01420848|242590|P2|NOT COMPLETED|Overall Study||0
99999|NCT01420848|242591|P1|NOT COMPLETED|Overall Study||0
100000|NCT01420848|242589|P3|COMPLETED|Overall Study||22
100001|NCT01420848|242590|P2|COMPLETED|Overall Study||25
100002|NCT01420848|242591|P1|COMPLETED|Overall Study||24
100003|NCT01420848|242589|P3|STARTED|Overall Study||22
100004|NCT01420848|242590|P2|STARTED|Overall Study||25
100005|NCT01420848|242591|P1|STARTED|Overall Study||24
100006|NCT01420289|242604|P2|NOT COMPLETED|Overall Study||0
100007|NCT01420289|242605|P1|NOT COMPLETED|Overall Study||0
100008|NCT01420289|242604|P2|COMPLETED|Overall Study||16
100009|NCT01420289|242605|P1|COMPLETED|Overall Study||18
100010|NCT01420289|242604|P2|STARTED|Overall Study||16
100011|NCT01420289|242605|P1|STARTED|Overall Study||18
100012|NCT01420146|242617|P1|NOT COMPLETED|Overall Study||0
100013|NCT01420146|242617|P1|COMPLETED|Overall Study||20
100014|NCT01420146|242617|P1|STARTED|Overall Study||20
100015|NCT01420081|242630|P9|NOT COMPLETED|Overall Study||3
100016|NCT01420081|242631|P8|NOT COMPLETED|Overall Study||3
100017|NCT01420081|242632|P7|NOT COMPLETED|Overall Study||3
100018|NCT01420081|242633|P6|NOT COMPLETED|Overall Study||20
100019|NCT01420081|242634|P5|NOT COMPLETED|Overall Study||20
100020|NCT01420081|242635|P4|NOT COMPLETED|Overall Study||3
100021|NCT01420081|242636|P3|NOT COMPLETED|Overall Study||11
100022|NCT01420081|242637|P2|NOT COMPLETED|Overall Study||1
100023|NCT01420081|242638|P1|NOT COMPLETED|Overall Study||3
100024|NCT01420081|242630|P9|COMPLETED|Overall Study||0
100025|NCT01420081|242631|P8|COMPLETED|Overall Study||0
100026|NCT01420081|242632|P7|COMPLETED|Overall Study||0
100027|NCT01420081|242633|P6|COMPLETED|Overall Study||0
100028|NCT01420081|242634|P5|COMPLETED|Overall Study||0
100029|NCT01420081|242635|P4|COMPLETED|Overall Study||0
100030|NCT01420081|242636|P3|COMPLETED|Overall Study||0
100031|NCT01420081|242637|P2|COMPLETED|Overall Study||0
100032|NCT01420081|242638|P1|COMPLETED|Overall Study||0
100033|NCT01420081|242630|P9|STARTED|Overall Study||3
100034|NCT01420081|242631|P8|STARTED|Overall Study||3
100035|NCT01420081|242632|P7|STARTED|Overall Study||3
100036|NCT01420081|242633|P6|STARTED|Overall Study||20
100037|NCT01420081|242634|P5|STARTED|Overall Study||20
100038|NCT01420081|242635|P4|STARTED|Overall Study||3
100039|NCT01420081|242636|P3|STARTED|Overall Study||11
100040|NCT01420081|242637|P2|STARTED|Overall Study||1
100041|NCT01420081|242638|P1|STARTED|Overall Study||3
100042|NCT01419977|242719|P2|NOT COMPLETED|Overall Study||0
100043|NCT01419977|242720|P1|NOT COMPLETED|Overall Study||0
100044|NCT01419977|242719|P2|COMPLETED|Overall Study||13
100045|NCT01419977|242720|P1|COMPLETED|Overall Study||16
100046|NCT01419977|242719|P2|STARTED|Overall Study||13
100047|NCT01419977|242720|P1|STARTED|Overall Study||16
100048|NCT01419795|242734|P2|NOT COMPLETED|Overall Study||0
100049|NCT01419795|242735|P1|NOT COMPLETED|Overall Study||0
100050|NCT01419795|242734|P2|COMPLETED|Overall Study||0
100051|NCT01419795|242735|P1|COMPLETED|Overall Study||3
100052|NCT01419795|242734|P2|STARTED|Overall Study||0
100053|NCT01419795|242735|P1|STARTED|Overall Study||3
100054|NCT01419769|242757|P1|NOT COMPLETED|Overall Study||4
100055|NCT01419769|242757|P1|COMPLETED|Overall Study||29
100056|NCT01419769|242757|P1|STARTED|Overall Study||33
100057|NCT01419639|242770|P1|NOT COMPLETED|Overall Study||1
100058|NCT01419639|242770|P1|COMPLETED|Overall Study||9
100059|NCT01419639|242770|P1|STARTED|Overall Study||10
100060|NCT01419314|242778|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
100061|NCT01419314|242779|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
100062|NCT01419314|242778|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
100063|NCT01419314|242779|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
100064|NCT01419314|242778|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
100065|NCT01419314|242779|P1|STARTED|Follow-up at Week 6 of the Trial||17
100066|NCT01419314|242778|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
100067|NCT01419314|242779|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
100068|NCT01419314|242778|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
100069|NCT01419314|242779|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
100070|NCT01419314|242778|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
100071|NCT01419314|242779|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
100072|NCT01419314|242778|P2|NOT COMPLETED|Start of Study||0
100073|NCT01419314|242779|P1|NOT COMPLETED|Start of Study||0
100074|NCT01419314|242778|P2|COMPLETED|Start of Study||22
100075|NCT01419314|242779|P1|COMPLETED|Start of Study||23
100076|NCT01419314|242778|P2|STARTED|Start of Study|No comfort issues reported.|22
100077|NCT01419314|242779|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
100078|NCT01419275|242799|P1|NOT COMPLETED|Overall Study||0
100079|NCT01419275|242799|P1|COMPLETED|Overall Study||126
100080|NCT01419275|242799|P1|STARTED|Overall Study||126
100081|NCT01419249|242805|P2|NOT COMPLETED|Overall Study||0
100082|NCT01419249|242806|P1|NOT COMPLETED|Overall Study||0
100083|NCT01419249|242805|P2|COMPLETED|Overall Study||140
100084|NCT01419249|242806|P1|COMPLETED|Overall Study||318
100085|NCT01419249|242805|P2|STARTED|Overall Study||140
100086|NCT01419249|242806|P1|STARTED|Overall Study||318
100087|NCT01419236|242820|P2|NOT COMPLETED|Overall Study||5
100088|NCT01419236|242821|P1|NOT COMPLETED|Overall Study||5
100089|NCT01419236|242820|P2|COMPLETED|Overall Study||35
100090|NCT01419236|242821|P1|COMPLETED|Overall Study||31
100091|NCT01419236|242820|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
100092|NCT01419236|242821|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
100093|NCT01419236|242820|P2|STARTED|Overall Study||40
100094|NCT01419236|242821|P1|STARTED|Overall Study||36
100095|NCT01419197|242845|P2|NOT COMPLETED|Overall Study||198
100096|NCT01419197|242846|P1|NOT COMPLETED|Overall Study||404
100097|NCT01419197|242845|P2|COMPLETED|Overall Study||0
100098|NCT01419197|242846|P1|COMPLETED|Overall Study||0
100099|NCT01419197|242845|P2|Switched to Trastuzumab Emtansine|Overall Study||94
100100|NCT01419197|242846|P1|Switched to Trastuzumab Emtansine|Overall Study||0
100101|NCT01419197|242845|P2|STARTED|Overall Study||198
100102|NCT01419197|242846|P1|STARTED|Overall Study||404
100103|NCT01419184|242871|P2|NOT COMPLETED|Overall Study||15
100104|NCT01419184|242872|P1|NOT COMPLETED|Overall Study||10
100105|NCT01419184|242871|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
100106|NCT01419184|242872|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
100107|NCT01419184|242871|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
100108|NCT01419184|242872|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
100109|NCT01419184|242871|P2|STARTED|Overall Study||121
100110|NCT01419184|242872|P1|STARTED|Overall Study||128
100111|NCT01419171|242888|P1|NOT COMPLETED|Overall Study||0
100112|NCT01419171|242888|P1|COMPLETED|Overall Study||328
100113|NCT01419171|242888|P1|STARTED|Overall Study||328
100114|NCT01419028|242905|P1|NOT COMPLETED|Overall Study||0
100115|NCT01419028|242905|P1|COMPLETED|Overall Study||48
100116|NCT01419028|242905|P1|STARTED|Overall Study||48
100117|NCT01418937|242910|P1|NOT COMPLETED|Overall Study||8
100118|NCT01418937|242910|P1|COMPLETED|Overall Study||156
100119|NCT01418937|242910|P1|STARTED|Overall Study||164
100120|NCT01418703|242919|P4|NOT COMPLETED|Overall Study||0
100121|NCT01418703|242920|P3|NOT COMPLETED|Overall Study||0
100122|NCT01418703|242921|P2|NOT COMPLETED|Overall Study||0
100123|NCT01418703|242922|P1|NOT COMPLETED|Overall Study||0
100124|NCT01418703|242919|P4|COMPLETED|Overall Study||6
100125|NCT01418703|242920|P3|COMPLETED|Overall Study||6
100126|NCT01418703|242921|P2|COMPLETED|Overall Study||13
100127|NCT01418703|242922|P1|COMPLETED|Overall Study||13
100128|NCT01418703|242919|P4|STARTED|Overall Study||6
100129|NCT01418703|242920|P3|STARTED|Overall Study||6
100130|NCT01418703|242921|P2|STARTED|Overall Study||13
100131|NCT01418703|242922|P1|STARTED|Overall Study||13
100132|NCT01418482|242933|P1|NOT COMPLETED|Overall Study||0
100133|NCT01418482|242933|P1|COMPLETED|Overall Study||15
100134|NCT01418482|242933|P1|STARTED|Overall Study||15
100135|NCT01418365|242941|P2|NOT COMPLETED|Second Intervention||1
100136|NCT01418365|242942|P1|NOT COMPLETED|Second Intervention||0
100137|NCT01418365|242941|P2|COMPLETED|Second Intervention||13
100138|NCT01418365|242942|P1|COMPLETED|Second Intervention||14
100139|NCT01418365|242941|P2|STARTED|Second Intervention||14
100140|NCT01418365|242942|P1|STARTED|Second Intervention||14
100141|NCT01418365|242941|P2|NOT COMPLETED|First Intervention||1
100142|NCT01418365|242942|P1|NOT COMPLETED|First Intervention||1
100143|NCT01418365|242941|P2|COMPLETED|First Intervention||14
100144|NCT01418365|242942|P1|COMPLETED|First Intervention||14
100145|NCT01418365|242941|P2|STARTED|First Intervention||15
100146|NCT01418365|242942|P1|STARTED|First Intervention||15
100147|NCT01418209|242953|P3|NOT COMPLETED|Overall Study||4
100148|NCT01418209|242954|P2|NOT COMPLETED|Overall Study||3
100149|NCT01418209|242955|P1|NOT COMPLETED|Overall Study||2
100150|NCT01418209|242953|P3|COMPLETED|Overall Study||142
100151|NCT01418209|242954|P2|COMPLETED|Overall Study||93
100152|NCT01418209|242955|P1|COMPLETED|Overall Study||95
100153|NCT01418209|242953|P3|STARTED|Overall Study||146
100154|NCT01418209|242954|P2|STARTED|Overall Study||96
100155|NCT01418209|242955|P1|STARTED|Overall Study||97
100156|NCT01418001|242984|P1|NOT COMPLETED|Overall Study||0
100157|NCT01418001|242984|P1|COMPLETED|Overall Study||5
100158|NCT01418001|242984|P1|STARTED|Overall Study||5
100159|NCT01417936|242989|P1|NOT COMPLETED|Overall Study||0
100160|NCT01417936|242989|P1|COMPLETED|Overall Study||26
100161|NCT01417936|242989|P1|STARTED|Overall Study||26
100162|NCT01417481|243010|P2|NOT COMPLETED|Second Period (8 Weeks)||0
100163|NCT01417481|243011|P1|NOT COMPLETED|Second Period (8 Weeks)||0
100164|NCT01417481|243010|P2|COMPLETED|Second Period (8 Weeks)||5
100165|NCT01417481|243011|P1|COMPLETED|Second Period (8 Weeks)||8
100166|NCT01417481|243010|P2|STARTED|Second Period (8 Weeks)||5
100167|NCT01417481|243011|P1|STARTED|Second Period (8 Weeks)||8
100168|NCT01417481|243010|P2|NOT COMPLETED|Washout (2 Weeks)||0
100169|NCT01417481|243011|P1|NOT COMPLETED|Washout (2 Weeks)||0
100170|NCT01417481|243010|P2|COMPLETED|Washout (2 Weeks)||5
100171|NCT01417481|243011|P1|COMPLETED|Washout (2 Weeks)||8
100172|NCT01417481|243010|P2|STARTED|Washout (2 Weeks)||5
100173|NCT01417481|243011|P1|STARTED|Washout (2 Weeks)||8
100174|NCT01417481|243010|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
100175|NCT01417481|243011|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
100176|NCT01417481|243010|P2|COMPLETED|First Intervention (8 Weeks)||5
100177|NCT01417481|243011|P1|COMPLETED|First Intervention (8 Weeks)||8
100178|NCT01417481|243010|P2|STARTED|First Intervention (8 Weeks)||7
100179|NCT01417481|243011|P1|STARTED|First Intervention (8 Weeks)||8
100180|NCT01417455|243043|P8|NOT COMPLETED|Overall Study||0
100181|NCT01417455|243044|P7|NOT COMPLETED|Overall Study||0
100182|NCT01417455|243045|P6|NOT COMPLETED|Overall Study||0
100183|NCT01417455|243046|P5|NOT COMPLETED|Overall Study||0
100184|NCT01417455|243047|P4|NOT COMPLETED|Overall Study||0
100185|NCT01417455|243048|P3|NOT COMPLETED|Overall Study||0
100186|NCT01417455|243049|P2|NOT COMPLETED|Overall Study||0
100187|NCT01417455|243050|P1|NOT COMPLETED|Overall Study||0
100188|NCT01417455|243043|P8|COMPLETED|Overall Study||25
100189|NCT01417455|243044|P7|COMPLETED|Overall Study||13
100190|NCT01417455|243045|P6|COMPLETED|Overall Study||13
100191|NCT01417455|243046|P5|COMPLETED|Overall Study||30
100192|NCT01417455|243047|P4|COMPLETED|Overall Study||17
100193|NCT01417455|243048|P3|COMPLETED|Overall Study||17
100194|NCT01417455|243049|P2|COMPLETED|Overall Study||16
100195|NCT01417455|243050|P1|COMPLETED|Overall Study||16
100196|NCT01417455|243043|P8|STARTED|Overall Study||25
100197|NCT01417455|243044|P7|STARTED|Overall Study||13
100198|NCT01417455|243045|P6|STARTED|Overall Study||13
100199|NCT01417455|243046|P5|STARTED|Overall Study||30
100200|NCT01417455|243047|P4|STARTED|Overall Study||17
100201|NCT01417455|243048|P3|STARTED|Overall Study||17
100202|NCT01417455|243049|P2|STARTED|Overall Study||16
100203|NCT01417455|243050|P1|STARTED|Overall Study||16
100204|NCT01417377|243076|P1|NOT COMPLETED|Overall Study||13
100205|NCT01417377|243076|P1|COMPLETED|Overall Study||9
100206|NCT01417377|243076|P1|Treated|Overall Study||21
100207|NCT01417377|243076|P1|STARTED|Overall Study||22
100208|NCT01417195|243085|P2|NOT COMPLETED|Overall Study||1
100209|NCT01417195|243086|P1|NOT COMPLETED|Overall Study||3
100210|NCT01417195|243085|P2|COMPLETED|Overall Study||61
100211|NCT01417195|243086|P1|COMPLETED|Overall Study||57
100212|NCT01417195|243085|P2|STARTED|Overall Study||62
100213|NCT01417195|243086|P1|STARTED|Overall Study||60
100214|NCT01417156|243102|P1|NOT COMPLETED|Overall Study||14
100215|NCT01417156|243102|P1|COMPLETED|Overall Study||6
100216|NCT01417156|243102|P1|STARTED|Overall Study||20
100217|NCT01417104|243112|P2|NOT COMPLETED|Overall Study||2
100218|NCT01417104|243113|P1|NOT COMPLETED|Overall Study||6
100219|NCT01417104|243112|P2|COMPLETED|Overall Study||35
100220|NCT01417104|243113|P1|COMPLETED|Overall Study||28
100221|NCT01417104|243112|P2|STARTED|Overall Study||37
100222|NCT01417104|243113|P1|STARTED|Overall Study||34
100223|NCT01417078|243123|P1|NOT COMPLETED|Overall Study||1
100224|NCT01417078|243123|P1|COMPLETED|Overall Study||30
100225|NCT01417078|243123|P1|STARTED|Overall Study||31
100226|NCT01417026|243135|P2|NOT COMPLETED|Overall Study||0
100227|NCT01417026|243136|P1|NOT COMPLETED|Overall Study||2
100228|NCT01417026|243135|P2|COMPLETED|Overall Study||13
100229|NCT01417026|243136|P1|COMPLETED|Overall Study||14
100230|NCT01417026|243135|P2|STARTED|Overall Study||13
100231|NCT01417026|243136|P1|STARTED|Overall Study||16
100232|NCT01417000|243148|P2|NOT COMPLETED|Overall Study||29
100233|NCT01417000|243149|P1|NOT COMPLETED|Overall Study||61
100234|NCT01417000|243148|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
100235|NCT01417000|243149|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
100236|NCT01417000|243148|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
100237|NCT01417000|243149|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
100238|NCT01416610|243157|P1|NOT COMPLETED|Overall Study||43
100239|NCT01416610|243157|P1|COMPLETED|Overall Study||45
100240|NCT01416610|243157|P1|Completed Follow-up|Overall Study||45
100241|NCT01416610|243157|P1|Completed Treatment|Overall Study||47
100242|NCT01416610|243157|P1|Per Protocol|Overall Study||83
100243|NCT01416610|243157|P1|Safety Population|Overall Study||86
100244|NCT01416610|243157|P1|Intention to Treat|Overall Study||88
100245|NCT01416610|243157|P1|STARTED|Overall Study||88
100246|NCT01416584|243174|P3|NOT COMPLETED|Overall Study||1
100247|NCT01416584|243175|P2|NOT COMPLETED|Overall Study||2
100248|NCT01416584|243176|P1|NOT COMPLETED|Overall Study||3
100249|NCT01416584|243174|P3|COMPLETED|Overall Study||32
100250|NCT01416584|243175|P2|COMPLETED|Overall Study||33
100251|NCT01416584|243176|P1|COMPLETED|Overall Study||27
100252|NCT01416584|243174|P3|STARTED|Overall Study||33
100253|NCT01416584|243175|P2|STARTED|Overall Study||35
100254|NCT01416584|243176|P1|STARTED|Overall Study||30
100255|NCT01416571|243211|P1|NOT COMPLETED|Overall Study||2
100256|NCT01416571|243211|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
100257|NCT01416571|243211|P1|STARTED|Overall Study||78
100258|NCT01416389|243240|P2|NOT COMPLETED|Overall Study||0
100259|NCT01416389|243241|P1|NOT COMPLETED|Overall Study||3
100260|NCT01416389|243240|P2|COMPLETED|Overall Study||13
100261|NCT01416389|243241|P1|COMPLETED|Overall Study||23
100262|NCT01416389|243240|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
100263|NCT01416389|243241|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
100264|NCT01416389|243240|P2|STARTED|Overall Study||13
100265|NCT01416389|243241|P1|STARTED|Overall Study||26
100266|NCT01416272|243258|P1|NOT COMPLETED|Overall Study||4
100267|NCT01416272|243258|P1|COMPLETED|Overall Study||8
100268|NCT01416272|243258|P1|STARTED|Overall Study||12
100269|NCT01416181|243266|P2|NOT COMPLETED|Part 2||286
100270|NCT01416181|243267|P1|NOT COMPLETED|Part 2||271
100271|NCT01416181|243266|P2|COMPLETED|Part 2||6
100272|NCT01416181|243267|P1|COMPLETED|Part 2||3
100273|NCT01416181|243266|P2|Completed Treatment for > 96 Weeks|Part 2||0
100274|NCT01416181|243267|P1|Completed Treatment for > 96 Weeks|Part 2||1
100275|NCT01416181|243266|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
100276|NCT01416181|243267|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
100277|NCT01416181|243266|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
100278|NCT01416181|243267|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
100279|NCT01416181|243266|P2|STARTED|Part 2||292
100280|NCT01416181|243267|P1|STARTED|Part 2||274
100281|NCT01416181|243266|P2|NOT COMPLETED|Part 1||114
100282|NCT01416181|243267|P1|NOT COMPLETED|Part 1||137
100283|NCT01416181|243266|P2|COMPLETED|Part 1|Completed Study through Week 108|326
100284|NCT01416181|243267|P1|COMPLETED|Part 1|Completed Study through Week 108|312
100285|NCT01416181|243266|P2|Withdrew Prior to Dosing|Part 1||1
100286|NCT01416181|243267|P1|Withdrew Prior to Dosing|Part 1||0
100287|NCT01416181|243266|P2|STARTED|Part 1||440
100288|NCT01416181|243267|P1|STARTED|Part 1||449
100289|NCT01416155|243329|P1|NOT COMPLETED|Overall Study||58
100290|NCT01416155|243329|P1|COMPLETED|Overall Study||39
100291|NCT01416155|243329|P1|STARTED|Overall Study||97
100292|NCT01416142|243336|P3|NOT COMPLETED|PureVision2 HD||1
100293|NCT01416142|243337|P2|NOT COMPLETED|PureVision2 HD||0
100294|NCT01416142|243338|P1|NOT COMPLETED|PureVision2 HD||0
100295|NCT01416142|243336|P3|COMPLETED|PureVision2 HD||62
100296|NCT01416142|243337|P2|COMPLETED|PureVision2 HD||0
100297|NCT01416142|243338|P1|COMPLETED|PureVision2 HD||0
100298|NCT01416142|243336|P3|STARTED|PureVision2 HD||63
100299|NCT01416142|243337|P2|STARTED|PureVision2 HD||0
100300|NCT01416142|243338|P1|STARTED|PureVision2 HD||0
100301|NCT01416142|243336|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
100302|NCT01416142|243337|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
100303|NCT01416142|243338|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
100304|NCT01416142|243336|P3|COMPLETED|Cross Over at Movie Intermission||0
100305|NCT01416142|243337|P2|COMPLETED|Cross Over at Movie Intermission||31
100306|NCT01416142|243338|P1|COMPLETED|Cross Over at Movie Intermission||32
100307|NCT01416142|243336|P3|STARTED|Cross Over at Movie Intermission||0
100308|NCT01416142|243337|P2|STARTED|Cross Over at Movie Intermission||31
100309|NCT01416142|243338|P1|STARTED|Cross Over at Movie Intermission||32
100310|NCT01416129|243349|P2|NOT COMPLETED|Experimental Condition: Brimless||0
100311|NCT01416129|243350|P1|NOT COMPLETED|Experimental Condition: Brimless||0
100312|NCT01416129|243349|P2|COMPLETED|Experimental Condition: Brimless||5
100313|NCT01416129|243350|P1|COMPLETED|Experimental Condition: Brimless||5
100314|NCT01416129|243349|P2|STARTED|Experimental Condition: Brimless||5
100315|NCT01416129|243350|P1|STARTED|Experimental Condition: Brimless||5
100316|NCT01416129|243349|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
100317|NCT01416129|243350|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
100318|NCT01416129|243349|P2|COMPLETED|Control Condition: Ischial Containment||5
100319|NCT01416129|243350|P1|COMPLETED|Control Condition: Ischial Containment||5
100320|NCT01416129|243349|P2|STARTED|Control Condition: Ischial Containment||5
100321|NCT01416129|243350|P1|STARTED|Control Condition: Ischial Containment||5
100322|NCT01416025|243358|P2|NOT COMPLETED|Overall Study||0
100323|NCT01416025|243359|P1|NOT COMPLETED|Overall Study||0
100324|NCT01416025|243358|P2|COMPLETED|Overall Study||15
100325|NCT01416025|243359|P1|COMPLETED|Overall Study||14
100326|NCT01416025|243358|P2|STARTED|Overall Study||15
100327|NCT01416025|243359|P1|STARTED|Overall Study||14
100328|NCT01415986|243365|P1|NOT COMPLETED|Overall Study||1
100329|NCT01415986|243365|P1|COMPLETED|Overall Study|Study terminated|0
100330|NCT01415986|243365|P1|STARTED|Overall Study||1
100331|NCT01415960|243370|P1|NOT COMPLETED|Overall Study||12
100332|NCT01415960|243370|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
100333|NCT01415960|243370|P1|PK Subgroup|Overall Study||30
100334|NCT01415960|243370|P1|ITT|Overall Study||161
100335|NCT01415960|243370|P1|STARTED|Overall Study||163
100336|NCT01415921|243382|P2|NOT COMPLETED|Overall Study||3
100337|NCT01415921|243383|P1|NOT COMPLETED|Overall Study||3
100338|NCT01415921|243382|P2|COMPLETED|Overall Study||14
100339|NCT01415921|243383|P1|COMPLETED|Overall Study||13
100340|NCT01415921|243382|P2|STARTED|Overall Study||17
100341|NCT01415921|243383|P1|STARTED|Overall Study||16
100342|NCT01415908|243393|P2|NOT COMPLETED|Overall Study||0
100343|NCT01415908|243394|P1|NOT COMPLETED|Overall Study||1
100344|NCT01415908|243393|P2|COMPLETED|Overall Study||4
100345|NCT01415908|243394|P1|COMPLETED|Overall Study||10
100346|NCT01415908|243393|P2|STARTED|Overall Study||4
100347|NCT01415908|243394|P1|STARTED|Overall Study||11
100348|NCT01415583|243422|P2|NOT COMPLETED|Overall Study||0
100349|NCT01415583|243423|P1|NOT COMPLETED|Overall Study||0
100350|NCT01415583|243422|P2|COMPLETED|Overall Study||157
100351|NCT01415583|243423|P1|COMPLETED|Overall Study||157
100352|NCT01415583|243422|P2|STARTED|Overall Study||157
100353|NCT01415583|243423|P1|STARTED|Overall Study||157
100354|NCT01415531|243431|P2|NOT COMPLETED|Overall Study||37
100355|NCT01415531|243432|P1|NOT COMPLETED|Overall Study||25
100356|NCT01415531|243431|P2|COMPLETED|Overall Study||390
100357|NCT01415531|243432|P1|COMPLETED|Overall Study||189
100358|NCT01415531|243431|P2|STARTED|Overall Study||427
100359|NCT01415531|243432|P1|STARTED|Overall Study||214
100360|NCT01415518|243442|P2|NOT COMPLETED|Overall Study||31
100361|NCT01415518|243443|P1|NOT COMPLETED|Overall Study||16
100362|NCT01415518|243442|P2|COMPLETED|Overall Study||261
100363|NCT01415518|243443|P1|COMPLETED|Overall Study||276
100364|NCT01415518|243442|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
100365|NCT01415518|243443|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
100366|NCT01415518|243442|P2|Patients Who Received Study Treatment|Overall Study||292
100367|NCT01415518|243443|P1|Patients Who Received Study Treatment|Overall Study||290
100368|NCT01415518|243442|P2|STARTED|Overall Study||292
100369|NCT01415518|243443|P1|STARTED|Overall Study||292
100370|NCT01415453|243495|P1|NOT COMPLETED|Overall Study||0
100371|NCT01415453|243495|P1|COMPLETED|Overall Study||1
100372|NCT01415453|243495|P1|Imaging Study|Overall Study||1
100373|NCT01415453|243495|P1|STARTED|Overall Study||1
100374|NCT01415427|243503|P4|NOT COMPLETED|Overall Study||56
100375|NCT01415427|243504|P3|NOT COMPLETED|Overall Study||58
100376|NCT01415427|243505|P2|NOT COMPLETED|Overall Study||29
100377|NCT01415427|243506|P1|NOT COMPLETED|Overall Study||29
100378|NCT01415427|243503|P4|COMPLETED|Overall Study||0
100379|NCT01415427|243504|P3|COMPLETED|Overall Study||1
100380|NCT01415427|243505|P2|COMPLETED|Overall Study||0
100381|NCT01415427|243506|P1|COMPLETED|Overall Study||0
100382|NCT01415427|243503|P4|STARTED|Overall Study||56
100383|NCT01415427|243504|P3|STARTED|Overall Study||59
100384|NCT01415427|243505|P2|STARTED|Overall Study||29
100385|NCT01415427|243506|P1|STARTED|Overall Study||29
100386|NCT01415401|243543|P1|NOT COMPLETED|Overall Study||7
100387|NCT01415401|243543|P1|COMPLETED|Overall Study||47
100388|NCT01415401|243543|P1|STARTED|Overall Study||54
100389|NCT01415349|243548|P2|NOT COMPLETED|Treatment Period 2||0
100390|NCT01415349|243549|P1|NOT COMPLETED|Treatment Period 2||0
100391|NCT01415349|243548|P2|COMPLETED|Treatment Period 2||19
100392|NCT01415349|243549|P1|COMPLETED|Treatment Period 2||21
100393|NCT01415349|243548|P2|STARTED|Treatment Period 2||19
100394|NCT01415349|243549|P1|STARTED|Treatment Period 2||21
100395|NCT01415349|243548|P2|NOT COMPLETED|Treatment Period 1||2
100396|NCT01415349|243549|P1|NOT COMPLETED|Treatment Period 1||0
100397|NCT01415349|243548|P2|COMPLETED|Treatment Period 1||19
100398|NCT01415349|243549|P1|COMPLETED|Treatment Period 1||21
100399|NCT01415349|243548|P2|STARTED|Treatment Period 1||21
100400|NCT01415349|243549|P1|STARTED|Treatment Period 1||21
100401|NCT01415232|243557|P1|NOT COMPLETED|Overall Study||0
100402|NCT01415232|243557|P1|COMPLETED|Overall Study||160
100403|NCT01415232|243557|P1|STARTED|Overall Study||160
100404|NCT01414855|243561|P1|NOT COMPLETED|Overall Study||29
100405|NCT01414855|243561|P1|COMPLETED|Overall Study||71
100406|NCT01414855|243561|P1|STARTED|Overall Study||100
100407|NCT01414634|243577|P8|NOT COMPLETED|Overall Study||0
100408|NCT01414634|243578|P7|NOT COMPLETED|Overall Study||0
100409|NCT01414634|243579|P6|NOT COMPLETED|Overall Study||0
100410|NCT01414634|243580|P5|NOT COMPLETED|Overall Study||0
100411|NCT01414634|243581|P4|NOT COMPLETED|Overall Study||0
100412|NCT01414634|243582|P3|NOT COMPLETED|Overall Study||0
100413|NCT01414634|243583|P2|NOT COMPLETED|Overall Study||0
100414|NCT01414634|243584|P1|NOT COMPLETED|Overall Study||0
100415|NCT01414634|243577|P8|COMPLETED|Overall Study||1
100416|NCT01414634|243578|P7|COMPLETED|Overall Study||1
100417|NCT01414634|243579|P6|COMPLETED|Overall Study||2
100418|NCT01414634|243580|P5|COMPLETED|Overall Study||1
100419|NCT01414634|243581|P4|COMPLETED|Overall Study||1
100420|NCT01414634|243582|P3|COMPLETED|Overall Study||1
100421|NCT01414634|243583|P2|COMPLETED|Overall Study||1
100422|NCT01414634|243584|P1|COMPLETED|Overall Study||1
100423|NCT01414634|243577|P8|STARTED|Overall Study||1
100424|NCT01414634|243578|P7|STARTED|Overall Study||1
100425|NCT01414634|243579|P6|STARTED|Overall Study||2
100426|NCT01414634|243580|P5|STARTED|Overall Study||1
100427|NCT01414634|243581|P4|STARTED|Overall Study||1
100428|NCT01414634|243582|P3|STARTED|Overall Study||1
100429|NCT01414634|243583|P2|STARTED|Overall Study||1
100430|NCT01414634|243584|P1|STARTED|Overall Study||1
100431|NCT01414413|243597|P2|NOT COMPLETED|Overall Study||0
100432|NCT01414413|243598|P1|NOT COMPLETED|Overall Study||0
100433|NCT01414413|243597|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
100434|NCT01414413|243598|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
100435|NCT01414413|243597|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
100436|NCT01414413|243598|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
100437|NCT01414244|243612|P2|NOT COMPLETED|Overall Study||0
100438|NCT01414244|243613|P1|NOT COMPLETED|Overall Study||0
100439|NCT01414244|243612|P2|COMPLETED|Overall Study||52
100440|NCT01414244|243613|P1|COMPLETED|Overall Study||54
100441|NCT01414244|243612|P2|STARTED|Overall Study||52
100442|NCT01414244|243613|P1|STARTED|Overall Study||54
100443|NCT01414205|243627|P2|NOT COMPLETED|Overall Study||7
100444|NCT01414205|243628|P1|NOT COMPLETED|Overall Study||7
100445|NCT01414205|243627|P2|COMPLETED|Overall Study||32
100446|NCT01414205|243628|P1|COMPLETED|Overall Study||34
100447|NCT01414205|243627|P2|Received Study Drug|Overall Study||38
100448|NCT01414205|243628|P1|Received Study Drug|Overall Study||40
100449|NCT01414205|243627|P2|STARTED|Overall Study||39
100450|NCT01414205|243628|P1|STARTED|Overall Study||41
100451|NCT01414192|243664|P4|NOT COMPLETED|Overall Study||0
100452|NCT01414192|243665|P3|NOT COMPLETED|Overall Study||0
100453|NCT01414192|243666|P2|NOT COMPLETED|Overall Study||0
100454|NCT01414192|243667|P1|NOT COMPLETED|Overall Study||0
100455|NCT01414192|243664|P4|COMPLETED|Overall Study||1726
100456|NCT01414192|243665|P3|COMPLETED|Overall Study||424
100457|NCT01414192|243666|P2|COMPLETED|Overall Study||575
100458|NCT01414192|243667|P1|COMPLETED|Overall Study||490
100459|NCT01414192|243664|P4|STARTED|Overall Study||1726
100460|NCT01414192|243665|P3|STARTED|Overall Study||424
100461|NCT01414192|243666|P2|STARTED|Overall Study||575
100462|NCT01414192|243667|P1|STARTED|Overall Study||490
100463|NCT01414166|243697|P2|NOT COMPLETED|Overall Study||83
100464|NCT01414166|243698|P1|NOT COMPLETED|Overall Study||91
100465|NCT01414166|243697|P2|COMPLETED|Overall Study||39
100466|NCT01414166|243698|P1|COMPLETED|Overall Study||31
100467|NCT01414166|243697|P2|Treated|Overall Study||121
100468|NCT01414166|243698|P1|Treated|Overall Study||120
100469|NCT01414166|243697|P2|STARTED|Overall Study||122
100470|NCT01414166|243698|P1|STARTED|Overall Study||122
100471|NCT01414153|243724|P4|NOT COMPLETED|Overall Study||4
100472|NCT01414153|243725|P3|NOT COMPLETED|Overall Study||4
100473|NCT01414153|243726|P2|NOT COMPLETED|Overall Study||2
100474|NCT01414153|243727|P1|NOT COMPLETED|Overall Study||8
100475|NCT01414153|243724|P4|COMPLETED|Overall Study||37
100476|NCT01414153|243725|P3|COMPLETED|Overall Study||35
100477|NCT01414153|243726|P2|COMPLETED|Overall Study||38
100478|NCT01414153|243727|P1|COMPLETED|Overall Study||30
100479|NCT01414153|243724|P4|STARTED|Overall Study||41
100480|NCT01414153|243725|P3|STARTED|Overall Study||39
100481|NCT01414153|243726|P2|STARTED|Overall Study||40
100482|NCT01414153|243727|P1|STARTED|Overall Study||38
100483|NCT01414114|243761|P1|NOT COMPLETED|Overall Study||5
100484|NCT01414114|243761|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
100485|NCT01414114|243761|P1|STARTED|Overall Study||37
100486|NCT01414036|243781|P2|NOT COMPLETED|Completed 3 Month Survey||5
100487|NCT01414036|243782|P1|NOT COMPLETED|Completed 3 Month Survey||9
100488|NCT01414036|243781|P2|COMPLETED|Completed 3 Month Survey||19
100489|NCT01414036|243782|P1|COMPLETED|Completed 3 Month Survey||14
100490|NCT01414036|243781|P2|STARTED|Completed 3 Month Survey||24
100491|NCT01414036|243782|P1|STARTED|Completed 3 Month Survey||23
100492|NCT01414036|243781|P2|NOT COMPLETED|Received Allocated Intervention||13
100493|NCT01414036|243782|P1|NOT COMPLETED|Received Allocated Intervention||0
100494|NCT01414036|243781|P2|COMPLETED|Received Allocated Intervention||11
100495|NCT01414036|243782|P1|COMPLETED|Received Allocated Intervention||23
100496|NCT01414036|243781|P2|STARTED|Received Allocated Intervention||24
100497|NCT01414036|243782|P1|STARTED|Received Allocated Intervention||23
100498|NCT01414010|243796|P4|NOT COMPLETED|Overall Study||0
100499|NCT01414010|243797|P3|NOT COMPLETED|Overall Study||0
100500|NCT01414010|243798|P2|NOT COMPLETED|Overall Study||0
100501|NCT01414010|243799|P1|NOT COMPLETED|Overall Study||2
100502|NCT01414010|243796|P4|COMPLETED|Overall Study||8
100503|NCT01414010|243797|P3|COMPLETED|Overall Study||8
100504|NCT01414010|243798|P2|COMPLETED|Overall Study||8
100505|NCT01414010|243799|P1|COMPLETED|Overall Study||6
100506|NCT01414010|243796|P4|STARTED|Overall Study||8
100507|NCT01414010|243797|P3|STARTED|Overall Study||8
100508|NCT01414010|243798|P2|STARTED|Overall Study||8
100509|NCT01414010|243799|P1|STARTED|Overall Study||8
100510|NCT01413958|243817|P2|NOT COMPLETED|Overall Study||1
100511|NCT01413958|243818|P1|NOT COMPLETED|Overall Study||0
100512|NCT01413958|243817|P2|COMPLETED|Overall Study||286
100513|NCT01413958|243818|P1|COMPLETED|Overall Study||288
100514|NCT01413958|243817|P2|STARTED|Overall Study||287
100515|NCT01413958|243818|P1|STARTED|Overall Study||288
100516|NCT01413750|243853|P4|NOT COMPLETED|Overall Study||0
100517|NCT01413750|243854|P3|NOT COMPLETED|Overall Study||0
100518|NCT01413750|243855|P2|NOT COMPLETED|Overall Study||0
100519|NCT01413750|243856|P1|NOT COMPLETED|Overall Study||0
100520|NCT01413750|243853|P4|COMPLETED|Overall Study||7
100521|NCT01413750|243854|P3|COMPLETED|Overall Study||4
100522|NCT01413750|243855|P2|COMPLETED|Overall Study||6
100523|NCT01413750|243856|P1|COMPLETED|Overall Study||6
100524|NCT01413750|243853|P4|STARTED|Overall Study||7
100525|NCT01413750|243854|P3|STARTED|Overall Study||4
100526|NCT01413750|243855|P2|STARTED|Overall Study||6
100527|NCT01413750|243856|P1|STARTED|Overall Study||6
100528|NCT01413542|243869|P4|NOT COMPLETED|Overall Study||1
100529|NCT01413542|243870|P3|NOT COMPLETED|Overall Study||3
100530|NCT01413542|243871|P2|NOT COMPLETED|Overall Study||0
100531|NCT01413542|243872|P1|NOT COMPLETED|Overall Study||1
100532|NCT01413542|243869|P4|COMPLETED|Overall Study||7
100533|NCT01413542|243870|P3|COMPLETED|Overall Study||6
100534|NCT01413542|243871|P2|COMPLETED|Overall Study||6
100535|NCT01413542|243872|P1|COMPLETED|Overall Study||5
100536|NCT01413542|243869|P4|STARTED|Overall Study||8
100537|NCT01413542|243870|P3|STARTED|Overall Study||9
100538|NCT01413542|243871|P2|STARTED|Overall Study||6
100539|NCT01413542|243872|P1|STARTED|Overall Study||6
100540|NCT01413516|243887|P2|NOT COMPLETED|Overall Study||0
100541|NCT01413516|243888|P1|NOT COMPLETED|Overall Study||0
100542|NCT01413516|243887|P2|COMPLETED|Overall Study||9
100543|NCT01413516|243888|P1|COMPLETED|Overall Study||8
100544|NCT01413516|243887|P2|STARTED|Overall Study||9
100545|NCT01413516|243888|P1|STARTED|Overall Study||8
100546|NCT01413360|243894|P1|NOT COMPLETED|Overall Study||3
100547|NCT01413360|243894|P1|COMPLETED|Overall Study||7
100548|NCT01413360|243894|P1|STARTED|Overall Study||10
100549|NCT01413204|243902|P3|NOT COMPLETED|Overall Study||19
100550|NCT01413204|243903|P2|NOT COMPLETED|Overall Study||6
100551|NCT01413204|243904|P1|NOT COMPLETED|Overall Study||6
100552|NCT01413204|243902|P3|COMPLETED|Overall Study||74
100553|NCT01413204|243903|P2|COMPLETED|Overall Study||83
100554|NCT01413204|243904|P1|COMPLETED|Overall Study||84
100555|NCT01413204|243902|P3|STARTED|Overall Study||93
100556|NCT01413204|243903|P2|STARTED|Overall Study||89
100557|NCT01413204|243904|P1|STARTED|Overall Study||90
100558|NCT01413191|243912|P1|NOT COMPLETED|Overall Study||11
100559|NCT01413191|243912|P1|COMPLETED|Overall Study||7
100560|NCT01413191|243912|P1|STARTED|Overall Study||18
100561|NCT01412983|243916|P2|NOT COMPLETED|2nd Period||0
100562|NCT01412983|243917|P1|NOT COMPLETED|2nd Period||0
100563|NCT01412983|243916|P2|COMPLETED|2nd Period||46
100564|NCT01412983|243917|P1|COMPLETED|2nd Period||50
100565|NCT01412983|243916|P2|STARTED|2nd Period||46
100566|NCT01412983|243917|P1|STARTED|2nd Period||50
100567|NCT01412983|243916|P2|NOT COMPLETED|1st Period||4
100568|NCT01412983|243917|P1|NOT COMPLETED|1st Period||0
100569|NCT01412983|243916|P2|COMPLETED|1st Period||46
100570|NCT01412983|243917|P1|COMPLETED|1st Period||50
100571|NCT01412983|243916|P2|STARTED|1st Period||50
100572|NCT01412983|243917|P1|STARTED|1st Period||50
100573|NCT01412957|243927|P2|NOT COMPLETED|Overall Study||157
100574|NCT01412957|243928|P1|NOT COMPLETED|Overall Study||149
100575|NCT01412957|243927|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
100576|NCT01412957|243928|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
100577|NCT01412957|243927|P2|STARTED|Overall Study||188
100578|NCT01412957|243928|P1|STARTED|Overall Study||189
100579|NCT01412944|243950|P6|NOT COMPLETED|Follow-up||0
100580|NCT01412944|243951|P5|NOT COMPLETED|Follow-up||0
100581|NCT01412944|243952|P4|NOT COMPLETED|Follow-up||0
100582|NCT01412944|243953|P3|NOT COMPLETED|Follow-up||0
100583|NCT01412944|243954|P2|NOT COMPLETED|Follow-up||0
100584|NCT01412944|243955|P1|NOT COMPLETED|Follow-up||0
100585|NCT01412944|243950|P6|COMPLETED|Follow-up||0
100586|NCT01412944|243951|P5|COMPLETED|Follow-up||2
100587|NCT01412944|243952|P4|COMPLETED|Follow-up||1
100588|NCT01412944|243953|P3|COMPLETED|Follow-up||2
100589|NCT01412944|243954|P2|COMPLETED|Follow-up||0
100590|NCT01412944|243955|P1|COMPLETED|Follow-up||0
100591|NCT01412944|243950|P6|STARTED|Follow-up||0
100592|NCT01412944|243951|P5|STARTED|Follow-up||2
100593|NCT01412944|243952|P4|STARTED|Follow-up||1
100594|NCT01412944|243953|P3|STARTED|Follow-up||2
100595|NCT01412944|243954|P2|STARTED|Follow-up||0
100596|NCT01412944|243955|P1|STARTED|Follow-up||0
100597|NCT01412944|243950|P6|NOT COMPLETED|Entire: IV + Maintenance||0
100598|NCT01412944|243951|P5|NOT COMPLETED|Entire: IV + Maintenance||0
100599|NCT01412944|243952|P4|NOT COMPLETED|Entire: IV + Maintenance||0
100600|NCT01412944|243953|P3|NOT COMPLETED|Entire: IV + Maintenance||0
100601|NCT01412944|243954|P2|NOT COMPLETED|Entire: IV + Maintenance||5
100602|NCT01412944|243955|P1|NOT COMPLETED|Entire: IV + Maintenance||2
100603|NCT01412944|243950|P6|COMPLETED|Entire: IV + Maintenance||0
100604|NCT01412944|243951|P5|COMPLETED|Entire: IV + Maintenance||0
100605|NCT01412944|243952|P4|COMPLETED|Entire: IV + Maintenance||0
100606|NCT01412944|243953|P3|COMPLETED|Entire: IV + Maintenance||0
100607|NCT01412944|243954|P2|COMPLETED|Entire: IV + Maintenance||17
100608|NCT01412944|243955|P1|COMPLETED|Entire: IV + Maintenance||19
100609|NCT01412944|243950|P6|STARTED|Entire: IV + Maintenance||0
100610|NCT01412944|243951|P5|STARTED|Entire: IV + Maintenance||0
100611|NCT01412944|243952|P4|STARTED|Entire: IV + Maintenance||0
100612|NCT01412944|243953|P3|STARTED|Entire: IV + Maintenance||0
100613|NCT01412944|243954|P2|STARTED|Entire: IV + Maintenance||22
100614|NCT01412944|243955|P1|STARTED|Entire: IV + Maintenance||21
100615|NCT01412944|243950|P6|NOT COMPLETED|Entire: IV + Maintenance||2
100616|NCT01412944|243951|P5|NOT COMPLETED|Entire: IV + Maintenance||3
100617|NCT01412944|243952|P4|NOT COMPLETED|Entire: IV + Maintenance||1
100618|NCT01412944|243953|P3|NOT COMPLETED|Entire: IV + Maintenance||1
100619|NCT01412944|243954|P2|NOT COMPLETED|Entire: IV + Maintenance||0
100620|NCT01412944|243955|P1|NOT COMPLETED|Entire: IV + Maintenance||0
100621|NCT01412944|243950|P6|COMPLETED|Entire: IV + Maintenance||6
100622|NCT01412944|243951|P5|COMPLETED|Entire: IV + Maintenance||11
100623|NCT01412944|243952|P4|COMPLETED|Entire: IV + Maintenance||5
100624|NCT01412944|243953|P3|COMPLETED|Entire: IV + Maintenance||14
100625|NCT01412944|243954|P2|COMPLETED|Entire: IV + Maintenance||0
100626|NCT01412944|243955|P1|COMPLETED|Entire: IV + Maintenance||0
100627|NCT01412944|243950|P6|STARTED|Entire: IV + Maintenance||8
100628|NCT01412944|243951|P5|STARTED|Entire: IV + Maintenance||14
100629|NCT01412944|243952|P4|STARTED|Entire: IV + Maintenance||6
100630|NCT01412944|243953|P3|STARTED|Entire: IV + Maintenance||15
100631|NCT01412944|243954|P2|STARTED|Entire: IV + Maintenance||0
100632|NCT01412944|243955|P1|STARTED|Entire: IV + Maintenance||0
100633|NCT01412944|243950|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
100634|NCT01412944|243951|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
100635|NCT01412944|243952|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
100636|NCT01412944|243953|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
100637|NCT01412944|243954|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
100638|NCT01412944|243955|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
100639|NCT01412944|243950|P6|COMPLETED|IV: Per CAIN457A2307||0
100640|NCT01412944|243951|P5|COMPLETED|IV: Per CAIN457A2307||0
100641|NCT01412944|243952|P4|COMPLETED|IV: Per CAIN457A2307||0
100642|NCT01412944|243953|P3|COMPLETED|IV: Per CAIN457A2307||0
100643|NCT01412944|243954|P2|COMPLETED|IV: Per CAIN457A2307||20
100644|NCT01412944|243955|P1|COMPLETED|IV: Per CAIN457A2307||20
100645|NCT01412944|243950|P6|STARTED|IV: Per CAIN457A2307||0
100646|NCT01412944|243951|P5|STARTED|IV: Per CAIN457A2307||0
100647|NCT01412944|243952|P4|STARTED|IV: Per CAIN457A2307||0
100648|NCT01412944|243953|P3|STARTED|IV: Per CAIN457A2307||0
100649|NCT01412944|243954|P2|STARTED|IV: Per CAIN457A2307||22
100650|NCT01412944|243955|P1|STARTED|IV: Per CAIN457A2307||21
100651|NCT01412944|243950|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
100652|NCT01412944|243951|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
100653|NCT01412944|243952|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
100654|NCT01412944|243953|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
100655|NCT01412944|243954|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
100656|NCT01412944|243955|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
100657|NCT01412944|243950|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
100658|NCT01412944|243951|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
100659|NCT01412944|243952|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
100660|NCT01412944|243953|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
100661|NCT01412944|243954|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
100662|NCT01412944|243955|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
100663|NCT01412944|243950|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
100664|NCT01412944|243951|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
100665|NCT01412944|243952|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
100666|NCT01412944|243953|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
100667|NCT01412944|243954|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
100668|NCT01412944|243955|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
100669|NCT01412918|243991|P2|NOT COMPLETED|Overall Study||0
100670|NCT01412918|243992|P1|NOT COMPLETED|Overall Study||0
100671|NCT01412918|243991|P2|COMPLETED|Overall Study||1
100672|NCT01412918|243992|P1|COMPLETED|Overall Study||20
100673|NCT01412918|243991|P2|STARTED|Overall Study||1
100674|NCT01412918|243992|P1|STARTED|Overall Study||20
100675|NCT01412879|244001|P3|NOT COMPLETED|Consolidation Therapy||0
100676|NCT01412879|244002|P2|NOT COMPLETED|Consolidation Therapy||0
100677|NCT01412879|244003|P1|NOT COMPLETED|Consolidation Therapy||0
100678|NCT01412879|244001|P3|COMPLETED|Consolidation Therapy||26
100679|NCT01412879|244002|P2|COMPLETED|Consolidation Therapy||0
100680|NCT01412879|244003|P1|COMPLETED|Consolidation Therapy||0
100681|NCT01412879|244001|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
100682|NCT01412879|244002|P2|STARTED|Consolidation Therapy||0
100683|NCT01412879|244003|P1|STARTED|Consolidation Therapy||0
100684|NCT01412879|244001|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
100685|NCT01412879|244002|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
100686|NCT01412879|244003|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
100687|NCT01412879|244001|P3|COMPLETED|Initial Registration (Induction Therapy)||0
100688|NCT01412879|244002|P2|COMPLETED|Initial Registration (Induction Therapy)||27
100689|NCT01412879|244003|P1|COMPLETED|Initial Registration (Induction Therapy)||5
100690|NCT01412879|244001|P3|Treatment Started|Initial Registration (Induction Therapy)||0
100691|NCT01412879|244002|P2|Treatment Started|Initial Registration (Induction Therapy)||35
100692|NCT01412879|244003|P1|Treatment Started|Initial Registration (Induction Therapy)||17
100693|NCT01412879|244001|P3|STARTED|Initial Registration (Induction Therapy)||0
100694|NCT01412879|244002|P2|STARTED|Initial Registration (Induction Therapy)||35
100695|NCT01412879|244003|P1|STARTED|Initial Registration (Induction Therapy)||18
100696|NCT01412801|244023|P6|NOT COMPLETED|Overall Study||3
100697|NCT01412801|244024|P5|NOT COMPLETED|Overall Study||3
100698|NCT01412801|244025|P4|NOT COMPLETED|Overall Study||4
100699|NCT01412801|244026|P3|NOT COMPLETED|Overall Study||7
100700|NCT01412801|244027|P2|NOT COMPLETED|Overall Study||5
100701|NCT01412801|244028|P1|NOT COMPLETED|Overall Study||4
100702|NCT01412801|244023|P6|COMPLETED|Overall Study||84
100703|NCT01412801|244024|P5|COMPLETED|Overall Study||85
100704|NCT01412801|244025|P4|COMPLETED|Overall Study||87
100705|NCT01412801|244026|P3|COMPLETED|Overall Study||83
100706|NCT01412801|244027|P2|COMPLETED|Overall Study||84
100707|NCT01412801|244028|P1|COMPLETED|Overall Study||87
100708|NCT01412801|244023|P6|STARTED|Overall Study||87
100709|NCT01412801|244024|P5|STARTED|Overall Study||88
100710|NCT01412801|244025|P4|STARTED|Overall Study||91
100711|NCT01412801|244026|P3|STARTED|Overall Study||90
100712|NCT01412801|244027|P2|STARTED|Overall Study||89
100713|NCT01412801|244028|P1|STARTED|Overall Study||91
100714|NCT01412710|244067|P2|NOT COMPLETED|Overall Study||5
100715|NCT01412710|244068|P1|NOT COMPLETED|Overall Study||4
100716|NCT01412710|244067|P2|COMPLETED|Overall Study||22
100717|NCT01412710|244068|P1|COMPLETED|Overall Study||46
100718|NCT01412710|244067|P2|STARTED|Overall Study||27
100719|NCT01412710|244068|P1|STARTED|Overall Study||50
100720|NCT01412541|244078|P2|NOT COMPLETED|Overall Study||20
100721|NCT01412541|244079|P1|NOT COMPLETED|Overall Study||36
100722|NCT01412541|244078|P2|COMPLETED|Overall Study||140
100723|NCT01412541|244079|P1|COMPLETED|Overall Study||280
100724|NCT01412541|244078|P2|STARTED|Overall Study||160
100725|NCT01412541|244079|P1|STARTED|Overall Study||316
100726|NCT01412424|244187|P1|NOT COMPLETED|Extension Treatment Period||6
100727|NCT01412424|244187|P1|COMPLETED|Extension Treatment Period||82
100728|NCT01412424|244187|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
100729|NCT01412424|244187|P1|NOT COMPLETED|Core Treatment Period||53
100730|NCT01412424|244187|P1|COMPLETED|Core Treatment Period||102
100731|NCT01412424|244187|P1|STARTED|Core Treatment Period||155
100732|NCT01412333|244205|P2|NOT COMPLETED|Overall Study||57
100733|NCT01412333|244206|P1|NOT COMPLETED|Overall Study||98
100734|NCT01412333|244205|P2|COMPLETED|Overall Study||360
100735|NCT01412333|244206|P1|COMPLETED|Overall Study||320
100736|NCT01412333|244205|P2|STARTED|Overall Study||417
100737|NCT01412333|244206|P1|STARTED|Overall Study||418
100738|NCT01412281|244241|P4|NOT COMPLETED|Overall Study||0
100739|NCT01412281|244242|P3|NOT COMPLETED|Overall Study||0
100740|NCT01412281|244243|P2|NOT COMPLETED|Overall Study||0
100741|NCT01412281|244244|P1|NOT COMPLETED|Overall Study||0
100742|NCT01412281|244241|P4|COMPLETED|Overall Study||110
100743|NCT01412281|244242|P3|COMPLETED|Overall Study||110
100744|NCT01412281|244243|P2|COMPLETED|Overall Study||110
100745|NCT01412281|244244|P1|COMPLETED|Overall Study||110
100746|NCT01412281|244241|P4|STARTED|Overall Study||110
100747|NCT01412281|244242|P3|STARTED|Overall Study||110
100748|NCT01412281|244243|P2|STARTED|Overall Study||110
100749|NCT01412281|244244|P1|STARTED|Overall Study||110
100750|NCT01412229|244266|P1|NOT COMPLETED|Overall Study||1
100751|NCT01412229|244266|P1|COMPLETED|Overall Study||38
100752|NCT01412229|244266|P1|STARTED|Overall Study||39
100753|NCT01412164|244278|P1|NOT COMPLETED|Overall Study||18
100754|NCT01412164|244278|P1|COMPLETED|Overall Study||712
100755|NCT01412164|244278|P1|STARTED|Overall Study||730
100756|NCT01412151|244282|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
100757|NCT01412151|244282|P1|COMPLETED|Week 306 - 310 - Washout Period||3
100758|NCT01412151|244282|P1|STARTED|Week 306 - 310 - Washout Period||5
100759|NCT01412151|244282|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
100760|NCT01412151|244282|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
100761|NCT01412151|244282|P1|STARTED|Week 0 - 306 - Treatment Period||10
100762|NCT01412086|244288|P1|NOT COMPLETED|Overall Study||0
100763|NCT01412086|244288|P1|COMPLETED|Overall Study||112
100764|NCT01412086|244288|P1|STARTED|Overall Study||112
100765|NCT01411995|244295|P2|NOT COMPLETED|Overall Study||1
100766|NCT01411995|244296|P1|NOT COMPLETED|Overall Study||0
100767|NCT01411995|244295|P2|COMPLETED|Overall Study||99
100768|NCT01411995|244296|P1|COMPLETED|Overall Study||100
100769|NCT01411995|244295|P2|STARTED|Overall Study||100
100770|NCT01411995|244296|P1|STARTED|Overall Study||100
100771|NCT01411891|244304|P2|NOT COMPLETED|Overall Study||2
100772|NCT01411891|244305|P1|NOT COMPLETED|Overall Study||3
100773|NCT01411891|244304|P2|COMPLETED|Overall Study||48
100774|NCT01411891|244305|P1|COMPLETED|Overall Study||47
100775|NCT01411891|244304|P2|STARTED|Overall Study||50
100776|NCT01411891|244305|P1|STARTED|Overall Study||50
100777|NCT01411852|244313|P2|NOT COMPLETED|Hospital Intervention Phase||18
100778|NCT01411852|244314|P1|NOT COMPLETED|Hospital Intervention Phase||24
100779|NCT01411852|244313|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
100866|NCT01410604|244536|P2|STARTED|Overall Study||16
100780|NCT01411852|244314|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
100781|NCT01411852|244313|P2|STARTED|Hospital Intervention Phase||89
100782|NCT01411852|244314|P1|STARTED|Hospital Intervention Phase||83
100783|NCT01411852|244313|P2|NOT COMPLETED|Prehospital Intervention Phase||7
100784|NCT01411852|244314|P1|NOT COMPLETED|Prehospital Intervention Phase||12
100785|NCT01411852|244313|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
100786|NCT01411852|244314|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
100787|NCT01411852|244313|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
100788|NCT01411852|244314|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
100789|NCT01411839|244359|P2|NOT COMPLETED|Overall Study||3
100790|NCT01411839|244360|P1|NOT COMPLETED|Overall Study||4
100791|NCT01411839|244359|P2|COMPLETED|Overall Study||17
100792|NCT01411839|244360|P1|COMPLETED|Overall Study||16
100793|NCT01411839|244359|P2|STARTED|Overall Study||20
100794|NCT01411839|244360|P1|STARTED|Overall Study||20
100795|NCT01411774|244372|P2|NOT COMPLETED|Overall Study||3
100796|NCT01411774|244373|P1|NOT COMPLETED|Overall Study||0
100797|NCT01411774|244372|P2|COMPLETED|Overall Study||67
100798|NCT01411774|244373|P1|COMPLETED|Overall Study||72
100799|NCT01411774|244372|P2|STARTED|Overall Study||70
100800|NCT01411774|244373|P1|STARTED|Overall Study||72
100801|NCT01411696|244381|P1|NOT COMPLETED|Overall Study||0
100802|NCT01411696|244381|P1|COMPLETED|Overall Study||289
100803|NCT01411696|244381|P1|STARTED|Overall Study||289
100804|NCT01411592|244390|P2|NOT COMPLETED|Overall Study||0
100805|NCT01411592|244391|P1|NOT COMPLETED|Overall Study||0
100806|NCT01411592|244390|P2|COMPLETED|Overall Study||16
100807|NCT01411592|244391|P1|COMPLETED|Overall Study||14
100808|NCT01411592|244390|P2|5-Year Time Frame|Overall Study||16
100809|NCT01411592|244391|P1|5-Year Time Frame|Overall Study||14
100810|NCT01411592|244390|P2|STARTED|Overall Study||16
100811|NCT01411592|244391|P1|STARTED|Overall Study||14
100812|NCT01411501|244403|P4|NOT COMPLETED|Overall Study||7
100813|NCT01411501|244404|P3|NOT COMPLETED|Overall Study||6
100814|NCT01411501|244405|P2|NOT COMPLETED|Overall Study||6
100815|NCT01411501|244406|P1|NOT COMPLETED|Overall Study||10
100816|NCT01411501|244403|P4|COMPLETED|Overall Study||163
100817|NCT01411501|244404|P3|COMPLETED|Overall Study||159
100818|NCT01411501|244405|P2|COMPLETED|Overall Study||166
100819|NCT01411501|244406|P1|COMPLETED|Overall Study||158
100820|NCT01411501|244403|P4|STARTED|Overall Study||170
100821|NCT01411501|244404|P3|STARTED|Overall Study||165
100822|NCT01411501|244405|P2|STARTED|Overall Study||172
100823|NCT01411501|244406|P1|STARTED|Overall Study||168
100824|NCT01411488|244438|P2|NOT COMPLETED|Overall Study||5
100825|NCT01411488|244439|P1|NOT COMPLETED|Overall Study||6
100826|NCT01411488|244438|P2|COMPLETED|Overall Study||38
100827|NCT01411488|244439|P1|COMPLETED|Overall Study||41
100828|NCT01411488|244438|P2|STARTED|Overall Study||43
100829|NCT01411488|244439|P1|STARTED|Overall Study||47
100830|NCT01411228|244448|P3|NOT COMPLETED|Overall Study||1
100831|NCT01411228|244449|P2|NOT COMPLETED|Overall Study||0
100832|NCT01411228|244450|P1|NOT COMPLETED|Overall Study||1
100833|NCT01411228|244448|P3|COMPLETED|Overall Study||4
100834|NCT01411228|244449|P2|COMPLETED|Overall Study||5
100835|NCT01411228|244450|P1|COMPLETED|Overall Study||4
100836|NCT01411228|244448|P3|STARTED|Overall Study||5
100837|NCT01411228|244449|P2|STARTED|Overall Study||5
100838|NCT01411228|244450|P1|STARTED|Overall Study||5
100839|NCT01411215|244472|P2|NOT COMPLETED|Overall Study||84
100840|NCT01411215|244473|P1|NOT COMPLETED|Overall Study||66
100841|NCT01411215|244472|P2|COMPLETED|Overall Study||7
100842|NCT01411215|244473|P1|COMPLETED|Overall Study||3
100843|NCT01411215|244472|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
100844|NCT01411215|244473|P1|Treated|Overall Study||69
100845|NCT01411215|244472|P2|STARTED|Overall Study||91
100846|NCT01411215|244473|P1|STARTED|Overall Study||69
100847|NCT01411137|244506|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
100848|NCT01411137|244506|P1|COMPLETED|Part 3: Open-Label Extension||12
100849|NCT01411137|244506|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
100850|NCT01411137|244506|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
100851|NCT01411137|244506|P1|COMPLETED|Part 2: Open-Label Extension||25
100852|NCT01411137|244506|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
100853|NCT01411137|244506|P1|NOT COMPLETED|Part 1: Dose Conversion||10
100854|NCT01411137|244506|P1|COMPLETED|Part 1: Dose Conversion||33
100855|NCT01411137|244506|P1|STARTED|Part 1: Dose Conversion||43
100856|NCT01411085|244525|P1|NOT COMPLETED|Overall Study||3
100857|NCT01411085|244525|P1|COMPLETED|Overall Study||7
100858|NCT01411085|244525|P1|STARTED|Overall Study||10
100859|NCT01410773|244529|P1|NOT COMPLETED|Overall Study||0
100860|NCT01410773|244529|P1|COMPLETED|Overall Study||110
100861|NCT01410773|244529|P1|STARTED|Overall Study||110
100862|NCT01410604|244536|P2|NOT COMPLETED|Overall Study||2
100863|NCT01410604|244537|P1|NOT COMPLETED|Overall Study||3
100864|NCT01410604|244536|P2|COMPLETED|Overall Study||14
100865|NCT01410604|244537|P1|COMPLETED|Overall Study||12
100867|NCT01410604|244537|P1|STARTED|Overall Study||15
100868|NCT01410565|244559|P3|NOT COMPLETED|Double Blind Phase||0
100869|NCT01410565|244560|P2|NOT COMPLETED|Double Blind Phase||15
100870|NCT01410565|244561|P1|NOT COMPLETED|Double Blind Phase||13
100871|NCT01410565|244559|P3|COMPLETED|Double Blind Phase||0
100872|NCT01410565|244560|P2|COMPLETED|Double Blind Phase||0
100873|NCT01410565|244561|P1|COMPLETED|Double Blind Phase||0
100874|NCT01410565|244559|P3|STARTED|Double Blind Phase||0
100875|NCT01410565|244560|P2|STARTED|Double Blind Phase||15
100876|NCT01410565|244561|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
100877|NCT01410565|244559|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
100878|NCT01410565|244560|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
100879|NCT01410565|244561|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
100880|NCT01410565|244559|P3|COMPLETED|Open Label Phase Apaziquone||58
100881|NCT01410565|244560|P2|COMPLETED|Open Label Phase Apaziquone||0
100882|NCT01410565|244561|P1|COMPLETED|Open Label Phase Apaziquone||0
100883|NCT01410565|244559|P3|STARTED|Open Label Phase Apaziquone||66
100884|NCT01410565|244560|P2|STARTED|Open Label Phase Apaziquone||0
100885|NCT01410565|244561|P1|STARTED|Open Label Phase Apaziquone||0
100886|NCT01410552|244571|P1|NOT COMPLETED|Overall Study||136
100887|NCT01410552|244571|P1|COMPLETED|Overall Study||877
100888|NCT01410552|244571|P1|STARTED|Overall Study||1013
100889|NCT01410474|244578|P2|NOT COMPLETED|Overall Study||1
100890|NCT01410474|244579|P1|NOT COMPLETED|Overall Study||0
100891|NCT01410474|244578|P2|COMPLETED|Overall Study||167
100892|NCT01410474|244579|P1|COMPLETED|Overall Study||173
100893|NCT01410474|244578|P2|STARTED|Overall Study||168
100894|NCT01410474|244579|P1|STARTED|Overall Study||173
100895|NCT01410448|244602|P2|NOT COMPLETED|Overall Study||35
100896|NCT01410448|244603|P1|NOT COMPLETED|Overall Study||12
100897|NCT01410448|244602|P2|COMPLETED|Overall Study||155
100898|NCT01410448|244603|P1|COMPLETED|Overall Study||181
100899|NCT01410448|244602|P2|Modified ITT Analysis Set|Overall Study||149
100900|NCT01410448|244603|P1|Modified ITT Analysis Set|Overall Study||161
100901|NCT01410448|244602|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
100902|NCT01410448|244603|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
100903|NCT01410448|244602|P2|STARTED|Overall Study||190
100904|NCT01410448|244603|P1|STARTED|Overall Study||193
100905|NCT01410409|244643|P2|NOT COMPLETED|Overall Study||4
100906|NCT01410409|244644|P1|NOT COMPLETED|Overall Study||1
100907|NCT01410409|244643|P2|COMPLETED|Overall Study||46
100908|NCT01410409|244644|P1|COMPLETED|Overall Study||49
100909|NCT01410409|244643|P2|STARTED|Overall Study||50
100910|NCT01410409|244644|P1|STARTED|Overall Study||50
100911|NCT01410357|244668|P2|NOT COMPLETED|Overall Study||24
100912|NCT01410357|244669|P1|NOT COMPLETED|Overall Study||26
100913|NCT01410357|244668|P2|COMPLETED|Overall Study||76
100914|NCT01410357|244669|P1|COMPLETED|Overall Study||74
100915|NCT01410357|244668|P2|STARTED|Overall Study||100
100916|NCT01410357|244669|P1|STARTED|Overall Study||100
100917|NCT01410344|244723|P1|NOT COMPLETED|Overall Study||3
100918|NCT01410344|244723|P1|COMPLETED|Overall Study||17
100919|NCT01410344|244723|P1|STARTED|Overall Study||20
100920|NCT01410240|244730|P3|NOT COMPLETED|Overall Study||2
100921|NCT01410240|244731|P2|NOT COMPLETED|Overall Study||1
100922|NCT01410240|244732|P1|NOT COMPLETED|Overall Study||1
100923|NCT01410240|244730|P3|COMPLETED|Overall Study||10
100924|NCT01410240|244731|P2|COMPLETED|Overall Study||52
100925|NCT01410240|244732|P1|COMPLETED|Overall Study||52
100926|NCT01410240|244730|P3|STARTED|Overall Study||12
100927|NCT01410240|244731|P2|STARTED|Overall Study||53
100928|NCT01410240|244732|P1|STARTED|Overall Study||53
100929|NCT01410227|244803|P4|NOT COMPLETED|Overall Study||1
100930|NCT01410227|244804|P3|NOT COMPLETED|Overall Study||2
100931|NCT01410227|244805|P2|NOT COMPLETED|Overall Study||0
100932|NCT01410227|244806|P1|NOT COMPLETED|Overall Study||4
100933|NCT01410227|244803|P4|COMPLETED|Overall Study||5
100934|NCT01410227|244804|P3|COMPLETED|Overall Study||13
100935|NCT01410227|244805|P2|COMPLETED|Overall Study||8
100936|NCT01410227|244806|P1|COMPLETED|Overall Study||4
100937|NCT01410227|244803|P4|STARTED|Overall Study||6
100938|NCT01410227|244804|P3|STARTED|Overall Study||15
100939|NCT01410227|244805|P2|STARTED|Overall Study||8
100940|NCT01410227|244806|P1|STARTED|Overall Study||8
100941|NCT01410110|244878|P2|NOT COMPLETED|Overall Study||2
100942|NCT01410110|244879|P1|NOT COMPLETED|Overall Study||4
100943|NCT01410110|244878|P2|COMPLETED|Overall Study||22
100944|NCT01410110|244879|P1|COMPLETED|Overall Study||20
100945|NCT01410110|244878|P2|6 Month Follow-up|Overall Study||22
100946|NCT01410110|244879|P1|6 Month Follow-up|Overall Study||20
100947|NCT01410110|244878|P2|3 Months (End of Intervention)|Overall Study||22
100948|NCT01410110|244879|P1|3 Months (End of Intervention)|Overall Study||20
100949|NCT01410110|244878|P2|Randomization|Overall Study||24
100950|NCT01410110|244879|P1|Randomization|Overall Study||24
100951|NCT01410110|244878|P2|STARTED|Overall Study||24
100952|NCT01410110|244879|P1|STARTED|Overall Study||24
100953|NCT01410097|244903|P2|NOT COMPLETED|Overall Study||3
100954|NCT01410097|244904|P1|NOT COMPLETED|Overall Study||5
100955|NCT01410097|244903|P2|COMPLETED|Overall Study||530
100956|NCT01410097|244904|P1|COMPLETED|Overall Study||551
100957|NCT01410097|244903|P2|STARTED|Overall Study||533
100958|NCT01410097|244904|P1|STARTED|Overall Study||556
100959|NCT01409993|244928|P4|NOT COMPLETED|Overall Study||5
100960|NCT01409993|244929|P3|NOT COMPLETED|Overall Study||3
100961|NCT01409993|244930|P2|NOT COMPLETED|Overall Study||5
100962|NCT01409993|244931|P1|NOT COMPLETED|Overall Study||4
100963|NCT01409993|244928|P4|COMPLETED|Overall Study||8
100964|NCT01409993|244929|P3|COMPLETED|Overall Study||11
100965|NCT01409993|244930|P2|COMPLETED|Overall Study||21
100966|NCT01409993|244931|P1|COMPLETED|Overall Study||21
100967|NCT01409993|244928|P4|STARTED|Overall Study||13
100968|NCT01409993|244929|P3|STARTED|Overall Study||14
100969|NCT01409993|244930|P2|STARTED|Overall Study||26
100970|NCT01409993|244931|P1|STARTED|Overall Study||25
100971|NCT01409837|244951|P2|NOT COMPLETED|Overall Study||2
100972|NCT01409837|244952|P1|NOT COMPLETED|Overall Study||3
100973|NCT01409837|244951|P2|COMPLETED|Overall Study||14
100974|NCT01409837|244952|P1|COMPLETED|Overall Study||14
100975|NCT01409837|244951|P2|282nd Week|Overall Study||14
100976|NCT01409837|244952|P1|282nd Week|Overall Study||14
100977|NCT01409837|244951|P2|186th Week|Overall Study||14
100978|NCT01409837|244952|P1|186th Week|Overall Study|Moved away to another location|14
100979|NCT01409837|244951|P2|138th Week|Overall Study||14
100980|NCT01409837|244952|P1|138th Week|Overall Study||15
100981|NCT01409837|244951|P2|114th Week|Overall Study||14
100982|NCT01409837|244952|P1|114th Week|Overall Study||15
100983|NCT01409837|244951|P2|102nd Week|Overall Study|Married another wife|14
100984|NCT01409837|244952|P1|102nd Week|Overall Study||15
100985|NCT01409837|244951|P2|96th Week|Overall Study||15
100986|NCT01409837|244952|P1|96th Week|Overall Study||15
100987|NCT01409837|244951|P2|48th Week|Overall Study||15
100988|NCT01409837|244952|P1|48th Week|Overall Study|Lost to follow-up|15
100989|NCT01409837|244951|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
100990|NCT01409837|244952|P1|24th Week|Overall Study||16
100991|NCT01409837|244951|P2|12th Week|Overall Study||16
100992|NCT01409837|244952|P1|12th Week|Overall Study|Moved away to another location|16
100993|NCT01409837|244951|P2|6th Week|Overall Study||16
100994|NCT01409837|244952|P1|6th Week|Overall Study||17
100995|NCT01409837|244951|P2|STARTED|Overall Study||16
100996|NCT01409837|244952|P1|STARTED|Overall Study||17
100997|NCT01409707|244977|P3|NOT COMPLETED|Overall Study||16
100998|NCT01409707|244978|P2|NOT COMPLETED|Overall Study||17
100999|NCT01409707|244979|P1|NOT COMPLETED|Overall Study||5
101000|NCT01409707|244977|P3|COMPLETED|Overall Study||24
101001|NCT01409707|244978|P2|COMPLETED|Overall Study||28
101002|NCT01409707|244979|P1|COMPLETED|Overall Study||36
101003|NCT01409707|244977|P3|STARTED|Overall Study||40
101004|NCT01409707|244978|P2|STARTED|Overall Study||45
101005|NCT01409707|244979|P1|STARTED|Overall Study||41
101006|NCT01409564|244991|P2|NOT COMPLETED|Overall Study||5
101007|NCT01409564|244992|P1|NOT COMPLETED|Overall Study||5
101008|NCT01409564|244991|P2|COMPLETED|Overall Study||18
101009|NCT01409564|244992|P1|COMPLETED|Overall Study||18
101010|NCT01409564|244991|P2|STARTED|Overall Study||23
101011|NCT01409564|244992|P1|STARTED|Overall Study||23
101012|NCT01409434|245010|P1|NOT COMPLETED|Overall Study||4
101013|NCT01409434|245010|P1|COMPLETED|Overall Study||40
101014|NCT01409434|245010|P1|STARTED|Overall Study||44
101015|NCT01409382|245020|P2|NOT COMPLETED|Overall Study||80
101016|NCT01409382|245021|P1|NOT COMPLETED|Overall Study||81
101017|NCT01409382|245020|P2|COMPLETED|Overall Study||160
101018|NCT01409382|245021|P1|COMPLETED|Overall Study||159
101019|NCT01409382|245020|P2|STARTED|Overall Study||240
101020|NCT01409382|245021|P1|STARTED|Overall Study||240
101021|NCT01409291|245035|P2|NOT COMPLETED|Overall Study||9
101022|NCT01409291|245036|P1|NOT COMPLETED|Overall Study||7
101023|NCT01409291|245035|P2|COMPLETED|Overall Study||19
101024|NCT01409291|245036|P1|COMPLETED|Overall Study||29
101025|NCT01409291|245035|P2|STARTED|Overall Study||28
101026|NCT01409291|245036|P1|STARTED|Overall Study||36
101027|NCT01409239|245046|P2|NOT COMPLETED|Overall Study||0
101028|NCT01409239|245047|P1|NOT COMPLETED|Overall Study||0
101029|NCT01409239|245046|P2|COMPLETED|Overall Study||17
101030|NCT01409239|245047|P1|COMPLETED|Overall Study||16
101031|NCT01409239|245046|P2|STARTED|Overall Study||17
101032|NCT01409239|245047|P1|STARTED|Overall Study||16
101033|NCT01409213|245053|P1|NOT COMPLETED|Overall Study||0
101034|NCT01409213|245053|P1|COMPLETED|Overall Study||1523
101035|NCT01409213|245053|P1|STARTED|Overall Study||1523
101036|NCT01409096|245060|P2|NOT COMPLETED|Overall Study||5
101037|NCT01409096|245061|P1|NOT COMPLETED|Overall Study||2
101038|NCT01409096|245060|P2|COMPLETED|Overall Study||35
101039|NCT01409096|245061|P1|COMPLETED|Overall Study||38
101040|NCT01409096|245060|P2|STARTED|Overall Study||40
101041|NCT01409096|245061|P1|STARTED|Overall Study||40
101042|NCT01408992|245073|P1|NOT COMPLETED|Overall Study||0
101043|NCT01408992|245073|P1|COMPLETED|Overall Study||558
101044|NCT01408992|245073|P1|STARTED|Overall Study||558
101045|NCT01408914|245088|P3|NOT COMPLETED|Overall Study||13
101046|NCT01408914|245089|P2|NOT COMPLETED|Overall Study||12
101047|NCT01408914|245090|P1|NOT COMPLETED|Overall Study||12
101048|NCT01408914|245088|P3|COMPLETED|Overall Study||47
101049|NCT01408914|245089|P2|COMPLETED|Overall Study||48
101050|NCT01408914|245090|P1|COMPLETED|Overall Study||48
101051|NCT01408914|245088|P3|STARTED|Overall Study||60
101052|NCT01408914|245089|P2|STARTED|Overall Study||60
101053|NCT01408914|245090|P1|STARTED|Overall Study||60
101054|NCT01408888|245104|P2|NOT COMPLETED|Second Intervention||0
101055|NCT01408888|245105|P1|NOT COMPLETED|Second Intervention||2
101056|NCT01408888|245104|P2|COMPLETED|Second Intervention||8
101057|NCT01408888|245105|P1|COMPLETED|Second Intervention||16
101058|NCT01408888|245104|P2|STARTED|Second Intervention||8
101059|NCT01408888|245105|P1|STARTED|Second Intervention||18
101060|NCT01408888|245104|P2|NOT COMPLETED|Washout of at Least 21 Days||0
101061|NCT01408888|245105|P1|NOT COMPLETED|Washout of at Least 21 Days||0
101062|NCT01408888|245104|P2|COMPLETED|Washout of at Least 21 Days||8
101063|NCT01408888|245105|P1|COMPLETED|Washout of at Least 21 Days||18
101064|NCT01408888|245104|P2|STARTED|Washout of at Least 21 Days||8
101065|NCT01408888|245105|P1|STARTED|Washout of at Least 21 Days||18
101066|NCT01408888|245104|P2|NOT COMPLETED|First Intervention||3
101067|NCT01408888|245105|P1|NOT COMPLETED|First Intervention||0
101068|NCT01408888|245104|P2|COMPLETED|First Intervention||8
101069|NCT01408888|245105|P1|COMPLETED|First Intervention||18
101070|NCT01408888|245104|P2|Received at Least 1 Dose of Drug|First Intervention||11
101071|NCT01408888|245105|P1|Received at Least 1 Dose of Drug|First Intervention||18
101072|NCT01408888|245104|P2|STARTED|First Intervention||11
101073|NCT01408888|245105|P1|STARTED|First Intervention||18
101074|NCT01408862|245128|P1|NOT COMPLETED|Overall Study||0
101075|NCT01408862|245128|P1|COMPLETED|Overall Study||20
101076|NCT01408862|245128|P1|STARTED|Overall Study||20
101077|NCT01408732|245133|P2|NOT COMPLETED|Overall Study||2
101078|NCT01408732|245134|P1|NOT COMPLETED|Overall Study||2
101079|NCT01408732|245133|P2|COMPLETED|Overall Study||7
101080|NCT01408732|245134|P1|COMPLETED|Overall Study||7
101081|NCT01408732|245133|P2|STARTED|Overall Study||9
101082|NCT01408732|245134|P1|STARTED|Overall Study||9
101083|NCT01408719|245160|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
101084|NCT01408719|245161|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
101085|NCT01408719|245162|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
101086|NCT01408719|245163|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
101087|NCT01408719|245164|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
101088|NCT01408719|245165|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
101089|NCT01408719|245166|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
101090|NCT01408719|245167|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
101091|NCT01408719|245168|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
101092|NCT01408719|245169|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
101093|NCT01408719|245170|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
101094|NCT01408719|245171|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
101095|NCT01408719|245172|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
101096|NCT01408719|245173|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
101097|NCT01408719|245174|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
101098|NCT01408719|245175|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
101099|NCT01408719|245176|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
101100|NCT01408719|245177|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
101101|NCT01408719|245178|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
101102|NCT01408719|245179|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
101103|NCT01408719|245160|P20|COMPLETED|Fourth Intervention (35 Days)||1
101104|NCT01408719|245161|P19|COMPLETED|Fourth Intervention (35 Days)||0
101105|NCT01408719|245162|P18|COMPLETED|Fourth Intervention (35 Days)||2
101106|NCT01408719|245163|P17|COMPLETED|Fourth Intervention (35 Days)||2
101107|NCT01408719|245164|P16|COMPLETED|Fourth Intervention (35 Days)||1
101108|NCT01408719|245165|P15|COMPLETED|Fourth Intervention (35 Days)||1
101109|NCT01408719|245166|P14|COMPLETED|Fourth Intervention (35 Days)||3
101110|NCT01408719|245167|P13|COMPLETED|Fourth Intervention (35 Days)||1
101111|NCT01408719|245168|P12|COMPLETED|Fourth Intervention (35 Days)||2
101112|NCT01408719|245169|P11|COMPLETED|Fourth Intervention (35 Days)||2
101113|NCT01408719|245170|P10|COMPLETED|Fourth Intervention (35 Days)||1
101114|NCT01408719|245171|P9|COMPLETED|Fourth Intervention (35 Days)||1
101115|NCT01408719|245172|P8|COMPLETED|Fourth Intervention (35 Days)||2
101116|NCT01408719|245173|P7|COMPLETED|Fourth Intervention (35 Days)||2
101117|NCT01408719|245174|P6|COMPLETED|Fourth Intervention (35 Days)||3
101118|NCT01408719|245175|P5|COMPLETED|Fourth Intervention (35 Days)||3
101119|NCT01408719|245176|P4|COMPLETED|Fourth Intervention (35 Days)||2
101120|NCT01408719|245177|P3|COMPLETED|Fourth Intervention (35 Days)||1
101121|NCT01408719|245178|P2|COMPLETED|Fourth Intervention (35 Days)||3
101122|NCT01408719|245179|P1|COMPLETED|Fourth Intervention (35 Days)||2
101123|NCT01408719|245160|P20|STARTED|Fourth Intervention (35 Days)||1
101124|NCT01408719|245161|P19|STARTED|Fourth Intervention (35 Days)||0
101125|NCT01408719|245162|P18|STARTED|Fourth Intervention (35 Days)||2
101126|NCT01408719|245163|P17|STARTED|Fourth Intervention (35 Days)||2
101127|NCT01408719|245164|P16|STARTED|Fourth Intervention (35 Days)||1
101128|NCT01408719|245165|P15|STARTED|Fourth Intervention (35 Days)||1
101129|NCT01408719|245166|P14|STARTED|Fourth Intervention (35 Days)||3
101130|NCT01408719|245167|P13|STARTED|Fourth Intervention (35 Days)||1
101131|NCT01408719|245168|P12|STARTED|Fourth Intervention (35 Days)||2
101132|NCT01408719|245169|P11|STARTED|Fourth Intervention (35 Days)||2
101133|NCT01408719|245170|P10|STARTED|Fourth Intervention (35 Days)||1
101134|NCT01408719|245171|P9|STARTED|Fourth Intervention (35 Days)||1
101135|NCT01408719|245172|P8|STARTED|Fourth Intervention (35 Days)||2
101136|NCT01408719|245173|P7|STARTED|Fourth Intervention (35 Days)||2
101137|NCT01408719|245174|P6|STARTED|Fourth Intervention (35 Days)||3
101138|NCT01408719|245175|P5|STARTED|Fourth Intervention (35 Days)||3
101139|NCT01408719|245176|P4|STARTED|Fourth Intervention (35 Days)||2
101140|NCT01408719|245177|P3|STARTED|Fourth Intervention (35 Days)||1
101141|NCT01408719|245178|P2|STARTED|Fourth Intervention (35 Days)||3
101142|NCT01408719|245179|P1|STARTED|Fourth Intervention (35 Days)||2
101143|NCT01408719|245160|P20|NOT COMPLETED|Washout Period (28 Days)||0
101144|NCT01408719|245161|P19|NOT COMPLETED|Washout Period (28 Days)||0
101145|NCT01408719|245162|P18|NOT COMPLETED|Washout Period (28 Days)||0
101146|NCT01408719|245163|P17|NOT COMPLETED|Washout Period (28 Days)||0
101147|NCT01408719|245164|P16|NOT COMPLETED|Washout Period (28 Days)||0
101148|NCT01408719|245165|P15|NOT COMPLETED|Washout Period (28 Days)||0
101149|NCT01408719|245166|P14|NOT COMPLETED|Washout Period (28 Days)||0
101150|NCT01408719|245167|P13|NOT COMPLETED|Washout Period (28 Days)||0
101151|NCT01408719|245168|P12|NOT COMPLETED|Washout Period (28 Days)||0
101152|NCT01408719|245169|P11|NOT COMPLETED|Washout Period (28 Days)||0
101153|NCT01408719|245170|P10|NOT COMPLETED|Washout Period (28 Days)||0
101154|NCT01408719|245171|P9|NOT COMPLETED|Washout Period (28 Days)||0
101155|NCT01408719|245172|P8|NOT COMPLETED|Washout Period (28 Days)||0
101156|NCT01408719|245173|P7|NOT COMPLETED|Washout Period (28 Days)||0
101157|NCT01408719|245174|P6|NOT COMPLETED|Washout Period (28 Days)||0
101158|NCT01408719|245175|P5|NOT COMPLETED|Washout Period (28 Days)||0
101159|NCT01408719|245176|P4|NOT COMPLETED|Washout Period (28 Days)||0
101160|NCT01408719|245177|P3|NOT COMPLETED|Washout Period (28 Days)||0
101161|NCT01408719|245178|P2|NOT COMPLETED|Washout Period (28 Days)||0
101162|NCT01408719|245179|P1|NOT COMPLETED|Washout Period (28 Days)||0
101163|NCT01408719|245160|P20|COMPLETED|Washout Period (28 Days)||1
101164|NCT01408719|245161|P19|COMPLETED|Washout Period (28 Days)||0
101165|NCT01408719|245162|P18|COMPLETED|Washout Period (28 Days)||2
101166|NCT01408719|245163|P17|COMPLETED|Washout Period (28 Days)||2
101167|NCT01408719|245164|P16|COMPLETED|Washout Period (28 Days)||1
101168|NCT01408719|245165|P15|COMPLETED|Washout Period (28 Days)||1
101169|NCT01408719|245166|P14|COMPLETED|Washout Period (28 Days)||3
101170|NCT01408719|245167|P13|COMPLETED|Washout Period (28 Days)||1
101171|NCT01408719|245168|P12|COMPLETED|Washout Period (28 Days)||2
101172|NCT01408719|245169|P11|COMPLETED|Washout Period (28 Days)||2
101173|NCT01408719|245170|P10|COMPLETED|Washout Period (28 Days)||1
101174|NCT01408719|245171|P9|COMPLETED|Washout Period (28 Days)||1
101175|NCT01408719|245172|P8|COMPLETED|Washout Period (28 Days)||2
101176|NCT01408719|245173|P7|COMPLETED|Washout Period (28 Days)||2
101177|NCT01408719|245174|P6|COMPLETED|Washout Period (28 Days)||3
101178|NCT01408719|245175|P5|COMPLETED|Washout Period (28 Days)||3
101179|NCT01408719|245176|P4|COMPLETED|Washout Period (28 Days)||2
101180|NCT01408719|245177|P3|COMPLETED|Washout Period (28 Days)||1
101181|NCT01408719|245178|P2|COMPLETED|Washout Period (28 Days)||3
101182|NCT01408719|245179|P1|COMPLETED|Washout Period (28 Days)||2
101183|NCT01408719|245160|P20|STARTED|Washout Period (28 Days)||1
101184|NCT01408719|245161|P19|STARTED|Washout Period (28 Days)||0
101185|NCT01408719|245162|P18|STARTED|Washout Period (28 Days)||2
101186|NCT01408719|245163|P17|STARTED|Washout Period (28 Days)||2
101187|NCT01408719|245164|P16|STARTED|Washout Period (28 Days)||1
101188|NCT01408719|245165|P15|STARTED|Washout Period (28 Days)||1
101189|NCT01408719|245166|P14|STARTED|Washout Period (28 Days)||3
101190|NCT01408719|245167|P13|STARTED|Washout Period (28 Days)||1
101191|NCT01408719|245168|P12|STARTED|Washout Period (28 Days)||2
101192|NCT01408719|245169|P11|STARTED|Washout Period (28 Days)||2
101193|NCT01408719|245170|P10|STARTED|Washout Period (28 Days)||1
101194|NCT01408719|245171|P9|STARTED|Washout Period (28 Days)||1
101195|NCT01408719|245172|P8|STARTED|Washout Period (28 Days)||2
101196|NCT01408719|245173|P7|STARTED|Washout Period (28 Days)||2
101197|NCT01408719|245174|P6|STARTED|Washout Period (28 Days)||3
101198|NCT01408719|245175|P5|STARTED|Washout Period (28 Days)||3
101199|NCT01408719|245176|P4|STARTED|Washout Period (28 Days)||2
101200|NCT01408719|245177|P3|STARTED|Washout Period (28 Days)||1
101201|NCT01408719|245178|P2|STARTED|Washout Period (28 Days)||3
101202|NCT01408719|245179|P1|STARTED|Washout Period (28 Days)||2
101203|NCT01408719|245160|P20|NOT COMPLETED|Third Intervention (35 Days)||0
101204|NCT01408719|245161|P19|NOT COMPLETED|Third Intervention (35 Days)||0
101205|NCT01408719|245162|P18|NOT COMPLETED|Third Intervention (35 Days)||0
101206|NCT01408719|245163|P17|NOT COMPLETED|Third Intervention (35 Days)||0
101207|NCT01408719|245164|P16|NOT COMPLETED|Third Intervention (35 Days)||0
101208|NCT01408719|245165|P15|NOT COMPLETED|Third Intervention (35 Days)||0
101209|NCT01408719|245166|P14|NOT COMPLETED|Third Intervention (35 Days)||0
101210|NCT01408719|245167|P13|NOT COMPLETED|Third Intervention (35 Days)||0
101211|NCT01408719|245168|P12|NOT COMPLETED|Third Intervention (35 Days)||0
101212|NCT01408719|245169|P11|NOT COMPLETED|Third Intervention (35 Days)||0
101213|NCT01408719|245170|P10|NOT COMPLETED|Third Intervention (35 Days)||0
101214|NCT01408719|245171|P9|NOT COMPLETED|Third Intervention (35 Days)||0
101215|NCT01408719|245172|P8|NOT COMPLETED|Third Intervention (35 Days)||1
101216|NCT01408719|245173|P7|NOT COMPLETED|Third Intervention (35 Days)||0
101217|NCT01408719|245174|P6|NOT COMPLETED|Third Intervention (35 Days)||0
101218|NCT01408719|245175|P5|NOT COMPLETED|Third Intervention (35 Days)||0
101219|NCT01408719|245176|P4|NOT COMPLETED|Third Intervention (35 Days)||0
101220|NCT01408719|245177|P3|NOT COMPLETED|Third Intervention (35 Days)||0
101221|NCT01408719|245178|P2|NOT COMPLETED|Third Intervention (35 Days)||0
101222|NCT01408719|245179|P1|NOT COMPLETED|Third Intervention (35 Days)||0
101223|NCT01408719|245160|P20|COMPLETED|Third Intervention (35 Days)||1
101224|NCT01408719|245161|P19|COMPLETED|Third Intervention (35 Days)||0
101225|NCT01408719|245162|P18|COMPLETED|Third Intervention (35 Days)||2
101226|NCT01408719|245163|P17|COMPLETED|Third Intervention (35 Days)||2
101227|NCT01408719|245164|P16|COMPLETED|Third Intervention (35 Days)||1
101228|NCT01408719|245165|P15|COMPLETED|Third Intervention (35 Days)||1
101229|NCT01408719|245166|P14|COMPLETED|Third Intervention (35 Days)||3
101230|NCT01408719|245167|P13|COMPLETED|Third Intervention (35 Days)||2
101231|NCT01408719|245168|P12|COMPLETED|Third Intervention (35 Days)||2
101232|NCT01408719|245169|P11|COMPLETED|Third Intervention (35 Days)||2
101233|NCT01408719|245170|P10|COMPLETED|Third Intervention (35 Days)||1
101234|NCT01408719|245171|P9|COMPLETED|Third Intervention (35 Days)||1
101235|NCT01408719|245172|P8|COMPLETED|Third Intervention (35 Days)||2
101236|NCT01408719|245173|P7|COMPLETED|Third Intervention (35 Days)||2
101237|NCT01408719|245174|P6|COMPLETED|Third Intervention (35 Days)||3
101238|NCT01408719|245175|P5|COMPLETED|Third Intervention (35 Days)||3
101239|NCT01408719|245176|P4|COMPLETED|Third Intervention (35 Days)||2
101240|NCT01408719|245177|P3|COMPLETED|Third Intervention (35 Days)||1
101241|NCT01408719|245178|P2|COMPLETED|Third Intervention (35 Days)||3
101242|NCT01408719|245179|P1|COMPLETED|Third Intervention (35 Days)||2
101243|NCT01408719|245160|P20|STARTED|Third Intervention (35 Days)||1
101244|NCT01408719|245161|P19|STARTED|Third Intervention (35 Days)||0
101245|NCT01408719|245162|P18|STARTED|Third Intervention (35 Days)||2
101246|NCT01408719|245163|P17|STARTED|Third Intervention (35 Days)||2
101247|NCT01408719|245164|P16|STARTED|Third Intervention (35 Days)||1
101248|NCT01408719|245165|P15|STARTED|Third Intervention (35 Days)||1
101249|NCT01408719|245166|P14|STARTED|Third Intervention (35 Days)||3
101250|NCT01408719|245167|P13|STARTED|Third Intervention (35 Days)||2
101251|NCT01408719|245168|P12|STARTED|Third Intervention (35 Days)||2
101252|NCT01408719|245169|P11|STARTED|Third Intervention (35 Days)||2
101253|NCT01408719|245170|P10|STARTED|Third Intervention (35 Days)||1
101254|NCT01408719|245171|P9|STARTED|Third Intervention (35 Days)||1
101255|NCT01408719|245172|P8|STARTED|Third Intervention (35 Days)||3
101256|NCT01408719|245173|P7|STARTED|Third Intervention (35 Days)||2
101257|NCT01408719|245174|P6|STARTED|Third Intervention (35 Days)||3
101258|NCT01408719|245175|P5|STARTED|Third Intervention (35 Days)||3
101259|NCT01408719|245176|P4|STARTED|Third Intervention (35 Days)||2
101260|NCT01408719|245177|P3|STARTED|Third Intervention (35 Days)||1
101261|NCT01408719|245178|P2|STARTED|Third Intervention (35 Days)||3
101262|NCT01408719|245179|P1|STARTED|Third Intervention (35 Days)||2
101263|NCT01408719|245160|P20|NOT COMPLETED|Washout Period (28 Days)||0
101264|NCT01408719|245161|P19|NOT COMPLETED|Washout Period (28 Days)||0
101265|NCT01408719|245162|P18|NOT COMPLETED|Washout Period (28 Days)||0
101266|NCT01408719|245163|P17|NOT COMPLETED|Washout Period (28 Days)||0
101267|NCT01408719|245164|P16|NOT COMPLETED|Washout Period (28 Days)||0
101268|NCT01408719|245165|P15|NOT COMPLETED|Washout Period (28 Days)||0
101269|NCT01408719|245166|P14|NOT COMPLETED|Washout Period (28 Days)||0
101270|NCT01408719|245167|P13|NOT COMPLETED|Washout Period (28 Days)||0
101271|NCT01408719|245168|P12|NOT COMPLETED|Washout Period (28 Days)||0
101272|NCT01408719|245169|P11|NOT COMPLETED|Washout Period (28 Days)||0
101273|NCT01408719|245170|P10|NOT COMPLETED|Washout Period (28 Days)||0
101274|NCT01408719|245171|P9|NOT COMPLETED|Washout Period (28 Days)||0
101275|NCT01408719|245172|P8|NOT COMPLETED|Washout Period (28 Days)||0
101276|NCT01408719|245173|P7|NOT COMPLETED|Washout Period (28 Days)||0
101277|NCT01408719|245174|P6|NOT COMPLETED|Washout Period (28 Days)||0
101278|NCT01408719|245175|P5|NOT COMPLETED|Washout Period (28 Days)||0
101279|NCT01408719|245176|P4|NOT COMPLETED|Washout Period (28 Days)||0
101280|NCT01408719|245177|P3|NOT COMPLETED|Washout Period (28 Days)||0
101281|NCT01408719|245178|P2|NOT COMPLETED|Washout Period (28 Days)||0
101282|NCT01408719|245179|P1|NOT COMPLETED|Washout Period (28 Days)||0
101283|NCT01408719|245160|P20|COMPLETED|Washout Period (28 Days)||1
101284|NCT01408719|245161|P19|COMPLETED|Washout Period (28 Days)||0
101285|NCT01408719|245162|P18|COMPLETED|Washout Period (28 Days)||2
101286|NCT01408719|245163|P17|COMPLETED|Washout Period (28 Days)||2
101287|NCT01408719|245164|P16|COMPLETED|Washout Period (28 Days)||1
101288|NCT01408719|245165|P15|COMPLETED|Washout Period (28 Days)||1
101289|NCT01408719|245166|P14|COMPLETED|Washout Period (28 Days)||3
101290|NCT01408719|245167|P13|COMPLETED|Washout Period (28 Days)||2
101291|NCT01408719|245168|P12|COMPLETED|Washout Period (28 Days)||2
101292|NCT01408719|245169|P11|COMPLETED|Washout Period (28 Days)||2
101293|NCT01408719|245170|P10|COMPLETED|Washout Period (28 Days)||1
101294|NCT01408719|245171|P9|COMPLETED|Washout Period (28 Days)||1
101295|NCT01408719|245172|P8|COMPLETED|Washout Period (28 Days)||3
101296|NCT01408719|245173|P7|COMPLETED|Washout Period (28 Days)||2
101297|NCT01408719|245174|P6|COMPLETED|Washout Period (28 Days)||3
101298|NCT01408719|245175|P5|COMPLETED|Washout Period (28 Days)||3
101299|NCT01408719|245176|P4|COMPLETED|Washout Period (28 Days)||2
101300|NCT01408719|245177|P3|COMPLETED|Washout Period (28 Days)||1
101301|NCT01408719|245178|P2|COMPLETED|Washout Period (28 Days)||3
101302|NCT01408719|245179|P1|COMPLETED|Washout Period (28 Days)||2
101303|NCT01408719|245160|P20|STARTED|Washout Period (28 Days)||1
101304|NCT01408719|245161|P19|STARTED|Washout Period (28 Days)||0
101305|NCT01408719|245162|P18|STARTED|Washout Period (28 Days)||2
101306|NCT01408719|245163|P17|STARTED|Washout Period (28 Days)||2
101307|NCT01408719|245164|P16|STARTED|Washout Period (28 Days)||1
101308|NCT01408719|245165|P15|STARTED|Washout Period (28 Days)||1
101309|NCT01408719|245166|P14|STARTED|Washout Period (28 Days)||3
101310|NCT01408719|245167|P13|STARTED|Washout Period (28 Days)||2
101311|NCT01408719|245168|P12|STARTED|Washout Period (28 Days)||2
101312|NCT01408719|245169|P11|STARTED|Washout Period (28 Days)||2
101313|NCT01408719|245170|P10|STARTED|Washout Period (28 Days)||1
101314|NCT01408719|245171|P9|STARTED|Washout Period (28 Days)||1
101315|NCT01408719|245172|P8|STARTED|Washout Period (28 Days)||3
101316|NCT01408719|245173|P7|STARTED|Washout Period (28 Days)||2
101317|NCT01408719|245174|P6|STARTED|Washout Period (28 Days)||3
101318|NCT01408719|245175|P5|STARTED|Washout Period (28 Days)||3
101319|NCT01408719|245176|P4|STARTED|Washout Period (28 Days)||2
101320|NCT01408719|245177|P3|STARTED|Washout Period (28 Days)||1
101321|NCT01408719|245178|P2|STARTED|Washout Period (28 Days)||3
101322|NCT01408719|245179|P1|STARTED|Washout Period (28 Days)||2
101323|NCT01408719|245160|P20|NOT COMPLETED|Second Intervention (35 Days)||0
101324|NCT01408719|245161|P19|NOT COMPLETED|Second Intervention (35 Days)||0
101325|NCT01408719|245162|P18|NOT COMPLETED|Second Intervention (35 Days)||0
101326|NCT01408719|245163|P17|NOT COMPLETED|Second Intervention (35 Days)||0
101327|NCT01408719|245164|P16|NOT COMPLETED|Second Intervention (35 Days)||0
101328|NCT01408719|245165|P15|NOT COMPLETED|Second Intervention (35 Days)||0
101329|NCT01408719|245166|P14|NOT COMPLETED|Second Intervention (35 Days)||1
101330|NCT01408719|245167|P13|NOT COMPLETED|Second Intervention (35 Days)||0
101331|NCT01408719|245168|P12|NOT COMPLETED|Second Intervention (35 Days)||0
101332|NCT01408719|245169|P11|NOT COMPLETED|Second Intervention (35 Days)||0
101333|NCT01408719|245170|P10|NOT COMPLETED|Second Intervention (35 Days)||0
101334|NCT01408719|245171|P9|NOT COMPLETED|Second Intervention (35 Days)||0
101335|NCT01408719|245172|P8|NOT COMPLETED|Second Intervention (35 Days)||0
101336|NCT01408719|245173|P7|NOT COMPLETED|Second Intervention (35 Days)||0
101337|NCT01408719|245174|P6|NOT COMPLETED|Second Intervention (35 Days)||0
101338|NCT01408719|245175|P5|NOT COMPLETED|Second Intervention (35 Days)||0
101339|NCT01408719|245176|P4|NOT COMPLETED|Second Intervention (35 Days)||0
101340|NCT01408719|245177|P3|NOT COMPLETED|Second Intervention (35 Days)||0
101341|NCT01408719|245178|P2|NOT COMPLETED|Second Intervention (35 Days)||0
101342|NCT01408719|245179|P1|NOT COMPLETED|Second Intervention (35 Days)||0
101343|NCT01408719|245160|P20|COMPLETED|Second Intervention (35 Days)||1
101344|NCT01408719|245161|P19|COMPLETED|Second Intervention (35 Days)||0
101345|NCT01408719|245162|P18|COMPLETED|Second Intervention (35 Days)||2
101346|NCT01408719|245163|P17|COMPLETED|Second Intervention (35 Days)||2
101347|NCT01408719|245164|P16|COMPLETED|Second Intervention (35 Days)||2
101348|NCT01408719|245165|P15|COMPLETED|Second Intervention (35 Days)||1
101349|NCT01408719|245166|P14|COMPLETED|Second Intervention (35 Days)||3
101350|NCT01408719|245167|P13|COMPLETED|Second Intervention (35 Days)||2
101351|NCT01408719|245168|P12|COMPLETED|Second Intervention (35 Days)||2
101352|NCT01408719|245169|P11|COMPLETED|Second Intervention (35 Days)||2
101353|NCT01408719|245170|P10|COMPLETED|Second Intervention (35 Days)||1
101354|NCT01408719|245171|P9|COMPLETED|Second Intervention (35 Days)||1
101355|NCT01408719|245172|P8|COMPLETED|Second Intervention (35 Days)||3
101356|NCT01408719|245173|P7|COMPLETED|Second Intervention (35 Days)||2
101357|NCT01408719|245174|P6|COMPLETED|Second Intervention (35 Days)||3
101358|NCT01408719|245175|P5|COMPLETED|Second Intervention (35 Days)||3
101359|NCT01408719|245176|P4|COMPLETED|Second Intervention (35 Days)||2
101360|NCT01408719|245177|P3|COMPLETED|Second Intervention (35 Days)||1
101361|NCT01408719|245178|P2|COMPLETED|Second Intervention (35 Days)||3
101362|NCT01408719|245179|P1|COMPLETED|Second Intervention (35 Days)||2
101363|NCT01408719|245160|P20|STARTED|Second Intervention (35 Days)||1
101364|NCT01408719|245161|P19|STARTED|Second Intervention (35 Days)||0
101365|NCT01408719|245162|P18|STARTED|Second Intervention (35 Days)||2
101366|NCT01408719|245163|P17|STARTED|Second Intervention (35 Days)||2
101367|NCT01408719|245164|P16|STARTED|Second Intervention (35 Days)||2
101368|NCT01408719|245165|P15|STARTED|Second Intervention (35 Days)||1
101369|NCT01408719|245166|P14|STARTED|Second Intervention (35 Days)||4
101370|NCT01408719|245167|P13|STARTED|Second Intervention (35 Days)||2
101371|NCT01408719|245168|P12|STARTED|Second Intervention (35 Days)||2
101372|NCT01408719|245169|P11|STARTED|Second Intervention (35 Days)||2
101373|NCT01408719|245170|P10|STARTED|Second Intervention (35 Days)||1
101374|NCT01408719|245171|P9|STARTED|Second Intervention (35 Days)||1
101375|NCT01408719|245172|P8|STARTED|Second Intervention (35 Days)||3
101376|NCT01408719|245173|P7|STARTED|Second Intervention (35 Days)||2
101377|NCT01408719|245174|P6|STARTED|Second Intervention (35 Days)||3
101378|NCT01408719|245175|P5|STARTED|Second Intervention (35 Days)||3
101379|NCT01408719|245176|P4|STARTED|Second Intervention (35 Days)||2
101380|NCT01408719|245177|P3|STARTED|Second Intervention (35 Days)||1
101381|NCT01408719|245178|P2|STARTED|Second Intervention (35 Days)||3
101382|NCT01408719|245179|P1|STARTED|Second Intervention (35 Days)||2
101383|NCT01408719|245160|P20|NOT COMPLETED|Washout Period (28 Days)||0
101384|NCT01408719|245161|P19|NOT COMPLETED|Washout Period (28 Days)||0
101385|NCT01408719|245162|P18|NOT COMPLETED|Washout Period (28 Days)||0
101386|NCT01408719|245163|P17|NOT COMPLETED|Washout Period (28 Days)||0
101387|NCT01408719|245164|P16|NOT COMPLETED|Washout Period (28 Days)||0
101388|NCT01408719|245165|P15|NOT COMPLETED|Washout Period (28 Days)||0
101389|NCT01408719|245166|P14|NOT COMPLETED|Washout Period (28 Days)||0
101390|NCT01408719|245167|P13|NOT COMPLETED|Washout Period (28 Days)||0
101391|NCT01408719|245168|P12|NOT COMPLETED|Washout Period (28 Days)||0
101392|NCT01408719|245169|P11|NOT COMPLETED|Washout Period (28 Days)||0
101393|NCT01408719|245170|P10|NOT COMPLETED|Washout Period (28 Days)||0
101394|NCT01408719|245171|P9|NOT COMPLETED|Washout Period (28 Days)||0
101395|NCT01408719|245172|P8|NOT COMPLETED|Washout Period (28 Days)||0
101396|NCT01408719|245173|P7|NOT COMPLETED|Washout Period (28 Days)||0
101397|NCT01408719|245174|P6|NOT COMPLETED|Washout Period (28 Days)||0
101398|NCT01408719|245175|P5|NOT COMPLETED|Washout Period (28 Days)||0
101399|NCT01408719|245176|P4|NOT COMPLETED|Washout Period (28 Days)||0
101400|NCT01408719|245177|P3|NOT COMPLETED|Washout Period (28 Days)||0
101401|NCT01408719|245178|P2|NOT COMPLETED|Washout Period (28 Days)||0
101402|NCT01408719|245179|P1|NOT COMPLETED|Washout Period (28 Days)||0
101403|NCT01408719|245160|P20|COMPLETED|Washout Period (28 Days)||1
101404|NCT01408719|245161|P19|COMPLETED|Washout Period (28 Days)||0
101405|NCT01408719|245162|P18|COMPLETED|Washout Period (28 Days)||2
101406|NCT01408719|245163|P17|COMPLETED|Washout Period (28 Days)||2
101407|NCT01408719|245164|P16|COMPLETED|Washout Period (28 Days)||2
101408|NCT01408719|245165|P15|COMPLETED|Washout Period (28 Days)||1
101409|NCT01408719|245166|P14|COMPLETED|Washout Period (28 Days)||4
101410|NCT01408719|245167|P13|COMPLETED|Washout Period (28 Days)||2
101411|NCT01408719|245168|P12|COMPLETED|Washout Period (28 Days)||2
101412|NCT01408719|245169|P11|COMPLETED|Washout Period (28 Days)||2
101413|NCT01408719|245170|P10|COMPLETED|Washout Period (28 Days)||1
101414|NCT01408719|245171|P9|COMPLETED|Washout Period (28 Days)||1
101415|NCT01408719|245172|P8|COMPLETED|Washout Period (28 Days)||3
101416|NCT01408719|245173|P7|COMPLETED|Washout Period (28 Days)||2
101417|NCT01408719|245174|P6|COMPLETED|Washout Period (28 Days)||3
101418|NCT01408719|245175|P5|COMPLETED|Washout Period (28 Days)||3
101419|NCT01408719|245176|P4|COMPLETED|Washout Period (28 Days)||2
101420|NCT01408719|245177|P3|COMPLETED|Washout Period (28 Days)||1
101421|NCT01408719|245178|P2|COMPLETED|Washout Period (28 Days)||3
101422|NCT01408719|245179|P1|COMPLETED|Washout Period (28 Days)||2
101423|NCT01408719|245160|P20|STARTED|Washout Period (28 Days)||1
101424|NCT01408719|245161|P19|STARTED|Washout Period (28 Days)||0
101425|NCT01408719|245162|P18|STARTED|Washout Period (28 Days)||2
101426|NCT01408719|245163|P17|STARTED|Washout Period (28 Days)||2
101427|NCT01408719|245164|P16|STARTED|Washout Period (28 Days)||2
101428|NCT01408719|245165|P15|STARTED|Washout Period (28 Days)||1
101429|NCT01408719|245166|P14|STARTED|Washout Period (28 Days)||4
101430|NCT01408719|245167|P13|STARTED|Washout Period (28 Days)||2
101431|NCT01408719|245168|P12|STARTED|Washout Period (28 Days)||2
101432|NCT01408719|245169|P11|STARTED|Washout Period (28 Days)||2
101433|NCT01408719|245170|P10|STARTED|Washout Period (28 Days)||1
101434|NCT01408719|245171|P9|STARTED|Washout Period (28 Days)||1
101435|NCT01408719|245172|P8|STARTED|Washout Period (28 Days)||3
101436|NCT01408719|245173|P7|STARTED|Washout Period (28 Days)||2
101437|NCT01408719|245174|P6|STARTED|Washout Period (28 Days)||3
101438|NCT01408719|245175|P5|STARTED|Washout Period (28 Days)||3
101439|NCT01408719|245176|P4|STARTED|Washout Period (28 Days)||2
101440|NCT01408719|245177|P3|STARTED|Washout Period (28 Days)||1
101441|NCT01408719|245178|P2|STARTED|Washout Period (28 Days)||3
101442|NCT01408719|245179|P1|STARTED|Washout Period (28 Days)||2
101443|NCT01408719|245160|P20|NOT COMPLETED|First Intervention (35 Days)||0
101444|NCT01408719|245161|P19|NOT COMPLETED|First Intervention (35 Days)||1
101445|NCT01408719|245162|P18|NOT COMPLETED|First Intervention (35 Days)||0
101446|NCT01408719|245163|P17|NOT COMPLETED|First Intervention (35 Days)||1
101447|NCT01408719|245164|P16|NOT COMPLETED|First Intervention (35 Days)||0
101448|NCT01408719|245165|P15|NOT COMPLETED|First Intervention (35 Days)||0
101449|NCT01408719|245166|P14|NOT COMPLETED|First Intervention (35 Days)||1
101450|NCT01408719|245167|P13|NOT COMPLETED|First Intervention (35 Days)||0
101451|NCT01408719|245168|P12|NOT COMPLETED|First Intervention (35 Days)||0
101452|NCT01408719|245169|P11|NOT COMPLETED|First Intervention (35 Days)||0
101453|NCT01408719|245170|P10|NOT COMPLETED|First Intervention (35 Days)||0
101454|NCT01408719|245171|P9|NOT COMPLETED|First Intervention (35 Days)||1
101455|NCT01408719|245172|P8|NOT COMPLETED|First Intervention (35 Days)||0
101456|NCT01408719|245173|P7|NOT COMPLETED|First Intervention (35 Days)||0
101457|NCT01408719|245174|P6|NOT COMPLETED|First Intervention (35 Days)||0
101458|NCT01408719|245175|P5|NOT COMPLETED|First Intervention (35 Days)||1
101459|NCT01408719|245176|P4|NOT COMPLETED|First Intervention (35 Days)||0
101460|NCT01408719|245177|P3|NOT COMPLETED|First Intervention (35 Days)||1
101461|NCT01408719|245178|P2|NOT COMPLETED|First Intervention (35 Days)||0
101462|NCT01408719|245179|P1|NOT COMPLETED|First Intervention (35 Days)||0
101463|NCT01408719|245160|P20|COMPLETED|First Intervention (35 Days)||1
101464|NCT01408719|245161|P19|COMPLETED|First Intervention (35 Days)||0
101465|NCT01408719|245162|P18|COMPLETED|First Intervention (35 Days)||2
101466|NCT01408719|245163|P17|COMPLETED|First Intervention (35 Days)||2
101467|NCT01408719|245164|P16|COMPLETED|First Intervention (35 Days)||2
101468|NCT01408719|245165|P15|COMPLETED|First Intervention (35 Days)||1
101469|NCT01408719|245166|P14|COMPLETED|First Intervention (35 Days)||4
101470|NCT01408719|245167|P13|COMPLETED|First Intervention (35 Days)||2
101471|NCT01408719|245168|P12|COMPLETED|First Intervention (35 Days)||2
101472|NCT01408719|245169|P11|COMPLETED|First Intervention (35 Days)||2
101473|NCT01408719|245170|P10|COMPLETED|First Intervention (35 Days)||1
101474|NCT01408719|245171|P9|COMPLETED|First Intervention (35 Days)||1
101475|NCT01408719|245172|P8|COMPLETED|First Intervention (35 Days)||3
101476|NCT01408719|245173|P7|COMPLETED|First Intervention (35 Days)||2
101477|NCT01408719|245174|P6|COMPLETED|First Intervention (35 Days)||3
101478|NCT01408719|245175|P5|COMPLETED|First Intervention (35 Days)||3
101479|NCT01408719|245176|P4|COMPLETED|First Intervention (35 Days)||2
101480|NCT01408719|245177|P3|COMPLETED|First Intervention (35 Days)||1
101481|NCT01408719|245178|P2|COMPLETED|First Intervention (35 Days)||3
101482|NCT01408719|245179|P1|COMPLETED|First Intervention (35 Days)||2
101483|NCT01408719|245160|P20|STARTED|First Intervention (35 Days)||1
101484|NCT01408719|245161|P19|STARTED|First Intervention (35 Days)||1
101485|NCT01408719|245162|P18|STARTED|First Intervention (35 Days)||2
101486|NCT01408719|245163|P17|STARTED|First Intervention (35 Days)||3
101487|NCT01408719|245164|P16|STARTED|First Intervention (35 Days)||2
101488|NCT01408719|245165|P15|STARTED|First Intervention (35 Days)||1
101489|NCT01408719|245166|P14|STARTED|First Intervention (35 Days)||5
101490|NCT01408719|245167|P13|STARTED|First Intervention (35 Days)||2
101491|NCT01408719|245168|P12|STARTED|First Intervention (35 Days)||2
101492|NCT01408719|245169|P11|STARTED|First Intervention (35 Days)||2
101493|NCT01408719|245170|P10|STARTED|First Intervention (35 Days)||1
101494|NCT01408719|245171|P9|STARTED|First Intervention (35 Days)||2
101495|NCT01408719|245172|P8|STARTED|First Intervention (35 Days)||3
101496|NCT01408719|245173|P7|STARTED|First Intervention (35 Days)||2
101497|NCT01408719|245174|P6|STARTED|First Intervention (35 Days)||3
101498|NCT01408719|245175|P5|STARTED|First Intervention (35 Days)||4
101499|NCT01408719|245176|P4|STARTED|First Intervention (35 Days)||2
101500|NCT01408719|245177|P3|STARTED|First Intervention (35 Days)||2
101501|NCT01408719|245178|P2|STARTED|First Intervention (35 Days)||3
101502|NCT01408719|245179|P1|STARTED|First Intervention (35 Days)||2
101503|NCT01408706|245191|P2|NOT COMPLETED|Overall Study||0
101504|NCT01408706|245192|P1|NOT COMPLETED|Overall Study||1
101505|NCT01408706|245191|P2|COMPLETED|Overall Study||30
101506|NCT01408706|245192|P1|COMPLETED|Overall Study||29
101507|NCT01408706|245191|P2|STARTED|Overall Study||30
101508|NCT01408706|245192|P1|STARTED|Overall Study||30
101509|NCT01408641|245204|P2|NOT COMPLETED|Overall Study||0
101510|NCT01408641|245205|P1|NOT COMPLETED|Overall Study||1
101511|NCT01408641|245204|P2|COMPLETED|Overall Study||0
101512|NCT01408641|245205|P1|COMPLETED|Overall Study||0
101513|NCT01408641|245204|P2|STARTED|Overall Study||0
101514|NCT01408641|245205|P1|STARTED|Overall Study||1
101515|NCT01408628|245213|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
101516|NCT01408628|245213|P1|COMPLETED|Completed 6 Month Follow-Up||25
101517|NCT01408628|245213|P1|STARTED|Completed 6 Month Follow-Up||39
101518|NCT01408628|245213|P1|NOT COMPLETED|Started Classes/Intervention||0
101519|NCT01408628|245213|P1|COMPLETED|Started Classes/Intervention||39
101520|NCT01408628|245213|P1|STARTED|Started Classes/Intervention||39
101521|NCT01408628|245213|P1|NOT COMPLETED|Consented||12
101522|NCT01408628|245213|P1|COMPLETED|Consented||39
101523|NCT01408628|245213|P1|STARTED|Consented||51
101524|NCT01408537|245219|P1|NOT COMPLETED|Overall Study||8
101525|NCT01408537|245219|P1|COMPLETED|Overall Study||144
101526|NCT01408537|245219|P1|STARTED|Overall Study||152
101527|NCT01408485|245235|P1|NOT COMPLETED|Overall Study||21
101528|NCT01408485|245235|P1|COMPLETED|Overall Study||179
101529|NCT01408485|245235|P1|STARTED|Overall Study||200
101530|NCT01408329|245243|P2|NOT COMPLETED|Overall Study||4
101531|NCT01408329|245244|P1|NOT COMPLETED|Overall Study||3
101532|NCT01408329|245243|P2|COMPLETED|Overall Study||11
101533|NCT01408329|245244|P1|COMPLETED|Overall Study||10
101534|NCT01408329|245243|P2|STARTED|Overall Study||15
101535|NCT01408329|245244|P1|STARTED|Overall Study||13
101536|NCT01408303|245253|P3|NOT COMPLETED|Overall Study||6
101537|NCT01408303|245254|P2|NOT COMPLETED|Overall Study||12
101538|NCT01408303|245255|P1|NOT COMPLETED|Overall Study||6
101539|NCT01408303|245253|P3|COMPLETED|Overall Study||210
101540|NCT01408303|245254|P2|COMPLETED|Overall Study||204
101541|NCT01408303|245255|P1|COMPLETED|Overall Study||209
101542|NCT01408303|245253|P3|STARTED|Overall Study||216
101543|NCT01408303|245254|P2|STARTED|Overall Study||216
101544|NCT01408303|245255|P1|STARTED|Overall Study||215
101545|NCT01408277|245265|P2|NOT COMPLETED|Overall Study||4
101546|NCT01408277|245266|P1|NOT COMPLETED|Overall Study||8
101547|NCT01408277|245265|P2|COMPLETED|Overall Study||23
101548|NCT01408277|245266|P1|COMPLETED|Overall Study||20
101549|NCT01408277|245265|P2|STARTED|Overall Study||27
101550|NCT01408277|245266|P1|STARTED|Overall Study||28
101551|NCT01407575|245274|P2|NOT COMPLETED|Overall Study||1
101552|NCT01407575|245275|P1|NOT COMPLETED|Overall Study||2
101553|NCT01407575|245274|P2|COMPLETED|Overall Study||5
101554|NCT01407575|245275|P1|COMPLETED|Overall Study||5
101555|NCT01407575|245274|P2|STARTED|Overall Study||6
101556|NCT01407575|245275|P1|STARTED|Overall Study||7
101557|NCT01407523|245293|P1|NOT COMPLETED|Overall Study||0
101558|NCT01407523|245293|P1|COMPLETED|Overall Study||16
101559|NCT01407523|245293|P1|STARTED|Overall Study||16
101560|NCT01407354|245303|P2|NOT COMPLETED|Second Intervention||2
101561|NCT01407354|245304|P1|NOT COMPLETED|Second Intervention||0
101562|NCT01407354|245303|P2|COMPLETED|Second Intervention||13
101563|NCT01407354|245304|P1|COMPLETED|Second Intervention||18
101564|NCT01407354|245303|P2|STARTED|Second Intervention||15
101565|NCT01407354|245304|P1|STARTED|Second Intervention||18
101566|NCT01407354|245303|P2|NOT COMPLETED|First Intervention||2
101567|NCT01407354|245304|P1|NOT COMPLETED|First Intervention||2
101568|NCT01407354|245303|P2|COMPLETED|First Intervention||15
101569|NCT01407354|245304|P1|COMPLETED|First Intervention||18
101570|NCT01407354|245303|P2|STARTED|First Intervention||17
101571|NCT01407354|245304|P1|STARTED|First Intervention||20
101572|NCT01407276|245320|P8|NOT COMPLETED|Overall Study||1
101573|NCT01407276|245321|P7|NOT COMPLETED|Overall Study||0
101574|NCT01407276|245322|P6|NOT COMPLETED|Overall Study||0
101575|NCT01407276|245323|P5|NOT COMPLETED|Overall Study||0
101576|NCT01407276|245324|P4|NOT COMPLETED|Overall Study||0
101577|NCT01407276|245325|P3|NOT COMPLETED|Overall Study||0
101578|NCT01407276|245326|P2|NOT COMPLETED|Overall Study||0
101579|NCT01407276|245327|P1|NOT COMPLETED|Overall Study||0
101580|NCT01407276|245320|P8|COMPLETED|Overall Study||6
101581|NCT01407276|245321|P7|COMPLETED|Overall Study||6
101582|NCT01407276|245322|P6|COMPLETED|Overall Study||6
101583|NCT01407276|245323|P5|COMPLETED|Overall Study||6
101584|NCT01407276|245324|P4|COMPLETED|Overall Study||6
101585|NCT01407276|245325|P3|COMPLETED|Overall Study||6
101586|NCT01407276|245326|P2|COMPLETED|Overall Study||6
101587|NCT01407276|245327|P1|COMPLETED|Overall Study||6
101588|NCT01407276|245320|P8|STARTED|Overall Study||7
101589|NCT01407276|245321|P7|STARTED|Overall Study||6
101590|NCT01407276|245322|P6|STARTED|Overall Study||6
101591|NCT01407276|245323|P5|STARTED|Overall Study||6
101592|NCT01407276|245324|P4|STARTED|Overall Study||6
101593|NCT01407276|245325|P3|STARTED|Overall Study||6
101594|NCT01407276|245326|P2|STARTED|Overall Study||6
101595|NCT01407276|245327|P1|STARTED|Overall Study||6
101596|NCT01407068|245451|P1|NOT COMPLETED|Overall Study||0
101597|NCT01407068|245451|P1|COMPLETED|Overall Study||60
101598|NCT01407068|245451|P1|STARTED|Overall Study||60
101599|NCT01406990|245460|P1|NOT COMPLETED|Overall Study||0
101600|NCT01406990|245460|P1|COMPLETED|Overall Study||15
101601|NCT01406990|245460|P1|STARTED|Overall Study||15
101602|NCT01406938|245466|P6|NOT COMPLETED|Follow up||3
101603|NCT01406938|245467|P5|NOT COMPLETED|Follow up||9
101604|NCT01406938|245468|P4|NOT COMPLETED|Follow up||3
101605|NCT01406938|245469|P3|NOT COMPLETED|Follow up||8
101606|NCT01406938|245470|P2|NOT COMPLETED|Follow up||5
101607|NCT01406938|245471|P1|NOT COMPLETED|Follow up||8
101608|NCT01406938|245466|P6|COMPLETED|Follow up||32
101609|NCT01406938|245467|P5|COMPLETED|Follow up||31
101610|NCT01406938|245468|P4|COMPLETED|Follow up||36
101611|NCT01406938|245469|P3|COMPLETED|Follow up||32
101612|NCT01406938|245470|P2|COMPLETED|Follow up||18
101613|NCT01406938|245471|P1|COMPLETED|Follow up||18
101614|NCT01406938|245466|P6|STARTED|Follow up||35
101615|NCT01406938|245467|P5|STARTED|Follow up||40
101616|NCT01406938|245468|P4|STARTED|Follow up||39
101617|NCT01406938|245469|P3|STARTED|Follow up||40
101618|NCT01406938|245470|P2|STARTED|Follow up||23
101619|NCT01406938|245471|P1|STARTED|Follow up||26
101620|NCT01406938|245466|P6|NOT COMPLETED|Maintenance Period||16
101621|NCT01406938|245467|P5|NOT COMPLETED|Maintenance Period||25
101622|NCT01406938|245468|P4|NOT COMPLETED|Maintenance Period||18
101623|NCT01406938|245469|P3|NOT COMPLETED|Maintenance Period||17
101624|NCT01406938|245470|P2|NOT COMPLETED|Maintenance Period||0
101625|NCT01406938|245471|P1|NOT COMPLETED|Maintenance Period||0
101626|NCT01406938|245466|P6|COMPLETED|Maintenance Period||201
101627|NCT01406938|245467|P5|COMPLETED|Maintenance Period||181
101628|NCT01406938|245468|P4|COMPLETED|Maintenance Period||199
101629|NCT01406938|245469|P3|COMPLETED|Maintenance Period||186
101630|NCT01406938|245470|P2|COMPLETED|Maintenance Period||0
101631|NCT01406938|245471|P1|COMPLETED|Maintenance Period||0
101632|NCT01406938|245466|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
101633|NCT01406938|245467|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
101634|NCT01406938|245468|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
101635|NCT01406938|245469|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
101636|NCT01406938|245470|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
101637|NCT01406938|245471|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
101638|NCT01406938|245466|P6|STARTED|Maintenance Period||217
101639|NCT01406938|245467|P5|STARTED|Maintenance Period||206
101640|NCT01406938|245468|P4|STARTED|Maintenance Period||217
101641|NCT01406938|245469|P3|STARTED|Maintenance Period||203
101642|NCT01406938|245470|P2|STARTED|Maintenance Period||0
101643|NCT01406938|245471|P1|STARTED|Maintenance Period||0
101644|NCT01406938|245466|P6|NOT COMPLETED|Induction Period||0
101645|NCT01406938|245467|P5|NOT COMPLETED|Induction Period||0
101646|NCT01406938|245468|P4|NOT COMPLETED|Induction Period||0
101647|NCT01406938|245469|P3|NOT COMPLETED|Induction Period||0
101648|NCT01406938|245470|P2|NOT COMPLETED|Induction Period||20
101649|NCT01406938|245471|P1|NOT COMPLETED|Induction Period||18
101650|NCT01406938|245466|P6|COMPLETED|Induction Period||0
101651|NCT01406938|245467|P5|COMPLETED|Induction Period||0
101652|NCT01406938|245468|P4|COMPLETED|Induction Period||0
101653|NCT01406938|245469|P3|COMPLETED|Induction Period||0
101654|NCT01406938|245470|P2|COMPLETED|Induction Period||464
101655|NCT01406938|245471|P1|COMPLETED|Induction Period||464
101656|NCT01406938|245466|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
101657|NCT01406938|245467|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
101658|NCT01406938|245468|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
101659|NCT01406938|245469|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
101660|NCT01406938|245470|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
101661|NCT01406938|245471|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
101662|NCT01406938|245466|P6|STARTED|Induction Period||0
101663|NCT01406938|245467|P5|STARTED|Induction Period||0
101664|NCT01406938|245468|P4|STARTED|Induction Period||0
101665|NCT01406938|245469|P3|STARTED|Induction Period||0
101666|NCT01406938|245470|P2|STARTED|Induction Period||484
101667|NCT01406938|245471|P1|STARTED|Induction Period||482
101668|NCT01406873|245589|P2|NOT COMPLETED|Overall Study||1
101669|NCT01406873|245590|P1|NOT COMPLETED|Overall Study||1
101670|NCT01406873|245589|P2|COMPLETED|Overall Study||20
101671|NCT01406873|245590|P1|COMPLETED|Overall Study||20
101672|NCT01406873|245589|P2|STARTED|Overall Study||21
101673|NCT01406873|245590|P1|STARTED|Overall Study||21
101674|NCT01406860|245608|P2|NOT COMPLETED|Overall Study||0
101675|NCT01406860|245609|P1|NOT COMPLETED|Overall Study||0
101676|NCT01406860|245608|P2|COMPLETED|Overall Study||8
101677|NCT01406860|245609|P1|COMPLETED|Overall Study||11
101678|NCT01406860|245608|P2|STARTED|Overall Study||8
101679|NCT01406860|245609|P1|STARTED|Overall Study||11
101680|NCT01406795|245621|P1|NOT COMPLETED|Overall Study||1
101681|NCT01406795|245621|P1|COMPLETED|Overall Study||0
101682|NCT01406795|245621|P1|STARTED|Overall Study||1
101683|NCT01406574|245635|P4|NOT COMPLETED|Overall Study||4
101684|NCT01406574|245636|P3|NOT COMPLETED|Overall Study||1
101685|NCT01406574|245637|P2|NOT COMPLETED|Overall Study||1
101686|NCT01406574|245638|P1|NOT COMPLETED|Overall Study||1
101687|NCT01406574|245635|P4|COMPLETED|Overall Study||1
101688|NCT01406574|245636|P3|COMPLETED|Overall Study||6
101689|NCT01406574|245637|P2|COMPLETED|Overall Study||3
101690|NCT01406574|245638|P1|COMPLETED|Overall Study||6
101691|NCT01406574|245635|P4|STARTED|Overall Study||5
101692|NCT01406574|245636|P3|STARTED|Overall Study||7
101693|NCT01406574|245637|P2|STARTED|Overall Study||4
101694|NCT01406574|245638|P1|STARTED|Overall Study||7
101695|NCT01406223|245654|P4|NOT COMPLETED|Overall Study||16
101696|NCT01406223|245655|P3|NOT COMPLETED|Overall Study||18
101697|NCT01406223|245656|P2|NOT COMPLETED|Overall Study||12
101698|NCT01406223|245657|P1|NOT COMPLETED|Overall Study||12
101699|NCT01406223|245654|P4|COMPLETED|Overall Study||3
101700|NCT01406223|245655|P3|COMPLETED|Overall Study||2
101701|NCT01406223|245656|P2|COMPLETED|Overall Study||7
101702|NCT01406223|245657|P1|COMPLETED|Overall Study||6
101703|NCT01406223|245654|P4|STARTED|Overall Study||19
101704|NCT01406223|245655|P3|STARTED|Overall Study||20
101705|NCT01406223|245656|P2|STARTED|Overall Study||19
101706|NCT01406223|245657|P1|STARTED|Overall Study||18
101707|NCT01406015|245673|P2|NOT COMPLETED|Overall Study||3
101708|NCT01406015|245674|P1|NOT COMPLETED|Overall Study||3
101709|NCT01406015|245673|P2|COMPLETED|Overall Study||16
101710|NCT01406015|245674|P1|COMPLETED|Overall Study||16
101711|NCT01406015|245673|P2|STARTED|Overall Study||19
101712|NCT01406015|245674|P1|STARTED|Overall Study||19
101713|NCT01405950|245690|P4|NOT COMPLETED|Overall Study||0
101714|NCT01405950|245691|P3|NOT COMPLETED|Overall Study||0
101715|NCT01405950|245692|P2|NOT COMPLETED|Overall Study||0
101716|NCT01405950|245693|P1|NOT COMPLETED|Overall Study||1
101717|NCT01405950|245690|P4|COMPLETED|Overall Study||0
101718|NCT01405950|245691|P3|COMPLETED|Overall Study||0
101719|NCT01405950|245692|P2|COMPLETED|Overall Study||2
101720|NCT01405950|245693|P1|COMPLETED|Overall Study||7
101721|NCT01405950|245690|P4|STARTED|Overall Study||0
101722|NCT01405950|245691|P3|STARTED|Overall Study||0
101723|NCT01405950|245692|P2|STARTED|Overall Study||2
101724|NCT01405950|245693|P1|STARTED|Overall Study||8
101725|NCT01405937|245707|P2|NOT COMPLETED|Overall Study||0
101726|NCT01405937|245708|P1|NOT COMPLETED|Overall Study||0
101727|NCT01405937|245707|P2|COMPLETED|Overall Study||26
101728|NCT01405937|245708|P1|COMPLETED|Overall Study||25
101729|NCT01405937|245707|P2|STARTED|Overall Study||26
101730|NCT01405937|245708|P1|STARTED|Overall Study||25
101731|NCT01405924|245728|P1|NOT COMPLETED|Overall Study||10
101732|NCT01405924|245728|P1|COMPLETED|Overall Study||101
101733|NCT01405924|245728|P1|STARTED|Overall Study||111
101734|NCT01405898|245740|P2|NOT COMPLETED|Overall Study||2
101735|NCT01405898|245741|P1|NOT COMPLETED|Overall Study||2
101736|NCT01405898|245740|P2|COMPLETED|Overall Study||32
101737|NCT01405898|245741|P1|COMPLETED|Overall Study||32
101738|NCT01405898|245740|P2|STARTED|Overall Study||34
101739|NCT01405898|245741|P1|STARTED|Overall Study||34
101740|NCT01405820|245765|P6|NOT COMPLETED|Open-Label Treatment Period||2
101741|NCT01405820|245766|P5|NOT COMPLETED|Open-Label Treatment Period||2
101742|NCT01405820|245767|P4|NOT COMPLETED|Open-Label Treatment Period||5
101743|NCT01405820|245768|P3|NOT COMPLETED|Open-Label Treatment Period||3
101744|NCT01405820|245769|P2|NOT COMPLETED|Open-Label Treatment Period||2
101745|NCT01405820|245770|P1|NOT COMPLETED|Open-Label Treatment Period||4
101746|NCT01405820|245765|P6|COMPLETED|Open-Label Treatment Period||30
101747|NCT01405820|245766|P5|COMPLETED|Open-Label Treatment Period||40
101748|NCT01405820|245767|P4|COMPLETED|Open-Label Treatment Period||37
101749|NCT01405820|245768|P3|COMPLETED|Open-Label Treatment Period||39
101750|NCT01405820|245769|P2|COMPLETED|Open-Label Treatment Period||33
101751|NCT01405820|245770|P1|COMPLETED|Open-Label Treatment Period||40
101752|NCT01405820|245765|P6|STARTED|Open-Label Treatment Period||32
101753|NCT01405820|245766|P5|STARTED|Open-Label Treatment Period||42
101754|NCT01405820|245767|P4|STARTED|Open-Label Treatment Period||42
101755|NCT01405820|245768|P3|STARTED|Open-Label Treatment Period||42
101756|NCT01405820|245769|P2|STARTED|Open-Label Treatment Period||35
101757|NCT01405820|245770|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
101758|NCT01405820|245765|P6|NOT COMPLETED|Randomized Treatment Period||37
101759|NCT01405820|245766|P5|NOT COMPLETED|Randomized Treatment Period||45
101760|NCT01405820|245767|P4|NOT COMPLETED|Randomized Treatment Period||51
101761|NCT01405820|245768|P3|NOT COMPLETED|Randomized Treatment Period||43
101762|NCT01405820|245769|P2|NOT COMPLETED|Randomized Treatment Period||10
101763|NCT01405820|245770|P1|NOT COMPLETED|Randomized Treatment Period||11
101764|NCT01405820|245765|P6|COMPLETED|Randomized Treatment Period||1
101765|NCT01405820|245766|P5|COMPLETED|Randomized Treatment Period||2
101766|NCT01405820|245767|P4|COMPLETED|Randomized Treatment Period||3
101767|NCT01405820|245768|P3|COMPLETED|Randomized Treatment Period||9
101768|NCT01405820|245769|P2|COMPLETED|Randomized Treatment Period||35
101769|NCT01405820|245770|P1|COMPLETED|Randomized Treatment Period||43
101770|NCT01405820|245765|P6|Safety Population|Randomized Treatment Period||38
101771|NCT01405820|245766|P5|Safety Population|Randomized Treatment Period||47
101772|NCT01405820|245767|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
101773|NCT01405820|245768|P3|Safety Population|Randomized Treatment Period||52
101774|NCT01405820|245769|P2|Safety Population|Randomized Treatment Period||45
101775|NCT01405820|245770|P1|Safety Population|Randomized Treatment Period||54
101776|NCT01405820|245765|P6|STARTED|Randomized Treatment Period||38
101777|NCT01405820|245766|P5|STARTED|Randomized Treatment Period||47
101778|NCT01405820|245767|P4|STARTED|Randomized Treatment Period||54
101779|NCT01405820|245768|P3|STARTED|Randomized Treatment Period||52
101780|NCT01405820|245769|P2|STARTED|Randomized Treatment Period||45
101781|NCT01405820|245770|P1|STARTED|Randomized Treatment Period||54
101782|NCT01405794|245790|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
101783|NCT01405794|245790|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
101784|NCT01405794|245790|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
101785|NCT01405794|245790|P1|NOT COMPLETED|72 hr Washout||0
101786|NCT01405794|245790|P1|COMPLETED|72 hr Washout||12
101787|NCT01405794|245790|P1|STARTED|72 hr Washout||12
101788|NCT01405794|245790|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
101789|NCT01405794|245790|P1|COMPLETED|First Dose Placebo (14 Days)||12
101790|NCT01405794|245790|P1|STARTED|First Dose Placebo (14 Days)||12
101791|NCT01405768|245866|P2|NOT COMPLETED|Overall Study||0
101792|NCT01405768|245867|P1|NOT COMPLETED|Overall Study||4
101793|NCT01405768|245866|P2|COMPLETED|Overall Study||28
101794|NCT01405768|245867|P1|COMPLETED|Overall Study||24
101795|NCT01405768|245866|P2|STARTED|Overall Study||28
101796|NCT01405768|245867|P1|STARTED|Overall Study||28
101797|NCT01405742|245879|P2|NOT COMPLETED|Overall Study||0
101798|NCT01405742|245880|P1|NOT COMPLETED|Overall Study||1
101799|NCT01405742|245879|P2|COMPLETED|Overall Study||2
101800|NCT01405742|245880|P1|COMPLETED|Overall Study||1
101801|NCT01405742|245879|P2|STARTED|Overall Study||2
101802|NCT01405742|245880|P1|STARTED|Overall Study||2
101803|NCT01405560|245890|P1|NOT COMPLETED|Overall Study||1
101804|NCT01405560|245890|P1|COMPLETED|Overall Study||41
101805|NCT01405560|245890|P1|STARTED|Overall Study||42
101806|NCT01405508|245905|P4|NOT COMPLETED|Overall Study||0
101807|NCT01405508|245906|P3|NOT COMPLETED|Overall Study||0
101808|NCT01405508|245907|P2|NOT COMPLETED|Overall Study||1
101809|NCT01405508|245908|P1|NOT COMPLETED|Overall Study||1
101810|NCT01405508|245905|P4|COMPLETED|Overall Study||26
101811|NCT01405508|245906|P3|COMPLETED|Overall Study||27
101812|NCT01405508|245907|P2|COMPLETED|Overall Study||25
101813|NCT01405508|245908|P1|COMPLETED|Overall Study||25
101814|NCT01405508|245905|P4|STARTED|Overall Study||26
101815|NCT01405508|245906|P3|STARTED|Overall Study||27
101816|NCT01405508|245907|P2|STARTED|Overall Study||26
101817|NCT01405508|245908|P1|STARTED|Overall Study||26
101818|NCT01405469|245926|P1|NOT COMPLETED|Overall Study||0
101819|NCT01405469|245926|P1|COMPLETED|Overall Study||16
101820|NCT01405469|245926|P1|STARTED|Overall Study||16
101821|NCT01405456|245940|P2|NOT COMPLETED|Overall Study||1
101822|NCT01405456|245941|P1|NOT COMPLETED|Overall Study||3
101823|NCT01405456|245940|P2|COMPLETED|Overall Study||20
101824|NCT01405456|245941|P1|COMPLETED|Overall Study||22
101825|NCT01405456|245940|P2|STARTED|Overall Study||21
101826|NCT01405456|245941|P1|STARTED|Overall Study||25
101827|NCT01405313|245969|P1|NOT COMPLETED|Overall Study||0
101828|NCT01405313|245969|P1|COMPLETED|Overall Study||21
101829|NCT01405313|245969|P1|STARTED|Overall Study||21
101830|NCT01405196|245981|P4|NOT COMPLETED|Overall Study||9
101831|NCT01405196|245982|P3|NOT COMPLETED|Overall Study||23
101832|NCT01405196|245983|P2|NOT COMPLETED|Overall Study||12
101833|NCT01405196|245984|P1|NOT COMPLETED|Overall Study||11
101834|NCT01405196|245981|P4|COMPLETED|Overall Study||36
101835|NCT01405196|245982|P3|COMPLETED|Overall Study||23
101836|NCT01405196|245983|P2|COMPLETED|Overall Study||35
101837|NCT01405196|245984|P1|COMPLETED|Overall Study||34
101838|NCT01405196|245981|P4|STARTED|Overall Study||45
101839|NCT01405196|245982|P3|STARTED|Overall Study||46
101840|NCT01405196|245983|P2|STARTED|Overall Study||47
101841|NCT01405196|245984|P1|STARTED|Overall Study||45
101842|NCT01405027|246071|P2|NOT COMPLETED|Overall Study||51
101843|NCT01405027|246072|P1|NOT COMPLETED|Overall Study||32
101844|NCT01405027|246071|P2|COMPLETED|Overall Study||62
101845|NCT01405027|246072|P1|COMPLETED|Overall Study||52
101846|NCT01405027|246071|P2|STARTED|Overall Study||113
101847|NCT01405027|246072|P1|STARTED|Overall Study||84
101848|NCT01404988|246089|P3|NOT COMPLETED|Overall Study||3
101849|NCT01404988|246090|P2|NOT COMPLETED|Overall Study||4
101850|NCT01404988|246091|P1|NOT COMPLETED|Overall Study||6
101851|NCT01404988|246089|P3|COMPLETED|Overall Study||30
101852|NCT01404988|246090|P2|COMPLETED|Overall Study||29
101853|NCT01404988|246091|P1|COMPLETED|Overall Study||27
101854|NCT01404988|246089|P3|STARTED|Overall Study||33
101855|NCT01404988|246090|P2|STARTED|Overall Study||33
101856|NCT01404988|246091|P1|STARTED|Overall Study||33
101857|NCT01404936|246108|P1|NOT COMPLETED|Overall Study||0
101858|NCT01404936|246108|P1|COMPLETED|Overall Study||30
101859|NCT01404936|246108|P1|STARTED|Overall Study||30
101860|NCT01404923|246114|P2|NOT COMPLETED|Overall Study||17
101861|NCT01404923|246115|P1|NOT COMPLETED|Overall Study||23
101862|NCT01404923|246114|P2|COMPLETED|Overall Study||197
101863|NCT01404923|246115|P1|COMPLETED|Overall Study||199
101864|NCT01404923|246114|P2|STARTED|Overall Study||214
101865|NCT01404923|246115|P1|STARTED|Overall Study||222
101866|NCT01404832|246123|P1|NOT COMPLETED|Overall Study||0
101867|NCT01404832|246123|P1|COMPLETED|Overall Study||21
101868|NCT01404832|246123|P1|STARTED|Overall Study||21
101869|NCT01404650|246128|P1|NOT COMPLETED|Overall Study||0
101870|NCT01404650|246128|P1|COMPLETED|Overall Study||25
101871|NCT01404650|246128|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
101872|NCT01404611|246138|P3|NOT COMPLETED|Overall Study||5
101873|NCT01404611|246139|P2|NOT COMPLETED|Overall Study||19
101874|NCT01404611|246140|P1|NOT COMPLETED|Overall Study||8
101875|NCT01404611|246138|P3|COMPLETED|Overall Study||106
101876|NCT01404611|246139|P2|COMPLETED|Overall Study||89
101877|NCT01404611|246140|P1|COMPLETED|Overall Study||104
101878|NCT01404611|246138|P3|STARTED|Overall Study||111
101879|NCT01404611|246139|P2|STARTED|Overall Study||108
101880|NCT01404611|246140|P1|STARTED|Overall Study||112
101881|NCT01404572|246148|P3|NOT COMPLETED|Overall Study||0
101882|NCT01404572|246149|P2|NOT COMPLETED|Overall Study||0
101883|NCT01404572|246150|P1|NOT COMPLETED|Overall Study||0
101884|NCT01404572|246148|P3|COMPLETED|Overall Study||4
101885|NCT01404572|246149|P2|COMPLETED|Overall Study||4
101886|NCT01404572|246150|P1|COMPLETED|Overall Study||4
101887|NCT01404572|246148|P3|STARTED|Overall Study||4
101888|NCT01404572|246149|P2|STARTED|Overall Study||4
101889|NCT01404572|246150|P1|STARTED|Overall Study||4
101890|NCT01404559|246181|P4|NOT COMPLETED|Overall Study||0
101891|NCT01404559|246182|P3|NOT COMPLETED|Overall Study||0
101892|NCT01404559|246183|P2|NOT COMPLETED|Overall Study||0
101893|NCT01404559|246184|P1|NOT COMPLETED|Overall Study||0
101894|NCT01404559|246181|P4|COMPLETED|Overall Study||14
101895|NCT01404559|246182|P3|COMPLETED|Overall Study||4
101896|NCT01404559|246183|P2|COMPLETED|Overall Study||5
101897|NCT01404559|246184|P1|COMPLETED|Overall Study||5
101898|NCT01404559|246181|P4|STARTED|Overall Study||14
101899|NCT01404559|246182|P3|STARTED|Overall Study||4
101900|NCT01404559|246183|P2|STARTED|Overall Study||5
101901|NCT01404559|246184|P1|STARTED|Overall Study||5
101902|NCT01404429|246197|P2|NOT COMPLETED|Overall Study||7
101903|NCT01404429|246198|P1|NOT COMPLETED|Overall Study||9
101904|NCT01404429|246197|P2|COMPLETED|Overall Study||46
101905|NCT01404429|246198|P1|COMPLETED|Overall Study||38
101906|NCT01404429|246197|P2|STARTED|Overall Study||53
101907|NCT01404429|246198|P1|STARTED|Overall Study||47
101908|NCT01404260|246212|P2|NOT COMPLETED|Overall Study||9
101909|NCT01404260|246213|P1|NOT COMPLETED|Overall Study||3
101910|NCT01404260|246212|P2|COMPLETED|Overall Study||101
101911|NCT01404260|246213|P1|COMPLETED|Overall Study||106
101912|NCT01404260|246212|P2|STARTED|Overall Study||110
101913|NCT01404260|246213|P1|STARTED|Overall Study||109
101914|NCT01404234|246219|P1|NOT COMPLETED|Overall Study||2
101915|NCT01404234|246219|P1|COMPLETED|Overall Study||59
101916|NCT01404234|246219|P1|STARTED|Overall Study||61
101917|NCT01404208|246235|P2|NOT COMPLETED|Overall Study||0
101918|NCT01404208|246236|P1|NOT COMPLETED|Overall Study||3
101919|NCT01404208|246235|P2|COMPLETED|Overall Study||72
101920|NCT01404208|246236|P1|COMPLETED|Overall Study||67
101921|NCT01404208|246235|P2|STARTED|Overall Study||72
101922|NCT01404208|246236|P1|STARTED|Overall Study||70
101923|NCT01404078|246246|P2|NOT COMPLETED|Overall Study||20
101924|NCT01404078|246247|P1|NOT COMPLETED|Overall Study||18
101925|NCT01404078|246246|P2|COMPLETED|Overall Study||237
101926|NCT01404078|246247|P1|COMPLETED|Overall Study||243
101927|NCT01404078|246246|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
101928|NCT01404078|246247|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
101929|NCT01404039|246262|P13|NOT COMPLETED|Overall Study||0
101930|NCT01404039|246263|P12|NOT COMPLETED|Overall Study||0
101931|NCT01404039|246264|P11|NOT COMPLETED|Overall Study||1
101932|NCT01404039|246265|P10|NOT COMPLETED|Overall Study||1
101933|NCT01404039|246266|P9|NOT COMPLETED|Overall Study||0
101934|NCT01404039|246267|P8|NOT COMPLETED|Overall Study||0
101935|NCT01404039|246268|P7|NOT COMPLETED|Overall Study||0
101936|NCT01404039|246269|P6|NOT COMPLETED|Overall Study||0
101937|NCT01404039|246270|P5|NOT COMPLETED|Overall Study||0
101938|NCT01404039|246271|P4|NOT COMPLETED|Overall Study||0
101939|NCT01404039|246272|P3|NOT COMPLETED|Overall Study||0
101940|NCT01404039|246273|P2|NOT COMPLETED|Overall Study||0
101941|NCT01404039|246274|P1|NOT COMPLETED|Overall Study||1
101942|NCT01404039|246262|P13|COMPLETED|Overall Study||0
101943|NCT01404039|246263|P12|COMPLETED|Overall Study||0
101944|NCT01404039|246264|P11|COMPLETED|Overall Study||14
101945|NCT01404039|246265|P10|COMPLETED|Overall Study||14
101946|NCT01404039|246266|P9|COMPLETED|Overall Study||15
101947|NCT01404039|246267|P8|COMPLETED|Overall Study||15
101948|NCT01404039|246268|P7|COMPLETED|Overall Study||10
101949|NCT01404039|246269|P6|COMPLETED|Overall Study||10
101950|NCT01404039|246270|P5|COMPLETED|Overall Study||10
101951|NCT01404039|246271|P4|COMPLETED|Overall Study||10
101952|NCT01404039|246272|P3|COMPLETED|Overall Study||5
101953|NCT01404039|246273|P2|COMPLETED|Overall Study||5
101954|NCT01404039|246274|P1|COMPLETED|Overall Study||4
101955|NCT01404039|246262|P13|STARTED|Overall Study||0
101956|NCT01404039|246263|P12|STARTED|Overall Study||0
101957|NCT01404039|246264|P11|STARTED|Overall Study||15
101958|NCT01404039|246265|P10|STARTED|Overall Study||15
101959|NCT01404039|246266|P9|STARTED|Overall Study||15
101960|NCT01404039|246267|P8|STARTED|Overall Study||15
101961|NCT01404039|246268|P7|STARTED|Overall Study||10
101962|NCT01404039|246269|P6|STARTED|Overall Study||10
101963|NCT01404039|246270|P5|STARTED|Overall Study||10
101964|NCT01404039|246271|P4|STARTED|Overall Study||10
101965|NCT01404039|246272|P3|STARTED|Overall Study||5
101966|NCT01404039|246273|P2|STARTED|Overall Study||5
101967|NCT01404039|246274|P1|STARTED|Overall Study||5
101968|NCT01403987|246301|P3|NOT COMPLETED|Overall Study||18
101969|NCT01403987|246302|P2|NOT COMPLETED|Overall Study||17
101970|NCT01403987|246303|P1|NOT COMPLETED|Overall Study||18
101971|NCT01403987|246301|P3|COMPLETED|Overall Study||50
101972|NCT01403987|246302|P2|COMPLETED|Overall Study||17
101973|NCT01403987|246303|P1|COMPLETED|Overall Study||16
101974|NCT01403987|246301|P3|STARTED|Overall Study||68
101975|NCT01403987|246302|P2|STARTED|Overall Study||34
101976|NCT01403987|246303|P1|STARTED|Overall Study||34
101977|NCT01403805|246319|P2|NOT COMPLETED|Overall Study||7
101978|NCT01403805|246320|P1|NOT COMPLETED|Overall Study||0
101979|NCT01403805|246319|P2|COMPLETED|Overall Study||98
101980|NCT01403805|246320|P1|COMPLETED|Overall Study||94
101981|NCT01403805|246319|P2|Pneumonia Diagnosis|Overall Study||2
101982|NCT01403805|246320|P1|Pneumonia Diagnosis|Overall Study||21
101983|NCT01403805|246319|P2|STARTED|Overall Study||105
101984|NCT01403805|246320|P1|STARTED|Overall Study||94
101985|NCT01403441|246332|P1|NOT COMPLETED|Overall Study||0
101986|NCT01403441|246332|P1|COMPLETED|Overall Study||3
101987|NCT01403441|246332|P1|STARTED|Overall Study||3
101988|NCT01403376|246342|P3|NOT COMPLETED|Overall Study||0
101989|NCT01403376|246343|P2|NOT COMPLETED|Overall Study||0
101990|NCT01403376|246344|P1|NOT COMPLETED|Overall Study||0
101991|NCT01403376|246342|P3|COMPLETED|Overall Study||46
101992|NCT01403376|246343|P2|COMPLETED|Overall Study||41
101993|NCT01403376|246344|P1|COMPLETED|Overall Study||41
101994|NCT01403376|246342|P3|STARTED|Overall Study||46
101995|NCT01403376|246343|P2|STARTED|Overall Study||41
101996|NCT01403376|246344|P1|STARTED|Overall Study||41
101997|NCT01403194|246364|P1|NOT COMPLETED|Overall Study||10
101998|NCT01403194|246364|P1|COMPLETED|Overall Study||1
101999|NCT01403194|246364|P1|STARTED|Overall Study||11
102000|NCT01403090|246370|P1|NOT COMPLETED|Overall Study||0
102001|NCT01403090|246370|P1|COMPLETED|Overall Study||8
102002|NCT01403090|246370|P1|STARTED|Overall Study||8
102003|NCT01403051|246376|P2|NOT COMPLETED|Overall Study||6
102004|NCT01403051|246377|P1|NOT COMPLETED|Overall Study||10
102005|NCT01403051|246376|P2|COMPLETED|Overall Study||80
102006|NCT01403051|246377|P1|COMPLETED|Overall Study||71
102007|NCT01403051|246376|P2|Initiated Study Treatment|Overall Study||86
102008|NCT01403051|246377|P1|Initiated Study Treatment|Overall Study||81
102009|NCT01403051|246376|P2|STARTED|Overall Study||86
102010|NCT01403051|246377|P1|STARTED|Overall Study||81
102011|NCT01402986|246413|P4|NOT COMPLETED|Overall Study||22
102012|NCT01402986|246414|P3|NOT COMPLETED|Overall Study||8
102013|NCT01402986|246415|P2|NOT COMPLETED|Overall Study||15
102014|NCT01402986|246416|P1|NOT COMPLETED|Overall Study||9
102015|NCT01402986|246413|P4|COMPLETED|Overall Study||129
102016|NCT01402986|246414|P3|COMPLETED|Overall Study||67
102017|NCT01402986|246415|P2|COMPLETED|Overall Study||135
102018|NCT01402986|246416|P1|COMPLETED|Overall Study||67
102019|NCT01402986|246413|P4|STARTED|Overall Study||151
102020|NCT01402986|246414|P3|STARTED|Overall Study||75
102021|NCT01402986|246415|P2|STARTED|Overall Study||150
102022|NCT01402986|246416|P1|STARTED|Overall Study||76
102023|NCT01402947|246551|P2|NOT COMPLETED|Second Intervention||0
102024|NCT01402947|246552|P1|NOT COMPLETED|Second Intervention||0
102025|NCT01402947|246551|P2|COMPLETED|Second Intervention||14
102026|NCT01402947|246552|P1|COMPLETED|Second Intervention||15
102027|NCT01402947|246551|P2|STARTED|Second Intervention||14
102028|NCT01402947|246552|P1|STARTED|Second Intervention||15
102029|NCT01402947|246551|P2|NOT COMPLETED|First Intervention||1
102030|NCT01402947|246552|P1|NOT COMPLETED|First Intervention||0
102031|NCT01402947|246551|P2|COMPLETED|First Intervention||14
102032|NCT01402947|246552|P1|COMPLETED|First Intervention||15
102033|NCT01402947|246551|P2|STARTED|First Intervention||15
102034|NCT01402947|246552|P1|STARTED|First Intervention||15
102035|NCT01402869|246563|P3|NOT COMPLETED|Overall Study||1
102036|NCT01402869|246564|P2|NOT COMPLETED|Overall Study||0
102037|NCT01402869|246565|P1|NOT COMPLETED|Overall Study||0
102038|NCT01402869|246563|P3|COMPLETED|Overall Study||30
102039|NCT01402869|246564|P2|COMPLETED|Overall Study||30
102040|NCT01402869|246565|P1|COMPLETED|Overall Study||30
102041|NCT01402869|246563|P3|STARTED|Overall Study||31
102042|NCT01402869|246564|P2|STARTED|Overall Study||30
102043|NCT01402869|246565|P1|STARTED|Overall Study||30
102044|NCT01402817|246579|P1|NOT COMPLETED|Overall Study||11
102045|NCT01402817|246579|P1|COMPLETED|Overall Study||8
102046|NCT01402817|246579|P1|STARTED|Overall Study||19
102047|NCT01402700|246584|P1|NOT COMPLETED|Overall Study||7
102048|NCT01402700|246584|P1|COMPLETED|Overall Study||68
102049|NCT01402700|246584|P1|STARTED|Overall Study||75
102050|NCT01402570|246588|P1|NOT COMPLETED|Overall Study||1
102051|NCT01402570|246588|P1|COMPLETED|Overall Study||19
102052|NCT01402570|246588|P1|STARTED|Overall Study||20
102053|NCT01402427|246597|P2|NOT COMPLETED|Overall Study||0
102054|NCT01402427|246598|P1|NOT COMPLETED|Overall Study||0
102055|NCT01402427|246597|P2|COMPLETED|Overall Study||294
102056|NCT01402427|246598|P1|COMPLETED|Overall Study||297
102057|NCT01402427|246597|P2|STARTED|Overall Study||294
102058|NCT01402427|246598|P1|STARTED|Overall Study||297
102059|NCT01402375|246622|P6|NOT COMPLETED|Overall Study||0
102060|NCT01402375|246623|P5|NOT COMPLETED|Overall Study||0
102061|NCT01402375|246624|P4|NOT COMPLETED|Overall Study||0
102062|NCT01402375|246625|P3|NOT COMPLETED|Overall Study||0
102063|NCT01402375|246626|P2|NOT COMPLETED|Overall Study||0
102064|NCT01402375|246627|P1|NOT COMPLETED|Overall Study||0
102065|NCT01402375|246622|P6|COMPLETED|Overall Study||120
102066|NCT01402375|246623|P5|COMPLETED|Overall Study||120
102067|NCT01402375|246624|P4|COMPLETED|Overall Study||120
102068|NCT01402375|246625|P3|COMPLETED|Overall Study||120
102069|NCT01402375|246626|P2|COMPLETED|Overall Study||120
102070|NCT01402375|246627|P1|COMPLETED|Overall Study||120
102071|NCT01402375|246622|P6|STARTED|Overall Study||120
102072|NCT01402375|246623|P5|STARTED|Overall Study||120
102073|NCT01402375|246624|P4|STARTED|Overall Study||120
102074|NCT01402375|246625|P3|STARTED|Overall Study||120
102075|NCT01402375|246626|P2|STARTED|Overall Study||120
102076|NCT01402375|246627|P1|STARTED|Overall Study||120
102077|NCT01402284|246659|P1|NOT COMPLETED|Overall Study||15
102078|NCT01402284|246659|P1|COMPLETED|Overall Study||30
102079|NCT01402284|246659|P1|STARTED|Overall Study||45
102080|NCT01402141|246672|P2|NOT COMPLETED|Overall Study||2
102081|NCT01402141|246673|P1|NOT COMPLETED|Overall Study||1
102082|NCT01402141|246672|P2|COMPLETED|Overall Study||28
102083|NCT01402141|246673|P1|COMPLETED|Overall Study||29
102084|NCT01402141|246672|P2|STARTED|Overall Study||30
102085|NCT01402141|246673|P1|STARTED|Overall Study||30
102086|NCT01402128|246695|P2|NOT COMPLETED|Overall Study||0
102087|NCT01402128|246696|P1|NOT COMPLETED|Overall Study||1
102088|NCT01402128|246695|P2|COMPLETED|Overall Study||40
102089|NCT01402128|246696|P1|COMPLETED|Overall Study||39
102090|NCT01402128|246695|P2|STARTED|Overall Study||40
102091|NCT01402128|246696|P1|STARTED|Overall Study||40
102092|NCT01402115|246724|P2|NOT COMPLETED|Overall Study||1
102093|NCT01402115|246725|P1|NOT COMPLETED|Overall Study||1
102094|NCT01402115|246724|P2|COMPLETED|Overall Study||29
102095|NCT01402115|246725|P1|COMPLETED|Overall Study||29
102096|NCT01402115|246724|P2|STARTED|Overall Study||30
102097|NCT01402115|246725|P1|STARTED|Overall Study||30
102098|NCT01402102|246741|P2|NOT COMPLETED|Overall Study||3
102099|NCT01402102|246742|P1|NOT COMPLETED|Overall Study||2
102100|NCT01402102|246741|P2|COMPLETED|Overall Study||27
102101|NCT01402102|246742|P1|COMPLETED|Overall Study||28
102102|NCT01402102|246741|P2|STARTED|Overall Study||30
102103|NCT01402102|246742|P1|STARTED|Overall Study||30
102104|NCT01402063|246762|P2|NOT COMPLETED|Overall Study||3
102105|NCT01402063|246763|P1|NOT COMPLETED|Overall Study||3
102106|NCT01402063|246762|P2|COMPLETED|Overall Study||18
102107|NCT01402063|246763|P1|COMPLETED|Overall Study||39
102108|NCT01402063|246762|P2|STARTED|Overall Study||21
102109|NCT01402063|246763|P1|STARTED|Overall Study||42
102110|NCT01401959|246772|P3|NOT COMPLETED|Treated||5
102111|NCT01401959|246773|P2|NOT COMPLETED|Treated||8
102112|NCT01401959|246774|P1|NOT COMPLETED|Treated||7
102113|NCT01401959|246772|P3|COMPLETED|Treated||26
102114|NCT01401959|246773|P2|COMPLETED|Treated||34
102115|NCT01401959|246774|P1|COMPLETED|Treated||46
102116|NCT01401959|246772|P3|STARTED|Treated||31
102117|NCT01401959|246773|P2|STARTED|Treated||42
102118|NCT01401959|246774|P1|STARTED|Treated||53
102119|NCT01401959|246772|P3|NOT COMPLETED|Enrolled||0
102120|NCT01401959|246773|P2|NOT COMPLETED|Enrolled||0
102121|NCT01401959|246774|P1|NOT COMPLETED|Enrolled||1
102122|NCT01401959|246772|P3|COMPLETED|Enrolled||31
102123|NCT01401959|246773|P2|COMPLETED|Enrolled||42
102124|NCT01401959|246774|P1|COMPLETED|Enrolled||53
102125|NCT01401959|246772|P3|STARTED|Enrolled||31
102126|NCT01401959|246773|P2|STARTED|Enrolled||42
102127|NCT01401959|246774|P1|STARTED|Enrolled||54
102128|NCT01401907|246790|P2|NOT COMPLETED|Overall Study||51
102129|NCT01401907|246791|P1|NOT COMPLETED|Overall Study||57
102130|NCT01401907|246790|P2|COMPLETED|Overall Study||124
102131|NCT01401907|246791|P1|COMPLETED|Overall Study||118
102132|NCT01401907|246790|P2|12 Week Outcomes|Overall Study||153
102133|NCT01401907|246791|P1|12 Week Outcomes|Overall Study||148
102134|NCT01401907|246790|P2|STARTED|Overall Study||175
102135|NCT01401907|246791|P1|STARTED|Overall Study||175
102136|NCT01401842|246811|P2|NOT COMPLETED|Overall Study||67
102137|NCT01401842|246812|P1|NOT COMPLETED|Overall Study||68
102138|NCT01401842|246811|P2|COMPLETED|Overall Study||217
102139|NCT01401842|246812|P1|COMPLETED|Overall Study||230
102140|NCT01401842|246811|P2|STARTED|Overall Study||284
102141|NCT01401842|246812|P1|STARTED|Overall Study||298
102142|NCT01401647|246825|P3|NOT COMPLETED|Overall Study||3
102143|NCT01401647|246826|P2|NOT COMPLETED|Overall Study||8
102144|NCT01401647|246827|P1|NOT COMPLETED|Overall Study||4
102145|NCT01401647|246825|P3|COMPLETED|Overall Study||1056
102146|NCT01401647|246826|P2|COMPLETED|Overall Study||985
102147|NCT01401647|246827|P1|COMPLETED|Overall Study||968
102148|NCT01401647|246825|P3|STARTED|Overall Study||1059
102149|NCT01401647|246826|P2|STARTED|Overall Study||993
102150|NCT01401647|246827|P1|STARTED|Overall Study||972
102151|NCT01401595|246840|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
102152|NCT01401595|246841|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
102153|NCT01401595|246840|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
102154|NCT01401595|246841|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
102155|NCT01401595|246840|P2|STARTED|Imaging and Treatment (for NE Arm)||10
102156|NCT01401595|246841|P1|STARTED|Imaging and Treatment (for NE Arm)||32
102157|NCT01401595|246840|P2|NOT COMPLETED|Recruitment and Screening||2
102158|NCT01401595|246841|P1|NOT COMPLETED|Recruitment and Screening||43
102159|NCT01401595|246840|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
102160|NCT01401595|246841|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
102161|NCT01401595|246840|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
102162|NCT01401595|246841|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
102163|NCT01401582|246852|P2|NOT COMPLETED|Overall Study||117
102164|NCT01401582|246853|P1|NOT COMPLETED|Overall Study||110
102165|NCT01401582|246852|P2|COMPLETED|Overall Study||291
102166|NCT01401582|246853|P1|COMPLETED|Overall Study||116
102167|NCT01401582|246852|P2|Baseline Completed|Overall Study||348
102168|NCT01401582|246853|P1|Baseline Completed|Overall Study||168
102169|NCT01401582|246852|P2|STARTED|Overall Study||408
102170|NCT01401582|246853|P1|STARTED|Overall Study||226
102171|NCT01401517|246872|P3|NOT COMPLETED|Overall Study||3
102172|NCT01401517|246873|P2|NOT COMPLETED|Overall Study||2
102173|NCT01401517|246874|P1|NOT COMPLETED|Overall Study||3
102174|NCT01401517|246872|P3|COMPLETED|Overall Study||15
102175|NCT01401517|246873|P2|COMPLETED|Overall Study||17
102176|NCT01401517|246874|P1|COMPLETED|Overall Study||15
102177|NCT01401517|246872|P3|STARTED|Overall Study||18
102178|NCT01401517|246873|P2|STARTED|Overall Study||19
102179|NCT01401517|246874|P1|STARTED|Overall Study||18
102180|NCT01401478|246882|P1|NOT COMPLETED|Overall Study||31
102181|NCT01401478|246882|P1|COMPLETED|Overall Study||55
102182|NCT01401478|246882|P1|STARTED|Overall Study||86
102183|NCT01401465|246895|P2|NOT COMPLETED|Treatment Period 2||2
102184|NCT01401465|246896|P1|NOT COMPLETED|Treatment Period 2||0
102185|NCT01401465|246895|P2|COMPLETED|Treatment Period 2||144
102186|NCT01401465|246896|P1|COMPLETED|Treatment Period 2||150
102187|NCT01401465|246895|P2|STARTED|Treatment Period 2||146
102188|NCT01401465|246896|P1|STARTED|Treatment Period 2||150
102189|NCT01401465|246895|P2|NOT COMPLETED|Washout||0
102190|NCT01401465|246896|P1|NOT COMPLETED|Washout||0
102191|NCT01401465|246895|P2|COMPLETED|Washout||146
102192|NCT01401465|246896|P1|COMPLETED|Washout||150
102193|NCT01401465|246895|P2|STARTED|Washout||146
102194|NCT01401465|246896|P1|STARTED|Washout||150
102195|NCT01401465|246895|P2|NOT COMPLETED|Treatment Period 1||16
102196|NCT01401465|246896|P1|NOT COMPLETED|Treatment Period 1||15
102197|NCT01401465|246895|P2|COMPLETED|Treatment Period 1||146
102198|NCT01401465|246896|P1|COMPLETED|Treatment Period 1||150
102199|NCT01401465|246895|P2|STARTED|Treatment Period 1||162
102200|NCT01401465|246896|P1|STARTED|Treatment Period 1||165
102201|NCT01401452|246959|P1|NOT COMPLETED|Overall Study||72
102202|NCT01401452|246959|P1|COMPLETED|Overall Study||174
102203|NCT01401452|246959|P1|Visit 5 (9 Months)|Overall Study||175
102204|NCT01401452|246959|P1|Visit 4 (6 Months)|Overall Study||172
102205|NCT01401452|246959|P1|Visit 3 (3 Months)|Overall Study||217
102206|NCT01401452|246959|P1|Visit 2 (1 Month)|Overall Study||225
102207|NCT01401452|246959|P1|Visit 1 (Baseline)|Overall Study||246
102208|NCT01401452|246959|P1|STARTED|Overall Study||246
102209|NCT01401361|246971|P1|NOT COMPLETED|Overall Study||28
102210|NCT01401361|246971|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
102211|NCT01401361|246971|P1|STARTED|Overall Study||150
102212|NCT01401322|246977|P1|NOT COMPLETED|Overall Study||2
102213|NCT01401322|246977|P1|COMPLETED|Overall Study||3
102214|NCT01401322|246977|P1|STARTED|Overall Study||5
102215|NCT01401283|246983|P2|NOT COMPLETED|Overall Study||10
102216|NCT01401283|246984|P1|NOT COMPLETED|Overall Study||10
102217|NCT01401283|246983|P2|COMPLETED|Overall Study||81
102218|NCT01401283|246984|P1|COMPLETED|Overall Study||79
102219|NCT01401283|246983|P2|STARTED|Overall Study||91
102220|NCT01401283|246984|P1|STARTED|Overall Study||89
102221|NCT01401257|246996|P4|NOT COMPLETED|Overall Study||2
102222|NCT01401257|246997|P3|NOT COMPLETED|Overall Study||3
102223|NCT01401257|246998|P2|NOT COMPLETED|Overall Study||2
102224|NCT01401257|246999|P1|NOT COMPLETED|Overall Study||0
102225|NCT01401257|246996|P4|COMPLETED|Overall Study||17
102226|NCT01401257|246997|P3|COMPLETED|Overall Study||16
102227|NCT01401257|246998|P2|COMPLETED|Overall Study||19
102228|NCT01401257|246999|P1|COMPLETED|Overall Study||21
102229|NCT01401257|246996|P4|STARTED|Overall Study||19
102230|NCT01401257|246997|P3|STARTED|Overall Study||19
102231|NCT01401257|246998|P2|STARTED|Overall Study||21
102232|NCT01401257|246999|P1|STARTED|Overall Study||21
102233|NCT01401166|247011|P4|NOT COMPLETED|Safety Follow-Up Period||19
102234|NCT01401166|247012|P3|NOT COMPLETED|Safety Follow-Up Period||17
102235|NCT01401166|247013|P2|NOT COMPLETED|Safety Follow-Up Period||18
102236|NCT01401166|247014|P1|NOT COMPLETED|Safety Follow-Up Period||25
102237|NCT01401166|247011|P4|COMPLETED|Safety Follow-Up Period||100
102238|NCT01401166|247012|P3|COMPLETED|Safety Follow-Up Period||104
102239|NCT01401166|247013|P2|COMPLETED|Safety Follow-Up Period||106
102240|NCT01401166|247014|P1|COMPLETED|Safety Follow-Up Period||99
102241|NCT01401166|247011|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
102242|NCT01401166|247012|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
102243|NCT01401166|247013|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
102244|NCT01401166|247014|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
102245|NCT01401166|247011|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
102246|NCT01401166|247012|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
102247|NCT01401166|247013|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
102248|NCT01401166|247014|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
102249|NCT01401166|247011|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
102250|NCT01401166|247012|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
102251|NCT01401166|247013|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
102252|NCT01401166|247014|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
102253|NCT01401166|247011|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
102254|NCT01401166|247012|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
102255|NCT01401166|247013|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
102256|NCT01401166|247014|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
102257|NCT01401166|247011|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
102258|NCT01401166|247012|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
102259|NCT01401166|247013|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
102260|NCT01401166|247014|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
102261|NCT01401166|247011|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
102262|NCT01401166|247012|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
102263|NCT01401166|247013|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
102264|NCT01401166|247014|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
102265|NCT01401166|247011|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
102266|NCT01401166|247012|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
102267|NCT01401166|247013|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
102268|NCT01401166|247014|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
102269|NCT01401166|247011|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
102270|NCT01401166|247012|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
102271|NCT01401166|247013|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
102272|NCT01401166|247014|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
102273|NCT01401166|247011|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
102274|NCT01401166|247012|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
102275|NCT01401166|247013|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
102276|NCT01401166|247014|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
102277|NCT01401166|247011|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
102278|NCT01401166|247012|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
102279|NCT01401166|247013|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
102280|NCT01401166|247014|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
102281|NCT01401153|247050|P2|NOT COMPLETED|Second Test Day||5
102282|NCT01401153|247051|P1|NOT COMPLETED|Second Test Day||0
102283|NCT01401153|247050|P2|COMPLETED|Second Test Day||60
102284|NCT01401153|247051|P1|COMPLETED|Second Test Day||45
102285|NCT01401153|247050|P2|STARTED|Second Test Day||65
102286|NCT01401153|247051|P1|STARTED|Second Test Day||45
102287|NCT01401153|247050|P2|NOT COMPLETED|First Test Day||10
102288|NCT01401153|247051|P1|NOT COMPLETED|First Test Day||1
102289|NCT01401153|247050|P2|COMPLETED|First Test Day||45
102290|NCT01401153|247051|P1|COMPLETED|First Test Day||65
102291|NCT01401153|247050|P2|STARTED|First Test Day||55
102292|NCT01401153|247051|P1|STARTED|First Test Day||66
102293|NCT01401101|247085|P2|NOT COMPLETED|Overall Study||27
102294|NCT01401101|247086|P1|NOT COMPLETED|Overall Study||22
102295|NCT01401101|247085|P2|COMPLETED|Overall Study||171
102296|NCT01401101|247086|P1|COMPLETED|Overall Study||184
102297|NCT01401101|247085|P2|STARTED|Overall Study||198
102298|NCT01401101|247086|P1|STARTED|Overall Study||206
102299|NCT01401062|247098|P2|NOT COMPLETED|Overall Study||8
102300|NCT01401062|247099|P1|NOT COMPLETED|Overall Study||11
102301|NCT01401062|247098|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
102302|NCT01401062|247099|P1|COMPLETED|Overall Study||0
102303|NCT01401062|247098|P2|STARTED|Overall Study||12
102304|NCT01401062|247099|P1|STARTED|Overall Study||11
102305|NCT01401049|247107|P2|NOT COMPLETED|Overall Study||0
102306|NCT01401049|247108|P1|NOT COMPLETED|Overall Study||0
102307|NCT01401049|247107|P2|COMPLETED|Overall Study||0
102308|NCT01401049|247108|P1|COMPLETED|Overall Study||0
102309|NCT01401049|247107|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
102310|NCT01401049|247108|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
102311|NCT01401023|247116|P1|NOT COMPLETED|Overall Study||0
102312|NCT01401023|247116|P1|COMPLETED|Overall Study||10
102313|NCT01401023|247116|P1|STARTED|Overall Study||10
102314|NCT01401010|247124|P2|NOT COMPLETED|Overall Study||0
102315|NCT01401010|247125|P1|NOT COMPLETED|Overall Study||1
102316|NCT01401010|247124|P2|COMPLETED|Overall Study||6
102317|NCT01401010|247125|P1|COMPLETED|Overall Study||5
102318|NCT01401010|247124|P2|STARTED|Overall Study||6
102319|NCT01401010|247125|P1|STARTED|Overall Study||6
102320|NCT01400958|247150|P2|NOT COMPLETED|Overall Study||2
102321|NCT01400958|247151|P1|NOT COMPLETED|Overall Study||1
102322|NCT01400958|247150|P2|COMPLETED|Overall Study||1
102323|NCT01400958|247151|P1|COMPLETED|Overall Study||2
102324|NCT01400958|247150|P2|STARTED|Overall Study||3
102325|NCT01400958|247151|P1|STARTED|Overall Study||3
102326|NCT01400932|247161|P2|NOT COMPLETED|Overall Study||15
102327|NCT01400932|247162|P1|NOT COMPLETED|Overall Study||14
102328|NCT01400932|247161|P2|COMPLETED|Overall Study||167
102329|NCT01400932|247162|P1|COMPLETED|Overall Study||164
102330|NCT01400932|247161|P2|STARTED|Overall Study||182
102331|NCT01400932|247162|P1|STARTED|Overall Study||178
102332|NCT01400919|247184|P1|NOT COMPLETED|Overall Study||8
102333|NCT01400919|247184|P1|COMPLETED|Overall Study||67
102334|NCT01400919|247184|P1|STARTED|Overall Study||75
102335|NCT01400906|247188|P6|NOT COMPLETED|Treatment Period 3||0
102336|NCT01400906|247189|P5|NOT COMPLETED|Treatment Period 3||0
102337|NCT01400906|247190|P4|NOT COMPLETED|Treatment Period 3||0
102338|NCT01400906|247191|P3|NOT COMPLETED|Treatment Period 3||0
102339|NCT01400906|247192|P2|NOT COMPLETED|Treatment Period 3||0
102340|NCT01400906|247193|P1|NOT COMPLETED|Treatment Period 3||0
102341|NCT01400906|247188|P6|COMPLETED|Treatment Period 3||5
102342|NCT01400906|247189|P5|COMPLETED|Treatment Period 3||6
102343|NCT01400906|247190|P4|COMPLETED|Treatment Period 3||6
102344|NCT01400906|247191|P3|COMPLETED|Treatment Period 3||6
102345|NCT01400906|247192|P2|COMPLETED|Treatment Period 3||6
102346|NCT01400906|247193|P1|COMPLETED|Treatment Period 3||6
102347|NCT01400906|247188|P6|STARTED|Treatment Period 3||5
102348|NCT01400906|247189|P5|STARTED|Treatment Period 3||6
102349|NCT01400906|247190|P4|STARTED|Treatment Period 3||6
102350|NCT01400906|247191|P3|STARTED|Treatment Period 3||6
102351|NCT01400906|247192|P2|STARTED|Treatment Period 3||6
102352|NCT01400906|247193|P1|STARTED|Treatment Period 3||6
102353|NCT01400906|247188|P6|NOT COMPLETED|Washout Period 2||0
102354|NCT01400906|247189|P5|NOT COMPLETED|Washout Period 2||0
102355|NCT01400906|247190|P4|NOT COMPLETED|Washout Period 2||0
102356|NCT01400906|247191|P3|NOT COMPLETED|Washout Period 2||0
102357|NCT01400906|247192|P2|NOT COMPLETED|Washout Period 2||0
102358|NCT01400906|247193|P1|NOT COMPLETED|Washout Period 2||0
102359|NCT01400906|247188|P6|COMPLETED|Washout Period 2||5
102360|NCT01400906|247189|P5|COMPLETED|Washout Period 2||6
102361|NCT01400906|247190|P4|COMPLETED|Washout Period 2||6
102362|NCT01400906|247191|P3|COMPLETED|Washout Period 2||6
102363|NCT01400906|247192|P2|COMPLETED|Washout Period 2||6
102364|NCT01400906|247193|P1|COMPLETED|Washout Period 2||6
102365|NCT01400906|247188|P6|STARTED|Washout Period 2||5
102366|NCT01400906|247189|P5|STARTED|Washout Period 2||6
102367|NCT01400906|247190|P4|STARTED|Washout Period 2||6
102368|NCT01400906|247191|P3|STARTED|Washout Period 2||6
102369|NCT01400906|247192|P2|STARTED|Washout Period 2||6
102370|NCT01400906|247193|P1|STARTED|Washout Period 2||6
102371|NCT01400906|247188|P6|NOT COMPLETED|Treatment Period 2||0
102372|NCT01400906|247189|P5|NOT COMPLETED|Treatment Period 2||0
102373|NCT01400906|247190|P4|NOT COMPLETED|Treatment Period 2||0
102374|NCT01400906|247191|P3|NOT COMPLETED|Treatment Period 2||0
102375|NCT01400906|247192|P2|NOT COMPLETED|Treatment Period 2||0
102376|NCT01400906|247193|P1|NOT COMPLETED|Treatment Period 2||0
102377|NCT01400906|247188|P6|COMPLETED|Treatment Period 2||5
102378|NCT01400906|247189|P5|COMPLETED|Treatment Period 2||6
102379|NCT01400906|247190|P4|COMPLETED|Treatment Period 2||6
102380|NCT01400906|247191|P3|COMPLETED|Treatment Period 2||6
102381|NCT01400906|247192|P2|COMPLETED|Treatment Period 2||6
102382|NCT01400906|247193|P1|COMPLETED|Treatment Period 2||6
102383|NCT01400906|247188|P6|STARTED|Treatment Period 2||5
102384|NCT01400906|247189|P5|STARTED|Treatment Period 2||6
102385|NCT01400906|247190|P4|STARTED|Treatment Period 2||6
102386|NCT01400906|247191|P3|STARTED|Treatment Period 2||6
102387|NCT01400906|247192|P2|STARTED|Treatment Period 2||6
102388|NCT01400906|247193|P1|STARTED|Treatment Period 2||6
102389|NCT01400906|247188|P6|NOT COMPLETED|Washout Period 1||0
102390|NCT01400906|247189|P5|NOT COMPLETED|Washout Period 1||0
102391|NCT01400906|247190|P4|NOT COMPLETED|Washout Period 1||0
102392|NCT01400906|247191|P3|NOT COMPLETED|Washout Period 1||0
102393|NCT01400906|247192|P2|NOT COMPLETED|Washout Period 1||0
102394|NCT01400906|247193|P1|NOT COMPLETED|Washout Period 1||0
102395|NCT01400906|247188|P6|COMPLETED|Washout Period 1||5
102396|NCT01400906|247189|P5|COMPLETED|Washout Period 1||6
102397|NCT01400906|247190|P4|COMPLETED|Washout Period 1||6
102398|NCT01400906|247191|P3|COMPLETED|Washout Period 1||6
102399|NCT01400906|247192|P2|COMPLETED|Washout Period 1||6
102400|NCT01400906|247193|P1|COMPLETED|Washout Period 1||6
102401|NCT01400906|247188|P6|STARTED|Washout Period 1||5
102402|NCT01400906|247189|P5|STARTED|Washout Period 1||6
102403|NCT01400906|247190|P4|STARTED|Washout Period 1||6
102404|NCT01400906|247191|P3|STARTED|Washout Period 1||6
102405|NCT01400906|247192|P2|STARTED|Washout Period 1||6
102406|NCT01400906|247193|P1|STARTED|Washout Period 1||6
102407|NCT01400906|247188|P6|NOT COMPLETED|Treatment Period 1||0
102408|NCT01400906|247189|P5|NOT COMPLETED|Treatment Period 1||0
102409|NCT01400906|247190|P4|NOT COMPLETED|Treatment Period 1||0
102410|NCT01400906|247191|P3|NOT COMPLETED|Treatment Period 1||0
102411|NCT01400906|247192|P2|NOT COMPLETED|Treatment Period 1||0
102412|NCT01400906|247193|P1|NOT COMPLETED|Treatment Period 1||0
102413|NCT01400906|247188|P6|COMPLETED|Treatment Period 1||5
102414|NCT01400906|247189|P5|COMPLETED|Treatment Period 1||6
102415|NCT01400906|247190|P4|COMPLETED|Treatment Period 1||6
102416|NCT01400906|247191|P3|COMPLETED|Treatment Period 1||6
102417|NCT01400906|247192|P2|COMPLETED|Treatment Period 1||6
102418|NCT01400906|247193|P1|COMPLETED|Treatment Period 1||6
102419|NCT01400906|247188|P6|STARTED|Treatment Period 1||5
102420|NCT01400906|247189|P5|STARTED|Treatment Period 1||6
102421|NCT01400906|247190|P4|STARTED|Treatment Period 1||6
102422|NCT01400906|247191|P3|STARTED|Treatment Period 1||6
102423|NCT01400906|247192|P2|STARTED|Treatment Period 1||6
102424|NCT01400906|247193|P1|STARTED|Treatment Period 1||6
102425|NCT01400893|247227|P2|NOT COMPLETED|Overall Study||27
102426|NCT01400893|247228|P1|NOT COMPLETED|Overall Study||27
102427|NCT01400893|247227|P2|COMPLETED|Overall Study||38
102428|NCT01400893|247228|P1|COMPLETED|Overall Study||42
102429|NCT01400893|247227|P2|STARTED|Overall Study||65
102430|NCT01400893|247228|P1|STARTED|Overall Study||69
102431|NCT01400880|247236|P1|NOT COMPLETED|Overall Study||2
102432|NCT01400880|247236|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
102433|NCT01400880|247236|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
102434|NCT01400841|247240|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
102435|NCT01400841|247240|P1|COMPLETED|Extended Study Phase (2 Years)||11
102436|NCT01400841|247240|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
102437|NCT01400841|247240|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
102438|NCT01400841|247240|P1|COMPLETED|Initial Study Phase (6 Months)||15
102439|NCT01400841|247240|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
102440|NCT01400698|247278|P6|NOT COMPLETED|Overall Study||6
102441|NCT01400698|247279|P5|NOT COMPLETED|Overall Study||7
102442|NCT01400698|247280|P4|NOT COMPLETED|Overall Study||8
102443|NCT01400698|247281|P3|NOT COMPLETED|Overall Study||2
102444|NCT01400698|247282|P2|NOT COMPLETED|Overall Study||11
102445|NCT01400698|247283|P1|NOT COMPLETED|Overall Study||15
102446|NCT01400698|247278|P6|COMPLETED|Overall Study||9
102447|NCT01400698|247279|P5|COMPLETED|Overall Study||7
102448|NCT01400698|247280|P4|COMPLETED|Overall Study||6
102449|NCT01400698|247281|P3|COMPLETED|Overall Study||0
102450|NCT01400698|247282|P2|COMPLETED|Overall Study||12
102451|NCT01400698|247283|P1|COMPLETED|Overall Study||8
102452|NCT01400698|247278|P6|STARTED|Overall Study||15
102453|NCT01400698|247279|P5|STARTED|Overall Study||14
102454|NCT01400698|247280|P4|STARTED|Overall Study||14
102455|NCT01400698|247281|P3|STARTED|Overall Study||2
102456|NCT01400698|247282|P2|STARTED|Overall Study||23
102457|NCT01400698|247283|P1|STARTED|Overall Study||23
102458|NCT01400516|247307|P2|NOT COMPLETED|Extension Trial||0
102459|NCT01400516|247308|P1|NOT COMPLETED|Extension Trial||0
102460|NCT01400516|247307|P2|COMPLETED|Extension Trial||7
102461|NCT01400516|247308|P1|COMPLETED|Extension Trial||6
102462|NCT01400516|247307|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
102549|NCT01399697|247503|P2|NOT COMPLETED|Overall Study||3
102463|NCT01400516|247308|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
102464|NCT01400516|247307|P2|NOT COMPLETED|Primary Trial||2
102465|NCT01400516|247308|P1|NOT COMPLETED|Primary Trial||0
102466|NCT01400516|247307|P2|COMPLETED|Primary Trial||12
102467|NCT01400516|247308|P1|COMPLETED|Primary Trial||12
102468|NCT01400516|247307|P2|STARTED|Primary Trial||14
102469|NCT01400516|247308|P1|STARTED|Primary Trial||12
102470|NCT01400503|247318|P1|NOT COMPLETED|Overall Study||60
102471|NCT01400503|247318|P1|COMPLETED|Overall Study||0
102472|NCT01400503|247318|P1|STARTED|Overall Study||60
102473|NCT01400451|247330|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
102474|NCT01400451|247331|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
102475|NCT01400451|247332|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
102476|NCT01400451|247330|P3|COMPLETED|Combination Treatment (or Intended)||0
102477|NCT01400451|247331|P2|COMPLETED|Combination Treatment (or Intended)||0
102478|NCT01400451|247332|P1|COMPLETED|Combination Treatment (or Intended)||0
102479|NCT01400451|247330|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
102480|NCT01400451|247331|P2|STARTED|Combination Treatment (or Intended)||4
102481|NCT01400451|247332|P1|STARTED|Combination Treatment (or Intended)||6
102482|NCT01400451|247330|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
102483|NCT01400451|247331|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
102484|NCT01400451|247332|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
102485|NCT01400451|247330|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
102486|NCT01400451|247331|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
102487|NCT01400451|247332|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
102488|NCT01400451|247330|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
102489|NCT01400451|247331|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
102490|NCT01400451|247332|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
102491|NCT01400425|247346|P1|NOT COMPLETED|Overall Study||10
102492|NCT01400425|247346|P1|COMPLETED|Overall Study||229
102493|NCT01400425|247346|P1|STARTED|Overall Study||239
102494|NCT01400412|247359|P2|NOT COMPLETED|Overall Study||17
102495|NCT01400412|247360|P1|NOT COMPLETED|Overall Study||10
102496|NCT01400412|247359|P2|COMPLETED|Overall Study||115
102497|NCT01400412|247360|P1|COMPLETED|Overall Study||120
102498|NCT01400412|247359|P2|STARTED|Overall Study||132
102499|NCT01400412|247360|P1|STARTED|Overall Study||130
102500|NCT01400243|247406|P2|NOT COMPLETED|Overall Study||11
102501|NCT01400243|247407|P1|NOT COMPLETED|Overall Study||8
102502|NCT01400243|247406|P2|COMPLETED|Overall Study||52
102503|NCT01400243|247407|P1|COMPLETED|Overall Study||56
102504|NCT01400243|247406|P2|STARTED|Overall Study||63
102505|NCT01400243|247407|P1|STARTED|Overall Study||64
102506|NCT01400139|247429|P1|NOT COMPLETED|HYD Extension Period||23
102507|NCT01400139|247429|P1|COMPLETED|HYD Extension Period||83
102508|NCT01400139|247429|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
102509|NCT01400139|247429|P1|NOT COMPLETED|HYD Core Study||512
102510|NCT01400139|247429|P1|COMPLETED|HYD Core Study||410
102511|NCT01400139|247429|P1|STARTED|HYD Core Study||922
102512|NCT01400113|247439|P2|NOT COMPLETED|Overall Study||1
102513|NCT01400113|247440|P1|NOT COMPLETED|Overall Study||1
102514|NCT01400113|247439|P2|COMPLETED|Overall Study||59
102515|NCT01400113|247440|P1|COMPLETED|Overall Study||59
102516|NCT01400113|247439|P2|STARTED|Overall Study||60
102517|NCT01400113|247440|P1|STARTED|Overall Study||60
102518|NCT01399866|247448|P2|NOT COMPLETED|Overall Study||2
102519|NCT01399866|247449|P1|NOT COMPLETED|Overall Study||4
102520|NCT01399866|247448|P2|COMPLETED|Overall Study||28
102521|NCT01399866|247449|P1|COMPLETED|Overall Study||28
102522|NCT01399866|247448|P2|STARTED|Overall Study||30
102523|NCT01399866|247449|P1|STARTED|Overall Study||32
102524|NCT01399788|247465|P2|NOT COMPLETED|Second Intervention Period||0
102525|NCT01399788|247466|P1|NOT COMPLETED|Second Intervention Period||0
102526|NCT01399788|247465|P2|COMPLETED|Second Intervention Period||18
102527|NCT01399788|247466|P1|COMPLETED|Second Intervention Period||17
102528|NCT01399788|247465|P2|STARTED|Second Intervention Period||18
102529|NCT01399788|247466|P1|STARTED|Second Intervention Period||17
102530|NCT01399788|247465|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
102531|NCT01399788|247466|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
102532|NCT01399788|247465|P2|COMPLETED|Washout Period (at Least 1 Week)||18
102533|NCT01399788|247466|P1|COMPLETED|Washout Period (at Least 1 Week)||17
102534|NCT01399788|247465|P2|STARTED|Washout Period (at Least 1 Week)||18
102535|NCT01399788|247466|P1|STARTED|Washout Period (at Least 1 Week)||17
102536|NCT01399788|247465|P2|NOT COMPLETED|First Intervention Period||0
102537|NCT01399788|247466|P1|NOT COMPLETED|First Intervention Period||1
102538|NCT01399788|247465|P2|COMPLETED|First Intervention Period||18
102539|NCT01399788|247466|P1|COMPLETED|First Intervention Period||17
102540|NCT01399788|247465|P2|STARTED|First Intervention Period||18
102541|NCT01399788|247466|P1|STARTED|First Intervention Period||18
102542|NCT01399723|247488|P2|NOT COMPLETED|Overall Study||1
102543|NCT01399723|247489|P1|NOT COMPLETED|Overall Study||0
102544|NCT01399723|247488|P2|COMPLETED|Overall Study||263
102545|NCT01399723|247489|P1|COMPLETED|Overall Study||263
102546|NCT01399723|247488|P2|STARTED|Overall Study||264
102547|NCT01399723|247489|P1|STARTED|Overall Study||263
102548|NCT01399697|247502|P3|NOT COMPLETED|Overall Study||4
102550|NCT01399697|247504|P1|NOT COMPLETED|Overall Study||41
102551|NCT01399697|247502|P3|COMPLETED|Overall Study||78
102552|NCT01399697|247503|P2|COMPLETED|Overall Study||80
102553|NCT01399697|247504|P1|COMPLETED|Overall Study||55
102554|NCT01399697|247502|P3|STARTED|Overall Study||82
102555|NCT01399697|247503|P2|STARTED|Overall Study||83
102556|NCT01399697|247504|P1|STARTED|Overall Study||96
102557|NCT01399619|247531|P4|NOT COMPLETED|Overall Study||17
102558|NCT01399619|247532|P3|NOT COMPLETED|Overall Study||12
102559|NCT01399619|247533|P2|NOT COMPLETED|Overall Study||0
102560|NCT01399619|247534|P1|NOT COMPLETED|Overall Study||25
102561|NCT01399619|247531|P4|COMPLETED|Overall Study||0
102562|NCT01399619|247532|P3|COMPLETED|Overall Study||74
102563|NCT01399619|247533|P2|COMPLETED|Overall Study||84
102564|NCT01399619|247534|P1|COMPLETED|Overall Study||98
102565|NCT01399619|247531|P4|STARTED|Overall Study||17
102566|NCT01399619|247532|P3|STARTED|Overall Study||86
102567|NCT01399619|247533|P2|STARTED|Overall Study||84
102568|NCT01399619|247534|P1|STARTED|Overall Study||123
102569|NCT01399593|247597|P2|NOT COMPLETED|Overall Study||2
102570|NCT01399593|247598|P1|NOT COMPLETED|Overall Study||3
102571|NCT01399593|247597|P2|COMPLETED|Overall Study||49
102572|NCT01399593|247598|P1|COMPLETED|Overall Study||48
102573|NCT01399593|247597|P2|STARTED|Overall Study||51
102574|NCT01399593|247598|P1|STARTED|Overall Study||51
102575|NCT01399268|247606|P2|NOT COMPLETED|Overall Study||0
102576|NCT01399268|247607|P1|NOT COMPLETED|Overall Study||0
102577|NCT01399268|247606|P2|COMPLETED|Overall Study||15
102578|NCT01399268|247607|P1|COMPLETED|Overall Study||15
102579|NCT01399268|247606|P2|STARTED|Overall Study||15
102580|NCT01399268|247607|P1|STARTED|Overall Study||15
102581|NCT01399229|247625|P3|NOT COMPLETED|Overall Study||0
102582|NCT01399229|247626|P2|NOT COMPLETED|Overall Study||0
102583|NCT01399229|247627|P1|NOT COMPLETED|Overall Study||0
102584|NCT01399229|247625|P3|COMPLETED|Overall Study||5
102585|NCT01399229|247626|P2|COMPLETED|Overall Study||5
102586|NCT01399229|247627|P1|COMPLETED|Overall Study||20
102587|NCT01399229|247625|P3|STARTED|Overall Study||5
102588|NCT01399229|247626|P2|STARTED|Overall Study||5
102589|NCT01399229|247627|P1|STARTED|Overall Study||20
102590|NCT01399190|247631|P1|NOT COMPLETED|Overall Study||20
102591|NCT01399190|247631|P1|COMPLETED|Overall Study||48
102592|NCT01399190|247631|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
102593|NCT01399190|247631|P1|Included in Final Analysis|Overall Study||63
102594|NCT01399190|247631|P1|STARTED|Overall Study||68
102595|NCT01399125|247639|P2|NOT COMPLETED|Overall Study||60
102596|NCT01399125|247640|P1|NOT COMPLETED|Overall Study||51
102597|NCT01399125|247639|P2|COMPLETED|Overall Study||193
102598|NCT01399125|247640|P1|COMPLETED|Overall Study||197
102599|NCT01399125|247639|P2|Per Protocol (PP) Population|Overall Study||188
102600|NCT01399125|247640|P1|Per Protocol (PP) Population|Overall Study||192
102601|NCT01399125|247639|P2|STARTED|Overall Study||253
102602|NCT01399125|247640|P1|STARTED|Overall Study||248
102603|NCT01399099|247654|P1|NOT COMPLETED|Overall Study||31
102604|NCT01399099|247654|P1|COMPLETED|Overall Study||36
102605|NCT01399099|247654|P1|6 Months|Overall Study||47
102606|NCT01399099|247654|P1|STARTED|Overall Study||67
102607|NCT01399047|247661|P2|NOT COMPLETED|Overall Study||1
102608|NCT01399047|247662|P1|NOT COMPLETED|Overall Study||0
102609|NCT01399047|247661|P2|COMPLETED|Overall Study||8
102610|NCT01399047|247662|P1|COMPLETED|Overall Study||10
102611|NCT01399047|247661|P2|STARTED|Overall Study||9
102612|NCT01399047|247662|P1|STARTED|Overall Study||10
102613|NCT01399008|247671|P3|NOT COMPLETED|Overall Study||2
102614|NCT01399008|247672|P2|NOT COMPLETED|Overall Study||5
102615|NCT01399008|247673|P1|NOT COMPLETED|Overall Study||3
102616|NCT01399008|247671|P3|COMPLETED|Overall Study||31
102617|NCT01399008|247672|P2|COMPLETED|Overall Study||27
102618|NCT01399008|247673|P1|COMPLETED|Overall Study||32
102619|NCT01399008|247671|P3|STARTED|Overall Study||33
102620|NCT01399008|247672|P2|STARTED|Overall Study||32
102621|NCT01399008|247673|P1|STARTED|Overall Study||35
102622|NCT01398982|247683|P2|NOT COMPLETED|Overall Study||2
102623|NCT01398982|247684|P1|NOT COMPLETED|Overall Study||6
102624|NCT01398982|247683|P2|COMPLETED|Overall Study||47
102625|NCT01398982|247684|P1|COMPLETED|Overall Study||38
102626|NCT01398982|247683|P2|STARTED|Overall Study||49
102627|NCT01398982|247684|P1|STARTED|Overall Study||44
102628|NCT01398956|247690|P1|NOT COMPLETED|Overall Study||10
102629|NCT01398956|247690|P1|COMPLETED|Overall Study||34
102630|NCT01398956|247690|P1|STARTED|Overall Study||44
102631|NCT01398943|247698|P4|NOT COMPLETED|Second Intervention (1 Day)||0
102632|NCT01398943|247699|P3|NOT COMPLETED|Second Intervention (1 Day)||0
102633|NCT01398943|247700|P2|NOT COMPLETED|Second Intervention (1 Day)||0
102634|NCT01398943|247701|P1|NOT COMPLETED|Second Intervention (1 Day)||0
102635|NCT01398943|247698|P4|COMPLETED|Second Intervention (1 Day)||15
102636|NCT01398943|247699|P3|COMPLETED|Second Intervention (1 Day)||15
102637|NCT01398943|247700|P2|COMPLETED|Second Intervention (1 Day)||15
102638|NCT01398943|247701|P1|COMPLETED|Second Intervention (1 Day)||15
102639|NCT01398943|247698|P4|STARTED|Second Intervention (1 Day)||15
102640|NCT01398943|247699|P3|STARTED|Second Intervention (1 Day)||15
102641|NCT01398943|247700|P2|STARTED|Second Intervention (1 Day)||15
102642|NCT01398943|247701|P1|STARTED|Second Intervention (1 Day)||15
102643|NCT01398943|247698|P4|NOT COMPLETED|Washout (2-7 Days)||0
102644|NCT01398943|247699|P3|NOT COMPLETED|Washout (2-7 Days)||0
102645|NCT01398943|247700|P2|NOT COMPLETED|Washout (2-7 Days)||0
102646|NCT01398943|247701|P1|NOT COMPLETED|Washout (2-7 Days)||0
102647|NCT01398943|247698|P4|COMPLETED|Washout (2-7 Days)||15
102648|NCT01398943|247699|P3|COMPLETED|Washout (2-7 Days)||15
102649|NCT01398943|247700|P2|COMPLETED|Washout (2-7 Days)||15
102650|NCT01398943|247701|P1|COMPLETED|Washout (2-7 Days)||15
102651|NCT01398943|247698|P4|STARTED|Washout (2-7 Days)||15
102652|NCT01398943|247699|P3|STARTED|Washout (2-7 Days)||15
102653|NCT01398943|247700|P2|STARTED|Washout (2-7 Days)||15
102654|NCT01398943|247701|P1|STARTED|Washout (2-7 Days)||15
102655|NCT01398943|247698|P4|NOT COMPLETED|First Intervention (1 Day)||0
102656|NCT01398943|247699|P3|NOT COMPLETED|First Intervention (1 Day)||0
102657|NCT01398943|247700|P2|NOT COMPLETED|First Intervention (1 Day)||0
102658|NCT01398943|247701|P1|NOT COMPLETED|First Intervention (1 Day)||0
102659|NCT01398943|247698|P4|COMPLETED|First Intervention (1 Day)||15
102660|NCT01398943|247699|P3|COMPLETED|First Intervention (1 Day)||15
102661|NCT01398943|247700|P2|COMPLETED|First Intervention (1 Day)||15
102662|NCT01398943|247701|P1|COMPLETED|First Intervention (1 Day)||15
102663|NCT01398943|247698|P4|STARTED|First Intervention (1 Day)||15
102664|NCT01398943|247699|P3|STARTED|First Intervention (1 Day)||15
102665|NCT01398943|247700|P2|STARTED|First Intervention (1 Day)||15
102666|NCT01398943|247701|P1|STARTED|First Intervention (1 Day)||15
102667|NCT01398852|247709|P1|NOT COMPLETED|Overall Study||372
102668|NCT01398852|247709|P1|COMPLETED|Overall Study||0
102669|NCT01398852|247709|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
102670|NCT01398839|247715|P2|NOT COMPLETED|Overall Study||0
102671|NCT01398839|247716|P1|NOT COMPLETED|Overall Study||0
102672|NCT01398839|247715|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
102673|NCT01398839|247716|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
102674|NCT01398839|247715|P2|STARTED|Overall Study||37
102675|NCT01398839|247716|P1|STARTED|Overall Study||35
102676|NCT01398787|247722|P1|NOT COMPLETED|Overall Study||1
102677|NCT01398787|247722|P1|COMPLETED|Overall Study||197
102678|NCT01398787|247722|P1|STARTED|Overall Study||198
102679|NCT01398514|247740|P2|NOT COMPLETED|Overall Study||6
102680|NCT01398514|247741|P1|NOT COMPLETED|Overall Study||8
102681|NCT01398514|247740|P2|COMPLETED|Overall Study||20
102682|NCT01398514|247741|P1|COMPLETED|Overall Study||18
102683|NCT01398514|247740|P2|STARTED|Overall Study||26
102684|NCT01398514|247741|P1|STARTED|Overall Study||26
102685|NCT01398475|247753|P4|NOT COMPLETED|Overall Study||0
102686|NCT01398475|247754|P3|NOT COMPLETED|Overall Study||0
102687|NCT01398475|247755|P2|NOT COMPLETED|Overall Study||0
102688|NCT01398475|247756|P1|NOT COMPLETED|Overall Study||0
102689|NCT01398475|247753|P4|COMPLETED|Overall Study||4
102690|NCT01398475|247754|P3|COMPLETED|Overall Study||4
102691|NCT01398475|247755|P2|COMPLETED|Overall Study||3
102692|NCT01398475|247756|P1|COMPLETED|Overall Study||4
102693|NCT01398475|247753|P4|Received Fourth Intervention|Overall Study||4
102694|NCT01398475|247754|P3|Received Fourth Intervention|Overall Study||4
102695|NCT01398475|247755|P2|Received Fourth Intervention|Overall Study||3
102696|NCT01398475|247756|P1|Received Fourth Intervention|Overall Study||4
102697|NCT01398475|247753|P4|Received Third Intervention|Overall Study||4
102698|NCT01398475|247754|P3|Received Third Intervention|Overall Study||4
102699|NCT01398475|247755|P2|Received Third Intervention|Overall Study||3
102700|NCT01398475|247756|P1|Received Third Intervention|Overall Study||4
102701|NCT01398475|247753|P4|Received Second Intervention|Overall Study||4
102702|NCT01398475|247754|P3|Received Second Intervention|Overall Study||4
102703|NCT01398475|247755|P2|Received Second Intervention|Overall Study||3
102704|NCT01398475|247756|P1|Received Second Intervention|Overall Study||4
102705|NCT01398475|247753|P4|Received First Intervention|Overall Study||4
102706|NCT01398475|247754|P3|Received First Intervention|Overall Study||4
102707|NCT01398475|247755|P2|Received First Intervention|Overall Study||3
102708|NCT01398475|247756|P1|Received First Intervention|Overall Study||4
102709|NCT01398475|247753|P4|STARTED|Overall Study||4
102710|NCT01398475|247754|P3|STARTED|Overall Study||4
102711|NCT01398475|247755|P2|STARTED|Overall Study||3
102712|NCT01398475|247756|P1|STARTED|Overall Study||4
102713|NCT01398410|247776|P2|NOT COMPLETED|Overall Study||56
102714|NCT01398410|247777|P1|NOT COMPLETED|Overall Study||58
102715|NCT01398410|247776|P2|COMPLETED|Overall Study||148
102716|NCT01398410|247777|P1|COMPLETED|Overall Study||143
102717|NCT01398410|247776|P2|STARTED|Overall Study||204
102718|NCT01398410|247777|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
102719|NCT01398358|247788|P3|NOT COMPLETED|Overall Study||21
102720|NCT01398358|247789|P2|NOT COMPLETED|Overall Study||23
102721|NCT01398358|247790|P1|NOT COMPLETED|Overall Study||15
102722|NCT01398358|247788|P3|COMPLETED|Overall Study||234
102723|NCT01398358|247789|P2|COMPLETED|Overall Study||201
102724|NCT01398358|247790|P1|COMPLETED|Overall Study||203
102725|NCT01398358|247788|P3|STARTED|Overall Study||255
102726|NCT01398358|247789|P2|STARTED|Overall Study||224
102727|NCT01398358|247790|P1|STARTED|Overall Study||218
102728|NCT01398176|247803|P2|NOT COMPLETED|Overall Study||6
102729|NCT01398176|247804|P1|NOT COMPLETED|Overall Study||3
102730|NCT01398176|247803|P2|COMPLETED|Overall Study||19
102731|NCT01398176|247804|P1|COMPLETED|Overall Study||23
102732|NCT01398176|247803|P2|STARTED|Overall Study||25
102733|NCT01398176|247804|P1|STARTED|Overall Study||26
102734|NCT01397890|247812|P2|NOT COMPLETED|Overall Study||31
102735|NCT01397890|247813|P1|NOT COMPLETED|Overall Study||23
102736|NCT01397890|247812|P2|COMPLETED|Overall Study||260
102737|NCT01397890|247813|P1|COMPLETED|Overall Study||264
102738|NCT01397890|247812|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
102739|NCT01397890|247813|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
102740|NCT01397890|247812|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
102741|NCT01397890|247813|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
102742|NCT01397890|247812|P2|STARTED|Overall Study||291
102743|NCT01397890|247813|P1|STARTED|Overall Study||287
102744|NCT01397851|247867|P2|NOT COMPLETED|Overall Study||46
102745|NCT01397851|247868|P1|NOT COMPLETED|Overall Study||79
102746|NCT01397851|247867|P2|COMPLETED|Overall Study||39917
102747|NCT01397851|247868|P1|COMPLETED|Overall Study||41555
102748|NCT01397851|247867|P2|STARTED|Overall Study||39963
102749|NCT01397851|247868|P1|STARTED|Overall Study||41634
102750|NCT01397825|247884|P5|NOT COMPLETED|Overall Study||0
102751|NCT01397825|247885|P4|NOT COMPLETED|Overall Study||3
102752|NCT01397825|247886|P3|NOT COMPLETED|Overall Study||25
102753|NCT01397825|247887|P2|NOT COMPLETED|Overall Study||4
102754|NCT01397825|247888|P1|NOT COMPLETED|Overall Study||13
102755|NCT01397825|247884|P5|COMPLETED|Overall Study||0
102756|NCT01397825|247885|P4|COMPLETED|Overall Study||0
102757|NCT01397825|247886|P3|COMPLETED|Overall Study||0
102758|NCT01397825|247887|P2|COMPLETED|Overall Study||0
102759|NCT01397825|247888|P1|COMPLETED|Overall Study||0
102760|NCT01397825|247884|P5|STARTED|Overall Study||0
102761|NCT01397825|247885|P4|STARTED|Overall Study||3
102762|NCT01397825|247886|P3|STARTED|Overall Study||25
102763|NCT01397825|247887|P2|STARTED|Overall Study||4
102764|NCT01397825|247888|P1|STARTED|Overall Study||13
102765|NCT01397786|247958|P3|NOT COMPLETED|Phase B||138
102766|NCT01397786|247959|P2|NOT COMPLETED|Phase B||95
102767|NCT01397786|247960|P1|NOT COMPLETED|Phase B||303
102768|NCT01397786|247958|P3|COMPLETED|Phase B||91
102769|NCT01397786|247959|P2|COMPLETED|Phase B||109
102770|NCT01397786|247960|P1|COMPLETED|Phase B||308
102771|NCT01397786|247958|P3|STARTED|Phase B||229
102772|NCT01397786|247959|P2|STARTED|Phase B||204
102773|NCT01397786|247960|P1|STARTED|Phase B||611
102774|NCT01397786|247958|P3|NOT COMPLETED|Phase A||28
102775|NCT01397786|247959|P2|NOT COMPLETED|Phase A||0
102776|NCT01397786|247960|P1|NOT COMPLETED|Phase A||0
102777|NCT01397786|247958|P3|COMPLETED|Phase A||199
102778|NCT01397786|247959|P2|COMPLETED|Phase A||0
102779|NCT01397786|247960|P1|COMPLETED|Phase A||12
102780|NCT01397786|247958|P3|STARTED|Phase A||227
102781|NCT01397786|247959|P2|STARTED|Phase A||0
102782|NCT01397786|247960|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
102783|NCT01397747|248026|P1|NOT COMPLETED|Overall Study||1027
102784|NCT01397747|248026|P1|COMPLETED|Overall Study||9989
102785|NCT01397747|248026|P1|STARTED|Overall Study||11016
102786|NCT01397617|248034|P3|NOT COMPLETED|Overall Study||29
102787|NCT01397617|248035|P2|NOT COMPLETED|Overall Study||23
102788|NCT01397617|248036|P1|NOT COMPLETED|Overall Study||31
102789|NCT01397617|248034|P3|COMPLETED|Overall Study||31
102790|NCT01397617|248035|P2|COMPLETED|Overall Study||30
102791|NCT01397617|248036|P1|COMPLETED|Overall Study||33
102792|NCT01397617|248034|P3|STARTED|Overall Study||60
102793|NCT01397617|248035|P2|STARTED|Overall Study||53
102794|NCT01397617|248036|P1|STARTED|Overall Study||64
102795|NCT01397591|248047|P1|NOT COMPLETED|Overall Study||0
102796|NCT01397591|248047|P1|COMPLETED|Overall Study||2
102797|NCT01397591|248047|P1|STARTED|Overall Study||2
102798|NCT01397461|248058|P3|NOT COMPLETED|Overall Study||2
102799|NCT01397461|248059|P2|NOT COMPLETED|Overall Study||6
102800|NCT01397461|248060|P1|NOT COMPLETED|Overall Study||2
102801|NCT01397461|248058|P3|COMPLETED|Overall Study||152
102802|NCT01397461|248059|P2|COMPLETED|Overall Study||150
102803|NCT01397461|248060|P1|COMPLETED|Overall Study||153
102804|NCT01397461|248058|P3|STARTED|Overall Study||154
102805|NCT01397461|248059|P2|STARTED|Overall Study||156
102806|NCT01397461|248060|P1|STARTED|Overall Study||155
102807|NCT01397448|248071|P3|NOT COMPLETED|Overall Study||18
102808|NCT01397448|248072|P2|NOT COMPLETED|Overall Study||15
102809|NCT01397448|248073|P1|NOT COMPLETED|Overall Study||18
102810|NCT01397448|248071|P3|COMPLETED|Overall Study||140
102811|NCT01397448|248072|P2|COMPLETED|Overall Study||142
102812|NCT01397448|248073|P1|COMPLETED|Overall Study||138
102813|NCT01397448|248071|P3|STARTED|Overall Study||158
102814|NCT01397448|248072|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
102815|NCT01397448|248073|P1|STARTED|Overall Study||156
102816|NCT01397422|248088|P4|NOT COMPLETED|Overall Study||8
102817|NCT01397422|248089|P3|NOT COMPLETED|Overall Study||3
102818|NCT01397422|248090|P2|NOT COMPLETED|Overall Study||3
102819|NCT01397422|248091|P1|NOT COMPLETED|Overall Study||2
102820|NCT01397422|248088|P4|COMPLETED|Overall Study||12
102821|NCT01397422|248089|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
102822|NCT01397422|248090|P2|COMPLETED|Overall Study||17
102823|NCT01397422|248091|P1|COMPLETED|Overall Study||20
102824|NCT01397422|248088|P4|STARTED|Overall Study||20
102825|NCT01397422|248089|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
102826|NCT01397422|248090|P2|STARTED|Overall Study||20
102827|NCT01397422|248091|P1|STARTED|Overall Study||22
102828|NCT01397409|248131|P10|NOT COMPLETED|Stage 3||0
102829|NCT01397409|248132|P9|NOT COMPLETED|Stage 3||0
102830|NCT01397409|248133|P8|NOT COMPLETED|Stage 3||2
102831|NCT01397409|248134|P7|NOT COMPLETED|Stage 3||0
102832|NCT01397409|248135|P6|NOT COMPLETED|Stage 3||0
102833|NCT01397409|248136|P5|NOT COMPLETED|Stage 3||0
102834|NCT01397409|248137|P4|NOT COMPLETED|Stage 3||0
102835|NCT01397409|248138|P3|NOT COMPLETED|Stage 3||0
102836|NCT01397409|248139|P2|NOT COMPLETED|Stage 3||0
102837|NCT01397409|248140|P1|NOT COMPLETED|Stage 3||0
102838|NCT01397409|248131|P10|COMPLETED|Stage 3||16
102839|NCT01397409|248132|P9|COMPLETED|Stage 3||25
102840|NCT01397409|248133|P8|COMPLETED|Stage 3||21
102841|NCT01397409|248134|P7|COMPLETED|Stage 3||0
102842|NCT01397409|248135|P6|COMPLETED|Stage 3||0
102843|NCT01397409|248136|P5|COMPLETED|Stage 3||0
102844|NCT01397409|248137|P4|COMPLETED|Stage 3||0
102845|NCT01397409|248138|P3|COMPLETED|Stage 3||0
102846|NCT01397409|248139|P2|COMPLETED|Stage 3||0
102847|NCT01397409|248140|P1|COMPLETED|Stage 3||0
102848|NCT01397409|248131|P10|STARTED|Stage 3||16
102849|NCT01397409|248132|P9|STARTED|Stage 3||25
102850|NCT01397409|248133|P8|STARTED|Stage 3||23
102851|NCT01397409|248134|P7|STARTED|Stage 3||0
102852|NCT01397409|248135|P6|STARTED|Stage 3||0
102853|NCT01397409|248136|P5|STARTED|Stage 3||0
102854|NCT01397409|248137|P4|STARTED|Stage 3||0
102855|NCT01397409|248138|P3|STARTED|Stage 3||0
102856|NCT01397409|248139|P2|STARTED|Stage 3||0
102857|NCT01397409|248140|P1|STARTED|Stage 3||0
102858|NCT01397409|248131|P10|NOT COMPLETED|Stage 2||0
102859|NCT01397409|248132|P9|NOT COMPLETED|Stage 2||0
102860|NCT01397409|248133|P8|NOT COMPLETED|Stage 2||0
102861|NCT01397409|248134|P7|NOT COMPLETED|Stage 2||0
102862|NCT01397409|248135|P6|NOT COMPLETED|Stage 2||4
102863|NCT01397409|248136|P5|NOT COMPLETED|Stage 2||8
102864|NCT01397409|248137|P4|NOT COMPLETED|Stage 2||0
102865|NCT01397409|248138|P3|NOT COMPLETED|Stage 2||0
102866|NCT01397409|248139|P2|NOT COMPLETED|Stage 2||0
102867|NCT01397409|248140|P1|NOT COMPLETED|Stage 2||0
102868|NCT01397409|248131|P10|COMPLETED|Stage 2||0
102869|NCT01397409|248132|P9|COMPLETED|Stage 2||0
102870|NCT01397409|248133|P8|COMPLETED|Stage 2||0
102871|NCT01397409|248134|P7|COMPLETED|Stage 2||58
102872|NCT01397409|248135|P6|COMPLETED|Stage 2||54
102873|NCT01397409|248136|P5|COMPLETED|Stage 2||59
102874|NCT01397409|248137|P4|COMPLETED|Stage 2||0
102875|NCT01397409|248138|P3|COMPLETED|Stage 2||0
102876|NCT01397409|248139|P2|COMPLETED|Stage 2||0
102877|NCT01397409|248140|P1|COMPLETED|Stage 2||0
102878|NCT01397409|248131|P10|STARTED|Stage 2||0
102879|NCT01397409|248132|P9|STARTED|Stage 2||0
102880|NCT01397409|248133|P8|STARTED|Stage 2||0
102881|NCT01397409|248134|P7|STARTED|Stage 2||58
102882|NCT01397409|248135|P6|STARTED|Stage 2||58
102883|NCT01397409|248136|P5|STARTED|Stage 2||67
102884|NCT01397409|248137|P4|STARTED|Stage 2||0
102885|NCT01397409|248138|P3|STARTED|Stage 2||0
102886|NCT01397409|248139|P2|STARTED|Stage 2||0
102887|NCT01397409|248140|P1|STARTED|Stage 2||0
102888|NCT01397409|248131|P10|NOT COMPLETED|Stage 1||0
102889|NCT01397409|248132|P9|NOT COMPLETED|Stage 1||0
102890|NCT01397409|248133|P8|NOT COMPLETED|Stage 1||0
102891|NCT01397409|248134|P7|NOT COMPLETED|Stage 1||0
102892|NCT01397409|248135|P6|NOT COMPLETED|Stage 1||0
102893|NCT01397409|248136|P5|NOT COMPLETED|Stage 1||0
102894|NCT01397409|248137|P4|NOT COMPLETED|Stage 1||0
102895|NCT01397409|248138|P3|NOT COMPLETED|Stage 1||0
102896|NCT01397409|248139|P2|NOT COMPLETED|Stage 1||0
102897|NCT01397409|248140|P1|NOT COMPLETED|Stage 1||0
102898|NCT01397409|248131|P10|COMPLETED|Stage 1||0
102899|NCT01397409|248132|P9|COMPLETED|Stage 1||0
102900|NCT01397409|248133|P8|COMPLETED|Stage 1||0
102901|NCT01397409|248134|P7|COMPLETED|Stage 1||0
102902|NCT01397409|248135|P6|COMPLETED|Stage 1||0
102903|NCT01397409|248136|P5|COMPLETED|Stage 1||0
102904|NCT01397409|248137|P4|COMPLETED|Stage 1||3
102905|NCT01397409|248138|P3|COMPLETED|Stage 1||6
102906|NCT01397409|248139|P2|COMPLETED|Stage 1||6
102907|NCT01397409|248140|P1|COMPLETED|Stage 1||9
102908|NCT01397409|248131|P10|STARTED|Stage 1||0
102909|NCT01397409|248132|P9|STARTED|Stage 1||0
102910|NCT01397409|248133|P8|STARTED|Stage 1||0
102911|NCT01397409|248134|P7|STARTED|Stage 1||0
102912|NCT01397409|248135|P6|STARTED|Stage 1||0
102913|NCT01397409|248136|P5|STARTED|Stage 1||0
102914|NCT01397409|248137|P4|STARTED|Stage 1||3
102915|NCT01397409|248138|P3|STARTED|Stage 1||6
102916|NCT01397409|248139|P2|STARTED|Stage 1||6
102917|NCT01397409|248140|P1|STARTED|Stage 1||9
102918|NCT01397253|248180|P2|NOT COMPLETED|Overall Study||149
102919|NCT01397253|248181|P1|NOT COMPLETED|Overall Study||126
102920|NCT01397253|248180|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
102921|NCT01397253|248181|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
102922|NCT01397253|248180|P2|STARTED|Overall Study||392
102923|NCT01397253|248181|P1|STARTED|Overall Study||443
102924|NCT01397084|248187|P1|NOT COMPLETED|Overall Study||8
102925|NCT01397084|248187|P1|COMPLETED|Overall Study||100
102926|NCT01397084|248187|P1|STARTED|Overall Study||108
102927|NCT01396525|248194|P1|NOT COMPLETED|Overall Study||26
102928|NCT01396525|248194|P1|COMPLETED|Overall Study||127
102929|NCT01396525|248194|P1|STARTED|Overall Study||153
102930|NCT01396512|248294|P2|NOT COMPLETED|Overall Study||1
102931|NCT01396512|248295|P1|NOT COMPLETED|Overall Study||0
102932|NCT01396512|248294|P2|COMPLETED|Overall Study||136
102933|NCT01396512|248295|P1|COMPLETED|Overall Study||137
102934|NCT01396512|248294|P2|STARTED|Overall Study||137
102935|NCT01396512|248295|P1|STARTED|Overall Study||137
102936|NCT01396447|248311|P4|NOT COMPLETED|Overall Study||52
102937|NCT01396447|248312|P3|NOT COMPLETED|Overall Study||30
102938|NCT01396447|248313|P2|NOT COMPLETED|Overall Study||40
102939|NCT01396447|248314|P1|NOT COMPLETED|Overall Study||43
102940|NCT01396447|248311|P4|COMPLETED|Overall Study||94
102941|NCT01396447|248312|P3|COMPLETED|Overall Study||117
102942|NCT01396447|248313|P2|COMPLETED|Overall Study||103
102943|NCT01396447|248314|P1|COMPLETED|Overall Study||105
102944|NCT01396447|248311|P4|Received Treatment|Overall Study||146
102945|NCT01396447|248312|P3|Received Treatment|Overall Study||146
102946|NCT01396447|248313|P2|Received Treatment|Overall Study||141
102947|NCT01396447|248314|P1|Received Treatment|Overall Study||145
102948|NCT01396447|248311|P4|STARTED|Overall Study||146
102949|NCT01396447|248312|P3|STARTED|Overall Study||147
102950|NCT01396447|248313|P2|STARTED|Overall Study||143
102951|NCT01396447|248314|P1|STARTED|Overall Study||148
102952|NCT01396434|248331|P3|NOT COMPLETED|Overall Study||0
102953|NCT01396434|248332|P2|NOT COMPLETED|Overall Study||0
102954|NCT01396434|248333|P1|NOT COMPLETED|Overall Study||11
102955|NCT01396434|248331|P3|COMPLETED|Overall Study||14
102956|NCT01396434|248332|P2|COMPLETED|Overall Study||175
102957|NCT01396434|248333|P1|COMPLETED|Overall Study||2806
102958|NCT01396434|248331|P3|STARTED|Overall Study||14
102959|NCT01396434|248332|P2|STARTED|Overall Study||175
102960|NCT01396434|248333|P1|STARTED|Overall Study||2817
102961|NCT01396421|248345|P4|NOT COMPLETED|Overall Study||75
102962|NCT01396421|248346|P3|NOT COMPLETED|Overall Study||34
102963|NCT01396421|248347|P2|NOT COMPLETED|Overall Study||58
102964|NCT01396421|248348|P1|NOT COMPLETED|Overall Study||59
102965|NCT01396421|248345|P4|COMPLETED|Overall Study||109
102966|NCT01396421|248346|P3|COMPLETED|Overall Study||56
102967|NCT01396421|248347|P2|COMPLETED|Overall Study||124
102968|NCT01396421|248348|P1|COMPLETED|Overall Study||121
102969|NCT01396421|248345|P4|STARTED|Overall Study||184
102970|NCT01396421|248346|P3|STARTED|Overall Study||90
102971|NCT01396421|248347|P2|STARTED|Overall Study||182
102972|NCT01396421|248348|P1|STARTED|Overall Study||180
102973|NCT01396395|248420|P2|NOT COMPLETED|Overall Study||27
102974|NCT01396395|248421|P1|NOT COMPLETED|Overall Study||40
102975|NCT01396395|248420|P2|COMPLETED|Overall Study||175
102976|NCT01396395|248421|P1|COMPLETED|Overall Study||160
102977|NCT01396395|248420|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
102978|NCT01396395|248421|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
102979|NCT01396395|248420|P2|STARTED|Overall Study||202
102980|NCT01396395|248421|P1|STARTED|Overall Study||200
102981|NCT01396382|248456|P1|NOT COMPLETED|Overall Study||0
102982|NCT01396382|248456|P1|COMPLETED|Overall Study||97
102983|NCT01396382|248456|P1|STARTED|Overall Study||97
102984|NCT01396317|248463|P2|NOT COMPLETED|Overall Study||0
102985|NCT01396317|248464|P1|NOT COMPLETED|Overall Study||1
102986|NCT01396317|248463|P2|COMPLETED|Overall Study||10
102987|NCT01396317|248464|P1|COMPLETED|Overall Study||9
102988|NCT01396317|248463|P2|STARTED|Overall Study||10
102989|NCT01396317|248464|P1|STARTED|Overall Study||10
102990|NCT01396265|248478|P1|NOT COMPLETED|Rifa+Afatinib||1
102991|NCT01396265|248478|P1|COMPLETED|Rifa+Afatinib||21
102992|NCT01396265|248478|P1|STARTED|Rifa+Afatinib||22
102993|NCT01396265|248478|P1|NOT COMPLETED|Washout||0
102994|NCT01396265|248478|P1|COMPLETED|Washout||22
102995|NCT01396265|248478|P1|STARTED|Washout||22
102996|NCT01396265|248478|P1|NOT COMPLETED|Afatinib||0
102997|NCT01396265|248478|P1|COMPLETED|Afatinib||22
102998|NCT01396265|248478|P1|STARTED|Afatinib||22
102999|NCT01396239|248505|P4|NOT COMPLETED|Overall Study||0
103000|NCT01396239|248506|P3|NOT COMPLETED|Overall Study||0
103001|NCT01396239|248507|P2|NOT COMPLETED|Overall Study||0
103002|NCT01396239|248508|P1|NOT COMPLETED|Overall Study||0
103003|NCT01396239|248505|P4|COMPLETED|Overall Study||2
103004|NCT01396239|248506|P3|COMPLETED|Overall Study||4
103005|NCT01396239|248507|P2|COMPLETED|Overall Study||2
103006|NCT01396239|248508|P1|COMPLETED|Overall Study||4
103007|NCT01396239|248505|P4|STARTED|Overall Study||2
103008|NCT01396239|248506|P3|STARTED|Overall Study||4
103009|NCT01396239|248507|P2|STARTED|Overall Study||2
103010|NCT01396239|248508|P1|STARTED|Overall Study||4
103011|NCT01396226|248531|P2|NOT COMPLETED|Overall Study||0
103012|NCT01396226|248532|P1|NOT COMPLETED|Overall Study||0
103013|NCT01396226|248531|P2|COMPLETED|Overall Study||6
103014|NCT01396226|248532|P1|COMPLETED|Overall Study||12
103015|NCT01396226|248531|P2|Patients Who Completed Treatment|Overall Study||6
103016|NCT01396226|248532|P1|Patients Who Completed Treatment|Overall Study||12
103017|NCT01396226|248531|P2|Patients Who Received Treatment|Overall Study||6
103018|NCT01396226|248532|P1|Patients Who Received Treatment|Overall Study||12
103019|NCT01396226|248531|P2|STARTED|Overall Study||6
103020|NCT01396226|248532|P1|STARTED|Overall Study||12
103021|NCT01396187|248567|P5|NOT COMPLETED|Overall Study||1
103022|NCT01396187|248568|P4|NOT COMPLETED|Overall Study||0
103023|NCT01396187|248569|P3|NOT COMPLETED|Overall Study||1
103024|NCT01396187|248570|P2|NOT COMPLETED|Overall Study||3
103025|NCT01396187|248571|P1|NOT COMPLETED|Overall Study||1
103026|NCT01396187|248567|P5|COMPLETED|Overall Study||9
103027|NCT01396187|248568|P4|COMPLETED|Overall Study||10
103028|NCT01396187|248569|P3|COMPLETED|Overall Study||9
103029|NCT01396187|248570|P2|COMPLETED|Overall Study||9
103030|NCT01396187|248571|P1|COMPLETED|Overall Study||7
103031|NCT01396187|248567|P5|STARTED|Overall Study||10
103032|NCT01396187|248568|P4|STARTED|Overall Study||10
103033|NCT01396187|248569|P3|STARTED|Overall Study||10
103034|NCT01396187|248570|P2|STARTED|Overall Study||12
103035|NCT01396187|248571|P1|STARTED|Overall Study||8
103036|NCT01396161|248671|P7|NOT COMPLETED|Overall Study||1
103037|NCT01396161|248672|P6|NOT COMPLETED|Overall Study||0
103038|NCT01396161|248673|P5|NOT COMPLETED|Overall Study||1
103039|NCT01396161|248674|P4|NOT COMPLETED|Overall Study||0
103040|NCT01396161|248675|P3|NOT COMPLETED|Overall Study||0
103041|NCT01396161|248676|P2|NOT COMPLETED|Overall Study||0
103042|NCT01396161|248677|P1|NOT COMPLETED|Overall Study||0
103043|NCT01396161|248671|P7|COMPLETED|Overall Study||10
103044|NCT01396161|248672|P6|COMPLETED|Overall Study||9
103045|NCT01396161|248673|P5|COMPLETED|Overall Study||8
103046|NCT01396161|248674|P4|COMPLETED|Overall Study||9
103047|NCT01396161|248675|P3|COMPLETED|Overall Study||9
103048|NCT01396161|248676|P2|COMPLETED|Overall Study||5
103049|NCT01396161|248677|P1|COMPLETED|Overall Study||12
103050|NCT01396161|248671|P7|STARTED|Overall Study||11
103051|NCT01396161|248672|P6|STARTED|Overall Study||9
103052|NCT01396161|248673|P5|STARTED|Overall Study||9
103053|NCT01396161|248674|P4|STARTED|Overall Study||9
103054|NCT01396161|248675|P3|STARTED|Overall Study||9
103055|NCT01396161|248676|P2|STARTED|Overall Study||5
103056|NCT01396161|248677|P1|STARTED|Overall Study||12
103057|NCT01396148|248730|P1|NOT COMPLETED|Overall Study||1
103058|NCT01396148|248730|P1|COMPLETED|Overall Study||5
103059|NCT01396148|248730|P1|STARTED|Overall Study||6
103060|NCT01396083|248757|P2|NOT COMPLETED|Overall Study||47
103061|NCT01396083|248758|P1|NOT COMPLETED|Overall Study||11
103062|NCT01396083|248757|P2|COMPLETED|Overall Study||72
103063|NCT01396083|248758|P1|COMPLETED|Overall Study||113
103064|NCT01396083|248757|P2|STARTED|Overall Study||119
103065|NCT01396083|248758|P1|STARTED|Overall Study||124
103066|NCT01396070|248782|P1|NOT COMPLETED|Overall Study||19
103067|NCT01396070|248782|P1|COMPLETED|Overall Study||17
103068|NCT01396070|248782|P1|STARTED|Overall Study||36
103069|NCT01396057|248791|P2|NOT COMPLETED|Overall Study||18
103070|NCT01396057|248792|P1|NOT COMPLETED|Overall Study||11
103071|NCT01396057|248791|P2|COMPLETED|Overall Study||100
103072|NCT01396057|248792|P1|COMPLETED|Overall Study||115
103073|NCT01396057|248791|P2|STARTED|Overall Study||118
103074|NCT01396057|248792|P1|STARTED|Overall Study||126
103075|NCT01396044|248818|P2|NOT COMPLETED|Overall Study||0
103076|NCT01396044|248819|P1|NOT COMPLETED|Overall Study||0
103077|NCT01396044|248818|P2|COMPLETED|Overall Study||171
103078|NCT01396044|248819|P1|COMPLETED|Overall Study||125
103079|NCT01396044|248818|P2|STARTED|Overall Study||171
103080|NCT01396044|248819|P1|STARTED|Overall Study||125
103081|NCT01396005|248841|P2|NOT COMPLETED|Overall Study||2
103082|NCT01396005|248842|P1|NOT COMPLETED|Overall Study||0
103083|NCT01396005|248841|P2|COMPLETED|Overall Study||9
103084|NCT01396005|248842|P1|COMPLETED|Overall Study||10
103085|NCT01396005|248841|P2|STARTED|Overall Study||11
103086|NCT01396005|248842|P1|STARTED|Overall Study||10
103087|NCT01395966|248861|P3|NOT COMPLETED|Overall Study||8
103088|NCT01395966|248862|P2|NOT COMPLETED|Overall Study||19
103089|NCT01395966|248863|P1|NOT COMPLETED|Overall Study||10
103090|NCT01395966|248861|P3|COMPLETED|Overall Study||104
103091|NCT01395966|248862|P2|COMPLETED|Overall Study||91
103092|NCT01395966|248863|P1|COMPLETED|Overall Study||99
103093|NCT01395966|248861|P3|STARTED|Overall Study||112
103094|NCT01395966|248862|P2|STARTED|Overall Study||110
103095|NCT01395966|248863|P1|STARTED|Overall Study||109
103096|NCT01395914|248873|P2|NOT COMPLETED|Overall Study||37
103097|NCT01395914|248874|P1|NOT COMPLETED|Overall Study||72
103098|NCT01395914|248873|P2|COMPLETED|Overall Study||131
103099|NCT01395914|248874|P1|COMPLETED|Overall Study||273
103100|NCT01395914|248873|P2|Safety Population|Overall Study||167
103101|NCT01395914|248874|P1|Safety Population|Overall Study||343
103102|NCT01395914|248873|P2|ITT Population|Overall Study||168
103103|NCT01395914|248874|P1|ITT Population|Overall Study||345
103104|NCT01395914|248873|P2|STARTED|Overall Study||168
103105|NCT01395914|248874|P1|STARTED|Overall Study||345
103106|NCT01395901|248888|P2|NOT COMPLETED|Overall Study||5
103107|NCT01395901|248889|P1|NOT COMPLETED|Overall Study||10
103108|NCT01395901|248888|P2|COMPLETED|Overall Study|Treated patients completing the study|329
103109|NCT01395901|248889|P1|COMPLETED|Overall Study|Treated patients completing the study|326
103110|NCT01395901|248888|P2|STARTED|Overall Study|Randomized Population|334
103111|NCT01395901|248889|P1|STARTED|Overall Study|Randomized Population|336
103112|NCT01395888|248905|P3|NOT COMPLETED|Treatment Period (TP)||17
103113|NCT01395888|248906|P2|NOT COMPLETED|Treatment Period (TP)||15
103114|NCT01395888|248907|P1|NOT COMPLETED|Treatment Period (TP)||0
103115|NCT01395888|248905|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
103116|NCT01395888|248906|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
103117|NCT01395888|248907|P1|COMPLETED|Treatment Period (TP)||0
103118|NCT01395888|248905|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
103119|NCT01395888|248906|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
103120|NCT01395888|248907|P1|Completed the Treatment Period|Treatment Period (TP)||0
103121|NCT01395888|248905|P3|STARTED|Treatment Period (TP)||130
103122|NCT01395888|248906|P2|STARTED|Treatment Period (TP)||127
103123|NCT01395888|248907|P1|STARTED|Treatment Period (TP)||0
103124|NCT01395888|248905|P3|NOT COMPLETED|2-week Run-in Period||0
103125|NCT01395888|248906|P2|NOT COMPLETED|2-week Run-in Period||0
103126|NCT01395888|248907|P1|NOT COMPLETED|2-week Run-in Period||22
103127|NCT01395888|248905|P3|COMPLETED|2-week Run-in Period||0
103128|NCT01395888|248906|P2|COMPLETED|2-week Run-in Period||0
103129|NCT01395888|248907|P1|COMPLETED|2-week Run-in Period||257
103130|NCT01395888|248905|P3|STARTED|2-week Run-in Period||0
103131|NCT01395888|248906|P2|STARTED|2-week Run-in Period||0
103132|NCT01395888|248907|P1|STARTED|2-week Run-in Period||279
103133|NCT01395823|248915|P2|NOT COMPLETED|Overall Study||9
103134|NCT01395823|248916|P1|NOT COMPLETED|Overall Study||15
103135|NCT01395823|248915|P2|COMPLETED|Overall Study||130
103136|NCT01395823|248916|P1|COMPLETED|Overall Study||122
103137|NCT01395823|248915|P2|STARTED|Overall Study||139
103138|NCT01395823|248916|P1|STARTED|Overall Study||137
103139|NCT01395810|248926|P4|NOT COMPLETED|Overall Study||0
103140|NCT01395810|248927|P3|NOT COMPLETED|Overall Study||0
103141|NCT01395810|248928|P2|NOT COMPLETED|Overall Study||4
103142|NCT01395810|248929|P1|NOT COMPLETED|Overall Study||2
103143|NCT01395810|248926|P4|COMPLETED|Overall Study||5
103144|NCT01395810|248927|P3|COMPLETED|Overall Study||0
103145|NCT01395810|248928|P2|COMPLETED|Overall Study||44
103146|NCT01395810|248929|P1|COMPLETED|Overall Study||16
103147|NCT01395810|248926|P4|After Switching the Arms|Overall Study||5
103148|NCT01395810|248927|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
103149|NCT01395810|248928|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
103150|NCT01395810|248929|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
103151|NCT01395810|248926|P4|STARTED|Overall Study||5
103152|NCT01395810|248927|P3|STARTED|Overall Study||0
103153|NCT01395810|248928|P2|STARTED|Overall Study||48
103154|NCT01395810|248929|P1|STARTED|Overall Study||18
103155|NCT01395797|248963|P6|NOT COMPLETED|Overall Study||3
103156|NCT01395797|248964|P5|NOT COMPLETED|Overall Study||2
103157|NCT01395797|248965|P4|NOT COMPLETED|Overall Study||2
103158|NCT01395797|248966|P3|NOT COMPLETED|Overall Study||4
103159|NCT01395797|248967|P2|NOT COMPLETED|Overall Study||1
103160|NCT01395797|248968|P1|NOT COMPLETED|Overall Study||3
103161|NCT01395797|248963|P6|COMPLETED|Overall Study||14
103162|NCT01395797|248964|P5|COMPLETED|Overall Study||7
103163|NCT01395797|248965|P4|COMPLETED|Overall Study||13
103164|NCT01395797|248966|P3|COMPLETED|Overall Study||14
103165|NCT01395797|248967|P2|COMPLETED|Overall Study||3
103166|NCT01395797|248968|P1|COMPLETED|Overall Study||16
103167|NCT01395797|248963|P6|STARTED|Overall Study||17
103168|NCT01395797|248964|P5|STARTED|Overall Study||9
103169|NCT01395797|248965|P4|STARTED|Overall Study||15
103170|NCT01395797|248966|P3|STARTED|Overall Study||18
103171|NCT01395797|248967|P2|STARTED|Overall Study||4
103172|NCT01395797|248968|P1|STARTED|Overall Study||19
103173|NCT01395784|248988|P1|NOT COMPLETED|Overall Study||15
103174|NCT01395784|248988|P1|COMPLETED|Overall Study||17
103175|NCT01395784|248988|P1|STARTED|Overall Study||32
103176|NCT01395758|248995|P3|NOT COMPLETED|Crossover Period||0
103177|NCT01395758|248996|P2|NOT COMPLETED|Crossover Period||0
103178|NCT01395758|248997|P1|NOT COMPLETED|Crossover Period||0
103179|NCT01395758|248995|P3|COMPLETED|Crossover Period||26
103180|NCT01395758|248996|P2|COMPLETED|Crossover Period||0
103181|NCT01395758|248997|P1|COMPLETED|Crossover Period||0
103182|NCT01395758|248995|P3|STARTED|Crossover Period||26
103183|NCT01395758|248996|P2|STARTED|Crossover Period||0
103184|NCT01395758|248997|P1|STARTED|Crossover Period||0
103185|NCT01395758|248995|P3|NOT COMPLETED|Open-label Treatment Period||0
103186|NCT01395758|248996|P2|NOT COMPLETED|Open-label Treatment Period||0
103187|NCT01395758|248997|P1|NOT COMPLETED|Open-label Treatment Period||4
103188|NCT01395758|248995|P3|COMPLETED|Open-label Treatment Period||0
103189|NCT01395758|248996|P2|COMPLETED|Open-label Treatment Period||45
103190|NCT01395758|248997|P1|COMPLETED|Open-label Treatment Period||47
103191|NCT01395758|248995|P3|STARTED|Open-label Treatment Period||0
103192|NCT01395758|248996|P2|STARTED|Open-label Treatment Period||45
103193|NCT01395758|248997|P1|STARTED|Open-label Treatment Period||51
103194|NCT01395524|249011|P3|NOT COMPLETED|Overall Study||17
103195|NCT01395524|249012|P2|NOT COMPLETED|Overall Study||16
103196|NCT01395524|249013|P1|NOT COMPLETED|Overall Study||18
103197|NCT01395524|249011|P3|COMPLETED|Overall Study||89
103198|NCT01395524|249012|P2|COMPLETED|Overall Study||83
103199|NCT01395524|249013|P1|COMPLETED|Overall Study||79
103200|NCT01395524|249011|P3|STARTED|Overall Study||106
103201|NCT01395524|249012|P2|STARTED|Overall Study||99
103202|NCT01395524|249013|P1|STARTED|Overall Study||97
103203|NCT01395394|249036|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
103204|NCT01395394|249037|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
103205|NCT01395394|249038|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
103206|NCT01395394|249036|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
103207|NCT01395394|249037|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
103208|NCT01395394|249038|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
103209|NCT01395394|249036|P3|STARTED|Study Visit 2 (Non-responders Only)||0
103210|NCT01395394|249037|P2|STARTED|Study Visit 2 (Non-responders Only)||0
103211|NCT01395394|249038|P1|STARTED|Study Visit 2 (Non-responders Only)||3
103212|NCT01395394|249036|P3|NOT COMPLETED|Baseline Study Visit||0
103213|NCT01395394|249037|P2|NOT COMPLETED|Baseline Study Visit||0
103214|NCT01395394|249038|P1|NOT COMPLETED|Baseline Study Visit||1
103215|NCT01395394|249036|P3|COMPLETED|Baseline Study Visit||5
103216|NCT01395394|249037|P2|COMPLETED|Baseline Study Visit||3
103217|NCT01395394|249038|P1|COMPLETED|Baseline Study Visit||3
103218|NCT01395394|249036|P3|STARTED|Baseline Study Visit||5
103219|NCT01395394|249037|P2|STARTED|Baseline Study Visit||3
103220|NCT01395394|249038|P1|STARTED|Baseline Study Visit||4
103221|NCT01395368|249049|P1|NOT COMPLETED|Overall Study||16
103222|NCT01395368|249049|P1|COMPLETED|Overall Study||92
103223|NCT01395368|249049|P1|STARTED|Overall Study||108
103224|NCT01395277|249055|P2|NOT COMPLETED|Overall Study||0
103225|NCT01395277|249056|P1|NOT COMPLETED|Overall Study||0
103226|NCT01395277|249055|P2|COMPLETED|Overall Study||15
103227|NCT01395277|249056|P1|COMPLETED|Overall Study||15
103228|NCT01395277|249055|P2|STARTED|Overall Study||15
103229|NCT01395277|249056|P1|STARTED|Overall Study||15
103230|NCT01395043|249064|P1|NOT COMPLETED|Overall Study||0
103231|NCT01395043|249064|P1|COMPLETED|Overall Study||15
103232|NCT01395043|249064|P1|STARTED|Overall Study||15
103233|NCT01395017|249071|P2|NOT COMPLETED|Overall Study||102
103234|NCT01395017|249072|P1|NOT COMPLETED|Overall Study||100
103235|NCT01395017|249071|P2|COMPLETED|Overall Study||0
103236|NCT01395017|249072|P1|COMPLETED|Overall Study||0
103237|NCT01395017|249071|P2|Treated|Overall Study||101
103238|NCT01395017|249072|P1|Treated|Overall Study||98
103239|NCT01395017|249071|P2|STARTED|Overall Study||102
103240|NCT01395017|249072|P1|STARTED|Overall Study||100
103241|NCT01394991|249082|P2|NOT COMPLETED|Overall Study||72
103242|NCT01394991|249083|P1|NOT COMPLETED|Overall Study||59
103243|NCT01394991|249082|P2|COMPLETED|Overall Study||190
103244|NCT01394991|249083|P1|COMPLETED|Overall Study||183
103245|NCT01394991|249082|P2|STARTED|Overall Study||262
103246|NCT01394991|249083|P1|STARTED|Overall Study||242
103247|NCT01394978|249105|P2|NOT COMPLETED|Overall Study||31
103248|NCT01394978|249106|P1|NOT COMPLETED|Overall Study||21
103249|NCT01394978|249105|P2|COMPLETED|Overall Study||245
103250|NCT01394978|249106|P1|COMPLETED|Overall Study||147
103251|NCT01394978|249105|P2|STARTED|Overall Study||276
103252|NCT01394978|249106|P1|STARTED|Overall Study||168
103253|NCT01394926|249112|P1|NOT COMPLETED|Overall Study||0
103254|NCT01394926|249112|P1|COMPLETED|Overall Study||21
103255|NCT01394926|249112|P1|STARTED|Overall Study||21
103256|NCT01394718|249123|P2|NOT COMPLETED|Overall Study||1
103257|NCT01394718|249124|P1|NOT COMPLETED|Overall Study||2
103258|NCT01394718|249123|P2|COMPLETED|Overall Study||29
103259|NCT01394718|249124|P1|COMPLETED|Overall Study||28
103260|NCT01394718|249123|P2|STARTED|Overall Study||30
103261|NCT01394718|249124|P1|STARTED|Overall Study||30
103262|NCT01394692|249138|P2|NOT COMPLETED|Overall Study||0
103263|NCT01394692|249139|P1|NOT COMPLETED|Overall Study||0
103264|NCT01394692|249138|P2|COMPLETED|Overall Study||29
103265|NCT01394692|249139|P1|COMPLETED|Overall Study||29
103266|NCT01394692|249138|P2|STARTED|Overall Study||29
103267|NCT01394692|249139|P1|STARTED|Overall Study||29
103268|NCT01394627|249145|P2|NOT COMPLETED|Second Intervention (1 Day)||0
103269|NCT01394627|249146|P1|NOT COMPLETED|Second Intervention (1 Day)||0
103270|NCT01394627|249145|P2|COMPLETED|Second Intervention (1 Day)||12
103271|NCT01394627|249146|P1|COMPLETED|Second Intervention (1 Day)||7
103272|NCT01394627|249145|P2|STARTED|Second Intervention (1 Day)||12
103273|NCT01394627|249146|P1|STARTED|Second Intervention (1 Day)||7
103274|NCT01394627|249145|P2|NOT COMPLETED|Washout (1-3 Months)||0
103275|NCT01394627|249146|P1|NOT COMPLETED|Washout (1-3 Months)||1
103276|NCT01394627|249145|P2|COMPLETED|Washout (1-3 Months)||12
103277|NCT01394627|249146|P1|COMPLETED|Washout (1-3 Months)||7
103278|NCT01394627|249145|P2|STARTED|Washout (1-3 Months)||12
103279|NCT01394627|249146|P1|STARTED|Washout (1-3 Months)||8
103280|NCT01394627|249145|P2|NOT COMPLETED|First Intervention (1 Day)||1
103281|NCT01394627|249146|P1|NOT COMPLETED|First Intervention (1 Day)||0
103282|NCT01394627|249145|P2|COMPLETED|First Intervention (1 Day)||12
103283|NCT01394627|249146|P1|COMPLETED|First Intervention (1 Day)||8
103284|NCT01394627|249145|P2|STARTED|First Intervention (1 Day)||13
103285|NCT01394627|249146|P1|STARTED|First Intervention (1 Day)||8
103286|NCT01394614|249156|P2|NOT COMPLETED|Overall Study||0
103287|NCT01394614|249157|P1|NOT COMPLETED|Overall Study||0
103288|NCT01394614|249156|P2|COMPLETED|Overall Study||16
103289|NCT01394614|249157|P1|COMPLETED|Overall Study||8
103290|NCT01394614|249156|P2|STARTED|Overall Study||16
103291|NCT01394614|249157|P1|STARTED|Overall Study||8
103292|NCT01394523|249166|P3|NOT COMPLETED|Overall Study||0
103293|NCT01394523|249167|P2|NOT COMPLETED|Overall Study||0
103294|NCT01394523|249168|P1|NOT COMPLETED|Overall Study||1
103295|NCT01394523|249166|P3|COMPLETED|Overall Study||13
103296|NCT01394523|249167|P2|COMPLETED|Overall Study||13
103297|NCT01394523|249168|P1|COMPLETED|Overall Study||12
103298|NCT01394523|249166|P3|STARTED|Overall Study||13
103299|NCT01394523|249167|P2|STARTED|Overall Study||13
103300|NCT01394523|249168|P1|STARTED|Overall Study||13
103301|NCT01394510|249176|P1|NOT COMPLETED|Overall Study||0
103302|NCT01394510|249176|P1|COMPLETED|Overall Study||13
103303|NCT01394510|249176|P1|STARTED|Overall Study||13
103304|NCT01394276|249182|P1|NOT COMPLETED|Overall Study||62
103305|NCT01394276|249182|P1|COMPLETED|Overall Study||260
103306|NCT01394276|249182|P1|STARTED|Overall Study||322
103307|NCT01394250|249206|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
103308|NCT01394250|249207|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
103309|NCT01394250|249206|P2|COMPLETED|Successful IV Placement & Follow-Up||110
103310|NCT01394250|249207|P1|COMPLETED|Successful IV Placement & Follow-Up||114
103311|NCT01394250|249206|P2|STARTED|Successful IV Placement & Follow-Up||121
103312|NCT01394250|249207|P1|STARTED|Successful IV Placement & Follow-Up||120
103313|NCT01394250|249206|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
103314|NCT01394250|249207|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
103315|NCT01394250|249206|P2|COMPLETED|Randomization and IV Placement Attempt||121
103316|NCT01394250|249207|P1|COMPLETED|Randomization and IV Placement Attempt||120
103317|NCT01394250|249206|P2|STARTED|Randomization and IV Placement Attempt||134
103318|NCT01394250|249207|P1|STARTED|Randomization and IV Placement Attempt||134
103319|NCT01394185|249215|P6|NOT COMPLETED|Overall Study||1
103320|NCT01394185|249216|P5|NOT COMPLETED|Overall Study||4
103321|NCT01394185|249217|P4|NOT COMPLETED|Overall Study||1
103322|NCT01394185|249218|P3|NOT COMPLETED|Overall Study||0
103323|NCT01394185|249219|P2|NOT COMPLETED|Overall Study||0
103324|NCT01394185|249220|P1|NOT COMPLETED|Overall Study||6
103325|NCT01394185|249215|P6|COMPLETED|Overall Study||2
103326|NCT01394185|249216|P5|COMPLETED|Overall Study||2
103327|NCT01394185|249217|P4|COMPLETED|Overall Study||3
103328|NCT01394185|249218|P3|COMPLETED|Overall Study||2
103329|NCT01394185|249219|P2|COMPLETED|Overall Study||2
103330|NCT01394185|249220|P1|COMPLETED|Overall Study||2
103331|NCT01394185|249215|P6|STARTED|Overall Study||3
103332|NCT01394185|249216|P5|STARTED|Overall Study||6
103333|NCT01394185|249217|P4|STARTED|Overall Study||4
103334|NCT01394185|249218|P3|STARTED|Overall Study||2
103335|NCT01394185|249219|P2|STARTED|Overall Study||2
103336|NCT01394185|249220|P1|STARTED|Overall Study||8
103337|NCT01394159|249233|P2|NOT COMPLETED|Overall Study||0
103338|NCT01394159|249234|P1|NOT COMPLETED|Overall Study||0
103339|NCT01394159|249233|P2|COMPLETED|Overall Study||28
103340|NCT01394159|249234|P1|COMPLETED|Overall Study||28
103341|NCT01394159|249233|P2|STARTED|Overall Study||28
103342|NCT01394159|249234|P1|STARTED|Overall Study||28
103343|NCT01394081|249246|P2|NOT COMPLETED|Overall Study||0
103344|NCT01394081|249247|P1|NOT COMPLETED|Overall Study||0
103345|NCT01394081|249246|P2|COMPLETED|Overall Study||102
103346|NCT01394081|249247|P1|COMPLETED|Overall Study||101
103347|NCT01394081|249246|P2|STARTED|Overall Study||102
103348|NCT01394081|249247|P1|STARTED|Overall Study||101
103349|NCT01393964|249258|P3|NOT COMPLETED|Overall Study||9
103350|NCT01393964|249259|P2|NOT COMPLETED|Overall Study||9
103351|NCT01393964|249260|P1|NOT COMPLETED|Overall Study||8
103352|NCT01393964|249258|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
103353|NCT01393964|249259|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
103354|NCT01393964|249260|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
103355|NCT01393964|249258|P3|STARTED|Overall Study||9
103356|NCT01393964|249259|P2|STARTED|Overall Study||9
103357|NCT01393964|249260|P1|STARTED|Overall Study||8
103358|NCT01393899|249301|P3|NOT COMPLETED|Overall Study||23
103359|NCT01393899|249302|P2|NOT COMPLETED|Overall Study||28
103360|NCT01393899|249303|P1|NOT COMPLETED|Overall Study||32
103361|NCT01393899|249301|P3|COMPLETED|Overall Study||38
103362|NCT01393899|249302|P2|COMPLETED|Overall Study||32
103363|NCT01393899|249303|P1|COMPLETED|Overall Study||27
103364|NCT01393899|249301|P3|STARTED|Overall Study||61
103365|NCT01393899|249302|P2|STARTED|Overall Study||60
103366|NCT01393899|249303|P1|STARTED|Overall Study||59
103367|NCT01393743|249357|P3|NOT COMPLETED|Extension Phase||60
103368|NCT01393743|249358|P2|NOT COMPLETED|Extension Phase||0
103369|NCT01393743|249359|P1|NOT COMPLETED|Extension Phase||0
103370|NCT01393743|249357|P3|COMPLETED|Extension Phase||78
103371|NCT01393743|249358|P2|COMPLETED|Extension Phase||0
103372|NCT01393743|249359|P1|COMPLETED|Extension Phase||0
103373|NCT01393743|249357|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
103374|NCT01393743|249358|P2|STARTED|Extension Phase||0
103375|NCT01393743|249359|P1|STARTED|Extension Phase||0
103376|NCT01393743|249357|P3|NOT COMPLETED|Core Study||0
103377|NCT01393743|249358|P2|NOT COMPLETED|Core Study||13
103378|NCT01393743|249359|P1|NOT COMPLETED|Core Study||10
103379|NCT01393743|249357|P3|COMPLETED|Core Study||0
103380|NCT01393743|249358|P2|COMPLETED|Core Study||68
103381|NCT01393743|249359|P1|COMPLETED|Core Study||72
103382|NCT01393743|249357|P3|STARTED|Core Study||0
103383|NCT01393743|249358|P2|STARTED|Core Study|Treated|81
103384|NCT01393743|249359|P1|STARTED|Core Study|Treated|82
103385|NCT01393730|249382|P1|NOT COMPLETED|Overall Study||6
103386|NCT01393730|249382|P1|COMPLETED|Overall Study||34
103387|NCT01393730|249382|P1|Evaluable AR Mutation|Overall Study||14
103388|NCT01393730|249382|P1|Evaluable AR Amplification|Overall Study||21
103389|NCT01393730|249382|P1|Treated|Overall Study||38
103390|NCT01393730|249382|P1|STARTED|Overall Study||40
103391|NCT01393717|249394|P2|NOT COMPLETED|Overall Study||0
103392|NCT01393717|249395|P1|NOT COMPLETED|Overall Study||0
103393|NCT01393717|249394|P2|COMPLETED|Overall Study||20
103394|NCT01393717|249395|P1|COMPLETED|Overall Study||37
103395|NCT01393717|249394|P2|STARTED|Overall Study||20
103396|NCT01393717|249395|P1|STARTED|Overall Study||37
103397|NCT01393704|249409|P2|NOT COMPLETED|Overall Study||0
103398|NCT01393704|249410|P1|NOT COMPLETED|Overall Study||0
103399|NCT01393704|249409|P2|COMPLETED|Overall Study||76
103400|NCT01393704|249410|P1|COMPLETED|Overall Study||76
103401|NCT01393704|249409|P2|STARTED|Overall Study||76
103402|NCT01393704|249410|P1|STARTED|Overall Study||76
103403|NCT01393626|249428|P4|NOT COMPLETED|Overall Study||1
103404|NCT01393626|249429|P3|NOT COMPLETED|Overall Study||12
103405|NCT01393626|249430|P2|NOT COMPLETED|Overall Study||12
103406|NCT01393626|249431|P1|NOT COMPLETED|Overall Study||18
103407|NCT01393626|249428|P4|COMPLETED|Overall Study||15
103408|NCT01393626|249429|P3|COMPLETED|Overall Study||74
103409|NCT01393626|249430|P2|COMPLETED|Overall Study||74
103410|NCT01393626|249431|P1|COMPLETED|Overall Study||73
103411|NCT01393626|249428|P4|STARTED|Overall Study||16
103412|NCT01393626|249429|P3|STARTED|Overall Study||86
103413|NCT01393626|249430|P2|STARTED|Overall Study||86
103414|NCT01393626|249431|P1|STARTED|Overall Study||91
103415|NCT01393613|249511|P4|NOT COMPLETED|Overall Study||66
103416|NCT01393613|249512|P3|NOT COMPLETED|Overall Study||54
103417|NCT01393613|249513|P2|NOT COMPLETED|Overall Study||57
103418|NCT01393613|249514|P1|NOT COMPLETED|Overall Study||39
103419|NCT01393613|249511|P4|COMPLETED|Overall Study||118
103420|NCT01393613|249512|P3|COMPLETED|Overall Study||130
103421|NCT01393613|249513|P2|COMPLETED|Overall Study||129
103422|NCT01393613|249514|P1|COMPLETED|Overall Study||81
103423|NCT01393613|249511|P4|STARTED|Overall Study||184
103424|NCT01393613|249512|P3|STARTED|Overall Study||184
103425|NCT01393613|249513|P2|STARTED|Overall Study||186
103426|NCT01393613|249514|P1|STARTED|Overall Study||120
103427|NCT01393600|249576|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
103428|NCT01393600|249577|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
103429|NCT01393600|249578|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
103430|NCT01393600|249579|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
103431|NCT01393600|249576|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
103432|NCT01393600|249577|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
103433|NCT01393600|249578|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
103434|NCT01393600|249579|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
103435|NCT01393600|249576|P4|STARTED|Follow-up Period (Day 29 to 35)||8
103436|NCT01393600|249577|P3|STARTED|Follow-up Period (Day 29 to 35)||7
103437|NCT01393600|249578|P2|STARTED|Follow-up Period (Day 29 to 35)||7
103438|NCT01393600|249579|P1|STARTED|Follow-up Period (Day 29 to 35)||9
103439|NCT01393600|249576|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
103440|NCT01393600|249577|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
103441|NCT01393600|249578|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
103442|NCT01393600|249579|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
103443|NCT01393600|249576|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
103444|NCT01393600|249577|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
103445|NCT01393600|249578|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
103446|NCT01393600|249579|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
103447|NCT01393600|249576|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
103448|NCT01393600|249577|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
103449|NCT01393600|249578|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
103450|NCT01393600|249579|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
103451|NCT01393600|249576|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
103452|NCT01393600|249577|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
103453|NCT01393600|249578|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
103454|NCT01393600|249579|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
103455|NCT01393600|249576|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
103456|NCT01393600|249577|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
103457|NCT01393600|249578|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
103458|NCT01393600|249579|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
103459|NCT01393600|249576|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
103460|NCT01393600|249577|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
103461|NCT01393600|249578|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
103462|NCT01393600|249579|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
103463|NCT01393457|249598|P4|NOT COMPLETED|Overall Study||12
103464|NCT01393457|249599|P3|NOT COMPLETED|Overall Study||15
103465|NCT01393457|249600|P2|NOT COMPLETED|Overall Study||12
103466|NCT01393457|249601|P1|NOT COMPLETED|Overall Study||12
103467|NCT01393457|249598|P4|COMPLETED|Overall Study||15
103468|NCT01393457|249599|P3|COMPLETED|Overall Study||16
103469|NCT01393457|249600|P2|COMPLETED|Overall Study||14
103470|NCT01393457|249601|P1|COMPLETED|Overall Study||14
103471|NCT01393457|249598|P4|STARTED|Overall Study||27
103472|NCT01393457|249599|P3|STARTED|Overall Study||31
103473|NCT01393457|249600|P2|STARTED|Overall Study||26
103474|NCT01393457|249601|P1|STARTED|Overall Study||26
103475|NCT01393444|249615|P1|NOT COMPLETED|Overall Study||3
103476|NCT01393444|249615|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
103477|NCT01393444|249615|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
103478|NCT01393444|249615|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
103479|NCT01393444|249615|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
103480|NCT01393444|249615|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
103481|NCT01393444|249615|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
103482|NCT01393444|249615|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
103483|NCT01393444|249615|P1|STARTED|Overall Study||6
103484|NCT01393405|249620|P3|NOT COMPLETED|Maintenance Period Week||24
103485|NCT01393405|249621|P2|NOT COMPLETED|Maintenance Period Week||29
103486|NCT01393405|249622|P1|NOT COMPLETED|Maintenance Period Week||0
103487|NCT01393405|249620|P3|COMPLETED|Maintenance Period Week||16
103488|NCT01393405|249621|P2|COMPLETED|Maintenance Period Week||15
103489|NCT01393405|249622|P1|COMPLETED|Maintenance Period Week||0
103490|NCT01393405|249620|P3|STARTED|Maintenance Period Week||40
103491|NCT01393405|249621|P2|STARTED|Maintenance Period Week||44
103492|NCT01393405|249622|P1|STARTED|Maintenance Period Week||0
103493|NCT01393405|249620|P3|NOT COMPLETED|Induction Period (week1-16)||0
103494|NCT01393405|249621|P2|NOT COMPLETED|Induction Period (week1-16)||0
103495|NCT01393405|249622|P1|NOT COMPLETED|Induction Period (week1-16)||95
103496|NCT01393405|249620|P3|COMPLETED|Induction Period (week1-16)||0
103497|NCT01393405|249621|P2|COMPLETED|Induction Period (week1-16)||0
103498|NCT01393405|249622|P1|COMPLETED|Induction Period (week1-16)||84
103499|NCT01393405|249620|P3|STARTED|Induction Period (week1-16)||0
103500|NCT01393405|249621|P2|STARTED|Induction Period (week1-16)||0
103501|NCT01393405|249622|P1|STARTED|Induction Period (week1-16)||179
103502|NCT01393132|249641|P2|NOT COMPLETED|Overall Study||0
103503|NCT01393132|249642|P1|NOT COMPLETED|Overall Study||0
103504|NCT01393132|249641|P2|COMPLETED|Overall Study||3
103505|NCT01393132|249642|P1|COMPLETED|Overall Study||6
103506|NCT01393132|249641|P2|STARTED|Overall Study||3
103507|NCT01393132|249642|P1|STARTED|Overall Study||6
103508|NCT01393106|249654|P1|NOT COMPLETED|Overall Study||5
103509|NCT01393106|249654|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
103510|NCT01393106|249654|P1|STARTED|Overall Study||25
103511|NCT01392742|249671|P1|NOT COMPLETED|Overall Study||201
103512|NCT01392742|249671|P1|COMPLETED|Overall Study||242
103513|NCT01392742|249671|P1|STARTED|Overall Study||443
103514|NCT01392703|249686|P3|NOT COMPLETED|Day 9||0
103515|NCT01392703|249687|P2|NOT COMPLETED|Day 9||0
103516|NCT01392703|249688|P1|NOT COMPLETED|Day 9||0
103517|NCT01392703|249686|P3|COMPLETED|Day 9||25
103518|NCT01392703|249687|P2|COMPLETED|Day 9||26
103519|NCT01392703|249688|P1|COMPLETED|Day 9||26
103520|NCT01392703|249686|P3|STARTED|Day 9||25
103521|NCT01392703|249687|P2|STARTED|Day 9||26
103522|NCT01392703|249688|P1|STARTED|Day 9||26
103523|NCT01392703|249686|P3|NOT COMPLETED|Day 5||0
103524|NCT01392703|249687|P2|NOT COMPLETED|Day 5||0
103525|NCT01392703|249688|P1|NOT COMPLETED|Day 5||0
103526|NCT01392703|249686|P3|COMPLETED|Day 5||26
103527|NCT01392703|249687|P2|COMPLETED|Day 5||25
103528|NCT01392703|249688|P1|COMPLETED|Day 5||26
103529|NCT01392703|249686|P3|STARTED|Day 5||26
103530|NCT01392703|249687|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
103531|NCT01392703|249688|P1|STARTED|Day 5||26
103532|NCT01392703|249686|P3|NOT COMPLETED|Day 1||0
103533|NCT01392703|249687|P2|NOT COMPLETED|Day 1||0
103534|NCT01392703|249688|P1|NOT COMPLETED|Day 1||0
103535|NCT01392703|249686|P3|COMPLETED|Day 1||26
103536|NCT01392703|249687|P2|COMPLETED|Day 1||26
103537|NCT01392703|249688|P1|COMPLETED|Day 1||26
103538|NCT01392703|249686|P3|STARTED|Day 1||26
103539|NCT01392703|249687|P2|STARTED|Day 1||26
103540|NCT01392703|249688|P1|STARTED|Day 1||26
103541|NCT01392677|249717|P2|NOT COMPLETED|Overall Study||8
103542|NCT01392677|249718|P1|NOT COMPLETED|Overall Study||8
103543|NCT01392677|249717|P2|COMPLETED|Overall Study||101
103544|NCT01392677|249718|P1|COMPLETED|Overall Study||101
103545|NCT01392677|249717|P2|STARTED|Overall Study||109
103546|NCT01392677|249718|P1|STARTED|Overall Study||109
103547|NCT01392625|249734|P2|NOT COMPLETED|Overall Study||1
103548|NCT01392625|249735|P1|NOT COMPLETED|Overall Study||2
103549|NCT01392625|249734|P2|COMPLETED|Overall Study||18
103550|NCT01392625|249735|P1|COMPLETED|Overall Study||16
103551|NCT01392625|249734|P2|STARTED|Overall Study||19
103552|NCT01392625|249735|P1|STARTED|Overall Study||18
103553|NCT01392573|249753|P2|NOT COMPLETED|Overall Study||35
103554|NCT01392573|249754|P1|NOT COMPLETED|Overall Study||32
103555|NCT01392573|249753|P2|COMPLETED|Overall Study||171
103556|NCT01392573|249754|P1|COMPLETED|Overall Study||175
103557|NCT01392573|249753|P2|Exposed|Overall Study||206
103558|NCT01392573|249754|P1|Exposed|Overall Study||207
103559|NCT01392573|249753|P2|STARTED|Overall Study||206
103560|NCT01392573|249754|P1|STARTED|Overall Study||207
103561|NCT01392560|249762|P1|NOT COMPLETED|Overall Study||12
103562|NCT01392560|249762|P1|COMPLETED|Overall Study||40
103563|NCT01392560|249762|P1|STARTED|Overall Study||52
103564|NCT01392547|249768|P1|NOT COMPLETED|Overall Study||8
103565|NCT01392547|249768|P1|COMPLETED|Overall Study||64
103566|NCT01392547|249768|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
103567|NCT01392495|249782|P1|NOT COMPLETED|Overall Study||16
103568|NCT01392495|249782|P1|COMPLETED|Overall Study||1
103569|NCT01392495|249782|P1|Received 400 mg|Overall Study||13
103570|NCT01392495|249782|P1|Received 200 mg|Overall Study||4
103571|NCT01392495|249782|P1|STARTED|Overall Study||17
103572|NCT01392378|249799|P5|NOT COMPLETED|Toddler Dose||1
103573|NCT01392378|249800|P4|NOT COMPLETED|Toddler Dose||2
103574|NCT01392378|249801|P3|NOT COMPLETED|Toddler Dose||0
103575|NCT01392378|249802|P2|NOT COMPLETED|Toddler Dose||1
103576|NCT01392378|249803|P1|NOT COMPLETED|Toddler Dose||0
103577|NCT01392378|249799|P5|COMPLETED|Toddler Dose||208
103578|NCT01392378|249800|P4|COMPLETED|Toddler Dose||173
103579|NCT01392378|249801|P3|COMPLETED|Toddler Dose||170
103580|NCT01392378|249802|P2|COMPLETED|Toddler Dose||172
103581|NCT01392378|249803|P1|COMPLETED|Toddler Dose||169
103582|NCT01392378|249799|P5|STARTED|Toddler Dose||209
103583|NCT01392378|249800|P4|STARTED|Toddler Dose||175
103584|NCT01392378|249801|P3|STARTED|Toddler Dose||170
103585|NCT01392378|249802|P2|STARTED|Toddler Dose||173
103586|NCT01392378|249803|P1|STARTED|Toddler Dose||169
103587|NCT01392378|249799|P5|NOT COMPLETED|After Infant Series||1
103588|NCT01392378|249800|P4|NOT COMPLETED|After Infant Series||0
103589|NCT01392378|249801|P3|NOT COMPLETED|After Infant Series||2
103590|NCT01392378|249802|P2|NOT COMPLETED|After Infant Series||1
103591|NCT01392378|249803|P1|NOT COMPLETED|After Infant Series||0
103592|NCT01392378|249799|P5|COMPLETED|After Infant Series||209
103593|NCT01392378|249800|P4|COMPLETED|After Infant Series||175
103594|NCT01392378|249801|P3|COMPLETED|After Infant Series||170
103595|NCT01392378|249802|P2|COMPLETED|After Infant Series||173
103596|NCT01392378|249803|P1|COMPLETED|After Infant Series||169
103597|NCT01392378|249799|P5|STARTED|After Infant Series||210
103598|NCT01392378|249800|P4|STARTED|After Infant Series||175
103599|NCT01392378|249801|P3|STARTED|After Infant Series||172
103600|NCT01392378|249802|P2|STARTED|After Infant Series||174
103601|NCT01392378|249803|P1|STARTED|After Infant Series||169
103602|NCT01392378|249799|P5|NOT COMPLETED|Infant Series||0
103603|NCT01392378|249800|P4|NOT COMPLETED|Infant Series||2
103604|NCT01392378|249801|P3|NOT COMPLETED|Infant Series||0
103605|NCT01392378|249802|P2|NOT COMPLETED|Infant Series||2
103606|NCT01392378|249803|P1|NOT COMPLETED|Infant Series||4
103607|NCT01392378|249799|P5|COMPLETED|Infant Series||210
103608|NCT01392378|249800|P4|COMPLETED|Infant Series||175
103609|NCT01392378|249801|P3|COMPLETED|Infant Series||172
103610|NCT01392378|249802|P2|COMPLETED|Infant Series||174
103611|NCT01392378|249803|P1|COMPLETED|Infant Series||169
103612|NCT01392378|249799|P5|Vaccinated Dose 3|Infant Series||210
103613|NCT01392378|249800|P4|Vaccinated Dose 3|Infant Series||176
103614|NCT01392378|249801|P3|Vaccinated Dose 3|Infant Series||172
103615|NCT01392378|249802|P2|Vaccinated Dose 3|Infant Series||174
103616|NCT01392378|249803|P1|Vaccinated Dose 3|Infant Series||170
103617|NCT01392378|249799|P5|Vaccinated Dose 2|Infant Series||210
103618|NCT01392378|249800|P4|Vaccinated Dose 2|Infant Series||177
103619|NCT01392378|249801|P3|Vaccinated Dose 2|Infant Series||172
103620|NCT01392378|249802|P2|Vaccinated Dose 2|Infant Series||174
103621|NCT01392378|249803|P1|Vaccinated Dose 2|Infant Series||171
103622|NCT01392378|249799|P5|Vaccinated Dose 1|Infant Series||210
103623|NCT01392378|249800|P4|Vaccinated Dose 1|Infant Series||177
103624|NCT01392378|249801|P3|Vaccinated Dose 1|Infant Series||172
103625|NCT01392378|249802|P2|Vaccinated Dose 1|Infant Series||176
103626|NCT01392378|249803|P1|Vaccinated Dose 1|Infant Series||173
103627|NCT01392378|249799|P5|STARTED|Infant Series||210
103628|NCT01392378|249800|P4|STARTED|Infant Series||177
103629|NCT01392378|249801|P3|STARTED|Infant Series||172
103630|NCT01392378|249802|P2|STARTED|Infant Series||176
103631|NCT01392378|249803|P1|STARTED|Infant Series||173
103632|NCT01392326|249943|P3|NOT COMPLETED|Overall Study||48
103633|NCT01392326|249944|P2|NOT COMPLETED|Overall Study||35
103634|NCT01392326|249945|P1|NOT COMPLETED|Overall Study||47
103635|NCT01392326|249943|P3|COMPLETED|Overall Study||154
103636|NCT01392326|249944|P2|COMPLETED|Overall Study||167
103637|NCT01392326|249945|P1|COMPLETED|Overall Study||155
103638|NCT01392326|249943|P3|STARTED|Overall Study||202
103639|NCT01392326|249944|P2|STARTED|Overall Study||202
103640|NCT01392326|249945|P1|STARTED|Overall Study||202
103641|NCT01392300|249982|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
103642|NCT01392300|249983|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
103643|NCT01392300|249984|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
103644|NCT01392300|249982|P3|COMPLETED|Open Label Extension (OLEX) Period||248
103645|NCT01392300|249983|P2|COMPLETED|Open Label Extension (OLEX) Period||0
103646|NCT01392300|249984|P1|COMPLETED|Open Label Extension (OLEX) Period||0
103647|NCT01392300|249982|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
103648|NCT01392300|249983|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
103649|NCT01392300|249984|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
103650|NCT01392300|249982|P3|NOT COMPLETED|Main Period (MP)||0
103651|NCT01392300|249983|P2|NOT COMPLETED|Main Period (MP)||7
103652|NCT01392300|249984|P1|NOT COMPLETED|Main Period (MP)||11
103653|NCT01392300|249982|P3|COMPLETED|Main Period (MP)||0
103654|NCT01392300|249983|P2|COMPLETED|Main Period (MP)||100
103655|NCT01392300|249984|P1|COMPLETED|Main Period (MP)||199
103656|NCT01392300|249982|P3|STARTED|Main Period (MP)||0
103657|NCT01392300|249983|P2|STARTED|Main Period (MP)||107
103658|NCT01392300|249984|P1|STARTED|Main Period (MP)||210
103659|NCT01392170|250089|P1|NOT COMPLETED|Overall Study||2
103660|NCT01392170|250089|P1|COMPLETED|Overall Study||0
103661|NCT01392170|250089|P1|STARTED|Overall Study||2
103662|NCT01392053|250095|P2|NOT COMPLETED|Overall Study||0
103663|NCT01392053|250096|P1|NOT COMPLETED|Overall Study||0
103664|NCT01392053|250095|P2|COMPLETED|Overall Study||23
103665|NCT01392053|250096|P1|COMPLETED|Overall Study||23
103666|NCT01392053|250095|P2|STARTED|Overall Study||23
103667|NCT01392053|250096|P1|STARTED|Overall Study||23
103668|NCT01391858|250116|P2|NOT COMPLETED|Overall Study||0
103669|NCT01391858|250117|P1|NOT COMPLETED|Overall Study||2
103670|NCT01391858|250116|P2|COMPLETED|Overall Study||24
103671|NCT01391858|250117|P1|COMPLETED|Overall Study||23
103672|NCT01391858|250116|P2|STARTED|Overall Study||24
103673|NCT01391858|250117|P1|STARTED|Overall Study||25
103674|NCT01391819|250137|P1|NOT COMPLETED|Overall Study||402
103675|NCT01391819|250137|P1|COMPLETED|Overall Study||1714
103676|NCT01391819|250137|P1|STARTED|Overall Study||2116
103677|NCT01391663|250168|P4|NOT COMPLETED|Overall Study||0
103678|NCT01391663|250169|P3|NOT COMPLETED|Overall Study||1
103679|NCT01391663|250170|P2|NOT COMPLETED|Overall Study||0
103680|NCT01391663|250171|P1|NOT COMPLETED|Overall Study||0
103681|NCT01391663|250168|P4|COMPLETED|Overall Study||12
103682|NCT01391663|250169|P3|COMPLETED|Overall Study||11
103683|NCT01391663|250170|P2|COMPLETED|Overall Study||12
103684|NCT01391663|250171|P1|COMPLETED|Overall Study||12
103685|NCT01391663|250168|P4|STARTED|Overall Study||12
103686|NCT01391663|250169|P3|STARTED|Overall Study||12
103687|NCT01391663|250170|P2|STARTED|Overall Study||12
103688|NCT01391663|250171|P1|STARTED|Overall Study||12
103689|NCT01391611|250201|P1|NOT COMPLETED|Overall Study||22
103690|NCT01391611|250201|P1|COMPLETED|Overall Study||3
103691|NCT01391611|250201|P1|STARTED|Overall Study||25
103692|NCT01391559|250206|P2|NOT COMPLETED|Second Intervention||0
103693|NCT01391559|250207|P1|NOT COMPLETED|Second Intervention||0
103694|NCT01391559|250206|P2|COMPLETED|Second Intervention||10
103695|NCT01391559|250207|P1|COMPLETED|Second Intervention||10
103696|NCT01391559|250206|P2|STARTED|Second Intervention||10
103697|NCT01391559|250207|P1|STARTED|Second Intervention||10
103698|NCT01391559|250206|P2|NOT COMPLETED|First Intervention||0
103699|NCT01391559|250207|P1|NOT COMPLETED|First Intervention||0
103700|NCT01391559|250206|P2|COMPLETED|First Intervention||10
103701|NCT01391559|250207|P1|COMPLETED|First Intervention||10
103702|NCT01391559|250206|P2|STARTED|First Intervention||10
103703|NCT01391559|250207|P1|STARTED|First Intervention||10
103704|NCT01391546|250215|P2|NOT COMPLETED|Overall Study||0
103705|NCT01391546|250216|P1|NOT COMPLETED|Overall Study||1
103706|NCT01391546|250215|P2|COMPLETED|Overall Study||177
103707|NCT01391546|250216|P1|COMPLETED|Overall Study||176
103708|NCT01391546|250215|P2|Vaccinated|Overall Study||177
103709|NCT01391546|250216|P1|Vaccinated|Overall Study||176
103710|NCT01391546|250215|P2|STARTED|Overall Study||177
103711|NCT01391546|250216|P1|STARTED|Overall Study||177
103712|NCT01391507|250238|P4|NOT COMPLETED|Overall Study||7
103713|NCT01391507|250239|P3|NOT COMPLETED|Overall Study||4
103714|NCT01391507|250240|P2|NOT COMPLETED|Overall Study||4
103715|NCT01391507|250241|P1|NOT COMPLETED|Overall Study||4
103716|NCT01391507|250238|P4|COMPLETED|Overall Study||5
103717|NCT01391507|250239|P3|COMPLETED|Overall Study||2
103718|NCT01391507|250240|P2|COMPLETED|Overall Study||4
103719|NCT01391507|250241|P1|COMPLETED|Overall Study||6
103720|NCT01391507|250238|P4|STARTED|Overall Study||12
103721|NCT01391507|250239|P3|STARTED|Overall Study||6
103722|NCT01391507|250240|P2|STARTED|Overall Study||8
103723|NCT01391507|250241|P1|STARTED|Overall Study||10
103724|NCT01391468|250289|P2|NOT COMPLETED|Overall Study||2
103725|NCT01391468|250290|P1|NOT COMPLETED|Overall Study||6
103726|NCT01391468|250289|P2|COMPLETED|Overall Study||21
103727|NCT01391468|250290|P1|COMPLETED|Overall Study||18
103728|NCT01391468|250289|P2|STARTED|Overall Study||23
103729|NCT01391468|250290|P1|STARTED|Overall Study||24
103730|NCT01391325|250302|P1|NOT COMPLETED|Overall Study||494
103731|NCT01391325|250302|P1|COMPLETED|Overall Study||1238
103732|NCT01391325|250302|P1|STARTED|Overall Study||1732
103733|NCT01391312|250311|P2|NOT COMPLETED|Overall Study||1
103734|NCT01391312|250312|P1|NOT COMPLETED|Overall Study||2
103735|NCT01391312|250311|P2|COMPLETED|Overall Study||19
103736|NCT01391312|250312|P1|COMPLETED|Overall Study||18
103737|NCT01391312|250311|P2|STARTED|Overall Study||20
103738|NCT01391312|250312|P1|STARTED|Overall Study||20
103739|NCT01391299|250325|P3|NOT COMPLETED|Overall Study||2
103740|NCT01391299|250326|P2|NOT COMPLETED|Overall Study||1
103741|NCT01391299|250327|P1|NOT COMPLETED|Overall Study||0
103742|NCT01391299|250325|P3|COMPLETED|Overall Study||56
103743|NCT01391299|250326|P2|COMPLETED|Overall Study||59
103744|NCT01391299|250327|P1|COMPLETED|Overall Study||57
103745|NCT01391299|250325|P3|STARTED|Overall Study||58
103746|NCT01391299|250326|P2|STARTED|Overall Study||60
103747|NCT01391299|250327|P1|STARTED|Overall Study||57
103748|NCT01391286|250349|P2|NOT COMPLETED|Overall Study||0
103749|NCT01391286|250350|P1|NOT COMPLETED|Overall Study||0
103750|NCT01391286|250349|P2|COMPLETED|Overall Study||18
103751|NCT01391286|250350|P1|COMPLETED|Overall Study||18
103752|NCT01391286|250349|P2|STARTED|Overall Study||18
103753|NCT01391286|250350|P1|STARTED|Overall Study||18
103754|NCT01391273|250364|P2|NOT COMPLETED|Overall Study||2
103755|NCT01391273|250365|P1|NOT COMPLETED|Overall Study||4
103756|NCT01391273|250364|P2|COMPLETED|Overall Study||83
103757|NCT01391273|250365|P1|COMPLETED|Overall Study||84
103758|NCT01391273|250364|P2|STARTED|Overall Study||85
103759|NCT01391273|250365|P1|STARTED|Overall Study||88
103760|NCT01391013|250379|P2|NOT COMPLETED|Overall Study||0
103761|NCT01391013|250380|P1|NOT COMPLETED|Overall Study||0
103762|NCT01391013|250379|P2|COMPLETED|Overall Study||15
103763|NCT01391013|250380|P1|COMPLETED|Overall Study||15
103764|NCT01391013|250379|P2|STARTED|Overall Study||15
103765|NCT01391013|250380|P1|STARTED|Overall Study||15
103766|NCT01391000|250420|P2|NOT COMPLETED|Overall Study||0
103767|NCT01391000|250421|P1|NOT COMPLETED|Overall Study||2
103768|NCT01391000|250420|P2|COMPLETED|Overall Study||35
103769|NCT01391000|250421|P1|COMPLETED|Overall Study||33
103770|NCT01391000|250420|P2|STARTED|Overall Study||35
103771|NCT01391000|250421|P1|STARTED|Overall Study||35
103772|NCT01390948|250434|P3|NOT COMPLETED|Overall Study||3
103773|NCT01390948|250435|P2|NOT COMPLETED|Overall Study||62
103774|NCT01390948|250436|P1|NOT COMPLETED|Overall Study||59
103775|NCT01390948|250434|P3|COMPLETED|Overall Study||0
103776|NCT01390948|250435|P2|COMPLETED|Overall Study||0
103777|NCT01390948|250436|P1|COMPLETED|Overall Study||0
103778|NCT01390948|250434|P3|Treated|Overall Study||3
103779|NCT01390948|250435|P2|Treated|Overall Study||60
103780|NCT01390948|250436|P1|Treated|Overall Study||56
103781|NCT01390948|250434|P3|STARTED|Overall Study||3
103782|NCT01390948|250435|P2|STARTED|Overall Study||62
103783|NCT01390948|250436|P1|STARTED|Overall Study||59
103784|NCT01390909|250475|P6|NOT COMPLETED|Overall Study||0
103785|NCT01390909|250476|P5|NOT COMPLETED|Overall Study||0
103786|NCT01390909|250477|P4|NOT COMPLETED|Overall Study||0
103787|NCT01390909|250478|P3|NOT COMPLETED|Overall Study||0
103788|NCT01390909|250479|P2|NOT COMPLETED|Overall Study||0
103789|NCT01390909|250480|P1|NOT COMPLETED|Overall Study||0
103790|NCT01390909|250475|P6|COMPLETED|Overall Study||613
103791|NCT01390909|250476|P5|COMPLETED|Overall Study||613
103792|NCT01390909|250477|P4|COMPLETED|Overall Study||602
103793|NCT01390909|250478|P3|COMPLETED|Overall Study||3552
103794|NCT01390909|250479|P2|COMPLETED|Overall Study||3552
103795|NCT01390909|250480|P1|COMPLETED|Overall Study||3454
103796|NCT01390909|250475|P6|Participants in Subgroup|Overall Study||0
103797|NCT01390909|250476|P5|Participants in Subgroup|Overall Study||602
103798|NCT01390909|250477|P4|Participants in Subgroup|Overall Study||0
103799|NCT01390909|250478|P3|Participants in Subgroup|Overall Study||0
103800|NCT01390909|250479|P2|Participants in Subgroup|Overall Study||3454
103801|NCT01390909|250480|P1|Participants in Subgroup|Overall Study||0
103802|NCT01390909|250475|P6|STARTED|Overall Study||613
103803|NCT01390909|250476|P5|STARTED|Overall Study||613
103804|NCT01390909|250477|P4|STARTED|Overall Study||602
103805|NCT01390909|250478|P3|STARTED|Overall Study||3552
103806|NCT01390909|250479|P2|STARTED|Overall Study||3552
103807|NCT01390909|250480|P1|STARTED|Overall Study||3454
103808|NCT01390870|250498|P1|NOT COMPLETED|Overall Study||0
103809|NCT01390870|250498|P1|COMPLETED|Overall Study||400
103810|NCT01390870|250498|P1|STARTED|Overall Study||400
103811|NCT01390857|250502|P1|NOT COMPLETED|Overall Study||10
103812|NCT01390857|250502|P1|COMPLETED|Overall Study||369
103813|NCT01390857|250502|P1|STARTED|Overall Study||379
103814|NCT01390844|250513|P4|NOT COMPLETED|Follow-Up Phase||0
103815|NCT01390844|250514|P3|NOT COMPLETED|Follow-Up Phase||1
103816|NCT01390844|250515|P2|NOT COMPLETED|Follow-Up Phase||1
103817|NCT01390844|250516|P1|NOT COMPLETED|Follow-Up Phase||1
103818|NCT01390844|250513|P4|COMPLETED|Follow-Up Phase||8
103819|NCT01390844|250514|P3|COMPLETED|Follow-Up Phase||25
103820|NCT01390844|250515|P2|COMPLETED|Follow-Up Phase||36
103821|NCT01390844|250516|P1|COMPLETED|Follow-Up Phase||92
103822|NCT01390844|250513|P4|STARTED|Follow-Up Phase||8
103823|NCT01390844|250514|P3|STARTED|Follow-Up Phase||26
103824|NCT01390844|250515|P2|STARTED|Follow-Up Phase||37
103825|NCT01390844|250516|P1|STARTED|Follow-Up Phase||93
103826|NCT01390844|250513|P4|NOT COMPLETED|Treatment Phase||19
103827|NCT01390844|250514|P3|NOT COMPLETED|Treatment Phase||31
103828|NCT01390844|250515|P2|NOT COMPLETED|Treatment Phase||28
103829|NCT01390844|250516|P1|NOT COMPLETED|Treatment Phase||40
103830|NCT01390844|250513|P4|COMPLETED|Treatment Phase||8
103831|NCT01390844|250514|P3|COMPLETED|Treatment Phase||26
103832|NCT01390844|250515|P2|COMPLETED|Treatment Phase||37
103833|NCT01390844|250516|P1|COMPLETED|Treatment Phase||93
103834|NCT01390844|250513|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
103835|NCT01390844|250514|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
103836|NCT01390844|250515|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
103837|NCT01390844|250516|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
103838|NCT01390844|250513|P4|STARTED|Treatment Phase||27
103839|NCT01390844|250514|P3|STARTED|Treatment Phase||57
103840|NCT01390844|250515|P2|STARTED|Treatment Phase||65
103841|NCT01390844|250516|P1|STARTED|Treatment Phase||133
103842|NCT01390818|250557|P15|NOT COMPLETED|Overall Study||0
103843|NCT01390818|250558|P14|NOT COMPLETED|Overall Study||0
103844|NCT01390818|250559|P13|NOT COMPLETED|Overall Study||0
103845|NCT01390818|250560|P12|NOT COMPLETED|Overall Study||0
103846|NCT01390818|250561|P11|NOT COMPLETED|Overall Study||0
103847|NCT01390818|250562|P10|NOT COMPLETED|Overall Study||0
103848|NCT01390818|250563|P9|NOT COMPLETED|Overall Study||0
103849|NCT01390818|250564|P8|NOT COMPLETED|Overall Study||0
103850|NCT01390818|250565|P7|NOT COMPLETED|Overall Study||0
103851|NCT01390818|250566|P6|NOT COMPLETED|Overall Study||0
103852|NCT01390818|250567|P5|NOT COMPLETED|Overall Study||0
103853|NCT01390818|250568|P4|NOT COMPLETED|Overall Study||0
103854|NCT01390818|250569|P3|NOT COMPLETED|Overall Study||0
103855|NCT01390818|250570|P2|NOT COMPLETED|Overall Study||0
103856|NCT01390818|250571|P1|NOT COMPLETED|Overall Study||0
103857|NCT01390818|250557|P15|COMPLETED|Overall Study||15
103858|NCT01390818|250558|P14|COMPLETED|Overall Study||18
103859|NCT01390818|250559|P13|COMPLETED|Overall Study||24
103860|NCT01390818|250560|P12|COMPLETED|Overall Study||26
103861|NCT01390818|250561|P11|COMPLETED|Overall Study||4
103862|NCT01390818|250562|P10|COMPLETED|Overall Study||3
103863|NCT01390818|250563|P9|COMPLETED|Overall Study||3
103864|NCT01390818|250564|P8|COMPLETED|Overall Study||14
103865|NCT01390818|250565|P7|COMPLETED|Overall Study||19
103866|NCT01390818|250566|P6|COMPLETED|Overall Study||3
103867|NCT01390818|250567|P5|COMPLETED|Overall Study||4
103868|NCT01390818|250568|P4|COMPLETED|Overall Study||4
103869|NCT01390818|250569|P3|COMPLETED|Overall Study||3
103870|NCT01390818|250570|P2|COMPLETED|Overall Study||3
103871|NCT01390818|250571|P1|COMPLETED|Overall Study||3
103872|NCT01390818|250557|P15|STARTED|Overall Study||15
103873|NCT01390818|250558|P14|STARTED|Overall Study||18
103874|NCT01390818|250559|P13|STARTED|Overall Study||24
103875|NCT01390818|250560|P12|STARTED|Overall Study||26
103876|NCT01390818|250561|P11|STARTED|Overall Study||4
103877|NCT01390818|250562|P10|STARTED|Overall Study||3
103878|NCT01390818|250563|P9|STARTED|Overall Study||3
103879|NCT01390818|250564|P8|STARTED|Overall Study||14
103880|NCT01390818|250565|P7|STARTED|Overall Study||19
103881|NCT01390818|250566|P6|STARTED|Overall Study||3
103882|NCT01390818|250567|P5|STARTED|Overall Study||4
103883|NCT01390818|250568|P4|STARTED|Overall Study||4
103884|NCT01390818|250569|P3|STARTED|Overall Study||3
103885|NCT01390818|250570|P2|STARTED|Overall Study||3
103886|NCT01390818|250571|P1|STARTED|Overall Study||3
103887|NCT01390779|250843|P1|NOT COMPLETED|Overall Study||1
103888|NCT01390779|250843|P1|COMPLETED|Overall Study||32
103889|NCT01390779|250843|P1|STARTED|Overall Study||33
103890|NCT01390649|250848|P1|NOT COMPLETED|Overall Study||1
103891|NCT01390649|250848|P1|COMPLETED|Overall Study||56
103892|NCT01390649|250848|P1|STARTED|Overall Study|Subjects treated with Privigen|57
103893|NCT01390441|250858|P5|NOT COMPLETED|Extension Period||0
103894|NCT01390441|250859|P4|NOT COMPLETED|Extension Period||1
103895|NCT01390441|250860|P3|NOT COMPLETED|Extension Period||0
103896|NCT01390441|250861|P2|NOT COMPLETED|Extension Period||1
103897|NCT01390441|250862|P1|NOT COMPLETED|Extension Period||3
103898|NCT01390441|250858|P5|COMPLETED|Extension Period||3
103899|NCT01390441|250859|P4|COMPLETED|Extension Period||0
103900|NCT01390441|250860|P3|COMPLETED|Extension Period||1
103901|NCT01390441|250861|P2|COMPLETED|Extension Period||12
103902|NCT01390441|250862|P1|COMPLETED|Extension Period||12
103903|NCT01390441|250858|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
103904|NCT01390441|250859|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
103905|NCT01390441|250860|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
103906|NCT01390441|250861|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
103907|NCT01390441|250862|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
103908|NCT01390441|250858|P5|NOT COMPLETED|Treatment Period||11
103909|NCT01390441|250859|P4|NOT COMPLETED|Treatment Period||13
103910|NCT01390441|250860|P3|NOT COMPLETED|Treatment Period||10
103911|NCT01390441|250861|P2|NOT COMPLETED|Treatment Period||1
103912|NCT01390441|250862|P1|NOT COMPLETED|Treatment Period||1
103913|NCT01390441|250858|P5|COMPLETED|Treatment Period||7
103914|NCT01390441|250859|P4|COMPLETED|Treatment Period||6
103915|NCT01390441|250860|P3|COMPLETED|Treatment Period||8
103916|NCT01390441|250861|P2|COMPLETED|Treatment Period||21
103917|NCT01390441|250862|P1|COMPLETED|Treatment Period||22
103918|NCT01390441|250858|P5|STARTED|Treatment Period||18
103919|NCT01390441|250859|P4|STARTED|Treatment Period||19
103920|NCT01390441|250860|P3|STARTED|Treatment Period||18
103921|NCT01390441|250861|P2|STARTED|Treatment Period||22
103922|NCT01390441|250862|P1|STARTED|Treatment Period||23
103923|NCT01390428|250927|P6|NOT COMPLETED|Overall Study||0
103924|NCT01390428|250928|P5|NOT COMPLETED|Overall Study||1
103925|NCT01390428|250929|P4|NOT COMPLETED|Overall Study||0
103926|NCT01390428|250930|P3|NOT COMPLETED|Overall Study||1
103927|NCT01390428|250931|P2|NOT COMPLETED|Overall Study||0
103928|NCT01390428|250932|P1|NOT COMPLETED|Overall Study||0
103929|NCT01390428|250927|P6|COMPLETED|Overall Study||8
103930|NCT01390428|250928|P5|COMPLETED|Overall Study||7
103931|NCT01390428|250929|P4|COMPLETED|Overall Study||9
103932|NCT01390428|250930|P3|COMPLETED|Overall Study||8
103933|NCT01390428|250931|P2|COMPLETED|Overall Study||8
103934|NCT01390428|250932|P1|COMPLETED|Overall Study||8
103935|NCT01390428|250927|P6|STARTED|Overall Study||8
103936|NCT01390428|250928|P5|STARTED|Overall Study||8
103937|NCT01390428|250929|P4|STARTED|Overall Study||9
103938|NCT01390428|250930|P3|STARTED|Overall Study||9
103939|NCT01390428|250931|P2|STARTED|Overall Study||8
103940|NCT01390428|250932|P1|STARTED|Overall Study||8
103941|NCT01390415|250984|P2|NOT COMPLETED|Overall Study||0
103942|NCT01390415|250985|P1|NOT COMPLETED|Overall Study||0
103943|NCT01390415|250984|P2|COMPLETED|Overall Study||37
103944|NCT01390415|250985|P1|COMPLETED|Overall Study||99
103945|NCT01390415|250984|P2|STARTED|Overall Study||37
103946|NCT01390415|250985|P1|STARTED|Overall Study||99
103947|NCT01390402|250995|P1|NOT COMPLETED|Overall Study||5
103948|NCT01390402|250995|P1|COMPLETED|Overall Study||1
103949|NCT01390402|250995|P1|STARTED|Overall Study||6
103950|NCT01390389|251001|P2|NOT COMPLETED|Overall Study||1
103951|NCT01390389|251002|P1|NOT COMPLETED|Overall Study||4
103952|NCT01390389|251001|P2|COMPLETED|Overall Study||8
103953|NCT01390389|251002|P1|COMPLETED|Overall Study||6
103954|NCT01390389|251001|P2|STARTED|Overall Study||9
103955|NCT01390389|251002|P1|STARTED|Overall Study||10
103956|NCT01390259|251012|P2|NOT COMPLETED|Overall Study||0
103957|NCT01390259|251013|P1|NOT COMPLETED|Overall Study||0
103958|NCT01390259|251012|P2|COMPLETED|Overall Study||6
103959|NCT01390259|251013|P1|COMPLETED|Overall Study||5
103960|NCT01390259|251012|P2|STARTED|Overall Study||6
103961|NCT01390259|251013|P1|STARTED|Overall Study||5
103962|NCT01390246|251024|P2|NOT COMPLETED|Overall Study||25
103963|NCT01390246|251025|P1|NOT COMPLETED|Overall Study||20
103964|NCT01390246|251024|P2|COMPLETED|Overall Study||10
103965|NCT01390246|251025|P1|COMPLETED|Overall Study||10
103966|NCT01390246|251024|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
103967|NCT01390246|251025|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
103968|NCT01390246|251024|P2|Visit 6: End of Treatment|Overall Study||15
103969|NCT01390246|251025|P1|Visit 6: End of Treatment|Overall Study||15
103970|NCT01390246|251024|P2|Visit 2: Quit Day|Overall Study||24
103971|NCT01390246|251025|P1|Visit 2: Quit Day|Overall Study||24
103972|NCT01390246|251024|P2|STARTED|Overall Study||35
103973|NCT01390246|251025|P1|STARTED|Overall Study||30
103974|NCT01390233|251040|P3|NOT COMPLETED|Overall Study||6
103975|NCT01390233|251041|P2|NOT COMPLETED|Overall Study||2
103976|NCT01390233|251042|P1|NOT COMPLETED|Overall Study||5
103977|NCT01390233|251040|P3|COMPLETED|Overall Study||30
103978|NCT01390233|251041|P2|COMPLETED|Overall Study||29
103979|NCT01390233|251042|P1|COMPLETED|Overall Study||30
103980|NCT01390233|251040|P3|STARTED|Overall Study||36
103981|NCT01390233|251041|P2|STARTED|Overall Study||31
103982|NCT01390233|251042|P1|STARTED|Overall Study||35
103983|NCT01390181|251050|P1|NOT COMPLETED|Overall Study||4
103984|NCT01390181|251050|P1|COMPLETED|Overall Study||0
103985|NCT01390181|251050|P1|STARTED|Overall Study||4
103986|NCT01390038|251054|P1|NOT COMPLETED|Overall Study||8
103987|NCT01390038|251054|P1|COMPLETED|Overall Study||149
103988|NCT01390038|251054|P1|STARTED|Overall Study||157
103989|NCT01389973|251064|P1|NOT COMPLETED|Overall Study||20
103990|NCT01389973|251064|P1|COMPLETED|Overall Study||0
103991|NCT01389973|251064|P1|STARTED|Overall Study||20
103992|NCT01389882|251074|P2|NOT COMPLETED|Overall Study||4
103993|NCT01389882|251075|P1|NOT COMPLETED|Overall Study||1
103994|NCT01389882|251074|P2|COMPLETED|Overall Study||7
103995|NCT01389882|251075|P1|COMPLETED|Overall Study||12
103996|NCT01389882|251074|P2|STARTED|Overall Study||11
103997|NCT01389882|251075|P1|STARTED|Overall Study||13
103998|NCT01389856|251105|P2|NOT COMPLETED|Overall Study||0
103999|NCT01389856|251106|P1|NOT COMPLETED|Overall Study||0
104000|NCT01389856|251105|P2|COMPLETED|Overall Study||8
104001|NCT01389856|251106|P1|COMPLETED|Overall Study||13
104002|NCT01389856|251105|P2|STARTED|Overall Study|Randomized and treated.|8
104003|NCT01389856|251106|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
104004|NCT01389817|251163|P2|NOT COMPLETED|Overall Study||0
104005|NCT01389817|251164|P1|NOT COMPLETED|Overall Study||4
104006|NCT01389817|251163|P2|COMPLETED|Overall Study||0
104007|NCT01389817|251164|P1|COMPLETED|Overall Study||0
104008|NCT01389817|251163|P2|STARTED|Overall Study||0
104009|NCT01389817|251164|P1|STARTED|Overall Study||4
104010|NCT01389596|251173|P3|NOT COMPLETED|Overall Study||10
104011|NCT01389596|251174|P2|NOT COMPLETED|Overall Study||16
104012|NCT01389596|251175|P1|NOT COMPLETED|Overall Study||10
104013|NCT01389596|251173|P3|COMPLETED|Overall Study||84
104014|NCT01389596|251174|P2|COMPLETED|Overall Study||81
104015|NCT01389596|251175|P1|COMPLETED|Overall Study||94
104016|NCT01389596|251173|P3|STARTED|Overall Study||94
104017|NCT01389596|251174|P2|STARTED|Overall Study||97
104018|NCT01389596|251175|P1|STARTED|Overall Study||104
104019|NCT01389323|251234|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
104020|NCT01389323|251234|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
104021|NCT01389323|251234|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
104022|NCT01389323|251234|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
104023|NCT01389323|251234|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
104024|NCT01389323|251234|P1|STARTED|Treatment Period (up to 48 Weeks)||246
104025|NCT01389284|251257|P3|NOT COMPLETED|Overall Study||0
104026|NCT01389284|251258|P2|NOT COMPLETED|Overall Study||0
104027|NCT01389284|251259|P1|NOT COMPLETED|Overall Study||0
104028|NCT01389284|251257|P3|COMPLETED|Overall Study||60
104029|NCT01389284|251258|P2|COMPLETED|Overall Study||120
104030|NCT01389284|251259|P1|COMPLETED|Overall Study||120
104031|NCT01389284|251257|P3|STARTED|Overall Study||60
104032|NCT01389284|251258|P2|STARTED|Overall Study||120
104033|NCT01389284|251259|P1|STARTED|Overall Study||120
104034|NCT01389102|251297|P6|NOT COMPLETED|Overall Study||8
104035|NCT01389102|251298|P5|NOT COMPLETED|Overall Study||13
104036|NCT01389102|251299|P4|NOT COMPLETED|Overall Study||7
104037|NCT01389102|251300|P3|NOT COMPLETED|Overall Study||19
104038|NCT01389102|251301|P2|NOT COMPLETED|Overall Study||12
104039|NCT01389102|251302|P1|NOT COMPLETED|Overall Study||18
104040|NCT01389102|251297|P6|COMPLETED|Overall Study||68
104041|NCT01389102|251298|P5|COMPLETED|Overall Study||61
104042|NCT01389102|251299|P4|COMPLETED|Overall Study||69
104043|NCT01389102|251300|P3|COMPLETED|Overall Study||58
104044|NCT01389102|251301|P2|COMPLETED|Overall Study||64
104045|NCT01389102|251302|P1|COMPLETED|Overall Study||57
104046|NCT01389102|251297|P6|STARTED|Overall Study||76
104047|NCT01389102|251298|P5|STARTED|Overall Study||74
104048|NCT01389102|251299|P4|STARTED|Overall Study||76
104049|NCT01389102|251300|P3|STARTED|Overall Study||77
104050|NCT01389102|251301|P2|STARTED|Overall Study||76
104051|NCT01389102|251302|P1|STARTED|Overall Study||75
104052|NCT01389076|251322|P1|NOT COMPLETED|Overall Study||0
104053|NCT01389076|251322|P1|COMPLETED|Overall Study||22
104054|NCT01389076|251322|P1|STARTED|Overall Study||22
104055|NCT01388946|251332|P2|NOT COMPLETED|Overall Study||3
104056|NCT01388946|251333|P1|NOT COMPLETED|Overall Study||6
104057|NCT01388946|251332|P2|COMPLETED|Overall Study||52
104058|NCT01388946|251333|P1|COMPLETED|Overall Study||49
104059|NCT01388946|251332|P2|STARTED|Overall Study||55
104060|NCT01388946|251333|P1|STARTED|Overall Study||55
104061|NCT01388920|251368|P3|NOT COMPLETED|Overall Study||0
104062|NCT01388920|251369|P2|NOT COMPLETED|Overall Study||0
104063|NCT01388920|251370|P1|NOT COMPLETED|Overall Study||0
104064|NCT01388920|251368|P3|COMPLETED|Overall Study||0
104065|NCT01388920|251369|P2|COMPLETED|Overall Study||1
104066|NCT01388920|251370|P1|COMPLETED|Overall Study||1
104067|NCT01388920|251368|P3|STARTED|Overall Study||0
104068|NCT01388920|251369|P2|STARTED|Overall Study||1
104069|NCT01388920|251370|P1|STARTED|Overall Study||1
104070|NCT01388907|251380|P2|NOT COMPLETED|Overall Study||0
104071|NCT01388907|251381|P1|NOT COMPLETED|Overall Study||2
104072|NCT01388907|251380|P2|COMPLETED|Overall Study||28
104073|NCT01388907|251381|P1|COMPLETED|Overall Study||31
104074|NCT01388907|251380|P2|STARTED|Overall Study||28
104075|NCT01388907|251381|P1|STARTED|Overall Study||33
104076|NCT01388816|251397|P4|NOT COMPLETED|Overall Study||0
104077|NCT01388816|251398|P3|NOT COMPLETED|Overall Study||3
104078|NCT01388816|251399|P2|NOT COMPLETED|Overall Study||4
104079|NCT01388816|251400|P1|NOT COMPLETED|Overall Study||2
104080|NCT01388816|251397|P4|COMPLETED|Overall Study||44
104081|NCT01388816|251398|P3|COMPLETED|Overall Study||41
104082|NCT01388816|251399|P2|COMPLETED|Overall Study||39
104083|NCT01388816|251400|P1|COMPLETED|Overall Study||43
104084|NCT01388816|251397|P4|STARTED|Overall Study||44
104085|NCT01388816|251398|P3|STARTED|Overall Study||44
104086|NCT01388816|251399|P2|STARTED|Overall Study||43
104087|NCT01388816|251400|P1|STARTED|Overall Study||45
104088|NCT01388790|251429|P1|NOT COMPLETED|Overall Study||8
104089|NCT01388790|251429|P1|COMPLETED|Overall Study||32
104090|NCT01388790|251429|P1|STARTED|Overall Study||40
104091|NCT01388647|251436|P2|NOT COMPLETED|Overall Study||2
104092|NCT01388647|251437|P1|NOT COMPLETED|Overall Study||1
104093|NCT01388647|251436|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
104094|NCT01388647|251437|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
104095|NCT01388647|251436|P2|STARTED|Overall Study||6
104096|NCT01388647|251437|P1|STARTED|Overall Study||6
104097|NCT01388530|251448|P1|NOT COMPLETED|Overall Study||5
104098|NCT01388530|251448|P1|COMPLETED|Overall Study||20
104099|NCT01388530|251448|P1|STARTED|Overall Study||25
104100|NCT01388491|251457|P2|NOT COMPLETED|Overall Study||29
104101|NCT01388491|251458|P1|NOT COMPLETED|Overall Study||34
104102|NCT01388491|251457|P2|COMPLETED|Overall Study||114
104103|NCT01388491|251458|P1|COMPLETED|Overall Study||116
104104|NCT01388491|251457|P2|Per Protocol (PP) Population|Overall Study||121
104105|NCT01388491|251458|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
104106|NCT01388491|251457|P2|Intent-to-Treat (ITT) Population|Overall Study||136
104107|NCT01388491|251458|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
104108|NCT01388491|251457|P2|Safety Population|Overall Study||142
104109|NCT01388491|251458|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
104110|NCT01388491|251457|P2|STARTED|Overall Study||143
104111|NCT01388491|251458|P1|STARTED|Overall Study|number randomized|150
104112|NCT01388361|251493|P3|NOT COMPLETED|Overall Study||14
104113|NCT01388361|251494|P2|NOT COMPLETED|Overall Study||12
104114|NCT01388361|251495|P1|NOT COMPLETED|Overall Study||12
104115|NCT01388361|251493|P3|COMPLETED|Overall Study||75
104116|NCT01388361|251494|P2|COMPLETED|Overall Study||76
104117|NCT01388361|251495|P1|COMPLETED|Overall Study||224
104118|NCT01388361|251493|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
104119|NCT01388361|251494|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
104120|NCT01388361|251495|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
104121|NCT01388361|251493|P3|STARTED|Overall Study||89
104122|NCT01388361|251494|P2|STARTED|Overall Study||88
104123|NCT01388361|251495|P1|STARTED|Overall Study||236
104124|NCT01388166|251512|P1|NOT COMPLETED|Overall Study||59
104125|NCT01388166|251512|P1|COMPLETED|Overall Study||1194
104126|NCT01388166|251512|P1|STARTED|Overall Study||1253
104127|NCT01387789|251518|P1|NOT COMPLETED|Overall Study||8
104128|NCT01387789|251518|P1|COMPLETED|Overall Study||63
104129|NCT01387789|251518|P1|STARTED|Overall Study||71
104130|NCT01387737|251532|P2|NOT COMPLETED|Overall Study||74
104131|NCT01387737|251533|P1|NOT COMPLETED|Overall Study||52
104132|NCT01387737|251532|P2|COMPLETED|Overall Study||641
104133|NCT01387737|251533|P1|COMPLETED|Overall Study||532
104134|NCT01387737|251532|P2|STARTED|Overall Study||715
104135|NCT01387737|251533|P1|STARTED|Overall Study||584
104136|NCT01387672|251545|P6|NOT COMPLETED|Overall Study||0
104137|NCT01387672|251546|P5|NOT COMPLETED|Overall Study||4
104138|NCT01387672|251547|P4|NOT COMPLETED|Overall Study||4
104139|NCT01387672|251548|P3|NOT COMPLETED|Overall Study||5
104140|NCT01387672|251549|P2|NOT COMPLETED|Overall Study||7
104141|NCT01387672|251550|P1|NOT COMPLETED|Overall Study||7
104142|NCT01387672|251545|P6|COMPLETED|Overall Study||37
104143|NCT01387672|251546|P5|COMPLETED|Overall Study||34
104144|NCT01387672|251547|P4|COMPLETED|Overall Study||35
104145|NCT01387672|251548|P3|COMPLETED|Overall Study||33
104146|NCT01387672|251549|P2|COMPLETED|Overall Study||31
104147|NCT01387672|251550|P1|COMPLETED|Overall Study||32
104148|NCT01387672|251545|P6|STARTED|Overall Study||37
104149|NCT01387672|251546|P5|STARTED|Overall Study||38
104150|NCT01387672|251547|P4|STARTED|Overall Study||39
104151|NCT01387672|251548|P3|STARTED|Overall Study||38
104152|NCT01387672|251549|P2|STARTED|Overall Study||38
104153|NCT01387672|251550|P1|STARTED|Overall Study||39
104154|NCT01387594|251567|P2|NOT COMPLETED|Overall Study||3
104155|NCT01387594|251568|P1|NOT COMPLETED|Overall Study||0
104156|NCT01387594|251567|P2|COMPLETED|Overall Study||36
104157|NCT01387594|251568|P1|COMPLETED|Overall Study||10
104158|NCT01387594|251567|P2|STARTED|Overall Study||39
104159|NCT01387594|251568|P1|STARTED|Overall Study||10
104160|NCT01387581|251583|P3|NOT COMPLETED|Overall Study||3
104161|NCT01387581|251584|P2|NOT COMPLETED|Overall Study||6
104162|NCT01387581|251585|P1|NOT COMPLETED|Overall Study||7
104163|NCT01387581|251583|P3|COMPLETED|Overall Study||9
104164|NCT01387581|251584|P2|COMPLETED|Overall Study||101
104165|NCT01387581|251585|P1|COMPLETED|Overall Study||101
104166|NCT01387581|251583|P3|STARTED|Overall Study||12
104167|NCT01387581|251584|P2|STARTED|Overall Study||107
104168|NCT01387581|251585|P1|STARTED|Overall Study||108
104169|NCT01387542|251596|P1|NOT COMPLETED|Overall Study||8
104170|NCT01387542|251596|P1|COMPLETED|Overall Study||32
104171|NCT01387542|251596|P1|Treated|Overall Study||38
104172|NCT01387542|251596|P1|STARTED|Overall Study||40
104173|NCT01387464|251605|P2|NOT COMPLETED|Overall Study||1
104174|NCT01387464|251606|P1|NOT COMPLETED|Overall Study||1
104175|NCT01387464|251605|P2|COMPLETED|Overall Study||29
104176|NCT01387464|251606|P1|COMPLETED|Overall Study||29
104177|NCT01387464|251605|P2|Per-Protocol Population|Overall Study||29
104178|NCT01387464|251606|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
104179|NCT01387464|251605|P2|Safety Population|Overall Study||29
104180|NCT01387464|251606|P1|Safety Population|Overall Study||30
104181|NCT01387464|251605|P2|STARTED|Overall Study||30
104182|NCT01387464|251606|P1|STARTED|Overall Study||30
104183|NCT01387347|251614|P2|NOT COMPLETED|Overall Study||1
104184|NCT01387347|251615|P1|NOT COMPLETED|Overall Study||2
104185|NCT01387347|251614|P2|COMPLETED|Overall Study||35
104186|NCT01387347|251615|P1|COMPLETED|Overall Study||34
104187|NCT01387347|251614|P2|STARTED|Overall Study||36
104188|NCT01387347|251615|P1|STARTED|Overall Study||36
104189|NCT01387282|251627|P2|NOT COMPLETED|Overall Study||47
104190|NCT01387282|251628|P1|NOT COMPLETED|Overall Study||97
104191|NCT01387282|251627|P2|COMPLETED|Overall Study||118
104192|NCT01387282|251628|P1|COMPLETED|Overall Study||233
104193|NCT01387282|251627|P2|Safety Population|Overall Study||161
104194|NCT01387282|251628|P1|Safety Population|Overall Study||330
104195|NCT01387282|251627|P2|MITT Population|Overall Study||136
104196|NCT01387282|251628|P1|MITT Population|Overall Study||268
104197|NCT01387282|251627|P2|ITT Population|Overall Study||165
104198|NCT01387282|251628|P1|ITT Population|Overall Study||330
104199|NCT01387282|251627|P2|STARTED|Overall Study||165
104200|NCT01387282|251628|P1|STARTED|Overall Study||330
104201|NCT01387269|251644|P2|NOT COMPLETED|Overall Study||40
104202|NCT01387269|251645|P1|NOT COMPLETED|Overall Study||92
104203|NCT01387269|251644|P2|COMPLETED|Overall Study||121
104204|NCT01387269|251645|P1|COMPLETED|Overall Study||231
104205|NCT01387269|251644|P2|Safety Population|Overall Study||161
104206|NCT01387269|251645|P1|Safety Population|Overall Study||320
104207|NCT01387269|251644|P2|MITT Population|Overall Study||141
104208|NCT01387269|251645|P1|MITT Population|Overall Study||284
104209|NCT01387269|251644|P2|ITT Population|Overall Study||161
104210|NCT01387269|251645|P1|ITT Population|Overall Study||323
104211|NCT01387269|251644|P2|STARTED|Overall Study||161
104212|NCT01387269|251645|P1|STARTED|Overall Study||323
104213|NCT01387230|251662|P3|NOT COMPLETED|Overall Study||13
104214|NCT01387230|251663|P2|NOT COMPLETED|Overall Study||7
104215|NCT01387230|251664|P1|NOT COMPLETED|Overall Study||18
104216|NCT01387230|251662|P3|COMPLETED|Overall Study||56
104217|NCT01387230|251663|P2|COMPLETED|Overall Study||62
104218|NCT01387230|251664|P1|COMPLETED|Overall Study||50
104219|NCT01387230|251662|P3|STARTED|Overall Study||69
104220|NCT01387230|251663|P2|STARTED|Overall Study||69
104221|NCT01387230|251664|P1|STARTED|Overall Study||68
104222|NCT01387178|251680|P2|NOT COMPLETED|Overall Study||0
104223|NCT01387178|251681|P1|NOT COMPLETED|Overall Study||0
104224|NCT01387178|251680|P2|COMPLETED|Overall Study||10641
104225|NCT01387178|251681|P1|COMPLETED|Overall Study||11582
104226|NCT01387178|251680|P2|STARTED|Overall Study||10641
104227|NCT01387178|251681|P1|STARTED|Overall Study||11582
104228|NCT01387139|251693|P2|NOT COMPLETED|Overall Study||0
104229|NCT01387139|251694|P1|NOT COMPLETED|Overall Study||0
104230|NCT01387139|251693|P2|COMPLETED|Overall Study||84
104231|NCT01387139|251694|P1|COMPLETED|Overall Study||99
104232|NCT01387139|251693|P2|STARTED|Overall Study||84
104233|NCT01387139|251694|P1|STARTED|Overall Study||99
104234|NCT01387074|251710|P1|NOT COMPLETED|Overall Study||8
104235|NCT01387074|251710|P1|COMPLETED|Overall Study||100
104236|NCT01387074|251710|P1|STARTED|Overall Study||108
104237|NCT01387022|251723|P2|NOT COMPLETED|Overall Study||4
104238|NCT01387022|251724|P1|NOT COMPLETED|Overall Study||1
104239|NCT01387022|251723|P2|COMPLETED|Overall Study||26
104240|NCT01387022|251724|P1|COMPLETED|Overall Study||28
104241|NCT01387022|251723|P2|STARTED|Overall Study||30
104242|NCT01387022|251724|P1|STARTED|Overall Study||29
104243|NCT01386983|251742|P2|NOT COMPLETED|Overall Study||0
104244|NCT01386983|251743|P1|NOT COMPLETED|Overall Study||0
104245|NCT01386983|251742|P2|COMPLETED|Overall Study||68
104246|NCT01386983|251743|P1|COMPLETED|Overall Study||264
104247|NCT01386983|251742|P2|STARTED|Overall Study||68
104248|NCT01386983|251743|P1|STARTED|Overall Study||264
104249|NCT01386944|251751|P1|NOT COMPLETED|Overall Study||56
104250|NCT01386944|251751|P1|COMPLETED|Overall Study||46
104251|NCT01386944|251751|P1|STARTED|Overall Study||102
104252|NCT01386788|251761|P1|NOT COMPLETED|Overall Study||2
104253|NCT01386788|251761|P1|COMPLETED|Overall Study||100
104254|NCT01386788|251761|P1|STARTED|Overall Study||102
104255|NCT01386684|251766|P1|NOT COMPLETED|Overall Study||293
104256|NCT01386684|251766|P1|COMPLETED|Overall Study||259
104257|NCT01386684|251766|P1|STARTED|Overall Study||552
104258|NCT01386632|251807|P2|NOT COMPLETED|Overall Study||4
104259|NCT01386632|251808|P1|NOT COMPLETED|Overall Study||5
104260|NCT01386632|251807|P2|COMPLETED|Overall Study||21
104261|NCT01386632|251808|P1|COMPLETED|Overall Study||20
104262|NCT01386632|251807|P2|STARTED|Overall Study||25
104263|NCT01386632|251808|P1|STARTED|Overall Study||25
104264|NCT01386606|251820|P4|NOT COMPLETED|Overall Study||1
104265|NCT01386606|251821|P3|NOT COMPLETED|Overall Study||3
104266|NCT01386606|251822|P2|NOT COMPLETED|Overall Study||4
104267|NCT01386606|251823|P1|NOT COMPLETED|Overall Study||4
104268|NCT01386606|251820|P4|COMPLETED|Overall Study||13
104269|NCT01386606|251821|P3|COMPLETED|Overall Study||13
104270|NCT01386606|251822|P2|COMPLETED|Overall Study||10
104271|NCT01386606|251823|P1|COMPLETED|Overall Study||12
104272|NCT01386606|251820|P4|STARTED|Overall Study||14
104273|NCT01386606|251821|P3|STARTED|Overall Study||16
104274|NCT01386606|251822|P2|STARTED|Overall Study||14
104275|NCT01386606|251823|P1|STARTED|Overall Study||16
104276|NCT01386554|251854|P3|NOT COMPLETED|Overall Study||6
104277|NCT01386554|251855|P2|NOT COMPLETED|Overall Study||9
104278|NCT01386554|251856|P1|NOT COMPLETED|Overall Study||3
104279|NCT01386554|251854|P3|COMPLETED|Overall Study||15
104280|NCT01386554|251855|P2|COMPLETED|Overall Study||26
104281|NCT01386554|251856|P1|COMPLETED|Overall Study||1
104282|NCT01386554|251854|P3|STARTED|Overall Study||21
104283|NCT01386554|251855|P2|STARTED|Overall Study||35
104284|NCT01386554|251856|P1|STARTED|Overall Study||4
104285|NCT01386528|251870|P1|NOT COMPLETED|Overall Study||0
104286|NCT01386528|251870|P1|COMPLETED|Overall Study||13
104287|NCT01386528|251870|P1|STARTED|Overall Study||13
104288|NCT01386125|251882|P2|NOT COMPLETED|Overall Study||37
104289|NCT01386125|251883|P1|NOT COMPLETED|Overall Study||25
104290|NCT01386125|251882|P2|COMPLETED|Overall Study||336
104291|NCT01386125|251883|P1|COMPLETED|Overall Study||350
104292|NCT01386125|251882|P2|STARTED|Overall Study||373
104293|NCT01386125|251883|P1|STARTED|Overall Study||375
104294|NCT01386008|251891|P1|NOT COMPLETED|Overall Study||20
104295|NCT01386008|251891|P1|COMPLETED|Overall Study||0
104296|NCT01386008|251891|P1|STARTED|Overall Study||20
104297|NCT01385995|251900|P2|NOT COMPLETED|Period 2, 2 Months||0
104298|NCT01385995|251901|P1|NOT COMPLETED|Period 2, 2 Months||0
104299|NCT01385995|251900|P2|COMPLETED|Period 2, 2 Months||25
104300|NCT01385995|251901|P1|COMPLETED|Period 2, 2 Months||24
104301|NCT01385995|251900|P2|STARTED|Period 2, 2 Months||25
104302|NCT01385995|251901|P1|STARTED|Period 2, 2 Months||24
104303|NCT01385995|251900|P2|NOT COMPLETED|Washout Period, 1 Month||0
104304|NCT01385995|251901|P1|NOT COMPLETED|Washout Period, 1 Month||0
104305|NCT01385995|251900|P2|COMPLETED|Washout Period, 1 Month||25
104306|NCT01385995|251901|P1|COMPLETED|Washout Period, 1 Month||24
104307|NCT01385995|251900|P2|STARTED|Washout Period, 1 Month||25
104308|NCT01385995|251901|P1|STARTED|Washout Period, 1 Month||24
104309|NCT01385995|251900|P2|NOT COMPLETED|Period 1, 2 Months||0
104310|NCT01385995|251901|P1|NOT COMPLETED|Period 1, 2 Months||1
104311|NCT01385995|251900|P2|COMPLETED|Period 1, 2 Months||25
104312|NCT01385995|251901|P1|COMPLETED|Period 1, 2 Months||24
104313|NCT01385995|251900|P2|STARTED|Period 1, 2 Months||25
104314|NCT01385995|251901|P1|STARTED|Period 1, 2 Months||25
104315|NCT01385748|251918|P3|NOT COMPLETED|Overall Study||13
104316|NCT01385748|251919|P2|NOT COMPLETED|Overall Study||14
104317|NCT01385748|251920|P1|NOT COMPLETED|Overall Study||15
104318|NCT01385748|251918|P3|COMPLETED|Overall Study||49
104319|NCT01385748|251919|P2|COMPLETED|Overall Study||51
104320|NCT01385748|251920|P1|COMPLETED|Overall Study||41
104321|NCT01385748|251918|P3|STARTED|Overall Study||62
104322|NCT01385748|251919|P2|STARTED|Overall Study||65
104323|NCT01385748|251920|P1|STARTED|Overall Study||56
104324|NCT01385696|251965|P2|NOT COMPLETED|Overall Study||0
104325|NCT01385696|251966|P1|NOT COMPLETED|Overall Study||0
104326|NCT01385696|251965|P2|COMPLETED|Overall Study||64
104327|NCT01385696|251966|P1|COMPLETED|Overall Study||66
104328|NCT01385696|251965|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
104329|NCT01385696|251966|P1|STARTED|Overall Study||66
104330|NCT01385644|251977|P2|NOT COMPLETED|Overall Study||0
104331|NCT01385644|251978|P1|NOT COMPLETED|Overall Study||0
104332|NCT01385644|251977|P2|COMPLETED|Overall Study||4
104333|NCT01385644|251978|P1|COMPLETED|Overall Study||4
104334|NCT01385644|251977|P2|STARTED|Overall Study||4
104335|NCT01385644|251978|P1|STARTED|Overall Study||4
104336|NCT01385579|251992|P2|NOT COMPLETED|Overall Study||0
104337|NCT01385579|251993|P1|NOT COMPLETED|Overall Study||0
104338|NCT01385579|251992|P2|COMPLETED|Overall Study||104
104339|NCT01385579|251993|P1|COMPLETED|Overall Study||98
104340|NCT01385579|251992|P2|STARTED|Overall Study||104
104341|NCT01385579|251993|P1|STARTED|Overall Study||98
104342|NCT01385566|252005|P6|NOT COMPLETED|Overall Study||0
104343|NCT01385566|252006|P5|NOT COMPLETED|Overall Study||0
104344|NCT01385566|252007|P4|NOT COMPLETED|Overall Study||1
104345|NCT01385566|252008|P3|NOT COMPLETED|Overall Study||0
104346|NCT01385566|252009|P2|NOT COMPLETED|Overall Study||0
104347|NCT01385566|252010|P1|NOT COMPLETED|Overall Study||1
104348|NCT01385566|252005|P6|COMPLETED|Overall Study||34
104349|NCT01385566|252006|P5|COMPLETED|Overall Study||34
104350|NCT01385566|252007|P4|COMPLETED|Overall Study||34
104351|NCT01385566|252008|P3|COMPLETED|Overall Study||34
104352|NCT01385566|252009|P2|COMPLETED|Overall Study||34
104353|NCT01385566|252010|P1|COMPLETED|Overall Study||51
104354|NCT01385566|252005|P6|STARTED|Overall Study||34
104355|NCT01385566|252006|P5|STARTED|Overall Study||34
104356|NCT01385566|252007|P4|STARTED|Overall Study||35
104357|NCT01385566|252008|P3|STARTED|Overall Study||34
104358|NCT01385566|252009|P2|STARTED|Overall Study||34
104359|NCT01385566|252010|P1|STARTED|Overall Study||52
104360|NCT01385371|252064|P2|NOT COMPLETED|Overall Study||97
104361|NCT01385371|252065|P1|NOT COMPLETED|Overall Study||149
104362|NCT01385371|252064|P2|COMPLETED|Overall Study||652
104363|NCT01385371|252065|P1|COMPLETED|Overall Study||603
104364|NCT01385371|252064|P2|STARTED|Overall Study||749
104365|NCT01385371|252065|P1|STARTED|Overall Study||752
104366|NCT01385293|252085|P1|NOT COMPLETED|Overall Study||0
104367|NCT01385293|252085|P1|COMPLETED|Overall Study||30
104368|NCT01385293|252085|P1|STARTED|Overall Study||30
104369|NCT01385202|252095|P1|NOT COMPLETED|Overall Study||18
104370|NCT01385202|252095|P1|COMPLETED|Overall Study||154
104371|NCT01385202|252095|P1|Undergoing Ablation|Overall Study||160
104372|NCT01385202|252095|P1|Study Catheter Inserted|Overall Study||161
104373|NCT01385202|252095|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
104374|NCT01385189|252107|P5|NOT COMPLETED|Overall Study||2
104375|NCT01385189|252108|P4|NOT COMPLETED|Overall Study||1
104376|NCT01385189|252109|P3|NOT COMPLETED|Overall Study||0
104377|NCT01385189|252110|P2|NOT COMPLETED|Overall Study||1
104378|NCT01385189|252111|P1|NOT COMPLETED|Overall Study||1
104379|NCT01385189|252107|P5|COMPLETED|Overall Study||6
104380|NCT01385189|252108|P4|COMPLETED|Overall Study||3
104381|NCT01385189|252109|P3|COMPLETED|Overall Study||4
104382|NCT01385189|252110|P2|COMPLETED|Overall Study||11
104383|NCT01385189|252111|P1|COMPLETED|Overall Study||11
104384|NCT01385189|252107|P5|STARTED|Overall Study||8
104385|NCT01385189|252108|P4|STARTED|Overall Study||4
104386|NCT01385189|252109|P3|STARTED|Overall Study||4
104387|NCT01385189|252110|P2|STARTED|Overall Study||12
104388|NCT01385189|252111|P1|STARTED|Overall Study||12
104389|NCT01385137|252132|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
104390|NCT01385137|252133|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
104391|NCT01385137|252132|P2|COMPLETED|Evaluable for Primary Endpoint||107
104392|NCT01385137|252133|P1|COMPLETED|Evaluable for Primary Endpoint||102
104393|NCT01385137|252132|P2|STARTED|Evaluable for Primary Endpoint||131
104394|NCT01385137|252133|P1|STARTED|Evaluable for Primary Endpoint||131
104395|NCT01385137|252132|P2|NOT COMPLETED|Evaluable at Baseline||4
104396|NCT01385137|252133|P1|NOT COMPLETED|Evaluable at Baseline||9
104397|NCT01385137|252132|P2|COMPLETED|Evaluable at Baseline||127
104398|NCT01385137|252133|P1|COMPLETED|Evaluable at Baseline||122
104399|NCT01385137|252132|P2|STARTED|Evaluable at Baseline||131
104400|NCT01385137|252133|P1|STARTED|Evaluable at Baseline||131
104401|NCT01385098|252147|P1|NOT COMPLETED|Overall Study||14
104402|NCT01385098|252147|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
104403|NCT01385098|252147|P1|STARTED|Overall Study||37
104404|NCT01385033|252155|P6|NOT COMPLETED|Part III||0
104405|NCT01385033|252156|P5|NOT COMPLETED|Part III||0
104406|NCT01385033|252157|P4|NOT COMPLETED|Part III||0
104407|NCT01385033|252158|P3|NOT COMPLETED|Part III||0
104408|NCT01385033|252159|P2|NOT COMPLETED|Part III||0
104409|NCT01385033|252160|P1|NOT COMPLETED|Part III||0
104410|NCT01385033|252155|P6|COMPLETED|Part III||0
104411|NCT01385033|252156|P5|COMPLETED|Part III||0
104412|NCT01385033|252157|P4|COMPLETED|Part III||0
104413|NCT01385033|252158|P3|COMPLETED|Part III||0
104414|NCT01385033|252159|P2|COMPLETED|Part III||0
104415|NCT01385033|252160|P1|COMPLETED|Part III||0
104416|NCT01385033|252155|P6|STARTED|Part III||0
104417|NCT01385033|252156|P5|STARTED|Part III||0
104418|NCT01385033|252157|P4|STARTED|Part III||0
104419|NCT01385033|252158|P3|STARTED|Part III||0
104420|NCT01385033|252159|P2|STARTED|Part III||0
104421|NCT01385033|252160|P1|STARTED|Part III||0
104422|NCT01385033|252155|P6|NOT COMPLETED|Part II||0
104423|NCT01385033|252156|P5|NOT COMPLETED|Part II||0
104424|NCT01385033|252157|P4|NOT COMPLETED|Part II||0
104425|NCT01385033|252158|P3|NOT COMPLETED|Part II||0
104426|NCT01385033|252159|P2|NOT COMPLETED|Part II||0
104427|NCT01385033|252160|P1|NOT COMPLETED|Part II||0
104428|NCT01385033|252155|P6|COMPLETED|Part II||0
104429|NCT01385033|252156|P5|COMPLETED|Part II||0
104430|NCT01385033|252157|P4|COMPLETED|Part II||0
104431|NCT01385033|252158|P3|COMPLETED|Part II||0
104432|NCT01385033|252159|P2|COMPLETED|Part II||0
104433|NCT01385033|252160|P1|COMPLETED|Part II||0
104434|NCT01385033|252155|P6|STARTED|Part II||0
104435|NCT01385033|252156|P5|STARTED|Part II||0
104436|NCT01385033|252157|P4|STARTED|Part II||0
104437|NCT01385033|252158|P3|STARTED|Part II||0
104438|NCT01385033|252159|P2|STARTED|Part II||0
104439|NCT01385033|252160|P1|STARTED|Part II||0
104440|NCT01385033|252155|P6|NOT COMPLETED|Part I||0
104441|NCT01385033|252156|P5|NOT COMPLETED|Part I||0
104442|NCT01385033|252157|P4|NOT COMPLETED|Part I||0
104443|NCT01385033|252158|P3|NOT COMPLETED|Part I||0
104444|NCT01385033|252159|P2|NOT COMPLETED|Part I||0
104445|NCT01385033|252160|P1|NOT COMPLETED|Part I||0
104446|NCT01385033|252155|P6|COMPLETED|Part I||0
104447|NCT01385033|252156|P5|COMPLETED|Part I||0
104448|NCT01385033|252157|P4|COMPLETED|Part I||0
104449|NCT01385033|252158|P3|COMPLETED|Part I||0
104450|NCT01385033|252159|P2|COMPLETED|Part I||14
104451|NCT01385033|252160|P1|COMPLETED|Part I||6
104452|NCT01385033|252155|P6|STARTED|Part I||0
104453|NCT01385033|252156|P5|STARTED|Part I||0
104454|NCT01385033|252157|P4|STARTED|Part I||0
104455|NCT01385033|252158|P3|STARTED|Part I||0
104456|NCT01385033|252159|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
104457|NCT01385033|252160|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
104458|NCT01384760|252169|P2|NOT COMPLETED|Overall Study||6
104459|NCT01384760|252170|P1|NOT COMPLETED|Overall Study||16
104460|NCT01384760|252169|P2|COMPLETED|Overall Study||37
104461|NCT01384760|252170|P1|COMPLETED|Overall Study||45
104462|NCT01384760|252169|P2|Randomized|Overall Study||43
104463|NCT01384760|252170|P1|Randomized|Overall Study||61
104464|NCT01384760|252169|P2|STARTED|Overall Study||43
104465|NCT01384760|252170|P1|STARTED|Overall Study||61
104466|NCT01384591|252181|P3|NOT COMPLETED|Overall Study||0
104467|NCT01384591|252182|P2|NOT COMPLETED|Overall Study||0
104468|NCT01384591|252183|P1|NOT COMPLETED|Overall Study||0
104469|NCT01384591|252181|P3|COMPLETED|Overall Study||2
104470|NCT01384591|252182|P2|COMPLETED|Overall Study||2
104471|NCT01384591|252183|P1|COMPLETED|Overall Study||2
104472|NCT01384591|252181|P3|STARTED|Overall Study||2
104473|NCT01384591|252182|P2|STARTED|Overall Study||2
104474|NCT01384591|252183|P1|STARTED|Overall Study||2
104475|NCT01384539|252313|P2|NOT COMPLETED|Overall Study||7
104476|NCT01384539|252314|P1|NOT COMPLETED|Overall Study||6
104477|NCT01384539|252313|P2|COMPLETED|Overall Study||57
104478|NCT01384539|252314|P1|COMPLETED|Overall Study||58
104479|NCT01384539|252313|P2|STARTED|Overall Study||64
104480|NCT01384539|252314|P1|STARTED|Overall Study||64
104481|NCT01384292|252323|P3|NOT COMPLETED|Part B||0
104482|NCT01384292|252324|P2|NOT COMPLETED|Part B||0
104483|NCT01384292|252325|P1|NOT COMPLETED|Part B||1
104484|NCT01384292|252323|P3|COMPLETED|Part B||0
104485|NCT01384292|252324|P2|COMPLETED|Part B||6
104486|NCT01384292|252325|P1|COMPLETED|Part B||2
104487|NCT01384292|252323|P3|STARTED|Part B||0
104488|NCT01384292|252324|P2|STARTED|Part B||6
104489|NCT01384292|252325|P1|STARTED|Part B||3
104490|NCT01384292|252323|P3|NOT COMPLETED|Part A||0
104491|NCT01384292|252324|P2|NOT COMPLETED|Part A||0
104492|NCT01384292|252325|P1|NOT COMPLETED|Part A||0
104493|NCT01384292|252323|P3|COMPLETED|Part A||4
104494|NCT01384292|252324|P2|COMPLETED|Part A||5
104495|NCT01384292|252325|P1|COMPLETED|Part A||5
104496|NCT01384292|252323|P3|STARTED|Part A||4
104497|NCT01384292|252324|P2|STARTED|Part A||5
104498|NCT01384292|252325|P1|STARTED|Part A||5
104499|NCT01384019|252337|P2|NOT COMPLETED|Overall Study||6
104500|NCT01384019|252338|P1|NOT COMPLETED|Overall Study||10
104501|NCT01384019|252337|P2|COMPLETED|Overall Study||55
104502|NCT01384019|252338|P1|COMPLETED|Overall Study||55
104503|NCT01384019|252337|P2|STARTED|Overall Study||61
104504|NCT01384019|252338|P1|STARTED|Overall Study||65
104505|NCT01383993|252347|P3|NOT COMPLETED|Overall Study||1
104506|NCT01383993|252348|P2|NOT COMPLETED|Overall Study||1
104507|NCT01383993|252349|P1|NOT COMPLETED|Overall Study||3
104508|NCT01383993|252347|P3|COMPLETED|Overall Study||1
104509|NCT01383993|252348|P2|COMPLETED|Overall Study||3
104510|NCT01383993|252349|P1|COMPLETED|Overall Study||12
104511|NCT01383993|252347|P3|STARTED|Overall Study||2
104512|NCT01383993|252348|P2|STARTED|Overall Study||4
104513|NCT01383993|252349|P1|STARTED|Overall Study||15
104514|NCT01383954|252396|P1|NOT COMPLETED|Overall Study||14
104515|NCT01383954|252396|P1|COMPLETED|Overall Study||38
104516|NCT01383954|252396|P1|Safety Population: Received Treatment|Overall Study||48
104517|NCT01383954|252396|P1|STARTED|Overall Study||52
104518|NCT01383928|252404|P3|NOT COMPLETED|Phase 2||40
104519|NCT01383928|252405|P2|NOT COMPLETED|Phase 2||0
104520|NCT01383928|252406|P1|NOT COMPLETED|Phase 2||0
104521|NCT01383928|252404|P3|COMPLETED|Phase 2||10
104522|NCT01383928|252405|P2|COMPLETED|Phase 2||0
104523|NCT01383928|252406|P1|COMPLETED|Phase 2||0
104524|NCT01383928|252404|P3|STARTED|Phase 2||50
104525|NCT01383928|252405|P2|STARTED|Phase 2||0
104526|NCT01383928|252406|P1|STARTED|Phase 2||0
104527|NCT01383928|252404|P3|NOT COMPLETED|Phase 1||0
104528|NCT01383928|252405|P2|NOT COMPLETED|Phase 1||7
104529|NCT01383928|252406|P1|NOT COMPLETED|Phase 1||5
104530|NCT01383928|252404|P3|COMPLETED|Phase 1||0
104531|NCT01383928|252405|P2|COMPLETED|Phase 1||0
104532|NCT01383928|252406|P1|COMPLETED|Phase 1||2
104533|NCT01383928|252404|P3|STARTED|Phase 1||0
104534|NCT01383928|252405|P2|STARTED|Phase 1||7
104535|NCT01383928|252406|P1|STARTED|Phase 1||7
104536|NCT01383720|252448|P1|NOT COMPLETED|Overall Study||0
104537|NCT01383720|252448|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
104538|NCT01383720|252448|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
104539|NCT01383720|252448|P1|STARTED|Overall Study||11
104540|NCT01383707|252470|P1|NOT COMPLETED|Overall Study||72
104541|NCT01383707|252470|P1|COMPLETED|Overall Study||5
104542|NCT01383707|252470|P1|STARTED|Overall Study||77
104543|NCT01383681|252479|P1|NOT COMPLETED|Overall Study||46
104544|NCT01383681|252479|P1|COMPLETED|Overall Study||189
104545|NCT01383681|252479|P1|STARTED|Overall Study||235
104546|NCT01383616|252486|P2|NOT COMPLETED|Overall Study||23
104547|NCT01383616|252487|P1|NOT COMPLETED|Overall Study||17
104548|NCT01383616|252486|P2|COMPLETED|Overall Study||21
104549|NCT01383616|252487|P1|COMPLETED|Overall Study||23
104550|NCT01383616|252486|P2|STARTED|Overall Study||44
104551|NCT01383616|252487|P1|STARTED|Overall Study||40
104552|NCT01383499|252510|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
104553|NCT01383499|252511|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
104554|NCT01383499|252512|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
104555|NCT01383499|252513|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
104556|NCT01383499|252510|P4|COMPLETED|Period 3 (4 Weeks)||25
104557|NCT01383499|252511|P3|COMPLETED|Period 3 (4 Weeks)||25
104558|NCT01383499|252512|P2|COMPLETED|Period 3 (4 Weeks)||24
104559|NCT01383499|252513|P1|COMPLETED|Period 3 (4 Weeks)||26
104560|NCT01383499|252510|P4|STARTED|Period 3 (4 Weeks)||25
104561|NCT01383499|252511|P3|STARTED|Period 3 (4 Weeks)||25
104562|NCT01383499|252512|P2|STARTED|Period 3 (4 Weeks)||24
104563|NCT01383499|252513|P1|STARTED|Period 3 (4 Weeks)||26
104564|NCT01383499|252510|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
104565|NCT01383499|252511|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
104566|NCT01383499|252512|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
104567|NCT01383499|252513|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
104568|NCT01383499|252510|P4|COMPLETED|Period 2 (4 Weeks)||25
104569|NCT01383499|252511|P3|COMPLETED|Period 2 (4 Weeks)||25
104570|NCT01383499|252512|P2|COMPLETED|Period 2 (4 Weeks)||24
104571|NCT01383499|252513|P1|COMPLETED|Period 2 (4 Weeks)||26
104572|NCT01383499|252510|P4|STARTED|Period 2 (4 Weeks)||25
104573|NCT01383499|252511|P3|STARTED|Period 2 (4 Weeks)||25
104574|NCT01383499|252512|P2|STARTED|Period 2 (4 Weeks)||24
104575|NCT01383499|252513|P1|STARTED|Period 2 (4 Weeks)||26
104576|NCT01383499|252510|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
104577|NCT01383499|252511|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
104578|NCT01383499|252512|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
104579|NCT01383499|252513|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
104580|NCT01383499|252510|P4|COMPLETED|Period 1 (4 Weeks)||25
104581|NCT01383499|252511|P3|COMPLETED|Period 1 (4 Weeks)||25
104582|NCT01383499|252512|P2|COMPLETED|Period 1 (4 Weeks)||24
104583|NCT01383499|252513|P1|COMPLETED|Period 1 (4 Weeks)||26
104584|NCT01383499|252510|P4|STARTED|Period 1 (4 Weeks)||25
104585|NCT01383499|252511|P3|STARTED|Period 1 (4 Weeks)||25
104586|NCT01383499|252512|P2|STARTED|Period 1 (4 Weeks)||24
104587|NCT01383499|252513|P1|STARTED|Period 1 (4 Weeks)||27
104588|NCT01383486|252563|P1|NOT COMPLETED|Overall Study||18
104589|NCT01383486|252563|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
104590|NCT01383486|252563|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
104591|NCT01383486|252563|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
104592|NCT01383447|252569|P1|NOT COMPLETED|Overall Study||2
104593|NCT01383447|252569|P1|COMPLETED|Overall Study||0
104594|NCT01383447|252569|P1|STARTED|Overall Study||2
104595|NCT01383421|252577|P1|NOT COMPLETED|Overall Study||346
104596|NCT01383421|252577|P1|COMPLETED|Overall Study||679
104597|NCT01383421|252577|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
104598|NCT01383356|252640|P2|NOT COMPLETED|Period 2||0
104599|NCT01383356|252641|P1|NOT COMPLETED|Period 2||0
104600|NCT01383356|252640|P2|COMPLETED|Period 2|Completed period 2.|23
104601|NCT01383356|252641|P1|COMPLETED|Period 2|Completed period 2.|21
104602|NCT01383356|252640|P2|STARTED|Period 2|Entered and treated.|23
104603|NCT01383356|252641|P1|STARTED|Period 2|Entered and treated.|21
104604|NCT01383356|252640|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
104605|NCT01383356|252641|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
104606|NCT01383356|252640|P2|COMPLETED|Washout Period (at Least 35 Days)||23
104607|NCT01383356|252641|P1|COMPLETED|Washout Period (at Least 35 Days)||21
104608|NCT01383356|252640|P2|STARTED|Washout Period (at Least 35 Days)||23
104609|NCT01383356|252641|P1|STARTED|Washout Period (at Least 35 Days)||21
104610|NCT01383356|252640|P2|NOT COMPLETED|Period 1||6
104611|NCT01383356|252641|P1|NOT COMPLETED|Period 1||8
104612|NCT01383356|252640|P2|COMPLETED|Period 1|Completed period 1.|23
104613|NCT01383356|252641|P1|COMPLETED|Period 1|Completed period 1.|21
104614|NCT01383356|252640|P2|STARTED|Period 1|Entered and treated.|29
104615|NCT01383356|252641|P1|STARTED|Period 1|Entered and treated.|29
104616|NCT01383317|252653|P2|NOT COMPLETED|Overall Study||2
104617|NCT01383317|252654|P1|NOT COMPLETED|Overall Study||3
104618|NCT01383317|252653|P2|COMPLETED|Overall Study||33
104619|NCT01383317|252654|P1|COMPLETED|Overall Study||26
104620|NCT01383317|252653|P2|STARTED|Overall Study||35
104621|NCT01383317|252654|P1|STARTED|Overall Study||29
104622|NCT01383213|252678|P2|NOT COMPLETED|Overall Study||0
104623|NCT01383213|252679|P1|NOT COMPLETED|Overall Study||0
104624|NCT01383213|252678|P2|COMPLETED|Overall Study||41
104625|NCT01383213|252679|P1|COMPLETED|Overall Study||40
104626|NCT01383213|252678|P2|STARTED|Overall Study||41
104627|NCT01383213|252679|P1|STARTED|Overall Study||40
104628|NCT01383200|252687|P2|NOT COMPLETED|Overall Study||0
104629|NCT01383200|252688|P1|NOT COMPLETED|Overall Study||0
104630|NCT01383200|252687|P2|COMPLETED|Overall Study||6
104631|NCT01383200|252688|P1|COMPLETED|Overall Study||5
104632|NCT01383200|252687|P2|STARTED|Overall Study||6
104633|NCT01383200|252688|P1|STARTED|Overall Study||5
104634|NCT01383174|252696|P2|NOT COMPLETED|6 Month Assessment||1
104635|NCT01383174|252697|P1|NOT COMPLETED|6 Month Assessment||5
104636|NCT01383174|252696|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
104637|NCT01383174|252697|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
104638|NCT01383174|252696|P2|STARTED|6 Month Assessment||74
104639|NCT01383174|252697|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
104640|NCT01383174|252696|P2|NOT COMPLETED|3 Month Assessment||1
104641|NCT01383174|252697|P1|NOT COMPLETED|3 Month Assessment||6
104642|NCT01383174|252696|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
104643|NCT01383174|252697|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
104644|NCT01383174|252696|P2|STARTED|3 Month Assessment||75
104645|NCT01383174|252697|P1|STARTED|3 Month Assessment||76
104646|NCT01383174|252696|P2|NOT COMPLETED|Baseline Assessment||0
104647|NCT01383174|252697|P1|NOT COMPLETED|Baseline Assessment||0
104648|NCT01383174|252696|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
104649|NCT01383174|252697|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
104650|NCT01383174|252696|P2|STARTED|Baseline Assessment||75
104651|NCT01383174|252697|P1|STARTED|Baseline Assessment||76
104652|NCT01383161|252723|P2|NOT COMPLETED|Overall Study||4
104653|NCT01383161|252724|P1|NOT COMPLETED|Overall Study||5
104654|NCT01383161|252723|P2|COMPLETED|Overall Study||17
104655|NCT01383161|252724|P1|COMPLETED|Overall Study||20
104656|NCT01383161|252723|P2|STARTED|Overall Study||21
104657|NCT01383161|252724|P1|STARTED|Overall Study||25
104658|NCT01383096|252743|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
104659|NCT01383096|252744|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
104660|NCT01383096|252745|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
104661|NCT01383096|252743|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
104662|NCT01383096|252744|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
104663|NCT01383096|252745|P1|COMPLETED|Fifth Intervention (8 Days)||11
104664|NCT01383096|252743|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
104665|NCT01383096|252744|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
104666|NCT01383096|252745|P1|STARTED|Fifth Intervention (8 Days)||13
104667|NCT01383096|252743|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
104668|NCT01383096|252744|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
104669|NCT01383096|252745|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
104670|NCT01383096|252743|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
104671|NCT01383096|252744|P2|COMPLETED|Fourth Intervention (8 Days)||12
104672|NCT01383096|252745|P1|COMPLETED|Fourth Intervention (8 Days)||13
104673|NCT01383096|252743|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
104674|NCT01383096|252744|P2|STARTED|Fourth Intervention (8 Days)||12
104675|NCT01383096|252745|P1|STARTED|Fourth Intervention (8 Days)||15
104676|NCT01383096|252743|P3|NOT COMPLETED|Third Intervention (8 Days)||0
104677|NCT01383096|252744|P2|NOT COMPLETED|Third Intervention (8 Days)||4
104678|NCT01383096|252745|P1|NOT COMPLETED|Third Intervention (8 Days)||4
104679|NCT01383096|252743|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
104680|NCT01383096|252744|P2|COMPLETED|Third Intervention (8 Days)||12
104681|NCT01383096|252745|P1|COMPLETED|Third Intervention (8 Days)||15
104682|NCT01383096|252743|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
104683|NCT01383096|252744|P2|STARTED|Third Intervention (8 Days)||16
104684|NCT01383096|252745|P1|STARTED|Third Intervention (8 Days)||19
104685|NCT01383096|252743|P3|NOT COMPLETED|Second Intervention (8 Days)||2
104686|NCT01383096|252744|P2|NOT COMPLETED|Second Intervention (8 Days)||1
104687|NCT01383096|252745|P1|NOT COMPLETED|Second Intervention (8 Days)||0
104688|NCT01383096|252743|P3|COMPLETED|Second Intervention (8 Days)||14
104689|NCT01383096|252744|P2|COMPLETED|Second Intervention (8 Days)||16
104690|NCT01383096|252745|P1|COMPLETED|Second Intervention (8 Days)||19
104691|NCT01383096|252743|P3|STARTED|Second Intervention (8 Days)||16
104692|NCT01383096|252744|P2|STARTED|Second Intervention (8 Days)||17
104693|NCT01383096|252745|P1|STARTED|Second Intervention (8 Days)||19
104694|NCT01383096|252743|P3|NOT COMPLETED|First Intervention (8 Days)||0
104695|NCT01383096|252744|P2|NOT COMPLETED|First Intervention (8 Days)||0
104696|NCT01383096|252745|P1|NOT COMPLETED|First Intervention (8 Days)||0
104697|NCT01383096|252743|P3|COMPLETED|First Intervention (8 Days)||16
104698|NCT01383096|252744|P2|COMPLETED|First Intervention (8 Days)||17
104699|NCT01383096|252745|P1|COMPLETED|First Intervention (8 Days)||19
104700|NCT01383096|252743|P3|STARTED|First Intervention (8 Days)||16
104701|NCT01383096|252744|P2|STARTED|First Intervention (8 Days)||17
104702|NCT01383096|252745|P1|STARTED|First Intervention (8 Days)||19
104703|NCT01383005|252793|P2|NOT COMPLETED|Overall Study||0
104704|NCT01383005|252794|P1|NOT COMPLETED|Overall Study||0
104705|NCT01383005|252793|P2|COMPLETED|Overall Study||60
104706|NCT01383005|252794|P1|COMPLETED|Overall Study||34
104707|NCT01383005|252793|P2|STARTED|Overall Study||60
104708|NCT01383005|252794|P1|STARTED|Overall Study||34
104709|NCT01382940|252813|P1|NOT COMPLETED|Overall Study||73
104710|NCT01382940|252813|P1|COMPLETED|Overall Study||278
104711|NCT01382940|252813|P1|Received Day 182 Infusion|Overall Study||278
104712|NCT01382940|252813|P1|Received Day 168 Infusion|Overall Study||290
104713|NCT01382940|252813|P1|Received Day 15 Infusions|Overall Study||341
104714|NCT01382940|252813|P1|Received Day 1 Infusion|Overall Study||351
104715|NCT01382940|252813|P1|STARTED|Overall Study||351
104716|NCT01382901|252825|P2|NOT COMPLETED|Overall Study||14
104717|NCT01382901|252826|P1|NOT COMPLETED|Overall Study||17
104718|NCT01382901|252825|P2|COMPLETED|Overall Study||7
104719|NCT01382901|252826|P1|COMPLETED|Overall Study||7
104720|NCT01382901|252825|P2|STARTED|Overall Study||21
104721|NCT01382901|252826|P1|STARTED|Overall Study||24
104722|NCT01382719|252836|P4|NOT COMPLETED|Overall Study||33
104723|NCT01382719|252837|P3|NOT COMPLETED|Overall Study||34
104724|NCT01382719|252838|P2|NOT COMPLETED|Overall Study||19
104725|NCT01382719|252839|P1|NOT COMPLETED|Overall Study||18
104726|NCT01382719|252836|P4|COMPLETED|Overall Study||66
104727|NCT01382719|252837|P3|COMPLETED|Overall Study||66
104728|NCT01382719|252838|P2|COMPLETED|Overall Study||81
104729|NCT01382719|252839|P1|COMPLETED|Overall Study||80
104730|NCT01382719|252836|P4|Subjects Not Dosed|Overall Study||1
104731|NCT01382719|252837|P3|Subjects Not Dosed|Overall Study||1
104732|NCT01382719|252838|P2|Subjects Not Dosed|Overall Study||0
104733|NCT01382719|252839|P1|Subjects Not Dosed|Overall Study||1
104734|NCT01382719|252836|P4|STARTED|Overall Study||99
104735|NCT01382719|252837|P3|STARTED|Overall Study||100
104736|NCT01382719|252838|P2|STARTED|Overall Study||100
104737|NCT01382719|252839|P1|STARTED|Overall Study||98
104738|NCT01382602|252875|P2|NOT COMPLETED|Overall Study||4
104739|NCT01382602|252876|P1|NOT COMPLETED|Overall Study||0
104740|NCT01382602|252875|P2|COMPLETED|Overall Study||46
104741|NCT01382602|252876|P1|COMPLETED|Overall Study||93
104742|NCT01382602|252875|P2|STARTED|Overall Study||50
104743|NCT01382602|252876|P1|STARTED|Overall Study||93
104744|NCT01382446|252884|P2|NOT COMPLETED|Overall Study||4
104745|NCT01382446|252885|P1|NOT COMPLETED|Overall Study||3
104746|NCT01382446|252884|P2|COMPLETED|Overall Study||29
104747|NCT01382446|252885|P1|COMPLETED|Overall Study||30
104748|NCT01382446|252884|P2|STARTED|Overall Study||33
104749|NCT01382446|252885|P1|STARTED|Overall Study||33
104750|NCT01382303|252893|P2|NOT COMPLETED|Overall Study||17
104751|NCT01382303|252894|P1|NOT COMPLETED|Overall Study||35
104752|NCT01382303|252893|P2|COMPLETED|Overall Study||70
104753|NCT01382303|252894|P1|COMPLETED|Overall Study||52
104754|NCT01382303|252893|P2|STARTED|Overall Study||87
104755|NCT01382303|252894|P1|STARTED|Overall Study||87
104756|NCT01382251|252912|P2|NOT COMPLETED|Overall Study||21
104757|NCT01382251|252913|P1|NOT COMPLETED|Overall Study||21
104758|NCT01382251|252912|P2|COMPLETED|Overall Study||102
104759|NCT01382251|252913|P1|COMPLETED|Overall Study||102
104760|NCT01382251|252912|P2|STARTED|Overall Study||123
104761|NCT01382251|252913|P1|STARTED|Overall Study||123
104762|NCT01382225|252926|P2|NOT COMPLETED|Overall Study||7
104763|NCT01382225|252927|P1|NOT COMPLETED|Overall Study||14
104764|NCT01382225|252926|P2|COMPLETED|Overall Study||722
104765|NCT01382225|252927|P1|COMPLETED|Overall Study||711
104766|NCT01382225|252926|P2|STARTED|Overall Study||729
104767|NCT01382225|252927|P1|STARTED|Overall Study||725
104768|NCT01382212|252949|P1|NOT COMPLETED|Overall Study||2
104769|NCT01382212|252949|P1|COMPLETED|Overall Study||11
104770|NCT01382212|252949|P1|STARTED|Overall Study||13
104771|NCT01382186|252975|P2|NOT COMPLETED|Overall Study||0
104772|NCT01382186|252976|P1|NOT COMPLETED|Overall Study||1
104773|NCT01382186|252975|P2|COMPLETED|Overall Study||819
104774|NCT01382186|252976|P1|COMPLETED|Overall Study||32
104775|NCT01382186|252975|P2|STARTED|Overall Study||819
104776|NCT01382186|252976|P1|STARTED|Overall Study||33
104777|NCT01382108|252992|P2|NOT COMPLETED|Overall Study||0
104778|NCT01382108|252993|P1|NOT COMPLETED|Overall Study||0
104779|NCT01382108|252992|P2|COMPLETED|Overall Study||19
104780|NCT01382108|252993|P1|COMPLETED|Overall Study||20
104781|NCT01382108|252992|P2|STARTED|Overall Study||19
104782|NCT01382108|252993|P1|STARTED|Overall Study||20
104783|NCT01381952|253003|P1|NOT COMPLETED|Overall Study||0
104784|NCT01381952|253003|P1|COMPLETED|Overall Study||20
104785|NCT01381952|253003|P1|Collected Dose and Image Information|Overall Study||20
104786|NCT01381952|253003|P1|STARTED|Overall Study||20
104787|NCT01381926|253012|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
104788|NCT01381926|253013|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
104789|NCT01381926|253012|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
104790|NCT01381926|253013|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
104791|NCT01381926|253012|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
104792|NCT01381926|253013|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
104793|NCT01381926|253012|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
104794|NCT01381926|253013|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
104795|NCT01381926|253012|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
104796|NCT01381926|253013|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
104797|NCT01381926|253012|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
104798|NCT01381926|253013|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
104799|NCT01381900|253026|P3|NOT COMPLETED|Overall Study||12
104800|NCT01381900|253027|P2|NOT COMPLETED|Overall Study||9
104801|NCT01381900|253028|P1|NOT COMPLETED|Overall Study||9
104802|NCT01381900|253026|P3|COMPLETED|Overall Study||215
104803|NCT01381900|253027|P2|COMPLETED|Overall Study||214
104804|NCT01381900|253028|P1|COMPLETED|Overall Study||217
104805|NCT01381900|253026|P3|STARTED|Overall Study||227
104806|NCT01381900|253027|P2|STARTED|Overall Study||223
104807|NCT01381900|253028|P1|STARTED|Overall Study||226
104808|NCT01381679|253048|P1|NOT COMPLETED|Overall Study||888
104809|NCT01381679|253048|P1|COMPLETED|Overall Study||794
104810|NCT01381679|253048|P1|STARTED|Overall Study||1682
104811|NCT01381575|253063|P3|NOT COMPLETED|Overall Study||7
104812|NCT01381575|253064|P2|NOT COMPLETED|Overall Study||10
104813|NCT01381575|253065|P1|NOT COMPLETED|Overall Study||2
104814|NCT01381575|253063|P3|COMPLETED|Overall Study||408
104815|NCT01381575|253064|P2|COMPLETED|Overall Study||472
104816|NCT01381575|253065|P1|COMPLETED|Overall Study||548
104817|NCT01381575|253063|P3|STARTED|Overall Study||415
104818|NCT01381575|253064|P2|STARTED|Overall Study||482
104819|NCT01381575|253065|P1|STARTED|Overall Study||550
104820|NCT01381562|253122|P3|NOT COMPLETED|Overall Study||0
104821|NCT01381562|253123|P2|NOT COMPLETED|Overall Study||1
104822|NCT01381562|253124|P1|NOT COMPLETED|Overall Study||0
104823|NCT01381562|253122|P3|COMPLETED|Overall Study||5
104824|NCT01381562|253123|P2|COMPLETED|Overall Study||3
104825|NCT01381562|253124|P1|COMPLETED|Overall Study||5
104826|NCT01381562|253122|P3|STARTED|Overall Study||5
104827|NCT01381562|253123|P2|STARTED|Overall Study||4
104828|NCT01381562|253124|P1|STARTED|Overall Study||5
104829|NCT01381549|253192|P3|NOT COMPLETED|Overall Study||1
104830|NCT01381549|253193|P2|NOT COMPLETED|Overall Study||0
104831|NCT01381549|253194|P1|NOT COMPLETED|Overall Study||0
104832|NCT01381549|253192|P3|COMPLETED|Overall Study||5
104833|NCT01381549|253193|P2|COMPLETED|Overall Study||8
104834|NCT01381549|253194|P1|COMPLETED|Overall Study||6
104835|NCT01381549|253192|P3|STARTED|Overall Study||6
104836|NCT01381549|253193|P2|STARTED|Overall Study||8
104837|NCT01381549|253194|P1|STARTED|Overall Study||6
104838|NCT01381471|253289|P1|NOT COMPLETED|Overall Study||0
104839|NCT01381471|253289|P1|COMPLETED|Overall Study||11060
104840|NCT01381471|253289|P1|STARTED|Overall Study||11060
104841|NCT01381406|253296|P2|NOT COMPLETED|Overall Study||0
104842|NCT01381406|253297|P1|NOT COMPLETED|Overall Study||0
104843|NCT01381406|253296|P2|COMPLETED|Overall Study||852
104844|NCT01381406|253297|P1|COMPLETED|Overall Study||2481
104845|NCT01381406|253296|P2|STARTED|Overall Study||852
104846|NCT01381406|253297|P1|STARTED|Overall Study||2481
104847|NCT01381120|253309|P2|NOT COMPLETED|Overall Study||9
104848|NCT01381120|253310|P1|NOT COMPLETED|Overall Study||11
104849|NCT01381120|253309|P2|COMPLETED|Overall Study||18
104850|NCT01381120|253310|P1|COMPLETED|Overall Study||39
104851|NCT01381120|253309|P2|STARTED|Overall Study||27
104852|NCT01381120|253310|P1|STARTED|Overall Study||50
104853|NCT01381016|253320|P2|NOT COMPLETED|Overall Study||6
104854|NCT01381016|253321|P1|NOT COMPLETED|Overall Study||3
104855|NCT01381016|253320|P2|COMPLETED|Overall Study||11
104856|NCT01381016|253321|P1|COMPLETED|Overall Study||10
104857|NCT01381016|253320|P2|STARTED|Overall Study||17
104858|NCT01381016|253321|P1|STARTED|Overall Study||13
104859|NCT01380834|253331|P2|NOT COMPLETED|Overall Study||0
104860|NCT01380834|253332|P1|NOT COMPLETED|Overall Study||1
104861|NCT01380834|253331|P2|COMPLETED|Overall Study||42
104862|NCT01380834|253332|P1|COMPLETED|Overall Study||41
104863|NCT01380834|253331|P2|STARTED|Overall Study||42
104864|NCT01380834|253332|P1|STARTED|Overall Study||42
104865|NCT01380782|253344|P4|NOT COMPLETED|Overall Study||4
104866|NCT01380782|253345|P3|NOT COMPLETED|Overall Study||11
104867|NCT01380782|253346|P2|NOT COMPLETED|Overall Study||10
104868|NCT01380782|253347|P1|NOT COMPLETED|Overall Study||12
104869|NCT01380782|253344|P4|COMPLETED|Overall Study||0
104870|NCT01380782|253345|P3|COMPLETED|Overall Study||0
104871|NCT01380782|253346|P2|COMPLETED|Overall Study||0
104872|NCT01380782|253347|P1|COMPLETED|Overall Study||0
104873|NCT01380782|253344|P4|STARTED|Overall Study||4
104874|NCT01380782|253345|P3|STARTED|Overall Study||11
104875|NCT01380782|253346|P2|STARTED|Overall Study||10
104876|NCT01380782|253347|P1|STARTED|Overall Study||12
104877|NCT01380769|253370|P2|NOT COMPLETED|Overall Study||14
104878|NCT01380769|253371|P1|NOT COMPLETED|Overall Study||9
104879|NCT01380769|253370|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
104880|NCT01380769|253371|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
104881|NCT01380769|253370|P2|STARTED|Overall Study||57
104882|NCT01380769|253371|P1|STARTED|Overall Study||100
104883|NCT01380730|253387|P8|NOT COMPLETED|Overall Study||0
104884|NCT01380730|253388|P7|NOT COMPLETED|Overall Study||0
104885|NCT01380730|253389|P6|NOT COMPLETED|Overall Study||0
104886|NCT01380730|253390|P5|NOT COMPLETED|Overall Study||1
104887|NCT01380730|253391|P4|NOT COMPLETED|Overall Study||0
104888|NCT01380730|253392|P3|NOT COMPLETED|Overall Study||0
104889|NCT01380730|253393|P2|NOT COMPLETED|Overall Study||0
104890|NCT01380730|253394|P1|NOT COMPLETED|Overall Study||0
104891|NCT01380730|253387|P8|COMPLETED|Overall Study||80
104892|NCT01380730|253388|P7|COMPLETED|Overall Study||79
104893|NCT01380730|253389|P6|COMPLETED|Overall Study||79
104894|NCT01380730|253390|P5|COMPLETED|Overall Study||77
104895|NCT01380730|253391|P4|COMPLETED|Overall Study||79
104896|NCT01380730|253392|P3|COMPLETED|Overall Study||79
104897|NCT01380730|253393|P2|COMPLETED|Overall Study||79
104898|NCT01380730|253394|P1|COMPLETED|Overall Study||78
104899|NCT01380730|253387|P8|Received Treatment|Overall Study||80
104900|NCT01380730|253388|P7|Received Treatment|Overall Study||79
104901|NCT01380730|253389|P6|Received Treatment|Overall Study||79
104902|NCT01380730|253390|P5|Received Treatment|Overall Study||78
104903|NCT01380730|253391|P4|Received Treatment|Overall Study||79
104904|NCT01380730|253392|P3|Received Treatment|Overall Study||79
104905|NCT01380730|253393|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
104906|NCT01380730|253394|P1|Received Treatment|Overall Study||78
104907|NCT01380730|253387|P8|STARTED|Overall Study||80
104908|NCT01380730|253388|P7|STARTED|Overall Study||79
104909|NCT01380730|253389|P6|STARTED|Overall Study||79
104910|NCT01380730|253390|P5|STARTED|Overall Study||78
104911|NCT01380730|253391|P4|STARTED|Overall Study||79
104912|NCT01380730|253392|P3|STARTED|Overall Study||79
104913|NCT01380730|253393|P2|STARTED|Overall Study||79
104914|NCT01380730|253394|P1|STARTED|Overall Study||78
104915|NCT01380639|253454|P2|NOT COMPLETED|Overall Study||4
104916|NCT01380639|253455|P1|NOT COMPLETED|Overall Study||6
104917|NCT01380639|253454|P2|COMPLETED|Overall Study||36
104918|NCT01380639|253455|P1|COMPLETED|Overall Study||36
104919|NCT01380639|253454|P2|STARTED|Overall Study||40
104920|NCT01380639|253455|P1|STARTED|Overall Study||42
104921|NCT01380379|253461|P1|NOT COMPLETED|Overall Study||1
104922|NCT01380379|253461|P1|COMPLETED|Overall Study||8
104923|NCT01380379|253461|P1|STARTED|Overall Study||9
104924|NCT01380366|253466|P1|NOT COMPLETED|Overall Study||0
104925|NCT01380366|253466|P1|COMPLETED|Overall Study||15
104926|NCT01380366|253466|P1|STARTED|Overall Study||15
104927|NCT01380327|253474|P3|NOT COMPLETED|Overall Study||7
104928|NCT01380327|253475|P2|NOT COMPLETED|Overall Study||3
104929|NCT01380327|253476|P1|NOT COMPLETED|Overall Study||3
104930|NCT01380327|253474|P3|COMPLETED|Overall Study||21
104931|NCT01380327|253475|P2|COMPLETED|Overall Study||28
104932|NCT01380327|253476|P1|COMPLETED|Overall Study||27
104933|NCT01380327|253474|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
104934|NCT01380327|253475|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
104935|NCT01380327|253476|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
104936|NCT01380197|253498|P2|NOT COMPLETED|Overall Study||0
104937|NCT01380197|253499|P1|NOT COMPLETED|Overall Study||0
104938|NCT01380197|253498|P2|COMPLETED|Overall Study||20
104939|NCT01380197|253499|P1|COMPLETED|Overall Study||20
104940|NCT01380197|253498|P2|STARTED|Overall Study||20
104941|NCT01380197|253499|P1|STARTED|Overall Study||20
104942|NCT01380145|253507|P1|NOT COMPLETED|Overall Study||4
104943|NCT01380145|253507|P1|COMPLETED|Overall Study||9
104944|NCT01380145|253507|P1|STARTED|Overall Study||13
104945|NCT01380093|253515|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
104946|NCT01380093|253516|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
104947|NCT01380093|253517|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
104948|NCT01380093|253518|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
104949|NCT01380093|253519|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
104950|NCT01380093|253520|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
104951|NCT01380093|253521|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
104952|NCT01380093|253522|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
104953|NCT01380093|253523|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
104954|NCT01380093|253515|P9|COMPLETED|Treatment Phase: Third Intervention||4
104955|NCT01380093|253516|P8|COMPLETED|Treatment Phase: Third Intervention||6
104956|NCT01380093|253517|P7|COMPLETED|Treatment Phase: Third Intervention||6
104957|NCT01380093|253518|P6|COMPLETED|Treatment Phase: Third Intervention||6
104958|NCT01380093|253519|P5|COMPLETED|Treatment Phase: Third Intervention||6
104959|NCT01380093|253520|P4|COMPLETED|Treatment Phase: Third Intervention||5
104960|NCT01380093|253521|P3|COMPLETED|Treatment Phase: Third Intervention||0
104961|NCT01380093|253522|P2|COMPLETED|Treatment Phase: Third Intervention||0
104962|NCT01380093|253523|P1|COMPLETED|Treatment Phase: Third Intervention||0
104963|NCT01380093|253515|P9|STARTED|Treatment Phase: Third Intervention||6
104964|NCT01380093|253516|P8|STARTED|Treatment Phase: Third Intervention||6
104965|NCT01380093|253517|P7|STARTED|Treatment Phase: Third Intervention||6
104966|NCT01380093|253518|P6|STARTED|Treatment Phase: Third Intervention||6
104967|NCT01380093|253519|P5|STARTED|Treatment Phase: Third Intervention||6
104968|NCT01380093|253520|P4|STARTED|Treatment Phase: Third Intervention||5
104969|NCT01380093|253521|P3|STARTED|Treatment Phase: Third Intervention||0
104970|NCT01380093|253522|P2|STARTED|Treatment Phase: Third Intervention||0
104971|NCT01380093|253523|P1|STARTED|Treatment Phase: Third Intervention||0
104972|NCT01380093|253515|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
104973|NCT01380093|253516|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
104974|NCT01380093|253517|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
104975|NCT01380093|253518|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
104976|NCT01380093|253519|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
104977|NCT01380093|253520|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
104978|NCT01380093|253521|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
104979|NCT01380093|253522|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
104980|NCT01380093|253523|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
104981|NCT01380093|253515|P9|COMPLETED|Treatment Phase: Washout Period||6
104982|NCT01380093|253516|P8|COMPLETED|Treatment Phase: Washout Period||6
104983|NCT01380093|253517|P7|COMPLETED|Treatment Phase: Washout Period||6
104984|NCT01380093|253518|P6|COMPLETED|Treatment Phase: Washout Period||6
104985|NCT01380093|253519|P5|COMPLETED|Treatment Phase: Washout Period||6
104986|NCT01380093|253520|P4|COMPLETED|Treatment Phase: Washout Period||5
104987|NCT01380093|253521|P3|COMPLETED|Treatment Phase: Washout Period||0
104988|NCT01380093|253522|P2|COMPLETED|Treatment Phase: Washout Period||0
104989|NCT01380093|253523|P1|COMPLETED|Treatment Phase: Washout Period||0
104990|NCT01380093|253515|P9|STARTED|Treatment Phase: Washout Period||6
104991|NCT01380093|253516|P8|STARTED|Treatment Phase: Washout Period||6
104992|NCT01380093|253517|P7|STARTED|Treatment Phase: Washout Period||6
104993|NCT01380093|253518|P6|STARTED|Treatment Phase: Washout Period||6
104994|NCT01380093|253519|P5|STARTED|Treatment Phase: Washout Period||6
104995|NCT01380093|253520|P4|STARTED|Treatment Phase: Washout Period||5
104996|NCT01380093|253521|P3|STARTED|Treatment Phase: Washout Period||0
104997|NCT01380093|253522|P2|STARTED|Treatment Phase: Washout Period||0
104998|NCT01380093|253523|P1|STARTED|Treatment Phase: Washout Period||0
104999|NCT01380093|253515|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
105000|NCT01380093|253516|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
105001|NCT01380093|253517|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
105002|NCT01380093|253518|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
105003|NCT01380093|253519|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
105004|NCT01380093|253520|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
105005|NCT01380093|253521|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
105006|NCT01380093|253522|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
105007|NCT01380093|253523|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
105008|NCT01380093|253515|P9|COMPLETED|Treatment Phase: Second Intervention||6
105009|NCT01380093|253516|P8|COMPLETED|Treatment Phase: Second Intervention||6
105010|NCT01380093|253517|P7|COMPLETED|Treatment Phase: Second Intervention||6
105011|NCT01380093|253518|P6|COMPLETED|Treatment Phase: Second Intervention||6
105012|NCT01380093|253519|P5|COMPLETED|Treatment Phase: Second Intervention||6
105013|NCT01380093|253520|P4|COMPLETED|Treatment Phase: Second Intervention||5
105014|NCT01380093|253521|P3|COMPLETED|Treatment Phase: Second Intervention||0
105015|NCT01380093|253522|P2|COMPLETED|Treatment Phase: Second Intervention||0
105016|NCT01380093|253523|P1|COMPLETED|Treatment Phase: Second Intervention||0
105017|NCT01380093|253515|P9|STARTED|Treatment Phase: Second Intervention||6
105018|NCT01380093|253516|P8|STARTED|Treatment Phase: Second Intervention||6
105019|NCT01380093|253517|P7|STARTED|Treatment Phase: Second Intervention||6
105020|NCT01380093|253518|P6|STARTED|Treatment Phase: Second Intervention||6
105021|NCT01380093|253519|P5|STARTED|Treatment Phase: Second Intervention||6
105022|NCT01380093|253520|P4|STARTED|Treatment Phase: Second Intervention||6
105023|NCT01380093|253521|P3|STARTED|Treatment Phase: Second Intervention||0
105024|NCT01380093|253522|P2|STARTED|Treatment Phase: Second Intervention||0
105025|NCT01380093|253523|P1|STARTED|Treatment Phase: Second Intervention||0
105026|NCT01380093|253515|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
105027|NCT01380093|253516|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
105028|NCT01380093|253517|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
105029|NCT01380093|253518|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
105030|NCT01380093|253519|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
105031|NCT01380093|253520|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
105032|NCT01380093|253521|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
105033|NCT01380093|253522|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
105034|NCT01380093|253523|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
105035|NCT01380093|253515|P9|COMPLETED|Treatment Phase: Washout Period||6
105036|NCT01380093|253516|P8|COMPLETED|Treatment Phase: Washout Period||6
105037|NCT01380093|253517|P7|COMPLETED|Treatment Phase: Washout Period||6
105038|NCT01380093|253518|P6|COMPLETED|Treatment Phase: Washout Period||6
105039|NCT01380093|253519|P5|COMPLETED|Treatment Phase: Washout Period||6
105040|NCT01380093|253520|P4|COMPLETED|Treatment Phase: Washout Period||6
105041|NCT01380093|253521|P3|COMPLETED|Treatment Phase: Washout Period||0
105042|NCT01380093|253522|P2|COMPLETED|Treatment Phase: Washout Period||0
105043|NCT01380093|253523|P1|COMPLETED|Treatment Phase: Washout Period||0
105044|NCT01380093|253515|P9|STARTED|Treatment Phase: Washout Period||6
105045|NCT01380093|253516|P8|STARTED|Treatment Phase: Washout Period||6
105046|NCT01380093|253517|P7|STARTED|Treatment Phase: Washout Period||6
105047|NCT01380093|253518|P6|STARTED|Treatment Phase: Washout Period||6
105048|NCT01380093|253519|P5|STARTED|Treatment Phase: Washout Period||6
105049|NCT01380093|253520|P4|STARTED|Treatment Phase: Washout Period||6
105050|NCT01380093|253521|P3|STARTED|Treatment Phase: Washout Period||0
105051|NCT01380093|253522|P2|STARTED|Treatment Phase: Washout Period||0
105052|NCT01380093|253523|P1|STARTED|Treatment Phase: Washout Period||0
105053|NCT01380093|253515|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
105054|NCT01380093|253516|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
105055|NCT01380093|253517|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
105056|NCT01380093|253518|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
105057|NCT01380093|253519|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
105058|NCT01380093|253520|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
105059|NCT01380093|253521|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
105060|NCT01380093|253522|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
105061|NCT01380093|253523|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
105062|NCT01380093|253515|P9|COMPLETED|Treatment Phase: First Intervention||6
105063|NCT01380093|253516|P8|COMPLETED|Treatment Phase: First Intervention||6
105064|NCT01380093|253517|P7|COMPLETED|Treatment Phase: First Intervention||6
105065|NCT01380093|253518|P6|COMPLETED|Treatment Phase: First Intervention||6
105066|NCT01380093|253519|P5|COMPLETED|Treatment Phase: First Intervention||6
105067|NCT01380093|253520|P4|COMPLETED|Treatment Phase: First Intervention||6
105068|NCT01380093|253521|P3|COMPLETED|Treatment Phase: First Intervention||0
105069|NCT01380093|253522|P2|COMPLETED|Treatment Phase: First Intervention||0
105070|NCT01380093|253523|P1|COMPLETED|Treatment Phase: First Intervention||0
105071|NCT01380093|253515|P9|STARTED|Treatment Phase: First Intervention||6
105072|NCT01380093|253516|P8|STARTED|Treatment Phase: First Intervention||6
105073|NCT01380093|253517|P7|STARTED|Treatment Phase: First Intervention||6
105074|NCT01380093|253518|P6|STARTED|Treatment Phase: First Intervention||6
105075|NCT01380093|253519|P5|STARTED|Treatment Phase: First Intervention||6
105076|NCT01380093|253520|P4|STARTED|Treatment Phase: First Intervention||6
105077|NCT01380093|253521|P3|STARTED|Treatment Phase: First Intervention||0
105078|NCT01380093|253522|P2|STARTED|Treatment Phase: First Intervention||0
105079|NCT01380093|253523|P1|STARTED|Treatment Phase: First Intervention||0
105080|NCT01380093|253515|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
105081|NCT01380093|253516|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
105082|NCT01380093|253517|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
105083|NCT01380093|253518|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
105084|NCT01380093|253519|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
105085|NCT01380093|253520|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
105086|NCT01380093|253521|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
105087|NCT01380093|253522|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
105088|NCT01380093|253523|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
105089|NCT01380093|253515|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
105090|NCT01380093|253516|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
105091|NCT01380093|253517|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
105092|NCT01380093|253518|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
105093|NCT01380093|253519|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
105094|NCT01380093|253520|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
105095|NCT01380093|253521|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
105096|NCT01380093|253522|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
105097|NCT01380093|253523|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
105098|NCT01380093|253515|P9|STARTED|Drug Discrimination Phase: Day 2||0
105099|NCT01380093|253516|P8|STARTED|Drug Discrimination Phase: Day 2||0
105100|NCT01380093|253517|P7|STARTED|Drug Discrimination Phase: Day 2||0
105101|NCT01380093|253518|P6|STARTED|Drug Discrimination Phase: Day 2||0
105102|NCT01380093|253519|P5|STARTED|Drug Discrimination Phase: Day 2||0
105103|NCT01380093|253520|P4|STARTED|Drug Discrimination Phase: Day 2||0
105104|NCT01380093|253521|P3|STARTED|Drug Discrimination Phase: Day 2||29
105105|NCT01380093|253522|P2|STARTED|Drug Discrimination Phase: Day 2||29
105106|NCT01380093|253523|P1|STARTED|Drug Discrimination Phase: Day 2||0
105107|NCT01380093|253515|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105108|NCT01380093|253516|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105109|NCT01380093|253517|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105110|NCT01380093|253518|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105111|NCT01380093|253519|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105112|NCT01380093|253520|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105113|NCT01380093|253521|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105114|NCT01380093|253522|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
105115|NCT01380093|253523|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
105116|NCT01380093|253515|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
105117|NCT01380093|253516|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
105118|NCT01380093|253517|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
105119|NCT01380093|253518|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
105120|NCT01380093|253519|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
105121|NCT01380093|253520|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
105122|NCT01380093|253521|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
105123|NCT01380093|253522|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
105124|NCT01380093|253523|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
105125|NCT01380093|253515|P9|STARTED|Drug Discrimination Phase: Day 1||0
105126|NCT01380093|253516|P8|STARTED|Drug Discrimination Phase: Day 1||0
105127|NCT01380093|253517|P7|STARTED|Drug Discrimination Phase: Day 1||0
105128|NCT01380093|253518|P6|STARTED|Drug Discrimination Phase: Day 1||0
105129|NCT01380093|253519|P5|STARTED|Drug Discrimination Phase: Day 1||0
105130|NCT01380093|253520|P4|STARTED|Drug Discrimination Phase: Day 1||0
105131|NCT01380093|253521|P3|STARTED|Drug Discrimination Phase: Day 1||29
105132|NCT01380093|253522|P2|STARTED|Drug Discrimination Phase: Day 1||30
105133|NCT01380093|253523|P1|STARTED|Drug Discrimination Phase: Day 1||0
105134|NCT01380093|253515|P9|NOT COMPLETED|Naloxone Challenge Phase||0
105135|NCT01380093|253516|P8|NOT COMPLETED|Naloxone Challenge Phase||0
105136|NCT01380093|253517|P7|NOT COMPLETED|Naloxone Challenge Phase||0
105137|NCT01380093|253518|P6|NOT COMPLETED|Naloxone Challenge Phase||0
105138|NCT01380093|253519|P5|NOT COMPLETED|Naloxone Challenge Phase||0
105139|NCT01380093|253520|P4|NOT COMPLETED|Naloxone Challenge Phase||0
105140|NCT01380093|253521|P3|NOT COMPLETED|Naloxone Challenge Phase||0
105141|NCT01380093|253522|P2|NOT COMPLETED|Naloxone Challenge Phase||0
105142|NCT01380093|253523|P1|NOT COMPLETED|Naloxone Challenge Phase||21
105143|NCT01380093|253515|P9|COMPLETED|Naloxone Challenge Phase||0
105144|NCT01380093|253516|P8|COMPLETED|Naloxone Challenge Phase||0
105145|NCT01380093|253517|P7|COMPLETED|Naloxone Challenge Phase||0
105146|NCT01380093|253518|P6|COMPLETED|Naloxone Challenge Phase||0
105147|NCT01380093|253519|P5|COMPLETED|Naloxone Challenge Phase||0
105148|NCT01380093|253520|P4|COMPLETED|Naloxone Challenge Phase||0
105149|NCT01380093|253521|P3|COMPLETED|Naloxone Challenge Phase||0
105150|NCT01380093|253522|P2|COMPLETED|Naloxone Challenge Phase||0
105151|NCT01380093|253523|P1|COMPLETED|Naloxone Challenge Phase||59
105152|NCT01380093|253515|P9|TREATED|Naloxone Challenge Phase||0
105153|NCT01380093|253516|P8|TREATED|Naloxone Challenge Phase||0
105154|NCT01380093|253517|P7|TREATED|Naloxone Challenge Phase||0
105155|NCT01380093|253518|P6|TREATED|Naloxone Challenge Phase||0
105156|NCT01380093|253519|P5|TREATED|Naloxone Challenge Phase||0
105157|NCT01380093|253520|P4|TREATED|Naloxone Challenge Phase||0
105158|NCT01380093|253521|P3|TREATED|Naloxone Challenge Phase||0
105159|NCT01380093|253522|P2|TREATED|Naloxone Challenge Phase||0
105160|NCT01380093|253523|P1|TREATED|Naloxone Challenge Phase||59
105161|NCT01380093|253515|P9|STARTED|Naloxone Challenge Phase||0
105162|NCT01380093|253516|P8|STARTED|Naloxone Challenge Phase||0
105163|NCT01380093|253517|P7|STARTED|Naloxone Challenge Phase||0
105164|NCT01380093|253518|P6|STARTED|Naloxone Challenge Phase||0
105165|NCT01380093|253519|P5|STARTED|Naloxone Challenge Phase||0
105166|NCT01380093|253520|P4|STARTED|Naloxone Challenge Phase||0
105167|NCT01380093|253521|P3|STARTED|Naloxone Challenge Phase||0
105168|NCT01380093|253522|P2|STARTED|Naloxone Challenge Phase||0
105169|NCT01380093|253523|P1|STARTED|Naloxone Challenge Phase||80
105170|NCT01380080|253815|P2|NOT COMPLETED|Overall Study||23
105171|NCT01380080|253816|P1|NOT COMPLETED|Overall Study||33
105172|NCT01380080|253815|P2|COMPLETED|Overall Study||403
105173|NCT01380080|253816|P1|COMPLETED|Overall Study||391
105174|NCT01380080|253815|P2|STARTED|Overall Study||426
105175|NCT01380080|253816|P1|STARTED|Overall Study||424
105176|NCT01379963|253832|P1|NOT COMPLETED|Overall Study||0
105177|NCT01379963|253832|P1|COMPLETED|Overall Study||780
105178|NCT01379963|253832|P1|STARTED|Overall Study||780
105179|NCT01379937|253841|P4|NOT COMPLETED|Overall Study||1
105180|NCT01379937|253842|P3|NOT COMPLETED|Overall Study||2
105181|NCT01379937|253843|P2|NOT COMPLETED|Overall Study||3
105182|NCT01379937|253844|P1|NOT COMPLETED|Overall Study||1
105183|NCT01379937|253841|P4|COMPLETED|Overall Study||103
105184|NCT01379937|253842|P3|COMPLETED|Overall Study||102
105185|NCT01379937|253843|P2|COMPLETED|Overall Study||153
105186|NCT01379937|253844|P1|COMPLETED|Overall Study||155
105187|NCT01379937|253841|P4|STARTED|Overall Study||104
105188|NCT01379937|253842|P3|STARTED|Overall Study||104
105189|NCT01379937|253843|P2|STARTED|Overall Study||156
105190|NCT01379937|253844|P1|STARTED|Overall Study||156
105191|NCT01379781|253926|P2|NOT COMPLETED|Overall Study||8
105192|NCT01379781|253927|P1|NOT COMPLETED|Overall Study||11
105193|NCT01379781|253926|P2|COMPLETED|Overall Study||19
105194|NCT01379781|253927|P1|COMPLETED|Overall Study||16
105195|NCT01379781|253926|P2|STARTED|Overall Study||27
105196|NCT01379781|253927|P1|STARTED|Overall Study||27
105197|NCT01379768|253936|P3|NOT COMPLETED|Overall Study||0
105198|NCT01379768|253937|P2|NOT COMPLETED|Overall Study||1
105199|NCT01379768|253938|P1|NOT COMPLETED|Overall Study||3
105200|NCT01379768|253936|P3|COMPLETED|Overall Study||20
105201|NCT01379768|253937|P2|COMPLETED|Overall Study||21
105202|NCT01379768|253938|P1|COMPLETED|Overall Study||20
105203|NCT01379768|253936|P3|STARTED|Overall Study||20
105204|NCT01379768|253937|P2|STARTED|Overall Study||22
105205|NCT01379768|253938|P1|STARTED|Overall Study||23
105206|NCT01379703|253961|P3|NOT COMPLETED|9 Months Through 18 Months||0
105207|NCT01379703|253962|P2|NOT COMPLETED|9 Months Through 18 Months||230
105208|NCT01379703|253963|P1|NOT COMPLETED|9 Months Through 18 Months||0
105209|NCT01379703|253961|P3|COMPLETED|9 Months Through 18 Months||0
105210|NCT01379703|253962|P2|COMPLETED|9 Months Through 18 Months||854
105211|NCT01379703|253963|P1|COMPLETED|9 Months Through 18 Months||0
105212|NCT01379703|253961|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
105213|NCT01379703|253962|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
105214|NCT01379703|253963|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
105215|NCT01379703|253961|P3|NOT COMPLETED|Study Start Through 9 Months||143
105216|NCT01379703|253962|P2|NOT COMPLETED|Study Start Through 9 Months||122
105217|NCT01379703|253963|P1|NOT COMPLETED|Study Start Through 9 Months||4
105218|NCT01379703|253961|P3|COMPLETED|Study Start Through 9 Months||873
105219|NCT01379703|253962|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
105220|NCT01379703|253963|P1|COMPLETED|Study Start Through 9 Months||62
105221|NCT01379703|253961|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
105222|NCT01379703|253962|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
105223|NCT01379703|253963|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
105224|NCT01379664|254026|P2|NOT COMPLETED|Overall Study||0
105225|NCT01379664|254027|P1|NOT COMPLETED|Overall Study||0
105226|NCT01379664|254026|P2|COMPLETED|Overall Study||870
105227|NCT01379664|254027|P1|COMPLETED|Overall Study||714
105228|NCT01379664|254026|P2|STARTED|Overall Study||870
105229|NCT01379664|254027|P1|STARTED|Overall Study||714
105230|NCT01379651|254039|P2|NOT COMPLETED|Overall Study||0
105231|NCT01379651|254040|P1|NOT COMPLETED|Overall Study||0
105232|NCT01379651|254039|P2|COMPLETED|Overall Study||10
105233|NCT01379651|254040|P1|COMPLETED|Overall Study||10
105234|NCT01379651|254039|P2|STARTED|Overall Study||10
105235|NCT01379651|254040|P1|STARTED|Overall Study||10
105236|NCT01379625|254050|P2|NOT COMPLETED|Overall Study||0
105237|NCT01379625|254051|P1|NOT COMPLETED|Overall Study||0
105238|NCT01379625|254050|P2|COMPLETED|Overall Study||16
105239|NCT01379625|254051|P1|COMPLETED|Overall Study||16
105240|NCT01379625|254050|P2|STARTED|Overall Study||16
105241|NCT01379625|254051|P1|STARTED|Overall Study||16
105242|NCT01379534|254063|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
105243|NCT01379534|254064|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
105244|NCT01379534|254063|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
105245|NCT01379534|254064|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
105246|NCT01379534|254063|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
105247|NCT01379534|254064|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
105248|NCT01379534|254063|P2|NOT COMPLETED|Treatment Phase||31
105249|NCT01379534|254064|P1|NOT COMPLETED|Treatment Phase||22
105250|NCT01379534|254063|P2|COMPLETED|Treatment Phase||0
105251|NCT01379534|254064|P1|COMPLETED|Treatment Phase||0
105252|NCT01379534|254063|P2|STARTED|Treatment Phase||31
105253|NCT01379534|254064|P1|STARTED|Treatment Phase||22
105254|NCT01379521|254084|P2|NOT COMPLETED|Post-Treatment Evaluations||21
105255|NCT01379521|254085|P1|NOT COMPLETED|Post-Treatment Evaluations||25
105256|NCT01379521|254084|P2|COMPLETED|Post-Treatment Evaluations||0
105257|NCT01379521|254085|P1|COMPLETED|Post-Treatment Evaluations||0
105258|NCT01379521|254084|P2|STARTED|Post-Treatment Evaluations||21
105259|NCT01379521|254085|P1|STARTED|Post-Treatment Evaluations||25
105260|NCT01379521|254084|P2|NOT COMPLETED|Overall Study -Treatment Period||26
105261|NCT01379521|254085|P1|NOT COMPLETED|Overall Study -Treatment Period||33
105262|NCT01379521|254084|P2|COMPLETED|Overall Study -Treatment Period||0
105263|NCT01379521|254085|P1|COMPLETED|Overall Study -Treatment Period||0
105264|NCT01379521|254084|P2|STARTED|Overall Study -Treatment Period||26
105265|NCT01379521|254085|P1|STARTED|Overall Study -Treatment Period||33
105266|NCT01379183|254105|P2|NOT COMPLETED|Overall Study||0
105267|NCT01379183|254106|P1|NOT COMPLETED|Overall Study||0
105268|NCT01379183|254105|P2|COMPLETED|Overall Study||21
105269|NCT01379183|254106|P1|COMPLETED|Overall Study||19
105270|NCT01379183|254105|P2|STARTED|Overall Study||21
105271|NCT01379183|254106|P1|STARTED|Overall Study||19
105272|NCT01378988|254124|P2|NOT COMPLETED|Overall Study||0
105273|NCT01378988|254125|P1|NOT COMPLETED|Overall Study||0
105274|NCT01378988|254124|P2|COMPLETED|Overall Study||3
105275|NCT01378988|254125|P1|COMPLETED|Overall Study||2
105276|NCT01378988|254124|P2|STARTED|Overall Study||3
105277|NCT01378988|254125|P1|STARTED|Overall Study||2
105278|NCT01378975|254155|P2|NOT COMPLETED|Overall Study||50
105279|NCT01378975|254156|P1|NOT COMPLETED|Overall Study||86
105280|NCT01378975|254155|P2|COMPLETED|Overall Study||6
105281|NCT01378975|254156|P1|COMPLETED|Overall Study||4
105282|NCT01378975|254155|P2|STARTED|Overall Study||56
105283|NCT01378975|254156|P1|STARTED|Overall Study||90
105284|NCT01378962|254182|P1|NOT COMPLETED|Overall Study||17
105285|NCT01378962|254182|P1|COMPLETED|Overall Study||33
105286|NCT01378962|254182|P1|STARTED|Overall Study||50
105287|NCT01378520|254195|P2|NOT COMPLETED|Second Intervention||0
105288|NCT01378520|254196|P1|NOT COMPLETED|Second Intervention||0
105289|NCT01378520|254195|P2|COMPLETED|Second Intervention||10
105290|NCT01378520|254196|P1|COMPLETED|Second Intervention||10
105291|NCT01378520|254195|P2|STARTED|Second Intervention||10
105292|NCT01378520|254196|P1|STARTED|Second Intervention||10
105293|NCT01378520|254195|P2|NOT COMPLETED|First Intervention||0
105294|NCT01378520|254196|P1|NOT COMPLETED|First Intervention||0
105295|NCT01378520|254195|P2|COMPLETED|First Intervention||10
105296|NCT01378520|254196|P1|COMPLETED|First Intervention||10
105297|NCT01378520|254195|P2|STARTED|First Intervention||10
105298|NCT01378520|254196|P1|STARTED|First Intervention||10
105299|NCT01378429|254208|P2|NOT COMPLETED|Overall Study||0
105300|NCT01378429|254209|P1|NOT COMPLETED|Overall Study||1
105301|NCT01378429|254208|P2|COMPLETED|Overall Study||47
105302|NCT01378429|254209|P1|COMPLETED|Overall Study||41
105303|NCT01378429|254208|P2|STARTED|Overall Study||47
105304|NCT01378429|254209|P1|STARTED|Overall Study||42
105305|NCT01378416|254241|P1|NOT COMPLETED|Overall Study||0
105306|NCT01378416|254241|P1|COMPLETED|Overall Study||16
105307|NCT01378416|254241|P1|STARTED|Overall Study||16
105308|NCT01378325|254251|P2|NOT COMPLETED|Overall Study||1
105309|NCT01378325|254252|P1|NOT COMPLETED|Overall Study||0
105310|NCT01378325|254251|P2|COMPLETED|Overall Study||39
105311|NCT01378325|254252|P1|COMPLETED|Overall Study||40
105312|NCT01378325|254251|P2|STARTED|Overall Study||40
105313|NCT01378325|254252|P1|STARTED|Overall Study||40
105314|NCT01378221|254260|P2|NOT COMPLETED|Overall Study||9
105315|NCT01378221|254261|P1|NOT COMPLETED|Overall Study||7
105316|NCT01378221|254260|P2|COMPLETED|Overall Study||30
105317|NCT01378221|254261|P1|COMPLETED|Overall Study||29
105318|NCT01378221|254260|P2|STARTED|Overall Study||39
105319|NCT01378221|254261|P1|STARTED|Overall Study||36
105320|NCT01378195|254269|P2|NOT COMPLETED|Overall Study||18
105321|NCT01378195|254270|P1|NOT COMPLETED|Overall Study||29
105322|NCT01378195|254269|P2|COMPLETED|Overall Study||57
105323|NCT01378195|254270|P1|COMPLETED|Overall Study||46
105324|NCT01378195|254269|P2|STARTED|Overall Study||75
105325|NCT01378195|254270|P1|STARTED|Overall Study||75
105326|NCT01378117|254283|P3|NOT COMPLETED|Overall Study||3
105327|NCT01378117|254284|P2|NOT COMPLETED|Overall Study||1
105328|NCT01378117|254285|P1|NOT COMPLETED|Overall Study||4
105329|NCT01378117|254283|P3|COMPLETED|Overall Study||26
105330|NCT01378117|254284|P2|COMPLETED|Overall Study||29
105331|NCT01378117|254285|P1|COMPLETED|Overall Study||27
105332|NCT01378117|254283|P3|STARTED|Overall Study||29
105333|NCT01378117|254284|P2|STARTED|Overall Study||30
105334|NCT01378117|254285|P1|STARTED|Overall Study||31
105335|NCT01378104|254295|P2|NOT COMPLETED|Overall Study||26
105336|NCT01378104|254296|P1|NOT COMPLETED|Overall Study||27
105337|NCT01378104|254295|P2|COMPLETED|Overall Study||60
105338|NCT01378104|254296|P1|COMPLETED|Overall Study||65
105339|NCT01378104|254295|P2|STARTED|Overall Study||86
105340|NCT01378104|254296|P1|STARTED|Overall Study||92
105341|NCT01378065|254304|P1|NOT COMPLETED|Overall Study||0
105342|NCT01378065|254304|P1|COMPLETED|Overall Study||30
105343|NCT01378065|254304|P1|12 Months|Overall Study||30
105344|NCT01378065|254304|P1|6 Months|Overall Study||30
105345|NCT01378065|254304|P1|3 Months|Overall Study||30
105346|NCT01378065|254304|P1|6 Week|Overall Study||30
105347|NCT01378065|254304|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
105348|NCT01377922|254343|P2|NOT COMPLETED|Overall Study||0
105349|NCT01377922|254344|P1|NOT COMPLETED|Overall Study||1
105350|NCT01377922|254343|P2|COMPLETED|Overall Study||16
105351|NCT01377922|254344|P1|COMPLETED|Overall Study||21
105352|NCT01377922|254343|P2|STARTED|Overall Study||16
105353|NCT01377922|254344|P1|STARTED|Overall Study||22
105354|NCT01377636|254356|P1|NOT COMPLETED|Overall Study||0
105355|NCT01377636|254356|P1|COMPLETED|Overall Study||20
105356|NCT01377636|254356|P1|STARTED|Overall Study||20
105357|NCT01377623|254370|P2|NOT COMPLETED|Overall Study||5
105358|NCT01377623|254371|P1|NOT COMPLETED|Overall Study||7
105359|NCT01377623|254370|P2|COMPLETED|Overall Study||28
105360|NCT01377623|254371|P1|COMPLETED|Overall Study||26
105361|NCT01377623|254370|P2|STARTED|Overall Study||33
105362|NCT01377623|254371|P1|STARTED|Overall Study||33
105363|NCT01377584|254391|P6|NOT COMPLETED|Overall Study||3
105364|NCT01377584|254392|P5|NOT COMPLETED|Overall Study||3
105365|NCT01377584|254393|P4|NOT COMPLETED|Overall Study||4
105366|NCT01377584|254394|P3|NOT COMPLETED|Overall Study||4
105367|NCT01377584|254395|P2|NOT COMPLETED|Overall Study||3
105368|NCT01377584|254396|P1|NOT COMPLETED|Overall Study||3
105369|NCT01377584|254391|P6|COMPLETED|Overall Study||9
105370|NCT01377584|254392|P5|COMPLETED|Overall Study||9
105371|NCT01377584|254393|P4|COMPLETED|Overall Study||6
105372|NCT01377584|254394|P3|COMPLETED|Overall Study||6
105373|NCT01377584|254395|P2|COMPLETED|Overall Study||5
105374|NCT01377584|254396|P1|COMPLETED|Overall Study||5
105375|NCT01377584|254391|P6|STARTED|Overall Study||12
105376|NCT01377584|254392|P5|STARTED|Overall Study||12
105377|NCT01377584|254393|P4|STARTED|Overall Study||10
105378|NCT01377584|254394|P3|STARTED|Overall Study||10
105379|NCT01377584|254395|P2|STARTED|Overall Study||8
105380|NCT01377584|254396|P1|STARTED|Overall Study||8
105381|NCT01377480|254429|P4|NOT COMPLETED|Overall Study||11
105382|NCT01377480|254430|P3|NOT COMPLETED|Overall Study||10
105383|NCT01377480|254431|P2|NOT COMPLETED|Overall Study||1
105384|NCT01377480|254432|P1|NOT COMPLETED|Overall Study||0
105385|NCT01377480|254429|P4|COMPLETED|Overall Study||19
105386|NCT01377480|254430|P3|COMPLETED|Overall Study||18
105387|NCT01377480|254431|P2|COMPLETED|Overall Study||29
105388|NCT01377480|254432|P1|COMPLETED|Overall Study||32
105389|NCT01377480|254429|P4|STARTED|Overall Study||30
105390|NCT01377480|254430|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
105391|NCT01377480|254431|P2|STARTED|Overall Study||30
105392|NCT01377480|254432|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
105393|NCT01377467|254444|P2|NOT COMPLETED|Overall Study||0
105394|NCT01377467|254445|P1|NOT COMPLETED|Overall Study||0
105395|NCT01377467|254444|P2|COMPLETED|Overall Study||44
105396|NCT01377467|254445|P1|COMPLETED|Overall Study||46
105397|NCT01377467|254444|P2|STARTED|Overall Study||44
105398|NCT01377467|254445|P1|STARTED|Overall Study||46
105399|NCT01377441|254493|P2|NOT COMPLETED|Overall Study||0
105400|NCT01377441|254494|P1|NOT COMPLETED|Overall Study||0
105401|NCT01377441|254493|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
105402|NCT01377441|254494|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
105403|NCT01377441|254493|P2|STARTED|Overall Study||0
105404|NCT01377441|254494|P1|STARTED|Overall Study||0
105405|NCT01377402|254502|P1|NOT COMPLETED|Overall Study||0
105406|NCT01377402|254502|P1|COMPLETED|Overall Study||982
105407|NCT01377402|254502|P1|STARTED|Overall Study||982
105408|NCT01377233|254513|P5|NOT COMPLETED|Double-blind||2
105409|NCT01377233|254514|P4|NOT COMPLETED|Double-blind||4
105410|NCT01377233|254515|P3|NOT COMPLETED|Double-blind||2
105411|NCT01377233|254516|P2|NOT COMPLETED|Double-blind||1
105412|NCT01377233|254517|P1|NOT COMPLETED|Double-blind||0
105413|NCT01377233|254513|P5|COMPLETED|Double-blind||8
105414|NCT01377233|254514|P4|COMPLETED|Double-blind||7
105415|NCT01377233|254515|P3|COMPLETED|Double-blind||8
105416|NCT01377233|254516|P2|COMPLETED|Double-blind||10
105417|NCT01377233|254517|P1|COMPLETED|Double-blind||0
105418|NCT01377233|254513|P5|STARTED|Double-blind||10
105419|NCT01377233|254514|P4|STARTED|Double-blind||11
105420|NCT01377233|254515|P3|STARTED|Double-blind||10
105421|NCT01377233|254516|P2|STARTED|Double-blind||11
105422|NCT01377233|254517|P1|STARTED|Double-blind||0
105423|NCT01377233|254513|P5|NOT COMPLETED|Open-label||0
105424|NCT01377233|254514|P4|NOT COMPLETED|Open-label||0
105425|NCT01377233|254515|P3|NOT COMPLETED|Open-label||0
105426|NCT01377233|254516|P2|NOT COMPLETED|Open-label||0
105427|NCT01377233|254517|P1|NOT COMPLETED|Open-label||4
105428|NCT01377233|254513|P5|COMPLETED|Open-label||0
105429|NCT01377233|254514|P4|COMPLETED|Open-label||0
105430|NCT01377233|254515|P3|COMPLETED|Open-label||0
105431|NCT01377233|254516|P2|COMPLETED|Open-label||0
105432|NCT01377233|254517|P1|COMPLETED|Open-label||42
105433|NCT01377233|254513|P5|STARTED|Open-label||0
105434|NCT01377233|254514|P4|STARTED|Open-label||0
105435|NCT01377233|254515|P3|STARTED|Open-label||0
105436|NCT01377233|254516|P2|STARTED|Open-label||0
105437|NCT01377233|254517|P1|STARTED|Open-label||46
105438|NCT01377194|254544|P3|NOT COMPLETED|Overall Study||46
105439|NCT01377194|254545|P2|NOT COMPLETED|Overall Study||43
105440|NCT01377194|254546|P1|NOT COMPLETED|Overall Study||32
105441|NCT01377194|254544|P3|COMPLETED|Overall Study||142
105442|NCT01377194|254545|P2|COMPLETED|Overall Study||145
105443|NCT01377194|254546|P1|COMPLETED|Overall Study||154
105444|NCT01377194|254544|P3|STARTED|Overall Study||188
105445|NCT01377194|254545|P2|STARTED|Overall Study||188
105446|NCT01377194|254546|P1|STARTED|Overall Study||186
105447|NCT01377012|254560|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
105448|NCT01377012|254561|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
105449|NCT01377012|254562|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
105450|NCT01377012|254560|P3|COMPLETED|Extension Study, Weeks 104-260||0
105451|NCT01377012|254561|P2|COMPLETED|Extension Study, Weeks 104-260||0
105452|NCT01377012|254562|P1|COMPLETED|Extension Study, Weeks 104-260||0
105453|NCT01377012|254560|P3|STARTED|Extension Study, Weeks 104-260||68
105454|NCT01377012|254561|P2|STARTED|Extension Study, Weeks 104-260||71
105455|NCT01377012|254562|P1|STARTED|Extension Study, Weeks 104-260||57
105456|NCT01377012|254560|P3|NOT COMPLETED|Core Study||134
105457|NCT01377012|254561|P2|NOT COMPLETED|Core Study||132
105458|NCT01377012|254562|P1|NOT COMPLETED|Core Study||134
105459|NCT01377012|254560|P3|COMPLETED|Core Study||80
105460|NCT01377012|254561|P2|COMPLETED|Core Study||81
105461|NCT01377012|254562|P1|COMPLETED|Core Study||76
105462|NCT01377012|254560|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
105463|NCT01377012|254561|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
105464|NCT01377012|254562|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
105465|NCT01377012|254560|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
105466|NCT01377012|254561|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
105467|NCT01377012|254562|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
105468|NCT01377012|254560|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
105469|NCT01377012|254561|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
105470|NCT01377012|254562|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
105471|NCT01377012|254560|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
105472|NCT01377012|254561|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
105473|NCT01377012|254562|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
105474|NCT01377012|254560|P3|STARTED|Core Study||214
105475|NCT01377012|254561|P2|STARTED|Core Study||213
105476|NCT01377012|254562|P1|STARTED|Core Study||210
105477|NCT01376908|254599|P2|NOT COMPLETED|Overall Study||3
105478|NCT01376908|254600|P1|NOT COMPLETED|Overall Study||2
105479|NCT01376908|254599|P2|COMPLETED|Overall Study||26
105480|NCT01376908|254600|P1|COMPLETED|Overall Study||25
105481|NCT01376908|254599|P2|STARTED|Overall Study||29
105482|NCT01376908|254600|P1|STARTED|Overall Study||27
105483|NCT01376804|254633|P1|NOT COMPLETED|Follow-up Period||0
105484|NCT01376804|254633|P1|COMPLETED|Follow-up Period||55
105485|NCT01376804|254633|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
105486|NCT01376804|254633|P1|NOT COMPLETED|Treatment Period||8
105487|NCT01376804|254633|P1|COMPLETED|Treatment Period||49
105488|NCT01376804|254633|P1|Received Study Drug|Treatment Period||56
105489|NCT01376804|254633|P1|STARTED|Treatment Period||57
105490|NCT01376700|254644|P1|NOT COMPLETED|Overall Study||16
105491|NCT01376700|254644|P1|COMPLETED|Overall Study||3
105492|NCT01376700|254644|P1|STARTED|Overall Study||19
105493|NCT01376557|254665|P5|NOT COMPLETED|Overall Study||7
105494|NCT01376557|254666|P4|NOT COMPLETED|Overall Study||6
105495|NCT01376557|254667|P3|NOT COMPLETED|Overall Study||5
105496|NCT01376557|254668|P2|NOT COMPLETED|Overall Study||6
105497|NCT01376557|254669|P1|NOT COMPLETED|Overall Study||8
105498|NCT01376557|254665|P5|COMPLETED|Overall Study||53
105499|NCT01376557|254666|P4|COMPLETED|Overall Study||54
105500|NCT01376557|254667|P3|COMPLETED|Overall Study||55
105501|NCT01376557|254668|P2|COMPLETED|Overall Study||54
105502|NCT01376557|254669|P1|COMPLETED|Overall Study||51
105503|NCT01376557|254665|P5|STARTED|Overall Study||60
105504|NCT01376557|254666|P4|STARTED|Overall Study||60
105505|NCT01376557|254667|P3|STARTED|Overall Study||60
105506|NCT01376557|254668|P2|STARTED|Overall Study||60
105507|NCT01376557|254669|P1|STARTED|Overall Study||59
105508|NCT01376388|254706|P1|NOT COMPLETED|Overall Study||18
105509|NCT01376388|254706|P1|COMPLETED|Overall Study||112
105510|NCT01376388|254706|P1|STARTED|Overall Study||130
105511|NCT01376362|254721|P1|NOT COMPLETED|Overall Study||0
105512|NCT01376362|254721|P1|COMPLETED|Overall Study||5
105513|NCT01376362|254721|P1|STARTED|Overall Study||5
105514|NCT01376349|254744|P3|NOT COMPLETED|Optional Continuation Phase||0
105515|NCT01376349|254745|P2|NOT COMPLETED|Optional Continuation Phase||0
105516|NCT01376349|254746|P1|NOT COMPLETED|Optional Continuation Phase||0
105517|NCT01376349|254744|P3|COMPLETED|Optional Continuation Phase||94
105518|NCT01376349|254745|P2|COMPLETED|Optional Continuation Phase||0
105519|NCT01376349|254746|P1|COMPLETED|Optional Continuation Phase||0
105520|NCT01376349|254744|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
105521|NCT01376349|254745|P2|STARTED|Optional Continuation Phase||0
105522|NCT01376349|254746|P1|STARTED|Optional Continuation Phase||0
105523|NCT01376349|254744|P3|NOT COMPLETED|Raondomized Treatment||29
105524|NCT01376349|254745|P2|NOT COMPLETED|Raondomized Treatment||35
105525|NCT01376349|254746|P1|NOT COMPLETED|Raondomized Treatment||24
105526|NCT01376349|254744|P3|COMPLETED|Raondomized Treatment||118
105527|NCT01376349|254745|P2|COMPLETED|Raondomized Treatment||114
105528|NCT01376349|254746|P1|COMPLETED|Raondomized Treatment||123
105529|NCT01376349|254744|P3|STARTED|Raondomized Treatment||147
105530|NCT01376349|254745|P2|STARTED|Raondomized Treatment||149
105531|NCT01376349|254746|P1|STARTED|Raondomized Treatment||147
105532|NCT01376323|254760|P5|NOT COMPLETED|Overall Study||1
105533|NCT01376323|254761|P4|NOT COMPLETED|Overall Study||5
105534|NCT01376323|254762|P3|NOT COMPLETED|Overall Study||3
105535|NCT01376323|254763|P2|NOT COMPLETED|Overall Study||1
105536|NCT01376323|254764|P1|NOT COMPLETED|Overall Study||2
105537|NCT01376323|254760|P5|COMPLETED|Overall Study||17
105538|NCT01376323|254761|P4|COMPLETED|Overall Study||14
105539|NCT01376323|254762|P3|COMPLETED|Overall Study||16
105540|NCT01376323|254763|P2|COMPLETED|Overall Study||17
105541|NCT01376323|254764|P1|COMPLETED|Overall Study||18
105542|NCT01376323|254760|P5|STARTED|Overall Study||18
105543|NCT01376323|254761|P4|STARTED|Overall Study||19
105544|NCT01376323|254762|P3|STARTED|Overall Study||19
105545|NCT01376323|254763|P2|STARTED|Overall Study||18
105546|NCT01376323|254764|P1|STARTED|Overall Study||20
105547|NCT01376297|254848|P2|NOT COMPLETED|Overall Study||49
105548|NCT01376297|254849|P1|NOT COMPLETED|Overall Study||128
105549|NCT01376297|254848|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
105550|NCT01376297|254849|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
105551|NCT01376297|254848|P2|STARTED|Overall Study|number of randomised patients|104
105552|NCT01376297|254849|P1|STARTED|Overall Study|number of randomised patients|309
105553|NCT01376245|254859|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
105554|NCT01376245|254860|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
105555|NCT01376245|254861|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
105556|NCT01376245|254862|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
105557|NCT01376245|254863|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
105558|NCT01376245|254859|P5|COMPLETED|24-week, Double-blind Treatment Period||134
105559|NCT01376245|254860|P4|COMPLETED|24-week, Double-blind Treatment Period||138
105560|NCT01376245|254861|P3|COMPLETED|24-week, Double-blind Treatment Period||135
105561|NCT01376245|254862|P2|COMPLETED|24-week, Double-blind Treatment Period||130
105562|NCT01376245|254863|P1|COMPLETED|24-week, Double-blind Treatment Period||0
105563|NCT01376245|254859|P5|STARTED|24-week, Double-blind Treatment Period||160
105564|NCT01376245|254860|P4|STARTED|24-week, Double-blind Treatment Period||161
105565|NCT01376245|254861|P3|STARTED|24-week, Double-blind Treatment Period||160
105566|NCT01376245|254862|P2|STARTED|24-week, Double-blind Treatment Period||162
105567|NCT01376245|254863|P1|STARTED|24-week, Double-blind Treatment Period||0
105568|NCT01376245|254859|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105569|NCT01376245|254860|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105570|NCT01376245|254861|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105571|NCT01376245|254862|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105572|NCT01376245|254863|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
105573|NCT01376245|254859|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105574|NCT01376245|254860|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105575|NCT01376245|254861|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105576|NCT01376245|254862|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
105577|NCT01376245|254863|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
105578|NCT01376245|254859|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
105579|NCT01376245|254860|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
105580|NCT01376245|254861|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
105581|NCT01376245|254862|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
105582|NCT01376245|254863|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
105583|NCT01376167|254880|P3|NOT COMPLETED|Overall Study||6
105584|NCT01376167|254881|P2|NOT COMPLETED|Overall Study||10
105585|NCT01376167|254882|P1|NOT COMPLETED|Overall Study||4
105586|NCT01376167|254880|P3|COMPLETED|Overall Study||123
105587|NCT01376167|254881|P2|COMPLETED|Overall Study||250
105588|NCT01376167|254882|P1|COMPLETED|Overall Study||129
105589|NCT01376167|254880|P3|STARTED|Overall Study||129
105590|NCT01376167|254881|P2|STARTED|Overall Study||260
105591|NCT01376167|254882|P1|STARTED|Overall Study||133
105592|NCT01376089|254953|P2|NOT COMPLETED|Overall Study||4
105593|NCT01376089|254954|P1|NOT COMPLETED|Overall Study||3
105594|NCT01376089|254953|P2|COMPLETED|Overall Study||144
105595|NCT01376089|254954|P1|COMPLETED|Overall Study||148
105596|NCT01376089|254953|P2|STARTED|Overall Study||148
105597|NCT01376089|254954|P1|STARTED|Overall Study||151
105598|NCT01376050|254966|P2|NOT COMPLETED|Overall Study||0
105599|NCT01376050|254967|P1|NOT COMPLETED|Overall Study||0
105600|NCT01376050|254966|P2|COMPLETED|Overall Study||11
105601|NCT01376050|254967|P1|COMPLETED|Overall Study||13
105602|NCT01376050|254966|P2|STARTED|Overall Study||11
105603|NCT01376050|254967|P1|STARTED|Overall Study||13
105604|NCT01376037|254977|P2|NOT COMPLETED|Overall Study||2
105605|NCT01376037|254978|P1|NOT COMPLETED|Overall Study||0
105606|NCT01376037|254977|P2|COMPLETED|Overall Study||29
105607|NCT01376037|254978|P1|COMPLETED|Overall Study||31
105608|NCT01376037|254977|P2|STARTED|Overall Study||31
105609|NCT01376037|254978|P1|STARTED|Overall Study||31
105610|NCT01375946|254984|P1|NOT COMPLETED|Overall Study||0
105611|NCT01375946|254984|P1|COMPLETED|Overall Study||24
105612|NCT01375946|254984|P1|STARTED|Overall Study||24
105613|NCT01375777|255001|P9|NOT COMPLETED|Overall Study||2
105614|NCT01375777|255002|P8|NOT COMPLETED|Overall Study||2
105615|NCT01375777|255003|P7|NOT COMPLETED|Overall Study||2
105616|NCT01375777|255004|P6|NOT COMPLETED|Overall Study||1
105617|NCT01375777|255005|P5|NOT COMPLETED|Overall Study||1
105618|NCT01375777|255006|P4|NOT COMPLETED|Overall Study||0
105619|NCT01375777|255007|P3|NOT COMPLETED|Overall Study||1
105620|NCT01375777|255008|P2|NOT COMPLETED|Overall Study||3
105621|NCT01375777|255009|P1|NOT COMPLETED|Overall Study||2
105622|NCT01375777|255001|P9|COMPLETED|Overall Study||44
105623|NCT01375777|255002|P8|COMPLETED|Overall Study||44
105624|NCT01375777|255003|P7|COMPLETED|Overall Study||44
105625|NCT01375777|255004|P6|COMPLETED|Overall Study||44
105626|NCT01375777|255005|P5|COMPLETED|Overall Study||45
105627|NCT01375777|255006|P4|COMPLETED|Overall Study||45
105628|NCT01375777|255007|P3|COMPLETED|Overall Study||45
105629|NCT01375777|255008|P2|COMPLETED|Overall Study||42
105630|NCT01375777|255009|P1|COMPLETED|Overall Study||44
105631|NCT01375777|255001|P9|Received Treatment|Overall Study||45
105632|NCT01375777|255002|P8|Received Treatment|Overall Study||45
105633|NCT01375777|255003|P7|Received Treatment|Overall Study||45
105634|NCT01375777|255004|P6|Received Treatment|Overall Study||45
105635|NCT01375777|255005|P5|Received Treatment|Overall Study||46
105636|NCT01375777|255006|P4|Received Treatment|Overall Study||45
105637|NCT01375777|255007|P3|Received Treatment|Overall Study||45
105638|NCT01375777|255008|P2|Received Treatment|Overall Study||45
105639|NCT01375777|255009|P1|Received Treatment|Overall Study||45
105640|NCT01375777|255001|P9|STARTED|Overall Study||46
105641|NCT01375777|255002|P8|STARTED|Overall Study||46
105642|NCT01375777|255003|P7|STARTED|Overall Study||46
105643|NCT01375777|255004|P6|STARTED|Overall Study||45
105644|NCT01375777|255005|P5|STARTED|Overall Study||46
105645|NCT01375777|255006|P4|STARTED|Overall Study||45
105646|NCT01375777|255007|P3|STARTED|Overall Study||46
105647|NCT01375777|255008|P2|STARTED|Overall Study||45
105648|NCT01375777|255009|P1|STARTED|Overall Study||46
105649|NCT01375764|255079|P5|NOT COMPLETED|Overall Study||1
105650|NCT01375764|255080|P4|NOT COMPLETED|Overall Study||1
105651|NCT01375764|255081|P3|NOT COMPLETED|Overall Study||0
105652|NCT01375764|255082|P2|NOT COMPLETED|Overall Study||1
105653|NCT01375764|255083|P1|NOT COMPLETED|Overall Study||2
105654|NCT01375764|255079|P5|COMPLETED|Overall Study||31
105655|NCT01375764|255080|P4|COMPLETED|Overall Study||31
105656|NCT01375764|255081|P3|COMPLETED|Overall Study||32
105657|NCT01375764|255082|P2|COMPLETED|Overall Study||30
105658|NCT01375764|255083|P1|COMPLETED|Overall Study||31
105659|NCT01375764|255079|P5|Received Treatment|Overall Study||32
105660|NCT01375764|255080|P4|Received Treatment|Overall Study||31
105661|NCT01375764|255081|P3|Received Treatment|Overall Study||32
105662|NCT01375764|255082|P2|Received Treatment|Overall Study||30
105663|NCT01375764|255083|P1|Received Treatment|Overall Study||32
105664|NCT01375764|255079|P5|STARTED|Overall Study||32
105665|NCT01375764|255080|P4|STARTED|Overall Study||32
105666|NCT01375764|255081|P3|STARTED|Overall Study||32
105667|NCT01375764|255082|P2|STARTED|Overall Study||31
105668|NCT01375764|255083|P1|STARTED|Overall Study||33
105669|NCT01375751|255129|P3|NOT COMPLETED|Overall Study||0
105670|NCT01375751|255130|P2|NOT COMPLETED|Overall Study||1
105671|NCT01375751|255131|P1|NOT COMPLETED|Overall Study||0
105672|NCT01375751|255129|P3|COMPLETED|Overall Study||56
105673|NCT01375751|255130|P2|COMPLETED|Overall Study||55
105674|NCT01375751|255131|P1|COMPLETED|Overall Study||56
105675|NCT01375751|255129|P3|Received Treatment|Overall Study||56
105676|NCT01375751|255130|P2|Received Treatment|Overall Study||55
105677|NCT01375751|255131|P1|Received Treatment|Overall Study||56
105678|NCT01375751|255129|P3|STARTED|Overall Study||56
105679|NCT01375751|255130|P2|STARTED|Overall Study||56
105680|NCT01375751|255131|P1|STARTED|Overall Study||56
105681|NCT01375660|255156|P2|NOT COMPLETED|Overall Study||16
105682|NCT01375660|255157|P1|NOT COMPLETED|Overall Study||16
105683|NCT01375660|255156|P2|COMPLETED|Overall Study||87
105684|NCT01375660|255157|P1|COMPLETED|Overall Study||86
105685|NCT01375660|255156|P2|STARTED|Overall Study||103
105686|NCT01375660|255157|P1|STARTED|Overall Study||102
105687|NCT01375608|255175|P1|NOT COMPLETED|Overall Study||2
105688|NCT01375608|255175|P1|COMPLETED|Overall Study||8
105689|NCT01375608|255175|P1|STARTED|Overall Study||10
105690|NCT01375569|255179|P1|NOT COMPLETED|Overall Study||0
105691|NCT01375569|255179|P1|COMPLETED|Overall Study||11
105692|NCT01375569|255179|P1|STARTED|Overall Study||11
105693|NCT01375374|255184|P1|NOT COMPLETED|Overall Study||1
105694|NCT01375374|255184|P1|COMPLETED|Overall Study||10
105695|NCT01375374|255184|P1|STARTED|Overall Study||11
105696|NCT01375127|255197|P6|NOT COMPLETED|Overall Study||0
105697|NCT01375127|255198|P5|NOT COMPLETED|Overall Study||0
105698|NCT01375127|255199|P4|NOT COMPLETED|Overall Study||0
105699|NCT01375127|255200|P3|NOT COMPLETED|Overall Study||0
105700|NCT01375127|255201|P2|NOT COMPLETED|Overall Study||0
105701|NCT01375127|255202|P1|NOT COMPLETED|Overall Study||0
105702|NCT01375127|255197|P6|COMPLETED|Overall Study||3
105703|NCT01375127|255198|P5|COMPLETED|Overall Study||5
105704|NCT01375127|255199|P4|COMPLETED|Overall Study||33
105705|NCT01375127|255200|P3|COMPLETED|Overall Study||40
105706|NCT01375127|255201|P2|COMPLETED|Overall Study||1
105707|NCT01375127|255202|P1|COMPLETED|Overall Study||1
105708|NCT01375127|255197|P6|STARTED|Overall Study||3
105709|NCT01375127|255198|P5|STARTED|Overall Study||5
105710|NCT01375127|255199|P4|STARTED|Overall Study||33
105711|NCT01375127|255200|P3|STARTED|Overall Study||40
105712|NCT01375127|255201|P2|STARTED|Overall Study||1
105713|NCT01375127|255202|P1|STARTED|Overall Study||1
105714|NCT01375049|255234|P1|NOT COMPLETED|Overall Study||50
105715|NCT01375049|255234|P1|COMPLETED|Overall Study||55
105716|NCT01375049|255234|P1|STARTED|Overall Study||105
105717|NCT01374971|255249|P1|NOT COMPLETED|Overall Study||1
105718|NCT01374971|255249|P1|COMPLETED|Overall Study||11
105719|NCT01374971|255249|P1|STARTED|Overall Study||12
105720|NCT01374919|255254|P1|NOT COMPLETED|Overall Study||2
105721|NCT01374919|255254|P1|COMPLETED|Overall Study||58
105722|NCT01374919|255254|P1|STARTED|Overall Study||60
105723|NCT01374906|255261|P2|NOT COMPLETED|Overall Study||48
105724|NCT01374906|255262|P1|NOT COMPLETED|Overall Study||40
105725|NCT01374906|255261|P2|COMPLETED|Overall Study||28
105726|NCT01374906|255262|P1|COMPLETED|Overall Study||34
105727|NCT01374906|255261|P2|Completed Extension Phase|Overall Study||15
105728|NCT01374906|255262|P1|Completed Extension Phase|Overall Study||24
105729|NCT01374906|255261|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
105730|NCT01374906|255262|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
105731|NCT01374906|255261|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
105732|NCT01374906|255262|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
105733|NCT01374906|255261|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
105734|NCT01374906|255262|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
105735|NCT01374906|255261|P2|Completed Core Phase|Overall Study||54
105736|NCT01374906|255262|P1|Completed Core Phase|Overall Study||50
105737|NCT01374906|255261|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
105738|NCT01374906|255262|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
105739|NCT01374906|255261|P2|STARTED|Overall Study||76
105740|NCT01374906|255262|P1|STARTED|Overall Study||74
105741|NCT01374802|255329|P1|NOT COMPLETED|Overall Study||0
105742|NCT01374802|255329|P1|COMPLETED|Overall Study||14
105743|NCT01374802|255329|P1|STARTED|Overall Study||14
105744|NCT01374568|255343|P2|NOT COMPLETED|Overall Study||2
105745|NCT01374568|255344|P1|NOT COMPLETED|Overall Study||0
105746|NCT01374568|255343|P2|COMPLETED|Overall Study||1
105747|NCT01374568|255344|P1|COMPLETED|Overall Study||2
105748|NCT01374568|255343|P2|STARTED|Overall Study||3
105749|NCT01374568|255344|P1|STARTED|Overall Study||2
105750|NCT01374451|255354|P2|NOT COMPLETED|Overall Study||0
105751|NCT01374451|255355|P1|NOT COMPLETED|Overall Study||1
105752|NCT01374451|255354|P2|COMPLETED|Overall Study||81
105753|NCT01374451|255355|P1|COMPLETED|Overall Study||78
105754|NCT01374451|255354|P2|STARTED|Overall Study||81
105755|NCT01374451|255355|P1|STARTED|Overall Study||79
105756|NCT01374438|255384|P2|NOT COMPLETED|Overall Study||0
105757|NCT01374438|255385|P1|NOT COMPLETED|Overall Study||0
105758|NCT01374438|255384|P2|COMPLETED|Overall Study||13
105759|NCT01374438|255385|P1|COMPLETED|Overall Study||16
105760|NCT01374438|255384|P2|STARTED|Overall Study||13
105761|NCT01374438|255385|P1|STARTED|Overall Study||16
105762|NCT01374425|255401|P2|NOT COMPLETED|Overall Study||188
105763|NCT01374425|255402|P1|NOT COMPLETED|Overall Study||188
105764|NCT01374425|255401|P2|COMPLETED|Overall Study||0
105765|NCT01374425|255402|P1|COMPLETED|Overall Study||0
105766|NCT01374425|255401|P2|STARTED|Overall Study||188
105767|NCT01374425|255402|P1|STARTED|Overall Study||188
105768|NCT01374269|255482|P2|NOT COMPLETED|Overall Study||5
105769|NCT01374269|255483|P1|NOT COMPLETED|Overall Study||6
105770|NCT01374269|255482|P2|COMPLETED|Overall Study||39
105771|NCT01374269|255483|P1|COMPLETED|Overall Study||40
105772|NCT01374269|255482|P2|STARTED|Overall Study||44
105773|NCT01374269|255483|P1|STARTED|Overall Study||46
105774|NCT01374178|255611|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
105775|NCT01374178|255612|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
105776|NCT01374178|255611|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
105777|NCT01374178|255612|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
105778|NCT01374178|255611|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
105779|NCT01374178|255612|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
105780|NCT01374178|255611|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
105781|NCT01374178|255612|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
105782|NCT01374178|255611|P2|COMPLETED|Washout Period of at Least 7 Days||5
105783|NCT01374178|255612|P1|COMPLETED|Washout Period of at Least 7 Days||10
105784|NCT01374178|255611|P2|STARTED|Washout Period of at Least 7 Days||5
105785|NCT01374178|255612|P1|STARTED|Washout Period of at Least 7 Days||11
105786|NCT01374178|255611|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
105787|NCT01374178|255612|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
105788|NCT01374178|255611|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
105789|NCT01374178|255612|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
105790|NCT01374178|255611|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
105791|NCT01374178|255612|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
105792|NCT01374178|255611|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
105793|NCT01374178|255612|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
105794|NCT01374087|255630|P2|NOT COMPLETED|Overall Study||16
105795|NCT01374087|255631|P1|NOT COMPLETED|Overall Study||15
105796|NCT01374087|255630|P2|COMPLETED|Overall Study||0
105797|NCT01374087|255631|P1|COMPLETED|Overall Study||0
105798|NCT01374087|255630|P2|STARTED|Overall Study||16
105799|NCT01374087|255631|P1|STARTED|Overall Study||15
105800|NCT01373918|255641|P2|NOT COMPLETED|Overall Study||1
105801|NCT01373918|255642|P1|NOT COMPLETED|Overall Study||0
105802|NCT01373918|255641|P2|COMPLETED|Overall Study||15
105803|NCT01373918|255642|P1|COMPLETED|Overall Study||20
105804|NCT01373918|255641|P2|STARTED|Overall Study||16
105805|NCT01373918|255642|P1|STARTED|Overall Study||20
105806|NCT01373671|255654|P1|NOT COMPLETED|Overall Study||92
105807|NCT01373671|255654|P1|COMPLETED|Overall Study||672
105808|NCT01373671|255654|P1|STARTED|Overall Study||764
105809|NCT01373580|255659|P1|NOT COMPLETED|Overall Study||56
105810|NCT01373580|255659|P1|COMPLETED|Overall Study||317
105811|NCT01373580|255659|P1|STARTED|Overall Study||373
105812|NCT01373450|255665|P6|NOT COMPLETED|Crossover Period 4||0
105813|NCT01373450|255666|P5|NOT COMPLETED|Crossover Period 4||0
105814|NCT01373450|255667|P4|NOT COMPLETED|Crossover Period 4||0
105815|NCT01373450|255668|P3|NOT COMPLETED|Crossover Period 4||0
105816|NCT01373450|255669|P2|NOT COMPLETED|Crossover Period 4||0
105817|NCT01373450|255670|P1|NOT COMPLETED|Crossover Period 4||0
105818|NCT01373450|255665|P6|COMPLETED|Crossover Period 4||2
105819|NCT01373450|255666|P5|COMPLETED|Crossover Period 4||2
105820|NCT01373450|255667|P4|COMPLETED|Crossover Period 4||2
105821|NCT01373450|255668|P3|COMPLETED|Crossover Period 4||2
105822|NCT01373450|255669|P2|COMPLETED|Crossover Period 4||2
105823|NCT01373450|255670|P1|COMPLETED|Crossover Period 4||2
105824|NCT01373450|255665|P6|STARTED|Crossover Period 4||2
105825|NCT01373450|255666|P5|STARTED|Crossover Period 4||2
105826|NCT01373450|255667|P4|STARTED|Crossover Period 4||2
105827|NCT01373450|255668|P3|STARTED|Crossover Period 4||2
105828|NCT01373450|255669|P2|STARTED|Crossover Period 4||2
105829|NCT01373450|255670|P1|STARTED|Crossover Period 4||2
105830|NCT01373450|255665|P6|NOT COMPLETED|7 Day Wash-out||0
105831|NCT01373450|255666|P5|NOT COMPLETED|7 Day Wash-out||0
105832|NCT01373450|255667|P4|NOT COMPLETED|7 Day Wash-out||0
105833|NCT01373450|255668|P3|NOT COMPLETED|7 Day Wash-out||0
105834|NCT01373450|255669|P2|NOT COMPLETED|7 Day Wash-out||0
105835|NCT01373450|255670|P1|NOT COMPLETED|7 Day Wash-out||0
105836|NCT01373450|255665|P6|COMPLETED|7 Day Wash-out||2
105837|NCT01373450|255666|P5|COMPLETED|7 Day Wash-out||2
105838|NCT01373450|255667|P4|COMPLETED|7 Day Wash-out||2
105839|NCT01373450|255668|P3|COMPLETED|7 Day Wash-out||2
105840|NCT01373450|255669|P2|COMPLETED|7 Day Wash-out||2
105841|NCT01373450|255670|P1|COMPLETED|7 Day Wash-out||2
105842|NCT01373450|255665|P6|STARTED|7 Day Wash-out||2
105843|NCT01373450|255666|P5|STARTED|7 Day Wash-out||2
105844|NCT01373450|255667|P4|STARTED|7 Day Wash-out||2
105845|NCT01373450|255668|P3|STARTED|7 Day Wash-out||2
105846|NCT01373450|255669|P2|STARTED|7 Day Wash-out||2
105847|NCT01373450|255670|P1|STARTED|7 Day Wash-out||2
105848|NCT01373450|255665|P6|NOT COMPLETED|Crossover Period 3||0
105849|NCT01373450|255666|P5|NOT COMPLETED|Crossover Period 3||0
105850|NCT01373450|255667|P4|NOT COMPLETED|Crossover Period 3||0
105851|NCT01373450|255668|P3|NOT COMPLETED|Crossover Period 3||0
105852|NCT01373450|255669|P2|NOT COMPLETED|Crossover Period 3||0
105853|NCT01373450|255670|P1|NOT COMPLETED|Crossover Period 3||0
105854|NCT01373450|255665|P6|COMPLETED|Crossover Period 3||2
105855|NCT01373450|255666|P5|COMPLETED|Crossover Period 3||2
105856|NCT01373450|255667|P4|COMPLETED|Crossover Period 3||2
105857|NCT01373450|255668|P3|COMPLETED|Crossover Period 3||2
105858|NCT01373450|255669|P2|COMPLETED|Crossover Period 3||2
105859|NCT01373450|255670|P1|COMPLETED|Crossover Period 3||2
105860|NCT01373450|255665|P6|STARTED|Crossover Period 3||2
105861|NCT01373450|255666|P5|STARTED|Crossover Period 3||2
105862|NCT01373450|255667|P4|STARTED|Crossover Period 3||2
105863|NCT01373450|255668|P3|STARTED|Crossover Period 3||2
105864|NCT01373450|255669|P2|STARTED|Crossover Period 3||2
105865|NCT01373450|255670|P1|STARTED|Crossover Period 3||2
105866|NCT01373450|255665|P6|NOT COMPLETED|7 Day Wash-out||0
105867|NCT01373450|255666|P5|NOT COMPLETED|7 Day Wash-out||0
105868|NCT01373450|255667|P4|NOT COMPLETED|7 Day Wash-out||0
105869|NCT01373450|255668|P3|NOT COMPLETED|7 Day Wash-out||0
105870|NCT01373450|255669|P2|NOT COMPLETED|7 Day Wash-out||0
105871|NCT01373450|255670|P1|NOT COMPLETED|7 Day Wash-out||0
105872|NCT01373450|255665|P6|COMPLETED|7 Day Wash-out||2
105873|NCT01373450|255666|P5|COMPLETED|7 Day Wash-out||2
105874|NCT01373450|255667|P4|COMPLETED|7 Day Wash-out||2
105875|NCT01373450|255668|P3|COMPLETED|7 Day Wash-out||2
105876|NCT01373450|255669|P2|COMPLETED|7 Day Wash-out||2
105877|NCT01373450|255670|P1|COMPLETED|7 Day Wash-out||2
105878|NCT01373450|255665|P6|STARTED|7 Day Wash-out||2
105879|NCT01373450|255666|P5|STARTED|7 Day Wash-out||2
105880|NCT01373450|255667|P4|STARTED|7 Day Wash-out||2
105881|NCT01373450|255668|P3|STARTED|7 Day Wash-out||2
105882|NCT01373450|255669|P2|STARTED|7 Day Wash-out||2
105883|NCT01373450|255670|P1|STARTED|7 Day Wash-out||2
105884|NCT01373450|255665|P6|NOT COMPLETED|Crossover Period 2||0
105885|NCT01373450|255666|P5|NOT COMPLETED|Crossover Period 2||0
105886|NCT01373450|255667|P4|NOT COMPLETED|Crossover Period 2||0
105887|NCT01373450|255668|P3|NOT COMPLETED|Crossover Period 2||0
105888|NCT01373450|255669|P2|NOT COMPLETED|Crossover Period 2||0
105889|NCT01373450|255670|P1|NOT COMPLETED|Crossover Period 2||0
105890|NCT01373450|255665|P6|COMPLETED|Crossover Period 2||2
105891|NCT01373450|255666|P5|COMPLETED|Crossover Period 2||2
105892|NCT01373450|255667|P4|COMPLETED|Crossover Period 2||2
105893|NCT01373450|255668|P3|COMPLETED|Crossover Period 2||2
105894|NCT01373450|255669|P2|COMPLETED|Crossover Period 2||2
105895|NCT01373450|255670|P1|COMPLETED|Crossover Period 2||2
105896|NCT01373450|255665|P6|STARTED|Crossover Period 2||2
105897|NCT01373450|255666|P5|STARTED|Crossover Period 2||2
105898|NCT01373450|255667|P4|STARTED|Crossover Period 2||2
105899|NCT01373450|255668|P3|STARTED|Crossover Period 2||2
105900|NCT01373450|255669|P2|STARTED|Crossover Period 2||2
105901|NCT01373450|255670|P1|STARTED|Crossover Period 2||2
105902|NCT01373450|255665|P6|NOT COMPLETED|7 Day Wash-out||0
105903|NCT01373450|255666|P5|NOT COMPLETED|7 Day Wash-out||0
105904|NCT01373450|255667|P4|NOT COMPLETED|7 Day Wash-out||0
105905|NCT01373450|255668|P3|NOT COMPLETED|7 Day Wash-out||0
105906|NCT01373450|255669|P2|NOT COMPLETED|7 Day Wash-out||0
105907|NCT01373450|255670|P1|NOT COMPLETED|7 Day Wash-out||0
105908|NCT01373450|255665|P6|COMPLETED|7 Day Wash-out||2
105909|NCT01373450|255666|P5|COMPLETED|7 Day Wash-out||2
105910|NCT01373450|255667|P4|COMPLETED|7 Day Wash-out||2
105911|NCT01373450|255668|P3|COMPLETED|7 Day Wash-out||2
105912|NCT01373450|255669|P2|COMPLETED|7 Day Wash-out||2
105913|NCT01373450|255670|P1|COMPLETED|7 Day Wash-out||2
105914|NCT01373450|255665|P6|STARTED|7 Day Wash-out||2
105915|NCT01373450|255666|P5|STARTED|7 Day Wash-out||2
105916|NCT01373450|255667|P4|STARTED|7 Day Wash-out||2
105917|NCT01373450|255668|P3|STARTED|7 Day Wash-out||2
105918|NCT01373450|255669|P2|STARTED|7 Day Wash-out||2
105919|NCT01373450|255670|P1|STARTED|7 Day Wash-out||2
105920|NCT01373450|255665|P6|NOT COMPLETED|Crossover Period 1||0
105921|NCT01373450|255666|P5|NOT COMPLETED|Crossover Period 1||0
105922|NCT01373450|255667|P4|NOT COMPLETED|Crossover Period 1||0
105923|NCT01373450|255668|P3|NOT COMPLETED|Crossover Period 1||0
105924|NCT01373450|255669|P2|NOT COMPLETED|Crossover Period 1||0
105925|NCT01373450|255670|P1|NOT COMPLETED|Crossover Period 1||0
105926|NCT01373450|255665|P6|COMPLETED|Crossover Period 1||2
105927|NCT01373450|255666|P5|COMPLETED|Crossover Period 1||2
105928|NCT01373450|255667|P4|COMPLETED|Crossover Period 1||2
105929|NCT01373450|255668|P3|COMPLETED|Crossover Period 1||2
105930|NCT01373450|255669|P2|COMPLETED|Crossover Period 1||2
105931|NCT01373450|255670|P1|COMPLETED|Crossover Period 1||2
105932|NCT01373450|255665|P6|STARTED|Crossover Period 1||2
105933|NCT01373450|255666|P5|STARTED|Crossover Period 1||2
105934|NCT01373450|255667|P4|STARTED|Crossover Period 1||2
105935|NCT01373450|255668|P3|STARTED|Crossover Period 1||2
105936|NCT01373450|255669|P2|STARTED|Crossover Period 1||2
105937|NCT01373450|255670|P1|STARTED|Crossover Period 1||2
105938|NCT01373346|255692|P1|NOT COMPLETED|Overall Study||1
105939|NCT01373346|255692|P1|COMPLETED|Overall Study||14
105940|NCT01373346|255692|P1|STARTED|Overall Study||15
105941|NCT01373294|255715|P2|NOT COMPLETED|Overall Study||0
105942|NCT01373294|255716|P1|NOT COMPLETED|Overall Study||1
105943|NCT01373294|255715|P2|COMPLETED|Overall Study||2
105944|NCT01373294|255716|P1|COMPLETED|Overall Study||14
105945|NCT01373294|255715|P2|STARTED|Overall Study||2
105946|NCT01373294|255716|P1|STARTED|Overall Study||15
105947|NCT01373281|255725|P2|NOT COMPLETED|Overall Study||45
105948|NCT01373281|255726|P1|NOT COMPLETED|Overall Study||79
105949|NCT01373281|255725|P2|COMPLETED|Overall Study||3379
105950|NCT01373281|255726|P1|COMPLETED|Overall Study||6772
105951|NCT01373281|255725|P2|STARTED|Overall Study||3424
105952|NCT01373281|255726|P1|STARTED|Overall Study||6851
105953|NCT01373229|255742|P1|NOT COMPLETED|Overall Study||6
105954|NCT01373229|255742|P1|COMPLETED|Overall Study||9
105955|NCT01373229|255742|P1|STARTED|Overall Study||15
105956|NCT01373164|255756|P5|NOT COMPLETED|Overall Study||2
105957|NCT01373164|255757|P4|NOT COMPLETED|Overall Study||12
105958|NCT01373164|255758|P3|NOT COMPLETED|Overall Study||1
105959|NCT01373164|255759|P2|NOT COMPLETED|Overall Study||1
105960|NCT01373164|255760|P1|NOT COMPLETED|Overall Study||0
105961|NCT01373164|255756|P5|COMPLETED|Overall Study||50
105962|NCT01373164|255757|P4|COMPLETED|Overall Study||92
105963|NCT01373164|255758|P3|COMPLETED|Overall Study||4
105964|NCT01373164|255759|P2|COMPLETED|Overall Study||3
105965|NCT01373164|255760|P1|COMPLETED|Overall Study||5
105966|NCT01373164|255756|P5|Received at Least One Dose|Overall Study||52
105967|NCT01373164|255757|P4|Received at Least One Dose|Overall Study||103
105968|NCT01373164|255758|P3|Received at Least One Dose|Overall Study||5
105969|NCT01373164|255759|P2|Received at Least One Dose|Overall Study||4
105970|NCT01373164|255760|P1|Received at Least One Dose|Overall Study||5
105971|NCT01373164|255756|P5|STARTED|Overall Study||52
105972|NCT01373164|255757|P4|STARTED|Overall Study||104
105973|NCT01373164|255758|P3|STARTED|Overall Study||5
105974|NCT01373164|255759|P2|STARTED|Overall Study||4
105975|NCT01373164|255760|P1|STARTED|Overall Study||5
105976|NCT01372995|255794|P3|NOT COMPLETED|Overall Study||1
105977|NCT01372995|255795|P2|NOT COMPLETED|Overall Study||1
105978|NCT01372995|255796|P1|NOT COMPLETED|Overall Study||0
105979|NCT01372995|255794|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
105980|NCT01372995|255795|P2|COMPLETED|Overall Study||9
105981|NCT01372995|255796|P1|COMPLETED|Overall Study||10
105982|NCT01372995|255794|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
105983|NCT01372995|255795|P2|STARTED|Overall Study||10
105984|NCT01372995|255796|P1|STARTED|Overall Study||10
105985|NCT01372878|255843|P1|NOT COMPLETED|Overall Study||184
105986|NCT01372878|255843|P1|COMPLETED|Overall Study||700
105987|NCT01372878|255843|P1|STARTED|Overall Study||884
105988|NCT01372813|255848|P1|NOT COMPLETED|Overall Study||0
105989|NCT01372813|255848|P1|COMPLETED|Overall Study||3
105990|NCT01372813|255848|P1|STARTED|Overall Study||3
105991|NCT01372748|255863|P2|NOT COMPLETED|Overall Study||39
105992|NCT01372748|255864|P1|NOT COMPLETED|Overall Study||23
105993|NCT01372748|255863|P2|COMPLETED|Overall Study|defined as having vital status|12603
105994|NCT01372748|255864|P1|COMPLETED|Overall Study|defined as having vital status|11022
105995|NCT01372748|255863|P2|STARTED|Overall Study||12642
105996|NCT01372748|255864|P1|STARTED|Overall Study||11045
105997|NCT01372618|255872|P1|NOT COMPLETED|Overall Study||9
105998|NCT01372618|255872|P1|COMPLETED|Overall Study||0
105999|NCT01372618|255872|P1|STARTED|Overall Study||9
106000|NCT01372605|255880|P2|NOT COMPLETED|Overall Study||10
106001|NCT01372605|255881|P1|NOT COMPLETED|Overall Study||12
106002|NCT01372605|255880|P2|COMPLETED|Overall Study||145
106003|NCT01372605|255881|P1|COMPLETED|Overall Study||137
106004|NCT01372605|255880|P2|STARTED|Overall Study||155
106005|NCT01372605|255881|P1|STARTED|Overall Study||149
106006|NCT01372501|255907|P1|NOT COMPLETED|Overall Study||5
106007|NCT01372501|255907|P1|COMPLETED|Overall Study||14
106008|NCT01372501|255907|P1|STARTED|Overall Study||19
106009|NCT01372462|255912|P1|NOT COMPLETED|No Treatment Control||0
106010|NCT01372462|255912|P1|COMPLETED|No Treatment Control||15
106011|NCT01372462|255912|P1|STARTED|No Treatment Control||15
106012|NCT01372462|255912|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
106013|NCT01372462|255912|P1|COMPLETED|Oxygen Nasal Cannula||15
106014|NCT01372462|255912|P1|STARTED|Oxygen Nasal Cannula||15
106015|NCT01372462|255912|P1|NOT COMPLETED|NIOV - Oxygen||0
106016|NCT01372462|255912|P1|COMPLETED|NIOV - Oxygen||15
106017|NCT01372462|255912|P1|STARTED|NIOV - Oxygen||15
106018|NCT01372462|255912|P1|NOT COMPLETED|NIOV - Room Air||0
106019|NCT01372462|255912|P1|COMPLETED|NIOV - Room Air||15
106020|NCT01372462|255912|P1|STARTED|NIOV - Room Air||15
106021|NCT01372410|255930|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
106022|NCT01372410|255931|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
106023|NCT01372410|255932|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
106024|NCT01372410|255933|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
106025|NCT01372410|255934|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
106026|NCT01372410|255935|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
106027|NCT01372410|255936|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
106028|NCT01372410|255937|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
106029|NCT01372410|255930|P8|COMPLETED|Treatment Period 3 (7 Days)||18
106030|NCT01372410|255931|P7|COMPLETED|Treatment Period 3 (7 Days)||15
106031|NCT01372410|255932|P6|COMPLETED|Treatment Period 3 (7 Days)||18
106032|NCT01372410|255933|P5|COMPLETED|Treatment Period 3 (7 Days)||20
106033|NCT01372410|255934|P4|COMPLETED|Treatment Period 3 (7 Days)||22
106034|NCT01372410|255935|P3|COMPLETED|Treatment Period 3 (7 Days)||15
106035|NCT01372410|255936|P2|COMPLETED|Treatment Period 3 (7 Days)||18
106036|NCT01372410|255937|P1|COMPLETED|Treatment Period 3 (7 Days)||21
106037|NCT01372410|255930|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
106038|NCT01372410|255931|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
106039|NCT01372410|255932|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
106040|NCT01372410|255933|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
106041|NCT01372410|255934|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
106042|NCT01372410|255935|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
106043|NCT01372410|255936|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
106044|NCT01372410|255937|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
106045|NCT01372410|255930|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
106046|NCT01372410|255931|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
106047|NCT01372410|255932|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
106048|NCT01372410|255933|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
106049|NCT01372410|255934|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
106050|NCT01372410|255935|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
106051|NCT01372410|255936|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
106052|NCT01372410|255937|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
106053|NCT01372410|255930|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
106054|NCT01372410|255931|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
106055|NCT01372410|255932|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
106056|NCT01372410|255933|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
106057|NCT01372410|255934|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
106058|NCT01372410|255935|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
106059|NCT01372410|255936|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
106060|NCT01372410|255937|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
106061|NCT01372410|255930|P8|STARTED|Washout Period 2 (10-14 Days)||19
106062|NCT01372410|255931|P7|STARTED|Washout Period 2 (10-14 Days)||21
106063|NCT01372410|255932|P6|STARTED|Washout Period 2 (10-14 Days)||16
106064|NCT01372410|255933|P5|STARTED|Washout Period 2 (10-14 Days)||19
106065|NCT01372410|255934|P4|STARTED|Washout Period 2 (10-14 Days)||17
106066|NCT01372410|255935|P3|STARTED|Washout Period 2 (10-14 Days)||22
106067|NCT01372410|255936|P2|STARTED|Washout Period 2 (10-14 Days)||21
106068|NCT01372410|255937|P1|STARTED|Washout Period 2 (10-14 Days)||19
106069|NCT01372410|255930|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106070|NCT01372410|255931|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106071|NCT01372410|255932|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106072|NCT01372410|255933|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106073|NCT01372410|255934|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106074|NCT01372410|255935|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106075|NCT01372410|255936|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106076|NCT01372410|255937|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
106077|NCT01372410|255930|P8|COMPLETED|Treatment Period 2 (7 Days)||19
106078|NCT01372410|255931|P7|COMPLETED|Treatment Period 2 (7 Days)||21
106079|NCT01372410|255932|P6|COMPLETED|Treatment Period 2 (7 Days)||16
106080|NCT01372410|255933|P5|COMPLETED|Treatment Period 2 (7 Days)||19
106081|NCT01372410|255934|P4|COMPLETED|Treatment Period 2 (7 Days)||17
106082|NCT01372410|255935|P3|COMPLETED|Treatment Period 2 (7 Days)||22
106083|NCT01372410|255936|P2|COMPLETED|Treatment Period 2 (7 Days)||21
106084|NCT01372410|255937|P1|COMPLETED|Treatment Period 2 (7 Days)||19
106085|NCT01372410|255930|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
106086|NCT01372410|255931|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
106087|NCT01372410|255932|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
106088|NCT01372410|255933|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
106089|NCT01372410|255934|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
106090|NCT01372410|255935|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
106091|NCT01372410|255936|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
106092|NCT01372410|255937|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
106093|NCT01372410|255930|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
106094|NCT01372410|255931|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
106095|NCT01372410|255932|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
106096|NCT01372410|255933|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
106097|NCT01372410|255934|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
106098|NCT01372410|255935|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
106099|NCT01372410|255936|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
106100|NCT01372410|255937|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
106101|NCT01372410|255930|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
106102|NCT01372410|255931|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
106103|NCT01372410|255932|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
106104|NCT01372410|255933|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
106105|NCT01372410|255934|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
106106|NCT01372410|255935|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
106107|NCT01372410|255936|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
106108|NCT01372410|255937|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
106109|NCT01372410|255930|P8|STARTED|Washout Period 1 (10-14 Days)||19
106110|NCT01372410|255931|P7|STARTED|Washout Period 1 (10-14 Days)||20
106111|NCT01372410|255932|P6|STARTED|Washout Period 1 (10-14 Days)||21
106112|NCT01372410|255933|P5|STARTED|Washout Period 1 (10-14 Days)||19
106113|NCT01372410|255934|P4|STARTED|Washout Period 1 (10-14 Days)||20
106114|NCT01372410|255935|P3|STARTED|Washout Period 1 (10-14 Days)||19
106115|NCT01372410|255936|P2|STARTED|Washout Period 1 (10-14 Days)||19
106116|NCT01372410|255937|P1|STARTED|Washout Period 1 (10-14 Days)||19
106117|NCT01372410|255930|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
106118|NCT01372410|255931|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
106119|NCT01372410|255932|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
106120|NCT01372410|255933|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
106121|NCT01372410|255934|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
106122|NCT01372410|255935|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
106123|NCT01372410|255936|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
106124|NCT01372410|255937|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
106125|NCT01372410|255930|P8|COMPLETED|Treatment Period 1 (7 Days)||19
106126|NCT01372410|255931|P7|COMPLETED|Treatment Period 1 (7 Days)||20
106127|NCT01372410|255932|P6|COMPLETED|Treatment Period 1 (7 Days)||21
106128|NCT01372410|255933|P5|COMPLETED|Treatment Period 1 (7 Days)||19
106129|NCT01372410|255934|P4|COMPLETED|Treatment Period 1 (7 Days)||20
106130|NCT01372410|255935|P3|COMPLETED|Treatment Period 1 (7 Days)||19
106131|NCT01372410|255936|P2|COMPLETED|Treatment Period 1 (7 Days)||19
106132|NCT01372410|255937|P1|COMPLETED|Treatment Period 1 (7 Days)||19
106133|NCT01372410|255930|P8|STARTED|Treatment Period 1 (7 Days)||19
106134|NCT01372410|255931|P7|STARTED|Treatment Period 1 (7 Days)||22
106135|NCT01372410|255932|P6|STARTED|Treatment Period 1 (7 Days)||21
106136|NCT01372410|255933|P5|STARTED|Treatment Period 1 (7 Days)||21
106137|NCT01372410|255934|P4|STARTED|Treatment Period 1 (7 Days)||20
106138|NCT01372410|255935|P3|STARTED|Treatment Period 1 (7 Days)||19
106139|NCT01372410|255936|P2|STARTED|Treatment Period 1 (7 Days)||21
106140|NCT01372410|255937|P1|STARTED|Treatment Period 1 (7 Days)||20
106141|NCT01372384|255974|P1|NOT COMPLETED|Overall Study||3
106142|NCT01372384|255974|P1|COMPLETED|Overall Study||3
106143|NCT01372384|255974|P1|STARTED|Overall Study||6
106144|NCT01372202|255984|P3|NOT COMPLETED|Overall Study||0
106145|NCT01372202|255985|P2|NOT COMPLETED|Overall Study||0
106146|NCT01372202|255986|P1|NOT COMPLETED|Overall Study||0
106147|NCT01372202|255984|P3|COMPLETED|Overall Study||9
106148|NCT01372202|255985|P2|COMPLETED|Overall Study||9
106149|NCT01372202|255986|P1|COMPLETED|Overall Study||13
106150|NCT01372202|255984|P3|STARTED|Overall Study||9
106151|NCT01372202|255985|P2|STARTED|Overall Study||9
106152|NCT01372202|255986|P1|STARTED|Overall Study||13
106153|NCT01372150|255997|P3|NOT COMPLETED|Overall Study||16
106154|NCT01372150|255998|P2|NOT COMPLETED|Overall Study||14
106155|NCT01372150|255999|P1|NOT COMPLETED|Overall Study||13
106156|NCT01372150|255997|P3|COMPLETED|Overall Study||99
106157|NCT01372150|255998|P2|COMPLETED|Overall Study||99
106158|NCT01372150|255999|P1|COMPLETED|Overall Study||99
106159|NCT01372150|255997|P3|Treated|Overall Study||115
106160|NCT01372150|255998|P2|Treated|Overall Study||112
106161|NCT01372150|255999|P1|Treated|Overall Study||112
106162|NCT01372150|255997|P3|STARTED|Overall Study||115
106163|NCT01372150|255998|P2|STARTED|Overall Study||113
106164|NCT01372150|255999|P1|STARTED|Overall Study||112
106165|NCT01371994|256018|P2|NOT COMPLETED|Overall Study||42
106166|NCT01371994|256019|P1|NOT COMPLETED|Overall Study||57
106167|NCT01371994|256018|P2|COMPLETED|Overall Study||278
106168|NCT01371994|256019|P1|COMPLETED|Overall Study||263
106169|NCT01371994|256018|P2|Received Treatment|Overall Study||313
106170|NCT01371994|256019|P1|Received Treatment|Overall Study||310
106171|NCT01371994|256018|P2|STARTED|Overall Study||320
106172|NCT01371994|256019|P1|STARTED|Overall Study||320
106173|NCT01371877|256063|P2|NOT COMPLETED|Overall Study||4
106174|NCT01371877|256064|P1|NOT COMPLETED|Overall Study||0
106175|NCT01371877|256063|P2|COMPLETED|Overall Study||17
106176|NCT01371877|256064|P1|COMPLETED|Overall Study||21
106177|NCT01371877|256063|P2|STARTED|Overall Study||21
106178|NCT01371877|256064|P1|STARTED|Overall Study||21
106179|NCT01371851|256076|P2|NOT COMPLETED|Overall Study||9
106180|NCT01371851|256077|P1|NOT COMPLETED|Overall Study||8
106181|NCT01371851|256076|P2|COMPLETED|Overall Study||2
106182|NCT01371851|256077|P1|COMPLETED|Overall Study||3
106183|NCT01371851|256076|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
106184|NCT01371851|256077|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
106185|NCT01371838|256085|P2|NOT COMPLETED|Overall Study||66
106186|NCT01371838|256086|P1|NOT COMPLETED|Overall Study||49
106187|NCT01371838|256085|P2|COMPLETED|Overall Study||317
106188|NCT01371838|256086|P1|COMPLETED|Overall Study||332
106189|NCT01371838|256085|P2|STARTED|Overall Study||383
106190|NCT01371838|256086|P1|STARTED|Overall Study||381
106191|NCT01371825|256122|P1|NOT COMPLETED|Long-term Treatment Period||0
106192|NCT01371825|256122|P1|COMPLETED|Long-term Treatment Period|This period is currently ongoing.|6
106193|NCT01371825|256122|P1|STARTED|Long-term Treatment Period||6
106194|NCT01371825|256122|P1|NOT COMPLETED|Primary Efficacy Analysis Period||3
106195|NCT01371825|256122|P1|COMPLETED|Primary Efficacy Analysis Period||6
106196|NCT01371825|256122|P1|STARTED|Primary Efficacy Analysis Period||9
106197|NCT01371786|256136|P2|NOT COMPLETED|Overall Study||0
106198|NCT01371786|256137|P1|NOT COMPLETED|Overall Study||0
106199|NCT01371786|256136|P2|COMPLETED|Overall Study||7
106200|NCT01371786|256137|P1|COMPLETED|Overall Study||7
106201|NCT01371786|256136|P2|STARTED|Overall Study||7
106202|NCT01371786|256137|P1|STARTED|Overall Study||7
106203|NCT01371747|256157|P6|NOT COMPLETED|Overall Study||14
106204|NCT01371747|256158|P5|NOT COMPLETED|Overall Study||7
106205|NCT01371747|256159|P4|NOT COMPLETED|Overall Study||9
106206|NCT01371747|256160|P3|NOT COMPLETED|Overall Study||24
106207|NCT01371747|256161|P2|NOT COMPLETED|Overall Study||23
106208|NCT01371747|256162|P1|NOT COMPLETED|Overall Study||18
106209|NCT01371747|256157|P6|COMPLETED|Overall Study||16
106210|NCT01371747|256158|P5|COMPLETED|Overall Study||21
106211|NCT01371747|256159|P4|COMPLETED|Overall Study||17
106212|NCT01371747|256160|P3|COMPLETED|Overall Study||50
106213|NCT01371747|256161|P2|COMPLETED|Overall Study||51
106214|NCT01371747|256162|P1|COMPLETED|Overall Study||56
106215|NCT01371747|256157|P6|STARTED|Overall Study||30
106216|NCT01371747|256158|P5|STARTED|Overall Study||28
106217|NCT01371747|256159|P4|STARTED|Overall Study||26
106218|NCT01371747|256160|P3|STARTED|Overall Study||74
106219|NCT01371747|256161|P2|STARTED|Overall Study||74
106220|NCT01371747|256162|P1|STARTED|Overall Study||74
106221|NCT01371734|256227|P3|NOT COMPLETED|Overall Study||17
106222|NCT01371734|256228|P2|NOT COMPLETED|Overall Study||19
106223|NCT01371734|256229|P1|NOT COMPLETED|Overall Study||23
106224|NCT01371734|256227|P3|COMPLETED|Overall Study||104
106225|NCT01371734|256228|P2|COMPLETED|Overall Study||103
106226|NCT01371734|256229|P1|COMPLETED|Overall Study||97
106227|NCT01371734|256227|P3|STARTED|Overall Study||121
106228|NCT01371734|256228|P2|STARTED|Overall Study||122
106229|NCT01371734|256229|P1|STARTED|Overall Study||120
106230|NCT01371721|256249|P3|NOT COMPLETED|Overall Study||30
106231|NCT01371721|256250|P2|NOT COMPLETED|Overall Study||24
106232|NCT01371721|256251|P1|NOT COMPLETED|Overall Study||29
106233|NCT01371721|256249|P3|COMPLETED|Overall Study||62
106234|NCT01371721|256250|P2|COMPLETED|Overall Study||65
106235|NCT01371721|256251|P1|COMPLETED|Overall Study||59
106236|NCT01371721|256249|P3|Treated|Overall Study||92
106237|NCT01371721|256250|P2|Treated|Overall Study||89
106238|NCT01371721|256251|P1|Treated|Overall Study||87
106239|NCT01371721|256249|P3|STARTED|Overall Study||92
106240|NCT01371721|256250|P2|STARTED|Overall Study||89
106241|NCT01371721|256251|P1|STARTED|Overall Study||88
106242|NCT01371708|256284|P3|NOT COMPLETED|Overall Study||39
106243|NCT01371708|256285|P2|NOT COMPLETED|Overall Study||30
106244|NCT01371708|256286|P1|NOT COMPLETED|Overall Study||26
106245|NCT01371708|256284|P3|COMPLETED|Overall Study||59
106246|NCT01371708|256285|P2|COMPLETED|Overall Study||63
106247|NCT01371708|256286|P1|COMPLETED|Overall Study||66
106248|NCT01371708|256284|P3|Received Treatment|Overall Study||97
106249|NCT01371708|256285|P2|Received Treatment|Overall Study||93
106250|NCT01371708|256286|P1|Received Treatment|Overall Study||91
106251|NCT01371708|256284|P3|STARTED|Overall Study||98
106252|NCT01371708|256285|P2|STARTED|Overall Study||93
106253|NCT01371708|256286|P1|STARTED|Overall Study||92
106254|NCT01371643|256318|P2|NOT COMPLETED|Overall Study||0
106255|NCT01371643|256319|P1|NOT COMPLETED|Overall Study||3
106256|NCT01371643|256318|P2|COMPLETED|Overall Study||26
106257|NCT01371643|256319|P1|COMPLETED|Overall Study||12
106258|NCT01371643|256318|P2|STARTED|Overall Study||26
106259|NCT01371643|256319|P1|STARTED|Overall Study||15
106260|NCT01371565|256329|P1|NOT COMPLETED|Overall Study||3
106261|NCT01371565|256329|P1|COMPLETED|Overall Study||1
106262|NCT01371565|256329|P1|STARTED|Overall Study||4
106263|NCT01371552|256333|P6|NOT COMPLETED|Part 2, One Week||0
106264|NCT01371552|256334|P5|NOT COMPLETED|Part 2, One Week||0
106265|NCT01371552|256335|P4|NOT COMPLETED|Part 2, One Week||0
106266|NCT01371552|256336|P3|NOT COMPLETED|Part 2, One Week||0
106267|NCT01371552|256337|P2|NOT COMPLETED|Part 2, One Week||0
106268|NCT01371552|256338|P1|NOT COMPLETED|Part 2, One Week||0
106269|NCT01371552|256333|P6|COMPLETED|Part 2, One Week||18
106270|NCT01371552|256334|P5|COMPLETED|Part 2, One Week||15
106271|NCT01371552|256335|P4|COMPLETED|Part 2, One Week||20
106272|NCT01371552|256336|P3|COMPLETED|Part 2, One Week||18
106273|NCT01371552|256337|P2|COMPLETED|Part 2, One Week||17
106274|NCT01371552|256338|P1|COMPLETED|Part 2, One Week||18
106275|NCT01371552|256333|P6|STARTED|Part 2, One Week||18
106276|NCT01371552|256334|P5|STARTED|Part 2, One Week||15
106277|NCT01371552|256335|P4|STARTED|Part 2, One Week||20
106278|NCT01371552|256336|P3|STARTED|Part 2, One Week||18
106279|NCT01371552|256337|P2|STARTED|Part 2, One Week||17
106280|NCT01371552|256338|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
106281|NCT01371552|256333|P6|NOT COMPLETED|Part 1, Third 3 Days||1
106282|NCT01371552|256334|P5|NOT COMPLETED|Part 1, Third 3 Days||1
106283|NCT01371552|256335|P4|NOT COMPLETED|Part 1, Third 3 Days||0
106284|NCT01371552|256336|P3|NOT COMPLETED|Part 1, Third 3 Days||0
106285|NCT01371552|256337|P2|NOT COMPLETED|Part 1, Third 3 Days||0
106286|NCT01371552|256338|P1|NOT COMPLETED|Part 1, Third 3 Days||0
106287|NCT01371552|256333|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
106288|NCT01371552|256334|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
106289|NCT01371552|256335|P4|COMPLETED|Part 1, Third 3 Days||20
106290|NCT01371552|256336|P3|COMPLETED|Part 1, Third 3 Days||18
106291|NCT01371552|256337|P2|COMPLETED|Part 1, Third 3 Days||17
106292|NCT01371552|256338|P1|COMPLETED|Part 1, Third 3 Days||19
106293|NCT01371552|256333|P6|STARTED|Part 1, Third 3 Days||18
106294|NCT01371552|256334|P5|STARTED|Part 1, Third 3 Days||15
106295|NCT01371552|256335|P4|STARTED|Part 1, Third 3 Days||20
106296|NCT01371552|256336|P3|STARTED|Part 1, Third 3 Days||18
106297|NCT01371552|256337|P2|STARTED|Part 1, Third 3 Days||17
106298|NCT01371552|256338|P1|STARTED|Part 1, Third 3 Days||19
106299|NCT01371552|256333|P6|NOT COMPLETED|Part 1, Second 3 Days||0
106300|NCT01371552|256334|P5|NOT COMPLETED|Part 1, Second 3 Days||0
106301|NCT01371552|256335|P4|NOT COMPLETED|Part 1, Second 3 Days||0
106302|NCT01371552|256336|P3|NOT COMPLETED|Part 1, Second 3 Days||0
106303|NCT01371552|256337|P2|NOT COMPLETED|Part 1, Second 3 Days||0
106304|NCT01371552|256338|P1|NOT COMPLETED|Part 1, Second 3 Days||1
106305|NCT01371552|256333|P6|COMPLETED|Part 1, Second 3 Days||18
106306|NCT01371552|256334|P5|COMPLETED|Part 1, Second 3 Days||15
106307|NCT01371552|256335|P4|COMPLETED|Part 1, Second 3 Days||20
106308|NCT01371552|256336|P3|COMPLETED|Part 1, Second 3 Days||18
106309|NCT01371552|256337|P2|COMPLETED|Part 1, Second 3 Days||17
106310|NCT01371552|256338|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
106311|NCT01371552|256333|P6|STARTED|Part 1, Second 3 Days||18
106312|NCT01371552|256334|P5|STARTED|Part 1, Second 3 Days||15
106313|NCT01371552|256335|P4|STARTED|Part 1, Second 3 Days||20
106314|NCT01371552|256336|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
106315|NCT01371552|256337|P2|STARTED|Part 1, Second 3 Days||17
106316|NCT01371552|256338|P1|STARTED|Part 1, Second 3 Days||19
106317|NCT01371552|256333|P6|NOT COMPLETED|Part 1, First 3 Days||0
106318|NCT01371552|256334|P5|NOT COMPLETED|Part 1, First 3 Days||0
106319|NCT01371552|256335|P4|NOT COMPLETED|Part 1, First 3 Days||0
106320|NCT01371552|256336|P3|NOT COMPLETED|Part 1, First 3 Days||1
106321|NCT01371552|256337|P2|NOT COMPLETED|Part 1, First 3 Days||0
106322|NCT01371552|256338|P1|NOT COMPLETED|Part 1, First 3 Days||0
106323|NCT01371552|256333|P6|COMPLETED|Part 1, First 3 Days||18
106324|NCT01371552|256334|P5|COMPLETED|Part 1, First 3 Days||15
106325|NCT01371552|256335|P4|COMPLETED|Part 1, First 3 Days||20
106326|NCT01371552|256336|P3|COMPLETED|Part 1, First 3 Days||19
106327|NCT01371552|256337|P2|COMPLETED|Part 1, First 3 Days||17
106328|NCT01371552|256338|P1|COMPLETED|Part 1, First 3 Days||19
106329|NCT01371552|256333|P6|STARTED|Part 1, First 3 Days||18
106330|NCT01371552|256334|P5|STARTED|Part 1, First 3 Days||15
106331|NCT01371552|256335|P4|STARTED|Part 1, First 3 Days||20
106332|NCT01371552|256336|P3|STARTED|Part 1, First 3 Days||20
106333|NCT01371552|256337|P2|STARTED|Part 1, First 3 Days||17
106334|NCT01371552|256338|P1|STARTED|Part 1, First 3 Days||19
106335|NCT01371539|256365|P2|NOT COMPLETED|Period Two: One Week||3
106336|NCT01371539|256366|P1|NOT COMPLETED|Period Two: One Week||0
106337|NCT01371539|256365|P2|COMPLETED|Period Two: One Week||47
106338|NCT01371539|256366|P1|COMPLETED|Period Two: One Week||53
106339|NCT01371539|256365|P2|STARTED|Period Two: One Week||50
106340|NCT01371539|256366|P1|STARTED|Period Two: One Week||53
106341|NCT01371539|256365|P2|NOT COMPLETED|Period One: One Week||1
106342|NCT01371539|256366|P1|NOT COMPLETED|Period One: One Week||0
106343|NCT01371539|256365|P2|COMPLETED|Period One: One Week||50
106344|NCT01371539|256366|P1|COMPLETED|Period One: One Week||53
106345|NCT01371539|256365|P2|STARTED|Period One: One Week||51
106346|NCT01371539|256366|P1|STARTED|Period One: One Week||53
106347|NCT01371110|256376|P2|NOT COMPLETED|Overall Study||0
106348|NCT01371110|256377|P1|NOT COMPLETED|Overall Study||0
106349|NCT01371110|256376|P2|COMPLETED|Overall Study||2
106350|NCT01371110|256377|P1|COMPLETED|Overall Study||1
106351|NCT01371110|256376|P2|STARTED|Overall Study||2
106352|NCT01371110|256377|P1|STARTED|Overall Study||1
106353|NCT01371006|256387|P2|NOT COMPLETED|Overall Study||0
106354|NCT01371006|256388|P1|NOT COMPLETED|Overall Study||1
106355|NCT01371006|256387|P2|COMPLETED|Overall Study||15
106356|NCT01371006|256388|P1|COMPLETED|Overall Study||13
106357|NCT01371006|256387|P2|STARTED|Overall Study||15
106358|NCT01371006|256388|P1|STARTED|Overall Study||14
106359|NCT01370863|256429|P2|NOT COMPLETED|Overall Study||3
106360|NCT01370863|256430|P1|NOT COMPLETED|Overall Study||2
106361|NCT01370863|256429|P2|COMPLETED|Overall Study||30
106362|NCT01370863|256430|P1|COMPLETED|Overall Study||32
106363|NCT01370863|256429|P2|STARTED|Overall Study||33
106364|NCT01370863|256430|P1|STARTED|Overall Study||34
106365|NCT01370837|256443|P3|NOT COMPLETED|Overall Study||0
106366|NCT01370837|256444|P2|NOT COMPLETED|Overall Study||0
106367|NCT01370837|256445|P1|NOT COMPLETED|Overall Study||0
106368|NCT01370837|256443|P3|COMPLETED|Overall Study||17
106369|NCT01370837|256444|P2|COMPLETED|Overall Study||12
106370|NCT01370837|256445|P1|COMPLETED|Overall Study||12
106371|NCT01370837|256443|P3|STARTED|Overall Study||17
106372|NCT01370837|256444|P2|STARTED|Overall Study||12
106373|NCT01370837|256445|P1|STARTED|Overall Study||12
106374|NCT01370733|256455|P2|NOT COMPLETED|Overall Study||22
106375|NCT01370733|256456|P1|NOT COMPLETED|Overall Study||17
106376|NCT01370733|256455|P2|COMPLETED|Overall Study||77
106377|NCT01370733|256456|P1|COMPLETED|Overall Study||86
106378|NCT01370733|256455|P2|STARTED|Overall Study||99
106379|NCT01370733|256456|P1|STARTED|Overall Study||103
106380|NCT01370694|256478|P1|NOT COMPLETED|Overall Study||6
106381|NCT01370694|256478|P1|COMPLETED|Overall Study||1
106382|NCT01370694|256478|P1|STARTED|Overall Study||7
106383|NCT01370655|256500|P12|NOT COMPLETED|Period 2||0
106384|NCT01370655|256501|P11|NOT COMPLETED|Period 2||1
106385|NCT01370655|256502|P10|NOT COMPLETED|Period 2||0
106386|NCT01370655|256503|P9|NOT COMPLETED|Period 2||2
106387|NCT01370655|256504|P8|NOT COMPLETED|Period 2||1
106388|NCT01370655|256505|P7|NOT COMPLETED|Period 2||1
106389|NCT01370655|256506|P6|NOT COMPLETED|Period 2||0
106390|NCT01370655|256507|P5|NOT COMPLETED|Period 2||1
106391|NCT01370655|256508|P4|NOT COMPLETED|Period 2||0
106392|NCT01370655|256509|P3|NOT COMPLETED|Period 2||2
106393|NCT01370655|256510|P2|NOT COMPLETED|Period 2||0
106394|NCT01370655|256511|P1|NOT COMPLETED|Period 2||0
106395|NCT01370655|256500|P12|COMPLETED|Period 2||3
106396|NCT01370655|256501|P11|COMPLETED|Period 2||2
106397|NCT01370655|256502|P10|COMPLETED|Period 2||2
106398|NCT01370655|256503|P9|COMPLETED|Period 2||1
106399|NCT01370655|256504|P8|COMPLETED|Period 2||3
106400|NCT01370655|256505|P7|COMPLETED|Period 2||2
106401|NCT01370655|256506|P6|COMPLETED|Period 2||4
106402|NCT01370655|256507|P5|COMPLETED|Period 2||2
106403|NCT01370655|256508|P4|COMPLETED|Period 2||3
106404|NCT01370655|256509|P3|COMPLETED|Period 2||1
106405|NCT01370655|256510|P2|COMPLETED|Period 2||7
106406|NCT01370655|256511|P1|COMPLETED|Period 2||5
106407|NCT01370655|256500|P12|STARTED|Period 2||3
106408|NCT01370655|256501|P11|STARTED|Period 2||3
106409|NCT01370655|256502|P10|STARTED|Period 2||2
106410|NCT01370655|256503|P9|STARTED|Period 2||3
106411|NCT01370655|256504|P8|STARTED|Period 2||4
106412|NCT01370655|256505|P7|STARTED|Period 2||3
106413|NCT01370655|256506|P6|STARTED|Period 2||4
106414|NCT01370655|256507|P5|STARTED|Period 2||3
106415|NCT01370655|256508|P4|STARTED|Period 2||3
106416|NCT01370655|256509|P3|STARTED|Period 2||3
106417|NCT01370655|256510|P2|STARTED|Period 2||7
106418|NCT01370655|256511|P1|STARTED|Period 2||5
106419|NCT01370655|256500|P12|NOT COMPLETED|Period 1||0
106420|NCT01370655|256501|P11|NOT COMPLETED|Period 1||0
106421|NCT01370655|256502|P10|NOT COMPLETED|Period 1||0
106422|NCT01370655|256503|P9|NOT COMPLETED|Period 1||0
106423|NCT01370655|256504|P8|NOT COMPLETED|Period 1||0
106424|NCT01370655|256505|P7|NOT COMPLETED|Period 1||1
106425|NCT01370655|256506|P6|NOT COMPLETED|Period 1||0
106426|NCT01370655|256507|P5|NOT COMPLETED|Period 1||0
106427|NCT01370655|256508|P4|NOT COMPLETED|Period 1||0
106428|NCT01370655|256509|P3|NOT COMPLETED|Period 1||0
106429|NCT01370655|256510|P2|NOT COMPLETED|Period 1||0
106430|NCT01370655|256511|P1|NOT COMPLETED|Period 1||2
106431|NCT01370655|256500|P12|COMPLETED|Period 1||3
106432|NCT01370655|256501|P11|COMPLETED|Period 1||3
106433|NCT01370655|256502|P10|COMPLETED|Period 1||2
106434|NCT01370655|256503|P9|COMPLETED|Period 1||3
106435|NCT01370655|256504|P8|COMPLETED|Period 1||4
106436|NCT01370655|256505|P7|COMPLETED|Period 1||3
106437|NCT01370655|256506|P6|COMPLETED|Period 1||4
106438|NCT01370655|256507|P5|COMPLETED|Period 1||3
106439|NCT01370655|256508|P4|COMPLETED|Period 1||3
106440|NCT01370655|256509|P3|COMPLETED|Period 1||3
106441|NCT01370655|256510|P2|COMPLETED|Period 1||7
106442|NCT01370655|256511|P1|COMPLETED|Period 1||5
106443|NCT01370655|256500|P12|STARTED|Period 1||3
106444|NCT01370655|256501|P11|STARTED|Period 1||3
106445|NCT01370655|256502|P10|STARTED|Period 1||2
106446|NCT01370655|256503|P9|STARTED|Period 1||3
106447|NCT01370655|256504|P8|STARTED|Period 1||4
106448|NCT01370655|256505|P7|STARTED|Period 1||4
106449|NCT01370655|256506|P6|STARTED|Period 1||4
106450|NCT01370655|256507|P5|STARTED|Period 1||3
106451|NCT01370655|256508|P4|STARTED|Period 1||3
106452|NCT01370655|256509|P3|STARTED|Period 1||3
106453|NCT01370655|256510|P2|STARTED|Period 1||7
106454|NCT01370655|256511|P1|STARTED|Period 1||7
106455|NCT01370642|256548|P3|NOT COMPLETED|Overall Study||29
106456|NCT01370642|256549|P2|NOT COMPLETED|Overall Study||6
106457|NCT01370642|256550|P1|NOT COMPLETED|Overall Study||8
106458|NCT01370642|256548|P3|COMPLETED|Overall Study||69
106459|NCT01370642|256549|P2|COMPLETED|Overall Study||92
106460|NCT01370642|256550|P1|COMPLETED|Overall Study||90
106461|NCT01370642|256548|P3|FAS Population|Overall Study||98
106462|NCT01370642|256549|P2|FAS Population|Overall Study||97
106463|NCT01370642|256550|P1|FAS Population|Overall Study||98
106464|NCT01370642|256548|P3|STARTED|Overall Study||98
106465|NCT01370642|256549|P2|STARTED|Overall Study||98
106466|NCT01370642|256550|P1|STARTED|Overall Study||98
106467|NCT01370616|256581|P2|NOT COMPLETED|Overall Study||67
106468|NCT01370616|256582|P1|NOT COMPLETED|Overall Study||62
106469|NCT01370616|256581|P2|COMPLETED|Overall Study||216
106470|NCT01370616|256582|P1|COMPLETED|Overall Study||220
106471|NCT01370616|256581|P2|Treated|Overall Study||275
106472|NCT01370616|256582|P1|Treated|Overall Study||275
106473|NCT01370616|256581|P2|STARTED|Overall Study|Participants randomized|283
106474|NCT01370616|256582|P1|STARTED|Overall Study|Participants randomized|282
106475|NCT01370603|256606|P2|NOT COMPLETED|Period 2||4
106476|NCT01370603|256607|P1|NOT COMPLETED|Period 2||3
106477|NCT01370603|256606|P2|COMPLETED|Period 2||146
106478|NCT01370603|256607|P1|COMPLETED|Period 2||138
106479|NCT01370603|256606|P2|STARTED|Period 2||150
106480|NCT01370603|256607|P1|STARTED|Period 2||141
106481|NCT01370603|256606|P2|NOT COMPLETED|Crossover Washout||4
106482|NCT01370603|256607|P1|NOT COMPLETED|Crossover Washout||9
106483|NCT01370603|256606|P2|COMPLETED|Crossover Washout||150
106484|NCT01370603|256607|P1|COMPLETED|Crossover Washout||141
106485|NCT01370603|256606|P2|STARTED|Crossover Washout||154
106486|NCT01370603|256607|P1|STARTED|Crossover Washout||150
106487|NCT01370603|256606|P2|NOT COMPLETED|Period 1||10
106488|NCT01370603|256607|P1|NOT COMPLETED|Period 1||14
106489|NCT01370603|256606|P2|COMPLETED|Period 1||154
106490|NCT01370603|256607|P1|COMPLETED|Period 1||150
106491|NCT01370603|256606|P2|STARTED|Period 1||164
106492|NCT01370603|256607|P1|STARTED|Period 1||164
106493|NCT01370590|256625|P2|NOT COMPLETED|Period 2||2
106494|NCT01370590|256626|P1|NOT COMPLETED|Period 2||1
106495|NCT01370590|256625|P2|COMPLETED|Period 2||184
106496|NCT01370590|256626|P1|COMPLETED|Period 2||180
106497|NCT01370590|256625|P2|STARTED|Period 2||186
106498|NCT01370590|256626|P1|STARTED|Period 2||181
106499|NCT01370590|256625|P2|NOT COMPLETED|Crossover Washout Period||6
106500|NCT01370590|256626|P1|NOT COMPLETED|Crossover Washout Period||6
106501|NCT01370590|256625|P2|COMPLETED|Crossover Washout Period||186
106502|NCT01370590|256626|P1|COMPLETED|Crossover Washout Period||181
106503|NCT01370590|256625|P2|STARTED|Crossover Washout Period||192
106504|NCT01370590|256626|P1|STARTED|Crossover Washout Period||187
106505|NCT01370590|256625|P2|NOT COMPLETED|Period 1||11
106506|NCT01370590|256626|P1|NOT COMPLETED|Period 1||16
106507|NCT01370590|256625|P2|COMPLETED|Period 1||192
106508|NCT01370590|256626|P1|COMPLETED|Period 1||187
106509|NCT01370590|256625|P2|STARTED|Period 1||203
106510|NCT01370590|256626|P1|STARTED|Period 1||203
106511|NCT01370538|256644|P2|NOT COMPLETED|Overall Study||19
106512|NCT01370538|256645|P1|NOT COMPLETED|Overall Study||19
106513|NCT01370538|256644|P2|COMPLETED|Overall Study||152
106514|NCT01370538|256645|P1|COMPLETED|Overall Study||151
106515|NCT01370538|256644|P2|Patients Who Completed Treatment|Overall Study||152
106516|NCT01370538|256645|P1|Patients Who Completed Treatment|Overall Study||151
106517|NCT01370538|256644|P2|Patients Who Received Treatment|Overall Study||161
106518|NCT01370538|256645|P1|Patients Who Received Treatment|Overall Study||165
106519|NCT01370538|256644|P2|STARTED|Overall Study||171
106520|NCT01370538|256645|P1|STARTED|Overall Study||170
106521|NCT01370525|256661|P2|NOT COMPLETED|Overall Study||11
106522|NCT01370525|256662|P1|NOT COMPLETED|Overall Study||8
106523|NCT01370525|256661|P2|COMPLETED|Overall Study||158
106524|NCT01370525|256662|P1|COMPLETED|Overall Study||163
106525|NCT01370525|256661|P2|Patients Who Completed Treatment|Overall Study||158
106526|NCT01370525|256662|P1|Patients Who Completed Treatment|Overall Study||163
106527|NCT01370525|256661|P2|Patients Who Received Treatment|Overall Study||163
106528|NCT01370525|256662|P1|Patients Who Received Treatment|Overall Study||168
106529|NCT01370525|256661|P2|STARTED|Overall Study||169
106530|NCT01370525|256662|P1|STARTED|Overall Study||171
106531|NCT01370460|256678|P2|NOT COMPLETED|Overall Study||0
106532|NCT01370460|256679|P1|NOT COMPLETED|Overall Study||0
106533|NCT01370460|256678|P2|COMPLETED|Overall Study||51
106534|NCT01370460|256679|P1|COMPLETED|Overall Study||50
106535|NCT01370460|256678|P2|STARTED|Overall Study||51
106536|NCT01370460|256679|P1|STARTED|Overall Study||50
106537|NCT01370408|256686|P1|NOT COMPLETED|Overall Study||9
106538|NCT01370408|256686|P1|COMPLETED|Overall Study||76
106539|NCT01370408|256686|P1|STARTED|Overall Study||85
106540|NCT01370369|256697|P1|NOT COMPLETED|Overall Study||0
106541|NCT01370369|256697|P1|COMPLETED|Overall Study||20
106542|NCT01370369|256697|P1|STARTED|Overall Study||20
106543|NCT01370356|256746|P2|NOT COMPLETED|Overall Study||227
106544|NCT01370356|256747|P1|NOT COMPLETED|Overall Study||192
106545|NCT01370356|256746|P2|COMPLETED|Overall Study||515
106546|NCT01370356|256747|P1|COMPLETED|Overall Study||559
106547|NCT01370356|256746|P2|STARTED|Overall Study||742
106548|NCT01370356|256747|P1|STARTED|Overall Study||751
106549|NCT01370265|256761|P2|NOT COMPLETED|Second Intervention||0
106550|NCT01370265|256762|P1|NOT COMPLETED|Second Intervention||0
106551|NCT01370265|256761|P2|COMPLETED|Second Intervention||5
106552|NCT01370265|256762|P1|COMPLETED|Second Intervention||5
106553|NCT01370265|256761|P2|STARTED|Second Intervention||5
106554|NCT01370265|256762|P1|STARTED|Second Intervention||5
106555|NCT01370265|256761|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
106556|NCT01370265|256762|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
106557|NCT01370265|256761|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
106558|NCT01370265|256762|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
106559|NCT01370265|256761|P2|STARTED|Washout Period (50-minute Period Decay)||5
106560|NCT01370265|256762|P1|STARTED|Washout Period (50-minute Period Decay)||5
106561|NCT01370265|256761|P2|NOT COMPLETED|First Intervention||1
106562|NCT01370265|256762|P1|NOT COMPLETED|First Intervention||1
106563|NCT01370265|256761|P2|COMPLETED|First Intervention||5
106564|NCT01370265|256762|P1|COMPLETED|First Intervention||5
106565|NCT01370265|256761|P2|STARTED|First Intervention||6
106566|NCT01370265|256762|P1|STARTED|First Intervention||6
106567|NCT01370265|256761|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
106568|NCT01370265|256762|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
106569|NCT01370265|256761|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
106570|NCT01370265|256762|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
106571|NCT01370265|256761|P2|STARTED|Washout Period (50-minute Period Decay)||6
106572|NCT01370265|256762|P1|STARTED|Washout Period (50-minute Period Decay)||6
106573|NCT01370265|256761|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
106574|NCT01370265|256762|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
106575|NCT01370265|256761|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
106576|NCT01370265|256762|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
106577|NCT01370265|256761|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
106578|NCT01370265|256762|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
106579|NCT01370083|256781|P2|NOT COMPLETED|Overall Study||1
106580|NCT01370083|256782|P1|NOT COMPLETED|Overall Study||2
106581|NCT01370083|256781|P2|COMPLETED|Overall Study||6
106582|NCT01370083|256782|P1|COMPLETED|Overall Study||5
106583|NCT01370083|256781|P2|STARTED|Overall Study||7
106584|NCT01370083|256782|P1|STARTED|Overall Study||7
106585|NCT01370005|256795|P3|NOT COMPLETED|Overall Study||11
106586|NCT01370005|256796|P2|NOT COMPLETED|Overall Study||11
106587|NCT01370005|256797|P1|NOT COMPLETED|Overall Study||16
106588|NCT01370005|256795|P3|COMPLETED|Overall Study||266
106589|NCT01370005|256796|P2|COMPLETED|Overall Study||265
106590|NCT01370005|256797|P1|COMPLETED|Overall Study||256
106591|NCT01370005|256795|P3|STARTED|Overall Study||277
106592|NCT01370005|256796|P2|STARTED|Overall Study||276
106593|NCT01370005|256797|P1|STARTED|Overall Study||272
106594|NCT01369888|256854|P4|NOT COMPLETED|Overall Study||0
106595|NCT01369888|256855|P3|NOT COMPLETED|Overall Study||0
106596|NCT01369888|256856|P2|NOT COMPLETED|Overall Study||0
106597|NCT01369888|256857|P1|NOT COMPLETED|Overall Study||0
106598|NCT01369888|256854|P4|COMPLETED|Overall Study||0
106599|NCT01369888|256855|P3|COMPLETED|Overall Study||0
106600|NCT01369888|256856|P2|COMPLETED|Overall Study||2
106601|NCT01369888|256857|P1|COMPLETED|Overall Study||1
106602|NCT01369888|256854|P4|STARTED|Overall Study||0
106603|NCT01369888|256855|P3|STARTED|Overall Study||0
106604|NCT01369888|256856|P2|STARTED|Overall Study||2
106605|NCT01369888|256857|P1|STARTED|Overall Study||1
106606|NCT01369875|256867|P2|NOT COMPLETED|Overall Study||0
106607|NCT01369875|256868|P1|NOT COMPLETED|Overall Study||0
106608|NCT01369875|256867|P2|COMPLETED|Overall Study||1
106609|NCT01369875|256868|P1|COMPLETED|Overall Study||1
106610|NCT01369875|256867|P2|STARTED|Overall Study||1
106611|NCT01369875|256868|P1|STARTED|Overall Study||1
106612|NCT01369849|256879|P3|NOT COMPLETED|Overall Study||1
106613|NCT01369849|256880|P2|NOT COMPLETED|Overall Study||1
106614|NCT01369849|256881|P1|NOT COMPLETED|Overall Study||0
106615|NCT01369849|256879|P3|COMPLETED|Overall Study||4
106616|NCT01369849|256880|P2|COMPLETED|Overall Study||3
106617|NCT01369849|256881|P1|COMPLETED|Overall Study||6
106618|NCT01369849|256879|P3|STARTED|Overall Study||5
106619|NCT01369849|256880|P2|STARTED|Overall Study||4
106620|NCT01369849|256881|P1|STARTED|Overall Study||6
106621|NCT01369784|256903|P1|NOT COMPLETED|Overall Study||12
106622|NCT01369784|256903|P1|COMPLETED|Overall Study||146
106623|NCT01369784|256903|P1|STARTED|Overall Study||158
106624|NCT01369758|256928|P1|NOT COMPLETED|Overall Study||0
106625|NCT01369758|256928|P1|COMPLETED|Overall Study||290
106626|NCT01369758|256928|P1|STARTED|Overall Study||290
106627|NCT01369745|256938|P5|NOT COMPLETED|Overall Study||18
106628|NCT01369745|256939|P4|NOT COMPLETED|Overall Study||20
106629|NCT01369745|256940|P3|NOT COMPLETED|Overall Study||2
106630|NCT01369745|256941|P2|NOT COMPLETED|Overall Study||13
106631|NCT01369745|256942|P1|NOT COMPLETED|Overall Study||7
106632|NCT01369745|256938|P5|COMPLETED|Overall Study||65
106633|NCT01369745|256939|P4|COMPLETED|Overall Study||64
106634|NCT01369745|256940|P3|COMPLETED|Overall Study||16
106635|NCT01369745|256941|P2|COMPLETED|Overall Study||28
106636|NCT01369745|256942|P1|COMPLETED|Overall Study||25
106637|NCT01369745|256938|P5|STARTED|Overall Study||83
106638|NCT01369745|256939|P4|STARTED|Overall Study||84
106639|NCT01369745|256940|P3|STARTED|Overall Study||18
106640|NCT01369745|256941|P2|STARTED|Overall Study||41
106641|NCT01369745|256942|P1|STARTED|Overall Study||32
106642|NCT01369732|256976|P2|NOT COMPLETED|Overall Study||2
106643|NCT01369732|256977|P1|NOT COMPLETED|Overall Study||4
106644|NCT01369732|256976|P2|COMPLETED|Overall Study||31
106645|NCT01369732|256977|P1|COMPLETED|Overall Study||29
106646|NCT01369732|256976|P2|STARTED|Overall Study||33
106647|NCT01369732|256977|P1|STARTED|Overall Study||33
106648|NCT01369706|256983|P1|NOT COMPLETED|Overall Study||0
106649|NCT01369706|256983|P1|COMPLETED|Overall Study||388
106650|NCT01369706|256983|P1|STARTED|Overall Study||388
106651|NCT01369680|256991|P4|NOT COMPLETED|Overall Study||2
106652|NCT01369680|256992|P3|NOT COMPLETED|Overall Study||1
106653|NCT01369680|256993|P2|NOT COMPLETED|Overall Study||0
106654|NCT01369680|256994|P1|NOT COMPLETED|Overall Study||0
106655|NCT01369680|256991|P4|COMPLETED|Overall Study||1
106656|NCT01369680|256992|P3|COMPLETED|Overall Study||2
106657|NCT01369680|256993|P2|COMPLETED|Overall Study||3
106658|NCT01369680|256994|P1|COMPLETED|Overall Study||3
106659|NCT01369680|256991|P4|STARTED|Overall Study||3
106660|NCT01369680|256992|P3|STARTED|Overall Study||3
106661|NCT01369680|256993|P2|STARTED|Overall Study||3
106662|NCT01369680|256994|P1|STARTED|Overall Study||3
106663|NCT01369641|257015|P1|NOT COMPLETED|Overall Study||1
106664|NCT01369641|257015|P1|COMPLETED|Overall Study||0
106665|NCT01369641|257015|P1|STARTED|Overall Study||1
106666|NCT01369615|257021|P2|NOT COMPLETED|Overall Study||2
106667|NCT01369615|257022|P1|NOT COMPLETED|Overall Study||0
106668|NCT01369615|257021|P2|COMPLETED|Overall Study||12
106669|NCT01369615|257022|P1|COMPLETED|Overall Study||9
106670|NCT01369615|257021|P2|STARTED|Overall Study||14
106671|NCT01369615|257022|P1|STARTED|Overall Study||9
106672|NCT01369485|257030|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
106673|NCT01369485|257031|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
106674|NCT01369485|257030|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
106675|NCT01369485|257031|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
106676|NCT01369485|257030|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
106677|NCT01369485|257031|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
106678|NCT01369485|257030|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
106679|NCT01369485|257031|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
106680|NCT01369485|257030|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
106681|NCT01369485|257031|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
106682|NCT01369485|257030|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
106683|NCT01369485|257031|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
106684|NCT01369355|257077|P6|NOT COMPLETED|Overall Study||272
106685|NCT01369355|257078|P5|NOT COMPLETED|Overall Study||154
106686|NCT01369355|257079|P4|NOT COMPLETED|Overall Study||30
106687|NCT01369355|257080|P3|NOT COMPLETED|Overall Study||31
106688|NCT01369355|257081|P2|NOT COMPLETED|Overall Study||29
106689|NCT01369355|257082|P1|NOT COMPLETED|Overall Study||31
106690|NCT01369355|257077|P6|COMPLETED|Overall Study||204
106691|NCT01369355|257078|P5|COMPLETED|Overall Study||131
106692|NCT01369355|257079|P4|COMPLETED|Overall Study||93
106693|NCT01369355|257080|P3|COMPLETED|Overall Study||101
106694|NCT01369355|257081|P2|COMPLETED|Overall Study||103
106695|NCT01369355|257082|P1|COMPLETED|Overall Study||102
106696|NCT01369355|257077|P6|Treated|Overall Study||476
106697|NCT01369355|257078|P5|Treated|Overall Study||285
106698|NCT01369355|257079|P4|Treated|Overall Study||123
106699|NCT01369355|257080|P3|Treated|Overall Study||131
106700|NCT01369355|257081|P2|Treated|Overall Study||132
106701|NCT01369355|257082|P1|Treated|Overall Study||133
106702|NCT01369355|257077|P6|STARTED|Overall Study||476
106703|NCT01369355|257078|P5|STARTED|Overall Study||285
106704|NCT01369355|257079|P4|STARTED|Overall Study||123
106705|NCT01369355|257080|P3|STARTED|Overall Study||132
106706|NCT01369355|257081|P2|STARTED|Overall Study||132
106707|NCT01369355|257082|P1|STARTED|Overall Study||133
106708|NCT01369342|257111|P3|NOT COMPLETED|Overall Study||3
106709|NCT01369342|257112|P2|NOT COMPLETED|Overall Study||9
106710|NCT01369342|257113|P1|NOT COMPLETED|Overall Study||13
106711|NCT01369342|257111|P3|COMPLETED|Overall Study||210
106712|NCT01369342|257112|P2|COMPLETED|Overall Study||204
106713|NCT01369342|257113|P1|COMPLETED|Overall Study||201
106714|NCT01369342|257111|P3|STARTED|Overall Study||213
106715|NCT01369342|257112|P2|STARTED|Overall Study||213
106716|NCT01369342|257113|P1|STARTED|Overall Study||214
106717|NCT01369329|257136|P3|NOT COMPLETED|Overall Study||14
106718|NCT01369329|257137|P2|NOT COMPLETED|Overall Study||11
106719|NCT01369329|257138|P1|NOT COMPLETED|Overall Study||12
106720|NCT01369329|257136|P3|COMPLETED|Overall Study||245
106721|NCT01369329|257137|P2|COMPLETED|Overall Study||243
106722|NCT01369329|257138|P1|COMPLETED|Overall Study||244
106723|NCT01369329|257136|P3|STARTED|Overall Study||259
106724|NCT01369329|257137|P2|STARTED|Overall Study||254
106725|NCT01369329|257138|P1|STARTED|Overall Study||256
106726|NCT01369225|257164|P6|NOT COMPLETED|Overall Study||0
106727|NCT01369225|257165|P5|NOT COMPLETED|Overall Study||2
106728|NCT01369225|257166|P4|NOT COMPLETED|Overall Study||2
106729|NCT01369225|257167|P3|NOT COMPLETED|Overall Study||3
106730|NCT01369225|257168|P2|NOT COMPLETED|Overall Study||0
106731|NCT01369225|257169|P1|NOT COMPLETED|Overall Study||2
106732|NCT01369225|257164|P6|COMPLETED|Overall Study||9
106733|NCT01369225|257165|P5|COMPLETED|Overall Study||10
106734|NCT01369225|257166|P4|COMPLETED|Overall Study||8
106735|NCT01369225|257167|P3|COMPLETED|Overall Study||9
106736|NCT01369225|257168|P2|COMPLETED|Overall Study||3
106737|NCT01369225|257169|P1|COMPLETED|Overall Study||4
106738|NCT01369225|257164|P6|STARTED|Overall Study||9
106739|NCT01369225|257165|P5|STARTED|Overall Study||12
106740|NCT01369225|257166|P4|STARTED|Overall Study||10
106741|NCT01369225|257167|P3|STARTED|Overall Study||12
106742|NCT01369225|257168|P2|STARTED|Overall Study||3
106743|NCT01369225|257169|P1|STARTED|Overall Study||6
106744|NCT01369108|257261|P1|NOT COMPLETED|Overall Study||11
106745|NCT01369108|257261|P1|COMPLETED|Overall Study||49
106746|NCT01369108|257261|P1|STARTED|Overall Study|120 teeth|60
106747|NCT01369030|257268|P1|NOT COMPLETED|Overall Study||40
106748|NCT01369030|257268|P1|COMPLETED|Overall Study||554
106749|NCT01369030|257268|P1|STARTED|Overall Study||594
106750|NCT01368965|257274|P1|NOT COMPLETED|Overall Study||12
106751|NCT01368965|257274|P1|COMPLETED|Overall Study||40
106752|NCT01368965|257274|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
106753|NCT01368965|257274|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
106754|NCT01368900|257283|P1|NOT COMPLETED|Overall Study||7
106755|NCT01368900|257283|P1|COMPLETED|Overall Study||61
106756|NCT01368900|257283|P1|STARTED|Overall Study||68
106757|NCT01368874|257296|P3|NOT COMPLETED|Overall Study||1
106758|NCT01368874|257297|P2|NOT COMPLETED|Overall Study||0
106759|NCT01368874|257298|P1|NOT COMPLETED|Overall Study||3
106760|NCT01368874|257296|P3|COMPLETED|Overall Study||24
106761|NCT01368874|257297|P2|COMPLETED|Overall Study||5
106762|NCT01368874|257298|P1|COMPLETED|Overall Study||31
106763|NCT01368874|257296|P3|STARTED|Overall Study||25
106764|NCT01368874|257297|P2|STARTED|Overall Study||5
106765|NCT01368874|257298|P1|STARTED|Overall Study||34
106766|NCT01368835|257358|P1|NOT COMPLETED|Overall Study||33
106767|NCT01368835|257358|P1|COMPLETED|Overall Study||70
106768|NCT01368835|257358|P1|STARTED|Overall Study|103 Subjects Enrolled|103
106769|NCT01368809|257367|P2|NOT COMPLETED|Overall Study||0
106770|NCT01368809|257368|P1|NOT COMPLETED|Overall Study||0
106771|NCT01368809|257367|P2|COMPLETED|Overall Study||50
106772|NCT01368809|257368|P1|COMPLETED|Overall Study||50
106773|NCT01368809|257367|P2|STARTED|Overall Study||50
106774|NCT01368809|257368|P1|STARTED|Overall Study||50
106775|NCT01368653|257380|P2|NOT COMPLETED|Overall Study||9
106776|NCT01368653|257381|P1|NOT COMPLETED|Overall Study||6
106777|NCT01368653|257380|P2|COMPLETED|Overall Study||37
106778|NCT01368653|257381|P1|COMPLETED|Overall Study||41
106779|NCT01368653|257380|P2|Randomized to Advice Only in Phase 2|Overall Study||10
106780|NCT01368653|257381|P1|Randomized to Advice Only in Phase 2|Overall Study||10
106781|NCT01368653|257380|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
106782|NCT01368653|257381|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
106783|NCT01368653|257380|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
106784|NCT01368653|257381|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
106785|NCT01368653|257380|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
106786|NCT01368653|257381|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
106787|NCT01368653|257380|P2|Completed 4-week Follow-up|Overall Study||37
106788|NCT01368653|257381|P1|Completed 4-week Follow-up|Overall Study||44
106789|NCT01368653|257380|P2|STARTED|Overall Study||46
106790|NCT01368653|257381|P1|STARTED|Overall Study||47
106791|NCT01368536|257400|P3|NOT COMPLETED|Overall Study||59
106792|NCT01368536|257401|P2|NOT COMPLETED|Overall Study||59
106793|NCT01368536|257402|P1|NOT COMPLETED|Overall Study||51
106794|NCT01368536|257400|P3|COMPLETED|Overall Study||83
106795|NCT01368536|257401|P2|COMPLETED|Overall Study||78
106796|NCT01368536|257402|P1|COMPLETED|Overall Study||87
106797|NCT01368536|257400|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
106798|NCT01368536|257401|P2|Full Analysis Set|Overall Study||137
106799|NCT01368536|257402|P1|Full Analysis Set|Overall Study||138
106800|NCT01368536|257400|P3|STARTED|Overall Study||142
106801|NCT01368536|257401|P2|STARTED|Overall Study||137
106802|NCT01368536|257402|P1|STARTED|Overall Study||138
106803|NCT01368432|257425|P2|NOT COMPLETED|Overall Study||1
106804|NCT01368432|257426|P1|NOT COMPLETED|Overall Study||0
106805|NCT01368432|257425|P2|COMPLETED|Overall Study||7
106806|NCT01368432|257426|P1|COMPLETED|Overall Study||6
106807|NCT01368432|257425|P2|STARTED|Overall Study||8
106808|NCT01368432|257426|P1|STARTED|Overall Study||6
106809|NCT01368406|257460|P2|NOT COMPLETED|Overall Study||13
106810|NCT01368406|257461|P1|NOT COMPLETED|Overall Study||21
106811|NCT01368406|257460|P2|COMPLETED|Overall Study||66
106812|NCT01368406|257461|P1|COMPLETED|Overall Study||60
106813|NCT01368406|257460|P2|STARTED|Overall Study||79
106814|NCT01368406|257461|P1|STARTED|Overall Study||81
106815|NCT01368276|257469|P2|NOT COMPLETED|Overall Study||10
106816|NCT01368276|257470|P1|NOT COMPLETED|Overall Study||1
106817|NCT01368276|257469|P2|COMPLETED|Overall Study||18
106818|NCT01368276|257470|P1|COMPLETED|Overall Study||2
106819|NCT01368276|257469|P2|STARTED|Overall Study||28
106820|NCT01368276|257470|P1|STARTED|Overall Study||3
106821|NCT01368263|257483|P3|NOT COMPLETED|Overall Study||0
106822|NCT01368263|257484|P2|NOT COMPLETED|Overall Study||0
106823|NCT01368263|257485|P1|NOT COMPLETED|Overall Study||0
106824|NCT01368263|257483|P3|COMPLETED|Overall Study||1
106825|NCT01368263|257484|P2|COMPLETED|Overall Study||1
106826|NCT01368263|257485|P1|COMPLETED|Overall Study||6
106827|NCT01368263|257483|P3|STARTED|Overall Study||1
106828|NCT01368263|257484|P2|STARTED|Overall Study||1
106829|NCT01368263|257485|P1|STARTED|Overall Study||6
106830|NCT01368211|257507|P2|NOT COMPLETED|Second Platelets Transfusion||2
106831|NCT01368211|257508|P1|NOT COMPLETED|Second Platelets Transfusion||1
106832|NCT01368211|257507|P2|COMPLETED|Second Platelets Transfusion||5
106833|NCT01368211|257508|P1|COMPLETED|Second Platelets Transfusion||7
106834|NCT01368211|257507|P2|STARTED|Second Platelets Transfusion||7
106835|NCT01368211|257508|P1|STARTED|Second Platelets Transfusion||8
106836|NCT01368211|257507|P2|NOT COMPLETED|First Platelets Transfusion||0
106837|NCT01368211|257508|P1|NOT COMPLETED|First Platelets Transfusion||0
106838|NCT01368211|257507|P2|COMPLETED|First Platelets Transfusion||7
106839|NCT01368211|257508|P1|COMPLETED|First Platelets Transfusion||8
106840|NCT01368211|257507|P2|STARTED|First Platelets Transfusion||7
106841|NCT01368211|257508|P1|STARTED|First Platelets Transfusion||8
106842|NCT01368185|257516|P1|NOT COMPLETED|Overall Study||0
106843|NCT01368185|257516|P1|COMPLETED|Overall Study||1705
106844|NCT01368185|257516|P1|STARTED|Overall Study||1705
106845|NCT01368081|257536|P13|NOT COMPLETED|Overall Study||7
106846|NCT01368081|257537|P12|NOT COMPLETED|Overall Study||3
106847|NCT01368081|257538|P11|NOT COMPLETED|Overall Study||9
106848|NCT01368081|257539|P10|NOT COMPLETED|Overall Study||10
106849|NCT01368081|257540|P9|NOT COMPLETED|Overall Study||8
106850|NCT01368081|257541|P8|NOT COMPLETED|Overall Study||7
106851|NCT01368081|257542|P7|NOT COMPLETED|Overall Study||12
106852|NCT01368081|257543|P6|NOT COMPLETED|Overall Study||10
106853|NCT01368081|257544|P5|NOT COMPLETED|Overall Study||2
106854|NCT01368081|257545|P4|NOT COMPLETED|Overall Study||5
106855|NCT01368081|257546|P3|NOT COMPLETED|Overall Study||4
106856|NCT01368081|257547|P2|NOT COMPLETED|Overall Study||9
106857|NCT01368081|257548|P1|NOT COMPLETED|Overall Study||10
106858|NCT01368081|257536|P13|COMPLETED|Overall Study||63
106859|NCT01368081|257537|P12|COMPLETED|Overall Study||67
106860|NCT01368081|257538|P11|COMPLETED|Overall Study||62
106861|NCT01368081|257539|P10|COMPLETED|Overall Study||58
106862|NCT01368081|257540|P9|COMPLETED|Overall Study||62
106863|NCT01368081|257541|P8|COMPLETED|Overall Study||62
106864|NCT01368081|257542|P7|COMPLETED|Overall Study||124
106865|NCT01368081|257543|P6|COMPLETED|Overall Study||127
106866|NCT01368081|257544|P5|COMPLETED|Overall Study||63
106867|NCT01368081|257545|P4|COMPLETED|Overall Study||63
106868|NCT01368081|257546|P3|COMPLETED|Overall Study||59
106869|NCT01368081|257547|P2|COMPLETED|Overall Study||128
106870|NCT01368081|257548|P1|COMPLETED|Overall Study||126
106871|NCT01368081|257536|P13|STARTED|Overall Study||70
106872|NCT01368081|257537|P12|STARTED|Overall Study||70
106873|NCT01368081|257538|P11|STARTED|Overall Study||71
106874|NCT01368081|257539|P10|STARTED|Overall Study||68
106875|NCT01368081|257540|P9|STARTED|Overall Study||70
106876|NCT01368081|257541|P8|STARTED|Overall Study||69
106877|NCT01368081|257542|P7|STARTED|Overall Study||136
106878|NCT01368081|257543|P6|STARTED|Overall Study||137
106879|NCT01368081|257544|P5|STARTED|Overall Study||65
106880|NCT01368081|257545|P4|STARTED|Overall Study||68
106881|NCT01368081|257546|P3|STARTED|Overall Study||63
106882|NCT01368081|257547|P2|STARTED|Overall Study||137
106883|NCT01368081|257548|P1|STARTED|Overall Study||136
106884|NCT01368042|257602|P1|NOT COMPLETED|Overall Study||30
106885|NCT01368042|257602|P1|COMPLETED|Overall Study||235
106886|NCT01368042|257602|P1|STARTED|Overall Study||265
106887|NCT01367886|257622|P1|NOT COMPLETED|Overall Study||7
106888|NCT01367886|257622|P1|COMPLETED|Overall Study||14
106889|NCT01367886|257622|P1|STARTED|Overall Study||21
106890|NCT01367860|257631|P2|NOT COMPLETED|Overall Study||0
106891|NCT01367860|257632|P1|NOT COMPLETED|Overall Study||0
106892|NCT01367860|257631|P2|COMPLETED|Overall Study||20
106893|NCT01367860|257632|P1|COMPLETED|Overall Study||20
106894|NCT01367860|257631|P2|STARTED|Overall Study||20
106895|NCT01367860|257632|P1|STARTED|Overall Study||20
106896|NCT01367834|257672|P2|NOT COMPLETED|Overall Study||3
106897|NCT01367834|257673|P1|NOT COMPLETED|Overall Study||2
106898|NCT01367834|257672|P2|COMPLETED|Overall Study||3
106899|NCT01367834|257673|P1|COMPLETED|Overall Study||9
106900|NCT01367834|257672|P2|STARTED|Overall Study||6
106901|NCT01367834|257673|P1|STARTED|Overall Study||11
106902|NCT01367704|257697|P2|NOT COMPLETED|Overall Study||161
106903|NCT01367704|257698|P1|NOT COMPLETED|Overall Study||47
106904|NCT01367704|257697|P2|COMPLETED|Overall Study||847
106905|NCT01367704|257698|P1|COMPLETED|Overall Study||951
106906|NCT01367704|257697|P2|STARTED|Overall Study||1008
106907|NCT01367704|257698|P1|STARTED|Overall Study||998
106908|NCT01367457|257711|P3|NOT COMPLETED|Overall Study||0
106909|NCT01367457|257712|P2|NOT COMPLETED|Overall Study||0
106910|NCT01367457|257713|P1|NOT COMPLETED|Overall Study||188
106911|NCT01367457|257711|P3|COMPLETED|Overall Study||26
106912|NCT01367457|257712|P2|COMPLETED|Overall Study||23
106913|NCT01367457|257713|P1|COMPLETED|Overall Study||5
106914|NCT01367457|257711|P3|STARTED|Overall Study||26
106915|NCT01367457|257712|P2|STARTED|Overall Study||23
106916|NCT01367457|257713|P1|STARTED|Overall Study||193
106917|NCT01367249|257735|P2|NOT COMPLETED|Overall Study||16
106918|NCT01367249|257736|P1|NOT COMPLETED|Overall Study||9
106919|NCT01367249|257735|P2|COMPLETED|Overall Study||202
106920|NCT01367249|257736|P1|COMPLETED|Overall Study||213
106921|NCT01367249|257735|P2|STARTED|Overall Study||218
106922|NCT01367249|257736|P1|STARTED|Overall Study||222
106923|NCT01367158|257755|P11|NOT COMPLETED|Overall Study||1
106924|NCT01367158|257756|P10|NOT COMPLETED|Overall Study||0
106925|NCT01367158|257757|P9|NOT COMPLETED|Overall Study||0
106926|NCT01367158|257758|P8|NOT COMPLETED|Overall Study||2
106927|NCT01367158|257759|P7|NOT COMPLETED|Overall Study||0
106928|NCT01367158|257760|P6|NOT COMPLETED|Overall Study||2
106929|NCT01367158|257761|P5|NOT COMPLETED|Overall Study||2
106930|NCT01367158|257762|P4|NOT COMPLETED|Overall Study||1
106931|NCT01367158|257763|P3|NOT COMPLETED|Overall Study||1
106932|NCT01367158|257764|P2|NOT COMPLETED|Overall Study||3
106933|NCT01367158|257765|P1|NOT COMPLETED|Overall Study||0
106934|NCT01367158|257755|P11|COMPLETED|Overall Study||72
106935|NCT01367158|257756|P10|COMPLETED|Overall Study||50
106936|NCT01367158|257757|P9|COMPLETED|Overall Study||23
106937|NCT01367158|257758|P8|COMPLETED|Overall Study||47
106938|NCT01367158|257759|P7|COMPLETED|Overall Study||25
106939|NCT01367158|257760|P6|COMPLETED|Overall Study||46
106940|NCT01367158|257761|P5|COMPLETED|Overall Study||23
106941|NCT01367158|257762|P4|COMPLETED|Overall Study||48
106942|NCT01367158|257763|P3|COMPLETED|Overall Study||23
106943|NCT01367158|257764|P2|COMPLETED|Overall Study||46
106944|NCT01367158|257765|P1|COMPLETED|Overall Study||25
106945|NCT01367158|257755|P11|STARTED|Overall Study||73
106946|NCT01367158|257756|P10|STARTED|Overall Study||50
106947|NCT01367158|257757|P9|STARTED|Overall Study||23
106948|NCT01367158|257758|P8|STARTED|Overall Study||49
106949|NCT01367158|257759|P7|STARTED|Overall Study||25
106950|NCT01367158|257760|P6|STARTED|Overall Study||48
106951|NCT01367158|257761|P5|STARTED|Overall Study||25
106952|NCT01367158|257762|P4|STARTED|Overall Study||49
106953|NCT01367158|257763|P3|STARTED|Overall Study||24
106954|NCT01367158|257764|P2|STARTED|Overall Study||49
106955|NCT01367158|257765|P1|STARTED|Overall Study||25
106956|NCT01367119|257909|P2|NOT COMPLETED|Overall Study||1
106957|NCT01367119|257910|P1|NOT COMPLETED|Overall Study||2
106958|NCT01367119|257909|P2|COMPLETED|Overall Study||16
106959|NCT01367119|257910|P1|COMPLETED|Overall Study||19
106960|NCT01367119|257909|P2|STARTED|Overall Study||17
106961|NCT01367119|257910|P1|STARTED|Overall Study||21
106962|NCT01367080|257922|P2|NOT COMPLETED|2nd Administration||0
106963|NCT01367080|257923|P1|NOT COMPLETED|2nd Administration||0
106964|NCT01367080|257922|P2|COMPLETED|2nd Administration||6
106965|NCT01367080|257923|P1|COMPLETED|2nd Administration||6
106966|NCT01367080|257922|P2|STARTED|2nd Administration||6
106967|NCT01367080|257923|P1|STARTED|2nd Administration||6
106968|NCT01367080|257922|P2|NOT COMPLETED|1st Administration||0
106969|NCT01367080|257923|P1|NOT COMPLETED|1st Administration||0
106970|NCT01367080|257922|P2|COMPLETED|1st Administration||6
106971|NCT01367080|257923|P1|COMPLETED|1st Administration||6
106972|NCT01367080|257922|P2|STARTED|1st Administration||6
106973|NCT01367080|257923|P1|STARTED|1st Administration||6
106974|NCT01366976|257937|P2|NOT COMPLETED|Overall Study||0
106975|NCT01366976|257938|P1|NOT COMPLETED|Overall Study||0
106976|NCT01366976|257937|P2|COMPLETED|Overall Study||30
106977|NCT01366976|257938|P1|COMPLETED|Overall Study||30
106978|NCT01366976|257937|P2|STARTED|Overall Study||30
106979|NCT01366976|257938|P1|STARTED|Overall Study||30
106980|NCT01366885|257950|P1|NOT COMPLETED|Overall Study||1
106981|NCT01366885|257950|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
106982|NCT01366885|257950|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
106983|NCT01366872|257955|P1|NOT COMPLETED|Overall Study||0
106984|NCT01366872|257955|P1|COMPLETED|Overall Study||50
106985|NCT01366872|257955|P1|STARTED|Overall Study||50
106986|NCT01366846|257965|P4|NOT COMPLETED|Overall Study||1
106987|NCT01366846|257966|P3|NOT COMPLETED|Overall Study||1
106988|NCT01366846|257967|P2|NOT COMPLETED|Overall Study||4
106989|NCT01366846|257968|P1|NOT COMPLETED|Overall Study||3
106990|NCT01366846|257965|P4|COMPLETED|Overall Study||45
106991|NCT01366846|257966|P3|COMPLETED|Overall Study||46
106992|NCT01366846|257967|P2|COMPLETED|Overall Study||224
106993|NCT01366846|257968|P1|COMPLETED|Overall Study||232
106994|NCT01366846|257965|P4|STARTED|Overall Study||46
106995|NCT01366846|257966|P3|STARTED|Overall Study||47
106996|NCT01366846|257967|P2|STARTED|Overall Study||228
106997|NCT01366846|257968|P1|STARTED|Overall Study||235
106998|NCT01366638|257991|P3|NOT COMPLETED|Overall Study||6
106999|NCT01366638|257992|P2|NOT COMPLETED|Overall Study||0
107000|NCT01366638|257993|P1|NOT COMPLETED|Overall Study||1
107001|NCT01366638|257991|P3|COMPLETED|Overall Study||20
107002|NCT01366638|257992|P2|COMPLETED|Overall Study||29
107003|NCT01366638|257993|P1|COMPLETED|Overall Study||23
107004|NCT01366638|257991|P3|STARTED|Overall Study||26
107005|NCT01366638|257992|P2|STARTED|Overall Study||29
107006|NCT01366638|257993|P1|STARTED|Overall Study||24
107007|NCT01366534|258030|P3|NOT COMPLETED|Overall Study||0
107008|NCT01366534|258031|P2|NOT COMPLETED|Overall Study||2
107009|NCT01366534|258032|P1|NOT COMPLETED|Overall Study||2
107010|NCT01366534|258030|P3|COMPLETED|Overall Study||12
107011|NCT01366534|258031|P2|COMPLETED|Overall Study||25
107012|NCT01366534|258032|P1|COMPLETED|Overall Study||26
107013|NCT01366534|258030|P3|STARTED|Overall Study||12
107014|NCT01366534|258031|P2|STARTED|Overall Study||27
107015|NCT01366534|258032|P1|STARTED|Overall Study||28
107016|NCT01366521|258082|P4|NOT COMPLETED|Overall Study||0
107017|NCT01366521|258083|P3|NOT COMPLETED|Overall Study||2
107018|NCT01366521|258084|P2|NOT COMPLETED|Overall Study||1
107019|NCT01366521|258085|P1|NOT COMPLETED|Overall Study||1
107020|NCT01366521|258082|P4|COMPLETED|Overall Study||11
107021|NCT01366521|258083|P3|COMPLETED|Overall Study||21
107022|NCT01366521|258084|P2|COMPLETED|Overall Study||14
107023|NCT01366521|258085|P1|COMPLETED|Overall Study||20
107024|NCT01366521|258082|P4|STARTED|Overall Study||11
107025|NCT01366521|258083|P3|STARTED|Overall Study||23
107026|NCT01366521|258084|P2|STARTED|Overall Study||15
107027|NCT01366521|258085|P1|STARTED|Overall Study||21
107028|NCT01366443|258160|P1|NOT COMPLETED|Overall Study||3
107029|NCT01366443|258160|P1|COMPLETED|Overall Study||285
107030|NCT01366443|258160|P1|STARTED|Overall Study||288
107031|NCT01366417|258165|P1|NOT COMPLETED|Overall Study||18
107032|NCT01366417|258165|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
107033|NCT01366417|258165|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
107034|NCT01366417|258165|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
107035|NCT01366417|258165|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
107036|NCT01366417|258165|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
107037|NCT01366417|258165|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
107038|NCT01366417|258165|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
107039|NCT01366417|258165|P1|STARTED|Overall Study||43
107040|NCT01366209|258174|P2|NOT COMPLETED|Overall Study||36
107041|NCT01366209|258175|P1|NOT COMPLETED|Overall Study||35
107042|NCT01366209|258174|P2|COMPLETED|Overall Study||241
107043|NCT01366209|258175|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
107044|NCT01366209|258174|P2|STARTED|Overall Study||277
107045|NCT01366209|258175|P1|STARTED|Overall Study||278
107046|NCT01366196|258183|P2|NOT COMPLETED|Overall Study||0
107047|NCT01366196|258184|P1|NOT COMPLETED|Overall Study||0
107048|NCT01366196|258183|P2|COMPLETED|Overall Study||43
107049|NCT01366196|258184|P1|COMPLETED|Overall Study||43
107050|NCT01366196|258183|P2|STARTED|Overall Study||43
107051|NCT01366196|258184|P1|STARTED|Overall Study||43
107052|NCT01366092|258198|P1|NOT COMPLETED|Overall Study||4
107053|NCT01366092|258198|P1|COMPLETED|Overall Study||31
107054|NCT01366092|258198|P1|STARTED|Overall Study||35
107055|NCT01365910|258207|P1|NOT COMPLETED|Overall Study||30
107056|NCT01365910|258207|P1|COMPLETED|Overall Study||0
107057|NCT01365910|258207|P1|STARTED|Overall Study||30
107058|NCT01365845|258214|P3|NOT COMPLETED|Treatment Phase||0
107059|NCT01365845|258215|P2|NOT COMPLETED|Treatment Phase||0
107060|NCT01365845|258216|P1|NOT COMPLETED|Treatment Phase||0
107061|NCT01365845|258214|P3|COMPLETED|Treatment Phase||18
107062|NCT01365845|258215|P2|COMPLETED|Treatment Phase||0
107063|NCT01365845|258216|P1|COMPLETED|Treatment Phase||0
107064|NCT01365845|258214|P3|STARTED|Treatment Phase||18
107065|NCT01365845|258215|P2|STARTED|Treatment Phase||0
107066|NCT01365845|258216|P1|STARTED|Treatment Phase||0
107067|NCT01365845|258214|P3|NOT COMPLETED|Induction Phase||0
107068|NCT01365845|258215|P2|NOT COMPLETED|Induction Phase||0
107069|NCT01365845|258216|P1|NOT COMPLETED|Induction Phase||0
107070|NCT01365845|258214|P3|COMPLETED|Induction Phase||0
107071|NCT01365845|258215|P2|COMPLETED|Induction Phase||0
107072|NCT01365845|258216|P1|COMPLETED|Induction Phase||18
107073|NCT01365845|258214|P3|STARTED|Induction Phase||0
107074|NCT01365845|258215|P2|STARTED|Induction Phase||0
107075|NCT01365845|258216|P1|STARTED|Induction Phase||18
107076|NCT01365819|258223|P2|NOT COMPLETED|Overall Study||13
107077|NCT01365819|258224|P1|NOT COMPLETED|Overall Study||13
107078|NCT01365819|258223|P2|COMPLETED|Overall Study||14
107079|NCT01365819|258224|P1|COMPLETED|Overall Study||12
107080|NCT01365819|258223|P2|STARTED|Overall Study||27
107081|NCT01365819|258224|P1|STARTED|Overall Study||25
107082|NCT01365650|258238|P1|NOT COMPLETED|Treatment C||0
107083|NCT01365650|258238|P1|COMPLETED|Treatment C||24
107084|NCT01365650|258238|P1|STARTED|Treatment C||24
107085|NCT01365650|258238|P1|NOT COMPLETED|Treatment B||0
107086|NCT01365650|258238|P1|COMPLETED|Treatment B||24
107087|NCT01365650|258238|P1|STARTED|Treatment B||24
107088|NCT01365650|258238|P1|NOT COMPLETED|Treatment A||0
107089|NCT01365650|258238|P1|COMPLETED|Treatment A||24
107090|NCT01365650|258238|P1|STARTED|Treatment A||24
107091|NCT01365624|258263|P2|NOT COMPLETED|Overall Study||0
107092|NCT01365624|258264|P1|NOT COMPLETED|Overall Study||0
107093|NCT01365624|258263|P2|COMPLETED|Overall Study||15
107094|NCT01365624|258264|P1|COMPLETED|Overall Study||15
107095|NCT01365624|258263|P2|STARTED|Overall Study||15
107096|NCT01365624|258264|P1|STARTED|Overall Study||15
107097|NCT01365611|258280|P1|NOT COMPLETED|Overall Study||0
107098|NCT01365611|258280|P1|COMPLETED|Overall Study||36
107099|NCT01365611|258280|P1|STARTED|Overall Study||36
107100|NCT01365585|258296|P1|NOT COMPLETED|Overall Study||0
107101|NCT01365585|258296|P1|COMPLETED|Overall Study||227
107102|NCT01365585|258296|P1|STARTED|Overall Study||227
107103|NCT01365546|258310|P1|NOT COMPLETED|Overall Study||11
107104|NCT01365546|258310|P1|COMPLETED|Overall Study||30
107105|NCT01365546|258310|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
107106|NCT01365507|258320|P2|NOT COMPLETED|Overall Study||9
107107|NCT01365507|258321|P1|NOT COMPLETED|Overall Study||9
107108|NCT01365507|258320|P2|COMPLETED|Overall Study||131
107109|NCT01365507|258321|P1|COMPLETED|Overall Study||127
107110|NCT01365507|258320|P2|Exposed|Overall Study||140
107111|NCT01365507|258321|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
107112|NCT01365507|258320|P2|STARTED|Overall Study||140
107113|NCT01365507|258321|P1|STARTED|Overall Study||136
107114|NCT01365494|258337|P2|NOT COMPLETED|Overall Study||3
107115|NCT01365494|258338|P1|NOT COMPLETED|Overall Study||2
107116|NCT01365494|258337|P2|COMPLETED|Overall Study||121
107117|NCT01365494|258338|P1|COMPLETED|Overall Study||124
107118|NCT01365494|258337|P2|STARTED|Overall Study||124
107119|NCT01365494|258338|P1|STARTED|Overall Study||126
107120|NCT01365481|258354|P4|NOT COMPLETED|Overall Study||7
107121|NCT01365481|258355|P3|NOT COMPLETED|Overall Study||4
107122|NCT01365481|258356|P2|NOT COMPLETED|Overall Study||15
107123|NCT01365481|258357|P1|NOT COMPLETED|Overall Study||7
107124|NCT01365481|258354|P4|COMPLETED|Overall Study||50
107125|NCT01365481|258355|P3|COMPLETED|Overall Study||14
107126|NCT01365481|258356|P2|COMPLETED|Overall Study||37
107127|NCT01365481|258357|P1|COMPLETED|Overall Study||16
107128|NCT01365481|258354|P4|STARTED|Overall Study||57
107129|NCT01365481|258355|P3|STARTED|Overall Study||18
107130|NCT01365481|258356|P2|STARTED|Overall Study||52
107131|NCT01365481|258357|P1|STARTED|Overall Study||23
107132|NCT01365468|258377|P2|NOT COMPLETED|Overall Study||0
107133|NCT01365468|258378|P1|NOT COMPLETED|Overall Study||4
107134|NCT01365468|258377|P2|COMPLETED|Overall Study||5
107135|NCT01365468|258378|P1|COMPLETED|Overall Study||0
107136|NCT01365468|258377|P2|STARTED|Overall Study||5
107137|NCT01365468|258378|P1|STARTED|Overall Study||4
107138|NCT01365455|258393|P5|NOT COMPLETED|Follow-up Period||0
107139|NCT01365455|258394|P4|NOT COMPLETED|Follow-up Period||0
107140|NCT01365455|258395|P3|NOT COMPLETED|Follow-up Period||0
107141|NCT01365455|258396|P2|NOT COMPLETED|Follow-up Period||0
107142|NCT01365455|258397|P1|NOT COMPLETED|Follow-up Period||0
107143|NCT01365455|258393|P5|COMPLETED|Follow-up Period||0
107144|NCT01365455|258394|P4|COMPLETED|Follow-up Period||0
107145|NCT01365455|258395|P3|COMPLETED|Follow-up Period||18
107146|NCT01365455|258396|P2|COMPLETED|Follow-up Period||47
107147|NCT01365455|258397|P1|COMPLETED|Follow-up Period||58
107148|NCT01365455|258393|P5|STARTED|Follow-up Period||0
107149|NCT01365455|258394|P4|STARTED|Follow-up Period||0
107150|NCT01365455|258395|P3|STARTED|Follow-up Period||18
107151|NCT01365455|258396|P2|STARTED|Follow-up Period||47
107152|NCT01365455|258397|P1|STARTED|Follow-up Period||58
107153|NCT01365455|258393|P5|NOT COMPLETED|Maintenance Period||13
107154|NCT01365455|258394|P4|NOT COMPLETED|Maintenance Period||9
107155|NCT01365455|258395|P3|NOT COMPLETED|Maintenance Period||3
107156|NCT01365455|258396|P2|NOT COMPLETED|Maintenance Period||23
107157|NCT01365455|258397|P1|NOT COMPLETED|Maintenance Period||29
107158|NCT01365455|258393|P5|COMPLETED|Maintenance Period||92
107159|NCT01365455|258394|P4|COMPLETED|Maintenance Period||100
107160|NCT01365455|258395|P3|COMPLETED|Maintenance Period||15
107161|NCT01365455|258396|P2|COMPLETED|Maintenance Period||215
107162|NCT01365455|258397|P1|COMPLETED|Maintenance Period||201
107163|NCT01365455|258393|P5|STARTED|Maintenance Period||105
107164|NCT01365455|258394|P4|STARTED|Maintenance Period||109
107165|NCT01365455|258395|P3|STARTED|Maintenance Period||18
107166|NCT01365455|258396|P2|STARTED|Maintenance Period||238
107167|NCT01365455|258397|P1|STARTED|Maintenance Period||230
107168|NCT01365455|258393|P5|NOT COMPLETED|Induction Period||0
107169|NCT01365455|258394|P4|NOT COMPLETED|Induction Period||0
107170|NCT01365455|258395|P3|NOT COMPLETED|Induction Period||16
107171|NCT01365455|258396|P2|NOT COMPLETED|Induction Period||7
107172|NCT01365455|258397|P1|NOT COMPLETED|Induction Period||15
107173|NCT01365455|258393|P5|COMPLETED|Induction Period||0
107174|NCT01365455|258394|P4|COMPLETED|Induction Period||0
107175|NCT01365455|258395|P3|COMPLETED|Induction Period||232
107176|NCT01365455|258396|P2|COMPLETED|Induction Period||238
107177|NCT01365455|258397|P1|COMPLETED|Induction Period||230
107178|NCT01365455|258393|P5|STARTED|Induction Period||0
107179|NCT01365455|258394|P4|STARTED|Induction Period||0
107180|NCT01365455|258395|P3|STARTED|Induction Period||248
107181|NCT01365455|258396|P2|STARTED|Induction Period||245
107182|NCT01365455|258397|P1|STARTED|Induction Period||245
107183|NCT01365273|258487|P2|NOT COMPLETED|Overall Study||1
107184|NCT01365273|258488|P1|NOT COMPLETED|Overall Study||2
107185|NCT01365273|258487|P2|COMPLETED|Overall Study||20
107186|NCT01365273|258488|P1|COMPLETED|Overall Study||20
107187|NCT01365273|258487|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
107188|NCT01365273|258488|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
107189|NCT01365273|258487|P2|STARTED|Overall Study||21
107190|NCT01365273|258488|P1|STARTED|Overall Study||22
107191|NCT01365130|258498|P1|NOT COMPLETED|Overall Study||2
107192|NCT01365130|258498|P1|COMPLETED|Overall Study||13
107193|NCT01365130|258498|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
107194|NCT01365091|258507|P4|NOT COMPLETED|Period 2||0
107195|NCT01365091|258508|P3|NOT COMPLETED|Period 2||1
107196|NCT01365091|258509|P2|NOT COMPLETED|Period 2||0
107197|NCT01365091|258510|P1|NOT COMPLETED|Period 2||1
107198|NCT01365091|258507|P4|COMPLETED|Period 2||25
107199|NCT01365091|258508|P3|COMPLETED|Period 2||24
107200|NCT01365091|258509|P2|COMPLETED|Period 2||26
107201|NCT01365091|258510|P1|COMPLETED|Period 2||25
107202|NCT01365091|258507|P4|STARTED|Period 2||25
107203|NCT01365091|258508|P3|STARTED|Period 2||25
107204|NCT01365091|258509|P2|STARTED|Period 2||26
107205|NCT01365091|258510|P1|STARTED|Period 2||26
107206|NCT01365091|258507|P4|NOT COMPLETED|Period 1||3
107207|NCT01365091|258508|P3|NOT COMPLETED|Period 1||3
107208|NCT01365091|258509|P2|NOT COMPLETED|Period 1||2
107209|NCT01365091|258510|P1|NOT COMPLETED|Period 1||2
107210|NCT01365091|258507|P4|COMPLETED|Period 1||25
107211|NCT01365091|258508|P3|COMPLETED|Period 1||25
107212|NCT01365091|258509|P2|COMPLETED|Period 1||26
107213|NCT01365091|258510|P1|COMPLETED|Period 1||26
107214|NCT01365091|258507|P4|STARTED|Period 1||28
107215|NCT01365091|258508|P3|STARTED|Period 1||28
107216|NCT01365091|258509|P2|STARTED|Period 1||28
107217|NCT01365091|258510|P1|STARTED|Period 1||28
107218|NCT01365052|258538|P2|NOT COMPLETED|Overall Study||4
107219|NCT01365052|258539|P1|NOT COMPLETED|Overall Study||4
107220|NCT01365052|258538|P2|COMPLETED|Overall Study||105
107221|NCT01365052|258539|P1|COMPLETED|Overall Study||213
107222|NCT01365052|258538|P2|STARTED|Overall Study||109
107223|NCT01365052|258539|P1|STARTED|Overall Study||217
107224|NCT01365039|258555|P2|NOT COMPLETED|Overall Study||0
107225|NCT01365039|258556|P1|NOT COMPLETED|Overall Study||1
107226|NCT01365039|258555|P2|COMPLETED|Overall Study||87
107227|NCT01365039|258556|P1|COMPLETED|Overall Study||85
107228|NCT01365039|258555|P2|STARTED|Overall Study||87
107229|NCT01365039|258556|P1|STARTED|Overall Study||86
107230|NCT01364922|258567|P3|NOT COMPLETED|Double-Blind (DB) Period||5
107231|NCT01364922|258568|P2|NOT COMPLETED|Double-Blind (DB) Period||5
107232|NCT01364922|258569|P1|NOT COMPLETED|Double-Blind (DB) Period||0
107233|NCT01364922|258567|P3|COMPLETED|Double-Blind (DB) Period||42
107234|NCT01364922|258568|P2|COMPLETED|Double-Blind (DB) Period||94
107235|NCT01364922|258569|P1|COMPLETED|Double-Blind (DB) Period||0
107236|NCT01364922|258567|P3|STARTED|Double-Blind (DB) Period||47
107237|NCT01364922|258568|P2|STARTED|Double-Blind (DB) Period||99
107238|NCT01364922|258569|P1|STARTED|Double-Blind (DB) Period||0
107239|NCT01364922|258567|P3|NOT COMPLETED|Open-label (OL) Period||0
107240|NCT01364922|258568|P2|NOT COMPLETED|Open-label (OL) Period||0
107241|NCT01364922|258569|P1|NOT COMPLETED|Open-label (OL) Period||22
107242|NCT01364922|258567|P3|COMPLETED|Open-label (OL) Period||0
107243|NCT01364922|258568|P2|COMPLETED|Open-label (OL) Period||0
107244|NCT01364922|258569|P1|COMPLETED|Open-label (OL) Period||146
107245|NCT01364922|258567|P3|STARTED|Open-label (OL) Period||0
107246|NCT01364922|258568|P2|STARTED|Open-label (OL) Period||0
107247|NCT01364922|258569|P1|STARTED|Open-label (OL) Period||168
107248|NCT01364896|258580|P1|NOT COMPLETED|Overall Study||0
107249|NCT01364896|258580|P1|COMPLETED|Overall Study||46
107250|NCT01364896|258580|P1|STARTED|Overall Study||46
107251|NCT01364870|258591|P3|NOT COMPLETED|Overall Study||14
107252|NCT01364870|258592|P2|NOT COMPLETED|Overall Study||30
107253|NCT01364870|258593|P1|NOT COMPLETED|Overall Study||22
107254|NCT01364870|258591|P3|COMPLETED|Overall Study||58
107255|NCT01364870|258592|P2|COMPLETED|Overall Study||93
107256|NCT01364870|258593|P1|COMPLETED|Overall Study||100
107257|NCT01364870|258591|P3|STARTED|Overall Study||72
107258|NCT01364870|258592|P2|STARTED|Overall Study||123
107259|NCT01364870|258593|P1|STARTED|Overall Study||122
107260|NCT01364740|258604|P1|NOT COMPLETED|Overall Study||0
107261|NCT01364740|258604|P1|COMPLETED|Overall Study||10
107262|NCT01364740|258604|P1|STARTED|Overall Study||10
107263|NCT01364727|258612|P1|NOT COMPLETED|Overall Study||2
107264|NCT01364727|258612|P1|COMPLETED|Overall Study||33
107265|NCT01364727|258612|P1|STARTED|Overall Study||35
107266|NCT01364649|258620|P2|NOT COMPLETED|Overall Study||43
107267|NCT01364649|258621|P1|NOT COMPLETED|Overall Study||56
107268|NCT01364649|258620|P2|COMPLETED|Overall Study||179
107269|NCT01364649|258621|P1|COMPLETED|Overall Study||169
107270|NCT01364649|258620|P2|STARTED|Overall Study||222
107271|NCT01364649|258621|P1|STARTED|Overall Study||225
107272|NCT01364558|258631|P3|NOT COMPLETED|Dose Three||0
107273|NCT01364558|258632|P2|NOT COMPLETED|Dose Three||0
107274|NCT01364558|258633|P1|NOT COMPLETED|Dose Three||0
107275|NCT01364558|258631|P3|COMPLETED|Dose Three||8
107276|NCT01364558|258632|P2|COMPLETED|Dose Three||8
107277|NCT01364558|258633|P1|COMPLETED|Dose Three||8
107278|NCT01364558|258631|P3|STARTED|Dose Three||8
107279|NCT01364558|258632|P2|STARTED|Dose Three||8
107280|NCT01364558|258633|P1|STARTED|Dose Three||8
107281|NCT01364558|258631|P3|NOT COMPLETED|Dose Two||0
107282|NCT01364558|258632|P2|NOT COMPLETED|Dose Two||0
107283|NCT01364558|258633|P1|NOT COMPLETED|Dose Two||0
107284|NCT01364558|258631|P3|COMPLETED|Dose Two||8
107285|NCT01364558|258632|P2|COMPLETED|Dose Two||8
107286|NCT01364558|258633|P1|COMPLETED|Dose Two||8
107287|NCT01364558|258631|P3|STARTED|Dose Two||8
107288|NCT01364558|258632|P2|STARTED|Dose Two||8
107289|NCT01364558|258633|P1|STARTED|Dose Two||8
107290|NCT01364558|258631|P3|NOT COMPLETED|Dose One||0
107291|NCT01364558|258632|P2|NOT COMPLETED|Dose One||0
107292|NCT01364558|258633|P1|NOT COMPLETED|Dose One||0
107293|NCT01364558|258631|P3|COMPLETED|Dose One||8
107294|NCT01364558|258632|P2|COMPLETED|Dose One||8
107295|NCT01364558|258633|P1|COMPLETED|Dose One||8
107296|NCT01364558|258631|P3|STARTED|Dose One||8
107297|NCT01364558|258632|P2|STARTED|Dose One||8
107298|NCT01364558|258633|P1|STARTED|Dose One||8
107299|NCT01364428|258643|P2|NOT COMPLETED|Overall Study||15
107300|NCT01364428|258644|P1|NOT COMPLETED|Overall Study||20
107301|NCT01364428|258643|P2|COMPLETED|Overall Study||172
107302|NCT01364428|258644|P1|COMPLETED|Overall Study||166
107303|NCT01364428|258643|P2|Exposed|Overall Study||187
107304|NCT01364428|258644|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
107305|NCT01364428|258643|P2|STARTED|Overall Study||187
107306|NCT01364428|258644|P1|STARTED|Overall Study||186
107307|NCT01364389|258661|P3|NOT COMPLETED|Overall Study||1
107308|NCT01364389|258662|P2|NOT COMPLETED|Overall Study||1
107309|NCT01364389|258663|P1|NOT COMPLETED|Overall Study||2
107310|NCT01364389|258661|P3|COMPLETED|Overall Study||4
107311|NCT01364389|258662|P2|COMPLETED|Overall Study||5
107312|NCT01364389|258663|P1|COMPLETED|Overall Study||3
107313|NCT01364389|258661|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
107314|NCT01364389|258662|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
107315|NCT01364389|258663|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
107316|NCT01364389|258661|P3|STARTED|Overall Study||5
107317|NCT01364389|258662|P2|STARTED|Overall Study||6
107318|NCT01364389|258663|P1|STARTED|Overall Study||5
107319|NCT01364298|258682|P2|NOT COMPLETED|Overall Study||23
107320|NCT01364298|258683|P1|NOT COMPLETED|Overall Study||14
107321|NCT01364298|258682|P2|COMPLETED|Overall Study||154
107322|NCT01364298|258683|P1|COMPLETED|Overall Study||162
107323|NCT01364298|258682|P2|Treated|Overall Study||174
107324|NCT01364298|258683|P1|Treated|Overall Study||174
107325|NCT01364298|258682|P2|STARTED|Overall Study||177
107326|NCT01364298|258683|P1|STARTED|Overall Study||176
107327|NCT01364259|258707|P2|NOT COMPLETED|Overall Study||0
107328|NCT01364259|258708|P1|NOT COMPLETED|Overall Study||0
107329|NCT01364259|258707|P2|COMPLETED|Overall Study||8
107330|NCT01364259|258708|P1|COMPLETED|Overall Study||9
107331|NCT01364259|258707|P2|STARTED|Overall Study||8
107332|NCT01364259|258708|P1|STARTED|Overall Study||9
107333|NCT01364207|258716|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
107334|NCT01364207|258717|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
107335|NCT01364207|258716|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
107336|NCT01364207|258717|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
107337|NCT01364207|258716|P2|STARTED|Second Visit (~1.5-2 Hours)||54
107338|NCT01364207|258717|P1|STARTED|Second Visit (~1.5-2 Hours)||52
107339|NCT01364207|258716|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
107340|NCT01364207|258717|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
107341|NCT01364207|258716|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
107342|NCT01364207|258717|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
107343|NCT01364207|258716|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
107344|NCT01364207|258717|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
107345|NCT01364207|258716|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
107346|NCT01364207|258717|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
107347|NCT01364207|258716|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
107348|NCT01364207|258717|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
107349|NCT01364207|258716|P2|STARTED|First Visit (~1.5-2 Hours)||58
107350|NCT01364207|258717|P1|STARTED|First Visit (~1.5-2 Hours)||54
107351|NCT01364090|258728|P3|NOT COMPLETED|Overall Study||6
107352|NCT01364090|258729|P2|NOT COMPLETED|Overall Study||3
107353|NCT01364090|258730|P1|NOT COMPLETED|Overall Study||14
107354|NCT01364090|258728|P3|COMPLETED|Overall Study||0
107355|NCT01364090|258729|P2|COMPLETED|Overall Study||58
107356|NCT01364090|258730|P1|COMPLETED|Overall Study||12
107357|NCT01364090|258728|P3|STARTED|Overall Study||6
107358|NCT01364090|258729|P2|STARTED|Overall Study||61
107359|NCT01364090|258730|P1|STARTED|Overall Study||26
107360|NCT01363986|258738|P1|NOT COMPLETED|Overall Study||1
107361|NCT01363986|258738|P1|COMPLETED|Overall Study||2
107362|NCT01363986|258738|P1|STARTED|Overall Study||3
107363|NCT01363908|258748|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
107364|NCT01363908|258749|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
107365|NCT01363908|258748|P2|COMPLETED|Chronic Dosing (CD) Phase||10
107366|NCT01363908|258749|P1|COMPLETED|Chronic Dosing (CD) Phase||3
107367|NCT01363908|258748|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
107368|NCT01363908|258749|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
107369|NCT01363908|258748|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
107370|NCT01363908|258749|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
107371|NCT01363908|258748|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
107372|NCT01363908|258749|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
107373|NCT01363908|258748|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
107374|NCT01363908|258749|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
107375|NCT01363908|258748|P2|NOT COMPLETED|Screening/Enrollment||0
107376|NCT01363908|258749|P1|NOT COMPLETED|Screening/Enrollment||1
107377|NCT01363908|258748|P2|COMPLETED|Screening/Enrollment||16
107378|NCT01363908|258749|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
107379|NCT01363908|258748|P2|STARTED|Screening/Enrollment||16
107380|NCT01363908|258749|P1|STARTED|Screening/Enrollment||14
107381|NCT01363843|258779|P1|NOT COMPLETED|Overall Study||1
107382|NCT01363843|258779|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
107383|NCT01363843|258779|P1|STARTED|Overall Study||39
107384|NCT01363765|258785|P2|NOT COMPLETED|Overall Study||4731
107385|NCT01363765|258786|P1|NOT COMPLETED|Overall Study||5800
107386|NCT01363765|258785|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
107387|NCT01363765|258786|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
107388|NCT01363765|258785|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
107389|NCT01363765|258786|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
107390|NCT01363713|258798|P1|NOT COMPLETED|Overall Study||6
107391|NCT01363713|258798|P1|COMPLETED|Overall Study|Analysed (n=130)|124
107392|NCT01363713|258798|P1|ALLOCATED|Overall Study||130
107393|NCT01363713|258798|P1|STARTED|Overall Study|Assessed for eligibility|130
107394|NCT01363700|258807|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
107395|NCT01363700|258808|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
107396|NCT01363700|258809|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
107397|NCT01363700|258810|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
107398|NCT01363700|258811|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
107399|NCT01363700|258807|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
107400|NCT01363700|258808|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
107401|NCT01363700|258809|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
107402|NCT01363700|258810|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
107403|NCT01363700|258811|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
107404|NCT01363700|258807|P5|STARTED|Epinastine vs Olopatadine Period2||43
107405|NCT01363700|258808|P4|STARTED|Epinastine vs Olopatadine Period2||43
107406|NCT01363700|258809|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
107407|NCT01363700|258810|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
107408|NCT01363700|258811|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
107409|NCT01363700|258807|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
107410|NCT01363700|258808|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
107411|NCT01363700|258809|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
107412|NCT01363700|258810|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
107413|NCT01363700|258811|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
107414|NCT01363700|258807|P5|COMPLETED|Epinastine vs Placebo Period1||0
107415|NCT01363700|258808|P4|COMPLETED|Epinastine vs Placebo Period1||0
107416|NCT01363700|258809|P3|COMPLETED|Epinastine vs Placebo Period1||22
107417|NCT01363700|258810|P2|COMPLETED|Epinastine vs Placebo Period1||21
107418|NCT01363700|258811|P1|COMPLETED|Epinastine vs Placebo Period1||43
107419|NCT01363700|258807|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
107420|NCT01363700|258808|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
107421|NCT01363700|258809|P3|STARTED|Epinastine vs Placebo Period1||22
107422|NCT01363700|258810|P2|STARTED|Epinastine vs Placebo Period1||22
107423|NCT01363700|258811|P1|STARTED|Epinastine vs Placebo Period1||43
107424|NCT01363661|258830|P2|NOT COMPLETED|Overall Study||4
107425|NCT01363661|258831|P1|NOT COMPLETED|Overall Study||14
107426|NCT01363661|258830|P2|COMPLETED|Overall Study||28
107427|NCT01363661|258831|P1|COMPLETED|Overall Study||18
107428|NCT01363661|258830|P2|STARTED|Overall Study||32
107429|NCT01363661|258831|P1|STARTED|Overall Study||32
107430|NCT01363492|258847|P1|NOT COMPLETED|Overall Study||0
107431|NCT01363492|258847|P1|COMPLETED|Overall Study||14
107432|NCT01363492|258847|P1|STARTED|Overall Study||14
107433|NCT01363479|258862|P2|NOT COMPLETED|Overall Study||21
107434|NCT01363479|258863|P1|NOT COMPLETED|Overall Study||12
107435|NCT01363479|258862|P2|COMPLETED|Overall Study||351
107436|NCT01363479|258863|P1|COMPLETED|Overall Study||359
107437|NCT01363479|258862|P2|STARTED|Overall Study|number of randomised patients|372
107438|NCT01363479|258863|P1|STARTED|Overall Study|number of randomised patients|371
107439|NCT01363440|258872|P3|NOT COMPLETED|Overall Study||27
107440|NCT01363440|258873|P2|NOT COMPLETED|Overall Study||31
107441|NCT01363440|258874|P1|NOT COMPLETED|Overall Study||23
107442|NCT01363440|258872|P3|COMPLETED|Overall Study|Completed Week 100|127
107443|NCT01363440|258873|P2|COMPLETED|Overall Study|Completed Week 100|125
107444|NCT01363440|258874|P1|COMPLETED|Overall Study|Completed Week 100|133
107445|NCT01363440|258872|P3|Completed Week 100|Overall Study||127
107446|NCT01363440|258873|P2|Completed Week 100|Overall Study||125
107447|NCT01363440|258874|P1|Completed Week 100|Overall Study||133
107448|NCT01363440|258872|P3|Completed Week 52|Overall Study||144
107449|NCT01363440|258873|P2|Completed Week 52|Overall Study||146
107450|NCT01363440|258874|P1|Completed Week 52|Overall Study||145
107451|NCT01363440|258872|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
107452|NCT01363440|258873|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
107453|NCT01363440|258874|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
107454|NCT01363440|258872|P3|STARTED|Overall Study|randomized|154
107455|NCT01363440|258873|P2|STARTED|Overall Study|randomized|156
107456|NCT01363440|258874|P1|STARTED|Overall Study|randomized|156
107457|NCT01363401|258905|P2|NOT COMPLETED|Overall Study||4
107458|NCT01363401|258906|P1|NOT COMPLETED|Overall Study||2
107459|NCT01363401|258905|P2|COMPLETED|Overall Study||27
107460|NCT01363401|258906|P1|COMPLETED|Overall Study||39
107461|NCT01363401|258905|P2|STARTED|Overall Study||31
107462|NCT01363401|258906|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
107463|NCT01363349|258920|P2|NOT COMPLETED|Overall Study||70
107464|NCT01363349|258921|P1|NOT COMPLETED|Overall Study||67
107465|NCT01363349|258920|P2|COMPLETED|Overall Study||66
107466|NCT01363349|258921|P1|COMPLETED|Overall Study||66
107467|NCT01363349|258920|P2|Randomized|Overall Study||136
107468|NCT01363349|258921|P1|Randomized|Overall Study||133
107469|NCT01363349|258920|P2|STARTED|Overall Study||136
107470|NCT01363349|258921|P1|STARTED|Overall Study||133
107471|NCT01363297|258932|P5|NOT COMPLETED|Overall Study||31
107472|NCT01363297|258933|P4|NOT COMPLETED|Overall Study||10
107473|NCT01363297|258934|P3|NOT COMPLETED|Overall Study||6
107474|NCT01363297|258935|P2|NOT COMPLETED|Overall Study||6
107475|NCT01363297|258936|P1|NOT COMPLETED|Overall Study||3
107476|NCT01363297|258932|P5|COMPLETED|Overall Study||4
107477|NCT01363297|258933|P4|COMPLETED|Overall Study||3
107478|NCT01363297|258934|P3|COMPLETED|Overall Study||3
107479|NCT01363297|258935|P2|COMPLETED|Overall Study||6
107480|NCT01363297|258936|P1|COMPLETED|Overall Study||0
107481|NCT01363297|258932|P5|STARTED|Overall Study||35
107482|NCT01363297|258933|P4|STARTED|Overall Study||13
107483|NCT01363297|258934|P3|STARTED|Overall Study||9
107484|NCT01363297|258935|P2|STARTED|Overall Study||12
107485|NCT01363297|258936|P1|STARTED|Overall Study||3
107486|NCT01363076|259028|P2|NOT COMPLETED|Overall Study||1
107487|NCT01363076|259029|P1|NOT COMPLETED|Overall Study||0
107488|NCT01363076|259028|P2|COMPLETED|Overall Study||12
107489|NCT01363076|259029|P1|COMPLETED|Overall Study||7
107490|NCT01363076|259028|P2|STARTED|Overall Study||13
107491|NCT01363076|259029|P1|STARTED|Overall Study||7
107492|NCT01363050|259047|P1|NOT COMPLETED|Overall Study||0
107493|NCT01363050|259047|P1|COMPLETED|Overall Study||15
107494|NCT01363050|259047|P1|STARTED|Overall Study||15
107495|NCT01363011|259061|P2|NOT COMPLETED|Extension Phase||8
107496|NCT01363011|259062|P1|NOT COMPLETED|Extension Phase||5
107497|NCT01363011|259061|P2|COMPLETED|Extension Phase||41
107498|NCT01363011|259062|P1|COMPLETED|Extension Phase||13
107499|NCT01363011|259061|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
107500|NCT01363011|259062|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
107501|NCT01363011|259061|P2|NOT COMPLETED|Main Study||9
107502|NCT01363011|259062|P1|NOT COMPLETED|Main Study||4
107503|NCT01363011|259061|P2|COMPLETED|Main Study||64
107504|NCT01363011|259062|P1|COMPLETED|Main Study||29
107505|NCT01363011|259061|P2|STARTED|Main Study||73
107506|NCT01363011|259062|P1|STARTED|Main Study||33
107507|NCT01362946|259102|P2|NOT COMPLETED|Second Behavior Modification Block||0
107508|NCT01362946|259103|P1|NOT COMPLETED|Second Behavior Modification Block||0
107509|NCT01362946|259102|P2|COMPLETED|Second Behavior Modification Block||24
107510|NCT01362946|259103|P1|COMPLETED|Second Behavior Modification Block||23
107511|NCT01362946|259102|P2|STARTED|Second Behavior Modification Block||24
107512|NCT01362946|259103|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
107513|NCT01362946|259102|P2|NOT COMPLETED|First Behavior Modification Block||0
107514|NCT01362946|259103|P1|NOT COMPLETED|First Behavior Modification Block||0
107515|NCT01362946|259102|P2|COMPLETED|First Behavior Modification Block||24
107516|NCT01362946|259103|P1|COMPLETED|First Behavior Modification Block||24
107517|NCT01362946|259102|P2|STARTED|First Behavior Modification Block||24
107518|NCT01362946|259103|P1|STARTED|First Behavior Modification Block||24
107519|NCT01362907|259136|P2|NOT COMPLETED|Period 2, One Week||0
107520|NCT01362907|259137|P1|NOT COMPLETED|Period 2, One Week||0
107521|NCT01362907|259136|P2|COMPLETED|Period 2, One Week||20
107522|NCT01362907|259137|P1|COMPLETED|Period 2, One Week||20
107523|NCT01362907|259136|P2|STARTED|Period 2, One Week||20
107524|NCT01362907|259137|P1|STARTED|Period 2, One Week||20
107525|NCT01362907|259136|P2|NOT COMPLETED|Period 1, One Week||0
107526|NCT01362907|259137|P1|NOT COMPLETED|Period 1, One Week||0
107527|NCT01362907|259136|P2|COMPLETED|Period 1, One Week||20
107528|NCT01362907|259137|P1|COMPLETED|Period 1, One Week||20
107529|NCT01362907|259136|P2|STARTED|Period 1, One Week||20
107530|NCT01362907|259137|P1|STARTED|Period 1, One Week||20
107531|NCT01362894|259151|P2|NOT COMPLETED|Period Two, 1 Week||0
107532|NCT01362894|259152|P1|NOT COMPLETED|Period Two, 1 Week||0
107533|NCT01362894|259151|P2|COMPLETED|Period Two, 1 Week||115
107534|NCT01362894|259152|P1|COMPLETED|Period Two, 1 Week||118
107535|NCT01362894|259151|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
107536|NCT01362894|259152|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
107537|NCT01362894|259151|P2|NOT COMPLETED|Period One, 1 Week||0
107538|NCT01362894|259152|P1|NOT COMPLETED|Period One, 1 Week||0
107539|NCT01362894|259151|P2|COMPLETED|Period One, 1 Week||117
107540|NCT01362894|259152|P1|COMPLETED|Period One, 1 Week||119
107541|NCT01362894|259151|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
107542|NCT01362894|259152|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
107543|NCT01362686|259169|P3|NOT COMPLETED|Overall Study||10
107544|NCT01362686|259170|P2|NOT COMPLETED|Overall Study||12
107545|NCT01362686|259171|P1|NOT COMPLETED|Overall Study||8
107546|NCT01362686|259169|P3|COMPLETED|Overall Study||53
107547|NCT01362686|259170|P2|COMPLETED|Overall Study||54
107548|NCT01362686|259171|P1|COMPLETED|Overall Study||59
107549|NCT01362686|259169|P3|STARTED|Overall Study||63
107550|NCT01362686|259170|P2|STARTED|Overall Study||66
107551|NCT01362686|259171|P1|STARTED|Overall Study||67
107552|NCT01362608|259187|P2|NOT COMPLETED|Overall Study||8
107553|NCT01362608|259188|P1|NOT COMPLETED|Overall Study||4
107554|NCT01362608|259187|P2|COMPLETED|Overall Study||61
107555|NCT01362608|259188|P1|COMPLETED|Overall Study||63
107556|NCT01362608|259187|P2|STARTED|Overall Study||69
107557|NCT01362608|259188|P1|STARTED|Overall Study||67
107558|NCT01362530|259226|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
107559|NCT01362530|259227|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
107560|NCT01362530|259226|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
107561|NCT01362530|259227|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
107562|NCT01362530|259226|P2|STARTED|Optional Extension (Cycles 2-6)||0
107563|NCT01362530|259227|P1|STARTED|Optional Extension (Cycles 2-6)||171
107564|NCT01362530|259226|P2|NOT COMPLETED|Base Study (Cycle 1)||3
107565|NCT01362530|259227|P1|NOT COMPLETED|Base Study (Cycle 1)||5
107566|NCT01362530|259226|P2|COMPLETED|Base Study (Cycle 1)||149
107567|NCT01362530|259227|P1|COMPLETED|Base Study (Cycle 1)||150
107568|NCT01362530|259226|P2|Received Study Treatment|Base Study (Cycle 1)||150
107569|NCT01362530|259227|P1|Received Study Treatment|Base Study (Cycle 1)||152
107570|NCT01362530|259226|P2|STARTED|Base Study (Cycle 1)||152
107571|NCT01362530|259227|P1|STARTED|Base Study (Cycle 1)||155
107572|NCT01362517|259240|P1|NOT COMPLETED|Overall Study||2
107573|NCT01362517|259240|P1|COMPLETED|Overall Study||129
107574|NCT01362517|259240|P1|STARTED|Overall Study||131
107575|NCT01362491|259251|P3|NOT COMPLETED|Overall Study||0
107576|NCT01362491|259252|P2|NOT COMPLETED|Overall Study||0
107577|NCT01362491|259253|P1|NOT COMPLETED|Overall Study||1
107578|NCT01362491|259251|P3|COMPLETED|Overall Study||46
107579|NCT01362491|259252|P2|COMPLETED|Overall Study||89
107580|NCT01362491|259253|P1|COMPLETED|Overall Study||90
107581|NCT01362491|259251|P3|STARTED|Overall Study||46
107582|NCT01362491|259252|P2|STARTED|Overall Study||89
107583|NCT01362491|259253|P1|STARTED|Overall Study||91
107584|NCT01362439|259301|P1|NOT COMPLETED|Overall Study||15
107585|NCT01362439|259301|P1|COMPLETED|Overall Study||118
107586|NCT01362439|259301|P1|STARTED|Overall Study||133
107587|NCT01362348|259316|P1|NOT COMPLETED|Overall Study||14
107588|NCT01362348|259316|P1|COMPLETED|Overall Study||5
107589|NCT01362348|259316|P1|STARTED|Overall Study||19
107590|NCT01362296|259335|P4|NOT COMPLETED|Crossover Phase||2
107591|NCT01362296|259336|P3|NOT COMPLETED|Crossover Phase||23
107592|NCT01362296|259337|P2|NOT COMPLETED|Crossover Phase||0
107593|NCT01362296|259338|P1|NOT COMPLETED|Crossover Phase||0
107594|NCT01362296|259335|P4|COMPLETED|Crossover Phase||0
107595|NCT01362296|259336|P3|COMPLETED|Crossover Phase||0
107596|NCT01362296|259337|P2|COMPLETED|Crossover Phase||0
107597|NCT01362296|259338|P1|COMPLETED|Crossover Phase||0
107598|NCT01362296|259335|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
107599|NCT01362296|259336|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
107600|NCT01362296|259337|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
107601|NCT01362296|259338|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
107602|NCT01362296|259335|P4|NOT COMPLETED|Randomized Phase (RP)||0
107603|NCT01362296|259336|P3|NOT COMPLETED|Randomized Phase (RP)||0
107604|NCT01362296|259337|P2|NOT COMPLETED|Randomized Phase (RP)||43
107605|NCT01362296|259338|P1|NOT COMPLETED|Randomized Phase (RP)||87
107606|NCT01362296|259335|P4|COMPLETED|Randomized Phase (RP)||0
107607|NCT01362296|259336|P3|COMPLETED|Randomized Phase (RP)||0
107608|NCT01362296|259337|P2|COMPLETED|Randomized Phase (RP)||0
107609|NCT01362296|259338|P1|COMPLETED|Randomized Phase (RP)||0
107610|NCT01362296|259335|P4|STARTED|Randomized Phase (RP)||0
107611|NCT01362296|259336|P3|STARTED|Randomized Phase (RP)||0
107612|NCT01362296|259337|P2|STARTED|Randomized Phase (RP)||43
107613|NCT01362296|259338|P1|STARTED|Randomized Phase (RP)||87
107614|NCT01362244|259386|P2|NOT COMPLETED|Overall Study||32
107615|NCT01362244|259387|P1|NOT COMPLETED|Overall Study||32
107616|NCT01362244|259386|P2|COMPLETED|Overall Study||19
107617|NCT01362244|259387|P1|COMPLETED|Overall Study||22
107618|NCT01362244|259386|P2|STARTED|Overall Study||51
107619|NCT01362244|259387|P1|STARTED|Overall Study||54
107620|NCT01362205|259460|P2|NOT COMPLETED|Overall Study||0
107621|NCT01362205|259461|P1|NOT COMPLETED|Overall Study||0
107622|NCT01362205|259460|P2|COMPLETED|Overall Study||27
107623|NCT01362205|259461|P1|COMPLETED|Overall Study||22
107624|NCT01362205|259460|P2|STARTED|Overall Study||27
107625|NCT01362205|259461|P1|STARTED|Overall Study||22
107626|NCT01362192|259487|P1|NOT COMPLETED|Overall Study||4
107627|NCT01362192|259487|P1|COMPLETED|Overall Study||16
107628|NCT01362192|259487|P1|STARTED|Overall Study||20
107629|NCT01362140|259499|P2|NOT COMPLETED|Overall Study||11
107630|NCT01362140|259500|P1|NOT COMPLETED|Overall Study||10
107631|NCT01362140|259499|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
107632|NCT01362140|259500|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
107633|NCT01362140|259499|P2|Received Treatment|Overall Study||97
107634|NCT01362140|259500|P1|Received Treatment|Overall Study||49
107635|NCT01362140|259499|P2|STARTED|Overall Study||98
107636|NCT01362140|259500|P1|STARTED|Overall Study||49
107637|NCT01362062|259524|P2|NOT COMPLETED|Overall Study||0
107638|NCT01362062|259525|P1|NOT COMPLETED|Overall Study||26
107639|NCT01362062|259524|P2|COMPLETED|Overall Study||62
107640|NCT01362062|259525|P1|COMPLETED|Overall Study||22
107641|NCT01362062|259524|P2|STARTED|Overall Study||62
107642|NCT01362062|259525|P1|STARTED|Overall Study||48
107643|NCT01362049|259546|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
107644|NCT01362049|259547|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
107731|NCT01361568|259658|P6|STARTED|Overall Study||13
107645|NCT01362049|259548|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
107646|NCT01362049|259549|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
107647|NCT01362049|259546|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
107648|NCT01362049|259547|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
107649|NCT01362049|259548|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
107650|NCT01362049|259549|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
107651|NCT01362049|259546|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
107652|NCT01362049|259547|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
107653|NCT01362049|259548|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
107654|NCT01362049|259549|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
107655|NCT01362049|259546|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
107656|NCT01362049|259547|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
107657|NCT01362049|259548|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
107658|NCT01362049|259549|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
107659|NCT01362049|259546|P4|COMPLETED|Follow-Up at 7 Weeks||24
107660|NCT01362049|259547|P3|COMPLETED|Follow-Up at 7 Weeks||30
107661|NCT01362049|259548|P2|COMPLETED|Follow-Up at 7 Weeks||16
107662|NCT01362049|259549|P1|COMPLETED|Follow-Up at 7 Weeks||23
107663|NCT01362049|259546|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
107664|NCT01362049|259547|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
107665|NCT01362049|259548|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
107666|NCT01362049|259549|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
107667|NCT01362049|259546|P4|STARTED|Follow-Up at 7 Weeks||25
107668|NCT01362049|259547|P3|STARTED|Follow-Up at 7 Weeks||32
107669|NCT01362049|259548|P2|STARTED|Follow-Up at 7 Weeks||19
107670|NCT01362049|259549|P1|STARTED|Follow-Up at 7 Weeks||26
107671|NCT01361867|259587|P1|NOT COMPLETED|Overall Study||0
107672|NCT01361867|259587|P1|COMPLETED|Overall Study||15
107673|NCT01361867|259587|P1|STARTED|Overall Study||15
107674|NCT01361854|259592|P2|NOT COMPLETED|Second Intervention||0
107675|NCT01361854|259593|P1|NOT COMPLETED|Second Intervention||0
107676|NCT01361854|259592|P2|COMPLETED|Second Intervention||48
107677|NCT01361854|259593|P1|COMPLETED|Second Intervention||47
107678|NCT01361854|259592|P2|STARTED|Second Intervention||48
107679|NCT01361854|259593|P1|STARTED|Second Intervention||47
107680|NCT01361854|259592|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
107681|NCT01361854|259593|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
107682|NCT01361854|259592|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
107683|NCT01361854|259593|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
107684|NCT01361854|259592|P2|STARTED|Wash-out, Maximum 2 Weeks||48
107685|NCT01361854|259593|P1|STARTED|Wash-out, Maximum 2 Weeks||47
107686|NCT01361854|259592|P2|NOT COMPLETED|Day 1||3
107687|NCT01361854|259593|P1|NOT COMPLETED|Day 1||4
107688|NCT01361854|259592|P2|COMPLETED|Day 1||48
107689|NCT01361854|259593|P1|COMPLETED|Day 1||47
107690|NCT01361854|259592|P2|STARTED|Day 1||51
107691|NCT01361854|259593|P1|STARTED|Day 1||51
107692|NCT01361633|259601|P2|NOT COMPLETED|Overall Study||3
107693|NCT01361633|259602|P1|NOT COMPLETED|Overall Study||6
107694|NCT01361633|259601|P2|COMPLETED|Overall Study||23
107695|NCT01361633|259602|P1|COMPLETED|Overall Study||19
107696|NCT01361633|259601|P2|STARTED|Overall Study||26
107697|NCT01361633|259602|P1|STARTED|Overall Study||25
107698|NCT01361620|259608|P1|NOT COMPLETED|Overall Study||0
107699|NCT01361620|259608|P1|COMPLETED|Overall Study||132
107700|NCT01361620|259608|P1|STARTED|Overall Study||132
107701|NCT01361607|259614|P2|NOT COMPLETED|Overall Study||41
107702|NCT01361607|259615|P1|NOT COMPLETED|Overall Study||64
107703|NCT01361607|259614|P2|COMPLETED|Overall Study||158
107704|NCT01361607|259615|P1|COMPLETED|Overall Study||136
107705|NCT01361607|259614|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
107706|NCT01361607|259615|P1|ITT Population|Overall Study||198
107707|NCT01361607|259614|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
107708|NCT01361607|259615|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
107709|NCT01361607|259614|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
107710|NCT01361607|259615|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
107711|NCT01361607|259614|P2|STARTED|Overall Study||199
107712|NCT01361607|259615|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
107713|NCT01361594|259643|P2|NOT COMPLETED|Overall Study||2
107714|NCT01361594|259644|P1|NOT COMPLETED|Overall Study||1
107715|NCT01361594|259643|P2|COMPLETED|Overall Study||151
107716|NCT01361594|259644|P1|COMPLETED|Overall Study||151
107717|NCT01361594|259643|P2|STARTED|Overall Study||153
107718|NCT01361594|259644|P1|STARTED|Overall Study||152
107719|NCT01361568|259658|P6|NOT COMPLETED|Overall Study||2
107720|NCT01361568|259659|P5|NOT COMPLETED|Overall Study||1
107721|NCT01361568|259660|P4|NOT COMPLETED|Overall Study||0
107722|NCT01361568|259661|P3|NOT COMPLETED|Overall Study||0
107723|NCT01361568|259662|P2|NOT COMPLETED|Overall Study||1
107724|NCT01361568|259663|P1|NOT COMPLETED|Overall Study||2
107725|NCT01361568|259658|P6|COMPLETED|Overall Study||11
107726|NCT01361568|259659|P5|COMPLETED|Overall Study||6
107727|NCT01361568|259660|P4|COMPLETED|Overall Study||21
107728|NCT01361568|259661|P3|COMPLETED|Overall Study||20
107729|NCT01361568|259662|P2|COMPLETED|Overall Study||70
107730|NCT01361568|259663|P1|COMPLETED|Overall Study||69
107732|NCT01361568|259659|P5|STARTED|Overall Study||7
107733|NCT01361568|259660|P4|STARTED|Overall Study||21
107734|NCT01361568|259661|P3|STARTED|Overall Study||20
107735|NCT01361568|259662|P2|STARTED|Overall Study||71
107736|NCT01361568|259663|P1|STARTED|Overall Study||71
107737|NCT01361464|259693|P1|NOT COMPLETED|Overall Study||3
107738|NCT01361464|259693|P1|COMPLETED|Overall Study||18
107739|NCT01361464|259693|P1|STARTED|Overall Study||21
107740|NCT01361308|259702|P2|NOT COMPLETED|Overall Study||30
107741|NCT01361308|259703|P1|NOT COMPLETED|Overall Study||35
107742|NCT01361308|259702|P2|COMPLETED|Overall Study||278
107743|NCT01361308|259703|P1|COMPLETED|Overall Study||271
107744|NCT01361308|259702|P2|STARTED|Overall Study||308
107745|NCT01361308|259703|P1|STARTED|Overall Study||306
107746|NCT01361178|259745|P2|NOT COMPLETED|Overall Study||0
107747|NCT01361178|259746|P1|NOT COMPLETED|Overall Study||13
107748|NCT01361178|259745|P2|COMPLETED|Overall Study||11
107749|NCT01361178|259746|P1|COMPLETED|Overall Study||109
107750|NCT01361178|259745|P2|STARTED|Overall Study||11
107751|NCT01361178|259746|P1|STARTED|Overall Study||122
107752|NCT01361126|259754|P2|NOT COMPLETED|Overall Study||2
107753|NCT01361126|259755|P1|NOT COMPLETED|Overall Study||0
107754|NCT01361126|259754|P2|COMPLETED|Overall Study||2
107755|NCT01361126|259755|P1|COMPLETED|Overall Study||13
107756|NCT01361126|259754|P2|STARTED|Overall Study||4
107757|NCT01361126|259755|P1|STARTED|Overall Study||13
107758|NCT01361113|259770|P1|NOT COMPLETED|Overall Study||0
107759|NCT01361113|259770|P1|COMPLETED|Overall Study||21
107760|NCT01361113|259770|P1|STARTED|Overall Study||21
107761|NCT01361048|259781|P3|NOT COMPLETED|Overall Study||1
107762|NCT01361048|259782|P2|NOT COMPLETED|Overall Study||0
107763|NCT01361048|259783|P1|NOT COMPLETED|Overall Study||0
107764|NCT01361048|259781|P3|COMPLETED|Overall Study||9
107765|NCT01361048|259782|P2|COMPLETED|Overall Study||10
107766|NCT01361048|259783|P1|COMPLETED|Overall Study||20
107767|NCT01361048|259781|P3|STARTED|Overall Study||10
107768|NCT01361048|259782|P2|STARTED|Overall Study||10
107769|NCT01361048|259783|P1|STARTED|Overall Study||20
107770|NCT01361009|259794|P1|NOT COMPLETED|Overall Study||116
107771|NCT01361009|259794|P1|COMPLETED|Overall Study||1901
107772|NCT01361009|259794|P1|STARTED|Overall Study||2017
107773|NCT01360996|259804|P3|NOT COMPLETED|Overall Study||2
107774|NCT01360996|259805|P2|NOT COMPLETED|Overall Study||3
107775|NCT01360996|259806|P1|NOT COMPLETED|Overall Study||6
107776|NCT01360996|259804|P3|COMPLETED|Overall Study||21
107777|NCT01360996|259805|P2|COMPLETED|Overall Study||18
107778|NCT01360996|259806|P1|COMPLETED|Overall Study||14
107779|NCT01360996|259804|P3|STARTED|Overall Study||23
107780|NCT01360996|259805|P2|STARTED|Overall Study||21
107781|NCT01360996|259806|P1|STARTED|Overall Study||20
107782|NCT01360840|259828|P3|NOT COMPLETED|Overall Study||9
107783|NCT01360840|259829|P2|NOT COMPLETED|Overall Study||10
107784|NCT01360840|259830|P1|NOT COMPLETED|Overall Study||10
107785|NCT01360840|259828|P3|COMPLETED|Overall Study||51
107786|NCT01360840|259829|P2|COMPLETED|Overall Study||50
107787|NCT01360840|259830|P1|COMPLETED|Overall Study||50
107788|NCT01360840|259828|P3|STARTED|Overall Study||60
107789|NCT01360840|259829|P2|STARTED|Overall Study||60
107790|NCT01360840|259830|P1|STARTED|Overall Study||60
107791|NCT01360645|259882|P4|NOT COMPLETED|Phase A+||24
107792|NCT01360645|259883|P3|NOT COMPLETED|Phase A+||0
107793|NCT01360645|259884|P2|NOT COMPLETED|Phase A+||0
107794|NCT01360645|259885|P1|NOT COMPLETED|Phase A+||0
107795|NCT01360645|259882|P4|COMPLETED|Phase A+||307
107796|NCT01360645|259883|P3|COMPLETED|Phase A+||0
107797|NCT01360645|259884|P2|COMPLETED|Phase A+||0
107798|NCT01360645|259885|P1|COMPLETED|Phase A+||0
107799|NCT01360645|259882|P4|STARTED|Phase A+||331
107800|NCT01360645|259883|P3|STARTED|Phase A+||0
107801|NCT01360645|259884|P2|STARTED|Phase A+||0
107802|NCT01360645|259885|P1|STARTED|Phase A+||0
107803|NCT01360645|259882|P4|NOT COMPLETED|Phase B (6 Weeks)||0
107804|NCT01360645|259883|P3|NOT COMPLETED|Phase B (6 Weeks)||13
107805|NCT01360645|259884|P2|NOT COMPLETED|Phase B (6 Weeks)||14
107806|NCT01360645|259885|P1|NOT COMPLETED|Phase B (6 Weeks)||0
107807|NCT01360645|259882|P4|COMPLETED|Phase B (6 Weeks)||0
107808|NCT01360645|259883|P3|COMPLETED|Phase B (6 Weeks)||178
107809|NCT01360645|259884|P2|COMPLETED|Phase B (6 Weeks)||174
107810|NCT01360645|259885|P1|COMPLETED|Phase B (6 Weeks)||0
107811|NCT01360645|259882|P4|STARTED|Phase B (6 Weeks)||0
107812|NCT01360645|259883|P3|STARTED|Phase B (6 Weeks)||191
107813|NCT01360645|259884|P2|STARTED|Phase B (6 Weeks)||188
107814|NCT01360645|259885|P1|STARTED|Phase B (6 Weeks)||0
107815|NCT01360645|259882|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107816|NCT01360645|259883|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107817|NCT01360645|259884|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107818|NCT01360645|259885|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
107819|NCT01360645|259882|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107820|NCT01360645|259883|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107821|NCT01360645|259884|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107822|NCT01360645|259885|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
107823|NCT01360645|259882|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107824|NCT01360645|259883|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107825|NCT01360645|259884|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
107826|NCT01360645|259885|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
107827|NCT01360632|259940|P5|NOT COMPLETED|Phase A+||25
107828|NCT01360632|259941|P4|NOT COMPLETED|Phase A+||0
107829|NCT01360632|259942|P3|NOT COMPLETED|Phase A+||0
107830|NCT01360632|259943|P2|NOT COMPLETED|Phase A+||0
107831|NCT01360632|259944|P1|NOT COMPLETED|Phase A+||0
107832|NCT01360632|259940|P5|COMPLETED|Phase A+||575
107833|NCT01360632|259941|P4|COMPLETED|Phase A+||0
107834|NCT01360632|259942|P3|COMPLETED|Phase A+||0
107835|NCT01360632|259943|P2|COMPLETED|Phase A+||0
107836|NCT01360632|259944|P1|COMPLETED|Phase A+||0
107837|NCT01360632|259940|P5|STARTED|Phase A+||600
107838|NCT01360632|259941|P4|STARTED|Phase A+||0
107839|NCT01360632|259942|P3|STARTED|Phase A+||0
107840|NCT01360632|259943|P2|STARTED|Phase A+||0
107841|NCT01360632|259944|P1|STARTED|Phase A+||0
107842|NCT01360632|259940|P5|NOT COMPLETED|Phase B (6 Weeks)||0
107843|NCT01360632|259941|P4|NOT COMPLETED|Phase B (6 Weeks)||13
107844|NCT01360632|259942|P3|NOT COMPLETED|Phase B (6 Weeks)||20
107845|NCT01360632|259943|P2|NOT COMPLETED|Phase B (6 Weeks)||10
107846|NCT01360632|259944|P1|NOT COMPLETED|Phase B (6 Weeks)||0
107847|NCT01360632|259940|P5|COMPLETED|Phase B (6 Weeks)||0
107848|NCT01360632|259941|P4|COMPLETED|Phase B (6 Weeks)||208
107849|NCT01360632|259942|P3|COMPLETED|Phase B (6 Weeks)||210
107850|NCT01360632|259943|P2|COMPLETED|Phase B (6 Weeks)||216
107851|NCT01360632|259944|P1|COMPLETED|Phase B (6 Weeks)||0
107852|NCT01360632|259940|P5|STARTED|Phase B (6 Weeks)||0
107853|NCT01360632|259941|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
107854|NCT01360632|259942|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
107855|NCT01360632|259943|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
107856|NCT01360632|259944|P1|STARTED|Phase B (6 Weeks)||0
107857|NCT01360632|259940|P5|NOT COMPLETED|Phase A (8 Weeks)||0
107858|NCT01360632|259941|P4|NOT COMPLETED|Phase A (8 Weeks)||0
107859|NCT01360632|259942|P3|NOT COMPLETED|Phase A (8 Weeks)||0
107860|NCT01360632|259943|P2|NOT COMPLETED|Phase A (8 Weeks)||0
107861|NCT01360632|259944|P1|NOT COMPLETED|Phase A (8 Weeks)||255
107862|NCT01360632|259940|P5|COMPLETED|Phase A (8 Weeks)||0
107863|NCT01360632|259941|P4|COMPLETED|Phase A (8 Weeks)||0
107864|NCT01360632|259942|P3|COMPLETED|Phase A (8 Weeks)||0
107865|NCT01360632|259943|P2|COMPLETED|Phase A (8 Weeks)||0
107866|NCT01360632|259944|P1|COMPLETED|Phase A (8 Weeks)||1277
107867|NCT01360632|259940|P5|STARTED|Phase A (8 Weeks)||0
107868|NCT01360632|259941|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
107869|NCT01360632|259942|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
107870|NCT01360632|259943|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
107871|NCT01360632|259944|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
107872|NCT01360554|260023|P2|NOT COMPLETED|Overall Study||439
107873|NCT01360554|260024|P1|NOT COMPLETED|Overall Study||439
107874|NCT01360554|260023|P2|COMPLETED|Overall Study||0
107875|NCT01360554|260024|P1|COMPLETED|Overall Study||0
107876|NCT01360554|260023|P2|Treated|Overall Study||436
107877|NCT01360554|260024|P1|Treated|Overall Study||436
107878|NCT01360554|260023|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
107879|NCT01360554|260024|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
107880|NCT01360450|260062|P2|NOT COMPLETED|Overall Study||0
107881|NCT01360450|260063|P1|NOT COMPLETED|Overall Study||0
107882|NCT01360450|260062|P2|COMPLETED|Overall Study||6
107883|NCT01360450|260063|P1|COMPLETED|Overall Study||6
107884|NCT01360450|260062|P2|Completed Treatment|Overall Study||6
107885|NCT01360450|260063|P1|Completed Treatment|Overall Study||6
107886|NCT01360450|260062|P2|STARTED|Overall Study||6
107887|NCT01360450|260063|P1|STARTED|Overall Study||6
107888|NCT01360021|260076|P3|NOT COMPLETED|Overall Study||7
107889|NCT01360021|260077|P2|NOT COMPLETED|Overall Study||4
107890|NCT01360021|260078|P1|NOT COMPLETED|Overall Study||8
107891|NCT01360021|260076|P3|COMPLETED|Overall Study|Patients who completed study|65
107892|NCT01360021|260077|P2|COMPLETED|Overall Study|Patients who completed study|67
107893|NCT01360021|260078|P1|COMPLETED|Overall Study|Patients who completed study|63
107894|NCT01360021|260076|P3|STARTED|Overall Study|Patients randomized|72
107895|NCT01360021|260077|P2|STARTED|Overall Study|Patients randomized|71
107896|NCT01360021|260078|P1|STARTED|Overall Study|Patients randomized|71
107897|NCT01359943|260104|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
107898|NCT01359943|260105|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
107899|NCT01359943|260106|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
107900|NCT01359943|260104|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
107901|NCT01359943|260105|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
107902|NCT01359943|260106|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
107903|NCT01359943|260104|P3|STARTED|Follow-up (Weeks 52 - 60)||44
107904|NCT01359943|260105|P2|STARTED|Follow-up (Weeks 52 - 60)||84
107905|NCT01359943|260106|P1|STARTED|Follow-up (Weeks 52 - 60)||86
107906|NCT01359943|260104|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
107907|NCT01359943|260105|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
107908|NCT01359943|260106|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
107909|NCT01359943|260104|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
108001|NCT01359644|260212|P7|STARTED|Treatment Period||41
107910|NCT01359943|260105|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
107911|NCT01359943|260106|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
107912|NCT01359943|260104|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
107913|NCT01359943|260105|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
107914|NCT01359943|260106|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
107915|NCT01359943|260104|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
107916|NCT01359943|260105|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
107917|NCT01359943|260106|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
107918|NCT01359943|260104|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
107919|NCT01359943|260105|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
107920|NCT01359943|260106|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
107921|NCT01359943|260104|P3|STARTED|Double-blind (Weeks 0 - 16)||44
107922|NCT01359943|260105|P2|STARTED|Double-blind (Weeks 0 - 16)||89
107923|NCT01359943|260106|P1|STARTED|Double-blind (Weeks 0 - 16)||88
107924|NCT01359904|260154|P2|NOT COMPLETED|Overall Study||0
107925|NCT01359904|260155|P1|NOT COMPLETED|Overall Study||1
107926|NCT01359904|260154|P2|COMPLETED|Overall Study||19
107927|NCT01359904|260155|P1|COMPLETED|Overall Study||14
107928|NCT01359904|260154|P2|STARTED|Overall Study||19
107929|NCT01359904|260155|P1|STARTED|Overall Study||15
107930|NCT01359748|260171|P4|NOT COMPLETED|Overall Study||0
107931|NCT01359748|260172|P3|NOT COMPLETED|Overall Study||0
107932|NCT01359748|260173|P2|NOT COMPLETED|Overall Study||0
107933|NCT01359748|260174|P1|NOT COMPLETED|Overall Study||0
107934|NCT01359748|260171|P4|COMPLETED|Overall Study||11
107935|NCT01359748|260172|P3|COMPLETED|Overall Study||10
107936|NCT01359748|260173|P2|COMPLETED|Overall Study||20
107937|NCT01359748|260174|P1|COMPLETED|Overall Study||48
107938|NCT01359748|260171|P4|STARTED|Overall Study||11
107939|NCT01359748|260172|P3|STARTED|Overall Study||10
107940|NCT01359748|260173|P2|STARTED|Overall Study||20
107941|NCT01359748|260174|P1|STARTED|Overall Study||48
107942|NCT01359735|260184|P2|NOT COMPLETED|Overall Study||0
107943|NCT01359735|260185|P1|NOT COMPLETED|Overall Study||0
107944|NCT01359735|260184|P2|COMPLETED|Overall Study||4
107945|NCT01359735|260185|P1|COMPLETED|Overall Study||4
107946|NCT01359735|260184|P2|STARTED|Overall Study||4
107947|NCT01359735|260185|P1|STARTED|Overall Study||4
107948|NCT01359644|260209|P10|NOT COMPLETED|Follow-up Period||0
107949|NCT01359644|260210|P9|NOT COMPLETED|Follow-up Period||0
107950|NCT01359644|260211|P8|NOT COMPLETED|Follow-up Period||2
107951|NCT01359644|260212|P7|NOT COMPLETED|Follow-up Period||1
107952|NCT01359644|260213|P6|NOT COMPLETED|Follow-up Period||1
107953|NCT01359644|260214|P5|NOT COMPLETED|Follow-up Period||0
107954|NCT01359644|260215|P4|NOT COMPLETED|Follow-up Period||0
107955|NCT01359644|260216|P3|NOT COMPLETED|Follow-up Period||0
107956|NCT01359644|260217|P2|NOT COMPLETED|Follow-up Period||0
107957|NCT01359644|260218|P1|NOT COMPLETED|Follow-up Period||0
107958|NCT01359644|260209|P10|COMPLETED|Follow-up Period||20
107959|NCT01359644|260210|P9|COMPLETED|Follow-up Period||21
107960|NCT01359644|260211|P8|COMPLETED|Follow-up Period||39
107961|NCT01359644|260212|P7|COMPLETED|Follow-up Period||40
107962|NCT01359644|260213|P6|COMPLETED|Follow-up Period||12
107963|NCT01359644|260214|P5|COMPLETED|Follow-up Period||15
107964|NCT01359644|260215|P4|COMPLETED|Follow-up Period||14
107965|NCT01359644|260216|P3|COMPLETED|Follow-up Period||14
107966|NCT01359644|260217|P2|COMPLETED|Follow-up Period||16
107967|NCT01359644|260218|P1|COMPLETED|Follow-up Period||15
107968|NCT01359644|260209|P10|STARTED|Follow-up Period||20
107969|NCT01359644|260210|P9|STARTED|Follow-up Period||21
107970|NCT01359644|260211|P8|STARTED|Follow-up Period||41
107971|NCT01359644|260212|P7|STARTED|Follow-up Period||41
107972|NCT01359644|260213|P6|STARTED|Follow-up Period||13
107973|NCT01359644|260214|P5|STARTED|Follow-up Period||15
107974|NCT01359644|260215|P4|STARTED|Follow-up Period||14
107975|NCT01359644|260216|P3|STARTED|Follow-up Period||14
107976|NCT01359644|260217|P2|STARTED|Follow-up Period||16
107977|NCT01359644|260218|P1|STARTED|Follow-up Period||15
107978|NCT01359644|260209|P10|NOT COMPLETED|Treatment Period||0
107979|NCT01359644|260210|P9|NOT COMPLETED|Treatment Period||0
107980|NCT01359644|260211|P8|NOT COMPLETED|Treatment Period||0
107981|NCT01359644|260212|P7|NOT COMPLETED|Treatment Period||0
107982|NCT01359644|260213|P6|NOT COMPLETED|Treatment Period||2
107983|NCT01359644|260214|P5|NOT COMPLETED|Treatment Period||0
107984|NCT01359644|260215|P4|NOT COMPLETED|Treatment Period||0
107985|NCT01359644|260216|P3|NOT COMPLETED|Treatment Period||1
107986|NCT01359644|260217|P2|NOT COMPLETED|Treatment Period||1
107987|NCT01359644|260218|P1|NOT COMPLETED|Treatment Period||0
107988|NCT01359644|260209|P10|COMPLETED|Treatment Period||20
107989|NCT01359644|260210|P9|COMPLETED|Treatment Period||21
107990|NCT01359644|260211|P8|COMPLETED|Treatment Period||41
107991|NCT01359644|260212|P7|COMPLETED|Treatment Period||41
107992|NCT01359644|260213|P6|COMPLETED|Treatment Period||12
107993|NCT01359644|260214|P5|COMPLETED|Treatment Period||15
107994|NCT01359644|260215|P4|COMPLETED|Treatment Period||14
107995|NCT01359644|260216|P3|COMPLETED|Treatment Period||13
107996|NCT01359644|260217|P2|COMPLETED|Treatment Period||15
107997|NCT01359644|260218|P1|COMPLETED|Treatment Period||15
107998|NCT01359644|260209|P10|STARTED|Treatment Period||20
107999|NCT01359644|260210|P9|STARTED|Treatment Period||21
108000|NCT01359644|260211|P8|STARTED|Treatment Period||41
108002|NCT01359644|260213|P6|STARTED|Treatment Period||14
108003|NCT01359644|260214|P5|STARTED|Treatment Period||15
108004|NCT01359644|260215|P4|STARTED|Treatment Period||14
108005|NCT01359644|260216|P3|STARTED|Treatment Period||14
108006|NCT01359644|260217|P2|STARTED|Treatment Period||16
108007|NCT01359644|260218|P1|STARTED|Treatment Period||15
108008|NCT01359449|260262|P2|NOT COMPLETED|Overall Study||4
108009|NCT01359449|260263|P1|NOT COMPLETED|Overall Study||4
108010|NCT01359449|260262|P2|COMPLETED|Overall Study||58
108011|NCT01359449|260263|P1|COMPLETED|Overall Study||57
108012|NCT01359449|260262|P2|STARTED|Overall Study||62
108013|NCT01359449|260263|P1|STARTED|Overall Study||61
108014|NCT01359410|260287|P2|NOT COMPLETED|Overall Study||0
108015|NCT01359410|260288|P1|NOT COMPLETED|Overall Study||0
108016|NCT01359410|260287|P2|COMPLETED|Overall Study||46
108017|NCT01359410|260288|P1|COMPLETED|Overall Study||54
108018|NCT01359410|260287|P2|STARTED|Overall Study||46
108019|NCT01359410|260288|P1|STARTED|Overall Study||54
108020|NCT01359371|260302|P1|NOT COMPLETED|Overall Study||0
108021|NCT01359371|260302|P1|COMPLETED|Overall Study||41
108022|NCT01359371|260302|P1|STARTED|Overall Study||41
108023|NCT01359254|260309|P2|NOT COMPLETED|Overall Study||0
108024|NCT01359254|260310|P1|NOT COMPLETED|Overall Study||1
108025|NCT01359254|260309|P2|COMPLETED|Overall Study||0
108026|NCT01359254|260310|P1|COMPLETED|Overall Study||0
108027|NCT01359254|260309|P2|STARTED|Overall Study||0
108028|NCT01359254|260310|P1|STARTED|Overall Study||1
108029|NCT01359150|260320|P2|NOT COMPLETED|Overall Study||5
108030|NCT01359150|260321|P1|NOT COMPLETED|Overall Study||7
108031|NCT01359150|260320|P2|COMPLETED|Overall Study||106
108032|NCT01359150|260321|P1|COMPLETED|Overall Study||105
108033|NCT01359150|260320|P2|STARTED|Overall Study||111
108034|NCT01359150|260321|P1|STARTED|Overall Study||112
108035|NCT01359111|260343|P1|NOT COMPLETED|Overall Study||0
108036|NCT01359111|260343|P1|COMPLETED|Overall Study||20
108037|NCT01359111|260343|P1|STARTED|Overall Study||20
108038|NCT01359007|260350|P1|NOT COMPLETED|Overall Study||2
108039|NCT01359007|260350|P1|COMPLETED|Overall Study||3
108040|NCT01359007|260350|P1|STARTED|Overall Study||5
108041|NCT01358877|260360|P2|NOT COMPLETED|Overall Study||2404
108042|NCT01358877|260361|P1|NOT COMPLETED|Overall Study||2400
108043|NCT01358877|260360|P2|COMPLETED|Overall Study||0
108044|NCT01358877|260361|P1|COMPLETED|Overall Study||0
108045|NCT01358877|260360|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
108046|NCT01358877|260361|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
108047|NCT01358877|260360|P2|Did Not Receive Study Drug|Overall Study||13
108048|NCT01358877|260361|P1|Did Not Receive Study Drug|Overall Study||22
108049|NCT01358877|260360|P2|STARTED|Overall Study||2404
108050|NCT01358877|260361|P1|STARTED|Overall Study||2400
108051|NCT01358864|260431|P8|NOT COMPLETED|Overall Study||55
108052|NCT01358864|260432|P7|NOT COMPLETED|Overall Study||65
108053|NCT01358864|260433|P6|NOT COMPLETED|Overall Study||13
108054|NCT01358864|260434|P5|NOT COMPLETED|Overall Study||11
108055|NCT01358864|260435|P4|NOT COMPLETED|Overall Study||19
108056|NCT01358864|260436|P3|NOT COMPLETED|Overall Study||16
108057|NCT01358864|260437|P2|NOT COMPLETED|Overall Study||13
108058|NCT01358864|260438|P1|NOT COMPLETED|Overall Study||31
108059|NCT01358864|260431|P8|COMPLETED|Overall Study||85
108060|NCT01358864|260432|P7|COMPLETED|Overall Study||81
108061|NCT01358864|260433|P6|COMPLETED|Overall Study||42
108062|NCT01358864|260434|P5|COMPLETED|Overall Study||46
108063|NCT01358864|260435|P4|COMPLETED|Overall Study||10
108064|NCT01358864|260436|P3|COMPLETED|Overall Study||87
108065|NCT01358864|260437|P2|COMPLETED|Overall Study||86
108066|NCT01358864|260438|P1|COMPLETED|Overall Study||18
108067|NCT01358864|260431|P8|STARTED|Overall Study||140
108068|NCT01358864|260432|P7|STARTED|Overall Study||146
108069|NCT01358864|260433|P6|STARTED|Overall Study||55
108070|NCT01358864|260434|P5|STARTED|Overall Study||57
108071|NCT01358864|260435|P4|STARTED|Overall Study||29
108072|NCT01358864|260436|P3|STARTED|Overall Study||103
108073|NCT01358864|260437|P2|STARTED|Overall Study||99
108074|NCT01358864|260438|P1|STARTED|Overall Study||49
108075|NCT01358825|260529|P2|NOT COMPLETED|Overall Study||1
108076|NCT01358825|260530|P1|NOT COMPLETED|Overall Study||0
108077|NCT01358825|260529|P2|COMPLETED|Overall Study||45
108078|NCT01358825|260530|P1|COMPLETED|Overall Study||12
108079|NCT01358825|260529|P2|STARTED|Overall Study||46
108080|NCT01358825|260530|P1|STARTED|Overall Study||12
108081|NCT01358760|260554|P3|NOT COMPLETED|Overall Study||25
108082|NCT01358760|260555|P2|NOT COMPLETED|Overall Study||20
108083|NCT01358760|260556|P1|NOT COMPLETED|Overall Study||22
108084|NCT01358760|260554|P3|COMPLETED|Overall Study||125
108085|NCT01358760|260555|P2|COMPLETED|Overall Study||128
108086|NCT01358760|260556|P1|COMPLETED|Overall Study||130
108087|NCT01358760|260554|P3|ITT Population|Overall Study||134
108088|NCT01358760|260555|P2|ITT Population|Overall Study||134
108089|NCT01358760|260556|P1|ITT Population|Overall Study||139
108090|NCT01358760|260554|P3|Safety Population|Overall Study||148
108091|NCT01358760|260555|P2|Safety Population|Overall Study||143
108092|NCT01358760|260556|P1|Safety Population|Overall Study||150
108093|NCT01358760|260554|P3|STARTED|Overall Study||150
108094|NCT01358760|260555|P2|STARTED|Overall Study||148
108095|NCT01358760|260556|P1|STARTED|Overall Study||152
108096|NCT01358734|260591|P3|NOT COMPLETED|Overall Study||29
108097|NCT01358734|260592|P2|NOT COMPLETED|Overall Study||37
108098|NCT01358734|260593|P1|NOT COMPLETED|Overall Study||15
108099|NCT01358734|260591|P3|COMPLETED|Overall Study|Includes participants still receiving study treatment|5
108100|NCT01358734|260592|P2|COMPLETED|Overall Study|Includes participants still receiving study treatment|2
108101|NCT01358734|260593|P1|COMPLETED|Overall Study||0
108102|NCT01358734|260591|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
108103|NCT01358734|260592|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
108104|NCT01358734|260593|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
108105|NCT01358734|260591|P3|STARTED|Overall Study||34
108106|NCT01358734|260592|P2|STARTED|Overall Study||39
108107|NCT01358734|260593|P1|STARTED|Overall Study||15
108108|NCT01358708|260612|P2|NOT COMPLETED|Open-Label Treatment Phase||0
108109|NCT01358708|260613|P1|NOT COMPLETED|Open-Label Treatment Phase||0
108110|NCT01358708|260612|P2|COMPLETED|Open-Label Treatment Phase||12
108111|NCT01358708|260613|P1|COMPLETED|Open-Label Treatment Phase||5
108112|NCT01358708|260612|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
108113|NCT01358708|260613|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
108114|NCT01358708|260612|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
108115|NCT01358708|260613|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
108116|NCT01358708|260612|P2|COMPLETED|Double-Blind Treatment Phase||13
108117|NCT01358708|260613|P1|COMPLETED|Double-Blind Treatment Phase||10
108118|NCT01358708|260612|P2|Received Study Medication|Double-Blind Treatment Phase||13
108119|NCT01358708|260613|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
108120|NCT01358708|260612|P2|Randomized|Double-Blind Treatment Phase||13
108121|NCT01358708|260613|P1|Randomized|Double-Blind Treatment Phase||13
108122|NCT01358708|260612|P2|STARTED|Double-Blind Treatment Phase||13
108123|NCT01358708|260613|P1|STARTED|Double-Blind Treatment Phase||13
108124|NCT01358578|260636|P6|NOT COMPLETED|Follow-up Period||0
108125|NCT01358578|260637|P5|NOT COMPLETED|Follow-up Period||0
108126|NCT01358578|260638|P4|NOT COMPLETED|Follow-up Period||19
108127|NCT01358578|260639|P3|NOT COMPLETED|Follow-up Period||5
108128|NCT01358578|260640|P2|NOT COMPLETED|Follow-up Period||6
108129|NCT01358578|260641|P1|NOT COMPLETED|Follow-up Period||10
108130|NCT01358578|260636|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
108131|NCT01358578|260637|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
108132|NCT01358578|260638|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
108133|NCT01358578|260639|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
108134|NCT01358578|260640|P2|COMPLETED|Follow-up Period||119
108135|NCT01358578|260641|P1|COMPLETED|Follow-up Period||138
108136|NCT01358578|260636|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
108137|NCT01358578|260637|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
108138|NCT01358578|260638|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
108139|NCT01358578|260639|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
108140|NCT01358578|260640|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
108141|NCT01358578|260641|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
108142|NCT01358578|260636|P6|NOT COMPLETED|Maintenance Period||11
108143|NCT01358578|260637|P5|NOT COMPLETED|Maintenance Period||17
108144|NCT01358578|260638|P4|NOT COMPLETED|Maintenance Period||42
108145|NCT01358578|260639|P3|NOT COMPLETED|Maintenance Period||2
108146|NCT01358578|260640|P2|NOT COMPLETED|Maintenance Period||22
108147|NCT01358578|260641|P1|NOT COMPLETED|Maintenance Period||39
108148|NCT01358578|260636|P6|COMPLETED|Maintenance Period||131
108149|NCT01358578|260637|P5|COMPLETED|Maintenance Period||125
108150|NCT01358578|260638|P4|COMPLETED|Maintenance Period||263
108151|NCT01358578|260639|P3|COMPLETED|Maintenance Period||15
108152|NCT01358578|260640|P2|COMPLETED|Maintenance Period||290
108153|NCT01358578|260641|P1|COMPLETED|Maintenance Period||276
108154|NCT01358578|260636|P6|STARTED|Maintenance Period||142
108155|NCT01358578|260637|P5|STARTED|Maintenance Period||142
108156|NCT01358578|260638|P4|STARTED|Maintenance Period||305
108157|NCT01358578|260639|P3|STARTED|Maintenance Period||17
108158|NCT01358578|260640|P2|STARTED|Maintenance Period||312
108159|NCT01358578|260641|P1|STARTED|Maintenance Period||315
108160|NCT01358578|260636|P6|NOT COMPLETED|Induction Period||0
108161|NCT01358578|260637|P5|NOT COMPLETED|Induction Period||0
108162|NCT01358578|260638|P4|NOT COMPLETED|Induction Period||21
108163|NCT01358578|260639|P3|NOT COMPLETED|Induction Period||25
108164|NCT01358578|260640|P2|NOT COMPLETED|Induction Period||15
108165|NCT01358578|260641|P1|NOT COMPLETED|Induction Period||12
108166|NCT01358578|260636|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
108167|NCT01358578|260637|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
108168|NCT01358578|260638|P4|COMPLETED|Induction Period||305
108169|NCT01358578|260639|P3|COMPLETED|Induction Period||301
108170|NCT01358578|260640|P2|COMPLETED|Induction Period||312
108171|NCT01358578|260641|P1|COMPLETED|Induction Period||315
108172|NCT01358578|260636|P6|STARTED|Induction Period|These groups are populated after the induction period|0
108173|NCT01358578|260637|P5|STARTED|Induction Period|These groups are populated after the induction period|0
108174|NCT01358578|260638|P4|STARTED|Induction Period||326
108175|NCT01358578|260639|P3|STARTED|Induction Period||326
108176|NCT01358578|260640|P2|STARTED|Induction Period||327
108177|NCT01358578|260641|P1|STARTED|Induction Period||327
108178|NCT01358526|260693|P3|NOT COMPLETED|Double-blind Phase||121
108179|NCT01358526|260694|P2|NOT COMPLETED|Double-blind Phase||80
108180|NCT01358526|260695|P1|NOT COMPLETED|Double-blind Phase||0
108181|NCT01358526|260693|P3|COMPLETED|Double-blind Phase||181
108182|NCT01358526|260694|P2|COMPLETED|Double-blind Phase||218
108183|NCT01358526|260695|P1|COMPLETED|Double-blind Phase||0
108184|NCT01358526|260693|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
108185|NCT01358526|260694|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
108186|NCT01358526|260695|P1|STARTED|Double-blind Phase||0
108187|NCT01358526|260693|P3|NOT COMPLETED|Open-label Titration Period||0
108188|NCT01358526|260694|P2|NOT COMPLETED|Open-label Titration Period||0
108189|NCT01358526|260695|P1|NOT COMPLETED|Open-label Titration Period||494
108190|NCT01358526|260693|P3|COMPLETED|Open-label Titration Period||0
108191|NCT01358526|260694|P2|COMPLETED|Open-label Titration Period||0
108192|NCT01358526|260695|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
108193|NCT01358526|260693|P3|STARTED|Open-label Titration Period||0
108194|NCT01358526|260694|P2|STARTED|Open-label Titration Period||0
108195|NCT01358526|260695|P1|STARTED|Open-label Titration Period||1095
108196|NCT01358357|260712|P3|NOT COMPLETED|Double-Blind Phase||0
108197|NCT01358357|260713|P2|NOT COMPLETED|Double-Blind Phase||100
108198|NCT01358357|260714|P1|NOT COMPLETED|Double-Blind Phase||80
108199|NCT01358357|260712|P3|COMPLETED|Double-Blind Phase||0
108200|NCT01358357|260713|P2|COMPLETED|Double-Blind Phase||150
108201|NCT01358357|260714|P1|COMPLETED|Double-Blind Phase||166
108202|NCT01358357|260712|P3|STARTED|Double-Blind Phase||0
108203|NCT01358357|260713|P2|STARTED|Double-Blind Phase||250
108204|NCT01358357|260714|P1|STARTED|Double-Blind Phase||246
108205|NCT01358357|260712|P3|NOT COMPLETED|Open Label Phase||462
108206|NCT01358357|260713|P2|NOT COMPLETED|Open Label Phase||0
108207|NCT01358357|260714|P1|NOT COMPLETED|Open Label Phase||0
108208|NCT01358357|260712|P3|COMPLETED|Open Label Phase||503
108209|NCT01358357|260713|P2|COMPLETED|Open Label Phase||0
108210|NCT01358357|260714|P1|COMPLETED|Open Label Phase||0
108211|NCT01358357|260712|P3|STARTED|Open Label Phase||965
108212|NCT01358357|260713|P2|STARTED|Open Label Phase||0
108213|NCT01358357|260714|P1|STARTED|Open Label Phase||0
108214|NCT01358175|260750|P3|NOT COMPLETED|Overall Study||32
108215|NCT01358175|260751|P2|NOT COMPLETED|Overall Study||28
108216|NCT01358175|260752|P1|NOT COMPLETED|Overall Study||21
108217|NCT01358175|260750|P3|COMPLETED|Overall Study||90
108218|NCT01358175|260751|P2|COMPLETED|Overall Study||97
108219|NCT01358175|260752|P1|COMPLETED|Overall Study||103
108220|NCT01358175|260750|P3|STARTED|Overall Study||122
108221|NCT01358175|260751|P2|STARTED|Overall Study||125
108222|NCT01358175|260752|P1|STARTED|Overall Study||124
108223|NCT01357980|260789|P4|NOT COMPLETED|Overall Study||0
108224|NCT01357980|260790|P3|NOT COMPLETED|Overall Study||1
108225|NCT01357980|260791|P2|NOT COMPLETED|Overall Study||1
108226|NCT01357980|260792|P1|NOT COMPLETED|Overall Study||0
108227|NCT01357980|260789|P4|COMPLETED|Overall Study||7
108228|NCT01357980|260790|P3|COMPLETED|Overall Study||16
108229|NCT01357980|260791|P2|COMPLETED|Overall Study||6
108230|NCT01357980|260792|P1|COMPLETED|Overall Study||16
108231|NCT01357980|260789|P4|STARTED|Overall Study||7
108232|NCT01357980|260790|P3|STARTED|Overall Study||17
108233|NCT01357980|260791|P2|STARTED|Overall Study||7
108234|NCT01357980|260792|P1|STARTED|Overall Study||16
108235|NCT01357915|260836|P2|NOT COMPLETED|Overall Study||0
108236|NCT01357915|260837|P1|NOT COMPLETED|Overall Study||3
108237|NCT01357915|260836|P2|COMPLETED|Overall Study||17
108238|NCT01357915|260837|P1|COMPLETED|Overall Study||27
108239|NCT01357915|260836|P2|STARTED|Overall Study||17
108240|NCT01357915|260837|P1|STARTED|Overall Study||30
108241|NCT01357889|260852|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
108242|NCT01357889|260853|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
108243|NCT01357889|260852|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
108244|NCT01357889|260853|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
108245|NCT01357889|260852|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
108246|NCT01357889|260853|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
108247|NCT01357889|260852|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
108248|NCT01357889|260853|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
108249|NCT01357889|260852|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
108250|NCT01357889|260853|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
108251|NCT01357889|260852|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
108252|NCT01357889|260853|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
108253|NCT01357889|260852|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
108254|NCT01357889|260853|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
108255|NCT01357889|260852|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
108256|NCT01357889|260853|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
108257|NCT01357889|260852|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
108258|NCT01357889|260853|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
108259|NCT01357850|260897|P4|NOT COMPLETED|Overall Study||0
108260|NCT01357850|260898|P3|NOT COMPLETED|Overall Study||0
108261|NCT01357850|260899|P2|NOT COMPLETED|Overall Study||0
108262|NCT01357850|260900|P1|NOT COMPLETED|Overall Study||1
108263|NCT01357850|260897|P4|COMPLETED|Overall Study||27
108264|NCT01357850|260898|P3|COMPLETED|Overall Study||13
108265|NCT01357850|260899|P2|COMPLETED|Overall Study||12
108266|NCT01357850|260900|P1|COMPLETED|Overall Study||29
108267|NCT01357850|260897|P4|STARTED|Overall Study||27
108268|NCT01357850|260898|P3|STARTED|Overall Study||13
108269|NCT01357850|260899|P2|STARTED|Overall Study||12
108270|NCT01357850|260900|P1|STARTED|Overall Study||30
108271|NCT01357720|260974|P2|NOT COMPLETED|Overall Study||5
108272|NCT01357720|260975|P1|NOT COMPLETED|Overall Study||2
108273|NCT01357720|260974|P2|COMPLETED|Overall Study||195
108274|NCT01357720|260975|P1|COMPLETED|Overall Study||198
108275|NCT01357720|260974|P2|STARTED|Overall Study||200
108276|NCT01357720|260975|P1|STARTED|Overall Study||200
108277|NCT01357655|260991|P2|NOT COMPLETED|Overall Study||0
108278|NCT01357655|260992|P1|NOT COMPLETED|Overall Study||66
108279|NCT01357655|260991|P2|COMPLETED|Overall Study||0
108280|NCT01357655|260992|P1|COMPLETED|Overall Study||0
108281|NCT01357655|260991|P2|STARTED|Overall Study||0
108282|NCT01357655|260992|P1|STARTED|Overall Study||66
108283|NCT01357616|261009|P2|NOT COMPLETED|Overall Study||9
108284|NCT01357616|261010|P1|NOT COMPLETED|Overall Study||10
108285|NCT01357616|261009|P2|COMPLETED|Overall Study||153
108286|NCT01357616|261010|P1|COMPLETED|Overall Study||156
108287|NCT01357616|261009|P2|STARTED|Overall Study||162
108288|NCT01357616|261010|P1|STARTED|Overall Study||166
108289|NCT01357551|261024|P2|NOT COMPLETED|Overall Study||11
108290|NCT01357551|261025|P1|NOT COMPLETED|Overall Study||22
108291|NCT01357551|261024|P2|COMPLETED|Overall Study||101
108292|NCT01357551|261025|P1|COMPLETED|Overall Study||88
108293|NCT01357551|261024|P2|STARTED|Overall Study||112
108294|NCT01357551|261025|P1|STARTED|Overall Study||110
108295|NCT01357512|261039|P2|NOT COMPLETED|Overall Study||5
108296|NCT01357512|261040|P1|NOT COMPLETED|Overall Study||12
108297|NCT01357512|261039|P2|COMPLETED|Overall Study||60
108298|NCT01357512|261040|P1|COMPLETED|Overall Study||53
108299|NCT01357512|261039|P2|STARTED|Overall Study||65
108300|NCT01357512|261040|P1|STARTED|Overall Study||65
108301|NCT01357239|261052|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
108302|NCT01357239|261053|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
108303|NCT01357239|261054|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
108304|NCT01357239|261055|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
108305|NCT01357239|261052|P4|COMPLETED|Stratum II: Partially-Methylated||18
108306|NCT01357239|261053|P3|COMPLETED|Stratum II: Partially-Methylated||21
108307|NCT01357239|261054|P2|COMPLETED|Stratum II: Partially-Methylated||21
108308|NCT01357239|261055|P1|COMPLETED|Stratum II: Partially-Methylated||23
108309|NCT01357239|261052|P4|STARTED|Stratum II: Partially-Methylated||20
108310|NCT01357239|261053|P3|STARTED|Stratum II: Partially-Methylated||22
108311|NCT01357239|261054|P2|STARTED|Stratum II: Partially-Methylated||21
108312|NCT01357239|261055|P1|STARTED|Stratum II: Partially-Methylated||23
108313|NCT01357239|261052|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
108314|NCT01357239|261053|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
108315|NCT01357239|261054|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
108316|NCT01357239|261055|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
108317|NCT01357239|261052|P4|COMPLETED|Stratum I: Fully-Methylated||22
108318|NCT01357239|261053|P3|COMPLETED|Stratum I: Fully-Methylated||16
108319|NCT01357239|261054|P2|COMPLETED|Stratum I: Fully-Methylated||6
108320|NCT01357239|261055|P1|COMPLETED|Stratum I: Fully-Methylated||8
108321|NCT01357239|261052|P4|STARTED|Stratum I: Fully-Methylated||22
108322|NCT01357239|261053|P3|STARTED|Stratum I: Fully-Methylated||17
108323|NCT01357239|261054|P2|STARTED|Stratum I: Fully-Methylated||6
108324|NCT01357239|261055|P1|STARTED|Stratum I: Fully-Methylated||8
108325|NCT01357239|261052|P4|NOT COMPLETED|Stratum: All Patients||2
108326|NCT01357239|261053|P3|NOT COMPLETED|Stratum: All Patients||2
108327|NCT01357239|261054|P2|NOT COMPLETED|Stratum: All Patients||0
108328|NCT01357239|261055|P1|NOT COMPLETED|Stratum: All Patients||0
108329|NCT01357239|261052|P4|COMPLETED|Stratum: All Patients||40
108330|NCT01357239|261053|P3|COMPLETED|Stratum: All Patients||37
108331|NCT01357239|261054|P2|COMPLETED|Stratum: All Patients||27
108332|NCT01357239|261055|P1|COMPLETED|Stratum: All Patients||31
108333|NCT01357239|261052|P4|STARTED|Stratum: All Patients||42
108334|NCT01357239|261053|P3|STARTED|Stratum: All Patients||39
108335|NCT01357239|261054|P2|STARTED|Stratum: All Patients||27
108336|NCT01357239|261055|P1|STARTED|Stratum: All Patients||31
108337|NCT01357161|261113|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
108338|NCT01357161|261114|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
108339|NCT01357161|261115|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
108340|NCT01357161|261113|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
108341|NCT01357161|261114|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
108342|NCT01357161|261115|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
108343|NCT01357161|261113|P3|Treated|Part 2 (Double-Blind Comparison)||60
108344|NCT01357161|261114|P2|Treated|Part 2 (Double-Blind Comparison)||59
108345|NCT01357161|261115|P1|Treated|Part 2 (Double-Blind Comparison)||0
108346|NCT01357161|261113|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
108347|NCT01357161|261114|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
108348|NCT01357161|261115|P1|STARTED|Part 2 (Double-Blind Comparison)||0
108349|NCT01357161|261113|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
108350|NCT01357161|261114|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
108351|NCT01357161|261115|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
108352|NCT01357161|261113|P3|COMPLETED|Part 1 (Open Label Run-in)||0
108353|NCT01357161|261114|P2|COMPLETED|Part 1 (Open Label Run-in)||0
108354|NCT01357161|261115|P1|COMPLETED|Part 1 (Open Label Run-in)||0
108355|NCT01357161|261113|P3|STARTED|Part 1 (Open Label Run-in)||0
108356|NCT01357161|261114|P2|STARTED|Part 1 (Open Label Run-in)||0
108357|NCT01357161|261115|P1|STARTED|Part 1 (Open Label Run-in)||15
108358|NCT01357148|261144|P1|NOT COMPLETED|Overall Study||0
108359|NCT01357148|261144|P1|COMPLETED|Overall Study||143
108360|NCT01357148|261144|P1|STARTED|Overall Study||143
108361|NCT01357135|261154|P3|NOT COMPLETED|Overall Study||263
108362|NCT01357135|261155|P2|NOT COMPLETED|Overall Study||223
108363|NCT01357135|261156|P1|NOT COMPLETED|Overall Study||598
108364|NCT01357135|261154|P3|COMPLETED|Overall Study||583
108365|NCT01357135|261155|P2|COMPLETED|Overall Study||510
108366|NCT01357135|261156|P1|COMPLETED|Overall Study||1276
108367|NCT01357135|261154|P3|STARTED|Overall Study||846
108368|NCT01357135|261155|P2|STARTED|Overall Study||733
108369|NCT01357135|261156|P1|STARTED|Overall Study||1874
108370|NCT01356966|261167|P2|NOT COMPLETED|Overall Study||2
108371|NCT01356966|261168|P1|NOT COMPLETED|Overall Study||2
108372|NCT01356966|261167|P2|COMPLETED|Overall Study||12
108373|NCT01356966|261168|P1|COMPLETED|Overall Study||16
108374|NCT01356966|261167|P2|STARTED|Overall Study||14
108375|NCT01356966|261168|P1|STARTED|Overall Study||18
108376|NCT01356940|261180|P2|NOT COMPLETED|Second Intervention (28 Days)||0
108377|NCT01356940|261181|P1|NOT COMPLETED|Second Intervention (28 Days)||1
108378|NCT01356940|261180|P2|COMPLETED|Second Intervention (28 Days)||21
108379|NCT01356940|261181|P1|COMPLETED|Second Intervention (28 Days)||20
108380|NCT01356940|261180|P2|STARTED|Second Intervention (28 Days)||21
108381|NCT01356940|261181|P1|STARTED|Second Intervention (28 Days)||21
108382|NCT01356940|261180|P2|NOT COMPLETED|Washout (14 Days)||0
108383|NCT01356940|261181|P1|NOT COMPLETED|Washout (14 Days)||0
108384|NCT01356940|261180|P2|COMPLETED|Washout (14 Days)||21
108385|NCT01356940|261181|P1|COMPLETED|Washout (14 Days)||21
108386|NCT01356940|261180|P2|STARTED|Washout (14 Days)||21
108387|NCT01356940|261181|P1|STARTED|Washout (14 Days)||21
108388|NCT01356940|261180|P2|NOT COMPLETED|First Intervention (28 Days)||0
108389|NCT01356940|261181|P1|NOT COMPLETED|First Intervention (28 Days)||1
108390|NCT01356940|261180|P2|COMPLETED|First Intervention (28 Days)||21
108391|NCT01356940|261181|P1|COMPLETED|First Intervention (28 Days)||21
108392|NCT01356940|261180|P2|STARTED|First Intervention (28 Days)||21
108393|NCT01356940|261181|P1|STARTED|First Intervention (28 Days)||22
108394|NCT01356667|261189|P2|NOT COMPLETED|Overall Study||6
108395|NCT01356667|261190|P1|NOT COMPLETED|Overall Study||4
108396|NCT01356667|261189|P2|COMPLETED|Overall Study||0
108397|NCT01356667|261190|P1|COMPLETED|Overall Study||0
108398|NCT01356667|261189|P2|STARTED|Overall Study||6
108399|NCT01356667|261190|P1|STARTED|Overall Study||4
108400|NCT01356628|261200|P1|NOT COMPLETED|Overall Study||0
108401|NCT01356628|261200|P1|COMPLETED|Overall Study||23
108402|NCT01356628|261200|P1|STARTED|Overall Study||23
108403|NCT01356602|261208|P3|NOT COMPLETED|Overall Study||24
108404|NCT01356602|261209|P2|NOT COMPLETED|Overall Study||15
108405|NCT01356602|261210|P1|NOT COMPLETED|Overall Study||9
108406|NCT01356602|261208|P3|COMPLETED|Overall Study||108
108407|NCT01356602|261209|P2|COMPLETED|Overall Study||117
108408|NCT01356602|261210|P1|COMPLETED|Overall Study||124
108409|NCT01356602|261208|P3|Full Analysis Set|Overall Study||129
108410|NCT01356602|261209|P2|Full Analysis Set|Overall Study||129
108411|NCT01356602|261210|P1|Full Analysis Set|Overall Study||131
108412|NCT01356602|261208|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
108413|NCT01356602|261209|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
108414|NCT01356602|261210|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
108415|NCT01356602|261208|P3|STARTED|Overall Study||132
108416|NCT01356602|261209|P2|STARTED|Overall Study||132
108417|NCT01356602|261210|P1|STARTED|Overall Study||133
108418|NCT01356589|261269|P1|NOT COMPLETED|Overall Study||5
108419|NCT01356589|261269|P1|COMPLETED|Overall Study||1283
108420|NCT01356589|261269|P1|Treated|Overall Study||1285
108421|NCT01356589|261269|P1|STARTED|Overall Study||1288
108422|NCT01356498|261281|P6|NOT COMPLETED|Overall Study||14
108423|NCT01356498|261282|P5|NOT COMPLETED|Overall Study||20
108424|NCT01356498|261283|P4|NOT COMPLETED|Overall Study||14
108425|NCT01356498|261284|P3|NOT COMPLETED|Overall Study||12
108426|NCT01356498|261285|P2|NOT COMPLETED|Overall Study||8
108427|NCT01356498|261286|P1|NOT COMPLETED|Overall Study||11
108428|NCT01356498|261281|P6|COMPLETED|Overall Study||2
108429|NCT01356498|261282|P5|COMPLETED|Overall Study||8
108430|NCT01356498|261283|P4|COMPLETED|Overall Study||8
108431|NCT01356498|261284|P3|COMPLETED|Overall Study||11
108432|NCT01356498|261285|P2|COMPLETED|Overall Study||17
108433|NCT01356498|261286|P1|COMPLETED|Overall Study||24
108434|NCT01356498|261281|P6|STARTED|Overall Study||16
108435|NCT01356498|261282|P5|STARTED|Overall Study||28
108436|NCT01356498|261283|P4|STARTED|Overall Study||22
108437|NCT01356498|261284|P3|STARTED|Overall Study||23
108438|NCT01356498|261285|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
108439|NCT01356498|261286|P1|STARTED|Overall Study||35
108440|NCT01356407|261326|P2|NOT COMPLETED|Overall Study||4
108441|NCT01356407|261327|P1|NOT COMPLETED|Overall Study||6
108442|NCT01356407|261326|P2|COMPLETED|Overall Study||146
108443|NCT01356407|261327|P1|COMPLETED|Overall Study||144
108444|NCT01356407|261326|P2|STARTED|Overall Study||150
108445|NCT01356407|261327|P1|STARTED|Overall Study||150
108446|NCT01356147|261345|P2|NOT COMPLETED|Overall Study||0
108447|NCT01356147|261346|P1|NOT COMPLETED|Overall Study||0
108448|NCT01356147|261345|P2|COMPLETED|Overall Study||6
108449|NCT01356147|261346|P1|COMPLETED|Overall Study||5
108450|NCT01356147|261345|P2|STARTED|Overall Study||6
108451|NCT01356147|261346|P1|STARTED|Overall Study||5
108452|NCT01355978|261352|P1|NOT COMPLETED|Overall Study||4
108453|NCT01355978|261352|P1|COMPLETED|Overall Study||18
108454|NCT01355978|261352|P1|STARTED|Overall Study||22
108455|NCT01355705|261358|P1|NOT COMPLETED|Overall Study||0
108456|NCT01355705|261358|P1|COMPLETED|Overall Study||14
108457|NCT01355705|261358|P1|STARTED|Overall Study||14
108458|NCT01355679|261365|P1|NOT COMPLETED|Overall Study||2
108459|NCT01355679|261365|P1|COMPLETED|Overall Study||14
108460|NCT01355679|261365|P1|STARTED|Overall Study||16
108461|NCT01355627|261374|P2|NOT COMPLETED|Overall Study||38
108462|NCT01355627|261375|P1|NOT COMPLETED|Overall Study||33
108463|NCT01355627|261374|P2|COMPLETED|Overall Study||326
108464|NCT01355627|261375|P1|COMPLETED|Overall Study||329
108465|NCT01355627|261374|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
108466|NCT01355627|261375|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
108467|NCT01355627|261374|P2|Safety Analysis Set|Overall Study||364
108468|NCT01355627|261375|P1|Safety Analysis Set|Overall Study||362
108469|NCT01355627|261374|P2|STARTED|Overall Study||364
108470|NCT01355627|261375|P1|STARTED|Overall Study||362
108471|NCT01355588|261387|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
108472|NCT01355588|261388|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
108473|NCT01355588|261389|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
108474|NCT01355588|261390|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
108475|NCT01355588|261387|P4|COMPLETED|Fourth Intervention (After Washout)||4
108476|NCT01355588|261388|P3|COMPLETED|Fourth Intervention (After Washout)||4
108477|NCT01355588|261389|P2|COMPLETED|Fourth Intervention (After Washout)||4
108478|NCT01355588|261390|P1|COMPLETED|Fourth Intervention (After Washout)||4
108479|NCT01355588|261387|P4|STARTED|Fourth Intervention (After Washout)||4
108480|NCT01355588|261388|P3|STARTED|Fourth Intervention (After Washout)||4
108481|NCT01355588|261389|P2|STARTED|Fourth Intervention (After Washout)||4
108482|NCT01355588|261390|P1|STARTED|Fourth Intervention (After Washout)||4
108483|NCT01355588|261387|P4|NOT COMPLETED|Washout (3-7 Days)||0
108484|NCT01355588|261388|P3|NOT COMPLETED|Washout (3-7 Days)||0
108485|NCT01355588|261389|P2|NOT COMPLETED|Washout (3-7 Days)||0
108486|NCT01355588|261390|P1|NOT COMPLETED|Washout (3-7 Days)||0
108487|NCT01355588|261387|P4|COMPLETED|Washout (3-7 Days)||4
108488|NCT01355588|261388|P3|COMPLETED|Washout (3-7 Days)||4
108489|NCT01355588|261389|P2|COMPLETED|Washout (3-7 Days)||4
108490|NCT01355588|261390|P1|COMPLETED|Washout (3-7 Days)||4
108491|NCT01355588|261387|P4|STARTED|Washout (3-7 Days)||4
108492|NCT01355588|261388|P3|STARTED|Washout (3-7 Days)||4
108493|NCT01355588|261389|P2|STARTED|Washout (3-7 Days)||4
108494|NCT01355588|261390|P1|STARTED|Washout (3-7 Days)||4
108495|NCT01355588|261387|P4|NOT COMPLETED|Third Intervention (After Washout)||0
108496|NCT01355588|261388|P3|NOT COMPLETED|Third Intervention (After Washout)||0
108497|NCT01355588|261389|P2|NOT COMPLETED|Third Intervention (After Washout)||0
108498|NCT01355588|261390|P1|NOT COMPLETED|Third Intervention (After Washout)||0
108499|NCT01355588|261387|P4|COMPLETED|Third Intervention (After Washout)||4
108500|NCT01355588|261388|P3|COMPLETED|Third Intervention (After Washout)||4
108501|NCT01355588|261389|P2|COMPLETED|Third Intervention (After Washout)||4
108502|NCT01355588|261390|P1|COMPLETED|Third Intervention (After Washout)||4
108503|NCT01355588|261387|P4|STARTED|Third Intervention (After Washout)||4
108504|NCT01355588|261388|P3|STARTED|Third Intervention (After Washout)||4
108505|NCT01355588|261389|P2|STARTED|Third Intervention (After Washout)||4
108506|NCT01355588|261390|P1|STARTED|Third Intervention (After Washout)||4
108507|NCT01355588|261387|P4|NOT COMPLETED|Washout (3-7 Days)||0
108508|NCT01355588|261388|P3|NOT COMPLETED|Washout (3-7 Days)||0
108509|NCT01355588|261389|P2|NOT COMPLETED|Washout (3-7 Days)||0
108510|NCT01355588|261390|P1|NOT COMPLETED|Washout (3-7 Days)||0
108511|NCT01355588|261387|P4|COMPLETED|Washout (3-7 Days)||4
108512|NCT01355588|261388|P3|COMPLETED|Washout (3-7 Days)||4
108513|NCT01355588|261389|P2|COMPLETED|Washout (3-7 Days)||4
108514|NCT01355588|261390|P1|COMPLETED|Washout (3-7 Days)||4
108515|NCT01355588|261387|P4|STARTED|Washout (3-7 Days)||4
108516|NCT01355588|261388|P3|STARTED|Washout (3-7 Days)||4
108517|NCT01355588|261389|P2|STARTED|Washout (3-7 Days)||4
108518|NCT01355588|261390|P1|STARTED|Washout (3-7 Days)||4
108519|NCT01355588|261387|P4|NOT COMPLETED|Second Intervention (After Washout)||0
108520|NCT01355588|261388|P3|NOT COMPLETED|Second Intervention (After Washout)||0
108521|NCT01355588|261389|P2|NOT COMPLETED|Second Intervention (After Washout)||0
108522|NCT01355588|261390|P1|NOT COMPLETED|Second Intervention (After Washout)||0
108523|NCT01355588|261387|P4|COMPLETED|Second Intervention (After Washout)||4
108524|NCT01355588|261388|P3|COMPLETED|Second Intervention (After Washout)||4
108525|NCT01355588|261389|P2|COMPLETED|Second Intervention (After Washout)||4
108526|NCT01355588|261390|P1|COMPLETED|Second Intervention (After Washout)||4
108527|NCT01355588|261387|P4|STARTED|Second Intervention (After Washout)||4
108528|NCT01355588|261388|P3|STARTED|Second Intervention (After Washout)||4
108529|NCT01355588|261389|P2|STARTED|Second Intervention (After Washout)||4
108530|NCT01355588|261390|P1|STARTED|Second Intervention (After Washout)||4
108531|NCT01355588|261387|P4|NOT COMPLETED|Washout (3-7 Days)||0
108532|NCT01355588|261388|P3|NOT COMPLETED|Washout (3-7 Days)||0
108533|NCT01355588|261389|P2|NOT COMPLETED|Washout (3-7 Days)||0
108534|NCT01355588|261390|P1|NOT COMPLETED|Washout (3-7 Days)||0
108535|NCT01355588|261387|P4|COMPLETED|Washout (3-7 Days)||4
108536|NCT01355588|261388|P3|COMPLETED|Washout (3-7 Days)||4
108537|NCT01355588|261389|P2|COMPLETED|Washout (3-7 Days)||4
108538|NCT01355588|261390|P1|COMPLETED|Washout (3-7 Days)||4
108539|NCT01355588|261387|P4|STARTED|Washout (3-7 Days)||4
108540|NCT01355588|261388|P3|STARTED|Washout (3-7 Days)||4
108541|NCT01355588|261389|P2|STARTED|Washout (3-7 Days)||4
108542|NCT01355588|261390|P1|STARTED|Washout (3-7 Days)||4
108543|NCT01355588|261387|P4|NOT COMPLETED|First Intervention (Day 1)||0
108544|NCT01355588|261388|P3|NOT COMPLETED|First Intervention (Day 1)||0
108545|NCT01355588|261389|P2|NOT COMPLETED|First Intervention (Day 1)||0
108546|NCT01355588|261390|P1|NOT COMPLETED|First Intervention (Day 1)||0
108547|NCT01355588|261387|P4|COMPLETED|First Intervention (Day 1)||4
108548|NCT01355588|261388|P3|COMPLETED|First Intervention (Day 1)||4
108549|NCT01355588|261389|P2|COMPLETED|First Intervention (Day 1)||4
108550|NCT01355588|261390|P1|COMPLETED|First Intervention (Day 1)||4
108551|NCT01355588|261387|P4|STARTED|First Intervention (Day 1)||4
108552|NCT01355588|261388|P3|STARTED|First Intervention (Day 1)||4
108553|NCT01355588|261389|P2|STARTED|First Intervention (Day 1)||4
108554|NCT01355588|261390|P1|STARTED|First Intervention (Day 1)||4
108555|NCT01355523|261414|P2|NOT COMPLETED|Overall Study||10
108556|NCT01355523|261415|P1|NOT COMPLETED|Overall Study||1
108557|NCT01355523|261414|P2|COMPLETED|Overall Study||16
108558|NCT01355523|261415|P1|COMPLETED|Overall Study||27
108559|NCT01355523|261414|P2|STARTED|Overall Study||26
108560|NCT01355523|261415|P1|STARTED|Overall Study||28
108561|NCT01355484|261459|P2|NOT COMPLETED|Overall Study||54
108562|NCT01355484|261460|P1|NOT COMPLETED|Overall Study||51
108563|NCT01355484|261459|P2|COMPLETED|Overall Study||107
108564|NCT01355484|261460|P1|COMPLETED|Overall Study||109
108565|NCT01355484|261459|P2|STARTED|Overall Study||161
108566|NCT01355484|261460|P1|STARTED|Overall Study||160
108567|NCT01355471|261470|P2|NOT COMPLETED|Overall Study||3
108568|NCT01355471|261471|P1|NOT COMPLETED|Overall Study||7
108569|NCT01355471|261470|P2|COMPLETED|Overall Study||142
108570|NCT01355471|261471|P1|COMPLETED|Overall Study||141
108571|NCT01355471|261470|P2|STARTED|Overall Study||145
108572|NCT01355471|261471|P1|STARTED|Overall Study||148
108573|NCT01355458|261479|P2|NOT COMPLETED|Overall Study||4
108574|NCT01355458|261480|P1|NOT COMPLETED|Overall Study||2
108575|NCT01355458|261479|P2|COMPLETED|Overall Study||127
108576|NCT01355458|261480|P1|COMPLETED|Overall Study||127
108577|NCT01355458|261479|P2|STARTED|Overall Study||131
108578|NCT01355458|261480|P1|STARTED|Overall Study||129
108579|NCT01355419|261486|P1|NOT COMPLETED|Overall Study||8
108580|NCT01355419|261486|P1|COMPLETED|Overall Study||142
108581|NCT01355419|261486|P1|STARTED|Overall Study||150
108582|NCT01355302|261491|P3|NOT COMPLETED|Phase 2||0
108583|NCT01355302|261492|P2|NOT COMPLETED|Phase 2||0
108584|NCT01355302|261493|P1|NOT COMPLETED|Phase 2||0
108585|NCT01355302|261491|P3|COMPLETED|Phase 2||0
108586|NCT01355302|261492|P2|COMPLETED|Phase 2||0
108587|NCT01355302|261493|P1|COMPLETED|Phase 2||0
108588|NCT01355302|261491|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
108589|NCT01355302|261492|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
108590|NCT01355302|261493|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
108591|NCT01355302|261491|P3|NOT COMPLETED|Phase 1b||0
108592|NCT01355302|261492|P2|NOT COMPLETED|Phase 1b||0
108593|NCT01355302|261493|P1|NOT COMPLETED|Phase 1b||6
108594|NCT01355302|261491|P3|COMPLETED|Phase 1b||0
108595|NCT01355302|261492|P2|COMPLETED|Phase 1b||0
108596|NCT01355302|261493|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
108597|NCT01355302|261491|P3|STARTED|Phase 1b||0
108598|NCT01355302|261492|P2|STARTED|Phase 1b||0
108599|NCT01355302|261493|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
108600|NCT01355289|261508|P5|NOT COMPLETED|Open Label Extension||34
108601|NCT01355289|261509|P4|NOT COMPLETED|Open Label Extension||0
108602|NCT01355289|261510|P3|NOT COMPLETED|Open Label Extension||0
108603|NCT01355289|261511|P2|NOT COMPLETED|Open Label Extension||0
108604|NCT01355289|261512|P1|NOT COMPLETED|Open Label Extension||0
108605|NCT01355289|261508|P5|COMPLETED|Open Label Extension||28
108606|NCT01355289|261509|P4|COMPLETED|Open Label Extension||0
108607|NCT01355289|261510|P3|COMPLETED|Open Label Extension||0
108608|NCT01355289|261511|P2|COMPLETED|Open Label Extension||0
108609|NCT01355289|261512|P1|COMPLETED|Open Label Extension||0
108610|NCT01355289|261508|P5|STARTED|Open Label Extension||62
108611|NCT01355289|261509|P4|STARTED|Open Label Extension||0
108612|NCT01355289|261510|P3|STARTED|Open Label Extension||0
108613|NCT01355289|261511|P2|STARTED|Open Label Extension||0
108614|NCT01355289|261512|P1|STARTED|Open Label Extension||0
108615|NCT01355289|261508|P5|NOT COMPLETED|Core Study||0
108616|NCT01355289|261509|P4|NOT COMPLETED|Core Study||2
108617|NCT01355289|261510|P3|NOT COMPLETED|Core Study||0
108618|NCT01355289|261511|P2|NOT COMPLETED|Core Study||0
108619|NCT01355289|261512|P1|NOT COMPLETED|Core Study||1
108620|NCT01355289|261508|P5|COMPLETED|Core Study||0
108621|NCT01355289|261509|P4|COMPLETED|Core Study||12
108622|NCT01355289|261510|P3|COMPLETED|Core Study||18
108623|NCT01355289|261511|P2|COMPLETED|Core Study||16
108624|NCT01355289|261512|P1|COMPLETED|Core Study||16
108625|NCT01355289|261508|P5|STARTED|Core Study||0
108626|NCT01355289|261509|P4|STARTED|Core Study||14
108627|NCT01355289|261510|P3|STARTED|Core Study||18
108628|NCT01355289|261511|P2|STARTED|Core Study||16
108629|NCT01355289|261512|P1|STARTED|Core Study||17
108630|NCT01355224|261539|P4|NOT COMPLETED|Overall Study||29
108631|NCT01355224|261540|P3|NOT COMPLETED|Overall Study||19
108632|NCT01355224|261541|P2|NOT COMPLETED|Overall Study||23
108633|NCT01355224|261542|P1|NOT COMPLETED|Overall Study||31
108634|NCT01355224|261539|P4|COMPLETED|Overall Study||172
108635|NCT01355224|261540|P3|COMPLETED|Overall Study||177
108636|NCT01355224|261541|P2|COMPLETED|Overall Study||180
108637|NCT01355224|261542|P1|COMPLETED|Overall Study||167
108638|NCT01355224|261539|P4|Competed Baseline|Overall Study||193
108639|NCT01355224|261540|P3|Competed Baseline|Overall Study||193
108640|NCT01355224|261541|P2|Competed Baseline|Overall Study||200
108641|NCT01355224|261542|P1|Competed Baseline|Overall Study||191
108642|NCT01355224|261539|P4|STARTED|Overall Study||201
108643|NCT01355224|261540|P3|STARTED|Overall Study||196
108644|NCT01355224|261541|P2|STARTED|Overall Study||203
108645|NCT01355224|261542|P1|STARTED|Overall Study||198
108646|NCT01355081|261565|P3|NOT COMPLETED|Overall Study||11
108647|NCT01355081|261566|P2|NOT COMPLETED|Overall Study||10
108648|NCT01355081|261567|P1|NOT COMPLETED|Overall Study||7
108649|NCT01355081|261565|P3|COMPLETED|Overall Study||113
108650|NCT01355081|261566|P2|COMPLETED|Overall Study||113
108651|NCT01355081|261567|P1|COMPLETED|Overall Study||112
108652|NCT01355081|261565|P3|STARTED|Overall Study||124
108653|NCT01355081|261566|P2|STARTED|Overall Study||123
108654|NCT01355081|261567|P1|STARTED|Overall Study||119
108655|NCT01355068|261590|P2|NOT COMPLETED|Second Intervention Period||0
108656|NCT01355068|261591|P1|NOT COMPLETED|Second Intervention Period||0
108657|NCT01355068|261590|P2|COMPLETED|Second Intervention Period||11
108658|NCT01355068|261591|P1|COMPLETED|Second Intervention Period||13
108659|NCT01355068|261590|P2|STARTED|Second Intervention Period||11
108660|NCT01355068|261591|P1|STARTED|Second Intervention Period||13
108661|NCT01355068|261590|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
108662|NCT01355068|261591|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
108663|NCT01355068|261590|P2|COMPLETED|Washout Period (at Least 7 Days)||11
108664|NCT01355068|261591|P1|COMPLETED|Washout Period (at Least 7 Days)||13
108665|NCT01355068|261590|P2|STARTED|Washout Period (at Least 7 Days)||11
108666|NCT01355068|261591|P1|STARTED|Washout Period (at Least 7 Days)||13
108667|NCT01355068|261590|P2|NOT COMPLETED|First Intervention Period||2
108668|NCT01355068|261591|P1|NOT COMPLETED|First Intervention Period||0
108669|NCT01355068|261590|P2|COMPLETED|First Intervention Period||11
108670|NCT01355068|261591|P1|COMPLETED|First Intervention Period||13
108671|NCT01355068|261590|P2|STARTED|First Intervention Period||13
108672|NCT01355068|261591|P1|STARTED|First Intervention Period||13
108673|NCT01354990|261607|P1|NOT COMPLETED|Overall Study||0
108674|NCT01354990|261607|P1|COMPLETED|Overall Study||2974
108675|NCT01354990|261607|P1|STARTED|Overall Study||2974
108676|NCT01354938|261614|P1|NOT COMPLETED|Overall Study||1
108677|NCT01354938|261614|P1|COMPLETED|Overall Study||219
108678|NCT01354938|261614|P1|STARTED|Overall Study||220
108679|NCT01354899|261620|P1|NOT COMPLETED|Overall Study||3
108680|NCT01354899|261620|P1|COMPLETED|Overall Study||21
108681|NCT01354899|261620|P1|STARTED|Overall Study||24
108682|NCT01354652|261628|P3|NOT COMPLETED|Overall Study||0
108683|NCT01354652|261629|P2|NOT COMPLETED|Overall Study||2
108684|NCT01354652|261630|P1|NOT COMPLETED|Overall Study||3
108685|NCT01354652|261628|P3|COMPLETED|Overall Study||0
108686|NCT01354652|261629|P2|COMPLETED|Overall Study||0
108687|NCT01354652|261630|P1|COMPLETED|Overall Study||0
108688|NCT01354652|261628|P3|STARTED|Overall Study||0
108689|NCT01354652|261629|P2|STARTED|Overall Study||2
108690|NCT01354652|261630|P1|STARTED|Overall Study||3
108691|NCT01354444|261655|P2|NOT COMPLETED|Overall Study||4
108692|NCT01354444|261656|P1|NOT COMPLETED|Overall Study||8
108693|NCT01354444|261655|P2|COMPLETED|Overall Study||11
108694|NCT01354444|261656|P1|COMPLETED|Overall Study||6
108695|NCT01354444|261655|P2|STARTED|Overall Study||15
108696|NCT01354444|261656|P1|STARTED|Overall Study||14
108697|NCT01354431|261669|P3|NOT COMPLETED|Participants Treated||54
108698|NCT01354431|261670|P2|NOT COMPLETED|Participants Treated||54
108699|NCT01354431|261671|P1|NOT COMPLETED|Participants Treated||59
108700|NCT01354431|261669|P3|COMPLETED|Participants Treated||0
108701|NCT01354431|261670|P2|COMPLETED|Participants Treated||0
108702|NCT01354431|261671|P1|COMPLETED|Participants Treated||0
108703|NCT01354431|261669|P3|STARTED|Participants Treated||54
108704|NCT01354431|261670|P2|STARTED|Participants Treated||54
108705|NCT01354431|261671|P1|STARTED|Participants Treated||59
108706|NCT01354431|261669|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
108707|NCT01354431|261670|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
108708|NCT01354431|261671|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
108709|NCT01354431|261669|P3|COMPLETED|Randomized to Enter Treatment Period||54
108710|NCT01354431|261670|P2|COMPLETED|Randomized to Enter Treatment Period||54
108711|NCT01354431|261671|P1|COMPLETED|Randomized to Enter Treatment Period||59
108712|NCT01354431|261669|P3|STARTED|Randomized to Enter Treatment Period||54
108713|NCT01354431|261670|P2|STARTED|Randomized to Enter Treatment Period||54
108714|NCT01354431|261671|P1|STARTED|Randomized to Enter Treatment Period||60
108715|NCT01354314|261695|P4|NOT COMPLETED|Overall Study||6
108716|NCT01354314|261696|P3|NOT COMPLETED|Overall Study||8
108717|NCT01354314|261697|P2|NOT COMPLETED|Overall Study||3
108718|NCT01354314|261698|P1|NOT COMPLETED|Overall Study||6
108719|NCT01354314|261695|P4|COMPLETED|Overall Study||5
108720|NCT01354314|261696|P3|COMPLETED|Overall Study||3
108721|NCT01354314|261697|P2|COMPLETED|Overall Study||8
108722|NCT01354314|261698|P1|COMPLETED|Overall Study||6
108723|NCT01354314|261695|P4|Completed (ITT)|Overall Study||10
108724|NCT01354314|261696|P3|Completed (ITT)|Overall Study||9
108725|NCT01354314|261697|P2|Completed (ITT)|Overall Study||11
108726|NCT01354314|261698|P1|Completed (ITT)|Overall Study||11
108727|NCT01354314|261695|P4|STARTED|Overall Study||11
108728|NCT01354314|261696|P3|STARTED|Overall Study||11
108729|NCT01354314|261697|P2|STARTED|Overall Study||11
108730|NCT01354314|261698|P1|STARTED|Overall Study||12
108731|NCT01354223|261834|P2|NOT COMPLETED|Overall Study||1
108732|NCT01354223|261835|P1|NOT COMPLETED|Overall Study||3
108733|NCT01354223|261834|P2|COMPLETED|Overall Study||29
108734|NCT01354223|261835|P1|COMPLETED|Overall Study||57
108735|NCT01354223|261834|P2|STARTED|Overall Study||30
108736|NCT01354223|261835|P1|STARTED|Overall Study||60
108737|NCT01354197|261851|P1|NOT COMPLETED|Overall Study||0
108738|NCT01354197|261851|P1|COMPLETED|Overall Study||4652
108739|NCT01354197|261851|P1|STARTED|Overall Study||4652
108740|NCT01354145|261859|P2|NOT COMPLETED|Overall Study||34
108741|NCT01354145|261860|P1|NOT COMPLETED|Overall Study||39
108742|NCT01354145|261859|P2|COMPLETED|Overall Study||63
108743|NCT01354145|261860|P1|COMPLETED|Overall Study||58
108744|NCT01354145|261859|P2|STARTED|Overall Study||97
108745|NCT01354145|261860|P1|STARTED|Overall Study||97
108746|NCT01354132|261894|P2|NOT COMPLETED|1 Month Post Study Medication||3
108747|NCT01354132|261895|P1|NOT COMPLETED|1 Month Post Study Medication||1
108748|NCT01354132|261894|P2|COMPLETED|1 Month Post Study Medication||16
108749|NCT01354132|261895|P1|COMPLETED|1 Month Post Study Medication||21
108750|NCT01354132|261894|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
108751|NCT01354132|261895|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
108752|NCT01354132|261894|P2|STARTED|1 Month Post Study Medication||19
108753|NCT01354132|261895|P1|STARTED|1 Month Post Study Medication||22
108754|NCT01354132|261894|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
108755|NCT01354132|261895|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
108756|NCT01354132|261894|P2|COMPLETED|Double Blind (Visits 1-7)||19
108757|NCT01354132|261895|P1|COMPLETED|Double Blind (Visits 1-7)||22
108758|NCT01354132|261894|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
108759|NCT01354132|261895|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
108760|NCT01354132|261894|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
108761|NCT01354132|261895|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
108762|NCT01354132|261894|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
108763|NCT01354132|261895|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
108764|NCT01354132|261894|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
108765|NCT01354132|261895|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
108766|NCT01354132|261894|P2|NOT COMPLETED|Randomization||1
108767|NCT01354132|261895|P1|NOT COMPLETED|Randomization||1
108768|NCT01354132|261894|P2|COMPLETED|Randomization||30
108769|NCT01354132|261895|P1|COMPLETED|Randomization||31
108770|NCT01354132|261894|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
108771|NCT01354132|261895|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
108772|NCT01354106|261933|P1|NOT COMPLETED|Overall Study||2
108773|NCT01354106|261933|P1|COMPLETED|Overall Study||24
108774|NCT01354106|261933|P1|STARTED|Overall Study||26
108775|NCT01354028|261939|P2|NOT COMPLETED|Overall Study||5
108776|NCT01354028|261940|P1|NOT COMPLETED|Overall Study||2
108777|NCT01354028|261939|P2|COMPLETED|Overall Study||10
108778|NCT01354028|261940|P1|COMPLETED|Overall Study||13
108779|NCT01354028|261939|P2|STARTED|Overall Study||15
108780|NCT01354028|261940|P1|STARTED|Overall Study||15
108781|NCT01354015|261954|P2|NOT COMPLETED|Overall Study||5
108782|NCT01354015|261955|P1|NOT COMPLETED|Overall Study||6
108783|NCT01354015|261954|P2|COMPLETED|Overall Study||43
108784|NCT01354015|261955|P1|COMPLETED|Overall Study||44
108785|NCT01354015|261954|P2|STARTED|Overall Study||48
108786|NCT01354015|261955|P1|STARTED|Overall Study||50
108787|NCT01353976|261965|P2|NOT COMPLETED|Overall Study||51
108788|NCT01353976|261966|P1|NOT COMPLETED|Overall Study||48
108789|NCT01353976|261965|P2|COMPLETED|Overall Study||83
108790|NCT01353976|261966|P1|COMPLETED|Overall Study||82
108791|NCT01353976|261965|P2|STARTED|Overall Study||134
108792|NCT01353976|261966|P1|STARTED|Overall Study||130
108793|NCT01353963|261976|P1|NOT COMPLETED|Overall Study||2
108794|NCT01353963|261976|P1|COMPLETED|Overall Study||11
108795|NCT01353963|261976|P1|STARTED|Overall Study||13
108796|NCT01353911|261994|P8|NOT COMPLETED|Overall Study||15
108797|NCT01353911|261995|P7|NOT COMPLETED|Overall Study||6
108798|NCT01353911|261996|P6|NOT COMPLETED|Overall Study||7
108799|NCT01353911|261997|P5|NOT COMPLETED|Overall Study||6
108800|NCT01353911|261998|P4|NOT COMPLETED|Overall Study||2
108801|NCT01353911|261999|P3|NOT COMPLETED|Overall Study||9
108802|NCT01353911|262000|P2|NOT COMPLETED|Overall Study||9
108803|NCT01353911|262001|P1|NOT COMPLETED|Overall Study||8
108804|NCT01353911|261994|P8|COMPLETED|Overall Study||51
108805|NCT01353911|261995|P7|COMPLETED|Overall Study||30
108806|NCT01353911|261996|P6|COMPLETED|Overall Study||36
108807|NCT01353911|261997|P5|COMPLETED|Overall Study||23
108808|NCT01353911|261998|P4|COMPLETED|Overall Study||22
108809|NCT01353911|261999|P3|COMPLETED|Overall Study||59
108810|NCT01353911|262000|P2|COMPLETED|Overall Study||57
108811|NCT01353911|262001|P1|COMPLETED|Overall Study||28
108812|NCT01353911|261994|P8|STARTED|Overall Study||66
108813|NCT01353911|261995|P7|STARTED|Overall Study||36
108814|NCT01353911|261996|P6|STARTED|Overall Study||43
108815|NCT01353911|261997|P5|STARTED|Overall Study||29
108816|NCT01353911|261998|P4|STARTED|Overall Study||24
108817|NCT01353911|261999|P3|STARTED|Overall Study||68
108818|NCT01353911|262000|P2|STARTED|Overall Study||66
108819|NCT01353911|262001|P1|STARTED|Overall Study||36
108820|NCT01353898|262081|P6|NOT COMPLETED|Overall Study||1
108821|NCT01353898|262082|P5|NOT COMPLETED|Overall Study||0
108822|NCT01353898|262083|P4|NOT COMPLETED|Overall Study||0
108823|NCT01353898|262084|P3|NOT COMPLETED|Overall Study||0
108824|NCT01353898|262085|P2|NOT COMPLETED|Overall Study||0
108825|NCT01353898|262086|P1|NOT COMPLETED|Overall Study||0
108826|NCT01353898|262081|P6|COMPLETED|Overall Study||1
108827|NCT01353898|262082|P5|COMPLETED|Overall Study||2
108828|NCT01353898|262083|P4|COMPLETED|Overall Study||2
108829|NCT01353898|262084|P3|COMPLETED|Overall Study||2
108830|NCT01353898|262085|P2|COMPLETED|Overall Study||2
108831|NCT01353898|262086|P1|COMPLETED|Overall Study||2
108832|NCT01353898|262081|P6|STARTED|Overall Study||2
108833|NCT01353898|262082|P5|STARTED|Overall Study||2
108834|NCT01353898|262083|P4|STARTED|Overall Study||2
108835|NCT01353898|262084|P3|STARTED|Overall Study||2
108836|NCT01353898|262085|P2|STARTED|Overall Study||2
108837|NCT01353898|262086|P1|STARTED|Overall Study||2
108838|NCT01353859|262112|P1|NOT COMPLETED|Overall Study||4
108839|NCT01353859|262112|P1|COMPLETED|Overall Study||35
108840|NCT01353859|262112|P1|STARTED|Overall Study||39
108841|NCT01353664|262125|P1|NOT COMPLETED|Overall Study||19
108842|NCT01353664|262125|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
108843|NCT01353664|262125|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
108844|NCT01353586|262131|P2|NOT COMPLETED|Overall Study||2
108845|NCT01353586|262132|P1|NOT COMPLETED|Overall Study||7
108846|NCT01353586|262131|P2|COMPLETED|Overall Study||17
108847|NCT01353586|262132|P1|COMPLETED|Overall Study||160
108848|NCT01353586|262131|P2|Participated in SNA Substudy|Overall Study||19
108849|NCT01353586|262132|P1|Participated in SNA Substudy|Overall Study||19
108850|NCT01353586|262131|P2|Participated in Roll-in Phase|Overall Study||0
108851|NCT01353586|262132|P1|Participated in Roll-in Phase|Overall Study||22
108852|NCT01353586|262131|P2|Participated in Workflow Phase|Overall Study||0
108853|NCT01353586|262132|P1|Participated in Workflow Phase|Overall Study||20
108854|NCT01353586|262131|P2|STARTED|Overall Study||19
108855|NCT01353586|262132|P1|STARTED|Overall Study||167
108856|NCT01353508|262150|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
108857|NCT01353508|262151|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
108858|NCT01353508|262152|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
108859|NCT01353508|262153|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
108860|NCT01353508|262150|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
108861|NCT01353508|262151|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
108862|NCT01353508|262152|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
108863|NCT01353508|262153|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
108864|NCT01353508|262150|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
108865|NCT01353508|262151|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
108866|NCT01353508|262152|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
108867|NCT01353508|262153|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
108868|NCT01353508|262150|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
108869|NCT01353508|262151|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
108870|NCT01353508|262152|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
108871|NCT01353508|262153|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
108872|NCT01353508|262150|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
108873|NCT01353508|262151|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
108874|NCT01353508|262152|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
108875|NCT01353508|262153|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
108876|NCT01353508|262150|P4|STARTED|Period 1 - First Intervention (7 Days)||8
108877|NCT01353508|262151|P3|STARTED|Period 1 - First Intervention (7 Days)||8
108878|NCT01353508|262152|P2|STARTED|Period 1 - First Intervention (7 Days)||8
108879|NCT01353508|262153|P1|STARTED|Period 1 - First Intervention (7 Days)||8
108880|NCT01353274|262231|P1|NOT COMPLETED|Overall Study||28
108881|NCT01353274|262231|P1|COMPLETED|Overall Study||1129
108882|NCT01353274|262231|P1|STARTED|Overall Study||1157
108883|NCT01353222|262241|P2|NOT COMPLETED|Overall Study||72
108884|NCT01353222|262242|P1|NOT COMPLETED|Overall Study||70
108885|NCT01353222|262241|P2|COMPLETED|Overall Study||0
108886|NCT01353222|262242|P1|COMPLETED|Overall Study||0
108887|NCT01353222|262241|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
108888|NCT01353222|262242|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
108889|NCT01353222|262241|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
108890|NCT01353222|262242|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
108891|NCT01353222|262241|P2|STARTED|Overall Study||72
108892|NCT01353222|262242|P1|STARTED|Overall Study||70
108893|NCT01353144|262250|P2|NOT COMPLETED|Overall Study||8
108894|NCT01353144|262251|P1|NOT COMPLETED|Overall Study||9
108895|NCT01353144|262250|P2|COMPLETED|Overall Study||81
108896|NCT01353144|262251|P1|COMPLETED|Overall Study||80
108897|NCT01353144|262250|P2|STARTED|Overall Study||89
108898|NCT01353144|262251|P1|STARTED|Overall Study||89
108899|NCT01353079|262261|P2|NOT COMPLETED|Overall Study||21
108900|NCT01353079|262262|P1|NOT COMPLETED|Overall Study||27
108901|NCT01353079|262261|P2|COMPLETED|Overall Study||190
108902|NCT01353079|262262|P1|COMPLETED|Overall Study||191
108903|NCT01353079|262261|P2|STARTED|Overall Study||211
108904|NCT01353079|262262|P1|STARTED|Overall Study||218
108905|NCT01352845|262276|P2|NOT COMPLETED|Overall Study||203
108906|NCT01352845|262277|P1|NOT COMPLETED|Overall Study||671
108907|NCT01352845|262276|P2|COMPLETED|Overall Study||619
108908|NCT01352845|262277|P1|COMPLETED|Overall Study||1800
108909|NCT01352845|262276|P2|STARTED|Overall Study||822
108910|NCT01352845|262277|P1|STARTED|Overall Study||2471
108911|NCT01352793|262366|P2|NOT COMPLETED|Overall Study||245
108912|NCT01352793|262367|P1|NOT COMPLETED|Overall Study||585
108913|NCT01352793|262366|P2|COMPLETED|Overall Study||1663
108914|NCT01352793|262367|P1|COMPLETED|Overall Study||3219
108915|NCT01352793|262366|P2|Vaccination 3|Overall Study||1710
108916|NCT01352793|262367|P1|Vaccination 3|Overall Study||3314
108917|NCT01352793|262366|P2|Vaccination 2|Overall Study||1806
108918|NCT01352793|262367|P1|Vaccination 2|Overall Study||3530
108919|NCT01352793|262366|P2|Vaccination 1|Overall Study||1908
108920|NCT01352793|262367|P1|Vaccination 1|Overall Study||3796
108921|NCT01352793|262366|P2|STARTED|Overall Study||1908
108922|NCT01352793|262367|P1|STARTED|Overall Study||3804
108923|NCT01352741|262391|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
108924|NCT01352741|262392|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
108925|NCT01352741|262391|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
108926|NCT01352741|262392|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
108927|NCT01352741|262391|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
108928|NCT01352741|262392|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
108929|NCT01352741|262391|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
108930|NCT01352741|262392|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
108931|NCT01352741|262391|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
108932|NCT01352741|262392|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
108933|NCT01352741|262391|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
108934|NCT01352741|262392|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
108935|NCT01352741|262391|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
108936|NCT01352741|262392|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
108937|NCT01352741|262391|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
108938|NCT01352741|262392|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
108939|NCT01352741|262391|P2|NOT COMPLETED|Double-blind Comparative Period||26
108940|NCT01352741|262392|P1|NOT COMPLETED|Double-blind Comparative Period||28
108941|NCT01352741|262391|P2|COMPLETED|Double-blind Comparative Period||133
108942|NCT01352741|262392|P1|COMPLETED|Double-blind Comparative Period||126
108943|NCT01352741|262391|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
108944|NCT01352741|262392|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
108945|NCT01352741|262391|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
109022|NCT01352468|262561|P1|COMPLETED|Overall Study||17
108946|NCT01352741|262392|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
108947|NCT01352741|262391|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
108948|NCT01352741|262392|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
108949|NCT01352741|262391|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
108950|NCT01352741|262392|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
108951|NCT01352741|262391|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
108952|NCT01352741|262392|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
108953|NCT01352741|262391|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
108954|NCT01352741|262392|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
108955|NCT01352741|262391|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
108956|NCT01352741|262392|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
108957|NCT01352741|262391|P2|Per Protocol Set|Double-blind Comparative Period||149
108958|NCT01352741|262392|P1|Per Protocol Set|Double-blind Comparative Period||139
108959|NCT01352741|262391|P2|Major Protocol Deviations|Double-blind Comparative Period||8
108960|NCT01352741|262392|P1|Major Protocol Deviations|Double-blind Comparative Period||13
108961|NCT01352741|262391|P2|Full Analysis Set|Double-blind Comparative Period||157
108962|NCT01352741|262392|P1|Full Analysis Set|Double-blind Comparative Period||152
108963|NCT01352741|262391|P2|No Pain Assessments Available|Double-blind Comparative Period||2
108964|NCT01352741|262392|P1|No Pain Assessments Available|Double-blind Comparative Period||2
108965|NCT01352741|262391|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
108966|NCT01352741|262392|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
108967|NCT01352741|262391|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
108968|NCT01352741|262392|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
108969|NCT01352741|262391|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
108970|NCT01352741|262392|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
108971|NCT01352741|262391|P2|COMPLETED|Open-label Tapentadol Titration Period||0
108972|NCT01352741|262392|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
108973|NCT01352741|262391|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
108974|NCT01352741|262392|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
108975|NCT01352741|262391|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
108976|NCT01352741|262392|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
108977|NCT01352741|262391|P2|STARTED|Open-label Tapentadol Titration Period||0
108978|NCT01352741|262392|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
108979|NCT01352715|262486|P2|NOT COMPLETED|Overall Study||46
108980|NCT01352715|262487|P1|NOT COMPLETED|Overall Study||45
108981|NCT01352715|262486|P2|COMPLETED|Overall Study||209
108982|NCT01352715|262487|P1|COMPLETED|Overall Study||215
108983|NCT01352715|262486|P2|STARTED|Overall Study||255
108984|NCT01352715|262487|P1|STARTED|Overall Study||260
108985|NCT01352585|262509|P1|NOT COMPLETED|Overall Study||11
108986|NCT01352585|262509|P1|COMPLETED|Overall Study||36
108987|NCT01352585|262509|P1|STARTED|Overall Study||47
108988|NCT01352546|262520|P1|NOT COMPLETED|Overall Study||0
108989|NCT01352546|262520|P1|COMPLETED|Overall Study||31
108990|NCT01352546|262520|P1|STARTED|Overall Study||31
108991|NCT01352507|262526|P2|NOT COMPLETED|Extension Phase||0
108992|NCT01352507|262527|P1|NOT COMPLETED|Extension Phase||0
108993|NCT01352507|262526|P2|COMPLETED|Extension Phase||173
108994|NCT01352507|262527|P1|COMPLETED|Extension Phase||164
108995|NCT01352507|262526|P2|STARTED|Extension Phase||173
108996|NCT01352507|262527|P1|STARTED|Extension Phase||164
108997|NCT01352507|262526|P2|NOT COMPLETED|Treatment Period 2||3
108998|NCT01352507|262527|P1|NOT COMPLETED|Treatment Period 2||6
108999|NCT01352507|262526|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
109000|NCT01352507|262527|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
109001|NCT01352507|262526|P2|Received Treatment|Treatment Period 2||181
109002|NCT01352507|262527|P1|Received Treatment|Treatment Period 2||173
109003|NCT01352507|262526|P2|STARTED|Treatment Period 2||183
109004|NCT01352507|262527|P1|STARTED|Treatment Period 2||176
109005|NCT01352507|262526|P2|NOT COMPLETED|Washout Period||1
109006|NCT01352507|262527|P1|NOT COMPLETED|Washout Period||0
109007|NCT01352507|262526|P2|COMPLETED|Washout Period||183
109008|NCT01352507|262527|P1|COMPLETED|Washout Period||176
109009|NCT01352507|262526|P2|STARTED|Washout Period||184
109010|NCT01352507|262527|P1|STARTED|Washout Period||176
109011|NCT01352507|262526|P2|NOT COMPLETED|Treatment Period 1||9
109012|NCT01352507|262527|P1|NOT COMPLETED|Treatment Period 1||14
109013|NCT01352507|262526|P2|COMPLETED|Treatment Period 1||184
109014|NCT01352507|262527|P1|COMPLETED|Treatment Period 1||176
109015|NCT01352507|262526|P2|Received Treatment|Treatment Period 1||188
109016|NCT01352507|262527|P1|Received Treatment|Treatment Period 1||182
109017|NCT01352507|262526|P2|STARTED|Treatment Period 1||193
109018|NCT01352507|262527|P1|STARTED|Treatment Period 1||190
109019|NCT01352468|262560|P2|NOT COMPLETED|Overall Study||4
109020|NCT01352468|262561|P1|NOT COMPLETED|Overall Study||5
109021|NCT01352468|262560|P2|COMPLETED|Overall Study||18
109023|NCT01352468|262560|P2|STARTED|Overall Study||22
109024|NCT01352468|262561|P1|STARTED|Overall Study||22
109025|NCT01352442|262571|P1|NOT COMPLETED|Overall Study||12
109026|NCT01352442|262571|P1|COMPLETED|Overall Study||139
109027|NCT01352442|262571|P1|STARTED|Overall Study||151
109028|NCT01352416|262580|P4|NOT COMPLETED|Overall Study||1
109029|NCT01352416|262581|P3|NOT COMPLETED|Overall Study||2
109030|NCT01352416|262582|P2|NOT COMPLETED|Overall Study||2
109031|NCT01352416|262583|P1|NOT COMPLETED|Overall Study||1
109032|NCT01352416|262580|P4|COMPLETED|Overall Study||1
109033|NCT01352416|262581|P3|COMPLETED|Overall Study||0
109034|NCT01352416|262582|P2|COMPLETED|Overall Study||5
109035|NCT01352416|262583|P1|COMPLETED|Overall Study||3
109036|NCT01352416|262580|P4|STARTED|Overall Study||2
109037|NCT01352416|262581|P3|STARTED|Overall Study||2
109038|NCT01352416|262582|P2|STARTED|Overall Study||7
109039|NCT01352416|262583|P1|STARTED|Overall Study||4
109040|NCT01352221|262595|P4|NOT COMPLETED|Open-label Phase||11
109041|NCT01352221|262596|P3|NOT COMPLETED|Open-label Phase||13
109042|NCT01352221|262597|P2|NOT COMPLETED|Open-label Phase||0
109043|NCT01352221|262598|P1|NOT COMPLETED|Open-label Phase||0
109044|NCT01352221|262595|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
109045|NCT01352221|262596|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
109046|NCT01352221|262597|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
109047|NCT01352221|262598|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
109048|NCT01352221|262595|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
109049|NCT01352221|262596|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
109050|NCT01352221|262597|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
109051|NCT01352221|262598|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
109052|NCT01352221|262595|P4|NOT COMPLETED|Double-blind Phase||0
109053|NCT01352221|262596|P3|NOT COMPLETED|Double-blind Phase||0
109054|NCT01352221|262597|P2|NOT COMPLETED|Double-blind Phase||11
109055|NCT01352221|262598|P1|NOT COMPLETED|Double-blind Phase||9
109056|NCT01352221|262595|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
109057|NCT01352221|262596|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
109058|NCT01352221|262597|P2|COMPLETED|Double-blind Phase||53
109059|NCT01352221|262598|P1|COMPLETED|Double-blind Phase||55
109060|NCT01352221|262595|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
109061|NCT01352221|262596|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
109062|NCT01352221|262597|P2|STARTED|Double-blind Phase||64
109063|NCT01352221|262598|P1|STARTED|Double-blind Phase||64
109064|NCT01352117|262658|P2|NOT COMPLETED|Overall Study||96
109065|NCT01352117|262659|P1|NOT COMPLETED|Overall Study||68
109066|NCT01352117|262658|P2|COMPLETED|Overall Study||0
109067|NCT01352117|262659|P1|COMPLETED|Overall Study||28
109068|NCT01352117|262658|P2|Study Week 96 Data Potential|Overall Study||61
109069|NCT01352117|262659|P1|Study Week 96 Data Potential|Overall Study||58
109070|NCT01352117|262658|P2|Study Week 48 Data Potential|Overall Study||83
109071|NCT01352117|262659|P1|Study Week 48 Data Potential|Overall Study||80
109072|NCT01352117|262658|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
109073|NCT01352117|262659|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
109074|NCT01352117|262658|P2|STARTED|Overall Study||96
109075|NCT01352117|262659|P1|STARTED|Overall Study||96
109076|NCT01351623|262711|P1|NOT COMPLETED|Overall Study||9
109077|NCT01351623|262711|P1|COMPLETED|Overall Study||35
109078|NCT01351623|262711|P1|STARTED|Overall Study||44
109079|NCT01351506|262717|P1|NOT COMPLETED|Overall Study||137
109080|NCT01351506|262717|P1|COMPLETED|Overall Study||465
109081|NCT01351506|262717|P1|STARTED|Overall Study||602
109082|NCT01351480|262727|P1|NOT COMPLETED|Overall Study||8
109083|NCT01351480|262727|P1|COMPLETED|Overall Study||26
109084|NCT01351480|262727|P1|STARTED|Overall Study||34
109085|NCT01351415|262737|P2|NOT COMPLETED|Overall Study||240
109086|NCT01351415|262738|P1|NOT COMPLETED|Overall Study||245
109087|NCT01351415|262737|P2|COMPLETED|Overall Study||0
109088|NCT01351415|262738|P1|COMPLETED|Overall Study||0
109089|NCT01351415|262737|P2|Treated Participants|Overall Study||232
109090|NCT01351415|262738|P1|Treated Participants|Overall Study||243
109091|NCT01351415|262737|P2|STARTED|Overall Study||240
109092|NCT01351415|262738|P1|STARTED|Overall Study||245
109093|NCT01351337|262758|P1|NOT COMPLETED|Overall Study||0
109094|NCT01351337|262758|P1|COMPLETED|Overall Study||58
109095|NCT01351337|262758|P1|STARTED|Overall Study||58
109096|NCT01351090|262767|P3|NOT COMPLETED|Overall Study||6
109097|NCT01351090|262768|P2|NOT COMPLETED|Overall Study||11
109098|NCT01351090|262769|P1|NOT COMPLETED|Overall Study||11
109099|NCT01351090|262767|P3|COMPLETED|Overall Study||36
109100|NCT01351090|262768|P2|COMPLETED|Overall Study||31
109101|NCT01351090|262769|P1|COMPLETED|Overall Study||32
109102|NCT01351090|262767|P3|STARTED|Overall Study||42
109103|NCT01351090|262768|P2|STARTED|Overall Study||42
109104|NCT01351090|262769|P1|STARTED|Overall Study||43
109105|NCT01351077|262788|P2|NOT COMPLETED|Overall Study||0
109106|NCT01351077|262789|P1|NOT COMPLETED|Overall Study||0
109107|NCT01351077|262788|P2|COMPLETED|Overall Study||180
109108|NCT01351077|262789|P1|COMPLETED|Overall Study||180
109109|NCT01351077|262788|P2|STARTED|Overall Study||180
109110|NCT01351077|262789|P1|STARTED|Overall Study||180
109111|NCT01351064|262805|P2|NOT COMPLETED|Overall Study||0
109112|NCT01351064|262806|P1|NOT COMPLETED|Overall Study||0
109113|NCT01351064|262805|P2|COMPLETED|Overall Study||42
109114|NCT01351064|262806|P1|COMPLETED|Overall Study||42
109115|NCT01351064|262805|P2|STARTED|Overall Study||42
109116|NCT01351064|262806|P1|STARTED|Overall Study||42
109117|NCT01351025|262816|P2|NOT COMPLETED|Week 44 - 48||0
109118|NCT01351025|262817|P1|NOT COMPLETED|Week 44 - 48||0
109119|NCT01351025|262816|P2|COMPLETED|Week 44 - 48||43
109120|NCT01351025|262817|P1|COMPLETED|Week 44 - 48||42
109121|NCT01351025|262816|P2|STARTED|Week 44 - 48||43
109122|NCT01351025|262817|P1|STARTED|Week 44 - 48||42
109123|NCT01351025|262816|P2|NOT COMPLETED|Week 24 - 44||4
109124|NCT01351025|262817|P1|NOT COMPLETED|Week 24 - 44||1
109125|NCT01351025|262816|P2|COMPLETED|Week 24 - 44||43
109126|NCT01351025|262817|P1|COMPLETED|Week 24 - 44||42
109127|NCT01351025|262816|P2|STARTED|Week 24 - 44||47
109128|NCT01351025|262817|P1|STARTED|Week 24 - 44||43
109129|NCT01351025|262816|P2|NOT COMPLETED|Week 20 - 24||0
109130|NCT01351025|262817|P1|NOT COMPLETED|Week 20 - 24||0
109131|NCT01351025|262816|P2|COMPLETED|Week 20 - 24||47
109132|NCT01351025|262817|P1|COMPLETED|Week 20 - 24||43
109133|NCT01351025|262816|P2|STARTED|Week 20 - 24||47
109134|NCT01351025|262817|P1|STARTED|Week 20 - 24||43
109135|NCT01351025|262816|P2|NOT COMPLETED|Week 0 - 20||1
109136|NCT01351025|262817|P1|NOT COMPLETED|Week 0 - 20||3
109137|NCT01351025|262816|P2|COMPLETED|Week 0 - 20||47
109138|NCT01351025|262817|P1|COMPLETED|Week 0 - 20||43
109139|NCT01351025|262816|P2|STARTED|Week 0 - 20||48
109140|NCT01351025|262817|P1|STARTED|Week 0 - 20||46
109141|NCT01350999|262850|P3|NOT COMPLETED|Overall Study||21
109142|NCT01350999|262851|P2|NOT COMPLETED|Overall Study||14
109143|NCT01350999|262852|P1|NOT COMPLETED|Overall Study||8
109144|NCT01350999|262850|P3|COMPLETED|Overall Study||146
109145|NCT01350999|262851|P2|COMPLETED|Overall Study||157
109146|NCT01350999|262852|P1|COMPLETED|Overall Study||157
109147|NCT01350999|262850|P3|Treated|Overall Study||167
109148|NCT01350999|262851|P2|Treated|Overall Study||171
109149|NCT01350999|262852|P1|Treated|Overall Study||165
109150|NCT01350999|262850|P3|STARTED|Overall Study||167
109151|NCT01350999|262851|P2|STARTED|Overall Study||171
109152|NCT01350999|262852|P1|STARTED|Overall Study||165
109153|NCT01350973|262890|P3|NOT COMPLETED|Overall Study||8
109154|NCT01350973|262891|P2|NOT COMPLETED|Overall Study||8
109155|NCT01350973|262892|P1|NOT COMPLETED|Overall Study||6
109156|NCT01350973|262890|P3|COMPLETED|Overall Study||187
109157|NCT01350973|262891|P2|COMPLETED|Overall Study||202
109158|NCT01350973|262892|P1|COMPLETED|Overall Study||200
109159|NCT01350973|262890|P3|Received Treatment|Overall Study||195
109160|NCT01350973|262891|P2|Received Treatment|Overall Study||210
109161|NCT01350973|262892|P1|Received Treatment|Overall Study||205
109162|NCT01350973|262890|P3|STARTED|Overall Study||195
109163|NCT01350973|262891|P2|STARTED|Overall Study||210
109164|NCT01350973|262892|P1|STARTED|Overall Study||206
109165|NCT01350947|262927|P1|NOT COMPLETED|Overall Study||0
109166|NCT01350947|262927|P1|COMPLETED|Overall Study||11
109167|NCT01350947|262927|P1|STARTED|Overall Study||11
109168|NCT01350934|262933|P2|NOT COMPLETED|Extension Study||4
109169|NCT01350934|262934|P1|NOT COMPLETED|Extension Study||5
109170|NCT01350934|262933|P2|COMPLETED|Extension Study||101
109171|NCT01350934|262934|P1|COMPLETED|Extension Study||95
109172|NCT01350934|262933|P2|STARTED|Extension Study||105
109173|NCT01350934|262934|P1|STARTED|Extension Study||100
109174|NCT01350934|262933|P2|NOT COMPLETED|Base Study||3
109175|NCT01350934|262934|P1|NOT COMPLETED|Base Study||11
109176|NCT01350934|262933|P2|COMPLETED|Base Study||105
109177|NCT01350934|262934|P1|COMPLETED|Base Study||100
109178|NCT01350934|262933|P2|STARTED|Base Study||108
109179|NCT01350934|262934|P1|STARTED|Base Study||111
109180|NCT01350804|262956|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
109181|NCT01350804|262957|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
109182|NCT01350804|262958|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
109183|NCT01350804|262959|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
109184|NCT01350804|262956|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
109185|NCT01350804|262957|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
109186|NCT01350804|262958|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
109187|NCT01350804|262959|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
109188|NCT01350804|262956|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
109189|NCT01350804|262957|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
109190|NCT01350804|262958|P2|STARTED|Extension Study, Weeks 52 - 260||79
109191|NCT01350804|262959|P1|STARTED|Extension Study, Weeks 52 - 260||80
109192|NCT01350804|262956|P4|NOT COMPLETED|Core Study||26
109193|NCT01350804|262957|P3|NOT COMPLETED|Core Study||47
109194|NCT01350804|262958|P2|NOT COMPLETED|Core Study||47
109195|NCT01350804|262959|P1|NOT COMPLETED|Core Study||41
109196|NCT01350804|262956|P4|COMPLETED|Core Study||112
109197|NCT01350804|262957|P3|COMPLETED|Core Study||91
109198|NCT01350804|262958|P2|COMPLETED|Core Study||90
109199|NCT01350804|262959|P1|COMPLETED|Core Study||97
109200|NCT01350804|262956|P4|Full Analysis Set|Core Study||138
109201|NCT01350804|262957|P3|Full Analysis Set|Core Study||138
109202|NCT01350804|262958|P2|Full Analysis Set|Core Study||137
109203|NCT01350804|262959|P1|Full Analysis Set|Core Study||138
109204|NCT01350804|262956|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
109205|NCT01350804|262957|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
109206|NCT01350804|262958|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
109207|NCT01350804|262959|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
109208|NCT01350804|262956|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
109209|NCT01350804|262957|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
109210|NCT01350804|262958|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
109211|NCT01350804|262959|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
109212|NCT01350804|262956|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
109213|NCT01350804|262957|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
109214|NCT01350804|262958|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
109215|NCT01350804|262959|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
109216|NCT01350804|262956|P4|STARTED|Core Study||138
109217|NCT01350804|262957|P3|STARTED|Core Study||138
109218|NCT01350804|262958|P2|STARTED|Core Study||137
109219|NCT01350804|262959|P1|STARTED|Core Study||138
109220|NCT01350583|263048|P1|NOT COMPLETED|Overall Study||0
109221|NCT01350583|263048|P1|COMPLETED|Overall Study||2
109222|NCT01350583|263048|P1|STARTED|Overall Study||2
109223|NCT01350544|263056|P2|NOT COMPLETED|Overall Study||22
109224|NCT01350544|263057|P1|NOT COMPLETED|Overall Study||23
109225|NCT01350544|263056|P2|COMPLETED|Overall Study||86
109226|NCT01350544|263057|P1|COMPLETED|Overall Study||85
109227|NCT01350544|263056|P2|STARTED|Overall Study||108
109228|NCT01350544|263057|P1|STARTED|Overall Study||108
109229|NCT01350479|263065|P2|NOT COMPLETED|Overall Study||0
109230|NCT01350479|263066|P1|NOT COMPLETED|Overall Study||0
109231|NCT01350479|263065|P2|COMPLETED|Overall Study||106
109232|NCT01350479|263066|P1|COMPLETED|Overall Study||94
109233|NCT01350479|263065|P2|STARTED|Overall Study||106
109234|NCT01350479|263066|P1|STARTED|Overall Study||94
109235|NCT01350414|263072|P1|NOT COMPLETED|Overall Study||19
109236|NCT01350414|263072|P1|COMPLETED|Overall Study||162
109237|NCT01350414|263072|P1|Year 5|Overall Study||162
109238|NCT01350414|263072|P1|Year 4|Overall Study||159
109239|NCT01350414|263072|P1|Year 3|Overall Study||162
109240|NCT01350414|263072|P1|Year 2|Overall Study||165
109241|NCT01350414|263072|P1|STARTED|Overall Study||181
109242|NCT01350401|263089|P1|NOT COMPLETED|Overall Study||0
109243|NCT01350401|263089|P1|COMPLETED|Overall Study||4
109244|NCT01350401|263089|P1|STARTED|Overall Study||4
109245|NCT01350388|263101|P2|NOT COMPLETED|Overall Study||1
109246|NCT01350388|263102|P1|NOT COMPLETED|Overall Study||3
109247|NCT01350388|263101|P2|COMPLETED|Overall Study||39
109248|NCT01350388|263102|P1|COMPLETED|Overall Study||37
109249|NCT01350388|263101|P2|STARTED|Overall Study||40
109250|NCT01350388|263102|P1|STARTED|Overall Study||40
109251|NCT01350271|263121|P3|NOT COMPLETED|Overall Study||26
109252|NCT01350271|263122|P2|NOT COMPLETED|Overall Study||17
109253|NCT01350271|263123|P1|NOT COMPLETED|Overall Study||21
109254|NCT01350271|263121|P3|COMPLETED|Overall Study||48
109255|NCT01350271|263122|P2|COMPLETED|Overall Study||53
109256|NCT01350271|263123|P1|COMPLETED|Overall Study||49
109257|NCT01350271|263121|P3|STARTED|Overall Study||74
109258|NCT01350271|263122|P2|STARTED|Overall Study||70
109259|NCT01350271|263123|P1|STARTED|Overall Study||70
109260|NCT01350258|263137|P1|NOT COMPLETED|Overall Study||0
109261|NCT01350258|263137|P1|COMPLETED|Overall Study||8
109262|NCT01350258|263137|P1|STARTED|Overall Study||8
109263|NCT01350245|263146|P1|NOT COMPLETED|Overall Study||0
109264|NCT01350245|263146|P1|COMPLETED|Overall Study||28
109265|NCT01350245|263146|P1|STARTED|Overall Study||28
109266|NCT01350232|263151|P1|NOT COMPLETED|Overall Study||0
109267|NCT01350232|263151|P1|COMPLETED|Overall Study||2
109268|NCT01350232|263151|P1|STARTED|Overall Study||2
109269|NCT01350141|263165|P3|NOT COMPLETED|Overall Study||1
109270|NCT01350141|263166|P2|NOT COMPLETED|Overall Study||0
109271|NCT01350141|263167|P1|NOT COMPLETED|Overall Study||3
109272|NCT01350141|263165|P3|COMPLETED|Overall Study||15
109273|NCT01350141|263166|P2|COMPLETED|Overall Study||15
109274|NCT01350141|263167|P1|COMPLETED|Overall Study||12
109275|NCT01350141|263165|P3|Treated|Overall Study||16
109276|NCT01350141|263166|P2|Treated|Overall Study||15
109277|NCT01350141|263167|P1|Treated|Overall Study||14
109278|NCT01350141|263165|P3|STARTED|Overall Study||16
109279|NCT01350141|263166|P2|STARTED|Overall Study||15
109280|NCT01350141|263167|P1|STARTED|Overall Study||15
109281|NCT01350128|263201|P1|NOT COMPLETED|Overall Study||14
109282|NCT01350128|263201|P1|COMPLETED|Overall Study||89
109283|NCT01350128|263201|P1|Atrovent HFA 34 µg BID|Overall Study||48
109284|NCT01350128|263201|P1|Placebo MDI BID|Overall Study||48
109285|NCT01350128|263201|P1|GP MDI 4.6 µg BID|Overall Study||45
109286|NCT01350128|263201|P1|GP MDI 9 µg BID|Overall Study||49
109287|NCT01350128|263201|P1|GP MDI 18 µg BID|Overall Study||49
109288|NCT01350128|263201|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
109289|NCT01350128|263201|P1|STARTED|Overall Study||103
109290|NCT01350115|263265|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
109291|NCT01350115|263266|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
109292|NCT01350115|263265|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
109293|NCT01350115|263266|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
109294|NCT01350115|263265|P2|STARTED|Long Term Follow-Up (All Patients)||2
109295|NCT01350115|263266|P1|STARTED|Long Term Follow-Up (All Patients)||8
109296|NCT01350115|263265|P2|NOT COMPLETED|Core Study (All Patients)||0
109297|NCT01350115|263266|P1|NOT COMPLETED|Core Study (All Patients)||0
109298|NCT01350115|263265|P2|COMPLETED|Core Study (All Patients)||2
109299|NCT01350115|263266|P1|COMPLETED|Core Study (All Patients)||8
109300|NCT01350115|263265|P2|Pharmacodynamic Set|Core Study (All Patients)||2
109301|NCT01350115|263266|P1|Pharmacodynamic Set|Core Study (All Patients)||7
109302|NCT01350115|263265|P2|Safety Anlysis Set|Core Study (All Patients)||2
109303|NCT01350115|263266|P1|Safety Anlysis Set|Core Study (All Patients)||8
109304|NCT01350115|263265|P2|STARTED|Core Study (All Patients)||2
109305|NCT01350115|263266|P1|STARTED|Core Study (All Patients)||8
109306|NCT01350102|263282|P4|NOT COMPLETED|Overall Study||0
109307|NCT01350102|263283|P3|NOT COMPLETED|Overall Study||1
109308|NCT01350102|263284|P2|NOT COMPLETED|Overall Study||0
109309|NCT01350102|263285|P1|NOT COMPLETED|Overall Study||0
109310|NCT01350102|263282|P4|COMPLETED|Overall Study||0
109311|NCT01350102|263283|P3|COMPLETED|Overall Study||0
109312|NCT01350102|263284|P2|COMPLETED|Overall Study||1
109313|NCT01350102|263285|P1|COMPLETED|Overall Study||0
109314|NCT01350102|263282|P4|STARTED|Overall Study||0
109315|NCT01350102|263283|P3|STARTED|Overall Study||1
109316|NCT01350102|263284|P2|STARTED|Overall Study||1
109317|NCT01350102|263285|P1|STARTED|Overall Study||0
109318|NCT01349972|263305|P2|NOT COMPLETED|Overall Study||2
109319|NCT01349972|263306|P1|NOT COMPLETED|Overall Study||5
109320|NCT01349972|263305|P2|COMPLETED|Overall Study||56
109321|NCT01349972|263306|P1|COMPLETED|Overall Study||109
109322|NCT01349972|263305|P2|STARTED|Overall Study||58
109323|NCT01349972|263306|P1|STARTED|Overall Study||114
109324|NCT01349959|263322|P1|NOT COMPLETED|Overall Study||7
109325|NCT01349959|263322|P1|COMPLETED|Overall Study||33
109326|NCT01349959|263322|P1|STARTED|Overall Study|58 consented, 18 failed screening and did not receive study treatment|40
109327|NCT01349933|263328|P1|NOT COMPLETED|Overall Study||0
109328|NCT01349933|263328|P1|COMPLETED|Overall Study||21
109329|NCT01349933|263328|P1|STARTED|Overall Study||21
109330|NCT01349920|263338|P1|NOT COMPLETED|Overall Study||0
109331|NCT01349920|263338|P1|COMPLETED|Overall Study||15
109332|NCT01349920|263338|P1|STARTED|Overall Study||15
109333|NCT01349907|263358|P2|NOT COMPLETED|Overall Study||43
109334|NCT01349907|263359|P1|NOT COMPLETED|Overall Study||139
109335|NCT01349907|263358|P2|COMPLETED|Overall Study||38
109336|NCT01349907|263359|P1|COMPLETED|Overall Study||102
109337|NCT01349907|263358|P2|STARTED|Overall Study|Enrolled and Treated|81
109338|NCT01349907|263359|P1|STARTED|Overall Study|Enrolled and Treated|241
109339|NCT01349829|263397|P2|NOT COMPLETED|Overall Study||23
109340|NCT01349829|263398|P1|NOT COMPLETED|Overall Study||9
109341|NCT01349829|263397|P2|COMPLETED|Overall Study||102
109342|NCT01349829|263398|P1|COMPLETED|Overall Study||117
109343|NCT01349829|263397|P2|STARTED|Overall Study||125
109344|NCT01349829|263398|P1|STARTED|Overall Study||126
109345|NCT01349816|263416|P1|NOT COMPLETED|Overall Study||30
109346|NCT01349816|263416|P1|COMPLETED|Overall Study||155
109347|NCT01349816|263416|P1|FF MDI 9.6 µg|Overall Study||61
109348|NCT01349816|263416|P1|GFF MDI 9/9.6 µg|Overall Study||57
109349|NCT01349816|263416|P1|GFF MDI 18/9.6 µg|Overall Study||57
109350|NCT01349816|263416|P1|GFF MDI 36/9.6 µg|Overall Study||56
109351|NCT01349816|263416|P1|GFF MDI 36/7.2 µg|Overall Study||58
109352|NCT01349816|263416|P1|GP MDI 36 µg|Overall Study||61
109353|NCT01349816|263416|P1|STARTED|Overall Study||185
109354|NCT01349803|263482|P4|NOT COMPLETED|Overall Study||2
109355|NCT01349803|263483|P3|NOT COMPLETED|Overall Study||3
109356|NCT01349803|263484|P2|NOT COMPLETED|Overall Study||1
109357|NCT01349803|263485|P1|NOT COMPLETED|Overall Study||1
109358|NCT01349803|263482|P4|COMPLETED|Overall Study||57
109359|NCT01349803|263483|P3|COMPLETED|Overall Study||57
109360|NCT01349803|263484|P2|COMPLETED|Overall Study||57
109361|NCT01349803|263485|P1|COMPLETED|Overall Study||59
109362|NCT01349803|263482|P4|STARTED|Overall Study||59
109363|NCT01349803|263483|P3|STARTED|Overall Study||60
109364|NCT01349803|263484|P2|STARTED|Overall Study||58
109365|NCT01349803|263485|P1|STARTED|Overall Study||60
109366|NCT01349790|263555|P1|NOT COMPLETED|Overall Study||9
109367|NCT01349790|263555|P1|COMPLETED|Overall Study||31
109368|NCT01349790|263555|P1|STARTED|Overall Study||40
109369|NCT01349660|263577|P3|NOT COMPLETED|Overall Study||76
109370|NCT01349660|263578|P2|NOT COMPLETED|Overall Study||6
109371|NCT01349660|263579|P1|NOT COMPLETED|Overall Study||6
109372|NCT01349660|263577|P3|COMPLETED|Overall Study||0
109373|NCT01349660|263578|P2|COMPLETED|Overall Study||0
109374|NCT01349660|263579|P1|COMPLETED|Overall Study||0
109375|NCT01349660|263577|P3|STARTED|Overall Study||76
109376|NCT01349660|263578|P2|STARTED|Overall Study||6
109377|NCT01349660|263579|P1|STARTED|Overall Study||6
109378|NCT01349595|263597|P2|NOT COMPLETED|Overall Study||2
109379|NCT01349595|263598|P1|NOT COMPLETED|Overall Study||2
109380|NCT01349595|263597|P2|COMPLETED|Overall Study||0
109381|NCT01349595|263598|P1|COMPLETED|Overall Study||0
109382|NCT01349595|263597|P2|STARTED|Overall Study||2
109383|NCT01349595|263598|P1|STARTED|Overall Study||2
109384|NCT01349491|263606|P2|NOT COMPLETED|Overall Study||0
109385|NCT01349491|263607|P1|NOT COMPLETED|Overall Study||0
109386|NCT01349491|263606|P2|COMPLETED|Overall Study||5
109387|NCT01349491|263607|P1|COMPLETED|Overall Study||5
109388|NCT01349491|263606|P2|STARTED|Overall Study||5
109389|NCT01349491|263607|P1|STARTED|Overall Study||5
109390|NCT01349465|263615|P2|NOT COMPLETED|Overall Study||22
109391|NCT01349465|263616|P1|NOT COMPLETED|Overall Study||18
109392|NCT01349465|263615|P2|COMPLETED|Overall Study||27
109393|NCT01349465|263616|P1|COMPLETED|Overall Study||182
109394|NCT01349465|263615|P2|STARTED|Overall Study||49
109395|NCT01349465|263616|P1|STARTED|Overall Study||200
109396|NCT01349231|263628|P1|NOT COMPLETED|Overall Study||0
109397|NCT01349231|263628|P1|COMPLETED|Overall Study||10
109398|NCT01349231|263628|P1|STARTED|Overall Study||10
109399|NCT01349192|263637|P2|NOT COMPLETED|Overall Study||6
109400|NCT01349192|263638|P1|NOT COMPLETED|Overall Study||3
109401|NCT01349192|263637|P2|COMPLETED|Overall Study||17
109402|NCT01349192|263638|P1|COMPLETED|Overall Study||21
109403|NCT01349192|263637|P2|Withdrawals|Overall Study||6
109404|NCT01349192|263638|P1|Withdrawals|Overall Study||3
109405|NCT01349192|263637|P2|Evaluable for Primary Endpoint|Overall Study||19
109406|NCT01349192|263638|P1|Evaluable for Primary Endpoint|Overall Study||22
109407|NCT01349192|263637|P2|STARTED|Overall Study||23
109408|NCT01349192|263638|P1|STARTED|Overall Study||24
109409|NCT01349114|263652|P2|NOT COMPLETED|Overall Study||0
109410|NCT01349114|263653|P1|NOT COMPLETED|Overall Study||0
109411|NCT01349114|263652|P2|COMPLETED|Overall Study||11
109412|NCT01349114|263653|P1|COMPLETED|Overall Study||10
109413|NCT01349114|263652|P2|STARTED|Overall Study||11
109414|NCT01349114|263653|P1|STARTED|Overall Study||10
109415|NCT01348854|263663|P2|NOT COMPLETED|Overall Study||1
109416|NCT01348854|263664|P1|NOT COMPLETED|Overall Study||3
109417|NCT01348854|263663|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
109418|NCT01348854|263664|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
109419|NCT01348854|263663|P2|STARTED|Overall Study|10 eyes of 6 participants|6
109420|NCT01348854|263664|P1|STARTED|Overall Study|53 eyes of 34 participants|34
109421|NCT01348789|263672|P1|NOT COMPLETED|Overall Study||4
109422|NCT01348789|263672|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
109423|NCT01348789|263672|P1|STARTED|Overall Study||37
109424|NCT01348776|263683|P1|NOT COMPLETED|Overall Study||3
109425|NCT01348776|263683|P1|COMPLETED|Overall Study||84
109426|NCT01348776|263683|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
109427|NCT01348607|263699|P3|NOT COMPLETED|Overall Study||0
109428|NCT01348607|263700|P2|NOT COMPLETED|Overall Study||0
109429|NCT01348607|263701|P1|NOT COMPLETED|Overall Study||0
109430|NCT01348607|263699|P3|COMPLETED|Overall Study||0
109431|NCT01348607|263700|P2|COMPLETED|Overall Study||0
109432|NCT01348607|263701|P1|COMPLETED|Overall Study||1
109433|NCT01348607|263699|P3|STARTED|Overall Study||0
109434|NCT01348607|263700|P2|STARTED|Overall Study||0
109435|NCT01348607|263701|P1|STARTED|Overall Study||1
109436|NCT01348425|263714|P2|NOT COMPLETED|Overall Study||1
109437|NCT01348425|263715|P1|NOT COMPLETED|Overall Study||1
109438|NCT01348425|263714|P2|COMPLETED|Overall Study||13
109439|NCT01348425|263715|P1|COMPLETED|Overall Study||30
109440|NCT01348425|263714|P2|STARTED|Overall Study||14
109441|NCT01348425|263715|P1|STARTED|Overall Study||31
109442|NCT01348165|263727|P7|NOT COMPLETED|Overall Study||1
109443|NCT01348165|263728|P6|NOT COMPLETED|Overall Study||0
109444|NCT01348165|263729|P5|NOT COMPLETED|Overall Study||0
109445|NCT01348165|263730|P4|NOT COMPLETED|Overall Study||0
109446|NCT01348165|263731|P3|NOT COMPLETED|Overall Study||0
109447|NCT01348165|263732|P2|NOT COMPLETED|Overall Study||0
109448|NCT01348165|263733|P1|NOT COMPLETED|Overall Study||0
109449|NCT01348165|263727|P7|COMPLETED|Overall Study||5
109450|NCT01348165|263728|P6|COMPLETED|Overall Study||1
109451|NCT01348165|263729|P5|COMPLETED|Overall Study||6
109452|NCT01348165|263730|P4|COMPLETED|Overall Study||6
109453|NCT01348165|263731|P3|COMPLETED|Overall Study||6
109454|NCT01348165|263732|P2|COMPLETED|Overall Study||5
109455|NCT01348165|263733|P1|COMPLETED|Overall Study||10
109456|NCT01348165|263727|P7|STARTED|Overall Study||6
109457|NCT01348165|263728|P6|STARTED|Overall Study||1
109458|NCT01348165|263729|P5|STARTED|Overall Study||6
109459|NCT01348165|263730|P4|STARTED|Overall Study||6
109460|NCT01348165|263731|P3|STARTED|Overall Study||6
109461|NCT01348165|263732|P2|STARTED|Overall Study||5
109462|NCT01348165|263733|P1|STARTED|Overall Study||10
109463|NCT01348139|263862|P6|NOT COMPLETED|Period 6||0
109464|NCT01348139|263863|P5|NOT COMPLETED|Period 6||0
109465|NCT01348139|263864|P4|NOT COMPLETED|Period 6||0
109466|NCT01348139|263865|P3|NOT COMPLETED|Period 6||0
109467|NCT01348139|263866|P2|NOT COMPLETED|Period 6||0
109468|NCT01348139|263867|P1|NOT COMPLETED|Period 6||0
109469|NCT01348139|263862|P6|COMPLETED|Period 6||4
109470|NCT01348139|263863|P5|COMPLETED|Period 6||5
109471|NCT01348139|263864|P4|COMPLETED|Period 6||4
109472|NCT01348139|263865|P3|COMPLETED|Period 6||4
109473|NCT01348139|263866|P2|COMPLETED|Period 6||4
109474|NCT01348139|263867|P1|COMPLETED|Period 6||4
109475|NCT01348139|263862|P6|STARTED|Period 6||4
109476|NCT01348139|263863|P5|STARTED|Period 6||5
109477|NCT01348139|263864|P4|STARTED|Period 6||4
109478|NCT01348139|263865|P3|STARTED|Period 6||4
109479|NCT01348139|263866|P2|STARTED|Period 6||4
109480|NCT01348139|263867|P1|STARTED|Period 6||4
109481|NCT01348139|263862|P6|NOT COMPLETED|Period 5||0
109482|NCT01348139|263863|P5|NOT COMPLETED|Period 5||0
109483|NCT01348139|263864|P4|NOT COMPLETED|Period 5||0
109484|NCT01348139|263865|P3|NOT COMPLETED|Period 5||0
109485|NCT01348139|263866|P2|NOT COMPLETED|Period 5||0
109486|NCT01348139|263867|P1|NOT COMPLETED|Period 5||0
109487|NCT01348139|263862|P6|COMPLETED|Period 5||4
109488|NCT01348139|263863|P5|COMPLETED|Period 5||5
109489|NCT01348139|263864|P4|COMPLETED|Period 5||4
109490|NCT01348139|263865|P3|COMPLETED|Period 5||4
109491|NCT01348139|263866|P2|COMPLETED|Period 5||4
109492|NCT01348139|263867|P1|COMPLETED|Period 5||4
109493|NCT01348139|263862|P6|STARTED|Period 5||4
109494|NCT01348139|263863|P5|STARTED|Period 5||5
109495|NCT01348139|263864|P4|STARTED|Period 5||4
109496|NCT01348139|263865|P3|STARTED|Period 5||4
109497|NCT01348139|263866|P2|STARTED|Period 5||4
109498|NCT01348139|263867|P1|STARTED|Period 5||4
109499|NCT01348139|263862|P6|NOT COMPLETED|Period 4||0
109500|NCT01348139|263863|P5|NOT COMPLETED|Period 4||0
109501|NCT01348139|263864|P4|NOT COMPLETED|Period 4||0
109502|NCT01348139|263865|P3|NOT COMPLETED|Period 4||0
109503|NCT01348139|263866|P2|NOT COMPLETED|Period 4||0
109504|NCT01348139|263867|P1|NOT COMPLETED|Period 4||0
109505|NCT01348139|263862|P6|COMPLETED|Period 4||4
109506|NCT01348139|263863|P5|COMPLETED|Period 4||5
109507|NCT01348139|263864|P4|COMPLETED|Period 4||4
109508|NCT01348139|263865|P3|COMPLETED|Period 4||4
109509|NCT01348139|263866|P2|COMPLETED|Period 4||4
109510|NCT01348139|263867|P1|COMPLETED|Period 4||4
109511|NCT01348139|263862|P6|STARTED|Period 4||4
109512|NCT01348139|263863|P5|STARTED|Period 4||5
109513|NCT01348139|263864|P4|STARTED|Period 4||4
109514|NCT01348139|263865|P3|STARTED|Period 4||4
109515|NCT01348139|263866|P2|STARTED|Period 4||4
109516|NCT01348139|263867|P1|STARTED|Period 4||4
109517|NCT01348139|263862|P6|NOT COMPLETED|Period 3||0
109518|NCT01348139|263863|P5|NOT COMPLETED|Period 3||0
109519|NCT01348139|263864|P4|NOT COMPLETED|Period 3||0
109520|NCT01348139|263865|P3|NOT COMPLETED|Period 3||0
109521|NCT01348139|263866|P2|NOT COMPLETED|Period 3||0
109522|NCT01348139|263867|P1|NOT COMPLETED|Period 3||0
109523|NCT01348139|263862|P6|COMPLETED|Period 3||4
109524|NCT01348139|263863|P5|COMPLETED|Period 3||5
109525|NCT01348139|263864|P4|COMPLETED|Period 3||4
109526|NCT01348139|263865|P3|COMPLETED|Period 3||4
109527|NCT01348139|263866|P2|COMPLETED|Period 3||4
109528|NCT01348139|263867|P1|COMPLETED|Period 3||4
109529|NCT01348139|263862|P6|STARTED|Period 3||4
109530|NCT01348139|263863|P5|STARTED|Period 3||5
109531|NCT01348139|263864|P4|STARTED|Period 3||4
109532|NCT01348139|263865|P3|STARTED|Period 3||4
109533|NCT01348139|263866|P2|STARTED|Period 3||4
109534|NCT01348139|263867|P1|STARTED|Period 3||4
109535|NCT01348139|263862|P6|NOT COMPLETED|Period 2||0
109536|NCT01348139|263863|P5|NOT COMPLETED|Period 2||0
109537|NCT01348139|263864|P4|NOT COMPLETED|Period 2||0
109538|NCT01348139|263865|P3|NOT COMPLETED|Period 2||0
109539|NCT01348139|263866|P2|NOT COMPLETED|Period 2||0
109540|NCT01348139|263867|P1|NOT COMPLETED|Period 2||0
109541|NCT01348139|263862|P6|COMPLETED|Period 2||4
109542|NCT01348139|263863|P5|COMPLETED|Period 2||5
109543|NCT01348139|263864|P4|COMPLETED|Period 2||4
109544|NCT01348139|263865|P3|COMPLETED|Period 2||4
109545|NCT01348139|263866|P2|COMPLETED|Period 2||4
109546|NCT01348139|263867|P1|COMPLETED|Period 2||4
109547|NCT01348139|263862|P6|STARTED|Period 2||4
109548|NCT01348139|263863|P5|STARTED|Period 2||5
109549|NCT01348139|263864|P4|STARTED|Period 2||4
109550|NCT01348139|263865|P3|STARTED|Period 2||4
109551|NCT01348139|263866|P2|STARTED|Period 2||4
109552|NCT01348139|263867|P1|STARTED|Period 2||4
109553|NCT01348139|263862|P6|NOT COMPLETED|Period 1||0
109554|NCT01348139|263863|P5|NOT COMPLETED|Period 1||0
109555|NCT01348139|263864|P4|NOT COMPLETED|Period 1||0
109556|NCT01348139|263865|P3|NOT COMPLETED|Period 1||0
109557|NCT01348139|263866|P2|NOT COMPLETED|Period 1||0
109558|NCT01348139|263867|P1|NOT COMPLETED|Period 1||1
109559|NCT01348139|263862|P6|COMPLETED|Period 1||4
109560|NCT01348139|263863|P5|COMPLETED|Period 1||5
109561|NCT01348139|263864|P4|COMPLETED|Period 1||4
109562|NCT01348139|263865|P3|COMPLETED|Period 1||4
109563|NCT01348139|263866|P2|COMPLETED|Period 1||4
109564|NCT01348139|263867|P1|COMPLETED|Period 1||4
109565|NCT01348139|263862|P6|STARTED|Period 1||4
109566|NCT01348139|263863|P5|STARTED|Period 1||5
109567|NCT01348139|263864|P4|STARTED|Period 1||4
109568|NCT01348139|263865|P3|STARTED|Period 1||4
109569|NCT01348139|263866|P2|STARTED|Period 1||4
109570|NCT01348139|263867|P1|STARTED|Period 1||5
109571|NCT01348100|263948|P7|NOT COMPLETED|Overall Study||3
109572|NCT01348100|263949|P6|NOT COMPLETED|Overall Study||2
109573|NCT01348100|263950|P5|NOT COMPLETED|Overall Study||1
109574|NCT01348100|263951|P4|NOT COMPLETED|Overall Study||1
109575|NCT01348100|263952|P3|NOT COMPLETED|Overall Study||2
109576|NCT01348100|263953|P2|NOT COMPLETED|Overall Study||0
109577|NCT01348100|263954|P1|NOT COMPLETED|Overall Study||0
109578|NCT01348100|263948|P7|COMPLETED|Overall Study||13
109579|NCT01348100|263949|P6|COMPLETED|Overall Study||14
109580|NCT01348100|263950|P5|COMPLETED|Overall Study||14
109581|NCT01348100|263951|P4|COMPLETED|Overall Study||14
109582|NCT01348100|263952|P3|COMPLETED|Overall Study||13
109583|NCT01348100|263953|P2|COMPLETED|Overall Study||2
109584|NCT01348100|263954|P1|COMPLETED|Overall Study||2
109585|NCT01348100|263948|P7|STARTED|Overall Study||16
109586|NCT01348100|263949|P6|STARTED|Overall Study||16
109587|NCT01348100|263950|P5|STARTED|Overall Study||15
109588|NCT01348100|263951|P4|STARTED|Overall Study||15
109589|NCT01348100|263952|P3|STARTED|Overall Study||15
109590|NCT01348100|263953|P2|STARTED|Overall Study||2
109591|NCT01348100|263954|P1|STARTED|Overall Study||2
109592|NCT01348087|263999|P1|NOT COMPLETED|Overall Study||148
109593|NCT01348087|263999|P1|COMPLETED|Overall Study||0
109594|NCT01348087|263999|P1|STARTED|Overall Study||148
109595|NCT01347931|264013|P1|NOT COMPLETED|NIOV System||0
109596|NCT01347931|264013|P1|COMPLETED|NIOV System||29
109597|NCT01347931|264013|P1|STARTED|NIOV System||29
109598|NCT01347931|264013|P1|NOT COMPLETED|Standard Oxygen Therapy||1
109599|NCT01347931|264013|P1|COMPLETED|Standard Oxygen Therapy||29
109600|NCT01347931|264013|P1|STARTED|Standard Oxygen Therapy||30
109601|NCT01347879|264025|P2|NOT COMPLETED|Overall Study||17
109602|NCT01347879|264026|P1|NOT COMPLETED|Overall Study||7
109603|NCT01347879|264025|P2|COMPLETED|Overall Study||83
109604|NCT01347879|264026|P1|COMPLETED|Overall Study||46
109605|NCT01347879|264025|P2|STARTED|Overall Study||100
109606|NCT01347879|264026|P1|STARTED|Overall Study||53
109607|NCT01347840|264058|P1|NOT COMPLETED|Overall Study||1
109608|NCT01347840|264058|P1|COMPLETED|Overall Study||0
109609|NCT01347840|264058|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
109610|NCT01347788|264071|P3|NOT COMPLETED|Overall Study||0
109611|NCT01347788|264072|P2|NOT COMPLETED|Overall Study||0
109612|NCT01347788|264073|P1|NOT COMPLETED|Overall Study||0
109613|NCT01347788|264071|P3|COMPLETED|Overall Study||13
109614|NCT01347788|264072|P2|COMPLETED|Overall Study||10
109615|NCT01347788|264073|P1|COMPLETED|Overall Study||11
109616|NCT01347788|264071|P3|STARTED|Overall Study||13
109617|NCT01347788|264072|P2|STARTED|Overall Study||10
109618|NCT01347788|264073|P1|STARTED|Overall Study||11
109619|NCT01347710|264081|P1|NOT COMPLETED|Overall Study||31
109620|NCT01347710|264081|P1|COMPLETED|Overall Study||764
109621|NCT01347710|264081|P1|STARTED|Overall Study||795
109622|NCT01347632|264096|P1|NOT COMPLETED|Overall Study||2
109623|NCT01347632|264096|P1|COMPLETED|Overall Study||33
109624|NCT01347632|264096|P1|STARTED|Overall Study||35
109625|NCT01347580|264103|P2|NOT COMPLETED|Overall Study||56
109626|NCT01347580|264104|P1|NOT COMPLETED|Overall Study||65
109627|NCT01347580|264103|P2|COMPLETED|Overall Study|based on randomized treatment|897
109628|NCT01347580|264104|P1|COMPLETED|Overall Study|based on randomized treatment|844
109629|NCT01347580|264103|P2|Safety Population|Overall Study|based on actual treatment|950
109630|NCT01347580|264104|P1|Safety Population|Overall Study|based on actual treatment|908
109631|NCT01347580|264103|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
109632|NCT01347580|264104|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
109633|NCT01347580|264103|P2|STARTED|Overall Study|based on randomized treatment|953
109634|NCT01347580|264104|P1|STARTED|Overall Study|based on randomized treatment|909
109635|NCT01347554|264134|P2|NOT COMPLETED|Overall Study||11
109636|NCT01347554|264135|P1|NOT COMPLETED|Overall Study||7
109637|NCT01347554|264134|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
109638|NCT01347554|264135|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
109639|NCT01347554|264134|P2|STARTED|Overall Study||242
109640|NCT01347554|264135|P1|STARTED|Overall Study||237
109641|NCT01347255|264147|P1|NOT COMPLETED|Overall Study||0
109642|NCT01347255|264147|P1|COMPLETED|Overall Study||24
109643|NCT01347255|264147|P1|STARTED|Overall Study||24
109644|NCT01347112|264172|P2|NOT COMPLETED|Overall Study||12
109645|NCT01347112|264173|P1|NOT COMPLETED|Overall Study||4
109646|NCT01347112|264172|P2|COMPLETED|Overall Study||5
109647|NCT01347112|264173|P1|COMPLETED|Overall Study||12
109648|NCT01347112|264172|P2|STARTED|Overall Study||17
109649|NCT01347112|264173|P1|STARTED|Overall Study||16
109650|NCT01347086|264193|P10|NOT COMPLETED|Overall Study||1
109651|NCT01347086|264194|P9|NOT COMPLETED|Overall Study||0
109652|NCT01347086|264195|P8|NOT COMPLETED|Overall Study||1
109653|NCT01347086|264196|P7|NOT COMPLETED|Overall Study||1
109654|NCT01347086|264197|P6|NOT COMPLETED|Overall Study||0
109655|NCT01347086|264198|P5|NOT COMPLETED|Overall Study||0
109656|NCT01347086|264199|P4|NOT COMPLETED|Overall Study||0
109657|NCT01347086|264200|P3|NOT COMPLETED|Overall Study||1
109658|NCT01347086|264201|P2|NOT COMPLETED|Overall Study||0
109659|NCT01347086|264202|P1|NOT COMPLETED|Overall Study||0
109660|NCT01347086|264193|P10|COMPLETED|Overall Study||6
109661|NCT01347086|264194|P9|COMPLETED|Overall Study||6
109662|NCT01347086|264195|P8|COMPLETED|Overall Study||6
109663|NCT01347086|264196|P7|COMPLETED|Overall Study||6
109664|NCT01347086|264197|P6|COMPLETED|Overall Study||6
109665|NCT01347086|264198|P5|COMPLETED|Overall Study||6
109666|NCT01347086|264199|P4|COMPLETED|Overall Study||6
109667|NCT01347086|264200|P3|COMPLETED|Overall Study||6
109668|NCT01347086|264201|P2|COMPLETED|Overall Study||6
109669|NCT01347086|264202|P1|COMPLETED|Overall Study||2
109670|NCT01347086|264193|P10|STARTED|Overall Study|One subject was not treated.|7
109671|NCT01347086|264194|P9|STARTED|Overall Study||6
109672|NCT01347086|264195|P8|STARTED|Overall Study|One subject was not treated.|7
109673|NCT01347086|264196|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
109674|NCT01347086|264197|P6|STARTED|Overall Study||6
109675|NCT01347086|264198|P5|STARTED|Overall Study||6
109676|NCT01347086|264199|P4|STARTED|Overall Study||6
109677|NCT01347086|264200|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
109678|NCT01347086|264201|P2|STARTED|Overall Study||6
109679|NCT01347086|264202|P1|STARTED|Overall Study||2
109680|NCT01347073|264301|P1|NOT COMPLETED|Overall Study||2
109681|NCT01347073|264301|P1|COMPLETED|Overall Study||21
109682|NCT01347073|264301|P1|STARTED|Overall Study||23
109683|NCT01347060|264315|P2|NOT COMPLETED|Overall Study||0
109684|NCT01347060|264316|P1|NOT COMPLETED|Overall Study||0
109685|NCT01347060|264315|P2|COMPLETED|Overall Study||7580
109686|NCT01347060|264316|P1|COMPLETED|Overall Study||9868
109687|NCT01347060|264315|P2|STARTED|Overall Study||7580
109688|NCT01347060|264316|P1|STARTED|Overall Study||9868
109689|NCT01347034|264328|P2|NOT COMPLETED|Overall Study||0
109690|NCT01347034|264329|P1|NOT COMPLETED|Overall Study||0
109691|NCT01347034|264328|P2|COMPLETED|Overall Study||14
109692|NCT01347034|264329|P1|COMPLETED|Overall Study||6
109693|NCT01347034|264328|P2|STARTED|Overall Study||14
109694|NCT01347034|264329|P1|STARTED|Overall Study||6
109695|NCT01347008|264339|P2|NOT COMPLETED|Overall Study||0
109696|NCT01347008|264340|P1|NOT COMPLETED|Overall Study||0
109697|NCT01347008|264339|P2|COMPLETED|Overall Study||20
109698|NCT01347008|264340|P1|COMPLETED|Overall Study||21
109699|NCT01347008|264339|P2|STARTED|Overall Study||20
109700|NCT01347008|264340|P1|STARTED|Overall Study||21
109701|NCT01346852|264352|P2|NOT COMPLETED|Overall Study||0
109702|NCT01346852|264353|P1|NOT COMPLETED|Overall Study||0
109703|NCT01346852|264352|P2|COMPLETED|Overall Study||59684
109704|NCT01346852|264353|P1|COMPLETED|Overall Study||41753
109705|NCT01346852|264352|P2|STARTED|Overall Study||59684
109706|NCT01346852|264353|P1|STARTED|Overall Study||41753
109707|NCT01346839|264363|P2|NOT COMPLETED|Overall Study||209
109708|NCT01346839|264364|P1|NOT COMPLETED|Overall Study||314
109709|NCT01346839|264363|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
109710|NCT01346839|264364|P1|COMPLETED|Overall Study||369
109711|NCT01346839|264363|P2|STARTED|Overall Study||573
109712|NCT01346839|264364|P1|STARTED|Overall Study||683
109713|NCT01346774|264380|P2|NOT COMPLETED|Overall Study||17
109714|NCT01346774|264381|P1|NOT COMPLETED|Overall Study||13
109715|NCT01346774|264380|P2|COMPLETED|Overall Study||63
109716|NCT01346774|264381|P1|COMPLETED|Overall Study||67
109717|NCT01346774|264380|P2|STARTED|Overall Study||80
109718|NCT01346774|264381|P1|STARTED|Overall Study||80
109719|NCT01346592|264390|P3|NOT COMPLETED|Overall Study||78
109720|NCT01346592|264391|P2|NOT COMPLETED|Overall Study||89
109721|NCT01346592|264392|P1|NOT COMPLETED|Overall Study||153
109722|NCT01346592|264390|P3|COMPLETED|Overall Study||1408
109723|NCT01346592|264391|P2|COMPLETED|Overall Study||1389
109724|NCT01346592|264392|P1|COMPLETED|Overall Study||2983
109725|NCT01346592|264390|P3|STARTED|Overall Study||1486
109726|NCT01346592|264391|P2|STARTED|Overall Study||1478
109727|NCT01346592|264392|P1|STARTED|Overall Study||3136
109728|NCT01346514|264484|P2|NOT COMPLETED|Overall Study||37
109729|NCT01346514|264485|P1|NOT COMPLETED|Overall Study||29
109730|NCT01346514|264484|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
109731|NCT01346514|264485|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
109732|NCT01346514|264484|P2|12 Month Assessment|Overall Study||53
109733|NCT01346514|264485|P1|12 Month Assessment|Overall Study||62
109734|NCT01346514|264484|P2|9 Month Assessment|Overall Study||59
109735|NCT01346514|264485|P1|9 Month Assessment|Overall Study||67
109736|NCT01346514|264484|P2|6 Month Assessment|Overall Study||61
109737|NCT01346514|264485|P1|6 Month Assessment|Overall Study||74
109738|NCT01346514|264484|P2|3 Month Assessment|Overall Study||68
109739|NCT01346514|264485|P1|3 Month Assessment|Overall Study||83
109740|NCT01346514|264484|P2|STARTED|Overall Study||90
109741|NCT01346514|264485|P1|STARTED|Overall Study||91
109742|NCT01346501|264505|P2|NOT COMPLETED|Overall Study||13
109743|NCT01346501|264506|P1|NOT COMPLETED|Overall Study||11
109744|NCT01346501|264505|P2|COMPLETED|Overall Study||80
109745|NCT01346501|264506|P1|COMPLETED|Overall Study||68
109746|NCT01346501|264505|P2|STARTED|Overall Study||93
109747|NCT01346501|264506|P1|STARTED|Overall Study||79
109748|NCT01346488|264519|P1|NOT COMPLETED|Overall Study||706
109749|NCT01346488|264519|P1|COMPLETED|Overall Study||1262
109750|NCT01346488|264519|P1|STARTED|Overall Study||1968
109751|NCT01346475|264539|P2|NOT COMPLETED|Second Intervention||0
109752|NCT01346475|264540|P1|NOT COMPLETED|Second Intervention||0
109753|NCT01346475|264539|P2|COMPLETED|Second Intervention||25
109754|NCT01346475|264540|P1|COMPLETED|Second Intervention||18
109755|NCT01346475|264539|P2|STARTED|Second Intervention||25
109756|NCT01346475|264540|P1|STARTED|Second Intervention||18
109757|NCT01346475|264539|P2|NOT COMPLETED|First Intervention||3
109758|NCT01346475|264540|P1|NOT COMPLETED|First Intervention||4
109759|NCT01346475|264539|P2|COMPLETED|First Intervention||25
109760|NCT01346475|264540|P1|COMPLETED|First Intervention||18
109761|NCT01346475|264539|P2|STARTED|First Intervention||28
109762|NCT01346475|264540|P1|STARTED|First Intervention||22
109763|NCT01346410|264552|P1|NOT COMPLETED|Overall Study||1
109764|NCT01346410|264552|P1|COMPLETED|Overall Study||0
109765|NCT01346410|264552|P1|STARTED|Overall Study||1
109766|NCT01346397|264558|P2|NOT COMPLETED|Overall Study||0
109767|NCT01346397|264559|P1|NOT COMPLETED|Overall Study||0
109768|NCT01346397|264558|P2|COMPLETED|Overall Study||85
109769|NCT01346397|264559|P1|COMPLETED|Overall Study||85
109770|NCT01346397|264558|P2|STARTED|Overall Study||85
109771|NCT01346397|264559|P1|STARTED|Overall Study||85
109772|NCT01346293|264569|P2|NOT COMPLETED|Overall Study||21
109773|NCT01346293|264570|P1|NOT COMPLETED|Overall Study||67
109774|NCT01346293|264569|P2|COMPLETED|Overall Study||608
109775|NCT01346293|264570|P1|COMPLETED|Overall Study||2676
109776|NCT01346293|264569|P2|STARTED|Overall Study||629
109777|NCT01346293|264570|P1|STARTED|Overall Study||2743
109778|NCT01346189|264600|P4|NOT COMPLETED|Overall Study||11
109779|NCT01346189|264601|P3|NOT COMPLETED|Overall Study||14
109780|NCT01346189|264602|P2|NOT COMPLETED|Overall Study||17
109781|NCT01346189|264603|P1|NOT COMPLETED|Overall Study||16
109782|NCT01346189|264600|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
109783|NCT01346189|264601|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
109784|NCT01346189|264602|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
109785|NCT01346189|264603|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
109786|NCT01346189|264600|P4|STARTED|Overall Study||366
109787|NCT01346189|264601|P3|STARTED|Overall Study||346
109788|NCT01346189|264602|P2|STARTED|Overall Study||358
109789|NCT01346189|264603|P1|STARTED|Overall Study||433
109790|NCT01346176|264620|P3|NOT COMPLETED|Completed Satisfaction Survey||6
109791|NCT01346176|264621|P2|NOT COMPLETED|Completed Satisfaction Survey||4
109792|NCT01346176|264622|P1|NOT COMPLETED|Completed Satisfaction Survey||6
109793|NCT01346176|264620|P3|COMPLETED|Completed Satisfaction Survey||27
109794|NCT01346176|264621|P2|COMPLETED|Completed Satisfaction Survey||22
109795|NCT01346176|264622|P1|COMPLETED|Completed Satisfaction Survey||29
109796|NCT01346176|264620|P3|STARTED|Completed Satisfaction Survey||33
109797|NCT01346176|264621|P2|STARTED|Completed Satisfaction Survey||26
109798|NCT01346176|264622|P1|STARTED|Completed Satisfaction Survey||35
109799|NCT01346176|264620|P3|NOT COMPLETED|Completed Advance Directive||10
109800|NCT01346176|264621|P2|NOT COMPLETED|Completed Advance Directive||14
109801|NCT01346176|264622|P1|NOT COMPLETED|Completed Advance Directive||13
109802|NCT01346176|264620|P3|COMPLETED|Completed Advance Directive||33
109803|NCT01346176|264621|P2|COMPLETED|Completed Advance Directive||26
109804|NCT01346176|264622|P1|COMPLETED|Completed Advance Directive||35
109805|NCT01346176|264620|P3|STARTED|Completed Advance Directive||43
109806|NCT01346176|264621|P2|STARTED|Completed Advance Directive||40
109807|NCT01346176|264622|P1|STARTED|Completed Advance Directive||48
109808|NCT01346176|264620|P3|NOT COMPLETED|Recruited||0
109809|NCT01346176|264621|P2|NOT COMPLETED|Recruited||0
109810|NCT01346176|264622|P1|NOT COMPLETED|Recruited||1
109811|NCT01346176|264620|P3|COMPLETED|Recruited||43
109812|NCT01346176|264621|P2|COMPLETED|Recruited||40
109813|NCT01346176|264622|P1|COMPLETED|Recruited||48
109814|NCT01346176|264620|P3|STARTED|Recruited||43
109815|NCT01346176|264621|P2|STARTED|Recruited||40
109816|NCT01346176|264622|P1|STARTED|Recruited||49
109817|NCT01346085|264633|P1|NOT COMPLETED|Overall Study||0
109818|NCT01346085|264633|P1|COMPLETED|Overall Study||10
109819|NCT01346085|264633|P1|STARTED|Overall Study||10
109820|NCT01346072|264640|P2|NOT COMPLETED|Overall Study||0
109821|NCT01346072|264641|P1|NOT COMPLETED|Overall Study||0
109822|NCT01346072|264640|P2|COMPLETED|Overall Study||10
109823|NCT01346072|264641|P1|COMPLETED|Overall Study||11
109824|NCT01346072|264640|P2|STARTED|Overall Study||10
109825|NCT01346072|264641|P1|STARTED|Overall Study||11
109826|NCT01346059|264651|P2|NOT COMPLETED|Overall Study||0
109827|NCT01346059|264652|P1|NOT COMPLETED|Overall Study||1
109828|NCT01346059|264651|P2|COMPLETED|Overall Study||1
109829|NCT01346059|264652|P1|COMPLETED|Overall Study||0
109830|NCT01346059|264651|P2|STARTED|Overall Study||1
109831|NCT01346059|264652|P1|STARTED|Overall Study||1
109832|NCT01345929|264664|P2|NOT COMPLETED|Overall Study||19
109833|NCT01345929|264665|P1|NOT COMPLETED|Overall Study||21
109834|NCT01345929|264664|P2|COMPLETED|Overall Study||516
109835|NCT01345929|264665|P1|COMPLETED|Overall Study||512
109836|NCT01345929|264664|P2|STARTED|Overall Study||535
109837|NCT01345929|264665|P1|STARTED|Overall Study||533
109838|NCT01345786|264677|P4|NOT COMPLETED|Overall Study||3
109839|NCT01345786|264678|P3|NOT COMPLETED|Overall Study||5
109840|NCT01345786|264679|P2|NOT COMPLETED|Overall Study||8
109841|NCT01345786|264680|P1|NOT COMPLETED|Overall Study||6
109842|NCT01345786|264677|P4|COMPLETED|Overall Study||35
109843|NCT01345786|264678|P3|COMPLETED|Overall Study||33
109844|NCT01345786|264679|P2|COMPLETED|Overall Study||33
109845|NCT01345786|264680|P1|COMPLETED|Overall Study||35
109846|NCT01345786|264677|P4|Treated|Overall Study||37
109847|NCT01345786|264678|P3|Treated|Overall Study||37
109848|NCT01345786|264679|P2|Treated|Overall Study||41
109849|NCT01345786|264680|P1|Treated|Overall Study||41
109850|NCT01345786|264677|P4|STARTED|Overall Study|Number randomized|38
109851|NCT01345786|264678|P3|STARTED|Overall Study|Number randomized|38
109852|NCT01345786|264679|P2|STARTED|Overall Study|Number randomized|41
109853|NCT01345786|264680|P1|STARTED|Overall Study|Number randomized|41
109854|NCT01345721|264729|P3|NOT COMPLETED|Overall Study||0
109855|NCT01345721|264730|P2|NOT COMPLETED|Overall Study||0
109856|NCT01345721|264731|P1|NOT COMPLETED|Overall Study||0
109857|NCT01345721|264729|P3|COMPLETED|Overall Study||65
109858|NCT01345721|264730|P2|COMPLETED|Overall Study||66
109859|NCT01345721|264731|P1|COMPLETED|Overall Study||74
109860|NCT01345721|264729|P3|STARTED|Overall Study||65
109861|NCT01345721|264730|P2|STARTED|Overall Study||66
109862|NCT01345721|264731|P1|STARTED|Overall Study||74
109863|NCT01345682|264760|P2|NOT COMPLETED|Overall Study||161
109864|NCT01345682|264761|P1|NOT COMPLETED|Overall Study||322
109865|NCT01345682|264760|P2|COMPLETED|Overall Study||0
109866|NCT01345682|264761|P1|COMPLETED|Overall Study||0
109867|NCT01345682|264760|P2|STARTED|Overall Study|Randomised|161
109868|NCT01345682|264761|P1|STARTED|Overall Study|Randomised|322
109869|NCT01345669|264795|P2|NOT COMPLETED|Overall Study||119
109870|NCT01345669|264796|P1|NOT COMPLETED|Overall Study||287
109871|NCT01345669|264795|P2|COMPLETED|Overall Study||87
109872|NCT01345669|264796|P1|COMPLETED|Overall Study||124
109873|NCT01345669|264795|P2|STARTED|Overall Study||206
109874|NCT01345669|264796|P1|STARTED|Overall Study||411
109875|NCT01345630|264814|P2|NOT COMPLETED|Overall Study||359
109876|NCT01345630|264815|P1|NOT COMPLETED|Overall Study||361
109877|NCT01345630|264814|P2|COMPLETED|Overall Study||42
109878|NCT01345630|264815|P1|COMPLETED|Overall Study||35
109879|NCT01345630|264814|P2|STARTED|Overall Study||401
109880|NCT01345630|264815|P1|STARTED|Overall Study||396
109881|NCT01345591|264871|P1|NOT COMPLETED|Overall Study||1
109882|NCT01345591|264871|P1|COMPLETED|Overall Study||19
109883|NCT01345591|264871|P1|STARTED|Overall Study||20
109884|NCT01345318|264880|P1|NOT COMPLETED|Overall Study||80
109885|NCT01345318|264880|P1|COMPLETED|Overall Study||111
109886|NCT01345318|264880|P1|STARTED|Overall Study||191
109887|NCT01345292|264888|P3|NOT COMPLETED|Overall Study||1
109888|NCT01345292|264889|P2|NOT COMPLETED|Overall Study||0
109889|NCT01345292|264890|P1|NOT COMPLETED|Overall Study||2
109890|NCT01345292|264888|P3|COMPLETED|Overall Study||74
109891|NCT01345292|264889|P2|COMPLETED|Overall Study||76
109892|NCT01345292|264890|P1|COMPLETED|Overall Study||73
109893|NCT01345292|264888|P3|STARTED|Overall Study||75
109894|NCT01345292|264889|P2|STARTED|Overall Study||76
109895|NCT01345292|264890|P1|STARTED|Overall Study||75
109896|NCT01345253|264921|P2|NOT COMPLETED|Overall Study||79
109897|NCT01345253|264922|P1|NOT COMPLETED|Overall Study||56
109898|NCT01345253|264921|P2|COMPLETED|Overall Study||372
109899|NCT01345253|264922|P1|COMPLETED|Overall Study||170
109900|NCT01345253|264921|P2|STARTED|Overall Study||451
109901|NCT01345253|264922|P1|STARTED|Overall Study||226
109902|NCT01345240|264941|P5|NOT COMPLETED|Overall Study||7
109903|NCT01345240|264942|P4|NOT COMPLETED|Overall Study||10
109904|NCT01345240|264943|P3|NOT COMPLETED|Overall Study||10
109905|NCT01345240|264944|P2|NOT COMPLETED|Overall Study||14
109906|NCT01345240|264945|P1|NOT COMPLETED|Overall Study||2
109907|NCT01345240|264941|P5|COMPLETED|Overall Study||132
109908|NCT01345240|264942|P4|COMPLETED|Overall Study||131
109909|NCT01345240|264943|P3|COMPLETED|Overall Study||131
109910|NCT01345240|264944|P2|COMPLETED|Overall Study||128
109911|NCT01345240|264945|P1|COMPLETED|Overall Study||140
109912|NCT01345240|264941|P5|STARTED|Overall Study||139
109913|NCT01345240|264942|P4|STARTED|Overall Study||141
109914|NCT01345240|264943|P3|STARTED|Overall Study||141
109915|NCT01345240|264944|P2|STARTED|Overall Study||142
109916|NCT01345240|264945|P1|STARTED|Overall Study||142
109917|NCT01345162|265040|P2|NOT COMPLETED|Overall Study||4
109918|NCT01345162|265041|P1|NOT COMPLETED|Overall Study||2
109919|NCT01345162|265040|P2|COMPLETED|Overall Study||96
109920|NCT01345162|265041|P1|COMPLETED|Overall Study||98
109921|NCT01345162|265040|P2|STARTED|Overall Study||100
109922|NCT01345162|265041|P1|STARTED|Overall Study||100
109923|NCT01345123|265050|P3|NOT COMPLETED|Overall Study||88
109924|NCT01345123|265051|P2|NOT COMPLETED|Overall Study||85
109925|NCT01345123|265052|P1|NOT COMPLETED|Overall Study||79
109926|NCT01345123|265050|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
109927|NCT01345123|265051|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
109928|NCT01345123|265052|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
109929|NCT01345123|265050|P3|STARTED|Overall Study||3291
109930|NCT01345123|265051|P2|STARTED|Overall Study||3311
109931|NCT01345123|265052|P1|STARTED|Overall Study||3323
109932|NCT01345058|265074|P2|NOT COMPLETED|Overall Study||0
109933|NCT01345058|265075|P1|NOT COMPLETED|Overall Study||5
109934|NCT01345058|265074|P2|COMPLETED|Overall Study||36
109935|NCT01345058|265075|P1|COMPLETED|Overall Study||15
109936|NCT01345058|265074|P2|Received Lacosamide|Overall Study||0
109937|NCT01345058|265075|P1|Received Lacosamide|Overall Study||19
109938|NCT01345058|265074|P2|STARTED|Overall Study||36
109939|NCT01345058|265075|P1|STARTED|Overall Study||20
109940|NCT01345019|265091|P2|NOT COMPLETED|Overall Study||272
109941|NCT01345019|265092|P1|NOT COMPLETED|Overall Study||263
109942|NCT01345019|265091|P2|COMPLETED|Overall Study|Still on study as of the data cut-off date|587
109943|NCT01345019|265092|P1|COMPLETED|Overall Study|Still on study as of the data cut-off date|596
109944|NCT01345019|265091|P2|Received Treatment|Overall Study||850
109945|NCT01345019|265092|P1|Received Treatment|Overall Study||852
109946|NCT01345019|265091|P2|STARTED|Overall Study||859
109947|NCT01345019|265092|P1|STARTED|Overall Study||859
109948|NCT01344876|265112|P5|NOT COMPLETED|Overall Study||1
109949|NCT01344876|265113|P4|NOT COMPLETED|Overall Study||3
109950|NCT01344876|265114|P3|NOT COMPLETED|Overall Study||1
109951|NCT01344876|265115|P2|NOT COMPLETED|Overall Study||0
109952|NCT01344876|265116|P1|NOT COMPLETED|Overall Study||1
109953|NCT01344876|265112|P5|COMPLETED|Overall Study||2
109954|NCT01344876|265113|P4|COMPLETED|Overall Study||3
109955|NCT01344876|265114|P3|COMPLETED|Overall Study||3
109956|NCT01344876|265115|P2|COMPLETED|Overall Study||3
109957|NCT01344876|265116|P1|COMPLETED|Overall Study||3
109958|NCT01344876|265112|P5|STARTED|Overall Study||3
109959|NCT01344876|265113|P4|STARTED|Overall Study||6
109960|NCT01344876|265114|P3|STARTED|Overall Study||4
109961|NCT01344876|265115|P2|STARTED|Overall Study||3
109962|NCT01344876|265116|P1|STARTED|Overall Study||4
109963|NCT01344824|265130|P1|NOT COMPLETED|Overall Study||37
109964|NCT01344824|265130|P1|COMPLETED|Overall Study||1
109965|NCT01344824|265130|P1|STARTED|Overall Study||38
109966|NCT01344759|265138|P2|NOT COMPLETED|Overall Study||2
109967|NCT01344759|265139|P1|NOT COMPLETED|Overall Study||0
109968|NCT01344759|265138|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
109969|NCT01344759|265139|P1|COMPLETED|Overall Study||30
109970|NCT01344759|265138|P2|STARTED|Overall Study||30
109971|NCT01344759|265139|P1|STARTED|Overall Study||30
109972|NCT01344629|265171|P2|NOT COMPLETED|Crossover Period 4||0
109973|NCT01344629|265172|P1|NOT COMPLETED|Crossover Period 4||0
109974|NCT01344629|265171|P2|COMPLETED|Crossover Period 4||31
109975|NCT01344629|265172|P1|COMPLETED|Crossover Period 4||32
109976|NCT01344629|265171|P2|STARTED|Crossover Period 4||31
109977|NCT01344629|265172|P1|STARTED|Crossover Period 4||32
109978|NCT01344629|265171|P2|NOT COMPLETED|Crossover Period 3||0
109979|NCT01344629|265172|P1|NOT COMPLETED|Crossover Period 3||0
109980|NCT01344629|265171|P2|COMPLETED|Crossover Period 3||31
109981|NCT01344629|265172|P1|COMPLETED|Crossover Period 3||32
109982|NCT01344629|265171|P2|STARTED|Crossover Period 3||31
109983|NCT01344629|265172|P1|STARTED|Crossover Period 3||32
109984|NCT01344629|265171|P2|NOT COMPLETED|Crossover Period 2||1
109985|NCT01344629|265172|P1|NOT COMPLETED|Crossover Period 2||0
109986|NCT01344629|265171|P2|COMPLETED|Crossover Period 2||31
109987|NCT01344629|265172|P1|COMPLETED|Crossover Period 2||32
109988|NCT01344629|265171|P2|STARTED|Crossover Period 2||32
109989|NCT01344629|265172|P1|STARTED|Crossover Period 2||32
109990|NCT01344629|265171|P2|NOT COMPLETED|Crossover Period 1||0
109991|NCT01344629|265172|P1|NOT COMPLETED|Crossover Period 1||0
109992|NCT01344629|265171|P2|COMPLETED|Crossover Period 1||32
109993|NCT01344629|265172|P1|COMPLETED|Crossover Period 1||32
109994|NCT01344629|265171|P2|STARTED|Crossover Period 1||32
109995|NCT01344629|265172|P1|STARTED|Crossover Period 1||32
109996|NCT01344616|265192|P2|NOT COMPLETED|Overall Study||44
109997|NCT01344616|265193|P1|NOT COMPLETED|Overall Study||35
109998|NCT01344616|265192|P2|COMPLETED|Overall Study||194
109999|NCT01344616|265193|P1|COMPLETED|Overall Study||209
110000|NCT01344616|265192|P2|STARTED|Overall Study||238
110001|NCT01344616|265193|P1|STARTED|Overall Study||244
110002|NCT01344538|265201|P2|NOT COMPLETED|Overall Study||1
110003|NCT01344538|265202|P1|NOT COMPLETED|Overall Study||2
110004|NCT01344538|265201|P2|COMPLETED|Overall Study||16
110005|NCT01344538|265202|P1|COMPLETED|Overall Study||14
110006|NCT01344538|265201|P2|STARTED|Overall Study||17
110007|NCT01344538|265202|P1|STARTED|Overall Study||16
110008|NCT01344460|265208|P1|NOT COMPLETED|Overall Study||3
110009|NCT01344460|265208|P1|COMPLETED|Overall Study||312
110010|NCT01344460|265208|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
110011|NCT01344460|265208|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
110012|NCT01344447|265253|P1|NOT COMPLETED|Overall Study||8
110013|NCT01344447|265253|P1|COMPLETED|Overall Study||471
110014|NCT01344447|265253|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
110015|NCT01344447|265253|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
110016|NCT01344369|265297|P2|NOT COMPLETED|Second Intervention||1
110017|NCT01344369|265298|P1|NOT COMPLETED|Second Intervention||0
110018|NCT01344369|265297|P2|COMPLETED|Second Intervention||16
110019|NCT01344369|265298|P1|COMPLETED|Second Intervention||17
110020|NCT01344369|265297|P2|STARTED|Second Intervention||17
110021|NCT01344369|265298|P1|STARTED|Second Intervention||17
110022|NCT01344369|265297|P2|NOT COMPLETED|Washout of 28 Days||1
110023|NCT01344369|265298|P1|NOT COMPLETED|Washout of 28 Days||1
110024|NCT01344369|265297|P2|COMPLETED|Washout of 28 Days||17
110025|NCT01344369|265298|P1|COMPLETED|Washout of 28 Days||17
110026|NCT01344369|265297|P2|STARTED|Washout of 28 Days||18
110027|NCT01344369|265298|P1|STARTED|Washout of 28 Days||18
110028|NCT01344369|265297|P2|NOT COMPLETED|First Intervention||0
110029|NCT01344369|265298|P1|NOT COMPLETED|First Intervention||0
110030|NCT01344369|265297|P2|COMPLETED|First Intervention||18
110031|NCT01344369|265298|P1|COMPLETED|First Intervention||18
110032|NCT01344369|265297|P2|STARTED|First Intervention||18
110033|NCT01344369|265298|P1|STARTED|First Intervention||18
110034|NCT01344161|265316|P2|NOT COMPLETED|Overall Study||3
110035|NCT01344161|265317|P1|NOT COMPLETED|Overall Study||5
110036|NCT01344161|265316|P2|COMPLETED|Overall Study||39
110037|NCT01344161|265317|P1|COMPLETED|Overall Study||38
110038|NCT01344161|265316|P2|STARTED|Overall Study||42
110039|NCT01344161|265317|P1|STARTED|Overall Study||43
110040|NCT01344057|265329|P1|NOT COMPLETED|Overall Study||1
110041|NCT01344057|265329|P1|COMPLETED|Overall Study||62
110042|NCT01344057|265329|P1|STARTED|Overall Study||63
110043|NCT01343901|265336|P1|NOT COMPLETED|Overall Study||113
110044|NCT01343901|265336|P1|COMPLETED|Overall Study||97
110045|NCT01343901|265336|P1|Efficacy Population|Overall Study||205
110046|NCT01343901|265336|P1|STARTED|Overall Study||210
110047|NCT01343888|265360|P3|NOT COMPLETED|Overall Study||22
110048|NCT01343888|265361|P2|NOT COMPLETED|Overall Study||39
110049|NCT01343888|265362|P1|NOT COMPLETED|Overall Study||25
110050|NCT01343888|265360|P3|COMPLETED|Overall Study||110
110051|NCT01343888|265361|P2|COMPLETED|Overall Study||222
110052|NCT01343888|265362|P1|COMPLETED|Overall Study||234
110053|NCT01343888|265360|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
110054|NCT01343888|265361|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
110055|NCT01343888|265362|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
110056|NCT01343823|265404|P4|NOT COMPLETED|Overall Study||1
110057|NCT01343823|265405|P3|NOT COMPLETED|Overall Study||0
110058|NCT01343823|265406|P2|NOT COMPLETED|Overall Study||0
110059|NCT01343823|265407|P1|NOT COMPLETED|Overall Study||2
110060|NCT01343823|265404|P4|COMPLETED|Overall Study||19
110061|NCT01343823|265405|P3|COMPLETED|Overall Study||19
110062|NCT01343823|265406|P2|COMPLETED|Overall Study||20
110063|NCT01343823|265407|P1|COMPLETED|Overall Study||18
110064|NCT01343823|265404|P4|STARTED|Overall Study||20
110065|NCT01343823|265405|P3|STARTED|Overall Study||19
110066|NCT01343823|265406|P2|STARTED|Overall Study||20
110067|NCT01343823|265407|P1|STARTED|Overall Study||20
110068|NCT01343667|265423|P2|NOT COMPLETED|Overall Study||56
110069|NCT01343667|265424|P1|NOT COMPLETED|Overall Study||12
110070|NCT01343667|265423|P2|COMPLETED|Overall Study||916
110071|NCT01343667|265424|P1|COMPLETED|Overall Study||413
110072|NCT01343667|265423|P2|STARTED|Overall Study||972
110073|NCT01343667|265424|P1|STARTED|Overall Study||425
110074|NCT01343485|265432|P2|NOT COMPLETED|Overall Study||134
110075|NCT01343485|265433|P1|NOT COMPLETED|Overall Study||149
110076|NCT01343485|265432|P2|COMPLETED|Overall Study||46
110077|NCT01343485|265433|P1|COMPLETED|Overall Study||36
110078|NCT01343485|265432|P2|STARTED|Overall Study||180
110079|NCT01343485|265433|P1|STARTED|Overall Study||185
110080|NCT01343368|265441|P2|NOT COMPLETED|Overall Study||0
110081|NCT01343368|265442|P1|NOT COMPLETED|Overall Study||2
110082|NCT01343368|265441|P2|COMPLETED|Overall Study||10
110083|NCT01343368|265442|P1|COMPLETED|Overall Study||7
110084|NCT01343368|265441|P2|STARTED|Overall Study||10
110085|NCT01343368|265442|P1|STARTED|Overall Study||9
110086|NCT01343277|265478|P2|NOT COMPLETED|Overall Study||193
110087|NCT01343277|265479|P1|NOT COMPLETED|Overall Study||384
110088|NCT01343277|265478|P2|COMPLETED|Overall Study||0
110089|NCT01343277|265479|P1|COMPLETED|Overall Study||0
110090|NCT01343277|265478|P2|Treated|Overall Study||172
110091|NCT01343277|265479|P1|Treated|Overall Study||378
110092|NCT01343277|265478|P2|STARTED|Overall Study||193
110093|NCT01343277|265479|P1|STARTED|Overall Study||384
110094|NCT01343251|265497|P2|NOT COMPLETED|Overall Study||0
110095|NCT01343251|265498|P1|NOT COMPLETED|Overall Study||0
110096|NCT01343251|265497|P2|COMPLETED|Overall Study||17
110097|NCT01343251|265498|P1|COMPLETED|Overall Study||16
110098|NCT01343251|265497|P2|STARTED|Overall Study||17
110099|NCT01343251|265498|P1|STARTED|Overall Study||16
110100|NCT01343095|265515|P3|NOT COMPLETED|Overall Study||0
110101|NCT01343095|265516|P2|NOT COMPLETED|Overall Study||0
110102|NCT01343095|265517|P1|NOT COMPLETED|Overall Study||0
110103|NCT01343095|265515|P3|COMPLETED|Overall Study||3
110104|NCT01343095|265516|P2|COMPLETED|Overall Study||3
110105|NCT01343095|265517|P1|COMPLETED|Overall Study||2
110106|NCT01343095|265515|P3|STARTED|Overall Study||3
110107|NCT01343095|265516|P2|STARTED|Overall Study||3
110108|NCT01343095|265517|P1|STARTED|Overall Study||2
110109|NCT01343082|265540|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
110110|NCT01343082|265541|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
110111|NCT01343082|265542|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
110112|NCT01343082|265540|P3|COMPLETED|Treatment Period , Switched to DE-111||31
110113|NCT01343082|265541|P2|COMPLETED|Treatment Period , Switched to DE-111||36
110114|NCT01343082|265542|P1|COMPLETED|Treatment Period , Switched to DE-111||43
110115|NCT01343082|265540|P3|STARTED|Treatment Period , Switched to DE-111||43
110116|NCT01343082|265541|P2|STARTED|Treatment Period , Switched to DE-111||45
110117|NCT01343082|265542|P1|STARTED|Treatment Period , Switched to DE-111||48
110118|NCT01343082|265540|P3|NOT COMPLETED|The run-in Period||5
110119|NCT01343082|265541|P2|NOT COMPLETED|The run-in Period||4
110120|NCT01343082|265542|P1|NOT COMPLETED|The run-in Period||3
110121|NCT01343082|265540|P3|COMPLETED|The run-in Period||43
110122|NCT01343082|265541|P2|COMPLETED|The run-in Period||45
110123|NCT01343082|265542|P1|COMPLETED|The run-in Period||48
110124|NCT01343082|265540|P3|STARTED|The run-in Period||48
110125|NCT01343082|265541|P2|STARTED|The run-in Period||49
110126|NCT01343082|265542|P1|STARTED|The run-in Period||51
110127|NCT01343056|265550|P4|NOT COMPLETED|Overall Study||9
110128|NCT01343056|265551|P3|NOT COMPLETED|Overall Study||3
110129|NCT01343056|265552|P2|NOT COMPLETED|Overall Study||5
110130|NCT01343056|265553|P1|NOT COMPLETED|Overall Study||7
110131|NCT01343056|265550|P4|COMPLETED|Overall Study||29
110132|NCT01343056|265551|P3|COMPLETED|Overall Study||29
110133|NCT01343056|265552|P2|COMPLETED|Overall Study||31
110134|NCT01343056|265553|P1|COMPLETED|Overall Study||28
110135|NCT01343056|265550|P4|STARTED|Overall Study||38
110136|NCT01343056|265551|P3|STARTED|Overall Study||32
110137|NCT01343056|265552|P2|STARTED|Overall Study||36
110138|NCT01343056|265553|P1|STARTED|Overall Study||35
110139|NCT01343004|265594|P3|NOT COMPLETED|Overall Study||160
110140|NCT01343004|265595|P2|NOT COMPLETED|Overall Study||218
110141|NCT01343004|265596|P1|NOT COMPLETED|Overall Study||184
110142|NCT01343004|265594|P3|COMPLETED|Overall Study||658
110143|NCT01343004|265595|P2|COMPLETED|Overall Study||606
110144|NCT01343004|265596|P1|COMPLETED|Overall Study||637
110145|NCT01343004|265594|P3|STARTED|Overall Study||818
110146|NCT01343004|265595|P2|STARTED|Overall Study||824
110147|NCT01343004|265596|P1|STARTED|Overall Study||821
110148|NCT01342965|265621|P2|NOT COMPLETED|Overall Study||107
110149|NCT01342965|265622|P1|NOT COMPLETED|Overall Study||109
110150|NCT01342965|265621|P2|COMPLETED|Overall Study||0
110151|NCT01342965|265622|P1|COMPLETED|Overall Study||1
110152|NCT01342965|265621|P2|Received Treatment|Overall Study||104
110153|NCT01342965|265622|P1|Received Treatment|Overall Study||110
110154|NCT01342965|265621|P2|STARTED|Overall Study||107
110155|NCT01342965|265622|P1|STARTED|Overall Study||110
110156|NCT01342926|265640|P4|NOT COMPLETED|Overall Study||12
110157|NCT01342926|265641|P3|NOT COMPLETED|Overall Study||14
110158|NCT01342926|265642|P2|NOT COMPLETED|Overall Study||15
110159|NCT01342926|265643|P1|NOT COMPLETED|Overall Study||9
110160|NCT01342926|265640|P4|COMPLETED|Overall Study||39
110161|NCT01342926|265641|P3|COMPLETED|Overall Study||34
110162|NCT01342926|265642|P2|COMPLETED|Overall Study||31
110163|NCT01342926|265643|P1|COMPLETED|Overall Study||37
110164|NCT01342926|265640|P4|STARTED|Overall Study||51
110165|NCT01342926|265641|P3|STARTED|Overall Study||48
110166|NCT01342926|265642|P2|STARTED|Overall Study||46
110167|NCT01342926|265643|P1|STARTED|Overall Study||46
110168|NCT01342913|265723|P3|NOT COMPLETED|Double-Blind Treatment Period||23
110169|NCT01342913|265724|P2|NOT COMPLETED|Double-Blind Treatment Period||16
110170|NCT01342913|265725|P1|NOT COMPLETED|Double-Blind Treatment Period||0
110171|NCT01342913|265723|P3|COMPLETED|Double-Blind Treatment Period||243
110172|NCT01342913|265724|P2|COMPLETED|Double-Blind Treatment Period||246
110173|NCT01342913|265725|P1|COMPLETED|Double-Blind Treatment Period||0
110174|NCT01342913|265723|P3|STARTED|Double-Blind Treatment Period||266
110175|NCT01342913|265724|P2|STARTED|Double-Blind Treatment Period||262
110176|NCT01342913|265725|P1|STARTED|Double-Blind Treatment Period||0
110177|NCT01342913|265723|P3|NOT COMPLETED|2-week Run-in Period||0
110178|NCT01342913|265724|P2|NOT COMPLETED|2-week Run-in Period||0
110179|NCT01342913|265725|P1|NOT COMPLETED|2-week Run-in Period||174
110180|NCT01342913|265723|P3|COMPLETED|2-week Run-in Period||0
110181|NCT01342913|265724|P2|COMPLETED|2-week Run-in Period||0
110182|NCT01342913|265725|P1|COMPLETED|2-week Run-in Period||528
110183|NCT01342913|265723|P3|STARTED|2-week Run-in Period||0
110184|NCT01342913|265724|P2|STARTED|2-week Run-in Period||0
110185|NCT01342913|265725|P1|STARTED|2-week Run-in Period||702
110186|NCT01342887|265735|P1|NOT COMPLETED|Overall Study||2
110187|NCT01342887|265735|P1|COMPLETED|Overall Study||4
110188|NCT01342887|265735|P1|STARTED|Overall Study||6
110189|NCT01342770|265742|P1|NOT COMPLETED|Overall Study||0
110190|NCT01342770|265742|P1|COMPLETED|Overall Study||6
110191|NCT01342770|265742|P1|STARTED|Overall Study||6
110192|NCT01342757|265760|P1|NOT COMPLETED|Overall Study||0
110193|NCT01342757|265760|P1|COMPLETED|Overall Study||12
110194|NCT01342757|265760|P1|STARTED|Overall Study||12
110195|NCT01342666|265769|P2|NOT COMPLETED|Overall Study||0
110196|NCT01342666|265770|P1|NOT COMPLETED|Overall Study||0
110197|NCT01342666|265769|P2|COMPLETED|Overall Study||24
110198|NCT01342666|265770|P1|COMPLETED|Overall Study||26
110199|NCT01342666|265769|P2|STARTED|Overall Study||24
110200|NCT01342666|265770|P1|STARTED|Overall Study||26
110201|NCT01342640|265776|P1|NOT COMPLETED|Overall Study||41
110202|NCT01342640|265776|P1|COMPLETED|Overall Study||29
110203|NCT01342640|265776|P1|STARTED|Overall Study||70
110204|NCT01342549|265784|P2|NOT COMPLETED|Overall Study||0
110205|NCT01342549|265785|P1|NOT COMPLETED|Overall Study||0
110206|NCT01342549|265784|P2|COMPLETED|Overall Study||31
110207|NCT01342549|265785|P1|COMPLETED|Overall Study||31
110208|NCT01342549|265784|P2|STARTED|Overall Study||31
110209|NCT01342549|265785|P1|STARTED|Overall Study||31
110210|NCT01342523|265823|P32|NOT COMPLETED|Overall Study||1
110211|NCT01342523|265824|P31|NOT COMPLETED|Overall Study||1
110212|NCT01342523|265825|P30|NOT COMPLETED|Overall Study||1
110213|NCT01342523|265826|P29|NOT COMPLETED|Overall Study||1
110214|NCT01342523|265827|P28|NOT COMPLETED|Overall Study||1
110215|NCT01342523|265828|P27|NOT COMPLETED|Overall Study||1
110216|NCT01342523|265829|P26|NOT COMPLETED|Overall Study||2
110217|NCT01342523|265830|P25|NOT COMPLETED|Overall Study||1
110218|NCT01342523|265831|P24|NOT COMPLETED|Overall Study||1
110219|NCT01342523|265832|P23|NOT COMPLETED|Overall Study||0
110220|NCT01342523|265833|P22|NOT COMPLETED|Overall Study||0
110221|NCT01342523|265834|P21|NOT COMPLETED|Overall Study||0
110222|NCT01342523|265835|P20|NOT COMPLETED|Overall Study||0
110223|NCT01342523|265836|P19|NOT COMPLETED|Overall Study||0
110224|NCT01342523|265837|P18|NOT COMPLETED|Overall Study||0
110225|NCT01342523|265838|P17|NOT COMPLETED|Overall Study||1
110226|NCT01342523|265839|P16|NOT COMPLETED|Overall Study||0
110227|NCT01342523|265840|P15|NOT COMPLETED|Overall Study||1
110228|NCT01342523|265841|P14|NOT COMPLETED|Overall Study||2
110229|NCT01342523|265842|P13|NOT COMPLETED|Overall Study||0
110230|NCT01342523|265843|P12|NOT COMPLETED|Overall Study||2
110231|NCT01342523|265844|P11|NOT COMPLETED|Overall Study||0
110232|NCT01342523|265845|P10|NOT COMPLETED|Overall Study||0
110233|NCT01342523|265846|P9|NOT COMPLETED|Overall Study||0
110234|NCT01342523|265847|P8|NOT COMPLETED|Overall Study||0
110235|NCT01342523|265848|P7|NOT COMPLETED|Overall Study||0
110236|NCT01342523|265849|P6|NOT COMPLETED|Overall Study||0
110237|NCT01342523|265850|P5|NOT COMPLETED|Overall Study||0
110238|NCT01342523|265851|P4|NOT COMPLETED|Overall Study||1
110239|NCT01342523|265852|P3|NOT COMPLETED|Overall Study||0
110240|NCT01342523|265853|P2|NOT COMPLETED|Overall Study||0
110241|NCT01342523|265854|P1|NOT COMPLETED|Overall Study||1
110242|NCT01342523|265823|P32|COMPLETED|Overall Study||27
110243|NCT01342523|265824|P31|COMPLETED|Overall Study||30
110244|NCT01342523|265825|P30|COMPLETED|Overall Study||28
110245|NCT01342523|265826|P29|COMPLETED|Overall Study||34
110246|NCT01342523|265827|P28|COMPLETED|Overall Study||30
110247|NCT01342523|265828|P27|COMPLETED|Overall Study||33
110248|NCT01342523|265829|P26|COMPLETED|Overall Study||36
110249|NCT01342523|265830|P25|COMPLETED|Overall Study||36
110250|NCT01342523|265831|P24|COMPLETED|Overall Study||35
110251|NCT01342523|265832|P23|COMPLETED|Overall Study||36
110252|NCT01342523|265833|P22|COMPLETED|Overall Study||30
110253|NCT01342523|265834|P21|COMPLETED|Overall Study||29
110254|NCT01342523|265835|P20|COMPLETED|Overall Study||27
110255|NCT01342523|265836|P19|COMPLETED|Overall Study||21
110256|NCT01342523|265837|P18|COMPLETED|Overall Study||27
110257|NCT01342523|265838|P17|COMPLETED|Overall Study||28
110258|NCT01342523|265839|P16|COMPLETED|Overall Study||32
110259|NCT01342523|265840|P15|COMPLETED|Overall Study||37
110260|NCT01342523|265841|P14|COMPLETED|Overall Study||36
110261|NCT01342523|265842|P13|COMPLETED|Overall Study||39
110262|NCT01342523|265843|P12|COMPLETED|Overall Study||36
110263|NCT01342523|265844|P11|COMPLETED|Overall Study||38
110264|NCT01342523|265845|P10|COMPLETED|Overall Study||28
110265|NCT01342523|265846|P9|COMPLETED|Overall Study||28
110266|NCT01342523|265847|P8|COMPLETED|Overall Study||27
110267|NCT01342523|265848|P7|COMPLETED|Overall Study||22
110268|NCT01342523|265849|P6|COMPLETED|Overall Study||36
110269|NCT01342523|265850|P5|COMPLETED|Overall Study||36
110270|NCT01342523|265851|P4|COMPLETED|Overall Study||32
110271|NCT01342523|265852|P3|COMPLETED|Overall Study||36
110272|NCT01342523|265853|P2|COMPLETED|Overall Study||32
110273|NCT01342523|265854|P1|COMPLETED|Overall Study||34
110274|NCT01342523|265823|P32|STARTED|Overall Study||28
110275|NCT01342523|265824|P31|STARTED|Overall Study||31
110276|NCT01342523|265825|P30|STARTED|Overall Study||29
110277|NCT01342523|265826|P29|STARTED|Overall Study||35
110278|NCT01342523|265827|P28|STARTED|Overall Study||31
110279|NCT01342523|265828|P27|STARTED|Overall Study||34
110280|NCT01342523|265829|P26|STARTED|Overall Study||38
110281|NCT01342523|265830|P25|STARTED|Overall Study||37
110282|NCT01342523|265831|P24|STARTED|Overall Study||36
110283|NCT01342523|265832|P23|STARTED|Overall Study||36
110284|NCT01342523|265833|P22|STARTED|Overall Study||30
110285|NCT01342523|265834|P21|STARTED|Overall Study||29
110286|NCT01342523|265835|P20|STARTED|Overall Study||27
110287|NCT01342523|265836|P19|STARTED|Overall Study||21
110288|NCT01342523|265837|P18|STARTED|Overall Study||27
110289|NCT01342523|265838|P17|STARTED|Overall Study||29
110290|NCT01342523|265839|P16|STARTED|Overall Study||32
110291|NCT01342523|265840|P15|STARTED|Overall Study||38
110292|NCT01342523|265841|P14|STARTED|Overall Study||38
110293|NCT01342523|265842|P13|STARTED|Overall Study||39
110294|NCT01342523|265843|P12|STARTED|Overall Study||38
110295|NCT01342523|265844|P11|STARTED|Overall Study||38
110296|NCT01342523|265845|P10|STARTED|Overall Study||28
110297|NCT01342523|265846|P9|STARTED|Overall Study||28
110298|NCT01342523|265847|P8|STARTED|Overall Study||27
110299|NCT01342523|265848|P7|STARTED|Overall Study||22
110300|NCT01342523|265849|P6|STARTED|Overall Study||36
110301|NCT01342523|265850|P5|STARTED|Overall Study||36
110302|NCT01342523|265851|P4|STARTED|Overall Study||33
110303|NCT01342523|265852|P3|STARTED|Overall Study||36
110304|NCT01342523|265853|P2|STARTED|Overall Study||32
110305|NCT01342523|265854|P1|STARTED|Overall Study||35
110306|NCT01342510|265871|P4|NOT COMPLETED|Overall Study||11
110307|NCT01342510|265872|P3|NOT COMPLETED|Overall Study||13
110308|NCT01342510|265873|P2|NOT COMPLETED|Overall Study||6
110309|NCT01342510|265874|P1|NOT COMPLETED|Overall Study||12
110310|NCT01342510|265871|P4|COMPLETED|Overall Study||39
110311|NCT01342510|265872|P3|COMPLETED|Overall Study||37
110312|NCT01342510|265873|P2|COMPLETED|Overall Study||44
110313|NCT01342510|265874|P1|COMPLETED|Overall Study||38
110314|NCT01342510|265871|P4|STARTED|Overall Study||50
110315|NCT01342510|265872|P3|STARTED|Overall Study||50
110316|NCT01342510|265873|P2|STARTED|Overall Study||50
110317|NCT01342510|265874|P1|STARTED|Overall Study||50
110318|NCT01342484|265887|P3|NOT COMPLETED|Overall Study||1
110319|NCT01342484|265888|P2|NOT COMPLETED|Overall Study||0
110320|NCT01342484|265889|P1|NOT COMPLETED|Overall Study||2
110321|NCT01342484|265887|P3|COMPLETED|Overall Study||13
110322|NCT01342484|265888|P2|COMPLETED|Overall Study||10
110323|NCT01342484|265889|P1|COMPLETED|Overall Study||13
110324|NCT01342484|265887|P3|STARTED|Overall Study||14
110325|NCT01342484|265888|P2|STARTED|Overall Study||10
110326|NCT01342484|265889|P1|STARTED|Overall Study||15
110327|NCT01342471|265905|P2|NOT COMPLETED|Overall Study||6
110328|NCT01342471|265906|P1|NOT COMPLETED|Overall Study||5
110329|NCT01342471|265905|P2|COMPLETED|Overall Study||23
110330|NCT01342471|265906|P1|COMPLETED|Overall Study||24
110331|NCT01342471|265905|P2|STARTED|Overall Study||29
110332|NCT01342471|265906|P1|STARTED|Overall Study||29
110333|NCT01342458|265922|P2|NOT COMPLETED|Overall Study||4
110334|NCT01342458|265923|P1|NOT COMPLETED|Overall Study||2
110335|NCT01342458|265922|P2|COMPLETED|Overall Study||24
110336|NCT01342458|265923|P1|COMPLETED|Overall Study||26
110337|NCT01342458|265922|P2|STARTED|Overall Study||28
110338|NCT01342458|265923|P1|STARTED|Overall Study||28
110339|NCT01342445|265945|P2|NOT COMPLETED|Overall Study||2
110340|NCT01342445|265946|P1|NOT COMPLETED|Overall Study||0
110341|NCT01342445|265945|P2|COMPLETED|Overall Study||22
110342|NCT01342445|265946|P1|COMPLETED|Overall Study||26
110343|NCT01342445|265945|P2|STARTED|Overall Study||24
110344|NCT01342445|265946|P1|STARTED|Overall Study||26
110345|NCT01342341|265962|P2|NOT COMPLETED|Overall Study||4
110346|NCT01342341|265963|P1|NOT COMPLETED|Overall Study||4
110347|NCT01342341|265962|P2|COMPLETED|Overall Study||20
110348|NCT01342341|265963|P1|COMPLETED|Overall Study||20
110349|NCT01342341|265962|P2|STARTED|Overall Study||24
110350|NCT01342341|265963|P1|STARTED|Overall Study||24
110351|NCT01342211|265974|P5|NOT COMPLETED|Overall Study||2
110352|NCT01342211|265975|P4|NOT COMPLETED|Overall Study||2
110353|NCT01342211|265976|P3|NOT COMPLETED|Overall Study||0
110354|NCT01342211|265977|P2|NOT COMPLETED|Overall Study||2
110355|NCT01342211|265978|P1|NOT COMPLETED|Overall Study||0
110356|NCT01342211|265974|P5|COMPLETED|Overall Study||16
110357|NCT01342211|265975|P4|COMPLETED|Overall Study||17
110358|NCT01342211|265976|P3|COMPLETED|Overall Study||18
110359|NCT01342211|265977|P2|COMPLETED|Overall Study||17
110360|NCT01342211|265978|P1|COMPLETED|Overall Study||19
110361|NCT01342211|265974|P5|Treated|Overall Study||17
110362|NCT01342211|265975|P4|Treated|Overall Study||19
110363|NCT01342211|265976|P3|Treated|Overall Study||18
110364|NCT01342211|265977|P2|Treated|Overall Study||17
110365|NCT01342211|265978|P1|Treated|Overall Study||19
110366|NCT01342211|265974|P5|STARTED|Overall Study||18
110367|NCT01342211|265975|P4|STARTED|Overall Study||19
110368|NCT01342211|265976|P3|STARTED|Overall Study||18
110369|NCT01342211|265977|P2|STARTED|Overall Study||19
110370|NCT01342211|265978|P1|STARTED|Overall Study||19
110371|NCT01342172|266044|P1|NOT COMPLETED|Overall Study||0
110372|NCT01342172|266044|P1|COMPLETED|Overall Study||9
110373|NCT01342172|266044|P1|STARTED|Overall Study||9
110374|NCT01342107|266050|P2|NOT COMPLETED|Overall Study||0
110375|NCT01342107|266051|P1|NOT COMPLETED|Overall Study||0
110376|NCT01342107|266050|P2|COMPLETED|Overall Study||32
110377|NCT01342107|266051|P1|COMPLETED|Overall Study||34
110378|NCT01342107|266050|P2|STARTED|Overall Study||32
110379|NCT01342107|266051|P1|STARTED|Overall Study||34
110380|NCT01342094|266059|P2|NOT COMPLETED|Overall Study||3
110381|NCT01342094|266060|P1|NOT COMPLETED|Overall Study||5
110382|NCT01342094|266059|P2|COMPLETED|Overall Study||81
110383|NCT01342094|266060|P1|COMPLETED|Overall Study||77
110384|NCT01342094|266059|P2|STARTED|Overall Study||84
110385|NCT01342094|266060|P1|STARTED|Overall Study||82
110386|NCT01342081|266069|P3|NOT COMPLETED|Overall Study||1
110387|NCT01342081|266070|P2|NOT COMPLETED|Overall Study||2
110388|NCT01342081|266071|P1|NOT COMPLETED|Overall Study||2
110389|NCT01342081|266069|P3|COMPLETED|Overall Study||163
110390|NCT01342081|266070|P2|COMPLETED|Overall Study||162
110391|NCT01342081|266071|P1|COMPLETED|Overall Study||159
110392|NCT01342081|266069|P3|STARTED|Overall Study||164
110393|NCT01342081|266070|P2|STARTED|Overall Study||164
110394|NCT01342081|266071|P1|STARTED|Overall Study||161
110395|NCT01342029|266079|P2|NOT COMPLETED|Period 2||0
110396|NCT01342029|266080|P1|NOT COMPLETED|Period 2||2
110397|NCT01342029|266079|P2|COMPLETED|Period 2||67
110398|NCT01342029|266080|P1|COMPLETED|Period 2||65
110399|NCT01342029|266079|P2|Dropout|Period 2||0
110400|NCT01342029|266080|P1|Dropout|Period 2||2
110401|NCT01342029|266079|P2|STARTED|Period 2||67
110402|NCT01342029|266080|P1|STARTED|Period 2||67
110403|NCT01342029|266079|P2|NOT COMPLETED|Washout||4
110404|NCT01342029|266080|P1|NOT COMPLETED|Washout||0
110405|NCT01342029|266079|P2|COMPLETED|Washout||67
110406|NCT01342029|266080|P1|COMPLETED|Washout||67
110407|NCT01342029|266079|P2|STARTED|Washout||71
110408|NCT01342029|266080|P1|STARTED|Washout||67
110409|NCT01342029|266079|P2|NOT COMPLETED|Period 1||1
110410|NCT01342029|266080|P1|NOT COMPLETED|Period 1||3
110411|NCT01342029|266079|P2|COMPLETED|Period 1||71
110412|NCT01342029|266080|P1|COMPLETED|Period 1||67
110413|NCT01342029|266079|P2|Dropout|Period 1||1
110414|NCT01342029|266080|P1|Dropout|Period 1||3
110415|NCT01342029|266079|P2|STARTED|Period 1||72
110416|NCT01342029|266080|P1|STARTED|Period 1||70
110417|NCT01341990|266090|P2|NOT COMPLETED|Overall Study||1
110418|NCT01341990|266091|P1|NOT COMPLETED|Overall Study||3
110419|NCT01341990|266090|P2|COMPLETED|Overall Study||32
110420|NCT01341990|266091|P1|COMPLETED|Overall Study||32
110421|NCT01341990|266090|P2|STARTED|Overall Study||33
110422|NCT01341990|266091|P1|STARTED|Overall Study||35
110423|NCT01341977|266101|P2|NOT COMPLETED|Overall Study||15
110424|NCT01341977|266102|P1|NOT COMPLETED|Overall Study||14
110425|NCT01341977|266101|P2|COMPLETED|Overall Study||270
110426|NCT01341977|266102|P1|COMPLETED|Overall Study||274
110427|NCT01341977|266101|P2|STARTED|Overall Study||285
110428|NCT01341977|266102|P1|STARTED|Overall Study||288
110429|NCT01341912|266108|P1|NOT COMPLETED|Overall Study||0
110430|NCT01341912|266108|P1|COMPLETED|Overall Study||3
110431|NCT01341912|266108|P1|STARTED|Overall Study||3
110432|NCT01341782|266115|P2|NOT COMPLETED|Overall Study||14
110433|NCT01341782|266116|P1|NOT COMPLETED|Overall Study||15
110434|NCT01341782|266115|P2|COMPLETED|Overall Study||114
110435|NCT01341782|266116|P1|COMPLETED|Overall Study||112
110436|NCT01341782|266115|P2|STARTED|Overall Study||128
110437|NCT01341782|266116|P1|STARTED|Overall Study||127
110438|NCT01341600|266135|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
110439|NCT01341600|266136|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
110440|NCT01341600|266137|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
110441|NCT01341600|266135|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
110442|NCT01341600|266136|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
110443|NCT01341600|266137|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
110444|NCT01341600|266135|P3|STARTED|Clopidogrel Plus Omeprazole||4
110445|NCT01341600|266136|P2|STARTED|Clopidogrel Plus Omeprazole||5
110446|NCT01341600|266137|P1|STARTED|Clopidogrel Plus Omeprazole||5
110447|NCT01341600|266135|P3|NOT COMPLETED|Clopidogrel 225 mg||0
110448|NCT01341600|266136|P2|NOT COMPLETED|Clopidogrel 225 mg||0
110449|NCT01341600|266137|P1|NOT COMPLETED|Clopidogrel 225 mg||0
110450|NCT01341600|266135|P3|COMPLETED|Clopidogrel 225 mg||6
110451|NCT01341600|266136|P2|COMPLETED|Clopidogrel 225 mg||6
110452|NCT01341600|266137|P1|COMPLETED|Clopidogrel 225 mg||6
110453|NCT01341600|266135|P3|STARTED|Clopidogrel 225 mg||6
110454|NCT01341600|266136|P2|STARTED|Clopidogrel 225 mg||6
110455|NCT01341600|266137|P1|STARTED|Clopidogrel 225 mg||6
110456|NCT01341600|266135|P3|NOT COMPLETED|Clopidogrel 150 mg||0
110457|NCT01341600|266136|P2|NOT COMPLETED|Clopidogrel 150 mg||0
110458|NCT01341600|266137|P1|NOT COMPLETED|Clopidogrel 150 mg||0
110459|NCT01341600|266135|P3|COMPLETED|Clopidogrel 150 mg||6
110460|NCT01341600|266136|P2|COMPLETED|Clopidogrel 150 mg||6
110461|NCT01341600|266137|P1|COMPLETED|Clopidogrel 150 mg||6
110462|NCT01341600|266135|P3|STARTED|Clopidogrel 150 mg||6
110463|NCT01341600|266136|P2|STARTED|Clopidogrel 150 mg||6
110464|NCT01341600|266137|P1|STARTED|Clopidogrel 150 mg||6
110465|NCT01341600|266135|P3|NOT COMPLETED|Clopidogrel 75 mg||0
110466|NCT01341600|266136|P2|NOT COMPLETED|Clopidogrel 75 mg||0
110467|NCT01341600|266137|P1|NOT COMPLETED|Clopidogrel 75 mg||0
110468|NCT01341600|266135|P3|COMPLETED|Clopidogrel 75 mg||6
110469|NCT01341600|266136|P2|COMPLETED|Clopidogrel 75 mg||6
110470|NCT01341600|266137|P1|COMPLETED|Clopidogrel 75 mg||6
110471|NCT01341600|266135|P3|STARTED|Clopidogrel 75 mg||6
110472|NCT01341600|266136|P2|STARTED|Clopidogrel 75 mg||6
110473|NCT01341600|266137|P1|STARTED|Clopidogrel 75 mg||6
110474|NCT01341587|266156|P2|NOT COMPLETED|Overall Study||10
110475|NCT01341587|266157|P1|NOT COMPLETED|Overall Study||4
110476|NCT01341587|266156|P2|COMPLETED|Overall Study||0
110477|NCT01341587|266157|P1|COMPLETED|Overall Study||0
110478|NCT01341587|266156|P2|STARTED|Overall Study||10
110479|NCT01341587|266157|P1|STARTED|Overall Study||4
110480|NCT01341444|266165|P2|NOT COMPLETED|Overall Study||3
110481|NCT01341444|266166|P1|NOT COMPLETED|Overall Study||5
110482|NCT01341444|266165|P2|COMPLETED|Overall Study||29
110483|NCT01341444|266166|P1|COMPLETED|Overall Study||26
110484|NCT01341444|266165|P2|STARTED|Overall Study||32
110485|NCT01341444|266166|P1|STARTED|Overall Study||31
110486|NCT01341301|266172|P1|NOT COMPLETED|Overall Study||0
110487|NCT01341301|266172|P1|COMPLETED|Overall Study||25
110488|NCT01341301|266172|P1|STARTED|Overall Study||25
110489|NCT01341067|266179|P1|NOT COMPLETED|Overall Study||4
110490|NCT01341067|266179|P1|COMPLETED|Overall Study||26
110491|NCT01341067|266179|P1|STARTED|Overall Study||30
110492|NCT01340937|266190|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
110493|NCT01340937|266191|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
110494|NCT01340937|266192|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
110495|NCT01340937|266193|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
110496|NCT01340937|266190|P4|COMPLETED|Period 3: Toddler Vaccinations||319
110497|NCT01340937|266191|P3|COMPLETED|Period 3: Toddler Vaccinations||660
110498|NCT01340937|266192|P2|COMPLETED|Period 3: Toddler Vaccinations||641
110499|NCT01340937|266193|P1|COMPLETED|Period 3: Toddler Vaccinations||666
110500|NCT01340937|266190|P4|STARTED|Period 3: Toddler Vaccinations||329
110501|NCT01340937|266191|P3|STARTED|Period 3: Toddler Vaccinations||669
110502|NCT01340937|266192|P2|STARTED|Period 3: Toddler Vaccinations||658
110503|NCT01340937|266193|P1|STARTED|Period 3: Toddler Vaccinations||675
110504|NCT01340937|266190|P4|NOT COMPLETED|Period 2: Interim Period||41
110505|NCT01340937|266191|P3|NOT COMPLETED|Period 2: Interim Period||84
110506|NCT01340937|266192|P2|NOT COMPLETED|Period 2: Interim Period||79
110507|NCT01340937|266193|P1|NOT COMPLETED|Period 2: Interim Period||67
110508|NCT01340937|266190|P4|COMPLETED|Period 2: Interim Period||329
110509|NCT01340937|266191|P3|COMPLETED|Period 2: Interim Period||669
110510|NCT01340937|266192|P2|COMPLETED|Period 2: Interim Period||658
110511|NCT01340937|266193|P1|COMPLETED|Period 2: Interim Period||675
110512|NCT01340937|266190|P4|STARTED|Period 2: Interim Period||370
110513|NCT01340937|266191|P3|STARTED|Period 2: Interim Period||753
110514|NCT01340937|266192|P2|STARTED|Period 2: Interim Period||737
110515|NCT01340937|266193|P1|STARTED|Period 2: Interim Period||742
110516|NCT01340937|266190|P4|NOT COMPLETED|Period 1: Infant Series||32
110517|NCT01340937|266191|P3|NOT COMPLETED|Period 1: Infant Series||56
110518|NCT01340937|266192|P2|NOT COMPLETED|Period 1: Infant Series||60
110519|NCT01340937|266193|P1|NOT COMPLETED|Period 1: Infant Series||58
110520|NCT01340937|266190|P4|COMPLETED|Period 1: Infant Series||370
110521|NCT01340937|266191|P3|COMPLETED|Period 1: Infant Series||753
110522|NCT01340937|266192|P2|COMPLETED|Period 1: Infant Series||737
110523|NCT01340937|266193|P1|COMPLETED|Period 1: Infant Series||742
110524|NCT01340937|266190|P4|STARTED|Period 1: Infant Series||402
110525|NCT01340937|266191|P3|STARTED|Period 1: Infant Series||809
110526|NCT01340937|266192|P2|STARTED|Period 1: Infant Series||797
110527|NCT01340937|266193|P1|STARTED|Period 1: Infant Series||800
110528|NCT01340794|266352|P2|NOT COMPLETED|Overall Study||1
110529|NCT01340794|266353|P1|NOT COMPLETED|Overall Study||0
110530|NCT01340794|266352|P2|COMPLETED|Overall Study||4
110531|NCT01340794|266353|P1|COMPLETED|Overall Study||2
110532|NCT01340794|266352|P2|STARTED|Overall Study||5
110533|NCT01340794|266353|P1|STARTED|Overall Study||2
110534|NCT01340768|266369|P2|NOT COMPLETED|Overall Study||5
110535|NCT01340768|266370|P1|NOT COMPLETED|Overall Study||17
110536|NCT01340768|266369|P2|COMPLETED|Overall Study||429
110537|NCT01340768|266370|P1|COMPLETED|Overall Study||419
110538|NCT01340768|266369|P2|STARTED|Overall Study||434
110539|NCT01340768|266370|P1|STARTED|Overall Study||436
110540|NCT01340664|266381|P3|NOT COMPLETED|Overall Study||13
110541|NCT01340664|266382|P2|NOT COMPLETED|Overall Study||8
110542|NCT01340664|266383|P1|NOT COMPLETED|Overall Study||7
110543|NCT01340664|266381|P3|COMPLETED|Overall Study||80
110544|NCT01340664|266382|P2|COMPLETED|Overall Study||85
110545|NCT01340664|266383|P1|COMPLETED|Overall Study||86
110546|NCT01340664|266381|P3|STARTED|Overall Study||93
110547|NCT01340664|266382|P2|STARTED|Overall Study||93
110548|NCT01340664|266383|P1|STARTED|Overall Study||93
110549|NCT01340651|266400|P1|NOT COMPLETED|Overall Study||17
110550|NCT01340651|266400|P1|COMPLETED|Overall Study||24
110551|NCT01340651|266400|P1|STARTED|Overall Study||41
110552|NCT01340625|266416|P2|NOT COMPLETED|Second Intervention||0
110553|NCT01340625|266417|P1|NOT COMPLETED|Second Intervention||0
110554|NCT01340625|266416|P2|COMPLETED|Second Intervention||18
110555|NCT01340625|266417|P1|COMPLETED|Second Intervention||16
110556|NCT01340625|266416|P2|STARTED|Second Intervention||18
110557|NCT01340625|266417|P1|STARTED|Second Intervention||16
110558|NCT01340625|266416|P2|NOT COMPLETED|Washout Period of 28 Days||0
110559|NCT01340625|266417|P1|NOT COMPLETED|Washout Period of 28 Days||1
110560|NCT01340625|266416|P2|COMPLETED|Washout Period of 28 Days||18
110561|NCT01340625|266417|P1|COMPLETED|Washout Period of 28 Days||16
110562|NCT01340625|266416|P2|STARTED|Washout Period of 28 Days||18
110563|NCT01340625|266417|P1|STARTED|Washout Period of 28 Days||17
110564|NCT01340625|266416|P2|NOT COMPLETED|First Intervention||0
110565|NCT01340625|266417|P1|NOT COMPLETED|First Intervention||1
110566|NCT01340625|266416|P2|COMPLETED|First Intervention||18
110567|NCT01340625|266417|P1|COMPLETED|First Intervention||17
110568|NCT01340625|266416|P2|STARTED|First Intervention||18
110569|NCT01340625|266417|P1|STARTED|First Intervention||18
110570|NCT01340586|266435|P2|NOT COMPLETED|Overall Study||0
110571|NCT01340586|266436|P1|NOT COMPLETED|Overall Study||0
110572|NCT01340586|266435|P2|COMPLETED|Overall Study||8
110573|NCT01340586|266436|P1|COMPLETED|Overall Study||8
110574|NCT01340586|266435|P2|STARTED|Overall Study||8
110575|NCT01340586|266436|P1|STARTED|Overall Study||8
110576|NCT01340573|266501|P1|NOT COMPLETED|Overall Study||3
110577|NCT01340573|266501|P1|COMPLETED|Overall Study||0
110578|NCT01340573|266501|P1|STARTED|Overall Study||3
110579|NCT01340495|266522|P1|NOT COMPLETED|Overall Study||1
110580|NCT01340495|266522|P1|COMPLETED|Overall Study||69
110581|NCT01340495|266522|P1|STARTED|Overall Study||70
110582|NCT01340300|266532|P4|NOT COMPLETED|Overall Study||21
110583|NCT01340300|266533|P3|NOT COMPLETED|Overall Study||21
110584|NCT01340300|266534|P2|NOT COMPLETED|Overall Study||14
110585|NCT01340300|266535|P1|NOT COMPLETED|Overall Study||15
110586|NCT01340300|266532|P4|COMPLETED|Overall Study||13
110587|NCT01340300|266533|P3|COMPLETED|Overall Study||14
110588|NCT01340300|266534|P2|COMPLETED|Overall Study||21
110589|NCT01340300|266535|P1|COMPLETED|Overall Study||20
110590|NCT01340300|266532|P4|Completed Treatment|Overall Study||17
110591|NCT01340300|266533|P3|Completed Treatment|Overall Study||18
110592|NCT01340300|266534|P2|Completed Treatment|Overall Study||24
110593|NCT01340300|266535|P1|Completed Treatment|Overall Study||23
110594|NCT01340300|266532|P4|Follow-up Blood Sample|Overall Study||17
110595|NCT01340300|266533|P3|Follow-up Blood Sample|Overall Study||19
110596|NCT01340300|266534|P2|Follow-up Blood Sample|Overall Study||26
110597|NCT01340300|266535|P1|Follow-up Blood Sample|Overall Study||25
110598|NCT01340300|266532|P4|Baseline Blood Sample|Overall Study||29
110599|NCT01340300|266533|P3|Baseline Blood Sample|Overall Study||32
110600|NCT01340300|266534|P2|Baseline Blood Sample|Overall Study||34
110601|NCT01340300|266535|P1|Baseline Blood Sample|Overall Study||33
110602|NCT01340300|266532|P4|STARTED|Overall Study||34
110603|NCT01340300|266533|P3|STARTED|Overall Study||35
110604|NCT01340300|266534|P2|STARTED|Overall Study||35
110605|NCT01340300|266535|P1|STARTED|Overall Study||35
110606|NCT01340209|266568|P3|NOT COMPLETED|Overall Study||8
110607|NCT01340209|266569|P2|NOT COMPLETED|Overall Study||8
110608|NCT01340209|266570|P1|NOT COMPLETED|Overall Study||5
110609|NCT01340209|266568|P3|COMPLETED|Overall Study||106
110610|NCT01340209|266569|P2|COMPLETED|Overall Study||106
110611|NCT01340209|266570|P1|COMPLETED|Overall Study||52
110612|NCT01340209|266568|P3|STARTED|Overall Study||114
110613|NCT01340209|266569|P2|STARTED|Overall Study||114
110614|NCT01340209|266570|P1|STARTED|Overall Study||57
110615|NCT01340196|266605|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
110616|NCT01340196|266605|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
110617|NCT01340196|266605|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
110618|NCT01340196|266605|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
110619|NCT01340196|266605|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
110620|NCT01340196|266605|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
110621|NCT01340196|266605|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
110622|NCT01340196|266605|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
110623|NCT01340196|266605|P1|STARTED|Treat. Period 1 (Tenofovir)||16
110624|NCT01340144|266636|P2|NOT COMPLETED|Overall Study||58
110625|NCT01340144|266637|P1|NOT COMPLETED|Overall Study||72
110626|NCT01340144|266636|P2|COMPLETED|Overall Study||567
110627|NCT01340144|266637|P1|COMPLETED|Overall Study||553
110628|NCT01340144|266636|P2|STARTED|Overall Study||625
110629|NCT01340144|266637|P1|STARTED|Overall Study||625
110630|NCT01340066|266645|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
110631|NCT01340066|266646|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
110632|NCT01340066|266647|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
110633|NCT01340066|266645|P3|COMPLETED|5 Week Double Blind Randomization Period||31
110634|NCT01340066|266646|P2|COMPLETED|5 Week Double Blind Randomization Period||28
110635|NCT01340066|266647|P1|COMPLETED|5 Week Double Blind Randomization Period||0
110636|NCT01340066|266645|P3|STARTED|5 Week Double Blind Randomization Period||34
110637|NCT01340066|266646|P2|STARTED|5 Week Double Blind Randomization Period||33
110638|NCT01340066|266647|P1|STARTED|5 Week Double Blind Randomization Period||0
110639|NCT01340066|266645|P3|NOT COMPLETED|Placebo Run in Period||0
110640|NCT01340066|266646|P2|NOT COMPLETED|Placebo Run in Period||0
110641|NCT01340066|266647|P1|NOT COMPLETED|Placebo Run in Period||27
110642|NCT01340066|266645|P3|COMPLETED|Placebo Run in Period||0
110643|NCT01340066|266646|P2|COMPLETED|Placebo Run in Period||0
110644|NCT01340066|266647|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
110645|NCT01340066|266645|P3|STARTED|Placebo Run in Period||0
110646|NCT01340066|266646|P2|STARTED|Placebo Run in Period||0
110647|NCT01340066|266647|P1|STARTED|Placebo Run in Period||94
110648|NCT01340027|266666|P12|NOT COMPLETED|Overall Study||4
110649|NCT01340027|266667|P11|NOT COMPLETED|Overall Study||2
110650|NCT01340027|266668|P10|NOT COMPLETED|Overall Study||6
110651|NCT01340027|266669|P9|NOT COMPLETED|Overall Study||8
110652|NCT01340027|266670|P8|NOT COMPLETED|Overall Study||7
110653|NCT01340027|266671|P7|NOT COMPLETED|Overall Study||7
110654|NCT01340027|266672|P6|NOT COMPLETED|Overall Study||4
110655|NCT01340027|266673|P5|NOT COMPLETED|Overall Study||10
110656|NCT01340027|266674|P4|NOT COMPLETED|Overall Study||4
110657|NCT01340027|266675|P3|NOT COMPLETED|Overall Study||4
110658|NCT01340027|266676|P2|NOT COMPLETED|Overall Study||7
110659|NCT01340027|266677|P1|NOT COMPLETED|Overall Study||5
110660|NCT01340027|266666|P12|COMPLETED|Overall Study||77
110661|NCT01340027|266667|P11|COMPLETED|Overall Study||79
110662|NCT01340027|266668|P10|COMPLETED|Overall Study||146
110663|NCT01340027|266669|P9|COMPLETED|Overall Study||136
110664|NCT01340027|266670|P8|COMPLETED|Overall Study||142
110665|NCT01340027|266671|P7|COMPLETED|Overall Study||142
110666|NCT01340027|266672|P6|COMPLETED|Overall Study||74
110667|NCT01340027|266673|P5|COMPLETED|Overall Study||146
110668|NCT01340027|266674|P4|COMPLETED|Overall Study||75
110669|NCT01340027|266675|P3|COMPLETED|Overall Study||75
110670|NCT01340027|266676|P2|COMPLETED|Overall Study||71
110671|NCT01340027|266677|P1|COMPLETED|Overall Study||76
110672|NCT01340027|266666|P12|Received Treatment|Overall Study||81
110673|NCT01340027|266667|P11|Received Treatment|Overall Study||81
110674|NCT01340027|266668|P10|Received Treatment|Overall Study||152
110675|NCT01340027|266669|P9|Received Treatment|Overall Study||144
110676|NCT01340027|266670|P8|Received Treatment|Overall Study||149
110677|NCT01340027|266671|P7|Received Treatment|Overall Study||149
110678|NCT01340027|266672|P6|Received Treatment|Overall Study||78
110679|NCT01340027|266673|P5|Received Treatment|Overall Study||156
110680|NCT01340027|266674|P4|Received Treatment|Overall Study||79
110681|NCT01340027|266675|P3|Received Treatment|Overall Study||78
110682|NCT01340027|266676|P2|Received Treatment|Overall Study||78
110683|NCT01340027|266677|P1|Received Treatment|Overall Study||81
110684|NCT01340027|266666|P12|STARTED|Overall Study||81
110685|NCT01340027|266667|P11|STARTED|Overall Study||81
110686|NCT01340027|266668|P10|STARTED|Overall Study||152
110687|NCT01340027|266669|P9|STARTED|Overall Study||144
110688|NCT01340027|266670|P8|STARTED|Overall Study||149
110689|NCT01340027|266671|P7|STARTED|Overall Study||149
110690|NCT01340027|266672|P6|STARTED|Overall Study||78
110691|NCT01340027|266673|P5|STARTED|Overall Study||156
110692|NCT01340027|266674|P4|STARTED|Overall Study||79
110693|NCT01340027|266675|P3|STARTED|Overall Study||79
110694|NCT01340027|266676|P2|STARTED|Overall Study||78
110695|NCT01340027|266677|P1|STARTED|Overall Study||81
110696|NCT01340014|267053|P2|NOT COMPLETED|Period 2, Second 7 Days||1
110697|NCT01340014|267054|P1|NOT COMPLETED|Period 2, Second 7 Days||0
110698|NCT01340014|267053|P2|COMPLETED|Period 2, Second 7 Days||56
110699|NCT01340014|267054|P1|COMPLETED|Period 2, Second 7 Days||53
110700|NCT01340014|267053|P2|STARTED|Period 2, Second 7 Days||57
110701|NCT01340014|267054|P1|STARTED|Period 2, Second 7 Days||53
110702|NCT01340014|267053|P2|NOT COMPLETED|Period 1, First 7 Days||0
110703|NCT01340014|267054|P1|NOT COMPLETED|Period 1, First 7 Days||2
110704|NCT01340014|267053|P2|COMPLETED|Period 1, First 7 Days||57
110705|NCT01340014|267054|P1|COMPLETED|Period 1, First 7 Days||53
110706|NCT01340014|267053|P2|STARTED|Period 1, First 7 Days||57
110707|NCT01340014|267054|P1|STARTED|Period 1, First 7 Days||55
110708|NCT01339936|267062|P1|NOT COMPLETED|Overall Study||2
110709|NCT01339936|267062|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
110710|NCT01339936|267062|P1|STARTED|Overall Study|plus 2 screen failures|38
110711|NCT01339923|267075|P7|NOT COMPLETED|Overall Study||14
110712|NCT01339923|267076|P6|NOT COMPLETED|Overall Study||9
110713|NCT01339923|267077|P5|NOT COMPLETED|Overall Study||5
110714|NCT01339923|267078|P4|NOT COMPLETED|Overall Study||4
110715|NCT01339923|267079|P3|NOT COMPLETED|Overall Study||8
110716|NCT01339923|267080|P2|NOT COMPLETED|Overall Study||16
110717|NCT01339923|267081|P1|NOT COMPLETED|Overall Study||14
110718|NCT01339923|267075|P7|COMPLETED|Overall Study||111
110719|NCT01339923|267076|P6|COMPLETED|Overall Study||117
110720|NCT01339923|267077|P5|COMPLETED|Overall Study||295
110721|NCT01339923|267078|P4|COMPLETED|Overall Study||100
110722|NCT01339923|267079|P3|COMPLETED|Overall Study||243
110723|NCT01339923|267080|P2|COMPLETED|Overall Study||234
110724|NCT01339923|267081|P1|COMPLETED|Overall Study||239
110725|NCT01339923|267075|P7|STARTED|Overall Study||125
110726|NCT01339923|267076|P6|STARTED|Overall Study||126
110727|NCT01339923|267077|P5|STARTED|Overall Study||300
110728|NCT01339923|267078|P4|STARTED|Overall Study||104
110729|NCT01339923|267079|P3|STARTED|Overall Study||251
110730|NCT01339923|267080|P2|STARTED|Overall Study||250
110731|NCT01339923|267081|P1|STARTED|Overall Study||253
110732|NCT01339910|267152|P2|NOT COMPLETED|Overall Study||4
110733|NCT01339910|267153|P1|NOT COMPLETED|Overall Study||3
110734|NCT01339910|267152|P2|COMPLETED|Overall Study||133
110735|NCT01339910|267153|P1|COMPLETED|Overall Study||132
110736|NCT01339910|267152|P2|STARTED|Overall Study||137
110737|NCT01339910|267153|P1|STARTED|Overall Study||135
110738|NCT01339897|267191|P4|NOT COMPLETED|Overall Study||1
110739|NCT01339897|267192|P3|NOT COMPLETED|Overall Study||0
110740|NCT01339897|267193|P2|NOT COMPLETED|Overall Study||0
110741|NCT01339897|267194|P1|NOT COMPLETED|Overall Study||1
110742|NCT01339897|267191|P4|COMPLETED|Overall Study||5
110743|NCT01339897|267192|P3|COMPLETED|Overall Study||6
110744|NCT01339897|267193|P2|COMPLETED|Overall Study||6
110745|NCT01339897|267194|P1|COMPLETED|Overall Study||6
110746|NCT01339897|267191|P4|STARTED|Overall Study||6
110747|NCT01339897|267192|P3|STARTED|Overall Study||6
110748|NCT01339897|267193|P2|STARTED|Overall Study||6
110749|NCT01339897|267194|P1|STARTED|Overall Study||7
110750|NCT01339832|267220|P1|NOT COMPLETED|Overall Study||14
110751|NCT01339832|267220|P1|COMPLETED|Overall Study||37
110752|NCT01339832|267220|P1|STARTED|Overall Study||51
110753|NCT01339429|267231|P1|NOT COMPLETED|Overall Study||4
110754|NCT01339429|267231|P1|COMPLETED|Overall Study||37
110755|NCT01339429|267231|P1|STARTED|Overall Study||41
110756|NCT01339416|267236|P1|NOT COMPLETED|Overall Study||0
110757|NCT01339416|267236|P1|COMPLETED|Overall Study||8202
110758|NCT01339416|267236|P1|STARTED|Overall Study||8202
110759|NCT01339403|267248|P2|NOT COMPLETED|Overall Study||0
110760|NCT01339403|267249|P1|NOT COMPLETED|Overall Study||0
110761|NCT01339403|267248|P2|COMPLETED|Overall Study||257600
110762|NCT01339403|267249|P1|COMPLETED|Overall Study||24768
110763|NCT01339403|267248|P2|STARTED|Overall Study||257600
110764|NCT01339403|267249|P1|STARTED|Overall Study||24768
110765|NCT01339390|267271|P2|NOT COMPLETED|Overall Study||156
110766|NCT01339390|267272|P1|NOT COMPLETED|Overall Study||157
110767|NCT01339390|267271|P2|COMPLETED|Overall Study||1442
110768|NCT01339390|267272|P1|COMPLETED|Overall Study||1414
110769|NCT01339390|267271|P2|STARTED|Overall Study||1598
110770|NCT01339390|267272|P1|STARTED|Overall Study||1571
110771|NCT01339299|267280|P2|NOT COMPLETED|Overall Study||0
110772|NCT01339299|267281|P1|NOT COMPLETED|Overall Study||0
110773|NCT01339299|267280|P2|COMPLETED|Overall Study||50
110774|NCT01339299|267281|P1|COMPLETED|Overall Study||50
110775|NCT01339299|267280|P2|STARTED|Overall Study||50
110776|NCT01339299|267281|P1|STARTED|Overall Study||50
110777|NCT01339260|267289|P2|NOT COMPLETED|Multi-cycle Extension||193
110778|NCT01339260|267290|P1|NOT COMPLETED|Multi-cycle Extension||186
110779|NCT01339260|267289|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
110780|NCT01339260|267290|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
110781|NCT01339260|267289|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
110782|NCT01339260|267290|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
110783|NCT01339260|267289|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
110784|NCT01339260|267290|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
110785|NCT01339260|267289|P2|NOT COMPLETED|Cycle 1||10
110786|NCT01339260|267290|P1|NOT COMPLETED|Cycle 1||7
110787|NCT01339260|267289|P2|COMPLETED|Cycle 1||719
110788|NCT01339260|267290|P1|COMPLETED|Cycle 1||719
110789|NCT01339260|267289|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
110790|NCT01339260|267290|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
110791|NCT01339260|267289|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
110792|NCT01339260|267290|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
110793|NCT01339260|267289|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
110794|NCT01339260|267290|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
110795|NCT01339247|267302|P2|NOT COMPLETED|Period 2||0
110796|NCT01339247|267303|P1|NOT COMPLETED|Period 2||0
110797|NCT01339247|267302|P2|COMPLETED|Period 2||30
110798|NCT01339247|267303|P1|COMPLETED|Period 2||30
110799|NCT01339247|267302|P2|STARTED|Period 2||30
110800|NCT01339247|267303|P1|STARTED|Period 2||30
110801|NCT01339247|267302|P2|NOT COMPLETED|Period 1||0
110802|NCT01339247|267303|P1|NOT COMPLETED|Period 1||0
110803|NCT01339247|267302|P2|COMPLETED|Period 1||30
110804|NCT01339247|267303|P1|COMPLETED|Period 1||30
110805|NCT01339247|267302|P2|STARTED|Period 1||30
110806|NCT01339247|267303|P1|STARTED|Period 1||30
110807|NCT01339091|267315|P2|NOT COMPLETED|Overall Study||28
110808|NCT01339091|267316|P1|NOT COMPLETED|Overall Study||27
110809|NCT01339091|267315|P2|COMPLETED|Overall Study||257
110810|NCT01339091|267316|P1|COMPLETED|Overall Study||261
110811|NCT01339091|267315|P2|Safety Population|Overall Study||284
110812|NCT01339091|267316|P1|Safety Population|Overall Study||284
110813|NCT01339091|267315|P2|STARTED|Overall Study||285
110814|NCT01339091|267316|P1|STARTED|Overall Study||288
110815|NCT01339052|267330|P2|NOT COMPLETED|Overall Study||50
110816|NCT01339052|267331|P1|NOT COMPLETED|Overall Study||15
110817|NCT01339052|267330|P2|COMPLETED|Overall Study||0
110818|NCT01339052|267331|P1|COMPLETED|Overall Study||0
110819|NCT01339052|267330|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
110820|NCT01339052|267331|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
110821|NCT01339052|267330|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
110822|NCT01339052|267331|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
110823|NCT01339052|267330|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
110824|NCT01339052|267331|P1|Measurable Disease|Overall Study||11
110825|NCT01339052|267330|P2|STARTED|Overall Study||50
110826|NCT01339052|267331|P1|STARTED|Overall Study||15
110827|NCT01339013|267351|P1|NOT COMPLETED|Overall Study||0
110828|NCT01339013|267351|P1|COMPLETED|Overall Study||6
110829|NCT01339013|267351|P1|STARTED|Overall Study||6
110830|NCT01339000|267357|P2|NOT COMPLETED|Overall Study||0
110831|NCT01339000|267358|P1|NOT COMPLETED|Overall Study||1
110832|NCT01339000|267357|P2|COMPLETED|Overall Study||0
110833|NCT01339000|267358|P1|COMPLETED|Overall Study||0
110834|NCT01339000|267357|P2|STARTED|Overall Study||0
110835|NCT01339000|267358|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
110836|NCT01338870|267378|P6|NOT COMPLETED|Overall Study||6
110837|NCT01338870|267379|P5|NOT COMPLETED|Overall Study||6
110838|NCT01338870|267380|P4|NOT COMPLETED|Overall Study||9
110839|NCT01338870|267381|P3|NOT COMPLETED|Overall Study||11
110840|NCT01338870|267382|P2|NOT COMPLETED|Overall Study||12
110841|NCT01338870|267383|P1|NOT COMPLETED|Overall Study||9
110842|NCT01338870|267378|P6|COMPLETED|Overall Study||44
110843|NCT01338870|267379|P5|COMPLETED|Overall Study||46
110844|NCT01338870|267380|P4|COMPLETED|Overall Study||41
110845|NCT01338870|267381|P3|COMPLETED|Overall Study||39
110846|NCT01338870|267382|P2|COMPLETED|Overall Study||37
110847|NCT01338870|267383|P1|COMPLETED|Overall Study||41
110848|NCT01338870|267378|P6|STARTED|Overall Study||50
110849|NCT01338870|267379|P5|STARTED|Overall Study||52
110850|NCT01338870|267380|P4|STARTED|Overall Study||50
110851|NCT01338870|267381|P3|STARTED|Overall Study||50
110852|NCT01338870|267382|P2|STARTED|Overall Study||49
110853|NCT01338870|267383|P1|STARTED|Overall Study||50
110854|NCT01338857|267433|P1|NOT COMPLETED|Overall Study||11
110855|NCT01338857|267433|P1|COMPLETED|Overall Study||1
110856|NCT01338857|267433|P1|STARTED|Overall Study||12
110857|NCT01338818|267438|P1|NOT COMPLETED|Overall Study||36
110858|NCT01338818|267438|P1|COMPLETED|Overall Study||262
110859|NCT01338818|267438|P1|STARTED|Overall Study||298
110860|NCT01338792|267444|P1|NOT COMPLETED|Overall Study||4
110861|NCT01338792|267444|P1|COMPLETED|Overall Study||43
110862|NCT01338792|267444|P1|STARTED|Overall Study||47
110863|NCT01338649|267452|P2|NOT COMPLETED|Overall Study||0
110864|NCT01338649|267453|P1|NOT COMPLETED|Overall Study||0
110865|NCT01338649|267452|P2|COMPLETED|Overall Study||14
110866|NCT01338649|267453|P1|COMPLETED|Overall Study||13
110867|NCT01338649|267452|P2|STARTED|Overall Study||14
110868|NCT01338649|267453|P1|STARTED|Overall Study||13
110869|NCT01338636|267459|P1|NOT COMPLETED|Overall Study||8
110870|NCT01338636|267459|P1|COMPLETED|Overall Study||22
110871|NCT01338636|267459|P1|STARTED|Overall Study||30
110872|NCT01338610|267473|P3|NOT COMPLETED|Overall Study||1
110873|NCT01338610|267474|P2|NOT COMPLETED|Overall Study||1
110874|NCT01338610|267475|P1|NOT COMPLETED|Overall Study||5
110875|NCT01338610|267473|P3|COMPLETED|Overall Study||28
110876|NCT01338610|267474|P2|COMPLETED|Overall Study||55
110877|NCT01338610|267475|P1|COMPLETED|Overall Study||34
110878|NCT01338610|267473|P3|STARTED|Overall Study||29
110879|NCT01338610|267474|P2|STARTED|Overall Study||56
110880|NCT01338610|267475|P1|STARTED|Overall Study||39
110881|NCT01338493|267482|P1|NOT COMPLETED|24 Months Follow up||0
110882|NCT01338493|267482|P1|COMPLETED|24 Months Follow up||104
110883|NCT01338493|267482|P1|STARTED|24 Months Follow up||104
110884|NCT01338493|267482|P1|NOT COMPLETED|12 Months Follow up||9
110885|NCT01338493|267482|P1|COMPLETED|12 Months Follow up||104
110886|NCT01338493|267482|P1|STARTED|12 Months Follow up||113
110887|NCT01338493|267482|P1|NOT COMPLETED|6 Months Follow up||19
110888|NCT01338493|267482|P1|COMPLETED|6 Months Follow up||113
110889|NCT01338493|267482|P1|STARTED|6 Months Follow up||132
110890|NCT01338493|267482|P1|NOT COMPLETED|Discharge||2
110891|NCT01338493|267482|P1|COMPLETED|Discharge||132
110892|NCT01338493|267482|P1|STARTED|Discharge||134
110893|NCT01338493|267482|P1|NOT COMPLETED|Implant||0
110894|NCT01338493|267482|P1|COMPLETED|Implant||134
110895|NCT01338493|267482|P1|STARTED|Implant||134
110896|NCT01338493|267482|P1|NOT COMPLETED|Enrolled||5
110897|NCT01338493|267482|P1|COMPLETED|Enrolled||134
110898|NCT01338493|267482|P1|STARTED|Enrolled||139
110899|NCT01338415|267489|P2|NOT COMPLETED|Overall Study||9
110900|NCT01338415|267490|P1|NOT COMPLETED|Overall Study||10
110901|NCT01338415|267489|P2|COMPLETED|Overall Study||22
110902|NCT01338415|267490|P1|COMPLETED|Overall Study||23
110903|NCT01338415|267489|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
110904|NCT01338415|267490|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
110905|NCT01338415|267489|P2|STARTED|Overall Study||31
110906|NCT01338415|267490|P1|STARTED|Overall Study||33
110907|NCT01338298|267512|P2|NOT COMPLETED|Overall Study||3
110908|NCT01338298|267513|P1|NOT COMPLETED|Overall Study||4
110909|NCT01338298|267512|P2|COMPLETED|Overall Study||15
110910|NCT01338298|267513|P1|COMPLETED|Overall Study||20
110911|NCT01338298|267512|P2|STARTED|Overall Study||18
110912|NCT01338298|267513|P1|STARTED|Overall Study||24
110913|NCT01338025|267523|P2|NOT COMPLETED|Overall Study||11
110914|NCT01338025|267524|P1|NOT COMPLETED|Overall Study||11
110915|NCT01338025|267523|P2|COMPLETED|Overall Study||6
110916|NCT01338025|267524|P1|COMPLETED|Overall Study||5
110917|NCT01338025|267523|P2|STARTED|Overall Study||17
110918|NCT01338025|267524|P1|STARTED|Overall Study||16
110919|NCT01338012|267536|P1|NOT COMPLETED|Overall Study||8
110920|NCT01338012|267536|P1|COMPLETED|Overall Study||0
110921|NCT01338012|267536|P1|STARTED|Overall Study||8
110922|NCT01337960|267543|P3|NOT COMPLETED|Overall Study||0
110923|NCT01337960|267544|P2|NOT COMPLETED|Overall Study||0
110924|NCT01337960|267545|P1|NOT COMPLETED|Overall Study||2
110925|NCT01337960|267543|P3|COMPLETED|Overall Study||6
110926|NCT01337960|267544|P2|COMPLETED|Overall Study||14
110927|NCT01337960|267545|P1|COMPLETED|Overall Study||12
110928|NCT01337960|267543|P3|STARTED|Overall Study||6
110929|NCT01337960|267544|P2|STARTED|Overall Study||14
110930|NCT01337960|267545|P1|STARTED|Overall Study||14
110931|NCT01337739|267567|P2|NOT COMPLETED|Overall Study||0
110932|NCT01337739|267568|P1|NOT COMPLETED|Overall Study||0
110933|NCT01337739|267567|P2|COMPLETED|Overall Study||4
110934|NCT01337739|267568|P1|COMPLETED|Overall Study||6
110935|NCT01337739|267567|P2|STARTED|Overall Study||4
110936|NCT01337739|267568|P1|STARTED|Overall Study||6
110937|NCT01337674|267578|P4|NOT COMPLETED|Treatment Period 2||0
110938|NCT01337674|267579|P3|NOT COMPLETED|Treatment Period 2||1
110939|NCT01337674|267580|P2|NOT COMPLETED|Treatment Period 2||0
110940|NCT01337674|267581|P1|NOT COMPLETED|Treatment Period 2||0
110941|NCT01337674|267578|P4|COMPLETED|Treatment Period 2||6
110942|NCT01337674|267579|P3|COMPLETED|Treatment Period 2||5
110943|NCT01337674|267580|P2|COMPLETED|Treatment Period 2||6
110944|NCT01337674|267581|P1|COMPLETED|Treatment Period 2||6
110945|NCT01337674|267578|P4|STARTED|Treatment Period 2||6
110946|NCT01337674|267579|P3|STARTED|Treatment Period 2||6
110947|NCT01337674|267580|P2|STARTED|Treatment Period 2||6
110948|NCT01337674|267581|P1|STARTED|Treatment Period 2||6
110949|NCT01337674|267578|P4|NOT COMPLETED|Two-week Washout Period||0
110950|NCT01337674|267579|P3|NOT COMPLETED|Two-week Washout Period||0
110951|NCT01337674|267580|P2|NOT COMPLETED|Two-week Washout Period||0
110952|NCT01337674|267581|P1|NOT COMPLETED|Two-week Washout Period||0
110953|NCT01337674|267578|P4|COMPLETED|Two-week Washout Period||6
110954|NCT01337674|267579|P3|COMPLETED|Two-week Washout Period||6
110955|NCT01337674|267580|P2|COMPLETED|Two-week Washout Period||6
110956|NCT01337674|267581|P1|COMPLETED|Two-week Washout Period||6
110957|NCT01337674|267578|P4|STARTED|Two-week Washout Period||6
110958|NCT01337674|267579|P3|STARTED|Two-week Washout Period||6
110959|NCT01337674|267580|P2|STARTED|Two-week Washout Period||6
110960|NCT01337674|267581|P1|STARTED|Two-week Washout Period||6
110961|NCT01337674|267578|P4|NOT COMPLETED|Treatment Period 1||1
110962|NCT01337674|267579|P3|NOT COMPLETED|Treatment Period 1||0
110963|NCT01337674|267580|P2|NOT COMPLETED|Treatment Period 1||1
110964|NCT01337674|267581|P1|NOT COMPLETED|Treatment Period 1||0
110965|NCT01337674|267578|P4|COMPLETED|Treatment Period 1||6
110966|NCT01337674|267579|P3|COMPLETED|Treatment Period 1||6
110967|NCT01337674|267580|P2|COMPLETED|Treatment Period 1||6
110968|NCT01337674|267581|P1|COMPLETED|Treatment Period 1||6
110969|NCT01337674|267578|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
110970|NCT01337674|267579|P3|STARTED|Treatment Period 1||6
110971|NCT01337674|267580|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
110972|NCT01337674|267581|P1|STARTED|Treatment Period 1||6
110973|NCT01337635|267599|P2|NOT COMPLETED|Overall Study||1
110974|NCT01337635|267600|P1|NOT COMPLETED|Overall Study||0
110975|NCT01337635|267599|P2|COMPLETED|Overall Study||2
110976|NCT01337635|267600|P1|COMPLETED|Overall Study||4
110977|NCT01337635|267599|P2|STARTED|Overall Study||3
110978|NCT01337635|267600|P1|STARTED|Overall Study||4
110979|NCT01337609|267609|P3|NOT COMPLETED|Overall Study||0
110980|NCT01337609|267610|P2|NOT COMPLETED|Overall Study||0
110981|NCT01337609|267611|P1|NOT COMPLETED|Overall Study||1
110982|NCT01337609|267609|P3|COMPLETED|Overall Study||2
110983|NCT01337609|267610|P2|COMPLETED|Overall Study||2
110984|NCT01337609|267611|P1|COMPLETED|Overall Study||0
110985|NCT01337609|267609|P3|STARTED|Overall Study||2
110986|NCT01337609|267610|P2|STARTED|Overall Study||2
110987|NCT01337609|267611|P1|STARTED|Overall Study||1
110988|NCT01337336|267633|P2|NOT COMPLETED|Overall Study||0
110989|NCT01337336|267634|P1|NOT COMPLETED|Overall Study||0
110990|NCT01337336|267633|P2|COMPLETED|Overall Study||2923
110991|NCT01337336|267634|P1|COMPLETED|Overall Study||1078
110992|NCT01337336|267633|P2|STARTED|Overall Study||2923
110993|NCT01337336|267634|P1|STARTED|Overall Study||1078
110994|NCT01337297|267648|P2|NOT COMPLETED|Overall Study||6
110995|NCT01337297|267649|P1|NOT COMPLETED|Overall Study||5
110996|NCT01337297|267648|P2|COMPLETED|Overall Study||3
110997|NCT01337297|267649|P1|COMPLETED|Overall Study||6
110998|NCT01337297|267648|P2|STARTED|Overall Study||9
110999|NCT01337297|267649|P1|STARTED|Overall Study||11
111000|NCT01337167|267657|P2|NOT COMPLETED|Toddler Vaccinations||13
111001|NCT01337167|267658|P1|NOT COMPLETED|Toddler Vaccinations||14
111002|NCT01337167|267657|P2|COMPLETED|Toddler Vaccinations||407
111003|NCT01337167|267658|P1|COMPLETED|Toddler Vaccinations||829
111004|NCT01337167|267657|P2|STARTED|Toddler Vaccinations||420
111005|NCT01337167|267658|P1|STARTED|Toddler Vaccinations||843
111006|NCT01337167|267657|P2|NOT COMPLETED|Interim Period||40
111007|NCT01337167|267658|P1|NOT COMPLETED|Interim Period||81
111008|NCT01337167|267657|P2|COMPLETED|Interim Period||420
111009|NCT01337167|267658|P1|COMPLETED|Interim Period||843
111010|NCT01337167|267657|P2|STARTED|Interim Period||460
111011|NCT01337167|267658|P1|STARTED|Interim Period||924
111012|NCT01337167|267657|P2|NOT COMPLETED|Infant Series||27
111013|NCT01337167|267658|P1|NOT COMPLETED|Infant Series||62
111014|NCT01337167|267657|P2|COMPLETED|Infant Series||460
111015|NCT01337167|267658|P1|COMPLETED|Infant Series||924
111016|NCT01337167|267657|P2|STARTED|Infant Series||487
111017|NCT01337167|267658|P1|STARTED|Infant Series||986
111018|NCT01337115|267726|P2|NOT COMPLETED|Overall Study||0
111019|NCT01337115|267727|P1|NOT COMPLETED|Overall Study||2
111020|NCT01337115|267726|P2|COMPLETED|Overall Study||25
111021|NCT01337115|267727|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
111022|NCT01337115|267726|P2|STARTED|Overall Study||25
111023|NCT01337115|267727|P1|STARTED|Overall Study||25
111024|NCT01337089|267739|P1|NOT COMPLETED|Overall Study||404
111025|NCT01337089|267739|P1|COMPLETED|Overall Study||256
111026|NCT01337089|267739|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
111027|NCT01337089|267739|P1|Safety Population|Overall Study||660
111028|NCT01337089|267739|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
111029|NCT01337089|267739|P1|STARTED|Overall Study||660
111030|NCT01337076|267747|P1|NOT COMPLETED|Overall Study||2
111031|NCT01337076|267747|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
111032|NCT01337076|267747|P1|STARTED|Overall Study|subjects implanted|21
111033|NCT01337050|267754|P3|NOT COMPLETED|Overall Study||19
111034|NCT01337050|267755|P2|NOT COMPLETED|Overall Study||13
111035|NCT01337050|267756|P1|NOT COMPLETED|Overall Study||4
111036|NCT01337050|267754|P3|COMPLETED|Overall Study||0
111037|NCT01337050|267755|P2|COMPLETED|Overall Study||0
111038|NCT01337050|267756|P1|COMPLETED|Overall Study||0
111039|NCT01337050|267754|P3|STARTED|Overall Study||19
111040|NCT01337050|267755|P2|STARTED|Overall Study||13
111041|NCT01337050|267756|P1|STARTED|Overall Study||4
111042|NCT01336972|267817|P3|NOT COMPLETED|Overall Study||0
111043|NCT01336972|267818|P2|NOT COMPLETED|Overall Study||1
111044|NCT01336972|267819|P1|NOT COMPLETED|Overall Study||1
111045|NCT01336972|267817|P3|COMPLETED|Overall Study||9
111046|NCT01336972|267818|P2|COMPLETED|Overall Study||9
111047|NCT01336972|267819|P1|COMPLETED|Overall Study||9
111048|NCT01336972|267817|P3|STARTED|Overall Study||9
111049|NCT01336972|267818|P2|STARTED|Overall Study||10
111050|NCT01336972|267819|P1|STARTED|Overall Study||10
111051|NCT01336894|267856|P2|NOT COMPLETED|Follow-up||7
111052|NCT01336894|267857|P1|NOT COMPLETED|Follow-up||2
111053|NCT01336894|267856|P2|COMPLETED|Follow-up||0
111054|NCT01336894|267857|P1|COMPLETED|Follow-up||2
111055|NCT01336894|267856|P2|STARTED|Follow-up||7
111056|NCT01336894|267857|P1|STARTED|Follow-up||4
111057|NCT01336894|267856|P2|NOT COMPLETED|Protocol Interventions||0
111058|NCT01336894|267857|P1|NOT COMPLETED|Protocol Interventions||0
111059|NCT01336894|267856|P2|COMPLETED|Protocol Interventions||7
111060|NCT01336894|267857|P1|COMPLETED|Protocol Interventions||4
111061|NCT01336894|267856|P2|STARTED|Protocol Interventions||7
111062|NCT01336894|267857|P1|STARTED|Protocol Interventions||4
111063|NCT01336764|267877|P2|NOT COMPLETED|Overall Study||5
111064|NCT01336764|267878|P1|NOT COMPLETED|Overall Study||5
111065|NCT01336764|267877|P2|COMPLETED|Overall Study||5
111066|NCT01336764|267878|P1|COMPLETED|Overall Study||7
111067|NCT01336764|267877|P2|STARTED|Overall Study||10
111068|NCT01336764|267878|P1|STARTED|Overall Study||12
111069|NCT01336738|267889|P5|NOT COMPLETED|Overall Study||10
111070|NCT01336738|267890|P4|NOT COMPLETED|Overall Study||7
111071|NCT01336738|267891|P3|NOT COMPLETED|Overall Study||8
111072|NCT01336738|267892|P2|NOT COMPLETED|Overall Study||9
111073|NCT01336738|267893|P1|NOT COMPLETED|Overall Study||7
111074|NCT01336738|267889|P5|COMPLETED|Overall Study||43
111075|NCT01336738|267890|P4|COMPLETED|Overall Study||47
111076|NCT01336738|267891|P3|COMPLETED|Overall Study||45
111077|NCT01336738|267892|P2|COMPLETED|Overall Study||45
111078|NCT01336738|267893|P1|COMPLETED|Overall Study||45
111079|NCT01336738|267889|P5|STARTED|Overall Study||53
111080|NCT01336738|267890|P4|STARTED|Overall Study||54
111081|NCT01336738|267891|P3|STARTED|Overall Study||53
111082|NCT01336738|267892|P2|STARTED|Overall Study||54
111083|NCT01336738|267893|P1|STARTED|Overall Study||52
111084|NCT01336712|267935|P1|NOT COMPLETED|Overall Study||3
111085|NCT01336712|267935|P1|COMPLETED|Overall Study||27
111086|NCT01336712|267935|P1|STARTED|Overall Study||30
111087|NCT01336647|267948|P3|NOT COMPLETED|Overall Study||3
111088|NCT01336647|267949|P2|NOT COMPLETED|Overall Study||1
111089|NCT01336647|267950|P1|NOT COMPLETED|Overall Study||4
111090|NCT01336647|267948|P3|COMPLETED|Overall Study||44
111091|NCT01336647|267949|P2|COMPLETED|Overall Study||48
111092|NCT01336647|267950|P1|COMPLETED|Overall Study||42
111093|NCT01336647|267948|P3|STARTED|Overall Study||47
111094|NCT01336647|267949|P2|STARTED|Overall Study||49
111095|NCT01336647|267950|P1|STARTED|Overall Study||46
111096|NCT01336634|267964|P3|NOT COMPLETED|Overall Study||36
111097|NCT01336634|267965|P2|NOT COMPLETED|Overall Study||57
111098|NCT01336634|267966|P1|NOT COMPLETED|Overall Study||84
111099|NCT01336634|267964|P3|COMPLETED|Overall Study||0
111100|NCT01336634|267965|P2|COMPLETED|Overall Study||0
111101|NCT01336634|267966|P1|COMPLETED|Overall Study||0
111102|NCT01336634|267964|P3|STARTED|Overall Study||36
111103|NCT01336634|267965|P2|STARTED|Overall Study||57
111104|NCT01336634|267966|P1|STARTED|Overall Study||84
111105|NCT01336621|268007|P1|NOT COMPLETED|Overall Study||98
111106|NCT01336621|268007|P1|COMPLETED|Overall Study||0
111107|NCT01336621|268007|P1|STARTED|Overall Study||98
111108|NCT01336608|268051|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
111109|NCT01336608|268052|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
111110|NCT01336608|268053|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
111111|NCT01336608|268054|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
111112|NCT01336608|268051|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
111113|NCT01336608|268052|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
111114|NCT01336608|268053|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
111115|NCT01336608|268054|P1|COMPLETED|24-week, Double-blind Treatment Period||0
111116|NCT01336608|268051|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
111117|NCT01336608|268052|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
111118|NCT01336608|268053|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
111119|NCT01336608|268054|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
111120|NCT01336608|268051|P4|STARTED|24-week, Double-blind Treatment Period||135
111121|NCT01336608|268052|P3|STARTED|24-week, Double-blind Treatment Period||154
111122|NCT01336608|268053|P2|STARTED|24-week, Double-blind Treatment Period||141
111123|NCT01336608|268054|P1|STARTED|24-week, Double-blind Treatment Period||0
111124|NCT01336608|268051|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
111125|NCT01336608|268052|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
111214|NCT01335867|268225|P1|COMPLETED|Overall Study||9
111126|NCT01336608|268053|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
111127|NCT01336608|268054|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
111128|NCT01336608|268051|P4|COMPLETED|2-week, Single-blind Run-In Period||0
111129|NCT01336608|268052|P3|COMPLETED|2-week, Single-blind Run-In Period||0
111130|NCT01336608|268053|P2|COMPLETED|2-week, Single-blind Run-In Period||0
111131|NCT01336608|268054|P1|COMPLETED|2-week, Single-blind Run-In Period||444
111132|NCT01336608|268051|P4|STARTED|2-week, Single-blind Run-In Period||0
111133|NCT01336608|268052|P3|STARTED|2-week, Single-blind Run-In Period||0
111134|NCT01336608|268053|P2|STARTED|2-week, Single-blind Run-In Period||0
111135|NCT01336608|268054|P1|STARTED|2-week, Single-blind Run-In Period||559
111136|NCT01336569|268068|P1|NOT COMPLETED|Overall Study||4
111137|NCT01336569|268068|P1|COMPLETED|Overall Study||45
111138|NCT01336569|268068|P1|STARTED|Overall Study||49
111139|NCT01336413|268074|P2|NOT COMPLETED|Overall Study||8
111140|NCT01336413|268075|P1|NOT COMPLETED|Overall Study||1
111141|NCT01336413|268074|P2|COMPLETED|Overall Study||18
111142|NCT01336413|268075|P1|COMPLETED|Overall Study||26
111143|NCT01336413|268074|P2|STARTED|Overall Study||26
111144|NCT01336413|268075|P1|STARTED|Overall Study||27
111145|NCT01336296|268093|P2|NOT COMPLETED|Overall Study||4
111146|NCT01336296|268094|P1|NOT COMPLETED|Overall Study||5
111147|NCT01336296|268093|P2|COMPLETED|Overall Study||17
111148|NCT01336296|268094|P1|COMPLETED|Overall Study||35
111149|NCT01336296|268093|P2|STARTED|Overall Study||21
111150|NCT01336296|268094|P1|STARTED|Overall Study||40
111151|NCT01336205|268110|P2|NOT COMPLETED|Overall Study||89
111152|NCT01336205|268111|P1|NOT COMPLETED|Overall Study||233
111153|NCT01336205|268110|P2|COMPLETED|Overall Study||192
111154|NCT01336205|268111|P1|COMPLETED|Overall Study||330
111155|NCT01336205|268110|P2|STARTED|Overall Study||281
111156|NCT01336205|268111|P1|STARTED|Overall Study||563
111157|NCT01336140|268123|P2|NOT COMPLETED|Overall Study||0
111158|NCT01336140|268124|P1|NOT COMPLETED|Overall Study||0
111159|NCT01336140|268123|P2|COMPLETED|Overall Study||150
111160|NCT01336140|268124|P1|COMPLETED|Overall Study||150
111161|NCT01336140|268123|P2|STARTED|Overall Study||150
111162|NCT01336140|268124|P1|STARTED|Overall Study||150
111163|NCT01336023|268139|P3|NOT COMPLETED|Week 27 to 52||28
111164|NCT01336023|268140|P2|NOT COMPLETED|Week 27 to 52||44
111165|NCT01336023|268141|P1|NOT COMPLETED|Week 27 to 52||28
111166|NCT01336023|268139|P3|COMPLETED|Week 27 to 52||285
111167|NCT01336023|268140|P2|COMPLETED|Week 27 to 52||621
111168|NCT01336023|268141|P1|COMPLETED|Week 27 to 52||305
111169|NCT01336023|268139|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
111170|NCT01336023|268140|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
111171|NCT01336023|268141|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
111172|NCT01336023|268139|P3|NOT COMPLETED|Week 0 to Week 26||73
111173|NCT01336023|268140|P2|NOT COMPLETED|Week 0 to Week 26||98
111174|NCT01336023|268141|P1|NOT COMPLETED|Week 0 to Week 26||48
111175|NCT01336023|268139|P3|COMPLETED|Week 0 to Week 26||342
111176|NCT01336023|268140|P2|COMPLETED|Week 0 to Week 26||736
111177|NCT01336023|268141|P1|COMPLETED|Week 0 to Week 26||366
111178|NCT01336023|268139|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
111179|NCT01336023|268140|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
111180|NCT01336023|268141|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
111181|NCT01336023|268139|P3|STARTED|Week 0 to Week 26||415
111182|NCT01336023|268140|P2|STARTED|Week 0 to Week 26||834
111183|NCT01336023|268141|P1|STARTED|Week 0 to Week 26||414
111184|NCT01335997|268162|P2|NOT COMPLETED|Period III||79
111185|NCT01335997|268163|P1|NOT COMPLETED|Period III||78
111186|NCT01335997|268162|P2|COMPLETED|Period III||4
111187|NCT01335997|268163|P1|COMPLETED|Period III||6
111188|NCT01335997|268162|P2|STARTED|Period III||83
111189|NCT01335997|268163|P1|STARTED|Period III||84
111190|NCT01335997|268162|P2|NOT COMPLETED|Period I and II||479
111191|NCT01335997|268163|P1|NOT COMPLETED|Period I and II||493
111192|NCT01335997|268162|P2|COMPLETED|Period I and II||83
111193|NCT01335997|268163|P1|COMPLETED|Period I and II||84
111194|NCT01335997|268162|P2|STARTED|Period I and II||562
111195|NCT01335997|268163|P1|STARTED|Period I and II||577
111196|NCT01335971|268176|P3|NOT COMPLETED|Overall Study||1
111197|NCT01335971|268177|P2|NOT COMPLETED|Overall Study||1
111198|NCT01335971|268178|P1|NOT COMPLETED|Overall Study||2
111199|NCT01335971|268176|P3|COMPLETED|Overall Study||28
111200|NCT01335971|268177|P2|COMPLETED|Overall Study||28
111201|NCT01335971|268178|P1|COMPLETED|Overall Study||29
111202|NCT01335971|268176|P3|STARTED|Overall Study||29
111203|NCT01335971|268177|P2|STARTED|Overall Study||29
111204|NCT01335971|268178|P1|STARTED|Overall Study||31
111205|NCT01335932|268215|P2|NOT COMPLETED|Overall Study||4
111206|NCT01335932|268216|P1|NOT COMPLETED|Overall Study||0
111207|NCT01335932|268215|P2|COMPLETED|Overall Study||72
111208|NCT01335932|268216|P1|COMPLETED|Overall Study||84
111209|NCT01335932|268215|P2|STARTED|Overall Study||76
111210|NCT01335932|268216|P1|STARTED|Overall Study||84
111211|NCT01335867|268224|P2|NOT COMPLETED|Overall Study||4
111212|NCT01335867|268225|P1|NOT COMPLETED|Overall Study||7
111213|NCT01335867|268224|P2|COMPLETED|Overall Study||12
111215|NCT01335867|268224|P2|STARTED|Overall Study||16
111216|NCT01335867|268225|P1|STARTED|Overall Study||16
111217|NCT01335789|268235|P2|NOT COMPLETED|Overall Study||0
111218|NCT01335789|268236|P1|NOT COMPLETED|Overall Study||0
111219|NCT01335789|268235|P2|COMPLETED|Overall Study||8
111220|NCT01335789|268236|P1|COMPLETED|Overall Study||8
111221|NCT01335789|268235|P2|STARTED|Overall Study||8
111222|NCT01335789|268236|P1|STARTED|Overall Study||8
111223|NCT01335750|268246|P1|NOT COMPLETED|Overall Study||0
111224|NCT01335750|268246|P1|COMPLETED|Overall Study||32
111225|NCT01335750|268246|P1|STARTED|Overall Study||32
111226|NCT01335724|268267|P2|NOT COMPLETED|Overall Study||0
111227|NCT01335724|268268|P1|NOT COMPLETED|Overall Study||0
111228|NCT01335724|268267|P2|COMPLETED|Overall Study||36
111229|NCT01335724|268268|P1|COMPLETED|Overall Study||36
111230|NCT01335724|268267|P2|STARTED|Overall Study||36
111231|NCT01335724|268268|P1|STARTED|Overall Study||36
111232|NCT01335698|268283|P5|NOT COMPLETED|Treatment Stage 2||6
111233|NCT01335698|268284|P4|NOT COMPLETED|Treatment Stage 2||24
111234|NCT01335698|268285|P3|NOT COMPLETED|Treatment Stage 2||16
111235|NCT01335698|268286|P2|NOT COMPLETED|Treatment Stage 2||4
111236|NCT01335698|268287|P1|NOT COMPLETED|Treatment Stage 2||15
111237|NCT01335698|268283|P5|COMPLETED|Treatment Stage 2||0
111238|NCT01335698|268284|P4|COMPLETED|Treatment Stage 2||2
111239|NCT01335698|268285|P3|COMPLETED|Treatment Stage 2||0
111240|NCT01335698|268286|P2|COMPLETED|Treatment Stage 2||0
111241|NCT01335698|268287|P1|COMPLETED|Treatment Stage 2||0
111242|NCT01335698|268283|P5|STARTED|Treatment Stage 2||6
111243|NCT01335698|268284|P4|STARTED|Treatment Stage 2||26
111244|NCT01335698|268285|P3|STARTED|Treatment Stage 2||16
111245|NCT01335698|268286|P2|STARTED|Treatment Stage 2||4
111246|NCT01335698|268287|P1|STARTED|Treatment Stage 2||15
111247|NCT01335698|268283|P5|NOT COMPLETED|Treatment Stage 1||2
111248|NCT01335698|268284|P4|NOT COMPLETED|Treatment Stage 1||9
111249|NCT01335698|268285|P3|NOT COMPLETED|Treatment Stage 1||5
111250|NCT01335698|268286|P2|NOT COMPLETED|Treatment Stage 1||8
111251|NCT01335698|268287|P1|NOT COMPLETED|Treatment Stage 1||8
111252|NCT01335698|268283|P5|COMPLETED|Treatment Stage 1||6
111253|NCT01335698|268284|P4|COMPLETED|Treatment Stage 1||26
111254|NCT01335698|268285|P3|COMPLETED|Treatment Stage 1||16
111255|NCT01335698|268286|P2|COMPLETED|Treatment Stage 1||4
111256|NCT01335698|268287|P1|COMPLETED|Treatment Stage 1||15
111257|NCT01335698|268283|P5|STARTED|Treatment Stage 1||8
111258|NCT01335698|268284|P4|STARTED|Treatment Stage 1||35
111259|NCT01335698|268285|P3|STARTED|Treatment Stage 1||21
111260|NCT01335698|268286|P2|STARTED|Treatment Stage 1||12
111261|NCT01335698|268287|P1|STARTED|Treatment Stage 1||23
111262|NCT01335685|268338|P8|NOT COMPLETED|Overall Study||3
111263|NCT01335685|268339|P7|NOT COMPLETED|Overall Study||2
111264|NCT01335685|268340|P6|NOT COMPLETED|Overall Study||5
111265|NCT01335685|268341|P5|NOT COMPLETED|Overall Study||0
111266|NCT01335685|268342|P4|NOT COMPLETED|Overall Study||11
111267|NCT01335685|268343|P3|NOT COMPLETED|Overall Study||2
111268|NCT01335685|268344|P2|NOT COMPLETED|Overall Study||1
111269|NCT01335685|268345|P1|NOT COMPLETED|Overall Study||3
111270|NCT01335685|268338|P8|COMPLETED|Overall Study||3
111271|NCT01335685|268339|P7|COMPLETED|Overall Study||2
111272|NCT01335685|268340|P6|COMPLETED|Overall Study||1
111273|NCT01335685|268341|P5|COMPLETED|Overall Study||5
111274|NCT01335685|268342|P4|COMPLETED|Overall Study||15
111275|NCT01335685|268343|P3|COMPLETED|Overall Study||1
111276|NCT01335685|268344|P2|COMPLETED|Overall Study||3
111277|NCT01335685|268345|P1|COMPLETED|Overall Study||4
111278|NCT01335685|268338|P8|STARTED|Overall Study||6
111279|NCT01335685|268339|P7|STARTED|Overall Study||4
111280|NCT01335685|268340|P6|STARTED|Overall Study||6
111281|NCT01335685|268341|P5|STARTED|Overall Study||5
111282|NCT01335685|268342|P4|STARTED|Overall Study||26
111283|NCT01335685|268343|P3|STARTED|Overall Study||3
111284|NCT01335685|268344|P2|STARTED|Overall Study||4
111285|NCT01335685|268345|P1|STARTED|Overall Study||7
111286|NCT01335542|268449|P2|NOT COMPLETED|Overall Study||0
111287|NCT01335542|268450|P1|NOT COMPLETED|Overall Study||0
111288|NCT01335542|268449|P2|COMPLETED|Overall Study||45
111289|NCT01335542|268450|P1|COMPLETED|Overall Study||45
111290|NCT01335542|268449|P2|STARTED|Overall Study||45
111291|NCT01335542|268450|P1|STARTED|Overall Study||45
111292|NCT01335477|268458|P2|NOT COMPLETED|Overall Study||59
111293|NCT01335477|268459|P1|NOT COMPLETED|Overall Study||41
111294|NCT01335477|268458|P2|COMPLETED|Overall Study||272
111295|NCT01335477|268459|P1|COMPLETED|Overall Study||179
111296|NCT01335477|268458|P2|STARTED|Overall Study||331
111297|NCT01335477|268459|P1|STARTED|Overall Study||220
111298|NCT01335464|268523|P2|NOT COMPLETED|Overall Study||49
111299|NCT01335464|268524|P1|NOT COMPLETED|Overall Study||32
111300|NCT01335464|268523|P2|COMPLETED|Overall Study||260
111301|NCT01335464|268524|P1|COMPLETED|Overall Study||174
111302|NCT01335464|268523|P2|STARTED|Overall Study||309
111303|NCT01335464|268524|P1|STARTED|Overall Study||206
111304|NCT01335308|268589|P3|NOT COMPLETED|Overall Study||81
111305|NCT01335308|268590|P2|NOT COMPLETED|Overall Study||67
111306|NCT01335308|268591|P1|NOT COMPLETED|Overall Study||40
111307|NCT01335308|268589|P3|COMPLETED|Overall Study||154
111308|NCT01335308|268590|P2|COMPLETED|Overall Study||145
111309|NCT01335308|268591|P1|COMPLETED|Overall Study||158
111310|NCT01335308|268589|P3|STARTED|Overall Study||235
111311|NCT01335308|268590|P2|STARTED|Overall Study||212
111312|NCT01335308|268591|P1|STARTED|Overall Study||198
111313|NCT01335230|268612|P4|NOT COMPLETED|Overall Study||0
111314|NCT01335230|268613|P3|NOT COMPLETED|Overall Study||0
111315|NCT01335230|268614|P2|NOT COMPLETED|Overall Study||0
111316|NCT01335230|268615|P1|NOT COMPLETED|Overall Study||0
111317|NCT01335230|268612|P4|COMPLETED|Overall Study|subjects|10
111318|NCT01335230|268613|P3|COMPLETED|Overall Study|subjects|10
111319|NCT01335230|268614|P2|COMPLETED|Overall Study|subjects|10
111320|NCT01335230|268615|P1|COMPLETED|Overall Study|subjects|10
111321|NCT01335230|268612|P4|STARTED|Overall Study|subjects|10
111322|NCT01335230|268613|P3|STARTED|Overall Study|subjects|10
111323|NCT01335230|268614|P2|STARTED|Overall Study|subjects|10
111324|NCT01335230|268615|P1|STARTED|Overall Study|subjects|10
111325|NCT01335191|268627|P2|NOT COMPLETED|Overall Study||0
111326|NCT01335191|268628|P1|NOT COMPLETED|Overall Study||0
111327|NCT01335191|268627|P2|COMPLETED|Overall Study||11
111328|NCT01335191|268628|P1|COMPLETED|Overall Study||16
111329|NCT01335191|268627|P2|STARTED|Overall Study||11
111330|NCT01335191|268628|P1|STARTED|Overall Study||16
111331|NCT01335061|268634|P1|NOT COMPLETED|Overall Study||0
111332|NCT01335061|268634|P1|COMPLETED|Overall Study||25
111333|NCT01335061|268634|P1|STARTED|Overall Study||25
111334|NCT01334957|268649|P1|NOT COMPLETED|Overall Study||0
111335|NCT01334957|268649|P1|COMPLETED|Overall Study||300
111336|NCT01334957|268649|P1|Received Multiple Doses|Overall Study||48
111337|NCT01334957|268649|P1|Received Single Dose|Overall Study||252
111338|NCT01334957|268649|P1|STARTED|Overall Study||300
111339|NCT01334944|268657|P2|NOT COMPLETED|Overall Study||0
111340|NCT01334944|268658|P1|NOT COMPLETED|Overall Study||0
111341|NCT01334944|268657|P2|COMPLETED|Overall Study||139
111342|NCT01334944|268658|P1|COMPLETED|Overall Study||11
111343|NCT01334944|268657|P2|Received Multiple Doses|Overall Study||43
111344|NCT01334944|268658|P1|Received Multiple Doses|Overall Study||10
111345|NCT01334944|268657|P2|Received Singel Dose|Overall Study||96
111346|NCT01334944|268658|P1|Received Singel Dose|Overall Study||1
111347|NCT01334944|268657|P2|STARTED|Overall Study||139
111348|NCT01334944|268658|P1|STARTED|Overall Study||11
111349|NCT01334918|268684|P2|NOT COMPLETED|Overall Study||1
111350|NCT01334918|268685|P1|NOT COMPLETED|Overall Study||8
111351|NCT01334918|268684|P2|COMPLETED|Overall Study||60
111352|NCT01334918|268685|P1|COMPLETED|Overall Study||55
111353|NCT01334918|268684|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
111354|NCT01334918|268685|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
111355|NCT01334918|268684|P2|STARTED|Overall Study||61
111356|NCT01334918|268685|P1|STARTED|Overall Study||63
111357|NCT01334866|268711|P1|NOT COMPLETED|Overall Study||19
111358|NCT01334866|268711|P1|COMPLETED|Overall Study||72
111359|NCT01334866|268711|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
111360|NCT01334723|268721|P2|NOT COMPLETED|Overall Study||0
111361|NCT01334723|268722|P1|NOT COMPLETED|Overall Study||0
111362|NCT01334723|268721|P2|COMPLETED|Overall Study||17739
111363|NCT01334723|268722|P1|COMPLETED|Overall Study||17293
111364|NCT01334723|268721|P2|STARTED|Overall Study||17739
111365|NCT01334723|268722|P1|STARTED|Overall Study||17293
111366|NCT01334710|268748|P1|NOT COMPLETED|Overall Study||3
111367|NCT01334710|268748|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
111368|NCT01334710|268748|P1|STARTED|Overall Study||3
111369|NCT01334606|268753|P1|NOT COMPLETED|Overall Study||18
111370|NCT01334606|268753|P1|COMPLETED|Overall Study||3
111371|NCT01334606|268753|P1|STARTED|Overall Study||21
111372|NCT01334554|268761|P2|NOT COMPLETED|Overall Study||2
111373|NCT01334554|268762|P1|NOT COMPLETED|Overall Study||4
111374|NCT01334554|268761|P2|COMPLETED|Overall Study||21
111375|NCT01334554|268762|P1|COMPLETED|Overall Study||19
111376|NCT01334554|268761|P2|STARTED|Overall Study||23
111377|NCT01334554|268762|P1|STARTED|Overall Study||23
111378|NCT01334515|268772|P2|NOT COMPLETED|Overall Study||29
111379|NCT01334515|268773|P1|NOT COMPLETED|Overall Study||12
111380|NCT01334515|268772|P2|COMPLETED|Overall Study||7
111381|NCT01334515|268773|P1|COMPLETED|Overall Study||4
111382|NCT01334515|268772|P2|STARTED|Overall Study||36
111383|NCT01334515|268773|P1|STARTED|Overall Study||16
111384|NCT01334229|268783|P2|NOT COMPLETED|Overall Study||0
111385|NCT01334229|268784|P1|NOT COMPLETED|Overall Study||0
111386|NCT01334229|268783|P2|COMPLETED|Overall Study||11
111387|NCT01334229|268784|P1|COMPLETED|Overall Study||11
111388|NCT01334229|268783|P2|STARTED|Overall Study||11
111389|NCT01334229|268784|P1|STARTED|Overall Study||11
111390|NCT01334216|268802|P2|NOT COMPLETED|Overall Study||0
111391|NCT01334216|268803|P1|NOT COMPLETED|Overall Study||0
111392|NCT01334216|268802|P2|COMPLETED|Overall Study||194
111393|NCT01334216|268803|P1|COMPLETED|Overall Study||168
111394|NCT01334216|268802|P2|STARTED|Overall Study||194
111395|NCT01334216|268803|P1|STARTED|Overall Study||168
111396|NCT01334125|268811|P2|NOT COMPLETED|Overall Study||3
111397|NCT01334125|268812|P1|NOT COMPLETED|Overall Study||3
111398|NCT01334125|268811|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
111399|NCT01334125|268812|P1|COMPLETED|Overall Study|3 subjects move to another city|12
111400|NCT01334125|268811|P2|STARTED|Overall Study||13
111401|NCT01334125|268812|P1|STARTED|Overall Study||15
111402|NCT01333956|268828|P4|NOT COMPLETED|Overall Study||2
111403|NCT01333956|268829|P3|NOT COMPLETED|Overall Study||1
111404|NCT01333956|268830|P2|NOT COMPLETED|Overall Study||4
111405|NCT01333956|268831|P1|NOT COMPLETED|Overall Study||2
111406|NCT01333956|268828|P4|COMPLETED|Overall Study||28
111407|NCT01333956|268829|P3|COMPLETED|Overall Study||29
111408|NCT01333956|268830|P2|COMPLETED|Overall Study||26
111409|NCT01333956|268831|P1|COMPLETED|Overall Study||28
111410|NCT01333956|268828|P4|STARTED|Overall Study||30
111411|NCT01333956|268829|P3|STARTED|Overall Study||30
111412|NCT01333956|268830|P2|STARTED|Overall Study||30
111413|NCT01333956|268831|P1|STARTED|Overall Study||30
111414|NCT01333943|268867|P2|NOT COMPLETED|Overall Study||0
111415|NCT01333943|268868|P1|NOT COMPLETED|Overall Study||1
111416|NCT01333943|268867|P2|COMPLETED|Overall Study||47
111417|NCT01333943|268868|P1|COMPLETED|Overall Study||46
111418|NCT01333943|268867|P2|STARTED|Overall Study||47
111419|NCT01333943|268868|P1|STARTED|Overall Study||47
111420|NCT01333865|268884|P1|NOT COMPLETED|Overall Study||2
111421|NCT01333865|268884|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
111422|NCT01333865|268884|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
111423|NCT01333813|268889|P1|NOT COMPLETED|Overall Study||0
111424|NCT01333813|268889|P1|COMPLETED|Overall Study||297
111425|NCT01333813|268889|P1|STARTED|Overall Study||297
111426|NCT01333722|268904|P2|NOT COMPLETED|Overall Study||3
111427|NCT01333722|268905|P1|NOT COMPLETED|Overall Study||0
111428|NCT01333722|268904|P2|COMPLETED|Overall Study||46
111429|NCT01333722|268905|P1|COMPLETED|Overall Study||51
111430|NCT01333722|268904|P2|STARTED|Overall Study||49
111431|NCT01333722|268905|P1|STARTED|Overall Study||51
111432|NCT01333592|268919|P2|NOT COMPLETED|Overall Study||17
111433|NCT01333592|268920|P1|NOT COMPLETED|Overall Study||9
111434|NCT01333592|268919|P2|COMPLETED|Overall Study||52
111435|NCT01333592|268920|P1|COMPLETED|Overall Study||58
111436|NCT01333592|268919|P2|STARTED|Overall Study||69
111437|NCT01333592|268920|P1|STARTED|Overall Study||67
111438|NCT01333501|268930|P2|NOT COMPLETED|Overall Study||21
111439|NCT01333501|268931|P1|NOT COMPLETED|Overall Study||9
111440|NCT01333501|268930|P2|COMPLETED|Overall Study||30
111441|NCT01333501|268931|P1|COMPLETED|Overall Study||97
111442|NCT01333501|268930|P2|Safety Population|Overall Study||47
111443|NCT01333501|268931|P1|Safety Population|Overall Study||104
111444|NCT01333501|268930|P2|Full Analysis Set (FAS)|Overall Study||28
111445|NCT01333501|268931|P1|Full Analysis Set (FAS)|Overall Study||80
111446|NCT01333501|268930|P2|STARTED|Overall Study||51
111447|NCT01333501|268931|P1|STARTED|Overall Study||106
111448|NCT01333488|268980|P3|NOT COMPLETED|Overall Study||0
111449|NCT01333488|268981|P2|NOT COMPLETED|Overall Study||0
111450|NCT01333488|268982|P1|NOT COMPLETED|Overall Study||0
111451|NCT01333488|268980|P3|COMPLETED|Overall Study||3
111452|NCT01333488|268981|P2|COMPLETED|Overall Study||1
111453|NCT01333488|268982|P1|COMPLETED|Overall Study||2
111454|NCT01333488|268980|P3|STARTED|Overall Study||3
111455|NCT01333488|268981|P2|STARTED|Overall Study||1
111456|NCT01333488|268982|P1|STARTED|Overall Study||2
111457|NCT01333475|268998|P2|NOT COMPLETED|Overall Study||3
111458|NCT01333475|268999|P1|NOT COMPLETED|Overall Study||2
111459|NCT01333475|268998|P2|COMPLETED|Overall Study||6
111460|NCT01333475|268999|P1|COMPLETED|Overall Study||10
111461|NCT01333475|268998|P2|STARTED|Overall Study||9
111462|NCT01333475|268999|P1|STARTED|Overall Study||12
111463|NCT01333436|269009|P2|NOT COMPLETED|Overall Study||0
111464|NCT01333436|269010|P1|NOT COMPLETED|Overall Study||0
111465|NCT01333436|269009|P2|COMPLETED|Overall Study||50
111466|NCT01333436|269010|P1|COMPLETED|Overall Study||43
111467|NCT01333436|269009|P2|STARTED|Overall Study||50
111468|NCT01333436|269010|P1|STARTED|Overall Study||43
111469|NCT01333397|269025|P5|NOT COMPLETED|Overall Study||0
111470|NCT01333397|269026|P4|NOT COMPLETED|Overall Study||1
111471|NCT01333397|269027|P3|NOT COMPLETED|Overall Study||0
111472|NCT01333397|269028|P2|NOT COMPLETED|Overall Study||0
111473|NCT01333397|269029|P1|NOT COMPLETED|Overall Study||1
111474|NCT01333397|269025|P5|COMPLETED|Overall Study||35
111475|NCT01333397|269026|P4|COMPLETED|Overall Study||34
111476|NCT01333397|269027|P3|COMPLETED|Overall Study||35
111477|NCT01333397|269028|P2|COMPLETED|Overall Study||36
111478|NCT01333397|269029|P1|COMPLETED|Overall Study||34
111479|NCT01333397|269025|P5|STARTED|Overall Study||35
111480|NCT01333397|269026|P4|STARTED|Overall Study||35
111481|NCT01333397|269027|P3|STARTED|Overall Study||35
111482|NCT01333397|269028|P2|STARTED|Overall Study||36
111483|NCT01333397|269029|P1|STARTED|Overall Study||35
111484|NCT01333189|269103|P2|NOT COMPLETED|Overall Study||2
111485|NCT01333189|269104|P1|NOT COMPLETED|Overall Study||2
111486|NCT01333189|269103|P2|COMPLETED|Overall Study||11
111487|NCT01333189|269104|P1|COMPLETED|Overall Study||11
111488|NCT01333189|269103|P2|STARTED|Overall Study||13
111489|NCT01333189|269104|P1|STARTED|Overall Study||13
111490|NCT01333111|269135|P3|NOT COMPLETED|Overall Study||2
111491|NCT01333111|269136|P2|NOT COMPLETED|Overall Study||3
111492|NCT01333111|269137|P1|NOT COMPLETED|Overall Study||2
111493|NCT01333111|269135|P3|COMPLETED|Overall Study||13
111494|NCT01333111|269136|P2|COMPLETED|Overall Study||26
111495|NCT01333111|269137|P1|COMPLETED|Overall Study||28
111496|NCT01333111|269135|P3|STARTED|Overall Study||15
111497|NCT01333111|269136|P2|STARTED|Overall Study||29
111498|NCT01333111|269137|P1|STARTED|Overall Study||30
111499|NCT01332994|269161|P1|NOT COMPLETED|Overall Study||71
111500|NCT01332994|269161|P1|COMPLETED|Overall Study||448
111501|NCT01332994|269161|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
111502|NCT01332994|269161|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
111503|NCT01332994|269161|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
111504|NCT01332994|269161|P1|Completed Week 16|Overall Study||463
111505|NCT01332994|269161|P1|STARTED|Overall Study||519
111506|NCT01332981|269217|P1|NOT COMPLETED|Overall Study||0
111507|NCT01332981|269217|P1|COMPLETED|Overall Study||220
111508|NCT01332981|269217|P1|STARTED|Overall Study||220
111509|NCT01332968|269230|P8|NOT COMPLETED|Follow-Up Period||531
111510|NCT01332968|269231|P7|NOT COMPLETED|Follow-Up Period||542
111511|NCT01332968|269232|P6|NOT COMPLETED|Follow-Up Period||0
111512|NCT01332968|269233|P5|NOT COMPLETED|Follow-Up Period||0
111513|NCT01332968|269234|P4|NOT COMPLETED|Follow-Up Period||0
111514|NCT01332968|269235|P3|NOT COMPLETED|Follow-Up Period||0
111515|NCT01332968|269236|P2|NOT COMPLETED|Follow-Up Period||0
111516|NCT01332968|269237|P1|NOT COMPLETED|Follow-Up Period||0
111517|NCT01332968|269230|P8|COMPLETED|Follow-Up Period||0
111518|NCT01332968|269231|P7|COMPLETED|Follow-Up Period||0
111519|NCT01332968|269232|P6|COMPLETED|Follow-Up Period||0
111520|NCT01332968|269233|P5|COMPLETED|Follow-Up Period||0
111521|NCT01332968|269234|P4|COMPLETED|Follow-Up Period||0
111522|NCT01332968|269235|P3|COMPLETED|Follow-Up Period||0
111523|NCT01332968|269236|P2|COMPLETED|Follow-Up Period||0
111524|NCT01332968|269237|P1|COMPLETED|Follow-Up Period||0
111525|NCT01332968|269230|P8|STARTED|Follow-Up Period||531
111526|NCT01332968|269231|P7|STARTED|Follow-Up Period||542
111527|NCT01332968|269232|P6|STARTED|Follow-Up Period||0
111528|NCT01332968|269233|P5|STARTED|Follow-Up Period||0
111529|NCT01332968|269234|P4|STARTED|Follow-Up Period||0
111530|NCT01332968|269235|P3|STARTED|Follow-Up Period||0
111531|NCT01332968|269236|P2|STARTED|Follow-Up Period||0
111532|NCT01332968|269237|P1|STARTED|Follow-Up Period||0
111533|NCT01332968|269230|P8|NOT COMPLETED|Maintenance/Observation Period||0
111534|NCT01332968|269231|P7|NOT COMPLETED|Maintenance/Observation Period||0
111535|NCT01332968|269232|P6|NOT COMPLETED|Maintenance/Observation Period||9
111536|NCT01332968|269233|P5|NOT COMPLETED|Maintenance/Observation Period||10
111537|NCT01332968|269234|P4|NOT COMPLETED|Maintenance/Observation Period||207
111538|NCT01332968|269235|P3|NOT COMPLETED|Maintenance/Observation Period||213
111539|NCT01332968|269236|P2|NOT COMPLETED|Maintenance/Observation Period||0
111540|NCT01332968|269237|P1|NOT COMPLETED|Maintenance/Observation Period||0
111541|NCT01332968|269230|P8|COMPLETED|Maintenance/Observation Period||0
111542|NCT01332968|269231|P7|COMPLETED|Maintenance/Observation Period||0
111543|NCT01332968|269232|P6|COMPLETED|Maintenance/Observation Period||2
111544|NCT01332968|269233|P5|COMPLETED|Maintenance/Observation Period||2
111545|NCT01332968|269234|P4|COMPLETED|Maintenance/Observation Period||417
111546|NCT01332968|269235|P3|COMPLETED|Maintenance/Observation Period||399
111547|NCT01332968|269236|P2|COMPLETED|Maintenance/Observation Period||0
111548|NCT01332968|269237|P1|COMPLETED|Maintenance/Observation Period||0
111549|NCT01332968|269230|P8|STARTED|Maintenance/Observation Period||0
111550|NCT01332968|269231|P7|STARTED|Maintenance/Observation Period||0
111551|NCT01332968|269232|P6|STARTED|Maintenance/Observation Period||11
111552|NCT01332968|269233|P5|STARTED|Maintenance/Observation Period||12
111553|NCT01332968|269234|P4|STARTED|Maintenance/Observation Period||624
111554|NCT01332968|269235|P3|STARTED|Maintenance/Observation Period||612
111555|NCT01332968|269236|P2|STARTED|Maintenance/Observation Period||0
111556|NCT01332968|269237|P1|STARTED|Maintenance/Observation Period||0
111557|NCT01332968|269230|P8|NOT COMPLETED|Induction Period||0
111558|NCT01332968|269231|P7|NOT COMPLETED|Induction Period||0
111559|NCT01332968|269232|P6|NOT COMPLETED|Induction Period||0
111560|NCT01332968|269233|P5|NOT COMPLETED|Induction Period||0
111561|NCT01332968|269234|P4|NOT COMPLETED|Induction Period||0
111562|NCT01332968|269235|P3|NOT COMPLETED|Induction Period||0
111563|NCT01332968|269236|P2|NOT COMPLETED|Induction Period||56
111564|NCT01332968|269237|P1|NOT COMPLETED|Induction Period||58
111565|NCT01332968|269230|P8|COMPLETED|Induction Period||0
111566|NCT01332968|269231|P7|COMPLETED|Induction Period||0
111567|NCT01332968|269232|P6|COMPLETED|Induction Period||0
111568|NCT01332968|269233|P5|COMPLETED|Induction Period||0
111569|NCT01332968|269234|P4|COMPLETED|Induction Period||0
111570|NCT01332968|269235|P3|COMPLETED|Induction Period||0
111571|NCT01332968|269236|P2|COMPLETED|Induction Period||646
111572|NCT01332968|269237|P1|COMPLETED|Induction Period||641
111573|NCT01332968|269230|P8|STARTED|Induction Period||0
111574|NCT01332968|269231|P7|STARTED|Induction Period||0
111575|NCT01332968|269232|P6|STARTED|Induction Period||0
111576|NCT01332968|269233|P5|STARTED|Induction Period||0
111577|NCT01332968|269234|P4|STARTED|Induction Period||0
111578|NCT01332968|269235|P3|STARTED|Induction Period||0
111579|NCT01332968|269236|P2|STARTED|Induction Period||702
111580|NCT01332968|269237|P1|STARTED|Induction Period||699
111581|NCT01332721|269301|P1|NOT COMPLETED|Overall Study||0
111582|NCT01332721|269301|P1|COMPLETED|Overall Study||38
111583|NCT01332721|269301|P1|STARTED|Overall Study||38
111584|NCT01332578|269307|P2|NOT COMPLETED|Period II||0
111585|NCT01332578|269308|P1|NOT COMPLETED|Period II||0
111586|NCT01332578|269307|P2|COMPLETED|Period II||13
111587|NCT01332578|269308|P1|COMPLETED|Period II||12
111588|NCT01332578|269307|P2|STARTED|Period II||13
111589|NCT01332578|269308|P1|STARTED|Period II||12
111590|NCT01332578|269307|P2|NOT COMPLETED|Washout Period||0
111591|NCT01332578|269308|P1|NOT COMPLETED|Washout Period||0
111592|NCT01332578|269307|P2|COMPLETED|Washout Period||13
111593|NCT01332578|269308|P1|COMPLETED|Washout Period||12
111594|NCT01332578|269307|P2|STARTED|Washout Period||13
111595|NCT01332578|269308|P1|STARTED|Washout Period||12
111596|NCT01332578|269307|P2|NOT COMPLETED|Period I||0
111597|NCT01332578|269308|P1|NOT COMPLETED|Period I||0
111598|NCT01332578|269307|P2|COMPLETED|Period I||13
111599|NCT01332578|269308|P1|COMPLETED|Period I||12
111600|NCT01332578|269307|P2|STARTED|Period I||13
111601|NCT01332578|269308|P1|STARTED|Period I||12
111602|NCT01332500|269331|P4|NOT COMPLETED|Overall Study||0
111603|NCT01332500|269332|P3|NOT COMPLETED|Overall Study||0
111604|NCT01332500|269333|P2|NOT COMPLETED|Overall Study||0
111605|NCT01332500|269334|P1|NOT COMPLETED|Overall Study||0
111606|NCT01332500|269331|P4|COMPLETED|Overall Study||5806
111607|NCT01332500|269332|P3|COMPLETED|Overall Study||2903
111608|NCT01332500|269333|P2|COMPLETED|Overall Study||39771
111609|NCT01332500|269334|P1|COMPLETED|Overall Study||13257
111610|NCT01332500|269331|P4|STARTED|Overall Study||5806
111611|NCT01332500|269332|P3|STARTED|Overall Study||2903
111612|NCT01332500|269333|P2|STARTED|Overall Study||39771
111613|NCT01332500|269334|P1|STARTED|Overall Study||13257
111614|NCT01332487|269354|P2|NOT COMPLETED|Overall Study||0
111615|NCT01332487|269355|P1|NOT COMPLETED|Overall Study||0
111616|NCT01332487|269354|P2|COMPLETED|Overall Study||3063
111617|NCT01332487|269355|P1|COMPLETED|Overall Study||5554
111618|NCT01332487|269354|P2|STARTED|Overall Study||3063
111619|NCT01332487|269355|P1|STARTED|Overall Study||5554
111620|NCT01332461|269365|P2|NOT COMPLETED|Overall Study||0
111621|NCT01332461|269366|P1|NOT COMPLETED|Overall Study||0
111622|NCT01332461|269365|P2|COMPLETED|Overall Study||4386
111623|NCT01332461|269366|P1|COMPLETED|Overall Study||1291
111624|NCT01332461|269365|P2|STARTED|Overall Study||4386
111625|NCT01332461|269366|P1|STARTED|Overall Study||1291
111626|NCT01332435|269380|P4|NOT COMPLETED|Overall Study||0
111627|NCT01332435|269381|P3|NOT COMPLETED|Overall Study||0
111628|NCT01332435|269382|P2|NOT COMPLETED|Overall Study||0
111629|NCT01332435|269383|P1|NOT COMPLETED|Overall Study||0
111630|NCT01332435|269380|P4|COMPLETED|Overall Study||1656
111631|NCT01332435|269381|P3|COMPLETED|Overall Study||2604
111632|NCT01332435|269382|P2|COMPLETED|Overall Study||1064
111633|NCT01332435|269383|P1|COMPLETED|Overall Study||1572
111634|NCT01332435|269380|P4|STARTED|Overall Study||1656
111635|NCT01332435|269381|P3|STARTED|Overall Study||2604
111636|NCT01332435|269382|P2|STARTED|Overall Study||1064
111637|NCT01332435|269383|P1|STARTED|Overall Study||1572
111638|NCT01332357|269413|P1|NOT COMPLETED|Overall Study||0
111639|NCT01332357|269413|P1|COMPLETED|Overall Study||6139
111640|NCT01332357|269413|P1|STARTED|Overall Study||6139
111641|NCT01332318|269421|P4|NOT COMPLETED|Overall Study||2
111642|NCT01332318|269422|P3|NOT COMPLETED|Overall Study||1
111643|NCT01332318|269423|P2|NOT COMPLETED|Overall Study||4
111644|NCT01332318|269424|P1|NOT COMPLETED|Overall Study||2
111645|NCT01332318|269421|P4|COMPLETED|Overall Study||28
111646|NCT01332318|269422|P3|COMPLETED|Overall Study||33
111647|NCT01332318|269423|P2|COMPLETED|Overall Study||28
111648|NCT01332318|269424|P1|COMPLETED|Overall Study||32
111649|NCT01332318|269421|P4|STARTED|Overall Study||30
111650|NCT01332318|269422|P3|STARTED|Overall Study||34
111651|NCT01332318|269423|P2|STARTED|Overall Study||32
111652|NCT01332318|269424|P1|STARTED|Overall Study||34
111653|NCT01332305|269535|P5|NOT COMPLETED|Overall Study||12
111654|NCT01332305|269536|P4|NOT COMPLETED|Overall Study||8
111655|NCT01332305|269537|P3|NOT COMPLETED|Overall Study||14
111656|NCT01332305|269538|P2|NOT COMPLETED|Overall Study||14
111657|NCT01332305|269539|P1|NOT COMPLETED|Overall Study||10
111658|NCT01332305|269535|P5|COMPLETED|Overall Study||33
111659|NCT01332305|269536|P4|COMPLETED|Overall Study||30
111660|NCT01332305|269537|P3|COMPLETED|Overall Study||31
111661|NCT01332305|269538|P2|COMPLETED|Overall Study||34
111662|NCT01332305|269539|P1|COMPLETED|Overall Study||31
111663|NCT01332305|269535|P5|STARTED|Overall Study||45
111664|NCT01332305|269536|P4|STARTED|Overall Study||38
111665|NCT01332305|269537|P3|STARTED|Overall Study||45
111666|NCT01332305|269538|P2|STARTED|Overall Study||48
111667|NCT01332305|269539|P1|STARTED|Overall Study||41
111668|NCT01332292|269561|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
111669|NCT01332292|269562|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
111670|NCT01332292|269561|P2|COMPLETED|Treatment Period 2 (14 Days)||11
111671|NCT01332292|269562|P1|COMPLETED|Treatment Period 2 (14 Days)||11
111672|NCT01332292|269561|P2|STARTED|Treatment Period 2 (14 Days)||12
111673|NCT01332292|269562|P1|STARTED|Treatment Period 2 (14 Days)||12
111674|NCT01332292|269561|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
111675|NCT01332292|269562|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
111676|NCT01332292|269561|P2|COMPLETED|Washout Period (>=7 Days)||12
111677|NCT01332292|269562|P1|COMPLETED|Washout Period (>=7 Days)||12
111678|NCT01332292|269561|P2|STARTED|Washout Period (>=7 Days)||12
111679|NCT01332292|269562|P1|STARTED|Washout Period (>=7 Days)||12
111680|NCT01332292|269561|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
111681|NCT01332292|269562|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
111682|NCT01332292|269561|P2|COMPLETED|Treatment Period 1 (14 Days)||12
111683|NCT01332292|269562|P1|COMPLETED|Treatment Period 1 (14 Days)||12
111684|NCT01332292|269561|P2|STARTED|Treatment Period 1 (14 Days)||13
111685|NCT01332292|269562|P1|STARTED|Treatment Period 1 (14 Days)||14
111686|NCT01332253|269624|P2|NOT COMPLETED|Overall Study||0
111687|NCT01332253|269625|P1|NOT COMPLETED|Overall Study||0
111688|NCT01332253|269624|P2|COMPLETED|Overall Study||79
111689|NCT01332253|269625|P1|COMPLETED|Overall Study||82
111690|NCT01332253|269624|P2|STARTED|Overall Study||79
111691|NCT01332253|269625|P1|STARTED|Overall Study||82
111692|NCT01332227|269653|P2|NOT COMPLETED|Overall Study||5
111693|NCT01332227|269654|P1|NOT COMPLETED|Overall Study||16
111694|NCT01332227|269653|P2|COMPLETED|Overall Study||32
111695|NCT01332227|269654|P1|COMPLETED|Overall Study||56
111696|NCT01332227|269653|P2|STARTED|Overall Study|Participants who received treatment|37
111697|NCT01332227|269654|P1|STARTED|Overall Study|Participants who received treatment|72
111698|NCT01332188|269676|P4|NOT COMPLETED|Overall Study||0
111699|NCT01332188|269677|P3|NOT COMPLETED|Overall Study||4
111700|NCT01332188|269678|P2|NOT COMPLETED|Overall Study||1
111701|NCT01332188|269679|P1|NOT COMPLETED|Overall Study||2
111702|NCT01332188|269676|P4|COMPLETED|Overall Study||25
111703|NCT01332188|269677|P3|COMPLETED|Overall Study||21
111704|NCT01332188|269678|P2|COMPLETED|Overall Study||25
111705|NCT01332188|269679|P1|COMPLETED|Overall Study||23
111706|NCT01332188|269676|P4|STARTED|Overall Study||25
111707|NCT01332188|269677|P3|STARTED|Overall Study||25
111708|NCT01332188|269678|P2|STARTED|Overall Study||26
111709|NCT01332188|269679|P1|STARTED|Overall Study||25
111710|NCT01332149|269835|P2|NOT COMPLETED|Overall Study||38
111711|NCT01332149|269836|P1|NOT COMPLETED|Overall Study||30
111712|NCT01332149|269835|P2|COMPLETED|Overall Study||271
111713|NCT01332149|269836|P1|COMPLETED|Overall Study||284
111714|NCT01332149|269835|P2|Treated|Overall Study||307
111715|NCT01332149|269836|P1|Treated|Overall Study||313
111716|NCT01332149|269835|P2|STARTED|Overall Study|Assigned to study treatment.|309
111717|NCT01332149|269836|P1|STARTED|Overall Study|Assigned to study treatment.|314
111718|NCT01332123|269890|P1|NOT COMPLETED|Overall Study||0
111719|NCT01332123|269890|P1|COMPLETED|Overall Study||10
111720|NCT01332123|269890|P1|STARTED|Overall Study||10
111721|NCT01332071|269895|P2|NOT COMPLETED|Period 2||0
111722|NCT01332071|269896|P1|NOT COMPLETED|Period 2||0
111723|NCT01332071|269895|P2|COMPLETED|Period 2||13
111724|NCT01332071|269896|P1|COMPLETED|Period 2||13
111725|NCT01332071|269895|P2|STARTED|Period 2||13
111726|NCT01332071|269896|P1|STARTED|Period 2||13
111727|NCT01332071|269895|P2|NOT COMPLETED|7-Day Washout Period||0
111728|NCT01332071|269896|P1|NOT COMPLETED|7-Day Washout Period||0
111729|NCT01332071|269895|P2|COMPLETED|7-Day Washout Period||13
111730|NCT01332071|269896|P1|COMPLETED|7-Day Washout Period||13
111731|NCT01332071|269895|P2|STARTED|7-Day Washout Period||13
111732|NCT01332071|269896|P1|STARTED|7-Day Washout Period||13
111733|NCT01332071|269895|P2|NOT COMPLETED|Period 1||0
111734|NCT01332071|269896|P1|NOT COMPLETED|Period 1||0
111735|NCT01332071|269895|P2|COMPLETED|Period 1||13
111736|NCT01332071|269896|P1|COMPLETED|Period 1||13
111737|NCT01332071|269895|P2|STARTED|Period 1||13
111738|NCT01332071|269896|P1|STARTED|Period 1||13
111739|NCT01332019|269914|P2|NOT COMPLETED|Overall Study||122
111740|NCT01332019|269915|P1|NOT COMPLETED|Overall Study||113
111741|NCT01332019|269914|P2|COMPLETED|Overall Study||425
111742|NCT01332019|269915|P1|COMPLETED|Overall Study||417
111743|NCT01332019|269914|P2|STARTED|Overall Study||547
111744|NCT01332019|269915|P1|STARTED|Overall Study||530
111745|NCT01331837|269999|P2|NOT COMPLETED|Overall Study||67
111746|NCT01331837|270000|P1|NOT COMPLETED|Overall Study||56
111747|NCT01331837|269999|P2|COMPLETED|Overall Study||1475
111748|NCT01331837|270000|P1|COMPLETED|Overall Study||1482
111749|NCT01331837|269999|P2|STARTED|Overall Study||1542
111750|NCT01331837|270000|P1|STARTED|Overall Study||1538
111751|NCT01331824|270040|P1|NOT COMPLETED|Overall Study||13
111752|NCT01331824|270040|P1|COMPLETED|Overall Study||9
111753|NCT01331824|270040|P1|STARTED|Overall Study||22
111754|NCT01331694|270053|P6|NOT COMPLETED|Overall Study||0
111755|NCT01331694|270054|P5|NOT COMPLETED|Overall Study||0
111756|NCT01331694|270055|P4|NOT COMPLETED|Overall Study||0
111757|NCT01331694|270056|P3|NOT COMPLETED|Overall Study||0
111758|NCT01331694|270057|P2|NOT COMPLETED|Overall Study||0
111759|NCT01331694|270058|P1|NOT COMPLETED|Overall Study||0
111760|NCT01331694|270053|P6|COMPLETED|Overall Study||9126
111761|NCT01331694|270054|P5|COMPLETED|Overall Study||10617
111762|NCT01331694|270055|P4|COMPLETED|Overall Study||12595
111763|NCT01331694|270056|P3|COMPLETED|Overall Study||12659
111764|NCT01331694|270057|P2|COMPLETED|Overall Study||14449
111765|NCT01331694|270058|P1|COMPLETED|Overall Study||16684
111766|NCT01331694|270053|P6|STARTED|Overall Study||9126
111767|NCT01331694|270054|P5|STARTED|Overall Study||10617
111768|NCT01331694|270055|P4|STARTED|Overall Study||12595
111769|NCT01331694|270056|P3|STARTED|Overall Study||12659
111770|NCT01331694|270057|P2|STARTED|Overall Study||14449
111771|NCT01331694|270058|P1|STARTED|Overall Study||16684
111772|NCT01331681|270075|P3|NOT COMPLETED|Overall Study||35
111773|NCT01331681|270076|P2|NOT COMPLETED|Overall Study||34
111774|NCT01331681|270077|P1|NOT COMPLETED|Overall Study||35
111775|NCT01331681|270075|P3|COMPLETED|Overall Study|Completed Week 148|100
111776|NCT01331681|270076|P2|COMPLETED|Overall Study|Completed Week 148|101
111777|NCT01331681|270077|P1|COMPLETED|Overall Study|Completed Week 148|101
111778|NCT01331681|270075|P3|Completed Week 148|Overall Study||100
111779|NCT01331681|270076|P2|Completed Week 148|Overall Study||101
111780|NCT01331681|270077|P1|Completed Week 148|Overall Study||101
111781|NCT01331681|270075|P3|Completed Week 100|Overall Study||105
111782|NCT01331681|270076|P2|Completed Week 100|Overall Study||110
111783|NCT01331681|270077|P1|Completed Week 100|Overall Study||115
111784|NCT01331681|270075|P3|Completed Week 52|Overall Study||115
111785|NCT01331681|270076|P2|Completed Week 52|Overall Study||121
111786|NCT01331681|270077|P1|Completed Week 52|Overall Study||125
111787|NCT01331681|270075|P3|Participants Received Treatment|Overall Study|safety population|133
111788|NCT01331681|270076|P2|Participants Received Treatment|Overall Study|safety population|135
111789|NCT01331681|270077|P1|Participants Received Treatment|Overall Study|safety population|136
111790|NCT01331681|270075|P3|STARTED|Overall Study|randomized|135
111791|NCT01331681|270076|P2|STARTED|Overall Study|randomized|135
111792|NCT01331681|270077|P1|STARTED|Overall Study|randomized|136
111793|NCT01331304|270105|P2|NOT COMPLETED|Overall Study||60
111794|NCT01331304|270106|P1|NOT COMPLETED|Overall Study||58
111795|NCT01331304|270105|P2|COMPLETED|Overall Study||182
111796|NCT01331304|270106|P1|COMPLETED|Overall Study||182
111797|NCT01331304|270105|P2|STARTED|Overall Study||242
111798|NCT01331304|270106|P1|STARTED|Overall Study||240
111799|NCT01331291|270120|P2|NOT COMPLETED|Overall Study||9
111800|NCT01331291|270121|P1|NOT COMPLETED|Overall Study||2
111801|NCT01331291|270120|P2|COMPLETED|Overall Study||0
111802|NCT01331291|270121|P1|COMPLETED|Overall Study||0
111803|NCT01331291|270120|P2|STARTED|Overall Study||9
111804|NCT01331291|270121|P1|STARTED|Overall Study||2
111805|NCT01331213|270134|P2|NOT COMPLETED|Overall Study||0
111806|NCT01331213|270135|P1|NOT COMPLETED|Overall Study||0
111807|NCT01331213|270134|P2|COMPLETED|Overall Study||10
111808|NCT01331213|270135|P1|COMPLETED|Overall Study||8
111809|NCT01331213|270134|P2|STARTED|Overall Study||10
111810|NCT01331213|270135|P1|STARTED|Overall Study||8
111811|NCT01331161|270155|P2|NOT COMPLETED|Overall Study||2
111812|NCT01331161|270156|P1|NOT COMPLETED|Overall Study||1
111813|NCT01331161|270155|P2|COMPLETED|Overall Study||31
111814|NCT01331161|270156|P1|COMPLETED|Overall Study||43
111815|NCT01331161|270155|P2|STARTED|Overall Study||33
111816|NCT01331161|270156|P1|STARTED|Overall Study||44
111817|NCT01331109|270164|P1|NOT COMPLETED|Overall Study||57
111818|NCT01331109|270164|P1|COMPLETED|Overall Study||0
111819|NCT01331109|270164|P1|STARTED|Overall Study||57
111820|NCT01331005|270176|P2|NOT COMPLETED|Overall Study||4
111821|NCT01331005|270177|P1|NOT COMPLETED|Overall Study||4
111822|NCT01331005|270176|P2|COMPLETED|Overall Study||57
111823|NCT01331005|270177|P1|COMPLETED|Overall Study||60
111824|NCT01331005|270176|P2|STARTED|Overall Study||61
111825|NCT01331005|270177|P1|STARTED|Overall Study||64
111826|NCT01330914|270183|P1|NOT COMPLETED|Overall Study||7
111827|NCT01330914|270183|P1|COMPLETED|Overall Study||48
111828|NCT01330914|270183|P1|STARTED|Overall Study||55
111829|NCT01330628|270189|P2|NOT COMPLETED|Overall Study||40
111830|NCT01330628|270190|P1|NOT COMPLETED|Overall Study||70
111831|NCT01330628|270189|P2|COMPLETED|Overall Study||42
111832|NCT01330628|270190|P1|COMPLETED|Overall Study||100
111833|NCT01330628|270189|P2|6 Month Follow-up|Overall Study||60
111834|NCT01330628|270190|P1|6 Month Follow-up|Overall Study||135
111835|NCT01330628|270189|P2|30 Day Follow-up|Overall Study||73
111836|NCT01330628|270190|P1|30 Day Follow-up|Overall Study||165
111837|NCT01330628|270189|P2|STARTED|Overall Study||82
111838|NCT01330628|270190|P1|STARTED|Overall Study||170
111839|NCT01330433|270200|P2|NOT COMPLETED|Overall Study||3
111840|NCT01330433|270201|P1|NOT COMPLETED|Overall Study||2
111841|NCT01330433|270200|P2|COMPLETED|Overall Study||16
111842|NCT01330433|270201|P1|COMPLETED|Overall Study||14
111843|NCT01330433|270200|P2|STARTED|Overall Study||19
111844|NCT01330433|270201|P1|STARTED|Overall Study||16
111845|NCT01330420|270221|P1|NOT COMPLETED|Overall Study||4
111846|NCT01330420|270221|P1|COMPLETED|Overall Study||24
111847|NCT01330420|270221|P1|STARTED|Overall Study||28
111848|NCT01330394|270231|P2|NOT COMPLETED|Overall Study||0
111849|NCT01330394|270232|P1|NOT COMPLETED|Overall Study||0
111850|NCT01330394|270231|P2|COMPLETED|Overall Study||16
111851|NCT01330394|270232|P1|COMPLETED|Overall Study||17
111852|NCT01330394|270231|P2|STARTED|Overall Study||16
111853|NCT01330394|270232|P1|STARTED|Overall Study||17
111854|NCT01330381|270240|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
111855|NCT01330381|270241|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
111856|NCT01330381|270242|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
111857|NCT01330381|270240|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
111858|NCT01330381|270241|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
111859|NCT01330381|270242|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
111860|NCT01330381|270240|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
111861|NCT01330381|270241|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
111862|NCT01330381|270242|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
111863|NCT01330381|270240|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
111864|NCT01330381|270241|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
111865|NCT01330381|270242|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
111866|NCT01330381|270240|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
111867|NCT01330381|270241|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
111868|NCT01330381|270242|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
111869|NCT01330381|270240|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
111870|NCT01330381|270241|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
111871|NCT01330381|270242|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
111872|NCT01330381|270240|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
111873|NCT01330381|270241|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
111874|NCT01330381|270242|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
111875|NCT01330355|270288|P2|NOT COMPLETED|Overall Study||0
111876|NCT01330355|270289|P1|NOT COMPLETED|Overall Study||0
111877|NCT01330355|270288|P2|COMPLETED|Overall Study||17
111878|NCT01330355|270289|P1|COMPLETED|Overall Study||16
111879|NCT01330355|270288|P2|STARTED|Overall Study||17
111880|NCT01330355|270289|P1|STARTED|Overall Study||16
111881|NCT01330316|270303|P2|NOT COMPLETED|Overall Study||15
111882|NCT01330316|270304|P1|NOT COMPLETED|Overall Study||2
111883|NCT01330316|270303|P2|COMPLETED|Overall Study||60
111884|NCT01330316|270304|P1|COMPLETED|Overall Study||41
111885|NCT01330316|270303|P2|STARTED|Overall Study||75
111886|NCT01330316|270304|P1|STARTED|Overall Study||43
111887|NCT01330303|270340|P2|NOT COMPLETED|Period 2||0
111888|NCT01330303|270341|P1|NOT COMPLETED|Period 2||0
111889|NCT01330303|270340|P2|COMPLETED|Period 2||18
111890|NCT01330303|270341|P1|COMPLETED|Period 2||19
111891|NCT01330303|270340|P2|STARTED|Period 2||18
111892|NCT01330303|270341|P1|STARTED|Period 2||19
111893|NCT01330303|270340|P2|NOT COMPLETED|7-Day Washout Period||0
111894|NCT01330303|270341|P1|NOT COMPLETED|7-Day Washout Period||0
111895|NCT01330303|270340|P2|COMPLETED|7-Day Washout Period||18
111896|NCT01330303|270341|P1|COMPLETED|7-Day Washout Period||19
111897|NCT01330303|270340|P2|STARTED|7-Day Washout Period||18
111898|NCT01330303|270341|P1|STARTED|7-Day Washout Period||19
111899|NCT01330303|270340|P2|NOT COMPLETED|Period 1||2
111900|NCT01330303|270341|P1|NOT COMPLETED|Period 1||1
111901|NCT01330303|270340|P2|COMPLETED|Period 1||18
111902|NCT01330303|270341|P1|COMPLETED|Period 1||19
111903|NCT01330303|270340|P2|STARTED|Period 1||20
111904|NCT01330303|270341|P1|STARTED|Period 1||20
111905|NCT01330290|270351|P1|NOT COMPLETED|Overall Study||0
111906|NCT01330290|270351|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
111907|NCT01330290|270351|P1|STARTED|Overall Study||148
111908|NCT01330108|270375|P1|NOT COMPLETED|Overall Study||4
111909|NCT01330108|270375|P1|COMPLETED|Overall Study||28
111910|NCT01330108|270375|P1|STARTED|Overall Study||32
111911|NCT01330043|270382|P2|NOT COMPLETED|Overall Study||4
111912|NCT01330043|270383|P1|NOT COMPLETED|Overall Study||0
111913|NCT01330043|270382|P2|COMPLETED|Overall Study||108
111914|NCT01330043|270383|P1|COMPLETED|Overall Study||111
111915|NCT01330043|270382|P2|STARTED|Overall Study||112
111916|NCT01330043|270383|P1|STARTED|Overall Study||111
111917|NCT01330030|270393|P2|NOT COMPLETED|Overall Study||17
111918|NCT01330030|270394|P1|NOT COMPLETED|Overall Study||16
111919|NCT01330030|270393|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
111920|NCT01330030|270394|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
111921|NCT01330030|270393|P2|STARTED|Overall Study||122
111922|NCT01330030|270394|P1|STARTED|Overall Study||121
111923|NCT01330017|270405|P5|NOT COMPLETED|Overall Study||3
111924|NCT01330017|270406|P4|NOT COMPLETED|Overall Study||12
111925|NCT01330017|270407|P3|NOT COMPLETED|Overall Study||8
111926|NCT01330017|270408|P2|NOT COMPLETED|Overall Study||4
111927|NCT01330017|270409|P1|NOT COMPLETED|Overall Study||5
111928|NCT01330017|270405|P5|COMPLETED|Overall Study||100
111929|NCT01330017|270406|P4|COMPLETED|Overall Study||100
111930|NCT01330017|270407|P3|COMPLETED|Overall Study||99
111931|NCT01330017|270408|P2|COMPLETED|Overall Study||104
111932|NCT01330017|270409|P1|COMPLETED|Overall Study||104
111933|NCT01330017|270405|P5|STARTED|Overall Study||103
111934|NCT01330017|270406|P4|STARTED|Overall Study||112
111935|NCT01330017|270407|P3|STARTED|Overall Study||107
111936|NCT01330017|270408|P2|STARTED|Overall Study||108
111937|NCT01330017|270409|P1|STARTED|Overall Study||109
111938|NCT01329978|270458|P5|NOT COMPLETED|Rerandomization Treatment Period||4
111939|NCT01329978|270459|P4|NOT COMPLETED|Rerandomization Treatment Period||5
111940|NCT01329978|270460|P3|NOT COMPLETED|Rerandomization Treatment Period||0
111941|NCT01329978|270461|P2|NOT COMPLETED|Rerandomization Treatment Period||0
111942|NCT01329978|270462|P1|NOT COMPLETED|Rerandomization Treatment Period||0
111943|NCT01329978|270458|P5|COMPLETED|Rerandomization Treatment Period||71
111944|NCT01329978|270459|P4|COMPLETED|Rerandomization Treatment Period||70
111945|NCT01329978|270460|P3|COMPLETED|Rerandomization Treatment Period||0
111946|NCT01329978|270461|P2|COMPLETED|Rerandomization Treatment Period||0
111947|NCT01329978|270462|P1|COMPLETED|Rerandomization Treatment Period||0
111948|NCT01329978|270458|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
111949|NCT01329978|270459|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
111950|NCT01329978|270460|P3|STARTED|Rerandomization Treatment Period||0
111951|NCT01329978|270461|P2|STARTED|Rerandomization Treatment Period||0
111952|NCT01329978|270462|P1|STARTED|Rerandomization Treatment Period||0
111953|NCT01329978|270458|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
111954|NCT01329978|270459|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
111955|NCT01329978|270460|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
111956|NCT01329978|270461|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
111957|NCT01329978|270462|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
111958|NCT01329978|270458|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
111959|NCT01329978|270459|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
111960|NCT01329978|270460|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
111961|NCT01329978|270461|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
111962|NCT01329978|270462|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
111963|NCT01329978|270458|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
111964|NCT01329978|270459|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
111965|NCT01329978|270460|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
111966|NCT01329978|270461|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
111967|NCT01329978|270462|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
111968|NCT01329939|270536|P4|NOT COMPLETED|Overall Study||5
111969|NCT01329939|270537|P3|NOT COMPLETED|Overall Study||1
111970|NCT01329939|270538|P2|NOT COMPLETED|Overall Study||1
111971|NCT01329939|270539|P1|NOT COMPLETED|Overall Study||3
111972|NCT01329939|270536|P4|COMPLETED|Overall Study||4
111973|NCT01329939|270537|P3|COMPLETED|Overall Study||4
111974|NCT01329939|270538|P2|COMPLETED|Overall Study||4
111975|NCT01329939|270539|P1|COMPLETED|Overall Study||4
111976|NCT01329939|270536|P4|STARTED|Overall Study||9
111977|NCT01329939|270537|P3|STARTED|Overall Study||5
111978|NCT01329939|270538|P2|STARTED|Overall Study||5
111979|NCT01329939|270539|P1|STARTED|Overall Study||7
111980|NCT01329848|270577|P1|NOT COMPLETED|Overall Study||29
111981|NCT01329848|270577|P1|COMPLETED|Overall Study||54
111982|NCT01329848|270577|P1|STARTED|Overall Study||83
111983|NCT01329679|270582|P2|NOT COMPLETED|Overall Study||0
111984|NCT01329679|270583|P1|NOT COMPLETED|Overall Study||0
111985|NCT01329679|270582|P2|COMPLETED|Overall Study||13
111986|NCT01329679|270583|P1|COMPLETED|Overall Study||13
111987|NCT01329679|270582|P2|STARTED|Overall Study||13
111988|NCT01329679|270583|P1|STARTED|Overall Study||13
111989|NCT01329562|270603|P2|NOT COMPLETED|Overall Study||7
111990|NCT01329562|270604|P1|NOT COMPLETED|Overall Study||9
111991|NCT01329562|270603|P2|COMPLETED|Overall Study||14
111992|NCT01329562|270604|P1|COMPLETED|Overall Study||11
111993|NCT01329562|270603|P2|STARTED|Overall Study||21
111994|NCT01329562|270604|P1|STARTED|Overall Study||20
111995|NCT01329549|270653|P1|NOT COMPLETED|Overall Study||2
111996|NCT01329549|270653|P1|COMPLETED|Overall Study||0
111997|NCT01329549|270653|P1|STARTED|Overall Study||2
111998|NCT01329419|270664|P1|NOT COMPLETED|Overall Study||235
111999|NCT01329419|270664|P1|COMPLETED|Overall Study||4158
112000|NCT01329419|270664|P1|STARTED|Overall Study||4393
112001|NCT01329263|270672|P2|NOT COMPLETED|Overall Study||23
112002|NCT01329263|270673|P1|NOT COMPLETED|Overall Study||5
112003|NCT01329263|270672|P2|COMPLETED|Overall Study||22
112004|NCT01329263|270673|P1|COMPLETED|Overall Study||10
112005|NCT01329263|270672|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
112006|NCT01329263|270673|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
112007|NCT01329263|270672|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
112008|NCT01329263|270673|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
112009|NCT01329263|270672|P2|Completed Period 1 Own Menthol|Overall Study||45
112010|NCT01329263|270673|P1|Completed Period 1 Own Menthol|Overall Study||15
112011|NCT01329263|270672|P2|STARTED|Overall Study||45
112012|NCT01329263|270673|P1|STARTED|Overall Study||15
112013|NCT01329198|270687|P2|NOT COMPLETED|Overall Study||0
112014|NCT01329198|270688|P1|NOT COMPLETED|Overall Study||0
112015|NCT01329198|270687|P2|COMPLETED|Overall Study||2
112016|NCT01329198|270688|P1|COMPLETED|Overall Study||3
112017|NCT01329198|270687|P2|STARTED|Overall Study||2
112018|NCT01329198|270688|P1|STARTED|Overall Study||3
112019|NCT01329185|270701|P2|NOT COMPLETED|Overall Study||0
112020|NCT01329185|270702|P1|NOT COMPLETED|Overall Study||0
112021|NCT01329185|270701|P2|COMPLETED|Overall Study||7
112022|NCT01329185|270702|P1|COMPLETED|Overall Study||10
112023|NCT01329185|270701|P2|PTLD|Overall Study||0
112024|NCT01329185|270702|P1|PTLD|Overall Study||1
112025|NCT01329185|270701|P2|CMV Disease|Overall Study||0
112026|NCT01329185|270702|P1|CMV Disease|Overall Study||1
112027|NCT01329185|270701|P2|STARTED|Overall Study||7
112028|NCT01329185|270702|P1|STARTED|Overall Study||10
112029|NCT01329029|270710|P2|NOT COMPLETED|Overall Study||192
112030|NCT01329029|270711|P1|NOT COMPLETED|Overall Study||269
112031|NCT01329029|270710|P2|COMPLETED|Overall Study||780
112032|NCT01329029|270711|P1|COMPLETED|Overall Study||704
112033|NCT01329029|270710|P2|Safety Population|Overall Study||967
112034|NCT01329029|270711|P1|Safety Population|Overall Study||968
112035|NCT01329029|270710|P2|Full Analysis Set (FAS)|Overall Study||966
112036|NCT01329029|270711|P1|Full Analysis Set (FAS)|Overall Study||969
112037|NCT01329029|270710|P2|STARTED|Overall Study||972
112038|NCT01329029|270711|P1|STARTED|Overall Study||973
112039|NCT01328964|270784|P3|NOT COMPLETED|Overall Study||0
112040|NCT01328964|270785|P2|NOT COMPLETED|Overall Study||0
112041|NCT01328964|270786|P1|NOT COMPLETED|Overall Study||0
112042|NCT01328964|270784|P3|COMPLETED|Overall Study||4424
112043|NCT01328964|270785|P2|COMPLETED|Overall Study||3270
112044|NCT01328964|270786|P1|COMPLETED|Overall Study||2212
112045|NCT01328964|270784|P3|STARTED|Overall Study||4424
112046|NCT01328964|270785|P2|STARTED|Overall Study||3270
112047|NCT01328964|270786|P1|STARTED|Overall Study||2212
112048|NCT01328951|270801|P2|NOT COMPLETED|Overall Study||322
112049|NCT01328951|270802|P1|NOT COMPLETED|Overall Study||321
112050|NCT01328951|270801|P2|COMPLETED|Overall Study||0
112051|NCT01328951|270802|P1|COMPLETED|Overall Study||0
112052|NCT01328951|270801|P2|STARTED|Overall Study||322
112053|NCT01328951|270802|P1|STARTED|Overall Study||321
112054|NCT01328873|270826|P1|NOT COMPLETED|Overall Study||0
112055|NCT01328873|270826|P1|COMPLETED|Overall Study||49
112056|NCT01328873|270826|P1|STARTED|Overall Study||49
112057|NCT01328782|270838|P3|NOT COMPLETED|Overall Study||0
112058|NCT01328782|270839|P2|NOT COMPLETED|Overall Study||0
112059|NCT01328782|270840|P1|NOT COMPLETED|Overall Study||0
112060|NCT01328782|270838|P3|COMPLETED|Overall Study||39
112061|NCT01328782|270839|P2|COMPLETED|Overall Study||42
112062|NCT01328782|270840|P1|COMPLETED|Overall Study||43
112063|NCT01328782|270838|P3|STARTED|Overall Study||39
112064|NCT01328782|270839|P2|STARTED|Overall Study||42
112065|NCT01328782|270840|P1|STARTED|Overall Study||43
112066|NCT01328769|270862|P2|NOT COMPLETED|Overall Study||1
112067|NCT01328769|270863|P1|NOT COMPLETED|Overall Study||0
112068|NCT01328769|270862|P2|COMPLETED|Overall Study||23
112069|NCT01328769|270863|P1|COMPLETED|Overall Study||25
112070|NCT01328769|270862|P2|STARTED|Overall Study||24
112071|NCT01328769|270863|P1|STARTED|Overall Study||25
112072|NCT01328756|270871|P1|NOT COMPLETED|Overall Study||123
112073|NCT01328756|270871|P1|COMPLETED|Overall Study||191
112074|NCT01328756|270871|P1|STARTED|Overall Study||314
112075|NCT01328717|270888|P1|NOT COMPLETED|Overall Study||1
112076|NCT01328717|270888|P1|COMPLETED|Overall Study||77
112077|NCT01328717|270888|P1|STARTED|Overall Study||78
112078|NCT01328574|270893|P1|NOT COMPLETED|Overall Study||1
112079|NCT01328574|270893|P1|COMPLETED|Overall Study||12
112080|NCT01328574|270893|P1|STARTED|Overall Study||13
112081|NCT01328548|270907|P2|NOT COMPLETED|Overall Study||0
112082|NCT01328548|270908|P1|NOT COMPLETED|Overall Study||4
112083|NCT01328548|270907|P2|COMPLETED|Overall Study||50
112084|NCT01328548|270908|P1|COMPLETED|Overall Study||187
112085|NCT01328548|270907|P2|STARTED|Overall Study||50
112086|NCT01328548|270908|P1|STARTED|Overall Study||191
112087|NCT01328496|270928|P2|NOT COMPLETED|Overall Study||0
112088|NCT01328496|270929|P1|NOT COMPLETED|Overall Study||1
112089|NCT01328496|270928|P2|COMPLETED|Overall Study||4
112090|NCT01328496|270929|P1|COMPLETED|Overall Study||9
112091|NCT01328496|270928|P2|STARTED|Overall Study||4
112092|NCT01328496|270929|P1|STARTED|Overall Study||10
112093|NCT01328444|270947|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
112094|NCT01328444|270948|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
112095|NCT01328444|270949|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
112096|NCT01328444|270950|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
112097|NCT01328444|270951|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
112098|NCT01328444|270952|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
112099|NCT01328444|270947|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
112100|NCT01328444|270948|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
112101|NCT01328444|270949|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
112102|NCT01328444|270950|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
112103|NCT01328444|270951|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
112104|NCT01328444|270952|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
112105|NCT01328444|270947|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
112106|NCT01328444|270948|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
112107|NCT01328444|270949|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
112108|NCT01328444|270950|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
112109|NCT01328444|270951|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
112110|NCT01328444|270952|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
112111|NCT01328444|270947|P6|NOT COMPLETED|Washout Period (14 Days)||4
112112|NCT01328444|270948|P5|NOT COMPLETED|Washout Period (14 Days)||1
112113|NCT01328444|270949|P4|NOT COMPLETED|Washout Period (14 Days)||1
112114|NCT01328444|270950|P3|NOT COMPLETED|Washout Period (14 Days)||0
112115|NCT01328444|270951|P2|NOT COMPLETED|Washout Period (14 Days)||1
112116|NCT01328444|270952|P1|NOT COMPLETED|Washout Period (14 Days)||1
112117|NCT01328444|270947|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
112118|NCT01328444|270948|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
112201|NCT01328054|271156|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
112119|NCT01328444|270949|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
112120|NCT01328444|270950|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
112121|NCT01328444|270951|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
112122|NCT01328444|270952|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
112123|NCT01328444|270947|P6|STARTED|Washout Period (14 Days)||72
112124|NCT01328444|270948|P5|STARTED|Washout Period (14 Days)||67
112125|NCT01328444|270949|P4|STARTED|Washout Period (14 Days)||33
112126|NCT01328444|270950|P3|STARTED|Washout Period (14 Days)||25
112127|NCT01328444|270951|P2|STARTED|Washout Period (14 Days)||21
112128|NCT01328444|270952|P1|STARTED|Washout Period (14 Days)||83
112129|NCT01328444|270947|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
112130|NCT01328444|270948|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
112131|NCT01328444|270949|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
112132|NCT01328444|270950|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
112133|NCT01328444|270951|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
112134|NCT01328444|270952|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
112135|NCT01328444|270947|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
112136|NCT01328444|270948|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
112137|NCT01328444|270949|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
112138|NCT01328444|270950|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
112139|NCT01328444|270951|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
112140|NCT01328444|270952|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
112141|NCT01328444|270947|P6|STARTED|Treatment Period 1 (12 Weeks)||78
112142|NCT01328444|270948|P5|STARTED|Treatment Period 1 (12 Weeks)||81
112143|NCT01328444|270949|P4|STARTED|Treatment Period 1 (12 Weeks)||41
112144|NCT01328444|270950|P3|STARTED|Treatment Period 1 (12 Weeks)||28
112145|NCT01328444|270951|P2|STARTED|Treatment Period 1 (12 Weeks)||26
112146|NCT01328444|270952|P1|STARTED|Treatment Period 1 (12 Weeks)||94
112147|NCT01328431|270998|P2|NOT COMPLETED|12 Month (12M)||97
112148|NCT01328431|270999|P1|NOT COMPLETED|12 Month (12M)||84
112149|NCT01328431|270998|P2|COMPLETED|12 Month (12M)||289
112150|NCT01328431|270999|P1|COMPLETED|12 Month (12M)||304
112151|NCT01328431|270998|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
112152|NCT01328431|270999|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
112153|NCT01328431|270998|P2|NOT COMPLETED|3 Month (3M)||72
112154|NCT01328431|270999|P1|NOT COMPLETED|3 Month (3M)||77
112155|NCT01328431|270998|P2|COMPLETED|3 Month (3M)||316
112156|NCT01328431|270999|P1|COMPLETED|3 Month (3M)||313
112157|NCT01328431|270998|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
112158|NCT01328431|270999|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
112159|NCT01328431|270998|P2|NOT COMPLETED|1 Month (1M)||58
112160|NCT01328431|270999|P1|NOT COMPLETED|1 Month (1M)||55
112161|NCT01328431|270998|P2|COMPLETED|1 Month (1M)||330
112162|NCT01328431|270999|P1|COMPLETED|1 Month (1M)||335
112163|NCT01328431|270998|P2|STARTED|1 Month (1M)||388
112164|NCT01328431|270999|P1|STARTED|1 Month (1M)||390
112165|NCT01328431|270998|P2|NOT COMPLETED|Baseline||2
112166|NCT01328431|270999|P1|NOT COMPLETED|Baseline||0
112167|NCT01328431|270998|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
112168|NCT01328431|270999|P1|COMPLETED|Baseline||390
112169|NCT01328431|270998|P2|STARTED|Baseline||390
112170|NCT01328431|270999|P1|STARTED|Baseline||390
112171|NCT01328405|271009|P2|NOT COMPLETED|Overall Study||0
112172|NCT01328405|271010|P1|NOT COMPLETED|Overall Study||0
112173|NCT01328405|271009|P2|COMPLETED|Overall Study||48
112174|NCT01328405|271010|P1|COMPLETED|Overall Study||52
112175|NCT01328405|271009|P2|STARTED|Overall Study||48
112176|NCT01328405|271010|P1|STARTED|Overall Study||52
112177|NCT01328379|271027|P3|NOT COMPLETED|Overall Study||0
112178|NCT01328379|271028|P2|NOT COMPLETED|Overall Study||0
112179|NCT01328379|271029|P1|NOT COMPLETED|Overall Study||1
112180|NCT01328379|271027|P3|COMPLETED|Overall Study||143
112181|NCT01328379|271028|P2|COMPLETED|Overall Study||144
112182|NCT01328379|271029|P1|COMPLETED|Overall Study||142
112183|NCT01328379|271027|P3|STARTED|Overall Study||143
112184|NCT01328379|271028|P2|STARTED|Overall Study||144
112185|NCT01328379|271029|P1|STARTED|Overall Study||143
112186|NCT01328366|271055|P1|NOT COMPLETED|Overall Study||10
112187|NCT01328366|271055|P1|COMPLETED|Overall Study||143
112188|NCT01328366|271055|P1|STARTED|Overall Study||153
112189|NCT01328184|271073|P1|NOT COMPLETED|Overall Study||0
112190|NCT01328184|271073|P1|COMPLETED|Overall Study||18
112191|NCT01328184|271073|P1|STARTED|Overall Study||18
112192|NCT01328158|271113|P1|NOT COMPLETED|Overall Study||0
112193|NCT01328158|271113|P1|COMPLETED|Overall Study||220
112194|NCT01328158|271113|P1|STARTED|Overall Study||220
112195|NCT01328080|271151|P1|NOT COMPLETED|Overall Study||5
112196|NCT01328080|271151|P1|COMPLETED|Overall Study||6
112197|NCT01328080|271151|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
112198|NCT01328054|271155|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
112199|NCT01328054|271156|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
112200|NCT01328054|271155|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
112202|NCT01328054|271155|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
112203|NCT01328054|271156|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
112204|NCT01328054|271155|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
112205|NCT01328054|271156|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
112206|NCT01328054|271155|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
112207|NCT01328054|271156|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
112208|NCT01328054|271155|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
112209|NCT01328054|271156|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
112210|NCT01328041|271181|P1|NOT COMPLETED|Overall Study||57
112211|NCT01328041|271181|P1|COMPLETED|Overall Study||126
112212|NCT01328041|271181|P1|STARTED|Overall Study||183
112213|NCT01327989|271203|P1|NOT COMPLETED|Overall Study||14
112214|NCT01327989|271203|P1|COMPLETED|Overall Study||188
112215|NCT01327989|271203|P1|STARTED|Overall Study||202
112216|NCT01327976|271217|P2|NOT COMPLETED|Overall Study||7
112217|NCT01327976|271218|P1|NOT COMPLETED|Overall Study||8
112218|NCT01327976|271217|P2|COMPLETED|Overall Study||70
112219|NCT01327976|271218|P1|COMPLETED|Overall Study||154
112220|NCT01327976|271217|P2|STARTED|Overall Study||77
112221|NCT01327976|271218|P1|STARTED|Overall Study||162
112222|NCT01327885|271230|P2|NOT COMPLETED|Overall Study||224
112223|NCT01327885|271231|P1|NOT COMPLETED|Overall Study||228
112224|NCT01327885|271230|P2|COMPLETED|Overall Study||0
112225|NCT01327885|271231|P1|COMPLETED|Overall Study||0
112226|NCT01327885|271230|P2|STARTED|Overall Study||224
112227|NCT01327885|271231|P1|STARTED|Overall Study||228
112228|NCT01327703|271243|P2|NOT COMPLETED|Second Treatment Period||2
112229|NCT01327703|271244|P1|NOT COMPLETED|Second Treatment Period||1
112230|NCT01327703|271243|P2|COMPLETED|Second Treatment Period||42
112231|NCT01327703|271244|P1|COMPLETED|Second Treatment Period||39
112232|NCT01327703|271243|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
112233|NCT01327703|271244|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
112234|NCT01327703|271243|P2|NOT COMPLETED|First Treatment Period||0
112235|NCT01327703|271244|P1|NOT COMPLETED|First Treatment Period||0
112236|NCT01327703|271243|P2|COMPLETED|First Treatment Period||45
112237|NCT01327703|271244|P1|COMPLETED|First Treatment Period||42
112238|NCT01327703|271243|P2|STARTED|First Treatment Period||45
112239|NCT01327703|271244|P1|STARTED|First Treatment Period||42
112240|NCT01327677|271278|P2|NOT COMPLETED|Overall Study||13
112241|NCT01327677|271279|P1|NOT COMPLETED|Overall Study||20
112242|NCT01327677|271278|P2|COMPLETED|Overall Study||56
112243|NCT01327677|271279|P1|COMPLETED|Overall Study||48
112244|NCT01327677|271278|P2|STARTED|Overall Study||69
112245|NCT01327677|271279|P1|STARTED|Overall Study||68
112246|NCT01327651|271300|P9|NOT COMPLETED|Post Study Follow-up||2
112247|NCT01327651|271301|P8|NOT COMPLETED|Post Study Follow-up||1
112248|NCT01327651|271302|P7|NOT COMPLETED|Post Study Follow-up||4
112249|NCT01327651|271303|P6|NOT COMPLETED|Post Study Follow-up||0
112250|NCT01327651|271304|P5|NOT COMPLETED|Post Study Follow-up||0
112251|NCT01327651|271305|P4|NOT COMPLETED|Post Study Follow-up||0
112252|NCT01327651|271306|P3|NOT COMPLETED|Post Study Follow-up||1
112253|NCT01327651|271307|P2|NOT COMPLETED|Post Study Follow-up||1
112254|NCT01327651|271308|P1|NOT COMPLETED|Post Study Follow-up||0
112255|NCT01327651|271300|P9|COMPLETED|Post Study Follow-up||47
112256|NCT01327651|271301|P8|COMPLETED|Post Study Follow-up||49
112257|NCT01327651|271302|P7|COMPLETED|Post Study Follow-up||45
112258|NCT01327651|271303|P6|COMPLETED|Post Study Follow-up||59
112259|NCT01327651|271304|P5|COMPLETED|Post Study Follow-up||56
112260|NCT01327651|271305|P4|COMPLETED|Post Study Follow-up||57
112261|NCT01327651|271306|P3|COMPLETED|Post Study Follow-up||55
112262|NCT01327651|271307|P2|COMPLETED|Post Study Follow-up||55
112263|NCT01327651|271308|P1|COMPLETED|Post Study Follow-up||56
112264|NCT01327651|271300|P9|STARTED|Post Study Follow-up||49
112265|NCT01327651|271301|P8|STARTED|Post Study Follow-up||50
112266|NCT01327651|271302|P7|STARTED|Post Study Follow-up||49
112267|NCT01327651|271303|P6|STARTED|Post Study Follow-up||59
112268|NCT01327651|271304|P5|STARTED|Post Study Follow-up||56
112269|NCT01327651|271305|P4|STARTED|Post Study Follow-up||57
112270|NCT01327651|271306|P3|STARTED|Post Study Follow-up||56
112271|NCT01327651|271307|P2|STARTED|Post Study Follow-up||56
112272|NCT01327651|271308|P1|STARTED|Post Study Follow-up||56
112273|NCT01327651|271300|P9|NOT COMPLETED|Self-administered Dosing Period||11
112274|NCT01327651|271301|P8|NOT COMPLETED|Self-administered Dosing Period||10
112275|NCT01327651|271302|P7|NOT COMPLETED|Self-administered Dosing Period||10
112276|NCT01327651|271303|P6|NOT COMPLETED|Self-administered Dosing Period||0
112277|NCT01327651|271304|P5|NOT COMPLETED|Self-administered Dosing Period||3
112278|NCT01327651|271305|P4|NOT COMPLETED|Self-administered Dosing Period||3
112279|NCT01327651|271306|P3|NOT COMPLETED|Self-administered Dosing Period||4
112280|NCT01327651|271307|P2|NOT COMPLETED|Self-administered Dosing Period||3
112281|NCT01327651|271308|P1|NOT COMPLETED|Self-administered Dosing Period||4
112282|NCT01327651|271300|P9|COMPLETED|Self-administered Dosing Period||49
112283|NCT01327651|271301|P8|COMPLETED|Self-administered Dosing Period||50
112284|NCT01327651|271302|P7|COMPLETED|Self-administered Dosing Period||49
112285|NCT01327651|271303|P6|COMPLETED|Self-administered Dosing Period||59
112286|NCT01327651|271304|P5|COMPLETED|Self-administered Dosing Period||56
112287|NCT01327651|271305|P4|COMPLETED|Self-administered Dosing Period||57
112288|NCT01327651|271306|P3|COMPLETED|Self-administered Dosing Period||56
112289|NCT01327651|271307|P2|COMPLETED|Self-administered Dosing Period||56
112290|NCT01327651|271308|P1|COMPLETED|Self-administered Dosing Period||56
112291|NCT01327651|271300|P9|Week 26|Self-administered Dosing Period||49
112292|NCT01327651|271301|P8|Week 26|Self-administered Dosing Period||51
112293|NCT01327651|271302|P7|Week 26|Self-administered Dosing Period||50
112294|NCT01327651|271303|P6|Week 26|Self-administered Dosing Period||58
112295|NCT01327651|271304|P5|Week 26|Self-administered Dosing Period||56
112296|NCT01327651|271305|P4|Week 26|Self-administered Dosing Period||57
112297|NCT01327651|271306|P3|Week 26|Self-administered Dosing Period||53
112298|NCT01327651|271307|P2|Week 26|Self-administered Dosing Period||56
112299|NCT01327651|271308|P1|Week 26|Self-administered Dosing Period||58
112300|NCT01327651|271300|P9|Week 22|Self-administered Dosing Period||51
112301|NCT01327651|271301|P8|Week 22|Self-administered Dosing Period||50
112302|NCT01327651|271302|P7|Week 22|Self-administered Dosing Period||50
112303|NCT01327651|271303|P6|Week 22|Self-administered Dosing Period||59
112304|NCT01327651|271304|P5|Week 22|Self-administered Dosing Period||56
112305|NCT01327651|271305|P4|Week 22|Self-administered Dosing Period||58
112306|NCT01327651|271306|P3|Week 22|Self-administered Dosing Period||55
112307|NCT01327651|271307|P2|Week 22|Self-administered Dosing Period||56
112308|NCT01327651|271308|P1|Week 22|Self-administered Dosing Period||59
112309|NCT01327651|271300|P9|Week 18|Self-administered Dosing Period||53
112310|NCT01327651|271301|P8|Week 18|Self-administered Dosing Period||49
112311|NCT01327651|271302|P7|Week 18|Self-administered Dosing Period||53
112312|NCT01327651|271303|P6|Week 18|Self-administered Dosing Period||59
112313|NCT01327651|271304|P5|Week 18|Self-administered Dosing Period||57
112314|NCT01327651|271305|P4|Week 18|Self-administered Dosing Period||60
112315|NCT01327651|271306|P3|Week 18|Self-administered Dosing Period||56
112316|NCT01327651|271307|P2|Week 18|Self-administered Dosing Period||56
112317|NCT01327651|271308|P1|Week 18|Self-administered Dosing Period||57
112318|NCT01327651|271300|P9|Week 14|Self-administered Dosing Period||54
112319|NCT01327651|271301|P8|Week 14|Self-administered Dosing Period||51
112320|NCT01327651|271302|P7|Week 14|Self-administered Dosing Period||54
112321|NCT01327651|271303|P6|Week 14|Self-administered Dosing Period||59
112322|NCT01327651|271304|P5|Week 14|Self-administered Dosing Period||58
112323|NCT01327651|271305|P4|Week 14|Self-administered Dosing Period||60
112324|NCT01327651|271306|P3|Week 14|Self-administered Dosing Period||57
112325|NCT01327651|271307|P2|Week 14|Self-administered Dosing Period||55
112326|NCT01327651|271308|P1|Week 14|Self-administered Dosing Period||59
112327|NCT01327651|271300|P9|Week 10|Self-administered Dosing Period||56
112328|NCT01327651|271301|P8|Week 10|Self-administered Dosing Period||57
112329|NCT01327651|271302|P7|Week 10|Self-administered Dosing Period||57
112330|NCT01327651|271303|P6|Week 10|Self-administered Dosing Period||59
112331|NCT01327651|271304|P5|Week 10|Self-administered Dosing Period||59
112332|NCT01327651|271305|P4|Week 10|Self-administered Dosing Period||60
112333|NCT01327651|271306|P3|Week 10|Self-administered Dosing Period||60
112334|NCT01327651|271307|P2|Week 10|Self-administered Dosing Period||58
112335|NCT01327651|271308|P1|Week 10|Self-administered Dosing Period||59
112336|NCT01327651|271300|P9|STARTED|Self-administered Dosing Period||60
112337|NCT01327651|271301|P8|STARTED|Self-administered Dosing Period||60
112338|NCT01327651|271302|P7|STARTED|Self-administered Dosing Period||59
112339|NCT01327651|271303|P6|STARTED|Self-administered Dosing Period||59
112340|NCT01327651|271304|P5|STARTED|Self-administered Dosing Period||59
112341|NCT01327651|271305|P4|STARTED|Self-administered Dosing Period||60
112342|NCT01327651|271306|P3|STARTED|Self-administered Dosing Period||60
112343|NCT01327651|271307|P2|STARTED|Self-administered Dosing Period||59
112344|NCT01327651|271308|P1|STARTED|Self-administered Dosing Period||60
112345|NCT01327599|271427|P1|NOT COMPLETED|Overall Study||3
112346|NCT01327599|271427|P1|COMPLETED|Overall Study||57
112347|NCT01327599|271427|P1|STARTED|Overall Study||60
112348|NCT01327547|271437|P2|NOT COMPLETED|Overall Study||22
112349|NCT01327547|271438|P1|NOT COMPLETED|Overall Study||20
112350|NCT01327547|271437|P2|COMPLETED|Overall Study||45
112351|NCT01327547|271438|P1|COMPLETED|Overall Study||50
112352|NCT01327547|271437|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
112353|NCT01327547|271438|P1|Randomized and Not Treated|Overall Study||0
112354|NCT01327547|271437|P2|STARTED|Overall Study||67
112355|NCT01327547|271438|P1|STARTED|Overall Study||70
112356|NCT01327508|271491|P2|NOT COMPLETED|Overall Study||0
112357|NCT01327508|271492|P1|NOT COMPLETED|Overall Study||0
112358|NCT01327508|271491|P2|COMPLETED|Overall Study||30
112359|NCT01327508|271492|P1|COMPLETED|Overall Study||30
112360|NCT01327508|271491|P2|STARTED|Overall Study||30
112361|NCT01327508|271492|P1|STARTED|Overall Study||30
112362|NCT01327495|271506|P6|NOT COMPLETED|Overall Study||2
112363|NCT01327495|271507|P5|NOT COMPLETED|Overall Study||3
112364|NCT01327495|271508|P4|NOT COMPLETED|Overall Study||0
112365|NCT01327495|271509|P3|NOT COMPLETED|Overall Study||2
112366|NCT01327495|271510|P2|NOT COMPLETED|Overall Study||2
112367|NCT01327495|271511|P1|NOT COMPLETED|Overall Study||2
112368|NCT01327495|271506|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
112369|NCT01327495|271507|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
112370|NCT01327495|271508|P4|COMPLETED|Overall Study||9
112371|NCT01327495|271509|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
112372|NCT01327495|271510|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
112373|NCT01327495|271511|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
112374|NCT01327495|271506|P6|STARTED|Overall Study||11
112375|NCT01327495|271507|P5|STARTED|Overall Study||11
112376|NCT01327495|271508|P4|STARTED|Overall Study||9
112377|NCT01327495|271509|P3|STARTED|Overall Study||10
112378|NCT01327495|271510|P2|STARTED|Overall Study||11
112379|NCT01327495|271511|P1|STARTED|Overall Study||10
112380|NCT01327482|271603|P1|NOT COMPLETED|Overall Study||1
112381|NCT01327482|271603|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
112382|NCT01327482|271603|P1|STARTED|Overall Study||10
112383|NCT01327339|271608|P1|NOT COMPLETED|Overall Study||8
112384|NCT01327339|271608|P1|COMPLETED|Overall Study||747
112385|NCT01327339|271608|P1|STARTED|Overall Study||755
112386|NCT01327313|271618|P4|NOT COMPLETED|Overall Study||0
112387|NCT01327313|271619|P3|NOT COMPLETED|Overall Study||0
112388|NCT01327313|271620|P2|NOT COMPLETED|Overall Study||0
112389|NCT01327313|271621|P1|NOT COMPLETED|Overall Study||0
112390|NCT01327313|271618|P4|COMPLETED|Overall Study||7
112391|NCT01327313|271619|P3|COMPLETED|Overall Study||6
112392|NCT01327313|271620|P2|COMPLETED|Overall Study||6
112393|NCT01327313|271621|P1|COMPLETED|Overall Study||8
112394|NCT01327313|271618|P4|STARTED|Overall Study||7
112395|NCT01327313|271619|P3|STARTED|Overall Study||6
112396|NCT01327313|271620|P2|STARTED|Overall Study||6
112397|NCT01327313|271621|P1|STARTED|Overall Study||8
112398|NCT01327300|271743|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
112399|NCT01327300|271744|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
112400|NCT01327300|271743|P2|COMPLETED|Second Intervention (12 Weeks)||2
112401|NCT01327300|271744|P1|COMPLETED|Second Intervention (12 Weeks)||4
112402|NCT01327300|271743|P2|STARTED|Second Intervention (12 Weeks)||2
112403|NCT01327300|271744|P1|STARTED|Second Intervention (12 Weeks)||4
112404|NCT01327300|271743|P2|NOT COMPLETED|Washout (3 Weeks)||0
112405|NCT01327300|271744|P1|NOT COMPLETED|Washout (3 Weeks)||1
112406|NCT01327300|271743|P2|COMPLETED|Washout (3 Weeks)||2
112407|NCT01327300|271744|P1|COMPLETED|Washout (3 Weeks)||4
112408|NCT01327300|271743|P2|STARTED|Washout (3 Weeks)||2
112409|NCT01327300|271744|P1|STARTED|Washout (3 Weeks)||5
112410|NCT01327300|271743|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
112411|NCT01327300|271744|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
112412|NCT01327300|271743|P2|COMPLETED|First Intervention (12 Weeks)||2
112413|NCT01327300|271744|P1|COMPLETED|First Intervention (12 Weeks)||5
112414|NCT01327300|271743|P2|STARTED|First Intervention (12 Weeks)||2
112415|NCT01327300|271744|P1|STARTED|First Intervention (12 Weeks)||5
112416|NCT01327274|271760|P1|NOT COMPLETED|Overall Study||0
112417|NCT01327274|271760|P1|COMPLETED|Overall Study||15
112418|NCT01327274|271760|P1|STARTED|Overall Study||15
112419|NCT01327053|271769|P2|NOT COMPLETED|Overall Study||105
112420|NCT01327053|271770|P1|NOT COMPLETED|Overall Study||40
112421|NCT01327053|271769|P2|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|46
112422|NCT01327053|271770|P1|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|39
112423|NCT01327053|271769|P2|STARTED|Overall Study||151
112424|NCT01327053|271770|P1|STARTED|Overall Study||79
112425|NCT01326962|271798|P1|NOT COMPLETED|Overall Study||7
112426|NCT01326962|271798|P1|COMPLETED|Overall Study||21
112427|NCT01326962|271798|P1|STARTED|Overall Study||28
112428|NCT01326910|271816|P2|NOT COMPLETED|Overall Study||3
112429|NCT01326910|271817|P1|NOT COMPLETED|Overall Study||4
112430|NCT01326910|271816|P2|COMPLETED|Overall Study||42
112431|NCT01326910|271817|P1|COMPLETED|Overall Study||41
112432|NCT01326910|271816|P2|STARTED|Overall Study||45
112433|NCT01326910|271817|P1|STARTED|Overall Study||45
112434|NCT01326845|271831|P2|NOT COMPLETED|Overall Study||5
112435|NCT01326845|271832|P1|NOT COMPLETED|Overall Study||7
112436|NCT01326845|271831|P2|COMPLETED|Overall Study|Study terminated early|0
112437|NCT01326845|271832|P1|COMPLETED|Overall Study|Study terminated early|0
112438|NCT01326845|271831|P2|STARTED|Overall Study||5
112439|NCT01326845|271832|P1|STARTED|Overall Study||7
112440|NCT01326533|271856|P2|NOT COMPLETED|Overall Study||0
112441|NCT01326533|271857|P1|NOT COMPLETED|Overall Study||4
112442|NCT01326533|271856|P2|COMPLETED|Overall Study||15
112443|NCT01326533|271857|P1|COMPLETED|Overall Study||13
112444|NCT01326533|271856|P2|STARTED|Overall Study||15
112445|NCT01326533|271857|P1|STARTED|Overall Study||17
112446|NCT01326026|271867|P2|NOT COMPLETED|Overall Study||13
112447|NCT01326026|271868|P1|NOT COMPLETED|Overall Study||12
112448|NCT01326026|271867|P2|COMPLETED|Overall Study||98
112449|NCT01326026|271868|P1|COMPLETED|Overall Study||99
112450|NCT01326026|271867|P2|Exposed|Overall Study||111
112451|NCT01326026|271868|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
112452|NCT01326026|271867|P2|STARTED|Overall Study||111
112453|NCT01326026|271868|P1|STARTED|Overall Study||111
112454|NCT01325870|271885|P3|NOT COMPLETED|Overall Study||8
112455|NCT01325870|271886|P2|NOT COMPLETED|Overall Study||13
112456|NCT01325870|271887|P1|NOT COMPLETED|Overall Study||11
112457|NCT01325870|271885|P3|COMPLETED|Overall Study||6
112458|NCT01325870|271886|P2|COMPLETED|Overall Study||3
112459|NCT01325870|271887|P1|COMPLETED|Overall Study||7
112460|NCT01325870|271885|P3|STARTED|Overall Study||14
112461|NCT01325870|271886|P2|STARTED|Overall Study||16
112462|NCT01325870|271887|P1|STARTED|Overall Study||18
112463|NCT01325792|271901|P1|NOT COMPLETED|Overall Study||17
112464|NCT01325792|271901|P1|COMPLETED|Overall Study||87
112465|NCT01325792|271901|P1|STARTED|Overall Study||104
112466|NCT01325714|271908|P2|NOT COMPLETED|Overall Study||31
112467|NCT01325714|271909|P1|NOT COMPLETED|Overall Study||34
112468|NCT01325714|271908|P2|COMPLETED|Overall Study||71
112469|NCT01325714|271909|P1|COMPLETED|Overall Study||67
112470|NCT01325714|271908|P2|12 Month Assessment|Overall Study||71
112471|NCT01325714|271909|P1|12 Month Assessment|Overall Study||67
112472|NCT01325714|271908|P2|6 Month Asessment|Overall Study||82
112473|NCT01325714|271909|P1|6 Month Asessment|Overall Study||75
112474|NCT01325714|271908|P2|3 Month Assessment|Overall Study||86
112475|NCT01325714|271909|P1|3 Month Assessment|Overall Study||82
112476|NCT01325714|271908|P2|STARTED|Overall Study||102
112477|NCT01325714|271909|P1|STARTED|Overall Study||101
112478|NCT01325701|271933|P2|NOT COMPLETED|Overall Study||3
112479|NCT01325701|271934|P1|NOT COMPLETED|Overall Study||21
112480|NCT01325701|271933|P2|COMPLETED|Overall Study||5
112481|NCT01325701|271934|P1|COMPLETED|Overall Study||49
112482|NCT01325701|271933|P2|STARTED|Overall Study||8
112483|NCT01325701|271934|P1|STARTED|Overall Study||70
112484|NCT01325623|271944|P1|NOT COMPLETED|Overall Study||3
112485|NCT01325623|271944|P1|COMPLETED|Overall Study||28
112486|NCT01325623|271944|P1|STARTED|Overall Study||31
112487|NCT01325532|271988|P2|NOT COMPLETED|Overall Study||0
112488|NCT01325532|271989|P1|NOT COMPLETED|Overall Study||2
112489|NCT01325532|271988|P2|COMPLETED|Overall Study||13
112490|NCT01325532|271989|P1|COMPLETED|Overall Study||15
112491|NCT01325532|271988|P2|STARTED|Overall Study||13
112492|NCT01325532|271989|P1|STARTED|Overall Study||17
112493|NCT01325493|272001|P2|NOT COMPLETED|Overall Study||3
112494|NCT01325493|272002|P1|NOT COMPLETED|Overall Study||1
112495|NCT01325493|272001|P2|COMPLETED|Overall Study||21
112496|NCT01325493|272002|P1|COMPLETED|Overall Study||29
112497|NCT01325493|272001|P2|STARTED|Overall Study||24
112498|NCT01325493|272002|P1|STARTED|Overall Study||30
112499|NCT01325428|272014|P1|NOT COMPLETED|Part B||3
112500|NCT01325428|272014|P1|COMPLETED|Part B||7
112501|NCT01325428|272014|P1|STARTED|Part B||10
112502|NCT01325428|272014|P1|NOT COMPLETED|Part A||16
112503|NCT01325428|272014|P1|COMPLETED|Part A||10
112504|NCT01325428|272014|P1|STARTED|Part A||26
112505|NCT01325350|272034|P5|NOT COMPLETED|Overall Study||12
112506|NCT01325350|272035|P4|NOT COMPLETED|Overall Study||9
112507|NCT01325350|272036|P3|NOT COMPLETED|Overall Study||17
112508|NCT01325350|272037|P2|NOT COMPLETED|Overall Study||5
112509|NCT01325350|272038|P1|NOT COMPLETED|Overall Study||6
112510|NCT01325350|272034|P5|COMPLETED|Overall Study||50
112511|NCT01325350|272035|P4|COMPLETED|Overall Study||52
112512|NCT01325350|272036|P3|COMPLETED|Overall Study||44
112513|NCT01325350|272037|P2|COMPLETED|Overall Study||56
112514|NCT01325350|272038|P1|COMPLETED|Overall Study||55
112515|NCT01325350|272034|P5|STARTED|Overall Study||62
112516|NCT01325350|272035|P4|STARTED|Overall Study||61
112517|NCT01325350|272036|P3|STARTED|Overall Study||61
112518|NCT01325350|272037|P2|STARTED|Overall Study||61
112519|NCT01325350|272038|P1|STARTED|Overall Study||61
112520|NCT01325337|272080|P5|NOT COMPLETED|Overall Study||8
112521|NCT01325337|272081|P4|NOT COMPLETED|Overall Study||10
112522|NCT01325337|272082|P3|NOT COMPLETED|Overall Study||9
112523|NCT01325337|272083|P2|NOT COMPLETED|Overall Study||9
112524|NCT01325337|272084|P1|NOT COMPLETED|Overall Study||5
112525|NCT01325337|272080|P5|COMPLETED|Overall Study||53
112526|NCT01325337|272081|P4|COMPLETED|Overall Study||52
112527|NCT01325337|272082|P3|COMPLETED|Overall Study||53
112528|NCT01325337|272083|P2|COMPLETED|Overall Study||52
112529|NCT01325337|272084|P1|COMPLETED|Overall Study||56
112530|NCT01325337|272080|P5|STARTED|Overall Study||61
112531|NCT01325337|272081|P4|STARTED|Overall Study||62
112532|NCT01325337|272082|P3|STARTED|Overall Study||62
112533|NCT01325337|272083|P2|STARTED|Overall Study||61
112534|NCT01325337|272084|P1|STARTED|Overall Study||61
112535|NCT01325311|272123|P2|NOT COMPLETED|Overall Study||0
112536|NCT01325311|272124|P1|NOT COMPLETED|Overall Study||0
112537|NCT01325311|272123|P2|COMPLETED|Overall Study||7
112538|NCT01325311|272124|P1|COMPLETED|Overall Study||8
112539|NCT01325311|272123|P2|STARTED|Overall Study||7
112540|NCT01325311|272124|P1|STARTED|Overall Study||8
112541|NCT01325181|272160|P2|NOT COMPLETED|Overall Study||2
112542|NCT01325181|272161|P1|NOT COMPLETED|Overall Study||0
112543|NCT01325181|272160|P2|COMPLETED|Overall Study||14
112544|NCT01325181|272161|P1|COMPLETED|Overall Study||18
112545|NCT01325181|272160|P2|STARTED|Overall Study||16
112546|NCT01325181|272161|P1|STARTED|Overall Study||18
112547|NCT01324999|272167|P1|NOT COMPLETED|Overall Study||5
112548|NCT01324999|272167|P1|COMPLETED|Overall Study||7
112549|NCT01324999|272167|P1|STARTED|Overall Study||12
112550|NCT01324947|272178|P1|NOT COMPLETED|Overall Study||74
112551|NCT01324947|272178|P1|COMPLETED|Overall Study||0
112552|NCT01324947|272178|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
112553|NCT01324947|272178|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
112554|NCT01324947|272178|P1|STARTED|Overall Study||74
112555|NCT01324882|272191|P2|NOT COMPLETED|Overall Study||0
112556|NCT01324882|272192|P1|NOT COMPLETED|Overall Study||0
112557|NCT01324882|272191|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
112558|NCT01324882|272192|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
112559|NCT01324882|272191|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
112560|NCT01324882|272192|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
112561|NCT01324700|272204|P4|NOT COMPLETED|Overall Study||11
112562|NCT01324700|272205|P3|NOT COMPLETED|Overall Study||16
112563|NCT01324700|272206|P2|NOT COMPLETED|Overall Study||4
112564|NCT01324700|272207|P1|NOT COMPLETED|Overall Study||9
112565|NCT01324700|272204|P4|COMPLETED|Overall Study||37
112566|NCT01324700|272205|P3|COMPLETED|Overall Study||33
112567|NCT01324700|272206|P2|COMPLETED|Overall Study||16
112568|NCT01324700|272207|P1|COMPLETED|Overall Study||13
112569|NCT01324700|272204|P4|STARTED|Overall Study||48
112570|NCT01324700|272205|P3|STARTED|Overall Study||49
112571|NCT01324700|272206|P2|STARTED|Overall Study||20
112572|NCT01324700|272207|P1|STARTED|Overall Study||22
112573|NCT01324687|272223|P2|NOT COMPLETED|Overall Study||15
112574|NCT01324687|272224|P1|NOT COMPLETED|Overall Study||0
112575|NCT01324687|272223|P2|COMPLETED|Overall Study||479
112576|NCT01324687|272224|P1|COMPLETED|Overall Study||1058
112577|NCT01324687|272223|P2|STARTED|Overall Study||494
112578|NCT01324687|272224|P1|STARTED|Overall Study||1058
112579|NCT01324622|272234|P2|NOT COMPLETED|Overall Study||7
112580|NCT01324622|272235|P1|NOT COMPLETED|Overall Study||9
112581|NCT01324622|272234|P2|COMPLETED|Overall Study||4
112582|NCT01324622|272235|P1|COMPLETED|Overall Study||4
112583|NCT01324622|272234|P2|STARTED|Overall Study||11
112584|NCT01324622|272235|P1|STARTED|Overall Study||13
112585|NCT01324570|272265|P2|NOT COMPLETED|Overall Study||14
112586|NCT01324570|272266|P1|NOT COMPLETED|Overall Study||4
112587|NCT01324570|272265|P2|COMPLETED|Overall Study||21
112588|NCT01324570|272266|P1|COMPLETED|Overall Study||2
112589|NCT01324570|272265|P2|STARTED|Overall Study||35
112590|NCT01324570|272266|P1|STARTED|Overall Study||6
112591|NCT01324453|272280|P2|NOT COMPLETED|Overall Study||0
112592|NCT01324453|272281|P1|NOT COMPLETED|Overall Study||0
112593|NCT01324453|272280|P2|COMPLETED|Overall Study||49
112594|NCT01324453|272281|P1|COMPLETED|Overall Study||54
112595|NCT01324453|272280|P2|STARTED|Overall Study||49
112596|NCT01324453|272281|P1|STARTED|Overall Study||54
112597|NCT01324440|272303|P2|NOT COMPLETED|Overall Study||1
112598|NCT01324440|272304|P1|NOT COMPLETED|Overall Study||0
112599|NCT01324440|272303|P2|COMPLETED|Overall Study||31
112600|NCT01324440|272304|P1|COMPLETED|Overall Study||32
112601|NCT01324440|272303|P2|STARTED|Overall Study||32
112602|NCT01324440|272304|P1|STARTED|Overall Study||32
112603|NCT01324401|272318|P2|NOT COMPLETED|Overall Study||6
112604|NCT01324401|272319|P1|NOT COMPLETED|Overall Study||1
112605|NCT01324401|272318|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
112606|NCT01324401|272319|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
112607|NCT01324401|272318|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
112608|NCT01324401|272319|P1|STARTED|Overall Study||4
112609|NCT01324388|272330|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
112610|NCT01324388|272331|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
112611|NCT01324388|272332|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
112612|NCT01324388|272333|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
112613|NCT01324388|272330|P4|COMPLETED|Part 2 of Study: Second Intervention||9
112614|NCT01324388|272331|P3|COMPLETED|Part 2 of Study: Second Intervention||9
112615|NCT01324388|272332|P2|COMPLETED|Part 2 of Study: Second Intervention||0
112616|NCT01324388|272333|P1|COMPLETED|Part 2 of Study: Second Intervention||0
112617|NCT01324388|272330|P4|STARTED|Part 2 of Study: Second Intervention||9
112618|NCT01324388|272331|P3|STARTED|Part 2 of Study: Second Intervention||10
112619|NCT01324388|272332|P2|STARTED|Part 2 of Study: Second Intervention||0
112620|NCT01324388|272333|P1|STARTED|Part 2 of Study: Second Intervention||0
112621|NCT01324388|272330|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
112622|NCT01324388|272331|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
112623|NCT01324388|272332|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
112624|NCT01324388|272333|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
112625|NCT01324388|272330|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
112626|NCT01324388|272331|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
112627|NCT01324388|272332|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
112628|NCT01324388|272333|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
112629|NCT01324388|272330|P4|STARTED|Part 2: Washout of at Least 21 Days||9
112630|NCT01324388|272331|P3|STARTED|Part 2: Washout of at Least 21 Days||10
112631|NCT01324388|272332|P2|STARTED|Part 2: Washout of at Least 21 Days||0
112632|NCT01324388|272333|P1|STARTED|Part 2: Washout of at Least 21 Days||0
112633|NCT01324388|272330|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
112634|NCT01324388|272331|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
112635|NCT01324388|272332|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
112636|NCT01324388|272333|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
112637|NCT01324388|272330|P4|COMPLETED|Part 2 of Study: First Intervention||9
112638|NCT01324388|272331|P3|COMPLETED|Part 2 of Study: First Intervention||10
112639|NCT01324388|272332|P2|COMPLETED|Part 2 of Study: First Intervention||0
112640|NCT01324388|272333|P1|COMPLETED|Part 2 of Study: First Intervention||0
112641|NCT01324388|272330|P4|STARTED|Part 2 of Study: First Intervention||10
112642|NCT01324388|272331|P3|STARTED|Part 2 of Study: First Intervention||10
112643|NCT01324388|272332|P2|STARTED|Part 2 of Study: First Intervention||0
112644|NCT01324388|272333|P1|STARTED|Part 2 of Study: First Intervention||0
112645|NCT01324388|272330|P4|NOT COMPLETED|Part 1 of Study||0
112646|NCT01324388|272331|P3|NOT COMPLETED|Part 1 of Study||0
112647|NCT01324388|272332|P2|NOT COMPLETED|Part 1 of Study||2
112648|NCT01324388|272333|P1|NOT COMPLETED|Part 1 of Study||4
112649|NCT01324388|272330|P4|COMPLETED|Part 1 of Study||0
112650|NCT01324388|272331|P3|COMPLETED|Part 1 of Study||0
112651|NCT01324388|272332|P2|COMPLETED|Part 1 of Study||6
112652|NCT01324388|272333|P1|COMPLETED|Part 1 of Study||19
112653|NCT01324388|272330|P4|Received at Least 1 Dose|Part 1 of Study||0
112654|NCT01324388|272331|P3|Received at Least 1 Dose|Part 1 of Study||0
112655|NCT01324388|272332|P2|Received at Least 1 Dose|Part 1 of Study||8
112656|NCT01324388|272333|P1|Received at Least 1 Dose|Part 1 of Study||23
112657|NCT01324388|272330|P4|STARTED|Part 1 of Study||0
112658|NCT01324388|272331|P3|STARTED|Part 1 of Study||0
112659|NCT01324388|272332|P2|STARTED|Part 1 of Study||8
112660|NCT01324388|272333|P1|STARTED|Part 1 of Study||23
112661|NCT01324349|272354|P2|NOT COMPLETED|Overall Study||2
112662|NCT01324349|272355|P1|NOT COMPLETED|Overall Study||1
112663|NCT01324349|272354|P2|COMPLETED|Overall Study||16
112664|NCT01324349|272355|P1|COMPLETED|Overall Study||31
112665|NCT01324349|272354|P2|STARTED|Overall Study||18
112666|NCT01324349|272355|P1|STARTED|Overall Study||32
112667|NCT01324323|272365|P1|NOT COMPLETED|Overall Study||1
112668|NCT01324323|272365|P1|COMPLETED|Overall Study||13
112669|NCT01324323|272365|P1|STARTED|Overall Study||14
112670|NCT01324310|272385|P1|NOT COMPLETED|Overall Study||2
112671|NCT01324310|272385|P1|COMPLETED|Overall Study||13
112672|NCT01324310|272385|P1|STARTED|Overall Study||15
112673|NCT01324271|272405|P2|NOT COMPLETED|Overall Study||0
112674|NCT01324271|272406|P1|NOT COMPLETED|Overall Study||4
112675|NCT01324271|272405|P2|COMPLETED|Overall Study||28
112676|NCT01324271|272406|P1|COMPLETED|Overall Study||53
112677|NCT01324271|272405|P2|STARTED|Overall Study||28
112678|NCT01324271|272406|P1|STARTED|Overall Study||57
112679|NCT01324128|272414|P4|NOT COMPLETED|Stage 2||3
112680|NCT01324128|272415|P3|NOT COMPLETED|Stage 2||8
112681|NCT01324128|272416|P2|NOT COMPLETED|Stage 2||0
112682|NCT01324128|272417|P1|NOT COMPLETED|Stage 2||0
112683|NCT01324128|272414|P4|COMPLETED|Stage 2||46
112684|NCT01324128|272415|P3|COMPLETED|Stage 2||42
112685|NCT01324128|272416|P2|COMPLETED|Stage 2||0
112686|NCT01324128|272417|P1|COMPLETED|Stage 2||0
112687|NCT01324128|272414|P4|STARTED|Stage 2||49
112688|NCT01324128|272415|P3|STARTED|Stage 2||50
112689|NCT01324128|272416|P2|STARTED|Stage 2||0
112690|NCT01324128|272417|P1|STARTED|Stage 2||0
112691|NCT01324128|272414|P4|NOT COMPLETED|Stage 1||0
112692|NCT01324128|272415|P3|NOT COMPLETED|Stage 1||0
112693|NCT01324128|272416|P2|NOT COMPLETED|Stage 1||56
112694|NCT01324128|272417|P1|NOT COMPLETED|Stage 1||195
112695|NCT01324128|272414|P4|COMPLETED|Stage 1||0
112696|NCT01324128|272415|P3|COMPLETED|Stage 1||0
112697|NCT01324128|272416|P2|COMPLETED|Stage 1||293
112698|NCT01324128|272417|P1|COMPLETED|Stage 1||515
112699|NCT01324128|272414|P4|STARTED|Stage 1||0
112700|NCT01324128|272415|P3|STARTED|Stage 1||0
112701|NCT01324128|272416|P2|STARTED|Stage 1||349
112702|NCT01324128|272417|P1|STARTED|Stage 1||710
112703|NCT01324102|272429|P2|NOT COMPLETED|Overall Study||6
112704|NCT01324102|272430|P1|NOT COMPLETED|Overall Study||1
112705|NCT01324102|272429|P2|COMPLETED|Overall Study||6
112706|NCT01324102|272430|P1|COMPLETED|Overall Study||10
112707|NCT01324102|272429|P2|STARTED|Overall Study|Yoga group 4 and 6|12
112708|NCT01324102|272430|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
112709|NCT01324024|272437|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
112710|NCT01324024|272438|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
112711|NCT01324024|272437|P2|COMPLETED|Second Intervention (4 Weeks)||16
112712|NCT01324024|272438|P1|COMPLETED|Second Intervention (4 Weeks)||16
112713|NCT01324024|272437|P2|STARTED|Second Intervention (4 Weeks)||17
112714|NCT01324024|272438|P1|STARTED|Second Intervention (4 Weeks)||18
112715|NCT01324024|272437|P2|NOT COMPLETED|Washout (2 Weeks)||0
112716|NCT01324024|272438|P1|NOT COMPLETED|Washout (2 Weeks)||0
112717|NCT01324024|272437|P2|COMPLETED|Washout (2 Weeks)||17
112718|NCT01324024|272438|P1|COMPLETED|Washout (2 Weeks)||18
112719|NCT01324024|272437|P2|STARTED|Washout (2 Weeks)||17
112720|NCT01324024|272438|P1|STARTED|Washout (2 Weeks)||18
112721|NCT01324024|272437|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
112722|NCT01324024|272438|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
112723|NCT01324024|272437|P2|COMPLETED|First Intervention (4 Weeks)||17
112724|NCT01324024|272438|P1|COMPLETED|First Intervention (4 Weeks)||18
112725|NCT01324024|272437|P2|STARTED|First Intervention (4 Weeks)||17
112726|NCT01324024|272438|P1|STARTED|First Intervention (4 Weeks)||18
112727|NCT01323998|272456|P5|NOT COMPLETED|Overall Study||0
112728|NCT01323998|272457|P4|NOT COMPLETED|Overall Study||0
112729|NCT01323998|272458|P3|NOT COMPLETED|Overall Study||0
112730|NCT01323998|272459|P2|NOT COMPLETED|Overall Study||0
112731|NCT01323998|272460|P1|NOT COMPLETED|Overall Study||0
112732|NCT01323998|272456|P5|COMPLETED|Overall Study||6735
112733|NCT01323998|272457|P4|COMPLETED|Overall Study||12052
112734|NCT01323998|272458|P3|COMPLETED|Overall Study||10294
112735|NCT01323998|272459|P2|COMPLETED|Overall Study||18681
112736|NCT01323998|272460|P1|COMPLETED|Overall Study||200631
112737|NCT01323998|272456|P5|STARTED|Overall Study||6735
112738|NCT01323998|272457|P4|STARTED|Overall Study||12052
112739|NCT01323998|272458|P3|STARTED|Overall Study||10294
112740|NCT01323998|272459|P2|STARTED|Overall Study||18681
112741|NCT01323998|272460|P1|STARTED|Overall Study||200631
112742|NCT01323972|272476|P4|NOT COMPLETED|Overall Study||1
112743|NCT01323972|272477|P3|NOT COMPLETED|Overall Study||2
112744|NCT01323972|272478|P2|NOT COMPLETED|Overall Study||3
112745|NCT01323972|272479|P1|NOT COMPLETED|Overall Study||2
112746|NCT01323972|272476|P4|COMPLETED|Overall Study||79
112747|NCT01323972|272477|P3|COMPLETED|Overall Study||78
112748|NCT01323972|272478|P2|COMPLETED|Overall Study||76
112749|NCT01323972|272479|P1|COMPLETED|Overall Study||79
112750|NCT01323972|272476|P4|STARTED|Overall Study||80
112751|NCT01323972|272477|P3|STARTED|Overall Study||80
112752|NCT01323972|272478|P2|STARTED|Overall Study||79
112753|NCT01323972|272479|P1|STARTED|Overall Study||81
112754|NCT01323959|272514|P3|NOT COMPLETED|Overall Study||0
112755|NCT01323959|272515|P2|NOT COMPLETED|Overall Study||0
112756|NCT01323959|272516|P1|NOT COMPLETED|Overall Study||0
112757|NCT01323959|272514|P3|COMPLETED|Overall Study||72
112758|NCT01323959|272515|P2|COMPLETED|Overall Study||72
112759|NCT01323959|272516|P1|COMPLETED|Overall Study||67
112760|NCT01323959|272514|P3|STARTED|Overall Study||72
112761|NCT01323959|272515|P2|STARTED|Overall Study||72
112762|NCT01323959|272516|P1|STARTED|Overall Study||67
112763|NCT01323920|272572|P1|NOT COMPLETED|Overall Study||6
112764|NCT01323920|272572|P1|COMPLETED|Overall Study||29
112765|NCT01323920|272572|P1|STARTED|Overall Study||35
112766|NCT01323855|272584|P5|NOT COMPLETED|Overall Study||0
112767|NCT01323855|272585|P4|NOT COMPLETED|Overall Study||0
112768|NCT01323855|272586|P3|NOT COMPLETED|Overall Study||0
112769|NCT01323855|272587|P2|NOT COMPLETED|Overall Study||0
112770|NCT01323855|272588|P1|NOT COMPLETED|Overall Study||0
112771|NCT01323855|272584|P5|COMPLETED|Overall Study||11
112772|NCT01323855|272585|P4|COMPLETED|Overall Study||9
112773|NCT01323855|272586|P3|COMPLETED|Overall Study||8
112774|NCT01323855|272587|P2|COMPLETED|Overall Study||9
112775|NCT01323855|272588|P1|COMPLETED|Overall Study||9
112776|NCT01323855|272584|P5|STARTED|Overall Study||11
112777|NCT01323855|272585|P4|STARTED|Overall Study||9
112778|NCT01323855|272586|P3|STARTED|Overall Study||8
112779|NCT01323855|272587|P2|STARTED|Overall Study||9
112780|NCT01323855|272588|P1|STARTED|Overall Study||9
112781|NCT01323790|272613|P3|NOT COMPLETED|Overall Study||45
112782|NCT01323790|272614|P2|NOT COMPLETED|Overall Study||60
112783|NCT01323790|272615|P1|NOT COMPLETED|Overall Study||55
112784|NCT01323790|272613|P3|COMPLETED|Overall Study||188
112785|NCT01323790|272614|P2|COMPLETED|Overall Study||174
112786|NCT01323790|272615|P1|COMPLETED|Overall Study||178
112787|NCT01323790|272613|P3|STARTED|Overall Study||233
112788|NCT01323790|272614|P2|STARTED|Overall Study||234
112789|NCT01323790|272615|P1|STARTED|Overall Study||233
112790|NCT01323777|272653|P1|NOT COMPLETED|Overall Study||0
112791|NCT01323777|272653|P1|COMPLETED|Overall Study||65
112792|NCT01323777|272653|P1|STARTED|Overall Study||65
112793|NCT01323673|272666|P2|NOT COMPLETED|Overall Study||5
112794|NCT01323673|272667|P1|NOT COMPLETED|Overall Study||3
112795|NCT01323673|272666|P2|COMPLETED|Overall Study||58
112796|NCT01323673|272667|P1|COMPLETED|Overall Study||59
112797|NCT01323673|272666|P2|STARTED|Overall Study||63
112798|NCT01323673|272667|P1|STARTED|Overall Study||62
112799|NCT01323660|272687|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
112800|NCT01323660|272688|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
112801|NCT01323660|272689|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
112802|NCT01323660|272690|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
112803|NCT01323660|272691|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
112804|NCT01323660|272692|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
112805|NCT01323660|272687|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
112806|NCT01323660|272688|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
112807|NCT01323660|272689|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
112808|NCT01323660|272690|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
112809|NCT01323660|272691|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
112810|NCT01323660|272692|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
112811|NCT01323660|272687|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
112812|NCT01323660|272688|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
112813|NCT01323660|272689|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
112814|NCT01323660|272690|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
112815|NCT01323660|272691|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
112816|NCT01323660|272692|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
112817|NCT01323660|272687|P6|NOT COMPLETED|Washout Period (14 Days)||2
112818|NCT01323660|272688|P5|NOT COMPLETED|Washout Period (14 Days)||3
112819|NCT01323660|272689|P4|NOT COMPLETED|Washout Period (14 Days)||3
112820|NCT01323660|272690|P3|NOT COMPLETED|Washout Period (14 Days)||1
112821|NCT01323660|272691|P2|NOT COMPLETED|Washout Period (14 Days)||0
112822|NCT01323660|272692|P1|NOT COMPLETED|Washout Period (14 Days)||0
112823|NCT01323660|272687|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
112824|NCT01323660|272688|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
112825|NCT01323660|272689|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
112826|NCT01323660|272690|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
112827|NCT01323660|272691|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
112828|NCT01323660|272692|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
112829|NCT01323660|272687|P6|STARTED|Washout Period (14 Days)||61
112830|NCT01323660|272688|P5|STARTED|Washout Period (14 Days)||61
112831|NCT01323660|272689|P4|STARTED|Washout Period (14 Days)||31
112832|NCT01323660|272690|P3|STARTED|Washout Period (14 Days)||19
112833|NCT01323660|272691|P2|STARTED|Washout Period (14 Days)||21
112834|NCT01323660|272692|P1|STARTED|Washout Period (14 Days)||65
112835|NCT01323660|272687|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
112836|NCT01323660|272688|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
112837|NCT01323660|272689|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
112838|NCT01323660|272690|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
112839|NCT01323660|272691|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
112840|NCT01323660|272692|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
112841|NCT01323660|272687|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
112842|NCT01323660|272688|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
112843|NCT01323660|272689|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
112844|NCT01323660|272690|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
112845|NCT01323660|272691|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
112846|NCT01323660|272692|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
112847|NCT01323660|272687|P6|STARTED|Treatment Period 1 (12 Weeks)||70
112848|NCT01323660|272688|P5|STARTED|Treatment Period 1 (12 Weeks)||71
112849|NCT01323660|272689|P4|STARTED|Treatment Period 1 (12 Weeks)||36
112850|NCT01323660|272690|P3|STARTED|Treatment Period 1 (12 Weeks)||24
112851|NCT01323660|272691|P2|STARTED|Treatment Period 1 (12 Weeks)||22
112852|NCT01323660|272692|P1|STARTED|Treatment Period 1 (12 Weeks)||84
112853|NCT01323647|272738|P2|NOT COMPLETED|Overall Study||0
112854|NCT01323647|272739|P1|NOT COMPLETED|Overall Study||9
112855|NCT01323647|272738|P2|COMPLETED|Overall Study||487
112856|NCT01323647|272739|P1|COMPLETED|Overall Study||461
112857|NCT01323647|272738|P2|STARTED|Overall Study||487
112858|NCT01323647|272739|P1|STARTED|Overall Study||470
112859|NCT01323634|272756|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
112860|NCT01323634|272757|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
112861|NCT01323634|272758|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
112862|NCT01323634|272756|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
112863|NCT01323634|272757|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
112864|NCT01323634|272758|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
112865|NCT01323634|272756|P3|STARTED|Double-Blind (DB) Treatment Period||261
112866|NCT01323634|272757|P2|STARTED|Double-Blind (DB) Treatment Period||260
112867|NCT01323634|272758|P1|STARTED|Double-Blind (DB) Treatment Period||0
112868|NCT01323634|272756|P3|NOT COMPLETED|2-week Run-in Period||0
112869|NCT01323634|272757|P2|NOT COMPLETED|2-week Run-in Period||0
112870|NCT01323634|272758|P1|NOT COMPLETED|2-week Run-in Period||212
112871|NCT01323634|272756|P3|COMPLETED|2-week Run-in Period||0
112872|NCT01323634|272757|P2|COMPLETED|2-week Run-in Period||0
112873|NCT01323634|272758|P1|COMPLETED|2-week Run-in Period||521
112874|NCT01323634|272756|P3|STARTED|2-week Run-in Period||0
112875|NCT01323634|272757|P2|STARTED|2-week Run-in Period||0
112876|NCT01323634|272758|P1|STARTED|2-week Run-in Period||733
112877|NCT01323621|272768|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
112878|NCT01323621|272769|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
112879|NCT01323621|272770|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
112880|NCT01323621|272768|P3|COMPLETED|12-week, Double-blind Treatment Period||239
112881|NCT01323621|272769|P2|COMPLETED|12-week, Double-blind Treatment Period||237
112882|NCT01323621|272770|P1|COMPLETED|12-week, Double-blind Treatment Period||0
112883|NCT01323621|272768|P3|STARTED|12-week, Double-blind Treatment Period||259
112884|NCT01323621|272769|P2|STARTED|12-week, Double-blind Treatment Period||252
112885|NCT01323621|272770|P1|STARTED|12-week, Double-blind Treatment Period||0
112886|NCT01323621|272768|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
112887|NCT01323621|272769|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
112888|NCT01323621|272770|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
112889|NCT01323621|272768|P3|COMPLETED|2-week, Single-blind Run In Period||0
112890|NCT01323621|272769|P2|COMPLETED|2-week, Single-blind Run In Period||0
112891|NCT01323621|272770|P1|COMPLETED|2-week, Single-blind Run In Period||511
112892|NCT01323621|272768|P3|STARTED|2-week, Single-blind Run In Period||0
112893|NCT01323621|272769|P2|STARTED|2-week, Single-blind Run In Period||0
112894|NCT01323621|272770|P1|STARTED|2-week, Single-blind Run In Period||739
112895|NCT01323595|272780|P2|NOT COMPLETED|Overall Study||21
112896|NCT01323595|272781|P1|NOT COMPLETED|Overall Study||23
112897|NCT01323595|272780|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
112898|NCT01323595|272781|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
112899|NCT01323595|272780|P2|STARTED|Overall Study||39
112900|NCT01323595|272781|P1|STARTED|Overall Study||39
112901|NCT01323582|272789|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
112902|NCT01323582|272790|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
112903|NCT01323582|272789|P2|COMPLETED|Weeks 8-11 (Period 2)||10
112904|NCT01323582|272790|P1|COMPLETED|Weeks 8-11 (Period 2)||10
112905|NCT01323582|272789|P2|STARTED|Weeks 8-11 (Period 2)||11
112906|NCT01323582|272790|P1|STARTED|Weeks 8-11 (Period 2)||10
112907|NCT01323582|272789|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
112908|NCT01323582|272790|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
112909|NCT01323582|272789|P2|COMPLETED|Weeks 5-7 (Washout)||11
112910|NCT01323582|272790|P1|COMPLETED|Weeks 5-7 (Washout)||10
112911|NCT01323582|272789|P2|STARTED|Weeks 5-7 (Washout)||12
112912|NCT01323582|272790|P1|STARTED|Weeks 5-7 (Washout)||10
112913|NCT01323582|272789|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
112914|NCT01323582|272790|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
112915|NCT01323582|272789|P2|COMPLETED|Weeks 1-4 (First Period)||12
112916|NCT01323582|272790|P1|COMPLETED|Weeks 1-4 (First Period)||10
112917|NCT01323582|272789|P2|STARTED|Weeks 1-4 (First Period)||14
112918|NCT01323582|272790|P1|STARTED|Weeks 1-4 (First Period)||12
112919|NCT01323517|272806|P1|NOT COMPLETED|Overall Study||0
112920|NCT01323517|272806|P1|COMPLETED|Overall Study||26
112921|NCT01323517|272806|P1|STARTED|Overall Study||26
112922|NCT01323478|272813|P1|NOT COMPLETED|Overall Study||24
112923|NCT01323478|272813|P1|COMPLETED|Overall Study||47
112924|NCT01323478|272813|P1|STARTED|Overall Study||71
112925|NCT01323387|272826|P1|NOT COMPLETED|Overall Study||84
112926|NCT01323387|272826|P1|COMPLETED|Overall Study||94
112927|NCT01323387|272826|P1|STARTED|Overall Study||178
112928|NCT01323270|272839|P2|NOT COMPLETED|Overall Study||29
112929|NCT01323270|272840|P1|NOT COMPLETED|Overall Study||43
112930|NCT01323270|272839|P2|COMPLETED|Overall Study||347
112931|NCT01323270|272840|P1|COMPLETED|Overall Study||330
112932|NCT01323270|272839|P2|STARTED|Overall Study||376
112933|NCT01323270|272840|P1|STARTED|Overall Study||373
112934|NCT01323192|272862|P2|NOT COMPLETED|Overall Study||6
112935|NCT01323192|272863|P1|NOT COMPLETED|Overall Study||9
112936|NCT01323192|272862|P2|COMPLETED|Overall Study||135
112937|NCT01323192|272863|P1|COMPLETED|Overall Study||134
112938|NCT01323192|272862|P2|STARTED|Overall Study||141
112939|NCT01323192|272863|P1|STARTED|Overall Study||143
112940|NCT01323140|272879|P1|NOT COMPLETED|Overall Study||2
112941|NCT01323140|272879|P1|COMPLETED|Overall Study||38
112942|NCT01323140|272879|P1|STARTED|Overall Study||40
112943|NCT01323010|272885|P2|NOT COMPLETED|Overall Study||0
112944|NCT01323010|272886|P1|NOT COMPLETED|Overall Study||0
112945|NCT01323010|272885|P2|COMPLETED|Overall Study||59
112946|NCT01323010|272886|P1|COMPLETED|Overall Study||60
112947|NCT01323010|272885|P2|STARTED|Overall Study||59
112948|NCT01323010|272886|P1|STARTED|Overall Study||60
112949|NCT01322971|272937|P2|NOT COMPLETED|Overall Study||1
112950|NCT01322971|272938|P1|NOT COMPLETED|Overall Study||1
112951|NCT01322971|272937|P2|COMPLETED|Overall Study||0
112952|NCT01322971|272938|P1|COMPLETED|Overall Study||0
112953|NCT01322971|272937|P2|STARTED|Overall Study||1
112954|NCT01322971|272938|P1|STARTED|Overall Study||1
112955|NCT01322945|272952|P2|NOT COMPLETED|Overall Study||0
112956|NCT01322945|272953|P1|NOT COMPLETED|Overall Study||0
112957|NCT01322945|272952|P2|COMPLETED|Overall Study||42
112958|NCT01322945|272953|P1|COMPLETED|Overall Study||52
112959|NCT01322945|272952|P2|STARTED|Overall Study||42
112960|NCT01322945|272953|P1|STARTED|Overall Study||52
112961|NCT01322841|272963|P2|NOT COMPLETED|Overall Study||0
112962|NCT01322841|272964|P1|NOT COMPLETED|Overall Study||0
112963|NCT01322841|272963|P2|COMPLETED|Overall Study||1123
112964|NCT01322841|272964|P1|COMPLETED|Overall Study||1116
112965|NCT01322841|272963|P2|STARTED|Overall Study||1123
112966|NCT01322841|272964|P1|STARTED|Overall Study||1116
112967|NCT01322815|272974|P2|NOT COMPLETED|Overall Study||0
112968|NCT01322815|272975|P1|NOT COMPLETED|Overall Study||0
112969|NCT01322815|272974|P2|COMPLETED|Overall Study||4
112970|NCT01322815|272975|P1|COMPLETED|Overall Study||7
112971|NCT01322815|272974|P2|STARTED|Overall Study||4
112972|NCT01322815|272975|P1|STARTED|Overall Study||7
112973|NCT01322633|272983|P2|NOT COMPLETED|Overall Study||0
112974|NCT01322633|272984|P1|NOT COMPLETED|Overall Study||0
112975|NCT01322633|272983|P2|COMPLETED|Overall Study||27686
112976|NCT01322633|272984|P1|COMPLETED|Overall Study||34178
112977|NCT01322633|272983|P2|STARTED|Overall Study||27686
112978|NCT01322633|272984|P1|STARTED|Overall Study||34178
112979|NCT01322607|272996|P2|NOT COMPLETED|Overall Study||0
112980|NCT01322607|272997|P1|NOT COMPLETED|Overall Study||1
112981|NCT01322607|272996|P2|COMPLETED|Overall Study||9
112982|NCT01322607|272997|P1|COMPLETED|Overall Study||10
112983|NCT01322607|272996|P2|STARTED|Overall Study||9
112984|NCT01322607|272997|P1|STARTED|Overall Study||11
112985|NCT01322594|273015|P6|NOT COMPLETED|Overall Study||0
112986|NCT01322594|273016|P5|NOT COMPLETED|Overall Study||0
112987|NCT01322594|273017|P4|NOT COMPLETED|Overall Study||0
112988|NCT01322594|273018|P3|NOT COMPLETED|Overall Study||0
112989|NCT01322594|273019|P2|NOT COMPLETED|Overall Study||0
112990|NCT01322594|273020|P1|NOT COMPLETED|Overall Study||0
112991|NCT01322594|273015|P6|COMPLETED|Overall Study||6
112992|NCT01322594|273016|P5|COMPLETED|Overall Study||7
112993|NCT01322594|273017|P4|COMPLETED|Overall Study||6
112994|NCT01322594|273018|P3|COMPLETED|Overall Study||3
112995|NCT01322594|273019|P2|COMPLETED|Overall Study||3
112996|NCT01322594|273020|P1|COMPLETED|Overall Study||6
112997|NCT01322594|273015|P6|STARTED|Overall Study||6
112998|NCT01322594|273016|P5|STARTED|Overall Study||7
112999|NCT01322594|273017|P4|STARTED|Overall Study||6
113000|NCT01322594|273018|P3|STARTED|Overall Study||3
113001|NCT01322594|273019|P2|STARTED|Overall Study||3
113002|NCT01322594|273020|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
113003|NCT01322386|273102|P2|NOT COMPLETED|Overall Study||2
113004|NCT01322386|273103|P1|NOT COMPLETED|Overall Study||0
113005|NCT01322386|273102|P2|COMPLETED|Overall Study||9
113006|NCT01322386|273103|P1|COMPLETED|Overall Study||10
113007|NCT01322386|273102|P2|STARTED|Overall Study||11
113008|NCT01322386|273103|P1|STARTED|Overall Study||10
113009|NCT01322360|273111|P1|NOT COMPLETED|Overall Study||0
113010|NCT01322360|273111|P1|COMPLETED|Overall Study||50
113011|NCT01322360|273111|P1|STARTED|Overall Study||50
113012|NCT01322347|273118|P2|NOT COMPLETED|Overall Study||35
113013|NCT01322347|273119|P1|NOT COMPLETED|Overall Study||51
113014|NCT01322347|273118|P2|COMPLETED|Overall Study||112
113015|NCT01322347|273119|P1|COMPLETED|Overall Study||96
113016|NCT01322347|273118|P2|Completed St 3|Overall Study||86
113017|NCT01322347|273119|P1|Completed St 3|Overall Study||82
113018|NCT01322347|273118|P2|Enrolled in St 3|Overall Study||113
113019|NCT01322347|273119|P1|Enrolled in St 3|Overall Study||101
113020|NCT01322347|273118|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
113021|NCT01322347|273119|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
113022|NCT01322347|273118|P2|Completed 48 Wks in St 2|Overall Study||22
113023|NCT01322347|273119|P1|Completed 48 Wks in St 2|Overall Study||28
113024|NCT01322347|273118|P2|STARTED|Overall Study||147
113025|NCT01322347|273119|P1|STARTED|Overall Study||147
113026|NCT01322048|273156|P2|NOT COMPLETED|Overall Study||0
113027|NCT01322048|273157|P1|NOT COMPLETED|Overall Study||0
113028|NCT01322048|273156|P2|COMPLETED|Overall Study||26
113029|NCT01322048|273157|P1|COMPLETED|Overall Study||21
113030|NCT01322048|273156|P2|STARTED|Overall Study||26
113031|NCT01322048|273157|P1|STARTED|Overall Study||21
113032|NCT01322022|273167|P2|NOT COMPLETED|Overall Study||2
113033|NCT01322022|273168|P1|NOT COMPLETED|Overall Study||5
113034|NCT01322022|273167|P2|COMPLETED|Overall Study||18
113035|NCT01322022|273168|P1|COMPLETED|Overall Study||15
113036|NCT01322022|273167|P2|Week 4|Overall Study||18
113037|NCT01322022|273168|P1|Week 4|Overall Study||15
113038|NCT01322022|273167|P2|STARTED|Overall Study||20
113039|NCT01322022|273168|P1|STARTED|Overall Study||20
113040|NCT01322009|273182|P2|NOT COMPLETED|Overall Study||3
113041|NCT01322009|273183|P1|NOT COMPLETED|Overall Study||0
113042|NCT01322009|273182|P2|COMPLETED|Overall Study||4
113043|NCT01322009|273183|P1|COMPLETED|Overall Study||7
113044|NCT01322009|273182|P2|STARTED|Overall Study||7
113045|NCT01322009|273183|P1|STARTED|Overall Study||7
113046|NCT01321749|273193|P2|NOT COMPLETED|Overall Study||22
113047|NCT01321749|273194|P1|NOT COMPLETED|Overall Study||13
113048|NCT01321749|273193|P2|COMPLETED|Overall Study||30
113049|NCT01321749|273194|P1|COMPLETED|Overall Study||38
113050|NCT01321749|273193|P2|STARTED|Overall Study||52
113051|NCT01321749|273194|P1|STARTED|Overall Study||51
113052|NCT01321723|273203|P3|NOT COMPLETED|Overall Study||4
113053|NCT01321723|273204|P2|NOT COMPLETED|Overall Study||5
113054|NCT01321723|273205|P1|NOT COMPLETED|Overall Study||5
113055|NCT01321723|273203|P3|COMPLETED|Overall Study||28
113056|NCT01321723|273204|P2|COMPLETED|Overall Study||28
113057|NCT01321723|273205|P1|COMPLETED|Overall Study||27
113058|NCT01321723|273203|P3|STARTED|Overall Study||32
113059|NCT01321723|273204|P2|STARTED|Overall Study||33
113060|NCT01321723|273205|P1|STARTED|Overall Study||32
113061|NCT01321710|273227|P3|NOT COMPLETED|Overall Study||0
113062|NCT01321710|273228|P2|NOT COMPLETED|Overall Study||5
113063|NCT01321710|273229|P1|NOT COMPLETED|Overall Study||4
113064|NCT01321710|273227|P3|COMPLETED|Overall Study||44
113065|NCT01321710|273228|P2|COMPLETED|Overall Study||53
113066|NCT01321710|273229|P1|COMPLETED|Overall Study||46
113067|NCT01321710|273227|P3|STARTED|Overall Study||44
113068|NCT01321710|273228|P2|STARTED|Overall Study||58
113069|NCT01321710|273229|P1|STARTED|Overall Study||50
113070|NCT01321697|273244|P1|NOT COMPLETED|Overall Study||7
113071|NCT01321697|273244|P1|COMPLETED|Overall Study||0
113072|NCT01321697|273244|P1|STARTED|Overall Study||7
113073|NCT01321554|273250|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
113074|NCT01321554|273251|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
113075|NCT01321554|273252|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
113076|NCT01321554|273253|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
113077|NCT01321554|273250|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
113078|NCT01321554|273251|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
113079|NCT01321554|273252|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
113080|NCT01321554|273253|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
113081|NCT01321554|273250|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
113082|NCT01321554|273251|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
113083|NCT01321554|273252|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
113084|NCT01321554|273253|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
113085|NCT01321554|273250|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
113086|NCT01321554|273251|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
113087|NCT01321554|273252|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
113088|NCT01321554|273253|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
113089|NCT01321554|273250|P4|STARTED|OOL Lenvatinib Treatment Period||27
113090|NCT01321554|273251|P3|STARTED|OOL Lenvatinib Treatment Period||82
113091|NCT01321554|273252|P2|STARTED|OOL Lenvatinib Treatment Period||0
113092|NCT01321554|273253|P1|STARTED|OOL Lenvatinib Treatment Period||0
113093|NCT01321554|273250|P4|NOT COMPLETED|Randomization Phase||0
113094|NCT01321554|273251|P3|NOT COMPLETED|Randomization Phase||0
113095|NCT01321554|273252|P2|NOT COMPLETED|Randomization Phase||4
113096|NCT01321554|273253|P1|NOT COMPLETED|Randomization Phase||45
113097|NCT01321554|273250|P4|COMPLETED|Randomization Phase||0
113098|NCT01321554|273251|P3|COMPLETED|Randomization Phase||0
113099|NCT01321554|273252|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
113100|NCT01321554|273253|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
113101|NCT01321554|273250|P4|Discontinued Due to Disease Progression|Randomization Phase||0
113102|NCT01321554|273251|P3|Discontinued Due to Disease Progression|Randomization Phase||0
113103|NCT01321554|273252|P2|Discontinued Due to Disease Progression|Randomization Phase||119
113104|NCT01321554|273253|P1|Discontinued Due to Disease Progression|Randomization Phase||94
113105|NCT01321554|273250|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
113106|NCT01321554|273251|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
113107|NCT01321554|273252|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
113108|NCT01321554|273253|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
113109|NCT01321554|273250|P4|STARTED|Randomization Phase||0
113110|NCT01321554|273251|P3|STARTED|Randomization Phase||0
113111|NCT01321554|273252|P2|STARTED|Randomization Phase||131
113112|NCT01321554|273253|P1|STARTED|Randomization Phase||261
113113|NCT01321073|273266|P1|NOT COMPLETED|Overall Study||7
113114|NCT01321073|273266|P1|COMPLETED|Overall Study||57
113115|NCT01321073|273266|P1|STARTED|Overall Study||64
113116|NCT01321008|273270|P1|NOT COMPLETED|Overall Study||1
113117|NCT01321008|273270|P1|COMPLETED|Overall Study||0
113118|NCT01321008|273270|P1|STARTED|Overall Study||1
113119|NCT01320943|273276|P2|NOT COMPLETED|Overall Study||2
113120|NCT01320943|273277|P1|NOT COMPLETED|Overall Study||1
113121|NCT01320943|273276|P2|COMPLETED|Overall Study||20
113122|NCT01320943|273277|P1|COMPLETED|Overall Study||20
113123|NCT01320943|273276|P2|STARTED|Overall Study||22
113124|NCT01320943|273277|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
113125|NCT01320826|273296|P1|NOT COMPLETED|Overall Study||0
113126|NCT01320826|273296|P1|COMPLETED|Overall Study||577
113127|NCT01320826|273296|P1|STARTED|Overall Study||577
113128|NCT01320735|273311|P1|NOT COMPLETED|Overall Study||106
113129|NCT01320735|273311|P1|COMPLETED|Overall Study||194
113130|NCT01320735|273311|P1|STARTED|Overall Study||300
113131|NCT01320722|273333|P5|NOT COMPLETED|Overall Study||8
113132|NCT01320722|273334|P4|NOT COMPLETED|Overall Study||14
113133|NCT01320722|273335|P3|NOT COMPLETED|Overall Study||7
113134|NCT01320722|273336|P2|NOT COMPLETED|Overall Study||6
113135|NCT01320722|273337|P1|NOT COMPLETED|Overall Study||3
113136|NCT01320722|273333|P5|COMPLETED|Overall Study||45
113137|NCT01320722|273334|P4|COMPLETED|Overall Study||35
113138|NCT01320722|273335|P3|COMPLETED|Overall Study||40
113139|NCT01320722|273336|P2|COMPLETED|Overall Study||41
113140|NCT01320722|273337|P1|COMPLETED|Overall Study||43
113141|NCT01320722|273333|P5|Received Intervention|Overall Study||51
113142|NCT01320722|273334|P4|Received Intervention|Overall Study||48
113143|NCT01320722|273335|P3|Received Intervention|Overall Study||46
113144|NCT01320722|273336|P2|Received Intervention|Overall Study||45
113145|NCT01320722|273337|P1|Received Intervention|Overall Study||43
113146|NCT01320722|273333|P5|STARTED|Overall Study||53
113147|NCT01320722|273334|P4|STARTED|Overall Study||49
113148|NCT01320722|273335|P3|STARTED|Overall Study||47
113149|NCT01320722|273336|P2|STARTED|Overall Study||47
113150|NCT01320722|273337|P1|STARTED|Overall Study||46
113151|NCT01320683|273374|P1|NOT COMPLETED|Overall Study||1
113152|NCT01320683|273374|P1|COMPLETED|Overall Study||0
113153|NCT01320683|273374|P1|STARTED|Overall Study||1
113154|NCT01320553|273383|P4|NOT COMPLETED|Overall Study||1
113155|NCT01320553|273384|P3|NOT COMPLETED|Overall Study||2
113156|NCT01320553|273385|P2|NOT COMPLETED|Overall Study||4
113157|NCT01320553|273386|P1|NOT COMPLETED|Overall Study||1
113158|NCT01320553|273383|P4|COMPLETED|Overall Study||29
113159|NCT01320553|273384|P3|COMPLETED|Overall Study||29
113160|NCT01320553|273385|P2|COMPLETED|Overall Study||26
113161|NCT01320553|273386|P1|COMPLETED|Overall Study||30
113162|NCT01320553|273383|P4|STARTED|Overall Study||30
113163|NCT01320553|273384|P3|STARTED|Overall Study||31
113164|NCT01320553|273385|P2|STARTED|Overall Study||30
113165|NCT01320553|273386|P1|STARTED|Overall Study||31
113166|NCT01320293|273400|P1|NOT COMPLETED|Overall Study||2
113167|NCT01320293|273400|P1|COMPLETED|Overall Study||16
113168|NCT01320293|273400|P1|STARTED|Overall Study||18
113169|NCT01320202|273408|P2|NOT COMPLETED|Overall Study||44
113170|NCT01320202|273409|P1|NOT COMPLETED|Overall Study||56
113171|NCT01320202|273408|P2|COMPLETED|Overall Study||109
113172|NCT01320202|273409|P1|COMPLETED|Overall Study||96
113173|NCT01320202|273408|P2|Completed St 3|Overall Study||82
113174|NCT01320202|273409|P1|Completed St 3|Overall Study||79
113175|NCT01320202|273408|P2|Enrolled in St 3|Overall Study||109
113176|NCT01320202|273409|P1|Enrolled in St 3|Overall Study||98
113177|NCT01320202|273408|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
113178|NCT01320202|273409|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
113179|NCT01320202|273408|P2|Comp 48 Wks in St 2|Overall Study||27
113180|NCT01320202|273409|P1|Comp 48 Wks in St 2|Overall Study||27
113181|NCT01320202|273408|P2|STARTED|Overall Study||153
113182|NCT01320202|273409|P1|STARTED|Overall Study||152
113183|NCT01320137|273446|P2|NOT COMPLETED|Overall Study||0
113184|NCT01320137|273447|P1|NOT COMPLETED|Overall Study||0
113185|NCT01320137|273446|P2|COMPLETED|Overall Study||40
113186|NCT01320137|273447|P1|COMPLETED|Overall Study||40
113187|NCT01320137|273446|P2|STARTED|Overall Study||40
113188|NCT01320137|273447|P1|STARTED|Overall Study||40
113189|NCT01320072|273461|P2|NOT COMPLETED|Overall Study||0
113190|NCT01320072|273462|P1|NOT COMPLETED|Overall Study||0
113191|NCT01320072|273461|P2|COMPLETED|Overall Study||13
113192|NCT01320072|273462|P1|COMPLETED|Overall Study||16
113193|NCT01320072|273461|P2|STARTED|Overall Study||13
113194|NCT01320072|273462|P1|STARTED|Overall Study||16
113195|NCT01319877|273473|P2|NOT COMPLETED|Overall Study||45
113196|NCT01319877|273474|P1|NOT COMPLETED|Overall Study||108
113197|NCT01319877|273473|P2|COMPLETED|Overall Study||108
113198|NCT01319877|273474|P1|COMPLETED|Overall Study||345
113199|NCT01319877|273473|P2|STARTED|Overall Study||153
113200|NCT01319877|273474|P1|STARTED|Overall Study||453
113201|NCT01319851|273509|P1|NOT COMPLETED|Overall Study||0
113202|NCT01319851|273509|P1|COMPLETED|Overall Study||3
113203|NCT01319851|273509|P1|STARTED|Overall Study||3
113204|NCT01319812|273521|P2|NOT COMPLETED|Overall Study||22
113205|NCT01319812|273522|P1|NOT COMPLETED|Overall Study||16
113206|NCT01319812|273521|P2|COMPLETED|Overall Study||280
113207|NCT01319812|273522|P1|COMPLETED|Overall Study||145
113208|NCT01319812|273521|P2|STARTED|Overall Study||302
113209|NCT01319812|273522|P1|STARTED|Overall Study||161
113210|NCT01319799|273594|P1|NOT COMPLETED|Overall Study||0
113211|NCT01319799|273594|P1|COMPLETED|Overall Study||10
113212|NCT01319799|273594|P1|STARTED|Overall Study||10
113213|NCT01319773|273604|P5|NOT COMPLETED|Overall Study||0
113214|NCT01319773|273605|P4|NOT COMPLETED|Overall Study||0
113215|NCT01319773|273606|P3|NOT COMPLETED|Overall Study||0
113216|NCT01319773|273607|P2|NOT COMPLETED|Overall Study||0
113217|NCT01319773|273608|P1|NOT COMPLETED|Overall Study||0
113218|NCT01319773|273604|P5|COMPLETED|Overall Study||8
113219|NCT01319773|273605|P4|COMPLETED|Overall Study||8
113220|NCT01319773|273606|P3|COMPLETED|Overall Study||8
113221|NCT01319773|273607|P2|COMPLETED|Overall Study||10
113222|NCT01319773|273608|P1|COMPLETED|Overall Study||10
113223|NCT01319773|273604|P5|STARTED|Overall Study||8
113224|NCT01319773|273605|P4|STARTED|Overall Study||8
113225|NCT01319773|273606|P3|STARTED|Overall Study||8
113226|NCT01319773|273607|P2|STARTED|Overall Study||10
113227|NCT01319773|273608|P1|STARTED|Overall Study||10
113228|NCT01319721|273624|P2|NOT COMPLETED|Overall Study||6
113229|NCT01319721|273625|P1|NOT COMPLETED|Overall Study||1
113230|NCT01319721|273624|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
113231|NCT01319721|273625|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
113232|NCT01319721|273624|P2|STARTED|Overall Study|The unit of measure is eyes.|48
113233|NCT01319721|273625|P1|STARTED|Overall Study|The unit of measure is eyes.|48
113234|NCT01319617|273639|P1|NOT COMPLETED|Overall Study||1
113235|NCT01319617|273639|P1|COMPLETED|Overall Study||40
113236|NCT01319617|273639|P1|STARTED|Overall Study||41
113237|NCT01319552|273643|P1|NOT COMPLETED|Overall Study||0
113238|NCT01319552|273643|P1|COMPLETED|Overall Study||14
113239|NCT01319552|273643|P1|STARTED|Overall Study||14
113240|NCT01319539|273648|P1|NOT COMPLETED|Overall Study||0
113241|NCT01319539|273648|P1|COMPLETED|Overall Study||12
113242|NCT01319539|273648|P1|STARTED|Overall Study||12
113243|NCT01319500|273658|P2|NOT COMPLETED|Overall Study||0
113244|NCT01319500|273659|P1|NOT COMPLETED|Overall Study||0
113245|NCT01319500|273658|P2|COMPLETED|Overall Study||2589
113246|NCT01319500|273659|P1|COMPLETED|Overall Study||1187
113247|NCT01319500|273658|P2|STARTED|Overall Study||2589
113248|NCT01319500|273659|P1|STARTED|Overall Study||1187
113249|NCT01319422|273678|P2|NOT COMPLETED|Overall Study||0
113250|NCT01319422|273679|P1|NOT COMPLETED|Overall Study||1
113251|NCT01319422|273678|P2|COMPLETED|Overall Study||20
113252|NCT01319422|273679|P1|COMPLETED|Overall Study||19
113253|NCT01319422|273678|P2|STARTED|Overall Study||20
113254|NCT01319422|273679|P1|STARTED|Overall Study||20
113255|NCT01319396|273693|P1|NOT COMPLETED|Overall Study||0
113256|NCT01319396|273693|P1|COMPLETED|Overall Study||24
113257|NCT01319396|273693|P1|STARTED|Overall Study||24
113258|NCT01319383|273697|P2|NOT COMPLETED|Overall Study||10
113259|NCT01319383|273698|P1|NOT COMPLETED|Overall Study||12
113260|NCT01319383|273697|P2|COMPLETED|Overall Study||3
113261|NCT01319383|273698|P1|COMPLETED|Overall Study||0
113262|NCT01319383|273697|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
113263|NCT01319383|273698|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
113264|NCT01319383|273697|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
113265|NCT01319383|273698|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
113266|NCT01319383|273697|P2|Step 2|Overall Study||0
113267|NCT01319383|273698|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
113268|NCT01319383|273697|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
113269|NCT01319383|273698|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
113270|NCT01319383|273697|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
113271|NCT01319383|273698|P1|Step 1|Overall Study||8
113272|NCT01319383|273697|P2|STARTED|Overall Study||13
113273|NCT01319383|273698|P1|STARTED|Overall Study||12
113274|NCT01319318|273715|P1|NOT COMPLETED|Overall Study||0
113275|NCT01319318|273715|P1|COMPLETED|Overall Study||25
113276|NCT01319318|273715|P1|STARTED|Overall Study||25
113277|NCT01319110|273721|P2|NOT COMPLETED|Overall Study||0
113278|NCT01319110|273722|P1|NOT COMPLETED|Overall Study||0
113279|NCT01319110|273721|P2|COMPLETED|Overall Study||5
113280|NCT01319110|273722|P1|COMPLETED|Overall Study||5
113281|NCT01319110|273721|P2|STARTED|Overall Study||5
113282|NCT01319110|273722|P1|STARTED|Overall Study||5
113283|NCT01319045|273730|P1|NOT COMPLETED|Overall Study||2
113284|NCT01319045|273730|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
113285|NCT01319045|273730|P1|STARTED|Overall Study||5
113286|NCT01318993|273737|P1|NOT COMPLETED|Overall Study||398
113287|NCT01318993|273737|P1|COMPLETED|Overall Study||0
113288|NCT01318993|273737|P1|STARTED|Overall Study||398
113289|NCT01318967|273753|P1|NOT COMPLETED|Overall Study||0
113290|NCT01318967|273753|P1|COMPLETED|Overall Study||10
113291|NCT01318967|273753|P1|STARTED|Overall Study||10
113292|NCT01318915|273758|P1|NOT COMPLETED|Overall Study||8
113293|NCT01318915|273758|P1|COMPLETED|Overall Study||2
113294|NCT01318915|273758|P1|STARTED|Overall Study||10
113295|NCT01318876|273762|P1|NOT COMPLETED|Day 29 Survey||1825
113296|NCT01318876|273762|P1|COMPLETED|Day 29 Survey||5724
113297|NCT01318876|273762|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
113298|NCT01318876|273762|P1|NOT COMPLETED|Day 8 Survey||1820
113299|NCT01318876|273762|P1|COMPLETED|Day 8 Survey||5825
113300|NCT01318876|273762|P1|STARTED|Day 8 Survey||7645
113301|NCT01318733|273767|P1|NOT COMPLETED|Overall Study||170
113302|NCT01318733|273767|P1|COMPLETED|Overall Study||279
113303|NCT01318733|273767|P1|STARTED|Overall Study||449
113304|NCT01318694|273775|P4|NOT COMPLETED|Overall Study||68
113305|NCT01318694|273776|P3|NOT COMPLETED|Overall Study||43
113306|NCT01318694|273777|P2|NOT COMPLETED|Overall Study||58
113307|NCT01318694|273778|P1|NOT COMPLETED|Overall Study||52
113308|NCT01318694|273775|P4|COMPLETED|Overall Study||200
113309|NCT01318694|273776|P3|COMPLETED|Overall Study||225
113310|NCT01318694|273777|P2|COMPLETED|Overall Study||212
113311|NCT01318694|273778|P1|COMPLETED|Overall Study||223
113312|NCT01318694|273775|P4|Safety Set|Overall Study||265
113313|NCT01318694|273776|P3|Safety Set|Overall Study||265
113314|NCT01318694|273777|P2|Safety Set|Overall Study||268
113315|NCT01318694|273778|P1|Safety Set|Overall Study||273
113316|NCT01318694|273775|P4|Full Analysis Set|Overall Study||268
113317|NCT01318694|273776|P3|Full Analysis Set|Overall Study||265
113318|NCT01318694|273777|P2|Full Analysis Set|Overall Study||270
113319|NCT01318694|273778|P1|Full Analysis Set|Overall Study||274
113320|NCT01318694|273775|P4|STARTED|Overall Study||268
113321|NCT01318694|273776|P3|STARTED|Overall Study||268
113322|NCT01318694|273777|P2|STARTED|Overall Study||270
113323|NCT01318694|273778|P1|STARTED|Overall Study||275
113324|NCT01318538|273834|P3|NOT COMPLETED|Overall Study||0
113325|NCT01318538|273835|P2|NOT COMPLETED|Overall Study||0
113326|NCT01318538|273836|P1|NOT COMPLETED|Overall Study||0
113327|NCT01318538|273834|P3|COMPLETED|Overall Study||8
113328|NCT01318538|273835|P2|COMPLETED|Overall Study||106
113329|NCT01318538|273836|P1|COMPLETED|Overall Study||52
113330|NCT01318538|273834|P3|STARTED|Overall Study||8
113331|NCT01318538|273835|P2|STARTED|Overall Study||106
113332|NCT01318538|273836|P1|STARTED|Overall Study||52
113333|NCT01318512|273860|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
113334|NCT01318512|273860|P1|COMPLETED|Maintenance Period (6 Months)||329
113335|NCT01318512|273860|P1|STARTED|Maintenance Period (6 Months)||340
113336|NCT01318512|273860|P1|NOT COMPLETED|Titration Period (4 Months)||0
113337|NCT01318512|273860|P1|COMPLETED|Titration Period (4 Months)||340
113338|NCT01318512|273860|P1|STARTED|Titration Period (4 Months)||340
113339|NCT01318499|273879|P3|NOT COMPLETED|Overall Study||147
113340|NCT01318499|273880|P2|NOT COMPLETED|Overall Study||76
113341|NCT01318499|273881|P1|NOT COMPLETED|Overall Study||65
113342|NCT01318499|273879|P3|COMPLETED|Overall Study||121
113343|NCT01318499|273880|P2|COMPLETED|Overall Study||458
113344|NCT01318499|273881|P1|COMPLETED|Overall Study||475
113345|NCT01318499|273879|P3|STARTED|Overall Study||268
113346|NCT01318499|273880|P2|STARTED|Overall Study||534
113347|NCT01318499|273881|P1|STARTED|Overall Study||540
113348|NCT01318408|273899|P1|NOT COMPLETED|Overall Study||8
113349|NCT01318408|273899|P1|COMPLETED|Overall Study||16
113350|NCT01318408|273899|P1|STARTED|Overall Study||24
113351|NCT01318382|273904|P1|NOT COMPLETED|Overall Study||13
113352|NCT01318382|273904|P1|COMPLETED|Overall Study||289
113353|NCT01318382|273904|P1|STARTED|Overall Study||302
113354|NCT01318278|273914|P3|NOT COMPLETED|Overall Study||0
113355|NCT01318278|273915|P2|NOT COMPLETED|Overall Study||0
113356|NCT01318278|273916|P1|NOT COMPLETED|Overall Study||0
113357|NCT01318278|273914|P3|COMPLETED|Overall Study||50
113358|NCT01318278|273915|P2|COMPLETED|Overall Study||10
113359|NCT01318278|273916|P1|COMPLETED|Overall Study||10
113360|NCT01318278|273914|P3|STARTED|Overall Study||50
113361|NCT01318278|273915|P2|STARTED|Overall Study||10
113362|NCT01318278|273916|P1|STARTED|Overall Study||10
113363|NCT01318135|273962|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
113364|NCT01318135|273963|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
113365|NCT01318135|273964|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
113366|NCT01318135|273965|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
113367|NCT01318135|273966|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
113368|NCT01318135|273967|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
113369|NCT01318135|273968|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
113370|NCT01318135|273969|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
113371|NCT01318135|273962|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
113372|NCT01318135|273963|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
113373|NCT01318135|273964|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
113374|NCT01318135|273965|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
113375|NCT01318135|273966|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
113376|NCT01318135|273967|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
113377|NCT01318135|273968|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
113378|NCT01318135|273969|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
113379|NCT01318135|273962|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
113380|NCT01318135|273963|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
113381|NCT01318135|273964|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
113382|NCT01318135|273965|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
113383|NCT01318135|273966|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
113384|NCT01318135|273967|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
113385|NCT01318135|273968|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
113386|NCT01318135|273969|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
113387|NCT01318135|273962|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113388|NCT01318135|273963|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113389|NCT01318135|273964|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113390|NCT01318135|273965|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113391|NCT01318135|273966|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113392|NCT01318135|273967|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113393|NCT01318135|273968|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113394|NCT01318135|273969|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
113395|NCT01318135|273962|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
113396|NCT01318135|273963|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
113397|NCT01318135|273964|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
113398|NCT01318135|273965|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
113399|NCT01318135|273966|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
113400|NCT01318135|273967|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
113401|NCT01318135|273968|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
113402|NCT01318135|273969|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
113403|NCT01318135|273962|P8|STARTED|Enrolled - Long-Term Extension Study||49
113404|NCT01318135|273963|P7|STARTED|Enrolled - Long-Term Extension Study||50
113405|NCT01318135|273964|P6|STARTED|Enrolled - Long-Term Extension Study||90
113406|NCT01318135|273965|P5|STARTED|Enrolled - Long-Term Extension Study||91
113407|NCT01318135|273966|P4|STARTED|Enrolled - Long-Term Extension Study||49
113408|NCT01318135|273967|P3|STARTED|Enrolled - Long-Term Extension Study||46
113409|NCT01318135|273968|P2|STARTED|Enrolled - Long-Term Extension Study||102
113410|NCT01318135|273969|P1|STARTED|Enrolled - Long-Term Extension Study||99
113411|NCT01318122|274101|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
113412|NCT01318122|274102|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
113413|NCT01318122|274103|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
113414|NCT01318122|274104|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
113415|NCT01318122|274101|P4|COMPLETED|Entered - Long-Term Extension Study||48
113416|NCT01318122|274102|P3|COMPLETED|Entered - Long-Term Extension Study||49
113417|NCT01318122|274103|P2|COMPLETED|Entered - Long-Term Extension Study||99
113418|NCT01318122|274104|P1|COMPLETED|Entered - Long-Term Extension Study||96
113419|NCT01318122|274101|P4|STARTED|Entered - Long-Term Extension Study||52
113420|NCT01318122|274102|P3|STARTED|Entered - Long-Term Extension Study||55
113421|NCT01318122|274103|P2|STARTED|Entered - Long-Term Extension Study||110
113422|NCT01318122|274104|P1|STARTED|Entered - Long-Term Extension Study||105
113423|NCT01318122|274101|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
113424|NCT01318122|274102|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
113425|NCT01318122|274103|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
113426|NCT01318122|274104|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
113427|NCT01318122|274101|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
113428|NCT01318122|274102|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
113429|NCT01318122|274103|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
113430|NCT01318122|274104|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
113431|NCT01318122|274101|P4|STARTED|Enrolled - Long-Term Extension Study||53
113432|NCT01318122|274102|P3|STARTED|Enrolled - Long-Term Extension Study||57
113433|NCT01318122|274103|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
113434|NCT01318122|274104|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
113435|NCT01318109|274173|P3|NOT COMPLETED|Overall Study||0
113436|NCT01318109|274174|P2|NOT COMPLETED|Overall Study||3
113437|NCT01318109|274175|P1|NOT COMPLETED|Overall Study||1
113438|NCT01318109|274173|P3|COMPLETED|Overall Study||100
113439|NCT01318109|274174|P2|COMPLETED|Overall Study||93
113440|NCT01318109|274175|P1|COMPLETED|Overall Study||91
113441|NCT01318109|274173|P3|STARTED|Overall Study||100
113442|NCT01318109|274174|P2|STARTED|Overall Study||96
113443|NCT01318109|274175|P1|STARTED|Overall Study||92
113444|NCT01318083|274210|P3|NOT COMPLETED|Overall Study||5
113445|NCT01318083|274211|P2|NOT COMPLETED|Overall Study||2
113446|NCT01318083|274212|P1|NOT COMPLETED|Overall Study||6
113447|NCT01318083|274210|P3|COMPLETED|Overall Study||98
113448|NCT01318083|274211|P2|COMPLETED|Overall Study||102
113449|NCT01318083|274212|P1|COMPLETED|Overall Study||99
113450|NCT01318083|274210|P3|STARTED|Overall Study||103
113451|NCT01318083|274211|P2|STARTED|Overall Study||104
113452|NCT01318083|274212|P1|STARTED|Overall Study||105
113453|NCT01318070|274247|P3|NOT COMPLETED|Overall Study||7
113454|NCT01318070|274248|P2|NOT COMPLETED|Overall Study||2
113455|NCT01318070|274249|P1|NOT COMPLETED|Overall Study||2
113456|NCT01318070|274247|P3|COMPLETED|Overall Study||108
113457|NCT01318070|274248|P2|COMPLETED|Overall Study||111
113458|NCT01318070|274249|P1|COMPLETED|Overall Study||109
113459|NCT01318070|274247|P3|STARTED|Overall Study||115
113460|NCT01318070|274248|P2|STARTED|Overall Study||113
113461|NCT01318070|274249|P1|STARTED|Overall Study||111
113462|NCT01317901|274283|P2|NOT COMPLETED|Overall Study||0
113463|NCT01317901|274284|P1|NOT COMPLETED|Overall Study||0
113464|NCT01317901|274283|P2|COMPLETED|Overall Study||6
113465|NCT01317901|274284|P1|COMPLETED|Overall Study||6
113466|NCT01317901|274283|P2|STARTED|Overall Study||6
113467|NCT01317901|274284|P1|STARTED|Overall Study||6
113468|NCT01317797|274293|P3|NOT COMPLETED|Overall Study||1
113469|NCT01317797|274294|P2|NOT COMPLETED|Overall Study||1
113470|NCT01317797|274295|P1|NOT COMPLETED|Overall Study||0
113471|NCT01317797|274293|P3|COMPLETED|Overall Study||8
113472|NCT01317797|274294|P2|COMPLETED|Overall Study||6
113473|NCT01317797|274295|P1|COMPLETED|Overall Study||8
113474|NCT01317797|274293|P3|STARTED|Overall Study||9
113475|NCT01317797|274294|P2|STARTED|Overall Study||7
113476|NCT01317797|274295|P1|STARTED|Overall Study||8
113477|NCT01317667|274350|P3|NOT COMPLETED|Overall Study||0
113478|NCT01317667|274351|P2|NOT COMPLETED|Overall Study||0
113479|NCT01317667|274352|P1|NOT COMPLETED|Overall Study||0
113480|NCT01317667|274350|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
113481|NCT01317667|274351|P2|COMPLETED|Overall Study||10
113482|NCT01317667|274352|P1|COMPLETED|Overall Study||10
113483|NCT01317667|274350|P3|STARTED|Overall Study||10
113484|NCT01317667|274351|P2|STARTED|Overall Study||10
113485|NCT01317667|274352|P1|STARTED|Overall Study||10
113486|NCT01317641|274372|P9|NOT COMPLETED|Overall Study||5
113487|NCT01317641|274373|P8|NOT COMPLETED|Overall Study||5
113488|NCT01317641|274374|P7|NOT COMPLETED|Overall Study||3
113489|NCT01317641|274375|P6|NOT COMPLETED|Overall Study||0
113490|NCT01317641|274376|P5|NOT COMPLETED|Overall Study||0
113491|NCT01317641|274377|P4|NOT COMPLETED|Overall Study||1
113492|NCT01317641|274378|P3|NOT COMPLETED|Overall Study||0
113493|NCT01317641|274379|P2|NOT COMPLETED|Overall Study||1
113494|NCT01317641|274380|P1|NOT COMPLETED|Overall Study||1
113495|NCT01317641|274372|P9|COMPLETED|Overall Study||31
113496|NCT01317641|274373|P8|COMPLETED|Overall Study||33
113497|NCT01317641|274374|P7|COMPLETED|Overall Study||35
113498|NCT01317641|274375|P6|COMPLETED|Overall Study||3
113499|NCT01317641|274376|P5|COMPLETED|Overall Study||3
113500|NCT01317641|274377|P4|COMPLETED|Overall Study||3
113501|NCT01317641|274378|P3|COMPLETED|Overall Study||3
113502|NCT01317641|274379|P2|COMPLETED|Overall Study||6
113503|NCT01317641|274380|P1|COMPLETED|Overall Study||3
113504|NCT01317641|274372|P9|STARTED|Overall Study||36
113505|NCT01317641|274373|P8|STARTED|Overall Study||38
113506|NCT01317641|274374|P7|STARTED|Overall Study||38
113507|NCT01317641|274375|P6|STARTED|Overall Study||3
113508|NCT01317641|274376|P5|STARTED|Overall Study||3
113509|NCT01317641|274377|P4|STARTED|Overall Study||4
113510|NCT01317641|274378|P3|STARTED|Overall Study||3
113511|NCT01317641|274379|P2|STARTED|Overall Study||7
113512|NCT01317641|274380|P1|STARTED|Overall Study||4
113513|NCT01317615|274482|P1|NOT COMPLETED|Overall Study||49
113514|NCT01317615|274482|P1|COMPLETED|Overall Study||0
113515|NCT01317615|274482|P1|STARTED|Overall Study||49
113516|NCT01317160|274493|P2|NOT COMPLETED|Overall Study||6
113517|NCT01317160|274494|P1|NOT COMPLETED|Overall Study||4
113518|NCT01317160|274493|P2|COMPLETED|Overall Study||69
113519|NCT01317160|274494|P1|COMPLETED|Overall Study||71
113520|NCT01317160|274493|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
113521|NCT01317160|274494|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
113522|NCT01317160|274493|P2|STARTED|Overall Study||75
113523|NCT01317160|274494|P1|STARTED|Overall Study||75
113524|NCT01317095|274504|P2|NOT COMPLETED|Overall Study||0
113525|NCT01317095|274505|P1|NOT COMPLETED|Overall Study||0
113526|NCT01317095|274504|P2|COMPLETED|Overall Study||41
113527|NCT01317095|274505|P1|COMPLETED|Overall Study||39
113528|NCT01317095|274504|P2|STARTED|Overall Study||41
113529|NCT01317095|274505|P1|STARTED|Overall Study||39
113530|NCT01317004|274519|P2|NOT COMPLETED|Overall Study||9
113531|NCT01317004|274520|P1|NOT COMPLETED|Overall Study||4
113532|NCT01317004|274519|P2|COMPLETED|Overall Study||5
113533|NCT01317004|274520|P1|COMPLETED|Overall Study||47
113534|NCT01317004|274519|P2|Safety Set|Overall Study||11
113535|NCT01317004|274520|P1|Safety Set|Overall Study||50
113536|NCT01317004|274519|P2|STARTED|Overall Study||14
113537|NCT01317004|274520|P1|STARTED|Overall Study||51
113538|NCT01316939|274541|P3|NOT COMPLETED|Overall Study||69
113539|NCT01316939|274542|P2|NOT COMPLETED|Overall Study||68
113540|NCT01316939|274543|P1|NOT COMPLETED|Overall Study||63
113541|NCT01316939|274541|P3|COMPLETED|Overall Study||7
113542|NCT01316939|274542|P2|COMPLETED|Overall Study||9
113543|NCT01316939|274543|P1|COMPLETED|Overall Study||13
113544|NCT01316939|274541|P3|STARTED|Overall Study||76
113545|NCT01316939|274542|P2|STARTED|Overall Study||77
113546|NCT01316939|274543|P1|STARTED|Overall Study||76
113547|NCT01316926|274623|P2|NOT COMPLETED|Period 2||0
113548|NCT01316926|274624|P1|NOT COMPLETED|Period 2||0
113549|NCT01316926|274623|P2|COMPLETED|Period 2||30
113550|NCT01316926|274624|P1|COMPLETED|Period 2||29
113551|NCT01316926|274623|P2|STARTED|Period 2||30
113552|NCT01316926|274624|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
113553|NCT01316926|274623|P2|NOT COMPLETED|Period 1||0
113554|NCT01316926|274624|P1|NOT COMPLETED|Period 1||0
113555|NCT01316926|274623|P2|COMPLETED|Period 1||30
113556|NCT01316926|274624|P1|COMPLETED|Period 1||30
113557|NCT01316926|274623|P2|STARTED|Period 1||30
113558|NCT01316926|274624|P1|STARTED|Period 1||30
113559|NCT01316913|274638|P4|NOT COMPLETED|Overall Study||39
113560|NCT01316913|274639|P3|NOT COMPLETED|Overall Study||49
113561|NCT01316913|274640|P2|NOT COMPLETED|Overall Study||54
113562|NCT01316913|274641|P1|NOT COMPLETED|Overall Study||57
113563|NCT01316913|274638|P4|COMPLETED|Overall Study||176
113564|NCT01316913|274639|P3|COMPLETED|Overall Study||166
113565|NCT01316913|274640|P2|COMPLETED|Overall Study||163
113566|NCT01316913|274641|P1|COMPLETED|Overall Study||165
113567|NCT01316913|274638|P4|STARTED|Overall Study||215
113568|NCT01316913|274639|P3|STARTED|Overall Study||215
113569|NCT01316913|274640|P2|STARTED|Overall Study||217
113570|NCT01316913|274641|P1|STARTED|Overall Study||222
113571|NCT01316900|274663|P4|NOT COMPLETED|Overall Study||31
113572|NCT01316900|274664|P3|NOT COMPLETED|Overall Study||41
113573|NCT01316900|274665|P2|NOT COMPLETED|Overall Study||31
113574|NCT01316900|274666|P1|NOT COMPLETED|Overall Study||44
113575|NCT01316900|274663|P4|COMPLETED|Overall Study||177
113576|NCT01316900|274664|P3|COMPLETED|Overall Study||173
113577|NCT01316900|274665|P2|COMPLETED|Overall Study||181
113578|NCT01316900|274666|P1|COMPLETED|Overall Study||165
113579|NCT01316900|274663|P4|STARTED|Overall Study||208
113580|NCT01316900|274664|P3|STARTED|Overall Study||214
113581|NCT01316900|274665|P2|STARTED|Overall Study||212
113582|NCT01316900|274666|P1|STARTED|Overall Study||209
113583|NCT01316887|274687|P3|NOT COMPLETED|Overall Study||83
113584|NCT01316887|274688|P2|NOT COMPLETED|Overall Study||94
113585|NCT01316887|274689|P1|NOT COMPLETED|Overall Study||43
113586|NCT01316887|274687|P3|COMPLETED|Overall Study||143
113587|NCT01316887|274688|P2|COMPLETED|Overall Study||133
113588|NCT01316887|274689|P1|COMPLETED|Overall Study||66
113589|NCT01316887|274687|P3|STARTED|Overall Study||226
113590|NCT01316887|274688|P2|STARTED|Overall Study||227
113591|NCT01316887|274689|P1|STARTED|Overall Study||109
113592|NCT01316692|274751|P1|NOT COMPLETED|Overall Study||12
113593|NCT01316692|274751|P1|COMPLETED|Overall Study||0
113594|NCT01316692|274751|P1|STARTED|Overall Study||12
113595|NCT01316614|274760|P1|NOT COMPLETED|Overall Study||37
113596|NCT01316614|274760|P1|COMPLETED|Overall Study||100
113597|NCT01316614|274760|P1|STARTED|Overall Study||137
113598|NCT01316575|274777|P2|NOT COMPLETED|Overall Study||1
113599|NCT01316575|274778|P1|NOT COMPLETED|Overall Study||2
113600|NCT01316575|274777|P2|COMPLETED|Overall Study||19
113601|NCT01316575|274778|P1|COMPLETED|Overall Study||18
113602|NCT01316575|274777|P2|STARTED|Overall Study||20
113603|NCT01316575|274778|P1|STARTED|Overall Study||20
113604|NCT01316419|274790|P1|NOT COMPLETED|Overall Study||265
113605|NCT01316419|274790|P1|COMPLETED|Overall Study||1824
113606|NCT01316419|274790|P1|STARTED|Overall Study||2089
113607|NCT01316380|274816|P3|NOT COMPLETED|Overall Study||3
113608|NCT01316380|274817|P2|NOT COMPLETED|Overall Study||5
113609|NCT01316380|274818|P1|NOT COMPLETED|Overall Study||2
113610|NCT01316380|274816|P3|COMPLETED|Overall Study||152
113611|NCT01316380|274817|P2|COMPLETED|Overall Study||149
113612|NCT01316380|274818|P1|COMPLETED|Overall Study||154
113613|NCT01316380|274816|P3|STARTED|Overall Study||155
113614|NCT01316380|274817|P2|STARTED|Overall Study||154
113615|NCT01316380|274818|P1|STARTED|Overall Study||156
113616|NCT01316341|274859|P3|NOT COMPLETED|Overall Study||0
113617|NCT01316341|274860|P2|NOT COMPLETED|Overall Study||0
113618|NCT01316341|274861|P1|NOT COMPLETED|Overall Study||0
113619|NCT01316341|274859|P3|COMPLETED|Overall Study||9
113620|NCT01316341|274860|P2|COMPLETED|Overall Study||9
113621|NCT01316341|274861|P1|COMPLETED|Overall Study||6
113622|NCT01316341|274859|P3|STARTED|Overall Study||9
113623|NCT01316341|274860|P2|STARTED|Overall Study||9
113624|NCT01316341|274861|P1|STARTED|Overall Study||6
113625|NCT01316315|274929|P2|NOT COMPLETED|Sequence 2||0
113626|NCT01316315|274930|P1|NOT COMPLETED|Sequence 2||0
113627|NCT01316315|274929|P2|COMPLETED|Sequence 2||7
113628|NCT01316315|274930|P1|COMPLETED|Sequence 2||7
113629|NCT01316315|274929|P2|STARTED|Sequence 2||7
113630|NCT01316315|274930|P1|STARTED|Sequence 2||7
113631|NCT01316315|274929|P2|NOT COMPLETED|Sequence 1||0
113632|NCT01316315|274930|P1|NOT COMPLETED|Sequence 1||0
113633|NCT01316315|274929|P2|COMPLETED|Sequence 1||7
113634|NCT01316315|274930|P1|COMPLETED|Sequence 1||7
113635|NCT01316315|274929|P2|STARTED|Sequence 1||7
113636|NCT01316315|274930|P1|STARTED|Sequence 1||7
113637|NCT01316302|274944|P2|NOT COMPLETED|Overall Study||11
113638|NCT01316302|274945|P1|NOT COMPLETED|Overall Study||10
113639|NCT01316302|274944|P2|COMPLETED|Overall Study||22
113640|NCT01316302|274945|P1|COMPLETED|Overall Study||20
113641|NCT01316302|274944|P2|STARTED|Overall Study||33
113642|NCT01316302|274945|P1|STARTED|Overall Study||30
113643|NCT01316263|274957|P2|NOT COMPLETED|Overall Study||0
113644|NCT01316263|274958|P1|NOT COMPLETED|Overall Study||0
113645|NCT01316263|274957|P2|COMPLETED|Overall Study||14
113646|NCT01316263|274958|P1|COMPLETED|Overall Study||7
113647|NCT01316263|274957|P2|Received Any Study Drug|Overall Study||14
113648|NCT01316263|274958|P1|Received Any Study Drug|Overall Study||7
113649|NCT01316263|274957|P2|STARTED|Overall Study||14
113650|NCT01316263|274958|P1|STARTED|Overall Study||7
113651|NCT01316224|274984|P1|NOT COMPLETED|Overall Study||10
113652|NCT01316224|274984|P1|COMPLETED|Overall Study||42
113653|NCT01316224|274984|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
113654|NCT01316224|274984|P1|Completed Visit 4 to Dermatologist|Overall Study||42
113655|NCT01316224|274984|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
113656|NCT01316224|274984|P1|Completed Visit 3 to Dermatologist|Overall Study||48
113657|NCT01316224|274984|P1|Completed Visit 2 to Dermatologist|Overall Study||51
113658|NCT01316224|274984|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
113659|NCT01316224|274984|P1|Completed Visit 1 to Dermatologist|Overall Study||52
113660|NCT01316224|274984|P1|STARTED|Overall Study||52
113661|NCT01316055|275001|P3|NOT COMPLETED|Overall Study||0
113662|NCT01316055|275002|P2|NOT COMPLETED|Overall Study||0
113663|NCT01316055|275003|P1|NOT COMPLETED|Overall Study||1
113664|NCT01316055|275001|P3|COMPLETED|Overall Study||12
113665|NCT01316055|275002|P2|COMPLETED|Overall Study||17
113666|NCT01316055|275003|P1|COMPLETED|Overall Study||12
113667|NCT01316055|275001|P3|STARTED|Overall Study||12
113668|NCT01316055|275002|P2|STARTED|Overall Study||17
113669|NCT01316055|275003|P1|STARTED|Overall Study||13
113670|NCT01316042|275019|P2|NOT COMPLETED|Overall Study||1
113671|NCT01316042|275020|P1|NOT COMPLETED|Overall Study||0
113672|NCT01316042|275019|P2|COMPLETED|Overall Study||1
113673|NCT01316042|275020|P1|COMPLETED|Overall Study||2
113674|NCT01316042|275019|P2|STARTED|Overall Study||2
113675|NCT01316042|275020|P1|STARTED|Overall Study||2
113676|NCT01315873|275026|P1|NOT COMPLETED|Overall Study||0
113677|NCT01315873|275026|P1|COMPLETED|Overall Study||24
113678|NCT01315873|275026|P1|STARTED|Overall Study||24
113679|NCT01315847|275034|P2|NOT COMPLETED|Part III, Period 2||0
113680|NCT01315847|275035|P1|NOT COMPLETED|Part III, Period 2||0
113681|NCT01315847|275034|P2|COMPLETED|Part III, Period 2||3
113682|NCT01315847|275035|P1|COMPLETED|Part III, Period 2||0
113683|NCT01315847|275034|P2|Received [11C]MK-4232|Part III, Period 2||3
113684|NCT01315847|275035|P1|Received [11C]MK-4232|Part III, Period 2||0
113685|NCT01315847|275034|P2|Received Telcagepant|Part III, Period 2||3
113686|NCT01315847|275035|P1|Received Telcagepant|Part III, Period 2||0
113687|NCT01315847|275034|P2|STARTED|Part III, Period 2||3
113688|NCT01315847|275035|P1|STARTED|Part III, Period 2||0
113689|NCT01315847|275034|P2|NOT COMPLETED|Part III, Period 1||1
113690|NCT01315847|275035|P1|NOT COMPLETED|Part III, Period 1||0
113691|NCT01315847|275034|P2|COMPLETED|Part III, Period 1||3
113692|NCT01315847|275035|P1|COMPLETED|Part III, Period 1||0
113693|NCT01315847|275034|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
113694|NCT01315847|275035|P1|Received [11C]MK-4232|Part III, Period 1||0
113695|NCT01315847|275034|P2|Received Telcagepant|Part III, Period 1||4
113696|NCT01315847|275035|P1|Received Telcagepant|Part III, Period 1||0
113697|NCT01315847|275034|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
113698|NCT01315847|275035|P1|STARTED|Part III, Period 1||0
113699|NCT01315847|275034|P2|NOT COMPLETED|Part I, Period 2||0
113700|NCT01315847|275035|P1|NOT COMPLETED|Part I, Period 2||0
113701|NCT01315847|275034|P2|COMPLETED|Part I, Period 2||0
113702|NCT01315847|275035|P1|COMPLETED|Part I, Period 2||3
113703|NCT01315847|275034|P2|Received [11C]MK-4232|Part I, Period 2||0
113704|NCT01315847|275035|P1|Received [11C]MK-4232|Part I, Period 2||3
113705|NCT01315847|275034|P2|Received Telcagepant|Part I, Period 2||0
113706|NCT01315847|275035|P1|Received Telcagepant|Part I, Period 2||3
113707|NCT01315847|275034|P2|STARTED|Part I, Period 2||0
113708|NCT01315847|275035|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
113709|NCT01315847|275034|P2|NOT COMPLETED|Part I, Period 1||0
113710|NCT01315847|275035|P1|NOT COMPLETED|Part I, Period 1||3
113711|NCT01315847|275034|P2|COMPLETED|Part I, Period 1||0
113712|NCT01315847|275035|P1|COMPLETED|Part I, Period 1||2
113713|NCT01315847|275034|P2|Received [11C]MK-4232|Part I, Period 1||0
113714|NCT01315847|275035|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
113715|NCT01315847|275034|P2|Received Telcagepant|Part I, Period 1||0
113716|NCT01315847|275035|P1|Received Telcagepant|Part I, Period 1||5
113717|NCT01315847|275034|P2|STARTED|Part I, Period 1||0
113718|NCT01315847|275035|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
113719|NCT01315665|275049|P2|NOT COMPLETED|Overall Study||0
113720|NCT01315665|275050|P1|NOT COMPLETED|Overall Study||0
113721|NCT01315665|275049|P2|COMPLETED|Overall Study||5
113722|NCT01315665|275050|P1|COMPLETED|Overall Study||10
113723|NCT01315665|275049|P2|STARTED|Overall Study||5
113724|NCT01315665|275050|P1|STARTED|Overall Study||10
113725|NCT01315574|275066|P2|NOT COMPLETED|Overall Study||0
113726|NCT01315574|275067|P1|NOT COMPLETED|Overall Study||0
113727|NCT01315574|275066|P2|COMPLETED|Overall Study||7
113728|NCT01315574|275067|P1|COMPLETED|Overall Study||7
113729|NCT01315574|275066|P2|STARTED|Overall Study||7
113730|NCT01315574|275067|P1|STARTED|Overall Study||7
113731|NCT01315353|275080|P3|NOT COMPLETED|Overall Study||13
113732|NCT01315353|275081|P2|NOT COMPLETED|Overall Study||23
113733|NCT01315353|275082|P1|NOT COMPLETED|Overall Study||29
113734|NCT01315353|275080|P3|COMPLETED|Overall Study||166
113735|NCT01315353|275081|P2|COMPLETED|Overall Study||120
113736|NCT01315353|275082|P1|COMPLETED|Overall Study||116
113737|NCT01315353|275080|P3|STARTED|Overall Study||179
113738|NCT01315353|275081|P2|STARTED|Overall Study||143
113739|NCT01315353|275082|P1|STARTED|Overall Study||145
113740|NCT01315249|275109|P2|NOT COMPLETED|Overall Study||47
113741|NCT01315249|275110|P1|NOT COMPLETED|Overall Study||44
113742|NCT01315249|275109|P2|COMPLETED|Overall Study||217
113743|NCT01315249|275110|P1|COMPLETED|Overall Study||215
113744|NCT01315249|275109|P2|STARTED|Overall Study||264
113745|NCT01315249|275110|P1|STARTED|Overall Study||259
113746|NCT01315158|275138|P2|NOT COMPLETED|Overall Study||0
113747|NCT01315158|275139|P1|NOT COMPLETED|Overall Study||0
113748|NCT01315158|275138|P2|COMPLETED|Overall Study||19
113749|NCT01315158|275139|P1|COMPLETED|Overall Study||17
113750|NCT01315158|275138|P2|STARTED|Overall Study||19
113751|NCT01315158|275139|P1|STARTED|Overall Study||17
113752|NCT01315145|275163|P2|NOT COMPLETED|Overall Study||5
113753|NCT01315145|275164|P1|NOT COMPLETED|Overall Study||17
113754|NCT01315145|275163|P2|COMPLETED|Overall Study||11
113755|NCT01315145|275164|P1|COMPLETED|Overall Study||105
113756|NCT01315145|275163|P2|STARTED|Overall Study||16
113757|NCT01315145|275164|P1|STARTED|Overall Study||122
113758|NCT01315028|275172|P2|NOT COMPLETED|Overall Study||1
113759|NCT01315028|275173|P1|NOT COMPLETED|Overall Study||1
113760|NCT01315028|275172|P2|COMPLETED|Overall Study||9
113761|NCT01315028|275173|P1|COMPLETED|Overall Study||9
113762|NCT01315028|275172|P2|STARTED|Overall Study||10
113763|NCT01315028|275173|P1|STARTED|Overall Study||10
113764|NCT01315002|275185|P2|NOT COMPLETED|Overall Study||5
113765|NCT01315002|275186|P1|NOT COMPLETED|Overall Study||5
113766|NCT01315002|275185|P2|COMPLETED|Overall Study||55
113767|NCT01315002|275186|P1|COMPLETED|Overall Study||56
113768|NCT01315002|275185|P2|STARTED|Overall Study||60
113769|NCT01315002|275186|P1|STARTED|Overall Study||61
113770|NCT01314963|275192|P1|NOT COMPLETED|Overall Study||0
113771|NCT01314963|275192|P1|COMPLETED|Overall Study||50
113772|NCT01314963|275192|P1|STARTED|Overall Study||50
113773|NCT01314872|275209|P15|NOT COMPLETED|Period 2||24
113774|NCT01314872|275210|P14|NOT COMPLETED|Period 2||53
113775|NCT01314872|275211|P13|NOT COMPLETED|Period 2||60
113776|NCT01314872|275212|P12|NOT COMPLETED|Period 2||48
113777|NCT01314872|275213|P11|NOT COMPLETED|Period 2||0
113778|NCT01314872|275214|P10|NOT COMPLETED|Period 2||0
113779|NCT01314872|275215|P9|NOT COMPLETED|Period 2||0
113780|NCT01314872|275216|P8|NOT COMPLETED|Period 2||0
113781|NCT01314872|275217|P7|NOT COMPLETED|Period 2||0
113782|NCT01314872|275218|P6|NOT COMPLETED|Period 2||0
113783|NCT01314872|275219|P5|NOT COMPLETED|Period 2||0
113784|NCT01314872|275220|P4|NOT COMPLETED|Period 2||0
113785|NCT01314872|275221|P3|NOT COMPLETED|Period 2||0
113786|NCT01314872|275222|P2|NOT COMPLETED|Period 2||0
113787|NCT01314872|275223|P1|NOT COMPLETED|Period 2||0
113788|NCT01314872|275209|P15|COMPLETED|Period 2||110
113789|NCT01314872|275210|P14|COMPLETED|Period 2||187
113790|NCT01314872|275211|P13|COMPLETED|Period 2||188
113791|NCT01314872|275212|P12|COMPLETED|Period 2||175
113792|NCT01314872|275213|P11|COMPLETED|Period 2||0
113793|NCT01314872|275214|P10|COMPLETED|Period 2||0
113794|NCT01314872|275215|P9|COMPLETED|Period 2||0
113795|NCT01314872|275216|P8|COMPLETED|Period 2||0
113796|NCT01314872|275217|P7|COMPLETED|Period 2||0
113797|NCT01314872|275218|P6|COMPLETED|Period 2||0
113798|NCT01314872|275219|P5|COMPLETED|Period 2||0
113799|NCT01314872|275220|P4|COMPLETED|Period 2||0
113800|NCT01314872|275221|P3|COMPLETED|Period 2||0
113801|NCT01314872|275222|P2|COMPLETED|Period 2||0
113802|NCT01314872|275223|P1|COMPLETED|Period 2||0
113803|NCT01314872|275209|P15|STARTED|Period 2||134
113804|NCT01314872|275210|P14|STARTED|Period 2||240
113805|NCT01314872|275211|P13|STARTED|Period 2||248
113806|NCT01314872|275212|P12|STARTED|Period 2||223
113807|NCT01314872|275213|P11|STARTED|Period 2||0
113808|NCT01314872|275214|P10|STARTED|Period 2||0
113809|NCT01314872|275215|P9|STARTED|Period 2||0
113810|NCT01314872|275216|P8|STARTED|Period 2||0
113811|NCT01314872|275217|P7|STARTED|Period 2||0
113812|NCT01314872|275218|P6|STARTED|Period 2||0
113813|NCT01314872|275219|P5|STARTED|Period 2||0
113814|NCT01314872|275220|P4|STARTED|Period 2||0
113815|NCT01314872|275221|P3|STARTED|Period 2||0
113816|NCT01314872|275222|P2|STARTED|Period 2||0
113817|NCT01314872|275223|P1|STARTED|Period 2||0
113818|NCT01314872|275209|P15|NOT COMPLETED|Treatment Period 1||0
113819|NCT01314872|275210|P14|NOT COMPLETED|Treatment Period 1||0
113820|NCT01314872|275211|P13|NOT COMPLETED|Treatment Period 1||0
113821|NCT01314872|275212|P12|NOT COMPLETED|Treatment Period 1||0
113822|NCT01314872|275213|P11|NOT COMPLETED|Treatment Period 1||3
113823|NCT01314872|275214|P10|NOT COMPLETED|Treatment Period 1||4
113824|NCT01314872|275215|P9|NOT COMPLETED|Treatment Period 1||6
113825|NCT01314872|275216|P8|NOT COMPLETED|Treatment Period 1||7
113826|NCT01314872|275217|P7|NOT COMPLETED|Treatment Period 1||8
113827|NCT01314872|275218|P6|NOT COMPLETED|Treatment Period 1||7
113828|NCT01314872|275219|P5|NOT COMPLETED|Treatment Period 1||7
113829|NCT01314872|275220|P4|NOT COMPLETED|Treatment Period 1||7
113830|NCT01314872|275221|P3|NOT COMPLETED|Treatment Period 1||6
113831|NCT01314872|275222|P2|NOT COMPLETED|Treatment Period 1||6
113832|NCT01314872|275223|P1|NOT COMPLETED|Treatment Period 1||10
113833|NCT01314872|275209|P15|COMPLETED|Treatment Period 1||0
113834|NCT01314872|275210|P14|COMPLETED|Treatment Period 1||0
113835|NCT01314872|275211|P13|COMPLETED|Treatment Period 1||0
113836|NCT01314872|275212|P12|COMPLETED|Treatment Period 1||0
113837|NCT01314872|275213|P11|COMPLETED|Treatment Period 1||107
113838|NCT01314872|275214|P10|COMPLETED|Treatment Period 1||118
113839|NCT01314872|275215|P9|COMPLETED|Treatment Period 1||106
113840|NCT01314872|275216|P8|COMPLETED|Treatment Period 1||57
113841|NCT01314872|275217|P7|COMPLETED|Treatment Period 1||126
113842|NCT01314872|275218|P6|COMPLETED|Treatment Period 1||128
113843|NCT01314872|275219|P5|COMPLETED|Treatment Period 1||142
113844|NCT01314872|275220|P4|COMPLETED|Treatment Period 1||143
113845|NCT01314872|275221|P3|COMPLETED|Treatment Period 1||128
113846|NCT01314872|275222|P2|COMPLETED|Treatment Period 1||138
113847|NCT01314872|275223|P1|COMPLETED|Treatment Period 1||131
113848|NCT01314872|275209|P15|STARTED|Treatment Period 1||0
113849|NCT01314872|275210|P14|STARTED|Treatment Period 1||0
113850|NCT01314872|275211|P13|STARTED|Treatment Period 1||0
113851|NCT01314872|275212|P12|STARTED|Treatment Period 1||0
113852|NCT01314872|275213|P11|STARTED|Treatment Period 1||110
113853|NCT01314872|275214|P10|STARTED|Treatment Period 1||122
113854|NCT01314872|275215|P9|STARTED|Treatment Period 1||112
113855|NCT01314872|275216|P8|STARTED|Treatment Period 1||64
113856|NCT01314872|275217|P7|STARTED|Treatment Period 1||134
113857|NCT01314872|275218|P6|STARTED|Treatment Period 1||135
113858|NCT01314872|275219|P5|STARTED|Treatment Period 1||149
113859|NCT01314872|275220|P4|STARTED|Treatment Period 1||150
113860|NCT01314872|275221|P3|STARTED|Treatment Period 1||134
113861|NCT01314872|275222|P2|STARTED|Treatment Period 1||144
113862|NCT01314872|275223|P1|STARTED|Treatment Period 1||141
113863|NCT01314742|275316|P2|NOT COMPLETED|Overall Study||0
113864|NCT01314742|275317|P1|NOT COMPLETED|Overall Study||0
113865|NCT01314742|275316|P2|COMPLETED|Overall Study||21
113866|NCT01314742|275317|P1|COMPLETED|Overall Study||20
113867|NCT01314742|275316|P2|STARTED|Overall Study||21
113868|NCT01314742|275317|P1|STARTED|Overall Study||20
113869|NCT01314716|275327|P2|NOT COMPLETED|Open-Label Phase||12
113870|NCT01314716|275328|P1|NOT COMPLETED|Open-Label Phase||10
113871|NCT01314716|275327|P2|COMPLETED|Open-Label Phase||98
113872|NCT01314716|275328|P1|COMPLETED|Open-Label Phase||102
113873|NCT01314716|275327|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
113874|NCT01314716|275328|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
113875|NCT01314716|275327|P2|NOT COMPLETED|Double-Blind Phase||15
113876|NCT01314716|275328|P1|NOT COMPLETED|Double-Blind Phase||17
113877|NCT01314716|275327|P2|COMPLETED|Double-Blind Phase||123
113878|NCT01314716|275328|P1|COMPLETED|Double-Blind Phase||119
113879|NCT01314716|275327|P2|Randomized and Treated|Double-Blind Phase||137
113880|NCT01314716|275328|P1|Randomized and Treated|Double-Blind Phase||135
113881|NCT01314716|275327|P2|STARTED|Double-Blind Phase||138
113882|NCT01314716|275328|P1|STARTED|Double-Blind Phase||136
113883|NCT01314703|275340|P1|NOT COMPLETED|Overall Study||8
113884|NCT01314703|275340|P1|COMPLETED|Overall Study||27
113885|NCT01314703|275340|P1|Discontinued When Enrollment Completed|Overall Study||3
113886|NCT01314703|275340|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
113887|NCT01314703|275340|P1|Excluded Prior to Screening Baseline|Overall Study||2
113888|NCT01314703|275340|P1|Completed Study|Overall Study||27
113889|NCT01314703|275340|P1|Completed Treatment Visit|Overall Study||27
113890|NCT01314703|275340|P1|Completed Screen Visit|Overall Study||33
113891|NCT01314703|275340|P1|Signed Informed Consent|Overall Study||35
113892|NCT01314703|275340|P1|STARTED|Overall Study||35
113893|NCT01314443|275349|P4|NOT COMPLETED|Overall Study||2
113894|NCT01314443|275350|P3|NOT COMPLETED|Overall Study||2
113895|NCT01314443|275351|P2|NOT COMPLETED|Overall Study||3
113896|NCT01314443|275352|P1|NOT COMPLETED|Overall Study||4
113897|NCT01314443|275349|P4|COMPLETED|Overall Study||13
113898|NCT01314443|275350|P3|COMPLETED|Overall Study||13
113899|NCT01314443|275351|P2|COMPLETED|Overall Study||16
113900|NCT01314443|275352|P1|COMPLETED|Overall Study||14
113901|NCT01314443|275349|P4|STARTED|Overall Study||15
113902|NCT01314443|275350|P3|STARTED|Overall Study||15
113903|NCT01314443|275351|P2|STARTED|Overall Study||19
113904|NCT01314443|275352|P1|STARTED|Overall Study||18
113905|NCT01314417|275370|P1|NOT COMPLETED|Overall Study||0
113906|NCT01314417|275370|P1|COMPLETED|Overall Study||2
113907|NCT01314417|275370|P1|STARTED|Overall Study||2
113908|NCT01314261|275401|P4|NOT COMPLETED|Overall Study||3
113909|NCT01314261|275402|P3|NOT COMPLETED|Overall Study||3
113910|NCT01314261|275403|P2|NOT COMPLETED|Overall Study||4
113911|NCT01314261|275404|P1|NOT COMPLETED|Overall Study||2
113912|NCT01314261|275401|P4|COMPLETED|Overall Study||6
113913|NCT01314261|275402|P3|COMPLETED|Overall Study||7
113914|NCT01314261|275403|P2|COMPLETED|Overall Study||5
113915|NCT01314261|275404|P1|COMPLETED|Overall Study||7
113916|NCT01314261|275401|P4|Discontinued pegIFN/RBV|Overall Study||1
113917|NCT01314261|275402|P3|Discontinued pegIFN/RBV|Overall Study||5
113918|NCT01314261|275403|P2|Discontinued pegIFN/RBV|Overall Study||4
113919|NCT01314261|275404|P1|Discontinued pegIFN/RBV|Overall Study||1
113920|NCT01314261|275401|P4|Discontinued ABT-267 or Placebo|Overall Study||0
113921|NCT01314261|275402|P3|Discontinued ABT-267 or Placebo|Overall Study||1
113922|NCT01314261|275403|P2|Discontinued ABT-267 or Placebo|Overall Study||0
113923|NCT01314261|275404|P1|Discontinued ABT-267 or Placebo|Overall Study||1
113924|NCT01314261|275401|P4|STARTED|Overall Study||9
113925|NCT01314261|275402|P3|STARTED|Overall Study||10
113926|NCT01314261|275403|P2|STARTED|Overall Study||9
113927|NCT01314261|275404|P1|STARTED|Overall Study||9
113928|NCT01314118|275455|P1|NOT COMPLETED|Overall Study||131
113929|NCT01314118|275455|P1|COMPLETED|Overall Study||0
113930|NCT01314118|275455|P1|STARTED|Overall Study||131
113931|NCT01314105|275464|P2|NOT COMPLETED|Overall Study||12
113932|NCT01314105|275465|P1|NOT COMPLETED|Overall Study||7
113933|NCT01314105|275464|P2|COMPLETED|Overall Study||0
113934|NCT01314105|275465|P1|COMPLETED|Overall Study||0
113935|NCT01314105|275464|P2|STARTED|Overall Study||12
113936|NCT01314105|275465|P1|STARTED|Overall Study||7
113937|NCT01314014|275507|P1|NOT COMPLETED|Overall Study||0
113938|NCT01314014|275507|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
113939|NCT01314014|275507|P1|STARTED|Overall Study||22
113940|NCT01314001|275518|P6|NOT COMPLETED|Overall Study||71
113941|NCT01314001|275519|P5|NOT COMPLETED|Overall Study||72
113942|NCT01314001|275520|P4|NOT COMPLETED|Overall Study||69
113943|NCT01314001|275521|P3|NOT COMPLETED|Overall Study||69
113944|NCT01314001|275522|P2|NOT COMPLETED|Overall Study||69
113945|NCT01314001|275523|P1|NOT COMPLETED|Overall Study||75
113946|NCT01314001|275518|P6|COMPLETED|Overall Study||129
113947|NCT01314001|275519|P5|COMPLETED|Overall Study||148
113948|NCT01314001|275520|P4|COMPLETED|Overall Study||122
113949|NCT01314001|275521|P3|COMPLETED|Overall Study||158
113950|NCT01314001|275522|P2|COMPLETED|Overall Study||124
113951|NCT01314001|275523|P1|COMPLETED|Overall Study||140
113952|NCT01314001|275518|P6|6-Month Follow Up Survey|Overall Study||139
113953|NCT01314001|275519|P5|6-Month Follow Up Survey|Overall Study||157
113954|NCT01314001|275520|P4|6-Month Follow Up Survey|Overall Study||135
113955|NCT01314001|275521|P3|6-Month Follow Up Survey|Overall Study||165
113956|NCT01314001|275522|P2|6-Month Follow Up Survey|Overall Study||137
113957|NCT01314001|275523|P1|6-Month Follow Up Survey|Overall Study||146
113958|NCT01314001|275518|P6|End-of-Treatment Visit|Overall Study||160
113959|NCT01314001|275519|P5|End-of-Treatment Visit|Overall Study||174
113960|NCT01314001|275520|P4|End-of-Treatment Visit|Overall Study||146
113961|NCT01314001|275521|P3|End-of-Treatment Visit|Overall Study||179
113962|NCT01314001|275522|P2|End-of-Treatment Visit|Overall Study||141
113963|NCT01314001|275523|P1|End-of-Treatment Visit|Overall Study||156
113964|NCT01314001|275518|P6|STARTED|Overall Study||200
113965|NCT01314001|275519|P5|STARTED|Overall Study||220
113966|NCT01314001|275520|P4|STARTED|Overall Study||191
113967|NCT01314001|275521|P3|STARTED|Overall Study||227
113968|NCT01314001|275522|P2|STARTED|Overall Study||193
113969|NCT01314001|275523|P1|STARTED|Overall Study||215
113970|NCT01313936|275569|P2|NOT COMPLETED|Overall Study||0
113971|NCT01313936|275570|P1|NOT COMPLETED|Overall Study||0
113972|NCT01313936|275569|P2|COMPLETED|Overall Study||26
113973|NCT01313936|275570|P1|COMPLETED|Overall Study||6
113974|NCT01313936|275569|P2|STARTED|Overall Study||26
113975|NCT01313936|275570|P1|STARTED|Overall Study||6
113976|NCT01313923|275578|P1|NOT COMPLETED|Overall Study||3
113977|NCT01313923|275578|P1|COMPLETED|Overall Study||0
113978|NCT01313923|275578|P1|STARTED|Overall Study||3
113979|NCT01313910|275582|P1|NOT COMPLETED|Overall Study||0
113980|NCT01313910|275582|P1|COMPLETED|Overall Study||8
113981|NCT01313910|275582|P1|STARTED|Overall Study||8
113982|NCT01313897|275590|P1|NOT COMPLETED|Overall Study||2
113983|NCT01313897|275590|P1|COMPLETED|Overall Study||8
113984|NCT01313897|275590|P1|STARTED|Overall Study||10
113985|NCT01313884|275594|P1|NOT COMPLETED|Overall Study||1
113986|NCT01313884|275594|P1|COMPLETED|Overall Study||2
113987|NCT01313884|275594|P1|STARTED|Overall Study||3
113988|NCT01313858|275602|P3|NOT COMPLETED|Overall Study||238
113989|NCT01313858|275603|P2|NOT COMPLETED|Overall Study||270
113990|NCT01313858|275604|P1|NOT COMPLETED|Overall Study||286
113991|NCT01313858|275602|P3|COMPLETED|Overall Study||305
113992|NCT01313858|275603|P2|COMPLETED|Overall Study||276
113993|NCT01313858|275604|P1|COMPLETED|Overall Study||238
113994|NCT01313858|275602|P3|STARTED|Overall Study||543
113995|NCT01313858|275603|P2|STARTED|Overall Study||546
113996|NCT01313858|275604|P1|STARTED|Overall Study||524
113997|NCT01313780|275627|P2|NOT COMPLETED|Overall Study||28
113998|NCT01313780|275628|P1|NOT COMPLETED|Overall Study||25
113999|NCT01313780|275627|P2|COMPLETED|Overall Study|PPS|31
114000|NCT01313780|275628|P1|COMPLETED|Overall Study|PPS|33
114001|NCT01313780|275627|P2|STARTED|Overall Study|FAS|59
114002|NCT01313780|275628|P1|STARTED|Overall Study|FAS|58
114003|NCT01313728|275636|P1|NOT COMPLETED|Baseline to Completion||0
114004|NCT01313728|275636|P1|COMPLETED|Baseline to Completion||25
114005|NCT01313728|275636|P1|STARTED|Baseline to Completion||25
114006|NCT01313728|275636|P1|NOT COMPLETED|Informed Consent to Baseline||1
114007|NCT01313728|275636|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
114008|NCT01313728|275636|P1|STARTED|Informed Consent to Baseline||26
114009|NCT01313689|275653|P4|NOT COMPLETED|24-Week Randomization 2||1
114010|NCT01313689|275654|P3|NOT COMPLETED|24-Week Randomization 2||3
114011|NCT01313689|275655|P2|NOT COMPLETED|24-Week Randomization 2||0
114012|NCT01313689|275656|P1|NOT COMPLETED|24-Week Randomization 2||0
114013|NCT01313689|275653|P4|COMPLETED|24-Week Randomization 2||12
114014|NCT01313689|275654|P3|COMPLETED|24-Week Randomization 2||21
114015|NCT01313689|275655|P2|COMPLETED|24-Week Randomization 2||0
114016|NCT01313689|275656|P1|COMPLETED|24-Week Randomization 2||0
114017|NCT01313689|275653|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
114018|NCT01313689|275654|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
114019|NCT01313689|275655|P2|STARTED|24-Week Randomization 2||0
114020|NCT01313689|275656|P1|STARTED|24-Week Randomization 2||0
114021|NCT01313689|275653|P4|NOT COMPLETED|24-Week Randomization 1||0
114022|NCT01313689|275654|P3|NOT COMPLETED|24-Week Randomization 1||0
114023|NCT01313689|275655|P2|NOT COMPLETED|24-Week Randomization 1||10
114024|NCT01313689|275656|P1|NOT COMPLETED|24-Week Randomization 1||19
114025|NCT01313689|275653|P4|COMPLETED|24-Week Randomization 1||0
114026|NCT01313689|275654|P3|COMPLETED|24-Week Randomization 1||0
114027|NCT01313689|275655|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
114028|NCT01313689|275656|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
114029|NCT01313689|275653|P4|STARTED|24-Week Randomization 1||0
114030|NCT01313689|275654|P3|STARTED|24-Week Randomization 1||0
114031|NCT01313689|275655|P2|STARTED|24-Week Randomization 1||43
114032|NCT01313689|275656|P1|STARTED|24-Week Randomization 1||79
114033|NCT01313676|275723|P4|NOT COMPLETED|Overall Study||994
114034|NCT01313676|275724|P3|NOT COMPLETED|Overall Study||1088
114035|NCT01313676|275725|P2|NOT COMPLETED|Overall Study||1113
114036|NCT01313676|275726|P1|NOT COMPLETED|Overall Study||1250
114037|NCT01313676|275723|P4|COMPLETED|Overall Study||3146
114038|NCT01313676|275724|P3|COMPLETED|Overall Study||3052
114039|NCT01313676|275725|P2|COMPLETED|Overall Study||3044
114040|NCT01313676|275726|P1|COMPLETED|Overall Study||2881
114041|NCT01313676|275723|P4|STARTED|Overall Study||4140
114042|NCT01313676|275724|P3|STARTED|Overall Study||4140
114043|NCT01313676|275725|P2|STARTED|Overall Study||4157
114044|NCT01313676|275726|P1|STARTED|Overall Study||4131
114045|NCT01313663|275746|P2|NOT COMPLETED|Overall Study||8
114046|NCT01313663|275747|P1|NOT COMPLETED|Overall Study||4
114047|NCT01313663|275746|P2|COMPLETED|Overall Study||3
114048|NCT01313663|275747|P1|COMPLETED|Overall Study||5
114049|NCT01313663|275746|P2|STARTED|Overall Study||11
114050|NCT01313663|275747|P1|STARTED|Overall Study||9
114051|NCT01313650|275785|P4|NOT COMPLETED|Overall Study||81
114052|NCT01313650|275786|P3|NOT COMPLETED|Overall Study||103
114053|NCT01313650|275787|P2|NOT COMPLETED|Overall Study||94
114054|NCT01313650|275788|P1|NOT COMPLETED|Overall Study||76
114055|NCT01313650|275785|P4|COMPLETED|Overall Study||332
114056|NCT01313650|275786|P3|COMPLETED|Overall Study||318
114057|NCT01313650|275787|P2|COMPLETED|Overall Study||324
114058|NCT01313650|275788|P1|COMPLETED|Overall Study||204
114059|NCT01313650|275785|P4|STARTED|Overall Study||413
114060|NCT01313650|275786|P3|STARTED|Overall Study||421
114061|NCT01313650|275787|P2|STARTED|Overall Study||418
114062|NCT01313650|275788|P1|STARTED|Overall Study||280
114063|NCT01313637|275814|P4|NOT COMPLETED|Overall Study||78
114064|NCT01313637|275815|P3|NOT COMPLETED|Overall Study||106
114065|NCT01313637|275816|P2|NOT COMPLETED|Overall Study||95
114066|NCT01313637|275817|P1|NOT COMPLETED|Overall Study||92
114067|NCT01313637|275814|P4|COMPLETED|Overall Study||325
114068|NCT01313637|275815|P3|COMPLETED|Overall Study||298
114069|NCT01313637|275816|P2|COMPLETED|Overall Study||312
114070|NCT01313637|275817|P1|COMPLETED|Overall Study||183
114071|NCT01313637|275814|P4|STARTED|Overall Study||403
114072|NCT01313637|275815|P3|STARTED|Overall Study||404
114073|NCT01313637|275816|P2|STARTED|Overall Study||407
114074|NCT01313637|275817|P1|STARTED|Overall Study||275
114075|NCT01313624|275841|P2|NOT COMPLETED|Open-Label Phase||13
114076|NCT01313624|275842|P1|NOT COMPLETED|Open-Label Phase||4
114077|NCT01313624|275841|P2|COMPLETED|Open-Label Phase||109
114078|NCT01313624|275842|P1|COMPLETED|Open-Label Phase||92
114079|NCT01313624|275841|P2|STARTED|Open-Label Phase||122
114080|NCT01313624|275842|P1|STARTED|Open-Label Phase||96
114081|NCT01313624|275841|P2|NOT COMPLETED|Double-Blind Phase||10
114082|NCT01313624|275842|P1|NOT COMPLETED|Double-Blind Phase||38
114083|NCT01313624|275841|P2|COMPLETED|Double-Blind Phase||122
114084|NCT01313624|275842|P1|COMPLETED|Double-Blind Phase||96
114085|NCT01313624|275841|P2|STARTED|Double-Blind Phase||132
114086|NCT01313624|275842|P1|STARTED|Double-Blind Phase||134
114087|NCT01313559|275856|P2|NOT COMPLETED|Overall Study||2
114088|NCT01313559|275857|P1|NOT COMPLETED|Overall Study||4
114089|NCT01313559|275856|P2|COMPLETED|Overall Study||0
114090|NCT01313559|275857|P1|COMPLETED|Overall Study||0
114091|NCT01313559|275856|P2|STARTED|Overall Study||2
114092|NCT01313559|275857|P1|STARTED|Overall Study||4
114093|NCT01313520|275871|P2|NOT COMPLETED|Overall Study||0
114094|NCT01313520|275872|P1|NOT COMPLETED|Overall Study||0
114095|NCT01313520|275871|P2|COMPLETED|Overall Study||31
114096|NCT01313520|275872|P1|COMPLETED|Overall Study||30
114097|NCT01313520|275871|P2|STARTED|Overall Study||31
114098|NCT01313520|275872|P1|STARTED|Overall Study||30
114099|NCT01313507|275892|P1|NOT COMPLETED|Overall Study||0
114100|NCT01313507|275892|P1|COMPLETED|Overall Study||21
114101|NCT01313507|275892|P1|STARTED|Overall Study||21
114102|NCT01313494|275900|P2|NOT COMPLETED|Overall Study||50
114103|NCT01313494|275901|P1|NOT COMPLETED|Overall Study||67
114104|NCT01313494|275900|P2|COMPLETED|Overall Study||263
114105|NCT01313494|275901|P1|COMPLETED|Overall Study||246
114106|NCT01313494|275900|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
114107|NCT01313494|275901|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
114108|NCT01313494|275900|P2|STARTED|Overall Study||313
114109|NCT01313494|275901|P1|STARTED|Overall Study||313
114110|NCT01313312|275953|P1|NOT COMPLETED|Overall Study||36
114111|NCT01313312|275953|P1|COMPLETED|Overall Study||222
114112|NCT01313312|275953|P1|Cycle 5|Overall Study||11
114113|NCT01313312|275953|P1|Cycle 4|Overall Study||81
114114|NCT01313312|275953|P1|Cycle 3|Overall Study||175
114115|NCT01313312|275953|P1|Cycle 2|Overall Study||229
114116|NCT01313312|275953|P1|Cycle 1|Overall Study||254
114117|NCT01313312|275953|P1|STARTED|Overall Study||258
114118|NCT01313299|276000|P3|NOT COMPLETED|Overall Study||4
114119|NCT01313299|276001|P2|NOT COMPLETED|Overall Study||3
114120|NCT01313299|276002|P1|NOT COMPLETED|Overall Study||7
114121|NCT01313299|276000|P3|COMPLETED|Overall Study||77
114122|NCT01313299|276001|P2|COMPLETED|Overall Study||78
114123|NCT01313299|276002|P1|COMPLETED|Overall Study||74
114124|NCT01313299|276000|P3|STARTED|Overall Study||81
114125|NCT01313299|276001|P2|STARTED|Overall Study||81
114126|NCT01313299|276002|P1|STARTED|Overall Study||81
114127|NCT01313273|276018|P2|NOT COMPLETED|Overall Study||1
114128|NCT01313273|276019|P1|NOT COMPLETED|Overall Study||2
114129|NCT01313273|276018|P2|COMPLETED|Overall Study||0
114130|NCT01313273|276019|P1|COMPLETED|Overall Study||0
114131|NCT01313273|276018|P2|STARTED|Overall Study||1
114132|NCT01313273|276019|P1|STARTED|Overall Study||2
114133|NCT01313221|276034|P3|NOT COMPLETED|Overall Study||23
114134|NCT01313221|276035|P2|NOT COMPLETED|Overall Study||8
114135|NCT01313221|276036|P1|NOT COMPLETED|Overall Study||12
114136|NCT01313221|276034|P3|COMPLETED|Overall Study||0
114137|NCT01313221|276035|P2|COMPLETED|Overall Study||135
114138|NCT01313221|276036|P1|COMPLETED|Overall Study||132
114139|NCT01313221|276034|P3|Randomized|Overall Study||0
114140|NCT01313221|276035|P2|Randomized|Overall Study||143
114141|NCT01313221|276036|P1|Randomized|Overall Study||144
114142|NCT01313221|276034|P3|STARTED|Overall Study||23
114143|NCT01313221|276035|P2|STARTED|Overall Study||143
114144|NCT01313221|276036|P1|STARTED|Overall Study||144
114145|NCT01313208|276088|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
114146|NCT01313208|276089|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
114147|NCT01313208|276088|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
114148|NCT01313208|276089|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
114149|NCT01313208|276088|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
114150|NCT01313208|276089|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
114151|NCT01313208|276088|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
114152|NCT01313208|276089|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
114153|NCT01313208|276088|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
114154|NCT01313208|276089|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
114155|NCT01313208|276088|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
114156|NCT01313208|276089|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
114157|NCT01313182|276179|P2|NOT COMPLETED|Overall Study||92
114158|NCT01313182|276180|P1|NOT COMPLETED|Overall Study||66
114159|NCT01313182|276179|P2|COMPLETED|Overall Study||763
114160|NCT01313182|276180|P1|COMPLETED|Overall Study||776
114161|NCT01313182|276179|P2|STARTED|Overall Study||855
114162|NCT01313182|276180|P1|STARTED|Overall Study||842
114163|NCT01313117|276186|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
114164|NCT01313117|276186|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
114165|NCT01313117|276186|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
114166|NCT01313117|276186|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
114167|NCT01313117|276186|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
114168|NCT01313117|276186|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
114169|NCT01313117|276186|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
114170|NCT01313117|276186|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
114171|NCT01313117|276186|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
114172|NCT01313117|276186|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
114173|NCT01313117|276186|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
114174|NCT01313117|276186|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
114175|NCT01313117|276186|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
114176|NCT01313117|276186|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
114177|NCT01313117|276186|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
114178|NCT01313078|276193|P1|NOT COMPLETED|Overall Study||3
114179|NCT01313078|276193|P1|COMPLETED|Overall Study||1
114180|NCT01313078|276193|P1|STARTED|Overall Study||4
114181|NCT01313039|276198|P1|NOT COMPLETED|Overall Study||2
114182|NCT01313039|276198|P1|COMPLETED|Overall Study||2
114183|NCT01313039|276198|P1|STARTED|Overall Study||4
114184|NCT01312961|276204|P2|NOT COMPLETED|Overall Study||7
114185|NCT01312961|276205|P1|NOT COMPLETED|Overall Study||17
114186|NCT01312961|276204|P2|COMPLETED|Overall Study||45
114187|NCT01312961|276205|P1|COMPLETED|Overall Study||35
114188|NCT01312961|276204|P2|Treated|Overall Study||52
114189|NCT01312961|276205|P1|Treated|Overall Study||52
114190|NCT01312961|276204|P2|STARTED|Overall Study||52
114191|NCT01312961|276205|P1|STARTED|Overall Study||52
114192|NCT01312948|276231|P1|NOT COMPLETED|Overall Study||0
114193|NCT01312948|276231|P1|COMPLETED|Overall Study||6
114194|NCT01312948|276231|P1|STARTED|Overall Study||6
114195|NCT01312844|276240|P2|NOT COMPLETED|Overall Study||0
114196|NCT01312844|276241|P1|NOT COMPLETED|Overall Study||0
114197|NCT01312844|276240|P2|COMPLETED|Overall Study||3
114198|NCT01312844|276241|P1|COMPLETED|Overall Study||4
114199|NCT01312844|276240|P2|STARTED|Overall Study||3
114200|NCT01312844|276241|P1|STARTED|Overall Study||4
114201|NCT01312818|276263|P1|NOT COMPLETED|Overall Study||0
114202|NCT01312818|276263|P1|COMPLETED|Overall Study||2
114203|NCT01312818|276263|P1|STARTED|Overall Study||2
114204|NCT01312805|276271|P2|NOT COMPLETED|Overall Study||0
114205|NCT01312805|276272|P1|NOT COMPLETED|Overall Study||0
114206|NCT01312805|276271|P2|COMPLETED|Overall Study||1082
114207|NCT01312805|276272|P1|COMPLETED|Overall Study||1016
114208|NCT01312805|276271|P2|STARTED|Overall Study||1082
114209|NCT01312805|276272|P1|STARTED|Overall Study||1016
114210|NCT01312766|276280|P2|NOT COMPLETED|Overall Study||5
114211|NCT01312766|276281|P1|NOT COMPLETED|Overall Study||6
114212|NCT01312766|276280|P2|COMPLETED|Overall Study||130
114213|NCT01312766|276281|P1|COMPLETED|Overall Study||129
114214|NCT01312766|276280|P2|STARTED|Overall Study||135
114215|NCT01312766|276281|P1|STARTED|Overall Study||135
114216|NCT01312519|276313|P2|NOT COMPLETED|Overall Study||0
114217|NCT01312519|276314|P1|NOT COMPLETED|Overall Study||0
114218|NCT01312519|276313|P2|COMPLETED|Overall Study||24
114219|NCT01312519|276314|P1|COMPLETED|Overall Study||26
114220|NCT01312519|276313|P2|STARTED|Overall Study||24
114221|NCT01312519|276314|P1|STARTED|Overall Study||26
114222|NCT01312467|276322|P1|NOT COMPLETED|Overall Study||13
114223|NCT01312467|276322|P1|COMPLETED|Overall Study||32
114224|NCT01312467|276322|P1|STARTED|Overall Study||45
114225|NCT01312428|276331|P2|NOT COMPLETED|Overall Study||4
114226|NCT01312428|276332|P1|NOT COMPLETED|Overall Study||3
114227|NCT01312428|276331|P2|COMPLETED|Overall Study||0
114228|NCT01312428|276332|P1|COMPLETED|Overall Study||0
114229|NCT01312428|276331|P2|STARTED|Overall Study||4
114230|NCT01312428|276332|P1|STARTED|Overall Study||3
114231|NCT01312272|276342|P2|NOT COMPLETED|Overall Study||1
114232|NCT01312272|276343|P1|NOT COMPLETED|Overall Study||0
114233|NCT01312272|276342|P2|COMPLETED|Overall Study||11
114234|NCT01312272|276343|P1|COMPLETED|Overall Study||12
114235|NCT01312272|276342|P2|STARTED|Overall Study||12
114236|NCT01312272|276343|P1|STARTED|Overall Study||12
114237|NCT01312181|276362|P3|NOT COMPLETED|Overall Study||8
114238|NCT01312181|276363|P2|NOT COMPLETED|Overall Study||6
114239|NCT01312181|276364|P1|NOT COMPLETED|Overall Study||2
114240|NCT01312181|276362|P3|COMPLETED|Overall Study||75
114241|NCT01312181|276363|P2|COMPLETED|Overall Study||71
114242|NCT01312181|276364|P1|COMPLETED|Overall Study||78
114243|NCT01312181|276362|P3|STARTED|Overall Study||83
114244|NCT01312181|276363|P2|STARTED|Overall Study||77
114245|NCT01312181|276364|P1|STARTED|Overall Study||80
114246|NCT01312129|276377|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
114247|NCT01312129|276378|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
114248|NCT01312129|276377|P2|COMPLETED|Second Intervention (24 Hours)||6
114249|NCT01312129|276378|P1|COMPLETED|Second Intervention (24 Hours)||6
114250|NCT01312129|276377|P2|Alcohol Cue|Second Intervention (24 Hours)||6
114251|NCT01312129|276378|P1|Alcohol Cue|Second Intervention (24 Hours)||6
114252|NCT01312129|276377|P2|Control Cue|Second Intervention (24 Hours)||6
114253|NCT01312129|276378|P1|Control Cue|Second Intervention (24 Hours)||6
114254|NCT01312129|276377|P2|STARTED|Second Intervention (24 Hours)||7
114255|NCT01312129|276378|P1|STARTED|Second Intervention (24 Hours)||6
114256|NCT01312129|276377|P2|NOT COMPLETED|Washout (1 Week)||0
114257|NCT01312129|276378|P1|NOT COMPLETED|Washout (1 Week)||0
114258|NCT01312129|276377|P2|COMPLETED|Washout (1 Week)||7
114259|NCT01312129|276378|P1|COMPLETED|Washout (1 Week)||6
114260|NCT01312129|276377|P2|STARTED|Washout (1 Week)||7
114261|NCT01312129|276378|P1|STARTED|Washout (1 Week)||6
114262|NCT01312129|276377|P2|NOT COMPLETED|First Intervention (24 Hours)||0
114263|NCT01312129|276378|P1|NOT COMPLETED|First Intervention (24 Hours)||0
114264|NCT01312129|276377|P2|COMPLETED|First Intervention (24 Hours)||7
114265|NCT01312129|276378|P1|COMPLETED|First Intervention (24 Hours)||6
114266|NCT01312129|276377|P2|Alcohol Cue|First Intervention (24 Hours)||7
114267|NCT01312129|276378|P1|Alcohol Cue|First Intervention (24 Hours)||6
114268|NCT01312129|276377|P2|Control Cue|First Intervention (24 Hours)||7
114269|NCT01312129|276378|P1|Control Cue|First Intervention (24 Hours)||6
114270|NCT01312129|276377|P2|STARTED|First Intervention (24 Hours)||7
114271|NCT01312129|276378|P1|STARTED|First Intervention (24 Hours)||6
114272|NCT01312038|276386|P2|NOT COMPLETED|Overall Study||0
114273|NCT01312038|276387|P1|NOT COMPLETED|Overall Study||0
114274|NCT01312038|276386|P2|COMPLETED|Overall Study||12
114275|NCT01312038|276387|P1|COMPLETED|Overall Study||13
114276|NCT01312038|276386|P2|STARTED|Overall Study||12
114277|NCT01312038|276387|P1|STARTED|Overall Study||13
114278|NCT01311895|276395|P2|NOT COMPLETED|Overall Study||0
114279|NCT01311895|276396|P1|NOT COMPLETED|Overall Study||0
114280|NCT01311895|276395|P2|COMPLETED|Overall Study||175
114281|NCT01311895|276396|P1|COMPLETED|Overall Study||175
114282|NCT01311895|276395|P2|STARTED|Overall Study||175
114283|NCT01311895|276396|P1|STARTED|Overall Study||175
114284|NCT01311687|276408|P2|NOT COMPLETED|PFS Follow-up Phase||1
114285|NCT01311687|276409|P1|NOT COMPLETED|PFS Follow-up Phase||3
114286|NCT01311687|276408|P2|COMPLETED|PFS Follow-up Phase||7
114287|NCT01311687|276409|P1|COMPLETED|PFS Follow-up Phase||5
114288|NCT01311687|276408|P2|STARTED|PFS Follow-up Phase||8
114289|NCT01311687|276409|P1|STARTED|PFS Follow-up Phase||8
114290|NCT01311687|276408|P2|NOT COMPLETED|Treatment Phase||11
114291|NCT01311687|276409|P1|NOT COMPLETED|Treatment Phase||60
114292|NCT01311687|276408|P2|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|142
114293|NCT01311687|276409|P1|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|242
114294|NCT01311687|276408|P2|Received Study Treatment|Treatment Phase||150
114295|NCT01311687|276409|P1|Received Study Treatment|Treatment Phase||300
114296|NCT01311687|276408|P2|STARTED|Treatment Phase||153
114297|NCT01311687|276409|P1|STARTED|Treatment Phase||302
114298|NCT01311661|276459|P1|NOT COMPLETED|Overall Study||7
114299|NCT01311661|276459|P1|COMPLETED|Overall Study||199
114300|NCT01311661|276459|P1|Received Olo 10 mcg qd|Overall Study||102
114301|NCT01311661|276459|P1|Received Olo 5 mcg Bid|Overall Study||101
114302|NCT01311661|276459|P1|Received Olo 5 mcg qd|Overall Study||101
114303|NCT01311661|276459|P1|Received Olo 2.5 mcg Bid|Overall Study||101
114304|NCT01311661|276459|P1|Received Placebo|Overall Study||201
114305|NCT01311661|276459|P1|STARTED|Overall Study|Entered and treated|206
114306|NCT01311557|276603|P2|NOT COMPLETED|Overall Study||6
114307|NCT01311557|276604|P1|NOT COMPLETED|Overall Study||5
114308|NCT01311557|276603|P2|COMPLETED|Overall Study||645
114309|NCT01311557|276604|P1|COMPLETED|Overall Study||646
114310|NCT01311557|276603|P2|STARTED|Overall Study||651
114311|NCT01311557|276604|P1|STARTED|Overall Study||651
114312|NCT01311505|276620|P2|NOT COMPLETED|Second Intervention Period||0
114313|NCT01311505|276621|P1|NOT COMPLETED|Second Intervention Period||0
114314|NCT01311505|276620|P2|COMPLETED|Second Intervention Period||10
114315|NCT01311505|276621|P1|COMPLETED|Second Intervention Period||10
114316|NCT01311505|276620|P2|STARTED|Second Intervention Period||10
114317|NCT01311505|276621|P1|STARTED|Second Intervention Period||10
114318|NCT01311505|276620|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
114319|NCT01311505|276621|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
114320|NCT01311505|276620|P2|COMPLETED|Washout Period (at Least 7 Days)||10
114321|NCT01311505|276621|P1|COMPLETED|Washout Period (at Least 7 Days)||10
114322|NCT01311505|276620|P2|STARTED|Washout Period (at Least 7 Days)||10
114323|NCT01311505|276621|P1|STARTED|Washout Period (at Least 7 Days)||10
114324|NCT01311505|276620|P2|NOT COMPLETED|First Intervention Period||1
114325|NCT01311505|276621|P1|NOT COMPLETED|First Intervention Period||0
114326|NCT01311505|276620|P2|COMPLETED|First Intervention Period||10
114327|NCT01311505|276621|P1|COMPLETED|First Intervention Period||10
114328|NCT01311505|276620|P2|STARTED|First Intervention Period||11
114329|NCT01311505|276621|P1|STARTED|First Intervention Period||10
114330|NCT01311362|276649|P1|NOT COMPLETED|Ambrisentan and SJW||0
114331|NCT01311362|276649|P1|COMPLETED|Ambrisentan and SJW||20
114332|NCT01311362|276649|P1|STARTED|Ambrisentan and SJW||20
114333|NCT01311362|276649|P1|NOT COMPLETED|Ambrisentan Steady-state||0
114334|NCT01311362|276649|P1|COMPLETED|Ambrisentan Steady-state||20
114335|NCT01311362|276649|P1|STARTED|Ambrisentan Steady-state||20
114336|NCT01311362|276649|P1|NOT COMPLETED|Ambrisentan Single Dose||0
114337|NCT01311362|276649|P1|COMPLETED|Ambrisentan Single Dose||20
114338|NCT01311362|276649|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
114339|NCT01311102|276662|P2|NOT COMPLETED|Overall Study||0
114340|NCT01311102|276663|P1|NOT COMPLETED|Overall Study||0
114341|NCT01311102|276662|P2|COMPLETED|Overall Study||20
114342|NCT01311102|276663|P1|COMPLETED|Overall Study||20
114343|NCT01311102|276662|P2|STARTED|Overall Study||20
114344|NCT01311102|276663|P1|STARTED|Overall Study||20
114345|NCT01311024|276677|P2|NOT COMPLETED|Overall Study||22
114346|NCT01311024|276678|P1|NOT COMPLETED|Overall Study||35
114347|NCT01311024|276677|P2|COMPLETED|Overall Study||789
114348|NCT01311024|276678|P1|COMPLETED|Overall Study||1495
114349|NCT01311024|276677|P2|STARTED|Overall Study||811
114350|NCT01311024|276678|P1|STARTED|Overall Study||1530
114351|NCT01310868|276684|P1|NOT COMPLETED|Overall Study||13
114352|NCT01310868|276684|P1|COMPLETED|Overall Study||59
114353|NCT01310868|276684|P1|STARTED|Overall Study||72
114354|NCT01310855|276692|P2|NOT COMPLETED|Overall Study||0
114355|NCT01310855|276693|P1|NOT COMPLETED|Overall Study||0
114356|NCT01310855|276692|P2|COMPLETED|Overall Study||19
114357|NCT01310855|276693|P1|COMPLETED|Overall Study||19
114358|NCT01310855|276692|P2|STARTED|Overall Study||19
114359|NCT01310855|276693|P1|STARTED|Overall Study||19
114360|NCT01310803|276701|P2|NOT COMPLETED|Overall Study||0
114361|NCT01310803|276702|P1|NOT COMPLETED|Overall Study||1
114362|NCT01310803|276701|P2|COMPLETED|Overall Study||0
114363|NCT01310803|276702|P1|COMPLETED|Overall Study||0
114364|NCT01310803|276701|P2|STARTED|Overall Study||0
114365|NCT01310803|276702|P1|STARTED|Overall Study||1
114366|NCT01310777|276713|P3|NOT COMPLETED|Overall Study||30
114367|NCT01310777|276714|P2|NOT COMPLETED|Overall Study||14
114368|NCT01310777|276715|P1|NOT COMPLETED|Overall Study||33
114369|NCT01310777|276713|P3|COMPLETED|Overall Study||145
114370|NCT01310777|276714|P2|COMPLETED|Overall Study||178
114371|NCT01310777|276715|P1|COMPLETED|Overall Study||160
114372|NCT01310777|276713|P3|STARTED|Overall Study||175
114373|NCT01310777|276714|P2|STARTED|Overall Study||192
114374|NCT01310777|276715|P1|STARTED|Overall Study||193
114375|NCT01310699|276725|P2|NOT COMPLETED|Overall Study||6
114376|NCT01310699|276726|P1|NOT COMPLETED|Overall Study||4
114377|NCT01310699|276725|P2|COMPLETED|Overall Study||143
114378|NCT01310699|276726|P1|COMPLETED|Overall Study||128
114379|NCT01310699|276725|P2|STARTED|Overall Study||149
114380|NCT01310699|276726|P1|STARTED|Overall Study||132
114381|NCT01310582|276738|P2|NOT COMPLETED|Overall Study||0
114382|NCT01310582|276739|P1|NOT COMPLETED|Overall Study||0
114383|NCT01310582|276738|P2|COMPLETED|Overall Study||26
114384|NCT01310582|276739|P1|COMPLETED|Overall Study||31
114385|NCT01310582|276738|P2|STARTED|Overall Study||26
114386|NCT01310582|276739|P1|STARTED|Overall Study||31
114387|NCT01310413|276753|P7|NOT COMPLETED|From Day U0 to Day U385||3
114388|NCT01310413|276754|P6|NOT COMPLETED|From Day U0 to Day U385||0
114389|NCT01310413|276755|P5|NOT COMPLETED|From Day U0 to Day U385||0
114390|NCT01310413|276756|P4|NOT COMPLETED|From Day U0 to Day U385||0
114391|NCT01310413|276757|P3|NOT COMPLETED|From Day U0 to Day U385||0
114392|NCT01310413|276758|P2|NOT COMPLETED|From Day U0 to Day U385||0
114393|NCT01310413|276759|P1|NOT COMPLETED|From Day U0 to Day U385||0
114394|NCT01310413|276753|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
114395|NCT01310413|276754|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
114396|NCT01310413|276755|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
114397|NCT01310413|276756|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
114398|NCT01310413|276757|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
114399|NCT01310413|276758|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
114400|NCT01310413|276759|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
114401|NCT01310413|276753|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
114402|NCT01310413|276754|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
114403|NCT01310413|276755|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
114404|NCT01310413|276756|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
114405|NCT01310413|276757|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
114406|NCT01310413|276758|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
114407|NCT01310413|276759|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
114408|NCT01310413|276753|P7|NOT COMPLETED|Day 0 to Day 385||0
114409|NCT01310413|276754|P6|NOT COMPLETED|Day 0 to Day 385||3
114410|NCT01310413|276755|P5|NOT COMPLETED|Day 0 to Day 385||3
114411|NCT01310413|276756|P4|NOT COMPLETED|Day 0 to Day 385||8
114412|NCT01310413|276757|P3|NOT COMPLETED|Day 0 to Day 385||7
114413|NCT01310413|276758|P2|NOT COMPLETED|Day 0 to Day 385||8
114414|NCT01310413|276759|P1|NOT COMPLETED|Day 0 to Day 385||27
114415|NCT01310413|276753|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
114416|NCT01310413|276754|P6|COMPLETED|Day 0 to Day 385||77
114417|NCT01310413|276755|P5|COMPLETED|Day 0 to Day 385||73
114418|NCT01310413|276756|P4|COMPLETED|Day 0 to Day 385||67
114419|NCT01310413|276757|P3|COMPLETED|Day 0 to Day 385||203
114420|NCT01310413|276758|P2|COMPLETED|Day 0 to Day 385||190
114421|NCT01310413|276759|P1|COMPLETED|Day 0 to Day 385||172
114422|NCT01310413|276753|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
114423|NCT01310413|276754|P6|STARTED|Day 0 to Day 385||80
114424|NCT01310413|276755|P5|STARTED|Day 0 to Day 385||76
114425|NCT01310413|276756|P4|STARTED|Day 0 to Day 385||75
114426|NCT01310413|276757|P3|STARTED|Day 0 to Day 385||210
114427|NCT01310413|276758|P2|STARTED|Day 0 to Day 385||198
114428|NCT01310413|276759|P1|STARTED|Day 0 to Day 385||199
114429|NCT01310400|276915|P3|NOT COMPLETED|Overall Study||30
114430|NCT01310400|276916|P2|NOT COMPLETED|Overall Study||32
114431|NCT01310400|276917|P1|NOT COMPLETED|Overall Study||28
114432|NCT01310400|276915|P3|COMPLETED|Overall Study||422
114433|NCT01310400|276916|P2|COMPLETED|Overall Study||420
114434|NCT01310400|276917|P1|COMPLETED|Overall Study||424
114435|NCT01310400|276915|P3|STARTED|Overall Study||452
114436|NCT01310400|276916|P2|STARTED|Overall Study||452
114437|NCT01310400|276917|P1|STARTED|Overall Study||452
114438|NCT01310179|276934|P1|NOT COMPLETED|Overall Study||0
114439|NCT01310179|276934|P1|COMPLETED|Overall Study||12
114440|NCT01310179|276934|P1|STARTED|Overall Study||12
114441|NCT01310127|276941|P2|NOT COMPLETED|Overall Study||1
114442|NCT01310127|276942|P1|NOT COMPLETED|Overall Study||2
114443|NCT01310127|276941|P2|COMPLETED|Overall Study||10
114444|NCT01310127|276942|P1|COMPLETED|Overall Study||10
114445|NCT01310127|276941|P2|STARTED|Overall Study||11
114446|NCT01310127|276942|P1|STARTED|Overall Study||12
114447|NCT01309997|276956|P2|NOT COMPLETED|Overall Study||6
114448|NCT01309997|276957|P1|NOT COMPLETED|Overall Study||5
114449|NCT01309997|276956|P2|COMPLETED|Overall Study||31
114450|NCT01309997|276957|P1|COMPLETED|Overall Study||30
114451|NCT01309997|276956|P2|Crossed Over to Second Arm|Overall Study||23
114452|NCT01309997|276957|P1|Crossed Over to Second Arm|Overall Study||19
114453|NCT01309997|276956|P2|Remained on First Arm Only|Overall Study||14
114454|NCT01309997|276957|P1|Remained on First Arm Only|Overall Study||16
114455|NCT01309997|276956|P2|STARTED|Overall Study||37
114456|NCT01309997|276957|P1|STARTED|Overall Study||35
114457|NCT01309919|276981|P2|NOT COMPLETED|Overall Study||48
114458|NCT01309919|276982|P1|NOT COMPLETED|Overall Study||17
114459|NCT01309919|276981|P2|COMPLETED|Overall Study||27
114460|NCT01309919|276982|P1|COMPLETED|Overall Study||58
114461|NCT01309919|276981|P2|STARTED|Overall Study||75
114462|NCT01309919|276982|P1|STARTED|Overall Study||75
114463|NCT01309893|276994|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
114464|NCT01309893|276995|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
114465|NCT01309893|276994|P2|COMPLETED|Week 2 - Crossover Intervention||32
114466|NCT01309893|276995|P1|COMPLETED|Week 2 - Crossover Intervention||32
114467|NCT01309893|276994|P2|STARTED|Week 2 - Crossover Intervention||33
114468|NCT01309893|276995|P1|STARTED|Week 2 - Crossover Intervention||33
114469|NCT01309893|276994|P2|NOT COMPLETED|Week 1 - First Intervention||0
114470|NCT01309893|276995|P1|NOT COMPLETED|Week 1 - First Intervention||0
114471|NCT01309893|276994|P2|COMPLETED|Week 1 - First Intervention||33
114472|NCT01309893|276995|P1|COMPLETED|Week 1 - First Intervention||33
114473|NCT01309893|276994|P2|STARTED|Week 1 - First Intervention||33
114474|NCT01309893|276995|P1|STARTED|Week 1 - First Intervention||33
114475|NCT01309880|277005|P2|NOT COMPLETED|Overall Study||0
114476|NCT01309880|277006|P1|NOT COMPLETED|Overall Study||0
114477|NCT01309880|277005|P2|COMPLETED|Overall Study||33
114478|NCT01309880|277006|P1|COMPLETED|Overall Study||33
114479|NCT01309880|277005|P2|STARTED|Overall Study||33
114480|NCT01309880|277006|P1|STARTED|Overall Study||33
114481|NCT01309841|277019|P3|NOT COMPLETED|Overall Study||37
114482|NCT01309841|277020|P2|NOT COMPLETED|Overall Study||41
114483|NCT01309841|277021|P1|NOT COMPLETED|Overall Study||39
114484|NCT01309841|277019|P3|COMPLETED|Overall Study||180
114485|NCT01309841|277020|P2|COMPLETED|Overall Study||177
114486|NCT01309841|277021|P1|COMPLETED|Overall Study||178
114487|NCT01309841|277019|P3|STARTED|Overall Study||217
114488|NCT01309841|277020|P2|STARTED|Overall Study||218
114489|NCT01309841|277021|P1|STARTED|Overall Study||217
114490|NCT01309828|277061|P2|NOT COMPLETED|Overall Study||16
114491|NCT01309828|277062|P1|NOT COMPLETED|Overall Study||16
114492|NCT01309828|277061|P2|COMPLETED|Overall Study||60
114493|NCT01309828|277062|P1|COMPLETED|Overall Study||61
114494|NCT01309828|277061|P2|STARTED|Overall Study||76
114495|NCT01309828|277062|P1|STARTED|Overall Study||77
114496|NCT01309802|277076|P2|NOT COMPLETED|Overall Study||9
114497|NCT01309802|277077|P1|NOT COMPLETED|Overall Study||12
114498|NCT01309802|277076|P2|COMPLETED|Overall Study||14
114499|NCT01309802|277077|P1|COMPLETED|Overall Study||13
114500|NCT01309802|277076|P2|STARTED|Overall Study||23
114501|NCT01309802|277077|P1|STARTED|Overall Study||25
114502|NCT01309737|277096|P5|NOT COMPLETED|Week 16 to 52||33
114503|NCT01309737|277097|P4|NOT COMPLETED|Week 16 to 52||34
114504|NCT01309737|277098|P3|NOT COMPLETED|Week 16 to 52||0
114505|NCT01309737|277099|P2|NOT COMPLETED|Week 16 to 52||103
114506|NCT01309737|277100|P1|NOT COMPLETED|Week 16 to 52||133
114507|NCT01309737|277096|P5|COMPLETED|Week 16 to 52||44
114508|NCT01309737|277097|P4|COMPLETED|Week 16 to 52||41
114509|NCT01309737|277098|P3|COMPLETED|Week 16 to 52||0
114510|NCT01309737|277099|P2|COMPLETED|Week 16 to 52||238
114511|NCT01309737|277100|P1|COMPLETED|Week 16 to 52||198
114512|NCT01309737|277096|P5|STARTED|Week 16 to 52||77
114513|NCT01309737|277097|P4|STARTED|Week 16 to 52||75
114514|NCT01309737|277098|P3|STARTED|Week 16 to 52||0
114515|NCT01309737|277099|P2|STARTED|Week 16 to 52||341
114516|NCT01309737|277100|P1|STARTED|Week 16 to 52||331
114517|NCT01309737|277096|P5|NOT COMPLETED|Week 0 to 16||0
114518|NCT01309737|277097|P4|NOT COMPLETED|Week 0 to 16||0
114519|NCT01309737|277098|P3|NOT COMPLETED|Week 0 to 16||44
114520|NCT01309737|277099|P2|NOT COMPLETED|Week 0 to 16||40
114521|NCT01309737|277100|P1|NOT COMPLETED|Week 0 to 16||52
114522|NCT01309737|277096|P5|COMPLETED|Week 0 to 16||0
114523|NCT01309737|277097|P4|COMPLETED|Week 0 to 16||0
114524|NCT01309737|277098|P3|COMPLETED|Week 0 to 16||152
114525|NCT01309737|277099|P2|COMPLETED|Week 0 to 16||341
114526|NCT01309737|277100|P1|COMPLETED|Week 0 to 16||331
114527|NCT01309737|277096|P5|Treated|Week 0 to 16||0
114528|NCT01309737|277097|P4|Treated|Week 0 to 16||0
114529|NCT01309737|277098|P3|Treated|Week 0 to 16||196
114530|NCT01309737|277099|P2|Treated|Week 0 to 16||381
114531|NCT01309737|277100|P1|Treated|Week 0 to 16||382
114532|NCT01309737|277096|P5|STARTED|Week 0 to 16||0
114533|NCT01309737|277097|P4|STARTED|Week 0 to 16||0
114534|NCT01309737|277098|P3|STARTED|Week 0 to 16||196
114535|NCT01309737|277099|P2|STARTED|Week 0 to 16||381
114536|NCT01309737|277100|P1|STARTED|Week 0 to 16||383
114537|NCT01309672|277295|P1|NOT COMPLETED|Overall Study||37
114538|NCT01309672|277295|P1|COMPLETED|Overall Study||4
114539|NCT01309672|277295|P1|Received Protocol Treatment|Overall Study||40
114540|NCT01309672|277295|P1|STARTED|Overall Study||41
114541|NCT01309659|277305|P2|NOT COMPLETED|Overall Study||1
114542|NCT01309659|277306|P1|NOT COMPLETED|Overall Study||0
114543|NCT01309659|277305|P2|COMPLETED|Overall Study||9
114544|NCT01309659|277306|P1|COMPLETED|Overall Study||9
114545|NCT01309659|277305|P2|STARTED|Overall Study||10
114546|NCT01309659|277306|P1|STARTED|Overall Study||9
114547|NCT01309646|277348|P2|NOT COMPLETED|Overall Study||0
114548|NCT01309646|277349|P1|NOT COMPLETED|Overall Study||0
114549|NCT01309646|277348|P2|COMPLETED|Overall Study||227
114550|NCT01309646|277349|P1|COMPLETED|Overall Study||224
114551|NCT01309646|277348|P2|STARTED|Overall Study||227
114552|NCT01309646|277349|P1|STARTED|Overall Study||224
114553|NCT01309581|277389|P2|NOT COMPLETED|Overall Study||0
114554|NCT01309581|277390|P1|NOT COMPLETED|Overall Study||0
114555|NCT01309581|277389|P2|COMPLETED|Overall Study||1
114556|NCT01309581|277390|P1|COMPLETED|Overall Study||2
114557|NCT01309581|277389|P2|STARTED|Overall Study||1
114558|NCT01309581|277390|P1|STARTED|Overall Study||2
114559|NCT01309451|277400|P2|NOT COMPLETED|Overall Study||3
114560|NCT01309451|277401|P1|NOT COMPLETED|Overall Study||2
114561|NCT01309451|277400|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
114562|NCT01309451|277401|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
114563|NCT01309451|277400|P2|STARTED|Overall Study|unit of measure is number of eyes|21
114564|NCT01309451|277401|P1|STARTED|Overall Study|unit of measure is number of eyes|19
114565|NCT01309386|277411|P2|NOT COMPLETED|Overall Study||21
114566|NCT01309386|277412|P1|NOT COMPLETED|Overall Study||22
114567|NCT01309386|277411|P2|COMPLETED|Overall Study||29
114568|NCT01309386|277412|P1|COMPLETED|Overall Study||28
114569|NCT01309386|277411|P2|STARTED|Overall Study||50
114570|NCT01309386|277412|P1|STARTED|Overall Study||50
114571|NCT01309360|277433|P3|NOT COMPLETED|Overall Study||0
114572|NCT01309360|277434|P2|NOT COMPLETED|Overall Study||0
114573|NCT01309360|277435|P1|NOT COMPLETED|Overall Study||0
114574|NCT01309360|277433|P3|COMPLETED|Overall Study||40
114575|NCT01309360|277434|P2|COMPLETED|Overall Study||40
114576|NCT01309360|277435|P1|COMPLETED|Overall Study||40
114577|NCT01309360|277433|P3|STARTED|Overall Study||40
114578|NCT01309360|277434|P2|STARTED|Overall Study||40
114579|NCT01309360|277435|P1|STARTED|Overall Study||40
114580|NCT01309308|277460|P2|NOT COMPLETED|Overall Study||4
114581|NCT01309308|277461|P1|NOT COMPLETED|Overall Study||6
114582|NCT01309308|277460|P2|COMPLETED|Overall Study||71
114583|NCT01309308|277461|P1|COMPLETED|Overall Study||69
114584|NCT01309308|277460|P2|STARTED|Overall Study||75
114585|NCT01309308|277461|P1|STARTED|Overall Study||75
114586|NCT01309282|277469|P1|NOT COMPLETED|Overall Study||1
114587|NCT01309282|277469|P1|COMPLETED|Overall Study||8
114588|NCT01309282|277469|P1|STARTED|Overall Study||9
114589|NCT01309269|277486|P1|NOT COMPLETED|Overall Study||840
114590|NCT01309269|277486|P1|COMPLETED|Overall Study||245
114591|NCT01309269|277486|P1|Treated|Overall Study||978
114592|NCT01309269|277486|P1|STARTED|Overall Study||1085
114593|NCT01309243|277494|P2|NOT COMPLETED|Extension Phase||0
114594|NCT01309243|277495|P1|NOT COMPLETED|Extension Phase||6
114595|NCT01309243|277494|P2|COMPLETED|Extension Phase||117
114596|NCT01309243|277495|P1|COMPLETED|Extension Phase||34
114597|NCT01309243|277494|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
114598|NCT01309243|277495|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
114599|NCT01309243|277494|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
114600|NCT01309243|277495|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
114601|NCT01309243|277494|P2|COMPLETED|Randomized Phase Through Week 96||290
114602|NCT01309243|277495|P1|COMPLETED|Randomized Phase Through Week 96||316
114603|NCT01309243|277494|P2|Randomized and Treated|Randomized Phase Through Week 96||392
114604|NCT01309243|277495|P1|Randomized and Treated|Randomized Phase Through Week 96||394
114605|NCT01309243|277494|P2|STARTED|Randomized Phase Through Week 96||399
114606|NCT01309243|277495|P1|STARTED|Randomized Phase Through Week 96||400
114607|NCT01309204|277521|P2|NOT COMPLETED|Overall Study||75
114608|NCT01309204|277522|P1|NOT COMPLETED|Overall Study||67
114609|NCT01309204|277521|P2|COMPLETED|Overall Study||361
114610|NCT01309204|277522|P1|COMPLETED|Overall Study||385
114611|NCT01309204|277521|P2|STARTED|Overall Study||436
114612|NCT01309204|277522|P1|STARTED|Overall Study||452
114613|NCT01309100|277528|P1|NOT COMPLETED|Overall Study||2
114614|NCT01309100|277528|P1|COMPLETED|Overall Study||142
114615|NCT01309100|277528|P1|STARTED|Overall Study||144
114616|NCT01308918|277539|P1|NOT COMPLETED|Overall Study||0
114617|NCT01308918|277539|P1|COMPLETED|Overall Study||50
114618|NCT01308918|277539|P1|STARTED|Overall Study||50
114619|NCT01308840|277546|P1|NOT COMPLETED|Overall Study||0
114620|NCT01308840|277546|P1|COMPLETED|Overall Study||31
114621|NCT01308840|277546|P1|STARTED|Overall Study||31
114622|NCT01308814|277555|P2|NOT COMPLETED|Overall Study||23
114623|NCT01308814|277556|P1|NOT COMPLETED|Overall Study||17
114624|NCT01308814|277555|P2|COMPLETED|Overall Study||63
114625|NCT01308814|277556|P1|COMPLETED|Overall Study||69
114626|NCT01308814|277555|P2|STARTED|Overall Study||86
114627|NCT01308814|277556|P1|STARTED|Overall Study||86
114628|NCT01308788|277576|P2|NOT COMPLETED|2-year Treatment||11
114629|NCT01308788|277577|P1|NOT COMPLETED|2-year Treatment||4
114630|NCT01308788|277576|P2|COMPLETED|2-year Treatment||10
114631|NCT01308788|277577|P1|COMPLETED|2-year Treatment||10
114632|NCT01308788|277576|P2|STARTED|2-year Treatment||21
114633|NCT01308788|277577|P1|STARTED|2-year Treatment||14
114634|NCT01308788|277576|P2|NOT COMPLETED|6-month Treatment||0
114635|NCT01308788|277577|P1|NOT COMPLETED|6-month Treatment||0
114636|NCT01308788|277576|P2|COMPLETED|6-month Treatment||21
114637|NCT01308788|277577|P1|COMPLETED|6-month Treatment||14
114638|NCT01308788|277576|P2|STARTED|6-month Treatment||21
114639|NCT01308788|277577|P1|STARTED|6-month Treatment||14
114640|NCT01308762|277612|P3|NOT COMPLETED|Overall Study||0
114641|NCT01308762|277613|P2|NOT COMPLETED|Overall Study||1
114642|NCT01308762|277614|P1|NOT COMPLETED|Overall Study||0
114643|NCT01308762|277612|P3|COMPLETED|Overall Study||6
114644|NCT01308762|277613|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
114645|NCT01308762|277614|P1|COMPLETED|Overall Study||6
114646|NCT01308762|277612|P3|STARTED|Overall Study||6
114647|NCT01308762|277613|P2|STARTED|Overall Study||7
114648|NCT01308762|277614|P1|STARTED|Overall Study||6
114649|NCT01308749|277627|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
114650|NCT01308749|277628|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
114651|NCT01308749|277627|P2|COMPLETED|Period 2: Open Label Treatment||11
114652|NCT01308749|277628|P1|COMPLETED|Period 2: Open Label Treatment||11
114653|NCT01308749|277627|P2|STARTED|Period 2: Open Label Treatment||13
114654|NCT01308749|277628|P1|STARTED|Period 2: Open Label Treatment||11
114655|NCT01308749|277627|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
114656|NCT01308749|277628|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
114657|NCT01308749|277627|P2|COMPLETED|Period 1: Double Blind Treatment||13
114658|NCT01308749|277628|P1|COMPLETED|Period 1: Double Blind Treatment||11
114659|NCT01308749|277627|P2|STARTED|Period 1: Double Blind Treatment||13
114660|NCT01308749|277628|P1|STARTED|Period 1: Double Blind Treatment||12
114661|NCT01308736|277658|P2|NOT COMPLETED|Overall Study||5
114662|NCT01308736|277659|P1|NOT COMPLETED|Overall Study||6
114663|NCT01308736|277658|P2|COMPLETED|Overall Study||27
114664|NCT01308736|277659|P1|COMPLETED|Overall Study||25
114665|NCT01308736|277658|P2|STARTED|Overall Study||32
114666|NCT01308736|277659|P1|STARTED|Overall Study||31
114667|NCT01308619|277667|P2|NOT COMPLETED|Overall Study||3
114668|NCT01308619|277668|P1|NOT COMPLETED|Overall Study||7
114669|NCT01308619|277667|P2|COMPLETED|Overall Study||83
114670|NCT01308619|277668|P1|COMPLETED|Overall Study||77
114671|NCT01308619|277667|P2|STARTED|Overall Study||86
114672|NCT01308619|277668|P1|STARTED|Overall Study||84
114673|NCT01308580|277682|P2|NOT COMPLETED|Overall Study||7
114674|NCT01308580|277683|P1|NOT COMPLETED|Overall Study||12
114675|NCT01308580|277682|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
114676|NCT01308580|277683|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
114677|NCT01308580|277682|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
114678|NCT01308580|277683|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
114679|NCT01308580|277682|P2|STARTED|Overall Study||602
114680|NCT01308580|277683|P1|STARTED|Overall Study||598
114681|NCT01308567|277726|P3|NOT COMPLETED|Overall Study||4
114682|NCT01308567|277727|P2|NOT COMPLETED|Overall Study||4
114683|NCT01308567|277728|P1|NOT COMPLETED|Overall Study||2
114684|NCT01308567|277726|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
114685|NCT01308567|277727|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
114686|NCT01308567|277728|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
114687|NCT01308567|277726|P3|Ongoing Treatment at Data Cut-off|Overall Study||3
114688|NCT01308567|277727|P2|Ongoing Treatment at Data Cut-off|Overall Study||6
114689|NCT01308567|277728|P1|Ongoing Treatment at Data Cut-off|Overall Study||4
114690|NCT01308567|277726|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
114691|NCT01308567|277727|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
114692|NCT01308567|277728|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
114693|NCT01308567|277726|P3|STARTED|Overall Study|Randomized|388
114694|NCT01308567|277727|P2|STARTED|Overall Study|Randomized|389
114695|NCT01308567|277728|P1|STARTED|Overall Study|Randomized|391
114696|NCT01308476|277768|P2|NOT COMPLETED|Overall Study||2
114697|NCT01308476|277769|P1|NOT COMPLETED|Overall Study||3
114698|NCT01308476|277768|P2|COMPLETED|Overall Study||45
114699|NCT01308476|277769|P1|COMPLETED|Overall Study||45
114700|NCT01308476|277768|P2|STARTED|Overall Study|Entered and treated.|47
114701|NCT01308476|277769|P1|STARTED|Overall Study|Entered and treated.|48
114702|NCT01308463|277789|P1|NOT COMPLETED|Overall Study||29
114703|NCT01308463|277789|P1|COMPLETED|Overall Study||0
114704|NCT01308463|277789|P1|12 Years|Overall Study||2
114705|NCT01308463|277789|P1|11 Years|Overall Study||8
114706|NCT01308463|277789|P1|10 Years|Overall Study||8
114707|NCT01308463|277789|P1|9 Years|Overall Study||11
114708|NCT01308463|277789|P1|8 Years|Overall Study||14
114709|NCT01308463|277789|P1|7 Years|Overall Study||12
114710|NCT01308463|277789|P1|6 Years|Overall Study||11
114711|NCT01308463|277789|P1|5 Years|Overall Study||20
114712|NCT01308463|277789|P1|4 Years|Overall Study||20
114713|NCT01308463|277789|P1|3 Years|Overall Study||17
114714|NCT01308463|277789|P1|2 Years|Overall Study||18
114715|NCT01308463|277789|P1|1 Year|Overall Study||21
114716|NCT01308463|277789|P1|6 Months|Overall Study||23
114717|NCT01308463|277789|P1|STARTED|Overall Study||29
114718|NCT01308450|277796|P1|NOT COMPLETED|Overall Study||2
114719|NCT01308450|277796|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
114720|NCT01308450|277796|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
114721|NCT01308424|277802|P3|NOT COMPLETED|Randomization||2
114722|NCT01308424|277803|P2|NOT COMPLETED|Randomization||3
114723|NCT01308424|277804|P1|NOT COMPLETED|Randomization||0
114724|NCT01308424|277802|P3|COMPLETED|Randomization||82
114725|NCT01308424|277803|P2|COMPLETED|Randomization||84
114726|NCT01308424|277804|P1|COMPLETED|Randomization||0
114727|NCT01308424|277802|P3|STARTED|Randomization||84
114728|NCT01308424|277803|P2|STARTED|Randomization||87
114729|NCT01308424|277804|P1|STARTED|Randomization||0
114730|NCT01308424|277802|P3|NOT COMPLETED|Baseline Eligibility||0
114731|NCT01308424|277803|P2|NOT COMPLETED|Baseline Eligibility||0
114732|NCT01308424|277804|P1|NOT COMPLETED|Baseline Eligibility||71
114733|NCT01308424|277802|P3|COMPLETED|Baseline Eligibility||0
114734|NCT01308424|277803|P2|COMPLETED|Baseline Eligibility||0
114735|NCT01308424|277804|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
114736|NCT01308424|277802|P3|STARTED|Baseline Eligibility||0
114737|NCT01308424|277803|P2|STARTED|Baseline Eligibility||0
114738|NCT01308424|277804|P1|STARTED|Baseline Eligibility||242
114739|NCT01307956|277811|P1|NOT COMPLETED|Overall Study||0
114740|NCT01307956|277811|P1|COMPLETED|Overall Study||11
114741|NCT01307956|277811|P1|STARTED|Overall Study||11
114742|NCT01307891|277817|P2|NOT COMPLETED|Overall Study||1
114743|NCT01307891|277818|P1|NOT COMPLETED|Overall Study||3
114744|NCT01307891|277817|P2|COMPLETED|Overall Study||21
114745|NCT01307891|277818|P1|COMPLETED|Overall Study||39
114746|NCT01307891|277817|P2|STARTED|Overall Study||22
114747|NCT01307891|277818|P1|STARTED|Overall Study||42
114748|NCT01307787|277830|P2|NOT COMPLETED|Overall Study||0
114749|NCT01307787|277831|P1|NOT COMPLETED|Overall Study||2
114750|NCT01307787|277830|P2|COMPLETED|Overall Study||15
114751|NCT01307787|277831|P1|COMPLETED|Overall Study||17
114752|NCT01307787|277830|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
114753|NCT01307787|277831|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
114754|NCT01307787|277830|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
114755|NCT01307787|277831|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
114756|NCT01307787|277830|P2|STARTED|Overall Study||15
114757|NCT01307787|277831|P1|STARTED|Overall Study||19
114758|NCT01307631|277851|P2|NOT COMPLETED|Overall Study||0
114759|NCT01307631|277852|P1|NOT COMPLETED|Overall Study||0
114760|NCT01307631|277851|P2|COMPLETED|Overall Study||28
114761|NCT01307631|277852|P1|COMPLETED|Overall Study||9
114762|NCT01307631|277851|P2|STARTED|Overall Study||28
114763|NCT01307631|277852|P1|STARTED|Overall Study||9
114764|NCT01307618|277862|P2|NOT COMPLETED|Overall Study||0
114765|NCT01307618|277863|P1|NOT COMPLETED|Overall Study||0
114766|NCT01307618|277862|P2|COMPLETED|Overall Study||5
114767|NCT01307618|277863|P1|COMPLETED|Overall Study||5
114768|NCT01307618|277862|P2|STARTED|Overall Study||5
114769|NCT01307618|277863|P1|STARTED|Overall Study||5
114770|NCT01307462|277879|P1|NOT COMPLETED|Overall Study||1
114771|NCT01307462|277879|P1|COMPLETED|Overall Study||35
114772|NCT01307462|277879|P1|STARTED|Overall Study||36
114773|NCT01307423|277895|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
114774|NCT01307423|277896|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
114775|NCT01307423|277897|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
114776|NCT01307423|277898|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
114777|NCT01307423|277899|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
114778|NCT01307423|277900|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
114779|NCT01307423|277901|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
114780|NCT01307423|277895|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
114781|NCT01307423|277896|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
114782|NCT01307423|277897|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
114783|NCT01307423|277898|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
114784|NCT01307423|277899|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
114785|NCT01307423|277900|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
114786|NCT01307423|277901|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
114787|NCT01307423|277895|P7|STARTED|Active Treatment Phase (Week 25-52)||26
114788|NCT01307423|277896|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
114789|NCT01307423|277897|P5|STARTED|Active Treatment Phase (Week 25-52)||26
114790|NCT01307423|277898|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
114791|NCT01307423|277899|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
114792|NCT01307423|277900|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
114793|NCT01307423|277901|P1|STARTED|Active Treatment Phase (Week 25-52)||0
114794|NCT01307423|277895|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114795|NCT01307423|277896|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114796|NCT01307423|277897|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114797|NCT01307423|277898|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114798|NCT01307423|277899|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
114799|NCT01307423|277900|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
114800|NCT01307423|277901|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
114801|NCT01307423|277895|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114802|NCT01307423|277896|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114803|NCT01307423|277897|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114804|NCT01307423|277898|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
114805|NCT01307423|277899|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
114806|NCT01307423|277900|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
114807|NCT01307423|277901|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
114808|NCT01307423|277895|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114809|NCT01307423|277896|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114810|NCT01307423|277897|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114811|NCT01307423|277898|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114812|NCT01307423|277899|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
114813|NCT01307423|277900|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
114814|NCT01307423|277901|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
114815|NCT01307423|277895|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114816|NCT01307423|277896|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114817|NCT01307423|277897|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114818|NCT01307423|277898|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
114819|NCT01307423|277899|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
114820|NCT01307423|277900|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
114821|NCT01307423|277901|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
114822|NCT01307423|277895|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
114823|NCT01307423|277896|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
114824|NCT01307423|277897|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
114825|NCT01307423|277898|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
114826|NCT01307423|277899|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
114827|NCT01307423|277900|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
114828|NCT01307423|277901|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
114829|NCT01307423|277895|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
114830|NCT01307423|277896|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
114831|NCT01307423|277897|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
114832|NCT01307423|277898|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
114833|NCT01307423|277899|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
114834|NCT01307423|277900|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
114835|NCT01307423|277901|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
114836|NCT01307397|278010|P1|NOT COMPLETED|Overall Study||0
114837|NCT01307397|278010|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
114838|NCT01307397|278010|P1|STARTED|Overall Study||3219
114839|NCT01307319|278032|P3|NOT COMPLETED|Overall Study||7
114840|NCT01307319|278033|P2|NOT COMPLETED|Overall Study||8
114841|NCT01307319|278034|P1|NOT COMPLETED|Overall Study||4
114842|NCT01307319|278032|P3|COMPLETED|Overall Study||227
114843|NCT01307319|278033|P2|COMPLETED|Overall Study||234
114844|NCT01307319|278034|P1|COMPLETED|Overall Study||235
114845|NCT01307319|278032|P3|ITT Population|Overall Study||234
114846|NCT01307319|278033|P2|ITT Population|Overall Study||241
114847|NCT01307319|278034|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
114848|NCT01307319|278032|P3|Safety Population|Overall Study||234
114849|NCT01307319|278033|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
114850|NCT01307319|278034|P1|Safety Population|Overall Study||239
114851|NCT01307319|278032|P3|STARTED|Overall Study|Randomized|234
114852|NCT01307319|278033|P2|STARTED|Overall Study|Randomized|242
114853|NCT01307319|278034|P1|STARTED|Overall Study|Randomized|239
114854|NCT01307111|278048|P2|NOT COMPLETED|1-2 Week IUD Check up||2
114855|NCT01307111|278049|P1|NOT COMPLETED|1-2 Week IUD Check up||2
114856|NCT01307111|278048|P2|COMPLETED|1-2 Week IUD Check up||38
114857|NCT01307111|278049|P1|COMPLETED|1-2 Week IUD Check up||38
114858|NCT01307111|278048|P2|STARTED|1-2 Week IUD Check up||40
114859|NCT01307111|278049|P1|STARTED|1-2 Week IUD Check up||40
114860|NCT01307111|278048|P2|NOT COMPLETED|IUD Insertion||0
114861|NCT01307111|278049|P1|NOT COMPLETED|IUD Insertion||2
114862|NCT01307111|278048|P2|COMPLETED|IUD Insertion||40
114863|NCT01307111|278049|P1|COMPLETED|IUD Insertion||40
114864|NCT01307111|278048|P2|STARTED|IUD Insertion||40
114865|NCT01307111|278049|P1|STARTED|IUD Insertion||42
114866|NCT01307046|278059|P2|NOT COMPLETED|Overall Study||11
114867|NCT01307046|278060|P1|NOT COMPLETED|Overall Study||12
114868|NCT01307046|278059|P2|COMPLETED|Overall Study||159
114869|NCT01307046|278060|P1|COMPLETED|Overall Study||154
114870|NCT01307046|278059|P2|STARTED|Overall Study||170
114871|NCT01307046|278060|P1|STARTED|Overall Study||166
114872|NCT01307033|278072|P4|NOT COMPLETED|44-week Open-label Extension||12
114873|NCT01307033|278073|P3|NOT COMPLETED|44-week Open-label Extension||11
114874|NCT01307033|278074|P2|NOT COMPLETED|44-week Open-label Extension||0
114875|NCT01307033|278075|P1|NOT COMPLETED|44-week Open-label Extension||0
114876|NCT01307033|278072|P4|COMPLETED|44-week Open-label Extension||115
114877|NCT01307033|278073|P3|COMPLETED|44-week Open-label Extension||120
114878|NCT01307033|278074|P2|COMPLETED|44-week Open-label Extension||0
114879|NCT01307033|278075|P1|COMPLETED|44-week Open-label Extension||0
114880|NCT01307033|278072|P4|STARTED|44-week Open-label Extension||127
114881|NCT01307033|278073|P3|STARTED|44-week Open-label Extension||131
114882|NCT01307033|278074|P2|STARTED|44-week Open-label Extension||0
114883|NCT01307033|278075|P1|STARTED|44-week Open-label Extension||0
114884|NCT01307033|278072|P4|NOT COMPLETED|8-week Double-blind Period||0
114885|NCT01307033|278073|P3|NOT COMPLETED|8-week Double-blind Period||0
114886|NCT01307033|278074|P2|NOT COMPLETED|8-week Double-blind Period||7
114887|NCT01307033|278075|P1|NOT COMPLETED|8-week Double-blind Period||13
114888|NCT01307033|278072|P4|COMPLETED|8-week Double-blind Period||0
114889|NCT01307033|278073|P3|COMPLETED|8-week Double-blind Period||0
114890|NCT01307033|278074|P2|COMPLETED|8-week Double-blind Period||127
114891|NCT01307033|278075|P1|COMPLETED|8-week Double-blind Period||131
114892|NCT01307033|278072|P4|STARTED|8-week Double-blind Period||0
114893|NCT01307033|278073|P3|STARTED|8-week Double-blind Period||0
114894|NCT01307033|278074|P2|STARTED|8-week Double-blind Period||134
114895|NCT01307033|278075|P1|STARTED|8-week Double-blind Period||144
114896|NCT01307020|278097|P10|NOT COMPLETED|Overall Study||0
114897|NCT01307020|278098|P9|NOT COMPLETED|Overall Study||0
114898|NCT01307020|278099|P8|NOT COMPLETED|Overall Study||0
114899|NCT01307020|278100|P7|NOT COMPLETED|Overall Study||1
114900|NCT01307020|278101|P6|NOT COMPLETED|Overall Study||0
114901|NCT01307020|278102|P5|NOT COMPLETED|Overall Study||0
114902|NCT01307020|278103|P4|NOT COMPLETED|Overall Study||1
114903|NCT01307020|278104|P3|NOT COMPLETED|Overall Study||1
114904|NCT01307020|278105|P2|NOT COMPLETED|Overall Study||1
114905|NCT01307020|278106|P1|NOT COMPLETED|Overall Study||0
114906|NCT01307020|278097|P10|COMPLETED|Overall Study||62
114907|NCT01307020|278098|P9|COMPLETED|Overall Study||61
114908|NCT01307020|278099|P8|COMPLETED|Overall Study||60
114909|NCT01307020|278100|P7|COMPLETED|Overall Study||58
114910|NCT01307020|278101|P6|COMPLETED|Overall Study||61
114911|NCT01307020|278102|P5|COMPLETED|Overall Study||60
114912|NCT01307020|278103|P4|COMPLETED|Overall Study||60
114913|NCT01307020|278104|P3|COMPLETED|Overall Study||62
114914|NCT01307020|278105|P2|COMPLETED|Overall Study||62
114915|NCT01307020|278106|P1|COMPLETED|Overall Study||61
114916|NCT01307020|278097|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
114917|NCT01307020|278098|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
114918|NCT01307020|278099|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
114919|NCT01307020|278100|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
114920|NCT01307020|278101|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
114921|NCT01307020|278102|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
114922|NCT01307020|278103|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
114923|NCT01307020|278104|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
114924|NCT01307020|278105|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
114925|NCT01307020|278106|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
114926|NCT01307020|278097|P10|Safety Population|Overall Study||62
114927|NCT01307020|278098|P9|Safety Population|Overall Study||61
114928|NCT01307020|278099|P8|Safety Population|Overall Study||60
114929|NCT01307020|278100|P7|Safety Population|Overall Study||59
114930|NCT01307020|278101|P6|Safety Population|Overall Study||61
114931|NCT01307020|278102|P5|Safety Population|Overall Study||60
114932|NCT01307020|278103|P4|Safety Population|Overall Study||61
114933|NCT01307020|278104|P3|Safety Population|Overall Study||63
114934|NCT01307020|278105|P2|Safety Population|Overall Study||63
114935|NCT01307020|278106|P1|Safety Population|Overall Study||61
114936|NCT01307020|278097|P10|STARTED|Overall Study||62
114937|NCT01307020|278098|P9|STARTED|Overall Study||61
114938|NCT01307020|278099|P8|STARTED|Overall Study||60
114939|NCT01307020|278100|P7|STARTED|Overall Study||59
114940|NCT01307020|278101|P6|STARTED|Overall Study||61
114941|NCT01307020|278102|P5|STARTED|Overall Study||60
114942|NCT01307020|278103|P4|STARTED|Overall Study||61
114943|NCT01307020|278104|P3|STARTED|Overall Study||63
114944|NCT01307020|278105|P2|STARTED|Overall Study||63
114945|NCT01307020|278106|P1|STARTED|Overall Study||61
114946|NCT01307007|278150|P2|NOT COMPLETED|Overall Study||0
114947|NCT01307007|278151|P1|NOT COMPLETED|Overall Study||0
114948|NCT01307007|278150|P2|COMPLETED|Overall Study||30
114949|NCT01307007|278151|P1|COMPLETED|Overall Study||25
114950|NCT01307007|278150|P2|STARTED|Overall Study||30
114951|NCT01307007|278151|P1|STARTED|Overall Study||25
114952|NCT01306968|278161|P4|NOT COMPLETED|Overall Study||4
114953|NCT01306968|278162|P3|NOT COMPLETED|Overall Study||1
114954|NCT01306968|278163|P2|NOT COMPLETED|Overall Study||3
114955|NCT01306968|278164|P1|NOT COMPLETED|Overall Study||1
114956|NCT01306968|278161|P4|COMPLETED|Overall Study||21
114957|NCT01306968|278162|P3|COMPLETED|Overall Study||23
114958|NCT01306968|278163|P2|COMPLETED|Overall Study||20
114959|NCT01306968|278164|P1|COMPLETED|Overall Study||6
114960|NCT01306968|278161|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
114961|NCT01306968|278162|P3|STARTED|Overall Study||24
114962|NCT01306968|278163|P2|STARTED|Overall Study||23
114963|NCT01306968|278164|P1|STARTED|Overall Study||7
114964|NCT01306877|278188|P2|NOT COMPLETED|Overall Study||4
114965|NCT01306877|278189|P1|NOT COMPLETED|Overall Study||3
114966|NCT01306877|278188|P2|COMPLETED|Overall Study||67
114967|NCT01306877|278189|P1|COMPLETED|Overall Study||75
114968|NCT01306877|278188|P2|STARTED|Overall Study||71
114969|NCT01306877|278189|P1|STARTED|Overall Study||78
114970|NCT01306643|278207|P1|NOT COMPLETED|Overall Study||13
114971|NCT01306643|278207|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
114972|NCT01306643|278207|P1|STARTED|Overall Study||18
114973|NCT01306617|278219|P3|NOT COMPLETED|Overall Study||5
114974|NCT01306617|278220|P2|NOT COMPLETED|Overall Study||1
114975|NCT01306617|278221|P1|NOT COMPLETED|Overall Study||1
114976|NCT01306617|278219|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
114977|NCT01306617|278220|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
114978|NCT01306617|278221|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
114979|NCT01306617|278219|P3|STARTED|Overall Study||17
114980|NCT01306617|278220|P2|STARTED|Overall Study||14
114981|NCT01306617|278221|P1|STARTED|Overall Study||19
114982|NCT01306305|278264|P2|NOT COMPLETED|Overall Study||0
114983|NCT01306305|278265|P1|NOT COMPLETED|Overall Study||2
114984|NCT01306305|278264|P2|COMPLETED|Overall Study||55
114985|NCT01306305|278265|P1|COMPLETED|Overall Study||53
114986|NCT01306305|278264|P2|STARTED|Overall Study||55
114987|NCT01306305|278265|P1|STARTED|Overall Study||55
114988|NCT01306292|278281|P4|NOT COMPLETED|Second Injection||0
114989|NCT01306292|278282|P3|NOT COMPLETED|Second Injection||1
114990|NCT01306292|278283|P2|NOT COMPLETED|Second Injection||0
114991|NCT01306292|278284|P1|NOT COMPLETED|Second Injection||0
114992|NCT01306292|278281|P4|COMPLETED|Second Injection||10
114993|NCT01306292|278282|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
114994|NCT01306292|278283|P2|COMPLETED|Second Injection||8
114995|NCT01306292|278284|P1|COMPLETED|Second Injection||10
114996|NCT01306292|278281|P4|STARTED|Second Injection||10
114997|NCT01306292|278282|P3|STARTED|Second Injection||8
114998|NCT01306292|278283|P2|STARTED|Second Injection||8
114999|NCT01306292|278284|P1|STARTED|Second Injection||10
115000|NCT01306292|278281|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
115001|NCT01306292|278282|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
115002|NCT01306292|278283|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
115003|NCT01306292|278284|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
115004|NCT01306292|278281|P4|COMPLETED|Washout (at Least 10 Minutes)||10
115005|NCT01306292|278282|P3|COMPLETED|Washout (at Least 10 Minutes)||8
115006|NCT01306292|278283|P2|COMPLETED|Washout (at Least 10 Minutes)||8
115007|NCT01306292|278284|P1|COMPLETED|Washout (at Least 10 Minutes)||10
115008|NCT01306292|278281|P4|STARTED|Washout (at Least 10 Minutes)||10
115009|NCT01306292|278282|P3|STARTED|Washout (at Least 10 Minutes)||8
115010|NCT01306292|278283|P2|STARTED|Washout (at Least 10 Minutes)||8
115011|NCT01306292|278284|P1|STARTED|Washout (at Least 10 Minutes)||10
115012|NCT01306292|278281|P4|NOT COMPLETED|First Injection||0
115013|NCT01306292|278282|P3|NOT COMPLETED|First Injection||0
115014|NCT01306292|278283|P2|NOT COMPLETED|First Injection||0
115015|NCT01306292|278284|P1|NOT COMPLETED|First Injection||0
115016|NCT01306292|278281|P4|COMPLETED|First Injection||10
115017|NCT01306292|278282|P3|COMPLETED|First Injection||8
115018|NCT01306292|278283|P2|COMPLETED|First Injection||8
115019|NCT01306292|278284|P1|COMPLETED|First Injection||10
115020|NCT01306292|278281|P4|STARTED|First Injection||10
115021|NCT01306292|278282|P3|STARTED|First Injection||8
115022|NCT01306292|278283|P2|STARTED|First Injection||8
115023|NCT01306292|278284|P1|STARTED|First Injection||10
115024|NCT01306253|278302|P2|NOT COMPLETED|Overall Study||1
115025|NCT01306253|278303|P1|NOT COMPLETED|Overall Study||1
115026|NCT01306253|278302|P2|COMPLETED|Overall Study||56
115027|NCT01306253|278303|P1|COMPLETED|Overall Study||56
115028|NCT01306253|278302|P2|STARTED|Overall Study||57
115029|NCT01306253|278303|P1|STARTED|Overall Study||57
115030|NCT01306214|278320|P3|NOT COMPLETED|Overall Study||22
115031|NCT01306214|278321|P2|NOT COMPLETED|Overall Study||28
115032|NCT01306214|278322|P1|NOT COMPLETED|Overall Study||28
115033|NCT01306214|278320|P3|COMPLETED|Overall Study||168
115034|NCT01306214|278321|P2|COMPLETED|Overall Study||159
115035|NCT01306214|278322|P1|COMPLETED|Overall Study||161
115036|NCT01306214|278320|P3|STARTED|Overall Study||190
115037|NCT01306214|278321|P2|STARTED|Overall Study||187
115038|NCT01306214|278322|P1|STARTED|Overall Study||189
115039|NCT01306201|278339|P1|NOT COMPLETED|Overall Study||10
115040|NCT01306201|278339|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
115041|NCT01306201|278339|P1|STARTED|Overall Study||63
115042|NCT01306175|278347|P1|NOT COMPLETED|Second Intervention||0
115043|NCT01306175|278347|P1|COMPLETED|Second Intervention||20
115044|NCT01306175|278347|P1|STARTED|Second Intervention||20
115045|NCT01306175|278347|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
115046|NCT01306175|278347|P1|COMPLETED|Washout Period of at Least 14 Days||20
115047|NCT01306175|278347|P1|STARTED|Washout Period of at Least 14 Days||20
115048|NCT01306175|278347|P1|NOT COMPLETED|First Intervention||0
115049|NCT01306175|278347|P1|COMPLETED|First Intervention||20
115050|NCT01306175|278347|P1|STARTED|First Intervention||20
115051|NCT01306162|278361|P4|NOT COMPLETED|Period 4||0
115052|NCT01306162|278362|P3|NOT COMPLETED|Period 4||0
115053|NCT01306162|278363|P2|NOT COMPLETED|Period 4||0
115054|NCT01306162|278364|P1|NOT COMPLETED|Period 4||0
115055|NCT01306162|278361|P4|COMPLETED|Period 4||8
115056|NCT01306162|278362|P3|COMPLETED|Period 4||9
115057|NCT01306162|278363|P2|COMPLETED|Period 4||8
115058|NCT01306162|278364|P1|COMPLETED|Period 4||9
115059|NCT01306162|278361|P4|STARTED|Period 4||8
115060|NCT01306162|278362|P3|STARTED|Period 4||9
115061|NCT01306162|278363|P2|STARTED|Period 4||8
115062|NCT01306162|278364|P1|STARTED|Period 4||9
115063|NCT01306162|278361|P4|NOT COMPLETED|Washout 2||0
115064|NCT01306162|278362|P3|NOT COMPLETED|Washout 2||0
115065|NCT01306162|278363|P2|NOT COMPLETED|Washout 2||0
115066|NCT01306162|278364|P1|NOT COMPLETED|Washout 2||0
115067|NCT01306162|278361|P4|COMPLETED|Washout 2||8
115068|NCT01306162|278362|P3|COMPLETED|Washout 2||9
115069|NCT01306162|278363|P2|COMPLETED|Washout 2||8
115070|NCT01306162|278364|P1|COMPLETED|Washout 2||9
115071|NCT01306162|278361|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
115072|NCT01306162|278362|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
115073|NCT01306162|278363|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
115074|NCT01306162|278364|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
115075|NCT01306162|278361|P4|NOT COMPLETED|Period 3||0
115076|NCT01306162|278362|P3|NOT COMPLETED|Period 3||0
115077|NCT01306162|278363|P2|NOT COMPLETED|Period 3||0
115078|NCT01306162|278364|P1|NOT COMPLETED|Period 3||0
115079|NCT01306162|278361|P4|COMPLETED|Period 3||8
115080|NCT01306162|278362|P3|COMPLETED|Period 3||9
115081|NCT01306162|278363|P2|COMPLETED|Period 3||8
115082|NCT01306162|278364|P1|COMPLETED|Period 3||9
115083|NCT01306162|278361|P4|STARTED|Period 3||8
115084|NCT01306162|278362|P3|STARTED|Period 3||9
115085|NCT01306162|278363|P2|STARTED|Period 3||8
115086|NCT01306162|278364|P1|STARTED|Period 3||9
115087|NCT01306162|278361|P4|NOT COMPLETED|Period 2||0
115088|NCT01306162|278362|P3|NOT COMPLETED|Period 2||0
115089|NCT01306162|278363|P2|NOT COMPLETED|Period 2||0
115090|NCT01306162|278364|P1|NOT COMPLETED|Period 2||0
115091|NCT01306162|278361|P4|COMPLETED|Period 2||8
115092|NCT01306162|278362|P3|COMPLETED|Period 2||9
115093|NCT01306162|278363|P2|COMPLETED|Period 2||8
115094|NCT01306162|278364|P1|COMPLETED|Period 2||9
115095|NCT01306162|278361|P4|STARTED|Period 2|No washout phase after Period 2.|8
115096|NCT01306162|278362|P3|STARTED|Period 2|No washout phase after Period 2.|9
115097|NCT01306162|278363|P2|STARTED|Period 2|No washout phase after Period 2.|8
115098|NCT01306162|278364|P1|STARTED|Period 2|No washout phase after Period 2.|9
115099|NCT01306162|278361|P4|NOT COMPLETED|Washout 1||0
115100|NCT01306162|278362|P3|NOT COMPLETED|Washout 1||0
115101|NCT01306162|278363|P2|NOT COMPLETED|Washout 1||1
115102|NCT01306162|278364|P1|NOT COMPLETED|Washout 1||0
115103|NCT01306162|278361|P4|COMPLETED|Washout 1||8
115104|NCT01306162|278362|P3|COMPLETED|Washout 1||9
115105|NCT01306162|278363|P2|COMPLETED|Washout 1||8
115106|NCT01306162|278364|P1|COMPLETED|Washout 1||9
115107|NCT01306162|278361|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
115108|NCT01306162|278362|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
115109|NCT01306162|278363|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
115110|NCT01306162|278364|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
115111|NCT01306162|278361|P4|NOT COMPLETED|Period 1||1
115112|NCT01306162|278362|P3|NOT COMPLETED|Period 1||0
115113|NCT01306162|278363|P2|NOT COMPLETED|Period 1||0
115114|NCT01306162|278364|P1|NOT COMPLETED|Period 1||0
115115|NCT01306162|278361|P4|COMPLETED|Period 1||8
115116|NCT01306162|278362|P3|COMPLETED|Period 1||9
115117|NCT01306162|278363|P2|COMPLETED|Period 1||9
115118|NCT01306162|278364|P1|COMPLETED|Period 1||9
115119|NCT01306162|278361|P4|STARTED|Period 1||9
115120|NCT01306162|278362|P3|STARTED|Period 1||9
115121|NCT01306162|278363|P2|STARTED|Period 1||9
115122|NCT01306162|278364|P1|STARTED|Period 1||9
115123|NCT01306058|278392|P1|NOT COMPLETED|Overall Study||2
115124|NCT01306058|278392|P1|COMPLETED|Overall Study||25
115125|NCT01306058|278392|P1|STARTED|Overall Study||27
115126|NCT01306032|278418|P6|NOT COMPLETED|Disease Progression/Crossover||0
115127|NCT01306032|278419|P5|NOT COMPLETED|Disease Progression/Crossover||0
115128|NCT01306032|278420|P4|NOT COMPLETED|Disease Progression/Crossover||3
115129|NCT01306032|278421|P3|NOT COMPLETED|Disease Progression/Crossover||0
115130|NCT01306032|278422|P2|NOT COMPLETED|Disease Progression/Crossover||2
115131|NCT01306032|278423|P1|NOT COMPLETED|Disease Progression/Crossover||0
115132|NCT01306032|278418|P6|COMPLETED|Disease Progression/Crossover||0
115133|NCT01306032|278419|P5|COMPLETED|Disease Progression/Crossover||0
115134|NCT01306032|278420|P4|COMPLETED|Disease Progression/Crossover||26
115135|NCT01306032|278421|P3|COMPLETED|Disease Progression/Crossover||0
115136|NCT01306032|278422|P2|COMPLETED|Disease Progression/Crossover||14
115137|NCT01306032|278423|P1|COMPLETED|Disease Progression/Crossover||0
115138|NCT01306032|278418|P6|STARTED|Disease Progression/Crossover||0
115139|NCT01306032|278419|P5|STARTED|Disease Progression/Crossover||0
115140|NCT01306032|278420|P4|STARTED|Disease Progression/Crossover||29
115141|NCT01306032|278421|P3|STARTED|Disease Progression/Crossover||0
115142|NCT01306032|278422|P2|STARTED|Disease Progression/Crossover||16
115143|NCT01306032|278423|P1|STARTED|Disease Progression/Crossover||0
115144|NCT01306032|278418|P6|NOT COMPLETED|First Intervention||2
115145|NCT01306032|278419|P5|NOT COMPLETED|First Intervention||2
115146|NCT01306032|278420|P4|NOT COMPLETED|First Intervention||1
115147|NCT01306032|278421|P3|NOT COMPLETED|First Intervention||2
115148|NCT01306032|278422|P2|NOT COMPLETED|First Intervention||2
115149|NCT01306032|278423|P1|NOT COMPLETED|First Intervention||1
115150|NCT01306032|278418|P6|COMPLETED|First Intervention||0
115151|NCT01306032|278419|P5|COMPLETED|First Intervention||0
115152|NCT01306032|278420|P4|COMPLETED|First Intervention||37
115153|NCT01306032|278421|P3|COMPLETED|First Intervention||35
115154|NCT01306032|278422|P2|COMPLETED|First Intervention||18
115155|NCT01306032|278423|P1|COMPLETED|First Intervention||21
115156|NCT01306032|278418|P6|STARTED|First Intervention||2
115157|NCT01306032|278419|P5|STARTED|First Intervention||2
115158|NCT01306032|278420|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
115159|NCT01306032|278421|P3|STARTED|First Intervention||37
115160|NCT01306032|278422|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
115161|NCT01306032|278423|P1|STARTED|First Intervention||22
115162|NCT01305941|278475|P1|NOT COMPLETED|Overall Study||10
115163|NCT01305941|278475|P1|COMPLETED|Overall Study||22
115164|NCT01305941|278475|P1|STARTED|Overall Study||32
115165|NCT01305811|278489|P2|NOT COMPLETED|Overall Study||11
115166|NCT01305811|278490|P1|NOT COMPLETED|Overall Study||8
115167|NCT01305811|278489|P2|COMPLETED|Overall Study||41
115168|NCT01305811|278490|P1|COMPLETED|Overall Study||44
115169|NCT01305811|278489|P2|STARTED|Overall Study||52
115170|NCT01305811|278490|P1|STARTED|Overall Study||52
115171|NCT01305772|278500|P2|NOT COMPLETED|Overall Study||0
115172|NCT01305772|278501|P1|NOT COMPLETED|Overall Study||0
115173|NCT01305772|278500|P2|COMPLETED|Overall Study||1
115174|NCT01305772|278501|P1|COMPLETED|Overall Study||5
115175|NCT01305772|278500|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
115176|NCT01305772|278501|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
115177|NCT01305772|278500|P2|Surgery/Biopsy #2|Overall Study||1
115178|NCT01305772|278501|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
115179|NCT01305772|278500|P2|Research PET/CT #2|Overall Study||1
115180|NCT01305772|278501|P1|Research PET/CT #2|Overall Study||5
115181|NCT01305772|278500|P2|Panitumumab Dose #1|Overall Study||1
115182|NCT01305772|278501|P1|Panitumumab Dose #1|Overall Study||5
115183|NCT01305772|278500|P2|Research PET/CT #1|Overall Study||1
115184|NCT01305772|278501|P1|Research PET/CT #1|Overall Study||5
115185|NCT01305772|278500|P2|Genomic Screening + Biopsy #1|Overall Study||1
115186|NCT01305772|278501|P1|Genomic Screening + Biopsy #1|Overall Study||5
115187|NCT01305772|278500|P2|STARTED|Overall Study||1
115188|NCT01305772|278501|P1|STARTED|Overall Study||5
115189|NCT01305655|278508|P1|NOT COMPLETED|Overall Study||0
115190|NCT01305655|278508|P1|COMPLETED|Overall Study|December 31, 2014|47
115191|NCT01305655|278508|P1|STARTED|Overall Study|July 2008|47
115192|NCT01305577|278515|P3|NOT COMPLETED|Overall Study||10
115193|NCT01305577|278516|P2|NOT COMPLETED|Overall Study||11
115194|NCT01305577|278517|P1|NOT COMPLETED|Overall Study||13
115195|NCT01305577|278515|P3|COMPLETED|Overall Study||112
115196|NCT01305577|278516|P2|COMPLETED|Overall Study||110
115197|NCT01305577|278517|P1|COMPLETED|Overall Study||107
115198|NCT01305577|278515|P3|Received Treatment|Overall Study||122
115199|NCT01305577|278516|P2|Received Treatment|Overall Study||121
115200|NCT01305577|278517|P1|Received Treatment|Overall Study||119
115201|NCT01305577|278515|P3|STARTED|Overall Study||122
115202|NCT01305577|278516|P2|STARTED|Overall Study||121
115203|NCT01305577|278517|P1|STARTED|Overall Study||120
115204|NCT01305564|278546|P1|NOT COMPLETED|Overall Study||37
115205|NCT01305564|278546|P1|COMPLETED|Overall Study||163
115206|NCT01305564|278546|P1|STARTED|Overall Study||200
115207|NCT01305473|278561|P1|NOT COMPLETED|Overall Study||0
115208|NCT01305473|278561|P1|COMPLETED|Overall Study||90
115209|NCT01305473|278561|P1|STARTED|Overall Study||90
115210|NCT01305408|278573|P2|NOT COMPLETED|Overall Study||31
115211|NCT01305408|278574|P1|NOT COMPLETED|Overall Study||32
115212|NCT01305408|278573|P2|COMPLETED|Overall Study||169
115213|NCT01305408|278574|P1|COMPLETED|Overall Study||167
115214|NCT01305408|278573|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
115215|NCT01305408|278574|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
115216|NCT01305408|278573|P2|Safety Population|Overall Study|Treated participants.|200
115217|NCT01305408|278574|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
115218|NCT01305408|278573|P2|STARTED|Overall Study||200
115219|NCT01305408|278574|P1|STARTED|Overall Study||199
115220|NCT01305265|278626|P2|NOT COMPLETED|Overall Study||6
115221|NCT01305265|278627|P1|NOT COMPLETED|Overall Study||2
115222|NCT01305265|278626|P2|COMPLETED|Overall Study||64
115223|NCT01305265|278627|P1|COMPLETED|Overall Study||69
115224|NCT01305265|278626|P2|STARTED|Overall Study||70
115225|NCT01305265|278627|P1|STARTED|Overall Study||71
115226|NCT01305252|278635|P2|NOT COMPLETED|Overall Study||0
115227|NCT01305252|278636|P1|NOT COMPLETED|Overall Study||1
115228|NCT01305252|278635|P2|COMPLETED|Overall Study||11
115229|NCT01305252|278636|P1|COMPLETED|Overall Study||9
115230|NCT01305252|278635|P2|STARTED|Overall Study||11
115231|NCT01305252|278636|P1|STARTED|Overall Study||10
115232|NCT01305239|278650|P1|NOT COMPLETED|Overall Study||23
115233|NCT01305239|278650|P1|COMPLETED|Overall Study||375
115234|NCT01305239|278650|P1|Intent to Treat Population|Overall Study||287
115235|NCT01305239|278650|P1|Safety Set|Overall Study||397
115236|NCT01305239|278650|P1|STARTED|Overall Study||398
115237|NCT01305213|278660|P2|NOT COMPLETED|Overall Study||0
115238|NCT01305213|278661|P1|NOT COMPLETED|Overall Study||0
115239|NCT01305213|278660|P2|COMPLETED|Overall Study||54
115240|NCT01305213|278661|P1|COMPLETED|Overall Study||53
115241|NCT01305213|278660|P2|STARTED|Overall Study||54
115242|NCT01305213|278661|P1|STARTED|Overall Study||53
115243|NCT01305200|278680|P3|NOT COMPLETED|Overall Study||3
115244|NCT01305200|278681|P2|NOT COMPLETED|Overall Study||31
115245|NCT01305200|278682|P1|NOT COMPLETED|Overall Study||29
115246|NCT01305200|278680|P3|COMPLETED|Overall Study||0
115247|NCT01305200|278681|P2|COMPLETED|Overall Study||81
115248|NCT01305200|278682|P1|COMPLETED|Overall Study||82
115249|NCT01305200|278680|P3|STARTED|Overall Study||3
115250|NCT01305200|278681|P2|STARTED|Overall Study||112
115251|NCT01305200|278682|P1|STARTED|Overall Study||111
115252|NCT01305044|278712|P2|NOT COMPLETED|Overall Study||6
115253|NCT01305044|278713|P1|NOT COMPLETED|Overall Study||3
115254|NCT01305044|278712|P2|COMPLETED|Overall Study||25
115255|NCT01305044|278713|P1|COMPLETED|Overall Study||29
115256|NCT01305044|278712|P2|STARTED|Overall Study||31
115257|NCT01305044|278713|P1|STARTED|Overall Study||32
115258|NCT01304966|278737|P1|NOT COMPLETED|Overall Study||0
115259|NCT01304966|278737|P1|COMPLETED|Overall Study||15
115260|NCT01304966|278737|P1|STARTED|Overall Study||15
115261|NCT01304706|278743|P1|NOT COMPLETED|Overall Study||17
115262|NCT01304706|278743|P1|COMPLETED|Overall Study||104
115263|NCT01304706|278743|P1|STARTED|Overall Study||121
115264|NCT01304693|278752|P5|NOT COMPLETED|Overall Study||1
115265|NCT01304693|278753|P4|NOT COMPLETED|Overall Study||1
115266|NCT01304693|278754|P3|NOT COMPLETED|Overall Study||1
115267|NCT01304693|278755|P2|NOT COMPLETED|Overall Study||0
115268|NCT01304693|278756|P1|NOT COMPLETED|Overall Study||0
115269|NCT01304693|278752|P5|COMPLETED|Overall Study||60
115270|NCT01304693|278753|P4|COMPLETED|Overall Study||39
115271|NCT01304693|278754|P3|COMPLETED|Overall Study||47
115272|NCT01304693|278755|P2|COMPLETED|Overall Study||35
115273|NCT01304693|278756|P1|COMPLETED|Overall Study||10
115274|NCT01304693|278752|P5|STARTED|Overall Study||61
115275|NCT01304693|278753|P4|STARTED|Overall Study||40
115276|NCT01304693|278754|P3|STARTED|Overall Study||48
115277|NCT01304693|278755|P2|STARTED|Overall Study||35
115278|NCT01304693|278756|P1|STARTED|Overall Study||10
115279|NCT01304641|278775|P2|NOT COMPLETED|Overall Study||0
115280|NCT01304641|278776|P1|NOT COMPLETED|Overall Study||0
115281|NCT01304641|278775|P2|COMPLETED|Overall Study||20132
115282|NCT01304641|278776|P1|COMPLETED|Overall Study||11470
115283|NCT01304641|278775|P2|STARTED|Overall Study||20132
115284|NCT01304641|278776|P1|STARTED|Overall Study||11470
115285|NCT01304589|278794|P1|NOT COMPLETED|Overall Study||13
115286|NCT01304589|278794|P1|COMPLETED|Overall Study||18
115287|NCT01304589|278794|P1|STARTED|Overall Study||31
115288|NCT01304498|278803|P2|NOT COMPLETED|Overall Study||5
115289|NCT01304498|278804|P1|NOT COMPLETED|Overall Study||6
115290|NCT01304498|278803|P2|COMPLETED|Overall Study||295
115291|NCT01304498|278804|P1|COMPLETED|Overall Study||294
115292|NCT01304498|278803|P2|Received ≥1 Dose|Overall Study||300
115293|NCT01304498|278804|P1|Received ≥1 Dose|Overall Study||300
115294|NCT01304498|278803|P2|STARTED|Overall Study||300
115295|NCT01304498|278804|P1|STARTED|Overall Study||300
115296|NCT01304329|278824|P6|NOT COMPLETED|Third Intervention (3 Days)||0
115297|NCT01304329|278825|P5|NOT COMPLETED|Third Intervention (3 Days)||0
115298|NCT01304329|278826|P4|NOT COMPLETED|Third Intervention (3 Days)||0
115299|NCT01304329|278827|P3|NOT COMPLETED|Third Intervention (3 Days)||0
115300|NCT01304329|278828|P2|NOT COMPLETED|Third Intervention (3 Days)||1
115301|NCT01304329|278829|P1|NOT COMPLETED|Third Intervention (3 Days)||0
115302|NCT01304329|278824|P6|COMPLETED|Third Intervention (3 Days)||3
115303|NCT01304329|278825|P5|COMPLETED|Third Intervention (3 Days)||3
115304|NCT01304329|278826|P4|COMPLETED|Third Intervention (3 Days)||3
115305|NCT01304329|278827|P3|COMPLETED|Third Intervention (3 Days)||3
115306|NCT01304329|278828|P2|COMPLETED|Third Intervention (3 Days)||2
115307|NCT01304329|278829|P1|COMPLETED|Third Intervention (3 Days)||3
115308|NCT01304329|278824|P6|STARTED|Third Intervention (3 Days)||3
115309|NCT01304329|278825|P5|STARTED|Third Intervention (3 Days)||3
115310|NCT01304329|278826|P4|STARTED|Third Intervention (3 Days)||3
115311|NCT01304329|278827|P3|STARTED|Third Intervention (3 Days)||3
115312|NCT01304329|278828|P2|STARTED|Third Intervention (3 Days)||3
115313|NCT01304329|278829|P1|STARTED|Third Intervention (3 Days)||3
115314|NCT01304329|278824|P6|NOT COMPLETED|Second Intervention (3 Days)||0
115315|NCT01304329|278825|P5|NOT COMPLETED|Second Intervention (3 Days)||0
115316|NCT01304329|278826|P4|NOT COMPLETED|Second Intervention (3 Days)||0
115317|NCT01304329|278827|P3|NOT COMPLETED|Second Intervention (3 Days)||0
115318|NCT01304329|278828|P2|NOT COMPLETED|Second Intervention (3 Days)||0
115319|NCT01304329|278829|P1|NOT COMPLETED|Second Intervention (3 Days)||0
115320|NCT01304329|278824|P6|COMPLETED|Second Intervention (3 Days)||3
115321|NCT01304329|278825|P5|COMPLETED|Second Intervention (3 Days)||3
115322|NCT01304329|278826|P4|COMPLETED|Second Intervention (3 Days)||3
115323|NCT01304329|278827|P3|COMPLETED|Second Intervention (3 Days)||3
115324|NCT01304329|278828|P2|COMPLETED|Second Intervention (3 Days)||3
115325|NCT01304329|278829|P1|COMPLETED|Second Intervention (3 Days)||3
115326|NCT01304329|278824|P6|STARTED|Second Intervention (3 Days)||3
115327|NCT01304329|278825|P5|STARTED|Second Intervention (3 Days)||3
115328|NCT01304329|278826|P4|STARTED|Second Intervention (3 Days)||3
115329|NCT01304329|278827|P3|STARTED|Second Intervention (3 Days)||3
115330|NCT01304329|278828|P2|STARTED|Second Intervention (3 Days)||3
115331|NCT01304329|278829|P1|STARTED|Second Intervention (3 Days)||3
115332|NCT01304329|278824|P6|NOT COMPLETED|First Intervention (3 Days)||0
115333|NCT01304329|278825|P5|NOT COMPLETED|First Intervention (3 Days)||0
115334|NCT01304329|278826|P4|NOT COMPLETED|First Intervention (3 Days)||0
115335|NCT01304329|278827|P3|NOT COMPLETED|First Intervention (3 Days)||0
115336|NCT01304329|278828|P2|NOT COMPLETED|First Intervention (3 Days)||0
115337|NCT01304329|278829|P1|NOT COMPLETED|First Intervention (3 Days)||0
115338|NCT01304329|278824|P6|COMPLETED|First Intervention (3 Days)||3
115339|NCT01304329|278825|P5|COMPLETED|First Intervention (3 Days)||3
115340|NCT01304329|278826|P4|COMPLETED|First Intervention (3 Days)||3
115341|NCT01304329|278827|P3|COMPLETED|First Intervention (3 Days)||3
115342|NCT01304329|278828|P2|COMPLETED|First Intervention (3 Days)||3
115343|NCT01304329|278829|P1|COMPLETED|First Intervention (3 Days)||3
115344|NCT01304329|278824|P6|STARTED|First Intervention (3 Days)||3
115345|NCT01304329|278825|P5|STARTED|First Intervention (3 Days)||3
115346|NCT01304329|278826|P4|STARTED|First Intervention (3 Days)||3
115347|NCT01304329|278827|P3|STARTED|First Intervention (3 Days)||3
115348|NCT01304329|278828|P2|STARTED|First Intervention (3 Days)||3
115349|NCT01304329|278829|P1|STARTED|First Intervention (3 Days)||3
115350|NCT01304316|278846|P1|NOT COMPLETED|Overall Study||0
115351|NCT01304316|278846|P1|COMPLETED|Overall Study||12
115352|NCT01304316|278846|P1|STARTED|Overall Study||12
115353|NCT01304277|278860|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
115354|NCT01304277|278860|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
115355|NCT01304277|278860|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
115356|NCT01304277|278860|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
115357|NCT01304277|278860|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
115358|NCT01304277|278860|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
115359|NCT01304238|278882|P10|NOT COMPLETED|Overall Study||0
115360|NCT01304238|278883|P9|NOT COMPLETED|Overall Study||0
115361|NCT01304238|278884|P8|NOT COMPLETED|Overall Study||0
115362|NCT01304238|278885|P7|NOT COMPLETED|Overall Study||0
115363|NCT01304238|278886|P6|NOT COMPLETED|Overall Study||0
115364|NCT01304238|278887|P5|NOT COMPLETED|Overall Study||0
115365|NCT01304238|278888|P4|NOT COMPLETED|Overall Study||0
115366|NCT01304238|278889|P3|NOT COMPLETED|Overall Study||0
115367|NCT01304238|278890|P2|NOT COMPLETED|Overall Study||0
115368|NCT01304238|278891|P1|NOT COMPLETED|Overall Study||0
115369|NCT01304238|278882|P10|COMPLETED|Overall Study||3
115370|NCT01304238|278883|P9|COMPLETED|Overall Study||1
115371|NCT01304238|278884|P8|COMPLETED|Overall Study||4
115372|NCT01304238|278885|P7|COMPLETED|Overall Study||5
115373|NCT01304238|278886|P6|COMPLETED|Overall Study||11
115374|NCT01304238|278887|P5|COMPLETED|Overall Study||11
115375|NCT01304238|278888|P4|COMPLETED|Overall Study||78
115376|NCT01304238|278889|P3|COMPLETED|Overall Study||46
115377|NCT01304238|278890|P2|COMPLETED|Overall Study||4
115378|NCT01304238|278891|P1|COMPLETED|Overall Study||32
115379|NCT01304238|278882|P10|STARTED|Overall Study||3
115380|NCT01304238|278883|P9|STARTED|Overall Study||1
115381|NCT01304238|278884|P8|STARTED|Overall Study||4
115382|NCT01304238|278885|P7|STARTED|Overall Study||5
115383|NCT01304238|278886|P6|STARTED|Overall Study||11
115384|NCT01304238|278887|P5|STARTED|Overall Study||11
115385|NCT01304238|278888|P4|STARTED|Overall Study||78
115386|NCT01304238|278889|P3|STARTED|Overall Study||46
115387|NCT01304238|278890|P2|STARTED|Overall Study||4
115388|NCT01304238|278891|P1|STARTED|Overall Study||32
115389|NCT01304147|278963|P2|NOT COMPLETED|Second Intervention (7days)||1
115390|NCT01304147|278964|P1|NOT COMPLETED|Second Intervention (7days)||1
115391|NCT01304147|278963|P2|COMPLETED|Second Intervention (7days)||9
115392|NCT01304147|278964|P1|COMPLETED|Second Intervention (7days)||9
115393|NCT01304147|278963|P2|STARTED|Second Intervention (7days)||10
115394|NCT01304147|278964|P1|STARTED|Second Intervention (7days)||10
115395|NCT01304147|278963|P2|NOT COMPLETED|Washout (1 Day)||0
115396|NCT01304147|278964|P1|NOT COMPLETED|Washout (1 Day)||0
115397|NCT01304147|278963|P2|COMPLETED|Washout (1 Day)||10
115398|NCT01304147|278964|P1|COMPLETED|Washout (1 Day)||10
115399|NCT01304147|278963|P2|STARTED|Washout (1 Day)||10
115400|NCT01304147|278964|P1|STARTED|Washout (1 Day)||10
115401|NCT01304147|278963|P2|NOT COMPLETED|First Intervention (7days)||0
115402|NCT01304147|278964|P1|NOT COMPLETED|First Intervention (7days)||0
115403|NCT01304147|278963|P2|COMPLETED|First Intervention (7days)||10
115404|NCT01304147|278964|P1|COMPLETED|First Intervention (7days)||10
115405|NCT01304147|278963|P2|STARTED|First Intervention (7days)||10
115406|NCT01304147|278964|P1|STARTED|First Intervention (7days)||10
115407|NCT01304082|278972|P5|NOT COMPLETED|Overall Study||0
115408|NCT01304082|278973|P4|NOT COMPLETED|Overall Study||0
115409|NCT01304082|278974|P3|NOT COMPLETED|Overall Study||0
115410|NCT01304082|278975|P2|NOT COMPLETED|Overall Study||0
115411|NCT01304082|278976|P1|NOT COMPLETED|Overall Study||0
115412|NCT01304082|278972|P5|COMPLETED|Overall Study||5
115413|NCT01304082|278973|P4|COMPLETED|Overall Study||8
115414|NCT01304082|278974|P3|COMPLETED|Overall Study||11
115415|NCT01304082|278975|P2|COMPLETED|Overall Study||2
115416|NCT01304082|278976|P1|COMPLETED|Overall Study||3
115417|NCT01304082|278972|P5|Third Intervention|Overall Study||5
115418|NCT01304082|278973|P4|Third Intervention|Overall Study||8
115419|NCT01304082|278974|P3|Third Intervention|Overall Study||11
115420|NCT01304082|278975|P2|Third Intervention|Overall Study||2
115421|NCT01304082|278976|P1|Third Intervention|Overall Study||3
115422|NCT01304082|278972|P5|Second Intervention|Overall Study||5
115423|NCT01304082|278973|P4|Second Intervention|Overall Study||8
115424|NCT01304082|278974|P3|Second Intervention|Overall Study||11
115425|NCT01304082|278975|P2|Second Intervention|Overall Study||2
115426|NCT01304082|278976|P1|Second Intervention|Overall Study||3
115427|NCT01304082|278972|P5|First Intervention|Overall Study||5
115428|NCT01304082|278973|P4|First Intervention|Overall Study||8
115429|NCT01304082|278974|P3|First Intervention|Overall Study||11
115430|NCT01304082|278975|P2|First Intervention|Overall Study||2
115431|NCT01304082|278976|P1|First Intervention|Overall Study||3
115432|NCT01304082|278972|P5|STARTED|Overall Study||5
115433|NCT01304082|278973|P4|STARTED|Overall Study||8
115434|NCT01304082|278974|P3|STARTED|Overall Study||11
115435|NCT01304082|278975|P2|STARTED|Overall Study||2
115436|NCT01304082|278976|P1|STARTED|Overall Study||3
115437|NCT01303861|278998|P4|NOT COMPLETED|Overall Study||59
115438|NCT01303861|278999|P3|NOT COMPLETED|Overall Study||36
115439|NCT01303861|279000|P2|NOT COMPLETED|Overall Study||25
115440|NCT01303861|279001|P1|NOT COMPLETED|Overall Study||58
115441|NCT01303861|278998|P4|COMPLETED|Overall Study||54
115442|NCT01303861|278999|P3|COMPLETED|Overall Study||19
115443|NCT01303861|279000|P2|COMPLETED|Overall Study||25
115444|NCT01303861|279001|P1|COMPLETED|Overall Study||51
115445|NCT01303861|278998|P4|Finished Treatment Phase|Overall Study||72
115446|NCT01303861|278999|P3|Finished Treatment Phase|Overall Study||39
115447|NCT01303861|279000|P2|Finished Treatment Phase|Overall Study||34
115448|NCT01303861|279001|P1|Finished Treatment Phase|Overall Study||71
115449|NCT01303861|278998|P4|STARTED|Overall Study||113
115450|NCT01303861|278999|P3|STARTED|Overall Study||55
115451|NCT01303861|279000|P2|STARTED|Overall Study||50
115452|NCT01303861|279001|P1|STARTED|Overall Study||109
115453|NCT01303835|279022|P2|NOT COMPLETED|Overall Study||25
115454|NCT01303835|279023|P1|NOT COMPLETED|Overall Study||19
115455|NCT01303835|279022|P2|COMPLETED|Overall Study||31
115456|NCT01303835|279023|P1|COMPLETED|Overall Study||35
115457|NCT01303835|279022|P2|STARTED|Overall Study||56
115458|NCT01303835|279023|P1|STARTED|Overall Study||54
115459|NCT01303744|279037|P4|NOT COMPLETED|Overall Study||0
115460|NCT01303744|279038|P3|NOT COMPLETED|Overall Study||0
115461|NCT01303744|279039|P2|NOT COMPLETED|Overall Study||0
115462|NCT01303744|279040|P1|NOT COMPLETED|Overall Study||0
115463|NCT01303744|279037|P4|COMPLETED|Overall Study||24
115464|NCT01303744|279038|P3|COMPLETED|Overall Study||24
115465|NCT01303744|279039|P2|COMPLETED|Overall Study||24
115466|NCT01303744|279040|P1|COMPLETED|Overall Study||24
115467|NCT01303744|279037|P4|STARTED|Overall Study||24
115468|NCT01303744|279038|P3|STARTED|Overall Study||24
115469|NCT01303744|279039|P2|STARTED|Overall Study||24
115470|NCT01303744|279040|P1|STARTED|Overall Study||24
115471|NCT01303627|279060|P2|NOT COMPLETED|Overall Study||1
115472|NCT01303627|279061|P1|NOT COMPLETED|Overall Study||0
115473|NCT01303627|279060|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
115474|NCT01303627|279061|P1|COMPLETED|Overall Study||21
115475|NCT01303627|279060|P2|STARTED|Overall Study||21
115476|NCT01303627|279061|P1|STARTED|Overall Study||21
115477|NCT01303510|279069|P2|NOT COMPLETED|Overall Study||0
115478|NCT01303510|279070|P1|NOT COMPLETED|Overall Study||1
115479|NCT01303510|279069|P2|COMPLETED|Overall Study||56
115480|NCT01303510|279070|P1|COMPLETED|Overall Study||54
115481|NCT01303510|279069|P2|STARTED|Overall Study||56
115482|NCT01303510|279070|P1|STARTED|Overall Study||55
115483|NCT01303445|279084|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
115484|NCT01303445|279085|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
115485|NCT01303445|279084|P2|COMPLETED|Follow-up Period (14 Days)||25
115486|NCT01303445|279085|P1|COMPLETED|Follow-up Period (14 Days)||26
115487|NCT01303445|279084|P2|STARTED|Follow-up Period (14 Days)||26
115488|NCT01303445|279085|P1|STARTED|Follow-up Period (14 Days)||26
115489|NCT01303445|279084|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
115490|NCT01303445|279085|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
115491|NCT01303445|279084|P2|COMPLETED|Fourth Intervention (7 Days)||26
115492|NCT01303445|279085|P1|COMPLETED|Fourth Intervention (7 Days)||26
115493|NCT01303445|279084|P2|STARTED|Fourth Intervention (7 Days)||26
115494|NCT01303445|279085|P1|STARTED|Fourth Intervention (7 Days)||27
115495|NCT01303445|279084|P2|NOT COMPLETED|Third Intervention (7 Days)||0
115496|NCT01303445|279085|P1|NOT COMPLETED|Third Intervention (7 Days)||0
115497|NCT01303445|279084|P2|COMPLETED|Third Intervention (7 Days)||26
115498|NCT01303445|279085|P1|COMPLETED|Third Intervention (7 Days)||27
115499|NCT01303445|279084|P2|STARTED|Third Intervention (7 Days)||26
115500|NCT01303445|279085|P1|STARTED|Third Intervention (7 Days)||27
115501|NCT01303445|279084|P2|NOT COMPLETED|Washout (14 Days)||2
115502|NCT01303445|279085|P1|NOT COMPLETED|Washout (14 Days)||1
115503|NCT01303445|279084|P2|COMPLETED|Washout (14 Days)||26
115504|NCT01303445|279085|P1|COMPLETED|Washout (14 Days)||27
115505|NCT01303445|279084|P2|STARTED|Washout (14 Days)||28
115506|NCT01303445|279085|P1|STARTED|Washout (14 Days)||28
115507|NCT01303445|279084|P2|NOT COMPLETED|Second Intervention (7 Days)||2
115508|NCT01303445|279085|P1|NOT COMPLETED|Second Intervention (7 Days)||1
115509|NCT01303445|279084|P2|COMPLETED|Second Intervention (7 Days)||28
115510|NCT01303445|279085|P1|COMPLETED|Second Intervention (7 Days)||28
115511|NCT01303445|279084|P2|STARTED|Second Intervention (7 Days)||30
115512|NCT01303445|279085|P1|STARTED|Second Intervention (7 Days)||29
115513|NCT01303445|279084|P2|NOT COMPLETED|First Intervention (7 Days)||0
115514|NCT01303445|279085|P1|NOT COMPLETED|First Intervention (7 Days)||1
115515|NCT01303445|279084|P2|COMPLETED|First Intervention (7 Days)||30
115516|NCT01303445|279085|P1|COMPLETED|First Intervention (7 Days)||29
115517|NCT01303445|279084|P2|STARTED|First Intervention (7 Days)||30
115518|NCT01303445|279085|P1|STARTED|First Intervention (7 Days)||30
115519|NCT01303406|279117|P2|NOT COMPLETED|Overall Study||1
115520|NCT01303406|279118|P1|NOT COMPLETED|Overall Study||0
115521|NCT01303406|279117|P2|COMPLETED|Overall Study||15
115522|NCT01303406|279118|P1|COMPLETED|Overall Study||13
115523|NCT01303406|279117|P2|STARTED|Overall Study||16
115524|NCT01303406|279118|P1|STARTED|Overall Study||13
115525|NCT01303380|279126|P1|NOT COMPLETED|Overall Study||1
115526|NCT01303380|279126|P1|COMPLETED|Overall Study||8
115527|NCT01303380|279126|P1|STARTED|Overall Study||9
115528|NCT01303224|279156|P4|NOT COMPLETED|Overall Study||10
115529|NCT01303224|279157|P3|NOT COMPLETED|Overall Study||6
115530|NCT01303224|279158|P2|NOT COMPLETED|Overall Study||11
115531|NCT01303224|279159|P1|NOT COMPLETED|Overall Study||11
115532|NCT01303224|279156|P4|COMPLETED|Overall Study||133
115533|NCT01303224|279157|P3|COMPLETED|Overall Study||133
115534|NCT01303224|279158|P2|COMPLETED|Overall Study||131
115535|NCT01303224|279159|P1|COMPLETED|Overall Study||130
115536|NCT01303224|279156|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
115537|NCT01303224|279157|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
115538|NCT01303224|279158|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
115539|NCT01303224|279159|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
115540|NCT01303224|279156|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
115541|NCT01303224|279157|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
115542|NCT01303224|279158|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
115543|NCT01303224|279159|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
115544|NCT01303159|279185|P1|NOT COMPLETED|Overall Study||23
115545|NCT01303159|279185|P1|COMPLETED|Overall Study||6
115546|NCT01303159|279185|P1|STARTED|Overall Study||29
115547|NCT01302938|279192|P2|NOT COMPLETED|Overall Study||0
115548|NCT01302938|279193|P1|NOT COMPLETED|Overall Study||2
115549|NCT01302938|279192|P2|COMPLETED|Overall Study||6
115550|NCT01302938|279193|P1|COMPLETED|Overall Study||10
115551|NCT01302938|279192|P2|STARTED|Overall Study||6
115552|NCT01302938|279193|P1|STARTED|Overall Study||12
115553|NCT01302899|279238|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
115554|NCT01302899|279239|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
115555|NCT01302899|279238|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
115556|NCT01302899|279239|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
115557|NCT01302899|279238|P2|STARTED|Period 4 (Weeks 19 to 26)||3
115558|NCT01302899|279239|P1|STARTED|Period 4 (Weeks 19 to 26)||3
115559|NCT01302899|279238|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
115560|NCT01302899|279239|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
115561|NCT01302899|279238|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
115562|NCT01302899|279239|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
115563|NCT01302899|279238|P2|STARTED|Period 3 (Weeks 13 to 18)||3
115564|NCT01302899|279239|P1|STARTED|Period 3 (Weeks 13 to 18)||3
115565|NCT01302899|279238|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
115566|NCT01302899|279239|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
115567|NCT01302899|279238|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
115568|NCT01302899|279239|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
115569|NCT01302899|279238|P2|STARTED|Period 2 (Weeks 7 to 12)||4
115570|NCT01302899|279239|P1|STARTED|Period 2 (Weeks 7 to 12)||4
115571|NCT01302899|279238|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
115572|NCT01302899|279239|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
115573|NCT01302899|279238|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
115574|NCT01302899|279239|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
115575|NCT01302899|279238|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
115576|NCT01302899|279239|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
115577|NCT01302860|279289|P1|NOT COMPLETED|Overall Study||0
115578|NCT01302860|279289|P1|COMPLETED|Overall Study||17
115579|NCT01302860|279289|P1|STARTED|Overall Study||17
115580|NCT01302743|279304|P3|NOT COMPLETED|Overall Study||2
115581|NCT01302743|279305|P2|NOT COMPLETED|Overall Study||1
115582|NCT01302743|279306|P1|NOT COMPLETED|Overall Study||1
115583|NCT01302743|279304|P3|COMPLETED|Overall Study||8
115584|NCT01302743|279305|P2|COMPLETED|Overall Study||7
115585|NCT01302743|279306|P1|COMPLETED|Overall Study||6
115586|NCT01302743|279304|P3|STARTED|Overall Study||10
115587|NCT01302743|279305|P2|STARTED|Overall Study||8
115588|NCT01302743|279306|P1|STARTED|Overall Study||7
115589|NCT01302691|279319|P2|NOT COMPLETED|Overall Study||6
115590|NCT01302691|279320|P1|NOT COMPLETED|Overall Study||10
115591|NCT01302691|279319|P2|COMPLETED|Overall Study||157
115592|NCT01302691|279320|P1|COMPLETED|Overall Study||154
115593|NCT01302691|279319|P2|STARTED|Overall Study||163
115594|NCT01302691|279320|P1|STARTED|Overall Study||164
115595|NCT01302548|279340|P2|NOT COMPLETED|Overall Study||1
115596|NCT01302548|279341|P1|NOT COMPLETED|Overall Study||2
115597|NCT01302548|279340|P2|COMPLETED|Overall Study||18
115598|NCT01302548|279341|P1|COMPLETED|Overall Study||12
115599|NCT01302548|279340|P2|STARTED|Overall Study||19
115600|NCT01302548|279341|P1|STARTED|Overall Study||14
115601|NCT01302483|279353|P2|NOT COMPLETED|Overall Study||0
115602|NCT01302483|279354|P1|NOT COMPLETED|Overall Study||0
115603|NCT01302483|279353|P2|COMPLETED|Overall Study||15
115604|NCT01302483|279354|P1|COMPLETED|Overall Study||30
115605|NCT01302483|279353|P2|STARTED|Overall Study||15
115606|NCT01302483|279354|P1|STARTED|Overall Study||30
115607|NCT01302444|279370|P2|NOT COMPLETED|Overall Study||0
115608|NCT01302444|279371|P1|NOT COMPLETED|Overall Study||0
115609|NCT01302444|279370|P2|COMPLETED|Overall Study||0
115610|NCT01302444|279371|P1|COMPLETED|Overall Study||1
115611|NCT01302444|279370|P2|STARTED|Overall Study||0
115612|NCT01302444|279371|P1|STARTED|Overall Study||1
115613|NCT01302418|279391|P1|NOT COMPLETED|Overall Study||18
115614|NCT01302418|279391|P1|COMPLETED|Overall Study||254
115615|NCT01302418|279391|P1|STARTED|Overall Study||272
115616|NCT01302392|279397|P2|NOT COMPLETED|Overall Study||1
115617|NCT01302392|279398|P1|NOT COMPLETED|Overall Study||7
115618|NCT01302392|279397|P2|COMPLETED|Overall Study||156
115619|NCT01302392|279398|P1|COMPLETED|Overall Study||151
115620|NCT01302392|279397|P2|Treated|Overall Study||157
115621|NCT01302392|279398|P1|Treated|Overall Study||153
115622|NCT01302392|279397|P2|STARTED|Overall Study||157
115623|NCT01302392|279398|P1|STARTED|Overall Study||158
115624|NCT01302366|279418|P1|NOT COMPLETED|Overall Study||5
115625|NCT01302366|279418|P1|COMPLETED|Overall Study||15
115626|NCT01302366|279418|P1|STARTED|Overall Study||20
115627|NCT01302119|279426|P2|NOT COMPLETED|Overall Study||28
115628|NCT01302119|279427|P1|NOT COMPLETED|Overall Study||50
115629|NCT01302119|279426|P2|COMPLETED|Overall Study||177
115630|NCT01302119|279427|P1|COMPLETED|Overall Study||349
115631|NCT01302119|279426|P2|STARTED|Overall Study||205
115632|NCT01302119|279427|P1|STARTED|Overall Study||399
115633|NCT01302067|279442|P3|NOT COMPLETED|Overall Study||98
115634|NCT01302067|279443|P2|NOT COMPLETED|Overall Study||34
115635|NCT01302067|279444|P1|NOT COMPLETED|Overall Study||78
115636|NCT01302067|279442|P3|COMPLETED|Overall Study||681
115637|NCT01302067|279443|P2|COMPLETED|Overall Study||352
115638|NCT01302067|279444|P1|COMPLETED|Overall Study||712
115639|NCT01302067|279442|P3|STARTED|Overall Study||779
115640|NCT01302067|279443|P2|STARTED|Overall Study||386
115641|NCT01302067|279444|P1|STARTED|Overall Study||790
115642|NCT01302054|279515|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
115643|NCT01302054|279516|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
115644|NCT01302054|279517|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
115645|NCT01302054|279515|P3|COMPLETED|Double-Blind Treatment Phase||255
115646|NCT01302054|279516|P2|COMPLETED|Double-Blind Treatment Phase||281
115647|NCT01302054|279517|P1|COMPLETED|Double-Blind Treatment Phase||0
115648|NCT01302054|279515|P3|STARTED|Double-Blind Treatment Phase||301
115649|NCT01302054|279516|P2|STARTED|Double-Blind Treatment Phase||308
115650|NCT01302054|279517|P1|STARTED|Double-Blind Treatment Phase||0
115651|NCT01302054|279515|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
115652|NCT01302054|279516|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
115653|NCT01302054|279517|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
115654|NCT01302054|279515|P3|COMPLETED|Between Open-Label and Double Blind||0
115655|NCT01302054|279516|P2|COMPLETED|Between Open-Label and Double Blind||0
115656|NCT01302054|279517|P1|COMPLETED|Between Open-Label and Double Blind||609
115657|NCT01302054|279515|P3|STARTED|Between Open-Label and Double Blind||0
115658|NCT01302054|279516|P2|STARTED|Between Open-Label and Double Blind||0
115659|NCT01302054|279517|P1|STARTED|Between Open-Label and Double Blind||611
115660|NCT01302054|279515|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
115661|NCT01302054|279516|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
115662|NCT01302054|279517|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
115663|NCT01302054|279515|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
115664|NCT01302054|279516|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
115665|NCT01302054|279517|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
115666|NCT01302054|279515|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
115667|NCT01302054|279516|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
115668|NCT01302054|279517|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
115669|NCT01302041|279544|P1|NOT COMPLETED|Overall Study||50
115670|NCT01302041|279544|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|17
115671|NCT01302041|279544|P1|STARTED|Overall Study||67
115672|NCT01301963|279575|P2|NOT COMPLETED|Overall Study||0
115673|NCT01301963|279576|P1|NOT COMPLETED|Overall Study||0
115674|NCT01301963|279575|P2|COMPLETED|Overall Study||4
115675|NCT01301963|279576|P1|COMPLETED|Overall Study||5
115676|NCT01301963|279575|P2|STARTED|Overall Study||4
115677|NCT01301963|279576|P1|STARTED|Overall Study||5
115678|NCT01301950|279586|P2|NOT COMPLETED|Overall Study||1
115679|NCT01301950|279587|P1|NOT COMPLETED|Overall Study||0
115680|NCT01301950|279586|P2|COMPLETED|Overall Study||14
115681|NCT01301950|279587|P1|COMPLETED|Overall Study||15
115682|NCT01301950|279586|P2|STARTED|Overall Study||15
115683|NCT01301950|279587|P1|STARTED|Overall Study||15
115684|NCT01301833|279605|P4|NOT COMPLETED|Overall Study||7
115685|NCT01301833|279606|P3|NOT COMPLETED|Overall Study||7
115686|NCT01301833|279607|P2|NOT COMPLETED|Overall Study||8
115687|NCT01301833|279608|P1|NOT COMPLETED|Overall Study||15
115688|NCT01301833|279605|P4|COMPLETED|Overall Study||68
115689|NCT01301833|279606|P3|COMPLETED|Overall Study||88
115690|NCT01301833|279607|P2|COMPLETED|Overall Study||72
115691|NCT01301833|279608|P1|COMPLETED|Overall Study||197
115692|NCT01301833|279605|P4|STARTED|Overall Study||75
115693|NCT01301833|279606|P3|STARTED|Overall Study||95
115694|NCT01301833|279607|P2|STARTED|Overall Study||80
115695|NCT01301833|279608|P1|STARTED|Overall Study||212
115696|NCT01301742|279634|P2|NOT COMPLETED|Second Intervention||0
115697|NCT01301742|279635|P1|NOT COMPLETED|Second Intervention||0
115698|NCT01301742|279634|P2|COMPLETED|Second Intervention||9
115699|NCT01301742|279635|P1|COMPLETED|Second Intervention||9
115700|NCT01301742|279634|P2|STARTED|Second Intervention||9
115701|NCT01301742|279635|P1|STARTED|Second Intervention||9
115702|NCT01301742|279634|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
115703|NCT01301742|279635|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
115704|NCT01301742|279634|P2|COMPLETED|Washout Period of at Least 7 Days||9
115705|NCT01301742|279635|P1|COMPLETED|Washout Period of at Least 7 Days||9
115706|NCT01301742|279634|P2|STARTED|Washout Period of at Least 7 Days||9
115707|NCT01301742|279635|P1|STARTED|Washout Period of at Least 7 Days||9
115708|NCT01301742|279634|P2|NOT COMPLETED|First Intervention||0
115709|NCT01301742|279635|P1|NOT COMPLETED|First Intervention||0
115710|NCT01301742|279634|P2|COMPLETED|First Intervention||9
115711|NCT01301742|279635|P1|COMPLETED|First Intervention||9
115712|NCT01301742|279634|P2|STARTED|First Intervention||9
115713|NCT01301742|279635|P1|STARTED|First Intervention||9
115714|NCT01301729|279646|P1|NOT COMPLETED|Overall Study||4
115715|NCT01301729|279646|P1|COMPLETED|Overall Study||28
115716|NCT01301729|279646|P1|STARTED|Overall Study||32
115717|NCT01301508|279659|P2|NOT COMPLETED|Overall Study||3
115718|NCT01301508|279660|P1|NOT COMPLETED|Overall Study||1
115719|NCT01301508|279659|P2|COMPLETED|Overall Study||22
115720|NCT01301508|279660|P1|COMPLETED|Overall Study||20
115721|NCT01301508|279659|P2|STARTED|Overall Study||25
115722|NCT01301508|279660|P1|STARTED|Overall Study||21
115723|NCT01301456|279690|P12|NOT COMPLETED|Stage 2||0
115724|NCT01301456|279691|P11|NOT COMPLETED|Stage 2||1
115725|NCT01301456|279692|P10|NOT COMPLETED|Stage 2||0
115726|NCT01301456|279693|P9|NOT COMPLETED|Stage 2||0
115727|NCT01301456|279694|P8|NOT COMPLETED|Stage 2||0
115728|NCT01301456|279695|P7|NOT COMPLETED|Stage 2||0
115729|NCT01301456|279696|P6|NOT COMPLETED|Stage 2||0
115730|NCT01301456|279697|P5|NOT COMPLETED|Stage 2||0
115731|NCT01301456|279698|P4|NOT COMPLETED|Stage 2||0
115732|NCT01301456|279699|P3|NOT COMPLETED|Stage 2||0
115733|NCT01301456|279700|P2|NOT COMPLETED|Stage 2||0
115734|NCT01301456|279701|P1|NOT COMPLETED|Stage 2||0
115735|NCT01301456|279690|P12|COMPLETED|Stage 2||6
115736|NCT01301456|279691|P11|COMPLETED|Stage 2||6
115737|NCT01301456|279692|P10|COMPLETED|Stage 2||7
115738|NCT01301456|279693|P9|COMPLETED|Stage 2||5
115739|NCT01301456|279694|P8|COMPLETED|Stage 2||7
115740|NCT01301456|279695|P7|COMPLETED|Stage 2||0
115741|NCT01301456|279696|P6|COMPLETED|Stage 2||0
115742|NCT01301456|279697|P5|COMPLETED|Stage 2||0
115743|NCT01301456|279698|P4|COMPLETED|Stage 2||0
115744|NCT01301456|279699|P3|COMPLETED|Stage 2||0
115745|NCT01301456|279700|P2|COMPLETED|Stage 2||0
115746|NCT01301456|279701|P1|COMPLETED|Stage 2||0
115747|NCT01301456|279690|P12|Received Treatment|Stage 2||6
115748|NCT01301456|279691|P11|Received Treatment|Stage 2||7
115749|NCT01301456|279692|P10|Received Treatment|Stage 2||7
115750|NCT01301456|279693|P9|Received Treatment|Stage 2||5
115751|NCT01301456|279694|P8|Received Treatment|Stage 2||7
115752|NCT01301456|279695|P7|Received Treatment|Stage 2||0
115753|NCT01301456|279696|P6|Received Treatment|Stage 2||0
115754|NCT01301456|279697|P5|Received Treatment|Stage 2||0
115755|NCT01301456|279698|P4|Received Treatment|Stage 2||0
115756|NCT01301456|279699|P3|Received Treatment|Stage 2||0
115757|NCT01301456|279700|P2|Received Treatment|Stage 2||0
115758|NCT01301456|279701|P1|Received Treatment|Stage 2||0
115759|NCT01301456|279690|P12|STARTED|Stage 2||6
115760|NCT01301456|279691|P11|STARTED|Stage 2||7
115761|NCT01301456|279692|P10|STARTED|Stage 2||7
115762|NCT01301456|279693|P9|STARTED|Stage 2||5
115763|NCT01301456|279694|P8|STARTED|Stage 2||7
115764|NCT01301456|279695|P7|STARTED|Stage 2||0
115765|NCT01301456|279696|P6|STARTED|Stage 2||0
115766|NCT01301456|279697|P5|STARTED|Stage 2||0
115767|NCT01301456|279698|P4|STARTED|Stage 2||0
115768|NCT01301456|279699|P3|STARTED|Stage 2||0
115769|NCT01301456|279700|P2|STARTED|Stage 2||0
115770|NCT01301456|279701|P1|STARTED|Stage 2||0
115771|NCT01301456|279690|P12|NOT COMPLETED|Stage 1||0
115772|NCT01301456|279691|P11|NOT COMPLETED|Stage 1||0
115773|NCT01301456|279692|P10|NOT COMPLETED|Stage 1||0
115774|NCT01301456|279693|P9|NOT COMPLETED|Stage 1||0
115775|NCT01301456|279694|P8|NOT COMPLETED|Stage 1||0
115776|NCT01301456|279695|P7|NOT COMPLETED|Stage 1||1
115777|NCT01301456|279696|P6|NOT COMPLETED|Stage 1||0
115778|NCT01301456|279697|P5|NOT COMPLETED|Stage 1||1
115779|NCT01301456|279698|P4|NOT COMPLETED|Stage 1||0
115780|NCT01301456|279699|P3|NOT COMPLETED|Stage 1||1
115781|NCT01301456|279700|P2|NOT COMPLETED|Stage 1||0
115782|NCT01301456|279701|P1|NOT COMPLETED|Stage 1||0
115783|NCT01301456|279690|P12|COMPLETED|Stage 1||0
115784|NCT01301456|279691|P11|COMPLETED|Stage 1||0
115785|NCT01301456|279692|P10|COMPLETED|Stage 1||0
115786|NCT01301456|279693|P9|COMPLETED|Stage 1||0
115787|NCT01301456|279694|P8|COMPLETED|Stage 1||0
115788|NCT01301456|279695|P7|COMPLETED|Stage 1||7
115789|NCT01301456|279696|P6|COMPLETED|Stage 1||5
115790|NCT01301456|279697|P5|COMPLETED|Stage 1||6
115791|NCT01301456|279698|P4|COMPLETED|Stage 1||6
115792|NCT01301456|279699|P3|COMPLETED|Stage 1||5
115793|NCT01301456|279700|P2|COMPLETED|Stage 1||5
115794|NCT01301456|279701|P1|COMPLETED|Stage 1||15
115795|NCT01301456|279690|P12|Received Treatment|Stage 1||0
115796|NCT01301456|279691|P11|Received Treatment|Stage 1||0
115797|NCT01301456|279692|P10|Received Treatment|Stage 1||0
115798|NCT01301456|279693|P9|Received Treatment|Stage 1||0
115799|NCT01301456|279694|P8|Received Treatment|Stage 1||0
115800|NCT01301456|279695|P7|Received Treatment|Stage 1||7
115801|NCT01301456|279696|P6|Received Treatment|Stage 1||5
115802|NCT01301456|279697|P5|Received Treatment|Stage 1||7
115803|NCT01301456|279698|P4|Received Treatment|Stage 1||6
115804|NCT01301456|279699|P3|Received Treatment|Stage 1||6
115805|NCT01301456|279700|P2|Received Treatment|Stage 1||5
115806|NCT01301456|279701|P1|Received Treatment|Stage 1||15
115807|NCT01301456|279690|P12|STARTED|Stage 1||0
115808|NCT01301456|279691|P11|STARTED|Stage 1||0
115809|NCT01301456|279692|P10|STARTED|Stage 1||0
115810|NCT01301456|279693|P9|STARTED|Stage 1||0
115811|NCT01301456|279694|P8|STARTED|Stage 1||0
115812|NCT01301456|279695|P7|STARTED|Stage 1||8
115813|NCT01301456|279696|P6|STARTED|Stage 1||5
115814|NCT01301456|279697|P5|STARTED|Stage 1||7
115815|NCT01301456|279698|P4|STARTED|Stage 1||6
115816|NCT01301456|279699|P3|STARTED|Stage 1||6
115817|NCT01301456|279700|P2|STARTED|Stage 1||5
115818|NCT01301456|279701|P1|STARTED|Stage 1||15
115819|NCT01301274|279929|P2|NOT COMPLETED|Overall Study||1
115820|NCT01301274|279930|P1|NOT COMPLETED|Overall Study||2
115821|NCT01301274|279929|P2|COMPLETED|Overall Study||31
115822|NCT01301274|279930|P1|COMPLETED|Overall Study||32
115823|NCT01301274|279929|P2|STARTED|Overall Study||32
115824|NCT01301274|279930|P1|STARTED|Overall Study||34
115825|NCT01301092|279945|P3|NOT COMPLETED|Overall Study||1
115826|NCT01301092|279946|P2|NOT COMPLETED|Overall Study||0
115827|NCT01301092|279947|P1|NOT COMPLETED|Overall Study||0
115828|NCT01301092|279945|P3|COMPLETED|Overall Study||7
115829|NCT01301092|279946|P2|COMPLETED|Overall Study||16
115830|NCT01301092|279947|P1|COMPLETED|Overall Study||6
115831|NCT01301092|279945|P3|STARTED|Overall Study||8
115832|NCT01301092|279946|P2|STARTED|Overall Study||16
115833|NCT01301092|279947|P1|STARTED|Overall Study||6
115834|NCT01301079|279964|P2|NOT COMPLETED|Overall Study||2
115835|NCT01301079|279965|P1|NOT COMPLETED|Overall Study||2
115836|NCT01301079|279964|P2|COMPLETED|Overall Study||28
115837|NCT01301079|279965|P1|COMPLETED|Overall Study||28
115838|NCT01301079|279964|P2|STARTED|Overall Study||30
115839|NCT01301079|279965|P1|STARTED|Overall Study||30
115840|NCT01301066|280043|P2|NOT COMPLETED|Overall Study||35
115841|NCT01301066|280044|P1|NOT COMPLETED|Overall Study||27
115842|NCT01301066|280043|P2|COMPLETED|Overall Study||91
115843|NCT01301066|280044|P1|COMPLETED|Overall Study||99
115844|NCT01301066|280043|P2|STARTED|Overall Study||126
115845|NCT01301066|280044|P1|STARTED|Overall Study||126
115846|NCT01301027|280052|P2|NOT COMPLETED|Overall Study||10
115847|NCT01301027|280053|P1|NOT COMPLETED|Overall Study||8
115848|NCT01301027|280052|P2|COMPLETED|Overall Study||37
115849|NCT01301027|280053|P1|COMPLETED|Overall Study||40
115850|NCT01301027|280052|P2|STARTED|Overall Study||47
115851|NCT01301027|280053|P1|STARTED|Overall Study||48
115852|NCT01301001|280065|P2|NOT COMPLETED|Second Intervention||0
115853|NCT01301001|280066|P1|NOT COMPLETED|Second Intervention||4
115854|NCT01301001|280065|P2|COMPLETED|Second Intervention||36
115855|NCT01301001|280066|P1|COMPLETED|Second Intervention||30
115856|NCT01301001|280065|P2|STARTED|Second Intervention||36
115857|NCT01301001|280066|P1|STARTED|Second Intervention||34
115858|NCT01301001|280065|P2|NOT COMPLETED|Washout (2 Weeks)||0
115859|NCT01301001|280066|P1|NOT COMPLETED|Washout (2 Weeks)||0
115860|NCT01301001|280065|P2|COMPLETED|Washout (2 Weeks)||36
115861|NCT01301001|280066|P1|COMPLETED|Washout (2 Weeks)||34
115862|NCT01301001|280065|P2|STARTED|Washout (2 Weeks)||36
115863|NCT01301001|280066|P1|STARTED|Washout (2 Weeks)||34
115864|NCT01301001|280065|P2|NOT COMPLETED|First Intervention||9
115865|NCT01301001|280066|P1|NOT COMPLETED|First Intervention||10
115866|NCT01301001|280065|P2|COMPLETED|First Intervention||36
115867|NCT01301001|280066|P1|COMPLETED|First Intervention||34
115868|NCT01301001|280065|P2|STARTED|First Intervention||45
115869|NCT01301001|280066|P1|STARTED|First Intervention||44
115870|NCT01300923|280076|P2|NOT COMPLETED|Overall Study||2
115871|NCT01300923|280077|P1|NOT COMPLETED|Overall Study||0
115872|NCT01300923|280076|P2|COMPLETED|Overall Study||0
115873|NCT01300923|280077|P1|COMPLETED|Overall Study||12
115874|NCT01300923|280076|P2|STARTED|Overall Study||2
115875|NCT01300923|280077|P1|STARTED|Overall Study||12
115876|NCT01300819|280090|P2|NOT COMPLETED|Overall Study||44
115877|NCT01300819|280091|P1|NOT COMPLETED|Overall Study||22
115878|NCT01300819|280090|P2|COMPLETED|Overall Study||180
115879|NCT01300819|280091|P1|COMPLETED|Overall Study||103
115880|NCT01300819|280090|P2|STARTED|Overall Study||224
115881|NCT01300819|280091|P1|STARTED|Overall Study||125
115882|NCT01300767|280119|P1|NOT COMPLETED|Overall Study||4
115883|NCT01300767|280119|P1|COMPLETED|Overall Study||70
115884|NCT01300767|280119|P1|STARTED|Overall Study||74
115885|NCT01300741|280147|P1|NOT COMPLETED|Overall Study||3
115886|NCT01300741|280147|P1|COMPLETED|Overall Study||72
115887|NCT01300741|280147|P1|STARTED|Overall Study||75
115888|NCT01300728|280177|P2|NOT COMPLETED|Overall Study||1
115889|NCT01300728|280178|P1|NOT COMPLETED|Overall Study||2
115890|NCT01300728|280177|P2|COMPLETED|Overall Study||25
115891|NCT01300728|280178|P1|COMPLETED|Overall Study||24
115892|NCT01300728|280177|P2|STARTED|Overall Study||26
115893|NCT01300728|280178|P1|STARTED|Overall Study||26
115894|NCT01300650|280192|P1|NOT COMPLETED|Overall Study||1
115895|NCT01300650|280192|P1|COMPLETED|Overall Study||7
115896|NCT01300650|280192|P1|STARTED|Overall Study||8
115897|NCT01300624|280198|P1|NOT COMPLETED|Overall Study||0
115898|NCT01300624|280198|P1|COMPLETED|Overall Study||11
115899|NCT01300624|280198|P1|STARTED|Overall Study||11
115900|NCT01300559|280210|P2|NOT COMPLETED|Overall Study||0
115901|NCT01300559|280211|P1|NOT COMPLETED|Overall Study||0
115902|NCT01300559|280210|P2|COMPLETED|Overall Study||30
115903|NCT01300559|280211|P1|COMPLETED|Overall Study||30
115904|NCT01300559|280210|P2|STARTED|Overall Study||30
115905|NCT01300559|280211|P1|STARTED|Overall Study||30
115906|NCT01300546|280219|P2|NOT COMPLETED|Overall Study||6
115907|NCT01300546|280220|P1|NOT COMPLETED|Overall Study||1
115908|NCT01300546|280219|P2|COMPLETED|Overall Study||14
115909|NCT01300546|280220|P1|COMPLETED|Overall Study||18
115910|NCT01300546|280219|P2|STARTED|Overall Study||20
115911|NCT01300546|280220|P1|STARTED|Overall Study||19
115912|NCT01300455|280250|P2|NOT COMPLETED|Period 2||0
115913|NCT01300455|280251|P1|NOT COMPLETED|Period 2||0
115914|NCT01300455|280250|P2|COMPLETED|Period 2||13
115915|NCT01300455|280251|P1|COMPLETED|Period 2||12
115916|NCT01300455|280250|P2|STARTED|Period 2||13
115917|NCT01300455|280251|P1|STARTED|Period 2||12
115918|NCT01300455|280250|P2|NOT COMPLETED|Washout||0
115919|NCT01300455|280251|P1|NOT COMPLETED|Washout||1
115920|NCT01300455|280250|P2|COMPLETED|Washout||13
115921|NCT01300455|280251|P1|COMPLETED|Washout||12
115922|NCT01300455|280250|P2|STARTED|Washout||13
115923|NCT01300455|280251|P1|STARTED|Washout||13
115924|NCT01300455|280250|P2|NOT COMPLETED|Period 1||0
115925|NCT01300455|280251|P1|NOT COMPLETED|Period 1||0
115926|NCT01300455|280250|P2|COMPLETED|Period 1||13
115927|NCT01300455|280251|P1|COMPLETED|Period 1||13
115928|NCT01300455|280250|P2|STARTED|Period 1||13
115929|NCT01300455|280251|P1|STARTED|Period 1||13
115930|NCT01300351|280271|P2|NOT COMPLETED|Overall Study||38
115931|NCT01300351|280272|P1|NOT COMPLETED|Overall Study||36
115932|NCT01300351|280271|P2|COMPLETED|Overall Study||72
115933|NCT01300351|280272|P1|COMPLETED|Overall Study||75
115934|NCT01300351|280271|P2|Received Study Treatment|Overall Study||110
115935|NCT01300351|280272|P1|Received Study Treatment|Overall Study||109
115936|NCT01300351|280271|P2|STARTED|Overall Study||110
115937|NCT01300351|280272|P1|STARTED|Overall Study||111
115938|NCT01300338|280288|P2|NOT COMPLETED|Overall Study||0
115939|NCT01300338|280289|P1|NOT COMPLETED|Overall Study||5
115940|NCT01300338|280288|P2|COMPLETED|Overall Study||25
115941|NCT01300338|280289|P1|COMPLETED|Overall Study||20
115942|NCT01300338|280288|P2|STARTED|Overall Study||25
115943|NCT01300338|280289|P1|STARTED|Overall Study||25
115944|NCT01300286|280297|P1|NOT COMPLETED|Overall Study||1
115945|NCT01300286|280297|P1|COMPLETED|Overall Study||22
115946|NCT01300286|280297|P1|STARTED|Overall Study||23
115947|NCT01300260|280307|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
115948|NCT01300260|280308|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
115949|NCT01300260|280307|P2|COMPLETED|Period 2 of Study: Second Intervention||15
115950|NCT01300260|280308|P1|COMPLETED|Period 2 of Study: Second Intervention||14
115951|NCT01300260|280307|P2|STARTED|Period 2 of Study: Second Intervention||16
115952|NCT01300260|280308|P1|STARTED|Period 2 of Study: Second Intervention||14
115953|NCT01300260|280307|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
115954|NCT01300260|280308|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
115955|NCT01300260|280307|P2|COMPLETED|Washout Period of at Least 28 Days||16
115956|NCT01300260|280308|P1|COMPLETED|Washout Period of at Least 28 Days||14
115957|NCT01300260|280307|P2|STARTED|Washout Period of at Least 28 Days||16
115958|NCT01300260|280308|P1|STARTED|Washout Period of at Least 28 Days||14
115959|NCT01300260|280307|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
115960|NCT01300260|280308|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
115961|NCT01300260|280307|P2|COMPLETED|Period 1 of Study: First Intervention||16
115962|NCT01300260|280308|P1|COMPLETED|Period 1 of Study: First Intervention||14
115963|NCT01300260|280307|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
115964|NCT01300260|280308|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
115965|NCT01300260|280307|P2|STARTED|Period 1 of Study: First Intervention||17
115966|NCT01300260|280308|P1|STARTED|Period 1 of Study: First Intervention||15
115967|NCT01300247|280340|P2|NOT COMPLETED|Overall Study||2
115968|NCT01300247|280341|P1|NOT COMPLETED|Overall Study||4
115969|NCT01300247|280340|P2|COMPLETED|Overall Study||18
115970|NCT01300247|280341|P1|COMPLETED|Overall Study||17
115971|NCT01300247|280340|P2|STARTED|Overall Study||20
115972|NCT01300247|280341|P1|STARTED|Overall Study||21
115973|NCT01300234|280373|P2|NOT COMPLETED|Overall Study||10
115974|NCT01300234|280374|P1|NOT COMPLETED|Overall Study||4
115975|NCT01300234|280373|P2|COMPLETED|Overall Study||245
115976|NCT01300234|280374|P1|COMPLETED|Overall Study||253
115977|NCT01300234|280373|P2|STARTED|Overall Study||255
115978|NCT01300234|280374|P1|STARTED|Overall Study||257
115979|NCT01300052|280406|P2|NOT COMPLETED|Overall Study||3
115980|NCT01300052|280407|P1|NOT COMPLETED|Overall Study||6
115981|NCT01300052|280406|P2|COMPLETED|Overall Study||19
115982|NCT01300052|280407|P1|COMPLETED|Overall Study||40
115983|NCT01300052|280406|P2|STARTED|Overall Study||22
115984|NCT01300052|280407|P1|STARTED|Overall Study||46
115985|NCT01299961|280425|P1|NOT COMPLETED|Overall Study||6
115986|NCT01299961|280425|P1|COMPLETED|Overall Study||19
115987|NCT01299961|280425|P1|STARTED|Overall Study||25
115988|NCT01299909|280434|P3|NOT COMPLETED|Overall Study||17
115989|NCT01299909|280435|P2|NOT COMPLETED|Overall Study||18
115990|NCT01299909|280436|P1|NOT COMPLETED|Overall Study||22
115991|NCT01299909|280434|P3|COMPLETED|Overall Study||23
115992|NCT01299909|280435|P2|COMPLETED|Overall Study||49
115993|NCT01299909|280436|P1|COMPLETED|Overall Study||46
115994|NCT01299909|280434|P3|STARTED|Overall Study||40
115995|NCT01299909|280435|P2|STARTED|Overall Study||67
115996|NCT01299909|280436|P1|STARTED|Overall Study||68
115997|NCT01299896|280451|P2|NOT COMPLETED|Overall Study||18
115998|NCT01299896|280452|P1|NOT COMPLETED|Overall Study||1
115999|NCT01299896|280451|P2|COMPLETED|Overall Study||296
116000|NCT01299896|280452|P1|COMPLETED|Overall Study||318
116001|NCT01299896|280451|P2|STARTED|Overall Study||314
116002|NCT01299896|280452|P1|STARTED|Overall Study||319
116003|NCT01299805|280460|P2|NOT COMPLETED|Overall Study||0
116004|NCT01299805|280461|P1|NOT COMPLETED|Overall Study||2
116005|NCT01299805|280460|P2|COMPLETED|Overall Study||5
116006|NCT01299805|280461|P1|COMPLETED|Overall Study||10
116007|NCT01299805|280460|P2|STARTED|Overall Study||5
116008|NCT01299805|280461|P1|STARTED|Overall Study||12
116009|NCT01299610|280492|P3|NOT COMPLETED|Overall Study||0
116010|NCT01299610|280493|P2|NOT COMPLETED|Overall Study||0
116011|NCT01299610|280494|P1|NOT COMPLETED|Overall Study||0
116012|NCT01299610|280492|P3|COMPLETED|Overall Study||10
116013|NCT01299610|280493|P2|COMPLETED|Overall Study||5
116014|NCT01299610|280494|P1|COMPLETED|Overall Study||10
116015|NCT01299610|280492|P3|STARTED|Overall Study||10
116016|NCT01299610|280493|P2|STARTED|Overall Study||5
116017|NCT01299610|280494|P1|STARTED|Overall Study||10
116018|NCT01299584|280539|P1|NOT COMPLETED|Overall Study||9
116019|NCT01299584|280539|P1|COMPLETED|Overall Study||766
116020|NCT01299584|280539|P1|STARTED|Overall Study||775
116021|NCT01299571|280546|P1|NOT COMPLETED|Overall Study||107
116022|NCT01299571|280546|P1|COMPLETED|Overall Study||3870
116023|NCT01299571|280546|P1|STARTED|Overall Study||3977
116024|NCT01299480|280557|P5|NOT COMPLETED|Overall Study||20
116025|NCT01299480|280558|P4|NOT COMPLETED|Overall Study||25
116026|NCT01299480|280559|P3|NOT COMPLETED|Overall Study||41
116027|NCT01299480|280560|P2|NOT COMPLETED|Overall Study||35
116028|NCT01299480|280561|P1|NOT COMPLETED|Overall Study||42
116029|NCT01299480|280557|P5|COMPLETED|Overall Study||123
116030|NCT01299480|280558|P4|COMPLETED|Overall Study||261
116031|NCT01299480|280559|P3|COMPLETED|Overall Study||386
116032|NCT01299480|280560|P2|COMPLETED|Overall Study||395
116033|NCT01299480|280561|P1|COMPLETED|Overall Study||385
116034|NCT01299480|280557|P5|STARTED|Overall Study||143
116035|NCT01299480|280558|P4|STARTED|Overall Study||286
116036|NCT01299480|280559|P3|STARTED|Overall Study||427
116037|NCT01299480|280560|P2|STARTED|Overall Study||430
116038|NCT01299480|280561|P1|STARTED|Overall Study||427
116039|NCT01299454|280600|P4|NOT COMPLETED|Overall Study||0
116040|NCT01299454|280601|P3|NOT COMPLETED|Overall Study||0
116041|NCT01299454|280602|P2|NOT COMPLETED|Overall Study||0
116042|NCT01299454|280603|P1|NOT COMPLETED|Overall Study||0
116043|NCT01299454|280600|P4|COMPLETED|Overall Study||23
116044|NCT01299454|280601|P3|COMPLETED|Overall Study||6
116045|NCT01299454|280602|P2|COMPLETED|Overall Study||8
116046|NCT01299454|280603|P1|COMPLETED|Overall Study||8
116047|NCT01299454|280600|P4|STARTED|Overall Study||23
116048|NCT01299454|280601|P3|STARTED|Overall Study||6
116049|NCT01299454|280602|P2|STARTED|Overall Study||8
116050|NCT01299454|280603|P1|STARTED|Overall Study||8
116051|NCT01299389|280763|P4|NOT COMPLETED|Post-observational||6
116052|NCT01299389|280764|P3|NOT COMPLETED|Post-observational||12
116053|NCT01299389|280765|P2|NOT COMPLETED|Post-observational||0
116054|NCT01299389|280766|P1|NOT COMPLETED|Post-observational||0
116055|NCT01299389|280763|P4|COMPLETED|Post-observational||149
116056|NCT01299389|280764|P3|COMPLETED|Post-observational||144
116057|NCT01299389|280765|P2|COMPLETED|Post-observational||0
116058|NCT01299389|280766|P1|COMPLETED|Post-observational||0
116059|NCT01299389|280763|P4|STARTED|Post-observational||155
116060|NCT01299389|280764|P3|STARTED|Post-observational||156
116061|NCT01299389|280765|P2|STARTED|Post-observational||0
116062|NCT01299389|280766|P1|STARTED|Post-observational||0
116063|NCT01299389|280763|P4|NOT COMPLETED|Double-blind||0
116064|NCT01299389|280764|P3|NOT COMPLETED|Double-blind||0
116065|NCT01299389|280765|P2|NOT COMPLETED|Double-blind||64
116066|NCT01299389|280766|P1|NOT COMPLETED|Double-blind||109
116067|NCT01299389|280763|P4|COMPLETED|Double-blind||0
116068|NCT01299389|280764|P3|COMPLETED|Double-blind||0
116069|NCT01299389|280765|P2|COMPLETED|Double-blind||95
116070|NCT01299389|280766|P1|COMPLETED|Double-blind||55
116071|NCT01299389|280763|P4|STARTED|Double-blind||0
116072|NCT01299389|280764|P3|STARTED|Double-blind||0
116073|NCT01299389|280765|P2|STARTED|Double-blind||159
116074|NCT01299389|280766|P1|STARTED|Double-blind||164
116075|NCT01299376|280788|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
116076|NCT01299376|280789|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
116077|NCT01299376|280788|P2|COMPLETED|Extension (Weeks 9 to 52)||118
116078|NCT01299376|280789|P1|COMPLETED|Extension (Weeks 9 to 52)||124
116079|NCT01299376|280788|P2|STARTED|Extension (Weeks 9 to 52)||133
116080|NCT01299376|280789|P1|STARTED|Extension (Weeks 9 to 52)||134
116081|NCT01299376|280788|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
116082|NCT01299376|280789|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
116083|NCT01299376|280788|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
116084|NCT01299376|280789|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
116085|NCT01299376|280788|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
116086|NCT01299376|280789|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
116087|NCT01299285|280819|P1|NOT COMPLETED|Overall Study||0
116088|NCT01299285|280819|P1|COMPLETED|Overall Study||6
116089|NCT01299285|280819|P1|STARTED|Overall Study||6
116090|NCT01299272|280832|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
116091|NCT01299272|280833|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
116092|NCT01299272|280834|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
116093|NCT01299272|280835|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
116094|NCT01299272|280832|P4|COMPLETED|Double-blind (DB) Randomized Period||234
116095|NCT01299272|280833|P3|COMPLETED|Double-blind (DB) Randomized Period||224
116096|NCT01299272|280834|P2|COMPLETED|Double-blind (DB) Randomized Period||0
116097|NCT01299272|280835|P1|COMPLETED|Double-blind (DB) Randomized Period||0
116098|NCT01299272|280832|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
116099|NCT01299272|280833|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
116100|NCT01299272|280834|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
116101|NCT01299272|280835|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
116102|NCT01299272|280832|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
116103|NCT01299272|280833|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
116104|NCT01299272|280834|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
116105|NCT01299272|280835|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
116106|NCT01299272|280832|P4|STARTED|Double-blind (DB) Randomized Period||292
116107|NCT01299272|280833|P3|STARTED|Double-blind (DB) Randomized Period||294
116108|NCT01299272|280834|P2|STARTED|Double-blind (DB) Randomized Period||0
116109|NCT01299272|280835|P1|STARTED|Double-blind (DB) Randomized Period||0
116110|NCT01299272|280832|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
116111|NCT01299272|280833|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
116112|NCT01299272|280834|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
116113|NCT01299272|280835|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
116114|NCT01299272|280832|P4|COMPLETED|Stabilization Open-label (OL) Period||0
116115|NCT01299272|280833|P3|COMPLETED|Stabilization Open-label (OL) Period||0
116116|NCT01299272|280834|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
116117|NCT01299272|280835|P1|COMPLETED|Stabilization Open-label (OL) Period||0
116118|NCT01299272|280832|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
116119|NCT01299272|280833|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
116120|NCT01299272|280834|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
116121|NCT01299272|280835|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
116122|NCT01299272|280832|P4|STARTED|Stabilization Open-label (OL) Period||0
116123|NCT01299272|280833|P3|STARTED|Stabilization Open-label (OL) Period||0
116124|NCT01299272|280834|P2|STARTED|Stabilization Open-label (OL) Period||835
116125|NCT01299272|280835|P1|STARTED|Stabilization Open-label (OL) Period||0
116126|NCT01299272|280832|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
116127|NCT01299272|280833|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
116128|NCT01299272|280834|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
116129|NCT01299272|280835|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
116130|NCT01299272|280832|P4|COMPLETED|Acute Open-label (OL) Period||0
116131|NCT01299272|280833|P3|COMPLETED|Acute Open-label (OL) Period||0
116132|NCT01299272|280834|P2|COMPLETED|Acute Open-label (OL) Period||0
116133|NCT01299272|280835|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
116134|NCT01299272|280832|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
116135|NCT01299272|280833|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
116136|NCT01299272|280834|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
116137|NCT01299272|280835|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
116138|NCT01299272|280832|P4|STARTED|Acute Open-label (OL) Period||0
116139|NCT01299272|280833|P3|STARTED|Acute Open-label (OL) Period||0
116140|NCT01299272|280834|P2|STARTED|Acute Open-label (OL) Period||0
116141|NCT01299272|280835|P1|STARTED|Acute Open-label (OL) Period||1249
116142|NCT01299116|280890|P3|NOT COMPLETED|Overall Study||11
116143|NCT01299116|280891|P2|NOT COMPLETED|Overall Study||9
116144|NCT01299116|280892|P1|NOT COMPLETED|Overall Study||65
116145|NCT01299116|280890|P3|COMPLETED|Overall Study||184
116146|NCT01299116|280891|P2|COMPLETED|Overall Study||168
116147|NCT01299116|280892|P1|COMPLETED|Overall Study||457
116148|NCT01299116|280890|P3|STARTED|Overall Study||195
116149|NCT01299116|280891|P2|STARTED|Overall Study||177
116150|NCT01299116|280892|P1|STARTED|Overall Study||522
116151|NCT01299103|280909|P3|NOT COMPLETED|Overall Study||2
116152|NCT01299103|280910|P2|NOT COMPLETED|Overall Study||2
116153|NCT01299103|280911|P1|NOT COMPLETED|Overall Study||0
116154|NCT01299103|280909|P3|COMPLETED|Overall Study||8
116155|NCT01299103|280910|P2|COMPLETED|Overall Study||13
116156|NCT01299103|280911|P1|COMPLETED|Overall Study||15
116157|NCT01299103|280909|P3|STARTED|Overall Study||10
116158|NCT01299103|280910|P2|STARTED|Overall Study||15
116159|NCT01299103|280911|P1|STARTED|Overall Study||15
116160|NCT01299090|280922|P1|NOT COMPLETED|Overall Study||0
116161|NCT01299090|280922|P1|COMPLETED|Overall Study||49
116162|NCT01299090|280922|P1|STARTED|Overall Study||49
116163|NCT01299077|280927|P1|NOT COMPLETED|Overall Study||0
116164|NCT01299077|280927|P1|COMPLETED|Overall Study||478
116165|NCT01299077|280927|P1|STARTED|Overall Study||478
116166|NCT01299025|280937|P2|NOT COMPLETED|Overall Study||1
116167|NCT01299025|280938|P1|NOT COMPLETED|Overall Study||3
116168|NCT01299025|280937|P2|COMPLETED|Overall Study||41
116169|NCT01299025|280938|P1|COMPLETED|Overall Study||39
116170|NCT01299025|280937|P2|STARTED|Overall Study||42
116171|NCT01299025|280938|P1|STARTED|Overall Study||42
116172|NCT01298778|280952|P2|NOT COMPLETED|Overall Study||6
116173|NCT01298778|280953|P1|NOT COMPLETED|Overall Study||3
116174|NCT01298778|280952|P2|COMPLETED|Overall Study||30
116175|NCT01298778|280953|P1|COMPLETED|Overall Study||30
116176|NCT01298778|280952|P2|STARTED|Overall Study||36
116177|NCT01298778|280953|P1|STARTED|Overall Study||33
116178|NCT01298661|280976|P3|NOT COMPLETED|Overall Study||2
116179|NCT01298661|280977|P2|NOT COMPLETED|Overall Study||0
116180|NCT01298661|280978|P1|NOT COMPLETED|Overall Study||2
116181|NCT01298661|280976|P3|COMPLETED|Overall Study||32
116182|NCT01298661|280977|P2|COMPLETED|Overall Study||24
116183|NCT01298661|280978|P1|COMPLETED|Overall Study||31
116184|NCT01298661|280976|P3|STARTED|Overall Study||34
116185|NCT01298661|280977|P2|STARTED|Overall Study||24
116186|NCT01298661|280978|P1|STARTED|Overall Study||33
116187|NCT01298648|281056|P1|NOT COMPLETED|Overall Study||23
116188|NCT01298648|281056|P1|COMPLETED|Overall Study||1693
116189|NCT01298648|281056|P1|STARTED|Overall Study||1716
116190|NCT01298570|281067|P2|NOT COMPLETED|Overall Study||61
116191|NCT01298570|281068|P1|NOT COMPLETED|Overall Study||120
116192|NCT01298570|281067|P2|COMPLETED|Overall Study||0
116193|NCT01298570|281068|P1|COMPLETED|Overall Study||0
116194|NCT01298570|281067|P2|STARTED|Overall Study||61
116195|NCT01298570|281068|P1|STARTED|Overall Study||120
116196|NCT01298544|281084|P1|NOT COMPLETED|Overall Study||0
116197|NCT01298544|281084|P1|COMPLETED|Overall Study||335
116198|NCT01298544|281084|P1|STARTED|Overall Study||335
116199|NCT01298531|281095|P2|NOT COMPLETED|Overall Study||7
116200|NCT01298531|281096|P1|NOT COMPLETED|Overall Study||9
116201|NCT01298531|281095|P2|COMPLETED|Overall Study||41
116202|NCT01298531|281096|P1|COMPLETED|Overall Study||33
116203|NCT01298531|281095|P2|STARTED|Overall Study||48
116204|NCT01298531|281096|P1|STARTED|Overall Study||42
116205|NCT01298518|281225|P3|NOT COMPLETED|Overall Study||1
116206|NCT01298518|281226|P2|NOT COMPLETED|Overall Study||0
116207|NCT01298518|281227|P1|NOT COMPLETED|Overall Study||0
116208|NCT01298518|281225|P3|COMPLETED|Overall Study||15
116209|NCT01298518|281226|P2|COMPLETED|Overall Study||16
116210|NCT01298518|281227|P1|COMPLETED|Overall Study||16
116211|NCT01298518|281225|P3|STARTED|Overall Study||16
116212|NCT01298518|281226|P2|STARTED|Overall Study||16
116213|NCT01298518|281227|P1|STARTED|Overall Study||16
116214|NCT01298492|281279|P1|NOT COMPLETED|Overall Study||119
116215|NCT01298492|281279|P1|COMPLETED|Overall Study||149
116216|NCT01298492|281279|P1|STARTED|Overall Study||268
116217|NCT01298362|281287|P2|NOT COMPLETED|Overall Study||43
116218|NCT01298362|281288|P1|NOT COMPLETED|Overall Study||38
116219|NCT01298362|281287|P2|COMPLETED|Overall Study||123
116220|NCT01298362|281288|P1|COMPLETED|Overall Study||86
116221|NCT01298362|281287|P2|STARTED|Overall Study||166
116222|NCT01298362|281288|P1|STARTED|Overall Study||124
116223|NCT01298323|281308|P2|NOT COMPLETED|Overall Study||88
116224|NCT01298323|281309|P1|NOT COMPLETED|Overall Study||86
116225|NCT01298323|281308|P2|COMPLETED|Overall Study||15
116226|NCT01298323|281309|P1|COMPLETED|Overall Study||16
116227|NCT01298323|281308|P2|Ongoing|Overall Study||55
116228|NCT01298323|281309|P1|Ongoing|Overall Study||55
116229|NCT01298323|281308|P2|STARTED|Overall Study||103
116230|NCT01298323|281309|P1|STARTED|Overall Study||102
116231|NCT01298167|281317|P2|NOT COMPLETED|Overall Study||0
116232|NCT01298167|281318|P1|NOT COMPLETED|Overall Study||1
116233|NCT01298167|281317|P2|COMPLETED|Overall Study||8
116234|NCT01298167|281318|P1|COMPLETED|Overall Study||5
116235|NCT01298167|281317|P2|STARTED|Overall Study||8
116236|NCT01298167|281318|P1|STARTED|Overall Study||6
116237|NCT01298128|281326|P2|NOT COMPLETED|Overall Study||8
116238|NCT01298128|281327|P1|NOT COMPLETED|Overall Study||9
116239|NCT01298128|281326|P2|COMPLETED|Overall Study||27
116240|NCT01298128|281327|P1|COMPLETED|Overall Study||26
116241|NCT01298128|281326|P2|STARTED|Overall Study||35
116242|NCT01298128|281327|P1|STARTED|Overall Study||35
116243|NCT01298063|281338|P5|NOT COMPLETED|Overall Study||0
116244|NCT01298063|281339|P4|NOT COMPLETED|Overall Study||0
116245|NCT01298063|281340|P3|NOT COMPLETED|Overall Study||0
116246|NCT01298063|281341|P2|NOT COMPLETED|Overall Study||0
116247|NCT01298063|281342|P1|NOT COMPLETED|Overall Study||0
116248|NCT01298063|281338|P5|COMPLETED|Overall Study||8
116249|NCT01298063|281339|P4|COMPLETED|Overall Study||8
116250|NCT01298063|281340|P3|COMPLETED|Overall Study||8
116251|NCT01298063|281341|P2|COMPLETED|Overall Study||3
116252|NCT01298063|281342|P1|COMPLETED|Overall Study||8
116253|NCT01298063|281338|P5|STARTED|Overall Study||8
116254|NCT01298063|281339|P4|STARTED|Overall Study||8
116255|NCT01298063|281340|P3|STARTED|Overall Study||8
116256|NCT01298063|281341|P2|STARTED|Overall Study||3
116257|NCT01298063|281342|P1|STARTED|Overall Study||8
116258|NCT01297920|281372|P3|NOT COMPLETED|Overall Study||57
116259|NCT01297920|281373|P2|NOT COMPLETED|Overall Study||27
116260|NCT01297920|281374|P1|NOT COMPLETED|Overall Study||58
116261|NCT01297920|281372|P3|COMPLETED|Overall Study||178
116262|NCT01297920|281373|P2|COMPLETED|Overall Study||207
116263|NCT01297920|281374|P1|COMPLETED|Overall Study||163
116264|NCT01297920|281372|P3|STARTED|Overall Study||235
116265|NCT01297920|281373|P2|STARTED|Overall Study||234
116266|NCT01297920|281374|P1|STARTED|Overall Study||221
116267|NCT01297595|281382|P2|NOT COMPLETED|Second Intervention Period||0
116268|NCT01297595|281383|P1|NOT COMPLETED|Second Intervention Period||0
116269|NCT01297595|281382|P2|COMPLETED|Second Intervention Period||11
116270|NCT01297595|281383|P1|COMPLETED|Second Intervention Period||11
116271|NCT01297595|281382|P2|STARTED|Second Intervention Period||11
116272|NCT01297595|281383|P1|STARTED|Second Intervention Period||11
116273|NCT01297595|281382|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
116274|NCT01297595|281383|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
116275|NCT01297595|281382|P2|COMPLETED|Washout Period (At Least 14 Days)||11
116276|NCT01297595|281383|P1|COMPLETED|Washout Period (At Least 14 Days)||11
116277|NCT01297595|281382|P2|STARTED|Washout Period (At Least 14 Days)||11
116278|NCT01297595|281383|P1|STARTED|Washout Period (At Least 14 Days)||11
116279|NCT01297595|281382|P2|NOT COMPLETED|First Intervention Period||0
116280|NCT01297595|281383|P1|NOT COMPLETED|First Intervention Period||0
116281|NCT01297595|281382|P2|COMPLETED|First Intervention Period||11
116282|NCT01297595|281383|P1|COMPLETED|First Intervention Period||11
116283|NCT01297595|281382|P2|STARTED|First Intervention Period||11
116284|NCT01297595|281383|P1|STARTED|First Intervention Period||11
116285|NCT01297517|281418|P3|NOT COMPLETED|Overall Study||27
116286|NCT01297517|281419|P2|NOT COMPLETED|Overall Study||12
116287|NCT01297517|281420|P1|NOT COMPLETED|Overall Study||27
116288|NCT01297517|281418|P3|COMPLETED|Overall Study||193
116289|NCT01297517|281419|P2|COMPLETED|Overall Study||214
116290|NCT01297517|281420|P1|COMPLETED|Overall Study||187
116291|NCT01297517|281418|P3|STARTED|Overall Study||220
116292|NCT01297517|281419|P2|STARTED|Overall Study||226
116293|NCT01297517|281420|P1|STARTED|Overall Study||214
116294|NCT01297504|281428|P1|NOT COMPLETED|Overall Study||67
116295|NCT01297504|281428|P1|COMPLETED|Overall Study||397
116296|NCT01297504|281428|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
116297|NCT01297504|281428|P1|STARTED|Overall Study||464
116298|NCT01297491|281442|P2|NOT COMPLETED|Overall Study||33
116299|NCT01297491|281443|P1|NOT COMPLETED|Overall Study||30
116300|NCT01297491|281442|P2|COMPLETED|Overall Study||0
116301|NCT01297491|281443|P1|COMPLETED|Overall Study||0
116302|NCT01297491|281442|P2|STARTED|Overall Study||33
116303|NCT01297491|281443|P1|STARTED|Overall Study||30
116304|NCT01297465|281461|P2|NOT COMPLETED|Overall Study||10
116305|NCT01297465|281462|P1|NOT COMPLETED|Overall Study||8
116306|NCT01297465|281461|P2|COMPLETED|Overall Study||93
116307|NCT01297465|281462|P1|COMPLETED|Overall Study||91
116308|NCT01297465|281461|P2|STARTED|Overall Study||103
116309|NCT01297465|281462|P1|STARTED|Overall Study||99
116310|NCT01297348|281496|P2|NOT COMPLETED|Overall Study||0
116311|NCT01297348|281497|P1|NOT COMPLETED|Overall Study||0
116312|NCT01297348|281496|P2|COMPLETED|Overall Study||586401
116313|NCT01297348|281497|P1|COMPLETED|Overall Study||12281
116314|NCT01297348|281496|P2|STARTED|Overall Study||586401
116315|NCT01297348|281497|P1|STARTED|Overall Study||12281
116316|NCT01297335|281507|P1|NOT COMPLETED|Overall Study||0
116317|NCT01297335|281507|P1|COMPLETED|Overall Study||10
116318|NCT01297335|281507|P1|STARTED|Overall Study||10
116319|NCT01297322|281515|P2|NOT COMPLETED|Overall Study||1
116320|NCT01297322|281516|P1|NOT COMPLETED|Overall Study||1
116321|NCT01297322|281515|P2|COMPLETED|Overall Study||274
116322|NCT01297322|281516|P1|COMPLETED|Overall Study||141
116323|NCT01297322|281515|P2|STARTED|Overall Study||275
116324|NCT01297322|281516|P1|STARTED|Overall Study||142
116325|NCT01297283|281536|P1|NOT COMPLETED|Overall Study||19
116326|NCT01297283|281536|P1|COMPLETED|Overall Study||176
116327|NCT01297283|281536|P1|STARTED|Overall Study||195
116328|NCT01297270|281544|P3|NOT COMPLETED|Overall Study||29
116329|NCT01297270|281545|P2|NOT COMPLETED|Overall Study||72
116330|NCT01297270|281546|P1|NOT COMPLETED|Overall Study||45
116331|NCT01297270|281544|P3|COMPLETED|Overall Study||103
116332|NCT01297270|281545|P2|COMPLETED|Overall Study||192
116333|NCT01297270|281546|P1|COMPLETED|Overall Study||217
116334|NCT01297270|281544|P3|STARTED|Overall Study||132
116335|NCT01297270|281545|P2|STARTED|Overall Study||264
116336|NCT01297270|281546|P1|STARTED|Overall Study||262
116337|NCT01297257|281584|P1|NOT COMPLETED|Overall Study||0
116338|NCT01297257|281584|P1|COMPLETED|Overall Study||7740
116339|NCT01297257|281584|P1|STARTED|Overall Study||7740
116340|NCT01297062|281595|P7|NOT COMPLETED|Overall Study||8
116341|NCT01297062|281596|P6|NOT COMPLETED|Overall Study||1
116342|NCT01297062|281597|P5|NOT COMPLETED|Overall Study||2
116343|NCT01297062|281598|P4|NOT COMPLETED|Overall Study||1
116344|NCT01297062|281599|P3|NOT COMPLETED|Overall Study||2
116345|NCT01297062|281600|P2|NOT COMPLETED|Overall Study||1
116346|NCT01297062|281601|P1|NOT COMPLETED|Overall Study||4
116347|NCT01297062|281595|P7|COMPLETED|Overall Study||0
116348|NCT01297062|281596|P6|COMPLETED|Overall Study||13
116349|NCT01297062|281597|P5|COMPLETED|Overall Study||13
116350|NCT01297062|281598|P4|COMPLETED|Overall Study||13
116351|NCT01297062|281599|P3|COMPLETED|Overall Study||12
116352|NCT01297062|281600|P2|COMPLETED|Overall Study||13
116353|NCT01297062|281601|P1|COMPLETED|Overall Study||11
116354|NCT01297062|281595|P7|Evaluable Population|Overall Study||0
116355|NCT01297062|281596|P6|Evaluable Population|Overall Study||13
116356|NCT01297062|281597|P5|Evaluable Population|Overall Study||13
116357|NCT01297062|281598|P4|Evaluable Population|Overall Study||13
116358|NCT01297062|281599|P3|Evaluable Population|Overall Study||12
116359|NCT01297062|281600|P2|Evaluable Population|Overall Study||12
116360|NCT01297062|281601|P1|Evaluable Population|Overall Study||11
116361|NCT01297062|281595|P7|Intent to Treat (ITT)|Overall Study||0
116362|NCT01297062|281596|P6|Intent to Treat (ITT)|Overall Study||14
116363|NCT01297062|281597|P5|Intent to Treat (ITT)|Overall Study||15
116364|NCT01297062|281598|P4|Intent to Treat (ITT)|Overall Study||14
116365|NCT01297062|281599|P3|Intent to Treat (ITT)|Overall Study||14
116366|NCT01297062|281600|P2|Intent to Treat (ITT)|Overall Study||14
116367|NCT01297062|281601|P1|Intent to Treat (ITT)|Overall Study||15
116368|NCT01297062|281595|P7|STARTED|Overall Study||8
116369|NCT01297062|281596|P6|STARTED|Overall Study||14
116370|NCT01297062|281597|P5|STARTED|Overall Study||15
116371|NCT01297062|281598|P4|STARTED|Overall Study||14
116372|NCT01297062|281599|P3|STARTED|Overall Study||14
116373|NCT01297062|281600|P2|STARTED|Overall Study||14
116374|NCT01297062|281601|P1|STARTED|Overall Study||15
116375|NCT01296841|281625|P2|NOT COMPLETED|Overall Study||0
116376|NCT01296841|281626|P1|NOT COMPLETED|Overall Study||0
116377|NCT01296841|281625|P2|COMPLETED|Overall Study||15
116378|NCT01296841|281626|P1|COMPLETED|Overall Study||19
116379|NCT01296841|281625|P2|STARTED|Overall Study||15
116380|NCT01296841|281626|P1|STARTED|Overall Study||19
116381|NCT01296815|281638|P2|NOT COMPLETED|Overall Study||0
116382|NCT01296815|281639|P1|NOT COMPLETED|Overall Study||0
116383|NCT01296815|281638|P2|COMPLETED|Overall Study||7
116384|NCT01296815|281639|P1|COMPLETED|Overall Study||7
116385|NCT01296815|281638|P2|STARTED|Overall Study||7
116386|NCT01296815|281639|P1|STARTED|Overall Study||7
116387|NCT01296763|281648|P3|NOT COMPLETED|Overall Study||0
116388|NCT01296763|281649|P2|NOT COMPLETED|Overall Study||0
116389|NCT01296763|281650|P1|NOT COMPLETED|Overall Study||0
116390|NCT01296763|281648|P3|COMPLETED|Overall Study||6
116391|NCT01296763|281649|P2|COMPLETED|Overall Study||5
116392|NCT01296763|281650|P1|COMPLETED|Overall Study||7
116393|NCT01296763|281648|P3|STARTED|Overall Study||6
116394|NCT01296763|281649|P2|STARTED|Overall Study||5
116395|NCT01296763|281650|P1|STARTED|Overall Study||7
116396|NCT01296698|281663|P2|NOT COMPLETED|Overall Study||13
116397|NCT01296698|281664|P1|NOT COMPLETED|Overall Study||244
116398|NCT01296698|281663|P2|COMPLETED|Overall Study||0
116399|NCT01296698|281664|P1|COMPLETED|Overall Study||0
116400|NCT01296698|281663|P2|STARTED|Overall Study||13
116401|NCT01296698|281664|P1|STARTED|Overall Study||244
116402|NCT01296672|281718|P2|NOT COMPLETED|Overall Study||18
116403|NCT01296672|281719|P1|NOT COMPLETED|Overall Study||73
116404|NCT01296672|281718|P2|COMPLETED|Overall Study||59
116405|NCT01296672|281719|P1|COMPLETED|Overall Study||233
116406|NCT01296672|281718|P2|STARTED|Overall Study||77
116407|NCT01296672|281719|P1|STARTED|Overall Study||306
116408|NCT01296646|281731|P2|NOT COMPLETED|Overall Study||11
116409|NCT01296646|281732|P1|NOT COMPLETED|Overall Study||11
116410|NCT01296646|281731|P2|COMPLETED|Overall Study||29
116411|NCT01296646|281732|P1|COMPLETED|Overall Study||29
116412|NCT01296646|281731|P2|STARTED|Overall Study||40
116413|NCT01296646|281732|P1|STARTED|Overall Study||40
116414|NCT01296412|281742|P2|NOT COMPLETED|Overall Study||70
116415|NCT01296412|281743|P1|NOT COMPLETED|Overall Study||51
116416|NCT01296412|281742|P2|COMPLETED|Overall Study||257
116417|NCT01296412|281743|P1|COMPLETED|Overall Study||275
116418|NCT01296412|281742|P2|STARTED|Overall Study||327
116419|NCT01296412|281743|P1|STARTED|Overall Study||326
116420|NCT01296360|281757|P2|NOT COMPLETED|Overall Study||8
116421|NCT01296360|281758|P1|NOT COMPLETED|Overall Study||6
116422|NCT01296360|281757|P2|COMPLETED|Overall Study||142
116423|NCT01296360|281758|P1|COMPLETED|Overall Study||144
116424|NCT01296360|281757|P2|Visit 2a (Month 13)|Overall Study||0
116425|NCT01296360|281758|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
116426|NCT01296360|281757|P2|Visit 2 (Month 12)|Overall Study||149
116427|NCT01296360|281758|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
116428|NCT01296360|281757|P2|STARTED|Overall Study||150
116429|NCT01296360|281758|P1|STARTED|Overall Study||150
116430|NCT01296347|281766|P2|NOT COMPLETED|Overall Study||5
116431|NCT01296347|281767|P1|NOT COMPLETED|Overall Study||0
116432|NCT01296347|281766|P2|COMPLETED|Overall Study||47
116433|NCT01296347|281767|P1|COMPLETED|Overall Study||52
116434|NCT01296347|281766|P2|6 Weeks Afer Surgery|Overall Study||47
116435|NCT01296347|281767|P1|6 Weeks Afer Surgery|Overall Study||52
116436|NCT01296347|281766|P2|STARTED|Overall Study||52
116437|NCT01296347|281767|P1|STARTED|Overall Study||52
116438|NCT01296152|281773|P1|NOT COMPLETED|Overall Study||1
116439|NCT01296152|281773|P1|COMPLETED|Overall Study||24
116440|NCT01296152|281773|P1|STARTED|Overall Study||25
116441|NCT01296035|281800|P1|NOT COMPLETED|Overall Study||1
116442|NCT01296035|281800|P1|COMPLETED|Overall Study||7
116443|NCT01296035|281800|P1|STARTED|Overall Study||8
116444|NCT01295905|281807|P2|NOT COMPLETED|Overall Study||0
116445|NCT01295905|281808|P1|NOT COMPLETED|Overall Study||2
116446|NCT01295905|281807|P2|COMPLETED|Overall Study||30
116447|NCT01295905|281808|P1|COMPLETED|Overall Study||58
116448|NCT01295905|281807|P2|STARTED|Overall Study||30
116449|NCT01295905|281808|P1|STARTED|Overall Study||60
116450|NCT01295879|281820|P1|NOT COMPLETED|Overall Study||0
116451|NCT01295879|281820|P1|COMPLETED|Overall Study||29
116452|NCT01295879|281820|P1|STARTED|Overall Study||29
116453|NCT01295840|281826|P1|NOT COMPLETED|Overall Study||1
116454|NCT01295840|281826|P1|COMPLETED|Overall Study||50
116455|NCT01295840|281826|P1|STARTED|Overall Study||51
116456|NCT01295814|281842|P2|NOT COMPLETED|Overall Study||2
116457|NCT01295814|281843|P1|NOT COMPLETED|Overall Study||2
116458|NCT01295814|281842|P2|COMPLETED|Overall Study||19
116459|NCT01295814|281843|P1|COMPLETED|Overall Study||20
116460|NCT01295814|281842|P2|STARTED|Overall Study||21
116461|NCT01295814|281843|P1|STARTED|Overall Study||22
116462|NCT01295671|281860|P3|NOT COMPLETED|Overall Study||3
116463|NCT01295671|281861|P2|NOT COMPLETED|Overall Study||7
116464|NCT01295671|281862|P1|NOT COMPLETED|Overall Study||7
116465|NCT01295671|281860|P3|COMPLETED|Overall Study||66
116466|NCT01295671|281861|P2|COMPLETED|Overall Study||60
116467|NCT01295671|281862|P1|COMPLETED|Overall Study||60
116468|NCT01295671|281860|P3|STARTED|Overall Study||69
116469|NCT01295671|281861|P2|STARTED|Overall Study||67
116470|NCT01295671|281862|P1|STARTED|Overall Study||67
116471|NCT01295320|281900|P1|NOT COMPLETED|Overall Study||10
116472|NCT01295320|281900|P1|COMPLETED|Overall Study||119
116473|NCT01295320|281900|P1|STARTED|Overall Study||129
116474|NCT01295281|281917|P2|NOT COMPLETED|Second Intervention (7days)||0
116475|NCT01295281|281918|P1|NOT COMPLETED|Second Intervention (7days)||0
116476|NCT01295281|281917|P2|COMPLETED|Second Intervention (7days)||51
116477|NCT01295281|281918|P1|COMPLETED|Second Intervention (7days)||53
116478|NCT01295281|281917|P2|STARTED|Second Intervention (7days)||51
116479|NCT01295281|281918|P1|STARTED|Second Intervention (7days)||53
116480|NCT01295281|281917|P2|NOT COMPLETED|First Intervention (7 Days)||1
116481|NCT01295281|281918|P1|NOT COMPLETED|First Intervention (7 Days)||0
116482|NCT01295281|281917|P2|COMPLETED|First Intervention (7 Days)||51
116483|NCT01295281|281918|P1|COMPLETED|First Intervention (7 Days)||53
116484|NCT01295281|281917|P2|STARTED|First Intervention (7 Days)||52
116485|NCT01295281|281918|P1|STARTED|First Intervention (7 Days)||53
116486|NCT01295216|281926|P2|NOT COMPLETED|Overall Study||34
116487|NCT01295216|281927|P1|NOT COMPLETED|Overall Study||50
116488|NCT01295216|281926|P2|COMPLETED|Overall Study||287
116489|NCT01295216|281927|P1|COMPLETED|Overall Study||266
116490|NCT01295216|281926|P2|STARTED|Overall Study||321
116491|NCT01295216|281927|P1|STARTED|Overall Study||316
116492|NCT01295112|281945|P2|NOT COMPLETED|Overall Study||0
116493|NCT01295112|281946|P1|NOT COMPLETED|Overall Study||0
116494|NCT01295112|281945|P2|COMPLETED|Overall Study||33
116495|NCT01295112|281946|P1|COMPLETED|Overall Study||35
116496|NCT01295112|281945|P2|STARTED|Overall Study||33
116497|NCT01295112|281946|P1|STARTED|Overall Study||35
116498|NCT01295034|281956|P2|NOT COMPLETED|Overall Study||5
116499|NCT01295034|281957|P1|NOT COMPLETED|Overall Study||5
116500|NCT01295034|281956|P2|COMPLETED|Overall Study||25
116501|NCT01295034|281957|P1|COMPLETED|Overall Study||27
116502|NCT01295034|281956|P2|STARTED|Overall Study||30
116503|NCT01295034|281957|P1|STARTED|Overall Study||32
116504|NCT01294917|281965|P1|NOT COMPLETED|Overall Study||6
116505|NCT01294917|281965|P1|COMPLETED|Overall Study||36
116506|NCT01294917|281965|P1|Received OptiFree RepleniSH MPS|Overall Study||36
116507|NCT01294917|281965|P1|Received Clear Care|Overall Study||36
116508|NCT01294917|281965|P1|Received Investigational MPS|Overall Study||36
116509|NCT01294917|281965|P1|STARTED|Overall Study||42
116510|NCT01294800|281975|P4|NOT COMPLETED|Overall Study||16
116511|NCT01294800|281976|P3|NOT COMPLETED|Overall Study||17
116512|NCT01294800|281977|P2|NOT COMPLETED|Overall Study||10
116513|NCT01294800|281978|P1|NOT COMPLETED|Overall Study||11
116514|NCT01294800|281975|P4|COMPLETED|Overall Study||97
116515|NCT01294800|281976|P3|COMPLETED|Overall Study||96
116516|NCT01294800|281977|P2|COMPLETED|Overall Study||103
116517|NCT01294800|281978|P1|COMPLETED|Overall Study||100
116518|NCT01294800|281975|P4|STARTED|Overall Study||113
116519|NCT01294800|281976|P3|STARTED|Overall Study||113
116520|NCT01294800|281977|P2|STARTED|Overall Study||113
116521|NCT01294800|281978|P1|STARTED|Overall Study||111
116522|NCT01294787|282004|P6|NOT COMPLETED|Period 3||0
116523|NCT01294787|282005|P5|NOT COMPLETED|Period 3||1
116524|NCT01294787|282006|P4|NOT COMPLETED|Period 3||0
116525|NCT01294787|282007|P3|NOT COMPLETED|Period 3||0
116526|NCT01294787|282008|P2|NOT COMPLETED|Period 3||0
116527|NCT01294787|282009|P1|NOT COMPLETED|Period 3||0
116528|NCT01294787|282004|P6|COMPLETED|Period 3||13
116529|NCT01294787|282005|P5|COMPLETED|Period 3||13
116530|NCT01294787|282006|P4|COMPLETED|Period 3||9
116531|NCT01294787|282007|P3|COMPLETED|Period 3||13
116532|NCT01294787|282008|P2|COMPLETED|Period 3||13
116533|NCT01294787|282009|P1|COMPLETED|Period 3||12
116534|NCT01294787|282004|P6|STARTED|Period 3||13
116535|NCT01294787|282005|P5|STARTED|Period 3||14
116536|NCT01294787|282006|P4|STARTED|Period 3||9
116537|NCT01294787|282007|P3|STARTED|Period 3||13
116538|NCT01294787|282008|P2|STARTED|Period 3||13
116539|NCT01294787|282009|P1|STARTED|Period 3||12
116540|NCT01294787|282004|P6|NOT COMPLETED|Period 2||0
116541|NCT01294787|282005|P5|NOT COMPLETED|Period 2||0
116542|NCT01294787|282006|P4|NOT COMPLETED|Period 2||2
116543|NCT01294787|282007|P3|NOT COMPLETED|Period 2||0
116544|NCT01294787|282008|P2|NOT COMPLETED|Period 2||3
116545|NCT01294787|282009|P1|NOT COMPLETED|Period 2||0
116546|NCT01294787|282004|P6|COMPLETED|Period 2||13
116547|NCT01294787|282005|P5|COMPLETED|Period 2||14
116548|NCT01294787|282006|P4|COMPLETED|Period 2||9
116549|NCT01294787|282007|P3|COMPLETED|Period 2||13
116550|NCT01294787|282008|P2|COMPLETED|Period 2||13
116551|NCT01294787|282009|P1|COMPLETED|Period 2||12
116552|NCT01294787|282004|P6|STARTED|Period 2||13
116553|NCT01294787|282005|P5|STARTED|Period 2||14
116554|NCT01294787|282006|P4|STARTED|Period 2||11
116555|NCT01294787|282007|P3|STARTED|Period 2||13
116556|NCT01294787|282008|P2|STARTED|Period 2||16
116557|NCT01294787|282009|P1|STARTED|Period 2||12
116558|NCT01294787|282004|P6|NOT COMPLETED|Period 1||2
116559|NCT01294787|282005|P5|NOT COMPLETED|Period 1||2
116560|NCT01294787|282006|P4|NOT COMPLETED|Period 1||1
116561|NCT01294787|282007|P3|NOT COMPLETED|Period 1||1
116562|NCT01294787|282008|P2|NOT COMPLETED|Period 1||0
116563|NCT01294787|282009|P1|NOT COMPLETED|Period 1||0
116564|NCT01294787|282004|P6|COMPLETED|Period 1||13
116565|NCT01294787|282005|P5|COMPLETED|Period 1||14
116566|NCT01294787|282006|P4|COMPLETED|Period 1||11
116567|NCT01294787|282007|P3|COMPLETED|Period 1||13
116568|NCT01294787|282008|P2|COMPLETED|Period 1||16
116569|NCT01294787|282009|P1|COMPLETED|Period 1||12
116570|NCT01294787|282004|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
116571|NCT01294787|282005|P5|STARTED|Period 1||16
116572|NCT01294787|282006|P4|STARTED|Period 1||12
116573|NCT01294787|282007|P3|STARTED|Period 1||14
116574|NCT01294787|282008|P2|STARTED|Period 1||16
116575|NCT01294787|282009|P1|STARTED|Period 1||12
116576|NCT01294748|282053|P2|NOT COMPLETED|Overall Study||2
116577|NCT01294748|282054|P1|NOT COMPLETED|Overall Study||5
116578|NCT01294748|282053|P2|COMPLETED|Overall Study|At 270 days|59
116579|NCT01294748|282054|P1|COMPLETED|Overall Study|At 270 days|118
116580|NCT01294748|282053|P2|STARTED|Overall Study||61
116581|NCT01294748|282054|P1|STARTED|Overall Study||123
116582|NCT01294709|282080|P2|NOT COMPLETED|Period 2||0
116583|NCT01294709|282081|P1|NOT COMPLETED|Period 2||1
116584|NCT01294709|282080|P2|COMPLETED|Period 2||31
116585|NCT01294709|282081|P1|COMPLETED|Period 2||28
116586|NCT01294709|282080|P2|STARTED|Period 2||31
116587|NCT01294709|282081|P1|STARTED|Period 2||29
116588|NCT01294709|282080|P2|NOT COMPLETED|Washout Period||1
116589|NCT01294709|282081|P1|NOT COMPLETED|Washout Period||1
116590|NCT01294709|282080|P2|COMPLETED|Washout Period||31
116591|NCT01294709|282081|P1|COMPLETED|Washout Period||29
116592|NCT01294709|282080|P2|STARTED|Washout Period||32
116593|NCT01294709|282081|P1|STARTED|Washout Period||30
116594|NCT01294709|282080|P2|NOT COMPLETED|Period 1||1
116595|NCT01294709|282081|P1|NOT COMPLETED|Period 1||1
116596|NCT01294709|282080|P2|COMPLETED|Period 1||32
116597|NCT01294709|282081|P1|COMPLETED|Period 1||30
116598|NCT01294709|282080|P2|STARTED|Period 1||33
116599|NCT01294709|282081|P1|STARTED|Period 1||31
116600|NCT01294696|282100|P1|NOT COMPLETED|Overall Study||74
116601|NCT01294696|282100|P1|COMPLETED|Overall Study||1187
116602|NCT01294696|282100|P1|STARTED|Overall Study||1261
116603|NCT01294683|282114|P2|NOT COMPLETED|Post Crossover (Period III)||32
116604|NCT01294683|282115|P1|NOT COMPLETED|Post Crossover (Period III)||33
116605|NCT01294683|282114|P2|COMPLETED|Post Crossover (Period III)||190
116606|NCT01294683|282115|P1|COMPLETED|Post Crossover (Period III)||199
116607|NCT01294683|282114|P2|STARTED|Post Crossover (Period III)||222
116608|NCT01294683|282115|P1|STARTED|Post Crossover (Period III)||232
116609|NCT01294683|282114|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
116610|NCT01294683|282115|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
116611|NCT01294683|282114|P2|COMPLETED|Precrossover (Periods I/II)||222
116612|NCT01294683|282115|P1|COMPLETED|Precrossover (Periods I/II)||232
116613|NCT01294683|282114|P2|Treated|Precrossover (Periods I/II)||486
116614|NCT01294683|282115|P1|Treated|Precrossover (Periods I/II)||486
116615|NCT01294683|282114|P2|STARTED|Precrossover (Periods I/II)||488
116616|NCT01294683|282115|P1|STARTED|Precrossover (Periods I/II)||489
116617|NCT01294644|282168|P3|NOT COMPLETED|Overall Study||14
116618|NCT01294644|282169|P2|NOT COMPLETED|Overall Study||10
116619|NCT01294644|282170|P1|NOT COMPLETED|Overall Study||10
116620|NCT01294644|282168|P3|COMPLETED|Overall Study||103
116621|NCT01294644|282169|P2|COMPLETED|Overall Study||112
116622|NCT01294644|282170|P1|COMPLETED|Overall Study||111
116623|NCT01294644|282168|P3|Received Treatment|Overall Study||114
116624|NCT01294644|282169|P2|Received Treatment|Overall Study||122
116625|NCT01294644|282170|P1|Received Treatment|Overall Study||118
116626|NCT01294644|282168|P3|STARTED|Overall Study||117
116627|NCT01294644|282169|P2|STARTED|Overall Study||122
116628|NCT01294644|282170|P1|STARTED|Overall Study||121
116629|NCT01294592|282201|P2|NOT COMPLETED|Overall Study||73
116630|NCT01294592|282202|P1|NOT COMPLETED|Overall Study||77
116631|NCT01294592|282201|P2|COMPLETED|Overall Study||300
116632|NCT01294592|282202|P1|COMPLETED|Overall Study||292
116633|NCT01294592|282201|P2|STARTED|Overall Study||373
116634|NCT01294592|282202|P1|STARTED|Overall Study||369
116635|NCT01294553|282230|P1|NOT COMPLETED|Overall Study||269
116636|NCT01294553|282230|P1|COMPLETED|Overall Study||713
116637|NCT01294553|282230|P1|STARTED|Overall Study||982
116638|NCT01294514|282236|P1|NOT COMPLETED|Overall Study||1
116639|NCT01294514|282236|P1|COMPLETED|Overall Study||26
116640|NCT01294514|282236|P1|STARTED|Overall Study||27
116641|NCT01294462|282246|P2|NOT COMPLETED|Overall Study||63
116642|NCT01294462|282247|P1|NOT COMPLETED|Overall Study||66
116643|NCT01294462|282246|P2|COMPLETED|Overall Study||337
116644|NCT01294462|282247|P1|COMPLETED|Overall Study||335
116645|NCT01294462|282246|P2|Received Randomized Treatment|Overall Study||380
116646|NCT01294462|282247|P1|Received Randomized Treatment|Overall Study||387
116647|NCT01294462|282246|P2|STARTED|Overall Study||400
116648|NCT01294462|282247|P1|STARTED|Overall Study||401
116649|NCT01294449|282261|P2|NOT COMPLETED|Overall Study||15
116650|NCT01294449|282262|P1|NOT COMPLETED|Overall Study||12
116651|NCT01294449|282261|P2|COMPLETED|Overall Study||237
116652|NCT01294449|282262|P1|COMPLETED|Overall Study||144
116653|NCT01294449|282261|P2|Consent to Registry|Overall Study||245
116654|NCT01294449|282262|P1|Consent to Registry|Overall Study||149
116655|NCT01294449|282261|P2|STARTED|Overall Study||252
116656|NCT01294449|282262|P1|STARTED|Overall Study||156
116657|NCT01294436|282270|P2|NOT COMPLETED|Overall Study||70
116658|NCT01294436|282271|P1|NOT COMPLETED|Overall Study||28
116659|NCT01294436|282270|P2|COMPLETED|Overall Study||409
116660|NCT01294436|282271|P1|COMPLETED|Overall Study||221
116661|NCT01294436|282270|P2|STARTED|Overall Study||479
116662|NCT01294436|282271|P1|STARTED|Overall Study||249
116663|NCT01294423|282306|P3|NOT COMPLETED|Overall Study||8
116664|NCT01294423|282307|P2|NOT COMPLETED|Overall Study||9
116665|NCT01294423|282308|P1|NOT COMPLETED|Overall Study||5
116666|NCT01294423|282306|P3|COMPLETED|Overall Study||79
116667|NCT01294423|282307|P2|COMPLETED|Overall Study||79
116668|NCT01294423|282308|P1|COMPLETED|Overall Study||81
116669|NCT01294423|282306|P3|STARTED|Overall Study||87
116670|NCT01294423|282307|P2|STARTED|Overall Study||88
116671|NCT01294423|282308|P1|STARTED|Overall Study||86
116672|NCT01294397|282322|P1|NOT COMPLETED|Overall Study||2
116673|NCT01294397|282322|P1|COMPLETED|Overall Study||17
116674|NCT01294397|282322|P1|STARTED|Overall Study||19
116675|NCT01294384|282335|P3|NOT COMPLETED|Overall Study||9
116676|NCT01294384|282336|P2|NOT COMPLETED|Overall Study||6
116677|NCT01294384|282337|P1|NOT COMPLETED|Overall Study||4
116678|NCT01294384|282335|P3|COMPLETED|Overall Study||95
116679|NCT01294384|282336|P2|COMPLETED|Overall Study||94
116680|NCT01294384|282337|P1|COMPLETED|Overall Study||97
116681|NCT01294384|282335|P3|STARTED|Overall Study||104
116682|NCT01294384|282336|P2|STARTED|Overall Study||100
116683|NCT01294384|282337|P1|STARTED|Overall Study||101
116684|NCT01294371|282366|P1|NOT COMPLETED|Overall Study||34
116685|NCT01294371|282366|P1|COMPLETED|Overall Study||357
116686|NCT01294371|282366|P1|Treated|Overall Study||390
116687|NCT01294371|282366|P1|STARTED|Overall Study||391
116688|NCT01294319|282382|P8|NOT COMPLETED|Overall Study||0
116689|NCT01294319|282383|P7|NOT COMPLETED|Overall Study||0
116690|NCT01294319|282384|P6|NOT COMPLETED|Overall Study||0
116691|NCT01294319|282385|P5|NOT COMPLETED|Overall Study||0
116692|NCT01294319|282386|P4|NOT COMPLETED|Overall Study||0
116693|NCT01294319|282387|P3|NOT COMPLETED|Overall Study||0
116694|NCT01294319|282388|P2|NOT COMPLETED|Overall Study||0
116695|NCT01294319|282389|P1|NOT COMPLETED|Overall Study||0
116696|NCT01294319|282382|P8|COMPLETED|Overall Study||5
116697|NCT01294319|282383|P7|COMPLETED|Overall Study||5
116698|NCT01294319|282384|P6|COMPLETED|Overall Study||4
116699|NCT01294319|282385|P5|COMPLETED|Overall Study||5
116700|NCT01294319|282386|P4|COMPLETED|Overall Study||5
116701|NCT01294319|282387|P3|COMPLETED|Overall Study||5
116702|NCT01294319|282388|P2|COMPLETED|Overall Study||6
116703|NCT01294319|282389|P1|COMPLETED|Overall Study||4
116704|NCT01294319|282382|P8|STARTED|Overall Study||5
116705|NCT01294319|282383|P7|STARTED|Overall Study||5
116706|NCT01294319|282384|P6|STARTED|Overall Study||4
116707|NCT01294319|282385|P5|STARTED|Overall Study||5
116708|NCT01294319|282386|P4|STARTED|Overall Study||5
116709|NCT01294319|282387|P3|STARTED|Overall Study||5
116710|NCT01294319|282388|P2|STARTED|Overall Study||6
116711|NCT01294319|282389|P1|STARTED|Overall Study||4
116712|NCT01294306|282399|P2|NOT COMPLETED|Overall Study||0
116713|NCT01294306|282400|P1|NOT COMPLETED|Overall Study||0
116714|NCT01294306|282399|P2|COMPLETED|Overall Study||35
116715|NCT01294306|282400|P1|COMPLETED|Overall Study||45
116716|NCT01294306|282399|P2|STARTED|Overall Study||35
116717|NCT01294306|282400|P1|STARTED|Overall Study||45
116718|NCT01294267|282414|P1|NOT COMPLETED|Overall Study||0
116719|NCT01294267|282414|P1|COMPLETED|Overall Study||20
116720|NCT01294267|282414|P1|STARTED|Overall Study||20
116721|NCT01294241|282420|P1|NOT COMPLETED|Overall Study||0
116722|NCT01294241|282420|P1|COMPLETED|Overall Study||10
116723|NCT01294241|282420|P1|STARTED|Overall Study||10
116724|NCT01294228|282428|P1|NOT COMPLETED|Overall Study||0
116725|NCT01294228|282428|P1|COMPLETED|Overall Study||1001
116726|NCT01294228|282428|P1|STARTED|Overall Study||1001
116727|NCT01294163|282435|P3|NOT COMPLETED|Overall Study||3
116728|NCT01294163|282436|P2|NOT COMPLETED|Overall Study||0
116729|NCT01294163|282437|P1|NOT COMPLETED|Overall Study||1
116730|NCT01294163|282435|P3|COMPLETED|Overall Study||163
116731|NCT01294163|282436|P2|COMPLETED|Overall Study||165
116732|NCT01294163|282437|P1|COMPLETED|Overall Study||177
116733|NCT01294163|282435|P3|STARTED|Overall Study||166
116734|NCT01294163|282436|P2|STARTED|Overall Study||165
116735|NCT01294163|282437|P1|STARTED|Overall Study||178
116736|NCT01294150|282448|P2|NOT COMPLETED|Overall Study||2
116737|NCT01294150|282449|P1|NOT COMPLETED|Overall Study||2
116738|NCT01294150|282448|P2|COMPLETED|Overall Study||64
116739|NCT01294150|282449|P1|COMPLETED|Overall Study||138
116740|NCT01294150|282448|P2|STARTED|Overall Study||66
116741|NCT01294150|282449|P1|STARTED|Overall Study||140
116742|NCT01294098|282462|P3|NOT COMPLETED|Overall Study||1
116743|NCT01294098|282463|P2|NOT COMPLETED|Overall Study||1
116744|NCT01294098|282464|P1|NOT COMPLETED|Overall Study||0
116745|NCT01294098|282462|P3|COMPLETED|Overall Study||0
116746|NCT01294098|282463|P2|COMPLETED|Overall Study||0
116747|NCT01294098|282464|P1|COMPLETED|Overall Study||0
116748|NCT01294098|282462|P3|STARTED|Overall Study||1
116749|NCT01294098|282463|P2|STARTED|Overall Study||1
116750|NCT01294098|282464|P1|STARTED|Overall Study||0
116751|NCT01294046|282478|P1|NOT COMPLETED|Overall Study||3
116752|NCT01294046|282478|P1|COMPLETED|Overall Study||0
116753|NCT01294046|282478|P1|STARTED|Overall Study||3
116754|NCT01293968|282493|P2|NOT COMPLETED|Overall Study||3
116755|NCT01293968|282494|P1|NOT COMPLETED|Overall Study||3
116756|NCT01293968|282493|P2|COMPLETED|Overall Study||14
116757|NCT01293968|282494|P1|COMPLETED|Overall Study||17
116758|NCT01293968|282493|P2|STARTED|Overall Study||17
116759|NCT01293968|282494|P1|STARTED|Overall Study||20
116760|NCT01293825|282500|P1|NOT COMPLETED|Overall Study||10
116761|NCT01293825|282500|P1|COMPLETED|Overall Study||20
116762|NCT01293825|282500|P1|STARTED|Overall Study||30
116763|NCT01293695|282514|P2|NOT COMPLETED|Overall Study||7
116764|NCT01293695|282515|P1|NOT COMPLETED|Overall Study||15
116765|NCT01293695|282514|P2|COMPLETED|Overall Study||87
116766|NCT01293695|282515|P1|COMPLETED|Overall Study||78
116767|NCT01293695|282514|P2|STARTED|Overall Study||94
116768|NCT01293695|282515|P1|STARTED|Overall Study||93
116769|NCT01293539|282529|P1|NOT COMPLETED|Overall Study||1
116770|NCT01293539|282529|P1|COMPLETED|Overall Study||9
116771|NCT01293539|282529|P1|STARTED|Overall Study||10
116772|NCT01293240|282533|P1|NOT COMPLETED|Overall Study||2
116773|NCT01293240|282533|P1|COMPLETED|Overall Study||115
116774|NCT01293240|282533|P1|STARTED|Overall Study||117
116775|NCT01293084|282548|P1|NOT COMPLETED|Overall Study||5
116776|NCT01293084|282548|P1|COMPLETED|Overall Study||12
116777|NCT01293084|282548|P1|STARTED|Overall Study||17
116778|NCT01293032|282560|P4|NOT COMPLETED|Treatment||1
116779|NCT01293032|282561|P3|NOT COMPLETED|Treatment||1
116780|NCT01293032|282562|P2|NOT COMPLETED|Treatment||5
116781|NCT01293032|282563|P1|NOT COMPLETED|Treatment||2
116782|NCT01293032|282560|P4|COMPLETED|Treatment||13
116783|NCT01293032|282561|P3|COMPLETED|Treatment||10
116784|NCT01293032|282562|P2|COMPLETED|Treatment||14
116785|NCT01293032|282563|P1|COMPLETED|Treatment||10
116786|NCT01293032|282560|P4|STARTED|Treatment||14
116787|NCT01293032|282561|P3|STARTED|Treatment||11
116788|NCT01293032|282562|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
116789|NCT01293032|282563|P1|STARTED|Treatment||12
116790|NCT01293032|282560|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
116791|NCT01293032|282561|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
116792|NCT01293032|282562|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
116793|NCT01293032|282563|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
116794|NCT01293032|282560|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
116795|NCT01293032|282561|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
116796|NCT01293032|282562|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
116797|NCT01293032|282563|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
116798|NCT01293032|282560|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
116799|NCT01293032|282561|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
116800|NCT01293032|282562|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
116801|NCT01293032|282563|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
116802|NCT01293032|282560|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
116803|NCT01293032|282561|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
116804|NCT01293032|282562|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
116805|NCT01293032|282563|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
116806|NCT01293006|282574|P4|NOT COMPLETED|Period 2||0
116807|NCT01293006|282575|P3|NOT COMPLETED|Period 2||0
116808|NCT01293006|282576|P2|NOT COMPLETED|Period 2||0
116809|NCT01293006|282577|P1|NOT COMPLETED|Period 2||1
116810|NCT01293006|282574|P4|COMPLETED|Period 2||3
116811|NCT01293006|282575|P3|COMPLETED|Period 2||9
116812|NCT01293006|282576|P2|COMPLETED|Period 2||2
116813|NCT01293006|282577|P1|COMPLETED|Period 2||10
116814|NCT01293006|282574|P4|STARTED|Period 2||3
116815|NCT01293006|282575|P3|STARTED|Period 2||9
116816|NCT01293006|282576|P2|STARTED|Period 2||2
116817|NCT01293006|282577|P1|STARTED|Period 2||11
116818|NCT01293006|282574|P4|NOT COMPLETED|Washout||0
116819|NCT01293006|282575|P3|NOT COMPLETED|Washout||0
116820|NCT01293006|282576|P2|NOT COMPLETED|Washout||0
116821|NCT01293006|282577|P1|NOT COMPLETED|Washout||0
116822|NCT01293006|282574|P4|COMPLETED|Washout||3
116823|NCT01293006|282575|P3|COMPLETED|Washout||9
116824|NCT01293006|282576|P2|COMPLETED|Washout||2
116825|NCT01293006|282577|P1|COMPLETED|Washout||11
116826|NCT01293006|282574|P4|STARTED|Washout||3
116827|NCT01293006|282575|P3|STARTED|Washout||9
116828|NCT01293006|282576|P2|STARTED|Washout||2
116829|NCT01293006|282577|P1|STARTED|Washout||11
116830|NCT01293006|282574|P4|NOT COMPLETED|Period 1||0
116831|NCT01293006|282575|P3|NOT COMPLETED|Period 1||0
116832|NCT01293006|282576|P2|NOT COMPLETED|Period 1||0
116833|NCT01293006|282577|P1|NOT COMPLETED|Period 1||0
116834|NCT01293006|282574|P4|COMPLETED|Period 1||3
116835|NCT01293006|282575|P3|COMPLETED|Period 1||9
116836|NCT01293006|282576|P2|COMPLETED|Period 1||2
116837|NCT01293006|282577|P1|COMPLETED|Period 1||11
116838|NCT01293006|282574|P4|STARTED|Period 1||3
116839|NCT01293006|282575|P3|STARTED|Period 1||9
116840|NCT01293006|282576|P2|STARTED|Period 1||2
116841|NCT01293006|282577|P1|STARTED|Period 1||11
116842|NCT01292928|282598|P1|NOT COMPLETED|Overall Study||24
116843|NCT01292928|282598|P1|COMPLETED|Overall Study||275
116844|NCT01292928|282598|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
116845|NCT01292928|282598|P1|STARTED|Overall Study||299
116846|NCT01292876|282615|P1|NOT COMPLETED|Overall Study||4
116847|NCT01292876|282615|P1|COMPLETED|Overall Study||13
116848|NCT01292876|282615|P1|STARTED|Overall Study||17
116849|NCT01292837|282621|P1|NOT COMPLETED|Overall Study||2
116850|NCT01292837|282621|P1|COMPLETED|Overall Study||11
116851|NCT01292837|282621|P1|STARTED|Overall Study||13
116852|NCT01292798|282630|P1|NOT COMPLETED|Overall Study||0
116853|NCT01292798|282630|P1|COMPLETED|Overall Study||43
116854|NCT01292798|282630|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
116855|NCT01292798|282630|P1|STARTED|Overall Study||43
116856|NCT01292746|282636|P1|NOT COMPLETED|Overall Study||0
116857|NCT01292746|282636|P1|COMPLETED|Overall Study||14
116858|NCT01292746|282636|P1|STARTED|Overall Study||14
116859|NCT01292642|282640|P1|NOT COMPLETED|Overall Study||5
116860|NCT01292642|282640|P1|COMPLETED|Overall Study||7
116861|NCT01292642|282640|P1|STARTED|Overall Study||12
116862|NCT01292629|282648|P1|NOT COMPLETED|Overall Study||0
116863|NCT01292629|282648|P1|COMPLETED|Overall Study||125
116864|NCT01292629|282648|P1|STARTED|Overall Study||125
116865|NCT01292603|282658|P6|NOT COMPLETED|Part 2: Survival Follow-UP||13
116866|NCT01292603|282659|P5|NOT COMPLETED|Part 2: Survival Follow-UP||11
116867|NCT01292603|282660|P4|NOT COMPLETED|Part 2: Survival Follow-UP||0
116868|NCT01292603|282661|P3|NOT COMPLETED|Part 2: Survival Follow-UP||0
116869|NCT01292603|282662|P2|NOT COMPLETED|Part 2: Survival Follow-UP||0
116870|NCT01292603|282663|P1|NOT COMPLETED|Part 2: Survival Follow-UP||0
116871|NCT01292603|282658|P6|COMPLETED|Part 2: Survival Follow-UP||0
116872|NCT01292603|282659|P5|COMPLETED|Part 2: Survival Follow-UP||0
116873|NCT01292603|282660|P4|COMPLETED|Part 2: Survival Follow-UP||0
116874|NCT01292603|282661|P3|COMPLETED|Part 2: Survival Follow-UP||0
116875|NCT01292603|282662|P2|COMPLETED|Part 2: Survival Follow-UP||0
116876|NCT01292603|282663|P1|COMPLETED|Part 2: Survival Follow-UP||0
116877|NCT01292603|282658|P6|STARTED|Part 2: Survival Follow-UP||13
116878|NCT01292603|282659|P5|STARTED|Part 2: Survival Follow-UP||11
116879|NCT01292603|282660|P4|STARTED|Part 2: Survival Follow-UP||0
116880|NCT01292603|282661|P3|STARTED|Part 2: Survival Follow-UP||0
116881|NCT01292603|282662|P2|STARTED|Part 2: Survival Follow-UP||0
116882|NCT01292603|282663|P1|STARTED|Part 2: Survival Follow-UP||0
116883|NCT01292603|282658|P6|NOT COMPLETED|Part 2: Regular Follow-Up||78
116884|NCT01292603|282659|P5|NOT COMPLETED|Part 2: Regular Follow-Up||78
116885|NCT01292603|282660|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
116886|NCT01292603|282661|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
116887|NCT01292603|282662|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
116888|NCT01292603|282663|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
116889|NCT01292603|282658|P6|COMPLETED|Part 2: Regular Follow-Up||0
116890|NCT01292603|282659|P5|COMPLETED|Part 2: Regular Follow-Up||0
116891|NCT01292603|282660|P4|COMPLETED|Part 2: Regular Follow-Up||0
116892|NCT01292603|282661|P3|COMPLETED|Part 2: Regular Follow-Up||0
116893|NCT01292603|282662|P2|COMPLETED|Part 2: Regular Follow-Up||0
116894|NCT01292603|282663|P1|COMPLETED|Part 2: Regular Follow-Up||0
116895|NCT01292603|282658|P6|STARTED|Part 2: Regular Follow-Up||78
116896|NCT01292603|282659|P5|STARTED|Part 2: Regular Follow-Up||78
116897|NCT01292603|282660|P4|STARTED|Part 2: Regular Follow-Up||0
116898|NCT01292603|282661|P3|STARTED|Part 2: Regular Follow-Up||0
116899|NCT01292603|282662|P2|STARTED|Part 2: Regular Follow-Up||0
116900|NCT01292603|282663|P1|STARTED|Part 2: Regular Follow-Up||0
116901|NCT01292603|282658|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
116902|NCT01292603|282659|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
116903|NCT01292603|282660|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
116904|NCT01292603|282661|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
116905|NCT01292603|282662|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
116906|NCT01292603|282663|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
116907|NCT01292603|282658|P6|COMPLETED|Part 2: Dose Confirmation Period||73
116908|NCT01292603|282659|P5|COMPLETED|Part 2: Dose Confirmation Period||72
116909|NCT01292603|282660|P4|COMPLETED|Part 2: Dose Confirmation Period||0
116910|NCT01292603|282661|P3|COMPLETED|Part 2: Dose Confirmation Period||0
116911|NCT01292603|282662|P2|COMPLETED|Part 2: Dose Confirmation Period||0
116912|NCT01292603|282663|P1|COMPLETED|Part 2: Dose Confirmation Period||0
116913|NCT01292603|282658|P6|STARTED|Part 2: Dose Confirmation Period||88
116914|NCT01292603|282659|P5|STARTED|Part 2: Dose Confirmation Period||88
116915|NCT01292603|282660|P4|STARTED|Part 2: Dose Confirmation Period||0
116916|NCT01292603|282661|P3|STARTED|Part 2: Dose Confirmation Period||0
116917|NCT01292603|282662|P2|STARTED|Part 2: Dose Confirmation Period||0
116918|NCT01292603|282663|P1|STARTED|Part 2: Dose Confirmation Period||0
116919|NCT01292603|282658|P6|NOT COMPLETED|Part 1: Survival Follow-Up||0
116920|NCT01292603|282659|P5|NOT COMPLETED|Part 1: Survival Follow-Up||0
116921|NCT01292603|282660|P4|NOT COMPLETED|Part 1: Survival Follow-Up||0
116922|NCT01292603|282661|P3|NOT COMPLETED|Part 1: Survival Follow-Up||2
116923|NCT01292603|282662|P2|NOT COMPLETED|Part 1: Survival Follow-Up||2
116924|NCT01292603|282663|P1|NOT COMPLETED|Part 1: Survival Follow-Up||4
116925|NCT01292603|282658|P6|COMPLETED|Part 1: Survival Follow-Up||0
116926|NCT01292603|282659|P5|COMPLETED|Part 1: Survival Follow-Up||0
116927|NCT01292603|282660|P4|COMPLETED|Part 1: Survival Follow-Up||0
116928|NCT01292603|282661|P3|COMPLETED|Part 1: Survival Follow-Up||0
116929|NCT01292603|282662|P2|COMPLETED|Part 1: Survival Follow-Up||0
116930|NCT01292603|282663|P1|COMPLETED|Part 1: Survival Follow-Up||0
116931|NCT01292603|282658|P6|STARTED|Part 1: Survival Follow-Up||0
116932|NCT01292603|282659|P5|STARTED|Part 1: Survival Follow-Up||0
116933|NCT01292603|282660|P4|STARTED|Part 1: Survival Follow-Up||0
116934|NCT01292603|282661|P3|STARTED|Part 1: Survival Follow-Up||2
116935|NCT01292603|282662|P2|STARTED|Part 1: Survival Follow-Up||2
116936|NCT01292603|282663|P1|STARTED|Part 1: Survival Follow-Up||4
116937|NCT01292603|282658|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
116938|NCT01292603|282659|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
116939|NCT01292603|282660|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
116940|NCT01292603|282661|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||23
116941|NCT01292603|282662|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||17
116942|NCT01292603|282663|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||16
116943|NCT01292603|282658|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
116944|NCT01292603|282659|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
116945|NCT01292603|282660|P4|COMPLETED|Part 1: Regular Follow-Up Period||0
116946|NCT01292603|282661|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
116947|NCT01292603|282662|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
116948|NCT01292603|282663|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
116949|NCT01292603|282658|P6|STARTED|Part 1: Regular Follow-Up Period||0
116950|NCT01292603|282659|P5|STARTED|Part 1: Regular Follow-Up Period||0
116951|NCT01292603|282660|P4|STARTED|Part 1: Regular Follow-Up Period||0
116952|NCT01292603|282661|P3|STARTED|Part 1: Regular Follow-Up Period||23
116953|NCT01292603|282662|P2|STARTED|Part 1: Regular Follow-Up Period||17
116954|NCT01292603|282663|P1|STARTED|Part 1: Regular Follow-Up Period||16
116955|NCT01292603|282658|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
116956|NCT01292603|282659|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
116957|NCT01292603|282660|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
116958|NCT01292603|282661|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
116959|NCT01292603|282662|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
116960|NCT01292603|282663|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
116961|NCT01292603|282658|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
116962|NCT01292603|282659|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
116963|NCT01292603|282660|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
116964|NCT01292603|282661|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
116965|NCT01292603|282662|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
116966|NCT01292603|282663|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
116967|NCT01292603|282658|P6|STARTED|Part 1: Pilot Dose Selection Period||0
116968|NCT01292603|282659|P5|STARTED|Part 1: Pilot Dose Selection Period||0
116969|NCT01292603|282660|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
116970|NCT01292603|282661|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
116971|NCT01292603|282662|P2|STARTED|Part 1: Pilot Dose Selection Period||17
116972|NCT01292603|282663|P1|STARTED|Part 1: Pilot Dose Selection Period||16
116973|NCT01292538|282709|P2|NOT COMPLETED|Overall Study||0
116974|NCT01292538|282710|P1|NOT COMPLETED|Overall Study||0
116975|NCT01292538|282709|P2|COMPLETED|Overall Study||32
116976|NCT01292538|282710|P1|COMPLETED|Overall Study||35
116977|NCT01292538|282709|P2|STARTED|Overall Study||32
116978|NCT01292538|282710|P1|STARTED|Overall Study||35
116979|NCT01292486|282716|P1|NOT COMPLETED|Overall Study||6
116980|NCT01292486|282716|P1|COMPLETED|Overall Study||26
116981|NCT01292486|282716|P1|STARTED|Overall Study||32
116982|NCT01292473|282730|P4|NOT COMPLETED|Overall Study||12
116983|NCT01292473|282731|P3|NOT COMPLETED|Overall Study||9
116984|NCT01292473|282732|P2|NOT COMPLETED|Overall Study||7
116985|NCT01292473|282733|P1|NOT COMPLETED|Overall Study||5
116986|NCT01292473|282730|P4|COMPLETED|Overall Study||67
116987|NCT01292473|282731|P3|COMPLETED|Overall Study||74
116988|NCT01292473|282732|P2|COMPLETED|Overall Study||75
116989|NCT01292473|282733|P1|COMPLETED|Overall Study||74
116990|NCT01292473|282730|P4|STARTED|Overall Study||79
116991|NCT01292473|282731|P3|STARTED|Overall Study||83
116992|NCT01292473|282732|P2|STARTED|Overall Study||82
116993|NCT01292473|282733|P1|STARTED|Overall Study||79
116994|NCT01292304|282775|P1|NOT COMPLETED|Overall Study||0
116995|NCT01292304|282775|P1|COMPLETED|Overall Study||10
116996|NCT01292304|282775|P1|STARTED|Overall Study||10
116997|NCT01292265|282783|P1|NOT COMPLETED|Overall Study||0
116998|NCT01292265|282783|P1|COMPLETED|Overall Study||3
116999|NCT01292265|282783|P1|STARTED|Overall Study||3
117000|NCT01292239|282792|P2|NOT COMPLETED|Overall Study||7
117001|NCT01292239|282793|P1|NOT COMPLETED|Overall Study||4
117002|NCT01292239|282792|P2|COMPLETED|Overall Study||53
117003|NCT01292239|282793|P1|COMPLETED|Overall Study||119
117004|NCT01292239|282792|P2|STARTED|Overall Study||60
117005|NCT01292239|282793|P1|STARTED|Overall Study||123
117006|NCT01292226|282814|P1|NOT COMPLETED|Overall Study||13
117007|NCT01292226|282814|P1|COMPLETED|Overall Study||32
117008|NCT01292226|282814|P1|STARTED|Overall Study||45
117009|NCT01292187|282847|P2|NOT COMPLETED|Overall Study||13
117010|NCT01292187|282848|P1|NOT COMPLETED|Overall Study||17
117011|NCT01292187|282847|P2|COMPLETED|Overall Study||30
117012|NCT01292187|282848|P1|COMPLETED|Overall Study||69
117013|NCT01292187|282847|P2|STARTED|Overall Study||43
117014|NCT01292187|282848|P1|STARTED|Overall Study||86
117015|NCT01292135|282858|P2|NOT COMPLETED|Overall Study||9
117016|NCT01292135|282859|P1|NOT COMPLETED|Overall Study||0
117017|NCT01292135|282858|P2|COMPLETED|Overall Study||21
117018|NCT01292135|282859|P1|COMPLETED|Overall Study||3
117019|NCT01292135|282858|P2|STARTED|Overall Study||30
117020|NCT01292135|282859|P1|STARTED|Overall Study||3
117021|NCT01292070|282877|P1|NOT COMPLETED|Overall Study||0
117022|NCT01292070|282877|P1|COMPLETED|Overall Study||4
117023|NCT01292070|282877|P1|STARTED|Overall Study||4
117024|NCT01292057|282883|P2|NOT COMPLETED|Overall Study||2
117025|NCT01292057|282884|P1|NOT COMPLETED|Overall Study||2
117026|NCT01292057|282883|P2|COMPLETED|Overall Study||48
117027|NCT01292057|282884|P1|COMPLETED|Overall Study||47
117028|NCT01292057|282883|P2|STARTED|Overall Study||50
117029|NCT01292057|282884|P1|STARTED|Overall Study||49
117030|NCT01292005|282894|P2|NOT COMPLETED|Overall Study||0
117031|NCT01292005|282895|P1|NOT COMPLETED|Overall Study||0
117032|NCT01292005|282894|P2|COMPLETED|Overall Study||14
117033|NCT01292005|282895|P1|COMPLETED|Overall Study||14
117034|NCT01292005|282894|P2|STARTED|Overall Study||14
117035|NCT01292005|282895|P1|STARTED|Overall Study||14
117036|NCT01291836|282919|P2|NOT COMPLETED|Overall Study||0
117037|NCT01291836|282920|P1|NOT COMPLETED|Overall Study||0
117038|NCT01291836|282919|P2|COMPLETED|Overall Study||71
117039|NCT01291836|282920|P1|COMPLETED|Overall Study||930
117040|NCT01291836|282919|P2|STARTED|Overall Study||71
117041|NCT01291836|282920|P1|STARTED|Overall Study||930
117042|NCT01291784|282926|P3|NOT COMPLETED|Overall Study||0
117043|NCT01291784|282927|P2|NOT COMPLETED|Overall Study||1
117044|NCT01291784|282928|P1|NOT COMPLETED|Overall Study||0
117045|NCT01291784|282926|P3|COMPLETED|Overall Study||1
117046|NCT01291784|282927|P2|COMPLETED|Overall Study||0
117047|NCT01291784|282928|P1|COMPLETED|Overall Study||1
117048|NCT01291784|282926|P3|STARTED|Overall Study||1
117049|NCT01291784|282927|P2|STARTED|Overall Study||1
117050|NCT01291784|282928|P1|STARTED|Overall Study||1
117051|NCT01291498|282948|P1|NOT COMPLETED|Overall Study||1
117052|NCT01291498|282948|P1|COMPLETED|Overall Study||0
117053|NCT01291498|282948|P1|STARTED|Overall Study||1
117054|NCT01291277|282956|P2|NOT COMPLETED|Overall Study||3
117055|NCT01291277|282957|P1|NOT COMPLETED|Overall Study||5
117056|NCT01291277|282956|P2|COMPLETED|Overall Study||42
117057|NCT01291277|282957|P1|COMPLETED|Overall Study||40
117058|NCT01291277|282956|P2|STARTED|Overall Study||45
117059|NCT01291277|282957|P1|STARTED|Overall Study||45
117060|NCT01291264|282963|P1|NOT COMPLETED|Overall Study||0
117061|NCT01291264|282963|P1|COMPLETED|Overall Study||260
117062|NCT01291264|282963|P1|STARTED|Overall Study||260
117063|NCT01291225|282969|P2|NOT COMPLETED|Overall Study||39
117064|NCT01291225|282970|P1|NOT COMPLETED|Overall Study||85
117065|NCT01291225|282969|P2|COMPLETED|Overall Study||121
117066|NCT01291225|282970|P1|COMPLETED|Overall Study||66
117067|NCT01291225|282969|P2|STARTED|Overall Study||160
117068|NCT01291225|282970|P1|STARTED|Overall Study||151
117069|NCT01291173|282984|P4|NOT COMPLETED|Overall Study||13
117070|NCT01291173|282985|P3|NOT COMPLETED|Overall Study||13
117071|NCT01291173|282986|P2|NOT COMPLETED|Overall Study||15
117072|NCT01291173|282987|P1|NOT COMPLETED|Overall Study||17
117073|NCT01291173|282984|P4|COMPLETED|Overall Study||52
117074|NCT01291173|282985|P3|COMPLETED|Overall Study||52
117075|NCT01291173|282986|P2|COMPLETED|Overall Study||51
117076|NCT01291173|282987|P1|COMPLETED|Overall Study||47
117077|NCT01291173|282984|P4|STARTED|Overall Study||65
117078|NCT01291173|282985|P3|STARTED|Overall Study||65
117079|NCT01291173|282986|P2|STARTED|Overall Study||66
117080|NCT01291173|282987|P1|STARTED|Overall Study||64
117081|NCT01291160|283051|P2|NOT COMPLETED|Overall Study||16
117082|NCT01291160|283052|P1|NOT COMPLETED|Overall Study||18
117083|NCT01291160|283051|P2|COMPLETED|Overall Study||48
117084|NCT01291160|283052|P1|COMPLETED|Overall Study||48
117085|NCT01291160|283051|P2|STARTED|Overall Study||64
117086|NCT01291160|283052|P1|STARTED|Overall Study||66
117087|NCT01291108|283062|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
117088|NCT01291108|283063|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
117089|NCT01291108|283064|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
117090|NCT01291108|283065|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
117091|NCT01291108|283066|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
117092|NCT01291108|283067|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
117093|NCT01291108|283062|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
117094|NCT01291108|283063|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
117095|NCT01291108|283064|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
117096|NCT01291108|283065|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
117097|NCT01291108|283066|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
117098|NCT01291108|283067|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
117099|NCT01291108|283062|P6|STARTED|Month 2 (Adjunctive Therapy)||26
117100|NCT01291108|283063|P5|STARTED|Month 2 (Adjunctive Therapy)||34
117101|NCT01291108|283064|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
117102|NCT01291108|283065|P3|STARTED|Month 2 (Adjunctive Therapy)||24
117103|NCT01291108|283066|P2|STARTED|Month 2 (Adjunctive Therapy)||40
117104|NCT01291108|283067|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
117105|NCT01291108|283062|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
117106|NCT01291108|283063|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
117107|NCT01291108|283064|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
117108|NCT01291108|283065|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
117109|NCT01291108|283066|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
117110|NCT01291108|283067|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
117111|NCT01291108|283062|P6|COMPLETED|Month 1 (Monotherapy)||0
117112|NCT01291108|283063|P5|COMPLETED|Month 1 (Monotherapy)||0
117113|NCT01291108|283064|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
117114|NCT01291108|283065|P3|COMPLETED|Month 1 (Monotherapy)||0
117115|NCT01291108|283066|P2|COMPLETED|Month 1 (Monotherapy)||0
117116|NCT01291108|283067|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
117117|NCT01291108|283062|P6|STARTED|Month 1 (Monotherapy)||0
117118|NCT01291108|283063|P5|STARTED|Month 1 (Monotherapy)||0
117119|NCT01291108|283064|P4|STARTED|Month 1 (Monotherapy)||60
117120|NCT01291108|283065|P3|STARTED|Month 1 (Monotherapy)||0
117121|NCT01291108|283066|P2|STARTED|Month 1 (Monotherapy)||0
117122|NCT01291108|283067|P1|STARTED|Month 1 (Monotherapy)||65
117123|NCT01291056|283083|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
117124|NCT01291056|283084|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
117125|NCT01291056|283083|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
117126|NCT01291056|283084|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
117127|NCT01291056|283083|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
117128|NCT01291056|283084|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
117129|NCT01291056|283083|P2|NOT COMPLETED|Washout||0
117130|NCT01291056|283084|P1|NOT COMPLETED|Washout||0
117131|NCT01291056|283083|P2|COMPLETED|Washout||10
117132|NCT01291056|283084|P1|COMPLETED|Washout||10
117133|NCT01291056|283083|P2|STARTED|Washout||10
117134|NCT01291056|283084|P1|STARTED|Washout||10
117135|NCT01291056|283083|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
117136|NCT01291056|283084|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
117137|NCT01291056|283083|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
117138|NCT01291056|283084|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
117139|NCT01291056|283083|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
117140|NCT01291056|283084|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
117141|NCT01291017|283096|P1|NOT COMPLETED|Overall Study||5
117142|NCT01291017|283096|P1|COMPLETED|Overall Study||14
117143|NCT01291017|283096|P1|STARTED|Overall Study||19
117144|NCT01290978|283104|P1|NOT COMPLETED|Overall Study||0
117145|NCT01290978|283104|P1|COMPLETED|Overall Study||22
117146|NCT01290978|283104|P1|STARTED|Overall Study||22
117147|NCT01290952|283113|P2|NOT COMPLETED|Overall Study||14
117148|NCT01290952|283114|P1|NOT COMPLETED|Overall Study||12
117149|NCT01290952|283113|P2|COMPLETED|Overall Study||193
117150|NCT01290952|283114|P1|COMPLETED|Overall Study||192
117151|NCT01290952|283113|P2|STARTED|Overall Study||207
117152|NCT01290952|283114|P1|STARTED|Overall Study||204
117153|NCT01290913|283122|P1|NOT COMPLETED|Overall Study||1
117154|NCT01290913|283122|P1|COMPLETED|Overall Study||12
117155|NCT01290913|283122|P1|STARTED|Overall Study||13
117156|NCT01290887|283129|P2|NOT COMPLETED|Overall Study||536
117157|NCT01290887|283130|P1|NOT COMPLETED|Overall Study||466
117158|NCT01290887|283129|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
117159|NCT01290887|283130|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
117160|NCT01290887|283129|P2|Safety Analysis Set|Overall Study||571
117255|NCT01290315|283427|P2|STARTED|Overall Study||12
117161|NCT01290887|283130|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
117162|NCT01290887|283129|P2|STARTED|Overall Study||571
117163|NCT01290887|283130|P1|STARTED|Overall Study||481
117164|NCT01290874|283170|P2|NOT COMPLETED|Overall Study||404
117165|NCT01290874|283171|P1|NOT COMPLETED|Overall Study||410
117166|NCT01290874|283170|P2|COMPLETED|Overall Study||134
117167|NCT01290874|283171|P1|COMPLETED|Overall Study||122
117168|NCT01290874|283170|P2|STARTED|Overall Study||538
117169|NCT01290874|283171|P1|STARTED|Overall Study||532
117170|NCT01290822|283191|P1|NOT COMPLETED|Overall Study||11
117171|NCT01290822|283191|P1|COMPLETED|Overall Study||1
117172|NCT01290822|283191|P1|STARTED|Overall Study||12
117173|NCT01290796|283200|P1|NOT COMPLETED|Overall Study||30
117174|NCT01290796|283200|P1|COMPLETED|Overall Study||123
117175|NCT01290796|283200|P1|STARTED|Overall Study||153
117176|NCT01290757|283216|P2|NOT COMPLETED|Overall Study||2
117177|NCT01290757|283217|P1|NOT COMPLETED|Overall Study||2
117178|NCT01290757|283216|P2|COMPLETED|Overall Study||88
117179|NCT01290757|283217|P1|COMPLETED|Overall Study||88
117180|NCT01290757|283216|P2|STARTED|Overall Study||90
117181|NCT01290757|283217|P1|STARTED|Overall Study||90
117182|NCT01290731|283233|P1|NOT COMPLETED|Overall Study||1
117183|NCT01290731|283233|P1|COMPLETED|Overall Study||48
117184|NCT01290731|283233|P1|STARTED|Overall Study||49
117185|NCT01290718|283245|P1|NOT COMPLETED|Overall Study||4
117186|NCT01290718|283245|P1|COMPLETED|Overall Study||0
117187|NCT01290718|283245|P1|STARTED|Overall Study||4
117188|NCT01290679|283254|P2|NOT COMPLETED|Overall Study||21
117189|NCT01290679|283255|P1|NOT COMPLETED|Overall Study||16
117190|NCT01290679|283254|P2|COMPLETED|Overall Study||113
117191|NCT01290679|283255|P1|COMPLETED|Overall Study||241
117192|NCT01290679|283254|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
117193|NCT01290679|283255|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
117194|NCT01290666|283324|P1|NOT COMPLETED|Overall Study||38
117195|NCT01290666|283324|P1|COMPLETED|Overall Study||55
117196|NCT01290666|283324|P1|STARTED|Overall Study||93
117197|NCT01290640|283330|P2|NOT COMPLETED|Overall Study||0
117198|NCT01290640|283331|P1|NOT COMPLETED|Overall Study||0
117199|NCT01290640|283330|P2|COMPLETED|Overall Study||10
117200|NCT01290640|283331|P1|COMPLETED|Overall Study||12
117201|NCT01290640|283330|P2|STARTED|Overall Study||10
117202|NCT01290640|283331|P1|STARTED|Overall Study||12
117203|NCT01290627|283342|P3|NOT COMPLETED|Overall Study||0
117204|NCT01290627|283343|P2|NOT COMPLETED|Overall Study||0
117205|NCT01290627|283344|P1|NOT COMPLETED|Overall Study||0
117206|NCT01290627|283342|P3|COMPLETED|Overall Study||10
117207|NCT01290627|283343|P2|COMPLETED|Overall Study||10
117208|NCT01290627|283344|P1|COMPLETED|Overall Study||10
117209|NCT01290627|283342|P3|STARTED|Overall Study||10
117210|NCT01290627|283343|P2|STARTED|Overall Study||10
117211|NCT01290627|283344|P1|STARTED|Overall Study||10
117212|NCT01290614|283366|P2|NOT COMPLETED|Overall Study||0
117213|NCT01290614|283367|P1|NOT COMPLETED|Overall Study||552
117214|NCT01290614|283366|P2|COMPLETED|Overall Study||1129
117215|NCT01290614|283367|P1|COMPLETED|Overall Study||518
117216|NCT01290614|283366|P2|STARTED|Overall Study||1129
117217|NCT01290614|283367|P1|STARTED|Overall Study||1070
117218|NCT01290601|283377|P4|NOT COMPLETED|Overall Study||0
117219|NCT01290601|283378|P3|NOT COMPLETED|Overall Study||0
117220|NCT01290601|283379|P2|NOT COMPLETED|Overall Study||5
117221|NCT01290601|283380|P1|NOT COMPLETED|Overall Study||11
117222|NCT01290601|283377|P4|COMPLETED|Overall Study||0
117223|NCT01290601|283378|P3|COMPLETED|Overall Study||0
117224|NCT01290601|283379|P2|COMPLETED|Overall Study||19
117225|NCT01290601|283380|P1|COMPLETED|Overall Study||35
117226|NCT01290601|283377|P4|STARTED|Overall Study||0
117227|NCT01290601|283378|P3|STARTED|Overall Study||0
117228|NCT01290601|283379|P2|STARTED|Overall Study||24
117229|NCT01290601|283380|P1|STARTED|Overall Study||46
117230|NCT01290536|283394|P1|NOT COMPLETED|Overall Study||0
117231|NCT01290536|283394|P1|COMPLETED|Overall Study||42
117232|NCT01290536|283394|P1|STARTED|Overall Study||42
117233|NCT01290523|283401|P1|NOT COMPLETED|Overall Study||0
117234|NCT01290523|283401|P1|COMPLETED|Overall Study||14
117235|NCT01290523|283401|P1|STARTED|Overall Study||14
117236|NCT01290484|283406|P1|NOT COMPLETED|Overall Study||0
117237|NCT01290484|283406|P1|COMPLETED|Overall Study||7
117238|NCT01290484|283406|P1|STARTED|Overall Study||7
117239|NCT01290341|283412|P2|NOT COMPLETED|Overall Study||29
117240|NCT01290341|283413|P1|NOT COMPLETED|Overall Study||92
117241|NCT01290341|283412|P2|COMPLETED|Overall Study||258
117242|NCT01290341|283413|P1|COMPLETED|Overall Study||481
117243|NCT01290341|283412|P2|STARTED|Overall Study||287
117244|NCT01290341|283413|P1|STARTED|Overall Study||573
117245|NCT01290315|283425|P4|NOT COMPLETED|Overall Study||5
117246|NCT01290315|283426|P3|NOT COMPLETED|Overall Study||0
117247|NCT01290315|283427|P2|NOT COMPLETED|Overall Study||3
117248|NCT01290315|283428|P1|NOT COMPLETED|Overall Study||3
117249|NCT01290315|283425|P4|COMPLETED|Overall Study||8
117250|NCT01290315|283426|P3|COMPLETED|Overall Study||10
117251|NCT01290315|283427|P2|COMPLETED|Overall Study||9
117252|NCT01290315|283428|P1|COMPLETED|Overall Study||11
117253|NCT01290315|283425|P4|STARTED|Overall Study||13
117254|NCT01290315|283426|P3|STARTED|Overall Study||10
117256|NCT01290315|283428|P1|STARTED|Overall Study||14
117257|NCT01290263|283450|P5|NOT COMPLETED|Overall Study||37
117258|NCT01290263|283451|P4|NOT COMPLETED|Overall Study||27
117259|NCT01290263|283452|P3|NOT COMPLETED|Overall Study||7
117260|NCT01290263|283453|P2|NOT COMPLETED|Overall Study||3
117261|NCT01290263|283454|P1|NOT COMPLETED|Overall Study||11
117262|NCT01290263|283450|P5|COMPLETED|Overall Study||0
117263|NCT01290263|283451|P4|COMPLETED|Overall Study||0
117264|NCT01290263|283452|P3|COMPLETED|Overall Study||0
117265|NCT01290263|283453|P2|COMPLETED|Overall Study||0
117266|NCT01290263|283454|P1|COMPLETED|Overall Study||0
117267|NCT01290263|283450|P5|STARTED|Overall Study||37
117268|NCT01290263|283451|P4|STARTED|Overall Study||27
117269|NCT01290263|283452|P3|STARTED|Overall Study||7
117270|NCT01290263|283453|P2|STARTED|Overall Study||3
117271|NCT01290263|283454|P1|STARTED|Overall Study||11
117272|NCT01290237|283472|P2|NOT COMPLETED|Overall Study||2
117273|NCT01290237|283473|P1|NOT COMPLETED|Overall Study||11
117274|NCT01290237|283472|P2|COMPLETED|Overall Study||27
117275|NCT01290237|283473|P1|COMPLETED|Overall Study||19
117276|NCT01290237|283472|P2|STARTED|Overall Study||29
117277|NCT01290237|283473|P1|STARTED|Overall Study||30
117278|NCT01290224|283481|P1|NOT COMPLETED|Overall Study||5
117279|NCT01290224|283481|P1|COMPLETED|Overall Study||5
117280|NCT01290224|283481|P1|STARTED|Overall Study||10
117281|NCT01290094|283492|P1|NOT COMPLETED|Overall Study||6
117282|NCT01290094|283492|P1|COMPLETED|Overall Study||35
117283|NCT01290094|283492|P1|STARTED|Overall Study||41
117284|NCT01290068|283505|P2|NOT COMPLETED|Overall Study||6
117285|NCT01290068|283506|P1|NOT COMPLETED|Overall Study||7
117286|NCT01290068|283505|P2|COMPLETED|Overall Study||94
117287|NCT01290068|283506|P1|COMPLETED|Overall Study||101
117288|NCT01290068|283505|P2|Implanted|Overall Study||98
117289|NCT01290068|283506|P1|Implanted|Overall Study||108
117290|NCT01290068|283505|P2|STARTED|Overall Study||100
117291|NCT01290068|283506|P1|STARTED|Overall Study||108
117292|NCT01290029|283518|P1|NOT COMPLETED|Overall Study||2
117293|NCT01290029|283518|P1|COMPLETED|Overall Study||12
117294|NCT01290029|283518|P1|Received Study Treatment|Overall Study||12
117295|NCT01290029|283518|P1|STARTED|Overall Study||14
117296|NCT01289990|283544|P13|NOT COMPLETED|Overall Study||98
117297|NCT01289990|283545|P12|NOT COMPLETED|Overall Study||68
117298|NCT01289990|283546|P11|NOT COMPLETED|Overall Study||76
117299|NCT01289990|283547|P10|NOT COMPLETED|Overall Study||86
117300|NCT01289990|283548|P9|NOT COMPLETED|Overall Study||75
117301|NCT01289990|283549|P8|NOT COMPLETED|Overall Study||55
117302|NCT01289990|283550|P7|NOT COMPLETED|Overall Study||88
117303|NCT01289990|283551|P6|NOT COMPLETED|Overall Study||74
117304|NCT01289990|283552|P5|NOT COMPLETED|Overall Study||72
117305|NCT01289990|283553|P4|NOT COMPLETED|Overall Study||87
117306|NCT01289990|283554|P3|NOT COMPLETED|Overall Study||109
117307|NCT01289990|283555|P2|NOT COMPLETED|Overall Study||81
117308|NCT01289990|283556|P1|NOT COMPLETED|Overall Study||77
117309|NCT01289990|283544|P13|COMPLETED|Overall Study||127
117310|NCT01289990|283545|P12|COMPLETED|Overall Study||150
117311|NCT01289990|283546|P11|COMPLETED|Overall Study||150
117312|NCT01289990|283547|P10|COMPLETED|Overall Study||121
117313|NCT01289990|283548|P9|COMPLETED|Overall Study||139
117314|NCT01289990|283549|P8|COMPLETED|Overall Study||162
117315|NCT01289990|283550|P7|COMPLETED|Overall Study||78
117316|NCT01289990|283551|P6|COMPLETED|Overall Study||94
117317|NCT01289990|283552|P5|COMPLETED|Overall Study||93
117318|NCT01289990|283553|P4|COMPLETED|Overall Study||136
117319|NCT01289990|283554|P3|COMPLETED|Overall Study||119
117320|NCT01289990|283555|P2|COMPLETED|Overall Study||143
117321|NCT01289990|283556|P1|COMPLETED|Overall Study||147
117322|NCT01289990|283544|P13|STARTED|Overall Study||225
117323|NCT01289990|283545|P12|STARTED|Overall Study||218
117324|NCT01289990|283546|P11|STARTED|Overall Study||226
117325|NCT01289990|283547|P10|STARTED|Overall Study||207
117326|NCT01289990|283548|P9|STARTED|Overall Study||214
117327|NCT01289990|283549|P8|STARTED|Overall Study||217
117328|NCT01289990|283550|P7|STARTED|Overall Study||166
117329|NCT01289990|283551|P6|STARTED|Overall Study||168
117330|NCT01289990|283552|P5|STARTED|Overall Study||165
117331|NCT01289990|283553|P4|STARTED|Overall Study||223
117332|NCT01289990|283554|P3|STARTED|Overall Study||228
117333|NCT01289990|283555|P2|STARTED|Overall Study||224
117334|NCT01289990|283556|P1|STARTED|Overall Study||224
117335|NCT01289912|283742|P2|NOT COMPLETED|Overall Study||2
117336|NCT01289912|283743|P1|NOT COMPLETED|Overall Study||3
117337|NCT01289912|283742|P2|COMPLETED|Overall Study||13
117338|NCT01289912|283743|P1|COMPLETED|Overall Study||29
117339|NCT01289912|283742|P2|STARTED|Overall Study||15
117340|NCT01289912|283743|P1|STARTED|Overall Study||32
117341|NCT01289847|283773|P1|NOT COMPLETED|Overall Study||1
117342|NCT01289847|283773|P1|COMPLETED|Overall Study||24
117343|NCT01289847|283773|P1|STARTED|Overall Study||25
117344|NCT01289821|283782|P1|NOT COMPLETED|Survival Follow-up Period||18
117345|NCT01289821|283782|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
117346|NCT01289821|283782|P1|STARTED|Survival Follow-up Period||52
117347|NCT01289821|283782|P1|NOT COMPLETED|Safety Follow-up Period||5
117348|NCT01289821|283782|P1|COMPLETED|Safety Follow-up Period||49
117349|NCT01289821|283782|P1|STARTED|Safety Follow-up Period||54
117350|NCT01289821|283782|P1|NOT COMPLETED|Treatment Period||54
117351|NCT01289821|283782|P1|COMPLETED|Treatment Period||0
117352|NCT01289821|283782|P1|Participants Received Regorafenib|Treatment Period||54
117353|NCT01289821|283782|P1|STARTED|Treatment Period||54
117354|NCT01289782|283793|P2|NOT COMPLETED|Overall Study||12
117355|NCT01289782|283794|P1|NOT COMPLETED|Overall Study||25
117356|NCT01289782|283793|P2|COMPLETED|Overall Study||118
117357|NCT01289782|283794|P1|COMPLETED|Overall Study||239
117358|NCT01289782|283793|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
117359|NCT01289782|283794|P1|STARTED|Overall Study||264
117360|NCT01289639|283866|P3|NOT COMPLETED|Overall Study||0
117361|NCT01289639|283867|P2|NOT COMPLETED|Overall Study||0
117362|NCT01289639|283868|P1|NOT COMPLETED|Overall Study||1
117363|NCT01289639|283866|P3|COMPLETED|Overall Study||0
117364|NCT01289639|283867|P2|COMPLETED|Overall Study||6
117365|NCT01289639|283868|P1|COMPLETED|Overall Study||4
117366|NCT01289639|283866|P3|STARTED|Overall Study||0
117367|NCT01289639|283867|P2|STARTED|Overall Study||6
117368|NCT01289639|283868|P1|STARTED|Overall Study||5
117369|NCT01289574|283894|P3|NOT COMPLETED|Overall Study||3
117370|NCT01289574|283895|P2|NOT COMPLETED|Overall Study||3
117371|NCT01289574|283896|P1|NOT COMPLETED|Overall Study||7
117372|NCT01289574|283894|P3|COMPLETED|Overall Study||60
117373|NCT01289574|283895|P2|COMPLETED|Overall Study||57
117374|NCT01289574|283896|P1|COMPLETED|Overall Study||51
117375|NCT01289574|283894|P3|STARTED|Overall Study||63
117376|NCT01289574|283895|P2|STARTED|Overall Study||60
117377|NCT01289574|283896|P1|STARTED|Overall Study||58
117378|NCT01289548|283913|P3|NOT COMPLETED|Overall Study||0
117379|NCT01289548|283914|P2|NOT COMPLETED|Overall Study||0
117380|NCT01289548|283915|P1|NOT COMPLETED|Overall Study||0
117381|NCT01289548|283913|P3|COMPLETED|Overall Study||40
117382|NCT01289548|283914|P2|COMPLETED|Overall Study||40
117383|NCT01289548|283915|P1|COMPLETED|Overall Study||40
117384|NCT01289548|283913|P3|Recipients|Overall Study||20
117385|NCT01289548|283914|P2|Recipients|Overall Study||20
117386|NCT01289548|283915|P1|Recipients|Overall Study||20
117387|NCT01289548|283913|P3|Donors|Overall Study||20
117388|NCT01289548|283914|P2|Donors|Overall Study||20
117389|NCT01289548|283915|P1|Donors|Overall Study||20
117390|NCT01289548|283913|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
117391|NCT01289548|283914|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
117392|NCT01289548|283915|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
117393|NCT01289522|283959|P1|NOT COMPLETED|Overall Study||11
117394|NCT01289522|283959|P1|COMPLETED|Overall Study||43
117395|NCT01289522|283959|P1|STARTED|Overall Study||54
117396|NCT01289418|283968|P1|NOT COMPLETED|Day 29 Survey||2468
117397|NCT01289418|283968|P1|COMPLETED|Day 29 Survey||4057
117398|NCT01289418|283968|P1|STARTED|Day 29 Survey||6525
117399|NCT01289418|283968|P1|NOT COMPLETED|Day 8 Survey||2218
117400|NCT01289418|283968|P1|COMPLETED|Day 8 Survey||4307
117401|NCT01289418|283968|P1|STARTED|Day 8 Survey||6525
117402|NCT01289392|283977|P3|NOT COMPLETED|Overall Study||0
117403|NCT01289392|283978|P2|NOT COMPLETED|Overall Study||0
117404|NCT01289392|283979|P1|NOT COMPLETED|Overall Study||0
117405|NCT01289392|283977|P3|COMPLETED|Overall Study||7
117406|NCT01289392|283978|P2|COMPLETED|Overall Study||9
117407|NCT01289392|283979|P1|COMPLETED|Overall Study||9
117408|NCT01289392|283977|P3|STARTED|Overall Study||7
117409|NCT01289392|283978|P2|STARTED|Overall Study||9
117410|NCT01289392|283979|P1|STARTED|Overall Study||9
117411|NCT01289275|283991|P4|NOT COMPLETED|Overall Study||0
117412|NCT01289275|283992|P3|NOT COMPLETED|Overall Study||0
117413|NCT01289275|283993|P2|NOT COMPLETED|Overall Study||0
117414|NCT01289275|283994|P1|NOT COMPLETED|Overall Study||0
117415|NCT01289275|283991|P4|COMPLETED|Overall Study||316
117416|NCT01289275|283992|P3|COMPLETED|Overall Study||317
117417|NCT01289275|283993|P2|COMPLETED|Overall Study||320
117418|NCT01289275|283994|P1|COMPLETED|Overall Study||317
117419|NCT01289275|283991|P4|STARTED|Overall Study||316
117420|NCT01289275|283992|P3|STARTED|Overall Study||317
117421|NCT01289275|283993|P2|STARTED|Overall Study||320
117422|NCT01289275|283994|P1|STARTED|Overall Study||317
117423|NCT01289210|284004|P1|NOT COMPLETED|Overall Study||1
117424|NCT01289210|284004|P1|COMPLETED|Overall Study||1
117425|NCT01289210|284004|P1|STARTED|Overall Study||2
117426|NCT01289119|284014|P6|NOT COMPLETED|Overall Study||4
117427|NCT01289119|284015|P5|NOT COMPLETED|Overall Study||5
117428|NCT01289119|284016|P4|NOT COMPLETED|Overall Study||6
117429|NCT01289119|284017|P3|NOT COMPLETED|Overall Study||9
117430|NCT01289119|284018|P2|NOT COMPLETED|Overall Study||9
117431|NCT01289119|284019|P1|NOT COMPLETED|Overall Study||9
117432|NCT01289119|284014|P6|COMPLETED|Overall Study||57
117433|NCT01289119|284015|P5|COMPLETED|Overall Study||58
117434|NCT01289119|284016|P4|COMPLETED|Overall Study||93
117435|NCT01289119|284017|P3|COMPLETED|Overall Study||89
117436|NCT01289119|284018|P2|COMPLETED|Overall Study||83
117437|NCT01289119|284019|P1|COMPLETED|Overall Study||84
117438|NCT01289119|284014|P6|Treated|Overall Study||61
117439|NCT01289119|284015|P5|Treated|Overall Study||63
117440|NCT01289119|284016|P4|Treated|Overall Study||99
117441|NCT01289119|284017|P3|Treated|Overall Study||98
117442|NCT01289119|284018|P2|Treated|Overall Study||92
117443|NCT01289119|284019|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
117444|NCT01289119|284014|P6|STARTED|Overall Study||61
117445|NCT01289119|284015|P5|STARTED|Overall Study||63
117446|NCT01289119|284016|P4|STARTED|Overall Study||99
117447|NCT01289119|284017|P3|STARTED|Overall Study||98
117448|NCT01289119|284018|P2|STARTED|Overall Study||92
117449|NCT01289119|284019|P1|STARTED|Overall Study||93
117450|NCT01289080|284101|P2|NOT COMPLETED|Overall Study||0
117451|NCT01289080|284102|P1|NOT COMPLETED|Overall Study||0
117452|NCT01289080|284101|P2|COMPLETED|Overall Study||10
117453|NCT01289080|284102|P1|COMPLETED|Overall Study||9
117454|NCT01289080|284101|P2|STARTED|Overall Study||10
117455|NCT01289080|284102|P1|STARTED|Overall Study||9
117456|NCT01289067|284133|P1|NOT COMPLETED|Overall Study||0
117457|NCT01289067|284133|P1|COMPLETED|Overall Study||13
117458|NCT01289067|284133|P1|STARTED|Overall Study||13
117459|NCT01289041|284140|P1|NOT COMPLETED|Overall Study||70
117460|NCT01289041|284140|P1|COMPLETED|Overall Study||0
117461|NCT01289041|284140|P1|STARTED|Overall Study||70
117462|NCT01289028|284152|P1|NOT COMPLETED|Overall Study||83
117463|NCT01289028|284152|P1|COMPLETED|Overall Study||42
117464|NCT01289028|284152|P1|STARTED|Overall Study||125
117465|NCT01289015|284166|P2|NOT COMPLETED|Overall Study||54
117466|NCT01289015|284167|P1|NOT COMPLETED|Overall Study||99
117467|NCT01289015|284166|P2|COMPLETED|Overall Study||230
117468|NCT01289015|284167|P1|COMPLETED|Overall Study||472
117469|NCT01289015|284166|P2|STARTED|Overall Study||284
117470|NCT01289015|284167|P1|STARTED|Overall Study||571
117471|NCT01288976|284178|P3|NOT COMPLETED|Overall Study||20
117472|NCT01288976|284179|P2|NOT COMPLETED|Overall Study||27
117473|NCT01288976|284180|P1|NOT COMPLETED|Overall Study||178
117474|NCT01288976|284178|P3|COMPLETED|Overall Study||85
117475|NCT01288976|284179|P2|COMPLETED|Overall Study||22
117476|NCT01288976|284180|P1|COMPLETED|Overall Study||389
117477|NCT01288976|284178|P3|STARTED|Overall Study||105
117478|NCT01288976|284179|P2|STARTED|Overall Study||49
117479|NCT01288976|284180|P1|STARTED|Overall Study||567
117480|NCT01288911|284209|P2|NOT COMPLETED|Overall Study||170
117481|NCT01288911|284210|P1|NOT COMPLETED|Overall Study||125
117482|NCT01288911|284209|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|21
117483|NCT01288911|284210|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|59
117484|NCT01288911|284209|P2|Received Treatment|Overall Study||189
117485|NCT01288911|284210|P1|Received Treatment|Overall Study||183
117486|NCT01288911|284209|P2|STARTED|Overall Study||191
117487|NCT01288911|284210|P1|STARTED|Overall Study||184
117488|NCT01288859|284238|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117489|NCT01288859|284239|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117490|NCT01288859|284240|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117491|NCT01288859|284241|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117492|NCT01288859|284242|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117493|NCT01288859|284243|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117494|NCT01288859|284238|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117495|NCT01288859|284239|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
117496|NCT01288859|284240|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
117497|NCT01288859|284241|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117498|NCT01288859|284242|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117499|NCT01288859|284243|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
117500|NCT01288859|284238|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
117501|NCT01288859|284239|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
117502|NCT01288859|284240|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
117503|NCT01288859|284241|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
117504|NCT01288859|284242|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
117505|NCT01288859|284243|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
117506|NCT01288859|284238|P6|NOT COMPLETED|Washout Period of 1 Week||0
117507|NCT01288859|284239|P5|NOT COMPLETED|Washout Period of 1 Week||0
117508|NCT01288859|284240|P4|NOT COMPLETED|Washout Period of 1 Week||0
117509|NCT01288859|284241|P3|NOT COMPLETED|Washout Period of 1 Week||0
117510|NCT01288859|284242|P2|NOT COMPLETED|Washout Period of 1 Week||0
117511|NCT01288859|284243|P1|NOT COMPLETED|Washout Period of 1 Week||0
117512|NCT01288859|284238|P6|COMPLETED|Washout Period of 1 Week||0
117513|NCT01288859|284239|P5|COMPLETED|Washout Period of 1 Week||5
117514|NCT01288859|284240|P4|COMPLETED|Washout Period of 1 Week||5
117515|NCT01288859|284241|P3|COMPLETED|Washout Period of 1 Week||0
117516|NCT01288859|284242|P2|COMPLETED|Washout Period of 1 Week||0
117517|NCT01288859|284243|P1|COMPLETED|Washout Period of 1 Week||0
117518|NCT01288859|284238|P6|STARTED|Washout Period of 1 Week||0
117519|NCT01288859|284239|P5|STARTED|Washout Period of 1 Week||5
117520|NCT01288859|284240|P4|STARTED|Washout Period of 1 Week||5
117521|NCT01288859|284241|P3|STARTED|Washout Period of 1 Week||0
117522|NCT01288859|284242|P2|STARTED|Washout Period of 1 Week||0
117523|NCT01288859|284243|P1|STARTED|Washout Period of 1 Week||0
117524|NCT01288859|284238|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117525|NCT01288859|284239|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117526|NCT01288859|284240|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117527|NCT01288859|284241|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117528|NCT01288859|284242|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117529|NCT01288859|284243|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117530|NCT01288859|284238|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117531|NCT01288859|284239|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
117532|NCT01288859|284240|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
117533|NCT01288859|284241|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117534|NCT01288859|284242|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117535|NCT01288859|284243|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
117536|NCT01288859|284238|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
117537|NCT01288859|284239|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
117538|NCT01288859|284240|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
117539|NCT01288859|284241|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
117540|NCT01288859|284242|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
117541|NCT01288859|284243|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
117542|NCT01288859|284238|P6|NOT COMPLETED|Washout Period of 1 Week||0
117543|NCT01288859|284239|P5|NOT COMPLETED|Washout Period of 1 Week||0
117544|NCT01288859|284240|P4|NOT COMPLETED|Washout Period of 1 Week||0
117545|NCT01288859|284241|P3|NOT COMPLETED|Washout Period of 1 Week||0
117546|NCT01288859|284242|P2|NOT COMPLETED|Washout Period of 1 Week||0
117547|NCT01288859|284243|P1|NOT COMPLETED|Washout Period of 1 Week||0
117548|NCT01288859|284238|P6|COMPLETED|Washout Period of 1 Week||0
117549|NCT01288859|284239|P5|COMPLETED|Washout Period of 1 Week||5
117550|NCT01288859|284240|P4|COMPLETED|Washout Period of 1 Week||5
117551|NCT01288859|284241|P3|COMPLETED|Washout Period of 1 Week||0
117552|NCT01288859|284242|P2|COMPLETED|Washout Period of 1 Week||0
117553|NCT01288859|284243|P1|COMPLETED|Washout Period of 1 Week||0
117554|NCT01288859|284238|P6|STARTED|Washout Period of 1 Week||0
117555|NCT01288859|284239|P5|STARTED|Washout Period of 1 Week||5
117556|NCT01288859|284240|P4|STARTED|Washout Period of 1 Week||5
117557|NCT01288859|284241|P3|STARTED|Washout Period of 1 Week||0
117558|NCT01288859|284242|P2|STARTED|Washout Period of 1 Week||0
117559|NCT01288859|284243|P1|STARTED|Washout Period of 1 Week||0
117560|NCT01288859|284238|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117561|NCT01288859|284239|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117562|NCT01288859|284240|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117563|NCT01288859|284241|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117564|NCT01288859|284242|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117565|NCT01288859|284243|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117566|NCT01288859|284238|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117567|NCT01288859|284239|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117568|NCT01288859|284240|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117569|NCT01288859|284241|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
117570|NCT01288859|284242|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
117571|NCT01288859|284243|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117572|NCT01288859|284238|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117573|NCT01288859|284239|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117574|NCT01288859|284240|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117575|NCT01288859|284241|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
117576|NCT01288859|284242|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
117577|NCT01288859|284243|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
117578|NCT01288859|284238|P6|NOT COMPLETED|Washout Period of 1 Week||0
117579|NCT01288859|284239|P5|NOT COMPLETED|Washout Period of 1 Week||0
117580|NCT01288859|284240|P4|NOT COMPLETED|Washout Period of 1 Week||0
117581|NCT01288859|284241|P3|NOT COMPLETED|Washout Period of 1 Week||0
117582|NCT01288859|284242|P2|NOT COMPLETED|Washout Period of 1 Week||0
117583|NCT01288859|284243|P1|NOT COMPLETED|Washout Period of 1 Week||0
117584|NCT01288859|284238|P6|COMPLETED|Washout Period of 1 Week||0
117585|NCT01288859|284239|P5|COMPLETED|Washout Period of 1 Week||0
117586|NCT01288859|284240|P4|COMPLETED|Washout Period of 1 Week||0
117587|NCT01288859|284241|P3|COMPLETED|Washout Period of 1 Week||5
117588|NCT01288859|284242|P2|COMPLETED|Washout Period of 1 Week||5
117589|NCT01288859|284243|P1|COMPLETED|Washout Period of 1 Week||0
117590|NCT01288859|284238|P6|STARTED|Washout Period of 1 Week||0
117591|NCT01288859|284239|P5|STARTED|Washout Period of 1 Week||0
117592|NCT01288859|284240|P4|STARTED|Washout Period of 1 Week||0
117593|NCT01288859|284241|P3|STARTED|Washout Period of 1 Week||5
117594|NCT01288859|284242|P2|STARTED|Washout Period of 1 Week||5
117595|NCT01288859|284243|P1|STARTED|Washout Period of 1 Week||0
117596|NCT01288859|284238|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117597|NCT01288859|284239|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117598|NCT01288859|284240|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117599|NCT01288859|284241|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117600|NCT01288859|284242|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117601|NCT01288859|284243|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117602|NCT01288859|284238|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117603|NCT01288859|284239|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117604|NCT01288859|284240|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117605|NCT01288859|284241|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
117606|NCT01288859|284242|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
117607|NCT01288859|284243|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117608|NCT01288859|284238|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117609|NCT01288859|284239|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117610|NCT01288859|284240|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117611|NCT01288859|284241|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
117612|NCT01288859|284242|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
117613|NCT01288859|284243|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
117614|NCT01288859|284238|P6|NOT COMPLETED|Washout Period of 1 Week||0
117615|NCT01288859|284239|P5|NOT COMPLETED|Washout Period of 1 Week||0
117616|NCT01288859|284240|P4|NOT COMPLETED|Washout Period of 1 Week||0
117617|NCT01288859|284241|P3|NOT COMPLETED|Washout Period of 1 Week||0
117618|NCT01288859|284242|P2|NOT COMPLETED|Washout Period of 1 Week||0
117619|NCT01288859|284243|P1|NOT COMPLETED|Washout Period of 1 Week||0
117620|NCT01288859|284238|P6|COMPLETED|Washout Period of 1 Week||5
117621|NCT01288859|284239|P5|COMPLETED|Washout Period of 1 Week||0
117622|NCT01288859|284240|P4|COMPLETED|Washout Period of 1 Week||0
117623|NCT01288859|284241|P3|COMPLETED|Washout Period of 1 Week||0
117624|NCT01288859|284242|P2|COMPLETED|Washout Period of 1 Week||0
117625|NCT01288859|284243|P1|COMPLETED|Washout Period of 1 Week||5
117626|NCT01288859|284238|P6|STARTED|Washout Period of 1 Week||5
117627|NCT01288859|284239|P5|STARTED|Washout Period of 1 Week||0
117628|NCT01288859|284240|P4|STARTED|Washout Period of 1 Week||0
117629|NCT01288859|284241|P3|STARTED|Washout Period of 1 Week||0
117630|NCT01288859|284242|P2|STARTED|Washout Period of 1 Week||0
117631|NCT01288859|284243|P1|STARTED|Washout Period of 1 Week||5
117632|NCT01288859|284238|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117633|NCT01288859|284239|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117634|NCT01288859|284240|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117635|NCT01288859|284241|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117636|NCT01288859|284242|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117637|NCT01288859|284243|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117638|NCT01288859|284238|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
117639|NCT01288859|284239|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117640|NCT01288859|284240|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117641|NCT01288859|284241|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117642|NCT01288859|284242|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
117643|NCT01288859|284243|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
117644|NCT01288859|284238|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
117645|NCT01288859|284239|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
117646|NCT01288859|284240|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
117647|NCT01288859|284241|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
117648|NCT01288859|284242|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
117649|NCT01288859|284243|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
117650|NCT01288859|284238|P6|NOT COMPLETED|Washout Period of 1 Week||0
117651|NCT01288859|284239|P5|NOT COMPLETED|Washout Period of 1 Week||0
117652|NCT01288859|284240|P4|NOT COMPLETED|Washout Period of 1 Week||0
117653|NCT01288859|284241|P3|NOT COMPLETED|Washout Period of 1 Week||0
117654|NCT01288859|284242|P2|NOT COMPLETED|Washout Period of 1 Week||0
117655|NCT01288859|284243|P1|NOT COMPLETED|Washout Period of 1 Week||0
117656|NCT01288859|284238|P6|COMPLETED|Washout Period of 1 Week||5
117657|NCT01288859|284239|P5|COMPLETED|Washout Period of 1 Week||0
117658|NCT01288859|284240|P4|COMPLETED|Washout Period of 1 Week||0
117659|NCT01288859|284241|P3|COMPLETED|Washout Period of 1 Week||0
117660|NCT01288859|284242|P2|COMPLETED|Washout Period of 1 Week||0
117661|NCT01288859|284243|P1|COMPLETED|Washout Period of 1 Week||5
117662|NCT01288859|284238|P6|STARTED|Washout Period of 1 Week||5
117663|NCT01288859|284239|P5|STARTED|Washout Period of 1 Week||0
117664|NCT01288859|284240|P4|STARTED|Washout Period of 1 Week||0
117665|NCT01288859|284241|P3|STARTED|Washout Period of 1 Week||0
117666|NCT01288859|284242|P2|STARTED|Washout Period of 1 Week||0
117667|NCT01288859|284243|P1|STARTED|Washout Period of 1 Week||5
117668|NCT01288859|284238|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117669|NCT01288859|284239|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117670|NCT01288859|284240|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117671|NCT01288859|284241|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117672|NCT01288859|284242|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117673|NCT01288859|284243|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117674|NCT01288859|284238|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
117675|NCT01288859|284239|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117676|NCT01288859|284240|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117677|NCT01288859|284241|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117678|NCT01288859|284242|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
117679|NCT01288859|284243|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
117680|NCT01288859|284238|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
117681|NCT01288859|284239|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
117682|NCT01288859|284240|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
117683|NCT01288859|284241|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
117684|NCT01288859|284242|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
117685|NCT01288859|284243|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
117686|NCT01288833|284271|P2|NOT COMPLETED|Overall Study||0
117687|NCT01288833|284272|P1|NOT COMPLETED|Overall Study||0
117688|NCT01288833|284271|P2|COMPLETED|Overall Study||281
117689|NCT01288833|284272|P1|COMPLETED|Overall Study||277
117690|NCT01288833|284271|P2|STARTED|Overall Study||281
117691|NCT01288833|284272|P1|STARTED|Overall Study||277
117692|NCT01288781|284288|P2|NOT COMPLETED|Overall Study||0
117693|NCT01288781|284289|P1|NOT COMPLETED|Overall Study||0
117694|NCT01288781|284288|P2|COMPLETED|Overall Study||12
117695|NCT01288781|284289|P1|COMPLETED|Overall Study||11
117696|NCT01288781|284288|P2|STARTED|Overall Study||12
117697|NCT01288781|284289|P1|STARTED|Overall Study||11
117698|NCT01288729|284309|P2|NOT COMPLETED|Overall Study||0
117699|NCT01288729|284310|P1|NOT COMPLETED|Overall Study||1
117700|NCT01288729|284309|P2|COMPLETED|Overall Study||10
117701|NCT01288729|284310|P1|COMPLETED|Overall Study||9
117702|NCT01288729|284309|P2|STARTED|Overall Study||10
117703|NCT01288729|284310|P1|STARTED|Overall Study||10
117704|NCT01288612|284319|P3|NOT COMPLETED|Overall Study||82
117705|NCT01288612|284320|P2|NOT COMPLETED|Overall Study||82
117706|NCT01288612|284321|P1|NOT COMPLETED|Overall Study||89
117707|NCT01288612|284319|P3|COMPLETED|Overall Study||76
117708|NCT01288612|284320|P2|COMPLETED|Overall Study||69
117709|NCT01288612|284321|P1|COMPLETED|Overall Study||61
117710|NCT01288612|284319|P3|Agreed to Take Part|Overall Study||76
117711|NCT01288612|284320|P2|Agreed to Take Part|Overall Study||72
117712|NCT01288612|284321|P1|Agreed to Take Part|Overall Study||61
117713|NCT01288612|284319|P3|Contacted|Overall Study||138
117714|NCT01288612|284320|P2|Contacted|Overall Study||135
117715|NCT01288612|284321|P1|Contacted|Overall Study||139
117716|NCT01288612|284319|P3|STARTED|Overall Study||158
117717|NCT01288612|284320|P2|STARTED|Overall Study||151
117718|NCT01288612|284321|P1|STARTED|Overall Study||150
117719|NCT01288534|284350|P1|NOT COMPLETED|Overall Study||0
117720|NCT01288534|284350|P1|COMPLETED|Overall Study||68
117721|NCT01288534|284350|P1|STARTED|Overall Study||68
117722|NCT01288521|284360|P2|NOT COMPLETED|Overall Study||0
117723|NCT01288521|284361|P1|NOT COMPLETED|Overall Study||0
117724|NCT01288521|284360|P2|COMPLETED|Overall Study||5
117725|NCT01288521|284361|P1|COMPLETED|Overall Study||3
117726|NCT01288521|284360|P2|STARTED|Overall Study||5
117727|NCT01288521|284361|P1|STARTED|Overall Study||3
117728|NCT01288469|284370|P3|NOT COMPLETED|Overall Study||2
117729|NCT01288469|284371|P2|NOT COMPLETED|Overall Study||3
117730|NCT01288469|284372|P1|NOT COMPLETED|Overall Study||7
117731|NCT01288469|284370|P3|COMPLETED|Overall Study||28
117732|NCT01288469|284371|P2|COMPLETED|Overall Study||28
117733|NCT01288469|284372|P1|COMPLETED|Overall Study||24
117734|NCT01288469|284370|P3|Treated|Overall Study||30
117735|NCT01288469|284371|P2|Treated|Overall Study||31
117736|NCT01288469|284372|P1|Treated|Overall Study||31
117737|NCT01288469|284370|P3|STARTED|Overall Study|Randomized|30
117738|NCT01288469|284371|P2|STARTED|Overall Study|Randomized|31
117739|NCT01288469|284372|P1|STARTED|Overall Study|Randomized|31
117740|NCT01288443|284404|P6|NOT COMPLETED|Overall Study||5
117741|NCT01288443|284405|P5|NOT COMPLETED|Overall Study||7
117742|NCT01288443|284406|P4|NOT COMPLETED|Overall Study||4
117743|NCT01288443|284407|P3|NOT COMPLETED|Overall Study||1
117744|NCT01288443|284408|P2|NOT COMPLETED|Overall Study||1
117745|NCT01288443|284409|P1|NOT COMPLETED|Overall Study||0
117746|NCT01288443|284404|P6|COMPLETED|Overall Study||25
117747|NCT01288443|284405|P5|COMPLETED|Overall Study||23
117748|NCT01288443|284406|P4|COMPLETED|Overall Study||27
117749|NCT01288443|284407|P3|COMPLETED|Overall Study||30
117750|NCT01288443|284408|P2|COMPLETED|Overall Study||29
117751|NCT01288443|284409|P1|COMPLETED|Overall Study||31
117752|NCT01288443|284404|P6|Treated|Overall Study||30
117753|NCT01288443|284405|P5|Treated|Overall Study||29
117754|NCT01288443|284406|P4|Treated|Overall Study||31
117755|NCT01288443|284407|P3|Treated|Overall Study||31
117756|NCT01288443|284408|P2|Treated|Overall Study||30
117757|NCT01288443|284409|P1|Treated|Overall Study||31
117758|NCT01288443|284404|P6|STARTED|Overall Study|Randomized|30
117759|NCT01288443|284405|P5|STARTED|Overall Study|Randomized|30
117760|NCT01288443|284406|P4|STARTED|Overall Study|Randomized|31
117761|NCT01288443|284407|P3|STARTED|Overall Study|Randomized|31
117762|NCT01288443|284408|P2|STARTED|Overall Study|Randomized|30
117763|NCT01288443|284409|P1|STARTED|Overall Study|Randomized|31
117764|NCT01288287|284459|P1|NOT COMPLETED|Overall Study||46
117765|NCT01288287|284459|P1|COMPLETED|Overall Study||103
117766|NCT01288287|284459|P1|Full Analysis Set|Overall Study||111
117767|NCT01288287|284459|P1|Safety Set|Overall Study||147
117768|NCT01288287|284459|P1|STARTED|Overall Study||149
117769|NCT01288209|284474|P2|NOT COMPLETED|Overall Study||3
117770|NCT01288209|284475|P1|NOT COMPLETED|Overall Study||2
117771|NCT01288209|284474|P2|COMPLETED|Overall Study||50
117772|NCT01288209|284475|P1|COMPLETED|Overall Study||51
117773|NCT01288209|284474|P2|STARTED|Overall Study||53
117774|NCT01288209|284475|P1|STARTED|Overall Study||53
117775|NCT01288079|284505|P4|NOT COMPLETED|Overall Study||17
117776|NCT01288079|284506|P3|NOT COMPLETED|Overall Study||19
117777|NCT01288079|284507|P2|NOT COMPLETED|Overall Study||27
117778|NCT01288079|284508|P1|NOT COMPLETED|Overall Study||20
117779|NCT01288079|284505|P4|COMPLETED|Overall Study||18
117780|NCT01288079|284506|P3|COMPLETED|Overall Study||18
117781|NCT01288079|284507|P2|COMPLETED|Overall Study||9
117782|NCT01288079|284508|P1|COMPLETED|Overall Study||17
117783|NCT01288079|284505|P4|STARTED|Overall Study||35
117784|NCT01288079|284506|P3|STARTED|Overall Study||37
117785|NCT01288079|284507|P2|STARTED|Overall Study||36
117786|NCT01288079|284508|P1|STARTED|Overall Study||37
117787|NCT01288027|284518|P1|NOT COMPLETED|Overall Study||0
117788|NCT01288027|284518|P1|COMPLETED|Overall Study||16
117789|NCT01288027|284518|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
117790|NCT01288027|284518|P1|STARTED|Overall Study||16
117791|NCT01287897|284532|P4|NOT COMPLETED|Overall Study||7
117792|NCT01287897|284533|P3|NOT COMPLETED|Overall Study||12
117793|NCT01287897|284534|P2|NOT COMPLETED|Overall Study||11
117794|NCT01287897|284535|P1|NOT COMPLETED|Overall Study||11
117795|NCT01287897|284532|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
117796|NCT01287897|284533|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
117797|NCT01287897|284534|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
117798|NCT01287897|284535|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
117799|NCT01287897|284532|P4|Enrolled in NCT01345318|Overall Study||29
117800|NCT01287897|284533|P3|Enrolled in NCT01345318|Overall Study||56
117801|NCT01287897|284534|P2|Enrolled in NCT01345318|Overall Study||50
117802|NCT01287897|284535|P1|Enrolled in NCT01345318|Overall Study||56
117803|NCT01287897|284532|P4|Completed Follow-up Period|Overall Study||4
117804|NCT01287897|284533|P3|Completed Follow-up Period|Overall Study||3
117805|NCT01287897|284534|P2|Completed Follow-up Period|Overall Study||8
117806|NCT01287897|284535|P1|Completed Follow-up Period|Overall Study||3
117807|NCT01287897|284532|P4|Completed Treatment Period|Overall Study||29
117808|NCT01287897|284533|P3|Completed Treatment Period|Overall Study||58
117809|NCT01287897|284534|P2|Completed Treatment Period|Overall Study||52
117810|NCT01287897|284535|P1|Completed Treatment Period|Overall Study||58
117811|NCT01287897|284532|P4|Treated|Overall Study||40
117812|NCT01287897|284533|P3|Treated|Overall Study||71
117813|NCT01287897|284534|P2|Treated|Overall Study||67
117814|NCT01287897|284535|P1|Treated|Overall Study||69
117815|NCT01287897|284532|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
117816|NCT01287897|284533|P3|STARTED|Overall Study||71
117817|NCT01287897|284534|P2|STARTED|Overall Study||69
117818|NCT01287897|284535|P1|STARTED|Overall Study||70
117819|NCT01287832|284586|P2|NOT COMPLETED|Overall Study||1
117820|NCT01287832|284587|P1|NOT COMPLETED|Overall Study||1
117821|NCT01287832|284586|P2|COMPLETED|Overall Study||4
117822|NCT01287832|284587|P1|COMPLETED|Overall Study||5
117823|NCT01287832|284586|P2|STARTED|Overall Study||5
117824|NCT01287832|284587|P1|STARTED|Overall Study||6
117825|NCT01287754|284595|P2|NOT COMPLETED|Overall Study||21
117826|NCT01287754|284596|P1|NOT COMPLETED|Overall Study||3
117827|NCT01287754|284595|P2|COMPLETED|Overall Study||0
117828|NCT01287754|284596|P1|COMPLETED|Overall Study||0
117829|NCT01287754|284595|P2|STARTED|Overall Study||21
117830|NCT01287754|284596|P1|STARTED|Overall Study||3
117831|NCT01287741|284608|P2|NOT COMPLETED|Overall Study||706
117832|NCT01287741|284609|P1|NOT COMPLETED|Overall Study||712
117833|NCT01287741|284608|P2|COMPLETED|Overall Study||0
117834|NCT01287741|284609|P1|COMPLETED|Overall Study||0
117835|NCT01287741|284608|P2|STARTED|Overall Study||706
117836|NCT01287741|284609|P1|STARTED|Overall Study||712
117837|NCT01287611|284645|P2|NOT COMPLETED|Overall Study||19
117838|NCT01287611|284646|P1|NOT COMPLETED|Overall Study||33
117839|NCT01287611|284645|P2|COMPLETED|Overall Study||65
117840|NCT01287611|284646|P1|COMPLETED|Overall Study||51
117841|NCT01287611|284645|P2|The Number of Patients Who Underwent C/S|Overall Study||84
117842|NCT01287611|284646|P1|The Number of Patients Who Underwent C/S|Overall Study||84
117843|NCT01287611|284645|P2|STARTED|Overall Study||84
117844|NCT01287611|284646|P1|STARTED|Overall Study||84
117845|NCT01287416|284656|P2|NOT COMPLETED|6 Month Follow-up||2
117846|NCT01287416|284657|P1|NOT COMPLETED|6 Month Follow-up||3
117847|NCT01287416|284656|P2|COMPLETED|6 Month Follow-up||22
117848|NCT01287416|284657|P1|COMPLETED|6 Month Follow-up||28
117849|NCT01287416|284656|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
117850|NCT01287416|284657|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
117851|NCT01287416|284656|P2|NOT COMPLETED|Pre-post Training||25
117852|NCT01287416|284657|P1|NOT COMPLETED|Pre-post Training||22
117853|NCT01287416|284656|P2|COMPLETED|Pre-post Training||23
117854|NCT01287416|284657|P1|COMPLETED|Pre-post Training||26
117855|NCT01287416|284656|P2|Post Training Questionnaire|Pre-post Training||23
117856|NCT01287416|284657|P1|Post Training Questionnaire|Pre-post Training||26
117857|NCT01287416|284656|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
117858|NCT01287416|284657|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
117859|NCT01287416|284656|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
117860|NCT01287416|284657|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
117861|NCT01287403|284693|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
117862|NCT01287403|284693|P1|COMPLETED|6th and Last Intervention (1 Day)||13
117863|NCT01287403|284693|P1|STARTED|6th and Last Intervention (1 Day)||13
117864|NCT01287403|284693|P1|NOT COMPLETED|Washout (7 Days)||0
117865|NCT01287403|284693|P1|COMPLETED|Washout (7 Days)||13
117866|NCT01287403|284693|P1|STARTED|Washout (7 Days)||13
117867|NCT01287403|284693|P1|NOT COMPLETED|5th Intervention (1 Day)||0
117868|NCT01287403|284693|P1|COMPLETED|5th Intervention (1 Day)||13
117869|NCT01287403|284693|P1|STARTED|5th Intervention (1 Day)||13
117870|NCT01287403|284693|P1|NOT COMPLETED|Washout (7 Days)||0
117871|NCT01287403|284693|P1|COMPLETED|Washout (7 Days)||13
117872|NCT01287403|284693|P1|STARTED|Washout (7 Days)||13
117873|NCT01287403|284693|P1|NOT COMPLETED|4th Intervention (1 Day)||0
117874|NCT01287403|284693|P1|COMPLETED|4th Intervention (1 Day)||13
117875|NCT01287403|284693|P1|STARTED|4th Intervention (1 Day)||13
117876|NCT01287403|284693|P1|NOT COMPLETED|Washout (7 Days)||0
117877|NCT01287403|284693|P1|COMPLETED|Washout (7 Days)||13
117878|NCT01287403|284693|P1|STARTED|Washout (7 Days)||13
117879|NCT01287403|284693|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
117880|NCT01287403|284693|P1|COMPLETED|3rd Intervention (1 Day)||13
117881|NCT01287403|284693|P1|STARTED|3rd Intervention (1 Day)||13
117882|NCT01287403|284693|P1|NOT COMPLETED|Washout (7 Days)||0
117883|NCT01287403|284693|P1|COMPLETED|Washout (7 Days)||13
117884|NCT01287403|284693|P1|STARTED|Washout (7 Days)||13
117885|NCT01287403|284693|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
117886|NCT01287403|284693|P1|COMPLETED|2nd Intervention (1 Day)||13
117887|NCT01287403|284693|P1|STARTED|2nd Intervention (1 Day)||13
117888|NCT01287403|284693|P1|NOT COMPLETED|Washout 7 Days||0
117889|NCT01287403|284693|P1|COMPLETED|Washout 7 Days||13
117890|NCT01287403|284693|P1|STARTED|Washout 7 Days||13
117891|NCT01287403|284693|P1|NOT COMPLETED|1st Intervention (1 Day)||1
117892|NCT01287403|284693|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
117893|NCT01287403|284693|P1|STARTED|1st Intervention (1 Day)||14
117894|NCT01287403|284693|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
117895|NCT01287403|284693|P1|COMPLETED|Diet Restriction (7 Days)||14
117896|NCT01287403|284693|P1|STARTED|Diet Restriction (7 Days)||14
117897|NCT01287364|284709|P2|NOT COMPLETED|Overall Study||10
117898|NCT01287364|284710|P1|NOT COMPLETED|Overall Study||9
117899|NCT01287364|284709|P2|COMPLETED|Overall Study||81
117900|NCT01287364|284710|P1|COMPLETED|Overall Study||85
117901|NCT01287364|284709|P2|STARTED|Overall Study||91
117902|NCT01287364|284710|P1|STARTED|Overall Study||94
117903|NCT01287221|284732|P2|NOT COMPLETED|Overall Study||5
117904|NCT01287221|284733|P1|NOT COMPLETED|Overall Study||4
117905|NCT01287221|284732|P2|COMPLETED|Overall Study||45
117906|NCT01287221|284733|P1|COMPLETED|Overall Study||46
117907|NCT01287221|284732|P2|Completed 12 Months Follow-up|Overall Study||39
117908|NCT01287221|284733|P1|Completed 12 Months Follow-up|Overall Study||40
117909|NCT01287221|284732|P2|Completed 9 Months Follow-up|Overall Study||40
117910|NCT01287221|284733|P1|Completed 9 Months Follow-up|Overall Study||42
117911|NCT01287221|284732|P2|Completed 6 Months Follow-up|Overall Study||43
117912|NCT01287221|284733|P1|Completed 6 Months Follow-up|Overall Study||47
117913|NCT01287221|284732|P2|Completed 3 Months Follow-up|Overall Study||50
117914|NCT01287221|284733|P1|Completed 3 Months Follow-up|Overall Study||49
117915|NCT01287221|284732|P2|STARTED|Overall Study||50
117916|NCT01287221|284733|P1|STARTED|Overall Study||50
117917|NCT01287208|284753|P2|NOT COMPLETED|Phase 2: Team Competition||0
117918|NCT01287208|284754|P1|NOT COMPLETED|Phase 2: Team Competition||0
117919|NCT01287208|284753|P2|COMPLETED|Phase 2: Team Competition||49
117920|NCT01287208|284754|P1|COMPLETED|Phase 2: Team Competition||50
117921|NCT01287208|284753|P2|STARTED|Phase 2: Team Competition||49
117922|NCT01287208|284754|P1|STARTED|Phase 2: Team Competition||50
117923|NCT01287208|284753|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
117924|NCT01287208|284754|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
117925|NCT01287208|284753|P2|COMPLETED|Phase 1: Randomized Phase||49
117926|NCT01287208|284754|P1|COMPLETED|Phase 1: Randomized Phase||50
117927|NCT01287208|284753|P2|STARTED|Phase 1: Randomized Phase||52
117928|NCT01287208|284754|P1|STARTED|Phase 1: Randomized Phase||52
117929|NCT01287195|284768|P1|NOT COMPLETED|Overall Study||2
117930|NCT01287195|284768|P1|COMPLETED|Overall Study||4
117931|NCT01287195|284768|P1|STARTED|Overall Study||6
117932|NCT01287117|284783|P4|NOT COMPLETED|Overall Study||12
117933|NCT01287117|284784|P3|NOT COMPLETED|Overall Study||16
117934|NCT01287117|284785|P2|NOT COMPLETED|Overall Study||14
117935|NCT01287117|284786|P1|NOT COMPLETED|Overall Study||15
117936|NCT01287117|284783|P4|COMPLETED|Overall Study||69
117937|NCT01287117|284784|P3|COMPLETED|Overall Study||64
117938|NCT01287117|284785|P2|COMPLETED|Overall Study||64
117939|NCT01287117|284786|P1|COMPLETED|Overall Study||65
117940|NCT01287117|284783|P4|Received Treatment|Overall Study||81
117941|NCT01287117|284784|P3|Received Treatment|Overall Study||80
117942|NCT01287117|284785|P2|Received Treatment|Overall Study||77
117943|NCT01287117|284786|P1|Received Treatment|Overall Study||80
117944|NCT01287117|284783|P4|STARTED|Overall Study||81
117945|NCT01287117|284784|P3|STARTED|Overall Study||80
117946|NCT01287117|284785|P2|STARTED|Overall Study||78
117947|NCT01287117|284786|P1|STARTED|Overall Study||80
117948|NCT01287065|284832|P6|NOT COMPLETED|Treatment Period 3||0
117949|NCT01287065|284833|P5|NOT COMPLETED|Treatment Period 3||0
117950|NCT01287065|284834|P4|NOT COMPLETED|Treatment Period 3||0
117951|NCT01287065|284835|P3|NOT COMPLETED|Treatment Period 3||0
117952|NCT01287065|284836|P2|NOT COMPLETED|Treatment Period 3||0
117953|NCT01287065|284837|P1|NOT COMPLETED|Treatment Period 3||0
117954|NCT01287065|284832|P6|COMPLETED|Treatment Period 3||4
117955|NCT01287065|284833|P5|COMPLETED|Treatment Period 3||4
117956|NCT01287065|284834|P4|COMPLETED|Treatment Period 3||4
117957|NCT01287065|284835|P3|COMPLETED|Treatment Period 3||4
117958|NCT01287065|284836|P2|COMPLETED|Treatment Period 3||4
117959|NCT01287065|284837|P1|COMPLETED|Treatment Period 3||4
117960|NCT01287065|284832|P6|STARTED|Treatment Period 3||4
117961|NCT01287065|284833|P5|STARTED|Treatment Period 3||4
117962|NCT01287065|284834|P4|STARTED|Treatment Period 3||4
117963|NCT01287065|284835|P3|STARTED|Treatment Period 3||4
117964|NCT01287065|284836|P2|STARTED|Treatment Period 3||4
117965|NCT01287065|284837|P1|STARTED|Treatment Period 3||4
117966|NCT01287065|284832|P6|NOT COMPLETED|Washout Period 2||0
117967|NCT01287065|284833|P5|NOT COMPLETED|Washout Period 2||0
117968|NCT01287065|284834|P4|NOT COMPLETED|Washout Period 2||0
117969|NCT01287065|284835|P3|NOT COMPLETED|Washout Period 2||0
117970|NCT01287065|284836|P2|NOT COMPLETED|Washout Period 2||0
117971|NCT01287065|284837|P1|NOT COMPLETED|Washout Period 2||0
117972|NCT01287065|284832|P6|COMPLETED|Washout Period 2||4
117973|NCT01287065|284833|P5|COMPLETED|Washout Period 2||4
117974|NCT01287065|284834|P4|COMPLETED|Washout Period 2||4
117975|NCT01287065|284835|P3|COMPLETED|Washout Period 2||4
117976|NCT01287065|284836|P2|COMPLETED|Washout Period 2||4
117977|NCT01287065|284837|P1|COMPLETED|Washout Period 2||4
117978|NCT01287065|284832|P6|STARTED|Washout Period 2||4
117979|NCT01287065|284833|P5|STARTED|Washout Period 2||4
117980|NCT01287065|284834|P4|STARTED|Washout Period 2||4
117981|NCT01287065|284835|P3|STARTED|Washout Period 2||4
117982|NCT01287065|284836|P2|STARTED|Washout Period 2||4
117983|NCT01287065|284837|P1|STARTED|Washout Period 2||4
117984|NCT01287065|284832|P6|NOT COMPLETED|Treatment Period 2||0
117985|NCT01287065|284833|P5|NOT COMPLETED|Treatment Period 2||0
117986|NCT01287065|284834|P4|NOT COMPLETED|Treatment Period 2||0
117987|NCT01287065|284835|P3|NOT COMPLETED|Treatment Period 2||0
117988|NCT01287065|284836|P2|NOT COMPLETED|Treatment Period 2||0
117989|NCT01287065|284837|P1|NOT COMPLETED|Treatment Period 2||0
117990|NCT01287065|284832|P6|COMPLETED|Treatment Period 2||4
117991|NCT01287065|284833|P5|COMPLETED|Treatment Period 2||4
117992|NCT01287065|284834|P4|COMPLETED|Treatment Period 2||4
117993|NCT01287065|284835|P3|COMPLETED|Treatment Period 2||4
117994|NCT01287065|284836|P2|COMPLETED|Treatment Period 2||4
117995|NCT01287065|284837|P1|COMPLETED|Treatment Period 2||4
117996|NCT01287065|284832|P6|STARTED|Treatment Period 2||4
117997|NCT01287065|284833|P5|STARTED|Treatment Period 2||4
117998|NCT01287065|284834|P4|STARTED|Treatment Period 2||4
117999|NCT01287065|284835|P3|STARTED|Treatment Period 2||4
118000|NCT01287065|284836|P2|STARTED|Treatment Period 2||4
118001|NCT01287065|284837|P1|STARTED|Treatment Period 2||4
118002|NCT01287065|284832|P6|NOT COMPLETED|Washout Period 1||0
118003|NCT01287065|284833|P5|NOT COMPLETED|Washout Period 1||0
118004|NCT01287065|284834|P4|NOT COMPLETED|Washout Period 1||0
118005|NCT01287065|284835|P3|NOT COMPLETED|Washout Period 1||0
118006|NCT01287065|284836|P2|NOT COMPLETED|Washout Period 1||0
118007|NCT01287065|284837|P1|NOT COMPLETED|Washout Period 1||0
118008|NCT01287065|284832|P6|COMPLETED|Washout Period 1||4
118009|NCT01287065|284833|P5|COMPLETED|Washout Period 1||4
118010|NCT01287065|284834|P4|COMPLETED|Washout Period 1||4
118011|NCT01287065|284835|P3|COMPLETED|Washout Period 1||4
118012|NCT01287065|284836|P2|COMPLETED|Washout Period 1||4
118013|NCT01287065|284837|P1|COMPLETED|Washout Period 1||4
118014|NCT01287065|284832|P6|STARTED|Washout Period 1||4
118015|NCT01287065|284833|P5|STARTED|Washout Period 1||4
118016|NCT01287065|284834|P4|STARTED|Washout Period 1||4
118017|NCT01287065|284835|P3|STARTED|Washout Period 1||4
118018|NCT01287065|284836|P2|STARTED|Washout Period 1||4
118019|NCT01287065|284837|P1|STARTED|Washout Period 1||4
118020|NCT01287065|284832|P6|NOT COMPLETED|Treatment Period 1||1
118021|NCT01287065|284833|P5|NOT COMPLETED|Treatment Period 1||1
118022|NCT01287065|284834|P4|NOT COMPLETED|Treatment Period 1||0
118023|NCT01287065|284835|P3|NOT COMPLETED|Treatment Period 1||0
118024|NCT01287065|284836|P2|NOT COMPLETED|Treatment Period 1||0
118025|NCT01287065|284837|P1|NOT COMPLETED|Treatment Period 1||0
118026|NCT01287065|284832|P6|COMPLETED|Treatment Period 1||4
118027|NCT01287065|284833|P5|COMPLETED|Treatment Period 1||4
118028|NCT01287065|284834|P4|COMPLETED|Treatment Period 1||4
118029|NCT01287065|284835|P3|COMPLETED|Treatment Period 1||4
118030|NCT01287065|284836|P2|COMPLETED|Treatment Period 1||4
118031|NCT01287065|284837|P1|COMPLETED|Treatment Period 1||4
118032|NCT01287065|284832|P6|STARTED|Treatment Period 1||5
118033|NCT01287065|284833|P5|STARTED|Treatment Period 1||5
118034|NCT01287065|284834|P4|STARTED|Treatment Period 1||4
118035|NCT01287065|284835|P3|STARTED|Treatment Period 1||4
118036|NCT01287065|284836|P2|STARTED|Treatment Period 1||4
118037|NCT01287065|284837|P1|STARTED|Treatment Period 1||4
118038|NCT01287039|284856|P2|NOT COMPLETED|Overall Study||27
118039|NCT01287039|284857|P1|NOT COMPLETED|Overall Study||29
118040|NCT01287039|284856|P2|COMPLETED|Overall Study||218
118041|NCT01287039|284857|P1|COMPLETED|Overall Study||215
118042|NCT01287039|284856|P2|STARTED|Overall Study||245
118043|NCT01287039|284857|P1|STARTED|Overall Study||244
118044|NCT01287013|284890|P3|NOT COMPLETED|Overall Study||21
118045|NCT01287013|284891|P2|NOT COMPLETED|Overall Study||5
118046|NCT01287013|284892|P1|NOT COMPLETED|Overall Study||3
118047|NCT01287013|284890|P3|COMPLETED|Overall Study||0
118048|NCT01287013|284891|P2|COMPLETED|Overall Study||29
118049|NCT01287013|284892|P1|COMPLETED|Overall Study||29
118050|NCT01287013|284890|P3|STARTED|Overall Study||21
118051|NCT01287013|284891|P2|STARTED|Overall Study||34
118052|NCT01287013|284892|P1|STARTED|Overall Study||32
118053|NCT01286818|284907|P1|NOT COMPLETED|Overall Study||0
118054|NCT01286818|284907|P1|COMPLETED|Overall Study||6
118055|NCT01286818|284907|P1|Completed DLT Assessment Period|Overall Study||5
118056|NCT01286818|284907|P1|STARTED|Overall Study||6
118057|NCT01286805|284921|P2|NOT COMPLETED|Overall Study||1
118058|NCT01286805|284922|P1|NOT COMPLETED|Overall Study||0
118059|NCT01286805|284921|P2|COMPLETED|Overall Study||41
118060|NCT01286805|284922|P1|COMPLETED|Overall Study||41
118061|NCT01286805|284921|P2|STARTED|Overall Study||42
118062|NCT01286805|284922|P1|STARTED|Overall Study||41
118063|NCT01286753|284944|P2|NOT COMPLETED|Overall Study||25
118064|NCT01286753|284945|P1|NOT COMPLETED|Overall Study||26
118065|NCT01286753|284944|P2|COMPLETED|Overall Study||0
118066|NCT01286753|284945|P1|COMPLETED|Overall Study||0
118067|NCT01286753|284944|P2|STARTED|Overall Study||25
118068|NCT01286753|284945|P1|STARTED|Overall Study||26
118069|NCT01286740|284963|P1|NOT COMPLETED|Overall Study||2
118070|NCT01286740|284963|P1|COMPLETED|Overall Study||48
118071|NCT01286740|284963|P1|Week 12 (Primary Endpoint)|Overall Study||49
118072|NCT01286740|284963|P1|Enrolled and Treated|Overall Study||49
118073|NCT01286740|284963|P1|STARTED|Overall Study||50
118074|NCT01286558|284981|P2|NOT COMPLETED|Overall Study||2
118075|NCT01286558|284982|P1|NOT COMPLETED|Overall Study||1
118076|NCT01286558|284981|P2|COMPLETED|Overall Study||111
118077|NCT01286558|284982|P1|COMPLETED|Overall Study||111
118078|NCT01286558|284981|P2|STARTED|Overall Study||113
118079|NCT01286558|284982|P1|STARTED|Overall Study||112
118080|NCT01286493|285012|P1|NOT COMPLETED|Overall Study||3
118081|NCT01286493|285012|P1|COMPLETED|Overall Study||30
118082|NCT01286493|285012|P1|STARTED|Overall Study||33
118083|NCT01286480|285018|P2|NOT COMPLETED|Overall Study||3
118084|NCT01286480|285019|P1|NOT COMPLETED|Overall Study||5
118085|NCT01286480|285018|P2|COMPLETED|Overall Study||31
118086|NCT01286480|285019|P1|COMPLETED|Overall Study||27
118087|NCT01286480|285018|P2|STARTED|Overall Study||34
118088|NCT01286480|285019|P1|STARTED|Overall Study||32
118089|NCT01286454|285027|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
118090|NCT01286454|285028|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
118091|NCT01286454|285029|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
118092|NCT01286454|285030|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
118093|NCT01286454|285031|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
118094|NCT01286454|285032|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
118095|NCT01286454|285033|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
118096|NCT01286454|285034|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
118097|NCT01286454|285035|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
118098|NCT01286454|285036|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
118099|NCT01286454|285037|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
118100|NCT01286454|285027|P11|COMPLETED|Part II- Sixth Intervention Period||20
118101|NCT01286454|285028|P10|COMPLETED|Part II- Sixth Intervention Period||0
118102|NCT01286454|285029|P9|COMPLETED|Part II- Sixth Intervention Period||0
118103|NCT01286454|285030|P8|COMPLETED|Part II- Sixth Intervention Period||0
118104|NCT01286454|285031|P7|COMPLETED|Part II- Sixth Intervention Period||0
118105|NCT01286454|285032|P6|COMPLETED|Part II- Sixth Intervention Period||0
118106|NCT01286454|285033|P5|COMPLETED|Part II- Sixth Intervention Period||0
118107|NCT01286454|285034|P4|COMPLETED|Part II- Sixth Intervention Period||0
118108|NCT01286454|285035|P3|COMPLETED|Part II- Sixth Intervention Period||0
118109|NCT01286454|285036|P2|COMPLETED|Part II- Sixth Intervention Period||0
118110|NCT01286454|285037|P1|COMPLETED|Part II- Sixth Intervention Period||0
118111|NCT01286454|285027|P11|STARTED|Part II- Sixth Intervention Period||20
118112|NCT01286454|285028|P10|STARTED|Part II- Sixth Intervention Period||0
118113|NCT01286454|285029|P9|STARTED|Part II- Sixth Intervention Period||0
118114|NCT01286454|285030|P8|STARTED|Part II- Sixth Intervention Period||0
118115|NCT01286454|285031|P7|STARTED|Part II- Sixth Intervention Period||0
118116|NCT01286454|285032|P6|STARTED|Part II- Sixth Intervention Period||0
118117|NCT01286454|285033|P5|STARTED|Part II- Sixth Intervention Period||0
118118|NCT01286454|285034|P4|STARTED|Part II- Sixth Intervention Period||0
118119|NCT01286454|285035|P3|STARTED|Part II- Sixth Intervention Period||0
118120|NCT01286454|285036|P2|STARTED|Part II- Sixth Intervention Period||0
118121|NCT01286454|285037|P1|STARTED|Part II- Sixth Intervention Period||0
118122|NCT01286454|285027|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118123|NCT01286454|285028|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118124|NCT01286454|285029|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118125|NCT01286454|285030|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118126|NCT01286454|285031|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118127|NCT01286454|285032|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118128|NCT01286454|285033|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118129|NCT01286454|285034|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118130|NCT01286454|285035|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118131|NCT01286454|285036|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118132|NCT01286454|285037|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
118133|NCT01286454|285027|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
118134|NCT01286454|285028|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118135|NCT01286454|285029|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118136|NCT01286454|285030|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118137|NCT01286454|285031|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118138|NCT01286454|285032|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118139|NCT01286454|285033|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118140|NCT01286454|285034|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118141|NCT01286454|285035|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118142|NCT01286454|285036|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118143|NCT01286454|285037|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
118144|NCT01286454|285027|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
118145|NCT01286454|285028|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
118146|NCT01286454|285029|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
118147|NCT01286454|285030|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
118148|NCT01286454|285031|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
118149|NCT01286454|285032|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
118150|NCT01286454|285033|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
118151|NCT01286454|285034|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
118152|NCT01286454|285035|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
118153|NCT01286454|285036|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
118154|NCT01286454|285037|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
118155|NCT01286454|285027|P11|NOT COMPLETED|Fifth Intervention Period||0
118156|NCT01286454|285028|P10|NOT COMPLETED|Fifth Intervention Period||0
118157|NCT01286454|285029|P9|NOT COMPLETED|Fifth Intervention Period||0
118158|NCT01286454|285030|P8|NOT COMPLETED|Fifth Intervention Period||0
118159|NCT01286454|285031|P7|NOT COMPLETED|Fifth Intervention Period||0
118160|NCT01286454|285032|P6|NOT COMPLETED|Fifth Intervention Period||0
118161|NCT01286454|285033|P5|NOT COMPLETED|Fifth Intervention Period||0
118162|NCT01286454|285034|P4|NOT COMPLETED|Fifth Intervention Period||0
118163|NCT01286454|285035|P3|NOT COMPLETED|Fifth Intervention Period||0
118164|NCT01286454|285036|P2|NOT COMPLETED|Fifth Intervention Period||0
118165|NCT01286454|285037|P1|NOT COMPLETED|Fifth Intervention Period||0
118166|NCT01286454|285027|P11|COMPLETED|Fifth Intervention Period||0
118167|NCT01286454|285028|P10|COMPLETED|Fifth Intervention Period||2
118168|NCT01286454|285029|P9|COMPLETED|Fifth Intervention Period||2
118169|NCT01286454|285030|P8|COMPLETED|Fifth Intervention Period||2
118170|NCT01286454|285031|P7|COMPLETED|Fifth Intervention Period||2
118171|NCT01286454|285032|P6|COMPLETED|Fifth Intervention Period||2
118172|NCT01286454|285033|P5|COMPLETED|Fifth Intervention Period||2
118173|NCT01286454|285034|P4|COMPLETED|Fifth Intervention Period||2
118174|NCT01286454|285035|P3|COMPLETED|Fifth Intervention Period||2
118175|NCT01286454|285036|P2|COMPLETED|Fifth Intervention Period||2
118176|NCT01286454|285037|P1|COMPLETED|Fifth Intervention Period||2
118177|NCT01286454|285027|P11|STARTED|Fifth Intervention Period||0
118178|NCT01286454|285028|P10|STARTED|Fifth Intervention Period||2
118179|NCT01286454|285029|P9|STARTED|Fifth Intervention Period||2
118180|NCT01286454|285030|P8|STARTED|Fifth Intervention Period||2
118181|NCT01286454|285031|P7|STARTED|Fifth Intervention Period||2
118182|NCT01286454|285032|P6|STARTED|Fifth Intervention Period||2
118183|NCT01286454|285033|P5|STARTED|Fifth Intervention Period||2
118184|NCT01286454|285034|P4|STARTED|Fifth Intervention Period||2
118185|NCT01286454|285035|P3|STARTED|Fifth Intervention Period||2
118186|NCT01286454|285036|P2|STARTED|Fifth Intervention Period||2
118187|NCT01286454|285037|P1|STARTED|Fifth Intervention Period||2
118188|NCT01286454|285027|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118189|NCT01286454|285028|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118190|NCT01286454|285029|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118191|NCT01286454|285030|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118192|NCT01286454|285031|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118193|NCT01286454|285032|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118194|NCT01286454|285033|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118195|NCT01286454|285034|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118196|NCT01286454|285035|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118197|NCT01286454|285036|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118198|NCT01286454|285037|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118199|NCT01286454|285027|P11|COMPLETED|Washout Period (At Least 3 Days)||0
118200|NCT01286454|285028|P10|COMPLETED|Washout Period (At Least 3 Days)||2
118201|NCT01286454|285029|P9|COMPLETED|Washout Period (At Least 3 Days)||2
118202|NCT01286454|285030|P8|COMPLETED|Washout Period (At Least 3 Days)||2
118203|NCT01286454|285031|P7|COMPLETED|Washout Period (At Least 3 Days)||2
118204|NCT01286454|285032|P6|COMPLETED|Washout Period (At Least 3 Days)||2
118205|NCT01286454|285033|P5|COMPLETED|Washout Period (At Least 3 Days)||2
118206|NCT01286454|285034|P4|COMPLETED|Washout Period (At Least 3 Days)||2
118207|NCT01286454|285035|P3|COMPLETED|Washout Period (At Least 3 Days)||2
118208|NCT01286454|285036|P2|COMPLETED|Washout Period (At Least 3 Days)||2
118209|NCT01286454|285037|P1|COMPLETED|Washout Period (At Least 3 Days)||2
118210|NCT01286454|285027|P11|STARTED|Washout Period (At Least 3 Days)||0
118211|NCT01286454|285028|P10|STARTED|Washout Period (At Least 3 Days)||2
118212|NCT01286454|285029|P9|STARTED|Washout Period (At Least 3 Days)||2
118213|NCT01286454|285030|P8|STARTED|Washout Period (At Least 3 Days)||2
118214|NCT01286454|285031|P7|STARTED|Washout Period (At Least 3 Days)||2
118215|NCT01286454|285032|P6|STARTED|Washout Period (At Least 3 Days)||2
118216|NCT01286454|285033|P5|STARTED|Washout Period (At Least 3 Days)||2
118217|NCT01286454|285034|P4|STARTED|Washout Period (At Least 3 Days)||2
118218|NCT01286454|285035|P3|STARTED|Washout Period (At Least 3 Days)||2
118219|NCT01286454|285036|P2|STARTED|Washout Period (At Least 3 Days)||2
118220|NCT01286454|285037|P1|STARTED|Washout Period (At Least 3 Days)||2
118221|NCT01286454|285027|P11|NOT COMPLETED|Fourth Intervention Period||0
118222|NCT01286454|285028|P10|NOT COMPLETED|Fourth Intervention Period||0
118223|NCT01286454|285029|P9|NOT COMPLETED|Fourth Intervention Period||0
118224|NCT01286454|285030|P8|NOT COMPLETED|Fourth Intervention Period||0
118225|NCT01286454|285031|P7|NOT COMPLETED|Fourth Intervention Period||0
118226|NCT01286454|285032|P6|NOT COMPLETED|Fourth Intervention Period||0
118227|NCT01286454|285033|P5|NOT COMPLETED|Fourth Intervention Period||0
118228|NCT01286454|285034|P4|NOT COMPLETED|Fourth Intervention Period||0
118229|NCT01286454|285035|P3|NOT COMPLETED|Fourth Intervention Period||0
118230|NCT01286454|285036|P2|NOT COMPLETED|Fourth Intervention Period||0
118231|NCT01286454|285037|P1|NOT COMPLETED|Fourth Intervention Period||0
118232|NCT01286454|285027|P11|COMPLETED|Fourth Intervention Period||0
118233|NCT01286454|285028|P10|COMPLETED|Fourth Intervention Period||2
118234|NCT01286454|285029|P9|COMPLETED|Fourth Intervention Period||2
118235|NCT01286454|285030|P8|COMPLETED|Fourth Intervention Period||2
118236|NCT01286454|285031|P7|COMPLETED|Fourth Intervention Period||2
118237|NCT01286454|285032|P6|COMPLETED|Fourth Intervention Period||2
118238|NCT01286454|285033|P5|COMPLETED|Fourth Intervention Period||2
118239|NCT01286454|285034|P4|COMPLETED|Fourth Intervention Period||2
118240|NCT01286454|285035|P3|COMPLETED|Fourth Intervention Period||2
118241|NCT01286454|285036|P2|COMPLETED|Fourth Intervention Period||2
118242|NCT01286454|285037|P1|COMPLETED|Fourth Intervention Period||2
118243|NCT01286454|285027|P11|STARTED|Fourth Intervention Period||0
118244|NCT01286454|285028|P10|STARTED|Fourth Intervention Period||2
118245|NCT01286454|285029|P9|STARTED|Fourth Intervention Period||2
118246|NCT01286454|285030|P8|STARTED|Fourth Intervention Period||2
118247|NCT01286454|285031|P7|STARTED|Fourth Intervention Period||2
118248|NCT01286454|285032|P6|STARTED|Fourth Intervention Period||2
118249|NCT01286454|285033|P5|STARTED|Fourth Intervention Period||2
118250|NCT01286454|285034|P4|STARTED|Fourth Intervention Period||2
118251|NCT01286454|285035|P3|STARTED|Fourth Intervention Period||2
118252|NCT01286454|285036|P2|STARTED|Fourth Intervention Period||2
118253|NCT01286454|285037|P1|STARTED|Fourth Intervention Period||2
118254|NCT01286454|285027|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118255|NCT01286454|285028|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118256|NCT01286454|285029|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118257|NCT01286454|285030|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118258|NCT01286454|285031|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118259|NCT01286454|285032|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118260|NCT01286454|285033|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118261|NCT01286454|285034|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118262|NCT01286454|285035|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118263|NCT01286454|285036|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118264|NCT01286454|285037|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118265|NCT01286454|285027|P11|COMPLETED|Washout Period (At Least 3 Days)||0
118266|NCT01286454|285028|P10|COMPLETED|Washout Period (At Least 3 Days)||2
118267|NCT01286454|285029|P9|COMPLETED|Washout Period (At Least 3 Days)||2
118268|NCT01286454|285030|P8|COMPLETED|Washout Period (At Least 3 Days)||2
118269|NCT01286454|285031|P7|COMPLETED|Washout Period (At Least 3 Days)||2
118270|NCT01286454|285032|P6|COMPLETED|Washout Period (At Least 3 Days)||2
118271|NCT01286454|285033|P5|COMPLETED|Washout Period (At Least 3 Days)||2
118272|NCT01286454|285034|P4|COMPLETED|Washout Period (At Least 3 Days)||2
118273|NCT01286454|285035|P3|COMPLETED|Washout Period (At Least 3 Days)||2
118274|NCT01286454|285036|P2|COMPLETED|Washout Period (At Least 3 Days)||2
118275|NCT01286454|285037|P1|COMPLETED|Washout Period (At Least 3 Days)||2
118276|NCT01286454|285027|P11|STARTED|Washout Period (At Least 3 Days)||0
118277|NCT01286454|285028|P10|STARTED|Washout Period (At Least 3 Days)||2
118278|NCT01286454|285029|P9|STARTED|Washout Period (At Least 3 Days)||2
118279|NCT01286454|285030|P8|STARTED|Washout Period (At Least 3 Days)||2
118280|NCT01286454|285031|P7|STARTED|Washout Period (At Least 3 Days)||2
118281|NCT01286454|285032|P6|STARTED|Washout Period (At Least 3 Days)||2
118282|NCT01286454|285033|P5|STARTED|Washout Period (At Least 3 Days)||2
118283|NCT01286454|285034|P4|STARTED|Washout Period (At Least 3 Days)||2
118284|NCT01286454|285035|P3|STARTED|Washout Period (At Least 3 Days)||2
118285|NCT01286454|285036|P2|STARTED|Washout Period (At Least 3 Days)||2
118286|NCT01286454|285037|P1|STARTED|Washout Period (At Least 3 Days)||2
118287|NCT01286454|285027|P11|NOT COMPLETED|Third Intervention Period||0
118288|NCT01286454|285028|P10|NOT COMPLETED|Third Intervention Period||0
118289|NCT01286454|285029|P9|NOT COMPLETED|Third Intervention Period||0
118290|NCT01286454|285030|P8|NOT COMPLETED|Third Intervention Period||0
118291|NCT01286454|285031|P7|NOT COMPLETED|Third Intervention Period||0
118292|NCT01286454|285032|P6|NOT COMPLETED|Third Intervention Period||0
118293|NCT01286454|285033|P5|NOT COMPLETED|Third Intervention Period||0
118294|NCT01286454|285034|P4|NOT COMPLETED|Third Intervention Period||0
118295|NCT01286454|285035|P3|NOT COMPLETED|Third Intervention Period||0
118296|NCT01286454|285036|P2|NOT COMPLETED|Third Intervention Period||0
118297|NCT01286454|285037|P1|NOT COMPLETED|Third Intervention Period||0
118298|NCT01286454|285027|P11|COMPLETED|Third Intervention Period||0
118299|NCT01286454|285028|P10|COMPLETED|Third Intervention Period||2
118300|NCT01286454|285029|P9|COMPLETED|Third Intervention Period||2
118301|NCT01286454|285030|P8|COMPLETED|Third Intervention Period||2
118302|NCT01286454|285031|P7|COMPLETED|Third Intervention Period||2
118303|NCT01286454|285032|P6|COMPLETED|Third Intervention Period||2
118304|NCT01286454|285033|P5|COMPLETED|Third Intervention Period||2
118305|NCT01286454|285034|P4|COMPLETED|Third Intervention Period||2
118306|NCT01286454|285035|P3|COMPLETED|Third Intervention Period||2
118307|NCT01286454|285036|P2|COMPLETED|Third Intervention Period||2
118308|NCT01286454|285037|P1|COMPLETED|Third Intervention Period||2
118309|NCT01286454|285027|P11|STARTED|Third Intervention Period||0
118310|NCT01286454|285028|P10|STARTED|Third Intervention Period||2
118311|NCT01286454|285029|P9|STARTED|Third Intervention Period||2
118312|NCT01286454|285030|P8|STARTED|Third Intervention Period||2
118313|NCT01286454|285031|P7|STARTED|Third Intervention Period||2
118314|NCT01286454|285032|P6|STARTED|Third Intervention Period||2
118315|NCT01286454|285033|P5|STARTED|Third Intervention Period||2
118316|NCT01286454|285034|P4|STARTED|Third Intervention Period||2
118317|NCT01286454|285035|P3|STARTED|Third Intervention Period||2
118318|NCT01286454|285036|P2|STARTED|Third Intervention Period||2
118319|NCT01286454|285037|P1|STARTED|Third Intervention Period||2
118320|NCT01286454|285027|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118321|NCT01286454|285028|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118322|NCT01286454|285029|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118323|NCT01286454|285030|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118324|NCT01286454|285031|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118325|NCT01286454|285032|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118326|NCT01286454|285033|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118327|NCT01286454|285034|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118328|NCT01286454|285035|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118329|NCT01286454|285036|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118330|NCT01286454|285037|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118331|NCT01286454|285027|P11|COMPLETED|Washout Period (At Least 3 Days)||0
118332|NCT01286454|285028|P10|COMPLETED|Washout Period (At Least 3 Days)||2
118333|NCT01286454|285029|P9|COMPLETED|Washout Period (At Least 3 Days)||2
118334|NCT01286454|285030|P8|COMPLETED|Washout Period (At Least 3 Days)||2
118335|NCT01286454|285031|P7|COMPLETED|Washout Period (At Least 3 Days)||2
118336|NCT01286454|285032|P6|COMPLETED|Washout Period (At Least 3 Days)||2
118337|NCT01286454|285033|P5|COMPLETED|Washout Period (At Least 3 Days)||2
118338|NCT01286454|285034|P4|COMPLETED|Washout Period (At Least 3 Days)||2
118339|NCT01286454|285035|P3|COMPLETED|Washout Period (At Least 3 Days)||2
118340|NCT01286454|285036|P2|COMPLETED|Washout Period (At Least 3 Days)||2
118341|NCT01286454|285037|P1|COMPLETED|Washout Period (At Least 3 Days)||2
118342|NCT01286454|285027|P11|STARTED|Washout Period (At Least 3 Days)||0
118343|NCT01286454|285028|P10|STARTED|Washout Period (At Least 3 Days)||2
118344|NCT01286454|285029|P9|STARTED|Washout Period (At Least 3 Days)||2
118345|NCT01286454|285030|P8|STARTED|Washout Period (At Least 3 Days)||2
118346|NCT01286454|285031|P7|STARTED|Washout Period (At Least 3 Days)||2
118347|NCT01286454|285032|P6|STARTED|Washout Period (At Least 3 Days)||2
118348|NCT01286454|285033|P5|STARTED|Washout Period (At Least 3 Days)||2
118349|NCT01286454|285034|P4|STARTED|Washout Period (At Least 3 Days)||2
118350|NCT01286454|285035|P3|STARTED|Washout Period (At Least 3 Days)||2
118351|NCT01286454|285036|P2|STARTED|Washout Period (At Least 3 Days)||2
118352|NCT01286454|285037|P1|STARTED|Washout Period (At Least 3 Days)||2
118353|NCT01286454|285027|P11|NOT COMPLETED|Second Intervention Period||0
118354|NCT01286454|285028|P10|NOT COMPLETED|Second Intervention Period||0
118355|NCT01286454|285029|P9|NOT COMPLETED|Second Intervention Period||0
118356|NCT01286454|285030|P8|NOT COMPLETED|Second Intervention Period||0
118357|NCT01286454|285031|P7|NOT COMPLETED|Second Intervention Period||0
118358|NCT01286454|285032|P6|NOT COMPLETED|Second Intervention Period||0
118359|NCT01286454|285033|P5|NOT COMPLETED|Second Intervention Period||0
118360|NCT01286454|285034|P4|NOT COMPLETED|Second Intervention Period||0
118361|NCT01286454|285035|P3|NOT COMPLETED|Second Intervention Period||0
118362|NCT01286454|285036|P2|NOT COMPLETED|Second Intervention Period||0
118363|NCT01286454|285037|P1|NOT COMPLETED|Second Intervention Period||0
118364|NCT01286454|285027|P11|COMPLETED|Second Intervention Period||0
118365|NCT01286454|285028|P10|COMPLETED|Second Intervention Period||2
118366|NCT01286454|285029|P9|COMPLETED|Second Intervention Period||2
118367|NCT01286454|285030|P8|COMPLETED|Second Intervention Period||2
118368|NCT01286454|285031|P7|COMPLETED|Second Intervention Period||2
118369|NCT01286454|285032|P6|COMPLETED|Second Intervention Period||2
118370|NCT01286454|285033|P5|COMPLETED|Second Intervention Period||2
118371|NCT01286454|285034|P4|COMPLETED|Second Intervention Period||2
118372|NCT01286454|285035|P3|COMPLETED|Second Intervention Period||2
118373|NCT01286454|285036|P2|COMPLETED|Second Intervention Period||2
118374|NCT01286454|285037|P1|COMPLETED|Second Intervention Period||2
118375|NCT01286454|285027|P11|STARTED|Second Intervention Period||0
118376|NCT01286454|285028|P10|STARTED|Second Intervention Period||2
118377|NCT01286454|285029|P9|STARTED|Second Intervention Period||2
118378|NCT01286454|285030|P8|STARTED|Second Intervention Period||2
118379|NCT01286454|285031|P7|STARTED|Second Intervention Period||2
118380|NCT01286454|285032|P6|STARTED|Second Intervention Period||2
118381|NCT01286454|285033|P5|STARTED|Second Intervention Period||2
118382|NCT01286454|285034|P4|STARTED|Second Intervention Period||2
118383|NCT01286454|285035|P3|STARTED|Second Intervention Period||2
118384|NCT01286454|285036|P2|STARTED|Second Intervention Period||2
118385|NCT01286454|285037|P1|STARTED|Second Intervention Period||2
118386|NCT01286454|285027|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118387|NCT01286454|285028|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118388|NCT01286454|285029|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118389|NCT01286454|285030|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118390|NCT01286454|285031|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118391|NCT01286454|285032|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118392|NCT01286454|285033|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118393|NCT01286454|285034|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118394|NCT01286454|285035|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118395|NCT01286454|285036|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118396|NCT01286454|285037|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
118397|NCT01286454|285027|P11|COMPLETED|Washout Period (At Least 3 Days)||0
118398|NCT01286454|285028|P10|COMPLETED|Washout Period (At Least 3 Days)||2
118399|NCT01286454|285029|P9|COMPLETED|Washout Period (At Least 3 Days)||2
118400|NCT01286454|285030|P8|COMPLETED|Washout Period (At Least 3 Days)||2
118401|NCT01286454|285031|P7|COMPLETED|Washout Period (At Least 3 Days)||2
118402|NCT01286454|285032|P6|COMPLETED|Washout Period (At Least 3 Days)||2
118403|NCT01286454|285033|P5|COMPLETED|Washout Period (At Least 3 Days)||2
118404|NCT01286454|285034|P4|COMPLETED|Washout Period (At Least 3 Days)||2
118405|NCT01286454|285035|P3|COMPLETED|Washout Period (At Least 3 Days)||2
118406|NCT01286454|285036|P2|COMPLETED|Washout Period (At Least 3 Days)||2
118407|NCT01286454|285037|P1|COMPLETED|Washout Period (At Least 3 Days)||2
118408|NCT01286454|285027|P11|STARTED|Washout Period (At Least 3 Days)||0
118409|NCT01286454|285028|P10|STARTED|Washout Period (At Least 3 Days)||2
118410|NCT01286454|285029|P9|STARTED|Washout Period (At Least 3 Days)||2
118411|NCT01286454|285030|P8|STARTED|Washout Period (At Least 3 Days)||2
118412|NCT01286454|285031|P7|STARTED|Washout Period (At Least 3 Days)||2
118413|NCT01286454|285032|P6|STARTED|Washout Period (At Least 3 Days)||2
118414|NCT01286454|285033|P5|STARTED|Washout Period (At Least 3 Days)||2
118415|NCT01286454|285034|P4|STARTED|Washout Period (At Least 3 Days)||2
118416|NCT01286454|285035|P3|STARTED|Washout Period (At Least 3 Days)||2
118417|NCT01286454|285036|P2|STARTED|Washout Period (At Least 3 Days)||2
118418|NCT01286454|285037|P1|STARTED|Washout Period (At Least 3 Days)||2
118419|NCT01286454|285027|P11|NOT COMPLETED|Part I- First Intervention Period||0
118420|NCT01286454|285028|P10|NOT COMPLETED|Part I- First Intervention Period||0
118421|NCT01286454|285029|P9|NOT COMPLETED|Part I- First Intervention Period||0
118422|NCT01286454|285030|P8|NOT COMPLETED|Part I- First Intervention Period||0
118423|NCT01286454|285031|P7|NOT COMPLETED|Part I- First Intervention Period||0
118424|NCT01286454|285032|P6|NOT COMPLETED|Part I- First Intervention Period||0
118425|NCT01286454|285033|P5|NOT COMPLETED|Part I- First Intervention Period||0
118426|NCT01286454|285034|P4|NOT COMPLETED|Part I- First Intervention Period||0
118427|NCT01286454|285035|P3|NOT COMPLETED|Part I- First Intervention Period||0
118428|NCT01286454|285036|P2|NOT COMPLETED|Part I- First Intervention Period||0
118429|NCT01286454|285037|P1|NOT COMPLETED|Part I- First Intervention Period||0
118430|NCT01286454|285027|P11|COMPLETED|Part I- First Intervention Period||0
118431|NCT01286454|285028|P10|COMPLETED|Part I- First Intervention Period||2
118432|NCT01286454|285029|P9|COMPLETED|Part I- First Intervention Period||2
118433|NCT01286454|285030|P8|COMPLETED|Part I- First Intervention Period||2
118434|NCT01286454|285031|P7|COMPLETED|Part I- First Intervention Period||2
118435|NCT01286454|285032|P6|COMPLETED|Part I- First Intervention Period||2
118436|NCT01286454|285033|P5|COMPLETED|Part I- First Intervention Period||2
118437|NCT01286454|285034|P4|COMPLETED|Part I- First Intervention Period||2
118438|NCT01286454|285035|P3|COMPLETED|Part I- First Intervention Period||2
118439|NCT01286454|285036|P2|COMPLETED|Part I- First Intervention Period||2
118440|NCT01286454|285037|P1|COMPLETED|Part I- First Intervention Period||2
118441|NCT01286454|285027|P11|STARTED|Part I- First Intervention Period||0
118442|NCT01286454|285028|P10|STARTED|Part I- First Intervention Period||2
118443|NCT01286454|285029|P9|STARTED|Part I- First Intervention Period||2
118444|NCT01286454|285030|P8|STARTED|Part I- First Intervention Period||2
118445|NCT01286454|285031|P7|STARTED|Part I- First Intervention Period||2
118446|NCT01286454|285032|P6|STARTED|Part I- First Intervention Period||2
118447|NCT01286454|285033|P5|STARTED|Part I- First Intervention Period||2
118448|NCT01286454|285034|P4|STARTED|Part I- First Intervention Period||2
118449|NCT01286454|285035|P3|STARTED|Part I- First Intervention Period||2
118450|NCT01286454|285036|P2|STARTED|Part I- First Intervention Period||2
118451|NCT01286454|285037|P1|STARTED|Part I- First Intervention Period||2
118452|NCT01286402|285077|P2|NOT COMPLETED|Overall Study||0
118453|NCT01286402|285078|P1|NOT COMPLETED|Overall Study||0
118454|NCT01286402|285077|P2|COMPLETED|Overall Study||6
118455|NCT01286402|285078|P1|COMPLETED|Overall Study||5
118456|NCT01286402|285077|P2|STARTED|Overall Study||6
118457|NCT01286402|285078|P1|STARTED|Overall Study||5
118458|NCT01286324|285086|P2|NOT COMPLETED|Overall Study||0
118459|NCT01286324|285087|P1|NOT COMPLETED|Overall Study||0
118460|NCT01286324|285086|P2|COMPLETED|Overall Study||17
118461|NCT01286324|285087|P1|COMPLETED|Overall Study||17
118462|NCT01286324|285086|P2|STARTED|Overall Study||17
118463|NCT01286324|285087|P1|STARTED|Overall Study||17
118464|NCT01286311|285105|P2|NOT COMPLETED|Overall Study||0
118465|NCT01286311|285106|P1|NOT COMPLETED|Overall Study||14
118466|NCT01286311|285105|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
118467|NCT01286311|285106|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
118468|NCT01286311|285105|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
118469|NCT01286311|285106|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
118470|NCT01286207|285123|P3|NOT COMPLETED|Overall Study||90
118471|NCT01286207|285124|P2|NOT COMPLETED|Overall Study||248
118472|NCT01286207|285125|P1|NOT COMPLETED|Overall Study||298
118473|NCT01286207|285123|P3|COMPLETED|Overall Study||261
118474|NCT01286207|285124|P2|COMPLETED|Overall Study||609
118475|NCT01286207|285125|P1|COMPLETED|Overall Study||453
118476|NCT01286207|285123|P3|STARTED|Overall Study||351
118477|NCT01286207|285124|P2|STARTED|Overall Study||857
118478|NCT01286207|285125|P1|STARTED|Overall Study||751
118479|NCT01286168|285145|P1|NOT COMPLETED|Overall Study||3
118480|NCT01286168|285145|P1|COMPLETED|Overall Study||101
118481|NCT01286168|285145|P1|STARTED|Overall Study||104
118482|NCT01286129|285159|P2|NOT COMPLETED|Overall Study||5
118483|NCT01286129|285160|P1|NOT COMPLETED|Overall Study||8
118484|NCT01286129|285159|P2|COMPLETED|Overall Study||13
118485|NCT01286129|285160|P1|COMPLETED|Overall Study||19
118486|NCT01286129|285159|P2|STARTED|Overall Study||18
118487|NCT01286129|285160|P1|STARTED|Overall Study||27
118488|NCT01286077|285170|P2|NOT COMPLETED|Overall Study||7
118489|NCT01286077|285171|P1|NOT COMPLETED|Overall Study||10
118490|NCT01286077|285170|P2|COMPLETED|Overall Study||46
118491|NCT01286077|285171|P1|COMPLETED|Overall Study||41
118492|NCT01286077|285170|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
118493|NCT01286077|285171|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
118494|NCT01286012|285207|P2|NOT COMPLETED|Overall Study||14
118495|NCT01286012|285208|P1|NOT COMPLETED|Overall Study||13
118496|NCT01286012|285207|P2|COMPLETED|Overall Study||40
118497|NCT01286012|285208|P1|COMPLETED|Overall Study||41
118498|NCT01286012|285207|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
118499|NCT01286012|285208|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
118500|NCT01285947|285218|P2|NOT COMPLETED|Overall Study||0
118501|NCT01285947|285219|P1|NOT COMPLETED|Overall Study||0
118502|NCT01285947|285218|P2|COMPLETED|Overall Study||10
118503|NCT01285947|285219|P1|COMPLETED|Overall Study||10
118504|NCT01285947|285218|P2|STARTED|Overall Study||10
118505|NCT01285947|285219|P1|STARTED|Overall Study||10
118506|NCT01285908|285225|P3|NOT COMPLETED|Treatment Crossover||0
118507|NCT01285908|285226|P2|NOT COMPLETED|Treatment Crossover||0
118508|NCT01285908|285227|P1|NOT COMPLETED|Treatment Crossover||0
118509|NCT01285908|285225|P3|COMPLETED|Treatment Crossover||2
118510|NCT01285908|285226|P2|COMPLETED|Treatment Crossover||2
118511|NCT01285908|285227|P1|COMPLETED|Treatment Crossover||0
118512|NCT01285908|285225|P3|STARTED|Treatment Crossover||2
118513|NCT01285908|285226|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
118514|NCT01285908|285227|P1|STARTED|Treatment Crossover||0
118515|NCT01285908|285225|P3|NOT COMPLETED|Baseline Measurement||0
118516|NCT01285908|285226|P2|NOT COMPLETED|Baseline Measurement||0
118517|NCT01285908|285227|P1|NOT COMPLETED|Baseline Measurement||3
118518|NCT01285908|285225|P3|COMPLETED|Baseline Measurement||0
118519|NCT01285908|285226|P2|COMPLETED|Baseline Measurement||0
118520|NCT01285908|285227|P1|COMPLETED|Baseline Measurement||3
118521|NCT01285908|285225|P3|STARTED|Baseline Measurement||0
118522|NCT01285908|285226|P2|STARTED|Baseline Measurement||0
118523|NCT01285908|285227|P1|STARTED|Baseline Measurement||6
118524|NCT01285843|285261|P2|NOT COMPLETED|Overall Study||2
118525|NCT01285843|285262|P1|NOT COMPLETED|Overall Study||2
118526|NCT01285843|285261|P2|COMPLETED|Overall Study||18
118527|NCT01285843|285262|P1|COMPLETED|Overall Study||18
118528|NCT01285843|285261|P2|STARTED|Overall Study||20
118529|NCT01285843|285262|P1|STARTED|Overall Study||20
118530|NCT01285791|285277|P3|NOT COMPLETED|Overall Study||0
118531|NCT01285791|285278|P2|NOT COMPLETED|Overall Study||0
118532|NCT01285791|285279|P1|NOT COMPLETED|Overall Study||0
118533|NCT01285791|285277|P3|COMPLETED|Overall Study||13
118534|NCT01285791|285278|P2|COMPLETED|Overall Study||15
118535|NCT01285791|285279|P1|COMPLETED|Overall Study||11
118536|NCT01285791|285277|P3|STARTED|Overall Study||13
118537|NCT01285791|285278|P2|STARTED|Overall Study||15
118538|NCT01285791|285279|P1|STARTED|Overall Study||11
118539|NCT01285713|285289|P2|NOT COMPLETED|Overall Study||0
118540|NCT01285713|285290|P1|NOT COMPLETED|Overall Study||0
118541|NCT01285713|285289|P2|COMPLETED|Overall Study||41
118542|NCT01285713|285290|P1|COMPLETED|Overall Study||42
118543|NCT01285713|285289|P2|STARTED|Overall Study||41
118544|NCT01285713|285290|P1|STARTED|Overall Study||42
118545|NCT01285635|285299|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
118546|NCT01285635|285300|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
118547|NCT01285635|285301|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
118548|NCT01285635|285299|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
118549|NCT01285635|285300|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
118550|NCT01285635|285301|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
118551|NCT01285635|285299|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
118552|NCT01285635|285300|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
118553|NCT01285635|285301|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
118554|NCT01285635|285299|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
118555|NCT01285635|285300|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
118556|NCT01285635|285301|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
118557|NCT01285635|285299|P3|COMPLETED|First Intervention (2 Weeks)||11
118558|NCT01285635|285300|P2|COMPLETED|First Intervention (2 Weeks)||11
118559|NCT01285635|285301|P1|COMPLETED|First Intervention (2 Weeks)||13
118560|NCT01285635|285299|P3|STARTED|First Intervention (2 Weeks)||11
118561|NCT01285635|285300|P2|STARTED|First Intervention (2 Weeks)||11
118562|NCT01285635|285301|P1|STARTED|First Intervention (2 Weeks)||13
118563|NCT01285609|285321|P2|NOT COMPLETED|Treated With Blinded Therapy||353
118564|NCT01285609|285322|P1|NOT COMPLETED|Treated With Blinded Therapy||379
118565|NCT01285609|285321|P2|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|8
118566|NCT01285609|285322|P1|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|9
118567|NCT01285609|285321|P2|STARTED|Treated With Blinded Therapy||361
118568|NCT01285609|285322|P1|STARTED|Treated With Blinded Therapy||388
118569|NCT01285609|285321|P2|NOT COMPLETED|Randomized||116
118570|NCT01285609|285322|P1|NOT COMPLETED|Randomized||91
118571|NCT01285609|285321|P2|COMPLETED|Randomized||361
118572|NCT01285609|285322|P1|COMPLETED|Randomized||388
118573|NCT01285609|285321|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
118574|NCT01285609|285322|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
118575|NCT01285609|285321|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
118576|NCT01285609|285322|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
118577|NCT01285518|285340|P8|NOT COMPLETED|Overall Study||0
118578|NCT01285518|285341|P7|NOT COMPLETED|Overall Study||0
118579|NCT01285518|285342|P6|NOT COMPLETED|Overall Study||1
118580|NCT01285518|285343|P5|NOT COMPLETED|Overall Study||0
118581|NCT01285518|285344|P4|NOT COMPLETED|Overall Study||0
118582|NCT01285518|285345|P3|NOT COMPLETED|Overall Study||0
118583|NCT01285518|285346|P2|NOT COMPLETED|Overall Study||0
118584|NCT01285518|285347|P1|NOT COMPLETED|Overall Study||0
118585|NCT01285518|285340|P8|COMPLETED|Overall Study||14
118586|NCT01285518|285341|P7|COMPLETED|Overall Study||10
118587|NCT01285518|285342|P6|COMPLETED|Overall Study||9
118588|NCT01285518|285343|P5|COMPLETED|Overall Study||10
118589|NCT01285518|285344|P4|COMPLETED|Overall Study||10
118590|NCT01285518|285345|P3|COMPLETED|Overall Study||10
118591|NCT01285518|285346|P2|COMPLETED|Overall Study||10
118592|NCT01285518|285347|P1|COMPLETED|Overall Study||10
118593|NCT01285518|285340|P8|STARTED|Overall Study||14
118594|NCT01285518|285341|P7|STARTED|Overall Study||10
118595|NCT01285518|285342|P6|STARTED|Overall Study||10
118596|NCT01285518|285343|P5|STARTED|Overall Study||10
118597|NCT01285518|285344|P4|STARTED|Overall Study||10
118598|NCT01285518|285345|P3|STARTED|Overall Study||10
118599|NCT01285518|285346|P2|STARTED|Overall Study||10
118600|NCT01285518|285347|P1|STARTED|Overall Study||10
118601|NCT01285492|285607|P2|NOT COMPLETED|Overall Study||1
118602|NCT01285492|285608|P1|NOT COMPLETED|Overall Study||17
118603|NCT01285492|285607|P2|COMPLETED|Overall Study||38
118604|NCT01285492|285608|P1|COMPLETED|Overall Study||104
118605|NCT01285492|285607|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
118606|NCT01285492|285608|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
118607|NCT01285492|285607|P2|STARTED|Overall Study|All patients randomized to this group|39
118608|NCT01285492|285608|P1|STARTED|Overall Study|All patients randomized to this group|121
118609|NCT01285427|285626|P1|NOT COMPLETED|Overall Study||1
118610|NCT01285427|285626|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
118611|NCT01285427|285626|P1|STARTED|Overall Study||300
118612|NCT01285401|285640|P2|NOT COMPLETED|Overall Study||29
118613|NCT01285401|285641|P1|NOT COMPLETED|Overall Study||17
118614|NCT01285401|285640|P2|COMPLETED|Overall Study||88
118615|NCT01285401|285641|P1|COMPLETED|Overall Study||98
118616|NCT01285401|285640|P2|Treated|Overall Study||116
118617|NCT01285401|285641|P1|Treated|Overall Study||113
118618|NCT01285401|285640|P2|STARTED|Overall Study||117
118619|NCT01285401|285641|P1|STARTED|Overall Study||115
118620|NCT01285323|285681|P2|NOT COMPLETED|Overall Study||30
118621|NCT01285323|285682|P1|NOT COMPLETED|Overall Study||33
118622|NCT01285323|285681|P2|COMPLETED|Overall Study||202
118623|NCT01285323|285682|P1|COMPLETED|Overall Study||199
118624|NCT01285323|285681|P2|Safety Analysis Set|Overall Study||232
118625|NCT01285323|285682|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
118626|NCT01285323|285681|P2|Full Analysis Set|Overall Study||232
118627|NCT01285323|285682|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
118628|NCT01285323|285681|P2|STARTED|Overall Study||232
118629|NCT01285323|285682|P1|STARTED|Overall Study||232
118630|NCT01285310|285717|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
118631|NCT01285310|285718|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
118632|NCT01285310|285719|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
118633|NCT01285310|285720|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
118634|NCT01285310|285721|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
118635|NCT01285310|285717|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
118636|NCT01285310|285718|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
118637|NCT01285310|285719|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
118638|NCT01285310|285720|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
118639|NCT01285310|285721|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
118640|NCT01285310|285717|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
118641|NCT01285310|285718|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
118642|NCT01285310|285719|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
118643|NCT01285310|285720|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
118644|NCT01285310|285721|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
118645|NCT01285310|285717|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
118646|NCT01285310|285718|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
118647|NCT01285310|285719|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
118648|NCT01285310|285720|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
118649|NCT01285310|285721|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
118650|NCT01285310|285717|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
118651|NCT01285310|285718|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
118652|NCT01285310|285719|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
118653|NCT01285310|285720|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
118654|NCT01285310|285721|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
118655|NCT01285310|285717|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
118656|NCT01285310|285718|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
118657|NCT01285310|285719|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
118658|NCT01285310|285720|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
118659|NCT01285310|285721|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
118660|NCT01285076|285954|P1|NOT COMPLETED|Overall Study||0
118661|NCT01285076|285954|P1|COMPLETED|Overall Study||834
118662|NCT01285076|285954|P1|STARTED|Overall Study||834
118663|NCT01285050|285967|P1|NOT COMPLETED|Overall Study||1
118664|NCT01285050|285967|P1|COMPLETED|Overall Study||19
118665|NCT01285050|285967|P1|STARTED|Overall Study||20
118666|NCT01285024|285974|P2|NOT COMPLETED|Overall Study||0
118667|NCT01285024|285975|P1|NOT COMPLETED|Overall Study||0
118668|NCT01285024|285974|P2|COMPLETED|Overall Study||60
118669|NCT01285024|285975|P1|COMPLETED|Overall Study||49
118670|NCT01285024|285974|P2|STARTED|Overall Study||60
118671|NCT01285024|285975|P1|STARTED|Overall Study||49
118672|NCT01284959|285986|P3|NOT COMPLETED|Overall Study||1
118673|NCT01284959|285987|P2|NOT COMPLETED|Overall Study||0
118674|NCT01284959|285988|P1|NOT COMPLETED|Overall Study||1
118675|NCT01284959|285986|P3|COMPLETED|Overall Study||10
118676|NCT01284959|285987|P2|COMPLETED|Overall Study||12
118677|NCT01284959|285988|P1|COMPLETED|Overall Study||10
118678|NCT01284959|285986|P3|STARTED|Overall Study||11
118679|NCT01284959|285987|P2|STARTED|Overall Study||12
118680|NCT01284959|285988|P1|STARTED|Overall Study||11
118681|NCT01284634|286018|P4|NOT COMPLETED|Overall Study||1
118682|NCT01284634|286019|P3|NOT COMPLETED|Overall Study||2
118683|NCT01284634|286020|P2|NOT COMPLETED|Overall Study||0
118684|NCT01284634|286021|P1|NOT COMPLETED|Overall Study||1
118685|NCT01284634|286018|P4|COMPLETED|Overall Study||4
118686|NCT01284634|286019|P3|COMPLETED|Overall Study||5
118687|NCT01284634|286020|P2|COMPLETED|Overall Study||6
118688|NCT01284634|286021|P1|COMPLETED|Overall Study||6
118689|NCT01284634|286018|P4|STARTED|Overall Study||5
118690|NCT01284634|286019|P3|STARTED|Overall Study||7
118691|NCT01284634|286020|P2|STARTED|Overall Study||6
118692|NCT01284634|286021|P1|STARTED|Overall Study||7
118693|NCT01284621|286163|P6|NOT COMPLETED|Third Intervention (8 Days)||0
118694|NCT01284621|286164|P5|NOT COMPLETED|Third Intervention (8 Days)||0
118695|NCT01284621|286165|P4|NOT COMPLETED|Third Intervention (8 Days)||0
118696|NCT01284621|286166|P3|NOT COMPLETED|Third Intervention (8 Days)||0
118697|NCT01284621|286167|P2|NOT COMPLETED|Third Intervention (8 Days)||0
118698|NCT01284621|286168|P1|NOT COMPLETED|Third Intervention (8 Days)||0
118699|NCT01284621|286163|P6|COMPLETED|Third Intervention (8 Days)||4
118700|NCT01284621|286164|P5|COMPLETED|Third Intervention (8 Days)||3
118701|NCT01284621|286165|P4|COMPLETED|Third Intervention (8 Days)||4
118702|NCT01284621|286166|P3|COMPLETED|Third Intervention (8 Days)||4
118703|NCT01284621|286167|P2|COMPLETED|Third Intervention (8 Days)||4
118704|NCT01284621|286168|P1|COMPLETED|Third Intervention (8 Days)||3
118705|NCT01284621|286163|P6|STARTED|Third Intervention (8 Days)||4
118706|NCT01284621|286164|P5|STARTED|Third Intervention (8 Days)||3
118707|NCT01284621|286165|P4|STARTED|Third Intervention (8 Days)||4
118708|NCT01284621|286166|P3|STARTED|Third Intervention (8 Days)||4
118709|NCT01284621|286167|P2|STARTED|Third Intervention (8 Days)||4
118710|NCT01284621|286168|P1|STARTED|Third Intervention (8 Days)||3
118711|NCT01284621|286163|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
118712|NCT01284621|286164|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
118713|NCT01284621|286165|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
118714|NCT01284621|286166|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
118715|NCT01284621|286167|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
118716|NCT01284621|286168|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
118717|NCT01284621|286163|P6|COMPLETED|Washout Period 2 (7 Days)||4
118718|NCT01284621|286164|P5|COMPLETED|Washout Period 2 (7 Days)||3
118719|NCT01284621|286165|P4|COMPLETED|Washout Period 2 (7 Days)||4
118720|NCT01284621|286166|P3|COMPLETED|Washout Period 2 (7 Days)||4
118721|NCT01284621|286167|P2|COMPLETED|Washout Period 2 (7 Days)||4
118722|NCT01284621|286168|P1|COMPLETED|Washout Period 2 (7 Days)||3
118723|NCT01284621|286163|P6|STARTED|Washout Period 2 (7 Days)||4
118724|NCT01284621|286164|P5|STARTED|Washout Period 2 (7 Days)||3
118725|NCT01284621|286165|P4|STARTED|Washout Period 2 (7 Days)||4
118726|NCT01284621|286166|P3|STARTED|Washout Period 2 (7 Days)||4
118727|NCT01284621|286167|P2|STARTED|Washout Period 2 (7 Days)||4
118728|NCT01284621|286168|P1|STARTED|Washout Period 2 (7 Days)||3
118729|NCT01284621|286163|P6|NOT COMPLETED|Second Intervention (8 Days)||0
118730|NCT01284621|286164|P5|NOT COMPLETED|Second Intervention (8 Days)||0
118731|NCT01284621|286165|P4|NOT COMPLETED|Second Intervention (8 Days)||0
118732|NCT01284621|286166|P3|NOT COMPLETED|Second Intervention (8 Days)||0
118733|NCT01284621|286167|P2|NOT COMPLETED|Second Intervention (8 Days)||0
118734|NCT01284621|286168|P1|NOT COMPLETED|Second Intervention (8 Days)||0
118735|NCT01284621|286163|P6|COMPLETED|Second Intervention (8 Days)||4
118736|NCT01284621|286164|P5|COMPLETED|Second Intervention (8 Days)||3
118737|NCT01284621|286165|P4|COMPLETED|Second Intervention (8 Days)||4
118738|NCT01284621|286166|P3|COMPLETED|Second Intervention (8 Days)||4
118739|NCT01284621|286167|P2|COMPLETED|Second Intervention (8 Days)||4
118740|NCT01284621|286168|P1|COMPLETED|Second Intervention (8 Days)||3
118741|NCT01284621|286163|P6|STARTED|Second Intervention (8 Days)||4
118742|NCT01284621|286164|P5|STARTED|Second Intervention (8 Days)||3
118743|NCT01284621|286165|P4|STARTED|Second Intervention (8 Days)||4
118744|NCT01284621|286166|P3|STARTED|Second Intervention (8 Days)||4
118745|NCT01284621|286167|P2|STARTED|Second Intervention (8 Days)||4
118746|NCT01284621|286168|P1|STARTED|Second Intervention (8 Days)||3
118747|NCT01284621|286163|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
118748|NCT01284621|286164|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
118749|NCT01284621|286165|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
118750|NCT01284621|286166|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
118751|NCT01284621|286167|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
118752|NCT01284621|286168|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
118753|NCT01284621|286163|P6|COMPLETED|Washout Period 1 (7 Days)||4
118754|NCT01284621|286164|P5|COMPLETED|Washout Period 1 (7 Days)||3
118755|NCT01284621|286165|P4|COMPLETED|Washout Period 1 (7 Days)||4
118756|NCT01284621|286166|P3|COMPLETED|Washout Period 1 (7 Days)||4
118757|NCT01284621|286167|P2|COMPLETED|Washout Period 1 (7 Days)||4
118758|NCT01284621|286168|P1|COMPLETED|Washout Period 1 (7 Days)||3
118759|NCT01284621|286163|P6|STARTED|Washout Period 1 (7 Days)||4
118760|NCT01284621|286164|P5|STARTED|Washout Period 1 (7 Days)||4
118761|NCT01284621|286165|P4|STARTED|Washout Period 1 (7 Days)||4
118762|NCT01284621|286166|P3|STARTED|Washout Period 1 (7 Days)||4
118763|NCT01284621|286167|P2|STARTED|Washout Period 1 (7 Days)||4
118764|NCT01284621|286168|P1|STARTED|Washout Period 1 (7 Days)||3
118765|NCT01284621|286163|P6|NOT COMPLETED|First Intervention (8 Days)||0
118766|NCT01284621|286164|P5|NOT COMPLETED|First Intervention (8 Days)||0
118767|NCT01284621|286165|P4|NOT COMPLETED|First Intervention (8 Days)||0
118768|NCT01284621|286166|P3|NOT COMPLETED|First Intervention (8 Days)||0
118769|NCT01284621|286167|P2|NOT COMPLETED|First Intervention (8 Days)||0
118770|NCT01284621|286168|P1|NOT COMPLETED|First Intervention (8 Days)||0
118771|NCT01284621|286163|P6|COMPLETED|First Intervention (8 Days)||4
118772|NCT01284621|286164|P5|COMPLETED|First Intervention (8 Days)||4
118773|NCT01284621|286165|P4|COMPLETED|First Intervention (8 Days)||4
118774|NCT01284621|286166|P3|COMPLETED|First Intervention (8 Days)||4
118775|NCT01284621|286167|P2|COMPLETED|First Intervention (8 Days)||4
118776|NCT01284621|286168|P1|COMPLETED|First Intervention (8 Days)||3
118777|NCT01284621|286163|P6|STARTED|First Intervention (8 Days)||4
118778|NCT01284621|286164|P5|STARTED|First Intervention (8 Days)||4
118779|NCT01284621|286165|P4|STARTED|First Intervention (8 Days)||4
118780|NCT01284621|286166|P3|STARTED|First Intervention (8 Days)||4
118781|NCT01284621|286167|P2|STARTED|First Intervention (8 Days)||4
118782|NCT01284621|286168|P1|STARTED|First Intervention (8 Days)||3
118783|NCT01284517|286212|P2|NOT COMPLETED|Overall Study||36
118784|NCT01284517|286213|P1|NOT COMPLETED|Overall Study||32
118785|NCT01284517|286212|P2|COMPLETED|Overall Study||140
118786|NCT01284517|286213|P1|COMPLETED|Overall Study||148
118787|NCT01284517|286212|P2|STARTED|Overall Study||176
118788|NCT01284517|286213|P1|STARTED|Overall Study||180
118789|NCT01284504|286225|P2|NOT COMPLETED|Overall Study||0
118790|NCT01284504|286226|P1|NOT COMPLETED|Overall Study||0
118791|NCT01284504|286225|P2|COMPLETED|Overall Study||0
118792|NCT01284504|286226|P1|COMPLETED|Overall Study||0
118793|NCT01284504|286225|P2|STARTED|Overall Study||0
118794|NCT01284504|286226|P1|STARTED|Overall Study||0
118795|NCT01284491|286236|P1|NOT COMPLETED|Overall Study||13
118796|NCT01284491|286236|P1|COMPLETED|Overall Study||0
118797|NCT01284491|286236|P1|STARTED|Overall Study||13
118798|NCT01284426|286242|P1|NOT COMPLETED|Overall Study||2
118799|NCT01284426|286242|P1|COMPLETED|Overall Study||92
118800|NCT01284426|286242|P1|STARTED|Overall Study||94
118801|NCT01284361|286246|P1|NOT COMPLETED|Overall Study||9
118802|NCT01284361|286246|P1|COMPLETED|Overall Study||82
118803|NCT01284361|286246|P1|STARTED|Overall Study||91
118804|NCT01284296|286253|P1|NOT COMPLETED|Overall Study||0
118805|NCT01284296|286253|P1|COMPLETED|Overall Study||20
118806|NCT01284296|286253|P1|STARTED|Overall Study||20
118807|NCT01284244|286260|P2|NOT COMPLETED|Overall Study||0
118808|NCT01284244|286261|P1|NOT COMPLETED|Overall Study||0
118809|NCT01284244|286260|P2|COMPLETED|Overall Study||18
118810|NCT01284244|286261|P1|COMPLETED|Overall Study||18
118811|NCT01284244|286260|P2|STARTED|Overall Study||18
118812|NCT01284244|286261|P1|STARTED|Overall Study||18
118813|NCT01284140|286269|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
118814|NCT01284140|286270|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
118815|NCT01284140|286269|P2|COMPLETED|Subjects With Paired 24hr Collections||5
118816|NCT01284140|286270|P1|COMPLETED|Subjects With Paired 24hr Collections||6
118817|NCT01284140|286269|P2|STARTED|Subjects With Paired 24hr Collections||11
118818|NCT01284140|286270|P1|STARTED|Subjects With Paired 24hr Collections||11
118819|NCT01284140|286269|P2|NOT COMPLETED|Randomization and Intervention||0
118820|NCT01284140|286270|P1|NOT COMPLETED|Randomization and Intervention||0
118821|NCT01284140|286269|P2|COMPLETED|Randomization and Intervention||11
118822|NCT01284140|286270|P1|COMPLETED|Randomization and Intervention||11
118823|NCT01284140|286269|P2|STARTED|Randomization and Intervention||11
118824|NCT01284140|286270|P1|STARTED|Randomization and Intervention||11
118825|NCT01284114|286284|P1|NOT COMPLETED|Overall Study||4
118826|NCT01284114|286284|P1|COMPLETED|Overall Study||19
118827|NCT01284114|286284|P1|STARTED|Overall Study||23
118828|NCT01284062|286296|P4|NOT COMPLETED|Overall Study||14
118829|NCT01284062|286297|P3|NOT COMPLETED|Overall Study||6
118830|NCT01284062|286298|P2|NOT COMPLETED|Overall Study||8
118831|NCT01284062|286299|P1|NOT COMPLETED|Overall Study||11
118832|NCT01284062|286296|P4|COMPLETED|Overall Study||7
118833|NCT01284062|286297|P3|COMPLETED|Overall Study||15
118834|NCT01284062|286298|P2|COMPLETED|Overall Study||13
118835|NCT01284062|286299|P1|COMPLETED|Overall Study||10
118836|NCT01284062|286296|P4|STARTED|Overall Study||21
118837|NCT01284062|286297|P3|STARTED|Overall Study||21
118838|NCT01284062|286298|P2|STARTED|Overall Study||21
118839|NCT01284062|286299|P1|STARTED|Overall Study||21
118840|NCT01283971|286373|P2|NOT COMPLETED|Overall Study||12
118841|NCT01283971|286374|P1|NOT COMPLETED|Overall Study||15
118842|NCT01283971|286373|P2|COMPLETED|Overall Study||36
118843|NCT01283971|286374|P1|COMPLETED|Overall Study||33
118844|NCT01283971|286373|P2|Intent to Treat Population|Overall Study||48
118845|NCT01283971|286374|P1|Intent to Treat Population|Overall Study||46
118846|NCT01283971|286373|P2|STARTED|Overall Study||48
118847|NCT01283971|286374|P1|STARTED|Overall Study||48
118848|NCT01283581|286421|P3|NOT COMPLETED|Overall Study||20
118849|NCT01283581|286422|P2|NOT COMPLETED|Overall Study||14
118850|NCT01283581|286423|P1|NOT COMPLETED|Overall Study||12
118851|NCT01283581|286421|P3|COMPLETED|Overall Study||78
118852|NCT01283581|286422|P2|COMPLETED|Overall Study||63
118853|NCT01283581|286423|P1|COMPLETED|Overall Study||69
118854|NCT01283581|286421|P3|STARTED|Overall Study||98
118855|NCT01283581|286422|P2|STARTED|Overall Study||77
118856|NCT01283581|286423|P1|STARTED|Overall Study||81
118857|NCT01283555|286434|P2|NOT COMPLETED|Second Intervention||0
118858|NCT01283555|286435|P1|NOT COMPLETED|Second Intervention||0
118859|NCT01283555|286434|P2|COMPLETED|Second Intervention||12
118860|NCT01283555|286435|P1|COMPLETED|Second Intervention||13
118861|NCT01283555|286434|P2|STARTED|Second Intervention||12
118862|NCT01283555|286435|P1|STARTED|Second Intervention||13
118863|NCT01283555|286434|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
118864|NCT01283555|286435|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
118865|NCT01283555|286434|P2|COMPLETED|Washout Period of at Least 21 Days||12
118866|NCT01283555|286435|P1|COMPLETED|Washout Period of at Least 21 Days||13
118867|NCT01283555|286434|P2|STARTED|Washout Period of at Least 21 Days||12
118868|NCT01283555|286435|P1|STARTED|Washout Period of at Least 21 Days||13
118869|NCT01283555|286434|P2|NOT COMPLETED|First Intervention||0
118870|NCT01283555|286435|P1|NOT COMPLETED|First Intervention||0
118871|NCT01283555|286434|P2|COMPLETED|First Intervention||12
118872|NCT01283555|286435|P1|COMPLETED|First Intervention||13
118873|NCT01283555|286434|P2|STARTED|First Intervention||12
118874|NCT01283555|286435|P1|STARTED|First Intervention||13
118875|NCT01283516|286487|P9|NOT COMPLETED|Overall Study||122
118876|NCT01283516|286488|P8|NOT COMPLETED|Overall Study||3
118877|NCT01283516|286489|P7|NOT COMPLETED|Overall Study||8
118878|NCT01283516|286490|P6|NOT COMPLETED|Overall Study||8
118879|NCT01283516|286491|P5|NOT COMPLETED|Overall Study||13
118880|NCT01283516|286492|P4|NOT COMPLETED|Overall Study||3
118881|NCT01283516|286493|P3|NOT COMPLETED|Overall Study||2
118882|NCT01283516|286494|P2|NOT COMPLETED|Overall Study||2
118883|NCT01283516|286495|P1|NOT COMPLETED|Overall Study||2
118884|NCT01283516|286487|P9|COMPLETED|Overall Study||133
118885|NCT01283516|286488|P8|COMPLETED|Overall Study||2
118886|NCT01283516|286489|P7|COMPLETED|Overall Study||2
118887|NCT01283516|286490|P6|COMPLETED|Overall Study||2
118888|NCT01283516|286491|P5|COMPLETED|Overall Study||1
118889|NCT01283516|286492|P4|COMPLETED|Overall Study||0
118890|NCT01283516|286493|P3|COMPLETED|Overall Study||1
118891|NCT01283516|286494|P2|COMPLETED|Overall Study||0
118892|NCT01283516|286495|P1|COMPLETED|Overall Study|Completed = Treatment Ongoing|0
118893|NCT01283516|286487|P9|Dose-Determining Set (DDS)|Overall Study||8
118894|NCT01283516|286488|P8|Dose-Determining Set (DDS)|Overall Study||5
118895|NCT01283516|286489|P7|Dose-Determining Set (DDS)|Overall Study||10
118896|NCT01283516|286490|P6|Dose-Determining Set (DDS)|Overall Study||8
118897|NCT01283516|286491|P5|Dose-Determining Set (DDS)|Overall Study||14
118898|NCT01283516|286492|P4|Dose-Determining Set (DDS)|Overall Study||3
118899|NCT01283516|286493|P3|Dose-Determining Set (DDS)|Overall Study||3
118900|NCT01283516|286494|P2|Dose-Determining Set (DDS)|Overall Study||1
118901|NCT01283516|286495|P1|Dose-Determining Set (DDS)|Overall Study||2
118902|NCT01283516|286487|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
118903|NCT01283516|286488|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
118904|NCT01283516|286489|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
118905|NCT01283516|286490|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
118906|NCT01283516|286491|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
118907|NCT01283516|286492|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
118908|NCT01283516|286493|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
118909|NCT01283516|286494|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
118910|NCT01283516|286495|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
118911|NCT01283516|286487|P9|STARTED|Overall Study||255
118912|NCT01283516|286488|P8|STARTED|Overall Study||5
118913|NCT01283516|286489|P7|STARTED|Overall Study||10
118914|NCT01283516|286490|P6|STARTED|Overall Study||10
118915|NCT01283516|286491|P5|STARTED|Overall Study||14
118916|NCT01283516|286492|P4|STARTED|Overall Study||3
118917|NCT01283516|286493|P3|STARTED|Overall Study||3
118918|NCT01283516|286494|P2|STARTED|Overall Study||2
118919|NCT01283516|286495|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
118920|NCT01283464|286519|P2|NOT COMPLETED|Overall Study||1
118921|NCT01283464|286520|P1|NOT COMPLETED|Overall Study||2
118922|NCT01283464|286519|P2|COMPLETED|Overall Study||11
118923|NCT01283464|286520|P1|COMPLETED|Overall Study||10
118924|NCT01283464|286519|P2|STARTED|Overall Study||12
118925|NCT01283464|286520|P1|STARTED|Overall Study||12
118926|NCT01283334|286526|P1|NOT COMPLETED|Overall Study||7
118927|NCT01283334|286526|P1|COMPLETED|Overall Study||13
118928|NCT01283334|286526|P1|STARTED|Overall Study||20
118929|NCT01283321|286534|P2|NOT COMPLETED|Overall Study||0
118930|NCT01283321|286535|P1|NOT COMPLETED|Overall Study||0
118931|NCT01283321|286534|P2|COMPLETED|Overall Study||10
118932|NCT01283321|286535|P1|COMPLETED|Overall Study||10
118933|NCT01283321|286534|P2|STARTED|Overall Study||10
118934|NCT01283321|286535|P1|STARTED|Overall Study||10
118935|NCT01283282|286541|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
118936|NCT01283282|286542|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
118937|NCT01283282|286541|P2|COMPLETED|Second Intervention (6 Weeks)||19
118938|NCT01283282|286542|P1|COMPLETED|Second Intervention (6 Weeks)||22
118939|NCT01283282|286541|P2|STARTED|Second Intervention (6 Weeks)||19
118940|NCT01283282|286542|P1|STARTED|Second Intervention (6 Weeks)||22
118941|NCT01283282|286541|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
118942|NCT01283282|286542|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
118943|NCT01283282|286541|P2|COMPLETED|First Intervention (6 Weeks)||19
118944|NCT01283282|286542|P1|COMPLETED|First Intervention (6 Weeks)||22
118945|NCT01283282|286541|P2|STARTED|First Intervention (6 Weeks)||23
118946|NCT01283282|286542|P1|STARTED|First Intervention (6 Weeks)||25
118947|NCT01283152|286562|P2|NOT COMPLETED|Overall Study||0
118948|NCT01283152|286563|P1|NOT COMPLETED|Overall Study||2
118949|NCT01283152|286562|P2|COMPLETED|Overall Study||25
118950|NCT01283152|286563|P1|COMPLETED|Overall Study||23
118951|NCT01283152|286562|P2|24-hr HESA Attempted|Overall Study||25
118952|NCT01283152|286563|P1|24-hr HESA Attempted|Overall Study||25
118953|NCT01283152|286562|P2|Study Treatment Received|Overall Study||25
118954|NCT01283152|286563|P1|Study Treatment Received|Overall Study||25
118955|NCT01283152|286562|P2|ITT Population|Overall Study||25
118956|NCT01283152|286563|P1|ITT Population|Overall Study||25
118957|NCT01283152|286562|P2|STARTED|Overall Study||25
118958|NCT01283152|286563|P1|STARTED|Overall Study||25
118959|NCT01283139|286577|P4|NOT COMPLETED|Overall Study||15
118960|NCT01283139|286578|P3|NOT COMPLETED|Overall Study||18
118961|NCT01283139|286579|P2|NOT COMPLETED|Overall Study||18
118962|NCT01283139|286580|P1|NOT COMPLETED|Overall Study||17
118963|NCT01283139|286577|P4|COMPLETED|Overall Study||92
118964|NCT01283139|286578|P3|COMPLETED|Overall Study||91
118965|NCT01283139|286579|P2|COMPLETED|Overall Study||90
118966|NCT01283139|286580|P1|COMPLETED|Overall Study||91
118967|NCT01283139|286577|P4|STARTED|Overall Study||107
118968|NCT01283139|286578|P3|STARTED|Overall Study||109
118969|NCT01283139|286579|P2|STARTED|Overall Study||108
118970|NCT01283139|286580|P1|STARTED|Overall Study||108
118971|NCT01283035|286622|P1|NOT COMPLETED|Overall Study||1
118972|NCT01283035|286622|P1|COMPLETED|Overall Study||5
118973|NCT01283035|286622|P1|STARTED|Overall Study||6
118974|NCT01283022|286631|P1|NOT COMPLETED|Overall Study||0
118975|NCT01283022|286631|P1|COMPLETED|Overall Study||24
118976|NCT01283022|286631|P1|STARTED|Overall Study||24
118977|NCT01282866|286637|P1|NOT COMPLETED|Overall Study||1
118978|NCT01282866|286637|P1|COMPLETED|Overall Study||34
118979|NCT01282866|286637|P1|STARTED|Overall Study||35
118980|NCT01282814|286645|P2|NOT COMPLETED|Second Intervention||0
118981|NCT01282814|286646|P1|NOT COMPLETED|Second Intervention||0
118982|NCT01282814|286645|P2|COMPLETED|Second Intervention||9
118983|NCT01282814|286646|P1|COMPLETED|Second Intervention||10
118984|NCT01282814|286645|P2|STARTED|Second Intervention||9
118985|NCT01282814|286646|P1|STARTED|Second Intervention||10
118986|NCT01282814|286645|P2|NOT COMPLETED|Washout of 7 Days||0
118987|NCT01282814|286646|P1|NOT COMPLETED|Washout of 7 Days||2
118988|NCT01282814|286645|P2|COMPLETED|Washout of 7 Days||9
118989|NCT01282814|286646|P1|COMPLETED|Washout of 7 Days||10
118990|NCT01282814|286645|P2|STARTED|Washout of 7 Days||9
118991|NCT01282814|286646|P1|STARTED|Washout of 7 Days||12
118992|NCT01282814|286645|P2|NOT COMPLETED|First Intervention||3
118993|NCT01282814|286646|P1|NOT COMPLETED|First Intervention||0
118994|NCT01282814|286645|P2|COMPLETED|First Intervention||9
118995|NCT01282814|286646|P1|COMPLETED|First Intervention||12
118996|NCT01282814|286645|P2|STARTED|First Intervention||12
118997|NCT01282814|286646|P1|STARTED|First Intervention||12
118998|NCT01282801|286658|P2|NOT COMPLETED|Second Intervention||1
118999|NCT01282801|286659|P1|NOT COMPLETED|Second Intervention||0
119000|NCT01282801|286658|P2|COMPLETED|Second Intervention||8
119001|NCT01282801|286659|P1|COMPLETED|Second Intervention||9
119002|NCT01282801|286658|P2|STARTED|Second Intervention||9
119003|NCT01282801|286659|P1|STARTED|Second Intervention||9
119004|NCT01282801|286658|P2|NOT COMPLETED|Washout of 7 Days||0
119005|NCT01282801|286659|P1|NOT COMPLETED|Washout of 7 Days||0
119006|NCT01282801|286658|P2|COMPLETED|Washout of 7 Days||9
119007|NCT01282801|286659|P1|COMPLETED|Washout of 7 Days||9
119008|NCT01282801|286658|P2|STARTED|Washout of 7 Days||9
119009|NCT01282801|286659|P1|STARTED|Washout of 7 Days||9
119010|NCT01282801|286658|P2|NOT COMPLETED|First Intervention||0
119011|NCT01282801|286659|P1|NOT COMPLETED|First Intervention||0
119012|NCT01282801|286658|P2|COMPLETED|First Intervention||9
119013|NCT01282801|286659|P1|COMPLETED|First Intervention||9
119014|NCT01282801|286658|P2|STARTED|First Intervention||9
119015|NCT01282801|286659|P1|STARTED|First Intervention||9
119016|NCT01282723|286675|P1|NOT COMPLETED|Overall Study||0
119017|NCT01282723|286675|P1|COMPLETED|Overall Study||20
119018|NCT01282723|286675|P1|STARTED|Overall Study||20
119019|NCT01282710|286679|P1|NOT COMPLETED|Overall Study||0
119020|NCT01282710|286679|P1|COMPLETED|Overall Study||20
119021|NCT01282710|286679|P1|STARTED|Overall Study||20
119022|NCT01282476|286683|P1|NOT COMPLETED|Overall Study||11
119023|NCT01282476|286683|P1|COMPLETED|Overall Study||7
119024|NCT01282476|286683|P1|STARTED|Overall Study||18
119025|NCT01282424|286689|P1|NOT COMPLETED|Overall Study||76
119026|NCT01282424|286689|P1|COMPLETED|Overall Study||49
119027|NCT01282424|286689|P1|Completed: Death|Overall Study||8
119028|NCT01282424|286689|P1|Completed: Disease Progression|Overall Study||41
119029|NCT01282424|286689|P1|STARTED|Overall Study||125
119030|NCT01282372|286706|P1|NOT COMPLETED|Overall Study||79
119031|NCT01282372|286706|P1|COMPLETED|Overall Study||421
119032|NCT01282372|286706|P1|STARTED|Overall Study||500
119033|NCT01282294|286734|P1|NOT COMPLETED|Overall Study||19
119034|NCT01282294|286734|P1|COMPLETED|Overall Study||81
119035|NCT01282294|286734|P1|12 Months|Overall Study||86
119036|NCT01282294|286734|P1|6 Months|Overall Study||94
119037|NCT01282294|286734|P1|3 Months|Overall Study||95
119038|NCT01282294|286734|P1|6 Weeks|Overall Study||95
119039|NCT01282294|286734|P1|Post-operative|Overall Study||99
119040|NCT01282294|286734|P1|Intra-operative|Overall Study||99
119041|NCT01282294|286734|P1|STARTED|Overall Study||100
119042|NCT01282242|286754|P2|NOT COMPLETED|Overall Study||0
119043|NCT01282242|286755|P1|NOT COMPLETED|Overall Study||0
119044|NCT01282242|286754|P2|COMPLETED|Overall Study||8
119045|NCT01282242|286755|P1|COMPLETED|Overall Study||80
119046|NCT01282242|286754|P2|STARTED|Overall Study||8
119047|NCT01282242|286755|P1|STARTED|Overall Study||80
119048|NCT01282229|286763|P1|NOT COMPLETED|Overall Study||2
119049|NCT01282229|286763|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
119050|NCT01282229|286763|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
119051|NCT01282203|286793|P1|NOT COMPLETED|Overall Study||1
119052|NCT01282203|286793|P1|COMPLETED|Overall Study||1121
119053|NCT01282203|286793|P1|STARTED|Overall Study||1122
119054|NCT01282164|286815|P2|NOT COMPLETED|Overall Study||0
119055|NCT01282164|286816|P1|NOT COMPLETED|Overall Study||1
119056|NCT01282164|286815|P2|COMPLETED|Overall Study||14
119057|NCT01282164|286816|P1|COMPLETED|Overall Study||28
119058|NCT01282164|286815|P2|STARTED|Overall Study||14
119059|NCT01282164|286816|P1|STARTED|Overall Study||29
119060|NCT01282138|286841|P2|NOT COMPLETED|CAPT||0
119061|NCT01282138|286842|P1|NOT COMPLETED|CAPT||0
119062|NCT01282138|286841|P2|COMPLETED|CAPT||7
119063|NCT01282138|286842|P1|COMPLETED|CAPT||6
119064|NCT01282138|286841|P2|STARTED|CAPT||7
119065|NCT01282138|286842|P1|STARTED|CAPT||6
119066|NCT01282138|286841|P2|NOT COMPLETED|EEC||0
119067|NCT01282138|286842|P1|NOT COMPLETED|EEC||0
119068|NCT01282138|286841|P2|COMPLETED|EEC||7
119069|NCT01282138|286842|P1|COMPLETED|EEC||6
119070|NCT01282138|286841|P2|STARTED|EEC||7
119071|NCT01282138|286842|P1|STARTED|EEC||6
119072|NCT01282086|286850|P1|NOT COMPLETED|Overall Study||0
119073|NCT01282086|286850|P1|COMPLETED|Overall Study||1365
119074|NCT01282086|286850|P1|STARTED|Overall Study||1365
119075|NCT01281917|286867|P1|NOT COMPLETED|Overall Study||1
119076|NCT01281917|286867|P1|COMPLETED|Overall Study||39
119077|NCT01281917|286867|P1|STARTED|Overall Study||40
119078|NCT01281865|286879|P2|NOT COMPLETED|Overall Study||1
119079|NCT01281865|286880|P1|NOT COMPLETED|Overall Study||3
119080|NCT01281865|286879|P2|COMPLETED|Overall Study||1
119081|NCT01281865|286880|P1|COMPLETED|Overall Study||9
119082|NCT01281865|286879|P2|STARTED|Overall Study||2
119083|NCT01281865|286880|P1|STARTED|Overall Study||12
119084|NCT01281839|286888|P2|NOT COMPLETED|Overall Study||14
119085|NCT01281839|286889|P1|NOT COMPLETED|Overall Study||10
119086|NCT01281839|286888|P2|COMPLETED|Overall Study||119
119087|NCT01281839|286889|P1|COMPLETED|Overall Study||250
119088|NCT01281839|286888|P2|STARTED|Overall Study||133
119089|NCT01281839|286889|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
119090|NCT01281644|286950|P1|NOT COMPLETED|Overall Study||5
119091|NCT01281644|286950|P1|COMPLETED|Overall Study||18
119092|NCT01281644|286950|P1|STARTED|Overall Study||23
119093|NCT01281501|286960|P2|NOT COMPLETED|Overall Study||0
119094|NCT01281501|286961|P1|NOT COMPLETED|Overall Study||0
119095|NCT01281501|286960|P2|COMPLETED|Overall Study||43
119096|NCT01281501|286961|P1|COMPLETED|Overall Study||44
119097|NCT01281501|286960|P2|STARTED|Overall Study||43
119098|NCT01281501|286961|P1|STARTED|Overall Study||44
119099|NCT01281475|286975|P2|NOT COMPLETED|Overall Study||8
119100|NCT01281475|286976|P1|NOT COMPLETED|Overall Study||4
119101|NCT01281475|286975|P2|COMPLETED|Overall Study||26
119102|NCT01281475|286976|P1|COMPLETED|Overall Study||29
119103|NCT01281475|286975|P2|STARTED|Overall Study||34
119104|NCT01281475|286976|P1|STARTED|Overall Study||33
119105|NCT01281306|286991|P7|NOT COMPLETED|Overall Study||7
119106|NCT01281306|286992|P6|NOT COMPLETED|Overall Study||7
119107|NCT01281306|286993|P5|NOT COMPLETED|Overall Study||9
119108|NCT01281306|286994|P4|NOT COMPLETED|Overall Study||11
119109|NCT01281306|286995|P3|NOT COMPLETED|Overall Study||8
119110|NCT01281306|286996|P2|NOT COMPLETED|Overall Study||4
119111|NCT01281306|286997|P1|NOT COMPLETED|Overall Study||8
119112|NCT01281306|286991|P7|COMPLETED|Overall Study||51
119113|NCT01281306|286992|P6|COMPLETED|Overall Study||135
119114|NCT01281306|286993|P5|COMPLETED|Overall Study||134
119115|NCT01281306|286994|P4|COMPLETED|Overall Study||123
119116|NCT01281306|286995|P3|COMPLETED|Overall Study||133
119117|NCT01281306|286996|P2|COMPLETED|Overall Study||141
119118|NCT01281306|286997|P1|COMPLETED|Overall Study||136
119119|NCT01281306|286991|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
119120|NCT01281306|286992|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
119121|NCT01281306|286993|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
119122|NCT01281306|286994|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
119123|NCT01281306|286995|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
119124|NCT01281306|286996|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
119125|NCT01281306|286997|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
119126|NCT01281306|286991|P7|Safety Set|Overall Study||58
119127|NCT01281306|286992|P6|Safety Set|Overall Study||142
119128|NCT01281306|286993|P5|Safety Set|Overall Study||143
119129|NCT01281306|286994|P4|Safety Set|Overall Study||133
119130|NCT01281306|286995|P3|Safety Set|Overall Study||141
119131|NCT01281306|286996|P2|Safety Set|Overall Study||145
119132|NCT01281306|286997|P1|Safety Set|Overall Study||143
119133|NCT01281306|286991|P7|Full Analysis Set|Overall Study||58
119134|NCT01281306|286992|P6|Full Analysis Set|Overall Study||142
119135|NCT01281306|286993|P5|Full Analysis Set|Overall Study||143
119136|NCT01281306|286994|P4|Full Analysis Set|Overall Study||133
119137|NCT01281306|286995|P3|Full Analysis Set|Overall Study||141
119138|NCT01281306|286996|P2|Full Analysis Set|Overall Study||145
119139|NCT01281306|286997|P1|Full Analysis Set|Overall Study||143
119140|NCT01281306|286991|P7|STARTED|Overall Study||58
119141|NCT01281306|286992|P6|STARTED|Overall Study||142
119142|NCT01281306|286993|P5|STARTED|Overall Study||143
119143|NCT01281306|286994|P4|STARTED|Overall Study||134
119144|NCT01281306|286995|P3|STARTED|Overall Study||141
119145|NCT01281306|286996|P2|STARTED|Overall Study||145
119146|NCT01281306|286997|P1|STARTED|Overall Study||144
119147|NCT01281202|287113|P2|NOT COMPLETED|Overall Study||36
119148|NCT01281202|287114|P1|NOT COMPLETED|Overall Study||28
119149|NCT01281202|287113|P2|COMPLETED|Overall Study||68
119150|NCT01281202|287114|P1|COMPLETED|Overall Study||75
119151|NCT01281202|287113|P2|STARTED|Overall Study||104
119152|NCT01281202|287114|P1|STARTED|Overall Study||103
119153|NCT01281124|287122|P1|NOT COMPLETED|Overall Study||1
119154|NCT01281124|287122|P1|COMPLETED|Overall Study||0
119155|NCT01281124|287122|P1|STARTED|Overall Study||1
119156|NCT01281007|287130|P2|NOT COMPLETED|Overall Study||8
119157|NCT01281007|287131|P1|NOT COMPLETED|Overall Study||4
119158|NCT01281007|287130|P2|COMPLETED|Overall Study||67
119159|NCT01281007|287131|P1|COMPLETED|Overall Study||71
119160|NCT01281007|287130|P2|STARTED|Overall Study||75
119161|NCT01281007|287131|P1|STARTED|Overall Study||75
119162|NCT01280981|287137|P1|NOT COMPLETED|Overall Study||92
119163|NCT01280981|287137|P1|COMPLETED|Overall Study||196
119164|NCT01280981|287137|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
119165|NCT01280981|287137|P1|STARTED|Overall Study||288
119166|NCT01280968|287148|P2|NOT COMPLETED|Overall Study||3
119167|NCT01280968|287149|P1|NOT COMPLETED|Overall Study||18
119168|NCT01280968|287148|P2|COMPLETED|Overall Study||4
119169|NCT01280968|287149|P1|COMPLETED|Overall Study||27
119170|NCT01280968|287148|P2|STARTED|Overall Study||7
119171|NCT01280968|287149|P1|STARTED|Overall Study||45
119172|NCT01280955|287165|P1|NOT COMPLETED|Overall Study||3
119173|NCT01280955|287165|P1|COMPLETED|Overall Study||27
119174|NCT01280955|287165|P1|STARTED|Overall Study||30
119175|NCT01280942|287198|P2|NOT COMPLETED|Overall Study||0
119176|NCT01280942|287199|P1|NOT COMPLETED|Overall Study||0
119177|NCT01280942|287198|P2|COMPLETED|Overall Study||9911
119178|NCT01280942|287199|P1|COMPLETED|Overall Study||10120
119179|NCT01280942|287198|P2|STARTED|Overall Study||9911
119180|NCT01280942|287199|P1|STARTED|Overall Study||10120
119181|NCT01280903|287209|P2|NOT COMPLETED|Overall Study||16
119182|NCT01280903|287210|P1|NOT COMPLETED|Overall Study||23
119183|NCT01280903|287209|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
119184|NCT01280903|287210|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
119185|NCT01280903|287209|P2|STARTED|Overall Study||91
119186|NCT01280903|287210|P1|STARTED|Overall Study||91
119187|NCT01280695|287279|P5|NOT COMPLETED|Overall Study||2
119188|NCT01280695|287280|P4|NOT COMPLETED|Overall Study||4
119189|NCT01280695|287281|P3|NOT COMPLETED|Overall Study||5
119190|NCT01280695|287282|P2|NOT COMPLETED|Overall Study||1
119191|NCT01280695|287283|P1|NOT COMPLETED|Overall Study||0
119192|NCT01280695|287279|P5|COMPLETED|Overall Study||24
119193|NCT01280695|287280|P4|COMPLETED|Overall Study||22
119194|NCT01280695|287281|P3|COMPLETED|Overall Study||21
119195|NCT01280695|287282|P2|COMPLETED|Overall Study||24
119196|NCT01280695|287283|P1|COMPLETED|Overall Study||26
119197|NCT01280695|287279|P5|STARTED|Overall Study||26
119198|NCT01280695|287280|P4|STARTED|Overall Study||26
119199|NCT01280695|287281|P3|STARTED|Overall Study||26
119200|NCT01280695|287282|P2|STARTED|Overall Study||25
119201|NCT01280695|287283|P1|STARTED|Overall Study||26
119202|NCT01280656|287323|P3|NOT COMPLETED|Overall Study||63
119203|NCT01280656|287324|P2|NOT COMPLETED|Overall Study||47
119204|NCT01280656|287325|P1|NOT COMPLETED|Overall Study||3
119205|NCT01280656|287323|P3|COMPLETED|Overall Study||223
119206|NCT01280656|287324|P2|COMPLETED|Overall Study||265
119207|NCT01280656|287325|P1|COMPLETED|Overall Study||59
119208|NCT01280656|287323|P3|STARTED|Overall Study||286
119209|NCT01280656|287324|P2|STARTED|Overall Study||312
119210|NCT01280656|287325|P1|STARTED|Overall Study||62
119211|NCT01280604|287371|P2|NOT COMPLETED|Overall Study||5
119212|NCT01280604|287372|P1|NOT COMPLETED|Overall Study||9
119213|NCT01280604|287371|P2|COMPLETED|Overall Study||28
119214|NCT01280604|287372|P1|COMPLETED|Overall Study||24
119215|NCT01280604|287371|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
119216|NCT01280604|287372|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
119217|NCT01280604|287371|P2|STARTED|Overall Study||33
119218|NCT01280604|287372|P1|STARTED|Overall Study||33
119219|NCT01280591|287392|P4|NOT COMPLETED|Overall Study||3
119220|NCT01280591|287393|P3|NOT COMPLETED|Overall Study||0
119221|NCT01280591|287394|P2|NOT COMPLETED|Overall Study||0
119222|NCT01280591|287395|P1|NOT COMPLETED|Overall Study||0
119223|NCT01280591|287392|P4|COMPLETED|Overall Study||99
119224|NCT01280591|287393|P3|COMPLETED|Overall Study||203
119225|NCT01280591|287394|P2|COMPLETED|Overall Study||204
119226|NCT01280591|287395|P1|COMPLETED|Overall Study||203
119227|NCT01280591|287392|P4|STARTED|Overall Study||102
119228|NCT01280591|287393|P3|STARTED|Overall Study||203
119229|NCT01280591|287394|P2|STARTED|Overall Study||204
119230|NCT01280591|287395|P1|STARTED|Overall Study||203
119231|NCT01280552|287487|P2|NOT COMPLETED|Overall Study||1
119232|NCT01280552|287488|P1|NOT COMPLETED|Overall Study||6
119233|NCT01280552|287487|P2|COMPLETED|Overall Study||42
119234|NCT01280552|287488|P1|COMPLETED|Overall Study|Survival is still being assessed|75
119235|NCT01280552|287487|P2|STARTED|Overall Study||43
119236|NCT01280552|287488|P1|STARTED|Overall Study||81
119237|NCT01280357|287500|P1|NOT COMPLETED|Overall Study||26
119238|NCT01280357|287500|P1|COMPLETED|Overall Study||34
119239|NCT01280357|287500|P1|STARTED|Overall Study||60
119240|NCT01280266|287509|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
119241|NCT01280266|287510|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
119242|NCT01280266|287509|P2|COMPLETED|Second Intervention (Week 5-9)||12
119243|NCT01280266|287510|P1|COMPLETED|Second Intervention (Week 5-9)||14
119244|NCT01280266|287509|P2|STARTED|Second Intervention (Week 5-9)||12
119245|NCT01280266|287510|P1|STARTED|Second Intervention (Week 5-9)||14
119246|NCT01280266|287509|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
119247|NCT01280266|287510|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
119248|NCT01280266|287509|P2|COMPLETED|Washout Period (Week 4-5)||12
119249|NCT01280266|287510|P1|COMPLETED|Washout Period (Week 4-5)||14
119250|NCT01280266|287509|P2|STARTED|Washout Period (Week 4-5)||12
119251|NCT01280266|287510|P1|STARTED|Washout Period (Week 4-5)||14
119252|NCT01280266|287509|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
119253|NCT01280266|287510|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
119254|NCT01280266|287509|P2|COMPLETED|First Intervention (Week 1-4)||12
119255|NCT01280266|287510|P1|COMPLETED|First Intervention (Week 1-4)||14
119256|NCT01280266|287509|P2|STARTED|First Intervention (Week 1-4)||14
119257|NCT01280266|287510|P1|STARTED|First Intervention (Week 1-4)||15
119258|NCT01280123|287535|P3|NOT COMPLETED|Overall Study||1
119259|NCT01280123|287536|P2|NOT COMPLETED|Overall Study||4
119260|NCT01280123|287537|P1|NOT COMPLETED|Overall Study||1
119261|NCT01280123|287535|P3|COMPLETED|Overall Study||70
119262|NCT01280123|287536|P2|COMPLETED|Overall Study||63
119263|NCT01280123|287537|P1|COMPLETED|Overall Study||71
119264|NCT01280123|287535|P3|STARTED|Overall Study||71
119265|NCT01280123|287536|P2|STARTED|Overall Study||67
119266|NCT01280123|287537|P1|STARTED|Overall Study||72
119267|NCT01280110|287562|P2|NOT COMPLETED|Overall Study||0
119268|NCT01280110|287563|P1|NOT COMPLETED|Overall Study||0
119269|NCT01280110|287562|P2|COMPLETED|Overall Study||22
119270|NCT01280110|287563|P1|COMPLETED|Overall Study||22
119271|NCT01280110|287562|P2|STARTED|Overall Study||22
119272|NCT01280110|287563|P1|STARTED|Overall Study||22
119273|NCT01280058|287573|P2|NOT COMPLETED|Overall Study||0
119274|NCT01280058|287574|P1|NOT COMPLETED|Overall Study||0
119275|NCT01280058|287573|P2|COMPLETED|Overall Study||37
119276|NCT01280058|287574|P1|COMPLETED|Overall Study||36
119277|NCT01280058|287573|P2|STARTED|Overall Study||37
119278|NCT01280058|287574|P1|STARTED|Overall Study||36
119279|NCT01279681|287592|P2|NOT COMPLETED|Overall Study||17
119280|NCT01279681|287593|P1|NOT COMPLETED|Overall Study||15
119281|NCT01279681|287592|P2|COMPLETED|Overall Study||0
119282|NCT01279681|287593|P1|COMPLETED|Overall Study||0
119283|NCT01279681|287592|P2|STARTED|Overall Study||17
119284|NCT01279681|287593|P1|STARTED|Overall Study||15
119285|NCT01279564|287607|P2|NOT COMPLETED|Overall Study||0
119286|NCT01279564|287608|P1|NOT COMPLETED|Overall Study||0
119287|NCT01279564|287607|P2|COMPLETED|Overall Study||32
119288|NCT01279564|287608|P1|COMPLETED|Overall Study||40
119289|NCT01279564|287607|P2|STARTED|Overall Study||32
119290|NCT01279564|287608|P1|STARTED|Overall Study||40
119291|NCT01279447|287616|P2|NOT COMPLETED|Overall Study||1
119292|NCT01279447|287617|P1|NOT COMPLETED|Overall Study||3
119293|NCT01279447|287616|P2|COMPLETED|Overall Study||33
119294|NCT01279447|287617|P1|COMPLETED|Overall Study||31
119295|NCT01279447|287616|P2|STARTED|Overall Study||34
119296|NCT01279447|287617|P1|STARTED|Overall Study||34
119297|NCT01279317|287623|P2|NOT COMPLETED|Period 2||0
119298|NCT01279317|287624|P1|NOT COMPLETED|Period 2||0
119299|NCT01279317|287623|P2|COMPLETED|Period 2||6
119300|NCT01279317|287624|P1|COMPLETED|Period 2||6
119301|NCT01279317|287623|P2|STARTED|Period 2||6
119302|NCT01279317|287624|P1|STARTED|Period 2||6
119303|NCT01279317|287623|P2|NOT COMPLETED|Washout||0
119304|NCT01279317|287624|P1|NOT COMPLETED|Washout||0
119305|NCT01279317|287623|P2|COMPLETED|Washout||6
119306|NCT01279317|287624|P1|COMPLETED|Washout||6
119307|NCT01279317|287623|P2|STARTED|Washout||6
119308|NCT01279317|287624|P1|STARTED|Washout||6
119309|NCT01279317|287623|P2|NOT COMPLETED|Period 1||0
119310|NCT01279317|287624|P1|NOT COMPLETED|Period 1||0
119311|NCT01279317|287623|P2|COMPLETED|Period 1||6
119312|NCT01279317|287624|P1|COMPLETED|Period 1||6
119313|NCT01279317|287623|P2|STARTED|Period 1||6
119314|NCT01279317|287624|P1|STARTED|Period 1||6
119315|NCT01279265|287631|P2|NOT COMPLETED|Overall Study||6
119316|NCT01279265|287632|P1|NOT COMPLETED|Overall Study||4
119317|NCT01279265|287631|P2|COMPLETED|Overall Study||11
119318|NCT01279265|287632|P1|COMPLETED|Overall Study||9
119319|NCT01279265|287631|P2|STARTED|Overall Study||17
119320|NCT01279265|287632|P1|STARTED|Overall Study||13
119321|NCT01279200|287644|P2|NOT COMPLETED|Overall Study||7
119322|NCT01279200|287645|P1|NOT COMPLETED|Overall Study||2
119323|NCT01279200|287644|P2|COMPLETED|Overall Study||4
119324|NCT01279200|287645|P1|COMPLETED|Overall Study||8
119325|NCT01279200|287644|P2|STARTED|Overall Study||11
119326|NCT01279200|287645|P1|STARTED|Overall Study||10
119327|NCT01279187|287655|P2|NOT COMPLETED|Overall Study||0
119328|NCT01279187|287656|P1|NOT COMPLETED|Overall Study||0
119329|NCT01279187|287655|P2|COMPLETED|Overall Study||13
119330|NCT01279187|287656|P1|COMPLETED|Overall Study||14
119331|NCT01279187|287655|P2|STARTED|Overall Study||13
119332|NCT01279187|287656|P1|STARTED|Overall Study||14
119333|NCT01279109|287672|P2|NOT COMPLETED|Overall Study||12
119334|NCT01279109|287673|P1|NOT COMPLETED|Overall Study||13
119335|NCT01279109|287672|P2|COMPLETED|Overall Study||55
119336|NCT01279109|287673|P1|COMPLETED|Overall Study||55
119337|NCT01279109|287672|P2|STARTED|Overall Study||67
119338|NCT01279109|287673|P1|STARTED|Overall Study||68
119339|NCT01279070|287683|P2|NOT COMPLETED|Overall Study||4
119340|NCT01279070|287684|P1|NOT COMPLETED|Overall Study||5
119341|NCT01279070|287683|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
119342|NCT01279070|287684|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
119343|NCT01279070|287683|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
119344|NCT01279070|287684|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
119345|NCT01279044|287703|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
119346|NCT01279044|287704|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
119347|NCT01279044|287705|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
119348|NCT01279044|287703|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
119349|NCT01279044|287704|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
119350|NCT01279044|287705|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
119351|NCT01279044|287703|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
119352|NCT01279044|287704|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
119353|NCT01279044|287705|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
119354|NCT01279044|287703|P3|NOT COMPLETED|PHASE 1 - Formative||0
119355|NCT01279044|287704|P2|NOT COMPLETED|PHASE 1 - Formative||0
119356|NCT01279044|287705|P1|NOT COMPLETED|PHASE 1 - Formative||0
119357|NCT01279044|287703|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
119358|NCT01279044|287704|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
119359|NCT01279044|287705|P1|COMPLETED|PHASE 1 - Formative||59
119360|NCT01279044|287703|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
119361|NCT01279044|287704|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
119362|NCT01279044|287705|P1|STARTED|PHASE 1 - Formative||59
119363|NCT01278953|287725|P2|NOT COMPLETED|Overall Study||11
119364|NCT01278953|287726|P1|NOT COMPLETED|Overall Study||9
119365|NCT01278953|287725|P2|COMPLETED|Overall Study||134
119366|NCT01278953|287726|P1|COMPLETED|Overall Study||146
119367|NCT01278953|287725|P2|STARTED|Overall Study||145
119368|NCT01278953|287726|P1|STARTED|Overall Study||155
119369|NCT01278927|287738|P4|NOT COMPLETED|Overall Study||0
119370|NCT01278927|287739|P3|NOT COMPLETED|Overall Study||0
119371|NCT01278927|287740|P2|NOT COMPLETED|Overall Study||0
119372|NCT01278927|287741|P1|NOT COMPLETED|Overall Study||0
119373|NCT01278927|287738|P4|COMPLETED|Overall Study||175
119374|NCT01278927|287739|P3|COMPLETED|Overall Study||178
119375|NCT01278927|287740|P2|COMPLETED|Overall Study||178
119376|NCT01278927|287741|P1|COMPLETED|Overall Study||180
119377|NCT01278927|287738|P4|STARTED|Overall Study||175
119378|NCT01278927|287739|P3|STARTED|Overall Study||178
119379|NCT01278927|287740|P2|STARTED|Overall Study||178
119380|NCT01278927|287741|P1|STARTED|Overall Study||180
119381|NCT01278797|287779|P2|NOT COMPLETED|Period 2||0
119382|NCT01278797|287780|P1|NOT COMPLETED|Period 2||0
119383|NCT01278797|287779|P2|COMPLETED|Period 2||13
119384|NCT01278797|287780|P1|COMPLETED|Period 2||13
119385|NCT01278797|287779|P2|STARTED|Period 2||13
119386|NCT01278797|287780|P1|STARTED|Period 2||13
119387|NCT01278797|287779|P2|NOT COMPLETED|Washout Period of 21 Days||0
119388|NCT01278797|287780|P1|NOT COMPLETED|Washout Period of 21 Days||0
119389|NCT01278797|287779|P2|COMPLETED|Washout Period of 21 Days||13
119390|NCT01278797|287780|P1|COMPLETED|Washout Period of 21 Days||13
119391|NCT01278797|287779|P2|STARTED|Washout Period of 21 Days||13
119392|NCT01278797|287780|P1|STARTED|Washout Period of 21 Days||13
119393|NCT01278797|287779|P2|NOT COMPLETED|Period 1||1
119394|NCT01278797|287780|P1|NOT COMPLETED|Period 1||1
119395|NCT01278797|287779|P2|COMPLETED|Period 1||13
119396|NCT01278797|287780|P1|COMPLETED|Period 1||13
119397|NCT01278797|287779|P2|STARTED|Period 1||14
119398|NCT01278797|287780|P1|STARTED|Period 1||14
119399|NCT01278745|287792|P4|NOT COMPLETED|Overall Study||78
119400|NCT01278745|287793|P3|NOT COMPLETED|Overall Study||121
119401|NCT01278745|287794|P2|NOT COMPLETED|Overall Study||6
119402|NCT01278745|287795|P1|NOT COMPLETED|Overall Study||5
119403|NCT01278745|287792|P4|COMPLETED|Overall Study||0
119404|NCT01278745|287793|P3|COMPLETED|Overall Study||0
119405|NCT01278745|287794|P2|COMPLETED|Overall Study||68
119406|NCT01278745|287795|P1|COMPLETED|Overall Study||84
119407|NCT01278745|287792|P4|STARTED|Overall Study||78
119408|NCT01278745|287793|P3|STARTED|Overall Study||121
119409|NCT01278745|287794|P2|STARTED|Overall Study||74
119410|NCT01278745|287795|P1|STARTED|Overall Study||89
119411|NCT01278615|287827|P1|NOT COMPLETED|Overall Study||2
119412|NCT01278615|287827|P1|COMPLETED|Overall Study||14
119413|NCT01278615|287827|P1|STARTED|Overall Study||16
119414|NCT01278485|287837|P1|NOT COMPLETED|Overall Study||0
119415|NCT01278485|287837|P1|COMPLETED|Overall Study||719
119416|NCT01278485|287837|P1|STARTED|Overall Study||719
119417|NCT01278407|287853|P5|NOT COMPLETED|Extension Phase||30
119418|NCT01278407|287854|P4|NOT COMPLETED|Extension Phase||12
119419|NCT01278407|287855|P3|NOT COMPLETED|Extension Phase||0
119420|NCT01278407|287856|P2|NOT COMPLETED|Extension Phase||0
119421|NCT01278407|287857|P1|NOT COMPLETED|Extension Phase||0
119422|NCT01278407|287853|P5|COMPLETED|Extension Phase||66
119423|NCT01278407|287854|P4|COMPLETED|Extension Phase||34
119424|NCT01278407|287855|P3|COMPLETED|Extension Phase||0
119425|NCT01278407|287856|P2|COMPLETED|Extension Phase||0
119426|NCT01278407|287857|P1|COMPLETED|Extension Phase||0
119427|NCT01278407|287853|P5|STARTED|Extension Phase||96
119428|NCT01278407|287854|P4|STARTED|Extension Phase||46
119429|NCT01278407|287855|P3|STARTED|Extension Phase||0
119430|NCT01278407|287856|P2|STARTED|Extension Phase||0
119431|NCT01278407|287857|P1|STARTED|Extension Phase||0
119432|NCT01278407|287853|P5|NOT COMPLETED|Confirmatory Phase||0
119433|NCT01278407|287854|P4|NOT COMPLETED|Confirmatory Phase||0
119434|NCT01278407|287855|P3|NOT COMPLETED|Confirmatory Phase||6
119435|NCT01278407|287856|P2|NOT COMPLETED|Confirmatory Phase||16
119436|NCT01278407|287857|P1|NOT COMPLETED|Confirmatory Phase||9
119437|NCT01278407|287853|P5|COMPLETED|Confirmatory Phase||0
119438|NCT01278407|287854|P4|COMPLETED|Confirmatory Phase||0
119439|NCT01278407|287855|P3|COMPLETED|Confirmatory Phase||43
119440|NCT01278407|287856|P2|COMPLETED|Confirmatory Phase||31
119441|NCT01278407|287857|P1|COMPLETED|Confirmatory Phase||37
119442|NCT01278407|287853|P5|STARTED|Confirmatory Phase||0
119443|NCT01278407|287854|P4|STARTED|Confirmatory Phase||0
119444|NCT01278407|287855|P3|STARTED|Confirmatory Phase||49
119445|NCT01278407|287856|P2|STARTED|Confirmatory Phase||47
119446|NCT01278407|287857|P1|STARTED|Confirmatory Phase||46
119447|NCT01278394|287870|P1|NOT COMPLETED|Overall Study||1
119448|NCT01278394|287870|P1|COMPLETED|Overall Study||28
119449|NCT01278394|287870|P1|STARTED|Overall Study||29
119450|NCT01278342|287883|P3|NOT COMPLETED|Overall Study||0
119451|NCT01278342|287884|P2|NOT COMPLETED|Overall Study||1
119452|NCT01278342|287885|P1|NOT COMPLETED|Overall Study||4
119453|NCT01278342|287883|P3|COMPLETED|Overall Study||32
119454|NCT01278342|287884|P2|COMPLETED|Overall Study||30
119455|NCT01278342|287885|P1|COMPLETED|Overall Study||3
119456|NCT01278342|287883|P3|STARTED|Overall Study||32
119457|NCT01278342|287884|P2|STARTED|Overall Study||31
119458|NCT01278342|287885|P1|STARTED|Overall Study||7
119459|NCT01278303|287899|P1|NOT COMPLETED|Overall Study||0
119460|NCT01278303|287899|P1|COMPLETED|Overall Study||82
119461|NCT01278303|287899|P1|STARTED|Overall Study||82
119462|NCT01278173|287905|P1|NOT COMPLETED|Overall Study||27
119463|NCT01278173|287905|P1|COMPLETED|Overall Study||38
119464|NCT01278173|287905|P1|STARTED|Overall Study||65
119465|NCT01278160|287912|P2|NOT COMPLETED|Overall Study||6
119466|NCT01278160|287913|P1|NOT COMPLETED|Overall Study||5
119467|NCT01278160|287912|P2|COMPLETED|Overall Study||84
119468|NCT01278160|287913|P1|COMPLETED|Overall Study||84
119469|NCT01278160|287912|P2|STARTED|Overall Study||90
119470|NCT01278160|287913|P1|STARTED|Overall Study||89
119471|NCT01278030|287929|P2|NOT COMPLETED|Overall Study||4
119472|NCT01278030|287930|P1|NOT COMPLETED|Overall Study||8
119473|NCT01278030|287929|P2|COMPLETED|Overall Study||31
119474|NCT01278030|287930|P1|COMPLETED|Overall Study||35
119475|NCT01278030|287929|P2|STARTED|Overall Study||35
119476|NCT01278030|287930|P1|STARTED|Overall Study||43
119477|NCT01277887|287938|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
119478|NCT01277887|287939|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
119479|NCT01277887|287938|P2|COMPLETED|Post-Quit Treatment Phase||5
119480|NCT01277887|287939|P1|COMPLETED|Post-Quit Treatment Phase||3
119481|NCT01277887|287938|P2|STARTED|Post-Quit Treatment Phase||10
119482|NCT01277887|287939|P1|STARTED|Post-Quit Treatment Phase||6
119483|NCT01277887|287938|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
119484|NCT01277887|287939|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
119485|NCT01277887|287938|P2|COMPLETED|Pre-Quit Treatment Phase||10
119486|NCT01277887|287939|P1|COMPLETED|Pre-Quit Treatment Phase||6
119487|NCT01277887|287938|P2|Entered Study|Pre-Quit Treatment Phase||10
119488|NCT01277887|287939|P1|Entered Study|Pre-Quit Treatment Phase||7
119489|NCT01277887|287938|P2|STARTED|Pre-Quit Treatment Phase||10
119490|NCT01277887|287939|P1|STARTED|Pre-Quit Treatment Phase||9
119491|NCT01277861|287951|P2|NOT COMPLETED|Overall Study||2
119492|NCT01277861|287952|P1|NOT COMPLETED|Overall Study||2
119493|NCT01277861|287951|P2|COMPLETED|Overall Study||47
119494|NCT01277861|287952|P1|COMPLETED|Overall Study||49
119495|NCT01277861|287951|P2|STARTED|Overall Study||49
119496|NCT01277861|287952|P1|STARTED|Overall Study||51
119497|NCT01277822|287964|P2|NOT COMPLETED|Overall Study||11
119498|NCT01277822|287965|P1|NOT COMPLETED|Overall Study||15
119499|NCT01277822|287964|P2|COMPLETED|Overall Study||155
119500|NCT01277822|287965|P1|COMPLETED|Overall Study||153
119501|NCT01277822|287964|P2|STARTED|Overall Study||166
119502|NCT01277822|287965|P1|STARTED|Overall Study||168
119503|NCT01277757|287985|P1|NOT COMPLETED|Overall Study||2
119504|NCT01277757|287985|P1|COMPLETED|Overall Study||28
119505|NCT01277757|287985|P1|STARTED|Overall Study||30
119506|NCT01277718|287992|P2|NOT COMPLETED|Period 3 - Third Intervention||0
119507|NCT01277718|287993|P1|NOT COMPLETED|Period 3 - Third Intervention||0
119508|NCT01277718|287992|P2|COMPLETED|Period 3 - Third Intervention||7
119509|NCT01277718|287993|P1|COMPLETED|Period 3 - Third Intervention||10
119510|NCT01277718|287992|P2|STARTED|Period 3 - Third Intervention||7
119511|NCT01277718|287993|P1|STARTED|Period 3 - Third Intervention||10
119512|NCT01277718|287992|P2|NOT COMPLETED|Washout Period of 13 Days||0
119513|NCT01277718|287993|P1|NOT COMPLETED|Washout Period of 13 Days||0
119514|NCT01277718|287992|P2|COMPLETED|Washout Period of 13 Days||7
119515|NCT01277718|287993|P1|COMPLETED|Washout Period of 13 Days||10
119516|NCT01277718|287992|P2|STARTED|Washout Period of 13 Days||7
119517|NCT01277718|287993|P1|STARTED|Washout Period of 13 Days||10
119518|NCT01277718|287992|P2|NOT COMPLETED|Period 2 - Second Intervention||3
119519|NCT01277718|287993|P1|NOT COMPLETED|Period 2 - Second Intervention||0
119520|NCT01277718|287992|P2|COMPLETED|Period 2 - Second Intervention||7
119521|NCT01277718|287993|P1|COMPLETED|Period 2 - Second Intervention||10
119522|NCT01277718|287992|P2|STARTED|Period 2 - Second Intervention||10
119523|NCT01277718|287993|P1|STARTED|Period 2 - Second Intervention||10
119524|NCT01277718|287992|P2|NOT COMPLETED|Washout Period of 13 Days||0
119525|NCT01277718|287993|P1|NOT COMPLETED|Washout Period of 13 Days||0
119526|NCT01277718|287992|P2|COMPLETED|Washout Period of 13 Days||10
119527|NCT01277718|287993|P1|COMPLETED|Washout Period of 13 Days||10
119528|NCT01277718|287992|P2|STARTED|Washout Period of 13 Days||10
119529|NCT01277718|287993|P1|STARTED|Washout Period of 13 Days||10
119530|NCT01277718|287992|P2|NOT COMPLETED|Period 1 - First Intervention||0
119531|NCT01277718|287993|P1|NOT COMPLETED|Period 1 - First Intervention||0
119532|NCT01277718|287992|P2|COMPLETED|Period 1 - First Intervention||10
119533|NCT01277718|287993|P1|COMPLETED|Period 1 - First Intervention||10
119534|NCT01277718|287992|P2|STARTED|Period 1 - First Intervention||10
119535|NCT01277718|287993|P1|STARTED|Period 1 - First Intervention||10
119536|NCT01277666|288007|P3|NOT COMPLETED|Overall Study||49
119537|NCT01277666|288008|P2|NOT COMPLETED|Overall Study||59
119538|NCT01277666|288009|P1|NOT COMPLETED|Overall Study||45
119539|NCT01277666|288007|P3|COMPLETED|Overall Study||153
119540|NCT01277666|288008|P2|COMPLETED|Overall Study||144
119541|NCT01277666|288009|P1|COMPLETED|Overall Study||158
119542|NCT01277666|288007|P3|STARTED|Overall Study||202
119543|NCT01277666|288008|P2|STARTED|Overall Study||203
119544|NCT01277666|288009|P1|STARTED|Overall Study||203
119545|NCT01277601|288042|P4|NOT COMPLETED|Overall Study||36
119546|NCT01277601|288043|P3|NOT COMPLETED|Overall Study||27
119547|NCT01277601|288044|P2|NOT COMPLETED|Overall Study||48
119548|NCT01277601|288045|P1|NOT COMPLETED|Overall Study||37
119549|NCT01277601|288042|P4|COMPLETED|Overall Study||150
119550|NCT01277601|288043|P3|COMPLETED|Overall Study||163
119551|NCT01277601|288044|P2|COMPLETED|Overall Study||139
119552|NCT01277601|288045|P1|COMPLETED|Overall Study||151
119553|NCT01277601|288042|P4|STARTED|Overall Study||186
119554|NCT01277601|288043|P3|STARTED|Overall Study||190
119555|NCT01277601|288044|P2|STARTED|Overall Study||187
119556|NCT01277601|288045|P1|STARTED|Overall Study||188
119557|NCT01277549|288136|P2|NOT COMPLETED|Overall Study||14
119558|NCT01277549|288137|P1|NOT COMPLETED|Overall Study||26
119559|NCT01277549|288136|P2|COMPLETED|Overall Study||15
119560|NCT01277549|288137|P1|COMPLETED|Overall Study||15
119561|NCT01277549|288136|P2|STARTED|Overall Study||29
119562|NCT01277549|288137|P1|STARTED|Overall Study||41
119563|NCT01277523|288154|P3|NOT COMPLETED|Overall Study||0
119564|NCT01277523|288155|P2|NOT COMPLETED|Overall Study||1
119565|NCT01277523|288156|P1|NOT COMPLETED|Overall Study||3
119566|NCT01277523|288154|P3|COMPLETED|Overall Study||130
119567|NCT01277523|288155|P2|COMPLETED|Overall Study||126
119568|NCT01277523|288156|P1|COMPLETED|Overall Study||132
119569|NCT01277523|288154|P3|STARTED|Overall Study||130
119570|NCT01277523|288155|P2|STARTED|Overall Study||127
119571|NCT01277523|288156|P1|STARTED|Overall Study||135
119572|NCT01277510|288208|P2|NOT COMPLETED|Open-label Phase||3
119573|NCT01277510|288209|P1|NOT COMPLETED|Open-label Phase||7
119574|NCT01277510|288208|P2|COMPLETED|Open-label Phase|Completed investigational product|1
119575|NCT01277510|288209|P1|COMPLETED|Open-label Phase|Completed investigational product|1
119576|NCT01277510|288208|P2|Received Investigational Product|Open-label Phase||4
119577|NCT01277510|288209|P1|Received Investigational Product|Open-label Phase||6
119578|NCT01277510|288208|P2|STARTED|Open-label Phase||4
119579|NCT01277510|288209|P1|STARTED|Open-label Phase||8
119580|NCT01277510|288208|P2|NOT COMPLETED|Double-blind Phase||18
119581|NCT01277510|288209|P1|NOT COMPLETED|Double-blind Phase||13
119582|NCT01277510|288208|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
119583|NCT01277510|288209|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
119584|NCT01277510|288208|P2|Received Investigational Product|Double-blind Phase||22
119585|NCT01277510|288209|P1|Received Investigational Product|Double-blind Phase||21
119586|NCT01277510|288208|P2|STARTED|Double-blind Phase||22
119587|NCT01277510|288209|P1|STARTED|Double-blind Phase||21
119588|NCT01277354|288233|P2|NOT COMPLETED|Overall Study||0
119589|NCT01277354|288234|P1|NOT COMPLETED|Overall Study||0
119590|NCT01277354|288233|P2|COMPLETED|Overall Study||1
119591|NCT01277354|288234|P1|COMPLETED|Overall Study||1
119592|NCT01277354|288233|P2|STARTED|Overall Study||1
119593|NCT01277354|288234|P1|STARTED|Overall Study||1
119594|NCT01277302|288243|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
119595|NCT01277302|288244|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
119596|NCT01277302|288245|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
119597|NCT01277302|288243|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
119598|NCT01277302|288244|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
119599|NCT01277302|288245|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
119600|NCT01277302|288243|P3|STARTED|8-Month Alternate Dose Regimen Period||19
119601|NCT01277302|288244|P2|STARTED|8-Month Alternate Dose Regimen Period||86
119602|NCT01277302|288245|P1|STARTED|8-Month Alternate Dose Regimen Period||85
119603|NCT01277302|288243|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
119604|NCT01277302|288244|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
119605|NCT01277302|288245|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
119606|NCT01277302|288243|P3|COMPLETED|7-Month Fixed Treatment Period||19
119607|NCT01277302|288244|P2|COMPLETED|7-Month Fixed Treatment Period||86
119608|NCT01277302|288245|P1|COMPLETED|7-Month Fixed Treatment Period||85
119609|NCT01277302|288243|P3|STARTED|7-Month Fixed Treatment Period||31
119610|NCT01277302|288244|P2|STARTED|7-Month Fixed Treatment Period||86
119611|NCT01277302|288245|P1|STARTED|7-Month Fixed Treatment Period||85
119612|NCT01277211|288277|P2|NOT COMPLETED|Overall Study||63
119613|NCT01277211|288278|P1|NOT COMPLETED|Overall Study||150
119614|NCT01277211|288277|P2|COMPLETED|Overall Study||182
119615|NCT01277211|288278|P1|COMPLETED|Overall Study||588
119616|NCT01277211|288277|P2|Treated|Overall Study||232
119617|NCT01277211|288278|P1|Treated|Overall Study||714
119618|NCT01277211|288277|P2|STARTED|Overall Study||245
119619|NCT01277211|288278|P1|STARTED|Overall Study||738
119620|NCT01277159|288293|P5|NOT COMPLETED|Overall Study||5
119621|NCT01277159|288294|P4|NOT COMPLETED|Overall Study||3
119622|NCT01277159|288295|P3|NOT COMPLETED|Overall Study||3
119623|NCT01277159|288296|P2|NOT COMPLETED|Overall Study||1
119624|NCT01277159|288297|P1|NOT COMPLETED|Overall Study||4
119625|NCT01277159|288293|P5|COMPLETED|Overall Study||16
119626|NCT01277159|288294|P4|COMPLETED|Overall Study||19
119627|NCT01277159|288295|P3|COMPLETED|Overall Study||19
119628|NCT01277159|288296|P2|COMPLETED|Overall Study||21
119629|NCT01277159|288297|P1|COMPLETED|Overall Study||17
119630|NCT01277159|288293|P5|STARTED|Overall Study||21
119631|NCT01277159|288294|P4|STARTED|Overall Study||22
119632|NCT01277159|288295|P3|STARTED|Overall Study||22
119633|NCT01277159|288296|P2|STARTED|Overall Study||22
119634|NCT01277159|288297|P1|STARTED|Overall Study||21
119635|NCT01277081|288311|P2|NOT COMPLETED|Overall Study||0
119636|NCT01277081|288312|P1|NOT COMPLETED|Overall Study||0
119637|NCT01277081|288311|P2|COMPLETED|Overall Study||100
119638|NCT01277081|288312|P1|COMPLETED|Overall Study||100
119639|NCT01277081|288311|P2|STARTED|Overall Study||100
119640|NCT01277081|288312|P1|STARTED|Overall Study||100
119641|NCT01277042|288330|P2|NOT COMPLETED|Overall Study||5
119642|NCT01277042|288331|P1|NOT COMPLETED|Overall Study||8
119643|NCT01277042|288330|P2|COMPLETED|Overall Study||601
119644|NCT01277042|288331|P1|COMPLETED|Overall Study||598
119645|NCT01277042|288330|P2|STARTED|Overall Study||606
119646|NCT01277042|288331|P1|STARTED|Overall Study||606
119647|NCT01276847|288356|P3|NOT COMPLETED|Overall Study||0
119648|NCT01276847|288357|P2|NOT COMPLETED|Overall Study||0
119649|NCT01276847|288358|P1|NOT COMPLETED|Overall Study||1
119650|NCT01276847|288356|P3|COMPLETED|Overall Study||20
119651|NCT01276847|288357|P2|COMPLETED|Overall Study||10
119652|NCT01276847|288358|P1|COMPLETED|Overall Study||9
119653|NCT01276847|288356|P3|STARTED|Overall Study||20
119654|NCT01276847|288357|P2|STARTED|Overall Study||10
119655|NCT01276847|288358|P1|STARTED|Overall Study||10
119656|NCT01276821|288368|P2|NOT COMPLETED|Overall Study||1
119657|NCT01276821|288369|P1|NOT COMPLETED|Overall Study||0
119658|NCT01276821|288368|P2|COMPLETED|Overall Study||49
119659|NCT01276821|288369|P1|COMPLETED|Overall Study||50
119660|NCT01276821|288368|P2|STARTED|Overall Study||50
119661|NCT01276821|288369|P1|STARTED|Overall Study||50
119662|NCT01276756|288389|P2|NOT COMPLETED|Overall Study||2
119663|NCT01276756|288390|P1|NOT COMPLETED|Overall Study||5
119664|NCT01276756|288389|P2|COMPLETED|Overall Study||48
119665|NCT01276756|288390|P1|COMPLETED|Overall Study||45
119666|NCT01276756|288389|P2|STARTED|Overall Study||50
119667|NCT01276756|288390|P1|STARTED|Overall Study||50
119668|NCT01276652|288407|P3|NOT COMPLETED|Period 2: Observational||0
119669|NCT01276652|288408|P2|NOT COMPLETED|Period 2: Observational||0
119670|NCT01276652|288409|P1|NOT COMPLETED|Period 2: Observational||0
119671|NCT01276652|288407|P3|COMPLETED|Period 2: Observational||5
119672|NCT01276652|288408|P2|COMPLETED|Period 2: Observational||8
119673|NCT01276652|288409|P1|COMPLETED|Period 2: Observational||9
119674|NCT01276652|288407|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
119675|NCT01276652|288408|P2|STARTED|Period 2: Observational||8
119676|NCT01276652|288409|P1|STARTED|Period 2: Observational||9
119677|NCT01276652|288407|P3|NOT COMPLETED|Period 1: Randomization||0
119678|NCT01276652|288408|P2|NOT COMPLETED|Period 1: Randomization||0
119679|NCT01276652|288409|P1|NOT COMPLETED|Period 1: Randomization||0
119680|NCT01276652|288407|P3|COMPLETED|Period 1: Randomization||0
119681|NCT01276652|288408|P2|COMPLETED|Period 1: Randomization||8
119682|NCT01276652|288409|P1|COMPLETED|Period 1: Randomization||9
119683|NCT01276652|288407|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
119684|NCT01276652|288408|P2|STARTED|Period 1: Randomization||8
119685|NCT01276652|288409|P1|STARTED|Period 1: Randomization||9
119686|NCT01276639|288435|P5|NOT COMPLETED|Week 16 to 52||21
119687|NCT01276639|288436|P4|NOT COMPLETED|Week 16 to 52||16
119688|NCT01276639|288437|P3|NOT COMPLETED|Week 16 to 52||0
119689|NCT01276639|288438|P2|NOT COMPLETED|Week 16 to 52||101
119690|NCT01276639|288439|P1|NOT COMPLETED|Week 16 to 52||127
119691|NCT01276639|288435|P5|COMPLETED|Week 16 to 52||45
119692|NCT01276639|288436|P4|COMPLETED|Week 16 to 52||50
119693|NCT01276639|288437|P3|COMPLETED|Week 16 to 52||0
119694|NCT01276639|288438|P2|COMPLETED|Week 16 to 52||219
119695|NCT01276639|288439|P1|COMPLETED|Week 16 to 52||186
119696|NCT01276639|288435|P5|STARTED|Week 16 to 52||66
119697|NCT01276639|288436|P4|STARTED|Week 16 to 52||66
119698|NCT01276639|288437|P3|STARTED|Week 16 to 52||0
119699|NCT01276639|288438|P2|STARTED|Week 16 to 52||320
119700|NCT01276639|288439|P1|STARTED|Week 16 to 52||313
119701|NCT01276639|288435|P5|NOT COMPLETED|Week 0 to 16||0
119702|NCT01276639|288436|P4|NOT COMPLETED|Week 0 to 16||0
119703|NCT01276639|288437|P3|NOT COMPLETED|Week 0 to 16||45
119704|NCT01276639|288438|P2|NOT COMPLETED|Week 0 to 16||41
119705|NCT01276639|288439|P1|NOT COMPLETED|Week 0 to 16||50
119706|NCT01276639|288435|P5|COMPLETED|Week 0 to 16||0
119707|NCT01276639|288436|P4|COMPLETED|Week 0 to 16||0
119708|NCT01276639|288437|P3|COMPLETED|Week 0 to 16||132
119709|NCT01276639|288438|P2|COMPLETED|Week 0 to 16||320
119710|NCT01276639|288439|P1|COMPLETED|Week 0 to 16||313
119711|NCT01276639|288435|P5|Treated|Week 0 to 16||0
119712|NCT01276639|288436|P4|Treated|Week 0 to 16||0
119713|NCT01276639|288437|P3|Treated|Week 0 to 16||177
119714|NCT01276639|288438|P2|Treated|Week 0 to 16||360
119715|NCT01276639|288439|P1|Treated|Week 0 to 16||363
119716|NCT01276639|288435|P5|STARTED|Week 0 to 16||0
119717|NCT01276639|288436|P4|STARTED|Week 0 to 16||0
119718|NCT01276639|288437|P3|STARTED|Week 0 to 16||177
119719|NCT01276639|288438|P2|STARTED|Week 0 to 16||361
119720|NCT01276639|288439|P1|STARTED|Week 0 to 16||363
119721|NCT01276535|288634|P1|NOT COMPLETED|Overall Study||0
119722|NCT01276535|288634|P1|COMPLETED|Overall Study||12
119723|NCT01276535|288634|P1|STARTED|Overall Study||12
119724|NCT01276509|288644|P4|NOT COMPLETED|Overall Study||5
119725|NCT01276509|288645|P3|NOT COMPLETED|Overall Study||5
119726|NCT01276509|288646|P2|NOT COMPLETED|Overall Study||12
119727|NCT01276509|288647|P1|NOT COMPLETED|Overall Study||13
119728|NCT01276509|288644|P4|COMPLETED|Overall Study||58
119729|NCT01276509|288645|P3|COMPLETED|Overall Study||63
119730|NCT01276509|288646|P2|COMPLETED|Overall Study||53
119731|NCT01276509|288647|P1|COMPLETED|Overall Study||53
119732|NCT01276509|288644|P4|STARTED|Overall Study||63
119733|NCT01276509|288645|P3|STARTED|Overall Study||68
119734|NCT01276509|288646|P2|STARTED|Overall Study||65
119735|NCT01276509|288647|P1|STARTED|Overall Study||66
119736|NCT01276457|288700|P2|NOT COMPLETED|Extension Study||2
119737|NCT01276457|288701|P1|NOT COMPLETED|Extension Study||6
119738|NCT01276457|288700|P2|COMPLETED|Extension Study||110
119739|NCT01276457|288701|P1|COMPLETED|Extension Study||105
119740|NCT01276457|288700|P2|STARTED|Extension Study||112
119741|NCT01276457|288701|P1|STARTED|Extension Study||111
119742|NCT01276457|288700|P2|NOT COMPLETED|Core Study||20
119743|NCT01276457|288701|P1|NOT COMPLETED|Core Study||13
119744|NCT01276457|288700|P2|COMPLETED|Core Study||123
119745|NCT01276457|288701|P1|COMPLETED|Core Study||129
119746|NCT01276457|288700|P2|STARTED|Core Study||143
119747|NCT01276457|288701|P1|STARTED|Core Study||142
119748|NCT01276353|288715|P2|NOT COMPLETED|Extension||9
119749|NCT01276353|288716|P1|NOT COMPLETED|Extension||7
119750|NCT01276353|288715|P2|COMPLETED|Extension||14
119751|NCT01276353|288716|P1|COMPLETED|Extension||12
119752|NCT01276353|288715|P2|STARTED|Extension||23
119753|NCT01276353|288716|P1|STARTED|Extension||19
119754|NCT01276353|288715|P2|NOT COMPLETED|Double-blind||0
119755|NCT01276353|288716|P1|NOT COMPLETED|Double-blind||3
119756|NCT01276353|288715|P2|COMPLETED|Double-blind||23
119757|NCT01276353|288716|P1|COMPLETED|Double-blind||19
119758|NCT01276353|288715|P2|STARTED|Double-blind||23
119759|NCT01276353|288716|P1|STARTED|Double-blind||22
119760|NCT01276327|288728|P2|NOT COMPLETED|Overall Study||3
119761|NCT01276327|288729|P1|NOT COMPLETED|Overall Study||2
119762|NCT01276327|288728|P2|COMPLETED|Overall Study||29
119763|NCT01276327|288729|P1|COMPLETED|Overall Study||30
119764|NCT01276327|288728|P2|STARTED|Overall Study||32
119765|NCT01276327|288729|P1|STARTED|Overall Study||32
119766|NCT01276314|288755|P4|NOT COMPLETED|Overall Study||5
119767|NCT01276314|288756|P3|NOT COMPLETED|Overall Study||4
119768|NCT01276314|288757|P2|NOT COMPLETED|Overall Study||10
119769|NCT01276314|288758|P1|NOT COMPLETED|Overall Study||10
119770|NCT01276314|288755|P4|COMPLETED|Overall Study||17
119771|NCT01276314|288756|P3|COMPLETED|Overall Study||18
119772|NCT01276314|288757|P2|COMPLETED|Overall Study||33
119773|NCT01276314|288758|P1|COMPLETED|Overall Study||38
119774|NCT01276314|288755|P4|STARTED|Overall Study||22
119775|NCT01276314|288756|P3|STARTED|Overall Study||22
119776|NCT01276314|288757|P2|STARTED|Overall Study||43
119777|NCT01276314|288758|P1|STARTED|Overall Study||48
119778|NCT01276301|288768|P2|NOT COMPLETED|Second Intervention||0
119779|NCT01276301|288769|P1|NOT COMPLETED|Second Intervention||0
119780|NCT01276301|288768|P2|COMPLETED|Second Intervention||8
119781|NCT01276301|288769|P1|COMPLETED|Second Intervention||8
119782|NCT01276301|288768|P2|STARTED|Second Intervention||8
119783|NCT01276301|288769|P1|STARTED|Second Intervention||8
119784|NCT01276301|288768|P2|NOT COMPLETED|Washout Period of 7 Days||0
119785|NCT01276301|288769|P1|NOT COMPLETED|Washout Period of 7 Days||0
119786|NCT01276301|288768|P2|COMPLETED|Washout Period of 7 Days||8
119787|NCT01276301|288769|P1|COMPLETED|Washout Period of 7 Days||8
119788|NCT01276301|288768|P2|STARTED|Washout Period of 7 Days||8
119789|NCT01276301|288769|P1|STARTED|Washout Period of 7 Days||8
119790|NCT01276301|288768|P2|NOT COMPLETED|First Intervention||0
119791|NCT01276301|288769|P1|NOT COMPLETED|First Intervention||0
119792|NCT01276301|288768|P2|COMPLETED|First Intervention||8
119793|NCT01276301|288769|P1|COMPLETED|First Intervention||8
119794|NCT01276301|288768|P2|STARTED|First Intervention||8
119795|NCT01276301|288769|P1|STARTED|First Intervention||8
119796|NCT01276288|288796|P4|NOT COMPLETED|Overall Study||0
119797|NCT01276288|288797|P3|NOT COMPLETED|Overall Study||0
119798|NCT01276288|288798|P2|NOT COMPLETED|Overall Study||1
119799|NCT01276288|288799|P1|NOT COMPLETED|Overall Study||2
119800|NCT01276288|288796|P4|COMPLETED|Overall Study||5
119801|NCT01276288|288797|P3|COMPLETED|Overall Study||5
119802|NCT01276288|288798|P2|COMPLETED|Overall Study||5
119803|NCT01276288|288799|P1|COMPLETED|Overall Study||5
119804|NCT01276288|288796|P4|Received EMPA+TOR|Overall Study||5
119805|NCT01276288|288797|P3|Received EMPA+TOR|Overall Study||5
119806|NCT01276288|288798|P2|Received EMPA+TOR|Overall Study||0
119807|NCT01276288|288799|P1|Received EMPA+TOR|Overall Study||0
119808|NCT01276288|288796|P4|Received EMPA+HCT|Overall Study||0
119809|NCT01276288|288797|P3|Received EMPA+HCT|Overall Study||0
119810|NCT01276288|288798|P2|Received EMPA+HCT|Overall Study||5
119811|NCT01276288|288799|P1|Received EMPA+HCT|Overall Study||5
119812|NCT01276288|288796|P4|Received EMPA|Overall Study||5
119813|NCT01276288|288797|P3|Received EMPA|Overall Study||5
119814|NCT01276288|288798|P2|Received EMPA|Overall Study||5
119815|NCT01276288|288799|P1|Received EMPA|Overall Study||6
119816|NCT01276288|288796|P4|STARTED|Overall Study||5
119817|NCT01276288|288797|P3|STARTED|Overall Study||5
119818|NCT01276288|288798|P2|STARTED|Overall Study||6
119819|NCT01276288|288799|P1|STARTED|Overall Study||7
119820|NCT01276223|288926|P3|NOT COMPLETED|Overall Study||3
119821|NCT01276223|288927|P2|NOT COMPLETED|Overall Study||4
119822|NCT01276223|288928|P1|NOT COMPLETED|Overall Study||11
119823|NCT01276223|288926|P3|COMPLETED|Overall Study||101
119824|NCT01276223|288927|P2|COMPLETED|Overall Study||103
119825|NCT01276223|288928|P1|COMPLETED|Overall Study||67
119826|NCT01276223|288926|P3|STARTED|Overall Study||104
119827|NCT01276223|288927|P2|STARTED|Overall Study||107
119828|NCT01276223|288928|P1|STARTED|Overall Study||78
119829|NCT01276197|288937|P2|NOT COMPLETED|Overall Study||110
119830|NCT01276197|288938|P1|NOT COMPLETED|Overall Study||108
119831|NCT01276197|288937|P2|COMPLETED|Overall Study||200
119832|NCT01276197|288938|P1|COMPLETED|Overall Study||200
119833|NCT01276197|288937|P2|STARTED|Overall Study||310
119834|NCT01276197|288938|P1|STARTED|Overall Study||308
119835|NCT01276171|288949|P3|NOT COMPLETED|Overall Study||0
119836|NCT01276171|288950|P2|NOT COMPLETED|Overall Study||0
119837|NCT01276171|288951|P1|NOT COMPLETED|Overall Study||0
119838|NCT01276171|288949|P3|COMPLETED|Overall Study||256
119839|NCT01276171|288950|P2|COMPLETED|Overall Study||244
119840|NCT01276171|288951|P1|COMPLETED|Overall Study||249
119841|NCT01276171|288949|P3|STARTED|Overall Study||256
119842|NCT01276171|288950|P2|STARTED|Overall Study||244
119843|NCT01276171|288951|P1|STARTED|Overall Study||249
119844|NCT01276106|288969|P4|NOT COMPLETED|Overall Study||13
119845|NCT01276106|288970|P3|NOT COMPLETED|Overall Study||16
119846|NCT01276106|288971|P2|NOT COMPLETED|Overall Study||9
119847|NCT01276106|288972|P1|NOT COMPLETED|Overall Study||12
119848|NCT01276106|288969|P4|COMPLETED|Overall Study||52
119849|NCT01276106|288970|P3|COMPLETED|Overall Study||49
119850|NCT01276106|288971|P2|COMPLETED|Overall Study||55
119851|NCT01276106|288972|P1|COMPLETED|Overall Study||53
119852|NCT01276106|288969|P4|STARTED|Overall Study||65
119853|NCT01276106|288970|P3|STARTED|Overall Study||65
119854|NCT01276106|288971|P2|STARTED|Overall Study||64
119855|NCT01276106|288972|P1|STARTED|Overall Study||65
119856|NCT01276054|288984|P2|NOT COMPLETED|Overall Study||2
119857|NCT01276054|288985|P1|NOT COMPLETED|Overall Study||2
119858|NCT01276054|288984|P2|COMPLETED|Overall Study||0
119859|NCT01276054|288985|P1|COMPLETED|Overall Study||0
119860|NCT01276054|288984|P2|STARTED|Overall Study||2
119861|NCT01276054|288985|P1|STARTED|Overall Study||2
119862|NCT01275833|288993|P2|NOT COMPLETED|Overall Study||1
119863|NCT01275833|288994|P1|NOT COMPLETED|Overall Study||1
119864|NCT01275833|288993|P2|COMPLETED|Overall Study||0
119865|NCT01275833|288994|P1|COMPLETED|Overall Study||0
119866|NCT01275833|288993|P2|STARTED|Overall Study||1
119867|NCT01275833|288994|P1|STARTED|Overall Study||1
119868|NCT01275755|289002|P2|NOT COMPLETED|Run-out Placebo Period||0
119869|NCT01275755|289003|P1|NOT COMPLETED|Run-out Placebo Period||1
119870|NCT01275755|289002|P2|COMPLETED|Run-out Placebo Period||37
119871|NCT01275755|289003|P1|COMPLETED|Run-out Placebo Period||38
119872|NCT01275755|289002|P2|STARTED|Run-out Placebo Period||37
119873|NCT01275755|289003|P1|STARTED|Run-out Placebo Period||39
119874|NCT01275755|289002|P2|NOT COMPLETED|Double-blind Treatment Period||3
119875|NCT01275755|289003|P1|NOT COMPLETED|Double-blind Treatment Period||2
119876|NCT01275755|289002|P2|COMPLETED|Double-blind Treatment Period||37
119877|NCT01275755|289003|P1|COMPLETED|Double-blind Treatment Period||39
119878|NCT01275755|289002|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
119879|NCT01275755|289003|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
119880|NCT01275755|289002|P2|STARTED|Double-blind Treatment Period||40
119881|NCT01275755|289003|P1|STARTED|Double-blind Treatment Period||41
119882|NCT01275755|289002|P2|NOT COMPLETED|Run-in Placebo Period||0
119883|NCT01275755|289003|P1|NOT COMPLETED|Run-in Placebo Period||0
119884|NCT01275755|289002|P2|COMPLETED|Run-in Placebo Period||40
119885|NCT01275755|289003|P1|COMPLETED|Run-in Placebo Period||41
119886|NCT01275755|289002|P2|STARTED|Run-in Placebo Period||40
119887|NCT01275755|289003|P1|STARTED|Run-in Placebo Period||41
119888|NCT01275664|289009|P1|NOT COMPLETED|Overall Study||0
119889|NCT01275664|289009|P1|COMPLETED|Overall Study||4
119890|NCT01275664|289009|P1|STARTED|Overall Study||4
119891|NCT01275625|289017|P1|NOT COMPLETED|Overall Study||13
119892|NCT01275625|289017|P1|COMPLETED|Overall Study||64
119893|NCT01275625|289017|P1|Treated|Overall Study||77
119894|NCT01275625|289017|P1|STARTED|Overall Study||77
119895|NCT01275586|289031|P1|NOT COMPLETED|Overall Study||3
119896|NCT01275586|289031|P1|COMPLETED|Overall Study||3
119897|NCT01275586|289031|P1|STARTED|Overall Study||6
119898|NCT01275430|289035|P1|NOT COMPLETED|Overall Study||9
119899|NCT01275430|289035|P1|COMPLETED|Overall Study||18
119900|NCT01275430|289035|P1|STARTED|Overall Study||27
119901|NCT01275365|289047|P4|NOT COMPLETED|Overall Study||3
119902|NCT01275365|289048|P3|NOT COMPLETED|Overall Study||5
119903|NCT01275365|289049|P2|NOT COMPLETED|Overall Study||3
119904|NCT01275365|289050|P1|NOT COMPLETED|Overall Study||3
119905|NCT01275365|289047|P4|COMPLETED|Overall Study||19
119906|NCT01275365|289048|P3|COMPLETED|Overall Study||17
119907|NCT01275365|289049|P2|COMPLETED|Overall Study||21
119908|NCT01275365|289050|P1|COMPLETED|Overall Study||21
119909|NCT01275365|289047|P4|STARTED|Overall Study||22
119910|NCT01275365|289048|P3|STARTED|Overall Study||22
119911|NCT01275365|289049|P2|STARTED|Overall Study||24
119912|NCT01275365|289050|P1|STARTED|Overall Study||24
119913|NCT01275313|289098|P2|NOT COMPLETED|Overall Study||52
119914|NCT01275313|289099|P1|NOT COMPLETED|Overall Study||25
119915|NCT01275313|289098|P2|COMPLETED|Overall Study||79
119916|NCT01275313|289099|P1|COMPLETED|Overall Study||102
119917|NCT01275313|289098|P2|STARTED|Overall Study||131
119918|NCT01275313|289099|P1|STARTED|Overall Study||127
119919|NCT01275196|289107|P2|NOT COMPLETED|Overall Study||21
119920|NCT01275196|289108|P1|NOT COMPLETED|Overall Study||20
119921|NCT01275196|289107|P2|COMPLETED|Overall Study||113
119922|NCT01275196|289108|P1|COMPLETED|Overall Study||113
119923|NCT01275196|289107|P2|Intended to Continue Into Extension|Overall Study||113
119924|NCT01275196|289108|P1|Intended to Continue Into Extension|Overall Study||112
119925|NCT01275196|289107|P2|STARTED|Overall Study||134
119926|NCT01275196|289108|P1|STARTED|Overall Study||133
119927|NCT01275131|289151|P4|NOT COMPLETED|Period 2 (Crossover)||2
119928|NCT01275131|289152|P3|NOT COMPLETED|Period 2 (Crossover)||1
119929|NCT01275131|289153|P2|NOT COMPLETED|Period 2 (Crossover)||1
119930|NCT01275131|289154|P1|NOT COMPLETED|Period 2 (Crossover)||1
119931|NCT01275131|289151|P4|COMPLETED|Period 2 (Crossover)||8
119932|NCT01275131|289152|P3|COMPLETED|Period 2 (Crossover)||9
119933|NCT01275131|289153|P2|COMPLETED|Period 2 (Crossover)||8
119934|NCT01275131|289154|P1|COMPLETED|Period 2 (Crossover)||8
119935|NCT01275131|289151|P4|STARTED|Period 2 (Crossover)||10
119936|NCT01275131|289152|P3|STARTED|Period 2 (Crossover)||10
119937|NCT01275131|289153|P2|STARTED|Period 2 (Crossover)||9
119938|NCT01275131|289154|P1|STARTED|Period 2 (Crossover)||9
119939|NCT01275131|289151|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
119940|NCT01275131|289152|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
119941|NCT01275131|289153|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
119942|NCT01275131|289154|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
119943|NCT01275131|289151|P4|COMPLETED|5- to 14-Day Washout Period||10
119944|NCT01275131|289152|P3|COMPLETED|5- to 14-Day Washout Period||10
119945|NCT01275131|289153|P2|COMPLETED|5- to 14-Day Washout Period||9
119946|NCT01275131|289154|P1|COMPLETED|5- to 14-Day Washout Period||9
119947|NCT01275131|289151|P4|STARTED|5- to 14-Day Washout Period||10
119948|NCT01275131|289152|P3|STARTED|5- to 14-Day Washout Period||10
119949|NCT01275131|289153|P2|STARTED|5- to 14-Day Washout Period||9
119950|NCT01275131|289154|P1|STARTED|5- to 14-Day Washout Period||9
119951|NCT01275131|289151|P4|NOT COMPLETED|Period 1||2
119952|NCT01275131|289152|P3|NOT COMPLETED|Period 1||3
119953|NCT01275131|289153|P2|NOT COMPLETED|Period 1||0
119954|NCT01275131|289154|P1|NOT COMPLETED|Period 1||2
119955|NCT01275131|289151|P4|COMPLETED|Period 1||10
119956|NCT01275131|289152|P3|COMPLETED|Period 1||10
119957|NCT01275131|289153|P2|COMPLETED|Period 1||9
119958|NCT01275131|289154|P1|COMPLETED|Period 1||9
119959|NCT01275131|289151|P4|Received at Least One Dose of Study Drug|Period 1||12
119960|NCT01275131|289152|P3|Received at Least One Dose of Study Drug|Period 1||13
119961|NCT01275131|289153|P2|Received at Least One Dose of Study Drug|Period 1||9
119962|NCT01275131|289154|P1|Received at Least One Dose of Study Drug|Period 1||11
119963|NCT01275131|289151|P4|STARTED|Period 1||12
119964|NCT01275131|289152|P3|STARTED|Period 1||13
119965|NCT01275131|289153|P2|STARTED|Period 1||9
119966|NCT01275131|289154|P1|STARTED|Period 1||11
119967|NCT01275092|289188|P1|NOT COMPLETED|Overall Study||0
119968|NCT01275092|289188|P1|COMPLETED|Overall Study||164
119969|NCT01275092|289188|P1|STARTED|Overall Study||164
119970|NCT01275066|289197|P3|NOT COMPLETED|Overall Study||1
119971|NCT01275066|289198|P2|NOT COMPLETED|Overall Study||0
119972|NCT01275066|289199|P1|NOT COMPLETED|Overall Study||1
119973|NCT01275066|289197|P3|COMPLETED|Overall Study||57
119974|NCT01275066|289198|P2|COMPLETED|Overall Study||59
119975|NCT01275066|289199|P1|COMPLETED|Overall Study||59
119976|NCT01275066|289197|P3|Treated|Overall Study||58
119977|NCT01275066|289198|P2|Treated|Overall Study||59
119978|NCT01275066|289199|P1|Treated|Overall Study||59
119979|NCT01275066|289197|P3|STARTED|Overall Study||58
119980|NCT01275066|289198|P2|STARTED|Overall Study||59
119981|NCT01275066|289199|P1|STARTED|Overall Study||60
119982|NCT01275053|289213|P1|NOT COMPLETED|Overall Study||0
119983|NCT01275053|289213|P1|COMPLETED|Overall Study||12
119984|NCT01275053|289213|P1|STARTED|Overall Study||12
119985|NCT01274897|289219|P2|NOT COMPLETED|Overall Study||0
119986|NCT01274897|289220|P1|NOT COMPLETED|Overall Study||0
119987|NCT01274897|289219|P2|COMPLETED|Overall Study||153
119988|NCT01274897|289220|P1|COMPLETED|Overall Study||297
119989|NCT01274897|289219|P2|STARTED|Overall Study||153
119990|NCT01274897|289220|P1|STARTED|Overall Study||297
119991|NCT01274715|289232|P1|NOT COMPLETED|Overall Study||4
119992|NCT01274715|289232|P1|COMPLETED|Overall Study||8
119993|NCT01274715|289232|P1|Screened Out at Baseline|Overall Study||3
119994|NCT01274715|289232|P1|STARTED|Overall Study||12
119995|NCT01274637|289239|P2|NOT COMPLETED|Overall Study||2
119996|NCT01274637|289240|P1|NOT COMPLETED|Overall Study||0
119997|NCT01274637|289239|P2|COMPLETED|Overall Study||30
119998|NCT01274637|289240|P1|COMPLETED|Overall Study||30
119999|NCT01274637|289239|P2|STARTED|Overall Study||32
120000|NCT01274637|289240|P1|STARTED|Overall Study||30
120001|NCT01274611|289256|P1|NOT COMPLETED|Overall Study||0
120002|NCT01274611|289256|P1|COMPLETED|Overall Study||20
120003|NCT01274611|289256|P1|STARTED|Overall Study||20
120004|NCT01274585|289266|P2|NOT COMPLETED|Overall Study||0
120005|NCT01274585|289267|P1|NOT COMPLETED|Overall Study||0
120006|NCT01274585|289266|P2|COMPLETED|Overall Study||3
120007|NCT01274585|289267|P1|COMPLETED|Overall Study||2
120008|NCT01274585|289266|P2|STARTED|Overall Study||3
120009|NCT01274585|289267|P1|STARTED|Overall Study||2
120010|NCT01274559|289279|P2|NOT COMPLETED|Overall Study||145
120011|NCT01274559|289280|P1|NOT COMPLETED|Overall Study||197
120012|NCT01274559|289279|P2|COMPLETED|Overall Study||441
120013|NCT01274559|289280|P1|COMPLETED|Overall Study||390
120014|NCT01274559|289279|P2|Treated|Overall Study||572
120015|NCT01274559|289280|P1|Treated|Overall Study||572
120016|NCT01274559|289279|P2|STARTED|Overall Study||586
120017|NCT01274559|289280|P1|STARTED|Overall Study||587
120018|NCT01274533|289330|P1|NOT COMPLETED|Overall Study||4
120019|NCT01274533|289330|P1|COMPLETED|Overall Study||0
120020|NCT01274533|289330|P1|STARTED|Overall Study||4
120021|NCT01274429|289335|P1|NOT COMPLETED|Overall Study||5
120022|NCT01274429|289335|P1|COMPLETED|Overall Study||0
120023|NCT01274429|289335|P1|STARTED|Overall Study||5
120024|NCT01274182|289343|P3|NOT COMPLETED|Overall Study||12
120025|NCT01274182|289344|P2|NOT COMPLETED|Overall Study||18
120026|NCT01274182|289345|P1|NOT COMPLETED|Overall Study||21
120027|NCT01274182|289343|P3|COMPLETED|Overall Study||80
120028|NCT01274182|289344|P2|COMPLETED|Overall Study||69
120029|NCT01274182|289345|P1|COMPLETED|Overall Study||112
120030|NCT01274182|289343|P3|24 Weeks|Overall Study||84
120031|NCT01274182|289344|P2|24 Weeks|Overall Study||83
120032|NCT01274182|289345|P1|24 Weeks|Overall Study||123
120033|NCT01274182|289343|P3|STARTED|Overall Study||92
120034|NCT01274182|289344|P2|STARTED|Overall Study||87
120035|NCT01274182|289345|P1|STARTED|Overall Study||133
120036|NCT01273896|289382|P1|NOT COMPLETED|Overall Study||0
120037|NCT01273896|289382|P1|COMPLETED|Overall Study||22
120038|NCT01273896|289382|P1|STARTED|Overall Study||22
120039|NCT01273883|289386|P2|NOT COMPLETED|Second Intervention||1
120040|NCT01273883|289387|P1|NOT COMPLETED|Second Intervention||2
120041|NCT01273883|289386|P2|COMPLETED|Second Intervention||17
120042|NCT01273883|289387|P1|COMPLETED|Second Intervention||15
120043|NCT01273883|289386|P2|STARTED|Second Intervention||18
120044|NCT01273883|289387|P1|STARTED|Second Intervention||17
120045|NCT01273883|289386|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
120046|NCT01273883|289387|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
120047|NCT01273883|289386|P2|COMPLETED|Washout Period of 2 Weeks||18
120048|NCT01273883|289387|P1|COMPLETED|Washout Period of 2 Weeks||17
120049|NCT01273883|289386|P2|STARTED|Washout Period of 2 Weeks||18
120050|NCT01273883|289387|P1|STARTED|Washout Period of 2 Weeks||17
120051|NCT01273883|289386|P2|NOT COMPLETED|First Intervention||1
120052|NCT01273883|289387|P1|NOT COMPLETED|First Intervention||2
120053|NCT01273883|289386|P2|COMPLETED|First Intervention||18
120054|NCT01273883|289387|P1|COMPLETED|First Intervention||17
120055|NCT01273883|289386|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
120056|NCT01273883|289387|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
120057|NCT01273857|289401|P2|NOT COMPLETED|Overall Study||0
120058|NCT01273857|289402|P1|NOT COMPLETED|Overall Study||0
120059|NCT01273857|289401|P2|COMPLETED|Overall Study||7
120060|NCT01273857|289402|P1|COMPLETED|Overall Study||7
120061|NCT01273857|289401|P2|STARTED|Overall Study||7
120062|NCT01273857|289402|P1|STARTED|Overall Study||7
120063|NCT01273818|289413|P3|NOT COMPLETED|Overall Study||9
120064|NCT01273818|289414|P2|NOT COMPLETED|Overall Study||2
120065|NCT01273818|289415|P1|NOT COMPLETED|Overall Study||13
120066|NCT01273818|289413|P3|COMPLETED|Overall Study||91
120067|NCT01273818|289414|P2|COMPLETED|Overall Study||98
120068|NCT01273818|289415|P1|COMPLETED|Overall Study||87
120069|NCT01273818|289413|P3|STARTED|Overall Study||100
120070|NCT01273818|289414|P2|STARTED|Overall Study||100
120071|NCT01273818|289415|P1|STARTED|Overall Study||100
120072|NCT01273805|289425|P2|NOT COMPLETED|Overall Study||10
120073|NCT01273805|289426|P1|NOT COMPLETED|Overall Study||10
120074|NCT01273805|289425|P2|COMPLETED|Overall Study||0
120075|NCT01273805|289426|P1|COMPLETED|Overall Study||0
120076|NCT01273805|289425|P2|STARTED|Overall Study||10
120077|NCT01273805|289426|P1|STARTED|Overall Study||10
120078|NCT01273766|289445|P3|NOT COMPLETED|Overall Study||0
120079|NCT01273766|289446|P2|NOT COMPLETED|Overall Study||0
120080|NCT01273766|289447|P1|NOT COMPLETED|Overall Study||0
120081|NCT01273766|289445|P3|COMPLETED|Overall Study||5
120082|NCT01273766|289446|P2|COMPLETED|Overall Study||7
120083|NCT01273766|289447|P1|COMPLETED|Overall Study||4
120084|NCT01273766|289445|P3|STARTED|Overall Study||5
120085|NCT01273766|289446|P2|STARTED|Overall Study||7
120086|NCT01273766|289447|P1|STARTED|Overall Study||4
120087|NCT01273623|289457|P1|NOT COMPLETED|Overall Study||29
120088|NCT01273623|289457|P1|COMPLETED|Overall Study|met IVUS criteria|26
120089|NCT01273623|289457|P1|STARTED|Overall Study|met angiographic criteria|55
120090|NCT01273597|289464|P1|NOT COMPLETED|Overall Study||8
120091|NCT01273597|289464|P1|COMPLETED|Overall Study||52
120092|NCT01273597|289464|P1|STARTED|Overall Study||60
120093|NCT01273519|289479|P3|NOT COMPLETED|Overall Study||8
120094|NCT01273519|289480|P2|NOT COMPLETED|Overall Study||5
120095|NCT01273519|289481|P1|NOT COMPLETED|Overall Study||19
120096|NCT01273519|289479|P3|COMPLETED|Overall Study||39
120097|NCT01273519|289480|P2|COMPLETED|Overall Study||25
120098|NCT01273519|289481|P1|COMPLETED|Overall Study||59
120099|NCT01273519|289479|P3|STARTED|Overall Study||47
120100|NCT01273519|289480|P2|STARTED|Overall Study||30
120101|NCT01273519|289481|P1|STARTED|Overall Study||78
120102|NCT01273181|289518|P4|NOT COMPLETED|Phase 2, Dose 2||1
120103|NCT01273181|289519|P3|NOT COMPLETED|Phase 2, Dose 2||0
120104|NCT01273181|289520|P2|NOT COMPLETED|Phase 2, Dose 2||0
120105|NCT01273181|289521|P1|NOT COMPLETED|Phase 2, Dose 2||0
120106|NCT01273181|289518|P4|COMPLETED|Phase 2, Dose 2||0
120107|NCT01273181|289519|P3|COMPLETED|Phase 2, Dose 2||0
120108|NCT01273181|289520|P2|COMPLETED|Phase 2, Dose 2||0
120109|NCT01273181|289521|P1|COMPLETED|Phase 2, Dose 2||0
120110|NCT01273181|289518|P4|STARTED|Phase 2, Dose 2||1
120111|NCT01273181|289519|P3|STARTED|Phase 2, Dose 2||0
120112|NCT01273181|289520|P2|STARTED|Phase 2, Dose 2||0
120113|NCT01273181|289521|P1|STARTED|Phase 2, Dose 2||0
120114|NCT01273181|289518|P4|NOT COMPLETED|Phase 2, Dose 1||0
120115|NCT01273181|289519|P3|NOT COMPLETED|Phase 2, Dose 1||1
120116|NCT01273181|289520|P2|NOT COMPLETED|Phase 2, Dose 1||0
120117|NCT01273181|289521|P1|NOT COMPLETED|Phase 2, Dose 1||0
120118|NCT01273181|289518|P4|COMPLETED|Phase 2, Dose 1||0
120119|NCT01273181|289519|P3|COMPLETED|Phase 2, Dose 1||1
120120|NCT01273181|289520|P2|COMPLETED|Phase 2, Dose 1||0
120121|NCT01273181|289521|P1|COMPLETED|Phase 2, Dose 1||0
120122|NCT01273181|289518|P4|STARTED|Phase 2, Dose 1||0
120123|NCT01273181|289519|P3|STARTED|Phase 2, Dose 1||2
120124|NCT01273181|289520|P2|STARTED|Phase 2, Dose 1||0
120125|NCT01273181|289521|P1|STARTED|Phase 2, Dose 1||0
120126|NCT01273181|289518|P4|NOT COMPLETED|Phase I, Dose 2||0
120127|NCT01273181|289519|P3|NOT COMPLETED|Phase I, Dose 2||0
120128|NCT01273181|289520|P2|NOT COMPLETED|Phase I, Dose 2||1
120129|NCT01273181|289521|P1|NOT COMPLETED|Phase I, Dose 2||0
120130|NCT01273181|289518|P4|COMPLETED|Phase I, Dose 2||0
120131|NCT01273181|289519|P3|COMPLETED|Phase I, Dose 2||0
120132|NCT01273181|289520|P2|COMPLETED|Phase I, Dose 2||2
120133|NCT01273181|289521|P1|COMPLETED|Phase I, Dose 2||0
120134|NCT01273181|289518|P4|STARTED|Phase I, Dose 2||0
120135|NCT01273181|289519|P3|STARTED|Phase I, Dose 2||0
120136|NCT01273181|289520|P2|STARTED|Phase I, Dose 2||3
120137|NCT01273181|289521|P1|STARTED|Phase I, Dose 2||0
120138|NCT01273181|289518|P4|NOT COMPLETED|Phase I, Dose 1||0
120139|NCT01273181|289519|P3|NOT COMPLETED|Phase I, Dose 1||0
120140|NCT01273181|289520|P2|NOT COMPLETED|Phase I, Dose 1||0
120141|NCT01273181|289521|P1|NOT COMPLETED|Phase I, Dose 1||1
120142|NCT01273181|289518|P4|COMPLETED|Phase I, Dose 1||0
120143|NCT01273181|289519|P3|COMPLETED|Phase I, Dose 1||0
120144|NCT01273181|289520|P2|COMPLETED|Phase I, Dose 1||0
120145|NCT01273181|289521|P1|COMPLETED|Phase I, Dose 1||2
120146|NCT01273181|289518|P4|STARTED|Phase I, Dose 1||0
120147|NCT01273181|289519|P3|STARTED|Phase I, Dose 1||0
120148|NCT01273181|289520|P2|STARTED|Phase I, Dose 1||0
120149|NCT01273181|289521|P1|STARTED|Phase I, Dose 1||3
120150|NCT01273064|289540|P5|NOT COMPLETED|Overall Study||10
120151|NCT01273064|289541|P4|NOT COMPLETED|Overall Study||20
120152|NCT01273064|289542|P3|NOT COMPLETED|Overall Study||31
120153|NCT01273064|289543|P2|NOT COMPLETED|Overall Study||30
120154|NCT01273064|289544|P1|NOT COMPLETED|Overall Study||23
120155|NCT01273064|289540|P5|COMPLETED|Overall Study||0
120156|NCT01273064|289541|P4|COMPLETED|Overall Study||0
120157|NCT01273064|289542|P3|COMPLETED|Overall Study||0
120158|NCT01273064|289543|P2|COMPLETED|Overall Study||0
120159|NCT01273064|289544|P1|COMPLETED|Overall Study||0
120160|NCT01273064|289540|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
120161|NCT01273064|289541|P4|STARTED|Overall Study||20
120162|NCT01273064|289542|P3|STARTED|Overall Study||31
120163|NCT01273064|289543|P2|STARTED|Overall Study||30
120164|NCT01273064|289544|P1|STARTED|Overall Study||23
120165|NCT01273038|289563|P2|NOT COMPLETED|Second Intervention (14 Days)||2
120166|NCT01273038|289564|P1|NOT COMPLETED|Second Intervention (14 Days)||0
120167|NCT01273038|289563|P2|COMPLETED|Second Intervention (14 Days)||8
120168|NCT01273038|289564|P1|COMPLETED|Second Intervention (14 Days)||10
120169|NCT01273038|289563|P2|STARTED|Second Intervention (14 Days)||10
120170|NCT01273038|289564|P1|STARTED|Second Intervention (14 Days)||10
120171|NCT01273038|289563|P2|NOT COMPLETED|First Intervention (14 Days)||0
120172|NCT01273038|289564|P1|NOT COMPLETED|First Intervention (14 Days)||0
120173|NCT01273038|289563|P2|COMPLETED|First Intervention (14 Days)||10
120174|NCT01273038|289564|P1|COMPLETED|First Intervention (14 Days)||10
120175|NCT01273038|289563|P2|STARTED|First Intervention (14 Days)||10
120176|NCT01273038|289564|P1|STARTED|First Intervention (14 Days)||10
120177|NCT01272960|289572|P2|NOT COMPLETED|Overall Study||0
120178|NCT01272960|289573|P1|NOT COMPLETED|Overall Study||0
120179|NCT01272960|289572|P2|COMPLETED|Overall Study||15
120180|NCT01272960|289573|P1|COMPLETED|Overall Study||14
120181|NCT01272960|289572|P2|STARTED|Overall Study||15
120182|NCT01272960|289573|P1|STARTED|Overall Study||14
120183|NCT01272947|289587|P2|NOT COMPLETED|Overall Study||2
120184|NCT01272947|289588|P1|NOT COMPLETED|Overall Study||2
120185|NCT01272947|289587|P2|COMPLETED|Overall Study||98
120186|NCT01272947|289588|P1|COMPLETED|Overall Study||102
120187|NCT01272947|289587|P2|STARTED|Overall Study||100
120188|NCT01272947|289588|P1|STARTED|Overall Study||104
120189|NCT01272934|289598|P2|NOT COMPLETED|Overall Study||2
120190|NCT01272934|289599|P1|NOT COMPLETED|Overall Study||0
120191|NCT01272934|289598|P2|COMPLETED|Overall Study||101
120192|NCT01272934|289599|P1|COMPLETED|Overall Study||102
120193|NCT01272934|289598|P2|STARTED|Overall Study||103
120194|NCT01272934|289599|P1|STARTED|Overall Study||102
120195|NCT01272921|289609|P2|NOT COMPLETED|Overall Study||1
120196|NCT01272921|289610|P1|NOT COMPLETED|Overall Study||2
120197|NCT01272921|289609|P2|COMPLETED|Overall Study||70
120198|NCT01272921|289610|P1|COMPLETED|Overall Study||69
120199|NCT01272921|289609|P2|STARTED|Overall Study||71
120200|NCT01272921|289610|P1|STARTED|Overall Study||71
120201|NCT01272908|289618|P1|NOT COMPLETED|Re-Treatment Period||6
120202|NCT01272908|289618|P1|COMPLETED|Re-Treatment Period||71
120203|NCT01272908|289618|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
120204|NCT01272908|289618|P1|NOT COMPLETED|Initial Treatment Period||8
120205|NCT01272908|289618|P1|COMPLETED|Initial Treatment Period||112
120206|NCT01272908|289618|P1|STARTED|Initial Treatment Period||120
120207|NCT01272882|289652|P1|NOT COMPLETED|Overall Study||0
120208|NCT01272882|289652|P1|COMPLETED|Overall Study||13
120209|NCT01272882|289652|P1|STARTED|Overall Study||13
120210|NCT01272869|289658|P2|NOT COMPLETED|Period 2 (14 Days)||0
120211|NCT01272869|289659|P1|NOT COMPLETED|Period 2 (14 Days)||1
120212|NCT01272869|289658|P2|COMPLETED|Period 2 (14 Days)||10
120213|NCT01272869|289659|P1|COMPLETED|Period 2 (14 Days)||9
120214|NCT01272869|289658|P2|STARTED|Period 2 (14 Days)||10
120215|NCT01272869|289659|P1|STARTED|Period 2 (14 Days)||10
120216|NCT01272869|289658|P2|NOT COMPLETED|Period 1 (14 Days)||0
120217|NCT01272869|289659|P1|NOT COMPLETED|Period 1 (14 Days)||0
120218|NCT01272869|289658|P2|COMPLETED|Period 1 (14 Days)||10
120219|NCT01272869|289659|P1|COMPLETED|Period 1 (14 Days)||10
120220|NCT01272869|289658|P2|STARTED|Period 1 (14 Days)||10
120221|NCT01272869|289659|P1|STARTED|Period 1 (14 Days)||10
120222|NCT01272830|289667|P2|NOT COMPLETED|Overall Study||5
120223|NCT01272830|289668|P1|NOT COMPLETED|Overall Study||8
120224|NCT01272830|289667|P2|COMPLETED|Overall Study||21
120225|NCT01272830|289668|P1|COMPLETED|Overall Study||17
120226|NCT01272830|289667|P2|STARTED|Overall Study||26
120227|NCT01272830|289668|P1|STARTED|Overall Study||25
120228|NCT01272804|289686|P6|NOT COMPLETED|Overall Study||1
120229|NCT01272804|289687|P5|NOT COMPLETED|Overall Study||2
120230|NCT01272804|289688|P4|NOT COMPLETED|Overall Study||0
120231|NCT01272804|289689|P3|NOT COMPLETED|Overall Study||0
120232|NCT01272804|289690|P2|NOT COMPLETED|Overall Study||0
120233|NCT01272804|289691|P1|NOT COMPLETED|Overall Study||1
120234|NCT01272804|289686|P6|COMPLETED|Overall Study||15
120235|NCT01272804|289687|P5|COMPLETED|Overall Study||7
120236|NCT01272804|289688|P4|COMPLETED|Overall Study||9
120237|NCT01272804|289689|P3|COMPLETED|Overall Study||9
120238|NCT01272804|289690|P2|COMPLETED|Overall Study||9
120239|NCT01272804|289691|P1|COMPLETED|Overall Study||8
120240|NCT01272804|289686|P6|STARTED|Overall Study||16
120241|NCT01272804|289687|P5|STARTED|Overall Study||9
120242|NCT01272804|289688|P4|STARTED|Overall Study||9
120243|NCT01272804|289689|P3|STARTED|Overall Study||9
120244|NCT01272804|289690|P2|STARTED|Overall Study||9
120245|NCT01272804|289691|P1|STARTED|Overall Study||9
120246|NCT01272661|289849|P3|NOT COMPLETED|Overall Study||72
120247|NCT01272661|289850|P2|NOT COMPLETED|Overall Study||209
120248|NCT01272661|289851|P1|NOT COMPLETED|Overall Study||126
120249|NCT01272661|289849|P3|COMPLETED|Overall Study||314
120250|NCT01272661|289850|P2|COMPLETED|Overall Study||288
120251|NCT01272661|289851|P1|COMPLETED|Overall Study||287
120252|NCT01272661|289849|P3|STARTED|Overall Study||386
120253|NCT01272661|289850|P2|STARTED|Overall Study||497
120254|NCT01272661|289851|P1|STARTED|Overall Study||413
120255|NCT01272635|289876|P4|NOT COMPLETED|Overall Study||23
120256|NCT01272635|289877|P3|NOT COMPLETED|Overall Study||31
120257|NCT01272635|289878|P2|NOT COMPLETED|Overall Study||20
120258|NCT01272635|289879|P1|NOT COMPLETED|Overall Study||31
120259|NCT01272635|289876|P4|COMPLETED|Overall Study||129
120260|NCT01272635|289877|P3|COMPLETED|Overall Study||117
120261|NCT01272635|289878|P2|COMPLETED|Overall Study||134
120262|NCT01272635|289879|P1|COMPLETED|Overall Study||122
120263|NCT01272635|289876|P4|STARTED|Overall Study||152
120264|NCT01272635|289877|P3|STARTED|Overall Study||148
120265|NCT01272635|289878|P2|STARTED|Overall Study||154
120266|NCT01272635|289879|P1|STARTED|Overall Study||153
120267|NCT01272583|289897|P2|NOT COMPLETED|Overall Study||0
120268|NCT01272583|289898|P1|NOT COMPLETED|Overall Study||0
120269|NCT01272583|289897|P2|COMPLETED|Overall Study||8
120270|NCT01272583|289898|P1|COMPLETED|Overall Study||8
120271|NCT01272583|289897|P2|STARTED|Overall Study||8
120272|NCT01272583|289898|P1|STARTED|Overall Study||8
120273|NCT01272284|289927|P1|NOT COMPLETED|12-month Follow-up Visit||4
120274|NCT01272284|289927|P1|COMPLETED|12-month Follow-up Visit||105
120275|NCT01272284|289927|P1|STARTED|12-month Follow-up Visit||109
120276|NCT01272284|289927|P1|NOT COMPLETED|6-month Follow-up Visit||3
120277|NCT01272284|289927|P1|COMPLETED|6-month Follow-up Visit||109
120278|NCT01272284|289927|P1|STARTED|6-month Follow-up Visit||112
120279|NCT01272284|289927|P1|NOT COMPLETED|3-month Follow-up Visit||1
120280|NCT01272284|289927|P1|COMPLETED|3-month Follow-up Visit||112
120281|NCT01272284|289927|P1|STARTED|3-month Follow-up Visit||113
120282|NCT01272245|289941|P1|NOT COMPLETED|Overall Study||0
120283|NCT01272245|289941|P1|COMPLETED|Overall Study||36
120284|NCT01272245|289941|P1|STARTED|Overall Study||36
120285|NCT01272232|289952|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
120286|NCT01272232|289953|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
120287|NCT01272232|289954|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
120288|NCT01272232|289952|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
120289|NCT01272232|289953|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
120290|NCT01272232|289954|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
120291|NCT01272232|289952|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
120292|NCT01272232|289953|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
120293|NCT01272232|289954|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
120294|NCT01272232|289952|P3|NOT COMPLETED|Weeks 0-56||72
120295|NCT01272232|289953|P2|NOT COMPLETED|Weeks 0-56||47
120296|NCT01272232|289954|P1|NOT COMPLETED|Weeks 0-56||99
120297|NCT01272232|289952|P3|COMPLETED|Weeks 0-56||140
120298|NCT01272232|289953|P2|COMPLETED|Weeks 0-56||164
120299|NCT01272232|289954|P1|COMPLETED|Weeks 0-56||324
120300|NCT01272232|289952|P3|Exposed|Weeks 0-56||212
120301|NCT01272232|289953|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
120302|NCT01272232|289954|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
120303|NCT01272232|289952|P3|STARTED|Weeks 0-56||212
120304|NCT01272232|289953|P2|STARTED|Weeks 0-56||211
120305|NCT01272232|289954|P1|STARTED|Weeks 0-56||423
120306|NCT01272219|289999|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
120307|NCT01272219|290000|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
120308|NCT01272219|290001|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
120309|NCT01272219|290002|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
120310|NCT01272219|290003|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
120311|NCT01272219|290004|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
120312|NCT01272219|289999|P6|COMPLETED|Main + Extension Period: Week 0-172||327
120313|NCT01272219|290000|P5|COMPLETED|Main + Extension Period: Week 0-172||783
120314|NCT01272219|290001|P4|COMPLETED|Main + Extension Period: Week 0-172||0
120315|NCT01272219|290002|P3|COMPLETED|Main + Extension Period: Week 0-172||0
120316|NCT01272219|290003|P2|COMPLETED|Main + Extension Period: Week 0-172||0
120317|NCT01272219|290004|P1|COMPLETED|Main + Extension Period: Week 0-172||0
120318|NCT01272219|289999|P6|Exposed|Main + Extension Period: Week 0-172||747
120319|NCT01272219|290000|P5|Exposed|Main + Extension Period: Week 0-172||1501
120320|NCT01272219|290001|P4|Exposed|Main + Extension Period: Week 0-172||0
120321|NCT01272219|290002|P3|Exposed|Main + Extension Period: Week 0-172||0
120322|NCT01272219|290003|P2|Exposed|Main + Extension Period: Week 0-172||0
120323|NCT01272219|290004|P1|Exposed|Main + Extension Period: Week 0-172||0
120324|NCT01272219|289999|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
120325|NCT01272219|290000|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
120326|NCT01272219|290001|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
120327|NCT01272219|290002|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
120328|NCT01272219|290003|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
120329|NCT01272219|290004|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
120330|NCT01272219|289999|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
120331|NCT01272219|290000|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
120332|NCT01272219|290001|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
120333|NCT01272219|290002|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
120334|NCT01272219|290003|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
120335|NCT01272219|290004|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
120336|NCT01272219|289999|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
120337|NCT01272219|290000|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
120338|NCT01272219|290001|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
120339|NCT01272219|290002|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
120340|NCT01272219|290003|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
120341|NCT01272219|290004|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
120342|NCT01272219|289999|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
120343|NCT01272219|290000|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
120344|NCT01272219|290001|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
120345|NCT01272219|290002|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
120346|NCT01272219|290003|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
120347|NCT01272219|290004|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
120348|NCT01272219|289999|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
120349|NCT01272219|290000|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
120350|NCT01272219|290001|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
120351|NCT01272219|290002|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
120352|NCT01272219|290003|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
120353|NCT01272219|290004|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
120354|NCT01272219|289999|P6|COMPLETED|Main Period: Week 0 to Week 56||505
120355|NCT01272219|290000|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
120356|NCT01272219|290001|P4|COMPLETED|Main Period: Week 0 to Week 56||296
120357|NCT01272219|290002|P3|COMPLETED|Main Period: Week 0 to Week 56||0
120358|NCT01272219|290003|P2|COMPLETED|Main Period: Week 0 to Week 56||0
120359|NCT01272219|290004|P1|COMPLETED|Main Period: Week 0 to Week 56||679
120360|NCT01272219|289999|P6|Exposed|Main Period: Week 0 to Week 56||755
120361|NCT01272219|290000|P5|Exposed|Main Period: Week 0 to Week 56||1524
120362|NCT01272219|290001|P4|Exposed|Main Period: Week 0 to Week 56||487
120363|NCT01272219|290002|P3|Exposed|Main Period: Week 0 to Week 56||0
120364|NCT01272219|290003|P2|Exposed|Main Period: Week 0 to Week 56||0
120365|NCT01272219|290004|P1|Exposed|Main Period: Week 0 to Week 56||957
120366|NCT01272219|289999|P6|STARTED|Main Period: Week 0 to Week 56||757
120367|NCT01272219|290000|P5|STARTED|Main Period: Week 0 to Week 56||1528
120368|NCT01272219|290001|P4|STARTED|Main Period: Week 0 to Week 56||487
120369|NCT01272219|290002|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
120370|NCT01272219|290003|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
120371|NCT01272219|290004|P1|STARTED|Main Period: Week 0 to Week 56||959
120372|NCT01272193|290038|P2|NOT COMPLETED|Overall Study||12
120373|NCT01272193|290039|P1|NOT COMPLETED|Overall Study||10
120374|NCT01272193|290038|P2|COMPLETED|Overall Study||137
120375|NCT01272193|290039|P1|COMPLETED|Overall Study||137
120376|NCT01272193|290038|P2|STARTED|Overall Study||149
120377|NCT01272193|290039|P1|STARTED|Overall Study||147
120378|NCT01272180|290059|P4|NOT COMPLETED|Overall Study||14
120379|NCT01272180|290060|P3|NOT COMPLETED|Overall Study||13
120380|NCT01272180|290061|P2|NOT COMPLETED|Overall Study||21
120381|NCT01272180|290062|P1|NOT COMPLETED|Overall Study||17
120382|NCT01272180|290059|P4|COMPLETED|Overall Study||107
120383|NCT01272180|290060|P3|COMPLETED|Overall Study||109
120384|NCT01272180|290061|P2|COMPLETED|Overall Study||100
120385|NCT01272180|290062|P1|COMPLETED|Overall Study||103
120386|NCT01272180|290059|P4|STARTED|Overall Study||121
120387|NCT01272180|290060|P3|STARTED|Overall Study||122
120388|NCT01272180|290061|P2|STARTED|Overall Study||121
120389|NCT01272180|290062|P1|STARTED|Overall Study||120
120390|NCT01272141|290099|P1|NOT COMPLETED|Overall Study||0
120391|NCT01272141|290099|P1|COMPLETED|Overall Study||5
120392|NCT01272141|290099|P1|STARTED|Overall Study||5
120393|NCT01272076|290104|P1|NOT COMPLETED|Overall Study||0
120394|NCT01272076|290104|P1|COMPLETED|Overall Study||52
120395|NCT01272076|290104|P1|STARTED|Overall Study||52
120396|NCT01272011|290111|P3|NOT COMPLETED|Overall Study||0
120397|NCT01272011|290112|P2|NOT COMPLETED|Overall Study||2
120398|NCT01272011|290113|P1|NOT COMPLETED|Overall Study||0
120399|NCT01272011|290111|P3|COMPLETED|Overall Study||3
120400|NCT01272011|290112|P2|COMPLETED|Overall Study||8
120401|NCT01272011|290113|P1|COMPLETED|Overall Study||3
120402|NCT01272011|290111|P3|STARTED|Overall Study||3
120403|NCT01272011|290112|P2|STARTED|Overall Study||10
120404|NCT01272011|290113|P1|STARTED|Overall Study||3
120405|NCT01271946|290126|P2|NOT COMPLETED|Overall Study||0
120406|NCT01271946|290127|P1|NOT COMPLETED|Overall Study||0
120407|NCT01271946|290126|P2|COMPLETED|Overall Study||5
120408|NCT01271946|290127|P1|COMPLETED|Overall Study||346
120409|NCT01271946|290126|P2|STARTED|Overall Study||5
120410|NCT01271946|290127|P1|STARTED|Overall Study||346
120411|NCT01271907|290152|P3|NOT COMPLETED|Overall Study||0
120412|NCT01271907|290153|P2|NOT COMPLETED|Overall Study||0
120413|NCT01271907|290154|P1|NOT COMPLETED|Overall Study||0
120414|NCT01271907|290152|P3|COMPLETED|Overall Study||0
120415|NCT01271907|290153|P2|COMPLETED|Overall Study||0
120416|NCT01271907|290154|P1|COMPLETED|Overall Study||3
120417|NCT01271907|290152|P3|STARTED|Overall Study||0
120418|NCT01271907|290153|P2|STARTED|Overall Study||0
120419|NCT01271907|290154|P1|STARTED|Overall Study||3
120420|NCT01271855|290170|P2|NOT COMPLETED|Overall Study||0
120421|NCT01271855|290171|P1|NOT COMPLETED|Overall Study||0
120422|NCT01271855|290170|P2|COMPLETED|Overall Study||52
120423|NCT01271855|290171|P1|COMPLETED|Overall Study||48
120424|NCT01271855|290170|P2|STARTED|Overall Study||52
120425|NCT01271855|290171|P1|STARTED|Overall Study||48
120426|NCT01271803|290193|P12|NOT COMPLETED|Stage 2||39
120427|NCT01271803|290194|P11|NOT COMPLETED|Stage 2||27
120428|NCT01271803|290195|P10|NOT COMPLETED|Stage 2||0
120429|NCT01271803|290196|P9|NOT COMPLETED|Stage 2||0
120430|NCT01271803|290197|P8|NOT COMPLETED|Stage 2||0
120431|NCT01271803|290198|P7|NOT COMPLETED|Stage 2||0
120432|NCT01271803|290199|P6|NOT COMPLETED|Stage 2||0
120433|NCT01271803|290200|P5|NOT COMPLETED|Stage 2||0
120434|NCT01271803|290201|P4|NOT COMPLETED|Stage 2||0
120435|NCT01271803|290202|P3|NOT COMPLETED|Stage 2||0
120436|NCT01271803|290203|P2|NOT COMPLETED|Stage 2||0
120437|NCT01271803|290204|P1|NOT COMPLETED|Stage 2||0
120438|NCT01271803|290193|P12|COMPLETED|Stage 2||0
120439|NCT01271803|290194|P11|COMPLETED|Stage 2||0
120440|NCT01271803|290195|P10|COMPLETED|Stage 2||0
120441|NCT01271803|290196|P9|COMPLETED|Stage 2||0
120442|NCT01271803|290197|P8|COMPLETED|Stage 2||0
120443|NCT01271803|290198|P7|COMPLETED|Stage 2||0
120444|NCT01271803|290199|P6|COMPLETED|Stage 2||0
120445|NCT01271803|290200|P5|COMPLETED|Stage 2||0
120446|NCT01271803|290201|P4|COMPLETED|Stage 2||0
120447|NCT01271803|290202|P3|COMPLETED|Stage 2||0
120448|NCT01271803|290203|P2|COMPLETED|Stage 2||0
120449|NCT01271803|290204|P1|COMPLETED|Stage 2||0
120450|NCT01271803|290193|P12|STARTED|Stage 2||39
120451|NCT01271803|290194|P11|STARTED|Stage 2||27
120452|NCT01271803|290195|P10|STARTED|Stage 2||0
120453|NCT01271803|290196|P9|STARTED|Stage 2||0
120454|NCT01271803|290197|P8|STARTED|Stage 2||0
120455|NCT01271803|290198|P7|STARTED|Stage 2||0
120456|NCT01271803|290199|P6|STARTED|Stage 2||0
120457|NCT01271803|290200|P5|STARTED|Stage 2||0
120458|NCT01271803|290201|P4|STARTED|Stage 2||0
120459|NCT01271803|290202|P3|STARTED|Stage 2||0
120460|NCT01271803|290203|P2|STARTED|Stage 2||0
120461|NCT01271803|290204|P1|STARTED|Stage 2||0
120462|NCT01271803|290193|P12|NOT COMPLETED|Stage 1||0
120463|NCT01271803|290194|P11|NOT COMPLETED|Stage 1||0
120464|NCT01271803|290195|P10|NOT COMPLETED|Stage 1||2
120465|NCT01271803|290196|P9|NOT COMPLETED|Stage 1||5
120466|NCT01271803|290197|P8|NOT COMPLETED|Stage 1||3
120467|NCT01271803|290198|P7|NOT COMPLETED|Stage 1||4
120468|NCT01271803|290199|P6|NOT COMPLETED|Stage 1||4
120469|NCT01271803|290200|P5|NOT COMPLETED|Stage 1||4
120470|NCT01271803|290201|P4|NOT COMPLETED|Stage 1||3
120471|NCT01271803|290202|P3|NOT COMPLETED|Stage 1||27
120472|NCT01271803|290203|P2|NOT COMPLETED|Stage 1||8
120473|NCT01271803|290204|P1|NOT COMPLETED|Stage 1||5
120474|NCT01271803|290193|P12|COMPLETED|Stage 1||0
120475|NCT01271803|290194|P11|COMPLETED|Stage 1||0
120476|NCT01271803|290195|P10|COMPLETED|Stage 1||0
120477|NCT01271803|290196|P9|COMPLETED|Stage 1||0
120478|NCT01271803|290197|P8|COMPLETED|Stage 1||0
120479|NCT01271803|290198|P7|COMPLETED|Stage 1||0
120480|NCT01271803|290199|P6|COMPLETED|Stage 1||0
120481|NCT01271803|290200|P5|COMPLETED|Stage 1||0
120482|NCT01271803|290201|P4|COMPLETED|Stage 1||0
120483|NCT01271803|290202|P3|COMPLETED|Stage 1||0
120484|NCT01271803|290203|P2|COMPLETED|Stage 1||0
120485|NCT01271803|290204|P1|COMPLETED|Stage 1||0
120486|NCT01271803|290193|P12|STARTED|Stage 1||0
120487|NCT01271803|290194|P11|STARTED|Stage 1||0
120488|NCT01271803|290195|P10|STARTED|Stage 1||2
120489|NCT01271803|290196|P9|STARTED|Stage 1||5
120490|NCT01271803|290197|P8|STARTED|Stage 1||3
120491|NCT01271803|290198|P7|STARTED|Stage 1||4
120492|NCT01271803|290199|P6|STARTED|Stage 1||4
120493|NCT01271803|290200|P5|STARTED|Stage 1||4
120494|NCT01271803|290201|P4|STARTED|Stage 1||3
120495|NCT01271803|290202|P3|STARTED|Stage 1||27
120496|NCT01271803|290203|P2|STARTED|Stage 1||8
120497|NCT01271803|290204|P1|STARTED|Stage 1||5
120498|NCT01271712|290377|P2|NOT COMPLETED|Survival Follow-up||6
120499|NCT01271712|290378|P1|NOT COMPLETED|Survival Follow-up||15
120500|NCT01271712|290377|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
120501|NCT01271712|290378|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
120502|NCT01271712|290377|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
120503|NCT01271712|290378|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
120504|NCT01271712|290377|P2|NOT COMPLETED|Safety Follow-up||15
120505|NCT01271712|290378|P1|NOT COMPLETED|Safety Follow-up||21
120506|NCT01271712|290377|P2|COMPLETED|Safety Follow-up||37
120507|NCT01271712|290378|P1|COMPLETED|Safety Follow-up||97
120508|NCT01271712|290377|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
120509|NCT01271712|290378|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
120510|NCT01271712|290377|P2|NOT COMPLETED|Open Label Treatment||58
120511|NCT01271712|290378|P1|NOT COMPLETED|Open Label Treatment||91
120512|NCT01271712|290377|P2|COMPLETED|Open Label Treatment||0
120513|NCT01271712|290378|P1|COMPLETED|Open Label Treatment||0
120514|NCT01271712|290377|P2|STARTED|Open Label Treatment||58
120515|NCT01271712|290378|P1|STARTED|Open Label Treatment||91
120516|NCT01271712|290377|P2|NOT COMPLETED|Double Blind Treatment||8
120517|NCT01271712|290378|P1|NOT COMPLETED|Double Blind Treatment||42
120518|NCT01271712|290377|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
120519|NCT01271712|290378|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
120520|NCT01271712|290377|P2|Participants Received Treatment|Double Blind Treatment||66
120521|NCT01271712|290378|P1|Participants Received Treatment|Double Blind Treatment||132
120522|NCT01271712|290377|P2|STARTED|Double Blind Treatment||66
120523|NCT01271712|290378|P1|STARTED|Double Blind Treatment||133
120524|NCT01271686|290399|P1|NOT COMPLETED|Overall Study||0
120525|NCT01271686|290399|P1|COMPLETED|Overall Study||16
120526|NCT01271686|290399|P1|STARTED|Overall Study||16
120527|NCT01271543|290405|P2|NOT COMPLETED|Overall Study||1
120528|NCT01271543|290406|P1|NOT COMPLETED|Overall Study||1
120529|NCT01271543|290405|P2|COMPLETED|Overall Study||29
120530|NCT01271543|290406|P1|COMPLETED|Overall Study||29
120531|NCT01271543|290405|P2|STARTED|Overall Study||30
120532|NCT01271543|290406|P1|STARTED|Overall Study||30
120533|NCT01271452|290416|P2|NOT COMPLETED|Overall Study||8
120534|NCT01271452|290417|P1|NOT COMPLETED|Overall Study||7
120535|NCT01271452|290416|P2|COMPLETED|Overall Study||104
120536|NCT01271452|290417|P1|COMPLETED|Overall Study||105
120537|NCT01271452|290416|P2|STARTED|Overall Study||112
120538|NCT01271452|290417|P1|STARTED|Overall Study||112
120539|NCT01271413|290439|P2|NOT COMPLETED|Overall Study||8
120540|NCT01271413|290440|P1|NOT COMPLETED|Overall Study||9
120541|NCT01271413|290439|P2|COMPLETED|Overall Study||28
120542|NCT01271413|290440|P1|COMPLETED|Overall Study||28
120543|NCT01271413|290439|P2|STARTED|Overall Study||36
120544|NCT01271413|290440|P1|STARTED|Overall Study||37
120545|NCT01271244|290448|P2|NOT COMPLETED|Overall Study||3
120546|NCT01271244|290449|P1|NOT COMPLETED|Overall Study||7
120547|NCT01271244|290448|P2|COMPLETED|Overall Study||5
120548|NCT01271244|290449|P1|COMPLETED|Overall Study||11
120549|NCT01271244|290448|P2|STARTED|Overall Study||8
120550|NCT01271244|290449|P1|STARTED|Overall Study||18
120551|NCT01271036|290457|P2|NOT COMPLETED|Overall Study||0
120552|NCT01271036|290458|P1|NOT COMPLETED|Overall Study||0
120553|NCT01271036|290457|P2|COMPLETED|Overall Study||62
120554|NCT01271036|290458|P1|COMPLETED|Overall Study||62
120555|NCT01271036|290457|P2|STARTED|Overall Study||62
120556|NCT01271036|290458|P1|STARTED|Overall Study||62
120557|NCT01271010|290472|P1|NOT COMPLETED|Overall Study||61
120558|NCT01271010|290472|P1|COMPLETED|Overall Study||28
120559|NCT01271010|290472|P1|STARTED|Overall Study||89
120560|NCT01270971|290487|P2|NOT COMPLETED|Overall Study||23
120561|NCT01270971|290488|P1|NOT COMPLETED|Overall Study||52
120562|NCT01270971|290487|P2|COMPLETED|Overall Study||171
120563|NCT01270971|290488|P1|COMPLETED|Overall Study||348
120564|NCT01270971|290487|P2|STARTED|Overall Study||194
120565|NCT01270971|290488|P1|STARTED|Overall Study||400
120566|NCT01270958|290500|P1|NOT COMPLETED|Overall Study||4
120567|NCT01270958|290500|P1|COMPLETED|Overall Study||56
120568|NCT01270958|290500|P1|STARTED|Overall Study||60
120569|NCT01270919|290524|P1|NOT COMPLETED|Overall Study||0
120570|NCT01270919|290524|P1|COMPLETED|Overall Study||0
120571|NCT01270919|290524|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
120572|NCT01270880|290529|P1|NOT COMPLETED|Overall Study||1
120573|NCT01270880|290529|P1|COMPLETED|Overall Study||17
120574|NCT01270880|290529|P1|STARTED|Overall Study||18
120575|NCT01270867|290535|P2|NOT COMPLETED|Overall Study||0
120576|NCT01270867|290536|P1|NOT COMPLETED|Overall Study||1
120577|NCT01270867|290535|P2|COMPLETED|Overall Study||88
120578|NCT01270867|290536|P1|COMPLETED|Overall Study||89
120579|NCT01270867|290535|P2|STARTED|Overall Study||88
120580|NCT01270867|290536|P1|STARTED|Overall Study||90
120581|NCT01270841|290554|P4|NOT COMPLETED|Overall Study||13
120582|NCT01270841|290555|P3|NOT COMPLETED|Overall Study||11
120583|NCT01270841|290556|P2|NOT COMPLETED|Overall Study||14
120584|NCT01270841|290557|P1|NOT COMPLETED|Overall Study||13
120585|NCT01270841|290554|P4|COMPLETED|Overall Study||20
120586|NCT01270841|290555|P3|COMPLETED|Overall Study||18
120587|NCT01270841|290556|P2|COMPLETED|Overall Study||19
120588|NCT01270841|290557|P1|COMPLETED|Overall Study||16
120589|NCT01270841|290554|P4|STARTED|Overall Study||33
120590|NCT01270841|290555|P3|STARTED|Overall Study||29
120591|NCT01270841|290556|P2|STARTED|Overall Study||33
120592|NCT01270841|290557|P1|STARTED|Overall Study||29
120593|NCT01270828|290581|P3|NOT COMPLETED|Double Blind Phase||0
120594|NCT01270828|290582|P2|NOT COMPLETED|Double Blind Phase||45
120595|NCT01270828|290583|P1|NOT COMPLETED|Double Blind Phase||26
120596|NCT01270828|290581|P3|COMPLETED|Double Blind Phase||0
120597|NCT01270828|290582|P2|COMPLETED|Double Blind Phase||160
120598|NCT01270828|290583|P1|COMPLETED|Double Blind Phase||182
120599|NCT01270828|290581|P3|STARTED|Double Blind Phase||0
120600|NCT01270828|290582|P2|STARTED|Double Blind Phase||205
120601|NCT01270828|290583|P1|STARTED|Double Blind Phase||208
120602|NCT01270828|290581|P3|NOT COMPLETED|Pregabalin CR SB||146
120603|NCT01270828|290582|P2|NOT COMPLETED|Pregabalin CR SB||0
120604|NCT01270828|290583|P1|NOT COMPLETED|Pregabalin CR SB||0
120605|NCT01270828|290581|P3|COMPLETED|Pregabalin CR SB||660
120606|NCT01270828|290582|P2|COMPLETED|Pregabalin CR SB||0
120607|NCT01270828|290583|P1|COMPLETED|Pregabalin CR SB||0
120608|NCT01270828|290581|P3|STARTED|Pregabalin CR SB||806
120609|NCT01270828|290582|P2|STARTED|Pregabalin CR SB||0
120610|NCT01270828|290583|P1|STARTED|Pregabalin CR SB||0
120611|NCT01270802|290625|P2|NOT COMPLETED|Overall Study||1
120612|NCT01270802|290626|P1|NOT COMPLETED|Overall Study||2
120613|NCT01270802|290625|P2|COMPLETED|Overall Study||14
120614|NCT01270802|290626|P1|COMPLETED|Overall Study||13
120615|NCT01270802|290625|P2|STARTED|Overall Study||15
120616|NCT01270802|290626|P1|STARTED|Overall Study||15
120617|NCT01270711|290642|P8|NOT COMPLETED|Part 2: Effectiveness||0
120618|NCT01270711|290643|P7|NOT COMPLETED|Part 2: Effectiveness||0
120619|NCT01270711|290644|P6|NOT COMPLETED|Part 2: Effectiveness||0
120620|NCT01270711|290645|P5|NOT COMPLETED|Part 2: Effectiveness||0
120621|NCT01270711|290646|P4|NOT COMPLETED|Part 2: Effectiveness||0
120622|NCT01270711|290647|P3|NOT COMPLETED|Part 2: Effectiveness||0
120623|NCT01270711|290648|P2|NOT COMPLETED|Part 2: Effectiveness||0
120624|NCT01270711|290649|P1|NOT COMPLETED|Part 2: Effectiveness||0
120625|NCT01270711|290642|P8|COMPLETED|Part 2: Effectiveness||48
120626|NCT01270711|290643|P7|COMPLETED|Part 2: Effectiveness||2
120627|NCT01270711|290644|P6|COMPLETED|Part 2: Effectiveness||11
120628|NCT01270711|290645|P5|COMPLETED|Part 2: Effectiveness||0
120629|NCT01270711|290646|P4|COMPLETED|Part 2: Effectiveness||0
120630|NCT01270711|290647|P3|COMPLETED|Part 2: Effectiveness||0
120631|NCT01270711|290648|P2|COMPLETED|Part 2: Effectiveness||0
120632|NCT01270711|290649|P1|COMPLETED|Part 2: Effectiveness||0
120633|NCT01270711|290642|P8|STARTED|Part 2: Effectiveness||48
120634|NCT01270711|290643|P7|STARTED|Part 2: Effectiveness||2
120635|NCT01270711|290644|P6|STARTED|Part 2: Effectiveness||11
120636|NCT01270711|290645|P5|STARTED|Part 2: Effectiveness||0
120637|NCT01270711|290646|P4|STARTED|Part 2: Effectiveness||0
120638|NCT01270711|290647|P3|STARTED|Part 2: Effectiveness||0
120639|NCT01270711|290648|P2|STARTED|Part 2: Effectiveness||0
120640|NCT01270711|290649|P1|STARTED|Part 2: Effectiveness||0
120641|NCT01270711|290642|P8|NOT COMPLETED|Part 1: Compliance||0
120642|NCT01270711|290643|P7|NOT COMPLETED|Part 1: Compliance||0
120643|NCT01270711|290644|P6|NOT COMPLETED|Part 1: Compliance||0
120644|NCT01270711|290645|P5|NOT COMPLETED|Part 1: Compliance||0
120645|NCT01270711|290646|P4|NOT COMPLETED|Part 1: Compliance||0
120646|NCT01270711|290647|P3|NOT COMPLETED|Part 1: Compliance||0
120647|NCT01270711|290648|P2|NOT COMPLETED|Part 1: Compliance||0
120648|NCT01270711|290649|P1|NOT COMPLETED|Part 1: Compliance||0
120649|NCT01270711|290642|P8|COMPLETED|Part 1: Compliance||0
120650|NCT01270711|290643|P7|COMPLETED|Part 1: Compliance||0
120651|NCT01270711|290644|P6|COMPLETED|Part 1: Compliance||0
120652|NCT01270711|290645|P5|COMPLETED|Part 1: Compliance||2024
120653|NCT01270711|290646|P4|COMPLETED|Part 1: Compliance||5486
120654|NCT01270711|290647|P3|COMPLETED|Part 1: Compliance||326
120655|NCT01270711|290648|P2|COMPLETED|Part 1: Compliance||6580
120656|NCT01270711|290649|P1|COMPLETED|Part 1: Compliance||7537
120657|NCT01270711|290642|P8|STARTED|Part 1: Compliance||0
120658|NCT01270711|290643|P7|STARTED|Part 1: Compliance||0
120659|NCT01270711|290644|P6|STARTED|Part 1: Compliance||0
120660|NCT01270711|290645|P5|STARTED|Part 1: Compliance||2024
120661|NCT01270711|290646|P4|STARTED|Part 1: Compliance||5486
120662|NCT01270711|290647|P3|STARTED|Part 1: Compliance||326
120663|NCT01270711|290648|P2|STARTED|Part 1: Compliance||6580
120664|NCT01270711|290649|P1|STARTED|Part 1: Compliance||7537
120665|NCT01270659|290750|P4|NOT COMPLETED|Overall Study||0
120666|NCT01270659|290751|P3|NOT COMPLETED|Overall Study||0
120667|NCT01270659|290752|P2|NOT COMPLETED|Overall Study||0
120668|NCT01270659|290753|P1|NOT COMPLETED|Overall Study||0
120669|NCT01270659|290750|P4|COMPLETED|Overall Study||25
120670|NCT01270659|290751|P3|COMPLETED|Overall Study||4
120671|NCT01270659|290752|P2|COMPLETED|Overall Study||25
120672|NCT01270659|290753|P1|COMPLETED|Overall Study||6
120673|NCT01270659|290750|P4|STARTED|Overall Study||25
120674|NCT01270659|290751|P3|STARTED|Overall Study||4
120675|NCT01270659|290752|P2|STARTED|Overall Study||25
120676|NCT01270659|290753|P1|STARTED|Overall Study||6
120677|NCT01270620|290773|P2|NOT COMPLETED|Overall Study||3
120678|NCT01270620|290774|P1|NOT COMPLETED|Overall Study||1
120679|NCT01270620|290773|P2|COMPLETED|Overall Study||47
120680|NCT01270620|290774|P1|COMPLETED|Overall Study||49
120681|NCT01270620|290773|P2|STARTED|Overall Study||50
120682|NCT01270620|290774|P1|STARTED|Overall Study||50
120683|NCT01270581|290826|P2|NOT COMPLETED|Overall Study||0
120684|NCT01270581|290827|P1|NOT COMPLETED|Overall Study||1
120685|NCT01270581|290826|P2|COMPLETED|Overall Study||3
120686|NCT01270581|290827|P1|COMPLETED|Overall Study||3
120687|NCT01270581|290826|P2|STARTED|Overall Study||3
120688|NCT01270581|290827|P1|STARTED|Overall Study||4
120689|NCT01270555|290833|P1|NOT COMPLETED|Overall Study||13
120690|NCT01270555|290833|P1|COMPLETED|Overall Study||19
120691|NCT01270555|290833|P1|STARTED|Overall Study||32
120692|NCT01270542|290845|P2|NOT COMPLETED|Overall Study||1
120693|NCT01270542|290846|P1|NOT COMPLETED|Overall Study||1
120694|NCT01270542|290845|P2|COMPLETED|Overall Study||8
120695|NCT01270542|290846|P1|COMPLETED|Overall Study||9
120696|NCT01270542|290845|P2|STARTED|Overall Study||9
120697|NCT01270542|290846|P1|STARTED|Overall Study||10
120698|NCT01270529|290859|P3|NOT COMPLETED|Overall Study||0
120699|NCT01270529|290860|P2|NOT COMPLETED|Overall Study||0
120700|NCT01270529|290861|P1|NOT COMPLETED|Overall Study||0
120701|NCT01270529|290859|P3|COMPLETED|Overall Study||25
120702|NCT01270529|290860|P2|COMPLETED|Overall Study||7
120703|NCT01270529|290861|P1|COMPLETED|Overall Study||12
120704|NCT01270529|290859|P3|STARTED|Overall Study||25
120705|NCT01270529|290860|P2|STARTED|Overall Study||7
120706|NCT01270529|290861|P1|STARTED|Overall Study||12
120707|NCT01270503|290869|P1|NOT COMPLETED|Overall Study||1
120708|NCT01270503|290869|P1|COMPLETED|Overall Study||537
120709|NCT01270503|290869|P1|STARTED|Overall Study||538
120710|NCT01270464|290877|P3|NOT COMPLETED|Overall Study||18
120711|NCT01270464|290878|P2|NOT COMPLETED|Overall Study||12
120712|NCT01270464|290879|P1|NOT COMPLETED|Overall Study||20
120713|NCT01270464|290877|P3|COMPLETED|Overall Study||88
120714|NCT01270464|290878|P2|COMPLETED|Overall Study||92
120715|NCT01270464|290879|P1|COMPLETED|Overall Study||85
120716|NCT01270464|290877|P3|Pharmacokinetic Analysis Set|Overall Study||103
120717|NCT01270464|290878|P2|Pharmacokinetic Analysis Set|Overall Study||103
120718|NCT01270464|290879|P1|Pharmacokinetic Analysis Set|Overall Study||105
120719|NCT01270464|290877|P3|Full Analysis Set|Overall Study||103
120720|NCT01270464|290878|P2|Full Analysis Set|Overall Study||103
120721|NCT01270464|290879|P1|Full Analysis Set|Overall Study||105
120722|NCT01270464|290877|P3|Safety Analysis Set|Overall Study||103
120723|NCT01270464|290878|P2|Safety Analysis Set|Overall Study||103
120724|NCT01270464|290879|P1|Safety Analysis Set|Overall Study||105
120725|NCT01270464|290877|P3|STARTED|Overall Study||106
120726|NCT01270464|290878|P2|STARTED|Overall Study||104
120727|NCT01270464|290879|P1|STARTED|Overall Study||105
120728|NCT01270256|290928|P2|NOT COMPLETED|Overall Study||0
120729|NCT01270256|290929|P1|NOT COMPLETED|Overall Study||1
120730|NCT01270256|290928|P2|COMPLETED|Overall Study||20
120731|NCT01270256|290929|P1|COMPLETED|Overall Study||20
120732|NCT01270256|290928|P2|STARTED|Overall Study||20
120733|NCT01270256|290929|P1|STARTED|Overall Study||21
120734|NCT01270139|290938|P3|NOT COMPLETED|Overall Study||20
120735|NCT01270139|290939|P2|NOT COMPLETED|Overall Study||26
120736|NCT01270139|290940|P1|NOT COMPLETED|Overall Study||18
120737|NCT01270139|290938|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
120738|NCT01270139|290939|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
120739|NCT01270139|290940|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
120740|NCT01270139|290938|P3|STARTED|Overall Study|Intention-to-treat population|60
120741|NCT01270139|290939|P2|STARTED|Overall Study|Intention-to-treat population|60
120742|NCT01270139|290940|P1|STARTED|Overall Study|Intention-to-treat population|60
120743|NCT01270126|291000|P2|NOT COMPLETED|Overall Study||0
120744|NCT01270126|291001|P1|NOT COMPLETED|Overall Study||0
120745|NCT01270126|291000|P2|COMPLETED|Overall Study||10
120746|NCT01270126|291001|P1|COMPLETED|Overall Study||12
120747|NCT01270126|291000|P2|STARTED|Overall Study||10
120748|NCT01270126|291001|P1|STARTED|Overall Study||12
120749|NCT01269918|291009|P2|NOT COMPLETED|Overall Study||3
120750|NCT01269918|291010|P1|NOT COMPLETED|Overall Study||0
120751|NCT01269918|291009|P2|COMPLETED|Overall Study||68
120752|NCT01269918|291010|P1|COMPLETED|Overall Study||71
120753|NCT01269918|291009|P2|STARTED|Overall Study||71
120754|NCT01269918|291010|P1|STARTED|Overall Study||71
120755|NCT01269801|291044|P2|NOT COMPLETED|Overall Study||3
120756|NCT01269801|291045|P1|NOT COMPLETED|Overall Study||0
120757|NCT01269801|291044|P2|COMPLETED|Overall Study||77
120758|NCT01269801|291045|P1|COMPLETED|Overall Study||74
120759|NCT01269801|291044|P2|STARTED|Overall Study||80
120760|NCT01269801|291045|P1|STARTED|Overall Study||74
120761|NCT01269749|291053|P2|NOT COMPLETED|Overall Study||0
120762|NCT01269749|291054|P1|NOT COMPLETED|Overall Study||0
120763|NCT01269749|291053|P2|COMPLETED|Overall Study||3
120764|NCT01269749|291054|P1|COMPLETED|Overall Study||16
120765|NCT01269749|291053|P2|STARTED|Overall Study||3
120766|NCT01269749|291054|P1|STARTED|Overall Study||16
120767|NCT01269736|291064|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
120768|NCT01269736|291065|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
120769|NCT01269736|291064|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
120770|NCT01269736|291065|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
120771|NCT01269736|291064|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
120772|NCT01269736|291065|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
120773|NCT01269736|291064|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
120774|NCT01269736|291065|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
120775|NCT01269736|291064|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
120776|NCT01269736|291065|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
120777|NCT01269736|291064|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
120778|NCT01269736|291065|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
120779|NCT01269736|291064|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
120780|NCT01269736|291065|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
120781|NCT01269736|291064|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
120782|NCT01269736|291065|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
120783|NCT01269736|291064|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
120784|NCT01269736|291065|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
120785|NCT01269736|291064|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
120786|NCT01269736|291065|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
120787|NCT01269736|291064|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
120788|NCT01269736|291065|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
120789|NCT01269736|291064|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
120790|NCT01269736|291065|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
120791|NCT01269736|291064|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
120792|NCT01269736|291065|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
120793|NCT01269736|291064|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
120794|NCT01269736|291065|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
120795|NCT01269736|291064|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
120796|NCT01269736|291065|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
120797|NCT01269736|291064|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
120798|NCT01269736|291065|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
120799|NCT01269736|291064|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
120800|NCT01269736|291065|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
120801|NCT01269736|291064|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
120802|NCT01269736|291065|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
120803|NCT01269710|291077|P1|NOT COMPLETED|Overall Study||3
120804|NCT01269710|291077|P1|COMPLETED|Overall Study|This refers to Week 52.|1
120805|NCT01269710|291077|P1|Week 36|Overall Study||2
120806|NCT01269710|291077|P1|Week 12|Overall Study||3
120807|NCT01269710|291077|P1|STARTED|Overall Study||4
120808|NCT01269346|291085|P1|NOT COMPLETED|Extension Phase||43
120809|NCT01269346|291085|P1|COMPLETED|Extension Phase||0
120810|NCT01269346|291085|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
120811|NCT01269346|291085|P1|NOT COMPLETED|Treatment Phase||9
120812|NCT01269346|291085|P1|COMPLETED|Treatment Phase||43
120813|NCT01269346|291085|P1|Completed 6 Cycles|Treatment Phase||45
120814|NCT01269346|291085|P1|STARTED|Treatment Phase||52
120815|NCT01269125|291096|P3|NOT COMPLETED|Overall Study||0
120816|NCT01269125|291097|P2|NOT COMPLETED|Overall Study||5
120817|NCT01269125|291098|P1|NOT COMPLETED|Overall Study||7
120818|NCT01269125|291096|P3|COMPLETED|Overall Study||60
120819|NCT01269125|291097|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
120820|NCT01269125|291098|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
120821|NCT01269125|291096|P3|STARTED|Overall Study||60
120822|NCT01269125|291097|P2|STARTED|Overall Study||60
120823|NCT01269125|291098|P1|STARTED|Overall Study||60
120824|NCT01269047|291121|P3|NOT COMPLETED|Overall Study||1
120825|NCT01269047|291122|P2|NOT COMPLETED|Overall Study||2
120826|NCT01269047|291123|P1|NOT COMPLETED|Overall Study||1
120827|NCT01269047|291121|P3|COMPLETED|Overall Study||10
120828|NCT01269047|291122|P2|COMPLETED|Overall Study||11
120829|NCT01269047|291123|P1|COMPLETED|Overall Study||12
120830|NCT01269047|291121|P3|STARTED|Overall Study||11
120831|NCT01269047|291122|P2|STARTED|Overall Study||13
120832|NCT01269047|291123|P1|STARTED|Overall Study||13
120833|NCT01268943|291142|P4|NOT COMPLETED|Overall Study||0
120834|NCT01268943|291143|P3|NOT COMPLETED|Overall Study||0
120835|NCT01268943|291144|P2|NOT COMPLETED|Overall Study||0
120836|NCT01268943|291145|P1|NOT COMPLETED|Overall Study||0
120837|NCT01268943|291142|P4|COMPLETED|Overall Study||6
120838|NCT01268943|291143|P3|COMPLETED|Overall Study||3
120839|NCT01268943|291144|P2|COMPLETED|Overall Study||3
120840|NCT01268943|291145|P1|COMPLETED|Overall Study||6
120841|NCT01268943|291142|P4|STARTED|Overall Study||6
120842|NCT01268943|291143|P3|STARTED|Overall Study||3
120843|NCT01268943|291144|P2|STARTED|Overall Study||3
120844|NCT01268943|291145|P1|STARTED|Overall Study||6
120845|NCT01268891|291157|P2|NOT COMPLETED|Overall Study||8
120846|NCT01268891|291158|P1|NOT COMPLETED|Overall Study||8
120847|NCT01268891|291157|P2|COMPLETED|Overall Study||58
120848|NCT01268891|291158|P1|COMPLETED|Overall Study||58
120849|NCT01268891|291157|P2|STARTED|Overall Study||66
120850|NCT01268891|291158|P1|STARTED|Overall Study||66
120851|NCT01268683|291170|P1|NOT COMPLETED|Overall Study||0
120852|NCT01268683|291170|P1|COMPLETED|Overall Study||10
120853|NCT01268683|291170|P1|STARTED|Overall Study||10
120854|NCT01268566|291177|P1|NOT COMPLETED|Overall Study||43
120855|NCT01268566|291177|P1|COMPLETED|Overall Study||13
120856|NCT01268566|291177|P1|STARTED|Overall Study||56
120857|NCT01268553|291195|P1|NOT COMPLETED|Overall Study||0
120858|NCT01268553|291195|P1|COMPLETED|Overall Study||6
120859|NCT01268553|291195|P1|STARTED|Overall Study||6
120860|NCT01268501|291204|P1|NOT COMPLETED|Overall Study||9
120861|NCT01268501|291204|P1|COMPLETED|Overall Study||87
120862|NCT01268501|291204|P1|STARTED|Overall Study||96
120863|NCT01268488|291208|P1|NOT COMPLETED|Overall Study||5
120864|NCT01268488|291208|P1|COMPLETED|Overall Study||93
120865|NCT01268488|291208|P1|STARTED|Overall Study||98
120866|NCT01268306|291215|P1|NOT COMPLETED|Overall Study||1
120867|NCT01268306|291215|P1|COMPLETED|Overall Study||7
120868|NCT01268306|291215|P1|STARTED|Overall Study||8
120869|NCT01268293|291219|P1|NOT COMPLETED|Overall Study||9
120870|NCT01268293|291219|P1|COMPLETED|Overall Study||0
120871|NCT01268293|291219|P1|Completed Cycle 1|Overall Study||9
120872|NCT01268293|291219|P1|STARTED|Overall Study||9
120873|NCT01268267|291224|P1|NOT COMPLETED|Overall Study||1
120874|NCT01268267|291224|P1|COMPLETED|Overall Study||93
120875|NCT01268267|291224|P1|STARTED|Overall Study||94
120876|NCT01268189|291231|P1|NOT COMPLETED|Overall Study||3
120877|NCT01268189|291231|P1|COMPLETED|Overall Study||17
120878|NCT01268189|291231|P1|STARTED|Overall Study||20
120879|NCT01268150|291245|P1|NOT COMPLETED|Extension Phase||27
120880|NCT01268150|291245|P1|COMPLETED|Extension Phase||1
120881|NCT01268150|291245|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
120882|NCT01268150|291245|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
120883|NCT01268150|291245|P1|NOT COMPLETED|Treatment Phase||28
120884|NCT01268150|291245|P1|COMPLETED|Treatment Phase||28
120885|NCT01268150|291245|P1|STARTED|Treatment Phase||56
120886|NCT01268111|291255|P2|NOT COMPLETED|Overall Study||0
120887|NCT01268111|291256|P1|NOT COMPLETED|Overall Study||0
120888|NCT01268111|291255|P2|COMPLETED|Overall Study||6
120889|NCT01268111|291256|P1|COMPLETED|Overall Study||6
120890|NCT01268111|291255|P2|STARTED|Overall Study||6
120891|NCT01268111|291256|P1|STARTED|Overall Study||6
120892|NCT01268098|291264|P2|NOT COMPLETED|Overall Study||0
120893|NCT01268098|291265|P1|NOT COMPLETED|Overall Study||1
120894|NCT01268098|291264|P2|COMPLETED|Overall Study||23
120895|NCT01268098|291265|P1|COMPLETED|Overall Study||18
120896|NCT01268098|291264|P2|STARTED|Overall Study||23
120897|NCT01268098|291265|P1|STARTED|Overall Study||19
120898|NCT01267994|291273|P1|NOT COMPLETED|Overall Study||2
120899|NCT01267994|291273|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
120900|NCT01267994|291273|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
120901|NCT01267929|291280|P2|NOT COMPLETED|Overall Study||0
120902|NCT01267929|291281|P1|NOT COMPLETED|Overall Study||0
120903|NCT01267929|291280|P2|COMPLETED|Overall Study||15
120904|NCT01267929|291281|P1|COMPLETED|Overall Study||15
120905|NCT01267929|291280|P2|STARTED|Overall Study||15
120906|NCT01267929|291281|P1|STARTED|Overall Study||15
120907|NCT01267422|291287|P2|NOT COMPLETED|Safety and Efficacy Study||0
120908|NCT01267422|291288|P1|NOT COMPLETED|Safety and Efficacy Study||0
120909|NCT01267422|291287|P2|COMPLETED|Safety and Efficacy Study||4
120910|NCT01267422|291288|P1|COMPLETED|Safety and Efficacy Study||5
120911|NCT01267422|291287|P2|STARTED|Safety and Efficacy Study||4
120912|NCT01267422|291288|P1|STARTED|Safety and Efficacy Study||5
120913|NCT01267422|291287|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
120914|NCT01267422|291288|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
120915|NCT01267422|291287|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
120916|NCT01267422|291288|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
120917|NCT01267422|291287|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
120918|NCT01267422|291288|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
120919|NCT01267292|291308|P2|NOT COMPLETED|Overall Study||6
120920|NCT01267292|291309|P1|NOT COMPLETED|Overall Study||4
120921|NCT01267292|291308|P2|COMPLETED|Overall Study||20
120922|NCT01267292|291309|P1|COMPLETED|Overall Study||20
120923|NCT01267292|291308|P2|STARTED|Overall Study||26
120924|NCT01267292|291309|P1|STARTED|Overall Study||24
120925|NCT01267266|291343|P2|NOT COMPLETED|Randomized Phase||0
120926|NCT01267266|291344|P1|NOT COMPLETED|Randomized Phase||0
120927|NCT01267266|291343|P2|COMPLETED|Randomized Phase||5
120928|NCT01267266|291344|P1|COMPLETED|Randomized Phase||3
120929|NCT01267266|291343|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
120930|NCT01267266|291344|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
120931|NCT01267266|291343|P2|NOT COMPLETED|Lead-in Phase||0
120932|NCT01267266|291344|P1|NOT COMPLETED|Lead-in Phase||23
120933|NCT01267266|291343|P2|COMPLETED|Lead-in Phase||0
120934|NCT01267266|291344|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
120935|NCT01267266|291343|P2|STARTED|Lead-in Phase||0
120936|NCT01267266|291344|P1|STARTED|Lead-in Phase||31
120937|NCT01267266|291343|P2|NOT COMPLETED|Enrollment Phase||0
120938|NCT01267266|291344|P1|NOT COMPLETED|Enrollment Phase||2
120939|NCT01267266|291343|P2|COMPLETED|Enrollment Phase||0
120940|NCT01267266|291344|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
120941|NCT01267266|291343|P2|STARTED|Enrollment Phase||0
120942|NCT01267266|291344|P1|STARTED|Enrollment Phase||33
120943|NCT01267253|291357|P1|NOT COMPLETED|Overall Study||3
120944|NCT01267253|291357|P1|COMPLETED|Overall Study|Eligible and treated patients|28
120945|NCT01267253|291357|P1|STARTED|Overall Study||31
120946|NCT01267240|291365|P1|NOT COMPLETED|Overall Study||0
120947|NCT01267240|291365|P1|COMPLETED|Overall Study||25
120948|NCT01267240|291365|P1|STARTED|Overall Study||25
120949|NCT01267227|291375|P4|NOT COMPLETED|Overall Study||3
120950|NCT01267227|291376|P3|NOT COMPLETED|Overall Study||2
120951|NCT01267227|291377|P2|NOT COMPLETED|Overall Study||1
120952|NCT01267227|291378|P1|NOT COMPLETED|Overall Study||1
120953|NCT01267227|291375|P4|COMPLETED|Overall Study||17
120954|NCT01267227|291376|P3|COMPLETED|Overall Study||18
120955|NCT01267227|291377|P2|COMPLETED|Overall Study||19
120956|NCT01267227|291378|P1|COMPLETED|Overall Study||19
120957|NCT01267227|291375|P4|STARTED|Overall Study||20
120958|NCT01267227|291376|P3|STARTED|Overall Study||20
120959|NCT01267227|291377|P2|STARTED|Overall Study||20
120960|NCT01267227|291378|P1|STARTED|Overall Study||20
120961|NCT01267201|291396|P6|NOT COMPLETED|Third Intervention Period||0
120962|NCT01267201|291397|P5|NOT COMPLETED|Third Intervention Period||0
120963|NCT01267201|291398|P4|NOT COMPLETED|Third Intervention Period||0
120964|NCT01267201|291399|P3|NOT COMPLETED|Third Intervention Period||0
120965|NCT01267201|291400|P2|NOT COMPLETED|Third Intervention Period||0
120966|NCT01267201|291401|P1|NOT COMPLETED|Third Intervention Period||0
120967|NCT01267201|291396|P6|COMPLETED|Third Intervention Period||4
120968|NCT01267201|291397|P5|COMPLETED|Third Intervention Period||4
120969|NCT01267201|291398|P4|COMPLETED|Third Intervention Period||4
120970|NCT01267201|291399|P3|COMPLETED|Third Intervention Period||4
120971|NCT01267201|291400|P2|COMPLETED|Third Intervention Period||3
120972|NCT01267201|291401|P1|COMPLETED|Third Intervention Period||3
120973|NCT01267201|291396|P6|STARTED|Third Intervention Period||4
120974|NCT01267201|291397|P5|STARTED|Third Intervention Period||4
120975|NCT01267201|291398|P4|STARTED|Third Intervention Period||4
120976|NCT01267201|291399|P3|STARTED|Third Intervention Period||4
120977|NCT01267201|291400|P2|STARTED|Third Intervention Period||3
120978|NCT01267201|291401|P1|STARTED|Third Intervention Period||3
120979|NCT01267201|291396|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
120980|NCT01267201|291397|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
120981|NCT01267201|291398|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
120982|NCT01267201|291399|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
120983|NCT01267201|291400|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
120984|NCT01267201|291401|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
120985|NCT01267201|291396|P6|COMPLETED|Washout Period (At Least 2 Days)||4
120986|NCT01267201|291397|P5|COMPLETED|Washout Period (At Least 2 Days)||4
120987|NCT01267201|291398|P4|COMPLETED|Washout Period (At Least 2 Days)||4
120988|NCT01267201|291399|P3|COMPLETED|Washout Period (At Least 2 Days)||4
120989|NCT01267201|291400|P2|COMPLETED|Washout Period (At Least 2 Days)||3
120990|NCT01267201|291401|P1|COMPLETED|Washout Period (At Least 2 Days)||3
120991|NCT01267201|291396|P6|STARTED|Washout Period (At Least 2 Days)||4
120992|NCT01267201|291397|P5|STARTED|Washout Period (At Least 2 Days)||4
120993|NCT01267201|291398|P4|STARTED|Washout Period (At Least 2 Days)||4
120994|NCT01267201|291399|P3|STARTED|Washout Period (At Least 2 Days)||4
120995|NCT01267201|291400|P2|STARTED|Washout Period (At Least 2 Days)||3
120996|NCT01267201|291401|P1|STARTED|Washout Period (At Least 2 Days)||3
120997|NCT01267201|291396|P6|NOT COMPLETED|Second Intervention Period||0
120998|NCT01267201|291397|P5|NOT COMPLETED|Second Intervention Period||0
120999|NCT01267201|291398|P4|NOT COMPLETED|Second Intervention Period||0
121000|NCT01267201|291399|P3|NOT COMPLETED|Second Intervention Period||0
121001|NCT01267201|291400|P2|NOT COMPLETED|Second Intervention Period||1
121002|NCT01267201|291401|P1|NOT COMPLETED|Second Intervention Period||0
121003|NCT01267201|291396|P6|COMPLETED|Second Intervention Period||4
121004|NCT01267201|291397|P5|COMPLETED|Second Intervention Period||4
121005|NCT01267201|291398|P4|COMPLETED|Second Intervention Period||4
121006|NCT01267201|291399|P3|COMPLETED|Second Intervention Period||4
121007|NCT01267201|291400|P2|COMPLETED|Second Intervention Period||3
121008|NCT01267201|291401|P1|COMPLETED|Second Intervention Period||3
121009|NCT01267201|291396|P6|STARTED|Second Intervention Period||4
121010|NCT01267201|291397|P5|STARTED|Second Intervention Period||4
121011|NCT01267201|291398|P4|STARTED|Second Intervention Period||4
121012|NCT01267201|291399|P3|STARTED|Second Intervention Period||4
121013|NCT01267201|291400|P2|STARTED|Second Intervention Period||4
121014|NCT01267201|291401|P1|STARTED|Second Intervention Period||3
121015|NCT01267201|291396|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
121016|NCT01267201|291397|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
121017|NCT01267201|291398|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
121018|NCT01267201|291399|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
121019|NCT01267201|291400|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
121020|NCT01267201|291401|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
121021|NCT01267201|291396|P6|COMPLETED|Washout Period (At Least 2 Days)||4
121022|NCT01267201|291397|P5|COMPLETED|Washout Period (At Least 2 Days)||4
121023|NCT01267201|291398|P4|COMPLETED|Washout Period (At Least 2 Days)||4
121024|NCT01267201|291399|P3|COMPLETED|Washout Period (At Least 2 Days)||4
121025|NCT01267201|291400|P2|COMPLETED|Washout Period (At Least 2 Days)||4
121026|NCT01267201|291401|P1|COMPLETED|Washout Period (At Least 2 Days)||3
121027|NCT01267201|291396|P6|STARTED|Washout Period (At Least 2 Days)||4
121028|NCT01267201|291397|P5|STARTED|Washout Period (At Least 2 Days)||4
121029|NCT01267201|291398|P4|STARTED|Washout Period (At Least 2 Days)||4
121030|NCT01267201|291399|P3|STARTED|Washout Period (At Least 2 Days)||4
121031|NCT01267201|291400|P2|STARTED|Washout Period (At Least 2 Days)||4
121032|NCT01267201|291401|P1|STARTED|Washout Period (At Least 2 Days)||3
121033|NCT01267201|291396|P6|NOT COMPLETED|First Intervention Period||0
121034|NCT01267201|291397|P5|NOT COMPLETED|First Intervention Period||0
121035|NCT01267201|291398|P4|NOT COMPLETED|First Intervention Period||0
121036|NCT01267201|291399|P3|NOT COMPLETED|First Intervention Period||0
121037|NCT01267201|291400|P2|NOT COMPLETED|First Intervention Period||0
121038|NCT01267201|291401|P1|NOT COMPLETED|First Intervention Period||1
121039|NCT01267201|291396|P6|COMPLETED|First Intervention Period||4
121040|NCT01267201|291397|P5|COMPLETED|First Intervention Period||4
121041|NCT01267201|291398|P4|COMPLETED|First Intervention Period||4
121042|NCT01267201|291399|P3|COMPLETED|First Intervention Period||4
121043|NCT01267201|291400|P2|COMPLETED|First Intervention Period||4
121044|NCT01267201|291401|P1|COMPLETED|First Intervention Period||3
121045|NCT01267201|291396|P6|STARTED|First Intervention Period||4
121046|NCT01267201|291397|P5|STARTED|First Intervention Period||4
121047|NCT01267201|291398|P4|STARTED|First Intervention Period||4
121048|NCT01267201|291399|P3|STARTED|First Intervention Period||4
121049|NCT01267201|291400|P2|STARTED|First Intervention Period||4
121050|NCT01267201|291401|P1|STARTED|First Intervention Period||4
121051|NCT01267175|291418|P1|NOT COMPLETED|Overall Study||2
121052|NCT01267175|291418|P1|COMPLETED|Overall Study||29
121053|NCT01267175|291418|P1|STARTED|Overall Study||31
121054|NCT01267136|291425|P2|NOT COMPLETED|Overall Study||6
121055|NCT01267136|291426|P1|NOT COMPLETED|Overall Study||4
121056|NCT01267136|291425|P2|COMPLETED|Overall Study||36
121057|NCT01267136|291426|P1|COMPLETED|Overall Study||38
121058|NCT01267136|291425|P2|STARTED|Overall Study||42
121059|NCT01267136|291426|P1|STARTED|Overall Study||42
121060|NCT01267045|291436|P2|NOT COMPLETED|6-month Outcome||3
121061|NCT01267045|291437|P1|NOT COMPLETED|6-month Outcome||0
121062|NCT01267045|291436|P2|COMPLETED|6-month Outcome||23
121063|NCT01267045|291437|P1|COMPLETED|6-month Outcome||22
121064|NCT01267045|291436|P2|STARTED|6-month Outcome||26
121065|NCT01267045|291437|P1|STARTED|6-month Outcome||22
121066|NCT01267045|291436|P2|NOT COMPLETED|2-month Outcomes||3
121067|NCT01267045|291437|P1|NOT COMPLETED|2-month Outcomes||4
121068|NCT01267045|291436|P2|COMPLETED|2-month Outcomes||26
121069|NCT01267045|291437|P1|COMPLETED|2-month Outcomes||22
121070|NCT01267045|291436|P2|STARTED|2-month Outcomes||29
121071|NCT01267045|291437|P1|STARTED|2-month Outcomes||26
121072|NCT01267019|291472|P3|NOT COMPLETED|Overall Study||6
121073|NCT01267019|291473|P2|NOT COMPLETED|Overall Study||6
121074|NCT01267019|291474|P1|NOT COMPLETED|Overall Study||6
121075|NCT01267019|291472|P3|COMPLETED|Overall Study||47
121076|NCT01267019|291473|P2|COMPLETED|Overall Study||47
121077|NCT01267019|291474|P1|COMPLETED|Overall Study||41
121078|NCT01267019|291472|P3|STARTED|Overall Study||53
121079|NCT01267019|291473|P2|STARTED|Overall Study||53
121080|NCT01267019|291474|P1|STARTED|Overall Study||47
121081|NCT01266967|291490|P2|NOT COMPLETED|Overall Study||83
121082|NCT01266967|291491|P1|NOT COMPLETED|Overall Study||89
121083|NCT01266967|291490|P2|COMPLETED|Overall Study||0
121084|NCT01266967|291491|P1|COMPLETED|Overall Study||0
121085|NCT01266967|291490|P2|STARTED|Overall Study||83
121086|NCT01266967|291491|P1|STARTED|Overall Study||89
121087|NCT01266876|291543|P5|NOT COMPLETED|Overall Study||0
121088|NCT01266876|291544|P4|NOT COMPLETED|Overall Study||1
121089|NCT01266876|291545|P3|NOT COMPLETED|Overall Study||0
121090|NCT01266876|291546|P2|NOT COMPLETED|Overall Study||0
121091|NCT01266876|291547|P1|NOT COMPLETED|Overall Study||0
121092|NCT01266876|291543|P5|COMPLETED|Overall Study||16
121093|NCT01266876|291544|P4|COMPLETED|Overall Study||14
121094|NCT01266876|291545|P3|COMPLETED|Overall Study||16
121095|NCT01266876|291546|P2|COMPLETED|Overall Study||15
121096|NCT01266876|291547|P1|COMPLETED|Overall Study||15
121097|NCT01266876|291543|P5|STARTED|Overall Study||16
121098|NCT01266876|291544|P4|STARTED|Overall Study||15
121099|NCT01266876|291545|P3|STARTED|Overall Study||16
121100|NCT01266876|291546|P2|STARTED|Overall Study||15
121101|NCT01266876|291547|P1|STARTED|Overall Study||15
121102|NCT01266850|291654|P5|NOT COMPLETED|Overall Study||30
121103|NCT01266850|291655|P4|NOT COMPLETED|Overall Study||28
121104|NCT01266850|291656|P3|NOT COMPLETED|Overall Study||24
121105|NCT01266850|291657|P2|NOT COMPLETED|Overall Study||36
121106|NCT01266850|291658|P1|NOT COMPLETED|Overall Study||30
121107|NCT01266850|291654|P5|COMPLETED|Overall Study||297
121108|NCT01266850|291655|P4|COMPLETED|Overall Study||301
121109|NCT01266850|291656|P3|COMPLETED|Overall Study||214
121110|NCT01266850|291657|P2|COMPLETED|Overall Study||212
121111|NCT01266850|291658|P1|COMPLETED|Overall Study||212
121112|NCT01266850|291654|P5|Received Third Vaccine|Overall Study||299
121113|NCT01266850|291655|P4|Received Third Vaccine|Overall Study||0
121114|NCT01266850|291656|P3|Received Third Vaccine|Overall Study||217
121115|NCT01266850|291657|P2|Received Third Vaccine|Overall Study||221
121116|NCT01266850|291658|P1|Received Third Vaccine|Overall Study||221
121117|NCT01266850|291654|P5|Received Second Vaccine|Overall Study||307
121118|NCT01266850|291655|P4|Received Second Vaccine|Overall Study||311
121119|NCT01266850|291656|P3|Received Second Vaccine|Overall Study||227
121120|NCT01266850|291657|P2|Received Second Vaccine|Overall Study||233
121121|NCT01266850|291658|P1|Received Second Vaccine|Overall Study||231
121122|NCT01266850|291654|P5|STARTED|Overall Study||327
121123|NCT01266850|291655|P4|STARTED|Overall Study||329
121124|NCT01266850|291656|P3|STARTED|Overall Study||238
121125|NCT01266850|291657|P2|STARTED|Overall Study||248
121126|NCT01266850|291658|P1|STARTED|Overall Study||242
121127|NCT01266824|291712|P2|NOT COMPLETED|Overall Study||3
121128|NCT01266824|291713|P1|NOT COMPLETED|Overall Study||2
121129|NCT01266824|291712|P2|COMPLETED|Overall Study||0
121130|NCT01266824|291713|P1|COMPLETED|Overall Study||0
121131|NCT01266824|291712|P2|STARTED|Overall Study||3
121132|NCT01266824|291713|P1|STARTED|Overall Study||2
121133|NCT01266447|291725|P1|NOT COMPLETED|Overall Study||0
121134|NCT01266447|291725|P1|COMPLETED|Overall Study|Eligible and treated patients|27
121135|NCT01266447|291725|P1|STARTED|Overall Study||27
121136|NCT01266317|291734|P1|NOT COMPLETED|Overall Study||2
121137|NCT01266317|291734|P1|COMPLETED|Overall Study||7
121138|NCT01266317|291734|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
121139|NCT01266291|291739|P1|NOT COMPLETED|Overall Study||1
121140|NCT01266291|291739|P1|COMPLETED|Overall Study||0
121141|NCT01266291|291739|P1|STARTED|Overall Study||1
121142|NCT01266265|291746|P2|NOT COMPLETED|Overall Study||190
121143|NCT01266265|291747|P1|NOT COMPLETED|Overall Study||205
121144|NCT01266265|291746|P2|COMPLETED|Overall Study||477
121145|NCT01266265|291747|P1|COMPLETED|Overall Study||461
121146|NCT01266265|291746|P2|STARTED|Overall Study||667
121147|NCT01266265|291747|P1|STARTED|Overall Study||666
121148|NCT01266148|291755|P2|NOT COMPLETED|Overall Study||3
121149|NCT01266148|291756|P1|NOT COMPLETED|Overall Study||7
121150|NCT01266148|291755|P2|COMPLETED|Overall Study||56
121151|NCT01266148|291756|P1|COMPLETED|Overall Study||49
121152|NCT01266148|291755|P2|STARTED|Overall Study||59
121153|NCT01266148|291756|P1|STARTED|Overall Study||56
121154|NCT01266122|291784|P2|NOT COMPLETED|Overall Study||6
121155|NCT01266122|291785|P1|NOT COMPLETED|Overall Study||6
121156|NCT01266122|291784|P2|COMPLETED|Overall Study||42
121157|NCT01266122|291785|P1|COMPLETED|Overall Study||42
121158|NCT01266122|291784|P2|STARTED|Overall Study||48
121159|NCT01266122|291785|P1|STARTED|Overall Study||48
121160|NCT01266070|291793|P1|NOT COMPLETED|Overall Study||4
121161|NCT01266070|291793|P1|COMPLETED|Overall Study||2
121162|NCT01266070|291793|P1|STARTED|Overall Study||6
121163|NCT01266031|291801|P3|NOT COMPLETED|Overall Study||3
121164|NCT01266031|291802|P2|NOT COMPLETED|Overall Study||3
121165|NCT01266031|291803|P1|NOT COMPLETED|Overall Study||0
121166|NCT01266031|291801|P3|COMPLETED|Overall Study||46
121167|NCT01266031|291802|P2|COMPLETED|Overall Study||38
121168|NCT01266031|291803|P1|COMPLETED|Overall Study||6
121169|NCT01266031|291801|P3|STARTED|Overall Study||49
121170|NCT01266031|291802|P2|STARTED|Overall Study||41
121171|NCT01266031|291803|P1|STARTED|Overall Study||6
121172|NCT01266018|291811|P2|NOT COMPLETED|Overall Study||1
121173|NCT01266018|291812|P1|NOT COMPLETED|Overall Study||1
121174|NCT01266018|291811|P2|COMPLETED|Overall Study||12
121175|NCT01266018|291812|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
121176|NCT01266018|291811|P2|STARTED|Overall Study||13
121177|NCT01266018|291812|P1|STARTED|Overall Study||9
121178|NCT01265992|291823|P1|NOT COMPLETED|Overall Study||9
121179|NCT01265992|291823|P1|COMPLETED|Overall Study||41
121180|NCT01265992|291823|P1|Received Treatment|Overall Study||49
121181|NCT01265992|291823|P1|STARTED|Overall Study||50
121182|NCT01265966|291839|P3|NOT COMPLETED|Overall Study||2
121183|NCT01265966|291840|P2|NOT COMPLETED|Overall Study||2
121184|NCT01265966|291841|P1|NOT COMPLETED|Overall Study||3
121185|NCT01265966|291839|P3|COMPLETED|Overall Study||27
121186|NCT01265966|291840|P2|COMPLETED|Overall Study||39
121187|NCT01265966|291841|P1|COMPLETED|Overall Study||44
121188|NCT01265966|291839|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
121189|NCT01265966|291840|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
121190|NCT01265966|291841|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
121191|NCT01265966|291839|P3|STARTED|Overall Study||29
121192|NCT01265966|291840|P2|STARTED|Overall Study||41
121193|NCT01265966|291841|P1|STARTED|Overall Study||47
121194|NCT01265953|291851|P2|NOT COMPLETED|Overall Study||3
121195|NCT01265953|291852|P1|NOT COMPLETED|Overall Study||5
121196|NCT01265953|291851|P2|COMPLETED|Overall Study||45
121197|NCT01265953|291852|P1|COMPLETED|Overall Study||45
121198|NCT01265953|291851|P2|STARTED|Overall Study||48
121199|NCT01265953|291852|P1|STARTED|Overall Study||50
121200|NCT01265875|291864|P1|NOT COMPLETED|Overall Study||1
121201|NCT01265875|291864|P1|COMPLETED|Overall Study||11
121202|NCT01265875|291864|P1|STARTED|Overall Study||12
121203|NCT01265823|291872|P1|NOT COMPLETED|Overall Study||7
121204|NCT01265823|291872|P1|COMPLETED|Overall Study||143
121205|NCT01265823|291872|P1|STARTED|Overall Study||150
121206|NCT01265797|291901|P2|NOT COMPLETED|Open Label Month||1
121207|NCT01265797|291902|P1|NOT COMPLETED|Open Label Month||0
121208|NCT01265797|291901|P2|COMPLETED|Open Label Month||26
121209|NCT01265797|291902|P1|COMPLETED|Open Label Month||24
121210|NCT01265797|291901|P2|STARTED|Open Label Month||27
121211|NCT01265797|291902|P1|STARTED|Open Label Month||24
121212|NCT01265797|291901|P2|NOT COMPLETED|Blinded Month||2
121213|NCT01265797|291902|P1|NOT COMPLETED|Blinded Month||10
121214|NCT01265797|291901|P2|COMPLETED|Blinded Month||27
121215|NCT01265797|291902|P1|COMPLETED|Blinded Month||24
121216|NCT01265797|291901|P2|STARTED|Blinded Month||29
121217|NCT01265797|291902|P1|STARTED|Blinded Month||34
121218|NCT01265797|291901|P2|NOT COMPLETED|Run-in Month||5
121219|NCT01265797|291902|P1|NOT COMPLETED|Run-in Month||0
121220|NCT01265797|291901|P2|COMPLETED|Run-in Month||29
121221|NCT01265797|291902|P1|COMPLETED|Run-in Month||34
121222|NCT01265797|291901|P2|STARTED|Run-in Month||34
121223|NCT01265797|291902|P1|STARTED|Run-in Month||34
121224|NCT01265784|291933|P3|NOT COMPLETED|Overall Study||4
121225|NCT01265784|291934|P2|NOT COMPLETED|Overall Study||8
121226|NCT01265784|291935|P1|NOT COMPLETED|Overall Study||12
121227|NCT01265784|291933|P3|COMPLETED|Overall Study||26
121228|NCT01265784|291934|P2|COMPLETED|Overall Study||49
121229|NCT01265784|291935|P1|COMPLETED|Overall Study||44
121230|NCT01265784|291933|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
121231|NCT01265784|291934|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
121232|NCT01265784|291935|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
121233|NCT01265784|291933|P3|STARTED|Overall Study||30
121234|NCT01265784|291934|P2|STARTED|Overall Study||57
121235|NCT01265784|291935|P1|STARTED|Overall Study||56
121236|NCT01265667|292003|P2|NOT COMPLETED|Overall Study||13
121237|NCT01265667|292004|P1|NOT COMPLETED|Overall Study||20
121238|NCT01265667|292003|P2|COMPLETED|Overall Study||135
121239|NCT01265667|292004|P1|COMPLETED|Overall Study||125
121240|NCT01265667|292003|P2|STARTED|Overall Study||148
121241|NCT01265667|292004|P1|STARTED|Overall Study||145
121242|NCT01265615|292020|P4|NOT COMPLETED|Overall Study||3
121243|NCT01265615|292021|P3|NOT COMPLETED|Overall Study||4
121244|NCT01265615|292022|P2|NOT COMPLETED|Overall Study||2
121245|NCT01265615|292023|P1|NOT COMPLETED|Overall Study||2
121246|NCT01265615|292020|P4|COMPLETED|Overall Study||27
121247|NCT01265615|292021|P3|COMPLETED|Overall Study||26
121248|NCT01265615|292022|P2|COMPLETED|Overall Study||28
121249|NCT01265615|292023|P1|COMPLETED|Overall Study||28
121250|NCT01265615|292020|P4|STARTED|Overall Study||30
121251|NCT01265615|292021|P3|STARTED|Overall Study||30
121252|NCT01265615|292022|P2|STARTED|Overall Study||30
121253|NCT01265615|292023|P1|STARTED|Overall Study||30
121254|NCT01265563|292074|P5|NOT COMPLETED|Overall Study||2
121255|NCT01265563|292075|P4|NOT COMPLETED|Overall Study||0
121256|NCT01265563|292076|P3|NOT COMPLETED|Overall Study||1
121257|NCT01265563|292077|P2|NOT COMPLETED|Overall Study||1
121258|NCT01265563|292078|P1|NOT COMPLETED|Overall Study||0
121259|NCT01265563|292074|P5|COMPLETED|Overall Study||14
121260|NCT01265563|292075|P4|COMPLETED|Overall Study||16
121261|NCT01265563|292076|P3|COMPLETED|Overall Study||16
121262|NCT01265563|292077|P2|COMPLETED|Overall Study||12
121263|NCT01265563|292078|P1|COMPLETED|Overall Study||16
121264|NCT01265563|292074|P5|STARTED|Overall Study||16
121265|NCT01265563|292075|P4|STARTED|Overall Study||16
121266|NCT01265563|292076|P3|STARTED|Overall Study||17
121267|NCT01265563|292077|P2|STARTED|Overall Study||13
121268|NCT01265563|292078|P1|STARTED|Overall Study||16
121269|NCT01265550|292098|P3|NOT COMPLETED|Overall Study||20
121270|NCT01265550|292099|P2|NOT COMPLETED|Overall Study||8
121271|NCT01265550|292100|P1|NOT COMPLETED|Overall Study||15
121272|NCT01265550|292098|P3|COMPLETED|Overall Study||6
121273|NCT01265550|292099|P2|COMPLETED|Overall Study||19
121274|NCT01265550|292100|P1|COMPLETED|Overall Study||10
121275|NCT01265550|292098|P3|STARTED|Overall Study||26
121276|NCT01265550|292099|P2|STARTED|Overall Study||27
121277|NCT01265550|292100|P1|STARTED|Overall Study||25
121278|NCT01265524|292152|P2|NOT COMPLETED|Overall Study||6
121279|NCT01265524|292153|P1|NOT COMPLETED|Overall Study||18
121280|NCT01265524|292152|P2|COMPLETED|Overall Study||46
121281|NCT01265524|292153|P1|COMPLETED|Overall Study||41
121282|NCT01265524|292152|P2|STARTED|Overall Study||52
121283|NCT01265524|292153|P1|STARTED|Overall Study||59
121284|NCT01265511|292173|P2|NOT COMPLETED|Overall Study||3
121285|NCT01265511|292174|P1|NOT COMPLETED|Overall Study||2
121286|NCT01265511|292173|P2|COMPLETED|Overall Study||5
121287|NCT01265511|292174|P1|COMPLETED|Overall Study||0
121288|NCT01265511|292173|P2|STARTED|Overall Study||8
121289|NCT01265511|292174|P1|STARTED|Overall Study||2
121290|NCT01265498|292188|P2|NOT COMPLETED|Overall Study||33
121291|NCT01265498|292189|P1|NOT COMPLETED|Overall Study||31
121292|NCT01265498|292188|P2|COMPLETED|Overall Study||109
121293|NCT01265498|292189|P1|COMPLETED|Overall Study||110
121294|NCT01265498|292188|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
121295|NCT01265498|292189|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
121296|NCT01265498|292188|P2|STARTED|Overall Study||142
121297|NCT01265498|292189|P1|STARTED|Overall Study||141
121298|NCT01265459|292292|P3|NOT COMPLETED|Overall Study||2
121299|NCT01265459|292293|P2|NOT COMPLETED|Overall Study||0
121300|NCT01265459|292294|P1|NOT COMPLETED|Overall Study||0
121301|NCT01265459|292292|P3|COMPLETED|Overall Study||20
121302|NCT01265459|292293|P2|COMPLETED|Overall Study||23
121303|NCT01265459|292294|P1|COMPLETED|Overall Study||23
121304|NCT01265459|292292|P3|STARTED|Overall Study||22
121305|NCT01265459|292293|P2|STARTED|Overall Study||23
121306|NCT01265459|292294|P1|STARTED|Overall Study||23
121307|NCT01265446|292316|P2|NOT COMPLETED|Overall Study||0
121308|NCT01265446|292317|P1|NOT COMPLETED|Overall Study||1
121309|NCT01265446|292316|P2|COMPLETED|Overall Study||125
121310|NCT01265446|292317|P1|COMPLETED|Overall Study||124
121311|NCT01265446|292316|P2|STARTED|Overall Study||125
121312|NCT01265446|292317|P1|STARTED|Overall Study||125
121313|NCT01265420|292325|P1|NOT COMPLETED|Overall Study||1
121314|NCT01265420|292325|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
121315|NCT01265420|292325|P1|STARTED|Overall Study||7
121316|NCT01265394|292329|P1|NOT COMPLETED|Overall Study||37
121317|NCT01265394|292329|P1|COMPLETED|Overall Study||181
121318|NCT01265394|292329|P1|STARTED|Overall Study||218
121319|NCT01265056|292336|P2|NOT COMPLETED|Follow up||3
121320|NCT01265056|292337|P1|NOT COMPLETED|Follow up||7
121321|NCT01265056|292336|P2|COMPLETED|Follow up||24
121322|NCT01265056|292337|P1|COMPLETED|Follow up||19
121323|NCT01265056|292336|P2|STARTED|Follow up||27
121324|NCT01265056|292337|P1|STARTED|Follow up||26
121325|NCT01265056|292336|P2|NOT COMPLETED|Initial Study Period||2
121326|NCT01265056|292337|P1|NOT COMPLETED|Initial Study Period||2
121327|NCT01265056|292336|P2|COMPLETED|Initial Study Period||25
121328|NCT01265056|292337|P1|COMPLETED|Initial Study Period||24
121329|NCT01265056|292336|P2|STARTED|Initial Study Period||27
121330|NCT01265056|292337|P1|STARTED|Initial Study Period||26
121331|NCT01264952|292350|P3|NOT COMPLETED|Overall Study||0
121332|NCT01264952|292351|P2|NOT COMPLETED|Overall Study||0
121333|NCT01264952|292352|P1|NOT COMPLETED|Overall Study||0
121334|NCT01264952|292350|P3|COMPLETED|Overall Study||8
121335|NCT01264952|292351|P2|COMPLETED|Overall Study||2
121336|NCT01264952|292352|P1|COMPLETED|Overall Study||6
121337|NCT01264952|292350|P3|STARTED|Overall Study||8
121338|NCT01264952|292351|P2|STARTED|Overall Study||2
121339|NCT01264952|292352|P1|STARTED|Overall Study||6
121340|NCT01264939|292368|P2|NOT COMPLETED|Overall Study||28
121341|NCT01264939|292369|P1|NOT COMPLETED|Overall Study||18
121342|NCT01264939|292368|P2|COMPLETED|Overall Study||224
121343|NCT01264939|292369|P1|COMPLETED|Overall Study||66
121344|NCT01264939|292368|P2|STARTED|Overall Study||252
121345|NCT01264939|292369|P1|STARTED|Overall Study||84
121346|NCT01264887|292395|P1|NOT COMPLETED|Overall Study||31
121347|NCT01264887|292395|P1|COMPLETED|Overall Study||0
121348|NCT01264887|292395|P1|STARTED|Overall Study||31
121349|NCT01264835|292406|P1|NOT COMPLETED|Overall Study||1
121350|NCT01264835|292406|P1|COMPLETED|Overall Study||1
121351|NCT01264835|292406|P1|STARTED|Overall Study||2
121352|NCT01264770|292416|P6|NOT COMPLETED|Overall Study||6
121353|NCT01264770|292417|P5|NOT COMPLETED|Overall Study||8
121354|NCT01264770|292418|P4|NOT COMPLETED|Overall Study||6
121355|NCT01264770|292419|P3|NOT COMPLETED|Overall Study||16
121356|NCT01264770|292420|P2|NOT COMPLETED|Overall Study||10
121357|NCT01264770|292421|P1|NOT COMPLETED|Overall Study||18
121358|NCT01264770|292416|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
121359|NCT01264770|292417|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
121360|NCT01264770|292418|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
121361|NCT01264770|292419|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
121362|NCT01264770|292420|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
121363|NCT01264770|292421|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
121364|NCT01264770|292416|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
121365|NCT01264770|292417|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
121366|NCT01264770|292418|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
121367|NCT01264770|292419|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
121368|NCT01264770|292420|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
121369|NCT01264770|292421|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
121370|NCT01264770|292416|P6|STARTED|Overall Study|Patients who received treatment|25
121371|NCT01264770|292417|P5|STARTED|Overall Study|Patients who received treatment|27
121372|NCT01264770|292418|P4|STARTED|Overall Study|Patients who received treatment|54
121373|NCT01264770|292419|P3|STARTED|Overall Study|Patients who received treatment|57
121374|NCT01264770|292420|P2|STARTED|Overall Study|Patients who received treatment|48
121375|NCT01264770|292421|P1|STARTED|Overall Study|Patients who received treatment|54
121376|NCT01264679|292505|P1|NOT COMPLETED|Overall Study||5
121377|NCT01264679|292505|P1|COMPLETED|Overall Study||3
121378|NCT01264679|292505|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
121379|NCT01264679|292505|P1|STARTED|Overall Study||8
121380|NCT01264614|292513|P2|NOT COMPLETED|Overall Study||2
121381|NCT01264614|292514|P1|NOT COMPLETED|Overall Study||1
121382|NCT01264614|292513|P2|COMPLETED|Overall Study||7
121383|NCT01264614|292514|P1|COMPLETED|Overall Study||12
121384|NCT01264614|292513|P2|STARTED|Overall Study||9
121385|NCT01264614|292514|P1|STARTED|Overall Study||13
121386|NCT01264601|292530|P2|NOT COMPLETED|Overall Study||0
121387|NCT01264601|292531|P1|NOT COMPLETED|Overall Study||0
121388|NCT01264601|292530|P2|COMPLETED|Overall Study||14
121389|NCT01264601|292531|P1|COMPLETED|Overall Study||17
121390|NCT01264601|292530|P2|STARTED|Overall Study||14
121391|NCT01264601|292531|P1|STARTED|Overall Study||17
121392|NCT01264380|292539|P3|NOT COMPLETED|Period C||14
121393|NCT01264380|292540|P2|NOT COMPLETED|Period C||0
121394|NCT01264380|292541|P1|NOT COMPLETED|Period C||0
121395|NCT01264380|292539|P3|COMPLETED|Period C||2
121396|NCT01264380|292540|P2|COMPLETED|Period C||0
121397|NCT01264380|292541|P1|COMPLETED|Period C||0
121398|NCT01264380|292539|P3|STARTED|Period C||16
121399|NCT01264380|292540|P2|STARTED|Period C||0
121400|NCT01264380|292541|P1|STARTED|Period C||0
121401|NCT01264380|292539|P3|NOT COMPLETED|Period B||0
121402|NCT01264380|292540|P2|NOT COMPLETED|Period B||0
121403|NCT01264380|292541|P1|NOT COMPLETED|Period B||0
121404|NCT01264380|292539|P3|COMPLETED|Period B||0
121405|NCT01264380|292540|P2|COMPLETED|Period B||8
121406|NCT01264380|292541|P1|COMPLETED|Period B||8
121407|NCT01264380|292539|P3|STARTED|Period B||0
121408|NCT01264380|292540|P2|STARTED|Period B||8
121409|NCT01264380|292541|P1|STARTED|Period B||8
121410|NCT01264380|292539|P3|NOT COMPLETED|Period A||0
121411|NCT01264380|292540|P2|NOT COMPLETED|Period A||0
121412|NCT01264380|292541|P1|NOT COMPLETED|Period A||0
121413|NCT01264380|292539|P3|COMPLETED|Period A||0
121414|NCT01264380|292540|P2|COMPLETED|Period A||8
121415|NCT01264380|292541|P1|COMPLETED|Period A||8
121416|NCT01264380|292539|P3|STARTED|Period A||0
121417|NCT01264380|292540|P2|STARTED|Period A||8
121418|NCT01264380|292541|P1|STARTED|Period A||8
121419|NCT01264081|292562|P1|NOT COMPLETED|Analysis||0
121420|NCT01264081|292562|P1|COMPLETED|Analysis||2
121421|NCT01264081|292562|P1|STARTED|Analysis||2
121422|NCT01264081|292562|P1|NOT COMPLETED|Started Treatment||2
121423|NCT01264081|292562|P1|COMPLETED|Started Treatment||2
121424|NCT01264081|292562|P1|STARTED|Started Treatment||4
121425|NCT01264081|292562|P1|NOT COMPLETED|Participants Screened||30
121426|NCT01264081|292562|P1|COMPLETED|Participants Screened||4
121427|NCT01264081|292562|P1|STARTED|Participants Screened||34
121428|NCT01264016|292567|P1|NOT COMPLETED|Overall Study||2
121429|NCT01264016|292567|P1|COMPLETED|Overall Study||94
121430|NCT01264016|292567|P1|STARTED|Overall Study||96
121431|NCT01263925|292575|P2|NOT COMPLETED|Overall Study||52
121432|NCT01263925|292576|P1|NOT COMPLETED|Overall Study||51
121433|NCT01263925|292575|P2|COMPLETED|Overall Study||233
121434|NCT01263925|292576|P1|COMPLETED|Overall Study||225
121435|NCT01263925|292575|P2|Full Analysis Set|Overall Study||272
121436|NCT01263925|292576|P1|Full Analysis Set|Overall Study||269
121437|NCT01263925|292575|P2|STARTED|Overall Study||285
121438|NCT01263925|292576|P1|STARTED|Overall Study||276
121439|NCT01263873|292610|P2|NOT COMPLETED|Overall Study||1
121440|NCT01263873|292611|P1|NOT COMPLETED|Overall Study||1
121441|NCT01263873|292610|P2|COMPLETED|Overall Study||29
121442|NCT01263873|292611|P1|COMPLETED|Overall Study||29
121443|NCT01263873|292610|P2|STARTED|Overall Study||30
121444|NCT01263873|292611|P1|STARTED|Overall Study||30
121445|NCT01263717|292623|P2|NOT COMPLETED|Overall Study||6
121446|NCT01263717|292624|P1|NOT COMPLETED|Overall Study||5
121447|NCT01263717|292623|P2|COMPLETED|Overall Study||20
121448|NCT01263717|292624|P1|COMPLETED|Overall Study||23
121449|NCT01263717|292623|P2|Baseline Visit|Overall Study||22
121450|NCT01263717|292624|P1|Baseline Visit|Overall Study||28
121451|NCT01263717|292623|P2|STARTED|Overall Study||26
121452|NCT01263717|292624|P1|STARTED|Overall Study||28
121453|NCT01263704|292652|P1|NOT COMPLETED|Overall Study||29
121454|NCT01263704|292652|P1|COMPLETED|Overall Study||13
121455|NCT01263704|292652|P1|STARTED|Overall Study||42
121456|NCT01263691|292667|P6|NOT COMPLETED|Overall Study||0
121457|NCT01263691|292668|P5|NOT COMPLETED|Overall Study||0
121458|NCT01263691|292669|P4|NOT COMPLETED|Overall Study||1
121459|NCT01263691|292670|P3|NOT COMPLETED|Overall Study||1
121460|NCT01263691|292671|P2|NOT COMPLETED|Overall Study||0
121461|NCT01263691|292672|P1|NOT COMPLETED|Overall Study||3
121462|NCT01263691|292667|P6|COMPLETED|Overall Study||15
121463|NCT01263691|292668|P5|COMPLETED|Overall Study||18
121464|NCT01263691|292669|P4|COMPLETED|Overall Study||18
121465|NCT01263691|292670|P3|COMPLETED|Overall Study||16
121466|NCT01263691|292671|P2|COMPLETED|Overall Study||18
121467|NCT01263691|292672|P1|COMPLETED|Overall Study||15
121468|NCT01263691|292667|P6|STARTED|Overall Study||15
121469|NCT01263691|292668|P5|STARTED|Overall Study||18
121470|NCT01263691|292669|P4|STARTED|Overall Study||19
121471|NCT01263691|292670|P3|STARTED|Overall Study||17
121472|NCT01263691|292671|P2|STARTED|Overall Study||18
121473|NCT01263691|292672|P1|STARTED|Overall Study||18
121474|NCT01263665|292782|P1|NOT COMPLETED|Overall Study||9
121475|NCT01263665|292782|P1|COMPLETED|Overall Study||62
121476|NCT01263665|292782|P1|STARTED|Overall Study||71
121477|NCT01263639|292789|P2|NOT COMPLETED|Overall Study||79
121478|NCT01263639|292790|P1|NOT COMPLETED|Overall Study||73
121479|NCT01263639|292789|P2|COMPLETED|Overall Study||42
121480|NCT01263639|292790|P1|COMPLETED|Overall Study||34
121481|NCT01263639|292789|P2|STARTED|Overall Study||121
121482|NCT01263639|292790|P1|STARTED|Overall Study||107
121483|NCT01263561|292798|P2|NOT COMPLETED|Overall Study||2
121484|NCT01263561|292799|P1|NOT COMPLETED|Overall Study||1
121485|NCT01263561|292798|P2|COMPLETED|Overall Study||31
121486|NCT01263561|292799|P1|COMPLETED|Overall Study||30
121487|NCT01263561|292798|P2|STARTED|Overall Study||33
121488|NCT01263561|292799|P1|STARTED|Overall Study||31
121489|NCT01263509|292811|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
121490|NCT01263509|292812|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
121491|NCT01263509|292813|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
121492|NCT01263509|292814|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
121493|NCT01263509|292811|P4|COMPLETED|Entered - Long-Term Extension Study||24
121494|NCT01263509|292812|P3|COMPLETED|Entered - Long-Term Extension Study||27
121495|NCT01263509|292813|P2|COMPLETED|Entered - Long-Term Extension Study||48
121496|NCT01263509|292814|P1|COMPLETED|Entered - Long-Term Extension Study||53
121497|NCT01263509|292811|P4|STARTED|Entered - Long-Term Extension Study||26
121498|NCT01263509|292812|P3|STARTED|Entered - Long-Term Extension Study||32
121499|NCT01263509|292813|P2|STARTED|Entered - Long-Term Extension Study||60
121500|NCT01263509|292814|P1|STARTED|Entered - Long-Term Extension Study||61
121501|NCT01263509|292811|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121502|NCT01263509|292812|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121503|NCT01263509|292813|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121504|NCT01263509|292814|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121505|NCT01263509|292811|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
121506|NCT01263509|292812|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
121507|NCT01263509|292813|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
121508|NCT01263509|292814|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
121509|NCT01263509|292811|P4|STARTED|Enrolled - Long-Term Extension Study||26
121510|NCT01263509|292812|P3|STARTED|Enrolled - Long-Term Extension Study||32
121511|NCT01263509|292813|P2|STARTED|Enrolled - Long-Term Extension Study||60
121512|NCT01263509|292814|P1|STARTED|Enrolled - Long-Term Extension Study||61
121513|NCT01263496|292943|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
121514|NCT01263496|292944|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
121515|NCT01263496|292945|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
121516|NCT01263496|292946|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
121517|NCT01263496|292947|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
121518|NCT01263496|292948|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
121519|NCT01263496|292949|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
121520|NCT01263496|292950|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
121521|NCT01263496|292951|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
121522|NCT01263496|292943|P9|COMPLETED|Entered - Long-Term Extension Study||15
121523|NCT01263496|292944|P8|COMPLETED|Entered - Long-Term Extension Study||16
121524|NCT01263496|292945|P7|COMPLETED|Entered - Long-Term Extension Study||16
121525|NCT01263496|292946|P6|COMPLETED|Entered - Long-Term Extension Study||16
121526|NCT01263496|292947|P5|COMPLETED|Entered - Long-Term Extension Study||61
121527|NCT01263496|292948|P4|COMPLETED|Entered - Long-Term Extension Study||68
121528|NCT01263496|292949|P3|COMPLETED|Entered - Long-Term Extension Study||62
121529|NCT01263496|292950|P2|COMPLETED|Entered - Long-Term Extension Study||59
121530|NCT01263496|292951|P1|COMPLETED|Entered - Long-Term Extension Study||62
121531|NCT01263496|292943|P9|STARTED|Entered - Long-Term Extension Study||18
121532|NCT01263496|292944|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
121533|NCT01263496|292945|P7|STARTED|Entered - Long-Term Extension Study||17
121534|NCT01263496|292946|P6|STARTED|Entered - Long-Term Extension Study||17
121535|NCT01263496|292947|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
121536|NCT01263496|292948|P4|STARTED|Entered - Long-Term Extension Study||74
121537|NCT01263496|292949|P3|STARTED|Entered - Long-Term Extension Study||72
121538|NCT01263496|292950|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
121539|NCT01263496|292951|P1|STARTED|Entered - Long-Term Extension Study||71
121540|NCT01263496|292943|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121541|NCT01263496|292944|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121542|NCT01263496|292945|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121543|NCT01263496|292946|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121544|NCT01263496|292947|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
121545|NCT01263496|292948|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
121546|NCT01263496|292949|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121547|NCT01263496|292950|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
121548|NCT01263496|292951|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
121549|NCT01263496|292943|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
121550|NCT01263496|292944|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
121551|NCT01263496|292945|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
121552|NCT01263496|292946|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
121553|NCT01263496|292947|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
121554|NCT01263496|292948|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
121555|NCT01263496|292949|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
121556|NCT01263496|292950|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
121557|NCT01263496|292951|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
121558|NCT01263496|292943|P9|STARTED|Enrolled - Long-Term Extension Study||18
121559|NCT01263496|292944|P8|STARTED|Enrolled - Long-Term Extension Study||18
121560|NCT01263496|292945|P7|STARTED|Enrolled - Long-Term Extension Study||17
121561|NCT01263496|292946|P6|STARTED|Enrolled - Long-Term Extension Study||17
121562|NCT01263496|292947|P5|STARTED|Enrolled - Long-Term Extension Study||74
121563|NCT01263496|292948|P4|STARTED|Enrolled - Long-Term Extension Study||75
121564|NCT01263496|292949|P3|STARTED|Enrolled - Long-Term Extension Study||72
121565|NCT01263496|292950|P2|STARTED|Enrolled - Long-Term Extension Study||75
121566|NCT01263496|292951|P1|STARTED|Enrolled - Long-Term Extension Study||72
121567|NCT01263483|293246|P3|NOT COMPLETED|Overall Study||5
121568|NCT01263483|293247|P2|NOT COMPLETED|Overall Study||2
121569|NCT01263483|293248|P1|NOT COMPLETED|Overall Study||7
121570|NCT01263483|293246|P3|COMPLETED|Overall Study||74
121571|NCT01263483|293247|P2|COMPLETED|Overall Study||74
121572|NCT01263483|293248|P1|COMPLETED|Overall Study||68
121573|NCT01263483|293246|P3|STARTED|Overall Study||79
121574|NCT01263483|293247|P2|STARTED|Overall Study||76
121575|NCT01263483|293248|P1|STARTED|Overall Study||75
121576|NCT01263470|293310|P6|NOT COMPLETED|Overall Study||5
121577|NCT01263470|293311|P5|NOT COMPLETED|Overall Study||3
121578|NCT01263470|293312|P4|NOT COMPLETED|Overall Study||3
121579|NCT01263470|293313|P3|NOT COMPLETED|Overall Study||4
121580|NCT01263470|293314|P2|NOT COMPLETED|Overall Study||5
121581|NCT01263470|293315|P1|NOT COMPLETED|Overall Study||2
121582|NCT01263470|293310|P6|COMPLETED|Overall Study||78
121583|NCT01263470|293311|P5|COMPLETED|Overall Study||76
121584|NCT01263470|293312|P4|COMPLETED|Overall Study||77
121585|NCT01263470|293313|P3|COMPLETED|Overall Study||80
121586|NCT01263470|293314|P2|COMPLETED|Overall Study||74
121587|NCT01263470|293315|P1|COMPLETED|Overall Study||73
121588|NCT01263470|293310|P6|STARTED|Overall Study||83
121589|NCT01263470|293311|P5|STARTED|Overall Study||79
121590|NCT01263470|293312|P4|STARTED|Overall Study||80
121591|NCT01263470|293313|P3|STARTED|Overall Study||84
121592|NCT01263470|293314|P2|STARTED|Overall Study||79
121593|NCT01263470|293315|P1|STARTED|Overall Study||75
121594|NCT01263444|293425|P1|NOT COMPLETED|Overall Study||10
121595|NCT01263444|293425|P1|COMPLETED|Overall Study||37
121596|NCT01263444|293425|P1|STARTED|Overall Study||47
121597|NCT01263301|293434|P2|NOT COMPLETED|Overall Study||0
121598|NCT01263301|293435|P1|NOT COMPLETED|Overall Study||0
121599|NCT01263301|293434|P2|COMPLETED|Overall Study||11
121600|NCT01263301|293435|P1|COMPLETED|Overall Study||5
121601|NCT01263301|293434|P2|STARTED|Overall Study||11
121602|NCT01263301|293435|P1|STARTED|Overall Study||5
121603|NCT01263132|293449|P2|NOT COMPLETED|Overall Study||0
121604|NCT01263132|293450|P1|NOT COMPLETED|Overall Study||0
121605|NCT01263132|293449|P2|COMPLETED|Overall Study||37
121606|NCT01263132|293450|P1|COMPLETED|Overall Study||38
121607|NCT01263132|293449|P2|STARTED|Overall Study||37
121608|NCT01263132|293450|P1|STARTED|Overall Study||38
121609|NCT01263054|293466|P2|NOT COMPLETED|Overall Study||6
121610|NCT01263054|293467|P1|NOT COMPLETED|Overall Study||5
121611|NCT01263054|293466|P2|COMPLETED|Overall Study||28
121612|NCT01263054|293467|P1|COMPLETED|Overall Study||24
121613|NCT01263054|293466|P2|STARTED|Overall Study||34
121614|NCT01263054|293467|P1|STARTED|Overall Study||29
121615|NCT01263028|293485|P1|NOT COMPLETED|Overall Study||6
121616|NCT01263028|293485|P1|COMPLETED|Overall Study||0
121617|NCT01263028|293485|P1|STARTED|Overall Study||6
121618|NCT01263015|293495|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
121619|NCT01263015|293496|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
121620|NCT01263015|293495|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
121621|NCT01263015|293496|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
121622|NCT01263015|293495|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
121623|NCT01263015|293496|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
121624|NCT01263015|293495|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
121625|NCT01263015|293496|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
121626|NCT01263015|293495|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
121627|NCT01263015|293496|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
121628|NCT01263015|293495|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
121629|NCT01263015|293496|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
121630|NCT01262989|293522|P2|NOT COMPLETED|Period 2||1
121631|NCT01262989|293523|P1|NOT COMPLETED|Period 2||0
121632|NCT01262989|293522|P2|COMPLETED|Period 2||16
121633|NCT01262989|293523|P1|COMPLETED|Period 2||19
121634|NCT01262989|293522|P2|STARTED|Period 2||17
121635|NCT01262989|293523|P1|STARTED|Period 2||19
121636|NCT01262989|293522|P2|NOT COMPLETED|7-Day Washout Period||0
121637|NCT01262989|293523|P1|NOT COMPLETED|7-Day Washout Period||0
121638|NCT01262989|293522|P2|COMPLETED|7-Day Washout Period||17
121639|NCT01262989|293523|P1|COMPLETED|7-Day Washout Period||19
121640|NCT01262989|293522|P2|STARTED|7-Day Washout Period||17
121641|NCT01262989|293523|P1|STARTED|7-Day Washout Period||19
121642|NCT01262989|293522|P2|NOT COMPLETED|Period 1||3
121643|NCT01262989|293523|P1|NOT COMPLETED|Period 1||1
121644|NCT01262989|293522|P2|COMPLETED|Period 1||17
121645|NCT01262989|293523|P1|COMPLETED|Period 1||19
121646|NCT01262989|293522|P2|STARTED|Period 1||20
121647|NCT01262989|293523|P1|STARTED|Period 1||20
121648|NCT01262898|293537|P4|NOT COMPLETED|Overall Study||0
121649|NCT01262898|293538|P3|NOT COMPLETED|Overall Study||0
121650|NCT01262898|293539|P2|NOT COMPLETED|Overall Study||2
121651|NCT01262898|293540|P1|NOT COMPLETED|Overall Study||3
121652|NCT01262898|293537|P4|COMPLETED|Overall Study||22
121653|NCT01262898|293538|P3|COMPLETED|Overall Study||18
121654|NCT01262898|293539|P2|COMPLETED|Overall Study||16
121655|NCT01262898|293540|P1|COMPLETED|Overall Study||18
121656|NCT01262898|293537|P4|STARTED|Overall Study||22
121657|NCT01262898|293538|P3|STARTED|Overall Study||18
121658|NCT01262898|293539|P2|STARTED|Overall Study||18
121659|NCT01262898|293540|P1|STARTED|Overall Study||21
121660|NCT01262872|293668|P8|NOT COMPLETED|Step 2||6
121661|NCT01262872|293669|P7|NOT COMPLETED|Step 2||9
121662|NCT01262872|293670|P6|NOT COMPLETED|Step 2||9
121663|NCT01262872|293671|P5|NOT COMPLETED|Step 2||5
121664|NCT01262872|293672|P4|NOT COMPLETED|Step 2||10
121665|NCT01262872|293673|P3|NOT COMPLETED|Step 2||9
121666|NCT01262872|293674|P2|NOT COMPLETED|Step 2||0
121667|NCT01262872|293675|P1|NOT COMPLETED|Step 2||0
121668|NCT01262872|293668|P8|COMPLETED|Step 2||194
121669|NCT01262872|293669|P7|COMPLETED|Step 2||191
121670|NCT01262872|293670|P6|COMPLETED|Step 2||191
121671|NCT01262872|293671|P5|COMPLETED|Step 2||195
121672|NCT01262872|293672|P4|COMPLETED|Step 2||190
121673|NCT01262872|293673|P3|COMPLETED|Step 2||191
121674|NCT01262872|293674|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121675|NCT01262872|293675|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121676|NCT01262872|293668|P8|STARTED|Step 2||200
121677|NCT01262872|293669|P7|STARTED|Step 2||200
121678|NCT01262872|293670|P6|STARTED|Step 2||200
121679|NCT01262872|293671|P5|STARTED|Step 2||200
121680|NCT01262872|293672|P4|STARTED|Step 2||200
121681|NCT01262872|293673|P3|STARTED|Step 2||200
121682|NCT01262872|293674|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121683|NCT01262872|293675|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121684|NCT01262872|293668|P8|NOT COMPLETED|Step 1||0
121685|NCT01262872|293669|P7|NOT COMPLETED|Step 1||0
121686|NCT01262872|293670|P6|NOT COMPLETED|Step 1||0
121687|NCT01262872|293671|P5|NOT COMPLETED|Step 1||0
121688|NCT01262872|293672|P4|NOT COMPLETED|Step 1||0
121689|NCT01262872|293673|P3|NOT COMPLETED|Step 1||0
121690|NCT01262872|293674|P2|NOT COMPLETED|Step 1||0
121691|NCT01262872|293675|P1|NOT COMPLETED|Step 1||0
121692|NCT01262872|293668|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121693|NCT01262872|293669|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121694|NCT01262872|293670|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121695|NCT01262872|293671|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121696|NCT01262872|293672|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
121697|NCT01262872|293673|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121698|NCT01262872|293674|P2|COMPLETED|Step 1||60
121699|NCT01262872|293675|P1|COMPLETED|Step 1||60
121700|NCT01262872|293668|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121701|NCT01262872|293669|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121702|NCT01262872|293670|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121703|NCT01262872|293671|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121704|NCT01262872|293672|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121705|NCT01262872|293673|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
121706|NCT01262872|293674|P2|STARTED|Step 1||60
121707|NCT01262872|293675|P1|STARTED|Step 1||60
121708|NCT01262846|293930|P2|NOT COMPLETED|Overall Study||3
121709|NCT01262846|293931|P1|NOT COMPLETED|Overall Study||2
121710|NCT01262846|293930|P2|COMPLETED|Overall Study||97
121711|NCT01262846|293931|P1|COMPLETED|Overall Study||93
121712|NCT01262846|293930|P2|STARTED|Overall Study||100
121713|NCT01262846|293931|P1|STARTED|Overall Study||95
121714|NCT01262820|293937|P1|NOT COMPLETED|Overall Study||15
121715|NCT01262820|293937|P1|COMPLETED|Overall Study||0
121716|NCT01262820|293937|P1|STARTED|Overall Study||15
121717|NCT01262755|293944|P1|NOT COMPLETED|Overall Study||0
121718|NCT01262755|293944|P1|COMPLETED|Overall Study||450
121719|NCT01262755|293944|P1|STARTED|Overall Study||450
121720|NCT01262651|293950|P2|NOT COMPLETED|Overall Study||48
121721|NCT01262651|293951|P1|NOT COMPLETED|Overall Study||58
121722|NCT01262651|293950|P2|COMPLETED|Overall Study||150
121723|NCT01262651|293951|P1|COMPLETED|Overall Study||141
121724|NCT01262651|293950|P2|ITT Population|Overall Study||198
121725|NCT01262651|293951|P1|ITT Population|Overall Study||199
121726|NCT01262651|293950|P2|Safety Population|Overall Study||198
121727|NCT01262651|293951|P1|Safety Population|Overall Study||199
121728|NCT01262651|293950|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
121729|NCT01262651|293951|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
121730|NCT01262651|293950|P2|STARTED|Overall Study||198
121731|NCT01262651|293951|P1|STARTED|Overall Study||199
121732|NCT01262599|293979|P2|NOT COMPLETED|Overall Study||0
121733|NCT01262599|293980|P1|NOT COMPLETED|Overall Study||0
121734|NCT01262599|293979|P2|COMPLETED|Overall Study||16
121735|NCT01262599|293980|P1|COMPLETED|Overall Study||16
121736|NCT01262599|293979|P2|STARTED|Overall Study||16
121737|NCT01262599|293980|P1|STARTED|Overall Study||16
121738|NCT01262573|293988|P2|NOT COMPLETED|Overall Study||1
121739|NCT01262573|293989|P1|NOT COMPLETED|Overall Study||0
121740|NCT01262573|293988|P2|COMPLETED|Overall Study||31
121741|NCT01262573|293989|P1|COMPLETED|Overall Study||32
121742|NCT01262573|293988|P2|STARTED|Overall Study||32
121743|NCT01262573|293989|P1|STARTED|Overall Study||32
121744|NCT01262560|294000|P3|NOT COMPLETED|Overall Study||2
121745|NCT01262560|294001|P2|NOT COMPLETED|Overall Study||1
121746|NCT01262560|294002|P1|NOT COMPLETED|Overall Study||0
121747|NCT01262560|294000|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
121748|NCT01262560|294001|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
121749|NCT01262560|294002|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
121750|NCT01262560|294000|P3|STARTED|Overall Study||56
121751|NCT01262560|294001|P2|STARTED|Overall Study||54
121752|NCT01262560|294002|P1|STARTED|Overall Study||53
121753|NCT01262547|294037|P1|NOT COMPLETED|Overall Study||0
121754|NCT01262547|294037|P1|COMPLETED|Overall Study||3
121755|NCT01262547|294037|P1|STARTED|Overall Study||3
121756|NCT01262456|294051|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
121757|NCT01262456|294052|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
121758|NCT01262456|294053|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
121759|NCT01262456|294051|P3|COMPLETED|1-Month Open-Label Extension Period||98
121760|NCT01262456|294052|P2|COMPLETED|1-Month Open-Label Extension Period||97
121761|NCT01262456|294053|P1|COMPLETED|1-Month Open-Label Extension Period||120
121762|NCT01262456|294051|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
121763|NCT01262456|294052|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
121764|NCT01262456|294053|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
121765|NCT01262456|294051|P3|STARTED|1-Month Open-Label Extension Period||103
121766|NCT01262456|294052|P2|STARTED|1-Month Open-Label Extension Period||100
121767|NCT01262456|294053|P1|STARTED|1-Month Open-Label Extension Period||124
121768|NCT01262456|294051|P3|NOT COMPLETED|3-Month Double-Blind Period||26
121769|NCT01262456|294052|P2|NOT COMPLETED|3-Month Double-Blind Period||23
121770|NCT01262456|294053|P1|NOT COMPLETED|3-Month Double-Blind Period||19
121771|NCT01262456|294051|P3|COMPLETED|3-Month Double-Blind Period||103
121772|NCT01262456|294052|P2|COMPLETED|3-Month Double-Blind Period||100
121773|NCT01262456|294053|P1|COMPLETED|3-Month Double-Blind Period||124
121774|NCT01262456|294051|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
121775|NCT01262456|294052|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
121776|NCT01262456|294053|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
121777|NCT01262456|294051|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
121778|NCT01262456|294052|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
121779|NCT01262456|294053|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
121780|NCT01262456|294051|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
121781|NCT01262456|294052|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
121782|NCT01262456|294053|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
121783|NCT01262352|294096|P2|NOT COMPLETED|Period 2||0
121784|NCT01262352|294097|P1|NOT COMPLETED|Period 2||0
121785|NCT01262352|294096|P2|COMPLETED|Period 2||8
121786|NCT01262352|294097|P1|COMPLETED|Period 2||9
121787|NCT01262352|294096|P2|Dosed|Period 2||8
121788|NCT01262352|294097|P1|Dosed|Period 2||9
121789|NCT01262352|294096|P2|STARTED|Period 2||8
121790|NCT01262352|294097|P1|STARTED|Period 2||9
121791|NCT01262352|294096|P2|NOT COMPLETED|Washout||2
121792|NCT01262352|294097|P1|NOT COMPLETED|Washout||1
121793|NCT01262352|294096|P2|COMPLETED|Washout||8
121794|NCT01262352|294097|P1|COMPLETED|Washout||9
121795|NCT01262352|294096|P2|STARTED|Washout||10
121796|NCT01262352|294097|P1|STARTED|Washout||10
121797|NCT01262352|294096|P2|NOT COMPLETED|Period 1||0
121798|NCT01262352|294097|P1|NOT COMPLETED|Period 1||1
121799|NCT01262352|294096|P2|COMPLETED|Period 1||10
121800|NCT01262352|294097|P1|COMPLETED|Period 1||10
121801|NCT01262352|294096|P2|Dosed|Period 1||10
121802|NCT01262352|294097|P1|Dosed|Period 1||10
121803|NCT01262352|294096|P2|STARTED|Period 1||10
121804|NCT01262352|294097|P1|STARTED|Period 1||11
121805|NCT01262339|294109|P1|NOT COMPLETED|Overall Study||0
121806|NCT01262339|294109|P1|COMPLETED|Overall Study||2
121807|NCT01262339|294109|P1|STARTED|Overall Study||2
121808|NCT01262287|294115|P2|NOT COMPLETED|Overall Study||1
121809|NCT01262287|294116|P1|NOT COMPLETED|Overall Study||2
121810|NCT01262287|294115|P2|COMPLETED|Overall Study||18
121811|NCT01262287|294116|P1|COMPLETED|Overall Study||18
121812|NCT01262287|294115|P2|STARTED|Overall Study||19
121813|NCT01262287|294116|P1|STARTED|Overall Study||20
121814|NCT01262131|294129|P3|NOT COMPLETED|Overall Study||0
121815|NCT01262131|294130|P2|NOT COMPLETED|Overall Study||0
121816|NCT01262131|294131|P1|NOT COMPLETED|Overall Study||0
121817|NCT01262131|294129|P3|COMPLETED|Overall Study||4
121818|NCT01262131|294130|P2|COMPLETED|Overall Study||4
121819|NCT01262131|294131|P1|COMPLETED|Overall Study||5
121820|NCT01262131|294129|P3|STARTED|Overall Study||4
121821|NCT01262131|294130|P2|STARTED|Overall Study||4
121822|NCT01262131|294131|P1|STARTED|Overall Study||5
121823|NCT01262118|294141|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
121824|NCT01262118|294142|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
121825|NCT01262118|294141|P2|COMPLETED|Treatment Period (6 Weeks)||0
121826|NCT01262118|294142|P1|COMPLETED|Treatment Period (6 Weeks)||36
121827|NCT01262118|294141|P2|STARTED|Treatment Period (6 Weeks)||0
121828|NCT01262118|294142|P1|STARTED|Treatment Period (6 Weeks)||36
121829|NCT01262118|294141|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
121830|NCT01262118|294142|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
121831|NCT01262118|294141|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
121832|NCT01262118|294142|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
121833|NCT01262118|294141|P2|STARTED|Baseline Assessment Period (3 Days)||33
121834|NCT01262118|294142|P1|STARTED|Baseline Assessment Period (3 Days)||36
121835|NCT01262105|294168|P2|NOT COMPLETED|Overall Study||0
121836|NCT01262105|294169|P1|NOT COMPLETED|Overall Study||0
121837|NCT01262105|294168|P2|COMPLETED|Overall Study||10
121838|NCT01262105|294169|P1|COMPLETED|Overall Study||13
121839|NCT01262105|294168|P2|STARTED|Overall Study||10
121840|NCT01262105|294169|P1|STARTED|Overall Study||13
121841|NCT01262092|294177|P2|NOT COMPLETED|Gabapentin Taper||0
121842|NCT01262092|294178|P1|NOT COMPLETED|Gabapentin Taper||1
121843|NCT01262092|294177|P2|COMPLETED|Gabapentin Taper||11
121844|NCT01262092|294178|P1|COMPLETED|Gabapentin Taper||9
121845|NCT01262092|294177|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
121846|NCT01262092|294178|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
121847|NCT01262092|294177|P2|NOT COMPLETED|Buprenorphine Taper||1
121848|NCT01262092|294178|P1|NOT COMPLETED|Buprenorphine Taper||1
121849|NCT01262092|294177|P2|COMPLETED|Buprenorphine Taper||12
121850|NCT01262092|294178|P1|COMPLETED|Buprenorphine Taper||11
121851|NCT01262092|294177|P2|STARTED|Buprenorphine Taper||13
121852|NCT01262092|294178|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
121853|NCT01262092|294177|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
121854|NCT01262092|294178|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
121855|NCT01262092|294177|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
121856|NCT01262092|294178|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
121857|NCT01262092|294177|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
121858|NCT01262092|294178|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
121859|NCT01262027|294184|P1|NOT COMPLETED|Overall Study||5
121860|NCT01262027|294184|P1|COMPLETED|Overall Study||17
121861|NCT01262027|294184|P1|STARTED|Overall Study||22
121862|NCT01261975|294189|P1|NOT COMPLETED|Overall Study||1
121863|NCT01261975|294189|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
121864|NCT01261975|294189|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
121865|NCT01261780|294210|P2|NOT COMPLETED|Overall Study||2
121866|NCT01261780|294211|P1|NOT COMPLETED|Overall Study||2
121867|NCT01261780|294210|P2|COMPLETED|Overall Study||5
121868|NCT01261780|294211|P1|COMPLETED|Overall Study||5
121869|NCT01261780|294210|P2|STARTED|Overall Study||7
121870|NCT01261780|294211|P1|STARTED|Overall Study||7
121871|NCT01261624|294221|P2|NOT COMPLETED|Week 13 to Week 24||1
121872|NCT01261624|294222|P1|NOT COMPLETED|Week 13 to Week 24||0
121873|NCT01261624|294221|P2|COMPLETED|Week 13 to Week 24||10
121874|NCT01261624|294222|P1|COMPLETED|Week 13 to Week 24||1
121875|NCT01261624|294221|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
121876|NCT01261624|294222|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
121877|NCT01261624|294221|P2|NOT COMPLETED|Week 0 to Week 12||3
121878|NCT01261624|294222|P1|NOT COMPLETED|Week 0 to Week 12||1
121879|NCT01261624|294221|P2|COMPLETED|Week 0 to Week 12||3
121880|NCT01261624|294222|P1|COMPLETED|Week 0 to Week 12||9
121881|NCT01261624|294221|P2|STARTED|Week 0 to Week 12||6
121882|NCT01261624|294222|P1|STARTED|Week 0 to Week 12||10
121883|NCT01261559|294241|P2|NOT COMPLETED|Overall Study||0
121884|NCT01261559|294242|P1|NOT COMPLETED|Overall Study||0
121885|NCT01261559|294241|P2|COMPLETED|Overall Study||36
121886|NCT01261559|294242|P1|COMPLETED|Overall Study||36
121887|NCT01261559|294241|P2|STARTED|Overall Study||36
121888|NCT01261559|294242|P1|STARTED|Overall Study||36
121889|NCT01261507|294250|P1|NOT COMPLETED|Overall Study||0
121890|NCT01261507|294250|P1|COMPLETED|Overall Study||15
121891|NCT01261507|294250|P1|STARTED|Overall Study||15
121892|NCT01261390|294263|P4|NOT COMPLETED|Overall Study||8
121893|NCT01261390|294264|P3|NOT COMPLETED|Overall Study||7
121894|NCT01261390|294265|P2|NOT COMPLETED|Overall Study||9
121895|NCT01261390|294266|P1|NOT COMPLETED|Overall Study||7
121896|NCT01261390|294263|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
121897|NCT01261390|294264|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
121898|NCT01261390|294265|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
121899|NCT01261390|294266|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
121900|NCT01261390|294263|P4|12-Month Visit|Overall Study||19
121901|NCT01261390|294264|P3|12-Month Visit|Overall Study||19
121902|NCT01261390|294265|P2|12-Month Visit|Overall Study||21
121903|NCT01261390|294266|P1|12-Month Visit|Overall Study||23
121904|NCT01261390|294263|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
121905|NCT01261390|294264|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
121906|NCT01261390|294265|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
121907|NCT01261390|294266|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
121908|NCT01261390|294263|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
121909|NCT01261390|294264|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
121910|NCT01261390|294265|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
121911|NCT01261390|294266|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
121912|NCT01261325|294431|P3|NOT COMPLETED|Overall Study||26
121913|NCT01261325|294432|P2|NOT COMPLETED|Overall Study||29
121914|NCT01261325|294433|P1|NOT COMPLETED|Overall Study||17
121915|NCT01261325|294431|P3|COMPLETED|Overall Study||225
121916|NCT01261325|294432|P2|COMPLETED|Overall Study||225
121917|NCT01261325|294433|P1|COMPLETED|Overall Study||246
121918|NCT01261325|294431|P3|STARTED|Overall Study||251
121919|NCT01261325|294432|P2|STARTED|Overall Study||254
121920|NCT01261325|294433|P1|STARTED|Overall Study||263
121921|NCT01261247|294465|P1|NOT COMPLETED|Overall Study||2
121922|NCT01261247|294465|P1|COMPLETED|Overall Study||39
121923|NCT01261247|294465|P1|STARTED|Overall Study||41
121924|NCT01261052|294472|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
121925|NCT01261052|294472|P1|COMPLETED|APD Only Intervention (33 Hours)||14
121926|NCT01261052|294472|P1|STARTED|APD Only Intervention (33 Hours)||14
121927|NCT01261052|294472|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
121928|NCT01261052|294472|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
121929|NCT01261052|294472|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
121930|NCT01261000|294478|P1|NOT COMPLETED|Overall Study||1
121931|NCT01261000|294478|P1|COMPLETED|Overall Study||7
121932|NCT01261000|294478|P1|STARTED|Overall Study||8
121933|NCT01260948|294484|P2|NOT COMPLETED|Second Intervention||1
121934|NCT01260948|294485|P1|NOT COMPLETED|Second Intervention||0
121935|NCT01260948|294484|P2|COMPLETED|Second Intervention||9
121936|NCT01260948|294485|P1|COMPLETED|Second Intervention||12
121937|NCT01260948|294484|P2|STARTED|Second Intervention||10
121938|NCT01260948|294485|P1|STARTED|Second Intervention||12
121939|NCT01260948|294484|P2|NOT COMPLETED|Washout of 28 Days||3
121940|NCT01260948|294485|P1|NOT COMPLETED|Washout of 28 Days||1
121941|NCT01260948|294484|P2|COMPLETED|Washout of 28 Days||10
121942|NCT01260948|294485|P1|COMPLETED|Washout of 28 Days||12
121943|NCT01260948|294484|P2|STARTED|Washout of 28 Days||13
121944|NCT01260948|294485|P1|STARTED|Washout of 28 Days||13
121945|NCT01260948|294484|P2|NOT COMPLETED|First Intervention||0
121946|NCT01260948|294485|P1|NOT COMPLETED|First Intervention||0
121947|NCT01260948|294484|P2|COMPLETED|First Intervention||13
121948|NCT01260948|294485|P1|COMPLETED|First Intervention||13
121949|NCT01260948|294484|P2|STARTED|First Intervention||13
121950|NCT01260948|294485|P1|STARTED|First Intervention||13
121951|NCT01260922|294495|P2|NOT COMPLETED|Second Intervention||2
121952|NCT01260922|294496|P1|NOT COMPLETED|Second Intervention||0
121953|NCT01260922|294495|P2|COMPLETED|Second Intervention||8
121954|NCT01260922|294496|P1|COMPLETED|Second Intervention||9
121955|NCT01260922|294495|P2|STARTED|Second Intervention||10
121956|NCT01260922|294496|P1|STARTED|Second Intervention||9
121957|NCT01260922|294495|P2|NOT COMPLETED|Washout of 28 Days||2
121958|NCT01260922|294496|P1|NOT COMPLETED|Washout of 28 Days||4
121959|NCT01260922|294495|P2|COMPLETED|Washout of 28 Days||10
121960|NCT01260922|294496|P1|COMPLETED|Washout of 28 Days||9
121961|NCT01260922|294495|P2|STARTED|Washout of 28 Days||12
121962|NCT01260922|294496|P1|STARTED|Washout of 28 Days||13
121963|NCT01260922|294495|P2|NOT COMPLETED|First Intervention||1
121964|NCT01260922|294496|P1|NOT COMPLETED|First Intervention||0
121965|NCT01260922|294495|P2|COMPLETED|First Intervention||12
121966|NCT01260922|294496|P1|COMPLETED|First Intervention||13
121967|NCT01260922|294495|P2|STARTED|First Intervention||13
121968|NCT01260922|294496|P1|STARTED|First Intervention||13
121969|NCT01260896|294506|P2|NOT COMPLETED|Second Intervention||0
121970|NCT01260896|294507|P1|NOT COMPLETED|Second Intervention||0
121971|NCT01260896|294506|P2|COMPLETED|Second Intervention||12
121972|NCT01260896|294507|P1|COMPLETED|Second Intervention||10
121973|NCT01260896|294506|P2|STARTED|Second Intervention||12
121974|NCT01260896|294507|P1|STARTED|Second Intervention||10
121975|NCT01260896|294506|P2|NOT COMPLETED|Washout of 7 Days||0
121976|NCT01260896|294507|P1|NOT COMPLETED|Washout of 7 Days||0
121977|NCT01260896|294506|P2|COMPLETED|Washout of 7 Days||12
121978|NCT01260896|294507|P1|COMPLETED|Washout of 7 Days||10
121979|NCT01260896|294506|P2|STARTED|Washout of 7 Days||12
121980|NCT01260896|294507|P1|STARTED|Washout of 7 Days||10
121981|NCT01260896|294506|P2|NOT COMPLETED|First Intervention||0
121982|NCT01260896|294507|P1|NOT COMPLETED|First Intervention||2
121983|NCT01260896|294506|P2|COMPLETED|First Intervention||12
121984|NCT01260896|294507|P1|COMPLETED|First Intervention||10
121985|NCT01260896|294506|P2|STARTED|First Intervention||12
121986|NCT01260896|294507|P1|STARTED|First Intervention||12
121987|NCT01260883|294526|P3|NOT COMPLETED|Overall Study||0
121988|NCT01260883|294527|P2|NOT COMPLETED|Overall Study||0
121989|NCT01260883|294528|P1|NOT COMPLETED|Overall Study||0
121990|NCT01260883|294526|P3|COMPLETED|Overall Study||18
121991|NCT01260883|294527|P2|COMPLETED|Overall Study||11
121992|NCT01260883|294528|P1|COMPLETED|Overall Study||22
121993|NCT01260883|294526|P3|STARTED|Overall Study||18
121994|NCT01260883|294527|P2|STARTED|Overall Study||11
121995|NCT01260883|294528|P1|STARTED|Overall Study||22
121996|NCT01260701|294565|P1|NOT COMPLETED|Overall Study||75
121997|NCT01260701|294565|P1|COMPLETED|Overall Study||0
121998|NCT01260701|294565|P1|Eligible and Began Protocol Therapy|Overall Study||70
121999|NCT01260701|294565|P1|Eligible|Overall Study||71
122000|NCT01260701|294565|P1|STARTED|Overall Study||75
122001|NCT01260688|294574|P2|NOT COMPLETED|Overall Study||0
122002|NCT01260688|294575|P1|NOT COMPLETED|Overall Study||0
122003|NCT01260688|294574|P2|COMPLETED|Overall Study||11
122004|NCT01260688|294575|P1|COMPLETED|Overall Study||11
122005|NCT01260688|294574|P2|STARTED|Overall Study||11
122006|NCT01260688|294575|P1|STARTED|Overall Study||11
122007|NCT01260662|294612|P3|NOT COMPLETED|Overall Study||0
122008|NCT01260662|294613|P2|NOT COMPLETED|Overall Study||0
122009|NCT01260662|294614|P1|NOT COMPLETED|Overall Study||0
122010|NCT01260662|294612|P3|COMPLETED|Overall Study||96
122011|NCT01260662|294613|P2|COMPLETED|Overall Study||85
122012|NCT01260662|294614|P1|COMPLETED|Overall Study||90
122013|NCT01260662|294612|P3|STARTED|Overall Study||96
122014|NCT01260662|294613|P2|STARTED|Overall Study||85
122015|NCT01260662|294614|P1|STARTED|Overall Study||90
122016|NCT01260649|294633|P2|NOT COMPLETED|Overall Study||1
122017|NCT01260649|294634|P1|NOT COMPLETED|Overall Study||2
122018|NCT01260649|294633|P2|COMPLETED|Overall Study||8
122019|NCT01260649|294634|P1|COMPLETED|Overall Study||6
122020|NCT01260649|294633|P2|STARTED|Overall Study||9
122021|NCT01260649|294634|P1|STARTED|Overall Study||8
122022|NCT01260584|294646|P4|NOT COMPLETED|Period 2||1
122023|NCT01260584|294647|P3|NOT COMPLETED|Period 2||5
122024|NCT01260584|294648|P2|NOT COMPLETED|Period 2||3
122025|NCT01260584|294649|P1|NOT COMPLETED|Period 2||1
122026|NCT01260584|294646|P4|COMPLETED|Period 2||26
122027|NCT01260584|294647|P3|COMPLETED|Period 2||20
122028|NCT01260584|294648|P2|COMPLETED|Period 2||25
122029|NCT01260584|294649|P1|COMPLETED|Period 2||26
122030|NCT01260584|294646|P4|STARTED|Period 2||27
122031|NCT01260584|294647|P3|STARTED|Period 2||25
122032|NCT01260584|294648|P2|STARTED|Period 2||28
122033|NCT01260584|294649|P1|STARTED|Period 2||27
122034|NCT01260584|294646|P4|NOT COMPLETED|Period 1||1
122035|NCT01260584|294647|P3|NOT COMPLETED|Period 1||2
122036|NCT01260584|294648|P2|NOT COMPLETED|Period 1||0
122037|NCT01260584|294649|P1|NOT COMPLETED|Period 1||0
122038|NCT01260584|294646|P4|COMPLETED|Period 1||27
122039|NCT01260584|294647|P3|COMPLETED|Period 1||25
122040|NCT01260584|294648|P2|COMPLETED|Period 1||28
122041|NCT01260584|294649|P1|COMPLETED|Period 1||27
122042|NCT01260584|294646|P4|STARTED|Period 1||28
122043|NCT01260584|294647|P3|STARTED|Period 1||27
122044|NCT01260584|294648|P2|STARTED|Period 1||28
122045|NCT01260584|294649|P1|STARTED|Period 1||27
122046|NCT01260493|294685|P2|NOT COMPLETED|Overall Study||4
122047|NCT01260493|294686|P1|NOT COMPLETED|Overall Study||16
122048|NCT01260493|294685|P2|COMPLETED|Overall Study||85
122049|NCT01260493|294686|P1|COMPLETED|Overall Study||76
122050|NCT01260493|294685|P2|STARTED|Overall Study||89
122051|NCT01260493|294686|P1|STARTED|Overall Study||92
122052|NCT01260467|294692|P1|NOT COMPLETED|Overall Study||2
122053|NCT01260467|294692|P1|COMPLETED|Overall Study||2
122054|NCT01260467|294692|P1|STARTED|Overall Study||4
122055|NCT01260454|294698|P1|NOT COMPLETED|Overall Study||0
122056|NCT01260454|294698|P1|COMPLETED|Overall Study||6
122057|NCT01260454|294698|P1|STARTED|Overall Study||6
122058|NCT01260350|294724|P22|NOT COMPLETED|Overall Study||0
122059|NCT01260350|294725|P21|NOT COMPLETED|Overall Study||3
122060|NCT01260350|294726|P20|NOT COMPLETED|Overall Study||0
122061|NCT01260350|294727|P19|NOT COMPLETED|Overall Study||0
122062|NCT01260350|294728|P18|NOT COMPLETED|Overall Study||1
122063|NCT01260350|294729|P17|NOT COMPLETED|Overall Study||0
122064|NCT01260350|294730|P16|NOT COMPLETED|Overall Study||0
122065|NCT01260350|294731|P15|NOT COMPLETED|Overall Study||0
122066|NCT01260350|294732|P14|NOT COMPLETED|Overall Study||0
122067|NCT01260350|294733|P13|NOT COMPLETED|Overall Study||0
122068|NCT01260350|294734|P12|NOT COMPLETED|Overall Study||0
122069|NCT01260350|294735|P11|NOT COMPLETED|Overall Study||0
122070|NCT01260350|294736|P10|NOT COMPLETED|Overall Study||0
122071|NCT01260350|294737|P9|NOT COMPLETED|Overall Study||1
122072|NCT01260350|294738|P8|NOT COMPLETED|Overall Study||0
122073|NCT01260350|294739|P7|NOT COMPLETED|Overall Study||0
122074|NCT01260350|294740|P6|NOT COMPLETED|Overall Study||0
122075|NCT01260350|294741|P5|NOT COMPLETED|Overall Study||0
122076|NCT01260350|294742|P4|NOT COMPLETED|Overall Study||0
122077|NCT01260350|294743|P3|NOT COMPLETED|Overall Study||0
122078|NCT01260350|294744|P2|NOT COMPLETED|Overall Study||0
122079|NCT01260350|294745|P1|NOT COMPLETED|Overall Study||0
122080|NCT01260350|294724|P22|COMPLETED|Overall Study||0
122081|NCT01260350|294725|P21|COMPLETED|Overall Study||22
122082|NCT01260350|294726|P20|COMPLETED|Overall Study||14
122083|NCT01260350|294727|P19|COMPLETED|Overall Study||0
122084|NCT01260350|294728|P18|COMPLETED|Overall Study||9
122085|NCT01260350|294729|P17|COMPLETED|Overall Study||9
122086|NCT01260350|294730|P16|COMPLETED|Overall Study||10
122087|NCT01260350|294731|P15|COMPLETED|Overall Study||25
122088|NCT01260350|294732|P14|COMPLETED|Overall Study||10
122089|NCT01260350|294733|P13|COMPLETED|Overall Study||25
122090|NCT01260350|294734|P12|COMPLETED|Overall Study||9
122091|NCT01260350|294735|P11|COMPLETED|Overall Study||10
122092|NCT01260350|294736|P10|COMPLETED|Overall Study||25
122093|NCT01260350|294737|P9|COMPLETED|Overall Study||24
122094|NCT01260350|294738|P8|COMPLETED|Overall Study||25
122095|NCT01260350|294739|P7|COMPLETED|Overall Study||10
122096|NCT01260350|294740|P6|COMPLETED|Overall Study||10
122097|NCT01260350|294741|P5|COMPLETED|Overall Study||10
122098|NCT01260350|294742|P4|COMPLETED|Overall Study||11
122099|NCT01260350|294743|P3|COMPLETED|Overall Study||10
122100|NCT01260350|294744|P2|COMPLETED|Overall Study||9
122101|NCT01260350|294745|P1|COMPLETED|Overall Study||10
122102|NCT01260350|294724|P22|STARTED|Overall Study||0
122103|NCT01260350|294725|P21|STARTED|Overall Study||25
122104|NCT01260350|294726|P20|STARTED|Overall Study||14
122105|NCT01260350|294727|P19|STARTED|Overall Study||0
122106|NCT01260350|294728|P18|STARTED|Overall Study||10
122107|NCT01260350|294729|P17|STARTED|Overall Study||9
122108|NCT01260350|294730|P16|STARTED|Overall Study||10
122109|NCT01260350|294731|P15|STARTED|Overall Study||25
122110|NCT01260350|294732|P14|STARTED|Overall Study||10
122111|NCT01260350|294733|P13|STARTED|Overall Study||25
122112|NCT01260350|294734|P12|STARTED|Overall Study||9
122113|NCT01260350|294735|P11|STARTED|Overall Study||10
122114|NCT01260350|294736|P10|STARTED|Overall Study||25
122115|NCT01260350|294737|P9|STARTED|Overall Study||25
122116|NCT01260350|294738|P8|STARTED|Overall Study||25
122117|NCT01260350|294739|P7|STARTED|Overall Study||10
122118|NCT01260350|294740|P6|STARTED|Overall Study||10
122119|NCT01260350|294741|P5|STARTED|Overall Study||10
122120|NCT01260350|294742|P4|STARTED|Overall Study||11
122121|NCT01260350|294743|P3|STARTED|Overall Study||10
122122|NCT01260350|294744|P2|STARTED|Overall Study||9
122123|NCT01260350|294745|P1|STARTED|Overall Study||10
122124|NCT01260324|294937|P2|NOT COMPLETED|Overall Study||0
122125|NCT01260324|294938|P1|NOT COMPLETED|Overall Study||0
122126|NCT01260324|294937|P2|COMPLETED|Overall Study||20000
122127|NCT01260324|294938|P1|COMPLETED|Overall Study||1283
122128|NCT01260324|294937|P2|STARTED|Overall Study||20000
122129|NCT01260324|294938|P1|STARTED|Overall Study||1283
122130|NCT01260311|294952|P1|NOT COMPLETED|Overall Study||127
122131|NCT01260311|294952|P1|COMPLETED|Overall Study||381
122132|NCT01260311|294952|P1|STARTED|Overall Study||508
122133|NCT01260272|294962|P2|NOT COMPLETED|Overall Study||2
122134|NCT01260272|294963|P1|NOT COMPLETED|Overall Study||2
122135|NCT01260272|294962|P2|COMPLETED|Overall Study||30
122136|NCT01260272|294963|P1|COMPLETED|Overall Study||15
122137|NCT01260272|294962|P2|STARTED|Overall Study||32
122138|NCT01260272|294963|P1|STARTED|Overall Study||17
122139|NCT01260194|294983|P1|NOT COMPLETED|Overall Study||1
122140|NCT01260194|294983|P1|COMPLETED|Overall Study||3
122141|NCT01260194|294983|P1|STARTED|Overall Study||4
122142|NCT01260142|295001|P6|NOT COMPLETED|Treatment Period 2||0
122143|NCT01260142|295002|P5|NOT COMPLETED|Treatment Period 2||0
122144|NCT01260142|295003|P4|NOT COMPLETED|Treatment Period 2||0
122145|NCT01260142|295004|P3|NOT COMPLETED|Treatment Period 2||0
122146|NCT01260142|295005|P2|NOT COMPLETED|Treatment Period 2||0
122147|NCT01260142|295006|P1|NOT COMPLETED|Treatment Period 2||0
122148|NCT01260142|295001|P6|COMPLETED|Treatment Period 2||3
122149|NCT01260142|295002|P5|COMPLETED|Treatment Period 2||4
122150|NCT01260142|295003|P4|COMPLETED|Treatment Period 2||6
122151|NCT01260142|295004|P3|COMPLETED|Treatment Period 2||6
122152|NCT01260142|295005|P2|COMPLETED|Treatment Period 2||5
122153|NCT01260142|295006|P1|COMPLETED|Treatment Period 2||5
122154|NCT01260142|295001|P6|STARTED|Treatment Period 2||3
122155|NCT01260142|295002|P5|STARTED|Treatment Period 2||4
122156|NCT01260142|295003|P4|STARTED|Treatment Period 2||6
122157|NCT01260142|295004|P3|STARTED|Treatment Period 2||6
122158|NCT01260142|295005|P2|STARTED|Treatment Period 2||5
122159|NCT01260142|295006|P1|STARTED|Treatment Period 2||5
122160|NCT01260142|295001|P6|NOT COMPLETED|Treatment Period 1||3
122161|NCT01260142|295002|P5|NOT COMPLETED|Treatment Period 1||2
122162|NCT01260142|295003|P4|NOT COMPLETED|Treatment Period 1||0
122163|NCT01260142|295004|P3|NOT COMPLETED|Treatment Period 1||0
122164|NCT01260142|295005|P2|NOT COMPLETED|Treatment Period 1||1
122165|NCT01260142|295006|P1|NOT COMPLETED|Treatment Period 1||1
122166|NCT01260142|295001|P6|COMPLETED|Treatment Period 1||3
122167|NCT01260142|295002|P5|COMPLETED|Treatment Period 1||4
122168|NCT01260142|295003|P4|COMPLETED|Treatment Period 1||6
122169|NCT01260142|295004|P3|COMPLETED|Treatment Period 1||6
122170|NCT01260142|295005|P2|COMPLETED|Treatment Period 1||5
122171|NCT01260142|295006|P1|COMPLETED|Treatment Period 1||5
122172|NCT01260142|295001|P6|STARTED|Treatment Period 1||6
122173|NCT01260142|295002|P5|STARTED|Treatment Period 1||6
122174|NCT01260142|295003|P4|STARTED|Treatment Period 1||6
122175|NCT01260142|295004|P3|STARTED|Treatment Period 1||6
122176|NCT01260142|295005|P2|STARTED|Treatment Period 1||6
122177|NCT01260142|295006|P1|STARTED|Treatment Period 1||6
122178|NCT01259726|295060|P4|NOT COMPLETED|Overall Study||5
122179|NCT01259726|295061|P3|NOT COMPLETED|Overall Study||4
122180|NCT01259726|295062|P2|NOT COMPLETED|Overall Study||4
122181|NCT01259726|295063|P1|NOT COMPLETED|Overall Study||5
122182|NCT01259726|295060|P4|COMPLETED|Overall Study||36
122183|NCT01259726|295061|P3|COMPLETED|Overall Study||39
122184|NCT01259726|295062|P2|COMPLETED|Overall Study||37
122185|NCT01259726|295063|P1|COMPLETED|Overall Study||38
122186|NCT01259726|295060|P4|Treated|Overall Study||39
122187|NCT01259726|295061|P3|Treated|Overall Study||41
122188|NCT01259726|295062|P2|Treated|Overall Study||37
122189|NCT01259726|295063|P1|Treated|Overall Study||40
122190|NCT01259726|295060|P4|STARTED|Overall Study||41
122191|NCT01259726|295061|P3|STARTED|Overall Study||43
122192|NCT01259726|295062|P2|STARTED|Overall Study||41
122193|NCT01259726|295063|P1|STARTED|Overall Study||43
122194|NCT01259713|295095|P2|NOT COMPLETED|Overall Study||41
122195|NCT01259713|295096|P1|NOT COMPLETED|Overall Study||95
122196|NCT01259713|295095|P2|COMPLETED|Overall Study||77
122197|NCT01259713|295096|P1|COMPLETED|Overall Study||142
122198|NCT01259713|295095|P2|STARTED|Overall Study||118
122199|NCT01259713|295096|P1|STARTED|Overall Study||237
122200|NCT01259596|295120|P2|NOT COMPLETED|Overall Study||6
122201|NCT01259596|295121|P1|NOT COMPLETED|Overall Study||4
122202|NCT01259596|295120|P2|COMPLETED|Overall Study||65
122203|NCT01259596|295121|P1|COMPLETED|Overall Study||66
122204|NCT01259596|295120|P2|STARTED|Overall Study||71
122205|NCT01259596|295121|P1|STARTED|Overall Study||70
122206|NCT01259492|295143|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
122207|NCT01259492|295144|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
122208|NCT01259492|295145|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
122209|NCT01259492|295146|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
122210|NCT01259492|295143|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
122211|NCT01259492|295144|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
122212|NCT01259492|295145|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
122213|NCT01259492|295146|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
122214|NCT01259492|295143|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
122215|NCT01259492|295144|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
122216|NCT01259492|295145|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
122217|NCT01259492|295146|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
122218|NCT01259492|295143|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
122219|NCT01259492|295144|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
122220|NCT01259492|295145|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
122221|NCT01259492|295146|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
122222|NCT01259492|295143|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
122223|NCT01259492|295144|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
122224|NCT01259492|295145|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
122225|NCT01259492|295146|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
122226|NCT01259492|295143|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
122227|NCT01259492|295144|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
122228|NCT01259492|295145|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
122229|NCT01259492|295146|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
122230|NCT01259492|295143|P4|STARTED|Period 2 (Week 10 to Week 14)||153
122231|NCT01259492|295144|P3|STARTED|Period 2 (Week 10 to Week 14)||138
122232|NCT01259492|295145|P2|STARTED|Period 2 (Week 10 to Week 14)||141
122233|NCT01259492|295146|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
122234|NCT01259492|295143|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
122235|NCT01259492|295144|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
122236|NCT01259492|295145|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
122237|NCT01259492|295146|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
122238|NCT01259492|295143|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
122239|NCT01259492|295144|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
122240|NCT01259492|295145|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
122241|NCT01259492|295146|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
122242|NCT01259492|295143|P4|Full Analysis Set|Period 1 (9 Weeks)||172
122243|NCT01259492|295144|P3|Full Analysis Set|Period 1 (9 Weeks)||179
122244|NCT01259492|295145|P2|Full Analysis Set|Period 1 (9 Weeks)||175
122245|NCT01259492|295146|P1|Full Analysis Set|Period 1 (9 Weeks)||174
122246|NCT01259492|295143|P4|STARTED|Period 1 (9 Weeks)||181
122247|NCT01259492|295144|P3|STARTED|Period 1 (9 Weeks)||181
122248|NCT01259492|295145|P2|STARTED|Period 1 (9 Weeks)||182
122249|NCT01259492|295146|P1|STARTED|Period 1 (9 Weeks)||181
122250|NCT01259466|295195|P2|NOT COMPLETED|Overall Study||9
122251|NCT01259466|295196|P1|NOT COMPLETED|Overall Study||1
122252|NCT01259466|295195|P2|COMPLETED|Overall Study||18
122253|NCT01259466|295196|P1|COMPLETED|Overall Study||26
122254|NCT01259466|295195|P2|STARTED|Overall Study||27
122255|NCT01259466|295196|P1|STARTED|Overall Study||27
122256|NCT01259440|295206|P2|NOT COMPLETED|Overall Study||0
122257|NCT01259440|295207|P1|NOT COMPLETED|Overall Study||0
122258|NCT01259440|295206|P2|COMPLETED|Overall Study||10
122259|NCT01259440|295207|P1|COMPLETED|Overall Study||13
122260|NCT01259440|295206|P2|STARTED|Overall Study||10
122261|NCT01259440|295207|P1|STARTED|Overall Study||13
122262|NCT01259427|295215|P2|NOT COMPLETED|Overall Study||14
122263|NCT01259427|295216|P1|NOT COMPLETED|Overall Study||18
122264|NCT01259427|295215|P2|COMPLETED|Overall Study||110
122265|NCT01259427|295216|P1|COMPLETED|Overall Study||106
122266|NCT01259427|295215|P2|STARTED|Overall Study||124
122267|NCT01259427|295216|P1|STARTED|Overall Study||124
122268|NCT01259401|295234|P2|NOT COMPLETED|4-month Follow-up||2
122269|NCT01259401|295235|P1|NOT COMPLETED|4-month Follow-up||0
122270|NCT01259401|295234|P2|COMPLETED|4-month Follow-up||19
122271|NCT01259401|295235|P1|COMPLETED|4-month Follow-up||21
122272|NCT01259401|295234|P2|STARTED|4-month Follow-up||21
122273|NCT01259401|295235|P1|STARTED|4-month Follow-up||21
122274|NCT01259401|295234|P2|NOT COMPLETED|End of 4-week Intervention||0
122275|NCT01259401|295235|P1|NOT COMPLETED|End of 4-week Intervention||0
122276|NCT01259401|295234|P2|COMPLETED|End of 4-week Intervention||21
122277|NCT01259401|295235|P1|COMPLETED|End of 4-week Intervention||21
122278|NCT01259401|295234|P2|STARTED|End of 4-week Intervention||21
122279|NCT01259401|295235|P1|STARTED|End of 4-week Intervention||21
122280|NCT01259375|295243|P1|NOT COMPLETED|Overall Study||1
122281|NCT01259375|295243|P1|COMPLETED|Overall Study||23
122282|NCT01259375|295243|P1|STARTED|Overall Study||24
122283|NCT01259297|295260|P8|NOT COMPLETED|Double Blind Randomized Period||3
122284|NCT01259297|295261|P7|NOT COMPLETED|Double Blind Randomized Period||6
122285|NCT01259297|295262|P6|NOT COMPLETED|Double Blind Randomized Period||8
122286|NCT01259297|295263|P5|NOT COMPLETED|Double Blind Randomized Period||4
122287|NCT01259297|295264|P4|NOT COMPLETED|Double Blind Randomized Period||4
122288|NCT01259297|295265|P3|NOT COMPLETED|Double Blind Randomized Period||1
122289|NCT01259297|295266|P2|NOT COMPLETED|Double Blind Randomized Period||3
122290|NCT01259297|295267|P1|NOT COMPLETED|Double Blind Randomized Period||2
122291|NCT01259297|295260|P8|COMPLETED|Double Blind Randomized Period||196
122292|NCT01259297|295261|P7|COMPLETED|Double Blind Randomized Period||190
122293|NCT01259297|295262|P6|COMPLETED|Double Blind Randomized Period||245
122294|NCT01259297|295263|P5|COMPLETED|Double Blind Randomized Period||247
122295|NCT01259297|295264|P4|COMPLETED|Double Blind Randomized Period||191
122296|NCT01259297|295265|P3|COMPLETED|Double Blind Randomized Period||188
122297|NCT01259297|295266|P2|COMPLETED|Double Blind Randomized Period||229
122298|NCT01259297|295267|P1|COMPLETED|Double Blind Randomized Period||242
122299|NCT01259297|295260|P8|STARTED|Double Blind Randomized Period||199
122300|NCT01259297|295261|P7|STARTED|Double Blind Randomized Period||196
122301|NCT01259297|295262|P6|STARTED|Double Blind Randomized Period||253
122302|NCT01259297|295263|P5|STARTED|Double Blind Randomized Period||251
122303|NCT01259297|295264|P4|STARTED|Double Blind Randomized Period||195
122304|NCT01259297|295265|P3|STARTED|Double Blind Randomized Period||189
122305|NCT01259297|295266|P2|STARTED|Double Blind Randomized Period||232
122306|NCT01259297|295267|P1|STARTED|Double Blind Randomized Period||244
122307|NCT01259297|295260|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122308|NCT01259297|295261|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122309|NCT01259297|295262|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122310|NCT01259297|295263|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122311|NCT01259297|295264|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122312|NCT01259297|295265|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
122313|NCT01259297|295266|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122314|NCT01259297|295267|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
122315|NCT01259297|295260|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122316|NCT01259297|295261|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122317|NCT01259297|295262|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122318|NCT01259297|295263|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122319|NCT01259297|295264|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122320|NCT01259297|295265|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
122321|NCT01259297|295266|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
122322|NCT01259297|295267|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
122323|NCT01259297|295260|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
122324|NCT01259297|295261|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
122325|NCT01259297|295262|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
122326|NCT01259297|295263|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
122327|NCT01259297|295264|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
122328|NCT01259297|295265|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
122329|NCT01259297|295266|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
122330|NCT01259297|295267|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
122331|NCT01259284|295298|P3|NOT COMPLETED|Overall Study||0
122332|NCT01259284|295299|P2|NOT COMPLETED|Overall Study||0
122333|NCT01259284|295300|P1|NOT COMPLETED|Overall Study||2
122334|NCT01259284|295298|P3|COMPLETED|Overall Study||0
122335|NCT01259284|295299|P2|COMPLETED|Overall Study||0
122336|NCT01259284|295300|P1|COMPLETED|Overall Study||0
122337|NCT01259284|295298|P3|STARTED|Overall Study||0
122338|NCT01259284|295299|P2|STARTED|Overall Study||0
122339|NCT01259284|295300|P1|STARTED|Overall Study||2
122340|NCT01259245|295310|P2|NOT COMPLETED|Overall Study||26
122341|NCT01259245|295311|P1|NOT COMPLETED|Overall Study||28
122342|NCT01259245|295310|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
122343|NCT01259245|295311|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
122344|NCT01259245|295310|P2|STARTED|Overall Study||94
122345|NCT01259245|295311|P1|STARTED|Overall Study||98
122346|NCT01259115|295335|P2|NOT COMPLETED|Period 2||0
122347|NCT01259115|295336|P1|NOT COMPLETED|Period 2||1
122348|NCT01259115|295335|P2|COMPLETED|Period 2||9
122349|NCT01259115|295336|P1|COMPLETED|Period 2||6
122350|NCT01259115|295335|P2|STARTED|Period 2||9
122351|NCT01259115|295336|P1|STARTED|Period 2||7
122352|NCT01259115|295335|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
122353|NCT01259115|295336|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
122354|NCT01259115|295335|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
122355|NCT01259115|295336|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
122356|NCT01259115|295335|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
122357|NCT01259115|295336|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
122358|NCT01259115|295335|P2|NOT COMPLETED|Period 1||1
122359|NCT01259115|295336|P1|NOT COMPLETED|Period 1||3
122360|NCT01259115|295335|P2|COMPLETED|Period 1||9
122361|NCT01259115|295336|P1|COMPLETED|Period 1||7
122362|NCT01259115|295335|P2|STARTED|Period 1||10
122363|NCT01259115|295336|P1|STARTED|Period 1||10
122364|NCT01259102|295372|P5|NOT COMPLETED|Overall Study||1
122365|NCT01259102|295373|P4|NOT COMPLETED|Overall Study||2
122366|NCT01259102|295374|P3|NOT COMPLETED|Overall Study||2
122367|NCT01259102|295375|P2|NOT COMPLETED|Overall Study||0
122368|NCT01259102|295376|P1|NOT COMPLETED|Overall Study||1
122369|NCT01259102|295372|P5|COMPLETED|Overall Study||13
122370|NCT01259102|295373|P4|COMPLETED|Overall Study||12
122371|NCT01259102|295374|P3|COMPLETED|Overall Study||13
122372|NCT01259102|295375|P2|COMPLETED|Overall Study||14
122373|NCT01259102|295376|P1|COMPLETED|Overall Study||12
122374|NCT01259102|295372|P5|STARTED|Overall Study||14
122375|NCT01259102|295373|P4|STARTED|Overall Study||14
122376|NCT01259102|295374|P3|STARTED|Overall Study||15
122377|NCT01259102|295375|P2|STARTED|Overall Study||14
122378|NCT01259102|295376|P1|STARTED|Overall Study||13
122379|NCT01259063|295433|P1|NOT COMPLETED|Overall Study||0
122380|NCT01259063|295433|P1|COMPLETED|Overall Study||33
122381|NCT01259063|295433|P1|STARTED|Overall Study||33
122382|NCT01259024|295442|P1|NOT COMPLETED|Overall Study||1
122383|NCT01259024|295442|P1|COMPLETED|Overall Study||0
122384|NCT01259024|295442|P1|STARTED|Overall Study||1
122385|NCT01259011|295451|P2|NOT COMPLETED|After Patient Death||0
122386|NCT01259011|295452|P1|NOT COMPLETED|After Patient Death||0
122387|NCT01259011|295451|P2|COMPLETED|After Patient Death||28
122388|NCT01259011|295452|P1|COMPLETED|After Patient Death||17
122389|NCT01259011|295451|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
122390|NCT01259011|295452|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
122391|NCT01259011|295451|P2|NOT COMPLETED|Main Study Period||0
122392|NCT01259011|295452|P1|NOT COMPLETED|Main Study Period||0
122393|NCT01259011|295451|P2|COMPLETED|Main Study Period||109
122394|NCT01259011|295452|P1|COMPLETED|Main Study Period||101
122395|NCT01259011|295451|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
122396|NCT01259011|295452|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
122397|NCT01258998|295462|P1|NOT COMPLETED|Overall Study||1
122398|NCT01258998|295462|P1|COMPLETED|Overall Study||59
122399|NCT01258998|295462|P1|STARTED|Overall Study||60
122400|NCT01258985|295468|P2|NOT COMPLETED|Overall Study||0
122401|NCT01258985|295469|P1|NOT COMPLETED|Overall Study||0
122402|NCT01258985|295468|P2|COMPLETED|Overall Study||98
122403|NCT01258985|295469|P1|COMPLETED|Overall Study||106
122404|NCT01258985|295468|P2|STARTED|Overall Study||98
122405|NCT01258985|295469|P1|STARTED|Overall Study||106
122406|NCT01258803|295495|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
122407|NCT01258803|295496|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
122408|NCT01258803|295497|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
122409|NCT01258803|295498|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
122410|NCT01258803|295499|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
122411|NCT01258803|295500|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
122412|NCT01258803|295495|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
122413|NCT01258803|295496|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
122414|NCT01258803|295497|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
122415|NCT01258803|295498|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
122416|NCT01258803|295499|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
122417|NCT01258803|295500|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
122418|NCT01258803|295495|P6|STARTED|Treatment Period 4 (1 Dose)||15
122419|NCT01258803|295496|P5|STARTED|Treatment Period 4 (1 Dose)||15
122420|NCT01258803|295497|P4|STARTED|Treatment Period 4 (1 Dose)||15
122421|NCT01258803|295498|P3|STARTED|Treatment Period 4 (1 Dose)||14
122422|NCT01258803|295499|P2|STARTED|Treatment Period 4 (1 Dose)||14
122423|NCT01258803|295500|P1|STARTED|Treatment Period 4 (1 Dose)||14
122424|NCT01258803|295495|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
122425|NCT01258803|295496|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
122426|NCT01258803|295497|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
122427|NCT01258803|295498|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
122428|NCT01258803|295499|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
122429|NCT01258803|295500|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
122430|NCT01258803|295495|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
122431|NCT01258803|295496|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
122432|NCT01258803|295497|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
122433|NCT01258803|295498|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
122434|NCT01258803|295499|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
122435|NCT01258803|295500|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
122436|NCT01258803|295495|P6|STARTED|Treatment Period 3 (1 Dose)||15
122437|NCT01258803|295496|P5|STARTED|Treatment Period 3 (1 Dose)||15
122438|NCT01258803|295497|P4|STARTED|Treatment Period 3 (1 Dose)||15
122439|NCT01258803|295498|P3|STARTED|Treatment Period 3 (1 Dose)||15
122440|NCT01258803|295499|P2|STARTED|Treatment Period 3 (1 Dose)||14
122441|NCT01258803|295500|P1|STARTED|Treatment Period 3 (1 Dose)||14
122442|NCT01258803|295495|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
122443|NCT01258803|295496|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
122444|NCT01258803|295497|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
122445|NCT01258803|295498|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
122446|NCT01258803|295499|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
122447|NCT01258803|295500|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
122448|NCT01258803|295495|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
122449|NCT01258803|295496|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
122450|NCT01258803|295497|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
122451|NCT01258803|295498|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
122452|NCT01258803|295499|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
122453|NCT01258803|295500|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
122454|NCT01258803|295495|P6|STARTED|Treatment Period 2 (1 Dose)||16
122455|NCT01258803|295496|P5|STARTED|Treatment Period 2 (1 Dose)||15
122456|NCT01258803|295497|P4|STARTED|Treatment Period 2 (1 Dose)||15
122457|NCT01258803|295498|P3|STARTED|Treatment Period 2 (1 Dose)||15
122458|NCT01258803|295499|P2|STARTED|Treatment Period 2 (1 Dose)||16
122459|NCT01258803|295500|P1|STARTED|Treatment Period 2 (1 Dose)||15
122460|NCT01258803|295495|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
122461|NCT01258803|295496|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
122462|NCT01258803|295497|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
122463|NCT01258803|295498|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
122464|NCT01258803|295499|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
122465|NCT01258803|295500|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
122466|NCT01258803|295495|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
122467|NCT01258803|295496|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
122468|NCT01258803|295497|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
122469|NCT01258803|295498|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
122470|NCT01258803|295499|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
122471|NCT01258803|295500|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
122472|NCT01258803|295495|P6|STARTED|Treatment Period 1 (1 Dose)||16
122473|NCT01258803|295496|P5|STARTED|Treatment Period 1 (1 Dose)||15
122474|NCT01258803|295497|P4|STARTED|Treatment Period 1 (1 Dose)||15
122475|NCT01258803|295498|P3|STARTED|Treatment Period 1 (1 Dose)||15
122476|NCT01258803|295499|P2|STARTED|Treatment Period 1 (1 Dose)||16
122477|NCT01258803|295500|P1|STARTED|Treatment Period 1 (1 Dose)||15
122478|NCT01258790|295528|P2|NOT COMPLETED|Overall Study||0
122479|NCT01258790|295529|P1|NOT COMPLETED|Overall Study||0
122480|NCT01258790|295528|P2|COMPLETED|Overall Study||6
122481|NCT01258790|295529|P1|COMPLETED|Overall Study||6
122482|NCT01258790|295528|P2|STARTED|Overall Study||6
122483|NCT01258790|295529|P1|STARTED|Overall Study||6
122484|NCT01258738|295537|P2|NOT COMPLETED|Open-label Period||21
122485|NCT01258738|295538|P1|NOT COMPLETED|Open-label Period||17
122486|NCT01258738|295537|P2|COMPLETED|Open-label Period||85
122487|NCT01258738|295538|P1|COMPLETED|Open-label Period||85
122488|NCT01258738|295537|P2|STARTED|Open-label Period||106
122489|NCT01258738|295538|P1|STARTED|Open-label Period||102
122490|NCT01258738|295537|P2|NOT COMPLETED|Double-blind Period||7
122491|NCT01258738|295538|P1|NOT COMPLETED|Double-blind Period||9
122492|NCT01258738|295537|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
122493|NCT01258738|295538|P1|COMPLETED|Double-blind Period||102
122494|NCT01258738|295537|P2|Treated|Double-blind Period||113
122495|NCT01258738|295538|P1|Treated|Double-blind Period||111
122496|NCT01258738|295537|P2|STARTED|Double-blind Period||114
122497|NCT01258738|295538|P1|STARTED|Double-blind Period||111
122498|NCT01258660|295676|P2|NOT COMPLETED|Overall Study||11
122499|NCT01258660|295677|P1|NOT COMPLETED|Overall Study||11
122589|NCT01258101|295819|P4|STARTED|Overall Study||52
122500|NCT01258660|295676|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
122501|NCT01258660|295677|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
122502|NCT01258660|295676|P2|Completed Treatment|Overall Study||81
122503|NCT01258660|295677|P1|Completed Treatment|Overall Study||79
122504|NCT01258660|295676|P2|Received Treatment|Overall Study||82
122505|NCT01258660|295677|P1|Received Treatment|Overall Study||79
122506|NCT01258660|295676|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
122507|NCT01258660|295677|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
122508|NCT01258595|295696|P2|NOT COMPLETED|Overall Study||1
122509|NCT01258595|295697|P1|NOT COMPLETED|Overall Study||1
122510|NCT01258595|295696|P2|COMPLETED|Overall Study||151
122511|NCT01258595|295697|P1|COMPLETED|Overall Study||147
122512|NCT01258595|295696|P2|STARTED|Overall Study||152
122513|NCT01258595|295697|P1|STARTED|Overall Study||148
122514|NCT01258582|295713|P2|NOT COMPLETED|Overall Study||258
122515|NCT01258582|295714|P1|NOT COMPLETED|Overall Study||282
122516|NCT01258582|295713|P2|COMPLETED|Overall Study||563
122517|NCT01258582|295714|P1|COMPLETED|Overall Study||548
122518|NCT01258582|295713|P2|STARTED|Overall Study||821
122519|NCT01258582|295714|P1|STARTED|Overall Study||830
122520|NCT01258504|295720|P1|NOT COMPLETED|Bosentan and SJW||0
122521|NCT01258504|295720|P1|COMPLETED|Bosentan and SJW||13
122522|NCT01258504|295720|P1|STARTED|Bosentan and SJW||13
122523|NCT01258504|295720|P1|NOT COMPLETED|Bosentan Steady-state||0
122524|NCT01258504|295720|P1|COMPLETED|Bosentan Steady-state||13
122525|NCT01258504|295720|P1|STARTED|Bosentan Steady-state||13
122526|NCT01258504|295720|P1|NOT COMPLETED|Bosentan Single Dose||0
122527|NCT01258504|295720|P1|COMPLETED|Bosentan Single Dose||13
122528|NCT01258504|295720|P1|STARTED|Bosentan Single Dose||13
122529|NCT01258387|295739|P7|NOT COMPLETED|Overall Study||0
122530|NCT01258387|295740|P6|NOT COMPLETED|Overall Study||0
122531|NCT01258387|295741|P5|NOT COMPLETED|Overall Study||0
122532|NCT01258387|295742|P4|NOT COMPLETED|Overall Study||0
122533|NCT01258387|295743|P3|NOT COMPLETED|Overall Study||0
122534|NCT01258387|295744|P2|NOT COMPLETED|Overall Study||0
122535|NCT01258387|295745|P1|NOT COMPLETED|Overall Study||0
122536|NCT01258387|295739|P7|COMPLETED|Overall Study||4
122537|NCT01258387|295740|P6|COMPLETED|Overall Study||6
122538|NCT01258387|295741|P5|COMPLETED|Overall Study||6
122539|NCT01258387|295742|P4|COMPLETED|Overall Study||6
122540|NCT01258387|295743|P3|COMPLETED|Overall Study||6
122541|NCT01258387|295744|P2|COMPLETED|Overall Study||6
122542|NCT01258387|295745|P1|COMPLETED|Overall Study||6
122543|NCT01258387|295739|P7|Patients Randomized to Placebo|Overall Study||1
122544|NCT01258387|295740|P6|Patients Randomized to Placebo|Overall Study||2
122545|NCT01258387|295741|P5|Patients Randomized to Placebo|Overall Study||2
122546|NCT01258387|295742|P4|Patients Randomized to Placebo|Overall Study||2
122547|NCT01258387|295743|P3|Patients Randomized to Placebo|Overall Study||2
122548|NCT01258387|295744|P2|Patients Randomized to Placebo|Overall Study||2
122549|NCT01258387|295745|P1|Patients Randomized to Placebo|Overall Study||2
122550|NCT01258387|295739|P7|Patients Randomized to GGF2|Overall Study||3
122551|NCT01258387|295740|P6|Patients Randomized to GGF2|Overall Study||4
122552|NCT01258387|295741|P5|Patients Randomized to GGF2|Overall Study||4
122553|NCT01258387|295742|P4|Patients Randomized to GGF2|Overall Study||4
122554|NCT01258387|295743|P3|Patients Randomized to GGF2|Overall Study||4
122555|NCT01258387|295744|P2|Patients Randomized to GGF2|Overall Study||4
122556|NCT01258387|295745|P1|Patients Randomized to GGF2|Overall Study||4
122557|NCT01258387|295739|P7|STARTED|Overall Study||4
122558|NCT01258387|295740|P6|STARTED|Overall Study||6
122559|NCT01258387|295741|P5|STARTED|Overall Study||6
122560|NCT01258387|295742|P4|STARTED|Overall Study||6
122561|NCT01258387|295743|P3|STARTED|Overall Study||6
122562|NCT01258387|295744|P2|STARTED|Overall Study||6
122563|NCT01258387|295745|P1|STARTED|Overall Study||6
122564|NCT01258153|295790|P3|NOT COMPLETED|Overall Study||1
122565|NCT01258153|295791|P2|NOT COMPLETED|Overall Study||1
122566|NCT01258153|295792|P1|NOT COMPLETED|Overall Study||1
122567|NCT01258153|295790|P3|COMPLETED|Overall Study||36
122568|NCT01258153|295791|P2|COMPLETED|Overall Study||37
122569|NCT01258153|295792|P1|COMPLETED|Overall Study||39
122570|NCT01258153|295790|P3|STARTED|Overall Study||37
122571|NCT01258153|295791|P2|STARTED|Overall Study||38
122572|NCT01258153|295792|P1|STARTED|Overall Study||40
122573|NCT01258101|295819|P4|NOT COMPLETED|Overall Study||25
122574|NCT01258101|295820|P3|NOT COMPLETED|Overall Study||11
122575|NCT01258101|295821|P2|NOT COMPLETED|Overall Study||34
122576|NCT01258101|295822|P1|NOT COMPLETED|Overall Study||33
122577|NCT01258101|295819|P4|COMPLETED|Overall Study||27
122578|NCT01258101|295820|P3|COMPLETED|Overall Study||22
122579|NCT01258101|295821|P2|COMPLETED|Overall Study||110
122580|NCT01258101|295822|P1|COMPLETED|Overall Study||118
122581|NCT01258101|295819|P4|Standard Analysis Population|Overall Study||26
122582|NCT01258101|295820|P3|Standard Analysis Population|Overall Study||21
122583|NCT01258101|295821|P2|Standard Analysis Population|Overall Study||110
122584|NCT01258101|295822|P1|Standard Analysis Population|Overall Study||115
122585|NCT01258101|295819|P4|Safety Analysis Population|Overall Study||48
122586|NCT01258101|295820|P3|Safety Analysis Population|Overall Study||30
122587|NCT01258101|295821|P2|Safety Analysis Population|Overall Study||141
122588|NCT01258101|295822|P1|Safety Analysis Population|Overall Study||144
122590|NCT01258101|295820|P3|STARTED|Overall Study||33
122591|NCT01258101|295821|P2|STARTED|Overall Study||144
122592|NCT01258101|295822|P1|STARTED|Overall Study||151
122593|NCT01258049|295874|P2|NOT COMPLETED|Overall Study||2
122594|NCT01258049|295875|P1|NOT COMPLETED|Overall Study||2
122595|NCT01258049|295874|P2|COMPLETED|Overall Study||72
122596|NCT01258049|295875|P1|COMPLETED|Overall Study||75
122597|NCT01258049|295874|P2|STARTED|Overall Study||74
122598|NCT01258049|295875|P1|STARTED|Overall Study||77
122599|NCT01257880|295913|P2|NOT COMPLETED|Overall Study||0
122600|NCT01257880|295914|P1|NOT COMPLETED|Overall Study||0
122601|NCT01257880|295913|P2|COMPLETED|Overall Study||19
122602|NCT01257880|295914|P1|COMPLETED|Overall Study||12
122603|NCT01257880|295913|P2|STARTED|Overall Study||19
122604|NCT01257880|295914|P1|STARTED|Overall Study||12
122605|NCT01257802|295924|P2|NOT COMPLETED|Overall Study||6
122606|NCT01257802|295925|P1|NOT COMPLETED|Overall Study||1
122607|NCT01257802|295924|P2|COMPLETED|Overall Study||2
122608|NCT01257802|295925|P1|COMPLETED|Overall Study||5
122609|NCT01257802|295924|P2|6 Month / 24 Week Visit|Overall Study||2
122610|NCT01257802|295925|P1|6 Month / 24 Week Visit|Overall Study||5
122611|NCT01257802|295924|P2|STARTED|Overall Study||8
122612|NCT01257802|295925|P1|STARTED|Overall Study||6
122613|NCT01257750|295939|P1|NOT COMPLETED|Overall Study||0
122614|NCT01257750|295939|P1|COMPLETED|Overall Study||20
122615|NCT01257750|295939|P1|STARTED|Overall Study||20
122616|NCT01257737|295952|P2|NOT COMPLETED|Overall Study||4
122617|NCT01257737|295953|P1|NOT COMPLETED|Overall Study||2
122618|NCT01257737|295952|P2|COMPLETED|Overall Study||39
122619|NCT01257737|295953|P1|COMPLETED|Overall Study||43
122620|NCT01257737|295952|P2|STARTED|Overall Study||43
122621|NCT01257737|295953|P1|STARTED|Overall Study||45
122622|NCT01257581|295974|P3|NOT COMPLETED|Overall Study||6
122623|NCT01257581|295975|P2|NOT COMPLETED|Overall Study||3
122624|NCT01257581|295976|P1|NOT COMPLETED|Overall Study||5
122625|NCT01257581|295974|P3|COMPLETED|Overall Study||11
122626|NCT01257581|295975|P2|COMPLETED|Overall Study||18
122627|NCT01257581|295976|P1|COMPLETED|Overall Study||17
122628|NCT01257581|295974|P3|STARTED|Overall Study||17
122629|NCT01257581|295975|P2|STARTED|Overall Study||21
122630|NCT01257581|295976|P1|STARTED|Overall Study||22
122631|NCT01257542|296016|P2|NOT COMPLETED|Overall Study||7
122632|NCT01257542|296017|P1|NOT COMPLETED|Overall Study||3
122633|NCT01257542|296016|P2|COMPLETED|Overall Study||45
122634|NCT01257542|296017|P1|COMPLETED|Overall Study||52
122635|NCT01257542|296016|P2|STARTED|Overall Study||52
122636|NCT01257542|296017|P1|STARTED|Overall Study||55
122637|NCT01257503|296037|P2|NOT COMPLETED|Overall Study||11
122638|NCT01257503|296038|P1|NOT COMPLETED|Overall Study||8
122639|NCT01257503|296037|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
122640|NCT01257503|296038|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
122641|NCT01257503|296037|P2|Returned Dosage Logbooks|Overall Study||80
122642|NCT01257503|296038|P1|Returned Dosage Logbooks|Overall Study||75
122643|NCT01257503|296037|P2|Returned Symptom Diaries|Overall Study||83
122644|NCT01257503|296038|P1|Returned Symptom Diaries|Overall Study||80
122645|NCT01257503|296037|P2|STARTED|Overall Study||130
122646|NCT01257503|296038|P1|STARTED|Overall Study||133
122647|NCT01257438|296054|P2|NOT COMPLETED|Overall Study||46
122648|NCT01257438|296055|P1|NOT COMPLETED|Overall Study||30
122649|NCT01257438|296054|P2|COMPLETED|Overall Study||97
122650|NCT01257438|296055|P1|COMPLETED|Overall Study||102
122651|NCT01257438|296054|P2|STARTED|Overall Study||143
122652|NCT01257438|296055|P1|STARTED|Overall Study||132
122653|NCT01257425|296067|P2|NOT COMPLETED|Overall Study||6
122654|NCT01257425|296068|P1|NOT COMPLETED|Overall Study||6
122655|NCT01257425|296067|P2|COMPLETED|Overall Study||45
122656|NCT01257425|296068|P1|COMPLETED|Overall Study||46
122657|NCT01257425|296067|P2|STARTED|Overall Study||51
122658|NCT01257425|296068|P1|STARTED|Overall Study||52
122659|NCT01257347|296090|P4|NOT COMPLETED|Overall Study||0
122660|NCT01257347|296091|P3|NOT COMPLETED|Overall Study||0
122661|NCT01257347|296092|P2|NOT COMPLETED|Overall Study||0
122662|NCT01257347|296093|P1|NOT COMPLETED|Overall Study||0
122663|NCT01257347|296090|P4|COMPLETED|Overall Study||65
122664|NCT01257347|296091|P3|COMPLETED|Overall Study||35
122665|NCT01257347|296092|P2|COMPLETED|Overall Study||12
122666|NCT01257347|296093|P1|COMPLETED|Overall Study||12
122667|NCT01257347|296090|P4|STARTED|Overall Study||65
122668|NCT01257347|296091|P3|STARTED|Overall Study||35
122669|NCT01257347|296092|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
122670|NCT01257347|296093|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
122671|NCT01257230|296110|P3|NOT COMPLETED|Overall Study||6
122672|NCT01257230|296111|P2|NOT COMPLETED|Overall Study||10
122673|NCT01257230|296112|P1|NOT COMPLETED|Overall Study||6
122674|NCT01257230|296110|P3|COMPLETED|Overall Study||129
122675|NCT01257230|296111|P2|COMPLETED|Overall Study||115
122676|NCT01257230|296112|P1|COMPLETED|Overall Study||132
122677|NCT01257230|296110|P3|STARTED|Overall Study||135
122678|NCT01257230|296111|P2|STARTED|Overall Study||125
122679|NCT01257230|296112|P1|STARTED|Overall Study||138
122680|NCT01257217|296167|P2|NOT COMPLETED|Overall Study||0
122681|NCT01257217|296168|P1|NOT COMPLETED|Overall Study||2
122682|NCT01257217|296167|P2|COMPLETED|Overall Study||10
122683|NCT01257217|296168|P1|COMPLETED|Overall Study||13
122684|NCT01257217|296167|P2|STARTED|Overall Study||10
122685|NCT01257217|296168|P1|STARTED|Overall Study||15
122686|NCT01257204|296189|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
122687|NCT01257204|296190|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
122688|NCT01257204|296191|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
122689|NCT01257204|296189|P3|COMPLETED|Follow-up Period (up to Week 48)||39
122690|NCT01257204|296190|P2|COMPLETED|Follow-up Period (up to Week 48)||41
122691|NCT01257204|296191|P1|COMPLETED|Follow-up Period (up to Week 48)||48
122692|NCT01257204|296189|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
122693|NCT01257204|296190|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
122694|NCT01257204|296191|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
122695|NCT01257204|296189|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
122696|NCT01257204|296190|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
122697|NCT01257204|296191|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
122698|NCT01257204|296189|P3|COMPLETED|Treatment Period (up to Week 24)||42
122699|NCT01257204|296190|P2|COMPLETED|Treatment Period (up to Week 24)||44
122700|NCT01257204|296191|P1|COMPLETED|Treatment Period (up to Week 24)||45
122701|NCT01257204|296189|P3|STARTED|Treatment Period (up to Week 24)||51
122702|NCT01257204|296190|P2|STARTED|Treatment Period (up to Week 24)||50
122703|NCT01257204|296191|P1|STARTED|Treatment Period (up to Week 24)||50
122704|NCT01256983|296237|P2|NOT COMPLETED|Overall Study||3
122705|NCT01256983|296238|P1|NOT COMPLETED|Overall Study||1
122706|NCT01256983|296237|P2|COMPLETED|Overall Study||12
122707|NCT01256983|296238|P1|COMPLETED|Overall Study||14
122708|NCT01256983|296237|P2|STARTED|Overall Study||15
122709|NCT01256983|296238|P1|STARTED|Overall Study||15
122710|NCT01256944|296246|P2|NOT COMPLETED|Overall Study||0
122711|NCT01256944|296247|P1|NOT COMPLETED|Overall Study||0
122712|NCT01256944|296246|P2|COMPLETED|Overall Study||220
122713|NCT01256944|296247|P1|COMPLETED|Overall Study||70
122714|NCT01256944|296246|P2|STARTED|Overall Study||220
122715|NCT01256944|296247|P1|STARTED|Overall Study||70
122716|NCT01256918|296275|P1|NOT COMPLETED|Overall Study||0
122717|NCT01256918|296275|P1|COMPLETED|Overall Study||200
122718|NCT01256918|296275|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
122719|NCT01256918|296275|P1|STARTED|Overall Study||200
122720|NCT01256840|296289|P3|NOT COMPLETED|Overall Study||0
122721|NCT01256840|296290|P2|NOT COMPLETED|Overall Study||0
122722|NCT01256840|296291|P1|NOT COMPLETED|Overall Study||0
122723|NCT01256840|296289|P3|COMPLETED|Overall Study||25
122724|NCT01256840|296290|P2|COMPLETED|Overall Study||16
122725|NCT01256840|296291|P1|COMPLETED|Overall Study||30
122726|NCT01256840|296289|P3|STARTED|Overall Study||25
122727|NCT01256840|296290|P2|STARTED|Overall Study||16
122728|NCT01256840|296291|P1|STARTED|Overall Study||30
122729|NCT01256684|296302|P3|NOT COMPLETED|Overall Study||11
122730|NCT01256684|296303|P2|NOT COMPLETED|Overall Study||13
122731|NCT01256684|296304|P1|NOT COMPLETED|Overall Study||9
122732|NCT01256684|296302|P3|COMPLETED|Overall Study||76
122733|NCT01256684|296303|P2|COMPLETED|Overall Study||74
122734|NCT01256684|296304|P1|COMPLETED|Overall Study||72
122735|NCT01256684|296302|P3|ITT Population|Overall Study||81
122736|NCT01256684|296303|P2|ITT Population|Overall Study||79
122737|NCT01256684|296304|P1|ITT Population|Overall Study||77
122738|NCT01256684|296302|P3|Safety Population|Overall Study||87
122739|NCT01256684|296303|P2|Safety Population|Overall Study||86
122740|NCT01256684|296304|P1|Safety Population|Overall Study||80
122741|NCT01256684|296302|P3|STARTED|Overall Study||87
122742|NCT01256684|296303|P2|STARTED|Overall Study||87
122743|NCT01256684|296304|P1|STARTED|Overall Study||81
122744|NCT01256671|296336|P1|NOT COMPLETED|Overall Study||95
122745|NCT01256671|296336|P1|COMPLETED|Overall Study||435
122746|NCT01256671|296336|P1|Safety Population|Overall Study||521
122747|NCT01256671|296336|P1|STARTED|Overall Study||530
122748|NCT01256658|296349|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
122749|NCT01256658|296350|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
122750|NCT01256658|296349|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
122751|NCT01256658|296350|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
122752|NCT01256658|296349|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
122753|NCT01256658|296350|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
122754|NCT01256658|296349|P2|Death|Period 2 - Follow up Only - No Treatment||8
122755|NCT01256658|296350|P1|Death|Period 2 - Follow up Only - No Treatment||6
122756|NCT01256658|296349|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
122757|NCT01256658|296350|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
122758|NCT01256658|296349|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
122759|NCT01256658|296350|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
122760|NCT01256658|296349|P2|NOT COMPLETED|Period 1||748
122761|NCT01256658|296350|P1|NOT COMPLETED|Period 1||920
122762|NCT01256658|296349|P2|COMPLETED|Period 1||6510
122763|NCT01256658|296350|P1|COMPLETED|Period 1||5897
122764|NCT01256658|296349|P2|STARTED|Period 1||7258
122765|NCT01256658|296350|P1|STARTED|Period 1||6817
122766|NCT01256567|296400|P1|NOT COMPLETED|Overall Study||1
122767|NCT01256567|296400|P1|COMPLETED|Overall Study||6
122768|NCT01256567|296400|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
122769|NCT01256567|296400|P1|STARTED|Overall Study||7
122770|NCT01256502|296410|P1|NOT COMPLETED|Overall Study||10
122771|NCT01256502|296410|P1|COMPLETED|Overall Study||129
122772|NCT01256502|296410|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
122773|NCT01256476|296422|P2|NOT COMPLETED|Overall Study||7
122774|NCT01256476|296423|P1|NOT COMPLETED|Overall Study||6
122775|NCT01256476|296422|P2|COMPLETED|Overall Study||157
122776|NCT01256476|296423|P1|COMPLETED|Overall Study||158
122777|NCT01256476|296422|P2|STARTED|Overall Study||164
122778|NCT01256476|296423|P1|STARTED|Overall Study||164
122779|NCT01256450|296431|P3|NOT COMPLETED|Double-blind Treatment||37
122780|NCT01256450|296432|P2|NOT COMPLETED|Double-blind Treatment||28
122781|NCT01256450|296433|P1|NOT COMPLETED|Double-blind Treatment||0
122782|NCT01256450|296431|P3|COMPLETED|Double-blind Treatment||81
122783|NCT01256450|296432|P2|COMPLETED|Double-blind Treatment||89
122784|NCT01256450|296433|P1|COMPLETED|Double-blind Treatment||0
122785|NCT01256450|296431|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
122786|NCT01256450|296432|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
122787|NCT01256450|296433|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
122788|NCT01256450|296431|P3|NOT COMPLETED|Open-label Titration||0
122789|NCT01256450|296432|P2|NOT COMPLETED|Open-label Titration||0
122790|NCT01256450|296433|P1|NOT COMPLETED|Open-label Titration||99
122791|NCT01256450|296431|P3|COMPLETED|Open-label Titration||0
122792|NCT01256450|296432|P2|COMPLETED|Open-label Titration||0
122793|NCT01256450|296433|P1|COMPLETED|Open-label Titration||235
122794|NCT01256450|296431|P3|STARTED|Open-label Titration||0
122795|NCT01256450|296432|P2|STARTED|Open-label Titration||0
122796|NCT01256450|296433|P1|STARTED|Open-label Titration||334
122797|NCT01256424|296462|P4|NOT COMPLETED|Overall Study||7
122798|NCT01256424|296463|P3|NOT COMPLETED|Overall Study||7
122799|NCT01256424|296464|P2|NOT COMPLETED|Overall Study||8
122800|NCT01256424|296465|P1|NOT COMPLETED|Overall Study||9
122801|NCT01256424|296462|P4|COMPLETED|Overall Study||61
122802|NCT01256424|296463|P3|COMPLETED|Overall Study||55
122803|NCT01256424|296464|P2|COMPLETED|Overall Study||59
122804|NCT01256424|296465|P1|COMPLETED|Overall Study||56
122805|NCT01256424|296462|P4|STARTED|Overall Study||68
122806|NCT01256424|296463|P3|STARTED|Overall Study||62
122807|NCT01256424|296464|P2|STARTED|Overall Study||67
122808|NCT01256424|296465|P1|STARTED|Overall Study||65
122809|NCT01256411|296491|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
122810|NCT01256411|296492|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
122811|NCT01256411|296493|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
122812|NCT01256411|296494|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
122813|NCT01256411|296495|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
122814|NCT01256411|296496|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
122815|NCT01256411|296491|P6|COMPLETED|Extension by Mono or Combination Therapy||109
122816|NCT01256411|296492|P5|COMPLETED|Extension by Mono or Combination Therapy||211
122817|NCT01256411|296493|P4|COMPLETED|Extension by Mono or Combination Therapy||0
122818|NCT01256411|296494|P3|COMPLETED|Extension by Mono or Combination Therapy||0
122819|NCT01256411|296495|P2|COMPLETED|Extension by Mono or Combination Therapy||0
122820|NCT01256411|296496|P1|COMPLETED|Extension by Mono or Combination Therapy||0
122821|NCT01256411|296491|P6|STARTED|Extension by Mono or Combination Therapy||113
122822|NCT01256411|296492|P5|STARTED|Extension by Mono or Combination Therapy||228
122823|NCT01256411|296493|P4|STARTED|Extension by Mono or Combination Therapy||0
122824|NCT01256411|296494|P3|STARTED|Extension by Mono or Combination Therapy||0
122825|NCT01256411|296495|P2|STARTED|Extension by Mono or Combination Therapy||0
122826|NCT01256411|296496|P1|STARTED|Extension by Mono or Combination Therapy||0
122827|NCT01256411|296491|P6|NOT COMPLETED|Extension by Maximum Treatment||0
122828|NCT01256411|296492|P5|NOT COMPLETED|Extension by Maximum Treatment||0
122829|NCT01256411|296493|P4|NOT COMPLETED|Extension by Maximum Treatment||0
122830|NCT01256411|296494|P3|NOT COMPLETED|Extension by Maximum Treatment||4
122831|NCT01256411|296495|P2|NOT COMPLETED|Extension by Maximum Treatment||10
122832|NCT01256411|296496|P1|NOT COMPLETED|Extension by Maximum Treatment||7
122833|NCT01256411|296491|P6|COMPLETED|Extension by Maximum Treatment||0
122834|NCT01256411|296492|P5|COMPLETED|Extension by Maximum Treatment||0
122835|NCT01256411|296493|P4|COMPLETED|Extension by Maximum Treatment||4
122836|NCT01256411|296494|P3|COMPLETED|Extension by Maximum Treatment||105
122837|NCT01256411|296495|P2|COMPLETED|Extension by Maximum Treatment||79
122838|NCT01256411|296496|P1|COMPLETED|Extension by Maximum Treatment||132
122839|NCT01256411|296491|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
122840|NCT01256411|296492|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
122841|NCT01256411|296493|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
122842|NCT01256411|296494|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
122843|NCT01256411|296495|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
122844|NCT01256411|296496|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
122845|NCT01256411|296491|P6|STARTED|Extension by Maximum Treatment||0
122846|NCT01256411|296492|P5|STARTED|Extension by Maximum Treatment||0
122847|NCT01256411|296493|P4|STARTED|Extension by Maximum Treatment||4
122848|NCT01256411|296494|P3|STARTED|Extension by Maximum Treatment||109
122849|NCT01256411|296495|P2|STARTED|Extension by Maximum Treatment||89
122850|NCT01256411|296496|P1|STARTED|Extension by Maximum Treatment||139
122851|NCT01256385|296522|P2|NOT COMPLETED|Overall Study||3
122852|NCT01256385|296523|P1|NOT COMPLETED|Overall Study||3
122853|NCT01256385|296522|P2|COMPLETED|Overall Study||40
122854|NCT01256385|296523|P1|COMPLETED|Overall Study||40
122855|NCT01256385|296522|P2|Crossover From Arm B to Arm A|Overall Study||15
122856|NCT01256385|296523|P1|Crossover From Arm B to Arm A|Overall Study||0
122857|NCT01256385|296522|P2|STARTED|Overall Study||43
122858|NCT01256385|296523|P1|STARTED|Overall Study||43
122859|NCT01256294|296543|P2|NOT COMPLETED|Overall Study||2
122860|NCT01256294|296544|P1|NOT COMPLETED|Overall Study||4
122861|NCT01256294|296543|P2|COMPLETED|Overall Study||33
122862|NCT01256294|296544|P1|COMPLETED|Overall Study||32
122863|NCT01256294|296543|P2|STARTED|Overall Study||35
122864|NCT01256294|296544|P1|STARTED|Overall Study||36
122865|NCT01256281|296560|P1|NOT COMPLETED|Overall Study||0
122866|NCT01256281|296560|P1|COMPLETED|Overall Study||2
122867|NCT01256281|296560|P1|STARTED|Overall Study||2
122868|NCT01256190|296566|P2|NOT COMPLETED|Overall Study||0
122869|NCT01256190|296567|P1|NOT COMPLETED|Overall Study||2
122870|NCT01256190|296566|P2|COMPLETED|Overall Study||17
122871|NCT01256190|296567|P1|COMPLETED|Overall Study||37
122872|NCT01256190|296566|P2|STARTED|Overall Study||17
122873|NCT01256190|296567|P1|STARTED|Overall Study||39
122874|NCT01256177|296583|P2|NOT COMPLETED|Overall Study||37
122875|NCT01256177|296584|P1|NOT COMPLETED|Overall Study||50
122876|NCT01256177|296583|P2|COMPLETED|Overall Study||111
122877|NCT01256177|296584|P1|COMPLETED|Overall Study||98
122878|NCT01256177|296583|P2|STARTED|Overall Study||148
122879|NCT01256177|296584|P1|STARTED|Overall Study||148
122880|NCT01256164|296608|P2|NOT COMPLETED|Overall Study||0
122881|NCT01256164|296609|P1|NOT COMPLETED|Overall Study||0
122882|NCT01256164|296608|P2|COMPLETED|Overall Study||23
122883|NCT01256164|296609|P1|COMPLETED|Overall Study||47
122884|NCT01256164|296608|P2|STARTED|Overall Study||23
122885|NCT01256164|296609|P1|STARTED|Overall Study||47
122886|NCT01256086|296627|P4|NOT COMPLETED|Treatment Day 4||0
122887|NCT01256086|296628|P3|NOT COMPLETED|Treatment Day 4||0
122888|NCT01256086|296629|P2|NOT COMPLETED|Treatment Day 4||0
122889|NCT01256086|296630|P1|NOT COMPLETED|Treatment Day 4||0
122890|NCT01256086|296627|P4|COMPLETED|Treatment Day 4||11
122891|NCT01256086|296628|P3|COMPLETED|Treatment Day 4||9
122892|NCT01256086|296629|P2|COMPLETED|Treatment Day 4||10
122893|NCT01256086|296630|P1|COMPLETED|Treatment Day 4||11
122894|NCT01256086|296627|P4|STARTED|Treatment Day 4||11
122895|NCT01256086|296628|P3|STARTED|Treatment Day 4||9
122896|NCT01256086|296629|P2|STARTED|Treatment Day 4||10
122897|NCT01256086|296630|P1|STARTED|Treatment Day 4||11
122898|NCT01256086|296627|P4|NOT COMPLETED|Treatment Day 3||0
122899|NCT01256086|296628|P3|NOT COMPLETED|Treatment Day 3||0
122900|NCT01256086|296629|P2|NOT COMPLETED|Treatment Day 3||0
122901|NCT01256086|296630|P1|NOT COMPLETED|Treatment Day 3||0
122902|NCT01256086|296627|P4|COMPLETED|Treatment Day 3||11
122903|NCT01256086|296628|P3|COMPLETED|Treatment Day 3||9
122904|NCT01256086|296629|P2|COMPLETED|Treatment Day 3||10
122905|NCT01256086|296630|P1|COMPLETED|Treatment Day 3||11
122906|NCT01256086|296627|P4|STARTED|Treatment Day 3||11
122907|NCT01256086|296628|P3|STARTED|Treatment Day 3||9
122908|NCT01256086|296629|P2|STARTED|Treatment Day 3||10
122909|NCT01256086|296630|P1|STARTED|Treatment Day 3||11
122910|NCT01256086|296627|P4|NOT COMPLETED|Treatment Day 2||0
122911|NCT01256086|296628|P3|NOT COMPLETED|Treatment Day 2||0
122912|NCT01256086|296629|P2|NOT COMPLETED|Treatment Day 2||0
122913|NCT01256086|296630|P1|NOT COMPLETED|Treatment Day 2||0
122914|NCT01256086|296627|P4|COMPLETED|Treatment Day 2||11
122915|NCT01256086|296628|P3|COMPLETED|Treatment Day 2||9
122916|NCT01256086|296629|P2|COMPLETED|Treatment Day 2||10
122917|NCT01256086|296630|P1|COMPLETED|Treatment Day 2||11
122918|NCT01256086|296627|P4|STARTED|Treatment Day 2||11
122919|NCT01256086|296628|P3|STARTED|Treatment Day 2||9
122920|NCT01256086|296629|P2|STARTED|Treatment Day 2||10
122921|NCT01256086|296630|P1|STARTED|Treatment Day 2||11
122922|NCT01256086|296627|P4|NOT COMPLETED|Treatment Day 1||0
122923|NCT01256086|296628|P3|NOT COMPLETED|Treatment Day 1||0
122924|NCT01256086|296629|P2|NOT COMPLETED|Treatment Day 1||0
122925|NCT01256086|296630|P1|NOT COMPLETED|Treatment Day 1||0
122926|NCT01256086|296627|P4|COMPLETED|Treatment Day 1||11
122927|NCT01256086|296628|P3|COMPLETED|Treatment Day 1||11
122928|NCT01256086|296629|P2|COMPLETED|Treatment Day 1||11
122929|NCT01256086|296630|P1|COMPLETED|Treatment Day 1||11
122930|NCT01256086|296627|P4|STARTED|Treatment Day 1||11
122931|NCT01256086|296628|P3|STARTED|Treatment Day 1||11
122932|NCT01256086|296629|P2|STARTED|Treatment Day 1||11
122933|NCT01256086|296630|P1|STARTED|Treatment Day 1||11
122934|NCT01256060|296640|P4|NOT COMPLETED|Overall Study||0
122935|NCT01256060|296641|P3|NOT COMPLETED|Overall Study||0
122936|NCT01256060|296642|P2|NOT COMPLETED|Overall Study||1
122937|NCT01256060|296643|P1|NOT COMPLETED|Overall Study||0
122938|NCT01256060|296640|P4|COMPLETED|Overall Study||6
122939|NCT01256060|296641|P3|COMPLETED|Overall Study||3
122940|NCT01256060|296642|P2|COMPLETED|Overall Study||2
122941|NCT01256060|296643|P1|COMPLETED|Overall Study||3
122942|NCT01256060|296640|P4|STARTED|Overall Study||6
122943|NCT01256060|296641|P3|STARTED|Overall Study||3
122944|NCT01256060|296642|P2|STARTED|Overall Study||3
122945|NCT01256060|296643|P1|STARTED|Overall Study||3
122946|NCT01256034|296652|P2|NOT COMPLETED|Overall Study||25
122947|NCT01256034|296653|P1|NOT COMPLETED|Overall Study||25
122948|NCT01256034|296652|P2|COMPLETED|Overall Study||0
122949|NCT01256034|296653|P1|COMPLETED|Overall Study||0
122950|NCT01256034|296652|P2|STARTED|Overall Study||25
122951|NCT01256034|296653|P1|STARTED|Overall Study||25
122952|NCT01256008|296662|P3|NOT COMPLETED|Overall Study||21
122953|NCT01256008|296663|P2|NOT COMPLETED|Overall Study||7
122954|NCT01256008|296664|P1|NOT COMPLETED|Overall Study||8
122955|NCT01256008|296662|P3|COMPLETED|Overall Study||175
122956|NCT01256008|296663|P2|COMPLETED|Overall Study||91
122957|NCT01256008|296664|P1|COMPLETED|Overall Study||90
122958|NCT01256008|296662|P3|STARTED|Overall Study||196
122959|NCT01256008|296663|P2|STARTED|Overall Study||98
122960|NCT01256008|296664|P1|STARTED|Overall Study||98
122961|NCT01255904|296686|P2|NOT COMPLETED|Overall Study||4
122962|NCT01255904|296687|P1|NOT COMPLETED|Overall Study||1
122963|NCT01255904|296686|P2|COMPLETED|Overall Study||41
122964|NCT01255904|296687|P1|COMPLETED|Overall Study||44
122965|NCT01255904|296686|P2|STARTED|Overall Study||45
122966|NCT01255904|296687|P1|STARTED|Overall Study||45
122967|NCT01255787|296697|P4|NOT COMPLETED|Overall Study||22
122968|NCT01255787|296698|P3|NOT COMPLETED|Overall Study||18
122969|NCT01255787|296699|P2|NOT COMPLETED|Overall Study||17
122970|NCT01255787|296700|P1|NOT COMPLETED|Overall Study||16
122971|NCT01255787|296697|P4|COMPLETED|Overall Study||132
122972|NCT01255787|296698|P3|COMPLETED|Overall Study||132
122973|NCT01255787|296699|P2|COMPLETED|Overall Study||127
122974|NCT01255787|296700|P1|COMPLETED|Overall Study||136
122975|NCT01255787|296697|P4|Treated|Overall Study||150
122976|NCT01255787|296698|P3|Treated|Overall Study||148
122977|NCT01255787|296699|P2|Treated|Overall Study||144
122978|NCT01255787|296700|P1|Treated|Overall Study||152
122979|NCT01255787|296697|P4|STARTED|Overall Study||154
122980|NCT01255787|296698|P3|STARTED|Overall Study||150
122981|NCT01255787|296699|P2|STARTED|Overall Study||144
122982|NCT01255787|296700|P1|STARTED|Overall Study||152
122983|NCT01255761|296728|P2|NOT COMPLETED|Overall Study||175
122984|NCT01255761|296729|P1|NOT COMPLETED|Overall Study||182
122985|NCT01255761|296728|P2|COMPLETED|Overall Study||192
122986|NCT01255761|296729|P1|COMPLETED|Overall Study||187
122987|NCT01255761|296728|P2|STARTED|Overall Study||367
122988|NCT01255761|296729|P1|STARTED|Overall Study||369
122989|NCT01255722|296814|P3|NOT COMPLETED|Overall Study||1
122990|NCT01255722|296815|P2|NOT COMPLETED|Overall Study||1
122991|NCT01255722|296816|P1|NOT COMPLETED|Overall Study||3
122992|NCT01255722|296814|P3|COMPLETED|Overall Study||152
122993|NCT01255722|296815|P2|COMPLETED|Overall Study||159
122994|NCT01255722|296816|P1|COMPLETED|Overall Study||152
122995|NCT01255722|296814|P3|STARTED|Overall Study||153
122996|NCT01255722|296815|P2|STARTED|Overall Study||160
122997|NCT01255722|296816|P1|STARTED|Overall Study||155
122998|NCT01255631|296841|P2|NOT COMPLETED|Overall Study||6
122999|NCT01255631|296842|P1|NOT COMPLETED|Overall Study||9
123000|NCT01255631|296841|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
123001|NCT01255631|296842|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
123002|NCT01255631|296841|P2|STARTED|Overall Study||9
123003|NCT01255631|296842|P1|STARTED|Overall Study||13
123004|NCT01255592|296860|P2|NOT COMPLETED|Overall Study||1
123005|NCT01255592|296861|P1|NOT COMPLETED|Overall Study||6
123006|NCT01255592|296860|P2|COMPLETED|Overall Study||25
123007|NCT01255592|296861|P1|COMPLETED|Overall Study||20
123008|NCT01255592|296860|P2|STARTED|Overall Study||26
123009|NCT01255592|296861|P1|STARTED|Overall Study||26
123010|NCT01255449|296917|P1|NOT COMPLETED|Overall Study||0
123011|NCT01255449|296917|P1|COMPLETED|Overall Study||26
123012|NCT01255449|296917|P1|STARTED|Overall Study||26
123013|NCT01255436|296924|P2|NOT COMPLETED|Overall Study||194
123014|NCT01255436|296925|P1|NOT COMPLETED|Overall Study||182
123015|NCT01255436|296924|P2|COMPLETED|Overall Study||135
123016|NCT01255436|296925|P1|COMPLETED|Overall Study||151
123017|NCT01255436|296924|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
123018|NCT01255436|296925|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
123019|NCT01255423|296939|P2|NOT COMPLETED|Overall Study||3
123020|NCT01255423|296940|P1|NOT COMPLETED|Overall Study||3
123021|NCT01255423|296939|P2|COMPLETED|Overall Study||99
123022|NCT01255423|296940|P1|COMPLETED|Overall Study||101
123023|NCT01255423|296939|P2|STARTED|Overall Study||102
123024|NCT01255423|296940|P1|STARTED|Overall Study||104
123025|NCT01255306|296956|P2|NOT COMPLETED|Overall Study||1
123026|NCT01255306|296957|P1|NOT COMPLETED|Overall Study||1
123027|NCT01255306|296956|P2|COMPLETED|Overall Study||32
123028|NCT01255306|296957|P1|COMPLETED|Overall Study||25
123029|NCT01255306|296956|P2|STARTED|Overall Study||33
123030|NCT01255306|296957|P1|STARTED|Overall Study||26
123031|NCT01255163|296968|P2|NOT COMPLETED|Overall Study||5
123032|NCT01255163|296969|P1|NOT COMPLETED|Overall Study||4
123033|NCT01255163|296968|P2|COMPLETED|Overall Study||9
123034|NCT01255163|296969|P1|COMPLETED|Overall Study||9
123035|NCT01255163|296968|P2|STARTED|Overall Study||14
123036|NCT01255163|296969|P1|STARTED|Overall Study||13
123037|NCT01255137|296991|P1|NOT COMPLETED|Overall Study||0
123038|NCT01255137|296991|P1|COMPLETED|Overall Study||13
123039|NCT01255137|296991|P1|STARTED|Overall Study||13
123040|NCT01254890|296998|P2|NOT COMPLETED|Overall Study||10
123041|NCT01254890|296999|P1|NOT COMPLETED|Overall Study||1
123042|NCT01254890|296998|P2|COMPLETED|Overall Study||47
123043|NCT01254890|296999|P1|COMPLETED|Overall Study||2
123044|NCT01254890|296998|P2|STARTED|Overall Study||57
123045|NCT01254890|296999|P1|STARTED|Overall Study||3
123046|NCT01254877|297008|P3|NOT COMPLETED|Overall Study||5
123047|NCT01254877|297009|P2|NOT COMPLETED|Overall Study||11
123048|NCT01254877|297010|P1|NOT COMPLETED|Overall Study||10
123049|NCT01254877|297008|P3|COMPLETED|Overall Study||64
123050|NCT01254877|297009|P2|COMPLETED|Overall Study||58
123051|NCT01254877|297010|P1|COMPLETED|Overall Study||57
123052|NCT01254877|297008|P3|STARTED|Overall Study||69
123053|NCT01254877|297009|P2|STARTED|Overall Study||69
123054|NCT01254877|297010|P1|STARTED|Overall Study||67
123055|NCT01254851|297035|P2|NOT COMPLETED|Overall Study||9
123056|NCT01254851|297036|P1|NOT COMPLETED|Overall Study||8
123057|NCT01254851|297035|P2|COMPLETED|Overall Study||68
123058|NCT01254851|297036|P1|COMPLETED|Overall Study||61
123059|NCT01254851|297035|P2|STARTED|Overall Study||77
123060|NCT01254851|297036|P1|STARTED|Overall Study||69
123061|NCT01254760|297042|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
123062|NCT01254760|297043|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
123063|NCT01254760|297042|P2|COMPLETED|Second Period, 5 Days of Wear||38
123064|NCT01254760|297043|P1|COMPLETED|Second Period, 5 Days of Wear||34
123065|NCT01254760|297042|P2|STARTED|Second Period, 5 Days of Wear||38
123066|NCT01254760|297043|P1|STARTED|Second Period, 5 Days of Wear||34
123067|NCT01254760|297042|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
123068|NCT01254760|297043|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
123069|NCT01254760|297042|P2|COMPLETED|First Period, 5 Days of Wear||38
123070|NCT01254760|297043|P1|COMPLETED|First Period, 5 Days of Wear||34
123071|NCT01254760|297042|P2|STARTED|First Period, 5 Days of Wear||38
123072|NCT01254760|297043|P1|STARTED|First Period, 5 Days of Wear||34
123073|NCT01254747|297061|P4|NOT COMPLETED|Overall Study||2
123074|NCT01254747|297062|P3|NOT COMPLETED|Overall Study||4
123075|NCT01254747|297063|P2|NOT COMPLETED|Overall Study||6
123076|NCT01254747|297064|P1|NOT COMPLETED|Overall Study||0
123077|NCT01254747|297061|P4|COMPLETED|Overall Study||28
123078|NCT01254747|297062|P3|COMPLETED|Overall Study||26
123079|NCT01254747|297063|P2|COMPLETED|Overall Study||23
123080|NCT01254747|297064|P1|COMPLETED|Overall Study||40
123081|NCT01254747|297061|P4|STARTED|Overall Study||30
123082|NCT01254747|297062|P3|STARTED|Overall Study||30
123083|NCT01254747|297063|P2|STARTED|Overall Study||29
123084|NCT01254747|297064|P1|STARTED|Overall Study||40
123085|NCT01254721|297104|P2|NOT COMPLETED|Overall Study||22
123086|NCT01254721|297105|P1|NOT COMPLETED|Overall Study||15
123087|NCT01254721|297104|P2|COMPLETED|Overall Study||42
123088|NCT01254721|297105|P1|COMPLETED|Overall Study||52
123089|NCT01254721|297104|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
123090|NCT01254721|297105|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
123091|NCT01254669|297115|P2|NOT COMPLETED|Overall Study||4
123092|NCT01254669|297116|P1|NOT COMPLETED|Overall Study||3
123093|NCT01254669|297115|P2|COMPLETED|Overall Study||96
123094|NCT01254669|297116|P1|COMPLETED|Overall Study||97
123095|NCT01254669|297115|P2|STARTED|Overall Study||100
123096|NCT01254669|297116|P1|STARTED|Overall Study||100
123097|NCT01254656|297127|P3|NOT COMPLETED|Overall Study||18
123098|NCT01254656|297128|P2|NOT COMPLETED|Overall Study||43
123099|NCT01254656|297129|P1|NOT COMPLETED|Overall Study||47
123100|NCT01254656|297127|P3|COMPLETED|Overall Study||0
123101|NCT01254656|297128|P2|COMPLETED|Overall Study||0
123102|NCT01254656|297129|P1|COMPLETED|Overall Study||0
123103|NCT01254656|297127|P3|Treated|Overall Study||18
123104|NCT01254656|297128|P2|Treated|Overall Study||43
123105|NCT01254656|297129|P1|Treated|Overall Study||47
123106|NCT01254656|297127|P3|STARTED|Overall Study||18
123107|NCT01254656|297128|P2|STARTED|Overall Study||43
123108|NCT01254656|297129|P1|STARTED|Overall Study||47
123109|NCT01254643|297155|P1|NOT COMPLETED|Overall Study||1
123110|NCT01254643|297155|P1|COMPLETED|Overall Study||99
123111|NCT01254643|297155|P1|Vaccination 3|Overall Study||99
123112|NCT01254643|297155|P1|Vaccination 2|Overall Study||99
123113|NCT01254643|297155|P1|Vaccination 1|Overall Study||100
123114|NCT01254643|297155|P1|STARTED|Overall Study||100
123115|NCT01254630|297167|P4|NOT COMPLETED|Overall Study||1285
123116|NCT01254630|297168|P3|NOT COMPLETED|Overall Study||812
123117|NCT01254630|297169|P2|NOT COMPLETED|Overall Study||1288
123118|NCT01254630|297170|P1|NOT COMPLETED|Overall Study||802
123119|NCT01254630|297167|P4|COMPLETED|Overall Study||0
123120|NCT01254630|297168|P3|COMPLETED|Overall Study||552
123121|NCT01254630|297169|P2|COMPLETED|Overall Study||0
123122|NCT01254630|297170|P1|COMPLETED|Overall Study||546
123123|NCT01254630|297167|P4|Received Vaccination 4|Overall Study||1160
123124|NCT01254630|297168|P3|Received Vaccination 4|Overall Study||1212
123125|NCT01254630|297169|P2|Received Vaccination 4|Overall Study||1145
123126|NCT01254630|297170|P1|Received Vaccination 4|Overall Study||1155
123127|NCT01254630|297167|P4|Received Vaccination 3|Overall Study||1194
123128|NCT01254630|297168|P3|Received Vaccination 3|Overall Study||1247
123129|NCT01254630|297169|P2|Received Vaccination 3|Overall Study||1178
123130|NCT01254630|297170|P1|Received Vaccination 3|Overall Study||1198
123131|NCT01254630|297167|P4|Received Vaccination 2|Overall Study||1226
123132|NCT01254630|297168|P3|Received Vaccination 2|Overall Study||1286
123133|NCT01254630|297169|P2|Received Vaccination 2|Overall Study||1217
123134|NCT01254630|297170|P1|Received Vaccination 2|Overall Study||1255
123135|NCT01254630|297167|P4|Received Vaccination 1|Overall Study||1275
123136|NCT01254630|297168|P3|Received Vaccination 1|Overall Study||1350
123137|NCT01254630|297169|P2|Received Vaccination 1|Overall Study||1277
123138|NCT01254630|297170|P1|Received Vaccination 1|Overall Study||1328
123139|NCT01254630|297167|P4|STARTED|Overall Study||1285
123140|NCT01254630|297168|P3|STARTED|Overall Study||1364
123141|NCT01254630|297169|P2|STARTED|Overall Study||1288
123142|NCT01254630|297170|P1|STARTED|Overall Study||1348
123143|NCT01254604|297190|P2|NOT COMPLETED|Overall Study||9
123144|NCT01254604|297191|P1|NOT COMPLETED|Overall Study||8
123145|NCT01254604|297190|P2|COMPLETED|Overall Study||86
123146|NCT01254604|297191|P1|COMPLETED|Overall Study||87
123147|NCT01254604|297190|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
123148|NCT01254604|297191|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
123149|NCT01254604|297190|P2|STARTED|Overall Study||95
123150|NCT01254604|297191|P1|STARTED|Overall Study||95
123151|NCT01254565|297209|P6|NOT COMPLETED|Overall Study||4
123152|NCT01254565|297210|P5|NOT COMPLETED|Overall Study||4
123153|NCT01254565|297211|P4|NOT COMPLETED|Overall Study||1
123154|NCT01254565|297212|P3|NOT COMPLETED|Overall Study||0
123155|NCT01254565|297213|P2|NOT COMPLETED|Overall Study||1
123156|NCT01254565|297214|P1|NOT COMPLETED|Overall Study||1
123157|NCT01254565|297209|P6|COMPLETED|Overall Study||13
123158|NCT01254565|297210|P5|COMPLETED|Overall Study||12
123159|NCT01254565|297211|P4|COMPLETED|Overall Study||20
123160|NCT01254565|297212|P3|COMPLETED|Overall Study||21
123161|NCT01254565|297213|P2|COMPLETED|Overall Study||6
123162|NCT01254565|297214|P1|COMPLETED|Overall Study||4
123163|NCT01254565|297209|P6|Received Treatment|Overall Study||13
123164|NCT01254565|297210|P5|Received Treatment|Overall Study||13
123165|NCT01254565|297211|P4|Received Treatment|Overall Study||21
123166|NCT01254565|297212|P3|Received Treatment|Overall Study||21
123167|NCT01254565|297213|P2|Received Treatment|Overall Study||6
123168|NCT01254565|297214|P1|Received Treatment|Overall Study||4
123169|NCT01254565|297209|P6|STARTED|Overall Study||17
123170|NCT01254565|297210|P5|STARTED|Overall Study||16
123171|NCT01254565|297211|P4|STARTED|Overall Study||21
123172|NCT01254565|297212|P3|STARTED|Overall Study||21
123173|NCT01254565|297213|P2|STARTED|Overall Study||7
123174|NCT01254565|297214|P1|STARTED|Overall Study||5
123175|NCT01254409|297268|P4|NOT COMPLETED|Overall Study||0
123176|NCT01254409|297269|P3|NOT COMPLETED|Overall Study||0
123177|NCT01254409|297270|P2|NOT COMPLETED|Overall Study||1
123178|NCT01254409|297271|P1|NOT COMPLETED|Overall Study||0
123179|NCT01254409|297268|P4|COMPLETED|Overall Study||4
123180|NCT01254409|297269|P3|COMPLETED|Overall Study||5
123181|NCT01254409|297270|P2|COMPLETED|Overall Study||5
123182|NCT01254409|297271|P1|COMPLETED|Overall Study||6
123183|NCT01254409|297268|P4|STARTED|Overall Study||4
123184|NCT01254409|297269|P3|STARTED|Overall Study||5
123185|NCT01254409|297270|P2|STARTED|Overall Study||6
123186|NCT01254409|297271|P1|STARTED|Overall Study||6
123187|NCT01254396|297323|P2|NOT COMPLETED|Second Intervention Period||0
123188|NCT01254396|297324|P1|NOT COMPLETED|Second Intervention Period||0
123189|NCT01254396|297323|P2|COMPLETED|Second Intervention Period||6
123190|NCT01254396|297324|P1|COMPLETED|Second Intervention Period||6
123191|NCT01254396|297323|P2|STARTED|Second Intervention Period||6
123192|NCT01254396|297324|P1|STARTED|Second Intervention Period||6
123193|NCT01254396|297323|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
123194|NCT01254396|297324|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
123195|NCT01254396|297323|P2|COMPLETED|Washout Period (at Least 1 Day)||6
123196|NCT01254396|297324|P1|COMPLETED|Washout Period (at Least 1 Day)||6
123197|NCT01254396|297323|P2|STARTED|Washout Period (at Least 1 Day)||6
123198|NCT01254396|297324|P1|STARTED|Washout Period (at Least 1 Day)||6
123199|NCT01254396|297323|P2|NOT COMPLETED|First Intervention Period||0
123200|NCT01254396|297324|P1|NOT COMPLETED|First Intervention Period||0
123201|NCT01254396|297323|P2|COMPLETED|First Intervention Period||6
123202|NCT01254396|297324|P1|COMPLETED|First Intervention Period||6
123203|NCT01254396|297323|P2|STARTED|First Intervention Period||6
123204|NCT01254396|297324|P1|STARTED|First Intervention Period||6
123205|NCT01254344|297340|P2|NOT COMPLETED|Overall Study||19
123206|NCT01254344|297341|P1|NOT COMPLETED|Overall Study||13
123207|NCT01254344|297340|P2|COMPLETED|Overall Study||281
123208|NCT01254344|297341|P1|COMPLETED|Overall Study||286
123209|NCT01254344|297340|P2|Treated|Overall Study||297
123210|NCT01254344|297341|P1|Treated|Overall Study||290
123211|NCT01254344|297340|P2|STARTED|Overall Study||300
123212|NCT01254344|297341|P1|STARTED|Overall Study||299
123213|NCT01254331|297349|P1|NOT COMPLETED|Extension Phase||4
123214|NCT01254331|297349|P1|COMPLETED|Extension Phase||41
123215|NCT01254331|297349|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
123216|NCT01254331|297349|P1|NOT COMPLETED|Initial Phase||5
123217|NCT01254331|297349|P1|COMPLETED|Initial Phase||46
123218|NCT01254331|297349|P1|STARTED|Initial Phase||51
123219|NCT01254318|297367|P1|NOT COMPLETED|Overall Study||52
123220|NCT01254318|297367|P1|COMPLETED|Overall Study|Alive at end of study|78
123221|NCT01254318|297367|P1|STARTED|Overall Study|Alive at start of study|130
123222|NCT01254305|297376|P3|NOT COMPLETED|Overall Study||17
123223|NCT01254305|297377|P2|NOT COMPLETED|Overall Study||18
123224|NCT01254305|297378|P1|NOT COMPLETED|Overall Study||22
123225|NCT01254305|297376|P3|COMPLETED|Overall Study||62
123226|NCT01254305|297377|P2|COMPLETED|Overall Study||72
123227|NCT01254305|297378|P1|COMPLETED|Overall Study||71
123228|NCT01254305|297376|P3|Safety Population|Overall Study||77
123229|NCT01254305|297377|P2|Safety Population|Overall Study||85
123230|NCT01254305|297378|P1|Safety Population|Overall Study||89
123231|NCT01254305|297376|P3|STARTED|Overall Study||79
123232|NCT01254305|297377|P2|STARTED|Overall Study||90
123233|NCT01254305|297378|P1|STARTED|Overall Study||93
123234|NCT01254292|297394|P2|NOT COMPLETED|LCS12 Extension Phase||0
123235|NCT01254292|297395|P1|NOT COMPLETED|LCS12 Extension Phase||37
123236|NCT01254292|297394|P2|COMPLETED|LCS12 Extension Phase||0
123237|NCT01254292|297395|P1|COMPLETED|LCS12 Extension Phase||163
123238|NCT01254292|297394|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
123239|NCT01254292|297395|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
123240|NCT01254292|297394|P2|NOT COMPLETED|Comparative Phase||81
123241|NCT01254292|297395|P1|NOT COMPLETED|Comparative Phase||55
123242|NCT01254292|297394|P2|COMPLETED|Comparative Phase||204
123243|NCT01254292|297395|P1|COMPLETED|Comparative Phase||227
123244|NCT01254292|297394|P2|Participants Received Treatment|Comparative Phase|safety population|281
123245|NCT01254292|297395|P1|Participants Received Treatment|Comparative Phase|safety population|279
123246|NCT01254292|297394|P2|STARTED|Comparative Phase||285
123247|NCT01254292|297395|P1|STARTED|Comparative Phase||282
123248|NCT01254214|297457|P2|NOT COMPLETED|Overall Study||1
123249|NCT01254214|297458|P1|NOT COMPLETED|Overall Study||3
123250|NCT01254214|297457|P2|COMPLETED|Overall Study||27
123251|NCT01254214|297458|P1|COMPLETED|Overall Study||24
123252|NCT01254214|297457|P2|STARTED|Overall Study||28
123253|NCT01254214|297458|P1|STARTED|Overall Study||27
123254|NCT01254188|297472|P1|NOT COMPLETED|Overall Study||93
123255|NCT01254188|297472|P1|COMPLETED|Overall Study||328
123256|NCT01254188|297472|P1|STARTED|Overall Study||421
123257|NCT01254045|297483|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
123258|NCT01254045|297484|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
123259|NCT01254045|297485|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
123260|NCT01254045|297486|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
123261|NCT01254045|297487|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
123262|NCT01254045|297488|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
123263|NCT01254045|297483|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
123264|NCT01254045|297484|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
123265|NCT01254045|297485|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
123266|NCT01254045|297486|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
123267|NCT01254045|297487|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
123268|NCT01254045|297488|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
123269|NCT01254045|297483|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
123270|NCT01254045|297484|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
123271|NCT01254045|297485|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
123272|NCT01254045|297486|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
123273|NCT01254045|297487|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
123274|NCT01254045|297488|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
123275|NCT01254045|297483|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
123276|NCT01254045|297484|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
123277|NCT01254045|297485|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
123278|NCT01254045|297486|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
123279|NCT01254045|297487|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
123280|NCT01254045|297488|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
123281|NCT01254045|297483|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
123282|NCT01254045|297484|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
123283|NCT01254045|297485|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
123284|NCT01254045|297486|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
123285|NCT01254045|297487|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
123286|NCT01254045|297488|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
123287|NCT01254045|297483|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
123288|NCT01254045|297484|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
123289|NCT01254045|297485|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
123290|NCT01254045|297486|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
123291|NCT01254045|297487|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
123292|NCT01254045|297488|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
123293|NCT01254045|297483|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
123294|NCT01254045|297484|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
123295|NCT01254045|297485|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
123296|NCT01254045|297486|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
123297|NCT01254045|297487|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
123298|NCT01254045|297488|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
123299|NCT01254045|297483|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
123300|NCT01254045|297484|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
123301|NCT01254045|297485|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
123302|NCT01254045|297486|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
123303|NCT01254045|297487|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
123304|NCT01254045|297488|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
123305|NCT01254045|297483|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
123306|NCT01254045|297484|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
123307|NCT01254045|297485|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
123308|NCT01254045|297486|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
123309|NCT01254045|297487|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
123310|NCT01254045|297488|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
123311|NCT01253980|297501|P2|NOT COMPLETED|Overall Study||0
123312|NCT01253980|297502|P1|NOT COMPLETED|Overall Study||0
123313|NCT01253980|297501|P2|COMPLETED|Overall Study||39
123314|NCT01253980|297502|P1|COMPLETED|Overall Study||35
123315|NCT01253980|297501|P2|STARTED|Overall Study||39
123316|NCT01253980|297502|P1|STARTED|Overall Study||35
123317|NCT01253902|297511|P3|NOT COMPLETED|Overall Study||4
123318|NCT01253902|297512|P2|NOT COMPLETED|Overall Study||2
123319|NCT01253902|297513|P1|NOT COMPLETED|Overall Study||5
123320|NCT01253902|297511|P3|COMPLETED|Overall Study||51
123321|NCT01253902|297512|P2|COMPLETED|Overall Study||51
123322|NCT01253902|297513|P1|COMPLETED|Overall Study||51
123323|NCT01253902|297511|P3|STARTED|Overall Study||55
123324|NCT01253902|297512|P2|STARTED|Overall Study||53
123325|NCT01253902|297513|P1|STARTED|Overall Study||56
123326|NCT01253824|297529|P2|NOT COMPLETED|Overall Study||0
123327|NCT01253824|297530|P1|NOT COMPLETED|Overall Study||0
123328|NCT01253824|297529|P2|COMPLETED|Overall Study||7
123329|NCT01253824|297530|P1|COMPLETED|Overall Study||7
123330|NCT01253824|297529|P2|STARTED|Overall Study||7
123331|NCT01253824|297530|P1|STARTED|Overall Study||7
123332|NCT01253811|297542|P1|NOT COMPLETED|Overall Study||1
123333|NCT01253811|297542|P1|COMPLETED|Overall Study||5
123334|NCT01253811|297542|P1|Exposed|Overall Study||6
123335|NCT01253811|297542|P1|STARTED|Overall Study||6
123336|NCT01253642|297561|P1|NOT COMPLETED|Overall Study||5
123337|NCT01253642|297561|P1|COMPLETED|Overall Study||6
123338|NCT01253642|297561|P1|STARTED|Overall Study||11
123339|NCT01253577|297573|P1|NOT COMPLETED|Overall Study||3
123340|NCT01253577|297573|P1|COMPLETED|Overall Study||102
123341|NCT01253577|297573|P1|STARTED|Overall Study||105
123342|NCT01253564|297581|P1|NOT COMPLETED|Overall Study||24
123343|NCT01253564|297581|P1|COMPLETED|Overall Study||0
123344|NCT01253564|297581|P1|STARTED|Overall Study||24
123345|NCT01253525|297598|P1|NOT COMPLETED|Overall Study||0
123346|NCT01253525|297598|P1|COMPLETED|Overall Study||6
123347|NCT01253525|297598|P1|Received Any Quantity of Study Drug|Overall Study||6
123348|NCT01253525|297598|P1|STARTED|Overall Study||6
123349|NCT01253447|297625|P1|NOT COMPLETED|Overall Study||2
123350|NCT01253447|297625|P1|COMPLETED|Overall Study||17
123351|NCT01253447|297625|P1|STARTED|Overall Study||19
123352|NCT01253421|297633|P5|NOT COMPLETED|Drug+Scanning Visit||1
123353|NCT01253421|297634|P4|NOT COMPLETED|Drug+Scanning Visit||0
123354|NCT01253421|297635|P3|NOT COMPLETED|Drug+Scanning Visit||0
123355|NCT01253421|297636|P2|NOT COMPLETED|Drug+Scanning Visit||0
123356|NCT01253421|297637|P1|NOT COMPLETED|Drug+Scanning Visit||0
123357|NCT01253421|297633|P5|COMPLETED|Drug+Scanning Visit||14
123358|NCT01253421|297634|P4|COMPLETED|Drug+Scanning Visit||16
123359|NCT01253421|297635|P3|COMPLETED|Drug+Scanning Visit||14
123360|NCT01253421|297636|P2|COMPLETED|Drug+Scanning Visit||15
123361|NCT01253421|297637|P1|COMPLETED|Drug+Scanning Visit||0
123362|NCT01253421|297633|P5|Received Drug Challenge|Drug+Scanning Visit||15
123363|NCT01253421|297634|P4|Received Drug Challenge|Drug+Scanning Visit||16
123364|NCT01253421|297635|P3|Received Drug Challenge|Drug+Scanning Visit||14
123365|NCT01253421|297636|P2|Received Drug Challenge|Drug+Scanning Visit||15
123366|NCT01253421|297637|P1|Received Drug Challenge|Drug+Scanning Visit||0
123367|NCT01253421|297633|P5|STARTED|Drug+Scanning Visit||15
123368|NCT01253421|297634|P4|STARTED|Drug+Scanning Visit||16
123369|NCT01253421|297635|P3|STARTED|Drug+Scanning Visit||14
123370|NCT01253421|297636|P2|STARTED|Drug+Scanning Visit||15
123371|NCT01253421|297637|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
123372|NCT01253421|297633|P5|NOT COMPLETED|Assessment and Scheduling||0
123373|NCT01253421|297634|P4|NOT COMPLETED|Assessment and Scheduling||0
123374|NCT01253421|297635|P3|NOT COMPLETED|Assessment and Scheduling||0
123375|NCT01253421|297636|P2|NOT COMPLETED|Assessment and Scheduling||0
123376|NCT01253421|297637|P1|NOT COMPLETED|Assessment and Scheduling||99
123377|NCT01253421|297633|P5|COMPLETED|Assessment and Scheduling||0
123378|NCT01253421|297634|P4|COMPLETED|Assessment and Scheduling||0
123379|NCT01253421|297635|P3|COMPLETED|Assessment and Scheduling||0
123380|NCT01253421|297636|P2|COMPLETED|Assessment and Scheduling||0
123381|NCT01253421|297637|P1|COMPLETED|Assessment and Scheduling||60
123468|NCT01253200|297851|P2|10 Day Follow-up|Overall Study||111
123382|NCT01253421|297633|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
123383|NCT01253421|297634|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
123384|NCT01253421|297635|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
123385|NCT01253421|297636|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
123386|NCT01253421|297637|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
123387|NCT01253421|297633|P5|Eligible After Screening Visit|Assessment and Scheduling||0
123388|NCT01253421|297634|P4|Eligible After Screening Visit|Assessment and Scheduling||0
123389|NCT01253421|297635|P3|Eligible After Screening Visit|Assessment and Scheduling||0
123390|NCT01253421|297636|P2|Eligible After Screening Visit|Assessment and Scheduling||0
123391|NCT01253421|297637|P1|Eligible After Screening Visit|Assessment and Scheduling||85
123392|NCT01253421|297633|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
123393|NCT01253421|297634|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
123394|NCT01253421|297635|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
123395|NCT01253421|297636|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
123396|NCT01253421|297637|P1|STARTED|Assessment and Scheduling||159
123397|NCT01253408|297686|P3|NOT COMPLETED|Overall Study||0
123398|NCT01253408|297687|P2|NOT COMPLETED|Overall Study||1
123399|NCT01253408|297688|P1|NOT COMPLETED|Overall Study||0
123400|NCT01253408|297686|P3|COMPLETED|Overall Study||13
123401|NCT01253408|297687|P2|COMPLETED|Overall Study||12
123402|NCT01253408|297688|P1|COMPLETED|Overall Study||10
123403|NCT01253408|297686|P3|STARTED|Overall Study||13
123404|NCT01253408|297687|P2|STARTED|Overall Study||13
123405|NCT01253408|297688|P1|STARTED|Overall Study||10
123406|NCT01253369|297711|P1|NOT COMPLETED|Overall Study||33
123407|NCT01253369|297711|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
123408|NCT01253369|297711|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
123409|NCT01253369|297711|P1|STARTED|Overall Study||33
123410|NCT01253343|297718|P2|NOT COMPLETED|Overall Study||0
123411|NCT01253343|297719|P1|NOT COMPLETED|Overall Study||0
123412|NCT01253343|297718|P2|COMPLETED|Overall Study||8
123413|NCT01253343|297719|P1|COMPLETED|Overall Study||9
123414|NCT01253343|297718|P2|STARTED|Overall Study||8
123415|NCT01253343|297719|P1|STARTED|Overall Study||9
123416|NCT01253317|297741|P1|NOT COMPLETED|Overall Study||2
123417|NCT01253317|297741|P1|COMPLETED|Overall Study||10
123418|NCT01253317|297741|P1|STARTED|Overall Study||12
123419|NCT01253304|297753|P4|NOT COMPLETED|Overall Study||1
123420|NCT01253304|297754|P3|NOT COMPLETED|Overall Study||0
123421|NCT01253304|297755|P2|NOT COMPLETED|Overall Study||0
123422|NCT01253304|297756|P1|NOT COMPLETED|Overall Study||0
123423|NCT01253304|297753|P4|COMPLETED|Overall Study||2
123424|NCT01253304|297754|P3|COMPLETED|Overall Study||6
123425|NCT01253304|297755|P2|COMPLETED|Overall Study||6
123426|NCT01253304|297756|P1|COMPLETED|Overall Study||11
123427|NCT01253304|297753|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
123428|NCT01253304|297754|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
123429|NCT01253304|297755|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
123430|NCT01253304|297756|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
123431|NCT01253304|297753|P4|STARTED|Overall Study||3
123432|NCT01253304|297754|P3|STARTED|Overall Study||6
123433|NCT01253304|297755|P2|STARTED|Overall Study||6
123434|NCT01253304|297756|P1|STARTED|Overall Study||11
123435|NCT01253265|297795|P5|NOT COMPLETED|Overall Study||1
123436|NCT01253265|297796|P4|NOT COMPLETED|Overall Study||0
123437|NCT01253265|297797|P3|NOT COMPLETED|Overall Study||0
123438|NCT01253265|297798|P2|NOT COMPLETED|Overall Study||0
123439|NCT01253265|297799|P1|NOT COMPLETED|Overall Study||1
123440|NCT01253265|297795|P5|COMPLETED|Overall Study||7
123441|NCT01253265|297796|P4|COMPLETED|Overall Study||6
123442|NCT01253265|297797|P3|COMPLETED|Overall Study||6
123443|NCT01253265|297798|P2|COMPLETED|Overall Study||6
123444|NCT01253265|297799|P1|COMPLETED|Overall Study||5
123445|NCT01253265|297795|P5|STARTED|Overall Study||8
123446|NCT01253265|297796|P4|STARTED|Overall Study||6
123447|NCT01253265|297797|P3|STARTED|Overall Study||6
123448|NCT01253265|297798|P2|STARTED|Overall Study||6
123449|NCT01253265|297799|P1|STARTED|Overall Study||6
123450|NCT01253200|297848|P5|NOT COMPLETED|Overall Study||5
123451|NCT01253200|297849|P4|NOT COMPLETED|Overall Study||5
123452|NCT01253200|297850|P3|NOT COMPLETED|Overall Study||2
123453|NCT01253200|297851|P2|NOT COMPLETED|Overall Study||19
123454|NCT01253200|297852|P1|NOT COMPLETED|Overall Study||21
123455|NCT01253200|297848|P5|COMPLETED|Overall Study||0
123456|NCT01253200|297849|P4|COMPLETED|Overall Study||12
123457|NCT01253200|297850|P3|COMPLETED|Overall Study||28
123458|NCT01253200|297851|P2|COMPLETED|Overall Study||106
123459|NCT01253200|297852|P1|COMPLETED|Overall Study||104
123460|NCT01253200|297848|P5|3 Month Follow-up|Overall Study||0
123461|NCT01253200|297849|P4|3 Month Follow-up|Overall Study||12
123462|NCT01253200|297850|P3|3 Month Follow-up|Overall Study||28
123463|NCT01253200|297851|P2|3 Month Follow-up|Overall Study||106
123464|NCT01253200|297852|P1|3 Month Follow-up|Overall Study||104
123465|NCT01253200|297848|P5|10 Day Follow-up|Overall Study||0
123466|NCT01253200|297849|P4|10 Day Follow-up|Overall Study||12
123467|NCT01253200|297850|P3|10 Day Follow-up|Overall Study||28
123469|NCT01253200|297852|P1|10 Day Follow-up|Overall Study||106
123470|NCT01253200|297848|P5|Procedure|Overall Study||0
123471|NCT01253200|297849|P4|Procedure|Overall Study||12
123472|NCT01253200|297850|P3|Procedure|Overall Study||28
123473|NCT01253200|297851|P2|Procedure|Overall Study||111
123474|NCT01253200|297852|P1|Procedure|Overall Study||109
123475|NCT01253200|297848|P5|STARTED|Overall Study||5
123476|NCT01253200|297849|P4|STARTED|Overall Study||17
123477|NCT01253200|297850|P3|STARTED|Overall Study||30
123478|NCT01253200|297851|P2|STARTED|Overall Study||125
123479|NCT01253200|297852|P1|STARTED|Overall Study||125
123480|NCT01253187|297867|P6|NOT COMPLETED|Period 3||0
123481|NCT01253187|297868|P5|NOT COMPLETED|Period 3||1
123482|NCT01253187|297869|P4|NOT COMPLETED|Period 3||0
123483|NCT01253187|297870|P3|NOT COMPLETED|Period 3||0
123484|NCT01253187|297871|P2|NOT COMPLETED|Period 3||1
123485|NCT01253187|297872|P1|NOT COMPLETED|Period 3||1
123486|NCT01253187|297867|P6|COMPLETED|Period 3||6
123487|NCT01253187|297868|P5|COMPLETED|Period 3||7
123488|NCT01253187|297869|P4|COMPLETED|Period 3||7
123489|NCT01253187|297870|P3|COMPLETED|Period 3||7
123490|NCT01253187|297871|P2|COMPLETED|Period 3||7
123491|NCT01253187|297872|P1|COMPLETED|Period 3||6
123492|NCT01253187|297867|P6|STARTED|Period 3||6
123493|NCT01253187|297868|P5|STARTED|Period 3||8
123494|NCT01253187|297869|P4|STARTED|Period 3||7
123495|NCT01253187|297870|P3|STARTED|Period 3||7
123496|NCT01253187|297871|P2|STARTED|Period 3||8
123497|NCT01253187|297872|P1|STARTED|Period 3||7
123498|NCT01253187|297867|P6|NOT COMPLETED|Period 2||0
123499|NCT01253187|297868|P5|NOT COMPLETED|Period 2||1
123500|NCT01253187|297869|P4|NOT COMPLETED|Period 2||0
123501|NCT01253187|297870|P3|NOT COMPLETED|Period 2||0
123502|NCT01253187|297871|P2|NOT COMPLETED|Period 2||0
123503|NCT01253187|297872|P1|NOT COMPLETED|Period 2||0
123504|NCT01253187|297867|P6|COMPLETED|Period 2||6
123505|NCT01253187|297868|P5|COMPLETED|Period 2||8
123506|NCT01253187|297869|P4|COMPLETED|Period 2||7
123507|NCT01253187|297870|P3|COMPLETED|Period 2||7
123508|NCT01253187|297871|P2|COMPLETED|Period 2||8
123509|NCT01253187|297872|P1|COMPLETED|Period 2||7
123510|NCT01253187|297867|P6|STARTED|Period 2||6
123511|NCT01253187|297868|P5|STARTED|Period 2||9
123512|NCT01253187|297869|P4|STARTED|Period 2||7
123513|NCT01253187|297870|P3|STARTED|Period 2||7
123514|NCT01253187|297871|P2|STARTED|Period 2||8
123515|NCT01253187|297872|P1|STARTED|Period 2||7
123516|NCT01253187|297867|P6|NOT COMPLETED|Period 1||0
123517|NCT01253187|297868|P5|NOT COMPLETED|Period 1||0
123518|NCT01253187|297869|P4|NOT COMPLETED|Period 1||0
123519|NCT01253187|297870|P3|NOT COMPLETED|Period 1||0
123520|NCT01253187|297871|P2|NOT COMPLETED|Period 1||0
123521|NCT01253187|297872|P1|NOT COMPLETED|Period 1||0
123522|NCT01253187|297867|P6|COMPLETED|Period 1||6
123523|NCT01253187|297868|P5|COMPLETED|Period 1||9
123524|NCT01253187|297869|P4|COMPLETED|Period 1||7
123525|NCT01253187|297870|P3|COMPLETED|Period 1||7
123526|NCT01253187|297871|P2|COMPLETED|Period 1||8
123527|NCT01253187|297872|P1|COMPLETED|Period 1||7
123528|NCT01253187|297867|P6|STARTED|Period 1||6
123529|NCT01253187|297868|P5|STARTED|Period 1||9
123530|NCT01253187|297869|P4|STARTED|Period 1||7
123531|NCT01253187|297870|P3|STARTED|Period 1||7
123532|NCT01253187|297871|P2|STARTED|Period 1||8
123533|NCT01253187|297872|P1|STARTED|Period 1||7
123534|NCT01253174|297901|P6|NOT COMPLETED|Period 3||0
123535|NCT01253174|297902|P5|NOT COMPLETED|Period 3||1
123536|NCT01253174|297903|P4|NOT COMPLETED|Period 3||0
123537|NCT01253174|297904|P3|NOT COMPLETED|Period 3||1
123538|NCT01253174|297905|P2|NOT COMPLETED|Period 3||1
123539|NCT01253174|297906|P1|NOT COMPLETED|Period 3||0
123540|NCT01253174|297901|P6|COMPLETED|Period 3||7
123541|NCT01253174|297902|P5|COMPLETED|Period 3||7
123542|NCT01253174|297903|P4|COMPLETED|Period 3||7
123543|NCT01253174|297904|P3|COMPLETED|Period 3||6
123544|NCT01253174|297905|P2|COMPLETED|Period 3||8
123545|NCT01253174|297906|P1|COMPLETED|Period 3||6
123546|NCT01253174|297901|P6|STARTED|Period 3||7
123547|NCT01253174|297902|P5|STARTED|Period 3||8
123548|NCT01253174|297903|P4|STARTED|Period 3||7
123549|NCT01253174|297904|P3|STARTED|Period 3||7
123550|NCT01253174|297905|P2|STARTED|Period 3||9
123551|NCT01253174|297906|P1|STARTED|Period 3||6
123552|NCT01253174|297901|P6|NOT COMPLETED|Period 2||0
123553|NCT01253174|297902|P5|NOT COMPLETED|Period 2||0
123554|NCT01253174|297903|P4|NOT COMPLETED|Period 2||0
123555|NCT01253174|297904|P3|NOT COMPLETED|Period 2||1
123556|NCT01253174|297905|P2|NOT COMPLETED|Period 2||0
123557|NCT01253174|297906|P1|NOT COMPLETED|Period 2||0
123558|NCT01253174|297901|P6|COMPLETED|Period 2||7
123559|NCT01253174|297902|P5|COMPLETED|Period 2||8
123560|NCT01253174|297903|P4|COMPLETED|Period 2||7
123561|NCT01253174|297904|P3|COMPLETED|Period 2||7
123562|NCT01253174|297905|P2|COMPLETED|Period 2||9
123563|NCT01253174|297906|P1|COMPLETED|Period 2||6
123564|NCT01253174|297901|P6|STARTED|Period 2||7
123565|NCT01253174|297902|P5|STARTED|Period 2||8
123566|NCT01253174|297903|P4|STARTED|Period 2||7
123567|NCT01253174|297904|P3|STARTED|Period 2||8
123568|NCT01253174|297905|P2|STARTED|Period 2||9
123569|NCT01253174|297906|P1|STARTED|Period 2||6
123570|NCT01253174|297901|P6|NOT COMPLETED|Period 1||0
123571|NCT01253174|297902|P5|NOT COMPLETED|Period 1||1
123572|NCT01253174|297903|P4|NOT COMPLETED|Period 1||0
123573|NCT01253174|297904|P3|NOT COMPLETED|Period 1||1
123574|NCT01253174|297905|P2|NOT COMPLETED|Period 1||1
123575|NCT01253174|297906|P1|NOT COMPLETED|Period 1||0
123576|NCT01253174|297901|P6|COMPLETED|Period 1||7
123577|NCT01253174|297902|P5|COMPLETED|Period 1||8
123578|NCT01253174|297903|P4|COMPLETED|Period 1||7
123579|NCT01253174|297904|P3|COMPLETED|Period 1||8
123580|NCT01253174|297905|P2|COMPLETED|Period 1||9
123581|NCT01253174|297906|P1|COMPLETED|Period 1||6
123582|NCT01253174|297901|P6|STARTED|Period 1||7
123583|NCT01253174|297902|P5|STARTED|Period 1||9
123584|NCT01253174|297903|P4|STARTED|Period 1||7
123585|NCT01253174|297904|P3|STARTED|Period 1||9
123586|NCT01253174|297905|P2|STARTED|Period 1||10
123587|NCT01253174|297906|P1|STARTED|Period 1||6
123588|NCT01253148|297935|P1|NOT COMPLETED|Overall Study||0
123589|NCT01253148|297935|P1|COMPLETED|Overall Study||25
123590|NCT01253148|297935|P1|STARTED|Overall Study||25
123591|NCT01253135|297941|P1|NOT COMPLETED|Amended Protocol||1
123592|NCT01253135|297941|P1|COMPLETED|Amended Protocol||24
123593|NCT01253135|297941|P1|STARTED|Amended Protocol||25
123594|NCT01253135|297941|P1|NOT COMPLETED|Original Protocol||15
123595|NCT01253135|297941|P1|COMPLETED|Original Protocol||0
123596|NCT01253135|297941|P1|STARTED|Original Protocol||15
123597|NCT01253070|297949|P1|NOT COMPLETED|Overall Study||0
123598|NCT01253070|297949|P1|COMPLETED|Overall Study||54
123599|NCT01253070|297949|P1|STARTED|Overall Study||54
123600|NCT01253044|297960|P2|NOT COMPLETED|Overall Study||29
123601|NCT01253044|297961|P1|NOT COMPLETED|Overall Study||38
123602|NCT01253044|297960|P2|COMPLETED|Overall Study||51
123603|NCT01253044|297961|P1|COMPLETED|Overall Study||42
123604|NCT01253044|297960|P2|STARTED|Overall Study||80
123605|NCT01253044|297961|P1|STARTED|Overall Study||80
123606|NCT01253018|297971|P2|NOT COMPLETED|Overall Study||2
123607|NCT01253018|297972|P1|NOT COMPLETED|Overall Study||4
123608|NCT01253018|297971|P2|COMPLETED|Overall Study||21
123609|NCT01253018|297972|P1|COMPLETED|Overall Study||18
123610|NCT01253018|297971|P2|STARTED|Overall Study||23
123611|NCT01253018|297972|P1|STARTED|Overall Study||22
123612|NCT01252966|297986|P2|NOT COMPLETED|Overall Study||13
123613|NCT01252966|297987|P1|NOT COMPLETED|Overall Study||23
123614|NCT01252966|297986|P2|COMPLETED|Overall Study||92
123615|NCT01252966|297987|P1|COMPLETED|Overall Study||85
123616|NCT01252966|297986|P2|STARTED|Overall Study||105
123617|NCT01252966|297987|P1|STARTED|Overall Study||108
123618|NCT01252953|298003|P2|NOT COMPLETED|Overall Study||38
123619|NCT01252953|298004|P1|NOT COMPLETED|Overall Study||38
123620|NCT01252953|298003|P2|COMPLETED|Overall Study||15186
123621|NCT01252953|298004|P1|COMPLETED|Overall Study||15187
123622|NCT01252953|298003|P2|STARTED|Overall Study||15224
123623|NCT01252953|298004|P1|STARTED|Overall Study||15225
123624|NCT01252940|298018|P2|NOT COMPLETED|Extension Phase||3
123625|NCT01252940|298019|P1|NOT COMPLETED|Extension Phase||10
123626|NCT01252940|298018|P2|COMPLETED|Extension Phase||46
123627|NCT01252940|298019|P1|COMPLETED|Extension Phase||100
123628|NCT01252940|298018|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
123629|NCT01252940|298019|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
123630|NCT01252940|298018|P2|NOT COMPLETED|Main Study Phase||12
123631|NCT01252940|298019|P1|NOT COMPLETED|Main Study Phase||26
123632|NCT01252940|298018|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
123633|NCT01252940|298019|P1|COMPLETED|Main Study Phase||295
123634|NCT01252940|298018|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
123635|NCT01252940|298019|P1|Completed 24 Weeks|Main Study Phase||0
123636|NCT01252940|298018|P2|STARTED|Main Study Phase||161
123637|NCT01252940|298019|P1|STARTED|Main Study Phase||321
123638|NCT01252810|298050|P2|NOT COMPLETED|Overall Study||3
123639|NCT01252810|298051|P1|NOT COMPLETED|Overall Study||14
123640|NCT01252810|298050|P2|COMPLETED|Overall Study||139
123641|NCT01252810|298051|P1|COMPLETED|Overall Study||128
123642|NCT01252810|298050|P2|STARTED|Overall Study||142
123643|NCT01252810|298051|P1|STARTED|Overall Study||142
123644|NCT01252745|298064|P3|NOT COMPLETED|Overall Study||0
123645|NCT01252745|298065|P2|NOT COMPLETED|Overall Study||0
123646|NCT01252745|298066|P1|NOT COMPLETED|Overall Study||0
123647|NCT01252745|298064|P3|COMPLETED|Overall Study||7
123648|NCT01252745|298065|P2|COMPLETED|Overall Study||7
123649|NCT01252745|298066|P1|COMPLETED|Overall Study||8
123650|NCT01252745|298064|P3|STARTED|Overall Study||7
123651|NCT01252745|298065|P2|STARTED|Overall Study||7
123652|NCT01252745|298066|P1|STARTED|Overall Study||8
123653|NCT01252355|298083|P3|NOT COMPLETED|Overall Study||179
123654|NCT01252355|298084|P2|NOT COMPLETED|Overall Study||178
123655|NCT01252355|298085|P1|NOT COMPLETED|Overall Study||177
123656|NCT01252355|298083|P3|COMPLETED|Overall Study||0
123657|NCT01252355|298084|P2|COMPLETED|Overall Study||0
123658|NCT01252355|298085|P1|COMPLETED|Overall Study||0
123659|NCT01252355|298083|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
123660|NCT01252355|298084|P2|Treated|Overall Study||178
123661|NCT01252355|298085|P1|Treated|Overall Study||175
123662|NCT01252355|298083|P3|STARTED|Overall Study|Randomized.|179
123663|NCT01252355|298084|P2|STARTED|Overall Study|Randomized.|178
123664|NCT01252355|298085|P1|STARTED|Overall Study|Randomized.|177
123665|NCT01252290|298123|P1|NOT COMPLETED|Overall Study||1
123666|NCT01252290|298123|P1|COMPLETED|Overall Study||34
123667|NCT01252290|298123|P1|STARTED|Overall Study||35
123668|NCT01252277|298131|P1|NOT COMPLETED|Overall Study||2
123669|NCT01252277|298131|P1|COMPLETED|Overall Study||34
123670|NCT01252277|298131|P1|STARTED|Overall Study||36
123671|NCT01252251|298139|P1|NOT COMPLETED|Overall Study||1
123672|NCT01252251|298139|P1|COMPLETED|Overall Study||13
123673|NCT01252251|298139|P1|STARTED|Overall Study||14
123674|NCT01252238|298151|P3|NOT COMPLETED|Overall Study||4
123675|NCT01252238|298152|P2|NOT COMPLETED|Overall Study||4
123676|NCT01252238|298153|P1|NOT COMPLETED|Overall Study||4
123677|NCT01252238|298151|P3|COMPLETED|Overall Study|sponsor terminated study|4
123678|NCT01252238|298152|P2|COMPLETED|Overall Study|sponsor terminated study|4
123679|NCT01252238|298153|P1|COMPLETED|Overall Study|sponsor terminated study|4
123680|NCT01252238|298151|P3|STARTED|Overall Study||8
123681|NCT01252238|298152|P2|STARTED|Overall Study||8
123682|NCT01252238|298153|P1|STARTED|Overall Study||8
123683|NCT01252186|298170|P3|NOT COMPLETED|Overall Study||34
123684|NCT01252186|298171|P2|NOT COMPLETED|Overall Study||32
123685|NCT01252186|298172|P1|NOT COMPLETED|Overall Study||30
123686|NCT01252186|298170|P3|COMPLETED|Overall Study||53
123687|NCT01252186|298171|P2|COMPLETED|Overall Study||59
123688|NCT01252186|298172|P1|COMPLETED|Overall Study||57
123689|NCT01252186|298170|P3|Received Study Drug|Overall Study||80
123690|NCT01252186|298171|P2|Received Study Drug|Overall Study||89
123691|NCT01252186|298172|P1|Received Study Drug|Overall Study||83
123692|NCT01252186|298170|P3|STARTED|Overall Study||87
123693|NCT01252186|298171|P2|STARTED|Overall Study||91
123694|NCT01252186|298172|P1|STARTED|Overall Study||87
123695|NCT01252147|298240|P1|NOT COMPLETED|Overall Study||0
123696|NCT01252147|298240|P1|COMPLETED|Overall Study||68
123697|NCT01252147|298240|P1|STARTED|Overall Study||68
123698|NCT01252134|298245|P6|NOT COMPLETED|Period 3, 8 Hours||0
123699|NCT01252134|298246|P5|NOT COMPLETED|Period 3, 8 Hours||0
123700|NCT01252134|298247|P4|NOT COMPLETED|Period 3, 8 Hours||0
123701|NCT01252134|298248|P3|NOT COMPLETED|Period 3, 8 Hours||0
123702|NCT01252134|298249|P2|NOT COMPLETED|Period 3, 8 Hours||0
123703|NCT01252134|298250|P1|NOT COMPLETED|Period 3, 8 Hours||0
123704|NCT01252134|298245|P6|COMPLETED|Period 3, 8 Hours||4
123705|NCT01252134|298246|P5|COMPLETED|Period 3, 8 Hours||3
123706|NCT01252134|298247|P4|COMPLETED|Period 3, 8 Hours||5
123707|NCT01252134|298248|P3|COMPLETED|Period 3, 8 Hours||2
123708|NCT01252134|298249|P2|COMPLETED|Period 3, 8 Hours||3
123709|NCT01252134|298250|P1|COMPLETED|Period 3, 8 Hours||3
123710|NCT01252134|298245|P6|STARTED|Period 3, 8 Hours||4
123711|NCT01252134|298246|P5|STARTED|Period 3, 8 Hours||3
123712|NCT01252134|298247|P4|STARTED|Period 3, 8 Hours||5
123713|NCT01252134|298248|P3|STARTED|Period 3, 8 Hours||2
123714|NCT01252134|298249|P2|STARTED|Period 3, 8 Hours||3
123715|NCT01252134|298250|P1|STARTED|Period 3, 8 Hours||3
123716|NCT01252134|298245|P6|NOT COMPLETED|Period 2, 8 Hours||0
123717|NCT01252134|298246|P5|NOT COMPLETED|Period 2, 8 Hours||0
123718|NCT01252134|298247|P4|NOT COMPLETED|Period 2, 8 Hours||0
123719|NCT01252134|298248|P3|NOT COMPLETED|Period 2, 8 Hours||0
123720|NCT01252134|298249|P2|NOT COMPLETED|Period 2, 8 Hours||0
123721|NCT01252134|298250|P1|NOT COMPLETED|Period 2, 8 Hours||0
123722|NCT01252134|298245|P6|COMPLETED|Period 2, 8 Hours||4
123723|NCT01252134|298246|P5|COMPLETED|Period 2, 8 Hours||3
123724|NCT01252134|298247|P4|COMPLETED|Period 2, 8 Hours||5
123725|NCT01252134|298248|P3|COMPLETED|Period 2, 8 Hours||2
123726|NCT01252134|298249|P2|COMPLETED|Period 2, 8 Hours||3
123727|NCT01252134|298250|P1|COMPLETED|Period 2, 8 Hours||3
123728|NCT01252134|298245|P6|STARTED|Period 2, 8 Hours||4
123729|NCT01252134|298246|P5|STARTED|Period 2, 8 Hours||3
123730|NCT01252134|298247|P4|STARTED|Period 2, 8 Hours||5
123731|NCT01252134|298248|P3|STARTED|Period 2, 8 Hours||2
123732|NCT01252134|298249|P2|STARTED|Period 2, 8 Hours||3
123733|NCT01252134|298250|P1|STARTED|Period 2, 8 Hours||3
123734|NCT01252134|298245|P6|NOT COMPLETED|Period 1, 8 Hours||0
123735|NCT01252134|298246|P5|NOT COMPLETED|Period 1, 8 Hours||0
123736|NCT01252134|298247|P4|NOT COMPLETED|Period 1, 8 Hours||0
123737|NCT01252134|298248|P3|NOT COMPLETED|Period 1, 8 Hours||1
123738|NCT01252134|298249|P2|NOT COMPLETED|Period 1, 8 Hours||1
123739|NCT01252134|298250|P1|NOT COMPLETED|Period 1, 8 Hours||0
123740|NCT01252134|298245|P6|COMPLETED|Period 1, 8 Hours||4
123741|NCT01252134|298246|P5|COMPLETED|Period 1, 8 Hours||3
123742|NCT01252134|298247|P4|COMPLETED|Period 1, 8 Hours||5
123743|NCT01252134|298248|P3|COMPLETED|Period 1, 8 Hours||2
123744|NCT01252134|298249|P2|COMPLETED|Period 1, 8 Hours||3
123745|NCT01252134|298250|P1|COMPLETED|Period 1, 8 Hours||3
123746|NCT01252134|298245|P6|STARTED|Period 1, 8 Hours||4
123747|NCT01252134|298246|P5|STARTED|Period 1, 8 Hours||3
123748|NCT01252134|298247|P4|STARTED|Period 1, 8 Hours||5
123749|NCT01252134|298248|P3|STARTED|Period 1, 8 Hours||3
123750|NCT01252134|298249|P2|STARTED|Period 1, 8 Hours||4
123751|NCT01252134|298250|P1|STARTED|Period 1, 8 Hours||3
123752|NCT01252095|298269|P2|NOT COMPLETED|Overall Study||0
123753|NCT01252095|298270|P1|NOT COMPLETED|Overall Study||1
123754|NCT01252095|298269|P2|COMPLETED|Overall Study||1
123755|NCT01252095|298270|P1|COMPLETED|Overall Study||2
123756|NCT01252095|298269|P2|STARTED|Overall Study||1
123757|NCT01252095|298270|P1|STARTED|Overall Study||3
123758|NCT01251978|298278|P2|NOT COMPLETED|Overall Study||0
123759|NCT01251978|298279|P1|NOT COMPLETED|Overall Study||0
123760|NCT01251978|298278|P2|COMPLETED|Overall Study||3
123761|NCT01251978|298279|P1|COMPLETED|Overall Study||5
123762|NCT01251978|298278|P2|STARTED|Overall Study||3
123763|NCT01251978|298279|P1|STARTED|Overall Study||5
123764|NCT01251952|298288|P1|NOT COMPLETED|Overall Study||1
123765|NCT01251952|298288|P1|COMPLETED|Overall Study||1
123766|NCT01251952|298288|P1|STARTED|Overall Study||2
123767|NCT01251770|298294|P2|NOT COMPLETED|Overall Study||7
123768|NCT01251770|298295|P1|NOT COMPLETED|Overall Study||13
123769|NCT01251770|298294|P2|COMPLETED|Overall Study||29
123770|NCT01251770|298295|P1|COMPLETED|Overall Study||29
123771|NCT01251770|298294|P2|STARTED|Overall Study||36
123772|NCT01251770|298295|P1|STARTED|Overall Study||42
123773|NCT01251757|298306|P3|NOT COMPLETED|Overall Study||0
123774|NCT01251757|298307|P2|NOT COMPLETED|Overall Study||0
123775|NCT01251757|298308|P1|NOT COMPLETED|Overall Study||0
123776|NCT01251757|298306|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
123777|NCT01251757|298307|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
123778|NCT01251757|298308|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
123779|NCT01251757|298306|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
123780|NCT01251757|298307|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
123781|NCT01251757|298308|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
123782|NCT01251653|298346|P9|NOT COMPLETED|Overall Study||6
123783|NCT01251653|298347|P8|NOT COMPLETED|Overall Study||12
123784|NCT01251653|298348|P7|NOT COMPLETED|Overall Study||18
123785|NCT01251653|298349|P6|NOT COMPLETED|Overall Study||18
123786|NCT01251653|298350|P5|NOT COMPLETED|Overall Study||2
123787|NCT01251653|298351|P4|NOT COMPLETED|Overall Study||6
123788|NCT01251653|298352|P3|NOT COMPLETED|Overall Study||20
123789|NCT01251653|298353|P2|NOT COMPLETED|Overall Study||8
123790|NCT01251653|298354|P1|NOT COMPLETED|Overall Study||3
123791|NCT01251653|298346|P9|COMPLETED|Overall Study||0
123792|NCT01251653|298347|P8|COMPLETED|Overall Study||0
123793|NCT01251653|298348|P7|COMPLETED|Overall Study||0
123794|NCT01251653|298349|P6|COMPLETED|Overall Study||0
123795|NCT01251653|298350|P5|COMPLETED|Overall Study||0
123796|NCT01251653|298351|P4|COMPLETED|Overall Study||0
123797|NCT01251653|298352|P3|COMPLETED|Overall Study||0
123798|NCT01251653|298353|P2|COMPLETED|Overall Study||0
123799|NCT01251653|298354|P1|COMPLETED|Overall Study||0
123800|NCT01251653|298346|P9|STARTED|Overall Study||6
123801|NCT01251653|298347|P8|STARTED|Overall Study||12
123802|NCT01251653|298348|P7|STARTED|Overall Study||18
123803|NCT01251653|298349|P6|STARTED|Overall Study||18
123804|NCT01251653|298350|P5|STARTED|Overall Study||2
123805|NCT01251653|298351|P4|STARTED|Overall Study||6
123806|NCT01251653|298352|P3|STARTED|Overall Study||20
123807|NCT01251653|298353|P2|STARTED|Overall Study||8
123808|NCT01251653|298354|P1|STARTED|Overall Study||3
123809|NCT01251614|298482|P3|NOT COMPLETED|Overall Study||8
123810|NCT01251614|298483|P2|NOT COMPLETED|Overall Study||13
123811|NCT01251614|298484|P1|NOT COMPLETED|Overall Study||3
123812|NCT01251614|298482|P3|COMPLETED|Overall Study||30
123813|NCT01251614|298483|P2|COMPLETED|Overall Study||26
123814|NCT01251614|298484|P1|COMPLETED|Overall Study||34
123815|NCT01251614|298482|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
123816|NCT01251614|298483|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
123817|NCT01251614|298484|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
123818|NCT01251614|298482|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
123819|NCT01251614|298483|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
123820|NCT01251614|298484|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
123821|NCT01251614|298482|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
123822|NCT01251614|298483|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
123823|NCT01251614|298484|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
123824|NCT01251614|298482|P3|STARTED|Overall Study||38
123825|NCT01251614|298483|P2|STARTED|Overall Study||39
123826|NCT01251614|298484|P1|STARTED|Overall Study||37
123827|NCT01251588|298558|P2|NOT COMPLETED|Overall Study||4
123828|NCT01251588|298559|P1|NOT COMPLETED|Overall Study||0
123829|NCT01251588|298558|P2|COMPLETED|Overall Study||59
123830|NCT01251588|298559|P1|COMPLETED|Overall Study||65
123831|NCT01251588|298558|P2|STARTED|Overall Study||63
123832|NCT01251588|298559|P1|STARTED|Overall Study||65
123833|NCT01251380|298591|P1|NOT COMPLETED|Overall Study||22
123834|NCT01251380|298591|P1|COMPLETED|Overall Study||194
123835|NCT01251380|298591|P1|Cycle 4|Overall Study||11
123836|NCT01251380|298591|P1|Cycle 3|Overall Study||86
123837|NCT01251380|298591|P1|Cycle 2|Overall Study||175
123838|NCT01251380|298591|P1|Cycle 1|Overall Study||207
123839|NCT01251380|298591|P1|STARTED|Overall Study|Safety population.|216
123840|NCT01251367|298615|P1|NOT COMPLETED|Overall Study||76
123841|NCT01251367|298615|P1|COMPLETED|Overall Study||269
123842|NCT01251367|298615|P1|Cycle 4|Overall Study||139
123843|NCT01251367|298615|P1|Cycle 3|Overall Study||224
123844|NCT01251367|298615|P1|Cycle 2|Overall Study||297
123845|NCT01251367|298615|P1|Cycle 1|Overall Study||345
123846|NCT01251367|298615|P1|STARTED|Overall Study||345
123847|NCT01251354|298650|P1|NOT COMPLETED|Overall Study||6
123848|NCT01251354|298650|P1|COMPLETED|Overall Study||0
123849|NCT01251354|298650|P1|STARTED|Overall Study||6
123850|NCT01251315|298666|P6|NOT COMPLETED|Overall Study||0
123851|NCT01251315|298667|P5|NOT COMPLETED|Overall Study||0
123852|NCT01251315|298668|P4|NOT COMPLETED|Overall Study||0
123853|NCT01251315|298669|P3|NOT COMPLETED|Overall Study||0
123854|NCT01251315|298670|P2|NOT COMPLETED|Overall Study||0
123855|NCT01251315|298671|P1|NOT COMPLETED|Overall Study||0
123856|NCT01251315|298666|P6|COMPLETED|Overall Study||4
123857|NCT01251315|298667|P5|COMPLETED|Overall Study||4
123858|NCT01251315|298668|P4|COMPLETED|Overall Study||4
123859|NCT01251315|298669|P3|COMPLETED|Overall Study||4
123860|NCT01251315|298670|P2|COMPLETED|Overall Study||4
123861|NCT01251315|298671|P1|COMPLETED|Overall Study||4
123862|NCT01251315|298666|P6|STARTED|Overall Study||4
123863|NCT01251315|298667|P5|STARTED|Overall Study||4
123864|NCT01251315|298668|P4|STARTED|Overall Study||4
123865|NCT01251315|298669|P3|STARTED|Overall Study||4
123866|NCT01251315|298670|P2|STARTED|Overall Study||4
123867|NCT01251315|298671|P1|STARTED|Overall Study||4
123868|NCT01251276|298693|P2|NOT COMPLETED|Overall Study||1
123869|NCT01251276|298694|P1|NOT COMPLETED|Overall Study||1
123870|NCT01251276|298693|P2|COMPLETED|Overall Study||107
123871|NCT01251276|298694|P1|COMPLETED|Overall Study||95
123872|NCT01251276|298693|P2|Vaccinated|Overall Study||108
123873|NCT01251276|298694|P1|Vaccinated|Overall Study||96
123874|NCT01251276|298693|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
123875|NCT01251276|298694|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
123876|NCT01251146|298712|P2|NOT COMPLETED|Overall Study||10
123877|NCT01251146|298713|P1|NOT COMPLETED|Overall Study||3
123878|NCT01251146|298712|P2|COMPLETED|Overall Study||81
123879|NCT01251146|298713|P1|COMPLETED|Overall Study||83
123880|NCT01251146|298712|P2|STARTED|Overall Study||91
123881|NCT01251146|298713|P1|STARTED|Overall Study||86
123882|NCT01251120|298735|P2|NOT COMPLETED|Overall Study||1
123883|NCT01251120|298736|P1|NOT COMPLETED|Overall Study||0
123884|NCT01251120|298735|P2|COMPLETED|Overall Study||0
123885|NCT01251120|298736|P1|COMPLETED|Overall Study||1
123886|NCT01251120|298735|P2|STARTED|Overall Study||1
123887|NCT01251120|298736|P1|STARTED|Overall Study||1
123888|NCT01251042|298758|P2|NOT COMPLETED|Overall Study||0
123889|NCT01251042|298759|P1|NOT COMPLETED|Overall Study||0
123890|NCT01251042|298758|P2|COMPLETED|Overall Study||23
123891|NCT01251042|298759|P1|COMPLETED|Overall Study||26
123892|NCT01251042|298758|P2|STARTED|Overall Study||23
123893|NCT01251042|298759|P1|STARTED|Overall Study||26
123894|NCT01250990|298791|P2|NOT COMPLETED|Overall Study||2
123895|NCT01250990|298792|P1|NOT COMPLETED|Overall Study||4
123896|NCT01250990|298791|P2|COMPLETED|Overall Study||9
123897|NCT01250990|298792|P1|COMPLETED|Overall Study||7
123898|NCT01250990|298791|P2|STARTED|Overall Study||11
123899|NCT01250990|298792|P1|STARTED|Overall Study||11
123900|NCT01250925|298801|P3|NOT COMPLETED|Overall Study||2
123901|NCT01250925|298802|P2|NOT COMPLETED|Overall Study||3
123902|NCT01250925|298803|P1|NOT COMPLETED|Overall Study||5
123903|NCT01250925|298801|P3|COMPLETED|Overall Study||30
123904|NCT01250925|298802|P2|COMPLETED|Overall Study||28
123905|NCT01250925|298803|P1|COMPLETED|Overall Study||26
123906|NCT01250925|298801|P3|STARTED|Overall Study||32
123907|NCT01250925|298802|P2|STARTED|Overall Study||31
123908|NCT01250925|298803|P1|STARTED|Overall Study||31
123909|NCT01250899|298843|P2|NOT COMPLETED|Overall Study||0
123910|NCT01250899|298844|P1|NOT COMPLETED|Overall Study||0
123911|NCT01250899|298843|P2|COMPLETED|Overall Study||82
123912|NCT01250899|298844|P1|COMPLETED|Overall Study||40
123913|NCT01250899|298843|P2|STARTED|Overall Study||82
123914|NCT01250899|298844|P1|STARTED|Overall Study||40
123915|NCT01250834|298848|P1|NOT COMPLETED|Overall Study||0
123916|NCT01250834|298848|P1|COMPLETED|Overall Study||27
123917|NCT01250834|298848|P1|STARTED|Overall Study||27
123918|NCT01250769|298869|P4|NOT COMPLETED|Overall Study||0
123919|NCT01250769|298870|P3|NOT COMPLETED|Overall Study||2
123920|NCT01250769|298871|P2|NOT COMPLETED|Overall Study||1
123921|NCT01250769|298872|P1|NOT COMPLETED|Overall Study||0
123922|NCT01250769|298869|P4|COMPLETED|Overall Study||11
123923|NCT01250769|298870|P3|COMPLETED|Overall Study||73
123924|NCT01250769|298871|P2|COMPLETED|Overall Study||72
123925|NCT01250769|298872|P1|COMPLETED|Overall Study||11
123926|NCT01250769|298869|P4|Day 14|Overall Study||11
123927|NCT01250769|298870|P3|Day 14|Overall Study||74
123928|NCT01250769|298871|P2|Day 14|Overall Study||72
123929|NCT01250769|298872|P1|Day 14|Overall Study||11
123930|NCT01250769|298869|P4|STARTED|Overall Study||11
123931|NCT01250769|298870|P3|STARTED|Overall Study||75
123932|NCT01250769|298871|P2|STARTED|Overall Study||73
123933|NCT01250769|298872|P1|STARTED|Overall Study||11
123934|NCT01250756|298904|P2|NOT COMPLETED|After Toddler Dose||1
123935|NCT01250756|298905|P1|NOT COMPLETED|After Toddler Dose||0
123936|NCT01250756|298904|P2|COMPLETED|After Toddler Dose||147
123937|NCT01250756|298905|P1|COMPLETED|After Toddler Dose||0
123938|NCT01250756|298904|P2|STARTED|After Toddler Dose||148
123939|NCT01250756|298905|P1|STARTED|After Toddler Dose||0
123940|NCT01250756|298904|P2|NOT COMPLETED|Toddler Dose||1
123941|NCT01250756|298905|P1|NOT COMPLETED|Toddler Dose||0
123942|NCT01250756|298904|P2|COMPLETED|Toddler Dose||148
123943|NCT01250756|298905|P1|COMPLETED|Toddler Dose||122
123944|NCT01250756|298904|P2|STARTED|Toddler Dose||149
123945|NCT01250756|298905|P1|STARTED|Toddler Dose||122
123946|NCT01250756|298904|P2|NOT COMPLETED|After Infant Series||4
123947|NCT01250756|298905|P1|NOT COMPLETED|After Infant Series||11
123948|NCT01250756|298904|P2|COMPLETED|After Infant Series||149
123949|NCT01250756|298905|P1|COMPLETED|After Infant Series||122
123950|NCT01250756|298904|P2|STARTED|After Infant Series||153
123951|NCT01250756|298905|P1|STARTED|After Infant Series||133
123952|NCT01250756|298904|P2|NOT COMPLETED|Infant Series||7
123953|NCT01250756|298905|P1|NOT COMPLETED|Infant Series||28
123954|NCT01250756|298904|P2|COMPLETED|Infant Series||153
123955|NCT01250756|298905|P1|COMPLETED|Infant Series||133
123956|NCT01250756|298904|P2|Vaccinated Dose 3|Infant Series||155
123957|NCT01250756|298905|P1|Vaccinated Dose 3|Infant Series||133
123958|NCT01250756|298904|P2|Vaccinated Dose 2|Infant Series||157
123959|NCT01250756|298905|P1|Vaccinated Dose 2|Infant Series||147
123960|NCT01250756|298904|P2|Vaccinated Dose 1|Infant Series||158
123961|NCT01250756|298905|P1|Vaccinated Dose 1|Infant Series||159
123962|NCT01250756|298904|P2|STARTED|Infant Series||160
123963|NCT01250756|298905|P1|STARTED|Infant Series||161
123964|NCT01250730|298958|P3|NOT COMPLETED|Overall Study||0
123965|NCT01250730|298959|P2|NOT COMPLETED|Overall Study||0
123966|NCT01250730|298960|P1|NOT COMPLETED|Overall Study||0
123967|NCT01250730|298958|P3|COMPLETED|Overall Study||6
123968|NCT01250730|298959|P2|COMPLETED|Overall Study||6
123969|NCT01250730|298960|P1|COMPLETED|Overall Study||6
123970|NCT01250730|298958|P3|STARTED|Overall Study||6
123971|NCT01250730|298959|P2|STARTED|Overall Study||6
123972|NCT01250730|298960|P1|STARTED|Overall Study||6
123973|NCT01250717|299016|P1|NOT COMPLETED|Overall Study||0
123974|NCT01250717|299016|P1|COMPLETED|Overall Study||28
123975|NCT01250717|299016|P1|STARTED|Overall Study||28
123976|NCT01250509|299022|P2|NOT COMPLETED|Overall Study||2
123977|NCT01250509|299023|P1|NOT COMPLETED|Overall Study||5
123978|NCT01250509|299022|P2|COMPLETED|Overall Study||21
123979|NCT01250509|299023|P1|COMPLETED|Overall Study||19
123980|NCT01250509|299022|P2|STARTED|Overall Study||23
123981|NCT01250509|299023|P1|STARTED|Overall Study||24
123982|NCT01250418|299037|P2|NOT COMPLETED|Overall Study||1
123983|NCT01250418|299038|P1|NOT COMPLETED|Overall Study||1
123984|NCT01250418|299037|P2|COMPLETED|Overall Study||15
123985|NCT01250418|299038|P1|COMPLETED|Overall Study||8
123986|NCT01250418|299037|P2|STARTED|Overall Study||16
123987|NCT01250418|299038|P1|STARTED|Overall Study||9
123988|NCT01250379|299046|P2|NOT COMPLETED|Overall Study||193
123989|NCT01250379|299047|P1|NOT COMPLETED|Overall Study||202
123990|NCT01250379|299046|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
123991|NCT01250379|299047|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
123992|NCT01250379|299046|P2|STARTED|Overall Study||247
123993|NCT01250379|299047|P1|STARTED|Overall Study||247
123994|NCT01250184|299108|P3|NOT COMPLETED|Overall Study||0
123995|NCT01250184|299109|P2|NOT COMPLETED|Overall Study||0
123996|NCT01250184|299110|P1|NOT COMPLETED|Overall Study||0
123997|NCT01250184|299108|P3|COMPLETED|Overall Study||43
123998|NCT01250184|299109|P2|COMPLETED|Overall Study||41
123999|NCT01250184|299110|P1|COMPLETED|Overall Study||43
124000|NCT01250184|299108|P3|STARTED|Overall Study||43
124001|NCT01250184|299109|P2|STARTED|Overall Study||41
124002|NCT01250184|299110|P1|STARTED|Overall Study||43
124003|NCT01250171|299136|P3|NOT COMPLETED|Overall Study||0
124004|NCT01250171|299137|P2|NOT COMPLETED|Overall Study||0
124005|NCT01250171|299138|P1|NOT COMPLETED|Overall Study||1
124006|NCT01250171|299136|P3|COMPLETED|Overall Study||24
124007|NCT01250171|299137|P2|COMPLETED|Overall Study||22
124008|NCT01250171|299138|P1|COMPLETED|Overall Study||25
124009|NCT01250171|299136|P3|STARTED|Overall Study||24
124010|NCT01250171|299137|P2|STARTED|Overall Study||22
124011|NCT01250171|299138|P1|STARTED|Overall Study||26
124012|NCT01250145|299169|P2|NOT COMPLETED|Overall Study||5
124013|NCT01250145|299170|P1|NOT COMPLETED|Overall Study||2
124014|NCT01250145|299169|P2|COMPLETED|Overall Study||205
124015|NCT01250145|299170|P1|COMPLETED|Overall Study||39
124016|NCT01250145|299169|P2|STARTED|Overall Study||210
124017|NCT01250145|299170|P1|STARTED|Overall Study||41
124018|NCT01250119|299190|P2|NOT COMPLETED|Treatment Phase||41
124019|NCT01250119|299191|P1|NOT COMPLETED|Treatment Phase||0
124020|NCT01250119|299190|P2|COMPLETED|Treatment Phase||0
124021|NCT01250119|299191|P1|COMPLETED|Treatment Phase||0
124022|NCT01250119|299190|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
124023|NCT01250119|299191|P1|STARTED|Treatment Phase||0
124024|NCT01250119|299190|P2|NOT COMPLETED|Diagnostic Phase||0
124025|NCT01250119|299191|P1|NOT COMPLETED|Diagnostic Phase||113
124026|NCT01250119|299190|P2|COMPLETED|Diagnostic Phase||0
124027|NCT01250119|299191|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
124028|NCT01250119|299190|P2|STARTED|Diagnostic Phase||0
124029|NCT01250119|299191|P1|STARTED|Diagnostic Phase||688
124030|NCT01250054|299206|P2|NOT COMPLETED|Period 2, One Week of Wear||0
124031|NCT01250054|299207|P1|NOT COMPLETED|Period 2, One Week of Wear||1
124032|NCT01250054|299206|P2|COMPLETED|Period 2, One Week of Wear||8
124033|NCT01250054|299207|P1|COMPLETED|Period 2, One Week of Wear||6
124034|NCT01250054|299206|P2|STARTED|Period 2, One Week of Wear||8
124035|NCT01250054|299207|P1|STARTED|Period 2, One Week of Wear||7
124036|NCT01250054|299206|P2|NOT COMPLETED|Period 1, One Week of Wear||0
124037|NCT01250054|299207|P1|NOT COMPLETED|Period 1, One Week of Wear||0
124038|NCT01250054|299206|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
124039|NCT01250054|299207|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
124040|NCT01250054|299206|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
124041|NCT01250054|299207|P1|STARTED|Period 1, One Week of Wear||8
124042|NCT01250002|299215|P2|NOT COMPLETED|Overall Study||3
124043|NCT01250002|299216|P1|NOT COMPLETED|Overall Study||4
124044|NCT01250002|299215|P2|COMPLETED|Overall Study||32
124045|NCT01250002|299216|P1|COMPLETED|Overall Study||31
124046|NCT01250002|299215|P2|STARTED|Overall Study||35
124047|NCT01250002|299216|P1|STARTED|Overall Study||35
124048|NCT01249872|299230|P6|NOT COMPLETED|Overall Study||0
124049|NCT01249872|299231|P5|NOT COMPLETED|Overall Study||0
124050|NCT01249872|299232|P4|NOT COMPLETED|Overall Study||0
124051|NCT01249872|299233|P3|NOT COMPLETED|Overall Study||0
124052|NCT01249872|299234|P2|NOT COMPLETED|Overall Study||0
124053|NCT01249872|299235|P1|NOT COMPLETED|Overall Study||0
124054|NCT01249872|299230|P6|COMPLETED|Overall Study||16
124055|NCT01249872|299231|P5|COMPLETED|Overall Study||16
124056|NCT01249872|299232|P4|COMPLETED|Overall Study||16
124057|NCT01249872|299233|P3|COMPLETED|Overall Study||16
124058|NCT01249872|299234|P2|COMPLETED|Overall Study||16
124059|NCT01249872|299235|P1|COMPLETED|Overall Study||16
124060|NCT01249872|299230|P6|STARTED|Overall Study||16
124061|NCT01249872|299231|P5|STARTED|Overall Study||16
124062|NCT01249872|299232|P4|STARTED|Overall Study||16
124063|NCT01249872|299233|P3|STARTED|Overall Study||16
124064|NCT01249872|299234|P2|STARTED|Overall Study||16
124065|NCT01249872|299235|P1|STARTED|Overall Study||16
124066|NCT01249833|299281|P2|NOT COMPLETED|Overall Study||1
124067|NCT01249833|299282|P1|NOT COMPLETED|Overall Study||0
124068|NCT01249833|299281|P2|COMPLETED|Overall Study||62
124069|NCT01249833|299282|P1|COMPLETED|Overall Study||59
124070|NCT01249833|299281|P2|STARTED|Overall Study||63
124071|NCT01249833|299282|P1|STARTED|Overall Study||59
124072|NCT01249664|299296|P2|NOT COMPLETED|Overall Study||0
124073|NCT01249664|299297|P1|NOT COMPLETED|Overall Study||6
124074|NCT01249664|299296|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
124075|NCT01249664|299297|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
124076|NCT01249664|299296|P2|Completed 48 Weeks Treatment|Overall Study||24
124077|NCT01249664|299297|P1|Completed 48 Weeks Treatment|Overall Study||78
124078|NCT01249664|299296|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
124079|NCT01249664|299297|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
124080|NCT01249664|299296|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
124081|NCT01249664|299297|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
124082|NCT01249664|299296|P2|Participants Received Treatment|Overall Study|Safety population|31
124083|NCT01249664|299297|P1|Participants Received Treatment|Overall Study|Safety population|91
124084|NCT01249664|299296|P2|STARTED|Overall Study||31
124085|NCT01249664|299297|P1|STARTED|Overall Study||91
124086|NCT01249651|299347|P1|NOT COMPLETED|Overall Study||7
124087|NCT01249651|299347|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
124088|NCT01249651|299347|P1|STARTED|Overall Study|Enrolled|101
124089|NCT01249417|299357|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
124090|NCT01249417|299358|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
124091|NCT01249417|299359|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
124092|NCT01249417|299357|P3|COMPLETED|Treatment Phase - ITT Population||73
124093|NCT01249417|299358|P2|COMPLETED|Treatment Phase - ITT Population||75
124094|NCT01249417|299359|P1|COMPLETED|Treatment Phase - ITT Population||78
124095|NCT01249417|299357|P3|STARTED|Treatment Phase - ITT Population||77
124096|NCT01249417|299358|P2|STARTED|Treatment Phase - ITT Population||79
124097|NCT01249417|299359|P1|STARTED|Treatment Phase - ITT Population||79
124098|NCT01249417|299357|P3|NOT COMPLETED|Randomised Population||4
124099|NCT01249417|299358|P2|NOT COMPLETED|Randomised Population||1
124100|NCT01249417|299359|P1|NOT COMPLETED|Randomised Population||1
124101|NCT01249417|299357|P3|COMPLETED|Randomised Population||77
124102|NCT01249417|299358|P2|COMPLETED|Randomised Population||79
124103|NCT01249417|299359|P1|COMPLETED|Randomised Population||79
124104|NCT01249417|299357|P3|Treated|Randomised Population||79
124105|NCT01249417|299358|P2|Treated|Randomised Population||80
124106|NCT01249417|299359|P1|Treated|Randomised Population||80
124107|NCT01249417|299357|P3|STARTED|Randomised Population||81
124108|NCT01249417|299358|P2|STARTED|Randomised Population||80
124109|NCT01249417|299359|P1|STARTED|Randomised Population||80
124110|NCT01249404|299376|P3|NOT COMPLETED|Overall Study||7
124111|NCT01249404|299377|P2|NOT COMPLETED|Overall Study||8
124112|NCT01249404|299378|P1|NOT COMPLETED|Overall Study||7
124113|NCT01249404|299376|P3|COMPLETED|Overall Study||125
124114|NCT01249404|299377|P2|COMPLETED|Overall Study||121
124115|NCT01249404|299378|P1|COMPLETED|Overall Study||120
124116|NCT01249404|299376|P3|STARTED|Overall Study||132
124117|NCT01249404|299377|P2|STARTED|Overall Study||129
124118|NCT01249404|299378|P1|STARTED|Overall Study||127
124119|NCT01249274|299457|P2|NOT COMPLETED|Overall Study||6
124120|NCT01249274|299458|P1|NOT COMPLETED|Overall Study||4
124121|NCT01249274|299457|P2|COMPLETED|Overall Study||19
124122|NCT01249274|299458|P1|COMPLETED|Overall Study||21
124123|NCT01249274|299457|P2|Completed Post Trial Visit But Not tx|Overall Study||2
124124|NCT01249274|299458|P1|Completed Post Trial Visit But Not tx|Overall Study||1
124125|NCT01249274|299457|P2|Completed Treatment & Post Trial Visit|Overall Study||17
124126|NCT01249274|299458|P1|Completed Treatment & Post Trial Visit|Overall Study||20
124127|NCT01249274|299457|P2|Completed Treatment|Overall Study||19
124128|NCT01249274|299458|P1|Completed Treatment|Overall Study||21
124129|NCT01249274|299457|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
124130|NCT01249274|299458|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
124131|NCT01249261|299484|P2|NOT COMPLETED|Overall Study||0
124132|NCT01249261|299485|P1|NOT COMPLETED|Overall Study||1
124133|NCT01249261|299484|P2|COMPLETED|Overall Study||31
124134|NCT01249261|299485|P1|COMPLETED|Overall Study||29
124135|NCT01249261|299484|P2|STARTED|Overall Study||31
124136|NCT01249261|299485|P1|STARTED|Overall Study||30
124137|NCT01249157|299513|P1|NOT COMPLETED|Overall Study||1
124138|NCT01249157|299513|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
124139|NCT01249157|299513|P1|STARTED|Overall Study||1
124140|NCT01249131|299517|P6|NOT COMPLETED|Third Intervention||0
124141|NCT01249131|299518|P5|NOT COMPLETED|Third Intervention||0
124142|NCT01249131|299519|P4|NOT COMPLETED|Third Intervention||0
124143|NCT01249131|299520|P3|NOT COMPLETED|Third Intervention||0
124144|NCT01249131|299521|P2|NOT COMPLETED|Third Intervention||0
124145|NCT01249131|299522|P1|NOT COMPLETED|Third Intervention||0
124146|NCT01249131|299517|P6|COMPLETED|Third Intervention||4
124147|NCT01249131|299518|P5|COMPLETED|Third Intervention||2
124148|NCT01249131|299519|P4|COMPLETED|Third Intervention||3
124149|NCT01249131|299520|P3|COMPLETED|Third Intervention||4
124150|NCT01249131|299521|P2|COMPLETED|Third Intervention||3
124151|NCT01249131|299522|P1|COMPLETED|Third Intervention||3
124152|NCT01249131|299517|P6|STARTED|Third Intervention||4
124153|NCT01249131|299518|P5|STARTED|Third Intervention||2
124154|NCT01249131|299519|P4|STARTED|Third Intervention||3
124155|NCT01249131|299520|P3|STARTED|Third Intervention||4
124156|NCT01249131|299521|P2|STARTED|Third Intervention||3
124157|NCT01249131|299522|P1|STARTED|Third Intervention||3
124158|NCT01249131|299517|P6|NOT COMPLETED|Washout Period of 10 Days||0
124159|NCT01249131|299518|P5|NOT COMPLETED|Washout Period of 10 Days||0
124160|NCT01249131|299519|P4|NOT COMPLETED|Washout Period of 10 Days||0
124161|NCT01249131|299520|P3|NOT COMPLETED|Washout Period of 10 Days||0
124162|NCT01249131|299521|P2|NOT COMPLETED|Washout Period of 10 Days||0
124163|NCT01249131|299522|P1|NOT COMPLETED|Washout Period of 10 Days||0
124164|NCT01249131|299517|P6|COMPLETED|Washout Period of 10 Days||4
124165|NCT01249131|299518|P5|COMPLETED|Washout Period of 10 Days||2
124166|NCT01249131|299519|P4|COMPLETED|Washout Period of 10 Days||3
124167|NCT01249131|299520|P3|COMPLETED|Washout Period of 10 Days||4
124168|NCT01249131|299521|P2|COMPLETED|Washout Period of 10 Days||3
124169|NCT01249131|299522|P1|COMPLETED|Washout Period of 10 Days||3
124170|NCT01249131|299517|P6|STARTED|Washout Period of 10 Days||4
124171|NCT01249131|299518|P5|STARTED|Washout Period of 10 Days||2
124172|NCT01249131|299519|P4|STARTED|Washout Period of 10 Days||3
124173|NCT01249131|299520|P3|STARTED|Washout Period of 10 Days||4
124174|NCT01249131|299521|P2|STARTED|Washout Period of 10 Days||3
124175|NCT01249131|299522|P1|STARTED|Washout Period of 10 Days||3
124176|NCT01249131|299517|P6|NOT COMPLETED|Second Intervention||0
124177|NCT01249131|299518|P5|NOT COMPLETED|Second Intervention||0
124178|NCT01249131|299519|P4|NOT COMPLETED|Second Intervention||0
124179|NCT01249131|299520|P3|NOT COMPLETED|Second Intervention||0
124180|NCT01249131|299521|P2|NOT COMPLETED|Second Intervention||0
124181|NCT01249131|299522|P1|NOT COMPLETED|Second Intervention||0
124182|NCT01249131|299517|P6|COMPLETED|Second Intervention||4
124183|NCT01249131|299518|P5|COMPLETED|Second Intervention||2
124184|NCT01249131|299519|P4|COMPLETED|Second Intervention||3
124185|NCT01249131|299520|P3|COMPLETED|Second Intervention||4
124186|NCT01249131|299521|P2|COMPLETED|Second Intervention||3
124187|NCT01249131|299522|P1|COMPLETED|Second Intervention||3
124188|NCT01249131|299517|P6|STARTED|Second Intervention||4
124189|NCT01249131|299518|P5|STARTED|Second Intervention||2
124190|NCT01249131|299519|P4|STARTED|Second Intervention||3
124191|NCT01249131|299520|P3|STARTED|Second Intervention||4
124192|NCT01249131|299521|P2|STARTED|Second Intervention||3
124193|NCT01249131|299522|P1|STARTED|Second Intervention||3
124194|NCT01249131|299517|P6|NOT COMPLETED|Washout Period of 10 Days||0
124195|NCT01249131|299518|P5|NOT COMPLETED|Washout Period of 10 Days||1
124196|NCT01249131|299519|P4|NOT COMPLETED|Washout Period of 10 Days||0
124197|NCT01249131|299520|P3|NOT COMPLETED|Washout Period of 10 Days||0
124198|NCT01249131|299521|P2|NOT COMPLETED|Washout Period of 10 Days||0
124199|NCT01249131|299522|P1|NOT COMPLETED|Washout Period of 10 Days||0
124200|NCT01249131|299517|P6|COMPLETED|Washout Period of 10 Days||4
124201|NCT01249131|299518|P5|COMPLETED|Washout Period of 10 Days||2
124202|NCT01249131|299519|P4|COMPLETED|Washout Period of 10 Days||3
124203|NCT01249131|299520|P3|COMPLETED|Washout Period of 10 Days||4
124204|NCT01249131|299521|P2|COMPLETED|Washout Period of 10 Days||3
124205|NCT01249131|299522|P1|COMPLETED|Washout Period of 10 Days||3
124206|NCT01249131|299517|P6|STARTED|Washout Period of 10 Days||4
124207|NCT01249131|299518|P5|STARTED|Washout Period of 10 Days||3
124208|NCT01249131|299519|P4|STARTED|Washout Period of 10 Days||3
124209|NCT01249131|299520|P3|STARTED|Washout Period of 10 Days||4
124210|NCT01249131|299521|P2|STARTED|Washout Period of 10 Days||3
124211|NCT01249131|299522|P1|STARTED|Washout Period of 10 Days||3
124212|NCT01249131|299517|P6|NOT COMPLETED|First Intervention||0
124213|NCT01249131|299518|P5|NOT COMPLETED|First Intervention||0
124214|NCT01249131|299519|P4|NOT COMPLETED|First Intervention||0
124215|NCT01249131|299520|P3|NOT COMPLETED|First Intervention||0
124216|NCT01249131|299521|P2|NOT COMPLETED|First Intervention||0
124217|NCT01249131|299522|P1|NOT COMPLETED|First Intervention||0
124218|NCT01249131|299517|P6|COMPLETED|First Intervention||4
124219|NCT01249131|299518|P5|COMPLETED|First Intervention||3
124220|NCT01249131|299519|P4|COMPLETED|First Intervention||3
124221|NCT01249131|299520|P3|COMPLETED|First Intervention||4
124222|NCT01249131|299521|P2|COMPLETED|First Intervention||3
124223|NCT01249131|299522|P1|COMPLETED|First Intervention||3
124224|NCT01249131|299517|P6|STARTED|First Intervention||4
124225|NCT01249131|299518|P5|STARTED|First Intervention||3
124226|NCT01249131|299519|P4|STARTED|First Intervention||3
124227|NCT01249131|299520|P3|STARTED|First Intervention||4
124228|NCT01249131|299521|P2|STARTED|First Intervention||3
124229|NCT01249131|299522|P1|STARTED|First Intervention||3
124230|NCT01249118|299542|P3|NOT COMPLETED|Second Washout Period||0
124231|NCT01249118|299543|P2|NOT COMPLETED|Second Washout Period||0
124232|NCT01249118|299544|P1|NOT COMPLETED|Second Washout Period||0
124233|NCT01249118|299542|P3|COMPLETED|Second Washout Period||5
124234|NCT01249118|299543|P2|COMPLETED|Second Washout Period||5
124235|NCT01249118|299544|P1|COMPLETED|Second Washout Period||2
124236|NCT01249118|299542|P3|STARTED|Second Washout Period||5
124237|NCT01249118|299543|P2|STARTED|Second Washout Period||5
124238|NCT01249118|299544|P1|STARTED|Second Washout Period||2
124239|NCT01249118|299542|P3|NOT COMPLETED|Second Intervention Period||0
124240|NCT01249118|299543|P2|NOT COMPLETED|Second Intervention Period||0
124241|NCT01249118|299544|P1|NOT COMPLETED|Second Intervention Period||0
124242|NCT01249118|299542|P3|COMPLETED|Second Intervention Period||5
124243|NCT01249118|299543|P2|COMPLETED|Second Intervention Period||5
124244|NCT01249118|299544|P1|COMPLETED|Second Intervention Period||2
124245|NCT01249118|299542|P3|STARTED|Second Intervention Period||5
124246|NCT01249118|299543|P2|STARTED|Second Intervention Period||5
124247|NCT01249118|299544|P1|STARTED|Second Intervention Period||2
124248|NCT01249118|299542|P3|NOT COMPLETED|First Washout Period||0
124249|NCT01249118|299543|P2|NOT COMPLETED|First Washout Period||1
124250|NCT01249118|299544|P1|NOT COMPLETED|First Washout Period||0
124251|NCT01249118|299542|P3|COMPLETED|First Washout Period||5
124252|NCT01249118|299543|P2|COMPLETED|First Washout Period||5
124253|NCT01249118|299544|P1|COMPLETED|First Washout Period||2
124254|NCT01249118|299542|P3|STARTED|First Washout Period||5
124255|NCT01249118|299543|P2|STARTED|First Washout Period||6
124256|NCT01249118|299544|P1|STARTED|First Washout Period||2
124257|NCT01249118|299542|P3|NOT COMPLETED|First Intervention Period||0
124258|NCT01249118|299543|P2|NOT COMPLETED|First Intervention Period||0
124259|NCT01249118|299544|P1|NOT COMPLETED|First Intervention Period||0
124260|NCT01249118|299542|P3|COMPLETED|First Intervention Period||5
124261|NCT01249118|299543|P2|COMPLETED|First Intervention Period||6
124262|NCT01249118|299544|P1|COMPLETED|First Intervention Period||2
124263|NCT01249118|299542|P3|STARTED|First Intervention Period||5
124264|NCT01249118|299543|P2|STARTED|First Intervention Period||6
124265|NCT01249118|299544|P1|STARTED|First Intervention Period||2
124266|NCT01249092|299578|P1|NOT COMPLETED|Overall Study||2
124267|NCT01249092|299578|P1|COMPLETED|Overall Study||18
124268|NCT01249092|299578|P1|STARTED|Overall Study||20
124269|NCT01248949|299589|P5|NOT COMPLETED|Overall Study||4
124270|NCT01248949|299590|P4|NOT COMPLETED|Overall Study||10
124271|NCT01248949|299591|P3|NOT COMPLETED|Overall Study||37
124272|NCT01248949|299592|P2|NOT COMPLETED|Overall Study||13
124273|NCT01248949|299593|P1|NOT COMPLETED|Overall Study||33
124274|NCT01248949|299589|P5|COMPLETED|Overall Study||3
124275|NCT01248949|299590|P4|COMPLETED|Overall Study||3
124276|NCT01248949|299591|P3|COMPLETED|Overall Study||1
124277|NCT01248949|299592|P2|COMPLETED|Overall Study||3
124278|NCT01248949|299593|P1|COMPLETED|Overall Study||9
124279|NCT01248949|299589|P5|STARTED|Overall Study||7
124280|NCT01248949|299590|P4|STARTED|Overall Study||13
124281|NCT01248949|299591|P3|STARTED|Overall Study||38
124282|NCT01248949|299592|P2|STARTED|Overall Study||16
124283|NCT01248949|299593|P1|STARTED|Overall Study||42
124284|NCT01248936|299705|P1|NOT COMPLETED|Overall Study||374
124285|NCT01248936|299705|P1|COMPLETED|Overall Study||0
124286|NCT01248936|299705|P1|STARTED|Overall Study||374
124287|NCT01248884|299718|P3|NOT COMPLETED|Overall Study||1
124288|NCT01248884|299719|P2|NOT COMPLETED|Overall Study||3
124289|NCT01248884|299720|P1|NOT COMPLETED|Overall Study||2
124290|NCT01248884|299718|P3|COMPLETED|Overall Study||238
124291|NCT01248884|299719|P2|COMPLETED|Overall Study||239
124292|NCT01248884|299720|P1|COMPLETED|Overall Study||238
124293|NCT01248884|299718|P3|STARTED|Overall Study||239
124294|NCT01248884|299719|P2|STARTED|Overall Study||242
124295|NCT01248884|299720|P1|STARTED|Overall Study||240
124296|NCT01248793|299772|P2|NOT COMPLETED|Overall Study||6
124297|NCT01248793|299773|P1|NOT COMPLETED|Overall Study||4
124298|NCT01248793|299772|P2|COMPLETED|Overall Study||102
124299|NCT01248793|299773|P1|COMPLETED|Overall Study||101
124300|NCT01248793|299772|P2|STARTED|Overall Study||108
124301|NCT01248793|299773|P1|STARTED|Overall Study||105
124302|NCT01248780|299787|P2|NOT COMPLETED|Overall Study||15
124303|NCT01248780|299788|P1|NOT COMPLETED|Overall Study||9
124304|NCT01248780|299787|P2|COMPLETED|Overall Study||117
124305|NCT01248780|299788|P1|COMPLETED|Overall Study||123
124306|NCT01248780|299787|P2|STARTED|Overall Study||132
124307|NCT01248780|299788|P1|STARTED|Overall Study||132
124308|NCT01248728|299802|P2|NOT COMPLETED|Overall Study||2
124309|NCT01248728|299803|P1|NOT COMPLETED|Overall Study||4
124310|NCT01248728|299802|P2|COMPLETED|Overall Study||17
124311|NCT01248728|299803|P1|COMPLETED|Overall Study||15
124312|NCT01248728|299802|P2|STARTED|Overall Study||19
124313|NCT01248728|299803|P1|STARTED|Overall Study||19
124314|NCT01248715|299819|P2|NOT COMPLETED|Overall Study||510
124315|NCT01248715|299820|P1|NOT COMPLETED|Overall Study||501
124316|NCT01248715|299819|P2|COMPLETED|Overall Study||41
124317|NCT01248715|299820|P1|COMPLETED|Overall Study||55
124318|NCT01248715|299819|P2|STARTED|Overall Study||551
124319|NCT01248715|299820|P1|STARTED|Overall Study||556
124320|NCT01248468|299841|P3|NOT COMPLETED|Overall Study||4
124321|NCT01248468|299842|P2|NOT COMPLETED|Overall Study||14
124322|NCT01248468|299843|P1|NOT COMPLETED|Overall Study||15
124323|NCT01248468|299841|P3|COMPLETED|Overall Study||145
124324|NCT01248468|299842|P2|COMPLETED|Overall Study||290
124325|NCT01248468|299843|P1|COMPLETED|Overall Study||284
124326|NCT01248468|299841|P3|ITT Population|Overall Study||125
124327|NCT01248468|299842|P2|ITT Population|Overall Study||261
124328|NCT01248468|299843|P1|ITT Population|Overall Study||256
124329|NCT01248468|299841|P3|Safety Population|Overall Study||133
124330|NCT01248468|299842|P2|Safety Population|Overall Study||271
124331|NCT01248468|299843|P1|Safety Population|Overall Study||266
124332|NCT01248468|299841|P3|STARTED|Overall Study||149
124333|NCT01248468|299842|P2|STARTED|Overall Study||304
124334|NCT01248468|299843|P1|STARTED|Overall Study||299
124335|NCT01248455|299860|P1|NOT COMPLETED|Overall Study||1
124336|NCT01248455|299860|P1|COMPLETED|Overall Study||8
124337|NCT01248455|299860|P1|STARTED|Overall Study||9
124338|NCT01248364|299869|P4|NOT COMPLETED|Overall Study||0
124339|NCT01248364|299870|P3|NOT COMPLETED|Overall Study||0
124340|NCT01248364|299871|P2|NOT COMPLETED|Overall Study||1
124341|NCT01248364|299872|P1|NOT COMPLETED|Overall Study||0
124342|NCT01248364|299869|P4|COMPLETED|Overall Study||12
124343|NCT01248364|299870|P3|COMPLETED|Overall Study||13
124344|NCT01248364|299871|P2|COMPLETED|Overall Study||33
124345|NCT01248364|299872|P1|COMPLETED|Overall Study||32
124346|NCT01248364|299869|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
124347|NCT01248364|299870|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
124348|NCT01248364|299871|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
124349|NCT01248364|299872|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
124350|NCT01248364|299869|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
124351|NCT01248364|299870|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
124352|NCT01248364|299871|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
124353|NCT01248364|299872|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
124354|NCT01248364|299869|P4|STARTED|Overall Study||12
124355|NCT01248364|299870|P3|STARTED|Overall Study||13
124356|NCT01248364|299871|P2|STARTED|Overall Study||34
124357|NCT01248364|299872|P1|STARTED|Overall Study||32
124358|NCT01248221|299920|P2|NOT COMPLETED|Overall Study||0
124359|NCT01248221|299921|P1|NOT COMPLETED|Overall Study||0
124360|NCT01248221|299920|P2|COMPLETED|Overall Study||15
124361|NCT01248221|299921|P1|COMPLETED|Overall Study||15
124362|NCT01248221|299920|P2|STARTED|Overall Study||15
124363|NCT01248221|299921|P1|STARTED|Overall Study||15
124364|NCT01248130|299935|P2|NOT COMPLETED|Overall Study||0
124365|NCT01248130|299936|P1|NOT COMPLETED|Overall Study||2
124366|NCT01248130|299935|P2|COMPLETED|Overall Study||4
124367|NCT01248130|299936|P1|COMPLETED|Overall Study||1
124368|NCT01248130|299935|P2|STARTED|Overall Study||4
124369|NCT01248130|299936|P1|STARTED|Overall Study||3
124370|NCT01248065|299946|P2|NOT COMPLETED|Overall Study||22
124371|NCT01248065|299947|P1|NOT COMPLETED|Overall Study||26
124372|NCT01248065|299946|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
124373|NCT01248065|299947|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
124374|NCT01248065|299946|P2|STARTED|Overall Study||201
124375|NCT01248065|299947|P1|STARTED|Overall Study||207
124376|NCT01248013|299957|P1|NOT COMPLETED|Overall Study||14
124377|NCT01248013|299957|P1|COMPLETED|Overall Study||75
124378|NCT01248013|299957|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
124379|NCT01248013|299957|P1|STARTED|Overall Study||89
124380|NCT01247974|299963|P2|NOT COMPLETED|Overall Study||19
124381|NCT01247974|299964|P1|NOT COMPLETED|Overall Study||26
124382|NCT01247974|299963|P2|COMPLETED|Overall Study||203
124383|NCT01247974|299964|P1|COMPLETED|Overall Study||191
124384|NCT01247974|299963|P2|STARTED|Overall Study||222
124385|NCT01247974|299964|P1|STARTED|Overall Study||217
124386|NCT01247922|299972|P1|NOT COMPLETED|Overall Study||4
124387|NCT01247922|299972|P1|COMPLETED|Overall Study||0
124388|NCT01247922|299972|P1|Treated|Overall Study||4
124389|NCT01247922|299972|P1|STARTED|Overall Study||4
124390|NCT01247675|299982|P4|NOT COMPLETED|Overall Study||0
124391|NCT01247675|299983|P3|NOT COMPLETED|Overall Study||0
124392|NCT01247675|299984|P2|NOT COMPLETED|Overall Study||2
124393|NCT01247675|299985|P1|NOT COMPLETED|Overall Study||2
124394|NCT01247675|299982|P4|COMPLETED|Overall Study||8
124395|NCT01247675|299983|P3|COMPLETED|Overall Study||9
124396|NCT01247675|299984|P2|COMPLETED|Overall Study||8
124397|NCT01247675|299985|P1|COMPLETED|Overall Study||8
124398|NCT01247675|299982|P4|STARTED|Overall Study||8
124399|NCT01247675|299983|P3|STARTED|Overall Study||9
124400|NCT01247675|299984|P2|STARTED|Overall Study||10
124401|NCT01247675|299985|P1|STARTED|Overall Study||10
124402|NCT01247571|300007|P1|NOT COMPLETED|Overall Study||3
124403|NCT01247571|300007|P1|COMPLETED|Overall Study||19
124404|NCT01247571|300007|P1|STARTED|Overall Study||22
124405|NCT01247428|300015|P1|NOT COMPLETED|Overall Study||0
124406|NCT01247428|300015|P1|COMPLETED|Overall Study||30
124407|NCT01247428|300015|P1|STARTED|Overall Study||30
124408|NCT01247350|300041|P5|NOT COMPLETED|Overall Study||1
124409|NCT01247350|300042|P4|NOT COMPLETED|Overall Study||1
124410|NCT01247350|300043|P3|NOT COMPLETED|Overall Study||1
124411|NCT01247350|300044|P2|NOT COMPLETED|Overall Study||0
124412|NCT01247350|300045|P1|NOT COMPLETED|Overall Study||0
124413|NCT01247350|300041|P5|COMPLETED|Overall Study||8
124414|NCT01247350|300042|P4|COMPLETED|Overall Study||6
124415|NCT01247350|300043|P3|COMPLETED|Overall Study||5
124416|NCT01247350|300044|P2|COMPLETED|Overall Study||6
124417|NCT01247350|300045|P1|COMPLETED|Overall Study||6
124418|NCT01247350|300041|P5|Received Multiple Doses of Study Drug|Overall Study||5
124419|NCT01247350|300042|P4|Received Multiple Doses of Study Drug|Overall Study||6
124420|NCT01247350|300043|P3|Received Multiple Doses of Study Drug|Overall Study||6
124421|NCT01247350|300044|P2|Received Multiple Doses of Study Drug|Overall Study||0
124422|NCT01247350|300045|P1|Received Multiple Doses of Study Drug|Overall Study||0
124423|NCT01247350|300041|P5|STARTED|Overall Study||9
124424|NCT01247350|300042|P4|STARTED|Overall Study||7
124425|NCT01247350|300043|P3|STARTED|Overall Study||6
124426|NCT01247350|300044|P2|STARTED|Overall Study||6
124427|NCT01247350|300045|P1|STARTED|Overall Study||6
124428|NCT01247324|300103|P2|NOT COMPLETED|Overall Study||44
124429|NCT01247324|300104|P1|NOT COMPLETED|Overall Study||71
124430|NCT01247324|300103|P2|COMPLETED|Overall Study||366
124431|NCT01247324|300104|P1|COMPLETED|Overall Study||340
124432|NCT01247324|300103|P2|STARTED|Overall Study||410
124433|NCT01247324|300104|P1|STARTED|Overall Study||411
124434|NCT01247298|300135|P1|NOT COMPLETED|Overall Study||0
124435|NCT01247298|300135|P1|COMPLETED|Overall Study||17
124436|NCT01247298|300135|P1|STARTED|Overall Study||17
124437|NCT01247285|300145|P2|NOT COMPLETED|Second Intervention||0
124438|NCT01247285|300146|P1|NOT COMPLETED|Second Intervention||0
124439|NCT01247285|300145|P2|COMPLETED|Second Intervention||13
124440|NCT01247285|300146|P1|COMPLETED|Second Intervention||13
124441|NCT01247285|300145|P2|STARTED|Second Intervention||13
124442|NCT01247285|300146|P1|STARTED|Second Intervention||13
124443|NCT01247285|300145|P2|NOT COMPLETED|Washout of 28 Days||0
124444|NCT01247285|300146|P1|NOT COMPLETED|Washout of 28 Days||0
124445|NCT01247285|300145|P2|COMPLETED|Washout of 28 Days||13
124446|NCT01247285|300146|P1|COMPLETED|Washout of 28 Days||13
124447|NCT01247285|300145|P2|STARTED|Washout of 28 Days||13
124448|NCT01247285|300146|P1|STARTED|Washout of 28 Days||13
124449|NCT01247285|300145|P2|NOT COMPLETED|First Intervention||0
124450|NCT01247285|300146|P1|NOT COMPLETED|First Intervention||0
124451|NCT01247285|300145|P2|COMPLETED|First Intervention||13
124452|NCT01247285|300146|P1|COMPLETED|First Intervention||13
124453|NCT01247285|300145|P2|STARTED|First Intervention||13
124454|NCT01247285|300146|P1|STARTED|First Intervention||13
124455|NCT01247272|300164|P2|NOT COMPLETED|Second Intervention||0
124456|NCT01247272|300165|P1|NOT COMPLETED|Second Intervention||0
124457|NCT01247272|300164|P2|COMPLETED|Second Intervention||13
124458|NCT01247272|300165|P1|COMPLETED|Second Intervention||13
124459|NCT01247272|300164|P2|STARTED|Second Intervention||13
124460|NCT01247272|300165|P1|STARTED|Second Intervention||13
124461|NCT01247272|300164|P2|NOT COMPLETED|Washout of 28 Days||0
124462|NCT01247272|300165|P1|NOT COMPLETED|Washout of 28 Days||0
124463|NCT01247272|300164|P2|COMPLETED|Washout of 28 Days||13
124464|NCT01247272|300165|P1|COMPLETED|Washout of 28 Days||13
124465|NCT01247272|300164|P2|STARTED|Washout of 28 Days||13
124466|NCT01247272|300165|P1|STARTED|Washout of 28 Days||13
124467|NCT01247272|300164|P2|NOT COMPLETED|First Intervention||0
124468|NCT01247272|300165|P1|NOT COMPLETED|First Intervention||0
124469|NCT01247272|300164|P2|COMPLETED|First Intervention||13
124470|NCT01247272|300165|P1|COMPLETED|First Intervention||13
124471|NCT01247272|300164|P2|STARTED|First Intervention||13
124472|NCT01247272|300165|P1|STARTED|First Intervention||13
124473|NCT01247220|300183|P2|NOT COMPLETED|Overall Study||0
124474|NCT01247220|300184|P1|NOT COMPLETED|Overall Study||0
124475|NCT01247220|300183|P2|COMPLETED|Overall Study||6
124476|NCT01247220|300184|P1|COMPLETED|Overall Study||6
124477|NCT01247220|300183|P2|STARTED|Overall Study||6
124478|NCT01247220|300184|P1|STARTED|Overall Study||6
124479|NCT01247090|300197|P3|NOT COMPLETED|Overall Study||0
124480|NCT01247090|300198|P2|NOT COMPLETED|Overall Study||1
124481|NCT01247090|300199|P1|NOT COMPLETED|Overall Study||1
124482|NCT01247090|300197|P3|COMPLETED|Overall Study||4
124483|NCT01247090|300198|P2|COMPLETED|Overall Study||3
124484|NCT01247090|300199|P1|COMPLETED|Overall Study||3
124485|NCT01247090|300197|P3|STARTED|Overall Study||4
124486|NCT01247090|300198|P2|STARTED|Overall Study||4
124487|NCT01247090|300199|P1|STARTED|Overall Study||4
124488|NCT01247064|300209|P2|NOT COMPLETED|Overall Study||0
124489|NCT01247064|300210|P1|NOT COMPLETED|Overall Study||0
124490|NCT01247064|300209|P2|COMPLETED|Overall Study||31
124491|NCT01247064|300210|P1|COMPLETED|Overall Study||31
124492|NCT01247064|300209|P2|STARTED|Overall Study||31
124493|NCT01247064|300210|P1|STARTED|Overall Study||31
124494|NCT01246999|300228|P4|NOT COMPLETED|Overall Study||2
124495|NCT01246999|300229|P3|NOT COMPLETED|Overall Study||0
124496|NCT01246999|300230|P2|NOT COMPLETED|Overall Study||1
124497|NCT01246999|300231|P1|NOT COMPLETED|Overall Study||0
124498|NCT01246999|300228|P4|COMPLETED|Overall Study||15
124499|NCT01246999|300229|P3|COMPLETED|Overall Study||2
124500|NCT01246999|300230|P2|COMPLETED|Overall Study||3
124501|NCT01246999|300231|P1|COMPLETED|Overall Study||11
124502|NCT01246999|300228|P4|STARTED|Overall Study||17
124503|NCT01246999|300229|P3|STARTED|Overall Study||2
124504|NCT01246999|300230|P2|STARTED|Overall Study||4
124505|NCT01246999|300231|P1|STARTED|Overall Study||11
124506|NCT01246973|300266|P2|NOT COMPLETED|Overall Study||47
124507|NCT01246973|300267|P1|NOT COMPLETED|Overall Study||61
124508|NCT01246973|300266|P2|COMPLETED|Overall Study||295
124509|NCT01246973|300267|P1|COMPLETED|Overall Study||283
124510|NCT01246973|300266|P2|STARTED|Overall Study||342
124511|NCT01246973|300267|P1|STARTED|Overall Study||344
124512|NCT01246960|300277|P2|NOT COMPLETED|Overall Study||4
124513|NCT01246960|300278|P1|NOT COMPLETED|Overall Study||6
124514|NCT01246960|300277|P2|COMPLETED|Overall Study||80
124515|NCT01246960|300278|P1|COMPLETED|Overall Study||78
124516|NCT01246960|300277|P2|Received Any Quantity of Study Drug|Overall Study||80
124517|NCT01246960|300278|P1|Received Any Quantity of Study Drug|Overall Study||82
124518|NCT01246960|300277|P2|STARTED|Overall Study||84
124519|NCT01246960|300278|P1|STARTED|Overall Study||84
124520|NCT01246895|300298|P2|NOT COMPLETED|Overall Study||4
124521|NCT01246895|300299|P1|NOT COMPLETED|Overall Study||3
124522|NCT01246895|300298|P2|COMPLETED|Overall Study||26
124523|NCT01246895|300299|P1|COMPLETED|Overall Study||34
124524|NCT01246895|300298|P2|STARTED|Overall Study||30
124525|NCT01246895|300299|P1|STARTED|Overall Study||37
124526|NCT01246791|300313|P1|NOT COMPLETED|Overall Study||0
124527|NCT01246791|300313|P1|COMPLETED|Overall Study||12
124528|NCT01246791|300313|P1|STARTED|Overall Study||12
124529|NCT01246713|300328|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
124530|NCT01246713|300329|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
124531|NCT01246713|300328|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
124532|NCT01246713|300329|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
124533|NCT01246713|300328|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
124534|NCT01246713|300329|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
124535|NCT01246713|300328|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
124536|NCT01246713|300329|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
124537|NCT01246713|300328|P2|COMPLETED|Washout (at Least 14 Days)||9
124538|NCT01246713|300329|P1|COMPLETED|Washout (at Least 14 Days)||6
124539|NCT01246713|300328|P2|STARTED|Washout (at Least 14 Days)||9
124540|NCT01246713|300329|P1|STARTED|Washout (at Least 14 Days)||6
124541|NCT01246713|300328|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
124542|NCT01246713|300329|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
124543|NCT01246713|300328|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
124544|NCT01246713|300329|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
124545|NCT01246713|300328|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
124546|NCT01246713|300329|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
124547|NCT01246479|300335|P1|NOT COMPLETED|Overall Study||5
124548|NCT01246479|300335|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
124549|NCT01246479|300335|P1|STARTED|Overall Study||23
124550|NCT01246401|300341|P2|NOT COMPLETED|Overall Study||0
124551|NCT01246401|300342|P1|NOT COMPLETED|Overall Study||0
124552|NCT01246401|300341|P2|COMPLETED|Overall Study||27
124553|NCT01246401|300342|P1|COMPLETED|Overall Study||66
124554|NCT01246401|300341|P2|STARTED|Overall Study||27
124555|NCT01246401|300342|P1|STARTED|Overall Study||66
124556|NCT01246349|300368|P2|NOT COMPLETED|Overall Study||0
124557|NCT01246349|300369|P1|NOT COMPLETED|Overall Study||0
124558|NCT01246349|300368|P2|COMPLETED|Overall Study||20
124559|NCT01246349|300369|P1|COMPLETED|Overall Study||20
124560|NCT01246349|300368|P2|STARTED|Overall Study||20
124561|NCT01246349|300369|P1|STARTED|Overall Study||20
124562|NCT01246258|300381|P1|NOT COMPLETED|Overall Study||0
124563|NCT01246258|300381|P1|COMPLETED|Overall Study||5
124564|NCT01246258|300381|P1|STARTED|Overall Study||5
124565|NCT01246206|300386|P1|NOT COMPLETED|Overall Study||1
124566|NCT01246206|300386|P1|COMPLETED|Overall Study||20
124567|NCT01246206|300386|P1|STARTED|Overall Study||21
124568|NCT01246076|300397|P1|NOT COMPLETED|Overall Study||0
124569|NCT01246076|300397|P1|COMPLETED|Overall Study||24
124570|NCT01246076|300397|P1|STARTED|Overall Study||24
124571|NCT01246011|300409|P3|NOT COMPLETED|Overall Study||4
124572|NCT01246011|300410|P2|NOT COMPLETED|Overall Study||0
124573|NCT01246011|300411|P1|NOT COMPLETED|Overall Study||0
124574|NCT01246011|300409|P3|COMPLETED|Overall Study||5
124575|NCT01246011|300410|P2|COMPLETED|Overall Study||0
124576|NCT01246011|300411|P1|COMPLETED|Overall Study||0
124577|NCT01246011|300409|P3|STARTED|Overall Study||9
124578|NCT01246011|300410|P2|STARTED|Overall Study||0
124579|NCT01246011|300411|P1|STARTED|Overall Study||0
124580|NCT01245764|300426|P4|NOT COMPLETED|Study Phase B||0
124581|NCT01245764|300427|P3|NOT COMPLETED|Study Phase B||0
124582|NCT01245764|300428|P2|NOT COMPLETED|Study Phase B||0
124583|NCT01245764|300429|P1|NOT COMPLETED|Study Phase B||0
124584|NCT01245764|300426|P4|COMPLETED|Study Phase B||17
124585|NCT01245764|300427|P3|COMPLETED|Study Phase B||0
124586|NCT01245764|300428|P2|COMPLETED|Study Phase B||0
124587|NCT01245764|300429|P1|COMPLETED|Study Phase B||0
124588|NCT01245764|300426|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
124589|NCT01245764|300427|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
124590|NCT01245764|300428|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
124591|NCT01245764|300429|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
124592|NCT01245764|300426|P4|STARTED|Study Phase B||17
124593|NCT01245764|300427|P3|STARTED|Study Phase B||0
124594|NCT01245764|300428|P2|STARTED|Study Phase B||0
124595|NCT01245764|300429|P1|STARTED|Study Phase B||0
124596|NCT01245764|300426|P4|NOT COMPLETED|Study Phase A||3
124597|NCT01245764|300427|P3|NOT COMPLETED|Study Phase A||10
124598|NCT01245764|300428|P2|NOT COMPLETED|Study Phase A||5
124599|NCT01245764|300429|P1|NOT COMPLETED|Study Phase A||9
124600|NCT01245764|300426|P4|COMPLETED|Study Phase A||17
124601|NCT01245764|300427|P3|COMPLETED|Study Phase A||110
124602|NCT01245764|300428|P2|COMPLETED|Study Phase A||25
124603|NCT01245764|300429|P1|COMPLETED|Study Phase A||71
124604|NCT01245764|300426|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
124605|NCT01245764|300427|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
124606|NCT01245764|300428|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
124607|NCT01245764|300429|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
124608|NCT01245764|300426|P4|STARTED|Study Phase A||20
124609|NCT01245764|300427|P3|STARTED|Study Phase A||120
124610|NCT01245764|300428|P2|STARTED|Study Phase A||30
124611|NCT01245764|300429|P1|STARTED|Study Phase A||80
124612|NCT01245751|300467|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
124613|NCT01245751|300468|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
124614|NCT01245751|300469|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
124615|NCT01245751|300470|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
124616|NCT01245751|300467|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
124617|NCT01245751|300468|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
124618|NCT01245751|300469|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
124619|NCT01245751|300470|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
124620|NCT01245751|300467|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
124621|NCT01245751|300468|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
124622|NCT01245751|300469|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
124623|NCT01245751|300470|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
124624|NCT01245751|300467|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
124625|NCT01245751|300468|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
124626|NCT01245751|300469|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
124627|NCT01245751|300470|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
124628|NCT01245751|300467|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
124629|NCT01245751|300468|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
124630|NCT01245751|300469|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
124631|NCT01245751|300470|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
124632|NCT01245751|300467|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
124633|NCT01245751|300468|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
124634|NCT01245751|300469|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
124635|NCT01245751|300470|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
124636|NCT01245751|300467|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
124637|NCT01245751|300468|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
124638|NCT01245751|300469|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
124639|NCT01245751|300470|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
124640|NCT01245738|300483|P1|NOT COMPLETED|Overall Study||40
124641|NCT01245738|300483|P1|COMPLETED|Overall Study||474
124642|NCT01245738|300483|P1|STARTED|Overall Study||514
124643|NCT01245647|300502|P2|NOT COMPLETED|Overall Study||4
124644|NCT01245647|300503|P1|NOT COMPLETED|Overall Study||0
124645|NCT01245647|300502|P2|COMPLETED|Overall Study||8
124646|NCT01245647|300503|P1|COMPLETED|Overall Study||7
124647|NCT01245647|300502|P2|STARTED|Overall Study||12
124648|NCT01245647|300503|P1|STARTED|Overall Study||7
124649|NCT01245595|300519|P2|NOT COMPLETED|Overall Study||0
124650|NCT01245595|300520|P1|NOT COMPLETED|Overall Study||0
124651|NCT01245595|300519|P2|COMPLETED|Overall Study||72
124652|NCT01245595|300520|P1|COMPLETED|Overall Study||72
124653|NCT01245595|300519|P2|Completed Full Course of Study Drug|Overall Study||61
124654|NCT01245595|300520|P1|Completed Full Course of Study Drug|Overall Study||57
124655|NCT01245595|300519|P2|STARTED|Overall Study||72
124656|NCT01245595|300520|P1|STARTED|Overall Study||72
124657|NCT01245439|300526|P1|NOT COMPLETED|Overall Study||0
124658|NCT01245439|300526|P1|COMPLETED|Overall Study||65
124659|NCT01245439|300526|P1|STARTED|Overall Study||65
124660|NCT01245413|300557|P2|NOT COMPLETED|Athena First,||0
124661|NCT01245413|300558|P1|NOT COMPLETED|Athena First,||0
124662|NCT01245413|300557|P2|COMPLETED|Athena First,||16
124663|NCT01245413|300558|P1|COMPLETED|Athena First,||16
124664|NCT01245413|300557|P2|STARTED|Athena First,||16
124665|NCT01245413|300558|P1|STARTED|Athena First,||16
124666|NCT01245413|300557|P2|NOT COMPLETED|Sensura First,||0
124667|NCT01245413|300558|P1|NOT COMPLETED|Sensura First,||0
124668|NCT01245413|300557|P2|COMPLETED|Sensura First,||16
124669|NCT01245413|300558|P1|COMPLETED|Sensura First,||16
124670|NCT01245413|300557|P2|STARTED|Sensura First,||16
124671|NCT01245413|300558|P1|STARTED|Sensura First,||16
124672|NCT01245387|300564|P1|NOT COMPLETED|Overall Study||813
124673|NCT01245387|300564|P1|COMPLETED|Overall Study||188
124674|NCT01245387|300564|P1|STARTED|Overall Study||1001
124675|NCT01245374|300613|P1|NOT COMPLETED|Overall Study||4
124676|NCT01245374|300613|P1|COMPLETED|Overall Study||99
124677|NCT01245374|300613|P1|STARTED|Overall Study||103
124678|NCT01245283|300636|P3|NOT COMPLETED|Overall Study||11
124679|NCT01245283|300637|P2|NOT COMPLETED|Overall Study||11
124680|NCT01245283|300638|P1|NOT COMPLETED|Overall Study||14
124681|NCT01245283|300636|P3|COMPLETED|Overall Study||19
124682|NCT01245283|300637|P2|COMPLETED|Overall Study||17
124683|NCT01245283|300638|P1|COMPLETED|Overall Study||18
124684|NCT01245283|300636|P3|STARTED|Overall Study||30
124685|NCT01245283|300637|P2|STARTED|Overall Study||28
124686|NCT01245283|300638|P1|STARTED|Overall Study||32
124687|NCT01245270|300672|P2|NOT COMPLETED|Overall Study||0
124688|NCT01245270|300673|P1|NOT COMPLETED|Overall Study||0
124689|NCT01245270|300672|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
124690|NCT01245270|300673|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
124691|NCT01245270|300672|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
124692|NCT01245270|300673|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
124693|NCT01245140|300683|P2|NOT COMPLETED|Overall Study||10
124694|NCT01245140|300684|P1|NOT COMPLETED|Overall Study||3
124695|NCT01245140|300683|P2|COMPLETED|Overall Study||14
124696|NCT01245140|300684|P1|COMPLETED|Overall Study||6
124697|NCT01245140|300683|P2|STARTED|Overall Study||24
124698|NCT01245140|300684|P1|STARTED|Overall Study||9
124699|NCT01245101|300740|P2|NOT COMPLETED|Period 3 (Treatment)||0
124700|NCT01245101|300741|P1|NOT COMPLETED|Period 3 (Treatment)||1
124701|NCT01245101|300740|P2|COMPLETED|Period 3 (Treatment)||0
124702|NCT01245101|300741|P1|COMPLETED|Period 3 (Treatment)||11
124703|NCT01245101|300740|P2|STARTED|Period 3 (Treatment)||0
124704|NCT01245101|300741|P1|STARTED|Period 3 (Treatment)||12
124705|NCT01245101|300740|P2|NOT COMPLETED|Period 2 (Washout)||0
124706|NCT01245101|300741|P1|NOT COMPLETED|Period 2 (Washout)||1
124707|NCT01245101|300740|P2|COMPLETED|Period 2 (Washout)||0
124708|NCT01245101|300741|P1|COMPLETED|Period 2 (Washout)||12
124709|NCT01245101|300740|P2|STARTED|Period 2 (Washout)||0
124710|NCT01245101|300741|P1|STARTED|Period 2 (Washout)||13
124711|NCT01245101|300740|P2|NOT COMPLETED|Period 1 (Treatment)||0
124712|NCT01245101|300741|P1|NOT COMPLETED|Period 1 (Treatment)||2
124713|NCT01245101|300740|P2|COMPLETED|Period 1 (Treatment)||0
124714|NCT01245101|300741|P1|COMPLETED|Period 1 (Treatment)||13
124715|NCT01245101|300740|P2|STARTED|Period 1 (Treatment)||0
124716|NCT01245101|300741|P1|STARTED|Period 1 (Treatment)||15
124717|NCT01245062|300751|P3|NOT COMPLETED|Cross-over Phase||17
124718|NCT01245062|300752|P2|NOT COMPLETED|Cross-over Phase||0
124719|NCT01245062|300753|P1|NOT COMPLETED|Cross-over Phase||0
124720|NCT01245062|300751|P3|COMPLETED|Cross-over Phase||53
124721|NCT01245062|300752|P2|COMPLETED|Cross-over Phase||0
124722|NCT01245062|300753|P1|COMPLETED|Cross-over Phase||0
124723|NCT01245062|300751|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
124724|NCT01245062|300752|P2|STARTED|Cross-over Phase||0
124725|NCT01245062|300753|P1|STARTED|Cross-over Phase||0
124726|NCT01245062|300751|P3|NOT COMPLETED|Randomization and Crossover Phase||0
124727|NCT01245062|300752|P2|NOT COMPLETED|Randomization and Crossover Phase||31
124728|NCT01245062|300753|P1|NOT COMPLETED|Randomization and Crossover Phase||41
124729|NCT01245062|300751|P3|COMPLETED|Randomization and Crossover Phase||0
124730|NCT01245062|300752|P2|COMPLETED|Randomization and Crossover Phase||77
124731|NCT01245062|300753|P1|COMPLETED|Randomization and Crossover Phase||173
124732|NCT01245062|300751|P3|STARTED|Randomization and Crossover Phase||0
124733|NCT01245062|300752|P2|STARTED|Randomization and Crossover Phase||108
124734|NCT01245062|300753|P1|STARTED|Randomization and Crossover Phase||214
124735|NCT01245049|300791|P2|NOT COMPLETED|Overall Study||4
124736|NCT01245049|300792|P1|NOT COMPLETED|Overall Study||1
124737|NCT01245049|300791|P2|COMPLETED|Overall Study||126
124738|NCT01245049|300792|P1|COMPLETED|Overall Study||254
124739|NCT01245049|300791|P2|STARTED|Overall Study||130
124740|NCT01245049|300792|P1|STARTED|Overall Study||255
124741|NCT01244984|300845|P3|NOT COMPLETED|Overall Study||4
124742|NCT01244984|300846|P2|NOT COMPLETED|Overall Study||14
124743|NCT01244984|300847|P1|NOT COMPLETED|Overall Study||5
124744|NCT01244984|300845|P3|COMPLETED|Overall Study||86
124745|NCT01244984|300846|P2|COMPLETED|Overall Study||79
124746|NCT01244984|300847|P1|COMPLETED|Overall Study||55
124747|NCT01244984|300845|P3|STARTED|Overall Study||90
124748|NCT01244984|300846|P2|STARTED|Overall Study||93
124749|NCT01244984|300847|P1|STARTED|Overall Study||60
124750|NCT01244906|300921|P1|NOT COMPLETED|Overall Study||8
124751|NCT01244906|300921|P1|COMPLETED|Overall Study||18
124752|NCT01244906|300921|P1|STARTED|Overall Study||26
124753|NCT01244893|300930|P2|NOT COMPLETED|Final Visit||0
124754|NCT01244893|300931|P1|NOT COMPLETED|Final Visit||0
124755|NCT01244893|300930|P2|COMPLETED|Final Visit||21
124756|NCT01244893|300931|P1|COMPLETED|Final Visit||21
124757|NCT01244893|300930|P2|STARTED|Final Visit||21
124758|NCT01244893|300931|P1|STARTED|Final Visit||21
124759|NCT01244893|300930|P2|NOT COMPLETED|1-Week Follow Up||0
124760|NCT01244893|300931|P1|NOT COMPLETED|1-Week Follow Up||1
124761|NCT01244893|300930|P2|COMPLETED|1-Week Follow Up||21
124762|NCT01244893|300931|P1|COMPLETED|1-Week Follow Up||21
124763|NCT01244893|300930|P2|STARTED|1-Week Follow Up||21
124764|NCT01244893|300931|P1|STARTED|1-Week Follow Up||22
124765|NCT01244893|300930|P2|NOT COMPLETED|Baseline||1
124766|NCT01244893|300931|P1|NOT COMPLETED|Baseline||0
124767|NCT01244893|300930|P2|COMPLETED|Baseline||21
124768|NCT01244893|300931|P1|COMPLETED|Baseline||22
124769|NCT01244893|300930|P2|STARTED|Baseline||22
124770|NCT01244893|300931|P1|STARTED|Baseline||22
124771|NCT01244828|300943|P1|NOT COMPLETED|Overall Study||78
124772|NCT01244828|300943|P1|COMPLETED|Overall Study||79
124773|NCT01244828|300943|P1|STARTED|Overall Study|Received study drug|157
124774|NCT01244815|300959|P4|NOT COMPLETED|Overall Study||12
124775|NCT01244815|300960|P3|NOT COMPLETED|Overall Study||11
124776|NCT01244815|300961|P2|NOT COMPLETED|Overall Study||17
124777|NCT01244815|300962|P1|NOT COMPLETED|Overall Study||14
124778|NCT01244815|300959|P4|COMPLETED|Overall Study||87
124779|NCT01244815|300960|P3|COMPLETED|Overall Study||88
124780|NCT01244815|300961|P2|COMPLETED|Overall Study||88
124781|NCT01244815|300962|P1|COMPLETED|Overall Study||87
124782|NCT01244815|300959|P4|Treated|Overall Study||99
124783|NCT01244815|300960|P3|Treated|Overall Study||99
124784|NCT01244815|300961|P2|Treated|Overall Study||104
124785|NCT01244815|300962|P1|Treated|Overall Study||101
124786|NCT01244815|300959|P4|STARTED|Overall Study|Randomized|99
124787|NCT01244815|300960|P3|STARTED|Overall Study|Randomized|99
124788|NCT01244815|300961|P2|STARTED|Overall Study|Randomized|105
124789|NCT01244815|300962|P1|STARTED|Overall Study|Randomized|101
124790|NCT01244724|301036|P1|NOT COMPLETED|Overall Study||8
124791|NCT01244724|301036|P1|COMPLETED|Overall Study||9
124792|NCT01244724|301036|P1|Week 2 Visit|Overall Study||15
124793|NCT01244724|301036|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
124794|NCT01244711|301040|P1|NOT COMPLETED|Overall Study||0
124795|NCT01244711|301040|P1|COMPLETED|Overall Study||1
124796|NCT01244711|301040|P1|STARTED|Overall Study||1
124797|NCT01244633|301044|P1|NOT COMPLETED|Overall Study||3
124798|NCT01244633|301044|P1|COMPLETED|Overall Study||15
124799|NCT01244633|301044|P1|STARTED|Overall Study||18
124800|NCT01244620|301048|P4|NOT COMPLETED|Overall Study||4
124801|NCT01244620|301049|P3|NOT COMPLETED|Overall Study||4
124802|NCT01244620|301050|P2|NOT COMPLETED|Overall Study||4
124803|NCT01244620|301051|P1|NOT COMPLETED|Overall Study||4
124804|NCT01244620|301048|P4|COMPLETED|Overall Study||0
124805|NCT01244620|301049|P3|COMPLETED|Overall Study||0
124806|NCT01244620|301050|P2|COMPLETED|Overall Study||0
124807|NCT01244620|301051|P1|COMPLETED|Overall Study||0
124808|NCT01244620|301048|P4|STARTED|Overall Study||4
124809|NCT01244620|301049|P3|STARTED|Overall Study||4
124810|NCT01244620|301050|P2|STARTED|Overall Study||4
124811|NCT01244620|301051|P1|STARTED|Overall Study||4
124812|NCT01244529|301085|P1|NOT COMPLETED|Overall Study||0
124813|NCT01244529|301085|P1|COMPLETED|Overall Study||41
124814|NCT01244529|301085|P1|STARTED|Overall Study||41
124815|NCT01244516|301110|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
124816|NCT01244516|301111|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
124817|NCT01244516|301112|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
124818|NCT01244516|301110|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
124819|NCT01244516|301111|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
124820|NCT01244516|301112|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
124821|NCT01244516|301110|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
124822|NCT01244516|301111|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
124823|NCT01244516|301112|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
124824|NCT01244516|301110|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
124825|NCT01244516|301111|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
124826|NCT01244516|301112|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
124827|NCT01244516|301110|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
124828|NCT01244516|301111|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
124829|NCT01244516|301112|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
124830|NCT01244516|301110|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
124831|NCT01244516|301111|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
124832|NCT01244516|301112|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
124833|NCT01244503|301125|P1|NOT COMPLETED|Overall Study||0
124834|NCT01244503|301125|P1|COMPLETED|Overall Study||61
124835|NCT01244503|301125|P1|STARTED|Overall Study||61
124836|NCT01244490|301133|P3|NOT COMPLETED|Overall Study||23
124837|NCT01244490|301134|P2|NOT COMPLETED|Overall Study||24
124838|NCT01244490|301135|P1|NOT COMPLETED|Overall Study||19
124839|NCT01244490|301133|P3|COMPLETED|Overall Study||89
124840|NCT01244490|301134|P2|COMPLETED|Overall Study||91
124841|NCT01244490|301135|P1|COMPLETED|Overall Study||92
124842|NCT01244490|301133|P3|STARTED|Overall Study||112
124843|NCT01244490|301134|P2|STARTED|Overall Study||115
124844|NCT01244490|301135|P1|STARTED|Overall Study||111
124845|NCT01244477|301190|P2|NOT COMPLETED|Overall Study||3
124846|NCT01244477|301191|P1|NOT COMPLETED|Overall Study||20
124847|NCT01244477|301190|P2|COMPLETED|Overall Study||20
124848|NCT01244477|301191|P1|COMPLETED|Overall Study||18
124849|NCT01244477|301190|P2|STARTED|Overall Study||23
124850|NCT01244477|301191|P1|STARTED|Overall Study||38
124851|NCT01244425|301203|P2|NOT COMPLETED|Overall Study||3
124852|NCT01244425|301204|P1|NOT COMPLETED|Overall Study||3
124853|NCT01244425|301203|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
124854|NCT01244425|301204|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
124855|NCT01244425|301203|P2|STARTED|Overall Study||35
124856|NCT01244425|301204|P1|STARTED|Overall Study||35
124857|NCT01244412|301224|P1|NOT COMPLETED|Overall Study||0
124858|NCT01244412|301224|P1|COMPLETED|Overall Study||1
124859|NCT01244412|301224|P1|STARTED|Overall Study||1
124860|NCT01244243|301228|P1|NOT COMPLETED|Overall Study||0
124861|NCT01244243|301228|P1|COMPLETED|Overall Study||41
124862|NCT01244243|301228|P1|STARTED|Overall Study||41
124863|NCT01244126|301236|P3|NOT COMPLETED|Overall Study||9
124864|NCT01244126|301237|P2|NOT COMPLETED|Overall Study||3
124865|NCT01244126|301238|P1|NOT COMPLETED|Overall Study||3
124866|NCT01244126|301236|P3|COMPLETED|Overall Study||48
124867|NCT01244126|301237|P2|COMPLETED|Overall Study||52
124868|NCT01244126|301238|P1|COMPLETED|Overall Study||56
124869|NCT01244126|301236|P3|STARTED|Overall Study||57
124870|NCT01244126|301237|P2|STARTED|Overall Study||55
124871|NCT01244126|301238|P1|STARTED|Overall Study||59
124872|NCT01244061|301251|P2|NOT COMPLETED|Overall Study||103
124873|NCT01244061|301252|P1|NOT COMPLETED|Overall Study||82
124874|NCT01244061|301251|P2|COMPLETED|Overall Study||144
124875|NCT01244061|301252|P1|COMPLETED|Overall Study||169
124876|NCT01244061|301251|P2|STARTED|Overall Study||247
124877|NCT01244061|301252|P1|STARTED|Overall Study||251
124878|NCT01243944|301266|P2|NOT COMPLETED|Overall Study||108
124879|NCT01243944|301267|P1|NOT COMPLETED|Overall Study||17
124880|NCT01243944|301266|P2|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|3
124881|NCT01243944|301267|P1|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|93
124882|NCT01243944|301266|P2|STARTED|Overall Study|One subject withdrew consent 5 days after randomization to BAT arm and wasn't treated while on study|111
124883|NCT01243944|301267|P1|STARTED|Overall Study||110
124884|NCT01243892|301291|P2|NOT COMPLETED|Overall Study||0
124885|NCT01243892|301292|P1|NOT COMPLETED|Overall Study||2
124886|NCT01243892|301291|P2|COMPLETED|Overall Study||3
124887|NCT01243892|301292|P1|COMPLETED|Overall Study||13
124888|NCT01243892|301291|P2|STARTED|Overall Study||3
124889|NCT01243892|301292|P1|STARTED|Overall Study||15
124890|NCT01243775|301302|P1|NOT COMPLETED|Overall Study||2
124891|NCT01243775|301302|P1|COMPLETED|Overall Study||31
124892|NCT01243775|301302|P1|STARTED|Overall Study||33
124893|NCT01243762|301316|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
124894|NCT01243762|301317|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124895|NCT01243762|301318|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
124896|NCT01243762|301319|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
124897|NCT01243762|301320|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124898|NCT01243762|301321|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
124899|NCT01243762|301322|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
124900|NCT01243762|301316|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124901|NCT01243762|301317|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124902|NCT01243762|301318|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124903|NCT01243762|301319|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124904|NCT01243762|301320|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124905|NCT01243762|301321|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124906|NCT01243762|301322|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
124907|NCT01243762|301316|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
124908|NCT01243762|301317|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
124909|NCT01243762|301318|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
124910|NCT01243762|301319|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
124911|NCT01243762|301320|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
124912|NCT01243762|301321|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
124913|NCT01243762|301322|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
124914|NCT01243762|301316|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
124915|NCT01243762|301317|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
124916|NCT01243762|301318|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
124917|NCT01243762|301319|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
124918|NCT01243762|301320|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
124919|NCT01243762|301321|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
124920|NCT01243762|301322|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
124921|NCT01243762|301316|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
124922|NCT01243762|301317|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
124923|NCT01243762|301318|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
124924|NCT01243762|301319|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
124925|NCT01243762|301320|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
124926|NCT01243762|301321|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
124927|NCT01243762|301322|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
124928|NCT01243762|301316|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
124929|NCT01243762|301317|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
124930|NCT01243762|301318|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
124931|NCT01243762|301319|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
124932|NCT01243762|301320|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
124933|NCT01243762|301321|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
124934|NCT01243762|301322|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
124935|NCT01243671|301341|P1|NOT COMPLETED|Overall Study||5
124936|NCT01243671|301341|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
124937|NCT01243671|301341|P1|Completed 52 Weeks of Treatment|Overall Study||17
124938|NCT01243671|301341|P1|Completed 24 Weeks of Treatment|Overall Study||18
124939|NCT01243671|301341|P1|STARTED|Overall Study||20
124940|NCT01243619|301354|P1|NOT COMPLETED|Overall Study||0
124941|NCT01243619|301354|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
124942|NCT01243619|301354|P1|STARTED|Overall Study||5
124943|NCT01243580|301360|P2|NOT COMPLETED|Overall Study||2
124944|NCT01243580|301361|P1|NOT COMPLETED|Overall Study||0
124945|NCT01243580|301360|P2|COMPLETED|Overall Study||16
124946|NCT01243580|301361|P1|COMPLETED|Overall Study||18
124947|NCT01243580|301360|P2|STARTED|Overall Study||18
124948|NCT01243580|301361|P1|STARTED|Overall Study||18
124949|NCT01243567|301390|P2|NOT COMPLETED|Overall Study||0
124950|NCT01243567|301391|P1|NOT COMPLETED|Overall Study||1
124951|NCT01243567|301390|P2|COMPLETED|Overall Study||38
124952|NCT01243567|301391|P1|COMPLETED|Overall Study||42
124953|NCT01243567|301390|P2|STARTED|Overall Study||38
124954|NCT01243567|301391|P1|STARTED|Overall Study||43
124955|NCT01243450|301408|P3|NOT COMPLETED|Overall Study||67
124956|NCT01243450|301409|P2|NOT COMPLETED|Overall Study||25
124957|NCT01243450|301410|P1|NOT COMPLETED|Overall Study||83
124958|NCT01243450|301408|P3|COMPLETED|Overall Study||337
124959|NCT01243450|301409|P2|COMPLETED|Overall Study||110
124960|NCT01243450|301410|P1|COMPLETED|Overall Study||318
124961|NCT01243450|301408|P3|STARTED|Overall Study||404
124962|NCT01243450|301409|P2|STARTED|Overall Study||135
124963|NCT01243450|301410|P1|STARTED|Overall Study||401
124964|NCT01243411|301418|P1|NOT COMPLETED|Overall Study||41
124965|NCT01243411|301418|P1|COMPLETED|Overall Study||306
124966|NCT01243411|301418|P1|STARTED|Overall Study||347
124967|NCT01243320|301430|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
124968|NCT01243320|301430|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
124969|NCT01243320|301430|P1|STARTED|32ppm Oral Silver (14 Days)||24
124970|NCT01243320|301430|P1|NOT COMPLETED|Washout (3 Days)||0
124971|NCT01243320|301430|P1|COMPLETED|Washout (3 Days)||36
124972|NCT01243320|301430|P1|STARTED|Washout (3 Days)||36
124973|NCT01243320|301430|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
124974|NCT01243320|301430|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
124975|NCT01243320|301430|P1|STARTED|10ppm Oral Silver (14 Days)||36
124976|NCT01243320|301430|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
124977|NCT01243320|301430|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
124978|NCT01243320|301430|P1|STARTED|10ppm Oral Silver (7 Days)||36
124979|NCT01243320|301430|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
124980|NCT01243320|301430|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
124981|NCT01243320|301430|P1|STARTED|10ppm Oral Silver (3 Days)||36
124982|NCT01243294|301506|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
124983|NCT01243294|301507|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
124984|NCT01243294|301506|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
124985|NCT01243294|301507|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
124986|NCT01243294|301506|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
124987|NCT01243294|301507|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
124988|NCT01243294|301506|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
124989|NCT01243294|301507|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
124990|NCT01243294|301506|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
124991|NCT01243294|301507|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
124992|NCT01243294|301506|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
124993|NCT01243294|301507|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
124994|NCT01243242|301525|P2|NOT COMPLETED|Overall Study||4
124995|NCT01243242|301526|P1|NOT COMPLETED|Overall Study||3
124996|NCT01243242|301525|P2|COMPLETED|Overall Study||56
124997|NCT01243242|301526|P1|COMPLETED|Overall Study||57
124998|NCT01243242|301525|P2|STARTED|Overall Study||60
124999|NCT01243242|301526|P1|STARTED|Overall Study||60
125000|NCT01243177|301540|P2|NOT COMPLETED|Overall Study||178
125001|NCT01243177|301541|P1|NOT COMPLETED|Overall Study||178
125002|NCT01243177|301540|P2|COMPLETED|Overall Study||264
125003|NCT01243177|301541|P1|COMPLETED|Overall Study||266
125004|NCT01243177|301540|P2|STARTED|Overall Study||442
125005|NCT01243177|301541|P1|STARTED|Overall Study||444
125006|NCT01243112|301557|P1|NOT COMPLETED|Overall Study||0
125007|NCT01243112|301557|P1|COMPLETED|Overall Study||25
125008|NCT01243112|301557|P1|STARTED|Overall Study||25
125009|NCT01242813|301562|P1|NOT COMPLETED|Overall Study||2
125010|NCT01242813|301562|P1|COMPLETED|Overall Study||18
125011|NCT01242813|301562|P1|STARTED|Overall Study||20
125012|NCT01242748|301584|P2|NOT COMPLETED|Overall Study||14
125013|NCT01242748|301585|P1|NOT COMPLETED|Overall Study||38
125014|NCT01242748|301584|P2|COMPLETED|Overall Study||80
125015|NCT01242748|301585|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
125016|NCT01242748|301584|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
125017|NCT01242748|301585|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
125018|NCT01242748|301584|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
125019|NCT01242748|301585|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
125020|NCT01242748|301584|P2|STARTED|Overall Study||94
125021|NCT01242748|301585|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
125022|NCT01242527|301609|P4|NOT COMPLETED|Overall Study||9
125023|NCT01242527|301610|P3|NOT COMPLETED|Overall Study||14
125024|NCT01242527|301611|P2|NOT COMPLETED|Overall Study||7
125025|NCT01242527|301612|P1|NOT COMPLETED|Overall Study||5
125026|NCT01242527|301609|P4|COMPLETED|Overall Study||90
125027|NCT01242527|301610|P3|COMPLETED|Overall Study||87
125028|NCT01242527|301611|P2|COMPLETED|Overall Study||93
125029|NCT01242527|301612|P1|COMPLETED|Overall Study||94
125030|NCT01242527|301609|P4|STARTED|Overall Study||99
125031|NCT01242527|301610|P3|STARTED|Overall Study||101
125032|NCT01242527|301611|P2|STARTED|Overall Study||100
125033|NCT01242527|301612|P1|STARTED|Overall Study||99
125034|NCT01242514|301625|P3|NOT COMPLETED|Overall Study||212
125035|NCT01242514|301626|P2|NOT COMPLETED|Overall Study||357
125036|NCT01242514|301627|P1|NOT COMPLETED|Overall Study||1343
125037|NCT01242514|301625|P3|COMPLETED|Overall Study|Due to project closure.|0
125038|NCT01242514|301626|P2|COMPLETED|Overall Study|Due to project closure.|0
125039|NCT01242514|301627|P1|COMPLETED|Overall Study|Due to project closure.|0
125040|NCT01242514|301625|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
125041|NCT01242514|301626|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
125042|NCT01242514|301627|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
125043|NCT01242514|301625|P3|STARTED|Overall Study|Patients who received treatment|212
125044|NCT01242514|301626|P2|STARTED|Overall Study|Patients who received treatment|357
125045|NCT01242514|301627|P1|STARTED|Overall Study|Patients who received treatment|1343
125046|NCT01242371|301646|P2|NOT COMPLETED|Overall Study||5
125047|NCT01242371|301647|P1|NOT COMPLETED|Overall Study||2
125048|NCT01242371|301646|P2|COMPLETED|Overall Study||27
125049|NCT01242371|301647|P1|COMPLETED|Overall Study||31
125050|NCT01242371|301646|P2|STARTED|Overall Study||32
125051|NCT01242371|301647|P1|STARTED|Overall Study||33
125052|NCT01242176|301653|P2|NOT COMPLETED|Second Intervention||0
125053|NCT01242176|301654|P1|NOT COMPLETED|Second Intervention||0
125054|NCT01242176|301653|P2|COMPLETED|Second Intervention||10
125055|NCT01242176|301654|P1|COMPLETED|Second Intervention||11
125056|NCT01242176|301653|P2|STARTED|Second Intervention||10
125057|NCT01242176|301654|P1|STARTED|Second Intervention||11
125058|NCT01242176|301653|P2|NOT COMPLETED|Washout Period of 7 Days||2
125059|NCT01242176|301654|P1|NOT COMPLETED|Washout Period of 7 Days||1
125060|NCT01242176|301653|P2|COMPLETED|Washout Period of 7 Days||10
125061|NCT01242176|301654|P1|COMPLETED|Washout Period of 7 Days||11
125062|NCT01242176|301653|P2|STARTED|Washout Period of 7 Days||12
125063|NCT01242176|301654|P1|STARTED|Washout Period of 7 Days||12
125064|NCT01242176|301653|P2|NOT COMPLETED|First Intervention||0
125065|NCT01242176|301654|P1|NOT COMPLETED|First Intervention||0
125066|NCT01242176|301653|P2|COMPLETED|First Intervention||12
125067|NCT01242176|301654|P1|COMPLETED|First Intervention||12
125068|NCT01242176|301653|P2|STARTED|First Intervention||12
125069|NCT01242176|301654|P1|STARTED|First Intervention||12
125070|NCT01242111|301664|P1|NOT COMPLETED|Overall Study||3
125071|NCT01242111|301664|P1|COMPLETED|Overall Study||17
125072|NCT01242111|301664|P1|STARTED|Overall Study||20
125073|NCT01242085|301676|P3|NOT COMPLETED|Overall Study||0
125074|NCT01242085|301677|P2|NOT COMPLETED|Overall Study||7
125075|NCT01242085|301678|P1|NOT COMPLETED|Overall Study||8
125076|NCT01242085|301676|P3|COMPLETED|Overall Study||1
125077|NCT01242085|301677|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
125171|NCT01241292|302118|P2|COMPLETED|Overall Study|completed=treatment on-going|0
125078|NCT01242085|301678|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
125079|NCT01242085|301676|P3|STARTED|Overall Study||1
125080|NCT01242085|301677|P2|STARTED|Overall Study||33
125081|NCT01242085|301678|P1|STARTED|Overall Study||30
125082|NCT01242020|301688|P2|NOT COMPLETED|Overall Study||0
125083|NCT01242020|301689|P1|NOT COMPLETED|Overall Study||3
125084|NCT01242020|301688|P2|COMPLETED|Overall Study||0
125085|NCT01242020|301689|P1|COMPLETED|Overall Study||3
125086|NCT01242020|301688|P2|STARTED|Overall Study||0
125087|NCT01242020|301689|P1|STARTED|Overall Study||6
125088|NCT01241916|301699|P2|NOT COMPLETED|Overall Study||10
125089|NCT01241916|301700|P1|NOT COMPLETED|Overall Study||7
125090|NCT01241916|301699|P2|COMPLETED|Overall Study||21
125091|NCT01241916|301700|P1|COMPLETED|Overall Study||28
125092|NCT01241916|301699|P2|STARTED|Overall Study||31
125093|NCT01241916|301700|P1|STARTED|Overall Study||35
125094|NCT01241903|301710|P2|NOT COMPLETED|Overall Study||0
125095|NCT01241903|301711|P1|NOT COMPLETED|Overall Study||1
125096|NCT01241903|301710|P2|COMPLETED|Overall Study||27
125097|NCT01241903|301711|P1|COMPLETED|Overall Study||26
125098|NCT01241903|301710|P2|STARTED|Overall Study||27
125099|NCT01241903|301711|P1|STARTED|Overall Study||27
125100|NCT01241760|301719|P2|NOT COMPLETED|Overall Study||40
125101|NCT01241760|301720|P1|NOT COMPLETED|Overall Study||34
125102|NCT01241760|301719|P2|COMPLETED|Overall Study||329
125103|NCT01241760|301720|P1|COMPLETED|Overall Study||337
125104|NCT01241760|301719|P2|STARTED|Overall Study||369
125105|NCT01241760|301720|P1|STARTED|Overall Study||371
125106|NCT01241591|301743|P4|NOT COMPLETED|Overall Study||12
125107|NCT01241591|301744|P3|NOT COMPLETED|Overall Study||22
125108|NCT01241591|301745|P2|NOT COMPLETED|Overall Study||24
125109|NCT01241591|301746|P1|NOT COMPLETED|Overall Study||23
125110|NCT01241591|301743|P4|COMPLETED|Overall Study||95
125111|NCT01241591|301744|P3|COMPLETED|Overall Study||313
125112|NCT01241591|301745|P2|COMPLETED|Overall Study||306
125113|NCT01241591|301746|P1|COMPLETED|Overall Study||306
125114|NCT01241591|301743|P4|STARTED|Overall Study||107
125115|NCT01241591|301744|P3|STARTED|Overall Study||335
125116|NCT01241591|301745|P2|STARTED|Overall Study||330
125117|NCT01241591|301746|P1|STARTED|Overall Study||329
125118|NCT01241565|301936|P1|NOT COMPLETED|Overall Study||0
125119|NCT01241565|301936|P1|COMPLETED|Overall Study||50
125120|NCT01241565|301936|P1|STARTED|Overall Study||50
125121|NCT01241552|301949|P4|NOT COMPLETED|Overall Study||64
125122|NCT01241552|301950|P3|NOT COMPLETED|Overall Study||60
125123|NCT01241552|301951|P2|NOT COMPLETED|Overall Study||63
125124|NCT01241552|301952|P1|NOT COMPLETED|Overall Study||41
125125|NCT01241552|301949|P4|COMPLETED|Overall Study||340
125126|NCT01241552|301950|P3|COMPLETED|Overall Study||343
125127|NCT01241552|301951|P2|COMPLETED|Overall Study||340
125128|NCT01241552|301952|P1|COMPLETED|Overall Study||201
125129|NCT01241552|301949|P4|Treated|Overall Study||397
125130|NCT01241552|301950|P3|Treated|Overall Study||388
125131|NCT01241552|301951|P2|Treated|Overall Study||392
125132|NCT01241552|301952|P1|Treated|Overall Study||235
125133|NCT01241552|301949|P4|STARTED|Overall Study||404
125134|NCT01241552|301950|P3|STARTED|Overall Study||403
125135|NCT01241552|301951|P2|STARTED|Overall Study||403
125136|NCT01241552|301952|P1|STARTED|Overall Study||242
125137|NCT01241539|302018|P1|NOT COMPLETED|Period 2||0
125138|NCT01241539|302018|P1|COMPLETED|Period 2||7
125139|NCT01241539|302018|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
125140|NCT01241539|302018|P1|NOT COMPLETED|Period 1||0
125141|NCT01241539|302018|P1|COMPLETED|Period 1||7
125142|NCT01241539|302018|P1|STARTED|Period 1||7
125143|NCT01241513|302039|P2|NOT COMPLETED|Overall Study||0
125144|NCT01241513|302040|P1|NOT COMPLETED|Overall Study||0
125145|NCT01241513|302039|P2|COMPLETED|Overall Study||9
125146|NCT01241513|302040|P1|COMPLETED|Overall Study|Study has been completed|10
125147|NCT01241513|302039|P2|STARTED|Overall Study||9
125148|NCT01241513|302040|P1|STARTED|Overall Study||10
125149|NCT01241448|302049|P4|NOT COMPLETED|Overall Study||23
125150|NCT01241448|302050|P3|NOT COMPLETED|Overall Study||23
125151|NCT01241448|302051|P2|NOT COMPLETED|Overall Study||29
125152|NCT01241448|302052|P1|NOT COMPLETED|Overall Study||37
125153|NCT01241448|302049|P4|COMPLETED|Overall Study||43
125154|NCT01241448|302050|P3|COMPLETED|Overall Study||43
125155|NCT01241448|302051|P2|COMPLETED|Overall Study||36
125156|NCT01241448|302052|P1|COMPLETED|Overall Study||29
125157|NCT01241448|302049|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
125158|NCT01241448|302050|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
125159|NCT01241448|302051|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
125160|NCT01241448|302052|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
125161|NCT01241448|302049|P4|Intent-to-Treat Population (ITT)|Overall Study||64
125162|NCT01241448|302050|P3|Intent-to-Treat Population (ITT)|Overall Study||64
125163|NCT01241448|302051|P2|Intent-to-Treat Population (ITT)|Overall Study||63
125164|NCT01241448|302052|P1|Intent-to-Treat Population (ITT)|Overall Study||63
125165|NCT01241448|302049|P4|STARTED|Overall Study||66
125166|NCT01241448|302050|P3|STARTED|Overall Study||66
125167|NCT01241448|302051|P2|STARTED|Overall Study||65
125168|NCT01241448|302052|P1|STARTED|Overall Study||66
125169|NCT01241292|302118|P2|NOT COMPLETED|Overall Study||3
125170|NCT01241292|302119|P1|NOT COMPLETED|Overall Study||3
125172|NCT01241292|302119|P1|COMPLETED|Overall Study|completed=treatment on-going|0
125173|NCT01241292|302118|P2|Entered Treatment Period|Overall Study||3
125174|NCT01241292|302119|P1|Entered Treatment Period|Overall Study||3
125175|NCT01241292|302118|P2|STARTED|Overall Study||3
125176|NCT01241292|302119|P1|STARTED|Overall Study||3
125177|NCT01241279|302143|P2|NOT COMPLETED|Overall Study||1
125178|NCT01241279|302144|P1|NOT COMPLETED|Overall Study||0
125179|NCT01241279|302143|P2|COMPLETED|Overall Study||1
125180|NCT01241279|302144|P1|COMPLETED|Overall Study||4
125181|NCT01241279|302143|P2|STARTED|Overall Study||2
125182|NCT01241279|302144|P1|STARTED|Overall Study||4
125183|NCT01241240|302154|P2|NOT COMPLETED|Overall Study||9
125184|NCT01241240|302155|P1|NOT COMPLETED|Overall Study||8
125185|NCT01241240|302154|P2|COMPLETED|Overall Study||89
125186|NCT01241240|302155|P1|COMPLETED|Overall Study||86
125187|NCT01241240|302154|P2|STARTED|Overall Study||98
125188|NCT01241240|302155|P1|STARTED|Overall Study||94
125189|NCT01240915|302173|P9|NOT COMPLETED|Overall Study||8
125190|NCT01240915|302174|P8|NOT COMPLETED|Overall Study||4
125191|NCT01240915|302175|P7|NOT COMPLETED|Overall Study||8
125192|NCT01240915|302176|P6|NOT COMPLETED|Overall Study||10
125193|NCT01240915|302177|P5|NOT COMPLETED|Overall Study||4
125194|NCT01240915|302178|P4|NOT COMPLETED|Overall Study||3
125195|NCT01240915|302179|P3|NOT COMPLETED|Overall Study||0
125196|NCT01240915|302180|P2|NOT COMPLETED|Overall Study||1
125197|NCT01240915|302181|P1|NOT COMPLETED|Overall Study||2
125198|NCT01240915|302173|P9|COMPLETED|Overall Study||13
125199|NCT01240915|302174|P8|COMPLETED|Overall Study||15
125200|NCT01240915|302175|P7|COMPLETED|Overall Study||17
125201|NCT01240915|302176|P6|COMPLETED|Overall Study||13
125202|NCT01240915|302177|P5|COMPLETED|Overall Study||2
125203|NCT01240915|302178|P4|COMPLETED|Overall Study||1
125204|NCT01240915|302179|P3|COMPLETED|Overall Study||2
125205|NCT01240915|302180|P2|COMPLETED|Overall Study||2
125206|NCT01240915|302181|P1|COMPLETED|Overall Study||0
125207|NCT01240915|302173|P9|STARTED|Overall Study||21
125208|NCT01240915|302174|P8|STARTED|Overall Study||19
125209|NCT01240915|302175|P7|STARTED|Overall Study||25
125210|NCT01240915|302176|P6|STARTED|Overall Study||23
125211|NCT01240915|302177|P5|STARTED|Overall Study||6
125212|NCT01240915|302178|P4|STARTED|Overall Study||4
125213|NCT01240915|302179|P3|STARTED|Overall Study||2
125214|NCT01240915|302180|P2|STARTED|Overall Study||3
125215|NCT01240915|302181|P1|STARTED|Overall Study||2
125216|NCT01240902|302364|P4|NOT COMPLETED|Overall Study||165
125217|NCT01240902|302365|P3|NOT COMPLETED|Overall Study||100
125218|NCT01240902|302366|P2|NOT COMPLETED|Overall Study||79
125219|NCT01240902|302367|P1|NOT COMPLETED|Overall Study||211
125220|NCT01240902|302364|P4|COMPLETED|Overall Study||237
125221|NCT01240902|302365|P3|COMPLETED|Overall Study||295
125222|NCT01240902|302366|P2|COMPLETED|Overall Study||77
125223|NCT01240902|302367|P1|COMPLETED|Overall Study||289
125224|NCT01240902|302364|P4|STARTED|Overall Study||402
125225|NCT01240902|302365|P3|STARTED|Overall Study||395
125226|NCT01240902|302366|P2|STARTED|Overall Study||156
125227|NCT01240902|302367|P1|STARTED|Overall Study||500
125228|NCT01240863|302455|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
125229|NCT01240863|302456|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
125230|NCT01240863|302457|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
125231|NCT01240863|302455|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
125232|NCT01240863|302456|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
125233|NCT01240863|302457|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
125234|NCT01240863|302455|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
125235|NCT01240863|302456|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
125236|NCT01240863|302457|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
125237|NCT01240863|302455|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
125238|NCT01240863|302456|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
125239|NCT01240863|302457|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
125240|NCT01240863|302455|P3|NOT COMPLETED|Open-label Titration Period||0
125241|NCT01240863|302456|P2|NOT COMPLETED|Open-label Titration Period||0
125242|NCT01240863|302457|P1|NOT COMPLETED|Open-label Titration Period||97
125243|NCT01240863|302455|P3|COMPLETED|Open-label Titration Period||0
125244|NCT01240863|302456|P2|COMPLETED|Open-label Titration Period||0
125245|NCT01240863|302457|P1|COMPLETED|Open-label Titration Period||294
125246|NCT01240863|302455|P3|Safety Analysis Set|Open-label Titration Period||0
125247|NCT01240863|302456|P2|Safety Analysis Set|Open-label Titration Period||0
125248|NCT01240863|302457|P1|Safety Analysis Set|Open-label Titration Period||389
125249|NCT01240863|302455|P3|STARTED|Open-label Titration Period||0
125250|NCT01240863|302456|P2|STARTED|Open-label Titration Period||0
125251|NCT01240863|302457|P1|STARTED|Open-label Titration Period||391
125252|NCT01240811|302519|P3|NOT COMPLETED|Overall Study||1
125253|NCT01240811|302520|P2|NOT COMPLETED|Overall Study||1
125254|NCT01240811|302521|P1|NOT COMPLETED|Overall Study||0
125255|NCT01240811|302519|P3|COMPLETED|Overall Study||16
125256|NCT01240811|302520|P2|COMPLETED|Overall Study||16
125257|NCT01240811|302521|P1|COMPLETED|Overall Study||8
125258|NCT01240811|302519|P3|STARTED|Overall Study||17
125259|NCT01240811|302520|P2|STARTED|Overall Study||17
125260|NCT01240811|302521|P1|STARTED|Overall Study||8
125261|NCT01240785|302537|P2|NOT COMPLETED|Overall Study||3
125262|NCT01240785|302538|P1|NOT COMPLETED|Overall Study||1
125263|NCT01240785|302537|P2|COMPLETED|Overall Study||107
125264|NCT01240785|302538|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
125265|NCT01240785|302537|P2|STARTED|Overall Study||110
125266|NCT01240785|302538|P1|STARTED|Overall Study||111
125267|NCT01240746|302569|P3|NOT COMPLETED|Overall Study||243
125268|NCT01240746|302570|P2|NOT COMPLETED|Overall Study||48
125269|NCT01240746|302571|P1|NOT COMPLETED|Overall Study||59
125270|NCT01240746|302569|P3|COMPLETED|Overall Study||2659
125271|NCT01240746|302570|P2|COMPLETED|Overall Study||677
125272|NCT01240746|302571|P1|COMPLETED|Overall Study||677
125273|NCT01240746|302569|P3|STARTED|Overall Study||2902
125274|NCT01240746|302570|P2|STARTED|Overall Study||725
125275|NCT01240746|302571|P1|STARTED|Overall Study||736
125276|NCT01240590|302626|P5|NOT COMPLETED|Phase II||1
125277|NCT01240590|302627|P4|NOT COMPLETED|Phase II||2
125278|NCT01240590|302628|P3|NOT COMPLETED|Phase II||0
125279|NCT01240590|302629|P2|NOT COMPLETED|Phase II||0
125280|NCT01240590|302630|P1|NOT COMPLETED|Phase II||0
125281|NCT01240590|302626|P5|COMPLETED|Phase II||0
125282|NCT01240590|302627|P4|COMPLETED|Phase II||15
125283|NCT01240590|302628|P3|COMPLETED|Phase II||0
125284|NCT01240590|302629|P2|COMPLETED|Phase II||0
125285|NCT01240590|302630|P1|COMPLETED|Phase II||0
125286|NCT01240590|302626|P5|STARTED|Phase II||1
125287|NCT01240590|302627|P4|STARTED|Phase II||17
125288|NCT01240590|302628|P3|STARTED|Phase II||0
125289|NCT01240590|302629|P2|STARTED|Phase II||0
125290|NCT01240590|302630|P1|STARTED|Phase II||0
125291|NCT01240590|302626|P5|NOT COMPLETED|Phase I||0
125292|NCT01240590|302627|P4|NOT COMPLETED|Phase I||0
125293|NCT01240590|302628|P3|NOT COMPLETED|Phase I||3
125294|NCT01240590|302629|P2|NOT COMPLETED|Phase I||0
125295|NCT01240590|302630|P1|NOT COMPLETED|Phase I||0
125296|NCT01240590|302626|P5|COMPLETED|Phase I||0
125297|NCT01240590|302627|P4|COMPLETED|Phase I||0
125298|NCT01240590|302628|P3|COMPLETED|Phase I||0
125299|NCT01240590|302629|P2|COMPLETED|Phase I||6
125300|NCT01240590|302630|P1|COMPLETED|Phase I||0
125301|NCT01240590|302626|P5|STARTED|Phase I||0
125302|NCT01240590|302627|P4|STARTED|Phase I||0
125303|NCT01240590|302628|P3|STARTED|Phase I||3
125304|NCT01240590|302629|P2|STARTED|Phase I||6
125305|NCT01240590|302630|P1|STARTED|Phase I||0
125306|NCT01240551|302658|P2|NOT COMPLETED|Overall Study||3
125307|NCT01240551|302659|P1|NOT COMPLETED|Overall Study||4
125308|NCT01240551|302658|P2|COMPLETED|Overall Study||27
125309|NCT01240551|302659|P1|COMPLETED|Overall Study||26
125310|NCT01240551|302658|P2|STARTED|Overall Study||30
125311|NCT01240551|302659|P1|STARTED|Overall Study||30
125312|NCT01240382|302669|P2|NOT COMPLETED|Overall Study||4
125313|NCT01240382|302670|P1|NOT COMPLETED|Overall Study||2
125314|NCT01240382|302669|P2|COMPLETED|Overall Study||139
125315|NCT01240382|302670|P1|COMPLETED|Overall Study||142
125316|NCT01240382|302669|P2|STARTED|Overall Study||143
125317|NCT01240382|302670|P1|STARTED|Overall Study||144
125318|NCT01240356|302680|P2|NOT COMPLETED|Overall Study||0
125319|NCT01240356|302681|P1|NOT COMPLETED|Overall Study||3
125320|NCT01240356|302680|P2|COMPLETED|Overall Study||20
125321|NCT01240356|302681|P1|COMPLETED|Overall Study||15
125322|NCT01240356|302680|P2|STARTED|Overall Study||20
125323|NCT01240356|302681|P1|STARTED|Overall Study||18
125324|NCT01240330|302692|P1|NOT COMPLETED|Overall Study||0
125325|NCT01240330|302692|P1|COMPLETED|Overall Study||33
125326|NCT01240330|302692|P1|STARTED|Overall Study||33
125327|NCT01240200|302700|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
125328|NCT01240200|302701|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
125329|NCT01240200|302700|P2|COMPLETED|12-week Crossover Phase - Period 2||23
125330|NCT01240200|302701|P1|COMPLETED|12-week Crossover Phase - Period 2||23
125331|NCT01240200|302700|P2|STARTED|12-week Crossover Phase - Period 2||23
125332|NCT01240200|302701|P1|STARTED|12-week Crossover Phase - Period 2||23
125333|NCT01240200|302700|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
125334|NCT01240200|302701|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
125335|NCT01240200|302700|P2|COMPLETED|12-week Crossover Phase - Period 1||23
125336|NCT01240200|302701|P1|COMPLETED|12-week Crossover Phase - Period 1||23
125337|NCT01240200|302700|P2|STARTED|12-week Crossover Phase - Period 1||24
125338|NCT01240200|302701|P1|STARTED|12-week Crossover Phase - Period 1||25
125339|NCT01240135|302709|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
125340|NCT01240135|302710|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
125341|NCT01240135|302709|P2|COMPLETED|Period Two, 14 Days of Wear||43
125342|NCT01240135|302710|P1|COMPLETED|Period Two, 14 Days of Wear||43
125343|NCT01240135|302709|P2|STARTED|Period Two, 14 Days of Wear||45
125344|NCT01240135|302710|P1|STARTED|Period Two, 14 Days of Wear||44
125345|NCT01240135|302709|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
125346|NCT01240135|302710|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
125347|NCT01240135|302709|P2|COMPLETED|Period One, 14 Days of Wear||45
125348|NCT01240135|302710|P1|COMPLETED|Period One, 14 Days of Wear||44
125349|NCT01240135|302709|P2|STARTED|Period One, 14 Days of Wear||45
125350|NCT01240135|302710|P1|STARTED|Period One, 14 Days of Wear||44
125351|NCT01240122|302718|P1|NOT COMPLETED|Overall Study||0
125352|NCT01240122|302718|P1|COMPLETED|Overall Study||29
125353|NCT01240122|302718|P1|STARTED|Overall Study||29
125354|NCT01239992|302727|P1|NOT COMPLETED|Overall Study||2
125355|NCT01239992|302727|P1|COMPLETED|Overall Study||10
125356|NCT01239992|302727|P1|STARTED|Overall Study||12
125357|NCT01239797|302736|P2|NOT COMPLETED|Treated Participants||274
125358|NCT01239797|302737|P1|NOT COMPLETED|Treated Participants||235
125359|NCT01239797|302736|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
125360|NCT01239797|302737|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
125361|NCT01239797|302736|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
125362|NCT01239797|302737|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
125363|NCT01239797|302736|P2|NOT COMPLETED|Randomized Participants||9
125364|NCT01239797|302737|P1|NOT COMPLETED|Randomized Participants||2
125365|NCT01239797|302736|P2|COMPLETED|Randomized Participants||316
125366|NCT01239797|302737|P1|COMPLETED|Randomized Participants||319
125367|NCT01239797|302736|P2|STARTED|Randomized Participants||325
125368|NCT01239797|302737|P1|STARTED|Randomized Participants||321
125369|NCT01239745|302745|P1|NOT COMPLETED|Overall Study||46
125370|NCT01239745|302745|P1|COMPLETED|Overall Study||0
125371|NCT01239745|302745|P1|STARTED|Overall Study||46
125372|NCT01239732|302756|P1|NOT COMPLETED|Overall Study||1021
125373|NCT01239732|302756|P1|COMPLETED|Overall Study||0
125374|NCT01239732|302756|P1|STARTED|Overall Study||1021
125375|NCT01239680|302769|P2|NOT COMPLETED|Overall Study||0
125376|NCT01239680|302770|P1|NOT COMPLETED|Overall Study||2
125377|NCT01239680|302769|P2|COMPLETED|Overall Study||2
125378|NCT01239680|302770|P1|COMPLETED|Overall Study||1
125379|NCT01239680|302769|P2|STARTED|Overall Study||2
125380|NCT01239680|302770|P1|STARTED|Overall Study||3
125381|NCT01239511|302780|P4|NOT COMPLETED|Overall Study||9
125382|NCT01239511|302781|P3|NOT COMPLETED|Overall Study||4
125383|NCT01239511|302782|P2|NOT COMPLETED|Overall Study||5
125384|NCT01239511|302783|P1|NOT COMPLETED|Overall Study||1
125385|NCT01239511|302780|P4|COMPLETED|Overall Study||38
125386|NCT01239511|302781|P3|COMPLETED|Overall Study||43
125387|NCT01239511|302782|P2|COMPLETED|Overall Study||40
125388|NCT01239511|302783|P1|COMPLETED|Overall Study||46
125389|NCT01239511|302780|P4|STARTED|Overall Study||47
125390|NCT01239511|302781|P3|STARTED|Overall Study||47
125391|NCT01239511|302782|P2|STARTED|Overall Study||45
125392|NCT01239511|302783|P1|STARTED|Overall Study||47
125393|NCT01239394|302793|P1|NOT COMPLETED|Overall Study||1
125394|NCT01239394|302793|P1|COMPLETED|Overall Study||41
125395|NCT01239394|302793|P1|STARTED|Overall Study||42
125396|NCT01239381|302800|P1|NOT COMPLETED|Overall Study||2
125397|NCT01239381|302800|P1|COMPLETED|Overall Study||90
125398|NCT01239381|302800|P1|STARTED|Overall Study||92
125399|NCT01239355|302810|P1|NOT COMPLETED|Overall Study||0
125400|NCT01239355|302810|P1|COMPLETED|Overall Study||15
125401|NCT01239355|302810|P1|STARTED|Overall Study||15
125402|NCT01239342|302818|P2|NOT COMPLETED|Overall Study||6
125403|NCT01239342|302819|P1|NOT COMPLETED|Overall Study||3
125404|NCT01239342|302818|P2|COMPLETED|Overall Study||8
125405|NCT01239342|302819|P1|COMPLETED|Overall Study||26
125406|NCT01239342|302818|P2|STARTED|Overall Study||14
125407|NCT01239342|302819|P1|STARTED|Overall Study||29
125408|NCT01239316|302835|P1|NOT COMPLETED|Overall Study||12
125409|NCT01239316|302835|P1|COMPLETED|Overall Study||0
125410|NCT01239316|302835|P1|STARTED|Overall Study||12
125411|NCT01239212|302843|P1|NOT COMPLETED|Overall Study||0
125412|NCT01239212|302843|P1|COMPLETED|Overall Study||7
125413|NCT01239212|302843|P1|STARTED|Overall Study||7
125414|NCT01239121|302850|P3|NOT COMPLETED|Overall Study||0
125415|NCT01239121|302851|P2|NOT COMPLETED|Overall Study||4
125416|NCT01239121|302852|P1|NOT COMPLETED|Overall Study||2
125417|NCT01239121|302850|P3|COMPLETED|Overall Study||15
125418|NCT01239121|302851|P2|COMPLETED|Overall Study||195
125419|NCT01239121|302852|P1|COMPLETED|Overall Study||186
125420|NCT01239121|302850|P3|STARTED|Overall Study||15
125421|NCT01239121|302851|P2|STARTED|Overall Study||199
125422|NCT01239121|302852|P1|STARTED|Overall Study||188
125423|NCT01239056|302866|P1|NOT COMPLETED|Overall Study||0
125424|NCT01239056|302866|P1|COMPLETED|Overall Study||20
125425|NCT01239056|302866|P1|STARTED|Overall Study||20
125426|NCT01239043|302874|P2|NOT COMPLETED|Overall Study||1
125427|NCT01239043|302875|P1|NOT COMPLETED|Overall Study||2
125428|NCT01239043|302874|P2|COMPLETED|Overall Study||102
125429|NCT01239043|302875|P1|COMPLETED|Overall Study||34
125430|NCT01239043|302874|P2|STARTED|Overall Study||103
125431|NCT01239043|302875|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
125432|NCT01238991|302903|P10|NOT COMPLETED|Overall Study||2
125433|NCT01238991|302904|P9|NOT COMPLETED|Overall Study||4
125434|NCT01238991|302905|P8|NOT COMPLETED|Overall Study||5
125435|NCT01238991|302906|P7|NOT COMPLETED|Overall Study||8
125436|NCT01238991|302907|P6|NOT COMPLETED|Overall Study||0
125437|NCT01238991|302908|P5|NOT COMPLETED|Overall Study||2
125438|NCT01238991|302909|P4|NOT COMPLETED|Overall Study||2
125439|NCT01238991|302910|P3|NOT COMPLETED|Overall Study||6
125440|NCT01238991|302911|P2|NOT COMPLETED|Overall Study||0
125441|NCT01238991|302912|P1|NOT COMPLETED|Overall Study||2
125442|NCT01238991|302903|P10|COMPLETED|Overall Study||0
125443|NCT01238991|302904|P9|COMPLETED|Overall Study||0
125444|NCT01238991|302905|P8|COMPLETED|Overall Study||0
125445|NCT01238991|302906|P7|COMPLETED|Overall Study||0
125446|NCT01238991|302907|P6|COMPLETED|Overall Study||2
125447|NCT01238991|302908|P5|COMPLETED|Overall Study||3
125448|NCT01238991|302909|P4|COMPLETED|Overall Study||4
125449|NCT01238991|302910|P3|COMPLETED|Overall Study||5
125450|NCT01238991|302911|P2|COMPLETED|Overall Study||3
125451|NCT01238991|302912|P1|COMPLETED|Overall Study||5
125452|NCT01238991|302903|P10|Received Treatment|Overall Study||2
125453|NCT01238991|302904|P9|Received Treatment|Overall Study||4
125454|NCT01238991|302905|P8|Received Treatment|Overall Study||5
125455|NCT01238991|302906|P7|Received Treatment|Overall Study||8
125456|NCT01238991|302907|P6|Received Treatment|Overall Study||2
125457|NCT01238991|302908|P5|Received Treatment|Overall Study||5
125458|NCT01238991|302909|P4|Received Treatment|Overall Study||6
125459|NCT01238991|302910|P3|Received Treatment|Overall Study||11
125460|NCT01238991|302911|P2|Received Treatment|Overall Study||3
125461|NCT01238991|302912|P1|Received Treatment|Overall Study||7
125462|NCT01238991|302903|P10|STARTED|Overall Study||2
125463|NCT01238991|302904|P9|STARTED|Overall Study||4
125464|NCT01238991|302905|P8|STARTED|Overall Study||5
125465|NCT01238991|302906|P7|STARTED|Overall Study||8
125466|NCT01238991|302907|P6|STARTED|Overall Study||2
125467|NCT01238991|302908|P5|STARTED|Overall Study||5
125468|NCT01238991|302909|P4|STARTED|Overall Study||6
125469|NCT01238991|302910|P3|STARTED|Overall Study||11
125470|NCT01238991|302911|P2|STARTED|Overall Study||3
125471|NCT01238991|302912|P1|STARTED|Overall Study||7
125472|NCT01238900|302999|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
125473|NCT01238900|302999|P1|COMPLETED|<12 Months Post Stent Removal||18
125474|NCT01238900|302999|P1|STARTED|<12 Months Post Stent Removal||23
125475|NCT01238900|302999|P1|NOT COMPLETED|6 Months Post Stent Placement||0
125476|NCT01238900|302999|P1|COMPLETED|6 Months Post Stent Placement||23
125477|NCT01238900|302999|P1|STARTED|6 Months Post Stent Placement||23
125478|NCT01238861|303013|P6|NOT COMPLETED|Overall Study||15
125479|NCT01238861|303014|P5|NOT COMPLETED|Overall Study||13
125480|NCT01238861|303015|P4|NOT COMPLETED|Overall Study||13
125481|NCT01238861|303016|P3|NOT COMPLETED|Overall Study||11
125482|NCT01238861|303017|P2|NOT COMPLETED|Overall Study||8
125483|NCT01238861|303018|P1|NOT COMPLETED|Overall Study||11
125484|NCT01238861|303013|P6|COMPLETED|Overall Study||125
125485|NCT01238861|303014|P5|COMPLETED|Overall Study||129
125486|NCT01238861|303015|P4|COMPLETED|Overall Study||69
125487|NCT01238861|303016|P3|COMPLETED|Overall Study||70
125488|NCT01238861|303017|P2|COMPLETED|Overall Study||73
125489|NCT01238861|303018|P1|COMPLETED|Overall Study||69
125490|NCT01238861|303013|P6|STARTED|Overall Study||140
125491|NCT01238861|303014|P5|STARTED|Overall Study||142
125492|NCT01238861|303015|P4|STARTED|Overall Study||82
125493|NCT01238861|303016|P3|STARTED|Overall Study||81
125494|NCT01238861|303017|P2|STARTED|Overall Study||81
125495|NCT01238861|303018|P1|STARTED|Overall Study||80
125496|NCT01238848|303098|P2|NOT COMPLETED|Overall Study||5
125497|NCT01238848|303099|P1|NOT COMPLETED|Overall Study||13
125498|NCT01238848|303098|P2|COMPLETED|Overall Study||45
125499|NCT01238848|303099|P1|COMPLETED|Overall Study||37
125500|NCT01238848|303098|P2|STARTED|Overall Study||50
125501|NCT01238848|303099|P1|STARTED|Overall Study||50
125502|NCT01238822|303107|P1|NOT COMPLETED|Overall Study||3
125503|NCT01238822|303107|P1|COMPLETED|Overall Study||93
125504|NCT01238822|303107|P1|Received High Dosage|Overall Study||93
125505|NCT01238822|303107|P1|Received Medium Dosage|Overall Study||93
125506|NCT01238822|303107|P1|Received Low Dosage|Overall Study||93
125507|NCT01238822|303107|P1|Received Placebo|Overall Study||93
125508|NCT01238822|303107|P1|STARTED|Overall Study||96
125509|NCT01238640|303117|P1|NOT COMPLETED|Overall Study||0
125510|NCT01238640|303117|P1|COMPLETED|Overall Study||84
125511|NCT01238640|303117|P1|STARTED|Overall Study||84
125512|NCT01238588|303134|P1|NOT COMPLETED|Overall Study||3
125513|NCT01238588|303134|P1|COMPLETED|Overall Study||9
125514|NCT01238588|303134|P1|STARTED|Overall Study||12
125515|NCT01238575|303147|P2|NOT COMPLETED|Overall Study||4
125516|NCT01238575|303148|P1|NOT COMPLETED|Overall Study||4
125517|NCT01238575|303147|P2|COMPLETED|Overall Study||28
125518|NCT01238575|303148|P1|COMPLETED|Overall Study||26
125519|NCT01238575|303147|P2|STARTED|Overall Study||32
125520|NCT01238575|303148|P1|STARTED|Overall Study||30
125521|NCT01238536|303186|P2|NOT COMPLETED|Overall Study||50
125522|NCT01238536|303187|P1|NOT COMPLETED|Overall Study||47
125523|NCT01238536|303186|P2|COMPLETED|Overall Study||150
125524|NCT01238536|303187|P1|COMPLETED|Overall Study||153
125525|NCT01238536|303186|P2|STARTED|Overall Study||200
125526|NCT01238536|303187|P1|STARTED|Overall Study||200
125527|NCT01238471|303201|P2|NOT COMPLETED|Overall Study||0
125528|NCT01238471|303202|P1|NOT COMPLETED|Overall Study||0
125529|NCT01238471|303201|P2|COMPLETED|Overall Study||10
125530|NCT01238471|303202|P1|COMPLETED|Overall Study||10
125531|NCT01238471|303201|P2|STARTED|Overall Study||10
125532|NCT01238471|303202|P1|STARTED|Overall Study||10
125533|NCT01238341|303208|P1|NOT COMPLETED|Overall Study||0
125534|NCT01238341|303208|P1|COMPLETED|Overall Study||7
125535|NCT01238341|303208|P1|STARTED|Overall Study||7
125536|NCT01238211|303215|P1|NOT COMPLETED|Overall Study||58
125537|NCT01238211|303215|P1|COMPLETED|Overall Study||3
125538|NCT01238211|303215|P1|STARTED|Overall Study||61
125539|NCT01237678|303222|P3|NOT COMPLETED|Phase II||50
125540|NCT01237678|303223|P2|NOT COMPLETED|Phase II||98
125541|NCT01237678|303224|P1|NOT COMPLETED|Phase II||0
125542|NCT01237678|303222|P3|COMPLETED|Phase II||0
125543|NCT01237678|303223|P2|COMPLETED|Phase II||0
125544|NCT01237678|303224|P1|COMPLETED|Phase II||0
125545|NCT01237678|303222|P3|Received Intervention|Phase II||47
125546|NCT01237678|303223|P2|Received Intervention|Phase II||94
125547|NCT01237678|303224|P1|Received Intervention|Phase II||0
125548|NCT01237678|303222|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
125549|NCT01237678|303223|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
125550|NCT01237678|303224|P1|STARTED|Phase II||0
125551|NCT01237678|303222|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
125552|NCT01237678|303223|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
125553|NCT01237678|303224|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
125554|NCT01237678|303222|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
125555|NCT01237678|303223|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
125556|NCT01237678|303224|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
125557|NCT01237678|303222|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
125558|NCT01237678|303223|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
125559|NCT01237678|303224|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
125560|NCT01237678|303222|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
125561|NCT01237678|303223|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
125562|NCT01237678|303224|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
125563|NCT01237613|303243|P1|NOT COMPLETED|Overall Study||0
125564|NCT01237613|303243|P1|COMPLETED|Overall Study||4
125565|NCT01237613|303243|P1|STARTED|Overall Study||4
125566|NCT01237353|303267|P1|NOT COMPLETED|Overall Study||0
125567|NCT01237353|303267|P1|COMPLETED|Overall Study||6
125568|NCT01237353|303267|P1|STARTED|Overall Study||6
125569|NCT01237340|303272|P1|NOT COMPLETED|Overall Study||40
125570|NCT01237340|303272|P1|COMPLETED|Overall Study||19
125571|NCT01237340|303272|P1|STARTED|Overall Study||59
125572|NCT01237327|303286|P2|NOT COMPLETED|Overall Study||40
125573|NCT01237327|303287|P1|NOT COMPLETED|Overall Study||42
125574|NCT01237327|303286|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
125575|NCT01237327|303287|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
125576|NCT01237327|303286|P2|Continued Treatment in Extension Study|Overall Study||17
125577|NCT01237327|303287|P1|Continued Treatment in Extension Study|Overall Study||21
125578|NCT01237327|303286|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
125579|NCT01237327|303287|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
125580|NCT01237327|303286|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
125581|NCT01237327|303287|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
125582|NCT01237327|303286|P2|STARTED|Overall Study||41
125583|NCT01237327|303287|P1|STARTED|Overall Study||43
125584|NCT01237301|303303|P2|NOT COMPLETED|Overall Study||4
125585|NCT01237301|303304|P1|NOT COMPLETED|Overall Study||5
125586|NCT01237301|303303|P2|COMPLETED|Overall Study||55
125587|NCT01237301|303304|P1|COMPLETED|Overall Study||60
125588|NCT01237301|303303|P2|STARTED|Overall Study||59
125589|NCT01237301|303304|P1|STARTED|Overall Study||65
125590|NCT01237223|303316|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
125591|NCT01237223|303317|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
125592|NCT01237223|303318|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
125593|NCT01237223|303319|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
125594|NCT01237223|303320|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
125595|NCT01237223|303321|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
125596|NCT01237223|303316|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
125597|NCT01237223|303317|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
125598|NCT01237223|303318|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
125599|NCT01237223|303319|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
125600|NCT01237223|303320|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
125601|NCT01237223|303321|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
125602|NCT01237223|303316|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
125603|NCT01237223|303317|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
125604|NCT01237223|303318|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
125605|NCT01237223|303319|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
125606|NCT01237223|303320|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
125607|NCT01237223|303321|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
125608|NCT01237223|303316|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125609|NCT01237223|303317|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125610|NCT01237223|303318|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125611|NCT01237223|303319|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125612|NCT01237223|303320|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125613|NCT01237223|303321|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
125614|NCT01237223|303316|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125615|NCT01237223|303317|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125616|NCT01237223|303318|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125617|NCT01237223|303319|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125618|NCT01237223|303320|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
125619|NCT01237223|303321|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
125620|NCT01237223|303316|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
125621|NCT01237223|303317|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
125622|NCT01237223|303318|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
125623|NCT01237223|303319|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
125624|NCT01237223|303320|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
125625|NCT01237223|303321|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
125626|NCT01237197|303362|P2|NOT COMPLETED|Open Label Period||0
125627|NCT01237197|303363|P1|NOT COMPLETED|Open Label Period||0
125628|NCT01237197|303362|P2|COMPLETED|Open Label Period||10
125629|NCT01237197|303363|P1|COMPLETED|Open Label Period||12
125630|NCT01237197|303362|P2|STARTED|Open Label Period||10
125631|NCT01237197|303363|P1|STARTED|Open Label Period||12
125632|NCT01237197|303362|P2|NOT COMPLETED|Randomization Period||3
125633|NCT01237197|303363|P1|NOT COMPLETED|Randomization Period||1
125634|NCT01237197|303362|P2|COMPLETED|Randomization Period||10
125635|NCT01237197|303363|P1|COMPLETED|Randomization Period||12
125636|NCT01237197|303362|P2|STARTED|Randomization Period||13
125637|NCT01237197|303363|P1|STARTED|Randomization Period||13
125638|NCT01237080|303371|P2|NOT COMPLETED|Overall Study||0
125639|NCT01237080|303372|P1|NOT COMPLETED|Overall Study||0
125640|NCT01237080|303371|P2|COMPLETED|Overall Study||50
125641|NCT01237080|303372|P1|COMPLETED|Overall Study||50
125642|NCT01237080|303371|P2|STARTED|Overall Study||50
125643|NCT01237080|303372|P1|STARTED|Overall Study||50
125644|NCT01237054|303380|P1|NOT COMPLETED|Overall Study||1
125645|NCT01237054|303380|P1|COMPLETED|Overall Study||30
125646|NCT01237054|303380|P1|STARTED|Overall Study||31
125647|NCT01236768|303403|P2|NOT COMPLETED|Overall Study||61
125648|NCT01236768|303404|P1|NOT COMPLETED|Overall Study||89
125649|NCT01236768|303403|P2|COMPLETED|Overall Study||145
125650|NCT01236768|303404|P1|COMPLETED|Overall Study||112
125651|NCT01236768|303403|P2|STARTED|Overall Study||206
125652|NCT01236768|303404|P1|STARTED|Overall Study||201
125653|NCT01236742|303421|P3|NOT COMPLETED|Overall Study||3
125654|NCT01236742|303422|P2|NOT COMPLETED|Overall Study||3
125655|NCT01236742|303423|P1|NOT COMPLETED|Overall Study||3
125656|NCT01236742|303421|P3|COMPLETED|Overall Study||13
125657|NCT01236742|303422|P2|COMPLETED|Overall Study||16
125658|NCT01236742|303423|P1|COMPLETED|Overall Study||15
125659|NCT01236742|303421|P3|STARTED|Overall Study||16
125660|NCT01236742|303422|P2|STARTED|Overall Study||19
125661|NCT01236742|303423|P1|STARTED|Overall Study||18
125662|NCT01236573|303445|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
125663|NCT01236573|303446|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125664|NCT01236573|303447|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125665|NCT01236573|303448|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125666|NCT01236573|303449|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125667|NCT01236573|303450|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125668|NCT01236573|303451|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125669|NCT01236573|303452|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125670|NCT01236573|303453|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125671|NCT01236573|303454|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125672|NCT01236573|303455|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125673|NCT01236573|303445|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
125674|NCT01236573|303446|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125675|NCT01236573|303447|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125676|NCT01236573|303448|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125677|NCT01236573|303449|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125678|NCT01236573|303450|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125679|NCT01236573|303451|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125680|NCT01236573|303452|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125681|NCT01236573|303453|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125682|NCT01236573|303454|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125683|NCT01236573|303455|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125684|NCT01236573|303445|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
125685|NCT01236573|303446|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125686|NCT01236573|303447|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125687|NCT01236573|303448|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125688|NCT01236573|303449|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125689|NCT01236573|303450|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125690|NCT01236573|303451|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125691|NCT01236573|303452|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125692|NCT01236573|303453|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125693|NCT01236573|303454|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125694|NCT01236573|303455|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
125695|NCT01236573|303445|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125696|NCT01236573|303446|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
125697|NCT01236573|303447|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
125698|NCT01236573|303448|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125699|NCT01236573|303449|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
125700|NCT01236573|303450|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125701|NCT01236573|303451|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125702|NCT01236573|303452|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125703|NCT01236573|303453|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125704|NCT01236573|303454|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125705|NCT01236573|303455|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125706|NCT01236573|303445|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125707|NCT01236573|303446|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
125708|NCT01236573|303447|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
125709|NCT01236573|303448|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
125710|NCT01236573|303449|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
125711|NCT01236573|303450|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
125712|NCT01236573|303451|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
125713|NCT01236573|303452|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125714|NCT01236573|303453|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125715|NCT01236573|303454|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125716|NCT01236573|303455|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
125717|NCT01236573|303445|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
125718|NCT01236573|303446|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
125719|NCT01236573|303447|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
125720|NCT01236573|303448|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
125721|NCT01236573|303449|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
125722|NCT01236573|303450|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
125723|NCT01236573|303451|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
125724|NCT01236573|303452|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
125725|NCT01236573|303453|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
125726|NCT01236573|303454|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
125727|NCT01236573|303455|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
125728|NCT01236573|303445|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125729|NCT01236573|303446|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125730|NCT01236573|303447|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125731|NCT01236573|303448|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125732|NCT01236573|303449|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125733|NCT01236573|303450|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125734|NCT01236573|303451|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125735|NCT01236573|303452|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125736|NCT01236573|303453|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125737|NCT01236573|303454|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125738|NCT01236573|303455|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125739|NCT01236573|303445|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125740|NCT01236573|303446|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125741|NCT01236573|303447|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125742|NCT01236573|303448|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125743|NCT01236573|303449|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125744|NCT01236573|303450|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125745|NCT01236573|303451|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
125746|NCT01236573|303452|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
125747|NCT01236573|303453|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
125748|NCT01236573|303454|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
125749|NCT01236573|303455|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
125750|NCT01236573|303445|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
125751|NCT01236573|303446|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
125752|NCT01236573|303447|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
125753|NCT01236573|303448|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
125754|NCT01236573|303449|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
125755|NCT01236573|303450|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
125756|NCT01236573|303451|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
125757|NCT01236573|303452|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
125758|NCT01236573|303453|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
125759|NCT01236573|303454|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
125760|NCT01236573|303455|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
125761|NCT01236534|303493|P2|NOT COMPLETED|Overall Study||0
125762|NCT01236534|303494|P1|NOT COMPLETED|Overall Study||3
125763|NCT01236534|303493|P2|COMPLETED|Overall Study||10
125764|NCT01236534|303494|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
125765|NCT01236534|303493|P2|STARTED|Overall Study||10
125766|NCT01236534|303494|P1|STARTED|Overall Study||11
125767|NCT01236391|303502|P1|NOT COMPLETED|Overall Study||16
125768|NCT01236391|303502|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
125769|NCT01236391|303502|P1|STARTED|Overall Study|Participants who received study treatment|111
125770|NCT01236378|303510|P1|NOT COMPLETED|Overall Study||0
125771|NCT01236378|303510|P1|COMPLETED|Overall Study||24
125772|NCT01236378|303510|P1|STARTED|Overall Study||24
125773|NCT01236365|303524|P2|NOT COMPLETED|Overall Study||2
125774|NCT01236365|303525|P1|NOT COMPLETED|Overall Study||2
125775|NCT01236365|303524|P2|COMPLETED|Overall Study||19
125776|NCT01236365|303525|P1|COMPLETED|Overall Study||19
125777|NCT01236365|303524|P2|STARTED|Overall Study||21
125778|NCT01236365|303525|P1|STARTED|Overall Study||21
125779|NCT01236339|303539|P2|NOT COMPLETED|Overall Study||13
125780|NCT01236339|303540|P1|NOT COMPLETED|Overall Study||11
125781|NCT01236339|303539|P2|COMPLETED|Overall Study||0
125782|NCT01236339|303540|P1|COMPLETED|Overall Study||2
125783|NCT01236339|303539|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
125784|NCT01236339|303540|P1|LVP Crossover to TIPS|Overall Study||0
125785|NCT01236339|303539|P2|STARTED|Overall Study||13
125786|NCT01236339|303540|P1|STARTED|Overall Study||13
125787|NCT01236326|303560|P2|NOT COMPLETED|Overall Study||4
125788|NCT01236326|303561|P1|NOT COMPLETED|Overall Study||1
125789|NCT01236326|303560|P2|COMPLETED|Overall Study||51
125790|NCT01236326|303561|P1|COMPLETED|Overall Study||49
125791|NCT01236326|303560|P2|STARTED|Overall Study||55
125792|NCT01236326|303561|P1|STARTED|Overall Study||50
125793|NCT01236300|303575|P1|NOT COMPLETED|Overall Study||0
125794|NCT01236300|303575|P1|COMPLETED|Overall Study||66
125795|NCT01236300|303575|P1|STARTED|Overall Study||66
125796|NCT01236196|303585|P2|NOT COMPLETED|Overall Study||8
125797|NCT01236196|303586|P1|NOT COMPLETED|Overall Study||1
125798|NCT01236196|303585|P2|COMPLETED|Overall Study||13
125799|NCT01236196|303586|P1|COMPLETED|Overall Study||17
125800|NCT01236196|303585|P2|STARTED|Overall Study||21
125801|NCT01236196|303586|P1|STARTED|Overall Study||18
125802|NCT01236170|303598|P1|NOT COMPLETED|Overall Study||15
125803|NCT01236170|303598|P1|COMPLETED|Overall Study||482
125804|NCT01236170|303598|P1|STARTED|Overall Study||497
125805|NCT01236118|303608|P3|NOT COMPLETED|Overall Study||3
125806|NCT01236118|303609|P2|NOT COMPLETED|Overall Study||1
125807|NCT01236118|303610|P1|NOT COMPLETED|Overall Study||2
125808|NCT01236118|303608|P3|COMPLETED|Overall Study||14
125809|NCT01236118|303609|P2|COMPLETED|Overall Study||4
125810|NCT01236118|303610|P1|COMPLETED|Overall Study||4
125811|NCT01236118|303608|P3|STARTED|Overall Study||17
125812|NCT01236118|303609|P2|STARTED|Overall Study||5
125813|NCT01236118|303610|P1|STARTED|Overall Study||6
125814|NCT01236105|303618|P1|NOT COMPLETED|Overall Study||0
125815|NCT01236105|303618|P1|COMPLETED|Overall Study||21
125816|NCT01236105|303618|P1|STARTED|Overall Study||21
125817|NCT01236053|303654|P22|NOT COMPLETED|Overall Study||0
125818|NCT01236053|303655|P21|NOT COMPLETED|Overall Study||0
125819|NCT01236053|303656|P20|NOT COMPLETED|Overall Study||0
125820|NCT01236053|303657|P19|NOT COMPLETED|Overall Study||0
125821|NCT01236053|303658|P18|NOT COMPLETED|Overall Study||0
125822|NCT01236053|303659|P17|NOT COMPLETED|Overall Study||0
125823|NCT01236053|303660|P16|NOT COMPLETED|Overall Study||0
125824|NCT01236053|303661|P15|NOT COMPLETED|Overall Study||0
125825|NCT01236053|303662|P14|NOT COMPLETED|Overall Study||0
125826|NCT01236053|303663|P13|NOT COMPLETED|Overall Study||0
125827|NCT01236053|303664|P12|NOT COMPLETED|Overall Study||0
125828|NCT01236053|303665|P11|NOT COMPLETED|Overall Study||0
125829|NCT01236053|303666|P10|NOT COMPLETED|Overall Study||0
125830|NCT01236053|303667|P9|NOT COMPLETED|Overall Study||0
125831|NCT01236053|303668|P8|NOT COMPLETED|Overall Study||0
125832|NCT01236053|303669|P7|NOT COMPLETED|Overall Study||0
125833|NCT01236053|303670|P6|NOT COMPLETED|Overall Study||0
125834|NCT01236053|303671|P5|NOT COMPLETED|Overall Study||0
125835|NCT01236053|303672|P4|NOT COMPLETED|Overall Study||0
125836|NCT01236053|303673|P3|NOT COMPLETED|Overall Study||0
125837|NCT01236053|303674|P2|NOT COMPLETED|Overall Study||0
125838|NCT01236053|303675|P1|NOT COMPLETED|Overall Study||0
125839|NCT01236053|303654|P22|COMPLETED|Overall Study||12167
125840|NCT01236053|303655|P21|COMPLETED|Overall Study||1272
125841|NCT01236053|303656|P20|COMPLETED|Overall Study||20382
125842|NCT01236053|303657|P19|COMPLETED|Overall Study||2155
125843|NCT01236053|303658|P18|COMPLETED|Overall Study||380
125844|NCT01236053|303659|P17|COMPLETED|Overall Study||38
125845|NCT01236053|303660|P16|COMPLETED|Overall Study||43559
125846|NCT01236053|303661|P15|COMPLETED|Overall Study||4600
125847|NCT01236053|303662|P14|COMPLETED|Overall Study||1396
125848|NCT01236053|303663|P13|COMPLETED|Overall Study||148
125849|NCT01236053|303664|P12|COMPLETED|Overall Study||188924
125850|NCT01236053|303665|P11|COMPLETED|Overall Study||19564
125851|NCT01236053|303666|P10|COMPLETED|Overall Study||2935
125852|NCT01236053|303667|P9|COMPLETED|Overall Study||300
125853|NCT01236053|303668|P8|COMPLETED|Overall Study||102836
125854|NCT01236053|303669|P7|COMPLETED|Overall Study||10855
125855|NCT01236053|303670|P6|COMPLETED|Overall Study||2067
125856|NCT01236053|303671|P5|COMPLETED|Overall Study||212
125857|NCT01236053|303672|P4|COMPLETED|Overall Study||17853
125858|NCT01236053|303673|P3|COMPLETED|Overall Study||1877
125859|NCT01236053|303674|P2|COMPLETED|Overall Study||1710950
125860|NCT01236053|303675|P1|COMPLETED|Overall Study||179138
125861|NCT01236053|303654|P22|STARTED|Overall Study||12167
125862|NCT01236053|303655|P21|STARTED|Overall Study||1272
125863|NCT01236053|303656|P20|STARTED|Overall Study||20382
125864|NCT01236053|303657|P19|STARTED|Overall Study||2155
125865|NCT01236053|303658|P18|STARTED|Overall Study||380
125866|NCT01236053|303659|P17|STARTED|Overall Study||38
125867|NCT01236053|303660|P16|STARTED|Overall Study||43559
125868|NCT01236053|303661|P15|STARTED|Overall Study||4600
125869|NCT01236053|303662|P14|STARTED|Overall Study||1396
125870|NCT01236053|303663|P13|STARTED|Overall Study||148
125871|NCT01236053|303664|P12|STARTED|Overall Study||188924
125872|NCT01236053|303665|P11|STARTED|Overall Study||19564
125873|NCT01236053|303666|P10|STARTED|Overall Study||2935
125874|NCT01236053|303667|P9|STARTED|Overall Study||300
125875|NCT01236053|303668|P8|STARTED|Overall Study||102836
125876|NCT01236053|303669|P7|STARTED|Overall Study||10855
125877|NCT01236053|303670|P6|STARTED|Overall Study||2067
125878|NCT01236053|303671|P5|STARTED|Overall Study||212
125879|NCT01236053|303672|P4|STARTED|Overall Study||17853
125880|NCT01236053|303673|P3|STARTED|Overall Study||1877
125881|NCT01236053|303674|P2|STARTED|Overall Study||1710950
125882|NCT01236053|303675|P1|STARTED|Overall Study||179138
125883|NCT01236001|303811|P2|NOT COMPLETED|Overall Study||22
125884|NCT01236001|303812|P1|NOT COMPLETED|Overall Study||18
125885|NCT01236001|303811|P2|COMPLETED|Overall Study||65
125886|NCT01236001|303812|P1|COMPLETED|Overall Study||87
125887|NCT01236001|303811|P2|STARTED|Overall Study||87
125888|NCT01236001|303812|P1|STARTED|Overall Study||105
125889|NCT01235975|303844|P2|NOT COMPLETED|Overall Study||7
125890|NCT01235975|303845|P1|NOT COMPLETED|Overall Study||17
125891|NCT01235975|303844|P2|COMPLETED|Overall Study||88
125892|NCT01235975|303845|P1|COMPLETED|Overall Study||257
125893|NCT01235975|303844|P2|STARTED|Overall Study||95
125894|NCT01235975|303845|P1|STARTED|Overall Study||274
125895|NCT01235923|303879|P2|NOT COMPLETED|Overall Study||0
125896|NCT01235923|303880|P1|NOT COMPLETED|Overall Study||0
125897|NCT01235923|303879|P2|COMPLETED|Overall Study||10
125898|NCT01235923|303880|P1|COMPLETED|Overall Study||10
125899|NCT01235923|303879|P2|STARTED|Overall Study||10
125900|NCT01235923|303880|P1|STARTED|Overall Study||10
125901|NCT01235910|303888|P1|NOT COMPLETED|Overall Study||0
125902|NCT01235910|303888|P1|COMPLETED|Overall Study||1
125903|NCT01235910|303888|P1|STARTED|Overall Study||1
125904|NCT01235897|303892|P1|NOT COMPLETED|Overall Study||0
125905|NCT01235897|303892|P1|COMPLETED|Overall Study||16
125906|NCT01235897|303892|P1|STARTED|Overall Study||16
125907|NCT01235741|303900|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
125908|NCT01235741|303901|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
125909|NCT01235741|303902|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
125910|NCT01235741|303900|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
125911|NCT01235741|303901|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
125912|NCT01235741|303902|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
125913|NCT01235741|303900|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
125914|NCT01235741|303901|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
125915|NCT01235741|303902|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
125916|NCT01235741|303900|P3|NOT COMPLETED|Randomized to Treatment||36
125917|NCT01235741|303901|P2|NOT COMPLETED|Randomized to Treatment||36
125918|NCT01235741|303902|P1|NOT COMPLETED|Randomized to Treatment||0
125919|NCT01235741|303900|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
125920|NCT01235741|303901|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
125921|NCT01235741|303902|P1|COMPLETED|Randomized to Treatment||0
125922|NCT01235741|303900|P3|STARTED|Randomized to Treatment||36
125923|NCT01235741|303901|P2|STARTED|Randomized to Treatment||36
125924|NCT01235741|303902|P1|STARTED|Randomized to Treatment||0
125925|NCT01235741|303900|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
125926|NCT01235741|303901|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
125927|NCT01235741|303902|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
125928|NCT01235741|303900|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
125929|NCT01235741|303901|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
125930|NCT01235741|303902|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
125931|NCT01235741|303900|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
125932|NCT01235741|303901|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
125933|NCT01235741|303902|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
125934|NCT01235728|303929|P8|NOT COMPLETED|Overall Study||0
125935|NCT01235728|303930|P7|NOT COMPLETED|Overall Study||0
125936|NCT01235728|303931|P6|NOT COMPLETED|Overall Study||0
125937|NCT01235728|303932|P5|NOT COMPLETED|Overall Study||0
125938|NCT01235728|303933|P4|NOT COMPLETED|Overall Study||1
125939|NCT01235728|303934|P3|NOT COMPLETED|Overall Study||0
125940|NCT01235728|303935|P2|NOT COMPLETED|Overall Study||0
125941|NCT01235728|303936|P1|NOT COMPLETED|Overall Study||0
125942|NCT01235728|303929|P8|COMPLETED|Overall Study||3
125943|NCT01235728|303930|P7|COMPLETED|Overall Study||3
125944|NCT01235728|303931|P6|COMPLETED|Overall Study||3
125945|NCT01235728|303932|P5|COMPLETED|Overall Study||3
125946|NCT01235728|303933|P4|COMPLETED|Overall Study||2
125947|NCT01235728|303934|P3|COMPLETED|Overall Study||3
125948|NCT01235728|303935|P2|COMPLETED|Overall Study||3
125949|NCT01235728|303936|P1|COMPLETED|Overall Study||3
125950|NCT01235728|303929|P8|STARTED|Overall Study||3
125951|NCT01235728|303930|P7|STARTED|Overall Study||3
125952|NCT01235728|303931|P6|STARTED|Overall Study||3
125953|NCT01235728|303932|P5|STARTED|Overall Study||3
125954|NCT01235728|303933|P4|STARTED|Overall Study||3
125955|NCT01235728|303934|P3|STARTED|Overall Study||3
125956|NCT01235728|303935|P2|STARTED|Overall Study||3
125957|NCT01235728|303936|P1|STARTED|Overall Study||3
125958|NCT01235715|303946|P2|NOT COMPLETED|Overall Study||2
125959|NCT01235715|303947|P1|NOT COMPLETED|Overall Study||0
125960|NCT01235715|303946|P2|COMPLETED|Overall Study||100
125961|NCT01235715|303947|P1|COMPLETED|Overall Study||98
125962|NCT01235715|303946|P2|STARTED|Overall Study||102
125963|NCT01235715|303947|P1|STARTED|Overall Study||98
125964|NCT01235689|303987|P2|NOT COMPLETED|Overall Study||32
125965|NCT01235689|303988|P1|NOT COMPLETED|Overall Study||29
125966|NCT01235689|303987|P2|COMPLETED|Overall Study||90
125967|NCT01235689|303988|P1|COMPLETED|Overall Study||93
125968|NCT01235689|303987|P2|Randomized at Week 9|Overall Study||53
125969|NCT01235689|303988|P1|Randomized at Week 9|Overall Study||59
125970|NCT01235689|303987|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
125971|NCT01235689|303988|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
125972|NCT01235689|303987|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
125973|NCT01235689|303988|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
125974|NCT01235598|304060|P2|NOT COMPLETED|Overall Study||4
125975|NCT01235598|304061|P1|NOT COMPLETED|Overall Study||1
125976|NCT01235598|304060|P2|COMPLETED|Overall Study||24
125977|NCT01235598|304061|P1|COMPLETED|Overall Study||12
125978|NCT01235598|304060|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
125979|NCT01235598|304061|P1|STARTED|Overall Study||13
125980|NCT01235546|304106|P2|NOT COMPLETED|Overall Study||1
125981|NCT01235546|304107|P1|NOT COMPLETED|Overall Study||2
125982|NCT01235546|304106|P2|COMPLETED|Overall Study||1018
125983|NCT01235546|304107|P1|COMPLETED|Overall Study||992
125984|NCT01235546|304106|P2|STARTED|Overall Study||1019
125985|NCT01235546|304107|P1|STARTED|Overall Study||994
125986|NCT01235507|304131|P1|NOT COMPLETED|Overall Study||2
125987|NCT01235507|304131|P1|COMPLETED|Overall Study||69
125988|NCT01235507|304131|P1|STARTED|Overall Study||71
125989|NCT01235442|304145|P2|NOT COMPLETED|Overall Study||44
125990|NCT01235442|304146|P1|NOT COMPLETED|Overall Study||44
125991|NCT01235442|304145|P2|COMPLETED|Overall Study||251
125992|NCT01235442|304146|P1|COMPLETED|Overall Study||253
125993|NCT01235442|304145|P2|STARTED|Overall Study||295
125994|NCT01235442|304146|P1|STARTED|Overall Study||297
125995|NCT01235403|304164|P1|NOT COMPLETED|Overall Study||26
125996|NCT01235403|304164|P1|COMPLETED|Overall Study||74
125997|NCT01235403|304164|P1|STARTED|Overall Study||100
125998|NCT01235377|304172|P2|NOT COMPLETED|Overall Study||1
125999|NCT01235377|304173|P1|NOT COMPLETED|Overall Study||1
126000|NCT01235377|304172|P2|COMPLETED|Overall Study||8
126001|NCT01235377|304173|P1|COMPLETED|Overall Study||10
126002|NCT01235377|304172|P2|STARTED|Overall Study||9
126003|NCT01235377|304173|P1|STARTED|Overall Study||11
126004|NCT01235338|304181|P2|NOT COMPLETED|Overall Study||5
126005|NCT01235338|304182|P1|NOT COMPLETED|Overall Study||11
126006|NCT01235338|304181|P2|COMPLETED|Overall Study||33
126007|NCT01235338|304182|P1|COMPLETED|Overall Study||31
126008|NCT01235338|304181|P2|STARTED|Overall Study||38
126009|NCT01235338|304182|P1|STARTED|Overall Study||42
126010|NCT01235234|304227|P3|NOT COMPLETED|Overall Study||1
126011|NCT01235234|304228|P2|NOT COMPLETED|Overall Study||2
126012|NCT01235234|304229|P1|NOT COMPLETED|Overall Study||2
126013|NCT01235234|304227|P3|COMPLETED|Overall Study||80
126014|NCT01235234|304228|P2|COMPLETED|Overall Study||76
126015|NCT01235234|304229|P1|COMPLETED|Overall Study||75
126016|NCT01235234|304227|P3|STARTED|Overall Study||81
126017|NCT01235234|304228|P2|STARTED|Overall Study||78
126018|NCT01235234|304229|P1|STARTED|Overall Study||77
126019|NCT01235195|304237|P2|NOT COMPLETED|Second Intervention||0
126020|NCT01235195|304238|P1|NOT COMPLETED|Second Intervention||0
126021|NCT01235195|304237|P2|COMPLETED|Second Intervention||15
126022|NCT01235195|304238|P1|COMPLETED|Second Intervention||15
126023|NCT01235195|304237|P2|STARTED|Second Intervention||15
126024|NCT01235195|304238|P1|STARTED|Second Intervention||15
126025|NCT01235195|304237|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
126026|NCT01235195|304238|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
126027|NCT01235195|304237|P2|COMPLETED|Washout Period of At Least 8 Days||15
126028|NCT01235195|304238|P1|COMPLETED|Washout Period of At Least 8 Days||15
126029|NCT01235195|304237|P2|STARTED|Washout Period of At Least 8 Days||15
126030|NCT01235195|304238|P1|STARTED|Washout Period of At Least 8 Days||15
126031|NCT01235195|304237|P2|NOT COMPLETED|First Intervention||0
126032|NCT01235195|304238|P1|NOT COMPLETED|First Intervention||0
126033|NCT01235195|304237|P2|COMPLETED|First Intervention||15
126034|NCT01235195|304238|P1|COMPLETED|First Intervention||15
126035|NCT01235195|304237|P2|STARTED|First Intervention||15
126036|NCT01235195|304238|P1|STARTED|First Intervention||15
126037|NCT01234922|304258|P4|NOT COMPLETED|Overall Study||0
126038|NCT01234922|304259|P3|NOT COMPLETED|Overall Study||0
126039|NCT01234922|304260|P2|NOT COMPLETED|Overall Study||0
126040|NCT01234922|304261|P1|NOT COMPLETED|Overall Study||0
126041|NCT01234922|304258|P4|COMPLETED|Overall Study||2
126042|NCT01234922|304259|P3|COMPLETED|Overall Study||2
126043|NCT01234922|304260|P2|COMPLETED|Overall Study||1
126044|NCT01234922|304261|P1|COMPLETED|Overall Study||1
126045|NCT01234922|304258|P4|STARTED|Overall Study||2
126046|NCT01234922|304259|P3|STARTED|Overall Study||2
126047|NCT01234922|304260|P2|STARTED|Overall Study||1
126048|NCT01234922|304261|P1|STARTED|Overall Study||1
126049|NCT01234883|304277|P2|NOT COMPLETED|Overall Study||13
126050|NCT01234883|304278|P1|NOT COMPLETED|Overall Study||10
126051|NCT01234883|304277|P2|COMPLETED|Overall Study||36
126052|NCT01234883|304278|P1|COMPLETED|Overall Study||41
126053|NCT01234883|304277|P2|STARTED|Overall Study||49
126054|NCT01234883|304278|P1|STARTED|Overall Study||51
126055|NCT01234870|304284|P1|NOT COMPLETED|Overall Study||0
126056|NCT01234870|304284|P1|COMPLETED|Overall Study||40
126057|NCT01234870|304284|P1|STARTED|Overall Study||40
126058|NCT01234831|304291|P2|NOT COMPLETED|Overall Study||4
126059|NCT01234831|304292|P1|NOT COMPLETED|Overall Study||2
126060|NCT01234831|304291|P2|COMPLETED|Overall Study||198
126061|NCT01234831|304292|P1|COMPLETED|Overall Study||259
126062|NCT01234831|304291|P2|STARTED|Overall Study||202
126063|NCT01234831|304292|P1|STARTED|Overall Study||261
126064|NCT01234766|304304|P1|NOT COMPLETED|Overall Study||4
126065|NCT01234766|304304|P1|COMPLETED|Overall Study||35
126066|NCT01234766|304304|P1|STARTED|Overall Study||39
126067|NCT01234714|304308|P1|NOT COMPLETED|Overall Study||0
126068|NCT01234714|304308|P1|COMPLETED|Overall Study||84
126069|NCT01234714|304308|P1|STARTED|Overall Study||84
126070|NCT01234675|304325|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
126071|NCT01234675|304326|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
126072|NCT01234675|304325|P2|COMPLETED|Second Intervention (6 Weeks)||8
126073|NCT01234675|304326|P1|COMPLETED|Second Intervention (6 Weeks)||7
126074|NCT01234675|304325|P2|STARTED|Second Intervention (6 Weeks)||8
126075|NCT01234675|304326|P1|STARTED|Second Intervention (6 Weeks)||9
126076|NCT01234675|304325|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
126077|NCT01234675|304326|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
126078|NCT01234675|304325|P2|COMPLETED|First Intervention (6 Weeks)||8
126079|NCT01234675|304326|P1|COMPLETED|First Intervention (6 Weeks)||9
126080|NCT01234675|304325|P2|STARTED|First Intervention (6 Weeks)||9
126081|NCT01234675|304326|P1|STARTED|First Intervention (6 Weeks)||10
126082|NCT01234467|304340|P1|NOT COMPLETED|Overall Study||12
126083|NCT01234467|304340|P1|COMPLETED|Overall Study||11
126084|NCT01234467|304340|P1|STARTED|Overall Study||23
126085|NCT01234337|304351|P2|NOT COMPLETED|Overall Study||64
126086|NCT01234337|304352|P1|NOT COMPLETED|Overall Study||97
126087|NCT01234337|304351|P2|COMPLETED|Overall Study||207
126088|NCT01234337|304352|P1|COMPLETED|Overall Study||169
126089|NCT01234337|304351|P2|Participants Received Treatment|Overall Study||267
126090|NCT01234337|304352|P1|Participants Received Treatment|Overall Study||260
126091|NCT01234337|304351|P2|STARTED|Overall Study||271
126092|NCT01234337|304352|P1|STARTED|Overall Study||266
126093|NCT01234207|304380|P2|NOT COMPLETED|Second Intervention||0
126094|NCT01234207|304381|P1|NOT COMPLETED|Second Intervention||0
126095|NCT01234207|304380|P2|COMPLETED|Second Intervention||48
126096|NCT01234207|304381|P1|COMPLETED|Second Intervention||47
126097|NCT01234207|304380|P2|STARTED|Second Intervention||48
126098|NCT01234207|304381|P1|STARTED|Second Intervention||47
126099|NCT01234207|304380|P2|NOT COMPLETED|1-Week Washout Period||0
126100|NCT01234207|304381|P1|NOT COMPLETED|1-Week Washout Period||0
126101|NCT01234207|304380|P2|COMPLETED|1-Week Washout Period||48
126102|NCT01234207|304381|P1|COMPLETED|1-Week Washout Period||47
126103|NCT01234207|304380|P2|STARTED|1-Week Washout Period||48
126104|NCT01234207|304381|P1|STARTED|1-Week Washout Period||47
126105|NCT01234207|304380|P2|NOT COMPLETED|First Intervention||0
126106|NCT01234207|304381|P1|NOT COMPLETED|First Intervention||0
126107|NCT01234207|304380|P2|COMPLETED|First Intervention||48
126108|NCT01234207|304381|P1|COMPLETED|First Intervention||47
126109|NCT01234207|304380|P2|STARTED|First Intervention||48
126110|NCT01234207|304381|P1|STARTED|First Intervention||47
126111|NCT01234103|304403|P2|NOT COMPLETED|Overall Study||0
126112|NCT01234103|304404|P1|NOT COMPLETED|Overall Study||0
126113|NCT01234103|304403|P2|COMPLETED|Overall Study||391
126114|NCT01234103|304404|P1|COMPLETED|Overall Study||542
126115|NCT01234103|304403|P2|STARTED|Overall Study||391
126116|NCT01234103|304404|P1|STARTED|Overall Study||542
126117|NCT01233999|304412|P1|NOT COMPLETED|Overall Study||2
126118|NCT01233999|304412|P1|COMPLETED|Overall Study||8
126119|NCT01233999|304412|P1|STARTED|Overall Study||10
126120|NCT01233921|304418|P2|NOT COMPLETED|Overall Study||0
126121|NCT01233921|304419|P1|NOT COMPLETED|Overall Study||0
126122|NCT01233921|304418|P2|COMPLETED|Overall Study||3
126123|NCT01233921|304419|P1|COMPLETED|Overall Study||3
126124|NCT01233921|304418|P2|STARTED|Overall Study||3
126125|NCT01233921|304419|P1|STARTED|Overall Study||3
126126|NCT01233869|304431|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
126127|NCT01233869|304432|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
126128|NCT01233869|304433|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
126129|NCT01233869|304434|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
126130|NCT01233869|304431|P4|COMPLETED|Extended Treatment Period (46 Months)||18
126131|NCT01233869|304432|P3|COMPLETED|Extended Treatment Period (46 Months)||17
126132|NCT01233869|304433|P2|COMPLETED|Extended Treatment Period (46 Months)||0
126133|NCT01233869|304434|P1|COMPLETED|Extended Treatment Period (46 Months)||20
126134|NCT01233869|304431|P4|STARTED|Extended Treatment Period (46 Months)||34
126135|NCT01233869|304432|P3|STARTED|Extended Treatment Period (46 Months)||22
126136|NCT01233869|304433|P2|STARTED|Extended Treatment Period (46 Months)||3
126137|NCT01233869|304434|P1|STARTED|Extended Treatment Period (46 Months)||34
126138|NCT01233869|304431|P4|NOT COMPLETED|Washout Period 30 Days||0
126139|NCT01233869|304432|P3|NOT COMPLETED|Washout Period 30 Days||0
126140|NCT01233869|304433|P2|NOT COMPLETED|Washout Period 30 Days||0
126141|NCT01233869|304434|P1|NOT COMPLETED|Washout Period 30 Days||0
126142|NCT01233869|304431|P4|COMPLETED|Washout Period 30 Days||34
126143|NCT01233869|304432|P3|COMPLETED|Washout Period 30 Days||22
126144|NCT01233869|304433|P2|COMPLETED|Washout Period 30 Days||3
126145|NCT01233869|304434|P1|COMPLETED|Washout Period 30 Days||34
126146|NCT01233869|304431|P4|STARTED|Washout Period 30 Days||34
126147|NCT01233869|304432|P3|STARTED|Washout Period 30 Days||22
126148|NCT01233869|304433|P2|STARTED|Washout Period 30 Days||3
126149|NCT01233869|304434|P1|STARTED|Washout Period 30 Days||34
126150|NCT01233869|304431|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
126151|NCT01233869|304432|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
126152|NCT01233869|304433|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
126153|NCT01233869|304434|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
126154|NCT01233869|304431|P4|COMPLETED|Initial Treatment Period (24 Months)||34
126155|NCT01233869|304432|P3|COMPLETED|Initial Treatment Period (24 Months)||22
126156|NCT01233869|304433|P2|COMPLETED|Initial Treatment Period (24 Months)||3
126157|NCT01233869|304434|P1|COMPLETED|Initial Treatment Period (24 Months)||34
126158|NCT01233869|304431|P4|STARTED|Initial Treatment Period (24 Months)||56
126159|NCT01233869|304432|P3|STARTED|Initial Treatment Period (24 Months)||24
126160|NCT01233869|304433|P2|STARTED|Initial Treatment Period (24 Months)||31
126161|NCT01233869|304434|P1|STARTED|Initial Treatment Period (24 Months)||58
126162|NCT01233817|304520|P1|NOT COMPLETED|Overall Study||3
126163|NCT01233817|304520|P1|COMPLETED|Overall Study||9
126164|NCT01233817|304520|P1|STARTED|Overall Study||12
126165|NCT01233726|304527|P3|NOT COMPLETED|Overall Study||1
126166|NCT01233726|304528|P2|NOT COMPLETED|Overall Study||0
126167|NCT01233726|304529|P1|NOT COMPLETED|Overall Study||1
126168|NCT01233726|304527|P3|COMPLETED|Overall Study||52
126169|NCT01233726|304528|P2|COMPLETED|Overall Study||53
126170|NCT01233726|304529|P1|COMPLETED|Overall Study||52
126171|NCT01233726|304527|P3|STARTED|Overall Study||53
126172|NCT01233726|304528|P2|STARTED|Overall Study||53
126173|NCT01233726|304529|P1|STARTED|Overall Study||53
126174|NCT01233687|304567|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
126175|NCT01233687|304567|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
126176|NCT01233687|304567|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
126177|NCT01233687|304567|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
126178|NCT01233687|304567|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
126179|NCT01233687|304567|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
126180|NCT01233687|304567|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
126181|NCT01233609|304577|P2|NOT COMPLETED|Overall Study||2
126182|NCT01233609|304578|P1|NOT COMPLETED|Overall Study||9
126183|NCT01233609|304577|P2|COMPLETED|Overall Study||42
126184|NCT01233609|304578|P1|COMPLETED|Overall Study||37
126185|NCT01233609|304577|P2|STARTED|Overall Study||44
126186|NCT01233609|304578|P1|STARTED|Overall Study||46
126187|NCT01233284|304602|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
126188|NCT01233284|304603|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
126189|NCT01233284|304604|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
126190|NCT01233284|304605|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
126191|NCT01233284|304606|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
126192|NCT01233284|304602|P5|COMPLETED|Period 4 (4 Weeks)||1
126193|NCT01233284|304603|P4|COMPLETED|Period 4 (4 Weeks)||33
126194|NCT01233284|304604|P3|COMPLETED|Period 4 (4 Weeks)||35
126195|NCT01233284|304605|P2|COMPLETED|Period 4 (4 Weeks)||36
126196|NCT01233284|304606|P1|COMPLETED|Period 4 (4 Weeks)||36
126197|NCT01233284|304602|P5|STARTED|Period 4 (4 Weeks)||1
126198|NCT01233284|304603|P4|STARTED|Period 4 (4 Weeks)||34
126199|NCT01233284|304604|P3|STARTED|Period 4 (4 Weeks)||35
126200|NCT01233284|304605|P2|STARTED|Period 4 (4 Weeks)||37
126201|NCT01233284|304606|P1|STARTED|Period 4 (4 Weeks)||36
126202|NCT01233284|304602|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
126203|NCT01233284|304603|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
126204|NCT01233284|304604|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
126205|NCT01233284|304605|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
126206|NCT01233284|304606|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
126207|NCT01233284|304602|P5|COMPLETED|Period 3 (4 Weeks)||1
126208|NCT01233284|304603|P4|COMPLETED|Period 3 (4 Weeks)||34
126209|NCT01233284|304604|P3|COMPLETED|Period 3 (4 Weeks)||35
126210|NCT01233284|304605|P2|COMPLETED|Period 3 (4 Weeks)||37
126211|NCT01233284|304606|P1|COMPLETED|Period 3 (4 Weeks)||36
126212|NCT01233284|304602|P5|STARTED|Period 3 (4 Weeks)||1
126213|NCT01233284|304603|P4|STARTED|Period 3 (4 Weeks)||35
126214|NCT01233284|304604|P3|STARTED|Period 3 (4 Weeks)||36
126215|NCT01233284|304605|P2|STARTED|Period 3 (4 Weeks)||37
126216|NCT01233284|304606|P1|STARTED|Period 3 (4 Weeks)||36
126217|NCT01233284|304602|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
126218|NCT01233284|304603|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
126219|NCT01233284|304604|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
126220|NCT01233284|304605|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
126221|NCT01233284|304606|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
126222|NCT01233284|304602|P5|COMPLETED|Period 2 (4 Weeks)||1
126223|NCT01233284|304603|P4|COMPLETED|Period 2 (4 Weeks)||35
126224|NCT01233284|304604|P3|COMPLETED|Period 2 (4 Weeks)||36
126225|NCT01233284|304605|P2|COMPLETED|Period 2 (4 Weeks)||37
126226|NCT01233284|304606|P1|COMPLETED|Period 2 (4 Weeks)||36
126227|NCT01233284|304602|P5|STARTED|Period 2 (4 Weeks)||1
126228|NCT01233284|304603|P4|STARTED|Period 2 (4 Weeks)||35
126229|NCT01233284|304604|P3|STARTED|Period 2 (4 Weeks)||37
126230|NCT01233284|304605|P2|STARTED|Period 2 (4 Weeks)||37
126231|NCT01233284|304606|P1|STARTED|Period 2 (4 Weeks)||36
126232|NCT01233284|304602|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
126233|NCT01233284|304603|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
126234|NCT01233284|304604|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
126235|NCT01233284|304605|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
126236|NCT01233284|304606|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
126237|NCT01233284|304602|P5|COMPLETED|Period 1 (4 Weeks)||1
126238|NCT01233284|304603|P4|COMPLETED|Period 1 (4 Weeks)||35
126239|NCT01233284|304604|P3|COMPLETED|Period 1 (4 Weeks)||37
126240|NCT01233284|304605|P2|COMPLETED|Period 1 (4 Weeks)||37
126241|NCT01233284|304606|P1|COMPLETED|Period 1 (4 Weeks)||36
126242|NCT01233284|304602|P5|STARTED|Period 1 (4 Weeks)||1
126243|NCT01233284|304603|P4|STARTED|Period 1 (4 Weeks)||35
126244|NCT01233284|304604|P3|STARTED|Period 1 (4 Weeks)||38
126245|NCT01233284|304605|P2|STARTED|Period 1 (4 Weeks)||38
126246|NCT01233284|304606|P1|STARTED|Period 1 (4 Weeks)||37
126247|NCT01233258|304687|P6|NOT COMPLETED|Second Intervention (6 Months)||0
126248|NCT01233258|304688|P5|NOT COMPLETED|Second Intervention (6 Months)||0
126249|NCT01233258|304689|P4|NOT COMPLETED|Second Intervention (6 Months)||0
126250|NCT01233258|304690|P3|NOT COMPLETED|Second Intervention (6 Months)||0
126251|NCT01233258|304691|P2|NOT COMPLETED|Second Intervention (6 Months)||0
126252|NCT01233258|304692|P1|NOT COMPLETED|Second Intervention (6 Months)||0
126253|NCT01233258|304687|P6|COMPLETED|Second Intervention (6 Months)||15
126254|NCT01233258|304688|P5|COMPLETED|Second Intervention (6 Months)||16
126255|NCT01233258|304689|P4|COMPLETED|Second Intervention (6 Months)||15
126256|NCT01233258|304690|P3|COMPLETED|Second Intervention (6 Months)||13
126257|NCT01233258|304691|P2|COMPLETED|Second Intervention (6 Months)||10
126258|NCT01233258|304692|P1|COMPLETED|Second Intervention (6 Months)||10
126259|NCT01233258|304687|P6|STARTED|Second Intervention (6 Months)||15
126260|NCT01233258|304688|P5|STARTED|Second Intervention (6 Months)||16
126261|NCT01233258|304689|P4|STARTED|Second Intervention (6 Months)||15
126262|NCT01233258|304690|P3|STARTED|Second Intervention (6 Months)||13
126263|NCT01233258|304691|P2|STARTED|Second Intervention (6 Months)||10
126264|NCT01233258|304692|P1|STARTED|Second Intervention (6 Months)||10
126265|NCT01233258|304687|P6|NOT COMPLETED|Washout (2-3 Days)||0
126266|NCT01233258|304688|P5|NOT COMPLETED|Washout (2-3 Days)||0
126267|NCT01233258|304689|P4|NOT COMPLETED|Washout (2-3 Days)||0
126268|NCT01233258|304690|P3|NOT COMPLETED|Washout (2-3 Days)||0
126269|NCT01233258|304691|P2|NOT COMPLETED|Washout (2-3 Days)||0
126270|NCT01233258|304692|P1|NOT COMPLETED|Washout (2-3 Days)||0
126271|NCT01233258|304687|P6|COMPLETED|Washout (2-3 Days)||15
126272|NCT01233258|304688|P5|COMPLETED|Washout (2-3 Days)||16
126273|NCT01233258|304689|P4|COMPLETED|Washout (2-3 Days)||15
126274|NCT01233258|304690|P3|COMPLETED|Washout (2-3 Days)||13
126275|NCT01233258|304691|P2|COMPLETED|Washout (2-3 Days)||10
126276|NCT01233258|304692|P1|COMPLETED|Washout (2-3 Days)||10
126277|NCT01233258|304687|P6|STARTED|Washout (2-3 Days)||15
126278|NCT01233258|304688|P5|STARTED|Washout (2-3 Days)||16
126279|NCT01233258|304689|P4|STARTED|Washout (2-3 Days)||15
126280|NCT01233258|304690|P3|STARTED|Washout (2-3 Days)||13
126281|NCT01233258|304691|P2|STARTED|Washout (2-3 Days)||10
126282|NCT01233258|304692|P1|STARTED|Washout (2-3 Days)||10
126283|NCT01233258|304687|P6|NOT COMPLETED|First Intervention (6 Months)||1
126284|NCT01233258|304688|P5|NOT COMPLETED|First Intervention (6 Months)||0
126285|NCT01233258|304689|P4|NOT COMPLETED|First Intervention (6 Months)||1
126286|NCT01233258|304690|P3|NOT COMPLETED|First Intervention (6 Months)||1
126287|NCT01233258|304691|P2|NOT COMPLETED|First Intervention (6 Months)||0
126288|NCT01233258|304692|P1|NOT COMPLETED|First Intervention (6 Months)||1
126289|NCT01233258|304687|P6|COMPLETED|First Intervention (6 Months)||15
126290|NCT01233258|304688|P5|COMPLETED|First Intervention (6 Months)||16
126291|NCT01233258|304689|P4|COMPLETED|First Intervention (6 Months)||15
126292|NCT01233258|304690|P3|COMPLETED|First Intervention (6 Months)||13
126293|NCT01233258|304691|P2|COMPLETED|First Intervention (6 Months)||10
126294|NCT01233258|304692|P1|COMPLETED|First Intervention (6 Months)||10
126295|NCT01233258|304687|P6|Participants Received Treatment|First Intervention (6 Months)||15
126296|NCT01233258|304688|P5|Participants Received Treatment|First Intervention (6 Months)||16
126297|NCT01233258|304689|P4|Participants Received Treatment|First Intervention (6 Months)||15
126298|NCT01233258|304690|P3|Participants Received Treatment|First Intervention (6 Months)||13
126299|NCT01233258|304691|P2|Participants Received Treatment|First Intervention (6 Months)||10
126300|NCT01233258|304692|P1|Participants Received Treatment|First Intervention (6 Months)||11
126301|NCT01233258|304687|P6|STARTED|First Intervention (6 Months)||16
126302|NCT01233258|304688|P5|STARTED|First Intervention (6 Months)||16
126303|NCT01233258|304689|P4|STARTED|First Intervention (6 Months)||16
126304|NCT01233258|304690|P3|STARTED|First Intervention (6 Months)||14
126305|NCT01233258|304691|P2|STARTED|First Intervention (6 Months)||10
126306|NCT01233258|304692|P1|STARTED|First Intervention (6 Months)||11
126307|NCT01233232|304712|P3|NOT COMPLETED|Overall Study||0
126308|NCT01233232|304713|P2|NOT COMPLETED|Overall Study||0
126309|NCT01233232|304714|P1|NOT COMPLETED|Overall Study||1
126310|NCT01233232|304712|P3|COMPLETED|Overall Study||28
126311|NCT01233232|304713|P2|COMPLETED|Overall Study||30
126312|NCT01233232|304714|P1|COMPLETED|Overall Study||28
126313|NCT01233232|304712|P3|STARTED|Overall Study||28
126314|NCT01233232|304713|P2|STARTED|Overall Study||30
126315|NCT01233232|304714|P1|STARTED|Overall Study||29
126316|NCT01233076|304767|P2|NOT COMPLETED|Period 2, One Week||0
126317|NCT01233076|304768|P1|NOT COMPLETED|Period 2, One Week||1
126318|NCT01233076|304767|P2|COMPLETED|Period 2, One Week||30
126319|NCT01233076|304768|P1|COMPLETED|Period 2, One Week||29
126320|NCT01233076|304767|P2|STARTED|Period 2, One Week||30
126321|NCT01233076|304768|P1|STARTED|Period 2, One Week||30
126322|NCT01233076|304767|P2|NOT COMPLETED|Period 1, One Week||0
126323|NCT01233076|304768|P1|NOT COMPLETED|Period 1, One Week||0
126324|NCT01233076|304767|P2|COMPLETED|Period 1, One Week||30
126325|NCT01233076|304768|P1|COMPLETED|Period 1, One Week||30
126326|NCT01233076|304767|P2|STARTED|Period 1, One Week||30
126327|NCT01233076|304768|P1|STARTED|Period 1, One Week||30
126328|NCT01233050|304776|P2|NOT COMPLETED|Overall Study||6
126329|NCT01233050|304777|P1|NOT COMPLETED|Overall Study||8
126330|NCT01233050|304776|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
126331|NCT01233050|304777|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
126332|NCT01233050|304776|P2|STARTED|Overall Study||402
126333|NCT01233050|304777|P1|STARTED|Overall Study||400
126334|NCT01232920|304795|P2|NOT COMPLETED|Overall Study||7
126335|NCT01232920|304796|P1|NOT COMPLETED|Overall Study||6
126336|NCT01232920|304795|P2|COMPLETED|Overall Study||32
126337|NCT01232920|304796|P1|COMPLETED|Overall Study||35
126338|NCT01232920|304795|P2|STARTED|Overall Study||39
126339|NCT01232920|304796|P1|STARTED|Overall Study||41
126340|NCT01232894|304810|P2|NOT COMPLETED|Overall Study||8
126341|NCT01232894|304811|P1|NOT COMPLETED|Overall Study||12
126342|NCT01232894|304810|P2|COMPLETED|Overall Study||22
126343|NCT01232894|304811|P1|COMPLETED|Overall Study||48
126344|NCT01232894|304810|P2|Received Study Drug|Overall Study||28
126345|NCT01232894|304811|P1|Received Study Drug|Overall Study||59
126346|NCT01232894|304810|P2|STARTED|Overall Study||30
126347|NCT01232894|304811|P1|STARTED|Overall Study||60
126348|NCT01232868|304819|P2|NOT COMPLETED|Overall Study||4
126349|NCT01232868|304820|P1|NOT COMPLETED|Overall Study||2
126350|NCT01232868|304819|P2|COMPLETED|Overall Study||40
126351|NCT01232868|304820|P1|COMPLETED|Overall Study||20
126352|NCT01232868|304819|P2|STARTED|Overall Study||44
126353|NCT01232868|304820|P1|STARTED|Overall Study||22
126354|NCT01232829|304828|P1|NOT COMPLETED|Overall Study||0
126355|NCT01232829|304828|P1|COMPLETED|Overall Study||18
126356|NCT01232829|304828|P1|STARTED|Overall Study||18
126357|NCT01232790|304834|P2|NOT COMPLETED|Second Crossover||2
126358|NCT01232790|304835|P1|NOT COMPLETED|Second Crossover||1
126359|NCT01232790|304834|P2|COMPLETED|Second Crossover||9
126360|NCT01232790|304835|P1|COMPLETED|Second Crossover||10
126361|NCT01232790|304834|P2|STARTED|Second Crossover||11
126362|NCT01232790|304835|P1|STARTED|Second Crossover||11
126363|NCT01232790|304834|P2|NOT COMPLETED|First Crossover||0
126364|NCT01232790|304835|P1|NOT COMPLETED|First Crossover||1
126365|NCT01232790|304834|P2|COMPLETED|First Crossover||11
126366|NCT01232790|304835|P1|COMPLETED|First Crossover||11
126367|NCT01232790|304834|P2|STARTED|First Crossover||11
126368|NCT01232790|304835|P1|STARTED|First Crossover||12
126369|NCT01232790|304834|P2|NOT COMPLETED|Initial Assessment||1
126370|NCT01232790|304835|P1|NOT COMPLETED|Initial Assessment||0
126371|NCT01232790|304834|P2|COMPLETED|Initial Assessment||11
126372|NCT01232790|304835|P1|COMPLETED|Initial Assessment||12
126373|NCT01232790|304834|P2|STARTED|Initial Assessment||12
126374|NCT01232790|304835|P1|STARTED|Initial Assessment||12
126375|NCT01232790|304834|P2|NOT COMPLETED|Randomization||2
126376|NCT01232790|304835|P1|NOT COMPLETED|Randomization||2
126377|NCT01232790|304834|P2|COMPLETED|Randomization||12
126378|NCT01232790|304835|P1|COMPLETED|Randomization||12
126379|NCT01232790|304834|P2|STARTED|Randomization||14
126380|NCT01232790|304835|P1|STARTED|Randomization||14
126381|NCT01232738|304889|P1|NOT COMPLETED|Overall Study||13
126382|NCT01232738|304889|P1|COMPLETED|Overall Study||23
126383|NCT01232738|304889|P1|STARTED|Overall Study||36
126384|NCT01232569|304905|P4|NOT COMPLETED|Open-label Extension Period||27
126385|NCT01232569|304906|P3|NOT COMPLETED|Open-label Extension Period||27
126386|NCT01232569|304907|P2|NOT COMPLETED|Open-label Extension Period||0
126387|NCT01232569|304908|P1|NOT COMPLETED|Open-label Extension Period||0
126388|NCT01232569|304905|P4|COMPLETED|Open-label Extension Period||200
126389|NCT01232569|304906|P3|COMPLETED|Open-label Extension Period||203
126390|NCT01232569|304907|P2|COMPLETED|Open-label Extension Period||0
126391|NCT01232569|304908|P1|COMPLETED|Open-label Extension Period||0
126392|NCT01232569|304905|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
126393|NCT01232569|304906|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
126394|NCT01232569|304907|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
126395|NCT01232569|304908|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
126396|NCT01232569|304905|P4|NOT COMPLETED|Double-blind Treatment Period||0
126397|NCT01232569|304906|P3|NOT COMPLETED|Double-blind Treatment Period||0
126398|NCT01232569|304907|P2|NOT COMPLETED|Double-blind Treatment Period||9
126399|NCT01232569|304908|P1|NOT COMPLETED|Double-blind Treatment Period||28
126400|NCT01232569|304905|P4|COMPLETED|Double-blind Treatment Period||0
126401|NCT01232569|304906|P3|COMPLETED|Double-blind Treatment Period||0
126402|NCT01232569|304907|P2|COMPLETED|Double-blind Treatment Period||209
126403|NCT01232569|304908|P1|COMPLETED|Double-blind Treatment Period||410
126404|NCT01232569|304905|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
126405|NCT01232569|304906|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
126406|NCT01232569|304907|P2|STARTED|Double-blind Treatment Period||218
126407|NCT01232569|304908|P1|STARTED|Double-blind Treatment Period||438
126408|NCT01232504|304952|P3|NOT COMPLETED|Overall Study||8
126409|NCT01232504|304953|P2|NOT COMPLETED|Overall Study||2
126410|NCT01232504|304954|P1|NOT COMPLETED|Overall Study||9
126411|NCT01232504|304952|P3|COMPLETED|Overall Study||61
126412|NCT01232504|304953|P2|COMPLETED|Overall Study||67
126413|NCT01232504|304954|P1|COMPLETED|Overall Study||59
126414|NCT01232504|304952|P3|STARTED|Overall Study||69
126415|NCT01232504|304953|P2|STARTED|Overall Study||69
126416|NCT01232504|304954|P1|STARTED|Overall Study||68
126417|NCT01232491|304988|P2|NOT COMPLETED|Overall Study||63
126418|NCT01232491|304989|P1|NOT COMPLETED|Overall Study||60
126419|NCT01232491|304988|P2|COMPLETED|Overall Study||242
126420|NCT01232491|304989|P1|COMPLETED|Overall Study||246
126421|NCT01232491|304988|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
126422|NCT01232491|304989|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
126423|NCT01232491|304988|P2|STARTED|Overall Study||305
126424|NCT01232491|304989|P1|STARTED|Overall Study||306
126425|NCT01232465|305009|P2|NOT COMPLETED|Overall Study||0
126426|NCT01232465|305010|P1|NOT COMPLETED|Overall Study||0
126427|NCT01232465|305009|P2|COMPLETED|Overall Study||402
126428|NCT01232465|305010|P1|COMPLETED|Overall Study||337
126429|NCT01232465|305009|P2|STARTED|Overall Study||402
126430|NCT01232465|305010|P1|STARTED|Overall Study||337
126431|NCT01232296|305018|P2|NOT COMPLETED|Overall Study||83
126432|NCT01232296|305019|P1|NOT COMPLETED|Overall Study||82
126433|NCT01232296|305018|P2|COMPLETED|Overall Study||0
126434|NCT01232296|305019|P1|COMPLETED|Overall Study||0
126435|NCT01232296|305018|P2|Safety Set|Overall Study||83
126436|NCT01232296|305019|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
126437|NCT01232296|305018|P2|Full Analysis Set|Overall Study||83
126438|NCT01232296|305019|P1|Full Analysis Set|Overall Study||82
126439|NCT01232296|305018|P2|STARTED|Overall Study||83
126440|NCT01232296|305019|P1|STARTED|Overall Study||82
126441|NCT01232283|305036|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
126442|NCT01232283|305037|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
126443|NCT01232283|305038|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126444|NCT01232283|305039|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126445|NCT01232283|305040|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126446|NCT01232283|305041|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126447|NCT01232283|305042|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126448|NCT01232283|305043|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126449|NCT01232283|305044|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126450|NCT01232283|305045|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126451|NCT01232283|305036|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
126452|NCT01232283|305037|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
126453|NCT01232283|305038|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126454|NCT01232283|305039|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126455|NCT01232283|305040|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126456|NCT01232283|305041|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126457|NCT01232283|305042|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126458|NCT01232283|305043|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126459|NCT01232283|305044|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126460|NCT01232283|305045|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
126461|NCT01232283|305036|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
126462|NCT01232283|305037|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
126463|NCT01232283|305038|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126464|NCT01232283|305039|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126465|NCT01232283|305040|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126466|NCT01232283|305041|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126467|NCT01232283|305042|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126468|NCT01232283|305043|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126469|NCT01232283|305044|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126470|NCT01232283|305045|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
126471|NCT01232283|305036|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126472|NCT01232283|305037|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126473|NCT01232283|305038|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
126474|NCT01232283|305039|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
126475|NCT01232283|305040|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
126476|NCT01232283|305041|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
126477|NCT01232283|305042|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126478|NCT01232283|305043|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126479|NCT01232283|305044|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126480|NCT01232283|305045|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126481|NCT01232283|305036|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126482|NCT01232283|305037|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126483|NCT01232283|305038|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
126484|NCT01232283|305039|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
126485|NCT01232283|305040|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
126486|NCT01232283|305041|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
126487|NCT01232283|305042|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126488|NCT01232283|305043|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126489|NCT01232283|305044|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126490|NCT01232283|305045|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
126491|NCT01232283|305036|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126492|NCT01232283|305037|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126493|NCT01232283|305038|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
126494|NCT01232283|305039|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
126495|NCT01232283|305040|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126496|NCT01232283|305041|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126497|NCT01232283|305042|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126498|NCT01232283|305043|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126499|NCT01232283|305044|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126500|NCT01232283|305045|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
126501|NCT01232283|305036|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
126502|NCT01232283|305037|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
126503|NCT01232283|305038|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
126504|NCT01232283|305039|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
126505|NCT01232283|305040|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
126506|NCT01232283|305041|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
126507|NCT01232283|305042|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
126508|NCT01232283|305043|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
126509|NCT01232283|305044|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
126510|NCT01232283|305045|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
126511|NCT01232283|305036|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126512|NCT01232283|305037|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126513|NCT01232283|305038|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126514|NCT01232283|305039|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126515|NCT01232283|305040|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126516|NCT01232283|305041|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126517|NCT01232283|305042|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
126518|NCT01232283|305043|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
126519|NCT01232283|305044|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126520|NCT01232283|305045|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
126521|NCT01232283|305036|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
126522|NCT01232283|305037|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
126523|NCT01232283|305038|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
126524|NCT01232283|305039|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
126525|NCT01232283|305040|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
126526|NCT01232283|305041|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
126527|NCT01232283|305042|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
126528|NCT01232283|305043|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
126529|NCT01232283|305044|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
126530|NCT01232283|305045|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
126531|NCT01232283|305036|P10|STARTED|Maintenance Phase (Weeks16-32)||0
126532|NCT01232283|305037|P9|STARTED|Maintenance Phase (Weeks16-32)||0
126533|NCT01232283|305038|P8|STARTED|Maintenance Phase (Weeks16-32)||0
126534|NCT01232283|305039|P7|STARTED|Maintenance Phase (Weeks16-32)||0
126535|NCT01232283|305040|P6|STARTED|Maintenance Phase (Weeks16-32)||0
126536|NCT01232283|305041|P5|STARTED|Maintenance Phase (Weeks16-32)||0
126537|NCT01232283|305042|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
126616|NCT01231984|305114|P2|NOT COMPLETED|Study Period 2||2
126538|NCT01232283|305043|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
126539|NCT01232283|305044|P2|STARTED|Maintenance Phase (Weeks16-32)||0
126540|NCT01232283|305045|P1|STARTED|Maintenance Phase (Weeks16-32)||0
126541|NCT01232283|305036|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126542|NCT01232283|305037|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126543|NCT01232283|305038|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126544|NCT01232283|305039|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126545|NCT01232283|305040|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126546|NCT01232283|305041|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126547|NCT01232283|305042|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126548|NCT01232283|305043|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126549|NCT01232283|305044|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
126550|NCT01232283|305045|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
126551|NCT01232283|305036|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126552|NCT01232283|305037|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126553|NCT01232283|305038|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126554|NCT01232283|305039|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126555|NCT01232283|305040|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126556|NCT01232283|305041|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126557|NCT01232283|305042|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126558|NCT01232283|305043|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
126559|NCT01232283|305044|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
126560|NCT01232283|305045|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
126561|NCT01232283|305036|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126562|NCT01232283|305037|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126563|NCT01232283|305038|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126564|NCT01232283|305039|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126565|NCT01232283|305040|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126566|NCT01232283|305041|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126567|NCT01232283|305042|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126568|NCT01232283|305043|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
126569|NCT01232283|305044|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
126570|NCT01232283|305045|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
126571|NCT01232283|305036|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126572|NCT01232283|305037|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126573|NCT01232283|305038|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126574|NCT01232283|305039|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126575|NCT01232283|305040|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126576|NCT01232283|305041|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126577|NCT01232283|305042|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126578|NCT01232283|305043|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
126579|NCT01232283|305044|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
126580|NCT01232283|305045|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
126581|NCT01232205|305079|P2|NOT COMPLETED|Overall Study||3
126582|NCT01232205|305080|P1|NOT COMPLETED|Overall Study||3
126583|NCT01232205|305079|P2|COMPLETED|Overall Study||55
126584|NCT01232205|305080|P1|COMPLETED|Overall Study||49
126585|NCT01232205|305079|P2|STARTED|Overall Study||58
126586|NCT01232205|305080|P1|STARTED|Overall Study||52
126587|NCT01232127|305086|P3|NOT COMPLETED|Period 3: Days 18-24||0
126588|NCT01232127|305087|P2|NOT COMPLETED|Period 3: Days 18-24||0
126589|NCT01232127|305088|P1|NOT COMPLETED|Period 3: Days 18-24||0
126590|NCT01232127|305086|P3|COMPLETED|Period 3: Days 18-24||24
126591|NCT01232127|305087|P2|COMPLETED|Period 3: Days 18-24||0
126592|NCT01232127|305088|P1|COMPLETED|Period 3: Days 18-24||0
126593|NCT01232127|305086|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
126594|NCT01232127|305087|P2|STARTED|Period 3: Days 18-24||0
126595|NCT01232127|305088|P1|STARTED|Period 3: Days 18-24||0
126596|NCT01232127|305086|P3|NOT COMPLETED|Period 2: Days 11-17||0
126597|NCT01232127|305087|P2|NOT COMPLETED|Period 2: Days 11-17||0
126598|NCT01232127|305088|P1|NOT COMPLETED|Period 2: Days 11-17||0
126599|NCT01232127|305086|P3|COMPLETED|Period 2: Days 11-17||0
126600|NCT01232127|305087|P2|COMPLETED|Period 2: Days 11-17||24
126601|NCT01232127|305088|P1|COMPLETED|Period 2: Days 11-17||0
126602|NCT01232127|305086|P3|STARTED|Period 2: Days 11-17||0
126603|NCT01232127|305087|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
126604|NCT01232127|305088|P1|STARTED|Period 2: Days 11-17||0
126605|NCT01232127|305086|P3|NOT COMPLETED|Period 1: Days 1-10||0
126606|NCT01232127|305087|P2|NOT COMPLETED|Period 1: Days 1-10||0
126607|NCT01232127|305088|P1|NOT COMPLETED|Period 1: Days 1-10||1
126608|NCT01232127|305086|P3|COMPLETED|Period 1: Days 1-10||0
126609|NCT01232127|305087|P2|COMPLETED|Period 1: Days 1-10||0
126610|NCT01232127|305088|P1|COMPLETED|Period 1: Days 1-10||24
126611|NCT01232127|305086|P3|STARTED|Period 1: Days 1-10||0
126612|NCT01232127|305087|P2|STARTED|Period 1: Days 1-10||0
126613|NCT01232127|305088|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
126614|NCT01231984|305112|P4|NOT COMPLETED|Study Period 2||4
126615|NCT01231984|305113|P3|NOT COMPLETED|Study Period 2||0
126617|NCT01231984|305115|P1|NOT COMPLETED|Study Period 2||3
126618|NCT01231984|305112|P4|COMPLETED|Study Period 2||56
126619|NCT01231984|305113|P3|COMPLETED|Study Period 2||59
126620|NCT01231984|305114|P2|COMPLETED|Study Period 2||61
126621|NCT01231984|305115|P1|COMPLETED|Study Period 2||54
126622|NCT01231984|305112|P4|STARTED|Study Period 2||60
126623|NCT01231984|305113|P3|STARTED|Study Period 2||59
126624|NCT01231984|305114|P2|STARTED|Study Period 2||63
126625|NCT01231984|305115|P1|STARTED|Study Period 2||57
126626|NCT01231984|305112|P4|NOT COMPLETED|Study Period 1||9
126627|NCT01231984|305113|P3|NOT COMPLETED|Study Period 1||7
126628|NCT01231984|305114|P2|NOT COMPLETED|Study Period 1||7
126629|NCT01231984|305115|P1|NOT COMPLETED|Study Period 1||12
126630|NCT01231984|305112|P4|COMPLETED|Study Period 1||60
126631|NCT01231984|305113|P3|COMPLETED|Study Period 1||59
126632|NCT01231984|305114|P2|COMPLETED|Study Period 1||63
126633|NCT01231984|305115|P1|COMPLETED|Study Period 1||57
126634|NCT01231984|305112|P4|STARTED|Study Period 1||69
126635|NCT01231984|305113|P3|STARTED|Study Period 1||66
126636|NCT01231984|305114|P2|STARTED|Study Period 1||70
126637|NCT01231984|305115|P1|STARTED|Study Period 1||69
126638|NCT01231841|305136|P1|NOT COMPLETED|Overall Study||0
126639|NCT01231841|305136|P1|COMPLETED|Overall Study||20
126640|NCT01231841|305136|P1|STARTED|Overall Study||20
126641|NCT01231750|305142|P2|NOT COMPLETED|Overall Study||0
126642|NCT01231750|305143|P1|NOT COMPLETED|Overall Study||0
126643|NCT01231750|305142|P2|COMPLETED|Overall Study||4
126644|NCT01231750|305143|P1|COMPLETED|Overall Study||3
126645|NCT01231750|305142|P2|STARTED|Overall Study||4
126646|NCT01231750|305143|P1|STARTED|Overall Study||3
126647|NCT01231646|305161|P2|NOT COMPLETED|Overall Study||0
126648|NCT01231646|305162|P1|NOT COMPLETED|Overall Study||0
126649|NCT01231646|305161|P2|COMPLETED|Overall Study||10
126650|NCT01231646|305162|P1|COMPLETED|Overall Study||28
126651|NCT01231646|305161|P2|STARTED|Overall Study||10
126652|NCT01231646|305162|P1|STARTED|Overall Study||28
126653|NCT01231633|305170|P2|NOT COMPLETED|Overall Study||0
126654|NCT01231633|305171|P1|NOT COMPLETED|Overall Study||0
126655|NCT01231633|305170|P2|COMPLETED|Overall Study||13
126656|NCT01231633|305171|P1|COMPLETED|Overall Study||14
126657|NCT01231633|305170|P2|STARTED|Overall Study||13
126658|NCT01231633|305171|P1|STARTED|Overall Study||14
126659|NCT01231620|305184|P3|NOT COMPLETED|Overall Study||39
126660|NCT01231620|305185|P2|NOT COMPLETED|Overall Study||31
126661|NCT01231620|305186|P1|NOT COMPLETED|Overall Study||26
126662|NCT01231620|305184|P3|COMPLETED|Overall Study||166
126663|NCT01231620|305185|P2|COMPLETED|Overall Study||178
126664|NCT01231620|305186|P1|COMPLETED|Overall Study||175
126665|NCT01231620|305184|P3|STARTED|Overall Study||205
126666|NCT01231620|305185|P2|STARTED|Overall Study||209
126667|NCT01231620|305186|P1|STARTED|Overall Study||201
126668|NCT01231607|305292|P5|NOT COMPLETED|Overall Study||24
126669|NCT01231607|305293|P4|NOT COMPLETED|Overall Study||38
126670|NCT01231607|305294|P3|NOT COMPLETED|Overall Study||31
126671|NCT01231607|305295|P2|NOT COMPLETED|Overall Study||34
126672|NCT01231607|305296|P1|NOT COMPLETED|Overall Study||29
126673|NCT01231607|305292|P5|COMPLETED|Overall Study||157
126674|NCT01231607|305293|P4|COMPLETED|Overall Study||141
126675|NCT01231607|305294|P3|COMPLETED|Overall Study||153
126676|NCT01231607|305295|P2|COMPLETED|Overall Study||154
126677|NCT01231607|305296|P1|COMPLETED|Overall Study||156
126678|NCT01231607|305292|P5|STARTED|Overall Study||181
126679|NCT01231607|305293|P4|STARTED|Overall Study||179
126680|NCT01231607|305294|P3|STARTED|Overall Study||184
126681|NCT01231607|305295|P2|STARTED|Overall Study||188
126682|NCT01231607|305296|P1|STARTED|Overall Study||185
126683|NCT01231581|305388|P2|NOT COMPLETED|Overall Study||80
126684|NCT01231581|305389|P1|NOT COMPLETED|Overall Study||80
126685|NCT01231581|305388|P2|COMPLETED|Overall Study||0
126686|NCT01231581|305389|P1|COMPLETED|Overall Study||0
126687|NCT01231581|305388|P2|Ongoing|Overall Study||0
126688|NCT01231581|305389|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
126689|NCT01231581|305388|P2|STARTED|Overall Study||80
126690|NCT01231581|305389|P1|STARTED|Overall Study||80
126691|NCT01231555|305410|P3|NOT COMPLETED|Overall Study||8
126692|NCT01231555|305411|P2|NOT COMPLETED|Overall Study||7
126693|NCT01231555|305412|P1|NOT COMPLETED|Overall Study||8
126694|NCT01231555|305410|P3|COMPLETED|Overall Study||0
126695|NCT01231555|305411|P2|COMPLETED|Overall Study||0
126696|NCT01231555|305412|P1|COMPLETED|Overall Study||0
126697|NCT01231555|305410|P3|STARTED|Overall Study||8
126698|NCT01231555|305411|P2|STARTED|Overall Study||7
126699|NCT01231555|305412|P1|STARTED|Overall Study||8
126700|NCT01231516|305443|P2|NOT COMPLETED|Open-label Phase||26
126701|NCT01231516|305444|P1|NOT COMPLETED|Open-label Phase||295
126702|NCT01231516|305443|P2|COMPLETED|Open-label Phase||1
126703|NCT01231516|305444|P1|COMPLETED|Open-label Phase||0
126704|NCT01231516|305443|P2|Ongoing at the Time of Analysis|Open-label Phase||23
126705|NCT01231516|305444|P1|Ongoing at the Time of Analysis|Open-label Phase||282
126706|NCT01231516|305443|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
126707|NCT01231516|305444|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
126708|NCT01231516|305443|P2|NOT COMPLETED|48 Week Double-blind Phase||79
126709|NCT01231516|305444|P1|NOT COMPLETED|48 Week Double-blind Phase||58
126710|NCT01231516|305443|P2|COMPLETED|48 Week Double-blind Phase||283
126711|NCT01231516|305444|P1|COMPLETED|48 Week Double-blind Phase||299
126712|NCT01231516|305443|P2|STARTED|48 Week Double-blind Phase||362
126713|NCT01231516|305444|P1|STARTED|48 Week Double-blind Phase||357
126714|NCT01231503|305474|P8|NOT COMPLETED|Overall Study||8
126715|NCT01231503|305475|P7|NOT COMPLETED|Overall Study||7
126716|NCT01231503|305476|P6|NOT COMPLETED|Overall Study||16
126717|NCT01231503|305477|P5|NOT COMPLETED|Overall Study||10
126718|NCT01231503|305478|P4|NOT COMPLETED|Overall Study||8
126719|NCT01231503|305479|P3|NOT COMPLETED|Overall Study||12
126720|NCT01231503|305480|P2|NOT COMPLETED|Overall Study||13
126721|NCT01231503|305481|P1|NOT COMPLETED|Overall Study||14
126722|NCT01231503|305474|P8|COMPLETED|Overall Study||52
126723|NCT01231503|305475|P7|COMPLETED|Overall Study||53
126724|NCT01231503|305476|P6|COMPLETED|Overall Study||44
126725|NCT01231503|305477|P5|COMPLETED|Overall Study||50
126726|NCT01231503|305478|P4|COMPLETED|Overall Study||52
126727|NCT01231503|305479|P3|COMPLETED|Overall Study||48
126728|NCT01231503|305480|P2|COMPLETED|Overall Study||46
126729|NCT01231503|305481|P1|COMPLETED|Overall Study||46
126730|NCT01231503|305474|P8|STARTED|Overall Study||60
126731|NCT01231503|305475|P7|STARTED|Overall Study||60
126732|NCT01231503|305476|P6|STARTED|Overall Study||60
126733|NCT01231503|305477|P5|STARTED|Overall Study||60
126734|NCT01231503|305478|P4|STARTED|Overall Study||60
126735|NCT01231503|305479|P3|STARTED|Overall Study||60
126736|NCT01231503|305480|P2|STARTED|Overall Study||59
126737|NCT01231503|305481|P1|STARTED|Overall Study||60
126738|NCT01231464|305705|P2|NOT COMPLETED|Overall Study||7
126739|NCT01231464|305706|P1|NOT COMPLETED|Overall Study||5
126740|NCT01231464|305705|P2|COMPLETED|Overall Study||176
126741|NCT01231464|305706|P1|COMPLETED|Overall Study||177
126742|NCT01231464|305705|P2|STARTED|Overall Study||183
126743|NCT01231464|305706|P1|STARTED|Overall Study||182
126744|NCT01231412|305719|P3|NOT COMPLETED|Overall Study||0
126745|NCT01231412|305720|P2|NOT COMPLETED|Overall Study||1
126746|NCT01231412|305721|P1|NOT COMPLETED|Overall Study||0
126747|NCT01231412|305719|P3|COMPLETED|Overall Study||6
126748|NCT01231412|305720|P2|COMPLETED|Overall Study||90
126749|NCT01231412|305721|P1|COMPLETED|Overall Study||77
126750|NCT01231412|305719|P3|STARTED|Overall Study||6
126751|NCT01231412|305720|P2|STARTED|Overall Study||91
126752|NCT01231412|305721|P1|STARTED|Overall Study||77
126753|NCT01231399|305744|P1|NOT COMPLETED|Overall Study||0
126754|NCT01231399|305744|P1|COMPLETED|Overall Study||6
126755|NCT01231399|305744|P1|STARTED|Overall Study||6
126756|NCT01231373|305755|P4|NOT COMPLETED|Overall Study||1
126757|NCT01231373|305756|P3|NOT COMPLETED|Overall Study||0
126758|NCT01231373|305757|P2|NOT COMPLETED|Overall Study||1
126759|NCT01231373|305758|P1|NOT COMPLETED|Overall Study||3
126760|NCT01231373|305755|P4|COMPLETED|Overall Study||57
126761|NCT01231373|305756|P3|COMPLETED|Overall Study||60
126762|NCT01231373|305757|P2|COMPLETED|Overall Study||57
126763|NCT01231373|305758|P1|COMPLETED|Overall Study||56
126764|NCT01231373|305755|P4|Patients Receiving Blinded Treatment|Overall Study||58
126765|NCT01231373|305756|P3|Patients Receiving Blinded Treatment|Overall Study||60
126766|NCT01231373|305757|P2|Patients Receiving Blinded Treatment|Overall Study||57
126767|NCT01231373|305758|P1|Patients Receiving Blinded Treatment|Overall Study||57
126768|NCT01231373|305755|P4|STARTED|Overall Study||58
126769|NCT01231373|305756|P3|STARTED|Overall Study||60
126770|NCT01231373|305757|P2|STARTED|Overall Study||58
126771|NCT01231373|305758|P1|STARTED|Overall Study||59
126772|NCT01231334|305778|P2|NOT COMPLETED|Overall Study||21
126773|NCT01231334|305779|P1|NOT COMPLETED|Overall Study||19
126774|NCT01231334|305778|P2|COMPLETED|Overall Study||120
126775|NCT01231334|305779|P1|COMPLETED|Overall Study||126
126776|NCT01231334|305778|P2|STARTED|Overall Study||141
126777|NCT01231334|305779|P1|STARTED|Overall Study||145
126778|NCT01231321|305797|P1|NOT COMPLETED|Overall Study||5
126779|NCT01231321|305797|P1|COMPLETED|Overall Study||95
126780|NCT01231321|305797|P1|STARTED|Overall Study||100
126781|NCT01231230|305808|P1|NOT COMPLETED|Overall Study||0
126782|NCT01231230|305808|P1|COMPLETED|Overall Study||14
126783|NCT01231230|305808|P1|Placebo|Overall Study||14
126784|NCT01231230|305808|P1|Fluticasone/Salmeterol|Overall Study||14
126785|NCT01231230|305808|P1|Salmeterol|Overall Study||14
126786|NCT01231230|305808|P1|Fluticasone|Overall Study||14
126787|NCT01231230|305808|P1|STARTED|Overall Study||14
126788|NCT01230892|305820|P2|NOT COMPLETED|Overall Study||1
126789|NCT01230892|305821|P1|NOT COMPLETED|Overall Study||3
126790|NCT01230892|305820|P2|COMPLETED|Overall Study||13
126791|NCT01230892|305821|P1|COMPLETED|Overall Study||12
126792|NCT01230892|305820|P2|STARTED|Overall Study||14
126793|NCT01230892|305821|P1|STARTED|Overall Study||15
126794|NCT01230827|305831|P4|NOT COMPLETED|Overall Study||78
126795|NCT01230827|305832|P3|NOT COMPLETED|Overall Study||65
126796|NCT01230827|305833|P2|NOT COMPLETED|Overall Study||11
126797|NCT01230827|305834|P1|NOT COMPLETED|Overall Study||19
126798|NCT01230827|305831|P4|COMPLETED|Overall Study||0
126799|NCT01230827|305832|P3|COMPLETED|Overall Study||0
126800|NCT01230827|305833|P2|COMPLETED|Overall Study||0
126801|NCT01230827|305834|P1|COMPLETED|Overall Study||0
126802|NCT01230827|305831|P4|STARTED|Overall Study||78
126803|NCT01230827|305832|P3|STARTED|Overall Study||65
126804|NCT01230827|305833|P2|STARTED|Overall Study||11
126805|NCT01230827|305834|P1|STARTED|Overall Study||19
126806|NCT01230814|305850|P2|NOT COMPLETED|Overall Study||4
126807|NCT01230814|305851|P1|NOT COMPLETED|Overall Study||13
126808|NCT01230814|305850|P2|COMPLETED|Overall Study||112
126809|NCT01230814|305851|P1|COMPLETED|Overall Study||105
126810|NCT01230814|305850|P2|STARTED|Overall Study||116
126811|NCT01230814|305851|P1|STARTED|Overall Study||118
126812|NCT01230788|305863|P1|NOT COMPLETED|Overall Study||1
126813|NCT01230788|305863|P1|COMPLETED|Overall Study||0
126814|NCT01230788|305863|P1|STARTED|Overall Study||1
126815|NCT01230749|305875|P4|NOT COMPLETED|Overall Study||2
126816|NCT01230749|305876|P3|NOT COMPLETED|Overall Study||2
126817|NCT01230749|305877|P2|NOT COMPLETED|Overall Study||2
126818|NCT01230749|305878|P1|NOT COMPLETED|Overall Study||0
126819|NCT01230749|305875|P4|COMPLETED|Overall Study||20
126820|NCT01230749|305876|P3|COMPLETED|Overall Study||21
126821|NCT01230749|305877|P2|COMPLETED|Overall Study||20
126822|NCT01230749|305878|P1|COMPLETED|Overall Study||22
126823|NCT01230749|305875|P4|STARTED|Overall Study||22
126824|NCT01230749|305876|P3|STARTED|Overall Study||23
126825|NCT01230749|305877|P2|STARTED|Overall Study||22
126826|NCT01230749|305878|P1|STARTED|Overall Study||22
126827|NCT01230710|305913|P1|NOT COMPLETED|Overall Study||49
126828|NCT01230710|305913|P1|COMPLETED|Overall Study||2
126829|NCT01230710|305913|P1|STARTED|Overall Study||51
126830|NCT01230502|305924|P3|NOT COMPLETED|Overall Study||0
126831|NCT01230502|305925|P2|NOT COMPLETED|Overall Study||0
126832|NCT01230502|305926|P1|NOT COMPLETED|Overall Study||0
126833|NCT01230502|305924|P3|COMPLETED|Overall Study||0
126834|NCT01230502|305925|P2|COMPLETED|Overall Study||0
126835|NCT01230502|305926|P1|COMPLETED|Overall Study||9
126836|NCT01230502|305924|P3|STARTED|Overall Study||0
126837|NCT01230502|305925|P2|STARTED|Overall Study||0
126838|NCT01230502|305926|P1|STARTED|Overall Study||9
126839|NCT01230424|305939|P2|NOT COMPLETED|Overall Study||0
126840|NCT01230424|305940|P1|NOT COMPLETED|Overall Study||0
126841|NCT01230424|305939|P2|COMPLETED|Overall Study||70
126842|NCT01230424|305940|P1|COMPLETED|Overall Study||70
126843|NCT01230424|305939|P2|STARTED|Overall Study||70
126844|NCT01230424|305940|P1|STARTED|Overall Study||70
126845|NCT01230307|305968|P2|NOT COMPLETED|Overall Study||2
126846|NCT01230307|305969|P1|NOT COMPLETED|Overall Study||0
126847|NCT01230307|305968|P2|COMPLETED|Overall Study||4
126848|NCT01230307|305969|P1|COMPLETED|Overall Study||6
126849|NCT01230307|305968|P2|STARTED|Overall Study||6
126850|NCT01230307|305969|P1|STARTED|Overall Study||6
126851|NCT01230177|305981|P1|NOT COMPLETED|Overall Study||0
126852|NCT01230177|305981|P1|COMPLETED|Overall Study||3
126853|NCT01230177|305981|P1|STARTED|Overall Study||3
126854|NCT01230060|305989|P1|NOT COMPLETED|Overall Study||1
126855|NCT01230060|305989|P1|COMPLETED|Overall Study||121
126856|NCT01230060|305989|P1|STARTED|Overall Study||122
126857|NCT01230021|305993|P1|NOT COMPLETED|Overall Study||0
126858|NCT01230021|305993|P1|COMPLETED|Overall Study||6
126859|NCT01230021|305993|P1|STARTED|Overall Study||6
126860|NCT01229943|306015|P2|NOT COMPLETED|Overall Study||17
126861|NCT01229943|306016|P1|NOT COMPLETED|Overall Study||18
126862|NCT01229943|306015|P2|COMPLETED|Overall Study||58
126863|NCT01229943|306016|P1|COMPLETED|Overall Study||57
126864|NCT01229943|306015|P2|STARTED|Overall Study||75
126865|NCT01229943|306016|P1|STARTED|Overall Study||75
126866|NCT01229891|306029|P3|NOT COMPLETED|Overall Study||0
126867|NCT01229891|306030|P2|NOT COMPLETED|Overall Study||0
126868|NCT01229891|306031|P1|NOT COMPLETED|Overall Study||0
126869|NCT01229891|306029|P3|COMPLETED|Overall Study||30
126870|NCT01229891|306030|P2|COMPLETED|Overall Study||30
126871|NCT01229891|306031|P1|COMPLETED|Overall Study||30
126872|NCT01229891|306029|P3|STARTED|Overall Study||30
126873|NCT01229891|306030|P2|STARTED|Overall Study||30
126874|NCT01229891|306031|P1|STARTED|Overall Study||30
126875|NCT01229735|306062|P2|NOT COMPLETED|Overall Study||66
126876|NCT01229735|306063|P1|NOT COMPLETED|Overall Study||66
126877|NCT01229735|306062|P2|COMPLETED|Overall Study||100
126878|NCT01229735|306063|P1|COMPLETED|Overall Study||111
126879|NCT01229735|306062|P2|STARTED|Overall Study||166
126880|NCT01229735|306063|P1|STARTED|Overall Study||177
126881|NCT01229722|306079|P2|NOT COMPLETED|Overall Study||0
126882|NCT01229722|306080|P1|NOT COMPLETED|Overall Study||4
126883|NCT01229722|306079|P2|COMPLETED|Overall Study||36
126884|NCT01229722|306080|P1|COMPLETED|Overall Study||30
126885|NCT01229722|306079|P2|STARTED|Overall Study||36
126886|NCT01229722|306080|P1|STARTED|Overall Study||34
126887|NCT01229527|306089|P3|NOT COMPLETED|Overall Study||0
126888|NCT01229527|306090|P2|NOT COMPLETED|Overall Study||0
126889|NCT01229527|306091|P1|NOT COMPLETED|Overall Study||0
126890|NCT01229527|306089|P3|COMPLETED|Overall Study||30
126891|NCT01229527|306090|P2|COMPLETED|Overall Study||30
126892|NCT01229527|306091|P1|COMPLETED|Overall Study||30
126893|NCT01229527|306089|P3|STARTED|Overall Study||30
126894|NCT01229527|306090|P2|STARTED|Overall Study||30
126895|NCT01229527|306091|P1|STARTED|Overall Study||30
126896|NCT01229462|306104|P2|NOT COMPLETED|Overall Study||9
126897|NCT01229462|306105|P1|NOT COMPLETED|Overall Study||5
126898|NCT01229462|306104|P2|COMPLETED|Overall Study||109
126899|NCT01229462|306105|P1|COMPLETED|Overall Study||115
126900|NCT01229462|306104|P2|STARTED|Overall Study||118
126901|NCT01229462|306105|P1|STARTED|Overall Study||120
126902|NCT01229436|306111|P1|NOT COMPLETED|Overall Study||5
126903|NCT01229436|306111|P1|COMPLETED|Overall Study||249
126904|NCT01229436|306111|P1|STARTED|Overall Study||254
126905|NCT01229423|306149|P1|NOT COMPLETED|Overall Study||15
126906|NCT01229423|306149|P1|COMPLETED|Overall Study||47
126907|NCT01229423|306149|P1|STARTED|Overall Study||62
126908|NCT01229410|306160|P2|NOT COMPLETED|Overall Study||3
126909|NCT01229410|306161|P1|NOT COMPLETED|Overall Study||5
126910|NCT01229410|306160|P2|COMPLETED|Overall Study||9
126911|NCT01229410|306161|P1|COMPLETED|Overall Study||7
126912|NCT01229410|306160|P2|STARTED|Overall Study||12
126913|NCT01229410|306161|P1|STARTED|Overall Study||12
126914|NCT01229397|306173|P2|NOT COMPLETED|Overall Study||9
126915|NCT01229397|306174|P1|NOT COMPLETED|Overall Study||11
126916|NCT01229397|306173|P2|COMPLETED|Overall Study||93
126917|NCT01229397|306174|P1|COMPLETED|Overall Study||92
126918|NCT01229397|306173|P2|STARTED|Overall Study||102
126919|NCT01229397|306174|P1|STARTED|Overall Study||103
126920|NCT01229371|306192|P4|NOT COMPLETED|Overall Study||0
126921|NCT01229371|306193|P3|NOT COMPLETED|Overall Study||0
126922|NCT01229371|306194|P2|NOT COMPLETED|Overall Study||1
126923|NCT01229371|306195|P1|NOT COMPLETED|Overall Study||0
126924|NCT01229371|306192|P4|COMPLETED|Overall Study||110
126925|NCT01229371|306193|P3|COMPLETED|Overall Study||110
126926|NCT01229371|306194|P2|COMPLETED|Overall Study||110
126927|NCT01229371|306195|P1|COMPLETED|Overall Study||109
126928|NCT01229371|306192|P4|STARTED|Overall Study||110
126929|NCT01229371|306193|P3|STARTED|Overall Study||110
126930|NCT01229371|306194|P2|STARTED|Overall Study||111
126931|NCT01229371|306195|P1|STARTED|Overall Study||109
126932|NCT01229254|306220|P3|NOT COMPLETED|Overall Study||12
126933|NCT01229254|306221|P2|NOT COMPLETED|Overall Study||16
126934|NCT01229254|306222|P1|NOT COMPLETED|Overall Study||15
126935|NCT01229254|306220|P3|COMPLETED|Overall Study||61
126936|NCT01229254|306221|P2|COMPLETED|Overall Study||58
126937|NCT01229254|306222|P1|COMPLETED|Overall Study||27
126938|NCT01229254|306220|P3|STARTED|Overall Study||73
126939|NCT01229254|306221|P2|STARTED|Overall Study||74
126940|NCT01229254|306222|P1|STARTED|Overall Study||42
126941|NCT01229228|306236|P5|NOT COMPLETED|Overall Study||1
126942|NCT01229228|306237|P4|NOT COMPLETED|Overall Study||0
126943|NCT01229228|306238|P3|NOT COMPLETED|Overall Study||1
126944|NCT01229228|306239|P2|NOT COMPLETED|Overall Study||0
126945|NCT01229228|306240|P1|NOT COMPLETED|Overall Study||1
126946|NCT01229228|306236|P5|COMPLETED|Overall Study||50
126947|NCT01229228|306237|P4|COMPLETED|Overall Study||51
126948|NCT01229228|306238|P3|COMPLETED|Overall Study||49
126949|NCT01229228|306239|P2|COMPLETED|Overall Study||51
126950|NCT01229228|306240|P1|COMPLETED|Overall Study||50
126951|NCT01229228|306236|P5|STARTED|Overall Study||51
126952|NCT01229228|306237|P4|STARTED|Overall Study||51
126953|NCT01229228|306238|P3|STARTED|Overall Study||50
126954|NCT01229228|306239|P2|STARTED|Overall Study||51
126955|NCT01229228|306240|P1|STARTED|Overall Study||51
126956|NCT01229176|306260|P8|NOT COMPLETED|Overall Study||3
126957|NCT01229176|306261|P7|NOT COMPLETED|Overall Study||0
126958|NCT01229176|306262|P6|NOT COMPLETED|Overall Study||2
126959|NCT01229176|306263|P5|NOT COMPLETED|Overall Study||2
126960|NCT01229176|306264|P4|NOT COMPLETED|Overall Study||1
126961|NCT01229176|306265|P3|NOT COMPLETED|Overall Study||0
126962|NCT01229176|306266|P2|NOT COMPLETED|Overall Study||3
126963|NCT01229176|306267|P1|NOT COMPLETED|Overall Study||0
126964|NCT01229176|306260|P8|COMPLETED|Overall Study||17
126965|NCT01229176|306261|P7|COMPLETED|Overall Study||20
126966|NCT01229176|306262|P6|COMPLETED|Overall Study||18
126967|NCT01229176|306263|P5|COMPLETED|Overall Study||18
126968|NCT01229176|306264|P4|COMPLETED|Overall Study||19
126969|NCT01229176|306265|P3|COMPLETED|Overall Study||20
126970|NCT01229176|306266|P2|COMPLETED|Overall Study||37
126971|NCT01229176|306267|P1|COMPLETED|Overall Study||40
126972|NCT01229176|306260|P8|STARTED|Overall Study||20
126973|NCT01229176|306261|P7|STARTED|Overall Study||20
126974|NCT01229176|306262|P6|STARTED|Overall Study||20
126975|NCT01229176|306263|P5|STARTED|Overall Study||20
126976|NCT01229176|306264|P4|STARTED|Overall Study||20
126977|NCT01229176|306265|P3|STARTED|Overall Study||20
126978|NCT01229176|306266|P2|STARTED|Overall Study||40
126979|NCT01229176|306267|P1|STARTED|Overall Study||40
126980|NCT01229150|306321|P4|NOT COMPLETED|Overall Study||0
126981|NCT01229150|306322|P3|NOT COMPLETED|Overall Study||0
126982|NCT01229150|306323|P2|NOT COMPLETED|Overall Study||2
126983|NCT01229150|306324|P1|NOT COMPLETED|Overall Study||2
126984|NCT01229150|306321|P4|COMPLETED|Overall Study||19
126985|NCT01229150|306322|P3|COMPLETED|Overall Study||19
126986|NCT01229150|306323|P2|COMPLETED|Overall Study||9
126987|NCT01229150|306324|P1|COMPLETED|Overall Study||28
126988|NCT01229150|306321|P4|STARTED|Overall Study||19
126989|NCT01229150|306322|P3|STARTED|Overall Study||19
126990|NCT01229150|306323|P2|STARTED|Overall Study||11
126991|NCT01229150|306324|P1|STARTED|Overall Study||30
126992|NCT01229111|306381|P1|NOT COMPLETED|Overall Study||1
126993|NCT01229111|306381|P1|COMPLETED|Overall Study||13
126994|NCT01229111|306381|P1|STARTED|Overall Study||14
126995|NCT01228968|306389|P1|NOT COMPLETED|Overall Study||0
126996|NCT01228968|306389|P1|COMPLETED|Overall Study||9
126997|NCT01228968|306389|P1|STARTED|Overall Study||9
126998|NCT01228929|306399|P3|NOT COMPLETED|High Temperature Condition||0
126999|NCT01228929|306400|P2|NOT COMPLETED|High Temperature Condition||0
127000|NCT01228929|306401|P1|NOT COMPLETED|High Temperature Condition||0
127001|NCT01228929|306399|P3|COMPLETED|High Temperature Condition||6
127002|NCT01228929|306400|P2|COMPLETED|High Temperature Condition||6
127003|NCT01228929|306401|P1|COMPLETED|High Temperature Condition||6
127004|NCT01228929|306399|P3|STARTED|High Temperature Condition||6
127005|NCT01228929|306400|P2|STARTED|High Temperature Condition||6
127006|NCT01228929|306401|P1|STARTED|High Temperature Condition||6
127007|NCT01228929|306399|P3|NOT COMPLETED|Low Humidity Condition||0
127008|NCT01228929|306400|P2|NOT COMPLETED|Low Humidity Condition||0
127009|NCT01228929|306401|P1|NOT COMPLETED|Low Humidity Condition||0
127010|NCT01228929|306399|P3|COMPLETED|Low Humidity Condition||6
127011|NCT01228929|306400|P2|COMPLETED|Low Humidity Condition||6
127012|NCT01228929|306401|P1|COMPLETED|Low Humidity Condition||6
127013|NCT01228929|306399|P3|STARTED|Low Humidity Condition||6
127014|NCT01228929|306400|P2|STARTED|Low Humidity Condition||6
127015|NCT01228929|306401|P1|STARTED|Low Humidity Condition||6
127016|NCT01228929|306399|P3|NOT COMPLETED|Nominal Condition||0
127017|NCT01228929|306400|P2|NOT COMPLETED|Nominal Condition||0
127018|NCT01228929|306401|P1|NOT COMPLETED|Nominal Condition||0
127019|NCT01228929|306399|P3|COMPLETED|Nominal Condition||6
127020|NCT01228929|306400|P2|COMPLETED|Nominal Condition||6
127021|NCT01228929|306401|P1|COMPLETED|Nominal Condition||6
127022|NCT01228929|306399|P3|STARTED|Nominal Condition||6
127023|NCT01228929|306400|P2|STARTED|Nominal Condition||6
127024|NCT01228929|306401|P1|STARTED|Nominal Condition||6
127025|NCT01228903|306411|P2|NOT COMPLETED|Overall Study||5
127026|NCT01228903|306412|P1|NOT COMPLETED|Overall Study||5
127027|NCT01228903|306411|P2|COMPLETED|Overall Study||34
127028|NCT01228903|306412|P1|COMPLETED|Overall Study||36
127029|NCT01228903|306411|P2|STARTED|Overall Study||39
127030|NCT01228903|306412|P1|STARTED|Overall Study||41
127031|NCT01228747|306430|P2|NOT COMPLETED|Overall Study||45
127032|NCT01228747|306431|P1|NOT COMPLETED|Overall Study||65
127033|NCT01228747|306430|P2|COMPLETED|Overall Study||81
127034|NCT01228747|306431|P1|COMPLETED|Overall Study||60
127035|NCT01228747|306430|P2|STARTED|Overall Study||126
127036|NCT01228747|306431|P1|STARTED|Overall Study||125
127037|NCT01228734|306447|P2|NOT COMPLETED|Overall Study||8
127038|NCT01228734|306448|P1|NOT COMPLETED|Overall Study||16
127039|NCT01228734|306447|P2|COMPLETED|Overall Study||196
127040|NCT01228734|306448|P1|COMPLETED|Overall Study||177
127041|NCT01228734|306447|P2|Modified Safety Population|Overall Study||199
127042|NCT01228734|306448|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
127043|NCT01228734|306447|P2|Modified Intent-to-treat (MITT) Populati|Overall Study||200
127044|NCT01228734|306448|P1|Modified Intent-to-treat (MITT) Populati|Overall Study||193
127045|NCT01228734|306447|P2|STARTED|Overall Study||204
127046|NCT01228734|306448|P1|STARTED|Overall Study||193
127047|NCT01228591|306462|P2|NOT COMPLETED|Final Visit||0
127048|NCT01228591|306463|P1|NOT COMPLETED|Final Visit||0
127049|NCT01228591|306462|P2|COMPLETED|Final Visit||16
127050|NCT01228591|306463|P1|COMPLETED|Final Visit||17
127051|NCT01228591|306462|P2|STARTED|Final Visit||16
127052|NCT01228591|306463|P1|STARTED|Final Visit||17
127053|NCT01228591|306462|P2|NOT COMPLETED|1-Week Follow-Up||0
127054|NCT01228591|306463|P1|NOT COMPLETED|1-Week Follow-Up||0
127055|NCT01228591|306462|P2|COMPLETED|1-Week Follow-Up||16
127056|NCT01228591|306463|P1|COMPLETED|1-Week Follow-Up||17
127057|NCT01228591|306462|P2|STARTED|1-Week Follow-Up||16
127058|NCT01228591|306463|P1|STARTED|1-Week Follow-Up||17
127059|NCT01228591|306462|P2|NOT COMPLETED|Baseline||2
127060|NCT01228591|306463|P1|NOT COMPLETED|Baseline||1
127061|NCT01228591|306462|P2|COMPLETED|Baseline||16
127062|NCT01228591|306463|P1|COMPLETED|Baseline||17
127063|NCT01228591|306462|P2|STARTED|Baseline||18
127064|NCT01228591|306463|P1|STARTED|Baseline||18
127065|NCT01228435|306481|P2|NOT COMPLETED|Overall Study||0
127066|NCT01228435|306482|P1|NOT COMPLETED|Overall Study||0
127067|NCT01228435|306481|P2|COMPLETED|Overall Study||2
127068|NCT01228435|306482|P1|COMPLETED|Overall Study||1
127069|NCT01228435|306481|P2|STARTED|Overall Study||2
127070|NCT01228435|306482|P1|STARTED|Overall Study||1
127071|NCT01228175|306492|P2|NOT COMPLETED|Overall Study||53
127072|NCT01228175|306493|P1|NOT COMPLETED|Overall Study||66
127073|NCT01228175|306492|P2|COMPLETED|Overall Study||46
127074|NCT01228175|306493|P1|COMPLETED|Overall Study||53
127075|NCT01228175|306492|P2|STARTED|Overall Study||99
127076|NCT01228175|306493|P1|STARTED|Overall Study||119
127077|NCT01228149|306501|P2|NOT COMPLETED|Overall Study||4
127078|NCT01228149|306502|P1|NOT COMPLETED|Overall Study||5
127079|NCT01228149|306501|P2|COMPLETED|Overall Study||26
127080|NCT01228149|306502|P1|COMPLETED|Overall Study||27
127081|NCT01228149|306501|P2|STARTED|Overall Study||30
127082|NCT01228149|306502|P1|STARTED|Overall Study||32
127083|NCT01228084|306524|P1|NOT COMPLETED|Overall Study||4
127084|NCT01228084|306524|P1|COMPLETED|Overall Study||16
127085|NCT01228084|306524|P1|STARTED|Overall Study||20
127086|NCT01228071|306535|P1|NOT COMPLETED|Overall Study||2
127087|NCT01228071|306535|P1|COMPLETED|Overall Study||32
127088|NCT01228071|306535|P1|STARTED|Overall Study||34
127089|NCT01228019|306541|P1|NOT COMPLETED|Overall Study||304
127090|NCT01228019|306541|P1|COMPLETED|Overall Study||862
127091|NCT01228019|306541|P1|STARTED|Overall Study||1166
127092|NCT01227993|306556|P1|NOT COMPLETED|Overall Study||0
127093|NCT01227993|306556|P1|COMPLETED|Overall Study||3
127094|NCT01227993|306556|P1|STARTED|Overall Study||3
127095|NCT01227980|306568|P2|NOT COMPLETED|Overall Study||5
127096|NCT01227980|306569|P1|NOT COMPLETED|Overall Study||2
127097|NCT01227980|306568|P2|COMPLETED|Overall Study||25
127098|NCT01227980|306569|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
127099|NCT01227980|306568|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
127100|NCT01227980|306569|P1|Measure Drug Level Concentration|Overall Study||10
127101|NCT01227980|306568|P2|Scripts Challenge Sessions|Overall Study||25
127102|NCT01227980|306569|P1|Scripts Challenge Sessions|Overall Study||26
127103|NCT01227980|306568|P2|STARTED|Overall Study||30
127104|NCT01227980|306569|P1|STARTED|Overall Study||40
127105|NCT01227967|306607|P2|NOT COMPLETED|Overall Study||13
127106|NCT01227967|306608|P1|NOT COMPLETED|Overall Study||16
127107|NCT01227967|306607|P2|COMPLETED|Overall Study||303
127108|NCT01227967|306608|P1|COMPLETED|Overall Study||298
127109|NCT01227967|306607|P2|STARTED|Overall Study||316
127110|NCT01227967|306608|P1|STARTED|Overall Study||314
127111|NCT01227954|306642|P1|NOT COMPLETED|Overall Study||13
127112|NCT01227954|306642|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
127113|NCT01227954|306642|P1|STARTED|Overall Study||113
127114|NCT01227928|306656|P2|NOT COMPLETED|Overall Study||17
127115|NCT01227928|306657|P1|NOT COMPLETED|Overall Study||22
127116|NCT01227928|306656|P2|COMPLETED|Overall Study||56
127117|NCT01227928|306657|P1|COMPLETED|Overall Study||50
127118|NCT01227928|306656|P2|STARTED|Overall Study||73
127119|NCT01227928|306657|P1|STARTED|Overall Study||72
127120|NCT01227902|306695|P4|NOT COMPLETED|Overall Study||10
127121|NCT01227902|306696|P3|NOT COMPLETED|Overall Study||19
127122|NCT01227902|306697|P2|NOT COMPLETED|Overall Study||13
127123|NCT01227902|306698|P1|NOT COMPLETED|Overall Study||18
127124|NCT01227902|306695|P4|COMPLETED|Overall Study||42
127125|NCT01227902|306696|P3|COMPLETED|Overall Study||25
127126|NCT01227902|306697|P2|COMPLETED|Overall Study||38
127127|NCT01227902|306698|P1|COMPLETED|Overall Study||38
127128|NCT01227902|306695|P4|STARTED|Overall Study||52
127129|NCT01227902|306696|P3|STARTED|Overall Study||44
127130|NCT01227902|306697|P2|STARTED|Overall Study||51
127131|NCT01227902|306698|P1|STARTED|Overall Study||56
127132|NCT01227889|306791|P2|NOT COMPLETED|Crossover Phase||37
127133|NCT01227889|306792|P1|NOT COMPLETED|Crossover Phase||0
127134|NCT01227889|306791|P2|COMPLETED|Crossover Phase||0
127135|NCT01227889|306792|P1|COMPLETED|Crossover Phase||0
127136|NCT01227889|306791|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
127137|NCT01227889|306792|P1|STARTED|Crossover Phase||0
127138|NCT01227889|306791|P2|NOT COMPLETED|Randomized Phase (RP)||63
127139|NCT01227889|306792|P1|NOT COMPLETED|Randomized Phase (RP)||187
127140|NCT01227889|306791|P2|COMPLETED|Randomized Phase (RP)||0
127141|NCT01227889|306792|P1|COMPLETED|Randomized Phase (RP)||0
127142|NCT01227889|306791|P2|STARTED|Randomized Phase (RP)||63
127143|NCT01227889|306792|P1|STARTED|Randomized Phase (RP)||187
127144|NCT01227824|306819|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
127145|NCT01227824|306820|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
127146|NCT01227824|306821|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
127147|NCT01227824|306819|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
127148|NCT01227824|306820|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
127149|NCT01227824|306821|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
127150|NCT01227824|306819|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
127151|NCT01227824|306820|P2|STARTED|Open-label Phase: Median of 1267 Days||0
127152|NCT01227824|306821|P1|STARTED|Open-label Phase: Median of 1267 Days||0
127153|NCT01227824|306819|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
127154|NCT01227824|306820|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
127155|NCT01227824|306821|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
127156|NCT01227824|306819|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
127157|NCT01227824|306820|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
127158|NCT01227824|306821|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
127159|NCT01227824|306819|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
127160|NCT01227824|306820|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
127161|NCT01227824|306821|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
127162|NCT01227785|306850|P1|NOT COMPLETED|Overall Study||12
127163|NCT01227785|306850|P1|COMPLETED|Overall Study||108
127164|NCT01227785|306850|P1|STARTED|Overall Study||120
127165|NCT01227707|306916|P1|NOT COMPLETED|Overall Study||24
127166|NCT01227707|306916|P1|COMPLETED|Overall Study||19
127167|NCT01227707|306916|P1|STARTED|Overall Study||43
127168|NCT01227681|306935|P3|NOT COMPLETED|Overall Study||0
127169|NCT01227681|306936|P2|NOT COMPLETED|Overall Study||0
127170|NCT01227681|306937|P1|NOT COMPLETED|Overall Study||0
127171|NCT01227681|306935|P3|COMPLETED|Overall Study||0
127172|NCT01227681|306936|P2|COMPLETED|Overall Study||0
127173|NCT01227681|306937|P1|COMPLETED|Overall Study||4
127174|NCT01227681|306935|P3|STARTED|Overall Study||0
127175|NCT01227681|306936|P2|STARTED|Overall Study||0
127176|NCT01227681|306937|P1|STARTED|Overall Study||4
127177|NCT01227668|306943|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
127178|NCT01227668|306944|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
127179|NCT01227668|306943|P2|COMPLETED|Phase 2 (Randomization Phase)||19
127180|NCT01227668|306944|P1|COMPLETED|Phase 2 (Randomization Phase)||22
127181|NCT01227668|306943|P2|Received Treatment|Phase 2 (Randomization Phase)||43
127182|NCT01227668|306944|P1|Received Treatment|Phase 2 (Randomization Phase)||39
127183|NCT01227668|306943|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
127184|NCT01227668|306944|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
127185|NCT01227668|306943|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
127186|NCT01227668|306944|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
127187|NCT01227668|306943|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
127188|NCT01227668|306944|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
127189|NCT01227668|306943|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
127190|NCT01227668|306944|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
127191|NCT01227668|306943|P2|STARTED|Phase 1 (Stabilization Phase)||0
127192|NCT01227668|306944|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
127193|NCT01227655|306961|P3|NOT COMPLETED|Overall Study||14
127194|NCT01227655|306962|P2|NOT COMPLETED|Overall Study||26
127195|NCT01227655|306963|P1|NOT COMPLETED|Overall Study||11
127196|NCT01227655|306961|P3|COMPLETED|Overall Study||130
127197|NCT01227655|306962|P2|COMPLETED|Overall Study||128
127198|NCT01227655|306963|P1|COMPLETED|Overall Study||118
127199|NCT01227655|306961|P3|Full Analysis Set|Overall Study||135
127200|NCT01227655|306962|P2|Full Analysis Set|Overall Study||147
127201|NCT01227655|306963|P1|Full Analysis Set|Overall Study||125
127202|NCT01227655|306961|P3|Safety Set|Overall Study||136
127203|NCT01227655|306962|P2|Safety Set|Overall Study||150
127204|NCT01227655|306963|P1|Safety Set|Overall Study||125
127205|NCT01227655|306961|P3|STARTED|Overall Study||144
127206|NCT01227655|306962|P2|STARTED|Overall Study||154
127207|NCT01227655|306963|P1|STARTED|Overall Study||129
127208|NCT01227629|306990|P10|NOT COMPLETED|Overall Study||2
127209|NCT01227629|306991|P9|NOT COMPLETED|Overall Study||6
127210|NCT01227629|306992|P8|NOT COMPLETED|Overall Study||6
127211|NCT01227629|306993|P7|NOT COMPLETED|Overall Study||8
127212|NCT01227629|306994|P6|NOT COMPLETED|Overall Study||1
127213|NCT01227629|306995|P5|NOT COMPLETED|Overall Study||2
127214|NCT01227629|306996|P4|NOT COMPLETED|Overall Study||8
127215|NCT01227629|306997|P3|NOT COMPLETED|Overall Study||1
127216|NCT01227629|306998|P2|NOT COMPLETED|Overall Study||2
127217|NCT01227629|306999|P1|NOT COMPLETED|Overall Study||2
127218|NCT01227629|306990|P10|COMPLETED|Overall Study||68
127219|NCT01227629|306991|P9|COMPLETED|Overall Study||24
127220|NCT01227629|306992|P8|COMPLETED|Overall Study||27
127221|NCT01227629|306993|P7|COMPLETED|Overall Study||90
127222|NCT01227629|306994|P6|COMPLETED|Overall Study||32
127223|NCT01227629|306995|P5|COMPLETED|Overall Study||32
127224|NCT01227629|306996|P4|COMPLETED|Overall Study||91
127225|NCT01227629|306997|P3|COMPLETED|Overall Study||26
127226|NCT01227629|306998|P2|COMPLETED|Overall Study||18
127227|NCT01227629|306999|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
127228|NCT01227629|306990|P10|STARTED|Overall Study||70
127229|NCT01227629|306991|P9|STARTED|Overall Study||30
127230|NCT01227629|306992|P8|STARTED|Overall Study||33
127231|NCT01227629|306993|P7|STARTED|Overall Study||98
127232|NCT01227629|306994|P6|STARTED|Overall Study||33
127233|NCT01227629|306995|P5|STARTED|Overall Study||34
127234|NCT01227629|306996|P4|STARTED|Overall Study||99
127235|NCT01227629|306997|P3|STARTED|Overall Study||27
127236|NCT01227629|306998|P2|STARTED|Overall Study||20
127237|NCT01227629|306999|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
127238|NCT01227577|307235|P1|NOT COMPLETED|Overall Study||35
127239|NCT01227577|307235|P1|COMPLETED|Overall Study||93
127240|NCT01227577|307235|P1|STARTED|Overall Study||128
127241|NCT01227564|307250|P3|NOT COMPLETED|Overall Study||6
127242|NCT01227564|307251|P2|NOT COMPLETED|Overall Study||2
127243|NCT01227564|307252|P1|NOT COMPLETED|Overall Study||4
127244|NCT01227564|307250|P3|COMPLETED|Overall Study|Completed study|15
127245|NCT01227564|307251|P2|COMPLETED|Overall Study|Completed study|18
127246|NCT01227564|307252|P1|COMPLETED|Overall Study|Completed study|18
127247|NCT01227564|307250|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
127248|NCT01227564|307251|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
127249|NCT01227564|307252|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
127250|NCT01227564|307250|P3|Treated|Overall Study||21
127251|NCT01227564|307251|P2|Treated|Overall Study||20
127252|NCT01227564|307252|P1|Treated|Overall Study||22
127253|NCT01227564|307250|P3|STARTED|Overall Study||21
127254|NCT01227564|307251|P2|STARTED|Overall Study||20
127255|NCT01227564|307252|P1|STARTED|Overall Study||22
127256|NCT01227551|307383|P1|NOT COMPLETED|Overall Study||34
127257|NCT01227551|307383|P1|COMPLETED|Overall Study||23
127258|NCT01227551|307383|P1|STARTED|Overall Study||57
127259|NCT01227512|307390|P2|NOT COMPLETED|Overall Study||10
127260|NCT01227512|307391|P1|NOT COMPLETED|Overall Study||13
127261|NCT01227512|307390|P2|COMPLETED|Overall Study||48
127262|NCT01227512|307391|P1|COMPLETED|Overall Study||53
127263|NCT01227512|307390|P2|STARTED|Overall Study||58
127264|NCT01227512|307391|P1|STARTED|Overall Study||66
127265|NCT01227434|307413|P2|NOT COMPLETED|Overall Study||0
127266|NCT01227434|307414|P1|NOT COMPLETED|Overall Study||0
127267|NCT01227434|307413|P2|COMPLETED|Overall Study||16
127268|NCT01227434|307414|P1|COMPLETED|Overall Study||6
127269|NCT01227434|307413|P2|STARTED|Overall Study||16
127270|NCT01227434|307414|P1|STARTED|Overall Study||6
127271|NCT01227421|307425|P3|NOT COMPLETED|Overall Study||10
127272|NCT01227421|307426|P2|NOT COMPLETED|Overall Study||18
127273|NCT01227421|307427|P1|NOT COMPLETED|Overall Study||11
127274|NCT01227421|307425|P3|COMPLETED|Overall Study||201
127275|NCT01227421|307426|P2|COMPLETED|Overall Study||194
127276|NCT01227421|307427|P1|COMPLETED|Overall Study||190
127277|NCT01227421|307425|P3|STARTED|Overall Study||211
127278|NCT01227421|307426|P2|STARTED|Overall Study||212
127279|NCT01227421|307427|P1|STARTED|Overall Study||201
127280|NCT01227395|307479|P2|NOT COMPLETED|Overall Study||1
127281|NCT01227395|307480|P1|NOT COMPLETED|Overall Study||0
127282|NCT01227395|307479|P2|COMPLETED|Overall Study||84
127283|NCT01227395|307480|P1|COMPLETED|Overall Study||391
127284|NCT01227395|307479|P2|STARTED|Overall Study||85
127285|NCT01227395|307480|P1|STARTED|Overall Study||391
127286|NCT01227382|307508|P1|NOT COMPLETED|Overall Study||0
127287|NCT01227382|307508|P1|COMPLETED|Overall Study||26
127288|NCT01227382|307508|P1|STARTED|Overall Study||26
127289|NCT01227278|307520|P2|NOT COMPLETED|Overall Study||8
127290|NCT01227278|307521|P1|NOT COMPLETED|Overall Study||5
127291|NCT01227278|307520|P2|COMPLETED|Overall Study||43
127292|NCT01227278|307521|P1|COMPLETED|Overall Study||45
127293|NCT01227278|307520|P2|STARTED|Overall Study||51
127294|NCT01227278|307521|P1|STARTED|Overall Study||50
127295|NCT01227265|307548|P3|NOT COMPLETED|Overall Study||14
127296|NCT01227265|307549|P2|NOT COMPLETED|Overall Study||20
127297|NCT01227265|307550|P1|NOT COMPLETED|Overall Study||19
127298|NCT01227265|307548|P3|COMPLETED|Overall Study||145
127299|NCT01227265|307549|P2|COMPLETED|Overall Study||139
127300|NCT01227265|307550|P1|COMPLETED|Overall Study||139
127301|NCT01227265|307548|P3|Treated|Overall Study||159
127302|NCT01227265|307549|P2|Treated|Overall Study||157
127303|NCT01227265|307550|P1|Treated|Overall Study||157
127304|NCT01227265|307548|P3|STARTED|Overall Study||159
127305|NCT01227265|307549|P2|STARTED|Overall Study||159
127306|NCT01227265|307550|P1|STARTED|Overall Study||158
127307|NCT01227057|307578|P2|NOT COMPLETED|Overall Study||8
127308|NCT01227057|307579|P1|NOT COMPLETED|Overall Study||6
127309|NCT01227057|307578|P2|COMPLETED|Overall Study||19
127310|NCT01227057|307579|P1|COMPLETED|Overall Study||25
127311|NCT01227057|307578|P2|STARTED|Overall Study||27
127312|NCT01227057|307579|P1|STARTED|Overall Study||31
127313|NCT01227018|307587|P1|NOT COMPLETED|Overall Study||15
127314|NCT01227018|307587|P1|COMPLETED|Overall Study||0
127315|NCT01227018|307587|P1|STARTED|Overall Study||15
127316|NCT01227005|307597|P2|NOT COMPLETED|Overall Study||1
127317|NCT01227005|307598|P1|NOT COMPLETED|Overall Study||5
127318|NCT01227005|307597|P2|COMPLETED|Overall Study||51
127319|NCT01227005|307598|P1|COMPLETED|Overall Study||50
127320|NCT01227005|307597|P2|STARTED|Overall Study||52
127321|NCT01227005|307598|P1|STARTED|Overall Study||55
127322|NCT01226745|307614|P6|NOT COMPLETED|Overall Study||5
127323|NCT01226745|307615|P5|NOT COMPLETED|Overall Study||4
127324|NCT01226745|307616|P4|NOT COMPLETED|Overall Study||5
127325|NCT01226745|307617|P3|NOT COMPLETED|Overall Study||20
127326|NCT01226745|307618|P2|NOT COMPLETED|Overall Study||16
127327|NCT01226745|307619|P1|NOT COMPLETED|Overall Study||17
127328|NCT01226745|307614|P6|COMPLETED|Overall Study||24
127329|NCT01226745|307615|P5|COMPLETED|Overall Study||22
127330|NCT01226745|307616|P4|COMPLETED|Overall Study||24
127331|NCT01226745|307617|P3|COMPLETED|Overall Study||69
127332|NCT01226745|307618|P2|COMPLETED|Overall Study||71
127333|NCT01226745|307619|P1|COMPLETED|Overall Study||63
127334|NCT01226745|307614|P6|STARTED|Overall Study||29
127335|NCT01226745|307615|P5|STARTED|Overall Study||26
127336|NCT01226745|307616|P4|STARTED|Overall Study||29
127337|NCT01226745|307617|P3|STARTED|Overall Study||89
127338|NCT01226745|307618|P2|STARTED|Overall Study||87
127339|NCT01226745|307619|P1|STARTED|Overall Study||80
127340|NCT01226732|307699|P6|NOT COMPLETED|Overall Study||6
127341|NCT01226732|307700|P5|NOT COMPLETED|Overall Study||3
127342|NCT01226732|307701|P4|NOT COMPLETED|Overall Study||5
127343|NCT01226732|307702|P3|NOT COMPLETED|Overall Study||3
127344|NCT01226732|307703|P2|NOT COMPLETED|Overall Study||3
127345|NCT01226732|307704|P1|NOT COMPLETED|Overall Study||3
127346|NCT01226732|307699|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
127347|NCT01226732|307700|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
127348|NCT01226732|307701|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
127349|NCT01226732|307702|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
127350|NCT01226732|307703|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
127351|NCT01226732|307704|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
127352|NCT01226732|307699|P6|STARTED|Overall Study||6
127353|NCT01226732|307700|P5|STARTED|Overall Study||3
127354|NCT01226732|307701|P4|STARTED|Overall Study||5
127355|NCT01226732|307702|P3|STARTED|Overall Study||3
127356|NCT01226732|307703|P2|STARTED|Overall Study||3
127357|NCT01226732|307704|P1|STARTED|Overall Study||3
127358|NCT01226719|307720|P1|NOT COMPLETED|Overall Study||13
127359|NCT01226719|307720|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
127360|NCT01226719|307720|P1|STARTED|Overall Study||15
127361|NCT01226706|307730|P2|NOT COMPLETED|Overall Study||0
127362|NCT01226706|307731|P1|NOT COMPLETED|Overall Study||0
127363|NCT01226706|307730|P2|COMPLETED|Overall Study||11
127364|NCT01226706|307731|P1|COMPLETED|Overall Study||10
127365|NCT01226706|307730|P2|STARTED|Overall Study||11
127366|NCT01226706|307731|P1|STARTED|Overall Study||10
127367|NCT01226511|307815|P2|NOT COMPLETED|Taper Period||3
127368|NCT01226511|307816|P1|NOT COMPLETED|Taper Period||5
127369|NCT01226511|307815|P2|COMPLETED|Taper Period||54
127370|NCT01226511|307816|P1|COMPLETED|Taper Period||46
127371|NCT01226511|307815|P2|STARTED|Taper Period||57
127372|NCT01226511|307816|P1|STARTED|Taper Period||51
127373|NCT01226511|307815|P2|NOT COMPLETED|Extension Treatment Period||27
127374|NCT01226511|307816|P1|NOT COMPLETED|Extension Treatment Period||27
127375|NCT01226511|307815|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
127376|NCT01226511|307816|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
127377|NCT01226511|307815|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
127378|NCT01226511|307816|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
127379|NCT01226511|307815|P2|NOT COMPLETED|Acute Treatment Period||31
127380|NCT01226511|307816|P1|NOT COMPLETED|Acute Treatment Period||32
127381|NCT01226511|307815|P2|COMPLETED|Acute Treatment Period||110
127382|NCT01226511|307816|P1|COMPLETED|Acute Treatment Period||108
127383|NCT01226511|307815|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
127384|NCT01226511|307816|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
127385|NCT01226459|307854|P2|NOT COMPLETED|Overall Study||32
127386|NCT01226459|307855|P1|NOT COMPLETED|Overall Study||21
127387|NCT01226459|307854|P2|COMPLETED|Overall Study||171
127388|NCT01226459|307855|P1|COMPLETED|Overall Study||180
127389|NCT01226459|307854|P2|STARTED|Overall Study||203
127390|NCT01226459|307855|P1|STARTED|Overall Study||201
127391|NCT01226420|307865|P1|NOT COMPLETED|Overall Study||0
127392|NCT01226420|307865|P1|COMPLETED|Overall Study||6
127393|NCT01226420|307865|P1|STARTED|Overall Study||6
127394|NCT01226121|307873|P3|NOT COMPLETED|Overall Study||1
127395|NCT01226121|307874|P2|NOT COMPLETED|Overall Study||0
127396|NCT01226121|307875|P1|NOT COMPLETED|Overall Study||2
127397|NCT01226121|307873|P3|COMPLETED|Overall Study||12
127398|NCT01226121|307874|P2|COMPLETED|Overall Study||11
127399|NCT01226121|307875|P1|COMPLETED|Overall Study||11
127400|NCT01226121|307873|P3|30 Day Evaluation|Overall Study||13
127401|NCT01226121|307874|P2|30 Day Evaluation|Overall Study||11
127402|NCT01226121|307875|P1|30 Day Evaluation|Overall Study||12
127403|NCT01226121|307873|P3|STARTED|Overall Study||13
127404|NCT01226121|307874|P2|STARTED|Overall Study||11
127405|NCT01226121|307875|P1|STARTED|Overall Study||13
127406|NCT01226095|307886|P1|NOT COMPLETED|Overall Study||1
127407|NCT01226095|307886|P1|COMPLETED|Overall Study||518
127408|NCT01226095|307886|P1|STARTED|Overall Study||519
127409|NCT01226043|307911|P4|NOT COMPLETED|30-week Observational Phase||13
127410|NCT01226043|307912|P3|NOT COMPLETED|30-week Observational Phase||6
127411|NCT01226043|307913|P2|NOT COMPLETED|30-week Observational Phase||0
127412|NCT01226043|307914|P1|NOT COMPLETED|30-week Observational Phase||0
127413|NCT01226043|307911|P4|COMPLETED|30-week Observational Phase||140
127414|NCT01226043|307912|P3|COMPLETED|30-week Observational Phase||153
127415|NCT01226043|307913|P2|COMPLETED|30-week Observational Phase||0
127416|NCT01226043|307914|P1|COMPLETED|30-week Observational Phase||0
127417|NCT01226043|307911|P4|TREATED|30-week Observational Phase||153
127418|NCT01226043|307912|P3|TREATED|30-week Observational Phase||159
127419|NCT01226043|307913|P2|TREATED|30-week Observational Phase||0
127420|NCT01226043|307914|P1|TREATED|30-week Observational Phase||0
127421|NCT01226043|307911|P4|STARTED|30-week Observational Phase||153
127422|NCT01226043|307912|P3|STARTED|30-week Observational Phase||159
127423|NCT01226043|307913|P2|STARTED|30-week Observational Phase||0
127424|NCT01226043|307914|P1|STARTED|30-week Observational Phase||0
127425|NCT01226043|307911|P4|NOT COMPLETED|6-week Re-randomization Phase||11
127426|NCT01226043|307912|P3|NOT COMPLETED|6-week Re-randomization Phase||7
127427|NCT01226043|307913|P2|NOT COMPLETED|6-week Re-randomization Phase||0
127428|NCT01226043|307914|P1|NOT COMPLETED|6-week Re-randomization Phase||0
127429|NCT01226043|307911|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
127430|NCT01226043|307912|P3|COMPLETED|6-week Re-randomization Phase||159
127431|NCT01226043|307913|P2|COMPLETED|6-week Re-randomization Phase||0
127432|NCT01226043|307914|P1|COMPLETED|6-week Re-randomization Phase||0
127433|NCT01226043|307911|P4|TREATED|6-week Re-randomization Phase||165
127434|NCT01226043|307912|P3|TREATED|6-week Re-randomization Phase||165
127435|NCT01226043|307913|P2|TREATED|6-week Re-randomization Phase||0
127436|NCT01226043|307914|P1|TREATED|6-week Re-randomization Phase||0
127437|NCT01226043|307911|P4|STARTED|6-week Re-randomization Phase||167
127438|NCT01226043|307912|P3|STARTED|6-week Re-randomization Phase||166
127439|NCT01226043|307913|P2|STARTED|6-week Re-randomization Phase||0
127440|NCT01226043|307914|P1|STARTED|6-week Re-randomization Phase||0
127441|NCT01226043|307911|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
127442|NCT01226043|307912|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
127443|NCT01226043|307913|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
127444|NCT01226043|307914|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
127445|NCT01226043|307911|P4|COMPLETED|4-week Crossover Phase - Period 2||0
127446|NCT01226043|307912|P3|COMPLETED|4-week Crossover Phase - Period 2||0
127447|NCT01226043|307913|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
127448|NCT01226043|307914|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
127449|NCT01226043|307911|P4|TREATED|4-week Crossover Phase - Period 2||0
127450|NCT01226043|307912|P3|TREATED|4-week Crossover Phase - Period 2||0
127451|NCT01226043|307913|P2|TREATED|4-week Crossover Phase - Period 2||194
127452|NCT01226043|307914|P1|TREATED|4-week Crossover Phase - Period 2||199
127453|NCT01226043|307911|P4|STARTED|4-week Crossover Phase - Period 2||0
127454|NCT01226043|307912|P3|STARTED|4-week Crossover Phase - Period 2||0
127455|NCT01226043|307913|P2|STARTED|4-week Crossover Phase - Period 2||194
127456|NCT01226043|307914|P1|STARTED|4-week Crossover Phase - Period 2||199
127457|NCT01226043|307911|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
127458|NCT01226043|307912|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
127459|NCT01226043|307913|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
127460|NCT01226043|307914|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
127461|NCT01226043|307911|P4|COMPLETED|4-week Crossover Phase - Period 1||0
127462|NCT01226043|307912|P3|COMPLETED|4-week Crossover Phase - Period 1||0
127463|NCT01226043|307913|P2|COMPLETED|4-week Crossover Phase - Period 1||194
127464|NCT01226043|307914|P1|COMPLETED|4-week Crossover Phase - Period 1||199
127465|NCT01226043|307911|P4|TREATED|4-week Crossover Phase - Period 1||0
127466|NCT01226043|307912|P3|TREATED|4-week Crossover Phase - Period 1||0
127467|NCT01226043|307913|P2|TREATED|4-week Crossover Phase - Period 1||200
127468|NCT01226043|307914|P1|TREATED|4-week Crossover Phase - Period 1||202
127469|NCT01226043|307911|P4|STARTED|4-week Crossover Phase - Period 1||0
127470|NCT01226043|307912|P3|STARTED|4-week Crossover Phase - Period 1||0
127471|NCT01226043|307913|P2|STARTED|4-week Crossover Phase - Period 1||203
127472|NCT01226043|307914|P1|STARTED|4-week Crossover Phase - Period 1||202
127473|NCT01225991|307952|P1|NOT COMPLETED|Overall Study||6
127474|NCT01225991|307952|P1|COMPLETED|Overall Study||12
127475|NCT01225991|307952|P1|STARTED|Overall Study||18
127476|NCT01225952|307963|P3|NOT COMPLETED|Overall Study||6
127477|NCT01225952|307964|P2|NOT COMPLETED|Overall Study||4
127478|NCT01225952|307965|P1|NOT COMPLETED|Overall Study||6
127479|NCT01225952|307963|P3|COMPLETED|Overall Study||25
127480|NCT01225952|307964|P2|COMPLETED|Overall Study||27
127481|NCT01225952|307965|P1|COMPLETED|Overall Study||25
127482|NCT01225952|307963|P3|STARTED|Overall Study||31
127483|NCT01225952|307964|P2|STARTED|Overall Study||31
127484|NCT01225952|307965|P1|STARTED|Overall Study||31
127485|NCT01225926|308050|P2|NOT COMPLETED|Overall Study||0
127486|NCT01225926|308051|P1|NOT COMPLETED|Overall Study||0
127487|NCT01225926|308050|P2|COMPLETED|Overall Study||12
127488|NCT01225926|308051|P1|COMPLETED|Overall Study||12
127489|NCT01225926|308050|P2|STARTED|Overall Study||12
127490|NCT01225926|308051|P1|STARTED|Overall Study||12
127491|NCT01225887|308057|P1|NOT COMPLETED|Overall Study||5
127492|NCT01225887|308057|P1|COMPLETED|Overall Study||32
127493|NCT01225887|308057|P1|STARTED|Overall Study||37
127494|NCT01225835|308067|P2|NOT COMPLETED|Overall Study||3
127495|NCT01225835|308068|P1|NOT COMPLETED|Overall Study||7
127496|NCT01225835|308067|P2|COMPLETED|Overall Study|hCG criterion met|59
127497|NCT01225835|308068|P1|COMPLETED|Overall Study|hCG criterion met|55
127498|NCT01225835|308067|P2|Per Protocol Population|Overall Study||58
127499|NCT01225835|308068|P1|Per Protocol Population|Overall Study||48
127500|NCT01225835|308067|P2|STARTED|Overall Study||62
127501|NCT01225835|308068|P1|STARTED|Overall Study||62
127502|NCT01225822|308116|P5|NOT COMPLETED|Overall Study||31
127503|NCT01225822|308117|P4|NOT COMPLETED|Overall Study||52
127504|NCT01225822|308118|P3|NOT COMPLETED|Overall Study||38
127505|NCT01225822|308119|P2|NOT COMPLETED|Overall Study||56
127506|NCT01225822|308120|P1|NOT COMPLETED|Overall Study||38
127507|NCT01225822|308116|P5|COMPLETED|Overall Study||361
127508|NCT01225822|308117|P4|COMPLETED|Overall Study||333
127509|NCT01225822|308118|P3|COMPLETED|Overall Study||355
127510|NCT01225822|308119|P2|COMPLETED|Overall Study||334
127511|NCT01225822|308120|P1|COMPLETED|Overall Study||351
127512|NCT01225822|308116|P5|STARTED|Overall Study||392
127513|NCT01225822|308117|P4|STARTED|Overall Study||385
127514|NCT01225822|308118|P3|STARTED|Overall Study||393
127515|NCT01225822|308119|P2|STARTED|Overall Study||390
127516|NCT01225822|308120|P1|STARTED|Overall Study||389
127517|NCT01225731|308187|P13|NOT COMPLETED|Part 3||7
127518|NCT01225731|308188|P12|NOT COMPLETED|Part 3||10
127519|NCT01225731|308189|P11|NOT COMPLETED|Part 3||6
127520|NCT01225731|308190|P10|NOT COMPLETED|Part 3||0
127521|NCT01225731|308191|P9|NOT COMPLETED|Part 3||0
127522|NCT01225731|308192|P8|NOT COMPLETED|Part 3||0
127523|NCT01225731|308193|P7|NOT COMPLETED|Part 3||0
127524|NCT01225731|308194|P6|NOT COMPLETED|Part 3||0
127525|NCT01225731|308195|P5|NOT COMPLETED|Part 3||0
127526|NCT01225731|308196|P4|NOT COMPLETED|Part 3||0
127527|NCT01225731|308197|P3|NOT COMPLETED|Part 3||0
127528|NCT01225731|308198|P2|NOT COMPLETED|Part 3||0
127529|NCT01225731|308199|P1|NOT COMPLETED|Part 3||0
127530|NCT01225731|308187|P13|COMPLETED|Part 3||60
127531|NCT01225731|308188|P12|COMPLETED|Part 3||116
127532|NCT01225731|308189|P11|COMPLETED|Part 3||80
127533|NCT01225731|308190|P10|COMPLETED|Part 3||10
127534|NCT01225731|308191|P9|COMPLETED|Part 3||0
127535|NCT01225731|308192|P8|COMPLETED|Part 3||0
127536|NCT01225731|308193|P7|COMPLETED|Part 3||0
127537|NCT01225731|308194|P6|COMPLETED|Part 3||0
127538|NCT01225731|308195|P5|COMPLETED|Part 3||0
127539|NCT01225731|308196|P4|COMPLETED|Part 3||0
127540|NCT01225731|308197|P3|COMPLETED|Part 3||0
127541|NCT01225731|308198|P2|COMPLETED|Part 3||0
127542|NCT01225731|308199|P1|COMPLETED|Part 3||0
127543|NCT01225731|308187|P13|STARTED|Part 3|Not all participants entered follow-up|67
127544|NCT01225731|308188|P12|STARTED|Part 3|Not all participants entered follow-up|126
127545|NCT01225731|308189|P11|STARTED|Part 3|Not all participants entered follow-up|86
127546|NCT01225731|308190|P10|STARTED|Part 3|Not all participants entered follow-up|10
127547|NCT01225731|308191|P9|STARTED|Part 3|Participants could enter the follow-up period|0
127548|NCT01225731|308192|P8|STARTED|Part 3|Participants could enter the follow-up period|0
127549|NCT01225731|308193|P7|STARTED|Part 3|Participants could enter the follow-up period|0
127550|NCT01225731|308194|P6|STARTED|Part 3|Participants could enter the follow-up period|0
127551|NCT01225731|308195|P5|STARTED|Part 3||0
127552|NCT01225731|308196|P4|STARTED|Part 3||0
127553|NCT01225731|308197|P3|STARTED|Part 3||0
127554|NCT01225731|308198|P2|STARTED|Part 3||0
127555|NCT01225731|308199|P1|STARTED|Part 3||0
127556|NCT01225731|308187|P13|NOT COMPLETED|Part 2||0
127557|NCT01225731|308188|P12|NOT COMPLETED|Part 2||0
127558|NCT01225731|308189|P11|NOT COMPLETED|Part 2||0
127559|NCT01225731|308190|P10|NOT COMPLETED|Part 2||0
127560|NCT01225731|308191|P9|NOT COMPLETED|Part 2||11
127561|NCT01225731|308192|P8|NOT COMPLETED|Part 2||25
127562|NCT01225731|308193|P7|NOT COMPLETED|Part 2||8
127563|NCT01225731|308194|P6|NOT COMPLETED|Part 2||3
127564|NCT01225731|308195|P5|NOT COMPLETED|Part 2||0
127565|NCT01225731|308196|P4|NOT COMPLETED|Part 2||0
127566|NCT01225731|308197|P3|NOT COMPLETED|Part 2||0
127567|NCT01225731|308198|P2|NOT COMPLETED|Part 2||0
127568|NCT01225731|308199|P1|NOT COMPLETED|Part 2||0
127569|NCT01225731|308187|P13|COMPLETED|Part 2||0
127570|NCT01225731|308188|P12|COMPLETED|Part 2||0
127571|NCT01225731|308189|P11|COMPLETED|Part 2||0
127572|NCT01225731|308190|P10|COMPLETED|Part 2||0
127573|NCT01225731|308191|P9|COMPLETED|Part 2||68
127574|NCT01225731|308192|P8|COMPLETED|Part 2||128
127575|NCT01225731|308193|P7|COMPLETED|Part 2||86
127576|NCT01225731|308194|P6|COMPLETED|Part 2||10
127577|NCT01225731|308195|P5|COMPLETED|Part 2||0
127578|NCT01225731|308196|P4|COMPLETED|Part 2||0
127579|NCT01225731|308197|P3|COMPLETED|Part 2||0
127580|NCT01225731|308198|P2|COMPLETED|Part 2||0
127581|NCT01225731|308199|P1|COMPLETED|Part 2||0
127582|NCT01225731|308187|P13|STARTED|Part 2||0
127583|NCT01225731|308188|P12|STARTED|Part 2||0
127584|NCT01225731|308189|P11|STARTED|Part 2||0
127585|NCT01225731|308190|P10|STARTED|Part 2||0
127586|NCT01225731|308191|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
127587|NCT01225731|308192|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
127588|NCT01225731|308193|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
127589|NCT01225731|308194|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
127590|NCT01225731|308195|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
127591|NCT01225731|308196|P4|STARTED|Part 2|Participants could progress into Part 2|0
127592|NCT01225731|308197|P3|STARTED|Part 2|Participants could progress into Part 2|0
127593|NCT01225731|308198|P2|STARTED|Part 2|Participants could progress into Part 2|0
127594|NCT01225731|308199|P1|STARTED|Part 2|Participants could progress into Part 2|0
127595|NCT01225731|308187|P13|NOT COMPLETED|Part 1||0
127596|NCT01225731|308188|P12|NOT COMPLETED|Part 1||0
127597|NCT01225731|308189|P11|NOT COMPLETED|Part 1||0
127598|NCT01225731|308190|P10|NOT COMPLETED|Part 1||0
127599|NCT01225731|308191|P9|NOT COMPLETED|Part 1||0
127600|NCT01225731|308192|P8|NOT COMPLETED|Part 1||0
127601|NCT01225731|308193|P7|NOT COMPLETED|Part 1||0
127602|NCT01225731|308194|P6|NOT COMPLETED|Part 1||0
127603|NCT01225731|308195|P5|NOT COMPLETED|Part 1||6
127604|NCT01225731|308196|P4|NOT COMPLETED|Part 1||2
127605|NCT01225731|308197|P3|NOT COMPLETED|Part 1||1
127606|NCT01225731|308198|P2|NOT COMPLETED|Part 1||5
127607|NCT01225731|308199|P1|NOT COMPLETED|Part 1||2
127608|NCT01225731|308187|P13|COMPLETED|Part 1||0
127609|NCT01225731|308188|P12|COMPLETED|Part 1||0
127610|NCT01225731|308189|P11|COMPLETED|Part 1||0
127611|NCT01225731|308190|P10|COMPLETED|Part 1||0
127612|NCT01225731|308191|P9|COMPLETED|Part 1||0
127613|NCT01225731|308192|P8|COMPLETED|Part 1||0
127614|NCT01225731|308193|P7|COMPLETED|Part 1||0
127615|NCT01225731|308194|P6|COMPLETED|Part 1||0
127616|NCT01225731|308195|P5|COMPLETED|Part 1||40
127617|NCT01225731|308196|P4|COMPLETED|Part 1||84
127618|NCT01225731|308197|P3|COMPLETED|Part 1||88
127619|NCT01225731|308198|P2|COMPLETED|Part 1||87
127620|NCT01225731|308199|P1|COMPLETED|Part 1||40
127621|NCT01225731|308187|P13|STARTED|Part 1||0
127622|NCT01225731|308188|P12|STARTED|Part 1||0
127623|NCT01225731|308189|P11|STARTED|Part 1||0
127624|NCT01225731|308190|P10|STARTED|Part 1||0
127625|NCT01225731|308191|P9|STARTED|Part 1||0
127626|NCT01225731|308192|P8|STARTED|Part 1||0
127627|NCT01225731|308193|P7|STARTED|Part 1||0
127628|NCT01225731|308194|P6|STARTED|Part 1||0
127629|NCT01225731|308195|P5|STARTED|Part 1||46
127630|NCT01225731|308196|P4|STARTED|Part 1||86
127631|NCT01225731|308197|P3|STARTED|Part 1||89
127632|NCT01225731|308198|P2|STARTED|Part 1||92
127633|NCT01225731|308199|P1|STARTED|Part 1||42
127634|NCT01225562|308294|P3|NOT COMPLETED|Overall Study||53
127635|NCT01225562|308295|P2|NOT COMPLETED|Overall Study||56
127636|NCT01225562|308296|P1|NOT COMPLETED|Overall Study||55
127637|NCT01225562|308294|P3|COMPLETED|Overall Study||7014
127638|NCT01225562|308295|P2|COMPLETED|Overall Study||6989
127639|NCT01225562|308296|P1|COMPLETED|Overall Study||6995
127640|NCT01225562|308294|P3|STARTED|Overall Study||7067
127641|NCT01225562|308295|P2|STARTED|Overall Study||7045
127642|NCT01225562|308296|P1|STARTED|Overall Study||7050
127643|NCT01225549|308313|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127644|NCT01225549|308314|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127645|NCT01225549|308315|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127646|NCT01225549|308316|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127647|NCT01225549|308317|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127648|NCT01225549|308318|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127649|NCT01225549|308319|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127650|NCT01225549|308320|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127651|NCT01225549|308321|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127652|NCT01225549|308322|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
127653|NCT01225549|308313|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
127654|NCT01225549|308314|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
127655|NCT01225549|308315|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
127656|NCT01225549|308316|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
127657|NCT01225549|308317|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
127658|NCT01225549|308318|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
127659|NCT01225549|308319|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
127660|NCT01225549|308320|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
127661|NCT01225549|308321|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
127662|NCT01225549|308322|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
127663|NCT01225549|308313|P10|STARTED|Period 7 - Fourth Treatment Period||1
127664|NCT01225549|308314|P9|STARTED|Period 7 - Fourth Treatment Period||4
127665|NCT01225549|308315|P8|STARTED|Period 7 - Fourth Treatment Period||1
127666|NCT01225549|308316|P7|STARTED|Period 7 - Fourth Treatment Period||3
127667|NCT01225549|308317|P6|STARTED|Period 7 - Fourth Treatment Period||1
127668|NCT01225549|308318|P5|STARTED|Period 7 - Fourth Treatment Period||1
127669|NCT01225549|308319|P4|STARTED|Period 7 - Fourth Treatment Period||0
127670|NCT01225549|308320|P3|STARTED|Period 7 - Fourth Treatment Period||3
127671|NCT01225549|308321|P2|STARTED|Period 7 - Fourth Treatment Period||3
127672|NCT01225549|308322|P1|STARTED|Period 7 - Fourth Treatment Period||1
127673|NCT01225549|308313|P10|NOT COMPLETED|Period 6 - Washout||0
127674|NCT01225549|308314|P9|NOT COMPLETED|Period 6 - Washout||0
127675|NCT01225549|308315|P8|NOT COMPLETED|Period 6 - Washout||0
127676|NCT01225549|308316|P7|NOT COMPLETED|Period 6 - Washout||0
127677|NCT01225549|308317|P6|NOT COMPLETED|Period 6 - Washout||0
127678|NCT01225549|308318|P5|NOT COMPLETED|Period 6 - Washout||0
127679|NCT01225549|308319|P4|NOT COMPLETED|Period 6 - Washout||1
127680|NCT01225549|308320|P3|NOT COMPLETED|Period 6 - Washout||0
127681|NCT01225549|308321|P2|NOT COMPLETED|Period 6 - Washout||0
127682|NCT01225549|308322|P1|NOT COMPLETED|Period 6 - Washout||0
127683|NCT01225549|308313|P10|COMPLETED|Period 6 - Washout||1
127684|NCT01225549|308314|P9|COMPLETED|Period 6 - Washout||4
127685|NCT01225549|308315|P8|COMPLETED|Period 6 - Washout||1
127686|NCT01225549|308316|P7|COMPLETED|Period 6 - Washout||3
127687|NCT01225549|308317|P6|COMPLETED|Period 6 - Washout||1
127688|NCT01225549|308318|P5|COMPLETED|Period 6 - Washout||1
127689|NCT01225549|308319|P4|COMPLETED|Period 6 - Washout||0
127690|NCT01225549|308320|P3|COMPLETED|Period 6 - Washout||3
127691|NCT01225549|308321|P2|COMPLETED|Period 6 - Washout||3
127692|NCT01225549|308322|P1|COMPLETED|Period 6 - Washout||1
127693|NCT01225549|308313|P10|STARTED|Period 6 - Washout||1
127694|NCT01225549|308314|P9|STARTED|Period 6 - Washout||4
127695|NCT01225549|308315|P8|STARTED|Period 6 - Washout||1
127696|NCT01225549|308316|P7|STARTED|Period 6 - Washout||3
127697|NCT01225549|308317|P6|STARTED|Period 6 - Washout||1
127698|NCT01225549|308318|P5|STARTED|Period 6 - Washout||1
127699|NCT01225549|308319|P4|STARTED|Period 6 - Washout||1
127700|NCT01225549|308320|P3|STARTED|Period 6 - Washout||3
127701|NCT01225549|308321|P2|STARTED|Period 6 - Washout||3
127702|NCT01225549|308322|P1|STARTED|Period 6 - Washout||1
127703|NCT01225549|308313|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
127704|NCT01225549|308314|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
127705|NCT01225549|308315|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
127706|NCT01225549|308316|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
127707|NCT01225549|308317|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
127708|NCT01225549|308318|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
127709|NCT01225549|308319|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
127710|NCT01225549|308320|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
127711|NCT01225549|308321|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
127712|NCT01225549|308322|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
127713|NCT01225549|308313|P10|COMPLETED|Period 5 - Third Treatment Period||1
127714|NCT01225549|308314|P9|COMPLETED|Period 5 - Third Treatment Period||4
127715|NCT01225549|308315|P8|COMPLETED|Period 5 - Third Treatment Period||1
127716|NCT01225549|308316|P7|COMPLETED|Period 5 - Third Treatment Period||3
127717|NCT01225549|308317|P6|COMPLETED|Period 5 - Third Treatment Period||1
127718|NCT01225549|308318|P5|COMPLETED|Period 5 - Third Treatment Period||1
127719|NCT01225549|308319|P4|COMPLETED|Period 5 - Third Treatment Period||1
127720|NCT01225549|308320|P3|COMPLETED|Period 5 - Third Treatment Period||3
127721|NCT01225549|308321|P2|COMPLETED|Period 5 - Third Treatment Period||3
127722|NCT01225549|308322|P1|COMPLETED|Period 5 - Third Treatment Period||1
127723|NCT01225549|308313|P10|STARTED|Period 5 - Third Treatment Period||1
127724|NCT01225549|308314|P9|STARTED|Period 5 - Third Treatment Period||4
127725|NCT01225549|308315|P8|STARTED|Period 5 - Third Treatment Period||1
127726|NCT01225549|308316|P7|STARTED|Period 5 - Third Treatment Period||3
127727|NCT01225549|308317|P6|STARTED|Period 5 - Third Treatment Period||1
127728|NCT01225549|308318|P5|STARTED|Period 5 - Third Treatment Period||1
127729|NCT01225549|308319|P4|STARTED|Period 5 - Third Treatment Period||1
127730|NCT01225549|308320|P3|STARTED|Period 5 - Third Treatment Period||3
127731|NCT01225549|308321|P2|STARTED|Period 5 - Third Treatment Period||3
127732|NCT01225549|308322|P1|STARTED|Period 5 - Third Treatment Period||1
127733|NCT01225549|308313|P10|NOT COMPLETED|Period 4 - Washout||0
127734|NCT01225549|308314|P9|NOT COMPLETED|Period 4 - Washout||0
127735|NCT01225549|308315|P8|NOT COMPLETED|Period 4 - Washout||0
127736|NCT01225549|308316|P7|NOT COMPLETED|Period 4 - Washout||0
127737|NCT01225549|308317|P6|NOT COMPLETED|Period 4 - Washout||0
127738|NCT01225549|308318|P5|NOT COMPLETED|Period 4 - Washout||0
127739|NCT01225549|308319|P4|NOT COMPLETED|Period 4 - Washout||0
127740|NCT01225549|308320|P3|NOT COMPLETED|Period 4 - Washout||0
127741|NCT01225549|308321|P2|NOT COMPLETED|Period 4 - Washout||1
127742|NCT01225549|308322|P1|NOT COMPLETED|Period 4 - Washout||0
127743|NCT01225549|308313|P10|COMPLETED|Period 4 - Washout||1
127744|NCT01225549|308314|P9|COMPLETED|Period 4 - Washout||4
127745|NCT01225549|308315|P8|COMPLETED|Period 4 - Washout||1
127746|NCT01225549|308316|P7|COMPLETED|Period 4 - Washout||3
127747|NCT01225549|308317|P6|COMPLETED|Period 4 - Washout||1
127748|NCT01225549|308318|P5|COMPLETED|Period 4 - Washout||1
127749|NCT01225549|308319|P4|COMPLETED|Period 4 - Washout||1
127750|NCT01225549|308320|P3|COMPLETED|Period 4 - Washout||3
127751|NCT01225549|308321|P2|COMPLETED|Period 4 - Washout||3
127752|NCT01225549|308322|P1|COMPLETED|Period 4 - Washout||1
127753|NCT01225549|308313|P10|STARTED|Period 4 - Washout||1
127754|NCT01225549|308314|P9|STARTED|Period 4 - Washout||4
127755|NCT01225549|308315|P8|STARTED|Period 4 - Washout||1
127756|NCT01225549|308316|P7|STARTED|Period 4 - Washout||3
127757|NCT01225549|308317|P6|STARTED|Period 4 - Washout||1
127758|NCT01225549|308318|P5|STARTED|Period 4 - Washout||1
127759|NCT01225549|308319|P4|STARTED|Period 4 - Washout||1
127760|NCT01225549|308320|P3|STARTED|Period 4 - Washout||3
127761|NCT01225549|308321|P2|STARTED|Period 4 - Washout||4
127762|NCT01225549|308322|P1|STARTED|Period 4 - Washout||1
127763|NCT01225549|308313|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
127764|NCT01225549|308314|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
127765|NCT01225549|308315|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
127766|NCT01225549|308316|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
127767|NCT01225549|308317|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
127768|NCT01225549|308318|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
127769|NCT01225549|308319|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
127770|NCT01225549|308320|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
127771|NCT01225549|308321|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
127772|NCT01225549|308322|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
127773|NCT01225549|308313|P10|COMPLETED|Period 3 - Second Treatment Period||1
127774|NCT01225549|308314|P9|COMPLETED|Period 3 - Second Treatment Period||4
127775|NCT01225549|308315|P8|COMPLETED|Period 3 - Second Treatment Period||1
127776|NCT01225549|308316|P7|COMPLETED|Period 3 - Second Treatment Period||3
127777|NCT01225549|308317|P6|COMPLETED|Period 3 - Second Treatment Period||1
127778|NCT01225549|308318|P5|COMPLETED|Period 3 - Second Treatment Period||1
127779|NCT01225549|308319|P4|COMPLETED|Period 3 - Second Treatment Period||1
127780|NCT01225549|308320|P3|COMPLETED|Period 3 - Second Treatment Period||3
127781|NCT01225549|308321|P2|COMPLETED|Period 3 - Second Treatment Period||4
127782|NCT01225549|308322|P1|COMPLETED|Period 3 - Second Treatment Period||1
127783|NCT01225549|308313|P10|STARTED|Period 3 - Second Treatment Period||1
127784|NCT01225549|308314|P9|STARTED|Period 3 - Second Treatment Period||4
127785|NCT01225549|308315|P8|STARTED|Period 3 - Second Treatment Period||1
127786|NCT01225549|308316|P7|STARTED|Period 3 - Second Treatment Period||3
127787|NCT01225549|308317|P6|STARTED|Period 3 - Second Treatment Period||1
127788|NCT01225549|308318|P5|STARTED|Period 3 - Second Treatment Period||1
127789|NCT01225549|308319|P4|STARTED|Period 3 - Second Treatment Period||1
127790|NCT01225549|308320|P3|STARTED|Period 3 - Second Treatment Period||3
127791|NCT01225549|308321|P2|STARTED|Period 3 - Second Treatment Period||4
127792|NCT01225549|308322|P1|STARTED|Period 3 - Second Treatment Period||1
127793|NCT01225549|308313|P10|NOT COMPLETED|Period 2 - Washout||0
127794|NCT01225549|308314|P9|NOT COMPLETED|Period 2 - Washout||0
127795|NCT01225549|308315|P8|NOT COMPLETED|Period 2 - Washout||0
127796|NCT01225549|308316|P7|NOT COMPLETED|Period 2 - Washout||0
127797|NCT01225549|308317|P6|NOT COMPLETED|Period 2 - Washout||0
127798|NCT01225549|308318|P5|NOT COMPLETED|Period 2 - Washout||0
127799|NCT01225549|308319|P4|NOT COMPLETED|Period 2 - Washout||0
127800|NCT01225549|308320|P3|NOT COMPLETED|Period 2 - Washout||0
127801|NCT01225549|308321|P2|NOT COMPLETED|Period 2 - Washout||0
127802|NCT01225549|308322|P1|NOT COMPLETED|Period 2 - Washout||0
127803|NCT01225549|308313|P10|COMPLETED|Period 2 - Washout||1
127804|NCT01225549|308314|P9|COMPLETED|Period 2 - Washout||4
127805|NCT01225549|308315|P8|COMPLETED|Period 2 - Washout||1
127806|NCT01225549|308316|P7|COMPLETED|Period 2 - Washout||3
127807|NCT01225549|308317|P6|COMPLETED|Period 2 - Washout||1
127808|NCT01225549|308318|P5|COMPLETED|Period 2 - Washout||1
127809|NCT01225549|308319|P4|COMPLETED|Period 2 - Washout||1
127810|NCT01225549|308320|P3|COMPLETED|Period 2 - Washout||3
127811|NCT01225549|308321|P2|COMPLETED|Period 2 - Washout||4
127812|NCT01225549|308322|P1|COMPLETED|Period 2 - Washout||1
127813|NCT01225549|308313|P10|STARTED|Period 2 - Washout||1
127814|NCT01225549|308314|P9|STARTED|Period 2 - Washout||4
127815|NCT01225549|308315|P8|STARTED|Period 2 - Washout||1
127816|NCT01225549|308316|P7|STARTED|Period 2 - Washout||3
127817|NCT01225549|308317|P6|STARTED|Period 2 - Washout||1
127818|NCT01225549|308318|P5|STARTED|Period 2 - Washout||1
127819|NCT01225549|308319|P4|STARTED|Period 2 - Washout||1
127820|NCT01225549|308320|P3|STARTED|Period 2 - Washout||3
127821|NCT01225549|308321|P2|STARTED|Period 2 - Washout||4
127822|NCT01225549|308322|P1|STARTED|Period 2 - Washout||1
127823|NCT01225549|308313|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
127824|NCT01225549|308314|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
127825|NCT01225549|308315|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
127826|NCT01225549|308316|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
127827|NCT01225549|308317|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
127828|NCT01225549|308318|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
127829|NCT01225549|308319|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
127830|NCT01225549|308320|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
127831|NCT01225549|308321|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
127832|NCT01225549|308322|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
127833|NCT01225549|308313|P10|COMPLETED|Period 1 - First Treatment Period||1
127834|NCT01225549|308314|P9|COMPLETED|Period 1 - First Treatment Period||4
127835|NCT01225549|308315|P8|COMPLETED|Period 1 - First Treatment Period||1
127836|NCT01225549|308316|P7|COMPLETED|Period 1 - First Treatment Period||3
127837|NCT01225549|308317|P6|COMPLETED|Period 1 - First Treatment Period||1
127838|NCT01225549|308318|P5|COMPLETED|Period 1 - First Treatment Period||1
127839|NCT01225549|308319|P4|COMPLETED|Period 1 - First Treatment Period||1
127840|NCT01225549|308320|P3|COMPLETED|Period 1 - First Treatment Period||3
127841|NCT01225549|308321|P2|COMPLETED|Period 1 - First Treatment Period||4
127842|NCT01225549|308322|P1|COMPLETED|Period 1 - First Treatment Period||1
127843|NCT01225549|308313|P10|STARTED|Period 1 - First Treatment Period||1
127844|NCT01225549|308314|P9|STARTED|Period 1 - First Treatment Period||4
127845|NCT01225549|308315|P8|STARTED|Period 1 - First Treatment Period||1
127846|NCT01225549|308316|P7|STARTED|Period 1 - First Treatment Period||3
127847|NCT01225549|308317|P6|STARTED|Period 1 - First Treatment Period||1
127848|NCT01225549|308318|P5|STARTED|Period 1 - First Treatment Period||1
127849|NCT01225549|308319|P4|STARTED|Period 1 - First Treatment Period||1
127850|NCT01225549|308320|P3|STARTED|Period 1 - First Treatment Period||3
127851|NCT01225549|308321|P2|STARTED|Period 1 - First Treatment Period||4
127852|NCT01225549|308322|P1|STARTED|Period 1 - First Treatment Period||1
127853|NCT01225354|308364|P1|NOT COMPLETED|Overall Study||1
127854|NCT01225354|308364|P1|COMPLETED|Overall Study||19
127855|NCT01225354|308364|P1|STARTED|Overall Study||20
127856|NCT01225289|308371|P2|NOT COMPLETED|Overall Study||1
127857|NCT01225289|308372|P1|NOT COMPLETED|Overall Study||0
127858|NCT01225289|308371|P2|COMPLETED|Overall Study||17
127859|NCT01225289|308372|P1|COMPLETED|Overall Study||18
127860|NCT01225289|308371|P2|STARTED|Overall Study||18
127861|NCT01225289|308372|P1|STARTED|Overall Study||18
127862|NCT01225263|308386|P2|NOT COMPLETED|Weeks 13 to 24||1
127863|NCT01225263|308387|P1|NOT COMPLETED|Weeks 13 to 24||4
127864|NCT01225263|308386|P2|COMPLETED|Weeks 13 to 24||28
127865|NCT01225263|308387|P1|COMPLETED|Weeks 13 to 24||24
127866|NCT01225263|308386|P2|STARTED|Weeks 13 to 24||29
127867|NCT01225263|308387|P1|STARTED|Weeks 13 to 24||28
127868|NCT01225263|308386|P2|NOT COMPLETED|Weeks 1 to 12||0
127869|NCT01225263|308387|P1|NOT COMPLETED|Weeks 1 to 12||0
127870|NCT01225263|308386|P2|COMPLETED|Weeks 1 to 12||29
127871|NCT01225263|308387|P1|COMPLETED|Weeks 1 to 12||28
127872|NCT01225263|308386|P2|STARTED|Weeks 1 to 12||29
127873|NCT01225263|308387|P1|STARTED|Weeks 1 to 12||28
127874|NCT01225211|308405|P10|NOT COMPLETED|Overall Study||5
127875|NCT01225211|308406|P9|NOT COMPLETED|Overall Study||1
127876|NCT01225211|308407|P8|NOT COMPLETED|Overall Study||0
127877|NCT01225211|308408|P7|NOT COMPLETED|Overall Study||1
127878|NCT01225211|308409|P6|NOT COMPLETED|Overall Study||0
127879|NCT01225211|308410|P5|NOT COMPLETED|Overall Study||0
127880|NCT01225211|308411|P4|NOT COMPLETED|Overall Study||0
127881|NCT01225211|308412|P3|NOT COMPLETED|Overall Study||1
127882|NCT01225211|308413|P2|NOT COMPLETED|Overall Study||0
127883|NCT01225211|308414|P1|NOT COMPLETED|Overall Study||0
127884|NCT01225211|308405|P10|COMPLETED|Overall Study||57
127885|NCT01225211|308406|P9|COMPLETED|Overall Study||62
127886|NCT01225211|308407|P8|COMPLETED|Overall Study||11
127887|NCT01225211|308408|P7|COMPLETED|Overall Study||41
127888|NCT01225211|308409|P6|COMPLETED|Overall Study||21
127889|NCT01225211|308410|P5|COMPLETED|Overall Study||23
127890|NCT01225211|308411|P4|COMPLETED|Overall Study||27
127891|NCT01225211|308412|P3|COMPLETED|Overall Study||20
127892|NCT01225211|308413|P2|COMPLETED|Overall Study||20
127893|NCT01225211|308414|P1|COMPLETED|Overall Study||21
127894|NCT01225211|308405|P10|STARTED|Overall Study||62
127895|NCT01225211|308406|P9|STARTED|Overall Study||63
127896|NCT01225211|308407|P8|STARTED|Overall Study||11
127897|NCT01225211|308408|P7|STARTED|Overall Study||42
127898|NCT01225211|308409|P6|STARTED|Overall Study||21
127899|NCT01225211|308410|P5|STARTED|Overall Study||23
127900|NCT01225211|308411|P4|STARTED|Overall Study||27
127901|NCT01225211|308412|P3|STARTED|Overall Study||21
127902|NCT01225211|308413|P2|STARTED|Overall Study||20
127903|NCT01225211|308414|P1|STARTED|Overall Study||21
127904|NCT01225159|308517|P2|NOT COMPLETED|Overall Study||0
127905|NCT01225159|308518|P1|NOT COMPLETED|Overall Study||1
127906|NCT01225159|308517|P2|COMPLETED|Overall Study||100
127907|NCT01225159|308518|P1|COMPLETED|Overall Study||99
127908|NCT01225159|308517|P2|STARTED|Overall Study||100
127909|NCT01225159|308518|P1|STARTED|Overall Study||100
127910|NCT01225146|308528|P2|NOT COMPLETED|Overall Study||2
127911|NCT01225146|308529|P1|NOT COMPLETED|Overall Study||0
127912|NCT01225146|308528|P2|COMPLETED|Overall Study||0
127913|NCT01225146|308529|P1|COMPLETED|Overall Study||6
127914|NCT01225146|308528|P2|STARTED|Overall Study||2
127915|NCT01225146|308529|P1|STARTED|Overall Study||6
127916|NCT01225068|308547|P2|NOT COMPLETED|Overall Study||1
127917|NCT01225068|308548|P1|NOT COMPLETED|Overall Study||4
127918|NCT01225068|308547|P2|COMPLETED|Overall Study||19
127919|NCT01225068|308548|P1|COMPLETED|Overall Study||16
127920|NCT01225068|308547|P2|STARTED|Overall Study||20
127921|NCT01225068|308548|P1|STARTED|Overall Study||20
127922|NCT01225055|308557|P3|NOT COMPLETED|Overall Study||3
127923|NCT01225055|308558|P2|NOT COMPLETED|Overall Study||2
127924|NCT01225055|308559|P1|NOT COMPLETED|Overall Study||0
127925|NCT01225055|308557|P3|COMPLETED|Overall Study||18
127926|NCT01225055|308558|P2|COMPLETED|Overall Study||18
127927|NCT01225055|308559|P1|COMPLETED|Overall Study||20
127928|NCT01225055|308557|P3|STARTED|Overall Study||21
127929|NCT01225055|308558|P2|STARTED|Overall Study||20
127930|NCT01225055|308559|P1|STARTED|Overall Study||20
127931|NCT01225029|308584|P2|NOT COMPLETED|Overall Study||0
127932|NCT01225029|308585|P1|NOT COMPLETED|Overall Study||0
127933|NCT01225029|308584|P2|COMPLETED|Overall Study||32
127934|NCT01225029|308585|P1|COMPLETED|Overall Study||32
127935|NCT01225029|308584|P2|STARTED|Overall Study||32
127936|NCT01225029|308585|P1|STARTED|Overall Study||32
127937|NCT01224821|308595|P1|NOT COMPLETED|Long-Term Follow-Up||11
127938|NCT01224821|308595|P1|COMPLETED|Long-Term Follow-Up||0
127939|NCT01224821|308595|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
127940|NCT01224821|308595|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
127941|NCT01224821|308595|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
127942|NCT01224821|308595|P1|STARTED|Dosimetric and Therapeutic Treatment||47
127943|NCT01224782|308614|P1|NOT COMPLETED|Overall Study||264
127944|NCT01224782|308614|P1|COMPLETED|Overall Study||730
127945|NCT01224782|308614|P1|STARTED|Overall Study||994
127946|NCT01224639|308631|P8|NOT COMPLETED|Overall Study||2
127947|NCT01224639|308632|P7|NOT COMPLETED|Overall Study||1
127948|NCT01224639|308633|P6|NOT COMPLETED|Overall Study||0
127949|NCT01224639|308634|P5|NOT COMPLETED|Overall Study||2
127950|NCT01224639|308635|P4|NOT COMPLETED|Overall Study||0
127951|NCT01224639|308636|P3|NOT COMPLETED|Overall Study||0
127952|NCT01224639|308637|P2|NOT COMPLETED|Overall Study||0
127953|NCT01224639|308638|P1|NOT COMPLETED|Overall Study||0
127954|NCT01224639|308631|P8|COMPLETED|Overall Study||3
127955|NCT01224639|308632|P7|COMPLETED|Overall Study||17
127956|NCT01224639|308633|P6|COMPLETED|Overall Study||4
127957|NCT01224639|308634|P5|COMPLETED|Overall Study||19
127958|NCT01224639|308635|P4|COMPLETED|Overall Study||3
127959|NCT01224639|308636|P3|COMPLETED|Overall Study||21
127960|NCT01224639|308637|P2|COMPLETED|Overall Study||5
127961|NCT01224639|308638|P1|COMPLETED|Overall Study||19
127962|NCT01224639|308631|P8|STARTED|Overall Study||5
127963|NCT01224639|308632|P7|STARTED|Overall Study||18
127964|NCT01224639|308633|P6|STARTED|Overall Study||4
127965|NCT01224639|308634|P5|STARTED|Overall Study||21
127966|NCT01224639|308635|P4|STARTED|Overall Study||3
127967|NCT01224639|308636|P3|STARTED|Overall Study||21
127968|NCT01224639|308637|P2|STARTED|Overall Study||5
127969|NCT01224639|308638|P1|STARTED|Overall Study||19
127970|NCT01224626|308744|P1|NOT COMPLETED|Overall Study||1
127971|NCT01224626|308744|P1|COMPLETED|Overall Study||41
127972|NCT01224626|308744|P1|STARTED|Overall Study||42
127973|NCT01224444|308750|P1|NOT COMPLETED|Overall Study||0
127974|NCT01224444|308750|P1|COMPLETED|Overall Study||269
127975|NCT01224444|308750|P1|STARTED|Overall Study||269
127976|NCT01224431|308756|P2|NOT COMPLETED|Overall Study||5
127977|NCT01224431|308757|P1|NOT COMPLETED|Overall Study||0
127978|NCT01224431|308756|P2|COMPLETED|Overall Study||25
127979|NCT01224431|308757|P1|COMPLETED|Overall Study||30
127980|NCT01224431|308756|P2|STARTED|Overall Study||30
127981|NCT01224431|308757|P1|STARTED|Overall Study||30
127982|NCT01224236|308765|P2|NOT COMPLETED|Overall Study||1
127983|NCT01224236|308766|P1|NOT COMPLETED|Overall Study||1
127984|NCT01224236|308765|P2|COMPLETED|Overall Study||73
127985|NCT01224236|308766|P1|COMPLETED|Overall Study||75
127986|NCT01224236|308765|P2|STARTED|Overall Study||74
127987|NCT01224236|308766|P1|STARTED|Overall Study||76
127988|NCT01224171|308776|P2|NOT COMPLETED|Overall Study||13
127989|NCT01224171|308777|P1|NOT COMPLETED|Overall Study||15
127990|NCT01224171|308776|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
127991|NCT01224171|308777|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
127992|NCT01224171|308776|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
127993|NCT01224171|308777|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
127994|NCT01224171|308776|P2|STARTED|Overall Study||209
127995|NCT01224171|308777|P1|STARTED|Overall Study||207
127996|NCT01224015|308800|P3|NOT COMPLETED|Overall Study||13
127997|NCT01224015|308801|P2|NOT COMPLETED|Overall Study||16
127998|NCT01224015|308802|P1|NOT COMPLETED|Overall Study||14
127999|NCT01224015|308800|P3|COMPLETED|Overall Study||83
128000|NCT01224015|308801|P2|COMPLETED|Overall Study||211
128001|NCT01224015|308802|P1|COMPLETED|Overall Study||347
128002|NCT01224015|308800|P3|STARTED|Overall Study||96
128003|NCT01224015|308801|P2|STARTED|Overall Study||227
128004|NCT01224015|308802|P1|STARTED|Overall Study||361
128005|NCT01223963|308810|P1|NOT COMPLETED|Overall Study||0
128006|NCT01223963|308810|P1|COMPLETED|Overall Study||93
128007|NCT01223963|308810|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
128008|NCT01223937|308817|P2|NOT COMPLETED|Overall Study||18
128009|NCT01223937|308818|P1|NOT COMPLETED|Overall Study||17
128010|NCT01223937|308817|P2|COMPLETED|Overall Study||119
128011|NCT01223937|308818|P1|COMPLETED|Overall Study||114
128012|NCT01223937|308817|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
128013|NCT01223937|308818|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
128014|NCT01223937|308817|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
128015|NCT01223937|308818|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
128016|NCT01223937|308817|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
128017|NCT01223937|308818|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
128018|NCT01223703|308842|P2|NOT COMPLETED|Overall Study||0
128019|NCT01223703|308843|P1|NOT COMPLETED|Overall Study||0
128020|NCT01223703|308842|P2|COMPLETED|Overall Study||66
128021|NCT01223703|308843|P1|COMPLETED|Overall Study||67
128022|NCT01223703|308842|P2|STARTED|Overall Study||66
128023|NCT01223703|308843|P1|STARTED|Overall Study||67
128024|NCT01223469|308857|P2|NOT COMPLETED|Overall Study||0
128025|NCT01223469|308858|P1|NOT COMPLETED|Overall Study||0
128026|NCT01223469|308857|P2|COMPLETED|Overall Study||43
128027|NCT01223469|308858|P1|COMPLETED|Overall Study||34
128028|NCT01223469|308857|P2|STARTED|Overall Study||43
128029|NCT01223469|308858|P1|STARTED|Overall Study||34
128030|NCT01223404|308864|P6|NOT COMPLETED|Third Intervention (1 Day)||0
128031|NCT01223404|308865|P5|NOT COMPLETED|Third Intervention (1 Day)||0
128032|NCT01223404|308866|P4|NOT COMPLETED|Third Intervention (1 Day)||1
128033|NCT01223404|308867|P3|NOT COMPLETED|Third Intervention (1 Day)||0
128034|NCT01223404|308868|P2|NOT COMPLETED|Third Intervention (1 Day)||0
128035|NCT01223404|308869|P1|NOT COMPLETED|Third Intervention (1 Day)||0
128036|NCT01223404|308864|P6|COMPLETED|Third Intervention (1 Day)||3
128037|NCT01223404|308865|P5|COMPLETED|Third Intervention (1 Day)||2
128038|NCT01223404|308866|P4|COMPLETED|Third Intervention (1 Day)||3
128039|NCT01223404|308867|P3|COMPLETED|Third Intervention (1 Day)||4
128040|NCT01223404|308868|P2|COMPLETED|Third Intervention (1 Day)||3
128041|NCT01223404|308869|P1|COMPLETED|Third Intervention (1 Day)||3
128042|NCT01223404|308864|P6|STARTED|Third Intervention (1 Day)||3
128043|NCT01223404|308865|P5|STARTED|Third Intervention (1 Day)||2
128044|NCT01223404|308866|P4|STARTED|Third Intervention (1 Day)||4
128045|NCT01223404|308867|P3|STARTED|Third Intervention (1 Day)||4
128046|NCT01223404|308868|P2|STARTED|Third Intervention (1 Day)||3
128047|NCT01223404|308869|P1|STARTED|Third Intervention (1 Day)||3
128048|NCT01223404|308864|P6|NOT COMPLETED|Second Intervention (1 Day)||0
128049|NCT01223404|308865|P5|NOT COMPLETED|Second Intervention (1 Day)||0
128050|NCT01223404|308866|P4|NOT COMPLETED|Second Intervention (1 Day)||0
128051|NCT01223404|308867|P3|NOT COMPLETED|Second Intervention (1 Day)||0
128052|NCT01223404|308868|P2|NOT COMPLETED|Second Intervention (1 Day)||0
128053|NCT01223404|308869|P1|NOT COMPLETED|Second Intervention (1 Day)||1
128054|NCT01223404|308864|P6|COMPLETED|Second Intervention (1 Day)||3
128055|NCT01223404|308865|P5|COMPLETED|Second Intervention (1 Day)||2
128056|NCT01223404|308866|P4|COMPLETED|Second Intervention (1 Day)||4
128057|NCT01223404|308867|P3|COMPLETED|Second Intervention (1 Day)||4
128058|NCT01223404|308868|P2|COMPLETED|Second Intervention (1 Day)||3
128059|NCT01223404|308869|P1|COMPLETED|Second Intervention (1 Day)||3
128060|NCT01223404|308864|P6|STARTED|Second Intervention (1 Day)||3
128061|NCT01223404|308865|P5|STARTED|Second Intervention (1 Day)||2
128062|NCT01223404|308866|P4|STARTED|Second Intervention (1 Day)||4
128063|NCT01223404|308867|P3|STARTED|Second Intervention (1 Day)||4
128064|NCT01223404|308868|P2|STARTED|Second Intervention (1 Day)||3
128065|NCT01223404|308869|P1|STARTED|Second Intervention (1 Day)||4
128066|NCT01223404|308864|P6|NOT COMPLETED|First Intervention (1 Day)||0
128067|NCT01223404|308865|P5|NOT COMPLETED|First Intervention (1 Day)||0
128068|NCT01223404|308866|P4|NOT COMPLETED|First Intervention (1 Day)||1
128069|NCT01223404|308867|P3|NOT COMPLETED|First Intervention (1 Day)||0
128070|NCT01223404|308868|P2|NOT COMPLETED|First Intervention (1 Day)||0
128071|NCT01223404|308869|P1|NOT COMPLETED|First Intervention (1 Day)||0
128072|NCT01223404|308864|P6|COMPLETED|First Intervention (1 Day)||3
128073|NCT01223404|308865|P5|COMPLETED|First Intervention (1 Day)||2
128074|NCT01223404|308866|P4|COMPLETED|First Intervention (1 Day)||4
128075|NCT01223404|308867|P3|COMPLETED|First Intervention (1 Day)||4
128076|NCT01223404|308868|P2|COMPLETED|First Intervention (1 Day)||3
128077|NCT01223404|308869|P1|COMPLETED|First Intervention (1 Day)||4
128078|NCT01223404|308864|P6|STARTED|First Intervention (1 Day)||3
128079|NCT01223404|308865|P5|STARTED|First Intervention (1 Day)||2
128080|NCT01223404|308866|P4|STARTED|First Intervention (1 Day)||5
128081|NCT01223404|308867|P3|STARTED|First Intervention (1 Day)||4
128082|NCT01223404|308868|P2|STARTED|First Intervention (1 Day)||3
128083|NCT01223404|308869|P1|STARTED|First Intervention (1 Day)||4
128084|NCT01223365|308892|P1|NOT COMPLETED|Open-label Treatment Period||102
128085|NCT01223365|308892|P1|COMPLETED|Open-label Treatment Period||189
128086|NCT01223365|308892|P1|STARTED|Open-label Treatment Period||291
128087|NCT01223365|308892|P1|NOT COMPLETED|Open-label Titration Period||39
128088|NCT01223365|308892|P1|COMPLETED|Open-label Titration Period||291
128089|NCT01223365|308892|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
128090|NCT01223365|308892|P1|Safety Analysis Set|Open-label Titration Period||329
128091|NCT01223365|308892|P1|STARTED|Open-label Titration Period||330
128092|NCT01223352|308935|P2|NOT COMPLETED|Overall Study||0
128093|NCT01223352|308936|P1|NOT COMPLETED|Overall Study||0
128094|NCT01223352|308935|P2|COMPLETED|Overall Study||33
128095|NCT01223352|308936|P1|COMPLETED|Overall Study||31
128096|NCT01223352|308935|P2|STARTED|Overall Study||33
128097|NCT01223352|308936|P1|STARTED|Overall Study||31
128098|NCT01223235|308956|P1|NOT COMPLETED|Overall Study||1
128099|NCT01223235|308956|P1|COMPLETED|Overall Study||21
128100|NCT01223235|308956|P1|STARTED|Overall Study||22
128101|NCT01223196|308964|P2|NOT COMPLETED|Overall Study||0
128102|NCT01223196|308965|P1|NOT COMPLETED|Overall Study||4
128103|NCT01223196|308964|P2|COMPLETED|Overall Study||11
128104|NCT01223196|308965|P1|COMPLETED|Overall Study||9
128105|NCT01223196|308964|P2|STARTED|Overall Study||11
128106|NCT01223196|308965|P1|STARTED|Overall Study||13
128107|NCT01223183|308977|P2|NOT COMPLETED|Imaging Day 2||0
128108|NCT01223183|308978|P1|NOT COMPLETED|Imaging Day 2||0
128109|NCT01223183|308977|P2|COMPLETED|Imaging Day 2||9
128110|NCT01223183|308978|P1|COMPLETED|Imaging Day 2||8
128111|NCT01223183|308977|P2|STARTED|Imaging Day 2||9
128112|NCT01223183|308978|P1|STARTED|Imaging Day 2||8
128113|NCT01223183|308977|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
128114|NCT01223183|308978|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
128115|NCT01223183|308977|P2|COMPLETED|Washout Period (5-24 Days)||9
128116|NCT01223183|308978|P1|COMPLETED|Washout Period (5-24 Days)||8
128117|NCT01223183|308977|P2|STARTED|Washout Period (5-24 Days)||9
128118|NCT01223183|308978|P1|STARTED|Washout Period (5-24 Days)||10
128119|NCT01223183|308977|P2|NOT COMPLETED|Imaging Day 1||1
128120|NCT01223183|308978|P1|NOT COMPLETED|Imaging Day 1||0
128121|NCT01223183|308977|P2|COMPLETED|Imaging Day 1||9
128122|NCT01223183|308978|P1|COMPLETED|Imaging Day 1||10
128123|NCT01223183|308977|P2|STARTED|Imaging Day 1||10
128124|NCT01223183|308978|P1|STARTED|Imaging Day 1||10
128125|NCT01223027|308988|P2|NOT COMPLETED|Overall Study||277
128126|NCT01223027|308989|P1|NOT COMPLETED|Overall Study||274
128127|NCT01223027|308988|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
128128|NCT01223027|308989|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
128129|NCT01223027|308988|P2|STARTED|Overall Study||286
128130|NCT01223027|308989|P1|STARTED|Overall Study||284
128131|NCT01223001|309012|P2|NOT COMPLETED|Overall Study||4
128132|NCT01223001|309013|P1|NOT COMPLETED|Overall Study||4
128133|NCT01223001|309012|P2|COMPLETED|Overall Study||0
128134|NCT01223001|309013|P1|COMPLETED|Overall Study||0
128135|NCT01223001|309012|P2|STARTED|Overall Study||4
128136|NCT01223001|309013|P1|STARTED|Overall Study||4
128137|NCT01222884|309021|P2|NOT COMPLETED|Overall Study||4
128138|NCT01222884|309022|P1|NOT COMPLETED|Overall Study||24
128139|NCT01222884|309021|P2|COMPLETED|Overall Study||113
128140|NCT01222884|309022|P1|COMPLETED|Overall Study||210
128141|NCT01222884|309021|P2|STARTED|Overall Study||117
128142|NCT01222884|309022|P1|STARTED|Overall Study||234
128143|NCT01222832|309032|P2|NOT COMPLETED|Overall Study||1
128144|NCT01222832|309033|P1|NOT COMPLETED|Overall Study||0
128145|NCT01222832|309032|P2|COMPLETED|Overall Study||112
128146|NCT01222832|309033|P1|COMPLETED|Overall Study||113
128147|NCT01222832|309032|P2|STARTED|Overall Study||113
128148|NCT01222832|309033|P1|STARTED|Overall Study||113
128149|NCT01222715|309041|P2|NOT COMPLETED|Overall Study||27
128150|NCT01222715|309042|P1|NOT COMPLETED|Overall Study||36
128151|NCT01222715|309041|P2|COMPLETED|Overall Study||16
128152|NCT01222715|309042|P1|COMPLETED|Overall Study||8
128153|NCT01222715|309041|P2|STARTED|Overall Study||43
128154|NCT01222715|309042|P1|STARTED|Overall Study||44
128155|NCT01222689|309052|P1|NOT COMPLETED|Overall Study||0
128156|NCT01222689|309052|P1|COMPLETED|Overall Study||46
128157|NCT01222689|309052|P1|STARTED|Overall Study||46
128158|NCT01222585|309065|P1|NOT COMPLETED|Overall Study||0
128159|NCT01222585|309065|P1|COMPLETED|Overall Study||24
128160|NCT01222585|309065|P1|STARTED|Overall Study||24
128161|NCT01222572|309075|P3|NOT COMPLETED|Overall Study||0
128162|NCT01222572|309076|P2|NOT COMPLETED|Overall Study||0
128163|NCT01222572|309077|P1|NOT COMPLETED|Overall Study||0
128164|NCT01222572|309075|P3|COMPLETED|Overall Study||0
128165|NCT01222572|309076|P2|COMPLETED|Overall Study||0
128166|NCT01222572|309077|P1|COMPLETED|Overall Study||1
128167|NCT01222572|309075|P3|STARTED|Overall Study||0
128168|NCT01222572|309076|P2|STARTED|Overall Study||0
128169|NCT01222572|309077|P1|STARTED|Overall Study||1
128170|NCT01222533|309081|P1|NOT COMPLETED|Overall Study||14
128171|NCT01222533|309081|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
128172|NCT01222533|309081|P1|Received Tio HH18|Overall Study||146
128173|NCT01222533|309081|P1|Received Tio R5|Overall Study||150
128174|NCT01222533|309081|P1|Received Tio R2.5|Overall Study||145
128175|NCT01222533|309081|P1|Received Tio R1.25|Overall Study||147
128176|NCT01222533|309081|P1|Received Placebo|Overall Study||147
128177|NCT01222533|309081|P1|STARTED|Overall Study|Entered and treated.|154
128178|NCT01222520|309220|P2|NOT COMPLETED|Double-blind Period||2
128179|NCT01222520|309221|P1|NOT COMPLETED|Double-blind Period||1
128180|NCT01222520|309220|P2|COMPLETED|Double-blind Period||85
128181|NCT01222520|309221|P1|COMPLETED|Double-blind Period||86
128182|NCT01222520|309220|P2|STARTED|Double-blind Period||87
128183|NCT01222520|309221|P1|STARTED|Double-blind Period||87
128184|NCT01222520|309220|P2|NOT COMPLETED|Open-label run-in Period||23
128185|NCT01222520|309221|P1|NOT COMPLETED|Open-label run-in Period||0
128186|NCT01222520|309220|P2|COMPLETED|Open-label run-in Period||174
128187|NCT01222520|309221|P1|COMPLETED|Open-label run-in Period||0
128188|NCT01222520|309220|P2|STARTED|Open-label run-in Period||197
128189|NCT01222520|309221|P1|STARTED|Open-label run-in Period||0
128190|NCT01222507|309239|P1|NOT COMPLETED|Overall Study||2
128191|NCT01222507|309239|P1|COMPLETED|Overall Study||60
128192|NCT01222507|309239|P1|STARTED|Overall Study||62
128193|NCT01222416|309245|P2|NOT COMPLETED|Overall Study||0
128194|NCT01222416|309246|P1|NOT COMPLETED|Overall Study||20
128195|NCT01222416|309245|P2|COMPLETED|Overall Study||0
128196|NCT01222416|309246|P1|COMPLETED|Overall Study||30
128197|NCT01222416|309245|P2|STARTED|Overall Study||0
128198|NCT01222416|309246|P1|STARTED|Overall Study||50
128199|NCT01222403|309256|P2|NOT COMPLETED|Overall Study||2
128200|NCT01222403|309257|P1|NOT COMPLETED|Overall Study||0
128201|NCT01222403|309256|P2|COMPLETED|Overall Study||379
128202|NCT01222403|309257|P1|COMPLETED|Overall Study||386
128203|NCT01222403|309256|P2|STARTED|Overall Study||381
128204|NCT01222403|309257|P1|STARTED|Overall Study||386
128205|NCT01222390|309267|P1|NOT COMPLETED|Overall Study||0
128206|NCT01222390|309267|P1|COMPLETED|Overall Study||12
128207|NCT01222390|309267|P1|STARTED|Overall Study||12
128208|NCT01222286|309273|P2|NOT COMPLETED|Overall Study||0
128209|NCT01222286|309274|P1|NOT COMPLETED|Overall Study||0
128210|NCT01222286|309273|P2|COMPLETED|Overall Study||14
128211|NCT01222286|309274|P1|COMPLETED|Overall Study||16
128212|NCT01222286|309273|P2|STARTED|Overall Study||14
128213|NCT01222286|309274|P1|STARTED|Overall Study||16
128214|NCT01222273|309286|P1|NOT COMPLETED|Overall Study||0
128215|NCT01222273|309286|P1|COMPLETED|Overall Study||7
128216|NCT01222273|309286|P1|STARTED|Overall Study||7
128217|NCT01222234|309295|P3|NOT COMPLETED|Overall Study||2
128218|NCT01222234|309296|P2|NOT COMPLETED|Overall Study||2
128219|NCT01222234|309297|P1|NOT COMPLETED|Overall Study||0
128220|NCT01222234|309295|P3|COMPLETED|Overall Study||22
128221|NCT01222234|309296|P2|COMPLETED|Overall Study||15
128222|NCT01222234|309297|P1|COMPLETED|Overall Study||15
128223|NCT01222234|309295|P3|STARTED|Overall Study||24
128224|NCT01222234|309296|P2|STARTED|Overall Study||17
128225|NCT01222234|309297|P1|STARTED|Overall Study||15
128226|NCT01222195|309306|P1|NOT COMPLETED|Overall Study||0
128227|NCT01222195|309306|P1|COMPLETED|Overall Study||1
128228|NCT01222195|309306|P1|STARTED|Overall Study||1
128229|NCT01222117|309321|P11|NOT COMPLETED|Overall Study||0
128230|NCT01222117|309322|P10|NOT COMPLETED|Overall Study||2
128231|NCT01222117|309323|P9|NOT COMPLETED|Overall Study||3
128232|NCT01222117|309324|P8|NOT COMPLETED|Overall Study||0
128233|NCT01222117|309325|P7|NOT COMPLETED|Overall Study||0
128234|NCT01222117|309326|P6|NOT COMPLETED|Overall Study||1
128235|NCT01222117|309327|P5|NOT COMPLETED|Overall Study||1
128236|NCT01222117|309328|P4|NOT COMPLETED|Overall Study||1
128237|NCT01222117|309329|P3|NOT COMPLETED|Overall Study||0
128238|NCT01222117|309330|P2|NOT COMPLETED|Overall Study||1
128239|NCT01222117|309331|P1|NOT COMPLETED|Overall Study||3
128240|NCT01222117|309321|P11|COMPLETED|Overall Study||6
128241|NCT01222117|309322|P10|COMPLETED|Overall Study||17
128242|NCT01222117|309323|P9|COMPLETED|Overall Study||20
128243|NCT01222117|309324|P8|COMPLETED|Overall Study||12
128244|NCT01222117|309325|P7|COMPLETED|Overall Study||13
128245|NCT01222117|309326|P6|COMPLETED|Overall Study||9
128246|NCT01222117|309327|P5|COMPLETED|Overall Study||8
128247|NCT01222117|309328|P4|COMPLETED|Overall Study||19
128248|NCT01222117|309329|P3|COMPLETED|Overall Study||22
128249|NCT01222117|309330|P2|COMPLETED|Overall Study||19
128250|NCT01222117|309331|P1|COMPLETED|Overall Study||17
128251|NCT01222117|309321|P11|STARTED|Overall Study||6
128252|NCT01222117|309322|P10|STARTED|Overall Study||19
128253|NCT01222117|309323|P9|STARTED|Overall Study||23
128254|NCT01222117|309324|P8|STARTED|Overall Study||12
128255|NCT01222117|309325|P7|STARTED|Overall Study||13
128256|NCT01222117|309326|P6|STARTED|Overall Study||10
128257|NCT01222117|309327|P5|STARTED|Overall Study||9
128258|NCT01222117|309328|P4|STARTED|Overall Study||20
128259|NCT01222117|309329|P3|STARTED|Overall Study||22
128260|NCT01222117|309330|P2|STARTED|Overall Study||20
128261|NCT01222117|309331|P1|STARTED|Overall Study||20
128262|NCT01222104|309366|P1|NOT COMPLETED|Overall Study||47
128263|NCT01222104|309366|P1|COMPLETED|Overall Study||587
128264|NCT01222104|309366|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
128265|NCT01222104|309366|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
128266|NCT01222104|309366|P1|Successful Deployment and Hemostasis|Overall Study||524
128267|NCT01222104|309366|P1|Successful Deployment|Overall Study||529
128268|NCT01222104|309366|P1|Angio-Seal Deployment Attempted|Overall Study||534
128269|NCT01222104|309366|P1|STARTED|Overall Study||634
128270|NCT01222078|309380|P1|NOT COMPLETED|Overall Study||1
128271|NCT01222078|309380|P1|COMPLETED|Overall Study||0
128272|NCT01222078|309380|P1|STARTED|Overall Study||1
128273|NCT01221948|309414|P1|NOT COMPLETED|Overall Study||14
128274|NCT01221948|309414|P1|COMPLETED|Overall Study||39
128275|NCT01221948|309414|P1|STARTED|Overall Study||53
128276|NCT01221753|309425|P1|NOT COMPLETED|Overall Study||1
128277|NCT01221753|309425|P1|COMPLETED|Overall Study||6
128278|NCT01221753|309425|P1|STARTED|Overall Study||7
128279|NCT01221727|309432|P2|NOT COMPLETED|Overall Study||1
128280|NCT01221727|309433|P1|NOT COMPLETED|Overall Study||3
128281|NCT01221727|309432|P2|COMPLETED|Overall Study||8
128282|NCT01221727|309433|P1|COMPLETED|Overall Study||18
128283|NCT01221727|309432|P2|Treated|Overall Study|Number of subjects received investigational product|8
128284|NCT01221727|309433|P1|Treated|Overall Study|Number of subjects received investigational product|19
128285|NCT01221727|309432|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
128286|NCT01221727|309433|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
128287|NCT01221623|309454|P2|NOT COMPLETED|Overall Study||14
128288|NCT01221623|309455|P1|NOT COMPLETED|Overall Study||38
128289|NCT01221623|309454|P2|COMPLETED|Overall Study||127
128290|NCT01221623|309455|P1|COMPLETED|Overall Study||236
128291|NCT01221623|309454|P2|STARTED|Overall Study||141
128292|NCT01221623|309455|P1|STARTED|Overall Study||274
128293|NCT01221597|309479|P2|NOT COMPLETED|Overall Study||16
128294|NCT01221597|309480|P1|NOT COMPLETED|Overall Study||36
128295|NCT01221597|309479|P2|COMPLETED|Overall Study||124
128296|NCT01221597|309480|P1|COMPLETED|Overall Study||241
128297|NCT01221597|309479|P2|STARTED|Overall Study||140
128298|NCT01221597|309480|P1|STARTED|Overall Study||277
128299|NCT01221441|309504|P2|NOT COMPLETED|Overall Study||12
128300|NCT01221441|309505|P1|NOT COMPLETED|Overall Study||22
128301|NCT01221441|309504|P2|COMPLETED|Overall Study||23
128302|NCT01221441|309505|P1|COMPLETED|Overall Study||45
128303|NCT01221441|309504|P2|STARTED|Overall Study||35
128304|NCT01221441|309505|P1|STARTED|Overall Study||67
128305|NCT01221363|309537|P2|NOT COMPLETED|Overall Study||5
128306|NCT01221363|309538|P1|NOT COMPLETED|Overall Study||12
128307|NCT01221363|309537|P2|COMPLETED|Overall Study||68
128308|NCT01221363|309538|P1|COMPLETED|Overall Study||81
128309|NCT01221363|309537|P2|STARTED|Overall Study||73
128310|NCT01221363|309538|P1|STARTED|Overall Study||93
128311|NCT01221350|309548|P2|NOT COMPLETED|Overall Study||3
128312|NCT01221350|309549|P1|NOT COMPLETED|Overall Study||5
128313|NCT01221350|309548|P2|COMPLETED|Overall Study||24
128314|NCT01221350|309549|P1|COMPLETED|Overall Study||23
128315|NCT01221350|309548|P2|Analysis Population|Overall Study||24
128316|NCT01221350|309549|P1|Analysis Population|Overall Study||23
128317|NCT01221350|309548|P2|Received Intervention|Overall Study||27
128318|NCT01221350|309549|P1|Received Intervention|Overall Study||28
128319|NCT01221350|309548|P2|STARTED|Overall Study||27
128320|NCT01221350|309549|P1|STARTED|Overall Study||28
128321|NCT01221311|309591|P2|NOT COMPLETED|Overall Study||0
128322|NCT01221311|309592|P1|NOT COMPLETED|Overall Study||0
128323|NCT01221311|309591|P2|COMPLETED|Overall Study||55
128324|NCT01221311|309592|P1|COMPLETED|Overall Study||57
128325|NCT01221311|309591|P2|STARTED|Overall Study||55
128326|NCT01221311|309592|P1|STARTED|Overall Study||57
128327|NCT01221298|309598|P1|NOT COMPLETED|Overall Study||0
128328|NCT01221298|309598|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
128329|NCT01221298|309598|P1|STARTED|Overall Study||11
128330|NCT01221285|309608|P1|NOT COMPLETED|Overall Study||1
128331|NCT01221285|309608|P1|COMPLETED|Overall Study||10
128332|NCT01221285|309608|P1|STARTED|Overall Study||11
128333|NCT01221272|309617|P2|NOT COMPLETED|Period 2||2
128334|NCT01221272|309618|P1|NOT COMPLETED|Period 2||0
128335|NCT01221272|309617|P2|COMPLETED|Period 2||37
128336|NCT01221272|309618|P1|COMPLETED|Period 2||39
128337|NCT01221272|309617|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
128338|NCT01221272|309618|P1|STARTED|Period 2||39
128339|NCT01221272|309617|P2|NOT COMPLETED|Period 1||2
128340|NCT01221272|309618|P1|NOT COMPLETED|Period 1||2
128341|NCT01221272|309617|P2|COMPLETED|Period 1||38
128342|NCT01221272|309618|P1|COMPLETED|Period 1||39
128343|NCT01221272|309617|P2|STARTED|Period 1||40
128344|NCT01221272|309618|P1|STARTED|Period 1||41
128345|NCT01221090|309637|P4|NOT COMPLETED|Overall Study||22
128346|NCT01221090|309638|P3|NOT COMPLETED|Overall Study||42
128347|NCT01221090|309639|P2|NOT COMPLETED|Overall Study||34
128348|NCT01221090|309640|P1|NOT COMPLETED|Overall Study||15
128349|NCT01221090|309637|P4|COMPLETED|Overall Study||73
128350|NCT01221090|309638|P3|COMPLETED|Overall Study||57
128351|NCT01221090|309639|P2|COMPLETED|Overall Study||47
128352|NCT01221090|309640|P1|COMPLETED|Overall Study||86
128353|NCT01221090|309637|P4|STARTED|Overall Study||95
128354|NCT01221090|309638|P3|STARTED|Overall Study||99
128355|NCT01221090|309639|P2|STARTED|Overall Study||81
128356|NCT01221090|309640|P1|STARTED|Overall Study||101
128357|NCT01220973|309666|P1|NOT COMPLETED|Overall Study||4
128358|NCT01220973|309666|P1|COMPLETED|Overall Study||23
128359|NCT01220973|309666|P1|STARTED|Overall Study||27
128360|NCT01220869|309670|P1|NOT COMPLETED|Overall Study||6
128361|NCT01220869|309670|P1|COMPLETED|Overall Study||104
128362|NCT01220869|309670|P1|STARTED|Overall Study||110
128363|NCT01220739|309680|P2|NOT COMPLETED|Overall Study||0
128364|NCT01220739|309681|P1|NOT COMPLETED|Overall Study||0
128365|NCT01220739|309680|P2|COMPLETED|Overall Study||5
128366|NCT01220739|309681|P1|COMPLETED|Overall Study||7
128367|NCT01220739|309680|P2|STARTED|Overall Study||5
128368|NCT01220739|309681|P1|STARTED|Overall Study||7
128369|NCT01220609|309689|P1|NOT COMPLETED|Overall Study||3
128370|NCT01220609|309689|P1|COMPLETED|Overall Study|Eligible and treated patients|23
128371|NCT01220609|309689|P1|STARTED|Overall Study||26
128372|NCT01220557|309703|P2|NOT COMPLETED|Overall Study||5
128373|NCT01220557|309704|P1|NOT COMPLETED|Overall Study||6
128374|NCT01220557|309703|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
128375|NCT01220557|309704|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
128376|NCT01220557|309703|P2|STARTED|Overall Study||79
128377|NCT01220557|309704|P1|STARTED|Overall Study||81
128378|NCT01220466|309713|P3|NOT COMPLETED|Overall Study||0
128379|NCT01220466|309714|P2|NOT COMPLETED|Overall Study||0
128380|NCT01220466|309715|P1|NOT COMPLETED|Overall Study||0
128381|NCT01220466|309713|P3|COMPLETED|Overall Study|16 eyes|10
128382|NCT01220466|309714|P2|COMPLETED|Overall Study|108 eyes|56
128383|NCT01220466|309715|P1|COMPLETED|Overall Study|19 eyes|11
128384|NCT01220466|309713|P3|STARTED|Overall Study|16 eyes|10
128385|NCT01220466|309714|P2|STARTED|Overall Study|108 eyes|56
128386|NCT01220466|309715|P1|STARTED|Overall Study|19 eyes|11
128387|NCT01220414|309737|P4|NOT COMPLETED|Overall Study||1
128388|NCT01220414|309738|P3|NOT COMPLETED|Overall Study||0
128389|NCT01220414|309739|P2|NOT COMPLETED|Overall Study||0
128390|NCT01220414|309740|P1|NOT COMPLETED|Overall Study||1
128391|NCT01220414|309737|P4|COMPLETED|Overall Study||14
128392|NCT01220414|309738|P3|COMPLETED|Overall Study||14
128393|NCT01220414|309739|P2|COMPLETED|Overall Study||14
128394|NCT01220414|309740|P1|COMPLETED|Overall Study||14
128395|NCT01220414|309737|P4|STARTED|Overall Study||15
128396|NCT01220414|309738|P3|STARTED|Overall Study||14
128397|NCT01220414|309739|P2|STARTED|Overall Study||14
128398|NCT01220414|309740|P1|STARTED|Overall Study||15
128399|NCT01220401|309747|P1|NOT COMPLETED|Overall Study||3
128400|NCT01220401|309747|P1|COMPLETED|Overall Study||18
128401|NCT01220401|309747|P1|STARTED|Overall Study||21
128402|NCT01220297|309756|P1|NOT COMPLETED|Overall Study||3
128403|NCT01220297|309756|P1|COMPLETED|Overall Study||0
128404|NCT01220297|309756|P1|STARTED|Overall Study||3
128405|NCT01220180|309773|P1|NOT COMPLETED|Overall Study||207
128406|NCT01220180|309773|P1|COMPLETED|Overall Study||3968
128407|NCT01220180|309773|P1|Treated|Overall Study||4174
128408|NCT01220180|309773|P1|STARTED|Overall Study||4175
128409|NCT01220128|309803|P7|NOT COMPLETED|Overall Study||5
128410|NCT01220128|309804|P6|NOT COMPLETED|Overall Study||0
128411|NCT01220128|309805|P5|NOT COMPLETED|Overall Study||0
128412|NCT01220128|309806|P4|NOT COMPLETED|Overall Study||0
128413|NCT01220128|309807|P3|NOT COMPLETED|Overall Study||3
128414|NCT01220128|309808|P2|NOT COMPLETED|Overall Study||1
128415|NCT01220128|309809|P1|NOT COMPLETED|Overall Study||4
128416|NCT01220128|309803|P7|COMPLETED|Overall Study||3
128417|NCT01220128|309804|P6|COMPLETED|Overall Study||4
128418|NCT01220128|309805|P5|COMPLETED|Overall Study||11
128419|NCT01220128|309806|P4|COMPLETED|Overall Study||6
128420|NCT01220128|309807|P3|COMPLETED|Overall Study||6
128421|NCT01220128|309808|P2|COMPLETED|Overall Study||6
128422|NCT01220128|309809|P1|COMPLETED|Overall Study||11
128423|NCT01220128|309803|P7|STARTED|Overall Study||8
128424|NCT01220128|309804|P6|STARTED|Overall Study||4
128425|NCT01220128|309805|P5|STARTED|Overall Study||11
128426|NCT01220128|309806|P4|STARTED|Overall Study||6
128427|NCT01220128|309807|P3|STARTED|Overall Study||9
128428|NCT01220128|309808|P2|STARTED|Overall Study||7
128429|NCT01220128|309809|P1|STARTED|Overall Study||15
128430|NCT01219985|310014|P1|NOT COMPLETED|Overall Study||20
128431|NCT01219985|310014|P1|COMPLETED|Overall Study||30
128432|NCT01219985|310014|P1|STARTED|Overall Study||50
128433|NCT01219933|310020|P1|NOT COMPLETED|Overall Study||38
128434|NCT01219933|310020|P1|COMPLETED|Overall Study||30
128435|NCT01219933|310020|P1|STARTED|Overall Study||68
128436|NCT01219881|310059|P2|NOT COMPLETED|Overall Study||5
128437|NCT01219881|310060|P1|NOT COMPLETED|Overall Study||4
128438|NCT01219881|310059|P2|COMPLETED|Overall Study||32
128439|NCT01219881|310060|P1|COMPLETED|Overall Study||34
128440|NCT01219881|310059|P2|STARTED|Overall Study||37
128441|NCT01219881|310060|P1|STARTED|Overall Study||38
128442|NCT01219855|310077|P5|NOT COMPLETED|Overall Study||1
128443|NCT01219855|310078|P4|NOT COMPLETED|Overall Study||1
128444|NCT01219855|310079|P3|NOT COMPLETED|Overall Study||1
128445|NCT01219855|310080|P2|NOT COMPLETED|Overall Study||5
128446|NCT01219855|310081|P1|NOT COMPLETED|Overall Study||1
128447|NCT01219855|310077|P5|COMPLETED|Overall Study||13
128448|NCT01219855|310078|P4|COMPLETED|Overall Study||12
128449|NCT01219855|310079|P3|COMPLETED|Overall Study||16
128450|NCT01219855|310080|P2|COMPLETED|Overall Study||12
128451|NCT01219855|310081|P1|COMPLETED|Overall Study||16
128452|NCT01219855|310077|P5|STARTED|Overall Study||14
128453|NCT01219855|310078|P4|STARTED|Overall Study||13
128454|NCT01219855|310079|P3|STARTED|Overall Study||17
128455|NCT01219855|310080|P2|STARTED|Overall Study||17
128456|NCT01219855|310081|P1|STARTED|Overall Study||17
128457|NCT01219777|310117|P1|NOT COMPLETED|Overall Study||0
128458|NCT01219777|310117|P1|COMPLETED|Overall Study||9
128459|NCT01219777|310117|P1|STARTED|Overall Study||9
128460|NCT01219738|310122|P1|NOT COMPLETED|Overall Study||0
128461|NCT01219738|310122|P1|COMPLETED|Overall Study||20
128462|NCT01219738|310122|P1|Budesonide 720- 4 Times|Overall Study||20
128463|NCT01219738|310122|P1|Budesonide 1440|Overall Study||20
128464|NCT01219738|310122|P1|Budesonide 720|Overall Study||20
128465|NCT01219738|310122|P1|Budesonide 360|Overall Study||20
128466|NCT01219738|310122|P1|STARTED|Overall Study||20
128467|NCT01219673|310143|P8|NOT COMPLETED|Overall Study||0
128468|NCT01219673|310144|P7|NOT COMPLETED|Overall Study||0
128469|NCT01219673|310145|P6|NOT COMPLETED|Overall Study||0
128470|NCT01219673|310146|P5|NOT COMPLETED|Overall Study||0
128471|NCT01219673|310147|P4|NOT COMPLETED|Overall Study||0
128472|NCT01219673|310148|P3|NOT COMPLETED|Overall Study||0
128473|NCT01219673|310149|P2|NOT COMPLETED|Overall Study||0
128474|NCT01219673|310150|P1|NOT COMPLETED|Overall Study||0
128475|NCT01219673|310143|P8|COMPLETED|Overall Study||0
128476|NCT01219673|310144|P7|COMPLETED|Overall Study||0
128477|NCT01219673|310145|P6|COMPLETED|Overall Study||0
128478|NCT01219673|310146|P5|COMPLETED|Overall Study||0
128479|NCT01219673|310147|P4|COMPLETED|Overall Study||0
128480|NCT01219673|310148|P3|COMPLETED|Overall Study||1
128481|NCT01219673|310149|P2|COMPLETED|Overall Study||0
128482|NCT01219673|310150|P1|COMPLETED|Overall Study||0
128483|NCT01219673|310143|P8|STARTED|Overall Study||0
128484|NCT01219673|310144|P7|STARTED|Overall Study||0
128485|NCT01219673|310145|P6|STARTED|Overall Study||0
128486|NCT01219673|310146|P5|STARTED|Overall Study||0
128487|NCT01219673|310147|P4|STARTED|Overall Study||0
128488|NCT01219673|310148|P3|STARTED|Overall Study||1
128489|NCT01219673|310149|P2|STARTED|Overall Study||0
128490|NCT01219673|310150|P1|STARTED|Overall Study||0
128491|NCT01218997|310170|P2|NOT COMPLETED|Overall Study||41
128492|NCT01218997|310171|P1|NOT COMPLETED|Overall Study||245
128493|NCT01218997|310170|P2|COMPLETED|Overall Study||24
128494|NCT01218997|310171|P1|COMPLETED|Overall Study||126
128495|NCT01218997|310170|P2|STARTED|Overall Study||65
128496|NCT01218997|310171|P1|STARTED|Overall Study||371
128497|NCT01218984|310180|P3|NOT COMPLETED|Overall Study||3
128498|NCT01218984|310181|P2|NOT COMPLETED|Overall Study||2
128499|NCT01218984|310182|P1|NOT COMPLETED|Overall Study||1
128500|NCT01218984|310180|P3|COMPLETED|Overall Study||7
128501|NCT01218984|310181|P2|COMPLETED|Overall Study||6
128502|NCT01218984|310182|P1|COMPLETED|Overall Study||8
128503|NCT01218984|310180|P3|STARTED|Overall Study||10
128504|NCT01218984|310181|P2|STARTED|Overall Study||8
128505|NCT01218984|310182|P1|STARTED|Overall Study||9
128506|NCT01218971|310192|P2|NOT COMPLETED|Overall Study||80
128507|NCT01218971|310193|P1|NOT COMPLETED|Overall Study||104
128508|NCT01218971|310192|P2|COMPLETED|Overall Study||77
128509|NCT01218971|310193|P1|COMPLETED|Overall Study||71
128510|NCT01218971|310192|P2|STARTED|Overall Study||157
128511|NCT01218971|310193|P1|STARTED|Overall Study||175
128512|NCT01218958|310206|P3|NOT COMPLETED|Overall Study||81
128513|NCT01218958|310207|P2|NOT COMPLETED|Overall Study||81
128514|NCT01218958|310208|P1|NOT COMPLETED|Overall Study||84
128515|NCT01218958|310206|P3|COMPLETED|Overall Study||128
128516|NCT01218958|310207|P2|COMPLETED|Overall Study||124
128517|NCT01218958|310208|P1|COMPLETED|Overall Study||126
128518|NCT01218958|310206|P3|STARTED|Overall Study||209
128519|NCT01218958|310207|P2|STARTED|Overall Study||205
128520|NCT01218958|310208|P1|STARTED|Overall Study||210
128521|NCT01218867|310230|P11|NOT COMPLETED|Overall Study||0
128522|NCT01218867|310231|P10|NOT COMPLETED|Overall Study||0
128523|NCT01218867|310232|P9|NOT COMPLETED|Overall Study||0
128524|NCT01218867|310233|P8|NOT COMPLETED|Overall Study||0
128525|NCT01218867|310234|P7|NOT COMPLETED|Overall Study||1
128526|NCT01218867|310235|P6|NOT COMPLETED|Overall Study||0
128527|NCT01218867|310236|P5|NOT COMPLETED|Overall Study||0
128528|NCT01218867|310237|P4|NOT COMPLETED|Overall Study||0
128529|NCT01218867|310238|P3|NOT COMPLETED|Overall Study||0
128530|NCT01218867|310239|P2|NOT COMPLETED|Overall Study||0
128531|NCT01218867|310240|P1|NOT COMPLETED|Overall Study||0
128532|NCT01218867|310230|P11|COMPLETED|Overall Study||2
128533|NCT01218867|310231|P10|COMPLETED|Overall Study||4
128534|NCT01218867|310232|P9|COMPLETED|Overall Study||3
128535|NCT01218867|310233|P8|COMPLETED|Overall Study||3
128536|NCT01218867|310234|P7|COMPLETED|Overall Study||3
128537|NCT01218867|310235|P6|COMPLETED|Overall Study||1
128538|NCT01218867|310236|P5|COMPLETED|Overall Study||1
128539|NCT01218867|310237|P4|COMPLETED|Overall Study||1
128540|NCT01218867|310238|P3|COMPLETED|Overall Study||3
128541|NCT01218867|310239|P2|COMPLETED|Overall Study||1
128542|NCT01218867|310240|P1|COMPLETED|Overall Study||1
128543|NCT01218867|310230|P11|STARTED|Overall Study||2
128544|NCT01218867|310231|P10|STARTED|Overall Study||4
128545|NCT01218867|310232|P9|STARTED|Overall Study||3
128546|NCT01218867|310233|P8|STARTED|Overall Study||3
128547|NCT01218867|310234|P7|STARTED|Overall Study||4
128548|NCT01218867|310235|P6|STARTED|Overall Study||1
128549|NCT01218867|310236|P5|STARTED|Overall Study||1
128550|NCT01218867|310237|P4|STARTED|Overall Study||1
128551|NCT01218867|310238|P3|STARTED|Overall Study||3
128552|NCT01218867|310239|P2|STARTED|Overall Study||1
128553|NCT01218867|310240|P1|STARTED|Overall Study||1
128554|NCT01218802|310288|P2|NOT COMPLETED|Overall Study||18
128555|NCT01218802|310289|P1|NOT COMPLETED|Overall Study||10
128556|NCT01218802|310288|P2|COMPLETED|Overall Study||57
128557|NCT01218802|310289|P1|COMPLETED|Overall Study||62
128558|NCT01218802|310288|P2|STARTED|Overall Study||75
128559|NCT01218802|310289|P1|STARTED|Overall Study||72
128560|NCT01218646|310301|P4|NOT COMPLETED|Overall Study||1
128561|NCT01218646|310302|P3|NOT COMPLETED|Overall Study||2
128562|NCT01218646|310303|P2|NOT COMPLETED|Overall Study||0
128563|NCT01218646|310304|P1|NOT COMPLETED|Overall Study||1
128564|NCT01218646|310301|P4|COMPLETED|Overall Study||63
128565|NCT01218646|310302|P3|COMPLETED|Overall Study||223
128566|NCT01218646|310303|P2|COMPLETED|Overall Study||225
128567|NCT01218646|310304|P1|COMPLETED|Overall Study||224
128568|NCT01218646|310301|P4|STARTED|Overall Study||64
128569|NCT01218646|310302|P3|STARTED|Overall Study||225
128570|NCT01218646|310303|P2|STARTED|Overall Study||225
128571|NCT01218646|310304|P1|STARTED|Overall Study||225
128572|NCT01218594|310342|P1|NOT COMPLETED|Overall Study||12
128573|NCT01218594|310342|P1|COMPLETED|Overall Study||36
128574|NCT01218594|310342|P1|STARTED|Overall Study||48
128575|NCT01218477|310350|P4|NOT COMPLETED|Overall Study||2
128576|NCT01218477|310351|P3|NOT COMPLETED|Overall Study||14
128577|NCT01218477|310352|P2|NOT COMPLETED|Overall Study||8
128578|NCT01218477|310353|P1|NOT COMPLETED|Overall Study||3
128579|NCT01218477|310350|P4|COMPLETED|Overall Study|Still receiving study drug|0
128580|NCT01218477|310351|P3|COMPLETED|Overall Study|Still receiving study drug|0
128581|NCT01218477|310352|P2|COMPLETED|Overall Study|Still receiving study drug|0
128582|NCT01218477|310353|P1|COMPLETED|Overall Study|Still receiving study drug|0
128583|NCT01218477|310350|P4|STARTED|Overall Study|Participants who received treatment|2
128584|NCT01218477|310351|P3|STARTED|Overall Study|Participants who received treatment|14
128585|NCT01218477|310352|P2|STARTED|Overall Study|Participants who received treatment|8
128586|NCT01218477|310353|P1|STARTED|Overall Study|Participants who received treatment|3
128587|NCT01218438|310370|P1|NOT COMPLETED|Epoch 4||3
128588|NCT01218438|310370|P1|COMPLETED|Epoch 4||67
128589|NCT01218438|310370|P1|STARTED|Epoch 4||70
128590|NCT01218438|310370|P1|NOT COMPLETED|Epoch 3||4
128591|NCT01218438|310370|P1|COMPLETED|Epoch 3||70
128592|NCT01218438|310370|P1|STARTED|Epoch 3||74
128593|NCT01218438|310370|P1|NOT COMPLETED|Epoch 2||0
128594|NCT01218438|310370|P1|COMPLETED|Epoch 2||45
128595|NCT01218438|310370|P1|STARTED|Epoch 2||45
128596|NCT01218438|310370|P1|NOT COMPLETED|Epoch 1||3
128597|NCT01218438|310370|P1|COMPLETED|Epoch 1||74
128598|NCT01218438|310370|P1|STARTED|Epoch 1||77
128599|NCT01218399|310525|P2|NOT COMPLETED|Overall Study||0
128600|NCT01218399|310526|P1|NOT COMPLETED|Overall Study||0
128601|NCT01218399|310525|P2|COMPLETED|Overall Study||5
128602|NCT01218399|310526|P1|COMPLETED|Overall Study||5
128603|NCT01218399|310525|P2|STARTED|Overall Study||5
128604|NCT01218399|310526|P1|STARTED|Overall Study||5
128605|NCT01218308|310536|P2|NOT COMPLETED|Overall Study||120
128606|NCT01218308|310537|P1|NOT COMPLETED|Overall Study||103
128607|NCT01218308|310536|P2|COMPLETED|Overall Study||2464
128608|NCT01218308|310537|P1|COMPLETED|Overall Study||2481
128609|NCT01218308|310536|P2|STARTED|Overall Study||2584
128610|NCT01218308|310537|P1|STARTED|Overall Study||2584
128611|NCT01218243|310581|P2|NOT COMPLETED|Overall Study||14
128612|NCT01218243|310582|P1|NOT COMPLETED|Overall Study||9
128613|NCT01218243|310581|P2|COMPLETED|Overall Study||36
128614|NCT01218243|310582|P1|COMPLETED|Overall Study||41
128615|NCT01218243|310581|P2|Treatment Completed|Overall Study||42
128616|NCT01218243|310582|P1|Treatment Completed|Overall Study||45
128617|NCT01218243|310581|P2|STARTED|Overall Study||50
128618|NCT01218243|310582|P1|STARTED|Overall Study||50
128619|NCT01218204|310598|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
128620|NCT01218204|310599|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
128621|NCT01218204|310600|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
128622|NCT01218204|310601|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
128623|NCT01218204|310598|P4|COMPLETED|Part B Pooled Treatment Arm||127
128624|NCT01218204|310599|P3|COMPLETED|Part B Pooled Treatment Arm||0
128625|NCT01218204|310600|P2|COMPLETED|Part B Pooled Treatment Arm||0
128626|NCT01218204|310601|P1|COMPLETED|Part B Pooled Treatment Arm||0
128627|NCT01218204|310598|P4|STARTED|Part B Pooled Treatment Arm||130
128628|NCT01218204|310599|P3|STARTED|Part B Pooled Treatment Arm||0
128629|NCT01218204|310600|P2|STARTED|Part B Pooled Treatment Arm||0
128630|NCT01218204|310601|P1|STARTED|Part B Pooled Treatment Arm||0
128631|NCT01218204|310598|P4|NOT COMPLETED|Part B Run-in||0
128632|NCT01218204|310599|P3|NOT COMPLETED|Part B Run-in||6
128633|NCT01218204|310600|P2|NOT COMPLETED|Part B Run-in||0
128634|NCT01218204|310601|P1|NOT COMPLETED|Part B Run-in||0
128635|NCT01218204|310598|P4|COMPLETED|Part B Run-in||0
128636|NCT01218204|310599|P3|COMPLETED|Part B Run-in||83
128637|NCT01218204|310600|P2|COMPLETED|Part B Run-in||0
128638|NCT01218204|310601|P1|COMPLETED|Part B Run-in||0
128639|NCT01218204|310598|P4|STARTED|Part B Run-in||0
128640|NCT01218204|310599|P3|STARTED|Part B Run-in||89
128641|NCT01218204|310600|P2|STARTED|Part B Run-in||0
128642|NCT01218204|310601|P1|STARTED|Part B Run-in||0
128643|NCT01218204|310598|P4|NOT COMPLETED|Part B Washout||0
128644|NCT01218204|310599|P3|NOT COMPLETED|Part B Washout||0
128645|NCT01218204|310600|P2|NOT COMPLETED|Part B Washout||145
128646|NCT01218204|310601|P1|NOT COMPLETED|Part B Washout||0
128647|NCT01218204|310598|P4|COMPLETED|Part B Washout||0
128648|NCT01218204|310599|P3|COMPLETED|Part B Washout||0
128649|NCT01218204|310600|P2|COMPLETED|Part B Washout||136
128650|NCT01218204|310601|P1|COMPLETED|Part B Washout||0
128651|NCT01218204|310598|P4|STARTED|Part B Washout||0
128652|NCT01218204|310599|P3|STARTED|Part B Washout||0
128653|NCT01218204|310600|P2|STARTED|Part B Washout||281
128654|NCT01218204|310601|P1|STARTED|Part B Washout||0
128655|NCT01218204|310598|P4|NOT COMPLETED|Part A||0
128656|NCT01218204|310599|P3|NOT COMPLETED|Part A||0
128657|NCT01218204|310600|P2|NOT COMPLETED|Part A||0
128658|NCT01218204|310601|P1|NOT COMPLETED|Part A||0
128659|NCT01218204|310598|P4|COMPLETED|Part A||0
128660|NCT01218204|310599|P3|COMPLETED|Part A||0
128661|NCT01218204|310600|P2|COMPLETED|Part A||0
128662|NCT01218204|310601|P1|COMPLETED|Part A||6
128663|NCT01218204|310598|P4|STARTED|Part A||0
128664|NCT01218204|310599|P3|STARTED|Part A||0
128665|NCT01218204|310600|P2|STARTED|Part A||0
128666|NCT01218204|310601|P1|STARTED|Part A||6
128667|NCT01218126|310865|P4|NOT COMPLETED|Overall Study||35
128668|NCT01218126|310866|P3|NOT COMPLETED|Overall Study||24
128669|NCT01218126|310867|P2|NOT COMPLETED|Overall Study||22
128670|NCT01218126|310868|P1|NOT COMPLETED|Overall Study||24
128671|NCT01218126|310865|P4|COMPLETED|Overall Study||114
128672|NCT01218126|310866|P3|COMPLETED|Overall Study||127
128673|NCT01218126|310867|P2|COMPLETED|Overall Study||127
128674|NCT01218126|310868|P1|COMPLETED|Overall Study||129
128675|NCT01218126|310865|P4|STARTED|Overall Study||149
128676|NCT01218126|310866|P3|STARTED|Overall Study||151
128677|NCT01218126|310867|P2|STARTED|Overall Study||149
128678|NCT01218126|310868|P1|STARTED|Overall Study||153
128679|NCT01218113|310909|P3|NOT COMPLETED|Overall Study||6
128680|NCT01218113|310910|P2|NOT COMPLETED|Overall Study||1
128681|NCT01218113|310911|P1|NOT COMPLETED|Overall Study||5
128682|NCT01218113|310909|P3|COMPLETED|Overall Study||58
128683|NCT01218113|310910|P2|COMPLETED|Overall Study||63
128684|NCT01218113|310911|P1|COMPLETED|Overall Study||57
128685|NCT01218113|310909|P3|STARTED|Overall Study||64
128686|NCT01218113|310910|P2|STARTED|Overall Study||64
128687|NCT01218113|310911|P1|STARTED|Overall Study||62
128688|NCT01218100|311092|P4|NOT COMPLETED|Overall Study||34
128689|NCT01218100|311093|P3|NOT COMPLETED|Overall Study||27
128690|NCT01218100|311094|P2|NOT COMPLETED|Overall Study||25
128691|NCT01218100|311095|P1|NOT COMPLETED|Overall Study||24
128692|NCT01218100|311092|P4|COMPLETED|Overall Study||156
128693|NCT01218100|311093|P3|COMPLETED|Overall Study||162
128694|NCT01218100|311094|P2|COMPLETED|Overall Study||165
128695|NCT01218100|311095|P1|COMPLETED|Overall Study||71
128696|NCT01218100|311092|P4|STARTED|Overall Study||190
128697|NCT01218100|311093|P3|STARTED|Overall Study||189
128698|NCT01218100|311094|P2|STARTED|Overall Study||190
128699|NCT01218100|311095|P1|STARTED|Overall Study||95
128700|NCT01218087|311111|P2|NOT COMPLETED|Overall Study||6
128701|NCT01218087|311112|P1|NOT COMPLETED|Overall Study||15
128702|NCT01218087|311111|P2|COMPLETED|Overall Study||35
128703|NCT01218087|311112|P1|COMPLETED|Overall Study||27
128704|NCT01218087|311111|P2|STARTED|Overall Study||41
128705|NCT01218087|311112|P1|STARTED|Overall Study||42
128706|NCT01218009|311122|P2|NOT COMPLETED|Overall Study||165
128707|NCT01218009|311123|P1|NOT COMPLETED|Overall Study||166
128708|NCT01218009|311122|P2|COMPLETED|Overall Study||0
128709|NCT01218009|311123|P1|COMPLETED|Overall Study||0
128710|NCT01218009|311122|P2|STARTED|Overall Study||165
128711|NCT01218009|311123|P1|STARTED|Overall Study||166
128712|NCT01217957|311146|P5|NOT COMPLETED|Phase 2||1
128713|NCT01217957|311147|P4|NOT COMPLETED|Phase 2||0
128714|NCT01217957|311148|P3|NOT COMPLETED|Phase 2||0
128715|NCT01217957|311149|P2|NOT COMPLETED|Phase 2||0
128716|NCT01217957|311150|P1|NOT COMPLETED|Phase 2||0
128717|NCT01217957|311146|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
128718|NCT01217957|311147|P4|COMPLETED|Phase 2||0
128719|NCT01217957|311148|P3|COMPLETED|Phase 2||0
128720|NCT01217957|311149|P2|COMPLETED|Phase 2||0
128721|NCT01217957|311150|P1|COMPLETED|Phase 2||0
128722|NCT01217957|311146|P5|STARTED|Phase 2||50
128723|NCT01217957|311147|P4|STARTED|Phase 2||0
128724|NCT01217957|311148|P3|STARTED|Phase 2||0
128725|NCT01217957|311149|P2|STARTED|Phase 2||0
128726|NCT01217957|311150|P1|STARTED|Phase 2||0
128727|NCT01217957|311146|P5|NOT COMPLETED|Phase 1||0
128728|NCT01217957|311147|P4|NOT COMPLETED|Phase 1||1
128729|NCT01217957|311148|P3|NOT COMPLETED|Phase 1||1
128730|NCT01217957|311149|P2|NOT COMPLETED|Phase 1||0
128731|NCT01217957|311150|P1|NOT COMPLETED|Phase 1||1
128732|NCT01217957|311146|P5|COMPLETED|Phase 1||0
128733|NCT01217957|311147|P4|COMPLETED|Phase 1||2
128734|NCT01217957|311148|P3|COMPLETED|Phase 1||5
128735|NCT01217957|311149|P2|COMPLETED|Phase 1||3
128736|NCT01217957|311150|P1|COMPLETED|Phase 1||2
128737|NCT01217957|311146|P5|STARTED|Phase 1||0
128738|NCT01217957|311147|P4|STARTED|Phase 1||3
128739|NCT01217957|311148|P3|STARTED|Phase 1||6
128740|NCT01217957|311149|P2|STARTED|Phase 1||3
128741|NCT01217957|311150|P1|STARTED|Phase 1||3
128742|NCT01217944|311209|P3|NOT COMPLETED|Overall Study||0
128743|NCT01217944|311210|P2|NOT COMPLETED|Overall Study||4
128744|NCT01217944|311211|P1|NOT COMPLETED|Overall Study||6
128745|NCT01217944|311209|P3|COMPLETED|Overall Study||55
128746|NCT01217944|311210|P2|COMPLETED|Overall Study||112
128747|NCT01217944|311211|P1|COMPLETED|Overall Study||100
128748|NCT01217944|311209|P3|Completed 6 Months|Overall Study||55
128749|NCT01217944|311210|P2|Completed 6 Months|Overall Study||116
128750|NCT01217944|311211|P1|Completed 6 Months|Overall Study||103
128751|NCT01217944|311209|P3|Completed 3 Months|Overall Study||55
128752|NCT01217944|311210|P2|Completed 3 Months|Overall Study||116
128753|NCT01217944|311211|P1|Completed 3 Months|Overall Study||105
128754|NCT01217944|311209|P3|STARTED|Overall Study||55
128755|NCT01217944|311210|P2|STARTED|Overall Study||116
128756|NCT01217944|311211|P1|STARTED|Overall Study||106
128757|NCT01217892|311254|P4|NOT COMPLETED|Overall Study||8
128758|NCT01217892|311255|P3|NOT COMPLETED|Overall Study||9
128759|NCT01217892|311256|P2|NOT COMPLETED|Overall Study||6
128760|NCT01217892|311257|P1|NOT COMPLETED|Overall Study||7
128761|NCT01217892|311254|P4|COMPLETED|Overall Study||93
128762|NCT01217892|311255|P3|COMPLETED|Overall Study||90
128763|NCT01217892|311256|P2|COMPLETED|Overall Study||94
128764|NCT01217892|311257|P1|COMPLETED|Overall Study||93
128765|NCT01217892|311254|P4|STARTED|Overall Study||101
128766|NCT01217892|311255|P3|STARTED|Overall Study||99
128767|NCT01217892|311256|P2|STARTED|Overall Study||100
128768|NCT01217892|311257|P1|STARTED|Overall Study||100
128769|NCT01217840|311285|P2|NOT COMPLETED|Overall Study||3
128770|NCT01217840|311286|P1|NOT COMPLETED|Overall Study||6
128771|NCT01217840|311285|P2|COMPLETED|Overall Study||17
128772|NCT01217840|311286|P1|COMPLETED|Overall Study||14
128773|NCT01217840|311285|P2|STARTED|Overall Study||20
128774|NCT01217840|311286|P1|STARTED|Overall Study||20
128775|NCT01217827|311310|P2|NOT COMPLETED|Overall Study||0
128776|NCT01217827|311311|P1|NOT COMPLETED|Overall Study||0
128777|NCT01217827|311310|P2|COMPLETED|Overall Study||43
128778|NCT01217827|311311|P1|COMPLETED|Overall Study||46
128779|NCT01217827|311310|P2|STARTED|Overall Study||43
128780|NCT01217827|311311|P1|STARTED|Overall Study||46
128781|NCT01217814|311320|P3|NOT COMPLETED|Overall Study||1
128782|NCT01217814|311321|P2|NOT COMPLETED|Overall Study||1
128783|NCT01217814|311322|P1|NOT COMPLETED|Overall Study||1
128784|NCT01217814|311320|P3|COMPLETED|Overall Study||6
128785|NCT01217814|311321|P2|COMPLETED|Overall Study||4
128786|NCT01217814|311322|P1|COMPLETED|Overall Study||3
128787|NCT01217814|311320|P3|STARTED|Overall Study||7
128788|NCT01217814|311321|P2|STARTED|Overall Study||5
128789|NCT01217814|311322|P1|STARTED|Overall Study||4
128790|NCT01217801|311348|P2|NOT COMPLETED|Period 2||0
128791|NCT01217801|311349|P1|NOT COMPLETED|Period 2||0
128792|NCT01217801|311348|P2|COMPLETED|Period 2||22
128793|NCT01217801|311349|P1|COMPLETED|Period 2||23
128794|NCT01217801|311348|P2|STARTED|Period 2||22
128795|NCT01217801|311349|P1|STARTED|Period 2||23
128796|NCT01217801|311348|P2|NOT COMPLETED|Period 1||2
128797|NCT01217801|311349|P1|NOT COMPLETED|Period 1||1
128798|NCT01217801|311348|P2|COMPLETED|Period 1||22
128799|NCT01217801|311349|P1|COMPLETED|Period 1||23
128800|NCT01217801|311348|P2|STARTED|Period 1||24
128801|NCT01217801|311349|P1|STARTED|Period 1||24
128802|NCT01217749|311358|P3|NOT COMPLETED|Overall Study||2
128803|NCT01217749|311359|P2|NOT COMPLETED|Overall Study||3
128804|NCT01217749|311360|P1|NOT COMPLETED|Overall Study||3
128805|NCT01217749|311358|P3|COMPLETED|Overall Study||22
128806|NCT01217749|311359|P2|COMPLETED|Overall Study||17
128807|NCT01217749|311360|P1|COMPLETED|Overall Study||24
128808|NCT01217749|311358|P3|STARTED|Overall Study||24
128809|NCT01217749|311359|P2|STARTED|Overall Study||20
128810|NCT01217749|311360|P1|STARTED|Overall Study||27
128811|NCT01217606|311378|P2|NOT COMPLETED|9-Month Masked Extension||11
128812|NCT01217606|311379|P1|NOT COMPLETED|9-Month Masked Extension||13
128813|NCT01217606|311378|P2|COMPLETED|9-Month Masked Extension||62
128814|NCT01217606|311379|P1|COMPLETED|9-Month Masked Extension||54
128815|NCT01217606|311378|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
128816|NCT01217606|311379|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
128817|NCT01217606|311378|P2|STARTED|9-Month Masked Extension||73
128818|NCT01217606|311379|P1|STARTED|9-Month Masked Extension||67
128819|NCT01217606|311378|P2|NOT COMPLETED|Initial Treatment Phase||12
128820|NCT01217606|311379|P1|NOT COMPLETED|Initial Treatment Phase||14
128821|NCT01217606|311378|P2|COMPLETED|Initial Treatment Phase||83
128822|NCT01217606|311379|P1|COMPLETED|Initial Treatment Phase||76
128823|NCT01217606|311378|P2|STARTED|Initial Treatment Phase||95
128824|NCT01217606|311379|P1|STARTED|Initial Treatment Phase||90
128825|NCT01217515|311392|P3|NOT COMPLETED|Overall Study||10
128826|NCT01217515|311393|P2|NOT COMPLETED|Overall Study||8
128827|NCT01217515|311394|P1|NOT COMPLETED|Overall Study||7
128828|NCT01217515|311392|P3|COMPLETED|Overall Study||145
128829|NCT01217515|311393|P2|COMPLETED|Overall Study||148
128830|NCT01217515|311394|P1|COMPLETED|Overall Study||147
128831|NCT01217515|311392|P3|STARTED|Overall Study||155
128832|NCT01217515|311393|P2|STARTED|Overall Study||156
128833|NCT01217515|311394|P1|STARTED|Overall Study||154
128834|NCT01217476|311410|P2|NOT COMPLETED|Overall Study||7
128835|NCT01217476|311411|P1|NOT COMPLETED|Overall Study||12
128836|NCT01217476|311410|P2|COMPLETED|Overall Study||95
128837|NCT01217476|311411|P1|COMPLETED|Overall Study||93
128838|NCT01217476|311410|P2|STARTED|Overall Study||102
128839|NCT01217476|311411|P1|STARTED|Overall Study||105
128840|NCT01217463|311421|P2|NOT COMPLETED|Overall Study||8
128841|NCT01217463|311422|P1|NOT COMPLETED|Overall Study||13
128842|NCT01217463|311421|P2|COMPLETED|Overall Study||94
128843|NCT01217463|311422|P1|COMPLETED|Overall Study||86
128844|NCT01217463|311421|P2|STARTED|Overall Study||102
128845|NCT01217463|311422|P1|STARTED|Overall Study||99
128846|NCT01217411|311433|P3|NOT COMPLETED|Overall Study||0
128847|NCT01217411|311434|P2|NOT COMPLETED|Overall Study||0
128848|NCT01217411|311435|P1|NOT COMPLETED|Overall Study||0
128849|NCT01217411|311433|P3|COMPLETED|Overall Study||0
128850|NCT01217411|311434|P2|COMPLETED|Overall Study||0
128851|NCT01217411|311435|P1|COMPLETED|Overall Study||5
128852|NCT01217411|311433|P3|STARTED|Overall Study||0
128853|NCT01217411|311434|P2|STARTED|Overall Study||0
128854|NCT01217411|311435|P1|STARTED|Overall Study||5
128855|NCT01217307|311442|P2|NOT COMPLETED|Overall Study||1
128856|NCT01217307|311443|P1|NOT COMPLETED|Overall Study||0
128857|NCT01217307|311442|P2|COMPLETED|Overall Study||188
128858|NCT01217307|311443|P1|COMPLETED|Overall Study||191
128859|NCT01217307|311442|P2|STARTED|Overall Study||189
128860|NCT01217307|311443|P1|STARTED|Overall Study||191
128861|NCT01217229|311449|P1|NOT COMPLETED|Overall Study||0
128862|NCT01217229|311449|P1|COMPLETED|Overall Study||20
128863|NCT01217229|311449|P1|STARTED|Overall Study||20
128864|NCT01217112|311458|P5|NOT COMPLETED|Overall Study||1
128865|NCT01217112|311459|P4|NOT COMPLETED|Overall Study||2
128866|NCT01217112|311460|P3|NOT COMPLETED|Overall Study||1
128867|NCT01217112|311461|P2|NOT COMPLETED|Overall Study||2
128868|NCT01217112|311462|P1|NOT COMPLETED|Overall Study||0
128869|NCT01217112|311458|P5|COMPLETED|Overall Study||13
128870|NCT01217112|311459|P4|COMPLETED|Overall Study||10
128871|NCT01217112|311460|P3|COMPLETED|Overall Study||12
128872|NCT01217112|311461|P2|COMPLETED|Overall Study||10
128873|NCT01217112|311462|P1|COMPLETED|Overall Study||11
128874|NCT01217112|311458|P5|STARTED|Overall Study||14
128875|NCT01217112|311459|P4|STARTED|Overall Study||12
128876|NCT01217112|311460|P3|STARTED|Overall Study||13
128877|NCT01217112|311461|P2|STARTED|Overall Study||12
128878|NCT01217112|311462|P1|STARTED|Overall Study||11
128879|NCT01217073|311695|P8|NOT COMPLETED|Extension Period||20
128880|NCT01217073|311696|P7|NOT COMPLETED|Extension Period||91
128881|NCT01217073|311697|P6|NOT COMPLETED|Extension Period||0
128882|NCT01217073|311698|P5|NOT COMPLETED|Extension Period||0
128883|NCT01217073|311699|P4|NOT COMPLETED|Extension Period||0
128884|NCT01217073|311700|P3|NOT COMPLETED|Extension Period||0
128885|NCT01217073|311701|P2|NOT COMPLETED|Extension Period||0
128886|NCT01217073|311702|P1|NOT COMPLETED|Extension Period||0
128887|NCT01217073|311695|P8|COMPLETED|Extension Period||60
128888|NCT01217073|311696|P7|COMPLETED|Extension Period||314
128889|NCT01217073|311697|P6|COMPLETED|Extension Period||0
128890|NCT01217073|311698|P5|COMPLETED|Extension Period||0
128891|NCT01217073|311699|P4|COMPLETED|Extension Period||0
128892|NCT01217073|311700|P3|COMPLETED|Extension Period||0
128893|NCT01217073|311701|P2|COMPLETED|Extension Period||0
128894|NCT01217073|311702|P1|COMPLETED|Extension Period||0
128895|NCT01217073|311695|P8|STARTED|Extension Period||80
128896|NCT01217073|311696|P7|STARTED|Extension Period||405
128897|NCT01217073|311697|P6|STARTED|Extension Period||0
128898|NCT01217073|311698|P5|STARTED|Extension Period||0
128899|NCT01217073|311699|P4|STARTED|Extension Period||0
128900|NCT01217073|311700|P3|STARTED|Extension Period||0
128901|NCT01217073|311701|P2|STARTED|Extension Period||0
128902|NCT01217073|311702|P1|STARTED|Extension Period||0
128903|NCT01217073|311695|P8|NOT COMPLETED|Base Period||0
128904|NCT01217073|311696|P7|NOT COMPLETED|Base Period||0
128905|NCT01217073|311697|P6|NOT COMPLETED|Base Period||9
128906|NCT01217073|311698|P5|NOT COMPLETED|Base Period||15
128907|NCT01217073|311699|P4|NOT COMPLETED|Base Period||2
128908|NCT01217073|311700|P3|NOT COMPLETED|Base Period||7
128909|NCT01217073|311701|P2|NOT COMPLETED|Base Period||5
128910|NCT01217073|311702|P1|NOT COMPLETED|Base Period||7
128911|NCT01217073|311695|P8|COMPLETED|Base Period||0
128912|NCT01217073|311696|P7|COMPLETED|Base Period||0
128913|NCT01217073|311697|P6|COMPLETED|Base Period||105
128914|NCT01217073|311698|P5|COMPLETED|Base Period||99
128915|NCT01217073|311699|P4|COMPLETED|Base Period||113
128916|NCT01217073|311700|P3|COMPLETED|Base Period||107
128917|NCT01217073|311701|P2|COMPLETED|Base Period||110
128918|NCT01217073|311702|P1|COMPLETED|Base Period||106
128919|NCT01217073|311695|P8|STARTED|Base Period||0
128920|NCT01217073|311696|P7|STARTED|Base Period||0
128921|NCT01217073|311697|P6|STARTED|Base Period||114
128922|NCT01217073|311698|P5|STARTED|Base Period||114
128923|NCT01217073|311699|P4|STARTED|Base Period||115
128924|NCT01217073|311700|P3|STARTED|Base Period||114
128925|NCT01217073|311701|P2|STARTED|Base Period||115
128926|NCT01217073|311702|P1|STARTED|Base Period||113
128927|NCT01216943|311770|P1|NOT COMPLETED|Overall Study||13
128928|NCT01216943|311770|P1|COMPLETED|Overall Study||113
128929|NCT01216943|311770|P1|STARTED|Overall Study||126
128930|NCT01216761|311774|P3|NOT COMPLETED|Overall Study||0
128931|NCT01216761|311775|P2|NOT COMPLETED|Overall Study||0
128932|NCT01216761|311776|P1|NOT COMPLETED|Overall Study||0
128933|NCT01216761|311774|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
128934|NCT01216761|311775|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
128935|NCT01216761|311776|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
128936|NCT01216761|311774|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
128937|NCT01216761|311775|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
128938|NCT01216761|311776|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
128939|NCT01216748|311784|P1|NOT COMPLETED|Overall Study||0
128940|NCT01216748|311784|P1|COMPLETED|Overall Study||10
128941|NCT01216748|311784|P1|Eucapnic Hyperventilation|Overall Study||10
128942|NCT01216748|311784|P1|Hypercapnic Hyperventilation|Overall Study||10
128943|NCT01216748|311784|P1|Hypocapnic Hyperventilation|Overall Study||10
128944|NCT01216748|311784|P1|Quiet Breathing|Overall Study||10
128945|NCT01216748|311784|P1|STARTED|Overall Study||10
128946|NCT01216735|311791|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
128947|NCT01216735|311792|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
128948|NCT01216735|311791|P2|COMPLETED|Second Intervention (3 Weeks)||7
128949|NCT01216735|311792|P1|COMPLETED|Second Intervention (3 Weeks)||8
128950|NCT01216735|311791|P2|STARTED|Second Intervention (3 Weeks)||7
128951|NCT01216735|311792|P1|STARTED|Second Intervention (3 Weeks)||8
128952|NCT01216735|311791|P2|NOT COMPLETED|Washout (3 Weeks)||0
128953|NCT01216735|311792|P1|NOT COMPLETED|Washout (3 Weeks)||0
128954|NCT01216735|311791|P2|COMPLETED|Washout (3 Weeks)||7
128955|NCT01216735|311792|P1|COMPLETED|Washout (3 Weeks)||8
128956|NCT01216735|311791|P2|STARTED|Washout (3 Weeks)||7
128957|NCT01216735|311792|P1|STARTED|Washout (3 Weeks)||8
128958|NCT01216735|311791|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
128959|NCT01216735|311792|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
128960|NCT01216735|311791|P2|COMPLETED|First Intervention (3 Weeks)||7
128961|NCT01216735|311792|P1|COMPLETED|First Intervention (3 Weeks)||8
128962|NCT01216735|311791|P2|STARTED|First Intervention (3 Weeks)||7
128963|NCT01216735|311792|P1|STARTED|First Intervention (3 Weeks)||8
128964|NCT01216631|311803|P3|NOT COMPLETED|Overall Study||0
128965|NCT01216631|311804|P2|NOT COMPLETED|Overall Study||0
128966|NCT01216631|311805|P1|NOT COMPLETED|Overall Study||0
128967|NCT01216631|311803|P3|COMPLETED|Overall Study||1
128968|NCT01216631|311804|P2|COMPLETED|Overall Study||0
128969|NCT01216631|311805|P1|COMPLETED|Overall Study||0
128970|NCT01216631|311803|P3|STARTED|Overall Study||1
128971|NCT01216631|311804|P2|STARTED|Overall Study||0
128972|NCT01216631|311805|P1|STARTED|Overall Study||0
128973|NCT01216410|311816|P3|NOT COMPLETED|Overall Study||3
128974|NCT01216410|311817|P2|NOT COMPLETED|Overall Study||1
128975|NCT01216410|311818|P1|NOT COMPLETED|Overall Study||2
128976|NCT01216410|311816|P3|COMPLETED|Overall Study||100
128977|NCT01216410|311817|P2|COMPLETED|Overall Study||99
128978|NCT01216410|311818|P1|COMPLETED|Overall Study||101
128979|NCT01216410|311816|P3|STARTED|Overall Study||103
128980|NCT01216410|311817|P2|STARTED|Overall Study||100
128981|NCT01216410|311818|P1|STARTED|Overall Study||103
128982|NCT01216397|311838|P2|NOT COMPLETED|Period 2||0
128983|NCT01216397|311839|P1|NOT COMPLETED|Period 2||0
128984|NCT01216397|311838|P2|COMPLETED|Period 2||20
128985|NCT01216397|311839|P1|COMPLETED|Period 2||20
128986|NCT01216397|311838|P2|STARTED|Period 2||20
128987|NCT01216397|311839|P1|STARTED|Period 2||20
128988|NCT01216397|311838|P2|NOT COMPLETED|Washout (35 Days)||0
128989|NCT01216397|311839|P1|NOT COMPLETED|Washout (35 Days)||0
128990|NCT01216397|311838|P2|COMPLETED|Washout (35 Days)||20
128991|NCT01216397|311839|P1|COMPLETED|Washout (35 Days)||20
128992|NCT01216397|311838|P2|STARTED|Washout (35 Days)||20
128993|NCT01216397|311839|P1|STARTED|Washout (35 Days)||20
128994|NCT01216397|311838|P2|NOT COMPLETED|Period 1||0
128995|NCT01216397|311839|P1|NOT COMPLETED|Period 1||0
128996|NCT01216397|311838|P2|COMPLETED|Period 1||20
128997|NCT01216397|311839|P1|COMPLETED|Period 1||20
128998|NCT01216397|311838|P2|STARTED|Period 1||20
128999|NCT01216397|311839|P1|STARTED|Period 1||20
129000|NCT01216319|311891|P1|NOT COMPLETED|Overall Study||4
129001|NCT01216319|311891|P1|COMPLETED|Overall Study||46
129002|NCT01216319|311891|P1|STARTED|Overall Study||50
129003|NCT01216241|311898|P2|NOT COMPLETED|Overall Study||0
129004|NCT01216241|311899|P1|NOT COMPLETED|Overall Study||0
129005|NCT01216241|311898|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
129006|NCT01216241|311899|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
129007|NCT01216241|311898|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
129008|NCT01216241|311899|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
129009|NCT01216163|311908|P3|NOT COMPLETED|Overall Study||0
129010|NCT01216163|311909|P2|NOT COMPLETED|Overall Study||1
129011|NCT01216163|311910|P1|NOT COMPLETED|Overall Study||1
129012|NCT01216163|311908|P3|COMPLETED|Overall Study||85
129013|NCT01216163|311909|P2|COMPLETED|Overall Study||87
129014|NCT01216163|311910|P1|COMPLETED|Overall Study||44
129015|NCT01216163|311908|P3|STARTED|Overall Study||85
129016|NCT01216163|311909|P2|STARTED|Overall Study||88
129017|NCT01216163|311910|P1|STARTED|Overall Study||45
129018|NCT01216072|311962|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
129019|NCT01216072|311963|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
129020|NCT01216072|311962|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
129021|NCT01216072|311963|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
129022|NCT01216072|311962|P2|Safety Set|Open-Label Extension Period (3 Months)||193
129023|NCT01216072|311963|P1|Safety Set|Open-Label Extension Period (3 Months)||0
129024|NCT01216072|311962|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
129025|NCT01216072|311963|P1|STARTED|Open-Label Extension Period (3 Months)||0
129026|NCT01216072|311962|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
129027|NCT01216072|311963|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
129028|NCT01216072|311962|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
129029|NCT01216072|311963|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
129030|NCT01216072|311962|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
129031|NCT01216072|311963|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
129032|NCT01216072|311962|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
129033|NCT01216072|311963|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
129034|NCT01216072|311962|P2|STARTED|Open-Label Core Period ( 6 Months)||263
129035|NCT01216072|311963|P1|STARTED|Open-Label Core Period ( 6 Months)||790
129036|NCT01215981|311991|P2|NOT COMPLETED|Overall Study||1
129037|NCT01215981|311992|P1|NOT COMPLETED|Overall Study||2
129038|NCT01215981|311991|P2|COMPLETED|Overall Study||32
129039|NCT01215981|311992|P1|COMPLETED|Overall Study||33
129040|NCT01215981|311991|P2|STARTED|Overall Study||33
129041|NCT01215981|311992|P1|STARTED|Overall Study||35
129042|NCT01215968|312002|P2|NOT COMPLETED|Overall Study||7
129043|NCT01215968|312003|P1|NOT COMPLETED|Overall Study||2
129044|NCT01215968|312002|P2|COMPLETED|Overall Study||18
129045|NCT01215968|312003|P1|COMPLETED|Overall Study||11
129046|NCT01215968|312002|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
129047|NCT01215968|312003|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
129048|NCT01215968|312002|P2|STARTED|Overall Study||25
129049|NCT01215968|312003|P1|STARTED|Overall Study||13
129050|NCT01215955|312023|P4|NOT COMPLETED|Overall Study||53
129051|NCT01215955|312024|P3|NOT COMPLETED|Overall Study||48
129052|NCT01215955|312025|P2|NOT COMPLETED|Overall Study||53
129053|NCT01215955|312026|P1|NOT COMPLETED|Overall Study||45
129054|NCT01215955|312023|P4|COMPLETED|Overall Study||241
129055|NCT01215955|312024|P3|COMPLETED|Overall Study||244
129056|NCT01215955|312025|P2|COMPLETED|Overall Study||210
129057|NCT01215955|312026|P1|COMPLETED|Overall Study||223
129058|NCT01215955|312023|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
129059|NCT01215955|312024|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
129060|NCT01215955|312025|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
129061|NCT01215955|312026|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
129062|NCT01215955|312023|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
129063|NCT01215955|312024|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
129064|NCT01215955|312025|P2|STARTED|Overall Study||263
129065|NCT01215955|312026|P1|STARTED|Overall Study||268
129066|NCT01215929|312094|P2|NOT COMPLETED|Overall Study||5
129067|NCT01215929|312095|P1|NOT COMPLETED|Overall Study||6
129068|NCT01215929|312094|P2|COMPLETED|Overall Study||12
129069|NCT01215929|312095|P1|COMPLETED|Overall Study||12
129070|NCT01215929|312094|P2|STARTED|Overall Study||17
129071|NCT01215929|312095|P1|STARTED|Overall Study||18
129072|NCT01215851|312107|P6|NOT COMPLETED|Follow up Period||1
129073|NCT01215851|312108|P5|NOT COMPLETED|Follow up Period||0
129074|NCT01215851|312109|P4|NOT COMPLETED|Follow up Period||0
129075|NCT01215851|312110|P3|NOT COMPLETED|Follow up Period||0
129076|NCT01215851|312111|P2|NOT COMPLETED|Follow up Period||0
129077|NCT01215851|312112|P1|NOT COMPLETED|Follow up Period||0
129078|NCT01215851|312107|P6|COMPLETED|Follow up Period||13
129079|NCT01215851|312108|P5|COMPLETED|Follow up Period||10
129080|NCT01215851|312109|P4|COMPLETED|Follow up Period||12
129081|NCT01215851|312110|P3|COMPLETED|Follow up Period||14
129082|NCT01215851|312111|P2|COMPLETED|Follow up Period||14
129083|NCT01215851|312112|P1|COMPLETED|Follow up Period||14
129084|NCT01215851|312107|P6|STARTED|Follow up Period||14
129085|NCT01215851|312108|P5|STARTED|Follow up Period||10
129086|NCT01215851|312109|P4|STARTED|Follow up Period||12
129087|NCT01215851|312110|P3|STARTED|Follow up Period||14
129088|NCT01215851|312111|P2|STARTED|Follow up Period||14
129089|NCT01215851|312112|P1|STARTED|Follow up Period||14
129090|NCT01215851|312107|P6|NOT COMPLETED|Treatment Period||1
129091|NCT01215851|312108|P5|NOT COMPLETED|Treatment Period||0
129092|NCT01215851|312109|P4|NOT COMPLETED|Treatment Period||3
129093|NCT01215851|312110|P3|NOT COMPLETED|Treatment Period||1
129094|NCT01215851|312111|P2|NOT COMPLETED|Treatment Period||1
129095|NCT01215851|312112|P1|NOT COMPLETED|Treatment Period||1
129096|NCT01215851|312107|P6|COMPLETED|Treatment Period||14
129097|NCT01215851|312108|P5|COMPLETED|Treatment Period||10
129098|NCT01215851|312109|P4|COMPLETED|Treatment Period||12
129099|NCT01215851|312110|P3|COMPLETED|Treatment Period||14
129100|NCT01215851|312111|P2|COMPLETED|Treatment Period||14
129101|NCT01215851|312112|P1|COMPLETED|Treatment Period||14
129102|NCT01215851|312107|P6|STARTED|Treatment Period||15
129103|NCT01215851|312108|P5|STARTED|Treatment Period||10
129104|NCT01215851|312109|P4|STARTED|Treatment Period||15
129105|NCT01215851|312110|P3|STARTED|Treatment Period||15
129106|NCT01215851|312111|P2|STARTED|Treatment Period||15
129107|NCT01215851|312112|P1|STARTED|Treatment Period||15
129108|NCT01215786|312153|P3|NOT COMPLETED|Overall Study||0
129109|NCT01215786|312154|P2|NOT COMPLETED|Overall Study||0
129110|NCT01215786|312155|P1|NOT COMPLETED|Overall Study||0
129111|NCT01215786|312153|P3|COMPLETED|Overall Study||10
129112|NCT01215786|312154|P2|COMPLETED|Overall Study||19
129113|NCT01215786|312155|P1|COMPLETED|Overall Study||21
129114|NCT01215786|312153|P3|STARTED|Overall Study||10
129115|NCT01215786|312154|P2|STARTED|Overall Study||19
129116|NCT01215786|312155|P1|STARTED|Overall Study||21
129117|NCT01215734|312171|P2|NOT COMPLETED|Overall Study||1
129118|NCT01215734|312172|P1|NOT COMPLETED|Overall Study||0
129119|NCT01215734|312171|P2|COMPLETED|Overall Study||14
129120|NCT01215734|312172|P1|COMPLETED|Overall Study||29
129121|NCT01215734|312171|P2|STARTED|Overall Study||15
129122|NCT01215734|312172|P1|STARTED|Overall Study||29
129123|NCT01215721|312180|P1|NOT COMPLETED|Overall Study||2
129124|NCT01215721|312180|P1|COMPLETED|Overall Study||38
129125|NCT01215721|312180|P1|STARTED|Overall Study||40
129126|NCT01215695|312186|P2|NOT COMPLETED|Overall Study||0
129127|NCT01215695|312187|P1|NOT COMPLETED|Overall Study||0
129128|NCT01215695|312186|P2|COMPLETED|Overall Study||70
129129|NCT01215695|312187|P1|COMPLETED|Overall Study||70
129130|NCT01215695|312186|P2|STARTED|Overall Study||70
129131|NCT01215695|312187|P1|STARTED|Overall Study||70
129132|NCT01215643|312206|P5|NOT COMPLETED|Overall Study||11
129133|NCT01215643|312207|P4|NOT COMPLETED|Overall Study||4
129134|NCT01215643|312208|P3|NOT COMPLETED|Overall Study||12
129135|NCT01215643|312209|P2|NOT COMPLETED|Overall Study||4
129136|NCT01215643|312210|P1|NOT COMPLETED|Overall Study||9
129137|NCT01215643|312206|P5|COMPLETED|Overall Study||29
129138|NCT01215643|312207|P4|COMPLETED|Overall Study||35
129139|NCT01215643|312208|P3|COMPLETED|Overall Study||82
129140|NCT01215643|312209|P2|COMPLETED|Overall Study||80
129141|NCT01215643|312210|P1|COMPLETED|Overall Study||74
129142|NCT01215643|312206|P5|STARTED|Overall Study||40
129143|NCT01215643|312207|P4|STARTED|Overall Study||39
129144|NCT01215643|312208|P3|STARTED|Overall Study||94
129145|NCT01215643|312209|P2|STARTED|Overall Study||84
129146|NCT01215643|312210|P1|STARTED|Overall Study||83
129147|NCT01215513|312312|P1|NOT COMPLETED|Overall Study||45
129148|NCT01215513|312312|P1|COMPLETED|Overall Study||112
129149|NCT01215513|312312|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
129150|NCT01215513|312312|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
129151|NCT01215513|312312|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
129152|NCT01215513|312312|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
129153|NCT01215435|312321|P2|NOT COMPLETED|Overall Study||16
129154|NCT01215435|312322|P1|NOT COMPLETED|Overall Study||19
129155|NCT01215435|312321|P2|COMPLETED|Overall Study||107
129156|NCT01215435|312322|P1|COMPLETED|Overall Study||103
129157|NCT01215435|312321|P2|STARTED|Overall Study||123
129158|NCT01215435|312322|P1|STARTED|Overall Study||122
129159|NCT01215422|312336|P4|NOT COMPLETED|Overall Study||8
129160|NCT01215422|312337|P3|NOT COMPLETED|Overall Study||3
129161|NCT01215422|312338|P2|NOT COMPLETED|Overall Study||0
129162|NCT01215422|312339|P1|NOT COMPLETED|Overall Study||8
129163|NCT01215422|312336|P4|COMPLETED|Overall Study||193
129164|NCT01215422|312337|P3|COMPLETED|Overall Study||193
129165|NCT01215422|312338|P2|COMPLETED|Overall Study||249
129166|NCT01215422|312339|P1|COMPLETED|Overall Study||6
129167|NCT01215422|312336|P4|STARTED|Overall Study||201
129168|NCT01215422|312337|P3|STARTED|Overall Study||196
129169|NCT01215422|312338|P2|STARTED|Overall Study||249
129170|NCT01215422|312339|P1|STARTED|Overall Study||14
129171|NCT01215357|312361|P1|NOT COMPLETED|Overall Study||12
129172|NCT01215357|312361|P1|COMPLETED|Overall Study||22
129173|NCT01215357|312361|P1|STARTED|Overall Study||34
129174|NCT01215344|312367|P2|NOT COMPLETED|Overall Study||0
129175|NCT01215344|312368|P1|NOT COMPLETED|Overall Study||10
129176|NCT01215344|312367|P2|COMPLETED|Overall Study||3
129177|NCT01215344|312368|P1|COMPLETED|Overall Study||23
129178|NCT01215344|312367|P2|STARTED|Overall Study||3
129179|NCT01215344|312368|P1|STARTED|Overall Study||33
129180|NCT01215292|312381|P5|NOT COMPLETED|Overall Study||0
129181|NCT01215292|312382|P4|NOT COMPLETED|Overall Study||0
129182|NCT01215292|312383|P3|NOT COMPLETED|Overall Study||0
129183|NCT01215292|312384|P2|NOT COMPLETED|Overall Study||0
129184|NCT01215292|312385|P1|NOT COMPLETED|Overall Study||0
129185|NCT01215292|312381|P5|COMPLETED|Overall Study||8
129186|NCT01215292|312382|P4|COMPLETED|Overall Study||8
129187|NCT01215292|312383|P3|COMPLETED|Overall Study||8
129188|NCT01215292|312384|P2|COMPLETED|Overall Study||8
129189|NCT01215292|312385|P1|COMPLETED|Overall Study||8
129190|NCT01215292|312381|P5|STARTED|Overall Study||8
129191|NCT01215292|312382|P4|STARTED|Overall Study||8
129192|NCT01215292|312383|P3|STARTED|Overall Study||8
129193|NCT01215292|312384|P2|STARTED|Overall Study||8
129194|NCT01215292|312385|P1|STARTED|Overall Study||8
129195|NCT01215279|312409|P2|NOT COMPLETED|Overall Study||0
129196|NCT01215279|312410|P1|NOT COMPLETED|Overall Study||0
129197|NCT01215279|312409|P2|COMPLETED|Overall Study||32
129198|NCT01215279|312410|P1|COMPLETED|Overall Study||31
129199|NCT01215279|312409|P2|STARTED|Overall Study||32
129200|NCT01215279|312410|P1|STARTED|Overall Study||31
129201|NCT01215227|312480|P6|NOT COMPLETED|Overall Study||58
129202|NCT01215227|312481|P5|NOT COMPLETED|Overall Study||48
129203|NCT01215227|312482|P4|NOT COMPLETED|Overall Study||49
129204|NCT01215227|312483|P3|NOT COMPLETED|Overall Study||57
129205|NCT01215227|312484|P2|NOT COMPLETED|Overall Study||119
129206|NCT01215227|312485|P1|NOT COMPLETED|Overall Study||121
129207|NCT01215227|312480|P6|COMPLETED|Overall Study||51
129208|NCT01215227|312481|P5|COMPLETED|Overall Study||45
129209|NCT01215227|312482|P4|COMPLETED|Overall Study||48
129210|NCT01215227|312483|P3|COMPLETED|Overall Study||50
129211|NCT01215227|312484|P2|COMPLETED|Overall Study||96
129212|NCT01215227|312485|P1|COMPLETED|Overall Study||97
129213|NCT01215227|312480|P6|Treated|Overall Study||108
129214|NCT01215227|312481|P5|Treated|Overall Study||93
129215|NCT01215227|312482|P4|Treated|Overall Study||96
129216|NCT01215227|312483|P3|Treated|Overall Study||106
129217|NCT01215227|312484|P2|Treated|Overall Study||215
129218|NCT01215227|312485|P1|Treated|Overall Study||218
129219|NCT01215227|312480|P6|STARTED|Overall Study||109
129220|NCT01215227|312481|P5|STARTED|Overall Study||93
129221|NCT01215227|312482|P4|STARTED|Overall Study||97
129222|NCT01215227|312483|P3|STARTED|Overall Study||107
129223|NCT01215227|312484|P2|STARTED|Overall Study||215
129224|NCT01215227|312485|P1|STARTED|Overall Study||218
129225|NCT01215123|312529|P1|NOT COMPLETED|Overall Study||0
129226|NCT01215123|312529|P1|COMPLETED|Overall Study||28
129227|NCT01215123|312529|P1|STARTED|Overall Study||28
129228|NCT01215110|312539|P5|NOT COMPLETED|Overall Study||0
129229|NCT01215110|312540|P4|NOT COMPLETED|Overall Study||1
129230|NCT01215110|312541|P3|NOT COMPLETED|Overall Study||2
129231|NCT01215110|312542|P2|NOT COMPLETED|Overall Study||0
129232|NCT01215110|312543|P1|NOT COMPLETED|Overall Study||0
129233|NCT01215110|312539|P5|COMPLETED|Overall Study||8
129234|NCT01215110|312540|P4|COMPLETED|Overall Study||14
129235|NCT01215110|312541|P3|COMPLETED|Overall Study||13
129236|NCT01215110|312542|P2|COMPLETED|Overall Study||15
129237|NCT01215110|312543|P1|COMPLETED|Overall Study||15
129238|NCT01215110|312539|P5|STARTED|Overall Study||8
129239|NCT01215110|312540|P4|STARTED|Overall Study||15
129240|NCT01215110|312541|P3|STARTED|Overall Study||15
129241|NCT01215110|312542|P2|STARTED|Overall Study||15
129242|NCT01215110|312543|P1|STARTED|Overall Study||15
129243|NCT01215097|312604|P2|NOT COMPLETED|Overall Study||14
129244|NCT01215097|312605|P1|NOT COMPLETED|Overall Study||12
129245|NCT01215097|312604|P2|COMPLETED|Overall Study||191
129246|NCT01215097|312605|P1|COMPLETED|Overall Study||88
129247|NCT01215097|312604|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
129248|NCT01215097|312605|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
129249|NCT01215032|312637|P1|NOT COMPLETED|Overall Study||20
129250|NCT01215032|312637|P1|COMPLETED|Overall Study||1
129251|NCT01215032|312637|P1|STARTED|Overall Study||21
129252|NCT01214980|312647|P2|NOT COMPLETED|Overall Study||2
129253|NCT01214980|312648|P1|NOT COMPLETED|Overall Study||3
129254|NCT01214980|312647|P2|COMPLETED|Overall Study||14
129255|NCT01214980|312648|P1|COMPLETED|Overall Study||13
129256|NCT01214980|312647|P2|STARTED|Overall Study||16
129257|NCT01214980|312648|P1|STARTED|Overall Study||16
129258|NCT01214915|312662|P1|NOT COMPLETED|Overall Study||11
129259|NCT01214915|312662|P1|COMPLETED|Overall Study||42
129260|NCT01214915|312662|P1|STARTED|Overall Study||53
129261|NCT01214850|312673|P3|NOT COMPLETED|Overall Study||161
129262|NCT01214850|312674|P2|NOT COMPLETED|Overall Study||144
129263|NCT01214850|312675|P1|NOT COMPLETED|Overall Study||183
129264|NCT01214850|312673|P3|COMPLETED|Overall Study||826
129265|NCT01214850|312674|P2|COMPLETED|Overall Study||844
129266|NCT01214850|312675|P1|COMPLETED|Overall Study||796
129267|NCT01214850|312673|P3|STARTED|Overall Study||987
129268|NCT01214850|312674|P2|STARTED|Overall Study||988
129269|NCT01214850|312675|P1|STARTED|Overall Study||979
129270|NCT01214837|312759|P3|NOT COMPLETED|Overall Study||62
129271|NCT01214837|312760|P2|NOT COMPLETED|Overall Study||64
129272|NCT01214837|312761|P1|NOT COMPLETED|Overall Study||54
129273|NCT01214837|312759|P3|COMPLETED|Overall Study||184
129274|NCT01214837|312760|P2|COMPLETED|Overall Study||192
129275|NCT01214837|312761|P1|COMPLETED|Overall Study||195
129276|NCT01214837|312759|P3|STARTED|Overall Study||246
129277|NCT01214837|312760|P2|STARTED|Overall Study||256
129278|NCT01214837|312761|P1|STARTED|Overall Study||249
129279|NCT01214824|312798|P1|NOT COMPLETED|Overall Study||3
129280|NCT01214824|312798|P1|COMPLETED|Overall Study||29
129281|NCT01214824|312798|P1|STARTED|Overall Study||32
129282|NCT01214811|312805|P1|NOT COMPLETED|Overall Study||3
129283|NCT01214811|312805|P1|COMPLETED|Overall Study||24
129284|NCT01214811|312805|P1|STARTED|Overall Study||27
129285|NCT01214759|312809|P1|NOT COMPLETED|Overall Study||48
129286|NCT01214759|312809|P1|COMPLETED|Overall Study||55
129287|NCT01214759|312809|P1|28 Days nPEP Completion|Overall Study||85
129288|NCT01214759|312809|P1|STARTED|Overall Study||103
129289|NCT01214720|312817|P2|NOT COMPLETED|Overall Study||68
129290|NCT01214720|312818|P1|NOT COMPLETED|Overall Study||85
129291|NCT01214720|312817|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
129292|NCT01214720|312818|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
129293|NCT01214720|312817|P2|STARTED|Overall Study||301
129294|NCT01214720|312818|P1|STARTED|Overall Study||306
129295|NCT01214616|312839|P4|NOT COMPLETED|Overall Study||6
129296|NCT01214616|312840|P3|NOT COMPLETED|Overall Study||3
129297|NCT01214616|312841|P2|NOT COMPLETED|Overall Study||5
129298|NCT01214616|312842|P1|NOT COMPLETED|Overall Study||3
129299|NCT01214616|312839|P4|COMPLETED|Overall Study||0
129300|NCT01214616|312840|P3|COMPLETED|Overall Study||0
129301|NCT01214616|312841|P2|COMPLETED|Overall Study||0
129302|NCT01214616|312842|P1|COMPLETED|Overall Study||0
129303|NCT01214616|312839|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
129304|NCT01214616|312840|P3|STARTED|Overall Study||3
129305|NCT01214616|312841|P2|STARTED|Overall Study||5
129306|NCT01214616|312842|P1|STARTED|Overall Study||3
129307|NCT01214434|312878|P2|NOT COMPLETED|Overall Study||2
129308|NCT01214434|312879|P1|NOT COMPLETED|Overall Study||4
129309|NCT01214434|312878|P2|COMPLETED|Overall Study||25
129310|NCT01214434|312879|P1|COMPLETED|Overall Study||11
129311|NCT01214434|312878|P2|STARTED|Overall Study||27
129312|NCT01214434|312879|P1|STARTED|Overall Study||15
129313|NCT01214395|312895|P1|NOT COMPLETED|Overall Study||5
129314|NCT01214395|312895|P1|COMPLETED|Overall Study||0
129315|NCT01214395|312895|P1|STARTED|Overall Study||5
129316|NCT01214330|312900|P1|NOT COMPLETED|Overall Study||48
129317|NCT01214330|312900|P1|COMPLETED|Overall Study||102
129318|NCT01214330|312900|P1|STARTED|Overall Study||150
129319|NCT01214252|312904|P1|NOT COMPLETED|Overall Study||82
129320|NCT01214252|312904|P1|COMPLETED|Overall Study||343
129321|NCT01214252|312904|P1|STARTED|Overall Study||425
129322|NCT01214239|312912|P2|NOT COMPLETED|Overall Study||18
129323|NCT01214239|312913|P1|NOT COMPLETED|Overall Study||12
129324|NCT01214239|312912|P2|COMPLETED|Overall Study||182
129325|NCT01214239|312913|P1|COMPLETED|Overall Study||87
129326|NCT01214239|312912|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
129327|NCT01214239|312913|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
129328|NCT01214187|312947|P2|NOT COMPLETED|Overall Study||6
129329|NCT01214187|312948|P1|NOT COMPLETED|Overall Study||7
129330|NCT01214187|312947|P2|COMPLETED|Overall Study||23
129331|NCT01214187|312948|P1|COMPLETED|Overall Study||22
129332|NCT01214187|312947|P2|STARTED|Overall Study||29
129333|NCT01214187|312948|P1|STARTED|Overall Study||29
129334|NCT01214174|312965|P3|NOT COMPLETED|Overall Study||1
129335|NCT01214174|312966|P2|NOT COMPLETED|Overall Study||0
129336|NCT01214174|312967|P1|NOT COMPLETED|Overall Study||0
129337|NCT01214174|312965|P3|COMPLETED|Overall Study||13
129338|NCT01214174|312966|P2|COMPLETED|Overall Study||16
129339|NCT01214174|312967|P1|COMPLETED|Overall Study||13
129340|NCT01214174|312965|P3|STARTED|Overall Study||14
129341|NCT01214174|312966|P2|STARTED|Overall Study||16
129342|NCT01214174|312967|P1|STARTED|Overall Study||13
129343|NCT01214161|312977|P2|NOT COMPLETED|Overall Study||0
129344|NCT01214161|312978|P1|NOT COMPLETED|Overall Study||0
129345|NCT01214161|312977|P2|COMPLETED|Overall Study||100
129346|NCT01214161|312978|P1|COMPLETED|Overall Study||100
129347|NCT01214161|312977|P2|STARTED|Overall Study||100
129348|NCT01214161|312978|P1|STARTED|Overall Study||100
129349|NCT01214109|312988|P4|NOT COMPLETED|Overall Study||0
129350|NCT01214109|312989|P3|NOT COMPLETED|Overall Study||0
129351|NCT01214109|312990|P2|NOT COMPLETED|Overall Study||0
129352|NCT01214109|312991|P1|NOT COMPLETED|Overall Study||0
129353|NCT01214109|312988|P4|COMPLETED|Overall Study||24
129354|NCT01214109|312989|P3|COMPLETED|Overall Study||24
129355|NCT01214109|312990|P2|COMPLETED|Overall Study||24
129356|NCT01214109|312991|P1|COMPLETED|Overall Study||24
129357|NCT01214109|312988|P4|STARTED|Overall Study||24
129358|NCT01214109|312989|P3|STARTED|Overall Study||24
129359|NCT01214109|312990|P2|STARTED|Overall Study||24
129360|NCT01214109|312991|P1|STARTED|Overall Study||24
129361|NCT01214083|313083|P3|NOT COMPLETED|Overall Study||10
129362|NCT01214083|313084|P2|NOT COMPLETED|Overall Study||10
129363|NCT01214083|313085|P1|NOT COMPLETED|Overall Study||12
129364|NCT01214083|313083|P3|COMPLETED|Overall Study||21
129365|NCT01214083|313084|P2|COMPLETED|Overall Study||23
129366|NCT01214083|313085|P1|COMPLETED|Overall Study||19
129367|NCT01214083|313083|P3|STARTED|Overall Study||31
129368|NCT01214083|313084|P2|STARTED|Overall Study||33
129369|NCT01214083|313085|P1|STARTED|Overall Study||31
129370|NCT01213966|313121|P4|NOT COMPLETED|Overall Study||1
129371|NCT01213966|313122|P3|NOT COMPLETED|Overall Study||3
129372|NCT01213966|313123|P2|NOT COMPLETED|Overall Study||0
129373|NCT01213966|313124|P1|NOT COMPLETED|Overall Study||1
129374|NCT01213966|313121|P4|COMPLETED|Overall Study||20
129375|NCT01213966|313122|P3|COMPLETED|Overall Study||17
129376|NCT01213966|313123|P2|COMPLETED|Overall Study||20
129377|NCT01213966|313124|P1|COMPLETED|Overall Study||19
129378|NCT01213966|313121|P4|STARTED|Overall Study||21
129379|NCT01213966|313122|P3|STARTED|Overall Study||20
129380|NCT01213966|313123|P2|STARTED|Overall Study||20
129381|NCT01213966|313124|P1|STARTED|Overall Study||20
129382|NCT01213836|313136|P2|NOT COMPLETED|Period 2, Second Intervention||0
129383|NCT01213836|313137|P1|NOT COMPLETED|Period 2, Second Intervention||0
129384|NCT01213836|313136|P2|COMPLETED|Period 2, Second Intervention||29
129385|NCT01213836|313137|P1|COMPLETED|Period 2, Second Intervention||31
129386|NCT01213836|313136|P2|STARTED|Period 2, Second Intervention||29
129387|NCT01213836|313137|P1|STARTED|Period 2, Second Intervention||31
129388|NCT01213836|313136|P2|NOT COMPLETED|Period 1, First Intervention||3
129389|NCT01213836|313137|P1|NOT COMPLETED|Period 1, First Intervention||3
129390|NCT01213836|313136|P2|COMPLETED|Period 1, First Intervention||29
129391|NCT01213836|313137|P1|COMPLETED|Period 1, First Intervention||31
129392|NCT01213836|313136|P2|STARTED|Period 1, First Intervention||32
129393|NCT01213836|313137|P1|STARTED|Period 1, First Intervention||34
129394|NCT01213823|313157|P2|NOT COMPLETED|Overall Study||0
129395|NCT01213823|313158|P1|NOT COMPLETED|Overall Study||0
129396|NCT01213823|313157|P2|COMPLETED|Overall Study||467
129397|NCT01213823|313158|P1|COMPLETED|Overall Study||69
129398|NCT01213823|313157|P2|STARTED|Overall Study||467
129399|NCT01213823|313158|P1|STARTED|Overall Study||69
129400|NCT01213706|313164|P1|NOT COMPLETED|WBPA||0
129401|NCT01213706|313164|P1|COMPLETED|WBPA||45
129402|NCT01213706|313164|P1|STARTED|WBPA||45
129403|NCT01213706|313164|P1|NOT COMPLETED|Washout (1 Hour)||0
129404|NCT01213706|313164|P1|COMPLETED|Washout (1 Hour)||45
129405|NCT01213706|313164|P1|STARTED|Washout (1 Hour)||45
129406|NCT01213706|313164|P1|NOT COMPLETED|Sham WBPA||0
129407|NCT01213706|313164|P1|COMPLETED|Sham WBPA||45
129408|NCT01213706|313164|P1|STARTED|Sham WBPA||45
129409|NCT01213589|313173|P3|NOT COMPLETED|Overall Study||8
129410|NCT01213589|313174|P2|NOT COMPLETED|Overall Study||5
129411|NCT01213589|313175|P1|NOT COMPLETED|Overall Study||13
129412|NCT01213589|313173|P3|COMPLETED|Overall Study||18
129413|NCT01213589|313174|P2|COMPLETED|Overall Study||19
129414|NCT01213589|313175|P1|COMPLETED|Overall Study||37
129415|NCT01213589|313173|P3|STARTED|Overall Study||26
129416|NCT01213589|313174|P2|STARTED|Overall Study||24
129417|NCT01213589|313175|P1|STARTED|Overall Study||50
129418|NCT01213576|313205|P4|NOT COMPLETED|Overall Study||4
129419|NCT01213576|313206|P3|NOT COMPLETED|Overall Study||5
129420|NCT01213576|313207|P2|NOT COMPLETED|Overall Study||4
129421|NCT01213576|313208|P1|NOT COMPLETED|Overall Study||3
129422|NCT01213576|313205|P4|COMPLETED|Overall Study||13
129423|NCT01213576|313206|P3|COMPLETED|Overall Study||13
129424|NCT01213576|313207|P2|COMPLETED|Overall Study||13
129425|NCT01213576|313208|P1|COMPLETED|Overall Study||15
129426|NCT01213576|313205|P4|STARTED|Overall Study||17
129427|NCT01213576|313206|P3|STARTED|Overall Study||18
129428|NCT01213576|313207|P2|STARTED|Overall Study||17
129429|NCT01213576|313208|P1|STARTED|Overall Study||18
129430|NCT01213329|313224|P2|NOT COMPLETED|Phase 2||0
129431|NCT01213329|313225|P1|NOT COMPLETED|Phase 2||0
129432|NCT01213329|313224|P2|COMPLETED|Phase 2||0
129433|NCT01213329|313225|P1|COMPLETED|Phase 2||0
129434|NCT01213329|313224|P2|STARTED|Phase 2||0
129435|NCT01213329|313225|P1|STARTED|Phase 2||0
129436|NCT01213329|313224|P2|NOT COMPLETED|Screening||0
129437|NCT01213329|313225|P1|NOT COMPLETED|Screening||0
129438|NCT01213329|313224|P2|COMPLETED|Screening||25
129439|NCT01213329|313225|P1|COMPLETED|Screening||25
129440|NCT01213329|313224|P2|STARTED|Screening||25
129441|NCT01213329|313225|P1|STARTED|Screening||25
129442|NCT01213316|313231|P1|NOT COMPLETED|Overall Study||0
129443|NCT01213316|313231|P1|COMPLETED|Overall Study||451
129444|NCT01213316|313231|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
129445|NCT01213316|313231|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
129446|NCT01213316|313231|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
129447|NCT01213316|313231|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
129448|NCT01213316|313231|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
129449|NCT01213264|313250|P3|NOT COMPLETED|Overall Study||6
129450|NCT01213264|313251|P2|NOT COMPLETED|Overall Study||2
129451|NCT01213264|313252|P1|NOT COMPLETED|Overall Study||2
129452|NCT01213264|313250|P3|COMPLETED|Overall Study||321
129453|NCT01213264|313251|P2|COMPLETED|Overall Study||175
129454|NCT01213264|313252|P1|COMPLETED|Overall Study||153
129455|NCT01213264|313250|P3|STARTED|Overall Study||327
129456|NCT01213264|313251|P2|STARTED|Overall Study||177
129457|NCT01213264|313252|P1|STARTED|Overall Study||155
129458|NCT01213251|313272|P3|NOT COMPLETED|Overall Study||11
129459|NCT01213251|313273|P2|NOT COMPLETED|Overall Study||4
129460|NCT01213251|313274|P1|NOT COMPLETED|Overall Study||6
129461|NCT01213251|313272|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
129462|NCT01213251|313273|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
129463|NCT01213251|313274|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
129464|NCT01213251|313272|P3|STARTED|Overall Study||45
129465|NCT01213251|313273|P2|STARTED|Overall Study||41
129466|NCT01213251|313274|P1|STARTED|Overall Study||40
129467|NCT01213199|313295|P1|NOT COMPLETED|Overall Study||4
129468|NCT01213199|313295|P1|COMPLETED|Overall Study||16
129469|NCT01213199|313295|P1|STARTED|Overall Study||20
129470|NCT01213173|313301|P2|NOT COMPLETED|Overall Study||16
129471|NCT01213173|313302|P1|NOT COMPLETED|Overall Study||12
129472|NCT01213173|313301|P2|COMPLETED|Overall Study|Patients who completed the study|110
129473|NCT01213173|313302|P1|COMPLETED|Overall Study|Patients who completed the study|113
129474|NCT01213173|313301|P2|Patients Included in PP Population|Overall Study||89
129475|NCT01213173|313302|P1|Patients Included in PP Population|Overall Study||102
129476|NCT01213173|313301|P2|Patients Included in ITT Population|Overall Study||115
129477|NCT01213173|313302|P1|Patients Included in ITT Population|Overall Study||116
129478|NCT01213173|313301|P2|Patients Included in Safety Population|Overall Study||112
129479|NCT01213173|313302|P1|Patients Included in Safety Population|Overall Study||139
129480|NCT01213173|313301|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
129481|NCT01213173|313302|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
129482|NCT01213043|313334|P2|NOT COMPLETED|Follow-up||0
129483|NCT01213043|313335|P1|NOT COMPLETED|Follow-up||0
129484|NCT01213043|313334|P2|COMPLETED|Follow-up||15
129485|NCT01213043|313335|P1|COMPLETED|Follow-up||15
129486|NCT01213043|313334|P2|STARTED|Follow-up||15
129487|NCT01213043|313335|P1|STARTED|Follow-up||15
129488|NCT01213043|313334|P2|NOT COMPLETED|Treatment Period 2||0
129489|NCT01213043|313335|P1|NOT COMPLETED|Treatment Period 2||0
129490|NCT01213043|313334|P2|COMPLETED|Treatment Period 2||15
129491|NCT01213043|313335|P1|COMPLETED|Treatment Period 2||15
129492|NCT01213043|313334|P2|STARTED|Treatment Period 2||15
129493|NCT01213043|313335|P1|STARTED|Treatment Period 2||15
129494|NCT01213043|313334|P2|NOT COMPLETED|Washout Period||0
129495|NCT01213043|313335|P1|NOT COMPLETED|Washout Period||0
129496|NCT01213043|313334|P2|COMPLETED|Washout Period||15
129497|NCT01213043|313335|P1|COMPLETED|Washout Period||15
129498|NCT01213043|313334|P2|STARTED|Washout Period||15
129499|NCT01213043|313335|P1|STARTED|Washout Period||15
129500|NCT01213043|313334|P2|NOT COMPLETED|Treatment Period 1||0
129501|NCT01213043|313335|P1|NOT COMPLETED|Treatment Period 1||0
129502|NCT01213043|313334|P2|COMPLETED|Treatment Period 1||15
129503|NCT01213043|313335|P1|COMPLETED|Treatment Period 1||15
129504|NCT01213043|313334|P2|STARTED|Treatment Period 1||15
129505|NCT01213043|313335|P1|STARTED|Treatment Period 1||15
129506|NCT01212991|313363|P2|NOT COMPLETED|Overall Study||374
129507|NCT01212991|313364|P1|NOT COMPLETED|Overall Study||613
129508|NCT01212991|313363|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
129509|NCT01212991|313364|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
129510|NCT01212991|313363|P2|STARTED|Overall Study||845
129511|NCT01212991|313364|P1|STARTED|Overall Study||872
129512|NCT01212874|313384|P2|NOT COMPLETED|Overall Study||23
129513|NCT01212874|313385|P1|NOT COMPLETED|Overall Study||22
129514|NCT01212874|313384|P2|COMPLETED|Overall Study||12
129515|NCT01212874|313385|P1|COMPLETED|Overall Study||13
129516|NCT01212874|313384|P2|Received Allocated Intervention|Overall Study||12
129517|NCT01212874|313385|P1|Received Allocated Intervention|Overall Study||13
129518|NCT01212874|313384|P2|STARTED|Overall Study||35
129519|NCT01212874|313385|P1|STARTED|Overall Study||35
129520|NCT01212770|313396|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
129521|NCT01212770|313397|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
129522|NCT01212770|313398|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
129523|NCT01212770|313399|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
129524|NCT01212770|313400|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
129525|NCT01212770|313401|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
129526|NCT01212770|313402|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
129527|NCT01212770|313403|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
129528|NCT01212770|313404|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
129529|NCT01212770|313396|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
129530|NCT01212770|313397|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
129531|NCT01212770|313398|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
129532|NCT01212770|313399|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
129533|NCT01212770|313400|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
129534|NCT01212770|313401|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
129535|NCT01212770|313402|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
129536|NCT01212770|313403|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
129537|NCT01212770|313404|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
129538|NCT01212770|313396|P9|STARTED|Long-term Safety Phase (Year 5)||42
129539|NCT01212770|313397|P8|STARTED|Long-term Safety Phase (Year 5)||32
129540|NCT01212770|313398|P7|STARTED|Long-term Safety Phase (Year 5)||0
129541|NCT01212770|313399|P6|STARTED|Long-term Safety Phase (Year 5)||0
129542|NCT01212770|313400|P5|STARTED|Long-term Safety Phase (Year 5)||0
129543|NCT01212770|313401|P4|STARTED|Long-term Safety Phase (Year 5)||0
129544|NCT01212770|313402|P3|STARTED|Long-term Safety Phase (Year 5)||83
129545|NCT01212770|313403|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
129546|NCT01212770|313404|P1|STARTED|Long-term Safety Phase (Year 5)||0
129547|NCT01212770|313396|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
129548|NCT01212770|313397|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
129549|NCT01212770|313398|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
129550|NCT01212770|313399|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
129551|NCT01212770|313400|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
129552|NCT01212770|313401|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
129553|NCT01212770|313402|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
129554|NCT01212770|313403|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
129555|NCT01212770|313404|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
129556|NCT01212770|313396|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
129557|NCT01212770|313397|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
129558|NCT01212770|313398|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
129559|NCT01212770|313399|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
129560|NCT01212770|313400|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
129561|NCT01212770|313401|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
129562|NCT01212770|313402|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
129563|NCT01212770|313403|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
129564|NCT01212770|313404|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
129565|NCT01212770|313396|P9|STARTED|Long-term Safety Phase (Year 4)||44
129566|NCT01212770|313397|P8|STARTED|Long-term Safety Phase (Year 4)||35
129567|NCT01212770|313398|P7|STARTED|Long-term Safety Phase (Year 4)||0
129568|NCT01212770|313399|P6|STARTED|Long-term Safety Phase (Year 4)||0
129569|NCT01212770|313400|P5|STARTED|Long-term Safety Phase (Year 4)||0
129570|NCT01212770|313401|P4|STARTED|Long-term Safety Phase (Year 4)||0
129571|NCT01212770|313402|P3|STARTED|Long-term Safety Phase (Year 4)||94
129572|NCT01212770|313403|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
129573|NCT01212770|313404|P1|STARTED|Long-term Safety Phase (Year 4)||0
129574|NCT01212770|313396|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
129575|NCT01212770|313397|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
129576|NCT01212770|313398|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
129577|NCT01212770|313399|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
129578|NCT01212770|313400|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
129579|NCT01212770|313401|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
129580|NCT01212770|313402|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
129581|NCT01212770|313403|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
129582|NCT01212770|313404|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
129583|NCT01212770|313396|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
129584|NCT01212770|313397|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
129585|NCT01212770|313398|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
129586|NCT01212770|313399|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
129587|NCT01212770|313400|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
129588|NCT01212770|313401|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
129589|NCT01212770|313402|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
129590|NCT01212770|313403|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
129591|NCT01212770|313404|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
129592|NCT01212770|313396|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
129593|NCT01212770|313397|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
129594|NCT01212770|313398|P7|STARTED|Long-term Safety Phase (Year 3)||0
129595|NCT01212770|313399|P6|STARTED|Long-term Safety Phase (Year 3)||0
129596|NCT01212770|313400|P5|STARTED|Long-term Safety Phase (Year 3)||0
129597|NCT01212770|313401|P4|STARTED|Long-term Safety Phase (Year 3)||0
129598|NCT01212770|313402|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
129599|NCT01212770|313403|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
129600|NCT01212770|313404|P1|STARTED|Long-term Safety Phase (Year 3)||0
129601|NCT01212770|313396|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
129602|NCT01212770|313397|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
129603|NCT01212770|313398|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
129604|NCT01212770|313399|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
129605|NCT01212770|313400|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
129606|NCT01212770|313401|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
129607|NCT01212770|313402|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
129608|NCT01212770|313403|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
129609|NCT01212770|313404|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
129610|NCT01212770|313396|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
129611|NCT01212770|313397|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
129612|NCT01212770|313398|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
129613|NCT01212770|313399|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
129614|NCT01212770|313400|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
129615|NCT01212770|313401|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
129616|NCT01212770|313402|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
129617|NCT01212770|313403|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
129618|NCT01212770|313404|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
129619|NCT01212770|313396|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
129620|NCT01212770|313397|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
129621|NCT01212770|313398|P7|STARTED|Long-term Safety Phase (Year 2)||0
129622|NCT01212770|313399|P6|STARTED|Long-term Safety Phase (Year 2)||0
129623|NCT01212770|313400|P5|STARTED|Long-term Safety Phase (Year 2)||0
129624|NCT01212770|313401|P4|STARTED|Long-term Safety Phase (Year 2)||0
129625|NCT01212770|313402|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
129626|NCT01212770|313403|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
129627|NCT01212770|313404|P1|STARTED|Long-term Safety Phase (Year 2)||0
129628|NCT01212770|313396|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
129629|NCT01212770|313397|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
129630|NCT01212770|313398|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
129631|NCT01212770|313399|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
129632|NCT01212770|313400|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
129633|NCT01212770|313401|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
129634|NCT01212770|313402|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
129635|NCT01212770|313403|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
129636|NCT01212770|313404|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
129637|NCT01212770|313396|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
129638|NCT01212770|313397|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
129639|NCT01212770|313398|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
129640|NCT01212770|313399|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
129641|NCT01212770|313400|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
129642|NCT01212770|313401|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
129643|NCT01212770|313402|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
129644|NCT01212770|313403|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
129645|NCT01212770|313404|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
129646|NCT01212770|313396|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
129647|NCT01212770|313397|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
129648|NCT01212770|313398|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
129649|NCT01212770|313399|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
129650|NCT01212770|313400|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
129651|NCT01212770|313401|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
129652|NCT01212770|313402|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
129653|NCT01212770|313403|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
129654|NCT01212770|313404|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
129655|NCT01212770|313396|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129656|NCT01212770|313397|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129657|NCT01212770|313398|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129658|NCT01212770|313399|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129659|NCT01212770|313400|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129660|NCT01212770|313401|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129661|NCT01212770|313402|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
129662|NCT01212770|313403|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
129663|NCT01212770|313404|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
129664|NCT01212770|313396|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129665|NCT01212770|313397|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129666|NCT01212770|313398|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129667|NCT01212770|313399|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129668|NCT01212770|313400|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129669|NCT01212770|313401|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129670|NCT01212770|313402|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
129671|NCT01212770|313403|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
129672|NCT01212770|313404|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
129673|NCT01212770|313396|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129674|NCT01212770|313397|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129675|NCT01212770|313398|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129676|NCT01212770|313399|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129677|NCT01212770|313400|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129678|NCT01212770|313401|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129679|NCT01212770|313402|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
129680|NCT01212770|313403|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
129681|NCT01212770|313404|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
129682|NCT01212770|313396|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129683|NCT01212770|313397|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129684|NCT01212770|313398|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129685|NCT01212770|313399|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129686|NCT01212770|313400|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129687|NCT01212770|313401|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129688|NCT01212770|313402|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
129689|NCT01212770|313403|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
129690|NCT01212770|313404|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
129691|NCT01212770|313396|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129692|NCT01212770|313397|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129693|NCT01212770|313398|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129694|NCT01212770|313399|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129695|NCT01212770|313400|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129696|NCT01212770|313401|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129697|NCT01212770|313402|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
129698|NCT01212770|313403|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
129699|NCT01212770|313404|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
129700|NCT01212770|313396|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129701|NCT01212770|313397|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129702|NCT01212770|313398|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129703|NCT01212770|313399|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129704|NCT01212770|313400|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129705|NCT01212770|313401|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129706|NCT01212770|313402|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
129707|NCT01212770|313403|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
129708|NCT01212770|313404|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
129709|NCT01212757|313601|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
129710|NCT01212757|313602|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
129711|NCT01212757|313603|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
129712|NCT01212757|313604|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
129713|NCT01212757|313605|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
129714|NCT01212757|313606|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
129715|NCT01212757|313607|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
129716|NCT01212757|313608|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
129717|NCT01212757|313609|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
129718|NCT01212757|313601|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
129719|NCT01212757|313602|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
129720|NCT01212757|313603|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
129721|NCT01212757|313604|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
129722|NCT01212757|313605|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
129723|NCT01212757|313606|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
129724|NCT01212757|313607|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
129725|NCT01212757|313608|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
129726|NCT01212757|313609|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
129727|NCT01212757|313601|P9|STARTED|Long-Term Safety Phase (Year 5)||39
129728|NCT01212757|313602|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
129729|NCT01212757|313603|P7|STARTED|Long-Term Safety Phase (Year 5)||0
129730|NCT01212757|313604|P6|STARTED|Long-Term Safety Phase (Year 5)||0
129731|NCT01212757|313605|P5|STARTED|Long-Term Safety Phase (Year 5)||0
129732|NCT01212757|313606|P4|STARTED|Long-Term Safety Phase (Year 5)||0
129733|NCT01212757|313607|P3|STARTED|Long-Term Safety Phase (Year 5)||77
129734|NCT01212757|313608|P2|STARTED|Long-Term Safety Phase (Year 5)||80
129735|NCT01212757|313609|P1|STARTED|Long-Term Safety Phase (Year 5)||0
129736|NCT01212757|313601|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
129737|NCT01212757|313602|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
129738|NCT01212757|313603|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
129739|NCT01212757|313604|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
129740|NCT01212757|313605|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
129741|NCT01212757|313606|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
129742|NCT01212757|313607|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
129743|NCT01212757|313608|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
129744|NCT01212757|313609|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
129745|NCT01212757|313601|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
129746|NCT01212757|313602|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
129747|NCT01212757|313603|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
129748|NCT01212757|313604|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
129749|NCT01212757|313605|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
129750|NCT01212757|313606|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
129751|NCT01212757|313607|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
129752|NCT01212757|313608|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
129753|NCT01212757|313609|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
129754|NCT01212757|313601|P9|STARTED|Long-Term Safety Phase (Year 4)||46
129755|NCT01212757|313602|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
129756|NCT01212757|313603|P7|STARTED|Long-Term Safety Phase (Year 4)||0
129757|NCT01212757|313604|P6|STARTED|Long-Term Safety Phase (Year 4)||0
129758|NCT01212757|313605|P5|STARTED|Long-Term Safety Phase (Year 4)||0
129759|NCT01212757|313606|P4|STARTED|Long-Term Safety Phase (Year 4)||0
129760|NCT01212757|313607|P3|STARTED|Long-Term Safety Phase (Year 4)||84
129761|NCT01212757|313608|P2|STARTED|Long-Term Safety Phase (Year 4)||89
129762|NCT01212757|313609|P1|STARTED|Long-Term Safety Phase (Year 4)||0
129763|NCT01212757|313601|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
129764|NCT01212757|313602|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
129765|NCT01212757|313603|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
129766|NCT01212757|313604|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
129767|NCT01212757|313605|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
129768|NCT01212757|313606|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
129769|NCT01212757|313607|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
129770|NCT01212757|313608|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
129771|NCT01212757|313609|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
129772|NCT01212757|313601|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
129773|NCT01212757|313602|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
129774|NCT01212757|313603|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
129775|NCT01212757|313604|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
129776|NCT01212757|313605|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
129777|NCT01212757|313606|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
129778|NCT01212757|313607|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
129779|NCT01212757|313608|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
129780|NCT01212757|313609|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
129781|NCT01212757|313601|P9|STARTED|Long-Term Safety Phase (Year 3)||51
129782|NCT01212757|313602|P8|STARTED|Long-Term Safety Phase (Year 3)||48
129783|NCT01212757|313603|P7|STARTED|Long-Term Safety Phase (Year 3)||0
129784|NCT01212757|313604|P6|STARTED|Long-Term Safety Phase (Year 3)||0
129785|NCT01212757|313605|P5|STARTED|Long-Term Safety Phase (Year 3)||0
129786|NCT01212757|313606|P4|STARTED|Long-Term Safety Phase (Year 3)||0
129787|NCT01212757|313607|P3|STARTED|Long-Term Safety Phase (Year 3)||95
129788|NCT01212757|313608|P2|STARTED|Long-Term Safety Phase (Year 3)||107
129789|NCT01212757|313609|P1|STARTED|Long-Term Safety Phase (Year 3)||0
129790|NCT01212757|313601|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
129791|NCT01212757|313602|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
129792|NCT01212757|313603|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
129793|NCT01212757|313604|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
129794|NCT01212757|313605|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
129795|NCT01212757|313606|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
129796|NCT01212757|313607|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
129797|NCT01212757|313608|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
129798|NCT01212757|313609|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
129799|NCT01212757|313601|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
129800|NCT01212757|313602|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
129801|NCT01212757|313603|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
129802|NCT01212757|313604|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
129803|NCT01212757|313605|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
129804|NCT01212757|313606|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
129805|NCT01212757|313607|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
129806|NCT01212757|313608|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
129807|NCT01212757|313609|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
129808|NCT01212757|313601|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
129809|NCT01212757|313602|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
129810|NCT01212757|313603|P7|STARTED|Long-Term Safety Phase (Year 2)||0
129811|NCT01212757|313604|P6|STARTED|Long-Term Safety Phase (Year 2)||0
129812|NCT01212757|313605|P5|STARTED|Long-Term Safety Phase (Year 2)||0
129813|NCT01212757|313606|P4|STARTED|Long-Term Safety Phase (Year 2)||0
129814|NCT01212757|313607|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
129815|NCT01212757|313608|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
129816|NCT01212757|313609|P1|STARTED|Long-Term Safety Phase (Year 2)||0
129817|NCT01212757|313601|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
129818|NCT01212757|313602|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
129819|NCT01212757|313603|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
129820|NCT01212757|313604|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
129821|NCT01212757|313605|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
129822|NCT01212757|313606|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
129823|NCT01212757|313607|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
129824|NCT01212757|313608|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
129825|NCT01212757|313609|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
129826|NCT01212757|313601|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
129827|NCT01212757|313602|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
129828|NCT01212757|313603|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
129829|NCT01212757|313604|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
129830|NCT01212757|313605|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
129831|NCT01212757|313606|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
129832|NCT01212757|313607|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
129833|NCT01212757|313608|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
129834|NCT01212757|313609|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
129835|NCT01212757|313601|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
129836|NCT01212757|313602|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
129837|NCT01212757|313603|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
129838|NCT01212757|313604|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
129839|NCT01212757|313605|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
129840|NCT01212757|313606|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
129841|NCT01212757|313607|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
129842|NCT01212757|313608|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
129843|NCT01212757|313609|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
129844|NCT01212757|313601|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129845|NCT01212757|313602|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129846|NCT01212757|313603|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129847|NCT01212757|313604|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129848|NCT01212757|313605|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129849|NCT01212757|313606|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129850|NCT01212757|313607|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
129851|NCT01212757|313608|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
129852|NCT01212757|313609|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
129853|NCT01212757|313601|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129854|NCT01212757|313602|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129855|NCT01212757|313603|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129856|NCT01212757|313604|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129857|NCT01212757|313605|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129858|NCT01212757|313606|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
129859|NCT01212757|313607|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
129860|NCT01212757|313608|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
129861|NCT01212757|313609|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
129862|NCT01212757|313601|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129863|NCT01212757|313602|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129864|NCT01212757|313603|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129865|NCT01212757|313604|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129866|NCT01212757|313605|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129867|NCT01212757|313606|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129868|NCT01212757|313607|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
129869|NCT01212757|313608|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
129870|NCT01212757|313609|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
129871|NCT01212757|313601|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129872|NCT01212757|313602|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129873|NCT01212757|313603|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129874|NCT01212757|313604|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129875|NCT01212757|313605|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129876|NCT01212757|313606|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
129877|NCT01212757|313607|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
129961|NCT01212094|313882|P3|COMPLETED|Year 1: Baseline Monitoring||0
129878|NCT01212757|313608|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
129879|NCT01212757|313609|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
129880|NCT01212757|313601|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129881|NCT01212757|313602|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129882|NCT01212757|313603|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129883|NCT01212757|313604|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129884|NCT01212757|313605|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129885|NCT01212757|313606|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
129886|NCT01212757|313607|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
129887|NCT01212757|313608|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
129888|NCT01212757|313609|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
129889|NCT01212757|313601|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129890|NCT01212757|313602|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129891|NCT01212757|313603|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129892|NCT01212757|313604|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129893|NCT01212757|313605|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129894|NCT01212757|313606|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
129895|NCT01212757|313607|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
129896|NCT01212757|313608|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
129897|NCT01212757|313609|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
129898|NCT01212627|313793|P1|NOT COMPLETED|Overall Study||0
129899|NCT01212627|313793|P1|COMPLETED|Overall Study||12
129900|NCT01212627|313793|P1|STARTED|Overall Study||12
129901|NCT01212484|313797|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
129902|NCT01212484|313798|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
129903|NCT01212484|313797|P2|COMPLETED|Second Intervention (4 Weeks)||3
129904|NCT01212484|313798|P1|COMPLETED|Second Intervention (4 Weeks)||5
129905|NCT01212484|313797|P2|STARTED|Second Intervention (4 Weeks)||4
129906|NCT01212484|313798|P1|STARTED|Second Intervention (4 Weeks)||5
129907|NCT01212484|313797|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
129908|NCT01212484|313798|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
129909|NCT01212484|313797|P2|COMPLETED|First Intervention (4 Weeks)||4
129910|NCT01212484|313798|P1|COMPLETED|First Intervention (4 Weeks)||5
129911|NCT01212484|313797|P2|STARTED|First Intervention (4 Weeks)||6
129912|NCT01212484|313798|P1|STARTED|First Intervention (4 Weeks)||5
129913|NCT01212484|313797|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
129914|NCT01212484|313798|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
129915|NCT01212484|313797|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
129916|NCT01212484|313798|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
129917|NCT01212484|313797|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
129918|NCT01212484|313798|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
129919|NCT01212445|313811|P3|NOT COMPLETED|Overall Study||0
129920|NCT01212445|313812|P2|NOT COMPLETED|Overall Study||0
129921|NCT01212445|313813|P1|NOT COMPLETED|Overall Study||0
129922|NCT01212445|313811|P3|COMPLETED|Overall Study||51
129923|NCT01212445|313812|P2|COMPLETED|Overall Study||51
129924|NCT01212445|313813|P1|COMPLETED|Overall Study||52
129925|NCT01212445|313811|P3|STARTED|Overall Study||51
129926|NCT01212445|313812|P2|STARTED|Overall Study||51
129927|NCT01212445|313813|P1|STARTED|Overall Study||52
129928|NCT01212302|313842|P1|NOT COMPLETED|Overall Study||0
129929|NCT01212302|313842|P1|COMPLETED|Overall Study||504
129930|NCT01212302|313842|P1|STARTED|Overall Study||504
129931|NCT01212185|313848|P2|NOT COMPLETED|Overall Study||1
129932|NCT01212185|313849|P1|NOT COMPLETED|Overall Study||2
129933|NCT01212185|313848|P2|COMPLETED|Overall Study||7
129934|NCT01212185|313849|P1|COMPLETED|Overall Study||4
129935|NCT01212185|313848|P2|STARTED|Overall Study||8
129936|NCT01212185|313849|P1|STARTED|Overall Study||6
129937|NCT01212172|313857|P2|NOT COMPLETED|Overall Study||1
129938|NCT01212172|313858|P1|NOT COMPLETED|Overall Study||1
129939|NCT01212172|313857|P2|COMPLETED|Overall Study||9
129940|NCT01212172|313858|P1|COMPLETED|Overall Study||9
129941|NCT01212172|313857|P2|STARTED|Overall Study||10
129942|NCT01212172|313858|P1|STARTED|Overall Study||10
129943|NCT01212159|313868|P2|NOT COMPLETED|Overall Study||12
129944|NCT01212159|313869|P1|NOT COMPLETED|Overall Study||12
129945|NCT01212159|313868|P2|COMPLETED|Overall Study||32
129946|NCT01212159|313869|P1|COMPLETED|Overall Study||14
129947|NCT01212159|313868|P2|STARTED|Overall Study||44
129948|NCT01212159|313869|P1|STARTED|Overall Study||26
129949|NCT01212094|313882|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
129950|NCT01212094|313883|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
129951|NCT01212094|313884|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
129952|NCT01212094|313882|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
129953|NCT01212094|313883|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
129954|NCT01212094|313884|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
129955|NCT01212094|313882|P3|STARTED|Years 2 & 3: Treatment Randomization||18
129956|NCT01212094|313883|P2|STARTED|Years 2 & 3: Treatment Randomization||9
129957|NCT01212094|313884|P1|STARTED|Years 2 & 3: Treatment Randomization||0
129958|NCT01212094|313882|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
129959|NCT01212094|313883|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
129960|NCT01212094|313884|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
129962|NCT01212094|313883|P2|COMPLETED|Year 1: Baseline Monitoring||0
129963|NCT01212094|313884|P1|COMPLETED|Year 1: Baseline Monitoring||27
129964|NCT01212094|313882|P3|STARTED|Year 1: Baseline Monitoring||0
129965|NCT01212094|313883|P2|STARTED|Year 1: Baseline Monitoring||0
129966|NCT01212094|313884|P1|STARTED|Year 1: Baseline Monitoring||43
129967|NCT01211873|313918|P3|NOT COMPLETED|Overall Study||2
129968|NCT01211873|313919|P2|NOT COMPLETED|Overall Study||2
129969|NCT01211873|313920|P1|NOT COMPLETED|Overall Study||5
129970|NCT01211873|313918|P3|COMPLETED|Overall Study||36
129971|NCT01211873|313919|P2|COMPLETED|Overall Study||117
129972|NCT01211873|313920|P1|COMPLETED|Overall Study||240
129973|NCT01211873|313918|P3|STARTED|Overall Study||38
129974|NCT01211873|313919|P2|STARTED|Overall Study||119
129975|NCT01211873|313920|P1|STARTED|Overall Study||245
129976|NCT01211769|313931|P4|NOT COMPLETED|Overall Study||11
129977|NCT01211769|313932|P3|NOT COMPLETED|Overall Study||8
129978|NCT01211769|313933|P2|NOT COMPLETED|Overall Study||10
129979|NCT01211769|313934|P1|NOT COMPLETED|Overall Study||9
129980|NCT01211769|313931|P4|COMPLETED|Overall Study||9
129981|NCT01211769|313932|P3|COMPLETED|Overall Study||12
129982|NCT01211769|313933|P2|COMPLETED|Overall Study||10
129983|NCT01211769|313934|P1|COMPLETED|Overall Study||11
129984|NCT01211769|313931|P4|Participants/Group|Overall Study||20
129985|NCT01211769|313932|P3|Participants/Group|Overall Study||20
129986|NCT01211769|313933|P2|Participants/Group|Overall Study||20
129987|NCT01211769|313934|P1|Participants/Group|Overall Study||20
129988|NCT01211769|313931|P4|STARTED|Overall Study||20
129989|NCT01211769|313932|P3|STARTED|Overall Study||20
129990|NCT01211769|313933|P2|STARTED|Overall Study||20
129991|NCT01211769|313934|P1|STARTED|Overall Study||20
129992|NCT01211730|313954|P2|NOT COMPLETED|Overall Study||0
129993|NCT01211730|313955|P1|NOT COMPLETED|Overall Study||0
129994|NCT01211730|313954|P2|COMPLETED|Overall Study||82
129995|NCT01211730|313955|P1|COMPLETED|Overall Study||82
129996|NCT01211730|313954|P2|STARTED|Overall Study||82
129997|NCT01211730|313955|P1|STARTED|Overall Study||82
129998|NCT01211665|313973|P2|NOT COMPLETED|Overall Study||0
129999|NCT01211665|313974|P1|NOT COMPLETED|Overall Study||2
130000|NCT01211665|313973|P2|COMPLETED|Overall Study|completed treatment with study drug|1
130001|NCT01211665|313974|P1|COMPLETED|Overall Study||0
130002|NCT01211665|313973|P2|STARTED|Overall Study||1
130003|NCT01211665|313974|P1|STARTED|Overall Study||2
130004|NCT01211613|314001|P3|NOT COMPLETED|Overall Study||2
130005|NCT01211613|314002|P2|NOT COMPLETED|Overall Study||2
130006|NCT01211613|314003|P1|NOT COMPLETED|Overall Study||3
130007|NCT01211613|314001|P3|COMPLETED|Overall Study||33
130008|NCT01211613|314002|P2|COMPLETED|Overall Study||33
130009|NCT01211613|314003|P1|COMPLETED|Overall Study||34
130010|NCT01211613|314001|P3|STARTED|Overall Study||35
130011|NCT01211613|314002|P2|STARTED|Overall Study||35
130012|NCT01211613|314003|P1|STARTED|Overall Study||37
130013|NCT01211535|314016|P2|NOT COMPLETED|Overall Study||1
130014|NCT01211535|314017|P1|NOT COMPLETED|Overall Study||0
130015|NCT01211535|314016|P2|COMPLETED|Overall Study||51
130016|NCT01211535|314017|P1|COMPLETED|Overall Study||52
130017|NCT01211535|314016|P2|STARTED|Overall Study||52
130018|NCT01211535|314017|P1|STARTED|Overall Study||52
130019|NCT01211340|314025|P2|NOT COMPLETED|Overall Study||0
130020|NCT01211340|314026|P1|NOT COMPLETED|Overall Study||0
130021|NCT01211340|314025|P2|COMPLETED|Overall Study||223
130022|NCT01211340|314026|P1|COMPLETED|Overall Study||223
130023|NCT01211340|314025|P2|STARTED|Overall Study||223
130024|NCT01211340|314026|P1|STARTED|Overall Study||223
130025|NCT01211197|314036|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
130026|NCT01211197|314037|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
130027|NCT01211197|314038|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
130028|NCT01211197|314039|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
130029|NCT01211197|314040|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
130030|NCT01211197|314041|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
130031|NCT01211197|314036|P6|COMPLETED|Treatment Period 3 (1 Day)||2
130032|NCT01211197|314037|P5|COMPLETED|Treatment Period 3 (1 Day)||2
130033|NCT01211197|314038|P4|COMPLETED|Treatment Period 3 (1 Day)||3
130034|NCT01211197|314039|P3|COMPLETED|Treatment Period 3 (1 Day)||2
130035|NCT01211197|314040|P2|COMPLETED|Treatment Period 3 (1 Day)||3
130036|NCT01211197|314041|P1|COMPLETED|Treatment Period 3 (1 Day)||2
130037|NCT01211197|314036|P6|STARTED|Treatment Period 3 (1 Day)||2
130038|NCT01211197|314037|P5|STARTED|Treatment Period 3 (1 Day)||2
130039|NCT01211197|314038|P4|STARTED|Treatment Period 3 (1 Day)||3
130040|NCT01211197|314039|P3|STARTED|Treatment Period 3 (1 Day)||2
130041|NCT01211197|314040|P2|STARTED|Treatment Period 3 (1 Day)||3
130042|NCT01211197|314041|P1|STARTED|Treatment Period 3 (1 Day)||2
130043|NCT01211197|314036|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
130044|NCT01211197|314037|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
130045|NCT01211197|314038|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
130046|NCT01211197|314039|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
130047|NCT01211197|314040|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
130048|NCT01211197|314041|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
130049|NCT01211197|314036|P6|COMPLETED|Washout Period 2 (7 Days)||2
130050|NCT01211197|314037|P5|COMPLETED|Washout Period 2 (7 Days)||2
130051|NCT01211197|314038|P4|COMPLETED|Washout Period 2 (7 Days)||3
130052|NCT01211197|314039|P3|COMPLETED|Washout Period 2 (7 Days)||2
130053|NCT01211197|314040|P2|COMPLETED|Washout Period 2 (7 Days)||3
130054|NCT01211197|314041|P1|COMPLETED|Washout Period 2 (7 Days)||2
130055|NCT01211197|314036|P6|STARTED|Washout Period 2 (7 Days)||2
130056|NCT01211197|314037|P5|STARTED|Washout Period 2 (7 Days)||2
130057|NCT01211197|314038|P4|STARTED|Washout Period 2 (7 Days)||3
130058|NCT01211197|314039|P3|STARTED|Washout Period 2 (7 Days)||2
130059|NCT01211197|314040|P2|STARTED|Washout Period 2 (7 Days)||3
130060|NCT01211197|314041|P1|STARTED|Washout Period 2 (7 Days)||3
130061|NCT01211197|314036|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
130062|NCT01211197|314037|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
130063|NCT01211197|314038|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
130064|NCT01211197|314039|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
130065|NCT01211197|314040|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
130066|NCT01211197|314041|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
130067|NCT01211197|314036|P6|COMPLETED|Treatment Period 2 (1 Day)||2
130068|NCT01211197|314037|P5|COMPLETED|Treatment Period 2 (1 Day)||2
130069|NCT01211197|314038|P4|COMPLETED|Treatment Period 2 (1 Day)||3
130070|NCT01211197|314039|P3|COMPLETED|Treatment Period 2 (1 Day)||2
130071|NCT01211197|314040|P2|COMPLETED|Treatment Period 2 (1 Day)||3
130072|NCT01211197|314041|P1|COMPLETED|Treatment Period 2 (1 Day)||3
130073|NCT01211197|314036|P6|STARTED|Treatment Period 2 (1 Day)||2
130074|NCT01211197|314037|P5|STARTED|Treatment Period 2 (1 Day)||2
130075|NCT01211197|314038|P4|STARTED|Treatment Period 2 (1 Day)||3
130076|NCT01211197|314039|P3|STARTED|Treatment Period 2 (1 Day)||2
130077|NCT01211197|314040|P2|STARTED|Treatment Period 2 (1 Day)||3
130078|NCT01211197|314041|P1|STARTED|Treatment Period 2 (1 Day)||3
130079|NCT01211197|314036|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
130080|NCT01211197|314037|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
130081|NCT01211197|314038|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
130082|NCT01211197|314039|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
130083|NCT01211197|314040|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
130084|NCT01211197|314041|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
130085|NCT01211197|314036|P6|COMPLETED|Washout Period 1 (7 Days)||2
130086|NCT01211197|314037|P5|COMPLETED|Washout Period 1 (7 Days)||2
130087|NCT01211197|314038|P4|COMPLETED|Washout Period 1 (7 Days)||3
130088|NCT01211197|314039|P3|COMPLETED|Washout Period 1 (7 Days)||2
130089|NCT01211197|314040|P2|COMPLETED|Washout Period 1 (7 Days)||3
130090|NCT01211197|314041|P1|COMPLETED|Washout Period 1 (7 Days)||3
130091|NCT01211197|314036|P6|STARTED|Washout Period 1 (7 Days)||2
130092|NCT01211197|314037|P5|STARTED|Washout Period 1 (7 Days)||2
130093|NCT01211197|314038|P4|STARTED|Washout Period 1 (7 Days)||3
130094|NCT01211197|314039|P3|STARTED|Washout Period 1 (7 Days)||3
130095|NCT01211197|314040|P2|STARTED|Washout Period 1 (7 Days)||3
130096|NCT01211197|314041|P1|STARTED|Washout Period 1 (7 Days)||3
130097|NCT01211197|314036|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
130098|NCT01211197|314037|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
130099|NCT01211197|314038|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
130100|NCT01211197|314039|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
130101|NCT01211197|314040|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
130102|NCT01211197|314041|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
130103|NCT01211197|314036|P6|COMPLETED|Treatment Period 1 (1 Day)||2
130104|NCT01211197|314037|P5|COMPLETED|Treatment Period 1 (1 Day)||2
130105|NCT01211197|314038|P4|COMPLETED|Treatment Period 1 (1 Day)||3
130106|NCT01211197|314039|P3|COMPLETED|Treatment Period 1 (1 Day)||3
130107|NCT01211197|314040|P2|COMPLETED|Treatment Period 1 (1 Day)||3
130108|NCT01211197|314041|P1|COMPLETED|Treatment Period 1 (1 Day)||3
130109|NCT01211197|314036|P6|STARTED|Treatment Period 1 (1 Day)||2
130110|NCT01211197|314037|P5|STARTED|Treatment Period 1 (1 Day)||2
130111|NCT01211197|314038|P4|STARTED|Treatment Period 1 (1 Day)||3
130112|NCT01211197|314039|P3|STARTED|Treatment Period 1 (1 Day)||3
130113|NCT01211197|314040|P2|STARTED|Treatment Period 1 (1 Day)||3
130114|NCT01211197|314041|P1|STARTED|Treatment Period 1 (1 Day)||3
130115|NCT01211184|314088|P3|NOT COMPLETED|Overall Study||1
130116|NCT01211184|314089|P2|NOT COMPLETED|Overall Study||2
130117|NCT01211184|314090|P1|NOT COMPLETED|Overall Study||0
130118|NCT01211184|314088|P3|COMPLETED|Overall Study||19
130119|NCT01211184|314089|P2|COMPLETED|Overall Study||18
130120|NCT01211184|314090|P1|COMPLETED|Overall Study||20
130121|NCT01211184|314088|P3|STARTED|Overall Study||20
130122|NCT01211184|314089|P2|STARTED|Overall Study||20
130123|NCT01211184|314090|P1|STARTED|Overall Study||20
130124|NCT01211145|314105|P4|NOT COMPLETED|Overall Study||20
130125|NCT01211145|314106|P3|NOT COMPLETED|Overall Study||13
130126|NCT01211145|314107|P2|NOT COMPLETED|Overall Study||17
130127|NCT01211145|314108|P1|NOT COMPLETED|Overall Study||26
130128|NCT01211145|314105|P4|COMPLETED|Overall Study||268
130129|NCT01211145|314106|P3|COMPLETED|Overall Study||86
130130|NCT01211145|314107|P2|COMPLETED|Overall Study||98
130131|NCT01211145|314108|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
130132|NCT01211145|314105|P4|STARTED|Overall Study||288
130133|NCT01211145|314106|P3|STARTED|Overall Study||99
130134|NCT01211145|314107|P2|STARTED|Overall Study||115
130135|NCT01211145|314108|P1|STARTED|Overall Study||296
130136|NCT01211106|314140|P2|NOT COMPLETED|Overall Study||11
130137|NCT01211106|314141|P1|NOT COMPLETED|Overall Study||13
130138|NCT01211106|314140|P2|COMPLETED|Overall Study||77
130139|NCT01211106|314141|P1|COMPLETED|Overall Study||82
130140|NCT01211106|314140|P2|STARTED|Overall Study||88
130141|NCT01211106|314141|P1|STARTED|Overall Study||95
130142|NCT01210820|314151|P2|NOT COMPLETED|Overall Study||0
130143|NCT01210820|314152|P1|NOT COMPLETED|Overall Study||0
130144|NCT01210820|314151|P2|COMPLETED|Overall Study||4
130145|NCT01210820|314152|P1|COMPLETED|Overall Study||17
130146|NCT01210820|314151|P2|STARTED|Overall Study||4
130147|NCT01210820|314152|P1|STARTED|Overall Study||17
130148|NCT01210807|314162|P2|NOT COMPLETED|Overall Study||3
130149|NCT01210807|314163|P1|NOT COMPLETED|Overall Study||3
130150|NCT01210807|314162|P2|COMPLETED|Overall Study||31
130151|NCT01210807|314163|P1|COMPLETED|Overall Study||33
130152|NCT01210807|314162|P2|STARTED|Overall Study||34
130153|NCT01210807|314163|P1|STARTED|Overall Study||36
130154|NCT01210716|314171|P2|NOT COMPLETED|Second TPE Procedure||0
130155|NCT01210716|314172|P1|NOT COMPLETED|Second TPE Procedure||3
130156|NCT01210716|314171|P2|COMPLETED|Second TPE Procedure||15
130157|NCT01210716|314172|P1|COMPLETED|Second TPE Procedure||15
130158|NCT01210716|314171|P2|STARTED|Second TPE Procedure||15
130159|NCT01210716|314172|P1|STARTED|Second TPE Procedure||18
130160|NCT01210716|314171|P2|NOT COMPLETED|First TPE Procedure||2
130161|NCT01210716|314172|P1|NOT COMPLETED|First TPE Procedure||2
130162|NCT01210716|314171|P2|COMPLETED|First TPE Procedure||15
130163|NCT01210716|314172|P1|COMPLETED|First TPE Procedure||18
130164|NCT01210716|314171|P2|STARTED|First TPE Procedure||17
130165|NCT01210716|314172|P1|STARTED|First TPE Procedure||20
130166|NCT01210690|314178|P1|NOT COMPLETED|Overall Study||26
130167|NCT01210690|314178|P1|COMPLETED|Overall Study||75
130168|NCT01210690|314178|P1|STARTED|Overall Study||101
130169|NCT01210651|314193|P2|NOT COMPLETED|Overall Study||8
130170|NCT01210651|314194|P1|NOT COMPLETED|Overall Study||5
130171|NCT01210651|314193|P2|COMPLETED|Overall Study||10
130172|NCT01210651|314194|P1|COMPLETED|Overall Study||15
130173|NCT01210651|314193|P2|Number Attending 1st Assigned Session|Overall Study||12
130174|NCT01210651|314194|P1|Number Attending 1st Assigned Session|Overall Study||18
130175|NCT01210651|314193|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
130176|NCT01210651|314194|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
130177|NCT01210495|314212|P4|NOT COMPLETED|Overall Study||68
130178|NCT01210495|314213|P3|NOT COMPLETED|Overall Study||134
130179|NCT01210495|314214|P2|NOT COMPLETED|Overall Study||7
130180|NCT01210495|314215|P1|NOT COMPLETED|Overall Study||15
130181|NCT01210495|314212|P4|COMPLETED|Overall Study||0
130182|NCT01210495|314213|P3|COMPLETED|Overall Study||0
130183|NCT01210495|314214|P2|COMPLETED|Overall Study||0
130184|NCT01210495|314215|P1|COMPLETED|Overall Study||0
130185|NCT01210495|314212|P4|STARTED|Overall Study||68
130186|NCT01210495|314213|P3|STARTED|Overall Study||134
130187|NCT01210495|314214|P2|STARTED|Overall Study||7
130188|NCT01210495|314215|P1|STARTED|Overall Study||15
130189|NCT01210443|314277|P1|NOT COMPLETED|Overall Study||2
130190|NCT01210443|314277|P1|COMPLETED|Overall Study||0
130191|NCT01210443|314277|P1|STARTED|Overall Study||2
130192|NCT01210222|314285|P1|NOT COMPLETED|Overall Study||3
130193|NCT01210222|314285|P1|COMPLETED|Overall Study||32
130194|NCT01210222|314285|P1|STARTED|Overall Study||35
130195|NCT01210170|314298|P1|NOT COMPLETED|Overall Study||7
130196|NCT01210170|314298|P1|COMPLETED|Overall Study||15
130197|NCT01210170|314298|P1|STARTED|Overall Study||22
130198|NCT01210144|314321|P2|NOT COMPLETED|Overall Study||0
130199|NCT01210144|314322|P1|NOT COMPLETED|Overall Study||3
130200|NCT01210144|314321|P2|COMPLETED|Overall Study||11
130201|NCT01210144|314322|P1|COMPLETED|Overall Study||10
130202|NCT01210144|314321|P2|STARTED|Overall Study||11
130203|NCT01210144|314322|P1|STARTED|Overall Study||13
130204|NCT01210118|314344|P2|NOT COMPLETED|Overall Study||5
130205|NCT01210118|314345|P1|NOT COMPLETED|Overall Study||3
130206|NCT01210118|314344|P2|COMPLETED|Overall Study||42
130207|NCT01210118|314345|P1|COMPLETED|Overall Study||42
130208|NCT01210118|314344|P2|STARTED|Overall Study||47
130209|NCT01210118|314345|P1|STARTED|Overall Study||45
130210|NCT01210079|314359|P2|NOT COMPLETED|Overall Study||0
130211|NCT01210079|314360|P1|NOT COMPLETED|Overall Study||0
130212|NCT01210079|314359|P2|COMPLETED|Overall Study||16
130213|NCT01210079|314360|P1|COMPLETED|Overall Study||10
130214|NCT01210079|314359|P2|STARTED|Overall Study||16
130215|NCT01210079|314360|P1|STARTED|Overall Study||10
130216|NCT01210001|314369|P3|NOT COMPLETED|Overall Study||12
130217|NCT01210001|314370|P2|NOT COMPLETED|Overall Study||11
130218|NCT01210001|314371|P1|NOT COMPLETED|Overall Study||19
130219|NCT01210001|314369|P3|COMPLETED|Overall Study||156
130220|NCT01210001|314370|P2|COMPLETED|Overall Study||154
130221|NCT01210001|314371|P1|COMPLETED|Overall Study||147
130222|NCT01210001|314369|P3|STARTED|Overall Study||168
130223|NCT01210001|314370|P2|STARTED|Overall Study||165
130224|NCT01210001|314371|P1|STARTED|Overall Study||166
130225|NCT01209949|314391|P1|NOT COMPLETED|Overall Study||3
130226|NCT01209949|314391|P1|COMPLETED|Overall Study||27
130227|NCT01209949|314391|P1|STARTED|Overall Study||30
130228|NCT01209780|314401|P5|NOT COMPLETED|Overall Study||5
130229|NCT01209780|314402|P4|NOT COMPLETED|Overall Study||10
130230|NCT01209780|314403|P3|NOT COMPLETED|Overall Study||4
130231|NCT01209780|314404|P2|NOT COMPLETED|Overall Study||18
130232|NCT01209780|314405|P1|NOT COMPLETED|Overall Study||26
130233|NCT01209780|314401|P5|COMPLETED|Overall Study||407
130234|NCT01209780|314402|P4|COMPLETED|Overall Study||807
130235|NCT01209780|314403|P3|COMPLETED|Overall Study||44
130236|NCT01209780|314404|P2|COMPLETED|Overall Study||467
130237|NCT01209780|314405|P1|COMPLETED|Overall Study||1016
130238|NCT01209780|314401|P5|STARTED|Overall Study||412
130239|NCT01209780|314402|P4|STARTED|Overall Study||817
130240|NCT01209780|314403|P3|STARTED|Overall Study||48
130241|NCT01209780|314404|P2|STARTED|Overall Study||485
130242|NCT01209780|314405|P1|STARTED|Overall Study||1042
130243|NCT01209767|314431|P1|NOT COMPLETED|Overall Study||4
130244|NCT01209767|314431|P1|COMPLETED|Overall Study||18
130245|NCT01209767|314431|P1|STARTED|Overall Study||22
130246|NCT01209702|314441|P4|NOT COMPLETED|Overall Study||153
130247|NCT01209702|314442|P3|NOT COMPLETED|Overall Study||51
130248|NCT01209702|314443|P2|NOT COMPLETED|Overall Study||51
130249|NCT01209702|314444|P1|NOT COMPLETED|Overall Study||51
130250|NCT01209702|314441|P4|COMPLETED|Overall Study||0
130251|NCT01209702|314442|P3|COMPLETED|Overall Study||0
130252|NCT01209702|314443|P2|COMPLETED|Overall Study||0
130253|NCT01209702|314444|P1|COMPLETED|Overall Study||0
130254|NCT01209702|314441|P4|Completed 24 Weeks Treatment|Overall Study||10
130255|NCT01209702|314442|P3|Completed 24 Weeks Treatment|Overall Study||3
130256|NCT01209702|314443|P2|Completed 24 Weeks Treatment|Overall Study||28
130257|NCT01209702|314444|P1|Completed 24 Weeks Treatment|Overall Study||19
130258|NCT01209702|314441|P4|Completed 12 Weeks Treatment|Overall Study||59
130259|NCT01209702|314442|P3|Completed 12 Weeks Treatment|Overall Study||12
130260|NCT01209702|314443|P2|Completed 12 Weeks Treatment|Overall Study||48
130261|NCT01209702|314444|P1|Completed 12 Weeks Treatment|Overall Study||50
130262|NCT01209702|314441|P4|Escape or Switched to Tocilizumab|Overall Study||0
130263|NCT01209702|314442|P3|Escape or Switched to Tocilizumab|Overall Study||6
130264|NCT01209702|314443|P2|Escape or Switched to Tocilizumab|Overall Study||0
130265|NCT01209702|314444|P1|Escape or Switched to Tocilizumab|Overall Study||51
130266|NCT01209702|314441|P4|Treated|Overall Study||152
130267|NCT01209702|314442|P3|Treated|Overall Study||51
130268|NCT01209702|314443|P2|Treated|Overall Study||51
130269|NCT01209702|314444|P1|Treated|Overall Study||51
130270|NCT01209702|314441|P4|STARTED|Overall Study||153
130271|NCT01209702|314442|P3|STARTED|Overall Study||51
130272|NCT01209702|314443|P2|STARTED|Overall Study||51
130273|NCT01209702|314444|P1|STARTED|Overall Study||51
130274|NCT01209689|314500|P2|NOT COMPLETED|Overall Study||22
130275|NCT01209689|314501|P1|NOT COMPLETED|Overall Study||91
130276|NCT01209689|314500|P2|COMPLETED|Overall Study||0
130277|NCT01209689|314501|P1|COMPLETED|Overall Study||0
130278|NCT01209689|314500|P2|STARTED|Overall Study||22
130279|NCT01209689|314501|P1|STARTED|Overall Study||91
130280|NCT01209624|314507|P1|NOT COMPLETED|Overall Study||326
130281|NCT01209624|314507|P1|COMPLETED|Overall Study||576
130282|NCT01209624|314507|P1|Per Protocol Population|Overall Study||469
130283|NCT01209624|314507|P1|STARTED|Overall Study||902
130284|NCT01209598|314540|P2|NOT COMPLETED|Overall Study||0
130285|NCT01209598|314541|P1|NOT COMPLETED|Overall Study||1
130286|NCT01209598|314540|P2|COMPLETED|Overall Study||60
130287|NCT01209598|314541|P1|COMPLETED|Overall Study||29
130288|NCT01209598|314540|P2|STARTED|Overall Study||60
130289|NCT01209598|314541|P1|STARTED|Overall Study||30
130290|NCT01209520|314549|P1|NOT COMPLETED|Overall Study||3
130291|NCT01209520|314549|P1|COMPLETED|Overall Study||3
130292|NCT01209520|314549|P1|STARTED|Overall Study||6
130293|NCT01209286|314557|P3|NOT COMPLETED|Overall Study||3
130294|NCT01209286|314558|P2|NOT COMPLETED|Overall Study||10
130295|NCT01209286|314559|P1|NOT COMPLETED|Overall Study||5
130296|NCT01209286|314557|P3|COMPLETED|Overall Study||3
130297|NCT01209286|314558|P2|COMPLETED|Overall Study||13
130298|NCT01209286|314559|P1|COMPLETED|Overall Study||2
130299|NCT01209286|314557|P3|STARTED|Overall Study||6
130300|NCT01209286|314558|P2|STARTED|Overall Study||23
130301|NCT01209286|314559|P1|STARTED|Overall Study||7
130302|NCT01209260|314612|P2|NOT COMPLETED|Overall Study||0
130303|NCT01209260|314613|P1|NOT COMPLETED|Overall Study||0
130304|NCT01209260|314612|P2|COMPLETED|Overall Study||36
130305|NCT01209260|314613|P1|COMPLETED|Overall Study||36
130306|NCT01209260|314612|P2|STARTED|Overall Study||36
130307|NCT01209260|314613|P1|STARTED|Overall Study||36
130308|NCT01209195|314627|P6|NOT COMPLETED|Overall Study||0
130309|NCT01209195|314628|P5|NOT COMPLETED|Overall Study||0
130310|NCT01209195|314629|P4|NOT COMPLETED|Overall Study||0
130311|NCT01209195|314630|P3|NOT COMPLETED|Overall Study||0
130312|NCT01209195|314631|P2|NOT COMPLETED|Overall Study||0
130313|NCT01209195|314632|P1|NOT COMPLETED|Overall Study||0
130314|NCT01209195|314627|P6|COMPLETED|Overall Study||13
130315|NCT01209195|314628|P5|COMPLETED|Overall Study||6
130316|NCT01209195|314629|P4|COMPLETED|Overall Study||6
130317|NCT01209195|314630|P3|COMPLETED|Overall Study||6
130318|NCT01209195|314631|P2|COMPLETED|Overall Study||3
130319|NCT01209195|314632|P1|COMPLETED|Overall Study||7
130320|NCT01209195|314627|P6|STARTED|Overall Study||13
130321|NCT01209195|314628|P5|STARTED|Overall Study||6
130322|NCT01209195|314629|P4|STARTED|Overall Study||6
130323|NCT01209195|314630|P3|STARTED|Overall Study||6
130324|NCT01209195|314631|P2|STARTED|Overall Study||3
130325|NCT01209195|314632|P1|STARTED|Overall Study||7
130326|NCT01209143|314668|P2|NOT COMPLETED|Overall Study||20
130327|NCT01209143|314669|P1|NOT COMPLETED|Overall Study||19
130328|NCT01209143|314668|P2|COMPLETED|Overall Study||8
130329|NCT01209143|314669|P1|COMPLETED|Overall Study||5
130330|NCT01209143|314668|P2|STARTED|Overall Study||28
130331|NCT01209143|314669|P1|STARTED|Overall Study||24
130332|NCT01209078|314679|P2|NOT COMPLETED|Overall Study||3
130333|NCT01209078|314680|P1|NOT COMPLETED|Overall Study||16
130334|NCT01209078|314679|P2|COMPLETED|Overall Study||24
130335|NCT01209078|314680|P1|COMPLETED|Overall Study||41
130336|NCT01209078|314679|P2|STARTED|Overall Study||27
130337|NCT01209078|314680|P1|STARTED|Overall Study||57
130338|NCT01208961|314755|P2|NOT COMPLETED|High-Fat Period IV||0
130339|NCT01208961|314756|P1|NOT COMPLETED|High-Fat Period IV||0
130340|NCT01208961|314755|P2|COMPLETED|High-Fat Period IV||26
130341|NCT01208961|314756|P1|COMPLETED|High-Fat Period IV||25
130342|NCT01208961|314755|P2|STARTED|High-Fat Period IV||26
130343|NCT01208961|314756|P1|STARTED|High-Fat Period IV||25
130344|NCT01208961|314755|P2|NOT COMPLETED|High-Fat Period III||0
130345|NCT01208961|314756|P1|NOT COMPLETED|High-Fat Period III||1
130346|NCT01208961|314755|P2|COMPLETED|High-Fat Period III||26
130347|NCT01208961|314756|P1|COMPLETED|High-Fat Period III||25
130348|NCT01208961|314755|P2|STARTED|High-Fat Period III||26
130349|NCT01208961|314756|P1|STARTED|High-Fat Period III||26
130350|NCT01208961|314755|P2|NOT COMPLETED|Low-Fat Period II||0
130351|NCT01208961|314756|P1|NOT COMPLETED|Low-Fat Period II||0
130352|NCT01208961|314755|P2|COMPLETED|Low-Fat Period II||27
130353|NCT01208961|314756|P1|COMPLETED|Low-Fat Period II||26
130354|NCT01208961|314755|P2|STARTED|Low-Fat Period II||27
130355|NCT01208961|314756|P1|STARTED|Low-Fat Period II||26
130356|NCT01208961|314755|P2|NOT COMPLETED|Low-Fat Period I||0
130357|NCT01208961|314756|P1|NOT COMPLETED|Low-Fat Period I||0
130358|NCT01208961|314755|P2|COMPLETED|Low-Fat Period I||27
130359|NCT01208961|314756|P1|COMPLETED|Low-Fat Period I||27
130360|NCT01208961|314755|P2|STARTED|Low-Fat Period I||27
130361|NCT01208961|314756|P1|STARTED|Low-Fat Period I||27
130362|NCT01208870|314767|P2|NOT COMPLETED|Overall Study||8
130363|NCT01208870|314768|P1|NOT COMPLETED|Overall Study||2
130364|NCT01208870|314767|P2|COMPLETED|Overall Study||36
130365|NCT01208870|314768|P1|COMPLETED|Overall Study||44
130366|NCT01208870|314767|P2|Pilot 2|Overall Study||22
130367|NCT01208870|314768|P1|Pilot 2|Overall Study||26
130368|NCT01208870|314767|P2|Pilot 1|Overall Study||22
130369|NCT01208870|314768|P1|Pilot 1|Overall Study||20
130370|NCT01208870|314767|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
130371|NCT01208870|314768|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
130372|NCT01208415|314784|P1|NOT COMPLETED|Overall Study||40
130373|NCT01208415|314784|P1|COMPLETED|Overall Study||0
130374|NCT01208415|314784|P1|6 Months|Overall Study||37
130375|NCT01208415|314784|P1|STARTED|Overall Study||40
130376|NCT01208402|314790|P2|NOT COMPLETED|Overall Study||0
130377|NCT01208402|314791|P1|NOT COMPLETED|Overall Study||1
130378|NCT01208402|314790|P2|COMPLETED|Overall Study||28
130379|NCT01208402|314791|P1|COMPLETED|Overall Study||30
130380|NCT01208402|314790|P2|STARTED|Overall Study||28
130381|NCT01208402|314791|P1|STARTED|Overall Study||31
130382|NCT01208337|314807|P1|NOT COMPLETED|Overall Study||3
130383|NCT01208337|314807|P1|COMPLETED|Overall Study||20
130384|NCT01208337|314807|P1|Five-year Follow-up|Overall Study||20
130385|NCT01208337|314807|P1|One-year Follow-up|Overall Study||23
130386|NCT01208337|314807|P1|STARTED|Overall Study||23
130387|NCT01208233|314821|P6|NOT COMPLETED|Overall Study||21
130388|NCT01208233|314822|P5|NOT COMPLETED|Overall Study||24
130389|NCT01208233|314823|P4|NOT COMPLETED|Overall Study||1
130390|NCT01208233|314824|P3|NOT COMPLETED|Overall Study||4
130391|NCT01208233|314825|P2|NOT COMPLETED|Overall Study||3
130392|NCT01208233|314826|P1|NOT COMPLETED|Overall Study||5
130393|NCT01208233|314821|P6|COMPLETED|Overall Study||46
130394|NCT01208233|314822|P5|COMPLETED|Overall Study||46
130395|NCT01208233|314823|P4|COMPLETED|Overall Study||9
130396|NCT01208233|314824|P3|COMPLETED|Overall Study||7
130397|NCT01208233|314825|P2|COMPLETED|Overall Study||6
130398|NCT01208233|314826|P1|COMPLETED|Overall Study||6
130399|NCT01208233|314821|P6|STARTED|Overall Study||67
130400|NCT01208233|314822|P5|STARTED|Overall Study||70
130401|NCT01208233|314823|P4|STARTED|Overall Study||10
130402|NCT01208233|314824|P3|STARTED|Overall Study||11
130403|NCT01208233|314825|P2|STARTED|Overall Study||9
130404|NCT01208233|314826|P1|STARTED|Overall Study||11
130405|NCT01208220|314939|P2|NOT COMPLETED|Overall Study||0
130406|NCT01208220|314940|P1|NOT COMPLETED|Overall Study||0
130407|NCT01208220|314939|P2|COMPLETED|Overall Study||1
130408|NCT01208220|314940|P1|COMPLETED|Overall Study||1
130409|NCT01208220|314939|P2|STARTED|Overall Study||1
130410|NCT01208220|314940|P1|STARTED|Overall Study||1
130411|NCT01208207|314951|P7|NOT COMPLETED|Part II||11
130412|NCT01208207|314952|P6|NOT COMPLETED|Part II||16
130413|NCT01208207|314953|P5|NOT COMPLETED|Part II||23
130414|NCT01208207|314954|P4|NOT COMPLETED|Part II||32
130415|NCT01208207|314955|P3|NOT COMPLETED|Part II||0
130416|NCT01208207|314956|P2|NOT COMPLETED|Part II||0
130417|NCT01208207|314957|P1|NOT COMPLETED|Part II||0
130418|NCT01208207|314951|P7|COMPLETED|Part II||131
130419|NCT01208207|314952|P6|COMPLETED|Part II||129
130420|NCT01208207|314953|P5|COMPLETED|Part II||295
130421|NCT01208207|314954|P4|COMPLETED|Part II||282
130422|NCT01208207|314955|P3|COMPLETED|Part II||0
130423|NCT01208207|314956|P2|COMPLETED|Part II||0
130424|NCT01208207|314957|P1|COMPLETED|Part II||0
130425|NCT01208207|314951|P7|STARTED|Part II||142
130426|NCT01208207|314952|P6|STARTED|Part II||145
130427|NCT01208207|314953|P5|STARTED|Part II||318
130428|NCT01208207|314954|P4|STARTED|Part II||314
130429|NCT01208207|314955|P3|STARTED|Part II||0
130430|NCT01208207|314956|P2|STARTED|Part II||0
130431|NCT01208207|314957|P1|STARTED|Part II||0
130432|NCT01208207|314951|P7|NOT COMPLETED|Part I||0
130433|NCT01208207|314952|P6|NOT COMPLETED|Part I||0
130434|NCT01208207|314953|P5|NOT COMPLETED|Part I||0
130435|NCT01208207|314954|P4|NOT COMPLETED|Part I||0
130436|NCT01208207|314955|P3|NOT COMPLETED|Part I||15
130437|NCT01208207|314956|P2|NOT COMPLETED|Part I||11
130438|NCT01208207|314957|P1|NOT COMPLETED|Part I||70
130439|NCT01208207|314951|P7|COMPLETED|Part I||0
130440|NCT01208207|314952|P6|COMPLETED|Part I||0
130441|NCT01208207|314953|P5|COMPLETED|Part I||0
130442|NCT01208207|314954|P4|COMPLETED|Part I||0
130443|NCT01208207|314955|P3|COMPLETED|Part I||142
130444|NCT01208207|314956|P2|COMPLETED|Part I||145
130445|NCT01208207|314957|P1|COMPLETED|Part I||632
130446|NCT01208207|314951|P7|STARTED|Part I||0
130447|NCT01208207|314952|P6|STARTED|Part I||0
130448|NCT01208207|314953|P5|STARTED|Part I||0
130449|NCT01208207|314954|P4|STARTED|Part I||0
130450|NCT01208207|314955|P3|STARTED|Part I||157
130451|NCT01208207|314956|P2|STARTED|Part I||156
130452|NCT01208207|314957|P1|STARTED|Part I||702
130453|NCT01208181|314984|P5|NOT COMPLETED|Part 2||0
130454|NCT01208181|314985|P4|NOT COMPLETED|Part 2||20
130455|NCT01208181|314986|P3|NOT COMPLETED|Part 2||16
130456|NCT01208181|314987|P2|NOT COMPLETED|Part 2||0
130457|NCT01208181|314988|P1|NOT COMPLETED|Part 2||0
130458|NCT01208181|314984|P5|COMPLETED|Part 2||0
130459|NCT01208181|314985|P4|COMPLETED|Part 2||343
130460|NCT01208181|314986|P3|COMPLETED|Part 2||334
130461|NCT01208181|314987|P2|COMPLETED|Part 2||0
130462|NCT01208181|314988|P1|COMPLETED|Part 2||0
130463|NCT01208181|314984|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
130464|NCT01208181|314985|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
130465|NCT01208181|314986|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
130466|NCT01208181|314987|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
130467|NCT01208181|314988|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
130468|NCT01208181|314984|P5|NOT COMPLETED|Part 1||22
130469|NCT01208181|314985|P4|NOT COMPLETED|Part 1||0
130470|NCT01208181|314986|P3|NOT COMPLETED|Part 1||0
130471|NCT01208181|314987|P2|NOT COMPLETED|Part 1||55
130472|NCT01208181|314988|P1|NOT COMPLETED|Part 1||99
130473|NCT01208181|314984|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
130474|NCT01208181|314985|P4|COMPLETED|Part 1||0
130475|NCT01208181|314986|P3|COMPLETED|Part 1||0
130476|NCT01208181|314987|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
130477|NCT01208181|314988|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
130478|NCT01208181|314984|P5|STARTED|Part 1||118
130479|NCT01208181|314985|P4|STARTED|Part 1||0
130480|NCT01208181|314986|P3|STARTED|Part 1||0
130481|NCT01208181|314987|P2|STARTED|Part 1||468
130482|NCT01208181|314988|P1|STARTED|Part 1||818
130483|NCT01207934|315020|P3|NOT COMPLETED|Overall Study||0
130484|NCT01207934|315021|P2|NOT COMPLETED|Overall Study||0
130485|NCT01207934|315022|P1|NOT COMPLETED|Overall Study||0
130486|NCT01207934|315020|P3|COMPLETED|Overall Study||6
130487|NCT01207934|315021|P2|COMPLETED|Overall Study||6
130488|NCT01207934|315022|P1|COMPLETED|Overall Study||6
130489|NCT01207934|315020|P3|STARTED|Overall Study||6
130490|NCT01207934|315021|P2|STARTED|Overall Study||6
130491|NCT01207934|315022|P1|STARTED|Overall Study||6
130492|NCT01207765|315039|P1|NOT COMPLETED|Overall Study||0
130493|NCT01207765|315039|P1|COMPLETED|Overall Study||8
130494|NCT01207765|315039|P1|STARTED|Overall Study||8
130495|NCT01207687|315045|P1|NOT COMPLETED|Overall Study||2
130496|NCT01207687|315045|P1|COMPLETED|Overall Study||12
130497|NCT01207687|315045|P1|STARTED|Overall Study||14
130498|NCT01207648|315071|P1|NOT COMPLETED|Overall Study||0
130499|NCT01207648|315071|P1|COMPLETED|Overall Study||307
130500|NCT01207648|315071|P1|STARTED|Overall Study||307
130501|NCT01207596|315079|P1|NOT COMPLETED|Overall Study||9
130502|NCT01207596|315079|P1|COMPLETED|Overall Study||21
130503|NCT01207596|315079|P1|STARTED|Overall Study||30
130504|NCT01207583|315092|P3|NOT COMPLETED|Overall Study||1
130505|NCT01207583|315093|P2|NOT COMPLETED|Overall Study||5
130506|NCT01207583|315094|P1|NOT COMPLETED|Overall Study||1
130507|NCT01207583|315092|P3|COMPLETED|Overall Study||54
130508|NCT01207583|315093|P2|COMPLETED|Overall Study||26
130509|NCT01207583|315094|P1|COMPLETED|Overall Study||13
130510|NCT01207583|315092|P3|Dose 4|Overall Study||0
130511|NCT01207583|315093|P2|Dose 4|Overall Study||0
130512|NCT01207583|315094|P1|Dose 4|Overall Study||7
130513|NCT01207583|315092|P3|Dose 3|Overall Study||0
130514|NCT01207583|315093|P2|Dose 3|Overall Study||27
130515|NCT01207583|315094|P1|Dose 3|Overall Study||13
130516|NCT01207583|315092|P3|Dose 2|Overall Study||54
130517|NCT01207583|315093|P2|Dose 2|Overall Study||29
130518|NCT01207583|315094|P1|Dose 2|Overall Study||13
130519|NCT01207583|315092|P3|Dose 1|Overall Study||55
130520|NCT01207583|315093|P2|Dose 1|Overall Study||31
130521|NCT01207583|315094|P1|Dose 1|Overall Study||14
130522|NCT01207583|315092|P3|STARTED|Overall Study||55
130523|NCT01207583|315093|P2|STARTED|Overall Study||31
130524|NCT01207583|315094|P1|STARTED|Overall Study||14
130525|NCT01207570|315134|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
130526|NCT01207570|315135|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
130527|NCT01207570|315134|P2|COMPLETED|The Second Stage (After Crossover)||23
130528|NCT01207570|315135|P1|COMPLETED|The Second Stage (After Crossover)||31
130529|NCT01207570|315134|P2|STARTED|The Second Stage (After Crossover)||23
130530|NCT01207570|315135|P1|STARTED|The Second Stage (After Crossover)||31
130531|NCT01207570|315134|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
130532|NCT01207570|315135|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
130533|NCT01207570|315134|P2|COMPLETED|The First Stage (Before Crossover)||31
130534|NCT01207570|315135|P1|COMPLETED|The First Stage (Before Crossover)||23
130535|NCT01207570|315134|P2|STARTED|The First Stage (Before Crossover)||31
130536|NCT01207570|315135|P1|STARTED|The First Stage (Before Crossover)||23
130537|NCT01207492|315147|P1|NOT COMPLETED|Overall Study||15
130538|NCT01207492|315147|P1|COMPLETED|Overall Study||2
130539|NCT01207492|315147|P1|STARTED|Overall Study||17
130540|NCT01207466|315153|P2|NOT COMPLETED|Period 2, One Week of Wear||0
130541|NCT01207466|315154|P1|NOT COMPLETED|Period 2, One Week of Wear||0
130542|NCT01207466|315153|P2|COMPLETED|Period 2, One Week of Wear||48
130543|NCT01207466|315154|P1|COMPLETED|Period 2, One Week of Wear||45
130544|NCT01207466|315153|P2|STARTED|Period 2, One Week of Wear||48
130545|NCT01207466|315154|P1|STARTED|Period 2, One Week of Wear||45
130546|NCT01207466|315153|P2|NOT COMPLETED|Period 1, One Week of Wear||0
130547|NCT01207466|315154|P1|NOT COMPLETED|Period 1, One Week of Wear||0
130548|NCT01207466|315153|P2|COMPLETED|Period 1, One Week of Wear||48
130549|NCT01207466|315154|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
130550|NCT01207466|315153|P2|STARTED|Period 1, One Week of Wear||48
130551|NCT01207466|315154|P1|STARTED|Period 1, One Week of Wear||46
130552|NCT01207453|315162|P2|NOT COMPLETED|2nd Intervention||2
130553|NCT01207453|315163|P1|NOT COMPLETED|2nd Intervention||2
130554|NCT01207453|315162|P2|COMPLETED|2nd Intervention||15
130555|NCT01207453|315163|P1|COMPLETED|2nd Intervention||17
130556|NCT01207453|315162|P2|STARTED|2nd Intervention||17
130557|NCT01207453|315163|P1|STARTED|2nd Intervention||19
130558|NCT01207453|315162|P2|NOT COMPLETED|Washout||0
130559|NCT01207453|315163|P1|NOT COMPLETED|Washout||2
130560|NCT01207453|315162|P2|COMPLETED|Washout||17
130561|NCT01207453|315163|P1|COMPLETED|Washout||19
130562|NCT01207453|315162|P2|STARTED|Washout||17
130563|NCT01207453|315163|P1|STARTED|Washout||21
130564|NCT01207453|315162|P2|NOT COMPLETED|First Intervention||1
130565|NCT01207453|315163|P1|NOT COMPLETED|First Intervention||2
130566|NCT01207453|315162|P2|COMPLETED|First Intervention||17
130567|NCT01207453|315163|P1|COMPLETED|First Intervention||21
130568|NCT01207453|315162|P2|STARTED|First Intervention||18
130569|NCT01207453|315163|P1|STARTED|First Intervention||23
130570|NCT01207427|315185|P3|NOT COMPLETED|Run-out Placebo Period||0
130571|NCT01207427|315186|P2|NOT COMPLETED|Run-out Placebo Period||0
130572|NCT01207427|315187|P1|NOT COMPLETED|Run-out Placebo Period||0
130573|NCT01207427|315185|P3|COMPLETED|Run-out Placebo Period||41
130574|NCT01207427|315186|P2|COMPLETED|Run-out Placebo Period||43
130575|NCT01207427|315187|P1|COMPLETED|Run-out Placebo Period||40
130576|NCT01207427|315185|P3|STARTED|Run-out Placebo Period||41
130577|NCT01207427|315186|P2|STARTED|Run-out Placebo Period||43
130578|NCT01207427|315187|P1|STARTED|Run-out Placebo Period||40
130579|NCT01207427|315185|P3|NOT COMPLETED|Double-blind Treatment Period||2
130580|NCT01207427|315186|P2|NOT COMPLETED|Double-blind Treatment Period||2
130581|NCT01207427|315187|P1|NOT COMPLETED|Double-blind Treatment Period||3
130582|NCT01207427|315185|P3|COMPLETED|Double-blind Treatment Period||41
130583|NCT01207427|315186|P2|COMPLETED|Double-blind Treatment Period||43
130584|NCT01207427|315187|P1|COMPLETED|Double-blind Treatment Period||40
130585|NCT01207427|315185|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
130586|NCT01207427|315186|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
130587|NCT01207427|315187|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
130588|NCT01207427|315185|P3|STARTED|Double-blind Treatment Period||43
130589|NCT01207427|315186|P2|STARTED|Double-blind Treatment Period||45
130590|NCT01207427|315187|P1|STARTED|Double-blind Treatment Period||43
130591|NCT01207427|315185|P3|NOT COMPLETED|Run-in Placebo Period||0
130592|NCT01207427|315186|P2|NOT COMPLETED|Run-in Placebo Period||0
130593|NCT01207427|315187|P1|NOT COMPLETED|Run-in Placebo Period||0
130594|NCT01207427|315185|P3|COMPLETED|Run-in Placebo Period||43
130595|NCT01207427|315186|P2|COMPLETED|Run-in Placebo Period||45
130596|NCT01207427|315187|P1|COMPLETED|Run-in Placebo Period||43
130597|NCT01207427|315185|P3|STARTED|Run-in Placebo Period||43
130598|NCT01207427|315186|P2|STARTED|Run-in Placebo Period||45
130599|NCT01207427|315187|P1|STARTED|Run-in Placebo Period||43
130600|NCT01207414|315197|P2|NOT COMPLETED|Overall Study||82
130601|NCT01207414|315198|P1|NOT COMPLETED|Overall Study||73
130602|NCT01207414|315197|P2|COMPLETED|Overall Study||178
130603|NCT01207414|315198|P1|COMPLETED|Overall Study||168
130604|NCT01207414|315197|P2|Safety Population: Received Study Drug|Overall Study||260
130605|NCT01207414|315198|P1|Safety Population: Received Study Drug|Overall Study||240
130606|NCT01207414|315197|P2|STARTED|Overall Study||260
130607|NCT01207414|315198|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
130608|NCT01207401|315216|P2|NOT COMPLETED|Overall Study||0
130609|NCT01207401|315217|P1|NOT COMPLETED|Overall Study||0
130610|NCT01207401|315216|P2|COMPLETED|Overall Study||24
130611|NCT01207401|315217|P1|COMPLETED|Overall Study||26
130612|NCT01207401|315216|P2|STARTED|Overall Study||24
130613|NCT01207401|315217|P1|STARTED|Overall Study||26
130614|NCT01207388|315223|P1|NOT COMPLETED|Overall Study||33
130615|NCT01207388|315223|P1|COMPLETED|Overall Study|Completed the core study|83
130616|NCT01207388|315223|P1|STARTED|Overall Study||116
130617|NCT01207219|315246|P3|NOT COMPLETED|Overall Study||7
130618|NCT01207219|315247|P2|NOT COMPLETED|Overall Study||11
130619|NCT01207219|315248|P1|NOT COMPLETED|Overall Study||11
130620|NCT01207219|315246|P3|COMPLETED|Overall Study||32
130621|NCT01207219|315247|P2|COMPLETED|Overall Study||29
130622|NCT01207219|315248|P1|COMPLETED|Overall Study||34
130623|NCT01207219|315246|P3|Included in ITT Analysis|Overall Study||38
130624|NCT01207219|315247|P2|Included in ITT Analysis|Overall Study||37
130625|NCT01207219|315248|P1|Included in ITT Analysis|Overall Study||40
130626|NCT01207219|315246|P3|STARTED|Overall Study||39
130627|NCT01207219|315247|P2|STARTED|Overall Study||40
130628|NCT01207219|315248|P1|STARTED|Overall Study||45
130629|NCT01207102|315268|P1|NOT COMPLETED|Overall Study||10
130630|NCT01207102|315268|P1|COMPLETED|Overall Study||0
130631|NCT01207102|315268|P1|STARTED|Overall Study||10
130632|NCT01206777|315273|P1|NOT COMPLETED|Overall Study||2
130633|NCT01206777|315273|P1|COMPLETED|Overall Study||50
130634|NCT01206777|315273|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
130635|NCT01206777|315273|P1|STARTED|Overall Study||52
130636|NCT01206738|315282|P3|NOT COMPLETED|Overall Study||19
130637|NCT01206738|315283|P2|NOT COMPLETED|Overall Study||25
130638|NCT01206738|315284|P1|NOT COMPLETED|Overall Study||23
130639|NCT01206738|315282|P3|COMPLETED|Overall Study||42
130640|NCT01206738|315283|P2|COMPLETED|Overall Study||49
130641|NCT01206738|315284|P1|COMPLETED|Overall Study||40
130642|NCT01206738|315282|P3|STARTED|Overall Study||61
130643|NCT01206738|315283|P2|STARTED|Overall Study||74
130644|NCT01206738|315284|P1|STARTED|Overall Study||63
130645|NCT01206660|315296|P2|NOT COMPLETED|Overall Study||0
130646|NCT01206660|315297|P1|NOT COMPLETED|Overall Study||0
130647|NCT01206660|315296|P2|COMPLETED|Overall Study||60
130648|NCT01206660|315297|P1|COMPLETED|Overall Study||60
130649|NCT01206660|315296|P2|STARTED|Overall Study||60
130650|NCT01206660|315297|P1|STARTED|Overall Study||60
130651|NCT01206608|315309|P2|NOT COMPLETED|Overall Study||0
130652|NCT01206608|315310|P1|NOT COMPLETED|Overall Study||0
130653|NCT01206608|315309|P2|COMPLETED|Overall Study||20
130654|NCT01206608|315310|P1|COMPLETED|Overall Study||20
130655|NCT01206608|315309|P2|STARTED|Overall Study||20
130656|NCT01206608|315310|P1|STARTED|Overall Study||20
130657|NCT01206595|315318|P2|NOT COMPLETED|Overall Study||0
130658|NCT01206595|315319|P1|NOT COMPLETED|Overall Study||0
130659|NCT01206595|315318|P2|COMPLETED|Overall Study||20
130660|NCT01206595|315319|P1|COMPLETED|Overall Study||38
130661|NCT01206595|315318|P2|STARTED|Overall Study||20
130662|NCT01206595|315319|P1|STARTED|Overall Study||38
130663|NCT01206582|315329|P2|NOT COMPLETED|Overall Study||2
130664|NCT01206582|315330|P1|NOT COMPLETED|Overall Study||2
130665|NCT01206582|315329|P2|COMPLETED|Overall Study||7
130666|NCT01206582|315330|P1|COMPLETED|Overall Study||9
130667|NCT01206582|315329|P2|STARTED|Overall Study||9
130668|NCT01206582|315330|P1|STARTED|Overall Study||11
130669|NCT01206517|315362|P6|NOT COMPLETED|Overall Study||0
130670|NCT01206517|315363|P5|NOT COMPLETED|Overall Study||1
130671|NCT01206517|315364|P4|NOT COMPLETED|Overall Study||0
130672|NCT01206517|315365|P3|NOT COMPLETED|Overall Study||2
130673|NCT01206517|315366|P2|NOT COMPLETED|Overall Study||0
130674|NCT01206517|315367|P1|NOT COMPLETED|Overall Study||0
130675|NCT01206517|315362|P6|COMPLETED|Overall Study||4
130676|NCT01206517|315363|P5|COMPLETED|Overall Study||3
130677|NCT01206517|315364|P4|COMPLETED|Overall Study||4
130678|NCT01206517|315365|P3|COMPLETED|Overall Study||4
130679|NCT01206517|315366|P2|COMPLETED|Overall Study||6
130680|NCT01206517|315367|P1|COMPLETED|Overall Study||6
130681|NCT01206517|315362|P6|STARTED|Overall Study||4
130682|NCT01206517|315363|P5|STARTED|Overall Study||4
130683|NCT01206517|315364|P4|STARTED|Overall Study||4
130684|NCT01206517|315365|P3|STARTED|Overall Study||6
130685|NCT01206517|315366|P2|STARTED|Overall Study||6
130686|NCT01206517|315367|P1|STARTED|Overall Study||6
130687|NCT01206478|315398|P2|NOT COMPLETED|Overall Study||5
130688|NCT01206478|315399|P1|NOT COMPLETED|Overall Study||2
130689|NCT01206478|315398|P2|COMPLETED|Overall Study||7
130690|NCT01206478|315399|P1|COMPLETED|Overall Study||7
130691|NCT01206478|315398|P2|STARTED|Overall Study||12
130692|NCT01206478|315399|P1|STARTED|Overall Study||9
130693|NCT01206452|315409|P2|NOT COMPLETED|Overall Study||0
130694|NCT01206452|315410|P1|NOT COMPLETED|Overall Study||0
130695|NCT01206452|315409|P2|COMPLETED|Overall Study||30
130696|NCT01206452|315410|P1|COMPLETED|Overall Study||30
130697|NCT01206452|315409|P2|STARTED|Overall Study||30
130698|NCT01206452|315410|P1|STARTED|Overall Study||30
130699|NCT01206439|315424|P1|NOT COMPLETED|Overall Study||1
130700|NCT01206439|315424|P1|COMPLETED|Overall Study||1
130701|NCT01206439|315424|P1|STARTED|Overall Study||2
130702|NCT01206387|315430|P2|NOT COMPLETED|Overall Study||0
130703|NCT01206387|315431|P1|NOT COMPLETED|Overall Study||1
130704|NCT01206387|315430|P2|COMPLETED|Overall Study||60
130705|NCT01206387|315431|P1|COMPLETED|Overall Study||59
130706|NCT01206387|315430|P2|STARTED|Overall Study||60
130707|NCT01206387|315431|P1|STARTED|Overall Study||60
130708|NCT01206322|315447|P4|NOT COMPLETED|Overall Study||1
130709|NCT01206322|315448|P3|NOT COMPLETED|Overall Study||0
130710|NCT01206322|315449|P2|NOT COMPLETED|Overall Study||0
130711|NCT01206322|315450|P1|NOT COMPLETED|Overall Study||0
130712|NCT01206322|315447|P4|COMPLETED|Overall Study||5
130713|NCT01206322|315448|P3|COMPLETED|Overall Study||9
130714|NCT01206322|315449|P2|COMPLETED|Overall Study||11
130715|NCT01206322|315450|P1|COMPLETED|Overall Study||4
130716|NCT01206322|315447|P4|STARTED|Overall Study||6
130717|NCT01206322|315448|P3|STARTED|Overall Study||9
130718|NCT01206322|315449|P2|STARTED|Overall Study||11
130719|NCT01206322|315450|P1|STARTED|Overall Study||4
130720|NCT01206140|315466|P2|NOT COMPLETED|Overall Study||0
130721|NCT01206140|315467|P1|NOT COMPLETED|Overall Study||1
130722|NCT01206140|315466|P2|COMPLETED|Overall Study||35
130723|NCT01206140|315467|P1|COMPLETED|Overall Study||34
130724|NCT01206140|315466|P2|STARTED|Overall Study||35
130725|NCT01206140|315467|P1|STARTED|Overall Study||35
130726|NCT01206101|315479|P2|NOT COMPLETED|Overall Study||1
130727|NCT01206101|315480|P1|NOT COMPLETED|Overall Study||2
130728|NCT01206101|315479|P2|COMPLETED|Overall Study||0
130729|NCT01206101|315480|P1|COMPLETED|Overall Study||0
130730|NCT01206101|315479|P2|STARTED|Overall Study||1
130731|NCT01206101|315480|P1|STARTED|Overall Study||2
130732|NCT01206062|315498|P2|NOT COMPLETED|Overall Study||0
130733|NCT01206062|315499|P1|NOT COMPLETED|Overall Study||0
130734|NCT01206062|315498|P2|COMPLETED|Overall Study||4683
130735|NCT01206062|315499|P1|COMPLETED|Overall Study||4678
130736|NCT01206062|315498|P2|STARTED|Overall Study||4683
130737|NCT01206062|315499|P1|STARTED|Overall Study||4678
130738|NCT01205828|315511|P1|NOT COMPLETED|Overall Study||0
130739|NCT01205828|315511|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
130740|NCT01205828|315511|P1|STARTED|Overall Study||16
130741|NCT01205776|315521|P2|NOT COMPLETED|3 Years Follow-up||24
130742|NCT01205776|315522|P1|NOT COMPLETED|3 Years Follow-up||16
130743|NCT01205776|315521|P2|COMPLETED|3 Years Follow-up||889
130744|NCT01205776|315522|P1|COMPLETED|3 Years Follow-up||911
130745|NCT01205776|315521|P2|STARTED|3 Years Follow-up||913
130746|NCT01205776|315522|P1|STARTED|3 Years Follow-up||927
130747|NCT01205776|315521|P2|NOT COMPLETED|2 Years Follow-up||32
130748|NCT01205776|315522|P1|NOT COMPLETED|2 Years Follow-up||16
130749|NCT01205776|315521|P2|COMPLETED|2 Years Follow-up||913
130750|NCT01205776|315522|P1|COMPLETED|2 Years Follow-up||927
130751|NCT01205776|315521|P2|STARTED|2 Years Follow-up||945
130752|NCT01205776|315522|P1|STARTED|2 Years Follow-up||943
130753|NCT01205776|315521|P2|NOT COMPLETED|1 Month Follow-up||12
130754|NCT01205776|315522|P1|NOT COMPLETED|1 Month Follow-up||5
130755|NCT01205776|315521|P2|COMPLETED|1 Month Follow-up||945
130756|NCT01205776|315522|P1|COMPLETED|1 Month Follow-up||943
130757|NCT01205776|315521|P2|STARTED|1 Month Follow-up||957
130758|NCT01205776|315522|P1|STARTED|1 Month Follow-up||948
130759|NCT01205685|315662|P1|NOT COMPLETED|Overall Study||11
130760|NCT01205685|315662|P1|COMPLETED|Overall Study||0
130761|NCT01205685|315662|P1|STARTED|Overall Study||11
130762|NCT01205646|315669|P1|NOT COMPLETED|Overall Study||0
130763|NCT01205646|315669|P1|COMPLETED|Overall Study||11
130764|NCT01205646|315669|P1|STARTED|Overall Study||11
130765|NCT01205581|315682|P6|NOT COMPLETED|Overall Study||0
130766|NCT01205581|315683|P5|NOT COMPLETED|Overall Study||0
130767|NCT01205581|315684|P4|NOT COMPLETED|Overall Study||0
130768|NCT01205581|315685|P3|NOT COMPLETED|Overall Study||0
130769|NCT01205581|315686|P2|NOT COMPLETED|Overall Study||0
130770|NCT01205581|315687|P1|NOT COMPLETED|Overall Study||1
130771|NCT01205581|315682|P6|COMPLETED|Overall Study||20
130772|NCT01205581|315683|P5|COMPLETED|Overall Study||20
130773|NCT01205581|315684|P4|COMPLETED|Overall Study||9
130774|NCT01205581|315685|P3|COMPLETED|Overall Study||8
130775|NCT01205581|315686|P2|COMPLETED|Overall Study||13
130776|NCT01205581|315687|P1|COMPLETED|Overall Study||13
130777|NCT01205581|315682|P6|STARTED|Overall Study||20
130778|NCT01205581|315683|P5|STARTED|Overall Study||20
130779|NCT01205581|315684|P4|STARTED|Overall Study||9
130780|NCT01205581|315685|P3|STARTED|Overall Study||8
130781|NCT01205581|315686|P2|STARTED|Overall Study||13
130782|NCT01205581|315687|P1|STARTED|Overall Study||14
130783|NCT01205568|315751|P2|NOT COMPLETED|Overall Study||0
130784|NCT01205568|315752|P1|NOT COMPLETED|Overall Study||0
130785|NCT01205568|315751|P2|COMPLETED|Overall Study||47
130786|NCT01205568|315752|P1|COMPLETED|Overall Study||65
130870|NCT01205269|315832|P3|NOT COMPLETED|Period 2 - Washout||0
130787|NCT01205568|315751|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
130788|NCT01205568|315752|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
130789|NCT01205529|315757|P1|NOT COMPLETED|Overall Study||55
130790|NCT01205529|315757|P1|COMPLETED|Overall Study||106
130791|NCT01205529|315757|P1|STARTED|Overall Study||161
130792|NCT01205503|315763|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
130793|NCT01205503|315764|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
130794|NCT01205503|315763|P2|COMPLETED|Second Intervention (2nd Cycle)||16
130795|NCT01205503|315764|P1|COMPLETED|Second Intervention (2nd Cycle)||16
130796|NCT01205503|315763|P2|STARTED|Second Intervention (2nd Cycle)||16
130797|NCT01205503|315764|P1|STARTED|Second Intervention (2nd Cycle)||16
130798|NCT01205503|315763|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
130799|NCT01205503|315764|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
130800|NCT01205503|315763|P2|COMPLETED|First Intervention (1st Cycle)||16
130801|NCT01205503|315764|P1|COMPLETED|First Intervention (1st Cycle)||16
130802|NCT01205503|315763|P2|STARTED|First Intervention (1st Cycle)||16
130803|NCT01205503|315764|P1|STARTED|First Intervention (1st Cycle)||16
130804|NCT01205451|315780|P2|NOT COMPLETED|Overall Study||10
130805|NCT01205451|315781|P1|NOT COMPLETED|Overall Study||6
130806|NCT01205451|315780|P2|COMPLETED|Overall Study||46
130807|NCT01205451|315781|P1|COMPLETED|Overall Study||47
130808|NCT01205451|315780|P2|STARTED|Overall Study||56
130809|NCT01205451|315781|P1|STARTED|Overall Study||53
130810|NCT01205399|315823|P1|NOT COMPLETED|Overall Study||0
130811|NCT01205399|315823|P1|COMPLETED|Overall Study||78
130812|NCT01205399|315823|P1|STARTED|Overall Study||78
130813|NCT01205269|315829|P6|NOT COMPLETED|Period 5 - Third Intervention||0
130814|NCT01205269|315830|P5|NOT COMPLETED|Period 5 - Third Intervention||0
130815|NCT01205269|315831|P4|NOT COMPLETED|Period 5 - Third Intervention||0
130816|NCT01205269|315832|P3|NOT COMPLETED|Period 5 - Third Intervention||0
130817|NCT01205269|315833|P2|NOT COMPLETED|Period 5 - Third Intervention||0
130818|NCT01205269|315834|P1|NOT COMPLETED|Period 5 - Third Intervention||0
130819|NCT01205269|315829|P6|COMPLETED|Period 5 - Third Intervention||5
130820|NCT01205269|315830|P5|COMPLETED|Period 5 - Third Intervention||5
130821|NCT01205269|315831|P4|COMPLETED|Period 5 - Third Intervention||5
130822|NCT01205269|315832|P3|COMPLETED|Period 5 - Third Intervention||4
130823|NCT01205269|315833|P2|COMPLETED|Period 5 - Third Intervention||4
130824|NCT01205269|315834|P1|COMPLETED|Period 5 - Third Intervention||4
130825|NCT01205269|315829|P6|STARTED|Period 5 - Third Intervention||5
130826|NCT01205269|315830|P5|STARTED|Period 5 - Third Intervention||5
130827|NCT01205269|315831|P4|STARTED|Period 5 - Third Intervention||5
130828|NCT01205269|315832|P3|STARTED|Period 5 - Third Intervention||4
130829|NCT01205269|315833|P2|STARTED|Period 5 - Third Intervention||4
130830|NCT01205269|315834|P1|STARTED|Period 5 - Third Intervention||4
130831|NCT01205269|315829|P6|NOT COMPLETED|Period 4 - Washout||0
130832|NCT01205269|315830|P5|NOT COMPLETED|Period 4 - Washout||0
130833|NCT01205269|315831|P4|NOT COMPLETED|Period 4 - Washout||1
130834|NCT01205269|315832|P3|NOT COMPLETED|Period 4 - Washout||0
130835|NCT01205269|315833|P2|NOT COMPLETED|Period 4 - Washout||0
130836|NCT01205269|315834|P1|NOT COMPLETED|Period 4 - Washout||0
130837|NCT01205269|315829|P6|COMPLETED|Period 4 - Washout||5
130838|NCT01205269|315830|P5|COMPLETED|Period 4 - Washout||5
130839|NCT01205269|315831|P4|COMPLETED|Period 4 - Washout||5
130840|NCT01205269|315832|P3|COMPLETED|Period 4 - Washout||4
130841|NCT01205269|315833|P2|COMPLETED|Period 4 - Washout||4
130842|NCT01205269|315834|P1|COMPLETED|Period 4 - Washout||4
130843|NCT01205269|315829|P6|STARTED|Period 4 - Washout||5
130844|NCT01205269|315830|P5|STARTED|Period 4 - Washout||5
130845|NCT01205269|315831|P4|STARTED|Period 4 - Washout||6
130846|NCT01205269|315832|P3|STARTED|Period 4 - Washout||4
130847|NCT01205269|315833|P2|STARTED|Period 4 - Washout||4
130848|NCT01205269|315834|P1|STARTED|Period 4 - Washout||4
130849|NCT01205269|315829|P6|NOT COMPLETED|Period 3 - Second Intervention||0
130850|NCT01205269|315830|P5|NOT COMPLETED|Period 3 - Second Intervention||0
130851|NCT01205269|315831|P4|NOT COMPLETED|Period 3 - Second Intervention||0
130852|NCT01205269|315832|P3|NOT COMPLETED|Period 3 - Second Intervention||0
130853|NCT01205269|315833|P2|NOT COMPLETED|Period 3 - Second Intervention||0
130854|NCT01205269|315834|P1|NOT COMPLETED|Period 3 - Second Intervention||0
130855|NCT01205269|315829|P6|COMPLETED|Period 3 - Second Intervention||5
130856|NCT01205269|315830|P5|COMPLETED|Period 3 - Second Intervention||5
130857|NCT01205269|315831|P4|COMPLETED|Period 3 - Second Intervention||6
130858|NCT01205269|315832|P3|COMPLETED|Period 3 - Second Intervention||4
130859|NCT01205269|315833|P2|COMPLETED|Period 3 - Second Intervention||4
130860|NCT01205269|315834|P1|COMPLETED|Period 3 - Second Intervention||4
130861|NCT01205269|315829|P6|STARTED|Period 3 - Second Intervention||5
130862|NCT01205269|315830|P5|STARTED|Period 3 - Second Intervention||5
130863|NCT01205269|315831|P4|STARTED|Period 3 - Second Intervention||6
130864|NCT01205269|315832|P3|STARTED|Period 3 - Second Intervention||4
130865|NCT01205269|315833|P2|STARTED|Period 3 - Second Intervention||4
130866|NCT01205269|315834|P1|STARTED|Period 3 - Second Intervention||4
130867|NCT01205269|315829|P6|NOT COMPLETED|Period 2 - Washout||0
130868|NCT01205269|315830|P5|NOT COMPLETED|Period 2 - Washout||0
130869|NCT01205269|315831|P4|NOT COMPLETED|Period 2 - Washout||0
130871|NCT01205269|315833|P2|NOT COMPLETED|Period 2 - Washout||0
130872|NCT01205269|315834|P1|NOT COMPLETED|Period 2 - Washout||0
130873|NCT01205269|315829|P6|COMPLETED|Period 2 - Washout||5
130874|NCT01205269|315830|P5|COMPLETED|Period 2 - Washout||5
130875|NCT01205269|315831|P4|COMPLETED|Period 2 - Washout||6
130876|NCT01205269|315832|P3|COMPLETED|Period 2 - Washout||4
130877|NCT01205269|315833|P2|COMPLETED|Period 2 - Washout||4
130878|NCT01205269|315834|P1|COMPLETED|Period 2 - Washout||4
130879|NCT01205269|315829|P6|STARTED|Period 2 - Washout||5
130880|NCT01205269|315830|P5|STARTED|Period 2 - Washout||5
130881|NCT01205269|315831|P4|STARTED|Period 2 - Washout||6
130882|NCT01205269|315832|P3|STARTED|Period 2 - Washout||4
130883|NCT01205269|315833|P2|STARTED|Period 2 - Washout||4
130884|NCT01205269|315834|P1|STARTED|Period 2 - Washout||4
130885|NCT01205269|315829|P6|NOT COMPLETED|Period 1 - First Intervention||0
130886|NCT01205269|315830|P5|NOT COMPLETED|Period 1 - First Intervention||0
130887|NCT01205269|315831|P4|NOT COMPLETED|Period 1 - First Intervention||0
130888|NCT01205269|315832|P3|NOT COMPLETED|Period 1 - First Intervention||0
130889|NCT01205269|315833|P2|NOT COMPLETED|Period 1 - First Intervention||0
130890|NCT01205269|315834|P1|NOT COMPLETED|Period 1 - First Intervention||0
130891|NCT01205269|315829|P6|COMPLETED|Period 1 - First Intervention||5
130892|NCT01205269|315830|P5|COMPLETED|Period 1 - First Intervention||5
130893|NCT01205269|315831|P4|COMPLETED|Period 1 - First Intervention||6
130894|NCT01205269|315832|P3|COMPLETED|Period 1 - First Intervention||4
130895|NCT01205269|315833|P2|COMPLETED|Period 1 - First Intervention||4
130896|NCT01205269|315834|P1|COMPLETED|Period 1 - First Intervention||4
130897|NCT01205269|315829|P6|STARTED|Period 1 - First Intervention||5
130898|NCT01205269|315830|P5|STARTED|Period 1 - First Intervention||5
130899|NCT01205269|315831|P4|STARTED|Period 1 - First Intervention||6
130900|NCT01205269|315832|P3|STARTED|Period 1 - First Intervention||4
130901|NCT01205269|315833|P2|STARTED|Period 1 - First Intervention||4
130902|NCT01205269|315834|P1|STARTED|Period 1 - First Intervention||4
130903|NCT01205230|315874|P2|NOT COMPLETED|Overall Study||0
130904|NCT01205230|315875|P1|NOT COMPLETED|Overall Study||5
130905|NCT01205230|315874|P2|COMPLETED|Overall Study||13
130906|NCT01205230|315875|P1|COMPLETED|Overall Study||16
130907|NCT01205230|315874|P2|Combination Therapy|Overall Study||13
130908|NCT01205230|315875|P1|Combination Therapy|Overall Study||21
130909|NCT01205230|315874|P2|STARTED|Overall Study||13
130910|NCT01205230|315875|P1|STARTED|Overall Study||21
130911|NCT01205165|315918|P1|NOT COMPLETED|Overall Study||2
130912|NCT01205165|315918|P1|COMPLETED|Overall Study||102
130913|NCT01205165|315918|P1|STARTED|Overall Study||104
130914|NCT01205152|315931|P1|NOT COMPLETED|Overall Study||1
130915|NCT01205152|315931|P1|COMPLETED|Overall Study||9
130916|NCT01205152|315931|P1|STARTED|Overall Study||10
130917|NCT01205126|315944|P2|NOT COMPLETED|Maintenance Phase||40
130918|NCT01205126|315945|P1|NOT COMPLETED|Maintenance Phase||37
130919|NCT01205126|315944|P2|COMPLETED|Maintenance Phase||67
130920|NCT01205126|315945|P1|COMPLETED|Maintenance Phase||70
130921|NCT01205126|315944|P2|STARTED|Maintenance Phase||107
130922|NCT01205126|315945|P1|STARTED|Maintenance Phase||107
130923|NCT01205126|315944|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
130924|NCT01205126|315945|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
130925|NCT01205126|315944|P2|COMPLETED|Between Titration & Maintenance Phase||107
130926|NCT01205126|315945|P1|COMPLETED|Between Titration & Maintenance Phase||107
130927|NCT01205126|315944|P2|STARTED|Between Titration & Maintenance Phase||111
130928|NCT01205126|315945|P1|STARTED|Between Titration & Maintenance Phase||107
130929|NCT01205126|315944|P2|NOT COMPLETED|Titration Phase||19
130930|NCT01205126|315945|P1|NOT COMPLETED|Titration Phase||23
130931|NCT01205126|315944|P2|COMPLETED|Titration Phase||111
130932|NCT01205126|315945|P1|COMPLETED|Titration Phase||107
130933|NCT01205126|315944|P2|STARTED|Titration Phase||130
130934|NCT01205126|315945|P1|STARTED|Titration Phase||130
130935|NCT01205035|315963|P2|NOT COMPLETED|Overall Study||0
130936|NCT01205035|315964|P1|NOT COMPLETED|Overall Study||2
130937|NCT01205035|315963|P2|COMPLETED|Overall Study||3
130938|NCT01205035|315964|P1|COMPLETED|Overall Study||1
130939|NCT01205035|315963|P2|STARTED|Overall Study||3
130940|NCT01205035|315964|P1|STARTED|Overall Study||3
130941|NCT01204918|315981|P3|NOT COMPLETED|Overall Study||5
130942|NCT01204918|315982|P2|NOT COMPLETED|Overall Study||10
130943|NCT01204918|315983|P1|NOT COMPLETED|Overall Study||4
130944|NCT01204918|315981|P3|COMPLETED|Overall Study||35
130945|NCT01204918|315982|P2|COMPLETED|Overall Study||29
130946|NCT01204918|315983|P1|COMPLETED|Overall Study||21
130947|NCT01204918|315981|P3|Stage 2 End|Overall Study||35
130948|NCT01204918|315982|P2|Stage 2 End|Overall Study||29
130949|NCT01204918|315983|P1|Stage 2 End|Overall Study||21
130950|NCT01204918|315981|P3|Stage 2 Begin|Overall Study||36
130951|NCT01204918|315982|P2|Stage 2 Begin|Overall Study||35
130952|NCT01204918|315983|P1|Stage 2 Begin|Overall Study||22
130953|NCT01204918|315981|P3|Stage 1 End|Overall Study||36
130954|NCT01204918|315982|P2|Stage 1 End|Overall Study||35
130955|NCT01204918|315983|P1|Stage 1 End|Overall Study||22
130956|NCT01204918|315981|P3|Stage 1 Begin|Overall Study||40
130957|NCT01204918|315982|P2|Stage 1 Begin|Overall Study||39
130958|NCT01204918|315983|P1|Stage 1 Begin|Overall Study||25
130959|NCT01204918|315981|P3|STARTED|Overall Study||40
130960|NCT01204918|315982|P2|STARTED|Overall Study||39
130961|NCT01204918|315983|P1|STARTED|Overall Study||25
130962|NCT01204853|316000|P1|NOT COMPLETED|Overall Study||0
130963|NCT01204853|316000|P1|COMPLETED|Overall Study||2
130964|NCT01204853|316000|P1|STARTED|Overall Study||2
130965|NCT01204788|316012|P2|NOT COMPLETED|Overall Study||3
130966|NCT01204788|316013|P1|NOT COMPLETED|Overall Study||1
130967|NCT01204788|316012|P2|COMPLETED|Overall Study||0
130968|NCT01204788|316013|P1|COMPLETED|Overall Study||0
130969|NCT01204788|316012|P2|STARTED|Overall Study||3
130970|NCT01204788|316013|P1|STARTED|Overall Study||1
130971|NCT01204775|316021|P2|NOT COMPLETED|Overall Study||1
130972|NCT01204775|316022|P1|NOT COMPLETED|Overall Study||1
130973|NCT01204775|316021|P2|COMPLETED|Overall Study||3
130974|NCT01204775|316022|P1|COMPLETED|Overall Study||3
130975|NCT01204775|316021|P2|Double-blind Treatment Period|Overall Study||4
130976|NCT01204775|316022|P1|Double-blind Treatment Period|Overall Study||4
130977|NCT01204775|316021|P2|STARTED|Overall Study||4
130978|NCT01204775|316022|P1|STARTED|Overall Study||4
130979|NCT01204736|316032|P4|NOT COMPLETED|Overall Study||0
130980|NCT01204736|316033|P3|NOT COMPLETED|Overall Study||0
130981|NCT01204736|316034|P2|NOT COMPLETED|Overall Study||0
130982|NCT01204736|316035|P1|NOT COMPLETED|Overall Study||0
130983|NCT01204736|316032|P4|COMPLETED|Overall Study||2
130984|NCT01204736|316033|P3|COMPLETED|Overall Study||3
130985|NCT01204736|316034|P2|COMPLETED|Overall Study||5
130986|NCT01204736|316035|P1|COMPLETED|Overall Study||4
130987|NCT01204736|316032|P4|STARTED|Overall Study||2
130988|NCT01204736|316033|P3|STARTED|Overall Study||3
130989|NCT01204736|316034|P2|STARTED|Overall Study||5
130990|NCT01204736|316035|P1|STARTED|Overall Study||4
130991|NCT01204697|316047|P2|NOT COMPLETED|Overall Study||36
130992|NCT01204697|316048|P1|NOT COMPLETED|Overall Study||31
130993|NCT01204697|316047|P2|COMPLETED|Overall Study||2
130994|NCT01204697|316048|P1|COMPLETED|Overall Study||5
130995|NCT01204697|316047|P2|Treated|Overall Study||37
130996|NCT01204697|316048|P1|Treated|Overall Study||36
130997|NCT01204697|316047|P2|STARTED|Overall Study||38
130998|NCT01204697|316048|P1|STARTED|Overall Study||36
130999|NCT01204671|316069|P5|NOT COMPLETED|Overall Study||4
131000|NCT01204671|316070|P4|NOT COMPLETED|Overall Study||13
131001|NCT01204671|316071|P3|NOT COMPLETED|Overall Study||13
131002|NCT01204671|316072|P2|NOT COMPLETED|Overall Study||15
131003|NCT01204671|316073|P1|NOT COMPLETED|Overall Study||14
131004|NCT01204671|316069|P5|COMPLETED|Overall Study||606
131005|NCT01204671|316070|P4|COMPLETED|Overall Study||997
131006|NCT01204671|316071|P3|COMPLETED|Overall Study||998
131007|NCT01204671|316072|P2|COMPLETED|Overall Study||998
131008|NCT01204671|316073|P1|COMPLETED|Overall Study||998
131009|NCT01204671|316069|P5|STARTED|Overall Study||610
131010|NCT01204671|316070|P4|STARTED|Overall Study||1010
131011|NCT01204671|316071|P3|STARTED|Overall Study||1011
131012|NCT01204671|316072|P2|STARTED|Overall Study||1013
131013|NCT01204671|316073|P1|STARTED|Overall Study||1012
131014|NCT01204658|316135|P4|NOT COMPLETED|Booster Phase||0
131015|NCT01204658|316136|P3|NOT COMPLETED|Booster Phase||0
131016|NCT01204658|316137|P2|NOT COMPLETED|Booster Phase||0
131017|NCT01204658|316138|P1|NOT COMPLETED|Booster Phase||0
131018|NCT01204658|316135|P4|COMPLETED|Booster Phase||140
131019|NCT01204658|316136|P3|COMPLETED|Booster Phase||140
131020|NCT01204658|316137|P2|COMPLETED|Booster Phase||140
131021|NCT01204658|316138|P1|COMPLETED|Booster Phase||144
131022|NCT01204658|316135|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
131023|NCT01204658|316136|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
131024|NCT01204658|316137|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
131025|NCT01204658|316138|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
131026|NCT01204658|316135|P4|NOT COMPLETED|Primary Phase||0
131027|NCT01204658|316136|P3|NOT COMPLETED|Primary Phase||1
131028|NCT01204658|316137|P2|NOT COMPLETED|Primary Phase||0
131029|NCT01204658|316138|P1|NOT COMPLETED|Primary Phase||0
131030|NCT01204658|316135|P4|COMPLETED|Primary Phase||142
131031|NCT01204658|316136|P3|COMPLETED|Primary Phase||144
131032|NCT01204658|316137|P2|COMPLETED|Primary Phase||142
131033|NCT01204658|316138|P1|COMPLETED|Primary Phase||146
131034|NCT01204658|316135|P4|STARTED|Primary Phase||142
131035|NCT01204658|316136|P3|STARTED|Primary Phase||145
131036|NCT01204658|316137|P2|STARTED|Primary Phase||142
131037|NCT01204658|316138|P1|STARTED|Primary Phase||146
131038|NCT01204398|316248|P1|NOT COMPLETED|Overall Study||1
131039|NCT01204398|316248|P1|COMPLETED|Overall Study|Completed trial medication.|26
131040|NCT01204398|316248|P1|STARTED|Overall Study|Entered and treated.|27
131041|NCT01204294|316265|P7|NOT COMPLETED|Overall Study||2
131042|NCT01204294|316266|P6|NOT COMPLETED|Overall Study||5
131043|NCT01204294|316267|P5|NOT COMPLETED|Overall Study||2
131044|NCT01204294|316268|P4|NOT COMPLETED|Overall Study||11
131045|NCT01204294|316269|P3|NOT COMPLETED|Overall Study||5
131046|NCT01204294|316270|P2|NOT COMPLETED|Overall Study||8
131047|NCT01204294|316271|P1|NOT COMPLETED|Overall Study||3
131048|NCT01204294|316265|P7|COMPLETED|Overall Study||59
131049|NCT01204294|316266|P6|COMPLETED|Overall Study||58
131050|NCT01204294|316267|P5|COMPLETED|Overall Study||83
131051|NCT01204294|316268|P4|COMPLETED|Overall Study||132
131052|NCT01204294|316269|P3|COMPLETED|Overall Study||69
131053|NCT01204294|316270|P2|COMPLETED|Overall Study||58
131054|NCT01204294|316271|P1|COMPLETED|Overall Study||79
131055|NCT01204294|316265|P7|STARTED|Overall Study||61
131056|NCT01204294|316266|P6|STARTED|Overall Study||63
131057|NCT01204294|316267|P5|STARTED|Overall Study||85
131058|NCT01204294|316268|P4|STARTED|Overall Study||143
131059|NCT01204294|316269|P3|STARTED|Overall Study||74
131060|NCT01204294|316270|P2|STARTED|Overall Study||66
131061|NCT01204294|316271|P1|STARTED|Overall Study||82
131062|NCT01204255|316294|P1|NOT COMPLETED|Overall Study||1
131063|NCT01204255|316294|P1|COMPLETED|Overall Study||10
131064|NCT01204255|316294|P1|STARTED|Overall Study||11
131065|NCT01204203|316299|P1|NOT COMPLETED|Overall Study||0
131066|NCT01204203|316299|P1|COMPLETED|Overall Study||8
131067|NCT01204203|316299|P1|STARTED|Overall Study||8
131068|NCT01203956|316305|P2|NOT COMPLETED|Second Two-week Period||6
131069|NCT01203956|316306|P1|NOT COMPLETED|Second Two-week Period||5
131070|NCT01203956|316305|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
131071|NCT01203956|316306|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
131072|NCT01203956|316305|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
131073|NCT01203956|316306|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
131074|NCT01203956|316305|P2|STARTED|Second Two-week Period||13
131075|NCT01203956|316306|P1|STARTED|Second Two-week Period||15
131076|NCT01203956|316305|P2|NOT COMPLETED|First Two-week Period||0
131077|NCT01203956|316306|P1|NOT COMPLETED|First Two-week Period||0
131078|NCT01203956|316305|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
131079|NCT01203956|316306|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
131080|NCT01203956|316305|P2|STARTED|First Two-week Period||13
131081|NCT01203956|316306|P1|STARTED|First Two-week Period||15
131082|NCT01203930|316315|P2|NOT COMPLETED|Overall Study||41
131083|NCT01203930|316316|P1|NOT COMPLETED|Overall Study||21
131084|NCT01203930|316315|P2|COMPLETED|Overall Study||0
131085|NCT01203930|316316|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
131086|NCT01203930|316315|P2|STARTED|Overall Study||41
131087|NCT01203930|316316|P1|STARTED|Overall Study||64
131088|NCT01203917|316338|P1|NOT COMPLETED|Overall Study||36
131089|NCT01203917|316338|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
131090|NCT01203917|316338|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
131091|NCT01203878|316351|P3|NOT COMPLETED|Overall Study||3
131092|NCT01203878|316352|P2|NOT COMPLETED|Overall Study||0
131093|NCT01203878|316353|P1|NOT COMPLETED|Overall Study||0
131094|NCT01203878|316351|P3|COMPLETED|Overall Study||0
131095|NCT01203878|316352|P2|COMPLETED|Overall Study||9
131096|NCT01203878|316353|P1|COMPLETED|Overall Study||9
131097|NCT01203878|316351|P3|STARTED|Overall Study||3
131098|NCT01203878|316352|P2|STARTED|Overall Study||9
131099|NCT01203878|316353|P1|STARTED|Overall Study||9
131100|NCT01203852|316364|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
131101|NCT01203852|316364|P1|COMPLETED|Chlorthalidone 8 Weeks||328
131102|NCT01203852|316364|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
131103|NCT01203852|316364|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
131104|NCT01203852|316364|P1|NOT COMPLETED|Washout 2 Weeks||46
131105|NCT01203852|316364|P1|COMPLETED|Washout 2 Weeks||282
131106|NCT01203852|316364|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
131107|NCT01203852|316364|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
131108|NCT01203852|316364|P1|COMPLETED|Metoprolol 8 Weeks||369
131109|NCT01203852|316364|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
131110|NCT01203826|316373|P2|NOT COMPLETED|Overall Study||0
131111|NCT01203826|316374|P1|NOT COMPLETED|Overall Study||0
131112|NCT01203826|316373|P2|COMPLETED|Overall Study||6
131113|NCT01203826|316374|P1|COMPLETED|Overall Study||6
131114|NCT01203826|316373|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
131115|NCT01203826|316374|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
131116|NCT01203787|316382|P2|NOT COMPLETED|Overall Study||27
131117|NCT01203787|316383|P1|NOT COMPLETED|Overall Study||31
131118|NCT01203787|316382|P2|COMPLETED|Overall Study||30
131119|NCT01203787|316383|P1|COMPLETED|Overall Study||32
131120|NCT01203787|316382|P2|STARTED|Overall Study||57
131121|NCT01203787|316383|P1|STARTED|Overall Study||63
131122|NCT01203644|316403|P2|NOT COMPLETED|Overall Study||0
131123|NCT01203644|316404|P1|NOT COMPLETED|Overall Study||0
131124|NCT01203644|316403|P2|COMPLETED|Overall Study||50
131125|NCT01203644|316404|P1|COMPLETED|Overall Study||26
131126|NCT01203644|316403|P2|STARTED|Overall Study||50
131127|NCT01203644|316404|P1|STARTED|Overall Study||26
131128|NCT01203319|316416|P3|NOT COMPLETED|Overall Study||5
131129|NCT01203319|316417|P2|NOT COMPLETED|Overall Study||9
131130|NCT01203319|316418|P1|NOT COMPLETED|Overall Study||6
131131|NCT01203319|316416|P3|COMPLETED|Overall Study||217
131132|NCT01203319|316417|P2|COMPLETED|Overall Study||426
131133|NCT01203319|316418|P1|COMPLETED|Overall Study||428
131134|NCT01203319|316416|P3|STARTED|Overall Study||222
131135|NCT01203319|316417|P2|STARTED|Overall Study||435
131136|NCT01203319|316418|P1|STARTED|Overall Study||434
131137|NCT01203189|316435|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
131138|NCT01203189|316436|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
131139|NCT01203189|316437|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
131140|NCT01203189|316435|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
131141|NCT01203189|316436|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
131142|NCT01203189|316437|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
131143|NCT01203189|316435|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
131144|NCT01203189|316436|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
131145|NCT01203189|316437|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
131146|NCT01203189|316435|P3|NOT COMPLETED|First 4 Weeks Treatment||0
131147|NCT01203189|316436|P2|NOT COMPLETED|First 4 Weeks Treatment||2
131148|NCT01203189|316437|P1|NOT COMPLETED|First 4 Weeks Treatment||2
131149|NCT01203189|316435|P3|COMPLETED|First 4 Weeks Treatment||3
131150|NCT01203189|316436|P2|COMPLETED|First 4 Weeks Treatment||8
131151|NCT01203189|316437|P1|COMPLETED|First 4 Weeks Treatment||8
131152|NCT01203189|316435|P3|STARTED|First 4 Weeks Treatment||3
131153|NCT01203189|316436|P2|STARTED|First 4 Weeks Treatment||10
131154|NCT01203189|316437|P1|STARTED|First 4 Weeks Treatment||10
131155|NCT01203098|316454|P3|NOT COMPLETED|Overall Study||11
131156|NCT01203098|316455|P2|NOT COMPLETED|Overall Study||4
131157|NCT01203098|316456|P1|NOT COMPLETED|Overall Study||6
131158|NCT01203098|316454|P3|COMPLETED|Overall Study||78
131159|NCT01203098|316455|P2|COMPLETED|Overall Study||82
131160|NCT01203098|316456|P1|COMPLETED|Overall Study||83
131161|NCT01203098|316454|P3|Safety Analysis Dataset|Overall Study||87
131162|NCT01203098|316455|P2|Safety Analysis Dataset|Overall Study||85
131163|NCT01203098|316456|P1|Safety Analysis Dataset|Overall Study||89
131164|NCT01203098|316454|P3|STARTED|Overall Study||89
131165|NCT01203098|316455|P2|STARTED|Overall Study||86
131166|NCT01203098|316456|P1|STARTED|Overall Study||89
131167|NCT01203072|316472|P5|NOT COMPLETED|Overall Study||6
131168|NCT01203072|316473|P4|NOT COMPLETED|Overall Study||6
131169|NCT01203072|316474|P3|NOT COMPLETED|Overall Study||3
131170|NCT01203072|316475|P2|NOT COMPLETED|Overall Study||6
131171|NCT01203072|316476|P1|NOT COMPLETED|Overall Study||10
131172|NCT01203072|316472|P5|COMPLETED|Overall Study||96
131173|NCT01203072|316473|P4|COMPLETED|Overall Study||100
131174|NCT01203072|316474|P3|COMPLETED|Overall Study||101
131175|NCT01203072|316475|P2|COMPLETED|Overall Study||100
131176|NCT01203072|316476|P1|COMPLETED|Overall Study||95
131177|NCT01203072|316472|P5|STARTED|Overall Study||102
131178|NCT01203072|316473|P4|STARTED|Overall Study||106
131179|NCT01203072|316474|P3|STARTED|Overall Study||104
131180|NCT01203072|316475|P2|STARTED|Overall Study||106
131181|NCT01203072|316476|P1|STARTED|Overall Study||105
131182|NCT01203046|316495|P2|NOT COMPLETED|Overall Study||0
131183|NCT01203046|316496|P1|NOT COMPLETED|Overall Study||0
131184|NCT01203046|316495|P2|COMPLETED|Overall Study||28
131185|NCT01203046|316496|P1|COMPLETED|Overall Study||28
131186|NCT01203046|316495|P2|STARTED|Overall Study||28
131187|NCT01203046|316496|P1|STARTED|Overall Study||28
131188|NCT01202994|316504|P1|NOT COMPLETED|Overall Study||0
131189|NCT01202994|316504|P1|COMPLETED|Overall Study||27
131190|NCT01202994|316504|P1|STARTED|Overall Study||27
131191|NCT01202955|316511|P2|NOT COMPLETED|Period 3: 10 Days||0
131192|NCT01202955|316512|P1|NOT COMPLETED|Period 3: 10 Days||0
131193|NCT01202955|316511|P2|COMPLETED|Period 3: 10 Days||8
131194|NCT01202955|316512|P1|COMPLETED|Period 3: 10 Days||9
131195|NCT01202955|316511|P2|STARTED|Period 3: 10 Days||8
131196|NCT01202955|316512|P1|STARTED|Period 3: 10 Days||9
131197|NCT01202955|316511|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
131198|NCT01202955|316512|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
131199|NCT01202955|316511|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
131200|NCT01202955|316512|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
131201|NCT01202955|316511|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
131202|NCT01202955|316512|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
131203|NCT01202955|316511|P2|NOT COMPLETED|Period 1: 10 Days||2
131204|NCT01202955|316512|P1|NOT COMPLETED|Period 1: 10 Days||0
131205|NCT01202955|316511|P2|COMPLETED|Period 1: 10 Days||8
131206|NCT01202955|316512|P1|COMPLETED|Period 1: 10 Days||9
131207|NCT01202955|316511|P2|STARTED|Period 1: 10 Days||10
131208|NCT01202955|316512|P1|STARTED|Period 1: 10 Days||9
131209|NCT01202903|316524|P2|NOT COMPLETED|Overall Study||16
131210|NCT01202903|316525|P1|NOT COMPLETED|Overall Study||11
131211|NCT01202903|316524|P2|COMPLETED|Overall Study||292
131212|NCT01202903|316525|P1|COMPLETED|Overall Study||297
131213|NCT01202903|316524|P2|Safety Set*|Overall Study||299
131214|NCT01202903|316525|P1|Safety Set*|Overall Study||310
131215|NCT01202903|316524|P2|Full Analysis Set|Overall Study||302
131216|NCT01202903|316525|P1|Full Analysis Set|Overall Study||306
131217|NCT01202903|316524|P2|STARTED|Overall Study||308
131218|NCT01202903|316525|P1|STARTED|Overall Study||308
131219|NCT01202877|316552|P3|NOT COMPLETED|Overall Study||6
131220|NCT01202877|316553|P2|NOT COMPLETED|Overall Study||1
131221|NCT01202877|316554|P1|NOT COMPLETED|Overall Study||0
131222|NCT01202877|316552|P3|COMPLETED|Overall Study||34
131223|NCT01202877|316553|P2|COMPLETED|Overall Study||7
131224|NCT01202877|316554|P1|COMPLETED|Overall Study||6
131225|NCT01202877|316552|P3|STARTED|Overall Study||40
131226|NCT01202877|316553|P2|STARTED|Overall Study||8
131227|NCT01202877|316554|P1|STARTED|Overall Study||6
131228|NCT01202773|316566|P3|NOT COMPLETED|Overall Study||55
131229|NCT01202773|316567|P2|NOT COMPLETED|Overall Study||43
131230|NCT01202773|316568|P1|NOT COMPLETED|Overall Study||57
131231|NCT01202773|316566|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
131232|NCT01202773|316567|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
131233|NCT01202773|316568|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
131234|NCT01202773|316566|P3|Post-Treatment Follow-Up Population|Overall Study||51
131235|NCT01202773|316567|P2|Post-Treatment Follow-Up Population|Overall Study||36
131236|NCT01202773|316568|P1|Post-Treatment Follow-Up Population|Overall Study||46
131237|NCT01202773|316566|P3|Week 16 NR|Overall Study||37
131238|NCT01202773|316567|P2|Week 16 NR|Overall Study||33
131239|NCT01202773|316568|P1|Week 16 NR|Overall Study||23
131240|NCT01202773|316566|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
131241|NCT01202773|316567|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
131242|NCT01202773|316568|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
131243|NCT01202773|316566|P3|STARTED|Overall Study||155
131244|NCT01202773|316567|P2|STARTED|Overall Study||148
131245|NCT01202773|316568|P1|STARTED|Overall Study||153
131246|NCT01202760|316645|P3|NOT COMPLETED|Overall Study||35
131247|NCT01202760|316646|P2|NOT COMPLETED|Overall Study||52
131248|NCT01202760|316647|P1|NOT COMPLETED|Overall Study||47
131249|NCT01202760|316645|P3|COMPLETED|Overall Study||216
131250|NCT01202760|316646|P2|COMPLETED|Overall Study||322
131251|NCT01202760|316647|P1|COMPLETED|Overall Study||332
131252|NCT01202760|316645|P3|Received at Least One Dose of Study Drug|Overall Study||250
131253|NCT01202760|316646|P2|Received at Least One Dose of Study Drug|Overall Study||371
131254|NCT01202760|316647|P1|Received at Least One Dose of Study Drug|Overall Study||379
131255|NCT01202760|316645|P3|STARTED|Overall Study||251
131256|NCT01202760|316646|P2|STARTED|Overall Study||374
131257|NCT01202760|316647|P1|STARTED|Overall Study||379
131258|NCT01202747|316715|P1|NOT COMPLETED|Overall Study||1
131259|NCT01202747|316715|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
131260|NCT01202747|316715|P1|STARTED|Overall Study||50
131261|NCT01202656|316721|P2|NOT COMPLETED|CrossoverCycle||0
131262|NCT01202656|316722|P1|NOT COMPLETED|CrossoverCycle||0
131263|NCT01202656|316721|P2|COMPLETED|CrossoverCycle||14
131264|NCT01202656|316722|P1|COMPLETED|CrossoverCycle||18
131265|NCT01202656|316721|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
131266|NCT01202656|316722|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
131267|NCT01202656|316721|P2|NOT COMPLETED|Cycle 1||0
131268|NCT01202656|316722|P1|NOT COMPLETED|Cycle 1||0
131269|NCT01202656|316721|P2|COMPLETED|Cycle 1||62
131270|NCT01202656|316722|P1|COMPLETED|Cycle 1||67
131271|NCT01202656|316721|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
131272|NCT01202656|316722|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
131273|NCT01202643|316732|P2|NOT COMPLETED|Crossover Cycle||0
131274|NCT01202643|316733|P1|NOT COMPLETED|Crossover Cycle||0
131275|NCT01202643|316732|P2|COMPLETED|Crossover Cycle||2
131276|NCT01202643|316733|P1|COMPLETED|Crossover Cycle||1
131277|NCT01202643|316732|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
131278|NCT01202643|316733|P1|STARTED|Crossover Cycle|On patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
131279|NCT01202643|316732|P2|NOT COMPLETED|Period 1||0
131280|NCT01202643|316733|P1|NOT COMPLETED|Period 1||0
131281|NCT01202643|316732|P2|COMPLETED|Period 1||6
131282|NCT01202643|316733|P1|COMPLETED|Period 1||6
131283|NCT01202643|316732|P2|STARTED|Period 1||6
131284|NCT01202643|316733|P1|STARTED|Period 1||6
131285|NCT01202591|316747|P6|NOT COMPLETED|Overall Study||4
131286|NCT01202591|316748|P5|NOT COMPLETED|Overall Study||5
131287|NCT01202591|316749|P4|NOT COMPLETED|Overall Study||7
131288|NCT01202591|316750|P3|NOT COMPLETED|Overall Study||11
131289|NCT01202591|316751|P2|NOT COMPLETED|Overall Study||5
131290|NCT01202591|316752|P1|NOT COMPLETED|Overall Study||5
131291|NCT01202591|316747|P6|COMPLETED|Overall Study||0
131292|NCT01202591|316748|P5|COMPLETED|Overall Study||0
131293|NCT01202591|316749|P4|COMPLETED|Overall Study||2
131294|NCT01202591|316750|P3|COMPLETED|Overall Study||1
131295|NCT01202591|316751|P2|COMPLETED|Overall Study||0
131296|NCT01202591|316752|P1|COMPLETED|Overall Study||0
131297|NCT01202591|316747|P6|STARTED|Overall Study||4
131298|NCT01202591|316748|P5|STARTED|Overall Study||5
131299|NCT01202591|316749|P4|STARTED|Overall Study||9
131300|NCT01202591|316750|P3|STARTED|Overall Study||12
131301|NCT01202591|316751|P2|STARTED|Overall Study||5
131302|NCT01202591|316752|P1|STARTED|Overall Study||5
131303|NCT01202578|316766|P1|NOT COMPLETED|Overall Study||0
131304|NCT01202578|316766|P1|COMPLETED|Overall Study||53
131305|NCT01202578|316766|P1|STARTED|Overall Study||53
131306|NCT01202565|316773|P1|NOT COMPLETED|Overall Study||67
131307|NCT01202565|316773|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
131400|NCT01201772|317120|P2|STARTED|Overall Study||21
131308|NCT01202565|316773|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
131309|NCT01202565|316773|P1|STARTED|Overall Study||506
131310|NCT01202279|316798|P2|NOT COMPLETED|Overall Study||27
131311|NCT01202279|316799|P1|NOT COMPLETED|Overall Study||37
131312|NCT01202279|316798|P2|COMPLETED|Overall Study||561
131313|NCT01202279|316799|P1|COMPLETED|Overall Study||554
131314|NCT01202279|316798|P2|STARTED|Overall Study||588
131315|NCT01202279|316799|P1|STARTED|Overall Study||591
131316|NCT01202253|316807|P1|NOT COMPLETED|Overall Study||0
131317|NCT01202253|316807|P1|COMPLETED|Overall Study||50
131318|NCT01202253|316807|P1|STARTED|Overall Study||50
131319|NCT01202227|316851|P1|NOT COMPLETED|Overall Study||19
131320|NCT01202227|316851|P1|COMPLETED|Overall Study||84
131321|NCT01202227|316851|P1|STARTED|Overall Study|Treated|103
131322|NCT01202188|316875|P5|NOT COMPLETED|Overall Study||45
131323|NCT01202188|316876|P4|NOT COMPLETED|Overall Study||42
131324|NCT01202188|316877|P3|NOT COMPLETED|Overall Study||53
131325|NCT01202188|316878|P2|NOT COMPLETED|Overall Study||56
131326|NCT01202188|316879|P1|NOT COMPLETED|Overall Study||38
131327|NCT01202188|316875|P5|COMPLETED|Overall Study||189
131328|NCT01202188|316876|P4|COMPLETED|Overall Study||441
131329|NCT01202188|316877|P3|COMPLETED|Overall Study||422
131330|NCT01202188|316878|P2|COMPLETED|Overall Study||421
131331|NCT01202188|316879|P1|COMPLETED|Overall Study||437
131332|NCT01202188|316875|P5|Safety Set; Received Study Drug|Overall Study||232
131333|NCT01202188|316876|P4|Safety Set; Received Study Drug|Overall Study||480
131334|NCT01202188|316877|P3|Safety Set; Received Study Drug|Overall Study||473
131335|NCT01202188|316878|P2|Safety Set; Received Study Drug|Overall Study||476
131336|NCT01202188|316879|P1|Safety Set; Received Study Drug|Overall Study||474
131337|NCT01202188|316875|P5|STARTED|Overall Study||234
131338|NCT01202188|316876|P4|STARTED|Overall Study||483
131339|NCT01202188|316877|P3|STARTED|Overall Study||475
131340|NCT01202188|316878|P2|STARTED|Overall Study||477
131341|NCT01202188|316879|P1|STARTED|Overall Study||475
131342|NCT01202162|316987|P2|NOT COMPLETED|Overall Study||2
131343|NCT01202162|316988|P1|NOT COMPLETED|Overall Study||3
131344|NCT01202162|316987|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
131345|NCT01202162|316988|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
131346|NCT01202162|316987|P2|STARTED|Overall Study||42
131347|NCT01202162|316988|P1|STARTED|Overall Study||43
131348|NCT01202110|316998|P2|NOT COMPLETED|Overall Study||0
131349|NCT01202110|316999|P1|NOT COMPLETED|Overall Study||0
131350|NCT01202110|316998|P2|COMPLETED|Overall Study||0
131351|NCT01202110|316999|P1|COMPLETED|Overall Study||10
131352|NCT01202110|316998|P2|STARTED|Overall Study||0
131353|NCT01202110|316999|P1|STARTED|Overall Study||10
131354|NCT01202071|317003|P4|NOT COMPLETED|Overall Study||0
131355|NCT01202071|317004|P3|NOT COMPLETED|Overall Study||0
131356|NCT01202071|317005|P2|NOT COMPLETED|Overall Study||0
131357|NCT01202071|317006|P1|NOT COMPLETED|Overall Study||0
131358|NCT01202071|317003|P4|COMPLETED|Overall Study||6
131359|NCT01202071|317004|P3|COMPLETED|Overall Study||6
131360|NCT01202071|317005|P2|COMPLETED|Overall Study||6
131361|NCT01202071|317006|P1|COMPLETED|Overall Study||6
131362|NCT01202071|317003|P4|STARTED|Overall Study||6
131363|NCT01202071|317004|P3|STARTED|Overall Study||6
131364|NCT01202071|317005|P2|STARTED|Overall Study||6
131365|NCT01202071|317006|P1|STARTED|Overall Study||6
131366|NCT01201967|317026|P2|NOT COMPLETED|Overall Study||5
131367|NCT01201967|317027|P1|NOT COMPLETED|Overall Study||6
131368|NCT01201967|317026|P2|COMPLETED|Overall Study||86
131369|NCT01201967|317027|P1|COMPLETED|Overall Study||86
131370|NCT01201967|317026|P2|STARTED|Overall Study||91
131371|NCT01201967|317027|P1|STARTED|Overall Study||92
131372|NCT01201915|317052|P3|NOT COMPLETED|Overall Study||6
131373|NCT01201915|317053|P2|NOT COMPLETED|Overall Study||11
131374|NCT01201915|317054|P1|NOT COMPLETED|Overall Study||8
131375|NCT01201915|317052|P3|COMPLETED|Overall Study||19
131376|NCT01201915|317053|P2|COMPLETED|Overall Study||14
131377|NCT01201915|317054|P1|COMPLETED|Overall Study||16
131378|NCT01201915|317052|P3|STARTED|Overall Study||25
131379|NCT01201915|317053|P2|STARTED|Overall Study||25
131380|NCT01201915|317054|P1|STARTED|Overall Study||24
131381|NCT01201811|317065|P1|NOT COMPLETED|Overall Study||19
131382|NCT01201811|317065|P1|COMPLETED|Overall Study||25
131383|NCT01201811|317065|P1|STARTED|Overall Study||44
131384|NCT01201798|317087|P2|NOT COMPLETED|Overall Study||15
131385|NCT01201798|317088|P1|NOT COMPLETED|Overall Study||9
131386|NCT01201798|317087|P2|COMPLETED|Overall Study||39
131387|NCT01201798|317088|P1|COMPLETED|Overall Study||47
131388|NCT01201798|317087|P2|STARTED|Overall Study||54
131389|NCT01201798|317088|P1|STARTED|Overall Study||56
131390|NCT01201785|317112|P1|NOT COMPLETED|Overall Study||16
131391|NCT01201785|317112|P1|COMPLETED|Overall Study||20
131392|NCT01201785|317112|P1|STARTED|Overall Study||36
131393|NCT01201772|317119|P3|NOT COMPLETED|Overall Study||0
131394|NCT01201772|317120|P2|NOT COMPLETED|Overall Study||0
131395|NCT01201772|317121|P1|NOT COMPLETED|Overall Study||1
131396|NCT01201772|317119|P3|COMPLETED|Overall Study||21
131397|NCT01201772|317120|P2|COMPLETED|Overall Study||21
131398|NCT01201772|317121|P1|COMPLETED|Overall Study||22
131399|NCT01201772|317119|P3|STARTED|Overall Study||21
131401|NCT01201772|317121|P1|STARTED|Overall Study||23
131402|NCT01201759|317129|P2|NOT COMPLETED|Visit 5||0
131403|NCT01201759|317130|P1|NOT COMPLETED|Visit 5||0
131404|NCT01201759|317129|P2|COMPLETED|Visit 5||3
131405|NCT01201759|317130|P1|COMPLETED|Visit 5||7
131406|NCT01201759|317129|P2|STARTED|Visit 5||3
131407|NCT01201759|317130|P1|STARTED|Visit 5||7
131408|NCT01201759|317129|P2|NOT COMPLETED|Visit 4 Crossover||1
131409|NCT01201759|317130|P1|NOT COMPLETED|Visit 4 Crossover||0
131410|NCT01201759|317129|P2|COMPLETED|Visit 4 Crossover||3
131411|NCT01201759|317130|P1|COMPLETED|Visit 4 Crossover||7
131412|NCT01201759|317129|P2|STARTED|Visit 4 Crossover||4
131413|NCT01201759|317130|P1|STARTED|Visit 4 Crossover||7
131414|NCT01201759|317129|P2|NOT COMPLETED|Visit 3 - Washout||3
131415|NCT01201759|317130|P1|NOT COMPLETED|Visit 3 - Washout||1
131416|NCT01201759|317129|P2|COMPLETED|Visit 3 - Washout||4
131417|NCT01201759|317130|P1|COMPLETED|Visit 3 - Washout||7
131418|NCT01201759|317129|P2|STARTED|Visit 3 - Washout||7
131419|NCT01201759|317130|P1|STARTED|Visit 3 - Washout||8
131420|NCT01201759|317129|P2|NOT COMPLETED|Visit 2||0
131421|NCT01201759|317130|P1|NOT COMPLETED|Visit 2||0
131422|NCT01201759|317129|P2|COMPLETED|Visit 2||7
131423|NCT01201759|317130|P1|COMPLETED|Visit 2||8
131424|NCT01201759|317129|P2|STARTED|Visit 2||7
131425|NCT01201759|317130|P1|STARTED|Visit 2||8
131426|NCT01201759|317129|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
131427|NCT01201759|317130|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
131428|NCT01201759|317129|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
131429|NCT01201759|317130|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
131430|NCT01201759|317129|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
131431|NCT01201759|317130|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
131432|NCT01201629|317144|P2|NOT COMPLETED|Overall Study||0
131433|NCT01201629|317145|P1|NOT COMPLETED|Overall Study||0
131434|NCT01201629|317144|P2|COMPLETED|Overall Study||8
131435|NCT01201629|317145|P1|COMPLETED|Overall Study||8
131436|NCT01201629|317144|P2|STARTED|Overall Study||8
131437|NCT01201629|317145|P1|STARTED|Overall Study||8
131438|NCT01201486|317155|P1|NOT COMPLETED|Overall Study||0
131439|NCT01201486|317155|P1|COMPLETED|Overall Study||6781
131440|NCT01201486|317155|P1|STARTED|Overall Study||6781
131441|NCT01201343|317159|P1|NOT COMPLETED|Overall Study||19
131442|NCT01201343|317159|P1|COMPLETED|Overall Study||60
131443|NCT01201343|317159|P1|Treated|Overall Study||76
131444|NCT01201343|317159|P1|STARTED|Overall Study||79
131445|NCT01201317|317173|P3|NOT COMPLETED|Overall Study||8
131446|NCT01201317|317174|P2|NOT COMPLETED|Overall Study||7
131447|NCT01201317|317175|P1|NOT COMPLETED|Overall Study||9
131448|NCT01201317|317173|P3|COMPLETED|Overall Study||33
131449|NCT01201317|317174|P2|COMPLETED|Overall Study||38
131450|NCT01201317|317175|P1|COMPLETED|Overall Study||39
131451|NCT01201317|317173|P3|STARTED|Overall Study||41
131452|NCT01201317|317174|P2|STARTED|Overall Study||45
131453|NCT01201317|317175|P1|STARTED|Overall Study||48
131454|NCT01201265|317195|P1|NOT COMPLETED|Overall Study||38
131455|NCT01201265|317195|P1|COMPLETED|Overall Study||2
131456|NCT01201265|317195|P1|STARTED|Overall Study||40
131457|NCT01200992|317209|P2|NOT COMPLETED|Overall Study||41
131458|NCT01200992|317210|P1|NOT COMPLETED|Overall Study||37
131459|NCT01200992|317209|P2|COMPLETED|Overall Study||4
131460|NCT01200992|317210|P1|COMPLETED|Overall Study||2
131461|NCT01200992|317209|P2|STARTED|Overall Study||45
131462|NCT01200992|317210|P1|STARTED|Overall Study||39
131463|NCT01200875|317218|P1|NOT COMPLETED|Overall Study||0
131464|NCT01200875|317218|P1|COMPLETED|Overall Study||25
131465|NCT01200875|317218|P1|STARTED|Overall Study||25
131466|NCT01200810|317224|P2|NOT COMPLETED|Overall Study||5
131467|NCT01200810|317225|P1|NOT COMPLETED|Overall Study||5
131468|NCT01200810|317224|P2|COMPLETED|Overall Study||0
131469|NCT01200810|317225|P1|COMPLETED|Overall Study||0
131470|NCT01200810|317224|P2|STARTED|Overall Study||5
131471|NCT01200810|317225|P1|STARTED|Overall Study||5
131472|NCT01200797|317245|P1|NOT COMPLETED|Overall Study||19
131473|NCT01200797|317245|P1|COMPLETED|Overall Study||0
131474|NCT01200797|317245|P1|STARTED|Overall Study||19
131475|NCT01200758|317255|P4|NOT COMPLETED|Stage 2||50
131476|NCT01200758|317256|P3|NOT COMPLETED|Stage 2||41
131477|NCT01200758|317257|P2|NOT COMPLETED|Stage 2||0
131478|NCT01200758|317258|P1|NOT COMPLETED|Stage 2||0
131479|NCT01200758|317255|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
131480|NCT01200758|317256|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
131481|NCT01200758|317257|P2|COMPLETED|Stage 2||0
131482|NCT01200758|317258|P1|COMPLETED|Stage 2||0
131483|NCT01200758|317255|P4|STARTED|Stage 2||142
131484|NCT01200758|317256|P3|STARTED|Stage 2||141
131485|NCT01200758|317257|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
131486|NCT01200758|317258|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
131487|NCT01200758|317255|P4|NOT COMPLETED|Stage I||0
131488|NCT01200758|317256|P3|NOT COMPLETED|Stage I||0
131489|NCT01200758|317257|P2|NOT COMPLETED|Stage I||17
131490|NCT01200758|317258|P1|NOT COMPLETED|Stage I||18
131491|NCT01200758|317255|P4|COMPLETED|Stage I||0
131492|NCT01200758|317256|P3|COMPLETED|Stage I||0
131493|NCT01200758|317257|P2|COMPLETED|Stage I|Participants completed treatment period.|46
131494|NCT01200758|317258|P1|COMPLETED|Stage I|Participants completed treatment period.|46
131495|NCT01200758|317255|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
131496|NCT01200758|317256|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
131497|NCT01200758|317257|P2|STARTED|Stage I||63
131498|NCT01200758|317258|P1|STARTED|Stage I||64
131499|NCT01200602|317314|P2|NOT COMPLETED|Overall Study||0
131500|NCT01200602|317315|P1|NOT COMPLETED|Overall Study||0
131501|NCT01200602|317314|P2|COMPLETED|Overall Study||0
131502|NCT01200602|317315|P1|COMPLETED|Overall Study||0
131503|NCT01200602|317314|P2|STARTED|Overall Study||0
131504|NCT01200602|317315|P1|STARTED|Overall Study||0
131505|NCT01200589|317331|P2|NOT COMPLETED|Overall Study||189
131506|NCT01200589|317332|P1|NOT COMPLETED|Overall Study||190
131507|NCT01200589|317331|P2|COMPLETED|Overall Study||30
131508|NCT01200589|317332|P1|COMPLETED|Overall Study||29
131509|NCT01200589|317331|P2|Safety Set|Overall Study||218
131510|NCT01200589|317332|P1|Safety Set|Overall Study||217
131511|NCT01200589|317331|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
131512|NCT01200589|317332|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
131513|NCT01200589|317331|P2|STARTED|Overall Study||219
131514|NCT01200589|317332|P1|STARTED|Overall Study||219
131515|NCT01200524|317359|P3|NOT COMPLETED|Overall Study||4
131516|NCT01200524|317360|P2|NOT COMPLETED|Overall Study||1
131517|NCT01200524|317361|P1|NOT COMPLETED|Overall Study||2
131518|NCT01200524|317359|P3|COMPLETED|Overall Study||40
131519|NCT01200524|317360|P2|COMPLETED|Overall Study||47
131520|NCT01200524|317361|P1|COMPLETED|Overall Study||39
131521|NCT01200524|317359|P3|STARTED|Overall Study||44
131522|NCT01200524|317360|P2|STARTED|Overall Study||48
131523|NCT01200524|317361|P1|STARTED|Overall Study||41
131524|NCT01200511|317381|P1|NOT COMPLETED|Overall Study||5
131525|NCT01200511|317381|P1|COMPLETED|Overall Study||44
131526|NCT01200511|317381|P1|STARTED|Overall Study||49
131527|NCT01200498|317389|P1|NOT COMPLETED|Overall Study||0
131528|NCT01200498|317389|P1|COMPLETED|Overall Study||22
131529|NCT01200498|317389|P1|STARTED|Overall Study||22
131530|NCT01200433|317395|P2|NOT COMPLETED|Overall Study||0
131531|NCT01200433|317396|P1|NOT COMPLETED|Overall Study||0
131532|NCT01200433|317395|P2|COMPLETED|Overall Study||23
131533|NCT01200433|317396|P1|COMPLETED|Overall Study||21
131534|NCT01200433|317395|P2|STARTED|Overall Study||23
131535|NCT01200433|317396|P1|STARTED|Overall Study||21
131536|NCT01200368|317419|P3|NOT COMPLETED|Toddler Dose||1
131537|NCT01200368|317420|P2|NOT COMPLETED|Toddler Dose||3
131538|NCT01200368|317421|P1|NOT COMPLETED|Toddler Dose||0
131539|NCT01200368|317419|P3|COMPLETED|Toddler Dose||168
131540|NCT01200368|317420|P2|COMPLETED|Toddler Dose||159
131541|NCT01200368|317421|P1|COMPLETED|Toddler Dose||162
131542|NCT01200368|317419|P3|STARTED|Toddler Dose||169
131543|NCT01200368|317420|P2|STARTED|Toddler Dose||162
131544|NCT01200368|317421|P1|STARTED|Toddler Dose||162
131545|NCT01200368|317419|P3|NOT COMPLETED|After Infant Series||9
131546|NCT01200368|317420|P2|NOT COMPLETED|After Infant Series||16
131547|NCT01200368|317421|P1|NOT COMPLETED|After Infant Series||18
131548|NCT01200368|317419|P3|COMPLETED|After Infant Series||169
131549|NCT01200368|317420|P2|COMPLETED|After Infant Series||162
131550|NCT01200368|317421|P1|COMPLETED|After Infant Series||162
131551|NCT01200368|317419|P3|STARTED|After Infant Series||178
131552|NCT01200368|317420|P2|STARTED|After Infant Series||178
131553|NCT01200368|317421|P1|STARTED|After Infant Series||180
131554|NCT01200368|317419|P3|NOT COMPLETED|Infant Series||6
131555|NCT01200368|317420|P2|NOT COMPLETED|Infant Series||6
131556|NCT01200368|317421|P1|NOT COMPLETED|Infant Series||3
131557|NCT01200368|317419|P3|COMPLETED|Infant Series||178
131558|NCT01200368|317420|P2|COMPLETED|Infant Series||178
131559|NCT01200368|317421|P1|COMPLETED|Infant Series||180
131560|NCT01200368|317419|P3|Vaccinated Dose 3|Infant Series||182
131561|NCT01200368|317420|P2|Vaccinated Dose 3|Infant Series||178
131562|NCT01200368|317421|P1|Vaccinated Dose 3|Infant Series||181
131563|NCT01200368|317419|P3|Vaccinated Dose 2|Infant Series||183
131564|NCT01200368|317420|P2|Vaccinated Dose 2|Infant Series||182
131565|NCT01200368|317421|P1|Vaccinated Dose 2|Infant Series||183
131566|NCT01200368|317419|P3|Vaccinated Dose 1|Infant Series||183
131567|NCT01200368|317420|P2|Vaccinated Dose 1|Infant Series||183
131568|NCT01200368|317421|P1|Vaccinated Dose 1|Infant Series||183
131569|NCT01200368|317419|P3|STARTED|Infant Series||184
131570|NCT01200368|317420|P2|STARTED|Infant Series||184
131571|NCT01200368|317421|P1|STARTED|Infant Series||183
131572|NCT01200355|317487|P2|NOT COMPLETED|Overall Study||2
131573|NCT01200355|317488|P1|NOT COMPLETED|Overall Study||7
131574|NCT01200355|317487|P2|COMPLETED|Overall Study||53
131575|NCT01200355|317488|P1|COMPLETED|Overall Study||51
131576|NCT01200355|317487|P2|STARTED|Overall Study||55
131577|NCT01200355|317488|P1|STARTED|Overall Study||58
131578|NCT01200342|317502|P1|NOT COMPLETED|Overall Study||1
131579|NCT01200342|317502|P1|COMPLETED|Overall Study||6
131580|NCT01200342|317502|P1|STARTED|Overall Study||7
131581|NCT01200290|317507|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
131582|NCT01200290|317507|P1|COMPLETED|Post-Treatment Follow-Up Period||16
131583|NCT01200290|317507|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
131584|NCT01200290|317507|P1|NOT COMPLETED|Treatment Period||1
131585|NCT01200290|317507|P1|COMPLETED|Treatment Period||17
131586|NCT01200290|317507|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
131587|NCT01200290|317507|P1|STARTED|Treatment Period||18
131588|NCT01200160|317518|P1|NOT COMPLETED|Overall Study||62
131589|NCT01200160|317518|P1|COMPLETED|Overall Study||66
131590|NCT01200160|317518|P1|STARTED|Overall Study||128
131591|NCT01200069|317524|P2|NOT COMPLETED|Overall Study||1
131592|NCT01200069|317525|P1|NOT COMPLETED|Overall Study||0
131593|NCT01200069|317524|P2|COMPLETED|Overall Study||5
131594|NCT01200069|317525|P1|COMPLETED|Overall Study||8
131595|NCT01200069|317524|P2|STARTED|Overall Study||6
131596|NCT01200069|317525|P1|STARTED|Overall Study||8
131597|NCT01199965|317579|P2|NOT COMPLETED|Overall Study||0
131598|NCT01199965|317580|P1|NOT COMPLETED|Overall Study||1
131599|NCT01199965|317579|P2|COMPLETED|Overall Study||24
131600|NCT01199965|317580|P1|COMPLETED|Overall Study||22
131601|NCT01199965|317579|P2|STARTED|Overall Study||24
131602|NCT01199965|317580|P1|STARTED|Overall Study||23
131603|NCT01199939|317594|P1|NOT COMPLETED|Overall Study||13
131604|NCT01199939|317594|P1|COMPLETED|Overall Study||41
131605|NCT01199939|317594|P1|STARTED|Overall Study|Number of enrolled participants|54
131606|NCT01199926|317613|P2|NOT COMPLETED|Overall Study||4
131607|NCT01199926|317614|P1|NOT COMPLETED|Overall Study||7
131608|NCT01199926|317613|P2|COMPLETED|Overall Study||13
131609|NCT01199926|317614|P1|COMPLETED|Overall Study||10
131610|NCT01199926|317613|P2|STARTED|Overall Study||17
131611|NCT01199926|317614|P1|STARTED|Overall Study||17
131612|NCT01199861|317626|P2|NOT COMPLETED|Overall Study||0
131613|NCT01199861|317627|P1|NOT COMPLETED|Overall Study||2
131614|NCT01199861|317626|P2|COMPLETED|Overall Study||43
131615|NCT01199861|317627|P1|COMPLETED|Overall Study||93
131616|NCT01199861|317626|P2|STARTED|Overall Study||43
131617|NCT01199861|317627|P1|STARTED|Overall Study||95
131618|NCT01199822|317648|P3|NOT COMPLETED|Overall Study||0
131619|NCT01199822|317649|P2|NOT COMPLETED|Overall Study||1
131620|NCT01199822|317650|P1|NOT COMPLETED|Overall Study||0
131621|NCT01199822|317648|P3|COMPLETED|Overall Study||6
131622|NCT01199822|317649|P2|COMPLETED|Overall Study||6
131623|NCT01199822|317650|P1|COMPLETED|Overall Study||3
131624|NCT01199822|317648|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
131625|NCT01199822|317649|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
131626|NCT01199822|317650|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
131627|NCT01199822|317648|P3|STARTED|Overall Study||6
131628|NCT01199822|317649|P2|STARTED|Overall Study||7
131629|NCT01199822|317650|P1|STARTED|Overall Study||3
131630|NCT01199744|317683|P1|NOT COMPLETED|Overall Study||0
131631|NCT01199744|317683|P1|COMPLETED|Overall Study||1575
131632|NCT01199744|317683|P1|STARTED|Overall Study||1575
131633|NCT01199731|317699|P3|NOT COMPLETED|Overall Study||10
131634|NCT01199731|317700|P2|NOT COMPLETED|Overall Study||11
131635|NCT01199731|317701|P1|NOT COMPLETED|Overall Study||9
131636|NCT01199731|317699|P3|COMPLETED|Overall Study||0
131637|NCT01199731|317700|P2|COMPLETED|Overall Study||0
131638|NCT01199731|317701|P1|COMPLETED|Overall Study||0
131639|NCT01199731|317699|P3|STARTED|Overall Study||10
131640|NCT01199731|317700|P2|STARTED|Overall Study||11
131641|NCT01199731|317701|P1|STARTED|Overall Study||9
131642|NCT01199705|317739|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
131643|NCT01199705|317739|P1|COMPLETED|SCIG Treatment (Efficacy)||24
131644|NCT01199705|317739|P1|STARTED|SCIG Treatment (Efficacy)||24
131645|NCT01199705|317739|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
131646|NCT01199705|317739|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
131647|NCT01199705|317739|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
131648|NCT01199705|317739|P1|NOT COMPLETED|IVIG Treatment||0
131649|NCT01199705|317739|P1|COMPLETED|IVIG Treatment||25
131650|NCT01199705|317739|P1|STARTED|IVIG Treatment||25
131651|NCT01199601|317771|P2|NOT COMPLETED|Overall Study||78
131652|NCT01199601|317772|P1|NOT COMPLETED|Overall Study||69
131653|NCT01199601|317771|P2|COMPLETED|Overall Study||344
131654|NCT01199601|317772|P1|COMPLETED|Overall Study||353
131655|NCT01199601|317771|P2|STARTED|Overall Study|Intervention Group|422
131656|NCT01199601|317772|P1|STARTED|Overall Study|Control Group|422
131657|NCT01199471|317782|P1|NOT COMPLETED|Overall Study||6
131658|NCT01199471|317782|P1|COMPLETED|Overall Study||3994
131659|NCT01199471|317782|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
131660|NCT01199237|317793|P2|NOT COMPLETED|Overall Study||0
131661|NCT01199237|317794|P1|NOT COMPLETED|Overall Study||0
131662|NCT01199237|317793|P2|COMPLETED|Overall Study||40
131663|NCT01199237|317794|P1|COMPLETED|Overall Study||41
131664|NCT01199237|317793|P2|STARTED|Overall Study||40
131665|NCT01199237|317794|P1|STARTED|Overall Study||41
131666|NCT01199146|317808|P1|NOT COMPLETED|Overall Study||3
131667|NCT01199146|317808|P1|COMPLETED|Overall Study||39
131668|NCT01199146|317808|P1|STARTED|Overall Study||42
131669|NCT01199042|317814|P1|NOT COMPLETED|At Home (3 Months)||1
131670|NCT01199042|317814|P1|COMPLETED|At Home (3 Months)||26
131671|NCT01199042|317814|P1|STARTED|At Home (3 Months)||27
131672|NCT01199042|317814|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
131673|NCT01199042|317814|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
131674|NCT01199042|317814|P1|STARTED|Sleep Laboratory (3 Nights)||29
131675|NCT01199016|317823|P1|NOT COMPLETED|Overall Study||77
131676|NCT01199016|317823|P1|COMPLETED|Overall Study||162
131677|NCT01199016|317823|P1|Treated|Overall Study||236
131678|NCT01199016|317823|P1|STARTED|Overall Study||239
131679|NCT01198977|317832|P2|NOT COMPLETED|Overall Study||0
131680|NCT01198977|317833|P1|NOT COMPLETED|Overall Study||1
131681|NCT01198977|317832|P2|COMPLETED|Overall Study||33
131682|NCT01198977|317833|P1|COMPLETED|Overall Study||30
131683|NCT01198977|317832|P2|STARTED|Overall Study||33
131684|NCT01198977|317833|P1|STARTED|Overall Study||31
131685|NCT01198873|317845|P2|NOT COMPLETED|Overall Study||32
131686|NCT01198873|317846|P1|NOT COMPLETED|Overall Study||37
131687|NCT01198873|317845|P2|COMPLETED|Overall Study||3
131688|NCT01198873|317846|P1|COMPLETED|Overall Study||4
131689|NCT01198873|317845|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
131690|NCT01198873|317846|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
131691|NCT01198873|317845|P2|Treated|Overall Study||35
131692|NCT01198873|317846|P1|Treated|Overall Study||41
131693|NCT01198873|317845|P2|STARTED|Overall Study||35
131694|NCT01198873|317846|P1|STARTED|Overall Study||41
131695|NCT01198795|317860|P1|NOT COMPLETED|Overall Study||82
131696|NCT01198795|317860|P1|COMPLETED|Overall Study||80
131697|NCT01198795|317860|P1|STARTED|Overall Study||162
131698|NCT01198769|317864|P1|NOT COMPLETED|Overall Study||0
131699|NCT01198769|317864|P1|COMPLETED|Overall Study||15
131700|NCT01198769|317864|P1|STARTED|Overall Study||15
131701|NCT01198756|317877|P4|NOT COMPLETED|Overall Study||26
131702|NCT01198756|317878|P3|NOT COMPLETED|Overall Study||30
131703|NCT01198756|317879|P2|NOT COMPLETED|Overall Study||40
131704|NCT01198756|317880|P1|NOT COMPLETED|Overall Study||38
131705|NCT01198756|317877|P4|COMPLETED|Overall Study||275
131706|NCT01198756|317878|P3|COMPLETED|Overall Study||902
131707|NCT01198756|317879|P2|COMPLETED|Overall Study||889
131708|NCT01198756|317880|P1|COMPLETED|Overall Study||894
131709|NCT01198756|317877|P4|STARTED|Overall Study||301
131710|NCT01198756|317878|P3|STARTED|Overall Study||932
131711|NCT01198756|317879|P2|STARTED|Overall Study||929
131712|NCT01198756|317880|P1|STARTED|Overall Study||932
131713|NCT01198691|317978|P2|NOT COMPLETED|6 Week Post-partum Survey||24
131714|NCT01198691|317979|P1|NOT COMPLETED|6 Week Post-partum Survey||29
131715|NCT01198691|317978|P2|COMPLETED|6 Week Post-partum Survey||26
131716|NCT01198691|317979|P1|COMPLETED|6 Week Post-partum Survey||21
131717|NCT01198691|317978|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
131718|NCT01198691|317979|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
131719|NCT01198691|317978|P2|NOT COMPLETED|Survey Prior to Discharge||33
131720|NCT01198691|317979|P1|NOT COMPLETED|Survey Prior to Discharge||32
131721|NCT01198691|317978|P2|COMPLETED|Survey Prior to Discharge||17
131722|NCT01198691|317979|P1|COMPLETED|Survey Prior to Discharge||18
131723|NCT01198691|317978|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
131724|NCT01198691|317979|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
131725|NCT01198691|317978|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
131726|NCT01198691|317979|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
131727|NCT01198691|317978|P2|COMPLETED|Completed VAS Score at Discharge||44
131728|NCT01198691|317979|P1|COMPLETED|Completed VAS Score at Discharge||45
131729|NCT01198691|317978|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
131730|NCT01198691|317979|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
131731|NCT01198691|317978|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
131732|NCT01198691|317979|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
131733|NCT01198691|317978|P2|COMPLETED|Completed VAS Score Postop Day 1||46
131734|NCT01198691|317979|P1|COMPLETED|Completed VAS Score Postop Day 1||47
131735|NCT01198691|317978|P2|STARTED|Completed VAS Score Postop Day 1||50
131736|NCT01198691|317979|P1|STARTED|Completed VAS Score Postop Day 1||50
131737|NCT01198691|317978|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
131738|NCT01198691|317979|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
131739|NCT01198691|317978|P2|COMPLETED|Completed Surgery -Received Intervention||50
131740|NCT01198691|317979|P1|COMPLETED|Completed Surgery -Received Intervention||50
131741|NCT01198691|317978|P2|STARTED|Completed Surgery -Received Intervention||50
131742|NCT01198691|317979|P1|STARTED|Completed Surgery -Received Intervention||50
131743|NCT01198600|317991|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
131744|NCT01198600|317992|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
131745|NCT01198600|317993|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
131746|NCT01198600|317994|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
131747|NCT01198600|317991|P4|COMPLETED|Phase 3: 43 Days of Wear||38
131748|NCT01198600|317992|P3|COMPLETED|Phase 3: 43 Days of Wear||0
131749|NCT01198600|317993|P2|COMPLETED|Phase 3: 43 Days of Wear||0
131750|NCT01198600|317994|P1|COMPLETED|Phase 3: 43 Days of Wear||0
131751|NCT01198600|317991|P4|STARTED|Phase 3: 43 Days of Wear||38
131752|NCT01198600|317992|P3|STARTED|Phase 3: 43 Days of Wear||0
131753|NCT01198600|317993|P2|STARTED|Phase 3: 43 Days of Wear||0
131754|NCT01198600|317994|P1|STARTED|Phase 3: 43 Days of Wear||0
131755|NCT01198600|317991|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
131756|NCT01198600|317992|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
131757|NCT01198600|317993|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
131758|NCT01198600|317994|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
131759|NCT01198600|317991|P4|COMPLETED|Phase 2: 56 Days of Wear||0
131760|NCT01198600|317992|P3|COMPLETED|Phase 2: 56 Days of Wear||62
131761|NCT01198600|317993|P2|COMPLETED|Phase 2: 56 Days of Wear||0
131762|NCT01198600|317994|P1|COMPLETED|Phase 2: 56 Days of Wear||0
131763|NCT01198600|317991|P4|STARTED|Phase 2: 56 Days of Wear||0
131764|NCT01198600|317992|P3|STARTED|Phase 2: 56 Days of Wear||67
131765|NCT01198600|317993|P2|STARTED|Phase 2: 56 Days of Wear||0
131766|NCT01198600|317994|P1|STARTED|Phase 2: 56 Days of Wear||0
131767|NCT01198600|317991|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
131768|NCT01198600|317992|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
131769|NCT01198600|317993|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
131770|NCT01198600|317994|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
131771|NCT01198600|317991|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
131772|NCT01198600|317992|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
131773|NCT01198600|317993|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
131774|NCT01198600|317994|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
131775|NCT01198600|317991|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
131776|NCT01198600|317992|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
131777|NCT01198600|317993|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
131778|NCT01198600|317994|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
131779|NCT01198600|317991|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
131780|NCT01198600|317992|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
131781|NCT01198600|317993|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
131782|NCT01198600|317994|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
131783|NCT01198600|317991|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
131784|NCT01198600|317992|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
131785|NCT01198600|317993|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
131786|NCT01198600|317994|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
131787|NCT01198600|317991|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
131788|NCT01198600|317992|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
131789|NCT01198600|317993|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
131790|NCT01198600|317994|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
131791|NCT01198574|318020|P4|NOT COMPLETED|Overall Study||4
131792|NCT01198574|318021|P3|NOT COMPLETED|Overall Study||1
131793|NCT01198574|318022|P2|NOT COMPLETED|Overall Study||1
131794|NCT01198574|318023|P1|NOT COMPLETED|Overall Study||4
131795|NCT01198574|318020|P4|COMPLETED|Overall Study||98
131796|NCT01198574|318021|P3|COMPLETED|Overall Study||99
131797|NCT01198574|318022|P2|COMPLETED|Overall Study||101
131798|NCT01198574|318023|P1|COMPLETED|Overall Study||94
131799|NCT01198574|318020|P4|STARTED|Overall Study||102
131800|NCT01198574|318021|P3|STARTED|Overall Study||100
131801|NCT01198574|318022|P2|STARTED|Overall Study||102
131802|NCT01198574|318023|P1|STARTED|Overall Study||98
131803|NCT01198548|318041|P1|NOT COMPLETED|Overall Study||10
131804|NCT01198548|318041|P1|COMPLETED|Overall Study||0
131805|NCT01198548|318041|P1|STARTED|Overall Study||10
131806|NCT01198509|318056|P6|NOT COMPLETED|Overall Study||0
131807|NCT01198509|318057|P5|NOT COMPLETED|Overall Study||0
131808|NCT01198509|318058|P4|NOT COMPLETED|Overall Study||0
131809|NCT01198509|318059|P3|NOT COMPLETED|Overall Study||0
131810|NCT01198509|318060|P2|NOT COMPLETED|Overall Study||0
131811|NCT01198509|318061|P1|NOT COMPLETED|Overall Study||1
131812|NCT01198509|318056|P6|COMPLETED|Overall Study||58
131813|NCT01198509|318057|P5|COMPLETED|Overall Study||20
131814|NCT01198509|318058|P4|COMPLETED|Overall Study||66
131815|NCT01198509|318059|P3|COMPLETED|Overall Study||19
131816|NCT01198509|318060|P2|COMPLETED|Overall Study||10
131817|NCT01198509|318061|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
131818|NCT01198509|318056|P6|STARTED|Overall Study||58
131819|NCT01198509|318057|P5|STARTED|Overall Study||20
131820|NCT01198509|318058|P4|STARTED|Overall Study||66
131821|NCT01198509|318059|P3|STARTED|Overall Study||19
131822|NCT01198509|318060|P2|STARTED|Overall Study||10
131823|NCT01198509|318061|P1|STARTED|Overall Study||5
131824|NCT01198366|318084|P6|NOT COMPLETED|Overall Study||13
131825|NCT01198366|318085|P5|NOT COMPLETED|Overall Study||15
131826|NCT01198366|318086|P4|NOT COMPLETED|Overall Study||5
131827|NCT01198366|318087|P3|NOT COMPLETED|Overall Study||8
131828|NCT01198366|318088|P2|NOT COMPLETED|Overall Study||7
131829|NCT01198366|318089|P1|NOT COMPLETED|Overall Study||12
131830|NCT01198366|318084|P6|COMPLETED|Overall Study||128
131831|NCT01198366|318085|P5|COMPLETED|Overall Study||125
131832|NCT01198366|318086|P4|COMPLETED|Overall Study||47
131833|NCT01198366|318087|P3|COMPLETED|Overall Study||43
131834|NCT01198366|318088|P2|COMPLETED|Overall Study||44
131835|NCT01198366|318089|P1|COMPLETED|Overall Study||40
131836|NCT01198366|318084|P6|STARTED|Overall Study||141
131837|NCT01198366|318085|P5|STARTED|Overall Study||140
131838|NCT01198366|318086|P4|STARTED|Overall Study||52
131839|NCT01198366|318087|P3|STARTED|Overall Study||51
131840|NCT01198366|318088|P2|STARTED|Overall Study||51
131841|NCT01198366|318089|P1|STARTED|Overall Study||52
131842|NCT01198327|318127|P1|NOT COMPLETED|Overall Study||10
131843|NCT01198327|318127|P1|COMPLETED|Overall Study||56
131844|NCT01198327|318127|P1|STARTED|Overall Study||66
131845|NCT01198275|318137|P2|NOT COMPLETED|Overall Study||5
131846|NCT01198275|318138|P1|NOT COMPLETED|Overall Study||6
131847|NCT01198275|318137|P2|COMPLETED|Overall Study||94
131848|NCT01198275|318138|P1|COMPLETED|Overall Study||94
131849|NCT01198275|318137|P2|STARTED|Overall Study||99
131850|NCT01198275|318138|P1|STARTED|Overall Study||100
131851|NCT01198145|318146|P2|NOT COMPLETED|Overall Study||1
131852|NCT01198145|318147|P1|NOT COMPLETED|Overall Study||1
131853|NCT01198145|318146|P2|COMPLETED|Overall Study||42
131854|NCT01198145|318147|P1|COMPLETED|Overall Study||43
131855|NCT01198145|318146|P2|STARTED|Overall Study||43
131856|NCT01198145|318147|P1|STARTED|Overall Study||44
131857|NCT01198132|318169|P2|NOT COMPLETED|Overall Study||21
131858|NCT01198132|318170|P1|NOT COMPLETED|Overall Study||18
131859|NCT01198132|318169|P2|COMPLETED|Overall Study||45
131860|NCT01198132|318170|P1|COMPLETED|Overall Study||45
131861|NCT01198132|318169|P2|STARTED|Overall Study||66
131862|NCT01198132|318170|P1|STARTED|Overall Study||63
131863|NCT01198002|318197|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
131864|NCT01198002|318198|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
131865|NCT01198002|318199|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
131866|NCT01198002|318197|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
131867|NCT01198002|318198|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
131868|NCT01198002|318199|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
131869|NCT01198002|318197|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
131870|NCT01198002|318198|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
131871|NCT01198002|318199|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
131872|NCT01198002|318197|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
131873|NCT01198002|318198|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
131874|NCT01198002|318199|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
131875|NCT01198002|318197|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
131876|NCT01198002|318198|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
131877|NCT01198002|318199|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
131878|NCT01198002|318197|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
131879|NCT01198002|318198|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
131880|NCT01198002|318199|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
131881|NCT01198002|318197|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
131882|NCT01198002|318198|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
131883|NCT01198002|318199|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
131884|NCT01198002|318197|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
131885|NCT01198002|318198|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
131886|NCT01198002|318199|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
131887|NCT01198002|318197|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
131888|NCT01198002|318198|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
131889|NCT01198002|318199|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
131890|NCT01197911|318314|P3|NOT COMPLETED|Overall Study||1
131891|NCT01197911|318315|P2|NOT COMPLETED|Overall Study||0
131892|NCT01197911|318316|P1|NOT COMPLETED|Overall Study||0
131893|NCT01197911|318314|P3|COMPLETED|Overall Study||9
131894|NCT01197911|318315|P2|COMPLETED|Overall Study||10
131895|NCT01197911|318316|P1|COMPLETED|Overall Study||18
131896|NCT01197911|318314|P3|STARTED|Overall Study||10
131897|NCT01197911|318315|P2|STARTED|Overall Study||10
131898|NCT01197911|318316|P1|STARTED|Overall Study||18
131899|NCT01197898|318401|P2|NOT COMPLETED|Overall Study||0
131900|NCT01197898|318402|P1|NOT COMPLETED|Overall Study||0
131901|NCT01197898|318401|P2|COMPLETED|Overall Study||5
131902|NCT01197898|318402|P1|COMPLETED|Overall Study||5
131903|NCT01197898|318401|P2|STARTED|Overall Study||5
131904|NCT01197898|318402|P1|STARTED|Overall Study||5
131905|NCT01197833|318411|P3|NOT COMPLETED|Overall Study||0
131906|NCT01197833|318412|P2|NOT COMPLETED|Overall Study||0
131907|NCT01197833|318413|P1|NOT COMPLETED|Overall Study||0
131908|NCT01197833|318411|P3|COMPLETED|Overall Study||40
131909|NCT01197833|318412|P2|COMPLETED|Overall Study||39
131910|NCT01197833|318413|P1|COMPLETED|Overall Study||38
131911|NCT01197833|318411|P3|STARTED|Overall Study||40
131912|NCT01197833|318412|P2|STARTED|Overall Study||39
131913|NCT01197833|318413|P1|STARTED|Overall Study||38
131914|NCT01197794|318431|P7|NOT COMPLETED|Overall Study||21
131915|NCT01197794|318432|P6|NOT COMPLETED|Overall Study||19
131916|NCT01197794|318433|P5|NOT COMPLETED|Overall Study||14
131917|NCT01197794|318434|P4|NOT COMPLETED|Overall Study||12
131918|NCT01197794|318435|P3|NOT COMPLETED|Overall Study||13
131919|NCT01197794|318436|P2|NOT COMPLETED|Overall Study||15
131920|NCT01197794|318437|P1|NOT COMPLETED|Overall Study||16
131921|NCT01197794|318431|P7|COMPLETED|Overall Study||142
131922|NCT01197794|318432|P6|COMPLETED|Overall Study||144
131923|NCT01197794|318433|P5|COMPLETED|Overall Study||149
131924|NCT01197794|318434|P4|COMPLETED|Overall Study||152
131925|NCT01197794|318435|P3|COMPLETED|Overall Study||153
131926|NCT01197794|318436|P2|COMPLETED|Overall Study||146
131927|NCT01197794|318437|P1|COMPLETED|Overall Study||148
131928|NCT01197794|318431|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
131929|NCT01197794|318432|P6|STARTED|Overall Study||163
131930|NCT01197794|318433|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
131931|NCT01197794|318434|P4|STARTED|Overall Study||164
131932|NCT01197794|318435|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
131933|NCT01197794|318436|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
131934|NCT01197794|318437|P1|STARTED|Overall Study||164
131935|NCT01197755|318519|P3|NOT COMPLETED|Overall Study||54
131936|NCT01197755|318520|P2|NOT COMPLETED|Overall Study||43
131937|NCT01197755|318521|P1|NOT COMPLETED|Overall Study||38
131938|NCT01197755|318519|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
131939|NCT01197755|318520|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
131940|NCT01197755|318521|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
131941|NCT01197755|318519|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
131942|NCT01197755|318520|P2|Randomised But Did Not Receive Treatment|Overall Study||0
131943|NCT01197755|318521|P1|Randomised But Did Not Receive Treatment|Overall Study||0
131944|NCT01197755|318519|P3|STARTED|Overall Study|Patients who received treatment|109
131945|NCT01197755|318520|P2|STARTED|Overall Study|Patients who received treatment|108
131946|NCT01197755|318521|P1|STARTED|Overall Study|Patients who received treatment|105
131947|NCT01197612|318561|P1|NOT COMPLETED|Overall Study||12
131948|NCT01197612|318561|P1|COMPLETED|Overall Study||6
131949|NCT01197612|318561|P1|Returned for Week 24|Overall Study||6
131950|NCT01197612|318561|P1|Week 3|Overall Study||16
131951|NCT01197612|318561|P1|STARTED|Overall Study||18
131952|NCT01197560|318574|P2|NOT COMPLETED|Overall Study||53
131953|NCT01197560|318575|P1|NOT COMPLETED|Overall Study||46
131954|NCT01197560|318574|P2|COMPLETED|Overall Study|Completed = those completed and ongoing on treatment at the time of the data cut-off of 04 July 2013|4
131955|NCT01197560|318575|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 04 July 2013|8
131956|NCT01197560|318574|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||3
131957|NCT01197560|318575|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||7
131958|NCT01197560|318574|P2|Lenalidomide Crossover|Overall Study||29
131959|NCT01197560|318575|P1|Lenalidomide Crossover|Overall Study||0
131960|NCT01197560|318574|P2|Received ≥ One Dose Study Drug|Overall Study||55
131961|NCT01197560|318575|P1|Received ≥ One Dose Study Drug|Overall Study||54
131962|NCT01197560|318574|P2|STARTED|Overall Study|This is the intent to treat population|57
131963|NCT01197560|318575|P1|STARTED|Overall Study|This is the intent to treat population|54
131964|NCT01197547|318599|P1|NOT COMPLETED|Overall Study||22
131965|NCT01197547|318599|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
131966|NCT01197547|318599|P1|STARTED|Overall Study||1014
131967|NCT01197534|318608|P3|NOT COMPLETED|Overall Study||173
131968|NCT01197534|318609|P2|NOT COMPLETED|Overall Study||130
131969|NCT01197534|318610|P1|NOT COMPLETED|Overall Study||134
131970|NCT01197534|318608|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
131971|NCT01197534|318609|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
131972|NCT01197534|318610|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
131973|NCT01197534|318608|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
131974|NCT01197534|318609|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
131975|NCT01197534|318610|P1|Randomised But Did Not Receive Treatment|Overall Study||0
131976|NCT01197534|318608|P3|STARTED|Overall Study|Patients who received treatment|302
131977|NCT01197534|318609|P2|STARTED|Overall Study|Patients who received treatment|298
131978|NCT01197534|318610|P1|STARTED|Overall Study|Patients who received treatment|308
131979|NCT01197521|318654|P3|NOT COMPLETED|Overall Study||143
131980|NCT01197521|318655|P2|NOT COMPLETED|Overall Study||113
131981|NCT01197521|318656|P1|NOT COMPLETED|Overall Study||103
131982|NCT01197521|318654|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
131983|NCT01197521|318655|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
131984|NCT01197521|318656|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
131985|NCT01197521|318654|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
131986|NCT01197521|318655|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
131987|NCT01197521|318656|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
131988|NCT01197521|318654|P3|STARTED|Overall Study|Patients who received treatment|304
131989|NCT01197521|318655|P2|STARTED|Overall Study|Patients who received treatment|304
131990|NCT01197521|318656|P1|STARTED|Overall Study|Patients who received treatment|310
131991|NCT01197508|318701|P4|NOT COMPLETED|Overall Study||16
131992|NCT01197508|318702|P3|NOT COMPLETED|Overall Study||49
131993|NCT01197508|318703|P2|NOT COMPLETED|Overall Study||30
131994|NCT01197508|318704|P1|NOT COMPLETED|Overall Study||23
131995|NCT01197508|318701|P4|COMPLETED|Overall Study||158
131996|NCT01197508|318702|P3|COMPLETED|Overall Study||125
131997|NCT01197508|318703|P2|COMPLETED|Overall Study||144
131998|NCT01197508|318704|P1|COMPLETED|Overall Study||151
131999|NCT01197508|318701|P4|Received Treatment|Overall Study||174
132000|NCT01197508|318702|P3|Received Treatment|Overall Study||171
132001|NCT01197508|318703|P2|Received Treatment|Overall Study||174
132002|NCT01197508|318704|P1|Received Treatment|Overall Study||174
132003|NCT01197508|318701|P4|STARTED|Overall Study||174
132004|NCT01197508|318702|P3|STARTED|Overall Study||174
132005|NCT01197508|318703|P2|STARTED|Overall Study||174
132006|NCT01197508|318704|P1|STARTED|Overall Study||174
132007|NCT01197495|318800|P2|NOT COMPLETED|Overall Study||7
132008|NCT01197495|318801|P1|NOT COMPLETED|Overall Study||13
132009|NCT01197495|318800|P2|COMPLETED|Overall Study||49
132010|NCT01197495|318801|P1|COMPLETED|Overall Study||144
132011|NCT01197495|318800|P2|STARTED|Overall Study||56
132012|NCT01197495|318801|P1|STARTED|Overall Study||157
132013|NCT01197417|318814|P2|NOT COMPLETED|Overall Study||18
132014|NCT01197417|318815|P1|NOT COMPLETED|Overall Study||8
132015|NCT01197417|318814|P2|COMPLETED|Overall Study||86
132016|NCT01197417|318815|P1|COMPLETED|Overall Study||96
132017|NCT01197417|318814|P2|Received Study Drug|Overall Study||103
132018|NCT01197417|318815|P1|Received Study Drug|Overall Study||101
132019|NCT01197417|318814|P2|STARTED|Overall Study||104
132020|NCT01197417|318815|P1|STARTED|Overall Study||104
132021|NCT01197326|318835|P2|NOT COMPLETED|Overall Study||0
132022|NCT01197326|318836|P1|NOT COMPLETED|Overall Study||0
132023|NCT01197326|318835|P2|COMPLETED|Overall Study||209
132024|NCT01197326|318836|P1|COMPLETED|Overall Study||205
132025|NCT01197326|318835|P2|STARTED|Overall Study||209
132026|NCT01197326|318836|P1|STARTED|Overall Study||205
132027|NCT01196988|318848|P4|NOT COMPLETED|Overall Study||1
132028|NCT01196988|318849|P3|NOT COMPLETED|Overall Study||25
132029|NCT01196988|318850|P2|NOT COMPLETED|Overall Study||32
132030|NCT01196988|318851|P1|NOT COMPLETED|Overall Study||24
132031|NCT01196988|318848|P4|COMPLETED|Overall Study||276
132032|NCT01196988|318849|P3|COMPLETED|Overall Study||886
132033|NCT01196988|318850|P2|COMPLETED|Overall Study||880
132034|NCT01196988|318851|P1|COMPLETED|Overall Study||891
132035|NCT01196988|318848|P4|STARTED|Overall Study||277
132036|NCT01196988|318849|P3|STARTED|Overall Study||911
132037|NCT01196988|318850|P2|STARTED|Overall Study||912
132038|NCT01196988|318851|P1|STARTED|Overall Study||915
132039|NCT01196975|318945|P5|NOT COMPLETED|Overall Study||13
132040|NCT01196975|318946|P4|NOT COMPLETED|Overall Study||6
132041|NCT01196975|318947|P3|NOT COMPLETED|Overall Study||5
132042|NCT01196975|318948|P2|NOT COMPLETED|Overall Study||9
132043|NCT01196975|318949|P1|NOT COMPLETED|Overall Study||15
132044|NCT01196975|318945|P5|COMPLETED|Overall Study||205
132045|NCT01196975|318946|P4|COMPLETED|Overall Study||207
132046|NCT01196975|318947|P3|COMPLETED|Overall Study||420
132047|NCT01196975|318948|P2|COMPLETED|Overall Study||415
132048|NCT01196975|318949|P1|COMPLETED|Overall Study||408
132049|NCT01196975|318945|P5|STARTED|Overall Study||218
132050|NCT01196975|318946|P4|STARTED|Overall Study||213
132051|NCT01196975|318947|P3|STARTED|Overall Study||425
132052|NCT01196975|318948|P2|STARTED|Overall Study||424
132053|NCT01196975|318949|P1|STARTED|Overall Study||423
132054|NCT01196923|319081|P1|NOT COMPLETED|Overall Study||0
132055|NCT01196923|319081|P1|COMPLETED|Overall Study||20
132056|NCT01196923|319081|P1|STARTED|Overall Study||20
132057|NCT01196819|319087|P2|NOT COMPLETED|Overall Study||28
132058|NCT01196819|319088|P1|NOT COMPLETED|Overall Study||28
132059|NCT01196819|319087|P2|COMPLETED|Overall Study||199
132060|NCT01196819|319088|P1|COMPLETED|Overall Study||203
132061|NCT01196819|319087|P2|STARTED|Overall Study||227
132062|NCT01196819|319088|P1|STARTED|Overall Study||231
132063|NCT01196741|319110|P2|NOT COMPLETED|Overall Study||28
132064|NCT01196741|319111|P1|NOT COMPLETED|Overall Study||60
132065|NCT01196741|319110|P2|COMPLETED|Overall Study||8
132066|NCT01196741|319111|P1|COMPLETED|Overall Study||11
132067|NCT01196741|319110|P2|STARTED|Overall Study||36
132068|NCT01196741|319111|P1|STARTED|Overall Study||71
132069|NCT01196442|319125|P1|NOT COMPLETED|Overall Study||0
132070|NCT01196442|319125|P1|COMPLETED|Overall Study||39
132071|NCT01196442|319125|P1|STARTED|Overall Study||39
132072|NCT01196429|319137|P2|NOT COMPLETED|Overall Study||0
132073|NCT01196429|319138|P1|NOT COMPLETED|Overall Study||3
132074|NCT01196429|319137|P2|COMPLETED|Overall Study||45
132075|NCT01196429|319138|P1|COMPLETED|Overall Study||42
132076|NCT01196429|319137|P2|STARTED|Overall Study||45
132077|NCT01196429|319138|P1|STARTED|Overall Study||45
132078|NCT01196416|319154|P1|NOT COMPLETED|Overall Study||2
132079|NCT01196416|319154|P1|COMPLETED|Overall Study||12
132080|NCT01196416|319154|P1|STARTED|Overall Study||14
132081|NCT01196377|319165|P4|NOT COMPLETED|Overall Study||0
132082|NCT01196377|319166|P3|NOT COMPLETED|Overall Study||0
132083|NCT01196377|319167|P2|NOT COMPLETED|Overall Study||0
132084|NCT01196377|319168|P1|NOT COMPLETED|Overall Study||0
132085|NCT01196377|319165|P4|COMPLETED|Overall Study||4
132086|NCT01196377|319166|P3|COMPLETED|Overall Study||4
132087|NCT01196377|319167|P2|COMPLETED|Overall Study||4
132088|NCT01196377|319168|P1|COMPLETED|Overall Study||4
132089|NCT01196377|319165|P4|STARTED|Overall Study||4
132090|NCT01196377|319166|P3|STARTED|Overall Study||4
132091|NCT01196377|319167|P2|STARTED|Overall Study||4
132092|NCT01196377|319168|P1|STARTED|Overall Study||4
132093|NCT01196104|319180|P2|NOT COMPLETED|Overall Study||5
132094|NCT01196104|319181|P1|NOT COMPLETED|Overall Study||4
132095|NCT01196104|319180|P2|COMPLETED|Overall Study||15
132096|NCT01196104|319181|P1|COMPLETED|Overall Study||15
132097|NCT01196104|319180|P2|STARTED|Overall Study||20
132098|NCT01196104|319181|P1|STARTED|Overall Study||19
132099|NCT01196078|319223|P2|NOT COMPLETED|Overall Study||37
132100|NCT01196078|319224|P1|NOT COMPLETED|Overall Study||33
132101|NCT01196078|319223|P2|COMPLETED|Overall Study||20
132102|NCT01196078|319224|P1|COMPLETED|Overall Study||24
132103|NCT01196078|319223|P2|STARTED|Overall Study||57
132104|NCT01196078|319224|P1|STARTED|Overall Study||57
132105|NCT01196052|319252|P1|NOT COMPLETED|Overall Study||23
132106|NCT01196052|319252|P1|COMPLETED|Overall Study||130
132107|NCT01196052|319252|P1|Received Trastuzumab Emtansine|Overall Study||148
132108|NCT01196052|319252|P1|STARTED|Overall Study||153
132109|NCT01196026|319269|P6|NOT COMPLETED|Overall Study||0
132110|NCT01196026|319270|P5|NOT COMPLETED|Overall Study||1
132111|NCT01196026|319271|P4|NOT COMPLETED|Overall Study||0
132112|NCT01196026|319272|P3|NOT COMPLETED|Overall Study||0
132113|NCT01196026|319273|P2|NOT COMPLETED|Overall Study||8
132114|NCT01196026|319274|P1|NOT COMPLETED|Overall Study||1
132115|NCT01196026|319269|P6|COMPLETED|Overall Study||24
132116|NCT01196026|319270|P5|COMPLETED|Overall Study||42
132117|NCT01196026|319271|P4|COMPLETED|Overall Study||10
132118|NCT01196026|319272|P3|COMPLETED|Overall Study||23
132119|NCT01196026|319273|P2|COMPLETED|Overall Study||36
132120|NCT01196026|319274|P1|COMPLETED|Overall Study||9
132121|NCT01196026|319269|P6|Completed at Day 28|Overall Study||24
132122|NCT01196026|319270|P5|Completed at Day 28|Overall Study||42
132123|NCT01196026|319271|P4|Completed at Day 28|Overall Study||10
132124|NCT01196026|319272|P3|Completed at Day 28|Overall Study||23
132125|NCT01196026|319273|P2|Completed at Day 28|Overall Study||41
132126|NCT01196026|319274|P1|Completed at Day 28|Overall Study||9
132127|NCT01196026|319269|P6|STARTED|Overall Study||24
132128|NCT01196026|319270|P5|STARTED|Overall Study||43
132129|NCT01196026|319271|P4|STARTED|Overall Study||10
132130|NCT01196026|319272|P3|STARTED|Overall Study||23
132131|NCT01196026|319273|P2|STARTED|Overall Study||44
132132|NCT01196026|319274|P1|STARTED|Overall Study||10
132133|NCT01195948|319510|P3|NOT COMPLETED|Overall Study||2
132134|NCT01195948|319511|P2|NOT COMPLETED|Overall Study||1
132135|NCT01195948|319512|P1|NOT COMPLETED|Overall Study||0
132136|NCT01195948|319510|P3|COMPLETED|Overall Study||9
132137|NCT01195948|319511|P2|COMPLETED|Overall Study||9
132138|NCT01195948|319512|P1|COMPLETED|Overall Study||10
132139|NCT01195948|319510|P3|Week 24|Overall Study||10
132140|NCT01195948|319511|P2|Week 24|Overall Study||10
132141|NCT01195948|319512|P1|Week 24|Overall Study||10
132142|NCT01195948|319510|P3|STARTED|Overall Study||11
132143|NCT01195948|319511|P2|STARTED|Overall Study||10
132144|NCT01195948|319512|P1|STARTED|Overall Study||10
132145|NCT01195922|319538|P1|NOT COMPLETED|Overall Study||0
132146|NCT01195922|319538|P1|COMPLETED|Overall Study||16
132147|NCT01195922|319538|P1|STARTED|Overall Study||16
132148|NCT01195844|319544|P1|NOT COMPLETED|Overall Study||40
132149|NCT01195844|319544|P1|COMPLETED|Overall Study||190
132150|NCT01195844|319544|P1|STARTED|Overall Study||230
132151|NCT01195831|319561|P2|NOT COMPLETED|Overall Study||10
132152|NCT01195831|319562|P1|NOT COMPLETED|Overall Study||8
132153|NCT01195831|319561|P2|COMPLETED|Overall Study||114
132154|NCT01195831|319562|P1|COMPLETED|Overall Study||112
132155|NCT01195831|319561|P2|STARTED|Overall Study||124
132156|NCT01195831|319562|P1|STARTED|Overall Study||120
132157|NCT01195779|319590|P14|NOT COMPLETED|Overall Study||0
132158|NCT01195779|319591|P13|NOT COMPLETED|Overall Study||0
132159|NCT01195779|319592|P12|NOT COMPLETED|Overall Study||0
132160|NCT01195779|319593|P11|NOT COMPLETED|Overall Study||0
132161|NCT01195779|319594|P10|NOT COMPLETED|Overall Study||0
132162|NCT01195779|319595|P9|NOT COMPLETED|Overall Study||0
132163|NCT01195779|319596|P8|NOT COMPLETED|Overall Study||0
132164|NCT01195779|319597|P7|NOT COMPLETED|Overall Study||0
132165|NCT01195779|319598|P6|NOT COMPLETED|Overall Study||0
132166|NCT01195779|319599|P5|NOT COMPLETED|Overall Study||0
132167|NCT01195779|319600|P4|NOT COMPLETED|Overall Study||0
132168|NCT01195779|319601|P3|NOT COMPLETED|Overall Study||0
132169|NCT01195779|319602|P2|NOT COMPLETED|Overall Study||0
132170|NCT01195779|319603|P1|NOT COMPLETED|Overall Study||0
132171|NCT01195779|319590|P14|COMPLETED|Overall Study||1
132172|NCT01195779|319591|P13|COMPLETED|Overall Study||0
132173|NCT01195779|319592|P12|COMPLETED|Overall Study||1
132174|NCT01195779|319593|P11|COMPLETED|Overall Study||0
132175|NCT01195779|319594|P10|COMPLETED|Overall Study||0
132176|NCT01195779|319595|P9|COMPLETED|Overall Study||0
132177|NCT01195779|319596|P8|COMPLETED|Overall Study||1
132178|NCT01195779|319597|P7|COMPLETED|Overall Study||0
132179|NCT01195779|319598|P6|COMPLETED|Overall Study||0
132180|NCT01195779|319599|P5|COMPLETED|Overall Study||1
132181|NCT01195779|319600|P4|COMPLETED|Overall Study||0
132182|NCT01195779|319601|P3|COMPLETED|Overall Study||0
132183|NCT01195779|319602|P2|COMPLETED|Overall Study||0
132184|NCT01195779|319603|P1|COMPLETED|Overall Study||0
132185|NCT01195779|319590|P14|STARTED|Overall Study||1
132186|NCT01195779|319591|P13|STARTED|Overall Study||0
132187|NCT01195779|319592|P12|STARTED|Overall Study||1
132188|NCT01195779|319593|P11|STARTED|Overall Study||0
132189|NCT01195779|319594|P10|STARTED|Overall Study||0
132190|NCT01195779|319595|P9|STARTED|Overall Study||0
132191|NCT01195779|319596|P8|STARTED|Overall Study||1
132192|NCT01195779|319597|P7|STARTED|Overall Study||0
132193|NCT01195779|319598|P6|STARTED|Overall Study||0
132194|NCT01195779|319599|P5|STARTED|Overall Study||1
132195|NCT01195779|319600|P4|STARTED|Overall Study||0
132196|NCT01195779|319601|P3|STARTED|Overall Study||0
132197|NCT01195779|319602|P2|STARTED|Overall Study||0
132198|NCT01195779|319603|P1|STARTED|Overall Study||0
132199|NCT01195701|319775|P2|NOT COMPLETED|Overall Study||5
132200|NCT01195701|319776|P1|NOT COMPLETED|Overall Study||0
132201|NCT01195701|319775|P2|COMPLETED|Overall Study||20
132202|NCT01195701|319776|P1|COMPLETED|Overall Study||10
132203|NCT01195701|319775|P2|STARTED|Overall Study||25
132204|NCT01195701|319776|P1|STARTED|Overall Study||10
132205|NCT01195675|319802|P1|NOT COMPLETED|Overall Study||3
132206|NCT01195675|319802|P1|COMPLETED|Overall Study||27
132207|NCT01195675|319802|P1|Received Placebo 2|Overall Study||28
132208|NCT01195675|319802|P1|Received Placebo 1|Overall Study||29
132209|NCT01195675|319802|P1|Received Moxifloxacin|Overall Study||29
132210|NCT01195675|319802|P1|Received Empa 200mg|Overall Study||30
132211|NCT01195675|319802|P1|Received Empa 25mg|Overall Study||28
132212|NCT01195675|319802|P1|STARTED|Overall Study||30
132213|NCT01195662|319835|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
132214|NCT01195662|319836|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
132215|NCT01195662|319837|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
132216|NCT01195662|319835|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
132217|NCT01195662|319836|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
132218|NCT01195662|319837|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
132219|NCT01195662|319835|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
132220|NCT01195662|319836|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
132221|NCT01195662|319837|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
132222|NCT01195662|319835|P3|NOT COMPLETED|Double Blind Treatment Period||14
132223|NCT01195662|319836|P2|NOT COMPLETED|Double Blind Treatment Period||14
132224|NCT01195662|319837|P1|NOT COMPLETED|Double Blind Treatment Period||22
132225|NCT01195662|319835|P3|COMPLETED|Double Blind Treatment Period||119
132226|NCT01195662|319836|P2|COMPLETED|Double Blind Treatment Period||211
132227|NCT01195662|319837|P1|COMPLETED|Double Blind Treatment Period||202
132228|NCT01195662|319835|P3|STARTED|Double Blind Treatment Period||133
132229|NCT01195662|319836|P2|STARTED|Double Blind Treatment Period||225
132230|NCT01195662|319837|P1|STARTED|Double Blind Treatment Period||224
132231|NCT01195636|319867|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
132232|NCT01195636|319868|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
132233|NCT01195636|319867|P2|COMPLETED|Second Intervention (3 Weeks)||27
132234|NCT01195636|319868|P1|COMPLETED|Second Intervention (3 Weeks)||27
132235|NCT01195636|319867|P2|STARTED|Second Intervention (3 Weeks)||29
132236|NCT01195636|319868|P1|STARTED|Second Intervention (3 Weeks)||28
132237|NCT01195636|319867|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
132238|NCT01195636|319868|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
132239|NCT01195636|319867|P2|COMPLETED|Washout Period (2 Weeks)||29
132240|NCT01195636|319868|P1|COMPLETED|Washout Period (2 Weeks)||28
132241|NCT01195636|319867|P2|STARTED|Washout Period (2 Weeks)||32
132242|NCT01195636|319868|P1|STARTED|Washout Period (2 Weeks)||30
132243|NCT01195636|319867|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
132244|NCT01195636|319868|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
132245|NCT01195636|319867|P2|COMPLETED|First Intervention (3 Weeks)||32
132246|NCT01195636|319868|P1|COMPLETED|First Intervention (3 Weeks)||30
132247|NCT01195636|319867|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
132248|NCT01195636|319868|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
132249|NCT01195636|319867|P2|STARTED|First Intervention (3 Weeks)||35
132250|NCT01195636|319868|P1|STARTED|First Intervention (3 Weeks)||35
132251|NCT01195623|319894|P2|NOT COMPLETED|Overall Study||37
132252|NCT01195623|319895|P1|NOT COMPLETED|Overall Study||35
132253|NCT01195623|319894|P2|COMPLETED|Overall Study|129 legs|108
132254|NCT01195623|319895|P1|COMPLETED|Overall Study|127 legs|113
132255|NCT01195623|319894|P2|STARTED|Overall Study|177 legs total operated|145
132256|NCT01195623|319895|P1|STARTED|Overall Study|166 legs total operated|148
132257|NCT01195597|319903|P1|NOT COMPLETED|Overall Study||13
132258|NCT01195597|319903|P1|COMPLETED|Overall Study||27
132259|NCT01195597|319903|P1|STARTED|Overall Study||40
132260|NCT01195584|319911|P3|NOT COMPLETED|Overall Study||0
132261|NCT01195584|319912|P2|NOT COMPLETED|Overall Study||0
132262|NCT01195584|319913|P1|NOT COMPLETED|Overall Study||0
132263|NCT01195584|319911|P3|COMPLETED|Overall Study||27
132264|NCT01195584|319912|P2|COMPLETED|Overall Study||25
132265|NCT01195584|319913|P1|COMPLETED|Overall Study||20
132266|NCT01195584|319911|P3|STARTED|Overall Study||27
132267|NCT01195584|319912|P2|STARTED|Overall Study||25
132268|NCT01195584|319913|P1|STARTED|Overall Study||20
132269|NCT01195467|319924|P1|NOT COMPLETED|Overall Study||10
132270|NCT01195467|319924|P1|COMPLETED|Overall Study||30
132271|NCT01195467|319924|P1|STARTED|Overall Study||40
132272|NCT01195415|319929|P1|NOT COMPLETED|Overall Study||2
132273|NCT01195415|319929|P1|COMPLETED|Overall Study||23
132274|NCT01195415|319929|P1|STARTED|Overall Study||25
132275|NCT01195363|319938|P2|NOT COMPLETED|Overall Study||9
132276|NCT01195363|319939|P1|NOT COMPLETED|Overall Study||11
132277|NCT01195363|319938|P2|COMPLETED|Overall Study||4
132278|NCT01195363|319939|P1|COMPLETED|Overall Study||4
132279|NCT01195363|319938|P2|STARTED|Overall Study||13
132280|NCT01195363|319939|P1|STARTED|Overall Study||15
132281|NCT01195272|319945|P1|NOT COMPLETED|Overall Study||4
132282|NCT01195272|319945|P1|COMPLETED|Overall Study||17
132283|NCT01195272|319945|P1|STARTED|Overall Study||21
132284|NCT01195116|319964|P2|NOT COMPLETED|Overall Study||0
132285|NCT01195116|319965|P1|NOT COMPLETED|Overall Study||0
132286|NCT01195116|319964|P2|COMPLETED|Overall Study||20
132287|NCT01195116|319965|P1|COMPLETED|Overall Study||21
132288|NCT01195116|319964|P2|STARTED|Overall Study||20
132289|NCT01195116|319965|P1|STARTED|Overall Study||21
132290|NCT01195103|319974|P3|NOT COMPLETED|Overall Study||0
132291|NCT01195103|319975|P2|NOT COMPLETED|Overall Study||0
132292|NCT01195103|319976|P1|NOT COMPLETED|Overall Study||1
132293|NCT01195103|319974|P3|COMPLETED|Overall Study||5
132294|NCT01195103|319975|P2|COMPLETED|Overall Study||2
132295|NCT01195103|319976|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
132296|NCT01195103|319974|P3|STARTED|Overall Study||5
132297|NCT01195103|319975|P2|STARTED|Overall Study||2
132298|NCT01195103|319976|P1|STARTED|Overall Study||6
132299|NCT01195090|319986|P2|NOT COMPLETED|Overall Study||8
132300|NCT01195090|319987|P1|NOT COMPLETED|Overall Study||6
132301|NCT01195090|319986|P2|COMPLETED|Overall Study||52
132302|NCT01195090|319987|P1|COMPLETED|Overall Study||54
132303|NCT01195090|319986|P2|STARTED|Overall Study||60
132304|NCT01195090|319987|P1|STARTED|Overall Study||60
132305|NCT01195025|320045|P5|NOT COMPLETED|Third Intervention C||0
132306|NCT01195025|320046|P4|NOT COMPLETED|Third Intervention C||0
132307|NCT01195025|320047|P3|NOT COMPLETED|Third Intervention C||0
132308|NCT01195025|320048|P2|NOT COMPLETED|Third Intervention C||0
132309|NCT01195025|320049|P1|NOT COMPLETED|Third Intervention C||0
132310|NCT01195025|320045|P5|COMPLETED|Third Intervention C||1
132311|NCT01195025|320046|P4|COMPLETED|Third Intervention C||2
132312|NCT01195025|320047|P3|COMPLETED|Third Intervention C||2
132313|NCT01195025|320048|P2|COMPLETED|Third Intervention C||3
132314|NCT01195025|320049|P1|COMPLETED|Third Intervention C||2
132315|NCT01195025|320045|P5|STARTED|Third Intervention C||1
132316|NCT01195025|320046|P4|STARTED|Third Intervention C||2
132317|NCT01195025|320047|P3|STARTED|Third Intervention C||2
132318|NCT01195025|320048|P2|STARTED|Third Intervention C||3
132319|NCT01195025|320049|P1|STARTED|Third Intervention C||2
132320|NCT01195025|320045|P5|NOT COMPLETED|Second Intervention B||0
132321|NCT01195025|320046|P4|NOT COMPLETED|Second Intervention B||0
132322|NCT01195025|320047|P3|NOT COMPLETED|Second Intervention B||0
132323|NCT01195025|320048|P2|NOT COMPLETED|Second Intervention B||0
132324|NCT01195025|320049|P1|NOT COMPLETED|Second Intervention B||0
132325|NCT01195025|320045|P5|COMPLETED|Second Intervention B||1
132326|NCT01195025|320046|P4|COMPLETED|Second Intervention B||2
132327|NCT01195025|320047|P3|COMPLETED|Second Intervention B||2
132328|NCT01195025|320048|P2|COMPLETED|Second Intervention B||3
132329|NCT01195025|320049|P1|COMPLETED|Second Intervention B||2
132330|NCT01195025|320045|P5|STARTED|Second Intervention B||1
132331|NCT01195025|320046|P4|STARTED|Second Intervention B||2
132332|NCT01195025|320047|P3|STARTED|Second Intervention B||2
132333|NCT01195025|320048|P2|STARTED|Second Intervention B||3
132334|NCT01195025|320049|P1|STARTED|Second Intervention B||2
132335|NCT01195025|320045|P5|NOT COMPLETED|First Intervention A||0
132336|NCT01195025|320046|P4|NOT COMPLETED|First Intervention A||0
132337|NCT01195025|320047|P3|NOT COMPLETED|First Intervention A||0
132338|NCT01195025|320048|P2|NOT COMPLETED|First Intervention A||0
132339|NCT01195025|320049|P1|NOT COMPLETED|First Intervention A||0
132340|NCT01195025|320045|P5|COMPLETED|First Intervention A||1
132341|NCT01195025|320046|P4|COMPLETED|First Intervention A||2
132342|NCT01195025|320047|P3|COMPLETED|First Intervention A||2
132343|NCT01195025|320048|P2|COMPLETED|First Intervention A||3
132344|NCT01195025|320049|P1|COMPLETED|First Intervention A||2
132345|NCT01195025|320045|P5|STARTED|First Intervention A||1
132346|NCT01195025|320046|P4|STARTED|First Intervention A||2
132347|NCT01195025|320047|P3|STARTED|First Intervention A||2
132348|NCT01195025|320048|P2|STARTED|First Intervention A||3
132349|NCT01195025|320049|P1|STARTED|First Intervention A||2
132350|NCT01194999|320056|P1|NOT COMPLETED|Overall Study||17
132351|NCT01194999|320056|P1|COMPLETED|Overall Study||115
132352|NCT01194999|320056|P1|STARTED|Overall Study||132
132353|NCT01194973|320060|P1|NOT COMPLETED|26 Week Treatment Period||3
132354|NCT01194973|320060|P1|COMPLETED|26 Week Treatment Period||38
132355|NCT01194973|320060|P1|STARTED|26 Week Treatment Period||41
132356|NCT01194973|320060|P1|NOT COMPLETED|Screening Period||3
132357|NCT01194973|320060|P1|COMPLETED|Screening Period||41
132358|NCT01194973|320060|P1|STARTED|Screening Period||44
132359|NCT01194908|320075|P1|NOT COMPLETED|Overall Study||0
132360|NCT01194908|320075|P1|COMPLETED|Overall Study||5
132361|NCT01194908|320075|P1|STARTED|Overall Study||5
132362|NCT01194869|320080|P1|NOT COMPLETED|Overall Study||4
132363|NCT01194869|320080|P1|COMPLETED|Overall Study||21
132364|NCT01194869|320080|P1|STARTED|Overall Study||25
132365|NCT01194856|320088|P2|NOT COMPLETED|Overall Study||0
132366|NCT01194856|320089|P1|NOT COMPLETED|Overall Study||1
132367|NCT01194856|320088|P2|COMPLETED|Overall Study||0
132368|NCT01194856|320089|P1|COMPLETED|Overall Study||0
132369|NCT01194856|320088|P2|STARTED|Overall Study||0
132370|NCT01194856|320089|P1|STARTED|Overall Study||1
132371|NCT01194830|320111|P2|NOT COMPLETED|Overall Study||27
132372|NCT01194830|320112|P1|NOT COMPLETED|Overall Study||36
132373|NCT01194830|320111|P2|COMPLETED|Overall Study||83
132374|NCT01194830|320112|P1|COMPLETED|Overall Study||88
132375|NCT01194830|320111|P2|STARTED|Overall Study||110
132376|NCT01194830|320112|P1|STARTED|Overall Study||124
132377|NCT01194674|320134|P1|NOT COMPLETED|Overall Study||0
132378|NCT01194674|320134|P1|COMPLETED|Overall Study||2
132379|NCT01194674|320134|P1|STARTED|Overall Study||2
132380|NCT01194570|320143|P2|NOT COMPLETED|Overall Study||488
132381|NCT01194570|320144|P1|NOT COMPLETED|Overall Study||244
132382|NCT01194570|320143|P2|COMPLETED|Overall Study||0
132383|NCT01194570|320144|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
132384|NCT01194570|320143|P2|STARTED|Overall Study||488
132385|NCT01194570|320144|P1|STARTED|Overall Study||244
132386|NCT01194531|320164|P2|NOT COMPLETED|Overall Study||3
132387|NCT01194531|320165|P1|NOT COMPLETED|Overall Study||5
132388|NCT01194531|320164|P2|COMPLETED|Overall Study||27
132389|NCT01194531|320165|P1|COMPLETED|Overall Study||24
132390|NCT01194531|320164|P2|STARTED|Overall Study||30
132391|NCT01194531|320165|P1|STARTED|Overall Study||29
132392|NCT01194479|320173|P4|NOT COMPLETED|Overall Study||0
132393|NCT01194479|320174|P3|NOT COMPLETED|Overall Study||0
132394|NCT01194479|320175|P2|NOT COMPLETED|Overall Study||0
132395|NCT01194479|320176|P1|NOT COMPLETED|Overall Study||0
132396|NCT01194479|320173|P4|COMPLETED|Overall Study||5
132397|NCT01194479|320174|P3|COMPLETED|Overall Study||2
132398|NCT01194479|320175|P2|COMPLETED|Overall Study||4
132399|NCT01194479|320176|P1|COMPLETED|Overall Study||3
132400|NCT01194479|320173|P4|Cross-over at Second Visit|Overall Study||5
132401|NCT01194479|320174|P3|Cross-over at Second Visit|Overall Study||2
132402|NCT01194479|320175|P2|Cross-over at Second Visit|Overall Study||4
132403|NCT01194479|320176|P1|Cross-over at Second Visit|Overall Study||3
132404|NCT01194479|320173|P4|STARTED|Overall Study||5
132405|NCT01194479|320174|P3|STARTED|Overall Study||2
132406|NCT01194479|320175|P2|STARTED|Overall Study||4
132407|NCT01194479|320176|P1|STARTED|Overall Study||3
132408|NCT01194453|320200|P2|NOT COMPLETED|Overall Study||17
132409|NCT01194453|320201|P1|NOT COMPLETED|Overall Study||17
132410|NCT01194453|320200|P2|COMPLETED|Overall Study||127
132411|NCT01194453|320201|P1|COMPLETED|Overall Study||127
132412|NCT01194453|320200|P2|STARTED|Overall Study||144
132413|NCT01194453|320201|P1|STARTED|Overall Study||144
132414|NCT01194440|320209|P1|NOT COMPLETED|Overall Study||12
132415|NCT01194440|320209|P1|COMPLETED|Overall Study||47
132416|NCT01194440|320209|P1|STARTED|Overall Study||59
132417|NCT01194427|320213|P1|NOT COMPLETED|Overall Study||0
132418|NCT01194427|320213|P1|COMPLETED|Overall Study||2
132419|NCT01194427|320213|P1|STARTED|Overall Study||2
132420|NCT01194414|320219|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
132421|NCT01194414|320220|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
132422|NCT01194414|320221|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
132423|NCT01194414|320222|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
132424|NCT01194414|320219|P4|COMPLETED|72 Weeks Open Label Extension||160
132425|NCT01194414|320220|P3|COMPLETED|72 Weeks Open Label Extension||40
132426|NCT01194414|320221|P2|COMPLETED|72 Weeks Open Label Extension||311
132427|NCT01194414|320222|P1|COMPLETED|72 Weeks Open Label Extension||445
132428|NCT01194414|320219|P4|STARTED|72 Weeks Open Label Extension||186
132429|NCT01194414|320220|P3|STARTED|72 Weeks Open Label Extension||48
132430|NCT01194414|320221|P2|STARTED|72 Weeks Open Label Extension||377
132431|NCT01194414|320222|P1|STARTED|72 Weeks Open Label Extension||524
132432|NCT01194414|320219|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
132433|NCT01194414|320220|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
132434|NCT01194414|320221|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
132435|NCT01194414|320222|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
132436|NCT01194414|320219|P4|COMPLETED|24 Weeks Double Blind Period||0
132437|NCT01194414|320220|P3|COMPLETED|24 Weeks Double Blind Period||0
132438|NCT01194414|320221|P2|COMPLETED|24 Weeks Double Blind Period||564
132439|NCT01194414|320222|P1|COMPLETED|24 Weeks Double Blind Period||572
132440|NCT01194414|320219|P4|Per Protocol Population|24 Weeks Double Blind Period||0
132441|NCT01194414|320220|P3|Per Protocol Population|24 Weeks Double Blind Period||0
132442|NCT01194414|320221|P2|Per Protocol Population|24 Weeks Double Blind Period||537
132443|NCT01194414|320222|P1|Per Protocol Population|24 Weeks Double Blind Period||558
132444|NCT01194414|320219|P4|STARTED|24 Weeks Double Blind Period||0
132445|NCT01194414|320220|P3|STARTED|24 Weeks Double Blind Period||0
132446|NCT01194414|320221|P2|STARTED|24 Weeks Double Blind Period||631
132447|NCT01194414|320222|P1|STARTED|24 Weeks Double Blind Period||631
132448|NCT01194297|320284|P2|NOT COMPLETED|Overall Study||0
132449|NCT01194297|320285|P1|NOT COMPLETED|Overall Study||0
132450|NCT01194297|320284|P2|COMPLETED|Overall Study||1
132451|NCT01194297|320285|P1|COMPLETED|Overall Study||2
132452|NCT01194297|320284|P2|STARTED|Overall Study||1
132453|NCT01194297|320285|P1|STARTED|Overall Study||2
132454|NCT01194258|320293|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
132455|NCT01194258|320294|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
132456|NCT01194258|320295|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
132457|NCT01194258|320296|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
132458|NCT01194258|320297|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
132459|NCT01194258|320293|P5|COMPLETED|Period 2 (12 Weeks)||30
132460|NCT01194258|320294|P4|COMPLETED|Period 2 (12 Weeks)||29
132461|NCT01194258|320295|P3|COMPLETED|Period 2 (12 Weeks)||29
132462|NCT01194258|320296|P2|COMPLETED|Period 2 (12 Weeks)||27
132463|NCT01194258|320297|P1|COMPLETED|Period 2 (12 Weeks)||0
132464|NCT01194258|320293|P5|STARTED|Period 2 (12 Weeks)||32
132465|NCT01194258|320294|P4|STARTED|Period 2 (12 Weeks)||29
132466|NCT01194258|320295|P3|STARTED|Period 2 (12 Weeks)||30
132467|NCT01194258|320296|P2|STARTED|Period 2 (12 Weeks)||29
132468|NCT01194258|320297|P1|STARTED|Period 2 (12 Weeks)||0
132469|NCT01194258|320293|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
132470|NCT01194258|320294|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
132471|NCT01194258|320295|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
132472|NCT01194258|320296|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
132473|NCT01194258|320297|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
132474|NCT01194258|320293|P5|COMPLETED|Period 1 (12 Weeks)||32
132475|NCT01194258|320294|P4|COMPLETED|Period 1 (12 Weeks)||29
132476|NCT01194258|320295|P3|COMPLETED|Period 1 (12 Weeks)||30
132477|NCT01194258|320296|P2|COMPLETED|Period 1 (12 Weeks)||29
132478|NCT01194258|320297|P1|COMPLETED|Period 1 (12 Weeks)||0
132479|NCT01194258|320293|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
132480|NCT01194258|320294|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
132481|NCT01194258|320295|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
132482|NCT01194258|320296|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
132483|NCT01194258|320297|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
132484|NCT01194258|320293|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
132485|NCT01194258|320294|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
132486|NCT01194258|320295|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
132487|NCT01194258|320296|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
132488|NCT01194258|320297|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
132489|NCT01194258|320293|P5|NOT COMPLETED|Titration Period||0
132490|NCT01194258|320294|P4|NOT COMPLETED|Titration Period||0
132491|NCT01194258|320295|P3|NOT COMPLETED|Titration Period||0
132492|NCT01194258|320296|P2|NOT COMPLETED|Titration Period||0
132493|NCT01194258|320297|P1|NOT COMPLETED|Titration Period||11
132494|NCT01194258|320293|P5|COMPLETED|Titration Period||0
132495|NCT01194258|320294|P4|COMPLETED|Titration Period||0
132496|NCT01194258|320295|P3|COMPLETED|Titration Period||0
132497|NCT01194258|320296|P2|COMPLETED|Titration Period||0
132498|NCT01194258|320297|P1|COMPLETED|Titration Period||121
132499|NCT01194258|320293|P5|STARTED|Titration Period||0
132500|NCT01194258|320294|P4|STARTED|Titration Period||0
132501|NCT01194258|320295|P3|STARTED|Titration Period||0
132502|NCT01194258|320296|P2|STARTED|Titration Period||0
132503|NCT01194258|320297|P1|STARTED|Titration Period||132
132504|NCT01194245|320321|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
132505|NCT01194245|320322|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
132506|NCT01194245|320323|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
132507|NCT01194245|320324|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
132508|NCT01194245|320325|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
132509|NCT01194245|320321|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
132510|NCT01194245|320322|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
132511|NCT01194245|320323|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
132512|NCT01194245|320324|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
132513|NCT01194245|320325|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
132514|NCT01194245|320321|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
132515|NCT01194245|320322|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
132516|NCT01194245|320323|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
132517|NCT01194245|320324|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
132518|NCT01194245|320325|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
132519|NCT01194245|320321|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
132520|NCT01194245|320322|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
132521|NCT01194245|320323|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
132522|NCT01194245|320324|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
132523|NCT01194245|320325|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
132524|NCT01194245|320321|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
132525|NCT01194245|320322|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
132526|NCT01194245|320323|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
132527|NCT01194245|320324|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
132528|NCT01194245|320325|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
132529|NCT01194245|320321|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
132530|NCT01194245|320322|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
132531|NCT01194245|320323|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
132532|NCT01194245|320324|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
132533|NCT01194245|320325|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
132534|NCT01194245|320321|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
132535|NCT01194245|320322|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
132536|NCT01194245|320323|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
132537|NCT01194245|320324|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
132538|NCT01194245|320325|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
132539|NCT01194245|320321|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
132540|NCT01194245|320322|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
132541|NCT01194245|320323|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
132542|NCT01194245|320324|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
132543|NCT01194245|320325|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
132544|NCT01194245|320321|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
132545|NCT01194245|320322|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
132546|NCT01194245|320323|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
132547|NCT01194245|320324|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
132548|NCT01194245|320325|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
132549|NCT01194245|320321|P5|STARTED|Titration Period (4 to 6 Weeks)||0
132550|NCT01194245|320322|P4|STARTED|Titration Period (4 to 6 Weeks)||0
132551|NCT01194245|320323|P3|STARTED|Titration Period (4 to 6 Weeks)||0
132552|NCT01194245|320324|P2|STARTED|Titration Period (4 to 6 Weeks)||0
132553|NCT01194245|320325|P1|STARTED|Titration Period (4 to 6 Weeks)||135
132554|NCT01194219|320346|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
132555|NCT01194219|320347|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
132556|NCT01194219|320348|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132557|NCT01194219|320349|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132558|NCT01194219|320350|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132559|NCT01194219|320351|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132560|NCT01194219|320352|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132561|NCT01194219|320353|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132562|NCT01194219|320354|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132563|NCT01194219|320355|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
132564|NCT01194219|320346|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
132565|NCT01194219|320347|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
132566|NCT01194219|320348|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132567|NCT01194219|320349|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132568|NCT01194219|320350|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132569|NCT01194219|320351|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132570|NCT01194219|320352|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132571|NCT01194219|320353|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132572|NCT01194219|320354|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132573|NCT01194219|320355|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
132574|NCT01194219|320346|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
132575|NCT01194219|320347|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
132576|NCT01194219|320348|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132577|NCT01194219|320349|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132578|NCT01194219|320350|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132579|NCT01194219|320351|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132580|NCT01194219|320352|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132581|NCT01194219|320353|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132582|NCT01194219|320354|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132583|NCT01194219|320355|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
132584|NCT01194219|320346|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
132585|NCT01194219|320347|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
132586|NCT01194219|320348|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
132587|NCT01194219|320349|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
132588|NCT01194219|320350|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
132589|NCT01194219|320351|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
132590|NCT01194219|320352|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
132591|NCT01194219|320353|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
132592|NCT01194219|320354|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
132593|NCT01194219|320355|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
132594|NCT01194219|320346|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132595|NCT01194219|320347|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132596|NCT01194219|320348|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
132597|NCT01194219|320349|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
132598|NCT01194219|320350|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
132599|NCT01194219|320351|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
132600|NCT01194219|320352|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132601|NCT01194219|320353|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132602|NCT01194219|320354|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132603|NCT01194219|320355|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132604|NCT01194219|320346|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132672|NCT01194219|320354|P2|STARTED|Maintenance Phase Weeks16-32||0
132605|NCT01194219|320347|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132606|NCT01194219|320348|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
132607|NCT01194219|320349|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
132608|NCT01194219|320350|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
132609|NCT01194219|320351|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
132610|NCT01194219|320352|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132611|NCT01194219|320353|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132612|NCT01194219|320354|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132613|NCT01194219|320355|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
132614|NCT01194219|320346|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132615|NCT01194219|320347|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132616|NCT01194219|320348|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
132617|NCT01194219|320349|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
132618|NCT01194219|320350|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132619|NCT01194219|320351|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132620|NCT01194219|320352|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132621|NCT01194219|320353|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132622|NCT01194219|320354|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132623|NCT01194219|320355|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
132624|NCT01194219|320346|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
132625|NCT01194219|320347|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
132626|NCT01194219|320348|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
132627|NCT01194219|320349|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
132628|NCT01194219|320350|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
132629|NCT01194219|320351|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
132630|NCT01194219|320352|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
132631|NCT01194219|320353|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
132632|NCT01194219|320354|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
132633|NCT01194219|320355|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
132634|NCT01194219|320346|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132635|NCT01194219|320347|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132636|NCT01194219|320348|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132637|NCT01194219|320349|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132638|NCT01194219|320350|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132639|NCT01194219|320351|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132640|NCT01194219|320352|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
132641|NCT01194219|320353|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
132642|NCT01194219|320354|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132643|NCT01194219|320355|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
132644|NCT01194219|320346|P10|COMPLETED|Maintenance Phase Weeks16-32||0
132645|NCT01194219|320347|P9|COMPLETED|Maintenance Phase Weeks16-32||0
132646|NCT01194219|320348|P8|COMPLETED|Maintenance Phase Weeks16-32||0
132647|NCT01194219|320349|P7|COMPLETED|Maintenance Phase Weeks16-32||0
132648|NCT01194219|320350|P6|COMPLETED|Maintenance Phase Weeks16-32||0
132649|NCT01194219|320351|P5|COMPLETED|Maintenance Phase Weeks16-32||0
132650|NCT01194219|320352|P4|COMPLETED|Maintenance Phase Weeks16-32||215
132651|NCT01194219|320353|P3|COMPLETED|Maintenance Phase Weeks16-32||424
132652|NCT01194219|320354|P2|COMPLETED|Maintenance Phase Weeks16-32||0
132653|NCT01194219|320355|P1|COMPLETED|Maintenance Phase Weeks16-32||0
132654|NCT01194219|320346|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
132655|NCT01194219|320347|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
132656|NCT01194219|320348|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
132657|NCT01194219|320349|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
132658|NCT01194219|320350|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
132659|NCT01194219|320351|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
132660|NCT01194219|320352|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
132661|NCT01194219|320353|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
132662|NCT01194219|320354|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
132663|NCT01194219|320355|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
132664|NCT01194219|320346|P10|STARTED|Maintenance Phase Weeks16-32||0
132665|NCT01194219|320347|P9|STARTED|Maintenance Phase Weeks16-32||0
132666|NCT01194219|320348|P8|STARTED|Maintenance Phase Weeks16-32||0
132667|NCT01194219|320349|P7|STARTED|Maintenance Phase Weeks16-32||0
132668|NCT01194219|320350|P6|STARTED|Maintenance Phase Weeks16-32||0
132669|NCT01194219|320351|P5|STARTED|Maintenance Phase Weeks16-32||0
132670|NCT01194219|320352|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
132671|NCT01194219|320353|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
132673|NCT01194219|320355|P1|STARTED|Maintenance Phase Weeks16-32||0
132674|NCT01194219|320346|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132675|NCT01194219|320347|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132676|NCT01194219|320348|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132677|NCT01194219|320349|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132678|NCT01194219|320350|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132679|NCT01194219|320351|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132680|NCT01194219|320352|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132681|NCT01194219|320353|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132682|NCT01194219|320354|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
132683|NCT01194219|320355|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
132684|NCT01194219|320346|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132685|NCT01194219|320347|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132686|NCT01194219|320348|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132687|NCT01194219|320349|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132688|NCT01194219|320350|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132689|NCT01194219|320351|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132690|NCT01194219|320352|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132691|NCT01194219|320353|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
132692|NCT01194219|320354|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
132693|NCT01194219|320355|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
132694|NCT01194219|320346|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132695|NCT01194219|320347|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132696|NCT01194219|320348|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132697|NCT01194219|320349|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132698|NCT01194219|320350|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132699|NCT01194219|320351|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132700|NCT01194219|320352|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132701|NCT01194219|320353|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
132702|NCT01194219|320354|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
132703|NCT01194219|320355|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
132704|NCT01194219|320346|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132705|NCT01194219|320347|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132706|NCT01194219|320348|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132707|NCT01194219|320349|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132708|NCT01194219|320350|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132709|NCT01194219|320351|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132710|NCT01194219|320352|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132711|NCT01194219|320353|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
132712|NCT01194219|320354|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
132713|NCT01194219|320355|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
132714|NCT01194154|320389|P2|NOT COMPLETED|Overall Study||33
132715|NCT01194154|320390|P1|NOT COMPLETED|Overall Study||49
132716|NCT01194154|320389|P2|COMPLETED|Overall Study||91
132717|NCT01194154|320390|P1|COMPLETED|Overall Study||68
132718|NCT01194154|320389|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
132719|NCT01194154|320390|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
132720|NCT01194154|320389|P2|Full Analysis Set|Overall Study||120
132721|NCT01194154|320390|P1|Full Analysis Set|Overall Study||115
132722|NCT01194154|320389|P2|STARTED|Overall Study||124
132723|NCT01194154|320390|P1|STARTED|Overall Study||117
132724|NCT01194089|320410|P2|NOT COMPLETED|Overall Study||0
132725|NCT01194089|320411|P1|NOT COMPLETED|Overall Study||0
132726|NCT01194089|320410|P2|COMPLETED|Overall Study||47
132727|NCT01194089|320411|P1|COMPLETED|Overall Study||42
132728|NCT01194089|320410|P2|STARTED|Overall Study||47
132729|NCT01194089|320411|P1|STARTED|Overall Study||42
132730|NCT01193920|320431|P10|NOT COMPLETED|Overall Study||7
132731|NCT01193920|320432|P9|NOT COMPLETED|Overall Study||5
132732|NCT01193920|320433|P8|NOT COMPLETED|Overall Study||4
132733|NCT01193920|320434|P7|NOT COMPLETED|Overall Study||6
132734|NCT01193920|320435|P6|NOT COMPLETED|Overall Study||4
132735|NCT01193920|320436|P5|NOT COMPLETED|Overall Study||6
132736|NCT01193920|320437|P4|NOT COMPLETED|Overall Study||4
132737|NCT01193920|320438|P3|NOT COMPLETED|Overall Study||6
132738|NCT01193920|320439|P2|NOT COMPLETED|Overall Study||0
132739|NCT01193920|320440|P1|NOT COMPLETED|Overall Study||3
132740|NCT01193920|320431|P10|COMPLETED|Overall Study||74
132741|NCT01193920|320432|P9|COMPLETED|Overall Study||71
132742|NCT01193920|320433|P8|COMPLETED|Overall Study||76
132743|NCT01193920|320434|P7|COMPLETED|Overall Study||74
132744|NCT01193920|320435|P6|COMPLETED|Overall Study||76
132745|NCT01193920|320436|P5|COMPLETED|Overall Study||74
132746|NCT01193920|320437|P4|COMPLETED|Overall Study||76
132747|NCT01193920|320438|P3|COMPLETED|Overall Study||74
132748|NCT01193920|320439|P2|COMPLETED|Overall Study||20
132749|NCT01193920|320440|P1|COMPLETED|Overall Study||37
132750|NCT01193920|320431|P10|STARTED|Overall Study||81
132751|NCT01193920|320432|P9|STARTED|Overall Study||76
132752|NCT01193920|320433|P8|STARTED|Overall Study||80
132753|NCT01193920|320434|P7|STARTED|Overall Study||80
132754|NCT01193920|320435|P6|STARTED|Overall Study||80
132755|NCT01193920|320436|P5|STARTED|Overall Study||80
132756|NCT01193920|320437|P4|STARTED|Overall Study||80
132757|NCT01193920|320438|P3|STARTED|Overall Study||80
132758|NCT01193920|320439|P2|STARTED|Overall Study||20
132759|NCT01193920|320440|P1|STARTED|Overall Study||40
132760|NCT01193907|320494|P4|NOT COMPLETED|Overall Study||1
132761|NCT01193907|320495|P3|NOT COMPLETED|Overall Study||0
132762|NCT01193907|320496|P2|NOT COMPLETED|Overall Study||0
132763|NCT01193907|320497|P1|NOT COMPLETED|Overall Study||1
132764|NCT01193907|320494|P4|COMPLETED|Overall Study||21
132765|NCT01193907|320495|P3|COMPLETED|Overall Study||22
132766|NCT01193907|320496|P2|COMPLETED|Overall Study||22
132767|NCT01193907|320497|P1|COMPLETED|Overall Study||21
132768|NCT01193907|320494|P4|STARTED|Overall Study||22
132769|NCT01193907|320495|P3|STARTED|Overall Study||22
132770|NCT01193907|320496|P2|STARTED|Overall Study||22
132771|NCT01193907|320497|P1|STARTED|Overall Study||22
132772|NCT01193868|320519|P1|NOT COMPLETED|Overall Study||0
132773|NCT01193868|320519|P1|COMPLETED|Overall Study||6
132774|NCT01193868|320519|P1|STARTED|Overall Study||6
132775|NCT01193686|320533|P2|NOT COMPLETED|Overall Study||1
132776|NCT01193686|320534|P1|NOT COMPLETED|Overall Study||7
132777|NCT01193686|320533|P2|COMPLETED|Overall Study||8
132778|NCT01193686|320534|P1|COMPLETED|Overall Study||8
132779|NCT01193686|320533|P2|Completed Visits and Final Assessment|Overall Study||8
132780|NCT01193686|320534|P1|Completed Visits and Final Assessment|Overall Study||8
132781|NCT01193686|320533|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
132782|NCT01193686|320534|P1|Completed Mentor Training|Overall Study||9
132783|NCT01193686|320533|P2|Completed Baseline Assessment|Overall Study||9
132784|NCT01193686|320534|P1|Completed Baseline Assessment|Overall Study||15
132785|NCT01193686|320533|P2|STARTED|Overall Study||9
132786|NCT01193686|320534|P1|STARTED|Overall Study||15
132787|NCT01193660|320551|P3|NOT COMPLETED|Overall Study||2
132788|NCT01193660|320552|P2|NOT COMPLETED|Overall Study||3
132789|NCT01193660|320553|P1|NOT COMPLETED|Overall Study||4
132790|NCT01193660|320551|P3|COMPLETED|Overall Study||32
132791|NCT01193660|320552|P2|COMPLETED|Overall Study||33
132792|NCT01193660|320553|P1|COMPLETED|Overall Study||31
132793|NCT01193660|320551|P3|STARTED|Overall Study||34
132794|NCT01193660|320552|P2|STARTED|Overall Study||36
132795|NCT01193660|320553|P1|STARTED|Overall Study||35
132796|NCT01193608|320597|P6|NOT COMPLETED|Overall Study||2
132797|NCT01193608|320598|P5|NOT COMPLETED|Overall Study||5
132798|NCT01193608|320599|P4|NOT COMPLETED|Overall Study||3
132799|NCT01193608|320600|P3|NOT COMPLETED|Overall Study||2
132800|NCT01193608|320601|P2|NOT COMPLETED|Overall Study||2
132801|NCT01193608|320602|P1|NOT COMPLETED|Overall Study||0
132802|NCT01193608|320597|P6|COMPLETED|Overall Study||17
132803|NCT01193608|320598|P5|COMPLETED|Overall Study||19
132804|NCT01193608|320599|P4|COMPLETED|Overall Study||14
132805|NCT01193608|320600|P3|COMPLETED|Overall Study||14
132806|NCT01193608|320601|P2|COMPLETED|Overall Study||4
132807|NCT01193608|320602|P1|COMPLETED|Overall Study||6
132808|NCT01193608|320597|P6|STARTED|Overall Study||19
132809|NCT01193608|320598|P5|STARTED|Overall Study||24
132810|NCT01193608|320599|P4|STARTED|Overall Study||17
132811|NCT01193608|320600|P3|STARTED|Overall Study||16
132812|NCT01193608|320601|P2|STARTED|Overall Study||6
132813|NCT01193608|320602|P1|STARTED|Overall Study||6
132814|NCT01193582|320839|P4|NOT COMPLETED|12 Month Follow-up||11
132815|NCT01193582|320840|P3|NOT COMPLETED|12 Month Follow-up||4
132816|NCT01193582|320841|P2|NOT COMPLETED|12 Month Follow-up||0
132817|NCT01193582|320842|P1|NOT COMPLETED|12 Month Follow-up||6
132818|NCT01193582|320839|P4|COMPLETED|12 Month Follow-up||166
132819|NCT01193582|320840|P3|COMPLETED|12 Month Follow-up||113
132820|NCT01193582|320841|P2|COMPLETED|12 Month Follow-up||88
132821|NCT01193582|320842|P1|COMPLETED|12 Month Follow-up||83
132822|NCT01193582|320839|P4|STARTED|12 Month Follow-up||177
132823|NCT01193582|320840|P3|STARTED|12 Month Follow-up||117
132824|NCT01193582|320841|P2|STARTED|12 Month Follow-up||88
132825|NCT01193582|320842|P1|STARTED|12 Month Follow-up||89
132826|NCT01193582|320839|P4|NOT COMPLETED|Vaccination Series||3
132827|NCT01193582|320840|P3|NOT COMPLETED|Vaccination Series||8
132828|NCT01193582|320841|P2|NOT COMPLETED|Vaccination Series||13
132829|NCT01193582|320842|P1|NOT COMPLETED|Vaccination Series||11
132830|NCT01193582|320839|P4|COMPLETED|Vaccination Series||177
132831|NCT01193582|320840|P3|COMPLETED|Vaccination Series||117
132832|NCT01193582|320841|P2|COMPLETED|Vaccination Series||88
132833|NCT01193582|320842|P1|COMPLETED|Vaccination Series||89
132834|NCT01193582|320839|P4|Vaccinated Dose 4|Vaccination Series||0
132835|NCT01193582|320840|P3|Vaccinated Dose 4|Vaccination Series||0
132836|NCT01193582|320841|P2|Vaccinated Dose 4|Vaccination Series||0
132837|NCT01193582|320842|P1|Vaccinated Dose 4|Vaccination Series||90
132838|NCT01193582|320839|P4|Vaccinated Dose 3|Vaccination Series||0
132839|NCT01193582|320840|P3|Vaccinated Dose 3|Vaccination Series||0
132840|NCT01193582|320841|P2|Vaccinated Dose 3|Vaccination Series||89
132841|NCT01193582|320842|P1|Vaccinated Dose 3|Vaccination Series||90
132842|NCT01193582|320839|P4|Vaccinated Dose 2|Vaccination Series||0
132843|NCT01193582|320840|P3|Vaccinated Dose 2|Vaccination Series||118
132844|NCT01193582|320841|P2|Vaccinated Dose 2|Vaccination Series||91
132845|NCT01193582|320842|P1|Vaccinated Dose 2|Vaccination Series||92
132846|NCT01193582|320839|P4|Vaccinated Dose 1|Vaccination Series||180
132847|NCT01193582|320840|P3|Vaccinated Dose 1|Vaccination Series||125
132848|NCT01193582|320841|P2|Vaccinated Dose 1|Vaccination Series||100
132849|NCT01193582|320842|P1|Vaccinated Dose 1|Vaccination Series||100
132850|NCT01193582|320839|P4|STARTED|Vaccination Series||180
132851|NCT01193582|320840|P3|STARTED|Vaccination Series||125
132852|NCT01193582|320841|P2|STARTED|Vaccination Series||101
132853|NCT01193582|320842|P1|STARTED|Vaccination Series||100
132854|NCT01193556|320872|P2|NOT COMPLETED|Overall Study||25
132855|NCT01193556|320873|P1|NOT COMPLETED|Overall Study||26
132856|NCT01193556|320872|P2|COMPLETED|Overall Study||0
132857|NCT01193556|320873|P1|COMPLETED|Overall Study||0
132858|NCT01193556|320872|P2|STARTED|Overall Study||25
132859|NCT01193556|320873|P1|STARTED|Overall Study||26
132860|NCT01193348|320881|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
132861|NCT01193348|320881|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
132862|NCT01193348|320881|P1|STARTED|Post Treatment Period (Patients Who Disc||10
132863|NCT01193348|320881|P1|NOT COMPLETED|Extension Treatment Period||1
132864|NCT01193348|320881|P1|COMPLETED|Extension Treatment Period||16
132865|NCT01193348|320881|P1|STARTED|Extension Treatment Period||17
132866|NCT01193348|320881|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
132867|NCT01193348|320881|P1|COMPLETED|Treatment Period (26 Weeks)||19
132868|NCT01193348|320881|P1|STARTED|Treatment Period (26 Weeks)||22
132869|NCT01193348|320881|P1|NOT COMPLETED|Screening Period||5
132870|NCT01193348|320881|P1|COMPLETED|Screening Period||22
132871|NCT01193348|320881|P1|STARTED|Screening Period||27
132872|NCT01193335|320901|P2|NOT COMPLETED|2-Year Follow-up||8
132873|NCT01193335|320902|P1|NOT COMPLETED|2-Year Follow-up||7
132874|NCT01193335|320901|P2|COMPLETED|2-Year Follow-up||80
132875|NCT01193335|320902|P1|COMPLETED|2-Year Follow-up||81
132876|NCT01193335|320901|P2|STARTED|2-Year Follow-up||88
132877|NCT01193335|320902|P1|STARTED|2-Year Follow-up||88
132878|NCT01193335|320901|P2|NOT COMPLETED|1-Year Follow-up||9
132879|NCT01193335|320902|P1|NOT COMPLETED|1-Year Follow-up||11
132880|NCT01193335|320901|P2|COMPLETED|1-Year Follow-up||88
132881|NCT01193335|320902|P1|COMPLETED|1-Year Follow-up||88
132882|NCT01193335|320901|P2|STARTED|1-Year Follow-up||97
132883|NCT01193335|320902|P1|STARTED|1-Year Follow-up||99
132884|NCT01193335|320901|P2|NOT COMPLETED|Toddler Dose||0
132885|NCT01193335|320902|P1|NOT COMPLETED|Toddler Dose||0
132886|NCT01193335|320901|P2|COMPLETED|Toddler Dose||97
132887|NCT01193335|320902|P1|COMPLETED|Toddler Dose||99
132888|NCT01193335|320901|P2|STARTED|Toddler Dose||97
132889|NCT01193335|320902|P1|STARTED|Toddler Dose||99
132890|NCT01193335|320901|P2|NOT COMPLETED|After Infant Series||3
132891|NCT01193335|320902|P1|NOT COMPLETED|After Infant Series||1
132892|NCT01193335|320901|P2|COMPLETED|After Infant Series||97
132893|NCT01193335|320902|P1|COMPLETED|After Infant Series||99
132894|NCT01193335|320901|P2|STARTED|After Infant Series||100
132895|NCT01193335|320902|P1|STARTED|After Infant Series||100
132896|NCT01193335|320901|P2|NOT COMPLETED|Infant Series||0
132897|NCT01193335|320902|P1|NOT COMPLETED|Infant Series||0
132898|NCT01193335|320901|P2|COMPLETED|Infant Series||100
132899|NCT01193335|320902|P1|COMPLETED|Infant Series||100
132900|NCT01193335|320901|P2|STARTED|Infant Series||100
132901|NCT01193335|320902|P1|STARTED|Infant Series||100
132902|NCT01193283|320997|P1|NOT COMPLETED|Overall Study||1
132903|NCT01193283|320997|P1|COMPLETED|Overall Study||21
132904|NCT01193283|320997|P1|STARTED|Overall Study||22
132905|NCT01193244|321003|P2|NOT COMPLETED|Overall Study||390
132906|NCT01193244|321004|P1|NOT COMPLETED|Overall Study||388
132907|NCT01193244|321003|P2|COMPLETED|Overall Study||391
132908|NCT01193244|321004|P1|COMPLETED|Overall Study||391
132909|NCT01193244|321003|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
132910|NCT01193244|321004|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
132911|NCT01193244|321003|P2|STARTED|Overall Study||781
132912|NCT01193244|321004|P1|STARTED|Overall Study||779
132913|NCT01193218|321059|P8|NOT COMPLETED|12-52 Weeks||4
132914|NCT01193218|321060|P7|NOT COMPLETED|12-52 Weeks||3
132915|NCT01193218|321061|P6|NOT COMPLETED|12-52 Weeks||5
132916|NCT01193218|321062|P5|NOT COMPLETED|12-52 Weeks||4
132917|NCT01193218|321063|P4|NOT COMPLETED|12-52 Weeks||3
132918|NCT01193218|321064|P3|NOT COMPLETED|12-52 Weeks||4
132919|NCT01193218|321065|P2|NOT COMPLETED|12-52 Weeks||0
132920|NCT01193218|321066|P1|NOT COMPLETED|12-52 Weeks||5
132921|NCT01193218|321059|P8|COMPLETED|12-52 Weeks||49
132922|NCT01193218|321060|P7|COMPLETED|12-52 Weeks||51
132923|NCT01193218|321061|P6|COMPLETED|12-52 Weeks||101
132924|NCT01193218|321062|P5|COMPLETED|12-52 Weeks||104
132925|NCT01193218|321063|P4|COMPLETED|12-52 Weeks||50
132926|NCT01193218|321064|P3|COMPLETED|12-52 Weeks||50
132927|NCT01193218|321065|P2|COMPLETED|12-52 Weeks||50
132928|NCT01193218|321066|P1|COMPLETED|12-52 Weeks||45
132929|NCT01193218|321059|P8|STARTED|12-52 Weeks||53
132930|NCT01193218|321060|P7|STARTED|12-52 Weeks||54
132931|NCT01193218|321061|P6|STARTED|12-52 Weeks||106
132932|NCT01193218|321062|P5|STARTED|12-52 Weeks||108
132933|NCT01193218|321063|P4|STARTED|12-52 Weeks||53
132934|NCT01193218|321064|P3|STARTED|12-52 Weeks||54
132935|NCT01193218|321065|P2|STARTED|12-52 Weeks||50
132936|NCT01193218|321066|P1|STARTED|12-52 Weeks||50
132937|NCT01193218|321059|P8|NOT COMPLETED|0-12 Weeks||0
132938|NCT01193218|321060|P7|NOT COMPLETED|0-12 Weeks||3
132939|NCT01193218|321061|P6|NOT COMPLETED|0-12 Weeks||3
132940|NCT01193218|321062|P5|NOT COMPLETED|0-12 Weeks||1
132941|NCT01193218|321063|P4|NOT COMPLETED|0-12 Weeks||0
132942|NCT01193218|321064|P3|NOT COMPLETED|0-12 Weeks||3
132943|NCT01193218|321065|P2|NOT COMPLETED|0-12 Weeks||0
132944|NCT01193218|321066|P1|NOT COMPLETED|0-12 Weeks||9
132945|NCT01193218|321059|P8|COMPLETED|0-12 Weeks||0
132946|NCT01193218|321060|P7|COMPLETED|0-12 Weeks||107
132947|NCT01193218|321061|P6|COMPLETED|0-12 Weeks||106
132948|NCT01193218|321062|P5|COMPLETED|0-12 Weeks||108
132949|NCT01193218|321063|P4|COMPLETED|0-12 Weeks||0
132950|NCT01193218|321064|P3|COMPLETED|0-12 Weeks||107
132951|NCT01193218|321065|P2|COMPLETED|0-12 Weeks||0
132952|NCT01193218|321066|P1|COMPLETED|0-12 Weeks||100
132953|NCT01193218|321059|P8|STARTED|0-12 Weeks|It is actually N/A|0
132954|NCT01193218|321060|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
132955|NCT01193218|321061|P6|STARTED|0-12 Weeks||109
132956|NCT01193218|321062|P5|STARTED|0-12 Weeks||109
132957|NCT01193218|321063|P4|STARTED|0-12 Weeks|It is actually N/A|0
132958|NCT01193218|321064|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
132959|NCT01193218|321065|P2|STARTED|0-12 Weeks|It is actually N/A|0
132960|NCT01193218|321066|P1|STARTED|0-12 Weeks|It is actually placebo group|109
132961|NCT01193153|321097|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
132962|NCT01193153|321098|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
132963|NCT01193153|321097|P2|COMPLETED|Double Blind Relapse Prevention Period||65
132964|NCT01193153|321098|P1|COMPLETED|Double Blind Relapse Prevention Period||100
132965|NCT01193153|321097|P2|STARTED|Double Blind Relapse Prevention Period||170
132966|NCT01193153|321098|P1|STARTED|Double Blind Relapse Prevention Period||164
132967|NCT01193153|321097|P2|NOT COMPLETED|Open-label Stabilization Period||0
132968|NCT01193153|321098|P1|NOT COMPLETED|Open-label Stabilization Period||98
132969|NCT01193153|321097|P2|COMPLETED|Open-label Stabilization Period||0
132970|NCT01193153|321098|P1|COMPLETED|Open-label Stabilization Period||334
132971|NCT01193153|321097|P2|STARTED|Open-label Stabilization Period||0
132972|NCT01193153|321098|P1|STARTED|Open-label Stabilization Period||432
132973|NCT01193153|321097|P2|NOT COMPLETED|Open-label Lead in Period||0
132974|NCT01193153|321098|P1|NOT COMPLETED|Open-label Lead in Period||235
132975|NCT01193153|321097|P2|COMPLETED|Open-label Lead in Period||0
132976|NCT01193153|321098|P1|COMPLETED|Open-label Lead in Period||432
132977|NCT01193153|321097|P2|STARTED|Open-label Lead in Period||0
132978|NCT01193153|321098|P1|STARTED|Open-label Lead in Period||667
132979|NCT01193127|321133|P4|NOT COMPLETED|Treated||1
132980|NCT01193127|321134|P3|NOT COMPLETED|Treated||0
132981|NCT01193127|321135|P2|NOT COMPLETED|Treated||0
132982|NCT01193127|321136|P1|NOT COMPLETED|Treated||0
132983|NCT01193127|321133|P4|COMPLETED|Treated||55
132984|NCT01193127|321134|P3|COMPLETED|Treated||55
132985|NCT01193127|321135|P2|COMPLETED|Treated||54
132986|NCT01193127|321136|P1|COMPLETED|Treated||57
132987|NCT01193127|321133|P4|STARTED|Treated||56
132988|NCT01193127|321134|P3|STARTED|Treated||55
132989|NCT01193127|321135|P2|STARTED|Treated||54
132990|NCT01193127|321136|P1|STARTED|Treated||57
132991|NCT01193127|321133|P4|NOT COMPLETED|Randomized||1
132992|NCT01193127|321134|P3|NOT COMPLETED|Randomized||0
132993|NCT01193127|321135|P2|NOT COMPLETED|Randomized||0
132994|NCT01193127|321136|P1|NOT COMPLETED|Randomized||0
132995|NCT01193127|321133|P4|COMPLETED|Randomized||56
132996|NCT01193127|321134|P3|COMPLETED|Randomized||55
132997|NCT01193127|321135|P2|COMPLETED|Randomized||54
132998|NCT01193127|321136|P1|COMPLETED|Randomized||57
132999|NCT01193127|321133|P4|STARTED|Randomized||57
133000|NCT01193127|321134|P3|STARTED|Randomized||55
133001|NCT01193127|321135|P2|STARTED|Randomized||54
133002|NCT01193127|321136|P1|STARTED|Randomized||57
133003|NCT01193114|321440|P2|NOT COMPLETED|Overall Study||0
133004|NCT01193114|321441|P1|NOT COMPLETED|Overall Study||0
133005|NCT01193114|321440|P2|COMPLETED|Overall Study||30
133006|NCT01193114|321441|P1|COMPLETED|Overall Study||30
133007|NCT01193114|321440|P2|STARTED|Overall Study||30
133008|NCT01193114|321441|P1|STARTED|Overall Study||30
133009|NCT01193101|321461|P4|NOT COMPLETED|Overall Study||12
133010|NCT01193101|321462|P3|NOT COMPLETED|Overall Study||3
133011|NCT01193101|321463|P2|NOT COMPLETED|Overall Study||7
133012|NCT01193101|321464|P1|NOT COMPLETED|Overall Study||5
133013|NCT01193101|321461|P4|COMPLETED|Overall Study||80
133014|NCT01193101|321462|P3|COMPLETED|Overall Study||93
133015|NCT01193101|321463|P2|COMPLETED|Overall Study||94
133016|NCT01193101|321464|P1|COMPLETED|Overall Study||95
133017|NCT01193101|321461|P4|Placebo Withdrawal Set|Overall Study||80
133018|NCT01193101|321462|P3|Placebo Withdrawal Set|Overall Study||93
133019|NCT01193101|321463|P2|Placebo Withdrawal Set|Overall Study||94
133020|NCT01193101|321464|P1|Placebo Withdrawal Set|Overall Study||95
133021|NCT01193101|321461|P4|Full Analysis Set|Overall Study||92
133022|NCT01193101|321462|P3|Full Analysis Set|Overall Study||96
133023|NCT01193101|321463|P2|Full Analysis Set|Overall Study||101
133024|NCT01193101|321464|P1|Full Analysis Set|Overall Study||100
133025|NCT01193101|321461|P4|STARTED|Overall Study||92
133026|NCT01193101|321462|P3|STARTED|Overall Study||96
133027|NCT01193101|321463|P2|STARTED|Overall Study||101
133028|NCT01193101|321464|P1|STARTED|Overall Study||100
133029|NCT01193049|321520|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
133030|NCT01193049|321521|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
133031|NCT01193049|321520|P2|COMPLETED|Period 3 : Double Blind Crossover||6
133032|NCT01193049|321521|P1|COMPLETED|Period 3 : Double Blind Crossover||5
133033|NCT01193049|321520|P2|STARTED|Period 3 : Double Blind Crossover||6
133034|NCT01193049|321521|P1|STARTED|Period 3 : Double Blind Crossover||5
133035|NCT01193049|321520|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
133036|NCT01193049|321521|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
133037|NCT01193049|321520|P2|COMPLETED|Washout 2 : 21 Day Washout||6
133038|NCT01193049|321521|P1|COMPLETED|Washout 2 : 21 Day Washout||5
133039|NCT01193049|321520|P2|STARTED|Washout 2 : 21 Day Washout||6
133040|NCT01193049|321521|P1|STARTED|Washout 2 : 21 Day Washout||5
133041|NCT01193049|321520|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
133042|NCT01193049|321521|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
133043|NCT01193049|321520|P2|COMPLETED|Period 2 : Double Blind Crossover||6
133044|NCT01193049|321521|P1|COMPLETED|Period 2 : Double Blind Crossover||5
133045|NCT01193049|321520|P2|STARTED|Period 2 : Double Blind Crossover||6
133046|NCT01193049|321521|P1|STARTED|Period 2 : Double Blind Crossover||5
133047|NCT01193049|321520|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
133048|NCT01193049|321521|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
133049|NCT01193049|321520|P2|COMPLETED|Washout 1 : 21 Day Washout||6
133050|NCT01193049|321521|P1|COMPLETED|Washout 1 : 21 Day Washout||5
133051|NCT01193049|321520|P2|STARTED|Washout 1 : 21 Day Washout||6
133052|NCT01193049|321521|P1|STARTED|Washout 1 : 21 Day Washout||5
133053|NCT01193049|321520|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
133054|NCT01193049|321521|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
133055|NCT01193049|321520|P2|COMPLETED|Period 1: Placebo Run-In||6
133056|NCT01193049|321521|P1|COMPLETED|Period 1: Placebo Run-In||5
133057|NCT01193049|321520|P2|STARTED|Period 1: Placebo Run-In||6
133058|NCT01193049|321521|P1|STARTED|Period 1: Placebo Run-In||5
133059|NCT01192776|321555|P4|NOT COMPLETED|Overall Study||20
133060|NCT01192776|321556|P3|NOT COMPLETED|Overall Study||21
133061|NCT01192776|321557|P2|NOT COMPLETED|Overall Study||21
133062|NCT01192776|321558|P1|NOT COMPLETED|Overall Study||11
133063|NCT01192776|321555|P4|COMPLETED|Overall Study||63
133064|NCT01192776|321556|P3|COMPLETED|Overall Study||75
133065|NCT01192776|321557|P2|COMPLETED|Overall Study||69
133066|NCT01192776|321558|P1|COMPLETED|Overall Study||84
133067|NCT01192776|321555|P4|Died After Discharge|Overall Study||1
133068|NCT01192776|321556|P3|Died After Discharge|Overall Study||3
133069|NCT01192776|321557|P2|Died After Discharge|Overall Study||2
133070|NCT01192776|321558|P1|Died After Discharge|Overall Study||1
133071|NCT01192776|321555|P4|Died Prior to Discharge|Overall Study||14
133072|NCT01192776|321556|P3|Died Prior to Discharge|Overall Study||15
133073|NCT01192776|321557|P2|Died Prior to Discharge|Overall Study||13
133074|NCT01192776|321558|P1|Died Prior to Discharge|Overall Study||7
133075|NCT01192776|321555|P4|STARTED|Overall Study||83
133076|NCT01192776|321556|P3|STARTED|Overall Study||96
133077|NCT01192776|321557|P2|STARTED|Overall Study||90
133078|NCT01192776|321558|P1|STARTED|Overall Study||95
133079|NCT01192698|321610|P2|NOT COMPLETED|Overall Study||0
133080|NCT01192698|321611|P1|NOT COMPLETED|Overall Study||0
133081|NCT01192698|321610|P2|COMPLETED|Overall Study||5
133082|NCT01192698|321611|P1|COMPLETED|Overall Study||10
133083|NCT01192698|321610|P2|STARTED|Overall Study||5
133084|NCT01192698|321611|P1|STARTED|Overall Study||10
133085|NCT01192542|321617|P2|NOT COMPLETED|Period 2||0
133086|NCT01192542|321618|P1|NOT COMPLETED|Period 2||0
133087|NCT01192542|321617|P2|COMPLETED|Period 2||20
133088|NCT01192542|321618|P1|COMPLETED|Period 2||18
133089|NCT01192542|321617|P2|STARTED|Period 2||20
133090|NCT01192542|321618|P1|STARTED|Period 2||18
133091|NCT01192542|321617|P2|NOT COMPLETED|Period 1||0
133092|NCT01192542|321618|P1|NOT COMPLETED|Period 1||0
133093|NCT01192542|321617|P2|COMPLETED|Period 1||20
133094|NCT01192542|321618|P1|COMPLETED|Period 1||18
133095|NCT01192542|321617|P2|STARTED|Period 1||20
133096|NCT01192542|321618|P1|STARTED|Period 1||18
133097|NCT01192516|321632|P3|NOT COMPLETED|Overall Study||8
133098|NCT01192516|321633|P2|NOT COMPLETED|Overall Study||17
133099|NCT01192516|321634|P1|NOT COMPLETED|Overall Study||20
133100|NCT01192516|321632|P3|COMPLETED|Overall Study||55
133101|NCT01192516|321633|P2|COMPLETED|Overall Study||49
133102|NCT01192516|321634|P1|COMPLETED|Overall Study||46
133103|NCT01192516|321632|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
133104|NCT01192516|321633|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
133105|NCT01192516|321634|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
133106|NCT01192412|321668|P2|NOT COMPLETED|Overall Study||2
133107|NCT01192412|321669|P1|NOT COMPLETED|Overall Study||4
133108|NCT01192412|321668|P2|COMPLETED|Overall Study||488
133109|NCT01192412|321669|P1|COMPLETED|Overall Study||493
133110|NCT01192412|321668|P2|STARTED|Overall Study||490
133111|NCT01192412|321669|P1|STARTED|Overall Study||497
133112|NCT01192399|321677|P1|NOT COMPLETED|Overall Study||2
133113|NCT01192399|321677|P1|COMPLETED|Overall Study||27
133114|NCT01192399|321677|P1|STARTED|Overall Study||29
133115|NCT01192347|321687|P1|NOT COMPLETED|Overall Study||12
133116|NCT01192347|321687|P1|COMPLETED|Overall Study||163
133117|NCT01192347|321687|P1|STARTED|Overall Study||175
133118|NCT01192295|321710|P2|NOT COMPLETED|Overall Study||23
133119|NCT01192295|321711|P1|NOT COMPLETED|Overall Study||10
133120|NCT01192295|321710|P2|COMPLETED|Overall Study||105
133121|NCT01192295|321711|P1|COMPLETED|Overall Study||17
133122|NCT01192295|321710|P2|STARTED|Overall Study||128
133123|NCT01192295|321711|P1|STARTED|Overall Study||27
133124|NCT01192282|321728|P1|NOT COMPLETED|Overall Study||0
133125|NCT01192282|321728|P1|COMPLETED|Overall Study||156
133126|NCT01192282|321728|P1|STARTED|Overall Study||156
133127|NCT01192204|321745|P2|NOT COMPLETED|Overall Study||0
133128|NCT01192204|321746|P1|NOT COMPLETED|Overall Study||1
133129|NCT01192204|321745|P2|COMPLETED|Overall Study||18
133130|NCT01192204|321746|P1|COMPLETED|Overall Study||22
133131|NCT01192204|321745|P2|STARTED|Overall Study||18
133132|NCT01192204|321746|P1|STARTED|Overall Study||23
133133|NCT01192191|321758|P2|NOT COMPLETED|Overall Study||21
133134|NCT01192191|321759|P1|NOT COMPLETED|Overall Study||11
133135|NCT01192191|321758|P2|COMPLETED|Overall Study||106
133136|NCT01192191|321759|P1|COMPLETED|Overall Study||49
133137|NCT01192191|321758|P2|STARTED|Overall Study||127
133138|NCT01192191|321759|P1|STARTED|Overall Study||60
133139|NCT01192178|321785|P2|NOT COMPLETED|Overall Study||23
133140|NCT01192178|321786|P1|NOT COMPLETED|Overall Study||24
133141|NCT01192178|321785|P2|COMPLETED|Overall Study||145
133142|NCT01192178|321786|P1|COMPLETED|Overall Study||147
133143|NCT01192178|321785|P2|STARTED|Overall Study||168
133144|NCT01192178|321786|P1|STARTED|Overall Study||171
133145|NCT01192152|321806|P2|NOT COMPLETED|Period 3||0
133146|NCT01192152|321807|P1|NOT COMPLETED|Period 3||1
133147|NCT01192152|321806|P2|COMPLETED|Period 3||0
133148|NCT01192152|321807|P1|COMPLETED|Period 3||14
133149|NCT01192152|321806|P2|STARTED|Period 3||0
133150|NCT01192152|321807|P1|STARTED|Period 3||15
133151|NCT01192152|321806|P2|NOT COMPLETED|Period 2||0
133152|NCT01192152|321807|P1|NOT COMPLETED|Period 2||0
133153|NCT01192152|321806|P2|COMPLETED|Period 2||14
133154|NCT01192152|321807|P1|COMPLETED|Period 2||15
133155|NCT01192152|321806|P2|STARTED|Period 2||14
133156|NCT01192152|321807|P1|STARTED|Period 2||15
133157|NCT01192152|321806|P2|NOT COMPLETED|Period 1||1
133158|NCT01192152|321807|P1|NOT COMPLETED|Period 1||0
133159|NCT01192152|321806|P2|COMPLETED|Period 1||14
133160|NCT01192152|321807|P1|COMPLETED|Period 1||15
133161|NCT01192152|321806|P2|STARTED|Period 1||15
133162|NCT01192152|321807|P1|STARTED|Period 1||15
133163|NCT01192139|321908|P6|NOT COMPLETED|Period 3||0
133164|NCT01192139|321909|P5|NOT COMPLETED|Period 3||0
133165|NCT01192139|321910|P4|NOT COMPLETED|Period 3||0
133166|NCT01192139|321911|P3|NOT COMPLETED|Period 3||0
133167|NCT01192139|321912|P2|NOT COMPLETED|Period 3||0
133168|NCT01192139|321913|P1|NOT COMPLETED|Period 3||0
133169|NCT01192139|321908|P6|COMPLETED|Period 3||5
133170|NCT01192139|321909|P5|COMPLETED|Period 3||5
133171|NCT01192139|321910|P4|COMPLETED|Period 3||5
133172|NCT01192139|321911|P3|COMPLETED|Period 3||5
133173|NCT01192139|321912|P2|COMPLETED|Period 3||5
133174|NCT01192139|321913|P1|COMPLETED|Period 3||5
133175|NCT01192139|321908|P6|STARTED|Period 3||5
133176|NCT01192139|321909|P5|STARTED|Period 3||5
133177|NCT01192139|321910|P4|STARTED|Period 3||5
133178|NCT01192139|321911|P3|STARTED|Period 3||5
133179|NCT01192139|321912|P2|STARTED|Period 3||5
133180|NCT01192139|321913|P1|STARTED|Period 3||5
133181|NCT01192139|321908|P6|NOT COMPLETED|Period 2||0
133182|NCT01192139|321909|P5|NOT COMPLETED|Period 2||0
133183|NCT01192139|321910|P4|NOT COMPLETED|Period 2||0
133184|NCT01192139|321911|P3|NOT COMPLETED|Period 2||0
133185|NCT01192139|321912|P2|NOT COMPLETED|Period 2||0
133186|NCT01192139|321913|P1|NOT COMPLETED|Period 2||0
133187|NCT01192139|321908|P6|COMPLETED|Period 2||5
133188|NCT01192139|321909|P5|COMPLETED|Period 2||5
133189|NCT01192139|321910|P4|COMPLETED|Period 2||5
133190|NCT01192139|321911|P3|COMPLETED|Period 2||5
133191|NCT01192139|321912|P2|COMPLETED|Period 2||5
133192|NCT01192139|321913|P1|COMPLETED|Period 2||5
133193|NCT01192139|321908|P6|STARTED|Period 2||5
133194|NCT01192139|321909|P5|STARTED|Period 2||5
133195|NCT01192139|321910|P4|STARTED|Period 2||5
133196|NCT01192139|321911|P3|STARTED|Period 2||5
133197|NCT01192139|321912|P2|STARTED|Period 2||5
133198|NCT01192139|321913|P1|STARTED|Period 2||5
133199|NCT01192139|321908|P6|NOT COMPLETED|Period 1||0
133200|NCT01192139|321909|P5|NOT COMPLETED|Period 1||0
133201|NCT01192139|321910|P4|NOT COMPLETED|Period 1||0
133202|NCT01192139|321911|P3|NOT COMPLETED|Period 1||0
133203|NCT01192139|321912|P2|NOT COMPLETED|Period 1||0
133204|NCT01192139|321913|P1|NOT COMPLETED|Period 1||0
133205|NCT01192139|321908|P6|COMPLETED|Period 1||5
133206|NCT01192139|321909|P5|COMPLETED|Period 1||5
133207|NCT01192139|321910|P4|COMPLETED|Period 1||5
133208|NCT01192139|321911|P3|COMPLETED|Period 1||5
133209|NCT01192139|321912|P2|COMPLETED|Period 1||5
133210|NCT01192139|321913|P1|COMPLETED|Period 1||5
133211|NCT01192139|321908|P6|STARTED|Period 1||5
133212|NCT01192139|321909|P5|STARTED|Period 1||5
133213|NCT01192139|321910|P4|STARTED|Period 1||5
133214|NCT01192139|321911|P3|STARTED|Period 1||5
133215|NCT01192139|321912|P2|STARTED|Period 1||5
133216|NCT01192139|321913|P1|STARTED|Period 1||5
133217|NCT01192126|321978|P2|NOT COMPLETED|Second Intervention (1 Week)||0
133218|NCT01192126|321979|P1|NOT COMPLETED|Second Intervention (1 Week)||0
133219|NCT01192126|321978|P2|COMPLETED|Second Intervention (1 Week)||50
133220|NCT01192126|321979|P1|COMPLETED|Second Intervention (1 Week)||49
133221|NCT01192126|321978|P2|STARTED|Second Intervention (1 Week)||50
133222|NCT01192126|321979|P1|STARTED|Second Intervention (1 Week)||49
133223|NCT01192126|321978|P2|NOT COMPLETED|First Intervention (1 Week)||1
133224|NCT01192126|321979|P1|NOT COMPLETED|First Intervention (1 Week)||2
133225|NCT01192126|321978|P2|COMPLETED|First Intervention (1 Week)||50
133226|NCT01192126|321979|P1|COMPLETED|First Intervention (1 Week)||49
133227|NCT01192126|321978|P2|STARTED|First Intervention (1 Week)||51
133228|NCT01192126|321979|P1|STARTED|First Intervention (1 Week)||51
133229|NCT01192022|321991|P5|NOT COMPLETED|Overall Study||1
133230|NCT01192022|321992|P4|NOT COMPLETED|Overall Study||2
133231|NCT01192022|321993|P3|NOT COMPLETED|Overall Study||1
133232|NCT01192022|321994|P2|NOT COMPLETED|Overall Study||11
133233|NCT01192022|321995|P1|NOT COMPLETED|Overall Study||13
133234|NCT01192022|321991|P5|COMPLETED|Overall Study||11
133235|NCT01192022|321992|P4|COMPLETED|Overall Study||7
133236|NCT01192022|321993|P3|COMPLETED|Overall Study||7
133237|NCT01192022|321994|P2|COMPLETED|Overall Study||99
133238|NCT01192022|321995|P1|COMPLETED|Overall Study||101
133239|NCT01192022|321991|P5|Safety Population-Received Treatment|Overall Study||12
133240|NCT01192022|321992|P4|Safety Population-Received Treatment|Overall Study||9
133241|NCT01192022|321993|P3|Safety Population-Received Treatment|Overall Study||8
133242|NCT01192022|321994|P2|Safety Population-Received Treatment|Overall Study||109
133243|NCT01192022|321995|P1|Safety Population-Received Treatment|Overall Study||114
133244|NCT01192022|321991|P5|STARTED|Overall Study||12
133245|NCT01192022|321992|P4|STARTED|Overall Study||9
133246|NCT01192022|321993|P3|STARTED|Overall Study||8
133247|NCT01192022|321994|P2|STARTED|Overall Study||110
133248|NCT01192022|321995|P1|STARTED|Overall Study||114
133249|NCT01191944|322018|P2|NOT COMPLETED|Overall Study||19
133250|NCT01191944|322019|P1|NOT COMPLETED|Overall Study||17
133251|NCT01191944|322018|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
133252|NCT01191944|322019|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
133253|NCT01191944|322018|P2|STARTED|Overall Study|Treated titration/maintenance|239
133254|NCT01191944|322019|P1|STARTED|Overall Study|Treated titration/maintenance|234
133255|NCT01191840|322065|P2|NOT COMPLETED|Overall Study||15
133256|NCT01191840|322066|P1|NOT COMPLETED|Overall Study||14
133257|NCT01191840|322065|P2|COMPLETED|Overall Study||240
133258|NCT01191840|322066|P1|COMPLETED|Overall Study||240
133259|NCT01191840|322065|P2|STARTED|Overall Study||255
133260|NCT01191840|322066|P1|STARTED|Overall Study||254
133261|NCT01191827|322082|P2|NOT COMPLETED|Overall Study||0
133262|NCT01191827|322083|P1|NOT COMPLETED|Overall Study||0
133263|NCT01191827|322082|P2|COMPLETED|Overall Study||20
133264|NCT01191827|322083|P1|COMPLETED|Overall Study||20
133265|NCT01191827|322082|P2|STARTED|Overall Study||20
133266|NCT01191827|322083|P1|STARTED|Overall Study||20
133267|NCT01191801|322091|P2|NOT COMPLETED|Overall Study||337
133268|NCT01191801|322092|P1|NOT COMPLETED|Overall Study||316
133269|NCT01191801|322091|P2|COMPLETED|Overall Study||18
133270|NCT01191801|322092|P1|COMPLETED|Overall Study||40
133271|NCT01191801|322091|P2|STARTED|Overall Study||355
133272|NCT01191801|322092|P1|STARTED|Overall Study||356
133273|NCT01191788|322112|P2|NOT COMPLETED|Overall Study||22
133274|NCT01191788|322113|P1|NOT COMPLETED|Overall Study||21
133275|NCT01191788|322112|P2|COMPLETED|Overall Study|Completed 3-month followup|137
133276|NCT01191788|322113|P1|COMPLETED|Overall Study|Completed 3-month followup|119
133277|NCT01191788|322112|P2|STARTED|Overall Study||159
133278|NCT01191788|322113|P1|STARTED|Overall Study||140
133279|NCT01191762|322123|P2|NOT COMPLETED|Overall Study||0
133280|NCT01191762|322124|P1|NOT COMPLETED|Overall Study||1
133281|NCT01191762|322123|P2|COMPLETED|Overall Study||15
133282|NCT01191762|322124|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
133283|NCT01191762|322123|P2|STARTED|Overall Study||15
133284|NCT01191762|322124|P1|STARTED|Overall Study||15
133285|NCT01191749|322130|P1|NOT COMPLETED|Overall Study||0
133286|NCT01191749|322130|P1|COMPLETED|Overall Study||7
133287|NCT01191749|322130|P1|STARTED|Overall Study||7
133288|NCT01191736|322141|P7|NOT COMPLETED|Overall Study||0
133289|NCT01191736|322142|P6|NOT COMPLETED|Overall Study||0
133290|NCT01191736|322143|P5|NOT COMPLETED|Overall Study||0
133291|NCT01191736|322144|P4|NOT COMPLETED|Overall Study||0
133292|NCT01191736|322145|P3|NOT COMPLETED|Overall Study||0
133293|NCT01191736|322146|P2|NOT COMPLETED|Overall Study||0
133294|NCT01191736|322147|P1|NOT COMPLETED|Overall Study||0
133295|NCT01191736|322141|P7|COMPLETED|Overall Study||45
133296|NCT01191736|322142|P6|COMPLETED|Overall Study||50
133297|NCT01191736|322143|P5|COMPLETED|Overall Study||48
133298|NCT01191736|322144|P4|COMPLETED|Overall Study||46
133299|NCT01191736|322145|P3|COMPLETED|Overall Study||49
133300|NCT01191736|322146|P2|COMPLETED|Overall Study||47
133301|NCT01191736|322147|P1|COMPLETED|Overall Study||51
133302|NCT01191736|322141|P7|STARTED|Overall Study||45
133303|NCT01191736|322142|P6|STARTED|Overall Study||50
133304|NCT01191736|322143|P5|STARTED|Overall Study||48
133305|NCT01191736|322144|P4|STARTED|Overall Study||46
133306|NCT01191736|322145|P3|STARTED|Overall Study||49
133307|NCT01191736|322146|P2|STARTED|Overall Study||47
133308|NCT01191736|322147|P1|STARTED|Overall Study||51
133309|NCT01191723|322170|P6|NOT COMPLETED|Overall Study||0
133310|NCT01191723|322171|P5|NOT COMPLETED|Overall Study||0
133311|NCT01191723|322172|P4|NOT COMPLETED|Overall Study||0
133312|NCT01191723|322173|P3|NOT COMPLETED|Overall Study||0
133313|NCT01191723|322174|P2|NOT COMPLETED|Overall Study||0
133314|NCT01191723|322175|P1|NOT COMPLETED|Overall Study||0
133315|NCT01191723|322170|P6|COMPLETED|Overall Study||9
133316|NCT01191723|322171|P5|COMPLETED|Overall Study||9
133317|NCT01191723|322172|P4|COMPLETED|Overall Study||9
133318|NCT01191723|322173|P3|COMPLETED|Overall Study||9
133319|NCT01191723|322174|P2|COMPLETED|Overall Study||9
133320|NCT01191723|322175|P1|COMPLETED|Overall Study||9
133321|NCT01191723|322170|P6|STARTED|Overall Study||9
133322|NCT01191723|322171|P5|STARTED|Overall Study||9
133323|NCT01191723|322172|P4|STARTED|Overall Study||9
133324|NCT01191723|322173|P3|STARTED|Overall Study||9
133325|NCT01191723|322174|P2|STARTED|Overall Study||9
133326|NCT01191723|322175|P1|STARTED|Overall Study||9
133327|NCT01191476|322196|P3|NOT COMPLETED|Overall Study||0
133328|NCT01191476|322197|P2|NOT COMPLETED|Overall Study||4
133329|NCT01191476|322198|P1|NOT COMPLETED|Overall Study||3
133330|NCT01191476|322196|P3|COMPLETED|Overall Study||111
133331|NCT01191476|322197|P2|COMPLETED|Overall Study||107
133332|NCT01191476|322198|P1|COMPLETED|Overall Study||109
133333|NCT01191476|322196|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
133334|NCT01191476|322197|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
133335|NCT01191476|322198|P1|STARTED|Overall Study||112
133336|NCT01191411|322221|P3|NOT COMPLETED|Overall Study||3427
133337|NCT01191411|322222|P2|NOT COMPLETED|Overall Study||361
133338|NCT01191411|322223|P1|NOT COMPLETED|Overall Study||945
133339|NCT01191411|322221|P3|COMPLETED|Overall Study||471
133340|NCT01191411|322222|P2|COMPLETED|Overall Study||118
133341|NCT01191411|322223|P1|COMPLETED|Overall Study||648
133342|NCT01191411|322221|P3|STARTED|Overall Study||3898
133343|NCT01191411|322222|P2|STARTED|Overall Study||479
133344|NCT01191411|322223|P1|STARTED|Overall Study||1593
133345|NCT01191398|322234|P3|NOT COMPLETED|Overall Study||0
133346|NCT01191398|322235|P2|NOT COMPLETED|Overall Study||0
133347|NCT01191398|322236|P1|NOT COMPLETED|Overall Study||0
133348|NCT01191398|322234|P3|COMPLETED|Overall Study||18
133349|NCT01191398|322235|P2|COMPLETED|Overall Study||17
133350|NCT01191398|322236|P1|COMPLETED|Overall Study||17
133351|NCT01191398|322234|P3|STARTED|Overall Study||18
133352|NCT01191398|322235|P2|STARTED|Overall Study||17
133353|NCT01191398|322236|P1|STARTED|Overall Study||17
133354|NCT01191333|322249|P2|NOT COMPLETED|Overall Study||18
133355|NCT01191333|322250|P1|NOT COMPLETED|Overall Study||21
133356|NCT01191333|322249|P2|COMPLETED|Overall Study||65
133357|NCT01191333|322250|P1|COMPLETED|Overall Study||60
133358|NCT01191333|322249|P2|STARTED|Overall Study||83
133359|NCT01191333|322250|P1|STARTED|Overall Study||81
133360|NCT01191320|322269|P3|NOT COMPLETED|Overall Study||7
133361|NCT01191320|322270|P2|NOT COMPLETED|Overall Study||6
133362|NCT01191320|322271|P1|NOT COMPLETED|Overall Study||7
133363|NCT01191320|322269|P3|COMPLETED|Overall Study||31
133364|NCT01191320|322270|P2|COMPLETED|Overall Study||32
133365|NCT01191320|322271|P1|COMPLETED|Overall Study||36
133366|NCT01191320|322269|P3|STARTED|Overall Study||38
133367|NCT01191320|322270|P2|STARTED|Overall Study||38
133368|NCT01191320|322271|P1|STARTED|Overall Study||43
133369|NCT01191268|322282|P3|NOT COMPLETED|Overall Study||52
133370|NCT01191268|322283|P2|NOT COMPLETED|Overall Study||55
133371|NCT01191268|322284|P1|NOT COMPLETED|Overall Study||58
133372|NCT01191268|322282|P3|COMPLETED|Overall Study||244
133373|NCT01191268|322283|P2|COMPLETED|Overall Study||238
133374|NCT01191268|322284|P1|COMPLETED|Overall Study||237
133375|NCT01191268|322282|P3|Received at Least One Dose of Study Drug|Overall Study||296
133376|NCT01191268|322283|P2|Received at Least One Dose of Study Drug|Overall Study||293
133377|NCT01191268|322284|P1|Received at Least One Dose of Study Drug|Overall Study||295
133378|NCT01191268|322282|P3|STARTED|Overall Study||296
133379|NCT01191268|322283|P2|STARTED|Overall Study||293
133380|NCT01191268|322284|P1|STARTED|Overall Study||295
133381|NCT01191255|322381|P4|NOT COMPLETED|Efficacy Assessment Period||6
133382|NCT01191255|322382|P3|NOT COMPLETED|Efficacy Assessment Period||26
133383|NCT01191255|322383|P2|NOT COMPLETED|Efficacy Assessment Period||0
133384|NCT01191255|322384|P1|NOT COMPLETED|Efficacy Assessment Period||0
133385|NCT01191255|322381|P4|COMPLETED|Efficacy Assessment Period||90
133386|NCT01191255|322382|P3|COMPLETED|Efficacy Assessment Period||70
133387|NCT01191255|322383|P2|COMPLETED|Efficacy Assessment Period||0
133388|NCT01191255|322384|P1|COMPLETED|Efficacy Assessment Period||0
133389|NCT01191255|322381|P4|STARTED|Efficacy Assessment Period||96
133390|NCT01191255|322382|P3|STARTED|Efficacy Assessment Period||96
133391|NCT01191255|322383|P2|STARTED|Efficacy Assessment Period||0
133392|NCT01191255|322384|P1|STARTED|Efficacy Assessment Period||0
133393|NCT01191255|322381|P4|NOT COMPLETED|Safety Assessment Period||0
133394|NCT01191255|322382|P3|NOT COMPLETED|Safety Assessment Period||0
133395|NCT01191255|322383|P2|NOT COMPLETED|Safety Assessment Period||99
133396|NCT01191255|322384|P1|NOT COMPLETED|Safety Assessment Period||38
133397|NCT01191255|322381|P4|COMPLETED|Safety Assessment Period||0
133398|NCT01191255|322382|P3|COMPLETED|Safety Assessment Period||0
133399|NCT01191255|322383|P2|COMPLETED|Safety Assessment Period||193
133400|NCT01191255|322384|P1|COMPLETED|Safety Assessment Period||111
133401|NCT01191255|322381|P4|Safety Population|Safety Assessment Period||0
133402|NCT01191255|322382|P3|Safety Population|Safety Assessment Period||0
133403|NCT01191255|322383|P2|Safety Population|Safety Assessment Period||289
133404|NCT01191255|322384|P1|Safety Population|Safety Assessment Period||149
133405|NCT01191255|322381|P4|STARTED|Safety Assessment Period||0
133406|NCT01191255|322382|P3|STARTED|Safety Assessment Period||0
133407|NCT01191255|322383|P2|STARTED|Safety Assessment Period||292
133408|NCT01191255|322384|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
133409|NCT01191242|322410|P1|NOT COMPLETED|Overall Study||0
133410|NCT01191242|322410|P1|COMPLETED|Overall Study||31
133411|NCT01191242|322410|P1|STARTED|Overall Study||31
133412|NCT01191190|322425|P1|NOT COMPLETED|Overall Study||1
133413|NCT01191190|322425|P1|COMPLETED|Overall Study||20
133414|NCT01191190|322425|P1|STARTED|Overall Study||21
133415|NCT01191086|322438|P1|NOT COMPLETED|Overall Study||62
133416|NCT01191086|322438|P1|COMPLETED|Overall Study||148
133417|NCT01191086|322438|P1|STARTED|Overall Study||210
133418|NCT01191008|322442|P1|NOT COMPLETED|Overall Study||15
133419|NCT01191008|322442|P1|COMPLETED|Overall Study||618
133420|NCT01191008|322442|P1|STARTED|Overall Study||633
133421|NCT01190891|322450|P2|NOT COMPLETED|Overall Study||0
133422|NCT01190891|322451|P1|NOT COMPLETED|Overall Study||6
133423|NCT01190891|322450|P2|COMPLETED|Overall Study||52
133424|NCT01190891|322451|P1|COMPLETED|Overall Study||46
133425|NCT01190891|322450|P2|STARTED|Overall Study||52
133426|NCT01190891|322451|P1|STARTED|Overall Study||52
133427|NCT01190878|322463|P4|NOT COMPLETED|Overall Study||20
133428|NCT01190878|322464|P3|NOT COMPLETED|Overall Study||5
133429|NCT01190878|322465|P2|NOT COMPLETED|Overall Study||3
133430|NCT01190878|322466|P1|NOT COMPLETED|Overall Study||3
133431|NCT01190878|322463|P4|COMPLETED|Overall Study||22
133432|NCT01190878|322464|P3|COMPLETED|Overall Study||37
133433|NCT01190878|322465|P2|COMPLETED|Overall Study||42
133434|NCT01190878|322466|P1|COMPLETED|Overall Study||37
133435|NCT01190878|322463|P4|STARTED|Overall Study||42
133436|NCT01190878|322464|P3|STARTED|Overall Study||42
133437|NCT01190878|322465|P2|STARTED|Overall Study||45
133438|NCT01190878|322466|P1|STARTED|Overall Study||40
133439|NCT01190865|322476|P1|NOT COMPLETED|Overall Study||3
133440|NCT01190865|322476|P1|COMPLETED|Overall Study||25
133441|NCT01190865|322476|P1|STARTED|Overall Study||28
133442|NCT01190839|322483|P2|NOT COMPLETED|Overall Study||147
133443|NCT01190839|322484|P1|NOT COMPLETED|Overall Study||150
133444|NCT01190839|322483|P2|COMPLETED|Overall Study||0
133445|NCT01190839|322484|P1|COMPLETED|Overall Study||0
133446|NCT01190839|322483|P2|Treated|Overall Study||143
133447|NCT01190839|322484|P1|Treated|Overall Study||148
133448|NCT01190839|322483|P2|STARTED|Overall Study||147
133449|NCT01190839|322484|P1|STARTED|Overall Study||150
133450|NCT01190813|322498|P2|NOT COMPLETED|Overall Study||4
133451|NCT01190813|322499|P1|NOT COMPLETED|Overall Study||4
133452|NCT01190813|322498|P2|COMPLETED|Overall Study||45
133453|NCT01190813|322499|P1|COMPLETED|Overall Study||86
133454|NCT01190813|322498|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
133455|NCT01190813|322499|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
133456|NCT01190813|322498|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
133457|NCT01190813|322499|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
133458|NCT01190813|322498|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
133459|NCT01190813|322499|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
133460|NCT01190813|322498|P2|16-week Visit|Overall Study|2 dropped|46
133461|NCT01190813|322499|P1|16-week Visit|Overall Study|1 dropped|87
133462|NCT01190813|322498|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
133463|NCT01190813|322499|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
133464|NCT01190813|322498|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
133465|NCT01190813|322499|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
133466|NCT01190813|322498|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
133467|NCT01190813|322499|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
133468|NCT01190813|322498|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
133469|NCT01190813|322499|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
133470|NCT01190813|322498|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
133471|NCT01190813|322499|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
133472|NCT01190813|322498|P2|STARTED|Overall Study||49
133473|NCT01190813|322499|P1|STARTED|Overall Study||90
133474|NCT01190566|322591|P2|NOT COMPLETED|Overall Study||0
133475|NCT01190566|322592|P1|NOT COMPLETED|Overall Study||0
133476|NCT01190566|322591|P2|COMPLETED|Overall Study||42
133477|NCT01190566|322592|P1|COMPLETED|Overall Study||6
133478|NCT01190566|322591|P2|STARTED|Overall Study||42
133479|NCT01190566|322592|P1|STARTED|Overall Study||6
133480|NCT01190527|322613|P1|NOT COMPLETED|Overall Study||0
133481|NCT01190527|322613|P1|COMPLETED|Overall Study||42
133482|NCT01190527|322613|P1|STARTED|Overall Study||42
133483|NCT01190514|322620|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
133484|NCT01190514|322621|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
133485|NCT01190514|322622|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
133486|NCT01190514|322623|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
133487|NCT01190514|322620|P4|COMPLETED|Fourth Intervention (Period 4)||10
133488|NCT01190514|322621|P3|COMPLETED|Fourth Intervention (Period 4)||10
133489|NCT01190514|322622|P2|COMPLETED|Fourth Intervention (Period 4)||10
133490|NCT01190514|322623|P1|COMPLETED|Fourth Intervention (Period 4)||9
133491|NCT01190514|322620|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
133492|NCT01190514|322621|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
133493|NCT01190514|322622|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
133494|NCT01190514|322623|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
133495|NCT01190514|322620|P4|NOT COMPLETED|Third Intervention (Period 3)||0
133496|NCT01190514|322621|P3|NOT COMPLETED|Third Intervention (Period 3)||0
133497|NCT01190514|322622|P2|NOT COMPLETED|Third Intervention (Period 3)||0
133498|NCT01190514|322623|P1|NOT COMPLETED|Third Intervention (Period 3)||1
133499|NCT01190514|322620|P4|COMPLETED|Third Intervention (Period 3)||10
133500|NCT01190514|322621|P3|COMPLETED|Third Intervention (Period 3)||10
133501|NCT01190514|322622|P2|COMPLETED|Third Intervention (Period 3)||10
133502|NCT01190514|322623|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
133503|NCT01190514|322620|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
133504|NCT01190514|322621|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
133505|NCT01190514|322622|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
133506|NCT01190514|322623|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
133507|NCT01190514|322620|P4|NOT COMPLETED|Second Intervention (Period 2)||0
133508|NCT01190514|322621|P3|NOT COMPLETED|Second Intervention (Period 2)||0
133509|NCT01190514|322622|P2|NOT COMPLETED|Second Intervention (Period 2)||0
133510|NCT01190514|322623|P1|NOT COMPLETED|Second Intervention (Period 2)||0
133511|NCT01190514|322620|P4|COMPLETED|Second Intervention (Period 2)||10
133512|NCT01190514|322621|P3|COMPLETED|Second Intervention (Period 2)||10
133513|NCT01190514|322622|P2|COMPLETED|Second Intervention (Period 2)||10
133514|NCT01190514|322623|P1|COMPLETED|Second Intervention (Period 2)||10
133515|NCT01190514|322620|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
133516|NCT01190514|322621|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
133517|NCT01190514|322622|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
133518|NCT01190514|322623|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
133519|NCT01190514|322620|P4|NOT COMPLETED|First Intervention (Period 1)||0
133520|NCT01190514|322621|P3|NOT COMPLETED|First Intervention (Period 1)||0
133521|NCT01190514|322622|P2|NOT COMPLETED|First Intervention (Period 1)||0
133522|NCT01190514|322623|P1|NOT COMPLETED|First Intervention (Period 1)||1
133523|NCT01190514|322620|P4|COMPLETED|First Intervention (Period 1)||10
133524|NCT01190514|322621|P3|COMPLETED|First Intervention (Period 1)||10
133525|NCT01190514|322622|P2|COMPLETED|First Intervention (Period 1)||10
133526|NCT01190514|322623|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
133527|NCT01190514|322620|P4|STARTED|First Intervention (Period 1)||10
133528|NCT01190514|322621|P3|STARTED|First Intervention (Period 1)||10
133529|NCT01190514|322622|P2|STARTED|First Intervention (Period 1)||10
133530|NCT01190514|322623|P1|STARTED|First Intervention (Period 1)||11
133531|NCT01190475|322656|P3|NOT COMPLETED|Overall Study||1
133532|NCT01190475|322657|P2|NOT COMPLETED|Overall Study||0
133533|NCT01190475|322658|P1|NOT COMPLETED|Overall Study||0
133534|NCT01190475|322656|P3|COMPLETED|Overall Study||1
133535|NCT01190475|322657|P2|COMPLETED|Overall Study||2
133536|NCT01190475|322658|P1|COMPLETED|Overall Study||2
133537|NCT01190475|322656|P3|STARTED|Overall Study||2
133538|NCT01190475|322657|P2|STARTED|Overall Study||2
133539|NCT01190475|322658|P1|STARTED|Overall Study||2
133540|NCT01190436|322666|P1|NOT COMPLETED|Overall Study||39
133541|NCT01190436|322666|P1|COMPLETED|Overall Study||86
133542|NCT01190436|322666|P1|STARTED|Overall Study||125
133543|NCT01190306|322682|P2|NOT COMPLETED|Overall Study||0
133544|NCT01190306|322683|P1|NOT COMPLETED|Overall Study||0
133545|NCT01190306|322682|P2|COMPLETED|Overall Study||66
133546|NCT01190306|322683|P1|COMPLETED|Overall Study||61
133547|NCT01190306|322682|P2|STARTED|Overall Study||66
133548|NCT01190306|322683|P1|STARTED|Overall Study||61
133549|NCT01190267|322691|P2|NOT COMPLETED|Overall Study||4
133550|NCT01190267|322692|P1|NOT COMPLETED|Overall Study||41
133551|NCT01190267|322691|P2|COMPLETED|Overall Study||4
133552|NCT01190267|322692|P1|COMPLETED|Overall Study||155
133553|NCT01190267|322691|P2|STARTED|Overall Study||8
133554|NCT01190267|322692|P1|STARTED|Overall Study||196
133555|NCT01190254|322703|P3|NOT COMPLETED|Overall Study||22
133556|NCT01190254|322704|P2|NOT COMPLETED|Overall Study||17
133557|NCT01190254|322705|P1|NOT COMPLETED|Overall Study||21
133558|NCT01190254|322703|P3|COMPLETED|Overall Study||84
133559|NCT01190254|322704|P2|COMPLETED|Overall Study||81
133560|NCT01190254|322705|P1|COMPLETED|Overall Study||81
133561|NCT01190254|322703|P3|Treated|Overall Study||106
133562|NCT01190254|322704|P2|Treated|Overall Study||98
133563|NCT01190254|322705|P1|Treated|Overall Study||102
133564|NCT01190254|322703|P3|STARTED|Overall Study||106
133565|NCT01190254|322704|P2|STARTED|Overall Study||98
133566|NCT01190254|322705|P1|STARTED|Overall Study||102
133567|NCT01190228|322770|P3|NOT COMPLETED|Overall Study||0
133568|NCT01190228|322771|P2|NOT COMPLETED|Overall Study||0
133569|NCT01190228|322772|P1|NOT COMPLETED|Overall Study||5
133570|NCT01190228|322770|P3|COMPLETED|Overall Study||59
133571|NCT01190228|322771|P2|COMPLETED|Overall Study||46
133572|NCT01190228|322772|P1|COMPLETED|Overall Study||344
133573|NCT01190228|322770|P3|STARTED|Overall Study||59
133574|NCT01190228|322771|P2|STARTED|Overall Study||46
133575|NCT01190228|322772|P1|STARTED|Overall Study||349
133576|NCT01190215|322795|P2|NOT COMPLETED|Up to Month 6||0
133577|NCT01190215|322796|P1|NOT COMPLETED|Up to Month 6||2
133578|NCT01190215|322795|P2|COMPLETED|Up to Month 6||39
133579|NCT01190215|322796|P1|COMPLETED|Up to Month 6||36
133580|NCT01190215|322795|P2|STARTED|Up to Month 6||39
133581|NCT01190215|322796|P1|STARTED|Up to Month 6||38
133582|NCT01190215|322795|P2|NOT COMPLETED|Up to Day 28||0
133583|NCT01190215|322796|P1|NOT COMPLETED|Up to Day 28||0
133584|NCT01190215|322795|P2|COMPLETED|Up to Day 28||39
133585|NCT01190215|322796|P1|COMPLETED|Up to Day 28||38
133586|NCT01190215|322795|P2|STARTED|Up to Day 28||39
133587|NCT01190215|322796|P1|STARTED|Up to Day 28||38
133588|NCT01190150|322866|P2|NOT COMPLETED|Second Treatment||0
133589|NCT01190150|322867|P1|NOT COMPLETED|Second Treatment||0
133590|NCT01190150|322866|P2|COMPLETED|Second Treatment||7
133591|NCT01190150|322867|P1|COMPLETED|Second Treatment||10
133592|NCT01190150|322866|P2|STARTED|Second Treatment||7
133593|NCT01190150|322867|P1|STARTED|Second Treatment||10
133594|NCT01190150|322866|P2|NOT COMPLETED|Washout||2
133595|NCT01190150|322867|P1|NOT COMPLETED|Washout||0
133596|NCT01190150|322866|P2|COMPLETED|Washout||7
133597|NCT01190150|322867|P1|COMPLETED|Washout||10
133598|NCT01190150|322866|P2|STARTED|Washout||9
133599|NCT01190150|322867|P1|STARTED|Washout||10
133600|NCT01190150|322866|P2|NOT COMPLETED|First Treatment||0
133601|NCT01190150|322867|P1|NOT COMPLETED|First Treatment||1
133602|NCT01190150|322866|P2|COMPLETED|First Treatment||9
133603|NCT01190150|322867|P1|COMPLETED|First Treatment||10
133604|NCT01190150|322866|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
133605|NCT01190150|322867|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
133606|NCT01190124|322894|P3|NOT COMPLETED|Overall Study||1
133607|NCT01190124|322895|P2|NOT COMPLETED|Overall Study||0
133608|NCT01190124|322896|P1|NOT COMPLETED|Overall Study||17
133609|NCT01190124|322894|P3|COMPLETED|Overall Study||19
133610|NCT01190124|322895|P2|COMPLETED|Overall Study||24
133611|NCT01190124|322896|P1|COMPLETED|Overall Study||90
133612|NCT01190124|322894|P3|STARTED|Overall Study||20
133613|NCT01190124|322895|P2|STARTED|Overall Study||24
133614|NCT01190124|322896|P1|STARTED|Overall Study||107
133615|NCT01190098|322934|P2|NOT COMPLETED|Overall Study||2
133616|NCT01190098|322935|P1|NOT COMPLETED|Overall Study||3
133617|NCT01190098|322934|P2|COMPLETED|Overall Study||8
133618|NCT01190098|322935|P1|COMPLETED|Overall Study||39
133619|NCT01190098|322934|P2|STARTED|Overall Study||10
133620|NCT01190098|322935|P1|STARTED|Overall Study||42
133621|NCT01190085|322958|P3|NOT COMPLETED|Overall Study||0
133622|NCT01190085|322959|P2|NOT COMPLETED|Overall Study||0
133623|NCT01190085|322960|P1|NOT COMPLETED|Overall Study||0
133624|NCT01190085|322958|P3|COMPLETED|Overall Study||18
133625|NCT01190085|322959|P2|COMPLETED|Overall Study||14
133626|NCT01190085|322960|P1|COMPLETED|Overall Study||13
133627|NCT01190085|322958|P3|STARTED|Overall Study||18
133628|NCT01190085|322959|P2|STARTED|Overall Study||14
133629|NCT01190085|322960|P1|STARTED|Overall Study||13
133630|NCT01190007|322974|P1|NOT COMPLETED|Overall Study||14
133631|NCT01190007|322974|P1|COMPLETED|Overall Study||145
133632|NCT01190007|322974|P1|STARTED|Overall Study|Treated|159
133633|NCT01189890|322991|P2|NOT COMPLETED|Overall Study||39
133634|NCT01189890|322992|P1|NOT COMPLETED|Overall Study||37
133635|NCT01189890|322991|P2|COMPLETED|Overall Study||200
133636|NCT01189890|322992|P1|COMPLETED|Overall Study||204
133637|NCT01189890|322991|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
133638|NCT01189890|322992|P1|STARTED|Overall Study||241
133639|NCT01189812|323014|P2|NOT COMPLETED|Overall Study||8
133640|NCT01189812|323015|P1|NOT COMPLETED|Overall Study||8
133641|NCT01189812|323014|P2|COMPLETED|Overall Study||32
133642|NCT01189812|323015|P1|COMPLETED|Overall Study||32
133643|NCT01189812|323014|P2|STARTED|Overall Study||40
133644|NCT01189812|323015|P1|STARTED|Overall Study||40
133645|NCT01189760|323024|P3|NOT COMPLETED|Overall Study||51
133646|NCT01189760|323025|P2|NOT COMPLETED|Overall Study||23
133647|NCT01189760|323026|P1|NOT COMPLETED|Overall Study||14
133648|NCT01189760|323024|P3|COMPLETED|Overall Study||255
133649|NCT01189760|323025|P2|COMPLETED|Overall Study||283
133650|NCT01189760|323026|P1|COMPLETED|Overall Study||291
133651|NCT01189760|323024|P3|STARTED|Overall Study||306
133652|NCT01189760|323025|P2|STARTED|Overall Study||306
133653|NCT01189760|323026|P1|STARTED|Overall Study||305
133654|NCT01189747|323060|P2|NOT COMPLETED|Overall Study||18
133655|NCT01189747|323061|P1|NOT COMPLETED|Overall Study||12
133656|NCT01189747|323060|P2|COMPLETED|Overall Study||206
133657|NCT01189747|323061|P1|COMPLETED|Overall Study||210
133658|NCT01189747|323060|P2|STARTED|Overall Study||224
133659|NCT01189747|323061|P1|STARTED|Overall Study||222
133660|NCT01189617|323085|P2|NOT COMPLETED|Overall Study||0
133661|NCT01189617|323086|P1|NOT COMPLETED|Overall Study||0
133662|NCT01189617|323085|P2|COMPLETED|Overall Study||35
133663|NCT01189617|323086|P1|COMPLETED|Overall Study||35
133664|NCT01189617|323085|P2|STARTED|Overall Study||35
133665|NCT01189617|323086|P1|STARTED|Overall Study||35
133666|NCT01189604|323099|P7|NOT COMPLETED|Overall Study||1
133667|NCT01189604|323100|P6|NOT COMPLETED|Overall Study||1
133668|NCT01189604|323101|P5|NOT COMPLETED|Overall Study||2
133669|NCT01189604|323102|P4|NOT COMPLETED|Overall Study||0
133670|NCT01189604|323103|P3|NOT COMPLETED|Overall Study||0
133671|NCT01189604|323104|P2|NOT COMPLETED|Overall Study||1
133672|NCT01189604|323105|P1|NOT COMPLETED|Overall Study||1
133673|NCT01189604|323099|P7|COMPLETED|Overall Study||9
133674|NCT01189604|323100|P6|COMPLETED|Overall Study||10
133675|NCT01189604|323101|P5|COMPLETED|Overall Study||18
133676|NCT01189604|323102|P4|COMPLETED|Overall Study||20
133677|NCT01189604|323103|P3|COMPLETED|Overall Study||20
133678|NCT01189604|323104|P2|COMPLETED|Overall Study||20
133679|NCT01189604|323105|P1|COMPLETED|Overall Study||20
133680|NCT01189604|323099|P7|Administered Study Drug|Overall Study||10
133681|NCT01189604|323100|P6|Administered Study Drug|Overall Study||10
133682|NCT01189604|323101|P5|Administered Study Drug|Overall Study||20
133683|NCT01189604|323102|P4|Administered Study Drug|Overall Study||20
133684|NCT01189604|323103|P3|Administered Study Drug|Overall Study||20
133685|NCT01189604|323104|P2|Administered Study Drug|Overall Study||20
133686|NCT01189604|323105|P1|Administered Study Drug|Overall Study||20
133687|NCT01189604|323099|P7|STARTED|Overall Study||10
133688|NCT01189604|323100|P6|STARTED|Overall Study||11
133689|NCT01189604|323101|P5|STARTED|Overall Study||20
133690|NCT01189604|323102|P4|STARTED|Overall Study||20
133691|NCT01189604|323103|P3|STARTED|Overall Study||20
133692|NCT01189604|323104|P2|STARTED|Overall Study||21
133693|NCT01189604|323105|P1|STARTED|Overall Study||21
133694|NCT01189500|323149|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
133695|NCT01189500|323149|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
133696|NCT01189500|323149|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
133697|NCT01189500|323149|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
133698|NCT01189500|323149|P1|COMPLETED|Period 1: TAMOX Alone||29
133699|NCT01189500|323149|P1|STARTED|Period 1: TAMOX Alone||30
133700|NCT01189487|323210|P1|NOT COMPLETED|Overall Study||3
133701|NCT01189487|323210|P1|COMPLETED|Overall Study||44
133702|NCT01189487|323210|P1|STARTED|Overall Study|Treated participants|47
133703|NCT01189461|323218|P1|NOT COMPLETED|Overall Study||34
133704|NCT01189461|323218|P1|COMPLETED|Overall Study||12
133705|NCT01189461|323218|P1|STARTED|Overall Study||46
133706|NCT01189435|323225|P1|NOT COMPLETED|Overall Study||2
133707|NCT01189435|323225|P1|COMPLETED|Overall Study||0
133708|NCT01189435|323225|P1|STARTED|Overall Study||2
133709|NCT01189370|323229|P3|NOT COMPLETED|Dose Level 3||6
133710|NCT01189370|323230|P2|NOT COMPLETED|Dose Level 3||0
133711|NCT01189370|323231|P1|NOT COMPLETED|Dose Level 3||0
133712|NCT01189370|323229|P3|COMPLETED|Dose Level 3||6
133713|NCT01189370|323230|P2|COMPLETED|Dose Level 3||0
133714|NCT01189370|323231|P1|COMPLETED|Dose Level 3||0
133715|NCT01189370|323229|P3|STARTED|Dose Level 3||12
133716|NCT01189370|323230|P2|STARTED|Dose Level 3||0
133717|NCT01189370|323231|P1|STARTED|Dose Level 3||0
133718|NCT01189370|323229|P3|NOT COMPLETED|Dose Level 2||0
133719|NCT01189370|323230|P2|NOT COMPLETED|Dose Level 2||4
133720|NCT01189370|323231|P1|NOT COMPLETED|Dose Level 2||0
133721|NCT01189370|323229|P3|COMPLETED|Dose Level 2||0
133722|NCT01189370|323230|P2|COMPLETED|Dose Level 2||12
133723|NCT01189370|323231|P1|COMPLETED|Dose Level 2||0
133724|NCT01189370|323229|P3|STARTED|Dose Level 2||0
133725|NCT01189370|323230|P2|STARTED|Dose Level 2||16
133726|NCT01189370|323231|P1|STARTED|Dose Level 2||0
133727|NCT01189370|323229|P3|NOT COMPLETED|Dose Level 1||0
133728|NCT01189370|323230|P2|NOT COMPLETED|Dose Level 1||0
133729|NCT01189370|323231|P1|NOT COMPLETED|Dose Level 1||9
133730|NCT01189370|323229|P3|COMPLETED|Dose Level 1||0
133731|NCT01189370|323230|P2|COMPLETED|Dose Level 1||0
133732|NCT01189370|323231|P1|COMPLETED|Dose Level 1||16
133733|NCT01189370|323229|P3|STARTED|Dose Level 1||0
133734|NCT01189370|323230|P2|STARTED|Dose Level 1||0
133735|NCT01189370|323231|P1|STARTED|Dose Level 1||25
133736|NCT01189292|323240|P2|NOT COMPLETED|Per Protocol Analysis||16
133737|NCT01189292|323241|P1|NOT COMPLETED|Per Protocol Analysis||11
133738|NCT01189292|323240|P2|COMPLETED|Per Protocol Analysis||60
133739|NCT01189292|323241|P1|COMPLETED|Per Protocol Analysis||65
133740|NCT01189292|323240|P2|STARTED|Per Protocol Analysis||76
133741|NCT01189292|323241|P1|STARTED|Per Protocol Analysis||76
133742|NCT01189292|323240|P2|NOT COMPLETED|Intention to Treat Analysis||0
133743|NCT01189292|323241|P1|NOT COMPLETED|Intention to Treat Analysis||0
133744|NCT01189292|323240|P2|COMPLETED|Intention to Treat Analysis||76
133745|NCT01189292|323241|P1|COMPLETED|Intention to Treat Analysis||76
133746|NCT01189292|323240|P2|STARTED|Intention to Treat Analysis||76
133747|NCT01189292|323241|P1|STARTED|Intention to Treat Analysis||76
133748|NCT01189279|323262|P3|NOT COMPLETED|Overall Study||1
133749|NCT01189279|323263|P2|NOT COMPLETED|Overall Study||0
133750|NCT01189279|323264|P1|NOT COMPLETED|Overall Study||1
133751|NCT01189279|323262|P3|COMPLETED|Overall Study||13
133752|NCT01189279|323263|P2|COMPLETED|Overall Study||14
133753|NCT01189279|323264|P1|COMPLETED|Overall Study||13
133754|NCT01189279|323262|P3|STARTED|Overall Study||14
133755|NCT01189279|323263|P2|STARTED|Overall Study||14
133756|NCT01189279|323264|P1|STARTED|Overall Study||14
133757|NCT01189240|323284|P3|NOT COMPLETED|Overall Study||0
133758|NCT01189240|323285|P2|NOT COMPLETED|Overall Study||0
133759|NCT01189240|323286|P1|NOT COMPLETED|Overall Study||0
133760|NCT01189240|323284|P3|COMPLETED|Overall Study||3
133761|NCT01189240|323285|P2|COMPLETED|Overall Study||6
133762|NCT01189240|323286|P1|COMPLETED|Overall Study||4
133763|NCT01189240|323284|P3|STARTED|Overall Study||3
133764|NCT01189240|323285|P2|STARTED|Overall Study||6
133765|NCT01189240|323286|P1|STARTED|Overall Study||4
133766|NCT01189227|323307|P2|NOT COMPLETED|Overall Study||3
133767|NCT01189227|323308|P1|NOT COMPLETED|Overall Study||6
133768|NCT01189227|323307|P2|COMPLETED|Overall Study||0
133769|NCT01189227|323308|P1|COMPLETED|Overall Study||0
133770|NCT01189227|323307|P2|STARTED|Overall Study||3
133771|NCT01189227|323308|P1|STARTED|Overall Study||6
133772|NCT01189201|323314|P1|NOT COMPLETED|Overall Study||1
133773|NCT01189201|323314|P1|COMPLETED|Overall Study||41
133774|NCT01189201|323314|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
133775|NCT01189201|323314|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
133776|NCT01189201|323314|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
133777|NCT01189201|323314|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
133778|NCT01189201|323314|P1|STARTED|Overall Study||42
133779|NCT01189136|323370|P2|NOT COMPLETED|Overall Study||0
133780|NCT01189136|323371|P1|NOT COMPLETED|Overall Study||0
133781|NCT01189136|323370|P2|COMPLETED|Overall Study||42
133782|NCT01189136|323371|P1|COMPLETED|Overall Study||42
133783|NCT01189136|323370|P2|STARTED|Overall Study||42
133784|NCT01189136|323371|P1|STARTED|Overall Study||42
133785|NCT01189123|323385|P2|NOT COMPLETED|Overall Study||6
133786|NCT01189123|323386|P1|NOT COMPLETED|Overall Study||2
133787|NCT01189123|323385|P2|COMPLETED|Overall Study||47
133788|NCT01189123|323386|P1|COMPLETED|Overall Study||50
133789|NCT01189123|323385|P2|STARTED|Overall Study||53
133790|NCT01189123|323386|P1|STARTED|Overall Study||52
133791|NCT01189110|323396|P2|NOT COMPLETED|Overall Study||0
133792|NCT01189110|323397|P1|NOT COMPLETED|Overall Study||0
133793|NCT01189110|323396|P2|COMPLETED|Overall Study||61
133794|NCT01189110|323397|P1|COMPLETED|Overall Study|February, 2011|64
133795|NCT01189110|323396|P2|STARTED|Overall Study||61
133796|NCT01189110|323397|P1|STARTED|Overall Study|September, 2010|64
133797|NCT01189071|323405|P2|NOT COMPLETED|Overall Study||0
133798|NCT01189071|323406|P1|NOT COMPLETED|Overall Study||0
133799|NCT01189071|323405|P2|COMPLETED|Overall Study||0
133800|NCT01189071|323406|P1|COMPLETED|Overall Study||0
133801|NCT01189071|323405|P2|STARTED|Overall Study||0
133802|NCT01189071|323406|P1|STARTED|Overall Study||0
133803|NCT01189032|323417|P3|NOT COMPLETED|Overall Study||6
133804|NCT01189032|323418|P2|NOT COMPLETED|Overall Study||7
133805|NCT01189032|323419|P1|NOT COMPLETED|Overall Study||5
133806|NCT01189032|323417|P3|COMPLETED|Overall Study||90
133807|NCT01189032|323418|P2|COMPLETED|Overall Study||89
133808|NCT01189032|323419|P1|COMPLETED|Overall Study||89
133809|NCT01189032|323417|P3|STARTED|Overall Study||96
133810|NCT01189032|323418|P2|STARTED|Overall Study||96
133811|NCT01189032|323419|P1|STARTED|Overall Study||94
133812|NCT01188967|323429|P2|NOT COMPLETED|Overall Study||4
133813|NCT01188967|323430|P1|NOT COMPLETED|Overall Study||5
133814|NCT01188967|323429|P2|COMPLETED|Overall Study||4
133815|NCT01188967|323430|P1|COMPLETED|Overall Study||5
133816|NCT01188967|323429|P2|STARTED|Overall Study||8
133817|NCT01188967|323430|P1|STARTED|Overall Study||10
133818|NCT01188928|323446|P4|NOT COMPLETED|Overall Study||18
133819|NCT01188928|323447|P3|NOT COMPLETED|Overall Study||14
133820|NCT01188928|323448|P2|NOT COMPLETED|Overall Study||62
133821|NCT01188928|323449|P1|NOT COMPLETED|Overall Study||38
133822|NCT01188928|323446|P4|COMPLETED|Overall Study||77
133823|NCT01188928|323447|P3|COMPLETED|Overall Study||82
133824|NCT01188928|323448|P2|COMPLETED|Overall Study||417
133825|NCT01188928|323449|P1|COMPLETED|Overall Study||444
133826|NCT01188928|323446|P4|STARTED|Overall Study||95
133827|NCT01188928|323447|P3|STARTED|Overall Study||96
133828|NCT01188928|323448|P2|STARTED|Overall Study||479
133829|NCT01188928|323449|P1|STARTED|Overall Study||482
133830|NCT01188876|323471|P1|NOT COMPLETED|Overall Study||0
133831|NCT01188876|323471|P1|COMPLETED|Overall Study||50
133832|NCT01188876|323471|P1|STARTED|Overall Study||50
133833|NCT01188811|323483|P2|NOT COMPLETED|Overall Study||2
133834|NCT01188811|323484|P1|NOT COMPLETED|Overall Study||6
133835|NCT01188811|323483|P2|COMPLETED|Overall Study||24
133836|NCT01188811|323484|P1|COMPLETED|Overall Study||22
133837|NCT01188811|323483|P2|STARTED|Overall Study||26
133838|NCT01188811|323484|P1|STARTED|Overall Study||28
133839|NCT01188798|323496|P2|NOT COMPLETED|Overall Study||3
133840|NCT01188798|323497|P1|NOT COMPLETED|Overall Study||2
133841|NCT01188798|323496|P2|COMPLETED|Overall Study||1
133842|NCT01188798|323497|P1|COMPLETED|Overall Study||0
133843|NCT01188798|323496|P2|STARTED|Overall Study||4
133844|NCT01188798|323497|P1|STARTED|Overall Study||2
133845|NCT01188772|323509|P4|NOT COMPLETED|Overall Study||1
133846|NCT01188772|323510|P3|NOT COMPLETED|Overall Study||11
133847|NCT01188772|323511|P2|NOT COMPLETED|Overall Study||3
133848|NCT01188772|323512|P1|NOT COMPLETED|Overall Study||5
133849|NCT01188772|323509|P4|COMPLETED|Overall Study||24
133850|NCT01188772|323510|P3|COMPLETED|Overall Study||15
133851|NCT01188772|323511|P2|COMPLETED|Overall Study||45
133852|NCT01188772|323512|P1|COMPLETED|Overall Study||43
133853|NCT01188772|323509|P4|Randomized and Treated|Overall Study||25
133854|NCT01188772|323510|P3|Randomized and Treated|Overall Study||26
133855|NCT01188772|323511|P2|Randomized and Treated|Overall Study||47
133856|NCT01188772|323512|P1|Randomized and Treated|Overall Study||48
133857|NCT01188772|323509|P4|STARTED|Overall Study||25
133858|NCT01188772|323510|P3|STARTED|Overall Study||26
133859|NCT01188772|323511|P2|STARTED|Overall Study||48
133860|NCT01188772|323512|P1|STARTED|Overall Study||48
133861|NCT01188694|323570|P3|NOT COMPLETED|Overall Study||1
133862|NCT01188694|323571|P2|NOT COMPLETED|Overall Study||1
133863|NCT01188694|323572|P1|NOT COMPLETED|Overall Study||5
133864|NCT01188694|323570|P3|COMPLETED|Overall Study||10
133865|NCT01188694|323571|P2|COMPLETED|Overall Study||15
133866|NCT01188694|323572|P1|COMPLETED|Overall Study||10
133867|NCT01188694|323570|P3|STARTED|Overall Study||11
133868|NCT01188694|323571|P2|STARTED|Overall Study||16
133869|NCT01188694|323572|P1|STARTED|Overall Study||15
133870|NCT01188681|323584|P4|NOT COMPLETED|Overall Study||1
133871|NCT01188681|323585|P3|NOT COMPLETED|Overall Study||1
133872|NCT01188681|323586|P2|NOT COMPLETED|Overall Study||0
133873|NCT01188681|323587|P1|NOT COMPLETED|Overall Study||0
133874|NCT01188681|323584|P4|COMPLETED|Overall Study||33
133875|NCT01188681|323585|P3|COMPLETED|Overall Study||32
133876|NCT01188681|323586|P2|COMPLETED|Overall Study||6
133877|NCT01188681|323587|P1|COMPLETED|Overall Study||6
133878|NCT01188681|323584|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
133879|NCT01188681|323585|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
133880|NCT01188681|323586|P2|STARTED|Overall Study||6
133881|NCT01188681|323587|P1|STARTED|Overall Study||6
133882|NCT01188668|323601|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
133883|NCT01188668|323601|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
133884|NCT01188668|323601|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
133885|NCT01188668|323601|P1|NOT COMPLETED|Period 1: ARIP Alone||2
133886|NCT01188668|323601|P1|COMPLETED|Period 1: ARIP Alone||36
133887|NCT01188668|323601|P1|STARTED|Period 1: ARIP Alone||38
133888|NCT01188655|323634|P1|NOT COMPLETED|Overall Study||13
133889|NCT01188655|323634|P1|COMPLETED|Overall Study||76
133890|NCT01188655|323634|P1|STARTED|Overall Study||89
133891|NCT01188603|323649|P1|NOT COMPLETED|Overall Study||0
133892|NCT01188603|323649|P1|COMPLETED|Overall Study||24
133893|NCT01188603|323649|P1|STARTED|Overall Study||24
133894|NCT01188577|323659|P2|NOT COMPLETED|Visit 2||0
133895|NCT01188577|323660|P1|NOT COMPLETED|Visit 2||0
133896|NCT01188577|323659|P2|COMPLETED|Visit 2||12
133897|NCT01188577|323660|P1|COMPLETED|Visit 2||11
133898|NCT01188577|323659|P2|STARTED|Visit 2||12
133899|NCT01188577|323660|P1|STARTED|Visit 2||11
133900|NCT01188577|323659|P2|NOT COMPLETED|3-14 Day Washout||0
133901|NCT01188577|323660|P1|NOT COMPLETED|3-14 Day Washout||0
133902|NCT01188577|323659|P2|COMPLETED|3-14 Day Washout||12
133903|NCT01188577|323660|P1|COMPLETED|3-14 Day Washout||11
133904|NCT01188577|323659|P2|STARTED|3-14 Day Washout||12
133905|NCT01188577|323660|P1|STARTED|3-14 Day Washout||11
133906|NCT01188577|323659|P2|NOT COMPLETED|Visit 1||0
133907|NCT01188577|323660|P1|NOT COMPLETED|Visit 1||0
133908|NCT01188577|323659|P2|COMPLETED|Visit 1||12
133909|NCT01188577|323660|P1|COMPLETED|Visit 1||11
133910|NCT01188577|323659|P2|STARTED|Visit 1||12
133911|NCT01188577|323660|P1|STARTED|Visit 1||11
133912|NCT01188564|323678|P2|NOT COMPLETED|Open Label Phase||0
133913|NCT01188564|323679|P1|NOT COMPLETED|Open Label Phase||0
133914|NCT01188564|323678|P2|COMPLETED|Open Label Phase||20
133915|NCT01188564|323679|P1|COMPLETED|Open Label Phase||24
133916|NCT01188564|323678|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
133917|NCT01188564|323679|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
133918|NCT01188564|323678|P2|NOT COMPLETED|Double-blind Phase||0
133919|NCT01188564|323679|P1|NOT COMPLETED|Double-blind Phase||1
133920|NCT01188564|323678|P2|COMPLETED|Double-blind Phase||31
133921|NCT01188564|323679|P1|COMPLETED|Double-blind Phase||43
133922|NCT01188564|323678|P2|STARTED|Double-blind Phase||31
133923|NCT01188564|323679|P1|STARTED|Double-blind Phase||44
133924|NCT01188551|323691|P4|NOT COMPLETED|Overall Study||0
133925|NCT01188551|323692|P3|NOT COMPLETED|Overall Study||0
133926|NCT01188551|323693|P2|NOT COMPLETED|Overall Study||0
133927|NCT01188551|323694|P1|NOT COMPLETED|Overall Study||1
133928|NCT01188551|323691|P4|COMPLETED|Overall Study||25
133929|NCT01188551|323692|P3|COMPLETED|Overall Study||25
133930|NCT01188551|323693|P2|COMPLETED|Overall Study||25
133931|NCT01188551|323694|P1|COMPLETED|Overall Study||24
133932|NCT01188551|323691|P4|STARTED|Overall Study||25
133933|NCT01188551|323692|P3|STARTED|Overall Study||25
133934|NCT01188551|323693|P2|STARTED|Overall Study||25
133935|NCT01188551|323694|P1|STARTED|Overall Study||25
133936|NCT01188538|323710|P2|NOT COMPLETED|Overall Study||1
133937|NCT01188538|323711|P1|NOT COMPLETED|Overall Study||0
133938|NCT01188538|323710|P2|COMPLETED|Overall Study||19
133939|NCT01188538|323711|P1|COMPLETED|Overall Study||20
133940|NCT01188538|323710|P2|STARTED|Overall Study||20
133941|NCT01188538|323711|P1|STARTED|Overall Study||20
133942|NCT01188499|323724|P5|NOT COMPLETED|Overall Study||0
133943|NCT01188499|323725|P4|NOT COMPLETED|Overall Study||0
133944|NCT01188499|323726|P3|NOT COMPLETED|Overall Study||0
133945|NCT01188499|323727|P2|NOT COMPLETED|Overall Study||0
133946|NCT01188499|323728|P1|NOT COMPLETED|Overall Study||0
133947|NCT01188499|323724|P5|COMPLETED|Overall Study||18
133948|NCT01188499|323725|P4|COMPLETED|Overall Study||18
133949|NCT01188499|323726|P3|COMPLETED|Overall Study||33
133950|NCT01188499|323727|P2|COMPLETED|Overall Study||83
133951|NCT01188499|323728|P1|COMPLETED|Overall Study||24
133952|NCT01188499|323724|P5|STARTED|Overall Study||18
133953|NCT01188499|323725|P4|STARTED|Overall Study||18
133954|NCT01188499|323726|P3|STARTED|Overall Study||33
133955|NCT01188499|323727|P2|STARTED|Overall Study||83
133956|NCT01188499|323728|P1|STARTED|Overall Study||24
133957|NCT01188460|323747|P2|NOT COMPLETED|Overall Study||0
133958|NCT01188460|323748|P1|NOT COMPLETED|Overall Study||0
133959|NCT01188460|323747|P2|COMPLETED|Overall Study||23
133960|NCT01188460|323748|P1|COMPLETED|Overall Study||25
133961|NCT01188460|323747|P2|STARTED|Overall Study||23
133962|NCT01188460|323748|P1|STARTED|Overall Study||25
133963|NCT01188447|323774|P1|NOT COMPLETED|Overall Study||0
133964|NCT01188447|323774|P1|COMPLETED|Overall Study||4034
133965|NCT01188447|323774|P1|STARTED|Overall Study||4034
133966|NCT01188421|323785|P3|NOT COMPLETED|Overall Study||14
133967|NCT01188421|323786|P2|NOT COMPLETED|Overall Study||10
133968|NCT01188421|323787|P1|NOT COMPLETED|Overall Study||3
133969|NCT01188421|323785|P3|COMPLETED|Overall Study||22
133970|NCT01188421|323786|P2|COMPLETED|Overall Study||26
133971|NCT01188421|323787|P1|COMPLETED|Overall Study||28
133972|NCT01188421|323785|P3|STARTED|Overall Study||36
133973|NCT01188421|323786|P2|STARTED|Overall Study||36
133974|NCT01188421|323787|P1|STARTED|Overall Study||31
133975|NCT01188343|323798|P3|NOT COMPLETED|Overall Study||1
133976|NCT01188343|323799|P2|NOT COMPLETED|Overall Study||26
133977|NCT01188343|323800|P1|NOT COMPLETED|Overall Study||1
133978|NCT01188343|323798|P3|COMPLETED|Overall Study||220
133979|NCT01188343|323799|P2|COMPLETED|Overall Study||193
133980|NCT01188343|323800|P1|COMPLETED|Overall Study||101
133981|NCT01188343|323798|P3|STARTED|Overall Study||221
133982|NCT01188343|323799|P2|STARTED|Overall Study||219
133983|NCT01188343|323800|P1|STARTED|Overall Study||102
133984|NCT01188226|323826|P1|NOT COMPLETED|Overall Study||4
133985|NCT01188226|323826|P1|COMPLETED|Overall Study||6
133986|NCT01188226|323826|P1|STARTED|Overall Study||10
133987|NCT01188109|323865|P1|NOT COMPLETED|Overall Study||0
133988|NCT01188109|323865|P1|COMPLETED|Overall Study||22
133989|NCT01188109|323865|P1|STARTED|Overall Study||22
133990|NCT01187953|323872|P2|NOT COMPLETED|Overall Study||21
133991|NCT01187953|323873|P1|NOT COMPLETED|Overall Study||15
133992|NCT01187953|323872|P2|COMPLETED|Overall Study||254
133993|NCT01187953|323873|P1|COMPLETED|Overall Study||253
133994|NCT01187953|323872|P2|Dosed|Overall Study||271
133995|NCT01187953|323873|P1|Dosed|Overall Study||266
133996|NCT01187953|323872|P2|STARTED|Overall Study||275
133997|NCT01187953|323873|P1|STARTED|Overall Study||268
133998|NCT01187914|323881|P1|NOT COMPLETED|Overall Study||0
133999|NCT01187914|323881|P1|COMPLETED|Overall Study||40
134000|NCT01187914|323881|P1|STARTED|Overall Study||40
134001|NCT01187901|323887|P2|NOT COMPLETED|Overall Study||10
134002|NCT01187901|323888|P1|NOT COMPLETED|Overall Study||9
134003|NCT01187901|323887|P2|COMPLETED|Overall Study||36
134004|NCT01187901|323888|P1|COMPLETED|Overall Study||37
134005|NCT01187901|323887|P2|STARTED|Overall Study||46
134006|NCT01187901|323888|P1|STARTED|Overall Study||46
134007|NCT01187771|323906|P2|NOT COMPLETED|Overall Study||3
134008|NCT01187771|323907|P1|NOT COMPLETED|Overall Study||3
134009|NCT01187771|323906|P2|COMPLETED|Overall Study||18
134010|NCT01187771|323907|P1|COMPLETED|Overall Study||25
134011|NCT01187771|323906|P2|STARTED|Overall Study||21
134012|NCT01187771|323907|P1|STARTED|Overall Study||28
134013|NCT01187550|323929|P2|NOT COMPLETED|Overall Study||1
134014|NCT01187550|323930|P1|NOT COMPLETED|Overall Study||14
134015|NCT01187550|323929|P2|COMPLETED|Overall Study||29
134016|NCT01187550|323930|P1|COMPLETED|Overall Study||169
134017|NCT01187550|323929|P2|Treated|Overall Study||30
134018|NCT01187550|323930|P1|Treated|Overall Study||175
134019|NCT01187550|323929|P2|STARTED|Overall Study||30
134020|NCT01187550|323930|P1|STARTED|Overall Study||183
134021|NCT01187511|323948|P2|NOT COMPLETED|Overall Study||1
134022|NCT01187511|323949|P1|NOT COMPLETED|Overall Study||8
134023|NCT01187511|323948|P2|COMPLETED|Overall Study||21
134024|NCT01187511|323949|P1|COMPLETED|Overall Study||14
134025|NCT01187511|323948|P2|STARTED|Overall Study||22
134026|NCT01187511|323949|P1|STARTED|Overall Study||22
134027|NCT01187498|324057|P2|NOT COMPLETED|Overall Study||10
134028|NCT01187498|324058|P1|NOT COMPLETED|Overall Study||9
134029|NCT01187498|324057|P2|COMPLETED|Overall Study||60
134030|NCT01187498|324058|P1|COMPLETED|Overall Study||64
134031|NCT01187498|324057|P2|STARTED|Overall Study||70
134032|NCT01187498|324058|P1|STARTED|Overall Study||73
134033|NCT01187446|324086|P2|NOT COMPLETED|Overall Study||1
134034|NCT01187446|324087|P1|NOT COMPLETED|Overall Study||0
134035|NCT01187446|324086|P2|COMPLETED|Overall Study||13
134036|NCT01187446|324087|P1|COMPLETED|Overall Study||14
134037|NCT01187446|324086|P2|STARTED|Overall Study||14
134038|NCT01187446|324087|P1|STARTED|Overall Study||14
134039|NCT01187433|324103|P2|NOT COMPLETED|Overall Study||4
134040|NCT01187433|324104|P1|NOT COMPLETED|Overall Study||11
134041|NCT01187433|324103|P2|COMPLETED|Overall Study||46
134042|NCT01187433|324104|P1|COMPLETED|Overall Study||89
134043|NCT01187433|324103|P2|STARTED|Overall Study||50
134044|NCT01187433|324104|P1|STARTED|Overall Study||100
134045|NCT01187407|324134|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
134046|NCT01187407|324135|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
134047|NCT01187407|324136|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
134048|NCT01187407|324137|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
134049|NCT01187407|324138|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134050|NCT01187407|324134|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
134051|NCT01187407|324135|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
134052|NCT01187407|324136|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
134053|NCT01187407|324137|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
134054|NCT01187407|324138|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134055|NCT01187407|324134|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
134056|NCT01187407|324135|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
134057|NCT01187407|324136|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
134058|NCT01187407|324137|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
134059|NCT01187407|324138|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134060|NCT01187407|324134|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
134061|NCT01187407|324135|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
134062|NCT01187407|324136|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
134063|NCT01187407|324137|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
134064|NCT01187407|324138|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134065|NCT01187407|324134|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134066|NCT01187407|324135|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134067|NCT01187407|324136|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134068|NCT01187407|324137|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134069|NCT01187407|324138|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
134070|NCT01187407|324134|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134071|NCT01187407|324135|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134072|NCT01187407|324136|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134073|NCT01187407|324137|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134074|NCT01187407|324138|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
134075|NCT01187407|324134|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
134076|NCT01187407|324135|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
134077|NCT01187407|324136|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
134078|NCT01187407|324137|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
134079|NCT01187407|324138|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
134080|NCT01187407|324134|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
134081|NCT01187407|324135|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
134082|NCT01187407|324136|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
134083|NCT01187407|324137|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
134084|NCT01187407|324138|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
134085|NCT01187381|324208|P1|NOT COMPLETED|Overall Study||0
134086|NCT01187381|324208|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
134087|NCT01187381|324208|P1|STARTED|Overall Study||250
134088|NCT01187355|324220|P2|NOT COMPLETED|Overall Study||20
134089|NCT01187355|324221|P1|NOT COMPLETED|Overall Study||18
134090|NCT01187355|324220|P2|COMPLETED|Overall Study||277
134091|NCT01187355|324221|P1|COMPLETED|Overall Study||276
134092|NCT01187355|324220|P2|STARTED|Overall Study||297
134093|NCT01187355|324221|P1|STARTED|Overall Study||294
134094|NCT01187043|324236|P5|NOT COMPLETED|Overall Study||2
134095|NCT01187043|324237|P4|NOT COMPLETED|Overall Study||0
134096|NCT01187043|324238|P3|NOT COMPLETED|Overall Study||4
134097|NCT01187043|324239|P2|NOT COMPLETED|Overall Study||0
134098|NCT01187043|324240|P1|NOT COMPLETED|Overall Study||1
134099|NCT01187043|324236|P5|COMPLETED|Overall Study||10
134100|NCT01187043|324237|P4|COMPLETED|Overall Study||12
134101|NCT01187043|324238|P3|COMPLETED|Overall Study||8
134102|NCT01187043|324239|P2|COMPLETED|Overall Study||10
134103|NCT01187043|324240|P1|COMPLETED|Overall Study||11
134104|NCT01187043|324236|P5|STARTED|Overall Study||12
134105|NCT01187043|324237|P4|STARTED|Overall Study||12
134106|NCT01187043|324238|P3|STARTED|Overall Study||12
134107|NCT01187043|324239|P2|STARTED|Overall Study||10
134108|NCT01187043|324240|P1|STARTED|Overall Study||12
134109|NCT01187017|324252|P1|NOT COMPLETED|Overall Study||0
134110|NCT01187017|324252|P1|COMPLETED|Overall Study||1
134111|NCT01187017|324252|P1|STARTED|Overall Study||1
134112|NCT01187004|324258|P2|NOT COMPLETED|Overall Study||0
134113|NCT01187004|324259|P1|NOT COMPLETED|Overall Study||0
134114|NCT01187004|324258|P2|COMPLETED|Overall Study||144
134115|NCT01187004|324259|P1|COMPLETED|Overall Study||20
134116|NCT01187004|324258|P2|STARTED|Overall Study||144
134117|NCT01187004|324259|P1|STARTED|Overall Study||20
134118|NCT01186939|324266|P1|NOT COMPLETED|Overall Study||40
134119|NCT01186939|324266|P1|COMPLETED|Overall Study||0
134120|NCT01186939|324266|P1|STARTED|Overall Study||40
134121|NCT01186848|324270|P1|NOT COMPLETED|Overall Study||8
134122|NCT01186848|324270|P1|COMPLETED|Overall Study||22
134123|NCT01186848|324270|P1|STARTED|Overall Study||30
134124|NCT01186796|324278|P2|NOT COMPLETED|Overall Study||2
134125|NCT01186796|324279|P1|NOT COMPLETED|Overall Study||4
134126|NCT01186796|324278|P2|COMPLETED|Overall Study||14
134127|NCT01186796|324279|P1|COMPLETED|Overall Study||10
134128|NCT01186796|324278|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
134129|NCT01186796|324279|P1|STARTED|Overall Study||14
134130|NCT01186744|324299|P6|NOT COMPLETED|Overall Study||26
134131|NCT01186744|324300|P5|NOT COMPLETED|Overall Study||6
134132|NCT01186744|324301|P4|NOT COMPLETED|Overall Study||12
134133|NCT01186744|324302|P3|NOT COMPLETED|Overall Study||6
134134|NCT01186744|324303|P2|NOT COMPLETED|Overall Study||152
134135|NCT01186744|324304|P1|NOT COMPLETED|Overall Study||208
134136|NCT01186744|324299|P6|COMPLETED|Overall Study||107
134137|NCT01186744|324300|P5|COMPLETED|Overall Study||39
134138|NCT01186744|324301|P4|COMPLETED|Overall Study||70
134139|NCT01186744|324302|P3|COMPLETED|Overall Study||25
134140|NCT01186744|324303|P2|COMPLETED|Overall Study||5
134141|NCT01186744|324304|P1|COMPLETED|Overall Study||10
134142|NCT01186744|324299|P6|STARTED|Overall Study||133
134143|NCT01186744|324300|P5|STARTED|Overall Study||45
134144|NCT01186744|324301|P4|STARTED|Overall Study||82
134145|NCT01186744|324302|P3|STARTED|Overall Study||31
134146|NCT01186744|324303|P2|STARTED|Overall Study||157
134147|NCT01186744|324304|P1|STARTED|Overall Study||218
134148|NCT01186705|324720|P1|NOT COMPLETED|Overall Study||0
134149|NCT01186705|324720|P1|COMPLETED|Overall Study||1
134150|NCT01186705|324720|P1|STARTED|Overall Study||1
134151|NCT01186692|324724|P1|NOT COMPLETED|Overall Study||32
134152|NCT01186692|324724|P1|COMPLETED|Overall Study||99
134153|NCT01186692|324724|P1|STARTED|Overall Study||131
134154|NCT01186562|324734|P2|NOT COMPLETED|Overall Study||2
134155|NCT01186562|324735|P1|NOT COMPLETED|Overall Study||4
134156|NCT01186562|324734|P2|COMPLETED|Overall Study||27
134157|NCT01186562|324735|P1|COMPLETED|Overall Study||50
134158|NCT01186562|324734|P2|STARTED|Overall Study||29
134159|NCT01186562|324735|P1|STARTED|Overall Study||54
134160|NCT01186458|324751|P1|NOT COMPLETED|Overall Study||1
134161|NCT01186458|324751|P1|COMPLETED|Overall Study||3
134162|NCT01186458|324751|P1|STARTED|Overall Study||4
134163|NCT01186419|324760|P2|NOT COMPLETED|Overall Study||9
134164|NCT01186419|324761|P1|NOT COMPLETED|Overall Study||7
134165|NCT01186419|324760|P2|COMPLETED|Overall Study||18
134166|NCT01186419|324761|P1|COMPLETED|Overall Study||17
134167|NCT01186419|324760|P2|STARTED|Overall Study||27
134168|NCT01186419|324761|P1|STARTED|Overall Study||24
134169|NCT01186406|324768|P1|NOT COMPLETED|Overall Study||0
134170|NCT01186406|324768|P1|COMPLETED|Overall Study||41
134171|NCT01186406|324768|P1|STARTED|Overall Study||41
134172|NCT01186250|324777|P2|NOT COMPLETED|Overall Study||0
134173|NCT01186250|324778|P1|NOT COMPLETED|Overall Study||1
134174|NCT01186250|324777|P2|COMPLETED|Overall Study||9
134175|NCT01186250|324778|P1|COMPLETED|Overall Study||8
134176|NCT01186250|324777|P2|STARTED|Overall Study||9
134177|NCT01186250|324778|P1|STARTED|Overall Study||9
134178|NCT01185964|324799|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
134179|NCT01185964|324800|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
134180|NCT01185964|324801|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
134181|NCT01185964|324802|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
134182|NCT01185964|324799|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
134183|NCT01185964|324800|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
134184|NCT01185964|324801|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
134185|NCT01185964|324802|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
134186|NCT01185964|324799|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
134187|NCT01185964|324800|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
134188|NCT01185964|324801|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
134189|NCT01185964|324802|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
134190|NCT01185964|324799|P4|NOT COMPLETED|Phase 1b and Phase 2||0
134191|NCT01185964|324800|P3|NOT COMPLETED|Phase 1b and Phase 2||9
134192|NCT01185964|324801|P2|NOT COMPLETED|Phase 1b and Phase 2||10
134193|NCT01185964|324802|P1|NOT COMPLETED|Phase 1b and Phase 2||2
134194|NCT01185964|324799|P4|COMPLETED|Phase 1b and Phase 2||0
134195|NCT01185964|324800|P3|COMPLETED|Phase 1b and Phase 2||58
134196|NCT01185964|324801|P2|COMPLETED|Phase 1b and Phase 2||56
134197|NCT01185964|324802|P1|COMPLETED|Phase 1b and Phase 2||13
134198|NCT01185964|324799|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
134199|NCT01185964|324800|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
134200|NCT01185964|324801|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
134201|NCT01185964|324802|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
134202|NCT01185964|324799|P4|STARTED|Phase 1b and Phase 2||0
134203|NCT01185964|324800|P3|STARTED|Phase 1b and Phase 2||67
134204|NCT01185964|324801|P2|STARTED|Phase 1b and Phase 2||66
134205|NCT01185964|324802|P1|STARTED|Phase 1b and Phase 2||15
134206|NCT01185834|324828|P1|NOT COMPLETED|Overall Study||14
134207|NCT01185834|324828|P1|COMPLETED|Overall Study||104
134208|NCT01185834|324828|P1|STARTED|Overall Study||118
134209|NCT01185821|324838|P5|NOT COMPLETED|Overall Study||24
134210|NCT01185821|324839|P4|NOT COMPLETED|Overall Study||6
134211|NCT01185821|324840|P3|NOT COMPLETED|Overall Study||10
134212|NCT01185821|324841|P2|NOT COMPLETED|Overall Study||9
134213|NCT01185821|324842|P1|NOT COMPLETED|Overall Study||7
134214|NCT01185821|324838|P5|COMPLETED|Overall Study||26
134215|NCT01185821|324839|P4|COMPLETED|Overall Study||23
134216|NCT01185821|324840|P3|COMPLETED|Overall Study||33
134217|NCT01185821|324841|P2|COMPLETED|Overall Study||20
134218|NCT01185821|324842|P1|COMPLETED|Overall Study||26
134219|NCT01185821|324838|P5|Patients on Placebo in Core|Overall Study||2
134220|NCT01185821|324839|P4|Patients on Placebo in Core|Overall Study||8
134221|NCT01185821|324840|P3|Patients on Placebo in Core|Overall Study||9
134222|NCT01185821|324841|P2|Patients on Placebo in Core|Overall Study||7
134223|NCT01185821|324842|P1|Patients on Placebo in Core|Overall Study||8
134224|NCT01185821|324838|P5|Patients Without Washout|Overall Study||17
134225|NCT01185821|324839|P4|Patients Without Washout|Overall Study||0
134226|NCT01185821|324840|P3|Patients Without Washout|Overall Study||4
134227|NCT01185821|324841|P2|Patients Without Washout|Overall Study||0
134228|NCT01185821|324842|P1|Patients Without Washout|Overall Study||0
134229|NCT01185821|324838|P5|Patients With Washout|Overall Study||33
134230|NCT01185821|324839|P4|Patients With Washout|Overall Study||29
134231|NCT01185821|324840|P3|Patients With Washout|Overall Study||39
134232|NCT01185821|324841|P2|Patients With Washout|Overall Study||29
134233|NCT01185821|324842|P1|Patients With Washout|Overall Study||33
134234|NCT01185821|324838|P5|STARTED|Overall Study||50
134235|NCT01185821|324839|P4|STARTED|Overall Study||29
134236|NCT01185821|324840|P3|STARTED|Overall Study||43
134237|NCT01185821|324841|P2|STARTED|Overall Study||29
134238|NCT01185821|324842|P1|STARTED|Overall Study||33
134239|NCT01185782|324893|P2|NOT COMPLETED|Overall Study||11
134240|NCT01185782|324894|P1|NOT COMPLETED|Overall Study||6
134241|NCT01185782|324893|P2|COMPLETED|Overall Study||125
134242|NCT01185782|324894|P1|COMPLETED|Overall Study||123
134243|NCT01185782|324893|P2|Treated|Overall Study||132
134244|NCT01185782|324894|P1|Treated|Overall Study||129
134245|NCT01185782|324893|P2|STARTED|Overall Study||136
134246|NCT01185782|324894|P1|STARTED|Overall Study||129
134247|NCT01185704|324922|P2|NOT COMPLETED|Overall Study||8
134248|NCT01185704|324923|P1|NOT COMPLETED|Overall Study||13
134249|NCT01185704|324922|P2|COMPLETED|Overall Study||60
134250|NCT01185704|324923|P1|COMPLETED|Overall Study||55
134251|NCT01185704|324922|P2|Treated|Overall Study||65
134252|NCT01185704|324923|P1|Treated|Overall Study||65
134253|NCT01185704|324922|P2|STARTED|Overall Study||68
134254|NCT01185704|324923|P1|STARTED|Overall Study||68
134255|NCT01185600|324959|P2|NOT COMPLETED|Overall Study||45
134256|NCT01185600|324960|P1|NOT COMPLETED|Overall Study||32
134257|NCT01185600|324959|P2|COMPLETED|Overall Study||59
134258|NCT01185600|324960|P1|COMPLETED|Overall Study||41
134259|NCT01185600|324959|P2|STARTED|Overall Study||104
134260|NCT01185600|324960|P1|STARTED|Overall Study||73
134261|NCT01185561|324982|P2|NOT COMPLETED|Overall Study||12
134262|NCT01185561|324983|P1|NOT COMPLETED|Overall Study||2
134263|NCT01185561|324982|P2|COMPLETED|Overall Study||26
134264|NCT01185561|324983|P1|COMPLETED|Overall Study||34
134265|NCT01185561|324982|P2|STARTED|Overall Study||38
134266|NCT01185561|324983|P1|STARTED|Overall Study||36
134267|NCT01185522|324995|P1|NOT COMPLETED|Overall Study||108
134268|NCT01185522|324995|P1|COMPLETED|Overall Study||585
134269|NCT01185522|324995|P1|STARTED|Overall Study||693
134270|NCT01185509|325021|P2|NOT COMPLETED|Overall Study||20
134271|NCT01185509|325022|P1|NOT COMPLETED|Overall Study||11
134272|NCT01185509|325021|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
134273|NCT01185509|325022|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
134274|NCT01185509|325021|P2|STARTED|Overall Study||20
134275|NCT01185509|325022|P1|STARTED|Overall Study||11
134276|NCT01185353|325037|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
134277|NCT01185353|325038|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
134278|NCT01185353|325039|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
134279|NCT01185353|325040|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
134280|NCT01185353|325041|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
134281|NCT01185353|325042|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
134282|NCT01185353|325043|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
134283|NCT01185353|325044|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
134284|NCT01185353|325045|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
134285|NCT01185353|325046|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
134286|NCT01185353|325037|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
134287|NCT01185353|325038|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
134288|NCT01185353|325039|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
134289|NCT01185353|325040|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
134290|NCT01185353|325041|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
134291|NCT01185353|325042|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
134292|NCT01185353|325043|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
134293|NCT01185353|325044|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
134294|NCT01185353|325045|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
134295|NCT01185353|325046|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
134296|NCT01185353|325037|P10|STARTED|Part D (Weeks 76 Through 128)||18
134297|NCT01185353|325038|P9|STARTED|Part D (Weeks 76 Through 128)||47
134298|NCT01185353|325039|P8|STARTED|Part D (Weeks 76 Through 128)||79
134299|NCT01185353|325040|P7|STARTED|Part D (Weeks 76 Through 128)||0
134300|NCT01185353|325041|P6|STARTED|Part D (Weeks 76 Through 128)||0
134301|NCT01185353|325042|P5|STARTED|Part D (Weeks 76 Through 128)||0
134302|NCT01185353|325043|P4|STARTED|Part D (Weeks 76 Through 128)||0
134303|NCT01185353|325044|P3|STARTED|Part D (Weeks 76 Through 128)||0
134304|NCT01185353|325045|P2|STARTED|Part D (Weeks 76 Through 128)||0
134305|NCT01185353|325046|P1|STARTED|Part D (Weeks 76 Through 128)||0
134306|NCT01185353|325037|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
134307|NCT01185353|325038|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
134308|NCT01185353|325039|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
134309|NCT01185353|325040|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
134310|NCT01185353|325041|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
134311|NCT01185353|325042|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
134312|NCT01185353|325043|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
134313|NCT01185353|325044|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
134314|NCT01185353|325045|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
134315|NCT01185353|325046|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
134316|NCT01185353|325037|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
134317|NCT01185353|325038|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
134318|NCT01185353|325039|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
134319|NCT01185353|325040|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
134320|NCT01185353|325041|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
134321|NCT01185353|325042|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
134322|NCT01185353|325043|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
134323|NCT01185353|325044|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
134324|NCT01185353|325045|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
134325|NCT01185353|325046|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
134326|NCT01185353|325037|P10|STARTED|Part C (Weeks 24 Through 76)||32
134327|NCT01185353|325038|P9|STARTED|Part C (Weeks 24 Through 76)||61
134328|NCT01185353|325039|P8|STARTED|Part C (Weeks 24 Through 76)||108
134329|NCT01185353|325040|P7|STARTED|Part C (Weeks 24 Through 76)||0
134330|NCT01185353|325041|P6|STARTED|Part C (Weeks 24 Through 76)||0
134331|NCT01185353|325042|P5|STARTED|Part C (Weeks 24 Through 76)||0
134332|NCT01185353|325043|P4|STARTED|Part C (Weeks 24 Through 76)||0
134333|NCT01185353|325044|P3|STARTED|Part C (Weeks 24 Through 76)||0
134334|NCT01185353|325045|P2|STARTED|Part C (Weeks 24 Through 76)||0
134335|NCT01185353|325046|P1|STARTED|Part C (Weeks 24 Through 76)||0
134336|NCT01185353|325037|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
134337|NCT01185353|325038|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
134338|NCT01185353|325039|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
134339|NCT01185353|325040|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
134340|NCT01185353|325041|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
134341|NCT01185353|325042|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
134342|NCT01185353|325043|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
134343|NCT01185353|325044|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
134344|NCT01185353|325045|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
134345|NCT01185353|325046|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
134346|NCT01185353|325037|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
134347|NCT01185353|325038|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
134348|NCT01185353|325039|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
134349|NCT01185353|325040|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
134350|NCT01185353|325041|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
134351|NCT01185353|325042|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
134352|NCT01185353|325043|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
134353|NCT01185353|325044|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
134354|NCT01185353|325045|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
134355|NCT01185353|325046|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
134356|NCT01185353|325037|P10|STARTED|Part B (Weeks 12 Through 24)||0
134357|NCT01185353|325038|P9|STARTED|Part B (Weeks 12 Through 24)||0
134358|NCT01185353|325039|P8|STARTED|Part B (Weeks 12 Through 24)||0
134359|NCT01185353|325040|P7|STARTED|Part B (Weeks 12 Through 24)||63
134360|NCT01185353|325041|P6|STARTED|Part B (Weeks 12 Through 24)||63
134361|NCT01185353|325042|P5|STARTED|Part B (Weeks 12 Through 24)||0
134362|NCT01185353|325043|P4|STARTED|Part B (Weeks 12 Through 24)||49
134363|NCT01185353|325044|P3|STARTED|Part B (Weeks 12 Through 24)||50
134364|NCT01185353|325045|P2|STARTED|Part B (Weeks 12 Through 24)||51
134365|NCT01185353|325046|P1|STARTED|Part B (Weeks 12 Through 24)||0
134366|NCT01185353|325037|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
134367|NCT01185353|325038|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
134368|NCT01185353|325039|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
134369|NCT01185353|325040|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
134370|NCT01185353|325041|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
134371|NCT01185353|325042|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
134372|NCT01185353|325043|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
134373|NCT01185353|325044|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
134374|NCT01185353|325045|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
134375|NCT01185353|325046|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
134376|NCT01185353|325037|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
134377|NCT01185353|325038|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
134378|NCT01185353|325039|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
134379|NCT01185353|325040|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
134380|NCT01185353|325041|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
134381|NCT01185353|325042|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
134382|NCT01185353|325043|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
134383|NCT01185353|325044|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
134384|NCT01185353|325045|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
134385|NCT01185353|325046|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
134386|NCT01185353|325037|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
134387|NCT01185353|325038|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
134388|NCT01185353|325039|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
134389|NCT01185353|325040|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
134390|NCT01185353|325041|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
134391|NCT01185353|325042|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
134392|NCT01185353|325043|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
134393|NCT01185353|325044|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
134394|NCT01185353|325045|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
134395|NCT01185353|325046|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
134396|NCT01185353|325037|P10|STARTED|Part A (Weeks 0 Through 12)||0
134397|NCT01185353|325038|P9|STARTED|Part A (Weeks 0 Through 12)||0
134398|NCT01185353|325039|P8|STARTED|Part A (Weeks 0 Through 12)||0
134399|NCT01185353|325040|P7|STARTED|Part A (Weeks 0 Through 12)||0
134400|NCT01185353|325041|P6|STARTED|Part A (Weeks 0 Through 12)||0
134401|NCT01185353|325042|P5|STARTED|Part A (Weeks 0 Through 12)||98
134402|NCT01185353|325043|P4|STARTED|Part A (Weeks 0 Through 12)||50
134403|NCT01185353|325044|P3|STARTED|Part A (Weeks 0 Through 12)||52
134404|NCT01185353|325045|P2|STARTED|Part A (Weeks 0 Through 12)||52
134405|NCT01185353|325046|P1|STARTED|Part A (Weeks 0 Through 12)||49
134406|NCT01185340|325207|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
134407|NCT01185340|325208|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
134408|NCT01185340|325209|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
134409|NCT01185340|325210|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134410|NCT01185340|325207|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
134411|NCT01185340|325208|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
134412|NCT01185340|325209|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
134413|NCT01185340|325210|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134414|NCT01185340|325207|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
134415|NCT01185340|325208|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
134416|NCT01185340|325209|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
134417|NCT01185340|325210|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134418|NCT01185340|325207|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
134419|NCT01185340|325208|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
134420|NCT01185340|325209|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
134421|NCT01185340|325210|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
134422|NCT01185340|325207|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134423|NCT01185340|325208|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134424|NCT01185340|325209|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134425|NCT01185340|325210|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
134426|NCT01185340|325207|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134427|NCT01185340|325208|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134428|NCT01185340|325209|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
134429|NCT01185340|325210|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
134430|NCT01185340|325207|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
134431|NCT01185340|325208|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
134432|NCT01185340|325209|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
134433|NCT01185340|325210|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
134434|NCT01185340|325207|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
134435|NCT01185340|325208|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
134436|NCT01185340|325209|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
134437|NCT01185340|325210|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
134438|NCT01185301|325262|P4|NOT COMPLETED|Overall Study||9
134439|NCT01185301|325263|P3|NOT COMPLETED|Overall Study||6
134440|NCT01185301|325264|P2|NOT COMPLETED|Overall Study||7
134441|NCT01185301|325265|P1|NOT COMPLETED|Overall Study||15
134442|NCT01185301|325262|P4|COMPLETED|Overall Study||89
134443|NCT01185301|325263|P3|COMPLETED|Overall Study||93
134444|NCT01185301|325264|P2|COMPLETED|Overall Study||93
134445|NCT01185301|325265|P1|COMPLETED|Overall Study||83
134446|NCT01185301|325262|P4|STARTED|Overall Study||98
134447|NCT01185301|325263|P3|STARTED|Overall Study||99
134448|NCT01185301|325264|P2|STARTED|Overall Study||100
134449|NCT01185301|325265|P1|STARTED|Overall Study||98
134450|NCT01185288|325325|P2|NOT COMPLETED|Overall Study||16
134451|NCT01185288|325326|P1|NOT COMPLETED|Overall Study||19
134452|NCT01185288|325325|P2|COMPLETED|Overall Study||139
134453|NCT01185288|325326|P1|COMPLETED|Overall Study||135
134454|NCT01185288|325325|P2|STARTED|Overall Study||155
134455|NCT01185288|325326|P1|STARTED|Overall Study||154
134456|NCT01185249|325344|P1|NOT COMPLETED|Overall Study||42
134457|NCT01185249|325344|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
134458|NCT01185249|325344|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
134459|NCT01185080|325352|P3|NOT COMPLETED|Overall Study||1
134460|NCT01185080|325353|P2|NOT COMPLETED|Overall Study||1
134461|NCT01185080|325354|P1|NOT COMPLETED|Overall Study||1
134462|NCT01185080|325352|P3|COMPLETED|Overall Study||16
134463|NCT01185080|325353|P2|COMPLETED|Overall Study||15
134464|NCT01185080|325354|P1|COMPLETED|Overall Study||49
134465|NCT01185080|325352|P3|STARTED|Overall Study||17
134466|NCT01185080|325353|P2|STARTED|Overall Study||16
134467|NCT01185080|325354|P1|STARTED|Overall Study||50
134468|NCT01185028|325401|P1|NOT COMPLETED|Overall Study||4
134469|NCT01185028|325401|P1|COMPLETED|Overall Study||4
134470|NCT01185028|325401|P1|STARTED|Overall Study||8
134471|NCT01184989|325406|P1|NOT COMPLETED|Overall Study||12
134472|NCT01184989|325406|P1|COMPLETED|Overall Study||100
134473|NCT01184989|325406|P1|STARTED|Overall Study|Treated Patients|112
134474|NCT01184898|325412|P1|NOT COMPLETED|Overall Study||0
134475|NCT01184898|325412|P1|COMPLETED|Overall Study||36
134476|NCT01184898|325412|P1|STARTED|Overall Study||36
134477|NCT01184885|325419|P1|NOT COMPLETED|Overall Study||0
134478|NCT01184885|325419|P1|COMPLETED|Overall Study||7
134479|NCT01184885|325419|P1|STARTED|Overall Study||7
134480|NCT01184872|325426|P2|NOT COMPLETED|Overall Study||8
134481|NCT01184872|325427|P1|NOT COMPLETED|Overall Study||10
134482|NCT01184872|325426|P2|COMPLETED|Overall Study||31
134483|NCT01184872|325427|P1|COMPLETED|Overall Study||71
134484|NCT01184872|325426|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
134485|NCT01184872|325427|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
134486|NCT01184872|325426|P2|Clinical Evaluable Set (CES)|Overall Study||30
134487|NCT01184872|325427|P1|Clinical Evaluable Set (CES)|Overall Study||73
134488|NCT01184872|325426|P2|Safety Set|Overall Study||40
134489|NCT01184872|325427|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
134490|NCT01184872|325426|P2|STARTED|Overall Study||39
134491|NCT01184872|325427|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
134492|NCT01184859|325446|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
134493|NCT01184859|325447|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
134494|NCT01184859|325448|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
134495|NCT01184859|325449|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
134496|NCT01184859|325450|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
134497|NCT01184859|325446|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
134498|NCT01184859|325447|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
134499|NCT01184859|325448|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
134500|NCT01184859|325449|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
134501|NCT01184859|325450|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
134502|NCT01184859|325446|P5|STARTED|Period 2: Daily Dose for 28 Days||23
134503|NCT01184859|325447|P4|STARTED|Period 2: Daily Dose for 28 Days||22
134504|NCT01184859|325448|P3|STARTED|Period 2: Daily Dose for 28 Days||22
134505|NCT01184859|325449|P2|STARTED|Period 2: Daily Dose for 28 Days||23
134506|NCT01184859|325450|P1|STARTED|Period 2: Daily Dose for 28 Days||23
134507|NCT01184859|325446|P5|NOT COMPLETED|Washout Period||0
134508|NCT01184859|325447|P4|NOT COMPLETED|Washout Period||0
134509|NCT01184859|325448|P3|NOT COMPLETED|Washout Period||0
134510|NCT01184859|325449|P2|NOT COMPLETED|Washout Period||0
134511|NCT01184859|325450|P1|NOT COMPLETED|Washout Period||0
134512|NCT01184859|325446|P5|COMPLETED|Washout Period||23
134513|NCT01184859|325447|P4|COMPLETED|Washout Period||22
134514|NCT01184859|325448|P3|COMPLETED|Washout Period||22
134515|NCT01184859|325449|P2|COMPLETED|Washout Period||23
134516|NCT01184859|325450|P1|COMPLETED|Washout Period||23
134517|NCT01184859|325446|P5|STARTED|Washout Period||23
134518|NCT01184859|325447|P4|STARTED|Washout Period||22
134519|NCT01184859|325448|P3|STARTED|Washout Period||22
134520|NCT01184859|325449|P2|STARTED|Washout Period||23
134521|NCT01184859|325450|P1|STARTED|Washout Period||23
134522|NCT01184859|325446|P5|NOT COMPLETED|Period 1: Single Dose||1
134523|NCT01184859|325447|P4|NOT COMPLETED|Period 1: Single Dose||0
134524|NCT01184859|325448|P3|NOT COMPLETED|Period 1: Single Dose||0
134525|NCT01184859|325449|P2|NOT COMPLETED|Period 1: Single Dose||2
134526|NCT01184859|325450|P1|NOT COMPLETED|Period 1: Single Dose||0
134527|NCT01184859|325446|P5|COMPLETED|Period 1: Single Dose||23
134528|NCT01184859|325447|P4|COMPLETED|Period 1: Single Dose||22
134529|NCT01184859|325448|P3|COMPLETED|Period 1: Single Dose||22
134530|NCT01184859|325449|P2|COMPLETED|Period 1: Single Dose||23
134531|NCT01184859|325450|P1|COMPLETED|Period 1: Single Dose||23
134532|NCT01184859|325446|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
134533|NCT01184859|325447|P4|Per Protocol (PP)|Period 1: Single Dose||21
134534|NCT01184859|325448|P3|Per Protocol (PP)|Period 1: Single Dose||22
134535|NCT01184859|325449|P2|Per Protocol (PP)|Period 1: Single Dose||23
134536|NCT01184859|325450|P1|Per Protocol (PP)|Period 1: Single Dose||23
134537|NCT01184859|325446|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
134538|NCT01184859|325447|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
134539|NCT01184859|325448|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
134540|NCT01184859|325449|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
134541|NCT01184859|325450|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
134542|NCT01184859|325446|P5|STARTED|Period 1: Single Dose||24
134543|NCT01184859|325447|P4|STARTED|Period 1: Single Dose||22
134544|NCT01184859|325448|P3|STARTED|Period 1: Single Dose||22
134545|NCT01184859|325449|P2|STARTED|Period 1: Single Dose||25
134546|NCT01184859|325450|P1|STARTED|Period 1: Single Dose||23
134547|NCT01184846|325542|P1|NOT COMPLETED|Overall Study||3
134548|NCT01184846|325542|P1|COMPLETED|Overall Study||25
134549|NCT01184846|325542|P1|STARTED|Overall Study||28
134550|NCT01184755|325563|P3|NOT COMPLETED|Overall Study||6
134551|NCT01184755|325564|P2|NOT COMPLETED|Overall Study||11
134552|NCT01184755|325565|P1|NOT COMPLETED|Overall Study||25
134553|NCT01184755|325563|P3|COMPLETED|Overall Study||56
134554|NCT01184755|325564|P2|COMPLETED|Overall Study||54
134555|NCT01184755|325565|P1|COMPLETED|Overall Study||101
134556|NCT01184755|325563|P3|STARTED|Overall Study||62
134557|NCT01184755|325564|P2|STARTED|Overall Study||65
134558|NCT01184755|325565|P1|STARTED|Overall Study||126
134559|NCT01184417|325575|P2|NOT COMPLETED|Overall Study||0
134560|NCT01184417|325576|P1|NOT COMPLETED|Overall Study||0
134561|NCT01184417|325575|P2|COMPLETED|Overall Study||51
134562|NCT01184417|325576|P1|COMPLETED|Overall Study||51
134563|NCT01184417|325575|P2|STARTED|Overall Study||51
134564|NCT01184417|325576|P1|STARTED|Overall Study||51
134565|NCT01184118|325596|P1|NOT COMPLETED|Overall Study||18
134566|NCT01184118|325596|P1|COMPLETED|Overall Study||18
134567|NCT01184118|325596|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
134568|NCT01184118|325596|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
134569|NCT01184118|325596|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
134570|NCT01184118|325596|P1|STARTED|Overall Study||36
134571|NCT01184079|325604|P2|NOT COMPLETED|Overall Study||2
134572|NCT01184079|325605|P1|NOT COMPLETED|Overall Study||14
134573|NCT01184079|325604|P2|COMPLETED|Overall Study||107
134574|NCT01184079|325605|P1|COMPLETED|Overall Study||97
134575|NCT01184079|325604|P2|Final Blood Draw|Overall Study||107
134576|NCT01184079|325605|P1|Final Blood Draw|Overall Study||97
134577|NCT01184079|325604|P2|Dose 3|Overall Study||107
134578|NCT01184079|325605|P1|Dose 3|Overall Study||101
134579|NCT01184079|325604|P2|Dose 2|Overall Study||108
134580|NCT01184079|325605|P1|Dose 2|Overall Study||110
134581|NCT01184079|325604|P2|STARTED|Overall Study||109
134582|NCT01184079|325605|P1|STARTED|Overall Study||111
134583|NCT01184053|325615|P1|NOT COMPLETED|Overall Study||3
134584|NCT01184053|325615|P1|COMPLETED|Overall Study||0
134585|NCT01184053|325615|P1|STARTED|Overall Study||3
134586|NCT01184014|325624|P2|NOT COMPLETED|Overall Study||6
134587|NCT01184014|325625|P1|NOT COMPLETED|Overall Study||5
134588|NCT01184014|325624|P2|COMPLETED|Overall Study||31
134589|NCT01184014|325625|P1|COMPLETED|Overall Study||30
134590|NCT01184014|325624|P2|STARTED|Overall Study||37
134591|NCT01184014|325625|P1|STARTED|Overall Study||35
134592|NCT01183975|325631|P1|NOT COMPLETED|Overall Study||73
134593|NCT01183975|325631|P1|COMPLETED|Overall Study||444
134594|NCT01183975|325631|P1|STARTED|Overall Study||517
134595|NCT01183858|325638|P2|NOT COMPLETED|Overall Study||156
134596|NCT01183858|325639|P1|NOT COMPLETED|Overall Study||153
134597|NCT01183858|325638|P2|COMPLETED|Overall Study||3
134598|NCT01183858|325639|P1|COMPLETED|Overall Study||1
134599|NCT01183858|325638|P2|Safety Population|Overall Study||158
134600|NCT01183858|325639|P1|Safety Population|Overall Study||154
134601|NCT01183858|325638|P2|STARTED|Overall Study||159
134602|NCT01183858|325639|P1|STARTED|Overall Study||154
134603|NCT01183780|325661|P2|NOT COMPLETED|Overall Study||25
134604|NCT01183780|325662|P1|NOT COMPLETED|Overall Study||31
134605|NCT01183780|325661|P2|COMPLETED|Overall Study||511
134606|NCT01183780|325662|P1|COMPLETED|Overall Study||505
134607|NCT01183780|325661|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
134608|NCT01183780|325662|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
134609|NCT01183780|325661|P2|STARTED|Overall Study||536
134610|NCT01183780|325662|P1|STARTED|Overall Study||536
134611|NCT01183728|325679|P1|NOT COMPLETED|Overall Study||0
134612|NCT01183728|325679|P1|COMPLETED|Overall Study||12
134613|NCT01183728|325679|P1|STARTED|Overall Study||12
134614|NCT01183689|325687|P3|NOT COMPLETED|Overall Study||0
134615|NCT01183689|325688|P2|NOT COMPLETED|Overall Study||0
134616|NCT01183689|325689|P1|NOT COMPLETED|Overall Study||0
134617|NCT01183689|325687|P3|COMPLETED|Overall Study||197
134618|NCT01183689|325688|P2|COMPLETED|Overall Study||200
134619|NCT01183689|325689|P1|COMPLETED|Overall Study||202
134620|NCT01183689|325687|P3|Year 4 Visit|Overall Study||30
134621|NCT01183689|325688|P2|Year 4 Visit|Overall Study||33
134622|NCT01183689|325689|P1|Year 4 Visit|Overall Study||38
134623|NCT01183689|325687|P3|Year 3 Visit|Overall Study||126
134624|NCT01183689|325688|P2|Year 3 Visit|Overall Study||125
134625|NCT01183689|325689|P1|Year 3 Visit|Overall Study||139
134626|NCT01183689|325687|P3|Year 2 Visit|Overall Study||174
134627|NCT01183689|325688|P2|Year 2 Visit|Overall Study||172
134628|NCT01183689|325689|P1|Year 2 Visit|Overall Study||178
134629|NCT01183689|325687|P3|Year 1 Visit|Overall Study||183
134630|NCT01183689|325688|P2|Year 1 Visit|Overall Study||172
134631|NCT01183689|325689|P1|Year 1 Visit|Overall Study||187
134632|NCT01183689|325687|P3|Month 4 Visit|Overall Study||187
134633|NCT01183689|325688|P2|Month 4 Visit|Overall Study||192
134634|NCT01183689|325689|P1|Month 4 Visit|Overall Study||197
134635|NCT01183689|325687|P3|STARTED|Overall Study||197
134636|NCT01183689|325688|P2|STARTED|Overall Study||200
134637|NCT01183689|325689|P1|STARTED|Overall Study||202
134638|NCT01183650|325759|P2|NOT COMPLETED|Overall Study||0
134639|NCT01183650|325760|P1|NOT COMPLETED|Overall Study||0
134640|NCT01183650|325759|P2|COMPLETED|Overall Study||12
134641|NCT01183650|325760|P1|COMPLETED|Overall Study||12
134642|NCT01183650|325759|P2|STARTED|Overall Study||12
134643|NCT01183650|325760|P1|STARTED|Overall Study||12
134644|NCT01183546|325770|P1|NOT COMPLETED|Overall Study||0
134645|NCT01183546|325770|P1|COMPLETED|Overall Study||53
134646|NCT01183546|325770|P1|STARTED|Overall Study||53
134647|NCT01183533|325777|P1|NOT COMPLETED|Overall Study||0
134648|NCT01183533|325777|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
134649|NCT01183533|325777|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
134650|NCT01183481|325783|P1|NOT COMPLETED|Overall Study||0
134651|NCT01183481|325783|P1|COMPLETED|Overall Study||19
134652|NCT01183481|325783|P1|STARTED|Overall Study||19
134653|NCT01183468|325795|P4|NOT COMPLETED|Overall Study||0
134654|NCT01183468|325796|P3|NOT COMPLETED|Overall Study||0
134655|NCT01183468|325797|P2|NOT COMPLETED|Overall Study||2
134656|NCT01183468|325798|P1|NOT COMPLETED|Overall Study||3
134657|NCT01183468|325795|P4|COMPLETED|Overall Study||0
134658|NCT01183468|325796|P3|COMPLETED|Overall Study||0
134659|NCT01183468|325797|P2|COMPLETED|Overall Study||7
134660|NCT01183468|325798|P1|COMPLETED|Overall Study||5
134661|NCT01183468|325795|P4|STARTED|Overall Study||0
134662|NCT01183468|325796|P3|STARTED|Overall Study||0
134663|NCT01183468|325797|P2|STARTED|Overall Study||9
134664|NCT01183468|325798|P1|STARTED|Overall Study||8
134665|NCT01183390|325808|P2|NOT COMPLETED|Second Intervention||0
134666|NCT01183390|325809|P1|NOT COMPLETED|Second Intervention||0
134667|NCT01183390|325808|P2|COMPLETED|Second Intervention||10
134668|NCT01183390|325809|P1|COMPLETED|Second Intervention||11
134669|NCT01183390|325808|P2|STARTED|Second Intervention||10
134670|NCT01183390|325809|P1|STARTED|Second Intervention||11
134671|NCT01183390|325808|P2|NOT COMPLETED|Washout of 21 Days||0
134672|NCT01183390|325809|P1|NOT COMPLETED|Washout of 21 Days||0
134673|NCT01183390|325808|P2|COMPLETED|Washout of 21 Days||10
134674|NCT01183390|325809|P1|COMPLETED|Washout of 21 Days||11
134675|NCT01183390|325808|P2|STARTED|Washout of 21 Days||10
134676|NCT01183390|325809|P1|STARTED|Washout of 21 Days||11
134677|NCT01183390|325808|P2|NOT COMPLETED|First Intervention||1
134678|NCT01183390|325809|P1|NOT COMPLETED|First Intervention||0
134679|NCT01183390|325808|P2|COMPLETED|First Intervention||10
134680|NCT01183390|325809|P1|COMPLETED|First Intervention||11
134681|NCT01183390|325808|P2|STARTED|First Intervention||11
134682|NCT01183390|325809|P1|STARTED|First Intervention||11
134683|NCT01183312|325819|P2|NOT COMPLETED|Second Intervention Day||0
134684|NCT01183312|325820|P1|NOT COMPLETED|Second Intervention Day||0
134685|NCT01183312|325819|P2|COMPLETED|Second Intervention Day||5
134686|NCT01183312|325820|P1|COMPLETED|Second Intervention Day||5
134687|NCT01183312|325819|P2|STARTED|Second Intervention Day||5
134688|NCT01183312|325820|P1|STARTED|Second Intervention Day||5
134689|NCT01183312|325819|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
134690|NCT01183312|325820|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
134691|NCT01183312|325819|P2|COMPLETED|Washout Period of at Least 1 Week||5
134692|NCT01183312|325820|P1|COMPLETED|Washout Period of at Least 1 Week||5
134693|NCT01183312|325819|P2|STARTED|Washout Period of at Least 1 Week||5
134694|NCT01183312|325820|P1|STARTED|Washout Period of at Least 1 Week||5
134695|NCT01183312|325819|P2|NOT COMPLETED|First Intervention Day||0
134696|NCT01183312|325820|P1|NOT COMPLETED|First Intervention Day||0
134697|NCT01183312|325819|P2|COMPLETED|First Intervention Day||5
134698|NCT01183312|325820|P1|COMPLETED|First Intervention Day||5
134699|NCT01183312|325819|P2|STARTED|First Intervention Day||5
134700|NCT01183312|325820|P1|STARTED|First Intervention Day||5
134701|NCT01183260|325842|P2|NOT COMPLETED|Overall Study||2
134702|NCT01183260|325843|P1|NOT COMPLETED|Overall Study||4
134703|NCT01183260|325842|P2|COMPLETED|Overall Study||9
134704|NCT01183260|325843|P1|COMPLETED|Overall Study||10
134705|NCT01183260|325842|P2|STARTED|Overall Study||11
134706|NCT01183260|325843|P1|STARTED|Overall Study||14
134707|NCT01183234|325853|P2|NOT COMPLETED|Second Intervention||0
134708|NCT01183234|325854|P1|NOT COMPLETED|Second Intervention||0
134709|NCT01183234|325853|P2|COMPLETED|Second Intervention||14
134710|NCT01183234|325854|P1|COMPLETED|Second Intervention||13
134711|NCT01183234|325853|P2|STARTED|Second Intervention||14
134712|NCT01183234|325854|P1|STARTED|Second Intervention||13
134713|NCT01183234|325853|P2|NOT COMPLETED|Washout||0
134714|NCT01183234|325854|P1|NOT COMPLETED|Washout||0
134715|NCT01183234|325853|P2|COMPLETED|Washout||14
134716|NCT01183234|325854|P1|COMPLETED|Washout||13
134717|NCT01183234|325853|P2|STARTED|Washout||14
134718|NCT01183234|325854|P1|STARTED|Washout||13
134719|NCT01183234|325853|P2|NOT COMPLETED|First Intervention||0
134720|NCT01183234|325854|P1|NOT COMPLETED|First Intervention||1
134721|NCT01183234|325853|P2|COMPLETED|First Intervention||14
134722|NCT01183234|325854|P1|COMPLETED|First Intervention||13
134723|NCT01183234|325853|P2|STARTED|First Intervention||14
134724|NCT01183234|325854|P1|STARTED|First Intervention||14
134725|NCT01183169|325868|P7|NOT COMPLETED|Post-switch Phase||9
134726|NCT01183169|325869|P6|NOT COMPLETED|Post-switch Phase||14
134727|NCT01183169|325870|P5|NOT COMPLETED|Post-switch Phase||0
134728|NCT01183169|325871|P4|NOT COMPLETED|Post-switch Phase||0
134729|NCT01183169|325872|P3|NOT COMPLETED|Post-switch Phase||0
134730|NCT01183169|325873|P2|NOT COMPLETED|Post-switch Phase||0
134731|NCT01183169|325874|P1|NOT COMPLETED|Post-switch Phase||0
134732|NCT01183169|325868|P7|COMPLETED|Post-switch Phase||21
134733|NCT01183169|325869|P6|COMPLETED|Post-switch Phase||21
134734|NCT01183169|325870|P5|COMPLETED|Post-switch Phase||0
134735|NCT01183169|325871|P4|COMPLETED|Post-switch Phase||0
134736|NCT01183169|325872|P3|COMPLETED|Post-switch Phase||0
134737|NCT01183169|325873|P2|COMPLETED|Post-switch Phase||0
134738|NCT01183169|325874|P1|COMPLETED|Post-switch Phase||0
134739|NCT01183169|325868|P7|Completed Treatment|Post-switch Phase||13
134740|NCT01183169|325869|P6|Completed Treatment|Post-switch Phase||12
134741|NCT01183169|325870|P5|Completed Treatment|Post-switch Phase||0
134742|NCT01183169|325871|P4|Completed Treatment|Post-switch Phase||0
134743|NCT01183169|325872|P3|Completed Treatment|Post-switch Phase||0
134744|NCT01183169|325873|P2|Completed Treatment|Post-switch Phase||0
134745|NCT01183169|325874|P1|Completed Treatment|Post-switch Phase||0
134746|NCT01183169|325868|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
134747|NCT01183169|325869|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
134748|NCT01183169|325870|P5|STARTED|Post-switch Phase|Not a post-switch group|0
134749|NCT01183169|325871|P4|STARTED|Post-switch Phase|Not a post-switch group|0
134750|NCT01183169|325872|P3|STARTED|Post-switch Phase|Not a post-switch group|0
134751|NCT01183169|325873|P2|STARTED|Post-switch Phase|Not a post-switch group|0
134752|NCT01183169|325874|P1|STARTED|Post-switch Phase|Not a post-switch group|0
134753|NCT01183169|325868|P7|NOT COMPLETED|Main Phase||0
134754|NCT01183169|325869|P6|NOT COMPLETED|Main Phase||0
134755|NCT01183169|325870|P5|NOT COMPLETED|Main Phase||26
134756|NCT01183169|325871|P4|NOT COMPLETED|Main Phase||37
134757|NCT01183169|325872|P3|NOT COMPLETED|Main Phase||41
134758|NCT01183169|325873|P2|NOT COMPLETED|Main Phase||22
134759|NCT01183169|325874|P1|NOT COMPLETED|Main Phase||27
134760|NCT01183169|325868|P7|COMPLETED|Main Phase||0
134761|NCT01183169|325869|P6|COMPLETED|Main Phase||0
134762|NCT01183169|325870|P5|COMPLETED|Main Phase||83
134763|NCT01183169|325871|P4|COMPLETED|Main Phase||18
134764|NCT01183169|325872|P3|COMPLETED|Main Phase||18
134765|NCT01183169|325873|P2|COMPLETED|Main Phase||93
134766|NCT01183169|325874|P1|COMPLETED|Main Phase||94
134767|NCT01183169|325868|P7|Switched to ALV|Main Phase||0
134768|NCT01183169|325869|P6|Switched to ALV|Main Phase||0
134769|NCT01183169|325870|P5|Switched to ALV|Main Phase||0
134770|NCT01183169|325871|P4|Switched to ALV|Main Phase||30
134771|NCT01183169|325872|P3|Switched to ALV|Main Phase||35
134772|NCT01183169|325873|P2|Switched to ALV|Main Phase||0
134773|NCT01183169|325874|P1|Switched to ALV|Main Phase||0
134774|NCT01183169|325868|P7|Completed Treatment|Main Phase||0
134775|NCT01183169|325869|P6|Completed Treatment|Main Phase||0
134776|NCT01183169|325870|P5|Completed Treatment|Main Phase||77
134777|NCT01183169|325871|P4|Completed Treatment|Main Phase||17
134778|NCT01183169|325872|P3|Completed Treatment|Main Phase||17
134779|NCT01183169|325873|P2|Completed Treatment|Main Phase||78
134780|NCT01183169|325874|P1|Completed Treatment|Main Phase||72
134781|NCT01183169|325868|P7|STARTED|Main Phase||0
134782|NCT01183169|325869|P6|STARTED|Main Phase||0
134783|NCT01183169|325870|P5|STARTED|Main Phase||109
134784|NCT01183169|325871|P4|STARTED|Main Phase||55
134785|NCT01183169|325872|P3|STARTED|Main Phase||59
134786|NCT01183169|325873|P2|STARTED|Main Phase||115
134787|NCT01183169|325874|P1|STARTED|Main Phase||121
134788|NCT01183143|325946|P1|NOT COMPLETED|Overall Study||150
134789|NCT01183143|325946|P1|COMPLETED|Overall Study||65
134790|NCT01183143|325946|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
134791|NCT01183143|325946|P1|STARTED|Overall Study||215
134792|NCT01183104|325962|P2|NOT COMPLETED|Overall Study||92
134793|NCT01183104|325963|P1|NOT COMPLETED|Overall Study||77
134794|NCT01183104|325962|P2|COMPLETED|Overall Study||60
134795|NCT01183104|325963|P1|COMPLETED|Overall Study||76
134796|NCT01183104|325962|P2|Enrolled in Extension Study|Overall Study||61
134797|NCT01183104|325963|P1|Enrolled in Extension Study|Overall Study||80
134798|NCT01183104|325962|P2|Completed 52-week Treatment|Overall Study||111
134799|NCT01183104|325963|P1|Completed 52-week Treatment|Overall Study||119
134800|NCT01183104|325962|P2|Continued Treatment for 12 Weeks|Overall Study||129
134801|NCT01183104|325963|P1|Continued Treatment for 12 Weeks|Overall Study||143
134802|NCT01183104|325962|P2|Received Study Drug|Overall Study||143
134803|NCT01183104|325963|P1|Received Study Drug|Overall Study||148
134804|NCT01183104|325962|P2|STARTED|Overall Study||152
134805|NCT01183104|325963|P1|STARTED|Overall Study||153
134806|NCT01183065|325979|P1|NOT COMPLETED|Overall Study||1
134807|NCT01183065|325979|P1|COMPLETED|Overall Study||12
134808|NCT01183065|325979|P1|STARTED|Overall Study||13
134809|NCT01183013|325990|P7|NOT COMPLETED|Overall Study||37
134810|NCT01183013|325991|P6|NOT COMPLETED|Overall Study||45
134811|NCT01183013|325992|P5|NOT COMPLETED|Overall Study||36
134812|NCT01183013|325993|P4|NOT COMPLETED|Overall Study||30
134813|NCT01183013|325994|P3|NOT COMPLETED|Overall Study||41
134814|NCT01183013|325995|P2|NOT COMPLETED|Overall Study||39
134815|NCT01183013|325996|P1|NOT COMPLETED|Overall Study||45
134816|NCT01183013|325990|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
134817|NCT01183013|325991|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
134818|NCT01183013|325992|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
134819|NCT01183013|325993|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
134820|NCT01183013|325994|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
134821|NCT01183013|325995|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
134822|NCT01183013|325996|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
134823|NCT01183013|325990|P7|STARTED|Overall Study||133
134824|NCT01183013|325991|P6|STARTED|Overall Study||133
134825|NCT01183013|325992|P5|STARTED|Overall Study||126
134826|NCT01183013|325993|P4|STARTED|Overall Study||135
134827|NCT01183013|325994|P3|STARTED|Overall Study||138
134828|NCT01183013|325995|P2|STARTED|Overall Study||140
134829|NCT01183013|325996|P1|STARTED|Overall Study||131
134830|NCT01182805|326075|P1|NOT COMPLETED|Overall Study||0
134831|NCT01182805|326075|P1|COMPLETED|Overall Study||50
134832|NCT01182805|326075|P1|STARTED|Overall Study||50
134833|NCT01182727|326084|P1|NOT COMPLETED|Overall Study||0
134834|NCT01182727|326084|P1|COMPLETED|Overall Study||10
134835|NCT01182727|326084|P1|STARTED|Overall Study||10
134836|NCT01182675|326090|P2|NOT COMPLETED|Overall Study||0
134837|NCT01182675|326091|P1|NOT COMPLETED|Overall Study||0
134838|NCT01182675|326090|P2|COMPLETED|Overall Study||0
134839|NCT01182675|326091|P1|COMPLETED|Overall Study||7
134840|NCT01182675|326090|P2|STARTED|Overall Study||0
134841|NCT01182675|326091|P1|STARTED|Overall Study||7
134842|NCT01182610|326097|P1|NOT COMPLETED|Overall Study||0
134843|NCT01182610|326097|P1|COMPLETED|Overall Study||1
134844|NCT01182610|326097|P1|STARTED|Overall Study||1
134845|NCT01182493|326107|P2|NOT COMPLETED|Overall Study||7
134846|NCT01182493|326108|P1|NOT COMPLETED|Overall Study||16
134847|NCT01182493|326107|P2|COMPLETED|Overall Study||156
134848|NCT01182493|326108|P1|COMPLETED|Overall Study||152
134849|NCT01182493|326107|P2|STARTED|Overall Study||163
134850|NCT01182493|326108|P1|STARTED|Overall Study||168
134851|NCT01182480|326126|P1|NOT COMPLETED|Overall Study||0
134852|NCT01182480|326126|P1|COMPLETED|Overall Study||47
134853|NCT01182480|326126|P1|STARTED|Overall Study||47
134854|NCT01182428|326132|P2|NOT COMPLETED|Overall Study||1
134855|NCT01182428|326133|P1|NOT COMPLETED|Overall Study||11
134856|NCT01182428|326132|P2|COMPLETED|Overall Study||150
134857|NCT01182428|326133|P1|COMPLETED|Overall Study||293
134858|NCT01182428|326132|P2|STARTED|Overall Study||151
134859|NCT01182428|326133|P1|STARTED|Overall Study||304
134860|NCT01182415|326197|P1|NOT COMPLETED|Overall Study||1
134861|NCT01182415|326197|P1|COMPLETED|Overall Study||29
134862|NCT01182415|326197|P1|STARTED|Overall Study||30
134863|NCT01182376|326206|P2|NOT COMPLETED|Overall Study||5
134864|NCT01182376|326207|P1|NOT COMPLETED|Overall Study||11
134865|NCT01182376|326206|P2|COMPLETED|Overall Study||13
134866|NCT01182376|326207|P1|COMPLETED|Overall Study||4
134867|NCT01182376|326206|P2|STARTED|Overall Study||18
134868|NCT01182376|326207|P1|STARTED|Overall Study||15
134869|NCT01182337|326215|P2|NOT COMPLETED|Overall Study||2
134870|NCT01182337|326216|P1|NOT COMPLETED|Overall Study||3
134871|NCT01182337|326215|P2|COMPLETED|Overall Study||7
134872|NCT01182337|326216|P1|COMPLETED|Overall Study||19
134873|NCT01182337|326215|P2|STARTED|Overall Study||9
134874|NCT01182337|326216|P1|STARTED|Overall Study||22
134875|NCT01182298|326234|P1|NOT COMPLETED|Overall Study||6
134876|NCT01182298|326234|P1|COMPLETED|Overall Study||4
134877|NCT01182298|326234|P1|STARTED|Overall Study||10
134878|NCT01182285|326238|P3|NOT COMPLETED|Third Intervention Week 11-52||8
134879|NCT01182285|326239|P2|NOT COMPLETED|Third Intervention Week 11-52||0
134880|NCT01182285|326240|P1|NOT COMPLETED|Third Intervention Week 11-52||0
134881|NCT01182285|326238|P3|COMPLETED|Third Intervention Week 11-52||0
134882|NCT01182285|326239|P2|COMPLETED|Third Intervention Week 11-52||0
134883|NCT01182285|326240|P1|COMPLETED|Third Intervention Week 11-52||0
134884|NCT01182285|326238|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
134885|NCT01182285|326239|P2|STARTED|Third Intervention Week 11-52||0
134886|NCT01182285|326240|P1|STARTED|Third Intervention Week 11-52||0
134887|NCT01182285|326238|P3|NOT COMPLETED|Second Intervention Week 11-17||0
134888|NCT01182285|326239|P2|NOT COMPLETED|Second Intervention Week 11-17||0
134889|NCT01182285|326240|P1|NOT COMPLETED|Second Intervention Week 11-17||0
134890|NCT01182285|326238|P3|COMPLETED|Second Intervention Week 11-17||0
134891|NCT01182285|326239|P2|COMPLETED|Second Intervention Week 11-17||0
134892|NCT01182285|326240|P1|COMPLETED|Second Intervention Week 11-17||0
134893|NCT01182285|326238|P3|STARTED|Second Intervention Week 11-17||0
134894|NCT01182285|326239|P2|STARTED|Second Intervention Week 11-17||0
134895|NCT01182285|326240|P1|STARTED|Second Intervention Week 11-17||0
134896|NCT01182285|326238|P3|NOT COMPLETED|First Intervention Week 1-10||0
134897|NCT01182285|326239|P2|NOT COMPLETED|First Intervention Week 1-10||0
134898|NCT01182285|326240|P1|NOT COMPLETED|First Intervention Week 1-10||3
134899|NCT01182285|326238|P3|COMPLETED|First Intervention Week 1-10||0
134900|NCT01182285|326239|P2|COMPLETED|First Intervention Week 1-10||0
134901|NCT01182285|326240|P1|COMPLETED|First Intervention Week 1-10||10
134902|NCT01182285|326238|P3|STARTED|First Intervention Week 1-10||0
134903|NCT01182285|326239|P2|STARTED|First Intervention Week 1-10||0
134904|NCT01182285|326240|P1|STARTED|First Intervention Week 1-10||13
134905|NCT01182207|326250|P2|NOT COMPLETED|Second Intervention||0
134906|NCT01182207|326251|P1|NOT COMPLETED|Second Intervention||1
134907|NCT01182207|326250|P2|COMPLETED|Second Intervention||14
134908|NCT01182207|326251|P1|COMPLETED|Second Intervention||17
134909|NCT01182207|326250|P2|STARTED|Second Intervention||14
134910|NCT01182207|326251|P1|STARTED|Second Intervention||18
134911|NCT01182207|326250|P2|NOT COMPLETED|Washout of 28 Days||0
134912|NCT01182207|326251|P1|NOT COMPLETED|Washout of 28 Days||0
134913|NCT01182207|326250|P2|COMPLETED|Washout of 28 Days||14
134914|NCT01182207|326251|P1|COMPLETED|Washout of 28 Days||18
134915|NCT01182207|326250|P2|STARTED|Washout of 28 Days||14
134916|NCT01182207|326251|P1|STARTED|Washout of 28 Days||18
134917|NCT01182207|326250|P2|NOT COMPLETED|First Intervention||1
134918|NCT01182207|326251|P1|NOT COMPLETED|First Intervention||0
134919|NCT01182207|326250|P2|COMPLETED|First Intervention||14
134920|NCT01182207|326251|P1|COMPLETED|First Intervention||18
134921|NCT01182207|326250|P2|STARTED|First Intervention||15
134922|NCT01182207|326251|P1|STARTED|First Intervention||18
134923|NCT01182194|326269|P2|NOT COMPLETED|Second Intervention||0
134924|NCT01182194|326270|P1|NOT COMPLETED|Second Intervention||0
134925|NCT01182194|326269|P2|COMPLETED|Second Intervention||16
134926|NCT01182194|326270|P1|COMPLETED|Second Intervention||15
134927|NCT01182194|326269|P2|STARTED|Second Intervention||16
134928|NCT01182194|326270|P1|STARTED|Second Intervention||15
134929|NCT01182194|326269|P2|NOT COMPLETED|Washout of 28 Days||0
134930|NCT01182194|326270|P1|NOT COMPLETED|Washout of 28 Days||1
134931|NCT01182194|326269|P2|COMPLETED|Washout of 28 Days||16
134932|NCT01182194|326270|P1|COMPLETED|Washout of 28 Days||15
134933|NCT01182194|326269|P2|STARTED|Washout of 28 Days||16
134934|NCT01182194|326270|P1|STARTED|Washout of 28 Days||16
134935|NCT01182194|326269|P2|NOT COMPLETED|First Intervention||0
134936|NCT01182194|326270|P1|NOT COMPLETED|First Intervention||0
134937|NCT01182194|326269|P2|COMPLETED|First Intervention||16
134938|NCT01182194|326270|P1|COMPLETED|First Intervention||16
134939|NCT01182194|326269|P2|STARTED|First Intervention||16
134940|NCT01182194|326270|P1|STARTED|First Intervention||16
134941|NCT01182181|326288|P2|NOT COMPLETED|Second Intervention||0
134942|NCT01182181|326289|P1|NOT COMPLETED|Second Intervention||0
134943|NCT01182181|326288|P2|COMPLETED|Second Intervention||10
134944|NCT01182181|326289|P1|COMPLETED|Second Intervention||10
134945|NCT01182181|326288|P2|STARTED|Second Intervention||10
134946|NCT01182181|326289|P1|STARTED|Second Intervention||10
134947|NCT01182181|326288|P2|NOT COMPLETED|Washout of 21 Days||1
134948|NCT01182181|326289|P1|NOT COMPLETED|Washout of 21 Days||0
134949|NCT01182181|326288|P2|COMPLETED|Washout of 21 Days||10
134950|NCT01182181|326289|P1|COMPLETED|Washout of 21 Days||10
134951|NCT01182181|326288|P2|STARTED|Washout of 21 Days||11
134952|NCT01182181|326289|P1|STARTED|Washout of 21 Days||10
134953|NCT01182181|326288|P2|NOT COMPLETED|First Intervention||0
134954|NCT01182181|326289|P1|NOT COMPLETED|First Intervention||1
134955|NCT01182181|326288|P2|COMPLETED|First Intervention||11
134956|NCT01182181|326289|P1|COMPLETED|First Intervention||10
134957|NCT01182181|326288|P2|STARTED|First Intervention||11
134958|NCT01182181|326289|P1|STARTED|First Intervention||11
134959|NCT01182103|326299|P2|NOT COMPLETED|Overall Study||0
134960|NCT01182103|326300|P1|NOT COMPLETED|Overall Study||0
134961|NCT01182103|326299|P2|COMPLETED|Overall Study||62
134962|NCT01182103|326300|P1|COMPLETED|Overall Study||48
134963|NCT01182103|326299|P2|STARTED|Overall Study||62
134964|NCT01182103|326300|P1|STARTED|Overall Study||48
134965|NCT01181986|326314|P3|NOT COMPLETED|Phase 2||0
134966|NCT01181986|326315|P2|NOT COMPLETED|Phase 2||4
134967|NCT01181986|326316|P1|NOT COMPLETED|Phase 2||0
134968|NCT01181986|326314|P3|COMPLETED|Phase 2||0
134969|NCT01181986|326315|P2|COMPLETED|Phase 2||18
134970|NCT01181986|326316|P1|COMPLETED|Phase 2||18
134971|NCT01181986|326314|P3|STARTED|Phase 2|N/A for Sub-study 2|0
134972|NCT01181986|326315|P2|STARTED|Phase 2||22
134973|NCT01181986|326316|P1|STARTED|Phase 2||18
134974|NCT01181986|326314|P3|NOT COMPLETED|Phase 1||2
134975|NCT01181986|326315|P2|NOT COMPLETED|Phase 1||1
134976|NCT01181986|326316|P1|NOT COMPLETED|Phase 1||1
134977|NCT01181986|326314|P3|COMPLETED|Phase 1||32
134978|NCT01181986|326315|P2|COMPLETED|Phase 1||22
134979|NCT01181986|326316|P1|COMPLETED|Phase 1||18
134980|NCT01181986|326314|P3|Exendin-9+Exenatide|Phase 1||33
134981|NCT01181986|326315|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
134982|NCT01181986|326316|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
134983|NCT01181986|326314|P3|Saline+Placebo|Phase 1||33
134984|NCT01181986|326315|P2|Saline+Placebo|Phase 1|N/A for this arm|0
134985|NCT01181986|326316|P1|Saline+Placebo|Phase 1|N/A for this arm|0
134986|NCT01181986|326314|P3|Saline+Exenatide|Phase 1||32
134987|NCT01181986|326315|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
134988|NCT01181986|326316|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
134989|NCT01181986|326314|P3|STARTED|Phase 1||34
134990|NCT01181986|326315|P2|STARTED|Phase 1||23
134991|NCT01181986|326316|P1|STARTED|Phase 1||19
134992|NCT01181947|326332|P1|NOT COMPLETED|Overall Study||0
134993|NCT01181947|326332|P1|COMPLETED|Overall Study||100
134994|NCT01181947|326332|P1|STARTED|Overall Study||100
134995|NCT01181921|326337|P1|NOT COMPLETED|Overall Study||1
134996|NCT01181921|326337|P1|COMPLETED|Overall Study||0
134997|NCT01181921|326337|P1|STARTED|Overall Study||1
134998|NCT01181895|326344|P3|NOT COMPLETED|Overall Study||18
134999|NCT01181895|326345|P2|NOT COMPLETED|Overall Study||14
135000|NCT01181895|326346|P1|NOT COMPLETED|Overall Study||17
135001|NCT01181895|326344|P3|COMPLETED|Overall Study||98
135002|NCT01181895|326345|P2|COMPLETED|Overall Study||101
135003|NCT01181895|326346|P1|COMPLETED|Overall Study||99
135004|NCT01181895|326344|P3|STARTED|Overall Study||116
135005|NCT01181895|326345|P2|STARTED|Overall Study||115
135006|NCT01181895|326346|P1|STARTED|Overall Study||116
135007|NCT01181804|326379|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
135008|NCT01181804|326380|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
135009|NCT01181804|326381|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
135010|NCT01181804|326382|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
135011|NCT01181804|326379|P4|COMPLETED|Period 4, Fasted (Part 2)||58
135012|NCT01181804|326380|P3|COMPLETED|Period 4, Fasted (Part 2)||58
135013|NCT01181804|326381|P2|COMPLETED|Period 4, Fasted (Part 2)||0
135014|NCT01181804|326382|P1|COMPLETED|Period 4, Fasted (Part 2)||0
135015|NCT01181804|326379|P4|STARTED|Period 4, Fasted (Part 2)||58
135016|NCT01181804|326380|P3|STARTED|Period 4, Fasted (Part 2)||59
135017|NCT01181804|326381|P2|STARTED|Period 4, Fasted (Part 2)||0
135018|NCT01181804|326382|P1|STARTED|Period 4, Fasted (Part 2)||0
135019|NCT01181804|326379|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
135020|NCT01181804|326380|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
135021|NCT01181804|326381|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
135022|NCT01181804|326382|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
135023|NCT01181804|326379|P4|COMPLETED|Period 3, Fasted (Part 2)||58
135024|NCT01181804|326380|P3|COMPLETED|Period 3, Fasted (Part 2)||59
135025|NCT01181804|326381|P2|COMPLETED|Period 3, Fasted (Part 2)||0
135026|NCT01181804|326382|P1|COMPLETED|Period 3, Fasted (Part 2)||0
135027|NCT01181804|326379|P4|STARTED|Period 3, Fasted (Part 2)||58
135028|NCT01181804|326380|P3|STARTED|Period 3, Fasted (Part 2)||59
135029|NCT01181804|326381|P2|STARTED|Period 3, Fasted (Part 2)||0
135030|NCT01181804|326382|P1|STARTED|Period 3, Fasted (Part 2)||0
135031|NCT01181804|326379|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
135032|NCT01181804|326380|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
135033|NCT01181804|326381|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
135034|NCT01181804|326382|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
135035|NCT01181804|326379|P4|COMPLETED|Period 2, Fed (Part 1)||0
135036|NCT01181804|326380|P3|COMPLETED|Period 2, Fed (Part 1)||0
135037|NCT01181804|326381|P2|COMPLETED|Period 2, Fed (Part 1)||30
135038|NCT01181804|326382|P1|COMPLETED|Period 2, Fed (Part 1)||30
135039|NCT01181804|326379|P4|STARTED|Period 2, Fed (Part 1)||0
135040|NCT01181804|326380|P3|STARTED|Period 2, Fed (Part 1)||0
135041|NCT01181804|326381|P2|STARTED|Period 2, Fed (Part 1)||30
135042|NCT01181804|326382|P1|STARTED|Period 2, Fed (Part 1)||30
135043|NCT01181804|326379|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
135044|NCT01181804|326380|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
135045|NCT01181804|326381|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
135046|NCT01181804|326382|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
135047|NCT01181804|326379|P4|COMPLETED|Period 1, Fed (Part 1)||0
135048|NCT01181804|326380|P3|COMPLETED|Period 1, Fed (Part 1)||0
135049|NCT01181804|326381|P2|COMPLETED|Period 1, Fed (Part 1)||30
135050|NCT01181804|326382|P1|COMPLETED|Period 1, Fed (Part 1)||30
135051|NCT01181804|326379|P4|STARTED|Period 1, Fed (Part 1)||0
135052|NCT01181804|326380|P3|STARTED|Period 1, Fed (Part 1)||0
135053|NCT01181804|326381|P2|STARTED|Period 1, Fed (Part 1)||30
135054|NCT01181804|326382|P1|STARTED|Period 1, Fed (Part 1)||30
135055|NCT01181778|326404|P1|NOT COMPLETED|Overall Study||48
135056|NCT01181778|326404|P1|COMPLETED|Overall Study||1871
135057|NCT01181778|326404|P1|STARTED|Overall Study||1919
135058|NCT01181726|326412|P2|NOT COMPLETED|Second Intervention||0
135059|NCT01181726|326413|P1|NOT COMPLETED|Second Intervention||0
135060|NCT01181726|326412|P2|COMPLETED|Second Intervention||20
135061|NCT01181726|326413|P1|COMPLETED|Second Intervention||19
135062|NCT01181726|326412|P2|STARTED|Second Intervention||20
135063|NCT01181726|326413|P1|STARTED|Second Intervention||19
135064|NCT01181726|326412|P2|NOT COMPLETED|Washout of 28 Days||0
135065|NCT01181726|326413|P1|NOT COMPLETED|Washout of 28 Days||0
135066|NCT01181726|326412|P2|COMPLETED|Washout of 28 Days||20
135067|NCT01181726|326413|P1|COMPLETED|Washout of 28 Days||19
135068|NCT01181726|326412|P2|STARTED|Washout of 28 Days||20
135069|NCT01181726|326413|P1|STARTED|Washout of 28 Days||19
135070|NCT01181726|326412|P2|NOT COMPLETED|First Intervention||0
135071|NCT01181726|326413|P1|NOT COMPLETED|First Intervention||1
135072|NCT01181726|326412|P2|COMPLETED|First Intervention||20
135073|NCT01181726|326413|P1|COMPLETED|First Intervention||19
135074|NCT01181726|326412|P2|STARTED|First Intervention||20
135075|NCT01181726|326413|P1|STARTED|First Intervention||20
135076|NCT01181609|326459|P1|NOT COMPLETED|Overall Study||53
135077|NCT01181609|326459|P1|COMPLETED|Overall Study||1
135078|NCT01181609|326459|P1|STARTED|Overall Study||54
135079|NCT01181531|326472|P2|NOT COMPLETED|Overall Study||53
135080|NCT01181531|326473|P1|NOT COMPLETED|Overall Study||61
135081|NCT01181531|326472|P2|COMPLETED|Overall Study||102
135082|NCT01181531|326473|P1|COMPLETED|Overall Study||96
135083|NCT01181531|326472|P2|Received Investigational Product|Overall Study||153
135084|NCT01181531|326473|P1|Received Investigational Product|Overall Study||155
135085|NCT01181531|326472|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
135086|NCT01181531|326473|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
135087|NCT01181492|326486|P3|NOT COMPLETED|Overall Study||0
135088|NCT01181492|326487|P2|NOT COMPLETED|Overall Study||0
135089|NCT01181492|326488|P1|NOT COMPLETED|Overall Study||0
135090|NCT01181492|326486|P3|COMPLETED|Overall Study||7
135091|NCT01181492|326487|P2|COMPLETED|Overall Study||66
135092|NCT01181492|326488|P1|COMPLETED|Overall Study||103
135093|NCT01181492|326486|P3|STARTED|Overall Study||7
135094|NCT01181492|326487|P2|STARTED|Overall Study||66
135095|NCT01181492|326488|P1|STARTED|Overall Study||103
135096|NCT01181349|326502|P1|NOT COMPLETED|Overall Study||0
135097|NCT01181349|326502|P1|COMPLETED|Overall Study||350
135098|NCT01181349|326502|P1|STARTED|Overall Study||350
135099|NCT01181323|326518|P4|NOT COMPLETED|Overall Study||3
135100|NCT01181323|326519|P3|NOT COMPLETED|Overall Study||1
135101|NCT01181323|326520|P2|NOT COMPLETED|Overall Study||3
135102|NCT01181323|326521|P1|NOT COMPLETED|Overall Study||1
135103|NCT01181323|326518|P4|COMPLETED|Overall Study||122
135104|NCT01181323|326519|P3|COMPLETED|Overall Study||123
135105|NCT01181323|326520|P2|COMPLETED|Overall Study||121
135106|NCT01181323|326521|P1|COMPLETED|Overall Study||123
135107|NCT01181323|326518|P4|STARTED|Overall Study||125
135108|NCT01181323|326519|P3|STARTED|Overall Study||124
135109|NCT01181323|326520|P2|STARTED|Overall Study||124
135110|NCT01181323|326521|P1|STARTED|Overall Study||124
135111|NCT01181271|326596|P1|NOT COMPLETED|Allogeneic Transplant||0
135112|NCT01181271|326596|P1|COMPLETED|Allogeneic Transplant||29
135113|NCT01181271|326596|P1|STARTED|Allogeneic Transplant||29
135114|NCT01181271|326596|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
135115|NCT01181271|326596|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
135116|NCT01181271|326596|P1|STARTED|Evaluation for Allogeneic Transplant||42
135117|NCT01181271|326596|P1|NOT COMPLETED|Autologous Transplant||0
135118|NCT01181271|326596|P1|COMPLETED|Autologous Transplant||42
135119|NCT01181271|326596|P1|STARTED|Autologous Transplant||42
135120|NCT01181258|326611|P1|NOT COMPLETED|Overall Study||0
135121|NCT01181258|326611|P1|COMPLETED|Overall Study||16
135122|NCT01181258|326611|P1|STARTED|Overall Study||16
135123|NCT01181167|326620|P2|NOT COMPLETED|Overall Study||32
135124|NCT01181167|326621|P1|NOT COMPLETED|Overall Study||23
135125|NCT01181167|326620|P2|COMPLETED|Overall Study||271
135126|NCT01181167|326621|P1|COMPLETED|Overall Study||284
135127|NCT01181167|326620|P2|Efficacy Analysis Population|Overall Study||248
135128|NCT01181167|326621|P1|Efficacy Analysis Population|Overall Study||255
135129|NCT01181167|326620|P2|STARTED|Overall Study||303
135130|NCT01181167|326621|P1|STARTED|Overall Study||307
135131|NCT01181141|326631|P2|NOT COMPLETED|Overall Study||4
135132|NCT01181141|326632|P1|NOT COMPLETED|Overall Study||12
135133|NCT01181141|326631|P2|COMPLETED|Overall Study||26
135134|NCT01181141|326632|P1|COMPLETED|Overall Study||50
135135|NCT01181141|326631|P2|Safety Analysis Population|Overall Study||29
135136|NCT01181141|326632|P1|Safety Analysis Population|Overall Study||59
135137|NCT01181141|326631|P2|STARTED|Overall Study||30
135138|NCT01181141|326632|P1|STARTED|Overall Study||62
135139|NCT01181128|326641|P3|NOT COMPLETED|Overall Study||1
135140|NCT01181128|326642|P2|NOT COMPLETED|Overall Study||5
135141|NCT01181128|326643|P1|NOT COMPLETED|Overall Study||6
135142|NCT01181128|326641|P3|COMPLETED|Overall Study||22
135143|NCT01181128|326642|P2|COMPLETED|Overall Study||19
135144|NCT01181128|326643|P1|COMPLETED|Overall Study||112
135145|NCT01181128|326641|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
135146|NCT01181128|326642|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
135147|NCT01181128|326643|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
135148|NCT01181128|326641|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
135149|NCT01181128|326642|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
135150|NCT01181128|326643|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
135151|NCT01181128|326641|P3|STARTED|Overall Study||23
135152|NCT01181128|326642|P2|STARTED|Overall Study||24
135153|NCT01181128|326643|P1|STARTED|Overall Study||118
135154|NCT01181102|326731|P2|NOT COMPLETED|Overall Study||46
135155|NCT01181102|326732|P1|NOT COMPLETED|Overall Study||51
135156|NCT01181102|326731|P2|COMPLETED|Overall Study||310
135157|NCT01181102|326732|P1|COMPLETED|Overall Study||309
135158|NCT01181102|326731|P2|Efficacy Analysis Population|Overall Study||295
135159|NCT01181102|326732|P1|Efficacy Analysis Population|Overall Study||299
135160|NCT01181102|326731|P2|Safety Analysis Set|Overall Study||349
135161|NCT01181102|326732|P1|Safety Analysis Set|Overall Study||354
135162|NCT01181102|326731|P2|STARTED|Overall Study||356
135163|NCT01181102|326732|P1|STARTED|Overall Study||360
135164|NCT01181050|326742|P2|NOT COMPLETED|Overall Study||0
135165|NCT01181050|326743|P1|NOT COMPLETED|Overall Study||0
135166|NCT01181050|326742|P2|COMPLETED|Overall Study||22
135167|NCT01181050|326743|P1|COMPLETED|Overall Study||41
135168|NCT01181050|326742|P2|STARTED|Overall Study||22
135169|NCT01181050|326743|P1|STARTED|Overall Study||41
135170|NCT01181011|326753|P1|NOT COMPLETED|Overall Study||3
135171|NCT01181011|326753|P1|COMPLETED|Overall Study||25
135172|NCT01181011|326753|P1|Received Amlodipine 5mg|Overall Study||26
135173|NCT01181011|326753|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
135174|NCT01181011|326753|P1|Received Telmisartan 80mg|Overall Study||27
135175|NCT01181011|326753|P1|STARTED|Overall Study||28
135176|NCT01180998|326803|P3|NOT COMPLETED|Overall Study||10
135177|NCT01180998|326804|P2|NOT COMPLETED|Overall Study||4
135178|NCT01180998|326805|P1|NOT COMPLETED|Overall Study||4
135179|NCT01180998|326803|P3|COMPLETED|Overall Study||51
135180|NCT01180998|326804|P2|COMPLETED|Overall Study||68
135181|NCT01180998|326805|P1|COMPLETED|Overall Study||63
135182|NCT01180998|326803|P3|STARTED|Overall Study||61
135183|NCT01180998|326804|P2|STARTED|Overall Study||72
135184|NCT01180998|326805|P1|STARTED|Overall Study||67
135185|NCT01180985|326819|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
135186|NCT01180985|326820|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
135187|NCT01180985|326819|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
135188|NCT01180985|326820|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
135189|NCT01180985|326819|P2|STARTED|Period 2 (7 +/- 1 Days)||26
135190|NCT01180985|326820|P1|STARTED|Period 2 (7 +/- 1 Days)||27
135191|NCT01180985|326819|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
135192|NCT01180985|326820|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
135193|NCT01180985|326819|P2|COMPLETED|Period 1 (7 +/- Days)||26
135194|NCT01180985|326820|P1|COMPLETED|Period 1 (7 +/- Days)||27
135195|NCT01180985|326819|P2|STARTED|Period 1 (7 +/- Days)||26
135196|NCT01180985|326820|P1|STARTED|Period 1 (7 +/- Days)||27
135197|NCT01180894|326839|P2|NOT COMPLETED|Overall Study||0
135198|NCT01180894|326840|P1|NOT COMPLETED|Overall Study||0
135199|NCT01180894|326839|P2|COMPLETED|Overall Study||75
135200|NCT01180894|326840|P1|COMPLETED|Overall Study||75
135201|NCT01180894|326839|P2|STARTED|Overall Study||75
135202|NCT01180894|326840|P1|STARTED|Overall Study||75
135203|NCT01180790|326859|P7|NOT COMPLETED|Overall Study||1
135204|NCT01180790|326860|P6|NOT COMPLETED|Overall Study||7
135205|NCT01180790|326861|P5|NOT COMPLETED|Overall Study||5
135206|NCT01180790|326862|P4|NOT COMPLETED|Overall Study||9
135207|NCT01180790|326863|P3|NOT COMPLETED|Overall Study||13
135208|NCT01180790|326864|P2|NOT COMPLETED|Overall Study||5
135209|NCT01180790|326865|P1|NOT COMPLETED|Overall Study||9
135210|NCT01180790|326859|P7|COMPLETED|Overall Study||18
135211|NCT01180790|326860|P6|COMPLETED|Overall Study||13
135212|NCT01180790|326861|P5|COMPLETED|Overall Study||14
135213|NCT01180790|326862|P4|COMPLETED|Overall Study||6
135214|NCT01180790|326863|P3|COMPLETED|Overall Study||4
135215|NCT01180790|326864|P2|COMPLETED|Overall Study||11
135216|NCT01180790|326865|P1|COMPLETED|Overall Study||7
135217|NCT01180790|326859|P7|STARTED|Overall Study||19
135218|NCT01180790|326860|P6|STARTED|Overall Study||20
135219|NCT01180790|326861|P5|STARTED|Overall Study||19
135220|NCT01180790|326862|P4|STARTED|Overall Study||15
135221|NCT01180790|326863|P3|STARTED|Overall Study||17
135222|NCT01180790|326864|P2|STARTED|Overall Study||16
135223|NCT01180790|326865|P1|STARTED|Overall Study||16
135224|NCT01180777|326930|P1|NOT COMPLETED|Overall Study||12
135225|NCT01180777|326930|P1|COMPLETED|Overall Study||80
135226|NCT01180777|326930|P1|STARTED|Overall Study||92
135227|NCT01180660|326944|P2|NOT COMPLETED|Overall Study||0
135228|NCT01180660|326945|P1|NOT COMPLETED|Overall Study||1
135229|NCT01180660|326944|P2|COMPLETED|Overall Study||26
135230|NCT01180660|326945|P1|COMPLETED|Overall Study||24
135231|NCT01180660|326944|P2|STARTED|Overall Study||26
135232|NCT01180660|326945|P1|STARTED|Overall Study||25
135233|NCT01180647|326955|P2|NOT COMPLETED|Overall Study||6
135234|NCT01180647|326956|P1|NOT COMPLETED|Overall Study||5
135235|NCT01180647|326955|P2|COMPLETED|Overall Study||11
135236|NCT01180647|326956|P1|COMPLETED|Overall Study||12
135237|NCT01180647|326955|P2|STARTED|Overall Study||17
135238|NCT01180647|326956|P1|STARTED|Overall Study||17
135239|NCT01180478|326974|P2|NOT COMPLETED|Overall Study||188
135240|NCT01180478|326975|P1|NOT COMPLETED|Overall Study||181
135241|NCT01180478|326974|P2|COMPLETED|Overall Study||293
135242|NCT01180478|326975|P1|COMPLETED|Overall Study||303
135243|NCT01180478|326974|P2|STARTED|Overall Study||481
135244|NCT01180478|326975|P1|STARTED|Overall Study||484
135245|NCT01180400|326991|P2|NOT COMPLETED|Overall Study||27
135246|NCT01180400|326992|P1|NOT COMPLETED|Overall Study||25
135247|NCT01180400|326991|P2|COMPLETED|Overall Study||121
135248|NCT01180400|326992|P1|COMPLETED|Overall Study||122
135249|NCT01180400|326991|P2|Received Treatment|Overall Study||146
135250|NCT01180400|326992|P1|Received Treatment|Overall Study||147
135251|NCT01180400|326991|P2|STARTED|Overall Study||148
135252|NCT01180400|326992|P1|STARTED|Overall Study||147
135253|NCT01180296|327040|P2|NOT COMPLETED|Overall Study||2
135254|NCT01180296|327041|P1|NOT COMPLETED|Overall Study||1
135255|NCT01180296|327040|P2|COMPLETED|Overall Study||14
135256|NCT01180296|327041|P1|COMPLETED|Overall Study||19
135257|NCT01180296|327040|P2|STARTED|Overall Study||16
135258|NCT01180296|327041|P1|STARTED|Overall Study||20
135259|NCT01180244|327049|P2|NOT COMPLETED|Overall Study||8
135260|NCT01180244|327050|P1|NOT COMPLETED|Overall Study||6
135261|NCT01180244|327049|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
135262|NCT01180244|327050|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
135263|NCT01180244|327049|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
135264|NCT01180244|327050|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
135265|NCT01180244|327049|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
135266|NCT01180244|327050|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
135267|NCT01180127|327068|P4|NOT COMPLETED|Overall Study||1
135268|NCT01180127|327069|P3|NOT COMPLETED|Overall Study||1
135269|NCT01180127|327070|P2|NOT COMPLETED|Overall Study||0
135270|NCT01180127|327071|P1|NOT COMPLETED|Overall Study||2
135271|NCT01180127|327068|P4|COMPLETED|Overall Study||9
135272|NCT01180127|327069|P3|COMPLETED|Overall Study||9
135273|NCT01180127|327070|P2|COMPLETED|Overall Study||11
135274|NCT01180127|327071|P1|COMPLETED|Overall Study||8
135275|NCT01180127|327068|P4|STARTED|Overall Study||10
135276|NCT01180127|327069|P3|STARTED|Overall Study||10
135277|NCT01180127|327070|P2|STARTED|Overall Study||11
135278|NCT01180127|327071|P1|STARTED|Overall Study||10
135279|NCT01180049|327095|P2|NOT COMPLETED|Overall Study||43
135280|NCT01180049|327096|P1|NOT COMPLETED|Overall Study||47
135281|NCT01180049|327095|P2|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
135282|NCT01180049|327096|P1|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
135283|NCT01180049|327095|P2|Treated|Overall Study||42
135284|NCT01180049|327096|P1|Treated|Overall Study||47
135285|NCT01180049|327095|P2|STARTED|Overall Study||43
135286|NCT01180049|327096|P1|STARTED|Overall Study||47
135287|NCT01179984|327116|P1|NOT COMPLETED|Overall Study||18
135288|NCT01179984|327116|P1|COMPLETED|Overall Study||58
135289|NCT01179984|327116|P1|STARTED|Overall Study||76
135290|NCT01179919|327122|P1|NOT COMPLETED|Overall Study||2
135291|NCT01179919|327122|P1|COMPLETED|Overall Study||19
135292|NCT01179919|327122|P1|STARTED|Overall Study||21
135293|NCT01179737|327131|P4|NOT COMPLETED|Extension||0
135294|NCT01179737|327132|P3|NOT COMPLETED|Extension||0
135295|NCT01179737|327133|P2|NOT COMPLETED|Extension||0
135296|NCT01179737|327134|P1|NOT COMPLETED|Extension||3
135297|NCT01179737|327131|P4|COMPLETED|Extension||0
135298|NCT01179737|327132|P3|COMPLETED|Extension||0
135299|NCT01179737|327133|P2|COMPLETED|Extension||0
135300|NCT01179737|327134|P1|COMPLETED|Extension||0
135301|NCT01179737|327131|P4|STARTED|Extension||0
135302|NCT01179737|327132|P3|STARTED|Extension||0
135303|NCT01179737|327133|P2|STARTED|Extension|One patient did not enrol in the extension|0
135304|NCT01179737|327134|P1|STARTED|Extension|Two patients did not enrol in the extension|3
135305|NCT01179737|327131|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
135306|NCT01179737|327132|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
135307|NCT01179737|327133|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
135308|NCT01179737|327134|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
135309|NCT01179737|327131|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
135310|NCT01179737|327132|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
135311|NCT01179737|327133|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
135312|NCT01179737|327134|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
135313|NCT01179737|327131|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
135314|NCT01179737|327132|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
135315|NCT01179737|327133|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
135316|NCT01179737|327134|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
135317|NCT01179737|327131|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
135318|NCT01179737|327132|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
135319|NCT01179737|327133|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
135320|NCT01179737|327134|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
135321|NCT01179737|327131|P4|COMPLETED|Cohort 1 & Cohort 2||0
135322|NCT01179737|327132|P3|COMPLETED|Cohort 1 & Cohort 2||0
135323|NCT01179737|327133|P2|COMPLETED|Cohort 1 & Cohort 2||1
135324|NCT01179737|327134|P1|COMPLETED|Cohort 1 & Cohort 2||7
135325|NCT01179737|327131|P4|STARTED|Cohort 1 & Cohort 2||4
135326|NCT01179737|327132|P3|STARTED|Cohort 1 & Cohort 2||4
135327|NCT01179737|327133|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
135328|NCT01179737|327134|P1|STARTED|Cohort 1 & Cohort 2||12
135329|NCT01179672|327145|P2|NOT COMPLETED|Overall Study||26
135330|NCT01179672|327146|P1|NOT COMPLETED|Overall Study||30
135331|NCT01179672|327145|P2|COMPLETED|Overall Study||176
135332|NCT01179672|327146|P1|COMPLETED|Overall Study||173
135333|NCT01179672|327145|P2|Entered Taper|Overall Study||177
135334|NCT01179672|327146|P1|Entered Taper|Overall Study||181
135335|NCT01179672|327145|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
135336|NCT01179672|327146|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
135337|NCT01179672|327145|P2|STARTED|Overall Study||202
135338|NCT01179672|327146|P1|STARTED|Overall Study||203
135339|NCT01179568|327176|P4|NOT COMPLETED|Overall Study||20
135340|NCT01179568|327177|P3|NOT COMPLETED|Overall Study||23
135341|NCT01179568|327178|P2|NOT COMPLETED|Overall Study||38
135342|NCT01179568|327179|P1|NOT COMPLETED|Overall Study||28
135343|NCT01179568|327176|P4|COMPLETED|Overall Study||76
135344|NCT01179568|327177|P3|COMPLETED|Overall Study||76
135345|NCT01179568|327178|P2|COMPLETED|Overall Study||61
135346|NCT01179568|327179|P1|COMPLETED|Overall Study||73
135347|NCT01179568|327176|P4|Completed Week 12 Assessment|Overall Study||75
135348|NCT01179568|327177|P3|Completed Week 12 Assessment|Overall Study||76
135349|NCT01179568|327178|P2|Completed Week 12 Assessment|Overall Study||69
135350|NCT01179568|327179|P1|Completed Week 12 Assessment|Overall Study||69
135351|NCT01179568|327176|P4|STARTED|Overall Study||96
135352|NCT01179568|327177|P3|STARTED|Overall Study||99
135353|NCT01179568|327178|P2|STARTED|Overall Study||99
135354|NCT01179568|327179|P1|STARTED|Overall Study||101
135355|NCT01179516|327202|P3|NOT COMPLETED|Overall Study||31
135356|NCT01179516|327203|P2|NOT COMPLETED|Overall Study||26
135357|NCT01179516|327204|P1|NOT COMPLETED|Overall Study||27
135358|NCT01179516|327202|P3|COMPLETED|Overall Study||121
135359|NCT01179516|327203|P2|COMPLETED|Overall Study||131
135360|NCT01179516|327204|P1|COMPLETED|Overall Study||133
135361|NCT01179516|327202|P3|Treated|Overall Study||151
135362|NCT01179516|327203|P2|Treated|Overall Study||154
135363|NCT01179516|327204|P1|Treated|Overall Study||160
135364|NCT01179516|327202|P3|STARTED|Overall Study||152
135365|NCT01179516|327203|P2|STARTED|Overall Study||157
135366|NCT01179516|327204|P1|STARTED|Overall Study||160
135367|NCT01179490|327227|P1|NOT COMPLETED|Overall Study||0
135368|NCT01179490|327227|P1|COMPLETED|Overall Study||5
135369|NCT01179490|327227|P1|STARTED|Overall Study||5
135370|NCT01179399|327248|P1|NOT COMPLETED|Overall Study||32
135371|NCT01179399|327248|P1|COMPLETED|Overall Study||0
135372|NCT01179399|327248|P1|STARTED|Overall Study||32
135373|NCT01179347|327254|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
135374|NCT01179347|327255|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
135375|NCT01179347|327254|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
135376|NCT01179347|327255|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
135377|NCT01179347|327254|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
135378|NCT01179347|327255|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
135379|NCT01179347|327254|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
135380|NCT01179347|327255|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
135381|NCT01179347|327254|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
135382|NCT01179347|327255|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
135383|NCT01179347|327254|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
135384|NCT01179347|327255|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
135385|NCT01179334|327277|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
135386|NCT01179334|327278|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
135387|NCT01179334|327277|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
135388|NCT01179334|327278|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
135389|NCT01179334|327277|P2|STARTED|Long-term Extension (LTE) Period||6
135390|NCT01179334|327278|P1|STARTED|Long-term Extension (LTE) Period||11
135391|NCT01179334|327277|P2|NOT COMPLETED|Treatment Period||0
135392|NCT01179334|327278|P1|NOT COMPLETED|Treatment Period||1
135393|NCT01179334|327277|P2|COMPLETED|Treatment Period||6
135394|NCT01179334|327278|P1|COMPLETED|Treatment Period||11
135395|NCT01179334|327277|P2|Participants Received Treatment|Treatment Period||6
135396|NCT01179334|327278|P1|Participants Received Treatment|Treatment Period||12
135397|NCT01179334|327277|P2|STARTED|Treatment Period||6
135398|NCT01179334|327278|P1|STARTED|Treatment Period||12
135399|NCT01179217|327308|P2|NOT COMPLETED|Overall Study||19
135400|NCT01179217|327309|P1|NOT COMPLETED|Overall Study||55
135401|NCT01179217|327308|P2|COMPLETED|Overall Study||59
135402|NCT01179217|327309|P1|COMPLETED|Overall Study||97
135403|NCT01179217|327308|P2|STARTED|Overall Study||78
135404|NCT01179217|327309|P1|STARTED|Overall Study||152
135405|NCT01179191|327333|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
135406|NCT01179191|327333|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
135407|NCT01179191|327333|P1|STARTED|Maintenance Phase (8 Weeks)||351
135408|NCT01179191|327333|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
135409|NCT01179191|327333|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
135410|NCT01179191|327333|P1|STARTED|Titration Phase (up to 6 Weeks)||684
135411|NCT01179113|327352|P2|NOT COMPLETED|Overall Study||0
135412|NCT01179113|327353|P1|NOT COMPLETED|Overall Study||0
135413|NCT01179113|327352|P2|COMPLETED|Overall Study||16
135414|NCT01179113|327353|P1|COMPLETED|Overall Study||17
135415|NCT01179113|327352|P2|STARTED|Overall Study||16
135416|NCT01179113|327353|P1|STARTED|Overall Study||17
135417|NCT01179048|327365|P2|NOT COMPLETED|Overall Study||159
135418|NCT01179048|327366|P1|NOT COMPLETED|Overall Study||139
135419|NCT01179048|327365|P2|COMPLETED|Overall Study||4513
135420|NCT01179048|327366|P1|COMPLETED|Overall Study||4529
135421|NCT01179048|327365|P2|STARTED|Overall Study||4672
135422|NCT01179048|327366|P1|STARTED|Overall Study||4668
135423|NCT01178944|327382|P1|NOT COMPLETED|Overall Study||0
135424|NCT01178944|327382|P1|COMPLETED|Overall Study||35
135425|NCT01178944|327382|P1|STARTED|Overall Study||35
135426|NCT01178853|327393|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
135427|NCT01178853|327394|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
135428|NCT01178853|327393|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
135429|NCT01178853|327394|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
135430|NCT01178853|327393|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
135431|NCT01178853|327394|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
135432|NCT01178853|327393|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
135433|NCT01178853|327394|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
135434|NCT01178853|327393|P2|COMPLETED|Period 3 (Warfarin Titration)||22
135435|NCT01178853|327394|P1|COMPLETED|Period 3 (Warfarin Titration)||21
135436|NCT01178853|327393|P2|STARTED|Period 3 (Warfarin Titration)||22
135437|NCT01178853|327394|P1|STARTED|Period 3 (Warfarin Titration)||22
135438|NCT01178853|327393|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
135439|NCT01178853|327394|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
135440|NCT01178853|327393|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
135441|NCT01178853|327394|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
135442|NCT01178853|327393|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
135443|NCT01178853|327394|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
135444|NCT01178853|327393|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
135445|NCT01178853|327394|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
135446|NCT01178853|327393|P2|COMPLETED|Period 1 (Warfarin Titration)||22
135447|NCT01178853|327394|P1|COMPLETED|Period 1 (Warfarin Titration)||23
135448|NCT01178853|327393|P2|STARTED|Period 1 (Warfarin Titration)||24
135449|NCT01178853|327394|P1|STARTED|Period 1 (Warfarin Titration)||24
135450|NCT01178827|327403|P3|NOT COMPLETED|Overall Study||0
135451|NCT01178827|327404|P2|NOT COMPLETED|Overall Study||0
135452|NCT01178827|327405|P1|NOT COMPLETED|Overall Study||0
135453|NCT01178827|327403|P3|COMPLETED|Overall Study||4
135454|NCT01178827|327404|P2|COMPLETED|Overall Study||10
135455|NCT01178827|327405|P1|COMPLETED|Overall Study||6
135456|NCT01178827|327403|P3|STARTED|Overall Study||4
135457|NCT01178827|327404|P2|STARTED|Overall Study||10
135458|NCT01178827|327405|P1|STARTED|Overall Study||6
135459|NCT01178762|327434|P1|NOT COMPLETED|Overall Study||15
135460|NCT01178762|327434|P1|COMPLETED|Overall Study||27
135461|NCT01178762|327434|P1|STARTED|Overall Study||42
135462|NCT01178671|327440|P2|NOT COMPLETED|Overall Study||15
135463|NCT01178671|327441|P1|NOT COMPLETED|Overall Study||12
135464|NCT01178671|327440|P2|COMPLETED|Overall Study||3
135465|NCT01178671|327441|P1|COMPLETED|Overall Study||6
135466|NCT01178671|327440|P2|STARTED|Overall Study||18
135467|NCT01178671|327441|P1|STARTED|Overall Study||18
135468|NCT01178528|327468|P3|NOT COMPLETED|Overall Study||0
135469|NCT01178528|327469|P2|NOT COMPLETED|Overall Study||0
135470|NCT01178528|327470|P1|NOT COMPLETED|Overall Study||0
135471|NCT01178528|327468|P3|COMPLETED|Overall Study||42
135472|NCT01178528|327469|P2|COMPLETED|Overall Study||38
135473|NCT01178528|327470|P1|COMPLETED|Overall Study||41
135474|NCT01178528|327468|P3|STARTED|Overall Study||42
135475|NCT01178528|327469|P2|STARTED|Overall Study||38
135476|NCT01178528|327470|P1|STARTED|Overall Study||41
135477|NCT01178385|327489|P2|NOT COMPLETED|Overall Study||0
135478|NCT01178385|327490|P1|NOT COMPLETED|Overall Study||2
135479|NCT01178385|327489|P2|COMPLETED|Overall Study||21
135480|NCT01178385|327490|P1|COMPLETED|Overall Study||22
135481|NCT01178385|327489|P2|STARTED|Overall Study||21
135482|NCT01178385|327490|P1|STARTED|Overall Study||24
135483|NCT01178333|327503|P3|NOT COMPLETED|Overall Study||0
135484|NCT01178333|327504|P2|NOT COMPLETED|Overall Study||0
135485|NCT01178333|327505|P1|NOT COMPLETED|Overall Study||0
135486|NCT01178333|327503|P3|COMPLETED|Overall Study||87
135487|NCT01178333|327504|P2|COMPLETED|Overall Study||284
135488|NCT01178333|327505|P1|COMPLETED|Overall Study||71
135489|NCT01178333|327503|P3|STARTED|Overall Study||87
135490|NCT01178333|327504|P2|STARTED|Overall Study||284
135491|NCT01178333|327505|P1|STARTED|Overall Study||71
135492|NCT01178294|327559|P1|NOT COMPLETED|Overall Study||11
135493|NCT01178294|327559|P1|COMPLETED|Overall Study||18
135494|NCT01178294|327559|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
135495|NCT01178281|327582|P2|NOT COMPLETED|Overall Study||77
135496|NCT01178281|327583|P1|NOT COMPLETED|Overall Study||149
135497|NCT01178281|327582|P2|COMPLETED|Overall Study|Participants remain on treatment|7
135498|NCT01178281|327583|P1|COMPLETED|Overall Study|Participants remain on treatment|19
135499|NCT01178281|327582|P2|STARTED|Overall Study|Intent to Treat Population (ITT)|84
135500|NCT01178281|327583|P1|STARTED|Overall Study|Intent to Treat Population (ITT)|168
135501|NCT01178268|327591|P2|NOT COMPLETED|Overall Study||1
135502|NCT01178268|327592|P1|NOT COMPLETED|Overall Study||7
135503|NCT01178268|327591|P2|COMPLETED|Overall Study||120
135504|NCT01178268|327592|P1|COMPLETED|Overall Study||360
135505|NCT01178268|327591|P2|STARTED|Overall Study||121
135506|NCT01178268|327592|P1|STARTED|Overall Study||367
135507|NCT01178138|327809|P1|NOT COMPLETED|Overall Study||23
135508|NCT01178138|327809|P1|COMPLETED|Overall Study||1
135509|NCT01178138|327809|P1|Completed 3 Sessions|Overall Study||1
135510|NCT01178138|327809|P1|Completed 5 Sessions|Overall Study||1
135511|NCT01178138|327809|P1|Completed 6 Sessions|Overall Study||1
135512|NCT01178138|327809|P1|STARTED|Overall Study||24
135513|NCT01178125|327830|P1|NOT COMPLETED|Overall Study||1178
135514|NCT01178125|327830|P1|COMPLETED|Overall Study||1680
135515|NCT01178125|327830|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
135516|NCT01178125|327830|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
135517|NCT01178125|327830|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
135518|NCT01178125|327830|P1|STARTED|Overall Study|Number enrolled.|2858
135519|NCT01178099|327861|P2|NOT COMPLETED|Overall Study||1
135520|NCT01178099|327862|P1|NOT COMPLETED|Overall Study||0
135521|NCT01178099|327861|P2|COMPLETED|Overall Study||12
135522|NCT01178099|327862|P1|COMPLETED|Overall Study||13
135523|NCT01178099|327861|P2|STARTED|Overall Study||13
135524|NCT01178099|327862|P1|STARTED|Overall Study||13
135525|NCT01178073|327903|P3|NOT COMPLETED|Overall Study||46
135526|NCT01178073|327904|P2|NOT COMPLETED|Overall Study||44
135527|NCT01178073|327905|P1|NOT COMPLETED|Overall Study||62
135528|NCT01178073|327903|P3|COMPLETED|Overall Study||105
135529|NCT01178073|327904|P2|COMPLETED|Overall Study||108
135530|NCT01178073|327905|P1|COMPLETED|Overall Study||240
135531|NCT01178073|327903|P3|STARTED|Overall Study||151
135532|NCT01178073|327904|P2|STARTED|Overall Study||152
135533|NCT01178073|327905|P1|STARTED|Overall Study||302
135534|NCT01177969|327936|P2|NOT COMPLETED|Overall Study||3
135535|NCT01177969|327937|P1|NOT COMPLETED|Overall Study||3
135536|NCT01177969|327936|P2|COMPLETED|Overall Study||11
135537|NCT01177969|327937|P1|COMPLETED|Overall Study||16
135538|NCT01177969|327936|P2|STARTED|Overall Study||14
135539|NCT01177969|327937|P1|STARTED|Overall Study||19
135540|NCT01177956|327945|P1|NOT COMPLETED|Overall Study||0
135541|NCT01177956|327945|P1|COMPLETED|Overall Study||68
135542|NCT01177956|327945|P1|STARTED|Overall Study||68
135543|NCT01177943|327960|P2|NOT COMPLETED|Second Intervention||0
135544|NCT01177943|327961|P1|NOT COMPLETED|Second Intervention||0
135545|NCT01177943|327960|P2|COMPLETED|Second Intervention||21
135546|NCT01177943|327961|P1|COMPLETED|Second Intervention||19
135547|NCT01177943|327960|P2|STARTED|Second Intervention||21
135548|NCT01177943|327961|P1|STARTED|Second Intervention||19
135549|NCT01177943|327960|P2|NOT COMPLETED|First Intervention||0
135550|NCT01177943|327961|P1|NOT COMPLETED|First Intervention||2
135551|NCT01177943|327960|P2|COMPLETED|First Intervention||21
135552|NCT01177943|327961|P1|COMPLETED|First Intervention||19
135553|NCT01177943|327960|P2|STARTED|First Intervention||21
135554|NCT01177943|327961|P1|STARTED|First Intervention||21
135555|NCT01177813|327974|P5|NOT COMPLETED|Overall Study||9
135556|NCT01177813|327975|P4|NOT COMPLETED|Overall Study||17
135557|NCT01177813|327976|P3|NOT COMPLETED|Overall Study||20
135558|NCT01177813|327977|P2|NOT COMPLETED|Overall Study||18
135559|NCT01177813|327978|P1|NOT COMPLETED|Overall Study||41
135560|NCT01177813|327974|P5|COMPLETED|Overall Study||78
135561|NCT01177813|327975|P4|COMPLETED|Overall Study||206
135562|NCT01177813|327976|P3|COMPLETED|Overall Study||204
135563|NCT01177813|327977|P2|COMPLETED|Overall Study||206
135564|NCT01177813|327978|P1|COMPLETED|Overall Study||187
135565|NCT01177813|327974|P5|STARTED|Overall Study||87
135566|NCT01177813|327975|P4|STARTED|Overall Study||223
135567|NCT01177813|327976|P3|STARTED|Overall Study||224
135568|NCT01177813|327977|P2|STARTED|Overall Study||224
135569|NCT01177813|327978|P1|STARTED|Overall Study||228
135570|NCT01177800|328007|P2|NOT COMPLETED|Overall Study||5
135571|NCT01177800|328008|P1|NOT COMPLETED|Overall Study||10
135572|NCT01177800|328007|P2|COMPLETED|Overall Study||40
135573|NCT01177800|328008|P1|COMPLETED|Overall Study||74
135574|NCT01177800|328007|P2|STARTED|Overall Study||45
135575|NCT01177800|328008|P1|STARTED|Overall Study||84
135576|NCT01177735|328022|P1|NOT COMPLETED|Overall Study||71
135577|NCT01177735|328022|P1|COMPLETED|Overall Study||0
135578|NCT01177735|328022|P1|STARTED|Overall Study||71
135579|NCT01177722|328030|P4|NOT COMPLETED|Overall Study||7
135580|NCT01177722|328031|P3|NOT COMPLETED|Overall Study||9
135581|NCT01177722|328032|P2|NOT COMPLETED|Overall Study||10
135582|NCT01177722|328033|P1|NOT COMPLETED|Overall Study||13
135583|NCT01177722|328030|P4|COMPLETED|Overall Study||338
135584|NCT01177722|328031|P3|COMPLETED|Overall Study||333
135585|NCT01177722|328032|P2|COMPLETED|Overall Study||334
135586|NCT01177722|328033|P1|COMPLETED|Overall Study||331
135587|NCT01177722|328030|P4|STARTED|Overall Study||345
135588|NCT01177722|328031|P3|STARTED|Overall Study||342
135589|NCT01177722|328032|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
135590|NCT01177722|328033|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
135591|NCT01177709|328059|P1|NOT COMPLETED|Overall Study||0
135592|NCT01177709|328059|P1|COMPLETED|Overall Study||12
135593|NCT01177709|328059|P1|STARTED|Overall Study||12
135594|NCT01177670|328065|P1|NOT COMPLETED|Overall Study||169
135595|NCT01177670|328065|P1|COMPLETED|Overall Study||0
135596|NCT01177670|328065|P1|STARTED|Overall Study||169
135597|NCT01177553|328072|P2|NOT COMPLETED|Overall Study||0
135598|NCT01177553|328073|P1|NOT COMPLETED|Overall Study||1
135599|NCT01177553|328072|P2|COMPLETED|Overall Study|data as of March 2009|2
135600|NCT01177553|328073|P1|COMPLETED|Overall Study|data as of March 2009|2
135601|NCT01177553|328072|P2|STARTED|Overall Study||2
135602|NCT01177553|328073|P1|STARTED|Overall Study||3
135603|NCT01177410|328082|P3|NOT COMPLETED|Overall Study||5
135604|NCT01177410|328083|P2|NOT COMPLETED|Overall Study||7
135605|NCT01177410|328084|P1|NOT COMPLETED|Overall Study||1
135606|NCT01177410|328082|P3|COMPLETED|Overall Study||45
135607|NCT01177410|328083|P2|COMPLETED|Overall Study||40
135608|NCT01177410|328084|P1|COMPLETED|Overall Study||50
135609|NCT01177410|328082|P3|STARTED|Overall Study||50
135610|NCT01177410|328083|P2|STARTED|Overall Study||47
135611|NCT01177410|328084|P1|STARTED|Overall Study||51
135612|NCT01177384|328097|P2|NOT COMPLETED|Overall Study||26
135613|NCT01177384|328098|P1|NOT COMPLETED|Overall Study||14
135614|NCT01177384|328097|P2|COMPLETED|Overall Study||164
135615|NCT01177384|328098|P1|COMPLETED|Overall Study||177
135616|NCT01177384|328097|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
135617|NCT01177384|328098|P1|STARTED|Overall Study||191
135618|NCT01177293|328110|P2|NOT COMPLETED|Second Intervention Period||0
135619|NCT01177293|328111|P1|NOT COMPLETED|Second Intervention Period||0
135620|NCT01177293|328110|P2|COMPLETED|Second Intervention Period||6
135621|NCT01177293|328111|P1|COMPLETED|Second Intervention Period||7
135622|NCT01177293|328110|P2|STARTED|Second Intervention Period||6
135623|NCT01177293|328111|P1|STARTED|Second Intervention Period||7
135624|NCT01177293|328110|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
135625|NCT01177293|328111|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
135626|NCT01177293|328110|P2|COMPLETED|Washout Period (of 14 Days)||6
135627|NCT01177293|328111|P1|COMPLETED|Washout Period (of 14 Days)||7
135628|NCT01177293|328110|P2|STARTED|Washout Period (of 14 Days)||7
135629|NCT01177293|328111|P1|STARTED|Washout Period (of 14 Days)||7
135630|NCT01177293|328110|P2|NOT COMPLETED|First Intervention Period||0
135631|NCT01177293|328111|P1|NOT COMPLETED|First Intervention Period||0
135632|NCT01177293|328110|P2|COMPLETED|First Intervention Period||7
135633|NCT01177293|328111|P1|COMPLETED|First Intervention Period||7
135634|NCT01177293|328110|P2|STARTED|First Intervention Period||7
135635|NCT01177293|328111|P1|STARTED|First Intervention Period||7
135636|NCT01177228|328129|P4|NOT COMPLETED|Overall Study||0
135637|NCT01177228|328130|P3|NOT COMPLETED|Overall Study||0
135638|NCT01177228|328131|P2|NOT COMPLETED|Overall Study||2
135639|NCT01177228|328132|P1|NOT COMPLETED|Overall Study||1
135640|NCT01177228|328129|P4|COMPLETED|Overall Study||11
135641|NCT01177228|328130|P3|COMPLETED|Overall Study||14
135642|NCT01177228|328131|P2|COMPLETED|Overall Study||11
135643|NCT01177228|328132|P1|COMPLETED|Overall Study||8
135644|NCT01177228|328129|P4|Received Treatment|Overall Study||11
135645|NCT01177228|328130|P3|Received Treatment|Overall Study||14
135646|NCT01177228|328131|P2|Received Treatment|Overall Study||12
135647|NCT01177228|328132|P1|Received Treatment|Overall Study||9
135648|NCT01177228|328129|P4|STARTED|Overall Study||11
135649|NCT01177228|328130|P3|STARTED|Overall Study||14
135650|NCT01177228|328131|P2|STARTED|Overall Study||13
135651|NCT01177228|328132|P1|STARTED|Overall Study||9
135652|NCT01177098|328172|P2|NOT COMPLETED|Overall Study||12
135653|NCT01177098|328173|P1|NOT COMPLETED|Overall Study||9
135654|NCT01177098|328172|P2|COMPLETED|Overall Study||271
135655|NCT01177098|328173|P1|COMPLETED|Overall Study||269
135656|NCT01177098|328172|P2|STARTED|Overall Study||283
135657|NCT01177098|328173|P1|STARTED|Overall Study||278
135658|NCT01177007|328189|P1|NOT COMPLETED|Overall Study||38
135659|NCT01177007|328189|P1|COMPLETED|Overall Study||12
135660|NCT01177007|328189|P1|Completed First Clinical and Imaging|Overall Study||43
135661|NCT01177007|328189|P1|Completed First Y90 Treatment|Overall Study||50
135662|NCT01177007|328189|P1|STARTED|Overall Study||50
135663|NCT01176968|328203|P2|NOT COMPLETED|Overall Study||82
135664|NCT01176968|328204|P1|NOT COMPLETED|Overall Study||84
135665|NCT01176968|328203|P2|COMPLETED|Overall Study||424
135666|NCT01176968|328204|P1|COMPLETED|Overall Study||422
135667|NCT01176968|328203|P2|Treated|Overall Study||505
135668|NCT01176968|328204|P1|Treated|Overall Study||505
135669|NCT01176968|328203|P2|STARTED|Overall Study||506
135670|NCT01176968|328204|P1|STARTED|Overall Study||506
135671|NCT01176955|328238|P2|NOT COMPLETED|Overall Study||2
135672|NCT01176955|328239|P1|NOT COMPLETED|Overall Study||3
135673|NCT01176955|328238|P2|COMPLETED|Overall Study||8
135674|NCT01176955|328239|P1|COMPLETED|Overall Study||7
135675|NCT01176955|328238|P2|STARTED|Overall Study||10
135676|NCT01176955|328239|P1|STARTED|Overall Study||10
135677|NCT01176877|328250|P1|NOT COMPLETED|Overall Study||9
135678|NCT01176877|328250|P1|COMPLETED|Overall Study||31
135679|NCT01176877|328250|P1|STARTED|Overall Study||40
135680|NCT01176773|328255|P1|NOT COMPLETED|Overall Study||3
135681|NCT01176773|328255|P1|COMPLETED|Overall Study||59
135682|NCT01176773|328255|P1|STARTED|Overall Study||62
135683|NCT01176617|328266|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
135684|NCT01176617|328267|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
135685|NCT01176617|328268|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
135686|NCT01176617|328266|P3|COMPLETED|6 - 12 Months (Randomized)||0
135687|NCT01176617|328267|P2|COMPLETED|6 - 12 Months (Randomized)||20
135688|NCT01176617|328268|P1|COMPLETED|6 - 12 Months (Randomized)||13
135689|NCT01176617|328266|P3|STARTED|6 - 12 Months (Randomized)||0
135690|NCT01176617|328267|P2|STARTED|6 - 12 Months (Randomized)||20
135691|NCT01176617|328268|P1|STARTED|6 - 12 Months (Randomized)||18
135692|NCT01176617|328266|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
135693|NCT01176617|328267|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
135694|NCT01176617|328268|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
135695|NCT01176617|328266|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
135696|NCT01176617|328267|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
135697|NCT01176617|328268|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
135698|NCT01176617|328266|P3|STARTED|1 - 6 Months (Ron-randomized)||38
135699|NCT01176617|328267|P2|STARTED|1 - 6 Months (Ron-randomized)||0
135700|NCT01176617|328268|P1|STARTED|1 - 6 Months (Ron-randomized)||0
135701|NCT01176565|328279|P2|NOT COMPLETED|Overall Study||19
135702|NCT01176565|328280|P1|NOT COMPLETED|Overall Study||20
135703|NCT01176565|328279|P2|COMPLETED|Overall Study||481
135704|NCT01176565|328280|P1|COMPLETED|Overall Study||480
135705|NCT01176565|328279|P2|STARTED|Overall Study||500
135706|NCT01176565|328280|P1|STARTED|Overall Study||500
135707|NCT01176513|328298|P1|NOT COMPLETED|Overall Study||3
135708|NCT01176513|328298|P1|COMPLETED|Overall Study||22
135709|NCT01176513|328298|P1|STARTED|Overall Study||25
135710|NCT01176448|328303|P1|NOT COMPLETED|Overall Study||0
135711|NCT01176448|328303|P1|COMPLETED|Overall Study||6
135712|NCT01176448|328303|P1|STARTED|Overall Study||6
135713|NCT01176435|328314|P3|NOT COMPLETED|Overall Study||0
135714|NCT01176435|328315|P2|NOT COMPLETED|Overall Study||0
135715|NCT01176435|328316|P1|NOT COMPLETED|Overall Study||0
135716|NCT01176435|328314|P3|COMPLETED|Overall Study||15
135717|NCT01176435|328315|P2|COMPLETED|Overall Study||15
135718|NCT01176435|328316|P1|COMPLETED|Overall Study||15
135719|NCT01176435|328314|P3|STARTED|Overall Study||15
135720|NCT01176435|328315|P2|STARTED|Overall Study||15
135721|NCT01176435|328316|P1|STARTED|Overall Study||15
135722|NCT01176292|328326|P2|NOT COMPLETED|Overall Study||9
135723|NCT01176292|328327|P1|NOT COMPLETED|Overall Study||5
135724|NCT01176292|328326|P2|COMPLETED|Overall Study||62
135725|NCT01176292|328327|P1|COMPLETED|Overall Study||66
135726|NCT01176292|328326|P2|STARTED|Overall Study||71
135727|NCT01176292|328327|P1|STARTED|Overall Study||71
135728|NCT01176266|328345|P1|NOT COMPLETED|Overall Study||9
135729|NCT01176266|328345|P1|COMPLETED|Overall Study||60
135730|NCT01176266|328345|P1|STARTED|Overall Study||69
135731|NCT01176240|328369|P2|NOT COMPLETED|Study 306B||17
135732|NCT01176240|328370|P1|NOT COMPLETED|Study 306B||26
135733|NCT01176240|328369|P2|COMPLETED|Study 306B||68
135734|NCT01176240|328370|P1|COMPLETED|Study 306B||63
135735|NCT01176240|328369|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
135736|NCT01176240|328370|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
135737|NCT01176240|328369|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
135738|NCT01176240|328370|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
135739|NCT01176240|328369|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
135740|NCT01176240|328370|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
135741|NCT01176240|328369|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
135742|NCT01176240|328370|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
135743|NCT01176240|328369|P2|STARTED|Study 306B||85
135744|NCT01176240|328370|P1|STARTED|Study 306B||89
135745|NCT01176240|328369|P2|NOT COMPLETED|Study 306A||3
135746|NCT01176240|328370|P1|NOT COMPLETED|Study 306A||3
135747|NCT01176240|328369|P2|COMPLETED|Study 306A||24
135748|NCT01176240|328370|P1|COMPLETED|Study 306A||21
135749|NCT01176240|328369|P2|STARTED|Study 306A||27
135750|NCT01176240|328370|P1|STARTED|Study 306A||24
135751|NCT01176058|328396|P2|NOT COMPLETED|Overall Study||3
135752|NCT01176058|328397|P1|NOT COMPLETED|Overall Study||4
135753|NCT01176058|328396|P2|COMPLETED|Overall Study||5
135754|NCT01176058|328397|P1|COMPLETED|Overall Study||5
135755|NCT01176058|328396|P2|STARTED|Overall Study||8
135756|NCT01176058|328397|P1|STARTED|Overall Study||9
135757|NCT01176032|328421|P2|NOT COMPLETED|Overall Study||1
135758|NCT01176032|328422|P1|NOT COMPLETED|Overall Study||6
135759|NCT01176032|328421|P2|COMPLETED|Overall Study||36
135760|NCT01176032|328422|P1|COMPLETED|Overall Study||31
135761|NCT01176032|328421|P2|Intention-to-treat (ITT) Population|Overall Study||37
135762|NCT01176032|328422|P1|Intention-to-treat (ITT) Population|Overall Study||32
135763|NCT01176032|328421|P2|STARTED|Overall Study||37
135764|NCT01176032|328422|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
135765|NCT01175902|328482|P2|NOT COMPLETED|Overall Study||0
135766|NCT01175902|328483|P1|NOT COMPLETED|Overall Study||0
135767|NCT01175902|328482|P2|COMPLETED|Overall Study||22
135768|NCT01175902|328483|P1|COMPLETED|Overall Study||22
135769|NCT01175902|328482|P2|STARTED|Overall Study||22
135770|NCT01175902|328483|P1|STARTED|Overall Study||22
135771|NCT01175850|328501|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
135772|NCT01175850|328502|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
135773|NCT01175850|328501|P2|COMPLETED|IN.PACT SFA II Phase||55
135774|NCT01175850|328502|P1|COMPLETED|IN.PACT SFA II Phase||109
135775|NCT01175850|328501|P2|STARTED|IN.PACT SFA II Phase||60
135776|NCT01175850|328502|P1|STARTED|IN.PACT SFA II Phase||121
135777|NCT01175850|328501|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
135778|NCT01175850|328502|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
135779|NCT01175850|328501|P2|COMPLETED|IN.PACT SFA I Phase||49
135780|NCT01175850|328502|P1|COMPLETED|IN.PACT SFA I Phase||88
135781|NCT01175850|328501|P2|STARTED|IN.PACT SFA I Phase||51
135782|NCT01175850|328502|P1|STARTED|IN.PACT SFA I Phase||99
135783|NCT01175824|328546|P2|NOT COMPLETED|Overall Study||22
135784|NCT01175824|328547|P1|NOT COMPLETED|Overall Study||16
135785|NCT01175824|328546|P2|COMPLETED|Overall Study||220
135786|NCT01175824|328547|P1|COMPLETED|Overall Study||220
135787|NCT01175824|328546|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
135788|NCT01175824|328547|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
135789|NCT01175824|328546|P2|STARTED|Overall Study||242
135790|NCT01175824|328547|P1|STARTED|Overall Study||236
135791|NCT01175811|328581|P2|NOT COMPLETED|Overall Study||14
135792|NCT01175811|328582|P1|NOT COMPLETED|Overall Study||16
135793|NCT01175811|328581|P2|COMPLETED|Overall Study||189
135794|NCT01175811|328582|P1|COMPLETED|Overall Study||183
135795|NCT01175811|328581|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
135796|NCT01175811|328582|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
135797|NCT01175811|328581|P2|STARTED|Overall Study||203
135798|NCT01175811|328582|P1|STARTED|Overall Study||199
135799|NCT01175798|328608|P2|NOT COMPLETED|Overall Study||21
135800|NCT01175798|328609|P1|NOT COMPLETED|Overall Study||7
135801|NCT01175798|328608|P2|COMPLETED|Overall Study||41
135802|NCT01175798|328609|P1|COMPLETED|Overall Study||27
135803|NCT01175798|328608|P2|STARTED|Overall Study||62
135804|NCT01175798|328609|P1|STARTED|Overall Study||34
135805|NCT01175707|328617|P2|NOT COMPLETED|Overall Study||6
135806|NCT01175707|328618|P1|NOT COMPLETED|Overall Study||4
135807|NCT01175707|328617|P2|COMPLETED|Overall Study||34
135808|NCT01175707|328618|P1|COMPLETED|Overall Study||36
135809|NCT01175707|328617|P2|STARTED|Overall Study||40
135810|NCT01175707|328618|P1|STARTED|Overall Study||40
135811|NCT01175668|328654|P2|NOT COMPLETED|Overall Study||0
135812|NCT01175668|328655|P1|NOT COMPLETED|Overall Study||2
135813|NCT01175668|328654|P2|COMPLETED|Overall Study||34
135814|NCT01175668|328655|P1|COMPLETED|Overall Study||32
135815|NCT01175668|328654|P2|STARTED|Overall Study||34
135816|NCT01175668|328655|P1|STARTED|Overall Study||34
135817|NCT01175590|328665|P2|NOT COMPLETED|Overall Study||10
135818|NCT01175590|328666|P1|NOT COMPLETED|Overall Study||12
135819|NCT01175590|328665|P2|COMPLETED|Overall Study||161
135820|NCT01175590|328666|P1|COMPLETED|Overall Study||335
135821|NCT01175590|328665|P2|Safety Population|Overall Study||170
135822|NCT01175590|328666|P1|Safety Population|Overall Study||344
135823|NCT01175590|328665|P2|Modified Intent to Treat Population|Overall Study||87
135824|NCT01175590|328666|P1|Modified Intent to Treat Population|Overall Study||212
135825|NCT01175590|328665|P2|STARTED|Overall Study||171
135826|NCT01175590|328666|P1|STARTED|Overall Study||347
135827|NCT01175473|328700|P2|NOT COMPLETED|Overall Study||2
135828|NCT01175473|328701|P1|NOT COMPLETED|Overall Study||2
135829|NCT01175473|328700|P2|COMPLETED|Overall Study||69
135830|NCT01175473|328701|P1|COMPLETED|Overall Study||75
135831|NCT01175473|328700|P2|Pharmacodynamic (PD) Population|Overall Study||68
135832|NCT01175473|328701|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
135833|NCT01175473|328700|P2|Safety Population|Overall Study||71
135834|NCT01175473|328701|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
135835|NCT01175473|328700|P2|STARTED|Overall Study||71
135836|NCT01175473|328701|P1|STARTED|Overall Study|Randomized and treated.|77
135837|NCT01175434|328727|P2|NOT COMPLETED|Overall Study||0
135838|NCT01175434|328728|P1|NOT COMPLETED|Overall Study||0
135839|NCT01175434|328727|P2|COMPLETED|Overall Study||51
135840|NCT01175434|328728|P1|COMPLETED|Overall Study||48
135841|NCT01175434|328727|P2|STARTED|Overall Study||51
135842|NCT01175434|328728|P1|STARTED|Overall Study||48
135843|NCT01175395|328734|P1|NOT COMPLETED|Overall Study||0
135844|NCT01175395|328734|P1|COMPLETED|Overall Study||10
135845|NCT01175395|328734|P1|STARTED|Overall Study||10
135846|NCT01175382|328742|P3|NOT COMPLETED|Overall Study||6
135847|NCT01175382|328743|P2|NOT COMPLETED|Overall Study||7
135848|NCT01175382|328744|P1|NOT COMPLETED|Overall Study||8
135849|NCT01175382|328742|P3|COMPLETED|Overall Study||59
135850|NCT01175382|328743|P2|COMPLETED|Overall Study||61
135851|NCT01175382|328744|P1|COMPLETED|Overall Study||63
135852|NCT01175382|328742|P3|STARTED|Overall Study||65
135853|NCT01175382|328743|P2|STARTED|Overall Study||68
135854|NCT01175382|328744|P1|STARTED|Overall Study||71
135855|NCT01175369|328823|P2|NOT COMPLETED|Overall Study||5
135856|NCT01175369|328824|P1|NOT COMPLETED|Overall Study||2
135857|NCT01175369|328823|P2|COMPLETED|Overall Study||260
135858|NCT01175369|328824|P1|COMPLETED|Overall Study||263
135859|NCT01175369|328823|P2|STARTED|Overall Study||265
135860|NCT01175369|328824|P1|STARTED|Overall Study||265
135861|NCT01175356|328830|P1|NOT COMPLETED|Overall Study||81
135862|NCT01175356|328830|P1|COMPLETED|Overall Study||18
135863|NCT01175356|328830|P1|STARTED|Overall Study||99
135864|NCT01175343|328836|P1|NOT COMPLETED|Overall Study||0
135865|NCT01175343|328836|P1|COMPLETED|Overall Study||44
135866|NCT01175343|328836|P1|STARTED|Overall Study||44
135867|NCT01175317|328848|P2|NOT COMPLETED|Overall Study||0
135868|NCT01175317|328849|P1|NOT COMPLETED|Overall Study||0
135869|NCT01175317|328848|P2|COMPLETED|Overall Study||31
135870|NCT01175317|328849|P1|COMPLETED|Overall Study||27
135871|NCT01175317|328848|P2|STARTED|Overall Study||31
135872|NCT01175317|328849|P1|STARTED|Overall Study||27
135873|NCT01175226|328859|P2|NOT COMPLETED|Overall Study||5
135874|NCT01175226|328860|P1|NOT COMPLETED|Overall Study||11
135875|NCT01175226|328859|P2|COMPLETED|Overall Study||140
135876|NCT01175226|328860|P1|COMPLETED|Overall Study||144
135877|NCT01175226|328859|P2|STARTED|Overall Study||145
135878|NCT01175226|328860|P1|STARTED|Overall Study||155
135879|NCT01175213|328870|P2|NOT COMPLETED|Safety Follow-up||0
135880|NCT01175213|328871|P1|NOT COMPLETED|Safety Follow-up||1
135881|NCT01175213|328870|P2|COMPLETED|Safety Follow-up||3
135882|NCT01175213|328871|P1|COMPLETED|Safety Follow-up||47
135883|NCT01175213|328870|P2|STARTED|Safety Follow-up||3
135884|NCT01175213|328871|P1|STARTED|Safety Follow-up||48
135885|NCT01175213|328870|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
135886|NCT01175213|328871|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
135887|NCT01175213|328870|P2|COMPLETED|IGSC, 10%/rHuPH20||3
135888|NCT01175213|328871|P1|COMPLETED|IGSC, 10%/rHuPH20||48
135889|NCT01175213|328870|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
135890|NCT01175213|328871|P1|STARTED|IGSC, 10%/rHuPH20||63
135891|NCT01175148|328918|P2|NOT COMPLETED|Overall Study||0
135892|NCT01175148|328919|P1|NOT COMPLETED|Overall Study||0
135893|NCT01175148|328918|P2|COMPLETED|Overall Study||30
135894|NCT01175148|328919|P1|COMPLETED|Overall Study||30
135895|NCT01175148|328918|P2|STARTED|Overall Study||30
135896|NCT01175148|328919|P1|STARTED|Overall Study||30
135897|NCT01175135|328928|P4|NOT COMPLETED|Overall Study||14
135898|NCT01175135|328929|P3|NOT COMPLETED|Overall Study||12
135899|NCT01175135|328930|P2|NOT COMPLETED|Overall Study||22
135900|NCT01175135|328931|P1|NOT COMPLETED|Overall Study||16
135901|NCT01175135|328928|P4|COMPLETED|Overall Study||60
135902|NCT01175135|328929|P3|COMPLETED|Overall Study||25
135903|NCT01175135|328930|P2|COMPLETED|Overall Study||52
135904|NCT01175135|328931|P1|COMPLETED|Overall Study||58
135905|NCT01175135|328928|P4|Analyzed for Efficacy|Overall Study||73
135906|NCT01175135|328929|P3|Analyzed for Efficacy|Overall Study||34
135907|NCT01175135|328930|P2|Analyzed for Efficacy|Overall Study||73
135908|NCT01175135|328931|P1|Analyzed for Efficacy|Overall Study||74
135909|NCT01175135|328928|P4|Treated|Overall Study||74
135910|NCT01175135|328929|P3|Treated|Overall Study||36
135911|NCT01175135|328930|P2|Treated|Overall Study||74
135912|NCT01175135|328931|P1|Treated|Overall Study||74
135913|NCT01175135|328928|P4|STARTED|Overall Study||74
135914|NCT01175135|328929|P3|STARTED|Overall Study||37
135915|NCT01175135|328930|P2|STARTED|Overall Study||74
135916|NCT01175135|328931|P1|STARTED|Overall Study||74
135917|NCT01175031|329013|P1|NOT COMPLETED|Overall Study||0
135918|NCT01175031|329013|P1|COMPLETED|Overall Study||45
135919|NCT01175031|329013|P1|STARTED|Overall Study||45
135920|NCT01175018|329023|P2|NOT COMPLETED|Overall Study||1
135921|NCT01175018|329024|P1|NOT COMPLETED|Overall Study||3
135922|NCT01175018|329023|P2|COMPLETED|Overall Study||14
135923|NCT01175018|329024|P1|COMPLETED|Overall Study||12
135924|NCT01175018|329023|P2|STARTED|Overall Study||15
135925|NCT01175018|329024|P1|STARTED|Overall Study||15
135926|NCT01175005|329060|P1|NOT COMPLETED|Overall Study||0
135927|NCT01175005|329060|P1|COMPLETED|Overall Study||62
135928|NCT01175005|329060|P1|STARTED|Overall Study||62
135929|NCT01174784|329065|P1|NOT COMPLETED|Overall Study||0
135930|NCT01174784|329065|P1|COMPLETED|Overall Study||88
135931|NCT01174784|329065|P1|STARTED|Overall Study||88
135932|NCT01174576|329070|P1|NOT COMPLETED|Overall Study||0
135933|NCT01174576|329070|P1|COMPLETED|Overall Study||16
135934|NCT01174576|329070|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
135935|NCT01174550|329113|P2|NOT COMPLETED|Overall Study||873
135936|NCT01174550|329114|P1|NOT COMPLETED|Overall Study||1270
135937|NCT01174550|329113|P2|COMPLETED|Overall Study||4123
135938|NCT01174550|329114|P1|COMPLETED|Overall Study||3737
135939|NCT01174550|329113|P2|STARTED|Overall Study||4996
135940|NCT01174550|329114|P1|STARTED|Overall Study||5007
135941|NCT01174459|329142|P1|NOT COMPLETED|Overall Study||5
135942|NCT01174459|329142|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
135943|NCT01174459|329142|P1|STARTED|Overall Study|Registered patients|571
135944|NCT01174446|329147|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
135945|NCT01174446|329148|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
135946|NCT01174446|329149|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
135947|NCT01174446|329150|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
135948|NCT01174446|329147|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
135949|NCT01174446|329148|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
135950|NCT01174446|329149|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
135951|NCT01174446|329150|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
135952|NCT01174446|329147|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
135953|NCT01174446|329148|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
135954|NCT01174446|329149|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
135955|NCT01174446|329150|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
135956|NCT01174446|329147|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
135957|NCT01174446|329148|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
135958|NCT01174446|329149|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
135959|NCT01174446|329150|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
135960|NCT01174446|329147|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
135961|NCT01174446|329148|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
135962|NCT01174446|329149|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
135963|NCT01174446|329150|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
135964|NCT01174446|329147|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
135965|NCT01174446|329148|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
135966|NCT01174446|329149|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
135967|NCT01174446|329150|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
135968|NCT01174446|329147|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
135969|NCT01174446|329148|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
135970|NCT01174446|329149|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
135971|NCT01174446|329150|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
135972|NCT01174446|329147|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
135973|NCT01174446|329148|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
135974|NCT01174446|329149|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
135975|NCT01174446|329150|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
135976|NCT01174446|329147|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
135977|NCT01174446|329148|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
135978|NCT01174446|329149|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
135979|NCT01174446|329150|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
135980|NCT01174342|329337|P1|NOT COMPLETED|Overall Study||4
135981|NCT01174342|329337|P1|COMPLETED|Overall Study||26
135982|NCT01174342|329337|P1|STARTED|Overall Study||30
135983|NCT01174264|329344|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
135984|NCT01174264|329345|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
135985|NCT01174264|329346|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
135986|NCT01174264|329344|P3|COMPLETED|Steady-state Pharmacokinetics||27
135987|NCT01174264|329345|P2|COMPLETED|Steady-state Pharmacokinetics||0
135988|NCT01174264|329346|P1|COMPLETED|Steady-state Pharmacokinetics||25
135989|NCT01174264|329344|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
135990|NCT01174264|329345|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
135991|NCT01174264|329346|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
135992|NCT01174264|329344|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
135993|NCT01174264|329345|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
135994|NCT01174264|329346|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
135995|NCT01174264|329344|P3|COMPLETED|Single Dose Pharmacokinetics||18
135996|NCT01174264|329345|P2|COMPLETED|Single Dose Pharmacokinetics||20
135997|NCT01174264|329346|P1|COMPLETED|Single Dose Pharmacokinetics||22
135998|NCT01174264|329344|P3|STARTED|Single Dose Pharmacokinetics||20
135999|NCT01174264|329345|P2|STARTED|Single Dose Pharmacokinetics||20
136000|NCT01174264|329346|P1|STARTED|Single Dose Pharmacokinetics||23
136001|NCT01174186|329380|P2|NOT COMPLETED|Overall Study||3
136002|NCT01174186|329381|P1|NOT COMPLETED|Overall Study||0
136003|NCT01174186|329380|P2|COMPLETED|Overall Study||12
136004|NCT01174186|329381|P1|COMPLETED|Overall Study||15
136005|NCT01174186|329380|P2|STARTED|Overall Study||15
136006|NCT01174186|329381|P1|STARTED|Overall Study|Patients were included over three years|15
136007|NCT01174173|329388|P1|NOT COMPLETED|Overall Study||1
136008|NCT01174173|329388|P1|COMPLETED|Overall Study||10
136009|NCT01174173|329388|P1|STARTED|Overall Study||11
136010|NCT01174160|329399|P2|NOT COMPLETED|Overall Study||6
136011|NCT01174160|329400|P1|NOT COMPLETED|Overall Study||8
136012|NCT01174160|329399|P2|COMPLETED|Overall Study||56
136013|NCT01174160|329400|P1|COMPLETED|Overall Study||53
136014|NCT01174160|329399|P2|Discontinued Post Dose|Overall Study||0
136015|NCT01174160|329400|P1|Discontinued Post Dose|Overall Study||2
136016|NCT01174160|329399|P2|Dosed|Overall Study||56
136017|NCT01174160|329400|P1|Dosed|Overall Study||55
136018|NCT01174160|329399|P2|Discontinued Pre Dose|Overall Study||6
136019|NCT01174160|329400|P1|Discontinued Pre Dose|Overall Study||6
136020|NCT01174160|329399|P2|STARTED|Overall Study||62
136021|NCT01174160|329400|P1|STARTED|Overall Study||61
136022|NCT01174043|329406|P1|NOT COMPLETED|Overall Study||11
136023|NCT01174043|329406|P1|COMPLETED|Overall Study||0
136024|NCT01174043|329406|P1|STARTED|Overall Study||11
136025|NCT01174030|329417|P5|NOT COMPLETED|Overall Study||1
136026|NCT01174030|329418|P4|NOT COMPLETED|Overall Study||2
136027|NCT01174030|329419|P3|NOT COMPLETED|Overall Study||2
136028|NCT01174030|329420|P2|NOT COMPLETED|Overall Study||2
136029|NCT01174030|329421|P1|NOT COMPLETED|Overall Study||2
136030|NCT01174030|329417|P5|COMPLETED|Overall Study||52
136031|NCT01174030|329418|P4|COMPLETED|Overall Study||53
136032|NCT01174030|329419|P3|COMPLETED|Overall Study||52
136033|NCT01174030|329420|P2|COMPLETED|Overall Study||52
136034|NCT01174030|329421|P1|COMPLETED|Overall Study||51
136035|NCT01174030|329417|P5|STARTED|Overall Study||53
136036|NCT01174030|329418|P4|STARTED|Overall Study||55
136037|NCT01174030|329419|P3|STARTED|Overall Study||54
136038|NCT01174030|329420|P2|STARTED|Overall Study||54
136039|NCT01174030|329421|P1|STARTED|Overall Study||53
136040|NCT01174004|329445|P2|NOT COMPLETED|Overall Study||16
136041|NCT01174004|329446|P1|NOT COMPLETED|Overall Study||7
136042|NCT01174004|329445|P2|COMPLETED|Overall Study||89
136043|NCT01174004|329446|P1|COMPLETED|Overall Study||87
136044|NCT01174004|329445|P2|STARTED|Overall Study||105
136045|NCT01174004|329446|P1|STARTED|Overall Study||94
136046|NCT01173874|329456|P2|NOT COMPLETED|Overall Study||23
136047|NCT01173874|329457|P1|NOT COMPLETED|Overall Study||23
136048|NCT01173874|329456|P2|COMPLETED|Overall Study||41
136049|NCT01173874|329457|P1|COMPLETED|Overall Study||33
136050|NCT01173874|329456|P2|STARTED|Overall Study||64
136051|NCT01173874|329457|P1|STARTED|Overall Study||56
136052|NCT01173848|329471|P2|NOT COMPLETED|Overall Study||8
136053|NCT01173848|329472|P1|NOT COMPLETED|Overall Study||4
136054|NCT01173848|329471|P2|COMPLETED|Overall Study||3
136055|NCT01173848|329472|P1|COMPLETED|Overall Study||4
136056|NCT01173848|329471|P2|STARTED|Overall Study||11
136057|NCT01173848|329472|P1|STARTED|Overall Study||8
136058|NCT01173718|329477|P1|NOT COMPLETED|Overall Study||44
136059|NCT01173718|329477|P1|COMPLETED|Overall Study||94
136060|NCT01173718|329477|P1|STARTED|Overall Study||138
136061|NCT01173679|329486|P1|NOT COMPLETED|Overall Study||1
136062|NCT01173679|329486|P1|COMPLETED|Overall Study||9
136063|NCT01173679|329486|P1|STARTED|Overall Study||10
136064|NCT01173653|329494|P2|NOT COMPLETED|Overall Study||41
136065|NCT01173653|329495|P1|NOT COMPLETED|Overall Study||53
136066|NCT01173653|329494|P2|COMPLETED|Overall Study||49
136067|NCT01173653|329495|P1|COMPLETED|Overall Study||56
136068|NCT01173653|329494|P2|STARTED|Overall Study||90
136069|NCT01173653|329495|P1|STARTED|Overall Study||109
136070|NCT01173601|329505|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
136071|NCT01173601|329506|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
136072|NCT01173601|329507|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
136073|NCT01173601|329508|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
136074|NCT01173601|329509|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
136075|NCT01173601|329505|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
136076|NCT01173601|329506|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
136077|NCT01173601|329507|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
136078|NCT01173601|329508|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
136079|NCT01173601|329509|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
136080|NCT01173601|329505|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
136081|NCT01173601|329506|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
136082|NCT01173601|329507|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
136083|NCT01173601|329508|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
136084|NCT01173601|329509|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
136085|NCT01173601|329505|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
136086|NCT01173601|329506|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
136087|NCT01173601|329507|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
136088|NCT01173601|329508|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
136089|NCT01173601|329509|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
136090|NCT01173601|329505|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
136091|NCT01173601|329506|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
136092|NCT01173601|329507|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
136093|NCT01173601|329508|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
136094|NCT01173601|329509|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
136095|NCT01173601|329505|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136096|NCT01173601|329506|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136097|NCT01173601|329507|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136098|NCT01173601|329508|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136099|NCT01173601|329509|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
136100|NCT01173601|329505|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136101|NCT01173601|329506|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136102|NCT01173601|329507|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136103|NCT01173601|329508|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
136104|NCT01173601|329509|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
136105|NCT01173601|329505|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
136106|NCT01173601|329506|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
136107|NCT01173601|329507|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
136108|NCT01173601|329508|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
136109|NCT01173601|329509|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
136110|NCT01173601|329505|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
136111|NCT01173601|329506|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
136112|NCT01173601|329507|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
136113|NCT01173601|329508|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
136114|NCT01173601|329509|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
136115|NCT01173523|329586|P2|NOT COMPLETED|Overall Study||12
136116|NCT01173523|329587|P1|NOT COMPLETED|Overall Study||13
136117|NCT01173523|329586|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
136118|NCT01173523|329587|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
136119|NCT01173523|329586|P2|STARTED|Overall Study||12
136120|NCT01173523|329587|P1|STARTED|Overall Study||13
136121|NCT01173471|329603|P4|NOT COMPLETED|Overall Study||1
136122|NCT01173471|329604|P3|NOT COMPLETED|Overall Study||3
136123|NCT01173471|329605|P2|NOT COMPLETED|Overall Study||0
136124|NCT01173471|329606|P1|NOT COMPLETED|Overall Study||2
136125|NCT01173471|329603|P4|COMPLETED|Overall Study|Completed study|18
136126|NCT01173471|329604|P3|COMPLETED|Overall Study|Completed study|15
136127|NCT01173471|329605|P2|COMPLETED|Overall Study|Completed study|7
136128|NCT01173471|329606|P1|COMPLETED|Overall Study|Completed study|4
136129|NCT01173471|329603|P4|Completed Treatment|Overall Study||18
136130|NCT01173471|329604|P3|Completed Treatment|Overall Study||15
136131|NCT01173471|329605|P2|Completed Treatment|Overall Study||7
136132|NCT01173471|329606|P1|Completed Treatment|Overall Study||4
136133|NCT01173471|329603|P4|Received Treatment|Overall Study||19
136134|NCT01173471|329604|P3|Received Treatment|Overall Study||18
136135|NCT01173471|329605|P2|Received Treatment|Overall Study||7
136136|NCT01173471|329606|P1|Received Treatment|Overall Study||6
136137|NCT01173471|329603|P4|STARTED|Overall Study|Randomized|19
136138|NCT01173471|329604|P3|STARTED|Overall Study|Randomized|18
136139|NCT01173471|329605|P2|STARTED|Overall Study|Randomized|7
136140|NCT01173471|329606|P1|STARTED|Overall Study|Randomized|6
136141|NCT01173211|329630|P6|NOT COMPLETED|Overall Study||0
136142|NCT01173211|329631|P5|NOT COMPLETED|Overall Study||0
136143|NCT01173211|329632|P4|NOT COMPLETED|Overall Study||0
136144|NCT01173211|329633|P3|NOT COMPLETED|Overall Study||2
136145|NCT01173211|329634|P2|NOT COMPLETED|Overall Study||1
136146|NCT01173211|329635|P1|NOT COMPLETED|Overall Study||2
136147|NCT01173211|329630|P6|COMPLETED|Overall Study||13
136148|NCT01173211|329631|P5|COMPLETED|Overall Study||16
136149|NCT01173211|329632|P4|COMPLETED|Overall Study||15
136150|NCT01173211|329633|P3|COMPLETED|Overall Study||44
136151|NCT01173211|329634|P2|COMPLETED|Overall Study||44
136152|NCT01173211|329635|P1|COMPLETED|Overall Study||46
136153|NCT01173211|329630|P6|STARTED|Overall Study||13
136154|NCT01173211|329631|P5|STARTED|Overall Study||16
136155|NCT01173211|329632|P4|STARTED|Overall Study||15
136156|NCT01173211|329633|P3|STARTED|Overall Study||46
136157|NCT01173211|329634|P2|STARTED|Overall Study||45
136158|NCT01173211|329635|P1|STARTED|Overall Study||48
136159|NCT01173120|329736|P1|NOT COMPLETED|Overall Study||62
136160|NCT01173120|329736|P1|COMPLETED|Overall Study||0
136161|NCT01173120|329736|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
136162|NCT01173120|329736|P1|Switched Back to Main Study|Overall Study||57
136163|NCT01173120|329736|P1|STARTED|Overall Study||62
136164|NCT01173055|329754|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
136165|NCT01173055|329755|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
136166|NCT01173055|329754|P2|COMPLETED|Period 2 - Day 64 to 112||9
136167|NCT01173055|329755|P1|COMPLETED|Period 2 - Day 64 to 112||8
136168|NCT01173055|329754|P2|STARTED|Period 2 - Day 64 to 112||10
136169|NCT01173055|329755|P1|STARTED|Period 2 - Day 64 to 112||8
136170|NCT01173055|329754|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
136171|NCT01173055|329755|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
136172|NCT01173055|329754|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
136173|NCT01173055|329755|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
136174|NCT01173055|329754|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
136175|NCT01173055|329755|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
136176|NCT01173055|329754|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
136177|NCT01173055|329755|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
136178|NCT01173055|329754|P2|COMPLETED|Period 1 - Day 1 to 49||10
136179|NCT01173055|329755|P1|COMPLETED|Period 1 - Day 1 to 49||8
136180|NCT01173055|329754|P2|STARTED|Period 1 - Day 1 to 49||12
136181|NCT01173055|329755|P1|STARTED|Period 1 - Day 1 to 49||10
136182|NCT01173029|329773|P2|NOT COMPLETED|Overall Study||0
136183|NCT01173029|329774|P1|NOT COMPLETED|Overall Study||0
136184|NCT01173029|329773|P2|COMPLETED|Overall Study||31
136185|NCT01173029|329774|P1|COMPLETED|Overall Study||61
136186|NCT01173029|329773|P2|STARTED|Overall Study||31
136187|NCT01173029|329774|P1|STARTED|Overall Study||61
136188|NCT01172938|329794|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
136189|NCT01172938|329795|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
136190|NCT01172938|329796|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136191|NCT01172938|329797|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136192|NCT01172938|329798|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136193|NCT01172938|329799|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136194|NCT01172938|329800|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
136195|NCT01172938|329801|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
136196|NCT01172938|329802|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136197|NCT01172938|329794|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
136198|NCT01172938|329795|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
136199|NCT01172938|329796|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136200|NCT01172938|329797|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136201|NCT01172938|329798|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136202|NCT01172938|329799|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136203|NCT01172938|329800|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
136204|NCT01172938|329801|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
136205|NCT01172938|329802|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
136206|NCT01172938|329794|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136207|NCT01172938|329795|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
136208|NCT01172938|329796|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136209|NCT01172938|329797|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136210|NCT01172938|329798|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136211|NCT01172938|329799|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136212|NCT01172938|329800|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136213|NCT01172938|329801|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136214|NCT01172938|329802|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
136215|NCT01172938|329794|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
136216|NCT01172938|329795|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
136217|NCT01172938|329796|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
136218|NCT01172938|329797|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
136219|NCT01172938|329798|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
136220|NCT01172938|329799|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
136221|NCT01172938|329800|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
136222|NCT01172938|329801|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
136223|NCT01172938|329802|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
136224|NCT01172938|329794|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
136225|NCT01172938|329795|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
136226|NCT01172938|329796|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136227|NCT01172938|329797|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136228|NCT01172938|329798|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136229|NCT01172938|329799|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136230|NCT01172938|329800|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
136231|NCT01172938|329801|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
136232|NCT01172938|329802|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136233|NCT01172938|329794|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
136234|NCT01172938|329795|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
136235|NCT01172938|329796|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136236|NCT01172938|329797|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136237|NCT01172938|329798|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136238|NCT01172938|329799|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136239|NCT01172938|329800|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
136240|NCT01172938|329801|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
136241|NCT01172938|329802|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
136242|NCT01172938|329794|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
136243|NCT01172938|329795|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
136244|NCT01172938|329796|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
136245|NCT01172938|329797|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
136246|NCT01172938|329798|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
136247|NCT01172938|329799|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
136248|NCT01172938|329800|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
136249|NCT01172938|329801|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
136250|NCT01172938|329802|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
136251|NCT01172938|329794|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
136252|NCT01172938|329795|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
136253|NCT01172938|329796|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136254|NCT01172938|329797|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136255|NCT01172938|329798|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136256|NCT01172938|329799|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136257|NCT01172938|329800|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
136258|NCT01172938|329801|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
136259|NCT01172938|329802|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136260|NCT01172938|329794|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
136261|NCT01172938|329795|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
136262|NCT01172938|329796|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136263|NCT01172938|329797|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136264|NCT01172938|329798|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136265|NCT01172938|329799|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136266|NCT01172938|329800|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
136267|NCT01172938|329801|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
136268|NCT01172938|329802|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
136269|NCT01172938|329794|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
136270|NCT01172938|329795|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
136271|NCT01172938|329796|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
136272|NCT01172938|329797|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
136273|NCT01172938|329798|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
136274|NCT01172938|329799|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
136275|NCT01172938|329800|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
136276|NCT01172938|329801|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
136277|NCT01172938|329802|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
136278|NCT01172938|329794|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
136279|NCT01172938|329795|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
136280|NCT01172938|329796|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136281|NCT01172938|329797|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136282|NCT01172938|329798|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136283|NCT01172938|329799|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136284|NCT01172938|329800|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
136285|NCT01172938|329801|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
136286|NCT01172938|329802|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136287|NCT01172938|329794|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
136288|NCT01172938|329795|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
136289|NCT01172938|329796|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136290|NCT01172938|329797|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136291|NCT01172938|329798|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136292|NCT01172938|329799|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136293|NCT01172938|329800|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
136294|NCT01172938|329801|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
136295|NCT01172938|329802|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
136296|NCT01172938|329794|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
136297|NCT01172938|329795|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
136298|NCT01172938|329796|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
136299|NCT01172938|329797|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
136300|NCT01172938|329798|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
136301|NCT01172938|329799|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
136302|NCT01172938|329800|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
136303|NCT01172938|329801|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
136304|NCT01172938|329802|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
136305|NCT01172938|329794|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
136306|NCT01172938|329795|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
136307|NCT01172938|329796|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
136308|NCT01172938|329797|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
136309|NCT01172938|329798|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
136310|NCT01172938|329799|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
136311|NCT01172938|329800|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
136312|NCT01172938|329801|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
136313|NCT01172938|329802|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
136314|NCT01172938|329794|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
136315|NCT01172938|329795|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
136316|NCT01172938|329796|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
136317|NCT01172938|329797|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
136318|NCT01172938|329798|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
136319|NCT01172938|329799|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
136320|NCT01172938|329800|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
136321|NCT01172938|329801|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
136322|NCT01172938|329802|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
136323|NCT01172938|329794|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
136324|NCT01172938|329795|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
136325|NCT01172938|329796|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
136326|NCT01172938|329797|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
136327|NCT01172938|329798|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
136328|NCT01172938|329799|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
136329|NCT01172938|329800|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
136330|NCT01172938|329801|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
136331|NCT01172938|329802|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
136332|NCT01172938|329794|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136333|NCT01172938|329795|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136334|NCT01172938|329796|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136335|NCT01172938|329797|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136336|NCT01172938|329798|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136337|NCT01172938|329799|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136338|NCT01172938|329800|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
136339|NCT01172938|329801|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
136340|NCT01172938|329802|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
136341|NCT01172938|329794|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136342|NCT01172938|329795|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136343|NCT01172938|329796|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136344|NCT01172938|329797|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136345|NCT01172938|329798|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136346|NCT01172938|329799|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
136347|NCT01172938|329800|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
136348|NCT01172938|329801|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
136349|NCT01172938|329802|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
136350|NCT01172938|329794|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
136351|NCT01172938|329795|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
136352|NCT01172938|329796|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
136353|NCT01172938|329797|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
136354|NCT01172938|329798|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
136355|NCT01172938|329799|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
136356|NCT01172938|329800|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
136357|NCT01172938|329801|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
136358|NCT01172938|329802|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
136359|NCT01172938|329794|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
136360|NCT01172938|329795|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
136361|NCT01172938|329796|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
136362|NCT01172938|329797|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
136363|NCT01172938|329798|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
136364|NCT01172938|329799|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
136365|NCT01172938|329800|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
136366|NCT01172938|329801|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
136367|NCT01172938|329802|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
136368|NCT01172938|329794|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
136369|NCT01172938|329795|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
136370|NCT01172938|329796|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
136371|NCT01172938|329797|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
136372|NCT01172938|329798|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
136373|NCT01172938|329799|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
136374|NCT01172938|329800|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
136375|NCT01172938|329801|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
136376|NCT01172938|329802|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
136377|NCT01172938|329794|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
136378|NCT01172938|329795|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
136379|NCT01172938|329796|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
136380|NCT01172938|329797|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
136381|NCT01172938|329798|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
136382|NCT01172938|329799|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
136383|NCT01172938|329800|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
136384|NCT01172938|329801|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
136385|NCT01172938|329802|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
136386|NCT01172873|329988|P2|NOT COMPLETED|Overall Study||2
136387|NCT01172873|329989|P1|NOT COMPLETED|Overall Study||3
136388|NCT01172873|329988|P2|COMPLETED|Overall Study||3
136389|NCT01172873|329989|P1|COMPLETED|Overall Study||8
136390|NCT01172873|329988|P2|STARTED|Overall Study||5
136391|NCT01172873|329989|P1|STARTED|Overall Study||11
136392|NCT01172847|329999|P1|NOT COMPLETED|Overall Study||3
136393|NCT01172847|329999|P1|COMPLETED|Overall Study||21
136394|NCT01172847|329999|P1|Oseltamivir + Rimantadine|Overall Study||21
136395|NCT01172847|329999|P1|Rimantadine|Overall Study||22
136396|NCT01172847|329999|P1|Oseltamivir|Overall Study||24
136397|NCT01172847|329999|P1|STARTED|Overall Study||24
136398|NCT01172821|330028|P4|NOT COMPLETED|Overall Study||17
136399|NCT01172821|330029|P3|NOT COMPLETED|Overall Study||13
136400|NCT01172821|330030|P2|NOT COMPLETED|Overall Study||12
136401|NCT01172821|330031|P1|NOT COMPLETED|Overall Study||14
136402|NCT01172821|330028|P4|COMPLETED|Overall Study||249
136403|NCT01172821|330029|P3|COMPLETED|Overall Study||240
136404|NCT01172821|330030|P2|COMPLETED|Overall Study||245
136405|NCT01172821|330031|P1|COMPLETED|Overall Study||240
136406|NCT01172821|330028|P4|STARTED|Overall Study|Entered and Treated|266
136407|NCT01172821|330029|P3|STARTED|Overall Study|Entered and Treated|253
136408|NCT01172821|330030|P2|STARTED|Overall Study|Entered and Treated|257
136409|NCT01172821|330031|P1|STARTED|Overall Study|Entered and Treated|254
136410|NCT01172808|330121|P4|NOT COMPLETED|Overall Study||15
136411|NCT01172808|330122|P3|NOT COMPLETED|Overall Study||23
136412|NCT01172808|330123|P2|NOT COMPLETED|Overall Study||13
136413|NCT01172808|330124|P1|NOT COMPLETED|Overall Study||21
136414|NCT01172808|330121|P4|COMPLETED|Overall Study||260
136415|NCT01172808|330122|P3|COMPLETED|Overall Study||241
136416|NCT01172808|330123|P2|COMPLETED|Overall Study||249
136417|NCT01172808|330124|P1|COMPLETED|Overall Study||248
136418|NCT01172808|330121|P4|STARTED|Overall Study|Entered and Treated|275
136419|NCT01172808|330122|P3|STARTED|Overall Study|Entered and Treated|264
136420|NCT01172808|330123|P2|STARTED|Overall Study|Entered and Treated|262
136421|NCT01172808|330124|P1|STARTED|Overall Study|Entered and Treated|269
136422|NCT01172600|330212|P2|NOT COMPLETED|Overall Study||0
136423|NCT01172600|330213|P1|NOT COMPLETED|Overall Study||0
136424|NCT01172600|330212|P2|COMPLETED|Overall Study||39
136425|NCT01172600|330213|P1|COMPLETED|Overall Study||39
136426|NCT01172600|330212|P2|STARTED|Overall Study||39
136427|NCT01172600|330213|P1|STARTED|Overall Study||39
136428|NCT01172535|330243|P1|NOT COMPLETED|Overall Study||8
136429|NCT01172535|330243|P1|COMPLETED|Overall Study||89
136430|NCT01172535|330243|P1|STARTED|Overall Study||97
136431|NCT01172522|330260|P2|NOT COMPLETED|Overall Study||0
136432|NCT01172522|330261|P1|NOT COMPLETED|Overall Study||0
136433|NCT01172522|330260|P2|COMPLETED|Overall Study||15
136434|NCT01172522|330261|P1|COMPLETED|Overall Study||15
136435|NCT01172522|330260|P2|STARTED|Overall Study||15
136436|NCT01172522|330261|P1|STARTED|Overall Study||15
136437|NCT01172418|330268|P2|NOT COMPLETED|Overall Study||0
136438|NCT01172418|330269|P1|NOT COMPLETED|Overall Study||0
136439|NCT01172418|330268|P2|COMPLETED|Overall Study||100
136440|NCT01172418|330269|P1|COMPLETED|Overall Study||100
136441|NCT01172418|330268|P2|STARTED|Overall Study||100
136442|NCT01172418|330269|P1|STARTED|Overall Study||100
136443|NCT01172353|330285|P2|NOT COMPLETED|Overall Study||0
136444|NCT01172353|330286|P1|NOT COMPLETED|Overall Study||0
136445|NCT01172353|330285|P2|COMPLETED|Overall Study||151
136446|NCT01172353|330286|P1|COMPLETED|Overall Study||150
136447|NCT01172353|330285|P2|STARTED|Overall Study||151
136448|NCT01172353|330286|P1|STARTED|Overall Study||150
136449|NCT01172288|330296|P2|NOT COMPLETED|Overall Study||1
136450|NCT01172288|330297|P1|NOT COMPLETED|Overall Study||1
136451|NCT01172288|330296|P2|COMPLETED|Overall Study||13
136452|NCT01172288|330297|P1|COMPLETED|Overall Study||16
136453|NCT01172288|330296|P2|STARTED|Overall Study||14
136454|NCT01172288|330297|P1|STARTED|Overall Study||17
136455|NCT01172197|330313|P2|NOT COMPLETED|Overall Study||0
136456|NCT01172197|330314|P1|NOT COMPLETED|Overall Study||0
136457|NCT01172197|330313|P2|COMPLETED|Overall Study||7
136458|NCT01172197|330314|P1|COMPLETED|Overall Study||7
136459|NCT01172197|330313|P2|STARTED|Overall Study||7
136460|NCT01172197|330314|P1|STARTED|Overall Study||7
136461|NCT01172184|330320|P1|NOT COMPLETED|Overall Study||0
136462|NCT01172184|330320|P1|COMPLETED|Overall Study||111
136463|NCT01172184|330320|P1|STARTED|Overall Study||111
136464|NCT01172145|330328|P2|NOT COMPLETED|Overall Study||0
136465|NCT01172145|330329|P1|NOT COMPLETED|Overall Study||0
136466|NCT01172145|330328|P2|COMPLETED|Overall Study||11
136467|NCT01172145|330329|P1|COMPLETED|Overall Study||11
136468|NCT01172145|330328|P2|STARTED|Overall Study||11
136469|NCT01172145|330329|P1|STARTED|Overall Study||11
136470|NCT01171989|330352|P3|NOT COMPLETED|Overall Study||1
136471|NCT01171989|330353|P2|NOT COMPLETED|Overall Study||0
136472|NCT01171989|330354|P1|NOT COMPLETED|Overall Study||0
136473|NCT01171989|330352|P3|COMPLETED|Overall Study||120
136474|NCT01171989|330353|P2|COMPLETED|Overall Study||133
136475|NCT01171989|330354|P1|COMPLETED|Overall Study||137
136476|NCT01171989|330352|P3|STARTED|Overall Study||121
136477|NCT01171989|330353|P2|STARTED|Overall Study||133
136478|NCT01171989|330354|P1|STARTED|Overall Study||137
136479|NCT01171976|330428|P3|NOT COMPLETED|Overall Study||15
136480|NCT01171976|330429|P2|NOT COMPLETED|Overall Study||11
136481|NCT01171976|330430|P1|NOT COMPLETED|Overall Study||14
136482|NCT01171976|330428|P3|COMPLETED|Overall Study||108
136483|NCT01171976|330429|P2|COMPLETED|Overall Study||117
136484|NCT01171976|330430|P1|COMPLETED|Overall Study||107
136485|NCT01171976|330428|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
136486|NCT01171976|330429|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
136487|NCT01171976|330430|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
136488|NCT01171976|330428|P3|STARTED|Overall Study||123
136489|NCT01171976|330429|P2|STARTED|Overall Study||128
136490|NCT01171976|330430|P1|STARTED|Overall Study||121
136491|NCT01171963|330467|P2|NOT COMPLETED|Overall Study||168
136492|NCT01171963|330468|P1|NOT COMPLETED|Overall Study||148
136493|NCT01171963|330467|P2|COMPLETED|Overall Study||1499
136494|NCT01171963|330468|P1|COMPLETED|Overall Study||1518
136495|NCT01171963|330467|P2|STARTED|Overall Study||1667
136496|NCT01171963|330468|P1|STARTED|Overall Study||1666
136497|NCT01171924|330526|P2|NOT COMPLETED|Overall Study||23
136498|NCT01171924|330527|P1|NOT COMPLETED|Overall Study||23
136499|NCT01171924|330526|P2|COMPLETED|Overall Study||0
136500|NCT01171924|330527|P1|COMPLETED|Overall Study||0
136501|NCT01171924|330526|P2|STARTED|Overall Study||23
136502|NCT01171924|330527|P1|STARTED|Overall Study||23
136503|NCT01171820|330535|P2|NOT COMPLETED|Overall Study||6
136504|NCT01171820|330536|P1|NOT COMPLETED|Overall Study||6
136505|NCT01171820|330535|P2|COMPLETED|Overall Study||212
136506|NCT01171820|330536|P1|COMPLETED|Overall Study||100
136507|NCT01171820|330535|P2|STARTED|Overall Study||218
136508|NCT01171820|330536|P1|STARTED|Overall Study||106
136509|NCT01171794|330592|P2|NOT COMPLETED|Overall Study||0
136510|NCT01171794|330593|P1|NOT COMPLETED|Overall Study||3
136511|NCT01171794|330592|P2|COMPLETED|Overall Study||42
136512|NCT01171794|330593|P1|COMPLETED|Overall Study||44
136513|NCT01171794|330592|P2|STARTED|Overall Study||42
136514|NCT01171794|330593|P1|STARTED|Overall Study||47
136515|NCT01171690|330603|P2|NOT COMPLETED|Overall Study||0
136516|NCT01171690|330604|P1|NOT COMPLETED|Overall Study||0
136517|NCT01171690|330603|P2|COMPLETED|Overall Study||5
136518|NCT01171690|330604|P1|COMPLETED|Overall Study||5
136519|NCT01171690|330603|P2|STARTED|Overall Study||5
136520|NCT01171690|330604|P1|STARTED|Overall Study||5
136521|NCT01171677|330614|P2|NOT COMPLETED|Overall Study||3
136522|NCT01171677|330615|P1|NOT COMPLETED|Overall Study||6
136523|NCT01171677|330614|P2|COMPLETED|Overall Study||12
136524|NCT01171677|330615|P1|COMPLETED|Overall Study||11
136525|NCT01171677|330614|P2|STARTED|Overall Study||15
136526|NCT01171677|330615|P1|STARTED|Overall Study||17
136527|NCT01171612|330647|P1|NOT COMPLETED|Overall Study||51
136528|NCT01171612|330647|P1|COMPLETED|Overall Study||432
136529|NCT01171612|330647|P1|STARTED|Overall Study||483
136530|NCT01171534|330657|P2|NOT COMPLETED|Overall Study||3
136531|NCT01171534|330658|P1|NOT COMPLETED|Overall Study||0
136532|NCT01171534|330657|P2|COMPLETED|Overall Study||4
136533|NCT01171534|330658|P1|COMPLETED|Overall Study||0
136534|NCT01171534|330657|P2|STARTED|Overall Study||7
136535|NCT01171534|330658|P1|STARTED|Overall Study|retrospective arm never performed on study|0
136536|NCT01171521|330670|P1|NOT COMPLETED|Overall Study||6
136537|NCT01171521|330670|P1|COMPLETED|Overall Study||0
136538|NCT01171521|330670|P1|STARTED|Overall Study||6
136539|NCT01171183|330677|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
136540|NCT01171183|330678|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
136541|NCT01171183|330677|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
136542|NCT01171183|330678|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
136543|NCT01171183|330677|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
136544|NCT01171183|330678|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
136545|NCT01171183|330677|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
136546|NCT01171183|330678|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
136547|NCT01171183|330677|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
136548|NCT01171183|330678|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
136549|NCT01171183|330677|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
136550|NCT01171183|330678|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
136551|NCT01171118|330686|P1|NOT COMPLETED|Overall Study||0
136552|NCT01171118|330686|P1|COMPLETED|Overall Study||10
136553|NCT01171118|330686|P1|STARTED|Overall Study||10
136554|NCT01170962|330699|P3|NOT COMPLETED|Follow up Period||6
136555|NCT01170962|330700|P2|NOT COMPLETED|Follow up Period||27
136556|NCT01170962|330701|P1|NOT COMPLETED|Follow up Period||39
136557|NCT01170962|330699|P3|COMPLETED|Follow up Period||9
136558|NCT01170962|330700|P2|COMPLETED|Follow up Period||165
136559|NCT01170962|330701|P1|COMPLETED|Follow up Period||159
136560|NCT01170962|330699|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
136561|NCT01170962|330700|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
136562|NCT01170962|330701|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
136563|NCT01170962|330699|P3|NOT COMPLETED|Treatment Period||12
136564|NCT01170962|330700|P2|NOT COMPLETED|Treatment Period||111
136565|NCT01170962|330701|P1|NOT COMPLETED|Treatment Period||127
136566|NCT01170962|330699|P3|COMPLETED|Treatment Period||5
136567|NCT01170962|330700|P2|COMPLETED|Treatment Period||88
136568|NCT01170962|330701|P1|COMPLETED|Treatment Period||76
136569|NCT01170962|330699|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
136570|NCT01170962|330700|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
136571|NCT01170962|330701|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
136572|NCT01170962|330699|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
136573|NCT01170962|330700|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
136574|NCT01170962|330701|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
136575|NCT01170962|330699|P3|No PDR|Treatment Period||17
136576|NCT01170962|330700|P2|No PDR|Treatment Period||127
136577|NCT01170962|330701|P1|No PDR|Treatment Period||145
136578|NCT01170962|330699|P3|STARTED|Treatment Period||17
136579|NCT01170962|330700|P2|STARTED|Treatment Period||199
136580|NCT01170962|330701|P1|STARTED|Treatment Period||203
136581|NCT01170949|330747|P2|NOT COMPLETED|Overall Study||4
136582|NCT01170949|330748|P1|NOT COMPLETED|Overall Study||7
136583|NCT01170949|330747|P2|COMPLETED|Overall Study||22
136584|NCT01170949|330748|P1|COMPLETED|Overall Study||43
136585|NCT01170949|330747|P2|STARTED|Overall Study||26
136586|NCT01170949|330748|P1|STARTED|Overall Study||50
136587|NCT01170884|330756|P2|NOT COMPLETED|Overall Study||2
136588|NCT01170884|330757|P1|NOT COMPLETED|Overall Study||5
136589|NCT01170884|330756|P2|COMPLETED|Overall Study||60
136590|NCT01170884|330757|P1|COMPLETED|Overall Study||54
136591|NCT01170884|330756|P2|STARTED|Overall Study||62
136592|NCT01170884|330757|P1|STARTED|Overall Study||59
136593|NCT01170754|330765|P2|NOT COMPLETED|Overall Study||0
136594|NCT01170754|330766|P1|NOT COMPLETED|Overall Study||0
136595|NCT01170754|330765|P2|COMPLETED|Overall Study||70
136596|NCT01170754|330766|P1|COMPLETED|Overall Study||66
136597|NCT01170754|330765|P2|STARTED|Overall Study||70
136598|NCT01170754|330766|P1|STARTED|Overall Study||66
136599|NCT01170663|330796|P2|NOT COMPLETED|Overall Study||20
136600|NCT01170663|330797|P1|NOT COMPLETED|Overall Study||14
136601|NCT01170663|330796|P2|COMPLETED|Overall Study||315
136602|NCT01170663|330797|P1|COMPLETED|Overall Study||316
136603|NCT01170663|330796|P2|Received Any Treatment (Safety Pop)|Overall Study||329
136604|NCT01170663|330797|P1|Received Any Treatment (Safety Pop)|Overall Study||327
136605|NCT01170663|330796|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
136606|NCT01170663|330797|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
136607|NCT01170598|330825|P1|NOT COMPLETED|Overall Study||6
136608|NCT01170598|330825|P1|COMPLETED|Overall Study||29
136609|NCT01170598|330825|P1|STARTED|Overall Study||35
136610|NCT01170546|330844|P4|NOT COMPLETED|Overall Study||0
136611|NCT01170546|330845|P3|NOT COMPLETED|Overall Study||0
136612|NCT01170546|330846|P2|NOT COMPLETED|Overall Study||0
136613|NCT01170546|330847|P1|NOT COMPLETED|Overall Study||0
136614|NCT01170546|330844|P4|COMPLETED|Overall Study||8
136615|NCT01170546|330845|P3|COMPLETED|Overall Study||6
136616|NCT01170546|330846|P2|COMPLETED|Overall Study||7
136617|NCT01170546|330847|P1|COMPLETED|Overall Study||7
136618|NCT01170546|330844|P4|STARTED|Overall Study||8
136619|NCT01170546|330845|P3|STARTED|Overall Study||6
136620|NCT01170546|330846|P2|STARTED|Overall Study||7
136621|NCT01170546|330847|P1|STARTED|Overall Study||7
136622|NCT01170533|330857|P2|NOT COMPLETED|Pantoprazole Cross-over||0
136623|NCT01170533|330858|P1|NOT COMPLETED|Pantoprazole Cross-over||0
136624|NCT01170533|330857|P2|COMPLETED|Pantoprazole Cross-over||20
136625|NCT01170533|330858|P1|COMPLETED|Pantoprazole Cross-over||0
136626|NCT01170533|330857|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
136627|NCT01170533|330858|P1|STARTED|Pantoprazole Cross-over||0
136628|NCT01170533|330857|P2|NOT COMPLETED|Omeprazole Cross-over||0
136629|NCT01170533|330858|P1|NOT COMPLETED|Omeprazole Cross-over||0
136630|NCT01170533|330857|P2|COMPLETED|Omeprazole Cross-over||0
136631|NCT01170533|330858|P1|COMPLETED|Omeprazole Cross-over||20
136632|NCT01170533|330857|P2|STARTED|Omeprazole Cross-over||0
136633|NCT01170533|330858|P1|STARTED|Omeprazole Cross-over||20
136634|NCT01170390|330870|P3|NOT COMPLETED|Randomized Treatment||0
136635|NCT01170390|330871|P2|NOT COMPLETED|Randomized Treatment||1
136636|NCT01170390|330872|P1|NOT COMPLETED|Randomized Treatment||0
136637|NCT01170390|330870|P3|COMPLETED|Randomized Treatment||15
136638|NCT01170390|330871|P2|COMPLETED|Randomized Treatment||16
136639|NCT01170390|330872|P1|COMPLETED|Randomized Treatment||0
136640|NCT01170390|330870|P3|STARTED|Randomized Treatment||15
136641|NCT01170390|330871|P2|STARTED|Randomized Treatment||17
136642|NCT01170390|330872|P1|STARTED|Randomized Treatment||0
136643|NCT01170390|330870|P3|NOT COMPLETED|Oral Contraceptives||0
136644|NCT01170390|330871|P2|NOT COMPLETED|Oral Contraceptives||0
136645|NCT01170390|330872|P1|NOT COMPLETED|Oral Contraceptives||1
136646|NCT01170390|330870|P3|COMPLETED|Oral Contraceptives||0
136647|NCT01170390|330871|P2|COMPLETED|Oral Contraceptives||0
136648|NCT01170390|330872|P1|COMPLETED|Oral Contraceptives||31
136649|NCT01170390|330870|P3|STARTED|Oral Contraceptives||0
136650|NCT01170390|330871|P2|STARTED|Oral Contraceptives||0
136651|NCT01170390|330872|P1|STARTED|Oral Contraceptives||32
136652|NCT01170364|330888|P2|NOT COMPLETED|Overall Study||1
136653|NCT01170364|330889|P1|NOT COMPLETED|Overall Study||4
136654|NCT01170364|330888|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
136655|NCT01170364|330889|P1|COMPLETED|Overall Study||4
136656|NCT01170364|330888|P2|STARTED|Overall Study||6
136657|NCT01170364|330889|P1|STARTED|Overall Study||8
136658|NCT01170273|330897|P2|NOT COMPLETED|Overall Study||9
136659|NCT01170273|330898|P1|NOT COMPLETED|Overall Study||8
136660|NCT01170273|330897|P2|COMPLETED|Overall Study||57
136661|NCT01170273|330898|P1|COMPLETED|Overall Study||56
136662|NCT01170273|330897|P2|STARTED|Overall Study||66
136663|NCT01170273|330898|P1|STARTED|Overall Study||64
136664|NCT01170247|330906|P2|NOT COMPLETED|Overall Study||0
136665|NCT01170247|330907|P1|NOT COMPLETED|Overall Study||0
136666|NCT01170247|330906|P2|COMPLETED|Overall Study||1
136667|NCT01170247|330907|P1|COMPLETED|Overall Study||2
136668|NCT01170247|330906|P2|STARTED|Overall Study||1
136669|NCT01170247|330907|P1|STARTED|Overall Study||2
136670|NCT01170221|330915|P2|NOT COMPLETED|Overall Study||28
136671|NCT01170221|330916|P1|NOT COMPLETED|Overall Study||33
136672|NCT01170221|330915|P2|COMPLETED|Overall Study||307
136673|NCT01170221|330916|P1|COMPLETED|Overall Study||299
136674|NCT01170221|330915|P2|STARTED|Overall Study||335
136675|NCT01170221|330916|P1|STARTED|Overall Study||332
136676|NCT01170208|330939|P3|NOT COMPLETED|Overall Study||2
136677|NCT01170208|330940|P2|NOT COMPLETED|Overall Study||0
136678|NCT01170208|330941|P1|NOT COMPLETED|Overall Study||6
136679|NCT01170208|330939|P3|COMPLETED|Overall Study||4
136680|NCT01170208|330940|P2|COMPLETED|Overall Study||20
136681|NCT01170208|330941|P1|COMPLETED|Overall Study||14
136682|NCT01170208|330939|P3|STARTED|Overall Study||6
136683|NCT01170208|330940|P2|STARTED|Overall Study||20
136684|NCT01170208|330941|P1|STARTED|Overall Study||20
136685|NCT01170117|330951|P2|NOT COMPLETED|Overall Study||20
136686|NCT01170117|330952|P1|NOT COMPLETED|Overall Study||30
136687|NCT01170117|330951|P2|COMPLETED|Overall Study||55
136688|NCT01170117|330952|P1|COMPLETED|Overall Study||47
136689|NCT01170117|330951|P2|STARTED|Overall Study||75
136690|NCT01170117|330952|P1|STARTED|Overall Study||77
136691|NCT01170091|330960|P1|NOT COMPLETED|Overall Study||24
136692|NCT01170091|330960|P1|COMPLETED|Overall Study||627
136693|NCT01170091|330960|P1|STARTED|Overall Study||651
136694|NCT01170039|330969|P2|NOT COMPLETED|Overall Study||6
136695|NCT01170039|330970|P1|NOT COMPLETED|Overall Study||8
136696|NCT01170039|330969|P2|COMPLETED|Overall Study||33
136697|NCT01170039|330970|P1|COMPLETED|Overall Study||29
136698|NCT01170039|330969|P2|STARTED|Overall Study||39
136699|NCT01170039|330970|P1|STARTED|Overall Study||37
136700|NCT01169987|330982|P1|NOT COMPLETED|Overall Study||31
136701|NCT01169987|330982|P1|COMPLETED|Overall Study||160
136702|NCT01169987|330982|P1|STARTED|Overall Study||191
136703|NCT01169779|331048|P2|NOT COMPLETED|Overall Study||17
136704|NCT01169779|331049|P1|NOT COMPLETED|Overall Study||11
136705|NCT01169779|331048|P2|COMPLETED|Overall Study||179
136706|NCT01169779|331049|P1|COMPLETED|Overall Study||184
136707|NCT01169779|331048|P2|Subgroup for Standardized Meal Test|Overall Study||121
136708|NCT01169779|331049|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
136709|NCT01169779|331048|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
136710|NCT01169779|331049|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
136711|NCT01169779|331048|P2|Treated/Safety Population|Overall Study||196
136712|NCT01169779|331049|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
136713|NCT01169779|331048|P2|STARTED|Overall Study||196
136714|NCT01169779|331049|P1|STARTED|Overall Study|Randomized.|195
136715|NCT01169753|331075|P2|NOT COMPLETED|Overall Study||1
136716|NCT01169753|331076|P1|NOT COMPLETED|Overall Study||0
136717|NCT01169753|331075|P2|COMPLETED|Overall Study||0
136718|NCT01169753|331076|P1|COMPLETED|Overall Study||0
136719|NCT01169753|331075|P2|STARTED|Overall Study||1
136720|NCT01169753|331076|P1|STARTED|Overall Study||0
136721|NCT01169701|331084|P2|NOT COMPLETED|Overall Study||10
136722|NCT01169701|331085|P1|NOT COMPLETED|Overall Study||5
136723|NCT01169701|331084|P2|COMPLETED|Overall Study||25
136724|NCT01169701|331085|P1|COMPLETED|Overall Study||31
136725|NCT01169701|331084|P2|Intent to Treat (ITT) Set|Overall Study||28
136726|NCT01169701|331085|P1|Intent to Treat (ITT) Set|Overall Study||32
136727|NCT01169701|331084|P2|Safety Set|Overall Study||35
136728|NCT01169701|331085|P1|Safety Set|Overall Study||36
136729|NCT01169701|331084|P2|STARTED|Overall Study||35
136730|NCT01169701|331085|P1|STARTED|Overall Study||36
136731|NCT01169675|331122|P5|NOT COMPLETED|Overall Study||6
136732|NCT01169675|331123|P4|NOT COMPLETED|Overall Study||17
136733|NCT01169675|331124|P3|NOT COMPLETED|Overall Study||7
136734|NCT01169675|331125|P2|NOT COMPLETED|Overall Study||3
136735|NCT01169675|331126|P1|NOT COMPLETED|Overall Study||20
136736|NCT01169675|331122|P5|COMPLETED|Overall Study||0
136737|NCT01169675|331123|P4|COMPLETED|Overall Study||0
136738|NCT01169675|331124|P3|COMPLETED|Overall Study||0
136739|NCT01169675|331125|P2|COMPLETED|Overall Study||0
136740|NCT01169675|331126|P1|COMPLETED|Overall Study||0
136741|NCT01169675|331122|P5|STARTED|Overall Study||6
136742|NCT01169675|331123|P4|STARTED|Overall Study||17
136743|NCT01169675|331124|P3|STARTED|Overall Study||7
136744|NCT01169675|331125|P2|STARTED|Overall Study||3
136745|NCT01169675|331126|P1|STARTED|Overall Study||20
136746|NCT01169649|331163|P1|NOT COMPLETED|Overall Study||3
136747|NCT01169649|331163|P1|COMPLETED|Overall Study||8
136748|NCT01169649|331163|P1|STARTED|Overall Study||11
136749|NCT01169610|331167|P1|NOT COMPLETED|Overall Study||0
136750|NCT01169610|331167|P1|COMPLETED|Overall Study||1
136751|NCT01169610|331167|P1|STARTED|Overall Study||1
136752|NCT01169558|331175|P1|NOT COMPLETED|Overall Study||156
136753|NCT01169558|331175|P1|COMPLETED|Overall Study||6
136754|NCT01169558|331175|P1|STARTED|Overall Study||162
136755|NCT01169519|331182|P1|NOT COMPLETED|Overall Study||0
136756|NCT01169519|331182|P1|COMPLETED|Overall Study||21
136757|NCT01169519|331182|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
136758|NCT01169493|331200|P6|NOT COMPLETED|Period 3 (6 Months)||0
136759|NCT01169493|331201|P5|NOT COMPLETED|Period 3 (6 Months)||0
136760|NCT01169493|331202|P4|NOT COMPLETED|Period 3 (6 Months)||0
136761|NCT01169493|331203|P3|NOT COMPLETED|Period 3 (6 Months)||1
136762|NCT01169493|331204|P2|NOT COMPLETED|Period 3 (6 Months)||2
136763|NCT01169493|331205|P1|NOT COMPLETED|Period 3 (6 Months)||0
136764|NCT01169493|331200|P6|COMPLETED|Period 3 (6 Months)||2
136765|NCT01169493|331201|P5|COMPLETED|Period 3 (6 Months)||0
136766|NCT01169493|331202|P4|COMPLETED|Period 3 (6 Months)||0
136767|NCT01169493|331203|P3|COMPLETED|Period 3 (6 Months)||2
136768|NCT01169493|331204|P2|COMPLETED|Period 3 (6 Months)||1
136769|NCT01169493|331205|P1|COMPLETED|Period 3 (6 Months)||2
136770|NCT01169493|331200|P6|STARTED|Period 3 (6 Months)||2
136771|NCT01169493|331201|P5|STARTED|Period 3 (6 Months)||0
136772|NCT01169493|331202|P4|STARTED|Period 3 (6 Months)||0
136773|NCT01169493|331203|P3|STARTED|Period 3 (6 Months)||3
136774|NCT01169493|331204|P2|STARTED|Period 3 (6 Months)||3
136775|NCT01169493|331205|P1|STARTED|Period 3 (6 Months)||2
136776|NCT01169493|331200|P6|NOT COMPLETED|Period 2 (6 Months)||0
136777|NCT01169493|331201|P5|NOT COMPLETED|Period 2 (6 Months)||0
136778|NCT01169493|331202|P4|NOT COMPLETED|Period 2 (6 Months)||0
136779|NCT01169493|331203|P3|NOT COMPLETED|Period 2 (6 Months)||0
136780|NCT01169493|331204|P2|NOT COMPLETED|Period 2 (6 Months)||0
136781|NCT01169493|331205|P1|NOT COMPLETED|Period 2 (6 Months)||0
136782|NCT01169493|331200|P6|COMPLETED|Period 2 (6 Months)||2
136783|NCT01169493|331201|P5|COMPLETED|Period 2 (6 Months)||0
136784|NCT01169493|331202|P4|COMPLETED|Period 2 (6 Months)||0
136785|NCT01169493|331203|P3|COMPLETED|Period 2 (6 Months)||3
136786|NCT01169493|331204|P2|COMPLETED|Period 2 (6 Months)||3
136787|NCT01169493|331205|P1|COMPLETED|Period 2 (6 Months)||2
136788|NCT01169493|331200|P6|STARTED|Period 2 (6 Months)||2
136789|NCT01169493|331201|P5|STARTED|Period 2 (6 Months)||0
136790|NCT01169493|331202|P4|STARTED|Period 2 (6 Months)||0
136791|NCT01169493|331203|P3|STARTED|Period 2 (6 Months)||3
136792|NCT01169493|331204|P2|STARTED|Period 2 (6 Months)||3
136793|NCT01169493|331205|P1|STARTED|Period 2 (6 Months)||2
136794|NCT01169493|331200|P6|NOT COMPLETED|Period 1 (6 Months)||3
136795|NCT01169493|331201|P5|NOT COMPLETED|Period 1 (6 Months)||0
136796|NCT01169493|331202|P4|NOT COMPLETED|Period 1 (6 Months)||0
136797|NCT01169493|331203|P3|NOT COMPLETED|Period 1 (6 Months)||2
136798|NCT01169493|331204|P2|NOT COMPLETED|Period 1 (6 Months)||1
136799|NCT01169493|331205|P1|NOT COMPLETED|Period 1 (6 Months)||0
136800|NCT01169493|331200|P6|COMPLETED|Period 1 (6 Months)||2
136801|NCT01169493|331201|P5|COMPLETED|Period 1 (6 Months)||0
136802|NCT01169493|331202|P4|COMPLETED|Period 1 (6 Months)||0
136803|NCT01169493|331203|P3|COMPLETED|Period 1 (6 Months)||3
136804|NCT01169493|331204|P2|COMPLETED|Period 1 (6 Months)||3
136805|NCT01169493|331205|P1|COMPLETED|Period 1 (6 Months)||2
136806|NCT01169493|331200|P6|STARTED|Period 1 (6 Months)||5
136807|NCT01169493|331201|P5|STARTED|Period 1 (6 Months)||0
136808|NCT01169493|331202|P4|STARTED|Period 1 (6 Months)||0
136809|NCT01169493|331203|P3|STARTED|Period 1 (6 Months)||5
136810|NCT01169493|331204|P2|STARTED|Period 1 (6 Months)||4
136811|NCT01169493|331205|P1|STARTED|Period 1 (6 Months)||2
136812|NCT01169467|331236|P2|NOT COMPLETED|Overall Study||4
136813|NCT01169467|331237|P1|NOT COMPLETED|Overall Study||7
136814|NCT01169467|331236|P2|COMPLETED|Overall Study||36
136815|NCT01169467|331237|P1|COMPLETED|Overall Study||37
136816|NCT01169467|331236|P2|STARTED|Overall Study||40
136817|NCT01169467|331237|P1|STARTED|Overall Study||44
136818|NCT01169350|331251|P1|NOT COMPLETED|Overall Study||5
136819|NCT01169350|331251|P1|COMPLETED|Overall Study||3
136820|NCT01169350|331251|P1|STARTED|Overall Study||8
136821|NCT01169311|331258|P1|NOT COMPLETED|Overall Study||0
136822|NCT01169311|331258|P1|COMPLETED|Overall Study||27
136823|NCT01169311|331258|P1|STARTED|Overall Study||27
136824|NCT01169103|331272|P2|NOT COMPLETED|Overall Study||4
136825|NCT01169103|331273|P1|NOT COMPLETED|Overall Study||6
136826|NCT01169103|331272|P2|COMPLETED|Overall Study||7
136827|NCT01169103|331273|P1|COMPLETED|Overall Study||5
136828|NCT01169103|331272|P2|STARTED|Overall Study||11
136829|NCT01169103|331273|P1|STARTED|Overall Study||11
136830|NCT01169064|331289|P2|NOT COMPLETED|Overall Study||0
136831|NCT01169064|331290|P1|NOT COMPLETED|Overall Study||0
136832|NCT01169064|331289|P2|COMPLETED|Overall Study||236
136833|NCT01169064|331290|P1|COMPLETED|Overall Study||239
136834|NCT01169064|331289|P2|STARTED|Overall Study||236
136835|NCT01169064|331290|P1|STARTED|Overall Study||239
136836|NCT01169038|331300|P1|NOT COMPLETED|Overall Study||7
136837|NCT01169038|331300|P1|COMPLETED|Overall Study||8
136838|NCT01169038|331300|P1|STARTED|Overall Study||15
136839|NCT01168999|331308|P4|NOT COMPLETED|Overall Study||0
136840|NCT01168999|331309|P3|NOT COMPLETED|Overall Study||0
136841|NCT01168999|331310|P2|NOT COMPLETED|Overall Study||1
136842|NCT01168999|331311|P1|NOT COMPLETED|Overall Study||2
136843|NCT01168999|331308|P4|COMPLETED|Overall Study||28
136844|NCT01168999|331309|P3|COMPLETED|Overall Study||27
136845|NCT01168999|331310|P2|COMPLETED|Overall Study||26
136846|NCT01168999|331311|P1|COMPLETED|Overall Study||26
136847|NCT01168999|331308|P4|STARTED|Overall Study||28
136848|NCT01168999|331309|P3|STARTED|Overall Study||27
136849|NCT01168999|331310|P2|STARTED|Overall Study||27
136850|NCT01168999|331311|P1|STARTED|Overall Study||28
136851|NCT01168986|331356|P3|NOT COMPLETED|Overall Study||0
136852|NCT01168986|331357|P2|NOT COMPLETED|Overall Study||1
136853|NCT01168986|331358|P1|NOT COMPLETED|Overall Study||2
136854|NCT01168986|331356|P3|COMPLETED|Overall Study||21
136855|NCT01168986|331357|P2|COMPLETED|Overall Study||20
136856|NCT01168986|331358|P1|COMPLETED|Overall Study||18
136857|NCT01168986|331356|P3|STARTED|Overall Study||21
136858|NCT01168986|331357|P2|STARTED|Overall Study||21
136859|NCT01168986|331358|P1|STARTED|Overall Study||20
136860|NCT01168973|331377|P2|NOT COMPLETED|Overall Study||611
136861|NCT01168973|331378|P1|NOT COMPLETED|Overall Study||613
136862|NCT01168973|331377|P2|COMPLETED|Overall Study||14
136863|NCT01168973|331378|P1|COMPLETED|Overall Study||15
136864|NCT01168973|331377|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
136865|NCT01168973|331378|P1|Received Any Quantity of Any Study Drug|Overall Study||624
136866|NCT01168973|331377|P2|STARTED|Overall Study||625
136867|NCT01168973|331378|P1|STARTED|Overall Study||628
136868|NCT01168934|331399|P2|NOT COMPLETED|Second Intervention Period||0
136869|NCT01168934|331400|P1|NOT COMPLETED|Second Intervention Period||0
136870|NCT01168934|331399|P2|COMPLETED|Second Intervention Period||7
136871|NCT01168934|331400|P1|COMPLETED|Second Intervention Period||7
136872|NCT01168934|331399|P2|STARTED|Second Intervention Period||7
136873|NCT01168934|331400|P1|STARTED|Second Intervention Period||7
136874|NCT01168934|331399|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
136875|NCT01168934|331400|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
136876|NCT01168934|331399|P2|COMPLETED|Washout Period (at Least 14 Days)||7
136877|NCT01168934|331400|P1|COMPLETED|Washout Period (at Least 14 Days)||7
136878|NCT01168934|331399|P2|STARTED|Washout Period (at Least 14 Days)||7
136879|NCT01168934|331400|P1|STARTED|Washout Period (at Least 14 Days)||7
136880|NCT01168934|331399|P2|NOT COMPLETED|First Intervention Period||0
136881|NCT01168934|331400|P1|NOT COMPLETED|First Intervention Period||0
136882|NCT01168934|331399|P2|COMPLETED|First Intervention Period||7
136883|NCT01168934|331400|P1|COMPLETED|First Intervention Period||7
136884|NCT01168934|331399|P2|STARTED|First Intervention Period||7
136885|NCT01168934|331400|P1|STARTED|First Intervention Period||7
136886|NCT01168908|331434|P2|NOT COMPLETED|Open Label||1
136887|NCT01168908|331435|P1|NOT COMPLETED|Open Label||1
136888|NCT01168908|331434|P2|COMPLETED|Open Label||7
136889|NCT01168908|331435|P1|COMPLETED|Open Label||6
136890|NCT01168908|331434|P2|STARTED|Open Label||8
136891|NCT01168908|331435|P1|STARTED|Open Label||7
136892|NCT01168908|331434|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
136893|NCT01168908|331435|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
136894|NCT01168908|331434|P2|COMPLETED|Double Blind, Placebo Controlled||8
136895|NCT01168908|331435|P1|COMPLETED|Double Blind, Placebo Controlled||7
136896|NCT01168908|331434|P2|STARTED|Double Blind, Placebo Controlled||10
136897|NCT01168908|331435|P1|STARTED|Double Blind, Placebo Controlled||10
136898|NCT01168856|331451|P2|NOT COMPLETED|Overall Study||343
136899|NCT01168856|331452|P1|NOT COMPLETED|Overall Study||18
136900|NCT01168856|331451|P2|COMPLETED|Overall Study||215
136901|NCT01168856|331452|P1|COMPLETED|Overall Study||158
136902|NCT01168856|331451|P2|STARTED|Overall Study||558
136903|NCT01168856|331452|P1|STARTED|Overall Study||176
136904|NCT01168726|331512|P3|NOT COMPLETED|Overall Study||5
136905|NCT01168726|331513|P2|NOT COMPLETED|Overall Study||9
136906|NCT01168726|331514|P1|NOT COMPLETED|Overall Study||8
136907|NCT01168726|331512|P3|COMPLETED|Overall Study||128
136908|NCT01168726|331513|P2|COMPLETED|Overall Study||112
136909|NCT01168726|331514|P1|COMPLETED|Overall Study||103
136910|NCT01168726|331512|P3|STARTED|Overall Study||133
136911|NCT01168726|331513|P2|STARTED|Overall Study||121
136912|NCT01168726|331514|P1|STARTED|Overall Study||111
136913|NCT01168687|331533|P2|NOT COMPLETED|Overall Study||0
136914|NCT01168687|331534|P1|NOT COMPLETED|Overall Study||0
136915|NCT01168687|331533|P2|COMPLETED|Overall Study||23
136916|NCT01168687|331534|P1|COMPLETED|Overall Study||23
136917|NCT01168687|331533|P2|STARTED|Overall Study||23
136918|NCT01168687|331534|P1|STARTED|Overall Study||23
136919|NCT01168674|331540|P2|NOT COMPLETED|Overall Study||0
136920|NCT01168674|331541|P1|NOT COMPLETED|Overall Study||0
136921|NCT01168674|331540|P2|COMPLETED|Overall Study||24
136922|NCT01168674|331541|P1|COMPLETED|Overall Study||25
136923|NCT01168674|331540|P2|STARTED|Overall Study||24
136924|NCT01168674|331541|P1|STARTED|Overall Study||25
136925|NCT01168596|331550|P2|NOT COMPLETED|Overall Study||1
136926|NCT01168596|331551|P1|NOT COMPLETED|Overall Study||3
136927|NCT01168596|331550|P2|COMPLETED|Overall Study||13
136928|NCT01168596|331551|P1|COMPLETED|Overall Study||13
136929|NCT01168596|331550|P2|STARTED|Overall Study||14
136930|NCT01168596|331551|P1|STARTED|Overall Study||16
136931|NCT01168427|331595|P1|NOT COMPLETED|Overall Study||1
136932|NCT01168427|331595|P1|COMPLETED|Overall Study||65
136933|NCT01168427|331595|P1|STARTED|Overall Study||66
136934|NCT01168349|331600|P1|NOT COMPLETED|Overall Study||301
136935|NCT01168349|331600|P1|COMPLETED|Overall Study||754
136936|NCT01168349|331600|P1|STARTED|Overall Study||1055
136937|NCT01168232|331706|P1|NOT COMPLETED|Overall Study||8
136938|NCT01168232|331706|P1|COMPLETED|Overall Study|Eligible and treated patients|34
136939|NCT01168232|331706|P1|STARTED|Overall Study||42
136940|NCT01168219|331713|P1|NOT COMPLETED|Overall Study||0
136941|NCT01168219|331713|P1|COMPLETED|Overall Study||68
136942|NCT01168219|331713|P1|STARTED|Overall Study||68
136943|NCT01168024|331719|P2|NOT COMPLETED|Overall Study||0
136944|NCT01168024|331720|P1|NOT COMPLETED|Overall Study||0
136945|NCT01168024|331719|P2|COMPLETED|Overall Study||3
136946|NCT01168024|331720|P1|COMPLETED|Overall Study||13
136947|NCT01168024|331719|P2|STARTED|Overall Study||3
136948|NCT01168024|331720|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
136949|NCT01167907|331734|P2|NOT COMPLETED|Overall Study||1
136950|NCT01167907|331735|P1|NOT COMPLETED|Overall Study||2
136951|NCT01167907|331734|P2|COMPLETED|Overall Study||14
136952|NCT01167907|331735|P1|COMPLETED|Overall Study||15
136953|NCT01167907|331734|P2|STARTED|Overall Study||15
136954|NCT01167907|331735|P1|STARTED|Overall Study||17
136955|NCT01167881|331753|P2|NOT COMPLETED|Overall Study||191
136956|NCT01167881|331754|P1|NOT COMPLETED|Overall Study||159
136957|NCT01167881|331753|P2|COMPLETED|Overall Study||589
136958|NCT01167881|331754|P1|COMPLETED|Overall Study||610
136959|NCT01167881|331753|P2|Completed After 4 Years Treatment|Overall Study||462
136960|NCT01167881|331754|P1|Completed After 4 Years Treatment|Overall Study||515
136961|NCT01167881|331753|P2|Completed After 2 Years Treatment|Overall Study||127
136962|NCT01167881|331754|P1|Completed After 2 Years Treatment|Overall Study||95
136963|NCT01167881|331753|P2|STARTED|Overall Study||780
136964|NCT01167881|331754|P1|STARTED|Overall Study||769
136965|NCT01167829|331778|P1|NOT COMPLETED|Overall Study||0
136966|NCT01167829|331778|P1|COMPLETED|Overall Study||12
136967|NCT01167829|331778|P1|STARTED|Overall Study||12
136968|NCT01167712|331793|P2|NOT COMPLETED|Overall Study||0
136969|NCT01167712|331794|P1|NOT COMPLETED|Overall Study||0
136970|NCT01167712|331793|P2|COMPLETED|Overall Study||346
136971|NCT01167712|331794|P1|COMPLETED|Overall Study||346
136972|NCT01167712|331793|P2|STARTED|Overall Study||346
136973|NCT01167712|331794|P1|STARTED|Overall Study||346
136974|NCT01167634|331808|P4|NOT COMPLETED|Overall Study||4
136975|NCT01167634|331809|P3|NOT COMPLETED|Overall Study||3
136976|NCT01167634|331810|P2|NOT COMPLETED|Overall Study||4
136977|NCT01167634|331811|P1|NOT COMPLETED|Overall Study||2
136978|NCT01167634|331808|P4|COMPLETED|Overall Study||29
136979|NCT01167634|331809|P3|COMPLETED|Overall Study||30
136980|NCT01167634|331810|P2|COMPLETED|Overall Study||29
136981|NCT01167634|331811|P1|COMPLETED|Overall Study||31
136982|NCT01167634|331808|P4|STARTED|Overall Study||33
136983|NCT01167634|331809|P3|STARTED|Overall Study||33
136984|NCT01167634|331810|P2|STARTED|Overall Study||33
136985|NCT01167634|331811|P1|STARTED|Overall Study||33
136986|NCT01167608|331821|P1|NOT COMPLETED|Overall Study||114
136987|NCT01167608|331821|P1|COMPLETED|Overall Study||769
136988|NCT01167608|331821|P1|STARTED|Overall Study||883
136989|NCT01167582|331832|P2|NOT COMPLETED|Overall Study||1
136990|NCT01167582|331833|P1|NOT COMPLETED|Overall Study||0
136991|NCT01167582|331832|P2|COMPLETED|Overall Study||54
136992|NCT01167582|331833|P1|COMPLETED|Overall Study||55
136993|NCT01167582|331832|P2|STARTED|Overall Study||55
136994|NCT01167582|331833|P1|STARTED|Overall Study||55
136995|NCT01167504|331845|P1|NOT COMPLETED|Overall Study||3
136996|NCT01167504|331845|P1|COMPLETED|Overall Study||12
136997|NCT01167504|331845|P1|STARTED|Overall Study||15
136998|NCT01167452|331850|P1|NOT COMPLETED|Overall Study||0
136999|NCT01167452|331850|P1|COMPLETED|Overall Study||36
137000|NCT01167452|331850|P1|STARTED|Overall Study||36
137001|NCT01167426|331855|P1|NOT COMPLETED|Overall Study||10
137002|NCT01167426|331855|P1|COMPLETED|Overall Study||138
137003|NCT01167426|331855|P1|STARTED|Overall Study||148
137004|NCT01167257|331863|P2|NOT COMPLETED|Overall Study||3
137005|NCT01167257|331864|P1|NOT COMPLETED|Overall Study||3
137006|NCT01167257|331863|P2|COMPLETED|Overall Study||28
137007|NCT01167257|331864|P1|COMPLETED|Overall Study||28
137008|NCT01167257|331863|P2|STARTED|Overall Study||31
137009|NCT01167257|331864|P1|STARTED|Overall Study||31
137010|NCT01167192|331886|P1|NOT COMPLETED|Overall Study||4
137011|NCT01167192|331886|P1|COMPLETED|Overall Study||6
137012|NCT01167192|331886|P1|STARTED|Overall Study||10
137013|NCT01167179|331903|P2|NOT COMPLETED|Overall Study||21
137014|NCT01167179|331904|P1|NOT COMPLETED|Overall Study||15
137015|NCT01167179|331903|P2|COMPLETED|Overall Study||59
137016|NCT01167179|331904|P1|COMPLETED|Overall Study||65
137017|NCT01167179|331903|P2|STARTED|Overall Study||80
137018|NCT01167179|331904|P1|STARTED|Overall Study||80
137019|NCT01167153|331914|P2|NOT COMPLETED|Overall Study||33
137020|NCT01167153|331915|P1|NOT COMPLETED|Overall Study||18
137021|NCT01167153|331914|P2|COMPLETED|Overall Study||249
137022|NCT01167153|331915|P1|COMPLETED|Overall Study||264
137023|NCT01167153|331914|P2|Intention to Treat (ITT)|Overall Study||268
137024|NCT01167153|331915|P1|Intention to Treat (ITT)|Overall Study||272
137025|NCT01167153|331914|P2|STARTED|Overall Study||282
137026|NCT01167153|331915|P1|STARTED|Overall Study||282
137027|NCT01167140|331933|P1|NOT COMPLETED|Overall Study||1
137028|NCT01167140|331933|P1|COMPLETED|Overall Study||41
137029|NCT01167140|331933|P1|STARTED|Overall Study||42
137030|NCT01167023|331941|P3|NOT COMPLETED|Overall Study||2
137031|NCT01167023|331942|P2|NOT COMPLETED|Overall Study||3
137032|NCT01167023|331943|P1|NOT COMPLETED|Overall Study||0
137033|NCT01167023|331941|P3|COMPLETED|Overall Study||39
137034|NCT01167023|331942|P2|COMPLETED|Overall Study||18
137035|NCT01167023|331943|P1|COMPLETED|Overall Study||0
137036|NCT01167023|331941|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
137037|NCT01167023|331942|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
137038|NCT01167023|331943|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
137039|NCT01167023|331941|P3|STARTED|Overall Study||41
137040|NCT01167023|331942|P2|STARTED|Overall Study||21
137041|NCT01167023|331943|P1|STARTED|Overall Study||0
137042|NCT01166997|331963|P2|NOT COMPLETED|Overall Study||0
137043|NCT01166997|331964|P1|NOT COMPLETED|Overall Study||2
137044|NCT01166997|331963|P2|COMPLETED|Overall Study||30
137045|NCT01166997|331964|P1|COMPLETED|Overall Study||27
137046|NCT01166997|331963|P2|STARTED|Overall Study||30
137047|NCT01166997|331964|P1|STARTED|Overall Study||29
137048|NCT01166971|331974|P2|NOT COMPLETED|Overall Study||1
137049|NCT01166971|331975|P1|NOT COMPLETED|Overall Study||1
137050|NCT01166971|331974|P2|COMPLETED|Overall Study||30
137051|NCT01166971|331975|P1|COMPLETED|Overall Study||32
137052|NCT01166971|331974|P2|STARTED|Overall Study||31
137053|NCT01166971|331975|P1|STARTED|Overall Study||33
137054|NCT01166958|331983|P2|NOT COMPLETED|Overall Study||0
137055|NCT01166958|331984|P1|NOT COMPLETED|Overall Study||1
137056|NCT01166958|331983|P2|COMPLETED|Overall Study||13
137057|NCT01166958|331984|P1|COMPLETED|Overall Study||12
137058|NCT01166958|331983|P2|STARTED|Overall Study||13
137059|NCT01166958|331984|P1|STARTED|Overall Study||13
137060|NCT01166763|331998|P1|NOT COMPLETED|Overall Study||3
137061|NCT01166763|331998|P1|COMPLETED|Overall Study||27
137062|NCT01166763|331998|P1|STARTED|Overall Study||30
137063|NCT01166750|332006|P2|NOT COMPLETED|Overall Study||0
137064|NCT01166750|332007|P1|NOT COMPLETED|Overall Study||1
137065|NCT01166750|332006|P2|COMPLETED|Overall Study||13
137066|NCT01166750|332007|P1|COMPLETED|Overall Study||9
137067|NCT01166750|332006|P2|STARTED|Overall Study||13
137068|NCT01166750|332007|P1|STARTED|Overall Study||10
137069|NCT01166724|332015|P2|NOT COMPLETED|Overall Study||5
137070|NCT01166724|332016|P1|NOT COMPLETED|Overall Study||7
137071|NCT01166724|332015|P2|COMPLETED|Overall Study||0
137072|NCT01166724|332016|P1|COMPLETED|Overall Study||0
137073|NCT01166724|332015|P2|STARTED|Overall Study||5
137074|NCT01166724|332016|P1|STARTED|Overall Study||7
137075|NCT01166659|332024|P1|NOT COMPLETED|Overall Study||13
137076|NCT01166659|332024|P1|COMPLETED|Overall Study||35
137077|NCT01166659|332024|P1|STARTED|Overall Study||48
137078|NCT01166646|332033|P2|NOT COMPLETED|Overall Study||1
137079|NCT01166646|332034|P1|NOT COMPLETED|Overall Study||1
137080|NCT01166646|332033|P2|COMPLETED|Overall Study||21
137081|NCT01166646|332034|P1|COMPLETED|Overall Study||20
137082|NCT01166646|332033|P2|STARTED|Overall Study||22
137083|NCT01166646|332034|P1|STARTED|Overall Study||21
137084|NCT01166438|332052|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
137085|NCT01166438|332053|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
137086|NCT01166438|332052|P2|COMPLETED|Off Treatment Follow-up Phase||33
137087|NCT01166438|332053|P1|COMPLETED|Off Treatment Follow-up Phase||51
137088|NCT01166438|332052|P2|STARTED|Off Treatment Follow-up Phase||89
137089|NCT01166438|332053|P1|STARTED|Off Treatment Follow-up Phase||85
137090|NCT01166438|332052|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
137091|NCT01166438|332053|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
137092|NCT01166438|332052|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
137093|NCT01166438|332053|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
137094|NCT01166438|332052|P2|Treated|Double-blind Phase: 1st 6 Months||126
137095|NCT01166438|332053|P1|Treated|Double-blind Phase: 1st 6 Months||121
137096|NCT01166438|332052|P2|STARTED|Double-blind Phase: 1st 6 Months||127
137097|NCT01166438|332053|P1|STARTED|Double-blind Phase: 1st 6 Months||122
137098|NCT01166347|332069|P2|NOT COMPLETED|Overall Study||1
137099|NCT01166347|332070|P1|NOT COMPLETED|Overall Study||2
137100|NCT01166347|332069|P2|COMPLETED|Overall Study||148
137101|NCT01166347|332070|P1|COMPLETED|Overall Study||295
137102|NCT01166347|332069|P2|STARTED|Overall Study||149
137103|NCT01166347|332070|P1|STARTED|Overall Study||297
137104|NCT01166282|332102|P3|NOT COMPLETED|Open-label Period||17
137105|NCT01166282|332103|P2|NOT COMPLETED|Open-label Period||0
137106|NCT01166282|332104|P1|NOT COMPLETED|Open-label Period||0
137107|NCT01166282|332102|P3|COMPLETED|Open-label Period||29
137108|NCT01166282|332103|P2|COMPLETED|Open-label Period||0
137109|NCT01166282|332104|P1|COMPLETED|Open-label Period||0
137110|NCT01166282|332102|P3|STARTED|Open-label Period||46
137111|NCT01166282|332103|P2|STARTED|Open-label Period||0
137112|NCT01166282|332104|P1|STARTED|Open-label Period||0
137113|NCT01166282|332102|P3|NOT COMPLETED|Double-blind Period||0
137114|NCT01166282|332103|P2|NOT COMPLETED|Double-blind Period||0
137115|NCT01166282|332104|P1|NOT COMPLETED|Double-blind Period||0
137116|NCT01166282|332102|P3|COMPLETED|Double-blind Period||0
137117|NCT01166282|332103|P2|COMPLETED|Double-blind Period||31
137118|NCT01166282|332104|P1|COMPLETED|Double-blind Period||15
137119|NCT01166282|332102|P3|STARTED|Double-blind Period||0
137120|NCT01166282|332103|P2|STARTED|Double-blind Period||31
137121|NCT01166282|332104|P1|STARTED|Double-blind Period||15
137122|NCT01166230|332128|P2|NOT COMPLETED|Overall Study||16
137123|NCT01166230|332129|P1|NOT COMPLETED|Overall Study||19
137124|NCT01166230|332128|P2|COMPLETED|Overall Study||255
137125|NCT01166230|332129|P1|COMPLETED|Overall Study||261
137126|NCT01166230|332128|P2|STARTED|Overall Study||271
137127|NCT01166230|332129|P1|STARTED|Overall Study||280
137128|NCT01166178|332143|P2|NOT COMPLETED|Overall Study||8
137129|NCT01166178|332144|P1|NOT COMPLETED|Overall Study||21
137130|NCT01166178|332143|P2|COMPLETED|Overall Study||0
137131|NCT01166178|332144|P1|COMPLETED|Overall Study||0
137132|NCT01166178|332143|P2|STARTED|Overall Study||8
137133|NCT01166178|332144|P1|STARTED|Overall Study||21
137134|NCT01166139|332170|P1|NOT COMPLETED|Overall Study||3
137135|NCT01166139|332170|P1|COMPLETED|Overall Study||7
137136|NCT01166139|332170|P1|STARTED|Overall Study||10
137137|NCT01166126|332176|P1|NOT COMPLETED|Overall Study||0
137138|NCT01166126|332176|P1|COMPLETED|Overall Study||4
137139|NCT01166126|332176|P1|STARTED|Overall Study||4
137140|NCT01165996|332183|P1|NOT COMPLETED|Overall Study||2
137141|NCT01165996|332183|P1|COMPLETED|Overall Study||23
137142|NCT01165996|332183|P1|Maintenance Phase|Overall Study||23
137143|NCT01165996|332183|P1|Induction Phase|Overall Study||25
137144|NCT01165996|332183|P1|STARTED|Overall Study||25
137145|NCT01165983|332191|P2|NOT COMPLETED|Overall Study||7
137146|NCT01165983|332192|P1|NOT COMPLETED|Overall Study||5
137147|NCT01165983|332191|P2|COMPLETED|Overall Study||42
137148|NCT01165983|332192|P1|COMPLETED|Overall Study||46
137149|NCT01165983|332191|P2|STARTED|Overall Study||49
137150|NCT01165983|332192|P1|STARTED|Overall Study||51
137151|NCT01165840|332236|P1|NOT COMPLETED|Overall Study||0
137152|NCT01165840|332236|P1|COMPLETED|Overall Study||36
137153|NCT01165840|332236|P1|STARTED|Overall Study||36
137154|NCT01165775|332240|P1|NOT COMPLETED|Overall Study||2
137155|NCT01165775|332240|P1|COMPLETED|Overall Study||15
137156|NCT01165775|332240|P1|STARTED|Overall Study||17
137157|NCT01165684|332250|P2|NOT COMPLETED|Overall Study||52
137158|NCT01165684|332251|P1|NOT COMPLETED|Overall Study||28
137159|NCT01165684|332250|P2|COMPLETED|Overall Study||148
137160|NCT01165684|332251|P1|COMPLETED|Overall Study||173
137161|NCT01165684|332250|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
137162|NCT01165684|332251|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
137163|NCT01165684|332250|P2|STARTED|Overall Study||200
137164|NCT01165684|332251|P1|STARTED|Overall Study||201
137165|NCT01165554|332285|P1|NOT COMPLETED|Overall Study||23
137166|NCT01165554|332285|P1|COMPLETED|Overall Study||180
137167|NCT01165554|332285|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
137168|NCT01165541|332292|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
137169|NCT01165541|332292|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
137170|NCT01165541|332292|P1|STARTED|Quetiapine XR and Mirtazepine||16
137171|NCT01165541|332292|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
137172|NCT01165541|332292|P1|COMPLETED|Quetiapine XR Monotherapy||16
137173|NCT01165541|332292|P1|STARTED|Quetiapine XR Monotherapy||20
137174|NCT01165450|332298|P1|NOT COMPLETED|Overall Study||0
137175|NCT01165450|332298|P1|COMPLETED|Overall Study||2
137176|NCT01165450|332298|P1|STARTED|Overall Study||2
137177|NCT01165424|332308|P1|NOT COMPLETED|Overall Study||4
137178|NCT01165424|332308|P1|COMPLETED|Overall Study||76
137179|NCT01165424|332308|P1|STARTED|Overall Study||80
137180|NCT01165320|332315|P3|NOT COMPLETED|Overall Study||0
137181|NCT01165320|332316|P2|NOT COMPLETED|Overall Study||4
137182|NCT01165320|332317|P1|NOT COMPLETED|Overall Study||3
137183|NCT01165320|332315|P3|COMPLETED|Overall Study||0
137184|NCT01165320|332316|P2|COMPLETED|Overall Study||4
137185|NCT01165320|332317|P1|COMPLETED|Overall Study||9
137186|NCT01165320|332315|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
137187|NCT01165320|332316|P2|STARTED|Overall Study||8
137188|NCT01165320|332317|P1|STARTED|Overall Study||12
137189|NCT01165307|332327|P2|NOT COMPLETED|Overall Study||3
137190|NCT01165307|332328|P1|NOT COMPLETED|Overall Study||14
137191|NCT01165307|332327|P2|COMPLETED|Overall Study||31
137192|NCT01165307|332328|P1|COMPLETED|Overall Study||19
137193|NCT01165307|332327|P2|STARTED|Overall Study||34
137194|NCT01165307|332328|P1|STARTED|Overall Study||33
137195|NCT01165281|332358|P2|NOT COMPLETED|Overall Study||51
137196|NCT01165281|332359|P1|NOT COMPLETED|Overall Study||58
137197|NCT01165281|332358|P2|COMPLETED|Overall Study||121
137198|NCT01165281|332359|P1|COMPLETED|Overall Study||110
137199|NCT01165281|332358|P2|STARTED|Overall Study||172
137200|NCT01165281|332359|P1|STARTED|Overall Study||168
137201|NCT01165242|332380|P3|NOT COMPLETED|Overall Study||14
137202|NCT01165242|332381|P2|NOT COMPLETED|Overall Study||10
137203|NCT01165242|332382|P1|NOT COMPLETED|Overall Study||10
137204|NCT01165242|332380|P3|COMPLETED|Overall Study||324
137205|NCT01165242|332381|P2|COMPLETED|Overall Study||326
137206|NCT01165242|332382|P1|COMPLETED|Overall Study||327
137207|NCT01165242|332380|P3|STARTED|Overall Study||338
137208|NCT01165242|332381|P2|STARTED|Overall Study||336
137209|NCT01165242|332382|P1|STARTED|Overall Study||337
137210|NCT01165229|332416|P2|NOT COMPLETED|Overall Study||1189
137211|NCT01165229|332417|P1|NOT COMPLETED|Overall Study||1180
137212|NCT01165229|332416|P2|COMPLETED|Overall Study||5761
137213|NCT01165229|332417|P1|COMPLETED|Overall Study||5770
137214|NCT01165229|332416|P2|STARTED|Overall Study||6950
137215|NCT01165229|332417|P1|STARTED|Overall Study||6950
137216|NCT01165216|332545|P2|NOT COMPLETED|Overall Study||7
137217|NCT01165216|332546|P1|NOT COMPLETED|Overall Study||8
137218|NCT01165216|332545|P2|COMPLETED|Overall Study|Completed=still on study drug|0
137219|NCT01165216|332546|P1|COMPLETED|Overall Study|Completed=still on study drug|0
137220|NCT01165216|332545|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
137221|NCT01165216|332546|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
137222|NCT01165216|332545|P2|STARTED|Overall Study|Participants who received any study drug|7
137223|NCT01165216|332546|P1|STARTED|Overall Study|Participants who received any study drug|8
137224|NCT01165203|332568|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
137225|NCT01165203|332569|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
137226|NCT01165203|332568|P2|COMPLETED|Extended Safety Follow-up Phase||45
137227|NCT01165203|332569|P1|COMPLETED|Extended Safety Follow-up Phase||67
137228|NCT01165203|332568|P2|STARTED|Extended Safety Follow-up Phase||49
137229|NCT01165203|332569|P1|STARTED|Extended Safety Follow-up Phase||74
137230|NCT01165203|332568|P2|NOT COMPLETED|Active Phase||2
137231|NCT01165203|332569|P1|NOT COMPLETED|Active Phase||5
137232|NCT01165203|332568|P2|COMPLETED|Active Phase||47
137233|NCT01165203|332569|P1|COMPLETED|Active Phase||69
137234|NCT01165203|332568|P2|STARTED|Active Phase||49
137235|NCT01165203|332569|P1|STARTED|Active Phase||74
137236|NCT01165177|332659|P2|NOT COMPLETED|Overall Study||902
137237|NCT01165177|332660|P1|NOT COMPLETED|Overall Study||922
137238|NCT01165177|332659|P2|COMPLETED|Overall Study||6808
137239|NCT01165177|332660|P1|COMPLETED|Overall Study||6773
137240|NCT01165177|332659|P2|STARTED|Overall Study||7710
137241|NCT01165177|332660|P1|STARTED|Overall Study||7695
137242|NCT01165138|332785|P4|NOT COMPLETED|Overall Study||22
137243|NCT01165138|332786|P3|NOT COMPLETED|Overall Study||20
137244|NCT01165138|332787|P2|NOT COMPLETED|Overall Study||52
137245|NCT01165138|332788|P1|NOT COMPLETED|Overall Study||0
137246|NCT01165138|332785|P4|COMPLETED|Overall Study||179
137247|NCT01165138|332786|P3|COMPLETED|Overall Study||185
137248|NCT01165138|332787|P2|COMPLETED|Overall Study||151
137249|NCT01165138|332788|P1|COMPLETED|Overall Study||0
137250|NCT01165138|332785|P4|STARTED|Overall Study||201
137251|NCT01165138|332786|P3|STARTED|Overall Study||205
137252|NCT01165138|332787|P2|STARTED|Overall Study||203
137253|NCT01165138|332788|P1|STARTED|Overall Study||0
137254|NCT01165112|332847|P1|NOT COMPLETED|Overall Study||0
137255|NCT01165112|332847|P1|COMPLETED|Overall Study||48
137256|NCT01165112|332847|P1|STARTED|Overall Study||48
137257|NCT01165047|332854|P1|NOT COMPLETED|Overall Study||0
137258|NCT01165047|332854|P1|COMPLETED|Overall Study||10
137259|NCT01165047|332854|P1|STARTED|Overall Study||10
137260|NCT01165021|332858|P1|NOT COMPLETED|Overall Study||1
137261|NCT01165021|332858|P1|COMPLETED|Overall Study||18
137262|NCT01165021|332858|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
137263|NCT01165021|332858|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
137264|NCT01165021|332858|P1|≥1 Dose Chemo|Overall Study||19
137265|NCT01165021|332858|P1|STARTED|Overall Study||19
137266|NCT01164891|332866|P1|NOT COMPLETED|Overall Study||6
137267|NCT01164891|332866|P1|COMPLETED|Overall Study||1
137268|NCT01164891|332866|P1|STARTED|Overall Study||7
137269|NCT01164865|332886|P2|NOT COMPLETED|Overall Study||1
137270|NCT01164865|332887|P1|NOT COMPLETED|Overall Study||2
137271|NCT01164865|332886|P2|COMPLETED|Overall Study||38
137272|NCT01164865|332887|P1|COMPLETED|Overall Study||37
137273|NCT01164865|332886|P2|STARTED|Overall Study||39
137274|NCT01164865|332887|P1|STARTED|Overall Study||39
137275|NCT01164722|332897|P2|NOT COMPLETED|Overall Study||15
137276|NCT01164722|332898|P1|NOT COMPLETED|Overall Study||18
137277|NCT01164722|332897|P2|COMPLETED|Overall Study||45
137278|NCT01164722|332898|P1|COMPLETED|Overall Study||42
137279|NCT01164722|332897|P2|STARTED|Overall Study||60
137280|NCT01164722|332898|P1|STARTED|Overall Study||60
137281|NCT01164644|332914|P2|NOT COMPLETED|Overall Study||1
137282|NCT01164644|332915|P1|NOT COMPLETED|Overall Study||3
137283|NCT01164644|332914|P2|COMPLETED|Overall Study||13
137284|NCT01164644|332915|P1|COMPLETED|Overall Study||9
137285|NCT01164644|332914|P2|STARTED|Overall Study||14
137286|NCT01164644|332915|P1|STARTED|Overall Study||12
137287|NCT01164579|332928|P3|NOT COMPLETED|Overall Study||16
137288|NCT01164579|332929|P2|NOT COMPLETED|Overall Study||9
137289|NCT01164579|332930|P1|NOT COMPLETED|Overall Study||8
137290|NCT01164579|332928|P3|COMPLETED|Overall Study||21
137291|NCT01164579|332929|P2|COMPLETED|Overall Study||27
137292|NCT01164579|332930|P1|COMPLETED|Overall Study||28
137293|NCT01164579|332928|P3|STARTED|Overall Study||37
137294|NCT01164579|332929|P2|STARTED|Overall Study||36
137295|NCT01164579|332930|P1|STARTED|Overall Study||36
137296|NCT01164501|333010|P3|NOT COMPLETED|Overall Study||42
137297|NCT01164501|333011|P2|NOT COMPLETED|Overall Study||10
137298|NCT01164501|333012|P1|NOT COMPLETED|Overall Study||43
137299|NCT01164501|333010|P3|COMPLETED|Overall Study||280
137300|NCT01164501|333011|P2|COMPLETED|Overall Study||88
137301|NCT01164501|333012|P1|COMPLETED|Overall Study||278
137302|NCT01164501|333010|P3|STARTED|Overall Study||322
137303|NCT01164501|333011|P2|STARTED|Overall Study||98
137304|NCT01164501|333012|P1|STARTED|Overall Study||321
137305|NCT01164475|333029|P2|NOT COMPLETED|Overall Study||2
137306|NCT01164475|333030|P1|NOT COMPLETED|Overall Study||2
137307|NCT01164475|333029|P2|COMPLETED|Overall Study||29
137308|NCT01164475|333030|P1|COMPLETED|Overall Study||28
137309|NCT01164475|333029|P2|STARTED|Overall Study||31
137310|NCT01164475|333030|P1|STARTED|Overall Study||30
137311|NCT01164137|333056|P2|NOT COMPLETED|Overall Study||0
137312|NCT01164137|333057|P1|NOT COMPLETED|Overall Study||3
137313|NCT01164137|333056|P2|COMPLETED|Overall Study||76
137314|NCT01164137|333057|P1|COMPLETED|Overall Study||77
137315|NCT01164137|333056|P2|STARTED|Overall Study||76
137316|NCT01164137|333057|P1|STARTED|Overall Study||80
137317|NCT01164007|333071|P1|NOT COMPLETED|Overall Study||40
137318|NCT01164007|333071|P1|COMPLETED|Overall Study||0
137319|NCT01164007|333071|P1|Treated|Overall Study||37
137320|NCT01164007|333071|P1|STARTED|Overall Study||40
137321|NCT01163955|333087|P2|NOT COMPLETED|Overall Study||4
137322|NCT01163955|333088|P1|NOT COMPLETED|Overall Study||0
137323|NCT01163955|333087|P2|COMPLETED|Overall Study||26
137324|NCT01163955|333088|P1|COMPLETED|Overall Study||26
137325|NCT01163955|333087|P2|STARTED|Overall Study||30
137326|NCT01163955|333088|P1|STARTED|Overall Study||26
137327|NCT01163916|333097|P3|NOT COMPLETED|Overall Study||20
137328|NCT01163916|333098|P2|NOT COMPLETED|Overall Study||4
137329|NCT01163916|333099|P1|NOT COMPLETED|Overall Study||30
137330|NCT01163916|333097|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
137331|NCT01163916|333098|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
137332|NCT01163916|333099|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
137333|NCT01163916|333097|P3|Safety Population|Overall Study||91
137334|NCT01163916|333098|P2|Safety Population|Overall Study||35
137335|NCT01163916|333099|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
137336|NCT01163916|333097|P3|STARTED|Overall Study||91
137337|NCT01163916|333098|P2|STARTED|Overall Study||35
137338|NCT01163916|333099|P1|STARTED|Overall Study||126
137339|NCT01163851|333137|P2|NOT COMPLETED|Overall Study||1
137340|NCT01163851|333138|P1|NOT COMPLETED|Overall Study||1
137341|NCT01163851|333137|P2|COMPLETED|Overall Study||11
137342|NCT01163851|333138|P1|COMPLETED|Overall Study||12
137343|NCT01163851|333137|P2|Treated|Overall Study||12
137344|NCT01163851|333138|P1|Treated|Overall Study||12
137345|NCT01163851|333137|P2|STARTED|Overall Study||12
137346|NCT01163851|333138|P1|STARTED|Overall Study||13
137347|NCT01163760|333216|P4|NOT COMPLETED|Period 4 (Follow-up)||0
137348|NCT01163760|333217|P3|NOT COMPLETED|Period 4 (Follow-up)||0
137349|NCT01163760|333218|P2|NOT COMPLETED|Period 4 (Follow-up)||0
137350|NCT01163760|333219|P1|NOT COMPLETED|Period 4 (Follow-up)||0
137351|NCT01163760|333216|P4|COMPLETED|Period 4 (Follow-up)||12
137352|NCT01163760|333217|P3|COMPLETED|Period 4 (Follow-up)||13
137353|NCT01163760|333218|P2|COMPLETED|Period 4 (Follow-up)||13
137354|NCT01163760|333219|P1|COMPLETED|Period 4 (Follow-up)||12
137355|NCT01163760|333216|P4|STARTED|Period 4 (Follow-up)||12
137356|NCT01163760|333217|P3|STARTED|Period 4 (Follow-up)||13
137357|NCT01163760|333218|P2|STARTED|Period 4 (Follow-up)||13
137358|NCT01163760|333219|P1|STARTED|Period 4 (Follow-up)||12
137359|NCT01163760|333216|P4|NOT COMPLETED|Period 3 (Fit)||0
137360|NCT01163760|333217|P3|NOT COMPLETED|Period 3 (Fit)||0
137361|NCT01163760|333218|P2|NOT COMPLETED|Period 3 (Fit)||0
137362|NCT01163760|333219|P1|NOT COMPLETED|Period 3 (Fit)||0
137363|NCT01163760|333216|P4|COMPLETED|Period 3 (Fit)||12
137364|NCT01163760|333217|P3|COMPLETED|Period 3 (Fit)||13
137365|NCT01163760|333218|P2|COMPLETED|Period 3 (Fit)||13
137366|NCT01163760|333219|P1|COMPLETED|Period 3 (Fit)||12
137367|NCT01163760|333216|P4|STARTED|Period 3 (Fit)||12
137368|NCT01163760|333217|P3|STARTED|Period 3 (Fit)||13
137369|NCT01163760|333218|P2|STARTED|Period 3 (Fit)||13
137370|NCT01163760|333219|P1|STARTED|Period 3 (Fit)||12
137371|NCT01163760|333216|P4|NOT COMPLETED|Period 2 (Follow-up)||0
137372|NCT01163760|333217|P3|NOT COMPLETED|Period 2 (Follow-up)||0
137373|NCT01163760|333218|P2|NOT COMPLETED|Period 2 (Follow-up)||0
137374|NCT01163760|333219|P1|NOT COMPLETED|Period 2 (Follow-up)||0
137375|NCT01163760|333216|P4|COMPLETED|Period 2 (Follow-up)||12
137376|NCT01163760|333217|P3|COMPLETED|Period 2 (Follow-up)||13
137377|NCT01163760|333218|P2|COMPLETED|Period 2 (Follow-up)||13
137378|NCT01163760|333219|P1|COMPLETED|Period 2 (Follow-up)||12
137379|NCT01163760|333216|P4|STARTED|Period 2 (Follow-up)||12
137380|NCT01163760|333217|P3|STARTED|Period 2 (Follow-up)||13
137381|NCT01163760|333218|P2|STARTED|Period 2 (Follow-up)||13
137382|NCT01163760|333219|P1|STARTED|Period 2 (Follow-up)||12
137383|NCT01163760|333216|P4|NOT COMPLETED|Period 1 (Fit)||0
137384|NCT01163760|333217|P3|NOT COMPLETED|Period 1 (Fit)||0
137385|NCT01163760|333218|P2|NOT COMPLETED|Period 1 (Fit)||0
137386|NCT01163760|333219|P1|NOT COMPLETED|Period 1 (Fit)||0
137387|NCT01163760|333216|P4|COMPLETED|Period 1 (Fit)||12
137388|NCT01163760|333217|P3|COMPLETED|Period 1 (Fit)||13
137389|NCT01163760|333218|P2|COMPLETED|Period 1 (Fit)||13
137390|NCT01163760|333219|P1|COMPLETED|Period 1 (Fit)||12
137391|NCT01163760|333216|P4|STARTED|Period 1 (Fit)||12
137392|NCT01163760|333217|P3|STARTED|Period 1 (Fit)||13
137393|NCT01163760|333218|P2|STARTED|Period 1 (Fit)||13
137394|NCT01163760|333219|P1|STARTED|Period 1 (Fit)||12
137395|NCT01163747|333233|P2|NOT COMPLETED|Overall Study||11
137396|NCT01163747|333234|P1|NOT COMPLETED|Overall Study||6
137397|NCT01163747|333233|P2|COMPLETED|Overall Study||49
137398|NCT01163747|333234|P1|COMPLETED|Overall Study||25
137399|NCT01163747|333233|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
137400|NCT01163747|333234|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
137401|NCT01163747|333233|P2|STARTED|Overall Study||60
137402|NCT01163747|333234|P1|STARTED|Overall Study||31
137403|NCT01163721|333254|P2|NOT COMPLETED|Overall Study||12
137404|NCT01163721|333255|P1|NOT COMPLETED|Overall Study||8
137405|NCT01163721|333254|P2|COMPLETED|Overall Study||29
137406|NCT01163721|333255|P1|COMPLETED|Overall Study||31
137407|NCT01163721|333254|P2|STARTED|Overall Study||41
137408|NCT01163721|333255|P1|STARTED|Overall Study||39
137409|NCT01163656|333267|P2|NOT COMPLETED|Overall Study||3
137410|NCT01163656|333268|P1|NOT COMPLETED|Overall Study||3
137411|NCT01163656|333267|P2|COMPLETED|Overall Study||30
137412|NCT01163656|333268|P1|COMPLETED|Overall Study||30
137413|NCT01163656|333267|P2|STARTED|Overall Study||33
137414|NCT01163656|333268|P1|STARTED|Overall Study||33
137415|NCT01163617|333274|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137416|NCT01163617|333275|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137417|NCT01163617|333276|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137418|NCT01163617|333277|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137419|NCT01163617|333278|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137420|NCT01163617|333279|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137421|NCT01163617|333280|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137422|NCT01163617|333281|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
137423|NCT01163617|333274|P8|COMPLETED|Phase B (Injection Time), Week 4||20
137424|NCT01163617|333275|P7|COMPLETED|Phase B (Injection Time), Week 4||16
137425|NCT01163617|333276|P6|COMPLETED|Phase B (Injection Time), Week 4||27
137426|NCT01163617|333277|P5|COMPLETED|Phase B (Injection Time), Week 4||18
137427|NCT01163617|333278|P4|COMPLETED|Phase B (Injection Time), Week 4||0
137428|NCT01163617|333279|P3|COMPLETED|Phase B (Injection Time), Week 4||0
137429|NCT01163617|333280|P2|COMPLETED|Phase B (Injection Time), Week 4||0
137430|NCT01163617|333281|P1|COMPLETED|Phase B (Injection Time), Week 4||0
137431|NCT01163617|333274|P8|STARTED|Phase B (Injection Time), Week 4||20
137432|NCT01163617|333275|P7|STARTED|Phase B (Injection Time), Week 4||16
137433|NCT01163617|333276|P6|STARTED|Phase B (Injection Time), Week 4||27
137434|NCT01163617|333277|P5|STARTED|Phase B (Injection Time), Week 4||18
137435|NCT01163617|333278|P4|STARTED|Phase B (Injection Time), Week 4||0
137436|NCT01163617|333279|P3|STARTED|Phase B (Injection Time), Week 4||0
137437|NCT01163617|333280|P2|STARTED|Phase B (Injection Time), Week 4||0
137438|NCT01163617|333281|P1|STARTED|Phase B (Injection Time), Week 4||0
137439|NCT01163617|333274|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137440|NCT01163617|333275|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137441|NCT01163617|333276|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137442|NCT01163617|333277|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137443|NCT01163617|333278|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137444|NCT01163617|333279|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
137445|NCT01163617|333280|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
137446|NCT01163617|333281|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137447|NCT01163617|333274|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137448|NCT01163617|333275|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137449|NCT01163617|333276|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137450|NCT01163617|333277|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
137451|NCT01163617|333278|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
137452|NCT01163617|333279|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
137453|NCT01163617|333280|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
137454|NCT01163617|333281|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
137455|NCT01163617|333274|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
137456|NCT01163617|333275|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
137457|NCT01163617|333276|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
137458|NCT01163617|333277|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
137459|NCT01163617|333278|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
137460|NCT01163617|333279|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
137461|NCT01163617|333280|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
137462|NCT01163617|333281|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
137463|NCT01163604|333303|P2|NOT COMPLETED|Overall Study||0
137464|NCT01163604|333304|P1|NOT COMPLETED|Overall Study||0
137465|NCT01163604|333303|P2|COMPLETED|Overall Study|August 2011|56
137466|NCT01163604|333304|P1|COMPLETED|Overall Study|August 2011|58
137467|NCT01163604|333303|P2|STARTED|Overall Study|August 2010|56
137468|NCT01163604|333304|P1|STARTED|Overall Study|August 2010|58
137469|NCT01163474|333310|P1|NOT COMPLETED|Overall Study||16
137470|NCT01163474|333310|P1|COMPLETED|Overall Study||24
137471|NCT01163474|333310|P1|STARTED|Overall Study||40
137472|NCT01163461|333316|P2|NOT COMPLETED|Overall Study||0
137473|NCT01163461|333317|P1|NOT COMPLETED|Overall Study||0
137474|NCT01163461|333316|P2|COMPLETED|Overall Study||14
137475|NCT01163461|333317|P1|COMPLETED|Overall Study||14
137476|NCT01163461|333316|P2|STARTED|Overall Study||14
137477|NCT01163461|333317|P1|STARTED|Overall Study||14
137478|NCT01163318|333321|P1|NOT COMPLETED|Overall Study||268
137479|NCT01163318|333321|P1|COMPLETED|Overall Study||284
137480|NCT01163318|333321|P1|STARTED|Overall Study||552
137481|NCT01163292|333330|P2|NOT COMPLETED|Overall Study||22
137482|NCT01163292|333331|P1|NOT COMPLETED|Overall Study||41
137483|NCT01163292|333330|P2|COMPLETED|Overall Study||92
137484|NCT01163292|333331|P1|COMPLETED|Overall Study||65
137485|NCT01163292|333330|P2|STARTED|Overall Study||114
137486|NCT01163292|333331|P1|STARTED|Overall Study||106
137487|NCT01163279|333347|P2|NOT COMPLETED|Overall Study||0
137488|NCT01163279|333348|P1|NOT COMPLETED|Overall Study||2
137489|NCT01163279|333347|P2|COMPLETED|Overall Study||9
137490|NCT01163279|333348|P1|COMPLETED|Overall Study||8
137491|NCT01163279|333347|P2|STARTED|Overall Study||9
137492|NCT01163279|333348|P1|STARTED|Overall Study||10
137493|NCT01163266|333377|P3|NOT COMPLETED|Overall Study||28
137494|NCT01163266|333378|P2|NOT COMPLETED|Overall Study||31
137495|NCT01163266|333379|P1|NOT COMPLETED|Overall Study||18
137496|NCT01163266|333377|P3|COMPLETED|Overall Study||122
137497|NCT01163266|333378|P2|COMPLETED|Overall Study||124
137498|NCT01163266|333379|P1|COMPLETED|Overall Study||139
137499|NCT01163266|333377|P3|Treated|Overall Study||150
137500|NCT01163266|333378|P2|Treated|Overall Study||155
137501|NCT01163266|333379|P1|Treated|Overall Study||157
137502|NCT01163266|333377|P3|STARTED|Overall Study||150
137503|NCT01163266|333378|P2|STARTED|Overall Study||155
137504|NCT01163266|333379|P1|STARTED|Overall Study||157
137505|NCT01163253|333404|P2|NOT COMPLETED|Overall Study||586
137506|NCT01163253|333405|P1|NOT COMPLETED|Overall Study||2281
137507|NCT01163253|333404|P2|COMPLETED|Overall Study||0
137508|NCT01163253|333405|P1|COMPLETED|Overall Study||0
137509|NCT01163253|333404|P2|STARTED|Overall Study||586
137510|NCT01163253|333405|P1|STARTED|Overall Study||2281
137511|NCT01163214|333567|P2|NOT COMPLETED|Overall Study||0
137512|NCT01163214|333568|P1|NOT COMPLETED|Overall Study||0
137513|NCT01163214|333567|P2|COMPLETED|Overall Study||81
137514|NCT01163214|333568|P1|COMPLETED|Overall Study||79
137515|NCT01163214|333567|P2|STARTED|Overall Study||81
137516|NCT01163214|333568|P1|STARTED|Overall Study||79
137517|NCT01163162|333584|P1|NOT COMPLETED|Overall Study||0
137518|NCT01163162|333584|P1|COMPLETED|Overall Study||16
137519|NCT01163162|333584|P1|STARTED|Overall Study||16
137520|NCT01163149|333593|P3|NOT COMPLETED|Extension Treatment Period||2
137521|NCT01163149|333594|P2|NOT COMPLETED|Extension Treatment Period||1
137522|NCT01163149|333595|P1|NOT COMPLETED|Extension Treatment Period||2
137523|NCT01163149|333593|P3|COMPLETED|Extension Treatment Period||4
137524|NCT01163149|333594|P2|COMPLETED|Extension Treatment Period||5
137525|NCT01163149|333595|P1|COMPLETED|Extension Treatment Period||5
137526|NCT01163149|333593|P3|STARTED|Extension Treatment Period||6
137527|NCT01163149|333594|P2|STARTED|Extension Treatment Period||6
137528|NCT01163149|333595|P1|STARTED|Extension Treatment Period||7
137529|NCT01163149|333593|P3|NOT COMPLETED|Primary Treatment Period||0
137530|NCT01163149|333594|P2|NOT COMPLETED|Primary Treatment Period||0
137531|NCT01163149|333595|P1|NOT COMPLETED|Primary Treatment Period||0
137532|NCT01163149|333593|P3|COMPLETED|Primary Treatment Period||6
137533|NCT01163149|333594|P2|COMPLETED|Primary Treatment Period||6
137534|NCT01163149|333595|P1|COMPLETED|Primary Treatment Period||7
137535|NCT01163149|333593|P3|STARTED|Primary Treatment Period||6
137536|NCT01163149|333594|P2|STARTED|Primary Treatment Period||6
137537|NCT01163149|333595|P1|STARTED|Primary Treatment Period||7
137538|NCT01163097|333640|P3|NOT COMPLETED|Overall Study||0
137539|NCT01163097|333641|P2|NOT COMPLETED|Overall Study||0
137540|NCT01163097|333642|P1|NOT COMPLETED|Overall Study||6
137541|NCT01163097|333640|P3|COMPLETED|Overall Study||8
137542|NCT01163097|333641|P2|COMPLETED|Overall Study||16
137543|NCT01163097|333642|P1|COMPLETED|Overall Study||14
137544|NCT01163097|333640|P3|STARTED|Overall Study||8
137545|NCT01163097|333641|P2|STARTED|Overall Study||16
137546|NCT01163097|333642|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
137547|NCT01163032|333695|P3|NOT COMPLETED|Open Label Extension Phase||16
137548|NCT01163032|333696|P2|NOT COMPLETED|Open Label Extension Phase||0
137549|NCT01163032|333697|P1|NOT COMPLETED|Open Label Extension Phase||0
137550|NCT01163032|333695|P3|COMPLETED|Open Label Extension Phase||39
137551|NCT01163032|333696|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
137552|NCT01163032|333697|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
137553|NCT01163032|333695|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
137554|NCT01163032|333696|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
137555|NCT01163032|333697|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
137556|NCT01163032|333695|P3|NOT COMPLETED|Randomization Phase||0
137557|NCT01163032|333696|P2|NOT COMPLETED|Randomization Phase||12
137558|NCT01163032|333697|P1|NOT COMPLETED|Randomization Phase||10
137559|NCT01163032|333695|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
137560|NCT01163032|333696|P2|COMPLETED|Randomization Phase||30
137561|NCT01163032|333697|P1|COMPLETED|Randomization Phase||32
137562|NCT01163032|333695|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
137563|NCT01163032|333696|P2|STARTED|Randomization Phase||42
137564|NCT01163032|333697|P1|STARTED|Randomization Phase||42
137565|NCT01162863|333730|P3|NOT COMPLETED|Overall Study||0
137566|NCT01162863|333731|P2|NOT COMPLETED|Overall Study||1
137567|NCT01162863|333732|P1|NOT COMPLETED|Overall Study||1
137568|NCT01162863|333730|P3|COMPLETED|Overall Study||17
137569|NCT01162863|333731|P2|COMPLETED|Overall Study||16
137570|NCT01162863|333732|P1|COMPLETED|Overall Study||17
137571|NCT01162863|333730|P3|STARTED|Overall Study||17
137572|NCT01162863|333731|P2|STARTED|Overall Study||17
137573|NCT01162863|333732|P1|STARTED|Overall Study||18
137574|NCT01162733|333748|P2|NOT COMPLETED|Overall Study||25
137575|NCT01162733|333749|P1|NOT COMPLETED|Overall Study||27
137576|NCT01162733|333748|P2|COMPLETED|Overall Study||25
137577|NCT01162733|333749|P1|COMPLETED|Overall Study||22
137578|NCT01162733|333748|P2|STARTED|Overall Study||50
137579|NCT01162733|333749|P1|STARTED|Overall Study||49
137580|NCT01162499|333757|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
137581|NCT01162499|333758|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
137582|NCT01162499|333757|P2|COMPLETED|Intervention 2 (4 Hours)||3
137583|NCT01162499|333758|P1|COMPLETED|Intervention 2 (4 Hours)||3
137584|NCT01162499|333757|P2|STARTED|Intervention 2 (4 Hours)||3
137585|NCT01162499|333758|P1|STARTED|Intervention 2 (4 Hours)||3
137586|NCT01162499|333757|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
137587|NCT01162499|333758|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
137588|NCT01162499|333757|P2|COMPLETED|Intervention 1 (4 Hours)||3
137589|NCT01162499|333758|P1|COMPLETED|Intervention 1 (4 Hours)||3
137590|NCT01162499|333757|P2|Received Intervention|Intervention 1 (4 Hours)||3
137591|NCT01162499|333758|P1|Received Intervention|Intervention 1 (4 Hours)||3
137592|NCT01162499|333757|P2|STARTED|Intervention 1 (4 Hours)||4
137593|NCT01162499|333758|P1|STARTED|Intervention 1 (4 Hours)||3
137594|NCT01162473|333780|P2|NOT COMPLETED|Overall Study||5
137595|NCT01162473|333781|P1|NOT COMPLETED|Overall Study||2
137596|NCT01162473|333780|P2|COMPLETED|Overall Study||12
137597|NCT01162473|333781|P1|COMPLETED|Overall Study||6
137598|NCT01162473|333780|P2|STARTED|Overall Study||17
137599|NCT01162473|333781|P1|STARTED|Overall Study||8
137600|NCT01162421|333789|P2|NOT COMPLETED|Overall Study||13
137601|NCT01162421|333790|P1|NOT COMPLETED|Overall Study||8
137602|NCT01162421|333789|P2|COMPLETED|Overall Study||27
137603|NCT01162421|333790|P1|COMPLETED|Overall Study||29
137604|NCT01162421|333789|P2|STARTED|Overall Study||40
137605|NCT01162421|333790|P1|STARTED|Overall Study||37
137606|NCT01162343|333868|P1|NOT COMPLETED|Overall Study||92
137607|NCT01162343|333868|P1|COMPLETED|Overall Study||406
137608|NCT01162343|333868|P1|STARTED|Overall Study||498
137609|NCT01162317|333874|P2|NOT COMPLETED|Overall Study||2
137610|NCT01162317|333875|P1|NOT COMPLETED|Overall Study||3
137611|NCT01162317|333874|P2|COMPLETED|Overall Study||28
137612|NCT01162317|333875|P1|COMPLETED|Overall Study||27
137613|NCT01162317|333874|P2|STARTED|Overall Study||30
137614|NCT01162317|333875|P1|STARTED|Overall Study||30
137615|NCT01162304|333883|P1|NOT COMPLETED|Overall Study||11
137616|NCT01162304|333883|P1|COMPLETED|Overall Study||7
137617|NCT01162304|333883|P1|STARTED|Overall Study||18
137618|NCT01162135|333897|P1|NOT COMPLETED|Overall Study||3
137619|NCT01162135|333897|P1|COMPLETED|Overall Study||13
137620|NCT01162135|333897|P1|STARTED|Overall Study||16
137621|NCT01162122|333903|P2|NOT COMPLETED|Overall Study||196
137622|NCT01162122|333904|P1|NOT COMPLETED|Overall Study||191
137623|NCT01162122|333903|P2|COMPLETED|Overall Study||3356
137624|NCT01162122|333904|P1|COMPLETED|Overall Study||3361
137625|NCT01162122|333903|P2|Vaccinated|Overall Study||3541
137626|NCT01162122|333904|P1|Vaccinated|Overall Study||3541
137627|NCT01162122|333903|P2|STARTED|Overall Study||3552
137628|NCT01162122|333904|P1|STARTED|Overall Study||3552
137629|NCT01162096|333961|P1|NOT COMPLETED|Overall Study||0
137630|NCT01162096|333961|P1|COMPLETED|Overall Study||34
137631|NCT01162096|333961|P1|STARTED|Overall Study||34
137632|NCT01161862|333969|P2|NOT COMPLETED|Overall Study||0
137633|NCT01161862|333970|P1|NOT COMPLETED|Overall Study||0
137634|NCT01161862|333969|P2|COMPLETED|Overall Study||12
137635|NCT01161862|333970|P1|COMPLETED|Overall Study||12
137636|NCT01161862|333969|P2|STARTED|Overall Study||12
137637|NCT01161862|333970|P1|STARTED|Overall Study||12
137638|NCT01161771|333990|P1|NOT COMPLETED|Overall Study||0
137639|NCT01161771|333990|P1|COMPLETED|Overall Study||32
137640|NCT01161771|333990|P1|STARTED|Overall Study||32
137641|NCT01161628|333999|P1|NOT COMPLETED|Overall Study||8
137642|NCT01161628|333999|P1|COMPLETED|Overall Study||17
137643|NCT01161628|333999|P1|STARTED|Overall Study||25
137644|NCT01161563|334013|P2|NOT COMPLETED|Overall Study||6
137645|NCT01161563|334014|P1|NOT COMPLETED|Overall Study||5
137646|NCT01161563|334013|P2|COMPLETED|Overall Study||49
137647|NCT01161563|334014|P1|COMPLETED|Overall Study||58
137648|NCT01161563|334013|P2|STARTED|Overall Study||55
137649|NCT01161563|334014|P1|STARTED|Overall Study||63
137650|NCT01161537|334022|P1|NOT COMPLETED|Part B||2
137651|NCT01161537|334022|P1|COMPLETED|Part B||7
137652|NCT01161537|334022|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
137653|NCT01161537|334022|P1|NOT COMPLETED|Part A||0
137654|NCT01161537|334022|P1|COMPLETED|Part A||8
137655|NCT01161537|334022|P1|STARTED|Part A||8
137656|NCT01161498|334040|P2|NOT COMPLETED|Overall Study||1
137657|NCT01161498|334041|P1|NOT COMPLETED|Overall Study||0
137658|NCT01161498|334040|P2|COMPLETED|Overall Study||1
137659|NCT01161498|334041|P1|COMPLETED|Overall Study||3
137660|NCT01161498|334040|P2|STARTED|Overall Study||2
137661|NCT01161498|334041|P1|STARTED|Overall Study||3
137662|NCT01161472|334065|P4|NOT COMPLETED|Fourth Intervention Period||0
137663|NCT01161472|334066|P3|NOT COMPLETED|Fourth Intervention Period||0
137664|NCT01161472|334067|P2|NOT COMPLETED|Fourth Intervention Period||0
137665|NCT01161472|334068|P1|NOT COMPLETED|Fourth Intervention Period||0
137666|NCT01161472|334065|P4|COMPLETED|Fourth Intervention Period||5
137667|NCT01161472|334066|P3|COMPLETED|Fourth Intervention Period||5
137668|NCT01161472|334067|P2|COMPLETED|Fourth Intervention Period||5
137669|NCT01161472|334068|P1|COMPLETED|Fourth Intervention Period||4
137670|NCT01161472|334065|P4|STARTED|Fourth Intervention Period||5
137671|NCT01161472|334066|P3|STARTED|Fourth Intervention Period||5
137672|NCT01161472|334067|P2|STARTED|Fourth Intervention Period||5
137673|NCT01161472|334068|P1|STARTED|Fourth Intervention Period||4
137674|NCT01161472|334065|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137675|NCT01161472|334066|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137676|NCT01161472|334067|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137677|NCT01161472|334068|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137678|NCT01161472|334065|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137679|NCT01161472|334066|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137680|NCT01161472|334067|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137681|NCT01161472|334068|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
137682|NCT01161472|334065|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
137683|NCT01161472|334066|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
137684|NCT01161472|334067|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
137685|NCT01161472|334068|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
137686|NCT01161472|334065|P4|NOT COMPLETED|Third Intervention Period||0
137687|NCT01161472|334066|P3|NOT COMPLETED|Third Intervention Period||0
137688|NCT01161472|334067|P2|NOT COMPLETED|Third Intervention Period||0
137689|NCT01161472|334068|P1|NOT COMPLETED|Third Intervention Period||0
137690|NCT01161472|334065|P4|COMPLETED|Third Intervention Period||5
137691|NCT01161472|334066|P3|COMPLETED|Third Intervention Period||5
137692|NCT01161472|334067|P2|COMPLETED|Third Intervention Period||5
137693|NCT01161472|334068|P1|COMPLETED|Third Intervention Period||4
137694|NCT01161472|334065|P4|STARTED|Third Intervention Period||5
137695|NCT01161472|334066|P3|STARTED|Third Intervention Period||5
137696|NCT01161472|334067|P2|STARTED|Third Intervention Period||5
137697|NCT01161472|334068|P1|STARTED|Third Intervention Period||4
137698|NCT01161472|334065|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137699|NCT01161472|334066|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137700|NCT01161472|334067|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137701|NCT01161472|334068|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
137702|NCT01161472|334065|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137703|NCT01161472|334066|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137704|NCT01161472|334067|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137705|NCT01161472|334068|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
137706|NCT01161472|334065|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
137707|NCT01161472|334066|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
137708|NCT01161472|334067|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
137709|NCT01161472|334068|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
137710|NCT01161472|334065|P4|NOT COMPLETED|Second Intervention Period||0
137711|NCT01161472|334066|P3|NOT COMPLETED|Second Intervention Period||0
137712|NCT01161472|334067|P2|NOT COMPLETED|Second Intervention Period||0
137713|NCT01161472|334068|P1|NOT COMPLETED|Second Intervention Period||0
137714|NCT01161472|334065|P4|COMPLETED|Second Intervention Period||5
137715|NCT01161472|334066|P3|COMPLETED|Second Intervention Period||5
137716|NCT01161472|334067|P2|COMPLETED|Second Intervention Period||5
137717|NCT01161472|334068|P1|COMPLETED|Second Intervention Period||5
137718|NCT01161472|334065|P4|STARTED|Second Intervention Period||5
137719|NCT01161472|334066|P3|STARTED|Second Intervention Period||5
137720|NCT01161472|334067|P2|STARTED|Second Intervention Period||5
137721|NCT01161472|334068|P1|STARTED|Second Intervention Period||5
137722|NCT01161472|334065|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137723|NCT01161472|334066|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137724|NCT01161472|334067|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137725|NCT01161472|334068|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
137726|NCT01161472|334065|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137727|NCT01161472|334066|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137728|NCT01161472|334067|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137729|NCT01161472|334068|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
137730|NCT01161472|334065|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
137731|NCT01161472|334066|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
137732|NCT01161472|334067|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
137733|NCT01161472|334068|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
137734|NCT01161472|334065|P4|NOT COMPLETED|First Intervention Period||0
137735|NCT01161472|334066|P3|NOT COMPLETED|First Intervention Period||0
137736|NCT01161472|334067|P2|NOT COMPLETED|First Intervention Period||0
137737|NCT01161472|334068|P1|NOT COMPLETED|First Intervention Period||0
137738|NCT01161472|334065|P4|COMPLETED|First Intervention Period||5
137739|NCT01161472|334066|P3|COMPLETED|First Intervention Period||5
137740|NCT01161472|334067|P2|COMPLETED|First Intervention Period||5
137741|NCT01161472|334068|P1|COMPLETED|First Intervention Period||5
137742|NCT01161472|334065|P4|Treated|First Intervention Period||5
137743|NCT01161472|334066|P3|Treated|First Intervention Period||5
137744|NCT01161472|334067|P2|Treated|First Intervention Period||5
137745|NCT01161472|334068|P1|Treated|First Intervention Period||5
137746|NCT01161472|334065|P4|STARTED|First Intervention Period||5
137747|NCT01161472|334066|P3|STARTED|First Intervention Period||5
137748|NCT01161472|334067|P2|STARTED|First Intervention Period||5
137749|NCT01161472|334068|P1|STARTED|First Intervention Period||5
137750|NCT01161446|334124|P2|NOT COMPLETED|Overall Study||15
137751|NCT01161446|334125|P1|NOT COMPLETED|Overall Study||18
137752|NCT01161446|334124|P2|COMPLETED|Overall Study||99
137753|NCT01161446|334125|P1|COMPLETED|Overall Study||98
137754|NCT01161446|334124|P2|STARTED|Overall Study||114
137755|NCT01161446|334125|P1|STARTED|Overall Study||116
137756|NCT01161420|334137|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
137757|NCT01161420|334137|P1|COMPLETED|Withdrawal Study - Withdrawal||23
137758|NCT01161420|334137|P1|STARTED|Withdrawal Study - Withdrawal||23
137759|NCT01161420|334137|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
137760|NCT01161420|334137|P1|COMPLETED|Withdrawal Study - Maintenance||23
137761|NCT01161420|334137|P1|STARTED|Withdrawal Study - Maintenance||23
137762|NCT01161420|334137|P1|NOT COMPLETED|Inspire Therapy||2
137763|NCT01161420|334137|P1|COMPLETED|Inspire Therapy||124
137764|NCT01161420|334137|P1|STARTED|Inspire Therapy||126
137765|NCT01161407|334151|P2|NOT COMPLETED|Overall Study||1
137766|NCT01161407|334152|P1|NOT COMPLETED|Overall Study||3
137767|NCT01161407|334151|P2|COMPLETED|Overall Study||5
137768|NCT01161407|334152|P1|COMPLETED|Overall Study||3
137769|NCT01161407|334151|P2|STARTED|Overall Study||6
137770|NCT01161407|334152|P1|STARTED|Overall Study||6
137771|NCT01161329|334164|P2|NOT COMPLETED|Overall Study||10
137772|NCT01161329|334165|P1|NOT COMPLETED|Overall Study||4
137773|NCT01161329|334164|P2|COMPLETED|Overall Study||24
137774|NCT01161329|334165|P1|COMPLETED|Overall Study||29
137775|NCT01161329|334164|P2|STARTED|Overall Study||34
137776|NCT01161329|334165|P1|STARTED|Overall Study||33
137777|NCT01161225|334176|P3|NOT COMPLETED|Overall Study||2
137778|NCT01161225|334177|P2|NOT COMPLETED|Overall Study||9
137779|NCT01161225|334178|P1|NOT COMPLETED|Overall Study||14
137780|NCT01161225|334176|P3|COMPLETED|Overall Study||12
137781|NCT01161225|334177|P2|COMPLETED|Overall Study||44
137782|NCT01161225|334178|P1|COMPLETED|Overall Study||45
137783|NCT01161225|334176|P3|STARTED|Overall Study||14
137784|NCT01161225|334177|P2|STARTED|Overall Study||53
137785|NCT01161225|334178|P1|STARTED|Overall Study||59
137786|NCT01161173|334207|P1|NOT COMPLETED|Overall Study||347
137787|NCT01161173|334207|P1|COMPLETED|Overall Study||0
137788|NCT01161173|334207|P1|STARTED|Overall Study||347
137789|NCT01161160|334219|P3|NOT COMPLETED|Overall Study||0
137790|NCT01161160|334220|P2|NOT COMPLETED|Overall Study||0
137791|NCT01161160|334221|P1|NOT COMPLETED|Overall Study||0
137792|NCT01161160|334219|P3|COMPLETED|Overall Study||58
137793|NCT01161160|334220|P2|COMPLETED|Overall Study||75
137794|NCT01161160|334221|P1|COMPLETED|Overall Study||76
137795|NCT01161160|334219|P3|STARTED|Overall Study||58
137796|NCT01161160|334220|P2|STARTED|Overall Study||75
137797|NCT01161160|334221|P1|STARTED|Overall Study||76
137798|NCT01161121|334292|P1|NOT COMPLETED|Overall Study||0
137799|NCT01161121|334292|P1|COMPLETED|Overall Study||46
137800|NCT01161121|334292|P1|STARTED|Overall Study||46
137801|NCT01160848|334304|P2|NOT COMPLETED|Overall Study||0
137802|NCT01160848|334305|P1|NOT COMPLETED|Overall Study||0
137803|NCT01160848|334304|P2|COMPLETED|Overall Study||8
137804|NCT01160848|334305|P1|COMPLETED|Overall Study||12
137805|NCT01160848|334304|P2|STARTED|Overall Study||8
137806|NCT01160848|334305|P1|STARTED|Overall Study||12
137807|NCT01160822|334334|P7|NOT COMPLETED|Overall Study||9
137808|NCT01160822|334335|P6|NOT COMPLETED|Overall Study||7
137809|NCT01160822|334336|P5|NOT COMPLETED|Overall Study||9
137810|NCT01160822|334337|P4|NOT COMPLETED|Overall Study||0
137811|NCT01160822|334338|P3|NOT COMPLETED|Overall Study||0
137812|NCT01160822|334339|P2|NOT COMPLETED|Overall Study||0
137813|NCT01160822|334340|P1|NOT COMPLETED|Overall Study||0
137814|NCT01160822|334334|P7|COMPLETED|Overall Study||44
137815|NCT01160822|334335|P6|COMPLETED|Overall Study||40
137816|NCT01160822|334336|P5|COMPLETED|Overall Study||36
137817|NCT01160822|334337|P4|COMPLETED|Overall Study||5
137818|NCT01160822|334338|P3|COMPLETED|Overall Study||6
137819|NCT01160822|334339|P2|COMPLETED|Overall Study||7
137820|NCT01160822|334340|P1|COMPLETED|Overall Study||6
137821|NCT01160822|334334|P7|STARTED|Overall Study||53
137822|NCT01160822|334335|P6|STARTED|Overall Study||47
137823|NCT01160822|334336|P5|STARTED|Overall Study||45
137824|NCT01160822|334337|P4|STARTED|Overall Study||5
137825|NCT01160822|334338|P3|STARTED|Overall Study||6
137826|NCT01160822|334339|P2|STARTED|Overall Study||7
137827|NCT01160822|334340|P1|STARTED|Overall Study||6
137828|NCT01160770|334429|P1|NOT COMPLETED|Overall Study||79
137829|NCT01160770|334429|P1|COMPLETED|Overall Study||188
137830|NCT01160770|334429|P1|STARTED|Overall Study||267
137831|NCT01160744|334442|P4|NOT COMPLETED|Overall Study||22
137832|NCT01160744|334443|P3|NOT COMPLETED|Overall Study||20
137833|NCT01160744|334444|P2|NOT COMPLETED|Overall Study||25
137834|NCT01160744|334445|P1|NOT COMPLETED|Overall Study||20
137835|NCT01160744|334442|P4|COMPLETED|Overall Study||49
137836|NCT01160744|334443|P3|COMPLETED|Overall Study||49
137837|NCT01160744|334444|P2|COMPLETED|Overall Study||44
137838|NCT01160744|334445|P1|COMPLETED|Overall Study||51
137839|NCT01160744|334442|P4|Received Study Drug|Overall Study||71
137840|NCT01160744|334443|P3|Received Study Drug|Overall Study||63
137841|NCT01160744|334444|P2|Received Study Drug|Overall Study||67
137842|NCT01160744|334445|P1|Received Study Drug|Overall Study||69
137843|NCT01160744|334442|P4|STARTED|Overall Study||71
137844|NCT01160744|334443|P3|STARTED|Overall Study||69
137845|NCT01160744|334444|P2|STARTED|Overall Study||69
137846|NCT01160744|334445|P1|STARTED|Overall Study||71
137847|NCT01160640|334481|P2|NOT COMPLETED|Overall Study||6
137848|NCT01160640|334482|P1|NOT COMPLETED|Overall Study||4
137849|NCT01160640|334481|P2|COMPLETED|Overall Study||110
137850|NCT01160640|334482|P1|COMPLETED|Overall Study||113
137851|NCT01160640|334481|P2|STARTED|Overall Study||116
137852|NCT01160640|334482|P1|STARTED|Overall Study||117
137853|NCT01160614|334498|P2|NOT COMPLETED|Overall Study||2
137854|NCT01160614|334499|P1|NOT COMPLETED|Overall Study||0
137855|NCT01160614|334498|P2|COMPLETED|Overall Study||23
137856|NCT01160614|334499|P1|COMPLETED|Overall Study||5
137857|NCT01160614|334498|P2|STARTED|Overall Study||25
137858|NCT01160614|334499|P1|STARTED|Overall Study||5
137859|NCT01160484|334547|P1|NOT COMPLETED|Overall Study||18
137860|NCT01160484|334547|P1|COMPLETED|Overall Study||22
137861|NCT01160484|334547|P1|STARTED|Overall Study||40
137862|NCT01160458|334557|P1|NOT COMPLETED|Overall Study||0
137863|NCT01160458|334557|P1|COMPLETED|Overall Study||20
137864|NCT01160458|334557|P1|STARTED|Overall Study||20
137865|NCT01160445|334567|P2|NOT COMPLETED|Overall Study||0
137866|NCT01160445|334568|P1|NOT COMPLETED|Overall Study||0
137867|NCT01160445|334567|P2|COMPLETED|Overall Study||2
137868|NCT01160445|334568|P1|COMPLETED|Overall Study||7
137869|NCT01160445|334567|P2|STARTED|Overall Study||2
137870|NCT01160445|334568|P1|STARTED|Overall Study||7
137871|NCT01160380|334578|P2|NOT COMPLETED|Overall Study||5
137872|NCT01160380|334579|P1|NOT COMPLETED|Overall Study||8
137873|NCT01160380|334578|P2|COMPLETED|Overall Study||20
137874|NCT01160380|334579|P1|COMPLETED|Overall Study||17
137875|NCT01160380|334578|P2|STARTED|Overall Study||25
137876|NCT01160380|334579|P1|STARTED|Overall Study||25
137877|NCT01160237|334600|P3|NOT COMPLETED|Overall Study||0
137878|NCT01160237|334601|P2|NOT COMPLETED|Overall Study||0
137879|NCT01160237|334602|P1|NOT COMPLETED|Overall Study||0
137880|NCT01160237|334600|P3|COMPLETED|Overall Study||0
137881|NCT01160237|334601|P2|COMPLETED|Overall Study||3
137882|NCT01160237|334602|P1|COMPLETED|Overall Study||4
137883|NCT01160237|334600|P3|STARTED|Overall Study||0
137884|NCT01160237|334601|P2|STARTED|Overall Study||3
137885|NCT01160237|334602|P1|STARTED|Overall Study||4
137886|NCT01160198|334628|P3|NOT COMPLETED|Overall Study||1
137887|NCT01160198|334629|P2|NOT COMPLETED|Overall Study||3
137888|NCT01160198|334630|P1|NOT COMPLETED|Overall Study||2
137889|NCT01160198|334628|P3|COMPLETED|Overall Study||89
137890|NCT01160198|334629|P2|COMPLETED|Overall Study||88
137891|NCT01160198|334630|P1|COMPLETED|Overall Study||87
137892|NCT01160198|334628|P3|STARTED|Overall Study||90
137893|NCT01160198|334629|P2|STARTED|Overall Study||91
137894|NCT01160198|334630|P1|STARTED|Overall Study||89
137895|NCT01159938|334652|P5|NOT COMPLETED|Second Study Period||0
137896|NCT01159938|334653|P4|NOT COMPLETED|Second Study Period||0
137897|NCT01159938|334654|P3|NOT COMPLETED|Second Study Period||0
137898|NCT01159938|334655|P2|NOT COMPLETED|Second Study Period||0
137899|NCT01159938|334656|P1|NOT COMPLETED|Second Study Period||0
137900|NCT01159938|334652|P5|COMPLETED|Second Study Period||12
137901|NCT01159938|334653|P4|COMPLETED|Second Study Period||12
137902|NCT01159938|334654|P3|COMPLETED|Second Study Period||10
137903|NCT01159938|334655|P2|COMPLETED|Second Study Period||11
137904|NCT01159938|334656|P1|COMPLETED|Second Study Period||0
137905|NCT01159938|334652|P5|STARTED|Second Study Period||12
137906|NCT01159938|334653|P4|STARTED|Second Study Period||12
137907|NCT01159938|334654|P3|STARTED|Second Study Period||10
137908|NCT01159938|334655|P2|STARTED|Second Study Period||11
137909|NCT01159938|334656|P1|STARTED|Second Study Period||0
137910|NCT01159938|334652|P5|NOT COMPLETED|First Study Period||0
137911|NCT01159938|334653|P4|NOT COMPLETED|First Study Period||0
137912|NCT01159938|334654|P3|NOT COMPLETED|First Study Period||1
137913|NCT01159938|334655|P2|NOT COMPLETED|First Study Period||0
137914|NCT01159938|334656|P1|NOT COMPLETED|First Study Period||0
137915|NCT01159938|334652|P5|COMPLETED|First Study Period||12
137916|NCT01159938|334653|P4|COMPLETED|First Study Period||12
137917|NCT01159938|334654|P3|COMPLETED|First Study Period||10
137918|NCT01159938|334655|P2|COMPLETED|First Study Period||11
137919|NCT01159938|334656|P1|COMPLETED|First Study Period||26
137920|NCT01159938|334652|P5|Safety and Efficacy Analysis Population|First Study Period||12
137921|NCT01159938|334653|P4|Safety and Efficacy Analysis Population|First Study Period||12
137922|NCT01159938|334654|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
137923|NCT01159938|334655|P2|Safety and Efficacy Analysis Population|First Study Period||11
137924|NCT01159938|334656|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
137925|NCT01159938|334652|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
137926|NCT01159938|334653|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
137927|NCT01159938|334654|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
137928|NCT01159938|334655|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
137929|NCT01159938|334656|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
137930|NCT01159938|334652|P5|STARTED|First Study Period||12
137931|NCT01159938|334653|P4|STARTED|First Study Period||12
137932|NCT01159938|334654|P3|STARTED|First Study Period||11
137933|NCT01159938|334655|P2|STARTED|First Study Period||11
137934|NCT01159938|334656|P1|STARTED|First Study Period||26
137935|NCT01159912|334719|P3|NOT COMPLETED|Overall Study||26
137936|NCT01159912|334720|P2|NOT COMPLETED|Overall Study||22
137937|NCT01159912|334721|P1|NOT COMPLETED|Overall Study||40
137938|NCT01159912|334719|P3|COMPLETED|Overall Study||88
137939|NCT01159912|334720|P2|COMPLETED|Overall Study||92
137940|NCT01159912|334721|P1|COMPLETED|Overall Study||75
137941|NCT01159912|334719|P3|STARTED|Overall Study||114
137942|NCT01159912|334720|P2|STARTED|Overall Study||114
137943|NCT01159912|334721|P1|STARTED|Overall Study||115
137944|NCT01159769|334744|P1|NOT COMPLETED|Overall Study||1
137945|NCT01159769|334744|P1|COMPLETED|Overall Study||214
137946|NCT01159769|334744|P1|STARTED|Overall Study||215
137947|NCT01159743|334751|P2|NOT COMPLETED|Overall Study||0
137948|NCT01159743|334752|P1|NOT COMPLETED|Overall Study||0
137949|NCT01159743|334751|P2|COMPLETED|Overall Study||109
137950|NCT01159743|334752|P1|COMPLETED|Overall Study||237
137951|NCT01159743|334751|P2|STARTED|Overall Study||109
137952|NCT01159743|334752|P1|STARTED|Overall Study||237
137953|NCT01159691|334764|P1|NOT COMPLETED|Overall Study||22
137954|NCT01159691|334764|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
137955|NCT01159691|334764|P1|STARTED|Overall Study||76
137956|NCT01159665|334777|P6|NOT COMPLETED|Overall Study||0
137957|NCT01159665|334778|P5|NOT COMPLETED|Overall Study||0
137958|NCT01159665|334779|P4|NOT COMPLETED|Overall Study||0
137959|NCT01159665|334780|P3|NOT COMPLETED|Overall Study||0
137960|NCT01159665|334781|P2|NOT COMPLETED|Overall Study||1
137961|NCT01159665|334782|P1|NOT COMPLETED|Overall Study||0
137962|NCT01159665|334777|P6|COMPLETED|Overall Study||4
137963|NCT01159665|334778|P5|COMPLETED|Overall Study||4
137964|NCT01159665|334779|P4|COMPLETED|Overall Study||4
137965|NCT01159665|334780|P3|COMPLETED|Overall Study||8
137966|NCT01159665|334781|P2|COMPLETED|Overall Study||8
137967|NCT01159665|334782|P1|COMPLETED|Overall Study||9
137968|NCT01159665|334777|P6|STARTED|Overall Study||4
137969|NCT01159665|334778|P5|STARTED|Overall Study||4
137970|NCT01159665|334779|P4|STARTED|Overall Study||4
137971|NCT01159665|334780|P3|STARTED|Overall Study||8
137972|NCT01159665|334781|P2|STARTED|Overall Study||9
137973|NCT01159665|334782|P1|STARTED|Overall Study||9
137974|NCT01159600|334810|P8|NOT COMPLETED|Overall Study||18
137975|NCT01159600|334811|P7|NOT COMPLETED|Overall Study||19
137976|NCT01159600|334812|P6|NOT COMPLETED|Overall Study||18
137977|NCT01159600|334813|P5|NOT COMPLETED|Overall Study||24
137978|NCT01159600|334814|P4|NOT COMPLETED|Overall Study||11
137979|NCT01159600|334815|P3|NOT COMPLETED|Overall Study||18
137980|NCT01159600|334816|P2|NOT COMPLETED|Overall Study||8
137981|NCT01159600|334817|P1|NOT COMPLETED|Overall Study||21
137982|NCT01159600|334810|P8|COMPLETED|Overall Study||85
137983|NCT01159600|334811|P7|COMPLETED|Overall Study||199
137984|NCT01159600|334812|P6|COMPLETED|Overall Study||208
137985|NCT01159600|334813|P5|COMPLETED|Overall Study||201
137986|NCT01159600|334814|P4|COMPLETED|Overall Study||58
137987|NCT01159600|334815|P3|COMPLETED|Overall Study||196
137988|NCT01159600|334816|P2|COMPLETED|Overall Study||209
137989|NCT01159600|334817|P1|COMPLETED|Overall Study||186
137990|NCT01159600|334810|P8|STARTED|Overall Study||103
137991|NCT01159600|334811|P7|STARTED|Overall Study||218
137992|NCT01159600|334812|P6|STARTED|Overall Study||226
137993|NCT01159600|334813|P5|STARTED|Overall Study||225
137994|NCT01159600|334814|P4|STARTED|Overall Study||69
137995|NCT01159600|334815|P3|STARTED|Overall Study||214
137996|NCT01159600|334816|P2|STARTED|Overall Study||217
137997|NCT01159600|334817|P1|STARTED|Overall Study||207
137998|NCT01159574|334859|P1|NOT COMPLETED|Follow Up Phase||20
137999|NCT01159574|334859|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
138000|NCT01159574|334859|P1|STARTED|Follow Up Phase||112
138001|NCT01159574|334859|P1|NOT COMPLETED|Treatment Phase||21
138002|NCT01159574|334859|P1|COMPLETED|Treatment Phase||100
138003|NCT01159574|334859|P1|STARTED|Treatment Phase||121
138004|NCT01159535|334868|P3|NOT COMPLETED|Overall Study||31
138005|NCT01159535|334869|P2|NOT COMPLETED|Overall Study||24
138006|NCT01159535|334870|P1|NOT COMPLETED|Overall Study||24
138007|NCT01159535|334868|P3|COMPLETED|Overall Study||64
138008|NCT01159535|334869|P2|COMPLETED|Overall Study||64
138009|NCT01159535|334870|P1|COMPLETED|Overall Study||79
138010|NCT01159535|334868|P3|STARTED|Overall Study||95
138011|NCT01159535|334869|P2|STARTED|Overall Study||88
138012|NCT01159535|334870|P1|STARTED|Overall Study||103
138013|NCT01159431|334880|P2|NOT COMPLETED|Overall Study||6
138014|NCT01159431|334881|P1|NOT COMPLETED|Overall Study||2
138015|NCT01159431|334880|P2|COMPLETED|Overall Study||19
138016|NCT01159431|334881|P1|COMPLETED|Overall Study||23
138017|NCT01159431|334880|P2|STARTED|Overall Study||25
138018|NCT01159431|334881|P1|STARTED|Overall Study||25
138019|NCT01159262|334900|P3|NOT COMPLETED|Overall Study||0
138020|NCT01159262|334901|P2|NOT COMPLETED|Overall Study||0
138021|NCT01159262|334902|P1|NOT COMPLETED|Overall Study||0
138022|NCT01159262|334900|P3|COMPLETED|Overall Study||8
138023|NCT01159262|334901|P2|COMPLETED|Overall Study||14
138024|NCT01159262|334902|P1|COMPLETED|Overall Study||14
138025|NCT01159262|334900|P3|STARTED|Overall Study||8
138026|NCT01159262|334901|P2|STARTED|Overall Study||14
138027|NCT01159262|334902|P1|STARTED|Overall Study||14
138028|NCT01159171|334934|P1|NOT COMPLETED|Overall Study||50
138029|NCT01159171|334934|P1|COMPLETED|Overall Study||0
138030|NCT01159171|334934|P1|STARTED|Overall Study||50
138031|NCT01159054|334949|P1|NOT COMPLETED|Overall Study||20
138032|NCT01159054|334949|P1|COMPLETED|Overall Study||2
138033|NCT01159054|334949|P1|STARTED|Overall Study||22
138034|NCT01158976|334963|P2|NOT COMPLETED|Overall Study||4
138035|NCT01158976|334964|P1|NOT COMPLETED|Overall Study||9
138036|NCT01158976|334963|P2|COMPLETED|Overall Study||17
138037|NCT01158976|334964|P1|COMPLETED|Overall Study||34
138038|NCT01158976|334963|P2|STARTED|Overall Study||21
138039|NCT01158976|334964|P1|STARTED|Overall Study||43
138040|NCT01158924|335008|P2|NOT COMPLETED|Overall Study||3
138041|NCT01158924|335009|P1|NOT COMPLETED|Overall Study||1
138042|NCT01158924|335008|P2|COMPLETED|Overall Study||23
138043|NCT01158924|335009|P1|COMPLETED|Overall Study||13
138044|NCT01158924|335008|P2|STARTED|Overall Study||26
138045|NCT01158924|335009|P1|STARTED|Overall Study||14
138046|NCT01158716|335025|P2|NOT COMPLETED|Overall Study||1
138047|NCT01158716|335026|P1|NOT COMPLETED|Overall Study||1
138048|NCT01158716|335025|P2|COMPLETED|Overall Study||47
138049|NCT01158716|335026|P1|COMPLETED|Overall Study||47
138050|NCT01158716|335025|P2|STARTED|Overall Study||48
138051|NCT01158716|335026|P1|STARTED|Overall Study||48
138052|NCT01158703|335034|P2|NOT COMPLETED|Overall Study||0
138053|NCT01158703|335035|P1|NOT COMPLETED|Overall Study||0
138054|NCT01158703|335034|P2|COMPLETED|Overall Study||8
138055|NCT01158703|335035|P1|COMPLETED|Overall Study||12
138056|NCT01158703|335034|P2|STARTED|Overall Study||8
138057|NCT01158703|335035|P1|STARTED|Overall Study||12
138058|NCT01158573|335055|P4|NOT COMPLETED|Overall Study||0
138059|NCT01158573|335056|P3|NOT COMPLETED|Overall Study||0
138060|NCT01158573|335057|P2|NOT COMPLETED|Overall Study||0
138061|NCT01158573|335058|P1|NOT COMPLETED|Overall Study||0
138062|NCT01158573|335055|P4|COMPLETED|Overall Study||28
138063|NCT01158573|335056|P3|COMPLETED|Overall Study||29
138064|NCT01158573|335057|P2|COMPLETED|Overall Study||30
138065|NCT01158573|335058|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
138066|NCT01158573|335055|P4|STARTED|Overall Study||28
138067|NCT01158573|335056|P3|STARTED|Overall Study||29
138068|NCT01158573|335057|P2|STARTED|Overall Study||30
138069|NCT01158573|335058|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
138070|NCT01158534|335080|P1|NOT COMPLETED|Overall Study||3
138071|NCT01158534|335080|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
138072|NCT01158534|335080|P1|STARTED|Overall Study||17
138073|NCT01158378|335090|P2|NOT COMPLETED|Overall Study||9
138074|NCT01158378|335091|P1|NOT COMPLETED|Overall Study||10
138075|NCT01158378|335090|P2|COMPLETED|Overall Study||117
138076|NCT01158378|335091|P1|COMPLETED|Overall Study||114
138077|NCT01158378|335090|P2|STARTED|Overall Study||126
138078|NCT01158378|335091|P1|STARTED|Overall Study||124
138079|NCT01158261|335103|P1|NOT COMPLETED|Overall Study||17
138080|NCT01158261|335103|P1|COMPLETED|Overall Study||283
138081|NCT01158261|335103|P1|STARTED|Overall Study||300
138082|NCT01158118|335109|P2|NOT COMPLETED|Overall Study||3
138083|NCT01158118|335110|P1|NOT COMPLETED|Overall Study||1
138084|NCT01158118|335109|P2|COMPLETED|Overall Study||21
138085|NCT01158118|335110|P1|COMPLETED|Overall Study||23
138086|NCT01158118|335109|P2|STARTED|Overall Study||24
138087|NCT01158118|335110|P1|STARTED|Overall Study||24
138088|NCT01157845|335126|P1|NOT COMPLETED|Overall Study||35
138089|NCT01157845|335126|P1|COMPLETED|Overall Study||130
138090|NCT01157845|335126|P1|STARTED|Overall Study||165
138091|NCT01157533|335131|P1|NOT COMPLETED|Overall Study||0
138092|NCT01157533|335131|P1|COMPLETED|Overall Study||1
138093|NCT01157533|335131|P1|STARTED|Overall Study||1
138094|NCT01157429|335137|P2|NOT COMPLETED|Overall Study||4
138095|NCT01157429|335138|P1|NOT COMPLETED|Overall Study||4
138096|NCT01157429|335137|P2|COMPLETED|Overall Study||8
138097|NCT01157429|335138|P1|COMPLETED|Overall Study||8
138098|NCT01157429|335137|P2|STARTED|Overall Study||12
138099|NCT01157429|335138|P1|STARTED|Overall Study||12
138100|NCT01157416|335146|P2|NOT COMPLETED|Overall Study||0
138101|NCT01157416|335147|P1|NOT COMPLETED|Overall Study||2
138102|NCT01157416|335146|P2|COMPLETED|Overall Study||16
138103|NCT01157416|335147|P1|COMPLETED|Overall Study||15
138104|NCT01157416|335146|P2|STARTED|Overall Study||16
138105|NCT01157416|335147|P1|STARTED|Overall Study||17
138106|NCT01157377|335160|P7|NOT COMPLETED|Overall Study||2
138107|NCT01157377|335161|P6|NOT COMPLETED|Overall Study||3
138108|NCT01157377|335162|P5|NOT COMPLETED|Overall Study||2
138109|NCT01157377|335163|P4|NOT COMPLETED|Overall Study||1
138110|NCT01157377|335164|P3|NOT COMPLETED|Overall Study||1
138111|NCT01157377|335165|P2|NOT COMPLETED|Overall Study||3
138112|NCT01157377|335166|P1|NOT COMPLETED|Overall Study||2
138113|NCT01157377|335160|P7|COMPLETED|Overall Study||27
138114|NCT01157377|335161|P6|COMPLETED|Overall Study||16
138115|NCT01157377|335162|P5|COMPLETED|Overall Study||18
138116|NCT01157377|335163|P4|COMPLETED|Overall Study||14
138117|NCT01157377|335164|P3|COMPLETED|Overall Study||26
138118|NCT01157377|335165|P2|COMPLETED|Overall Study||20
138119|NCT01157377|335166|P1|COMPLETED|Overall Study||21
138120|NCT01157377|335160|P7|STARTED|Overall Study||29
138121|NCT01157377|335161|P6|STARTED|Overall Study||19
138122|NCT01157377|335162|P5|STARTED|Overall Study||20
138123|NCT01157377|335163|P4|STARTED|Overall Study||15
138124|NCT01157377|335164|P3|STARTED|Overall Study||27
138125|NCT01157377|335165|P2|STARTED|Overall Study||23
138126|NCT01157377|335166|P1|STARTED|Overall Study||23
138127|NCT01157351|335184|P2|NOT COMPLETED|Overall Study||132
138128|NCT01157351|335185|P1|NOT COMPLETED|Overall Study||137
138129|NCT01157351|335184|P2|COMPLETED|Overall Study||88
138130|NCT01157351|335185|P1|COMPLETED|Overall Study||93
138131|NCT01157351|335184|P2|Treated|Overall Study||218
138132|NCT01157351|335185|P1|Treated|Overall Study||226
138133|NCT01157351|335184|P2|STARTED|Overall Study||220
138134|NCT01157351|335185|P1|STARTED|Overall Study||230
138135|NCT01157234|335203|P2|NOT COMPLETED|Overall Study||0
138136|NCT01157234|335204|P1|NOT COMPLETED|Overall Study||1
138137|NCT01157234|335203|P2|COMPLETED|Overall Study||15
138138|NCT01157234|335204|P1|COMPLETED|Overall Study||14
138139|NCT01157234|335203|P2|STARTED|Overall Study||15
138140|NCT01157234|335204|P1|STARTED|Overall Study||15
138141|NCT01157182|335236|P2|NOT COMPLETED|Second Intervention||0
138142|NCT01157182|335237|P1|NOT COMPLETED|Second Intervention||0
138143|NCT01157182|335236|P2|COMPLETED|Second Intervention||18
138144|NCT01157182|335237|P1|COMPLETED|Second Intervention||16
138145|NCT01157182|335236|P2|STARTED|Second Intervention||18
138146|NCT01157182|335237|P1|STARTED|Second Intervention||16
138147|NCT01157182|335236|P2|NOT COMPLETED|Washout of 28 Days||0
138148|NCT01157182|335237|P1|NOT COMPLETED|Washout of 28 Days||2
138149|NCT01157182|335236|P2|COMPLETED|Washout of 28 Days||18
138150|NCT01157182|335237|P1|COMPLETED|Washout of 28 Days||16
138151|NCT01157182|335236|P2|STARTED|Washout of 28 Days||18
138152|NCT01157182|335237|P1|STARTED|Washout of 28 Days||18
138153|NCT01157182|335236|P2|NOT COMPLETED|First Intervention||0
138154|NCT01157182|335237|P1|NOT COMPLETED|First Intervention||0
138155|NCT01157182|335236|P2|COMPLETED|First Intervention||18
138156|NCT01157182|335237|P1|COMPLETED|First Intervention||18
138157|NCT01157182|335236|P2|STARTED|First Intervention||18
138158|NCT01157182|335237|P1|STARTED|First Intervention||18
138159|NCT01157169|335285|P2|NOT COMPLETED|Second Intervention||1
138160|NCT01157169|335286|P1|NOT COMPLETED|Second Intervention||0
138161|NCT01157169|335285|P2|COMPLETED|Second Intervention||17
138162|NCT01157169|335286|P1|COMPLETED|Second Intervention||16
138163|NCT01157169|335285|P2|STARTED|Second Intervention||18
138164|NCT01157169|335286|P1|STARTED|Second Intervention||16
138165|NCT01157169|335285|P2|NOT COMPLETED|Washout of 10 Days||0
138166|NCT01157169|335286|P1|NOT COMPLETED|Washout of 10 Days||0
138167|NCT01157169|335285|P2|COMPLETED|Washout of 10 Days||18
138168|NCT01157169|335286|P1|COMPLETED|Washout of 10 Days||16
138169|NCT01157169|335285|P2|STARTED|Washout of 10 Days||18
138170|NCT01157169|335286|P1|STARTED|Washout of 10 Days||16
138171|NCT01157169|335285|P2|NOT COMPLETED|First Intervention||2
138172|NCT01157169|335286|P1|NOT COMPLETED|First Intervention||4
138173|NCT01157169|335285|P2|COMPLETED|First Intervention||18
138174|NCT01157169|335286|P1|COMPLETED|First Intervention||16
138175|NCT01157169|335285|P2|STARTED|First Intervention||20
138176|NCT01157169|335286|P1|STARTED|First Intervention||20
138177|NCT01157117|335305|P3|NOT COMPLETED|Overall Study||15
138178|NCT01157117|335306|P2|NOT COMPLETED|Overall Study||11
138179|NCT01157117|335307|P1|NOT COMPLETED|Overall Study||9
138180|NCT01157117|335305|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
138181|NCT01157117|335306|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
138182|NCT01157117|335307|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
138183|NCT01157117|335305|P3|Completed Final Month 38 Study Visit|Overall Study||3
138184|NCT01157117|335306|P2|Completed Final Month 38 Study Visit|Overall Study||18
138185|NCT01157117|335307|P1|Completed Final Month 38 Study Visit|Overall Study||19
138186|NCT01157117|335305|P3|Completed Month 32 Tolerance OFC|Overall Study||0
138187|NCT01157117|335306|P2|Completed Month 32 Tolerance OFC|Overall Study||20
138188|NCT01157117|335307|P1|Completed Month 32 Tolerance OFC|Overall Study||24
138189|NCT01157117|335305|P3|Discontinued Milk OIT at Month 30|Overall Study||0
138190|NCT01157117|335306|P2|Discontinued Milk OIT at Month 30|Overall Study||20
138191|NCT01157117|335307|P1|Discontinued Milk OIT at Month 30|Overall Study||24
138192|NCT01157117|335305|P3|Completed Month 28 Desensitization OFC|Overall Study||0
138193|NCT01157117|335306|P2|Completed Month 28 Desensitization OFC|Overall Study||24
138194|NCT01157117|335307|P1|Completed Month 28 Desensitization OFC|Overall Study||26
138195|NCT01157117|335305|P3|Unblinded at Month 16|Overall Study||0
138196|NCT01157117|335306|P2|Unblinded at Month 16|Overall Study||26
138197|NCT01157117|335307|P1|Unblinded at Month 16|Overall Study||26
138198|NCT01157117|335305|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
138199|NCT01157117|335306|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
138200|NCT01157117|335307|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
138201|NCT01157117|335305|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
138202|NCT01157117|335306|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
138203|NCT01157117|335307|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
138204|NCT01157117|335305|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
138205|NCT01157117|335306|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
138206|NCT01157117|335307|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
138207|NCT01157117|335305|P3|STARTED|Overall Study||20
138208|NCT01157117|335306|P2|STARTED|Overall Study||29
138209|NCT01157117|335307|P1|STARTED|Overall Study||28
138210|NCT01157078|335348|P2|NOT COMPLETED|Overall Study||36
138211|NCT01157078|335349|P1|NOT COMPLETED|Overall Study||35
138212|NCT01157078|335348|P2|COMPLETED|Overall Study||124
138213|NCT01157078|335349|P1|COMPLETED|Overall Study||124
138214|NCT01157078|335348|P2|Received Treatment|Overall Study||159
138215|NCT01157078|335349|P1|Received Treatment|Overall Study||157
138216|NCT01157078|335348|P2|STARTED|Overall Study||160
138217|NCT01157078|335349|P1|STARTED|Overall Study||159
138218|NCT01157065|335399|P2|NOT COMPLETED|Overall Study||1
138219|NCT01157065|335400|P1|NOT COMPLETED|Overall Study||0
138220|NCT01157065|335399|P2|COMPLETED|Overall Study||10
138221|NCT01157065|335400|P1|COMPLETED|Overall Study||38
138222|NCT01157065|335399|P2|STARTED|Overall Study||11
138223|NCT01157065|335400|P1|STARTED|Overall Study||38
138224|NCT01156987|335410|P2|NOT COMPLETED|Overall Study||11
138225|NCT01156987|335411|P1|NOT COMPLETED|Overall Study||0
138226|NCT01156987|335410|P2|COMPLETED|Overall Study||12
138227|NCT01156987|335411|P1|COMPLETED|Overall Study||8
138228|NCT01156987|335410|P2|STARTED|Overall Study||23
138229|NCT01156987|335411|P1|STARTED|Overall Study||8
138230|NCT01156844|335421|P4|NOT COMPLETED|Overall Study||6
138231|NCT01156844|335422|P3|NOT COMPLETED|Overall Study||6
138232|NCT01156844|335423|P2|NOT COMPLETED|Overall Study||2
138233|NCT01156844|335424|P1|NOT COMPLETED|Overall Study||2
138234|NCT01156844|335421|P4|COMPLETED|Overall Study||41
138235|NCT01156844|335422|P3|COMPLETED|Overall Study||42
138236|NCT01156844|335423|P2|COMPLETED|Overall Study||46
138237|NCT01156844|335424|P1|COMPLETED|Overall Study||46
138238|NCT01156844|335421|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
138239|NCT01156844|335422|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
138240|NCT01156844|335423|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
138241|NCT01156844|335424|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
138242|NCT01156844|335421|P4|STARTED|Overall Study||47
138243|NCT01156844|335422|P3|STARTED|Overall Study||48
138244|NCT01156844|335423|P2|STARTED|Overall Study||48
138245|NCT01156844|335424|P1|STARTED|Overall Study|Randomized participants.|48
138246|NCT01156792|335443|P1|NOT COMPLETED|Overall Study||69
138247|NCT01156792|335443|P1|COMPLETED|Overall Study||93
138248|NCT01156792|335443|P1|STARTED|Overall Study||162
138249|NCT01156701|335508|P4|NOT COMPLETED|Overall Study||0
138250|NCT01156701|335509|P3|NOT COMPLETED|Overall Study||0
138251|NCT01156701|335510|P2|NOT COMPLETED|Overall Study||0
138252|NCT01156701|335511|P1|NOT COMPLETED|Overall Study||0
138253|NCT01156701|335508|P4|COMPLETED|Overall Study||6725
138254|NCT01156701|335509|P3|COMPLETED|Overall Study||163716
138255|NCT01156701|335510|P2|COMPLETED|Overall Study||1007
138256|NCT01156701|335511|P1|COMPLETED|Overall Study||257
138257|NCT01156701|335508|P4|STARTED|Overall Study||6725
138258|NCT01156701|335509|P3|STARTED|Overall Study||163716
138259|NCT01156701|335510|P2|STARTED|Overall Study||1007
138260|NCT01156701|335511|P1|STARTED|Overall Study||257
138261|NCT01156675|335548|P3|NOT COMPLETED|Overall Study||2
138262|NCT01156675|335549|P2|NOT COMPLETED|Overall Study||25
138263|NCT01156675|335550|P1|NOT COMPLETED|Overall Study||34
138264|NCT01156675|335548|P3|COMPLETED|Overall Study||0
138265|NCT01156675|335549|P2|COMPLETED|Overall Study||81
138266|NCT01156675|335550|P1|COMPLETED|Overall Study||73
138267|NCT01156675|335548|P3|STARTED|Overall Study||2
138268|NCT01156675|335549|P2|STARTED|Overall Study||106
138269|NCT01156675|335550|P1|STARTED|Overall Study||107
138270|NCT01156597|335581|P2|NOT COMPLETED|Overall Study||1
138271|NCT01156597|335582|P1|NOT COMPLETED|Overall Study||3
138272|NCT01156597|335581|P2|COMPLETED|Overall Study||13
138273|NCT01156597|335582|P1|COMPLETED|Overall Study||13
138274|NCT01156597|335581|P2|STARTED|Overall Study||14
138275|NCT01156597|335582|P1|STARTED|Overall Study||16
138276|NCT01156571|335594|P2|NOT COMPLETED|Overall Study||19
138277|NCT01156571|335595|P1|NOT COMPLETED|Overall Study||17
138278|NCT01156571|335594|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
138279|NCT01156571|335595|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
138280|NCT01156571|335594|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
138281|NCT01156571|335595|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
138282|NCT01156532|335605|P1|NOT COMPLETED|Overall Study||2
138283|NCT01156532|335605|P1|COMPLETED|Overall Study||28
138284|NCT01156532|335605|P1|STARTED|Overall Study||30
138285|NCT01156480|335617|P2|NOT COMPLETED|Overall Study||1
138286|NCT01156480|335618|P1|NOT COMPLETED|Overall Study||0
138287|NCT01156480|335617|P2|COMPLETED|Overall Study||1
138288|NCT01156480|335618|P1|COMPLETED|Overall Study||0
138289|NCT01156480|335617|P2|STARTED|Overall Study||2
138290|NCT01156480|335618|P1|STARTED|Overall Study||0
138291|NCT01156376|335629|P3|NOT COMPLETED|Overall Study||4
138292|NCT01156376|335630|P2|NOT COMPLETED|Overall Study||0
138293|NCT01156376|335631|P1|NOT COMPLETED|Overall Study||1
138294|NCT01156376|335629|P3|COMPLETED|Overall Study||23
138295|NCT01156376|335630|P2|COMPLETED|Overall Study||26
138296|NCT01156376|335631|P1|COMPLETED|Overall Study||26
138297|NCT01156376|335629|P3|STARTED|Overall Study||27
138298|NCT01156376|335630|P2|STARTED|Overall Study||26
138299|NCT01156376|335631|P1|STARTED|Overall Study||27
138300|NCT01156363|335852|P1|NOT COMPLETED|Overall Study||22
138301|NCT01156363|335852|P1|COMPLETED|Overall Study||64
138302|NCT01156363|335852|P1|STARTED|Overall Study||86
138303|NCT01156311|335874|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
138304|NCT01156311|335875|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
138305|NCT01156311|335876|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
138306|NCT01156311|335877|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
138307|NCT01156311|335874|P4|COMPLETED|6-month Add-on Therapy Period||37
138308|NCT01156311|335875|P3|COMPLETED|6-month Add-on Therapy Period||45
138309|NCT01156311|335876|P2|COMPLETED|6-month Add-on Therapy Period||0
138310|NCT01156311|335877|P1|COMPLETED|6-month Add-on Therapy Period||0
138311|NCT01156311|335874|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
138312|NCT01156311|335875|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
138313|NCT01156311|335876|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
138314|NCT01156311|335877|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
138315|NCT01156311|335874|P4|STARTED|6-month Add-on Therapy Period||47
138316|NCT01156311|335875|P3|STARTED|6-month Add-on Therapy Period||57
138317|NCT01156311|335876|P2|STARTED|6-month Add-on Therapy Period||0
138318|NCT01156311|335877|P1|STARTED|6-month Add-on Therapy Period||0
138319|NCT01156311|335874|P4|NOT COMPLETED|2-Month Monotherapy Period||0
138320|NCT01156311|335875|P3|NOT COMPLETED|2-Month Monotherapy Period||0
138321|NCT01156311|335876|P2|NOT COMPLETED|2-Month Monotherapy Period||2
138322|NCT01156311|335877|P1|NOT COMPLETED|2-Month Monotherapy Period||2
138323|NCT01156311|335874|P4|COMPLETED|2-Month Monotherapy Period||0
138324|NCT01156311|335875|P3|COMPLETED|2-Month Monotherapy Period||0
138325|NCT01156311|335876|P2|COMPLETED|2-Month Monotherapy Period||47
138326|NCT01156311|335877|P1|COMPLETED|2-Month Monotherapy Period||57
138327|NCT01156311|335874|P4|STARTED|2-Month Monotherapy Period||0
138328|NCT01156311|335875|P3|STARTED|2-Month Monotherapy Period||0
138329|NCT01156311|335876|P2|STARTED|2-Month Monotherapy Period||49
138330|NCT01156311|335877|P1|STARTED|2-Month Monotherapy Period||59
138331|NCT01156142|335901|P2|NOT COMPLETED|Overall Study||7
138332|NCT01156142|335902|P1|NOT COMPLETED|Overall Study||8
138333|NCT01156142|335901|P2|COMPLETED|Overall Study||71
138334|NCT01156142|335902|P1|COMPLETED|Overall Study||69
138335|NCT01156142|335901|P2|STARTED|Overall Study||78
138336|NCT01156142|335902|P1|STARTED|Overall Study||77
138337|NCT01156116|335920|P2|NOT COMPLETED|Overall Study||1
138338|NCT01156116|335921|P1|NOT COMPLETED|Overall Study||5
138339|NCT01156116|335920|P2|COMPLETED|Overall Study||12
138340|NCT01156116|335921|P1|COMPLETED|Overall Study||21
138341|NCT01156116|335920|P2|STARTED|Overall Study||13
138342|NCT01156116|335921|P1|STARTED|Overall Study||26
138343|NCT01156051|335935|P2|NOT COMPLETED|Overall Study||1
138344|NCT01156051|335936|P1|NOT COMPLETED|Overall Study||1
138345|NCT01156051|335935|P2|COMPLETED|Overall Study||16
138346|NCT01156051|335936|P1|COMPLETED|Overall Study||11
138347|NCT01156051|335935|P2|STARTED|Overall Study||17
138348|NCT01156051|335936|P1|STARTED|Overall Study||12
138349|NCT01156012|335950|P2|NOT COMPLETED|Overall Study||3
138350|NCT01156012|335951|P1|NOT COMPLETED|Overall Study||7
138351|NCT01156012|335950|P2|COMPLETED|Overall Study||186
138352|NCT01156012|335951|P1|COMPLETED|Overall Study||206
138353|NCT01156012|335950|P2|STARTED|Overall Study||189
138354|NCT01156012|335951|P1|STARTED|Overall Study||213
138355|NCT01155999|335959|P2|NOT COMPLETED|Overall Study||4
138356|NCT01155999|335960|P1|NOT COMPLETED|Overall Study||7
138357|NCT01155999|335959|P2|COMPLETED|Overall Study||136
138358|NCT01155999|335960|P1|COMPLETED|Overall Study||139
138359|NCT01155999|335959|P2|STARTED|Overall Study||140
138360|NCT01155999|335960|P1|STARTED|Overall Study||146
138361|NCT01155869|335968|P2|NOT COMPLETED|Overall Study||1
138362|NCT01155869|335969|P1|NOT COMPLETED|Overall Study||3
138363|NCT01155869|335968|P2|COMPLETED|Overall Study||3
138364|NCT01155869|335969|P1|COMPLETED|Overall Study||0
138365|NCT01155869|335968|P2|STARTED|Overall Study||4
138366|NCT01155869|335969|P1|STARTED|Overall Study||3
138367|NCT01155830|335980|P3|NOT COMPLETED|Overall Study||0
138368|NCT01155830|335981|P2|NOT COMPLETED|Overall Study||0
138369|NCT01155830|335982|P1|NOT COMPLETED|Overall Study||0
138370|NCT01155830|335980|P3|COMPLETED|Overall Study||21
138371|NCT01155830|335981|P2|COMPLETED|Overall Study||0
138372|NCT01155830|335982|P1|COMPLETED|Overall Study||0
138373|NCT01155830|335980|P3|STARTED|Overall Study||21
138374|NCT01155830|335981|P2|STARTED|Overall Study||0
138375|NCT01155830|335982|P1|STARTED|Overall Study||0
138376|NCT01155726|335993|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
138377|NCT01155726|335994|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
138378|NCT01155726|335995|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
138379|NCT01155726|335996|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
138380|NCT01155726|335993|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
138381|NCT01155726|335994|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
138382|NCT01155726|335995|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
138383|NCT01155726|335996|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
138384|NCT01155726|335993|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
138385|NCT01155726|335994|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
138386|NCT01155726|335995|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
138387|NCT01155726|335996|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
138388|NCT01155726|335993|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
138389|NCT01155726|335994|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
138390|NCT01155726|335995|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
138391|NCT01155726|335996|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
138392|NCT01155726|335993|P4|COMPLETED|Period 1, 3 Days (Masked)||25
138393|NCT01155726|335994|P3|COMPLETED|Period 1, 3 Days (Masked)||28
138394|NCT01155726|335995|P2|COMPLETED|Period 1, 3 Days (Masked)||20
138395|NCT01155726|335996|P1|COMPLETED|Period 1, 3 Days (Masked)||23
138396|NCT01155726|335993|P4|STARTED|Period 1, 3 Days (Masked)||25
138397|NCT01155726|335994|P3|STARTED|Period 1, 3 Days (Masked)||30
138398|NCT01155726|335995|P2|STARTED|Period 1, 3 Days (Masked)||20
138399|NCT01155726|335996|P1|STARTED|Period 1, 3 Days (Masked)||24
138400|NCT01155661|336018|P1|NOT COMPLETED|Overall Study||280
138401|NCT01155661|336018|P1|COMPLETED|Overall Study||328
138402|NCT01155661|336018|P1|STARTED|Overall Study||608
138403|NCT01155570|336044|P1|NOT COMPLETED|Overall Study||142
138404|NCT01155570|336044|P1|COMPLETED|Overall Study||592
138405|NCT01155570|336044|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
138406|NCT01155570|336044|P1|STARTED|Overall Study|Safety Analysis Population|734
138407|NCT01155531|336078|P4|NOT COMPLETED|Overall Study||1
138408|NCT01155531|336079|P3|NOT COMPLETED|Overall Study||2
138409|NCT01155531|336080|P2|NOT COMPLETED|Overall Study||0
138410|NCT01155531|336081|P1|NOT COMPLETED|Overall Study||1
138411|NCT01155531|336078|P4|COMPLETED|Overall Study||9
138412|NCT01155531|336079|P3|COMPLETED|Overall Study||8
138413|NCT01155531|336080|P2|COMPLETED|Overall Study||10
138414|NCT01155531|336081|P1|COMPLETED|Overall Study||9
138415|NCT01155531|336078|P4|STARTED|Overall Study||10
138416|NCT01155531|336079|P3|STARTED|Overall Study||10
138417|NCT01155531|336080|P2|STARTED|Overall Study||10
138418|NCT01155531|336081|P1|STARTED|Overall Study||10
138419|NCT01155479|336104|P5|NOT COMPLETED|Part II||55
138420|NCT01155479|336105|P4|NOT COMPLETED|Part II||50
138421|NCT01155479|336106|P3|NOT COMPLETED|Part II||58
138422|NCT01155479|336107|P2|NOT COMPLETED|Part II||61
138423|NCT01155479|336108|P1|NOT COMPLETED|Part II||59
138424|NCT01155479|336104|P5|COMPLETED|Part II||126
138425|NCT01155479|336105|P4|COMPLETED|Part II||127
138426|NCT01155479|336106|P3|COMPLETED|Part II||109
138427|NCT01155479|336107|P2|COMPLETED|Part II||116
138428|NCT01155479|336108|P1|COMPLETED|Part II||107
138429|NCT01155479|336104|P5|STARTED|Part II||181
138430|NCT01155479|336105|P4|STARTED|Part II||177
138431|NCT01155479|336106|P3|STARTED|Part II||167
138432|NCT01155479|336107|P2|STARTED|Part II||177
138433|NCT01155479|336108|P1|STARTED|Part II||166
138434|NCT01155479|336104|P5|NOT COMPLETED|Part I||23
138435|NCT01155479|336105|P4|NOT COMPLETED|Part I||27
138436|NCT01155479|336106|P3|NOT COMPLETED|Part I||39
138437|NCT01155479|336107|P2|NOT COMPLETED|Part I||27
138438|NCT01155479|336108|P1|NOT COMPLETED|Part I||38
138439|NCT01155479|336104|P5|COMPLETED|Part I||181
138440|NCT01155479|336105|P4|COMPLETED|Part I||177
138441|NCT01155479|336106|P3|COMPLETED|Part I||167
138442|NCT01155479|336107|P2|COMPLETED|Part I||177
138443|NCT01155479|336108|P1|COMPLETED|Part I||166
138444|NCT01155479|336104|P5|Treated|Part I||203
138445|NCT01155479|336105|P4|Treated|Part I||198
138446|NCT01155479|336106|P3|Treated|Part I||204
138447|NCT01155479|336107|P2|Treated|Part I||202
138448|NCT01155479|336108|P1|Treated|Part I||200
138449|NCT01155479|336104|P5|STARTED|Part I||204
138450|NCT01155479|336105|P4|STARTED|Part I||204
138451|NCT01155479|336106|P3|STARTED|Part I||206
138452|NCT01155479|336107|P2|STARTED|Part I||204
138453|NCT01155479|336108|P1|STARTED|Part I||204
138454|NCT01155466|336160|P5|NOT COMPLETED|Overall Study||27
138455|NCT01155466|336161|P4|NOT COMPLETED|Overall Study||21
138456|NCT01155466|336162|P3|NOT COMPLETED|Overall Study||20
138457|NCT01155466|336163|P2|NOT COMPLETED|Overall Study||25
138458|NCT01155466|336164|P1|NOT COMPLETED|Overall Study||22
138459|NCT01155466|336160|P5|COMPLETED|Overall Study|Completed treatment phase|129
138460|NCT01155466|336161|P4|COMPLETED|Overall Study|Completed treatment phase|134
138461|NCT01155466|336162|P3|COMPLETED|Overall Study|Completed treatment phase|136
138462|NCT01155466|336163|P2|COMPLETED|Overall Study|Completed treatment phase|130
138463|NCT01155466|336164|P1|COMPLETED|Overall Study|Completed treatment phase|134
138464|NCT01155466|336160|P5|Treated|Overall Study||154
138465|NCT01155466|336161|P4|Treated|Overall Study||155
138466|NCT01155466|336162|P3|Treated|Overall Study||153
138467|NCT01155466|336163|P2|Treated|Overall Study||153
138468|NCT01155466|336164|P1|Treated|Overall Study||154
138469|NCT01155466|336160|P5|STARTED|Overall Study||156
138470|NCT01155466|336161|P4|STARTED|Overall Study||155
138471|NCT01155466|336162|P3|STARTED|Overall Study||156
138472|NCT01155466|336163|P2|STARTED|Overall Study||155
138473|NCT01155466|336164|P1|STARTED|Overall Study||156
138474|NCT01155388|336218|P2|NOT COMPLETED|Overall Study||0
138475|NCT01155388|336219|P1|NOT COMPLETED|Overall Study||1
138476|NCT01155388|336218|P2|COMPLETED|Overall Study||6
138477|NCT01155388|336219|P1|COMPLETED|Overall Study||7
138478|NCT01155388|336218|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
138479|NCT01155388|336219|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
138480|NCT01155388|336218|P2|STARTED|Overall Study||6
138481|NCT01155388|336219|P1|STARTED|Overall Study||8
138482|NCT01155375|336229|P2|NOT COMPLETED|Overall Study||0
138483|NCT01155375|336230|P1|NOT COMPLETED|Overall Study||1
138484|NCT01155375|336229|P2|COMPLETED|Overall Study||6
138485|NCT01155375|336230|P1|COMPLETED|Overall Study||7
138486|NCT01155375|336229|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
138487|NCT01155375|336230|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
138488|NCT01155375|336229|P2|STARTED|Overall Study||6
138489|NCT01155375|336230|P1|STARTED|Overall Study||8
138490|NCT01155336|336240|P2|NOT COMPLETED|Overall Study||0
138491|NCT01155336|336241|P1|NOT COMPLETED|Overall Study||0
138492|NCT01155336|336240|P2|COMPLETED|Overall Study|We did not complete the study.|4
138493|NCT01155336|336241|P1|COMPLETED|Overall Study|We did not complete the study.|0
138494|NCT01155336|336240|P2|STARTED|Overall Study|We did not complete the study.|4
138495|NCT01155336|336241|P1|STARTED|Overall Study|We did not complete the study.|0
138496|NCT01155323|336249|P2|NOT COMPLETED|Second Intervention||1
138497|NCT01155323|336250|P1|NOT COMPLETED|Second Intervention||1
138498|NCT01155323|336249|P2|COMPLETED|Second Intervention||56
138499|NCT01155323|336250|P1|COMPLETED|Second Intervention||58
138500|NCT01155323|336249|P2|STARTED|Second Intervention||57
138501|NCT01155323|336250|P1|STARTED|Second Intervention||59
138502|NCT01155323|336249|P2|NOT COMPLETED|First Intervention||1
138503|NCT01155323|336250|P1|NOT COMPLETED|First Intervention||1
138504|NCT01155323|336249|P2|COMPLETED|First Intervention||57
138505|NCT01155323|336250|P1|COMPLETED|First Intervention||59
138506|NCT01155323|336249|P2|STARTED|First Intervention||58
138507|NCT01155323|336250|P1|STARTED|First Intervention||60
138508|NCT01155284|336268|P2|NOT COMPLETED|Overall Study||5
138509|NCT01155284|336269|P1|NOT COMPLETED|Overall Study||7
138510|NCT01155284|336268|P2|COMPLETED|Overall Study||18
138511|NCT01155284|336269|P1|COMPLETED|Overall Study||40
138512|NCT01155284|336268|P2|STARTED|Overall Study||23
138513|NCT01155284|336269|P1|STARTED|Overall Study||47
138514|NCT01155219|336279|P2|NOT COMPLETED|Overall Study||3
138515|NCT01155219|336280|P1|NOT COMPLETED|Overall Study||4
138516|NCT01155219|336279|P2|COMPLETED|Overall Study||70
138517|NCT01155219|336280|P1|COMPLETED|Overall Study||73
138518|NCT01155219|336279|P2|STARTED|Overall Study||73
138519|NCT01155219|336280|P1|STARTED|Overall Study||77
138520|NCT01155180|336288|P2|NOT COMPLETED|Overall Study||0
138521|NCT01155180|336289|P1|NOT COMPLETED|Overall Study||0
138522|NCT01155180|336288|P2|COMPLETED|Overall Study||6
138523|NCT01155180|336289|P1|COMPLETED|Overall Study||18
138524|NCT01155180|336288|P2|STARTED|Overall Study||6
138525|NCT01155180|336289|P1|STARTED|Overall Study||18
138526|NCT01155167|336297|P2|NOT COMPLETED|Overall Study||0
138527|NCT01155167|336298|P1|NOT COMPLETED|Overall Study||3
138528|NCT01155167|336297|P2|COMPLETED|Overall Study||43
138529|NCT01155167|336298|P1|COMPLETED|Overall Study||40
138530|NCT01155167|336297|P2|STARTED|Overall Study||43
138531|NCT01155167|336298|P1|STARTED|Overall Study||43
138532|NCT01155154|336311|P3|NOT COMPLETED|Overall Study||0
138533|NCT01155154|336312|P2|NOT COMPLETED|Overall Study||0
138534|NCT01155154|336313|P1|NOT COMPLETED|Overall Study||0
138535|NCT01155154|336311|P3|COMPLETED|Overall Study||24
138536|NCT01155154|336312|P2|COMPLETED|Overall Study||24
138537|NCT01155154|336313|P1|COMPLETED|Overall Study||25
138538|NCT01155154|336311|P3|STARTED|Overall Study||24
138539|NCT01155154|336312|P2|STARTED|Overall Study||24
138540|NCT01155154|336313|P1|STARTED|Overall Study||25
138541|NCT01155141|336321|P1|NOT COMPLETED|Overall Study||2
138542|NCT01155141|336321|P1|COMPLETED|Overall Study||14
138543|NCT01155141|336321|P1|STARTED|Overall Study||16
138544|NCT01155063|336333|P1|NOT COMPLETED|Overall Study||89
138545|NCT01155063|336333|P1|COMPLETED|Overall Study||0
138546|NCT01155063|336333|P1|STARTED|Overall Study||89
138547|NCT01155024|336343|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
138548|NCT01155024|336344|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
138549|NCT01155024|336343|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
138550|NCT01155024|336344|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
138551|NCT01155024|336343|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
138552|NCT01155024|336344|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
138553|NCT01155024|336343|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
138554|NCT01155024|336344|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
138555|NCT01155024|336343|P2|COMPLETED|Second Socket Intervention Fitting||5
138556|NCT01155024|336344|P1|COMPLETED|Second Socket Intervention Fitting||5
138557|NCT01155024|336343|P2|STARTED|Second Socket Intervention Fitting||5
138558|NCT01155024|336344|P1|STARTED|Second Socket Intervention Fitting||5
138559|NCT01155024|336343|P2|NOT COMPLETED|First Socket Intervention Fitting||0
138560|NCT01155024|336344|P1|NOT COMPLETED|First Socket Intervention Fitting||0
138561|NCT01155024|336343|P2|COMPLETED|First Socket Intervention Fitting||5
138562|NCT01155024|336344|P1|COMPLETED|First Socket Intervention Fitting||5
138563|NCT01155024|336343|P2|STARTED|First Socket Intervention Fitting||5
138564|NCT01155024|336344|P1|STARTED|First Socket Intervention Fitting||5
138565|NCT01155011|336354|P2|NOT COMPLETED|6 to 12 Months||10
138566|NCT01155011|336355|P1|NOT COMPLETED|6 to 12 Months||9
138567|NCT01155011|336354|P2|COMPLETED|6 to 12 Months||121
138568|NCT01155011|336355|P1|COMPLETED|6 to 12 Months||120
138569|NCT01155011|336354|P2|STARTED|6 to 12 Months||131
138570|NCT01155011|336355|P1|STARTED|6 to 12 Months||129
138571|NCT01155011|336354|P2|NOT COMPLETED|Baseline to 6 Months||25
138572|NCT01155011|336355|P1|NOT COMPLETED|Baseline to 6 Months||22
138573|NCT01155011|336354|P2|COMPLETED|Baseline to 6 Months||131
138574|NCT01155011|336355|P1|COMPLETED|Baseline to 6 Months||129
138575|NCT01155011|336354|P2|STARTED|Baseline to 6 Months||156
138576|NCT01155011|336355|P1|STARTED|Baseline to 6 Months||151
138577|NCT01154985|336368|P3|NOT COMPLETED|Overall Study||18
138578|NCT01154985|336369|P2|NOT COMPLETED|Overall Study||27
138579|NCT01154985|336370|P1|NOT COMPLETED|Overall Study||17
138580|NCT01154985|336368|P3|COMPLETED|Overall Study||68
138581|NCT01154985|336369|P2|COMPLETED|Overall Study||55
138582|NCT01154985|336370|P1|COMPLETED|Overall Study||58
138583|NCT01154985|336368|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
138584|NCT01154985|336369|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
138585|NCT01154985|336370|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
138586|NCT01154985|336368|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
138587|NCT01154985|336369|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
138588|NCT01154985|336370|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
138589|NCT01154985|336368|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
138590|NCT01154985|336369|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
138591|NCT01154985|336370|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
138592|NCT01154985|336368|P3|STARTED|Overall Study|Randomized|86
138593|NCT01154985|336369|P2|STARTED|Overall Study|Randomized|82
138594|NCT01154985|336370|P1|STARTED|Overall Study|Randomized|75
138595|NCT01154816|336396|P12|NOT COMPLETED|Overall Study||4
138596|NCT01154816|336397|P11|NOT COMPLETED|Overall Study||11
138597|NCT01154816|336398|P10|NOT COMPLETED|Overall Study||10
138598|NCT01154816|336399|P9|NOT COMPLETED|Overall Study||9
138599|NCT01154816|336400|P8|NOT COMPLETED|Overall Study||7
138600|NCT01154816|336401|P7|NOT COMPLETED|Overall Study||6
138601|NCT01154816|336402|P6|NOT COMPLETED|Overall Study||8
138602|NCT01154816|336403|P5|NOT COMPLETED|Overall Study||10
138603|NCT01154816|336404|P4|NOT COMPLETED|Overall Study||10
138604|NCT01154816|336405|P3|NOT COMPLETED|Overall Study||10
138605|NCT01154816|336406|P2|NOT COMPLETED|Overall Study||10
138606|NCT01154816|336407|P1|NOT COMPLETED|Overall Study||20
138607|NCT01154816|336396|P12|COMPLETED|Overall Study||0
138608|NCT01154816|336397|P11|COMPLETED|Overall Study||0
138609|NCT01154816|336398|P10|COMPLETED|Overall Study||0
138610|NCT01154816|336399|P9|COMPLETED|Overall Study||1
138611|NCT01154816|336400|P8|COMPLETED|Overall Study||0
138612|NCT01154816|336401|P7|COMPLETED|Overall Study||0
138613|NCT01154816|336402|P6|COMPLETED|Overall Study||0
138614|NCT01154816|336403|P5|COMPLETED|Overall Study||0
138615|NCT01154816|336404|P4|COMPLETED|Overall Study||0
138616|NCT01154816|336405|P3|COMPLETED|Overall Study||0
138617|NCT01154816|336406|P2|COMPLETED|Overall Study||2
138618|NCT01154816|336407|P1|COMPLETED|Overall Study||0
138619|NCT01154816|336396|P12|STARTED|Overall Study||4
138620|NCT01154816|336397|P11|STARTED|Overall Study||11
138621|NCT01154816|336398|P10|STARTED|Overall Study||10
138622|NCT01154816|336399|P9|STARTED|Overall Study||10
138623|NCT01154816|336400|P8|STARTED|Overall Study||7
138624|NCT01154816|336401|P7|STARTED|Overall Study||6
138625|NCT01154816|336402|P6|STARTED|Overall Study||8
138626|NCT01154816|336403|P5|STARTED|Overall Study||10
138627|NCT01154816|336404|P4|STARTED|Overall Study||10
138628|NCT01154816|336405|P3|STARTED|Overall Study||10
138629|NCT01154816|336406|P2|STARTED|Overall Study||12
138630|NCT01154816|336407|P1|STARTED|Overall Study||20
138631|NCT01154751|336440|P1|NOT COMPLETED|3-year Follow-up||49
138632|NCT01154751|336440|P1|COMPLETED|3-year Follow-up||34
138633|NCT01154751|336440|P1|STARTED|3-year Follow-up||83
138634|NCT01154751|336440|P1|NOT COMPLETED|2-year Follow-up||10
138635|NCT01154751|336440|P1|COMPLETED|2-year Follow-up||83
138636|NCT01154751|336440|P1|STARTED|2-year Follow-up||93
138637|NCT01154751|336440|P1|NOT COMPLETED|1-year Follow-up||5
138638|NCT01154751|336440|P1|COMPLETED|1-year Follow-up||93
138639|NCT01154751|336440|P1|STARTED|1-year Follow-up||98
138640|NCT01154751|336440|P1|NOT COMPLETED|6-month Follow-up||11
138641|NCT01154751|336440|P1|COMPLETED|6-month Follow-up||98
138642|NCT01154751|336440|P1|STARTED|6-month Follow-up||109
138643|NCT01154699|336465|P2|NOT COMPLETED|Second Intervention||0
138644|NCT01154699|336466|P1|NOT COMPLETED|Second Intervention||0
138645|NCT01154699|336465|P2|COMPLETED|Second Intervention||8
138646|NCT01154699|336466|P1|COMPLETED|Second Intervention||13
138647|NCT01154699|336465|P2|Subjects With Asthma + OSA|Second Intervention||2
138648|NCT01154699|336466|P1|Subjects With Asthma + OSA|Second Intervention||6
138649|NCT01154699|336465|P2|Subjects With Asthma Only|Second Intervention||6
138650|NCT01154699|336466|P1|Subjects With Asthma Only|Second Intervention||7
138651|NCT01154699|336465|P2|STARTED|Second Intervention||8
138652|NCT01154699|336466|P1|STARTED|Second Intervention||13
138653|NCT01154699|336465|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
138654|NCT01154699|336466|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
138655|NCT01154699|336465|P2|COMPLETED|Washout Period (4 Weeks)||8
138656|NCT01154699|336466|P1|COMPLETED|Washout Period (4 Weeks)||13
138657|NCT01154699|336465|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
138658|NCT01154699|336466|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
138659|NCT01154699|336465|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
138660|NCT01154699|336466|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
138661|NCT01154699|336465|P2|STARTED|Washout Period (4 Weeks)||8
138662|NCT01154699|336466|P1|STARTED|Washout Period (4 Weeks)||13
138663|NCT01154699|336465|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
138664|NCT01154699|336466|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
138665|NCT01154699|336465|P2|COMPLETED|First Intervention (4 Weeks)||8
138666|NCT01154699|336466|P1|COMPLETED|First Intervention (4 Weeks)||13
138667|NCT01154699|336465|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
138668|NCT01154699|336466|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
138669|NCT01154699|336465|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
138670|NCT01154699|336466|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
138671|NCT01154699|336465|P2|STARTED|First Intervention (4 Weeks)||8
138672|NCT01154699|336466|P1|STARTED|First Intervention (4 Weeks)||13
138673|NCT01154673|336484|P2|NOT COMPLETED|Overall Study||0
138674|NCT01154673|336485|P1|NOT COMPLETED|Overall Study||2
138675|NCT01154673|336484|P2|COMPLETED|Overall Study||16
138676|NCT01154673|336485|P1|COMPLETED|Overall Study||14
138677|NCT01154673|336484|P2|STARTED|Overall Study||16
138678|NCT01154673|336485|P1|STARTED|Overall Study||16
138679|NCT01154634|336495|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
138680|NCT01154634|336496|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
138681|NCT01154634|336497|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
138682|NCT01154634|336498|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
138683|NCT01154634|336495|P4|COMPLETED|Period 7 - Fourth Intervention||5
138684|NCT01154634|336496|P3|COMPLETED|Period 7 - Fourth Intervention||4
138685|NCT01154634|336497|P2|COMPLETED|Period 7 - Fourth Intervention||7
138686|NCT01154634|336498|P1|COMPLETED|Period 7 - Fourth Intervention||4
138687|NCT01154634|336495|P4|STARTED|Period 7 - Fourth Intervention||5
138688|NCT01154634|336496|P3|STARTED|Period 7 - Fourth Intervention||4
138689|NCT01154634|336497|P2|STARTED|Period 7 - Fourth Intervention||7
138690|NCT01154634|336498|P1|STARTED|Period 7 - Fourth Intervention||4
138691|NCT01154634|336495|P4|NOT COMPLETED|Period 6 - Washout||0
138692|NCT01154634|336496|P3|NOT COMPLETED|Period 6 - Washout||0
138693|NCT01154634|336497|P2|NOT COMPLETED|Period 6 - Washout||0
138694|NCT01154634|336498|P1|NOT COMPLETED|Period 6 - Washout||0
138695|NCT01154634|336495|P4|COMPLETED|Period 6 - Washout||5
138696|NCT01154634|336496|P3|COMPLETED|Period 6 - Washout||4
138697|NCT01154634|336497|P2|COMPLETED|Period 6 - Washout||7
138698|NCT01154634|336498|P1|COMPLETED|Period 6 - Washout||4
138699|NCT01154634|336495|P4|STARTED|Period 6 - Washout||5
138700|NCT01154634|336496|P3|STARTED|Period 6 - Washout||4
138701|NCT01154634|336497|P2|STARTED|Period 6 - Washout||7
138702|NCT01154634|336498|P1|STARTED|Period 6 - Washout||4
138703|NCT01154634|336495|P4|NOT COMPLETED|Period 5 - Third Intervention||0
138704|NCT01154634|336496|P3|NOT COMPLETED|Period 5 - Third Intervention||0
138705|NCT01154634|336497|P2|NOT COMPLETED|Period 5 - Third Intervention||0
138706|NCT01154634|336498|P1|NOT COMPLETED|Period 5 - Third Intervention||0
138707|NCT01154634|336495|P4|COMPLETED|Period 5 - Third Intervention||5
138708|NCT01154634|336496|P3|COMPLETED|Period 5 - Third Intervention||4
138709|NCT01154634|336497|P2|COMPLETED|Period 5 - Third Intervention||7
138710|NCT01154634|336498|P1|COMPLETED|Period 5 - Third Intervention||4
138711|NCT01154634|336495|P4|STARTED|Period 5 - Third Intervention||5
138712|NCT01154634|336496|P3|STARTED|Period 5 - Third Intervention||4
138713|NCT01154634|336497|P2|STARTED|Period 5 - Third Intervention||7
138714|NCT01154634|336498|P1|STARTED|Period 5 - Third Intervention||4
138715|NCT01154634|336495|P4|NOT COMPLETED|Period 4 - Washout||0
138716|NCT01154634|336496|P3|NOT COMPLETED|Period 4 - Washout||0
138717|NCT01154634|336497|P2|NOT COMPLETED|Period 4 - Washout||0
138718|NCT01154634|336498|P1|NOT COMPLETED|Period 4 - Washout||0
138719|NCT01154634|336495|P4|COMPLETED|Period 4 - Washout||5
138720|NCT01154634|336496|P3|COMPLETED|Period 4 - Washout||4
138721|NCT01154634|336497|P2|COMPLETED|Period 4 - Washout||7
138722|NCT01154634|336498|P1|COMPLETED|Period 4 - Washout||4
138723|NCT01154634|336495|P4|STARTED|Period 4 - Washout||5
138724|NCT01154634|336496|P3|STARTED|Period 4 - Washout||4
138725|NCT01154634|336497|P2|STARTED|Period 4 - Washout||7
138726|NCT01154634|336498|P1|STARTED|Period 4 - Washout||4
138727|NCT01154634|336495|P4|NOT COMPLETED|Period 3- Second Intervention||0
138728|NCT01154634|336496|P3|NOT COMPLETED|Period 3- Second Intervention||0
138729|NCT01154634|336497|P2|NOT COMPLETED|Period 3- Second Intervention||0
138730|NCT01154634|336498|P1|NOT COMPLETED|Period 3- Second Intervention||0
138731|NCT01154634|336495|P4|COMPLETED|Period 3- Second Intervention||5
138732|NCT01154634|336496|P3|COMPLETED|Period 3- Second Intervention||4
138733|NCT01154634|336497|P2|COMPLETED|Period 3- Second Intervention||7
138734|NCT01154634|336498|P1|COMPLETED|Period 3- Second Intervention||4
138735|NCT01154634|336495|P4|STARTED|Period 3- Second Intervention||5
138736|NCT01154634|336496|P3|STARTED|Period 3- Second Intervention||4
138737|NCT01154634|336497|P2|STARTED|Period 3- Second Intervention||7
138738|NCT01154634|336498|P1|STARTED|Period 3- Second Intervention||4
138739|NCT01154634|336495|P4|NOT COMPLETED|Period 2 - Washout||0
138740|NCT01154634|336496|P3|NOT COMPLETED|Period 2 - Washout||0
138741|NCT01154634|336497|P2|NOT COMPLETED|Period 2 - Washout||0
138742|NCT01154634|336498|P1|NOT COMPLETED|Period 2 - Washout||0
138743|NCT01154634|336495|P4|COMPLETED|Period 2 - Washout||5
138744|NCT01154634|336496|P3|COMPLETED|Period 2 - Washout||4
138745|NCT01154634|336497|P2|COMPLETED|Period 2 - Washout||7
138746|NCT01154634|336498|P1|COMPLETED|Period 2 - Washout||4
138747|NCT01154634|336495|P4|STARTED|Period 2 - Washout||5
138748|NCT01154634|336496|P3|STARTED|Period 2 - Washout||4
138749|NCT01154634|336497|P2|STARTED|Period 2 - Washout||7
138750|NCT01154634|336498|P1|STARTED|Period 2 - Washout||4
138751|NCT01154634|336495|P4|NOT COMPLETED|Period 1 - First Intervention||0
138752|NCT01154634|336496|P3|NOT COMPLETED|Period 1 - First Intervention||0
138753|NCT01154634|336497|P2|NOT COMPLETED|Period 1 - First Intervention||0
138754|NCT01154634|336498|P1|NOT COMPLETED|Period 1 - First Intervention||0
138755|NCT01154634|336495|P4|COMPLETED|Period 1 - First Intervention||5
138756|NCT01154634|336496|P3|COMPLETED|Period 1 - First Intervention||4
138757|NCT01154634|336497|P2|COMPLETED|Period 1 - First Intervention||7
138758|NCT01154634|336498|P1|COMPLETED|Period 1 - First Intervention||4
138759|NCT01154634|336495|P4|STARTED|Period 1 - First Intervention||5
138760|NCT01154634|336496|P3|STARTED|Period 1 - First Intervention||4
138761|NCT01154634|336497|P2|STARTED|Period 1 - First Intervention||7
138762|NCT01154634|336498|P1|STARTED|Period 1 - First Intervention||4
138763|NCT01154452|336540|P4|NOT COMPLETED|Phase II||6
138764|NCT01154452|336541|P3|NOT COMPLETED|Phase II||5
138765|NCT01154452|336542|P2|NOT COMPLETED|Phase II||0
138766|NCT01154452|336543|P1|NOT COMPLETED|Phase II||0
138767|NCT01154452|336540|P4|COMPLETED|Phase II||27
138768|NCT01154452|336541|P3|COMPLETED|Phase II||30
138769|NCT01154452|336542|P2|COMPLETED|Phase II||0
138770|NCT01154452|336543|P1|COMPLETED|Phase II||0
138771|NCT01154452|336540|P4|STARTED|Phase II||33
138772|NCT01154452|336541|P3|STARTED|Phase II||35
138773|NCT01154452|336542|P2|STARTED|Phase II||0
138774|NCT01154452|336543|P1|STARTED|Phase II||0
138775|NCT01154452|336540|P4|NOT COMPLETED|Phase Ib||0
138776|NCT01154452|336541|P3|NOT COMPLETED|Phase Ib||0
138777|NCT01154452|336542|P2|NOT COMPLETED|Phase Ib||1
138778|NCT01154452|336543|P1|NOT COMPLETED|Phase Ib||3
138779|NCT01154452|336540|P4|COMPLETED|Phase Ib||0
138780|NCT01154452|336541|P3|COMPLETED|Phase Ib||0
138781|NCT01154452|336542|P2|COMPLETED|Phase Ib||3
138782|NCT01154452|336543|P1|COMPLETED|Phase Ib||3
138783|NCT01154452|336540|P4|STARTED|Phase Ib||0
138784|NCT01154452|336541|P3|STARTED|Phase Ib||0
138785|NCT01154452|336542|P2|STARTED|Phase Ib||4
138786|NCT01154452|336543|P1|STARTED|Phase Ib||6
138787|NCT01154335|336557|P3|NOT COMPLETED|Overall Study||5
138788|NCT01154335|336558|P2|NOT COMPLETED|Overall Study||6
138789|NCT01154335|336559|P1|NOT COMPLETED|Overall Study||7
138790|NCT01154335|336557|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
138791|NCT01154335|336558|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
138792|NCT01154335|336559|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
138793|NCT01154335|336557|P3|STARTED|Overall Study||5
138794|NCT01154335|336558|P2|STARTED|Overall Study||6
138795|NCT01154335|336559|P1|STARTED|Overall Study||7
138796|NCT01154322|336566|P1|NOT COMPLETED|Overall Study||2
138797|NCT01154322|336566|P1|COMPLETED|Overall Study||14
138798|NCT01154322|336566|P1|STARTED|Overall Study||16
138799|NCT01154296|336573|P2|NOT COMPLETED|6-month Follow-up||328
138800|NCT01154296|336574|P1|NOT COMPLETED|6-month Follow-up||328
138801|NCT01154296|336573|P2|COMPLETED|6-month Follow-up||2179
138802|NCT01154296|336574|P1|COMPLETED|6-month Follow-up||2177
138803|NCT01154296|336573|P2|STARTED|6-month Follow-up||2507
138804|NCT01154296|336574|P1|STARTED|6-month Follow-up||2505
138805|NCT01154296|336573|P2|NOT COMPLETED|Randomization and Intervention||2
138806|NCT01154296|336574|P1|NOT COMPLETED|Randomization and Intervention||5
138807|NCT01154296|336573|P2|COMPLETED|Randomization and Intervention||2505
138808|NCT01154296|336574|P1|COMPLETED|Randomization and Intervention||2500
138809|NCT01154296|336573|P2|STARTED|Randomization and Intervention||2507
138810|NCT01154296|336574|P1|STARTED|Randomization and Intervention||2505
138811|NCT01154283|336592|P2|NOT COMPLETED|7-12 Weeks||1
138812|NCT01154283|336593|P1|NOT COMPLETED|7-12 Weeks||1
138813|NCT01154283|336592|P2|COMPLETED|7-12 Weeks||10
138814|NCT01154283|336593|P1|COMPLETED|7-12 Weeks||6
138815|NCT01154283|336592|P2|STARTED|7-12 Weeks||11
138816|NCT01154283|336593|P1|STARTED|7-12 Weeks||7
138817|NCT01154283|336592|P2|NOT COMPLETED|0-6 Weeks||3
138818|NCT01154283|336593|P1|NOT COMPLETED|0-6 Weeks||7
138819|NCT01154283|336592|P2|COMPLETED|0-6 Weeks||11
138820|NCT01154283|336593|P1|COMPLETED|0-6 Weeks||7
138821|NCT01154283|336592|P2|STARTED|0-6 Weeks||14
138822|NCT01154283|336593|P1|STARTED|0-6 Weeks||14
138823|NCT01154231|336605|P1|NOT COMPLETED|Overall Study||2
138824|NCT01154231|336605|P1|COMPLETED|Overall Study||312
138825|NCT01154231|336605|P1|STARTED|Overall Study||314
138826|NCT01154218|336611|P4|NOT COMPLETED|Fourth Intervention Period||0
138827|NCT01154218|336612|P3|NOT COMPLETED|Fourth Intervention Period||0
138828|NCT01154218|336613|P2|NOT COMPLETED|Fourth Intervention Period||0
138829|NCT01154218|336614|P1|NOT COMPLETED|Fourth Intervention Period||1
138830|NCT01154218|336611|P4|COMPLETED|Fourth Intervention Period||8
138831|NCT01154218|336612|P3|COMPLETED|Fourth Intervention Period||9
138832|NCT01154218|336613|P2|COMPLETED|Fourth Intervention Period||8
138833|NCT01154218|336614|P1|COMPLETED|Fourth Intervention Period||8
138834|NCT01154218|336611|P4|STARTED|Fourth Intervention Period||8
138835|NCT01154218|336612|P3|STARTED|Fourth Intervention Period||9
138836|NCT01154218|336613|P2|STARTED|Fourth Intervention Period||8
138837|NCT01154218|336614|P1|STARTED|Fourth Intervention Period||9
138838|NCT01154218|336611|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
138839|NCT01154218|336612|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138840|NCT01154218|336613|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138841|NCT01154218|336614|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138842|NCT01154218|336611|P4|COMPLETED|Washout Period (at Least 14 Days)||8
138843|NCT01154218|336612|P3|COMPLETED|Washout Period (at Least 14 Days)||9
138844|NCT01154218|336613|P2|COMPLETED|Washout Period (at Least 14 Days)||8
138845|NCT01154218|336614|P1|COMPLETED|Washout Period (at Least 14 Days)||9
138846|NCT01154218|336611|P4|STARTED|Washout Period (at Least 14 Days)||9
138847|NCT01154218|336612|P3|STARTED|Washout Period (at Least 14 Days)||9
138848|NCT01154218|336613|P2|STARTED|Washout Period (at Least 14 Days)||8
138849|NCT01154218|336614|P1|STARTED|Washout Period (at Least 14 Days)||9
138850|NCT01154218|336611|P4|NOT COMPLETED|Third Intervention Period||0
138851|NCT01154218|336612|P3|NOT COMPLETED|Third Intervention Period||0
138852|NCT01154218|336613|P2|NOT COMPLETED|Third Intervention Period||1
138853|NCT01154218|336614|P1|NOT COMPLETED|Third Intervention Period||0
138854|NCT01154218|336611|P4|COMPLETED|Third Intervention Period||9
138855|NCT01154218|336612|P3|COMPLETED|Third Intervention Period||9
138856|NCT01154218|336613|P2|COMPLETED|Third Intervention Period||8
138857|NCT01154218|336614|P1|COMPLETED|Third Intervention Period||9
138858|NCT01154218|336611|P4|STARTED|Third Intervention Period||9
138859|NCT01154218|336612|P3|STARTED|Third Intervention Period||9
138860|NCT01154218|336613|P2|STARTED|Third Intervention Period||9
138861|NCT01154218|336614|P1|STARTED|Third Intervention Period||9
138862|NCT01154218|336611|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138863|NCT01154218|336612|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138864|NCT01154218|336613|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138865|NCT01154218|336614|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138866|NCT01154218|336611|P4|COMPLETED|Washout Period (at Least 14 Days)||9
138867|NCT01154218|336612|P3|COMPLETED|Washout Period (at Least 14 Days)||9
138868|NCT01154218|336613|P2|COMPLETED|Washout Period (at Least 14 Days)||9
138869|NCT01154218|336614|P1|COMPLETED|Washout Period (at Least 14 Days)||9
138870|NCT01154218|336611|P4|STARTED|Washout Period (at Least 14 Days)||9
138871|NCT01154218|336612|P3|STARTED|Washout Period (at Least 14 Days)||9
138872|NCT01154218|336613|P2|STARTED|Washout Period (at Least 14 Days)||9
138873|NCT01154218|336614|P1|STARTED|Washout Period (at Least 14 Days)||9
138874|NCT01154218|336611|P4|NOT COMPLETED|Second Intervention Period||0
138875|NCT01154218|336612|P3|NOT COMPLETED|Second Intervention Period||0
138876|NCT01154218|336613|P2|NOT COMPLETED|Second Intervention Period||0
138877|NCT01154218|336614|P1|NOT COMPLETED|Second Intervention Period||0
138878|NCT01154218|336611|P4|COMPLETED|Second Intervention Period||9
138879|NCT01154218|336612|P3|COMPLETED|Second Intervention Period||9
138880|NCT01154218|336613|P2|COMPLETED|Second Intervention Period||9
138881|NCT01154218|336614|P1|COMPLETED|Second Intervention Period||9
138882|NCT01154218|336611|P4|STARTED|Second Intervention Period||9
138883|NCT01154218|336612|P3|STARTED|Second Intervention Period||9
138884|NCT01154218|336613|P2|STARTED|Second Intervention Period||9
138885|NCT01154218|336614|P1|STARTED|Second Intervention Period||9
138886|NCT01154218|336611|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138887|NCT01154218|336612|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138888|NCT01154218|336613|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138889|NCT01154218|336614|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
138890|NCT01154218|336611|P4|COMPLETED|Washout Period (at Least 14 Days)||9
138891|NCT01154218|336612|P3|COMPLETED|Washout Period (at Least 14 Days)||9
138892|NCT01154218|336613|P2|COMPLETED|Washout Period (at Least 14 Days)||9
138893|NCT01154218|336614|P1|COMPLETED|Washout Period (at Least 14 Days)||9
138894|NCT01154218|336611|P4|STARTED|Washout Period (at Least 14 Days)||9
138895|NCT01154218|336612|P3|STARTED|Washout Period (at Least 14 Days)||9
138896|NCT01154218|336613|P2|STARTED|Washout Period (at Least 14 Days)||9
138897|NCT01154218|336614|P1|STARTED|Washout Period (at Least 14 Days)||9
138898|NCT01154218|336611|P4|NOT COMPLETED|First Intervention Period||0
138899|NCT01154218|336612|P3|NOT COMPLETED|First Intervention Period||0
138900|NCT01154218|336613|P2|NOT COMPLETED|First Intervention Period||0
138901|NCT01154218|336614|P1|NOT COMPLETED|First Intervention Period||0
138902|NCT01154218|336611|P4|COMPLETED|First Intervention Period||9
138903|NCT01154218|336612|P3|COMPLETED|First Intervention Period||9
138904|NCT01154218|336613|P2|COMPLETED|First Intervention Period||9
138905|NCT01154218|336614|P1|COMPLETED|First Intervention Period||9
138906|NCT01154218|336611|P4|STARTED|First Intervention Period||9
138907|NCT01154218|336612|P3|STARTED|First Intervention Period||9
138908|NCT01154218|336613|P2|STARTED|First Intervention Period||9
138909|NCT01154218|336614|P1|STARTED|First Intervention Period||9
138910|NCT01154166|336666|P2|NOT COMPLETED|Overall Study||12
138911|NCT01154166|336667|P1|NOT COMPLETED|Overall Study||34
138912|NCT01154166|336666|P2|COMPLETED|Overall Study||163
138913|NCT01154166|336667|P1|COMPLETED|Overall Study||135
138914|NCT01154166|336666|P2|STARTED|Overall Study||175
138915|NCT01154166|336667|P1|STARTED|Overall Study||169
138916|NCT01154153|336699|P2|NOT COMPLETED|Overall Study||3
138917|NCT01154153|336700|P1|NOT COMPLETED|Overall Study||5
138918|NCT01154153|336699|P2|COMPLETED|Overall Study||66
138919|NCT01154153|336700|P1|COMPLETED|Overall Study||66
138920|NCT01154153|336699|P2|STARTED|Overall Study||69
138921|NCT01154153|336700|P1|STARTED|Overall Study||71
138922|NCT01154140|336718|P2|NOT COMPLETED|Overall Study||102
138923|NCT01154140|336719|P1|NOT COMPLETED|Overall Study||91
138924|NCT01154140|336718|P2|COMPLETED|Overall Study||69
138925|NCT01154140|336719|P1|COMPLETED|Overall Study||81
138926|NCT01154140|336718|P2|Treated|Overall Study||169
138927|NCT01154140|336719|P1|Treated|Overall Study||171
138928|NCT01154140|336718|P2|STARTED|Overall Study||171
138929|NCT01154140|336719|P1|STARTED|Overall Study||172
138930|NCT01154127|336772|P2|NOT COMPLETED|Period 2 (21 Days)||1
138931|NCT01154127|336773|P1|NOT COMPLETED|Period 2 (21 Days)||0
138932|NCT01154127|336772|P2|COMPLETED|Period 2 (21 Days)||46
138933|NCT01154127|336773|P1|COMPLETED|Period 2 (21 Days)||49
138934|NCT01154127|336772|P2|STARTED|Period 2 (21 Days)||47
138935|NCT01154127|336773|P1|STARTED|Period 2 (21 Days)||49
138936|NCT01154127|336772|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
138937|NCT01154127|336773|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
138938|NCT01154127|336772|P2|COMPLETED|Washout (14 - 28 Days)||47
138939|NCT01154127|336773|P1|COMPLETED|Washout (14 - 28 Days)||49
138940|NCT01154127|336772|P2|STARTED|Washout (14 - 28 Days)||47
138941|NCT01154127|336773|P1|STARTED|Washout (14 - 28 Days)||52
138942|NCT01154127|336772|P2|NOT COMPLETED|Period 1 (21 Days)||6
138943|NCT01154127|336773|P1|NOT COMPLETED|Period 1 (21 Days)||3
138944|NCT01154127|336772|P2|COMPLETED|Period 1 (21 Days)||47
138945|NCT01154127|336773|P1|COMPLETED|Period 1 (21 Days)||52
138946|NCT01154127|336772|P2|STARTED|Period 1 (21 Days)||53
138947|NCT01154127|336773|P1|STARTED|Period 1 (21 Days)||55
138948|NCT01154101|336800|P5|NOT COMPLETED|Overall Study||1
138949|NCT01154101|336801|P4|NOT COMPLETED|Overall Study||2
138950|NCT01154101|336802|P3|NOT COMPLETED|Overall Study||3
138951|NCT01154101|336803|P2|NOT COMPLETED|Overall Study||4
138952|NCT01154101|336804|P1|NOT COMPLETED|Overall Study||0
138953|NCT01154101|336800|P5|COMPLETED|Overall Study||0
138954|NCT01154101|336801|P4|COMPLETED|Overall Study||9
138955|NCT01154101|336802|P3|COMPLETED|Overall Study||9
138956|NCT01154101|336803|P2|COMPLETED|Overall Study||5
138957|NCT01154101|336804|P1|COMPLETED|Overall Study||7
138958|NCT01154101|336800|P5|STARTED|Overall Study||1
138959|NCT01154101|336801|P4|STARTED|Overall Study||11
138960|NCT01154101|336802|P3|STARTED|Overall Study||12
138961|NCT01154101|336803|P2|STARTED|Overall Study||9
138962|NCT01154101|336804|P1|STARTED|Overall Study||7
138963|NCT01154036|336859|P8|NOT COMPLETED|Phase II||6
138964|NCT01154036|336860|P7|NOT COMPLETED|Phase II||9
138965|NCT01154036|336861|P6|NOT COMPLETED|Phase II||5
138966|NCT01154036|336862|P5|NOT COMPLETED|Phase II||8
138967|NCT01154036|336863|P4|NOT COMPLETED|Phase II||1
138968|NCT01154036|336864|P3|NOT COMPLETED|Phase II||0
138969|NCT01154036|336865|P2|NOT COMPLETED|Phase II||0
138970|NCT01154036|336866|P1|NOT COMPLETED|Phase II||0
138971|NCT01154036|336859|P8|COMPLETED|Phase II||200
138972|NCT01154036|336860|P7|COMPLETED|Phase II||225
138973|NCT01154036|336861|P6|COMPLETED|Phase II||121
138974|NCT01154036|336862|P5|COMPLETED|Phase II||116
138975|NCT01154036|336863|P4|COMPLETED|Phase II||27
138976|NCT01154036|336864|P3|COMPLETED|Phase II||0
138977|NCT01154036|336865|P2|COMPLETED|Phase II||0
138978|NCT01154036|336866|P1|COMPLETED|Phase II||0
138979|NCT01154036|336859|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
138980|NCT01154036|336860|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
138981|NCT01154036|336861|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
138982|NCT01154036|336862|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
138983|NCT01154036|336863|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
138984|NCT01154036|336864|P3|STARTED|Phase II||0
138985|NCT01154036|336865|P2|STARTED|Phase II||0
138986|NCT01154036|336866|P1|STARTED|Phase II||0
138987|NCT01154036|336859|P8|NOT COMPLETED|Phase I||0
138988|NCT01154036|336860|P7|NOT COMPLETED|Phase I||0
138989|NCT01154036|336861|P6|NOT COMPLETED|Phase I||0
138990|NCT01154036|336862|P5|NOT COMPLETED|Phase I||0
138991|NCT01154036|336863|P4|NOT COMPLETED|Phase I||0
138992|NCT01154036|336864|P3|NOT COMPLETED|Phase I||56
138993|NCT01154036|336865|P2|NOT COMPLETED|Phase I||28
138994|NCT01154036|336866|P1|NOT COMPLETED|Phase I||3
138995|NCT01154036|336859|P8|COMPLETED|Phase I||0
138996|NCT01154036|336860|P7|COMPLETED|Phase I||0
138997|NCT01154036|336861|P6|COMPLETED|Phase I||0
138998|NCT01154036|336862|P5|COMPLETED|Phase I||0
138999|NCT01154036|336863|P4|COMPLETED|Phase I||0
139000|NCT01154036|336864|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
139001|NCT01154036|336865|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
139002|NCT01154036|336866|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
139003|NCT01154036|336859|P8|STARTED|Phase I||0
139004|NCT01154036|336860|P7|STARTED|Phase I||0
139005|NCT01154036|336861|P6|STARTED|Phase I||0
139006|NCT01154036|336862|P5|STARTED|Phase I||0
139007|NCT01154036|336863|P4|STARTED|Phase I||0
139008|NCT01154036|336864|P3|STARTED|Phase I||944
139009|NCT01154036|336865|P2|STARTED|Phase I||483
139010|NCT01154036|336866|P1|STARTED|Phase I||120
139011|NCT01154010|336990|P2|NOT COMPLETED|Overall Study||1
139012|NCT01154010|336991|P1|NOT COMPLETED|Overall Study||0
139013|NCT01154010|336990|P2|COMPLETED|Overall Study||8
139014|NCT01154010|336991|P1|COMPLETED|Overall Study||9
139015|NCT01154010|336990|P2|STARTED|Overall Study||9
139016|NCT01154010|336991|P1|STARTED|Overall Study||9
139017|NCT01153984|336997|P1|NOT COMPLETED|Overall Study||2
139018|NCT01153984|336997|P1|COMPLETED|Overall Study||21
139019|NCT01153984|336997|P1|STARTED|Overall Study||23
139020|NCT01153971|337008|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
139021|NCT01153971|337008|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
139022|NCT01153971|337008|P1|STARTED|Follow-up (Months 17-40 of Study)||41
139023|NCT01153971|337008|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
139024|NCT01153971|337008|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
139025|NCT01153971|337008|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
139026|NCT01153971|337008|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
139027|NCT01153971|337008|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
139028|NCT01153971|337008|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
139029|NCT01153958|337031|P2|NOT COMPLETED|Overall Study||32
139030|NCT01153958|337032|P1|NOT COMPLETED|Overall Study||36
139031|NCT01153958|337031|P2|COMPLETED|Overall Study||35
139032|NCT01153958|337032|P1|COMPLETED|Overall Study||30
139033|NCT01153958|337031|P2|STARTED|Overall Study||67
139034|NCT01153958|337032|P1|STARTED|Overall Study||66
139035|NCT01153893|337050|P2|NOT COMPLETED|Overall Study||0
139036|NCT01153893|337051|P1|NOT COMPLETED|Overall Study||1
139037|NCT01153893|337050|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
139038|NCT01153893|337051|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
139039|NCT01153893|337050|P2|STARTED|Overall Study||36
139040|NCT01153893|337051|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
139041|NCT01153841|337077|P2|NOT COMPLETED|Overall Study||0
139042|NCT01153841|337078|P1|NOT COMPLETED|Overall Study||6
139043|NCT01153841|337077|P2|COMPLETED|Overall Study||99
139044|NCT01153841|337078|P1|COMPLETED|Overall Study||193
139045|NCT01153841|337077|P2|STARTED|Overall Study||99
139046|NCT01153841|337078|P1|STARTED|Overall Study||199
139047|NCT01153815|337094|P2|NOT COMPLETED|Overall Study||5
139048|NCT01153815|337095|P1|NOT COMPLETED|Overall Study||9
139049|NCT01153815|337094|P2|COMPLETED|Overall Study||82
139050|NCT01153815|337095|P1|COMPLETED|Overall Study||74
139051|NCT01153815|337094|P2|STARTED|Overall Study||87
139052|NCT01153815|337095|P1|STARTED|Overall Study||83
139053|NCT01153763|337117|P1|NOT COMPLETED|Overall Study||21
139054|NCT01153763|337117|P1|COMPLETED|Overall Study||71
139055|NCT01153763|337117|P1|STARTED|Overall Study||92
139056|NCT01153724|337133|P1|NOT COMPLETED|Treatment Period 2||2
139057|NCT01153724|337133|P1|COMPLETED|Treatment Period 2||32
139058|NCT01153724|337133|P1|STARTED|Treatment Period 2||34
139059|NCT01153724|337133|P1|NOT COMPLETED|Treatment Period 1||1
139060|NCT01153724|337133|P1|COMPLETED|Treatment Period 1||34
139061|NCT01153724|337133|P1|STARTED|Treatment Period 1||35
139062|NCT01153711|337153|P1|NOT COMPLETED|Overall Study||0
139063|NCT01153711|337153|P1|COMPLETED|Overall Study||32
139064|NCT01153711|337153|P1|STARTED|Overall Study||32
139065|NCT01153698|337173|P1|NOT COMPLETED|Overall Study||29
139066|NCT01153698|337173|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
139067|NCT01153698|337173|P1|STARTED|Overall Study|Entered and treated.|168
139068|NCT01153685|337189|P2|NOT COMPLETED|Overall Study||0
139069|NCT01153685|337190|P1|NOT COMPLETED|Overall Study||0
139070|NCT01153685|337189|P2|COMPLETED|Overall Study||70
139071|NCT01153685|337190|P1|COMPLETED|Overall Study||50
139072|NCT01153685|337189|P2|STARTED|Overall Study||70
139073|NCT01153685|337190|P1|STARTED|Overall Study||50
139074|NCT01153672|337214|P1|NOT COMPLETED|Overall Study||2
139075|NCT01153672|337214|P1|COMPLETED|Overall Study||6
139076|NCT01153672|337214|P1|STARTED|Overall Study||8
139077|NCT01153633|337224|P2|NOT COMPLETED|Overall Study||4
139078|NCT01153633|337225|P1|NOT COMPLETED|Overall Study||4
139079|NCT01153633|337224|P2|COMPLETED|Overall Study||13
139080|NCT01153633|337225|P1|COMPLETED|Overall Study||13
139081|NCT01153633|337224|P2|STARTED|Overall Study||17
139082|NCT01153633|337225|P1|STARTED|Overall Study||17
139083|NCT01153620|337243|P2|NOT COMPLETED|Overall Study||0
139084|NCT01153620|337244|P1|NOT COMPLETED|Overall Study||0
139085|NCT01153620|337243|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
139086|NCT01153620|337244|P1|COMPLETED|Overall Study||30
139087|NCT01153620|337243|P2|STARTED|Overall Study|30 patients (31 wounds)|30
139088|NCT01153620|337244|P1|STARTED|Overall Study||30
139089|NCT01153581|337250|P1|NOT COMPLETED|Overall Study||0
139090|NCT01153581|337250|P1|COMPLETED|Overall Study||109
139091|NCT01153581|337250|P1|STARTED|Overall Study||109
139092|NCT01153503|337263|P3|NOT COMPLETED|Overall Study||0
139093|NCT01153503|337264|P2|NOT COMPLETED|Overall Study||1
139094|NCT01153503|337265|P1|NOT COMPLETED|Overall Study||0
139095|NCT01153503|337263|P3|COMPLETED|Overall Study||25
139096|NCT01153503|337264|P2|COMPLETED|Overall Study||24
139097|NCT01153503|337265|P1|COMPLETED|Overall Study||25
139098|NCT01153503|337263|P3|STARTED|Overall Study||25
139099|NCT01153503|337264|P2|STARTED|Overall Study||25
139100|NCT01153503|337265|P1|STARTED|Overall Study||25
139101|NCT01153425|337275|P2|NOT COMPLETED|Overall Study||3
139102|NCT01153425|337276|P1|NOT COMPLETED|Overall Study||3
139103|NCT01153425|337275|P2|COMPLETED|Overall Study||14
139104|NCT01153425|337276|P1|COMPLETED|Overall Study||13
139105|NCT01153425|337275|P2|STARTED|Overall Study||17
139106|NCT01153425|337276|P1|STARTED|Overall Study||16
139107|NCT01153347|337288|P4|NOT COMPLETED|Overall Study||32
139108|NCT01153347|337289|P3|NOT COMPLETED|Overall Study||50
139109|NCT01153347|337290|P2|NOT COMPLETED|Overall Study||44
139110|NCT01153347|337291|P1|NOT COMPLETED|Overall Study||33
139111|NCT01153347|337288|P4|COMPLETED|Overall Study||129
139112|NCT01153347|337289|P3|COMPLETED|Overall Study||110
139113|NCT01153347|337290|P2|COMPLETED|Overall Study||116
139114|NCT01153347|337291|P1|COMPLETED|Overall Study||127
139115|NCT01153347|337288|P4|Received Treatment|Overall Study||160
139116|NCT01153347|337289|P3|Received Treatment|Overall Study||158
139117|NCT01153347|337290|P2|Received Treatment|Overall Study||158
139118|NCT01153347|337291|P1|Received Treatment|Overall Study||160
139119|NCT01153347|337288|P4|STARTED|Overall Study||161
139120|NCT01153347|337289|P3|STARTED|Overall Study||160
139121|NCT01153347|337290|P2|STARTED|Overall Study||160
139122|NCT01153347|337291|P1|STARTED|Overall Study||160
139123|NCT01153321|337391|P2|NOT COMPLETED|Overall Study||3
139124|NCT01153321|337392|P1|NOT COMPLETED|Overall Study||1
139125|NCT01153321|337391|P2|COMPLETED|Overall Study||19
139126|NCT01153321|337392|P1|COMPLETED|Overall Study||21
139127|NCT01153321|337391|P2|STARTED|Overall Study||22
139128|NCT01153321|337392|P1|STARTED|Overall Study||22
139129|NCT01153269|337504|P1|NOT COMPLETED|Overall Study||2
139130|NCT01153269|337504|P1|COMPLETED|Overall Study||31
139131|NCT01153269|337504|P1|Participants Analyzed|Overall Study||33
139132|NCT01153269|337504|P1|STARTED|Overall Study||33
139133|NCT01153009|337567|P4|NOT COMPLETED|Overall Study||37
139134|NCT01153009|337568|P3|NOT COMPLETED|Overall Study||41
139135|NCT01153009|337569|P2|NOT COMPLETED|Overall Study||34
139136|NCT01153009|337570|P1|NOT COMPLETED|Overall Study||32
139137|NCT01153009|337567|P4|COMPLETED|Overall Study||115
139138|NCT01153009|337568|P3|COMPLETED|Overall Study||113
139139|NCT01153009|337569|P2|COMPLETED|Overall Study||113
139140|NCT01153009|337570|P1|COMPLETED|Overall Study||129
139141|NCT01153009|337567|P4|Treated|Overall Study||150
139142|NCT01153009|337568|P3|Treated|Overall Study||154
139143|NCT01153009|337569|P2|Treated|Overall Study||147
139144|NCT01153009|337570|P1|Treated|Overall Study||159
139145|NCT01153009|337567|P4|STARTED|Overall Study||152
139146|NCT01153009|337568|P3|STARTED|Overall Study||154
139147|NCT01153009|337569|P2|STARTED|Overall Study||147
139148|NCT01153009|337570|P1|STARTED|Overall Study||161
139149|NCT01152996|337600|P1|NOT COMPLETED|Overall Study||537
139150|NCT01152996|337600|P1|COMPLETED|Overall Study||538
139151|NCT01152996|337600|P1|Treated|Overall Study||1073
139152|NCT01152996|337600|P1|STARTED|Overall Study||1075
139153|NCT01152814|337613|P1|NOT COMPLETED|Overall Study||2
139154|NCT01152814|337613|P1|COMPLETED|Overall Study||62
139155|NCT01152814|337613|P1|STARTED|Overall Study||64
139156|NCT01152788|337622|P2|NOT COMPLETED|Overall Study||4
139157|NCT01152788|337623|P1|NOT COMPLETED|Overall Study||0
139158|NCT01152788|337622|P2|COMPLETED|Overall Study||28
139159|NCT01152788|337623|P1|COMPLETED|Overall Study||32
139160|NCT01152788|337622|P2|STARTED|Overall Study||32
139161|NCT01152788|337623|P1|STARTED|Overall Study||32
139162|NCT01152697|337635|P1|NOT COMPLETED|Overall Study||19
139163|NCT01152697|337635|P1|COMPLETED|Overall Study||11
139164|NCT01152697|337635|P1|STARTED|Overall Study||30
139165|NCT01152580|337660|P2|NOT COMPLETED|Overall Study||1
139166|NCT01152580|337661|P1|NOT COMPLETED|Overall Study||0
139167|NCT01152580|337660|P2|COMPLETED|Overall Study||13
139168|NCT01152580|337661|P1|COMPLETED|Overall Study||5
139169|NCT01152580|337660|P2|STARTED|Overall Study||14
139170|NCT01152580|337661|P1|STARTED|Overall Study||5
139171|NCT01152554|337683|P2|NOT COMPLETED|Overall Study||111
139172|NCT01152554|337684|P1|NOT COMPLETED|Overall Study||334
139173|NCT01152554|337683|P2|COMPLETED|Overall Study||92
139174|NCT01152554|337684|P1|COMPLETED|Overall Study||276
139175|NCT01152554|337683|P2|Received Treatment|Overall Study||201
139176|NCT01152554|337684|P1|Received Treatment|Overall Study||607
139177|NCT01152554|337683|P2|STARTED|Overall Study||203
139178|NCT01152554|337684|P1|STARTED|Overall Study||610
139179|NCT01152450|337706|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
139180|NCT01152450|337707|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
139181|NCT01152450|337708|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
139182|NCT01152450|337709|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
139183|NCT01152450|337710|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
139184|NCT01152450|337711|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
139185|NCT01152450|337706|P6|COMPLETED|Period 3 (4 Weeks)||12
139186|NCT01152450|337707|P5|COMPLETED|Period 3 (4 Weeks)||16
139187|NCT01152450|337708|P4|COMPLETED|Period 3 (4 Weeks)||15
139188|NCT01152450|337709|P3|COMPLETED|Period 3 (4 Weeks)||16
139189|NCT01152450|337710|P2|COMPLETED|Period 3 (4 Weeks)||15
139190|NCT01152450|337711|P1|COMPLETED|Period 3 (4 Weeks)||15
139191|NCT01152450|337706|P6|STARTED|Period 3 (4 Weeks)||12
139192|NCT01152450|337707|P5|STARTED|Period 3 (4 Weeks)||16
139193|NCT01152450|337708|P4|STARTED|Period 3 (4 Weeks)||15
139194|NCT01152450|337709|P3|STARTED|Period 3 (4 Weeks)||16
139195|NCT01152450|337710|P2|STARTED|Period 3 (4 Weeks)||15
139196|NCT01152450|337711|P1|STARTED|Period 3 (4 Weeks)||15
139197|NCT01152450|337706|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
139198|NCT01152450|337707|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
139199|NCT01152450|337708|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
139200|NCT01152450|337709|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
139201|NCT01152450|337710|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
139202|NCT01152450|337711|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
139203|NCT01152450|337706|P6|COMPLETED|Period 2 (4 Weeks)||12
139204|NCT01152450|337707|P5|COMPLETED|Period 2 (4 Weeks)||16
139205|NCT01152450|337708|P4|COMPLETED|Period 2 (4 Weeks)||15
139206|NCT01152450|337709|P3|COMPLETED|Period 2 (4 Weeks)||16
139207|NCT01152450|337710|P2|COMPLETED|Period 2 (4 Weeks)||15
139208|NCT01152450|337711|P1|COMPLETED|Period 2 (4 Weeks)||15
139209|NCT01152450|337706|P6|STARTED|Period 2 (4 Weeks)||12
139210|NCT01152450|337707|P5|STARTED|Period 2 (4 Weeks)||16
139211|NCT01152450|337708|P4|STARTED|Period 2 (4 Weeks)||15
139212|NCT01152450|337709|P3|STARTED|Period 2 (4 Weeks)||16
139213|NCT01152450|337710|P2|STARTED|Period 2 (4 Weeks)||15
139214|NCT01152450|337711|P1|STARTED|Period 2 (4 Weeks)||15
139215|NCT01152450|337706|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
139216|NCT01152450|337707|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
139217|NCT01152450|337708|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
139218|NCT01152450|337709|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
139219|NCT01152450|337710|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
139220|NCT01152450|337711|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
139221|NCT01152450|337706|P6|COMPLETED|Period 1 (4 Weeks)||12
139222|NCT01152450|337707|P5|COMPLETED|Period 1 (4 Weeks)||16
139223|NCT01152450|337708|P4|COMPLETED|Period 1 (4 Weeks)||15
139224|NCT01152450|337709|P3|COMPLETED|Period 1 (4 Weeks)||16
139225|NCT01152450|337710|P2|COMPLETED|Period 1 (4 Weeks)||15
139226|NCT01152450|337711|P1|COMPLETED|Period 1 (4 Weeks)||15
139227|NCT01152450|337706|P6|STARTED|Period 1 (4 Weeks)||13
139228|NCT01152450|337707|P5|STARTED|Period 1 (4 Weeks)||18
139229|NCT01152450|337708|P4|STARTED|Period 1 (4 Weeks)||15
139230|NCT01152450|337709|P3|STARTED|Period 1 (4 Weeks)||17
139231|NCT01152450|337710|P2|STARTED|Period 1 (4 Weeks)||16
139232|NCT01152450|337711|P1|STARTED|Period 1 (4 Weeks)||15
139233|NCT01152437|337782|P3|NOT COMPLETED|Overall Study||43
139234|NCT01152437|337783|P2|NOT COMPLETED|Overall Study||15
139235|NCT01152437|337784|P1|NOT COMPLETED|Overall Study||36
139236|NCT01152437|337782|P3|COMPLETED|Overall Study||0
139237|NCT01152437|337783|P2|COMPLETED|Overall Study||0
139238|NCT01152437|337784|P1|COMPLETED|Overall Study||0
139239|NCT01152437|337782|P3|STARTED|Overall Study|entered|43
139240|NCT01152437|337783|P2|STARTED|Overall Study|randomised|15
139241|NCT01152437|337784|P1|STARTED|Overall Study|randomised|36
139242|NCT01152385|337804|P4|NOT COMPLETED|Overall Study||5
139243|NCT01152385|337805|P3|NOT COMPLETED|Overall Study||5
139244|NCT01152385|337806|P2|NOT COMPLETED|Overall Study||6
139245|NCT01152385|337807|P1|NOT COMPLETED|Overall Study||9
139246|NCT01152385|337804|P4|COMPLETED|Overall Study||50
139247|NCT01152385|337805|P3|COMPLETED|Overall Study||51
139248|NCT01152385|337806|P2|COMPLETED|Overall Study||52
139249|NCT01152385|337807|P1|COMPLETED|Overall Study||46
139250|NCT01152385|337804|P4|STARTED|Overall Study||55
139251|NCT01152385|337805|P3|STARTED|Overall Study||56
139252|NCT01152385|337806|P2|STARTED|Overall Study||58
139253|NCT01152385|337807|P1|STARTED|Overall Study||55
139254|NCT01152359|337847|P2|NOT COMPLETED|Overall Study||22
139255|NCT01152359|337848|P1|NOT COMPLETED|Overall Study||24
139256|NCT01152359|337847|P2|COMPLETED|Overall Study||80
139257|NCT01152359|337848|P1|COMPLETED|Overall Study||81
139258|NCT01152359|337847|P2|STARTED|Overall Study||102
139259|NCT01152359|337848|P1|STARTED|Overall Study||105
139260|NCT01152307|337856|P2|NOT COMPLETED|Overall Study||0
139261|NCT01152307|337857|P1|NOT COMPLETED|Overall Study||0
139262|NCT01152307|337856|P2|COMPLETED|Overall Study||214
139263|NCT01152307|337857|P1|COMPLETED|Overall Study||191
139264|NCT01152307|337856|P2|STARTED|Overall Study||214
139265|NCT01152307|337857|P1|STARTED|Overall Study||191
139266|NCT01152294|337865|P2|NOT COMPLETED|Overall Study||0
139267|NCT01152294|337866|P1|NOT COMPLETED|Overall Study||0
139268|NCT01152294|337865|P2|COMPLETED|Overall Study||188
139269|NCT01152294|337866|P1|COMPLETED|Overall Study||213
139270|NCT01152294|337865|P2|STARTED|Overall Study||188
139271|NCT01152294|337866|P1|STARTED|Overall Study||213
139272|NCT01152190|337874|P2|NOT COMPLETED|Overall Study||8
139273|NCT01152190|337875|P1|NOT COMPLETED|Overall Study||5
139274|NCT01152190|337874|P2|COMPLETED|Overall Study||39
139275|NCT01152190|337875|P1|COMPLETED|Overall Study||45
139276|NCT01152190|337874|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
139277|NCT01152190|337875|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
139278|NCT01152190|337874|P2|STARTED|Overall Study||47
139279|NCT01152190|337875|P1|STARTED|Overall Study||50
139280|NCT01152112|337889|P2|NOT COMPLETED|Overall Study||0
139281|NCT01152112|337890|P1|NOT COMPLETED|Overall Study||0
139282|NCT01152112|337889|P2|COMPLETED|Overall Study||32
139283|NCT01152112|337890|P1|COMPLETED|Overall Study||42
139284|NCT01152112|337889|P2|STARTED|Overall Study||32
139285|NCT01152112|337890|P1|STARTED|Overall Study||42
139286|NCT01151904|337896|P1|NOT COMPLETED|Overall Study||0
139287|NCT01151904|337896|P1|COMPLETED|Overall Study||17
139288|NCT01151904|337896|P1|STARTED|Overall Study||17
139289|NCT01151852|337904|P2|NOT COMPLETED|Overall Study||0
139290|NCT01151852|337905|P1|NOT COMPLETED|Overall Study||0
139291|NCT01151852|337904|P2|COMPLETED|Overall Study||40
139292|NCT01151852|337905|P1|COMPLETED|Overall Study||41
139293|NCT01151852|337904|P2|STARTED|Overall Study||40
139294|NCT01151852|337905|P1|STARTED|Overall Study||41
139295|NCT01151761|337921|P1|NOT COMPLETED|Overall Study||0
139296|NCT01151761|337921|P1|COMPLETED|Overall Study||2
139297|NCT01151761|337921|P1|STARTED|Overall Study||2
139298|NCT01151579|337934|P2|NOT COMPLETED|Overall Study||7
139299|NCT01151579|337935|P1|NOT COMPLETED|Overall Study||12
139300|NCT01151579|337934|P2|COMPLETED|Overall Study||24
139301|NCT01151579|337935|P1|COMPLETED|Overall Study||46
139302|NCT01151579|337934|P2|STARTED|Overall Study||31
139303|NCT01151579|337935|P1|STARTED|Overall Study||58
139304|NCT01151553|337945|P1|NOT COMPLETED|Overall Study||0
139305|NCT01151553|337945|P1|COMPLETED|Overall Study||5
139306|NCT01151553|337945|P1|STARTED|Overall Study||5
139307|NCT01151449|337949|P1|NOT COMPLETED|Overall Study||0
139308|NCT01151449|337949|P1|COMPLETED|Overall Study||6
139309|NCT01151449|337949|P1|STARTED|Overall Study||6
139310|NCT01151436|337957|P1|NOT COMPLETED|Overall Study||1
139311|NCT01151436|337957|P1|COMPLETED|Overall Study||76
139312|NCT01151436|337957|P1|STARTED|Overall Study||77
139313|NCT01151410|337989|P2|NOT COMPLETED|Overall Study||15
139314|NCT01151410|337990|P1|NOT COMPLETED|Overall Study||11
139315|NCT01151410|337989|P2|COMPLETED|Overall Study||89
139316|NCT01151410|337990|P1|COMPLETED|Overall Study||93
139317|NCT01151410|337989|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
139318|NCT01151410|337990|P1|Safety Set (SAF)|Overall Study||105
139319|NCT01151410|337989|P2|STARTED|Overall Study||104
139320|NCT01151410|337990|P1|STARTED|Overall Study||104
139321|NCT01151371|338003|P3|NOT COMPLETED|Overall Study||7
139322|NCT01151371|338004|P2|NOT COMPLETED|Overall Study||1
139323|NCT01151371|338005|P1|NOT COMPLETED|Overall Study||5
139324|NCT01151371|338003|P3|COMPLETED|Overall Study||146
139325|NCT01151371|338004|P2|COMPLETED|Overall Study||149
139326|NCT01151371|338005|P1|COMPLETED|Overall Study||144
139327|NCT01151371|338003|P3|STARTED|Overall Study||153
139328|NCT01151371|338004|P2|STARTED|Overall Study||150
139329|NCT01151371|338005|P1|STARTED|Overall Study||149
139330|NCT01151345|338034|P2|NOT COMPLETED|Second Intervention Period||0
139331|NCT01151345|338035|P1|NOT COMPLETED|Second Intervention Period||0
139332|NCT01151345|338034|P2|COMPLETED|Second Intervention Period||12
139333|NCT01151345|338035|P1|COMPLETED|Second Intervention Period||13
139334|NCT01151345|338034|P2|STARTED|Second Intervention Period||12
139335|NCT01151345|338035|P1|STARTED|Second Intervention Period||13
139336|NCT01151345|338034|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
139337|NCT01151345|338035|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
139338|NCT01151345|338034|P2|COMPLETED|Wash-out Period (7 Days)||12
139339|NCT01151345|338035|P1|COMPLETED|Wash-out Period (7 Days)||13
139340|NCT01151345|338034|P2|STARTED|Wash-out Period (7 Days)||12
139341|NCT01151345|338035|P1|STARTED|Wash-out Period (7 Days)||13
139342|NCT01151345|338034|P2|NOT COMPLETED|First Intervention Period||1
139343|NCT01151345|338035|P1|NOT COMPLETED|First Intervention Period||0
139344|NCT01151345|338034|P2|COMPLETED|First Intervention Period||12
139345|NCT01151345|338035|P1|COMPLETED|First Intervention Period||13
139346|NCT01151345|338034|P2|Treated|First Intervention Period||12
139347|NCT01151345|338035|P1|Treated|First Intervention Period||13
139348|NCT01151345|338034|P2|STARTED|First Intervention Period||13
139349|NCT01151345|338035|P1|STARTED|First Intervention Period||13
139350|NCT01151280|338049|P1|NOT COMPLETED|Overall Study||4
139351|NCT01151280|338049|P1|COMPLETED|Overall Study||6
139352|NCT01151280|338049|P1|STARTED|Overall Study||10
139353|NCT01151215|338062|P3|NOT COMPLETED|Overall Study||19
139354|NCT01151215|338063|P2|NOT COMPLETED|Overall Study||23
139355|NCT01151215|338064|P1|NOT COMPLETED|Overall Study||20
139356|NCT01151215|338062|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
139357|NCT01151215|338063|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
139358|NCT01151215|338064|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
139359|NCT01151215|338062|P3|STARTED|Overall Study||121
139360|NCT01151215|338063|P2|STARTED|Overall Study||118
139361|NCT01151215|338064|P1|STARTED|Overall Study||120
139362|NCT01151189|338077|P2|NOT COMPLETED|Overall Study||10
139363|NCT01151189|338078|P1|NOT COMPLETED|Overall Study||15
139364|NCT01151189|338077|P2|COMPLETED|Overall Study||314
139365|NCT01151189|338078|P1|COMPLETED|Overall Study||311
139366|NCT01151189|338077|P2|Received Vaccine|Overall Study||324
139367|NCT01151189|338078|P1|Received Vaccine|Overall Study||325
139368|NCT01151189|338077|P2|STARTED|Overall Study||324
139369|NCT01151189|338078|P1|STARTED|Overall Study||326
139370|NCT01151137|338102|P2|NOT COMPLETED|Overall Study||28
139371|NCT01151137|338103|P1|NOT COMPLETED|Overall Study||16
139372|NCT01151137|338102|P2|COMPLETED|Overall Study||1591
139373|NCT01151137|338103|P1|COMPLETED|Overall Study||1601
139374|NCT01151137|338102|P2|Discontinued Treatment|Overall Study||342
139375|NCT01151137|338103|P1|Discontinued Treatment|Overall Study||171
139376|NCT01151137|338102|P2|Treated|Overall Study||1613
139377|NCT01151137|338103|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
139378|NCT01151137|338102|P2|STARTED|Overall Study||1619
139379|NCT01151137|338103|P1|STARTED|Overall Study||1617
139380|NCT01151098|338121|P1|NOT COMPLETED|Overall Study||117
139381|NCT01151098|338121|P1|COMPLETED|Overall Study||72
139382|NCT01151098|338121|P1|STARTED|Overall Study|Extension Safety Population|189
139383|NCT01151085|338125|P1|NOT COMPLETED|Overall Study||56
139384|NCT01151085|338125|P1|COMPLETED|Overall Study||946
139385|NCT01151085|338125|P1|STARTED|Overall Study||1002
139386|NCT01151046|338143|P2|NOT COMPLETED|Overall Study||0
139387|NCT01151046|338144|P1|NOT COMPLETED|Overall Study||3
139388|NCT01151046|338143|P2|COMPLETED|Overall Study||59
139389|NCT01151046|338144|P1|COMPLETED|Overall Study||56
139390|NCT01151046|338143|P2|STARTED|Overall Study||59
139391|NCT01151046|338144|P1|STARTED|Overall Study||59
139392|NCT01151020|338156|P1|NOT COMPLETED|Overall Study||110
139393|NCT01151020|338156|P1|COMPLETED|Overall Study||0
139394|NCT01151020|338156|P1|12-month|Overall Study||99
139395|NCT01151020|338156|P1|30-day|Overall Study||110
139396|NCT01151020|338156|P1|STARTED|Overall Study||110
139397|NCT01150981|338163|P2|NOT COMPLETED|Overall Study||2
139398|NCT01150981|338164|P1|NOT COMPLETED|Overall Study||4
139399|NCT01150981|338163|P2|COMPLETED|Overall Study||13
139400|NCT01150981|338164|P1|COMPLETED|Overall Study||16
139401|NCT01150981|338163|P2|STARTED|Overall Study||15
139402|NCT01150981|338164|P1|STARTED|Overall Study||20
139403|NCT01150903|338174|P2|NOT COMPLETED|Overall Study||0
139404|NCT01150903|338175|P1|NOT COMPLETED|Overall Study||0
139405|NCT01150903|338174|P2|COMPLETED|Overall Study||74124
139406|NCT01150903|338175|P1|COMPLETED|Overall Study||24708
139407|NCT01150903|338174|P2|STARTED|Overall Study||74124
139408|NCT01150903|338175|P1|STARTED|Overall Study||24708
139409|NCT01150760|338191|P2|NOT COMPLETED|Overall Study||0
139410|NCT01150760|338192|P1|NOT COMPLETED|Overall Study||0
139411|NCT01150760|338191|P2|COMPLETED|Overall Study||3525
139412|NCT01150760|338192|P1|COMPLETED|Overall Study||3525
139413|NCT01150760|338191|P2|STARTED|Overall Study||3525
139414|NCT01150760|338192|P1|STARTED|Overall Study||3525
139415|NCT01150500|338224|P1|NOT COMPLETED|Overall Study||65
139416|NCT01150500|338224|P1|COMPLETED|Overall Study||0
139417|NCT01150500|338224|P1|STARTED|Overall Study||65
139418|NCT01150474|338235|P2|NOT COMPLETED|Overall Study||3
139419|NCT01150474|338236|P1|NOT COMPLETED|Overall Study||10
139420|NCT01150474|338235|P2|COMPLETED|Overall Study||49
139421|NCT01150474|338236|P1|COMPLETED|Overall Study||41
139422|NCT01150474|338235|P2|STARTED|Overall Study||52
139423|NCT01150474|338236|P1|STARTED|Overall Study||51
139424|NCT01150461|338260|P2|NOT COMPLETED|Overall Study||0
139425|NCT01150461|338261|P1|NOT COMPLETED|Overall Study||0
139426|NCT01150461|338260|P2|COMPLETED|Overall Study||9
139427|NCT01150461|338261|P1|COMPLETED|Overall Study||11
139428|NCT01150461|338260|P2|STARTED|Overall Study||9
139429|NCT01150461|338261|P1|STARTED|Overall Study||11
139430|NCT01150409|338271|P2|NOT COMPLETED|Overall Study||0
139431|NCT01150409|338272|P1|NOT COMPLETED|Overall Study||0
139432|NCT01150409|338271|P2|COMPLETED|Overall Study||0
139433|NCT01150409|338272|P1|COMPLETED|Overall Study||11
139434|NCT01150409|338271|P2|STARTED|Overall Study||0
139435|NCT01150409|338272|P1|STARTED|Overall Study||11
139436|NCT01150357|338281|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
139437|NCT01150357|338282|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
139438|NCT01150357|338283|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
139439|NCT01150357|338281|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
139440|NCT01150357|338282|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
139441|NCT01150357|338283|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
139442|NCT01150357|338281|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
139443|NCT01150357|338282|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
139444|NCT01150357|338283|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
139445|NCT01150357|338281|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
139446|NCT01150357|338282|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
139447|NCT01150357|338283|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
139448|NCT01150357|338281|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
139449|NCT01150357|338282|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
139450|NCT01150357|338283|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
139451|NCT01150357|338281|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
139452|NCT01150357|338282|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
139453|NCT01150357|338283|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
139454|NCT01150357|338281|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
139455|NCT01150357|338282|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
139456|NCT01150357|338283|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
139457|NCT01150357|338281|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
139458|NCT01150357|338282|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
139459|NCT01150357|338283|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
139460|NCT01150357|338281|P3|COMPLETED|Dose Response Phase (Phase 1)||102
139461|NCT01150357|338282|P2|COMPLETED|Dose Response Phase (Phase 1)||51
139462|NCT01150357|338283|P1|COMPLETED|Dose Response Phase (Phase 1)||107
139463|NCT01150357|338281|P3|STARTED|Dose Response Phase (Phase 1)||105
139464|NCT01150357|338282|P2|STARTED|Dose Response Phase (Phase 1)||54
139465|NCT01150357|338283|P1|STARTED|Dose Response Phase (Phase 1)||108
139466|NCT01150123|338363|P18|NOT COMPLETED|Overall Study||1
139467|NCT01150123|338364|P17|NOT COMPLETED|Overall Study||0
139468|NCT01150123|338365|P16|NOT COMPLETED|Overall Study||1
139469|NCT01150123|338366|P15|NOT COMPLETED|Overall Study||0
139470|NCT01150123|338367|P14|NOT COMPLETED|Overall Study||0
139471|NCT01150123|338368|P13|NOT COMPLETED|Overall Study||3
139472|NCT01150123|338369|P12|NOT COMPLETED|Overall Study||1
139473|NCT01150123|338370|P11|NOT COMPLETED|Overall Study||2
139474|NCT01150123|338371|P10|NOT COMPLETED|Overall Study||1
139475|NCT01150123|338372|P9|NOT COMPLETED|Overall Study||5
139476|NCT01150123|338373|P8|NOT COMPLETED|Overall Study||3
139477|NCT01150123|338374|P7|NOT COMPLETED|Overall Study||0
139478|NCT01150123|338375|P6|NOT COMPLETED|Overall Study||6
139479|NCT01150123|338376|P5|NOT COMPLETED|Overall Study||3
139480|NCT01150123|338377|P4|NOT COMPLETED|Overall Study||3
139481|NCT01150123|338378|P3|NOT COMPLETED|Overall Study||4
139482|NCT01150123|338379|P2|NOT COMPLETED|Overall Study||2
139483|NCT01150123|338380|P1|NOT COMPLETED|Overall Study||3
139484|NCT01150123|338363|P18|COMPLETED|Overall Study||19
139485|NCT01150123|338364|P17|COMPLETED|Overall Study||40
139486|NCT01150123|338365|P16|COMPLETED|Overall Study||39
139487|NCT01150123|338366|P15|COMPLETED|Overall Study||40
139488|NCT01150123|338367|P14|COMPLETED|Overall Study||40
139489|NCT01150123|338368|P13|COMPLETED|Overall Study||37
139490|NCT01150123|338369|P12|COMPLETED|Overall Study||39
139491|NCT01150123|338370|P11|COMPLETED|Overall Study||38
139492|NCT01150123|338371|P10|COMPLETED|Overall Study||39
139493|NCT01150123|338372|P9|COMPLETED|Overall Study||15
139494|NCT01150123|338373|P8|COMPLETED|Overall Study||37
139495|NCT01150123|338374|P7|COMPLETED|Overall Study||39
139496|NCT01150123|338375|P6|COMPLETED|Overall Study||34
139497|NCT01150123|338376|P5|COMPLETED|Overall Study||37
139498|NCT01150123|338377|P4|COMPLETED|Overall Study||37
139499|NCT01150123|338378|P3|COMPLETED|Overall Study||35
139500|NCT01150123|338379|P2|COMPLETED|Overall Study||38
139501|NCT01150123|338380|P1|COMPLETED|Overall Study||37
139502|NCT01150123|338363|P18|STARTED|Overall Study||20
139503|NCT01150123|338364|P17|STARTED|Overall Study||40
139504|NCT01150123|338365|P16|STARTED|Overall Study||40
139505|NCT01150123|338366|P15|STARTED|Overall Study||40
139506|NCT01150123|338367|P14|STARTED|Overall Study||40
139507|NCT01150123|338368|P13|STARTED|Overall Study||40
139508|NCT01150123|338369|P12|STARTED|Overall Study||40
139509|NCT01150123|338370|P11|STARTED|Overall Study||40
139510|NCT01150123|338371|P10|STARTED|Overall Study||40
139511|NCT01150123|338372|P9|STARTED|Overall Study||20
139512|NCT01150123|338373|P8|STARTED|Overall Study||40
139513|NCT01150123|338374|P7|STARTED|Overall Study||39
139514|NCT01150123|338375|P6|STARTED|Overall Study||40
139515|NCT01150123|338376|P5|STARTED|Overall Study||40
139516|NCT01150123|338377|P4|STARTED|Overall Study||40
139517|NCT01150123|338378|P3|STARTED|Overall Study||39
139518|NCT01150123|338379|P2|STARTED|Overall Study||40
139519|NCT01150123|338380|P1|STARTED|Overall Study||40
139520|NCT01150097|338556|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
139521|NCT01150097|338557|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
139522|NCT01150097|338558|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
139523|NCT01150097|338556|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
139524|NCT01150097|338557|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
139525|NCT01150097|338558|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
139526|NCT01150097|338556|P3|STARTED|Months 24 to 48 Post-transplantation||0
139527|NCT01150097|338557|P2|STARTED|Months 24 to 48 Post-transplantation||51
139528|NCT01150097|338558|P1|STARTED|Months 24 to 48 Post-transplantation||106
139529|NCT01150097|338556|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
139530|NCT01150097|338557|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
139531|NCT01150097|338558|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
139532|NCT01150097|338556|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
139533|NCT01150097|338557|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
139534|NCT01150097|338558|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
139535|NCT01150097|338556|P3|STARTED|Months 24 to 36 Post-transplantation||125
139536|NCT01150097|338557|P2|STARTED|Months 24 to 36 Post-transplantation||51
139537|NCT01150097|338558|P1|STARTED|Months 24 to 36 Post-transplantation||106
139538|NCT01149876|338585|P4|NOT COMPLETED|Overall Study||0
139539|NCT01149876|338586|P3|NOT COMPLETED|Overall Study||1
139540|NCT01149876|338587|P2|NOT COMPLETED|Overall Study||0
139541|NCT01149876|338588|P1|NOT COMPLETED|Overall Study||1
139542|NCT01149876|338585|P4|COMPLETED|Overall Study||18
139543|NCT01149876|338586|P3|COMPLETED|Overall Study||20
139544|NCT01149876|338587|P2|COMPLETED|Overall Study||20
139545|NCT01149876|338588|P1|COMPLETED|Overall Study||20
139546|NCT01149876|338585|P4|STARTED|Overall Study||18
139547|NCT01149876|338586|P3|STARTED|Overall Study||21
139548|NCT01149876|338587|P2|STARTED|Overall Study||20
139549|NCT01149876|338588|P1|STARTED|Overall Study||21
139550|NCT01149863|338602|P1|NOT COMPLETED|Overall Study||3
139551|NCT01149863|338602|P1|COMPLETED|Overall Study||31
139552|NCT01149863|338602|P1|STARTED|Overall Study||34
139553|NCT01149785|338607|P2|NOT COMPLETED|Second Intervention||0
139554|NCT01149785|338608|P1|NOT COMPLETED|Second Intervention||0
139555|NCT01149785|338607|P2|COMPLETED|Second Intervention||15
139556|NCT01149785|338608|P1|COMPLETED|Second Intervention||0
139557|NCT01149785|338607|P2|STARTED|Second Intervention||15
139558|NCT01149785|338608|P1|STARTED|Second Intervention||0
139559|NCT01149785|338607|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
139560|NCT01149785|338608|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
139561|NCT01149785|338607|P2|COMPLETED|Washout Period of at Least 14 Days||0
139562|NCT01149785|338608|P1|COMPLETED|Washout Period of at Least 14 Days||15
139563|NCT01149785|338607|P2|STARTED|Washout Period of at Least 14 Days||0
139564|NCT01149785|338608|P1|STARTED|Washout Period of at Least 14 Days||15
139565|NCT01149785|338607|P2|NOT COMPLETED|First Intervention||0
139566|NCT01149785|338608|P1|NOT COMPLETED|First Intervention||0
139567|NCT01149785|338607|P2|COMPLETED|First Intervention||0
139568|NCT01149785|338608|P1|COMPLETED|First Intervention||15
139569|NCT01149785|338607|P2|STARTED|First Intervention||0
139570|NCT01149785|338608|P1|STARTED|First Intervention||15
139571|NCT01149772|338642|P2|NOT COMPLETED|Overall Study||21
139572|NCT01149772|338643|P1|NOT COMPLETED|Overall Study||48
139573|NCT01149772|338642|P2|COMPLETED|Overall Study||101
139574|NCT01149772|338643|P1|COMPLETED|Overall Study||132
139575|NCT01149772|338642|P2|STARTED|Overall Study||122
139576|NCT01149772|338643|P1|STARTED|Overall Study||180
139577|NCT01149759|338659|P1|NOT COMPLETED|Overall Study||0
139578|NCT01149759|338659|P1|COMPLETED|Overall Study||9
139579|NCT01149759|338659|P1|STARTED|Overall Study||9
139580|NCT01149733|338666|P2|NOT COMPLETED|Overall Study||0
139581|NCT01149733|338667|P1|NOT COMPLETED|Overall Study||0
139582|NCT01149733|338666|P2|COMPLETED|Overall Study||16
139583|NCT01149733|338667|P1|COMPLETED|Overall Study||16
139584|NCT01149733|338666|P2|STARTED|Overall Study||16
139585|NCT01149733|338667|P1|STARTED|Overall Study||16
139586|NCT01149655|338679|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
139587|NCT01149655|338680|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
139588|NCT01149655|338681|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
139589|NCT01149655|338682|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
139590|NCT01149655|338679|P4|COMPLETED|Period 3-DB Maintenance Phase||6
139591|NCT01149655|338680|P3|COMPLETED|Period 3-DB Maintenance Phase||15
139592|NCT01149655|338681|P2|COMPLETED|Period 3-DB Maintenance Phase||0
139593|NCT01149655|338682|P1|COMPLETED|Period 3-DB Maintenance Phase||0
139594|NCT01149655|338679|P4|STARTED|Period 3-DB Maintenance Phase||48
139595|NCT01149655|338680|P3|STARTED|Period 3-DB Maintenance Phase||98
139596|NCT01149655|338681|P2|STARTED|Period 3-DB Maintenance Phase||0
139597|NCT01149655|338682|P1|STARTED|Period 3-DB Maintenance Phase||0
139598|NCT01149655|338679|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
139599|NCT01149655|338680|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
139600|NCT01149655|338681|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
139601|NCT01149655|338682|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
139602|NCT01149655|338679|P4|COMPLETED|Period 2-Stabilization Phase||0
139603|NCT01149655|338680|P3|COMPLETED|Period 2-Stabilization Phase||0
139604|NCT01149655|338681|P2|COMPLETED|Period 2-Stabilization Phase||146
139605|NCT01149655|338682|P1|COMPLETED|Period 2-Stabilization Phase||0
139606|NCT01149655|338679|P4|STARTED|Period 2-Stabilization Phase||0
139607|NCT01149655|338680|P3|STARTED|Period 2-Stabilization Phase||0
139608|NCT01149655|338681|P2|STARTED|Period 2-Stabilization Phase||183
139609|NCT01149655|338682|P1|STARTED|Period 2-Stabilization Phase||0
139610|NCT01149655|338679|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
139611|NCT01149655|338680|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
139612|NCT01149655|338681|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
139613|NCT01149655|338682|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
139614|NCT01149655|338679|P4|COMPLETED|Period 1 - Conversion Phase||0
139615|NCT01149655|338680|P3|COMPLETED|Period 1 - Conversion Phase||0
139616|NCT01149655|338681|P2|COMPLETED|Period 1 - Conversion Phase||0
139617|NCT01149655|338682|P1|COMPLETED|Period 1 - Conversion Phase||168
139618|NCT01149655|338679|P4|STARTED|Period 1 - Conversion Phase||0
139619|NCT01149655|338680|P3|STARTED|Period 1 - Conversion Phase||0
139620|NCT01149655|338681|P2|STARTED|Period 1 - Conversion Phase||0
139621|NCT01149655|338682|P1|STARTED|Period 1 - Conversion Phase||186
139622|NCT01149616|338712|P2|NOT COMPLETED|Overall Study||0
139623|NCT01149616|338713|P1|NOT COMPLETED|Overall Study||0
139624|NCT01149616|338712|P2|COMPLETED|Overall Study||41
139625|NCT01149616|338713|P1|COMPLETED|Overall Study||41
139626|NCT01149616|338712|P2|STARTED|Overall Study||41
139627|NCT01149616|338713|P1|STARTED|Overall Study||41
139628|NCT01149538|338725|P2|NOT COMPLETED|Overall Study||4
139629|NCT01149538|338726|P1|NOT COMPLETED|Overall Study||5
139630|NCT01149538|338725|P2|COMPLETED|Overall Study||25
139631|NCT01149538|338726|P1|COMPLETED|Overall Study||26
139632|NCT01149538|338725|P2|STARTED|Overall Study||29
139633|NCT01149538|338726|P1|STARTED|Overall Study||31
139634|NCT01149512|338740|P1|NOT COMPLETED|Overall Study||0
139635|NCT01149512|338740|P1|COMPLETED|Overall Study||178
139636|NCT01149512|338740|P1|STARTED|Overall Study||178
139637|NCT01149486|338747|P2|NOT COMPLETED|Second Intervention||0
139638|NCT01149486|338748|P1|NOT COMPLETED|Second Intervention||0
139639|NCT01149486|338747|P2|COMPLETED|Second Intervention||9
139640|NCT01149486|338748|P1|COMPLETED|Second Intervention||10
139641|NCT01149486|338747|P2|STARTED|Second Intervention||9
139642|NCT01149486|338748|P1|STARTED|Second Intervention||10
139643|NCT01149486|338747|P2|NOT COMPLETED|Washout of 7 Days||0
139644|NCT01149486|338748|P1|NOT COMPLETED|Washout of 7 Days||0
139645|NCT01149486|338747|P2|COMPLETED|Washout of 7 Days||9
139646|NCT01149486|338748|P1|COMPLETED|Washout of 7 Days||10
139647|NCT01149486|338747|P2|STARTED|Washout of 7 Days||9
139648|NCT01149486|338748|P1|STARTED|Washout of 7 Days||10
139649|NCT01149486|338747|P2|NOT COMPLETED|First Intervention||1
139650|NCT01149486|338748|P1|NOT COMPLETED|First Intervention||0
139651|NCT01149486|338747|P2|COMPLETED|First Intervention||9
139652|NCT01149486|338748|P1|COMPLETED|First Intervention||10
139653|NCT01149486|338747|P2|STARTED|First Intervention||10
139654|NCT01149486|338748|P1|STARTED|First Intervention||10
139655|NCT01149473|338772|P2|NOT COMPLETED|Second Intervention||0
139656|NCT01149473|338773|P1|NOT COMPLETED|Second Intervention||0
139657|NCT01149473|338772|P2|COMPLETED|Second Intervention||38
139658|NCT01149473|338773|P1|COMPLETED|Second Intervention||38
139659|NCT01149473|338772|P2|STARTED|Second Intervention||38
139660|NCT01149473|338773|P1|STARTED|Second Intervention||38
139661|NCT01149473|338772|P2|NOT COMPLETED|Washout of 7 Days||1
139662|NCT01149473|338773|P1|NOT COMPLETED|Washout of 7 Days||1
139663|NCT01149473|338772|P2|COMPLETED|Washout of 7 Days||38
139664|NCT01149473|338773|P1|COMPLETED|Washout of 7 Days||38
139665|NCT01149473|338772|P2|STARTED|Washout of 7 Days||39
139666|NCT01149473|338773|P1|STARTED|Washout of 7 Days||39
139667|NCT01149473|338772|P2|NOT COMPLETED|First Intervention||1
139668|NCT01149473|338773|P1|NOT COMPLETED|First Intervention||1
139669|NCT01149473|338772|P2|COMPLETED|First Intervention||39
139670|NCT01149473|338773|P1|COMPLETED|First Intervention||39
139671|NCT01149473|338772|P2|STARTED|First Intervention||40
139672|NCT01149473|338773|P1|STARTED|First Intervention||40
139673|NCT01149460|338791|P2|NOT COMPLETED|Overall Study||2
139674|NCT01149460|338792|P1|NOT COMPLETED|Overall Study||0
139675|NCT01149460|338791|P2|COMPLETED|Overall Study||16
139676|NCT01149460|338792|P1|COMPLETED|Overall Study||18
139677|NCT01149460|338791|P2|STARTED|Overall Study||18
139678|NCT01149460|338792|P1|STARTED|Overall Study||18
139679|NCT01149434|338810|P2|NOT COMPLETED|Overall Study||5
139680|NCT01149434|338811|P1|NOT COMPLETED|Overall Study||0
139681|NCT01149434|338810|P2|COMPLETED|Overall Study||10
139682|NCT01149434|338811|P1|COMPLETED|Overall Study||4
139683|NCT01149434|338810|P2|STARTED|Overall Study||15
139684|NCT01149434|338811|P1|STARTED|Overall Study||4
139685|NCT01149421|338825|P3|NOT COMPLETED|Overall Study||44
139686|NCT01149421|338826|P2|NOT COMPLETED|Overall Study||29
139687|NCT01149421|338827|P1|NOT COMPLETED|Overall Study||52
139688|NCT01149421|338825|P3|COMPLETED|Overall Study||206
139689|NCT01149421|338826|P2|COMPLETED|Overall Study||225
139690|NCT01149421|338827|P1|COMPLETED|Overall Study||199
139691|NCT01149421|338825|P3|Received at Least One Dose of Study Drug|Overall Study||250
139692|NCT01149421|338826|P2|Received at Least One Dose of Study Drug|Overall Study||254
139693|NCT01149421|338827|P1|Received at Least One Dose of Study Drug|Overall Study||251
139694|NCT01149421|338825|P3|STARTED|Overall Study||250
139695|NCT01149421|338826|P2|STARTED|Overall Study||254
139696|NCT01149421|338827|P1|STARTED|Overall Study||251
139697|NCT01149148|338908|P2|NOT COMPLETED|Overall Study||2
139698|NCT01149148|338909|P1|NOT COMPLETED|Overall Study||2
139699|NCT01149148|338908|P2|COMPLETED|Overall Study||11
139700|NCT01149148|338909|P1|COMPLETED|Overall Study||10
139701|NCT01149148|338908|P2|STARTED|Overall Study||13
139702|NCT01149148|338909|P1|STARTED|Overall Study||12
139703|NCT01149057|338917|P1|NOT COMPLETED|Overall Study||57
139704|NCT01149057|338917|P1|COMPLETED|Overall Study||88
139705|NCT01149057|338917|P1|STARTED|Overall Study||145
139706|NCT01148979|338944|P2|NOT COMPLETED|Overall Study||1
139707|NCT01148979|338945|P1|NOT COMPLETED|Overall Study||0
139708|NCT01148979|338944|P2|COMPLETED|Overall Study||15
139709|NCT01148979|338945|P1|COMPLETED|Overall Study||13
139710|NCT01148979|338944|P2|STARTED|Overall Study||16
139711|NCT01148979|338945|P1|STARTED|Overall Study||13
139712|NCT01148862|338951|P2|NOT COMPLETED|Second Intervention||2
139713|NCT01148862|338952|P1|NOT COMPLETED|Second Intervention||0
139714|NCT01148862|338951|P2|COMPLETED|Second Intervention||23
139715|NCT01148862|338952|P1|COMPLETED|Second Intervention||25
139716|NCT01148862|338951|P2|STARTED|Second Intervention||25
139717|NCT01148862|338952|P1|STARTED|Second Intervention||25
139718|NCT01148862|338951|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
139719|NCT01148862|338952|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
139720|NCT01148862|338951|P2|COMPLETED|Washout Period of 2 Weeks||25
139721|NCT01148862|338952|P1|COMPLETED|Washout Period of 2 Weeks||25
139722|NCT01148862|338951|P2|STARTED|Washout Period of 2 Weeks||25
139723|NCT01148862|338952|P1|STARTED|Washout Period of 2 Weeks||25
139724|NCT01148862|338951|P2|NOT COMPLETED|First Intervention||0
139725|NCT01148862|338952|P1|NOT COMPLETED|First Intervention||0
139726|NCT01148862|338951|P2|COMPLETED|First Intervention||25
139727|NCT01148862|338952|P1|COMPLETED|First Intervention||25
139728|NCT01148862|338951|P2|STARTED|First Intervention||25
139729|NCT01148862|338952|P1|STARTED|First Intervention||25
139730|NCT01148836|338962|P2|NOT COMPLETED|Overall Study||2
139731|NCT01148836|338963|P1|NOT COMPLETED|Overall Study||1
139732|NCT01148836|338962|P2|COMPLETED|Overall Study||8
139733|NCT01148836|338963|P1|COMPLETED|Overall Study|Enrollment completed|7
139734|NCT01148836|338962|P2|STARTED|Overall Study||10
139735|NCT01148836|338963|P1|STARTED|Overall Study|Enrollment completed|8
139736|NCT01148771|338984|P2|NOT COMPLETED|Second Intervention||0
139737|NCT01148771|338985|P1|NOT COMPLETED|Second Intervention||0
139738|NCT01148771|338984|P2|COMPLETED|Second Intervention||5
139739|NCT01148771|338985|P1|COMPLETED|Second Intervention||6
139740|NCT01148771|338984|P2|STARTED|Second Intervention||5
139741|NCT01148771|338985|P1|STARTED|Second Intervention||6
139742|NCT01148771|338984|P2|NOT COMPLETED|Washout Period||1
139743|NCT01148771|338985|P1|NOT COMPLETED|Washout Period||0
139744|NCT01148771|338984|P2|COMPLETED|Washout Period||5
139745|NCT01148771|338985|P1|COMPLETED|Washout Period||6
139746|NCT01148771|338984|P2|STARTED|Washout Period||6
139747|NCT01148771|338985|P1|STARTED|Washout Period||6
139748|NCT01148771|338984|P2|NOT COMPLETED|First Intervention||0
139749|NCT01148771|338985|P1|NOT COMPLETED|First Intervention||0
139750|NCT01148771|338984|P2|COMPLETED|First Intervention||6
139751|NCT01148771|338985|P1|COMPLETED|First Intervention||6
139752|NCT01148771|338984|P2|STARTED|First Intervention||6
139753|NCT01148771|338985|P1|STARTED|First Intervention||6
139754|NCT01148745|338997|P1|NOT COMPLETED|Overall Study||0
139755|NCT01148745|338997|P1|COMPLETED|Overall Study||15
139756|NCT01148745|338997|P1|STARTED|Overall Study||15
139757|NCT01148693|339005|P2|NOT COMPLETED|Overall Study||10
139758|NCT01148693|339006|P1|NOT COMPLETED|Overall Study||13
139759|NCT01148693|339005|P2|COMPLETED|Overall Study||57
139760|NCT01148693|339006|P1|COMPLETED|Overall Study||57
139761|NCT01148693|339005|P2|STARTED|Overall Study||67
139762|NCT01148693|339006|P1|STARTED|Overall Study||70
139763|NCT01148563|339014|P2|NOT COMPLETED|Overall Study||30
139764|NCT01148563|339015|P1|NOT COMPLETED|Overall Study||29
139765|NCT01148563|339014|P2|COMPLETED|Overall Study||37
139766|NCT01148563|339015|P1|COMPLETED|Overall Study||40
139767|NCT01148563|339014|P2|STARTED|Overall Study||67
139768|NCT01148563|339015|P1|STARTED|Overall Study||69
139769|NCT01148537|339026|P3|NOT COMPLETED|Overall Study||3
139770|NCT01148537|339027|P2|NOT COMPLETED|Overall Study||0
139771|NCT01148537|339028|P1|NOT COMPLETED|Overall Study||3
139772|NCT01148537|339026|P3|COMPLETED|Overall Study||41
139773|NCT01148537|339027|P2|COMPLETED|Overall Study||44
139774|NCT01148537|339028|P1|COMPLETED|Overall Study||41
139775|NCT01148537|339026|P3|STARTED|Overall Study||44
139776|NCT01148537|339027|P2|STARTED|Overall Study||44
139777|NCT01148537|339028|P1|STARTED|Overall Study||44
139778|NCT01148524|339058|P9|NOT COMPLETED|Overall Study||0
139779|NCT01148524|339059|P8|NOT COMPLETED|Overall Study||0
139780|NCT01148524|339060|P7|NOT COMPLETED|Overall Study||0
139781|NCT01148524|339061|P6|NOT COMPLETED|Overall Study||0
139782|NCT01148524|339062|P5|NOT COMPLETED|Overall Study||0
139783|NCT01148524|339063|P4|NOT COMPLETED|Overall Study||0
139784|NCT01148524|339064|P3|NOT COMPLETED|Overall Study||0
139785|NCT01148524|339065|P2|NOT COMPLETED|Overall Study||0
139786|NCT01148524|339066|P1|NOT COMPLETED|Overall Study||0
139787|NCT01148524|339058|P9|COMPLETED|Overall Study||151
139788|NCT01148524|339059|P8|COMPLETED|Overall Study||51
139789|NCT01148524|339060|P7|COMPLETED|Overall Study||153
139790|NCT01148524|339061|P6|COMPLETED|Overall Study||106
139791|NCT01148524|339062|P5|COMPLETED|Overall Study||57
139792|NCT01148524|339063|P4|COMPLETED|Overall Study||102
139793|NCT01148524|339064|P3|COMPLETED|Overall Study||53
139794|NCT01148524|339065|P2|COMPLETED|Overall Study||95
139795|NCT01148524|339066|P1|COMPLETED|Overall Study||49
139796|NCT01148524|339058|P9|STARTED|Overall Study||151
139797|NCT01148524|339059|P8|STARTED|Overall Study||51
139798|NCT01148524|339060|P7|STARTED|Overall Study||153
139799|NCT01148524|339061|P6|STARTED|Overall Study||106
139800|NCT01148524|339062|P5|STARTED|Overall Study||57
139801|NCT01148524|339063|P4|STARTED|Overall Study||102
139802|NCT01148524|339064|P3|STARTED|Overall Study||53
139803|NCT01148524|339065|P2|STARTED|Overall Study||95
139804|NCT01148524|339066|P1|STARTED|Overall Study||49
139805|NCT01148511|339114|P3|NOT COMPLETED|Randomized||6
139806|NCT01148511|339115|P2|NOT COMPLETED|Randomized||10
139807|NCT01148511|339116|P1|NOT COMPLETED|Randomized||0
139808|NCT01148511|339114|P3|COMPLETED|Randomized||39
139809|NCT01148511|339115|P2|COMPLETED|Randomized||38
139810|NCT01148511|339116|P1|COMPLETED|Randomized||0
139811|NCT01148511|339114|P3|STARTED|Randomized||45
139812|NCT01148511|339115|P2|STARTED|Randomized||48
139813|NCT01148511|339116|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
139814|NCT01148511|339114|P3|NOT COMPLETED|Exposed to Study Drug||0
139815|NCT01148511|339115|P2|NOT COMPLETED|Exposed to Study Drug||0
139816|NCT01148511|339116|P1|NOT COMPLETED|Exposed to Study Drug||6
139817|NCT01148511|339114|P3|COMPLETED|Exposed to Study Drug||0
139818|NCT01148511|339115|P2|COMPLETED|Exposed to Study Drug||0
139819|NCT01148511|339116|P1|COMPLETED|Exposed to Study Drug||93
139820|NCT01148511|339114|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
139821|NCT01148511|339115|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
139822|NCT01148511|339116|P1|STARTED|Exposed to Study Drug||99
139823|NCT01148420|339135|P1|NOT COMPLETED|Overall Study||0
139824|NCT01148420|339135|P1|COMPLETED|Overall Study||48
139825|NCT01148420|339135|P1|STARTED|Overall Study||48
139826|NCT01148056|339141|P1|NOT COMPLETED|Overall Study||0
139827|NCT01148056|339141|P1|COMPLETED|Overall Study||2
139828|NCT01148056|339141|P1|STARTED|Overall Study||2
139829|NCT01148017|339154|P4|NOT COMPLETED|Overall Study||0
139830|NCT01148017|339155|P3|NOT COMPLETED|Overall Study||0
139831|NCT01148017|339156|P2|NOT COMPLETED|Overall Study||34
139832|NCT01148017|339157|P1|NOT COMPLETED|Overall Study||80
139833|NCT01148017|339154|P4|COMPLETED|Overall Study||45
139834|NCT01148017|339155|P3|COMPLETED|Overall Study||53
139835|NCT01148017|339156|P2|COMPLETED|Overall Study||87
139836|NCT01148017|339157|P1|COMPLETED|Overall Study||134
139837|NCT01148017|339154|P4|STARTED|Overall Study||45
139838|NCT01148017|339155|P3|STARTED|Overall Study||53
139839|NCT01148017|339156|P2|STARTED|Overall Study||121
139840|NCT01148017|339157|P1|STARTED|Overall Study||214
139841|NCT01147926|339196|P2|NOT COMPLETED|Overall Study||29
139842|NCT01147926|339197|P1|NOT COMPLETED|Overall Study||27
139843|NCT01147926|339196|P2|COMPLETED|Overall Study||158
139844|NCT01147926|339197|P1|COMPLETED|Overall Study||160
139845|NCT01147926|339196|P2|STARTED|Overall Study||187
139846|NCT01147926|339197|P1|STARTED|Overall Study||187
139847|NCT01147900|339232|P3|NOT COMPLETED|At Year 10||0
139848|NCT01147900|339233|P2|NOT COMPLETED|At Year 10||1
139849|NCT01147900|339234|P1|NOT COMPLETED|At Year 10||0
139850|NCT01147900|339232|P3|COMPLETED|At Year 10||62
139851|NCT01147900|339233|P2|COMPLETED|At Year 10||59
139852|NCT01147900|339234|P1|COMPLETED|At Year 10||55
139853|NCT01147900|339232|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
139854|NCT01147900|339233|P2|STARTED|At Year 10||60
139855|NCT01147900|339234|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
139856|NCT01147900|339232|P3|NOT COMPLETED|At Year 8.5||0
139857|NCT01147900|339233|P2|NOT COMPLETED|At Year 8.5||0
139858|NCT01147900|339234|P1|NOT COMPLETED|At Year 8.5||0
139859|NCT01147900|339232|P3|COMPLETED|At Year 8.5||66
139860|NCT01147900|339233|P2|COMPLETED|At Year 8.5||60
139861|NCT01147900|339234|P1|COMPLETED|At Year 8.5||54
139862|NCT01147900|339232|P3|STARTED|At Year 8.5||66
139863|NCT01147900|339233|P2|STARTED|At Year 8.5||60
139864|NCT01147900|339234|P1|STARTED|At Year 8.5||54
139865|NCT01147874|339293|P1|NOT COMPLETED|Overall Study||67
139866|NCT01147874|339293|P1|COMPLETED|Overall Study||946
139867|NCT01147874|339293|P1|STARTED|Overall Study||1013
139868|NCT01147848|339301|P3|NOT COMPLETED|Randomized Phase||46
139869|NCT01147848|339302|P2|NOT COMPLETED|Randomized Phase||45
139870|NCT01147848|339303|P1|NOT COMPLETED|Randomized Phase||0
139871|NCT01147848|339301|P3|COMPLETED|Randomized Phase||357
139872|NCT01147848|339302|P2|COMPLETED|Randomized Phase||358
139873|NCT01147848|339303|P1|COMPLETED|Randomized Phase||0
139874|NCT01147848|339301|P3|STARTED|Randomized Phase||403
139875|NCT01147848|339302|P2|STARTED|Randomized Phase||403
139876|NCT01147848|339303|P1|STARTED|Randomized Phase||0
139877|NCT01147848|339301|P3|NOT COMPLETED|Run-in Period||0
139878|NCT01147848|339302|P2|NOT COMPLETED|Run-in Period||0
139879|NCT01147848|339303|P1|NOT COMPLETED|Run-in Period||758
139880|NCT01147848|339301|P3|COMPLETED|Run-in Period||0
139881|NCT01147848|339302|P2|COMPLETED|Run-in Period||0
139882|NCT01147848|339303|P1|COMPLETED|Run-in Period||806
139883|NCT01147848|339301|P3|STARTED|Run-in Period||0
139884|NCT01147848|339302|P2|STARTED|Run-in Period||0
139885|NCT01147848|339303|P1|STARTED|Run-in Period||1564
139886|NCT01147822|339335|P2|NOT COMPLETED|Overall Study||179
139887|NCT01147822|339336|P1|NOT COMPLETED|Overall Study||188
139888|NCT01147822|339335|P2|COMPLETED|Overall Study||0
139889|NCT01147822|339336|P1|COMPLETED|Overall Study||0
139890|NCT01147822|339335|P2|Not Completed/Ongoing|Overall Study||102
139891|NCT01147822|339336|P1|Not Completed/Ongoing|Overall Study||111
139892|NCT01147822|339335|P2|STARTED|Overall Study||179
139893|NCT01147822|339336|P1|STARTED|Overall Study||188
139894|NCT01147809|339356|P6|NOT COMPLETED|Phase II (168 Days)||33
139895|NCT01147809|339357|P5|NOT COMPLETED|Phase II (168 Days)||16
139896|NCT01147809|339358|P4|NOT COMPLETED|Phase II (168 Days)||0
139897|NCT01147809|339359|P3|NOT COMPLETED|Phase II (168 Days)||0
139898|NCT01147809|339360|P2|NOT COMPLETED|Phase II (168 Days)||0
139899|NCT01147809|339361|P1|NOT COMPLETED|Phase II (168 Days)||0
139900|NCT01147809|339356|P6|COMPLETED|Phase II (168 Days)||19
139901|NCT01147809|339357|P5|COMPLETED|Phase II (168 Days)||7
139902|NCT01147809|339358|P4|COMPLETED|Phase II (168 Days)||0
139903|NCT01147809|339359|P3|COMPLETED|Phase II (168 Days)||0
139904|NCT01147809|339360|P2|COMPLETED|Phase II (168 Days)||0
139905|NCT01147809|339361|P1|COMPLETED|Phase II (168 Days)||0
139906|NCT01147809|339356|P6|Ongoing|Phase II (168 Days)||0
139907|NCT01147809|339357|P5|Ongoing|Phase II (168 Days)||1
139908|NCT01147809|339358|P4|Ongoing|Phase II (168 Days)||0
139909|NCT01147809|339359|P3|Ongoing|Phase II (168 Days)||0
139910|NCT01147809|339360|P2|Ongoing|Phase II (168 Days)||0
139911|NCT01147809|339361|P1|Ongoing|Phase II (168 Days)||0
139912|NCT01147809|339356|P6|STARTED|Phase II (168 Days)||52
139913|NCT01147809|339357|P5|STARTED|Phase II (168 Days)||23
139914|NCT01147809|339358|P4|STARTED|Phase II (168 Days)||0
139915|NCT01147809|339359|P3|STARTED|Phase II (168 Days)||0
139916|NCT01147809|339360|P2|STARTED|Phase II (168 Days)||0
139917|NCT01147809|339361|P1|STARTED|Phase II (168 Days)||0
139918|NCT01147809|339356|P6|NOT COMPLETED|Phase I (168 Days)||0
139919|NCT01147809|339357|P5|NOT COMPLETED|Phase I (168 Days)||0
139920|NCT01147809|339358|P4|NOT COMPLETED|Phase I (168 Days)||5
139921|NCT01147809|339359|P3|NOT COMPLETED|Phase I (168 Days)||2
139922|NCT01147809|339360|P2|NOT COMPLETED|Phase I (168 Days)||1
139923|NCT01147809|339361|P1|NOT COMPLETED|Phase I (168 Days)||1
139924|NCT01147809|339356|P6|COMPLETED|Phase I (168 Days)||0
139925|NCT01147809|339357|P5|COMPLETED|Phase I (168 Days)||0
139926|NCT01147809|339358|P4|COMPLETED|Phase I (168 Days)||5
139927|NCT01147809|339359|P3|COMPLETED|Phase I (168 Days)||2
139928|NCT01147809|339360|P2|COMPLETED|Phase I (168 Days)||8
139929|NCT01147809|339361|P1|COMPLETED|Phase I (168 Days)||2
139930|NCT01147809|339356|P6|STARTED|Phase I (168 Days)||0
139931|NCT01147809|339357|P5|STARTED|Phase I (168 Days)||0
139932|NCT01147809|339358|P4|STARTED|Phase I (168 Days)||10
139933|NCT01147809|339359|P3|STARTED|Phase I (168 Days)||4
139934|NCT01147809|339360|P2|STARTED|Phase I (168 Days)||9
139935|NCT01147809|339361|P1|STARTED|Phase I (168 Days)||3
139936|NCT01147744|339482|P7|NOT COMPLETED|Overall Study||19
139937|NCT01147744|339483|P6|NOT COMPLETED|Overall Study||20
139938|NCT01147744|339484|P5|NOT COMPLETED|Overall Study||25
139939|NCT01147744|339485|P4|NOT COMPLETED|Overall Study||18
139940|NCT01147744|339486|P3|NOT COMPLETED|Overall Study||18
139941|NCT01147744|339487|P2|NOT COMPLETED|Overall Study||23
139942|NCT01147744|339488|P1|NOT COMPLETED|Overall Study||29
139943|NCT01147744|339482|P7|COMPLETED|Overall Study||78
139944|NCT01147744|339483|P6|COMPLETED|Overall Study||83
139945|NCT01147744|339484|P5|COMPLETED|Overall Study||76
139946|NCT01147744|339485|P4|COMPLETED|Overall Study||82
139947|NCT01147744|339486|P3|COMPLETED|Overall Study||82
139948|NCT01147744|339487|P2|COMPLETED|Overall Study||76
139949|NCT01147744|339488|P1|COMPLETED|Overall Study||71
139950|NCT01147744|339482|P7|STARTED|Overall Study||97
139951|NCT01147744|339483|P6|STARTED|Overall Study||103
139952|NCT01147744|339484|P5|STARTED|Overall Study||101
139953|NCT01147744|339485|P4|STARTED|Overall Study||100
139954|NCT01147744|339486|P3|STARTED|Overall Study||100
139955|NCT01147744|339487|P2|STARTED|Overall Study||99
139956|NCT01147744|339488|P1|STARTED|Overall Study||100
139957|NCT01147653|339583|P2|NOT COMPLETED|Year 2||3
139958|NCT01147653|339584|P1|NOT COMPLETED|Year 2||2
139959|NCT01147653|339583|P2|COMPLETED|Year 2||28
139960|NCT01147653|339584|P1|COMPLETED|Year 2||30
139961|NCT01147653|339583|P2|STARTED|Year 2||31
139962|NCT01147653|339584|P1|STARTED|Year 2||32
139963|NCT01147653|339583|P2|NOT COMPLETED|Year 1||0
139964|NCT01147653|339584|P1|NOT COMPLETED|Year 1||0
139965|NCT01147653|339583|P2|COMPLETED|Year 1||31
139966|NCT01147653|339584|P1|COMPLETED|Year 1||32
139967|NCT01147653|339583|P2|STARTED|Year 1||31
139968|NCT01147653|339584|P1|STARTED|Year 1||32
139969|NCT01147640|339645|P2|NOT COMPLETED|Overall Study||1
139970|NCT01147640|339646|P1|NOT COMPLETED|Overall Study||5
139971|NCT01147640|339645|P2|COMPLETED|Overall Study||38
139972|NCT01147640|339646|P1|COMPLETED|Overall Study||78
139973|NCT01147640|339645|P2|STARTED|Overall Study||39
139974|NCT01147640|339646|P1|STARTED|Overall Study||83
139975|NCT01147627|339657|P3|NOT COMPLETED|Overall Study||18
139976|NCT01147627|339658|P2|NOT COMPLETED|Overall Study||24
139977|NCT01147627|339659|P1|NOT COMPLETED|Overall Study||32
139978|NCT01147627|339657|P3|COMPLETED|Overall Study||118
139979|NCT01147627|339658|P2|COMPLETED|Overall Study||114
139980|NCT01147627|339659|P1|COMPLETED|Overall Study||110
139981|NCT01147627|339657|P3|STARTED|Overall Study||136
139982|NCT01147627|339658|P2|STARTED|Overall Study||138
139983|NCT01147627|339659|P1|STARTED|Overall Study||142
139984|NCT01147601|339669|P2|NOT COMPLETED|Overall Study||0
139985|NCT01147601|339670|P1|NOT COMPLETED|Overall Study||3
139986|NCT01147601|339669|P2|COMPLETED|Overall Study||1
139987|NCT01147601|339670|P1|COMPLETED|Overall Study||2
139988|NCT01147601|339669|P2|STARTED|Overall Study||1
139989|NCT01147601|339670|P1|STARTED|Overall Study||5
139990|NCT01147497|339678|P2|NOT COMPLETED|Overall Study||0
139991|NCT01147497|339679|P1|NOT COMPLETED|Overall Study||2
139992|NCT01147497|339678|P2|COMPLETED|Overall Study||36
139993|NCT01147497|339679|P1|COMPLETED|Overall Study||35
139994|NCT01147497|339678|P2|STARTED|Overall Study||36
139995|NCT01147497|339679|P1|STARTED|Overall Study||37
139996|NCT01147471|339699|P2|NOT COMPLETED|6 Month Follow Up||2
139997|NCT01147471|339700|P1|NOT COMPLETED|6 Month Follow Up||4
139998|NCT01147471|339699|P2|COMPLETED|6 Month Follow Up||4
139999|NCT01147471|339700|P1|COMPLETED|6 Month Follow Up||8
140000|NCT01147471|339699|P2|STARTED|6 Month Follow Up||6
140001|NCT01147471|339700|P1|STARTED|6 Month Follow Up||12
140002|NCT01147471|339699|P2|NOT COMPLETED|3 Month Follow Up||2
140003|NCT01147471|339700|P1|NOT COMPLETED|3 Month Follow Up||1
140004|NCT01147471|339699|P2|COMPLETED|3 Month Follow Up||6
140005|NCT01147471|339700|P1|COMPLETED|3 Month Follow Up||12
140006|NCT01147471|339699|P2|STARTED|3 Month Follow Up||8
140007|NCT01147471|339700|P1|STARTED|3 Month Follow Up||13
140008|NCT01147471|339699|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
140009|NCT01147471|339700|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
140010|NCT01147471|339699|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
140011|NCT01147471|339700|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
140012|NCT01147471|339699|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
140013|NCT01147471|339700|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
140014|NCT01147471|339699|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
140015|NCT01147471|339700|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
140016|NCT01147471|339699|P2|COMPLETED|Through Initial Hospital Discharge||11
140017|NCT01147471|339700|P1|COMPLETED|Through Initial Hospital Discharge||13
140018|NCT01147471|339699|P2|STARTED|Through Initial Hospital Discharge||11
140019|NCT01147471|339700|P1|STARTED|Through Initial Hospital Discharge||13
140020|NCT01147458|339714|P4|NOT COMPLETED|Second Intervention||4
140021|NCT01147458|339715|P3|NOT COMPLETED|Second Intervention||8
140022|NCT01147458|339716|P2|NOT COMPLETED|Second Intervention||7
140023|NCT01147458|339717|P1|NOT COMPLETED|Second Intervention||9
140024|NCT01147458|339714|P4|COMPLETED|Second Intervention||30
140025|NCT01147458|339715|P3|COMPLETED|Second Intervention||27
140026|NCT01147458|339716|P2|COMPLETED|Second Intervention||24
140027|NCT01147458|339717|P1|COMPLETED|Second Intervention||25
140028|NCT01147458|339714|P4|STARTED|Second Intervention||34
140029|NCT01147458|339715|P3|STARTED|Second Intervention||35
140030|NCT01147458|339716|P2|STARTED|Second Intervention||31
140031|NCT01147458|339717|P1|STARTED|Second Intervention||34
140032|NCT01147458|339714|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
140033|NCT01147458|339715|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
140034|NCT01147458|339716|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
140035|NCT01147458|339717|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
140036|NCT01147458|339714|P4|COMPLETED|Washout Period of 2 Weeks||34
140037|NCT01147458|339715|P3|COMPLETED|Washout Period of 2 Weeks||35
140038|NCT01147458|339716|P2|COMPLETED|Washout Period of 2 Weeks||31
140039|NCT01147458|339717|P1|COMPLETED|Washout Period of 2 Weeks||34
140040|NCT01147458|339714|P4|STARTED|Washout Period of 2 Weeks||34
140041|NCT01147458|339715|P3|STARTED|Washout Period of 2 Weeks||35
140042|NCT01147458|339716|P2|STARTED|Washout Period of 2 Weeks||31
140043|NCT01147458|339717|P1|STARTED|Washout Period of 2 Weeks||34
140044|NCT01147458|339714|P4|NOT COMPLETED|First Intervention||14
140045|NCT01147458|339715|P3|NOT COMPLETED|First Intervention||12
140046|NCT01147458|339716|P2|NOT COMPLETED|First Intervention||16
140047|NCT01147458|339717|P1|NOT COMPLETED|First Intervention||14
140048|NCT01147458|339714|P4|COMPLETED|First Intervention||34
140049|NCT01147458|339715|P3|COMPLETED|First Intervention||35
140050|NCT01147458|339716|P2|COMPLETED|First Intervention||31
140051|NCT01147458|339717|P1|COMPLETED|First Intervention||34
140052|NCT01147458|339714|P4|STARTED|First Intervention||48
140053|NCT01147458|339715|P3|STARTED|First Intervention||47
140054|NCT01147458|339716|P2|STARTED|First Intervention||47
140055|NCT01147458|339717|P1|STARTED|First Intervention||48
140056|NCT01147406|339771|P6|NOT COMPLETED|Overall Study||0
140057|NCT01147406|339772|P5|NOT COMPLETED|Overall Study||0
140058|NCT01147406|339773|P4|NOT COMPLETED|Overall Study||0
140059|NCT01147406|339774|P3|NOT COMPLETED|Overall Study||0
140060|NCT01147406|339775|P2|NOT COMPLETED|Overall Study||0
140061|NCT01147406|339776|P1|NOT COMPLETED|Overall Study||0
140062|NCT01147406|339771|P6|COMPLETED|Overall Study||10
140063|NCT01147406|339772|P5|COMPLETED|Overall Study||6
140064|NCT01147406|339773|P4|COMPLETED|Overall Study||6
140065|NCT01147406|339774|P3|COMPLETED|Overall Study||1
140066|NCT01147406|339775|P2|COMPLETED|Overall Study||12
140067|NCT01147406|339776|P1|COMPLETED|Overall Study||6
140068|NCT01147406|339771|P6|STARTED|Overall Study||10
140069|NCT01147406|339772|P5|STARTED|Overall Study||6
140070|NCT01147406|339773|P4|STARTED|Overall Study||6
140071|NCT01147406|339774|P3|STARTED|Overall Study||1
140072|NCT01147406|339775|P2|STARTED|Overall Study||12
140073|NCT01147406|339776|P1|STARTED|Overall Study||6
140074|NCT01147393|339796|P1|NOT COMPLETED|Dose Level -1||1
140075|NCT01147393|339796|P1|COMPLETED|Dose Level -1||0
140076|NCT01147393|339796|P1|STARTED|Dose Level -1||1
140077|NCT01147393|339796|P1|NOT COMPLETED|Dose Level 1||2
140078|NCT01147393|339796|P1|COMPLETED|Dose Level 1||1
140079|NCT01147393|339796|P1|STARTED|Dose Level 1||3
140080|NCT01147380|339806|P2|NOT COMPLETED|Overall Study||0
140081|NCT01147380|339807|P1|NOT COMPLETED|Overall Study||0
140082|NCT01147380|339806|P2|COMPLETED|Overall Study||12
140083|NCT01147380|339807|P1|COMPLETED|Overall Study||6
140084|NCT01147380|339806|P2|STARTED|Overall Study||12
140085|NCT01147380|339807|P1|STARTED|Overall Study||6
140086|NCT01147341|339817|P2|NOT COMPLETED|Open Label Period||0
140087|NCT01147341|339818|P1|NOT COMPLETED|Open Label Period||4
140088|NCT01147341|339817|P2|COMPLETED|Open Label Period||8
140089|NCT01147341|339818|P1|COMPLETED|Open Label Period||22
140090|NCT01147341|339817|P2|STARTED|Open Label Period||8
140091|NCT01147341|339818|P1|STARTED|Open Label Period||26
140092|NCT01147341|339817|P2|NOT COMPLETED|Double Blind Period||2
140093|NCT01147341|339818|P1|NOT COMPLETED|Double Blind Period||1
140094|NCT01147341|339817|P2|COMPLETED|Double Blind Period||8
140095|NCT01147341|339818|P1|COMPLETED|Double Blind Period||26
140096|NCT01147341|339817|P2|STARTED|Double Blind Period||10
140097|NCT01147341|339818|P1|STARTED|Double Blind Period||27
140098|NCT01147302|339848|P2|NOT COMPLETED|Overall Study||0
140099|NCT01147302|339849|P1|NOT COMPLETED|Overall Study||0
140100|NCT01147302|339848|P2|COMPLETED|Overall Study||9
140101|NCT01147302|339849|P1|COMPLETED|Overall Study||9
140102|NCT01147302|339848|P2|STARTED|Overall Study||9
140103|NCT01147302|339849|P1|STARTED|Overall Study||9
140104|NCT01147250|339881|P2|NOT COMPLETED|Overall Study||105
140105|NCT01147250|339882|P1|NOT COMPLETED|Overall Study||110
140106|NCT01147250|339881|P2|COMPLETED|Overall Study||2929
140107|NCT01147250|339882|P1|COMPLETED|Overall Study||2924
140108|NCT01147250|339881|P2|Treated|Overall Study||3031
140109|NCT01147250|339882|P1|Treated|Overall Study||3032
140110|NCT01147250|339881|P2|STARTED|Overall Study||3034
140111|NCT01147250|339882|P1|STARTED|Overall Study||3034
140112|NCT01147172|339894|P1|NOT COMPLETED|Overall Study||4
140113|NCT01147172|339894|P1|COMPLETED|Overall Study||96
140114|NCT01147172|339894|P1|STARTED|Overall Study||100
140115|NCT01147068|339912|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
140116|NCT01147068|339913|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
140117|NCT01147068|339914|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
140118|NCT01147068|339915|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
140119|NCT01147068|339916|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
140120|NCT01147068|339917|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
140121|NCT01147068|339918|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
140122|NCT01147068|339912|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
140123|NCT01147068|339913|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
140124|NCT01147068|339914|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
140125|NCT01147068|339915|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
140126|NCT01147068|339916|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
140127|NCT01147068|339917|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
140128|NCT01147068|339918|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
140129|NCT01147068|339912|P7|STARTED|Subjects That Completed Safety Follow-up||55
140130|NCT01147068|339913|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
140131|NCT01147068|339914|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
140132|NCT01147068|339915|P4|STARTED|Subjects That Completed Safety Follow-up||56
140133|NCT01147068|339916|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
140134|NCT01147068|339917|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
140135|NCT01147068|339918|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
140136|NCT01147068|339912|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
140137|NCT01147068|339913|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
140138|NCT01147068|339914|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
140139|NCT01147068|339915|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
140140|NCT01147068|339916|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
140141|NCT01147068|339917|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
140142|NCT01147068|339918|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
140143|NCT01147068|339912|P7|COMPLETED|Subjects That Received 2nd Dose||55
140144|NCT01147068|339913|P6|COMPLETED|Subjects That Received 2nd Dose||51
140145|NCT01147068|339914|P5|COMPLETED|Subjects That Received 2nd Dose||55
140146|NCT01147068|339915|P4|COMPLETED|Subjects That Received 2nd Dose||56
140147|NCT01147068|339916|P3|COMPLETED|Subjects That Received 2nd Dose||52
140148|NCT01147068|339917|P2|COMPLETED|Subjects That Received 2nd Dose||52
140149|NCT01147068|339918|P1|COMPLETED|Subjects That Received 2nd Dose||59
140150|NCT01147068|339912|P7|STARTED|Subjects That Received 2nd Dose||55
140151|NCT01147068|339913|P6|STARTED|Subjects That Received 2nd Dose||53
140152|NCT01147068|339914|P5|STARTED|Subjects That Received 2nd Dose||56
140153|NCT01147068|339915|P4|STARTED|Subjects That Received 2nd Dose||56
140154|NCT01147068|339916|P3|STARTED|Subjects That Received 2nd Dose||55
140155|NCT01147068|339917|P2|STARTED|Subjects That Received 2nd Dose||57
140156|NCT01147068|339918|P1|STARTED|Subjects That Received 2nd Dose||60
140157|NCT01147068|339912|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
140158|NCT01147068|339913|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
140159|NCT01147068|339914|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
140160|NCT01147068|339915|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
140161|NCT01147068|339916|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
140162|NCT01147068|339917|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
140163|NCT01147068|339918|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
140164|NCT01147068|339912|P7|COMPLETED|Subjects That Received 1st Dose||55
140165|NCT01147068|339913|P6|COMPLETED|Subjects That Received 1st Dose||53
140166|NCT01147068|339914|P5|COMPLETED|Subjects That Received 1st Dose||56
140167|NCT01147068|339915|P4|COMPLETED|Subjects That Received 1st Dose||56
140168|NCT01147068|339916|P3|COMPLETED|Subjects That Received 1st Dose||55
140169|NCT01147068|339917|P2|COMPLETED|Subjects That Received 1st Dose||57
140170|NCT01147068|339918|P1|COMPLETED|Subjects That Received 1st Dose||60
140171|NCT01147068|339912|P7|STARTED|Subjects That Received 1st Dose||55
140172|NCT01147068|339913|P6|STARTED|Subjects That Received 1st Dose||53
140173|NCT01147068|339914|P5|STARTED|Subjects That Received 1st Dose||56
140174|NCT01147068|339915|P4|STARTED|Subjects That Received 1st Dose||56
140175|NCT01147068|339916|P3|STARTED|Subjects That Received 1st Dose||55
140176|NCT01147068|339917|P2|STARTED|Subjects That Received 1st Dose||57
140177|NCT01147068|339918|P1|STARTED|Subjects That Received 1st Dose||60
140178|NCT01147055|339948|P2|NOT COMPLETED|Second Intervention Period||0
140179|NCT01147055|339949|P1|NOT COMPLETED|Second Intervention Period||0
140180|NCT01147055|339948|P2|COMPLETED|Second Intervention Period||14
140181|NCT01147055|339949|P1|COMPLETED|Second Intervention Period||0
140182|NCT01147055|339948|P2|STARTED|Second Intervention Period||14
140183|NCT01147055|339949|P1|STARTED|Second Intervention Period||0
140184|NCT01147055|339948|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
140185|NCT01147055|339949|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
140186|NCT01147055|339948|P2|COMPLETED|Washout Period (at Least 14 Days)||0
140187|NCT01147055|339949|P1|COMPLETED|Washout Period (at Least 14 Days)||14
140188|NCT01147055|339948|P2|STARTED|Washout Period (at Least 14 Days)||0
140189|NCT01147055|339949|P1|STARTED|Washout Period (at Least 14 Days)||14
140190|NCT01147055|339948|P2|NOT COMPLETED|First Intervention Period||0
140191|NCT01147055|339949|P1|NOT COMPLETED|First Intervention Period||1
140192|NCT01147055|339948|P2|COMPLETED|First Intervention Period||0
140193|NCT01147055|339949|P1|COMPLETED|First Intervention Period||14
140194|NCT01147055|339948|P2|STARTED|First Intervention Period||0
140195|NCT01147055|339949|P1|STARTED|First Intervention Period||15
140196|NCT01147042|339983|P2|NOT COMPLETED|Overall Study||0
140197|NCT01147042|339984|P1|NOT COMPLETED|Overall Study||0
140198|NCT01147042|339983|P2|COMPLETED|Overall Study||0
140199|NCT01147042|339984|P1|COMPLETED|Overall Study||2
140200|NCT01147042|339983|P2|STARTED|Overall Study||0
140201|NCT01147042|339984|P1|STARTED|Overall Study||2
140202|NCT01146951|339991|P2|NOT COMPLETED|Overall Study||1
140203|NCT01146951|339992|P1|NOT COMPLETED|Overall Study||4
140204|NCT01146951|339991|P2|COMPLETED|Overall Study||29
140205|NCT01146951|339992|P1|COMPLETED|Overall Study||25
140206|NCT01146951|339991|P2|STARTED|Overall Study||30
140207|NCT01146951|339992|P1|STARTED|Overall Study||29
140208|NCT01146912|340013|P8|NOT COMPLETED|Overall Study||0
140209|NCT01146912|340014|P7|NOT COMPLETED|Overall Study||56
140210|NCT01146912|340015|P6|NOT COMPLETED|Overall Study||61
140211|NCT01146912|340016|P5|NOT COMPLETED|Overall Study||41
140212|NCT01146912|340017|P4|NOT COMPLETED|Overall Study||17
140213|NCT01146912|340018|P3|NOT COMPLETED|Overall Study||17
140214|NCT01146912|340019|P2|NOT COMPLETED|Overall Study||822
140215|NCT01146912|340020|P1|NOT COMPLETED|Overall Study||817
140216|NCT01146912|340013|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
140217|NCT01146912|340014|P7|COMPLETED|Overall Study||1764
140218|NCT01146912|340015|P6|COMPLETED|Overall Study||1760
140219|NCT01146912|340016|P5|COMPLETED|Overall Study||1780
140220|NCT01146912|340017|P4|COMPLETED|Overall Study||577
140221|NCT01146912|340018|P3|COMPLETED|Overall Study||576
140222|NCT01146912|340019|P2|COMPLETED|Overall Study||3784
140223|NCT01146912|340020|P1|COMPLETED|Overall Study||3790
140224|NCT01146912|340013|P8|STARTED|Overall Study||14675
140225|NCT01146912|340014|P7|STARTED|Overall Study||1820
140226|NCT01146912|340015|P6|STARTED|Overall Study||1821
140227|NCT01146912|340016|P5|STARTED|Overall Study||1821
140228|NCT01146912|340017|P4|STARTED|Overall Study||594
140229|NCT01146912|340018|P3|STARTED|Overall Study||593
140230|NCT01146912|340019|P2|STARTED|Overall Study||4606
140231|NCT01146912|340020|P1|STARTED|Overall Study||4607
140232|NCT01146873|340042|P2|NOT COMPLETED|Overall Study||6
140233|NCT01146873|340043|P1|NOT COMPLETED|Overall Study||0
140234|NCT01146873|340042|P2|COMPLETED|Overall Study||144
140235|NCT01146873|340043|P1|COMPLETED|Overall Study||148
140236|NCT01146873|340042|P2|STARTED|Overall Study||150
140237|NCT01146873|340043|P1|STARTED|Overall Study||148
140238|NCT01146860|340059|P2|NOT COMPLETED|Overall Study||1
140239|NCT01146860|340060|P1|NOT COMPLETED|Overall Study||0
140240|NCT01146860|340059|P2|COMPLETED|Overall Study||191
140241|NCT01146860|340060|P1|COMPLETED|Overall Study||194
140242|NCT01146860|340059|P2|STARTED|Overall Study||192
140243|NCT01146860|340060|P1|STARTED|Overall Study||194
140244|NCT01146808|340074|P1|NOT COMPLETED|Overall Study||0
140245|NCT01146808|340074|P1|COMPLETED|Overall Study||16
140246|NCT01146808|340074|P1|STARTED|Overall Study||16
140247|NCT01146782|340080|P1|NOT COMPLETED|Primary Endpoint Cohort||6
140248|NCT01146782|340080|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
140249|NCT01146782|340080|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
140250|NCT01146782|340080|P1|NOT COMPLETED|Safety Cohort||83
140251|NCT01146782|340080|P1|COMPLETED|Safety Cohort||63
140252|NCT01146782|340080|P1|STARTED|Safety Cohort||146
140253|NCT01146782|340080|P1|NOT COMPLETED|Screening Cohort||221
140254|NCT01146782|340080|P1|COMPLETED|Screening Cohort||146
140255|NCT01146782|340080|P1|STARTED|Screening Cohort||367
140256|NCT01146613|340089|P2|NOT COMPLETED|Overall Study||12
140257|NCT01146613|340090|P1|NOT COMPLETED|Overall Study||7
140258|NCT01146613|340089|P2|COMPLETED|Overall Study||89
140259|NCT01146613|340090|P1|COMPLETED|Overall Study||92
140260|NCT01146613|340089|P2|STARTED|Overall Study||101
140261|NCT01146613|340090|P1|STARTED|Overall Study||99
140262|NCT01146600|340098|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
140263|NCT01146600|340099|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
140264|NCT01146600|340098|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
140265|NCT01146600|340099|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
140266|NCT01146600|340098|P2|STARTED|Period 2 (Weeks 4 & 5)||10
140267|NCT01146600|340099|P1|STARTED|Period 2 (Weeks 4 & 5)||10
140268|NCT01146600|340098|P2|NOT COMPLETED|Washout (Week 3)||0
140269|NCT01146600|340099|P1|NOT COMPLETED|Washout (Week 3)||0
140270|NCT01146600|340098|P2|COMPLETED|Washout (Week 3)||10
140271|NCT01146600|340099|P1|COMPLETED|Washout (Week 3)||10
140272|NCT01146600|340098|P2|STARTED|Washout (Week 3)||10
140273|NCT01146600|340099|P1|STARTED|Washout (Week 3)||10
140274|NCT01146600|340098|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
140275|NCT01146600|340099|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
140276|NCT01146600|340098|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
140277|NCT01146600|340099|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
140278|NCT01146600|340098|P2|STARTED|Period 1 (Weeks 1 & 2)||10
140279|NCT01146600|340099|P1|STARTED|Period 1 (Weeks 1 & 2)||13
140280|NCT01146457|340129|P5|NOT COMPLETED|Overall Study||0
140281|NCT01146457|340130|P4|NOT COMPLETED|Overall Study||0
140282|NCT01146457|340131|P3|NOT COMPLETED|Overall Study||1
140283|NCT01146457|340132|P2|NOT COMPLETED|Overall Study||0
140284|NCT01146457|340133|P1|NOT COMPLETED|Overall Study||0
140285|NCT01146457|340129|P5|COMPLETED|Overall Study||13
140286|NCT01146457|340130|P4|COMPLETED|Overall Study||13
140287|NCT01146457|340131|P3|COMPLETED|Overall Study||20
140288|NCT01146457|340132|P2|COMPLETED|Overall Study||17
140289|NCT01146457|340133|P1|COMPLETED|Overall Study||19
140290|NCT01146457|340129|P5|STARTED|Overall Study||13
140291|NCT01146457|340130|P4|STARTED|Overall Study||13
140292|NCT01146457|340131|P3|STARTED|Overall Study||21
140293|NCT01146457|340132|P2|STARTED|Overall Study||17
140294|NCT01146457|340133|P1|STARTED|Overall Study||19
140295|NCT01146418|340147|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
140296|NCT01146418|340148|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
140297|NCT01146418|340149|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
140298|NCT01146418|340150|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
140299|NCT01146418|340147|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
140300|NCT01146418|340148|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
140301|NCT01146418|340149|P2|COMPLETED|Live-Born Infant Follow Up||0
140302|NCT01146418|340150|P1|COMPLETED|Live-Born Infant Follow Up||0
140303|NCT01146418|340147|P4|STARTED|Live-Born Infant Follow Up||56
140304|NCT01146418|340148|P3|STARTED|Live-Born Infant Follow Up||61
140305|NCT01146418|340149|P2|STARTED|Live-Born Infant Follow Up||0
140306|NCT01146418|340150|P1|STARTED|Live-Born Infant Follow Up||0
140307|NCT01146418|340147|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
140308|NCT01146418|340148|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
140309|NCT01146418|340149|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
140310|NCT01146418|340150|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
140311|NCT01146418|340147|P4|COMPLETED|Women/Expectant Mother Follow Up||0
140312|NCT01146418|340148|P3|COMPLETED|Women/Expectant Mother Follow Up||0
140313|NCT01146418|340149|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
140314|NCT01146418|340150|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
140315|NCT01146418|340147|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
140316|NCT01146418|340148|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
140317|NCT01146418|340149|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
140318|NCT01146418|340150|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
140319|NCT01146418|340147|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
140320|NCT01146418|340148|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
140321|NCT01146418|340149|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
140322|NCT01146418|340150|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
140323|NCT01146418|340147|P4|STARTED|Women/Expectant Mother Follow Up||0
140324|NCT01146418|340148|P3|STARTED|Women/Expectant Mother Follow Up||0
140325|NCT01146418|340149|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
140326|NCT01146418|340150|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
140327|NCT01146418|340147|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
140328|NCT01146418|340148|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
140329|NCT01146418|340149|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
140330|NCT01146418|340150|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
140331|NCT01146418|340147|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
140332|NCT01146418|340148|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
140333|NCT01146418|340149|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
140334|NCT01146418|340150|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
140335|NCT01146418|340147|P4|STARTED|Base Study P06029 (NCT01144416)||0
140336|NCT01146418|340148|P3|STARTED|Base Study P06029 (NCT01144416)||0
140337|NCT01146418|340149|P2|STARTED|Base Study P06029 (NCT01144416)||696
140338|NCT01146418|340150|P1|STARTED|Base Study P06029 (NCT01144416)||694
140339|NCT01146379|340166|P4|NOT COMPLETED|Overall Study||1
140340|NCT01146379|340167|P3|NOT COMPLETED|Overall Study||0
140341|NCT01146379|340168|P2|NOT COMPLETED|Overall Study||1
140342|NCT01146379|340169|P1|NOT COMPLETED|Overall Study||1
140343|NCT01146379|340166|P4|COMPLETED|Overall Study||20
140344|NCT01146379|340167|P3|COMPLETED|Overall Study||21
140345|NCT01146379|340168|P2|COMPLETED|Overall Study||21
140346|NCT01146379|340169|P1|COMPLETED|Overall Study||20
140347|NCT01146379|340166|P4|STARTED|Overall Study||21
140348|NCT01146379|340167|P3|STARTED|Overall Study||21
140349|NCT01146379|340168|P2|STARTED|Overall Study||22
140350|NCT01146379|340169|P1|STARTED|Overall Study||21
140351|NCT01146288|340181|P2|NOT COMPLETED|Second Intervention (1 Day)||0
140352|NCT01146288|340182|P1|NOT COMPLETED|Second Intervention (1 Day)||0
140353|NCT01146288|340181|P2|COMPLETED|Second Intervention (1 Day)||5
140354|NCT01146288|340182|P1|COMPLETED|Second Intervention (1 Day)||7
140355|NCT01146288|340181|P2|STARTED|Second Intervention (1 Day)||5
140356|NCT01146288|340182|P1|STARTED|Second Intervention (1 Day)||7
140357|NCT01146288|340181|P2|NOT COMPLETED|First Intervention(1 Day)||1
140358|NCT01146288|340182|P1|NOT COMPLETED|First Intervention(1 Day)||0
140359|NCT01146288|340181|P2|COMPLETED|First Intervention(1 Day)||5
140360|NCT01146288|340182|P1|COMPLETED|First Intervention(1 Day)||7
140361|NCT01146288|340181|P2|STARTED|First Intervention(1 Day)||6
140362|NCT01146288|340182|P1|STARTED|First Intervention(1 Day)||7
140363|NCT01146275|340191|P1|NOT COMPLETED|Overall Study||0
140364|NCT01146275|340191|P1|COMPLETED|Overall Study||6
140365|NCT01146275|340191|P1|STARTED|Overall Study||6
140366|NCT01146054|340196|P1|NOT COMPLETED|Overall Study||10
140367|NCT01146054|340196|P1|COMPLETED|Overall Study||49
140368|NCT01146054|340196|P1|STARTED|Overall Study||59
140369|NCT01145898|340206|P2|NOT COMPLETED|3-year Treatment||16
140370|NCT01145898|340207|P1|NOT COMPLETED|3-year Treatment||3
140371|NCT01145898|340206|P2|COMPLETED|3-year Treatment||28
140372|NCT01145898|340207|P1|COMPLETED|3-year Treatment||9
140373|NCT01145898|340206|P2|STARTED|3-year Treatment||44
140374|NCT01145898|340207|P1|STARTED|3-year Treatment||12
140375|NCT01145898|340206|P2|NOT COMPLETED|6-month Treatment||0
140376|NCT01145898|340207|P1|NOT COMPLETED|6-month Treatment||0
140377|NCT01145898|340206|P2|COMPLETED|6-month Treatment||44
140378|NCT01145898|340207|P1|COMPLETED|6-month Treatment||12
140379|NCT01145898|340206|P2|STARTED|6-month Treatment||44
140380|NCT01145898|340207|P1|STARTED|6-month Treatment||12
140381|NCT01145755|340241|P3|NOT COMPLETED|Overall Study||25
140382|NCT01145755|340242|P2|NOT COMPLETED|Overall Study||28
140383|NCT01145755|340243|P1|NOT COMPLETED|Overall Study||20
140384|NCT01145755|340241|P3|COMPLETED|Overall Study||19
140385|NCT01145755|340242|P2|COMPLETED|Overall Study||19
140386|NCT01145755|340243|P1|COMPLETED|Overall Study||20
140387|NCT01145755|340241|P3|STARTED|Overall Study||44
140388|NCT01145755|340242|P2|STARTED|Overall Study||47
140389|NCT01145755|340243|P1|STARTED|Overall Study||40
140390|NCT01145638|340259|P2|NOT COMPLETED|Overall Study||57
140391|NCT01145638|340260|P1|NOT COMPLETED|Overall Study||90
140392|NCT01145638|340259|P2|COMPLETED|Overall Study||62
140393|NCT01145638|340260|P1|COMPLETED|Overall Study||141
140394|NCT01145638|340259|P2|STARTED|Overall Study||119
140395|NCT01145638|340260|P1|STARTED|Overall Study||231
140396|NCT01145625|340270|P2|NOT COMPLETED|Overall Study||31
140397|NCT01145625|340271|P1|NOT COMPLETED|Overall Study||24
140398|NCT01145625|340270|P2|COMPLETED|Overall Study||130
140399|NCT01145625|340271|P1|COMPLETED|Overall Study||137
140400|NCT01145625|340270|P2|STARTED|Overall Study||161
140401|NCT01145625|340271|P1|STARTED|Overall Study||161
140402|NCT01145560|340284|P3|NOT COMPLETED|Overall Study||2
140403|NCT01145560|340285|P2|NOT COMPLETED|Overall Study||4
140404|NCT01145560|340286|P1|NOT COMPLETED|Overall Study||4
140405|NCT01145560|340284|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
140406|NCT01145560|340285|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
140407|NCT01145560|340286|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
140408|NCT01145560|340284|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
140409|NCT01145560|340285|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
140410|NCT01145560|340286|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
140411|NCT01145560|340284|P3|Received Treatment|Overall Study||99
140412|NCT01145560|340285|P2|Received Treatment|Overall Study||98
140413|NCT01145560|340286|P1|Received Treatment|Overall Study||99
140414|NCT01145560|340284|P3|STARTED|Overall Study||100
140415|NCT01145560|340285|P2|STARTED|Overall Study||100
140416|NCT01145560|340286|P1|STARTED|Overall Study||100
140417|NCT01145547|340303|P2|NOT COMPLETED|Overall Study||0
140418|NCT01145547|340304|P1|NOT COMPLETED|Overall Study||0
140419|NCT01145547|340303|P2|COMPLETED|Overall Study||3
140420|NCT01145547|340304|P1|COMPLETED|Overall Study||4
140421|NCT01145547|340303|P2|STARTED|Overall Study||3
140422|NCT01145547|340304|P1|STARTED|Overall Study||4
140423|NCT01145508|340312|P2|NOT COMPLETED|Overall Study||2
140424|NCT01145508|340313|P1|NOT COMPLETED|Overall Study||5
140425|NCT01145508|340312|P2|COMPLETED|Overall Study||1
140426|NCT01145508|340313|P1|COMPLETED|Overall Study||2
140427|NCT01145508|340312|P2|Treated|Overall Study||2
140428|NCT01145508|340313|P1|Treated|Overall Study||6
140429|NCT01145508|340312|P2|STARTED|Overall Study||3
140430|NCT01145508|340313|P1|STARTED|Overall Study||7
140431|NCT01145495|340319|P1|NOT COMPLETED|Overall Study||12
140432|NCT01145495|340319|P1|COMPLETED|Overall Study||51
140433|NCT01145495|340319|P1|STARTED|Overall Study||63
140434|NCT01145482|340325|P2|NOT COMPLETED|Second Intervention (1 Day)||0
140435|NCT01145482|340326|P1|NOT COMPLETED|Second Intervention (1 Day)||0
140436|NCT01145482|340325|P2|COMPLETED|Second Intervention (1 Day)||6
140437|NCT01145482|340326|P1|COMPLETED|Second Intervention (1 Day)||5
140438|NCT01145482|340325|P2|STARTED|Second Intervention (1 Day)||6
140439|NCT01145482|340326|P1|STARTED|Second Intervention (1 Day)||5
140440|NCT01145482|340325|P2|NOT COMPLETED|First Intervention (1 Day)||1
140441|NCT01145482|340326|P1|NOT COMPLETED|First Intervention (1 Day)||0
140442|NCT01145482|340325|P2|COMPLETED|First Intervention (1 Day)||5
140443|NCT01145482|340326|P1|COMPLETED|First Intervention (1 Day)||6
140444|NCT01145482|340325|P2|STARTED|First Intervention (1 Day)||6
140445|NCT01145482|340326|P1|STARTED|First Intervention (1 Day)||6
140446|NCT01145417|340336|P2|NOT COMPLETED|Overall Study||47
140447|NCT01145417|340337|P1|NOT COMPLETED|Overall Study||41
140448|NCT01145417|340336|P2|COMPLETED|Overall Study||62
140449|NCT01145417|340337|P1|COMPLETED|Overall Study||67
140450|NCT01145417|340336|P2|STARTED|Overall Study||109
140451|NCT01145417|340337|P1|STARTED|Overall Study||108
140452|NCT01145391|340361|P2|NOT COMPLETED|Overall Study||0
140453|NCT01145391|340362|P1|NOT COMPLETED|Overall Study||0
140454|NCT01145391|340361|P2|COMPLETED|Overall Study||298
140455|NCT01145391|340362|P1|COMPLETED|Overall Study||293
140456|NCT01145391|340361|P2|9 Months Post-randomization|Overall Study||298
140457|NCT01145391|340362|P1|9 Months Post-randomization|Overall Study||293
140458|NCT01145391|340361|P2|STARTED|Overall Study||298
140459|NCT01145391|340362|P1|STARTED|Overall Study||293
140460|NCT01145352|340370|P1|NOT COMPLETED|Overall Study||11
140461|NCT01145352|340370|P1|COMPLETED|Overall Study||102
140462|NCT01145352|340370|P1|STARTED|Overall Study||113
140463|NCT01145053|340378|P1|NOT COMPLETED|Overall Study||93
140464|NCT01145053|340378|P1|COMPLETED|Overall Study||248
140465|NCT01145053|340378|P1|STARTED|Overall Study||341
140466|NCT01145001|340392|P4|NOT COMPLETED|Overall Study||6
140467|NCT01145001|340393|P3|NOT COMPLETED|Overall Study||5
140468|NCT01145001|340394|P2|NOT COMPLETED|Overall Study||6
140469|NCT01145001|340395|P1|NOT COMPLETED|Overall Study||8
140470|NCT01145001|340392|P4|COMPLETED|Overall Study||31
140471|NCT01145001|340393|P3|COMPLETED|Overall Study||39
140472|NCT01145001|340394|P2|COMPLETED|Overall Study||31
140473|NCT01145001|340395|P1|COMPLETED|Overall Study||28
140474|NCT01145001|340392|P4|STARTED|Overall Study||37
140475|NCT01145001|340393|P3|STARTED|Overall Study||44
140476|NCT01145001|340394|P2|STARTED|Overall Study||37
140477|NCT01145001|340395|P1|STARTED|Overall Study||36
140478|NCT01144949|340411|P2|NOT COMPLETED|Overall Study||14
140479|NCT01144949|340412|P1|NOT COMPLETED|Overall Study||11
140480|NCT01144949|340411|P2|COMPLETED|Overall Study||106
140481|NCT01144949|340412|P1|COMPLETED|Overall Study||108
140482|NCT01144949|340411|P2|STARTED|Overall Study||120
140483|NCT01144949|340412|P1|STARTED|Overall Study||119
140484|NCT01144715|340430|P2|NOT COMPLETED|Overall Study||3
140485|NCT01144715|340431|P1|NOT COMPLETED|Overall Study||4
140486|NCT01144715|340430|P2|COMPLETED|Overall Study||45
140487|NCT01144715|340431|P1|COMPLETED|Overall Study||47
140488|NCT01144715|340430|P2|STARTED|Overall Study||48
140489|NCT01144715|340431|P1|STARTED|Overall Study||51
140490|NCT01144624|340446|P3|NOT COMPLETED|Overall Study||0
140491|NCT01144624|340447|P2|NOT COMPLETED|Overall Study||0
140492|NCT01144624|340448|P1|NOT COMPLETED|Overall Study||0
140493|NCT01144624|340446|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
140494|NCT01144624|340447|P2|COMPLETED|Overall Study||7
140495|NCT01144624|340448|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
140496|NCT01144624|340446|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
140497|NCT01144624|340447|P2|Completed Treatment|Overall Study||7
140498|NCT01144624|340448|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
140499|NCT01144624|340446|P3|Received Treatment|Overall Study||6
140500|NCT01144624|340447|P2|Received Treatment|Overall Study||7
140501|NCT01144624|340448|P1|Received Treatment|Overall Study||7
140502|NCT01144624|340446|P3|STARTED|Overall Study||6
140503|NCT01144624|340447|P2|STARTED|Overall Study||7
140504|NCT01144624|340448|P1|STARTED|Overall Study||7
140505|NCT01144598|340462|P1|NOT COMPLETED|Overall Study||0
140506|NCT01144598|340462|P1|COMPLETED|Overall Study||356
140507|NCT01144598|340462|P1|Analysis Population|Overall Study||356
140508|NCT01144598|340462|P1|STARTED|Overall Study||356
140509|NCT01144455|340483|P3|NOT COMPLETED|Overall Study||36
140510|NCT01144455|340484|P2|NOT COMPLETED|Overall Study||42
140511|NCT01144455|340485|P1|NOT COMPLETED|Overall Study||50
140512|NCT01144455|340483|P3|COMPLETED|Overall Study||38
140513|NCT01144455|340484|P2|COMPLETED|Overall Study||29
140514|NCT01144455|340485|P1|COMPLETED|Overall Study||19
140515|NCT01144455|340483|P3|STARTED|Overall Study||74
140516|NCT01144455|340484|P2|STARTED|Overall Study||71
140517|NCT01144455|340485|P1|STARTED|Overall Study||69
140518|NCT01144442|340493|P1|NOT COMPLETED|Overall Study||0
140519|NCT01144442|340493|P1|COMPLETED|Overall Study||10
140520|NCT01144442|340493|P1|STARTED|Overall Study||10
140521|NCT01144416|340500|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
140522|NCT01144416|340501|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
140523|NCT01144416|340500|P2|COMPLETED|Pregnancy Follow-up Period||157
140524|NCT01144416|340501|P1|COMPLETED|Pregnancy Follow-up Period||146
140525|NCT01144416|340500|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
140601|NCT01144364|340582|P3|STARTED|Induction Phase||0
140526|NCT01144416|340501|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
140527|NCT01144416|340500|P2|NOT COMPLETED|Intervention Period||49
140528|NCT01144416|340501|P1|NOT COMPLETED|Intervention Period||62
140529|NCT01144416|340500|P2|COMPLETED|Intervention Period||647
140530|NCT01144416|340501|P1|COMPLETED|Intervention Period||632
140531|NCT01144416|340500|P2|STARTED|Intervention Period||696
140532|NCT01144416|340501|P1|STARTED|Intervention Period||694
140533|NCT01144403|340517|P1|NOT COMPLETED|Overall Study||5
140534|NCT01144403|340517|P1|COMPLETED|Overall Study||3
140535|NCT01144403|340517|P1|STARTED|Overall Study||8
140536|NCT01144377|340529|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
140537|NCT01144377|340530|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
140538|NCT01144377|340531|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
140539|NCT01144377|340532|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
140540|NCT01144377|340533|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
140541|NCT01144377|340529|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
140542|NCT01144377|340530|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
140543|NCT01144377|340531|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
140544|NCT01144377|340532|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
140545|NCT01144377|340533|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
140546|NCT01144377|340529|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
140547|NCT01144377|340530|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
140548|NCT01144377|340531|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
140549|NCT01144377|340532|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
140550|NCT01144377|340533|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
140551|NCT01144377|340529|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
140552|NCT01144377|340530|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
140553|NCT01144377|340531|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
140554|NCT01144377|340532|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
140555|NCT01144377|340533|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
140556|NCT01144377|340529|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
140557|NCT01144377|340530|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
140558|NCT01144377|340531|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
140559|NCT01144377|340532|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
140560|NCT01144377|340533|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
140561|NCT01144377|340529|P5|STARTED|12 Week Safety Follow-up Period||34
140562|NCT01144377|340530|P4|STARTED|12 Week Safety Follow-up Period||22
140563|NCT01144377|340531|P3|STARTED|12 Week Safety Follow-up Period||25
140564|NCT01144377|340532|P2|STARTED|12 Week Safety Follow-up Period||29
140565|NCT01144377|340533|P1|STARTED|12 Week Safety Follow-up Period||26
140566|NCT01144377|340529|P5|NOT COMPLETED|52 Week Treatment Period||3
140567|NCT01144377|340530|P4|NOT COMPLETED|52 Week Treatment Period||4
140568|NCT01144377|340531|P3|NOT COMPLETED|52 Week Treatment Period||5
140569|NCT01144377|340532|P2|NOT COMPLETED|52 Week Treatment Period||1
140570|NCT01144377|340533|P1|NOT COMPLETED|52 Week Treatment Period||5
140571|NCT01144377|340529|P5|COMPLETED|52 Week Treatment Period||34
140572|NCT01144377|340530|P4|COMPLETED|52 Week Treatment Period||22
140573|NCT01144377|340531|P3|COMPLETED|52 Week Treatment Period||25
140574|NCT01144377|340532|P2|COMPLETED|52 Week Treatment Period||29
140575|NCT01144377|340533|P1|COMPLETED|52 Week Treatment Period||26
140576|NCT01144377|340529|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
140577|NCT01144377|340530|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
140578|NCT01144377|340531|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
140579|NCT01144377|340532|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
140580|NCT01144377|340533|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
140581|NCT01144377|340529|P5|STARTED|52 Week Treatment Period||37
140582|NCT01144377|340530|P4|STARTED|52 Week Treatment Period||26
140583|NCT01144377|340531|P3|STARTED|52 Week Treatment Period||30
140584|NCT01144377|340532|P2|STARTED|52 Week Treatment Period||30
140585|NCT01144377|340533|P1|STARTED|52 Week Treatment Period||31
140586|NCT01144364|340582|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
140587|NCT01144364|340583|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
140588|NCT01144364|340584|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
140589|NCT01144364|340582|P3|COMPLETED|Follow-Up/Maintenance Phase||60
140590|NCT01144364|340583|P2|COMPLETED|Follow-Up/Maintenance Phase||66
140591|NCT01144364|340584|P1|COMPLETED|Follow-Up/Maintenance Phase||0
140592|NCT01144364|340582|P3|STARTED|Follow-Up/Maintenance Phase||101
140593|NCT01144364|340583|P2|STARTED|Follow-Up/Maintenance Phase||101
140594|NCT01144364|340584|P1|STARTED|Follow-Up/Maintenance Phase||0
140595|NCT01144364|340582|P3|NOT COMPLETED|Induction Phase||0
140596|NCT01144364|340583|P2|NOT COMPLETED|Induction Phase||0
140597|NCT01144364|340584|P1|NOT COMPLETED|Induction Phase||32
140598|NCT01144364|340582|P3|COMPLETED|Induction Phase||0
140599|NCT01144364|340583|P2|COMPLETED|Induction Phase||0
140600|NCT01144364|340584|P1|COMPLETED|Induction Phase||202
140602|NCT01144364|340583|P2|STARTED|Induction Phase||0
140603|NCT01144364|340584|P1|STARTED|Induction Phase||234
140604|NCT01144299|340610|P2|NOT COMPLETED|Overall Study||0
140605|NCT01144299|340611|P1|NOT COMPLETED|Overall Study||2
140606|NCT01144299|340610|P2|COMPLETED|Overall Study||54
140607|NCT01144299|340611|P1|COMPLETED|Overall Study||58
140608|NCT01144299|340610|P2|STARTED|Overall Study||54
140609|NCT01144299|340611|P1|STARTED|Overall Study||60
140610|NCT01144286|340637|P4|NOT COMPLETED|Overall Study||0
140611|NCT01144286|340638|P3|NOT COMPLETED|Overall Study||0
140612|NCT01144286|340639|P2|NOT COMPLETED|Overall Study||0
140613|NCT01144286|340640|P1|NOT COMPLETED|Overall Study||0
140614|NCT01144286|340637|P4|COMPLETED|Overall Study||56
140615|NCT01144286|340638|P3|COMPLETED|Overall Study||58
140616|NCT01144286|340639|P2|COMPLETED|Overall Study||58
140617|NCT01144286|340640|P1|COMPLETED|Overall Study||57
140618|NCT01144286|340637|P4|STARTED|Overall Study||56
140619|NCT01144286|340638|P3|STARTED|Overall Study||58
140620|NCT01144286|340639|P2|STARTED|Overall Study||58
140621|NCT01144286|340640|P1|STARTED|Overall Study||57
140622|NCT01144182|340656|P2|NOT COMPLETED|Overall Study||21
140623|NCT01144182|340657|P1|NOT COMPLETED|Overall Study||17
140624|NCT01144182|340656|P2|COMPLETED|Overall Study||47
140625|NCT01144182|340657|P1|COMPLETED|Overall Study||51
140626|NCT01144182|340656|P2|STARTED|Overall Study||68
140627|NCT01144182|340657|P1|STARTED|Overall Study||68
140628|NCT01144143|340690|P3|NOT COMPLETED|Overall Study||0
140629|NCT01144143|340691|P2|NOT COMPLETED|Overall Study||0
140630|NCT01144143|340692|P1|NOT COMPLETED|Overall Study||0
140631|NCT01144143|340690|P3|COMPLETED|Overall Study||4
140632|NCT01144143|340691|P2|COMPLETED|Overall Study||4
140633|NCT01144143|340692|P1|COMPLETED|Overall Study||8
140634|NCT01144143|340690|P3|STARTED|Overall Study||4
140635|NCT01144143|340691|P2|STARTED|Overall Study||4
140636|NCT01144143|340692|P1|STARTED|Overall Study||8
140637|NCT01144052|340717|P2|NOT COMPLETED|Overall Study||1
140638|NCT01144052|340718|P1|NOT COMPLETED|Overall Study||1
140639|NCT01144052|340717|P2|COMPLETED|Overall Study||8
140640|NCT01144052|340718|P1|COMPLETED|Overall Study||9
140641|NCT01144052|340717|P2|STARTED|Overall Study||9
140642|NCT01144052|340718|P1|STARTED|Overall Study||10
140643|NCT01144026|340740|P2|NOT COMPLETED|Overall Study||0
140644|NCT01144026|340741|P1|NOT COMPLETED|Overall Study||0
140645|NCT01144026|340740|P2|COMPLETED|Overall Study||5
140646|NCT01144026|340741|P1|COMPLETED|Overall Study||10
140647|NCT01144026|340740|P2|STARTED|Overall Study||5
140648|NCT01144026|340741|P1|STARTED|Overall Study||10
140649|NCT01143896|340749|P2|NOT COMPLETED|Overall Study||25
140650|NCT01143896|340750|P1|NOT COMPLETED|Overall Study||42
140651|NCT01143896|340749|P2|COMPLETED|Overall Study||128
140652|NCT01143896|340750|P1|COMPLETED|Overall Study||114
140653|NCT01143896|340749|P2|STARTED|Overall Study||153
140654|NCT01143896|340750|P1|STARTED|Overall Study||156
140655|NCT01143883|340768|P2|NOT COMPLETED|Overall Study||0
140656|NCT01143883|340769|P1|NOT COMPLETED|Overall Study||0
140657|NCT01143883|340768|P2|COMPLETED|Overall Study||55
140658|NCT01143883|340769|P1|COMPLETED|Overall Study||55
140659|NCT01143883|340768|P2|STARTED|Overall Study||55
140660|NCT01143883|340769|P1|STARTED|Overall Study||55
140661|NCT01143870|340778|P3|NOT COMPLETED|Overall Study||0
140662|NCT01143870|340779|P2|NOT COMPLETED|Overall Study||0
140663|NCT01143870|340780|P1|NOT COMPLETED|Overall Study||0
140664|NCT01143870|340778|P3|COMPLETED|Overall Study||61
140665|NCT01143870|340779|P2|COMPLETED|Overall Study||58
140666|NCT01143870|340780|P1|COMPLETED|Overall Study||58
140667|NCT01143870|340778|P3|A1C Imputed|Overall Study||30
140668|NCT01143870|340779|P2|A1C Imputed|Overall Study||29
140669|NCT01143870|340780|P1|A1C Imputed|Overall Study||31
140670|NCT01143870|340778|P3|Had Available 6-month A1C|Overall Study||31
140671|NCT01143870|340779|P2|Had Available 6-month A1C|Overall Study||29
140672|NCT01143870|340780|P1|Had Available 6-month A1C|Overall Study||27
140673|NCT01143870|340778|P3|Post-intervention Survey|Overall Study||61
140674|NCT01143870|340779|P2|Post-intervention Survey|Overall Study||50
140675|NCT01143870|340780|P1|Post-intervention Survey|Overall Study||53
140676|NCT01143870|340778|P3|STARTED|Overall Study||61
140677|NCT01143870|340779|P2|STARTED|Overall Study||58
140678|NCT01143870|340780|P1|STARTED|Overall Study||58
140679|NCT01143818|340788|P1|NOT COMPLETED|Overall Study||250
140680|NCT01143818|340788|P1|COMPLETED|Overall Study||799
140681|NCT01143818|340788|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
140682|NCT01143792|340798|P3|NOT COMPLETED|Overall Study||0
140683|NCT01143792|340799|P2|NOT COMPLETED|Overall Study||0
140684|NCT01143792|340800|P1|NOT COMPLETED|Overall Study||0
140685|NCT01143792|340798|P3|COMPLETED|Overall Study||91
140686|NCT01143792|340799|P2|COMPLETED|Overall Study||86
140687|NCT01143792|340800|P1|COMPLETED|Overall Study||93
140688|NCT01143792|340798|P3|STARTED|Overall Study||91
140689|NCT01143792|340799|P2|STARTED|Overall Study||86
140690|NCT01143792|340800|P1|STARTED|Overall Study||93
140691|NCT01143766|340834|P2|NOT COMPLETED|Overall Study||0
140692|NCT01143766|340835|P1|NOT COMPLETED|Overall Study||0
140693|NCT01143766|340834|P2|COMPLETED|Overall Study||31
140694|NCT01143766|340835|P1|COMPLETED|Overall Study||25
140695|NCT01143766|340834|P2|STARTED|Overall Study||31
140696|NCT01143766|340835|P1|STARTED|Overall Study||25
140697|NCT01143727|340851|P2|NOT COMPLETED|Overall Study||0
140698|NCT01143727|340852|P1|NOT COMPLETED|Overall Study||0
140699|NCT01143727|340851|P2|COMPLETED|Overall Study||8
140700|NCT01143727|340852|P1|COMPLETED|Overall Study||9
140701|NCT01143727|340851|P2|STARTED|Overall Study||8
140702|NCT01143727|340852|P1|STARTED|Overall Study||9
140703|NCT01143714|340862|P2|NOT COMPLETED|Overall Study||3
140704|NCT01143714|340863|P1|NOT COMPLETED|Overall Study||7
140705|NCT01143714|340862|P2|COMPLETED|Overall Study||25
140706|NCT01143714|340863|P1|COMPLETED|Overall Study||22
140707|NCT01143714|340862|P2|STARTED|Overall Study||28
140708|NCT01143714|340863|P1|STARTED|Overall Study||29
140709|NCT01143701|340873|P2|NOT COMPLETED|Overall Study||32
140710|NCT01143701|340874|P1|NOT COMPLETED|Overall Study||23
140711|NCT01143701|340873|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
140712|NCT01143701|340874|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
140713|NCT01143701|340873|P2|STARTED|Overall Study||319
140714|NCT01143701|340874|P1|STARTED|Overall Study||258
140715|NCT01143688|340882|P1|NOT COMPLETED|Overall Study||0
140716|NCT01143688|340882|P1|COMPLETED|Overall Study||39
140717|NCT01143688|340882|P1|STARTED|Overall Study||39
140718|NCT01143649|340901|P6|NOT COMPLETED|Overall Study||2
140719|NCT01143649|340902|P5|NOT COMPLETED|Overall Study||1
140720|NCT01143649|340903|P4|NOT COMPLETED|Overall Study||0
140721|NCT01143649|340904|P3|NOT COMPLETED|Overall Study||0
140722|NCT01143649|340905|P2|NOT COMPLETED|Overall Study||0
140723|NCT01143649|340906|P1|NOT COMPLETED|Overall Study||0
140724|NCT01143649|340901|P6|COMPLETED|Overall Study||3
140725|NCT01143649|340902|P5|COMPLETED|Overall Study||4
140726|NCT01143649|340903|P4|COMPLETED|Overall Study||10
140727|NCT01143649|340904|P3|COMPLETED|Overall Study||10
140728|NCT01143649|340905|P2|COMPLETED|Overall Study||7
140729|NCT01143649|340906|P1|COMPLETED|Overall Study||7
140730|NCT01143649|340901|P6|STARTED|Overall Study||5
140731|NCT01143649|340902|P5|STARTED|Overall Study||5
140732|NCT01143649|340903|P4|STARTED|Overall Study||10
140733|NCT01143649|340904|P3|STARTED|Overall Study||10
140734|NCT01143649|340905|P2|STARTED|Overall Study||7
140735|NCT01143649|340906|P1|STARTED|Overall Study||7
140736|NCT01143636|340923|P4|NOT COMPLETED|Overall Study||0
140737|NCT01143636|340924|P3|NOT COMPLETED|Overall Study||0
140738|NCT01143636|340925|P2|NOT COMPLETED|Overall Study||1
140739|NCT01143636|340926|P1|NOT COMPLETED|Overall Study||1
140740|NCT01143636|340923|P4|COMPLETED|Overall Study||7
140741|NCT01143636|340924|P3|COMPLETED|Overall Study||8
140742|NCT01143636|340925|P2|COMPLETED|Overall Study||4
140743|NCT01143636|340926|P1|COMPLETED|Overall Study||5
140744|NCT01143636|340923|P4|STARTED|Overall Study||7
140745|NCT01143636|340924|P3|STARTED|Overall Study||8
140746|NCT01143636|340925|P2|STARTED|Overall Study||5
140747|NCT01143636|340926|P1|STARTED|Overall Study||6
140748|NCT01143610|340956|P2|NOT COMPLETED|Overall Study||0
140749|NCT01143610|340957|P1|NOT COMPLETED|Overall Study||0
140750|NCT01143610|340956|P2|COMPLETED|Overall Study||8
140751|NCT01143610|340957|P1|COMPLETED|Overall Study||7
140752|NCT01143610|340956|P2|STARTED|Overall Study||8
140753|NCT01143610|340957|P1|STARTED|Overall Study||7
140754|NCT01143402|340968|P3|NOT COMPLETED|Overall Study||1
140755|NCT01143402|340969|P2|NOT COMPLETED|Overall Study||1
140756|NCT01143402|340970|P1|NOT COMPLETED|Overall Study||1
140757|NCT01143402|340968|P3|COMPLETED|Overall Study||18
140758|NCT01143402|340969|P2|COMPLETED|Overall Study||49
140759|NCT01143402|340970|P1|COMPLETED|Overall Study||50
140760|NCT01143402|340968|P3|STARTED|Overall Study||19
140761|NCT01143402|340969|P2|STARTED|Overall Study||50
140762|NCT01143402|340970|P1|STARTED|Overall Study||51
140763|NCT01143389|340981|P2|NOT COMPLETED|Overall Study||25
140764|NCT01143389|340982|P1|NOT COMPLETED|Overall Study||26
140765|NCT01143389|340981|P2|COMPLETED|Overall Study||232
140766|NCT01143389|340982|P1|COMPLETED|Overall Study||227
140767|NCT01143389|340981|P2|STARTED|Overall Study||257
140768|NCT01143389|340982|P1|STARTED|Overall Study||253
140769|NCT01143337|340996|P3|NOT COMPLETED|Overall Study||12
140770|NCT01143337|340997|P2|NOT COMPLETED|Overall Study||11
140771|NCT01143337|340998|P1|NOT COMPLETED|Overall Study||10
140772|NCT01143337|340996|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
140773|NCT01143337|340997|P2|COMPLETED|Overall Study||39
140774|NCT01143337|340998|P1|COMPLETED|Overall Study||39
140775|NCT01143337|340996|P3|STARTED|Overall Study||13
140776|NCT01143337|340997|P2|STARTED|Overall Study||50
140777|NCT01143337|340998|P1|STARTED|Overall Study||49
140778|NCT01143324|341012|P1|NOT COMPLETED|Overall Study||19
140779|NCT01143324|341012|P1|COMPLETED|Overall Study||233
140780|NCT01143324|341012|P1|STARTED|Overall Study||252
140781|NCT01143272|341030|P2|NOT COMPLETED|Overall Study||0
140782|NCT01143272|341031|P1|NOT COMPLETED|Overall Study||0
140783|NCT01143272|341030|P2|COMPLETED|Overall Study||231
140784|NCT01143272|341031|P1|COMPLETED|Overall Study||246
140785|NCT01143272|341030|P2|STARTED|Overall Study||231
140786|NCT01143272|341031|P1|STARTED|Overall Study||246
140787|NCT01143259|341051|P2|NOT COMPLETED|Overall Study||20
140788|NCT01143259|341052|P1|NOT COMPLETED|Overall Study||23
140789|NCT01143259|341051|P2|COMPLETED|Overall Study||118
140790|NCT01143259|341052|P1|COMPLETED|Overall Study||113
140791|NCT01143259|341051|P2|STARTED|Overall Study||138
140792|NCT01143259|341052|P1|STARTED|Overall Study||136
140793|NCT01143207|341060|P1|NOT COMPLETED|Overall Study||2
140794|NCT01143207|341060|P1|COMPLETED|Overall Study||24
140795|NCT01143207|341060|P1|STARTED|Overall Study||26
140796|NCT01143142|341071|P2|NOT COMPLETED|Overall Study||0
140797|NCT01143142|341072|P1|NOT COMPLETED|Overall Study||0
140798|NCT01143142|341071|P2|COMPLETED|Overall Study||34
140799|NCT01143142|341072|P1|COMPLETED|Overall Study||36
140800|NCT01143142|341071|P2|STARTED|Overall Study||34
140801|NCT01143142|341072|P1|STARTED|Overall Study||36
140802|NCT01143090|341080|P1|NOT COMPLETED|Overall Study||51
140803|NCT01143090|341080|P1|COMPLETED|Overall Study||98
140804|NCT01143090|341080|P1|STARTED|Overall Study||149
140805|NCT01143077|341087|P3|NOT COMPLETED|Overall Study||15
140806|NCT01143077|341088|P2|NOT COMPLETED|Overall Study||15
140807|NCT01143077|341089|P1|NOT COMPLETED|Overall Study||16
140808|NCT01143077|341087|P3|COMPLETED|Overall Study||67
140809|NCT01143077|341088|P2|COMPLETED|Overall Study||73
140810|NCT01143077|341089|P1|COMPLETED|Overall Study||58
140811|NCT01143077|341087|P3|STARTED|Overall Study||82
140812|NCT01143077|341088|P2|STARTED|Overall Study||88
140813|NCT01143077|341089|P1|STARTED|Overall Study||74
140814|NCT01143051|341106|P6|NOT COMPLETED|Visit 3||0
140815|NCT01143051|341107|P5|NOT COMPLETED|Visit 3||0
140816|NCT01143051|341108|P4|NOT COMPLETED|Visit 3||0
140817|NCT01143051|341109|P3|NOT COMPLETED|Visit 3||0
140818|NCT01143051|341110|P2|NOT COMPLETED|Visit 3||0
140819|NCT01143051|341111|P1|NOT COMPLETED|Visit 3||0
140820|NCT01143051|341106|P6|COMPLETED|Visit 3||3
140821|NCT01143051|341107|P5|COMPLETED|Visit 3||4
140822|NCT01143051|341108|P4|COMPLETED|Visit 3||4
140823|NCT01143051|341109|P3|COMPLETED|Visit 3||3
140824|NCT01143051|341110|P2|COMPLETED|Visit 3||4
140825|NCT01143051|341111|P1|COMPLETED|Visit 3||4
140826|NCT01143051|341106|P6|STARTED|Visit 3||3
140827|NCT01143051|341107|P5|STARTED|Visit 3||4
140828|NCT01143051|341108|P4|STARTED|Visit 3||4
140829|NCT01143051|341109|P3|STARTED|Visit 3||3
140830|NCT01143051|341110|P2|STARTED|Visit 3||4
140831|NCT01143051|341111|P1|STARTED|Visit 3||4
140832|NCT01143051|341106|P6|NOT COMPLETED|3-14 Day Washout||1
140833|NCT01143051|341107|P5|NOT COMPLETED|3-14 Day Washout||0
140834|NCT01143051|341108|P4|NOT COMPLETED|3-14 Day Washout||0
140835|NCT01143051|341109|P3|NOT COMPLETED|3-14 Day Washout||0
140836|NCT01143051|341110|P2|NOT COMPLETED|3-14 Day Washout||0
140837|NCT01143051|341111|P1|NOT COMPLETED|3-14 Day Washout||0
140838|NCT01143051|341106|P6|COMPLETED|3-14 Day Washout||3
140839|NCT01143051|341107|P5|COMPLETED|3-14 Day Washout||4
140840|NCT01143051|341108|P4|COMPLETED|3-14 Day Washout||4
140841|NCT01143051|341109|P3|COMPLETED|3-14 Day Washout||3
140842|NCT01143051|341110|P2|COMPLETED|3-14 Day Washout||4
140843|NCT01143051|341111|P1|COMPLETED|3-14 Day Washout||4
140844|NCT01143051|341106|P6|STARTED|3-14 Day Washout||4
140845|NCT01143051|341107|P5|STARTED|3-14 Day Washout||4
140846|NCT01143051|341108|P4|STARTED|3-14 Day Washout||4
140847|NCT01143051|341109|P3|STARTED|3-14 Day Washout||3
140848|NCT01143051|341110|P2|STARTED|3-14 Day Washout||4
140849|NCT01143051|341111|P1|STARTED|3-14 Day Washout||4
140850|NCT01143051|341106|P6|NOT COMPLETED|Visit 2||0
140851|NCT01143051|341107|P5|NOT COMPLETED|Visit 2||0
140852|NCT01143051|341108|P4|NOT COMPLETED|Visit 2||0
140853|NCT01143051|341109|P3|NOT COMPLETED|Visit 2||0
140854|NCT01143051|341110|P2|NOT COMPLETED|Visit 2||0
140855|NCT01143051|341111|P1|NOT COMPLETED|Visit 2||0
140856|NCT01143051|341106|P6|COMPLETED|Visit 2||4
140857|NCT01143051|341107|P5|COMPLETED|Visit 2||4
140858|NCT01143051|341108|P4|COMPLETED|Visit 2||4
140859|NCT01143051|341109|P3|COMPLETED|Visit 2||3
140860|NCT01143051|341110|P2|COMPLETED|Visit 2||4
140861|NCT01143051|341111|P1|COMPLETED|Visit 2||4
140862|NCT01143051|341106|P6|STARTED|Visit 2||4
140863|NCT01143051|341107|P5|STARTED|Visit 2||4
140864|NCT01143051|341108|P4|STARTED|Visit 2||4
140865|NCT01143051|341109|P3|STARTED|Visit 2||3
140866|NCT01143051|341110|P2|STARTED|Visit 2||4
140867|NCT01143051|341111|P1|STARTED|Visit 2||4
140868|NCT01143051|341106|P6|NOT COMPLETED|3-14 Day Washout||0
140869|NCT01143051|341107|P5|NOT COMPLETED|3-14 Day Washout||0
140870|NCT01143051|341108|P4|NOT COMPLETED|3-14 Day Washout||0
140871|NCT01143051|341109|P3|NOT COMPLETED|3-14 Day Washout||1
140872|NCT01143051|341110|P2|NOT COMPLETED|3-14 Day Washout||0
140873|NCT01143051|341111|P1|NOT COMPLETED|3-14 Day Washout||0
140874|NCT01143051|341106|P6|COMPLETED|3-14 Day Washout||4
140875|NCT01143051|341107|P5|COMPLETED|3-14 Day Washout||4
140876|NCT01143051|341108|P4|COMPLETED|3-14 Day Washout||4
140877|NCT01143051|341109|P3|COMPLETED|3-14 Day Washout||3
140878|NCT01143051|341110|P2|COMPLETED|3-14 Day Washout||4
140879|NCT01143051|341111|P1|COMPLETED|3-14 Day Washout||4
140880|NCT01143051|341106|P6|STARTED|3-14 Day Washout||4
140881|NCT01143051|341107|P5|STARTED|3-14 Day Washout||4
140882|NCT01143051|341108|P4|STARTED|3-14 Day Washout||4
140883|NCT01143051|341109|P3|STARTED|3-14 Day Washout||4
140884|NCT01143051|341110|P2|STARTED|3-14 Day Washout||4
140885|NCT01143051|341111|P1|STARTED|3-14 Day Washout||4
140886|NCT01143051|341106|P6|NOT COMPLETED|Visit 1||0
140887|NCT01143051|341107|P5|NOT COMPLETED|Visit 1||0
140888|NCT01143051|341108|P4|NOT COMPLETED|Visit 1||0
140889|NCT01143051|341109|P3|NOT COMPLETED|Visit 1||0
140890|NCT01143051|341110|P2|NOT COMPLETED|Visit 1||0
140891|NCT01143051|341111|P1|NOT COMPLETED|Visit 1||0
140892|NCT01143051|341106|P6|COMPLETED|Visit 1||4
140893|NCT01143051|341107|P5|COMPLETED|Visit 1||4
140894|NCT01143051|341108|P4|COMPLETED|Visit 1||4
140895|NCT01143051|341109|P3|COMPLETED|Visit 1||4
140896|NCT01143051|341110|P2|COMPLETED|Visit 1||4
140897|NCT01143051|341111|P1|COMPLETED|Visit 1||4
140898|NCT01143051|341106|P6|STARTED|Visit 1||4
140899|NCT01143051|341107|P5|STARTED|Visit 1||4
140900|NCT01143051|341108|P4|STARTED|Visit 1||4
140901|NCT01143051|341109|P3|STARTED|Visit 1||4
140902|NCT01143051|341110|P2|STARTED|Visit 1||4
140903|NCT01143051|341111|P1|STARTED|Visit 1||4
140904|NCT01143038|341134|P1|NOT COMPLETED|Overall Study||16
140905|NCT01143038|341134|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
140906|NCT01143038|341134|P1|STARTED|Overall Study||75
140907|NCT01142908|341144|P2|NOT COMPLETED|Overall Study||22
140908|NCT01142908|341145|P1|NOT COMPLETED|Overall Study||32
140909|NCT01142908|341144|P2|COMPLETED|Overall Study||191
140910|NCT01142908|341145|P1|COMPLETED|Overall Study||183
140911|NCT01142908|341144|P2|6 Month f/u|Overall Study||196
140912|NCT01142908|341145|P1|6 Month f/u|Overall Study||188
140913|NCT01142908|341144|P2|STARTED|Overall Study||213
140914|NCT01142908|341145|P1|STARTED|Overall Study||215
140915|NCT01142726|341194|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
140916|NCT01142726|341195|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
140917|NCT01142726|341196|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
140918|NCT01142726|341194|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
140919|NCT01142726|341195|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
140920|NCT01142726|341196|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
140921|NCT01142726|341194|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
140922|NCT01142726|341195|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
140923|NCT01142726|341196|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
140924|NCT01142726|341194|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
140925|NCT01142726|341195|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
140926|NCT01142726|341196|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
140927|NCT01142726|341194|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
140928|NCT01142726|341195|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
140929|NCT01142726|341196|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
140930|NCT01142726|341194|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
140931|NCT01142726|341195|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
140932|NCT01142726|341196|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
140933|NCT01142726|341194|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
140934|NCT01142726|341195|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
140935|NCT01142726|341196|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
140936|NCT01142726|341194|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
140937|NCT01142726|341195|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
140938|NCT01142726|341196|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
140939|NCT01142726|341194|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
140940|NCT01142726|341195|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
140941|NCT01142726|341196|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
140942|NCT01142661|341259|P1|NOT COMPLETED|Overall Study||4
140943|NCT01142661|341259|P1|COMPLETED|Overall Study||5
140944|NCT01142661|341259|P1|STARTED|Overall Study||9
140945|NCT01142596|341266|P2|NOT COMPLETED|Overall Study||86
140946|NCT01142596|341267|P1|NOT COMPLETED|Overall Study||29
140947|NCT01142596|341266|P2|COMPLETED|Overall Study||71
140948|NCT01142596|341267|P1|COMPLETED|Overall Study||15
140949|NCT01142596|341266|P2|STARTED|Overall Study||157
140950|NCT01142596|341267|P1|STARTED|Overall Study||44
140951|NCT01142466|341319|P2|NOT COMPLETED|Overall Study||2
140952|NCT01142466|341320|P1|NOT COMPLETED|Overall Study||3
140953|NCT01142466|341319|P2|COMPLETED|Overall Study||13
140954|NCT01142466|341320|P1|COMPLETED|Overall Study||12
140955|NCT01142466|341319|P2|STARTED|Overall Study||15
140956|NCT01142466|341320|P1|STARTED|Overall Study||15
140957|NCT01142388|341340|P2|NOT COMPLETED|Overall Study||47
140958|NCT01142388|341341|P1|NOT COMPLETED|Overall Study||47
140959|NCT01142388|341340|P2|COMPLETED|Overall Study||0
140960|NCT01142388|341341|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
140961|NCT01142388|341340|P2|Treated|Overall Study||44
140962|NCT01142388|341341|P1|Treated|Overall Study||40
140963|NCT01142388|341340|P2|Eligible|Overall Study||44
140964|NCT01142388|341341|P1|Eligible|Overall Study||43
140965|NCT01142388|341340|P2|STARTED|Overall Study||47
140966|NCT01142388|341341|P1|STARTED|Overall Study||47
140967|NCT01142336|341353|P2|NOT COMPLETED|Overall Study||2
140968|NCT01142336|341354|P1|NOT COMPLETED|Overall Study||1
140969|NCT01142336|341353|P2|COMPLETED|Overall Study||21
140970|NCT01142336|341354|P1|COMPLETED|Overall Study||25
140971|NCT01142336|341353|P2|STARTED|Overall Study||23
140972|NCT01142336|341354|P1|STARTED|Overall Study||26
140973|NCT01142323|341364|P1|NOT COMPLETED|Overall Study||0
140974|NCT01142323|341364|P1|COMPLETED|Overall Study||8
140975|NCT01142323|341364|P1|STARTED|Overall Study||8
140976|NCT01142297|341370|P1|NOT COMPLETED|Overall Study||6
140977|NCT01142297|341370|P1|COMPLETED|Overall Study||18
140978|NCT01142297|341370|P1|STARTED|Overall Study||24
140979|NCT01142193|341379|P2|NOT COMPLETED|Overall Study||11
140980|NCT01142193|341380|P1|NOT COMPLETED|Overall Study||21
140981|NCT01142193|341379|P2|COMPLETED|Overall Study||114
140982|NCT01142193|341380|P1|COMPLETED|Overall Study||103
140983|NCT01142193|341379|P2|STARTED|Overall Study||125
140984|NCT01142193|341380|P1|STARTED|Overall Study||124
140985|NCT01142128|341408|P1|NOT COMPLETED|Overall Study||4
140986|NCT01142128|341408|P1|COMPLETED|Overall Study||4
140987|NCT01142128|341408|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
140988|NCT01142128|341408|P1|Viokase 16 Plus Nexium|Overall Study||2
140989|NCT01142128|341408|P1|Placebo to Nexium, Alone|Overall Study||3
140990|NCT01142128|341408|P1|Nexium Alone|Overall Study||3
140991|NCT01142128|341408|P1|STARTED|Overall Study||8
140992|NCT01142115|341418|P2|NOT COMPLETED|Second Intervention||0
140993|NCT01142115|341419|P1|NOT COMPLETED|Second Intervention||0
140994|NCT01142115|341418|P2|COMPLETED|Second Intervention||19
140995|NCT01142115|341419|P1|COMPLETED|Second Intervention||19
140996|NCT01142115|341418|P2|STARTED|Second Intervention||19
140997|NCT01142115|341419|P1|STARTED|Second Intervention||19
140998|NCT01142115|341418|P2|NOT COMPLETED|First Intervention||1
140999|NCT01142115|341419|P1|NOT COMPLETED|First Intervention||2
141000|NCT01142115|341418|P2|COMPLETED|First Intervention||19
141001|NCT01142115|341419|P1|COMPLETED|First Intervention||19
141002|NCT01142115|341418|P2|STARTED|First Intervention||20
141003|NCT01142115|341419|P1|STARTED|First Intervention||21
141004|NCT01142089|341436|P2|NOT COMPLETED|Overall Study||21
141005|NCT01142089|341437|P1|NOT COMPLETED|Overall Study||12
141006|NCT01142089|341436|P2|COMPLETED|Overall Study||178
141007|NCT01142089|341437|P1|COMPLETED|Overall Study||53
141008|NCT01142089|341436|P2|STARTED|Overall Study||199
141009|NCT01142089|341437|P1|STARTED|Overall Study||65
141010|NCT01141725|341445|P3|NOT COMPLETED|Overall Study||0
141011|NCT01141725|341446|P2|NOT COMPLETED|Overall Study||0
141012|NCT01141725|341447|P1|NOT COMPLETED|Overall Study||0
141013|NCT01141725|341445|P3|COMPLETED|Overall Study||3
141014|NCT01141725|341446|P2|COMPLETED|Overall Study||33
141015|NCT01141725|341447|P1|COMPLETED|Overall Study||3
141016|NCT01141725|341445|P3|STARTED|Overall Study||3
141017|NCT01141725|341446|P2|STARTED|Overall Study||33
141018|NCT01141725|341447|P1|STARTED|Overall Study||3
141019|NCT01141712|341459|P1|NOT COMPLETED|Overall Study||3
141020|NCT01141712|341459|P1|COMPLETED|Overall Study||40
141021|NCT01141712|341459|P1|STARTED|Overall Study||43
141022|NCT01141660|341480|P2|NOT COMPLETED|Overall Study||12
141023|NCT01141660|341481|P1|NOT COMPLETED|Overall Study||0
141024|NCT01141660|341480|P2|COMPLETED|Overall Study||48
141025|NCT01141660|341481|P1|COMPLETED|Overall Study||71
141026|NCT01141660|341480|P2|STARTED|Overall Study||60
141027|NCT01141660|341481|P1|STARTED|Overall Study||71
141028|NCT01141647|341489|P1|NOT COMPLETED|Overall Study||46
141029|NCT01141647|341489|P1|COMPLETED|Overall Study||167
141030|NCT01141647|341489|P1|STARTED|Overall Study||213
141031|NCT01141595|341502|P1|NOT COMPLETED|Overall Study||2
141032|NCT01141595|341502|P1|COMPLETED|Overall Study||8
141033|NCT01141595|341502|P1|STARTED|Overall Study||10
141034|NCT01141569|341506|P1|NOT COMPLETED|Overall Study||0
141035|NCT01141569|341506|P1|COMPLETED|Overall Study||12
141036|NCT01141569|341506|P1|STARTED|Overall Study||12
141037|NCT01141491|341517|P2|NOT COMPLETED|Overall Study||47
141038|NCT01141491|341518|P1|NOT COMPLETED|Overall Study||48
141039|NCT01141491|341517|P2|COMPLETED|Overall Study||21
141040|NCT01141491|341518|P1|COMPLETED|Overall Study||20
141041|NCT01141491|341517|P2|STARTED|Overall Study||68
141042|NCT01141491|341518|P1|STARTED|Overall Study||68
141043|NCT01141374|341527|P3|NOT COMPLETED|Overall Study||0
141044|NCT01141374|341528|P2|NOT COMPLETED|Overall Study||0
141045|NCT01141374|341529|P1|NOT COMPLETED|Overall Study||0
141046|NCT01141374|341527|P3|COMPLETED|Overall Study||22
141047|NCT01141374|341528|P2|COMPLETED|Overall Study||27
141048|NCT01141374|341529|P1|COMPLETED|Overall Study||26
141049|NCT01141374|341527|P3|STARTED|Overall Study||22
141050|NCT01141374|341528|P2|STARTED|Overall Study||27
141051|NCT01141374|341529|P1|STARTED|Overall Study||26
141052|NCT01141283|341540|P1|NOT COMPLETED|Overall Study||88
141053|NCT01141283|341540|P1|COMPLETED|Overall Study||202
141054|NCT01141283|341540|P1|STARTED|Overall Study||290
141055|NCT01141205|341546|P2|NOT COMPLETED|Overall Study||2
141056|NCT01141205|341547|P1|NOT COMPLETED|Overall Study||3
141057|NCT01141205|341546|P2|COMPLETED|Overall Study||3
141058|NCT01141205|341547|P1|COMPLETED|Overall Study||15
141059|NCT01141205|341546|P2|STARTED|Overall Study||5
141060|NCT01141205|341547|P1|STARTED|Overall Study||18
141061|NCT01140906|341563|P4|NOT COMPLETED|Overall Study||16
141062|NCT01140906|341564|P3|NOT COMPLETED|Overall Study||26
141063|NCT01140906|341565|P2|NOT COMPLETED|Overall Study||34
141064|NCT01140906|341566|P1|NOT COMPLETED|Overall Study||25
141065|NCT01140906|341563|P4|COMPLETED|Overall Study||131
141066|NCT01140906|341564|P3|COMPLETED|Overall Study||125
141067|NCT01140906|341565|P2|COMPLETED|Overall Study||117
141068|NCT01140906|341566|P1|COMPLETED|Overall Study||133
141069|NCT01140906|341563|P4|STARTED|Overall Study||147
141070|NCT01140906|341564|P3|STARTED|Overall Study||151
141071|NCT01140906|341565|P2|STARTED|Overall Study||151
141072|NCT01140906|341566|P1|STARTED|Overall Study||158
141073|NCT01140880|341606|P2|NOT COMPLETED|Overall Study||44
141074|NCT01140880|341607|P1|NOT COMPLETED|Overall Study||14
141075|NCT01140880|341606|P2|COMPLETED|Overall Study||56
141076|NCT01140880|341607|P1|COMPLETED|Overall Study||56
141077|NCT01140880|341606|P2|STARTED|Overall Study||100
141078|NCT01140880|341607|P1|STARTED|Overall Study||70
141079|NCT01140867|341619|P1|NOT COMPLETED|Overall Study||33
141080|NCT01140867|341619|P1|COMPLETED|Overall Study||88
141081|NCT01140867|341619|P1|STARTED|Overall Study||121
141082|NCT01140815|341628|P2|NOT COMPLETED|Overall Study||0
141083|NCT01140815|341629|P1|NOT COMPLETED|Overall Study||0
141084|NCT01140815|341628|P2|COMPLETED|Overall Study||25
141085|NCT01140815|341629|P1|COMPLETED|Overall Study||25
141086|NCT01140815|341628|P2|STARTED|Overall Study||25
141087|NCT01140815|341629|P1|STARTED|Overall Study||25
141088|NCT01140646|341659|P1|NOT COMPLETED|Overall Study||9
141089|NCT01140646|341659|P1|COMPLETED|Overall Study||34
141090|NCT01140646|341659|P1|STARTED|Overall Study||43
141091|NCT01140503|341663|P1|NOT COMPLETED|Overall Study||1
141092|NCT01140503|341663|P1|COMPLETED|Overall Study||4
141093|NCT01140503|341663|P1|STARTED|Overall Study||5
141094|NCT01140477|341671|P2|NOT COMPLETED|Overall Study||6
141095|NCT01140477|341672|P1|NOT COMPLETED|Overall Study||8
141096|NCT01140477|341671|P2|COMPLETED|Overall Study||70
141097|NCT01140477|341672|P1|COMPLETED|Overall Study||145
141098|NCT01140477|341671|P2|STARTED|Overall Study||76
141099|NCT01140477|341672|P1|STARTED|Overall Study||153
141100|NCT01140360|341681|P1|NOT COMPLETED|Overall Study||6
141101|NCT01140360|341681|P1|COMPLETED|Overall Study||15
141102|NCT01140360|341681|P1|STARTED|Overall Study||21
141103|NCT01140347|341687|P2|NOT COMPLETED|Overall Study||14
141104|NCT01140347|341688|P1|NOT COMPLETED|Overall Study||18
141105|NCT01140347|341687|P2|COMPLETED|Overall Study||268
141106|NCT01140347|341688|P1|COMPLETED|Overall Study||265
141107|NCT01140347|341687|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
141108|NCT01140347|341688|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
141109|NCT01140347|341687|P2|STARTED|Overall Study||282
141110|NCT01140347|341688|P1|STARTED|Overall Study||283
141111|NCT01140295|341713|P2|NOT COMPLETED|Overall Study||2
141112|NCT01140295|341714|P1|NOT COMPLETED|Overall Study||1
141113|NCT01140295|341713|P2|COMPLETED|Overall Study||14
141114|NCT01140295|341714|P1|COMPLETED|Overall Study||16
141115|NCT01140295|341713|P2|STARTED|Overall Study||16
141116|NCT01140295|341714|P1|STARTED|Overall Study||17
141117|NCT01140191|341722|P1|NOT COMPLETED|Overall Study||0
141118|NCT01140191|341722|P1|COMPLETED|Overall Study||1
141119|NCT01140191|341722|P1|STARTED|Overall Study||1
141120|NCT01140061|341741|P10|NOT COMPLETED|Extension||1
141121|NCT01140061|341742|P9|NOT COMPLETED|Extension||0
141122|NCT01140061|341743|P8|NOT COMPLETED|Extension||0
141123|NCT01140061|341744|P7|NOT COMPLETED|Extension||0
141124|NCT01140061|341745|P6|NOT COMPLETED|Extension||0
141125|NCT01140061|341746|P5|NOT COMPLETED|Extension||0
141126|NCT01140061|341747|P4|NOT COMPLETED|Extension||0
141127|NCT01140061|341748|P3|NOT COMPLETED|Extension||0
141128|NCT01140061|341749|P2|NOT COMPLETED|Extension||0
141129|NCT01140061|341750|P1|NOT COMPLETED|Extension||0
141130|NCT01140061|341741|P10|COMPLETED|Extension||1
141131|NCT01140061|341742|P9|COMPLETED|Extension||7
141132|NCT01140061|341743|P8|COMPLETED|Extension||0
141133|NCT01140061|341744|P7|COMPLETED|Extension||0
141134|NCT01140061|341745|P6|COMPLETED|Extension||0
141135|NCT01140061|341746|P5|COMPLETED|Extension||0
141136|NCT01140061|341747|P4|COMPLETED|Extension||0
141137|NCT01140061|341748|P3|COMPLETED|Extension||0
141138|NCT01140061|341749|P2|COMPLETED|Extension||0
141139|NCT01140061|341750|P1|COMPLETED|Extension||0
141140|NCT01140061|341741|P10|STARTED|Extension||2
141141|NCT01140061|341742|P9|STARTED|Extension||7
141142|NCT01140061|341743|P8|STARTED|Extension||0
141143|NCT01140061|341744|P7|STARTED|Extension||0
141144|NCT01140061|341745|P6|STARTED|Extension||0
141145|NCT01140061|341746|P5|STARTED|Extension||0
141146|NCT01140061|341747|P4|STARTED|Extension||0
141147|NCT01140061|341748|P3|STARTED|Extension||0
141148|NCT01140061|341749|P2|STARTED|Extension||0
141149|NCT01140061|341750|P1|STARTED|Extension||0
141150|NCT01140061|341741|P10|NOT COMPLETED|Part III||0
141151|NCT01140061|341742|P9|NOT COMPLETED|Part III||0
141152|NCT01140061|341743|P8|NOT COMPLETED|Part III||0
141153|NCT01140061|341744|P7|NOT COMPLETED|Part III||0
141154|NCT01140061|341745|P6|NOT COMPLETED|Part III||0
141155|NCT01140061|341746|P5|NOT COMPLETED|Part III||0
141156|NCT01140061|341747|P4|NOT COMPLETED|Part III||0
141157|NCT01140061|341748|P3|NOT COMPLETED|Part III||0
141158|NCT01140061|341749|P2|NOT COMPLETED|Part III||0
141159|NCT01140061|341750|P1|NOT COMPLETED|Part III||0
141160|NCT01140061|341741|P10|COMPLETED|Part III||2
141161|NCT01140061|341742|P9|COMPLETED|Part III||7
141162|NCT01140061|341743|P8|COMPLETED|Part III||0
141163|NCT01140061|341744|P7|COMPLETED|Part III||0
141164|NCT01140061|341745|P6|COMPLETED|Part III||0
141165|NCT01140061|341746|P5|COMPLETED|Part III||0
141166|NCT01140061|341747|P4|COMPLETED|Part III||0
141167|NCT01140061|341748|P3|COMPLETED|Part III||0
141168|NCT01140061|341749|P2|COMPLETED|Part III||0
141169|NCT01140061|341750|P1|COMPLETED|Part III||0
141352|NCT01139515|341933|P4|COMPLETED|Second Intervention Period||4
141170|NCT01140061|341741|P10|STARTED|Part III|Includes 1 replacement participant|2
141171|NCT01140061|341742|P9|STARTED|Part III||7
141172|NCT01140061|341743|P8|STARTED|Part III||0
141173|NCT01140061|341744|P7|STARTED|Part III||0
141174|NCT01140061|341745|P6|STARTED|Part III||0
141175|NCT01140061|341746|P5|STARTED|Part III||0
141176|NCT01140061|341747|P4|STARTED|Part III||0
141177|NCT01140061|341748|P3|STARTED|Part III||0
141178|NCT01140061|341749|P2|STARTED|Part III||0
141179|NCT01140061|341750|P1|STARTED|Part III||0
141180|NCT01140061|341741|P10|NOT COMPLETED|Part II||0
141181|NCT01140061|341742|P9|NOT COMPLETED|Part II||0
141182|NCT01140061|341743|P8|NOT COMPLETED|Part II||0
141183|NCT01140061|341744|P7|NOT COMPLETED|Part II||0
141184|NCT01140061|341745|P6|NOT COMPLETED|Part II||0
141185|NCT01140061|341746|P5|NOT COMPLETED|Part II||0
141186|NCT01140061|341747|P4|NOT COMPLETED|Part II||0
141187|NCT01140061|341748|P3|NOT COMPLETED|Part II||0
141188|NCT01140061|341749|P2|NOT COMPLETED|Part II||0
141189|NCT01140061|341750|P1|NOT COMPLETED|Part II||0
141190|NCT01140061|341741|P10|COMPLETED|Part II||0
141191|NCT01140061|341742|P9|COMPLETED|Part II||0
141192|NCT01140061|341743|P8|COMPLETED|Part II||2
141193|NCT01140061|341744|P7|COMPLETED|Part II||6
141194|NCT01140061|341745|P6|COMPLETED|Part II||2
141195|NCT01140061|341746|P5|COMPLETED|Part II||6
141196|NCT01140061|341747|P4|COMPLETED|Part II||2
141197|NCT01140061|341748|P3|COMPLETED|Part II||6
141198|NCT01140061|341749|P2|COMPLETED|Part II||0
141199|NCT01140061|341750|P1|COMPLETED|Part II||0
141200|NCT01140061|341741|P10|STARTED|Part II||0
141201|NCT01140061|341742|P9|STARTED|Part II||0
141202|NCT01140061|341743|P8|STARTED|Part II||2
141203|NCT01140061|341744|P7|STARTED|Part II||6
141204|NCT01140061|341745|P6|STARTED|Part II||2
141205|NCT01140061|341746|P5|STARTED|Part II||6
141206|NCT01140061|341747|P4|STARTED|Part II||2
141207|NCT01140061|341748|P3|STARTED|Part II||6
141208|NCT01140061|341749|P2|STARTED|Part II||0
141209|NCT01140061|341750|P1|STARTED|Part II||0
141210|NCT01140061|341741|P10|NOT COMPLETED|Part I||0
141211|NCT01140061|341742|P9|NOT COMPLETED|Part I||0
141212|NCT01140061|341743|P8|NOT COMPLETED|Part I||0
141213|NCT01140061|341744|P7|NOT COMPLETED|Part I||0
141214|NCT01140061|341745|P6|NOT COMPLETED|Part I||0
141215|NCT01140061|341746|P5|NOT COMPLETED|Part I||0
141216|NCT01140061|341747|P4|NOT COMPLETED|Part I||0
141217|NCT01140061|341748|P3|NOT COMPLETED|Part I||0
141218|NCT01140061|341749|P2|NOT COMPLETED|Part I||0
141219|NCT01140061|341750|P1|NOT COMPLETED|Part I||1
141220|NCT01140061|341741|P10|COMPLETED|Part I||0
141221|NCT01140061|341742|P9|COMPLETED|Part I||0
141222|NCT01140061|341743|P8|COMPLETED|Part I||0
141223|NCT01140061|341744|P7|COMPLETED|Part I||0
141224|NCT01140061|341745|P6|COMPLETED|Part I||0
141225|NCT01140061|341746|P5|COMPLETED|Part I||0
141226|NCT01140061|341747|P4|COMPLETED|Part I||0
141227|NCT01140061|341748|P3|COMPLETED|Part I||0
141228|NCT01140061|341749|P2|COMPLETED|Part I||2
141229|NCT01140061|341750|P1|COMPLETED|Part I||6
141230|NCT01140061|341741|P10|STARTED|Part I||0
141231|NCT01140061|341742|P9|STARTED|Part I||0
141232|NCT01140061|341743|P8|STARTED|Part I||0
141233|NCT01140061|341744|P7|STARTED|Part I||0
141234|NCT01140061|341745|P6|STARTED|Part I||0
141235|NCT01140061|341746|P5|STARTED|Part I||0
141236|NCT01140061|341747|P4|STARTED|Part I||0
141237|NCT01140061|341748|P3|STARTED|Part I||0
141238|NCT01140061|341749|P2|STARTED|Part I||2
141239|NCT01140061|341750|P1|STARTED|Part I|Includes 1 replacement participant|7
141240|NCT01140048|341777|P1|NOT COMPLETED|Overall Study||45
141241|NCT01140048|341777|P1|COMPLETED|Overall Study||298
141242|NCT01140048|341777|P1|STARTED|Overall Study||343
141243|NCT01139996|341785|P2|NOT COMPLETED|Overall Study||0
141244|NCT01139996|341786|P1|NOT COMPLETED|Overall Study||0
141245|NCT01139996|341785|P2|COMPLETED|Overall Study||11
141246|NCT01139996|341786|P1|COMPLETED|Overall Study||11
141247|NCT01139996|341785|P2|STARTED|Overall Study||11
141248|NCT01139996|341786|P1|STARTED|Overall Study||11
141249|NCT01139879|341792|P1|NOT COMPLETED|Overall Study||0
141250|NCT01139879|341792|P1|COMPLETED|Overall Study||10
141251|NCT01139879|341792|P1|STARTED|Overall Study||10
141252|NCT01139814|341798|P1|NOT COMPLETED|Overall Study||0
141253|NCT01139814|341798|P1|COMPLETED|Overall Study||181
141254|NCT01139814|341798|P1|STARTED|Overall Study||181
141255|NCT01139775|341806|P3|NOT COMPLETED|Overall Study||6
141256|NCT01139775|341807|P2|NOT COMPLETED|Overall Study||13
141257|NCT01139775|341808|P1|NOT COMPLETED|Overall Study||1
141258|NCT01139775|341806|P3|COMPLETED|Overall Study||17
141259|NCT01139775|341807|P2|COMPLETED|Overall Study||26
141260|NCT01139775|341808|P1|COMPLETED|Overall Study||13
141261|NCT01139775|341806|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
141262|NCT01139775|341807|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
141263|NCT01139775|341808|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
141264|NCT01139775|341806|P3|STARTED|Overall Study||23
141265|NCT01139775|341807|P2|STARTED|Overall Study||39
141266|NCT01139775|341808|P1|STARTED|Overall Study||14
141267|NCT01139762|341840|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
141268|NCT01139762|341841|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
141269|NCT01139762|341842|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
141270|NCT01139762|341840|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
141271|NCT01139762|341841|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
141272|NCT01139762|341842|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
141273|NCT01139762|341840|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
141274|NCT01139762|341841|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
141275|NCT01139762|341842|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
141276|NCT01139762|341840|P3|STARTED|Double-Blind Randomized Active Treatment||350
141277|NCT01139762|341841|P2|STARTED|Double-Blind Randomized Active Treatment||346
141278|NCT01139762|341842|P1|STARTED|Double-Blind Randomized Active Treatment||0
141279|NCT01139762|341840|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
141280|NCT01139762|341841|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
141281|NCT01139762|341842|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
141282|NCT01139762|341840|P3|COMPLETED|Washout and Placebo Lead-In Period||0
141283|NCT01139762|341841|P2|COMPLETED|Washout and Placebo Lead-In Period||0
141284|NCT01139762|341842|P1|COMPLETED|Washout and Placebo Lead-In Period||696
141285|NCT01139762|341840|P3|STARTED|Washout and Placebo Lead-In Period||0
141286|NCT01139762|341841|P2|STARTED|Washout and Placebo Lead-In Period||0
141287|NCT01139762|341842|P1|STARTED|Washout and Placebo Lead-In Period||1070
141288|NCT01139658|341877|P2|NOT COMPLETED|Overall Study||113
141289|NCT01139658|341878|P1|NOT COMPLETED|Overall Study||56
141290|NCT01139658|341877|P2|COMPLETED|Overall Study||816
141291|NCT01139658|341878|P1|COMPLETED|Overall Study||691
141292|NCT01139658|341877|P2|STARTED|Overall Study||929
141293|NCT01139658|341878|P1|STARTED|Overall Study||747
141294|NCT01139580|341916|P2|NOT COMPLETED|Overall Study||18
141295|NCT01139580|341917|P1|NOT COMPLETED|Overall Study||23
141296|NCT01139580|341916|P2|COMPLETED|Overall Study||164
141297|NCT01139580|341917|P1|COMPLETED|Overall Study||158
141298|NCT01139580|341916|P2|STARTED|Overall Study||182
141299|NCT01139580|341917|P1|STARTED|Overall Study||181
141300|NCT01139515|341933|P4|NOT COMPLETED|Fourth Intervention Period||0
141301|NCT01139515|341934|P3|NOT COMPLETED|Fourth Intervention Period||0
141302|NCT01139515|341935|P2|NOT COMPLETED|Fourth Intervention Period||0
141303|NCT01139515|341936|P1|NOT COMPLETED|Fourth Intervention Period||0
141304|NCT01139515|341933|P4|COMPLETED|Fourth Intervention Period||4
141305|NCT01139515|341934|P3|COMPLETED|Fourth Intervention Period||4
141306|NCT01139515|341935|P2|COMPLETED|Fourth Intervention Period||4
141307|NCT01139515|341936|P1|COMPLETED|Fourth Intervention Period||4
141308|NCT01139515|341933|P4|STARTED|Fourth Intervention Period||4
141309|NCT01139515|341934|P3|STARTED|Fourth Intervention Period||4
141310|NCT01139515|341935|P2|STARTED|Fourth Intervention Period||4
141311|NCT01139515|341936|P1|STARTED|Fourth Intervention Period||4
141312|NCT01139515|341933|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
141313|NCT01139515|341934|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
141314|NCT01139515|341935|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
141315|NCT01139515|341936|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
141316|NCT01139515|341933|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
141317|NCT01139515|341934|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
141318|NCT01139515|341935|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
141319|NCT01139515|341936|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
141320|NCT01139515|341933|P4|STARTED|Washout Period 3 (46 Hrs)||4
141321|NCT01139515|341934|P3|STARTED|Washout Period 3 (46 Hrs)||4
141322|NCT01139515|341935|P2|STARTED|Washout Period 3 (46 Hrs)||4
141323|NCT01139515|341936|P1|STARTED|Washout Period 3 (46 Hrs)||4
141324|NCT01139515|341933|P4|NOT COMPLETED|Third Intervention Period||0
141325|NCT01139515|341934|P3|NOT COMPLETED|Third Intervention Period||0
141326|NCT01139515|341935|P2|NOT COMPLETED|Third Intervention Period||0
141327|NCT01139515|341936|P1|NOT COMPLETED|Third Intervention Period||0
141328|NCT01139515|341933|P4|COMPLETED|Third Intervention Period||4
141329|NCT01139515|341934|P3|COMPLETED|Third Intervention Period||4
141330|NCT01139515|341935|P2|COMPLETED|Third Intervention Period||4
141331|NCT01139515|341936|P1|COMPLETED|Third Intervention Period||4
141332|NCT01139515|341933|P4|STARTED|Third Intervention Period||4
141333|NCT01139515|341934|P3|STARTED|Third Intervention Period||4
141334|NCT01139515|341935|P2|STARTED|Third Intervention Period||4
141335|NCT01139515|341936|P1|STARTED|Third Intervention Period||4
141336|NCT01139515|341933|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
141337|NCT01139515|341934|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
141338|NCT01139515|341935|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
141339|NCT01139515|341936|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
141340|NCT01139515|341933|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
141341|NCT01139515|341934|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
141342|NCT01139515|341935|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
141343|NCT01139515|341936|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
141344|NCT01139515|341933|P4|STARTED|Washout Period 2 (46 Hrs)||4
141345|NCT01139515|341934|P3|STARTED|Washout Period 2 (46 Hrs)||4
141346|NCT01139515|341935|P2|STARTED|Washout Period 2 (46 Hrs)||4
141347|NCT01139515|341936|P1|STARTED|Washout Period 2 (46 Hrs)||4
141348|NCT01139515|341933|P4|NOT COMPLETED|Second Intervention Period||0
141349|NCT01139515|341934|P3|NOT COMPLETED|Second Intervention Period||0
141350|NCT01139515|341935|P2|NOT COMPLETED|Second Intervention Period||0
141351|NCT01139515|341936|P1|NOT COMPLETED|Second Intervention Period||0
141353|NCT01139515|341934|P3|COMPLETED|Second Intervention Period||4
141354|NCT01139515|341935|P2|COMPLETED|Second Intervention Period||4
141355|NCT01139515|341936|P1|COMPLETED|Second Intervention Period||4
141356|NCT01139515|341933|P4|STARTED|Second Intervention Period||4
141357|NCT01139515|341934|P3|STARTED|Second Intervention Period||4
141358|NCT01139515|341935|P2|STARTED|Second Intervention Period||4
141359|NCT01139515|341936|P1|STARTED|Second Intervention Period||4
141360|NCT01139515|341933|P4|NOT COMPLETED|Washout Period I (46hrs)||0
141361|NCT01139515|341934|P3|NOT COMPLETED|Washout Period I (46hrs)||0
141362|NCT01139515|341935|P2|NOT COMPLETED|Washout Period I (46hrs)||0
141363|NCT01139515|341936|P1|NOT COMPLETED|Washout Period I (46hrs)||0
141364|NCT01139515|341933|P4|COMPLETED|Washout Period I (46hrs)||4
141365|NCT01139515|341934|P3|COMPLETED|Washout Period I (46hrs)||4
141366|NCT01139515|341935|P2|COMPLETED|Washout Period I (46hrs)||4
141367|NCT01139515|341936|P1|COMPLETED|Washout Period I (46hrs)||4
141368|NCT01139515|341933|P4|STARTED|Washout Period I (46hrs)||4
141369|NCT01139515|341934|P3|STARTED|Washout Period I (46hrs)||4
141370|NCT01139515|341935|P2|STARTED|Washout Period I (46hrs)||4
141371|NCT01139515|341936|P1|STARTED|Washout Period I (46hrs)||4
141372|NCT01139515|341933|P4|NOT COMPLETED|First Intervention Period||0
141373|NCT01139515|341934|P3|NOT COMPLETED|First Intervention Period||0
141374|NCT01139515|341935|P2|NOT COMPLETED|First Intervention Period||0
141375|NCT01139515|341936|P1|NOT COMPLETED|First Intervention Period||0
141376|NCT01139515|341933|P4|COMPLETED|First Intervention Period||4
141377|NCT01139515|341934|P3|COMPLETED|First Intervention Period||4
141378|NCT01139515|341935|P2|COMPLETED|First Intervention Period||4
141379|NCT01139515|341936|P1|COMPLETED|First Intervention Period||4
141380|NCT01139515|341933|P4|STARTED|First Intervention Period||4
141381|NCT01139515|341934|P3|STARTED|First Intervention Period||4
141382|NCT01139515|341935|P2|STARTED|First Intervention Period||4
141383|NCT01139515|341936|P1|STARTED|First Intervention Period||4
141384|NCT01139450|341965|P3|NOT COMPLETED|Overall Study||38
141385|NCT01139450|341966|P2|NOT COMPLETED|Overall Study||25
141386|NCT01139450|341967|P1|NOT COMPLETED|Overall Study||27
141387|NCT01139450|341965|P3|COMPLETED|Overall Study||262
141388|NCT01139450|341966|P2|COMPLETED|Overall Study||272
141389|NCT01139450|341967|P1|COMPLETED|Overall Study||275
141390|NCT01139450|341965|P3|STARTED|Overall Study||300
141391|NCT01139450|341966|P2|STARTED|Overall Study||297
141392|NCT01139450|341967|P1|STARTED|Overall Study||302
141393|NCT01139411|341977|P2|NOT COMPLETED|Overall Study||4
141394|NCT01139411|341978|P1|NOT COMPLETED|Overall Study||2
141395|NCT01139411|341977|P2|COMPLETED|Overall Study||19
141396|NCT01139411|341978|P1|COMPLETED|Overall Study||24
141397|NCT01139411|341977|P2|STARTED|Overall Study||23
141398|NCT01139411|341978|P1|STARTED|Overall Study||26
141399|NCT01139294|341998|P2|NOT COMPLETED|Overall Study||0
141400|NCT01139294|341999|P1|NOT COMPLETED|Overall Study||0
141401|NCT01139294|341998|P2|COMPLETED|Overall Study||0
141402|NCT01139294|341999|P1|COMPLETED|Overall Study||0
141403|NCT01139294|341998|P2|STARTED|Overall Study||0
141404|NCT01139294|341999|P1|STARTED|Overall Study||0
141405|NCT01139190|342009|P2|NOT COMPLETED|Overall Study||1
141406|NCT01139190|342010|P1|NOT COMPLETED|Overall Study||0
141407|NCT01139190|342009|P2|COMPLETED|Overall Study||38
141408|NCT01139190|342010|P1|COMPLETED|Overall Study||38
141409|NCT01139190|342009|P2|STARTED|Overall Study||39
141410|NCT01139190|342010|P1|STARTED|Overall Study||38
141411|NCT01139164|342019|P3|NOT COMPLETED|Overall Study||0
141412|NCT01139164|342020|P2|NOT COMPLETED|Overall Study||2
141413|NCT01139164|342021|P1|NOT COMPLETED|Overall Study||0
141414|NCT01139164|342019|P3|COMPLETED|Overall Study||7
141415|NCT01139164|342020|P2|COMPLETED|Overall Study||65
141416|NCT01139164|342021|P1|COMPLETED|Overall Study||4
141417|NCT01139164|342019|P3|STARTED|Overall Study||7
141418|NCT01139164|342020|P2|STARTED|Overall Study||67
141419|NCT01139164|342021|P1|STARTED|Overall Study||4
141420|NCT01139125|342035|P1|NOT COMPLETED|Overall Study||1
141421|NCT01139125|342035|P1|COMPLETED|Overall Study||2
141422|NCT01139125|342035|P1|STARTED|Overall Study||3
141423|NCT01139047|342039|P1|NOT COMPLETED|Overall Study||1
141424|NCT01139047|342039|P1|COMPLETED|Overall Study||76
141425|NCT01139047|342039|P1|STARTED|Overall Study||77
141426|NCT01139021|342054|P6|NOT COMPLETED|Overall Study||0
141427|NCT01139021|342055|P5|NOT COMPLETED|Overall Study||9
141428|NCT01139021|342056|P4|NOT COMPLETED|Overall Study||1
141429|NCT01139021|342057|P3|NOT COMPLETED|Overall Study||0
141430|NCT01139021|342058|P2|NOT COMPLETED|Overall Study||0
141431|NCT01139021|342059|P1|NOT COMPLETED|Overall Study||1
141432|NCT01139021|342054|P6|COMPLETED|Overall Study||1
141433|NCT01139021|342055|P5|COMPLETED|Overall Study||107
141434|NCT01139021|342056|P4|COMPLETED|Overall Study||18
141435|NCT01139021|342057|P3|COMPLETED|Overall Study||67
141436|NCT01139021|342058|P2|COMPLETED|Overall Study||153
141437|NCT01139021|342059|P1|COMPLETED|Overall Study||151
141438|NCT01139021|342054|P6|STARTED|Overall Study||1
141439|NCT01139021|342055|P5|STARTED|Overall Study||116
141440|NCT01139021|342056|P4|STARTED|Overall Study||19
141441|NCT01139021|342057|P3|STARTED|Overall Study||67
141442|NCT01139021|342058|P2|STARTED|Overall Study||153
141443|NCT01139021|342059|P1|STARTED|Overall Study||152
141444|NCT01139008|342095|P1|NOT COMPLETED|Overall Study||6
141445|NCT01139008|342095|P1|COMPLETED|Overall Study||74
141446|NCT01139008|342095|P1|STARTED|Overall Study||80
141447|NCT01138995|342106|P2|NOT COMPLETED|Overall Study||25
141448|NCT01138995|342107|P1|NOT COMPLETED|Overall Study||10
141449|NCT01138995|342106|P2|COMPLETED|Overall Study||74
141450|NCT01138995|342107|P1|COMPLETED|Overall Study||88
141451|NCT01138995|342106|P2|STARTED|Overall Study||99
141452|NCT01138995|342107|P1|STARTED|Overall Study||98
141453|NCT01138969|342119|P2|NOT COMPLETED|Overall Study||0
141454|NCT01138969|342120|P1|NOT COMPLETED|Overall Study||0
141455|NCT01138969|342119|P2|COMPLETED|Overall Study||82
141456|NCT01138969|342120|P1|COMPLETED|Overall Study||83
141457|NCT01138969|342119|P2|STARTED|Overall Study||82
141458|NCT01138969|342120|P1|STARTED|Overall Study||83
141459|NCT01138826|342128|P6|NOT COMPLETED|Third Intervention Period||0
141460|NCT01138826|342129|P5|NOT COMPLETED|Third Intervention Period||0
141461|NCT01138826|342130|P4|NOT COMPLETED|Third Intervention Period||0
141462|NCT01138826|342131|P3|NOT COMPLETED|Third Intervention Period||0
141463|NCT01138826|342132|P2|NOT COMPLETED|Third Intervention Period||0
141464|NCT01138826|342133|P1|NOT COMPLETED|Third Intervention Period||0
141465|NCT01138826|342128|P6|COMPLETED|Third Intervention Period||3
141466|NCT01138826|342129|P5|COMPLETED|Third Intervention Period||2
141467|NCT01138826|342130|P4|COMPLETED|Third Intervention Period||3
141468|NCT01138826|342131|P3|COMPLETED|Third Intervention Period||3
141469|NCT01138826|342132|P2|COMPLETED|Third Intervention Period||2
141470|NCT01138826|342133|P1|COMPLETED|Third Intervention Period||2
141471|NCT01138826|342128|P6|STARTED|Third Intervention Period||3
141472|NCT01138826|342129|P5|STARTED|Third Intervention Period||2
141473|NCT01138826|342130|P4|STARTED|Third Intervention Period||3
141474|NCT01138826|342131|P3|STARTED|Third Intervention Period||3
141475|NCT01138826|342132|P2|STARTED|Third Intervention Period||2
141476|NCT01138826|342133|P1|STARTED|Third Intervention Period||2
141477|NCT01138826|342128|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
141478|NCT01138826|342129|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
141479|NCT01138826|342130|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
141480|NCT01138826|342131|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
141481|NCT01138826|342132|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
141482|NCT01138826|342133|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
141483|NCT01138826|342128|P6|COMPLETED|Washout Period II (of 16 Days)||3
141484|NCT01138826|342129|P5|COMPLETED|Washout Period II (of 16 Days)||2
141485|NCT01138826|342130|P4|COMPLETED|Washout Period II (of 16 Days)||3
141486|NCT01138826|342131|P3|COMPLETED|Washout Period II (of 16 Days)||3
141487|NCT01138826|342132|P2|COMPLETED|Washout Period II (of 16 Days)||2
141488|NCT01138826|342133|P1|COMPLETED|Washout Period II (of 16 Days)||2
141489|NCT01138826|342128|P6|STARTED|Washout Period II (of 16 Days)||3
141490|NCT01138826|342129|P5|STARTED|Washout Period II (of 16 Days)||2
141491|NCT01138826|342130|P4|STARTED|Washout Period II (of 16 Days)||3
141492|NCT01138826|342131|P3|STARTED|Washout Period II (of 16 Days)||3
141493|NCT01138826|342132|P2|STARTED|Washout Period II (of 16 Days)||2
141494|NCT01138826|342133|P1|STARTED|Washout Period II (of 16 Days)||2
141495|NCT01138826|342128|P6|NOT COMPLETED|Second Intervention Period||0
141496|NCT01138826|342129|P5|NOT COMPLETED|Second Intervention Period||0
141497|NCT01138826|342130|P4|NOT COMPLETED|Second Intervention Period||0
141498|NCT01138826|342131|P3|NOT COMPLETED|Second Intervention Period||0
141499|NCT01138826|342132|P2|NOT COMPLETED|Second Intervention Period||0
141500|NCT01138826|342133|P1|NOT COMPLETED|Second Intervention Period||0
141501|NCT01138826|342128|P6|COMPLETED|Second Intervention Period||3
141502|NCT01138826|342129|P5|COMPLETED|Second Intervention Period||2
141503|NCT01138826|342130|P4|COMPLETED|Second Intervention Period||3
141504|NCT01138826|342131|P3|COMPLETED|Second Intervention Period||3
141505|NCT01138826|342132|P2|COMPLETED|Second Intervention Period||2
141506|NCT01138826|342133|P1|COMPLETED|Second Intervention Period||2
141507|NCT01138826|342128|P6|STARTED|Second Intervention Period||3
141508|NCT01138826|342129|P5|STARTED|Second Intervention Period||2
141509|NCT01138826|342130|P4|STARTED|Second Intervention Period||3
141510|NCT01138826|342131|P3|STARTED|Second Intervention Period||3
141511|NCT01138826|342132|P2|STARTED|Second Intervention Period||2
141512|NCT01138826|342133|P1|STARTED|Second Intervention Period||2
141513|NCT01138826|342128|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
141514|NCT01138826|342129|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
141515|NCT01138826|342130|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
141516|NCT01138826|342131|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
141517|NCT01138826|342132|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
141518|NCT01138826|342133|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
141519|NCT01138826|342128|P6|COMPLETED|Washout Period I (of 16 Days)||3
141520|NCT01138826|342129|P5|COMPLETED|Washout Period I (of 16 Days)||2
141521|NCT01138826|342130|P4|COMPLETED|Washout Period I (of 16 Days)||3
141522|NCT01138826|342131|P3|COMPLETED|Washout Period I (of 16 Days)||3
141523|NCT01138826|342132|P2|COMPLETED|Washout Period I (of 16 Days)||2
141524|NCT01138826|342133|P1|COMPLETED|Washout Period I (of 16 Days)||2
141525|NCT01138826|342128|P6|STARTED|Washout Period I (of 16 Days)||3
141526|NCT01138826|342129|P5|STARTED|Washout Period I (of 16 Days)||3
141527|NCT01138826|342130|P4|STARTED|Washout Period I (of 16 Days)||3
141528|NCT01138826|342131|P3|STARTED|Washout Period I (of 16 Days)||3
141529|NCT01138826|342132|P2|STARTED|Washout Period I (of 16 Days)||3
141530|NCT01138826|342133|P1|STARTED|Washout Period I (of 16 Days)||3
141531|NCT01138826|342128|P6|NOT COMPLETED|First Intervention Period||0
141532|NCT01138826|342129|P5|NOT COMPLETED|First Intervention Period||0
141533|NCT01138826|342130|P4|NOT COMPLETED|First Intervention Period||0
141534|NCT01138826|342131|P3|NOT COMPLETED|First Intervention Period||0
141535|NCT01138826|342132|P2|NOT COMPLETED|First Intervention Period||0
141536|NCT01138826|342133|P1|NOT COMPLETED|First Intervention Period||0
141537|NCT01138826|342128|P6|COMPLETED|First Intervention Period||3
141538|NCT01138826|342129|P5|COMPLETED|First Intervention Period||3
141539|NCT01138826|342130|P4|COMPLETED|First Intervention Period||3
141540|NCT01138826|342131|P3|COMPLETED|First Intervention Period||3
141541|NCT01138826|342132|P2|COMPLETED|First Intervention Period||3
141542|NCT01138826|342133|P1|COMPLETED|First Intervention Period||3
141543|NCT01138826|342128|P6|STARTED|First Intervention Period||3
141544|NCT01138826|342129|P5|STARTED|First Intervention Period||3
141545|NCT01138826|342130|P4|STARTED|First Intervention Period||3
141546|NCT01138826|342131|P3|STARTED|First Intervention Period||3
141547|NCT01138826|342132|P2|STARTED|First Intervention Period||3
141548|NCT01138826|342133|P1|STARTED|First Intervention Period||3
141549|NCT01138735|342155|P2|NOT COMPLETED|Overall Study||17
141550|NCT01138735|342156|P1|NOT COMPLETED|Overall Study||8
141551|NCT01138735|342155|P2|COMPLETED|Overall Study||126
141552|NCT01138735|342156|P1|COMPLETED|Overall Study||134
141553|NCT01138735|342155|P2|STARTED|Overall Study||143
141554|NCT01138735|342156|P1|STARTED|Overall Study||142
141555|NCT01138657|342170|P2|NOT COMPLETED|Overall Study||18
141556|NCT01138657|342171|P1|NOT COMPLETED|Overall Study||8
141557|NCT01138657|342170|P2|COMPLETED|Overall Study||101
141558|NCT01138657|342171|P1|COMPLETED|Overall Study||112
141559|NCT01138657|342170|P2|Enrolled in Japan Sub-study|Overall Study||8
141560|NCT01138657|342171|P1|Enrolled in Japan Sub-study|Overall Study||8
141561|NCT01138657|342170|P2|Enrolled in Main Study|Overall Study||111
141562|NCT01138657|342171|P1|Enrolled in Main Study|Overall Study||112
141563|NCT01138657|342170|P2|STARTED|Overall Study||119
141564|NCT01138657|342171|P1|STARTED|Overall Study||120
141565|NCT01138514|342218|P3|NOT COMPLETED|Overall Study||93
141566|NCT01138514|342219|P2|NOT COMPLETED|Overall Study||53
141567|NCT01138514|342220|P1|NOT COMPLETED|Overall Study||48
141568|NCT01138514|342218|P3|COMPLETED|Overall Study||424
141569|NCT01138514|342219|P2|COMPLETED|Overall Study||463
141570|NCT01138514|342220|P1|COMPLETED|Overall Study||474
141571|NCT01138514|342218|P3|STARTED|Overall Study||517
141572|NCT01138514|342219|P2|STARTED|Overall Study||516
141573|NCT01138514|342220|P1|STARTED|Overall Study||522
141574|NCT01138501|342234|P1|NOT COMPLETED|Overall Study||5
141575|NCT01138501|342234|P1|COMPLETED|Overall Study||60
141576|NCT01138501|342234|P1|Exposed|Overall Study||63
141577|NCT01138501|342234|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
141578|NCT01138475|342242|P3|NOT COMPLETED|Overall Study||0
141579|NCT01138475|342243|P2|NOT COMPLETED|Overall Study||0
141580|NCT01138475|342244|P1|NOT COMPLETED|Overall Study||0
141581|NCT01138475|342242|P3|COMPLETED|Overall Study||17
141582|NCT01138475|342243|P2|COMPLETED|Overall Study||16
141583|NCT01138475|342244|P1|COMPLETED|Overall Study||16
141584|NCT01138475|342242|P3|STARTED|Overall Study||17
141585|NCT01138475|342243|P2|STARTED|Overall Study||16
141586|NCT01138475|342244|P1|STARTED|Overall Study||16
141587|NCT01138150|342278|P2|NOT COMPLETED|Overall Study||1
141588|NCT01138150|342279|P1|NOT COMPLETED|Overall Study||1
141589|NCT01138150|342278|P2|COMPLETED|Overall Study||17
141590|NCT01138150|342279|P1|COMPLETED|Overall Study||17
141591|NCT01138150|342278|P2|STARTED|Overall Study||18
141592|NCT01138150|342279|P1|STARTED|Overall Study||18
141593|NCT01138124|342335|P4|NOT COMPLETED|Overall Study||0
141594|NCT01138124|342336|P3|NOT COMPLETED|Overall Study||0
141595|NCT01138124|342337|P2|NOT COMPLETED|Overall Study||0
141596|NCT01138124|342338|P1|NOT COMPLETED|Overall Study||0
141597|NCT01138124|342335|P4|COMPLETED|Overall Study||19046
141598|NCT01138124|342336|P3|COMPLETED|Overall Study||1981
141599|NCT01138124|342337|P2|COMPLETED|Overall Study||30026
141600|NCT01138124|342338|P1|COMPLETED|Overall Study||3149
141601|NCT01138124|342335|P4|STARTED|Overall Study||19046
141602|NCT01138124|342336|P3|STARTED|Overall Study||1981
141603|NCT01138124|342337|P2|STARTED|Overall Study||30026
141604|NCT01138124|342338|P1|STARTED|Overall Study||3149
141605|NCT01138111|342360|P1|NOT COMPLETED|Overall Study||9
141606|NCT01138111|342360|P1|COMPLETED|Overall Study||36
141607|NCT01138111|342360|P1|STARTED|Overall Study||45
141608|NCT01138098|342391|P2|NOT COMPLETED|Overall Study||0
141609|NCT01138098|342392|P1|NOT COMPLETED|Overall Study||0
141610|NCT01138098|342391|P2|COMPLETED|Overall Study||90
141611|NCT01138098|342392|P1|COMPLETED|Overall Study||95
141612|NCT01138098|342391|P2|STARTED|Overall Study||90
141613|NCT01138098|342392|P1|STARTED|Overall Study||95
141614|NCT01138046|342414|P1|NOT COMPLETED|Overall Study||6
141615|NCT01138046|342414|P1|COMPLETED|Overall Study||6
141616|NCT01138046|342414|P1|STARTED|Overall Study||12
141617|NCT01138007|342434|P3|NOT COMPLETED|Overall Study||48
141618|NCT01138007|342435|P2|NOT COMPLETED|Overall Study||30
141619|NCT01138007|342436|P1|NOT COMPLETED|Overall Study||22
141620|NCT01138007|342434|P3|COMPLETED|Overall Study||144
141621|NCT01138007|342435|P2|COMPLETED|Overall Study||160
141622|NCT01138007|342436|P1|COMPLETED|Overall Study||165
141623|NCT01138007|342434|P3|STARTED|Overall Study||192
141624|NCT01138007|342435|P2|STARTED|Overall Study||190
141625|NCT01138007|342436|P1|STARTED|Overall Study||187
141626|NCT01137890|342470|P2|NOT COMPLETED|Overall Study||3
141627|NCT01137890|342471|P1|NOT COMPLETED|Overall Study||6
141628|NCT01137890|342470|P2|COMPLETED|Overall Study||2
141629|NCT01137890|342471|P1|COMPLETED|Overall Study||8
141630|NCT01137890|342470|P2|STARTED|Overall Study||5
141631|NCT01137890|342471|P1|STARTED|Overall Study||14
141632|NCT01137812|342543|P2|NOT COMPLETED|Overall Study||168
141633|NCT01137812|342544|P1|NOT COMPLETED|Overall Study||123
141634|NCT01137812|342543|P2|COMPLETED|Overall Study||210
141635|NCT01137812|342544|P1|COMPLETED|Overall Study||254
141636|NCT01137812|342543|P2|STARTED|Overall Study||378
141637|NCT01137812|342544|P1|STARTED|Overall Study||377
141638|NCT01137786|342564|P2|NOT COMPLETED|Overall Study||3
141639|NCT01137786|342565|P1|NOT COMPLETED|Overall Study||1
141640|NCT01137786|342564|P2|COMPLETED|Overall Study||21
141641|NCT01137786|342565|P1|COMPLETED|Overall Study||24
141642|NCT01137786|342564|P2|STARTED|Overall Study||24
141643|NCT01137786|342565|P1|STARTED|Overall Study||25
141644|NCT01137773|342575|P2|NOT COMPLETED|Overall Study||3
141645|NCT01137773|342576|P1|NOT COMPLETED|Overall Study||9
141646|NCT01137773|342575|P2|COMPLETED|Overall Study||20
141647|NCT01137773|342576|P1|COMPLETED|Overall Study||24
141648|NCT01137773|342575|P2|STARTED|Overall Study||23
141649|NCT01137773|342576|P1|STARTED|Overall Study||33
141650|NCT01137682|342587|P3|NOT COMPLETED|Overall Study||34
141651|NCT01137682|342588|P2|NOT COMPLETED|Overall Study||40
141652|NCT01137682|342589|P1|NOT COMPLETED|Overall Study||37
141653|NCT01137682|342587|P3|COMPLETED|Overall Study||34
141654|NCT01137682|342588|P2|COMPLETED|Overall Study||25
141655|NCT01137682|342589|P1|COMPLETED|Overall Study||28
141656|NCT01137682|342587|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
141657|NCT01137682|342588|P2|Safety Set - Extension|Overall Study||54
141658|NCT01137682|342589|P1|Safety Set - Extension|Overall Study||57
141659|NCT01137682|342587|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
141660|NCT01137682|342588|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
141661|NCT01137682|342589|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
141662|NCT01137682|342587|P3|Continuing Into Extension|Overall Study||63
141663|NCT01137682|342588|P2|Continuing Into Extension|Overall Study||54
141664|NCT01137682|342589|P1|Continuing Into Extension|Overall Study||57
141665|NCT01137682|342587|P3|Not Continuing Into Extension|Overall Study||2
141666|NCT01137682|342588|P2|Not Continuing Into Extension|Overall Study||3
141667|NCT01137682|342589|P1|Not Continuing Into Extension|Overall Study||2
141668|NCT01137682|342587|P3|Completed 24-Week Core Phase|Overall Study||65
141669|NCT01137682|342588|P2|Completed 24-Week Core Phase|Overall Study||57
141670|NCT01137682|342589|P1|Completed 24-Week Core Phase|Overall Study||59
141671|NCT01137682|342587|P3|Treated|Overall Study||67
141672|NCT01137682|342588|P2|Treated|Overall Study||63
141673|NCT01137682|342589|P1|Treated|Overall Study||63
141674|NCT01137682|342587|P3|Not Treated|Overall Study||1
141675|NCT01137682|342588|P2|Not Treated|Overall Study||2
141676|NCT01137682|342589|P1|Not Treated|Overall Study||2
141677|NCT01137682|342587|P3|STARTED|Overall Study||68
141678|NCT01137682|342588|P2|STARTED|Overall Study||65
141679|NCT01137682|342589|P1|STARTED|Overall Study||65
141680|NCT01137604|342639|P4|NOT COMPLETED|Overall Study||11
141681|NCT01137604|342640|P3|NOT COMPLETED|Overall Study||13
141682|NCT01137604|342641|P2|NOT COMPLETED|Overall Study||10
141683|NCT01137604|342642|P1|NOT COMPLETED|Overall Study||2
141684|NCT01137604|342639|P4|COMPLETED|Overall Study||21
141685|NCT01137604|342640|P3|COMPLETED|Overall Study||26
141686|NCT01137604|342641|P2|COMPLETED|Overall Study||32
141687|NCT01137604|342642|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
141688|NCT01137604|342639|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
141689|NCT01137604|342640|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
141690|NCT01137604|342641|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
141691|NCT01137604|342642|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
141692|NCT01137604|342639|P4|Disease Progression|Overall Study||21
141693|NCT01137604|342640|P3|Disease Progression|Overall Study||25
141694|NCT01137604|342641|P2|Disease Progression|Overall Study||29
141695|NCT01137604|342642|P1|Disease Progression|Overall Study||34
141696|NCT01137604|342639|P4|STARTED|Overall Study||32
141697|NCT01137604|342640|P3|STARTED|Overall Study||39
141698|NCT01137604|342641|P2|STARTED|Overall Study||42
141699|NCT01137604|342642|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
141700|NCT01137578|342676|P3|NOT COMPLETED|Overall Study||6
141701|NCT01137578|342677|P2|NOT COMPLETED|Overall Study||2
141702|NCT01137578|342678|P1|NOT COMPLETED|Overall Study||16
141703|NCT01137578|342676|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
141704|NCT01137578|342677|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
141705|NCT01137578|342678|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
141706|NCT01137578|342676|P3|STARTED|Overall Study||43
141707|NCT01137578|342677|P2|STARTED|Overall Study||14
141708|NCT01137578|342678|P1|STARTED|Overall Study||77
141709|NCT01137539|342718|P1|NOT COMPLETED|Overall Study||0
141710|NCT01137539|342718|P1|COMPLETED|Overall Study||50
141711|NCT01137539|342718|P1|STARTED|Overall Study||50
141712|NCT01137474|342727|P4|NOT COMPLETED|Overall Study||21
141713|NCT01137474|342728|P3|NOT COMPLETED|Overall Study||7
141714|NCT01137474|342729|P2|NOT COMPLETED|Overall Study||12
141715|NCT01137474|342730|P1|NOT COMPLETED|Overall Study||24
141716|NCT01137474|342727|P4|COMPLETED|Overall Study||281
141717|NCT01137474|342728|P3|COMPLETED|Overall Study||158
141718|NCT01137474|342729|P2|COMPLETED|Overall Study||154
141719|NCT01137474|342730|P1|COMPLETED|Overall Study||287
141720|NCT01137474|342727|P4|Received Treatment|Overall Study||302
141721|NCT01137474|342728|P3|Received Treatment|Overall Study||165
141722|NCT01137474|342729|P2|Received Treatment|Overall Study||166
141723|NCT01137474|342730|P1|Received Treatment|Overall Study||311
141724|NCT01137474|342727|P4|STARTED|Overall Study||302
141725|NCT01137474|342728|P3|STARTED|Overall Study||165
141726|NCT01137474|342729|P2|STARTED|Overall Study||166
141727|NCT01137474|342730|P1|STARTED|Overall Study||311
141728|NCT01137435|342748|P1|NOT COMPLETED|Overall Study||28
141729|NCT01137435|342748|P1|COMPLETED|Overall Study||659
141730|NCT01137435|342748|P1|STARTED|Overall Study||687
141731|NCT01137396|342757|P2|NOT COMPLETED|Overall Study||2
141732|NCT01137396|342758|P1|NOT COMPLETED|Overall Study||8
141733|NCT01137396|342757|P2|COMPLETED|Overall Study||25
141734|NCT01137396|342758|P1|COMPLETED|Overall Study||22
141735|NCT01137396|342757|P2|STARTED|Overall Study||27
141736|NCT01137396|342758|P1|STARTED|Overall Study||30
141737|NCT01137370|342768|P2|NOT COMPLETED|Overall Study||0
141738|NCT01137370|342769|P1|NOT COMPLETED|Overall Study||0
141739|NCT01137370|342768|P2|COMPLETED|Overall Study||87
141740|NCT01137370|342769|P1|COMPLETED|Overall Study||116
141741|NCT01137370|342768|P2|STARTED|Overall Study||87
141742|NCT01137370|342769|P1|STARTED|Overall Study||116
141743|NCT01137292|342775|P1|NOT COMPLETED|Overall Study||54
141744|NCT01137292|342775|P1|COMPLETED|Overall Study||123
141745|NCT01137292|342775|P1|STARTED|Overall Study||177
141746|NCT01137071|342782|P1|NOT COMPLETED|Overall Study||14
141747|NCT01137071|342782|P1|COMPLETED|Overall Study|Of the eligible patients|15
141748|NCT01137071|342782|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
141749|NCT01137032|342843|P1|NOT COMPLETED|Overall Study||0
141750|NCT01137032|342843|P1|COMPLETED|Overall Study||19
141751|NCT01137032|342843|P1|STARTED|Overall Study||19
141752|NCT01136967|342851|P2|NOT COMPLETED|Overall Study||27
141753|NCT01136967|342852|P1|NOT COMPLETED|Overall Study||24
141754|NCT01136967|342851|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
141755|NCT01136967|342852|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
141756|NCT01136967|342851|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
141757|NCT01136967|342852|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
141758|NCT01136967|342851|P2|Disease Progression|Overall Study||56
141759|NCT01136967|342852|P1|Disease Progression|Overall Study||55
141760|NCT01136967|342851|P2|STARTED|Overall Study||89
141761|NCT01136967|342852|P1|STARTED|Overall Study||93
141762|NCT01136954|342870|P2|NOT COMPLETED|Overall Study||21
141763|NCT01136954|342871|P1|NOT COMPLETED|Overall Study||24
141764|NCT01136954|342870|P2|COMPLETED|Overall Study||51
141765|NCT01136954|342871|P1|COMPLETED|Overall Study||48
141766|NCT01136954|342870|P2|STARTED|Overall Study||72
141767|NCT01136954|342871|P1|STARTED|Overall Study||72
141768|NCT01136915|342885|P2|NOT COMPLETED|Overall Study||1
141769|NCT01136915|342886|P1|NOT COMPLETED|Overall Study||2
141770|NCT01136915|342885|P2|COMPLETED|Overall Study||6
141771|NCT01136915|342886|P1|COMPLETED|Overall Study||6
141772|NCT01136915|342885|P2|STARTED|Overall Study||7
141773|NCT01136915|342886|P1|STARTED|Overall Study||8
141774|NCT01136876|342896|P2|NOT COMPLETED|Overall Study||6
141775|NCT01136876|342897|P1|NOT COMPLETED|Overall Study||3
141776|NCT01136876|342896|P2|COMPLETED|Overall Study||23
141777|NCT01136876|342897|P1|COMPLETED|Overall Study||25
141778|NCT01136876|342896|P2|STARTED|Overall Study||29
141779|NCT01136876|342897|P1|STARTED|Overall Study||28
141780|NCT01136785|342907|P2|NOT COMPLETED|Overall Study||1
141781|NCT01136785|342908|P1|NOT COMPLETED|Overall Study||2
141782|NCT01136785|342907|P2|COMPLETED|Overall Study||6
141783|NCT01136785|342908|P1|COMPLETED|Overall Study||13
141784|NCT01136785|342907|P2|STARTED|Overall Study||7
141785|NCT01136785|342908|P1|STARTED|Overall Study||15
141786|NCT01136772|342923|P2|NOT COMPLETED|Overall Study||110
141787|NCT01136772|342924|P1|NOT COMPLETED|Overall Study||116
141788|NCT01136772|342923|P2|COMPLETED|Overall Study||44
141789|NCT01136772|342924|P1|COMPLETED|Overall Study||41
141790|NCT01136772|342923|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
141791|NCT01136772|342924|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
141792|NCT01136772|342923|P2|STARTED|Overall Study||154
141793|NCT01136772|342924|P1|STARTED|Overall Study||157
141794|NCT01136746|342934|P2|NOT COMPLETED|Overall Study||3
141795|NCT01136746|342935|P1|NOT COMPLETED|Overall Study||3
141796|NCT01136746|342934|P2|COMPLETED|Overall Study||4
141797|NCT01136746|342935|P1|COMPLETED|Overall Study||6
141798|NCT01136746|342934|P2|STARTED|Overall Study||7
141799|NCT01136746|342935|P1|STARTED|Overall Study||9
141800|NCT01136655|342995|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
141801|NCT01136655|342995|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
141802|NCT01136655|342995|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
141803|NCT01136655|342995|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
141804|NCT01136655|342995|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
141805|NCT01136655|342995|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
141806|NCT01136655|342995|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
141807|NCT01136655|342995|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
141808|NCT01136655|342995|P1|STARTED|Washout After BUD 160 (7 Days)||51
141809|NCT01136655|342995|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
141810|NCT01136655|342995|P1|COMPLETED|BUD 160 (1 Dose)||51
141811|NCT01136655|342995|P1|STARTED|BUD 160 (1 Dose)||51
141812|NCT01136655|342995|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
141813|NCT01136655|342995|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
141814|NCT01136655|342995|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
141815|NCT01136655|342995|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
141816|NCT01136655|342995|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
141817|NCT01136655|342995|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
141818|NCT01136655|342995|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
141819|NCT01136655|342995|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
141820|NCT01136655|342995|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
141821|NCT01136655|342995|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
141822|NCT01136655|342995|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
141823|NCT01136655|342995|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
141824|NCT01136655|342995|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
141825|NCT01136655|342995|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
141826|NCT01136655|342995|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
141827|NCT01136655|342995|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
141828|NCT01136655|342995|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
141829|NCT01136655|342995|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
141830|NCT01136486|343021|P1|NOT COMPLETED|Overall Study||0
141831|NCT01136486|343021|P1|COMPLETED|Overall Study||56
141832|NCT01136486|343021|P1|STARTED|Overall Study||56
141833|NCT01136408|343028|P3|NOT COMPLETED|Overall Study||5
141834|NCT01136408|343029|P2|NOT COMPLETED|Overall Study||9
141835|NCT01136408|343030|P1|NOT COMPLETED|Overall Study||5
141836|NCT01136408|343028|P3|COMPLETED|Overall Study||57
141837|NCT01136408|343029|P2|COMPLETED|Overall Study||49
141838|NCT01136408|343030|P1|COMPLETED|Overall Study||41
141839|NCT01136408|343028|P3|STARTED|Overall Study||62
141840|NCT01136408|343029|P2|STARTED|Overall Study||58
141841|NCT01136408|343030|P1|STARTED|Overall Study||46
141842|NCT01136382|343087|P2|NOT COMPLETED|Overall Study||31
141843|NCT01136382|343088|P1|NOT COMPLETED|Overall Study||60
141844|NCT01136382|343087|P2|COMPLETED|Overall Study||121
141845|NCT01136382|343088|P1|COMPLETED|Overall Study||92
141846|NCT01136382|343087|P2|STARTED|Overall Study||152
141847|NCT01136382|343088|P1|STARTED|Overall Study||152
141848|NCT01136356|343114|P2|NOT COMPLETED|Second 18-day Withdrawal||1
141849|NCT01136356|343115|P1|NOT COMPLETED|Second 18-day Withdrawal||0
141850|NCT01136356|343114|P2|COMPLETED|Second 18-day Withdrawal||5
141851|NCT01136356|343115|P1|COMPLETED|Second 18-day Withdrawal||2
141852|NCT01136356|343114|P2|STARTED|Second 18-day Withdrawal||6
141853|NCT01136356|343115|P1|STARTED|Second 18-day Withdrawal||2
141854|NCT01136356|343114|P2|NOT COMPLETED|Second Intervention||0
141855|NCT01136356|343115|P1|NOT COMPLETED|Second Intervention||0
141856|NCT01136356|343114|P2|COMPLETED|Second Intervention||6
141857|NCT01136356|343115|P1|COMPLETED|Second Intervention||2
141858|NCT01136356|343114|P2|STARTED|Second Intervention||6
141859|NCT01136356|343115|P1|STARTED|Second Intervention||2
141860|NCT01136356|343114|P2|NOT COMPLETED|First 18-day Withdrawal||0
141861|NCT01136356|343115|P1|NOT COMPLETED|First 18-day Withdrawal||4
141862|NCT01136356|343114|P2|COMPLETED|First 18-day Withdrawal||6
141863|NCT01136356|343115|P1|COMPLETED|First 18-day Withdrawal||2
141864|NCT01136356|343114|P2|STARTED|First 18-day Withdrawal||6
141865|NCT01136356|343115|P1|STARTED|First 18-day Withdrawal||6
141866|NCT01136356|343114|P2|NOT COMPLETED|First Intervention||0
141867|NCT01136356|343115|P1|NOT COMPLETED|First Intervention||0
141868|NCT01136356|343114|P2|COMPLETED|First Intervention||6
141869|NCT01136356|343115|P1|COMPLETED|First Intervention||6
141870|NCT01136356|343114|P2|STARTED|First Intervention||6
141871|NCT01136356|343115|P1|STARTED|First Intervention||6
141872|NCT01136291|343126|P2|NOT COMPLETED|Overall Study||1
141873|NCT01136291|343127|P1|NOT COMPLETED|Overall Study||1
141874|NCT01136291|343126|P2|COMPLETED|Overall Study||41
141875|NCT01136291|343127|P1|COMPLETED|Overall Study||39
141876|NCT01136291|343126|P2|Follow|Overall Study||42
141877|NCT01136291|343127|P1|Follow|Overall Study||40
141878|NCT01136291|343126|P2|STARTED|Overall Study||42
141879|NCT01136291|343127|P1|STARTED|Overall Study||40
141880|NCT01136226|343137|P1|NOT COMPLETED|Overall Study||13
141881|NCT01136226|343137|P1|COMPLETED|Overall Study||29
141882|NCT01136226|343137|P1|STARTED|Overall Study||42
141883|NCT01136174|343145|P4|NOT COMPLETED|Overall Study||4
141884|NCT01136174|343146|P3|NOT COMPLETED|Overall Study||0
141885|NCT01136174|343147|P2|NOT COMPLETED|Overall Study||0
141886|NCT01136174|343148|P1|NOT COMPLETED|Overall Study||0
141887|NCT01136174|343145|P4|COMPLETED|Overall Study||20
141888|NCT01136174|343146|P3|COMPLETED|Overall Study||8
141889|NCT01136174|343147|P2|COMPLETED|Overall Study||6
141890|NCT01136174|343148|P1|COMPLETED|Overall Study||12
141891|NCT01136174|343145|P4|STARTED|Overall Study||24
141892|NCT01136174|343146|P3|STARTED|Overall Study||8
141893|NCT01136174|343147|P2|STARTED|Overall Study||6
141894|NCT01136174|343148|P1|STARTED|Overall Study||12
141895|NCT01135992|343228|P1|NOT COMPLETED|Overall Study||21
141896|NCT01135992|343228|P1|COMPLETED|Overall Study||122
141897|NCT01135992|343228|P1|Full Analysis Set|Overall Study||129
141898|NCT01135992|343228|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
141899|NCT01135992|343228|P1|STARTED|Overall Study||143
141900|NCT01135914|343240|P3|NOT COMPLETED|Overall Study||22
141901|NCT01135914|343241|P2|NOT COMPLETED|Overall Study||5
141902|NCT01135914|343242|P1|NOT COMPLETED|Overall Study||4
141903|NCT01135914|343240|P3|COMPLETED|Overall Study||59
141904|NCT01135914|343241|P2|COMPLETED|Overall Study||75
141905|NCT01135914|343242|P1|COMPLETED|Overall Study||74
141906|NCT01135914|343240|P3|Safety Population|Overall Study||74
141907|NCT01135914|343241|P2|Safety Population|Overall Study||75
141908|NCT01135914|343242|P1|Safety Population|Overall Study||73
141909|NCT01135914|343240|P3|Intent to Treat (ITT) Population|Overall Study||72
141910|NCT01135914|343241|P2|Intent to Treat (ITT) Population|Overall Study||75
141911|NCT01135914|343242|P1|Intent to Treat (ITT) Population|Overall Study||73
141912|NCT01135914|343240|P3|STARTED|Overall Study||81
141913|NCT01135914|343241|P2|STARTED|Overall Study||80
141914|NCT01135914|343242|P1|STARTED|Overall Study||78
141915|NCT01135524|343271|P1|NOT COMPLETED|Overall Study||196
141916|NCT01135524|343271|P1|COMPLETED|Overall Study||0
141917|NCT01135524|343271|P1|STARTED|Overall Study||196
141918|NCT01135511|343284|P9|NOT COMPLETED|Overall Study||1
141919|NCT01135511|343285|P8|NOT COMPLETED|Overall Study||1
141920|NCT01135511|343286|P7|NOT COMPLETED|Overall Study||1
141921|NCT01135511|343287|P6|NOT COMPLETED|Overall Study||1
141922|NCT01135511|343288|P5|NOT COMPLETED|Overall Study||1
141923|NCT01135511|343289|P4|NOT COMPLETED|Overall Study||3
141924|NCT01135511|343290|P3|NOT COMPLETED|Overall Study||8
141925|NCT01135511|343291|P2|NOT COMPLETED|Overall Study||3
141926|NCT01135511|343292|P1|NOT COMPLETED|Overall Study||0
141927|NCT01135511|343284|P9|COMPLETED|Overall Study||20
141928|NCT01135511|343285|P8|COMPLETED|Overall Study||20
141929|NCT01135511|343286|P7|COMPLETED|Overall Study||18
141930|NCT01135511|343287|P6|COMPLETED|Overall Study||20
141931|NCT01135511|343288|P5|COMPLETED|Overall Study||38
141932|NCT01135511|343289|P4|COMPLETED|Overall Study||37
141933|NCT01135511|343290|P3|COMPLETED|Overall Study||33
141934|NCT01135511|343291|P2|COMPLETED|Overall Study||39
141935|NCT01135511|343292|P1|COMPLETED|Overall Study||41
141936|NCT01135511|343284|P9|STARTED|Overall Study||21
141937|NCT01135511|343285|P8|STARTED|Overall Study||21
141938|NCT01135511|343286|P7|STARTED|Overall Study||19
141939|NCT01135511|343287|P6|STARTED|Overall Study||21
141940|NCT01135511|343288|P5|STARTED|Overall Study||39
141941|NCT01135511|343289|P4|STARTED|Overall Study||40
141942|NCT01135511|343290|P3|STARTED|Overall Study||41
141943|NCT01135511|343291|P2|STARTED|Overall Study||42
141944|NCT01135511|343292|P1|STARTED|Overall Study||41
141945|NCT01135498|343574|P1|NOT COMPLETED|Overall Study||90
141946|NCT01135498|343574|P1|COMPLETED|Overall Study||0
141947|NCT01135498|343574|P1|STARTED|Overall Study||90
141948|NCT01135420|343585|P2|NOT COMPLETED|Overall Study||32
141949|NCT01135420|343586|P1|NOT COMPLETED|Overall Study||44
141950|NCT01135420|343585|P2|COMPLETED|Overall Study||175
141951|NCT01135420|343586|P1|COMPLETED|Overall Study||155
141952|NCT01135420|343585|P2|STARTED|Overall Study||207
141953|NCT01135420|343586|P1|STARTED|Overall Study||199
141954|NCT01135381|343596|P4|NOT COMPLETED|Overall Study||1
141955|NCT01135381|343597|P3|NOT COMPLETED|Overall Study||4
141956|NCT01135381|343598|P2|NOT COMPLETED|Overall Study||7
141957|NCT01135381|343599|P1|NOT COMPLETED|Overall Study||21
141958|NCT01135381|343596|P4|COMPLETED|Overall Study||67
141959|NCT01135381|343597|P3|COMPLETED|Overall Study||65
141960|NCT01135381|343598|P2|COMPLETED|Overall Study||178
141961|NCT01135381|343599|P1|COMPLETED|Overall Study||168
141962|NCT01135381|343596|P4|STARTED|Overall Study||68
141963|NCT01135381|343597|P3|STARTED|Overall Study||69
141964|NCT01135381|343598|P2|STARTED|Overall Study||185
141965|NCT01135381|343599|P1|STARTED|Overall Study||189
141966|NCT01135368|343617|P1|NOT COMPLETED|Overall Study||251
141967|NCT01135368|343617|P1|COMPLETED|Overall Study||255
141968|NCT01135368|343617|P1|STARTED|Overall Study||506
141969|NCT01135186|343733|P1|NOT COMPLETED|Overall Study||0
141970|NCT01135186|343733|P1|COMPLETED|Overall Study||9
141971|NCT01135186|343733|P1|STARTED|Overall Study||9
141972|NCT01135134|343742|P2|NOT COMPLETED|Overall Study||1
141973|NCT01135134|343743|P1|NOT COMPLETED|Overall Study||2
141974|NCT01135134|343742|P2|COMPLETED|Overall Study||112
141975|NCT01135134|343743|P1|COMPLETED|Overall Study||218
141976|NCT01135134|343742|P2|STARTED|Overall Study||113
141977|NCT01135134|343743|P1|STARTED|Overall Study||220
141978|NCT01135069|343754|P3|NOT COMPLETED|Overall Study||10
141979|NCT01135069|343755|P2|NOT COMPLETED|Overall Study||32
141980|NCT01135069|343756|P1|NOT COMPLETED|Overall Study||36
141981|NCT01135069|343754|P3|COMPLETED|Overall Study||56
141982|NCT01135069|343755|P2|COMPLETED|Overall Study||177
141983|NCT01135069|343756|P1|COMPLETED|Overall Study||169
141984|NCT01135069|343754|P3|STARTED|Overall Study||66
141985|NCT01135069|343755|P2|STARTED|Overall Study||209
141986|NCT01135069|343756|P1|STARTED|Overall Study||205
141987|NCT01135017|343766|P2|NOT COMPLETED|Overall Study||12
141988|NCT01135017|343767|P1|NOT COMPLETED|Overall Study||6
141989|NCT01135017|343766|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
141990|NCT01135017|343767|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
141991|NCT01135017|343766|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
141992|NCT01135017|343767|P1|Evaluable for Efficacy|Overall Study||55
141993|NCT01135017|343766|P2|Treated|Overall Study||57
141994|NCT01135017|343767|P1|Treated|Overall Study||55
141995|NCT01135017|343766|P2|STARTED|Overall Study||57
141996|NCT01135017|343767|P1|STARTED|Overall Study||55
141997|NCT01134952|343783|P1|NOT COMPLETED|Overall Study||0
141998|NCT01134952|343783|P1|COMPLETED|Overall Study||11
141999|NCT01134952|343783|P1|STARTED|Overall Study||11
142000|NCT01134939|343805|P8|NOT COMPLETED|Overall Study||0
142001|NCT01134939|343806|P7|NOT COMPLETED|Overall Study||9
142002|NCT01134939|343807|P6|NOT COMPLETED|Overall Study||9
142003|NCT01134939|343808|P5|NOT COMPLETED|Overall Study||10
142004|NCT01134939|343809|P4|NOT COMPLETED|Overall Study||14
142005|NCT01134939|343810|P3|NOT COMPLETED|Overall Study||10
142006|NCT01134939|343811|P2|NOT COMPLETED|Overall Study||18
142007|NCT01134939|343812|P1|NOT COMPLETED|Overall Study||17
142008|NCT01134939|343805|P8|COMPLETED|Overall Study||1
142009|NCT01134939|343806|P7|COMPLETED|Overall Study||10
142010|NCT01134939|343807|P6|COMPLETED|Overall Study||5
142011|NCT01134939|343808|P5|COMPLETED|Overall Study||23
142012|NCT01134939|343809|P4|COMPLETED|Overall Study||32
142013|NCT01134939|343810|P3|COMPLETED|Overall Study||41
142014|NCT01134939|343811|P2|COMPLETED|Overall Study||24
142015|NCT01134939|343812|P1|COMPLETED|Overall Study||42
142016|NCT01134939|343805|P8|STARTED|Overall Study||1
142017|NCT01134939|343806|P7|STARTED|Overall Study||19
142018|NCT01134939|343807|P6|STARTED|Overall Study||14
142019|NCT01134939|343808|P5|STARTED|Overall Study||33
142020|NCT01134939|343809|P4|STARTED|Overall Study||46
142021|NCT01134939|343810|P3|STARTED|Overall Study||51
142022|NCT01134939|343811|P2|STARTED|Overall Study||42
142023|NCT01134939|343812|P1|STARTED|Overall Study||59
142024|NCT01134900|343924|P2|NOT COMPLETED|Overall Study||0
142025|NCT01134900|343925|P1|NOT COMPLETED|Overall Study||0
142026|NCT01134900|343924|P2|COMPLETED|Overall Study||196
142027|NCT01134900|343925|P1|COMPLETED|Overall Study||200
142028|NCT01134900|343924|P2|STARTED|Overall Study||196
142029|NCT01134900|343925|P1|STARTED|Overall Study||200
142030|NCT01134887|343937|P4|NOT COMPLETED|Overall Study||0
142031|NCT01134887|343938|P3|NOT COMPLETED|Overall Study||0
142032|NCT01134887|343939|P2|NOT COMPLETED|Overall Study||4
142033|NCT01134887|343940|P1|NOT COMPLETED|Overall Study||0
142034|NCT01134887|343937|P4|COMPLETED|Overall Study||5
142035|NCT01134887|343938|P3|COMPLETED|Overall Study||5
142036|NCT01134887|343939|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
142037|NCT01134887|343940|P1|COMPLETED|Overall Study||9
142038|NCT01134887|343937|P4|STARTED|Overall Study||5
142039|NCT01134887|343938|P3|STARTED|Overall Study||5
142040|NCT01134887|343939|P2|STARTED|Overall Study||11
142041|NCT01134887|343940|P1|STARTED|Overall Study||9
142042|NCT01134783|343950|P2|NOT COMPLETED|Overall Study||37
142043|NCT01134783|343951|P1|NOT COMPLETED|Overall Study||36
142044|NCT01134783|343950|P2|COMPLETED|Overall Study||180
142045|NCT01134783|343951|P1|COMPLETED|Overall Study||188
142046|NCT01134783|343950|P2|STARTED|Overall Study||217
142047|NCT01134783|343951|P1|STARTED|Overall Study||224
142048|NCT01134731|343970|P3|NOT COMPLETED|Overall Study||8
142049|NCT01134731|343971|P2|NOT COMPLETED|Overall Study||11
142050|NCT01134731|343972|P1|NOT COMPLETED|Overall Study||13
142051|NCT01134731|343970|P3|COMPLETED|Overall Study||2
142052|NCT01134731|343971|P2|COMPLETED|Overall Study||10
142053|NCT01134731|343972|P1|COMPLETED|Overall Study||10
142054|NCT01134731|343970|P3|STARTED|Overall Study||10
142055|NCT01134731|343971|P2|STARTED|Overall Study||21
142056|NCT01134731|343972|P1|STARTED|Overall Study||23
142057|NCT01134705|343985|P2|NOT COMPLETED|Overall Study||22
142058|NCT01134705|343986|P1|NOT COMPLETED|Overall Study||15
142059|NCT01134705|343985|P2|COMPLETED|Overall Study||216
142060|NCT01134705|343986|P1|COMPLETED|Overall Study||221
142061|NCT01134705|343985|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
142062|NCT01134705|343986|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
142063|NCT01134705|343985|P2|STARTED|Overall Study||238
142064|NCT01134705|343986|P1|STARTED|Overall Study||236
142065|NCT01134627|343998|P2|NOT COMPLETED|Overall Study||67
142066|NCT01134627|343999|P1|NOT COMPLETED|Overall Study||69
142067|NCT01134627|343998|P2|COMPLETED|Overall Study||88
142068|NCT01134627|343999|P1|COMPLETED|Overall Study||80
142069|NCT01134627|343998|P2|STARTED|Overall Study|Number of participants treated.|155
142070|NCT01134627|343999|P1|STARTED|Overall Study|Number of participants treated.|149
142071|NCT01134614|344029|P2|NOT COMPLETED|Overall Study||122
142072|NCT01134614|344030|P1|NOT COMPLETED|Overall Study||123
142073|NCT01134614|344029|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
142074|NCT01134614|344030|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
142075|NCT01134614|344029|P2|Treated and Toxicity Assessed|Overall Study||120
142076|NCT01134614|344030|P1|Treated and Toxicity Assessed|Overall Study||118
142077|NCT01134614|344029|P2|Treated|Overall Study||121
142078|NCT01134614|344030|P1|Treated|Overall Study||119
142079|NCT01134614|344029|P2|STARTED|Overall Study||122
142080|NCT01134614|344030|P1|STARTED|Overall Study||123
142081|NCT01134562|344045|P5|NOT COMPLETED|Overall Study||0
142082|NCT01134562|344046|P4|NOT COMPLETED|Overall Study||0
142083|NCT01134562|344047|P3|NOT COMPLETED|Overall Study||0
142084|NCT01134562|344048|P2|NOT COMPLETED|Overall Study||1
142085|NCT01134562|344049|P1|NOT COMPLETED|Overall Study||0
142086|NCT01134562|344045|P5|COMPLETED|Overall Study||8
142087|NCT01134562|344046|P4|COMPLETED|Overall Study||8
142088|NCT01134562|344047|P3|COMPLETED|Overall Study||4
142089|NCT01134562|344048|P2|COMPLETED|Overall Study||3
142090|NCT01134562|344049|P1|COMPLETED|Overall Study||4
142091|NCT01134562|344045|P5|STARTED|Overall Study||8
142092|NCT01134562|344046|P4|STARTED|Overall Study||8
142093|NCT01134562|344047|P3|STARTED|Overall Study||4
142094|NCT01134562|344048|P2|STARTED|Overall Study||4
142095|NCT01134562|344049|P1|STARTED|Overall Study||4
142096|NCT01134549|344118|P5|NOT COMPLETED|Overall Study||0
142097|NCT01134549|344119|P4|NOT COMPLETED|Overall Study||0
142098|NCT01134549|344120|P3|NOT COMPLETED|Overall Study||0
142099|NCT01134549|344121|P2|NOT COMPLETED|Overall Study||0
142100|NCT01134549|344122|P1|NOT COMPLETED|Overall Study||0
142101|NCT01134549|344118|P5|COMPLETED|Overall Study||6
142102|NCT01134549|344119|P4|COMPLETED|Overall Study||6
142103|NCT01134549|344120|P3|COMPLETED|Overall Study||6
142104|NCT01134549|344121|P2|COMPLETED|Overall Study||6
142105|NCT01134549|344122|P1|COMPLETED|Overall Study||8
142106|NCT01134549|344118|P5|STARTED|Overall Study||6
142107|NCT01134549|344119|P4|STARTED|Overall Study||6
142108|NCT01134549|344120|P3|STARTED|Overall Study||6
142109|NCT01134549|344121|P2|STARTED|Overall Study||6
142110|NCT01134549|344122|P1|STARTED|Overall Study||8
142111|NCT01134510|344208|P2|NOT COMPLETED|Overall Study||1
142112|NCT01134510|344209|P1|NOT COMPLETED|Overall Study||0
142113|NCT01134510|344208|P2|COMPLETED|Overall Study||9
142114|NCT01134510|344209|P1|COMPLETED|Overall Study||10
142115|NCT01134510|344208|P2|Month 3|Overall Study||9
142116|NCT01134510|344209|P1|Month 3|Overall Study||10
142117|NCT01134510|344208|P2|Month 1|Overall Study||10
142118|NCT01134510|344209|P1|Month 1|Overall Study||10
142119|NCT01134510|344208|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
142120|NCT01134510|344209|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
142121|NCT01134510|344208|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
142122|NCT01134510|344209|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
142123|NCT01134510|344208|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
142124|NCT01134510|344209|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
142125|NCT01134510|344208|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
142126|NCT01134510|344209|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
142127|NCT01134510|344208|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
142128|NCT01134510|344209|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
142129|NCT01134510|344208|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
142130|NCT01134510|344209|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
142131|NCT01134510|344208|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
142132|NCT01134510|344209|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
142133|NCT01134510|344208|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
142134|NCT01134510|344209|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
142135|NCT01134393|344221|P1|NOT COMPLETED|Overall Study||52
142136|NCT01134393|344221|P1|COMPLETED|Overall Study|Completed trial medication.|449
142137|NCT01134393|344221|P1|STARTED|Overall Study|Entered and treated.|501
142138|NCT01134328|344239|P4|NOT COMPLETED|Overall Study||4
142139|NCT01134328|344240|P3|NOT COMPLETED|Overall Study||3
142140|NCT01134328|344241|P2|NOT COMPLETED|Overall Study||3
142141|NCT01134328|344242|P1|NOT COMPLETED|Overall Study||2
142142|NCT01134328|344239|P4|COMPLETED|Overall Study||17
142143|NCT01134328|344240|P3|COMPLETED|Overall Study||17
142144|NCT01134328|344241|P2|COMPLETED|Overall Study||18
142145|NCT01134328|344242|P1|COMPLETED|Overall Study||19
142146|NCT01134328|344239|P4|STARTED|Overall Study||21
142147|NCT01134328|344240|P3|STARTED|Overall Study||20
142148|NCT01134328|344241|P2|STARTED|Overall Study||21
142149|NCT01134328|344242|P1|STARTED|Overall Study||21
142150|NCT01134315|344342|P2|NOT COMPLETED|Overall Study||19
142151|NCT01134315|344343|P1|NOT COMPLETED|Overall Study||9
142152|NCT01134315|344342|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
142153|NCT01134315|344343|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
142154|NCT01134315|344342|P2|STARTED|Overall Study||40
142155|NCT01134315|344343|P1|STARTED|Overall Study||21
142156|NCT01134276|344365|P2|NOT COMPLETED|Overall Study||0
142157|NCT01134276|344366|P1|NOT COMPLETED|Overall Study||0
142158|NCT01134276|344365|P2|COMPLETED|Overall Study||107
142159|NCT01134276|344366|P1|COMPLETED|Overall Study||104
142160|NCT01134276|344365|P2|STARTED|Overall Study||107
142161|NCT01134276|344366|P1|STARTED|Overall Study||104
142162|NCT01134107|344378|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
142163|NCT01134107|344379|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
142164|NCT01134107|344378|P2|COMPLETED|Period 2-Second Treatment Intervention||61
142165|NCT01134107|344379|P1|COMPLETED|Period 2-Second Treatment Intervention||57
142166|NCT01134107|344378|P2|STARTED|Period 2-Second Treatment Intervention||61
142167|NCT01134107|344379|P1|STARTED|Period 2-Second Treatment Intervention||61
142168|NCT01134107|344378|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
142169|NCT01134107|344379|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
142170|NCT01134107|344378|P2|COMPLETED|Period 1-First Treatment Intervention||61
142171|NCT01134107|344379|P1|COMPLETED|Period 1-First Treatment Intervention||61
142172|NCT01134107|344378|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
142173|NCT01134107|344379|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
142174|NCT01134107|344378|P2|STARTED|Period 1-First Treatment Intervention||66
142175|NCT01134107|344379|P1|STARTED|Period 1-First Treatment Intervention||67
142176|NCT01134081|344411|P1|NOT COMPLETED|Overall Study||0
142177|NCT01134081|344411|P1|COMPLETED|Overall Study||44
142178|NCT01134081|344411|P1|STARTED|Overall Study||44
142179|NCT01134055|344426|P7|NOT COMPLETED|Overall Study||11
142180|NCT01134055|344427|P6|NOT COMPLETED|Overall Study||7
142181|NCT01134055|344428|P5|NOT COMPLETED|Overall Study||6
142182|NCT01134055|344429|P4|NOT COMPLETED|Overall Study||6
142183|NCT01134055|344430|P3|NOT COMPLETED|Overall Study||3
142184|NCT01134055|344431|P2|NOT COMPLETED|Overall Study||6
142185|NCT01134055|344432|P1|NOT COMPLETED|Overall Study||8
142186|NCT01134055|344426|P7|COMPLETED|Overall Study||62
142187|NCT01134055|344427|P6|COMPLETED|Overall Study||65
142188|NCT01134055|344428|P5|COMPLETED|Overall Study||67
142189|NCT01134055|344429|P4|COMPLETED|Overall Study||67
142190|NCT01134055|344430|P3|COMPLETED|Overall Study||71
142191|NCT01134055|344431|P2|COMPLETED|Overall Study||66
142192|NCT01134055|344432|P1|COMPLETED|Overall Study||65
142193|NCT01134055|344426|P7|STARTED|Overall Study||73
142194|NCT01134055|344427|P6|STARTED|Overall Study||72
142195|NCT01134055|344428|P5|STARTED|Overall Study||73
142196|NCT01134055|344429|P4|STARTED|Overall Study||73
142197|NCT01134055|344430|P3|STARTED|Overall Study||74
142198|NCT01134055|344431|P2|STARTED|Overall Study||72
142199|NCT01134055|344432|P1|STARTED|Overall Study||73
142200|NCT01134042|344566|P3|NOT COMPLETED|Overall Study||34
142201|NCT01134042|344567|P2|NOT COMPLETED|Overall Study||28
142202|NCT01134042|344568|P1|NOT COMPLETED|Overall Study||48
142203|NCT01134042|344566|P3|COMPLETED|Overall Study||161
142204|NCT01134042|344567|P2|COMPLETED|Overall Study||169
142205|NCT01134042|344568|P1|COMPLETED|Overall Study||146
142206|NCT01134042|344566|P3|STARTED|Overall Study||195
142207|NCT01134042|344567|P2|STARTED|Overall Study||197
142208|NCT01134042|344568|P1|STARTED|Overall Study||194
142209|NCT01134016|344606|P1|NOT COMPLETED|Overall Study||3
142210|NCT01134016|344606|P1|COMPLETED|Overall Study||10
142211|NCT01134016|344606|P1|STARTED|Overall Study||13
142212|NCT01133977|344644|P5|NOT COMPLETED|Overall Study||38
142213|NCT01133977|344645|P4|NOT COMPLETED|Overall Study||39
142214|NCT01133977|344646|P3|NOT COMPLETED|Overall Study||6
142215|NCT01133977|344647|P2|NOT COMPLETED|Overall Study||7
142216|NCT01133977|344648|P1|NOT COMPLETED|Overall Study||3
142217|NCT01133977|344644|P5|COMPLETED|Overall Study||1
142218|NCT01133977|344645|P4|COMPLETED|Overall Study||3
142219|NCT01133977|344646|P3|COMPLETED|Overall Study||0
142220|NCT01133977|344647|P2|COMPLETED|Overall Study||0
142221|NCT01133977|344648|P1|COMPLETED|Overall Study||0
142222|NCT01133977|344644|P5|STARTED|Overall Study|Treated|39
142223|NCT01133977|344645|P4|STARTED|Overall Study|Treated|42
142224|NCT01133977|344646|P3|STARTED|Overall Study|Treated|6
142225|NCT01133977|344647|P2|STARTED|Overall Study|Treated|7
142226|NCT01133977|344648|P1|STARTED|Overall Study|Treated|3
142227|NCT01133860|344665|P1|NOT COMPLETED|Overall Study||0
142228|NCT01133860|344665|P1|COMPLETED|Overall Study||12
142229|NCT01133860|344665|P1|STARTED|Overall Study||12
142230|NCT01133847|344675|P3|NOT COMPLETED|Follow-Up Phase||7
142231|NCT01133847|344676|P2|NOT COMPLETED|Follow-Up Phase||3
142232|NCT01133847|344677|P1|NOT COMPLETED|Follow-Up Phase||1
142233|NCT01133847|344675|P3|COMPLETED|Follow-Up Phase||60
142234|NCT01133847|344676|P2|COMPLETED|Follow-Up Phase||70
142235|NCT01133847|344677|P1|COMPLETED|Follow-Up Phase||72
142236|NCT01133847|344675|P3|STARTED|Follow-Up Phase||67
142237|NCT01133847|344676|P2|STARTED|Follow-Up Phase||73
142238|NCT01133847|344677|P1|STARTED|Follow-Up Phase||73
142239|NCT01133847|344675|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
142240|NCT01133847|344676|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
142241|NCT01133847|344677|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
142242|NCT01133847|344675|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
142243|NCT01133847|344676|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
142244|NCT01133847|344677|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
142245|NCT01133847|344675|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
142246|NCT01133847|344676|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
142247|NCT01133847|344677|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
142248|NCT01133821|344717|P2|NOT COMPLETED|Overall Study||19
142249|NCT01133821|344718|P1|NOT COMPLETED|Overall Study||18
142250|NCT01133821|344717|P2|COMPLETED|Overall Study||28
142251|NCT01133821|344718|P1|COMPLETED|Overall Study||27
142252|NCT01133821|344717|P2|STARTED|Overall Study||47
142253|NCT01133821|344718|P1|STARTED|Overall Study||45
142254|NCT01133756|344729|P3|NOT COMPLETED|Overall Study||2
142255|NCT01133756|344730|P2|NOT COMPLETED|Overall Study||3
142256|NCT01133756|344731|P1|NOT COMPLETED|Overall Study||2
142257|NCT01133756|344729|P3|COMPLETED|Overall Study||0
142258|NCT01133756|344730|P2|COMPLETED|Overall Study||0
142259|NCT01133756|344731|P1|COMPLETED|Overall Study||0
142260|NCT01133756|344729|P3|Completed 6 Cycles|Overall Study||0
142261|NCT01133756|344730|P2|Completed 6 Cycles|Overall Study||0
142262|NCT01133756|344731|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
142263|NCT01133756|344729|P3|STARTED|Overall Study||2
142264|NCT01133756|344730|P2|STARTED|Overall Study||3
142265|NCT01133756|344731|P1|STARTED|Overall Study||2
142266|NCT01133704|344747|P2|NOT COMPLETED|Overall Study||26
142267|NCT01133704|344748|P1|NOT COMPLETED|Overall Study||49
142268|NCT01133704|344747|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
142269|NCT01133704|344748|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
142270|NCT01133704|344747|P2|STARTED|Overall Study||33
142271|NCT01133704|344748|P1|STARTED|Overall Study||65
142272|NCT01133665|344756|P1|NOT COMPLETED|Overall Study||2
142273|NCT01133665|344756|P1|COMPLETED|Overall Study||40
142274|NCT01133665|344756|P1|STARTED|Overall Study||42
142275|NCT01133626|344800|P3|NOT COMPLETED|Overall Study||2
142276|NCT01133626|344801|P2|NOT COMPLETED|Overall Study||5
142277|NCT01133626|344802|P1|NOT COMPLETED|Overall Study||1
142278|NCT01133626|344800|P3|COMPLETED|Overall Study||9
142279|NCT01133626|344801|P2|COMPLETED|Overall Study||41
142280|NCT01133626|344802|P1|COMPLETED|Overall Study||49
142281|NCT01133626|344800|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
142282|NCT01133626|344801|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
142283|NCT01133626|344802|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
142284|NCT01133626|344800|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
142285|NCT01133626|344801|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
142286|NCT01133626|344802|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
142287|NCT01133626|344800|P3|STARTED|Overall Study||11
142288|NCT01133626|344801|P2|STARTED|Overall Study||46
142289|NCT01133626|344802|P1|STARTED|Overall Study||50
142290|NCT01133522|344820|P10|NOT COMPLETED|Overall Study||0
142291|NCT01133522|344821|P9|NOT COMPLETED|Overall Study||0
142292|NCT01133522|344822|P8|NOT COMPLETED|Overall Study||0
142293|NCT01133522|344823|P7|NOT COMPLETED|Overall Study||0
142294|NCT01133522|344824|P6|NOT COMPLETED|Overall Study||0
142295|NCT01133522|344825|P5|NOT COMPLETED|Overall Study||1
142296|NCT01133522|344826|P4|NOT COMPLETED|Overall Study||1
142297|NCT01133522|344827|P3|NOT COMPLETED|Overall Study||0
142298|NCT01133522|344828|P2|NOT COMPLETED|Overall Study||1
142299|NCT01133522|344829|P1|NOT COMPLETED|Overall Study||0
142300|NCT01133522|344820|P10|COMPLETED|Overall Study||4
142301|NCT01133522|344821|P9|COMPLETED|Overall Study||2
142302|NCT01133522|344822|P8|COMPLETED|Overall Study||9
142303|NCT01133522|344823|P7|COMPLETED|Overall Study||2
142304|NCT01133522|344824|P6|COMPLETED|Overall Study||6
142305|NCT01133522|344825|P5|COMPLETED|Overall Study||6
142306|NCT01133522|344826|P4|COMPLETED|Overall Study||6
142307|NCT01133522|344827|P3|COMPLETED|Overall Study||6
142308|NCT01133522|344828|P2|COMPLETED|Overall Study||6
142309|NCT01133522|344829|P1|COMPLETED|Overall Study||10
142310|NCT01133522|344820|P10|Received Treatment|Overall Study||4
142311|NCT01133522|344821|P9|Received Treatment|Overall Study||2
142312|NCT01133522|344822|P8|Received Treatment|Overall Study||9
142313|NCT01133522|344823|P7|Received Treatment|Overall Study||2
142314|NCT01133522|344824|P6|Received Treatment|Overall Study||6
142315|NCT01133522|344825|P5|Received Treatment|Overall Study||6
142316|NCT01133522|344826|P4|Received Treatment|Overall Study||6
142317|NCT01133522|344827|P3|Received Treatment|Overall Study||6
142318|NCT01133522|344828|P2|Received Treatment|Overall Study||6
142319|NCT01133522|344829|P1|Received Treatment|Overall Study||10
142320|NCT01133522|344820|P10|STARTED|Overall Study||4
142321|NCT01133522|344821|P9|STARTED|Overall Study||2
142322|NCT01133522|344822|P8|STARTED|Overall Study||9
142323|NCT01133522|344823|P7|STARTED|Overall Study||2
142324|NCT01133522|344824|P6|STARTED|Overall Study||6
142325|NCT01133522|344825|P5|STARTED|Overall Study||7
142326|NCT01133522|344826|P4|STARTED|Overall Study||7
142327|NCT01133522|344827|P3|STARTED|Overall Study||6
142328|NCT01133522|344828|P2|STARTED|Overall Study||7
142329|NCT01133522|344829|P1|STARTED|Overall Study||10
142330|NCT01133418|344897|P2|NOT COMPLETED|Overall Study||6
142331|NCT01133418|344898|P1|NOT COMPLETED|Overall Study||5
142332|NCT01133418|344897|P2|COMPLETED|Overall Study||32
142333|NCT01133418|344898|P1|COMPLETED|Overall Study||29
142334|NCT01133418|344897|P2|STARTED|Overall Study||38
142335|NCT01133418|344898|P1|STARTED|Overall Study||34
142336|NCT01133392|344912|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
142337|NCT01133392|344913|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
142338|NCT01133392|344912|P2|COMPLETED|Fourth Intervention (1 Day)||16
142339|NCT01133392|344913|P1|COMPLETED|Fourth Intervention (1 Day)||20
142340|NCT01133392|344912|P2|STARTED|Fourth Intervention (1 Day)||16
142341|NCT01133392|344913|P1|STARTED|Fourth Intervention (1 Day)||20
142342|NCT01133392|344912|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
142343|NCT01133392|344913|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
142344|NCT01133392|344912|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
142345|NCT01133392|344913|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
142346|NCT01133392|344912|P2|STARTED|Interval Between Dosing (4-7 Days)||17
142347|NCT01133392|344913|P1|STARTED|Interval Between Dosing (4-7 Days)||20
142348|NCT01133392|344912|P2|NOT COMPLETED|Third Intervention (1 Day)||0
142349|NCT01133392|344913|P1|NOT COMPLETED|Third Intervention (1 Day)||0
142350|NCT01133392|344912|P2|COMPLETED|Third Intervention (1 Day)||17
142351|NCT01133392|344913|P1|COMPLETED|Third Intervention (1 Day)||20
142352|NCT01133392|344912|P2|STARTED|Third Intervention (1 Day)||17
142353|NCT01133392|344913|P1|STARTED|Third Intervention (1 Day)||20
142354|NCT01133392|344912|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
142355|NCT01133392|344913|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
142356|NCT01133392|344912|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
142357|NCT01133392|344913|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
142358|NCT01133392|344912|P2|STARTED|Interval Between Dosing (4-7 Days)||17
142359|NCT01133392|344913|P1|STARTED|Interval Between Dosing (4-7 Days)||20
142360|NCT01133392|344912|P2|NOT COMPLETED|Second Intervention (1 Day)||0
142361|NCT01133392|344913|P1|NOT COMPLETED|Second Intervention (1 Day)||0
142362|NCT01133392|344912|P2|COMPLETED|Second Intervention (1 Day)||17
142363|NCT01133392|344913|P1|COMPLETED|Second Intervention (1 Day)||20
142364|NCT01133392|344912|P2|STARTED|Second Intervention (1 Day)||17
142365|NCT01133392|344913|P1|STARTED|Second Intervention (1 Day)||20
142366|NCT01133392|344912|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
142367|NCT01133392|344913|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
142368|NCT01133392|344912|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
142369|NCT01133392|344913|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
142370|NCT01133392|344912|P2|STARTED|Interval Between Dosing (4-7 Days)||18
142371|NCT01133392|344913|P1|STARTED|Interval Between Dosing (4-7 Days)||20
142372|NCT01133392|344912|P2|NOT COMPLETED|First Intervention (1 Day )||0
142373|NCT01133392|344913|P1|NOT COMPLETED|First Intervention (1 Day )||0
142374|NCT01133392|344912|P2|COMPLETED|First Intervention (1 Day )||18
142375|NCT01133392|344913|P1|COMPLETED|First Intervention (1 Day )||20
142376|NCT01133392|344912|P2|STARTED|First Intervention (1 Day )||18
142377|NCT01133392|344913|P1|STARTED|First Intervention (1 Day )||20
142378|NCT01133379|344930|P3|NOT COMPLETED|Overall Study||2
142379|NCT01133379|344931|P2|NOT COMPLETED|Overall Study||2
142380|NCT01133379|344932|P1|NOT COMPLETED|Overall Study||1
142381|NCT01133379|344930|P3|COMPLETED|Overall Study||56
142382|NCT01133379|344931|P2|COMPLETED|Overall Study||56
142383|NCT01133379|344932|P1|COMPLETED|Overall Study||57
142384|NCT01133379|344930|P3|STARTED|Overall Study||58
142385|NCT01133379|344931|P2|STARTED|Overall Study||58
142386|NCT01133379|344932|P1|STARTED|Overall Study||58
142387|NCT01133288|344985|P1|NOT COMPLETED|Intervention Allocation||2
142388|NCT01133288|344985|P1|COMPLETED|Intervention Allocation||0
142389|NCT01133288|344985|P1|STARTED|Intervention Allocation||2
142390|NCT01133288|344985|P1|NOT COMPLETED|Eligibility Assessment||5
142391|NCT01133288|344985|P1|COMPLETED|Eligibility Assessment||2
142392|NCT01133288|344985|P1|STARTED|Eligibility Assessment||7
142393|NCT01133275|344990|P1|NOT COMPLETED|Overall Study||2
142394|NCT01133275|344990|P1|COMPLETED|Overall Study||26
142395|NCT01133275|344990|P1|STARTED|Overall Study||28
142396|NCT01133171|344998|P3|NOT COMPLETED|Overall Study||0
142397|NCT01133171|344999|P2|NOT COMPLETED|Overall Study||2
142398|NCT01133171|345000|P1|NOT COMPLETED|Overall Study||1
142399|NCT01133171|344998|P3|COMPLETED|Overall Study||25
142400|NCT01133171|344999|P2|COMPLETED|Overall Study||25
142401|NCT01133171|345000|P1|COMPLETED|Overall Study||24
142402|NCT01133171|344998|P3|STARTED|Overall Study||25
142403|NCT01133171|344999|P2|STARTED|Overall Study||27
142404|NCT01133171|345000|P1|STARTED|Overall Study||25
142405|NCT01132846|345013|P3|NOT COMPLETED|Overall Study||11
142406|NCT01132846|345014|P2|NOT COMPLETED|Overall Study||18
142407|NCT01132846|345015|P1|NOT COMPLETED|Overall Study||16
142408|NCT01132846|345013|P3|COMPLETED|Overall Study||108
142409|NCT01132846|345014|P2|COMPLETED|Overall Study||101
142410|NCT01132846|345015|P1|COMPLETED|Overall Study||106
142411|NCT01132846|345013|P3|STARTED|Overall Study||119
142412|NCT01132846|345014|P2|STARTED|Overall Study||119
142413|NCT01132846|345015|P1|STARTED|Overall Study||122
142414|NCT01132820|345065|P1|NOT COMPLETED|Overall Study||5
142415|NCT01132820|345065|P1|COMPLETED|Overall Study||48
142416|NCT01132820|345065|P1|STARTED|Overall Study||53
142417|NCT01132690|345076|P2|NOT COMPLETED|Overall Study||0
142418|NCT01132690|345077|P1|NOT COMPLETED|Overall Study||0
142419|NCT01132690|345076|P2|COMPLETED|Overall Study||5
142420|NCT01132690|345077|P1|COMPLETED|Overall Study||6
142421|NCT01132690|345076|P2|STARTED|Overall Study||5
142422|NCT01132690|345077|P1|STARTED|Overall Study||6
142423|NCT01132664|345098|P5|NOT COMPLETED|BM Cohort||6
142424|NCT01132664|345099|P4|NOT COMPLETED|BM Cohort||3
142425|NCT01132664|345100|P3|NOT COMPLETED|BM Cohort||0
142426|NCT01132664|345101|P2|NOT COMPLETED|BM Cohort||0
142427|NCT01132664|345102|P1|NOT COMPLETED|BM Cohort||0
142428|NCT01132664|345098|P5|COMPLETED|BM Cohort||0
142429|NCT01132664|345099|P4|COMPLETED|BM Cohort||0
142430|NCT01132664|345100|P3|COMPLETED|BM Cohort||0
142431|NCT01132664|345101|P2|COMPLETED|BM Cohort||0
142432|NCT01132664|345102|P1|COMPLETED|BM Cohort||0
142433|NCT01132664|345098|P5|STARTED|BM Cohort||6
142434|NCT01132664|345099|P4|STARTED|BM Cohort||3
142435|NCT01132664|345100|P3|STARTED|BM Cohort||0
142436|NCT01132664|345101|P2|STARTED|BM Cohort||0
142437|NCT01132664|345102|P1|STARTED|BM Cohort||0
142438|NCT01132664|345098|P5|NOT COMPLETED|Phase ll||0
142439|NCT01132664|345099|P4|NOT COMPLETED|Phase ll||0
142440|NCT01132664|345100|P3|NOT COMPLETED|Phase ll||50
142441|NCT01132664|345101|P2|NOT COMPLETED|Phase ll||0
142442|NCT01132664|345102|P1|NOT COMPLETED|Phase ll||0
142443|NCT01132664|345098|P5|COMPLETED|Phase ll||0
142444|NCT01132664|345099|P4|COMPLETED|Phase ll||0
142445|NCT01132664|345100|P3|COMPLETED|Phase ll||0
142446|NCT01132664|345101|P2|COMPLETED|Phase ll||0
142447|NCT01132664|345102|P1|COMPLETED|Phase ll||0
142448|NCT01132664|345098|P5|STARTED|Phase ll||0
142449|NCT01132664|345099|P4|STARTED|Phase ll||0
142450|NCT01132664|345100|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
142451|NCT01132664|345101|P2|STARTED|Phase ll||0
142452|NCT01132664|345102|P1|STARTED|Phase ll||0
142453|NCT01132664|345098|P5|NOT COMPLETED|Phase lb||0
142454|NCT01132664|345099|P4|NOT COMPLETED|Phase lb||0
142455|NCT01132664|345100|P3|NOT COMPLETED|Phase lb||0
142456|NCT01132664|345101|P2|NOT COMPLETED|Phase lb||12
142457|NCT01132664|345102|P1|NOT COMPLETED|Phase lb||5
142458|NCT01132664|345098|P5|COMPLETED|Phase lb||0
142459|NCT01132664|345099|P4|COMPLETED|Phase lb||0
142460|NCT01132664|345100|P3|COMPLETED|Phase lb||0
142461|NCT01132664|345101|P2|COMPLETED|Phase lb||0
142462|NCT01132664|345102|P1|COMPLETED|Phase lb||0
142463|NCT01132664|345098|P5|STARTED|Phase lb||0
142464|NCT01132664|345099|P4|STARTED|Phase lb||0
142465|NCT01132664|345100|P3|STARTED|Phase lb||0
142466|NCT01132664|345101|P2|STARTED|Phase lb||12
142467|NCT01132664|345102|P1|STARTED|Phase lb||5
142468|NCT01132651|345136|P2|NOT COMPLETED|Overall Study||1
142469|NCT01132651|345137|P1|NOT COMPLETED|Overall Study||1
142470|NCT01132651|345136|P2|COMPLETED|Overall Study||4
142471|NCT01132651|345137|P1|COMPLETED|Overall Study||3
142472|NCT01132651|345136|P2|STARTED|Overall Study||5
142473|NCT01132651|345137|P1|STARTED|Overall Study||4
142474|NCT01132612|345148|P3|NOT COMPLETED|Overall Study||170
142475|NCT01132612|345149|P2|NOT COMPLETED|Overall Study||35
142476|NCT01132612|345150|P1|NOT COMPLETED|Overall Study||40
142477|NCT01132612|345148|P3|COMPLETED|Overall Study||17
142478|NCT01132612|345149|P2|COMPLETED|Overall Study||7
142479|NCT01132612|345150|P1|COMPLETED|Overall Study||6
142480|NCT01132612|345148|P3|STARTED|Overall Study||187
142481|NCT01132612|345149|P2|STARTED|Overall Study||42
142482|NCT01132612|345150|P1|STARTED|Overall Study||46
142483|NCT01132547|345166|P2|NOT COMPLETED|Overall Study||1
142484|NCT01132547|345167|P1|NOT COMPLETED|Overall Study||4
142485|NCT01132547|345166|P2|COMPLETED|Overall Study||12
142486|NCT01132547|345167|P1|COMPLETED|Overall Study||5
142487|NCT01132547|345166|P2|STARTED|Overall Study||13
142488|NCT01132547|345167|P1|STARTED|Overall Study||9
142489|NCT01132508|345177|P1|NOT COMPLETED|Overall Study||9
142490|NCT01132508|345177|P1|COMPLETED|Overall Study||24
142491|NCT01132508|345177|P1|104 Weeks|Overall Study||27
142492|NCT01132508|345177|P1|78 Weeks|Overall Study||28
142493|NCT01132508|345177|P1|52 Weeks|Overall Study||30
142494|NCT01132508|345177|P1|26 Weeks|Overall Study||33
142495|NCT01132508|345177|P1|12 Weeks|Overall Study||33
142496|NCT01132508|345177|P1|6 Weeks|Overall Study||33
142497|NCT01132508|345177|P1|Treated at Baseline|Overall Study||33
142498|NCT01132508|345177|P1|STARTED|Overall Study||33
142499|NCT01132495|345237|P4|NOT COMPLETED|Overall Study||12
142500|NCT01132495|345238|P3|NOT COMPLETED|Overall Study||20
142501|NCT01132495|345239|P2|NOT COMPLETED|Overall Study||38
142502|NCT01132495|345240|P1|NOT COMPLETED|Overall Study||40
142503|NCT01132495|345237|P4|COMPLETED|Overall Study||104
142504|NCT01132495|345238|P3|COMPLETED|Overall Study||146
142505|NCT01132495|345239|P2|COMPLETED|Overall Study||403
142506|NCT01132495|345240|P1|COMPLETED|Overall Study||407
142507|NCT01132495|345237|P4|STARTED|Overall Study||116
142508|NCT01132495|345238|P3|STARTED|Overall Study||166
142509|NCT01132495|345239|P2|STARTED|Overall Study||441
142510|NCT01132495|345240|P1|STARTED|Overall Study||447
142511|NCT01132378|345248|P1|NOT COMPLETED|Overall Study||0
142512|NCT01132378|345248|P1|COMPLETED|Overall Study||40
142513|NCT01132378|345248|P1|STARTED|Overall Study||40
142514|NCT01132326|345253|P1|NOT COMPLETED|Overall Study||218
142515|NCT01132326|345253|P1|COMPLETED|Overall Study||132
142516|NCT01132326|345253|P1|STARTED|Overall Study||350
142517|NCT01132313|345269|P12|NOT COMPLETED|Overall Study||0
142518|NCT01132313|345270|P11|NOT COMPLETED|Overall Study||1
142519|NCT01132313|345271|P10|NOT COMPLETED|Overall Study||20
142520|NCT01132313|345272|P9|NOT COMPLETED|Overall Study||21
142521|NCT01132313|345273|P8|NOT COMPLETED|Overall Study||8
142522|NCT01132313|345274|P7|NOT COMPLETED|Overall Study||30
142523|NCT01132313|345275|P6|NOT COMPLETED|Overall Study||25
142524|NCT01132313|345276|P5|NOT COMPLETED|Overall Study||45
142525|NCT01132313|345277|P4|NOT COMPLETED|Overall Study||32
142526|NCT01132313|345278|P3|NOT COMPLETED|Overall Study||20
142527|NCT01132313|345279|P2|NOT COMPLETED|Overall Study||0
142528|NCT01132313|345280|P1|NOT COMPLETED|Overall Study||3
142529|NCT01132313|345269|P12|COMPLETED|Overall Study||2
142530|NCT01132313|345270|P11|COMPLETED|Overall Study||0
142531|NCT01132313|345271|P10|COMPLETED|Overall Study||5
142532|NCT01132313|345272|P9|COMPLETED|Overall Study||5
142533|NCT01132313|345273|P8|COMPLETED|Overall Study||24
142534|NCT01132313|345274|P7|COMPLETED|Overall Study||19
142535|NCT01132313|345275|P6|COMPLETED|Overall Study||54
142536|NCT01132313|345276|P5|COMPLETED|Overall Study||34
142537|NCT01132313|345277|P4|COMPLETED|Overall Study||48
142538|NCT01132313|345278|P3|COMPLETED|Overall Study||61
142539|NCT01132313|345279|P2|COMPLETED|Overall Study||17
142540|NCT01132313|345280|P1|COMPLETED|Overall Study||14
142541|NCT01132313|345269|P12|STARTED|Overall Study||2
142542|NCT01132313|345270|P11|STARTED|Overall Study||1
142543|NCT01132313|345271|P10|STARTED|Overall Study||25
142544|NCT01132313|345272|P9|STARTED|Overall Study||26
142545|NCT01132313|345273|P8|STARTED|Overall Study||32
142546|NCT01132313|345274|P7|STARTED|Overall Study||49
142547|NCT01132313|345275|P6|STARTED|Overall Study||79
142548|NCT01132313|345276|P5|STARTED|Overall Study||79
142549|NCT01132313|345277|P4|STARTED|Overall Study||80
142550|NCT01132313|345278|P3|STARTED|Overall Study||81
142551|NCT01132313|345279|P2|STARTED|Overall Study||17
142552|NCT01132313|345280|P1|STARTED|Overall Study||17
142553|NCT01132144|345337|P2|NOT COMPLETED|Overall Study||0
142554|NCT01132144|345338|P1|NOT COMPLETED|Overall Study||0
142555|NCT01132144|345337|P2|COMPLETED|Overall Study||79
142556|NCT01132144|345338|P1|COMPLETED|Overall Study||79
142557|NCT01132144|345337|P2|STARTED|Overall Study||79
142558|NCT01132144|345338|P1|STARTED|Overall Study||79
142559|NCT01132118|345360|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
142560|NCT01132118|345361|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
142561|NCT01132118|345360|P2|COMPLETED|Second Intervention (8 Weeks)||11
142562|NCT01132118|345361|P1|COMPLETED|Second Intervention (8 Weeks)||12
142563|NCT01132118|345360|P2|STARTED|Second Intervention (8 Weeks)||12
142564|NCT01132118|345361|P1|STARTED|Second Intervention (8 Weeks)||12
142565|NCT01132118|345360|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
142566|NCT01132118|345361|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
142567|NCT01132118|345360|P2|COMPLETED|First Intervention (8 Weeks)||12
142568|NCT01132118|345361|P1|COMPLETED|First Intervention (8 Weeks)||12
142569|NCT01132118|345360|P2|STARTED|First Intervention (8 Weeks)||15
142570|NCT01132118|345361|P1|STARTED|First Intervention (8 Weeks)||15
142571|NCT01131884|345381|P2|NOT COMPLETED|Overall Study||0
142572|NCT01131884|345382|P1|NOT COMPLETED|Overall Study||0
142573|NCT01131884|345381|P2|COMPLETED|Overall Study||0
142574|NCT01131884|345382|P1|COMPLETED|Overall Study||1
142575|NCT01131884|345381|P2|STARTED|Overall Study||0
142576|NCT01131884|345382|P1|STARTED|Overall Study||1
142577|NCT01131676|345391|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
142578|NCT01131676|345392|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
142579|NCT01131676|345393|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
142580|NCT01131676|345391|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
142581|NCT01131676|345392|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
142582|NCT01131676|345393|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
142583|NCT01131676|345391|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
142584|NCT01131676|345392|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
142585|NCT01131676|345393|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
142586|NCT01131676|345391|P3|STARTED|Discontinuation From Study (Treated Set)||2342
142587|NCT01131676|345392|P2|STARTED|Discontinuation From Study (Treated Set)||2345
142588|NCT01131676|345393|P1|STARTED|Discontinuation From Study (Treated Set)||2333
142589|NCT01131676|345391|P3|NOT COMPLETED|Discontinuation From Treatment||544
142590|NCT01131676|345392|P2|NOT COMPLETED|Discontinuation From Treatment||557
142591|NCT01131676|345393|P1|NOT COMPLETED|Discontinuation From Treatment||687
142592|NCT01131676|345391|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
142593|NCT01131676|345392|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
142594|NCT01131676|345393|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
142595|NCT01131676|345391|P3|STARTED|Discontinuation From Treatment|Randomised|2344
142596|NCT01131676|345392|P2|STARTED|Discontinuation From Treatment|Randomised|2347
142597|NCT01131676|345393|P1|STARTED|Discontinuation From Treatment|Randomised|2337
142598|NCT01131585|345428|P2|NOT COMPLETED|Overall Study||43
142599|NCT01131585|345429|P1|NOT COMPLETED|Overall Study||85
142600|NCT01131585|345428|P2|COMPLETED|Overall Study||0
142601|NCT01131585|345429|P1|COMPLETED|Overall Study||0
142602|NCT01131585|345428|P2|STARTED|Overall Study||43
142603|NCT01131585|345429|P1|STARTED|Overall Study||85
142604|NCT01131520|345437|P2|NOT COMPLETED|Overall Study||4
142605|NCT01131520|345438|P1|NOT COMPLETED|Overall Study||1
142606|NCT01131520|345437|P2|COMPLETED|Overall Study||176
142607|NCT01131520|345438|P1|COMPLETED|Overall Study||179
142608|NCT01131520|345437|P2|STARTED|Overall Study||180
142609|NCT01131520|345438|P1|STARTED|Overall Study||180
142610|NCT01131507|345460|P1|NOT COMPLETED|Overall Study||3
142611|NCT01131507|345460|P1|COMPLETED|Overall Study||12
142612|NCT01131507|345460|P1|STARTED|Overall Study||15
142613|NCT01131494|345465|P1|NOT COMPLETED|Overall Study||2
142614|NCT01131494|345465|P1|COMPLETED|Overall Study||15
142615|NCT01131494|345465|P1|STARTED|Overall Study||17
142616|NCT01131455|345475|P3|NOT COMPLETED|Overall Study||0
142617|NCT01131455|345476|P2|NOT COMPLETED|Overall Study||4
142618|NCT01131455|345477|P1|NOT COMPLETED|Overall Study||6
142619|NCT01131455|345475|P3|COMPLETED|Overall Study||0
142620|NCT01131455|345476|P2|COMPLETED|Overall Study||0
142621|NCT01131455|345477|P1|COMPLETED|Overall Study||0
142622|NCT01131455|345475|P3|STARTED|Overall Study||0
142623|NCT01131455|345476|P2|STARTED|Overall Study||4
142624|NCT01131455|345477|P1|STARTED|Overall Study||6
142625|NCT01131299|345485|P2|NOT COMPLETED|Overall Study||7
142626|NCT01131299|345486|P1|NOT COMPLETED|Overall Study||4
142627|NCT01131299|345485|P2|COMPLETED|Overall Study||37
142628|NCT01131299|345486|P1|COMPLETED|Overall Study||38
142629|NCT01131299|345485|P2|STARTED|Overall Study||44
142630|NCT01131299|345486|P1|STARTED|Overall Study||42
142631|NCT01131182|345499|P2|NOT COMPLETED|Overall Study||16
142632|NCT01131182|345500|P1|NOT COMPLETED|Overall Study||16
142633|NCT01131182|345499|P2|COMPLETED|Overall Study||521
142634|NCT01131182|345500|P1|COMPLETED|Overall Study||513
142635|NCT01131182|345499|P2|STARTED|Overall Study||537
142636|NCT01131182|345500|P1|STARTED|Overall Study||529
142637|NCT01131130|345508|P1|NOT COMPLETED|Period 3- Crossover||1
142638|NCT01131130|345508|P1|COMPLETED|Period 3- Crossover||116
142639|NCT01131130|345508|P1|STARTED|Period 3- Crossover||117
142640|NCT01131130|345508|P1|NOT COMPLETED|Period 2 - Crossover||0
142641|NCT01131130|345508|P1|COMPLETED|Period 2 - Crossover||117
142642|NCT01131130|345508|P1|STARTED|Period 2 - Crossover||117
142643|NCT01131130|345508|P1|NOT COMPLETED|Period 1 - Baseline||1
142644|NCT01131130|345508|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
142645|NCT01131130|345508|P1|STARTED|Period 1 - Baseline||118
142646|NCT01131104|345521|P1|NOT COMPLETED|Overall Study||13
142647|NCT01131104|345521|P1|COMPLETED|Overall Study||332
142648|NCT01131104|345521|P1|12-Month Analysis Set|Overall Study||26
142649|NCT01131104|345521|P1|42-Day Analysis Set|Overall Study||28
142650|NCT01131104|345521|P1|30-Day Analysis Set|Overall Study||24
142651|NCT01131104|345521|P1|Adjudication-Confirmed NAION Set|Overall Study||279
142652|NCT01131104|345521|P1|Study Set|Overall Study||344
142653|NCT01131104|345521|P1|STARTED|Overall Study||345
142654|NCT01131078|345528|P3|NOT COMPLETED|Overall Study||102
142655|NCT01131078|345529|P2|NOT COMPLETED|Overall Study||101
142656|NCT01131078|345530|P1|NOT COMPLETED|Overall Study||101
142657|NCT01131078|345528|P3|COMPLETED|Overall Study||1
142658|NCT01131078|345529|P2|COMPLETED|Overall Study||1
142659|NCT01131078|345530|P1|COMPLETED|Overall Study||0
142660|NCT01131078|345528|P3|STARTED|Overall Study||103
142661|NCT01131078|345529|P2|STARTED|Overall Study||102
142662|NCT01131078|345530|P1|STARTED|Overall Study||101
142663|NCT01131065|345586|P1|NOT COMPLETED|Overall Study||0
142664|NCT01131065|345586|P1|COMPLETED|Overall Study||15
142665|NCT01131065|345586|P1|STARTED|Overall Study||15
142666|NCT01131052|345594|P2|NOT COMPLETED|Overall Study||0
142667|NCT01131052|345595|P1|NOT COMPLETED|Overall Study||0
142668|NCT01131052|345594|P2|COMPLETED|Overall Study||75
142669|NCT01131052|345595|P1|COMPLETED|Overall Study||75
142670|NCT01131052|345594|P2|STARTED|Overall Study||75
142671|NCT01131052|345595|P1|STARTED|Overall Study||75
142672|NCT01130974|345617|P2|NOT COMPLETED|Overall Study||13
142673|NCT01130974|345618|P1|NOT COMPLETED|Overall Study||15
142674|NCT01130974|345617|P2|COMPLETED|Overall Study||87
142675|NCT01130974|345618|P1|COMPLETED|Overall Study||85
142676|NCT01130974|345617|P2|STARTED|Overall Study||100
142677|NCT01130974|345618|P1|STARTED|Overall Study||100
142678|NCT01130883|345638|P1|NOT COMPLETED|Overall Study||10
142679|NCT01130883|345638|P1|COMPLETED|Overall Study||3120
142680|NCT01130883|345638|P1|Participants Analyzed|Overall Study||3128
142681|NCT01130883|345638|P1|STARTED|Overall Study||3130
142682|NCT01130844|345655|P3|NOT COMPLETED|Overall Study||0
142683|NCT01130844|345656|P2|NOT COMPLETED|Overall Study||0
142684|NCT01130844|345657|P1|NOT COMPLETED|Overall Study||0
142685|NCT01130844|345655|P3|COMPLETED|Overall Study||9
142686|NCT01130844|345656|P2|COMPLETED|Overall Study||22
142687|NCT01130844|345657|P1|COMPLETED|Overall Study||21
142688|NCT01130844|345655|P3|STARTED|Overall Study||9
142689|NCT01130844|345656|P2|STARTED|Overall Study||22
142690|NCT01130844|345657|P1|STARTED|Overall Study||21
142691|NCT01130831|345695|P1|NOT COMPLETED|Overall Study||14
142692|NCT01130831|345695|P1|COMPLETED|Overall Study||52
142693|NCT01130831|345695|P1|STARTED|Overall Study||66
142694|NCT01130740|345723|P2|NOT COMPLETED|Overall Study||15
142695|NCT01130740|345724|P1|NOT COMPLETED|Overall Study||12
142696|NCT01130740|345723|P2|COMPLETED|Overall Study||136
142697|NCT01130740|345724|P1|COMPLETED|Overall Study||137
142698|NCT01130740|345723|P2|STARTED|Overall Study||151
142699|NCT01130740|345724|P1|STARTED|Overall Study||149
142700|NCT01130597|345734|P1|NOT COMPLETED|Overall Study||7
142701|NCT01130597|345734|P1|COMPLETED|Overall Study||56
142702|NCT01130597|345734|P1|STARTED|Overall Study||63
142703|NCT01130532|345759|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
142704|NCT01130532|345760|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
142705|NCT01130532|345761|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
142706|NCT01130532|345762|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
142707|NCT01130532|345759|P4|COMPLETED|Period IV (Weeks 13-16)||552
142708|NCT01130532|345760|P3|COMPLETED|Period IV (Weeks 13-16)||0
142709|NCT01130532|345761|P2|COMPLETED|Period IV (Weeks 13-16)||0
142710|NCT01130532|345762|P1|COMPLETED|Period IV (Weeks 13-16)||0
142711|NCT01130532|345759|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
142712|NCT01130532|345760|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
142713|NCT01130532|345761|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
142714|NCT01130532|345762|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
142715|NCT01130532|345759|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
142716|NCT01130532|345760|P3|STARTED|Period IV (Weeks 13-16)||0
142717|NCT01130532|345761|P2|STARTED|Period IV (Weeks 13-16)||0
142718|NCT01130532|345762|P1|STARTED|Period IV (Weeks 13-16)||0
142719|NCT01130532|345759|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
142720|NCT01130532|345760|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
142721|NCT01130532|345761|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
142722|NCT01130532|345762|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
142723|NCT01130532|345759|P4|COMPLETED|Period III (Weeks 0-12)||0
142724|NCT01130532|345760|P3|COMPLETED|Period III (Weeks 0-12)||190
142725|NCT01130532|345761|P2|COMPLETED|Period III (Weeks 0-12)||189
142726|NCT01130532|345762|P1|COMPLETED|Period III (Weeks 0-12)||186
142727|NCT01130532|345759|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
142728|NCT01130532|345760|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
142729|NCT01130532|345761|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
142730|NCT01130532|345762|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
142731|NCT01130532|345759|P4|STARTED|Period III (Weeks 0-12)||0
142732|NCT01130532|345760|P3|STARTED|Period III (Weeks 0-12)||209
142733|NCT01130532|345761|P2|STARTED|Period III (Weeks 0-12)||207
142734|NCT01130532|345762|P1|STARTED|Period III (Weeks 0-12)||207
142735|NCT01130493|345807|P3|NOT COMPLETED|Part 2: OLE||5
142736|NCT01130493|345808|P2|NOT COMPLETED|Part 2: OLE||3
142737|NCT01130493|345809|P1|NOT COMPLETED|Part 2: OLE||0
142738|NCT01130493|345807|P3|COMPLETED|Part 2: OLE||30
142739|NCT01130493|345808|P2|COMPLETED|Part 2: OLE||36
142740|NCT01130493|345809|P1|COMPLETED|Part 2: OLE||0
142741|NCT01130493|345807|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
142742|NCT01130493|345808|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
142743|NCT01130493|345809|P1|STARTED|Part 2: OLE||0
142744|NCT01130493|345807|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
142745|NCT01130493|345808|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
142746|NCT01130493|345809|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
142747|NCT01130493|345807|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
142748|NCT01130493|345808|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
142749|NCT01130493|345809|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
142750|NCT01130493|345807|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
142751|NCT01130493|345808|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
142752|NCT01130493|345809|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
142753|NCT01130493|345807|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
142754|NCT01130493|345808|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
142755|NCT01130493|345809|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
142756|NCT01130493|345807|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
142757|NCT01130493|345808|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
142758|NCT01130493|345809|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
142759|NCT01130493|345807|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
142760|NCT01130493|345808|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
142761|NCT01130493|345809|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
142762|NCT01130493|345807|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
142763|NCT01130493|345808|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
142764|NCT01130493|345809|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
142765|NCT01130493|345807|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
142766|NCT01130493|345808|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
142767|NCT01130493|345809|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
142768|NCT01130493|345807|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
142769|NCT01130493|345808|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
142770|NCT01130493|345809|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
142771|NCT01130493|345807|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
142772|NCT01130493|345808|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
142773|NCT01130493|345809|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
142774|NCT01130493|345807|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
142775|NCT01130493|345808|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
142776|NCT01130493|345809|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
142777|NCT01130493|345807|P3|STARTED|Open-label Dose Conversion to IPX066||0
142778|NCT01130493|345808|P2|STARTED|Open-label Dose Conversion to IPX066||0
142779|NCT01130493|345809|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
142780|NCT01130337|345826|P1|NOT COMPLETED|Overall Study||14
142781|NCT01130337|345826|P1|COMPLETED|Overall Study||22
142782|NCT01130337|345826|P1|STARTED|Overall Study||36
142783|NCT01130168|345833|P6|NOT COMPLETED|Period 3||0
142784|NCT01130168|345834|P5|NOT COMPLETED|Period 3||0
142785|NCT01130168|345835|P4|NOT COMPLETED|Period 3||0
142786|NCT01130168|345836|P3|NOT COMPLETED|Period 3||0
142787|NCT01130168|345837|P2|NOT COMPLETED|Period 3||0
142788|NCT01130168|345838|P1|NOT COMPLETED|Period 3||0
142789|NCT01130168|345833|P6|COMPLETED|Period 3||6
142790|NCT01130168|345834|P5|COMPLETED|Period 3||5
142791|NCT01130168|345835|P4|COMPLETED|Period 3||5
142792|NCT01130168|345836|P3|COMPLETED|Period 3||5
142793|NCT01130168|345837|P2|COMPLETED|Period 3||6
142794|NCT01130168|345838|P1|COMPLETED|Period 3||6
142795|NCT01130168|345833|P6|STARTED|Period 3||6
142796|NCT01130168|345834|P5|STARTED|Period 3||5
142797|NCT01130168|345835|P4|STARTED|Period 3||5
142798|NCT01130168|345836|P3|STARTED|Period 3||5
142799|NCT01130168|345837|P2|STARTED|Period 3||6
142800|NCT01130168|345838|P1|STARTED|Period 3||6
142801|NCT01130168|345833|P6|NOT COMPLETED|Period 2||0
142802|NCT01130168|345834|P5|NOT COMPLETED|Period 2||0
142803|NCT01130168|345835|P4|NOT COMPLETED|Period 2||0
142804|NCT01130168|345836|P3|NOT COMPLETED|Period 2||0
142805|NCT01130168|345837|P2|NOT COMPLETED|Period 2||0
142806|NCT01130168|345838|P1|NOT COMPLETED|Period 2||0
142807|NCT01130168|345833|P6|COMPLETED|Period 2||6
142808|NCT01130168|345834|P5|COMPLETED|Period 2||5
142809|NCT01130168|345835|P4|COMPLETED|Period 2||5
142810|NCT01130168|345836|P3|COMPLETED|Period 2||5
142811|NCT01130168|345837|P2|COMPLETED|Period 2||6
142812|NCT01130168|345838|P1|COMPLETED|Period 2||6
142813|NCT01130168|345833|P6|STARTED|Period 2||6
142814|NCT01130168|345834|P5|STARTED|Period 2||5
142815|NCT01130168|345835|P4|STARTED|Period 2||5
142816|NCT01130168|345836|P3|STARTED|Period 2||5
142817|NCT01130168|345837|P2|STARTED|Period 2||6
142818|NCT01130168|345838|P1|STARTED|Period 2||6
142819|NCT01130168|345833|P6|NOT COMPLETED|Period 1||0
142820|NCT01130168|345834|P5|NOT COMPLETED|Period 1||0
142821|NCT01130168|345835|P4|NOT COMPLETED|Period 1||3
142822|NCT01130168|345836|P3|NOT COMPLETED|Period 1||1
142823|NCT01130168|345837|P2|NOT COMPLETED|Period 1||1
142824|NCT01130168|345838|P1|NOT COMPLETED|Period 1||0
142825|NCT01130168|345833|P6|COMPLETED|Period 1||6
142826|NCT01130168|345834|P5|COMPLETED|Period 1||5
142827|NCT01130168|345835|P4|COMPLETED|Period 1||5
142828|NCT01130168|345836|P3|COMPLETED|Period 1||5
142829|NCT01130168|345837|P2|COMPLETED|Period 1||6
142830|NCT01130168|345838|P1|COMPLETED|Period 1||6
142831|NCT01130168|345833|P6|STARTED|Period 1||6
142832|NCT01130168|345834|P5|STARTED|Period 1||5
142833|NCT01130168|345835|P4|STARTED|Period 1||8
142834|NCT01130168|345836|P3|STARTED|Period 1||6
142835|NCT01130168|345837|P2|STARTED|Period 1||7
142836|NCT01130168|345838|P1|STARTED|Period 1||6
142837|NCT01130103|345875|P2|NOT COMPLETED|Maintenance Treatment||2
142838|NCT01130103|345876|P1|NOT COMPLETED|Maintenance Treatment||2
142839|NCT01130103|345875|P2|COMPLETED|Maintenance Treatment||11
142840|NCT01130103|345876|P1|COMPLETED|Maintenance Treatment||11
142841|NCT01130103|345875|P2|STARTED|Maintenance Treatment||13
142842|NCT01130103|345876|P1|STARTED|Maintenance Treatment||13
142843|NCT01130103|345875|P2|NOT COMPLETED|Randomized Treatment||5
142844|NCT01130103|345876|P1|NOT COMPLETED|Randomized Treatment||6
142845|NCT01130103|345875|P2|COMPLETED|Randomized Treatment||13
142846|NCT01130103|345876|P1|COMPLETED|Randomized Treatment||13
142847|NCT01130103|345875|P2|STARTED|Randomized Treatment||18
142848|NCT01130103|345876|P1|STARTED|Randomized Treatment||19
142849|NCT01130051|345890|P2|NOT COMPLETED|Period 2||0
142850|NCT01130051|345891|P1|NOT COMPLETED|Period 2||0
142851|NCT01130051|345890|P2|COMPLETED|Period 2||6
142852|NCT01130051|345891|P1|COMPLETED|Period 2||7
142853|NCT01130051|345890|P2|STARTED|Period 2||6
142854|NCT01130051|345891|P1|STARTED|Period 2||7
142855|NCT01130051|345890|P2|NOT COMPLETED|Washout Period of 14 Days||2
142856|NCT01130051|345891|P1|NOT COMPLETED|Washout Period of 14 Days||1
142857|NCT01130051|345890|P2|COMPLETED|Washout Period of 14 Days||6
142858|NCT01130051|345891|P1|COMPLETED|Washout Period of 14 Days||7
142859|NCT01130051|345890|P2|STARTED|Washout Period of 14 Days||8
142860|NCT01130051|345891|P1|STARTED|Washout Period of 14 Days||8
142861|NCT01130051|345890|P2|NOT COMPLETED|Period 1||0
142862|NCT01130051|345891|P1|NOT COMPLETED|Period 1||0
142863|NCT01130051|345890|P2|COMPLETED|Period 1||8
142864|NCT01130051|345891|P1|COMPLETED|Period 1||8
142865|NCT01130051|345890|P2|STARTED|Period 1||8
142866|NCT01130051|345891|P1|STARTED|Period 1||8
142867|NCT01129960|345905|P4|NOT COMPLETED|Overall Study||13
142868|NCT01129960|345906|P3|NOT COMPLETED|Overall Study||26
142869|NCT01129960|345907|P2|NOT COMPLETED|Overall Study||22
142870|NCT01129960|345908|P1|NOT COMPLETED|Overall Study||30
142871|NCT01129960|345905|P4|COMPLETED|Overall Study||70
142872|NCT01129960|345906|P3|COMPLETED|Overall Study||56
142873|NCT01129960|345907|P2|COMPLETED|Overall Study||61
142874|NCT01129960|345908|P1|COMPLETED|Overall Study||54
142875|NCT01129960|345905|P4|Full Analysis Set (FAS|Overall Study||71
142876|NCT01129960|345906|P3|Full Analysis Set (FAS|Overall Study||68
142877|NCT01129960|345907|P2|Full Analysis Set (FAS|Overall Study||67
142878|NCT01129960|345908|P1|Full Analysis Set (FAS|Overall Study||71
142879|NCT01129960|345905|P4|Per-Protocol|Overall Study||55
142880|NCT01129960|345906|P3|Per-Protocol|Overall Study||49
142881|NCT01129960|345907|P2|Per-Protocol|Overall Study||52
142882|NCT01129960|345908|P1|Per-Protocol|Overall Study||34
142883|NCT01129960|345905|P4|Intent-to-Treat|Overall Study||83
142884|NCT01129960|345906|P3|Intent-to-Treat|Overall Study||82
142885|NCT01129960|345907|P2|Intent-to-Treat|Overall Study||83
142886|NCT01129960|345908|P1|Intent-to-Treat|Overall Study||84
142887|NCT01129960|345905|P4|Safety|Overall Study||82
142888|NCT01129960|345906|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
142889|NCT01129960|345907|P2|Safety|Overall Study||83
142890|NCT01129960|345908|P1|Safety|Overall Study||84
142891|NCT01129960|345905|P4|STARTED|Overall Study||83
142892|NCT01129960|345906|P3|STARTED|Overall Study||82
142893|NCT01129960|345907|P2|STARTED|Overall Study||83
142894|NCT01129960|345908|P1|STARTED|Overall Study||84
142895|NCT01129921|345920|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
142896|NCT01129921|345921|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
142897|NCT01129921|345920|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
142898|NCT01129921|345921|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
142899|NCT01129921|345920|P2|STARTED|After Sham Cross-over to Mild, One Year||20
142900|NCT01129921|345921|P1|STARTED|After Sham Cross-over to Mild, One Year||20
142901|NCT01129921|345920|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
142902|NCT01129921|345921|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
142903|NCT01129921|345920|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
142904|NCT01129921|345921|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
142905|NCT01129921|345920|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
142906|NCT01129921|345921|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
142907|NCT01129778|345931|P1|NOT COMPLETED|Overall Study||7
142908|NCT01129778|345931|P1|COMPLETED|Overall Study||15
142909|NCT01129778|345931|P1|STARTED|Overall Study||22
142910|NCT01129765|345936|P1|NOT COMPLETED|Overall Study||0
142911|NCT01129765|345936|P1|COMPLETED|Overall Study||30
142912|NCT01129765|345936|P1|STARTED|Overall Study||30
142913|NCT01129622|345945|P1|NOT COMPLETED|Overall Study||2
142914|NCT01129622|345945|P1|COMPLETED|Overall Study||14
142915|NCT01129622|345945|P1|STARTED|Overall Study||16
142916|NCT01129583|345952|P2|NOT COMPLETED|Overall Study||2
142917|NCT01129583|345953|P1|NOT COMPLETED|Overall Study||3
142918|NCT01129583|345952|P2|COMPLETED|Overall Study||7
142919|NCT01129583|345953|P1|COMPLETED|Overall Study||6
142920|NCT01129583|345952|P2|STARTED|Overall Study||9
142921|NCT01129583|345953|P1|STARTED|Overall Study||9
142922|NCT01129557|345966|P3|NOT COMPLETED|Overall Study||4
142923|NCT01129557|345967|P2|NOT COMPLETED|Overall Study||5
142924|NCT01129557|345968|P1|NOT COMPLETED|Overall Study||4
142925|NCT01129557|345966|P3|COMPLETED|Overall Study||10
142926|NCT01129557|345967|P2|COMPLETED|Overall Study||12
142927|NCT01129557|345968|P1|COMPLETED|Overall Study||11
142928|NCT01129557|345966|P3|STARTED|Overall Study||14
142929|NCT01129557|345967|P2|STARTED|Overall Study||17
142930|NCT01129557|345968|P1|STARTED|Overall Study||15
142931|NCT01129531|346039|P3|NOT COMPLETED|Treatment Cycle 2||5
142932|NCT01129531|346040|P2|NOT COMPLETED|Treatment Cycle 2||3
142933|NCT01129531|346041|P1|NOT COMPLETED|Treatment Cycle 2||6
142934|NCT01129531|346039|P3|COMPLETED|Treatment Cycle 2||74
142935|NCT01129531|346040|P2|COMPLETED|Treatment Cycle 2||92
142936|NCT01129531|346041|P1|COMPLETED|Treatment Cycle 2||88
142937|NCT01129531|346039|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
142938|NCT01129531|346040|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
142939|NCT01129531|346041|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
142940|NCT01129531|346039|P3|NOT COMPLETED|Treatment Cycle 1||16
142941|NCT01129531|346040|P2|NOT COMPLETED|Treatment Cycle 1||6
142942|NCT01129531|346041|P1|NOT COMPLETED|Treatment Cycle 1||4
142943|NCT01129531|346039|P3|COMPLETED|Treatment Cycle 1||110
142944|NCT01129531|346040|P2|COMPLETED|Treatment Cycle 1||78
142945|NCT01129531|346041|P1|COMPLETED|Treatment Cycle 1||80
142946|NCT01129531|346039|P3|STARTED|Treatment Cycle 1||126
142947|NCT01129531|346040|P2|STARTED|Treatment Cycle 1||84
142948|NCT01129531|346041|P1|STARTED|Treatment Cycle 1||84
142949|NCT01129336|346063|P2|NOT COMPLETED|Overall Study||16
142950|NCT01129336|346064|P1|NOT COMPLETED|Overall Study||12
142951|NCT01129336|346063|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
142952|NCT01129336|346064|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
142953|NCT01129336|346063|P2|Completed Treatment|Overall Study||3
142954|NCT01129336|346064|P1|Completed Treatment|Overall Study||1
142955|NCT01129336|346063|P2|STARTED|Overall Study||29
142956|NCT01129336|346064|P1|STARTED|Overall Study||15
142957|NCT01129284|346079|P3|NOT COMPLETED|Overall Study||1
142958|NCT01129284|346080|P2|NOT COMPLETED|Overall Study||0
142959|NCT01129284|346081|P1|NOT COMPLETED|Overall Study||2
142960|NCT01129284|346079|P3|COMPLETED|Overall Study||4
142961|NCT01129284|346080|P2|COMPLETED|Overall Study||5
142962|NCT01129284|346081|P1|COMPLETED|Overall Study||3
142963|NCT01129284|346079|P3|STARTED|Overall Study||5
142964|NCT01129284|346080|P2|STARTED|Overall Study||5
142965|NCT01129284|346081|P1|STARTED|Overall Study||5
142966|NCT01129245|346094|P2|NOT COMPLETED|Overall Study||0
142967|NCT01129245|346095|P1|NOT COMPLETED|Overall Study||0
142968|NCT01129245|346094|P2|COMPLETED|Overall Study||4
142969|NCT01129245|346095|P1|COMPLETED|Overall Study||7
142970|NCT01129245|346094|P2|STARTED|Overall Study||4
142971|NCT01129245|346095|P1|STARTED|Overall Study||7
142972|NCT01129206|346101|P1|NOT COMPLETED|Overall Study||0
142973|NCT01129206|346101|P1|COMPLETED|Overall Study||6
142974|NCT01129206|346101|P1|STARTED|Overall Study||6
142975|NCT01129141|346111|P2|NOT COMPLETED|Overall Study||13
142976|NCT01129141|346112|P1|NOT COMPLETED|Overall Study||15
142977|NCT01129141|346111|P2|COMPLETED|Overall Study||91
142978|NCT01129141|346112|P1|COMPLETED|Overall Study||86
142979|NCT01129141|346111|P2|STARTED|Overall Study||104
142980|NCT01129141|346112|P1|STARTED|Overall Study||101
142981|NCT01129128|346121|P3|NOT COMPLETED|Overall Study||4
142982|NCT01129128|346122|P2|NOT COMPLETED|Overall Study||4
142983|NCT01129128|346123|P1|NOT COMPLETED|Overall Study||3
142984|NCT01129128|346121|P3|COMPLETED|Overall Study||19
142985|NCT01129128|346122|P2|COMPLETED|Overall Study||18
142986|NCT01129128|346123|P1|COMPLETED|Overall Study||19
142987|NCT01129128|346121|P3|STARTED|Overall Study||23
142988|NCT01129128|346122|P2|STARTED|Overall Study||22
142989|NCT01129128|346123|P1|STARTED|Overall Study||22
142990|NCT01129115|346147|P4|NOT COMPLETED|Overall Study||9
142991|NCT01129115|346148|P3|NOT COMPLETED|Overall Study||6
142992|NCT01129115|346149|P2|NOT COMPLETED|Overall Study||7
142993|NCT01129115|346150|P1|NOT COMPLETED|Overall Study||2
142994|NCT01129115|346147|P4|COMPLETED|Overall Study||15
142995|NCT01129115|346148|P3|COMPLETED|Overall Study||21
142996|NCT01129115|346149|P2|COMPLETED|Overall Study||18
142997|NCT01129115|346150|P1|COMPLETED|Overall Study||23
142998|NCT01129115|346147|P4|STARTED|Overall Study||24
142999|NCT01129115|346148|P3|STARTED|Overall Study||27
143000|NCT01129115|346149|P2|STARTED|Overall Study||25
143001|NCT01129115|346150|P1|STARTED|Overall Study||25
143002|NCT01129102|346187|P3|NOT COMPLETED|Overall Study||7
143003|NCT01129102|346188|P2|NOT COMPLETED|Overall Study||6
143004|NCT01129102|346189|P1|NOT COMPLETED|Overall Study||8
143005|NCT01129102|346187|P3|COMPLETED|Overall Study||48
143006|NCT01129102|346188|P2|COMPLETED|Overall Study||44
143007|NCT01129102|346189|P1|COMPLETED|Overall Study||102
143008|NCT01129102|346187|P3|STARTED|Overall Study||55
143009|NCT01129102|346188|P2|STARTED|Overall Study||50
143010|NCT01129102|346189|P1|STARTED|Overall Study||110
143011|NCT01129011|346200|P2|NOT COMPLETED|Overall Study||57
143012|NCT01129011|346201|P1|NOT COMPLETED|Overall Study||59
143013|NCT01129011|346200|P2|COMPLETED|Overall Study||153
143014|NCT01129011|346201|P1|COMPLETED|Overall Study||151
143015|NCT01129011|346200|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
143016|NCT01129011|346201|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
143017|NCT01128972|346223|P5|NOT COMPLETED|Period V||0
143018|NCT01128972|346224|P4|NOT COMPLETED|Period V||0
143019|NCT01128972|346225|P3|NOT COMPLETED|Period V||0
143020|NCT01128972|346226|P2|NOT COMPLETED|Period V||0
143021|NCT01128972|346227|P1|NOT COMPLETED|Period V||0
143022|NCT01128972|346223|P5|COMPLETED|Period V||7
143023|NCT01128972|346224|P4|COMPLETED|Period V||7
143024|NCT01128972|346225|P3|COMPLETED|Period V||7
143025|NCT01128972|346226|P2|COMPLETED|Period V||7
143026|NCT01128972|346227|P1|COMPLETED|Period V||8
143027|NCT01128972|346223|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
143028|NCT01128972|346224|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
143029|NCT01128972|346225|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
143030|NCT01128972|346226|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
143031|NCT01128972|346227|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
143032|NCT01128972|346223|P5|NOT COMPLETED|Period IV||0
143033|NCT01128972|346224|P4|NOT COMPLETED|Period IV||0
143034|NCT01128972|346225|P3|NOT COMPLETED|Period IV||0
143035|NCT01128972|346226|P2|NOT COMPLETED|Period IV||0
143036|NCT01128972|346227|P1|NOT COMPLETED|Period IV||0
143037|NCT01128972|346223|P5|COMPLETED|Period IV||7
143038|NCT01128972|346224|P4|COMPLETED|Period IV||7
143039|NCT01128972|346225|P3|COMPLETED|Period IV||7
143040|NCT01128972|346226|P2|COMPLETED|Period IV||8
143041|NCT01128972|346227|P1|COMPLETED|Period IV||7
143042|NCT01128972|346223|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
143043|NCT01128972|346224|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
143044|NCT01128972|346225|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
143045|NCT01128972|346226|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
143046|NCT01128972|346227|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
143047|NCT01128972|346223|P5|NOT COMPLETED|Period III||0
143048|NCT01128972|346224|P4|NOT COMPLETED|Period III||0
143049|NCT01128972|346225|P3|NOT COMPLETED|Period III||0
143050|NCT01128972|346226|P2|NOT COMPLETED|Period III||0
143051|NCT01128972|346227|P1|NOT COMPLETED|Period III||0
143052|NCT01128972|346223|P5|COMPLETED|Period III||7
143053|NCT01128972|346224|P4|COMPLETED|Period III||7
143054|NCT01128972|346225|P3|COMPLETED|Period III||8
143055|NCT01128972|346226|P2|COMPLETED|Period III||7
143056|NCT01128972|346227|P1|COMPLETED|Period III||7
143057|NCT01128972|346223|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
143058|NCT01128972|346224|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
143059|NCT01128972|346225|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
143060|NCT01128972|346226|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
143061|NCT01128972|346227|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
143062|NCT01128972|346223|P5|NOT COMPLETED|Period II||0
143063|NCT01128972|346224|P4|NOT COMPLETED|Period II||0
143064|NCT01128972|346225|P3|NOT COMPLETED|Period II||0
143065|NCT01128972|346226|P2|NOT COMPLETED|Period II||0
143066|NCT01128972|346227|P1|NOT COMPLETED|Period II||0
143067|NCT01128972|346223|P5|COMPLETED|Period II||7
143068|NCT01128972|346224|P4|COMPLETED|Period II||8
143069|NCT01128972|346225|P3|COMPLETED|Period II||7
143070|NCT01128972|346226|P2|COMPLETED|Period II||7
143071|NCT01128972|346227|P1|COMPLETED|Period II||7
143072|NCT01128972|346223|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
143073|NCT01128972|346224|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
143074|NCT01128972|346225|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
143075|NCT01128972|346226|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
143076|NCT01128972|346227|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
143077|NCT01128972|346223|P5|NOT COMPLETED|Period I||0
143078|NCT01128972|346224|P4|NOT COMPLETED|Period I||0
143079|NCT01128972|346225|P3|NOT COMPLETED|Period I||0
143080|NCT01128972|346226|P2|NOT COMPLETED|Period I||0
143081|NCT01128972|346227|P1|NOT COMPLETED|Period I||0
143082|NCT01128972|346223|P5|COMPLETED|Period I||8
143083|NCT01128972|346224|P4|COMPLETED|Period I||7
143084|NCT01128972|346225|P3|COMPLETED|Period I||7
143085|NCT01128972|346226|P2|COMPLETED|Period I||7
143086|NCT01128972|346227|P1|COMPLETED|Period I||7
143087|NCT01128972|346223|P5|STARTED|Period I||8
143088|NCT01128972|346224|P4|STARTED|Period I||7
143089|NCT01128972|346225|P3|STARTED|Period I||7
143090|NCT01128972|346226|P2|STARTED|Period I||7
143091|NCT01128972|346227|P1|STARTED|Period I||7
143092|NCT01128959|346256|P1|NOT COMPLETED|Treatment Period||4
143093|NCT01128959|346256|P1|COMPLETED|Treatment Period||101
143094|NCT01128959|346256|P1|STARTED|Treatment Period||105
143095|NCT01128959|346256|P1|NOT COMPLETED|Lead in Period||3
143096|NCT01128959|346256|P1|COMPLETED|Lead in Period||105
143097|NCT01128959|346256|P1|STARTED|Lead in Period||108
143098|NCT01128946|346262|P4|NOT COMPLETED|Period IV||0
143099|NCT01128946|346263|P3|NOT COMPLETED|Period IV||0
143100|NCT01128946|346264|P2|NOT COMPLETED|Period IV||0
143101|NCT01128946|346265|P1|NOT COMPLETED|Period IV||0
143102|NCT01128946|346262|P4|COMPLETED|Period IV||19
143103|NCT01128946|346263|P3|COMPLETED|Period IV||19
143104|NCT01128946|346264|P2|COMPLETED|Period IV||20
143105|NCT01128946|346265|P1|COMPLETED|Period IV||19
143106|NCT01128946|346262|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
143107|NCT01128946|346263|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
143108|NCT01128946|346264|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
143109|NCT01128946|346265|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
143110|NCT01128946|346262|P4|NOT COMPLETED|Period III||0
143111|NCT01128946|346263|P3|NOT COMPLETED|Period III||0
143112|NCT01128946|346264|P2|NOT COMPLETED|Period III||0
143113|NCT01128946|346265|P1|NOT COMPLETED|Period III||1
143114|NCT01128946|346262|P4|COMPLETED|Period III||19
143115|NCT01128946|346263|P3|COMPLETED|Period III||20
143116|NCT01128946|346264|P2|COMPLETED|Period III||19
143117|NCT01128946|346265|P1|COMPLETED|Period III||19
143118|NCT01128946|346262|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
143119|NCT01128946|346263|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
143120|NCT01128946|346264|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
143121|NCT01128946|346265|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
143122|NCT01128946|346262|P4|NOT COMPLETED|Period II||1
143123|NCT01128946|346263|P3|NOT COMPLETED|Period II||0
143124|NCT01128946|346264|P2|NOT COMPLETED|Period II||1
143125|NCT01128946|346265|P1|NOT COMPLETED|Period II||0
143126|NCT01128946|346262|P4|COMPLETED|Period II||19
143127|NCT01128946|346263|P3|COMPLETED|Period II||20
143128|NCT01128946|346264|P2|COMPLETED|Period II||19
143129|NCT01128946|346265|P1|COMPLETED|Period II||20
143130|NCT01128946|346262|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
143131|NCT01128946|346263|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
143132|NCT01128946|346264|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
143133|NCT01128946|346265|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
143134|NCT01128946|346262|P4|NOT COMPLETED|Period I||1
143135|NCT01128946|346263|P3|NOT COMPLETED|Period I||1
143136|NCT01128946|346264|P2|NOT COMPLETED|Period I||1
143137|NCT01128946|346265|P1|NOT COMPLETED|Period I||0
143138|NCT01128946|346262|P4|COMPLETED|Period I||20
143139|NCT01128946|346263|P3|COMPLETED|Period I||20
143140|NCT01128946|346264|P2|COMPLETED|Period I||20
143141|NCT01128946|346265|P1|COMPLETED|Period I||20
143142|NCT01128946|346262|P4|STARTED|Period I||21
143143|NCT01128946|346263|P3|STARTED|Period I||21
143144|NCT01128946|346264|P2|STARTED|Period I||21
143145|NCT01128946|346265|P1|STARTED|Period I||20
143146|NCT01128894|346283|P2|NOT COMPLETED|Overall Study||68
143147|NCT01128894|346284|P1|NOT COMPLETED|Overall Study||58
143148|NCT01128894|346283|P2|COMPLETED|Overall Study||340
143149|NCT01128894|346284|P1|COMPLETED|Overall Study||346
143150|NCT01128894|346283|P2|STARTED|Overall Study||408
143151|NCT01128894|346284|P1|STARTED|Overall Study||404
143152|NCT01128829|346302|P2|NOT COMPLETED|Overall Study||0
143153|NCT01128829|346303|P1|NOT COMPLETED|Overall Study||0
143154|NCT01128829|346302|P2|COMPLETED|Overall Study||11
143155|NCT01128829|346303|P1|COMPLETED|Overall Study||6
143156|NCT01128829|346302|P2|STARTED|Overall Study||11
143157|NCT01128829|346303|P1|STARTED|Overall Study||6
143158|NCT01128738|346309|P2|NOT COMPLETED|Second TP||3
143159|NCT01128738|346310|P1|NOT COMPLETED|Second TP||0
143160|NCT01128738|346309|P2|COMPLETED|Second TP||63
143161|NCT01128738|346310|P1|COMPLETED|Second TP||34
143162|NCT01128738|346309|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
143163|NCT01128738|346310|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
143164|NCT01128738|346309|P2|NOT COMPLETED|First Treatment Phase (TP)||1
143165|NCT01128738|346310|P1|NOT COMPLETED|First Treatment Phase (TP)||4
143166|NCT01128738|346309|P2|COMPLETED|First Treatment Phase (TP)||73
143167|NCT01128738|346310|P1|COMPLETED|First Treatment Phase (TP)||74
143168|NCT01128738|346309|P2|STARTED|First Treatment Phase (TP)||74
143169|NCT01128738|346310|P1|STARTED|First Treatment Phase (TP)||78
143170|NCT01128621|346435|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
143171|NCT01128621|346436|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
143172|NCT01128621|346435|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
143173|NCT01128621|346436|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
143174|NCT01128621|346435|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
143175|NCT01128621|346436|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
143176|NCT01128621|346435|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
143177|NCT01128621|346436|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
143178|NCT01128621|346435|P2|COMPLETED|Part A: GSK1292263 300 mg||0
143179|NCT01128621|346436|P1|COMPLETED|Part A: GSK1292263 300 mg||6
143180|NCT01128621|346435|P2|STARTED|Part A: GSK1292263 300 mg||0
143181|NCT01128621|346436|P1|STARTED|Part A: GSK1292263 300 mg||6
143182|NCT01128595|346557|P4|NOT COMPLETED|Treatment Period 4||0
143183|NCT01128595|346558|P3|NOT COMPLETED|Treatment Period 4||0
143184|NCT01128595|346559|P2|NOT COMPLETED|Treatment Period 4||0
143185|NCT01128595|346560|P1|NOT COMPLETED|Treatment Period 4||0
143186|NCT01128595|346557|P4|COMPLETED|Treatment Period 4||7
143187|NCT01128595|346558|P3|COMPLETED|Treatment Period 4||7
143188|NCT01128595|346559|P2|COMPLETED|Treatment Period 4||5
143189|NCT01128595|346560|P1|COMPLETED|Treatment Period 4||7
143190|NCT01128595|346557|P4|STARTED|Treatment Period 4||7
143191|NCT01128595|346558|P3|STARTED|Treatment Period 4||7
143192|NCT01128595|346559|P2|STARTED|Treatment Period 4||5
143193|NCT01128595|346560|P1|STARTED|Treatment Period 4||7
143194|NCT01128595|346557|P4|NOT COMPLETED|Washout Period 3||0
143195|NCT01128595|346558|P3|NOT COMPLETED|Washout Period 3||0
143196|NCT01128595|346559|P2|NOT COMPLETED|Washout Period 3||0
143197|NCT01128595|346560|P1|NOT COMPLETED|Washout Period 3||0
143198|NCT01128595|346557|P4|COMPLETED|Washout Period 3||7
143199|NCT01128595|346558|P3|COMPLETED|Washout Period 3||7
143200|NCT01128595|346559|P2|COMPLETED|Washout Period 3||5
143201|NCT01128595|346560|P1|COMPLETED|Washout Period 3||7
143202|NCT01128595|346557|P4|STARTED|Washout Period 3||7
143203|NCT01128595|346558|P3|STARTED|Washout Period 3||7
143204|NCT01128595|346559|P2|STARTED|Washout Period 3||5
143205|NCT01128595|346560|P1|STARTED|Washout Period 3||7
143206|NCT01128595|346557|P4|NOT COMPLETED|Treatment Period 3||0
143207|NCT01128595|346558|P3|NOT COMPLETED|Treatment Period 3||0
143208|NCT01128595|346559|P2|NOT COMPLETED|Treatment Period 3||1
143209|NCT01128595|346560|P1|NOT COMPLETED|Treatment Period 3||0
143210|NCT01128595|346557|P4|COMPLETED|Treatment Period 3||7
143211|NCT01128595|346558|P3|COMPLETED|Treatment Period 3||7
143212|NCT01128595|346559|P2|COMPLETED|Treatment Period 3||5
143213|NCT01128595|346560|P1|COMPLETED|Treatment Period 3||7
143214|NCT01128595|346557|P4|STARTED|Treatment Period 3||7
143215|NCT01128595|346558|P3|STARTED|Treatment Period 3||7
143216|NCT01128595|346559|P2|STARTED|Treatment Period 3||6
143217|NCT01128595|346560|P1|STARTED|Treatment Period 3||7
143218|NCT01128595|346557|P4|NOT COMPLETED|Washout Period 2||0
143219|NCT01128595|346558|P3|NOT COMPLETED|Washout Period 2||0
143220|NCT01128595|346559|P2|NOT COMPLETED|Washout Period 2||0
143221|NCT01128595|346560|P1|NOT COMPLETED|Washout Period 2||0
143222|NCT01128595|346557|P4|COMPLETED|Washout Period 2||7
143223|NCT01128595|346558|P3|COMPLETED|Washout Period 2||7
143224|NCT01128595|346559|P2|COMPLETED|Washout Period 2||6
143225|NCT01128595|346560|P1|COMPLETED|Washout Period 2||7
143226|NCT01128595|346557|P4|STARTED|Washout Period 2||7
143227|NCT01128595|346558|P3|STARTED|Washout Period 2||7
143228|NCT01128595|346559|P2|STARTED|Washout Period 2||6
143229|NCT01128595|346560|P1|STARTED|Washout Period 2||7
143230|NCT01128595|346557|P4|NOT COMPLETED|Treatment Period 2||0
143231|NCT01128595|346558|P3|NOT COMPLETED|Treatment Period 2||0
143232|NCT01128595|346559|P2|NOT COMPLETED|Treatment Period 2||0
143233|NCT01128595|346560|P1|NOT COMPLETED|Treatment Period 2||0
143234|NCT01128595|346557|P4|COMPLETED|Treatment Period 2||7
143235|NCT01128595|346558|P3|COMPLETED|Treatment Period 2||7
143236|NCT01128595|346559|P2|COMPLETED|Treatment Period 2||6
143237|NCT01128595|346560|P1|COMPLETED|Treatment Period 2||7
143238|NCT01128595|346557|P4|STARTED|Treatment Period 2||7
143239|NCT01128595|346558|P3|STARTED|Treatment Period 2||7
143240|NCT01128595|346559|P2|STARTED|Treatment Period 2||6
143241|NCT01128595|346560|P1|STARTED|Treatment Period 2||7
143242|NCT01128595|346557|P4|NOT COMPLETED|Washout Period 1||0
143243|NCT01128595|346558|P3|NOT COMPLETED|Washout Period 1||0
143244|NCT01128595|346559|P2|NOT COMPLETED|Washout Period 1||0
143245|NCT01128595|346560|P1|NOT COMPLETED|Washout Period 1||0
143246|NCT01128595|346557|P4|COMPLETED|Washout Period 1||7
143247|NCT01128595|346558|P3|COMPLETED|Washout Period 1||7
143248|NCT01128595|346559|P2|COMPLETED|Washout Period 1||6
143249|NCT01128595|346560|P1|COMPLETED|Washout Period 1||7
143250|NCT01128595|346557|P4|STARTED|Washout Period 1||7
143251|NCT01128595|346558|P3|STARTED|Washout Period 1||7
143252|NCT01128595|346559|P2|STARTED|Washout Period 1||6
143253|NCT01128595|346560|P1|STARTED|Washout Period 1||7
143254|NCT01128595|346557|P4|NOT COMPLETED|Treatment Period 1||0
143255|NCT01128595|346558|P3|NOT COMPLETED|Treatment Period 1||0
143256|NCT01128595|346559|P2|NOT COMPLETED|Treatment Period 1||0
143257|NCT01128595|346560|P1|NOT COMPLETED|Treatment Period 1||0
143258|NCT01128595|346557|P4|COMPLETED|Treatment Period 1||7
143259|NCT01128595|346558|P3|COMPLETED|Treatment Period 1||7
143260|NCT01128595|346559|P2|COMPLETED|Treatment Period 1||6
143261|NCT01128595|346560|P1|COMPLETED|Treatment Period 1||7
143262|NCT01128595|346557|P4|STARTED|Treatment Period 1||7
143263|NCT01128595|346558|P3|STARTED|Treatment Period 1||7
143264|NCT01128595|346559|P2|STARTED|Treatment Period 1||6
143265|NCT01128595|346560|P1|STARTED|Treatment Period 1||7
143266|NCT01128569|346590|P6|NOT COMPLETED|Treatment Period 3||0
143267|NCT01128569|346591|P5|NOT COMPLETED|Treatment Period 3||0
143268|NCT01128569|346592|P4|NOT COMPLETED|Treatment Period 3||0
143269|NCT01128569|346593|P3|NOT COMPLETED|Treatment Period 3||0
143270|NCT01128569|346594|P2|NOT COMPLETED|Treatment Period 3||0
143271|NCT01128569|346595|P1|NOT COMPLETED|Treatment Period 3||0
143272|NCT01128569|346590|P6|COMPLETED|Treatment Period 3||9
143273|NCT01128569|346591|P5|COMPLETED|Treatment Period 3||9
143274|NCT01128569|346592|P4|COMPLETED|Treatment Period 3||8
143275|NCT01128569|346593|P3|COMPLETED|Treatment Period 3||8
143276|NCT01128569|346594|P2|COMPLETED|Treatment Period 3||7
143277|NCT01128569|346595|P1|COMPLETED|Treatment Period 3||9
143278|NCT01128569|346590|P6|STARTED|Treatment Period 3||9
143279|NCT01128569|346591|P5|STARTED|Treatment Period 3||9
143280|NCT01128569|346592|P4|STARTED|Treatment Period 3||8
143281|NCT01128569|346593|P3|STARTED|Treatment Period 3||8
143282|NCT01128569|346594|P2|STARTED|Treatment Period 3||7
143283|NCT01128569|346595|P1|STARTED|Treatment Period 3||9
143284|NCT01128569|346590|P6|NOT COMPLETED|Washout Period 2||0
143285|NCT01128569|346591|P5|NOT COMPLETED|Washout Period 2||0
143286|NCT01128569|346592|P4|NOT COMPLETED|Washout Period 2||0
143287|NCT01128569|346593|P3|NOT COMPLETED|Washout Period 2||0
143288|NCT01128569|346594|P2|NOT COMPLETED|Washout Period 2||0
143289|NCT01128569|346595|P1|NOT COMPLETED|Washout Period 2||0
143290|NCT01128569|346590|P6|COMPLETED|Washout Period 2||9
143291|NCT01128569|346591|P5|COMPLETED|Washout Period 2||9
143292|NCT01128569|346592|P4|COMPLETED|Washout Period 2||8
143293|NCT01128569|346593|P3|COMPLETED|Washout Period 2||8
143294|NCT01128569|346594|P2|COMPLETED|Washout Period 2||7
143295|NCT01128569|346595|P1|COMPLETED|Washout Period 2||9
143296|NCT01128569|346590|P6|STARTED|Washout Period 2||9
143297|NCT01128569|346591|P5|STARTED|Washout Period 2||9
143298|NCT01128569|346592|P4|STARTED|Washout Period 2||8
143299|NCT01128569|346593|P3|STARTED|Washout Period 2||8
143300|NCT01128569|346594|P2|STARTED|Washout Period 2||7
143301|NCT01128569|346595|P1|STARTED|Washout Period 2||9
143302|NCT01128569|346590|P6|NOT COMPLETED|Treatment Period 2||0
143303|NCT01128569|346591|P5|NOT COMPLETED|Treatment Period 2||0
143304|NCT01128569|346592|P4|NOT COMPLETED|Treatment Period 2||0
143305|NCT01128569|346593|P3|NOT COMPLETED|Treatment Period 2||0
143306|NCT01128569|346594|P2|NOT COMPLETED|Treatment Period 2||1
143307|NCT01128569|346595|P1|NOT COMPLETED|Treatment Period 2||0
143308|NCT01128569|346590|P6|COMPLETED|Treatment Period 2||9
143309|NCT01128569|346591|P5|COMPLETED|Treatment Period 2||9
143310|NCT01128569|346592|P4|COMPLETED|Treatment Period 2||8
143311|NCT01128569|346593|P3|COMPLETED|Treatment Period 2||8
143312|NCT01128569|346594|P2|COMPLETED|Treatment Period 2||7
143313|NCT01128569|346595|P1|COMPLETED|Treatment Period 2||9
143314|NCT01128569|346590|P6|STARTED|Treatment Period 2||9
143315|NCT01128569|346591|P5|STARTED|Treatment Period 2||9
143316|NCT01128569|346592|P4|STARTED|Treatment Period 2||8
143317|NCT01128569|346593|P3|STARTED|Treatment Period 2||8
143318|NCT01128569|346594|P2|STARTED|Treatment Period 2||8
143319|NCT01128569|346595|P1|STARTED|Treatment Period 2||9
143320|NCT01128569|346590|P6|NOT COMPLETED|Washout Period 1||0
143321|NCT01128569|346591|P5|NOT COMPLETED|Washout Period 1||0
143322|NCT01128569|346592|P4|NOT COMPLETED|Washout Period 1||0
143323|NCT01128569|346593|P3|NOT COMPLETED|Washout Period 1||1
143324|NCT01128569|346594|P2|NOT COMPLETED|Washout Period 1||0
143325|NCT01128569|346595|P1|NOT COMPLETED|Washout Period 1||0
143326|NCT01128569|346590|P6|COMPLETED|Washout Period 1||9
143327|NCT01128569|346591|P5|COMPLETED|Washout Period 1||9
143328|NCT01128569|346592|P4|COMPLETED|Washout Period 1||8
143329|NCT01128569|346593|P3|COMPLETED|Washout Period 1||8
143330|NCT01128569|346594|P2|COMPLETED|Washout Period 1||8
143331|NCT01128569|346595|P1|COMPLETED|Washout Period 1||9
143332|NCT01128569|346590|P6|STARTED|Washout Period 1||9
143333|NCT01128569|346591|P5|STARTED|Washout Period 1||9
143334|NCT01128569|346592|P4|STARTED|Washout Period 1||8
143335|NCT01128569|346593|P3|STARTED|Washout Period 1||9
143336|NCT01128569|346594|P2|STARTED|Washout Period 1||8
143337|NCT01128569|346595|P1|STARTED|Washout Period 1||9
143338|NCT01128569|346590|P6|NOT COMPLETED|Treatment Period 1||0
143339|NCT01128569|346591|P5|NOT COMPLETED|Treatment Period 1||0
143340|NCT01128569|346592|P4|NOT COMPLETED|Treatment Period 1||0
143341|NCT01128569|346593|P3|NOT COMPLETED|Treatment Period 1||0
143342|NCT01128569|346594|P2|NOT COMPLETED|Treatment Period 1||0
143343|NCT01128569|346595|P1|NOT COMPLETED|Treatment Period 1||0
143344|NCT01128569|346590|P6|COMPLETED|Treatment Period 1||9
143345|NCT01128569|346591|P5|COMPLETED|Treatment Period 1||9
143346|NCT01128569|346592|P4|COMPLETED|Treatment Period 1||8
143347|NCT01128569|346593|P3|COMPLETED|Treatment Period 1||9
143348|NCT01128569|346594|P2|COMPLETED|Treatment Period 1||8
143349|NCT01128569|346595|P1|COMPLETED|Treatment Period 1||9
143350|NCT01128569|346590|P6|STARTED|Treatment Period 1||9
143351|NCT01128569|346591|P5|STARTED|Treatment Period 1||9
143352|NCT01128569|346592|P4|STARTED|Treatment Period 1||8
143353|NCT01128569|346593|P3|STARTED|Treatment Period 1||9
143354|NCT01128569|346594|P2|STARTED|Treatment Period 1||8
143355|NCT01128569|346595|P1|STARTED|Treatment Period 1||9
143356|NCT01128543|346612|P1|NOT COMPLETED|Overall Study||4
143357|NCT01128543|346612|P1|COMPLETED|Overall Study||25
143358|NCT01128543|346612|P1|STARTED|Overall Study||29
143359|NCT01128426|346618|P1|NOT COMPLETED|Overall Study||0
143360|NCT01128426|346618|P1|COMPLETED|Overall Study||53902
143361|NCT01128426|346618|P1|STARTED|Overall Study||53902
143362|NCT01128413|346638|P2|NOT COMPLETED|Overall Study||1
143363|NCT01128413|346639|P1|NOT COMPLETED|Overall Study||4
143364|NCT01128413|346638|P2|COMPLETED|Overall Study||10
143365|NCT01128413|346639|P1|COMPLETED|Overall Study||7
143366|NCT01128413|346638|P2|STARTED|Overall Study||11
143367|NCT01128413|346639|P1|STARTED|Overall Study||11
143368|NCT01128400|346648|P3|NOT COMPLETED|Overall Study||16
143369|NCT01128400|346649|P2|NOT COMPLETED|Overall Study||0
143370|NCT01128400|346650|P1|NOT COMPLETED|Overall Study||2
143371|NCT01128400|346648|P3|COMPLETED|Overall Study||7
143372|NCT01128400|346649|P2|COMPLETED|Overall Study||9
143373|NCT01128400|346650|P1|COMPLETED|Overall Study||6
143374|NCT01128400|346648|P3|STARTED|Overall Study||23
143375|NCT01128400|346649|P2|STARTED|Overall Study||9
143376|NCT01128400|346650|P1|STARTED|Overall Study||8
143377|NCT01128387|346663|P2|NOT COMPLETED|Overall Study||1
143378|NCT01128387|346664|P1|NOT COMPLETED|Overall Study||0
143379|NCT01128387|346663|P2|COMPLETED|Overall Study||5
143380|NCT01128387|346664|P1|COMPLETED|Overall Study||5
143381|NCT01128387|346663|P2|STARTED|Overall Study||6
143382|NCT01128387|346664|P1|STARTED|Overall Study||5
143383|NCT01128361|346674|P2|NOT COMPLETED|Overall Study||3
143384|NCT01128361|346675|P1|NOT COMPLETED|Overall Study||5
143385|NCT01128361|346674|P2|COMPLETED|Overall Study||34
143386|NCT01128361|346675|P1|COMPLETED|Overall Study||34
143387|NCT01128361|346674|P2|STARTED|Overall Study||37
143388|NCT01128361|346675|P1|STARTED|Overall Study||39
143389|NCT01128296|346687|P6|NOT COMPLETED|Overall Study||5
143390|NCT01128296|346688|P5|NOT COMPLETED|Overall Study||0
143391|NCT01128296|346689|P4|NOT COMPLETED|Overall Study||0
143392|NCT01128296|346690|P3|NOT COMPLETED|Overall Study||0
143393|NCT01128296|346691|P2|NOT COMPLETED|Overall Study||0
143394|NCT01128296|346692|P1|NOT COMPLETED|Overall Study||0
143395|NCT01128296|346687|P6|COMPLETED|Overall Study||21
143396|NCT01128296|346688|P5|COMPLETED|Overall Study||1
143397|NCT01128296|346689|P4|COMPLETED|Overall Study||1
143398|NCT01128296|346690|P3|COMPLETED|Overall Study||1
143399|NCT01128296|346691|P2|COMPLETED|Overall Study||1
143400|NCT01128296|346692|P1|COMPLETED|Overall Study||1
143401|NCT01128296|346687|P6|STARTED|Overall Study||26
143402|NCT01128296|346688|P5|STARTED|Overall Study||1
143403|NCT01128296|346689|P4|STARTED|Overall Study||1
143404|NCT01128296|346690|P3|STARTED|Overall Study||1
143405|NCT01128296|346691|P2|STARTED|Overall Study||1
143406|NCT01128296|346692|P1|STARTED|Overall Study||1
143407|NCT01128270|346710|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
143408|NCT01128270|346710|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
143409|NCT01128270|346710|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
143410|NCT01128270|346710|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
143411|NCT01128270|346710|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
143412|NCT01128270|346710|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
143413|NCT01128270|346710|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
143414|NCT01128270|346710|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
143415|NCT01128270|346710|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
143416|NCT01128270|346710|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
143417|NCT01128270|346710|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
143418|NCT01128270|346710|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
143419|NCT01128244|346723|P1|NOT COMPLETED|Overall Study||3
143420|NCT01128244|346723|P1|COMPLETED|Overall Study||10
143421|NCT01128244|346723|P1|STARTED|Overall Study||13
143422|NCT01128192|346733|P3|NOT COMPLETED|Overall Study||0
143423|NCT01128192|346734|P2|NOT COMPLETED|Overall Study||0
143424|NCT01128192|346735|P1|NOT COMPLETED|Overall Study||0
143425|NCT01128192|346733|P3|COMPLETED|Overall Study||7
143426|NCT01128192|346734|P2|COMPLETED|Overall Study||19
143427|NCT01128192|346735|P1|COMPLETED|Overall Study||19
143428|NCT01128192|346733|P3|STARTED|Overall Study||7
143429|NCT01128192|346734|P2|STARTED|Overall Study||19
143430|NCT01128192|346735|P1|STARTED|Overall Study||19
143431|NCT01128179|346764|P2|NOT COMPLETED|Overall Study||0
143432|NCT01128179|346765|P1|NOT COMPLETED|Overall Study||2
143433|NCT01128179|346764|P2|COMPLETED|Overall Study||12
143434|NCT01128179|346765|P1|COMPLETED|Overall Study||21
143435|NCT01128179|346764|P2|STARTED|Overall Study||12
143436|NCT01128179|346765|P1|STARTED|Overall Study||23
143437|NCT01128153|346785|P2|NOT COMPLETED|Overall Study||15
143438|NCT01128153|346786|P1|NOT COMPLETED|Overall Study||16
143439|NCT01128153|346785|P2|COMPLETED|Overall Study|Completed 24 weeks|113
143440|NCT01128153|346786|P1|COMPLETED|Overall Study|Completed 24 weeks|113
143441|NCT01128153|346785|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
143442|NCT01128153|346786|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
143443|NCT01128153|346785|P2|STARTED|Overall Study|Randomised|128
143444|NCT01128153|346786|P1|STARTED|Overall Study|Randomised|129
143445|NCT01128114|346802|P1|NOT COMPLETED|Overall Study||8
143446|NCT01128114|346802|P1|COMPLETED|Overall Study||24
143447|NCT01128114|346802|P1|STARTED|Overall Study||32
143448|NCT01128049|346809|P3|NOT COMPLETED|Overall Study||0
143449|NCT01128049|346810|P2|NOT COMPLETED|Overall Study||0
143450|NCT01128049|346811|P1|NOT COMPLETED|Overall Study||0
143451|NCT01128049|346809|P3|COMPLETED|Overall Study||5
143452|NCT01128049|346810|P2|COMPLETED|Overall Study||5
143453|NCT01128049|346811|P1|COMPLETED|Overall Study||5
143454|NCT01128049|346809|P3|STARTED|Overall Study||5
143455|NCT01128049|346810|P2|STARTED|Overall Study||5
143456|NCT01128049|346811|P1|STARTED|Overall Study||5
143457|NCT01127763|346819|P1|NOT COMPLETED|Overall Study||5
143458|NCT01127763|346819|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
143459|NCT01127763|346819|P1|STARTED|Overall Study||25
143460|NCT01127737|346830|P2|NOT COMPLETED|Overall Study||0
143461|NCT01127737|346831|P1|NOT COMPLETED|Overall Study||0
143462|NCT01127737|346830|P2|COMPLETED|Overall Study||38
143463|NCT01127737|346831|P1|COMPLETED|Overall Study||37
143464|NCT01127737|346830|P2|STARTED|Overall Study||38
143465|NCT01127737|346831|P1|STARTED|Overall Study||37
143466|NCT01127659|346843|P6|NOT COMPLETED|Overall Study||0
143467|NCT01127659|346844|P5|NOT COMPLETED|Overall Study||0
143468|NCT01127659|346845|P4|NOT COMPLETED|Overall Study||4
143469|NCT01127659|346846|P3|NOT COMPLETED|Overall Study||2
143470|NCT01127659|346847|P2|NOT COMPLETED|Overall Study||8
143471|NCT01127659|346848|P1|NOT COMPLETED|Overall Study||2
143472|NCT01127659|346843|P6|COMPLETED|Overall Study||21
143473|NCT01127659|346844|P5|COMPLETED|Overall Study||50
143474|NCT01127659|346845|P4|COMPLETED|Overall Study||6
143475|NCT01127659|346846|P3|COMPLETED|Overall Study||10
143476|NCT01127659|346847|P2|COMPLETED|Overall Study||14
143477|NCT01127659|346848|P1|COMPLETED|Overall Study||20
143478|NCT01127659|346843|P6|STARTED|Overall Study||21
143479|NCT01127659|346844|P5|STARTED|Overall Study||50
143480|NCT01127659|346845|P4|STARTED|Overall Study||10
143481|NCT01127659|346846|P3|STARTED|Overall Study||12
143482|NCT01127659|346847|P2|STARTED|Overall Study||22
143483|NCT01127659|346848|P1|STARTED|Overall Study||22
143484|NCT01127646|346864|P2|NOT COMPLETED|Overall Study||1
143485|NCT01127646|346865|P1|NOT COMPLETED|Overall Study||1
143486|NCT01127646|346864|P2|COMPLETED|Overall Study||7
143487|NCT01127646|346865|P1|COMPLETED|Overall Study||14
143488|NCT01127646|346864|P2|STARTED|Overall Study||8
143489|NCT01127646|346865|P1|STARTED|Overall Study||15
143490|NCT01127633|346899|P2|NOT COMPLETED|Overall Study||673
143491|NCT01127633|346900|P1|NOT COMPLETED|Overall Study||653
143492|NCT01127633|346899|P2|COMPLETED|Overall Study||61
143493|NCT01127633|346900|P1|COMPLETED|Overall Study||70
143494|NCT01127633|346899|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
143495|NCT01127633|346900|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
143496|NCT01127633|346899|P2|STARTED|Overall Study||734
143497|NCT01127633|346900|P1|STARTED|Overall Study||723
143498|NCT01127607|346932|P2|NOT COMPLETED|Phase II (Between Subjects)||2
143499|NCT01127607|346933|P1|NOT COMPLETED|Phase II (Between Subjects)||1
143500|NCT01127607|346932|P2|COMPLETED|Phase II (Between Subjects)||11
143501|NCT01127607|346933|P1|COMPLETED|Phase II (Between Subjects)||13
143502|NCT01127607|346932|P2|STARTED|Phase II (Between Subjects)||13
143503|NCT01127607|346933|P1|STARTED|Phase II (Between Subjects)||14
143504|NCT01127607|346932|P2|NOT COMPLETED|Phase I (Within Subjects)||0
143505|NCT01127607|346933|P1|NOT COMPLETED|Phase I (Within Subjects)||0
143506|NCT01127607|346932|P2|COMPLETED|Phase I (Within Subjects)||13
143507|NCT01127607|346933|P1|COMPLETED|Phase I (Within Subjects)||14
143508|NCT01127607|346932|P2|STARTED|Phase I (Within Subjects)||13
143509|NCT01127607|346933|P1|STARTED|Phase I (Within Subjects)||14
143510|NCT01127581|347006|P2|NOT COMPLETED|Overall Study||0
143511|NCT01127581|347007|P1|NOT COMPLETED|Overall Study||0
143512|NCT01127581|347006|P2|COMPLETED|Overall Study||680
143513|NCT01127581|347007|P1|COMPLETED|Overall Study||678
143514|NCT01127581|347006|P2|STARTED|Overall Study||680
143515|NCT01127581|347007|P1|STARTED|Overall Study||678
143516|NCT01127503|347035|P2|NOT COMPLETED|Overall Study||0
143517|NCT01127503|347036|P1|NOT COMPLETED|Overall Study||0
143518|NCT01127503|347035|P2|COMPLETED|Overall Study||1
143519|NCT01127503|347036|P1|COMPLETED|Overall Study||1
143520|NCT01127503|347035|P2|STARTED|Overall Study||1
143521|NCT01127503|347036|P1|STARTED|Overall Study||1
143522|NCT01127438|347048|P6|NOT COMPLETED|Overall Study||0
143523|NCT01127438|347049|P5|NOT COMPLETED|Overall Study||0
143524|NCT01127438|347050|P4|NOT COMPLETED|Overall Study||0
143525|NCT01127438|347051|P3|NOT COMPLETED|Overall Study||0
143526|NCT01127438|347052|P2|NOT COMPLETED|Overall Study||0
143527|NCT01127438|347053|P1|NOT COMPLETED|Overall Study||0
143528|NCT01127438|347048|P6|COMPLETED|Overall Study||25
143529|NCT01127438|347049|P5|COMPLETED|Overall Study||28
143530|NCT01127438|347050|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
143531|NCT01127438|347051|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
143532|NCT01127438|347052|P2|COMPLETED|Overall Study||25
143533|NCT01127438|347053|P1|COMPLETED|Overall Study||25
143534|NCT01127438|347048|P6|STARTED|Overall Study||25
143535|NCT01127438|347049|P5|STARTED|Overall Study||28
143536|NCT01127438|347050|P4|STARTED|Overall Study||24
143537|NCT01127438|347051|P3|STARTED|Overall Study||26
143538|NCT01127438|347052|P2|STARTED|Overall Study||25
143539|NCT01127438|347053|P1|STARTED|Overall Study||25
143540|NCT01127321|347080|P5|NOT COMPLETED|Overall Study||0
143541|NCT01127321|347081|P4|NOT COMPLETED|Overall Study||0
143542|NCT01127321|347082|P3|NOT COMPLETED|Overall Study||0
143543|NCT01127321|347083|P2|NOT COMPLETED|Overall Study||0
143544|NCT01127321|347084|P1|NOT COMPLETED|Overall Study||0
143545|NCT01127321|347080|P5|COMPLETED|Overall Study||5
143546|NCT01127321|347081|P4|COMPLETED|Overall Study||7
143547|NCT01127321|347082|P3|COMPLETED|Overall Study||1
143548|NCT01127321|347083|P2|COMPLETED|Overall Study||1
143549|NCT01127321|347084|P1|COMPLETED|Overall Study||3
143550|NCT01127321|347080|P5|STARTED|Overall Study||5
143551|NCT01127321|347081|P4|STARTED|Overall Study||7
143552|NCT01127321|347082|P3|STARTED|Overall Study||1
143553|NCT01127321|347083|P2|STARTED|Overall Study||1
143554|NCT01127321|347084|P1|STARTED|Overall Study||3
143555|NCT01127256|347108|P2|NOT COMPLETED|Overall Study||39
143556|NCT01127256|347109|P1|NOT COMPLETED|Overall Study||39
143557|NCT01127256|347108|P2|COMPLETED|Overall Study||65
143558|NCT01127256|347109|P1|COMPLETED|Overall Study||57
143559|NCT01127256|347108|P2|STARTED|Overall Study||104
143560|NCT01127256|347109|P1|STARTED|Overall Study||96
143561|NCT01127165|347121|P2|NOT COMPLETED|Overall Study||19
143562|NCT01127165|347122|P1|NOT COMPLETED|Overall Study||16
143563|NCT01127165|347121|P2|COMPLETED|Overall Study||41
143564|NCT01127165|347122|P1|COMPLETED|Overall Study||49
143565|NCT01127165|347121|P2|STARTED|Overall Study||60
143566|NCT01127165|347122|P1|STARTED|Overall Study||65
143567|NCT01127139|347134|P1|NOT COMPLETED|Overall Study||57
143568|NCT01127139|347134|P1|COMPLETED|Overall Study||3771
143569|NCT01127139|347134|P1|Number of Participants Analyzed|Overall Study||3828
143570|NCT01127139|347134|P1|STARTED|Overall Study||3828
143571|NCT01127087|347151|P2|NOT COMPLETED|Overall Study||0
143572|NCT01127087|347152|P1|NOT COMPLETED|Overall Study||0
143573|NCT01127087|347151|P2|COMPLETED|Overall Study||2
143574|NCT01127087|347152|P1|COMPLETED|Overall Study||8
143575|NCT01127087|347151|P2|STARTED|Overall Study||2
143576|NCT01127087|347152|P1|STARTED|Overall Study||8
143577|NCT01126957|347160|P1|NOT COMPLETED|Overall Study||0
143578|NCT01126957|347160|P1|COMPLETED|Overall Study||103
143579|NCT01126957|347160|P1|STARTED|Overall Study||103
143580|NCT01126801|347167|P2|NOT COMPLETED|Overall Study||0
143581|NCT01126801|347168|P1|NOT COMPLETED|Overall Study||0
143582|NCT01126801|347167|P2|COMPLETED|Overall Study||1
143583|NCT01126801|347168|P1|COMPLETED|Overall Study||1
143584|NCT01126801|347167|P2|STARTED|Overall Study||1
143585|NCT01126801|347168|P1|STARTED|Overall Study||1
143586|NCT01126723|347178|P2|NOT COMPLETED|Overall Study||3
143587|NCT01126723|347179|P1|NOT COMPLETED|Overall Study||6
143588|NCT01126723|347178|P2|COMPLETED|Overall Study||28
143589|NCT01126723|347179|P1|COMPLETED|Overall Study||29
143590|NCT01126723|347178|P2|STARTED|Overall Study||31
143591|NCT01126723|347179|P1|STARTED|Overall Study||35
143592|NCT01126671|347187|P2|NOT COMPLETED|Overall Study||0
143593|NCT01126671|347188|P1|NOT COMPLETED|Overall Study||0
143594|NCT01126671|347187|P2|COMPLETED|Overall Study||29
143595|NCT01126671|347188|P1|COMPLETED|Overall Study||25
143596|NCT01126671|347187|P2|STARTED|Overall Study||29
143597|NCT01126671|347188|P1|STARTED|Overall Study||25
143598|NCT01126619|347196|P1|NOT COMPLETED|Overall Study||17
143599|NCT01126619|347196|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
143600|NCT01126619|347196|P1|STARTED|Overall Study||103
143601|NCT01126593|347211|P3|NOT COMPLETED|Overall Study||2
143602|NCT01126593|347212|P2|NOT COMPLETED|Overall Study||2
143603|NCT01126593|347213|P1|NOT COMPLETED|Overall Study||4
143604|NCT01126593|347211|P3|COMPLETED|Overall Study||32
143605|NCT01126593|347212|P2|COMPLETED|Overall Study||27
143606|NCT01126593|347213|P1|COMPLETED|Overall Study||29
143607|NCT01126593|347211|P3|STARTED|Overall Study||34
143608|NCT01126593|347212|P2|STARTED|Overall Study||29
143609|NCT01126593|347213|P1|STARTED|Overall Study||33
143610|NCT01126580|347224|P3|NOT COMPLETED|Overall Study||55
143611|NCT01126580|347225|P2|NOT COMPLETED|Overall Study||52
143612|NCT01126580|347226|P1|NOT COMPLETED|Overall Study||49
143613|NCT01126580|347224|P3|COMPLETED|Overall Study||213
143614|NCT01126580|347225|P2|COMPLETED|Overall Study||218
143615|NCT01126580|347226|P1|COMPLETED|Overall Study||220
143616|NCT01126580|347224|P3|Completed 26 Weeks|Overall Study||226
143617|NCT01126580|347225|P2|Completed 26 Weeks|Overall Study||242
143618|NCT01126580|347226|P1|Completed 26 Weeks|Overall Study||233
143619|NCT01126580|347224|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
143620|NCT01126580|347225|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
143621|NCT01126580|347226|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
143622|NCT01126580|347224|P3|STARTED|Overall Study||268
143623|NCT01126580|347225|P2|STARTED|Overall Study||270
143624|NCT01126580|347226|P1|STARTED|Overall Study||269
143625|NCT01126541|347321|P3|NOT COMPLETED|Overall Study||26
143626|NCT01126541|347322|P2|NOT COMPLETED|Overall Study||12
143627|NCT01126541|347323|P1|NOT COMPLETED|Overall Study||10
143628|NCT01126541|347321|P3|COMPLETED|Overall Study||55
143629|NCT01126541|347322|P2|COMPLETED|Overall Study||61
143630|NCT01126541|347323|P1|COMPLETED|Overall Study||60
143631|NCT01126541|347321|P3|STARTED|Overall Study||81
143632|NCT01126541|347322|P2|STARTED|Overall Study||73
143633|NCT01126541|347323|P1|STARTED|Overall Study||70
143634|NCT01126437|347407|P3|NOT COMPLETED|Overall Study||1313
143635|NCT01126437|347408|P2|NOT COMPLETED|Overall Study||1330
143636|NCT01126437|347409|P1|NOT COMPLETED|Overall Study||1341
143637|NCT01126437|347407|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
143638|NCT01126437|347408|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
143639|NCT01126437|347409|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
143640|NCT01126437|347407|P3|STARTED|Overall Study||5713
143641|NCT01126437|347408|P2|STARTED|Overall Study||5729
143642|NCT01126437|347409|P1|STARTED|Overall Study||5741
143643|NCT01126424|347447|P6|NOT COMPLETED|Overall Study||0
143644|NCT01126424|347448|P5|NOT COMPLETED|Overall Study||2
143645|NCT01126424|347449|P4|NOT COMPLETED|Overall Study||3
143646|NCT01126424|347450|P3|NOT COMPLETED|Overall Study||1
143647|NCT01126424|347451|P2|NOT COMPLETED|Overall Study||0
143648|NCT01126424|347452|P1|NOT COMPLETED|Overall Study||0
143649|NCT01126424|347447|P6|COMPLETED|Overall Study||4
143650|NCT01126424|347448|P5|COMPLETED|Overall Study||2
143651|NCT01126424|347449|P4|COMPLETED|Overall Study||3
143652|NCT01126424|347450|P3|COMPLETED|Overall Study||4
143653|NCT01126424|347451|P2|COMPLETED|Overall Study||4
143654|NCT01126424|347452|P1|COMPLETED|Overall Study||3
143655|NCT01126424|347447|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
143656|NCT01126424|347448|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
143657|NCT01126424|347449|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
143658|NCT01126424|347450|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
143659|NCT01126424|347451|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
143660|NCT01126424|347452|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
143661|NCT01126424|347447|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
143662|NCT01126424|347448|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
143663|NCT01126424|347449|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
143664|NCT01126424|347450|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
143665|NCT01126424|347451|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
143666|NCT01126424|347452|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
143667|NCT01126359|347475|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
143668|NCT01126359|347476|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
143669|NCT01126359|347475|P2|COMPLETED|Second Intervention (20-minutes)||5
143670|NCT01126359|347476|P1|COMPLETED|Second Intervention (20-minutes)||5
143671|NCT01126359|347475|P2|STARTED|Second Intervention (20-minutes)||5
143672|NCT01126359|347476|P1|STARTED|Second Intervention (20-minutes)||5
143673|NCT01126359|347475|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
143674|NCT01126359|347476|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
143675|NCT01126359|347475|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
143676|NCT01126359|347476|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
143677|NCT01126359|347475|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
143678|NCT01126359|347476|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
143679|NCT01126359|347475|P2|NOT COMPLETED|First Intervention (20-minutes)||1
143680|NCT01126359|347476|P1|NOT COMPLETED|First Intervention (20-minutes)||0
143681|NCT01126359|347475|P2|COMPLETED|First Intervention (20-minutes)||5
143682|NCT01126359|347476|P1|COMPLETED|First Intervention (20-minutes)||5
143683|NCT01126359|347475|P2|STARTED|First Intervention (20-minutes)||6
143684|NCT01126359|347476|P1|STARTED|First Intervention (20-minutes)||5
143685|NCT01126268|347488|P1|NOT COMPLETED|Overall Study||1
143686|NCT01126268|347488|P1|COMPLETED|Overall Study||37
143687|NCT01126268|347488|P1|STARTED|Overall Study||38
143688|NCT01126099|347512|P2|NOT COMPLETED|Open-label Extension||1
143689|NCT01126099|347513|P1|NOT COMPLETED|Open-label Extension||1
143690|NCT01126099|347512|P2|COMPLETED|Open-label Extension||6
143691|NCT01126099|347513|P1|COMPLETED|Open-label Extension||4
143692|NCT01126099|347512|P2|STARTED|Open-label Extension||7
143693|NCT01126099|347513|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
143694|NCT01126099|347512|P2|NOT COMPLETED|Double Blind Phase||2
143695|NCT01126099|347513|P1|NOT COMPLETED|Double Blind Phase||4
143696|NCT01126099|347512|P2|COMPLETED|Double Blind Phase||7
143697|NCT01126099|347513|P1|COMPLETED|Double Blind Phase||7
143698|NCT01126099|347512|P2|STARTED|Double Blind Phase||9
143699|NCT01126099|347513|P1|STARTED|Double Blind Phase||11
143700|NCT01126060|347527|P2|NOT COMPLETED|Overall Study||2
143701|NCT01126060|347528|P1|NOT COMPLETED|Overall Study||0
143702|NCT01126060|347527|P2|COMPLETED|Overall Study||38
143703|NCT01126060|347528|P1|COMPLETED|Overall Study||40
143704|NCT01126060|347527|P2|STARTED|Overall Study||40
143705|NCT01126060|347528|P1|STARTED|Overall Study||40
143706|NCT01125930|347536|P2|NOT COMPLETED|Overall Study||10
143707|NCT01125930|347537|P1|NOT COMPLETED|Overall Study||1
143708|NCT01125930|347536|P2|COMPLETED|Overall Study||36
143709|NCT01125930|347537|P1|COMPLETED|Overall Study||21
143710|NCT01125930|347536|P2|STARTED|Overall Study||46
143711|NCT01125930|347537|P1|STARTED|Overall Study||22
143712|NCT01125917|347691|P1|NOT COMPLETED|Overall Study||339
143713|NCT01125917|347691|P1|COMPLETED|Overall Study||15
143714|NCT01125917|347691|P1|STARTED|Overall Study||354
143715|NCT01125813|347695|P1|NOT COMPLETED|Overall Study||6
143716|NCT01125813|347695|P1|COMPLETED|Overall Study||30
143717|NCT01125813|347695|P1|STARTED|Overall Study||36
143718|NCT01125800|347705|P5|NOT COMPLETED|Phase II||11
143719|NCT01125800|347706|P4|NOT COMPLETED|Phase II||1
143720|NCT01125800|347707|P3|NOT COMPLETED|Phase II||0
143721|NCT01125800|347708|P2|NOT COMPLETED|Phase II||0
143722|NCT01125800|347709|P1|NOT COMPLETED|Phase II||0
143723|NCT01125800|347705|P5|COMPLETED|Phase II||5
143724|NCT01125800|347706|P4|COMPLETED|Phase II||0
143725|NCT01125800|347707|P3|COMPLETED|Phase II||0
143726|NCT01125800|347708|P2|COMPLETED|Phase II||0
143727|NCT01125800|347709|P1|COMPLETED|Phase II||0
143728|NCT01125800|347705|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
143729|NCT01125800|347706|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
143730|NCT01125800|347707|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
143731|NCT01125800|347708|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
143732|NCT01125800|347709|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
143733|NCT01125800|347705|P5|NOT COMPLETED|Phase I||0
143734|NCT01125800|347706|P4|NOT COMPLETED|Phase I||11
143735|NCT01125800|347707|P3|NOT COMPLETED|Phase I||4
143736|NCT01125800|347708|P2|NOT COMPLETED|Phase I||9
143737|NCT01125800|347709|P1|NOT COMPLETED|Phase I||8
143738|NCT01125800|347705|P5|COMPLETED|Phase I||0
143739|NCT01125800|347706|P4|COMPLETED|Phase I||10
143740|NCT01125800|347707|P3|COMPLETED|Phase I||7
143741|NCT01125800|347708|P2|COMPLETED|Phase I||7
143742|NCT01125800|347709|P1|COMPLETED|Phase I||3
143743|NCT01125800|347705|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
143744|NCT01125800|347706|P4|STARTED|Phase I||21
143745|NCT01125800|347707|P3|STARTED|Phase I||11
143746|NCT01125800|347708|P2|STARTED|Phase I||16
143747|NCT01125800|347709|P1|STARTED|Phase I||11
143748|NCT01125774|347748|P4|NOT COMPLETED|Overall Study||3
143749|NCT01125774|347749|P3|NOT COMPLETED|Overall Study||9
143750|NCT01125774|347750|P2|NOT COMPLETED|Overall Study||554
143751|NCT01125774|347751|P1|NOT COMPLETED|Overall Study||1125
143752|NCT01125774|347748|P4|COMPLETED|Overall Study|Completed study at least once|3
143753|NCT01125774|347749|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
143754|NCT01125774|347750|P2|COMPLETED|Overall Study||948
143755|NCT01125774|347751|P1|COMPLETED|Overall Study||1893
143756|NCT01125774|347748|P4|Treated|Overall Study||5
143757|NCT01125774|347749|P3|Treated|Overall Study|Received telcagepant|21
143758|NCT01125774|347750|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
143759|NCT01125774|347751|P1|Treated|Overall Study||2638
143760|NCT01125774|347748|P4|STARTED|Overall Study|Unique participants randomized|6
143761|NCT01125774|347749|P3|STARTED|Overall Study|Unique participants randomized|22
143762|NCT01125774|347750|P2|STARTED|Overall Study|Randomized|1502
143763|NCT01125774|347751|P1|STARTED|Overall Study|Randomized|3018
143764|NCT01125748|347775|P2|NOT COMPLETED|Overall Study||14
143765|NCT01125748|347776|P1|NOT COMPLETED|Overall Study||10
143766|NCT01125748|347775|P2|COMPLETED|Overall Study||74
143767|NCT01125748|347776|P1|COMPLETED|Overall Study||78
143768|NCT01125748|347775|P2|STARTED|Overall Study||88
143769|NCT01125748|347776|P1|STARTED|Overall Study||88
143770|NCT01125722|347786|P2|NOT COMPLETED|Overall Study||1
143771|NCT01125722|347787|P1|NOT COMPLETED|Overall Study||3
143772|NCT01125722|347786|P2|COMPLETED|Overall Study||36
143773|NCT01125722|347787|P1|COMPLETED|Overall Study||34
143774|NCT01125722|347786|P2|STARTED|Overall Study||37
143775|NCT01125722|347787|P1|STARTED|Overall Study||37
143776|NCT01125605|347801|P1|NOT COMPLETED|Overall Study||0
143777|NCT01125605|347801|P1|COMPLETED|Overall Study||325
143778|NCT01125605|347801|P1|Safety|Overall Study|1 patient was only analysed for safety|326
143779|NCT01125605|347801|P1|STARTED|Overall Study|started = had baseline values|325
143780|NCT01125566|347834|P3|NOT COMPLETED|Patients Who Switched From AV to TV||24
143781|NCT01125566|347835|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
143782|NCT01125566|347836|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
143783|NCT01125566|347834|P3|COMPLETED|Patients Who Switched From AV to TV|On TV treatment at analysis cut-off date (03Sep2013)|49
143784|NCT01125566|347835|P2|COMPLETED|Patients Who Switched From AV to TV||0
143785|NCT01125566|347836|P1|COMPLETED|Patients Who Switched From AV to TV||0
143786|NCT01125566|347834|P3|STARTED|Patients Who Switched From AV to TV|All patients without disease progression who chose to switch from AV to TV by 08Jun2013|73
143787|NCT01125566|347835|P2|STARTED|Patients Who Switched From AV to TV||0
143788|NCT01125566|347836|P1|STARTED|Patients Who Switched From AV to TV||0
143789|NCT01125566|347834|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
143790|NCT01125566|347835|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||136
143791|NCT01125566|347836|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||260
143792|NCT01125566|347834|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
143793|NCT01125566|347835|P2|COMPLETED|Patients Before the Switch (26Apr2013)|On treatment at analysis cut-off date (03Sep2013)|33
143794|NCT01125566|347836|P1|COMPLETED|Patients Before the Switch (26Apr2013)|All patients without disease progression who were on treatment on 08Jun2013|79
143795|NCT01125566|347834|P3|STARTED|Patients Before the Switch (26Apr2013)||0
143796|NCT01125566|347835|P2|STARTED|Patients Before the Switch (26Apr2013)|Randomised|169
143797|NCT01125566|347836|P1|STARTED|Patients Before the Switch (26Apr2013)|Randomised|339
143798|NCT01125514|347849|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
143799|NCT01125514|347849|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
143800|NCT01125514|347849|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
143801|NCT01125514|347849|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
143802|NCT01125514|347849|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
143803|NCT01125514|347849|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
143804|NCT01125514|347849|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
143805|NCT01125514|347849|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
143806|NCT01125514|347849|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
143807|NCT01125514|347849|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
143808|NCT01125514|347849|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
143809|NCT01125202|347923|P2|NOT COMPLETED|Overall Study||7
143810|NCT01125202|347924|P1|NOT COMPLETED|Overall Study||12
143811|NCT01125202|347923|P2|COMPLETED|Overall Study||79
143812|NCT01125202|347924|P1|COMPLETED|Overall Study||81
143813|NCT01125202|347923|P2|STARTED|Overall Study||86
143814|NCT01125202|347924|P1|STARTED|Overall Study||93
143815|NCT01125189|347949|P3|NOT COMPLETED|Follow up Period||16
143816|NCT01125189|347950|P2|NOT COMPLETED|Follow up Period||15
143817|NCT01125189|347951|P1|NOT COMPLETED|Follow up Period||20
143818|NCT01125189|347949|P3|COMPLETED|Follow up Period||58
143819|NCT01125189|347950|P2|COMPLETED|Follow up Period||138
143820|NCT01125189|347951|P1|COMPLETED|Follow up Period||132
143821|NCT01125189|347949|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
143822|NCT01125189|347950|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
143823|NCT01125189|347951|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
143824|NCT01125189|347949|P3|NOT COMPLETED|Treatment Period||41
143825|NCT01125189|347950|P2|NOT COMPLETED|Treatment Period||35
143826|NCT01125189|347951|P1|NOT COMPLETED|Treatment Period||31
143827|NCT01125189|347949|P3|COMPLETED|Treatment Period||37
143828|NCT01125189|347950|P2|COMPLETED|Treatment Period||123
143829|NCT01125189|347951|P1|COMPLETED|Treatment Period||128
143830|NCT01125189|347949|P3|STARTED|Treatment Period||78
143831|NCT01125189|347950|P2|STARTED|Treatment Period||158
143832|NCT01125189|347951|P1|STARTED|Treatment Period||159
143833|NCT01125098|347979|P2|NOT COMPLETED|Overall Study||0
143834|NCT01125098|347980|P1|NOT COMPLETED|Overall Study||3
143835|NCT01125098|347979|P2|COMPLETED|Overall Study||90
143836|NCT01125098|347980|P1|COMPLETED|Overall Study||88
143837|NCT01125098|347979|P2|STARTED|Overall Study||90
143838|NCT01125098|347980|P1|STARTED|Overall Study||91
143839|NCT01124955|347988|P2|NOT COMPLETED|Overall Study||0
143840|NCT01124955|347989|P1|NOT COMPLETED|Overall Study||0
143841|NCT01124955|347988|P2|COMPLETED|Overall Study||40
143842|NCT01124955|347989|P1|COMPLETED|Overall Study||40
143843|NCT01124955|347988|P2|STARTED|Overall Study||40
143844|NCT01124955|347989|P1|STARTED|Overall Study||40
143845|NCT01124916|348005|P2|NOT COMPLETED|Overall Study||2
143846|NCT01124916|348006|P1|NOT COMPLETED|Overall Study||3
143847|NCT01124916|348005|P2|COMPLETED|Overall Study||38
143848|NCT01124916|348006|P1|COMPLETED|Overall Study||35
143849|NCT01124916|348005|P2|STARTED|Overall Study||40
143850|NCT01124916|348006|P1|STARTED|Overall Study||38
143851|NCT01124864|348020|P6|NOT COMPLETED|Overall Study||3
143852|NCT01124864|348021|P5|NOT COMPLETED|Overall Study||30
143853|NCT01124864|348022|P4|NOT COMPLETED|Overall Study||21
143854|NCT01124864|348023|P3|NOT COMPLETED|Overall Study||34
143855|NCT01124864|348024|P2|NOT COMPLETED|Overall Study||35
143856|NCT01124864|348025|P1|NOT COMPLETED|Overall Study||28
143857|NCT01124864|348020|P6|COMPLETED|Overall Study||0
143858|NCT01124864|348021|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
143859|NCT01124864|348022|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
143860|NCT01124864|348023|P3|COMPLETED|Overall Study||0
143861|NCT01124864|348024|P2|COMPLETED|Overall Study||0
143862|NCT01124864|348025|P1|COMPLETED|Overall Study||0
143863|NCT01124864|348020|P6|STARTED|Overall Study||3
143864|NCT01124864|348021|P5|STARTED|Overall Study||31
143865|NCT01124864|348022|P4|STARTED|Overall Study||22
143866|NCT01124864|348023|P3|STARTED|Overall Study||34
143867|NCT01124864|348024|P2|STARTED|Overall Study||35
143868|NCT01124864|348025|P1|STARTED|Overall Study||28
143869|NCT01124838|348059|P2|NOT COMPLETED|Overall Study||15
143870|NCT01124838|348060|P1|NOT COMPLETED|Overall Study||18
143871|NCT01124838|348059|P2|COMPLETED|Overall Study||116
143872|NCT01124838|348060|P1|COMPLETED|Overall Study||112
143873|NCT01124838|348059|P2|Enrolled in Japan Sub-study|Overall Study||16
143874|NCT01124838|348060|P1|Enrolled in Japan Sub-study|Overall Study||16
143875|NCT01124838|348059|P2|Enrolled in Main Study|Overall Study||115
143876|NCT01124838|348060|P1|Enrolled in Main Study|Overall Study||114
143877|NCT01124838|348059|P2|STARTED|Overall Study||131
143878|NCT01124838|348060|P1|STARTED|Overall Study||130
143879|NCT01124786|348106|P2|NOT COMPLETED|Overall Study||5
143880|NCT01124786|348107|P1|NOT COMPLETED|Overall Study||4
143881|NCT01124786|348106|P2|COMPLETED|Overall Study||180
143882|NCT01124786|348107|P1|COMPLETED|Overall Study||178
143883|NCT01124786|348106|P2|Tumor Evaluable Population|Overall Study||180
143884|NCT01124786|348107|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
143885|NCT01124786|348106|P2|Safety Population|Overall Study||181
143886|NCT01124786|348107|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
143887|NCT01124786|348106|P2|Intent-to-Treat (ITT) Population|Overall Study||185
143888|NCT01124786|348107|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
143889|NCT01124786|348106|P2|STARTED|Overall Study||185
143890|NCT01124786|348107|P1|STARTED|Overall Study||182
143891|NCT01124643|348127|P1|NOT COMPLETED|Overall Study||1
143892|NCT01124643|348127|P1|COMPLETED|Overall Study||34
143893|NCT01124643|348127|P1|STARTED|Overall Study||35
143894|NCT01124617|348141|P2|NOT COMPLETED|Overall Study||6
143895|NCT01124617|348142|P1|NOT COMPLETED|Overall Study||19
143896|NCT01124617|348141|P2|COMPLETED|Overall Study||25
143897|NCT01124617|348142|P1|COMPLETED|Overall Study||41
143898|NCT01124617|348141|P2|STARTED|Overall Study||31
143899|NCT01124617|348142|P1|STARTED|Overall Study||60
143900|NCT01124604|348174|P2|NOT COMPLETED|Overall Study||2
143901|NCT01124604|348175|P1|NOT COMPLETED|Overall Study||15
143902|NCT01124604|348174|P2|COMPLETED|Overall Study||29
143903|NCT01124604|348175|P1|COMPLETED|Overall Study||45
143904|NCT01124604|348174|P2|STARTED|Overall Study||31
143905|NCT01124604|348175|P1|STARTED|Overall Study||60
143906|NCT01124448|348214|P2|NOT COMPLETED|Overall Study||3
143907|NCT01124448|348215|P1|NOT COMPLETED|Overall Study||2
143908|NCT01124448|348214|P2|COMPLETED|Overall Study||12
143909|NCT01124448|348215|P1|COMPLETED|Overall Study||23
143910|NCT01124448|348214|P2|STARTED|Overall Study||15
143911|NCT01124448|348215|P1|STARTED|Overall Study||25
143912|NCT01124422|348223|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
143913|NCT01124422|348224|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
143914|NCT01124422|348225|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
143915|NCT01124422|348223|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
143916|NCT01124422|348224|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
143917|NCT01124422|348225|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
143918|NCT01124422|348223|P3|STARTED|4-Week Double-blind Treatment Phase||124
143919|NCT01124422|348224|P2|STARTED|4-Week Double-blind Treatment Phase||131
143920|NCT01124422|348225|P1|STARTED|4-Week Double-blind Treatment Phase||0
143921|NCT01124422|348223|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
143922|NCT01124422|348224|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
143923|NCT01124422|348225|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
143924|NCT01124422|348223|P3|COMPLETED|4-Week Open-label Run-in Phase||0
143925|NCT01124422|348224|P2|COMPLETED|4-Week Open-label Run-in Phase||0
143926|NCT01124422|348225|P1|COMPLETED|4-Week Open-label Run-in Phase||255
143927|NCT01124422|348223|P3|STARTED|4-Week Open-label Run-in Phase||0
143928|NCT01124422|348224|P2|STARTED|4-Week Open-label Run-in Phase||0
143929|NCT01124422|348225|P1|STARTED|4-Week Open-label Run-in Phase||338
143930|NCT01124370|348267|P1|NOT COMPLETED|Overall Study||20
143931|NCT01124370|348267|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
143932|NCT01124370|348267|P1|3 Month Visit|Overall Study|Defines evaluable population|47
143933|NCT01124370|348267|P1|Therapy Initiated|Overall Study||48
143934|NCT01124370|348267|P1|Successfully Implanted|Overall Study||50
143935|NCT01124370|348267|P1|STARTED|Overall Study|Underwent implant attempt|57
143936|NCT01124305|348279|P2|NOT COMPLETED|Overall Study||10
143937|NCT01124305|348280|P1|NOT COMPLETED|Overall Study||8
143938|NCT01124305|348279|P2|COMPLETED|Overall Study||26
143939|NCT01124305|348280|P1|COMPLETED|Overall Study||26
143940|NCT01124305|348279|P2|STARTED|Overall Study||36
143941|NCT01124305|348280|P1|STARTED|Overall Study||34
143942|NCT01124292|348295|P3|NOT COMPLETED|Overall Study||10
143943|NCT01124292|348296|P2|NOT COMPLETED|Overall Study||15
143944|NCT01124292|348297|P1|NOT COMPLETED|Overall Study||2
143945|NCT01124292|348295|P3|COMPLETED|Overall Study||11
143946|NCT01124292|348296|P2|COMPLETED|Overall Study||9
143947|NCT01124292|348297|P1|COMPLETED|Overall Study||14
143948|NCT01124292|348295|P3|STARTED|Overall Study||21
143949|NCT01124292|348296|P2|STARTED|Overall Study||24
143950|NCT01124292|348297|P1|STARTED|Overall Study||16
143951|NCT01124188|348355|P2|NOT COMPLETED|Overall Study||6
143952|NCT01124188|348356|P1|NOT COMPLETED|Overall Study||8
143953|NCT01124188|348355|P2|COMPLETED|Overall Study||65
143954|NCT01124188|348356|P1|COMPLETED|Overall Study||60
143955|NCT01124188|348355|P2|STARTED|Overall Study||71
143956|NCT01124188|348356|P1|STARTED|Overall Study||68
143957|NCT01124175|348368|P2|NOT COMPLETED|Second Intervention||0
143958|NCT01124175|348369|P1|NOT COMPLETED|Second Intervention||0
143959|NCT01124175|348368|P2|COMPLETED|Second Intervention||38
143960|NCT01124175|348369|P1|COMPLETED|Second Intervention||40
143961|NCT01124175|348368|P2|STARTED|Second Intervention||38
143962|NCT01124175|348369|P1|STARTED|Second Intervention||40
143963|NCT01124175|348368|P2|NOT COMPLETED|Washout of 7 Days||2
143964|NCT01124175|348369|P1|NOT COMPLETED|Washout of 7 Days||0
143965|NCT01124175|348368|P2|COMPLETED|Washout of 7 Days||38
143966|NCT01124175|348369|P1|COMPLETED|Washout of 7 Days||40
143967|NCT01124175|348368|P2|STARTED|Washout of 7 Days||40
143968|NCT01124175|348369|P1|STARTED|Washout of 7 Days||40
143969|NCT01124175|348368|P2|NOT COMPLETED|First Intervention||0
143970|NCT01124175|348369|P1|NOT COMPLETED|First Intervention||0
143971|NCT01124175|348368|P2|COMPLETED|First Intervention||40
143972|NCT01124175|348369|P1|COMPLETED|First Intervention||40
143973|NCT01124175|348368|P2|STARTED|First Intervention||40
143974|NCT01124175|348369|P1|STARTED|First Intervention||40
143975|NCT01124162|348387|P2|NOT COMPLETED|Second Intervention||0
143976|NCT01124162|348388|P1|NOT COMPLETED|Second Intervention||0
143977|NCT01124162|348387|P2|COMPLETED|Second Intervention||40
143978|NCT01124162|348388|P1|COMPLETED|Second Intervention||37
143979|NCT01124162|348387|P2|STARTED|Second Intervention||40
143980|NCT01124162|348388|P1|STARTED|Second Intervention||37
143981|NCT01124162|348387|P2|NOT COMPLETED|Washout of 7 Days||0
143982|NCT01124162|348388|P1|NOT COMPLETED|Washout of 7 Days||1
143983|NCT01124162|348387|P2|COMPLETED|Washout of 7 Days||40
143984|NCT01124162|348388|P1|COMPLETED|Washout of 7 Days||37
143985|NCT01124162|348387|P2|STARTED|Washout of 7 Days||40
143986|NCT01124162|348388|P1|STARTED|Washout of 7 Days||38
143987|NCT01124162|348387|P2|NOT COMPLETED|First Intervention||0
143988|NCT01124162|348388|P1|NOT COMPLETED|First Intervention||2
143989|NCT01124162|348387|P2|COMPLETED|First Intervention||40
143990|NCT01124162|348388|P1|COMPLETED|First Intervention||38
143991|NCT01124162|348387|P2|STARTED|First Intervention||40
143992|NCT01124162|348388|P1|STARTED|First Intervention||40
143993|NCT01124149|348404|P1|NOT COMPLETED|Maintenance Phase||96
143994|NCT01124149|348404|P1|COMPLETED|Maintenance Phase||373
143995|NCT01124149|348404|P1|STARTED|Maintenance Phase||469
143996|NCT01124149|348404|P1|NOT COMPLETED|Acute Phase||83
143997|NCT01124149|348404|P1|COMPLETED|Acute Phase||639
143998|NCT01124149|348404|P1|STARTED|Acute Phase||722
143999|NCT01124097|348424|P4|NOT COMPLETED|Overall Study||14
144000|NCT01124097|348425|P3|NOT COMPLETED|Overall Study||20
144001|NCT01124097|348426|P2|NOT COMPLETED|Overall Study||22
144002|NCT01124097|348427|P1|NOT COMPLETED|Overall Study||34
144003|NCT01124097|348424|P4|COMPLETED|Overall Study||46
144004|NCT01124097|348425|P3|COMPLETED|Overall Study||40
144005|NCT01124097|348426|P2|COMPLETED|Overall Study||38
144006|NCT01124097|348427|P1|COMPLETED|Overall Study||26
144007|NCT01124097|348424|P4|Efficacy Population|Overall Study||51
144008|NCT01124097|348425|P3|Efficacy Population|Overall Study||53
144009|NCT01124097|348426|P2|Efficacy Population|Overall Study||53
144010|NCT01124097|348427|P1|Efficacy Population|Overall Study||52
144011|NCT01124097|348424|P4|Safety Population|Overall Study||60
144012|NCT01124097|348425|P3|Safety Population|Overall Study||60
144013|NCT01124097|348426|P2|Safety Population|Overall Study||60
144014|NCT01124097|348427|P1|Safety Population|Overall Study||60
144015|NCT01124097|348424|P4|STARTED|Overall Study||60
144016|NCT01124097|348425|P3|STARTED|Overall Study||60
144017|NCT01124097|348426|P2|STARTED|Overall Study||60
144018|NCT01124097|348427|P1|STARTED|Overall Study||60
144019|NCT01124045|348439|P2|NOT COMPLETED|Overall Study||3
144020|NCT01124045|348440|P1|NOT COMPLETED|Overall Study||0
144021|NCT01124045|348439|P2|COMPLETED|Overall Study||37
144022|NCT01124045|348440|P1|COMPLETED|Overall Study||39
144023|NCT01124045|348439|P2|STARTED|Overall Study||40
144024|NCT01124045|348440|P1|STARTED|Overall Study||39
144025|NCT01124006|348473|P3|NOT COMPLETED|Overall Study||2
144026|NCT01124006|348474|P2|NOT COMPLETED|Overall Study||2
144027|NCT01124006|348475|P1|NOT COMPLETED|Overall Study||3
144028|NCT01124006|348473|P3|COMPLETED|Overall Study||2
144029|NCT01124006|348474|P2|COMPLETED|Overall Study||8
144030|NCT01124006|348475|P1|COMPLETED|Overall Study||7
144031|NCT01124006|348473|P3|STARTED|Overall Study||4
144032|NCT01124006|348474|P2|STARTED|Overall Study||10
144033|NCT01124006|348475|P1|STARTED|Overall Study||10
144034|NCT01123980|348503|P2|NOT COMPLETED|Overall Study||24
144035|NCT01123980|348504|P1|NOT COMPLETED|Overall Study||19
144036|NCT01123980|348503|P2|COMPLETED|Overall Study||236
144037|NCT01123980|348504|P1|COMPLETED|Overall Study||242
144038|NCT01123980|348503|P2|STARTED|Overall Study||260
144039|NCT01123980|348504|P1|STARTED|Overall Study||261
144040|NCT01123941|348524|P2|NOT COMPLETED|Overall Study||1
144041|NCT01123941|348525|P1|NOT COMPLETED|Overall Study||2
144042|NCT01123941|348524|P2|COMPLETED|Overall Study||24
144043|NCT01123941|348525|P1|COMPLETED|Overall Study||23
144044|NCT01123941|348524|P2|STARTED|Overall Study||25
144045|NCT01123941|348525|P1|STARTED|Overall Study||25
144046|NCT01123928|348539|P2|NOT COMPLETED|Overall Study||0
144047|NCT01123928|348540|P1|NOT COMPLETED|Overall Study||0
144048|NCT01123928|348539|P2|COMPLETED|Overall Study||222
144049|NCT01123928|348540|P1|COMPLETED|Overall Study||212
144050|NCT01123928|348539|P2|STARTED|Overall Study||222
144051|NCT01123928|348540|P1|STARTED|Overall Study||212
144052|NCT01123889|348560|P2|NOT COMPLETED|Overall Study||1
144053|NCT01123889|348561|P1|NOT COMPLETED|Overall Study||3
144054|NCT01123889|348560|P2|COMPLETED|Overall Study||6
144055|NCT01123889|348561|P1|COMPLETED|Overall Study||2
144056|NCT01123889|348560|P2|STARTED|Overall Study||7
144057|NCT01123889|348561|P1|STARTED|Overall Study||5
144058|NCT01123850|348571|P1|NOT COMPLETED|Overall Study||45
144059|NCT01123850|348571|P1|COMPLETED|Overall Study||0
144060|NCT01123850|348571|P1|STARTED|Overall Study||45
144061|NCT01123642|348576|P1|NOT COMPLETED|Overall Study||68
144062|NCT01123642|348576|P1|COMPLETED|Overall Study||277
144063|NCT01123642|348576|P1|STARTED|Overall Study||345
144064|NCT01123512|348582|P2|NOT COMPLETED|Overall Study||21
144065|NCT01123512|348583|P1|NOT COMPLETED|Overall Study||26
144066|NCT01123512|348582|P2|COMPLETED|Overall Study||126
144067|NCT01123512|348583|P1|COMPLETED|Overall Study||127
144068|NCT01123512|348582|P2|STARTED|Overall Study||147
144069|NCT01123512|348583|P1|STARTED|Overall Study||153
144070|NCT01123395|348589|P2|NOT COMPLETED|Period 2||0
144071|NCT01123395|348590|P1|NOT COMPLETED|Period 2||0
144072|NCT01123395|348589|P2|COMPLETED|Period 2||7
144073|NCT01123395|348590|P1|COMPLETED|Period 2||8
144074|NCT01123395|348589|P2|STARTED|Period 2||7
144075|NCT01123395|348590|P1|STARTED|Period 2||8
144076|NCT01123395|348589|P2|NOT COMPLETED|Washout Period of 14 Days||1
144077|NCT01123395|348590|P1|NOT COMPLETED|Washout Period of 14 Days||0
144078|NCT01123395|348589|P2|COMPLETED|Washout Period of 14 Days||7
144079|NCT01123395|348590|P1|COMPLETED|Washout Period of 14 Days||8
144080|NCT01123395|348589|P2|STARTED|Washout Period of 14 Days||8
144081|NCT01123395|348590|P1|STARTED|Washout Period of 14 Days||8
144082|NCT01123395|348589|P2|NOT COMPLETED|Period 1||0
144083|NCT01123395|348590|P1|NOT COMPLETED|Period 1||0
144084|NCT01123395|348589|P2|COMPLETED|Period 1||8
144085|NCT01123395|348590|P1|COMPLETED|Period 1||8
144086|NCT01123395|348589|P2|STARTED|Period 1||8
144087|NCT01123395|348590|P1|STARTED|Period 1||8
144088|NCT01123382|348602|P2|NOT COMPLETED|Overall Study||6
144089|NCT01123382|348603|P1|NOT COMPLETED|Overall Study||2
144090|NCT01123382|348602|P2|COMPLETED|Overall Study||6
144091|NCT01123382|348603|P1|COMPLETED|Overall Study||11
144092|NCT01123382|348602|P2|Received Intervention|Overall Study||10
144093|NCT01123382|348603|P1|Received Intervention|Overall Study||12
144094|NCT01123382|348602|P2|STARTED|Overall Study||12
144095|NCT01123382|348603|P1|STARTED|Overall Study||13
144096|NCT01123356|348625|P1|NOT COMPLETED|Overall Study||7
144097|NCT01123356|348625|P1|COMPLETED|Overall Study||14
144098|NCT01123356|348625|P1|STARTED|Overall Study||21
144099|NCT01123200|348633|P1|NOT COMPLETED|Overall Study||1
144100|NCT01123200|348633|P1|COMPLETED|Overall Study||0
144101|NCT01123200|348633|P1|STARTED|Overall Study||1
144102|NCT01123161|348640|P2|NOT COMPLETED|Overall Study||0
144103|NCT01123161|348641|P1|NOT COMPLETED|Overall Study||2
144104|NCT01123161|348640|P2|COMPLETED|Overall Study||63
144105|NCT01123161|348641|P1|COMPLETED|Overall Study||55
144106|NCT01123161|348640|P2|STARTED|Overall Study||63
144107|NCT01123161|348641|P1|STARTED|Overall Study||57
144108|NCT01123148|348659|P1|NOT COMPLETED|Overall Study||2
144109|NCT01123148|348659|P1|COMPLETED|Overall Study||12
144110|NCT01123148|348659|P1|BCI Calibration >50% Accuracy|Overall Study||13
144111|NCT01123148|348659|P1|STARTED|Overall Study||14
144112|NCT01123083|348665|P2|NOT COMPLETED|Overall Study||15
144113|NCT01123083|348666|P1|NOT COMPLETED|Overall Study||11
144114|NCT01123083|348665|P2|COMPLETED|Overall Study||103
144115|NCT01123083|348666|P1|COMPLETED|Overall Study||50
144116|NCT01123083|348665|P2|STARTED|Overall Study||118
144117|NCT01123083|348666|P1|STARTED|Overall Study||61
144118|NCT01122927|348690|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
144119|NCT01122927|348691|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
144120|NCT01122927|348690|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
144121|NCT01122927|348691|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
144122|NCT01122927|348690|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
144123|NCT01122927|348691|P1|STARTED|Period 2- Open-label Treatment Phase||0
144124|NCT01122927|348690|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
144125|NCT01122927|348691|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
144126|NCT01122927|348690|P2|COMPLETED|Period 1 - Conversion Phase||0
144127|NCT01122927|348691|P1|COMPLETED|Period 1 - Conversion Phase||283
144128|NCT01122927|348690|P2|STARTED|Period 1 - Conversion Phase||0
144129|NCT01122927|348691|P1|STARTED|Period 1 - Conversion Phase||297
144130|NCT01122901|348724|P2|NOT COMPLETED|Overall Study||0
144131|NCT01122901|348725|P1|NOT COMPLETED|Overall Study||0
144132|NCT01122901|348724|P2|COMPLETED|Overall Study||7
144133|NCT01122901|348725|P1|COMPLETED|Overall Study||40
144134|NCT01122901|348724|P2|STARTED|Overall Study||7
144135|NCT01122901|348725|P1|STARTED|Overall Study||40
144136|NCT01122862|348743|P3|NOT COMPLETED|Period 3||0
144137|NCT01122862|348744|P2|NOT COMPLETED|Period 3||0
144138|NCT01122862|348745|P1|NOT COMPLETED|Period 3||0
144139|NCT01122862|348743|P3|COMPLETED|Period 3||8
144140|NCT01122862|348744|P2|COMPLETED|Period 3||7
144141|NCT01122862|348745|P1|COMPLETED|Period 3||6
144142|NCT01122862|348743|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
144143|NCT01122862|348744|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
144144|NCT01122862|348745|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
144145|NCT01122862|348743|P3|NOT COMPLETED|Period 2||1
144146|NCT01122862|348744|P2|NOT COMPLETED|Period 2||0
144147|NCT01122862|348745|P1|NOT COMPLETED|Period 2||0
144148|NCT01122862|348743|P3|COMPLETED|Period 2||6
144149|NCT01122862|348744|P2|COMPLETED|Period 2||7
144150|NCT01122862|348745|P1|COMPLETED|Period 2||8
144151|NCT01122862|348743|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
144152|NCT01122862|348744|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
144153|NCT01122862|348745|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
144154|NCT01122862|348743|P3|NOT COMPLETED|Period 1||0
144155|NCT01122862|348744|P2|NOT COMPLETED|Period 1||1
144156|NCT01122862|348745|P1|NOT COMPLETED|Period 1||0
144157|NCT01122862|348743|P3|COMPLETED|Period 1||7
144158|NCT01122862|348744|P2|COMPLETED|Period 1||7
144159|NCT01122862|348745|P1|COMPLETED|Period 1||8
144160|NCT01122862|348743|P3|STARTED|Period 1||7
144161|NCT01122862|348744|P2|STARTED|Period 1||8
144162|NCT01122862|348745|P1|STARTED|Period 1||8
144163|NCT01122849|348766|P3|NOT COMPLETED|Overall Study||0
144164|NCT01122849|348767|P2|NOT COMPLETED|Overall Study||0
144165|NCT01122849|348768|P1|NOT COMPLETED|Overall Study||0
144166|NCT01122849|348766|P3|COMPLETED|Overall Study||20
144167|NCT01122849|348767|P2|COMPLETED|Overall Study||21
144168|NCT01122849|348768|P1|COMPLETED|Overall Study||20
144169|NCT01122849|348766|P3|STARTED|Overall Study||20
144170|NCT01122849|348767|P2|STARTED|Overall Study||21
144171|NCT01122849|348768|P1|STARTED|Overall Study||20
144172|NCT01122680|348851|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
144173|NCT01122680|348852|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
144174|NCT01122680|348853|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
144175|NCT01122680|348854|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
144176|NCT01122680|348851|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
144177|NCT01122680|348852|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
144178|NCT01122680|348853|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
144179|NCT01122680|348854|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
144180|NCT01122680|348851|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
144181|NCT01122680|348852|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
144182|NCT01122680|348853|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
144183|NCT01122680|348854|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
144184|NCT01122680|348851|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
144185|NCT01122680|348852|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
144186|NCT01122680|348853|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
144187|NCT01122680|348854|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
144188|NCT01122680|348851|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
144189|NCT01122680|348852|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
144190|NCT01122680|348853|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
144191|NCT01122680|348854|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
144192|NCT01122680|348851|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
144193|NCT01122680|348852|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
144194|NCT01122680|348853|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
144195|NCT01122680|348854|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
144196|NCT01122680|348851|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
144197|NCT01122680|348852|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
144198|NCT01122680|348853|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
144199|NCT01122680|348854|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
144200|NCT01122680|348851|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
144201|NCT01122680|348852|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
144202|NCT01122680|348853|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
144203|NCT01122680|348854|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
144204|NCT01122680|348851|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
144205|NCT01122680|348852|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
144206|NCT01122680|348853|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
144207|NCT01122680|348854|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
144208|NCT01122576|348919|P3|NOT COMPLETED|Post-Cataract Surgery||2
144209|NCT01122576|348920|P2|NOT COMPLETED|Post-Cataract Surgery||0
144210|NCT01122576|348921|P1|NOT COMPLETED|Post-Cataract Surgery||0
144211|NCT01122576|348919|P3|COMPLETED|Post-Cataract Surgery||22
144212|NCT01122576|348920|P2|COMPLETED|Post-Cataract Surgery||25
144213|NCT01122576|348921|P1|COMPLETED|Post-Cataract Surgery||26
144214|NCT01122576|348919|P3|STARTED|Post-Cataract Surgery||24
144215|NCT01122576|348920|P2|STARTED|Post-Cataract Surgery||25
144216|NCT01122576|348921|P1|STARTED|Post-Cataract Surgery||26
144217|NCT01122576|348919|P3|NOT COMPLETED|Pre-Cataract Surgery||2
144218|NCT01122576|348920|P2|NOT COMPLETED|Pre-Cataract Surgery||1
144219|NCT01122576|348921|P1|NOT COMPLETED|Pre-Cataract Surgery||0
144220|NCT01122576|348919|P3|COMPLETED|Pre-Cataract Surgery||24
144221|NCT01122576|348920|P2|COMPLETED|Pre-Cataract Surgery||25
144222|NCT01122576|348921|P1|COMPLETED|Pre-Cataract Surgery||26
144223|NCT01122576|348919|P3|STARTED|Pre-Cataract Surgery||26
144224|NCT01122576|348920|P2|STARTED|Pre-Cataract Surgery||26
144225|NCT01122576|348921|P1|STARTED|Pre-Cataract Surgery||26
144226|NCT01122511|349060|P2|NOT COMPLETED|Overall Study||2
144227|NCT01122511|349061|P1|NOT COMPLETED|Overall Study||2
144228|NCT01122511|349060|P2|COMPLETED|Overall Study||0
144229|NCT01122511|349061|P1|COMPLETED|Overall Study||0
144230|NCT01122511|349060|P2|STARTED|Overall Study||2
144231|NCT01122511|349061|P1|STARTED|Overall Study||2
144232|NCT01122394|349075|P2|NOT COMPLETED|Overall Study||4
144233|NCT01122394|349076|P1|NOT COMPLETED|Overall Study||3
144234|NCT01122394|349075|P2|COMPLETED|Overall Study||70
144235|NCT01122394|349076|P1|COMPLETED|Overall Study||63
144236|NCT01122394|349075|P2|STARTED|Overall Study||74
144237|NCT01122394|349076|P1|STARTED|Overall Study||66
144238|NCT01122381|349092|P2|NOT COMPLETED|Overall Study||1
144239|NCT01122381|349093|P1|NOT COMPLETED|Overall Study||0
144240|NCT01122381|349092|P2|COMPLETED|Overall Study||0
144241|NCT01122381|349093|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
144242|NCT01122381|349092|P2|STARTED|Overall Study||1
144243|NCT01122381|349093|P1|STARTED|Overall Study||1
144244|NCT01122264|349102|P3|NOT COMPLETED|Overall Study||47
144245|NCT01122264|349103|P2|NOT COMPLETED|Overall Study||29
144246|NCT01122264|349104|P1|NOT COMPLETED|Overall Study||32
144247|NCT01122264|349102|P3|COMPLETED|Overall Study||214
144248|NCT01122264|349103|P2|COMPLETED|Overall Study||228
144249|NCT01122264|349104|P1|COMPLETED|Overall Study||220
144250|NCT01122264|349102|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
144251|NCT01122264|349103|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
144252|NCT01122264|349104|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
144253|NCT01122264|349102|P3|STARTED|Overall Study||261
144254|NCT01122264|349103|P2|STARTED|Overall Study||257
144255|NCT01122264|349104|P1|STARTED|Overall Study||252
144256|NCT01122238|349177|P16|NOT COMPLETED|Overall Study||0
144257|NCT01122238|349178|P15|NOT COMPLETED|Overall Study||0
144258|NCT01122238|349179|P14|NOT COMPLETED|Overall Study||1
144259|NCT01122238|349180|P13|NOT COMPLETED|Overall Study||2
144260|NCT01122238|349181|P12|NOT COMPLETED|Overall Study||2
144261|NCT01122238|349182|P11|NOT COMPLETED|Overall Study||0
144262|NCT01122238|349183|P10|NOT COMPLETED|Overall Study||1
144263|NCT01122238|349184|P9|NOT COMPLETED|Overall Study||1
144264|NCT01122238|349185|P8|NOT COMPLETED|Overall Study||0
144265|NCT01122238|349186|P7|NOT COMPLETED|Overall Study||1
144266|NCT01122238|349187|P6|NOT COMPLETED|Overall Study||1
144267|NCT01122238|349188|P5|NOT COMPLETED|Overall Study||0
144268|NCT01122238|349189|P4|NOT COMPLETED|Overall Study||0
144269|NCT01122238|349190|P3|NOT COMPLETED|Overall Study||5
144270|NCT01122238|349191|P2|NOT COMPLETED|Overall Study||1
144271|NCT01122238|349192|P1|NOT COMPLETED|Overall Study||2
144272|NCT01122238|349177|P16|COMPLETED|Overall Study||31
144273|NCT01122238|349178|P15|COMPLETED|Overall Study||28
144274|NCT01122238|349179|P14|COMPLETED|Overall Study||31
144275|NCT01122238|349180|P13|COMPLETED|Overall Study||28
144276|NCT01122238|349181|P12|COMPLETED|Overall Study||31
144277|NCT01122238|349182|P11|COMPLETED|Overall Study||32
144278|NCT01122238|349183|P10|COMPLETED|Overall Study||33
144279|NCT01122238|349184|P9|COMPLETED|Overall Study||31
144280|NCT01122238|349185|P8|COMPLETED|Overall Study||32
144281|NCT01122238|349186|P7|COMPLETED|Overall Study||34
144282|NCT01122238|349187|P6|COMPLETED|Overall Study||31
144283|NCT01122238|349188|P5|COMPLETED|Overall Study||33
144284|NCT01122238|349189|P4|COMPLETED|Overall Study||33
144285|NCT01122238|349190|P3|COMPLETED|Overall Study||28
144286|NCT01122238|349191|P2|COMPLETED|Overall Study||36
144287|NCT01122238|349192|P1|COMPLETED|Overall Study||28
144288|NCT01122238|349177|P16|STARTED|Overall Study||31
144289|NCT01122238|349178|P15|STARTED|Overall Study||28
144290|NCT01122238|349179|P14|STARTED|Overall Study||32
144291|NCT01122238|349180|P13|STARTED|Overall Study||30
144292|NCT01122238|349181|P12|STARTED|Overall Study||33
144293|NCT01122238|349182|P11|STARTED|Overall Study||32
144294|NCT01122238|349183|P10|STARTED|Overall Study||34
144295|NCT01122238|349184|P9|STARTED|Overall Study||32
144296|NCT01122238|349185|P8|STARTED|Overall Study||32
144297|NCT01122238|349186|P7|STARTED|Overall Study||35
144298|NCT01122238|349187|P6|STARTED|Overall Study||32
144299|NCT01122238|349188|P5|STARTED|Overall Study||33
144300|NCT01122238|349189|P4|STARTED|Overall Study||33
144301|NCT01122238|349190|P3|STARTED|Overall Study||33
144302|NCT01122238|349191|P2|STARTED|Overall Study||37
144303|NCT01122238|349192|P1|STARTED|Overall Study||30
144304|NCT01122160|349214|P2|NOT COMPLETED|Second Intervention (7 Days)||0
144305|NCT01122160|349215|P1|NOT COMPLETED|Second Intervention (7 Days)||0
144306|NCT01122160|349214|P2|COMPLETED|Second Intervention (7 Days)||5
144307|NCT01122160|349215|P1|COMPLETED|Second Intervention (7 Days)||6
144308|NCT01122160|349214|P2|STARTED|Second Intervention (7 Days)||5
144309|NCT01122160|349215|P1|STARTED|Second Intervention (7 Days)||6
144310|NCT01122160|349214|P2|NOT COMPLETED|Washout (7-14 Days)||0
144311|NCT01122160|349215|P1|NOT COMPLETED|Washout (7-14 Days)||0
144312|NCT01122160|349214|P2|COMPLETED|Washout (7-14 Days)||5
144313|NCT01122160|349215|P1|COMPLETED|Washout (7-14 Days)||6
144314|NCT01122160|349214|P2|STARTED|Washout (7-14 Days)||5
144315|NCT01122160|349215|P1|STARTED|Washout (7-14 Days)||6
144316|NCT01122160|349214|P2|NOT COMPLETED|First Intervention (7 Days)||0
144317|NCT01122160|349215|P1|NOT COMPLETED|First Intervention (7 Days)||0
144318|NCT01122160|349214|P2|COMPLETED|First Intervention (7 Days)||5
144319|NCT01122160|349215|P1|COMPLETED|First Intervention (7 Days)||6
144320|NCT01122160|349214|P2|STARTED|First Intervention (7 Days)||5
144321|NCT01122160|349215|P1|STARTED|First Intervention (7 Days)||6
144322|NCT01122108|349221|P2|NOT COMPLETED|Overall Study||0
144323|NCT01122108|349222|P1|NOT COMPLETED|Overall Study||0
144324|NCT01122108|349221|P2|COMPLETED|Overall Study||21
144325|NCT01122108|349222|P1|COMPLETED|Overall Study||21
144326|NCT01122108|349221|P2|STARTED|Overall Study||21
144327|NCT01122108|349222|P1|STARTED|Overall Study||21
144328|NCT01122030|349238|P7|NOT COMPLETED|Overall Study||0
144329|NCT01122030|349239|P6|NOT COMPLETED|Overall Study||0
144330|NCT01122030|349240|P5|NOT COMPLETED|Overall Study||0
144331|NCT01122030|349241|P4|NOT COMPLETED|Overall Study||0
144332|NCT01122030|349242|P3|NOT COMPLETED|Overall Study||0
144333|NCT01122030|349243|P2|NOT COMPLETED|Overall Study||0
144334|NCT01122030|349244|P1|NOT COMPLETED|Overall Study||0
144335|NCT01122030|349238|P7|COMPLETED|Overall Study||9
144336|NCT01122030|349239|P6|COMPLETED|Overall Study||9
144337|NCT01122030|349240|P5|COMPLETED|Overall Study||9
144338|NCT01122030|349241|P4|COMPLETED|Overall Study||9
144339|NCT01122030|349242|P3|COMPLETED|Overall Study||9
144340|NCT01122030|349243|P2|COMPLETED|Overall Study||9
144341|NCT01122030|349244|P1|COMPLETED|Overall Study||18
144342|NCT01122030|349238|P7|Received Treatment|Overall Study||9
144343|NCT01122030|349239|P6|Received Treatment|Overall Study||9
144344|NCT01122030|349240|P5|Received Treatment|Overall Study||9
144345|NCT01122030|349241|P4|Received Treatment|Overall Study||9
144346|NCT01122030|349242|P3|Received Treatment|Overall Study||9
144347|NCT01122030|349243|P2|Received Treatment|Overall Study||9
144348|NCT01122030|349244|P1|Received Treatment|Overall Study||18
144349|NCT01122030|349238|P7|STARTED|Overall Study||9
144350|NCT01122030|349239|P6|STARTED|Overall Study||9
144351|NCT01122030|349240|P5|STARTED|Overall Study||9
144352|NCT01122030|349241|P4|STARTED|Overall Study||9
144353|NCT01122030|349242|P3|STARTED|Overall Study||9
144354|NCT01122030|349243|P2|STARTED|Overall Study||9
144355|NCT01122030|349244|P1|STARTED|Overall Study||18
144356|NCT01121991|349430|P1|NOT COMPLETED|Overall Study||6
144357|NCT01121991|349430|P1|COMPLETED|Overall Study||46
144358|NCT01121991|349430|P1|STARTED|Overall Study|Number of participants treated|52
144359|NCT01121939|349441|P1|NOT COMPLETED|Overall Study||43
144360|NCT01121939|349441|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
144361|NCT01121939|349441|P1|STARTED|Overall Study||43
144362|NCT01121926|349455|P2|NOT COMPLETED|Second Intervention Period||0
144363|NCT01121926|349456|P1|NOT COMPLETED|Second Intervention Period||0
144364|NCT01121926|349455|P2|COMPLETED|Second Intervention Period||13
144365|NCT01121926|349456|P1|COMPLETED|Second Intervention Period||14
144366|NCT01121926|349455|P2|STARTED|Second Intervention Period||13
144367|NCT01121926|349456|P1|STARTED|Second Intervention Period||14
144368|NCT01121926|349455|P2|NOT COMPLETED|Washout Period||2
144369|NCT01121926|349456|P1|NOT COMPLETED|Washout Period||0
144370|NCT01121926|349455|P2|COMPLETED|Washout Period||13
144371|NCT01121926|349456|P1|COMPLETED|Washout Period||14
144372|NCT01121926|349455|P2|STARTED|Washout Period||15
144373|NCT01121926|349456|P1|STARTED|Washout Period||14
144374|NCT01121926|349455|P2|NOT COMPLETED|First Intervention Period||0
144375|NCT01121926|349456|P1|NOT COMPLETED|First Intervention Period||1
144376|NCT01121926|349455|P2|COMPLETED|First Intervention Period||15
144377|NCT01121926|349456|P1|COMPLETED|First Intervention Period||14
144378|NCT01121926|349455|P2|STARTED|First Intervention Period||15
144379|NCT01121926|349456|P1|STARTED|First Intervention Period||15
144380|NCT01121913|349474|P4|NOT COMPLETED|Fourth Intervention Period||0
144381|NCT01121913|349475|P3|NOT COMPLETED|Fourth Intervention Period||0
144382|NCT01121913|349476|P2|NOT COMPLETED|Fourth Intervention Period||0
144383|NCT01121913|349477|P1|NOT COMPLETED|Fourth Intervention Period||0
144384|NCT01121913|349474|P4|COMPLETED|Fourth Intervention Period||6
144385|NCT01121913|349475|P3|COMPLETED|Fourth Intervention Period||3
144386|NCT01121913|349476|P2|COMPLETED|Fourth Intervention Period||6
144387|NCT01121913|349477|P1|COMPLETED|Fourth Intervention Period||4
144388|NCT01121913|349474|P4|STARTED|Fourth Intervention Period||6
144389|NCT01121913|349475|P3|STARTED|Fourth Intervention Period||3
144390|NCT01121913|349476|P2|STARTED|Fourth Intervention Period||6
144391|NCT01121913|349477|P1|STARTED|Fourth Intervention Period||4
144392|NCT01121913|349474|P4|NOT COMPLETED|Third Washout Period||0
144393|NCT01121913|349475|P3|NOT COMPLETED|Third Washout Period||0
144394|NCT01121913|349476|P2|NOT COMPLETED|Third Washout Period||0
144395|NCT01121913|349477|P1|NOT COMPLETED|Third Washout Period||1
144396|NCT01121913|349474|P4|COMPLETED|Third Washout Period||6
144397|NCT01121913|349475|P3|COMPLETED|Third Washout Period||3
144398|NCT01121913|349476|P2|COMPLETED|Third Washout Period||6
144399|NCT01121913|349477|P1|COMPLETED|Third Washout Period||4
144400|NCT01121913|349474|P4|STARTED|Third Washout Period||6
144401|NCT01121913|349475|P3|STARTED|Third Washout Period||3
144402|NCT01121913|349476|P2|STARTED|Third Washout Period||6
144403|NCT01121913|349477|P1|STARTED|Third Washout Period||5
144404|NCT01121913|349474|P4|NOT COMPLETED|Third Intervention Period||0
144405|NCT01121913|349475|P3|NOT COMPLETED|Third Intervention Period||0
144406|NCT01121913|349476|P2|NOT COMPLETED|Third Intervention Period||0
144407|NCT01121913|349477|P1|NOT COMPLETED|Third Intervention Period||0
144408|NCT01121913|349474|P4|COMPLETED|Third Intervention Period||6
144409|NCT01121913|349475|P3|COMPLETED|Third Intervention Period||3
144410|NCT01121913|349476|P2|COMPLETED|Third Intervention Period||6
144411|NCT01121913|349477|P1|COMPLETED|Third Intervention Period||5
144412|NCT01121913|349474|P4|STARTED|Third Intervention Period||6
144413|NCT01121913|349475|P3|STARTED|Third Intervention Period||3
144414|NCT01121913|349476|P2|STARTED|Third Intervention Period||6
144415|NCT01121913|349477|P1|STARTED|Third Intervention Period||5
144416|NCT01121913|349474|P4|NOT COMPLETED|Second Washout Period||0
144417|NCT01121913|349475|P3|NOT COMPLETED|Second Washout Period||1
144418|NCT01121913|349476|P2|NOT COMPLETED|Second Washout Period||0
144419|NCT01121913|349477|P1|NOT COMPLETED|Second Washout Period||0
144420|NCT01121913|349474|P4|COMPLETED|Second Washout Period||6
144421|NCT01121913|349475|P3|COMPLETED|Second Washout Period||3
144422|NCT01121913|349476|P2|COMPLETED|Second Washout Period||6
144423|NCT01121913|349477|P1|COMPLETED|Second Washout Period||5
144424|NCT01121913|349474|P4|STARTED|Second Washout Period||6
144425|NCT01121913|349475|P3|STARTED|Second Washout Period||4
144426|NCT01121913|349476|P2|STARTED|Second Washout Period||6
144427|NCT01121913|349477|P1|STARTED|Second Washout Period||5
144428|NCT01121913|349474|P4|NOT COMPLETED|Second Intervention Period||0
144429|NCT01121913|349475|P3|NOT COMPLETED|Second Intervention Period||1
144430|NCT01121913|349476|P2|NOT COMPLETED|Second Intervention Period||0
144431|NCT01121913|349477|P1|NOT COMPLETED|Second Intervention Period||0
144432|NCT01121913|349474|P4|COMPLETED|Second Intervention Period||6
144433|NCT01121913|349475|P3|COMPLETED|Second Intervention Period||4
144434|NCT01121913|349476|P2|COMPLETED|Second Intervention Period||6
144435|NCT01121913|349477|P1|COMPLETED|Second Intervention Period||5
144436|NCT01121913|349474|P4|STARTED|Second Intervention Period||6
144437|NCT01121913|349475|P3|STARTED|Second Intervention Period||5
144438|NCT01121913|349476|P2|STARTED|Second Intervention Period||6
144439|NCT01121913|349477|P1|STARTED|Second Intervention Period||5
144440|NCT01121913|349474|P4|NOT COMPLETED|First Washout Period||0
144441|NCT01121913|349475|P3|NOT COMPLETED|First Washout Period||0
144442|NCT01121913|349476|P2|NOT COMPLETED|First Washout Period||0
144443|NCT01121913|349477|P1|NOT COMPLETED|First Washout Period||1
144444|NCT01121913|349474|P4|COMPLETED|First Washout Period||6
144445|NCT01121913|349475|P3|COMPLETED|First Washout Period||5
144446|NCT01121913|349476|P2|COMPLETED|First Washout Period||6
144447|NCT01121913|349477|P1|COMPLETED|First Washout Period||5
144448|NCT01121913|349474|P4|STARTED|First Washout Period||6
144449|NCT01121913|349475|P3|STARTED|First Washout Period||5
144450|NCT01121913|349476|P2|STARTED|First Washout Period||6
144451|NCT01121913|349477|P1|STARTED|First Washout Period||6
144452|NCT01121913|349474|P4|NOT COMPLETED|First Intervention Period||0
144453|NCT01121913|349475|P3|NOT COMPLETED|First Intervention Period||1
144454|NCT01121913|349476|P2|NOT COMPLETED|First Intervention Period||0
144455|NCT01121913|349477|P1|NOT COMPLETED|First Intervention Period||0
144456|NCT01121913|349474|P4|COMPLETED|First Intervention Period||6
144457|NCT01121913|349475|P3|COMPLETED|First Intervention Period||5
144458|NCT01121913|349476|P2|COMPLETED|First Intervention Period||6
144459|NCT01121913|349477|P1|COMPLETED|First Intervention Period||6
144460|NCT01121913|349474|P4|STARTED|First Intervention Period||6
144461|NCT01121913|349475|P3|STARTED|First Intervention Period||6
144462|NCT01121913|349476|P2|STARTED|First Intervention Period||6
144463|NCT01121913|349477|P1|STARTED|First Intervention Period||6
144464|NCT01121900|349507|P2|NOT COMPLETED|Second Intervention Period||0
144465|NCT01121900|349508|P1|NOT COMPLETED|Second Intervention Period||0
144466|NCT01121900|349507|P2|COMPLETED|Second Intervention Period||11
144467|NCT01121900|349508|P1|COMPLETED|Second Intervention Period||12
144468|NCT01121900|349507|P2|STARTED|Second Intervention Period||11
144469|NCT01121900|349508|P1|STARTED|Second Intervention Period||12
144470|NCT01121900|349507|P2|NOT COMPLETED|Washout Period of 7 Days||1
144471|NCT01121900|349508|P1|NOT COMPLETED|Washout Period of 7 Days||0
144472|NCT01121900|349507|P2|COMPLETED|Washout Period of 7 Days||11
144473|NCT01121900|349508|P1|COMPLETED|Washout Period of 7 Days||12
144474|NCT01121900|349507|P2|STARTED|Washout Period of 7 Days||12
144475|NCT01121900|349508|P1|STARTED|Washout Period of 7 Days||12
144476|NCT01121900|349507|P2|NOT COMPLETED|First Intervention Period||1
144477|NCT01121900|349508|P1|NOT COMPLETED|First Intervention Period||1
144478|NCT01121900|349507|P2|COMPLETED|First Intervention Period||12
144479|NCT01121900|349508|P1|COMPLETED|First Intervention Period||12
144480|NCT01121900|349507|P2|STARTED|First Intervention Period||13
144481|NCT01121900|349508|P1|STARTED|First Intervention Period||13
144482|NCT01121757|349528|P2|NOT COMPLETED|Combination||1
144483|NCT01121757|349529|P1|NOT COMPLETED|Combination||2
144484|NCT01121757|349528|P2|COMPLETED|Combination||0
144485|NCT01121757|349529|P1|COMPLETED|Combination||0
144486|NCT01121757|349528|P2|STARTED|Combination||1
144487|NCT01121757|349529|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
144488|NCT01121757|349528|P2|NOT COMPLETED|Second Drug||0
144489|NCT01121757|349529|P1|NOT COMPLETED|Second Drug||0
144490|NCT01121757|349528|P2|COMPLETED|Second Drug||1
144491|NCT01121757|349529|P1|COMPLETED|Second Drug||4
144492|NCT01121757|349528|P2|STARTED|Second Drug||1
144493|NCT01121757|349529|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
144494|NCT01121757|349528|P2|NOT COMPLETED|First Drug||2
144495|NCT01121757|349529|P1|NOT COMPLETED|First Drug||1
144496|NCT01121757|349528|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
144497|NCT01121757|349529|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
144498|NCT01121757|349528|P2|STARTED|First Drug||3
144499|NCT01121757|349529|P1|STARTED|First Drug||6
144500|NCT01121666|349545|P2|NOT COMPLETED|Overall Study||10
144501|NCT01121666|349546|P1|NOT COMPLETED|Overall Study||29
144502|NCT01121666|349545|P2|COMPLETED|Overall Study||113
144503|NCT01121666|349546|P1|COMPLETED|Overall Study||220
144504|NCT01121666|349545|P2|STARTED|Overall Study||123
144505|NCT01121666|349546|P1|STARTED|Overall Study||249
144506|NCT01121575|349602|P6|NOT COMPLETED|Overall Study||12
144507|NCT01121575|349603|P5|NOT COMPLETED|Overall Study||25
144508|NCT01121575|349604|P4|NOT COMPLETED|Overall Study||6
144509|NCT01121575|349605|P3|NOT COMPLETED|Overall Study||7
144510|NCT01121575|349606|P2|NOT COMPLETED|Overall Study||6
144511|NCT01121575|349607|P1|NOT COMPLETED|Overall Study||14
144512|NCT01121575|349602|P6|COMPLETED|Overall Study||0
144513|NCT01121575|349603|P5|COMPLETED|Overall Study||0
144514|NCT01121575|349604|P4|COMPLETED|Overall Study||0
144515|NCT01121575|349605|P3|COMPLETED|Overall Study||0
144516|NCT01121575|349606|P2|COMPLETED|Overall Study||0
144517|NCT01121575|349607|P1|COMPLETED|Overall Study||0
144518|NCT01121575|349602|P6|Treated|Overall Study||12
144519|NCT01121575|349603|P5|Treated|Overall Study||25
144520|NCT01121575|349604|P4|Treated|Overall Study||6
144521|NCT01121575|349605|P3|Treated|Overall Study||7
144522|NCT01121575|349606|P2|Treated|Overall Study||6
144523|NCT01121575|349607|P1|Treated|Overall Study||14
144524|NCT01121575|349602|P6|STARTED|Overall Study||12
144525|NCT01121575|349603|P5|STARTED|Overall Study||25
144526|NCT01121575|349604|P4|STARTED|Overall Study||6
144527|NCT01121575|349605|P3|STARTED|Overall Study||7
144528|NCT01121575|349606|P2|STARTED|Overall Study||6
144529|NCT01121575|349607|P1|STARTED|Overall Study||14
144530|NCT01121562|349731|P1|NOT COMPLETED|Overall Study||12
144531|NCT01121562|349731|P1|COMPLETED|Overall Study||0
144532|NCT01121562|349731|P1|STARTED|Overall Study||12
144533|NCT01121549|349740|P1|NOT COMPLETED|Overall Study||347
144534|NCT01121549|349740|P1|COMPLETED|Overall Study||31
144535|NCT01121549|349740|P1|STARTED|Overall Study||378
144536|NCT01121536|349751|P1|NOT COMPLETED|Overall Study||361
144537|NCT01121536|349751|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
144538|NCT01121536|349751|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
144539|NCT01121536|349751|P1|Safety Population|Overall Study|Participants treated|863
144540|NCT01121536|349751|P1|STARTED|Overall Study||867
144541|NCT01121484|349772|P2|NOT COMPLETED|Overall Study||43
144542|NCT01121484|349773|P1|NOT COMPLETED|Overall Study||33
144543|NCT01121484|349772|P2|COMPLETED|Overall Study||178
144544|NCT01121484|349773|P1|COMPLETED|Overall Study||185
144545|NCT01121484|349772|P2|Treated|Overall Study||217
144546|NCT01121484|349773|P1|Treated|Overall Study||217
144547|NCT01121484|349772|P2|STARTED|Overall Study||221
144548|NCT01121484|349773|P1|STARTED|Overall Study||218
144549|NCT01121406|349791|P2|NOT COMPLETED|Overall Study||55
144550|NCT01121406|349792|P1|NOT COMPLETED|Overall Study||55
144551|NCT01121406|349791|P2|COMPLETED|Overall Study||0
144552|NCT01121406|349792|P1|COMPLETED|Overall Study||0
144553|NCT01121406|349791|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
144554|NCT01121406|349792|P1|STARTED|Overall Study||55
144555|NCT01121393|349842|P2|NOT COMPLETED|Overall Study||84
144556|NCT01121393|349843|P1|NOT COMPLETED|Overall Study||219
144557|NCT01121393|349842|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
144558|NCT01121393|349843|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (27 December 2013)|23
144559|NCT01121393|349842|P2|STARTED|Overall Study|randomised|122
144560|NCT01121393|349843|P1|STARTED|Overall Study|randomised|242
144561|NCT01121263|349888|P2|NOT COMPLETED|Overall Study||15
144562|NCT01121263|349889|P1|NOT COMPLETED|Overall Study||25
144563|NCT01121263|349888|P2|COMPLETED|Overall Study||83
144564|NCT01121263|349889|P1|COMPLETED|Overall Study||175
144565|NCT01121263|349888|P2|STARTED|Overall Study||98
144566|NCT01121263|349889|P1|STARTED|Overall Study||200
144567|NCT01121224|349899|P2|NOT COMPLETED|Overall Study||17
144568|NCT01121224|349900|P1|NOT COMPLETED|Overall Study||25
144569|NCT01121224|349899|P2|COMPLETED|Overall Study||275
144570|NCT01121224|349900|P1|COMPLETED|Overall Study||280
144571|NCT01121224|349899|P2|STARTED|Overall Study||292
144572|NCT01121224|349900|P1|STARTED|Overall Study||305
144573|NCT01121211|349924|P2|NOT COMPLETED|Overall Study||12
144574|NCT01121211|349925|P1|NOT COMPLETED|Overall Study||11
144575|NCT01121211|349924|P2|COMPLETED|Overall Study||35
144576|NCT01121211|349925|P1|COMPLETED|Overall Study||32
144577|NCT01121211|349924|P2|STARTED|Overall Study||47
144578|NCT01121211|349925|P1|STARTED|Overall Study||43
144579|NCT01121185|349935|P2|NOT COMPLETED|Overall Study||1
144580|NCT01121185|349936|P1|NOT COMPLETED|Overall Study||1
144581|NCT01121185|349935|P2|COMPLETED|Overall Study||5
144582|NCT01121185|349936|P1|COMPLETED|Overall Study||6
144583|NCT01121185|349935|P2|Transplanted|Overall Study||5
144584|NCT01121185|349936|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
144585|NCT01121185|349935|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
144586|NCT01121185|349936|P1|Infused|Overall Study||7
144587|NCT01121185|349935|P2|STARTED|Overall Study||6
144588|NCT01121185|349936|P1|STARTED|Overall Study||7
144589|NCT01121172|349960|P2|NOT COMPLETED|Overall Study||0
144590|NCT01121172|349961|P1|NOT COMPLETED|Overall Study||0
144591|NCT01121172|349960|P2|COMPLETED|Overall Study||90
144592|NCT01121172|349961|P1|COMPLETED|Overall Study||90
144593|NCT01121172|349960|P2|STARTED|Overall Study||90
144594|NCT01121172|349961|P1|STARTED|Overall Study||90
144595|NCT01121146|349970|P2|NOT COMPLETED|Overall Study||42
144596|NCT01121146|349971|P1|NOT COMPLETED|Overall Study||26
144597|NCT01121146|349970|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
144598|NCT01121146|349971|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
144599|NCT01121146|349970|P2|STARTED|Overall Study||114
144600|NCT01121146|349971|P1|STARTED|Overall Study||116
144601|NCT01120990|349985|P1|NOT COMPLETED|Overall Study||0
144602|NCT01120990|349985|P1|COMPLETED|Overall Study||51
144603|NCT01120990|349985|P1|STARTED|Overall Study||51
144604|NCT01120899|349992|P1|NOT COMPLETED|Overall Study||3
144605|NCT01120899|349992|P1|COMPLETED|Overall Study||3
144606|NCT01120899|349992|P1|Month 18|Overall Study||3
144607|NCT01120899|349992|P1|Month 12|Overall Study||3
144608|NCT01120899|349992|P1|Month 6|Overall Study||5
144609|NCT01120899|349992|P1|STARTED|Overall Study||6
144610|NCT01120834|350012|P1|NOT COMPLETED|Overall Study||0
144611|NCT01120834|350012|P1|COMPLETED|Overall Study||18
144612|NCT01120834|350012|P1|STARTED|Overall Study||18
144613|NCT01120808|350016|P1|NOT COMPLETED|Overall Study||46
144614|NCT01120808|350016|P1|COMPLETED|Overall Study||90
144615|NCT01120808|350016|P1|STARTED|Overall Study||136
144616|NCT01120782|350020|P1|NOT COMPLETED|Overall Study||11
144617|NCT01120782|350020|P1|COMPLETED|Overall Study||34
144618|NCT01120782|350020|P1|STARTED|Overall Study||45
144619|NCT01120717|350026|P2|NOT COMPLETED|Overall Study||24
144620|NCT01120717|350027|P1|NOT COMPLETED|Overall Study||32
144621|NCT01120717|350026|P2|COMPLETED|Overall Study||89
144622|NCT01120717|350027|P1|COMPLETED|Overall Study||194
144623|NCT01120717|350026|P2|Safety Population: Received Study Drug|Overall Study||113
144624|NCT01120717|350027|P1|Safety Population: Received Study Drug|Overall Study||225
144625|NCT01120717|350026|P2|STARTED|Overall Study||113
144626|NCT01120717|350027|P1|STARTED|Overall Study||226
144627|NCT01120704|350075|P32|NOT COMPLETED|Overall Study||1
144628|NCT01120704|350076|P31|NOT COMPLETED|Overall Study||2
144629|NCT01120704|350077|P30|NOT COMPLETED|Overall Study||3
144630|NCT01120704|350078|P29|NOT COMPLETED|Overall Study||5
144631|NCT01120704|350079|P28|NOT COMPLETED|Overall Study||2
144632|NCT01120704|350080|P27|NOT COMPLETED|Overall Study||3
144633|NCT01120704|350081|P26|NOT COMPLETED|Overall Study||0
144634|NCT01120704|350082|P25|NOT COMPLETED|Overall Study||2
144635|NCT01120704|350083|P24|NOT COMPLETED|Overall Study||3
144636|NCT01120704|350084|P23|NOT COMPLETED|Overall Study||4
144637|NCT01120704|350085|P22|NOT COMPLETED|Overall Study||0
144638|NCT01120704|350086|P21|NOT COMPLETED|Overall Study||3
144639|NCT01120704|350087|P20|NOT COMPLETED|Overall Study||3
144640|NCT01120704|350088|P19|NOT COMPLETED|Overall Study||2
144641|NCT01120704|350089|P18|NOT COMPLETED|Overall Study||0
144642|NCT01120704|350090|P17|NOT COMPLETED|Overall Study||1
144643|NCT01120704|350091|P16|NOT COMPLETED|Overall Study||2
144644|NCT01120704|350092|P15|NOT COMPLETED|Overall Study||1
144645|NCT01120704|350093|P14|NOT COMPLETED|Overall Study||4
144646|NCT01120704|350094|P13|NOT COMPLETED|Overall Study||3
144647|NCT01120704|350095|P12|NOT COMPLETED|Overall Study||2
144648|NCT01120704|350096|P11|NOT COMPLETED|Overall Study||1
144649|NCT01120704|350097|P10|NOT COMPLETED|Overall Study||1
144650|NCT01120704|350098|P9|NOT COMPLETED|Overall Study||3
144651|NCT01120704|350099|P8|NOT COMPLETED|Overall Study||2
144652|NCT01120704|350100|P7|NOT COMPLETED|Overall Study||3
144653|NCT01120704|350101|P6|NOT COMPLETED|Overall Study||1
144654|NCT01120704|350102|P5|NOT COMPLETED|Overall Study||2
144655|NCT01120704|350103|P4|NOT COMPLETED|Overall Study||4
144656|NCT01120704|350104|P3|NOT COMPLETED|Overall Study||1
144657|NCT01120704|350105|P2|NOT COMPLETED|Overall Study||4
144658|NCT01120704|350106|P1|NOT COMPLETED|Overall Study||3
144659|NCT01120704|350075|P32|COMPLETED|Overall Study||17
144660|NCT01120704|350076|P31|COMPLETED|Overall Study||12
144661|NCT01120704|350077|P30|COMPLETED|Overall Study||12
144662|NCT01120704|350078|P29|COMPLETED|Overall Study||14
144663|NCT01120704|350079|P28|COMPLETED|Overall Study||16
144664|NCT01120704|350080|P27|COMPLETED|Overall Study||15
144665|NCT01120704|350081|P26|COMPLETED|Overall Study||14
144666|NCT01120704|350082|P25|COMPLETED|Overall Study||16
144667|NCT01120704|350083|P24|COMPLETED|Overall Study||13
144668|NCT01120704|350084|P23|COMPLETED|Overall Study||17
144669|NCT01120704|350085|P22|COMPLETED|Overall Study||16
144670|NCT01120704|350086|P21|COMPLETED|Overall Study||14
144671|NCT01120704|350087|P20|COMPLETED|Overall Study||15
144672|NCT01120704|350088|P19|COMPLETED|Overall Study||15
144673|NCT01120704|350089|P18|COMPLETED|Overall Study||16
144674|NCT01120704|350090|P17|COMPLETED|Overall Study||13
144675|NCT01120704|350091|P16|COMPLETED|Overall Study||16
144676|NCT01120704|350092|P15|COMPLETED|Overall Study||17
144677|NCT01120704|350093|P14|COMPLETED|Overall Study||15
144678|NCT01120704|350094|P13|COMPLETED|Overall Study||14
144679|NCT01120704|350095|P12|COMPLETED|Overall Study||14
144680|NCT01120704|350096|P11|COMPLETED|Overall Study||16
144681|NCT01120704|350097|P10|COMPLETED|Overall Study||19
144682|NCT01120704|350098|P9|COMPLETED|Overall Study||19
144683|NCT01120704|350099|P8|COMPLETED|Overall Study||13
144684|NCT01120704|350100|P7|COMPLETED|Overall Study||12
144685|NCT01120704|350101|P6|COMPLETED|Overall Study||18
144686|NCT01120704|350102|P5|COMPLETED|Overall Study||14
144687|NCT01120704|350103|P4|COMPLETED|Overall Study||15
144688|NCT01120704|350104|P3|COMPLETED|Overall Study||13
144689|NCT01120704|350105|P2|COMPLETED|Overall Study||13
144690|NCT01120704|350106|P1|COMPLETED|Overall Study||10
144691|NCT01120704|350075|P32|STARTED|Overall Study||18
144692|NCT01120704|350076|P31|STARTED|Overall Study||14
144693|NCT01120704|350077|P30|STARTED|Overall Study||15
144694|NCT01120704|350078|P29|STARTED|Overall Study||19
144695|NCT01120704|350079|P28|STARTED|Overall Study||18
144696|NCT01120704|350080|P27|STARTED|Overall Study||18
144697|NCT01120704|350081|P26|STARTED|Overall Study||14
144698|NCT01120704|350082|P25|STARTED|Overall Study||18
144699|NCT01120704|350083|P24|STARTED|Overall Study||16
144700|NCT01120704|350084|P23|STARTED|Overall Study||21
144701|NCT01120704|350085|P22|STARTED|Overall Study||16
144702|NCT01120704|350086|P21|STARTED|Overall Study||17
144703|NCT01120704|350087|P20|STARTED|Overall Study||18
144704|NCT01120704|350088|P19|STARTED|Overall Study||17
144705|NCT01120704|350089|P18|STARTED|Overall Study||16
144706|NCT01120704|350090|P17|STARTED|Overall Study||14
144707|NCT01120704|350091|P16|STARTED|Overall Study||18
144708|NCT01120704|350092|P15|STARTED|Overall Study||18
144709|NCT01120704|350093|P14|STARTED|Overall Study||19
144710|NCT01120704|350094|P13|STARTED|Overall Study||17
144711|NCT01120704|350095|P12|STARTED|Overall Study||16
144712|NCT01120704|350096|P11|STARTED|Overall Study||17
144713|NCT01120704|350097|P10|STARTED|Overall Study||20
144714|NCT01120704|350098|P9|STARTED|Overall Study||22
144715|NCT01120704|350099|P8|STARTED|Overall Study||15
144716|NCT01120704|350100|P7|STARTED|Overall Study||15
144717|NCT01120704|350101|P6|STARTED|Overall Study||19
144718|NCT01120704|350102|P5|STARTED|Overall Study||16
144719|NCT01120704|350103|P4|STARTED|Overall Study||19
144720|NCT01120704|350104|P3|STARTED|Overall Study||14
144721|NCT01120704|350105|P2|STARTED|Overall Study||17
144722|NCT01120704|350106|P1|STARTED|Overall Study||13
144723|NCT01120691|350133|P3|NOT COMPLETED|Overall Study||183
144724|NCT01120691|350134|P2|NOT COMPLETED|Overall Study||203
144725|NCT01120691|350135|P1|NOT COMPLETED|Overall Study||171
144726|NCT01120691|350133|P3|COMPLETED|Overall Study||559
144727|NCT01120691|350134|P2|COMPLETED|Overall Study||538
144728|NCT01120691|350135|P1|COMPLETED|Overall Study||570
144729|NCT01120691|350133|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
144730|NCT01120691|350134|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
144731|NCT01120691|350135|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
144732|NCT01120691|350133|P3|Modified Safety Set (mSAF)|Overall Study||737
144733|NCT01120691|350134|P2|Modified Safety Set (mSAF)|Overall Study||740
144734|NCT01120691|350135|P1|Modified Safety Set (mSAF)|Overall Study||729
144735|NCT01120691|350133|P3|Safety Set (SAF)|Overall Study||739
144736|NCT01120691|350134|P2|Safety Set (SAF)|Overall Study||740
144737|NCT01120691|350135|P1|Safety Set (SAF)|Overall Study||736
144738|NCT01120691|350133|P3|Full Analysis Set (FAS)|Overall Study||739
144739|NCT01120691|350134|P2|Full Analysis Set (FAS)|Overall Study||739
144740|NCT01120691|350135|P1|Full Analysis Set (FAS)|Overall Study||736
144741|NCT01120691|350133|P3|STARTED|Overall Study||742
144742|NCT01120691|350134|P2|STARTED|Overall Study||741
144743|NCT01120691|350135|P1|STARTED|Overall Study||741
144744|NCT01120626|350179|P2|NOT COMPLETED|Overall Study||0
144745|NCT01120626|350180|P1|NOT COMPLETED|Overall Study||1
144746|NCT01120626|350179|P2|COMPLETED|Overall Study||22
144747|NCT01120626|350180|P1|COMPLETED|Overall Study||19
144748|NCT01120626|350179|P2|STARTED|Overall Study||22
144749|NCT01120626|350180|P1|STARTED|Overall Study||20
144750|NCT01120600|350190|P2|NOT COMPLETED|Overall Study||32
144751|NCT01120600|350191|P1|NOT COMPLETED|Overall Study||19
144752|NCT01120600|350190|P2|COMPLETED|Overall Study||115
144753|NCT01120600|350191|P1|COMPLETED|Overall Study||128
144754|NCT01120600|350190|P2|Treated|Overall Study||146
144755|NCT01120600|350191|P1|Treated|Overall Study||146
144756|NCT01120600|350190|P2|STARTED|Overall Study||147
144757|NCT01120600|350191|P1|STARTED|Overall Study||147
144758|NCT01120405|350217|P2|NOT COMPLETED|Overall Study||33
144759|NCT01120405|350218|P1|NOT COMPLETED|Overall Study||27
144760|NCT01120405|350217|P2|COMPLETED|Overall Study||269
144761|NCT01120405|350218|P1|COMPLETED|Overall Study||271
144762|NCT01120405|350217|P2|STARTED|Overall Study||302
144763|NCT01120405|350218|P1|STARTED|Overall Study||298
144764|NCT01120379|350246|P1|NOT COMPLETED|Four Year Timepoint||368
144765|NCT01120379|350246|P1|COMPLETED|Four Year Timepoint||3923
144766|NCT01120379|350246|P1|STARTED|Four Year Timepoint||4291
144767|NCT01120379|350246|P1|NOT COMPLETED|Three Year Timepoint||214
144768|NCT01120379|350246|P1|COMPLETED|Three Year Timepoint||4291
144769|NCT01120379|350246|P1|STARTED|Three Year Timepoint||4505
144770|NCT01120379|350246|P1|NOT COMPLETED|Two Year Timepoint||237
144771|NCT01120379|350246|P1|COMPLETED|Two Year Timepoint||4505
144772|NCT01120379|350246|P1|STARTED|Two Year Timepoint||4742
144773|NCT01120379|350246|P1|NOT COMPLETED|One Year Timepoint||278
144774|NCT01120379|350246|P1|COMPLETED|One Year Timepoint||4742
144775|NCT01120379|350246|P1|STARTED|One Year Timepoint||5020
144776|NCT01120275|350282|P1|NOT COMPLETED|Overall Study||36
144777|NCT01120275|350282|P1|COMPLETED|Overall Study||0
144778|NCT01120275|350282|P1|Eligible and Treated|Overall Study||32
144779|NCT01120275|350282|P1|STARTED|Overall Study||36
144780|NCT01120236|350291|P2|NOT COMPLETED|Overall Study||1
144781|NCT01120236|350292|P1|NOT COMPLETED|Overall Study||0
144782|NCT01120236|350291|P2|COMPLETED|Overall Study||105
144783|NCT01120236|350292|P1|COMPLETED|Overall Study||105
144784|NCT01120236|350291|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
144785|NCT01120236|350292|P1|Ineligble|Overall Study||0
144786|NCT01120236|350291|P2|STARTED|Overall Study||106
144787|NCT01120236|350292|P1|STARTED|Overall Study||105
144788|NCT01120223|350319|P1|NOT COMPLETED|Overall Study||4
144789|NCT01120223|350319|P1|COMPLETED|Overall Study||74
144790|NCT01120223|350319|P1|STARTED|Overall Study||78
144791|NCT01120210|350349|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
144792|NCT01120210|350350|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
144793|NCT01120210|350349|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
144794|NCT01120210|350350|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
144795|NCT01120210|350349|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
144796|NCT01120210|350350|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
144797|NCT01120210|350349|P2|NOT COMPLETED|MAIN INFUSION||1
144798|NCT01120210|350350|P1|NOT COMPLETED|MAIN INFUSION||1
144799|NCT01120210|350349|P2|COMPLETED|MAIN INFUSION||45
144800|NCT01120210|350350|P1|COMPLETED|MAIN INFUSION||15
144801|NCT01120210|350349|P2|STARTED|MAIN INFUSION||46
144802|NCT01120210|350350|P1|STARTED|MAIN INFUSION||16
144803|NCT01120197|350382|P2|NOT COMPLETED|Overall Study||10
144804|NCT01120197|350383|P1|NOT COMPLETED|Overall Study||9
144805|NCT01120197|350382|P2|COMPLETED|Overall Study||32
144806|NCT01120197|350383|P1|COMPLETED|Overall Study||38
144807|NCT01120197|350382|P2|STARTED|Overall Study||42
144808|NCT01120197|350383|P1|STARTED|Overall Study||47
144809|NCT01120184|350400|P3|NOT COMPLETED|Overall Study||363
144810|NCT01120184|350401|P2|NOT COMPLETED|Overall Study||367
144811|NCT01120184|350402|P1|NOT COMPLETED|Overall Study||365
144812|NCT01120184|350400|P3|COMPLETED|Overall Study||0
144813|NCT01120184|350401|P2|COMPLETED|Overall Study||0
144814|NCT01120184|350402|P1|COMPLETED|Overall Study||0
144815|NCT01120184|350400|P3|Treated|Overall Study||360
144816|NCT01120184|350401|P2|Treated|Overall Study||365
144817|NCT01120184|350402|P1|Treated|Overall Study||355
144818|NCT01120184|350400|P3|STARTED|Overall Study||363
144819|NCT01120184|350401|P2|STARTED|Overall Study||367
144820|NCT01120184|350402|P1|STARTED|Overall Study||365
144821|NCT01120093|350524|P5|NOT COMPLETED|Treatment Period 5||0
144822|NCT01120093|350525|P4|NOT COMPLETED|Treatment Period 5||1
144823|NCT01120093|350526|P3|NOT COMPLETED|Treatment Period 5||0
144824|NCT01120093|350527|P2|NOT COMPLETED|Treatment Period 5||1
144825|NCT01120093|350528|P1|NOT COMPLETED|Treatment Period 5||0
144826|NCT01120093|350524|P5|COMPLETED|Treatment Period 5||13
144827|NCT01120093|350525|P4|COMPLETED|Treatment Period 5||11
144828|NCT01120093|350526|P3|COMPLETED|Treatment Period 5||15
144829|NCT01120093|350527|P2|COMPLETED|Treatment Period 5||12
144830|NCT01120093|350528|P1|COMPLETED|Treatment Period 5||17
144831|NCT01120093|350524|P5|STARTED|Treatment Period 5||13
144832|NCT01120093|350525|P4|STARTED|Treatment Period 5||12
144833|NCT01120093|350526|P3|STARTED|Treatment Period 5||15
144834|NCT01120093|350527|P2|STARTED|Treatment Period 5||13
144835|NCT01120093|350528|P1|STARTED|Treatment Period 5||17
144836|NCT01120093|350524|P5|NOT COMPLETED|Treatment Period 4||0
144837|NCT01120093|350525|P4|NOT COMPLETED|Treatment Period 4||0
144838|NCT01120093|350526|P3|NOT COMPLETED|Treatment Period 4||0
144839|NCT01120093|350527|P2|NOT COMPLETED|Treatment Period 4||0
144840|NCT01120093|350528|P1|NOT COMPLETED|Treatment Period 4||1
144841|NCT01120093|350524|P5|COMPLETED|Treatment Period 4||13
144842|NCT01120093|350525|P4|COMPLETED|Treatment Period 4||12
144843|NCT01120093|350526|P3|COMPLETED|Treatment Period 4||15
144844|NCT01120093|350527|P2|COMPLETED|Treatment Period 4||13
144845|NCT01120093|350528|P1|COMPLETED|Treatment Period 4||17
144846|NCT01120093|350524|P5|STARTED|Treatment Period 4||13
144847|NCT01120093|350525|P4|STARTED|Treatment Period 4||12
144848|NCT01120093|350526|P3|STARTED|Treatment Period 4||15
144849|NCT01120093|350527|P2|STARTED|Treatment Period 4||13
144850|NCT01120093|350528|P1|STARTED|Treatment Period 4||18
144851|NCT01120093|350524|P5|NOT COMPLETED|Treatment Period 3||1
144852|NCT01120093|350525|P4|NOT COMPLETED|Treatment Period 3||1
144853|NCT01120093|350526|P3|NOT COMPLETED|Treatment Period 3||1
144854|NCT01120093|350527|P2|NOT COMPLETED|Treatment Period 3||0
144855|NCT01120093|350528|P1|NOT COMPLETED|Treatment Period 3||0
144856|NCT01120093|350524|P5|COMPLETED|Treatment Period 3||13
144857|NCT01120093|350525|P4|COMPLETED|Treatment Period 3||12
144858|NCT01120093|350526|P3|COMPLETED|Treatment Period 3||15
144859|NCT01120093|350527|P2|COMPLETED|Treatment Period 3||13
144860|NCT01120093|350528|P1|COMPLETED|Treatment Period 3||18
144861|NCT01120093|350524|P5|STARTED|Treatment Period 3||14
144862|NCT01120093|350525|P4|STARTED|Treatment Period 3||13
144863|NCT01120093|350526|P3|STARTED|Treatment Period 3||16
144864|NCT01120093|350527|P2|STARTED|Treatment Period 3||13
144865|NCT01120093|350528|P1|STARTED|Treatment Period 3||18
144866|NCT01120093|350524|P5|NOT COMPLETED|Treatment Period 2||1
144867|NCT01120093|350525|P4|NOT COMPLETED|Treatment Period 2||1
144868|NCT01120093|350526|P3|NOT COMPLETED|Treatment Period 2||0
144869|NCT01120093|350527|P2|NOT COMPLETED|Treatment Period 2||0
144870|NCT01120093|350528|P1|NOT COMPLETED|Treatment Period 2||0
144871|NCT01120093|350524|P5|COMPLETED|Treatment Period 2||14
144872|NCT01120093|350525|P4|COMPLETED|Treatment Period 2||13
144873|NCT01120093|350526|P3|COMPLETED|Treatment Period 2||16
144874|NCT01120093|350527|P2|COMPLETED|Treatment Period 2||13
144875|NCT01120093|350528|P1|COMPLETED|Treatment Period 2||18
144876|NCT01120093|350524|P5|STARTED|Treatment Period 2||15
144877|NCT01120093|350525|P4|STARTED|Treatment Period 2||14
144878|NCT01120093|350526|P3|STARTED|Treatment Period 2||16
144879|NCT01120093|350527|P2|STARTED|Treatment Period 2||13
144880|NCT01120093|350528|P1|STARTED|Treatment Period 2||18
144881|NCT01120093|350524|P5|NOT COMPLETED|Treatment Period 1||1
144882|NCT01120093|350525|P4|NOT COMPLETED|Treatment Period 1||0
144883|NCT01120093|350526|P3|NOT COMPLETED|Treatment Period 1||1
144884|NCT01120093|350527|P2|NOT COMPLETED|Treatment Period 1||1
144885|NCT01120093|350528|P1|NOT COMPLETED|Treatment Period 1||0
144886|NCT01120093|350524|P5|COMPLETED|Treatment Period 1||15
144887|NCT01120093|350525|P4|COMPLETED|Treatment Period 1||14
144888|NCT01120093|350526|P3|COMPLETED|Treatment Period 1||16
144889|NCT01120093|350527|P2|COMPLETED|Treatment Period 1||13
144890|NCT01120093|350528|P1|COMPLETED|Treatment Period 1||18
144891|NCT01120093|350524|P5|STARTED|Treatment Period 1||16
144892|NCT01120093|350525|P4|STARTED|Treatment Period 1||14
144893|NCT01120093|350526|P3|STARTED|Treatment Period 1||17
144894|NCT01120093|350527|P2|STARTED|Treatment Period 1||14
144895|NCT01120093|350528|P1|STARTED|Treatment Period 1||18
144896|NCT01120067|350557|P2|NOT COMPLETED|Overall Study||1
144897|NCT01120067|350558|P1|NOT COMPLETED|Overall Study||5
144898|NCT01120067|350557|P2|COMPLETED|Overall Study||10
144899|NCT01120067|350558|P1|COMPLETED|Overall Study||7
144900|NCT01120067|350557|P2|STARTED|Overall Study||11
144901|NCT01120067|350558|P1|STARTED|Overall Study||12
144902|NCT01119963|350566|P2|NOT COMPLETED|Overall Study||1
144903|NCT01119963|350567|P1|NOT COMPLETED|Overall Study||1
144904|NCT01119963|350566|P2|COMPLETED|Overall Study||77
144905|NCT01119963|350567|P1|COMPLETED|Overall Study||73
144906|NCT01119963|350566|P2|STARTED|Overall Study||78
144907|NCT01119963|350567|P1|STARTED|Overall Study||74
144908|NCT01119950|350575|P1|NOT COMPLETED|Overall Study||47
144909|NCT01119950|350575|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
144910|NCT01119950|350575|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
144911|NCT01119950|350575|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
144912|NCT01119950|350575|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
144913|NCT01119950|350575|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
144914|NCT01119950|350575|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
144915|NCT01119950|350575|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
144916|NCT01119950|350575|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
144917|NCT01119950|350575|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
144918|NCT01119950|350575|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
144919|NCT01119937|350822|P2|NOT COMPLETED|Overall Study||7
144920|NCT01119937|350823|P1|NOT COMPLETED|Overall Study||19
144921|NCT01119937|350822|P2|COMPLETED|Overall Study||33
144922|NCT01119937|350823|P1|COMPLETED|Overall Study||104
144923|NCT01119937|350822|P2|STARTED|Overall Study||40
144924|NCT01119937|350823|P1|STARTED|Overall Study||123
144925|NCT01119859|350851|P2|NOT COMPLETED|Overall Study||30
144926|NCT01119859|350852|P1|NOT COMPLETED|Overall Study||24
144927|NCT01119859|350851|P2|COMPLETED|Overall Study||133
144928|NCT01119859|350852|P1|COMPLETED|Overall Study||139
144929|NCT01119859|350851|P2|STARTED|Overall Study||163
144930|NCT01119859|350852|P1|STARTED|Overall Study||163
144931|NCT01119846|350871|P3|NOT COMPLETED|Overall Study||11
144932|NCT01119846|350872|P2|NOT COMPLETED|Overall Study||0
144933|NCT01119846|350873|P1|NOT COMPLETED|Overall Study||2
144934|NCT01119846|350871|P3|COMPLETED|Overall Study||72
144935|NCT01119846|350872|P2|COMPLETED|Overall Study||4
144936|NCT01119846|350873|P1|COMPLETED|Overall Study||11
144937|NCT01119846|350871|P3|STARTED|Overall Study||83
144938|NCT01119846|350872|P2|STARTED|Overall Study||4
144939|NCT01119846|350873|P1|STARTED|Overall Study||13
144940|NCT01119794|351081|P1|NOT COMPLETED|Overall Study||0
144941|NCT01119794|351081|P1|COMPLETED|Overall Study||10
144942|NCT01119794|351081|P1|STARTED|Overall Study||10
144943|NCT01119768|351087|P2|NOT COMPLETED|Follow-up||2
144944|NCT01119768|351088|P1|NOT COMPLETED|Follow-up||1
144945|NCT01119768|351087|P2|COMPLETED|Follow-up||122
144946|NCT01119768|351088|P1|COMPLETED|Follow-up||135
144947|NCT01119768|351087|P2|STARTED|Follow-up||124
144948|NCT01119768|351088|P1|STARTED|Follow-up||136
144949|NCT01119768|351087|P2|NOT COMPLETED|Treatment Period||25
144950|NCT01119768|351088|P1|NOT COMPLETED|Treatment Period||18
144951|NCT01119768|351087|P2|COMPLETED|Treatment Period||126
144952|NCT01119768|351088|P1|COMPLETED|Treatment Period||136
144953|NCT01119768|351087|P2|STARTED|Treatment Period||151
144954|NCT01119768|351088|P1|STARTED|Treatment Period||154
144955|NCT01119755|351110|P1|NOT COMPLETED|Overall Study||0
144956|NCT01119755|351110|P1|COMPLETED|Overall Study||80
144957|NCT01119755|351110|P1|STARTED|Overall Study||80
144958|NCT01119716|351121|P1|NOT COMPLETED|Overall Study||0
144959|NCT01119716|351121|P1|COMPLETED|Overall Study||4658
144960|NCT01119716|351121|P1|STARTED|Overall Study||4658
144961|NCT01119703|351144|P2|NOT COMPLETED|Overall Study||1
144962|NCT01119703|351145|P1|NOT COMPLETED|Overall Study||0
144963|NCT01119703|351144|P2|COMPLETED|Overall Study||143
144964|NCT01119703|351145|P1|COMPLETED|Overall Study||30
144965|NCT01119703|351144|P2|STARTED|Overall Study||144
144966|NCT01119703|351145|P1|STARTED|Overall Study||30
144967|NCT01119625|351159|P2|NOT COMPLETED|Overall Study||4
144968|NCT01119625|351160|P1|NOT COMPLETED|Overall Study||3
144969|NCT01119625|351159|P2|COMPLETED|Overall Study||116
144970|NCT01119625|351160|P1|COMPLETED|Overall Study||115
144971|NCT01119625|351159|P2|STARTED|Overall Study||120
144972|NCT01119625|351160|P1|STARTED|Overall Study||118
144973|NCT01119443|351202|P2|NOT COMPLETED|End of Study (All Patients)||0
144974|NCT01119443|351203|P1|NOT COMPLETED|End of Study (All Patients)||0
144975|NCT01119443|351202|P2|COMPLETED|End of Study (All Patients)||14
144976|NCT01119443|351203|P1|COMPLETED|End of Study (All Patients)||14
144977|NCT01119443|351202|P2|STARTED|End of Study (All Patients)||14
144978|NCT01119443|351203|P1|STARTED|End of Study (All Patients)||14
144979|NCT01119443|351202|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
144980|NCT01119443|351203|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
144981|NCT01119443|351202|P2|COMPLETED|Down-titration Period (1 Day)||13
144982|NCT01119443|351203|P1|COMPLETED|Down-titration Period (1 Day)||14
144983|NCT01119443|351202|P2|STARTED|Down-titration Period (1 Day)||13
144984|NCT01119443|351203|P1|STARTED|Down-titration Period (1 Day)||14
144985|NCT01119443|351202|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
144986|NCT01119443|351203|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
144987|NCT01119443|351202|P2|COMPLETED|Crossover Period 4 (5 Days)||13
144988|NCT01119443|351203|P1|COMPLETED|Crossover Period 4 (5 Days)||14
144989|NCT01119443|351202|P2|STARTED|Crossover Period 4 (5 Days)||13
144990|NCT01119443|351203|P1|STARTED|Crossover Period 4 (5 Days)||14
144991|NCT01119443|351202|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
144992|NCT01119443|351203|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
144993|NCT01119443|351202|P2|COMPLETED|Crossover Period 3 (5 Days)||13
144994|NCT01119443|351203|P1|COMPLETED|Crossover Period 3 (5 Days)||14
144995|NCT01119443|351202|P2|STARTED|Crossover Period 3 (5 Days)||13
144996|NCT01119443|351203|P1|STARTED|Crossover Period 3 (5 Days)||14
144997|NCT01119443|351202|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
144998|NCT01119443|351203|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
144999|NCT01119443|351202|P2|COMPLETED|Crossover Period 2 (5 Days)||13
145000|NCT01119443|351203|P1|COMPLETED|Crossover Period 2 (5 Days)||14
145001|NCT01119443|351202|P2|STARTED|Crossover Period 2 (5 Days)||13
145002|NCT01119443|351203|P1|STARTED|Crossover Period 2 (5 Days)||14
145003|NCT01119443|351202|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
145004|NCT01119443|351203|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
145005|NCT01119443|351202|P2|COMPLETED|Crossover Period 1 (5 Days)||13
145006|NCT01119443|351203|P1|COMPLETED|Crossover Period 1 (5 Days)||14
145007|NCT01119443|351202|P2|STARTED|Crossover Period 1 (5 Days)||14
145008|NCT01119443|351203|P1|STARTED|Crossover Period 1 (5 Days)||14
145009|NCT01119443|351202|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
145010|NCT01119443|351203|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
145011|NCT01119443|351202|P2|COMPLETED|Up-titration Period (10 Days)||14
145012|NCT01119443|351203|P1|COMPLETED|Up-titration Period (10 Days)||14
145013|NCT01119443|351202|P2|STARTED|Up-titration Period (10 Days)||14
145014|NCT01119443|351203|P1|STARTED|Up-titration Period (10 Days)||14
145015|NCT01119287|351246|P6|NOT COMPLETED|Overall Study||0
145016|NCT01119287|351247|P5|NOT COMPLETED|Overall Study||1
145017|NCT01119287|351248|P4|NOT COMPLETED|Overall Study||2
145018|NCT01119287|351249|P3|NOT COMPLETED|Overall Study||2
145019|NCT01119287|351250|P2|NOT COMPLETED|Overall Study||0
145020|NCT01119287|351251|P1|NOT COMPLETED|Overall Study||0
145021|NCT01119287|351246|P6|COMPLETED|Overall Study||32
145022|NCT01119287|351247|P5|COMPLETED|Overall Study||30
145023|NCT01119287|351248|P4|COMPLETED|Overall Study||29
145024|NCT01119287|351249|P3|COMPLETED|Overall Study||24
145025|NCT01119287|351250|P2|COMPLETED|Overall Study||24
145026|NCT01119287|351251|P1|COMPLETED|Overall Study||26
145027|NCT01119287|351246|P6|STARTED|Overall Study||32
145028|NCT01119287|351247|P5|STARTED|Overall Study||31
145029|NCT01119287|351248|P4|STARTED|Overall Study||31
145030|NCT01119287|351249|P3|STARTED|Overall Study||26
145031|NCT01119287|351250|P2|STARTED|Overall Study||24
145032|NCT01119287|351251|P1|STARTED|Overall Study||26
145033|NCT01119222|351264|P4|NOT COMPLETED|Overall Study||0
145034|NCT01119222|351265|P3|NOT COMPLETED|Overall Study||0
145035|NCT01119222|351266|P2|NOT COMPLETED|Overall Study||0
145036|NCT01119222|351267|P1|NOT COMPLETED|Overall Study||0
145037|NCT01119222|351264|P4|COMPLETED|Overall Study||4
145038|NCT01119222|351265|P3|COMPLETED|Overall Study||5
145039|NCT01119222|351266|P2|COMPLETED|Overall Study||5
145040|NCT01119222|351267|P1|COMPLETED|Overall Study||5
145041|NCT01119222|351264|P4|STARTED|Overall Study||4
145042|NCT01119222|351265|P3|STARTED|Overall Study||5
145043|NCT01119222|351266|P2|STARTED|Overall Study||5
145044|NCT01119222|351267|P1|STARTED|Overall Study||5
145045|NCT01119131|351308|P3|NOT COMPLETED|Overall Study||6
145046|NCT01119131|351309|P2|NOT COMPLETED|Overall Study||1
145047|NCT01119131|351310|P1|NOT COMPLETED|Overall Study||2
145048|NCT01119131|351308|P3|COMPLETED|Overall Study||24
145049|NCT01119131|351309|P2|COMPLETED|Overall Study||27
145050|NCT01119131|351310|P1|COMPLETED|Overall Study||8
145051|NCT01119131|351308|P3|STARTED|Overall Study||30
145052|NCT01119131|351309|P2|STARTED|Overall Study||28
145053|NCT01119131|351310|P1|STARTED|Overall Study||10
145054|NCT01119118|351339|P1|NOT COMPLETED|Overall Study||1
145055|NCT01119118|351339|P1|COMPLETED|Overall Study||5
145056|NCT01119118|351339|P1|STARTED|Overall Study||6
145057|NCT01119040|351347|P1|NOT COMPLETED|Overall Study||1
145058|NCT01119040|351347|P1|COMPLETED|Overall Study||0
145059|NCT01119040|351347|P1|STARTED|Overall Study||1
145060|NCT01119001|351351|P1|NOT COMPLETED|Overall Study||2
145061|NCT01119001|351351|P1|COMPLETED|Overall Study||11
145062|NCT01119001|351351|P1|STARTED|Overall Study||13
145063|NCT01118988|351360|P3|NOT COMPLETED|Overall Study||4
145064|NCT01118988|351361|P2|NOT COMPLETED|Overall Study||1
145065|NCT01118988|351362|P1|NOT COMPLETED|Overall Study||5
145066|NCT01118988|351360|P3|COMPLETED|Overall Study||3
145067|NCT01118988|351361|P2|COMPLETED|Overall Study||3
145068|NCT01118988|351362|P1|COMPLETED|Overall Study||11
145069|NCT01118988|351360|P3|STARTED|Overall Study||7
145070|NCT01118988|351361|P2|STARTED|Overall Study||4
145071|NCT01118988|351362|P1|STARTED|Overall Study||16
145072|NCT01118975|351395|P2|NOT COMPLETED|Overall Study||1
145073|NCT01118975|351396|P1|NOT COMPLETED|Overall Study||0
145074|NCT01118975|351395|P2|COMPLETED|Overall Study||2
145075|NCT01118975|351396|P1|COMPLETED|Overall Study||9
145076|NCT01118975|351395|P2|STARTED|Overall Study||3
145077|NCT01118975|351396|P1|STARTED|Overall Study||9
145078|NCT01118962|351402|P1|NOT COMPLETED|Overall Study||10
145079|NCT01118962|351402|P1|COMPLETED|Overall Study||29
145080|NCT01118962|351402|P1|STARTED|Overall Study||39
145081|NCT01118949|351407|P1|NOT COMPLETED|Overall Study||9
145082|NCT01118949|351407|P1|COMPLETED|Overall Study||40
145083|NCT01118949|351407|P1|STARTED|Overall Study||49
145084|NCT01118845|351416|P1|NOT COMPLETED|Overall Study||42
145085|NCT01118845|351416|P1|COMPLETED|Overall Study||17
145086|NCT01118845|351416|P1|STARTED|Overall Study||59
145087|NCT01118780|351437|P2|NOT COMPLETED|Overall Study||35
145088|NCT01118780|351438|P1|NOT COMPLETED|Overall Study||36
145089|NCT01118780|351437|P2|COMPLETED|Overall Study||105
145090|NCT01118780|351438|P1|COMPLETED|Overall Study||115
145091|NCT01118780|351437|P2|STARTED|Overall Study||140
145092|NCT01118780|351438|P1|STARTED|Overall Study||151
145093|NCT01118741|351487|P2|NOT COMPLETED|Overall Study||0
145094|NCT01118741|351488|P1|NOT COMPLETED|Overall Study||0
145095|NCT01118741|351487|P2|COMPLETED|Overall Study||10
145096|NCT01118741|351488|P1|COMPLETED|Overall Study||9
145097|NCT01118741|351487|P2|STARTED|Overall Study||10
145098|NCT01118741|351488|P1|STARTED|Overall Study||9
145099|NCT01118728|351496|P1|NOT COMPLETED|Overall Study||223
145100|NCT01118728|351496|P1|COMPLETED|Overall Study||0
145101|NCT01118728|351496|P1|STARTED|Overall Study||223
145102|NCT01118663|351503|P2|NOT COMPLETED|Overall Study||2
145103|NCT01118663|351504|P1|NOT COMPLETED|Overall Study||2
145104|NCT01118663|351503|P2|COMPLETED|Overall Study||8
145105|NCT01118663|351504|P1|COMPLETED|Overall Study||5
145106|NCT01118663|351503|P2|STARTED|Overall Study||10
145107|NCT01118663|351504|P1|STARTED|Overall Study||7
145108|NCT01118624|351518|P1|NOT COMPLETED|Overall Study||22
145109|NCT01118624|351518|P1|COMPLETED|Overall Study||0
145110|NCT01118624|351518|P1|STARTED|Overall Study||22
145111|NCT01118455|351527|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
145112|NCT01118455|351528|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
145113|NCT01118455|351527|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
145114|NCT01118455|351528|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
145115|NCT01118455|351527|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
145116|NCT01118455|351528|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
145117|NCT01118455|351527|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
145118|NCT01118455|351528|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
145119|NCT01118455|351527|P2|COMPLETED|Baseline [Visits 1 & 2]||69
145120|NCT01118455|351528|P1|COMPLETED|Baseline [Visits 1 & 2]||65
145121|NCT01118455|351527|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
145122|NCT01118455|351528|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
145123|NCT01118455|351527|P2|STARTED|Baseline [Visits 1 & 2]||69
145124|NCT01118455|351528|P1|STARTED|Baseline [Visits 1 & 2]||66
145125|NCT01118377|351556|P1|NOT COMPLETED|Overall Study||42
145126|NCT01118377|351556|P1|COMPLETED|Overall Study||3
145127|NCT01118377|351556|P1|STARTED|Overall Study||45
145128|NCT01118325|351565|P3|NOT COMPLETED|Overall Study||1
145129|NCT01118325|351566|P2|NOT COMPLETED|Overall Study||0
145130|NCT01118325|351567|P1|NOT COMPLETED|Overall Study||1
145131|NCT01118325|351565|P3|COMPLETED|Overall Study||45
145132|NCT01118325|351566|P2|COMPLETED|Overall Study||43
145133|NCT01118325|351567|P1|COMPLETED|Overall Study||49
145134|NCT01118325|351565|P3|STARTED|Overall Study||46
145135|NCT01118325|351566|P2|STARTED|Overall Study||43
145136|NCT01118325|351567|P1|STARTED|Overall Study||50
145137|NCT01118312|351613|P2|NOT COMPLETED|Overall Study||35
145138|NCT01118312|351614|P1|NOT COMPLETED|Overall Study||34
145139|NCT01118312|351613|P2|COMPLETED|Overall Study||164
145140|NCT01118312|351614|P1|COMPLETED|Overall Study||155
145141|NCT01118312|351613|P2|STARTED|Overall Study||199
145142|NCT01118312|351614|P1|STARTED|Overall Study||189
145143|NCT01118273|351628|P6|NOT COMPLETED|Overall Study||0
145144|NCT01118273|351629|P5|NOT COMPLETED|Overall Study||0
145145|NCT01118273|351630|P4|NOT COMPLETED|Overall Study||0
145146|NCT01118273|351631|P3|NOT COMPLETED|Overall Study||0
145147|NCT01118273|351632|P2|NOT COMPLETED|Overall Study||0
145148|NCT01118273|351633|P1|NOT COMPLETED|Overall Study||0
145149|NCT01118273|351628|P6|COMPLETED|Overall Study||27
145150|NCT01118273|351629|P5|COMPLETED|Overall Study||27
145151|NCT01118273|351630|P4|COMPLETED|Overall Study||27
145152|NCT01118273|351631|P3|COMPLETED|Overall Study||27
145153|NCT01118273|351632|P2|COMPLETED|Overall Study||27
145154|NCT01118273|351633|P1|COMPLETED|Overall Study||27
145155|NCT01118273|351628|P6|STARTED|Overall Study||27
145156|NCT01118273|351629|P5|STARTED|Overall Study||27
145157|NCT01118273|351630|P4|STARTED|Overall Study||27
145158|NCT01118273|351631|P3|STARTED|Overall Study||27
145159|NCT01118273|351632|P2|STARTED|Overall Study||27
145160|NCT01118273|351633|P1|STARTED|Overall Study||27
145161|NCT01118221|351799|P2|NOT COMPLETED|Overall Study||1
145162|NCT01118221|351800|P1|NOT COMPLETED|Overall Study||3
145163|NCT01118221|351799|P2|COMPLETED|Overall Study||10
145164|NCT01118221|351800|P1|COMPLETED|Overall Study||11
145165|NCT01118221|351799|P2|STARTED|Overall Study||11
145166|NCT01118221|351800|P1|STARTED|Overall Study||14
145167|NCT01118143|351812|P2|NOT COMPLETED|Overall Study||5
145168|NCT01118143|351813|P1|NOT COMPLETED|Overall Study||2
145169|NCT01118143|351812|P2|COMPLETED|Overall Study||64
145170|NCT01118143|351813|P1|COMPLETED|Overall Study||62
145171|NCT01118143|351812|P2|STARTED|Overall Study||69
145172|NCT01118143|351813|P1|STARTED|Overall Study||64
145173|NCT01118117|351823|P2|NOT COMPLETED|Overall Study||0
145174|NCT01118117|351824|P1|NOT COMPLETED|Overall Study||21
145175|NCT01118117|351823|P2|COMPLETED|Overall Study||15
145176|NCT01118117|351824|P1|COMPLETED|Overall Study||240
145177|NCT01118117|351823|P2|STARTED|Overall Study||15
145178|NCT01118117|351824|P1|STARTED|Overall Study||261
145179|NCT01118091|351845|P2|NOT COMPLETED|Overall Study||0
145180|NCT01118091|351846|P1|NOT COMPLETED|Overall Study||0
145181|NCT01118091|351845|P2|COMPLETED|Overall Study||5
145182|NCT01118091|351846|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
145183|NCT01118091|351845|P2|STARTED|Overall Study||5
145184|NCT01118091|351846|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
145185|NCT01118052|351856|P1|NOT COMPLETED|Overall Study||2
145186|NCT01118052|351856|P1|COMPLETED|Overall Study||20
145187|NCT01118052|351856|P1|STARTED|Overall Study||22
145188|NCT01118013|351869|P1|NOT COMPLETED|Overall Study||0
145189|NCT01118013|351869|P1|COMPLETED|Overall Study||6
145190|NCT01118013|351869|P1|STARTED|Overall Study||6
145191|NCT01117987|351879|P2|NOT COMPLETED|Overall Study||74
145192|NCT01117987|351880|P1|NOT COMPLETED|Overall Study||61
145193|NCT01117987|351879|P2|COMPLETED|Overall Study||4
145194|NCT01117987|351880|P1|COMPLETED|Overall Study||5
145195|NCT01117987|351879|P2|STARTED|Overall Study||78
145196|NCT01117987|351880|P1|STARTED|Overall Study||66
145197|NCT01117948|351892|P2|NOT COMPLETED|Open Label||47
145198|NCT01117948|351893|P1|NOT COMPLETED|Open Label||52
145199|NCT01117948|351892|P2|COMPLETED|Open Label||51
145200|NCT01117948|351893|P1|COMPLETED|Open Label||41
145201|NCT01117948|351892|P2|STARTED|Open Label||98
145202|NCT01117948|351893|P1|STARTED|Open Label||93
145203|NCT01117948|351892|P2|NOT COMPLETED|Double Blind||10
145204|NCT01117948|351893|P1|NOT COMPLETED|Double Blind||18
145205|NCT01117948|351892|P2|COMPLETED|Double Blind||98
145206|NCT01117948|351893|P1|COMPLETED|Double Blind||93
145207|NCT01117948|351892|P2|STARTED|Double Blind||108
145208|NCT01117948|351893|P1|STARTED|Double Blind||111
145209|NCT01117870|351901|P2|NOT COMPLETED|Overall Study||0
145210|NCT01117870|351902|P1|NOT COMPLETED|Overall Study||1
145211|NCT01117870|351901|P2|COMPLETED|Overall Study||16
145212|NCT01117870|351902|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
145213|NCT01117870|351901|P2|STARTED|Overall Study||16
145214|NCT01117870|351902|P1|STARTED|Overall Study||15
145215|NCT01117857|351916|P1|NOT COMPLETED|Overall Study||9
145216|NCT01117857|351916|P1|COMPLETED|Overall Study||13
145217|NCT01117857|351916|P1|STARTED|Overall Study||22
145218|NCT01117766|351924|P2|NOT COMPLETED|Second Intervention||5
145219|NCT01117766|351925|P1|NOT COMPLETED|Second Intervention||2
145220|NCT01117766|351924|P2|COMPLETED|Second Intervention||9
145221|NCT01117766|351925|P1|COMPLETED|Second Intervention||11
145222|NCT01117766|351924|P2|STARTED|Second Intervention||14
145223|NCT01117766|351925|P1|STARTED|Second Intervention||13
145224|NCT01117766|351924|P2|NOT COMPLETED|Washout Period||2
145225|NCT01117766|351925|P1|NOT COMPLETED|Washout Period||0
145226|NCT01117766|351924|P2|COMPLETED|Washout Period||14
145227|NCT01117766|351925|P1|COMPLETED|Washout Period||13
145228|NCT01117766|351924|P2|STARTED|Washout Period||16
145229|NCT01117766|351925|P1|STARTED|Washout Period||13
145230|NCT01117766|351924|P2|NOT COMPLETED|First Intervention||1
145231|NCT01117766|351925|P1|NOT COMPLETED|First Intervention||1
145232|NCT01117766|351924|P2|COMPLETED|First Intervention||16
145233|NCT01117766|351925|P1|COMPLETED|First Intervention||13
145234|NCT01117766|351924|P2|Received Treatment|First Intervention||17
145235|NCT01117766|351925|P1|Received Treatment|First Intervention||14
145236|NCT01117766|351924|P2|STARTED|First Intervention||17
145237|NCT01117766|351925|P1|STARTED|First Intervention||14
145238|NCT01117727|351949|P1|NOT COMPLETED|Overall Study||0
145239|NCT01117727|351949|P1|COMPLETED|Overall Study||1
145240|NCT01117727|351949|P1|STARTED|Overall Study||1
145241|NCT01117623|351962|P8|NOT COMPLETED|Overall Study||26
145242|NCT01117623|351963|P7|NOT COMPLETED|Overall Study||6
145243|NCT01117623|351964|P6|NOT COMPLETED|Overall Study||16
145244|NCT01117623|351965|P5|NOT COMPLETED|Overall Study||10
145245|NCT01117623|351966|P4|NOT COMPLETED|Overall Study||6
145246|NCT01117623|351967|P3|NOT COMPLETED|Overall Study||11
145247|NCT01117623|351968|P2|NOT COMPLETED|Overall Study||8
145248|NCT01117623|351969|P1|NOT COMPLETED|Overall Study||3
145249|NCT01117623|351962|P8|COMPLETED|Overall Study||0
145250|NCT01117623|351963|P7|COMPLETED|Overall Study||0
145251|NCT01117623|351964|P6|COMPLETED|Overall Study||0
145252|NCT01117623|351965|P5|COMPLETED|Overall Study||0
145253|NCT01117623|351966|P4|COMPLETED|Overall Study||0
145254|NCT01117623|351967|P3|COMPLETED|Overall Study||0
145255|NCT01117623|351968|P2|COMPLETED|Overall Study||0
145256|NCT01117623|351969|P1|COMPLETED|Overall Study||0
145257|NCT01117623|351962|P8|PK Population|Overall Study||24
145258|NCT01117623|351963|P7|PK Population|Overall Study||6
145259|NCT01117623|351964|P6|PK Population|Overall Study||14
145260|NCT01117623|351965|P5|PK Population|Overall Study||10
145261|NCT01117623|351966|P4|PK Population|Overall Study||6
145262|NCT01117623|351967|P3|PK Population|Overall Study||10
145263|NCT01117623|351968|P2|PK Population|Overall Study||8
145264|NCT01117623|351969|P1|PK Population|Overall Study||3
145265|NCT01117623|351962|P8|ITT Efficacy Analysis Population|Overall Study||22
145266|NCT01117623|351963|P7|ITT Efficacy Analysis Population|Overall Study||6
145267|NCT01117623|351964|P6|ITT Efficacy Analysis Population|Overall Study||16
145268|NCT01117623|351965|P5|ITT Efficacy Analysis Population|Overall Study||10
145269|NCT01117623|351966|P4|ITT Efficacy Analysis Population|Overall Study||5
145270|NCT01117623|351967|P3|ITT Efficacy Analysis Population|Overall Study||11
145271|NCT01117623|351968|P2|ITT Efficacy Analysis Population|Overall Study||8
145272|NCT01117623|351969|P1|ITT Efficacy Analysis Population|Overall Study||3
145273|NCT01117623|351962|P8|STARTED|Overall Study||26
145274|NCT01117623|351963|P7|STARTED|Overall Study||6
145275|NCT01117623|351964|P6|STARTED|Overall Study||16
145276|NCT01117623|351965|P5|STARTED|Overall Study||10
145277|NCT01117623|351966|P4|STARTED|Overall Study||6
145278|NCT01117623|351967|P3|STARTED|Overall Study||11
145279|NCT01117623|351968|P2|STARTED|Overall Study||8
145280|NCT01117623|351969|P1|STARTED|Overall Study||3
145281|NCT01117480|352121|P1|NOT COMPLETED|Overall Study||28
145282|NCT01117480|352121|P1|COMPLETED|Overall Study||985
145283|NCT01117480|352121|P1|STARTED|Overall Study||1013
145284|NCT01117454|352129|P2|NOT COMPLETED|Overall Study||1
145285|NCT01117454|352130|P1|NOT COMPLETED|Overall Study||0
145286|NCT01117454|352129|P2|COMPLETED|Overall Study||7
145287|NCT01117454|352130|P1|COMPLETED|Overall Study||6
145288|NCT01117454|352129|P2|STARTED|Overall Study||8
145289|NCT01117454|352130|P1|STARTED|Overall Study||6
145290|NCT01117428|352142|P6|NOT COMPLETED|Overall Study||20
145291|NCT01117428|352143|P5|NOT COMPLETED|Overall Study||17
145292|NCT01117428|352144|P4|NOT COMPLETED|Overall Study||12
145293|NCT01117428|352145|P3|NOT COMPLETED|Overall Study||13
145294|NCT01117428|352146|P2|NOT COMPLETED|Overall Study||29
145295|NCT01117428|352147|P1|NOT COMPLETED|Overall Study||20
145296|NCT01117428|352142|P6|COMPLETED|Overall Study||0
145297|NCT01117428|352143|P5|COMPLETED|Overall Study||0
145298|NCT01117428|352144|P4|COMPLETED|Overall Study||0
145299|NCT01117428|352145|P3|COMPLETED|Overall Study||0
145300|NCT01117428|352146|P2|COMPLETED|Overall Study||0
145301|NCT01117428|352147|P1|COMPLETED|Overall Study||0
145302|NCT01117428|352142|P6|STARTED|Overall Study||20
145303|NCT01117428|352143|P5|STARTED|Overall Study||17
145304|NCT01117428|352144|P4|STARTED|Overall Study||12
145305|NCT01117428|352145|P3|STARTED|Overall Study||13
145306|NCT01117428|352146|P2|STARTED|Overall Study||29
145307|NCT01117428|352147|P1|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
145308|NCT01117350|352181|P2|NOT COMPLETED|Extension Period||63
145309|NCT01117350|352182|P1|NOT COMPLETED|Extension Period||0
145310|NCT01117350|352181|P2|COMPLETED|Extension Period||147
145311|NCT01117350|352182|P1|COMPLETED|Extension Period||0
145312|NCT01117350|352181|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
145313|NCT01117350|352182|P1|mITT Population (Extension)|Extension Period||0
145314|NCT01117350|352181|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
145315|NCT01117350|352182|P1|TREATED = Safety Population (Extension)|Extension Period||0
145316|NCT01117350|352181|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
145317|NCT01117350|352182|P1|STARTED|Extension Period||0
145318|NCT01117350|352181|P2|NOT COMPLETED|Comparative Period||75
145319|NCT01117350|352182|P1|NOT COMPLETED|Comparative Period||42
145320|NCT01117350|352181|P2|COMPLETED|Comparative Period||414
145321|NCT01117350|352182|P1|COMPLETED|Comparative Period||447
145322|NCT01117350|352181|P2|mITT Population|Comparative Period||470
145323|NCT01117350|352182|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
145324|NCT01117350|352181|P2|TREATED = Safety Population|Comparative Period||481
145325|NCT01117350|352182|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
145326|NCT01117350|352181|P2|STARTED|Comparative Period||489
145327|NCT01117350|352182|P1|STARTED|Comparative Period|STARTED: randomized|489
145328|NCT01117337|352214|P2|NOT COMPLETED|Overall Study||0
145329|NCT01117337|352215|P1|NOT COMPLETED|Overall Study||4
145330|NCT01117337|352214|P2|COMPLETED|Overall Study||52
145420|NCT01116986|352341|P19|COMPLETED|Overall Study||20
145331|NCT01117337|352215|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
145332|NCT01117337|352214|P2|Underwent Surgery|Overall Study||52
145333|NCT01117337|352215|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
145334|NCT01117337|352214|P2|STARTED|Overall Study||52
145335|NCT01117337|352215|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
145336|NCT01117311|352225|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
145337|NCT01117311|352226|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
145338|NCT01117311|352225|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
145339|NCT01117311|352226|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
145340|NCT01117311|352225|P2|STARTED|Second Intervention - Mixed Meal 3||4
145341|NCT01117311|352226|P1|STARTED|Second Intervention - Mixed Meal 3||3
145342|NCT01117311|352225|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
145343|NCT01117311|352226|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
145344|NCT01117311|352225|P2|COMPLETED|First Intervention - Mixed Meal 2||4
145345|NCT01117311|352226|P1|COMPLETED|First Intervention - Mixed Meal 2||3
145346|NCT01117311|352225|P2|STARTED|First Intervention - Mixed Meal 2||4
145347|NCT01117311|352226|P1|STARTED|First Intervention - Mixed Meal 2||3
145348|NCT01117311|352225|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
145349|NCT01117311|352226|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
145350|NCT01117311|352225|P2|COMPLETED|Lead-in Mixed Meal 1||4
145351|NCT01117311|352226|P1|COMPLETED|Lead-in Mixed Meal 1||3
145352|NCT01117311|352225|P2|STARTED|Lead-in Mixed Meal 1||4
145353|NCT01117311|352226|P1|STARTED|Lead-in Mixed Meal 1||3
145354|NCT01117181|352236|P2|NOT COMPLETED|Overall Study||2
145355|NCT01117181|352237|P1|NOT COMPLETED|Overall Study||1
145356|NCT01117181|352236|P2|COMPLETED|Overall Study||29
145357|NCT01117181|352237|P1|COMPLETED|Overall Study||28
145358|NCT01117181|352236|P2|STARTED|Overall Study||31
145359|NCT01117181|352237|P1|STARTED|Overall Study||29
145360|NCT01117090|352255|P1|NOT COMPLETED|Overall Study||0
145361|NCT01117090|352255|P1|COMPLETED|Overall Study||47
145362|NCT01117090|352255|P1|STARTED|Overall Study||47
145363|NCT01117051|352268|P2|NOT COMPLETED|Overall Study||11
145364|NCT01117051|352269|P1|NOT COMPLETED|Overall Study||13
145365|NCT01117051|352268|P2|COMPLETED|Overall Study||77
145366|NCT01117051|352269|P1|COMPLETED|Overall Study||73
145367|NCT01117051|352268|P2|STARTED|Overall Study||88
145368|NCT01117051|352269|P1|STARTED|Overall Study||86
145369|NCT01117012|352279|P2|NOT COMPLETED|Overall Study||5
145370|NCT01117012|352280|P1|NOT COMPLETED|Overall Study||8
145371|NCT01117012|352279|P2|COMPLETED|Overall Study||98
145372|NCT01117012|352280|P1|COMPLETED|Overall Study||81
145373|NCT01117012|352279|P2|STARTED|Overall Study||103
145374|NCT01117012|352280|P1|STARTED|Overall Study||89
145375|NCT01116986|352328|P32|NOT COMPLETED|Overall Study||3
145376|NCT01116986|352329|P31|NOT COMPLETED|Overall Study||1
145377|NCT01116986|352330|P30|NOT COMPLETED|Overall Study||0
145378|NCT01116986|352331|P29|NOT COMPLETED|Overall Study||0
145379|NCT01116986|352332|P28|NOT COMPLETED|Overall Study||1
145380|NCT01116986|352333|P27|NOT COMPLETED|Overall Study||4
145381|NCT01116986|352334|P26|NOT COMPLETED|Overall Study||0
145382|NCT01116986|352335|P25|NOT COMPLETED|Overall Study||3
145383|NCT01116986|352336|P24|NOT COMPLETED|Overall Study||2
145384|NCT01116986|352337|P23|NOT COMPLETED|Overall Study||4
145385|NCT01116986|352338|P22|NOT COMPLETED|Overall Study||2
145386|NCT01116986|352339|P21|NOT COMPLETED|Overall Study||2
145387|NCT01116986|352340|P20|NOT COMPLETED|Overall Study||2
145388|NCT01116986|352341|P19|NOT COMPLETED|Overall Study||3
145389|NCT01116986|352342|P18|NOT COMPLETED|Overall Study||5
145390|NCT01116986|352343|P17|NOT COMPLETED|Overall Study||3
145391|NCT01116986|352344|P16|NOT COMPLETED|Overall Study||6
145392|NCT01116986|352345|P15|NOT COMPLETED|Overall Study||0
145393|NCT01116986|352346|P14|NOT COMPLETED|Overall Study||3
145394|NCT01116986|352347|P13|NOT COMPLETED|Overall Study||1
145395|NCT01116986|352348|P12|NOT COMPLETED|Overall Study||0
145396|NCT01116986|352349|P11|NOT COMPLETED|Overall Study||1
145397|NCT01116986|352350|P10|NOT COMPLETED|Overall Study||4
145398|NCT01116986|352351|P9|NOT COMPLETED|Overall Study||1
145399|NCT01116986|352352|P8|NOT COMPLETED|Overall Study||2
145400|NCT01116986|352353|P7|NOT COMPLETED|Overall Study||2
145401|NCT01116986|352354|P6|NOT COMPLETED|Overall Study||2
145402|NCT01116986|352355|P5|NOT COMPLETED|Overall Study||4
145403|NCT01116986|352356|P4|NOT COMPLETED|Overall Study||2
145404|NCT01116986|352357|P3|NOT COMPLETED|Overall Study||2
145405|NCT01116986|352358|P2|NOT COMPLETED|Overall Study||3
145406|NCT01116986|352359|P1|NOT COMPLETED|Overall Study||2
145407|NCT01116986|352328|P32|COMPLETED|Overall Study||14
145408|NCT01116986|352329|P31|COMPLETED|Overall Study||16
145409|NCT01116986|352330|P30|COMPLETED|Overall Study||17
145410|NCT01116986|352331|P29|COMPLETED|Overall Study||17
145411|NCT01116986|352332|P28|COMPLETED|Overall Study||18
145412|NCT01116986|352333|P27|COMPLETED|Overall Study||14
145413|NCT01116986|352334|P26|COMPLETED|Overall Study||19
145414|NCT01116986|352335|P25|COMPLETED|Overall Study||15
145415|NCT01116986|352336|P24|COMPLETED|Overall Study||19
145416|NCT01116986|352337|P23|COMPLETED|Overall Study||19
145417|NCT01116986|352338|P22|COMPLETED|Overall Study||18
145418|NCT01116986|352339|P21|COMPLETED|Overall Study||22
145419|NCT01116986|352340|P20|COMPLETED|Overall Study||13
145421|NCT01116986|352342|P18|COMPLETED|Overall Study||19
145422|NCT01116986|352343|P17|COMPLETED|Overall Study||13
145423|NCT01116986|352344|P16|COMPLETED|Overall Study||15
145424|NCT01116986|352345|P15|COMPLETED|Overall Study||17
145425|NCT01116986|352346|P14|COMPLETED|Overall Study||16
145426|NCT01116986|352347|P13|COMPLETED|Overall Study||16
145427|NCT01116986|352348|P12|COMPLETED|Overall Study||20
145428|NCT01116986|352349|P11|COMPLETED|Overall Study||18
145429|NCT01116986|352350|P10|COMPLETED|Overall Study||19
145430|NCT01116986|352351|P9|COMPLETED|Overall Study||19
145431|NCT01116986|352352|P8|COMPLETED|Overall Study||20
145432|NCT01116986|352353|P7|COMPLETED|Overall Study||20
145433|NCT01116986|352354|P6|COMPLETED|Overall Study||20
145434|NCT01116986|352355|P5|COMPLETED|Overall Study||20
145435|NCT01116986|352356|P4|COMPLETED|Overall Study||20
145436|NCT01116986|352357|P3|COMPLETED|Overall Study||16
145437|NCT01116986|352358|P2|COMPLETED|Overall Study||16
145438|NCT01116986|352359|P1|COMPLETED|Overall Study||22
145439|NCT01116986|352328|P32|STARTED|Overall Study||17
145440|NCT01116986|352329|P31|STARTED|Overall Study||17
145441|NCT01116986|352330|P30|STARTED|Overall Study||17
145442|NCT01116986|352331|P29|STARTED|Overall Study||17
145443|NCT01116986|352332|P28|STARTED|Overall Study||19
145444|NCT01116986|352333|P27|STARTED|Overall Study||18
145445|NCT01116986|352334|P26|STARTED|Overall Study||19
145446|NCT01116986|352335|P25|STARTED|Overall Study||18
145447|NCT01116986|352336|P24|STARTED|Overall Study||21
145448|NCT01116986|352337|P23|STARTED|Overall Study||23
145449|NCT01116986|352338|P22|STARTED|Overall Study||20
145450|NCT01116986|352339|P21|STARTED|Overall Study||24
145451|NCT01116986|352340|P20|STARTED|Overall Study||15
145452|NCT01116986|352341|P19|STARTED|Overall Study||23
145453|NCT01116986|352342|P18|STARTED|Overall Study||24
145454|NCT01116986|352343|P17|STARTED|Overall Study||16
145455|NCT01116986|352344|P16|STARTED|Overall Study||21
145456|NCT01116986|352345|P15|STARTED|Overall Study||17
145457|NCT01116986|352346|P14|STARTED|Overall Study||19
145458|NCT01116986|352347|P13|STARTED|Overall Study||17
145459|NCT01116986|352348|P12|STARTED|Overall Study||20
145460|NCT01116986|352349|P11|STARTED|Overall Study||19
145461|NCT01116986|352350|P10|STARTED|Overall Study||23
145462|NCT01116986|352351|P9|STARTED|Overall Study||20
145463|NCT01116986|352352|P8|STARTED|Overall Study||22
145464|NCT01116986|352353|P7|STARTED|Overall Study||22
145465|NCT01116986|352354|P6|STARTED|Overall Study||22
145466|NCT01116986|352355|P5|STARTED|Overall Study||24
145467|NCT01116986|352356|P4|STARTED|Overall Study||22
145468|NCT01116986|352357|P3|STARTED|Overall Study||18
145469|NCT01116986|352358|P2|STARTED|Overall Study||19
145470|NCT01116986|352359|P1|STARTED|Overall Study||24
145471|NCT01116934|352393|P2|NOT COMPLETED|Overall Study||0
145472|NCT01116934|352394|P1|NOT COMPLETED|Overall Study||0
145473|NCT01116934|352393|P2|COMPLETED|Overall Study||9
145474|NCT01116934|352394|P1|COMPLETED|Overall Study||8
145475|NCT01116934|352393|P2|STARTED|Overall Study||9
145476|NCT01116934|352394|P1|STARTED|Overall Study||8
145477|NCT01116921|352402|P2|NOT COMPLETED|Overall Study||0
145478|NCT01116921|352403|P1|NOT COMPLETED|Overall Study||0
145479|NCT01116921|352402|P2|COMPLETED|Overall Study||50
145480|NCT01116921|352403|P1|COMPLETED|Overall Study||53
145481|NCT01116921|352402|P2|STARTED|Overall Study||50
145482|NCT01116921|352403|P1|STARTED|Overall Study||53
145483|NCT01116882|352421|P2|NOT COMPLETED|12-month||99
145484|NCT01116882|352422|P1|NOT COMPLETED|12-month||267
145485|NCT01116882|352421|P2|COMPLETED|12-month||787
145486|NCT01116882|352422|P1|COMPLETED|12-month||2439
145487|NCT01116882|352421|P2|STARTED|12-month||886
145488|NCT01116882|352422|P1|STARTED|12-month||2706
145489|NCT01116882|352421|P2|NOT COMPLETED|30-day||31
145490|NCT01116882|352422|P1|NOT COMPLETED|30-day||68
145491|NCT01116882|352421|P2|COMPLETED|30-day||886
145492|NCT01116882|352422|P1|COMPLETED|30-day||2706
145493|NCT01116882|352421|P2|STARTED|30-day||917
145494|NCT01116882|352422|P1|STARTED|30-day||2774
145495|NCT01116687|352460|P1|NOT COMPLETED|Overall Study||4
145496|NCT01116687|352460|P1|COMPLETED|Overall Study||33
145497|NCT01116687|352460|P1|STARTED|Overall Study||37
145498|NCT01116466|352467|P1|NOT COMPLETED|Overall Study||0
145499|NCT01116466|352467|P1|COMPLETED|Overall Study||5
145500|NCT01116466|352467|P1|STARTED|Overall Study||5
145501|NCT01116427|352477|P2|NOT COMPLETED|Extension Phase||2
145502|NCT01116427|352478|P1|NOT COMPLETED|Extension Phase||9
145503|NCT01116427|352477|P2|COMPLETED|Extension Phase||18
145504|NCT01116427|352478|P1|COMPLETED|Extension Phase||29
145505|NCT01116427|352477|P2|STARTED|Extension Phase||20
145506|NCT01116427|352478|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
145507|NCT01116427|352477|P2|NOT COMPLETED|Core Phase||1
145508|NCT01116427|352478|P1|NOT COMPLETED|Core Phase||5
145509|NCT01116427|352477|P2|COMPLETED|Core Phase||20
145510|NCT01116427|352478|P1|COMPLETED|Core Phase||39
145511|NCT01116427|352477|P2|STARTED|Core Phase||21
145512|NCT01116427|352478|P1|STARTED|Core Phase||44
145513|NCT01116401|352514|P1|NOT COMPLETED|Overall Study||0
145514|NCT01116401|352514|P1|COMPLETED|Overall Study||29
145515|NCT01116401|352514|P1|STARTED|Overall Study||29
145516|NCT01116232|352519|P1|NOT COMPLETED|Overall Study||4
145517|NCT01116232|352519|P1|COMPLETED|Overall Study||0
145518|NCT01116232|352519|P1|STARTED|Overall Study||4
145519|NCT01116102|352532|P8|NOT COMPLETED|Overall Study||0
145520|NCT01116102|352533|P7|NOT COMPLETED|Overall Study||0
145521|NCT01116102|352534|P6|NOT COMPLETED|Overall Study||0
145522|NCT01116102|352535|P5|NOT COMPLETED|Overall Study||0
145523|NCT01116102|352536|P4|NOT COMPLETED|Overall Study||0
145524|NCT01116102|352537|P3|NOT COMPLETED|Overall Study||0
145525|NCT01116102|352538|P2|NOT COMPLETED|Overall Study||0
145526|NCT01116102|352539|P1|NOT COMPLETED|Overall Study||0
145527|NCT01116102|352532|P8|COMPLETED|Overall Study||3
145528|NCT01116102|352533|P7|COMPLETED|Overall Study||2
145529|NCT01116102|352534|P6|COMPLETED|Overall Study||2
145530|NCT01116102|352535|P5|COMPLETED|Overall Study||2
145531|NCT01116102|352536|P4|COMPLETED|Overall Study||3
145532|NCT01116102|352537|P3|COMPLETED|Overall Study||3
145533|NCT01116102|352538|P2|COMPLETED|Overall Study||3
145534|NCT01116102|352539|P1|COMPLETED|Overall Study||2
145535|NCT01116102|352532|P8|STARTED|Overall Study||3
145536|NCT01116102|352533|P7|STARTED|Overall Study||2
145537|NCT01116102|352534|P6|STARTED|Overall Study||2
145538|NCT01116102|352535|P5|STARTED|Overall Study||2
145539|NCT01116102|352536|P4|STARTED|Overall Study||3
145540|NCT01116102|352537|P3|STARTED|Overall Study||3
145541|NCT01116102|352538|P2|STARTED|Overall Study||3
145542|NCT01116102|352539|P1|STARTED|Overall Study||2
145543|NCT01116037|352581|P1|NOT COMPLETED|Overall Study||25
145544|NCT01116037|352581|P1|COMPLETED|Overall Study||1
145545|NCT01116037|352581|P1|STARTED|Overall Study||26
145546|NCT01116024|352586|P1|NOT COMPLETED|Overall Study||52
145547|NCT01116024|352586|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
145548|NCT01116024|352586|P1|STARTED|Overall Study|Patient Enrollment start date|148
145549|NCT01115998|352627|P2|NOT COMPLETED|Overall Study||6
145550|NCT01115998|352628|P1|NOT COMPLETED|Overall Study||6
145551|NCT01115998|352627|P2|COMPLETED|Overall Study||11
145552|NCT01115998|352628|P1|COMPLETED|Overall Study||11
145553|NCT01115998|352627|P2|STARTED|Overall Study||17
145554|NCT01115998|352628|P1|STARTED|Overall Study||17
145555|NCT01115933|352638|P1|NOT COMPLETED|Overall Study||1
145556|NCT01115933|352638|P1|COMPLETED|Overall Study||64
145557|NCT01115933|352638|P1|STARTED|Overall Study||65
145558|NCT01115855|352735|P2|NOT COMPLETED|Overall Study||36
145559|NCT01115855|352736|P1|NOT COMPLETED|Overall Study||36
145560|NCT01115855|352735|P2|COMPLETED|Overall Study||74
145561|NCT01115855|352736|P1|COMPLETED|Overall Study||75
145562|NCT01115855|352735|P2|STARTED|Overall Study||110
145563|NCT01115855|352736|P1|STARTED|Overall Study||111
145564|NCT01115738|352787|P3|NOT COMPLETED|Overall Study||27
145565|NCT01115738|352788|P2|NOT COMPLETED|Overall Study||21
145566|NCT01115738|352789|P1|NOT COMPLETED|Overall Study||25
145567|NCT01115738|352787|P3|COMPLETED|Overall Study||62
145568|NCT01115738|352788|P2|COMPLETED|Overall Study||62
145569|NCT01115738|352789|P1|COMPLETED|Overall Study||85
145570|NCT01115738|352787|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
145571|NCT01115738|352788|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
145572|NCT01115738|352789|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
145573|NCT01115738|352787|P3|Received Any Treatment|Overall Study||88
145574|NCT01115738|352788|P2|Received Any Treatment|Overall Study||79
145575|NCT01115738|352789|P1|Received Any Treatment|Overall Study||109
145576|NCT01115738|352787|P3|STARTED|Overall Study||89
145577|NCT01115738|352788|P2|STARTED|Overall Study||83
145578|NCT01115738|352789|P1|STARTED|Overall Study||110
145579|NCT01115699|352823|P1|NOT COMPLETED|Overall Study||0
145580|NCT01115699|352823|P1|COMPLETED|Overall Study||2
145581|NCT01115699|352823|P1|STARTED|Overall Study||2
145582|NCT01115673|352831|P3|NOT COMPLETED|Overall Study||0
145583|NCT01115673|352832|P2|NOT COMPLETED|Overall Study||0
145584|NCT01115673|352833|P1|NOT COMPLETED|Overall Study||0
145585|NCT01115673|352831|P3|COMPLETED|Overall Study||60
145586|NCT01115673|352832|P2|COMPLETED|Overall Study||241
145587|NCT01115673|352833|P1|COMPLETED|Overall Study||239
145588|NCT01115673|352831|P3|STARTED|Overall Study||60
145589|NCT01115673|352832|P2|STARTED|Overall Study||241
145590|NCT01115673|352833|P1|STARTED|Overall Study||239
145591|NCT01115660|352969|P2|NOT COMPLETED|Overall Study||0
145592|NCT01115660|352970|P1|NOT COMPLETED|Overall Study||1
145593|NCT01115660|352969|P2|COMPLETED|Overall Study||10
145594|NCT01115660|352970|P1|COMPLETED|Overall Study||19
145595|NCT01115660|352969|P2|STARTED|Overall Study||10
145596|NCT01115660|352970|P1|STARTED|Overall Study||20
145597|NCT01115582|352978|P1|NOT COMPLETED|Overall Study||0
145598|NCT01115582|352978|P1|COMPLETED|Overall Study||16
145599|NCT01115582|352978|P1|STARTED|Overall Study||16
145600|NCT01115569|352987|P2|NOT COMPLETED|Maintenance Phase||139
145601|NCT01115569|352988|P1|NOT COMPLETED|Maintenance Phase||0
145602|NCT01115569|352987|P2|COMPLETED|Maintenance Phase||285
145603|NCT01115569|352988|P1|COMPLETED|Maintenance Phase||0
145604|NCT01115569|352987|P2|STARTED|Maintenance Phase||424
145605|NCT01115569|352988|P1|STARTED|Maintenance Phase||0
145606|NCT01115569|352987|P2|NOT COMPLETED|Conversion/Titration Phase||0
145607|NCT01115569|352988|P1|NOT COMPLETED|Conversion/Titration Phase||214
145608|NCT01115569|352987|P2|COMPLETED|Conversion/Titration Phase||0
145609|NCT01115569|352988|P1|COMPLETED|Conversion/Titration Phase||424
145610|NCT01115569|352987|P2|STARTED|Conversion/Titration Phase||0
145611|NCT01115569|352988|P1|STARTED|Conversion/Titration Phase||638
145612|NCT01115556|352995|P2|NOT COMPLETED|Overall Study||0
145613|NCT01115556|352996|P1|NOT COMPLETED|Overall Study||0
145614|NCT01115556|352995|P2|COMPLETED|Overall Study||2
145615|NCT01115556|352996|P1|COMPLETED|Overall Study||7
145616|NCT01115556|352995|P2|STARTED|Overall Study||2
145617|NCT01115556|352996|P1|STARTED|Overall Study||7
145618|NCT01115517|353006|P2|NOT COMPLETED|Overall Study||5
145619|NCT01115517|353007|P1|NOT COMPLETED|Overall Study||4
145620|NCT01115517|353006|P2|COMPLETED|Overall Study||16
145621|NCT01115517|353007|P1|COMPLETED|Overall Study||14
145622|NCT01115517|353006|P2|STARTED|Overall Study||21
145623|NCT01115517|353007|P1|STARTED|Overall Study||18
145624|NCT01115491|353017|P1|NOT COMPLETED|Overall Study||30
145625|NCT01115491|353017|P1|COMPLETED|Overall Study||2
145626|NCT01115491|353017|P1|STARTED|Overall Study||32
145627|NCT01115452|353026|P1|NOT COMPLETED|Overall Study||0
145628|NCT01115452|353026|P1|COMPLETED|Overall Study||32
145629|NCT01115452|353026|P1|STARTED|Overall Study||32
145630|NCT01115244|353078|P2|NOT COMPLETED|Overall Study||0
145631|NCT01115244|353079|P1|NOT COMPLETED|Overall Study||0
145632|NCT01115244|353078|P2|COMPLETED|Overall Study||0
145633|NCT01115244|353079|P1|COMPLETED|Overall Study||0
145634|NCT01115244|353078|P2|STARTED|Overall Study||0
145635|NCT01115244|353079|P1|STARTED|Overall Study||0
145636|NCT01115166|353089|P1|NOT COMPLETED|Overall Study||0
145637|NCT01115166|353089|P1|COMPLETED|Overall Study||10
145638|NCT01115166|353089|P1|STARTED|Overall Study||10
145639|NCT01115101|353097|P2|NOT COMPLETED|Overall Study||0
145640|NCT01115101|353098|P1|NOT COMPLETED|Overall Study||0
145641|NCT01115101|353097|P2|COMPLETED|Overall Study||126
145642|NCT01115101|353098|P1|COMPLETED|Overall Study||113
145643|NCT01115101|353097|P2|STARTED|Overall Study||126
145644|NCT01115101|353098|P1|STARTED|Overall Study||113
145645|NCT01114997|353107|P3|NOT COMPLETED|Overall Study||0
145646|NCT01114997|353108|P2|NOT COMPLETED|Overall Study||0
145647|NCT01114997|353109|P1|NOT COMPLETED|Overall Study||0
145648|NCT01114997|353107|P3|COMPLETED|Overall Study||11
145649|NCT01114997|353108|P2|COMPLETED|Overall Study||10
145650|NCT01114997|353109|P1|COMPLETED|Overall Study||11
145651|NCT01114997|353107|P3|STARTED|Overall Study||11
145652|NCT01114997|353108|P2|STARTED|Overall Study||10
145653|NCT01114997|353109|P1|STARTED|Overall Study||11
145654|NCT01114945|353139|P4|NOT COMPLETED|Overall Study||0
145655|NCT01114945|353140|P3|NOT COMPLETED|Overall Study||0
145656|NCT01114945|353141|P2|NOT COMPLETED|Overall Study||0
145657|NCT01114945|353142|P1|NOT COMPLETED|Overall Study||0
145658|NCT01114945|353139|P4|COMPLETED|Overall Study||31
145659|NCT01114945|353140|P3|COMPLETED|Overall Study||30
145660|NCT01114945|353141|P2|COMPLETED|Overall Study||30
145661|NCT01114945|353142|P1|COMPLETED|Overall Study||30
145662|NCT01114945|353139|P4|STARTED|Overall Study||31
145663|NCT01114945|353140|P3|STARTED|Overall Study||30
145664|NCT01114945|353141|P2|STARTED|Overall Study||30
145665|NCT01114945|353142|P1|STARTED|Overall Study||30
145666|NCT01114893|353169|P5|NOT COMPLETED|Overall Study||0
145667|NCT01114893|353170|P4|NOT COMPLETED|Overall Study||0
145668|NCT01114893|353171|P3|NOT COMPLETED|Overall Study||0
145669|NCT01114893|353172|P2|NOT COMPLETED|Overall Study||0
145670|NCT01114893|353173|P1|NOT COMPLETED|Overall Study||0
145671|NCT01114893|353169|P5|COMPLETED|Overall Study||12
145672|NCT01114893|353170|P4|COMPLETED|Overall Study||13
145673|NCT01114893|353171|P3|COMPLETED|Overall Study||14
145674|NCT01114893|353172|P2|COMPLETED|Overall Study||14
145675|NCT01114893|353173|P1|COMPLETED|Overall Study||14
145676|NCT01114893|353169|P5|STARTED|Overall Study||12
145677|NCT01114893|353170|P4|STARTED|Overall Study||13
145678|NCT01114893|353171|P3|STARTED|Overall Study||14
145679|NCT01114893|353172|P2|STARTED|Overall Study||14
145680|NCT01114893|353173|P1|STARTED|Overall Study||14
145681|NCT01114880|353192|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
145682|NCT01114880|353193|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
145683|NCT01114880|353192|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
145684|NCT01114880|353193|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
145685|NCT01114880|353192|P2|STARTED|Period 2 (Week 12 to Week 24)||113
145686|NCT01114880|353193|P1|STARTED|Period 2 (Week 12 to Week 24)||224
145687|NCT01114880|353192|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
145688|NCT01114880|353193|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
145689|NCT01114880|353192|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
145690|NCT01114880|353193|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
145691|NCT01114880|353192|P2|STARTED|Period 1 (Week 0 to Week 12)||115
145692|NCT01114880|353193|P1|STARTED|Period 1 (Week 0 to Week 12)||229
145693|NCT01114828|353245|P2|NOT COMPLETED|Overall Study||4
145694|NCT01114828|353246|P1|NOT COMPLETED|Overall Study||3
145695|NCT01114828|353245|P2|COMPLETED|Overall Study||17
145696|NCT01114828|353246|P1|COMPLETED|Overall Study||16
145697|NCT01114828|353245|P2|STARTED|Overall Study||21
145698|NCT01114828|353246|P1|STARTED|Overall Study||19
145699|NCT01114737|353256|P2|NOT COMPLETED|Open-Label Treatment Period||2
145700|NCT01114737|353257|P1|NOT COMPLETED|Open-Label Treatment Period||5
145701|NCT01114737|353256|P2|COMPLETED|Open-Label Treatment Period||95
145702|NCT01114737|353257|P1|COMPLETED|Open-Label Treatment Period||100
145703|NCT01114737|353256|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
145704|NCT01114737|353257|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
145705|NCT01114737|353256|P2|NOT COMPLETED|Randomized Treatment Period||1
145706|NCT01114737|353257|P1|NOT COMPLETED|Randomized Treatment Period||3
145707|NCT01114737|353256|P2|COMPLETED|Randomized Treatment Period||97
145708|NCT01114737|353257|P1|COMPLETED|Randomized Treatment Period||105
145709|NCT01114737|353256|P2|STARTED|Randomized Treatment Period||98
145710|NCT01114737|353257|P1|STARTED|Randomized Treatment Period||108
145711|NCT01114724|353305|P1|NOT COMPLETED|Overall Study||10
145712|NCT01114724|353305|P1|COMPLETED|Overall Study||40
145713|NCT01114724|353305|P1|STARTED|Overall Study||50
145714|NCT01114672|353325|P2|NOT COMPLETED|Overall Study||2
145715|NCT01114672|353326|P1|NOT COMPLETED|Overall Study||4
145716|NCT01114672|353325|P2|COMPLETED|Overall Study||23
145717|NCT01114672|353326|P1|COMPLETED|Overall Study||21
145718|NCT01114672|353325|P2|STARTED|Overall Study||25
145719|NCT01114672|353326|P1|STARTED|Overall Study||25
145720|NCT01114620|353332|P1|NOT COMPLETED|Overall Study||0
145721|NCT01114620|353332|P1|COMPLETED|Overall Study||50
145722|NCT01114620|353332|P1|STARTED|Overall Study||50
145723|NCT01114581|353365|P2|NOT COMPLETED|Overall Study||0
145724|NCT01114581|353366|P1|NOT COMPLETED|Overall Study||0
145725|NCT01114581|353365|P2|COMPLETED|Overall Study||19
145726|NCT01114581|353366|P1|COMPLETED|Overall Study||19
145727|NCT01114581|353365|P2|STARTED|Overall Study||19
145728|NCT01114581|353366|P1|STARTED|Overall Study||19
145729|NCT01114529|353377|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
145730|NCT01114529|353378|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
145731|NCT01114529|353379|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
145732|NCT01114529|353377|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
145733|NCT01114529|353378|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
145734|NCT01114529|353379|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
145735|NCT01114529|353377|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
145736|NCT01114529|353378|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
145737|NCT01114529|353379|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
145738|NCT01114529|353377|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
145739|NCT01114529|353378|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
145740|NCT01114529|353379|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
145741|NCT01114529|353377|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
145742|NCT01114529|353378|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
145743|NCT01114529|353379|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
145744|NCT01114529|353377|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
145745|NCT01114529|353378|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
145746|NCT01114529|353379|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
145747|NCT01114516|353398|P2|NOT COMPLETED|Overall Study||1
145748|NCT01114516|353399|P1|NOT COMPLETED|Overall Study||2
145749|NCT01114516|353398|P2|COMPLETED|Overall Study||26
145750|NCT01114516|353399|P1|COMPLETED|Overall Study||24
145751|NCT01114516|353398|P2|STARTED|Overall Study||27
145752|NCT01114516|353399|P1|STARTED|Overall Study||26
145753|NCT01114503|353413|P1|NOT COMPLETED|Overall Study||0
145754|NCT01114503|353413|P1|COMPLETED|Overall Study||2
145755|NCT01114503|353413|P1|STARTED|Overall Study||2
145756|NCT01114438|353434|P1|NOT COMPLETED|Overall Study||14
145757|NCT01114438|353434|P1|COMPLETED|Overall Study||31
145758|NCT01114438|353434|P1|STARTED|Overall Study||45
145759|NCT01114373|353444|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
145760|NCT01114373|353445|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
145761|NCT01114373|353444|P2|COMPLETED|Intervention 2 (4 Weeks)||18
145762|NCT01114373|353445|P1|COMPLETED|Intervention 2 (4 Weeks)||18
145763|NCT01114373|353444|P2|STARTED|Intervention 2 (4 Weeks)||19
145764|NCT01114373|353445|P1|STARTED|Intervention 2 (4 Weeks)||18
145765|NCT01114373|353444|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
145766|NCT01114373|353445|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
145767|NCT01114373|353444|P2|COMPLETED|Intervention 1 (4 Weeks)||19
145768|NCT01114373|353445|P1|COMPLETED|Intervention 1 (4 Weeks)||18
145769|NCT01114373|353444|P2|STARTED|Intervention 1 (4 Weeks)||19
145770|NCT01114373|353445|P1|STARTED|Intervention 1 (4 Weeks)||21
145771|NCT01114360|353477|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
145772|NCT01114360|353478|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
145773|NCT01114360|353477|P2|COMPLETED|Intervention 2 (4 Weeks)||18
145774|NCT01114360|353478|P1|COMPLETED|Intervention 2 (4 Weeks)||18
145775|NCT01114360|353477|P2|STARTED|Intervention 2 (4 Weeks)||18
145776|NCT01114360|353478|P1|STARTED|Intervention 2 (4 Weeks)||18
145777|NCT01114360|353477|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
145778|NCT01114360|353478|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
145779|NCT01114360|353477|P2|COMPLETED|Intervention 1 (4 Weeks)||18
145780|NCT01114360|353478|P1|COMPLETED|Intervention 1 (4 Weeks)||18
145781|NCT01114360|353477|P2|STARTED|Intervention 1 (4 Weeks)||19
145782|NCT01114360|353478|P1|STARTED|Intervention 1 (4 Weeks)||18
145783|NCT01114334|353516|P2|NOT COMPLETED|Overall Study||22
145784|NCT01114334|353517|P1|NOT COMPLETED|Overall Study||21
145785|NCT01114334|353516|P2|COMPLETED|Overall Study||58
145786|NCT01114334|353517|P1|COMPLETED|Overall Study||67
145787|NCT01114334|353516|P2|STARTED|Overall Study||80
145788|NCT01114334|353517|P1|STARTED|Overall Study||88
145789|NCT01113931|353529|P2|NOT COMPLETED|Overall Study||17
145790|NCT01113931|353530|P1|NOT COMPLETED|Overall Study||19
145791|NCT01113931|353529|P2|COMPLETED|Overall Study||231
145792|NCT01113931|353530|P1|COMPLETED|Overall Study||228
145793|NCT01113931|353529|P2|mITT Population|Overall Study||190
145794|NCT01113931|353530|P1|mITT Population|Overall Study||188
145795|NCT01113931|353529|P2|Safety Population|Overall Study||248
145796|NCT01113931|353530|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
145797|NCT01113931|353529|P2|STARTED|Overall Study||248
145798|NCT01113931|353530|P1|STARTED|Overall Study||247
145799|NCT01113801|353546|P4|NOT COMPLETED|Overall Study||41
145800|NCT01113801|353547|P3|NOT COMPLETED|Overall Study||37
145801|NCT01113801|353548|P2|NOT COMPLETED|Overall Study||40
145802|NCT01113801|353549|P1|NOT COMPLETED|Overall Study||41
145803|NCT01113801|353546|P4|COMPLETED|Overall Study||65
145804|NCT01113801|353547|P3|COMPLETED|Overall Study||66
145805|NCT01113801|353548|P2|COMPLETED|Overall Study||65
145806|NCT01113801|353549|P1|COMPLETED|Overall Study||62
145807|NCT01113801|353546|P4|Received at Least One Dose of Drug|Overall Study||105
145808|NCT01113801|353547|P3|Received at Least One Dose of Drug|Overall Study||103
145809|NCT01113801|353548|P2|Received at Least One Dose of Drug|Overall Study||105
145810|NCT01113801|353549|P1|Received at Least One Dose of Drug|Overall Study||103
145811|NCT01113801|353546|P4|STARTED|Overall Study||106
145812|NCT01113801|353547|P3|STARTED|Overall Study||103
145813|NCT01113801|353548|P2|STARTED|Overall Study||105
145814|NCT01113801|353549|P1|STARTED|Overall Study||103
145815|NCT01113749|353577|P2|NOT COMPLETED|Overall Study||2
145816|NCT01113749|353578|P1|NOT COMPLETED|Overall Study||1
145817|NCT01113749|353577|P2|COMPLETED|Overall Study||127
145818|NCT01113749|353578|P1|COMPLETED|Overall Study||126
145819|NCT01113749|353577|P2|STARTED|Overall Study||129
145820|NCT01113749|353578|P1|STARTED|Overall Study||127
145821|NCT01113723|353590|P2|NOT COMPLETED|Overall Study||0
145822|NCT01113723|353591|P1|NOT COMPLETED|Overall Study||0
145823|NCT01113723|353590|P2|COMPLETED|Overall Study||70
145824|NCT01113723|353591|P1|COMPLETED|Overall Study||70
145825|NCT01113723|353590|P2|STARTED|Overall Study||70
145826|NCT01113723|353591|P1|STARTED|Overall Study||70
145827|NCT01113710|353601|P1|NOT COMPLETED|Overall Study||269
145828|NCT01113710|353601|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
145829|NCT01113710|353601|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
145830|NCT01113632|353612|P2|NOT COMPLETED|Overall Study||25
145831|NCT01113632|353613|P1|NOT COMPLETED|Overall Study||31
145832|NCT01113632|353612|P2|COMPLETED|Overall Study||19
145833|NCT01113632|353613|P1|COMPLETED|Overall Study||2
145834|NCT01113632|353612|P2|STARTED|Overall Study||44
145835|NCT01113632|353613|P1|STARTED|Overall Study||33
145836|NCT01113580|353629|P2|NOT COMPLETED|Overall Study||0
145837|NCT01113580|353630|P1|NOT COMPLETED|Overall Study||1
145838|NCT01113580|353629|P2|COMPLETED|Overall Study||60
145839|NCT01113580|353630|P1|COMPLETED|Overall Study||59
145840|NCT01113580|353629|P2|STARTED|Overall Study||60
145841|NCT01113580|353630|P1|STARTED|Overall Study||60
145842|NCT01113541|353644|P1|NOT COMPLETED|Overall Study||13
145843|NCT01113541|353644|P1|COMPLETED|Overall Study||0
145844|NCT01113541|353644|P1|STARTED|Overall Study||13
145845|NCT01113463|353677|P1|NOT COMPLETED|Overall Study||5
145846|NCT01113463|353677|P1|COMPLETED|Overall Study||12
145847|NCT01113463|353677|P1|STARTED|Overall Study||17
145848|NCT01113398|353682|P1|NOT COMPLETED|Overall Study||0
145849|NCT01113398|353682|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
145850|NCT01113398|353682|P1|STARTED|Overall Study||36
145851|NCT01113385|353689|P1|NOT COMPLETED|Overall Study||0
145852|NCT01113385|353689|P1|COMPLETED|Overall Study||7
145853|NCT01113385|353689|P1|STARTED|Overall Study||7
145854|NCT01113008|353696|P2|NOT COMPLETED|Overall Study||0
145855|NCT01113008|353697|P1|NOT COMPLETED|Overall Study||0
145856|NCT01113008|353696|P2|COMPLETED|Overall Study||133
145857|NCT01113008|353697|P1|COMPLETED|Overall Study||133
145858|NCT01113008|353696|P2|STARTED|Overall Study||133
145859|NCT01113008|353697|P1|STARTED|Overall Study||133
145860|NCT01112917|353707|P2|NOT COMPLETED|Overall Study||15
145861|NCT01112917|353708|P1|NOT COMPLETED|Overall Study||7
145862|NCT01112917|353707|P2|COMPLETED|Overall Study||38
145863|NCT01112917|353708|P1|COMPLETED|Overall Study||89
145864|NCT01112917|353707|P2|STARTED|Overall Study||53
145865|NCT01112917|353708|P1|STARTED|Overall Study||96
145866|NCT01112865|353713|P2|NOT COMPLETED|Second Intervention||0
145867|NCT01112865|353714|P1|NOT COMPLETED|Second Intervention||0
145868|NCT01112865|353713|P2|COMPLETED|Second Intervention||61
145869|NCT01112865|353714|P1|COMPLETED|Second Intervention||59
145870|NCT01112865|353713|P2|STARTED|Second Intervention||61
145871|NCT01112865|353714|P1|STARTED|Second Intervention||59
145872|NCT01112865|353713|P2|NOT COMPLETED|First Intervention||0
145873|NCT01112865|353714|P1|NOT COMPLETED|First Intervention||0
145874|NCT01112865|353713|P2|COMPLETED|First Intervention||61
145875|NCT01112865|353714|P1|COMPLETED|First Intervention||59
145876|NCT01112865|353713|P2|STARTED|First Intervention||61
145877|NCT01112865|353714|P1|STARTED|First Intervention||59
145878|NCT01112696|353724|P1|NOT COMPLETED|Overall Study||2
145879|NCT01112696|353724|P1|COMPLETED|Overall Study||98
145880|NCT01112696|353724|P1|STARTED|Overall Study||100
145881|NCT01112683|353731|P2|NOT COMPLETED|Overall Study||1
145882|NCT01112683|353732|P1|NOT COMPLETED|Overall Study||1
145883|NCT01112683|353731|P2|COMPLETED|Overall Study||19
145884|NCT01112683|353732|P1|COMPLETED|Overall Study||18
145885|NCT01112683|353731|P2|STARTED|Overall Study||20
145886|NCT01112683|353732|P1|STARTED|Overall Study||19
145887|NCT01112670|353742|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145888|NCT01112670|353743|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145889|NCT01112670|353744|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145890|NCT01112670|353745|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145891|NCT01112670|353746|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145892|NCT01112670|353747|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145893|NCT01112670|353742|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
145894|NCT01112670|353743|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145895|NCT01112670|353744|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
145896|NCT01112670|353745|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145897|NCT01112670|353746|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
145898|NCT01112670|353747|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
145899|NCT01112670|353742|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
145900|NCT01112670|353743|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
145901|NCT01112670|353744|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
145902|NCT01112670|353745|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
145903|NCT01112670|353746|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
145904|NCT01112670|353747|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
145905|NCT01112670|353742|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
145906|NCT01112670|353743|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
145907|NCT01112670|353744|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
145908|NCT01112670|353745|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
145909|NCT01112670|353746|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
145910|NCT01112670|353747|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
145911|NCT01112670|353742|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
145912|NCT01112670|353743|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
145913|NCT01112670|353744|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
145914|NCT01112670|353745|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
145915|NCT01112670|353746|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
145916|NCT01112670|353747|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
145917|NCT01112670|353742|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
145918|NCT01112670|353743|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
145919|NCT01112670|353744|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
145920|NCT01112670|353745|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
145921|NCT01112670|353746|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
145922|NCT01112670|353747|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
145923|NCT01112579|353785|P2|NOT COMPLETED|Overall Study||3
145924|NCT01112579|353786|P1|NOT COMPLETED|Overall Study||1
145925|NCT01112579|353785|P2|COMPLETED|Overall Study||21
145926|NCT01112579|353786|P1|COMPLETED|Overall Study||41
145927|NCT01112579|353785|P2|STARTED|Overall Study||24
145928|NCT01112579|353786|P1|STARTED|Overall Study||42
145929|NCT01112514|353796|P1|NOT COMPLETED|Overall Study||1
145930|NCT01112514|353796|P1|COMPLETED|Overall Study||3
145931|NCT01112514|353796|P1|STARTED|Overall Study||4
145932|NCT01112267|353802|P2|NOT COMPLETED|Overall Study||18
145933|NCT01112267|353803|P1|NOT COMPLETED|Overall Study||34
145934|NCT01112267|353802|P2|COMPLETED|Overall Study||104
145935|NCT01112267|353803|P1|COMPLETED|Overall Study||92
145936|NCT01112267|353802|P2|Treated|Overall Study||120
145937|NCT01112267|353803|P1|Treated|Overall Study||125
145938|NCT01112267|353802|P2|STARTED|Overall Study||122
145939|NCT01112267|353803|P1|STARTED|Overall Study||126
145940|NCT01112241|353821|P1|NOT COMPLETED|Overall Study||0
145941|NCT01112241|353821|P1|COMPLETED|Overall Study||17
145942|NCT01112241|353821|P1|STARTED|Overall Study||17
145943|NCT01112059|353836|P2|NOT COMPLETED|Overall Study||0
145944|NCT01112059|353837|P1|NOT COMPLETED|Overall Study||1
145945|NCT01112059|353836|P2|COMPLETED|Overall Study||20
145946|NCT01112059|353837|P1|COMPLETED|Overall Study||19
145947|NCT01112059|353836|P2|STARTED|Overall Study||20
145948|NCT01112059|353837|P1|STARTED|Overall Study||20
145949|NCT01111851|353851|P2|NOT COMPLETED|Overall Study||0
145950|NCT01111851|353852|P1|NOT COMPLETED|Overall Study||2
145951|NCT01111851|353851|P2|COMPLETED|Overall Study||8
145952|NCT01111851|353852|P1|COMPLETED|Overall Study||6
145953|NCT01111851|353851|P2|STARTED|Overall Study||8
145954|NCT01111851|353852|P1|STARTED|Overall Study||8
145955|NCT01111838|353864|P1|NOT COMPLETED|Overall Study||7
145956|NCT01111838|353864|P1|COMPLETED|Overall Study||15
145957|NCT01111838|353864|P1|STARTED|Overall Study||22
145958|NCT01111825|353872|P4|NOT COMPLETED|Overall Study||21
145959|NCT01111825|353873|P3|NOT COMPLETED|Overall Study||8
145960|NCT01111825|353874|P2|NOT COMPLETED|Overall Study||1
145961|NCT01111825|353875|P1|NOT COMPLETED|Overall Study||3
145962|NCT01111825|353872|P4|COMPLETED|Overall Study||27
145963|NCT01111825|353873|P3|COMPLETED|Overall Study||29
145964|NCT01111825|353874|P2|COMPLETED|Overall Study||5
145965|NCT01111825|353875|P1|COMPLETED|Overall Study||5
145966|NCT01111825|353872|P4|STARTED|Overall Study||48
145967|NCT01111825|353873|P3|STARTED|Overall Study||37
145968|NCT01111825|353874|P2|STARTED|Overall Study||6
145969|NCT01111825|353875|P1|STARTED|Overall Study||8
145970|NCT01111526|353894|P3|NOT COMPLETED|Overall Study||2
145971|NCT01111526|353895|P2|NOT COMPLETED|Overall Study||1
145972|NCT01111526|353896|P1|NOT COMPLETED|Overall Study||0
145973|NCT01111526|353894|P3|COMPLETED|Overall Study||8
145974|NCT01111526|353895|P2|COMPLETED|Overall Study||7
145975|NCT01111526|353896|P1|COMPLETED|Overall Study||4
145976|NCT01111526|353894|P3|STARTED|Overall Study||10
145977|NCT01111526|353895|P2|STARTED|Overall Study||8
145978|NCT01111526|353896|P1|STARTED|Overall Study||4
145979|NCT01111461|353908|P1|NOT COMPLETED|Overall Study||51
145980|NCT01111461|353908|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
145981|NCT01111461|353908|P1|STARTED|Overall Study||133
145982|NCT01111370|353921|P1|NOT COMPLETED|Overall Study||2
145983|NCT01111370|353921|P1|COMPLETED|Overall Study||58
145984|NCT01111370|353921|P1|STARTED|Overall Study||60
145985|NCT01111331|353925|P2|NOT COMPLETED|Overall Study||0
145986|NCT01111331|353926|P1|NOT COMPLETED|Overall Study||0
145987|NCT01111331|353925|P2|COMPLETED|Overall Study||9
145988|NCT01111331|353926|P1|COMPLETED|Overall Study||9
145989|NCT01111331|353925|P2|STARTED|Overall Study||9
145990|NCT01111331|353926|P1|STARTED|Overall Study||9
145991|NCT01111318|354008|P4|NOT COMPLETED|Overall Study||0
145992|NCT01111318|354009|P3|NOT COMPLETED|Overall Study||0
145993|NCT01111318|354010|P2|NOT COMPLETED|Overall Study||0
145994|NCT01111318|354011|P1|NOT COMPLETED|Overall Study||0
145995|NCT01111318|354008|P4|COMPLETED|Overall Study||8
145996|NCT01111318|354009|P3|COMPLETED|Overall Study||8
145997|NCT01111318|354010|P2|COMPLETED|Overall Study||8
145998|NCT01111318|354011|P1|COMPLETED|Overall Study||12
145999|NCT01111318|354008|P4|STARTED|Overall Study||8
146000|NCT01111318|354009|P3|STARTED|Overall Study||8
146001|NCT01111318|354010|P2|STARTED|Overall Study||8
146002|NCT01111318|354011|P1|STARTED|Overall Study||12
146003|NCT01111305|354075|P2|NOT COMPLETED|Overall Study||0
146004|NCT01111305|354076|P1|NOT COMPLETED|Overall Study||0
146005|NCT01111305|354075|P2|COMPLETED|Overall Study||4
146006|NCT01111305|354076|P1|COMPLETED|Overall Study||4
146007|NCT01111305|354075|P2|STARTED|Overall Study||4
146008|NCT01111305|354076|P1|STARTED|Overall Study||4
146009|NCT01111292|354088|P2|NOT COMPLETED|Follow-Up||0
146010|NCT01111292|354089|P1|NOT COMPLETED|Follow-Up||0
146011|NCT01111292|354088|P2|COMPLETED|Follow-Up||1
146012|NCT01111292|354089|P1|COMPLETED|Follow-Up||2
146013|NCT01111292|354088|P2|STARTED|Follow-Up||1
146014|NCT01111292|354089|P1|STARTED|Follow-Up||2
146015|NCT01111292|354088|P2|NOT COMPLETED|Post Treatment Biopsy||0
146016|NCT01111292|354089|P1|NOT COMPLETED|Post Treatment Biopsy||0
146017|NCT01111292|354088|P2|COMPLETED|Post Treatment Biopsy||1
146018|NCT01111292|354089|P1|COMPLETED|Post Treatment Biopsy||2
146019|NCT01111292|354088|P2|STARTED|Post Treatment Biopsy||1
146020|NCT01111292|354089|P1|STARTED|Post Treatment Biopsy||2
146021|NCT01111292|354088|P2|NOT COMPLETED|Treatment||1
146022|NCT01111292|354089|P1|NOT COMPLETED|Treatment||1
146023|NCT01111292|354088|P2|COMPLETED|Treatment||1
146024|NCT01111292|354089|P1|COMPLETED|Treatment||2
146025|NCT01111292|354088|P2|STARTED|Treatment||2
146026|NCT01111292|354089|P1|STARTED|Treatment||3
146027|NCT01111292|354088|P2|NOT COMPLETED|Randomization||0
146028|NCT01111292|354089|P1|NOT COMPLETED|Randomization||0
146029|NCT01111292|354088|P2|COMPLETED|Randomization||2
146030|NCT01111292|354089|P1|COMPLETED|Randomization||3
146031|NCT01111292|354088|P2|STARTED|Randomization||2
146032|NCT01111292|354089|P1|STARTED|Randomization||3
146033|NCT01111240|354095|P1|NOT COMPLETED|Overall Study||1066
146034|NCT01111240|354095|P1|COMPLETED|Overall Study||3569
146035|NCT01111240|354095|P1|STARTED|Overall Study||4635
146036|NCT01111162|354117|P1|NOT COMPLETED|Overall Study||0
146037|NCT01111162|354117|P1|COMPLETED|Overall Study||120
146038|NCT01111162|354117|P1|STARTED|Overall Study||120
146039|NCT01111149|354125|P3|NOT COMPLETED|Overall Study||4
146040|NCT01111149|354126|P2|NOT COMPLETED|Overall Study||1
146041|NCT01111149|354127|P1|NOT COMPLETED|Overall Study||2
146042|NCT01111149|354125|P3|COMPLETED|Overall Study||5
146043|NCT01111149|354126|P2|COMPLETED|Overall Study||5
146044|NCT01111149|354127|P1|COMPLETED|Overall Study||7
146045|NCT01111149|354125|P3|STARTED|Overall Study||9
146046|NCT01111149|354126|P2|STARTED|Overall Study||6
146047|NCT01111149|354127|P1|STARTED|Overall Study||9
146048|NCT01111123|354203|P2|NOT COMPLETED|Maintenance Phase||2
146049|NCT01111123|354204|P1|NOT COMPLETED|Maintenance Phase||0
146050|NCT01111123|354203|P2|COMPLETED|Maintenance Phase||18
146051|NCT01111123|354204|P1|COMPLETED|Maintenance Phase||21
146052|NCT01111123|354203|P2|STARTED|Maintenance Phase||20
146053|NCT01111123|354204|P1|STARTED|Maintenance Phase||21
146054|NCT01111123|354203|P2|NOT COMPLETED|Open- Label Phase||0
146055|NCT01111123|354204|P1|NOT COMPLETED|Open- Label Phase||14
146056|NCT01111123|354203|P2|COMPLETED|Open- Label Phase||0
146057|NCT01111123|354204|P1|COMPLETED|Open- Label Phase||41
146058|NCT01111123|354203|P2|STARTED|Open- Label Phase||0
146059|NCT01111123|354204|P1|STARTED|Open- Label Phase||55
146060|NCT01111110|354214|P2|NOT COMPLETED|Overall Study||0
146061|NCT01111110|354215|P1|NOT COMPLETED|Overall Study||0
146062|NCT01111110|354214|P2|COMPLETED|Overall Study||4
146063|NCT01111110|354215|P1|COMPLETED|Overall Study||3
146064|NCT01111110|354214|P2|STARTED|Overall Study||4
146065|NCT01111110|354215|P1|STARTED|Overall Study||3
146066|NCT01110967|354225|P1|NOT COMPLETED|Overall Study||9
146067|NCT01110967|354225|P1|COMPLETED|Overall Study||31
146068|NCT01110967|354225|P1|12 Months Follow up|Overall Study||31
146069|NCT01110967|354225|P1|6 Months Follow up|Overall Study||24
146070|NCT01110967|354225|P1|3 Months Follow up|Overall Study||28
146071|NCT01110967|354225|P1|1 Month Follow up|Overall Study||26
146072|NCT01110967|354225|P1|Surgery|Overall Study||40
146073|NCT01110967|354225|P1|STARTED|Overall Study||40
146074|NCT01110915|354238|P2|NOT COMPLETED|Overall Study||2
146075|NCT01110915|354239|P1|NOT COMPLETED|Overall Study||10
146076|NCT01110915|354238|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
146077|NCT01110915|354239|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
146078|NCT01110915|354238|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
146079|NCT01110915|354239|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
146080|NCT01110707|354256|P2|NOT COMPLETED|Overall Study||3
146081|NCT01110707|354257|P1|NOT COMPLETED|Overall Study||0
146082|NCT01110707|354256|P2|COMPLETED|Overall Study||65
146083|NCT01110707|354257|P1|COMPLETED|Overall Study||63
146084|NCT01110707|354256|P2|STARTED|Overall Study||68
146085|NCT01110707|354257|P1|STARTED|Overall Study||63
146086|NCT01110499|354287|P8|NOT COMPLETED|Overall Study||0
146087|NCT01110499|354288|P7|NOT COMPLETED|Overall Study||0
146088|NCT01110499|354289|P6|NOT COMPLETED|Overall Study||0
146089|NCT01110499|354290|P5|NOT COMPLETED|Overall Study||0
146090|NCT01110499|354291|P4|NOT COMPLETED|Overall Study||0
146091|NCT01110499|354292|P3|NOT COMPLETED|Overall Study||0
146092|NCT01110499|354293|P2|NOT COMPLETED|Overall Study||0
146093|NCT01110499|354294|P1|NOT COMPLETED|Overall Study||0
146094|NCT01110499|354287|P8|COMPLETED|Overall Study||40
146095|NCT01110499|354288|P7|COMPLETED|Overall Study||39
146096|NCT01110499|354289|P6|COMPLETED|Overall Study||14
146097|NCT01110499|354290|P5|COMPLETED|Overall Study||14
146098|NCT01110499|354291|P4|COMPLETED|Overall Study||14
146099|NCT01110499|354292|P3|COMPLETED|Overall Study||14
146100|NCT01110499|354293|P2|COMPLETED|Overall Study||14
146101|NCT01110499|354294|P1|COMPLETED|Overall Study||14
146102|NCT01110499|354287|P8|STARTED|Overall Study||40
146103|NCT01110499|354288|P7|STARTED|Overall Study||39
146104|NCT01110499|354289|P6|STARTED|Overall Study||14
146105|NCT01110499|354290|P5|STARTED|Overall Study||14
146106|NCT01110499|354291|P4|STARTED|Overall Study||14
146107|NCT01110499|354292|P3|STARTED|Overall Study||14
146108|NCT01110499|354293|P2|STARTED|Overall Study||14
146109|NCT01110499|354294|P1|STARTED|Overall Study||14
146110|NCT01110421|354316|P2|NOT COMPLETED|Overall Study||0
146111|NCT01110421|354317|P1|NOT COMPLETED|Overall Study||0
146112|NCT01110421|354316|P2|COMPLETED|Overall Study||2
146113|NCT01110421|354317|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
146114|NCT01110421|354316|P2|STARTED|Overall Study||2
146115|NCT01110421|354317|P1|STARTED|Overall Study||5
146116|NCT01110408|354337|P2|NOT COMPLETED|Overall Study||0
146117|NCT01110408|354338|P1|NOT COMPLETED|Overall Study||1
146118|NCT01110408|354337|P2|COMPLETED|Overall Study||10
146119|NCT01110408|354338|P1|COMPLETED|Overall Study||30
146120|NCT01110408|354337|P2|STARTED|Overall Study||10
146121|NCT01110408|354338|P1|STARTED|Overall Study||31
146122|NCT01110382|354358|P2|NOT COMPLETED|Overall Study||2
146123|NCT01110382|354359|P1|NOT COMPLETED|Overall Study||0
146124|NCT01110382|354358|P2|COMPLETED|Overall Study||8
146125|NCT01110382|354359|P1|COMPLETED|Overall Study||31
146126|NCT01110382|354358|P2|STARTED|Overall Study||10
146127|NCT01110382|354359|P1|STARTED|Overall Study||31
146128|NCT01110330|354380|P3|NOT COMPLETED|Overall Study||26
146129|NCT01110330|354381|P2|NOT COMPLETED|Overall Study||23
146130|NCT01110330|354382|P1|NOT COMPLETED|Overall Study||15
146131|NCT01110330|354380|P3|COMPLETED|Overall Study||208
146132|NCT01110330|354381|P2|COMPLETED|Overall Study||207
146133|NCT01110330|354382|P1|COMPLETED|Overall Study||104
146134|NCT01110330|354380|P3|Positive Baseline Culture Set|Overall Study||114
146135|NCT01110330|354381|P2|Positive Baseline Culture Set|Overall Study||111
146136|NCT01110330|354382|P1|Positive Baseline Culture Set|Overall Study||56
146137|NCT01110330|354380|P3|STARTED|Overall Study||234
146138|NCT01110330|354381|P2|STARTED|Overall Study||230
146139|NCT01110330|354382|P1|STARTED|Overall Study||119
146140|NCT01110252|354393|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
146141|NCT01110252|354393|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
146142|NCT01110252|354393|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
146143|NCT01110252|354393|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
146144|NCT01110252|354393|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
146145|NCT01110252|354393|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
146146|NCT01110239|354410|P4|NOT COMPLETED|10 Min Ischemia||0
146147|NCT01110239|354411|P3|NOT COMPLETED|10 Min Ischemia||0
146148|NCT01110239|354412|P2|NOT COMPLETED|10 Min Ischemia||0
146149|NCT01110239|354413|P1|NOT COMPLETED|10 Min Ischemia||0
146150|NCT01110239|354410|P4|COMPLETED|10 Min Ischemia||6
146151|NCT01110239|354411|P3|COMPLETED|10 Min Ischemia||0
146152|NCT01110239|354412|P2|COMPLETED|10 Min Ischemia||0
146153|NCT01110239|354413|P1|COMPLETED|10 Min Ischemia||0
146154|NCT01110239|354410|P4|STARTED|10 Min Ischemia||6
146155|NCT01110239|354411|P3|STARTED|10 Min Ischemia||0
146156|NCT01110239|354412|P2|STARTED|10 Min Ischemia||0
146157|NCT01110239|354413|P1|STARTED|10 Min Ischemia||0
146158|NCT01110239|354410|P4|NOT COMPLETED|7.5 Min Ischemia||0
146159|NCT01110239|354411|P3|NOT COMPLETED|7.5 Min Ischemia||1
146160|NCT01110239|354412|P2|NOT COMPLETED|7.5 Min Ischemia||0
146161|NCT01110239|354413|P1|NOT COMPLETED|7.5 Min Ischemia||0
146162|NCT01110239|354410|P4|COMPLETED|7.5 Min Ischemia||0
146163|NCT01110239|354411|P3|COMPLETED|7.5 Min Ischemia||6
146164|NCT01110239|354412|P2|COMPLETED|7.5 Min Ischemia||0
146165|NCT01110239|354413|P1|COMPLETED|7.5 Min Ischemia||0
146166|NCT01110239|354410|P4|STARTED|7.5 Min Ischemia||0
146167|NCT01110239|354411|P3|STARTED|7.5 Min Ischemia||7
146168|NCT01110239|354412|P2|STARTED|7.5 Min Ischemia||0
146169|NCT01110239|354413|P1|STARTED|7.5 Min Ischemia||0
146170|NCT01110239|354410|P4|NOT COMPLETED|5 Min Ischemia||0
146171|NCT01110239|354411|P3|NOT COMPLETED|5 Min Ischemia||0
146172|NCT01110239|354412|P2|NOT COMPLETED|5 Min Ischemia||14
146173|NCT01110239|354413|P1|NOT COMPLETED|5 Min Ischemia||0
146174|NCT01110239|354410|P4|COMPLETED|5 Min Ischemia||0
146175|NCT01110239|354411|P3|COMPLETED|5 Min Ischemia||0
146176|NCT01110239|354412|P2|COMPLETED|5 Min Ischemia||0
146177|NCT01110239|354413|P1|COMPLETED|5 Min Ischemia||0
146178|NCT01110239|354410|P4|STARTED|5 Min Ischemia||0
146179|NCT01110239|354411|P3|STARTED|5 Min Ischemia||0
146180|NCT01110239|354412|P2|STARTED|5 Min Ischemia||14
146181|NCT01110239|354413|P1|STARTED|5 Min Ischemia||0
146182|NCT01110239|354410|P4|NOT COMPLETED|Sham Preconditioning||0
146183|NCT01110239|354411|P3|NOT COMPLETED|Sham Preconditioning||1
146184|NCT01110239|354412|P2|NOT COMPLETED|Sham Preconditioning||0
146185|NCT01110239|354413|P1|NOT COMPLETED|Sham Preconditioning||0
146186|NCT01110239|354410|P4|COMPLETED|Sham Preconditioning||6
146187|NCT01110239|354411|P3|COMPLETED|Sham Preconditioning||6
146188|NCT01110239|354412|P2|COMPLETED|Sham Preconditioning||14
146189|NCT01110239|354413|P1|COMPLETED|Sham Preconditioning||7
146190|NCT01110239|354410|P4|STARTED|Sham Preconditioning||6
146191|NCT01110239|354411|P3|STARTED|Sham Preconditioning||7
146192|NCT01110239|354412|P2|STARTED|Sham Preconditioning||14
146193|NCT01110239|354413|P1|STARTED|Sham Preconditioning||7
146194|NCT01110200|354429|P2|NOT COMPLETED|Overall Study||121
146195|NCT01110200|354430|P1|NOT COMPLETED|Overall Study||106
146196|NCT01110200|354429|P2|COMPLETED|Overall Study||204
146197|NCT01110200|354430|P1|COMPLETED|Overall Study||208
146198|NCT01110200|354429|P2|STARTED|Overall Study||325
146199|NCT01110200|354430|P1|STARTED|Overall Study||314
146200|NCT01110187|354446|P2|NOT COMPLETED|Overall Study||0
146201|NCT01110187|354447|P1|NOT COMPLETED|Overall Study||0
146202|NCT01110187|354446|P2|COMPLETED|Overall Study|completed 7 day treatment|4
146203|NCT01110187|354447|P1|COMPLETED|Overall Study|completed 7 day treatment|7
146204|NCT01110187|354446|P2|STARTED|Overall Study||4
146205|NCT01110187|354447|P1|STARTED|Overall Study||7
146206|NCT01110135|354455|P1|NOT COMPLETED|Overall Study||9
146207|NCT01110135|354455|P1|COMPLETED|Overall Study||34
146208|NCT01110135|354455|P1|STARTED|Overall Study||43
146209|NCT01110005|354461|P2|NOT COMPLETED|Overall Study||5
146210|NCT01110005|354462|P1|NOT COMPLETED|Overall Study||4
146211|NCT01110005|354461|P2|COMPLETED|Overall Study||156
146212|NCT01110005|354462|P1|COMPLETED|Overall Study||153
146213|NCT01110005|354461|P2|STARTED|Overall Study||161
146214|NCT01110005|354462|P1|STARTED|Overall Study||157
146215|NCT01109979|354474|P2|NOT COMPLETED|Overall Study||1
146216|NCT01109979|354475|P1|NOT COMPLETED|Overall Study||2
146217|NCT01109979|354474|P2|COMPLETED|Overall Study||11
146218|NCT01109979|354475|P1|COMPLETED|Overall Study||10
146219|NCT01109979|354474|P2|STARTED|Overall Study||12
146220|NCT01109979|354475|P1|STARTED|Overall Study||12
146221|NCT01109849|354483|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
146222|NCT01109849|354484|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
146223|NCT01109849|354485|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
146224|NCT01109849|354486|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
146225|NCT01109849|354487|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
146226|NCT01109849|354483|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
146227|NCT01109849|354484|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
146228|NCT01109849|354485|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
146229|NCT01109849|354486|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
146230|NCT01109849|354487|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
146231|NCT01109849|354483|P5|STARTED|Adaptive Randomization: Weight Recovery||25
146232|NCT01109849|354484|P4|STARTED|Adaptive Randomization: Weight Recovery||23
146233|NCT01109849|354485|P3|STARTED|Adaptive Randomization: Weight Recovery||24
146234|NCT01109849|354486|P2|STARTED|Adaptive Randomization: Weight Recovery||0
146235|NCT01109849|354487|P1|STARTED|Adaptive Randomization: Weight Recovery||0
146236|NCT01109849|354483|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
146237|NCT01109849|354484|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
146238|NCT01109849|354485|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
146239|NCT01109849|354486|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
146240|NCT01109849|354487|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
146241|NCT01109849|354483|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
146242|NCT01109849|354484|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
146243|NCT01109849|354485|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
146244|NCT01109849|354486|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
146245|NCT01109849|354487|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
146246|NCT01109849|354483|P5|STARTED|Initial Randomization: ADHD Treatment||0
146247|NCT01109849|354484|P4|STARTED|Initial Randomization: ADHD Treatment||0
146248|NCT01109849|354485|P3|STARTED|Initial Randomization: ADHD Treatment||0
146249|NCT01109849|354486|P2|STARTED|Initial Randomization: ADHD Treatment||180
146250|NCT01109849|354487|P1|STARTED|Initial Randomization: ADHD Treatment||50
146251|NCT01109602|354539|P3|NOT COMPLETED|Overall Study||1
146252|NCT01109602|354540|P2|NOT COMPLETED|Overall Study||2
146253|NCT01109602|354541|P1|NOT COMPLETED|Overall Study||1
146254|NCT01109602|354539|P3|COMPLETED|Overall Study||9
146255|NCT01109602|354540|P2|COMPLETED|Overall Study||21
146256|NCT01109602|354541|P1|COMPLETED|Overall Study||13
146257|NCT01109602|354539|P3|STARTED|Overall Study||10
146258|NCT01109602|354540|P2|STARTED|Overall Study||23
146259|NCT01109602|354541|P1|STARTED|Overall Study||14
146260|NCT01109576|354552|P1|NOT COMPLETED|Overall Study||1
146261|NCT01109576|354552|P1|COMPLETED|Overall Study||12
146262|NCT01109576|354552|P1|STARTED|Overall Study||13
146263|NCT01109524|354556|P1|NOT COMPLETED|Overall Study||57
146264|NCT01109524|354556|P1|COMPLETED|Overall Study||3
146265|NCT01109524|354556|P1|STARTED|Overall Study||60
146266|NCT01109381|354566|P1|NOT COMPLETED|Overall Study||2
146267|NCT01109381|354566|P1|COMPLETED|Overall Study||31
146268|NCT01109381|354566|P1|STARTED|Overall Study||33
146269|NCT01109316|354578|P3|NOT COMPLETED|Study Period 3||1
146270|NCT01109316|354579|P2|NOT COMPLETED|Study Period 3||2
146271|NCT01109316|354580|P1|NOT COMPLETED|Study Period 3||0
146272|NCT01109316|354578|P3|COMPLETED|Study Period 3||38
146273|NCT01109316|354579|P2|COMPLETED|Study Period 3||39
146274|NCT01109316|354580|P1|COMPLETED|Study Period 3||39
146275|NCT01109316|354578|P3|STARTED|Study Period 3||39
146276|NCT01109316|354579|P2|STARTED|Study Period 3||41
146277|NCT01109316|354580|P1|STARTED|Study Period 3||39
146278|NCT01109316|354578|P3|NOT COMPLETED|Study Period 2||2
146279|NCT01109316|354579|P2|NOT COMPLETED|Study Period 2||2
146280|NCT01109316|354580|P1|NOT COMPLETED|Study Period 2||1
146281|NCT01109316|354578|P3|COMPLETED|Study Period 2||41
146282|NCT01109316|354579|P2|COMPLETED|Study Period 2||40
146283|NCT01109316|354580|P1|COMPLETED|Study Period 2||38
146284|NCT01109316|354578|P3|STARTED|Study Period 2||43
146285|NCT01109316|354579|P2|STARTED|Study Period 2||42
146286|NCT01109316|354580|P1|STARTED|Study Period 2||39
146287|NCT01109316|354578|P3|NOT COMPLETED|Study Period 1||4
146288|NCT01109316|354579|P2|NOT COMPLETED|Study Period 1||4
146289|NCT01109316|354580|P1|NOT COMPLETED|Study Period 1||0
146290|NCT01109316|354578|P3|COMPLETED|Study Period 1||40
146291|NCT01109316|354579|P2|COMPLETED|Study Period 1||40
146292|NCT01109316|354580|P1|COMPLETED|Study Period 1||44
146293|NCT01109316|354578|P3|Received at Least One Dose of Study Drug|Study Period 1||42
146294|NCT01109316|354579|P2|Received at Least One Dose of Study Drug|Study Period 1||44
146295|NCT01109316|354580|P1|Received at Least One Dose of Study Drug|Study Period 1||44
146296|NCT01109316|354578|P3|STARTED|Study Period 1||44
146297|NCT01109316|354579|P2|STARTED|Study Period 1||44
146298|NCT01109316|354580|P1|STARTED|Study Period 1||44
146299|NCT01109173|354628|P4|NOT COMPLETED|Overall Study||93
146300|NCT01109173|354629|P3|NOT COMPLETED|Overall Study||101
146301|NCT01109173|354630|P2|NOT COMPLETED|Overall Study||86
146302|NCT01109173|354631|P1|NOT COMPLETED|Overall Study||88
146303|NCT01109173|354628|P4|COMPLETED|Overall Study||120
146304|NCT01109173|354629|P3|COMPLETED|Overall Study||110
146305|NCT01109173|354630|P2|COMPLETED|Overall Study||759
146306|NCT01109173|354631|P1|COMPLETED|Overall Study||763
146307|NCT01109173|354628|P4|STARTED|Overall Study||213
146308|NCT01109173|354629|P3|STARTED|Overall Study||211
146309|NCT01109173|354630|P2|STARTED|Overall Study||845
146310|NCT01109173|354631|P1|STARTED|Overall Study||851
146311|NCT01109147|354648|P3|NOT COMPLETED|Overall Study||10
146312|NCT01109147|354649|P2|NOT COMPLETED|Overall Study||3
146313|NCT01109147|354650|P1|NOT COMPLETED|Overall Study||2
146314|NCT01109147|354648|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
146315|NCT01109147|354649|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
146316|NCT01109147|354650|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
146317|NCT01109147|354648|P3|STARTED|Overall Study||36
146318|NCT01109147|354649|P2|STARTED|Overall Study||14
146319|NCT01109147|354650|P1|STARTED|Overall Study||17
146320|NCT01109108|354660|P2|NOT COMPLETED|Overall Study||0
146321|NCT01109108|354661|P1|NOT COMPLETED|Overall Study||0
146322|NCT01109108|354660|P2|COMPLETED|Overall Study||4755
146323|NCT01109108|354661|P1|COMPLETED|Overall Study||4035
146324|NCT01109108|354660|P2|STARTED|Overall Study||4755
146325|NCT01109108|354661|P1|STARTED|Overall Study||4035
146326|NCT01109056|354669|P2|NOT COMPLETED|Overall Study||5
146327|NCT01109056|354670|P1|NOT COMPLETED|Overall Study||7
146328|NCT01109056|354669|P2|COMPLETED|Overall Study||53
146329|NCT01109056|354670|P1|COMPLETED|Overall Study||50
146330|NCT01109056|354669|P2|STARTED|Overall Study||58
146331|NCT01109056|354670|P1|STARTED|Overall Study||57
146332|NCT01108835|354682|P2|NOT COMPLETED|Overall Study||21
146333|NCT01108835|354683|P1|NOT COMPLETED|Overall Study||17
146334|NCT01108835|354682|P2|COMPLETED|Overall Study||69
146335|NCT01108835|354683|P1|COMPLETED|Overall Study||73
146336|NCT01108835|354682|P2|STARTED|Overall Study||90
146337|NCT01108835|354683|P1|STARTED|Overall Study||90
146338|NCT01108809|354697|P1|NOT COMPLETED|Overall Study||4
146339|NCT01108809|354697|P1|COMPLETED|Overall Study||291
146340|NCT01108809|354697|P1|STARTED|Overall Study||295
146341|NCT01108796|354714|P2|NOT COMPLETED|Overall Study||7
146342|NCT01108796|354715|P1|NOT COMPLETED|Overall Study||7
146343|NCT01108796|354714|P2|COMPLETED|Overall Study||1060
146344|NCT01108796|354715|P1|COMPLETED|Overall Study||767
146345|NCT01108796|354714|P2|STARTED|Overall Study||1067
146346|NCT01108796|354715|P1|STARTED|Overall Study||774
146347|NCT01108757|354749|P2|NOT COMPLETED|Overall Study||0
146348|NCT01108757|354750|P1|NOT COMPLETED|Overall Study||0
146349|NCT01108757|354749|P2|COMPLETED|Overall Study||26
146350|NCT01108757|354750|P1|COMPLETED|Overall Study||26
146351|NCT01108757|354749|P2|STARTED|Overall Study||26
146352|NCT01108757|354750|P1|STARTED|Overall Study||26
146353|NCT01108731|354758|P2|NOT COMPLETED|Overall Study||4
146354|NCT01108731|354759|P1|NOT COMPLETED|Overall Study||4
146355|NCT01108731|354758|P2|COMPLETED|Overall Study||13
146356|NCT01108731|354759|P1|COMPLETED|Overall Study||13
146357|NCT01108731|354758|P2|STARTED|Overall Study||17
146358|NCT01108731|354759|P1|STARTED|Overall Study||17
146359|NCT01108718|354771|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
146360|NCT01108718|354772|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
146361|NCT01108718|354771|P2|COMPLETED|Received Second Intervention (2 Months)||7
146362|NCT01108718|354772|P1|COMPLETED|Received Second Intervention (2 Months)||4
146363|NCT01108718|354771|P2|STARTED|Received Second Intervention (2 Months)||7
146364|NCT01108718|354772|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
146365|NCT01108718|354771|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
146366|NCT01108718|354772|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
146367|NCT01108718|354771|P2|COMPLETED|Received First Intervention (2 Months)||7
146368|NCT01108718|354772|P1|COMPLETED|Received First Intervention (2 Months)||5
146369|NCT01108718|354771|P2|STARTED|Received First Intervention (2 Months)||7
146370|NCT01108718|354772|P1|STARTED|Received First Intervention (2 Months)||5
146371|NCT01108523|354777|P1|NOT COMPLETED|Overall Study||4
146372|NCT01108523|354777|P1|COMPLETED|Overall Study||3
146373|NCT01108523|354777|P1|STARTED|Overall Study||7
146374|NCT01108510|354784|P2|NOT COMPLETED|Overall Study||268
146375|NCT01108510|354785|P1|NOT COMPLETED|Overall Study||279
146376|NCT01108510|354784|P2|COMPLETED|Overall Study||81
146377|NCT01108510|354785|P1|COMPLETED|Overall Study||70
146378|NCT01108510|354784|P2|STARTED|Overall Study||349
146379|NCT01108510|354785|P1|STARTED|Overall Study||349
146380|NCT01108458|354805|P1|NOT COMPLETED|Overall Study||1
146381|NCT01108458|354805|P1|COMPLETED|Overall Study||0
146382|NCT01108458|354805|P1|STARTED|Overall Study||1
146383|NCT01108445|354816|P2|NOT COMPLETED|Overall Study||49
146384|NCT01108445|354817|P1|NOT COMPLETED|Overall Study||56
146385|NCT01108445|354816|P2|COMPLETED|Overall Study||2
146386|NCT01108445|354817|P1|COMPLETED|Overall Study||1
146387|NCT01108445|354816|P2|STARTED|Overall Study||51
146388|NCT01108445|354817|P1|STARTED|Overall Study||57
146389|NCT01108406|354851|P1|NOT COMPLETED|Overall Study||0
146390|NCT01108406|354851|P1|COMPLETED|Overall Study||22
146391|NCT01108406|354851|P1|STARTED|Overall Study||22
146392|NCT01108341|354857|P1|NOT COMPLETED|Overall Study||5
146393|NCT01108341|354857|P1|COMPLETED|Overall Study||45
146394|NCT01108341|354857|P1|Safety Set (Enrolled and Treated)|Overall Study||49
146395|NCT01108341|354857|P1|STARTED|Overall Study||50
146396|NCT01108263|354864|P2|NOT COMPLETED|Overall Study||1
146397|NCT01108263|354865|P1|NOT COMPLETED|Overall Study||0
146398|NCT01108263|354864|P2|COMPLETED|Overall Study||2
146399|NCT01108263|354865|P1|COMPLETED|Overall Study||2
146400|NCT01108263|354864|P2|STARTED|Overall Study||3
146401|NCT01108263|354865|P1|STARTED|Overall Study||2
146402|NCT01108237|354875|P2|NOT COMPLETED|Overall Study||17
146403|NCT01108237|354876|P1|NOT COMPLETED|Overall Study||9
146404|NCT01108237|354875|P2|COMPLETED|Overall Study||84
146405|NCT01108237|354876|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
146406|NCT01108237|354875|P2|STARTED|Overall Study||101
146407|NCT01108237|354876|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
146408|NCT01108185|354882|P1|NOT COMPLETED|Overall Study||27
146409|NCT01108185|354882|P1|COMPLETED|Overall Study||3154
146410|NCT01108185|354882|P1|Per Protocol Population|Overall Study||3181
146411|NCT01108185|354882|P1|STARTED|Overall Study||3181
146412|NCT01108081|354899|P4|NOT COMPLETED|Overall Study||4
146413|NCT01108081|354900|P3|NOT COMPLETED|Overall Study||0
146414|NCT01108081|354901|P2|NOT COMPLETED|Overall Study||2
146415|NCT01108081|354902|P1|NOT COMPLETED|Overall Study||2
146416|NCT01108081|354899|P4|COMPLETED|Overall Study||39
146417|NCT01108081|354900|P3|COMPLETED|Overall Study||38
146418|NCT01108081|354901|P2|COMPLETED|Overall Study||40
146419|NCT01108081|354902|P1|COMPLETED|Overall Study||44
146420|NCT01108081|354899|P4|STARTED|Overall Study||43
146421|NCT01108081|354900|P3|STARTED|Overall Study||38
146422|NCT01108081|354901|P2|STARTED|Overall Study||42
146423|NCT01108081|354902|P1|STARTED|Overall Study||46
146424|NCT01108068|354918|P2|NOT COMPLETED|Overall Study||0
146425|NCT01108068|354919|P1|NOT COMPLETED|Overall Study||6
146426|NCT01108068|354918|P2|COMPLETED|Overall Study||16
146427|NCT01108068|354919|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
146428|NCT01108068|354918|P2|STARTED|Overall Study||16
146429|NCT01108068|354919|P1|STARTED|Overall Study||10
146430|NCT01108055|354926|P1|NOT COMPLETED|Overall Study||15
146431|NCT01108055|354926|P1|COMPLETED|Overall Study||28
146432|NCT01108055|354926|P1|Eligible and Started Treatment|Overall Study||32
146433|NCT01108055|354926|P1|STARTED|Overall Study||43
146434|NCT01108003|354936|P2|NOT COMPLETED|Overall Study||0
146435|NCT01108003|354937|P1|NOT COMPLETED|Overall Study||0
146436|NCT01108003|354936|P2|COMPLETED|Overall Study||3
146437|NCT01108003|354937|P1|COMPLETED|Overall Study||4
146438|NCT01108003|354936|P2|STARTED|Overall Study||3
146439|NCT01108003|354937|P1|STARTED|Overall Study||4
146440|NCT01107964|354947|P2|NOT COMPLETED|Overall Study||1
146441|NCT01107964|354948|P1|NOT COMPLETED|Overall Study||1
146442|NCT01107964|354947|P2|COMPLETED|Overall Study||13
146443|NCT01107964|354948|P1|COMPLETED|Overall Study||12
146444|NCT01107964|354947|P2|STARTED|Overall Study||14
146445|NCT01107964|354948|P1|STARTED|Overall Study||13
146446|NCT01107925|354964|P6|NOT COMPLETED|Period 3||0
146447|NCT01107925|354965|P5|NOT COMPLETED|Period 3||0
146448|NCT01107925|354966|P4|NOT COMPLETED|Period 3||0
146449|NCT01107925|354967|P3|NOT COMPLETED|Period 3||0
146450|NCT01107925|354968|P2|NOT COMPLETED|Period 3||0
146451|NCT01107925|354969|P1|NOT COMPLETED|Period 3||0
146452|NCT01107925|354964|P6|COMPLETED|Period 3||20
146453|NCT01107925|354965|P5|COMPLETED|Period 3||0
146454|NCT01107925|354966|P4|COMPLETED|Period 3||16
146455|NCT01107925|354967|P3|COMPLETED|Period 3||15
146456|NCT01107925|354968|P2|COMPLETED|Period 3||17
146457|NCT01107925|354969|P1|COMPLETED|Period 3||0
146458|NCT01107925|354964|P6|Took at Least 1 Dose of Study Drug|Period 3||20
146459|NCT01107925|354965|P5|Took at Least 1 Dose of Study Drug|Period 3||0
146460|NCT01107925|354966|P4|Took at Least 1 Dose of Study Drug|Period 3||16
146461|NCT01107925|354967|P3|Took at Least 1 Dose of Study Drug|Period 3||15
146462|NCT01107925|354968|P2|Took at Least 1 Dose of Study Drug|Period 3||17
146463|NCT01107925|354969|P1|Took at Least 1 Dose of Study Drug|Period 3||0
146464|NCT01107925|354964|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
146465|NCT01107925|354965|P5|STARTED|Period 3||0
146466|NCT01107925|354966|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
146467|NCT01107925|354967|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
146468|NCT01107925|354968|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
146469|NCT01107925|354969|P1|STARTED|Period 3||0
146470|NCT01107925|354964|P6|NOT COMPLETED|Period 2||1
146471|NCT01107925|354965|P5|NOT COMPLETED|Period 2||0
146472|NCT01107925|354966|P4|NOT COMPLETED|Period 2||0
146473|NCT01107925|354967|P3|NOT COMPLETED|Period 2||0
146474|NCT01107925|354968|P2|NOT COMPLETED|Period 2||1
146475|NCT01107925|354969|P1|NOT COMPLETED|Period 2||0
146476|NCT01107925|354964|P6|COMPLETED|Period 2||16
146477|NCT01107925|354965|P5|COMPLETED|Period 2||0
146478|NCT01107925|354966|P4|COMPLETED|Period 2||20
146479|NCT01107925|354967|P3|COMPLETED|Period 2||17
146480|NCT01107925|354968|P2|COMPLETED|Period 2||15
146481|NCT01107925|354969|P1|COMPLETED|Period 2||0
146482|NCT01107925|354964|P6|Took at Least 1 Dose of Study Drug|Period 2||17
146483|NCT01107925|354965|P5|Took at Least 1 Dose of Study Drug|Period 2||0
146484|NCT01107925|354966|P4|Took at Least 1 Dose of Study Drug|Period 2||20
146485|NCT01107925|354967|P3|Took at Least 1 Dose of Study Drug|Period 2||17
146486|NCT01107925|354968|P2|Took at Least 1 Dose of Study Drug|Period 2||16
146487|NCT01107925|354969|P1|Took at Least 1 Dose of Study Drug|Period 2||0
146488|NCT01107925|354964|P6|STARTED|Period 2||17
146489|NCT01107925|354965|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
146490|NCT01107925|354966|P4|STARTED|Period 2||20
146491|NCT01107925|354967|P3|STARTED|Period 2||17
146492|NCT01107925|354968|P2|STARTED|Period 2||16
146493|NCT01107925|354969|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
146494|NCT01107925|354964|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
146495|NCT01107925|354965|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
146496|NCT01107925|354966|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
146497|NCT01107925|354967|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
146498|NCT01107925|354968|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
146747|NCT01106898|355577|P1|NOT COMPLETED|Overall Study||6
146499|NCT01107925|354969|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
146500|NCT01107925|354964|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
146501|NCT01107925|354965|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
146502|NCT01107925|354966|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
146503|NCT01107925|354967|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
146504|NCT01107925|354968|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
146505|NCT01107925|354969|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
146506|NCT01107925|354964|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
146507|NCT01107925|354965|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
146508|NCT01107925|354966|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
146509|NCT01107925|354967|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
146510|NCT01107925|354968|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
146511|NCT01107925|354969|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
146512|NCT01107925|354964|P6|STARTED|Period 1-Randomization up Through Day 12||0
146513|NCT01107925|354965|P5|STARTED|Period 1-Randomization up Through Day 12||38
146514|NCT01107925|354966|P4|STARTED|Period 1-Randomization up Through Day 12||0
146515|NCT01107925|354967|P3|STARTED|Period 1-Randomization up Through Day 12||0
146516|NCT01107925|354968|P2|STARTED|Period 1-Randomization up Through Day 12||0
146517|NCT01107925|354969|P1|STARTED|Period 1-Randomization up Through Day 12||34
146518|NCT01107912|355007|P6|NOT COMPLETED|Period 3||0
146519|NCT01107912|355008|P5|NOT COMPLETED|Period 3||0
146520|NCT01107912|355009|P4|NOT COMPLETED|Period 3||1
146521|NCT01107912|355010|P3|NOT COMPLETED|Period 3||1
146522|NCT01107912|355011|P2|NOT COMPLETED|Period 3||1
146523|NCT01107912|355012|P1|NOT COMPLETED|Period 3||0
146524|NCT01107912|355007|P6|COMPLETED|Period 3||41
146525|NCT01107912|355008|P5|COMPLETED|Period 3||0
146526|NCT01107912|355009|P4|COMPLETED|Period 3||37
146527|NCT01107912|355010|P3|COMPLETED|Period 3||35
146528|NCT01107912|355011|P2|COMPLETED|Period 3||34
146529|NCT01107912|355012|P1|COMPLETED|Period 3||0
146530|NCT01107912|355007|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
146531|NCT01107912|355008|P5|STARTED|Period 3||0
146532|NCT01107912|355009|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
146533|NCT01107912|355010|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
146534|NCT01107912|355011|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
146535|NCT01107912|355012|P1|STARTED|Period 3||0
146536|NCT01107912|355007|P6|NOT COMPLETED|Period 2||0
146537|NCT01107912|355008|P5|NOT COMPLETED|Period 2||0
146538|NCT01107912|355009|P4|NOT COMPLETED|Period 2||0
146539|NCT01107912|355010|P3|NOT COMPLETED|Period 2||1
146540|NCT01107912|355011|P2|NOT COMPLETED|Period 2||0
146541|NCT01107912|355012|P1|NOT COMPLETED|Period 2||0
146542|NCT01107912|355007|P6|COMPLETED|Period 2||38
146543|NCT01107912|355008|P5|COMPLETED|Period 2||0
146544|NCT01107912|355009|P4|COMPLETED|Period 2||41
146545|NCT01107912|355010|P3|COMPLETED|Period 2||35
146546|NCT01107912|355011|P2|COMPLETED|Period 2||36
146547|NCT01107912|355012|P1|COMPLETED|Period 2||0
146548|NCT01107912|355007|P6|STARTED|Period 2||38
146549|NCT01107912|355008|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
146550|NCT01107912|355009|P4|STARTED|Period 2||41
146551|NCT01107912|355010|P3|STARTED|Period 2||36
146552|NCT01107912|355011|P2|STARTED|Period 2||36
146553|NCT01107912|355012|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
146554|NCT01107912|355007|P6|NOT COMPLETED|Period 1||0
146555|NCT01107912|355008|P5|NOT COMPLETED|Period 1||3
146556|NCT01107912|355009|P4|NOT COMPLETED|Period 1||0
146557|NCT01107912|355010|P3|NOT COMPLETED|Period 1||0
146558|NCT01107912|355011|P2|NOT COMPLETED|Period 1||0
146559|NCT01107912|355012|P1|NOT COMPLETED|Period 1||1
146560|NCT01107912|355007|P6|COMPLETED|Period 1||0
146561|NCT01107912|355008|P5|COMPLETED|Period 1||79
146562|NCT01107912|355009|P4|COMPLETED|Period 1||0
146563|NCT01107912|355010|P3|COMPLETED|Period 1||0
146564|NCT01107912|355011|P2|COMPLETED|Period 1||0
146565|NCT01107912|355012|P1|COMPLETED|Period 1||72
146566|NCT01107912|355007|P6|Received at Least 1 Dose of Study Drug|Period 1||0
146567|NCT01107912|355008|P5|Received at Least 1 Dose of Study Drug|Period 1||82
146568|NCT01107912|355009|P4|Received at Least 1 Dose of Study Drug|Period 1||0
146569|NCT01107912|355010|P3|Received at Least 1 Dose of Study Drug|Period 1||0
146570|NCT01107912|355011|P2|Received at Least 1 Dose of Study Drug|Period 1||0
146571|NCT01107912|355012|P1|Received at Least 1 Dose of Study Drug|Period 1||73
146572|NCT01107912|355007|P6|STARTED|Period 1||0
146573|NCT01107912|355008|P5|STARTED|Period 1||82
146574|NCT01107912|355009|P4|STARTED|Period 1||0
146575|NCT01107912|355010|P3|STARTED|Period 1||0
146576|NCT01107912|355011|P2|STARTED|Period 1||0
146577|NCT01107912|355012|P1|STARTED|Period 1||73
146578|NCT01107899|355049|P3|NOT COMPLETED|Overall Study||4
146579|NCT01107899|355050|P2|NOT COMPLETED|Overall Study||0
146580|NCT01107899|355051|P1|NOT COMPLETED|Overall Study||5
146581|NCT01107899|355049|P3|COMPLETED|Overall Study||5
146582|NCT01107899|355050|P2|COMPLETED|Overall Study||10
146583|NCT01107899|355051|P1|COMPLETED|Overall Study||5
146584|NCT01107899|355049|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
146585|NCT01107899|355050|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
146586|NCT01107899|355051|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
146587|NCT01107899|355049|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
146588|NCT01107899|355050|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
146589|NCT01107899|355051|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
146590|NCT01107899|355049|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
146591|NCT01107899|355050|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
146592|NCT01107899|355051|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
146593|NCT01107899|355049|P3|Received at Least One Dose of Study Drug|Overall Study||8
146594|NCT01107899|355050|P2|Received at Least One Dose of Study Drug|Overall Study||10
146595|NCT01107899|355051|P1|Received at Least One Dose of Study Drug|Overall Study||10
146596|NCT01107899|355049|P3|STARTED|Overall Study||9
146597|NCT01107899|355050|P2|STARTED|Overall Study||10
146598|NCT01107899|355051|P1|STARTED|Overall Study||10
146599|NCT01107886|355097|P2|NOT COMPLETED|Overall Study||214
146600|NCT01107886|355098|P1|NOT COMPLETED|Overall Study||202
146601|NCT01107886|355097|P2|COMPLETED|Overall Study|Completed subjects|7998
146602|NCT01107886|355098|P1|COMPLETED|Overall Study|Completed subjects|8078
146603|NCT01107886|355097|P2|STARTED|Overall Study|Randomized subjects|8212
146604|NCT01107886|355098|P1|STARTED|Overall Study|Randomized subjects|8280
146605|NCT01107834|355110|P2|NOT COMPLETED|Overall Study||0
146606|NCT01107834|355111|P1|NOT COMPLETED|Overall Study||0
146607|NCT01107834|355110|P2|COMPLETED|Overall Study||30
146608|NCT01107834|355111|P1|COMPLETED|Overall Study||30
146609|NCT01107834|355110|P2|STARTED|Overall Study||30
146610|NCT01107834|355111|P1|STARTED|Overall Study||30
146611|NCT01107743|355127|P1|NOT COMPLETED|Overall Study||46
146612|NCT01107743|355127|P1|COMPLETED|Overall Study||1245
146613|NCT01107743|355127|P1|STARTED|Overall Study||1291
146614|NCT01107730|355216|P3|NOT COMPLETED|Overall Study||0
146615|NCT01107730|355217|P2|NOT COMPLETED|Overall Study||0
146616|NCT01107730|355218|P1|NOT COMPLETED|Overall Study||0
146617|NCT01107730|355216|P3|COMPLETED|Overall Study||11
146618|NCT01107730|355217|P2|COMPLETED|Overall Study||11
146619|NCT01107730|355218|P1|COMPLETED|Overall Study||11
146620|NCT01107730|355216|P3|STARTED|Overall Study||11
146621|NCT01107730|355217|P2|STARTED|Overall Study||11
146622|NCT01107730|355218|P1|STARTED|Overall Study||11
146623|NCT01107535|355226|P1|NOT COMPLETED|Overall Study||5
146624|NCT01107535|355226|P1|COMPLETED|Overall Study||77
146625|NCT01107535|355226|P1|Number of Participants Analyzed|Overall Study||82
146626|NCT01107535|355226|P1|STARTED|Overall Study||82
146627|NCT01107457|355239|P6|NOT COMPLETED|Part B and C||120
146628|NCT01107457|355240|P5|NOT COMPLETED|Part B and C||0
146629|NCT01107457|355241|P4|NOT COMPLETED|Part B and C||0
146630|NCT01107457|355242|P3|NOT COMPLETED|Part B and C||0
146631|NCT01107457|355243|P2|NOT COMPLETED|Part B and C||0
146632|NCT01107457|355244|P1|NOT COMPLETED|Part B and C||0
146633|NCT01107457|355239|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
146634|NCT01107457|355240|P5|COMPLETED|Part B and C||0
146635|NCT01107457|355241|P4|COMPLETED|Part B and C||0
146636|NCT01107457|355242|P3|COMPLETED|Part B and C||0
146637|NCT01107457|355243|P2|COMPLETED|Part B and C||0
146638|NCT01107457|355244|P1|COMPLETED|Part B and C||0
146639|NCT01107457|355239|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
146640|NCT01107457|355240|P5|Post Treatment Safety Visits|Part B and C||0
146641|NCT01107457|355241|P4|Post Treatment Safety Visits|Part B and C||0
146642|NCT01107457|355242|P3|Post Treatment Safety Visits|Part B and C||0
146643|NCT01107457|355243|P2|Post Treatment Safety Visits|Part B and C||0
146644|NCT01107457|355244|P1|Post Treatment Safety Visits|Part B and C||0
146645|NCT01107457|355239|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
146646|NCT01107457|355240|P5|Completed Part C|Part B and C||0
146647|NCT01107457|355241|P4|Completed Part C|Part B and C||0
146648|NCT01107457|355242|P3|Completed Part C|Part B and C||0
146649|NCT01107457|355243|P2|Completed Part C|Part B and C||0
146650|NCT01107457|355244|P1|Completed Part C|Part B and C||0
146651|NCT01107457|355239|P6|Completed Part B (Week 240)|Part B and C||74
146652|NCT01107457|355240|P5|Completed Part B (Week 240)|Part B and C||0
146653|NCT01107457|355241|P4|Completed Part B (Week 240)|Part B and C||0
146654|NCT01107457|355242|P3|Completed Part B (Week 240)|Part B and C||0
146655|NCT01107457|355243|P2|Completed Part B (Week 240)|Part B and C||0
146656|NCT01107457|355244|P1|Completed Part B (Week 240)|Part B and C||0
146657|NCT01107457|355239|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
146658|NCT01107457|355240|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
146748|NCT01106898|355577|P1|COMPLETED|Overall Study||94
146659|NCT01107457|355241|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
146660|NCT01107457|355242|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
146661|NCT01107457|355243|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
146662|NCT01107457|355244|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
146663|NCT01107457|355239|P6|NOT COMPLETED|Part A||0
146664|NCT01107457|355240|P5|NOT COMPLETED|Part A||1
146665|NCT01107457|355241|P4|NOT COMPLETED|Part A||3
146666|NCT01107457|355242|P3|NOT COMPLETED|Part A||1
146667|NCT01107457|355243|P2|NOT COMPLETED|Part A||7
146668|NCT01107457|355244|P1|NOT COMPLETED|Part A||5
146669|NCT01107457|355239|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
146670|NCT01107457|355240|P5|COMPLETED|Part A||27
146671|NCT01107457|355241|P4|COMPLETED|Part A||26
146672|NCT01107457|355242|P3|COMPLETED|Part A||29
146673|NCT01107457|355243|P2|COMPLETED|Part A||21
146674|NCT01107457|355244|P1|COMPLETED|Part A||22
146675|NCT01107457|355239|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
146676|NCT01107457|355240|P5|Received at Least 1 Dose of Study Drug|Part A||28
146677|NCT01107457|355241|P4|Received at Least 1 Dose of Study Drug|Part A||29
146678|NCT01107457|355242|P3|Received at Least 1 Dose of Study Drug|Part A||30
146679|NCT01107457|355243|P2|Received at Least 1 Dose of Study Drug|Part A||28
146680|NCT01107457|355244|P1|Received at Least 1 Dose of Study Drug|Part A||27
146681|NCT01107457|355239|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
146682|NCT01107457|355240|P5|STARTED|Part A||28
146683|NCT01107457|355241|P4|STARTED|Part A||29
146684|NCT01107457|355242|P3|STARTED|Part A||30
146685|NCT01107457|355243|P2|STARTED|Part A||28
146686|NCT01107457|355244|P1|STARTED|Part A||27
146687|NCT01107418|355374|P1|NOT COMPLETED|Overall Study||52
146688|NCT01107418|355374|P1|COMPLETED|Overall Study||0
146689|NCT01107418|355374|P1|STARTED|Overall Study||52
146690|NCT01107405|355447|P5|NOT COMPLETED|Overall Study||3
146691|NCT01107405|355448|P4|NOT COMPLETED|Overall Study||3
146692|NCT01107405|355449|P3|NOT COMPLETED|Overall Study||2
146693|NCT01107405|355450|P2|NOT COMPLETED|Overall Study||1
146694|NCT01107405|355451|P1|NOT COMPLETED|Overall Study||2
146695|NCT01107405|355447|P5|COMPLETED|Overall Study||17
146696|NCT01107405|355448|P4|COMPLETED|Overall Study||17
146697|NCT01107405|355449|P3|COMPLETED|Overall Study||18
146698|NCT01107405|355450|P2|COMPLETED|Overall Study||19
146699|NCT01107405|355451|P1|COMPLETED|Overall Study||19
146700|NCT01107405|355447|P5|STARTED|Overall Study||20
146701|NCT01107405|355448|P4|STARTED|Overall Study||20
146702|NCT01107405|355449|P3|STARTED|Overall Study||20
146703|NCT01107405|355450|P2|STARTED|Overall Study||20
146704|NCT01107405|355451|P1|STARTED|Overall Study||21
146705|NCT01107392|355490|P2|NOT COMPLETED|Overall Study||3
146706|NCT01107392|355491|P1|NOT COMPLETED|Overall Study||5
146707|NCT01107392|355490|P2|COMPLETED|Overall Study||154
146708|NCT01107392|355491|P1|COMPLETED|Overall Study||153
146709|NCT01107392|355490|P2|STARTED|Overall Study||157
146710|NCT01107392|355491|P1|STARTED|Overall Study||158
146711|NCT01107379|355503|P1|NOT COMPLETED|Overall Study||21
146712|NCT01107379|355503|P1|COMPLETED|Overall Study||182
146713|NCT01107379|355503|P1|STARTED|Overall Study||203
146714|NCT01107353|355514|P2|NOT COMPLETED|Overall Study||0
146715|NCT01107353|355515|P1|NOT COMPLETED|Overall Study||1
146716|NCT01107353|355514|P2|COMPLETED|Overall Study||20
146717|NCT01107353|355515|P1|COMPLETED|Overall Study||19
146718|NCT01107353|355514|P2|STARTED|Overall Study||20
146719|NCT01107353|355515|P1|STARTED|Overall Study||20
146720|NCT01107197|355523|P2|NOT COMPLETED|Overall Study||23
146721|NCT01107197|355524|P1|NOT COMPLETED|Overall Study||20
146722|NCT01107197|355523|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
146723|NCT01107197|355524|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
146724|NCT01107197|355523|P2|STARTED|Overall Study||101
146725|NCT01107197|355524|P1|STARTED|Overall Study||99
146726|NCT01107015|355546|P4|NOT COMPLETED|Overall Study||18
146727|NCT01107015|355547|P3|NOT COMPLETED|Overall Study||11
146728|NCT01107015|355548|P2|NOT COMPLETED|Overall Study||15
146729|NCT01107015|355549|P1|NOT COMPLETED|Overall Study||6
146730|NCT01107015|355546|P4|COMPLETED|Overall Study||62
146731|NCT01107015|355547|P3|COMPLETED|Overall Study||22
146732|NCT01107015|355548|P2|COMPLETED|Overall Study||23
146733|NCT01107015|355549|P1|COMPLETED|Overall Study||56
146734|NCT01107015|355546|P4|STARTED|Overall Study||80
146735|NCT01107015|355547|P3|STARTED|Overall Study||33
146736|NCT01107015|355548|P2|STARTED|Overall Study||38
146737|NCT01107015|355549|P1|STARTED|Overall Study||62
146738|NCT01106976|355559|P1|NOT COMPLETED|Overall Study||8
146739|NCT01106976|355559|P1|COMPLETED|Overall Study||59
146740|NCT01106976|355559|P1|STARTED|Overall Study||67
146741|NCT01106950|355563|P1|NOT COMPLETED|Overall Study||0
146742|NCT01106950|355563|P1|COMPLETED|Overall Study||15
146743|NCT01106950|355563|P1|STARTED|Overall Study||15
146744|NCT01106911|355573|P1|NOT COMPLETED|Overall Study||5
146745|NCT01106911|355573|P1|COMPLETED|Overall Study||1080
146746|NCT01106911|355573|P1|STARTED|Overall Study||1085
146749|NCT01106898|355577|P1|STARTED|Overall Study||100
146750|NCT01106859|355581|P1|NOT COMPLETED|Overall Study||0
146751|NCT01106859|355581|P1|COMPLETED|Overall Study||40
146752|NCT01106859|355581|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
146753|NCT01106846|355622|P2|NOT COMPLETED|Overall Study||1
146754|NCT01106846|355623|P1|NOT COMPLETED|Overall Study||0
146755|NCT01106846|355622|P2|COMPLETED|Overall Study||9
146756|NCT01106846|355623|P1|COMPLETED|Overall Study||12
146757|NCT01106846|355622|P2|STARTED|Overall Study||10
146758|NCT01106846|355623|P1|STARTED|Overall Study||12
146759|NCT01106690|355632|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
146760|NCT01106690|355633|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
146761|NCT01106690|355634|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
146762|NCT01106690|355632|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
146763|NCT01106690|355633|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
146764|NCT01106690|355634|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
146765|NCT01106690|355632|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
146766|NCT01106690|355633|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
146767|NCT01106690|355634|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
146768|NCT01106690|355632|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
146769|NCT01106690|355633|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
146770|NCT01106690|355634|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
146771|NCT01106690|355632|P3|COMPLETED|Core Period: Baseline to Week 26||101
146772|NCT01106690|355633|P2|COMPLETED|Core Period: Baseline to Week 26||104
146773|NCT01106690|355634|P1|COMPLETED|Core Period: Baseline to Week 26||91
146774|NCT01106690|355632|P3|STARTED|Core Period: Baseline to Week 26||114
146775|NCT01106690|355633|P2|STARTED|Core Period: Baseline to Week 26||113
146776|NCT01106690|355634|P1|STARTED|Core Period: Baseline to Week 26||115
146777|NCT01106677|355670|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
146778|NCT01106677|355671|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
146779|NCT01106677|355672|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
146780|NCT01106677|355673|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
146781|NCT01106677|355670|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
146782|NCT01106677|355671|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
146783|NCT01106677|355672|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
146784|NCT01106677|355673|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
146785|NCT01106677|355670|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
146786|NCT01106677|355671|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
146787|NCT01106677|355672|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
146788|NCT01106677|355673|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
146789|NCT01106677|355670|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
146790|NCT01106677|355671|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
146791|NCT01106677|355672|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
146792|NCT01106677|355673|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
146793|NCT01106677|355670|P4|COMPLETED|Core Period: Baseline to Week 26||319
146794|NCT01106677|355671|P3|COMPLETED|Core Period: Baseline to Week 26||323
146795|NCT01106677|355672|P2|COMPLETED|Core Period: Baseline to Week 26||322
146796|NCT01106677|355673|P1|COMPLETED|Core Period: Baseline to Week 26||155
146797|NCT01106677|355670|P4|STARTED|Core Period: Baseline to Week 26||366
146798|NCT01106677|355671|P3|STARTED|Core Period: Baseline to Week 26||367
146799|NCT01106677|355672|P2|STARTED|Core Period: Baseline to Week 26||368
146800|NCT01106677|355673|P1|STARTED|Core Period: Baseline to Week 26||183
146801|NCT01106651|355736|P3|NOT COMPLETED|Overall Study||58
146802|NCT01106651|355737|P2|NOT COMPLETED|Overall Study||57
146803|NCT01106651|355738|P1|NOT COMPLETED|Overall Study||79
146804|NCT01106651|355736|P3|COMPLETED|Overall Study||178
146805|NCT01106651|355737|P2|COMPLETED|Overall Study||184
146806|NCT01106651|355738|P1|COMPLETED|Overall Study||158
146807|NCT01106651|355736|P3|STARTED|Overall Study||236
146808|NCT01106651|355737|P2|STARTED|Overall Study||241
146809|NCT01106651|355738|P1|STARTED|Overall Study||237
146810|NCT01106625|355791|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
146811|NCT01106625|355792|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
146812|NCT01106625|355793|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
146813|NCT01106625|355791|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
146814|NCT01106625|355792|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
146815|NCT01106625|355793|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
146816|NCT01106625|355791|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
146817|NCT01106625|355792|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
146818|NCT01106625|355793|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
146819|NCT01106625|355791|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
146820|NCT01106625|355792|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
146821|NCT01106625|355793|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
146822|NCT01106625|355791|P3|COMPLETED|Core Period: Baseline to Week 26||129
146823|NCT01106625|355792|P2|COMPLETED|Core Period: Baseline to Week 26||129
146824|NCT01106625|355793|P1|COMPLETED|Core Period: Baseline to Week 26||123
146825|NCT01106625|355791|P3|STARTED|Core Period: Baseline to Week 26||156
146826|NCT01106625|355792|P2|STARTED|Core Period: Baseline to Week 26||157
146827|NCT01106625|355793|P1|STARTED|Core Period: Baseline to Week 26||156
146828|NCT01106586|355824|P2|NOT COMPLETED|Overall Study||285
146829|NCT01106586|355825|P1|NOT COMPLETED|Overall Study||285
146830|NCT01106586|355824|P2|COMPLETED|Overall Study||70
146831|NCT01106586|355825|P1|COMPLETED|Overall Study||68
146832|NCT01106586|355824|P2|STARTED|Overall Study||355
146833|NCT01106586|355825|P1|STARTED|Overall Study||353
146834|NCT01106534|355843|P1|NOT COMPLETED|Overall Study||37
146835|NCT01106534|355843|P1|COMPLETED|Overall Study||2960
146836|NCT01106534|355843|P1|STARTED|Overall Study||2997
146837|NCT01106456|355866|P2|NOT COMPLETED|Overall Study||124
146838|NCT01106456|355867|P1|NOT COMPLETED|Overall Study||103
146839|NCT01106456|355866|P2|COMPLETED|Overall Study||96
146840|NCT01106456|355867|P1|COMPLETED|Overall Study||140
146841|NCT01106456|355866|P2|STARTED|Overall Study||220
146842|NCT01106456|355867|P1|STARTED|Overall Study||243
146843|NCT01106430|355875|P2|NOT COMPLETED|Overall Study||33
146844|NCT01106430|355876|P1|NOT COMPLETED|Overall Study||33
146845|NCT01106430|355875|P2|COMPLETED|Overall Study||101
146846|NCT01106430|355876|P1|COMPLETED|Overall Study||100
146847|NCT01106430|355875|P2|STARTED|Overall Study||134
146848|NCT01106430|355876|P1|STARTED|Overall Study||133
146849|NCT01106404|355898|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
146850|NCT01106404|355899|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
146851|NCT01106404|355898|P2|COMPLETED|Period II (Second 6 Weeks)||38
146852|NCT01106404|355899|P1|COMPLETED|Period II (Second 6 Weeks)||33
146853|NCT01106404|355898|P2|STARTED|Period II (Second 6 Weeks)||38
146854|NCT01106404|355899|P1|STARTED|Period II (Second 6 Weeks)||33
146855|NCT01106404|355898|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
146856|NCT01106404|355899|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
146857|NCT01106404|355898|P2|COMPLETED|Period I (First 6 Weeks)||38
146858|NCT01106404|355899|P1|COMPLETED|Period I (First 6 Weeks)||33
146859|NCT01106404|355898|P2|STARTED|Period I (First 6 Weeks)||40
146860|NCT01106404|355899|P1|STARTED|Period I (First 6 Weeks)||36
146861|NCT01106391|355912|P1|NOT COMPLETED|Overall Study||0
146862|NCT01106391|355912|P1|COMPLETED|Overall Study||60
146863|NCT01106391|355912|P1|STARTED|Overall Study||60
146864|NCT01106352|355922|P5|NOT COMPLETED|Overall Study||8
146865|NCT01106352|355923|P4|NOT COMPLETED|Overall Study||13
146866|NCT01106352|355924|P3|NOT COMPLETED|Overall Study||2
146867|NCT01106352|355925|P2|NOT COMPLETED|Overall Study||0
146868|NCT01106352|355926|P1|NOT COMPLETED|Overall Study||1
146869|NCT01106352|355922|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
146870|NCT01106352|355923|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
146871|NCT01106352|355924|P3|COMPLETED|Overall Study||5
146872|NCT01106352|355925|P2|COMPLETED|Overall Study||3
146873|NCT01106352|355926|P1|COMPLETED|Overall Study||6
146874|NCT01106352|355922|P5|Completed Safety Cohort|Overall Study||9
146875|NCT01106352|355923|P4|Completed Safety Cohort|Overall Study||23
146876|NCT01106352|355924|P3|Completed Safety Cohort|Overall Study||0
146877|NCT01106352|355925|P2|Completed Safety Cohort|Overall Study||0
146878|NCT01106352|355926|P1|Completed Safety Cohort|Overall Study||0
146879|NCT01106352|355922|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
146880|NCT01106352|355923|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
146881|NCT01106352|355924|P3|Treated Safety Cohort|Overall Study||0
146882|NCT01106352|355925|P2|Treated Safety Cohort|Overall Study||0
146883|NCT01106352|355926|P1|Treated Safety Cohort|Overall Study||0
146884|NCT01106352|355922|P5|Started Safety Cohort|Overall Study||17
146885|NCT01106352|355923|P4|Started Safety Cohort|Overall Study||36
146886|NCT01106352|355924|P3|Started Safety Cohort|Overall Study||0
146887|NCT01106352|355925|P2|Started Safety Cohort|Overall Study||0
146888|NCT01106352|355926|P1|Started Safety Cohort|Overall Study||0
146889|NCT01106352|355922|P5|Completed Dose Escalation|Overall Study||0
146890|NCT01106352|355923|P4|Completed Dose Escalation|Overall Study||0
146891|NCT01106352|355924|P3|Completed Dose Escalation|Overall Study||5
146892|NCT01106352|355925|P2|Completed Dose Escalation|Overall Study||3
146893|NCT01106352|355926|P1|Completed Dose Escalation|Overall Study||6
146894|NCT01106352|355922|P5|Started Dose Escalation|Overall Study||0
146895|NCT01106352|355923|P4|Started Dose Escalation|Overall Study||0
146896|NCT01106352|355924|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
146897|NCT01106352|355925|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
146898|NCT01106352|355926|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
146899|NCT01106352|355922|P5|STARTED|Overall Study||17
146900|NCT01106352|355923|P4|STARTED|Overall Study||36
146901|NCT01106352|355924|P3|STARTED|Overall Study||7
146902|NCT01106352|355925|P2|STARTED|Overall Study||3
146903|NCT01106352|355926|P1|STARTED|Overall Study||7
146904|NCT01106326|356012|P1|NOT COMPLETED|Overall Study||2
146905|NCT01106326|356012|P1|COMPLETED|Overall Study||28
146906|NCT01106326|356012|P1|STARTED|Overall Study||30
146907|NCT01106287|356022|P4|NOT COMPLETED|Overall Study||0
146908|NCT01106287|356023|P3|NOT COMPLETED|Overall Study||0
146909|NCT01106287|356024|P2|NOT COMPLETED|Overall Study||0
146910|NCT01106287|356025|P1|NOT COMPLETED|Overall Study||1
146911|NCT01106287|356022|P4|COMPLETED|Overall Study||3
146912|NCT01106287|356023|P3|COMPLETED|Overall Study||3
146913|NCT01106287|356024|P2|COMPLETED|Overall Study||3
146914|NCT01106287|356025|P1|COMPLETED|Overall Study||3
146915|NCT01106287|356022|P4|STARTED|Overall Study||3
146916|NCT01106287|356023|P3|STARTED|Overall Study||3
146917|NCT01106287|356024|P2|STARTED|Overall Study||3
146918|NCT01106287|356025|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
146919|NCT01106248|356045|P1|NOT COMPLETED|Overall Study||3
146920|NCT01106248|356045|P1|COMPLETED|Overall Study||23
146921|NCT01106248|356045|P1|STARTED|Overall Study||26
146922|NCT01106157|356053|P2|NOT COMPLETED|Overall Study||0
146923|NCT01106157|356054|P1|NOT COMPLETED|Overall Study||1
146924|NCT01106157|356053|P2|COMPLETED|Overall Study||8
146925|NCT01106157|356054|P1|COMPLETED|Overall Study||16
146926|NCT01106157|356053|P2|STARTED|Overall Study||8
146927|NCT01106157|356054|P1|STARTED|Overall Study||17
146928|NCT01106092|356082|P4|NOT COMPLETED|Overall Study||1
146929|NCT01106092|356083|P3|NOT COMPLETED|Overall Study||0
146930|NCT01106092|356084|P2|NOT COMPLETED|Overall Study||0
146931|NCT01106092|356085|P1|NOT COMPLETED|Overall Study||0
146932|NCT01106092|356082|P4|COMPLETED|Overall Study||77
146933|NCT01106092|356083|P3|COMPLETED|Overall Study||78
146934|NCT01106092|356084|P2|COMPLETED|Overall Study||78
146935|NCT01106092|356085|P1|COMPLETED|Overall Study||78
146936|NCT01106092|356082|P4|STARTED|Overall Study||78
146937|NCT01106092|356083|P3|STARTED|Overall Study||78
146938|NCT01106092|356084|P2|STARTED|Overall Study||78
146939|NCT01106092|356085|P1|STARTED|Overall Study||78
146940|NCT01106040|356163|P1|NOT COMPLETED|Overall Study||11
146941|NCT01106040|356163|P1|COMPLETED|Overall Study||152
146942|NCT01106040|356163|P1|STARTED|Overall Study||163
146943|NCT01106027|356168|P1|NOT COMPLETED|Overall Study||1
146944|NCT01106027|356168|P1|COMPLETED|Overall Study||1
146945|NCT01106027|356168|P1|STARTED|Overall Study||2
146946|NCT01106014|356174|P2|NOT COMPLETED|Overall Study||330
146947|NCT01106014|356175|P1|NOT COMPLETED|Overall Study||285
146948|NCT01106014|356174|P2|COMPLETED|Overall Study||252
146949|NCT01106014|356175|P1|COMPLETED|Overall Study||289
146950|NCT01106014|356174|P2|STARTED|Overall Study||582
146951|NCT01106014|356175|P1|STARTED|Overall Study||574
146952|NCT01105975|356195|P10|NOT COMPLETED|Overall Study||9
146953|NCT01105975|356196|P9|NOT COMPLETED|Overall Study||6
146954|NCT01105975|356197|P8|NOT COMPLETED|Overall Study||7
146955|NCT01105975|356198|P7|NOT COMPLETED|Overall Study||8
146956|NCT01105975|356199|P6|NOT COMPLETED|Overall Study||5
146957|NCT01105975|356200|P5|NOT COMPLETED|Overall Study||6
146958|NCT01105975|356201|P4|NOT COMPLETED|Overall Study||2
146959|NCT01105975|356202|P3|NOT COMPLETED|Overall Study||10
146960|NCT01105975|356203|P2|NOT COMPLETED|Overall Study||5
146961|NCT01105975|356204|P1|NOT COMPLETED|Overall Study||5
146962|NCT01105975|356195|P10|COMPLETED|Overall Study||32
146963|NCT01105975|356196|P9|COMPLETED|Overall Study||34
146964|NCT01105975|356197|P8|COMPLETED|Overall Study||33
146965|NCT01105975|356198|P7|COMPLETED|Overall Study||34
146966|NCT01105975|356199|P6|COMPLETED|Overall Study||30
146967|NCT01105975|356200|P5|COMPLETED|Overall Study||35
146968|NCT01105975|356201|P4|COMPLETED|Overall Study||36
146969|NCT01105975|356202|P3|COMPLETED|Overall Study||32
146970|NCT01105975|356203|P2|COMPLETED|Overall Study||34
146971|NCT01105975|356204|P1|COMPLETED|Overall Study||35
146972|NCT01105975|356195|P10|Took at Least One Dose of Study Drug|Overall Study||41
146973|NCT01105975|356196|P9|Took at Least One Dose of Study Drug|Overall Study||39
146974|NCT01105975|356197|P8|Took at Least One Dose of Study Drug|Overall Study||40
146975|NCT01105975|356198|P7|Took at Least One Dose of Study Drug|Overall Study||41
146976|NCT01105975|356199|P6|Took at Least One Dose of Study Drug|Overall Study||35
146977|NCT01105975|356200|P5|Took at Least One Dose of Study Drug|Overall Study||41
146978|NCT01105975|356201|P4|Took at Least One Dose of Study Drug|Overall Study||38
146979|NCT01105975|356202|P3|Took at Least One Dose of Study Drug|Overall Study||40
146980|NCT01105975|356203|P2|Took at Least One Dose of Study Drug|Overall Study||38
146981|NCT01105975|356204|P1|Took at Least One Dose of Study Drug|Overall Study||40
146982|NCT01105975|356195|P10|STARTED|Overall Study||41
146983|NCT01105975|356196|P9|STARTED|Overall Study||40
146984|NCT01105975|356197|P8|STARTED|Overall Study||40
146985|NCT01105975|356198|P7|STARTED|Overall Study||42
146986|NCT01105975|356199|P6|STARTED|Overall Study||35
146987|NCT01105975|356200|P5|STARTED|Overall Study||41
146988|NCT01105975|356201|P4|STARTED|Overall Study||38
146989|NCT01105975|356202|P3|STARTED|Overall Study||42
146990|NCT01105975|356203|P2|STARTED|Overall Study||39
146991|NCT01105975|356204|P1|STARTED|Overall Study||40
146992|NCT01105936|356352|P4|NOT COMPLETED|Period 3||0
146993|NCT01105936|356353|P3|NOT COMPLETED|Period 3||0
146994|NCT01105936|356354|P2|NOT COMPLETED|Period 3||2
146995|NCT01105936|356355|P1|NOT COMPLETED|Period 3||0
146996|NCT01105936|356352|P4|COMPLETED|Period 3||7
146997|NCT01105936|356353|P3|COMPLETED|Period 3||7
146998|NCT01105936|356354|P2|COMPLETED|Period 3||6
146999|NCT01105936|356355|P1|COMPLETED|Period 3||7
147000|NCT01105936|356352|P4|STARTED|Period 3||7
147001|NCT01105936|356353|P3|STARTED|Period 3||7
147002|NCT01105936|356354|P2|STARTED|Period 3||8
147003|NCT01105936|356355|P1|STARTED|Period 3||7
147004|NCT01105936|356352|P4|NOT COMPLETED|Wash-out Period 2||0
147005|NCT01105936|356353|P3|NOT COMPLETED|Wash-out Period 2||0
147006|NCT01105936|356354|P2|NOT COMPLETED|Wash-out Period 2||0
147007|NCT01105936|356355|P1|NOT COMPLETED|Wash-out Period 2||0
147008|NCT01105936|356352|P4|COMPLETED|Wash-out Period 2||7
147009|NCT01105936|356353|P3|COMPLETED|Wash-out Period 2||7
147010|NCT01105936|356354|P2|COMPLETED|Wash-out Period 2||8
147011|NCT01105936|356355|P1|COMPLETED|Wash-out Period 2||7
147012|NCT01105936|356352|P4|STARTED|Wash-out Period 2||7
147013|NCT01105936|356353|P3|STARTED|Wash-out Period 2||7
147014|NCT01105936|356354|P2|STARTED|Wash-out Period 2||8
147015|NCT01105936|356355|P1|STARTED|Wash-out Period 2||7
147016|NCT01105936|356352|P4|NOT COMPLETED|Period 2||0
147017|NCT01105936|356353|P3|NOT COMPLETED|Period 2||0
147018|NCT01105936|356354|P2|NOT COMPLETED|Period 2||0
147019|NCT01105936|356355|P1|NOT COMPLETED|Period 2||1
147020|NCT01105936|356352|P4|COMPLETED|Period 2||7
147021|NCT01105936|356353|P3|COMPLETED|Period 2||7
147022|NCT01105936|356354|P2|COMPLETED|Period 2||8
147023|NCT01105936|356355|P1|COMPLETED|Period 2||7
147024|NCT01105936|356352|P4|STARTED|Period 2||7
147025|NCT01105936|356353|P3|STARTED|Period 2||7
147026|NCT01105936|356354|P2|STARTED|Period 2||8
147027|NCT01105936|356355|P1|STARTED|Period 2||8
147028|NCT01105936|356352|P4|NOT COMPLETED|Wash-out Period 1||0
147029|NCT01105936|356353|P3|NOT COMPLETED|Wash-out Period 1||0
147030|NCT01105936|356354|P2|NOT COMPLETED|Wash-out Period 1||0
147031|NCT01105936|356355|P1|NOT COMPLETED|Wash-out Period 1||0
147032|NCT01105936|356352|P4|COMPLETED|Wash-out Period 1||7
147033|NCT01105936|356353|P3|COMPLETED|Wash-out Period 1||7
147034|NCT01105936|356354|P2|COMPLETED|Wash-out Period 1||8
147035|NCT01105936|356355|P1|COMPLETED|Wash-out Period 1||8
147036|NCT01105936|356352|P4|STARTED|Wash-out Period 1||7
147037|NCT01105936|356353|P3|STARTED|Wash-out Period 1||7
147038|NCT01105936|356354|P2|STARTED|Wash-out Period 1||8
147039|NCT01105936|356355|P1|STARTED|Wash-out Period 1||8
147040|NCT01105936|356352|P4|NOT COMPLETED|Period 1||1
147041|NCT01105936|356353|P3|NOT COMPLETED|Period 1||0
147042|NCT01105936|356354|P2|NOT COMPLETED|Period 1||0
147043|NCT01105936|356355|P1|NOT COMPLETED|Period 1||0
147044|NCT01105936|356352|P4|COMPLETED|Period 1||7
147045|NCT01105936|356353|P3|COMPLETED|Period 1||7
147046|NCT01105936|356354|P2|COMPLETED|Period 1||8
147047|NCT01105936|356355|P1|COMPLETED|Period 1||8
147048|NCT01105936|356352|P4|STARTED|Period 1||8
147049|NCT01105936|356353|P3|STARTED|Period 1||7
147050|NCT01105936|356354|P2|STARTED|Period 1||8
147051|NCT01105936|356355|P1|STARTED|Period 1||8
147052|NCT01105767|356384|P3|NOT COMPLETED|Overall Study||1184
147053|NCT01105767|356385|P2|NOT COMPLETED|Overall Study||1614
147054|NCT01105767|356386|P1|NOT COMPLETED|Overall Study||1160
147055|NCT01105767|356384|P3|COMPLETED|Overall Study||8846
147056|NCT01105767|356385|P2|COMPLETED|Overall Study||9250
147057|NCT01105767|356386|P1|COMPLETED|Overall Study||8155
147058|NCT01105767|356384|P3|STARTED|Overall Study||10030
147059|NCT01105767|356385|P2|STARTED|Overall Study||10864
147060|NCT01105767|356386|P1|STARTED|Overall Study||9315
147061|NCT01105754|356399|P2|NOT COMPLETED|Overall Study||12
147062|NCT01105754|356400|P1|NOT COMPLETED|Overall Study||15
147063|NCT01105754|356399|P2|COMPLETED|Overall Study||307
147064|NCT01105754|356400|P1|COMPLETED|Overall Study||304
147065|NCT01105754|356399|P2|STARTED|Overall Study||319
147066|NCT01105754|356400|P1|STARTED|Overall Study||319
147067|NCT01105702|356408|P1|NOT COMPLETED|Overall Study||18
147068|NCT01105702|356408|P1|COMPLETED|Overall Study||10
147069|NCT01105702|356408|P1|STARTED|Overall Study||28
147070|NCT01105650|356418|P4|NOT COMPLETED|Overall Study||0
147071|NCT01105650|356419|P3|NOT COMPLETED|Overall Study||0
147072|NCT01105650|356420|P2|NOT COMPLETED|Overall Study||0
147073|NCT01105650|356421|P1|NOT COMPLETED|Overall Study||0
147074|NCT01105650|356418|P4|COMPLETED|Overall Study||0
147075|NCT01105650|356419|P3|COMPLETED|Overall Study||7
147076|NCT01105650|356420|P2|COMPLETED|Overall Study||3
147077|NCT01105650|356421|P1|COMPLETED|Overall Study||3
147078|NCT01105650|356418|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
147079|NCT01105650|356419|P3|STARTED|Overall Study||7
147080|NCT01105650|356420|P2|STARTED|Overall Study||3
147081|NCT01105650|356421|P1|STARTED|Overall Study||3
147082|NCT01105533|356438|P9|NOT COMPLETED|Overall Study||12
147083|NCT01105533|356439|P8|NOT COMPLETED|Overall Study||4
147084|NCT01105533|356440|P7|NOT COMPLETED|Overall Study||8
147085|NCT01105533|356441|P6|NOT COMPLETED|Overall Study||7
147086|NCT01105533|356442|P5|NOT COMPLETED|Overall Study||7
147087|NCT01105533|356443|P4|NOT COMPLETED|Overall Study||3
147088|NCT01105533|356444|P3|NOT COMPLETED|Overall Study||3
147089|NCT01105533|356445|P2|NOT COMPLETED|Overall Study||1
147090|NCT01105533|356446|P1|NOT COMPLETED|Overall Study||1
147091|NCT01105533|356438|P9|COMPLETED|Overall Study||0
147092|NCT01105533|356439|P8|COMPLETED|Overall Study||0
147093|NCT01105533|356440|P7|COMPLETED|Overall Study||0
147094|NCT01105533|356441|P6|COMPLETED|Overall Study||0
147095|NCT01105533|356442|P5|COMPLETED|Overall Study||0
147096|NCT01105533|356443|P4|COMPLETED|Overall Study||0
147097|NCT01105533|356444|P3|COMPLETED|Overall Study||0
147098|NCT01105533|356445|P2|COMPLETED|Overall Study||0
147099|NCT01105533|356446|P1|COMPLETED|Overall Study||0
147100|NCT01105533|356438|P9|STARTED|Overall Study||12
147101|NCT01105533|356439|P8|STARTED|Overall Study||4
147102|NCT01105533|356440|P7|STARTED|Overall Study||8
147103|NCT01105533|356441|P6|STARTED|Overall Study||7
147104|NCT01105533|356442|P5|STARTED|Overall Study||7
147105|NCT01105533|356443|P4|STARTED|Overall Study||3
147106|NCT01105533|356444|P3|STARTED|Overall Study||3
147107|NCT01105533|356445|P2|STARTED|Overall Study||1
147108|NCT01105533|356446|P1|STARTED|Overall Study||1
147109|NCT01105377|356536|P2|NOT COMPLETED|Overall Study||1
147110|NCT01105377|356537|P1|NOT COMPLETED|Overall Study||0
147111|NCT01105377|356536|P2|COMPLETED|Overall Study||22
147112|NCT01105377|356537|P1|COMPLETED|Overall Study||24
147113|NCT01105377|356536|P2|STARTED|Overall Study||23
147114|NCT01105377|356537|P1|STARTED|Overall Study||24
147115|NCT01105312|356548|P3|NOT COMPLETED|Overall Study||0
147116|NCT01105312|356549|P2|NOT COMPLETED|Overall Study||0
147117|NCT01105312|356550|P1|NOT COMPLETED|Overall Study||3
147118|NCT01105312|356548|P3|COMPLETED|Overall Study||6
147119|NCT01105312|356549|P2|COMPLETED|Overall Study||6
147120|NCT01105312|356550|P1|COMPLETED|Overall Study||13
147121|NCT01105312|356548|P3|STARTED|Overall Study||6
147122|NCT01105312|356549|P2|STARTED|Overall Study||6
147123|NCT01105312|356550|P1|STARTED|Overall Study||16
147124|NCT01105247|356568|P2|NOT COMPLETED|Overall Study||0
147125|NCT01105247|356569|P1|NOT COMPLETED|Overall Study||37
147126|NCT01105247|356568|P2|COMPLETED|Overall Study||16
147127|NCT01105247|356569|P1|COMPLETED|Overall Study||79
147128|NCT01105247|356568|P2|STARTED|Overall Study||16
147129|NCT01105247|356569|P1|STARTED|Overall Study||116
147130|NCT01105130|356585|P3|NOT COMPLETED|Overall Study||10
147131|NCT01105130|356586|P2|NOT COMPLETED|Overall Study||11
147132|NCT01105130|356587|P1|NOT COMPLETED|Overall Study||10
147133|NCT01105130|356585|P3|COMPLETED|Overall Study||37
147134|NCT01105130|356586|P2|COMPLETED|Overall Study||34
147135|NCT01105130|356587|P1|COMPLETED|Overall Study||38
147136|NCT01105130|356585|P3|STARTED|Overall Study||47
147137|NCT01105130|356586|P2|STARTED|Overall Study||45
147138|NCT01105130|356587|P1|STARTED|Overall Study||48
147139|NCT01105117|356606|P2|NOT COMPLETED|Overall Study||0
147140|NCT01105117|356607|P1|NOT COMPLETED|Overall Study||0
147141|NCT01105117|356606|P2|COMPLETED|Overall Study||1
147142|NCT01105117|356607|P1|COMPLETED|Overall Study||1
147143|NCT01105117|356606|P2|STARTED|Overall Study||1
147144|NCT01105117|356607|P1|STARTED|Overall Study||1
147145|NCT01105091|356617|P2|NOT COMPLETED|Overall Study||0
147146|NCT01105091|356618|P1|NOT COMPLETED|Overall Study||2
147147|NCT01105091|356617|P2|COMPLETED|Overall Study||10
147148|NCT01105091|356618|P1|COMPLETED|Overall Study||18
147149|NCT01105091|356617|P2|STARTED|Overall Study||10
147150|NCT01105091|356618|P1|STARTED|Overall Study||20
147151|NCT01105065|356642|P1|NOT COMPLETED|Overall Study||6
147152|NCT01105065|356642|P1|COMPLETED|Overall Study||17
147153|NCT01105065|356642|P1|STARTED|Overall Study||23
147154|NCT01104870|356651|P3|NOT COMPLETED|Overall Study||2
147155|NCT01104870|356652|P2|NOT COMPLETED|Overall Study||1
147156|NCT01104870|356653|P1|NOT COMPLETED|Overall Study||1
147157|NCT01104870|356651|P3|COMPLETED|Overall Study||18
147158|NCT01104870|356652|P2|COMPLETED|Overall Study||18
147159|NCT01104870|356653|P1|COMPLETED|Overall Study||10
147160|NCT01104870|356651|P3|STARTED|Overall Study||20
147161|NCT01104870|356652|P2|STARTED|Overall Study||19
147162|NCT01104870|356653|P1|STARTED|Overall Study||11
147163|NCT01104701|356686|P4|NOT COMPLETED|Overall Study||2
147164|NCT01104701|356687|P3|NOT COMPLETED|Overall Study||2
147165|NCT01104701|356688|P2|NOT COMPLETED|Overall Study||3
147166|NCT01104701|356689|P1|NOT COMPLETED|Overall Study||0
147167|NCT01104701|356686|P4|COMPLETED|Overall Study||28
147168|NCT01104701|356687|P3|COMPLETED|Overall Study||29
147169|NCT01104701|356688|P2|COMPLETED|Overall Study||27
147170|NCT01104701|356689|P1|COMPLETED|Overall Study||30
147171|NCT01104701|356686|P4|STARTED|Overall Study||30
147172|NCT01104701|356687|P3|STARTED|Overall Study||31
147173|NCT01104701|356688|P2|STARTED|Overall Study||30
147174|NCT01104701|356689|P1|STARTED|Overall Study||30
147175|NCT01104662|356751|P8|NOT COMPLETED|Overall Study||0
147176|NCT01104662|356752|P7|NOT COMPLETED|Overall Study||0
147177|NCT01104662|356753|P6|NOT COMPLETED|Overall Study||4
147178|NCT01104662|356754|P5|NOT COMPLETED|Overall Study||1
147179|NCT01104662|356755|P4|NOT COMPLETED|Overall Study||1
147180|NCT01104662|356756|P3|NOT COMPLETED|Overall Study||1
147181|NCT01104662|356757|P2|NOT COMPLETED|Overall Study||10
147182|NCT01104662|356758|P1|NOT COMPLETED|Overall Study||10
147183|NCT01104662|356751|P8|COMPLETED|Overall Study||6
147184|NCT01104662|356752|P7|COMPLETED|Overall Study||5
147185|NCT01104662|356753|P6|COMPLETED|Overall Study||12
147186|NCT01104662|356754|P5|COMPLETED|Overall Study||14
147187|NCT01104662|356755|P4|COMPLETED|Overall Study||3
147188|NCT01104662|356756|P3|COMPLETED|Overall Study||4
147189|NCT01104662|356757|P2|COMPLETED|Overall Study||11
147190|NCT01104662|356758|P1|COMPLETED|Overall Study||10
147191|NCT01104662|356751|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
147192|NCT01104662|356752|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
147193|NCT01104662|356753|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
147194|NCT01104662|356754|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
147195|NCT01104662|356755|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
147196|NCT01104662|356756|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
147197|NCT01104662|356757|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
147198|NCT01104662|356758|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
147199|NCT01104662|356751|P8|STARTED|Overall Study||6
147200|NCT01104662|356752|P7|STARTED|Overall Study||5
147201|NCT01104662|356753|P6|STARTED|Overall Study||16
147202|NCT01104662|356754|P5|STARTED|Overall Study||15
147203|NCT01104662|356755|P4|STARTED|Overall Study||4
147204|NCT01104662|356756|P3|STARTED|Overall Study||5
147205|NCT01104662|356757|P2|STARTED|Overall Study||21
147206|NCT01104662|356758|P1|STARTED|Overall Study||20
147207|NCT01104636|356784|P1|NOT COMPLETED|Overall Study||178
147208|NCT01104636|356784|P1|COMPLETED|Overall Study||999
147209|NCT01104636|356784|P1|STARTED|Overall Study||1177
147210|NCT01104584|356789|P1|NOT COMPLETED|Overall Study||23
147211|NCT01104584|356789|P1|COMPLETED|Overall Study|study course completed|437
147212|NCT01104584|356789|P1|Fulfilled Requirements of FAS Population|Overall Study||397
147213|NCT01104584|356789|P1|Received Treatment|Overall Study|treatment started|439
147214|NCT01104584|356789|P1|STARTED|Overall Study|screened and enrolled|460
147215|NCT01104558|356859|P1|NOT COMPLETED|Overall Study||17
147216|NCT01104558|356859|P1|COMPLETED|Overall Study||83
147217|NCT01104558|356859|P1|STARTED|Overall Study||100
147218|NCT01104493|356902|P2|NOT COMPLETED|Overall Study||2
147219|NCT01104493|356903|P1|NOT COMPLETED|Overall Study||0
147220|NCT01104493|356902|P2|COMPLETED|Overall Study||58
147221|NCT01104493|356903|P1|COMPLETED|Overall Study||240
147222|NCT01104493|356902|P2|STARTED|Overall Study||60
147223|NCT01104493|356903|P1|STARTED|Overall Study||240
147224|NCT01104415|356921|P1|NOT COMPLETED|Overall Study||1
147225|NCT01104415|356921|P1|COMPLETED|Overall Study||14
147226|NCT01104415|356921|P1|STARTED|Overall Study||15
147227|NCT01104402|356945|P2|NOT COMPLETED|Overall Study||33
147228|NCT01104402|356946|P1|NOT COMPLETED|Overall Study||21
147229|NCT01104402|356945|P2|COMPLETED|Overall Study||102
147230|NCT01104402|356946|P1|COMPLETED|Overall Study||111
147231|NCT01104402|356945|P2|STARTED|Overall Study||135
147232|NCT01104402|356946|P1|STARTED|Overall Study||132
147233|NCT01104376|356964|P1|NOT COMPLETED|Overall Study||28
147234|NCT01104376|356964|P1|COMPLETED|Overall Study||61
147235|NCT01104376|356964|P1|STARTED|Overall Study||89
147236|NCT01104311|356970|P2|NOT COMPLETED|Overall Study||12
147237|NCT01104311|356971|P1|NOT COMPLETED|Overall Study||10
147238|NCT01104311|356970|P2|COMPLETED|Overall Study||54
147239|NCT01104311|356971|P1|COMPLETED|Overall Study||56
147240|NCT01104311|356970|P2|STARTED|Overall Study||66
147241|NCT01104311|356971|P1|STARTED|Overall Study||66
147242|NCT01104285|356991|P2|NOT COMPLETED|Overall Study||0
147243|NCT01104285|356992|P1|NOT COMPLETED|Overall Study||0
147244|NCT01104285|356991|P2|COMPLETED|Overall Study||86
147245|NCT01104285|356992|P1|COMPLETED|Overall Study||112
147246|NCT01104285|356991|P2|STARTED|Overall Study||86
147247|NCT01104285|356992|P1|STARTED|Overall Study||112
147248|NCT01104246|356998|P1|NOT COMPLETED|Overall Study||5
147249|NCT01104246|356998|P1|COMPLETED|Overall Study||35
147250|NCT01104246|356998|P1|Baseline Characteristics Measured|Overall Study||35
147251|NCT01104246|356998|P1|STARTED|Overall Study||40
147252|NCT01104207|357004|P2|NOT COMPLETED|Overall Study||3
147253|NCT01104207|357005|P1|NOT COMPLETED|Overall Study||3
147254|NCT01104207|357004|P2|COMPLETED|Overall Study||32
147255|NCT01104207|357005|P1|COMPLETED|Overall Study||32
147256|NCT01104207|357004|P2|STARTED|Overall Study||35
147257|NCT01104207|357005|P1|STARTED|Overall Study||35
147258|NCT01104155|357013|P2|NOT COMPLETED|Overall Study||18
147259|NCT01104155|357014|P1|NOT COMPLETED|Overall Study||25
147260|NCT01104155|357013|P2|COMPLETED|Overall Study||42
147261|NCT01104155|357014|P1|COMPLETED|Overall Study||38
147262|NCT01104155|357013|P2|STARTED|Overall Study||60
147263|NCT01104155|357014|P1|STARTED|Overall Study||63
147264|NCT01104116|357028|P1|NOT COMPLETED|Overall Study||0
147265|NCT01104116|357028|P1|COMPLETED|Overall Study||1
147266|NCT01104116|357028|P1|STARTED|Overall Study||1
147267|NCT01104103|357035|P2|NOT COMPLETED|Overall Study||0
147268|NCT01104103|357036|P1|NOT COMPLETED|Overall Study||0
147269|NCT01104103|357035|P2|COMPLETED|Overall Study||224
147270|NCT01104103|357036|P1|COMPLETED|Overall Study||243
147271|NCT01104103|357035|P2|STARTED|Overall Study||224
147272|NCT01104103|357036|P1|STARTED|Overall Study||243
147273|NCT01103973|357046|P2|NOT COMPLETED|Overall Study||0
147274|NCT01103973|357047|P1|NOT COMPLETED|Overall Study||0
147275|NCT01103973|357046|P2|COMPLETED|Overall Study||46
147276|NCT01103973|357047|P1|COMPLETED|Overall Study||51
147277|NCT01103973|357046|P2|STARTED|Overall Study||46
147278|NCT01103973|357047|P1|STARTED|Overall Study||51
147279|NCT01103960|357057|P2|NOT COMPLETED|Overall Study||2
147280|NCT01103960|357058|P1|NOT COMPLETED|Overall Study||5
147281|NCT01103960|357057|P2|COMPLETED|Overall Study|Completed study medication.|158
147282|NCT01103960|357058|P1|COMPLETED|Overall Study|Completed study medication.|159
147283|NCT01103960|357057|P2|STARTED|Overall Study|Randomised and treated.|160
147284|NCT01103960|357058|P1|STARTED|Overall Study|Randomised and treated.|164
147285|NCT01103934|357084|P2|NOT COMPLETED|Overall Study||0
147286|NCT01103934|357085|P1|NOT COMPLETED|Overall Study||0
147287|NCT01103934|357084|P2|COMPLETED|Overall Study||18
147288|NCT01103934|357085|P1|COMPLETED|Overall Study||17
147289|NCT01103934|357084|P2|STARTED|Overall Study||18
147290|NCT01103934|357085|P1|STARTED|Overall Study||17
147291|NCT01103713|357093|P1|NOT COMPLETED|Overall Study||13
147292|NCT01103713|357093|P1|COMPLETED|Overall Study||155
147293|NCT01103713|357093|P1|STARTED|Overall Study||168
147294|NCT01103492|357119|P1|NOT COMPLETED|Overall Study||0
147295|NCT01103492|357119|P1|COMPLETED|Overall Study||1
147296|NCT01103492|357119|P1|STARTED|Overall Study||1
147297|NCT01103479|357126|P3|NOT COMPLETED|Overall Study||14
147298|NCT01103479|357127|P2|NOT COMPLETED|Overall Study||9
147299|NCT01103479|357128|P1|NOT COMPLETED|Overall Study||5
147300|NCT01103479|357126|P3|COMPLETED|Overall Study||174
147301|NCT01103479|357127|P2|COMPLETED|Overall Study||201
147302|NCT01103479|357128|P1|COMPLETED|Overall Study||163
147303|NCT01103479|357126|P3|STARTED|Overall Study||188
147304|NCT01103479|357127|P2|STARTED|Overall Study||210
147305|NCT01103479|357128|P1|STARTED|Overall Study||168
147306|NCT01103466|357141|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
147307|NCT01103466|357142|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
147308|NCT01103466|357143|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
147309|NCT01103466|357141|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
147310|NCT01103466|357142|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
147311|NCT01103466|357143|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
147312|NCT01103466|357141|P3|STARTED|Third Period (14 +/- 3 Days)||14
147313|NCT01103466|357142|P2|STARTED|Third Period (14 +/- 3 Days)||8
147314|NCT01103466|357143|P1|STARTED|Third Period (14 +/- 3 Days)||8
147315|NCT01103466|357141|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
147316|NCT01103466|357142|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
147317|NCT01103466|357143|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
147318|NCT01103466|357141|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
147319|NCT01103466|357142|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
147320|NCT01103466|357143|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
147321|NCT01103466|357141|P3|STARTED|Second Period (14 +/- 3 Days)||7
147322|NCT01103466|357142|P2|STARTED|Second Period (14 +/- 3 Days)||13
147323|NCT01103466|357143|P1|STARTED|Second Period (14 +/- 3 Days)||15
147324|NCT01103466|357141|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
147325|NCT01103466|357142|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
147326|NCT01103466|357143|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
147327|NCT01103466|357141|P3|COMPLETED|First Period (14 +/- 3 Days)||13
147328|NCT01103466|357142|P2|COMPLETED|First Period (14 +/- 3 Days)||12
147329|NCT01103466|357143|P1|COMPLETED|First Period (14 +/- 3 Days)||10
147330|NCT01103466|357141|P3|STARTED|First Period (14 +/- 3 Days)||13
147331|NCT01103466|357142|P2|STARTED|First Period (14 +/- 3 Days)||12
147332|NCT01103466|357143|P1|STARTED|First Period (14 +/- 3 Days)||12
147333|NCT01103440|357153|P2|NOT COMPLETED|Overall Study||0
147334|NCT01103440|357154|P1|NOT COMPLETED|Overall Study||0
147335|NCT01103440|357153|P2|COMPLETED|Overall Study||18
147336|NCT01103440|357154|P1|COMPLETED|Overall Study||18
147337|NCT01103440|357153|P2|STARTED|Overall Study||18
147338|NCT01103440|357154|P1|STARTED|Overall Study||18
147339|NCT01103414|357167|P5|NOT COMPLETED|Overall Study||15
147340|NCT01103414|357168|P4|NOT COMPLETED|Overall Study||7
147341|NCT01103414|357169|P3|NOT COMPLETED|Overall Study||15
147342|NCT01103414|357170|P2|NOT COMPLETED|Overall Study||9
147343|NCT01103414|357171|P1|NOT COMPLETED|Overall Study||13
147344|NCT01103414|357167|P5|COMPLETED|Overall Study||56
147345|NCT01103414|357168|P4|COMPLETED|Overall Study||64
147346|NCT01103414|357169|P3|COMPLETED|Overall Study||56
147347|NCT01103414|357170|P2|COMPLETED|Overall Study||62
147348|NCT01103414|357171|P1|COMPLETED|Overall Study||59
147349|NCT01103414|357167|P5|STARTED|Overall Study||71
147350|NCT01103414|357168|P4|STARTED|Overall Study||71
147351|NCT01103414|357169|P3|STARTED|Overall Study||71
147352|NCT01103414|357170|P2|STARTED|Overall Study||71
147353|NCT01103414|357171|P1|STARTED|Overall Study||72
147354|NCT01103362|357233|P1|NOT COMPLETED|Overall Study||596
147355|NCT01103362|357233|P1|COMPLETED|Overall Study||0
147356|NCT01103362|357233|P1|STARTED|Overall Study||596
147357|NCT01103323|357239|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
147358|NCT01103323|357240|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
147359|NCT01103323|357239|P2|COMPLETED|Switched From Placebo to Regorafenib||3
147360|NCT01103323|357240|P1|COMPLETED|Switched From Placebo to Regorafenib||0
147361|NCT01103323|357239|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
147362|NCT01103323|357240|P1|STARTED|Switched From Placebo to Regorafenib||0
147363|NCT01103323|357239|P2|NOT COMPLETED|Without/Before Drug Switch||18
147364|NCT01103323|357240|P1|NOT COMPLETED|Without/Before Drug Switch||76
147365|NCT01103323|357239|P2|COMPLETED|Without/Before Drug Switch||237
147366|NCT01103323|357240|P1|COMPLETED|Without/Before Drug Switch||429
147367|NCT01103323|357239|P2|Participants Received Treatment|Without/Before Drug Switch||253
147368|NCT01103323|357240|P1|Participants Received Treatment|Without/Before Drug Switch||500
147369|NCT01103323|357239|P2|STARTED|Without/Before Drug Switch||255
147370|NCT01103323|357240|P1|STARTED|Without/Before Drug Switch||505
147371|NCT01103284|357257|P2|NOT COMPLETED|Overall Study||44
147372|NCT01103284|357258|P1|NOT COMPLETED|Overall Study||42
147373|NCT01103284|357257|P2|COMPLETED|Overall Study||195
147374|NCT01103284|357258|P1|COMPLETED|Overall Study||194
147375|NCT01103284|357257|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
147376|NCT01103284|357258|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
147377|NCT01103284|357257|P2|Treated|Overall Study||238
147378|NCT01103284|357258|P1|Treated|Overall Study||236
147379|NCT01103284|357257|P2|STARTED|Overall Study||239
147380|NCT01103284|357258|P1|STARTED|Overall Study||236
147381|NCT01103271|357274|P2|NOT COMPLETED|Overall Study||4
147382|NCT01103271|357275|P1|NOT COMPLETED|Overall Study||1
147383|NCT01103271|357274|P2|COMPLETED|Overall Study||5
147384|NCT01103271|357275|P1|COMPLETED|Overall Study||10
147385|NCT01103271|357274|P2|STARTED|Overall Study||9
147386|NCT01103271|357275|P1|STARTED|Overall Study||11
147387|NCT01103232|357284|P2|NOT COMPLETED|Overall Study||2
147388|NCT01103232|357285|P1|NOT COMPLETED|Overall Study||1
147389|NCT01103232|357284|P2|COMPLETED|Overall Study||11
147390|NCT01103232|357285|P1|COMPLETED|Overall Study||12
147391|NCT01103232|357284|P2|STARTED|Overall Study||13
147392|NCT01103232|357285|P1|STARTED|Overall Study||13
147393|NCT01103141|357293|P2|NOT COMPLETED|Overall Study||2
147394|NCT01103141|357294|P1|NOT COMPLETED|Overall Study||2
147395|NCT01103141|357293|P2|COMPLETED|Overall Study||74
147396|NCT01103141|357294|P1|COMPLETED|Overall Study||65
147397|NCT01103141|357293|P2|STARTED|Overall Study||76
147398|NCT01103141|357294|P1|STARTED|Overall Study||67
147399|NCT01103063|357302|P2|NOT COMPLETED|Overall Study||421
147400|NCT01103063|357303|P1|NOT COMPLETED|Overall Study||477
147401|NCT01103063|357302|P2|COMPLETED|Overall Study||1024
147402|NCT01103063|357303|P1|COMPLETED|Overall Study||969
147403|NCT01103063|357302|P2|STARTED|Overall Study||1445
147404|NCT01103063|357303|P1|STARTED|Overall Study||1446
147405|NCT01102972|357371|P2|NOT COMPLETED|Overall Study||14
147406|NCT01102972|357372|P1|NOT COMPLETED|Overall Study||29
147407|NCT01102972|357371|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
147408|NCT01102972|357372|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
147409|NCT01102972|357371|P2|Completed Week 24|Overall Study||88
147410|NCT01102972|357372|P1|Completed Week 24|Overall Study||180
147411|NCT01102972|357371|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
147412|NCT01102972|357372|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
147413|NCT01102894|357424|P1|NOT COMPLETED|Overall Study||0
147414|NCT01102894|357424|P1|COMPLETED|Overall Study||10
147415|NCT01102894|357424|P1|STARTED|Overall Study||10
147416|NCT01102803|357436|P2|NOT COMPLETED|Post to Follow-Up||3
147417|NCT01102803|357437|P1|NOT COMPLETED|Post to Follow-Up||1
147418|NCT01102803|357436|P2|COMPLETED|Post to Follow-Up||12
147419|NCT01102803|357437|P1|COMPLETED|Post to Follow-Up||10
147420|NCT01102803|357436|P2|STARTED|Post to Follow-Up||15
147421|NCT01102803|357437|P1|STARTED|Post to Follow-Up||11
147422|NCT01102803|357436|P2|NOT COMPLETED|Baseline to Post-Treatment||0
147423|NCT01102803|357437|P1|NOT COMPLETED|Baseline to Post-Treatment||3
147424|NCT01102803|357436|P2|COMPLETED|Baseline to Post-Treatment||15
147425|NCT01102803|357437|P1|COMPLETED|Baseline to Post-Treatment||11
147426|NCT01102803|357436|P2|STARTED|Baseline to Post-Treatment||15
147427|NCT01102803|357437|P1|STARTED|Baseline to Post-Treatment||14
147428|NCT01102777|357451|P2|NOT COMPLETED|Overall Study||16
147429|NCT01102777|357452|P1|NOT COMPLETED|Overall Study||9
147430|NCT01102777|357451|P2|COMPLETED|Overall Study||139
147431|NCT01102777|357452|P1|COMPLETED|Overall Study||75
147432|NCT01102777|357451|P2|STARTED|Overall Study||155
147433|NCT01102777|357452|P1|STARTED|Overall Study||84
147434|NCT01102764|357478|P2|NOT COMPLETED|Overall Study||13
147435|NCT01102764|357479|P1|NOT COMPLETED|Overall Study||21
147436|NCT01102764|357478|P2|COMPLETED|Overall Study||55
147437|NCT01102764|357479|P1|COMPLETED|Overall Study||43
147438|NCT01102764|357478|P2|STARTED|Overall Study||68
147439|NCT01102764|357479|P1|STARTED|Overall Study||64
147440|NCT01102491|357491|P2|NOT COMPLETED|Overall Study||12
147441|NCT01102491|357492|P1|NOT COMPLETED|Overall Study||11
147442|NCT01102491|357491|P2|COMPLETED|Overall Study|12 patients were excluded|59
147443|NCT01102491|357492|P1|COMPLETED|Overall Study|11 patient excluded|60
147444|NCT01102491|357491|P2|STARTED|Overall Study||71
147445|NCT01102491|357492|P1|STARTED|Overall Study||71
147446|NCT01102413|357500|P2|NOT COMPLETED|Overall Study||12
147447|NCT01102413|357501|P1|NOT COMPLETED|Overall Study||25
147448|NCT01102413|357500|P2|COMPLETED|Overall Study||106
147449|NCT01102413|357501|P1|COMPLETED|Overall Study||208
147450|NCT01102413|357500|P2|STARTED|Overall Study||118
147451|NCT01102413|357501|P1|STARTED|Overall Study||233
147452|NCT01102374|357511|P2|NOT COMPLETED|Overall Study||19
147453|NCT01102374|357512|P1|NOT COMPLETED|Overall Study||16
147454|NCT01102374|357511|P2|COMPLETED|Overall Study||33
147455|NCT01102374|357512|P1|COMPLETED|Overall Study||39
147456|NCT01102374|357511|P2|STARTED|Overall Study||52
147457|NCT01102374|357512|P1|STARTED|Overall Study||55
147458|NCT01102270|357546|P2|NOT COMPLETED|Overall Study||0
147459|NCT01102270|357547|P1|NOT COMPLETED|Overall Study||0
147460|NCT01102270|357546|P2|COMPLETED|Overall Study||9
147461|NCT01102270|357547|P1|COMPLETED|Overall Study||8
147462|NCT01102270|357546|P2|STARTED|Overall Study||9
147463|NCT01102270|357547|P1|STARTED|Overall Study||8
147464|NCT01102257|357561|P2|NOT COMPLETED|Overall Study||0
147465|NCT01102257|357562|P1|NOT COMPLETED|Overall Study||2
147466|NCT01102257|357561|P2|COMPLETED|Overall Study||9
147467|NCT01102257|357562|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
147468|NCT01102257|357561|P2|STARTED|Overall Study||9
147469|NCT01102257|357562|P1|STARTED|Overall Study||9
147470|NCT01102218|357570|P2|NOT COMPLETED|Overall Study||10
147471|NCT01102218|357571|P1|NOT COMPLETED|Overall Study||11
147472|NCT01102218|357570|P2|COMPLETED|Overall Study||14
147473|NCT01102218|357571|P1|COMPLETED|Overall Study||13
147474|NCT01102218|357570|P2|STARTED|Overall Study||24
147475|NCT01102218|357571|P1|STARTED|Overall Study||24
147476|NCT01102140|357579|P2|NOT COMPLETED|Overall Study||2
147477|NCT01102140|357580|P1|NOT COMPLETED|Overall Study||3
147478|NCT01102140|357579|P2|COMPLETED|Overall Study||5
147479|NCT01102140|357580|P1|COMPLETED|Overall Study||10
147480|NCT01102140|357579|P2|STARTED|Overall Study||7
147481|NCT01102140|357580|P1|STARTED|Overall Study||13
147482|NCT01101971|357592|P1|NOT COMPLETED|Overall Study||0
147483|NCT01101971|357592|P1|COMPLETED|Overall Study||45
147484|NCT01101971|357592|P1|STARTED|Overall Study||45
147485|NCT01101958|357598|P2|NOT COMPLETED|Overall Study||5
147486|NCT01101958|357599|P1|NOT COMPLETED|Overall Study||11
147487|NCT01101958|357598|P2|COMPLETED|Overall Study||29
147488|NCT01101958|357599|P1|COMPLETED|Overall Study||51
147489|NCT01101958|357598|P2|STARTED|Overall Study||34
147490|NCT01101958|357599|P1|STARTED|Overall Study||62
147491|NCT01101880|357605|P1|NOT COMPLETED|Overall Study||0
147492|NCT01101880|357605|P1|COMPLETED|Overall Study||50
147493|NCT01101880|357605|P1|STARTED|Overall Study||50
147494|NCT01101867|357616|P2|NOT COMPLETED|Overall Study||4
147495|NCT01101867|357617|P1|NOT COMPLETED|Overall Study||1
147496|NCT01101867|357616|P2|COMPLETED|Overall Study||59
147497|NCT01101867|357617|P1|COMPLETED|Overall Study||62
147498|NCT01101867|357616|P2|STARTED|Overall Study||63
147499|NCT01101867|357617|P1|STARTED|Overall Study||63
147500|NCT01101841|357635|P2|NOT COMPLETED|Overall Study||67
147501|NCT01101841|357636|P1|NOT COMPLETED|Overall Study||50
147502|NCT01101841|357635|P2|COMPLETED|Overall Study||218
147503|NCT01101841|357636|P1|COMPLETED|Overall Study||235
147504|NCT01101841|357635|P2|STARTED|Overall Study||285
147505|NCT01101841|357636|P1|STARTED|Overall Study||285
147506|NCT01101542|357674|P1|NOT COMPLETED|Year 6 Surveillance Period||991
147507|NCT01101542|357674|P1|COMPLETED|Year 6 Surveillance Period||2100
147508|NCT01101542|357674|P1|STARTED|Year 6 Surveillance Period||3091
147509|NCT01101542|357674|P1|NOT COMPLETED|Year 5 Surveillance Period||141
147510|NCT01101542|357674|P1|COMPLETED|Year 5 Surveillance Period||668
147511|NCT01101542|357674|P1|STARTED|Year 5 Surveillance Period||809
147512|NCT01101542|357674|P1|NOT COMPLETED|Year 4 Surveillance Period||287
147513|NCT01101542|357674|P1|COMPLETED|Year 4 Surveillance Period||282
147514|NCT01101542|357674|P1|STARTED|Year 4 Surveillance Period||569
147515|NCT01101542|357674|P1|NOT COMPLETED|Year 3 Surveillance Period||11
147516|NCT01101542|357674|P1|COMPLETED|Year 3 Surveillance Period||94
147517|NCT01101542|357674|P1|STARTED|Year 3 Surveillance Period||105
147518|NCT01101477|357693|P3|NOT COMPLETED|Overall Study||1
147519|NCT01101477|357694|P2|NOT COMPLETED|Overall Study||3
147520|NCT01101477|357695|P1|NOT COMPLETED|Overall Study||5
147521|NCT01101477|357693|P3|COMPLETED|Overall Study||45
147522|NCT01101477|357694|P2|COMPLETED|Overall Study||46
147523|NCT01101477|357695|P1|COMPLETED|Overall Study||44
147524|NCT01101477|357693|P3|STARTED|Overall Study||46
147525|NCT01101477|357694|P2|STARTED|Overall Study||49
147526|NCT01101477|357695|P1|STARTED|Overall Study||49
147527|NCT01101464|357705|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
147528|NCT01101464|357706|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
147529|NCT01101464|357705|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
147530|NCT01101464|357706|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
147531|NCT01101464|357705|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
147532|NCT01101464|357706|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
147533|NCT01101464|357705|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
147534|NCT01101464|357706|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
147535|NCT01101464|357705|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
147536|NCT01101464|357706|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
147537|NCT01101464|357705|P2|STARTED|Day 1 Through AM Dose of Day 5||4
147538|NCT01101464|357706|P1|STARTED|Day 1 Through AM Dose of Day 5||4
147539|NCT01101321|357716|P2|NOT COMPLETED|Period 2||0
147540|NCT01101321|357717|P1|NOT COMPLETED|Period 2||0
147541|NCT01101321|357716|P2|COMPLETED|Period 2||24
147542|NCT01101321|357717|P1|COMPLETED|Period 2||26
147543|NCT01101321|357716|P2|STARTED|Period 2||24
147544|NCT01101321|357717|P1|STARTED|Period 2||26
147545|NCT01101321|357716|P2|NOT COMPLETED|Period 1||4
147546|NCT01101321|357717|P1|NOT COMPLETED|Period 1||4
147547|NCT01101321|357716|P2|COMPLETED|Period 1||24
147548|NCT01101321|357717|P1|COMPLETED|Period 1||26
147549|NCT01101321|357716|P2|STARTED|Period 1||28
147550|NCT01101321|357717|P1|STARTED|Period 1||30
147551|NCT01101308|357727|P2|NOT COMPLETED|Period 2||0
147552|NCT01101308|357728|P1|NOT COMPLETED|Period 2||0
147553|NCT01101308|357727|P2|COMPLETED|Period 2||27
147554|NCT01101308|357728|P1|COMPLETED|Period 2||24
147555|NCT01101308|357727|P2|STARTED|Period 2||27
147556|NCT01101308|357728|P1|STARTED|Period 2||24
147557|NCT01101308|357727|P2|NOT COMPLETED|Period 1||1
147558|NCT01101308|357728|P1|NOT COMPLETED|Period 1||3
147559|NCT01101308|357727|P2|COMPLETED|Period 1||27
147560|NCT01101308|357728|P1|COMPLETED|Period 1||24
147561|NCT01101308|357727|P2|STARTED|Period 1||28
147562|NCT01101308|357728|P1|STARTED|Period 1||27
147563|NCT01101191|357739|P2|NOT COMPLETED|Period 2||0
147564|NCT01101191|357740|P1|NOT COMPLETED|Period 2||0
147565|NCT01101191|357739|P2|COMPLETED|Period 2||40
147566|NCT01101191|357740|P1|COMPLETED|Period 2||40
147567|NCT01101191|357739|P2|STARTED|Period 2||40
147568|NCT01101191|357740|P1|STARTED|Period 2||40
147569|NCT01101191|357739|P2|NOT COMPLETED|Period 1||2
147570|NCT01101191|357740|P1|NOT COMPLETED|Period 1||2
147571|NCT01101191|357739|P2|COMPLETED|Period 1||40
147572|NCT01101191|357740|P1|COMPLETED|Period 1||40
147573|NCT01101191|357739|P2|STARTED|Period 1||42
147574|NCT01101191|357740|P1|STARTED|Period 1||42
147575|NCT01101178|357751|P2|NOT COMPLETED|Period 2||1
147576|NCT01101178|357752|P1|NOT COMPLETED|Period 2||0
147577|NCT01101178|357751|P2|COMPLETED|Period 2||34
147578|NCT01101178|357752|P1|COMPLETED|Period 2||36
147579|NCT01101178|357751|P2|STARTED|Period 2||35
147580|NCT01101178|357752|P1|STARTED|Period 2||36
147581|NCT01101178|357751|P2|NOT COMPLETED|Period 1||4
147582|NCT01101178|357752|P1|NOT COMPLETED|Period 1||4
147583|NCT01101178|357751|P2|COMPLETED|Period 1||35
147584|NCT01101178|357752|P1|COMPLETED|Period 1||36
147585|NCT01101178|357751|P2|STARTED|Period 1||39
147586|NCT01101178|357752|P1|STARTED|Period 1||40
147587|NCT01101165|357763|P2|NOT COMPLETED|Period 2||1
147588|NCT01101165|357764|P1|NOT COMPLETED|Period 2||4
147589|NCT01101165|357763|P2|COMPLETED|Period 2||39
147590|NCT01101165|357764|P1|COMPLETED|Period 2||41
147591|NCT01101165|357763|P2|STARTED|Period 2||40
147592|NCT01101165|357764|P1|STARTED|Period 2||45
147593|NCT01101165|357763|P2|NOT COMPLETED|Period 1||5
147594|NCT01101165|357764|P1|NOT COMPLETED|Period 1||2
147595|NCT01101165|357763|P2|COMPLETED|Period 1||40
147596|NCT01101165|357764|P1|COMPLETED|Period 1||45
147597|NCT01101165|357763|P2|STARTED|Period 1||45
147598|NCT01101165|357764|P1|STARTED|Period 1||47
147599|NCT01101022|357776|P2|NOT COMPLETED|Overall Study||27
147600|NCT01101022|357777|P1|NOT COMPLETED|Overall Study||17
147601|NCT01101022|357776|P2|COMPLETED|Overall Study||53
147602|NCT01101022|357777|P1|COMPLETED|Overall Study||62
147603|NCT01101022|357776|P2|STARTED|Overall Study||80
147604|NCT01101022|357777|P1|STARTED|Overall Study||79
147605|NCT01100944|357811|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
147606|NCT01100944|357812|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
147607|NCT01100944|357813|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
147608|NCT01100944|357811|P3|COMPLETED|Expansion Phase - Phase 2||18
147609|NCT01100944|357812|P2|COMPLETED|Expansion Phase - Phase 2||0
147610|NCT01100944|357813|P1|COMPLETED|Expansion Phase - Phase 2||0
147611|NCT01100944|357811|P3|STARTED|Expansion Phase - Phase 2||18
147612|NCT01100944|357812|P2|STARTED|Expansion Phase - Phase 2||0
147613|NCT01100944|357813|P1|STARTED|Expansion Phase - Phase 2||0
147614|NCT01100944|357811|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
147615|NCT01100944|357812|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
147616|NCT01100944|357813|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
147617|NCT01100944|357811|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
147618|NCT01100944|357812|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
147619|NCT01100944|357813|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
147620|NCT01100944|357811|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
147621|NCT01100944|357812|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
147622|NCT01100944|357813|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
147623|NCT01100944|357811|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
147624|NCT01100944|357812|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
147625|NCT01100944|357813|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
147626|NCT01100944|357811|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
147627|NCT01100944|357812|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
147628|NCT01100944|357813|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
147629|NCT01100944|357811|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
147630|NCT01100944|357812|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
147631|NCT01100944|357813|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
147632|NCT01100931|357860|P2|NOT COMPLETED|Phase II||0
147633|NCT01100931|357861|P1|NOT COMPLETED|Phase II||0
147634|NCT01100931|357860|P2|COMPLETED|Phase II||19
147635|NCT01100931|357861|P1|COMPLETED|Phase II||0
147636|NCT01100931|357860|P2|STARTED|Phase II||19
147637|NCT01100931|357861|P1|STARTED|Phase II||0
147638|NCT01100931|357860|P2|NOT COMPLETED|Phase I||0
147639|NCT01100931|357861|P1|NOT COMPLETED|Phase I||0
147640|NCT01100931|357860|P2|COMPLETED|Phase I||0
147641|NCT01100931|357861|P1|COMPLETED|Phase I||22
147642|NCT01100931|357860|P2|STARTED|Phase I||0
147643|NCT01100931|357861|P1|STARTED|Phase I||22
147644|NCT01100853|357871|P2|NOT COMPLETED|Overall Study||23
147645|NCT01100853|357872|P1|NOT COMPLETED|Overall Study||27
147646|NCT01100853|357871|P2|COMPLETED|Overall Study||26
147647|NCT01100853|357872|P1|COMPLETED|Overall Study||24
147648|NCT01100853|357871|P2|STARTED|Overall Study||49
147649|NCT01100853|357872|P1|STARTED|Overall Study||51
147650|NCT01100762|357888|P1|NOT COMPLETED|Overall Study||0
147651|NCT01100762|357888|P1|COMPLETED|Overall Study||10
147652|NCT01100762|357888|P1|STARTED|Overall Study||10
147653|NCT01100723|357909|P1|NOT COMPLETED|Overall Study||14
147654|NCT01100723|357909|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
147655|NCT01100723|357909|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
147656|NCT01100723|357909|P1|STARTED|Overall Study||92
147657|NCT01100658|357918|P1|NOT COMPLETED|Overall Study||1
147658|NCT01100658|357918|P1|COMPLETED|Overall Study||0
147659|NCT01100658|357918|P1|STARTED|Overall Study||1
147660|NCT01100606|357923|P2|NOT COMPLETED|Second Treatment Period||0
147661|NCT01100606|357924|P1|NOT COMPLETED|Second Treatment Period||0
147662|NCT01100606|357923|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
147663|NCT01100606|357924|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
147664|NCT01100606|357923|P2|STARTED|Second Treatment Period||7
147665|NCT01100606|357924|P1|STARTED|Second Treatment Period||8
147666|NCT01100606|357923|P2|NOT COMPLETED|First Treatment Period||0
147667|NCT01100606|357924|P1|NOT COMPLETED|First Treatment Period||0
147668|NCT01100606|357923|P2|COMPLETED|First Treatment Period||7
147669|NCT01100606|357924|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
147670|NCT01100606|357923|P2|STARTED|First Treatment Period||7
147671|NCT01100606|357924|P1|STARTED|First Treatment Period||8
147672|NCT01100567|357950|P2|NOT COMPLETED|Overall Study||16
147673|NCT01100567|357951|P1|NOT COMPLETED|Overall Study||12
147674|NCT01100567|357950|P2|COMPLETED|Overall Study||35
147675|NCT01100567|357951|P1|COMPLETED|Overall Study||38
147676|NCT01100567|357950|P2|STARTED|Overall Study||51
147677|NCT01100567|357951|P1|STARTED|Overall Study||50
147678|NCT01100502|357961|P2|NOT COMPLETED|Long-Term Follow-up||139
147679|NCT01100502|357962|P1|NOT COMPLETED|Long-Term Follow-up||137
147680|NCT01100502|357961|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
147681|NCT01100502|357962|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
147682|NCT01100502|357961|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
147683|NCT01100502|357962|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
147684|NCT01100502|357961|P2|NOT COMPLETED|Treatment Period||83
147685|NCT01100502|357962|P1|NOT COMPLETED|Treatment Period||87
147686|NCT01100502|357961|P2|COMPLETED|Treatment Period||81
147687|NCT01100502|357962|P1|COMPLETED|Treatment Period||78
147688|NCT01100502|357961|P2|STARTED|Treatment Period||164
147689|NCT01100502|357962|P1|STARTED|Treatment Period||165
147690|NCT01100437|357972|P3|NOT COMPLETED|Treatment 2||0
147691|NCT01100437|357973|P2|NOT COMPLETED|Treatment 2||0
147692|NCT01100437|357974|P1|NOT COMPLETED|Treatment 2||0
147693|NCT01100437|357972|P3|COMPLETED|Treatment 2||0
147694|NCT01100437|357973|P2|COMPLETED|Treatment 2||2
147695|NCT01100437|357974|P1|COMPLETED|Treatment 2||4
147696|NCT01100437|357972|P3|STARTED|Treatment 2||0
147697|NCT01100437|357973|P2|STARTED|Treatment 2||2
147698|NCT01100437|357974|P1|STARTED|Treatment 2||4
147699|NCT01100437|357972|P3|NOT COMPLETED|Washout (4 Days)||0
147700|NCT01100437|357973|P2|NOT COMPLETED|Washout (4 Days)||0
147701|NCT01100437|357974|P1|NOT COMPLETED|Washout (4 Days)||0
147702|NCT01100437|357972|P3|COMPLETED|Washout (4 Days)||0
147703|NCT01100437|357973|P2|COMPLETED|Washout (4 Days)||2
147704|NCT01100437|357974|P1|COMPLETED|Washout (4 Days)||4
147705|NCT01100437|357972|P3|STARTED|Washout (4 Days)||0
147706|NCT01100437|357973|P2|STARTED|Washout (4 Days)||2
147707|NCT01100437|357974|P1|STARTED|Washout (4 Days)||4
147708|NCT01100437|357972|P3|NOT COMPLETED|Treatment 1||0
147709|NCT01100437|357973|P2|NOT COMPLETED|Treatment 1||0
147710|NCT01100437|357974|P1|NOT COMPLETED|Treatment 1||0
147711|NCT01100437|357972|P3|COMPLETED|Treatment 1||0
147712|NCT01100437|357973|P2|COMPLETED|Treatment 1||2
147713|NCT01100437|357974|P1|COMPLETED|Treatment 1||4
147714|NCT01100437|357972|P3|STARTED|Treatment 1||0
147715|NCT01100437|357973|P2|STARTED|Treatment 1||2
147716|NCT01100437|357974|P1|STARTED|Treatment 1||4
147717|NCT01100437|357972|P3|NOT COMPLETED|Maintenance||2
147718|NCT01100437|357973|P2|NOT COMPLETED|Maintenance||0
147719|NCT01100437|357974|P1|NOT COMPLETED|Maintenance||0
147720|NCT01100437|357972|P3|COMPLETED|Maintenance||0
147721|NCT01100437|357973|P2|COMPLETED|Maintenance||2
147722|NCT01100437|357974|P1|COMPLETED|Maintenance||4
147723|NCT01100437|357972|P3|STARTED|Maintenance||2
147724|NCT01100437|357973|P2|STARTED|Maintenance||2
147725|NCT01100437|357974|P1|STARTED|Maintenance||4
147726|NCT01100437|357972|P3|NOT COMPLETED|Titration/Stabilization||6
147727|NCT01100437|357973|P2|NOT COMPLETED|Titration/Stabilization||0
147728|NCT01100437|357974|P1|NOT COMPLETED|Titration/Stabilization||0
147729|NCT01100437|357972|P3|COMPLETED|Titration/Stabilization||2
147730|NCT01100437|357973|P2|COMPLETED|Titration/Stabilization||2
147731|NCT01100437|357974|P1|COMPLETED|Titration/Stabilization||4
147732|NCT01100437|357972|P3|STARTED|Titration/Stabilization||8
147733|NCT01100437|357973|P2|STARTED|Titration/Stabilization||2
147734|NCT01100437|357974|P1|STARTED|Titration/Stabilization||4
147735|NCT01100437|357972|P3|NOT COMPLETED|Screening||0
147736|NCT01100437|357973|P2|NOT COMPLETED|Screening||0
147737|NCT01100437|357974|P1|NOT COMPLETED|Screening||0
147738|NCT01100437|357972|P3|COMPLETED|Screening||8
147739|NCT01100437|357973|P2|COMPLETED|Screening||2
147740|NCT01100437|357974|P1|COMPLETED|Screening||4
147741|NCT01100437|357972|P3|STARTED|Screening||8
147742|NCT01100437|357973|P2|STARTED|Screening||2
147743|NCT01100437|357974|P1|STARTED|Screening||4
147744|NCT01100320|358011|P2|NOT COMPLETED|Period 2||1
147745|NCT01100320|358012|P1|NOT COMPLETED|Period 2||1
147746|NCT01100320|358011|P2|COMPLETED|Period 2||37
147747|NCT01100320|358012|P1|COMPLETED|Period 2||37
147748|NCT01100320|358011|P2|STARTED|Period 2||38
147749|NCT01100320|358012|P1|STARTED|Period 2||38
147750|NCT01100320|358011|P2|NOT COMPLETED|Period 1||7
147751|NCT01100320|358012|P1|NOT COMPLETED|Period 1||5
147752|NCT01100320|358011|P2|COMPLETED|Period 1||38
147753|NCT01100320|358012|P1|COMPLETED|Period 1||38
147754|NCT01100320|358011|P2|STARTED|Period 1||45
147755|NCT01100320|358012|P1|STARTED|Period 1||43
147756|NCT01100307|358024|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
147757|NCT01100307|358025|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
147758|NCT01100307|358024|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
147759|NCT01100307|358025|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
147760|NCT01100307|358024|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
147761|NCT01100307|358025|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
147762|NCT01100307|358024|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
147763|NCT01100307|358025|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
147764|NCT01100307|358024|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
147765|NCT01100307|358025|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
147766|NCT01100307|358024|P2|STARTED|Double Masked Phase (Up to Week 24)||120
147767|NCT01100307|358025|P1|STARTED|Double Masked Phase (Up to Week 24)||123
147768|NCT01100268|358067|P1|NOT COMPLETED|Overall Study||0
147769|NCT01100268|358067|P1|COMPLETED|Overall Study||4
147770|NCT01100268|358067|P1|STARTED|Overall Study||4
147771|NCT01100255|358074|P2|NOT COMPLETED|Overall Study||0
147772|NCT01100255|358075|P1|NOT COMPLETED|Overall Study||0
147773|NCT01100255|358074|P2|COMPLETED|Overall Study||7
147774|NCT01100255|358075|P1|COMPLETED|Overall Study||8
147775|NCT01100255|358074|P2|STARTED|Overall Study||7
147776|NCT01100255|358075|P1|STARTED|Overall Study||8
147777|NCT01100242|358081|P1|NOT COMPLETED|Overall Study||0
147778|NCT01100242|358081|P1|COMPLETED|Overall Study||17
147779|NCT01100242|358081|P1|STARTED|Overall Study||17
147780|NCT01100112|358087|P1|NOT COMPLETED|Overall Study||8
147781|NCT01100112|358087|P1|COMPLETED|Overall Study||52
147782|NCT01100112|358087|P1|STARTED|Overall Study||60
147783|NCT01100086|358094|P2|NOT COMPLETED|Period 2||0
147784|NCT01100086|358095|P1|NOT COMPLETED|Period 2||0
147785|NCT01100086|358094|P2|COMPLETED|Period 2||41
147786|NCT01100086|358095|P1|COMPLETED|Period 2||42
147787|NCT01100086|358094|P2|STARTED|Period 2||41
147788|NCT01100086|358095|P1|STARTED|Period 2||42
147789|NCT01100086|358094|P2|NOT COMPLETED|Period 1||0
147790|NCT01100086|358095|P1|NOT COMPLETED|Period 1||1
147791|NCT01100086|358094|P2|COMPLETED|Period 1||41
147792|NCT01100086|358095|P1|COMPLETED|Period 1||42
147793|NCT01100086|358094|P2|STARTED|Period 1||41
147794|NCT01100086|358095|P1|STARTED|Period 1||43
147795|NCT01100073|358105|P1|NOT COMPLETED|Overall Study||100
147796|NCT01100073|358105|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
147797|NCT01100073|358105|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
147798|NCT01099917|358120|P1|NOT COMPLETED|Overall Study||27
147799|NCT01099917|358120|P1|COMPLETED|Overall Study||18
147800|NCT01099917|358120|P1|STARTED|Overall Study||45
147801|NCT01099774|358126|P2|NOT COMPLETED|Overall Study||6
147802|NCT01099774|358127|P1|NOT COMPLETED|Overall Study||6
147803|NCT01099774|358126|P2|COMPLETED|Overall Study||289
147804|NCT01099774|358127|P1|COMPLETED|Overall Study||296
147805|NCT01099774|358126|P2|STARTED|Overall Study||295
147806|NCT01099774|358127|P1|STARTED|Overall Study||302
147807|NCT01099761|358143|P4|NOT COMPLETED|Overall Study||0
147808|NCT01099761|358144|P3|NOT COMPLETED|Overall Study||0
147809|NCT01099761|358145|P2|NOT COMPLETED|Overall Study||0
147810|NCT01099761|358146|P1|NOT COMPLETED|Overall Study||0
147811|NCT01099761|358143|P4|COMPLETED|Overall Study||6
147812|NCT01099761|358144|P3|COMPLETED|Overall Study||0
147813|NCT01099761|358145|P2|COMPLETED|Overall Study||9
147814|NCT01099761|358146|P1|COMPLETED|Overall Study||9
147815|NCT01099761|358143|P4|STARTED|Overall Study||6
147816|NCT01099761|358144|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
147817|NCT01099761|358145|P2|STARTED|Overall Study||9
147818|NCT01099761|358146|P1|STARTED|Overall Study||9
147819|NCT01099709|358182|P2|NOT COMPLETED|Period 2||0
147820|NCT01099709|358183|P1|NOT COMPLETED|Period 2||0
147821|NCT01099709|358182|P2|COMPLETED|Period 2||41
147822|NCT01099709|358183|P1|COMPLETED|Period 2||41
147823|NCT01099709|358182|P2|STARTED|Period 2||41
147824|NCT01099709|358183|P1|STARTED|Period 2||41
147825|NCT01099709|358182|P2|NOT COMPLETED|Period 1||2
147826|NCT01099709|358183|P1|NOT COMPLETED|Period 1||1
147827|NCT01099709|358182|P2|COMPLETED|Period 1||41
147828|NCT01099709|358183|P1|COMPLETED|Period 1||41
147829|NCT01099709|358182|P2|STARTED|Period 1||43
147830|NCT01099709|358183|P1|STARTED|Period 1||42
147831|NCT01099618|358196|P3|NOT COMPLETED|Overall Study||0
147832|NCT01099618|358197|P2|NOT COMPLETED|Overall Study||0
147833|NCT01099618|358198|P1|NOT COMPLETED|Overall Study||0
147834|NCT01099618|358196|P3|COMPLETED|Overall Study||15
147835|NCT01099618|358197|P2|COMPLETED|Overall Study||16
147836|NCT01099618|358198|P1|COMPLETED|Overall Study||17
147837|NCT01099618|358196|P3|STARTED|Overall Study||15
147838|NCT01099618|358197|P2|STARTED|Overall Study||16
147839|NCT01099618|358198|P1|STARTED|Overall Study||17
147840|NCT01099579|358209|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
147841|NCT01099579|358210|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
147842|NCT01099579|358211|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
147843|NCT01099579|358209|P3|COMPLETED|Stage 2 (ATV Capsule)||9
147844|NCT01099579|358210|P2|COMPLETED|Stage 2 (ATV Capsule)||9
147845|NCT01099579|358211|P1|COMPLETED|Stage 2 (ATV Capsule)||10
147846|NCT01099579|358209|P3|STARTED|Stage 2 (ATV Capsule)||15
147847|NCT01099579|358210|P2|STARTED|Stage 2 (ATV Capsule)||14
147848|NCT01099579|358211|P1|STARTED|Stage 2 (ATV Capsule)||16
147849|NCT01099579|358209|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
147850|NCT01099579|358210|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
147851|NCT01099579|358211|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
147852|NCT01099579|358209|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
147853|NCT01099579|358210|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
147854|NCT01099579|358211|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
147855|NCT01099579|358209|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
147856|NCT01099579|358210|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
147857|NCT01099579|358211|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
147858|NCT01099475|358267|P2|NOT COMPLETED|Overall Study||0
147859|NCT01099475|358268|P1|NOT COMPLETED|Overall Study||0
147860|NCT01099475|358267|P2|COMPLETED|Overall Study||10
147861|NCT01099475|358268|P1|COMPLETED|Overall Study||10
147862|NCT01099475|358267|P2|STARTED|Overall Study||10
147863|NCT01099475|358268|P1|STARTED|Overall Study||10
147864|NCT01099397|358280|P1|NOT COMPLETED|Overall Study||13
147865|NCT01099397|358280|P1|COMPLETED|Overall Study||26
147866|NCT01099397|358280|P1|STARTED|Overall Study||39
147867|NCT01099358|358285|P4|NOT COMPLETED|Overall Study||4
147868|NCT01099358|358286|P3|NOT COMPLETED|Overall Study||8
147869|NCT01099358|358287|P2|NOT COMPLETED|Overall Study||1
147870|NCT01099358|358288|P1|NOT COMPLETED|Overall Study||3
147871|NCT01099358|358285|P4|COMPLETED|Overall Study||12
147872|NCT01099358|358286|P3|COMPLETED|Overall Study||13
147873|NCT01099358|358287|P2|COMPLETED|Overall Study||5
147874|NCT01099358|358288|P1|COMPLETED|Overall Study||1
147875|NCT01099358|358285|P4|Received at Least One Dose of Study Drug|Overall Study||15
147876|NCT01099358|358286|P3|Received at Least One Dose of Study Drug|Overall Study||20
147877|NCT01099358|358287|P2|Received at Least One Dose of Study Drug|Overall Study||6
147878|NCT01099358|358288|P1|Received at Least One Dose of Study Drug|Overall Study||3
147879|NCT01099358|358285|P4|STARTED|Overall Study||16
147880|NCT01099358|358286|P3|STARTED|Overall Study||21
147881|NCT01099358|358287|P2|STARTED|Overall Study||6
147882|NCT01099358|358288|P1|STARTED|Overall Study||4
147883|NCT01099267|358307|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
147884|NCT01099267|358307|P1|COMPLETED|MDS-009 Extension Follow-up||54
147885|NCT01099267|358307|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
147886|NCT01099267|358307|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
147887|NCT01099267|358307|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
147888|NCT01099267|358307|P1|NOT COMPLETED|MDS-003 Study||124
147889|NCT01099267|358307|P1|COMPLETED|MDS-003 Study||24
147890|NCT01099267|358307|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
147891|NCT01099215|358317|P2|NOT COMPLETED|Overall Study||1
147892|NCT01099215|358318|P1|NOT COMPLETED|Overall Study||1
147893|NCT01099215|358317|P2|COMPLETED|Overall Study||9
147894|NCT01099215|358318|P1|COMPLETED|Overall Study||10
147895|NCT01099215|358317|P2|STARTED|Overall Study||10
147896|NCT01099215|358318|P1|STARTED|Overall Study||11
147897|NCT01099202|358356|P2|NOT COMPLETED|Overall Study||0
147898|NCT01099202|358357|P1|NOT COMPLETED|Overall Study||0
147899|NCT01099202|358356|P2|COMPLETED|Overall Study||54
147900|NCT01099202|358357|P1|COMPLETED|Overall Study||55
147901|NCT01099202|358356|P2|STARTED|Overall Study||54
147902|NCT01099202|358357|P1|STARTED|Overall Study||55
147903|NCT01099111|358370|P5|NOT COMPLETED|Overall Study||0
147904|NCT01099111|358371|P4|NOT COMPLETED|Overall Study||0
147905|NCT01099111|358372|P3|NOT COMPLETED|Overall Study||0
147906|NCT01099111|358373|P2|NOT COMPLETED|Overall Study||0
147907|NCT01099111|358374|P1|NOT COMPLETED|Overall Study||0
147908|NCT01099111|358370|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
147909|NCT01099111|358371|P4|COMPLETED|Overall Study||29
147910|NCT01099111|358372|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
147911|NCT01099111|358373|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
147912|NCT01099111|358374|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
147913|NCT01099111|358370|P5|STARTED|Overall Study||50
147914|NCT01099111|358371|P4|STARTED|Overall Study||29
147915|NCT01099111|358372|P3|STARTED|Overall Study||46
147916|NCT01099111|358373|P2|STARTED|Overall Study||50
147917|NCT01099111|358374|P1|STARTED|Overall Study||50
147918|NCT01098851|358388|P2|NOT COMPLETED|Overall Study||0
147919|NCT01098851|358389|P1|NOT COMPLETED|Overall Study||1
147920|NCT01098851|358388|P2|COMPLETED|Overall Study||10
147921|NCT01098851|358389|P1|COMPLETED|Overall Study||10
147922|NCT01098851|358388|P2|STARTED|Overall Study||10
147923|NCT01098851|358389|P1|STARTED|Overall Study||11
147924|NCT01098812|358400|P3|NOT COMPLETED|Overall Study||1
147925|NCT01098812|358401|P2|NOT COMPLETED|Overall Study||1
147926|NCT01098812|358402|P1|NOT COMPLETED|Overall Study||2
147927|NCT01098812|358400|P3|COMPLETED|Overall Study||71
147928|NCT01098812|358401|P2|COMPLETED|Overall Study||101
147929|NCT01098812|358402|P1|COMPLETED|Overall Study||93
147930|NCT01098812|358400|P3|STARTED|Overall Study||72
147931|NCT01098812|358401|P2|STARTED|Overall Study||102
147932|NCT01098812|358402|P1|STARTED|Overall Study||95
147933|NCT01098747|358416|P4|NOT COMPLETED|Overall Study||0
147934|NCT01098747|358417|P3|NOT COMPLETED|Overall Study||0
147935|NCT01098747|358418|P2|NOT COMPLETED|Overall Study||0
147936|NCT01098747|358419|P1|NOT COMPLETED|Overall Study||0
147937|NCT01098747|358416|P4|COMPLETED|Overall Study||87
147938|NCT01098747|358417|P3|COMPLETED|Overall Study||86
147939|NCT01098747|358418|P2|COMPLETED|Overall Study||95
147940|NCT01098747|358419|P1|COMPLETED|Overall Study||48
147941|NCT01098747|358416|P4|STARTED|Overall Study||87
147942|NCT01098747|358417|P3|STARTED|Overall Study||86
147943|NCT01098747|358418|P2|STARTED|Overall Study||95
147944|NCT01098747|358419|P1|STARTED|Overall Study||48
147945|NCT01098578|358469|P1|NOT COMPLETED|Overall Study||0
147946|NCT01098578|358469|P1|COMPLETED|Overall Study||20
147947|NCT01098578|358469|P1|STARTED|Overall Study||20
147948|NCT01098539|358478|P2|NOT COMPLETED|Overall Study||68
147949|NCT01098539|358479|P1|NOT COMPLETED|Overall Study||51
147950|NCT01098539|358478|P2|COMPLETED|Overall Study||178
147951|NCT01098539|358479|P1|COMPLETED|Overall Study||198
147952|NCT01098539|358478|P2|STARTED|Overall Study||246
147953|NCT01098539|358479|P1|STARTED|Overall Study||249
147954|NCT01098500|358515|P1|NOT COMPLETED|Overall Study||0
147955|NCT01098500|358515|P1|COMPLETED|Overall Study||3800
147956|NCT01098500|358515|P1|STARTED|Overall Study||3800
147957|NCT01098487|358530|P1|NOT COMPLETED|Overall Study||44
147958|NCT01098487|358530|P1|COMPLETED|Overall Study||118
147959|NCT01098487|358530|P1|STARTED|Overall Study||162
147960|NCT01098461|358546|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
147961|NCT01098461|358547|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
147962|NCT01098461|358548|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
147963|NCT01098461|358549|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
147964|NCT01098461|358546|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
147965|NCT01098461|358547|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
147966|NCT01098461|358548|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
147967|NCT01098461|358549|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
147968|NCT01098461|358546|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
147969|NCT01098461|358547|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
147970|NCT01098461|358548|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
147971|NCT01098461|358549|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
147972|NCT01098461|358546|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
147973|NCT01098461|358547|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
147974|NCT01098461|358548|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
147975|NCT01098461|358549|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
147976|NCT01098461|358546|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
147977|NCT01098461|358547|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
147978|NCT01098461|358548|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
147979|NCT01098461|358549|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
147980|NCT01098461|358546|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
147981|NCT01098461|358547|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
147982|NCT01098461|358548|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
147983|NCT01098461|358549|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
147984|NCT01098318|358582|P3|NOT COMPLETED|Overall Study||3
147985|NCT01098318|358583|P2|NOT COMPLETED|Overall Study||7
147986|NCT01098318|358584|P1|NOT COMPLETED|Overall Study||3
147987|NCT01098318|358582|P3|COMPLETED|Overall Study||15
147988|NCT01098318|358583|P2|COMPLETED|Overall Study||12
147989|NCT01098318|358584|P1|COMPLETED|Overall Study||17
147990|NCT01098318|358582|P3|STARTED|Overall Study||18
147991|NCT01098318|358583|P2|STARTED|Overall Study||19
147992|NCT01098318|358584|P1|STARTED|Overall Study||20
147993|NCT01098305|358609|P2|NOT COMPLETED|Overall Study||33
147994|NCT01098305|358610|P1|NOT COMPLETED|Overall Study||31
147995|NCT01098305|358609|P2|COMPLETED|Overall Study||85
147996|NCT01098305|358610|P1|COMPLETED|Overall Study||88
147997|NCT01098305|358609|P2|STARTED|Overall Study||118
147998|NCT01098305|358610|P1|STARTED|Overall Study||119
147999|NCT01098253|358620|P2|NOT COMPLETED|Overall Study||0
148000|NCT01098253|358621|P1|NOT COMPLETED|Overall Study||2
148001|NCT01098253|358620|P2|COMPLETED|Overall Study||88
148002|NCT01098253|358621|P1|COMPLETED|Overall Study||92
148003|NCT01098253|358620|P2|STARTED|Overall Study||88
148004|NCT01098253|358621|P1|STARTED|Overall Study||94
148005|NCT01098240|358629|P3|NOT COMPLETED|Double-Blind Phase||22
148006|NCT01098240|358630|P2|NOT COMPLETED|Double-Blind Phase||17
148007|NCT01098240|358631|P1|NOT COMPLETED|Double-Blind Phase||0
148008|NCT01098240|358629|P3|COMPLETED|Double-Blind Phase||63
148009|NCT01098240|358630|P2|COMPLETED|Double-Blind Phase||60
148010|NCT01098240|358631|P1|COMPLETED|Double-Blind Phase||0
148011|NCT01098240|358629|P3|STARTED|Double-Blind Phase||85
148012|NCT01098240|358630|P2|STARTED|Double-Blind Phase||77
148013|NCT01098240|358631|P1|STARTED|Double-Blind Phase||0
148014|NCT01098240|358629|P3|NOT COMPLETED|Open-Label Phase||0
148015|NCT01098240|358630|P2|NOT COMPLETED|Open-Label Phase||0
148016|NCT01098240|358631|P1|NOT COMPLETED|Open-Label Phase||135
148017|NCT01098240|358629|P3|COMPLETED|Open-Label Phase||0
148018|NCT01098240|358630|P2|COMPLETED|Open-Label Phase||0
148019|NCT01098240|358631|P1|COMPLETED|Open-Label Phase||162
148020|NCT01098240|358629|P3|STARTED|Open-Label Phase||0
148021|NCT01098240|358630|P2|STARTED|Open-Label Phase||0
148022|NCT01098240|358631|P1|STARTED|Open-Label Phase||297
148023|NCT01098162|358661|P1|NOT COMPLETED|Overall Study||112
148024|NCT01098162|358661|P1|COMPLETED|Overall Study||461
148025|NCT01098162|358661|P1|STARTED|Overall Study||573
148026|NCT01098110|358673|P3|NOT COMPLETED|Overall Study||94
148027|NCT01098110|358674|P2|NOT COMPLETED|Overall Study||73
148028|NCT01098110|358675|P1|NOT COMPLETED|Overall Study||62
148029|NCT01098110|358673|P3|COMPLETED|Overall Study||80
148030|NCT01098110|358674|P2|COMPLETED|Overall Study||109
148031|NCT01098110|358675|P1|COMPLETED|Overall Study||114
148032|NCT01098110|358673|P3|Treated|Overall Study|Received at least one dose of trial medication|174
148033|NCT01098110|358674|P2|Treated|Overall Study|Received at least one dose of trial medication|181
148034|NCT01098110|358675|P1|Treated|Overall Study|Received at least one dose of trial medication|175
148035|NCT01098110|358673|P3|STARTED|Overall Study|Randomized participants|174
148036|NCT01098110|358674|P2|STARTED|Overall Study|Randomized participants|182
148037|NCT01098110|358675|P1|STARTED|Overall Study|Randomized participants|176
148038|NCT01098097|358716|P1|NOT COMPLETED|Overall Study||82
148039|NCT01098097|358716|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
148040|NCT01098097|358716|P1|STARTED|Overall Study||963
148041|NCT01098071|358725|P1|NOT COMPLETED|Overall Study||15
148042|NCT01098071|358725|P1|COMPLETED|Overall Study||19
148043|NCT01098071|358725|P1|STARTED|Overall Study||34
148044|NCT01098032|358738|P2|NOT COMPLETED|Overall Study||1
148045|NCT01098032|358739|P1|NOT COMPLETED|Overall Study||1
148046|NCT01098032|358738|P2|COMPLETED|Overall Study||146
148047|NCT01098032|358739|P1|COMPLETED|Overall Study||146
148048|NCT01098032|358738|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
148049|NCT01098032|358739|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
148050|NCT01098006|358749|P4|NOT COMPLETED|Overall Study||0
148051|NCT01098006|358750|P3|NOT COMPLETED|Overall Study||0
148052|NCT01098006|358751|P2|NOT COMPLETED|Overall Study||0
148053|NCT01098006|358752|P1|NOT COMPLETED|Overall Study||0
148054|NCT01098006|358749|P4|COMPLETED|Overall Study||21
148055|NCT01098006|358750|P3|COMPLETED|Overall Study||60
148056|NCT01098006|358751|P2|COMPLETED|Overall Study||11
148057|NCT01098006|358752|P1|COMPLETED|Overall Study||7
148058|NCT01098006|358749|P4|STARTED|Overall Study||21
148059|NCT01098006|358750|P3|STARTED|Overall Study||60
148060|NCT01098006|358751|P2|STARTED|Overall Study||11
148061|NCT01098006|358752|P1|STARTED|Overall Study||7
148062|NCT01097915|358829|P3|NOT COMPLETED|Overall Study||30
148063|NCT01097915|358830|P2|NOT COMPLETED|Overall Study||42
148064|NCT01097915|358831|P1|NOT COMPLETED|Overall Study||23
148065|NCT01097915|358829|P3|COMPLETED|Overall Study||20
148066|NCT01097915|358830|P2|COMPLETED|Overall Study||28
148067|NCT01097915|358831|P1|COMPLETED|Overall Study||27
148068|NCT01097915|358829|P3|STARTED|Overall Study||50
148069|NCT01097915|358830|P2|STARTED|Overall Study||70
148070|NCT01097915|358831|P1|STARTED|Overall Study||50
148071|NCT01097863|358848|P3|NOT COMPLETED|Overall Study||2
148072|NCT01097863|358849|P2|NOT COMPLETED|Overall Study||0
148073|NCT01097863|358850|P1|NOT COMPLETED|Overall Study||1
148074|NCT01097863|358848|P3|COMPLETED|Overall Study||89
148075|NCT01097863|358849|P2|COMPLETED|Overall Study||98
148076|NCT01097863|358850|P1|COMPLETED|Overall Study||89
148077|NCT01097863|358848|P3|STARTED|Overall Study||91
148078|NCT01097863|358849|P2|STARTED|Overall Study||98
148079|NCT01097863|358850|P1|STARTED|Overall Study||90
148080|NCT01097785|358860|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
148081|NCT01097785|358861|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
148082|NCT01097785|358860|P2|COMPLETED|Cycle 3 (30 Days)||6
148083|NCT01097785|358861|P1|COMPLETED|Cycle 3 (30 Days)||6
148084|NCT01097785|358860|P2|STARTED|Cycle 3 (30 Days)||6
148085|NCT01097785|358861|P1|STARTED|Cycle 3 (30 Days)||6
148086|NCT01097785|358860|P2|NOT COMPLETED|Washout (2 Weeks)||0
148087|NCT01097785|358861|P1|NOT COMPLETED|Washout (2 Weeks)||0
148088|NCT01097785|358860|P2|COMPLETED|Washout (2 Weeks)||6
148089|NCT01097785|358861|P1|COMPLETED|Washout (2 Weeks)||6
148090|NCT01097785|358860|P2|STARTED|Washout (2 Weeks)||6
148091|NCT01097785|358861|P1|STARTED|Washout (2 Weeks)||6
148092|NCT01097785|358860|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
148093|NCT01097785|358861|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
148094|NCT01097785|358860|P2|COMPLETED|Cycle 1 (30 Days)||6
148095|NCT01097785|358861|P1|COMPLETED|Cycle 1 (30 Days)||6
148096|NCT01097785|358860|P2|STARTED|Cycle 1 (30 Days)||6
148097|NCT01097785|358861|P1|STARTED|Cycle 1 (30 Days)||6
148098|NCT01097694|358871|P2|NOT COMPLETED|Overall Study||4
148099|NCT01097694|358872|P1|NOT COMPLETED|Overall Study||8
148100|NCT01097694|358871|P2|COMPLETED|Overall Study||26
148101|NCT01097694|358872|P1|COMPLETED|Overall Study||24
148102|NCT01097694|358871|P2|STARTED|Overall Study||30
148103|NCT01097694|358872|P1|STARTED|Overall Study||32
148104|NCT01097668|358934|P2|NOT COMPLETED|Overall Study||2
148105|NCT01097668|358935|P1|NOT COMPLETED|Overall Study||2
148106|NCT01097668|358934|P2|COMPLETED|Overall Study||20
148107|NCT01097668|358935|P1|COMPLETED|Overall Study||19
148108|NCT01097668|358934|P2|Week 48|Overall Study||20
148109|NCT01097668|358935|P1|Week 48|Overall Study||19
148110|NCT01097668|358934|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
148111|NCT01097668|358935|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
148112|NCT01097668|358934|P2|STARTED|Overall Study||22
148113|NCT01097668|358935|P1|STARTED|Overall Study||21
148114|NCT01097655|358945|P1|NOT COMPLETED|Overall Study||10
148115|NCT01097655|358945|P1|COMPLETED|Overall Study|participants included for analysis|3039
148116|NCT01097655|358945|P1|STARTED|Overall Study||3049
148117|NCT01097629|358955|P8|NOT COMPLETED|DB RO Phase||1
148118|NCT01097629|358956|P7|NOT COMPLETED|DB RO Phase||3
148119|NCT01097629|358957|P6|NOT COMPLETED|DB RO Phase||1
148120|NCT01097629|358958|P5|NOT COMPLETED|DB RO Phase||0
148121|NCT01097629|358959|P4|NOT COMPLETED|DB RO Phase||1
148122|NCT01097629|358960|P3|NOT COMPLETED|DB RO Phase||0
148123|NCT01097629|358961|P2|NOT COMPLETED|DB RO Phase||0
148124|NCT01097629|358962|P1|NOT COMPLETED|DB RO Phase||0
148125|NCT01097629|358955|P8|COMPLETED|DB RO Phase||326
148126|NCT01097629|358956|P7|COMPLETED|DB RO Phase||168
148127|NCT01097629|358957|P6|COMPLETED|DB RO Phase||172
148128|NCT01097629|358958|P5|COMPLETED|DB RO Phase||108
148129|NCT01097629|358959|P4|COMPLETED|DB RO Phase||96
148130|NCT01097629|358960|P3|COMPLETED|DB RO Phase||0
148131|NCT01097629|358961|P2|COMPLETED|DB RO Phase||0
148132|NCT01097629|358962|P1|COMPLETED|DB RO Phase||0
148133|NCT01097629|358955|P8|STARTED|DB RO Phase||327
148134|NCT01097629|358956|P7|STARTED|DB RO Phase||171
148135|NCT01097629|358957|P6|STARTED|DB RO Phase||173
148136|NCT01097629|358958|P5|STARTED|DB RO Phase||108
148137|NCT01097629|358959|P4|STARTED|DB RO Phase||97
148138|NCT01097629|358960|P3|STARTED|DB RO Phase||0
148139|NCT01097629|358961|P2|STARTED|DB RO Phase||0
148140|NCT01097629|358962|P1|STARTED|DB RO Phase||0
148141|NCT01097629|358955|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148142|NCT01097629|358956|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148143|NCT01097629|358957|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148144|NCT01097629|358958|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148145|NCT01097629|358959|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148146|NCT01097629|358960|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
148147|NCT01097629|358961|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
148148|NCT01097629|358962|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
148149|NCT01097629|358955|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148150|NCT01097629|358956|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148151|NCT01097629|358957|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148152|NCT01097629|358958|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148153|NCT01097629|358959|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148154|NCT01097629|358960|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
148155|NCT01097629|358961|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
148156|NCT01097629|358962|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
148157|NCT01097629|358955|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148158|NCT01097629|358956|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148159|NCT01097629|358957|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148160|NCT01097629|358958|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148161|NCT01097629|358959|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148162|NCT01097629|358960|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
148163|NCT01097629|358961|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
148164|NCT01097629|358962|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
148165|NCT01097629|358955|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148166|NCT01097629|358956|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148167|NCT01097629|358957|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148168|NCT01097629|358958|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148169|NCT01097629|358959|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148170|NCT01097629|358960|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
148171|NCT01097629|358961|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
148342|NCT01096667|359277|P4|STARTED|Overall Study||39
148172|NCT01097629|358962|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
148173|NCT01097616|359013|P8|NOT COMPLETED|DB RO Phase||1
148174|NCT01097616|359014|P7|NOT COMPLETED|DB RO Phase||1
148175|NCT01097616|359015|P6|NOT COMPLETED|DB RO Phase||2
148176|NCT01097616|359016|P5|NOT COMPLETED|DB RO Phase||1
148177|NCT01097616|359017|P4|NOT COMPLETED|DB RO Phase||1
148178|NCT01097616|359018|P3|NOT COMPLETED|DB RO Phase||0
148179|NCT01097616|359019|P2|NOT COMPLETED|DB RO Phase||0
148180|NCT01097616|359020|P1|NOT COMPLETED|DB RO Phase||0
148181|NCT01097616|359013|P8|COMPLETED|DB RO Phase||326
148182|NCT01097616|359014|P7|COMPLETED|DB RO Phase||161
148183|NCT01097616|359015|P6|COMPLETED|DB RO Phase||159
148184|NCT01097616|359016|P5|COMPLETED|DB RO Phase||111
148185|NCT01097616|359017|P4|COMPLETED|DB RO Phase||100
148186|NCT01097616|359018|P3|COMPLETED|DB RO Phase||0
148187|NCT01097616|359019|P2|COMPLETED|DB RO Phase||0
148188|NCT01097616|359020|P1|COMPLETED|DB RO Phase||0
148189|NCT01097616|359013|P8|STARTED|DB RO Phase||327
148190|NCT01097616|359014|P7|STARTED|DB RO Phase||162
148191|NCT01097616|359015|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
148192|NCT01097616|359016|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
148193|NCT01097616|359017|P4|STARTED|DB RO Phase||101
148194|NCT01097616|359018|P3|STARTED|DB RO Phase||0
148195|NCT01097616|359019|P2|STARTED|DB RO Phase||0
148196|NCT01097616|359020|P1|STARTED|DB RO Phase||0
148197|NCT01097616|359013|P8|NOT COMPLETED|Optional DB EXT Phase||0
148198|NCT01097616|359014|P7|NOT COMPLETED|Optional DB EXT Phase||0
148199|NCT01097616|359015|P6|NOT COMPLETED|Optional DB EXT Phase||0
148200|NCT01097616|359016|P5|NOT COMPLETED|Optional DB EXT Phase||0
148201|NCT01097616|359017|P4|NOT COMPLETED|Optional DB EXT Phase||0
148202|NCT01097616|359018|P3|NOT COMPLETED|Optional DB EXT Phase||10
148203|NCT01097616|359019|P2|NOT COMPLETED|Optional DB EXT Phase||21
148204|NCT01097616|359020|P1|NOT COMPLETED|Optional DB EXT Phase||15
148205|NCT01097616|359013|P8|COMPLETED|Optional DB EXT Phase||0
148206|NCT01097616|359014|P7|COMPLETED|Optional DB EXT Phase||0
148207|NCT01097616|359015|P6|COMPLETED|Optional DB EXT Phase||0
148208|NCT01097616|359016|P5|COMPLETED|Optional DB EXT Phase||0
148209|NCT01097616|359017|P4|COMPLETED|Optional DB EXT Phase||0
148210|NCT01097616|359018|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
148211|NCT01097616|359019|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
148212|NCT01097616|359020|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
148213|NCT01097616|359013|P8|STARTED|Optional DB EXT Phase||0
148214|NCT01097616|359014|P7|STARTED|Optional DB EXT Phase||0
148215|NCT01097616|359015|P6|STARTED|Optional DB EXT Phase||0
148216|NCT01097616|359016|P5|STARTED|Optional DB EXT Phase||0
148217|NCT01097616|359017|P4|STARTED|Optional DB EXT Phase||0
148218|NCT01097616|359018|P3|STARTED|Optional DB EXT Phase||151
148219|NCT01097616|359019|P2|STARTED|Optional DB EXT Phase||172
148220|NCT01097616|359020|P1|STARTED|Optional DB EXT Phase||100
148221|NCT01097616|359013|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148222|NCT01097616|359014|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148223|NCT01097616|359015|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148224|NCT01097616|359016|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148225|NCT01097616|359017|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148226|NCT01097616|359018|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
148227|NCT01097616|359019|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
148228|NCT01097616|359020|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
148229|NCT01097616|359013|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148230|NCT01097616|359014|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148231|NCT01097616|359015|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148232|NCT01097616|359016|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148233|NCT01097616|359017|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
148234|NCT01097616|359018|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
148235|NCT01097616|359019|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
148236|NCT01097616|359020|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
148237|NCT01097616|359013|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148238|NCT01097616|359014|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148239|NCT01097616|359015|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148240|NCT01097616|359016|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148241|NCT01097616|359017|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
148242|NCT01097616|359018|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
148243|NCT01097616|359019|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
148244|NCT01097616|359020|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
148245|NCT01097616|359013|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148246|NCT01097616|359014|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148247|NCT01097616|359015|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148248|NCT01097616|359016|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148249|NCT01097616|359017|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
148250|NCT01097616|359018|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
148251|NCT01097616|359019|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
148252|NCT01097616|359020|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
148253|NCT01097460|359091|P1|NOT COMPLETED|Overall Study||0
148254|NCT01097460|359091|P1|COMPLETED|Overall Study||16
148255|NCT01097460|359091|P1|STARTED|Overall Study||16
148256|NCT01097421|359095|P1|NOT COMPLETED|Overall Study||14
148257|NCT01097421|359095|P1|COMPLETED|Overall Study||314
148258|NCT01097421|359095|P1|STARTED|Overall Study||328
148259|NCT01097343|359105|P2|NOT COMPLETED|Second Intervention- 30 Days||0
148260|NCT01097343|359106|P1|NOT COMPLETED|Second Intervention- 30 Days||0
148261|NCT01097343|359105|P2|COMPLETED|Second Intervention- 30 Days||25
148262|NCT01097343|359106|P1|COMPLETED|Second Intervention- 30 Days||25
148263|NCT01097343|359105|P2|STARTED|Second Intervention- 30 Days||25
148264|NCT01097343|359106|P1|STARTED|Second Intervention- 30 Days||25
148265|NCT01097343|359105|P2|NOT COMPLETED|First Intervention- 30 Days||0
148266|NCT01097343|359106|P1|NOT COMPLETED|First Intervention- 30 Days||0
148267|NCT01097343|359105|P2|COMPLETED|First Intervention- 30 Days||25
148268|NCT01097343|359106|P1|COMPLETED|First Intervention- 30 Days||25
148269|NCT01097343|359105|P2|STARTED|First Intervention- 30 Days||25
148270|NCT01097343|359106|P1|STARTED|First Intervention- 30 Days||25
148271|NCT01097304|359112|P1|NOT COMPLETED|Overall Study||7
148272|NCT01097304|359112|P1|COMPLETED|Overall Study||29
148273|NCT01097304|359112|P1|STARTED|Overall Study||36
148274|NCT01097057|359119|P1|NOT COMPLETED|Overall Study||3
148275|NCT01097057|359119|P1|COMPLETED|Overall Study||17
148276|NCT01097057|359119|P1|STARTED|Overall Study||20
148277|NCT01097005|359126|P1|NOT COMPLETED|Overall Study||365
148278|NCT01097005|359126|P1|COMPLETED|Overall Study||101
148279|NCT01097005|359126|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
148280|NCT01097005|359126|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
148281|NCT01097005|359126|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
148282|NCT01097005|359126|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
148283|NCT01097005|359126|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
148284|NCT01096875|359134|P2|NOT COMPLETED|Overall Study||1
148285|NCT01096875|359135|P1|NOT COMPLETED|Overall Study||0
148286|NCT01096875|359134|P2|COMPLETED|Overall Study||29
148287|NCT01096875|359135|P1|COMPLETED|Overall Study||30
148288|NCT01096875|359134|P2|STARTED|Overall Study||30
148289|NCT01096875|359135|P1|STARTED|Overall Study||30
148290|NCT01096823|359149|P2|NOT COMPLETED|Overall Study||1
148291|NCT01096823|359150|P1|NOT COMPLETED|Overall Study||3
148292|NCT01096823|359149|P2|COMPLETED|Overall Study||15
148293|NCT01096823|359150|P1|COMPLETED|Overall Study||11
148294|NCT01096823|359149|P2|STARTED|Overall Study||16
148295|NCT01096823|359150|P1|STARTED|Overall Study||14
148296|NCT01096810|359162|P1|NOT COMPLETED|Overall Study||0
148297|NCT01096810|359162|P1|COMPLETED|Overall Study||20
148298|NCT01096810|359162|P1|STARTED|Overall Study||20
148299|NCT01096784|359170|P2|NOT COMPLETED|Overall Study||14
148300|NCT01096784|359171|P1|NOT COMPLETED|Overall Study||15
148301|NCT01096784|359170|P2|COMPLETED|Overall Study||46
148302|NCT01096784|359171|P1|COMPLETED|Overall Study||46
148303|NCT01096784|359170|P2|STARTED|Overall Study||60
148304|NCT01096784|359171|P1|STARTED|Overall Study||61
148305|NCT01096771|359205|P2|NOT COMPLETED|Overall Study||0
148306|NCT01096771|359206|P1|NOT COMPLETED|Overall Study||0
148307|NCT01096771|359205|P2|COMPLETED|Overall Study||7
148308|NCT01096771|359206|P1|COMPLETED|Overall Study||7
148309|NCT01096771|359205|P2|STARTED|Overall Study||7
148310|NCT01096771|359206|P1|STARTED|Overall Study||7
148311|NCT01096680|359235|P5|NOT COMPLETED|Overall Study||0
148312|NCT01096680|359236|P4|NOT COMPLETED|Overall Study||0
148313|NCT01096680|359237|P3|NOT COMPLETED|Overall Study||0
148314|NCT01096680|359238|P2|NOT COMPLETED|Overall Study||0
148315|NCT01096680|359239|P1|NOT COMPLETED|Overall Study||0
148316|NCT01096680|359235|P5|COMPLETED|Overall Study||27
148317|NCT01096680|359236|P4|COMPLETED|Overall Study||27
148318|NCT01096680|359237|P3|COMPLETED|Overall Study||27
148319|NCT01096680|359238|P2|COMPLETED|Overall Study||27
148320|NCT01096680|359239|P1|COMPLETED|Overall Study||27
148321|NCT01096680|359235|P5|STARTED|Overall Study||27
148322|NCT01096680|359236|P4|STARTED|Overall Study||27
148323|NCT01096680|359237|P3|STARTED|Overall Study||27
148324|NCT01096680|359238|P2|STARTED|Overall Study||27
148325|NCT01096680|359239|P1|STARTED|Overall Study||27
148326|NCT01096667|359276|P5|NOT COMPLETED|Overall Study||0
148327|NCT01096667|359277|P4|NOT COMPLETED|Overall Study||3
148328|NCT01096667|359278|P3|NOT COMPLETED|Overall Study||2
148329|NCT01096667|359279|P2|NOT COMPLETED|Overall Study||2
148330|NCT01096667|359280|P1|NOT COMPLETED|Overall Study||3
148331|NCT01096667|359276|P5|COMPLETED|Overall Study||39
148332|NCT01096667|359277|P4|COMPLETED|Overall Study||36
148333|NCT01096667|359278|P3|COMPLETED|Overall Study||36
148334|NCT01096667|359279|P2|COMPLETED|Overall Study||37
148335|NCT01096667|359280|P1|COMPLETED|Overall Study||36
148336|NCT01096667|359276|P5|Treated|Overall Study||39
148337|NCT01096667|359277|P4|Treated|Overall Study||39
148338|NCT01096667|359278|P3|Treated|Overall Study||38
148339|NCT01096667|359279|P2|Treated|Overall Study||39
148340|NCT01096667|359280|P1|Treated|Overall Study||38
148341|NCT01096667|359276|P5|STARTED|Overall Study||39
148343|NCT01096667|359278|P3|STARTED|Overall Study||38
148344|NCT01096667|359279|P2|STARTED|Overall Study||39
148345|NCT01096667|359280|P1|STARTED|Overall Study||39
148346|NCT01096589|359422|P4|NOT COMPLETED|Overall Study||3
148347|NCT01096589|359423|P3|NOT COMPLETED|Overall Study||4
148348|NCT01096589|359424|P2|NOT COMPLETED|Overall Study||2
148349|NCT01096589|359425|P1|NOT COMPLETED|Overall Study||4
148350|NCT01096589|359422|P4|COMPLETED|Overall Study||15
148351|NCT01096589|359423|P3|COMPLETED|Overall Study||18
148352|NCT01096589|359424|P2|COMPLETED|Overall Study||18
148353|NCT01096589|359425|P1|COMPLETED|Overall Study||18
148354|NCT01096589|359422|P4|STARTED|Overall Study||18
148355|NCT01096589|359423|P3|STARTED|Overall Study||22
148356|NCT01096589|359424|P2|STARTED|Overall Study||20
148357|NCT01096589|359425|P1|STARTED|Overall Study||22
148358|NCT01096550|359437|P2|NOT COMPLETED|Overall Study||29
148359|NCT01096550|359438|P1|NOT COMPLETED|Overall Study||37
148360|NCT01096550|359437|P2|COMPLETED|Overall Study||146
148361|NCT01096550|359438|P1|COMPLETED|Overall Study||133
148362|NCT01096550|359437|P2|STARTED|Overall Study||175
148363|NCT01096550|359438|P1|STARTED|Overall Study||170
148364|NCT01096446|359446|P2|NOT COMPLETED|Overall Study||0
148365|NCT01096446|359447|P1|NOT COMPLETED|Overall Study||3
148366|NCT01096446|359446|P2|COMPLETED|Overall Study||10
148367|NCT01096446|359447|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
148368|NCT01096446|359446|P2|STARTED|Overall Study||10
148369|NCT01096446|359447|P1|STARTED|Overall Study||12
148370|NCT01096342|359452|P1|NOT COMPLETED|Overall Study||1
148371|NCT01096342|359452|P1|COMPLETED|Overall Study||15
148372|NCT01096342|359452|P1|STARTED|Overall Study||16
148373|NCT01096316|359460|P2|NOT COMPLETED|Overall Study||9
148374|NCT01096316|359461|P1|NOT COMPLETED|Overall Study||15
148375|NCT01096316|359460|P2|COMPLETED|Overall Study||94
148376|NCT01096316|359461|P1|COMPLETED|Overall Study||87
148377|NCT01096316|359460|P2|STARTED|Overall Study||103
148378|NCT01096316|359461|P1|STARTED|Overall Study||102
148379|NCT01096186|359471|P1|NOT COMPLETED|Overall Study||50
148380|NCT01096186|359471|P1|COMPLETED|Overall Study||567
148381|NCT01096186|359471|P1|STARTED|Overall Study||617
148382|NCT01096056|359479|P2|NOT COMPLETED|Overall Study||1
148383|NCT01096056|359480|P1|NOT COMPLETED|Overall Study||0
148384|NCT01096056|359479|P2|COMPLETED|Overall Study||19
148385|NCT01096056|359480|P1|COMPLETED|Overall Study||20
148386|NCT01096056|359479|P2|Completed at Day 42|Overall Study||20
148387|NCT01096056|359480|P1|Completed at Day 42|Overall Study||20
148388|NCT01096056|359479|P2|STARTED|Overall Study||20
148389|NCT01096056|359480|P1|STARTED|Overall Study||20
148390|NCT01096017|359512|P2|NOT COMPLETED|Treatment Period 2||1
148391|NCT01096017|359513|P1|NOT COMPLETED|Treatment Period 2||1
148392|NCT01096017|359512|P2|COMPLETED|Treatment Period 2||11
148393|NCT01096017|359513|P1|COMPLETED|Treatment Period 2||11
148394|NCT01096017|359512|P2|STARTED|Treatment Period 2||12
148395|NCT01096017|359513|P1|STARTED|Treatment Period 2||12
148396|NCT01096017|359512|P2|NOT COMPLETED|Washout 1 - 14 Days||0
148397|NCT01096017|359513|P1|NOT COMPLETED|Washout 1 - 14 Days||0
148398|NCT01096017|359512|P2|COMPLETED|Washout 1 - 14 Days||12
148399|NCT01096017|359513|P1|COMPLETED|Washout 1 - 14 Days||12
148400|NCT01096017|359512|P2|STARTED|Washout 1 - 14 Days||12
148401|NCT01096017|359513|P1|STARTED|Washout 1 - 14 Days||12
148402|NCT01096017|359512|P2|NOT COMPLETED|Treatment Period 1||0
148403|NCT01096017|359513|P1|NOT COMPLETED|Treatment Period 1||0
148404|NCT01096017|359512|P2|COMPLETED|Treatment Period 1||12
148405|NCT01096017|359513|P1|COMPLETED|Treatment Period 1||12
148406|NCT01096017|359512|P2|STARTED|Treatment Period 1||12
148407|NCT01096017|359513|P1|STARTED|Treatment Period 1||12
148408|NCT01095978|359541|P1|NOT COMPLETED|Overall Study||3
148409|NCT01095978|359541|P1|COMPLETED|Overall Study||2819
148410|NCT01095978|359541|P1|STARTED|Overall Study||2822
148411|NCT01095887|359568|P1|NOT COMPLETED|Overall Study||0
148412|NCT01095887|359568|P1|COMPLETED|Overall Study||6
148413|NCT01095887|359568|P1|STARTED|Overall Study||6
148414|NCT01095835|359575|P3|NOT COMPLETED|Overall Study||8
148415|NCT01095835|359576|P2|NOT COMPLETED|Overall Study||12
148416|NCT01095835|359577|P1|NOT COMPLETED|Overall Study||10
148417|NCT01095835|359575|P3|COMPLETED|Overall Study||17
148418|NCT01095835|359576|P2|COMPLETED|Overall Study||40
148419|NCT01095835|359577|P1|COMPLETED|Overall Study||41
148420|NCT01095835|359575|P3|STARTED|Overall Study||25
148421|NCT01095835|359576|P2|STARTED|Overall Study||52
148422|NCT01095835|359577|P1|STARTED|Overall Study||51
148423|NCT01095796|359615|P2|NOT COMPLETED|Overall Study||289
148424|NCT01095796|359616|P1|NOT COMPLETED|Overall Study||295
148425|NCT01095796|359615|P2|COMPLETED|Overall Study||65
148426|NCT01095796|359616|P1|COMPLETED|Overall Study||58
148427|NCT01095796|359615|P2|STARTED|Overall Study||354
148428|NCT01095796|359616|P1|STARTED|Overall Study||353
148429|NCT01095757|359634|P1|NOT COMPLETED|Overall Study||0
148430|NCT01095757|359634|P1|COMPLETED|Overall Study||45
148431|NCT01095757|359634|P1|STARTED|Overall Study||45
148432|NCT01095666|359646|P3|NOT COMPLETED|Overall Study||7
148433|NCT01095666|359647|P2|NOT COMPLETED|Overall Study||11
148434|NCT01095666|359648|P1|NOT COMPLETED|Overall Study||17
148435|NCT01095666|359646|P3|COMPLETED|Overall Study||145
148436|NCT01095666|359647|P2|COMPLETED|Overall Study||136
148437|NCT01095666|359648|P1|COMPLETED|Overall Study||128
148438|NCT01095666|359646|P3|STARTED|Overall Study||152
148439|NCT01095666|359647|P2|STARTED|Overall Study||147
148440|NCT01095666|359648|P1|STARTED|Overall Study||145
148441|NCT01095653|359671|P3|NOT COMPLETED|Overall Study||16
148442|NCT01095653|359672|P2|NOT COMPLETED|Overall Study||15
148443|NCT01095653|359673|P1|NOT COMPLETED|Overall Study||19
148444|NCT01095653|359671|P3|COMPLETED|Overall Study||117
148445|NCT01095653|359672|P2|COMPLETED|Overall Study||113
148446|NCT01095653|359673|P1|COMPLETED|Overall Study||113
148447|NCT01095653|359671|P3|STARTED|Overall Study||133
148448|NCT01095653|359672|P2|STARTED|Overall Study||128
148449|NCT01095653|359673|P1|STARTED|Overall Study||132
148450|NCT01095510|359696|P4|NOT COMPLETED|Overall Study||0
148451|NCT01095510|359697|P3|NOT COMPLETED|Overall Study||0
148452|NCT01095510|359698|P2|NOT COMPLETED|Overall Study||0
148453|NCT01095510|359699|P1|NOT COMPLETED|Overall Study||0
148454|NCT01095510|359696|P4|COMPLETED|Overall Study||3
148455|NCT01095510|359697|P3|COMPLETED|Overall Study||3
148456|NCT01095510|359698|P2|COMPLETED|Overall Study||0
148457|NCT01095510|359699|P1|COMPLETED|Overall Study||3
148458|NCT01095510|359696|P4|STARTED|Overall Study||3
148459|NCT01095510|359697|P3|STARTED|Overall Study||3
148460|NCT01095510|359698|P2|STARTED|Overall Study||0
148461|NCT01095510|359699|P1|STARTED|Overall Study||3
148462|NCT01095497|359718|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
148463|NCT01095497|359719|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
148464|NCT01095497|359718|P2|COMPLETED|Subcutaneous CINRYZE||12
148465|NCT01095497|359719|P1|COMPLETED|Subcutaneous CINRYZE||12
148466|NCT01095497|359718|P2|STARTED|Subcutaneous CINRYZE||12
148467|NCT01095497|359719|P1|STARTED|Subcutaneous CINRYZE||13
148468|NCT01095497|359718|P2|NOT COMPLETED|Intravenous CINRYZE||0
148469|NCT01095497|359719|P1|NOT COMPLETED|Intravenous CINRYZE||1
148470|NCT01095497|359718|P2|COMPLETED|Intravenous CINRYZE||12
148471|NCT01095497|359719|P1|COMPLETED|Intravenous CINRYZE||13
148472|NCT01095497|359718|P2|STARTED|Intravenous CINRYZE||12
148473|NCT01095497|359719|P1|STARTED|Intravenous CINRYZE||14
148474|NCT01095250|359731|P4|NOT COMPLETED|Overall Study||5
148475|NCT01095250|359732|P3|NOT COMPLETED|Overall Study||8
148476|NCT01095250|359733|P2|NOT COMPLETED|Overall Study||10
148477|NCT01095250|359734|P1|NOT COMPLETED|Overall Study||8
148478|NCT01095250|359731|P4|COMPLETED|Overall Study||0
148479|NCT01095250|359732|P3|COMPLETED|Overall Study||0
148480|NCT01095250|359733|P2|COMPLETED|Overall Study||0
148481|NCT01095250|359734|P1|COMPLETED|Overall Study||0
148482|NCT01095250|359731|P4|STARTED|Overall Study||5
148483|NCT01095250|359732|P3|STARTED|Overall Study||8
148484|NCT01095250|359733|P2|STARTED|Overall Study||10
148485|NCT01095250|359734|P1|STARTED|Overall Study||8
148486|NCT01095094|359764|P1|NOT COMPLETED|Overall Study||3
148487|NCT01095094|359764|P1|COMPLETED|Overall Study||16
148488|NCT01095094|359764|P1|STARTED|Overall Study||19
148489|NCT01094886|359769|P1|NOT COMPLETED|Overall Study||7
148490|NCT01094886|359769|P1|COMPLETED|Overall Study||46
148491|NCT01094886|359769|P1|STARTED|Overall Study||53
148492|NCT01094808|359779|P3|NOT COMPLETED|Overall Study||0
148493|NCT01094808|359780|P2|NOT COMPLETED|Overall Study||1
148494|NCT01094808|359781|P1|NOT COMPLETED|Overall Study||1
148495|NCT01094808|359779|P3|COMPLETED|Overall Study||21
148496|NCT01094808|359780|P2|COMPLETED|Overall Study||19
148497|NCT01094808|359781|P1|COMPLETED|Overall Study||20
148498|NCT01094808|359779|P3|STARTED|Overall Study||21
148499|NCT01094808|359780|P2|STARTED|Overall Study||20
148500|NCT01094808|359781|P1|STARTED|Overall Study||21
148501|NCT01094743|359816|P1|NOT COMPLETED|Period 2||0
148502|NCT01094743|359816|P1|COMPLETED|Period 2||50
148503|NCT01094743|359816|P1|STARTED|Period 2||50
148504|NCT01094743|359816|P1|NOT COMPLETED|Period 1||2
148505|NCT01094743|359816|P1|COMPLETED|Period 1||50
148506|NCT01094743|359816|P1|STARTED|Period 1||52
148507|NCT01094730|359833|P2|NOT COMPLETED|Period 2 (14 Days)||2
148508|NCT01094730|359834|P1|NOT COMPLETED|Period 2 (14 Days)||3
148509|NCT01094730|359833|P2|COMPLETED|Period 2 (14 Days)||84
148510|NCT01094730|359834|P1|COMPLETED|Period 2 (14 Days)||87
148511|NCT01094730|359833|P2|STARTED|Period 2 (14 Days)||86
148512|NCT01094730|359834|P1|STARTED|Period 2 (14 Days)||90
148513|NCT01094730|359833|P2|NOT COMPLETED|Period 1 (14 Days)||2
148514|NCT01094730|359834|P1|NOT COMPLETED|Period 1 (14 Days)||2
148515|NCT01094730|359833|P2|COMPLETED|Period 1 (14 Days)||86
148516|NCT01094730|359834|P1|COMPLETED|Period 1 (14 Days)||90
148517|NCT01094730|359833|P2|STARTED|Period 1 (14 Days)||88
148518|NCT01094730|359834|P1|STARTED|Period 1 (14 Days)||92
148519|NCT01094704|359847|P2|NOT COMPLETED|Overall Study||0
148520|NCT01094704|359848|P1|NOT COMPLETED|Overall Study||0
148521|NCT01094704|359847|P2|COMPLETED|Overall Study||8
148522|NCT01094704|359848|P1|COMPLETED|Overall Study||8
148523|NCT01094704|359847|P2|STARTED|Overall Study||8
148524|NCT01094704|359848|P1|STARTED|Overall Study||8
148525|NCT01094574|359860|P6|NOT COMPLETED|Overall Study||0
148526|NCT01094574|359861|P5|NOT COMPLETED|Overall Study||0
148527|NCT01094574|359862|P4|NOT COMPLETED|Overall Study||0
148528|NCT01094574|359863|P3|NOT COMPLETED|Overall Study||0
148529|NCT01094574|359864|P2|NOT COMPLETED|Overall Study||0
148530|NCT01094574|359865|P1|NOT COMPLETED|Overall Study||0
148531|NCT01094574|359860|P6|COMPLETED|Overall Study||2
148532|NCT01094574|359861|P5|COMPLETED|Overall Study||2
148533|NCT01094574|359862|P4|COMPLETED|Overall Study||2
148534|NCT01094574|359863|P3|COMPLETED|Overall Study||2
148535|NCT01094574|359864|P2|COMPLETED|Overall Study||1
148536|NCT01094574|359865|P1|COMPLETED|Overall Study||1
148537|NCT01094574|359860|P6|STARTED|Overall Study||2
148538|NCT01094574|359861|P5|STARTED|Overall Study||2
148539|NCT01094574|359862|P4|STARTED|Overall Study||2
148540|NCT01094574|359863|P3|STARTED|Overall Study||2
148541|NCT01094574|359864|P2|STARTED|Overall Study||1
148542|NCT01094574|359865|P1|STARTED|Overall Study||1
148543|NCT01094561|359912|P1|NOT COMPLETED|Overall Study||6
148544|NCT01094561|359912|P1|COMPLETED|Overall Study||17
148545|NCT01094561|359912|P1|STARTED|Overall Study||23
148546|NCT01094548|359919|P2|NOT COMPLETED|Overall Study||0
148547|NCT01094548|359920|P1|NOT COMPLETED|Overall Study||0
148548|NCT01094548|359919|P2|COMPLETED|Overall Study||17
148549|NCT01094548|359920|P1|COMPLETED|Overall Study||17
148550|NCT01094548|359919|P2|STARTED|Overall Study||17
148551|NCT01094548|359920|P1|STARTED|Overall Study||17
148552|NCT01094522|359940|P2|NOT COMPLETED|Overall Study||0
148553|NCT01094522|359941|P1|NOT COMPLETED|Overall Study||0
148554|NCT01094522|359940|P2|COMPLETED|Overall Study||20
148555|NCT01094522|359941|P1|COMPLETED|Overall Study||20
148556|NCT01094522|359940|P2|STARTED|Overall Study||20
148557|NCT01094522|359941|P1|STARTED|Overall Study||20
148558|NCT01094184|359953|P2|NOT COMPLETED|Overall Study||11
148559|NCT01094184|359954|P1|NOT COMPLETED|Overall Study||35
148560|NCT01094184|359953|P2|COMPLETED|Overall Study||2
148561|NCT01094184|359954|P1|COMPLETED|Overall Study||1
148562|NCT01094184|359953|P2|STARTED|Overall Study||13
148563|NCT01094184|359954|P1|STARTED|Overall Study||36
148564|NCT01094171|360188|P1|NOT COMPLETED|Overall Study||10
148565|NCT01094171|360188|P1|COMPLETED|Overall Study||390
148566|NCT01094171|360188|P1|STARTED|Overall Study||400
148567|NCT01094119|360197|P2|NOT COMPLETED|Overall Study||4
148568|NCT01094119|360198|P1|NOT COMPLETED|Overall Study||2
148569|NCT01094119|360197|P2|COMPLETED|Overall Study||32
148570|NCT01094119|360198|P1|COMPLETED|Overall Study||32
148571|NCT01094119|360197|P2|STARTED|Overall Study||36
148572|NCT01094119|360198|P1|STARTED|Overall Study||34
148573|NCT01093976|360206|P1|NOT COMPLETED|Overall Study||0
148574|NCT01093976|360206|P1|COMPLETED|Overall Study||14
148575|NCT01093976|360206|P1|STARTED|Overall Study||14
148576|NCT01093846|360213|P3|NOT COMPLETED|Overall Study||21
148577|NCT01093846|360214|P2|NOT COMPLETED|Overall Study||18
148578|NCT01093846|360215|P1|NOT COMPLETED|Overall Study||19
148579|NCT01093846|360213|P3|COMPLETED|Overall Study||1
148580|NCT01093846|360214|P2|COMPLETED|Overall Study||0
148581|NCT01093846|360215|P1|COMPLETED|Overall Study||0
148582|NCT01093846|360213|P3|STARTED|Overall Study||22
148583|NCT01093846|360214|P2|STARTED|Overall Study||18
148584|NCT01093846|360215|P1|STARTED|Overall Study||19
148585|NCT01093794|360221|P4|NOT COMPLETED|Treatment Period 4||0
148586|NCT01093794|360222|P3|NOT COMPLETED|Treatment Period 4||0
148587|NCT01093794|360223|P2|NOT COMPLETED|Treatment Period 4||0
148588|NCT01093794|360224|P1|NOT COMPLETED|Treatment Period 4||0
148589|NCT01093794|360221|P4|COMPLETED|Treatment Period 4||7
148590|NCT01093794|360222|P3|COMPLETED|Treatment Period 4||6
148591|NCT01093794|360223|P2|COMPLETED|Treatment Period 4||7
148592|NCT01093794|360224|P1|COMPLETED|Treatment Period 4||7
148593|NCT01093794|360221|P4|STARTED|Treatment Period 4||7
148594|NCT01093794|360222|P3|STARTED|Treatment Period 4||6
148595|NCT01093794|360223|P2|STARTED|Treatment Period 4||7
148596|NCT01093794|360224|P1|STARTED|Treatment Period 4||7
148597|NCT01093794|360221|P4|NOT COMPLETED|Treatment Period 3||0
148598|NCT01093794|360222|P3|NOT COMPLETED|Treatment Period 3||0
148599|NCT01093794|360223|P2|NOT COMPLETED|Treatment Period 3||0
148600|NCT01093794|360224|P1|NOT COMPLETED|Treatment Period 3||0
148601|NCT01093794|360221|P4|COMPLETED|Treatment Period 3||7
148602|NCT01093794|360222|P3|COMPLETED|Treatment Period 3||6
148603|NCT01093794|360223|P2|COMPLETED|Treatment Period 3||7
148604|NCT01093794|360224|P1|COMPLETED|Treatment Period 3||7
148605|NCT01093794|360221|P4|STARTED|Treatment Period 3||7
148606|NCT01093794|360222|P3|STARTED|Treatment Period 3||6
148607|NCT01093794|360223|P2|STARTED|Treatment Period 3||7
148608|NCT01093794|360224|P1|STARTED|Treatment Period 3||7
148609|NCT01093794|360221|P4|NOT COMPLETED|Treatment Period 2||0
148610|NCT01093794|360222|P3|NOT COMPLETED|Treatment Period 2||0
148611|NCT01093794|360223|P2|NOT COMPLETED|Treatment Period 2||0
148612|NCT01093794|360224|P1|NOT COMPLETED|Treatment Period 2||0
148613|NCT01093794|360221|P4|COMPLETED|Treatment Period 2||7
148614|NCT01093794|360222|P3|COMPLETED|Treatment Period 2||6
148615|NCT01093794|360223|P2|COMPLETED|Treatment Period 2||7
148616|NCT01093794|360224|P1|COMPLETED|Treatment Period 2||7
148617|NCT01093794|360221|P4|STARTED|Treatment Period 2||7
148618|NCT01093794|360222|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
148619|NCT01093794|360223|P2|STARTED|Treatment Period 2||7
148620|NCT01093794|360224|P1|STARTED|Treatment Period 2||7
148621|NCT01093794|360221|P4|NOT COMPLETED|Treatment Period 1||0
148622|NCT01093794|360222|P3|NOT COMPLETED|Treatment Period 1||0
148623|NCT01093794|360223|P2|NOT COMPLETED|Treatment Period 1||0
148624|NCT01093794|360224|P1|NOT COMPLETED|Treatment Period 1||0
148625|NCT01093794|360221|P4|COMPLETED|Treatment Period 1||7
148626|NCT01093794|360222|P3|COMPLETED|Treatment Period 1||7
148627|NCT01093794|360223|P2|COMPLETED|Treatment Period 1||7
148628|NCT01093794|360224|P1|COMPLETED|Treatment Period 1||7
148629|NCT01093794|360221|P4|STARTED|Treatment Period 1||7
148630|NCT01093794|360222|P3|STARTED|Treatment Period 1||7
148631|NCT01093794|360223|P2|STARTED|Treatment Period 1||7
148632|NCT01093794|360224|P1|STARTED|Treatment Period 1||7
148633|NCT01093755|360240|P2|NOT COMPLETED|Overall Study||4
148634|NCT01093755|360241|P1|NOT COMPLETED|Overall Study||3
148635|NCT01093755|360240|P2|COMPLETED|Overall Study||10
148636|NCT01093755|360241|P1|COMPLETED|Overall Study||13
148637|NCT01093755|360240|P2|STARTED|Overall Study||14
148638|NCT01093755|360241|P1|STARTED|Overall Study||16
148639|NCT01093690|360251|P2|NOT COMPLETED|Overall Study||0
148640|NCT01093690|360252|P1|NOT COMPLETED|Overall Study||0
148641|NCT01093690|360251|P2|COMPLETED|Overall Study||79
148642|NCT01093690|360252|P1|COMPLETED|Overall Study||83
148643|NCT01093690|360251|P2|STARTED|Overall Study||79
148644|NCT01093690|360252|P1|STARTED|Overall Study||83
148645|NCT01093651|360260|P2|NOT COMPLETED|Overall Study||0
148646|NCT01093651|360261|P1|NOT COMPLETED|Overall Study||0
148647|NCT01093651|360260|P2|COMPLETED|Overall Study||10
148648|NCT01093651|360261|P1|COMPLETED|Overall Study||10
148649|NCT01093651|360260|P2|STARTED|Overall Study||10
148650|NCT01093651|360261|P1|STARTED|Overall Study||10
148651|NCT01093625|360281|P2|NOT COMPLETED|1-Year Visit||3
148652|NCT01093625|360282|P1|NOT COMPLETED|1-Year Visit||5
148653|NCT01093625|360281|P2|COMPLETED|1-Year Visit||37
148654|NCT01093625|360282|P1|COMPLETED|1-Year Visit||29
148655|NCT01093625|360281|P2|STARTED|1-Year Visit||40
148656|NCT01093625|360282|P1|STARTED|1-Year Visit||34
148657|NCT01093625|360281|P2|NOT COMPLETED|6-Month Visit||9
148658|NCT01093625|360282|P1|NOT COMPLETED|6-Month Visit||8
148659|NCT01093625|360281|P2|COMPLETED|6-Month Visit||40
148660|NCT01093625|360282|P1|COMPLETED|6-Month Visit||34
148661|NCT01093625|360281|P2|STARTED|6-Month Visit||49
148662|NCT01093625|360282|P1|STARTED|6-Month Visit||42
148663|NCT01093625|360281|P2|NOT COMPLETED|3-Month Visit||0
148664|NCT01093625|360282|P1|NOT COMPLETED|3-Month Visit||2
148665|NCT01093625|360281|P2|COMPLETED|3-Month Visit||49
148666|NCT01093625|360282|P1|COMPLETED|3-Month Visit||42
148667|NCT01093625|360281|P2|STARTED|3-Month Visit||49
148668|NCT01093625|360282|P1|STARTED|3-Month Visit||44
148669|NCT01093625|360281|P2|NOT COMPLETED|1-Month Visit||0
148670|NCT01093625|360282|P1|NOT COMPLETED|1-Month Visit||2
148671|NCT01093625|360281|P2|COMPLETED|1-Month Visit||49
148672|NCT01093625|360282|P1|COMPLETED|1-Month Visit||44
148673|NCT01093625|360281|P2|STARTED|1-Month Visit||49
148674|NCT01093625|360282|P1|STARTED|1-Month Visit||46
148675|NCT01093625|360281|P2|NOT COMPLETED|2-Week Visit||0
148676|NCT01093625|360282|P1|NOT COMPLETED|2-Week Visit||1
148677|NCT01093625|360281|P2|COMPLETED|2-Week Visit||49
148678|NCT01093625|360282|P1|COMPLETED|2-Week Visit||46
148679|NCT01093625|360281|P2|STARTED|2-Week Visit||49
148680|NCT01093625|360282|P1|STARTED|2-Week Visit||47
148681|NCT01093625|360281|P2|NOT COMPLETED|Baseline and Dispensed||0
148682|NCT01093625|360282|P1|NOT COMPLETED|Baseline and Dispensed||2
148683|NCT01093625|360281|P2|COMPLETED|Baseline and Dispensed||49
148684|NCT01093625|360282|P1|COMPLETED|Baseline and Dispensed||47
148685|NCT01093625|360281|P2|STARTED|Baseline and Dispensed||49
148686|NCT01093625|360282|P1|STARTED|Baseline and Dispensed||49
148687|NCT01093599|360302|P2|NOT COMPLETED|Overall Study||46
148688|NCT01093599|360303|P1|NOT COMPLETED|Overall Study||32
148689|NCT01093599|360302|P2|COMPLETED|Overall Study||59
148690|NCT01093599|360303|P1|COMPLETED|Overall Study||59
148691|NCT01093599|360302|P2|STARTED|Overall Study||105
148692|NCT01093599|360303|P1|STARTED|Overall Study||91
148693|NCT01093534|360312|P3|NOT COMPLETED|Overall Study||9
148694|NCT01093534|360313|P2|NOT COMPLETED|Overall Study||16
148695|NCT01093534|360314|P1|NOT COMPLETED|Overall Study||10
148696|NCT01093534|360312|P3|COMPLETED|Overall Study||169
148697|NCT01093534|360313|P2|COMPLETED|Overall Study||167
148698|NCT01093534|360314|P1|COMPLETED|Overall Study||176
148699|NCT01093534|360312|P3|Received Study Treatment|Overall Study||175
148700|NCT01093534|360313|P2|Received Study Treatment|Overall Study||182
148701|NCT01093534|360314|P1|Received Study Treatment|Overall Study||186
148702|NCT01093534|360312|P3|STARTED|Overall Study||178
148703|NCT01093534|360313|P2|STARTED|Overall Study||183
148704|NCT01093534|360314|P1|STARTED|Overall Study||186
148705|NCT01093521|360419|P1|NOT COMPLETED|Overall Study||0
148706|NCT01093521|360419|P1|COMPLETED|Overall Study||20
148707|NCT01093521|360419|P1|STARTED|Overall Study||20
148708|NCT01093482|360434|P1|NOT COMPLETED|Overall Study||0
148709|NCT01093482|360434|P1|COMPLETED|Overall Study||8151
148710|NCT01093482|360434|P1|STARTED|Overall Study||8151
148711|NCT01093469|360441|P3|NOT COMPLETED|Overall Study||1
148712|NCT01093469|360442|P2|NOT COMPLETED|Overall Study||0
148713|NCT01093469|360443|P1|NOT COMPLETED|Overall Study||0
148714|NCT01093469|360441|P3|COMPLETED|Overall Study||12
148715|NCT01093469|360442|P2|COMPLETED|Overall Study||13
148716|NCT01093469|360443|P1|COMPLETED|Overall Study||13
148717|NCT01093469|360441|P3|STARTED|Overall Study||13
148718|NCT01093469|360442|P2|STARTED|Overall Study||13
148719|NCT01093469|360443|P1|STARTED|Overall Study||13
148720|NCT01093417|360453|P2|NOT COMPLETED|Overall Study||1
148721|NCT01093417|360454|P1|NOT COMPLETED|Overall Study||0
148722|NCT01093417|360453|P2|COMPLETED|Overall Study||29
148723|NCT01093417|360454|P1|COMPLETED|Overall Study||15
148724|NCT01093417|360453|P2|STARTED|Overall Study||30
148725|NCT01093417|360454|P1|STARTED|Overall Study||15
148726|NCT01093222|360462|P1|NOT COMPLETED|Overall Study||40
148727|NCT01093222|360462|P1|COMPLETED|Overall Study||0
148728|NCT01093222|360462|P1|Eligible and Began Protocol Therapy|Overall Study||34
148729|NCT01093222|360462|P1|STARTED|Overall Study||40
148730|NCT01093027|360471|P2|NOT COMPLETED|Visit 2||0
148731|NCT01093027|360472|P1|NOT COMPLETED|Visit 2||0
148732|NCT01093027|360471|P2|COMPLETED|Visit 2||10
148733|NCT01093027|360472|P1|COMPLETED|Visit 2||10
148734|NCT01093027|360471|P2|STARTED|Visit 2||10
148735|NCT01093027|360472|P1|STARTED|Visit 2||10
148736|NCT01093027|360471|P2|NOT COMPLETED|Visit 1||0
148737|NCT01093027|360472|P1|NOT COMPLETED|Visit 1||0
148738|NCT01093027|360471|P2|COMPLETED|Visit 1||10
148739|NCT01093027|360472|P1|COMPLETED|Visit 1||10
148740|NCT01093027|360471|P2|STARTED|Visit 1||10
148741|NCT01093027|360472|P1|STARTED|Visit 1||10
148742|NCT01093014|360483|P3|NOT COMPLETED|Overall Study||0
148743|NCT01093014|360484|P2|NOT COMPLETED|Overall Study||0
148744|NCT01093014|360485|P1|NOT COMPLETED|Overall Study||0
148745|NCT01093014|360483|P3|COMPLETED|Overall Study||12
148746|NCT01093014|360484|P2|COMPLETED|Overall Study||9
148747|NCT01093014|360485|P1|COMPLETED|Overall Study||12
148748|NCT01093014|360483|P3|STARTED|Overall Study||12
148749|NCT01093014|360484|P2|STARTED|Overall Study||9
148750|NCT01093014|360485|P1|STARTED|Overall Study||12
148751|NCT01092923|360504|P2|NOT COMPLETED|Overall Study||0
148752|NCT01092923|360505|P1|NOT COMPLETED|Overall Study||0
148753|NCT01092923|360504|P2|COMPLETED|Overall Study||10
148754|NCT01092923|360505|P1|COMPLETED|Overall Study||10
148755|NCT01092923|360504|P2|STARTED|Overall Study||10
148756|NCT01092923|360505|P1|STARTED|Overall Study||10
148757|NCT01092910|360514|P1|NOT COMPLETED|Overall Study||5
148758|NCT01092910|360514|P1|COMPLETED|Overall Study||52
148759|NCT01092910|360514|P1|10 Month Follow-up|Overall Study||52
148760|NCT01092910|360514|P1|4 Month Follow-up|Overall Study||54
148761|NCT01092910|360514|P1|STARTED|Overall Study||57
148762|NCT01092832|360526|P2|NOT COMPLETED|Overall Study||0
148763|NCT01092832|360527|P1|NOT COMPLETED|Overall Study||1
148764|NCT01092832|360526|P2|COMPLETED|Overall Study||8
148765|NCT01092832|360527|P1|COMPLETED|Overall Study||13
148766|NCT01092832|360526|P2|STARTED|Overall Study||8
148767|NCT01092832|360527|P1|STARTED|Overall Study||14
148768|NCT01092780|360539|P4|NOT COMPLETED|Treatment Period 4||0
148769|NCT01092780|360540|P3|NOT COMPLETED|Treatment Period 4||0
148770|NCT01092780|360541|P2|NOT COMPLETED|Treatment Period 4||0
148771|NCT01092780|360542|P1|NOT COMPLETED|Treatment Period 4||0
148772|NCT01092780|360539|P4|COMPLETED|Treatment Period 4||13
148773|NCT01092780|360540|P3|COMPLETED|Treatment Period 4||13
148774|NCT01092780|360541|P2|COMPLETED|Treatment Period 4||13
148775|NCT01092780|360542|P1|COMPLETED|Treatment Period 4||13
148776|NCT01092780|360539|P4|STARTED|Treatment Period 4||13
148777|NCT01092780|360540|P3|STARTED|Treatment Period 4||13
148778|NCT01092780|360541|P2|STARTED|Treatment Period 4||13
148779|NCT01092780|360542|P1|STARTED|Treatment Period 4||13
148780|NCT01092780|360539|P4|NOT COMPLETED|Washout Period 3||0
148781|NCT01092780|360540|P3|NOT COMPLETED|Washout Period 3||0
148782|NCT01092780|360541|P2|NOT COMPLETED|Washout Period 3||0
148783|NCT01092780|360542|P1|NOT COMPLETED|Washout Period 3||0
148784|NCT01092780|360539|P4|COMPLETED|Washout Period 3||13
148785|NCT01092780|360540|P3|COMPLETED|Washout Period 3||13
148786|NCT01092780|360541|P2|COMPLETED|Washout Period 3||13
148787|NCT01092780|360542|P1|COMPLETED|Washout Period 3||13
148788|NCT01092780|360539|P4|STARTED|Washout Period 3||13
148789|NCT01092780|360540|P3|STARTED|Washout Period 3||13
148790|NCT01092780|360541|P2|STARTED|Washout Period 3||13
148791|NCT01092780|360542|P1|STARTED|Washout Period 3||13
148792|NCT01092780|360539|P4|NOT COMPLETED|Treatment Period 3||0
148793|NCT01092780|360540|P3|NOT COMPLETED|Treatment Period 3||0
148794|NCT01092780|360541|P2|NOT COMPLETED|Treatment Period 3||0
148795|NCT01092780|360542|P1|NOT COMPLETED|Treatment Period 3||0
148796|NCT01092780|360539|P4|COMPLETED|Treatment Period 3||13
148797|NCT01092780|360540|P3|COMPLETED|Treatment Period 3||13
148798|NCT01092780|360541|P2|COMPLETED|Treatment Period 3||13
148799|NCT01092780|360542|P1|COMPLETED|Treatment Period 3||13
148800|NCT01092780|360539|P4|STARTED|Treatment Period 3||13
148801|NCT01092780|360540|P3|STARTED|Treatment Period 3||13
148802|NCT01092780|360541|P2|STARTED|Treatment Period 3||13
148803|NCT01092780|360542|P1|STARTED|Treatment Period 3||13
148804|NCT01092780|360539|P4|NOT COMPLETED|Washout Period 2||0
148805|NCT01092780|360540|P3|NOT COMPLETED|Washout Period 2||1
148806|NCT01092780|360541|P2|NOT COMPLETED|Washout Period 2||1
148807|NCT01092780|360542|P1|NOT COMPLETED|Washout Period 2||0
148808|NCT01092780|360539|P4|COMPLETED|Washout Period 2||13
148809|NCT01092780|360540|P3|COMPLETED|Washout Period 2||13
148810|NCT01092780|360541|P2|COMPLETED|Washout Period 2||13
148811|NCT01092780|360542|P1|COMPLETED|Washout Period 2||13
148812|NCT01092780|360539|P4|STARTED|Washout Period 2||13
148813|NCT01092780|360540|P3|STARTED|Washout Period 2||14
148814|NCT01092780|360541|P2|STARTED|Washout Period 2||14
148815|NCT01092780|360542|P1|STARTED|Washout Period 2||13
148816|NCT01092780|360539|P4|NOT COMPLETED|Treatment Period 2||0
148817|NCT01092780|360540|P3|NOT COMPLETED|Treatment Period 2||0
148818|NCT01092780|360541|P2|NOT COMPLETED|Treatment Period 2||0
148819|NCT01092780|360542|P1|NOT COMPLETED|Treatment Period 2||0
148820|NCT01092780|360539|P4|COMPLETED|Treatment Period 2||13
148821|NCT01092780|360540|P3|COMPLETED|Treatment Period 2||14
148822|NCT01092780|360541|P2|COMPLETED|Treatment Period 2||14
148823|NCT01092780|360542|P1|COMPLETED|Treatment Period 2||13
148824|NCT01092780|360539|P4|STARTED|Treatment Period 2||13
148825|NCT01092780|360540|P3|STARTED|Treatment Period 2||14
148826|NCT01092780|360541|P2|STARTED|Treatment Period 2||14
148827|NCT01092780|360542|P1|STARTED|Treatment Period 2||13
148828|NCT01092780|360539|P4|NOT COMPLETED|Washout Period 1||0
148829|NCT01092780|360540|P3|NOT COMPLETED|Washout Period 1||0
148830|NCT01092780|360541|P2|NOT COMPLETED|Washout Period 1||1
148831|NCT01092780|360542|P1|NOT COMPLETED|Washout Period 1||1
148832|NCT01092780|360539|P4|COMPLETED|Washout Period 1||13
148833|NCT01092780|360540|P3|COMPLETED|Washout Period 1||14
148834|NCT01092780|360541|P2|COMPLETED|Washout Period 1||14
148835|NCT01092780|360542|P1|COMPLETED|Washout Period 1||13
148836|NCT01092780|360539|P4|STARTED|Washout Period 1||13
148837|NCT01092780|360540|P3|STARTED|Washout Period 1||14
148838|NCT01092780|360541|P2|STARTED|Washout Period 1||15
148839|NCT01092780|360542|P1|STARTED|Washout Period 1||14
148840|NCT01092780|360539|P4|NOT COMPLETED|Treatment Period 1||0
148841|NCT01092780|360540|P3|NOT COMPLETED|Treatment Period 1||0
148842|NCT01092780|360541|P2|NOT COMPLETED|Treatment Period 1||0
148843|NCT01092780|360542|P1|NOT COMPLETED|Treatment Period 1||0
148844|NCT01092780|360539|P4|COMPLETED|Treatment Period 1||13
148845|NCT01092780|360540|P3|COMPLETED|Treatment Period 1||14
148846|NCT01092780|360541|P2|COMPLETED|Treatment Period 1||15
148847|NCT01092780|360542|P1|COMPLETED|Treatment Period 1||14
148848|NCT01092780|360539|P4|STARTED|Treatment Period 1||13
148849|NCT01092780|360540|P3|STARTED|Treatment Period 1||14
148850|NCT01092780|360541|P2|STARTED|Treatment Period 1||15
148851|NCT01092780|360542|P1|STARTED|Treatment Period 1||14
148852|NCT01092767|360572|P1|NOT COMPLETED|Overall Study||5
148853|NCT01092767|360572|P1|COMPLETED|Overall Study||45
148854|NCT01092767|360572|P1|STARTED|Overall Study||50
148855|NCT01092728|360578|P2|NOT COMPLETED|Overall Study||14
148856|NCT01092728|360579|P1|NOT COMPLETED|Overall Study||4
148857|NCT01092728|360578|P2|COMPLETED|Overall Study||0
148858|NCT01092728|360579|P1|COMPLETED|Overall Study||0
148859|NCT01092728|360578|P2|STARTED|Overall Study||14
148860|NCT01092728|360579|P1|STARTED|Overall Study||4
148861|NCT01092702|360587|P1|NOT COMPLETED|Overall Study||9
148862|NCT01092702|360587|P1|COMPLETED|Overall Study||23
148863|NCT01092702|360587|P1|STARTED|Overall Study||32
148864|NCT01092663|360593|P2|NOT COMPLETED|Overall Study||4
148865|NCT01092663|360594|P1|NOT COMPLETED|Overall Study||7
148866|NCT01092663|360593|P2|COMPLETED|Overall Study||26
148867|NCT01092663|360594|P1|COMPLETED|Overall Study||24
148868|NCT01092663|360593|P2|STARTED|Overall Study||30
148869|NCT01092663|360594|P1|STARTED|Overall Study||31
148870|NCT01092637|360642|P2|NOT COMPLETED|Overall Study||49
148871|NCT01092637|360643|P1|NOT COMPLETED|Overall Study||47
148872|NCT01092637|360642|P2|COMPLETED|Overall Study||86
148873|NCT01092637|360643|P1|COMPLETED|Overall Study||98
148874|NCT01092637|360642|P2|STARTED|Overall Study||135
148875|NCT01092637|360643|P1|STARTED|Overall Study||145
148876|NCT01092559|360653|P1|NOT COMPLETED|Overall Study||0
148877|NCT01092559|360653|P1|COMPLETED|Overall Study||10
148878|NCT01092559|360653|P1|STARTED|Overall Study||10
148879|NCT01092546|360658|P1|NOT COMPLETED|Overall Study||4
148880|NCT01092546|360658|P1|COMPLETED|Overall Study||12
148881|NCT01092546|360658|P1|STARTED|Overall Study||16
148882|NCT01092507|360665|P2|NOT COMPLETED|Overall Study||0
148883|NCT01092507|360666|P1|NOT COMPLETED|Overall Study||2
148884|NCT01092507|360665|P2|COMPLETED|Overall Study||150
148885|NCT01092507|360666|P1|COMPLETED|Overall Study||147
148886|NCT01092507|360665|P2|STARTED|Overall Study||150
148887|NCT01092507|360666|P1|STARTED|Overall Study||149
148888|NCT01092442|360686|P2|NOT COMPLETED|Overall Study||0
148889|NCT01092442|360687|P1|NOT COMPLETED|Overall Study||0
148890|NCT01092442|360686|P2|COMPLETED|Overall Study||60
148891|NCT01092442|360687|P1|COMPLETED|Overall Study||80
148892|NCT01092442|360686|P2|STARTED|Overall Study||60
148893|NCT01092442|360687|P1|STARTED|Overall Study||80
148894|NCT01092416|360701|P1|NOT COMPLETED|12-Month Follow-up||25
148895|NCT01092416|360701|P1|COMPLETED|12-Month Follow-up||413
148896|NCT01092416|360701|P1|STARTED|12-Month Follow-up||438
148897|NCT01092416|360701|P1|NOT COMPLETED|30-Day Follow-up||10
148898|NCT01092416|360701|P1|COMPLETED|30-Day Follow-up||430
148899|NCT01092416|360701|P1|STARTED|30-Day Follow-up||440
148900|NCT01092416|360701|P1|NOT COMPLETED|Enrollment||3
148901|NCT01092416|360701|P1|COMPLETED|Enrollment||440
148902|NCT01092416|360701|P1|STARTED|Enrollment||443
148903|NCT01092364|360713|P3|NOT COMPLETED|Overall Study||18
148904|NCT01092364|360714|P2|NOT COMPLETED|Overall Study||16
148905|NCT01092364|360715|P1|NOT COMPLETED|Overall Study||18
148906|NCT01092364|360713|P3|COMPLETED|Overall Study||105
148907|NCT01092364|360714|P2|COMPLETED|Overall Study||104
148908|NCT01092364|360715|P1|COMPLETED|Overall Study||104
148909|NCT01092364|360713|P3|STARTED|Overall Study||123
148910|NCT01092364|360714|P2|STARTED|Overall Study||120
148911|NCT01092364|360715|P1|STARTED|Overall Study||122
148912|NCT01092338|360725|P2|NOT COMPLETED|Overall Study||1
148913|NCT01092338|360726|P1|NOT COMPLETED|Overall Study||1
148914|NCT01092338|360725|P2|COMPLETED|Overall Study||21
148915|NCT01092338|360726|P1|COMPLETED|Overall Study||21
148916|NCT01092338|360725|P2|STARTED|Overall Study||22
148917|NCT01092338|360726|P1|STARTED|Overall Study||22
148918|NCT01091974|360738|P4|NOT COMPLETED|Overall Study||7
148919|NCT01091974|360739|P3|NOT COMPLETED|Overall Study||6
148920|NCT01091974|360740|P2|NOT COMPLETED|Overall Study||5
148921|NCT01091974|360741|P1|NOT COMPLETED|Overall Study||5
148922|NCT01091974|360738|P4|COMPLETED|Overall Study||17
148923|NCT01091974|360739|P3|COMPLETED|Overall Study||19
148924|NCT01091974|360740|P2|COMPLETED|Overall Study||18
148925|NCT01091974|360741|P1|COMPLETED|Overall Study||19
148926|NCT01091974|360738|P4|STARTED|Overall Study||24
148927|NCT01091974|360739|P3|STARTED|Overall Study||25
148928|NCT01091974|360740|P2|STARTED|Overall Study||23
148929|NCT01091974|360741|P1|STARTED|Overall Study||24
148930|NCT01091948|360757|P2|NOT COMPLETED|Overall Study||0
148931|NCT01091948|360758|P1|NOT COMPLETED|Overall Study||0
148932|NCT01091948|360757|P2|COMPLETED|Overall Study||38
148933|NCT01091948|360758|P1|COMPLETED|Overall Study||37
148934|NCT01091948|360757|P2|STARTED|Overall Study||38
148935|NCT01091948|360758|P1|STARTED|Overall Study||37
148936|NCT01091675|360776|P1|NOT COMPLETED|Overall Study||34
148937|NCT01091675|360776|P1|COMPLETED|Overall Study||23
148938|NCT01091675|360776|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
148939|NCT01091662|360782|P2|NOT COMPLETED|Overall Study||34
148940|NCT01091662|360783|P1|NOT COMPLETED|Overall Study||17
148941|NCT01091662|360782|P2|COMPLETED|Overall Study||80
148942|NCT01091662|360783|P1|COMPLETED|Overall Study||41
148943|NCT01091662|360782|P2|STARTED|Overall Study||114
148944|NCT01091662|360783|P1|STARTED|Overall Study||58
148945|NCT01091519|360821|P2|NOT COMPLETED|Overall Study||73
148946|NCT01091519|360822|P1|NOT COMPLETED|Overall Study||55
148947|NCT01091519|360821|P2|COMPLETED|Overall Study||362
148948|NCT01091519|360822|P1|COMPLETED|Overall Study||291
148949|NCT01091519|360821|P2|Treated|Overall Study||431
148950|NCT01091519|360822|P1|Treated|Overall Study||342
148951|NCT01091519|360821|P2|STARTED|Overall Study||435
148952|NCT01091519|360822|P1|STARTED|Overall Study||346
148953|NCT01091454|360834|P1|NOT COMPLETED|Overall Study||1
148954|NCT01091454|360834|P1|COMPLETED|Overall Study||47
148955|NCT01091454|360834|P1|STARTED|Overall Study||48
148956|NCT01091259|360843|P1|NOT COMPLETED|Overall Study||5
148957|NCT01091259|360843|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
148958|NCT01091259|360843|P1|STARTED|Overall Study||29
148959|NCT01091246|360854|P3|NOT COMPLETED|Overall Study||13
148960|NCT01091246|360855|P2|NOT COMPLETED|Overall Study||16
148961|NCT01091246|360856|P1|NOT COMPLETED|Overall Study||35
148962|NCT01091246|360854|P3|COMPLETED|Overall Study||450
148963|NCT01091246|360855|P2|COMPLETED|Overall Study||448
148964|NCT01091246|360856|P1|COMPLETED|Overall Study||1350
148965|NCT01091246|360854|P3|STARTED|Overall Study||463
148966|NCT01091246|360855|P2|STARTED|Overall Study||464
148967|NCT01091246|360856|P1|STARTED|Overall Study||1385
148968|NCT01091155|360930|P1|NOT COMPLETED|Overall Study||9
148969|NCT01091155|360930|P1|COMPLETED|Overall Study||279
148970|NCT01091155|360930|P1|STARTED|Overall Study||288
148971|NCT01091116|360939|P5|NOT COMPLETED|Overall Study||11
148972|NCT01091116|360940|P4|NOT COMPLETED|Overall Study||4
148973|NCT01091116|360941|P3|NOT COMPLETED|Overall Study||11
148974|NCT01091116|360942|P2|NOT COMPLETED|Overall Study||8
148975|NCT01091116|360943|P1|NOT COMPLETED|Overall Study||6
148976|NCT01091116|360939|P5|COMPLETED|Overall Study||73
148977|NCT01091116|360940|P4|COMPLETED|Overall Study||80
148978|NCT01091116|360941|P3|COMPLETED|Overall Study||73
148979|NCT01091116|360942|P2|COMPLETED|Overall Study||80
148980|NCT01091116|360943|P1|COMPLETED|Overall Study||77
148981|NCT01091116|360939|P5|STARTED|Overall Study||84
148982|NCT01091116|360940|P4|STARTED|Overall Study||84
148983|NCT01091116|360941|P3|STARTED|Overall Study||84
148984|NCT01091116|360942|P2|STARTED|Overall Study||88
148985|NCT01091116|360943|P1|STARTED|Overall Study||83
148986|NCT01091103|360995|P1|NOT COMPLETED|Overall Study||4
148987|NCT01091103|360995|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
148988|NCT01091103|360995|P1|STARTED|Overall Study||60
148989|NCT01090973|361015|P1|NOT COMPLETED|Overall Study||1
148990|NCT01090973|361015|P1|COMPLETED|Overall Study||0
148991|NCT01090973|361015|P1|STARTED|Overall Study||1
148992|NCT01090765|361031|P6|NOT COMPLETED|Overall Study||1
148993|NCT01090765|361032|P5|NOT COMPLETED|Overall Study||2
148994|NCT01090765|361033|P4|NOT COMPLETED|Overall Study||1
148995|NCT01090765|361034|P3|NOT COMPLETED|Overall Study||0
148996|NCT01090765|361035|P2|NOT COMPLETED|Overall Study||0
148997|NCT01090765|361036|P1|NOT COMPLETED|Overall Study||0
148998|NCT01090765|361031|P6|COMPLETED|Overall Study||3
148999|NCT01090765|361032|P5|COMPLETED|Overall Study||4
149000|NCT01090765|361033|P4|COMPLETED|Overall Study||1
149001|NCT01090765|361034|P3|COMPLETED|Overall Study||3
149002|NCT01090765|361035|P2|COMPLETED|Overall Study||3
149003|NCT01090765|361036|P1|COMPLETED|Overall Study||3
149004|NCT01090765|361031|P6|STARTED|Overall Study||4
149005|NCT01090765|361032|P5|STARTED|Overall Study||6
149006|NCT01090765|361033|P4|STARTED|Overall Study||2
149007|NCT01090765|361034|P3|STARTED|Overall Study||3
149008|NCT01090765|361035|P2|STARTED|Overall Study||3
149009|NCT01090765|361036|P1|STARTED|Overall Study||3
149010|NCT01090752|361071|P2|NOT COMPLETED|Overall Study||0
149011|NCT01090752|361072|P1|NOT COMPLETED|Overall Study||0
149012|NCT01090752|361071|P2|COMPLETED|Overall Study||8
149013|NCT01090752|361072|P1|COMPLETED|Overall Study||8
149014|NCT01090752|361071|P2|STARTED|Overall Study||8
149015|NCT01090752|361072|P1|STARTED|Overall Study||8
149016|NCT01090739|361082|P1|NOT COMPLETED|36 Month Follow-up||23
149017|NCT01090739|361082|P1|COMPLETED|36 Month Follow-up||115
149018|NCT01090739|361082|P1|STARTED|36 Month Follow-up||138
149019|NCT01090739|361082|P1|NOT COMPLETED|24 Month Follow-up||9
149020|NCT01090739|361082|P1|COMPLETED|24 Month Follow-up||138
149021|NCT01090739|361082|P1|STARTED|24 Month Follow-up||147
149022|NCT01090739|361082|P1|NOT COMPLETED|12 Month Follow-up||5
149023|NCT01090739|361082|P1|COMPLETED|12 Month Follow-up||147
149024|NCT01090739|361082|P1|STARTED|12 Month Follow-up||152
149025|NCT01090739|361082|P1|NOT COMPLETED|Enrollment||55
149026|NCT01090739|361082|P1|COMPLETED|Enrollment||152
149027|NCT01090739|361082|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
149028|NCT01090492|361107|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
149029|NCT01090492|361108|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
149030|NCT01090492|361109|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
149031|NCT01090492|361110|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
149032|NCT01090492|361111|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
149033|NCT01090492|361112|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
149034|NCT01090492|361113|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
149035|NCT01090492|361114|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
149036|NCT01090492|361107|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
149037|NCT01090492|361108|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
149038|NCT01090492|361109|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
149039|NCT01090492|361110|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
149040|NCT01090492|361111|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
149041|NCT01090492|361112|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
149042|NCT01090492|361113|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
149043|NCT01090492|361114|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
149044|NCT01090492|361107|P8|STARTED|Second Intervention Period (4 Weeks)||27
149045|NCT01090492|361108|P7|STARTED|Second Intervention Period (4 Weeks)||31
149046|NCT01090492|361109|P6|STARTED|Second Intervention Period (4 Weeks)||30
149047|NCT01090492|361110|P5|STARTED|Second Intervention Period (4 Weeks)||29
149048|NCT01090492|361111|P4|STARTED|Second Intervention Period (4 Weeks)||22
149049|NCT01090492|361112|P3|STARTED|Second Intervention Period (4 Weeks)||26
149050|NCT01090492|361113|P2|STARTED|Second Intervention Period (4 Weeks)||24
149051|NCT01090492|361114|P1|STARTED|Second Intervention Period (4 Weeks)||26
149052|NCT01090492|361107|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149053|NCT01090492|361108|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149054|NCT01090492|361109|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149055|NCT01090492|361110|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149056|NCT01090492|361111|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149057|NCT01090492|361112|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149058|NCT01090492|361113|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149059|NCT01090492|361114|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
149060|NCT01090492|361107|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
149061|NCT01090492|361108|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
149062|NCT01090492|361109|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
149063|NCT01090492|361110|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
149064|NCT01090492|361111|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
149065|NCT01090492|361112|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
149066|NCT01090492|361113|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
149067|NCT01090492|361114|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
149068|NCT01090492|361107|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
149069|NCT01090492|361108|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
149070|NCT01090492|361109|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
149071|NCT01090492|361110|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
149072|NCT01090492|361111|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
149073|NCT01090492|361112|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
149074|NCT01090492|361113|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
149075|NCT01090492|361114|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
149076|NCT01090492|361107|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
149077|NCT01090492|361108|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
149078|NCT01090492|361109|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
149079|NCT01090492|361110|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
149080|NCT01090492|361111|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
149081|NCT01090492|361112|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
149082|NCT01090492|361113|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
149083|NCT01090492|361114|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
149084|NCT01090492|361107|P8|COMPLETED|First Intervention Period (4 Weeks)||27
149085|NCT01090492|361108|P7|COMPLETED|First Intervention Period (4 Weeks)||31
149086|NCT01090492|361109|P6|COMPLETED|First Intervention Period (4 Weeks)||30
149087|NCT01090492|361110|P5|COMPLETED|First Intervention Period (4 Weeks)||29
149088|NCT01090492|361111|P4|COMPLETED|First Intervention Period (4 Weeks)||22
149089|NCT01090492|361112|P3|COMPLETED|First Intervention Period (4 Weeks)||26
149090|NCT01090492|361113|P2|COMPLETED|First Intervention Period (4 Weeks)||24
149091|NCT01090492|361114|P1|COMPLETED|First Intervention Period (4 Weeks)||26
149092|NCT01090492|361107|P8|STARTED|First Intervention Period (4 Weeks)||33
149093|NCT01090492|361108|P7|STARTED|First Intervention Period (4 Weeks)||32
149094|NCT01090492|361109|P6|STARTED|First Intervention Period (4 Weeks)||32
149095|NCT01090492|361110|P5|STARTED|First Intervention Period (4 Weeks)||33
149096|NCT01090492|361111|P4|STARTED|First Intervention Period (4 Weeks)||28
149097|NCT01090492|361112|P3|STARTED|First Intervention Period (4 Weeks)||29
149098|NCT01090492|361113|P2|STARTED|First Intervention Period (4 Weeks)||29
149099|NCT01090492|361114|P1|STARTED|First Intervention Period (4 Weeks)||27
149100|NCT01090479|361173|P2|NOT COMPLETED|Overall Study||0
149101|NCT01090479|361174|P1|NOT COMPLETED|Overall Study||0
149102|NCT01090479|361173|P2|COMPLETED|Overall Study||50
149103|NCT01090479|361174|P1|COMPLETED|Overall Study||50
149104|NCT01090479|361173|P2|STARTED|Overall Study||50
149105|NCT01090479|361174|P1|STARTED|Overall Study||50
149106|NCT01090453|361182|P2|NOT COMPLETED|Overall Study||14
149107|NCT01090453|361183|P1|NOT COMPLETED|Overall Study||13
149108|NCT01090453|361182|P2|COMPLETED|Overall Study||228
149109|NCT01090453|361183|P1|COMPLETED|Overall Study||225
149110|NCT01090453|361182|P2|STARTED|Overall Study||242
149111|NCT01090453|361183|P1|STARTED|Overall Study||238
149112|NCT01090427|361230|P7|NOT COMPLETED|After Controlled Period||2
149113|NCT01090427|361231|P6|NOT COMPLETED|After Controlled Period||5
149114|NCT01090427|361232|P5|NOT COMPLETED|After Controlled Period||0
149115|NCT01090427|361233|P4|NOT COMPLETED|After Controlled Period||2
149116|NCT01090427|361234|P3|NOT COMPLETED|After Controlled Period||0
149117|NCT01090427|361235|P2|NOT COMPLETED|After Controlled Period||0
149118|NCT01090427|361236|P1|NOT COMPLETED|After Controlled Period||0
149119|NCT01090427|361230|P7|COMPLETED|After Controlled Period||34
149120|NCT01090427|361231|P6|COMPLETED|After Controlled Period||32
149121|NCT01090427|361232|P5|COMPLETED|After Controlled Period||18
149122|NCT01090427|361233|P4|COMPLETED|After Controlled Period||17
149123|NCT01090427|361234|P3|COMPLETED|After Controlled Period||0
149124|NCT01090427|361235|P2|COMPLETED|After Controlled Period||0
149125|NCT01090427|361236|P1|COMPLETED|After Controlled Period||0
149126|NCT01090427|361230|P7|STARTED|After Controlled Period||36
149127|NCT01090427|361231|P6|STARTED|After Controlled Period||37
149128|NCT01090427|361232|P5|STARTED|After Controlled Period||18
149129|NCT01090427|361233|P4|STARTED|After Controlled Period||19
149130|NCT01090427|361234|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
149131|NCT01090427|361235|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
149132|NCT01090427|361236|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
149133|NCT01090427|361230|P7|NOT COMPLETED|Controlled Period||0
149134|NCT01090427|361231|P6|NOT COMPLETED|Controlled Period||0
149135|NCT01090427|361232|P5|NOT COMPLETED|Controlled Period||0
149136|NCT01090427|361233|P4|NOT COMPLETED|Controlled Period||0
149137|NCT01090427|361234|P3|NOT COMPLETED|Controlled Period||0
149138|NCT01090427|361235|P2|NOT COMPLETED|Controlled Period||0
149139|NCT01090427|361236|P1|NOT COMPLETED|Controlled Period||0
149140|NCT01090427|361230|P7|COMPLETED|Controlled Period||0
149141|NCT01090427|361231|P6|COMPLETED|Controlled Period||0
149142|NCT01090427|361232|P5|COMPLETED|Controlled Period||0
149143|NCT01090427|361233|P4|COMPLETED|Controlled Period||0
149144|NCT01090427|361234|P3|COMPLETED|Controlled Period||36
149145|NCT01090427|361235|P2|COMPLETED|Controlled Period||37
149146|NCT01090427|361236|P1|COMPLETED|Controlled Period||37
149147|NCT01090427|361230|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
149148|NCT01090427|361231|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
149149|NCT01090427|361232|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
149150|NCT01090427|361233|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
149151|NCT01090427|361234|P3|STARTED|Controlled Period||36
149152|NCT01090427|361235|P2|STARTED|Controlled Period||37
149153|NCT01090427|361236|P1|STARTED|Controlled Period||37
149154|NCT01090323|361271|P2|NOT COMPLETED|Overall Study||34
149155|NCT01090323|361272|P1|NOT COMPLETED|Overall Study||89
149156|NCT01090323|361271|P2|COMPLETED|Overall Study||19
149157|NCT01090323|361272|P1|COMPLETED|Overall Study||43
149158|NCT01090323|361271|P2|STARTED|Overall Study||53
149159|NCT01090323|361272|P1|STARTED|Overall Study||132
149160|NCT01090310|361284|P4|NOT COMPLETED|Extension Study||20
149161|NCT01090310|361285|P3|NOT COMPLETED|Extension Study||15
149162|NCT01090310|361286|P2|NOT COMPLETED|Extension Study||16
149163|NCT01090310|361287|P1|NOT COMPLETED|Extension Study||14
149164|NCT01090310|361284|P4|COMPLETED|Extension Study||1
149165|NCT01090310|361285|P3|COMPLETED|Extension Study||1
149166|NCT01090310|361286|P2|COMPLETED|Extension Study||0
149167|NCT01090310|361287|P1|COMPLETED|Extension Study||3
149168|NCT01090310|361284|P4|STARTED|Extension Study||21
149169|NCT01090310|361285|P3|STARTED|Extension Study||16
149170|NCT01090310|361286|P2|STARTED|Extension Study||16
149171|NCT01090310|361287|P1|STARTED|Extension Study||17
149172|NCT01090310|361284|P4|NOT COMPLETED|Core Study||7
149173|NCT01090310|361285|P3|NOT COMPLETED|Core Study||7
149174|NCT01090310|361286|P2|NOT COMPLETED|Core Study||11
149175|NCT01090310|361287|P1|NOT COMPLETED|Core Study||8
149176|NCT01090310|361284|P4|COMPLETED|Core Study||27
149177|NCT01090310|361285|P3|COMPLETED|Core Study||24
149178|NCT01090310|361286|P2|COMPLETED|Core Study||20
149179|NCT01090310|361287|P1|COMPLETED|Core Study||21
149180|NCT01090310|361284|P4|STARTED|Core Study||34
149181|NCT01090310|361285|P3|STARTED|Core Study||31
149182|NCT01090310|361286|P2|STARTED|Core Study||31
149183|NCT01090310|361287|P1|STARTED|Core Study||29
149184|NCT01090180|361315|P2|NOT COMPLETED|Overall Study||8
149185|NCT01090180|361316|P1|NOT COMPLETED|Overall Study||11
149186|NCT01090180|361315|P2|COMPLETED|Overall Study||21
149187|NCT01090180|361316|P1|COMPLETED|Overall Study||22
149188|NCT01090180|361315|P2|STARTED|Overall Study||29
149189|NCT01090180|361316|P1|STARTED|Overall Study||33
149190|NCT01090102|361326|P2|NOT COMPLETED|Second 12 Weeks||1
149191|NCT01090102|361327|P1|NOT COMPLETED|Second 12 Weeks||0
149192|NCT01090102|361326|P2|COMPLETED|Second 12 Weeks||15
149193|NCT01090102|361327|P1|COMPLETED|Second 12 Weeks||11
149194|NCT01090102|361326|P2|STARTED|Second 12 Weeks||16
149195|NCT01090102|361327|P1|STARTED|Second 12 Weeks||11
149196|NCT01090102|361326|P2|NOT COMPLETED|First 12 Weeks||2
149197|NCT01090102|361327|P1|NOT COMPLETED|First 12 Weeks||4
149198|NCT01090102|361326|P2|COMPLETED|First 12 Weeks||16
149199|NCT01090102|361327|P1|COMPLETED|First 12 Weeks||11
149200|NCT01090102|361326|P2|STARTED|First 12 Weeks||18
149201|NCT01090102|361327|P1|STARTED|First 12 Weeks||15
149202|NCT01090076|361337|P2|NOT COMPLETED|Overall Study||2
149203|NCT01090076|361338|P1|NOT COMPLETED|Overall Study||1
149204|NCT01090076|361337|P2|COMPLETED|Overall Study||12
149205|NCT01090076|361338|P1|COMPLETED|Overall Study||11
149206|NCT01090076|361337|P2|STARTED|Overall Study||14
149207|NCT01090076|361338|P1|STARTED|Overall Study||12
149208|NCT01090063|361348|P1|NOT COMPLETED|Treatment||4
149209|NCT01090063|361348|P1|COMPLETED|Treatment||20
149210|NCT01090063|361348|P1|STARTED|Treatment||24
149211|NCT01090063|361348|P1|NOT COMPLETED|Screen||4
149212|NCT01090063|361348|P1|COMPLETED|Screen||24
149213|NCT01090063|361348|P1|STARTED|Screen||28
149214|NCT01090050|361364|P2|NOT COMPLETED|Overall Study||7
149215|NCT01090050|361365|P1|NOT COMPLETED|Overall Study||1
149216|NCT01090050|361364|P2|COMPLETED|Overall Study||5
149217|NCT01090050|361365|P1|COMPLETED|Overall Study||15
149218|NCT01090050|361364|P2|STARTED|Overall Study||12
149219|NCT01090050|361365|P1|STARTED|Overall Study||16
149220|NCT01090011|361385|P1|NOT COMPLETED|Overall Study||171
149221|NCT01090011|361385|P1|COMPLETED|Overall Study||0
149222|NCT01090011|361385|P1|STARTED|Overall Study||171
149223|NCT01089751|361455|P2|NOT COMPLETED|Overall Study||27
149224|NCT01089751|361456|P1|NOT COMPLETED|Overall Study||34
149225|NCT01089751|361455|P2|COMPLETED|Overall Study||132
149226|NCT01089751|361456|P1|COMPLETED|Overall Study||129
149227|NCT01089751|361455|P2|STARTED|Overall Study||159
149228|NCT01089751|361456|P1|STARTED|Overall Study||163
149229|NCT01089608|361478|P2|NOT COMPLETED|Overall Study||6
149230|NCT01089608|361479|P1|NOT COMPLETED|Overall Study||0
149231|NCT01089608|361478|P2|COMPLETED|Overall Study||44
149232|NCT01089608|361479|P1|COMPLETED|Overall Study||43
149233|NCT01089608|361478|P2|STARTED|Overall Study||50
149234|NCT01089608|361479|P1|STARTED|Overall Study||43
149235|NCT01089595|361487|P2|NOT COMPLETED|Overall Study||0
149236|NCT01089595|361488|P1|NOT COMPLETED|Overall Study||0
149237|NCT01089595|361487|P2|COMPLETED|Overall Study||3
149238|NCT01089595|361488|P1|COMPLETED|Overall Study||2
149239|NCT01089595|361487|P2|STARTED|Overall Study||3
149240|NCT01089595|361488|P1|STARTED|Overall Study||2
149241|NCT01089582|361496|P1|NOT COMPLETED|Overall Study||30
149242|NCT01089582|361496|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
149243|NCT01089582|361496|P1|STARTED|Overall Study||603
149244|NCT01089569|361509|P3|NOT COMPLETED|Overall Study||4
149245|NCT01089569|361510|P2|NOT COMPLETED|Overall Study||3
149246|NCT01089569|361511|P1|NOT COMPLETED|Overall Study||4
149247|NCT01089569|361509|P3|COMPLETED|Overall Study||16
149248|NCT01089569|361510|P2|COMPLETED|Overall Study||17
149249|NCT01089569|361511|P1|COMPLETED|Overall Study||16
149250|NCT01089569|361509|P3|STARTED|Overall Study||20
149251|NCT01089569|361510|P2|STARTED|Overall Study||20
149252|NCT01089569|361511|P1|STARTED|Overall Study||20
149253|NCT01089556|361539|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
149254|NCT01089556|361540|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
149255|NCT01089556|361541|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
149256|NCT01089556|361542|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
149257|NCT01089556|361543|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
149258|NCT01089556|361544|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
149259|NCT01089556|361539|P6|COMPLETED|Study Period III (Weeks 9-16)||92
149260|NCT01089556|361540|P5|COMPLETED|Study Period III (Weeks 9-16)||83
149261|NCT01089556|361541|P4|COMPLETED|Study Period III (Weeks 9-16)||66
149262|NCT01089556|361542|P3|COMPLETED|Study Period III (Weeks 9-16)||60
149263|NCT01089556|361543|P2|COMPLETED|Study Period III (Weeks 9-16)||0
149264|NCT01089556|361544|P1|COMPLETED|Study Period III (Weeks 9-16)||0
149265|NCT01089556|361539|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
149266|NCT01089556|361540|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
149267|NCT01089556|361541|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
149268|NCT01089556|361542|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
149269|NCT01089556|361543|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
149270|NCT01089556|361544|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
149271|NCT01089556|361539|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
149272|NCT01089556|361540|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
149273|NCT01089556|361541|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
149274|NCT01089556|361542|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
149275|NCT01089556|361543|P2|STARTED|Study Period III (Weeks 9-16)||0
149276|NCT01089556|361544|P1|STARTED|Study Period III (Weeks 9-16)||0
149277|NCT01089556|361539|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
149278|NCT01089556|361540|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
149279|NCT01089556|361541|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
149280|NCT01089556|361542|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
149281|NCT01089556|361543|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
149282|NCT01089556|361544|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
149283|NCT01089556|361539|P6|COMPLETED|Study Period II (Weeks 1-8)||0
149284|NCT01089556|361540|P5|COMPLETED|Study Period II (Weeks 1-8)||0
149285|NCT01089556|361541|P4|COMPLETED|Study Period II (Weeks 1-8)||0
149286|NCT01089556|361542|P3|COMPLETED|Study Period II (Weeks 1-8)||0
149287|NCT01089556|361543|P2|COMPLETED|Study Period II (Weeks 1-8)||333
149288|NCT01089556|361544|P1|COMPLETED|Study Period II (Weeks 1-8)||333
149289|NCT01089556|361539|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
149290|NCT01089556|361540|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
149291|NCT01089556|361541|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
149292|NCT01089556|361542|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
149293|NCT01089556|361543|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
149294|NCT01089556|361544|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
149295|NCT01089556|361539|P6|Safety Population|Study Period II (Weeks 1-8)||0
149296|NCT01089556|361540|P5|Safety Population|Study Period II (Weeks 1-8)||0
149297|NCT01089556|361541|P4|Safety Population|Study Period II (Weeks 1-8)||0
149298|NCT01089556|361542|P3|Safety Population|Study Period II (Weeks 1-8)||0
149299|NCT01089556|361543|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
149300|NCT01089556|361544|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
149301|NCT01089556|361539|P6|STARTED|Study Period II (Weeks 1-8)||0
149302|NCT01089556|361540|P5|STARTED|Study Period II (Weeks 1-8)||0
149303|NCT01089556|361541|P4|STARTED|Study Period II (Weeks 1-8)||0
149304|NCT01089556|361542|P3|STARTED|Study Period II (Weeks 1-8)||0
149305|NCT01089556|361543|P2|STARTED|Study Period II (Weeks 1-8)||407
149306|NCT01089556|361544|P1|STARTED|Study Period II (Weeks 1-8)||404
149307|NCT01089543|361618|P4|NOT COMPLETED|Overall Study||2
149308|NCT01089543|361619|P3|NOT COMPLETED|Overall Study||3
149309|NCT01089543|361620|P2|NOT COMPLETED|Overall Study||4
149310|NCT01089543|361621|P1|NOT COMPLETED|Overall Study||3
149311|NCT01089543|361618|P4|COMPLETED|Overall Study||83
149312|NCT01089543|361619|P3|COMPLETED|Overall Study||81
149313|NCT01089543|361620|P2|COMPLETED|Overall Study||81
149314|NCT01089543|361621|P1|COMPLETED|Overall Study||81
149315|NCT01089543|361618|P4|STARTED|Overall Study||85
149316|NCT01089543|361619|P3|STARTED|Overall Study||84
149317|NCT01089543|361620|P2|STARTED|Overall Study||85
149318|NCT01089543|361621|P1|STARTED|Overall Study||84
149319|NCT01089517|361638|P3|NOT COMPLETED|Overall Study||5
149320|NCT01089517|361639|P2|NOT COMPLETED|Overall Study||5
149321|NCT01089517|361640|P1|NOT COMPLETED|Overall Study||4
149322|NCT01089517|361638|P3|COMPLETED|Overall Study||147
149323|NCT01089517|361639|P2|COMPLETED|Overall Study||144
149324|NCT01089517|361640|P1|COMPLETED|Overall Study||144
149325|NCT01089517|361638|P3|STARTED|Overall Study||152
149326|NCT01089517|361639|P2|STARTED|Overall Study||149
149327|NCT01089517|361640|P1|STARTED|Overall Study||148
149328|NCT01089504|361656|P2|NOT COMPLETED|Overall Study||1
149329|NCT01089504|361657|P1|NOT COMPLETED|Overall Study||3
149330|NCT01089504|361656|P2|COMPLETED|Overall Study||4
149331|NCT01089504|361657|P1|COMPLETED|Overall Study||5
149332|NCT01089504|361656|P2|STARTED|Overall Study||5
149333|NCT01089504|361657|P1|STARTED|Overall Study||8
149334|NCT01089413|361670|P1|NOT COMPLETED|Overall Study||201
149335|NCT01089413|361670|P1|COMPLETED|Overall Study||0
149336|NCT01089413|361670|P1|Received Bevacizumab in First Line|Overall Study||199
149337|NCT01089413|361670|P1|STARTED|Overall Study||201
149338|NCT01089361|361689|P2|NOT COMPLETED|Overall Study||0
149339|NCT01089361|361690|P1|NOT COMPLETED|Overall Study||1
149340|NCT01089361|361689|P2|COMPLETED|Overall Study||10
149341|NCT01089361|361690|P1|COMPLETED|Overall Study||8
149342|NCT01089361|361689|P2|STARTED|Overall Study||10
149343|NCT01089361|361690|P1|STARTED|Overall Study||9
149344|NCT01089231|361712|P4|NOT COMPLETED|Overall Study||1
149345|NCT01089231|361713|P3|NOT COMPLETED|Overall Study||2
149346|NCT01089231|361714|P2|NOT COMPLETED|Overall Study||2
149347|NCT01089231|361715|P1|NOT COMPLETED|Overall Study||4
149348|NCT01089231|361712|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
149349|NCT01089231|361713|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
149350|NCT01089231|361714|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
149351|NCT01089231|361715|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
149352|NCT01089231|361712|P4|STARTED|Overall Study||10
149353|NCT01089231|361713|P3|STARTED|Overall Study||10
149354|NCT01089231|361714|P2|STARTED|Overall Study||10
149355|NCT01089231|361715|P1|STARTED|Overall Study||10
149356|NCT01089127|361739|P6|NOT COMPLETED|Overall Study||3
149357|NCT01089127|361740|P5|NOT COMPLETED|Overall Study||2
149358|NCT01089127|361741|P4|NOT COMPLETED|Overall Study||1
149359|NCT01089127|361742|P3|NOT COMPLETED|Overall Study||2
149360|NCT01089127|361743|P2|NOT COMPLETED|Overall Study||5
149361|NCT01089127|361744|P1|NOT COMPLETED|Overall Study||8
149362|NCT01089127|361739|P6|COMPLETED|Overall Study||88
149363|NCT01089127|361740|P5|COMPLETED|Overall Study||90
149364|NCT01089127|361741|P4|COMPLETED|Overall Study||91
149365|NCT01089127|361742|P3|COMPLETED|Overall Study||92
149366|NCT01089127|361743|P2|COMPLETED|Overall Study||86
149367|NCT01089127|361744|P1|COMPLETED|Overall Study||84
149368|NCT01089127|361739|P6|Exposed to Study Drug|Overall Study||91
149369|NCT01089127|361740|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
149370|NCT01089127|361741|P4|Exposed to Study Drug|Overall Study||92
149371|NCT01089127|361742|P3|Exposed to Study Drug|Overall Study||94
149372|NCT01089127|361743|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
149373|NCT01089127|361744|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
149374|NCT01089127|361739|P6|STARTED|Overall Study||91
149375|NCT01089127|361740|P5|STARTED|Overall Study||92
149376|NCT01089127|361741|P4|STARTED|Overall Study||92
149377|NCT01089127|361742|P3|STARTED|Overall Study||94
149378|NCT01089127|361743|P2|STARTED|Overall Study||91
149379|NCT01089127|361744|P1|STARTED|Overall Study||92
149380|NCT01089062|361770|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
149381|NCT01089062|361771|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
149382|NCT01089062|361772|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
149383|NCT01089062|361773|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
149384|NCT01089062|361774|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
149385|NCT01089062|361775|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
149386|NCT01089062|361770|P6|COMPLETED|Follow-up Visit (Final Visit)||3
149387|NCT01089062|361771|P5|COMPLETED|Follow-up Visit (Final Visit)||3
149388|NCT01089062|361772|P4|COMPLETED|Follow-up Visit (Final Visit)||3
149389|NCT01089062|361773|P3|COMPLETED|Follow-up Visit (Final Visit)||3
149390|NCT01089062|361774|P2|COMPLETED|Follow-up Visit (Final Visit)||3
149391|NCT01089062|361775|P1|COMPLETED|Follow-up Visit (Final Visit)||3
149392|NCT01089062|361770|P6|STARTED|Follow-up Visit (Final Visit)||3
149393|NCT01089062|361771|P5|STARTED|Follow-up Visit (Final Visit)||3
149394|NCT01089062|361772|P4|STARTED|Follow-up Visit (Final Visit)||3
149395|NCT01089062|361773|P3|STARTED|Follow-up Visit (Final Visit)||3
149396|NCT01089062|361774|P2|STARTED|Follow-up Visit (Final Visit)||3
149397|NCT01089062|361775|P1|STARTED|Follow-up Visit (Final Visit)||3
149398|NCT01089062|361770|P6|NOT COMPLETED|Visit 4||0
149399|NCT01089062|361771|P5|NOT COMPLETED|Visit 4||0
149400|NCT01089062|361772|P4|NOT COMPLETED|Visit 4||0
149401|NCT01089062|361773|P3|NOT COMPLETED|Visit 4||0
149402|NCT01089062|361774|P2|NOT COMPLETED|Visit 4||0
149403|NCT01089062|361775|P1|NOT COMPLETED|Visit 4||0
149404|NCT01089062|361770|P6|COMPLETED|Visit 4||3
149405|NCT01089062|361771|P5|COMPLETED|Visit 4||3
149406|NCT01089062|361772|P4|COMPLETED|Visit 4||3
149407|NCT01089062|361773|P3|COMPLETED|Visit 4||3
149408|NCT01089062|361774|P2|COMPLETED|Visit 4||3
149409|NCT01089062|361775|P1|COMPLETED|Visit 4||3
149410|NCT01089062|361770|P6|STARTED|Visit 4||3
149411|NCT01089062|361771|P5|STARTED|Visit 4||3
149412|NCT01089062|361772|P4|STARTED|Visit 4||3
149413|NCT01089062|361773|P3|STARTED|Visit 4||3
149414|NCT01089062|361774|P2|STARTED|Visit 4||3
149415|NCT01089062|361775|P1|STARTED|Visit 4||3
149416|NCT01089062|361770|P6|NOT COMPLETED|Visit 3||0
149417|NCT01089062|361771|P5|NOT COMPLETED|Visit 3||0
149418|NCT01089062|361772|P4|NOT COMPLETED|Visit 3||1
149419|NCT01089062|361773|P3|NOT COMPLETED|Visit 3||0
149420|NCT01089062|361774|P2|NOT COMPLETED|Visit 3||0
149421|NCT01089062|361775|P1|NOT COMPLETED|Visit 3||0
149422|NCT01089062|361770|P6|COMPLETED|Visit 3||3
149423|NCT01089062|361771|P5|COMPLETED|Visit 3||3
149424|NCT01089062|361772|P4|COMPLETED|Visit 3||3
149425|NCT01089062|361773|P3|COMPLETED|Visit 3||3
149426|NCT01089062|361774|P2|COMPLETED|Visit 3||3
149427|NCT01089062|361775|P1|COMPLETED|Visit 3||3
149428|NCT01089062|361770|P6|STARTED|Visit 3||3
149429|NCT01089062|361771|P5|STARTED|Visit 3||3
149430|NCT01089062|361772|P4|STARTED|Visit 3||4
149431|NCT01089062|361773|P3|STARTED|Visit 3||3
149432|NCT01089062|361774|P2|STARTED|Visit 3||3
149433|NCT01089062|361775|P1|STARTED|Visit 3||3
149434|NCT01089062|361770|P6|NOT COMPLETED|Visit 2 (Randomization)||1
149435|NCT01089062|361771|P5|NOT COMPLETED|Visit 2 (Randomization)||1
149436|NCT01089062|361772|P4|NOT COMPLETED|Visit 2 (Randomization)||0
149437|NCT01089062|361773|P3|NOT COMPLETED|Visit 2 (Randomization)||1
149438|NCT01089062|361774|P2|NOT COMPLETED|Visit 2 (Randomization)||1
149439|NCT01089062|361775|P1|NOT COMPLETED|Visit 2 (Randomization)||1
149440|NCT01089062|361770|P6|COMPLETED|Visit 2 (Randomization)||3
149441|NCT01089062|361771|P5|COMPLETED|Visit 2 (Randomization)||3
149442|NCT01089062|361772|P4|COMPLETED|Visit 2 (Randomization)||4
149443|NCT01089062|361773|P3|COMPLETED|Visit 2 (Randomization)||3
149444|NCT01089062|361774|P2|COMPLETED|Visit 2 (Randomization)||3
149445|NCT01089062|361775|P1|COMPLETED|Visit 2 (Randomization)||3
149446|NCT01089062|361770|P6|STARTED|Visit 2 (Randomization)||4
149447|NCT01089062|361771|P5|STARTED|Visit 2 (Randomization)||4
149448|NCT01089062|361772|P4|STARTED|Visit 2 (Randomization)||4
149449|NCT01089062|361773|P3|STARTED|Visit 2 (Randomization)||4
149450|NCT01089062|361774|P2|STARTED|Visit 2 (Randomization)||4
149451|NCT01089062|361775|P1|STARTED|Visit 2 (Randomization)||4
149452|NCT01089023|361798|P1|NOT COMPLETED|Overall Study||7
149453|NCT01089023|361798|P1|COMPLETED|Overall Study||88
149454|NCT01089023|361798|P1|STARTED|Overall Study||95
149455|NCT01088997|361812|P2|NOT COMPLETED|Overall Study||3
149456|NCT01088997|361813|P1|NOT COMPLETED|Overall Study||3
149457|NCT01088997|361812|P2|COMPLETED|Overall Study||2
149458|NCT01088997|361813|P1|COMPLETED|Overall Study||4
149459|NCT01088997|361812|P2|STARTED|Overall Study||5
149460|NCT01088997|361813|P1|STARTED|Overall Study||7
149461|NCT01088984|361824|P2|NOT COMPLETED|Phase 2||32
149462|NCT01088984|361825|P1|NOT COMPLETED|Phase 2||0
149463|NCT01088984|361824|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
149464|NCT01088984|361825|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
149465|NCT01088984|361824|P2|STARTED|Phase 2||32
149466|NCT01088984|361825|P1|STARTED|Phase 2||0
149467|NCT01088984|361824|P2|NOT COMPLETED|Phase 1||6
149468|NCT01088984|361825|P1|NOT COMPLETED|Phase 1||5
149469|NCT01088984|361824|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
149470|NCT01088984|361825|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
149471|NCT01088984|361824|P2|STARTED|Phase 1||6
149472|NCT01088984|361825|P1|STARTED|Phase 1||5
149473|NCT01088711|361847|P4|NOT COMPLETED|Overall Study||0
149474|NCT01088711|361848|P3|NOT COMPLETED|Overall Study||0
149475|NCT01088711|361849|P2|NOT COMPLETED|Overall Study||0
149476|NCT01088711|361850|P1|NOT COMPLETED|Overall Study||0
149477|NCT01088711|361847|P4|COMPLETED|Overall Study||2
149478|NCT01088711|361848|P3|COMPLETED|Overall Study||6
149479|NCT01088711|361849|P2|COMPLETED|Overall Study||6
149480|NCT01088711|361850|P1|COMPLETED|Overall Study||18
149481|NCT01088711|361847|P4|STARTED|Overall Study||2
149482|NCT01088711|361848|P3|STARTED|Overall Study||6
149483|NCT01088711|361849|P2|STARTED|Overall Study||6
149484|NCT01088711|361850|P1|STARTED|Overall Study||18
149485|NCT01088672|361874|P1|NOT COMPLETED|Overall Study||0
149486|NCT01088672|361874|P1|COMPLETED|Overall Study||60
149487|NCT01088672|361874|P1|STARTED|Overall Study||60
149488|NCT01088646|361880|P1|NOT COMPLETED|Overall Study||0
149489|NCT01088646|361880|P1|COMPLETED|Overall Study||25
149490|NCT01088646|361880|P1|STARTED|Overall Study||25
149491|NCT01088529|361886|P2|NOT COMPLETED|Overall Study||1
149492|NCT01088529|361887|P1|NOT COMPLETED|Overall Study||0
149493|NCT01088529|361886|P2|COMPLETED|Overall Study||21
149494|NCT01088529|361887|P1|COMPLETED|Overall Study||44
149495|NCT01088529|361886|P2|Received Treatment|Overall Study||21
149496|NCT01088529|361887|P1|Received Treatment|Overall Study||44
149497|NCT01088529|361886|P2|STARTED|Overall Study||22
149498|NCT01088529|361887|P1|STARTED|Overall Study||44
149499|NCT01088503|361900|P3|NOT COMPLETED|Overall Study||17
149500|NCT01088503|361901|P2|NOT COMPLETED|Overall Study||685
149501|NCT01088503|361902|P1|NOT COMPLETED|Overall Study||182
149502|NCT01088503|361900|P3|COMPLETED|Overall Study||241
149503|NCT01088503|361901|P2|COMPLETED|Overall Study||8161
149504|NCT01088503|361902|P1|COMPLETED|Overall Study||2941
149505|NCT01088503|361900|P3|STARTED|Overall Study||258
149506|NCT01088503|361901|P2|STARTED|Overall Study||8846
149507|NCT01088503|361902|P1|STARTED|Overall Study||3123
149508|NCT01088464|361926|P3|NOT COMPLETED|Overall Study||0
149509|NCT01088464|361927|P2|NOT COMPLETED|Overall Study||0
149510|NCT01088464|361928|P1|NOT COMPLETED|Overall Study||0
149511|NCT01088464|361926|P3|COMPLETED|Overall Study||6
149512|NCT01088464|361927|P2|COMPLETED|Overall Study||6
149513|NCT01088464|361928|P1|COMPLETED|Overall Study||3
149514|NCT01088464|361926|P3|Received Any Quantity of Study Drug|Overall Study||6
149515|NCT01088464|361927|P2|Received Any Quantity of Study Drug|Overall Study||6
149516|NCT01088464|361928|P1|Received Any Quantity of Study Drug|Overall Study||3
149517|NCT01088464|361926|P3|STARTED|Overall Study||6
149518|NCT01088464|361927|P2|STARTED|Overall Study||6
149519|NCT01088464|361928|P1|STARTED|Overall Study||3
149520|NCT01088438|361980|P2|NOT COMPLETED|Overall Study||36
149521|NCT01088438|361981|P1|NOT COMPLETED|Overall Study||29
149522|NCT01088438|361980|P2|COMPLETED|Overall Study||59
149523|NCT01088438|361981|P1|COMPLETED|Overall Study||65
149524|NCT01088438|361980|P2|STARTED|Overall Study||95
149525|NCT01088438|361981|P1|STARTED|Overall Study||94
149526|NCT01088399|361994|P3|NOT COMPLETED|Overall Study||281
149527|NCT01088399|361995|P2|NOT COMPLETED|Overall Study||1347
149528|NCT01088399|361996|P1|NOT COMPLETED|Overall Study||7121
149529|NCT01088399|361994|P3|COMPLETED|Overall Study||21
149530|NCT01088399|361995|P2|COMPLETED|Overall Study||308
149531|NCT01088399|361996|P1|COMPLETED|Overall Study||1595
149532|NCT01088399|361994|P3|STARTED|Overall Study||302
149533|NCT01088399|361995|P2|STARTED|Overall Study||1655
149534|NCT01088399|361996|P1|STARTED|Overall Study||8716
149535|NCT01088295|362019|P1|NOT COMPLETED|Overall Study||1
149536|NCT01088295|362019|P1|COMPLETED|Overall Study||35
149537|NCT01088295|362019|P1|STARTED|Overall Study||36
149538|NCT01088243|362025|P2|NOT COMPLETED|Overall Study||0
149539|NCT01088243|362026|P1|NOT COMPLETED|Overall Study||1
149540|NCT01088243|362025|P2|COMPLETED|Overall Study||5
149541|NCT01088243|362026|P1|COMPLETED|Overall Study||12
149542|NCT01088243|362025|P2|STARTED|Overall Study||5
149543|NCT01088243|362026|P1|STARTED|Overall Study||13
149544|NCT01087996|362044|P2|NOT COMPLETED|Overall Study||0
149545|NCT01087996|362045|P1|NOT COMPLETED|Overall Study||0
149546|NCT01087996|362044|P2|COMPLETED|Overall Study||15
149547|NCT01087996|362045|P1|COMPLETED|Overall Study||15
149548|NCT01087996|362044|P2|STARTED|Overall Study||15
149549|NCT01087996|362045|P1|STARTED|Overall Study||15
149550|NCT01087970|362067|P1|NOT COMPLETED|Overall Study||2
149551|NCT01087970|362067|P1|COMPLETED|Overall Study||67
149552|NCT01087970|362067|P1|Received Carboplatin|Overall Study||63
149553|NCT01087970|362067|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
149554|NCT01087970|362067|P1|Completed 6 Cycles|Overall Study||69
149555|NCT01087970|362067|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
149556|NCT01087970|362067|P1|STARTED|Overall Study||69
149557|NCT01087957|362079|P2|NOT COMPLETED|Overall Study||55
149558|NCT01087957|362080|P1|NOT COMPLETED|Overall Study||41
149559|NCT01087957|362079|P2|COMPLETED|Overall Study||187
149560|NCT01087957|362080|P1|COMPLETED|Overall Study||212
149561|NCT01087957|362079|P2|STARTED|Overall Study||242
149562|NCT01087957|362080|P1|STARTED|Overall Study||253
149563|NCT01087944|362106|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
149564|NCT01087944|362107|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
149565|NCT01087944|362106|P2|COMPLETED|Period 2 (Week 4-6)||28
149566|NCT01087944|362107|P1|COMPLETED|Period 2 (Week 4-6)||29
149567|NCT01087944|362106|P2|STARTED|Period 2 (Week 4-6)||30
149568|NCT01087944|362107|P1|STARTED|Period 2 (Week 4-6)||29
149569|NCT01087944|362106|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
149570|NCT01087944|362107|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
149571|NCT01087944|362106|P2|COMPLETED|Period 1 (Week 1-3)||30
149572|NCT01087944|362107|P1|COMPLETED|Period 1 (Week 1-3)||29
149573|NCT01087944|362106|P2|STARTED|Period 1 (Week 1-3)||30
149574|NCT01087944|362107|P1|STARTED|Period 1 (Week 1-3)||30
149575|NCT01087918|362137|P2|NOT COMPLETED|Overall Study||0
149576|NCT01087918|362138|P1|NOT COMPLETED|Overall Study||0
149577|NCT01087918|362137|P2|COMPLETED|Overall Study||4
149578|NCT01087918|362138|P1|COMPLETED|Overall Study||5
149579|NCT01087918|362137|P2|STARTED|Overall Study||4
149580|NCT01087918|362138|P1|STARTED|Overall Study||5
149581|NCT01087905|362172|P8|NOT COMPLETED|Overall Study||29
149582|NCT01087905|362173|P7|NOT COMPLETED|Overall Study||23
149583|NCT01087905|362174|P6|NOT COMPLETED|Overall Study||28
149584|NCT01087905|362175|P5|NOT COMPLETED|Overall Study||31
149585|NCT01087905|362176|P4|NOT COMPLETED|Overall Study||36
149586|NCT01087905|362177|P3|NOT COMPLETED|Overall Study||22
149587|NCT01087905|362178|P2|NOT COMPLETED|Overall Study||32
149588|NCT01087905|362179|P1|NOT COMPLETED|Overall Study||29
149589|NCT01087905|362172|P8|COMPLETED|Overall Study||98
149590|NCT01087905|362173|P7|COMPLETED|Overall Study||98
149591|NCT01087905|362174|P6|COMPLETED|Overall Study||99
149592|NCT01087905|362175|P5|COMPLETED|Overall Study||91
149593|NCT01087905|362176|P4|COMPLETED|Overall Study||86
149594|NCT01087905|362177|P3|COMPLETED|Overall Study||101
149595|NCT01087905|362178|P2|COMPLETED|Overall Study||94
149596|NCT01087905|362179|P1|COMPLETED|Overall Study||90
149597|NCT01087905|362172|P8|STARTED|Overall Study||127
149598|NCT01087905|362173|P7|STARTED|Overall Study||121
149599|NCT01087905|362174|P6|STARTED|Overall Study||127
149600|NCT01087905|362175|P5|STARTED|Overall Study||122
149601|NCT01087905|362176|P4|STARTED|Overall Study||122
149602|NCT01087905|362177|P3|STARTED|Overall Study||123
149603|NCT01087905|362178|P2|STARTED|Overall Study||126
149604|NCT01087905|362179|P1|STARTED|Overall Study||119
149605|NCT01087814|362201|P2|NOT COMPLETED|Second Intervention (5 Days)||0
149606|NCT01087814|362202|P1|NOT COMPLETED|Second Intervention (5 Days)||1
149607|NCT01087814|362201|P2|COMPLETED|Second Intervention (5 Days)||6
149608|NCT01087814|362202|P1|COMPLETED|Second Intervention (5 Days)||4
149609|NCT01087814|362201|P2|STARTED|Second Intervention (5 Days)||6
149610|NCT01087814|362202|P1|STARTED|Second Intervention (5 Days)||5
149611|NCT01087814|362201|P2|NOT COMPLETED|First Intervention (5 Days)||1
149612|NCT01087814|362202|P1|NOT COMPLETED|First Intervention (5 Days)||3
149613|NCT01087814|362201|P2|COMPLETED|First Intervention (5 Days)||6
149614|NCT01087814|362202|P1|COMPLETED|First Intervention (5 Days)||5
149615|NCT01087814|362201|P2|STARTED|First Intervention (5 Days)||7
149616|NCT01087814|362202|P1|STARTED|First Intervention (5 Days)||8
149617|NCT01087801|362210|P2|NOT COMPLETED|Overall Study||5
149618|NCT01087801|362211|P1|NOT COMPLETED|Overall Study||4
149619|NCT01087801|362210|P2|COMPLETED|Overall Study||29
149620|NCT01087801|362211|P1|COMPLETED|Overall Study||26
149621|NCT01087801|362210|P2|STARTED|Overall Study||34
149622|NCT01087801|362211|P1|STARTED|Overall Study||30
149623|NCT01087788|362220|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
149624|NCT01087788|362221|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
149625|NCT01087788|362222|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
149626|NCT01087788|362220|P3|COMPLETED|Open-Label Period (OL-P)||86
149627|NCT01087788|362221|P2|COMPLETED|Open-Label Period (OL-P)||97
149628|NCT01087788|362222|P1|COMPLETED|Open-Label Period (OL-P)||81
149629|NCT01087788|362220|P3|STARTED|Open-Label Period (OL-P)||114
149630|NCT01087788|362221|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
149631|NCT01087788|362222|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
149632|NCT01087788|362220|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
149633|NCT01087788|362221|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
149634|NCT01087788|362222|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
149635|NCT01087788|362220|P3|COMPLETED|24-weeks Dose-blind Period||114
149636|NCT01087788|362221|P2|COMPLETED|24-weeks Dose-blind Period||123
149637|NCT01087788|362222|P1|COMPLETED|24-weeks Dose-blind Period||113
149638|NCT01087788|362220|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
149639|NCT01087788|362221|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
149640|NCT01087788|362222|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
149641|NCT01087788|362220|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
149642|NCT01087788|362221|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
149643|NCT01087788|362222|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
149644|NCT01087788|362220|P3|STARTED|24-weeks Dose-blind Period||120
149645|NCT01087788|362221|P2|STARTED|24-weeks Dose-blind Period||128
149646|NCT01087788|362222|P1|STARTED|24-weeks Dose-blind Period||120
149647|NCT01087788|362220|P3|NOT COMPLETED|24-weeks Double-blind Period||15
149648|NCT01087788|362221|P2|NOT COMPLETED|24-weeks Double-blind Period||10
149649|NCT01087788|362222|P1|NOT COMPLETED|24-weeks Double-blind Period||16
149650|NCT01087788|362220|P3|COMPLETED|24-weeks Double-blind Period||120
149651|NCT01087788|362221|P2|COMPLETED|24-weeks Double-blind Period||128
149652|NCT01087788|362222|P1|COMPLETED|24-weeks Double-blind Period||120
149653|NCT01087788|362220|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
149654|NCT01087788|362221|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
149655|NCT01087788|362222|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
149656|NCT01087788|362220|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
149657|NCT01087788|362221|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
149658|NCT01087788|362222|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
149659|NCT01087788|362220|P3|STARTED|24-weeks Double-blind Period||135
149660|NCT01087788|362221|P2|STARTED|24-weeks Double-blind Period||138
149661|NCT01087788|362222|P1|STARTED|24-weeks Double-blind Period||136
149662|NCT01087762|362252|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
149663|NCT01087762|362253|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
149664|NCT01087762|362254|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
149665|NCT01087762|362255|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
149666|NCT01087762|362256|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
149667|NCT01087762|362252|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
149668|NCT01087762|362253|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
149669|NCT01087762|362254|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
149670|NCT01087762|362255|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
149671|NCT01087762|362256|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
149672|NCT01087762|362252|P5|STARTED|Open-Label Period (Weeks 48-204)||157
149673|NCT01087762|362253|P4|STARTED|Open-Label Period (Weeks 48-204)||158
149674|NCT01087762|362254|P3|STARTED|Open-Label Period (Weeks 48-204)||0
149675|NCT01087762|362255|P2|STARTED|Open-Label Period (Weeks 48-204)||0
149676|NCT01087762|362256|P1|STARTED|Open-Label Period (Weeks 48-204)||0
149677|NCT01087762|362252|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
149678|NCT01087762|362253|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
149679|NCT01087762|362254|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
149680|NCT01087762|362255|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
149681|NCT01087762|362256|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
149682|NCT01087762|362252|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
149683|NCT01087762|362253|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
149684|NCT01087762|362254|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
149685|NCT01087762|362255|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
149686|NCT01087762|362256|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
149687|NCT01087762|362252|P5|STARTED|Double Blind Period (Weeks 0-24)||0
149688|NCT01087762|362253|P4|STARTED|Double Blind Period (Weeks 0-24)||0
149689|NCT01087762|362254|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
149690|NCT01087762|362255|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
149691|NCT01087762|362256|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
149692|NCT01087736|362304|P2|NOT COMPLETED|Overall Study||2
149693|NCT01087736|362305|P1|NOT COMPLETED|Overall Study||1
149694|NCT01087736|362304|P2|COMPLETED|Overall Study||14
149695|NCT01087736|362305|P1|COMPLETED|Overall Study||13
149696|NCT01087736|362304|P2|STARTED|Overall Study||16
149697|NCT01087736|362305|P1|STARTED|Overall Study||14
149698|NCT01087723|362315|P2|NOT COMPLETED|Overall Study||20
149699|NCT01087723|362316|P1|NOT COMPLETED|Overall Study||14
149700|NCT01087723|362315|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
149701|NCT01087723|362316|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
149702|NCT01087723|362315|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
149703|NCT01087723|362316|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
149704|NCT01087723|362315|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
149705|NCT01087723|362316|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
149706|NCT01087541|362340|P2|NOT COMPLETED|Overall Study||0
149707|NCT01087541|362341|P1|NOT COMPLETED|Overall Study||0
149708|NCT01087541|362340|P2|COMPLETED|Overall Study||3523
149709|NCT01087541|362341|P1|COMPLETED|Overall Study||3307
149710|NCT01087541|362340|P2|STARTED|Overall Study||3523
149711|NCT01087541|362341|P1|STARTED|Overall Study||3307
149712|NCT01087528|362357|P1|NOT COMPLETED|Overall Study||7
149713|NCT01087528|362357|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
149714|NCT01087528|362357|P1|STARTED|Overall Study||51
149715|NCT01087502|362363|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
149716|NCT01087502|362364|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
149717|NCT01087502|362363|P2|COMPLETED|Up to Final Analysis (Week 52)||95
149718|NCT01087502|362364|P1|COMPLETED|Up to Final Analysis (Week 52)||90
149719|NCT01087502|362363|P2|STARTED|Up to Final Analysis (Week 52)||118
149720|NCT01087502|362364|P1|STARTED|Up to Final Analysis (Week 52)||123
149721|NCT01087502|362363|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
149722|NCT01087502|362364|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
149723|NCT01087502|362363|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
149724|NCT01087502|362364|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
149725|NCT01087502|362363|P2|STARTED|Up to Interim Analysis (Week 12)||118
149726|NCT01087502|362364|P1|STARTED|Up to Interim Analysis (Week 12)||123
149727|NCT01087489|362383|P2|NOT COMPLETED|Overall Study||3
149728|NCT01087489|362384|P1|NOT COMPLETED|Overall Study||0
149729|NCT01087489|362383|P2|COMPLETED|Overall Study||31
149730|NCT01087489|362384|P1|COMPLETED|Overall Study||19
149731|NCT01087489|362383|P2|STARTED|Overall Study||34
149732|NCT01087489|362384|P1|STARTED|Overall Study||19
149733|NCT01086969|362397|P3|NOT COMPLETED|Overall Study||0
149734|NCT01086969|362398|P2|NOT COMPLETED|Overall Study||2
149735|NCT01086969|362399|P1|NOT COMPLETED|Overall Study||1
149736|NCT01086969|362397|P3|COMPLETED|Overall Study||100
149737|NCT01086969|362398|P2|COMPLETED|Overall Study||98
149738|NCT01086969|362399|P1|COMPLETED|Overall Study||99
149739|NCT01086969|362397|P3|STARTED|Overall Study||100
149740|NCT01086969|362398|P2|STARTED|Overall Study||100
149741|NCT01086969|362399|P1|STARTED|Overall Study||100
149742|NCT01086852|362416|P1|NOT COMPLETED|Overall Study||0
149743|NCT01086852|362416|P1|COMPLETED|Overall Study||4
149744|NCT01086852|362416|P1|STARTED|Overall Study||4
149745|NCT01086761|362432|P6|NOT COMPLETED|Overall Study||0
149746|NCT01086761|362433|P5|NOT COMPLETED|Overall Study||0
149747|NCT01086761|362434|P4|NOT COMPLETED|Overall Study||0
149748|NCT01086761|362435|P3|NOT COMPLETED|Overall Study||0
149749|NCT01086761|362436|P2|NOT COMPLETED|Overall Study||0
149750|NCT01086761|362437|P1|NOT COMPLETED|Overall Study||0
149751|NCT01086761|362432|P6|COMPLETED|Overall Study||0
149752|NCT01086761|362433|P5|COMPLETED|Overall Study||4
149753|NCT01086761|362434|P4|COMPLETED|Overall Study||6
149754|NCT01086761|362435|P3|COMPLETED|Overall Study||6
149755|NCT01086761|362436|P2|COMPLETED|Overall Study||7
149756|NCT01086761|362437|P1|COMPLETED|Overall Study||9
149757|NCT01086761|362432|P6|STARTED|Overall Study||0
149758|NCT01086761|362433|P5|STARTED|Overall Study||4
149759|NCT01086761|362434|P4|STARTED|Overall Study||6
149760|NCT01086761|362435|P3|STARTED|Overall Study||6
149761|NCT01086761|362436|P2|STARTED|Overall Study||7
149762|NCT01086761|362437|P1|STARTED|Overall Study||9
149763|NCT01086605|362477|P2|NOT COMPLETED|Overall Study||0
149764|NCT01086605|362478|P1|NOT COMPLETED|Overall Study||0
149765|NCT01086605|362477|P2|COMPLETED|Overall Study||22
149766|NCT01086605|362478|P1|COMPLETED|Overall Study||24
149767|NCT01086605|362477|P2|STARTED|Overall Study||22
149768|NCT01086605|362478|P1|STARTED|Overall Study||24
149769|NCT01086475|362495|P2|NOT COMPLETED|Overall Study||0
149770|NCT01086475|362496|P1|NOT COMPLETED|Overall Study||0
149771|NCT01086475|362495|P2|COMPLETED|Overall Study||33
149772|NCT01086475|362496|P1|COMPLETED|Overall Study||34
149773|NCT01086475|362495|P2|STARTED|Overall Study||33
149774|NCT01086475|362496|P1|STARTED|Overall Study||34
149775|NCT01086423|362509|P3|NOT COMPLETED|Overall Study||9
149776|NCT01086423|362510|P2|NOT COMPLETED|Overall Study||3
149777|NCT01086423|362511|P1|NOT COMPLETED|Overall Study||10
149778|NCT01086423|362509|P3|COMPLETED|Overall Study||321
149779|NCT01086423|362510|P2|COMPLETED|Overall Study||321
149780|NCT01086423|362511|P1|COMPLETED|Overall Study||320
149781|NCT01086423|362509|P3|STARTED|Overall Study||330
149782|NCT01086423|362510|P2|STARTED|Overall Study||324
149783|NCT01086423|362511|P1|STARTED|Overall Study||330
149784|NCT01086410|362556|P4|NOT COMPLETED|Overall Study||2
149785|NCT01086410|362557|P3|NOT COMPLETED|Overall Study||1
149786|NCT01086410|362558|P2|NOT COMPLETED|Overall Study||2
149787|NCT01086410|362559|P1|NOT COMPLETED|Overall Study||3
149788|NCT01086410|362556|P4|COMPLETED|Overall Study||13
149789|NCT01086410|362557|P3|COMPLETED|Overall Study||55
149790|NCT01086410|362558|P2|COMPLETED|Overall Study||54
149791|NCT01086410|362559|P1|COMPLETED|Overall Study||55
149792|NCT01086410|362556|P4|STARTED|Overall Study||15
149793|NCT01086410|362557|P3|STARTED|Overall Study||56
149794|NCT01086410|362558|P2|STARTED|Overall Study||56
149795|NCT01086410|362559|P1|STARTED|Overall Study||58
149796|NCT01086384|362655|P3|NOT COMPLETED|Treatment Period||124
149797|NCT01086384|362656|P2|NOT COMPLETED|Treatment Period||148
149798|NCT01086384|362657|P1|NOT COMPLETED|Treatment Period||0
149799|NCT01086384|362655|P3|COMPLETED|Treatment Period||885
149800|NCT01086384|362656|P2|COMPLETED|Treatment Period||863
149801|NCT01086384|362657|P1|COMPLETED|Treatment Period||0
149802|NCT01086384|362655|P3|STARTED|Treatment Period||1009
149803|NCT01086384|362656|P2|STARTED|Treatment Period||1011
149804|NCT01086384|362657|P1|STARTED|Treatment Period||0
149805|NCT01086384|362655|P3|NOT COMPLETED|2-week Run-in Period||0
149806|NCT01086384|362656|P2|NOT COMPLETED|2-week Run-in Period||0
149807|NCT01086384|362657|P1|NOT COMPLETED|2-week Run-in Period||163
149808|NCT01086384|362655|P3|COMPLETED|2-week Run-in Period||0
149809|NCT01086384|362656|P2|COMPLETED|2-week Run-in Period||0
149810|NCT01086384|362657|P1|COMPLETED|2-week Run-in Period||2020
149811|NCT01086384|362655|P3|STARTED|2-week Run-in Period||0
149812|NCT01086384|362656|P2|STARTED|2-week Run-in Period||0
149813|NCT01086384|362657|P1|STARTED|2-week Run-in Period||2183
149814|NCT01086358|362667|P2|NOT COMPLETED|Second Intervention||4
149815|NCT01086358|362668|P1|NOT COMPLETED|Second Intervention||4
149816|NCT01086358|362667|P2|COMPLETED|Second Intervention||20
149817|NCT01086358|362668|P1|COMPLETED|Second Intervention||17
149818|NCT01086358|362667|P2|STARTED|Second Intervention||24
149819|NCT01086358|362668|P1|STARTED|Second Intervention||21
149820|NCT01086358|362667|P2|NOT COMPLETED|First Intervention||5
149821|NCT01086358|362668|P1|NOT COMPLETED|First Intervention||9
149822|NCT01086358|362667|P2|COMPLETED|First Intervention||24
149823|NCT01086358|362668|P1|COMPLETED|First Intervention||21
149824|NCT01086358|362667|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
149825|NCT01086358|362668|P1|STARTED|First Intervention|30 subjects enrolled.|30
149826|NCT01086228|362680|P1|NOT COMPLETED|5-year Follow-up||652
149827|NCT01086228|362680|P1|COMPLETED|5-year Follow-up||1012
149828|NCT01086228|362680|P1|STARTED|5-year Follow-up||1664
149829|NCT01086228|362680|P1|NOT COMPLETED|4-year Follow-up||103
149830|NCT01086228|362680|P1|COMPLETED|4-year Follow-up||1664
149831|NCT01086228|362680|P1|STARTED|4-year Follow-up||1767
149832|NCT01086228|362680|P1|NOT COMPLETED|3-year Follow-up||67
149833|NCT01086228|362680|P1|COMPLETED|3-year Follow-up||1767
149834|NCT01086228|362680|P1|STARTED|3-year Follow-up||1834
149835|NCT01086228|362680|P1|NOT COMPLETED|2-year Follow-up||60
149836|NCT01086228|362680|P1|COMPLETED|2-year Follow-up||1834
149837|NCT01086228|362680|P1|STARTED|2-year Follow-up||1894
149838|NCT01086228|362680|P1|NOT COMPLETED|1-year Follow-up||44
149839|NCT01086228|362680|P1|COMPLETED|1-year Follow-up||1894
149840|NCT01086228|362680|P1|STARTED|1-year Follow-up||1938
149841|NCT01086228|362680|P1|NOT COMPLETED|8 Month Follow-up||71
149842|NCT01086228|362680|P1|COMPLETED|8 Month Follow-up||1938
149843|NCT01086228|362680|P1|STARTED|8 Month Follow-up|Analysis population|2009
149844|NCT01086215|362738|P4|NOT COMPLETED|Overall Study||3
149845|NCT01086215|362739|P3|NOT COMPLETED|Overall Study||26
149846|NCT01086215|362740|P2|NOT COMPLETED|Overall Study||47
149847|NCT01086215|362741|P1|NOT COMPLETED|Overall Study||36
149848|NCT01086215|362738|P4|COMPLETED|Overall Study||11
149849|NCT01086215|362739|P3|COMPLETED|Overall Study||47
149850|NCT01086215|362740|P2|COMPLETED|Overall Study||154
149851|NCT01086215|362741|P1|COMPLETED|Overall Study||176
149852|NCT01086215|362738|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
149853|NCT01086215|362739|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
149854|NCT01086215|362740|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
149855|NCT01086215|362741|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
149856|NCT01086215|362738|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
149857|NCT01086215|362739|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
149858|NCT01086215|362740|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
149859|NCT01086215|362741|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
149860|NCT01086215|362738|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
149861|NCT01086215|362739|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
149862|NCT01086215|362740|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
149863|NCT01086215|362741|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
149864|NCT01086215|362738|P4|STARTED|Overall Study||14
149865|NCT01086215|362739|P3|STARTED|Overall Study||73
149866|NCT01086215|362740|P2|STARTED|Overall Study||201
149867|NCT01086215|362741|P1|STARTED|Overall Study||212
149868|NCT01086033|362759|P1|NOT COMPLETED|Overall Study||304
149869|NCT01086033|362759|P1|COMPLETED|Overall Study||262
149870|NCT01086033|362759|P1|STARTED|Overall Study||566
149871|NCT01085968|362773|P2|NOT COMPLETED|Overall Study||4
149872|NCT01085968|362774|P1|NOT COMPLETED|Overall Study||10
149873|NCT01085968|362773|P2|COMPLETED|Overall Study||21
149874|NCT01085968|362774|P1|COMPLETED|Overall Study||19
149875|NCT01085968|362773|P2|STARTED|Overall Study||25
149876|NCT01085968|362774|P1|STARTED|Overall Study||29
149877|NCT01085903|362790|P3|NOT COMPLETED|Overall Study||0
149878|NCT01085903|362791|P2|NOT COMPLETED|Overall Study||0
149879|NCT01085903|362792|P1|NOT COMPLETED|Overall Study||0
149880|NCT01085903|362790|P3|COMPLETED|Overall Study||3
149881|NCT01085903|362791|P2|COMPLETED|Overall Study||4
149882|NCT01085903|362792|P1|COMPLETED|Overall Study||21
149883|NCT01085903|362790|P3|STARTED|Overall Study||3
149884|NCT01085903|362791|P2|STARTED|Overall Study||4
149885|NCT01085903|362792|P1|STARTED|Overall Study||21
149886|NCT01085825|362818|P2|NOT COMPLETED|Overall Study||1
149887|NCT01085825|362819|P1|NOT COMPLETED|Overall Study||1
149888|NCT01085825|362818|P2|COMPLETED|Overall Study||247
149889|NCT01085825|362819|P1|COMPLETED|Overall Study||251
149890|NCT01085825|362818|P2|STARTED|Overall Study||248
149891|NCT01085825|362819|P1|STARTED|Overall Study|1st participant enrolled|252
149892|NCT01085786|362827|P2|NOT COMPLETED|Overall Study||0
149893|NCT01085786|362828|P1|NOT COMPLETED|Overall Study||0
149894|NCT01085786|362827|P2|COMPLETED|Overall Study||117
149895|NCT01085786|362828|P1|COMPLETED|Overall Study||123
149896|NCT01085786|362827|P2|STARTED|Overall Study||117
149897|NCT01085786|362828|P1|STARTED|Overall Study||123
149898|NCT01085760|362838|P4|NOT COMPLETED|Overall Study||3
149899|NCT01085760|362839|P3|NOT COMPLETED|Overall Study||2
149900|NCT01085760|362840|P2|NOT COMPLETED|Overall Study||1
149901|NCT01085760|362841|P1|NOT COMPLETED|Overall Study||1
149902|NCT01085760|362838|P4|COMPLETED|Overall Study||6
149903|NCT01085760|362839|P3|COMPLETED|Overall Study||7
149904|NCT01085760|362840|P2|COMPLETED|Overall Study||8
149905|NCT01085760|362841|P1|COMPLETED|Overall Study||7
149906|NCT01085760|362838|P4|STARTED|Overall Study||9
149907|NCT01085760|362839|P3|STARTED|Overall Study||9
149908|NCT01085760|362840|P2|STARTED|Overall Study||9
149909|NCT01085760|362841|P1|STARTED|Overall Study||8
149910|NCT01085734|362865|P2|NOT COMPLETED|Overall Study||4
149911|NCT01085734|362866|P1|NOT COMPLETED|Overall Study||1
149912|NCT01085734|362865|P2|COMPLETED|Overall Study||11
149913|NCT01085734|362866|P1|COMPLETED|Overall Study||14
149914|NCT01085734|362865|P2|STARTED|Overall Study||15
149915|NCT01085734|362866|P1|STARTED|Overall Study||15
149916|NCT01085682|362878|P2|NOT COMPLETED|Overall Study||25
149917|NCT01085682|362879|P1|NOT COMPLETED|Overall Study||25
149918|NCT01085682|362878|P2|COMPLETED|Overall Study||3
149919|NCT01085682|362879|P1|COMPLETED|Overall Study||6
149920|NCT01085682|362878|P2|STARTED|Overall Study||28
149921|NCT01085682|362879|P1|STARTED|Overall Study||31
149922|NCT01085643|362885|P1|NOT COMPLETED|Overall Study||0
149923|NCT01085643|362885|P1|COMPLETED|Overall Study||4
149924|NCT01085643|362885|P1|STARTED|Overall Study||4
149925|NCT01085591|362897|P3|NOT COMPLETED|Overall Study||7
149926|NCT01085591|362898|P2|NOT COMPLETED|Overall Study||6
149927|NCT01085591|362899|P1|NOT COMPLETED|Overall Study||3
149928|NCT01085591|362897|P3|COMPLETED|Overall Study||63
149929|NCT01085591|362898|P2|COMPLETED|Overall Study||65
149930|NCT01085591|362899|P1|COMPLETED|Overall Study||66
149931|NCT01085591|362897|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
149932|NCT01085591|362898|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
149933|NCT01085591|362899|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
149934|NCT01085591|362897|P3|STARTED|Overall Study||70
149935|NCT01085591|362898|P2|STARTED|Overall Study||71
149936|NCT01085591|362899|P1|STARTED|Overall Study||69
149937|NCT01085539|362922|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
149938|NCT01085539|362922|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
149939|NCT01085539|362922|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
149940|NCT01085539|362922|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
149941|NCT01085539|362922|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
149942|NCT01085539|362922|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
149943|NCT01085539|362922|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
149944|NCT01085539|362922|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
149945|NCT01085539|362922|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
149946|NCT01085539|362922|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
149947|NCT01085539|362922|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
149948|NCT01085539|362922|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
149949|NCT01085539|362922|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
149950|NCT01085539|362922|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
149951|NCT01085539|362922|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
149952|NCT01085513|362928|P2|NOT COMPLETED|Overall Study||0
149953|NCT01085513|362929|P1|NOT COMPLETED|Overall Study||0
149954|NCT01085513|362928|P2|COMPLETED|Overall Study||68
149955|NCT01085513|362929|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
149956|NCT01085513|362928|P2|STARTED|Overall Study||68
149957|NCT01085513|362929|P1|STARTED|Overall Study||75
149958|NCT01085500|362937|P2|NOT COMPLETED|Overall Study||0
149959|NCT01085500|362938|P1|NOT COMPLETED|Overall Study||0
149960|NCT01085500|362937|P2|COMPLETED|Overall Study||24
149961|NCT01085500|362938|P1|COMPLETED|Overall Study||26
149962|NCT01085500|362937|P2|STARTED|Overall Study||24
149963|NCT01085500|362938|P1|STARTED|Overall Study||26
149964|NCT01085357|362950|P2|NOT COMPLETED|Overall Study||6
149965|NCT01085357|362951|P1|NOT COMPLETED|Overall Study||19
149966|NCT01085357|362950|P2|COMPLETED|Overall Study||125
149967|NCT01085357|362951|P1|COMPLETED|Overall Study||355
149968|NCT01085357|362950|P2|STARTED|Overall Study||131
149969|NCT01085357|362951|P1|STARTED|Overall Study||374
149970|NCT01085331|362963|P2|NOT COMPLETED|Overall Study||0
149971|NCT01085331|362964|P1|NOT COMPLETED|Overall Study||0
149972|NCT01085331|362963|P2|COMPLETED|Overall Study||6
149973|NCT01085331|362964|P1|COMPLETED|Overall Study||10
149974|NCT01085331|362963|P2|STARTED|Overall Study||6
149975|NCT01085331|362964|P1|STARTED|Overall Study||10
149976|NCT01085318|363003|P2|NOT COMPLETED|Overall Study||0
149977|NCT01085318|363004|P1|NOT COMPLETED|Overall Study||2
149978|NCT01085318|363003|P2|COMPLETED|Overall Study||15
149979|NCT01085318|363004|P1|COMPLETED|Overall Study||21
149980|NCT01085318|363003|P2|STARTED|Overall Study||15
149981|NCT01085318|363004|P1|STARTED|Overall Study||23
149982|NCT01085214|363014|P1|NOT COMPLETED|Overall Study||1
149983|NCT01085214|363014|P1|COMPLETED|Overall Study||36
149984|NCT01085214|363014|P1|STARTED|Overall Study||37
149985|NCT01085201|363026|P5|NOT COMPLETED|Overall Study||0
149986|NCT01085201|363027|P4|NOT COMPLETED|Overall Study||0
149987|NCT01085201|363028|P3|NOT COMPLETED|Overall Study||2
149988|NCT01085201|363029|P2|NOT COMPLETED|Overall Study||1
149989|NCT01085201|363030|P1|NOT COMPLETED|Overall Study||3
149990|NCT01085201|363026|P5|COMPLETED|Overall Study||3
149991|NCT01085201|363027|P4|COMPLETED|Overall Study||6
149992|NCT01085201|363028|P3|COMPLETED|Overall Study||3
149993|NCT01085201|363029|P2|COMPLETED|Overall Study||6
149994|NCT01085201|363030|P1|COMPLETED|Overall Study||15
149995|NCT01085201|363026|P5|STARTED|Overall Study||3
149996|NCT01085201|363027|P4|STARTED|Overall Study||6
149997|NCT01085201|363028|P3|STARTED|Overall Study||5
149998|NCT01085201|363029|P2|STARTED|Overall Study||7
149999|NCT01085201|363030|P1|STARTED|Overall Study||18
150000|NCT01085136|363052|P3|NOT COMPLETED|Part B||26
150001|NCT01085136|363053|P2|NOT COMPLETED|Part B||51
150002|NCT01085136|363054|P1|NOT COMPLETED|Part B||0
150003|NCT01085136|363052|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
150004|NCT01085136|363053|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
150005|NCT01085136|363054|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
150006|NCT01085136|363052|P3|STARTED|Part B||68
150007|NCT01085136|363053|P2|STARTED|Part B||138
150008|NCT01085136|363054|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
150009|NCT01085136|363052|P3|NOT COMPLETED|Part A||0
150010|NCT01085136|363053|P2|NOT COMPLETED|Part A||0
150011|NCT01085136|363054|P1|NOT COMPLETED|Part A||323
150012|NCT01085136|363052|P3|COMPLETED|Part A||0
150013|NCT01085136|363053|P2|COMPLETED|Part A||0
150014|NCT01085136|363054|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
150015|NCT01085136|363052|P3|Randomized to Part B|Part A||0
150016|NCT01085136|363053|P2|Randomized to Part B|Part A||0
150017|NCT01085136|363054|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
150018|NCT01085136|363052|P3|STARTED|Part A||0
150019|NCT01085136|363053|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
150020|NCT01085136|363054|P1|STARTED|Part A||1154
150021|NCT01085045|363070|P1|NOT COMPLETED|Part B||15
150022|NCT01085045|363070|P1|COMPLETED|Part B||89
150023|NCT01085045|363070|P1|GP MDI 36 µg (PT001)|Part B||0
150024|NCT01085045|363070|P1|Foradil 12 µg|Part B||41
150025|NCT01085045|363070|P1|Placebo MDI|Part B||47
150026|NCT01085045|363070|P1|FF MDI 7.2 µg (PT005)|Part B||43
150027|NCT01085045|363070|P1|FF MDI 9.6 µg (PT005)|Part B||43
150028|NCT01085045|363070|P1|Spiriva 18 µg|Part B||0
150029|NCT01085045|363070|P1|GFF MDI 36/9.6 µg|Part B||0
150030|NCT01085045|363070|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
150031|NCT01085045|363070|P1|STARTED|Part B||104
150032|NCT01085045|363070|P1|NOT COMPLETED|Part A||18
150033|NCT01085045|363070|P1|COMPLETED|Part A||104
150034|NCT01085045|363070|P1|Foradil 12 µg|Part A||14
150035|NCT01085045|363070|P1|Placebo MDI|Part A||5
150036|NCT01085045|363070|P1|FF MDI 7.2 µg (PT005)|Part A||21
150037|NCT01085045|363070|P1|FF MDI 9.6 µg (PT005)|Part A||20
150038|NCT01085045|363070|P1|Spiriva 18 µg|Part A||58
150039|NCT01085045|363070|P1|GP MDI 36 µg (PT001)|Part A||40
150040|NCT01085045|363070|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
150041|NCT01085045|363070|P1|GFF MDI 72/9.6mcg|Part A||40
150042|NCT01085045|363070|P1|STARTED|Part A||122
150043|NCT01085006|363172|P2|NOT COMPLETED|Overall Study||0
150044|NCT01085006|363173|P1|NOT COMPLETED|Overall Study||0
150045|NCT01085006|363172|P2|COMPLETED|Overall Study||50
150046|NCT01085006|363173|P1|COMPLETED|Overall Study||50
150047|NCT01085006|363172|P2|STARTED|Overall Study||50
150048|NCT01085006|363173|P1|STARTED|Overall Study||50
150049|NCT01084759|363179|P1|NOT COMPLETED|Overall Study||2
150050|NCT01084759|363179|P1|COMPLETED|Overall Study||14
150051|NCT01084759|363179|P1|STARTED|Overall Study||16
150052|NCT01084707|363185|P1|NOT COMPLETED|Overall Study||6
150053|NCT01084707|363185|P1|COMPLETED|Overall Study||34
150054|NCT01084707|363185|P1|STARTED|Overall Study||40
150055|NCT01084668|363219|P1|NOT COMPLETED|Overall Study||9
150056|NCT01084668|363219|P1|COMPLETED|Overall Study||33
150057|NCT01084668|363219|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
150058|NCT01084603|363228|P1|NOT COMPLETED|Oral Nicotine 4||0
150059|NCT01084603|363228|P1|COMPLETED|Oral Nicotine 4||39
150060|NCT01084603|363228|P1|STARTED|Oral Nicotine 4||39
150061|NCT01084603|363228|P1|NOT COMPLETED|Washout Period 4||1
150062|NCT01084603|363228|P1|COMPLETED|Washout Period 4||39
150063|NCT01084603|363228|P1|STARTED|Washout Period 4||40
150064|NCT01084603|363228|P1|NOT COMPLETED|Oral Nicotine 2||0
150065|NCT01084603|363228|P1|COMPLETED|Oral Nicotine 2||40
150066|NCT01084603|363228|P1|STARTED|Oral Nicotine 2||40
150067|NCT01084603|363228|P1|NOT COMPLETED|Washout Period 3||0
150068|NCT01084603|363228|P1|COMPLETED|Washout Period 3||40
150069|NCT01084603|363228|P1|STARTED|Washout Period 3||40
150070|NCT01084603|363228|P1|NOT COMPLETED|Oral Nicotine 1||1
150071|NCT01084603|363228|P1|COMPLETED|Oral Nicotine 1||40
150072|NCT01084603|363228|P1|STARTED|Oral Nicotine 1||41
150073|NCT01084603|363228|P1|NOT COMPLETED|Washout Period 2||0
150074|NCT01084603|363228|P1|COMPLETED|Washout Period 2||41
150075|NCT01084603|363228|P1|STARTED|Washout Period 2||41
150076|NCT01084603|363228|P1|NOT COMPLETED|Nicorette® Gum||1
150077|NCT01084603|363228|P1|COMPLETED|Nicorette® Gum||41
150078|NCT01084603|363228|P1|STARTED|Nicorette® Gum||42
150079|NCT01084603|363228|P1|NOT COMPLETED|Washout Period 1||0
150080|NCT01084603|363228|P1|COMPLETED|Washout Period 1||42
150081|NCT01084603|363228|P1|STARTED|Washout Period 1||42
150082|NCT01084603|363228|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
150083|NCT01084603|363228|P1|COMPLETED|NiQuitinTM Lozenge||42
150084|NCT01084603|363228|P1|STARTED|NiQuitinTM Lozenge||43
150085|NCT01084603|363228|P1|NOT COMPLETED|Baseline||2
150086|NCT01084603|363228|P1|COMPLETED|Baseline||43
150087|NCT01084603|363228|P1|STARTED|Baseline||45
150088|NCT01084551|363264|P3|NOT COMPLETED|Overall Study||8
150089|NCT01084551|363265|P2|NOT COMPLETED|Overall Study||14
150090|NCT01084551|363266|P1|NOT COMPLETED|Overall Study||9
150091|NCT01084551|363264|P3|COMPLETED|Overall Study||86
150092|NCT01084551|363265|P2|COMPLETED|Overall Study||81
150093|NCT01084551|363266|P1|COMPLETED|Overall Study||86
150094|NCT01084551|363264|P3|STARTED|Overall Study||94
150095|NCT01084551|363265|P2|STARTED|Overall Study||95
150096|NCT01084551|363266|P1|STARTED|Overall Study||95
150097|NCT01084538|363304|P1|NOT COMPLETED|Overall Study||68
150098|NCT01084538|363304|P1|COMPLETED|Overall Study||113
150099|NCT01084538|363304|P1|STARTED|Overall Study||181
150100|NCT01084278|363316|P5|NOT COMPLETED|Overall Study||0
150101|NCT01084278|363317|P4|NOT COMPLETED|Overall Study||0
150102|NCT01084278|363318|P3|NOT COMPLETED|Overall Study||0
150103|NCT01084278|363319|P2|NOT COMPLETED|Overall Study||0
150104|NCT01084278|363320|P1|NOT COMPLETED|Overall Study||0
150105|NCT01084278|363316|P5|COMPLETED|Overall Study||8
150106|NCT01084278|363317|P4|COMPLETED|Overall Study||8
150107|NCT01084278|363318|P3|COMPLETED|Overall Study||8
150108|NCT01084278|363319|P2|COMPLETED|Overall Study||8
150109|NCT01084278|363320|P1|COMPLETED|Overall Study||8
150110|NCT01084278|363316|P5|STARTED|Overall Study||8
150111|NCT01084278|363317|P4|STARTED|Overall Study||8
150112|NCT01084278|363318|P3|STARTED|Overall Study||8
150113|NCT01084278|363319|P2|STARTED|Overall Study||8
150114|NCT01084278|363320|P1|STARTED|Overall Study||8
150115|NCT01084265|363401|P1|NOT COMPLETED|Overall Study||0
150116|NCT01084265|363401|P1|COMPLETED|Overall Study||31
150117|NCT01084265|363401|P1|STARTED|Overall Study||31
150118|NCT01084239|363415|P2|NOT COMPLETED|28-Day Follow-up||9
150119|NCT01084239|363416|P1|NOT COMPLETED|28-Day Follow-up||4
150120|NCT01084239|363415|P2|COMPLETED|28-Day Follow-up||490
150121|NCT01084239|363416|P1|COMPLETED|28-Day Follow-up||497
150122|NCT01084239|363415|P2|STARTED|28-Day Follow-up||499
150123|NCT01084239|363416|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
150124|NCT01084239|363415|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
150125|NCT01084239|363416|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
150126|NCT01084239|363415|P2|COMPLETED|Randomization - Index Hospitalization||499
150127|NCT01084239|363416|P1|COMPLETED|Randomization - Index Hospitalization||501
150128|NCT01084239|363415|P2|STARTED|Randomization - Index Hospitalization||499
150129|NCT01084239|363416|P1|STARTED|Randomization - Index Hospitalization||501
150130|NCT01084174|363434|P2|NOT COMPLETED|Overall Study||4
150131|NCT01084174|363435|P1|NOT COMPLETED|Overall Study||1
150132|NCT01084174|363434|P2|COMPLETED|Overall Study||7
150133|NCT01084174|363435|P1|COMPLETED|Overall Study||9
150134|NCT01084174|363434|P2|STARTED|Overall Study||11
150135|NCT01084174|363435|P1|STARTED|Overall Study||10
150136|NCT01084148|363455|P2|NOT COMPLETED|Overall Study||16
150137|NCT01084148|363456|P1|NOT COMPLETED|Overall Study||30
150138|NCT01084148|363455|P2|COMPLETED|Overall Study||102
150139|NCT01084148|363456|P1|COMPLETED|Overall Study||88
150140|NCT01084148|363455|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
150141|NCT01084148|363456|P1|Treated Patients|Overall Study||118
150142|NCT01084148|363455|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
150143|NCT01084148|363456|P1|STARTED|Overall Study||118
150144|NCT01084135|363468|P2|NOT COMPLETED|20 Week||1
150145|NCT01084135|363469|P1|NOT COMPLETED|20 Week||0
150146|NCT01084135|363468|P2|COMPLETED|20 Week||10
150147|NCT01084135|363469|P1|COMPLETED|20 Week||12
150148|NCT01084135|363468|P2|STARTED|20 Week||11
150149|NCT01084135|363469|P1|STARTED|20 Week||12
150150|NCT01084135|363468|P2|NOT COMPLETED|12 Week||0
150151|NCT01084135|363469|P1|NOT COMPLETED|12 Week||0
150152|NCT01084135|363468|P2|COMPLETED|12 Week||4
150153|NCT01084135|363469|P1|COMPLETED|12 Week||4
150154|NCT01084135|363468|P2|STARTED|12 Week||4
150155|NCT01084135|363469|P1|STARTED|12 Week||4
150156|NCT01084083|363479|P1|NOT COMPLETED|Overall Study||12
150157|NCT01084083|363479|P1|COMPLETED|Overall Study||78
150158|NCT01084083|363479|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
150159|NCT01084083|363479|P1|CR to Induction Therapy|Overall Study||56
150160|NCT01084083|363479|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
150161|NCT01084083|363479|P1|Eligible|Overall Study||81
150162|NCT01084083|363479|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
150163|NCT01084083|363479|P1|STARTED|Overall Study||90
150164|NCT01084005|363487|P2|NOT COMPLETED|Overall Study||16
150165|NCT01084005|363488|P1|NOT COMPLETED|Overall Study||5
150166|NCT01084005|363487|P2|COMPLETED|Overall Study||146
150167|NCT01084005|363488|P1|COMPLETED|Overall Study||74
150168|NCT01084005|363487|P2|STARTED|Overall Study||162
150169|NCT01084005|363488|P1|STARTED|Overall Study||79
150170|NCT01083979|363516|P1|NOT COMPLETED|Overall Study||0
150171|NCT01083979|363516|P1|COMPLETED|Overall Study||1
150172|NCT01083979|363516|P1|STARTED|Overall Study||1
150173|NCT01083901|363524|P3|NOT COMPLETED|Overall Study||2
150174|NCT01083901|363525|P2|NOT COMPLETED|Overall Study||2
150175|NCT01083901|363526|P1|NOT COMPLETED|Overall Study||1
150176|NCT01083901|363524|P3|COMPLETED|Overall Study||11
150177|NCT01083901|363525|P2|COMPLETED|Overall Study||6
150178|NCT01083901|363526|P1|COMPLETED|Overall Study||12
150179|NCT01083901|363524|P3|STARTED|Overall Study||13
150180|NCT01083901|363525|P2|STARTED|Overall Study||8
150181|NCT01083901|363526|P1|STARTED|Overall Study||13
150182|NCT01083849|363545|P2|NOT COMPLETED|Overall Study||111
150183|NCT01083849|363546|P1|NOT COMPLETED|Overall Study||60
150184|NCT01083849|363545|P2|COMPLETED|Overall Study||527
150185|NCT01083849|363546|P1|COMPLETED|Overall Study||61
150186|NCT01083849|363545|P2|STARTED|Overall Study||638
150187|NCT01083849|363546|P1|STARTED|Overall Study||121
150188|NCT01083810|363569|P3|NOT COMPLETED|Overall Study||20
150189|NCT01083810|363570|P2|NOT COMPLETED|Overall Study||45
150190|NCT01083810|363571|P1|NOT COMPLETED|Overall Study||65
150191|NCT01083810|363569|P3|COMPLETED|Overall Study||35
150192|NCT01083810|363570|P2|COMPLETED|Overall Study||47
150193|NCT01083810|363571|P1|COMPLETED|Overall Study||72
150194|NCT01083810|363569|P3|STARTED|Overall Study||55
150195|NCT01083810|363570|P2|STARTED|Overall Study||92
150196|NCT01083810|363571|P1|STARTED|Overall Study||137
150197|NCT01083771|363592|P1|NOT COMPLETED|Overall Study||5
150198|NCT01083771|363592|P1|COMPLETED|Overall Study||16
150199|NCT01083771|363592|P1|STARTED|Overall Study||21
150200|NCT01083758|363597|P1|NOT COMPLETED|Overall Study||2
150201|NCT01083758|363597|P1|COMPLETED|Overall Study||29
150202|NCT01083758|363597|P1|STARTED|Overall Study||31
150203|NCT01083732|363631|P3|NOT COMPLETED|Overall Study||0
150204|NCT01083732|363632|P2|NOT COMPLETED|Overall Study||0
150205|NCT01083732|363633|P1|NOT COMPLETED|Overall Study||0
150206|NCT01083732|363631|P3|COMPLETED|Overall Study||3
150207|NCT01083732|363632|P2|COMPLETED|Overall Study||9
150208|NCT01083732|363633|P1|COMPLETED|Overall Study||6
150209|NCT01083732|363631|P3|STARTED|Overall Study||3
150210|NCT01083732|363632|P2|STARTED|Overall Study||9
150211|NCT01083732|363633|P1|STARTED|Overall Study||6
150212|NCT01083706|363684|P1|NOT COMPLETED|Overall Study||0
150213|NCT01083706|363684|P1|COMPLETED|Overall Study||39
150214|NCT01083706|363684|P1|STARTED|Overall Study||39
150215|NCT01083693|363693|P3|NOT COMPLETED|Overall Study||7
150216|NCT01083693|363694|P2|NOT COMPLETED|Overall Study||6
150217|NCT01083693|363695|P1|NOT COMPLETED|Overall Study||20
150218|NCT01083693|363693|P3|COMPLETED|Overall Study||33
150219|NCT01083693|363694|P2|COMPLETED|Overall Study||22
150220|NCT01083693|363695|P1|COMPLETED|Overall Study||73
150221|NCT01083693|363693|P3|STARTED|Overall Study||40
150222|NCT01083693|363694|P2|STARTED|Overall Study||28
150223|NCT01083693|363695|P1|STARTED|Overall Study||93
150224|NCT01083680|363730|P1|NOT COMPLETED|Overall Study||3844
150225|NCT01083680|363730|P1|COMPLETED|Overall Study||263
150226|NCT01083680|363730|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
150227|NCT01083680|363730|P1|STARTED|Overall Study||4107
150228|NCT01083667|363739|P1|NOT COMPLETED|Overall Study||10
150229|NCT01083667|363739|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
150230|NCT01083667|363739|P1|STARTED|Overall Study|enrolled|32
150231|NCT01083654|363746|P2|NOT COMPLETED|Overall Study||0
150232|NCT01083654|363747|P1|NOT COMPLETED|Overall Study||0
150233|NCT01083654|363746|P2|COMPLETED|Overall Study||50
150234|NCT01083654|363747|P1|COMPLETED|Overall Study||53
150235|NCT01083654|363746|P2|STARTED|Overall Study||50
150236|NCT01083654|363747|P1|STARTED|Overall Study||53
150237|NCT01083641|363753|P1|NOT COMPLETED|Overall Study||2
150238|NCT01083641|363753|P1|COMPLETED|Overall Study||15
150239|NCT01083641|363753|P1|STARTED|Overall Study||17
150240|NCT01083602|363760|P1|NOT COMPLETED|Overall Study||55
150241|NCT01083602|363760|P1|COMPLETED|Overall Study||0
150242|NCT01083602|363760|P1|STARTED|Overall Study||55
150243|NCT01083576|363771|P2|NOT COMPLETED|Overall Study||1
150244|NCT01083576|363772|P1|NOT COMPLETED|Overall Study||6
150245|NCT01083576|363771|P2|COMPLETED|Overall Study||14
150246|NCT01083576|363772|P1|COMPLETED|Overall Study||9
150247|NCT01083576|363771|P2|STARTED|Overall Study||15
150248|NCT01083576|363772|P1|STARTED|Overall Study||15
150249|NCT01083485|363802|P2|NOT COMPLETED|Overall Study||3
150250|NCT01083485|363803|P1|NOT COMPLETED|Overall Study||7
150251|NCT01083485|363802|P2|COMPLETED|Overall Study||64
150252|NCT01083485|363803|P1|COMPLETED|Overall Study||63
150253|NCT01083485|363802|P2|STARTED|Overall Study||67
150254|NCT01083485|363803|P1|STARTED|Overall Study||70
150255|NCT01083472|363813|P2|NOT COMPLETED|Overall Study||0
150256|NCT01083472|363814|P1|NOT COMPLETED|Overall Study||0
150257|NCT01083472|363813|P2|COMPLETED|Overall Study||19
150258|NCT01083472|363814|P1|COMPLETED|Overall Study||18
150259|NCT01083472|363813|P2|STARTED|Overall Study||19
150260|NCT01083472|363814|P1|STARTED|Overall Study||18
150261|NCT01083316|363820|P1|NOT COMPLETED|Overall Study||3
150262|NCT01083316|363820|P1|COMPLETED|Overall Study||32
150263|NCT01083316|363820|P1|STARTED|Overall Study||35
150264|NCT01083199|363826|P1|NOT COMPLETED|Overall Study||0
150265|NCT01083199|363826|P1|COMPLETED|Overall Study||10
150266|NCT01083199|363826|P1|STARTED|Overall Study||10
150267|NCT01083186|363831|P1|NOT COMPLETED|Overall Study||94
150268|NCT01083186|363831|P1|COMPLETED|Overall Study||406
150269|NCT01083186|363831|P1|STARTED|Overall Study||500
150270|NCT01083173|363872|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
150271|NCT01083173|363873|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
150272|NCT01083173|363872|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
150273|NCT01083173|363873|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
150274|NCT01083173|363872|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
150275|NCT01083173|363873|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
150276|NCT01083173|363872|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
150277|NCT01083173|363873|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
150278|NCT01083173|363872|P2|COMPLETED|Long-term Surveillance: Safety Group||479
150279|NCT01083173|363873|P1|COMPLETED|Long-term Surveillance: Safety Group||0
150280|NCT01083173|363872|P2|STARTED|Long-term Surveillance: Safety Group||595
150281|NCT01083173|363873|P1|STARTED|Long-term Surveillance: Safety Group||0
150282|NCT01083173|363872|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
150283|NCT01083173|363873|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
150284|NCT01083173|363872|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
150285|NCT01083173|363873|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
150286|NCT01083173|363872|P2|STARTED|Main Surveillance: Effectiveness Group||0
150287|NCT01083173|363873|P1|STARTED|Main Surveillance: Effectiveness Group||580
150288|NCT01083173|363872|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
150289|NCT01083173|363873|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
150290|NCT01083173|363872|P2|COMPLETED|Main Surveillance: Safety Group||0
150291|NCT01083173|363873|P1|COMPLETED|Main Surveillance: Safety Group||580
150292|NCT01083173|363872|P2|STARTED|Main Surveillance: Safety Group||0
150293|NCT01083173|363873|P1|STARTED|Main Surveillance: Safety Group||595
150294|NCT01083160|363891|P1|NOT COMPLETED|Overall Study||1
150295|NCT01083160|363891|P1|COMPLETED|Overall Study||81
150296|NCT01083160|363891|P1|Evaluable Population|Overall Study||71
150297|NCT01083160|363891|P1|STARTED|Overall Study||82
150298|NCT01083121|363898|P1|NOT COMPLETED|Overall Study||81
150299|NCT01083121|363898|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
150300|NCT01083121|363898|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
150301|NCT01082965|363908|P2|NOT COMPLETED|Overall Study||2
150302|NCT01082965|363909|P1|NOT COMPLETED|Overall Study||1
150303|NCT01082965|363908|P2|COMPLETED|Overall Study||6
150304|NCT01082965|363909|P1|COMPLETED|Overall Study||9
150305|NCT01082965|363908|P2|STARTED|Overall Study||8
150306|NCT01082965|363909|P1|STARTED|Overall Study||10
150307|NCT01082952|363929|P2|NOT COMPLETED|Overall Study||0
150308|NCT01082952|363930|P1|NOT COMPLETED|Overall Study||0
150309|NCT01082952|363929|P2|COMPLETED|Overall Study||6
150310|NCT01082952|363930|P1|COMPLETED|Overall Study||6
150311|NCT01082952|363929|P2|STARTED|Overall Study||6
150312|NCT01082952|363930|P1|STARTED|Overall Study||6
150313|NCT01082939|363938|P1|NOT COMPLETED|Overall Study||0
150314|NCT01082939|363938|P1|COMPLETED|Overall Study||80
150315|NCT01082939|363938|P1|STARTED|Overall Study||80
150316|NCT01082874|363946|P4|NOT COMPLETED|Overall Study||13
150317|NCT01082874|363947|P3|NOT COMPLETED|Overall Study||11
150318|NCT01082874|363948|P2|NOT COMPLETED|Overall Study||12
150319|NCT01082874|363949|P1|NOT COMPLETED|Overall Study||11
150320|NCT01082874|363946|P4|COMPLETED|Overall Study||2489
150321|NCT01082874|363947|P3|COMPLETED|Overall Study||2488
150322|NCT01082874|363948|P2|COMPLETED|Overall Study||2498
150323|NCT01082874|363949|P1|COMPLETED|Overall Study||2488
150324|NCT01082874|363946|P4|STARTED|Overall Study||2502
150325|NCT01082874|363947|P3|STARTED|Overall Study||2499
150326|NCT01082874|363948|P2|STARTED|Overall Study||2510
150327|NCT01082874|363949|P1|STARTED|Overall Study||2499
150328|NCT01082640|363962|P3|NOT COMPLETED|Overall Study||8
150329|NCT01082640|363963|P2|NOT COMPLETED|Overall Study||15
150330|NCT01082640|363964|P1|NOT COMPLETED|Overall Study||17
150331|NCT01082640|363962|P3|COMPLETED|Overall Study||24
150332|NCT01082640|363963|P2|COMPLETED|Overall Study||17
150333|NCT01082640|363964|P1|COMPLETED|Overall Study||15
150334|NCT01082640|363962|P3|STARTED|Overall Study||32
150335|NCT01082640|363963|P2|STARTED|Overall Study||32
150336|NCT01082640|363964|P1|STARTED|Overall Study||32
150337|NCT01082614|363986|P2|NOT COMPLETED|Overall Study||5
150338|NCT01082614|363987|P1|NOT COMPLETED|Overall Study||3
150339|NCT01082614|363986|P2|COMPLETED|Overall Study||18
150340|NCT01082614|363987|P1|COMPLETED|Overall Study||20
150341|NCT01082614|363986|P2|STARTED|Overall Study||23
150342|NCT01082614|363987|P1|STARTED|Overall Study||23
150343|NCT01082588|363999|P2|NOT COMPLETED|Overall Study||5
150344|NCT01082588|364000|P1|NOT COMPLETED|Overall Study||6
150345|NCT01082588|363999|P2|COMPLETED|Overall Study||25
150346|NCT01082588|364000|P1|COMPLETED|Overall Study||24
150347|NCT01082588|363999|P2|STARTED|Overall Study||30
150348|NCT01082588|364000|P1|STARTED|Overall Study||30
150349|NCT01082575|364018|P1|NOT COMPLETED|Overall Study||0
150350|NCT01082575|364018|P1|COMPLETED|Overall Study||100
150351|NCT01082575|364018|P1|STARTED|Overall Study||100
150352|NCT01082380|364023|P1|NOT COMPLETED|Overall Study||0
150353|NCT01082380|364023|P1|COMPLETED|Overall Study||6
150354|NCT01082380|364023|P1|STARTED|Overall Study||6
150355|NCT01082367|364058|P2|NOT COMPLETED|Follow-up (F-U) Period||1
150356|NCT01082367|364059|P1|NOT COMPLETED|Follow-up (F-U) Period||2
150357|NCT01082367|364058|P2|COMPLETED|Follow-up (F-U) Period||9
150358|NCT01082367|364059|P1|COMPLETED|Follow-up (F-U) Period||17
150359|NCT01082367|364058|P2|Treated in F-U|Follow-up (F-U) Period||5
150360|NCT01082367|364059|P1|Treated in F-U|Follow-up (F-U) Period||5
150361|NCT01082367|364058|P2|STARTED|Follow-up (F-U) Period||10
150362|NCT01082367|364059|P1|STARTED|Follow-up (F-U) Period||19
150363|NCT01082367|364058|P2|NOT COMPLETED|Double-blind Period||13
150364|NCT01082367|364059|P1|NOT COMPLETED|Double-blind Period||5
150365|NCT01082367|364058|P2|COMPLETED|Double-blind Period||12
150366|NCT01082367|364059|P1|COMPLETED|Double-blind Period||21
150367|NCT01082367|364058|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
150368|NCT01082367|364059|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
150369|NCT01082367|364058|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
150370|NCT01082367|364059|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
150371|NCT01082367|364058|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
150372|NCT01082367|364059|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
150373|NCT01082367|364058|P2|Entered OL TOBI|Double-blind Period||18
150374|NCT01082367|364059|P1|Entered OL TOBI|Double-blind Period||4
150375|NCT01082367|364058|P2|Stage 2:no tx|Double-blind Period||0
150376|NCT01082367|364059|P1|Stage 2:no tx|Double-blind Period||0
150377|NCT01082367|364058|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
150378|NCT01082367|364059|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
150379|NCT01082367|364058|P2|STARTED|Double-blind Period||25
150380|NCT01082367|364059|P1|STARTED|Double-blind Period||26
150381|NCT01082328|364073|P1|NOT COMPLETED|Overall Study||1
150382|NCT01082328|364073|P1|COMPLETED|Overall Study||58
150383|NCT01082328|364073|P1|STARTED|Overall Study||59
150384|NCT01082211|364082|P1|NOT COMPLETED|Overall Study||7
150385|NCT01082211|364082|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
150386|NCT01082211|364082|P1|STARTED|Overall Study||65
150387|NCT01082159|364093|P1|NOT COMPLETED|Overall Study||9
150388|NCT01082159|364093|P1|COMPLETED|Overall Study||46
150389|NCT01082159|364093|P1|STARTED|Overall Study||55
150390|NCT01082081|364102|P3|NOT COMPLETED|Overall Study||2
150391|NCT01082081|364103|P2|NOT COMPLETED|Overall Study||1
150392|NCT01082081|364104|P1|NOT COMPLETED|Overall Study||0
150393|NCT01082081|364102|P3|COMPLETED|Overall Study||58
150394|NCT01082081|364103|P2|COMPLETED|Overall Study||118
150395|NCT01082081|364104|P1|COMPLETED|Overall Study||121
150396|NCT01082081|364102|P3|STARTED|Overall Study||60
150397|NCT01082081|364103|P2|STARTED|Overall Study||119
150398|NCT01082081|364104|P1|STARTED|Overall Study||121
150399|NCT01081951|364156|P2|NOT COMPLETED|Overall Study||55
150400|NCT01081951|364157|P1|NOT COMPLETED|Overall Study||56
150401|NCT01081951|364156|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
150402|NCT01081951|364157|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
150403|NCT01081951|364156|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
150404|NCT01081951|364157|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
150405|NCT01081951|364156|P2|Entered Maintenance Phase|Overall Study||55
150406|NCT01081951|364157|P1|Entered Maintenance Phase|Overall Study||66
150407|NCT01081951|364156|P2|Received Study Treatment|Overall Study||75
150408|NCT01081951|364157|P1|Received Study Treatment|Overall Study||81
150409|NCT01081951|364156|P2|STARTED|Overall Study||81
150410|NCT01081951|364157|P1|STARTED|Overall Study||81
150411|NCT01081912|364167|P3|NOT COMPLETED|Maintenance Treatment||92
150412|NCT01081912|364168|P2|NOT COMPLETED|Maintenance Treatment||27
150413|NCT01081912|364169|P1|NOT COMPLETED|Maintenance Treatment||0
150414|NCT01081912|364167|P3|COMPLETED|Maintenance Treatment||59
150415|NCT01081912|364168|P2|COMPLETED|Maintenance Treatment||124
150416|NCT01081912|364169|P1|COMPLETED|Maintenance Treatment||0
150417|NCT01081912|364167|P3|STARTED|Maintenance Treatment||151
150418|NCT01081912|364168|P2|STARTED|Maintenance Treatment||151
150419|NCT01081912|364169|P1|STARTED|Maintenance Treatment||0
150420|NCT01081912|364167|P3|NOT COMPLETED|Conversion/Titration||0
150421|NCT01081912|364168|P2|NOT COMPLETED|Conversion/Titration||0
150422|NCT01081912|364169|P1|NOT COMPLETED|Conversion/Titration||208
150423|NCT01081912|364167|P3|COMPLETED|Conversion/Titration||0
150424|NCT01081912|364168|P2|COMPLETED|Conversion/Titration||0
150425|NCT01081912|364169|P1|COMPLETED|Conversion/Titration||302
150426|NCT01081912|364167|P3|STARTED|Conversion/Titration||0
150427|NCT01081912|364168|P2|STARTED|Conversion/Titration||0
150428|NCT01081912|364169|P1|STARTED|Conversion/Titration||510
150429|NCT01081886|364178|P2|NOT COMPLETED|Overall Study||13
150430|NCT01081886|364179|P1|NOT COMPLETED|Overall Study||11
150431|NCT01081886|364178|P2|COMPLETED|Overall Study||0
150432|NCT01081886|364179|P1|COMPLETED|Overall Study||0
150433|NCT01081886|364178|P2|STARTED|Overall Study||13
150434|NCT01081886|364179|P1|STARTED|Overall Study||11
150435|NCT01081873|364187|P1|NOT COMPLETED|Overall Study||298
150436|NCT01081873|364187|P1|COMPLETED|Overall Study||2416
150437|NCT01081873|364187|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
150438|NCT01081834|364259|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
150439|NCT01081834|364260|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
150440|NCT01081834|364261|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
150441|NCT01081834|364262|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
150442|NCT01081834|364263|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
150443|NCT01081834|364259|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
150444|NCT01081834|364260|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
150445|NCT01081834|364261|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
150446|NCT01081834|364262|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
150447|NCT01081834|364263|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
150448|NCT01081834|364259|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
150449|NCT01081834|364260|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
150450|NCT01081834|364261|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
150451|NCT01081834|364262|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
150452|NCT01081834|364263|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
150453|NCT01081834|364259|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
150454|NCT01081834|364260|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
150455|NCT01081834|364261|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
150456|NCT01081834|364262|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
150457|NCT01081834|364263|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
150458|NCT01081834|364259|P5|COMPLETED|Core Period: Baseline to Week 26||40
150459|NCT01081834|364260|P4|COMPLETED|Core Period: Baseline to Week 26||40
150460|NCT01081834|364261|P3|COMPLETED|Core Period: Baseline to Week 26||175
150461|NCT01081834|364262|P2|COMPLETED|Core Period: Baseline to Week 26||172
150462|NCT01081834|364263|P1|COMPLETED|Core Period: Baseline to Week 26||160
150463|NCT01081834|364259|P5|STARTED|Core Period: Baseline to Week 26||44
150464|NCT01081834|364260|P4|STARTED|Core Period: Baseline to Week 26||47
150465|NCT01081834|364261|P3|STARTED|Core Period: Baseline to Week 26||197
150466|NCT01081834|364262|P2|STARTED|Core Period: Baseline to Week 26||195
150467|NCT01081834|364263|P1|STARTED|Core Period: Baseline to Week 26||192
150468|NCT01081795|364324|P3|NOT COMPLETED|Overall Study||30
150469|NCT01081795|364325|P2|NOT COMPLETED|Overall Study||35
150470|NCT01081795|364326|P1|NOT COMPLETED|Overall Study||33
150471|NCT01081795|364324|P3|COMPLETED|Overall Study||97
150472|NCT01081795|364325|P2|COMPLETED|Overall Study||95
150473|NCT01081795|364326|P1|COMPLETED|Overall Study||97
150474|NCT01081795|364324|P3|STARTED|Overall Study||127
150475|NCT01081795|364325|P2|STARTED|Overall Study||130
150476|NCT01081795|364326|P1|STARTED|Overall Study||130
150477|NCT01081769|364363|P2|NOT COMPLETED|CORE Intent-To-Treat||97
150478|NCT01081769|364364|P1|NOT COMPLETED|CORE Intent-To-Treat||80
150479|NCT01081769|364363|P2|COMPLETED|CORE Intent-To-Treat||266
150480|NCT01081769|364364|P1|COMPLETED|CORE Intent-To-Treat||272
150481|NCT01081769|364363|P2|STARTED|CORE Intent-To-Treat||363
150482|NCT01081769|364364|P1|STARTED|CORE Intent-To-Treat||352
150483|NCT01081769|364363|P2|NOT COMPLETED|Whole Intent-to-Treat||25
150484|NCT01081769|364364|P1|NOT COMPLETED|Whole Intent-to-Treat||24
150485|NCT01081769|364363|P2|COMPLETED|Whole Intent-to-Treat||363
150486|NCT01081769|364364|P1|COMPLETED|Whole Intent-to-Treat||352
150487|NCT01081769|364363|P2|STARTED|Whole Intent-to-Treat||388
150488|NCT01081769|364364|P1|STARTED|Whole Intent-to-Treat||376
150489|NCT01081665|364398|P1|NOT COMPLETED|Overall Study||95
150490|NCT01081665|364398|P1|COMPLETED|Overall Study||142
150491|NCT01081665|364398|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
150492|NCT01081665|364398|P1|Full Analysis Set|Overall Study||237
150493|NCT01081665|364398|P1|STARTED|Overall Study||237
150494|NCT01081626|364410|P2|NOT COMPLETED|Overall Study||61
150495|NCT01081626|364411|P1|NOT COMPLETED|Overall Study||60
150496|NCT01081626|364410|P2|COMPLETED|Overall Study||94
150497|NCT01081626|364411|P1|COMPLETED|Overall Study||95
150498|NCT01081626|364410|P2|Assessed for Efficacy|Overall Study||125
150499|NCT01081626|364411|P1|Assessed for Efficacy|Overall Study||122
150500|NCT01081626|364410|P2|STARTED|Overall Study||155
150501|NCT01081626|364411|P1|STARTED|Overall Study||155
150502|NCT01081301|364437|P1|NOT COMPLETED|Overall Study||14
150503|NCT01081301|364437|P1|COMPLETED|Overall Study||22
150504|NCT01081301|364437|P1|STARTED|Overall Study||36
150505|NCT01081249|364475|P2|NOT COMPLETED|Overall Study||1
150506|NCT01081249|364476|P1|NOT COMPLETED|Overall Study||0
150507|NCT01081249|364475|P2|COMPLETED|Overall Study||6
150508|NCT01081249|364476|P1|COMPLETED|Overall Study||11
150509|NCT01081249|364475|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
150510|NCT01081249|364476|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
150511|NCT01081249|364475|P2|Washout (5-10 Days)|Overall Study||6
150512|NCT01081249|364476|P1|Washout (5-10 Days)|Overall Study||11
150513|NCT01081249|364475|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
150514|NCT01081249|364476|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
150515|NCT01081249|364475|P2|STARTED|Overall Study||7
150516|NCT01081249|364476|P1|STARTED|Overall Study||11
150517|NCT01081145|364482|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
150518|NCT01081145|364483|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
150519|NCT01081145|364482|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
150520|NCT01081145|364483|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
150521|NCT01081145|364482|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
150522|NCT01081145|364483|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
150523|NCT01081145|364482|P2|NOT COMPLETED|Open-Label Phase||0
150524|NCT01081145|364483|P1|NOT COMPLETED|Open-Label Phase||212
150525|NCT01081145|364482|P2|COMPLETED|Open-Label Phase||0
150526|NCT01081145|364483|P1|COMPLETED|Open-Label Phase||316
150527|NCT01081145|364482|P2|STARTED|Open-Label Phase||0
150528|NCT01081145|364483|P1|STARTED|Open-Label Phase||528
150529|NCT01081132|364511|P2|NOT COMPLETED|Overall Study||52
150530|NCT01081132|364512|P1|NOT COMPLETED|Overall Study||55
150531|NCT01081132|364511|P2|COMPLETED|Overall Study||105
150532|NCT01081132|364512|P1|COMPLETED|Overall Study||102
150533|NCT01081132|364511|P2|STARTED|Overall Study||157
150534|NCT01081132|364512|P1|STARTED|Overall Study||157
150535|NCT01081041|364553|P3|NOT COMPLETED|Overall Study||2
150536|NCT01081041|364554|P2|NOT COMPLETED|Overall Study||4
150537|NCT01081041|364555|P1|NOT COMPLETED|Overall Study||0
150538|NCT01081041|364553|P3|COMPLETED|Overall Study||71
150539|NCT01081041|364554|P2|COMPLETED|Overall Study||77
150540|NCT01081041|364555|P1|COMPLETED|Overall Study||33
150541|NCT01081041|364553|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
150542|NCT01081041|364554|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
150543|NCT01081041|364555|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
150544|NCT01081041|364553|P3|STARTED|Overall Study||73
150545|NCT01081041|364554|P2|STARTED|Overall Study||81
150546|NCT01081041|364555|P1|STARTED|Overall Study||33
150547|NCT01080976|364585|P2|NOT COMPLETED|Overall Study||0
150548|NCT01080976|364586|P1|NOT COMPLETED|Overall Study||0
150549|NCT01080976|364585|P2|COMPLETED|Overall Study||5
150550|NCT01080976|364586|P1|COMPLETED|Overall Study||5
150551|NCT01080976|364585|P2|STARTED|Overall Study||5
150552|NCT01080976|364586|P1|STARTED|Overall Study||5
150553|NCT01080807|364596|P2|NOT COMPLETED|Overall Study||23
150554|NCT01080807|364597|P1|NOT COMPLETED|Overall Study||35
150555|NCT01080807|364596|P2|COMPLETED|Overall Study||167
150556|NCT01080807|364597|P1|COMPLETED|Overall Study||158
150557|NCT01080807|364596|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
150558|NCT01080807|364597|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
150559|NCT01080794|364655|P4|NOT COMPLETED|Overall Study||2
150560|NCT01080794|364656|P3|NOT COMPLETED|Overall Study||2
150561|NCT01080794|364657|P2|NOT COMPLETED|Overall Study||2
150562|NCT01080794|364658|P1|NOT COMPLETED|Overall Study||5
150563|NCT01080794|364655|P4|COMPLETED|Overall Study||13
150564|NCT01080794|364656|P3|COMPLETED|Overall Study||10
150565|NCT01080794|364657|P2|COMPLETED|Overall Study||12
150566|NCT01080794|364658|P1|COMPLETED|Overall Study||15
150567|NCT01080794|364655|P4|STARTED|Overall Study||15
150568|NCT01080794|364656|P3|STARTED|Overall Study||12
150569|NCT01080794|364657|P2|STARTED|Overall Study||14
150570|NCT01080794|364658|P1|STARTED|Overall Study||20
150571|NCT01080768|364706|P2|NOT COMPLETED|Overall Study||1
150572|NCT01080768|364707|P1|NOT COMPLETED|Overall Study||2
150573|NCT01080768|364706|P2|COMPLETED|Overall Study||16
150574|NCT01080768|364707|P1|COMPLETED|Overall Study||12
150575|NCT01080768|364706|P2|STARTED|Overall Study||17
150576|NCT01080768|364707|P1|STARTED|Overall Study||14
150577|NCT01080677|364716|P3|NOT COMPLETED|Overall Study||0
150578|NCT01080677|364717|P2|NOT COMPLETED|Overall Study||0
150579|NCT01080677|364718|P1|NOT COMPLETED|Overall Study||0
150580|NCT01080677|364716|P3|COMPLETED|Overall Study||20
150581|NCT01080677|364717|P2|COMPLETED|Overall Study||20
150582|NCT01080677|364718|P1|COMPLETED|Overall Study||20
150583|NCT01080677|364716|P3|STARTED|Overall Study||20
150584|NCT01080677|364717|P2|STARTED|Overall Study||20
150585|NCT01080677|364718|P1|STARTED|Overall Study||20
150586|NCT01080625|364738|P3|NOT COMPLETED|Overall Study||1
150587|NCT01080625|364739|P2|NOT COMPLETED|Overall Study||2
150588|NCT01080625|364740|P1|NOT COMPLETED|Overall Study||0
150589|NCT01080625|364738|P3|COMPLETED|Overall Study||31
150590|NCT01080625|364739|P2|COMPLETED|Overall Study||31
150591|NCT01080625|364740|P1|COMPLETED|Overall Study||31
150592|NCT01080625|364738|P3|STARTED|Overall Study||32
150593|NCT01080625|364739|P2|STARTED|Overall Study||33
150594|NCT01080625|364740|P1|STARTED|Overall Study||31
150595|NCT01080391|364750|P2|NOT COMPLETED|Overall Study||13
150596|NCT01080391|364751|P1|NOT COMPLETED|Overall Study||23
150597|NCT01080391|364750|P2|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|383
150598|NCT01080391|364751|P1|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|373
150599|NCT01080391|364750|P2|Treated|Overall Study||392
150600|NCT01080391|364751|P1|Treated|Overall Study||389
150601|NCT01080391|364750|P2|STARTED|Overall Study||396
150602|NCT01080391|364751|P1|STARTED|Overall Study||396
150603|NCT01080326|364769|P1|NOT COMPLETED|Overall Study||4
150604|NCT01080326|364769|P1|COMPLETED|Overall Study||3
150605|NCT01080326|364769|P1|STARTED|Overall Study||7
150606|NCT01080300|364775|P2|NOT COMPLETED|Overall Study||104
150607|NCT01080300|364776|P1|NOT COMPLETED|Overall Study||94
150608|NCT01080300|364775|P2|COMPLETED|Overall Study||191
150609|NCT01080300|364776|P1|COMPLETED|Overall Study||206
150610|NCT01080300|364775|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
150611|NCT01080300|364776|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
150612|NCT01080261|364784|P1|NOT COMPLETED|Overall Study||0
150613|NCT01080261|364784|P1|COMPLETED|Overall Study||60
150614|NCT01080261|364784|P1|STARTED|Overall Study||60
150615|NCT01080248|364799|P1|NOT COMPLETED|Overall Study||0
150616|NCT01080248|364799|P1|COMPLETED|Overall Study||2
150617|NCT01080248|364799|P1|STARTED|Overall Study||2
150618|NCT01080209|364813|P7|NOT COMPLETED|Overall Study||7
150619|NCT01080209|364814|P6|NOT COMPLETED|Overall Study||0
150620|NCT01080209|364815|P5|NOT COMPLETED|Overall Study||0
150621|NCT01080209|364816|P4|NOT COMPLETED|Overall Study||5
150622|NCT01080209|364817|P3|NOT COMPLETED|Overall Study||5
150623|NCT01080209|364818|P2|NOT COMPLETED|Overall Study||11
150624|NCT01080209|364819|P1|NOT COMPLETED|Overall Study||6
150625|NCT01080209|364813|P7|COMPLETED|Overall Study||44
150626|NCT01080209|364814|P6|COMPLETED|Overall Study||2
150627|NCT01080209|364815|P5|COMPLETED|Overall Study||6
150628|NCT01080209|364816|P4|COMPLETED|Overall Study||37
150629|NCT01080209|364817|P3|COMPLETED|Overall Study||28
150630|NCT01080209|364818|P2|COMPLETED|Overall Study||42
150631|NCT01080209|364819|P1|COMPLETED|Overall Study||22
150632|NCT01080209|364813|P7|STARTED|Overall Study||51
150633|NCT01080209|364814|P6|STARTED|Overall Study||2
150634|NCT01080209|364815|P5|STARTED|Overall Study||6
150635|NCT01080209|364816|P4|STARTED|Overall Study||42
150636|NCT01080209|364817|P3|STARTED|Overall Study||33
150637|NCT01080209|364818|P2|STARTED|Overall Study||53
150638|NCT01080209|364819|P1|STARTED|Overall Study||28
150639|NCT01080196|364844|P2|NOT COMPLETED|Overall Study||0
150640|NCT01080196|364845|P1|NOT COMPLETED|Overall Study||0
150641|NCT01080196|364844|P2|COMPLETED|Overall Study||66
150642|NCT01080196|364845|P1|COMPLETED|Overall Study||68
150643|NCT01080196|364844|P2|STARTED|Overall Study||66
150644|NCT01080196|364845|P1|STARTED|Overall Study||68
150645|NCT01080131|364861|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
150646|NCT01080131|364862|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
150647|NCT01080131|364861|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
150648|NCT01080131|364862|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
150649|NCT01080131|364861|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
150650|NCT01080131|364862|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
150651|NCT01080131|364861|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
150652|NCT01080131|364862|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
150653|NCT01080131|364861|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
150654|NCT01080131|364862|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
150655|NCT01080131|364861|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
150656|NCT01080131|364862|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
150657|NCT01080131|364861|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
150658|NCT01080131|364862|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
150659|NCT01080131|364861|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
150660|NCT01080131|364862|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
150661|NCT01080131|364861|P2|COMPLETED|Core Study (0- 12 Weeks)||103
150662|NCT01080131|364862|P1|COMPLETED|Core Study (0- 12 Weeks)||99
150663|NCT01080131|364861|P2|STARTED|Core Study (0- 12 Weeks)||114
150664|NCT01080131|364862|P1|STARTED|Core Study (0- 12 Weeks)||112
150665|NCT01080118|364941|P4|NOT COMPLETED|Overall Study||0
150666|NCT01080118|364942|P3|NOT COMPLETED|Overall Study||0
150667|NCT01080118|364943|P2|NOT COMPLETED|Overall Study||0
150668|NCT01080118|364944|P1|NOT COMPLETED|Overall Study||0
150669|NCT01080118|364941|P4|COMPLETED|Overall Study||30
150670|NCT01080118|364942|P3|COMPLETED|Overall Study||30
150671|NCT01080118|364943|P2|COMPLETED|Overall Study||15
150672|NCT01080118|364944|P1|COMPLETED|Overall Study||15
150673|NCT01080118|364941|P4|STARTED|Overall Study||30
150674|NCT01080118|364942|P3|STARTED|Overall Study||30
150675|NCT01080118|364943|P2|STARTED|Overall Study||15
150676|NCT01080118|364944|P1|STARTED|Overall Study||15
150677|NCT01079988|364957|P5|NOT COMPLETED|Overall Study||1
150678|NCT01079988|364958|P4|NOT COMPLETED|Overall Study||3
150679|NCT01079988|364959|P3|NOT COMPLETED|Overall Study||0
150680|NCT01079988|364960|P2|NOT COMPLETED|Overall Study||0
150681|NCT01079988|364961|P1|NOT COMPLETED|Overall Study||1
150682|NCT01079988|364957|P5|COMPLETED|Overall Study||1
150683|NCT01079988|364958|P4|COMPLETED|Overall Study||17
150684|NCT01079988|364959|P3|COMPLETED|Overall Study||8
150685|NCT01079988|364960|P2|COMPLETED|Overall Study||1
150686|NCT01079988|364961|P1|COMPLETED|Overall Study||9
150687|NCT01079988|364957|P5|STARTED|Overall Study||2
150688|NCT01079988|364958|P4|STARTED|Overall Study||20
150689|NCT01079988|364959|P3|STARTED|Overall Study||8
150690|NCT01079988|364960|P2|STARTED|Overall Study||1
150691|NCT01079988|364961|P1|STARTED|Overall Study||10
150692|NCT01079962|364980|P2|NOT COMPLETED|Overall Study||15
150693|NCT01079962|364981|P1|NOT COMPLETED|Overall Study||15
150694|NCT01079962|364980|P2|COMPLETED|Overall Study||89
150695|NCT01079962|364981|P1|COMPLETED|Overall Study||90
150696|NCT01079962|364980|P2|STARTED|Overall Study||104
150697|NCT01079962|364981|P1|STARTED|Overall Study||105
150698|NCT01079949|365009|P2|NOT COMPLETED|Overall Study||13
150699|NCT01079949|365010|P1|NOT COMPLETED|Overall Study||15
150700|NCT01079949|365009|P2|COMPLETED|Overall Study||34
150701|NCT01079949|365010|P1|COMPLETED|Overall Study||31
150702|NCT01079949|365009|P2|STARTED|Overall Study||47
150703|NCT01079949|365010|P1|STARTED|Overall Study||46
150704|NCT01079936|365056|P5|NOT COMPLETED|Phase II||1
150705|NCT01079936|365057|P4|NOT COMPLETED|Phase II||0
150706|NCT01079936|365058|P3|NOT COMPLETED|Phase II||1
150707|NCT01079936|365059|P2|NOT COMPLETED|Phase II||0
150708|NCT01079936|365060|P1|NOT COMPLETED|Phase II||0
150709|NCT01079936|365056|P5|COMPLETED|Phase II||25
150710|NCT01079936|365057|P4|COMPLETED|Phase II||24
150711|NCT01079936|365058|P3|COMPLETED|Phase II||5
150712|NCT01079936|365059|P2|COMPLETED|Phase II||3
150713|NCT01079936|365060|P1|COMPLETED|Phase II||0
150714|NCT01079936|365056|P5|STARTED|Phase II||26
150715|NCT01079936|365057|P4|STARTED|Phase II||24
150716|NCT01079936|365058|P3|STARTED|Phase II||6
150717|NCT01079936|365059|P2|STARTED|Phase II||3
150718|NCT01079936|365060|P1|STARTED|Phase II||0
150719|NCT01079936|365056|P5|NOT COMPLETED|Phase I: MTD||0
150720|NCT01079936|365057|P4|NOT COMPLETED|Phase I: MTD||0
150721|NCT01079936|365058|P3|NOT COMPLETED|Phase I: MTD||0
150722|NCT01079936|365059|P2|NOT COMPLETED|Phase I: MTD||0
150723|NCT01079936|365060|P1|NOT COMPLETED|Phase I: MTD||4
150724|NCT01079936|365056|P5|COMPLETED|Phase I: MTD||0
150725|NCT01079936|365057|P4|COMPLETED|Phase I: MTD||0
150726|NCT01079936|365058|P3|COMPLETED|Phase I: MTD||0
150727|NCT01079936|365059|P2|COMPLETED|Phase I: MTD||0
150728|NCT01079936|365060|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
150729|NCT01079936|365056|P5|STARTED|Phase I: MTD||0
150730|NCT01079936|365057|P4|STARTED|Phase I: MTD||0
150731|NCT01079936|365058|P3|STARTED|Phase I: MTD||0
150732|NCT01079936|365059|P2|STARTED|Phase I: MTD||0
150733|NCT01079936|365060|P1|STARTED|Phase I: MTD||16
150734|NCT01079832|365079|P1|NOT COMPLETED|Overall Study||1
150735|NCT01079832|365079|P1|COMPLETED|Overall Study||49
150736|NCT01079832|365079|P1|STARTED|Overall Study||50
150737|NCT01079806|365089|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||2
150738|NCT01079806|365090|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||0
150739|NCT01079806|365089|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||4
150740|NCT01079806|365090|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||14
150741|NCT01079806|365089|P2|STARTED|Long-term Follow-up: Day 1-End of Study||6
150742|NCT01079806|365090|P1|STARTED|Long-term Follow-up: Day 1-End of Study||14
150743|NCT01079806|365089|P2|NOT COMPLETED|Day 1 to Week 96||4
150744|NCT01079806|365090|P1|NOT COMPLETED|Day 1 to Week 96||4
150745|NCT01079806|365089|P2|COMPLETED|Day 1 to Week 96|Includes 53 continuing treatment|56
150746|NCT01079806|365090|P1|COMPLETED|Day 1 to Week 96|Includes 91 continuing treatment|116
150747|NCT01079806|365089|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
150748|NCT01079806|365090|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
150749|NCT01079806|365089|P2|Received Treatment|Day 1 to Week 96||60
150750|NCT01079806|365090|P1|Received Treatment|Day 1 to Week 96||120
150751|NCT01079806|365089|P2|STARTED|Day 1 to Week 96|Randomized|60
150752|NCT01079806|365090|P1|STARTED|Day 1 to Week 96|Randomized|120
150753|NCT01079741|365115|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
150754|NCT01079741|365116|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
150755|NCT01079741|365117|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
150756|NCT01079741|365118|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
150757|NCT01079741|365119|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
150758|NCT01079741|365115|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
150759|NCT01079741|365116|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
150760|NCT01079741|365117|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
150761|NCT01079741|365118|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
150762|NCT01079741|365119|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
150763|NCT01079741|365115|P5|STARTED|Phase 2 (Weeks 37-48)||12
150764|NCT01079741|365116|P4|STARTED|Phase 2 (Weeks 37-48)||12
150765|NCT01079741|365117|P3|STARTED|Phase 2 (Weeks 37-48)||0
150766|NCT01079741|365118|P2|STARTED|Phase 2 (Weeks 37-48)||0
150767|NCT01079741|365119|P1|STARTED|Phase 2 (Weeks 37-48)||0
150768|NCT01079741|365115|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150769|NCT01079741|365116|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150770|NCT01079741|365117|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
150771|NCT01079741|365118|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150772|NCT01079741|365119|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150773|NCT01079741|365115|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150774|NCT01079741|365116|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150775|NCT01079741|365117|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150776|NCT01079741|365118|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150777|NCT01079741|365119|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150778|NCT01079741|365115|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150779|NCT01079741|365116|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150780|NCT01079741|365117|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
150781|NCT01079741|365118|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150782|NCT01079741|365119|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
150783|NCT01079741|365115|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150784|NCT01079741|365116|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150785|NCT01079741|365117|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150786|NCT01079741|365118|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
150787|NCT01079741|365119|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150788|NCT01079741|365115|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150789|NCT01079741|365116|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150790|NCT01079741|365117|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150791|NCT01079741|365118|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
150792|NCT01079741|365119|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150793|NCT01079741|365115|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150794|NCT01079741|365116|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150795|NCT01079741|365117|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150796|NCT01079741|365118|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
150797|NCT01079741|365119|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
150798|NCT01079741|365115|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150799|NCT01079741|365116|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150800|NCT01079741|365117|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150801|NCT01079741|365118|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150802|NCT01079741|365119|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150803|NCT01079741|365115|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150804|NCT01079741|365116|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150805|NCT01079741|365117|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150806|NCT01079741|365118|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150807|NCT01079741|365119|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
150808|NCT01079741|365115|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150809|NCT01079741|365116|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150810|NCT01079741|365117|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150811|NCT01079741|365118|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
150812|NCT01079741|365119|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
150813|NCT01079598|365133|P1|NOT COMPLETED|Overall Study||0
150814|NCT01079598|365133|P1|COMPLETED|Overall Study||8
150815|NCT01079598|365133|P1|STARTED|Overall Study||8
150816|NCT01079390|365143|P3|NOT COMPLETED|Overall Study||4
150817|NCT01079390|365144|P2|NOT COMPLETED|Overall Study||5
150818|NCT01079390|365145|P1|NOT COMPLETED|Overall Study||5
150819|NCT01079390|365143|P3|COMPLETED|Overall Study||10
150820|NCT01079390|365144|P2|COMPLETED|Overall Study||10
150821|NCT01079390|365145|P1|COMPLETED|Overall Study||10
150822|NCT01079390|365143|P3|STARTED|Overall Study||14
150823|NCT01079390|365144|P2|STARTED|Overall Study||15
150824|NCT01079390|365145|P1|STARTED|Overall Study||15
150825|NCT01079299|365157|P2|NOT COMPLETED|Overall Study||0
150826|NCT01079299|365158|P1|NOT COMPLETED|Overall Study||0
150827|NCT01079299|365157|P2|COMPLETED|Overall Study||25
150828|NCT01079299|365158|P1|COMPLETED|Overall Study||27
150829|NCT01079299|365157|P2|STARTED|Overall Study||25
150830|NCT01079299|365158|P1|STARTED|Overall Study||27
150831|NCT01079234|365167|P4|NOT COMPLETED|Extension: Week 27 to 52||16
150832|NCT01079234|365168|P3|NOT COMPLETED|Extension: Week 27 to 52||11
150833|NCT01079234|365169|P2|NOT COMPLETED|Extension: Week 27 to 52||0
150834|NCT01079234|365170|P1|NOT COMPLETED|Extension: Week 27 to 52||0
150835|NCT01079234|365167|P4|COMPLETED|Extension: Week 27 to 52||223
150836|NCT01079234|365168|P3|COMPLETED|Extension: Week 27 to 52||122
150837|NCT01079234|365169|P2|COMPLETED|Extension: Week 27 to 52||0
150838|NCT01079234|365170|P1|COMPLETED|Extension: Week 27 to 52||0
150839|NCT01079234|365167|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
150840|NCT01079234|365168|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
150841|NCT01079234|365169|P2|STARTED|Extension: Week 27 to 52||0
150842|NCT01079234|365170|P1|STARTED|Extension: Week 27 to 52||0
150843|NCT01079234|365167|P4|NOT COMPLETED|Main: Week 0 to 26||0
150844|NCT01079234|365168|P3|NOT COMPLETED|Main: Week 0 to 26||12
150845|NCT01079234|365169|P2|NOT COMPLETED|Main: Week 0 to 26||26
150846|NCT01079234|365170|P1|NOT COMPLETED|Main: Week 0 to 26||26
150847|NCT01079234|365167|P4|COMPLETED|Main: Week 0 to 26||0
150848|NCT01079234|365168|P3|COMPLETED|Main: Week 0 to 26||152
150849|NCT01079234|365169|P2|COMPLETED|Main: Week 0 to 26||139
150850|NCT01079234|365170|P1|COMPLETED|Main: Week 0 to 26||138
150851|NCT01079234|365167|P4|Exposed|Main: Week 0 to 26||0
150852|NCT01079234|365168|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
150853|NCT01079234|365169|P2|Exposed|Main: Week 0 to 26||165
150854|NCT01079234|365170|P1|Exposed|Main: Week 0 to 26||164
150855|NCT01079234|365167|P4|STARTED|Main: Week 0 to 26||0
150856|NCT01079234|365168|P3|STARTED|Main: Week 0 to 26||164
150857|NCT01079234|365169|P2|STARTED|Main: Week 0 to 26||165
150858|NCT01079234|365170|P1|STARTED|Main: Week 0 to 26||164
150859|NCT01079195|365188|P1|NOT COMPLETED|Overall Study||1431
150860|NCT01079195|365188|P1|COMPLETED|Overall Study||14442
150861|NCT01079195|365188|P1|STARTED|Overall Study||15873
150862|NCT01079182|365194|P1|NOT COMPLETED|Overall Study||2719
150863|NCT01079182|365194|P1|COMPLETED|Overall Study||1962
150864|NCT01079182|365194|P1|STARTED|Overall Study||4681
150865|NCT01079143|365225|P4|NOT COMPLETED|Overall Study||5
150866|NCT01079143|365226|P3|NOT COMPLETED|Overall Study||5
150867|NCT01079143|365227|P2|NOT COMPLETED|Overall Study||17
150868|NCT01079143|365228|P1|NOT COMPLETED|Overall Study||9
150869|NCT01079143|365225|P4|COMPLETED|Overall Study||54
150870|NCT01079143|365226|P3|COMPLETED|Overall Study||34
150871|NCT01079143|365227|P2|COMPLETED|Overall Study||43
150872|NCT01079143|365228|P1|COMPLETED|Overall Study||27
150873|NCT01079143|365225|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
150874|NCT01079143|365226|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
150875|NCT01079143|365227|P2|M3 and M12 Biopsies|Overall Study||43
150876|NCT01079143|365228|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
150877|NCT01079143|365225|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
150878|NCT01079143|365226|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
150879|NCT01079143|365227|P2|Month 12 (M12) Biopsies|Overall Study||43
150880|NCT01079143|365228|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
150881|NCT01079143|365225|P4|Month 3 (M3) Biopsies|Overall Study||59
150882|NCT01079143|365226|P3|Month 3 (M3) Biopsies|Overall Study||39
150883|NCT01079143|365227|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
150884|NCT01079143|365228|P1|Month 3 (M3) Biopsies|Overall Study||36
150885|NCT01079143|365225|P4|Exposed|Overall Study||59
150886|NCT01079143|365226|P3|Exposed|Overall Study||39
150887|NCT01079143|365227|P2|Exposed|Overall Study||60
150888|NCT01079143|365228|P1|Exposed|Overall Study||36
150889|NCT01079143|365225|P4|STARTED|Overall Study||59
150890|NCT01079143|365226|P3|STARTED|Overall Study||39
150891|NCT01079143|365227|P2|STARTED|Overall Study||60
150892|NCT01079143|365228|P1|STARTED|Overall Study||36
150893|NCT01079130|365302|P6|NOT COMPLETED|Overall Study||5
150894|NCT01079130|365303|P5|NOT COMPLETED|Overall Study||8
150895|NCT01079130|365304|P4|NOT COMPLETED|Overall Study||5
150896|NCT01079130|365305|P3|NOT COMPLETED|Overall Study||1
150897|NCT01079130|365306|P2|NOT COMPLETED|Overall Study||7
150898|NCT01079130|365307|P1|NOT COMPLETED|Overall Study||2
150899|NCT01079130|365302|P6|COMPLETED|Overall Study||80
150900|NCT01079130|365303|P5|COMPLETED|Overall Study||78
150901|NCT01079130|365304|P4|COMPLETED|Overall Study||81
150902|NCT01079130|365305|P3|COMPLETED|Overall Study||83
150903|NCT01079130|365306|P2|COMPLETED|Overall Study||78
150904|NCT01079130|365307|P1|COMPLETED|Overall Study||83
150905|NCT01079130|365302|P6|Full Analysis Set (FAS)|Overall Study||84
150906|NCT01079130|365303|P5|Full Analysis Set (FAS)|Overall Study||84
150907|NCT01079130|365304|P4|Full Analysis Set (FAS)|Overall Study||85
150908|NCT01079130|365305|P3|Full Analysis Set (FAS)|Overall Study||83
150995|NCT01078623|365470|P16|NOT COMPLETED|Treatment Period 4||1
150909|NCT01079130|365306|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
150910|NCT01079130|365307|P1|Full Analysis Set (FAS)|Overall Study||84
150911|NCT01079130|365302|P6|Safety Set: Received Study Drug|Overall Study||84
150912|NCT01079130|365303|P5|Safety Set: Received Study Drug|Overall Study||84
150913|NCT01079130|365304|P4|Safety Set: Received Study Drug|Overall Study||85
150914|NCT01079130|365305|P3|Safety Set: Received Study Drug|Overall Study||84
150915|NCT01079130|365306|P2|Safety Set: Received Study Drug|Overall Study||81
150916|NCT01079130|365307|P1|Safety Set: Received Study Drug|Overall Study||84
150917|NCT01079130|365302|P6|STARTED|Overall Study||85
150918|NCT01079130|365303|P5|STARTED|Overall Study||86
150919|NCT01079130|365304|P4|STARTED|Overall Study||86
150920|NCT01079130|365305|P3|STARTED|Overall Study||84
150921|NCT01079130|365306|P2|STARTED|Overall Study||85
150922|NCT01079130|365307|P1|STARTED|Overall Study||85
150923|NCT01078974|365327|P1|NOT COMPLETED|Overall Study||3
150924|NCT01078974|365327|P1|COMPLETED|Overall Study||4
150925|NCT01078974|365327|P1|STARTED|Overall Study||7
150926|NCT01078922|365332|P1|NOT COMPLETED|Overall Study||1
150927|NCT01078922|365332|P1|COMPLETED|Overall Study||10
150928|NCT01078922|365332|P1|STARTED|Overall Study||11
150929|NCT01078909|365342|P5|NOT COMPLETED|Overall Study||2
150930|NCT01078909|365343|P4|NOT COMPLETED|Overall Study||1
150931|NCT01078909|365344|P3|NOT COMPLETED|Overall Study||1
150932|NCT01078909|365345|P2|NOT COMPLETED|Overall Study||4
150933|NCT01078909|365346|P1|NOT COMPLETED|Overall Study||2
150934|NCT01078909|365342|P5|COMPLETED|Overall Study||23
150935|NCT01078909|365343|P4|COMPLETED|Overall Study||24
150936|NCT01078909|365344|P3|COMPLETED|Overall Study||24
150937|NCT01078909|365345|P2|COMPLETED|Overall Study||21
150938|NCT01078909|365346|P1|COMPLETED|Overall Study||23
150939|NCT01078909|365342|P5|STARTED|Overall Study||25
150940|NCT01078909|365343|P4|STARTED|Overall Study||25
150941|NCT01078909|365344|P3|STARTED|Overall Study||25
150942|NCT01078909|365345|P2|STARTED|Overall Study||25
150943|NCT01078909|365346|P1|STARTED|Overall Study||25
150944|NCT01078844|365368|P1|NOT COMPLETED|Overall Study||4
150945|NCT01078844|365368|P1|COMPLETED|Overall Study||0
150946|NCT01078844|365368|P1|STARTED|Overall Study||4
150947|NCT01078805|365373|P1|NOT COMPLETED|Overall Study||2050
150948|NCT01078805|365373|P1|COMPLETED|Overall Study||2117
150949|NCT01078805|365373|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
150950|NCT01078805|365373|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
150951|NCT01078805|365373|P1|STARTED|Overall Study||4167
150952|NCT01078753|365387|P2|NOT COMPLETED|Treatment Period II||0
150953|NCT01078753|365388|P1|NOT COMPLETED|Treatment Period II||0
150954|NCT01078753|365387|P2|COMPLETED|Treatment Period II||44
150955|NCT01078753|365388|P1|COMPLETED|Treatment Period II||45
150956|NCT01078753|365387|P2|Full Analysis Set|Treatment Period II||44
150957|NCT01078753|365388|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
150958|NCT01078753|365387|P2|STARTED|Treatment Period II||44
150959|NCT01078753|365388|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
150960|NCT01078753|365387|P2|NOT COMPLETED|Treatment Period I||0
150961|NCT01078753|365388|P1|NOT COMPLETED|Treatment Period I||0
150962|NCT01078753|365387|P2|COMPLETED|Treatment Period I||44
150963|NCT01078753|365388|P1|COMPLETED|Treatment Period I||45
150964|NCT01078753|365387|P2|Full Analysis Set|Treatment Period I||44
150965|NCT01078753|365388|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
150966|NCT01078753|365387|P2|STARTED|Treatment Period I||44
150967|NCT01078753|365388|P1|STARTED|Treatment Period I||45
150968|NCT01078675|365400|P2|NOT COMPLETED|Overall Study||6
150969|NCT01078675|365401|P1|NOT COMPLETED|Overall Study||68
150970|NCT01078675|365400|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
150971|NCT01078675|365401|P1|COMPLETED|Overall Study||182
150972|NCT01078675|365400|P2|Patients Treated|Overall Study||0
150973|NCT01078675|365401|P1|Patients Treated|Overall Study||198
150974|NCT01078675|365400|P2|STARTED|Overall Study||65
150975|NCT01078675|365401|P1|STARTED|Overall Study||250
150976|NCT01078662|365423|P5|NOT COMPLETED|Overall Study||11
150977|NCT01078662|365424|P4|NOT COMPLETED|Overall Study||7
150978|NCT01078662|365425|P3|NOT COMPLETED|Overall Study||21
150979|NCT01078662|365426|P2|NOT COMPLETED|Overall Study||168
150980|NCT01078662|365427|P1|NOT COMPLETED|Overall Study||58
150981|NCT01078662|365423|P5|COMPLETED|Overall Study||1
150982|NCT01078662|365424|P4|COMPLETED|Overall Study||1
150983|NCT01078662|365425|P3|COMPLETED|Overall Study||2
150984|NCT01078662|365426|P2|COMPLETED|Overall Study||25
150985|NCT01078662|365427|P1|COMPLETED|Overall Study||4
150986|NCT01078662|365423|P5|STARTED|Overall Study||12
150987|NCT01078662|365424|P4|STARTED|Overall Study||8
150988|NCT01078662|365425|P3|STARTED|Overall Study||23
150989|NCT01078662|365426|P2|STARTED|Overall Study||193
150990|NCT01078662|365427|P1|STARTED|Overall Study||62
150991|NCT01078623|365466|P20|NOT COMPLETED|Treatment Period 4||0
150992|NCT01078623|365467|P19|NOT COMPLETED|Treatment Period 4||0
150993|NCT01078623|365468|P18|NOT COMPLETED|Treatment Period 4||0
150994|NCT01078623|365469|P17|NOT COMPLETED|Treatment Period 4||0
150996|NCT01078623|365471|P15|NOT COMPLETED|Treatment Period 4||0
150997|NCT01078623|365472|P14|NOT COMPLETED|Treatment Period 4||0
150998|NCT01078623|365473|P13|NOT COMPLETED|Treatment Period 4||0
150999|NCT01078623|365474|P12|NOT COMPLETED|Treatment Period 4||0
151000|NCT01078623|365475|P11|NOT COMPLETED|Treatment Period 4||0
151001|NCT01078623|365476|P10|NOT COMPLETED|Treatment Period 4||0
151002|NCT01078623|365477|P9|NOT COMPLETED|Treatment Period 4||0
151003|NCT01078623|365478|P8|NOT COMPLETED|Treatment Period 4||0
151004|NCT01078623|365479|P7|NOT COMPLETED|Treatment Period 4||0
151005|NCT01078623|365480|P6|NOT COMPLETED|Treatment Period 4||0
151006|NCT01078623|365481|P5|NOT COMPLETED|Treatment Period 4||0
151007|NCT01078623|365482|P4|NOT COMPLETED|Treatment Period 4||0
151008|NCT01078623|365483|P3|NOT COMPLETED|Treatment Period 4||1
151009|NCT01078623|365484|P2|NOT COMPLETED|Treatment Period 4||0
151010|NCT01078623|365485|P1|NOT COMPLETED|Treatment Period 4||0
151011|NCT01078623|365466|P20|COMPLETED|Treatment Period 4||7
151012|NCT01078623|365467|P19|COMPLETED|Treatment Period 4||6
151013|NCT01078623|365468|P18|COMPLETED|Treatment Period 4||7
151014|NCT01078623|365469|P17|COMPLETED|Treatment Period 4||7
151015|NCT01078623|365470|P16|COMPLETED|Treatment Period 4||6
151016|NCT01078623|365471|P15|COMPLETED|Treatment Period 4||7
151017|NCT01078623|365472|P14|COMPLETED|Treatment Period 4||6
151018|NCT01078623|365473|P13|COMPLETED|Treatment Period 4||7
151019|NCT01078623|365474|P12|COMPLETED|Treatment Period 4||7
151020|NCT01078623|365475|P11|COMPLETED|Treatment Period 4||6
151021|NCT01078623|365476|P10|COMPLETED|Treatment Period 4||6
151022|NCT01078623|365477|P9|COMPLETED|Treatment Period 4||5
151023|NCT01078623|365478|P8|COMPLETED|Treatment Period 4||6
151024|NCT01078623|365479|P7|COMPLETED|Treatment Period 4||5
151025|NCT01078623|365480|P6|COMPLETED|Treatment Period 4||4
151026|NCT01078623|365481|P5|COMPLETED|Treatment Period 4||6
151027|NCT01078623|365482|P4|COMPLETED|Treatment Period 4||6
151028|NCT01078623|365483|P3|COMPLETED|Treatment Period 4||5
151029|NCT01078623|365484|P2|COMPLETED|Treatment Period 4||5
151030|NCT01078623|365485|P1|COMPLETED|Treatment Period 4||5
151031|NCT01078623|365466|P20|STARTED|Treatment Period 4||7
151032|NCT01078623|365467|P19|STARTED|Treatment Period 4||6
151033|NCT01078623|365468|P18|STARTED|Treatment Period 4||7
151034|NCT01078623|365469|P17|STARTED|Treatment Period 4||7
151035|NCT01078623|365470|P16|STARTED|Treatment Period 4||7
151036|NCT01078623|365471|P15|STARTED|Treatment Period 4||7
151037|NCT01078623|365472|P14|STARTED|Treatment Period 4||6
151038|NCT01078623|365473|P13|STARTED|Treatment Period 4||7
151039|NCT01078623|365474|P12|STARTED|Treatment Period 4||7
151040|NCT01078623|365475|P11|STARTED|Treatment Period 4||6
151041|NCT01078623|365476|P10|STARTED|Treatment Period 4||6
151042|NCT01078623|365477|P9|STARTED|Treatment Period 4||5
151043|NCT01078623|365478|P8|STARTED|Treatment Period 4||6
151044|NCT01078623|365479|P7|STARTED|Treatment Period 4||5
151045|NCT01078623|365480|P6|STARTED|Treatment Period 4||4
151046|NCT01078623|365481|P5|STARTED|Treatment Period 4||6
151047|NCT01078623|365482|P4|STARTED|Treatment Period 4||6
151048|NCT01078623|365483|P3|STARTED|Treatment Period 4||6
151049|NCT01078623|365484|P2|STARTED|Treatment Period 4||5
151050|NCT01078623|365485|P1|STARTED|Treatment Period 4||5
151051|NCT01078623|365466|P20|NOT COMPLETED|Treatment Period 3||0
151052|NCT01078623|365467|P19|NOT COMPLETED|Treatment Period 3||0
151053|NCT01078623|365468|P18|NOT COMPLETED|Treatment Period 3||0
151054|NCT01078623|365469|P17|NOT COMPLETED|Treatment Period 3||0
151055|NCT01078623|365470|P16|NOT COMPLETED|Treatment Period 3||0
151056|NCT01078623|365471|P15|NOT COMPLETED|Treatment Period 3||0
151057|NCT01078623|365472|P14|NOT COMPLETED|Treatment Period 3||1
151058|NCT01078623|365473|P13|NOT COMPLETED|Treatment Period 3||0
151059|NCT01078623|365474|P12|NOT COMPLETED|Treatment Period 3||0
151060|NCT01078623|365475|P11|NOT COMPLETED|Treatment Period 3||0
151061|NCT01078623|365476|P10|NOT COMPLETED|Treatment Period 3||0
151062|NCT01078623|365477|P9|NOT COMPLETED|Treatment Period 3||0
151063|NCT01078623|365478|P8|NOT COMPLETED|Treatment Period 3||0
151064|NCT01078623|365479|P7|NOT COMPLETED|Treatment Period 3||0
151065|NCT01078623|365480|P6|NOT COMPLETED|Treatment Period 3||0
151066|NCT01078623|365481|P5|NOT COMPLETED|Treatment Period 3||1
151067|NCT01078623|365482|P4|NOT COMPLETED|Treatment Period 3||0
151068|NCT01078623|365483|P3|NOT COMPLETED|Treatment Period 3||0
151069|NCT01078623|365484|P2|NOT COMPLETED|Treatment Period 3||0
151070|NCT01078623|365485|P1|NOT COMPLETED|Treatment Period 3||0
151071|NCT01078623|365466|P20|COMPLETED|Treatment Period 3||7
151072|NCT01078623|365467|P19|COMPLETED|Treatment Period 3||6
151073|NCT01078623|365468|P18|COMPLETED|Treatment Period 3||7
151074|NCT01078623|365469|P17|COMPLETED|Treatment Period 3||7
151075|NCT01078623|365470|P16|COMPLETED|Treatment Period 3||7
151076|NCT01078623|365471|P15|COMPLETED|Treatment Period 3||7
151077|NCT01078623|365472|P14|COMPLETED|Treatment Period 3||6
151078|NCT01078623|365473|P13|COMPLETED|Treatment Period 3||7
151079|NCT01078623|365474|P12|COMPLETED|Treatment Period 3||7
151080|NCT01078623|365475|P11|COMPLETED|Treatment Period 3||6
151081|NCT01078623|365476|P10|COMPLETED|Treatment Period 3||6
151082|NCT01078623|365477|P9|COMPLETED|Treatment Period 3||5
151083|NCT01078623|365478|P8|COMPLETED|Treatment Period 3||6
151084|NCT01078623|365479|P7|COMPLETED|Treatment Period 3||5
151085|NCT01078623|365480|P6|COMPLETED|Treatment Period 3||4
151086|NCT01078623|365481|P5|COMPLETED|Treatment Period 3||6
151087|NCT01078623|365482|P4|COMPLETED|Treatment Period 3||6
151088|NCT01078623|365483|P3|COMPLETED|Treatment Period 3||6
151089|NCT01078623|365484|P2|COMPLETED|Treatment Period 3||5
151090|NCT01078623|365485|P1|COMPLETED|Treatment Period 3||5
151091|NCT01078623|365466|P20|STARTED|Treatment Period 3||7
151092|NCT01078623|365467|P19|STARTED|Treatment Period 3||6
151093|NCT01078623|365468|P18|STARTED|Treatment Period 3||7
151094|NCT01078623|365469|P17|STARTED|Treatment Period 3||7
151095|NCT01078623|365470|P16|STARTED|Treatment Period 3||7
151096|NCT01078623|365471|P15|STARTED|Treatment Period 3||7
151097|NCT01078623|365472|P14|STARTED|Treatment Period 3||7
151098|NCT01078623|365473|P13|STARTED|Treatment Period 3||7
151099|NCT01078623|365474|P12|STARTED|Treatment Period 3||7
151100|NCT01078623|365475|P11|STARTED|Treatment Period 3||6
151101|NCT01078623|365476|P10|STARTED|Treatment Period 3||6
151102|NCT01078623|365477|P9|STARTED|Treatment Period 3||5
151103|NCT01078623|365478|P8|STARTED|Treatment Period 3||6
151104|NCT01078623|365479|P7|STARTED|Treatment Period 3||5
151105|NCT01078623|365480|P6|STARTED|Treatment Period 3||4
151106|NCT01078623|365481|P5|STARTED|Treatment Period 3||7
151107|NCT01078623|365482|P4|STARTED|Treatment Period 3||6
151108|NCT01078623|365483|P3|STARTED|Treatment Period 3||6
151109|NCT01078623|365484|P2|STARTED|Treatment Period 3||5
151110|NCT01078623|365485|P1|STARTED|Treatment Period 3||5
151111|NCT01078623|365466|P20|NOT COMPLETED|Treatment Period 2||0
151112|NCT01078623|365467|P19|NOT COMPLETED|Treatment Period 2||1
151113|NCT01078623|365468|P18|NOT COMPLETED|Treatment Period 2||0
151114|NCT01078623|365469|P17|NOT COMPLETED|Treatment Period 2||0
151115|NCT01078623|365470|P16|NOT COMPLETED|Treatment Period 2||0
151116|NCT01078623|365471|P15|NOT COMPLETED|Treatment Period 2||0
151117|NCT01078623|365472|P14|NOT COMPLETED|Treatment Period 2||0
151118|NCT01078623|365473|P13|NOT COMPLETED|Treatment Period 2||0
151119|NCT01078623|365474|P12|NOT COMPLETED|Treatment Period 2||0
151120|NCT01078623|365475|P11|NOT COMPLETED|Treatment Period 2||0
151121|NCT01078623|365476|P10|NOT COMPLETED|Treatment Period 2||0
151122|NCT01078623|365477|P9|NOT COMPLETED|Treatment Period 2||0
151123|NCT01078623|365478|P8|NOT COMPLETED|Treatment Period 2||0
151124|NCT01078623|365479|P7|NOT COMPLETED|Treatment Period 2||1
151125|NCT01078623|365480|P6|NOT COMPLETED|Treatment Period 2||1
151126|NCT01078623|365481|P5|NOT COMPLETED|Treatment Period 2||0
151127|NCT01078623|365482|P4|NOT COMPLETED|Treatment Period 2||0
151128|NCT01078623|365483|P3|NOT COMPLETED|Treatment Period 2||0
151129|NCT01078623|365484|P2|NOT COMPLETED|Treatment Period 2||0
151130|NCT01078623|365485|P1|NOT COMPLETED|Treatment Period 2||0
151131|NCT01078623|365466|P20|COMPLETED|Treatment Period 2||7
151132|NCT01078623|365467|P19|COMPLETED|Treatment Period 2||6
151133|NCT01078623|365468|P18|COMPLETED|Treatment Period 2||7
151134|NCT01078623|365469|P17|COMPLETED|Treatment Period 2||7
151135|NCT01078623|365470|P16|COMPLETED|Treatment Period 2||7
151136|NCT01078623|365471|P15|COMPLETED|Treatment Period 2||7
151137|NCT01078623|365472|P14|COMPLETED|Treatment Period 2||7
151138|NCT01078623|365473|P13|COMPLETED|Treatment Period 2||7
151139|NCT01078623|365474|P12|COMPLETED|Treatment Period 2||7
151140|NCT01078623|365475|P11|COMPLETED|Treatment Period 2||6
151141|NCT01078623|365476|P10|COMPLETED|Treatment Period 2||6
151142|NCT01078623|365477|P9|COMPLETED|Treatment Period 2||5
151143|NCT01078623|365478|P8|COMPLETED|Treatment Period 2||6
151144|NCT01078623|365479|P7|COMPLETED|Treatment Period 2||5
151145|NCT01078623|365480|P6|COMPLETED|Treatment Period 2||4
151146|NCT01078623|365481|P5|COMPLETED|Treatment Period 2||7
151147|NCT01078623|365482|P4|COMPLETED|Treatment Period 2||6
151148|NCT01078623|365483|P3|COMPLETED|Treatment Period 2||6
151149|NCT01078623|365484|P2|COMPLETED|Treatment Period 2||5
151150|NCT01078623|365485|P1|COMPLETED|Treatment Period 2||5
151151|NCT01078623|365466|P20|STARTED|Treatment Period 2||7
151152|NCT01078623|365467|P19|STARTED|Treatment Period 2||7
151153|NCT01078623|365468|P18|STARTED|Treatment Period 2||7
151154|NCT01078623|365469|P17|STARTED|Treatment Period 2||7
151155|NCT01078623|365470|P16|STARTED|Treatment Period 2||7
151156|NCT01078623|365471|P15|STARTED|Treatment Period 2||7
151157|NCT01078623|365472|P14|STARTED|Treatment Period 2||7
151158|NCT01078623|365473|P13|STARTED|Treatment Period 2||7
151159|NCT01078623|365474|P12|STARTED|Treatment Period 2||7
151160|NCT01078623|365475|P11|STARTED|Treatment Period 2||6
151161|NCT01078623|365476|P10|STARTED|Treatment Period 2||6
151162|NCT01078623|365477|P9|STARTED|Treatment Period 2||5
151163|NCT01078623|365478|P8|STARTED|Treatment Period 2||6
151164|NCT01078623|365479|P7|STARTED|Treatment Period 2||6
151165|NCT01078623|365480|P6|STARTED|Treatment Period 2||5
151166|NCT01078623|365481|P5|STARTED|Treatment Period 2||7
151167|NCT01078623|365482|P4|STARTED|Treatment Period 2||6
151168|NCT01078623|365483|P3|STARTED|Treatment Period 2||6
151169|NCT01078623|365484|P2|STARTED|Treatment Period 2||5
151170|NCT01078623|365485|P1|STARTED|Treatment Period 2||5
151171|NCT01078623|365466|P20|NOT COMPLETED|Treatment Period 1||0
151172|NCT01078623|365467|P19|NOT COMPLETED|Treatment Period 1||0
151173|NCT01078623|365468|P18|NOT COMPLETED|Treatment Period 1||0
151174|NCT01078623|365469|P17|NOT COMPLETED|Treatment Period 1||0
151175|NCT01078623|365470|P16|NOT COMPLETED|Treatment Period 1||0
151176|NCT01078623|365471|P15|NOT COMPLETED|Treatment Period 1||0
151177|NCT01078623|365472|P14|NOT COMPLETED|Treatment Period 1||0
151178|NCT01078623|365473|P13|NOT COMPLETED|Treatment Period 1||0
151179|NCT01078623|365474|P12|NOT COMPLETED|Treatment Period 1||0
151180|NCT01078623|365475|P11|NOT COMPLETED|Treatment Period 1||1
151181|NCT01078623|365476|P10|NOT COMPLETED|Treatment Period 1||1
151182|NCT01078623|365477|P9|NOT COMPLETED|Treatment Period 1||1
151183|NCT01078623|365478|P8|NOT COMPLETED|Treatment Period 1||1
151184|NCT01078623|365479|P7|NOT COMPLETED|Treatment Period 1||1
151185|NCT01078623|365480|P6|NOT COMPLETED|Treatment Period 1||1
151186|NCT01078623|365481|P5|NOT COMPLETED|Treatment Period 1||0
151187|NCT01078623|365482|P4|NOT COMPLETED|Treatment Period 1||0
151188|NCT01078623|365483|P3|NOT COMPLETED|Treatment Period 1||1
151189|NCT01078623|365484|P2|NOT COMPLETED|Treatment Period 1||1
151190|NCT01078623|365485|P1|NOT COMPLETED|Treatment Period 1||1
151191|NCT01078623|365466|P20|COMPLETED|Treatment Period 1||7
151192|NCT01078623|365467|P19|COMPLETED|Treatment Period 1||7
151193|NCT01078623|365468|P18|COMPLETED|Treatment Period 1||7
151194|NCT01078623|365469|P17|COMPLETED|Treatment Period 1||7
151195|NCT01078623|365470|P16|COMPLETED|Treatment Period 1||7
151196|NCT01078623|365471|P15|COMPLETED|Treatment Period 1||7
151197|NCT01078623|365472|P14|COMPLETED|Treatment Period 1||7
151198|NCT01078623|365473|P13|COMPLETED|Treatment Period 1||7
151199|NCT01078623|365474|P12|COMPLETED|Treatment Period 1||7
151200|NCT01078623|365475|P11|COMPLETED|Treatment Period 1||6
151201|NCT01078623|365476|P10|COMPLETED|Treatment Period 1||6
151202|NCT01078623|365477|P9|COMPLETED|Treatment Period 1||5
151203|NCT01078623|365478|P8|COMPLETED|Treatment Period 1||6
151204|NCT01078623|365479|P7|COMPLETED|Treatment Period 1||6
151205|NCT01078623|365480|P6|COMPLETED|Treatment Period 1||5
151206|NCT01078623|365481|P5|COMPLETED|Treatment Period 1||7
151207|NCT01078623|365482|P4|COMPLETED|Treatment Period 1||6
151208|NCT01078623|365483|P3|COMPLETED|Treatment Period 1||6
151209|NCT01078623|365484|P2|COMPLETED|Treatment Period 1||5
151210|NCT01078623|365485|P1|COMPLETED|Treatment Period 1||5
151211|NCT01078623|365466|P20|STARTED|Treatment Period 1||7
151212|NCT01078623|365467|P19|STARTED|Treatment Period 1||7
151213|NCT01078623|365468|P18|STARTED|Treatment Period 1||7
151214|NCT01078623|365469|P17|STARTED|Treatment Period 1||7
151215|NCT01078623|365470|P16|STARTED|Treatment Period 1||7
151216|NCT01078623|365471|P15|STARTED|Treatment Period 1||7
151217|NCT01078623|365472|P14|STARTED|Treatment Period 1||7
151218|NCT01078623|365473|P13|STARTED|Treatment Period 1||7
151219|NCT01078623|365474|P12|STARTED|Treatment Period 1||7
151220|NCT01078623|365475|P11|STARTED|Treatment Period 1||7
151221|NCT01078623|365476|P10|STARTED|Treatment Period 1||7
151222|NCT01078623|365477|P9|STARTED|Treatment Period 1||6
151223|NCT01078623|365478|P8|STARTED|Treatment Period 1||7
151224|NCT01078623|365479|P7|STARTED|Treatment Period 1||7
151225|NCT01078623|365480|P6|STARTED|Treatment Period 1||6
151226|NCT01078623|365481|P5|STARTED|Treatment Period 1||7
151227|NCT01078623|365482|P4|STARTED|Treatment Period 1||6
151228|NCT01078623|365483|P3|STARTED|Treatment Period 1||7
151229|NCT01078623|365484|P2|STARTED|Treatment Period 1||6
151230|NCT01078623|365485|P1|STARTED|Treatment Period 1||6
151231|NCT01078584|365507|P1|NOT COMPLETED|Overall Study||3010
151232|NCT01078584|365507|P1|COMPLETED|Overall Study||4983
151233|NCT01078584|365507|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
151234|NCT01078584|365507|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
151235|NCT01078584|365507|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
151236|NCT01078584|365507|P1|STARTED|Overall Study||7993
151237|NCT01078571|365588|P1|NOT COMPLETED|Overall Study||115
151238|NCT01078571|365588|P1|COMPLETED|Overall Study||590
151239|NCT01078571|365588|P1|Intent-to-treat (ITT) Population|Overall Study||591
151240|NCT01078571|365588|P1|Safety Population|Overall Study||675
151241|NCT01078571|365588|P1|STARTED|Overall Study||705
151242|NCT01078545|365604|P1|NOT COMPLETED|Overall Study||26
151243|NCT01078545|365604|P1|COMPLETED|Overall Study||703
151244|NCT01078545|365604|P1|Per Protocol Population|Overall Study||661
151245|NCT01078545|365604|P1|Intent-to-treat Population|Overall Study||729
151246|NCT01078545|365604|P1|STARTED|Overall Study||729
151247|NCT01078454|365614|P2|NOT COMPLETED|Overall Study||2
151248|NCT01078454|365615|P1|NOT COMPLETED|Overall Study||1
151249|NCT01078454|365614|P2|COMPLETED|Overall Study||3
151250|NCT01078454|365615|P1|COMPLETED|Overall Study||5
151251|NCT01078454|365614|P2|STARTED|Overall Study||5
151252|NCT01078454|365615|P1|STARTED|Overall Study||6
151253|NCT01078441|365621|P1|NOT COMPLETED|Overall Study||1
151254|NCT01078441|365621|P1|COMPLETED|Overall Study||1
151255|NCT01078441|365621|P1|STARTED|Overall Study||2
151256|NCT01078402|365628|P3|NOT COMPLETED|Overall Study||68
151257|NCT01078402|365629|P2|NOT COMPLETED|Overall Study||29
151258|NCT01078402|365630|P1|NOT COMPLETED|Overall Study||107
151259|NCT01078402|365628|P3|COMPLETED|Overall Study||166
151260|NCT01078402|365629|P2|COMPLETED|Overall Study||95
151261|NCT01078402|365630|P1|COMPLETED|Overall Study||324
151262|NCT01078402|365628|P3|STARTED|Overall Study||234
151263|NCT01078402|365629|P2|STARTED|Overall Study||124
151264|NCT01078402|365630|P1|STARTED|Overall Study||431
151265|NCT01078389|365661|P2|NOT COMPLETED|Overall Study||67
151266|NCT01078389|365662|P1|NOT COMPLETED|Overall Study||64
151267|NCT01078389|365661|P2|COMPLETED|Overall Study||90
151268|NCT01078389|365662|P1|COMPLETED|Overall Study||93
151269|NCT01078389|365661|P2|STARTED|Overall Study||157
151270|NCT01078389|365662|P1|STARTED|Overall Study||157
151271|NCT01078376|365680|P4|NOT COMPLETED|Overall Study||0
151272|NCT01078376|365681|P3|NOT COMPLETED|Overall Study||0
151273|NCT01078376|365682|P2|NOT COMPLETED|Overall Study||0
151274|NCT01078376|365683|P1|NOT COMPLETED|Overall Study||0
151275|NCT01078376|365680|P4|COMPLETED|Overall Study||3
151276|NCT01078376|365681|P3|COMPLETED|Overall Study||8
151277|NCT01078376|365682|P2|COMPLETED|Overall Study||9
151278|NCT01078376|365683|P1|COMPLETED|Overall Study||9
151279|NCT01078376|365680|P4|STARTED|Overall Study||3
151280|NCT01078376|365681|P3|STARTED|Overall Study||8
151281|NCT01078376|365682|P2|STARTED|Overall Study||9
151282|NCT01078376|365683|P1|STARTED|Overall Study||9
151283|NCT01078363|365804|P2|NOT COMPLETED|Overall Study||0
151284|NCT01078363|365805|P1|NOT COMPLETED|Overall Study||0
151285|NCT01078363|365804|P2|COMPLETED|Overall Study||49
151286|NCT01078363|365805|P1|COMPLETED|Overall Study||47
151287|NCT01078363|365804|P2|STARTED|Overall Study||49
151288|NCT01078363|365805|P1|STARTED|Overall Study||47
151289|NCT01078298|365823|P2|NOT COMPLETED|Overall Study||90
151290|NCT01078298|365824|P1|NOT COMPLETED|Overall Study||81
151291|NCT01078298|365823|P2|COMPLETED|Overall Study||179
151292|NCT01078298|365824|P1|COMPLETED|Overall Study||175
151293|NCT01078298|365823|P2|STARTED|Overall Study||269
151294|NCT01078298|365824|P1|STARTED|Overall Study||256
151295|NCT01078246|365857|P7|NOT COMPLETED|Overall Study||0
151296|NCT01078246|365858|P6|NOT COMPLETED|Overall Study||0
151297|NCT01078246|365859|P5|NOT COMPLETED|Overall Study||0
151298|NCT01078246|365860|P4|NOT COMPLETED|Overall Study||0
151299|NCT01078246|365861|P3|NOT COMPLETED|Overall Study||0
151300|NCT01078246|365862|P2|NOT COMPLETED|Overall Study||0
151301|NCT01078246|365863|P1|NOT COMPLETED|Overall Study||0
151302|NCT01078246|365857|P7|COMPLETED|Overall Study||22
151303|NCT01078246|365858|P6|COMPLETED|Overall Study||231
151304|NCT01078246|365859|P5|COMPLETED|Overall Study||3310
151305|NCT01078246|365860|P4|COMPLETED|Overall Study||152
151306|NCT01078246|365861|P3|COMPLETED|Overall Study||1963
151307|NCT01078246|365862|P2|COMPLETED|Overall Study||405
151308|NCT01078246|365863|P1|COMPLETED|Overall Study||1041
151309|NCT01078246|365857|P7|STARTED|Overall Study||22
151310|NCT01078246|365858|P6|STARTED|Overall Study||231
151311|NCT01078246|365859|P5|STARTED|Overall Study||3310
151312|NCT01078246|365860|P4|STARTED|Overall Study||152
151313|NCT01078246|365861|P3|STARTED|Overall Study||1963
151314|NCT01078246|365862|P2|STARTED|Overall Study||405
151315|NCT01078246|365863|P1|STARTED|Overall Study||1041
151316|NCT01078233|365895|P6|NOT COMPLETED|Overall Study||0
151317|NCT01078233|365896|P5|NOT COMPLETED|Overall Study||0
151318|NCT01078233|365897|P4|NOT COMPLETED|Overall Study||0
151319|NCT01078233|365898|P3|NOT COMPLETED|Overall Study||0
151320|NCT01078233|365899|P2|NOT COMPLETED|Overall Study||0
151321|NCT01078233|365900|P1|NOT COMPLETED|Overall Study||0
151322|NCT01078233|365895|P6|COMPLETED|Overall Study||154
151323|NCT01078233|365896|P5|COMPLETED|Overall Study||3199
151324|NCT01078233|365897|P4|COMPLETED|Overall Study||631
151325|NCT01078233|365898|P3|COMPLETED|Overall Study||1681
151326|NCT01078233|365899|P2|COMPLETED|Overall Study||296
151327|NCT01078233|365900|P1|COMPLETED|Overall Study||656
151328|NCT01078233|365895|P6|STARTED|Overall Study||154
151329|NCT01078233|365896|P5|STARTED|Overall Study||3199
151330|NCT01078233|365897|P4|STARTED|Overall Study||631
151331|NCT01078233|365898|P3|STARTED|Overall Study||1681
151332|NCT01078233|365899|P2|STARTED|Overall Study||296
151333|NCT01078233|365900|P1|STARTED|Overall Study||656
151334|NCT01078220|365917|P1|NOT COMPLETED|Overall Study||0
151335|NCT01078220|365917|P1|COMPLETED|Overall Study||189629
151336|NCT01078220|365917|P1|STARTED|Overall Study||189629
151337|NCT01078207|365927|P1|NOT COMPLETED|Overall Study||0
151338|NCT01078207|365927|P1|COMPLETED|Overall Study||100
151339|NCT01078207|365927|P1|STARTED|Overall Study||100
151340|NCT01078168|365934|P2|NOT COMPLETED|Overall Study||1
151341|NCT01078168|365935|P1|NOT COMPLETED|Overall Study||0
151342|NCT01078168|365934|P2|COMPLETED|Overall Study||10
151343|NCT01078168|365935|P1|COMPLETED|Overall Study||11
151344|NCT01078168|365934|P2|STARTED|Overall Study||11
151345|NCT01078168|365935|P1|STARTED|Overall Study||11
151346|NCT01078155|365941|P1|NOT COMPLETED|Overall Study||44
151347|NCT01078155|365941|P1|COMPLETED|Overall Study||87
151348|NCT01078155|365941|P1|STARTED|Overall Study||131
151349|NCT01078116|365957|P1|NOT COMPLETED|Overall Study||48
151350|NCT01078116|365957|P1|COMPLETED|Overall Study||76
151351|NCT01078116|365957|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
151352|NCT01078090|365965|P1|NOT COMPLETED|Overall Study||4593
151353|NCT01078090|365965|P1|COMPLETED|Overall Study||1152
151354|NCT01078090|365965|P1|STARTED|Overall Study||5745
151355|NCT01077973|366009|P3|NOT COMPLETED|Overall Study||0
151356|NCT01077973|366010|P2|NOT COMPLETED|Overall Study||0
151357|NCT01077973|366011|P1|NOT COMPLETED|Overall Study||0
151358|NCT01077973|366009|P3|COMPLETED|Overall Study||80
151359|NCT01077973|366010|P2|COMPLETED|Overall Study||79
151360|NCT01077973|366011|P1|COMPLETED|Overall Study||41
151361|NCT01077973|366009|P3|STARTED|Overall Study||80
151362|NCT01077973|366010|P2|STARTED|Overall Study||79
151363|NCT01077973|366011|P1|STARTED|Overall Study||41
151364|NCT01077960|366059|P1|NOT COMPLETED|Overall Study||16
151365|NCT01077960|366059|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
151366|NCT01077960|366059|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
151367|NCT01077921|366070|P2|NOT COMPLETED|Second Intervention||1
151368|NCT01077921|366071|P1|NOT COMPLETED|Second Intervention||0
151369|NCT01077921|366070|P2|COMPLETED|Second Intervention||9
151370|NCT01077921|366071|P1|COMPLETED|Second Intervention||13
151371|NCT01077921|366070|P2|STARTED|Second Intervention||10
151372|NCT01077921|366071|P1|STARTED|Second Intervention||13
151373|NCT01077921|366070|P2|NOT COMPLETED|Washout||2
151374|NCT01077921|366071|P1|NOT COMPLETED|Washout||0
151375|NCT01077921|366070|P2|COMPLETED|Washout||10
151376|NCT01077921|366071|P1|COMPLETED|Washout||13
151377|NCT01077921|366070|P2|STARTED|Washout||12
151378|NCT01077921|366071|P1|STARTED|Washout||13
151379|NCT01077921|366070|P2|NOT COMPLETED|First Intervention||1
151380|NCT01077921|366071|P1|NOT COMPLETED|First Intervention||1
151381|NCT01077921|366070|P2|COMPLETED|First Intervention||12
151382|NCT01077921|366071|P1|COMPLETED|First Intervention||13
151383|NCT01077921|366070|P2|STARTED|First Intervention||13
151384|NCT01077921|366071|P1|STARTED|First Intervention||14
151385|NCT01077856|366104|P3|NOT COMPLETED|Overall Study||0
151386|NCT01077856|366105|P2|NOT COMPLETED|Overall Study||0
151387|NCT01077856|366106|P1|NOT COMPLETED|Overall Study||0
151388|NCT01077856|366104|P3|COMPLETED|Overall Study||15713
151389|NCT01077856|366105|P2|COMPLETED|Overall Study||16604
151390|NCT01077856|366106|P1|COMPLETED|Overall Study||22199
151391|NCT01077856|366104|P3|STARTED|Overall Study||15713
151392|NCT01077856|366105|P2|STARTED|Overall Study||16604
151393|NCT01077856|366106|P1|STARTED|Overall Study||22199
151394|NCT01077830|366287|P2|NOT COMPLETED|Overall Study||0
151395|NCT01077830|366288|P1|NOT COMPLETED|Overall Study||0
151396|NCT01077830|366287|P2|COMPLETED|Overall Study||682
151397|NCT01077830|366288|P1|COMPLETED|Overall Study||677
151398|NCT01077830|366287|P2|STARTED|Overall Study||682
151399|NCT01077830|366288|P1|STARTED|Overall Study||677
151400|NCT01077817|366298|P1|NOT COMPLETED|Overall Study||0
151401|NCT01077817|366298|P1|COMPLETED|Overall Study||684815
151402|NCT01077817|366298|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
151403|NCT01077804|366309|P1|NOT COMPLETED|Overall Study||199
151404|NCT01077804|366309|P1|COMPLETED|Overall Study||7386
151405|NCT01077804|366309|P1|STARTED|Overall Study||7585
151406|NCT01077739|366318|P2|NOT COMPLETED|Overall Study||10
151407|NCT01077739|366319|P1|NOT COMPLETED|Overall Study||5
151408|NCT01077739|366318|P2|COMPLETED|Overall Study||40
151409|NCT01077739|366319|P1|COMPLETED|Overall Study||20
151410|NCT01077739|366318|P2|STARTED|Overall Study||50
151411|NCT01077739|366319|P1|STARTED|Overall Study||25
151412|NCT01077713|366333|P2|NOT COMPLETED|Overall Study||36
151413|NCT01077713|366334|P1|NOT COMPLETED|Overall Study||36
151414|NCT01077713|366333|P2|COMPLETED|Overall Study||6
151415|NCT01077713|366334|P1|COMPLETED|Overall Study||8
151416|NCT01077713|366333|P2|STARTED|Overall Study||42
151417|NCT01077713|366334|P1|STARTED|Overall Study||44
151418|NCT01077622|366358|P1|NOT COMPLETED|Overall Study||3
151419|NCT01077622|366358|P1|COMPLETED|Overall Study||7
151420|NCT01077622|366358|P1|STARTED|Overall Study||10
151421|NCT01077596|366416|P12|NOT COMPLETED|Overall Study||0
151422|NCT01077596|366417|P11|NOT COMPLETED|Overall Study||0
151423|NCT01077596|366418|P10|NOT COMPLETED|Overall Study||0
151424|NCT01077596|366419|P9|NOT COMPLETED|Overall Study||0
151425|NCT01077596|366420|P8|NOT COMPLETED|Overall Study||0
151426|NCT01077596|366421|P7|NOT COMPLETED|Overall Study||0
151427|NCT01077596|366422|P6|NOT COMPLETED|Overall Study||0
151428|NCT01077596|366423|P5|NOT COMPLETED|Overall Study||0
151429|NCT01077596|366424|P4|NOT COMPLETED|Overall Study||0
151430|NCT01077596|366425|P3|NOT COMPLETED|Overall Study||0
151431|NCT01077596|366426|P2|NOT COMPLETED|Overall Study||0
151432|NCT01077596|366427|P1|NOT COMPLETED|Overall Study||0
151433|NCT01077596|366416|P12|COMPLETED|Overall Study||22150
151434|NCT01077596|366417|P11|COMPLETED|Overall Study||2215
151435|NCT01077596|366418|P10|COMPLETED|Overall Study||28420
151436|NCT01077596|366419|P9|COMPLETED|Overall Study||2842
151437|NCT01077596|366420|P8|COMPLETED|Overall Study||837
151438|NCT01077596|366421|P7|COMPLETED|Overall Study||308
151439|NCT01077596|366422|P6|COMPLETED|Overall Study||882
151440|NCT01077596|366423|P5|COMPLETED|Overall Study||294
151441|NCT01077596|366424|P4|COMPLETED|Overall Study||1370
151442|NCT01077596|366425|P3|COMPLETED|Overall Study||457
151443|NCT01077596|366426|P2|COMPLETED|Overall Study||1050
151444|NCT01077596|366427|P1|COMPLETED|Overall Study||350
151445|NCT01077596|366416|P12|STARTED|Overall Study||22150
151446|NCT01077596|366417|P11|STARTED|Overall Study||2215
151447|NCT01077596|366418|P10|STARTED|Overall Study||28420
151448|NCT01077596|366419|P9|STARTED|Overall Study||2842
151449|NCT01077596|366420|P8|STARTED|Overall Study||837
151450|NCT01077596|366421|P7|STARTED|Overall Study||308
151451|NCT01077596|366422|P6|STARTED|Overall Study||882
151452|NCT01077596|366423|P5|STARTED|Overall Study||294
151453|NCT01077596|366424|P4|STARTED|Overall Study||1370
151454|NCT01077596|366425|P3|STARTED|Overall Study||457
151455|NCT01077596|366426|P2|STARTED|Overall Study||1050
151456|NCT01077596|366427|P1|STARTED|Overall Study||350
151457|NCT01077544|366478|P2|NOT COMPLETED|Overall Study||5
151458|NCT01077544|366479|P1|NOT COMPLETED|Overall Study||3
151459|NCT01077544|366478|P2|COMPLETED|Overall Study||2
151460|NCT01077544|366479|P1|COMPLETED|Overall Study||5
151461|NCT01077544|366478|P2|STARTED|Overall Study||7
151462|NCT01077544|366479|P1|STARTED|Overall Study||8
151463|NCT01077401|366507|P2|NOT COMPLETED|Overall Study||21
151464|NCT01077401|366508|P1|NOT COMPLETED|Overall Study||18
151465|NCT01077401|366507|P2|COMPLETED|Overall Study||54
151466|NCT01077401|366508|P1|COMPLETED|Overall Study||59
151467|NCT01077401|366507|P2|STARTED|Overall Study||75
151468|NCT01077401|366508|P1|STARTED|Overall Study||77
151469|NCT01077375|366520|P2|NOT COMPLETED|Overall Study||35
151470|NCT01077375|366521|P1|NOT COMPLETED|Overall Study||10
151471|NCT01077375|366520|P2|COMPLETED|Overall Study||51
151472|NCT01077375|366521|P1|COMPLETED|Overall Study||11
151473|NCT01077375|366520|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
151474|NCT01077375|366521|P1|STARTED|Overall Study||21
151475|NCT01077362|366532|P3|NOT COMPLETED|Overall Study||24
151476|NCT01077362|366533|P2|NOT COMPLETED|Overall Study||19
151477|NCT01077362|366534|P1|NOT COMPLETED|Overall Study||31
151478|NCT01077362|366532|P3|COMPLETED|Overall Study||81
151479|NCT01077362|366533|P2|COMPLETED|Overall Study||84
151480|NCT01077362|366534|P1|COMPLETED|Overall Study||73
151481|NCT01077362|366532|P3|STARTED|Overall Study||105
151482|NCT01077362|366533|P2|STARTED|Overall Study||103
151483|NCT01077362|366534|P1|STARTED|Overall Study||104
151484|NCT01077323|366570|P3|NOT COMPLETED|Overall Study||11912089
151485|NCT01077323|366571|P2|NOT COMPLETED|Overall Study||386263
151486|NCT01077323|366572|P1|NOT COMPLETED|Overall Study||11378
151487|NCT01077323|366570|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
151488|NCT01077323|366571|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
151489|NCT01077323|366572|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
151490|NCT01077323|366570|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
151491|NCT01077323|366571|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
151492|NCT01077323|366572|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
151493|NCT01077310|366591|P2|NOT COMPLETED|Overall Study||0
151494|NCT01077310|366592|P1|NOT COMPLETED|Overall Study||0
151495|NCT01077310|366591|P2|COMPLETED|Overall Study||33
151496|NCT01077310|366592|P1|COMPLETED|Overall Study||67
151497|NCT01077310|366591|P2|STARTED|Overall Study||33
151498|NCT01077310|366592|P1|STARTED|Overall Study||67
151499|NCT01077284|366615|P3|NOT COMPLETED|Overall Study||3
151500|NCT01077284|366616|P2|NOT COMPLETED|Overall Study||5
151501|NCT01077284|366617|P1|NOT COMPLETED|Overall Study||5
151502|NCT01077284|366615|P3|COMPLETED|Overall Study||30
151503|NCT01077284|366616|P2|COMPLETED|Overall Study||28
151504|NCT01077284|366617|P1|COMPLETED|Overall Study||28
151505|NCT01077284|366615|P3|STARTED|Overall Study||33
151506|NCT01077284|366616|P2|STARTED|Overall Study||33
151507|NCT01077284|366617|P1|STARTED|Overall Study||33
151508|NCT01077271|366638|P1|NOT COMPLETED|Overall Study||22
151509|NCT01077271|366638|P1|COMPLETED|Overall Study||102
151510|NCT01077271|366638|P1|Number of Participants Analyzed|Overall Study||120
151511|NCT01077271|366638|P1|Participants Treated With Palivizumab|Overall Study||120
151512|NCT01077271|366638|P1|STARTED|Overall Study||124
151513|NCT01077258|366676|P1|NOT COMPLETED|Overall Study||2568
151514|NCT01077258|366676|P1|COMPLETED|Overall Study||1640
151515|NCT01077258|366676|P1|STARTED|Overall Study||4208
151516|NCT01077193|366712|P1|NOT COMPLETED|Overall Study||44
151517|NCT01077193|366712|P1|COMPLETED|Overall Study||0
151518|NCT01077193|366712|P1|STARTED|Overall Study||44
151519|NCT01077128|366716|P1|NOT COMPLETED|Overall Study||67
151520|NCT01077128|366716|P1|COMPLETED|Overall Study||433
151521|NCT01077128|366716|P1|STARTED|Overall Study||500
151522|NCT01077076|366774|P6|NOT COMPLETED|Third Intervention||1
151523|NCT01077076|366775|P5|NOT COMPLETED|Third Intervention||0
151524|NCT01077076|366776|P4|NOT COMPLETED|Third Intervention||0
151525|NCT01077076|366777|P3|NOT COMPLETED|Third Intervention||0
151526|NCT01077076|366778|P2|NOT COMPLETED|Third Intervention||0
151527|NCT01077076|366779|P1|NOT COMPLETED|Third Intervention||0
151528|NCT01077076|366774|P6|COMPLETED|Third Intervention||4
151529|NCT01077076|366775|P5|COMPLETED|Third Intervention||5
151530|NCT01077076|366776|P4|COMPLETED|Third Intervention||5
151531|NCT01077076|366777|P3|COMPLETED|Third Intervention||5
151532|NCT01077076|366778|P2|COMPLETED|Third Intervention||5
151533|NCT01077076|366779|P1|COMPLETED|Third Intervention||4
151534|NCT01077076|366774|P6|STARTED|Third Intervention||5
151535|NCT01077076|366775|P5|STARTED|Third Intervention||5
151536|NCT01077076|366776|P4|STARTED|Third Intervention||5
151537|NCT01077076|366777|P3|STARTED|Third Intervention||5
151538|NCT01077076|366778|P2|STARTED|Third Intervention||5
151539|NCT01077076|366779|P1|STARTED|Third Intervention||4
151540|NCT01077076|366774|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
151541|NCT01077076|366775|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
151542|NCT01077076|366776|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
151543|NCT01077076|366777|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
151544|NCT01077076|366778|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
151545|NCT01077076|366779|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
151546|NCT01077076|366774|P6|COMPLETED|Washout Period of 2 Weeks||5
151547|NCT01077076|366775|P5|COMPLETED|Washout Period of 2 Weeks||5
151548|NCT01077076|366776|P4|COMPLETED|Washout Period of 2 Weeks||5
151549|NCT01077076|366777|P3|COMPLETED|Washout Period of 2 Weeks||5
151550|NCT01077076|366778|P2|COMPLETED|Washout Period of 2 Weeks||5
151551|NCT01077076|366779|P1|COMPLETED|Washout Period of 2 Weeks||4
151552|NCT01077076|366774|P6|STARTED|Washout Period of 2 Weeks||5
151553|NCT01077076|366775|P5|STARTED|Washout Period of 2 Weeks||5
151554|NCT01077076|366776|P4|STARTED|Washout Period of 2 Weeks||5
151555|NCT01077076|366777|P3|STARTED|Washout Period of 2 Weeks||5
151556|NCT01077076|366778|P2|STARTED|Washout Period of 2 Weeks||5
151557|NCT01077076|366779|P1|STARTED|Washout Period of 2 Weeks||4
151558|NCT01077076|366774|P6|NOT COMPLETED|Second Intervention||0
151559|NCT01077076|366775|P5|NOT COMPLETED|Second Intervention||0
151560|NCT01077076|366776|P4|NOT COMPLETED|Second Intervention||0
151561|NCT01077076|366777|P3|NOT COMPLETED|Second Intervention||0
151562|NCT01077076|366778|P2|NOT COMPLETED|Second Intervention||0
151563|NCT01077076|366779|P1|NOT COMPLETED|Second Intervention||0
151564|NCT01077076|366774|P6|COMPLETED|Second Intervention||5
151565|NCT01077076|366775|P5|COMPLETED|Second Intervention||5
151566|NCT01077076|366776|P4|COMPLETED|Second Intervention||5
151567|NCT01077076|366777|P3|COMPLETED|Second Intervention||5
151568|NCT01077076|366778|P2|COMPLETED|Second Intervention||5
151569|NCT01077076|366779|P1|COMPLETED|Second Intervention||4
151570|NCT01077076|366774|P6|STARTED|Second Intervention||5
151571|NCT01077076|366775|P5|STARTED|Second Intervention||5
151572|NCT01077076|366776|P4|STARTED|Second Intervention||5
151573|NCT01077076|366777|P3|STARTED|Second Intervention||5
151574|NCT01077076|366778|P2|STARTED|Second Intervention||5
151575|NCT01077076|366779|P1|STARTED|Second Intervention||4
151576|NCT01077076|366774|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
151577|NCT01077076|366775|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
151578|NCT01077076|366776|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
151579|NCT01077076|366777|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
151580|NCT01077076|366778|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
151581|NCT01077076|366779|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
151582|NCT01077076|366774|P6|COMPLETED|Washout Period of 2 Weeks||5
151583|NCT01077076|366775|P5|COMPLETED|Washout Period of 2 Weeks||5
151584|NCT01077076|366776|P4|COMPLETED|Washout Period of 2 Weeks||5
151585|NCT01077076|366777|P3|COMPLETED|Washout Period of 2 Weeks||5
151586|NCT01077076|366778|P2|COMPLETED|Washout Period of 2 Weeks||5
151587|NCT01077076|366779|P1|COMPLETED|Washout Period of 2 Weeks||4
151588|NCT01077076|366774|P6|STARTED|Washout Period of 2 Weeks||5
151589|NCT01077076|366775|P5|STARTED|Washout Period of 2 Weeks||5
151590|NCT01077076|366776|P4|STARTED|Washout Period of 2 Weeks||5
151591|NCT01077076|366777|P3|STARTED|Washout Period of 2 Weeks||5
151592|NCT01077076|366778|P2|STARTED|Washout Period of 2 Weeks||5
151593|NCT01077076|366779|P1|STARTED|Washout Period of 2 Weeks||4
151594|NCT01077076|366774|P6|NOT COMPLETED|First Intervention||0
151595|NCT01077076|366775|P5|NOT COMPLETED|First Intervention||0
151596|NCT01077076|366776|P4|NOT COMPLETED|First Intervention||0
151597|NCT01077076|366777|P3|NOT COMPLETED|First Intervention||0
151598|NCT01077076|366778|P2|NOT COMPLETED|First Intervention||0
151599|NCT01077076|366779|P1|NOT COMPLETED|First Intervention||1
151600|NCT01077076|366774|P6|COMPLETED|First Intervention||5
151601|NCT01077076|366775|P5|COMPLETED|First Intervention||5
151602|NCT01077076|366776|P4|COMPLETED|First Intervention||5
151603|NCT01077076|366777|P3|COMPLETED|First Intervention||5
151604|NCT01077076|366778|P2|COMPLETED|First Intervention||5
151605|NCT01077076|366779|P1|COMPLETED|First Intervention||4
151606|NCT01077076|366774|P6|STARTED|First Intervention||5
151607|NCT01077076|366775|P5|STARTED|First Intervention||5
151608|NCT01077076|366776|P4|STARTED|First Intervention||5
151609|NCT01077076|366777|P3|STARTED|First Intervention||5
151610|NCT01077076|366778|P2|STARTED|First Intervention||5
151611|NCT01077076|366779|P1|STARTED|First Intervention||5
151612|NCT01077063|366789|P2|NOT COMPLETED|Overall Study||3
151613|NCT01077063|366790|P1|NOT COMPLETED|Overall Study||4
151614|NCT01077063|366789|P2|COMPLETED|Overall Study||0
151615|NCT01077063|366790|P1|COMPLETED|Overall Study||0
151616|NCT01077063|366789|P2|STARTED|Overall Study||3
151617|NCT01077063|366790|P1|STARTED|Overall Study||4
151618|NCT01077050|366796|P1|NOT COMPLETED|Overall Study||9
151619|NCT01077050|366796|P1|COMPLETED|Overall Study||1942
151620|NCT01077050|366796|P1|STARTED|Overall Study||1951
151621|NCT01077024|366802|P2|NOT COMPLETED|Overall Study||28
151622|NCT01077024|366803|P1|NOT COMPLETED|Overall Study||31
151623|NCT01077024|366802|P2|COMPLETED|Overall Study||243
151624|NCT01077024|366803|P1|COMPLETED|Overall Study||236
151625|NCT01077024|366802|P2|STARTED|Overall Study||271
151626|NCT01077024|366803|P1|STARTED|Overall Study||267
151627|NCT01076985|366821|P1|NOT COMPLETED|Overall Study||0
151628|NCT01076985|366821|P1|COMPLETED|Overall Study||24
151629|NCT01076985|366821|P1|STARTED|Overall Study||24
151630|NCT01076972|366827|P1|NOT COMPLETED|Overall Study||0
151631|NCT01076972|366827|P1|COMPLETED|Overall Study||1184
151632|NCT01076972|366827|P1|STARTED|Overall Study||1184
151633|NCT01076959|366842|P1|NOT COMPLETED|Overall Study||2250
151634|NCT01076959|366842|P1|COMPLETED|Overall Study||5490
151635|NCT01076959|366842|P1|STARTED|Overall Study||7740
151636|NCT01076686|366863|P4|NOT COMPLETED|Overall Study||0
151637|NCT01076686|366864|P3|NOT COMPLETED|Overall Study||0
151638|NCT01076686|366865|P2|NOT COMPLETED|Overall Study||0
151639|NCT01076686|366866|P1|NOT COMPLETED|Overall Study||0
151640|NCT01076686|366863|P4|COMPLETED|Overall Study||31
151641|NCT01076686|366864|P3|COMPLETED|Overall Study||32
151642|NCT01076686|366865|P2|COMPLETED|Overall Study||14
151643|NCT01076686|366866|P1|COMPLETED|Overall Study||17
151644|NCT01076686|366863|P4|STARTED|Overall Study||31
151645|NCT01076686|366864|P3|STARTED|Overall Study||32
151646|NCT01076686|366865|P2|STARTED|Overall Study||14
151647|NCT01076686|366866|P1|STARTED|Overall Study||17
151648|NCT01076647|366878|P2|NOT COMPLETED|Overall Study||25
151649|NCT01076647|366879|P1|NOT COMPLETED|Overall Study||25
151650|NCT01076647|366878|P2|COMPLETED|Overall Study||209
151651|NCT01076647|366879|P1|COMPLETED|Overall Study||208
151652|NCT01076647|366878|P2|STARTED|Overall Study||234
151653|NCT01076647|366879|P1|STARTED|Overall Study||233
151654|NCT01076504|366887|P1|NOT COMPLETED|Overall Study||80
151655|NCT01076504|366887|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
151656|NCT01076504|366887|P1|STARTED|Overall Study||80
151657|NCT01076452|366897|P2|NOT COMPLETED|Overall Study||14
151658|NCT01076452|366898|P1|NOT COMPLETED|Overall Study||24
151659|NCT01076452|366897|P2|COMPLETED|Overall Study||138
151660|NCT01076452|366898|P1|COMPLETED|Overall Study||123
151661|NCT01076452|366897|P2|STARTED|Overall Study||152
151662|NCT01076452|366898|P1|STARTED|Overall Study||147
151663|NCT01076400|366910|P3|NOT COMPLETED|Overall Study||0
151664|NCT01076400|366911|P2|NOT COMPLETED|Overall Study||0
151665|NCT01076400|366912|P1|NOT COMPLETED|Overall Study||7
151666|NCT01076400|366910|P3|COMPLETED|Overall Study||0
151667|NCT01076400|366911|P2|COMPLETED|Overall Study||0
151668|NCT01076400|366912|P1|COMPLETED|Overall Study||0
151669|NCT01076400|366910|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
151670|NCT01076400|366911|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
151671|NCT01076400|366912|P1|STARTED|Overall Study||7
151672|NCT01076361|366918|P1|NOT COMPLETED|Overall Study||21
151673|NCT01076361|366918|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
151674|NCT01076361|366918|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
151675|NCT01076348|366922|P1|NOT COMPLETED|Overall Study||22
151676|NCT01076348|366922|P1|COMPLETED|Overall Study||51
151677|NCT01076348|366922|P1|STARTED|Overall Study||73
151678|NCT01076335|366926|P1|NOT COMPLETED|Overall Study||4
151679|NCT01076335|366926|P1|COMPLETED|Overall Study||36
151680|NCT01076335|366926|P1|STARTED|Overall Study||40
151681|NCT01076296|366930|P8|NOT COMPLETED|Overall Study||0
151682|NCT01076296|366931|P7|NOT COMPLETED|Overall Study||0
151683|NCT01076296|366932|P6|NOT COMPLETED|Overall Study||0
151684|NCT01076296|366933|P5|NOT COMPLETED|Overall Study||0
151685|NCT01076296|366934|P4|NOT COMPLETED|Overall Study||0
151686|NCT01076296|366935|P3|NOT COMPLETED|Overall Study||0
151687|NCT01076296|366936|P2|NOT COMPLETED|Overall Study||0
151688|NCT01076296|366937|P1|NOT COMPLETED|Overall Study||0
151689|NCT01076296|366930|P8|COMPLETED|Overall Study||199
151690|NCT01076296|366931|P7|COMPLETED|Overall Study||51
151691|NCT01076296|366932|P6|COMPLETED|Overall Study||191
151692|NCT01076296|366933|P5|COMPLETED|Overall Study||59
151693|NCT01076296|366934|P4|COMPLETED|Overall Study||199
151694|NCT01076296|366935|P3|COMPLETED|Overall Study||51
151695|NCT01076296|366936|P2|COMPLETED|Overall Study||196
151696|NCT01076296|366937|P1|COMPLETED|Overall Study||54
151697|NCT01076296|366930|P8|STARTED|Overall Study||199
151698|NCT01076296|366931|P7|STARTED|Overall Study||51
151699|NCT01076296|366932|P6|STARTED|Overall Study||191
151700|NCT01076296|366933|P5|STARTED|Overall Study||59
151701|NCT01076296|366934|P4|STARTED|Overall Study||199
151702|NCT01076296|366935|P3|STARTED|Overall Study||51
151703|NCT01076296|366936|P2|STARTED|Overall Study||196
151704|NCT01076296|366937|P1|STARTED|Overall Study||54
151705|NCT01076283|366957|P2|NOT COMPLETED|Overall Study||0
151706|NCT01076283|366958|P1|NOT COMPLETED|Overall Study||1
151707|NCT01076283|366957|P2|COMPLETED|Overall Study||7
151708|NCT01076283|366958|P1|COMPLETED|Overall Study||6
151709|NCT01076283|366957|P2|STARTED|Overall Study||7
151710|NCT01076283|366958|P1|STARTED|Overall Study||7
151711|NCT01076270|366966|P1|NOT COMPLETED|Overall Study||0
151712|NCT01076270|366966|P1|COMPLETED|Overall Study||1
151713|NCT01076270|366966|P1|STARTED|Overall Study||1
151714|NCT01076244|366971|P1|NOT COMPLETED|Overall Study||4
151715|NCT01076244|366971|P1|COMPLETED|Overall Study||42
151716|NCT01076244|366971|P1|STARTED|Overall Study||46
151717|NCT01076192|366978|P1|NOT COMPLETED|Overall Study||197
151718|NCT01076192|366978|P1|COMPLETED|Overall Study||350
151719|NCT01076192|366978|P1|STARTED|Overall Study||547
151720|NCT01076179|366993|P1|NOT COMPLETED|Overall Study||1
151721|NCT01076179|366993|P1|COMPLETED|Overall Study||501
151722|NCT01076179|366993|P1|STARTED|Overall Study||502
151723|NCT01076166|367016|P1|NOT COMPLETED|Overall Study||9
151724|NCT01076166|367016|P1|COMPLETED|Overall Study||328
151725|NCT01076166|367016|P1|STARTED|Overall Study||337
151726|NCT01076153|367023|P1|NOT COMPLETED|Overall Study||11
151727|NCT01076153|367023|P1|COMPLETED|Overall Study||749
151728|NCT01076153|367023|P1|STARTED|Overall Study||760
151729|NCT01076088|367037|P6|NOT COMPLETED|Overall Study||23
151730|NCT01076088|367038|P5|NOT COMPLETED|Overall Study||16
151731|NCT01076088|367039|P4|NOT COMPLETED|Overall Study||15
151732|NCT01076088|367040|P3|NOT COMPLETED|Overall Study||17
151733|NCT01076088|367041|P2|NOT COMPLETED|Overall Study||18
151734|NCT01076088|367042|P1|NOT COMPLETED|Overall Study||11
151735|NCT01076088|367037|P6|COMPLETED|Overall Study||104
151736|NCT01076088|367038|P5|COMPLETED|Overall Study||104
151737|NCT01076088|367039|P4|COMPLETED|Overall Study||109
151738|NCT01076088|367040|P3|COMPLETED|Overall Study||109
151739|NCT01076088|367041|P2|COMPLETED|Overall Study||107
151740|NCT01076088|367042|P1|COMPLETED|Overall Study||111
151741|NCT01076088|367037|P6|STARTED|Overall Study||127
151742|NCT01076088|367038|P5|STARTED|Overall Study||120
151743|NCT01076088|367039|P4|STARTED|Overall Study||124
151744|NCT01076088|367040|P3|STARTED|Overall Study||126
151745|NCT01076088|367041|P2|STARTED|Overall Study||125
151746|NCT01076088|367042|P1|STARTED|Overall Study||122
151747|NCT01076075|367070|P2|NOT COMPLETED|Overall Study||47
151748|NCT01076075|367071|P1|NOT COMPLETED|Overall Study||41
151749|NCT01076075|367070|P2|COMPLETED|Overall Study||167
151750|NCT01076075|367071|P1|COMPLETED|Overall Study||172
151751|NCT01076075|367070|P2|Completed Phase A|Overall Study||189
151752|NCT01076075|367071|P1|Completed Phase A|Overall Study||199
151753|NCT01076075|367070|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
151754|NCT01076075|367071|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
151755|NCT01076036|367085|P1|NOT COMPLETED|Overall Study||2
151756|NCT01076036|367085|P1|COMPLETED|Overall Study||8
151757|NCT01076036|367085|P1|Complete CorPath Procedures|Overall Study||8
151758|NCT01076036|367085|P1|# of Procedures|Overall Study||8
151759|NCT01076036|367085|P1|STARTED|Overall Study||10
151760|NCT01075984|367095|P5|NOT COMPLETED|Follow-up Phase||47
151761|NCT01075984|367096|P4|NOT COMPLETED|Follow-up Phase||2
151762|NCT01075984|367097|P3|NOT COMPLETED|Follow-up Phase||1
151763|NCT01075984|367098|P2|NOT COMPLETED|Follow-up Phase||0
151764|NCT01075984|367099|P1|NOT COMPLETED|Follow-up Phase||0
151765|NCT01075984|367095|P5|COMPLETED|Follow-up Phase||165
151766|NCT01075984|367096|P4|COMPLETED|Follow-up Phase||19
151767|NCT01075984|367097|P3|COMPLETED|Follow-up Phase||19
151768|NCT01075984|367098|P2|COMPLETED|Follow-up Phase||10
151769|NCT01075984|367099|P1|COMPLETED|Follow-up Phase||10
151770|NCT01075984|367095|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
151771|NCT01075984|367096|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
151772|NCT01075984|367097|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
151773|NCT01075984|367098|P2|STARTED|Follow-up Phase||10
151774|NCT01075984|367099|P1|STARTED|Follow-up Phase||10
151775|NCT01075984|367095|P5|NOT COMPLETED|Treatment Phase||60
151776|NCT01075984|367096|P4|NOT COMPLETED|Treatment Phase||7
151777|NCT01075984|367097|P3|NOT COMPLETED|Treatment Phase||7
151778|NCT01075984|367098|P2|NOT COMPLETED|Treatment Phase||1
151779|NCT01075984|367099|P1|NOT COMPLETED|Treatment Phase||0
151780|NCT01075984|367095|P5|COMPLETED|Treatment Phase||153
151781|NCT01075984|367096|P4|COMPLETED|Treatment Phase||17
151782|NCT01075984|367097|P3|COMPLETED|Treatment Phase||14
151783|NCT01075984|367098|P2|COMPLETED|Treatment Phase||10
151784|NCT01075984|367099|P1|COMPLETED|Treatment Phase||10
151785|NCT01075984|367095|P5|STARTED|Treatment Phase||213
151786|NCT01075984|367096|P4|STARTED|Treatment Phase||24
151787|NCT01075984|367097|P3|STARTED|Treatment Phase||21
151788|NCT01075984|367098|P2|STARTED|Treatment Phase||11
151789|NCT01075984|367099|P1|STARTED|Treatment Phase||10
151790|NCT01075971|367153|P1|NOT COMPLETED|Overall Study||0
151791|NCT01075971|367153|P1|COMPLETED|Overall Study||52
151792|NCT01075971|367153|P1|STARTED|Overall Study||52
151793|NCT01075958|367157|P1|NOT COMPLETED|Overall Study||44
151794|NCT01075958|367157|P1|COMPLETED|Overall Study||239
151795|NCT01075958|367157|P1|STARTED|Overall Study||283
151796|NCT01075815|367173|P2|NOT COMPLETED|Overall Study||4
151797|NCT01075815|367174|P1|NOT COMPLETED|Overall Study||10
151798|NCT01075815|367173|P2|COMPLETED|Overall Study||31
151799|NCT01075815|367174|P1|COMPLETED|Overall Study||30
151800|NCT01075815|367173|P2|STARTED|Overall Study|Number of participants treated.|35
151801|NCT01075815|367174|P1|STARTED|Overall Study|Number of participants treated.|40
151802|NCT01075763|367212|P2|NOT COMPLETED|Overall Study||4
151803|NCT01075763|367213|P1|NOT COMPLETED|Overall Study||4
151804|NCT01075763|367212|P2|COMPLETED|Overall Study||15
151805|NCT01075763|367213|P1|COMPLETED|Overall Study||19
151806|NCT01075763|367212|P2|STARTED|Overall Study||19
151807|NCT01075763|367213|P1|STARTED|Overall Study||23
151808|NCT01075685|367237|P2|NOT COMPLETED|Overall Study||226
151809|NCT01075685|367238|P1|NOT COMPLETED|Overall Study||592
151810|NCT01075685|367237|P2|COMPLETED|Overall Study||188
151811|NCT01075685|367238|P1|COMPLETED|Overall Study||151
151812|NCT01075685|367237|P2|Completed Baseline Measures|Overall Study||263
151813|NCT01075685|367238|P1|Completed Baseline Measures|Overall Study||225
151814|NCT01075685|367237|P2|Met Inclusion Criteria|Overall Study||413
151815|NCT01075685|367238|P1|Met Inclusion Criteria|Overall Study||734
151816|NCT01075685|367237|P2|STARTED|Overall Study||414
151817|NCT01075685|367238|P1|STARTED|Overall Study||743
151818|NCT01075646|367254|P4|NOT COMPLETED|Overall Study||2
151819|NCT01075646|367255|P3|NOT COMPLETED|Overall Study||1
151820|NCT01075646|367256|P2|NOT COMPLETED|Overall Study||3
151821|NCT01075646|367257|P1|NOT COMPLETED|Overall Study||4
151822|NCT01075646|367254|P4|COMPLETED|Overall Study||44
151823|NCT01075646|367255|P3|COMPLETED|Overall Study||52
151824|NCT01075646|367256|P2|COMPLETED|Overall Study||31
151825|NCT01075646|367257|P1|COMPLETED|Overall Study||29
151826|NCT01075646|367254|P4|STARTED|Overall Study||46
151827|NCT01075646|367255|P3|STARTED|Overall Study||53
151828|NCT01075646|367256|P2|STARTED|Overall Study||34
151829|NCT01075646|367257|P1|STARTED|Overall Study||33
151830|NCT01075412|367289|P2|NOT COMPLETED|Overall Study||1
151831|NCT01075412|367290|P1|NOT COMPLETED|Overall Study||0
151832|NCT01075412|367289|P2|COMPLETED|Overall Study||1
151833|NCT01075412|367290|P1|COMPLETED|Overall Study||4
151834|NCT01075412|367289|P2|STARTED|Overall Study||2
151835|NCT01075412|367290|P1|STARTED|Overall Study||4
151836|NCT01075399|367300|P1|NOT COMPLETED|Overall Study||8
151837|NCT01075399|367300|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
151838|NCT01075399|367300|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
151839|NCT01075347|367306|P2|NOT COMPLETED|Overall Study||0
151840|NCT01075347|367307|P1|NOT COMPLETED|Overall Study||0
151841|NCT01075347|367306|P2|COMPLETED|Overall Study||83
151842|NCT01075347|367307|P1|COMPLETED|Overall Study||82
151843|NCT01075347|367306|P2|STARTED|Overall Study||83
151844|NCT01075347|367307|P1|STARTED|Overall Study||82
151845|NCT01075282|367318|P3|NOT COMPLETED|Overall Study||27
151846|NCT01075282|367319|P2|NOT COMPLETED|Overall Study||29
151847|NCT01075282|367320|P1|NOT COMPLETED|Overall Study||31
151848|NCT01075282|367318|P3|COMPLETED|Overall Study||238
151849|NCT01075282|367319|P2|COMPLETED|Overall Study||243
151850|NCT01075282|367320|P1|COMPLETED|Overall Study||242
151851|NCT01075282|367318|P3|Received at Least One Dose of Study Drug|Overall Study||262
151852|NCT01075282|367319|P2|Received at Least One Dose of Study Drug|Overall Study||272
151853|NCT01075282|367320|P1|Received at Least One Dose of Study Drug|Overall Study||273
151854|NCT01075282|367318|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
151855|NCT01075282|367319|P2|STARTED|Overall Study||272
151856|NCT01075282|367320|P1|STARTED|Overall Study||273
151857|NCT01075256|367403|P3|NOT COMPLETED|Overall Study||0
151858|NCT01075256|367404|P2|NOT COMPLETED|Overall Study||0
151859|NCT01075256|367405|P1|NOT COMPLETED|Overall Study||1
151860|NCT01075256|367403|P3|COMPLETED|Overall Study||65
151861|NCT01075256|367404|P2|COMPLETED|Overall Study||66
151862|NCT01075256|367405|P1|COMPLETED|Overall Study||63
151863|NCT01075256|367403|P3|STARTED|Overall Study||65
151864|NCT01075256|367404|P2|STARTED|Overall Study||66
151865|NCT01075256|367405|P1|STARTED|Overall Study||64
151866|NCT01075243|367437|P3|NOT COMPLETED|Overall Study||0
151867|NCT01075243|367438|P2|NOT COMPLETED|Overall Study||3
151868|NCT01075243|367439|P1|NOT COMPLETED|Overall Study||6
151869|NCT01075243|367437|P3|COMPLETED|Overall Study||80
151870|NCT01075243|367438|P2|COMPLETED|Overall Study||155
151871|NCT01075243|367439|P1|COMPLETED|Overall Study||157
151872|NCT01075243|367437|P3|STARTED|Overall Study||80
151873|NCT01075243|367438|P2|STARTED|Overall Study||158
151874|NCT01075243|367439|P1|STARTED|Overall Study||163
151875|NCT01075217|367491|P2|NOT COMPLETED|Overall Study||1
151876|NCT01075217|367492|P1|NOT COMPLETED|Overall Study||2
151877|NCT01075217|367491|P2|COMPLETED|Overall Study||84
151878|NCT01075217|367492|P1|COMPLETED|Overall Study||82
151879|NCT01075217|367491|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
151880|NCT01075217|367492|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
151881|NCT01075204|367508|P1|NOT COMPLETED|Overall Study||0
151882|NCT01075204|367508|P1|COMPLETED|Overall Study||335
151883|NCT01075204|367508|P1|STARTED|Overall Study||335
151884|NCT01075191|367525|P1|NOT COMPLETED|Overall Study||18
151885|NCT01075191|367525|P1|COMPLETED|Overall Study||42
151886|NCT01075191|367525|P1|Discontinued Year 3|Overall Study||5
151887|NCT01075191|367525|P1|Discontinued Year 2|Overall Study||6
151888|NCT01075191|367525|P1|Discontinued Year 1|Overall Study||7
151889|NCT01075191|367525|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
151890|NCT01075178|367536|P2|NOT COMPLETED|Subject Chart Review||9
151891|NCT01075178|367537|P1|NOT COMPLETED|Subject Chart Review||9
151892|NCT01075178|367536|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
151893|NCT01075178|367537|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
151894|NCT01075178|367536|P2|STARTED|Subject Chart Review|subjects matched|1018
151895|NCT01075178|367537|P1|STARTED|Subject Chart Review|subjects matched|1018
151896|NCT01075178|367536|P2|NOT COMPLETED|Subject Matching||403
151897|NCT01075178|367537|P1|NOT COMPLETED|Subject Matching||130
151898|NCT01075178|367536|P2|COMPLETED|Subject Matching|subjects matched|1018
151899|NCT01075178|367537|P1|COMPLETED|Subject Matching|subjects matched|1018
151900|NCT01075178|367536|P2|STARTED|Subject Matching|eligible for matching|1421
151901|NCT01075178|367537|P1|STARTED|Subject Matching|eligible for matching|1148
151902|NCT01075152|367551|P2|NOT COMPLETED|Overall Study||0
151903|NCT01075152|367552|P1|NOT COMPLETED|Overall Study||1
151904|NCT01075152|367551|P2|COMPLETED|Overall Study||89
151905|NCT01075152|367552|P1|COMPLETED|Overall Study||87
151906|NCT01075152|367551|P2|STARTED|Overall Study|randomized|89
151907|NCT01075152|367552|P1|STARTED|Overall Study|randomized|88
151908|NCT01075100|367578|P2|NOT COMPLETED|Overall Study||53
151909|NCT01075100|367579|P1|NOT COMPLETED|Overall Study||49
151910|NCT01075100|367578|P2|COMPLETED|Overall Study||1
151911|NCT01075100|367579|P1|COMPLETED|Overall Study||0
151912|NCT01075100|367578|P2|STARTED|Overall Study||54
151913|NCT01075100|367579|P1|STARTED|Overall Study||49
151914|NCT01075087|367597|P2|NOT COMPLETED|Overall Study||0
151915|NCT01075087|367598|P1|NOT COMPLETED|Overall Study||0
151916|NCT01075087|367597|P2|COMPLETED|Overall Study||10
151917|NCT01075087|367598|P1|COMPLETED|Overall Study||9
151918|NCT01075087|367597|P2|STARTED|Overall Study||10
151919|NCT01075087|367598|P1|STARTED|Overall Study||9
151920|NCT01075074|367609|P3|NOT COMPLETED|Overall Study||2
151921|NCT01075074|367610|P2|NOT COMPLETED|Overall Study||2
151922|NCT01075074|367611|P1|NOT COMPLETED|Overall Study||1
151923|NCT01075074|367609|P3|COMPLETED|Overall Study||23
151924|NCT01075074|367610|P2|COMPLETED|Overall Study||23
151925|NCT01075074|367611|P1|COMPLETED|Overall Study||24
151926|NCT01075074|367609|P3|STARTED|Overall Study||25
151927|NCT01075074|367610|P2|STARTED|Overall Study||25
151928|NCT01075074|367611|P1|STARTED|Overall Study||25
151929|NCT01074944|367628|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
151930|NCT01074944|367629|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
151931|NCT01074944|367630|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
151932|NCT01074944|367631|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
151933|NCT01074944|367632|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
151934|NCT01074944|367628|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
151935|NCT01074944|367629|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
151936|NCT01074944|367630|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
151937|NCT01074944|367631|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
151938|NCT01074944|367632|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
151939|NCT01074944|367628|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
151940|NCT01074944|367629|P4|STARTED|Extended Treatment (up to 42 Months)||0
151941|NCT01074944|367630|P3|STARTED|Extended Treatment (up to 42 Months)||0
151942|NCT01074944|367631|P2|STARTED|Extended Treatment (up to 42 Months)||0
151943|NCT01074944|367632|P1|STARTED|Extended Treatment (up to 42 Months)||0
151944|NCT01074944|367628|P5|NOT COMPLETED|Long Term Treatment||0
151945|NCT01074944|367629|P4|NOT COMPLETED|Long Term Treatment||26
151946|NCT01074944|367630|P3|NOT COMPLETED|Long Term Treatment||0
151947|NCT01074944|367631|P2|NOT COMPLETED|Long Term Treatment||0
151948|NCT01074944|367632|P1|NOT COMPLETED|Long Term Treatment||0
151949|NCT01074944|367628|P5|COMPLETED|Long Term Treatment||0
151950|NCT01074944|367629|P4|COMPLETED|Long Term Treatment||95
151951|NCT01074944|367630|P3|COMPLETED|Long Term Treatment||0
151952|NCT01074944|367631|P2|COMPLETED|Long Term Treatment||0
151953|NCT01074944|367632|P1|COMPLETED|Long Term Treatment||0
151954|NCT01074944|367628|P5|STARTED|Long Term Treatment||0
151955|NCT01074944|367629|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
151956|NCT01074944|367630|P3|STARTED|Long Term Treatment||0
151957|NCT01074944|367631|P2|STARTED|Long Term Treatment||0
151958|NCT01074944|367632|P1|STARTED|Long Term Treatment||0
151959|NCT01074944|367628|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
151960|NCT01074944|367629|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
151961|NCT01074944|367630|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
151962|NCT01074944|367631|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
151963|NCT01074944|367632|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
151964|NCT01074944|367628|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
151965|NCT01074944|367629|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
151966|NCT01074944|367630|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
151967|NCT01074944|367631|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
151968|NCT01074944|367632|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
151969|NCT01074944|367628|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
151970|NCT01074944|367629|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
151971|NCT01074944|367630|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
151972|NCT01074944|367631|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
151973|NCT01074944|367632|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
151974|NCT01074944|367628|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
151975|NCT01074944|367629|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
151976|NCT01074944|367630|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
151977|NCT01074944|367631|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
151978|NCT01074944|367632|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
151979|NCT01074944|367628|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
151980|NCT01074944|367629|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
151981|NCT01074944|367630|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
151982|NCT01074944|367631|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
151983|NCT01074944|367632|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
151984|NCT01074944|367628|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
151985|NCT01074944|367629|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
151986|NCT01074944|367630|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
151987|NCT01074944|367631|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
151988|NCT01074944|367632|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
151989|NCT01074931|367686|P1|NOT COMPLETED|Overall Study||6
151990|NCT01074931|367686|P1|COMPLETED|Overall Study||92
151991|NCT01074931|367686|P1|STARTED|Overall Study||98
151992|NCT01074658|367698|P1|NOT COMPLETED|Overall Study||19
151993|NCT01074658|367698|P1|COMPLETED|Overall Study||996
151994|NCT01074658|367698|P1|Attempted Implant|Overall Study||996
151995|NCT01074658|367698|P1|STARTED|Overall Study||1015
151996|NCT01074554|367706|P2|NOT COMPLETED|Overall Study||4
151997|NCT01074554|367707|P1|NOT COMPLETED|Overall Study||3
151998|NCT01074554|367706|P2|COMPLETED|Overall Study||11
151999|NCT01074554|367707|P1|COMPLETED|Overall Study||11
152000|NCT01074554|367706|P2|STARTED|Overall Study||15
152001|NCT01074554|367707|P1|STARTED|Overall Study||14
152002|NCT01074502|367717|P1|NOT COMPLETED|Overall Study||1
152003|NCT01074502|367717|P1|COMPLETED|Overall Study||2
152004|NCT01074502|367717|P1|STARTED|Overall Study||3
152005|NCT01074463|367728|P2|NOT COMPLETED|Second Intervention||0
152006|NCT01074463|367729|P1|NOT COMPLETED|Second Intervention||0
152007|NCT01074463|367728|P2|COMPLETED|Second Intervention||12
152008|NCT01074463|367729|P1|COMPLETED|Second Intervention||12
152009|NCT01074463|367728|P2|STARTED|Second Intervention||12
152010|NCT01074463|367729|P1|STARTED|Second Intervention||12
152011|NCT01074463|367728|P2|NOT COMPLETED|Washout of 7 Days||0
152012|NCT01074463|367729|P1|NOT COMPLETED|Washout of 7 Days||0
152013|NCT01074463|367728|P2|COMPLETED|Washout of 7 Days||12
152014|NCT01074463|367729|P1|COMPLETED|Washout of 7 Days||12
152015|NCT01074463|367728|P2|STARTED|Washout of 7 Days||12
152016|NCT01074463|367729|P1|STARTED|Washout of 7 Days||12
152017|NCT01074463|367728|P2|NOT COMPLETED|First Intervention||0
152018|NCT01074463|367729|P1|NOT COMPLETED|First Intervention||0
152019|NCT01074463|367728|P2|COMPLETED|First Intervention||12
152020|NCT01074463|367729|P1|COMPLETED|First Intervention||12
152021|NCT01074463|367728|P2|STARTED|First Intervention||12
152022|NCT01074463|367729|P1|STARTED|First Intervention||12
152023|NCT01074450|367741|P2|NOT COMPLETED|Second Intervention||1
152024|NCT01074450|367742|P1|NOT COMPLETED|Second Intervention||1
152025|NCT01074450|367741|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
152026|NCT01074450|367742|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
152027|NCT01074450|367741|P2|STARTED|Second Intervention||10
152028|NCT01074450|367742|P1|STARTED|Second Intervention||12
152029|NCT01074450|367741|P2|NOT COMPLETED|Washout of 7 Days||0
152030|NCT01074450|367742|P1|NOT COMPLETED|Washout of 7 Days||0
152031|NCT01074450|367741|P2|COMPLETED|Washout of 7 Days||10
152032|NCT01074450|367742|P1|COMPLETED|Washout of 7 Days||12
152033|NCT01074450|367741|P2|STARTED|Washout of 7 Days||10
152034|NCT01074450|367742|P1|STARTED|Washout of 7 Days||12
152035|NCT01074450|367741|P2|NOT COMPLETED|First Intervention||2
152036|NCT01074450|367742|P1|NOT COMPLETED|First Intervention||0
152037|NCT01074450|367741|P2|COMPLETED|First Intervention||10
152038|NCT01074450|367742|P1|COMPLETED|First Intervention||12
152039|NCT01074450|367741|P2|STARTED|First Intervention||12
152040|NCT01074450|367742|P1|STARTED|First Intervention||12
152041|NCT01074437|367754|P2|NOT COMPLETED|Overall Study||0
152042|NCT01074437|367755|P1|NOT COMPLETED|Overall Study||0
152043|NCT01074437|367754|P2|COMPLETED|Overall Study||5
152044|NCT01074437|367755|P1|COMPLETED|Overall Study||4
152045|NCT01074437|367754|P2|STARTED|Overall Study||5
152046|NCT01074437|367755|P1|STARTED|Overall Study||4
152047|NCT01074307|367763|P2|NOT COMPLETED|Overall Study||12
152048|NCT01074307|367764|P1|NOT COMPLETED|Overall Study||22
152049|NCT01074307|367763|P2|COMPLETED|Overall Study||102
152050|NCT01074307|367764|P1|COMPLETED|Overall Study||44
152051|NCT01074307|367763|P2|STARTED|Overall Study||114
152052|NCT01074307|367764|P1|STARTED|Overall Study||66
152053|NCT01074268|367786|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
152054|NCT01074268|367787|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
152055|NCT01074268|367786|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
152056|NCT01074268|367787|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
152057|NCT01074268|367786|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
152058|NCT01074268|367787|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
152059|NCT01074268|367786|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
152060|NCT01074268|367787|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
152061|NCT01074268|367786|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
152062|NCT01074268|367787|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
152063|NCT01074268|367786|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
152064|NCT01074268|367787|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
152065|NCT01074268|367786|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
152066|NCT01074268|367787|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
152067|NCT01074268|367786|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
152068|NCT01074268|367787|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
152069|NCT01074255|367813|P1|NOT COMPLETED|Overall Study||2
152070|NCT01074255|367813|P1|COMPLETED|Overall Study||3139
152071|NCT01074255|367813|P1|Treated|Overall Study||3139
152072|NCT01074255|367813|P1|STARTED|Overall Study||3141
152073|NCT01074242|367817|P1|NOT COMPLETED|Overall Study||403
152074|NCT01074242|367817|P1|COMPLETED|Overall Study||3395
152075|NCT01074242|367817|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
152076|NCT01074242|367817|P1|STARTED|Overall Study||3798
152077|NCT01074229|367825|P3|NOT COMPLETED|Overall Study||4
152078|NCT01074229|367826|P2|NOT COMPLETED|Overall Study||3
152079|NCT01074229|367827|P1|NOT COMPLETED|Overall Study||2
152080|NCT01074229|367825|P3|COMPLETED|Overall Study||21
152081|NCT01074229|367826|P2|COMPLETED|Overall Study||22
152082|NCT01074229|367827|P1|COMPLETED|Overall Study||23
152083|NCT01074229|367825|P3|STARTED|Overall Study||25
152084|NCT01074229|367826|P2|STARTED|Overall Study||25
152085|NCT01074229|367827|P1|STARTED|Overall Study||25
152086|NCT01074216|367838|P1|NOT COMPLETED|Overall Study||13
152087|NCT01074216|367838|P1|COMPLETED|Overall Study||41
152088|NCT01074216|367838|P1|STARTED|Overall Study||54
152089|NCT01074177|367842|P1|NOT COMPLETED|Overall Study||0
152090|NCT01074177|367842|P1|COMPLETED|Overall Study||24
152091|NCT01074177|367842|P1|STARTED|Overall Study||24
152092|NCT01074164|367851|P2|NOT COMPLETED|Overall Study||1
152093|NCT01074164|367852|P1|NOT COMPLETED|Overall Study||3
152094|NCT01074164|367851|P2|COMPLETED|Overall Study||7
152095|NCT01074164|367852|P1|COMPLETED|Overall Study||4
152096|NCT01074164|367851|P2|STARTED|Overall Study||8
152097|NCT01074164|367852|P1|STARTED|Overall Study||7
152098|NCT01074125|367873|P3|NOT COMPLETED|Overall Study||12
152099|NCT01074125|367874|P2|NOT COMPLETED|Overall Study||5
152100|NCT01074125|367875|P1|NOT COMPLETED|Overall Study||12
152101|NCT01074125|367873|P3|COMPLETED|Overall Study||36
152102|NCT01074125|367874|P2|COMPLETED|Overall Study||47
152103|NCT01074125|367875|P1|COMPLETED|Overall Study||39
152104|NCT01074125|367873|P3|STARTED|Overall Study||48
152105|NCT01074125|367874|P2|STARTED|Overall Study||52
152106|NCT01074125|367875|P1|STARTED|Overall Study||51
152107|NCT01074099|367891|P2|NOT COMPLETED|Overall Study||0
152108|NCT01074099|367892|P1|NOT COMPLETED|Overall Study||0
152109|NCT01074099|367891|P2|COMPLETED|Overall Study||3
152110|NCT01074099|367892|P1|COMPLETED|Overall Study||2
152111|NCT01074099|367891|P2|STARTED|Overall Study||3
152112|NCT01074099|367892|P1|STARTED|Overall Study||2
152113|NCT01074047|367902|P2|NOT COMPLETED|Extension Phase||0
152114|NCT01074047|367903|P1|NOT COMPLETED|Extension Phase||22
152115|NCT01074047|367902|P2|COMPLETED|Extension Phase||0
152116|NCT01074047|367903|P1|COMPLETED|Extension Phase||0
152117|NCT01074047|367902|P2|Safety Population|Extension Phase||0
152118|NCT01074047|367903|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
152119|NCT01074047|367902|P2|STARTED|Extension Phase||0
152120|NCT01074047|367903|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
152121|NCT01074047|367902|P2|NOT COMPLETED|Survival Follow-Up Phase||136
152122|NCT01074047|367903|P1|NOT COMPLETED|Survival Follow-Up Phase||124
152123|NCT01074047|367902|P2|COMPLETED|Survival Follow-Up Phase||27
152124|NCT01074047|367903|P1|COMPLETED|Survival Follow-Up Phase||16
152125|NCT01074047|367902|P2|STARTED|Survival Follow-Up Phase||163
152126|NCT01074047|367903|P1|STARTED|Survival Follow-Up Phase||140
152127|NCT01074047|367902|P2|NOT COMPLETED|Treatment Phase||234
152128|NCT01074047|367903|P1|NOT COMPLETED|Treatment Phase||217
152129|NCT01074047|367902|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
152130|NCT01074047|367903|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
152131|NCT01074047|367902|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
152132|NCT01074047|367903|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
152133|NCT01074047|367902|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
152134|NCT01074047|367903|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
152135|NCT01074047|367902|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
152136|NCT01074047|367903|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
152137|NCT01074047|367902|P2|STARTED|Treatment Phase||247
152138|NCT01074047|367903|P1|STARTED|Treatment Phase||241
152139|NCT01074034|367977|P1|NOT COMPLETED|Overall Study||6
152140|NCT01074034|367977|P1|COMPLETED|Overall Study||205
152141|NCT01074034|367977|P1|STARTED|Overall Study||211
152142|NCT01074008|367991|P9|NOT COMPLETED|Overall Study||4
152143|NCT01074008|367992|P8|NOT COMPLETED|Overall Study||0
152144|NCT01074008|367993|P7|NOT COMPLETED|Overall Study||1
152145|NCT01074008|367994|P6|NOT COMPLETED|Overall Study||0
152146|NCT01074008|367995|P5|NOT COMPLETED|Overall Study||2
152147|NCT01074008|367996|P4|NOT COMPLETED|Overall Study||1
152148|NCT01074008|367997|P3|NOT COMPLETED|Overall Study||2
152149|NCT01074008|367998|P2|NOT COMPLETED|Overall Study||3
152150|NCT01074008|367999|P1|NOT COMPLETED|Overall Study||1
152151|NCT01074008|367991|P9|COMPLETED|Overall Study||7
152152|NCT01074008|367992|P8|COMPLETED|Overall Study||8
152153|NCT01074008|367993|P7|COMPLETED|Overall Study||7
152154|NCT01074008|367994|P6|COMPLETED|Overall Study||7
152155|NCT01074008|367995|P5|COMPLETED|Overall Study||6
152156|NCT01074008|367996|P4|COMPLETED|Overall Study||7
152157|NCT01074008|367997|P3|COMPLETED|Overall Study||6
152158|NCT01074008|367998|P2|COMPLETED|Overall Study||5
152159|NCT01074008|367999|P1|COMPLETED|Overall Study||7
152160|NCT01074008|367991|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
152161|NCT01074008|367992|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
152162|NCT01074008|367993|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
152163|NCT01074008|367994|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
152164|NCT01074008|367995|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
152165|NCT01074008|367996|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
152166|NCT01074008|367997|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
152167|NCT01074008|367998|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
152168|NCT01074008|367999|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
152169|NCT01074008|367991|P9|STARTED|Overall Study||11
152170|NCT01074008|367992|P8|STARTED|Overall Study||8
152171|NCT01074008|367993|P7|STARTED|Overall Study||8
152172|NCT01074008|367994|P6|STARTED|Overall Study||7
152173|NCT01074008|367995|P5|STARTED|Overall Study||8
152174|NCT01074008|367996|P4|STARTED|Overall Study||8
152175|NCT01074008|367997|P3|STARTED|Overall Study||8
152176|NCT01074008|367998|P2|STARTED|Overall Study||8
152177|NCT01074008|367999|P1|STARTED|Overall Study||8
152178|NCT01073943|368109|P2|NOT COMPLETED|Overall Study||8
152179|NCT01073943|368110|P1|NOT COMPLETED|Overall Study||13
152180|NCT01073943|368109|P2|COMPLETED|Overall Study||295
152181|NCT01073943|368110|P1|COMPLETED|Overall Study||287
152182|NCT01073943|368109|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
152183|NCT01073943|368110|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
152184|NCT01073943|368109|P2|Safety Population (Treated)|Overall Study||302
152185|NCT01073943|368110|P1|Safety Population (Treated)|Overall Study||296
152186|NCT01073943|368109|P2|STARTED|Overall Study||303
152187|NCT01073943|368110|P1|STARTED|Overall Study||300
152188|NCT01073930|368136|P2|NOT COMPLETED|Overall Study||6
152189|NCT01073930|368137|P1|NOT COMPLETED|Overall Study||3
152190|NCT01073930|368136|P2|COMPLETED|Overall Study||295
152191|NCT01073930|368137|P1|COMPLETED|Overall Study||304
152192|NCT01073930|368136|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
152193|NCT01073930|368137|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
152194|NCT01073930|368136|P2|Safety Population (Treated)|Overall Study||298
152195|NCT01073930|368137|P1|Safety Population (Treated)|Overall Study||305
152196|NCT01073930|368136|P2|STARTED|Overall Study||301
152197|NCT01073930|368137|P1|STARTED|Overall Study||307
152198|NCT01073865|368161|P2|NOT COMPLETED|Overall Study||39
152199|NCT01073865|368162|P1|NOT COMPLETED|Overall Study||28
152200|NCT01073865|368161|P2|COMPLETED|Overall Study|Number of patients completed the study|74
152201|NCT01073865|368162|P1|COMPLETED|Overall Study|Number of patients completed the study|81
152202|NCT01073865|368161|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
152203|NCT01073865|368162|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
152204|NCT01073865|368161|P2|STARTED|Overall Study|Number of patients randomised|113
152205|NCT01073865|368162|P1|STARTED|Overall Study|Number of patients randomised|109
152206|NCT01073657|368174|P2|NOT COMPLETED|Overall Study||0
152207|NCT01073657|368175|P1|NOT COMPLETED|Overall Study||0
152208|NCT01073657|368174|P2|COMPLETED|Overall Study||16
152209|NCT01073657|368175|P1|COMPLETED|Overall Study||17
152210|NCT01073657|368174|P2|STARTED|Overall Study||16
152211|NCT01073657|368175|P1|STARTED|Overall Study||17
152212|NCT01073631|368181|P1|NOT COMPLETED|Overall Study||169
152213|NCT01073631|368181|P1|COMPLETED|Overall Study||374
152214|NCT01073631|368181|P1|STARTED|Overall Study||543
152215|NCT01073618|368186|P1|NOT COMPLETED|Overall Study||307
152216|NCT01073618|368186|P1|COMPLETED|Overall Study||385
152217|NCT01073618|368186|P1|STARTED|Overall Study||692
152218|NCT01073605|368194|P3|NOT COMPLETED|Overall Study||61
152219|NCT01073605|368195|P2|NOT COMPLETED|Overall Study||67
152220|NCT01073605|368196|P1|NOT COMPLETED|Overall Study||62
152221|NCT01073605|368194|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
152222|NCT01073605|368195|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
152223|NCT01073605|368196|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
152224|NCT01073605|368194|P3|Received Treatment|Overall Study||68
152225|NCT01073605|368195|P2|Received Treatment|Overall Study||70
152226|NCT01073605|368196|P1|Received Treatment|Overall Study||68
152227|NCT01073605|368194|P3|STARTED|Overall Study||69
152228|NCT01073605|368195|P2|STARTED|Overall Study||71
152229|NCT01073605|368196|P1|STARTED|Overall Study||68
152230|NCT01073566|368242|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
152231|NCT01073566|368243|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
152232|NCT01073566|368242|P2|COMPLETED|Period 2 (6 Weeks)||19
152233|NCT01073566|368243|P1|COMPLETED|Period 2 (6 Weeks)||18
152234|NCT01073566|368242|P2|STARTED|Period 2 (6 Weeks)||19
152235|NCT01073566|368243|P1|STARTED|Period 2 (6 Weeks)||19
152236|NCT01073566|368242|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
152237|NCT01073566|368243|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
152238|NCT01073566|368242|P2|COMPLETED|Period 1 (6 Weeks)||19
152239|NCT01073566|368243|P1|COMPLETED|Period 1 (6 Weeks)||19
152240|NCT01073566|368242|P2|STARTED|Period 1 (6 Weeks)||19
152241|NCT01073566|368243|P1|STARTED|Period 1 (6 Weeks)||19
152242|NCT01073462|368255|P1|NOT COMPLETED|Overall Study||41
152243|NCT01073462|368255|P1|COMPLETED|Overall Study||26
152244|NCT01073462|368255|P1|STARTED|Overall Study||67
152245|NCT01073449|368266|P1|NOT COMPLETED|Overall Study||0
152246|NCT01073449|368266|P1|COMPLETED|Overall Study||3362
152247|NCT01073449|368266|P1|STARTED|Overall Study||3362
152248|NCT01073293|368274|P2|NOT COMPLETED|Overall Study||11
152249|NCT01073293|368275|P1|NOT COMPLETED|Overall Study||5
152250|NCT01073293|368274|P2|COMPLETED|Overall Study||517
152251|NCT01073293|368275|P1|COMPLETED|Overall Study||521
152252|NCT01073293|368274|P2|STARTED|Overall Study||528
152253|NCT01073293|368275|P1|STARTED|Overall Study||526
152254|NCT01073267|368297|P1|NOT COMPLETED|Overall Study||3
152255|NCT01073267|368297|P1|COMPLETED|Overall Study||1
152256|NCT01073267|368297|P1|STARTED|Overall Study||4
152257|NCT01073163|368301|P1|NOT COMPLETED|Overall Study||3
152258|NCT01073163|368301|P1|COMPLETED|Overall Study|Patients completed study|51
152259|NCT01073163|368301|P1|Treated With >=6 Cycles|Overall Study||49
152260|NCT01073163|368301|P1|Treated With <6 Cycles|Overall Study||4
152261|NCT01073163|368301|P1|Enrolled But Not Treated|Overall Study||1
152262|NCT01073163|368301|P1|STARTED|Overall Study||54
152263|NCT01072929|368324|P3|NOT COMPLETED|Overall Study||9
152264|NCT01072929|368325|P2|NOT COMPLETED|Overall Study||51
152265|NCT01072929|368326|P1|NOT COMPLETED|Overall Study||44
152266|NCT01072929|368324|P3|COMPLETED|Overall Study||24
152267|NCT01072929|368325|P2|COMPLETED|Overall Study||150
152268|NCT01072929|368326|P1|COMPLETED|Overall Study||155
152269|NCT01072929|368324|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
152270|NCT01072929|368325|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
152271|NCT01072929|368326|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
152272|NCT01072929|368324|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
152273|NCT01072929|368325|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
152274|NCT01072929|368326|P1|Safety Population|Overall Study|Treated participants|199
152275|NCT01072929|368324|P3|STARTED|Overall Study||33
152276|NCT01072929|368325|P2|STARTED|Overall Study||201
152277|NCT01072929|368326|P1|STARTED|Overall Study||199
152278|NCT01072877|368405|P5|NOT COMPLETED|Overall Study||0
152279|NCT01072877|368406|P4|NOT COMPLETED|Overall Study||2
152280|NCT01072877|368407|P3|NOT COMPLETED|Overall Study||0
152281|NCT01072877|368408|P2|NOT COMPLETED|Overall Study||1
152282|NCT01072877|368409|P1|NOT COMPLETED|Overall Study||1
152283|NCT01072877|368405|P5|COMPLETED|Overall Study||63
152284|NCT01072877|368406|P4|COMPLETED|Overall Study||50
152285|NCT01072877|368407|P3|COMPLETED|Overall Study||51
152286|NCT01072877|368408|P2|COMPLETED|Overall Study||56
152287|NCT01072877|368409|P1|COMPLETED|Overall Study||55
152288|NCT01072877|368405|P5|STARTED|Overall Study||63
152289|NCT01072877|368406|P4|STARTED|Overall Study||52
152290|NCT01072877|368407|P3|STARTED|Overall Study||51
152291|NCT01072877|368408|P2|STARTED|Overall Study||57
152292|NCT01072877|368409|P1|STARTED|Overall Study||56
152293|NCT01072773|368431|P1|NOT COMPLETED|Overall Study||0
152294|NCT01072773|368431|P1|COMPLETED|Overall Study||2
152295|NCT01072773|368431|P1|STARTED|Overall Study||2
152296|NCT01072669|368442|P2|NOT COMPLETED|Overall Study||0
152297|NCT01072669|368443|P1|NOT COMPLETED|Overall Study||0
152298|NCT01072669|368442|P2|COMPLETED|Overall Study||5
152299|NCT01072669|368443|P1|COMPLETED|Overall Study||15
152300|NCT01072669|368442|P2|STARTED|Overall Study||5
152301|NCT01072669|368443|P1|STARTED|Overall Study||15
152302|NCT01072656|368451|P2|NOT COMPLETED|Second Intervention||0
152303|NCT01072656|368452|P1|NOT COMPLETED|Second Intervention||0
152304|NCT01072656|368451|P2|COMPLETED|Second Intervention||4
152305|NCT01072656|368452|P1|COMPLETED|Second Intervention||5
152306|NCT01072656|368451|P2|STARTED|Second Intervention||4
152307|NCT01072656|368452|P1|STARTED|Second Intervention||5
152308|NCT01072656|368451|P2|NOT COMPLETED|First Intervention||0
152309|NCT01072656|368452|P1|NOT COMPLETED|First Intervention||0
152310|NCT01072656|368451|P2|COMPLETED|First Intervention||4
152311|NCT01072656|368452|P1|COMPLETED|First Intervention||5
152312|NCT01072656|368451|P2|STARTED|First Intervention||4
152313|NCT01072656|368452|P1|STARTED|First Intervention||5
152314|NCT01072643|368462|P1|NOT COMPLETED|Overall Study||0
152315|NCT01072643|368462|P1|COMPLETED|Overall Study||4
152316|NCT01072643|368462|P1|STARTED|Overall Study||4
152317|NCT01072630|368472|P3|NOT COMPLETED|Overall Study||13
152318|NCT01072630|368473|P2|NOT COMPLETED|Overall Study||60
152319|NCT01072630|368474|P1|NOT COMPLETED|Overall Study||55
152320|NCT01072630|368472|P3|COMPLETED|Overall Study||17
152321|NCT01072630|368473|P2|COMPLETED|Overall Study||172
152322|NCT01072630|368474|P1|COMPLETED|Overall Study||175
152323|NCT01072630|368472|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
152324|NCT01072630|368473|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
152415|NCT01072175|368707|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
152325|NCT01072630|368474|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
152326|NCT01072630|368472|P3|Safety Population|Overall Study|Treated participants.|30
152327|NCT01072630|368473|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
152328|NCT01072630|368474|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
152329|NCT01072630|368472|P3|STARTED|Overall Study||30
152330|NCT01072630|368473|P2|STARTED|Overall Study||232
152331|NCT01072630|368474|P1|STARTED|Overall Study||230
152332|NCT01072617|368548|P1|NOT COMPLETED|Overall Study||0
152333|NCT01072617|368548|P1|COMPLETED|Overall Study||8
152334|NCT01072617|368548|P1|STARTED|Overall Study||8
152335|NCT01072539|368555|P1|NOT COMPLETED|Overall Study||3
152336|NCT01072539|368555|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
152337|NCT01072539|368555|P1|STARTED|Overall Study||3172
152338|NCT01072526|368563|P2|NOT COMPLETED|Overall Study||0
152339|NCT01072526|368564|P1|NOT COMPLETED|Overall Study||0
152340|NCT01072526|368563|P2|COMPLETED|Overall Study||0
152341|NCT01072526|368564|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
152342|NCT01072526|368563|P2|STARTED|Overall Study||0
152343|NCT01072526|368564|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
152344|NCT01072500|368579|P2|NOT COMPLETED|Overall Study||14
152345|NCT01072500|368580|P1|NOT COMPLETED|Overall Study||24
152346|NCT01072500|368579|P2|COMPLETED|Overall Study||803
152347|NCT01072500|368580|P1|COMPLETED|Overall Study||794
152348|NCT01072500|368579|P2|STARTED|Overall Study||817
152349|NCT01072500|368580|P1|STARTED|Overall Study||818
152350|NCT01072448|368590|P2|NOT COMPLETED|Overall Study||30
152351|NCT01072448|368591|P1|NOT COMPLETED|Overall Study||19
152352|NCT01072448|368590|P2|COMPLETED|Overall Study||130
152353|NCT01072448|368591|P1|COMPLETED|Overall Study||144
152354|NCT01072448|368590|P2|STARTED|Overall Study||160
152355|NCT01072448|368591|P1|STARTED|Overall Study||163
152356|NCT01072409|368599|P1|NOT COMPLETED|Overall Study||7
152357|NCT01072409|368599|P1|COMPLETED|Overall Study||38
152358|NCT01072409|368599|P1|STARTED|Overall Study||45
152359|NCT01072396|368605|P2|NOT COMPLETED|Period Two||3
152360|NCT01072396|368606|P1|NOT COMPLETED|Period Two||1
152361|NCT01072396|368605|P2|COMPLETED|Period Two||57
152362|NCT01072396|368606|P1|COMPLETED|Period Two||57
152363|NCT01072396|368605|P2|STARTED|Period Two||60
152364|NCT01072396|368606|P1|STARTED|Period Two||58
152365|NCT01072396|368605|P2|NOT COMPLETED|Washout Period||1
152366|NCT01072396|368606|P1|NOT COMPLETED|Washout Period||0
152367|NCT01072396|368605|P2|COMPLETED|Washout Period||60
152368|NCT01072396|368606|P1|COMPLETED|Washout Period||58
152369|NCT01072396|368605|P2|STARTED|Washout Period||61
152370|NCT01072396|368606|P1|STARTED|Washout Period||58
152371|NCT01072396|368605|P2|NOT COMPLETED|Period One||2
152372|NCT01072396|368606|P1|NOT COMPLETED|Period One||5
152373|NCT01072396|368605|P2|COMPLETED|Period One||61
152374|NCT01072396|368606|P1|COMPLETED|Period One||58
152375|NCT01072396|368605|P2|STARTED|Period One||63
152376|NCT01072396|368606|P1|STARTED|Period One||63
152377|NCT01072357|368618|P2|NOT COMPLETED|Overall Study||1
152378|NCT01072357|368619|P1|NOT COMPLETED|Overall Study||0
152379|NCT01072357|368618|P2|COMPLETED|Overall Study||14
152380|NCT01072357|368619|P1|COMPLETED|Overall Study||15
152381|NCT01072357|368618|P2|STARTED|Overall Study||15
152382|NCT01072357|368619|P1|STARTED|Overall Study||15
152383|NCT01072344|368629|P2|NOT COMPLETED|Overall Study||18
152384|NCT01072344|368630|P1|NOT COMPLETED|Overall Study||11
152385|NCT01072344|368629|P2|COMPLETED|Overall Study||29
152386|NCT01072344|368630|P1|COMPLETED|Overall Study||35
152387|NCT01072344|368629|P2|STARTED|Overall Study||47
152388|NCT01072344|368630|P1|STARTED|Overall Study||46
152389|NCT01072331|368647|P3|NOT COMPLETED|Overall Study||0
152390|NCT01072331|368648|P2|NOT COMPLETED|Overall Study||0
152391|NCT01072331|368649|P1|NOT COMPLETED|Overall Study||0
152392|NCT01072331|368647|P3|COMPLETED|Overall Study||32
152393|NCT01072331|368648|P2|COMPLETED|Overall Study||33
152394|NCT01072331|368649|P1|COMPLETED|Overall Study||34
152395|NCT01072331|368647|P3|STARTED|Overall Study||32
152396|NCT01072331|368648|P2|STARTED|Overall Study||33
152397|NCT01072331|368649|P1|STARTED|Overall Study||34
152398|NCT01072201|368668|P2|NOT COMPLETED|Overall Study||1
152399|NCT01072201|368669|P1|NOT COMPLETED|Overall Study||0
152400|NCT01072201|368668|P2|COMPLETED|Overall Study||29
152401|NCT01072201|368669|P1|COMPLETED|Overall Study||30
152402|NCT01072201|368668|P2|STARTED|Overall Study||30
152403|NCT01072201|368669|P1|STARTED|Overall Study||30
152404|NCT01072188|368681|P2|NOT COMPLETED|Overall Study||0
152405|NCT01072188|368682|P1|NOT COMPLETED|Overall Study||0
152406|NCT01072188|368681|P2|COMPLETED|Overall Study||23
152407|NCT01072188|368682|P1|COMPLETED|Overall Study||22
152408|NCT01072188|368681|P2|STARTED|Overall Study||23
152409|NCT01072188|368682|P1|STARTED|Overall Study||22
152410|NCT01072175|368702|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
152411|NCT01072175|368703|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
152412|NCT01072175|368704|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
152413|NCT01072175|368705|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
152414|NCT01072175|368706|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
152416|NCT01072175|368708|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
152417|NCT01072175|368709|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
152418|NCT01072175|368710|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
152419|NCT01072175|368711|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
152420|NCT01072175|368712|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
152421|NCT01072175|368713|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
152422|NCT01072175|368714|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
152423|NCT01072175|368702|P13|COMPLETED|Part D (HPMC Capsules)||0
152424|NCT01072175|368703|P12|COMPLETED|Part D (HPMC Capsules)||0
152425|NCT01072175|368704|P11|COMPLETED|Part D (HPMC Capsules)||0
152426|NCT01072175|368705|P10|COMPLETED|Part D (HPMC Capsules)||0
152427|NCT01072175|368706|P9|COMPLETED|Part D (HPMC Capsules)||0
152428|NCT01072175|368707|P8|COMPLETED|Part D (HPMC Capsules)||0
152429|NCT01072175|368708|P7|COMPLETED|Part D (HPMC Capsules)||0
152430|NCT01072175|368709|P6|COMPLETED|Part D (HPMC Capsules)||0
152431|NCT01072175|368710|P5|COMPLETED|Part D (HPMC Capsules)||0
152432|NCT01072175|368711|P4|COMPLETED|Part D (HPMC Capsules)||0
152433|NCT01072175|368712|P3|COMPLETED|Part D (HPMC Capsules)||0
152434|NCT01072175|368713|P2|COMPLETED|Part D (HPMC Capsules)||0
152435|NCT01072175|368714|P1|COMPLETED|Part D (HPMC Capsules)||0
152436|NCT01072175|368702|P13|Ongoing|Part D (HPMC Capsules)||34
152437|NCT01072175|368703|P12|Ongoing|Part D (HPMC Capsules)||34
152438|NCT01072175|368704|P11|Ongoing|Part D (HPMC Capsules)||12
152439|NCT01072175|368705|P10|Ongoing|Part D (HPMC Capsules)||10
152440|NCT01072175|368706|P9|Ongoing|Part D (HPMC Capsules)||0
152441|NCT01072175|368707|P8|Ongoing|Part D (HPMC Capsules)||0
152442|NCT01072175|368708|P7|Ongoing|Part D (HPMC Capsules)||0
152443|NCT01072175|368709|P6|Ongoing|Part D (HPMC Capsules)||0
152444|NCT01072175|368710|P5|Ongoing|Part D (HPMC Capsules)||0
152445|NCT01072175|368711|P4|Ongoing|Part D (HPMC Capsules)||0
152446|NCT01072175|368712|P3|Ongoing|Part D (HPMC Capsules)||0
152447|NCT01072175|368713|P2|Ongoing|Part D (HPMC Capsules)||0
152448|NCT01072175|368714|P1|Ongoing|Part D (HPMC Capsules)||0
152449|NCT01072175|368702|P13|STARTED|Part D (HPMC Capsules)||39
152450|NCT01072175|368703|P12|STARTED|Part D (HPMC Capsules)||43
152451|NCT01072175|368704|P11|STARTED|Part D (HPMC Capsules)||16
152452|NCT01072175|368705|P10|STARTED|Part D (HPMC Capsules)||12
152453|NCT01072175|368706|P9|STARTED|Part D (HPMC Capsules)||0
152454|NCT01072175|368707|P8|STARTED|Part D (HPMC Capsules)||0
152455|NCT01072175|368708|P7|STARTED|Part D (HPMC Capsules)||0
152456|NCT01072175|368709|P6|STARTED|Part D (HPMC Capsules)||0
152457|NCT01072175|368710|P5|STARTED|Part D (HPMC Capsules)||0
152458|NCT01072175|368711|P4|STARTED|Part D (HPMC Capsules)||0
152459|NCT01072175|368712|P3|STARTED|Part D (HPMC Capsules)||0
152460|NCT01072175|368713|P2|STARTED|Part D (HPMC Capsules)||0
152461|NCT01072175|368714|P1|STARTED|Part D (HPMC Capsules)||0
152462|NCT01072175|368702|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152463|NCT01072175|368703|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152464|NCT01072175|368704|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152465|NCT01072175|368705|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152466|NCT01072175|368706|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||43
152467|NCT01072175|368707|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152468|NCT01072175|368708|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152469|NCT01072175|368709|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152470|NCT01072175|368710|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152471|NCT01072175|368711|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152472|NCT01072175|368712|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152473|NCT01072175|368713|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152474|NCT01072175|368714|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152475|NCT01072175|368702|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152476|NCT01072175|368703|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152477|NCT01072175|368704|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152478|NCT01072175|368705|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152479|NCT01072175|368706|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152480|NCT01072175|368707|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152481|NCT01072175|368708|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152482|NCT01072175|368709|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152483|NCT01072175|368710|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152484|NCT01072175|368711|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152485|NCT01072175|368712|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152486|NCT01072175|368713|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152487|NCT01072175|368714|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
152488|NCT01072175|368702|P13|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152489|NCT01072175|368703|P12|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152490|NCT01072175|368704|P11|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152491|NCT01072175|368705|P10|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152492|NCT01072175|368706|P9|Ongoing|Part C (Phase II: Crossover Phase [CP])||28
152493|NCT01072175|368707|P8|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152494|NCT01072175|368708|P7|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152495|NCT01072175|368709|P6|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152648|NCT01072175|368706|P9|STARTED|Part A (Drug-Drug Interaction)||0
152496|NCT01072175|368710|P5|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152497|NCT01072175|368711|P4|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152498|NCT01072175|368712|P3|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152499|NCT01072175|368713|P2|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152500|NCT01072175|368714|P1|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
152501|NCT01072175|368702|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152502|NCT01072175|368703|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152503|NCT01072175|368704|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152504|NCT01072175|368705|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152505|NCT01072175|368706|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||43
152506|NCT01072175|368707|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152507|NCT01072175|368708|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152508|NCT01072175|368709|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152509|NCT01072175|368710|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152510|NCT01072175|368711|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152511|NCT01072175|368712|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152512|NCT01072175|368713|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152513|NCT01072175|368714|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
152514|NCT01072175|368702|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152515|NCT01072175|368703|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152516|NCT01072175|368704|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152517|NCT01072175|368705|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152518|NCT01072175|368706|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152519|NCT01072175|368707|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
152520|NCT01072175|368708|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
152521|NCT01072175|368709|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
152522|NCT01072175|368710|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152523|NCT01072175|368711|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152524|NCT01072175|368712|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152525|NCT01072175|368713|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152526|NCT01072175|368714|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
152527|NCT01072175|368702|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
152528|NCT01072175|368703|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
152529|NCT01072175|368704|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
152530|NCT01072175|368705|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
152531|NCT01072175|368706|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
152532|NCT01072175|368707|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
152533|NCT01072175|368708|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
152534|NCT01072175|368709|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
152535|NCT01072175|368710|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
152536|NCT01072175|368711|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
152537|NCT01072175|368712|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
152538|NCT01072175|368713|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
152539|NCT01072175|368714|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
152540|NCT01072175|368702|P13|Ongoing|Part C (Phase II: Randomized Phase)||0
152541|NCT01072175|368703|P12|Ongoing|Part C (Phase II: Randomized Phase)||0
152542|NCT01072175|368704|P11|Ongoing|Part C (Phase II: Randomized Phase)||0
152543|NCT01072175|368705|P10|Ongoing|Part C (Phase II: Randomized Phase)||0
152544|NCT01072175|368706|P9|Ongoing|Part C (Phase II: Randomized Phase)||0
152545|NCT01072175|368707|P8|Ongoing|Part C (Phase II: Randomized Phase)||40
152546|NCT01072175|368708|P7|Ongoing|Part C (Phase II: Randomized Phase)||32
152547|NCT01072175|368709|P6|Ongoing|Part C (Phase II: Randomized Phase)||35
152548|NCT01072175|368710|P5|Ongoing|Part C (Phase II: Randomized Phase)||0
152549|NCT01072175|368711|P4|Ongoing|Part C (Phase II: Randomized Phase)||0
152550|NCT01072175|368712|P3|Ongoing|Part C (Phase II: Randomized Phase)||0
152551|NCT01072175|368713|P2|Ongoing|Part C (Phase II: Randomized Phase)||0
152552|NCT01072175|368714|P1|Ongoing|Part C (Phase II: Randomized Phase)||0
152553|NCT01072175|368702|P13|STARTED|Part C (Phase II: Randomized Phase)||0
152554|NCT01072175|368703|P12|STARTED|Part C (Phase II: Randomized Phase)||0
152555|NCT01072175|368704|P11|STARTED|Part C (Phase II: Randomized Phase)||0
152556|NCT01072175|368705|P10|STARTED|Part C (Phase II: Randomized Phase)||0
152557|NCT01072175|368706|P9|STARTED|Part C (Phase II: Randomized Phase)||0
152558|NCT01072175|368707|P8|STARTED|Part C (Phase II: Randomized Phase)||54
152559|NCT01072175|368708|P7|STARTED|Part C (Phase II: Randomized Phase)||54
152560|NCT01072175|368709|P6|STARTED|Part C (Phase II: Randomized Phase)||54
152561|NCT01072175|368710|P5|STARTED|Part C (Phase II: Randomized Phase)||0
152562|NCT01072175|368711|P4|STARTED|Part C (Phase II: Randomized Phase)||0
152563|NCT01072175|368712|P3|STARTED|Part C (Phase II: Randomized Phase)||0
152564|NCT01072175|368713|P2|STARTED|Part C (Phase II: Randomized Phase)||0
152565|NCT01072175|368714|P1|STARTED|Part C (Phase II: Randomized Phase)||0
152566|NCT01072175|368702|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152567|NCT01072175|368703|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152568|NCT01072175|368704|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152569|NCT01072175|368705|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152570|NCT01072175|368706|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152571|NCT01072175|368707|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152572|NCT01072175|368708|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152573|NCT01072175|368709|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152574|NCT01072175|368710|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||79
152575|NCT01072175|368711|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
152576|NCT01072175|368712|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
152577|NCT01072175|368713|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
152578|NCT01072175|368714|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
152579|NCT01072175|368702|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
152580|NCT01072175|368703|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
152581|NCT01072175|368704|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
152582|NCT01072175|368705|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
152583|NCT01072175|368706|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
152584|NCT01072175|368707|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
152585|NCT01072175|368708|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
152586|NCT01072175|368709|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
152587|NCT01072175|368710|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
152588|NCT01072175|368711|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
152589|NCT01072175|368712|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
152590|NCT01072175|368713|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
152591|NCT01072175|368714|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
152592|NCT01072175|368702|P13|Ongoing|Part B (Dose Escalation and Expansion)||0
152593|NCT01072175|368703|P12|Ongoing|Part B (Dose Escalation and Expansion)||0
152594|NCT01072175|368704|P11|Ongoing|Part B (Dose Escalation and Expansion)||0
152595|NCT01072175|368705|P10|Ongoing|Part B (Dose Escalation and Expansion)||0
152596|NCT01072175|368706|P9|Ongoing|Part B (Dose Escalation and Expansion)||0
152597|NCT01072175|368707|P8|Ongoing|Part B (Dose Escalation and Expansion)||0
152598|NCT01072175|368708|P7|Ongoing|Part B (Dose Escalation and Expansion)||0
152599|NCT01072175|368709|P6|Ongoing|Part B (Dose Escalation and Expansion)||0
152600|NCT01072175|368710|P5|Ongoing|Part B (Dose Escalation and Expansion)||28
152601|NCT01072175|368711|P4|Ongoing|Part B (Dose Escalation and Expansion)||9
152602|NCT01072175|368712|P3|Ongoing|Part B (Dose Escalation and Expansion)||10
152603|NCT01072175|368713|P2|Ongoing|Part B (Dose Escalation and Expansion)||2
152604|NCT01072175|368714|P1|Ongoing|Part B (Dose Escalation and Expansion)||0
152605|NCT01072175|368702|P13|STARTED|Part B (Dose Escalation and Expansion)||0
152606|NCT01072175|368703|P12|STARTED|Part B (Dose Escalation and Expansion)||0
152607|NCT01072175|368704|P11|STARTED|Part B (Dose Escalation and Expansion)||0
152608|NCT01072175|368705|P10|STARTED|Part B (Dose Escalation and Expansion)||0
152609|NCT01072175|368706|P9|STARTED|Part B (Dose Escalation and Expansion)||0
152610|NCT01072175|368707|P8|STARTED|Part B (Dose Escalation and Expansion)||0
152611|NCT01072175|368708|P7|STARTED|Part B (Dose Escalation and Expansion)||0
152612|NCT01072175|368709|P6|STARTED|Part B (Dose Escalation and Expansion)||0
152613|NCT01072175|368710|P5|STARTED|Part B (Dose Escalation and Expansion)||79
152614|NCT01072175|368711|P4|STARTED|Part B (Dose Escalation and Expansion)||27
152615|NCT01072175|368712|P3|STARTED|Part B (Dose Escalation and Expansion)||23
152616|NCT01072175|368713|P2|STARTED|Part B (Dose Escalation and Expansion)||6
152617|NCT01072175|368714|P1|STARTED|Part B (Dose Escalation and Expansion)||0
152618|NCT01072175|368702|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152619|NCT01072175|368703|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152620|NCT01072175|368704|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152621|NCT01072175|368705|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152622|NCT01072175|368706|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152623|NCT01072175|368707|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152624|NCT01072175|368708|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152625|NCT01072175|368709|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152626|NCT01072175|368710|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152627|NCT01072175|368711|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152628|NCT01072175|368712|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152629|NCT01072175|368713|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
152630|NCT01072175|368714|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
152631|NCT01072175|368702|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
152632|NCT01072175|368703|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
152633|NCT01072175|368704|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
152634|NCT01072175|368705|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
152635|NCT01072175|368706|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
152636|NCT01072175|368707|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
152637|NCT01072175|368708|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
152638|NCT01072175|368709|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
152639|NCT01072175|368710|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
152640|NCT01072175|368711|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
152641|NCT01072175|368712|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
152642|NCT01072175|368713|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
152643|NCT01072175|368714|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
152644|NCT01072175|368702|P13|STARTED|Part A (Drug-Drug Interaction)||0
152645|NCT01072175|368703|P12|STARTED|Part A (Drug-Drug Interaction)||0
152646|NCT01072175|368704|P11|STARTED|Part A (Drug-Drug Interaction)||0
152647|NCT01072175|368705|P10|STARTED|Part A (Drug-Drug Interaction)||0
152649|NCT01072175|368707|P8|STARTED|Part A (Drug-Drug Interaction)||0
152650|NCT01072175|368708|P7|STARTED|Part A (Drug-Drug Interaction)||0
152651|NCT01072175|368709|P6|STARTED|Part A (Drug-Drug Interaction)||0
152652|NCT01072175|368710|P5|STARTED|Part A (Drug-Drug Interaction)||0
152653|NCT01072175|368711|P4|STARTED|Part A (Drug-Drug Interaction)||0
152654|NCT01072175|368712|P3|STARTED|Part A (Drug-Drug Interaction)||0
152655|NCT01072175|368713|P2|STARTED|Part A (Drug-Drug Interaction)||0
152656|NCT01072175|368714|P1|STARTED|Part A (Drug-Drug Interaction)||8
152657|NCT01072149|368897|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152658|NCT01072149|368898|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152659|NCT01072149|368899|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152660|NCT01072149|368900|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152661|NCT01072149|368901|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
152662|NCT01072149|368902|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152663|NCT01072149|368903|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152664|NCT01072149|368904|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152665|NCT01072149|368905|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152666|NCT01072149|368906|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152667|NCT01072149|368907|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152668|NCT01072149|368908|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152669|NCT01072149|368909|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152670|NCT01072149|368910|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152671|NCT01072149|368911|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152672|NCT01072149|368912|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
152673|NCT01072149|368913|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152674|NCT01072149|368914|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
152675|NCT01072149|368897|P18|COMPLETED|Treatment Period 3 (28 Days)||2
152676|NCT01072149|368898|P17|COMPLETED|Treatment Period 3 (28 Days)||3
152677|NCT01072149|368899|P16|COMPLETED|Treatment Period 3 (28 Days)||1
152678|NCT01072149|368900|P15|COMPLETED|Treatment Period 3 (28 Days)||3
152679|NCT01072149|368901|P14|COMPLETED|Treatment Period 3 (28 Days)||2
152680|NCT01072149|368902|P13|COMPLETED|Treatment Period 3 (28 Days)||2
152681|NCT01072149|368903|P12|COMPLETED|Treatment Period 3 (28 Days)||3
152682|NCT01072149|368904|P11|COMPLETED|Treatment Period 3 (28 Days)||2
152683|NCT01072149|368905|P10|COMPLETED|Treatment Period 3 (28 Days)||3
152684|NCT01072149|368906|P9|COMPLETED|Treatment Period 3 (28 Days)||3
152685|NCT01072149|368907|P8|COMPLETED|Treatment Period 3 (28 Days)||2
152686|NCT01072149|368908|P7|COMPLETED|Treatment Period 3 (28 Days)||3
152687|NCT01072149|368909|P6|COMPLETED|Treatment Period 3 (28 Days)||3
152688|NCT01072149|368910|P5|COMPLETED|Treatment Period 3 (28 Days)||3
152689|NCT01072149|368911|P4|COMPLETED|Treatment Period 3 (28 Days)||3
152690|NCT01072149|368912|P3|COMPLETED|Treatment Period 3 (28 Days)||0
152691|NCT01072149|368913|P2|COMPLETED|Treatment Period 3 (28 Days)||2
152692|NCT01072149|368914|P1|COMPLETED|Treatment Period 3 (28 Days)||2
152693|NCT01072149|368897|P18|STARTED|Treatment Period 3 (28 Days)||2
152694|NCT01072149|368898|P17|STARTED|Treatment Period 3 (28 Days)||3
152695|NCT01072149|368899|P16|STARTED|Treatment Period 3 (28 Days)||1
152696|NCT01072149|368900|P15|STARTED|Treatment Period 3 (28 Days)||3
152697|NCT01072149|368901|P14|STARTED|Treatment Period 3 (28 Days)||3
152698|NCT01072149|368902|P13|STARTED|Treatment Period 3 (28 Days)||2
152699|NCT01072149|368903|P12|STARTED|Treatment Period 3 (28 Days)||3
152700|NCT01072149|368904|P11|STARTED|Treatment Period 3 (28 Days)||2
152701|NCT01072149|368905|P10|STARTED|Treatment Period 3 (28 Days)||3
152702|NCT01072149|368906|P9|STARTED|Treatment Period 3 (28 Days)||3
152703|NCT01072149|368907|P8|STARTED|Treatment Period 3 (28 Days)||2
152704|NCT01072149|368908|P7|STARTED|Treatment Period 3 (28 Days)||3
152705|NCT01072149|368909|P6|STARTED|Treatment Period 3 (28 Days)||3
152706|NCT01072149|368910|P5|STARTED|Treatment Period 3 (28 Days)||3
152707|NCT01072149|368911|P4|STARTED|Treatment Period 3 (28 Days)||3
152708|NCT01072149|368912|P3|STARTED|Treatment Period 3 (28 Days)||1
152709|NCT01072149|368913|P2|STARTED|Treatment Period 3 (28 Days)||2
152710|NCT01072149|368914|P1|STARTED|Treatment Period 3 (28 Days)||2
152711|NCT01072149|368897|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
152712|NCT01072149|368898|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
152713|NCT01072149|368899|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
152714|NCT01072149|368900|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
152715|NCT01072149|368901|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
152716|NCT01072149|368902|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
152717|NCT01072149|368903|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
152718|NCT01072149|368904|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
152719|NCT01072149|368905|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
152720|NCT01072149|368906|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
152721|NCT01072149|368907|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
152722|NCT01072149|368908|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
152723|NCT01072149|368909|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
152724|NCT01072149|368910|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
152725|NCT01072149|368911|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
152726|NCT01072149|368912|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
152727|NCT01072149|368913|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
152728|NCT01072149|368914|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
152729|NCT01072149|368897|P18|COMPLETED|Washout Period 2 (14 Days)||2
152730|NCT01072149|368898|P17|COMPLETED|Washout Period 2 (14 Days)||3
152731|NCT01072149|368899|P16|COMPLETED|Washout Period 2 (14 Days)||1
152732|NCT01072149|368900|P15|COMPLETED|Washout Period 2 (14 Days)||3
152733|NCT01072149|368901|P14|COMPLETED|Washout Period 2 (14 Days)||3
152734|NCT01072149|368902|P13|COMPLETED|Washout Period 2 (14 Days)||2
152735|NCT01072149|368903|P12|COMPLETED|Washout Period 2 (14 Days)||3
152736|NCT01072149|368904|P11|COMPLETED|Washout Period 2 (14 Days)||2
152737|NCT01072149|368905|P10|COMPLETED|Washout Period 2 (14 Days)||3
152738|NCT01072149|368906|P9|COMPLETED|Washout Period 2 (14 Days)||3
152739|NCT01072149|368907|P8|COMPLETED|Washout Period 2 (14 Days)||2
152740|NCT01072149|368908|P7|COMPLETED|Washout Period 2 (14 Days)||3
152741|NCT01072149|368909|P6|COMPLETED|Washout Period 2 (14 Days)||3
152742|NCT01072149|368910|P5|COMPLETED|Washout Period 2 (14 Days)||3
152743|NCT01072149|368911|P4|COMPLETED|Washout Period 2 (14 Days)||3
152744|NCT01072149|368912|P3|COMPLETED|Washout Period 2 (14 Days)||1
152745|NCT01072149|368913|P2|COMPLETED|Washout Period 2 (14 Days)||2
152746|NCT01072149|368914|P1|COMPLETED|Washout Period 2 (14 Days)||2
152747|NCT01072149|368897|P18|STARTED|Washout Period 2 (14 Days)||2
152748|NCT01072149|368898|P17|STARTED|Washout Period 2 (14 Days)||3
152749|NCT01072149|368899|P16|STARTED|Washout Period 2 (14 Days)||3
152750|NCT01072149|368900|P15|STARTED|Washout Period 2 (14 Days)||3
152751|NCT01072149|368901|P14|STARTED|Washout Period 2 (14 Days)||3
152752|NCT01072149|368902|P13|STARTED|Washout Period 2 (14 Days)||3
152753|NCT01072149|368903|P12|STARTED|Washout Period 2 (14 Days)||3
152754|NCT01072149|368904|P11|STARTED|Washout Period 2 (14 Days)||2
152755|NCT01072149|368905|P10|STARTED|Washout Period 2 (14 Days)||3
152756|NCT01072149|368906|P9|STARTED|Washout Period 2 (14 Days)||3
152757|NCT01072149|368907|P8|STARTED|Washout Period 2 (14 Days)||2
152758|NCT01072149|368908|P7|STARTED|Washout Period 2 (14 Days)||3
152759|NCT01072149|368909|P6|STARTED|Washout Period 2 (14 Days)||3
152760|NCT01072149|368910|P5|STARTED|Washout Period 2 (14 Days)||3
152761|NCT01072149|368911|P4|STARTED|Washout Period 2 (14 Days)||3
152762|NCT01072149|368912|P3|STARTED|Washout Period 2 (14 Days)||1
152763|NCT01072149|368913|P2|STARTED|Washout Period 2 (14 Days)||2
152764|NCT01072149|368914|P1|STARTED|Washout Period 2 (14 Days)||3
152765|NCT01072149|368897|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152766|NCT01072149|368898|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152767|NCT01072149|368899|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152768|NCT01072149|368900|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152769|NCT01072149|368901|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152770|NCT01072149|368902|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152771|NCT01072149|368903|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152772|NCT01072149|368904|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152773|NCT01072149|368905|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152774|NCT01072149|368906|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152775|NCT01072149|368907|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
152776|NCT01072149|368908|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152777|NCT01072149|368909|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152778|NCT01072149|368910|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152779|NCT01072149|368911|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152780|NCT01072149|368912|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
152781|NCT01072149|368913|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
152782|NCT01072149|368914|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
152783|NCT01072149|368897|P18|COMPLETED|Treatment Period 2 (28 Days)||2
152784|NCT01072149|368898|P17|COMPLETED|Treatment Period 2 (28 Days)||3
152785|NCT01072149|368899|P16|COMPLETED|Treatment Period 2 (28 Days)||3
152786|NCT01072149|368900|P15|COMPLETED|Treatment Period 2 (28 Days)||3
152787|NCT01072149|368901|P14|COMPLETED|Treatment Period 2 (28 Days)||3
152788|NCT01072149|368902|P13|COMPLETED|Treatment Period 2 (28 Days)||3
152789|NCT01072149|368903|P12|COMPLETED|Treatment Period 2 (28 Days)||3
152790|NCT01072149|368904|P11|COMPLETED|Treatment Period 2 (28 Days)||2
152791|NCT01072149|368905|P10|COMPLETED|Treatment Period 2 (28 Days)||3
152792|NCT01072149|368906|P9|COMPLETED|Treatment Period 2 (28 Days)||3
152793|NCT01072149|368907|P8|COMPLETED|Treatment Period 2 (28 Days)||2
152794|NCT01072149|368908|P7|COMPLETED|Treatment Period 2 (28 Days)||3
152795|NCT01072149|368909|P6|COMPLETED|Treatment Period 2 (28 Days)||3
152796|NCT01072149|368910|P5|COMPLETED|Treatment Period 2 (28 Days)||3
152797|NCT01072149|368911|P4|COMPLETED|Treatment Period 2 (28 Days)||3
152798|NCT01072149|368912|P3|COMPLETED|Treatment Period 2 (28 Days)||1
152799|NCT01072149|368913|P2|COMPLETED|Treatment Period 2 (28 Days)||2
152800|NCT01072149|368914|P1|COMPLETED|Treatment Period 2 (28 Days)||3
152801|NCT01072149|368897|P18|STARTED|Treatment Period 2 (28 Days)||2
152802|NCT01072149|368898|P17|STARTED|Treatment Period 2 (28 Days)||3
152803|NCT01072149|368899|P16|STARTED|Treatment Period 2 (28 Days)||3
152804|NCT01072149|368900|P15|STARTED|Treatment Period 2 (28 Days)||3
152805|NCT01072149|368901|P14|STARTED|Treatment Period 2 (28 Days)||3
152806|NCT01072149|368902|P13|STARTED|Treatment Period 2 (28 Days)||3
152807|NCT01072149|368903|P12|STARTED|Treatment Period 2 (28 Days)||3
152808|NCT01072149|368904|P11|STARTED|Treatment Period 2 (28 Days)||2
152809|NCT01072149|368905|P10|STARTED|Treatment Period 2 (28 Days)||3
152810|NCT01072149|368906|P9|STARTED|Treatment Period 2 (28 Days)||3
152811|NCT01072149|368907|P8|STARTED|Treatment Period 2 (28 Days)||3
152812|NCT01072149|368908|P7|STARTED|Treatment Period 2 (28 Days)||3
152813|NCT01072149|368909|P6|STARTED|Treatment Period 2 (28 Days)||3
152814|NCT01072149|368910|P5|STARTED|Treatment Period 2 (28 Days)||3
152815|NCT01072149|368911|P4|STARTED|Treatment Period 2 (28 Days)||3
152816|NCT01072149|368912|P3|STARTED|Treatment Period 2 (28 Days)||2
152817|NCT01072149|368913|P2|STARTED|Treatment Period 2 (28 Days)||3
152818|NCT01072149|368914|P1|STARTED|Treatment Period 2 (28 Days)||3
152819|NCT01072149|368897|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
152820|NCT01072149|368898|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
152821|NCT01072149|368899|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
152822|NCT01072149|368900|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
152823|NCT01072149|368901|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
152824|NCT01072149|368902|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
152825|NCT01072149|368903|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
152826|NCT01072149|368904|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
152827|NCT01072149|368905|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
152828|NCT01072149|368906|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
152829|NCT01072149|368907|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
152830|NCT01072149|368908|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
152831|NCT01072149|368909|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
152832|NCT01072149|368910|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
152833|NCT01072149|368911|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
152834|NCT01072149|368912|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
152835|NCT01072149|368913|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
152836|NCT01072149|368914|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
152837|NCT01072149|368897|P18|COMPLETED|Washout Period 1 (14 Days)||2
152838|NCT01072149|368898|P17|COMPLETED|Washout Period 1 (14 Days)||3
152839|NCT01072149|368899|P16|COMPLETED|Washout Period 1 (14 Days)||3
152840|NCT01072149|368900|P15|COMPLETED|Washout Period 1 (14 Days)||3
152841|NCT01072149|368901|P14|COMPLETED|Washout Period 1 (14 Days)||3
152842|NCT01072149|368902|P13|COMPLETED|Washout Period 1 (14 Days)||3
152843|NCT01072149|368903|P12|COMPLETED|Washout Period 1 (14 Days)||3
152844|NCT01072149|368904|P11|COMPLETED|Washout Period 1 (14 Days)||2
152845|NCT01072149|368905|P10|COMPLETED|Washout Period 1 (14 Days)||3
152846|NCT01072149|368906|P9|COMPLETED|Washout Period 1 (14 Days)||3
152847|NCT01072149|368907|P8|COMPLETED|Washout Period 1 (14 Days)||3
152848|NCT01072149|368908|P7|COMPLETED|Washout Period 1 (14 Days)||3
152849|NCT01072149|368909|P6|COMPLETED|Washout Period 1 (14 Days)||3
152850|NCT01072149|368910|P5|COMPLETED|Washout Period 1 (14 Days)||3
152851|NCT01072149|368911|P4|COMPLETED|Washout Period 1 (14 Days)||3
152852|NCT01072149|368912|P3|COMPLETED|Washout Period 1 (14 Days)||2
152853|NCT01072149|368913|P2|COMPLETED|Washout Period 1 (14 Days)||3
152854|NCT01072149|368914|P1|COMPLETED|Washout Period 1 (14 Days)||3
152855|NCT01072149|368897|P18|STARTED|Washout Period 1 (14 Days)||2
152856|NCT01072149|368898|P17|STARTED|Washout Period 1 (14 Days)||3
152857|NCT01072149|368899|P16|STARTED|Washout Period 1 (14 Days)||3
152858|NCT01072149|368900|P15|STARTED|Washout Period 1 (14 Days)||3
152859|NCT01072149|368901|P14|STARTED|Washout Period 1 (14 Days)||3
152860|NCT01072149|368902|P13|STARTED|Washout Period 1 (14 Days)||3
152861|NCT01072149|368903|P12|STARTED|Washout Period 1 (14 Days)||3
152862|NCT01072149|368904|P11|STARTED|Washout Period 1 (14 Days)||2
152863|NCT01072149|368905|P10|STARTED|Washout Period 1 (14 Days)||3
152864|NCT01072149|368906|P9|STARTED|Washout Period 1 (14 Days)||3
152865|NCT01072149|368907|P8|STARTED|Washout Period 1 (14 Days)||3
152866|NCT01072149|368908|P7|STARTED|Washout Period 1 (14 Days)||3
152867|NCT01072149|368909|P6|STARTED|Washout Period 1 (14 Days)||3
152868|NCT01072149|368910|P5|STARTED|Washout Period 1 (14 Days)||3
152869|NCT01072149|368911|P4|STARTED|Washout Period 1 (14 Days)||3
152870|NCT01072149|368912|P3|STARTED|Washout Period 1 (14 Days)||2
152871|NCT01072149|368913|P2|STARTED|Washout Period 1 (14 Days)||3
152872|NCT01072149|368914|P1|STARTED|Washout Period 1 (14 Days)||3
152873|NCT01072149|368897|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
152874|NCT01072149|368898|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152875|NCT01072149|368899|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152876|NCT01072149|368900|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152877|NCT01072149|368901|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152878|NCT01072149|368902|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152879|NCT01072149|368903|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152880|NCT01072149|368904|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
152881|NCT01072149|368905|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152882|NCT01072149|368906|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152883|NCT01072149|368907|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152884|NCT01072149|368908|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152885|NCT01072149|368909|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152886|NCT01072149|368910|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152887|NCT01072149|368911|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152888|NCT01072149|368912|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
152889|NCT01072149|368913|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152890|NCT01072149|368914|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
152891|NCT01072149|368897|P18|COMPLETED|Treatment Period 1 (28 Days)||2
152892|NCT01072149|368898|P17|COMPLETED|Treatment Period 1 (28 Days)||3
152893|NCT01072149|368899|P16|COMPLETED|Treatment Period 1 (28 Days)||3
152894|NCT01072149|368900|P15|COMPLETED|Treatment Period 1 (28 Days)||3
152895|NCT01072149|368901|P14|COMPLETED|Treatment Period 1 (28 Days)||3
152896|NCT01072149|368902|P13|COMPLETED|Treatment Period 1 (28 Days)||3
152897|NCT01072149|368903|P12|COMPLETED|Treatment Period 1 (28 Days)||3
152898|NCT01072149|368904|P11|COMPLETED|Treatment Period 1 (28 Days)||2
152899|NCT01072149|368905|P10|COMPLETED|Treatment Period 1 (28 Days)||3
152900|NCT01072149|368906|P9|COMPLETED|Treatment Period 1 (28 Days)||3
152901|NCT01072149|368907|P8|COMPLETED|Treatment Period 1 (28 Days)||3
152902|NCT01072149|368908|P7|COMPLETED|Treatment Period 1 (28 Days)||3
152903|NCT01072149|368909|P6|COMPLETED|Treatment Period 1 (28 Days)||3
152904|NCT01072149|368910|P5|COMPLETED|Treatment Period 1 (28 Days)||3
152905|NCT01072149|368911|P4|COMPLETED|Treatment Period 1 (28 Days)||3
152906|NCT01072149|368912|P3|COMPLETED|Treatment Period 1 (28 Days)||2
152907|NCT01072149|368913|P2|COMPLETED|Treatment Period 1 (28 Days)||3
152908|NCT01072149|368914|P1|COMPLETED|Treatment Period 1 (28 Days)||3
152909|NCT01072149|368897|P18|STARTED|Treatment Period 1 (28 Days)||3
152910|NCT01072149|368898|P17|STARTED|Treatment Period 1 (28 Days)||3
152911|NCT01072149|368899|P16|STARTED|Treatment Period 1 (28 Days)||3
152912|NCT01072149|368900|P15|STARTED|Treatment Period 1 (28 Days)||3
152913|NCT01072149|368901|P14|STARTED|Treatment Period 1 (28 Days)||3
152914|NCT01072149|368902|P13|STARTED|Treatment Period 1 (28 Days)||3
152915|NCT01072149|368903|P12|STARTED|Treatment Period 1 (28 Days)||3
152916|NCT01072149|368904|P11|STARTED|Treatment Period 1 (28 Days)||3
152917|NCT01072149|368905|P10|STARTED|Treatment Period 1 (28 Days)||3
152918|NCT01072149|368906|P9|STARTED|Treatment Period 1 (28 Days)||3
152919|NCT01072149|368907|P8|STARTED|Treatment Period 1 (28 Days)||3
152920|NCT01072149|368908|P7|STARTED|Treatment Period 1 (28 Days)||3
152921|NCT01072149|368909|P6|STARTED|Treatment Period 1 (28 Days)||3
152922|NCT01072149|368910|P5|STARTED|Treatment Period 1 (28 Days)||3
152923|NCT01072149|368911|P4|STARTED|Treatment Period 1 (28 Days)||3
152924|NCT01072149|368912|P3|STARTED|Treatment Period 1 (28 Days)||3
152925|NCT01072149|368913|P2|STARTED|Treatment Period 1 (28 Days)||3
152926|NCT01072149|368914|P1|STARTED|Treatment Period 1 (28 Days)||3
152927|NCT01072136|368934|P2|NOT COMPLETED|Overall Study||31
152928|NCT01072136|368935|P1|NOT COMPLETED|Overall Study||23
152929|NCT01072136|368934|P2|COMPLETED|Overall Study||12
152930|NCT01072136|368935|P1|COMPLETED|Overall Study||21
152931|NCT01072136|368934|P2|Met All Enrollment Criteria|Overall Study||25
152932|NCT01072136|368935|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
152933|NCT01072136|368934|P2|STARTED|Overall Study||43
152934|NCT01072136|368935|P1|STARTED|Overall Study||44
152935|NCT01072032|368959|P2|NOT COMPLETED|Overall Study||9
152936|NCT01072032|368960|P1|NOT COMPLETED|Overall Study||8
152937|NCT01072032|368959|P2|COMPLETED|Overall Study||5
152938|NCT01072032|368960|P1|COMPLETED|Overall Study||5
152939|NCT01072032|368959|P2|STARTED|Overall Study||14
152940|NCT01072032|368960|P1|STARTED|Overall Study||13
152941|NCT01072006|368974|P4|NOT COMPLETED|Overall Study||0
152942|NCT01072006|368975|P3|NOT COMPLETED|Overall Study||0
152943|NCT01072006|368976|P2|NOT COMPLETED|Overall Study||0
152944|NCT01072006|368977|P1|NOT COMPLETED|Overall Study||0
152945|NCT01072006|368974|P4|COMPLETED|Overall Study||11
152946|NCT01072006|368975|P3|COMPLETED|Overall Study||0
152947|NCT01072006|368976|P2|COMPLETED|Overall Study||5
152948|NCT01072006|368977|P1|COMPLETED|Overall Study||14
152949|NCT01072006|368974|P4|STARTED|Overall Study||11
152950|NCT01072006|368975|P3|STARTED|Overall Study||0
152951|NCT01072006|368976|P2|STARTED|Overall Study||5
152952|NCT01072006|368977|P1|STARTED|Overall Study||14
152953|NCT01071993|368996|P2|NOT COMPLETED|Overall Study||0
152954|NCT01071993|368997|P1|NOT COMPLETED|Overall Study||0
152955|NCT01071993|368996|P2|COMPLETED|Overall Study||0
152956|NCT01071993|368997|P1|COMPLETED|Overall Study||0
152957|NCT01071993|368996|P2|STARTED|Overall Study||0
152958|NCT01071993|368997|P1|STARTED|Overall Study||0
152959|NCT01071915|369003|P1|NOT COMPLETED|Overall Study||9
152960|NCT01071915|369003|P1|COMPLETED|Overall Study||148
152961|NCT01071915|369003|P1|Safety Analysis Set|Overall Study||156
152962|NCT01071915|369003|P1|Full Analysis Set (FAS)|Overall Study||155
152963|NCT01071915|369003|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
152964|NCT01071798|369013|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
152965|NCT01071798|369013|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
152966|NCT01071798|369013|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
152967|NCT01071798|369013|P1|STARTED|Subpopulation Who Received Two Cycles||820
152968|NCT01071798|369013|P1|NOT COMPLETED|Participants Who Received One Cycle||65
152969|NCT01071798|369013|P1|COMPLETED|Participants Who Received One Cycle||1588
152970|NCT01071798|369013|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
152971|NCT01071798|369013|P1|STARTED|Participants Who Received One Cycle||1653
152972|NCT01071538|369033|P1|NOT COMPLETED|Overall Study||2
152973|NCT01071538|369033|P1|COMPLETED|Overall Study||13
152974|NCT01071538|369033|P1|STARTED|Overall Study||15
152975|NCT01071512|369043|P1|NOT COMPLETED|Overall Study||5
152976|NCT01071512|369043|P1|COMPLETED|Overall Study||15
152977|NCT01071512|369043|P1|STARTED|Overall Study||20
152978|NCT01071395|369053|P2|NOT COMPLETED|Overall Study||2
152979|NCT01071395|369054|P1|NOT COMPLETED|Overall Study||5
152980|NCT01071395|369053|P2|COMPLETED|Overall Study||30
152981|NCT01071395|369054|P1|COMPLETED|Overall Study||31
152982|NCT01071395|369053|P2|STARTED|Overall Study||32
152983|NCT01071395|369054|P1|STARTED|Overall Study||36
152984|NCT01071356|369062|P2|NOT COMPLETED|Overall Study||9
152985|NCT01071356|369063|P1|NOT COMPLETED|Overall Study||7
152986|NCT01071356|369062|P2|COMPLETED|Overall Study||97
152987|NCT01071356|369063|P1|COMPLETED|Overall Study||104
152988|NCT01071356|369062|P2|STARTED|Overall Study||106
152989|NCT01071356|369063|P1|STARTED|Overall Study||111
152990|NCT01071278|369071|P1|NOT COMPLETED|Overall Study||713
152991|NCT01071278|369071|P1|COMPLETED|Overall Study||1677
152992|NCT01071278|369071|P1|STARTED|Overall Study||2390
152993|NCT01071252|369082|P5|NOT COMPLETED|Overall Study||11
152994|NCT01071252|369083|P4|NOT COMPLETED|Overall Study||7
152995|NCT01071252|369084|P3|NOT COMPLETED|Overall Study||4
152996|NCT01071252|369085|P2|NOT COMPLETED|Overall Study||10
152997|NCT01071252|369086|P1|NOT COMPLETED|Overall Study||15
152998|NCT01071252|369082|P5|COMPLETED|Overall Study||11
152999|NCT01071252|369083|P4|COMPLETED|Overall Study||20
153000|NCT01071252|369084|P3|COMPLETED|Overall Study||17
153001|NCT01071252|369085|P2|COMPLETED|Overall Study||16
153002|NCT01071252|369086|P1|COMPLETED|Overall Study||14
153003|NCT01071252|369082|P5|STARTED|Overall Study||22
153004|NCT01071252|369083|P4|STARTED|Overall Study||27
153005|NCT01071252|369084|P3|STARTED|Overall Study||21
153006|NCT01071252|369085|P2|STARTED|Overall Study||26
153007|NCT01071252|369086|P1|STARTED|Overall Study||29
153008|NCT01071200|369114|P2|NOT COMPLETED|Overall Study||3
153009|NCT01071200|369115|P1|NOT COMPLETED|Overall Study||7
153010|NCT01071200|369114|P2|COMPLETED|Overall Study||63
153011|NCT01071200|369115|P1|COMPLETED|Overall Study||60
153012|NCT01071200|369114|P2|STARTED|Overall Study||66
153013|NCT01071200|369115|P1|STARTED|Overall Study||67
153014|NCT01071096|369147|P2|NOT COMPLETED|Second Intervention (90 Days)||0
153015|NCT01071096|369148|P1|NOT COMPLETED|Second Intervention (90 Days)||0
153016|NCT01071096|369147|P2|COMPLETED|Second Intervention (90 Days)||10
153017|NCT01071096|369148|P1|COMPLETED|Second Intervention (90 Days)||9
153018|NCT01071096|369147|P2|STARTED|Second Intervention (90 Days)||10
153019|NCT01071096|369148|P1|STARTED|Second Intervention (90 Days)||9
153020|NCT01071096|369147|P2|NOT COMPLETED|Washout Period (30 Days)||0
153021|NCT01071096|369148|P1|NOT COMPLETED|Washout Period (30 Days)||0
153022|NCT01071096|369147|P2|COMPLETED|Washout Period (30 Days)||10
153023|NCT01071096|369148|P1|COMPLETED|Washout Period (30 Days)||9
153024|NCT01071096|369147|P2|STARTED|Washout Period (30 Days)||10
153025|NCT01071096|369148|P1|STARTED|Washout Period (30 Days)||9
153026|NCT01071096|369147|P2|NOT COMPLETED|First Intervention (90 Days)||0
153027|NCT01071096|369148|P1|NOT COMPLETED|First Intervention (90 Days)||1
153028|NCT01071096|369147|P2|COMPLETED|First Intervention (90 Days)||10
153029|NCT01071096|369148|P1|COMPLETED|First Intervention (90 Days)||9
153030|NCT01071096|369147|P2|STARTED|First Intervention (90 Days)||10
153031|NCT01071096|369148|P1|STARTED|First Intervention (90 Days)||10
153032|NCT01071083|369172|P5|NOT COMPLETED|Overall Study||8
153033|NCT01071083|369173|P4|NOT COMPLETED|Overall Study||2
153034|NCT01071083|369174|P3|NOT COMPLETED|Overall Study||5
153035|NCT01071083|369175|P2|NOT COMPLETED|Overall Study||2
153036|NCT01071083|369176|P1|NOT COMPLETED|Overall Study||7
153037|NCT01071083|369172|P5|COMPLETED|Overall Study||46
153038|NCT01071083|369173|P4|COMPLETED|Overall Study||15
153039|NCT01071083|369174|P3|COMPLETED|Overall Study||12
153040|NCT01071083|369175|P2|COMPLETED|Overall Study||43
153041|NCT01071083|369176|P1|COMPLETED|Overall Study||35
153042|NCT01071083|369172|P5|STARTED|Overall Study||54
153043|NCT01071083|369173|P4|STARTED|Overall Study||17
153044|NCT01071083|369174|P3|STARTED|Overall Study||17
153045|NCT01071083|369175|P2|STARTED|Overall Study||45
153046|NCT01071083|369176|P1|STARTED|Overall Study||42
153047|NCT01071070|369195|P2|NOT COMPLETED|Overall Study||3
153048|NCT01071070|369196|P1|NOT COMPLETED|Overall Study||4
153049|NCT01071070|369195|P2|COMPLETED|Overall Study||105
153050|NCT01071070|369196|P1|COMPLETED|Overall Study||104
153051|NCT01071070|369195|P2|STARTED|Overall Study||108
153052|NCT01071070|369196|P1|STARTED|Overall Study||108
153053|NCT01071044|369220|P2|NOT COMPLETED|Overall Study||0
153054|NCT01071044|369221|P1|NOT COMPLETED|Overall Study||2
153055|NCT01071044|369220|P2|COMPLETED|Overall Study||11
153056|NCT01071044|369221|P1|COMPLETED|Overall Study||13
153057|NCT01071044|369220|P2|STARTED|Overall Study||11
153058|NCT01071044|369221|P1|STARTED|Overall Study||15
153059|NCT01070979|369242|P3|NOT COMPLETED|Overall Study||13
153060|NCT01070979|369243|P2|NOT COMPLETED|Overall Study||12
153061|NCT01070979|369244|P1|NOT COMPLETED|Overall Study||11
153062|NCT01070979|369242|P3|COMPLETED|Overall Study||72
153063|NCT01070979|369243|P2|COMPLETED|Overall Study||73
153064|NCT01070979|369244|P1|COMPLETED|Overall Study||68
153065|NCT01070979|369242|P3|STARTED|Overall Study||85
153066|NCT01070979|369243|P2|STARTED|Overall Study||85
153067|NCT01070979|369244|P1|STARTED|Overall Study||79
153068|NCT01070966|369270|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
153069|NCT01070966|369270|P1|COMPLETED|Participants for Efficacy Evaluation||1929
153070|NCT01070966|369270|P1|STARTED|Participants for Efficacy Evaluation||2011
153071|NCT01070966|369270|P1|NOT COMPLETED|Participants for Safety Evaluation||78
153072|NCT01070966|369270|P1|COMPLETED|Participants for Safety Evaluation||2011
153073|NCT01070966|369270|P1|STARTED|Participants for Safety Evaluation||2089
153074|NCT01070953|369281|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
153075|NCT01070953|369281|P1|COMPLETED|Participants for Efficacy Evaluation||3309
153076|NCT01070953|369281|P1|STARTED|Participants for Efficacy Evaluation||3536
153077|NCT01070953|369281|P1|NOT COMPLETED|Participants for Safety Evaluation||931
153078|NCT01070953|369281|P1|COMPLETED|Participants for Safety Evaluation||3536
153079|NCT01070953|369281|P1|STARTED|Participants for Safety Evaluation||4467
153080|NCT01070888|369294|P2|NOT COMPLETED|Second Intervention (14 Days)||0
153081|NCT01070888|369295|P1|NOT COMPLETED|Second Intervention (14 Days)||0
153082|NCT01070888|369294|P2|COMPLETED|Second Intervention (14 Days)||2
153083|NCT01070888|369295|P1|COMPLETED|Second Intervention (14 Days)||1
153084|NCT01070888|369294|P2|STARTED|Second Intervention (14 Days)||2
153085|NCT01070888|369295|P1|STARTED|Second Intervention (14 Days)||1
153086|NCT01070888|369294|P2|NOT COMPLETED|Washout (14 Days)||0
153087|NCT01070888|369295|P1|NOT COMPLETED|Washout (14 Days)||1
153088|NCT01070888|369294|P2|COMPLETED|Washout (14 Days)||2
153089|NCT01070888|369295|P1|COMPLETED|Washout (14 Days)||1
153090|NCT01070888|369294|P2|STARTED|Washout (14 Days)||2
153091|NCT01070888|369295|P1|STARTED|Washout (14 Days)||2
153092|NCT01070888|369294|P2|NOT COMPLETED|First Intervention (14 Days)||2
153093|NCT01070888|369295|P1|NOT COMPLETED|First Intervention (14 Days)||0
153094|NCT01070888|369294|P2|COMPLETED|First Intervention (14 Days)||2
153095|NCT01070888|369295|P1|COMPLETED|First Intervention (14 Days)||2
153096|NCT01070888|369294|P2|STARTED|First Intervention (14 Days)||4
153097|NCT01070888|369295|P1|STARTED|First Intervention (14 Days)||2
153098|NCT01070810|369303|P2|NOT COMPLETED|Overall Study||0
153099|NCT01070810|369304|P1|NOT COMPLETED|Overall Study||0
153100|NCT01070810|369303|P2|COMPLETED|Overall Study||43
153101|NCT01070810|369304|P1|COMPLETED|Overall Study||45
153102|NCT01070810|369303|P2|STARTED|Overall Study||43
153103|NCT01070810|369304|P1|STARTED|Overall Study||45
153104|NCT01070784|369320|P2|NOT COMPLETED|Overall Study||18
153105|NCT01070784|369321|P1|NOT COMPLETED|Overall Study||20
153106|NCT01070784|369320|P2|COMPLETED|Overall Study||112
153107|NCT01070784|369321|P1|COMPLETED|Overall Study||110
153108|NCT01070784|369320|P2|STARTED|Overall Study||130
153109|NCT01070784|369321|P1|STARTED|Overall Study||130
153110|NCT01070771|369409|P1|NOT COMPLETED|Overall Study||3
153111|NCT01070771|369409|P1|COMPLETED|Overall Study|August 2012|200
153112|NCT01070771|369409|P1|STARTED|Overall Study|September 2008|203
153113|NCT01070693|369416|P2|NOT COMPLETED|Overall Study||39
153114|NCT01070693|369417|P1|NOT COMPLETED|Overall Study||28
153115|NCT01070693|369416|P2|COMPLETED|Overall Study||110
153116|NCT01070693|369417|P1|COMPLETED|Overall Study||122
153117|NCT01070693|369416|P2|STARTED|Overall Study||149
153118|NCT01070693|369417|P1|STARTED|Overall Study||150
153119|NCT01070550|369429|P6|NOT COMPLETED|Overall Study||7
153120|NCT01070550|369430|P5|NOT COMPLETED|Overall Study||1
153121|NCT01070550|369431|P4|NOT COMPLETED|Overall Study||77
153122|NCT01070550|369432|P3|NOT COMPLETED|Overall Study||216
153123|NCT01070550|369433|P2|NOT COMPLETED|Overall Study||62
153124|NCT01070550|369434|P1|NOT COMPLETED|Overall Study||1285
153125|NCT01070550|369429|P6|COMPLETED|Overall Study||35
153126|NCT01070550|369430|P5|COMPLETED|Overall Study||20
153127|NCT01070550|369431|P4|COMPLETED|Overall Study||124
153128|NCT01070550|369432|P3|COMPLETED|Overall Study||528
153129|NCT01070550|369433|P2|COMPLETED|Overall Study||254
153130|NCT01070550|369434|P1|COMPLETED|Overall Study||2071
153131|NCT01070550|369429|P6|STARTED|Overall Study||42
153132|NCT01070550|369430|P5|STARTED|Overall Study||21
153133|NCT01070550|369431|P4|STARTED|Overall Study||201
153134|NCT01070550|369432|P3|STARTED|Overall Study||744
153135|NCT01070550|369433|P2|STARTED|Overall Study||316
153136|NCT01070550|369434|P1|STARTED|Overall Study||3356
153137|NCT01070394|369574|P1|NOT COMPLETED|Overall Study||7
153138|NCT01070394|369574|P1|COMPLETED|Overall Study||33
153139|NCT01070394|369574|P1|STARTED|Overall Study||40
153140|NCT01070381|369585|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
153141|NCT01070381|369586|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
153142|NCT01070381|369585|P2|COMPLETED|Period 2, 1 Week of Wear||106
153143|NCT01070381|369586|P1|COMPLETED|Period 2, 1 Week of Wear||108
153144|NCT01070381|369585|P2|STARTED|Period 2, 1 Week of Wear||107
153145|NCT01070381|369586|P1|STARTED|Period 2, 1 Week of Wear||109
153146|NCT01070381|369585|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
153147|NCT01070381|369586|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
153148|NCT01070381|369585|P2|COMPLETED|Period 1, 1 Week of Wear||107
153149|NCT01070381|369586|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
153150|NCT01070381|369585|P2|STARTED|Period 1, 1 Week of Wear||107
153151|NCT01070381|369586|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
153152|NCT01070329|369594|P2|NOT COMPLETED|Overall Study||49
153153|NCT01070329|369595|P1|NOT COMPLETED|Overall Study||52
153154|NCT01070329|369594|P2|COMPLETED|Overall Study||217
153155|NCT01070329|369595|P1|COMPLETED|Overall Study||209
153156|NCT01070329|369594|P2|STARTED|Overall Study||266
153157|NCT01070329|369595|P1|STARTED|Overall Study||261
153158|NCT01070316|369627|P1|NOT COMPLETED|Extension Phase||4
153159|NCT01070316|369627|P1|COMPLETED|Extension Phase||14
153160|NCT01070316|369627|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
153161|NCT01070316|369627|P1|NOT COMPLETED|Main Phase||0
153162|NCT01070316|369627|P1|COMPLETED|Main Phase||20
153163|NCT01070316|369627|P1|STARTED|Main Phase||20
153164|NCT01070303|369634|P1|NOT COMPLETED|Overall Study||89
153165|NCT01070303|369634|P1|COMPLETED|Overall Study||88
153166|NCT01070303|369634|P1|STARTED|Overall Study||177
153167|NCT01070173|369693|P3|NOT COMPLETED|Overall Study||0
153168|NCT01070173|369694|P2|NOT COMPLETED|Overall Study||0
153169|NCT01070173|369695|P1|NOT COMPLETED|Overall Study||0
153170|NCT01070173|369693|P3|COMPLETED|Overall Study||11
153171|NCT01070173|369694|P2|COMPLETED|Overall Study||8
153172|NCT01070173|369695|P1|COMPLETED|Overall Study||33
153173|NCT01070173|369693|P3|STARTED|Overall Study||11
153174|NCT01070173|369694|P2|STARTED|Overall Study||8
153175|NCT01070173|369695|P1|STARTED|Overall Study||33
153176|NCT01070043|369708|P3|NOT COMPLETED|Double-Blind Treatment||2
153177|NCT01070043|369709|P2|NOT COMPLETED|Double-Blind Treatment||0
153178|NCT01070043|369710|P1|NOT COMPLETED|Double-Blind Treatment||0
153179|NCT01070043|369708|P3|COMPLETED|Double-Blind Treatment||19
153180|NCT01070043|369709|P2|COMPLETED|Double-Blind Treatment||21
153181|NCT01070043|369710|P1|COMPLETED|Double-Blind Treatment||0
153182|NCT01070043|369708|P3|STARTED|Double-Blind Treatment||21
153183|NCT01070043|369709|P2|STARTED|Double-Blind Treatment||21
153184|NCT01070043|369710|P1|STARTED|Double-Blind Treatment||0
153185|NCT01070043|369708|P3|NOT COMPLETED|Run-In Phase||0
153186|NCT01070043|369709|P2|NOT COMPLETED|Run-In Phase||0
153187|NCT01070043|369710|P1|NOT COMPLETED|Run-In Phase||18
153188|NCT01070043|369708|P3|COMPLETED|Run-In Phase||0
153189|NCT01070043|369709|P2|COMPLETED|Run-In Phase||0
153190|NCT01070043|369710|P1|COMPLETED|Run-In Phase||42
153191|NCT01070043|369708|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
153192|NCT01070043|369709|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
153193|NCT01070043|369710|P1|STARTED|Run-In Phase||60
153194|NCT01069939|369726|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
153195|NCT01069939|369727|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
153196|NCT01069939|369726|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
153197|NCT01069939|369727|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
153198|NCT01069939|369726|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
153199|NCT01069939|369727|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
153200|NCT01069939|369726|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
153201|NCT01069939|369727|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
153202|NCT01069939|369726|P2|COMPLETED|Randomised and Included in the Analyses||137
153203|NCT01069939|369727|P1|COMPLETED|Randomised and Included in the Analyses||164
153204|NCT01069939|369726|P2|STARTED|Randomised and Included in the Analyses||214
153205|NCT01069939|369727|P1|STARTED|Randomised and Included in the Analyses||213
153206|NCT01069900|369753|P2|NOT COMPLETED|Overall Study||4
153207|NCT01069900|369754|P1|NOT COMPLETED|Overall Study||18
153208|NCT01069900|369753|P2|COMPLETED|Overall Study||149
153209|NCT01069900|369754|P1|COMPLETED|Overall Study||287
153210|NCT01069900|369753|P2|Treated|Overall Study||150
153211|NCT01069900|369754|P1|Treated|Overall Study||301
153212|NCT01069900|369753|P2|STARTED|Overall Study||153
153213|NCT01069900|369754|P1|STARTED|Overall Study||305
153214|NCT01069861|369798|P1|NOT COMPLETED|Overall Study||3
153215|NCT01069861|369798|P1|COMPLETED|Overall Study||1
153216|NCT01069861|369798|P1|STARTED|Overall Study||4
153217|NCT01069627|369811|P1|NOT COMPLETED|Overall Study||20
153218|NCT01069627|369811|P1|COMPLETED|Overall Study||0
153219|NCT01069627|369811|P1|STARTED|Overall Study||20
153220|NCT01069562|369834|P2|NOT COMPLETED|Overall Study||0
153221|NCT01069562|369835|P1|NOT COMPLETED|Overall Study||0
153222|NCT01069562|369834|P2|COMPLETED|Overall Study||20
153223|NCT01069562|369835|P1|COMPLETED|Overall Study||20
153224|NCT01069562|369834|P2|STARTED|Overall Study||20
153225|NCT01069562|369835|P1|STARTED|Overall Study||20
153226|NCT01069523|369861|P2|NOT COMPLETED|Overall Study||7
153227|NCT01069523|369862|P1|NOT COMPLETED|Overall Study||4
153228|NCT01069523|369861|P2|COMPLETED|Overall Study||9
153229|NCT01069523|369862|P1|COMPLETED|Overall Study||9
153230|NCT01069523|369861|P2|STARTED|Overall Study||16
153231|NCT01069523|369862|P1|STARTED|Overall Study||13
153232|NCT01069484|369872|P2|NOT COMPLETED|Overall Study||3
153233|NCT01069484|369873|P1|NOT COMPLETED|Overall Study||12
153234|NCT01069484|369872|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
153235|NCT01069484|369873|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
153236|NCT01069484|369872|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
153237|NCT01069484|369873|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
153238|NCT01069419|369881|P1|NOT COMPLETED|Overall Study||715
153239|NCT01069419|369881|P1|COMPLETED|Overall Study||402
153240|NCT01069419|369881|P1|Full Analysis Set|Overall Study||851
153241|NCT01069419|369881|P1|Safety Set|Overall Study||1111
153242|NCT01069419|369881|P1|STARTED|Overall Study||1117
153243|NCT01069354|369888|P1|NOT COMPLETED|Overall Study||1
153244|NCT01069354|369888|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
153245|NCT01069354|369888|P1|STARTED|Overall Study||102
153246|NCT01069341|369910|P1|NOT COMPLETED|Overall Study||1
153247|NCT01069341|369910|P1|COMPLETED|Overall Study||3
153248|NCT01069341|369910|P1|STARTED|Overall Study||4
153249|NCT01069289|369923|P2|NOT COMPLETED|Overall Study||56
153250|NCT01069289|369924|P1|NOT COMPLETED|Overall Study||42
153251|NCT01069289|369923|P2|COMPLETED|Overall Study||601
153252|NCT01069289|369924|P1|COMPLETED|Overall Study||594
153253|NCT01069289|369923|P2|STARTED|Overall Study||657
153254|NCT01069289|369924|P1|STARTED|Overall Study||636
153255|NCT01069185|369964|P2|NOT COMPLETED|Overall Study||0
153256|NCT01069185|369965|P1|NOT COMPLETED|Overall Study||0
153257|NCT01069185|369964|P2|COMPLETED|Overall Study||45
153258|NCT01069185|369965|P1|COMPLETED|Overall Study||47
153259|NCT01069185|369964|P2|STARTED|Overall Study||45
153260|NCT01069185|369965|P1|STARTED|Overall Study||47
153261|NCT01069172|369973|P2|NOT COMPLETED|Overall Study||0
153262|NCT01069172|369974|P1|NOT COMPLETED|Overall Study||1
153263|NCT01069172|369973|P2|COMPLETED|Overall Study|30 eyes|30
153264|NCT01069172|369974|P1|COMPLETED|Overall Study|29 eyes|29
153265|NCT01069172|369973|P2|STARTED|Overall Study|30 eyes|30
153266|NCT01069172|369974|P1|STARTED|Overall Study|30 eyes|30
153267|NCT01069120|369984|P1|NOT COMPLETED|Overall Study||27
153268|NCT01069120|369984|P1|COMPLETED|Overall Study||0
153269|NCT01069120|369984|P1|STARTED|Overall Study||27
153270|NCT01069003|369993|P3|NOT COMPLETED|Overall Study||475
153271|NCT01069003|369994|P2|NOT COMPLETED|Overall Study||54
153272|NCT01069003|369995|P1|NOT COMPLETED|Overall Study||46
153273|NCT01069003|369993|P3|COMPLETED|Overall Study||976
153274|NCT01069003|369994|P2|COMPLETED|Overall Study||358
153275|NCT01069003|369995|P1|COMPLETED|Overall Study||353
153276|NCT01069003|369993|P3|STARTED|Overall Study||1451
153277|NCT01069003|369994|P2|STARTED|Overall Study||412
153278|NCT01069003|369995|P1|STARTED|Overall Study||399
153279|NCT01068964|370011|P2|NOT COMPLETED|Overall Study||10
153280|NCT01068964|370012|P1|NOT COMPLETED|Overall Study||8
153281|NCT01068964|370011|P2|COMPLETED|Overall Study||104
153282|NCT01068964|370012|P1|COMPLETED|Overall Study||113
153283|NCT01068964|370011|P2|STARTED|Overall Study||114
153284|NCT01068964|370012|P1|STARTED|Overall Study||121
153285|NCT01068912|370021|P3|NOT COMPLETED|Overall Study||15
153286|NCT01068912|370022|P2|NOT COMPLETED|Overall Study||22
153287|NCT01068912|370023|P1|NOT COMPLETED|Overall Study||11
153288|NCT01068912|370021|P3|COMPLETED|Overall Study||186
153289|NCT01068912|370022|P2|COMPLETED|Overall Study||173
153290|NCT01068912|370023|P1|COMPLETED|Overall Study||123
153291|NCT01068912|370021|P3|STARTED|Overall Study||201
153292|NCT01068912|370022|P2|STARTED|Overall Study||195
153293|NCT01068912|370023|P1|STARTED|Overall Study||134
153294|NCT01068860|370041|P10|NOT COMPLETED|Overall Study||4
153295|NCT01068860|370042|P9|NOT COMPLETED|Overall Study||0
153296|NCT01068860|370043|P8|NOT COMPLETED|Overall Study||0
153297|NCT01068860|370044|P7|NOT COMPLETED|Overall Study||0
153298|NCT01068860|370045|P6|NOT COMPLETED|Overall Study||2
153299|NCT01068860|370046|P5|NOT COMPLETED|Overall Study||0
153300|NCT01068860|370047|P4|NOT COMPLETED|Overall Study||1
153301|NCT01068860|370048|P3|NOT COMPLETED|Overall Study||0
153302|NCT01068860|370049|P2|NOT COMPLETED|Overall Study||1
153303|NCT01068860|370050|P1|NOT COMPLETED|Overall Study||0
153304|NCT01068860|370041|P10|COMPLETED|Overall Study||23
153305|NCT01068860|370042|P9|COMPLETED|Overall Study||28
153306|NCT01068860|370043|P8|COMPLETED|Overall Study||15
153307|NCT01068860|370044|P7|COMPLETED|Overall Study||28
153308|NCT01068860|370045|P6|COMPLETED|Overall Study||14
153309|NCT01068860|370046|P5|COMPLETED|Overall Study||32
153310|NCT01068860|370047|P4|COMPLETED|Overall Study||16
153311|NCT01068860|370048|P3|COMPLETED|Overall Study||33
153312|NCT01068860|370049|P2|COMPLETED|Overall Study||16
153313|NCT01068860|370050|P1|COMPLETED|Overall Study||33
153314|NCT01068860|370041|P10|STARTED|Overall Study||27
153315|NCT01068860|370042|P9|STARTED|Overall Study||28
153316|NCT01068860|370043|P8|STARTED|Overall Study||15
153317|NCT01068860|370044|P7|STARTED|Overall Study||28
153318|NCT01068860|370045|P6|STARTED|Overall Study||16
153319|NCT01068860|370046|P5|STARTED|Overall Study||32
153320|NCT01068860|370047|P4|STARTED|Overall Study||17
153321|NCT01068860|370048|P3|STARTED|Overall Study||33
153322|NCT01068860|370049|P2|STARTED|Overall Study||17
153323|NCT01068860|370050|P1|STARTED|Overall Study||33
153324|NCT01068821|370224|P2|NOT COMPLETED|Overall Study||0
153325|NCT01068821|370225|P1|NOT COMPLETED|Overall Study||1
153326|NCT01068821|370224|P2|COMPLETED|Overall Study||29
153327|NCT01068821|370225|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
153328|NCT01068821|370224|P2|STARTED|Overall Study||29
153329|NCT01068821|370225|P1|STARTED|Overall Study||31
153330|NCT01068769|370233|P1|NOT COMPLETED|Overall Study||1
153331|NCT01068769|370233|P1|COMPLETED|Overall Study||33
153332|NCT01068769|370233|P1|STARTED|Overall Study||34
153333|NCT01068743|370238|P4|NOT COMPLETED|Period 4||0
153334|NCT01068743|370239|P3|NOT COMPLETED|Period 4||0
153335|NCT01068743|370240|P2|NOT COMPLETED|Period 4||0
153336|NCT01068743|370241|P1|NOT COMPLETED|Period 4||0
153337|NCT01068743|370238|P4|COMPLETED|Period 4||6
153338|NCT01068743|370239|P3|COMPLETED|Period 4||6
153339|NCT01068743|370240|P2|COMPLETED|Period 4||5
153340|NCT01068743|370241|P1|COMPLETED|Period 4||6
153341|NCT01068743|370238|P4|STARTED|Period 4||6
153342|NCT01068743|370239|P3|STARTED|Period 4||6
153343|NCT01068743|370240|P2|STARTED|Period 4||5
153344|NCT01068743|370241|P1|STARTED|Period 4||6
153345|NCT01068743|370238|P4|NOT COMPLETED|Period 3||0
153346|NCT01068743|370239|P3|NOT COMPLETED|Period 3||0
153347|NCT01068743|370240|P2|NOT COMPLETED|Period 3||1
153348|NCT01068743|370241|P1|NOT COMPLETED|Period 3||0
153349|NCT01068743|370238|P4|COMPLETED|Period 3||6
153350|NCT01068743|370239|P3|COMPLETED|Period 3||6
153351|NCT01068743|370240|P2|COMPLETED|Period 3||5
153352|NCT01068743|370241|P1|COMPLETED|Period 3||6
153353|NCT01068743|370238|P4|STARTED|Period 3||6
153354|NCT01068743|370239|P3|STARTED|Period 3||6
153355|NCT01068743|370240|P2|STARTED|Period 3||6
153356|NCT01068743|370241|P1|STARTED|Period 3||6
153357|NCT01068743|370238|P4|NOT COMPLETED|Period 2||0
153358|NCT01068743|370239|P3|NOT COMPLETED|Period 2||0
153359|NCT01068743|370240|P2|NOT COMPLETED|Period 2||0
153360|NCT01068743|370241|P1|NOT COMPLETED|Period 2||0
153361|NCT01068743|370238|P4|COMPLETED|Period 2||6
153362|NCT01068743|370239|P3|COMPLETED|Period 2||6
153363|NCT01068743|370240|P2|COMPLETED|Period 2||6
153364|NCT01068743|370241|P1|COMPLETED|Period 2||6
153365|NCT01068743|370238|P4|STARTED|Period 2||6
153366|NCT01068743|370239|P3|STARTED|Period 2||6
153367|NCT01068743|370240|P2|STARTED|Period 2||6
153368|NCT01068743|370241|P1|STARTED|Period 2||6
153369|NCT01068743|370238|P4|NOT COMPLETED|Period 1||0
153370|NCT01068743|370239|P3|NOT COMPLETED|Period 1||0
153371|NCT01068743|370240|P2|NOT COMPLETED|Period 1||0
153372|NCT01068743|370241|P1|NOT COMPLETED|Period 1||0
153373|NCT01068743|370238|P4|COMPLETED|Period 1||6
153374|NCT01068743|370239|P3|COMPLETED|Period 1||6
153375|NCT01068743|370240|P2|COMPLETED|Period 1||6
153376|NCT01068743|370241|P1|COMPLETED|Period 1||6
153377|NCT01068743|370238|P4|STARTED|Period 1||6
153378|NCT01068743|370239|P3|STARTED|Period 1||6
153379|NCT01068743|370240|P2|STARTED|Period 1||6
153380|NCT01068743|370241|P1|STARTED|Period 1||6
153381|NCT01068730|370315|P4|NOT COMPLETED|Period 4||0
153382|NCT01068730|370316|P3|NOT COMPLETED|Period 4||0
153383|NCT01068730|370317|P2|NOT COMPLETED|Period 4||1
153384|NCT01068730|370318|P1|NOT COMPLETED|Period 4||0
153385|NCT01068730|370315|P4|COMPLETED|Period 4||7
153386|NCT01068730|370316|P3|COMPLETED|Period 4||7
153387|NCT01068730|370317|P2|COMPLETED|Period 4||6
153388|NCT01068730|370318|P1|COMPLETED|Period 4||6
153389|NCT01068730|370315|P4|STARTED|Period 4||7
153390|NCT01068730|370316|P3|STARTED|Period 4||7
153391|NCT01068730|370317|P2|STARTED|Period 4||7
153392|NCT01068730|370318|P1|STARTED|Period 4||6
153393|NCT01068730|370315|P4|NOT COMPLETED|Period 3||0
153394|NCT01068730|370316|P3|NOT COMPLETED|Period 3||0
153395|NCT01068730|370317|P2|NOT COMPLETED|Period 3||0
153396|NCT01068730|370318|P1|NOT COMPLETED|Period 3||1
153397|NCT01068730|370315|P4|COMPLETED|Period 3||7
153398|NCT01068730|370316|P3|COMPLETED|Period 3||7
153399|NCT01068730|370317|P2|COMPLETED|Period 3||7
153400|NCT01068730|370318|P1|COMPLETED|Period 3||6
153401|NCT01068730|370315|P4|STARTED|Period 3||7
153402|NCT01068730|370316|P3|STARTED|Period 3||7
153403|NCT01068730|370317|P2|STARTED|Period 3||7
153404|NCT01068730|370318|P1|STARTED|Period 3||7
153405|NCT01068730|370315|P4|NOT COMPLETED|Period 2||0
153406|NCT01068730|370316|P3|NOT COMPLETED|Period 2||0
153407|NCT01068730|370317|P2|NOT COMPLETED|Period 2||0
153408|NCT01068730|370318|P1|NOT COMPLETED|Period 2||0
153409|NCT01068730|370315|P4|COMPLETED|Period 2||7
153410|NCT01068730|370316|P3|COMPLETED|Period 2||7
153411|NCT01068730|370317|P2|COMPLETED|Period 2||7
153412|NCT01068730|370318|P1|COMPLETED|Period 2||7
153413|NCT01068730|370315|P4|STARTED|Period 2||7
153414|NCT01068730|370316|P3|STARTED|Period 2||7
153415|NCT01068730|370317|P2|STARTED|Period 2||7
153416|NCT01068730|370318|P1|STARTED|Period 2||7
153417|NCT01068730|370315|P4|NOT COMPLETED|Period 1||0
153418|NCT01068730|370316|P3|NOT COMPLETED|Period 1||0
153419|NCT01068730|370317|P2|NOT COMPLETED|Period 1||0
153420|NCT01068730|370318|P1|NOT COMPLETED|Period 1||0
153421|NCT01068730|370315|P4|COMPLETED|Period 1||7
153422|NCT01068730|370316|P3|COMPLETED|Period 1||7
153423|NCT01068730|370317|P2|COMPLETED|Period 1||7
153424|NCT01068730|370318|P1|COMPLETED|Period 1||7
153425|NCT01068730|370315|P4|STARTED|Period 1||7
153426|NCT01068730|370316|P3|STARTED|Period 1||7
153427|NCT01068730|370317|P2|STARTED|Period 1||7
153428|NCT01068730|370318|P1|STARTED|Period 1||7
153429|NCT01068717|370372|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
153430|NCT01068717|370373|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
153431|NCT01068717|370374|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
153432|NCT01068717|370375|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
153433|NCT01068717|370372|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
153434|NCT01068717|370373|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
153435|NCT01068717|370374|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
153436|NCT01068717|370375|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
153437|NCT01068717|370372|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
153438|NCT01068717|370373|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
153439|NCT01068717|370374|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
153440|NCT01068717|370375|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
153441|NCT01068717|370372|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
153442|NCT01068717|370373|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
153443|NCT01068717|370374|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
153444|NCT01068717|370375|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
153445|NCT01068717|370372|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
153446|NCT01068717|370373|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
153447|NCT01068717|370374|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
153448|NCT01068717|370375|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
153449|NCT01068717|370372|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
153450|NCT01068717|370373|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
153451|NCT01068717|370374|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
153452|NCT01068717|370375|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
153453|NCT01068717|370372|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
153454|NCT01068717|370373|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
153455|NCT01068717|370374|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
153456|NCT01068717|370375|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
153457|NCT01068717|370372|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
153458|NCT01068717|370373|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
153459|NCT01068717|370374|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
153460|NCT01068717|370375|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
153461|NCT01068717|370372|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
153462|NCT01068717|370373|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
153463|NCT01068717|370374|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
153464|NCT01068717|370375|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
153465|NCT01068717|370372|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
153466|NCT01068717|370373|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
153467|NCT01068717|370374|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
153468|NCT01068717|370375|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
153469|NCT01068717|370372|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
153470|NCT01068717|370373|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
153471|NCT01068717|370374|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
153472|NCT01068717|370375|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
153473|NCT01068717|370372|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
153474|NCT01068717|370373|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
153475|NCT01068717|370374|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
153476|NCT01068717|370375|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
153477|NCT01068678|370431|P2|NOT COMPLETED|Overall Study||24
153478|NCT01068678|370432|P1|NOT COMPLETED|Overall Study||38
153479|NCT01068678|370431|P2|COMPLETED|Overall Study||206
153480|NCT01068678|370432|P1|COMPLETED|Overall Study||192
153481|NCT01068678|370431|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
153482|NCT01068678|370432|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
153483|NCT01068678|370431|P2|STARTED|Overall Study||230
153484|NCT01068678|370432|P1|STARTED|Overall Study||230
153485|NCT01068665|370442|P2|NOT COMPLETED|Overall Study||29
153486|NCT01068665|370443|P1|NOT COMPLETED|Overall Study||30
153487|NCT01068665|370442|P2|COMPLETED|Overall Study||201
153488|NCT01068665|370443|P1|COMPLETED|Overall Study||200
153489|NCT01068665|370442|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
153490|NCT01068665|370443|P1|Exposed|Overall Study||228
153491|NCT01068665|370442|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
153492|NCT01068665|370443|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
153493|NCT01068665|370442|P2|STARTED|Overall Study||230
153494|NCT01068665|370443|P1|STARTED|Overall Study||230
153495|NCT01068652|370453|P2|NOT COMPLETED|Overall Study||15
153496|NCT01068652|370454|P1|NOT COMPLETED|Overall Study||18
153497|NCT01068652|370453|P2|COMPLETED|Overall Study||188
153498|NCT01068652|370454|P1|COMPLETED|Overall Study||182
153499|NCT01068652|370453|P2|STARTED|Overall Study||203
153500|NCT01068652|370454|P1|STARTED|Overall Study||200
153501|NCT01068626|370494|P2|NOT COMPLETED|Overall Study||2
153502|NCT01068626|370495|P1|NOT COMPLETED|Overall Study||3
153503|NCT01068626|370494|P2|COMPLETED|Overall Study||27
153504|NCT01068626|370495|P1|COMPLETED|Overall Study||27
153505|NCT01068626|370494|P2|STARTED|Overall Study||29
153506|NCT01068626|370495|P1|STARTED|Overall Study||30
153507|NCT01068600|370513|P2|NOT COMPLETED|Overall Study||17
153508|NCT01068600|370514|P1|NOT COMPLETED|Overall Study||11
153509|NCT01068600|370513|P2|COMPLETED|Overall Study||142
153510|NCT01068600|370514|P1|COMPLETED|Overall Study||148
153511|NCT01068600|370513|P2|STARTED|Overall Study||159
153512|NCT01068600|370514|P1|STARTED|Overall Study||159
153513|NCT01068548|370524|P2|NOT COMPLETED|Overall Study||0
153514|NCT01068548|370525|P1|NOT COMPLETED|Overall Study||0
153515|NCT01068548|370524|P2|COMPLETED|Overall Study||63
153516|NCT01068548|370525|P1|COMPLETED|Overall Study||66
153517|NCT01068548|370524|P2|STARTED|Overall Study||63
153518|NCT01068548|370525|P1|STARTED|Overall Study||66
153519|NCT01068509|370534|P3|NOT COMPLETED|Overall Study||21
153520|NCT01068509|370535|P2|NOT COMPLETED|Overall Study||22
153521|NCT01068509|370536|P1|NOT COMPLETED|Overall Study||6
153522|NCT01068509|370534|P3|COMPLETED|Overall Study||6
153523|NCT01068509|370535|P2|COMPLETED|Overall Study||7
153524|NCT01068509|370536|P1|COMPLETED|Overall Study||1
153525|NCT01068509|370534|P3|STARTED|Overall Study||27
153526|NCT01068509|370535|P2|STARTED|Overall Study||29
153527|NCT01068509|370536|P1|STARTED|Overall Study||7
153528|NCT01068418|370549|P1|NOT COMPLETED|Overall Study||12
153529|NCT01068418|370549|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
153530|NCT01068418|370549|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
153531|NCT01068418|370549|P1|STARTED|Overall Study|26 participants found to be eligible|26
153532|NCT01068262|370558|P4|NOT COMPLETED|Overall Study||0
153533|NCT01068262|370559|P3|NOT COMPLETED|Overall Study||1
153534|NCT01068262|370560|P2|NOT COMPLETED|Overall Study||1
153535|NCT01068262|370561|P1|NOT COMPLETED|Overall Study||3
153536|NCT01068262|370558|P4|COMPLETED|Overall Study||2
153537|NCT01068262|370559|P3|COMPLETED|Overall Study||9
153538|NCT01068262|370560|P2|COMPLETED|Overall Study||8
153539|NCT01068262|370561|P1|COMPLETED|Overall Study||20
153540|NCT01068262|370558|P4|STARTED|Overall Study||2
153541|NCT01068262|370559|P3|STARTED|Overall Study||10
153542|NCT01068262|370560|P2|STARTED|Overall Study||9
153543|NCT01068262|370561|P1|STARTED|Overall Study||23
153544|NCT01068158|370591|P2|NOT COMPLETED|Overall Study||4
153545|NCT01068158|370592|P1|NOT COMPLETED|Overall Study||8
153546|NCT01068158|370591|P2|COMPLETED|Overall Study||198
153547|NCT01068158|370592|P1|COMPLETED|Overall Study||161
153548|NCT01068158|370591|P2|STARTED|Overall Study||202
153549|NCT01068158|370592|P1|STARTED|Overall Study||169
153550|NCT01067976|370604|P1|NOT COMPLETED|Overall Study||22
153551|NCT01067976|370604|P1|COMPLETED|Overall Study|study course completed|424
153552|NCT01067976|370604|P1|Fulfilled Requirements of FAS Population|Overall Study||390
153553|NCT01067976|370604|P1|Received Treatment|Overall Study|treatment started|426
153554|NCT01067976|370604|P1|STARTED|Overall Study|screened and enrolled|446
153555|NCT01067846|370665|P2|NOT COMPLETED|Overall Study||19
153556|NCT01067846|370666|P1|NOT COMPLETED|Overall Study||19
153557|NCT01067846|370665|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
153558|NCT01067846|370666|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
153559|NCT01067846|370665|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
153560|NCT01067846|370666|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
153561|NCT01067846|370665|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
153562|NCT01067846|370666|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
153563|NCT01067781|370678|P4|NOT COMPLETED|180 to Day 720||89
153564|NCT01067781|370679|P3|NOT COMPLETED|180 to Day 720||89
153565|NCT01067781|370680|P2|NOT COMPLETED|180 to Day 720||164
153566|NCT01067781|370681|P1|NOT COMPLETED|180 to Day 720||170
153567|NCT01067781|370678|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
153568|NCT01067781|370679|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
153569|NCT01067781|370680|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
153570|NCT01067781|370681|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
153571|NCT01067781|370678|P4|STARTED|180 to Day 720||89
153572|NCT01067781|370679|P3|STARTED|180 to Day 720||89
153573|NCT01067781|370680|P2|STARTED|180 to Day 720||168
153574|NCT01067781|370681|P1|STARTED|180 to Day 720||173
153575|NCT01067781|370678|P4|NOT COMPLETED|Up to Day 180||12
153576|NCT01067781|370679|P3|NOT COMPLETED|Up to Day 180||8
153577|NCT01067781|370680|P2|NOT COMPLETED|Up to Day 180||31
153578|NCT01067781|370681|P1|NOT COMPLETED|Up to Day 180||30
153579|NCT01067781|370678|P4|COMPLETED|Up to Day 180||89
153580|NCT01067781|370679|P3|COMPLETED|Up to Day 180||89
153581|NCT01067781|370680|P2|COMPLETED|Up to Day 180||168
153582|NCT01067781|370681|P1|COMPLETED|Up to Day 180||173
153583|NCT01067781|370678|P4|STARTED|Up to Day 180||101
153584|NCT01067781|370679|P3|STARTED|Up to Day 180||97
153585|NCT01067781|370680|P2|STARTED|Up to Day 180||199
153586|NCT01067781|370681|P1|STARTED|Up to Day 180||203
153587|NCT01067768|370691|P2|NOT COMPLETED|Overall Study||0
153588|NCT01067768|370692|P1|NOT COMPLETED|Overall Study||0
153589|NCT01067768|370691|P2|COMPLETED|Overall Study||605
153590|NCT01067768|370692|P1|COMPLETED|Overall Study||604
153591|NCT01067768|370691|P2|STARTED|Overall Study||605
153592|NCT01067768|370692|P1|STARTED|Overall Study||604
153593|NCT01067716|370703|P3|NOT COMPLETED|Overall Study||0
153594|NCT01067716|370704|P2|NOT COMPLETED|Overall Study||0
153595|NCT01067716|370705|P1|NOT COMPLETED|Overall Study||0
153596|NCT01067716|370703|P3|COMPLETED|Overall Study|15 eyes|9
153597|NCT01067716|370704|P2|COMPLETED|Overall Study|25 eyes|13
153598|NCT01067716|370705|P1|COMPLETED|Overall Study|110 eyes|57
153599|NCT01067716|370703|P3|STARTED|Overall Study|15 eyes|9
153600|NCT01067716|370704|P2|STARTED|Overall Study|25 eyes|13
153601|NCT01067716|370705|P1|STARTED|Overall Study|110 eyes|57
153602|NCT01067456|370724|P2|NOT COMPLETED|Overall Study||0
153603|NCT01067456|370725|P1|NOT COMPLETED|Overall Study||0
153604|NCT01067456|370724|P2|COMPLETED|Overall Study||29
153605|NCT01067456|370725|P1|COMPLETED|Overall Study||30
153606|NCT01067456|370724|P2|STARTED|Overall Study||29
153607|NCT01067456|370725|P1|STARTED|Overall Study||30
153608|NCT01067352|370738|P3|NOT COMPLETED|Overall Study||1
153609|NCT01067352|370739|P2|NOT COMPLETED|Overall Study||3
153610|NCT01067352|370740|P1|NOT COMPLETED|Overall Study||1
153611|NCT01067352|370738|P3|COMPLETED|Overall Study||9
153612|NCT01067352|370739|P2|COMPLETED|Overall Study||3
153613|NCT01067352|370740|P1|COMPLETED|Overall Study||8
153614|NCT01067352|370738|P3|STARTED|Overall Study||10
153615|NCT01067352|370739|P2|STARTED|Overall Study||6
153616|NCT01067352|370740|P1|STARTED|Overall Study||9
153617|NCT01067339|370756|P2|NOT COMPLETED|Overall Study||5
153618|NCT01067339|370757|P1|NOT COMPLETED|Overall Study||6
153619|NCT01067339|370756|P2|COMPLETED|Overall Study||29
153620|NCT01067339|370757|P1|COMPLETED|Overall Study||25
153621|NCT01067339|370756|P2|STARTED|Overall Study||34
153622|NCT01067339|370757|P1|STARTED|Overall Study||31
153623|NCT01067326|370767|P2|NOT COMPLETED|Overall Study||3
153624|NCT01067326|370768|P1|NOT COMPLETED|Overall Study||2
153625|NCT01067326|370767|P2|COMPLETED|Overall Study||5
153626|NCT01067326|370768|P1|COMPLETED|Overall Study||12
153627|NCT01067326|370767|P2|STARTED|Overall Study||8
153628|NCT01067326|370768|P1|STARTED|Overall Study||14
153629|NCT01067105|370780|P1|NOT COMPLETED|Overall Study||141
153630|NCT01067105|370780|P1|COMPLETED|Overall Study||683
153631|NCT01067105|370780|P1|STARTED|Overall Study||824
153632|NCT01066923|370801|P4|NOT COMPLETED|Overall Study||8
153633|NCT01066923|370802|P3|NOT COMPLETED|Overall Study||8
153634|NCT01066923|370803|P2|NOT COMPLETED|Overall Study||3
153635|NCT01066923|370804|P1|NOT COMPLETED|Overall Study||3
153636|NCT01066923|370801|P4|COMPLETED|Overall Study||23
153637|NCT01066923|370802|P3|COMPLETED|Overall Study||25
153638|NCT01066923|370803|P2|COMPLETED|Overall Study||29
153639|NCT01066923|370804|P1|COMPLETED|Overall Study||25
153640|NCT01066923|370801|P4|Retinal Imaging|Overall Study||0
153641|NCT01066923|370802|P3|Retinal Imaging|Overall Study||0
153642|NCT01066923|370803|P2|Retinal Imaging|Overall Study||0
153643|NCT01066923|370804|P1|Retinal Imaging|Overall Study||0
153644|NCT01066923|370801|P4|Activation of Coagulation|Overall Study||0
153645|NCT01066923|370802|P3|Activation of Coagulation|Overall Study||0
153646|NCT01066923|370803|P2|Activation of Coagulation|Overall Study||0
153647|NCT01066923|370804|P1|Activation of Coagulation|Overall Study||0
153648|NCT01066923|370801|P4|Vascular Function|Overall Study||13
153649|NCT01066923|370802|P3|Vascular Function|Overall Study||12
153650|NCT01066923|370803|P2|Vascular Function|Overall Study||14
153651|NCT01066923|370804|P1|Vascular Function|Overall Study||13
153652|NCT01066923|370801|P4|Platelet Closure Time|Overall Study||23
153653|NCT01066923|370802|P3|Platelet Closure Time|Overall Study||25
153654|NCT01066923|370803|P2|Platelet Closure Time|Overall Study||29
153655|NCT01066923|370804|P1|Platelet Closure Time|Overall Study||25
153656|NCT01066923|370801|P4|STARTED|Overall Study||31
153657|NCT01066923|370802|P3|STARTED|Overall Study||33
153658|NCT01066923|370803|P2|STARTED|Overall Study||32
153659|NCT01066923|370804|P1|STARTED|Overall Study||28
153660|NCT01066897|370828|P2|NOT COMPLETED|Overall Study||0
153661|NCT01066897|370829|P1|NOT COMPLETED|Overall Study||2
153662|NCT01066897|370828|P2|COMPLETED|Overall Study||9
153663|NCT01066897|370829|P1|COMPLETED|Overall Study||5
153664|NCT01066897|370828|P2|STARTED|Overall Study||9
153665|NCT01066897|370829|P1|STARTED|Overall Study||7
153666|NCT01066871|370843|P4|NOT COMPLETED|Overall Study||5
153667|NCT01066871|370844|P3|NOT COMPLETED|Overall Study||6
153668|NCT01066871|370845|P2|NOT COMPLETED|Overall Study||5
153669|NCT01066871|370846|P1|NOT COMPLETED|Overall Study||4
153670|NCT01066871|370843|P4|COMPLETED|Overall Study||13
153671|NCT01066871|370844|P3|COMPLETED|Overall Study||12
153672|NCT01066871|370845|P2|COMPLETED|Overall Study||13
153673|NCT01066871|370846|P1|COMPLETED|Overall Study||16
153674|NCT01066871|370843|P4|STARTED|Overall Study||18
153675|NCT01066871|370844|P3|STARTED|Overall Study||18
153676|NCT01066871|370845|P2|STARTED|Overall Study||18
153677|NCT01066871|370846|P1|STARTED|Overall Study||20
153678|NCT01066819|370910|P6|NOT COMPLETED|Overall Study||6
153679|NCT01066819|370911|P5|NOT COMPLETED|Overall Study||4
153680|NCT01066819|370912|P4|NOT COMPLETED|Overall Study||17
153681|NCT01066819|370913|P3|NOT COMPLETED|Overall Study||146
153682|NCT01066819|370914|P2|NOT COMPLETED|Overall Study||171
153683|NCT01066819|370915|P1|NOT COMPLETED|Overall Study||689
153684|NCT01066819|370910|P6|COMPLETED|Overall Study||7
153685|NCT01066819|370911|P5|COMPLETED|Overall Study||3
153686|NCT01066819|370912|P4|COMPLETED|Overall Study||8
153687|NCT01066819|370913|P3|COMPLETED|Overall Study||111
153688|NCT01066819|370914|P2|COMPLETED|Overall Study||177
153689|NCT01066819|370915|P1|COMPLETED|Overall Study||317
153690|NCT01066819|370910|P6|STARTED|Overall Study||13
153691|NCT01066819|370911|P5|STARTED|Overall Study||7
153692|NCT01066819|370912|P4|STARTED|Overall Study||25
153693|NCT01066819|370913|P3|STARTED|Overall Study||257
153694|NCT01066819|370914|P2|STARTED|Overall Study||348
153695|NCT01066819|370915|P1|STARTED|Overall Study||1006
153696|NCT01066793|371056|P6|NOT COMPLETED|Overall Study||1
153697|NCT01066793|371057|P5|NOT COMPLETED|Overall Study||0
153698|NCT01066793|371058|P4|NOT COMPLETED|Overall Study||49
153699|NCT01066793|371059|P3|NOT COMPLETED|Overall Study||115
153700|NCT01066793|371060|P2|NOT COMPLETED|Overall Study||77
153701|NCT01066793|371061|P1|NOT COMPLETED|Overall Study||374
153702|NCT01066793|371056|P6|COMPLETED|Overall Study||4
153703|NCT01066793|371057|P5|COMPLETED|Overall Study||11
153704|NCT01066793|371058|P4|COMPLETED|Overall Study||94
153705|NCT01066793|371059|P3|COMPLETED|Overall Study||369
153706|NCT01066793|371060|P2|COMPLETED|Overall Study||495
153707|NCT01066793|371061|P1|COMPLETED|Overall Study||754
153708|NCT01066793|371056|P6|STARTED|Overall Study||5
153709|NCT01066793|371057|P5|STARTED|Overall Study||11
153710|NCT01066793|371058|P4|STARTED|Overall Study||143
153711|NCT01066793|371059|P3|STARTED|Overall Study||484
153712|NCT01066793|371060|P2|STARTED|Overall Study||572
153713|NCT01066793|371061|P1|STARTED|Overall Study||1128
153714|NCT01066780|371201|P2|NOT COMPLETED|Overall Study||1
153715|NCT01066780|371202|P1|NOT COMPLETED|Overall Study||1
153716|NCT01066780|371201|P2|COMPLETED|Overall Study||23
153717|NCT01066780|371202|P1|COMPLETED|Overall Study||23
153718|NCT01066780|371201|P2|STARTED|Overall Study||24
153719|NCT01066780|371202|P1|STARTED|Overall Study||24
153720|NCT01066624|371209|P3|NOT COMPLETED|Overall Study||0
153721|NCT01066624|371210|P2|NOT COMPLETED|Overall Study||0
153722|NCT01066624|371211|P1|NOT COMPLETED|Overall Study||0
153723|NCT01066624|371209|P3|COMPLETED|Overall Study||39
153724|NCT01066624|371210|P2|COMPLETED|Overall Study||40
153725|NCT01066624|371211|P1|COMPLETED|Overall Study||38
153726|NCT01066624|371209|P3|STARTED|Overall Study||39
153727|NCT01066624|371210|P2|STARTED|Overall Study||40
153728|NCT01066624|371211|P1|STARTED|Overall Study||38
153729|NCT01066585|371221|P2|NOT COMPLETED|Overall Study||3
153730|NCT01066585|371222|P1|NOT COMPLETED|Overall Study||1
153731|NCT01066585|371221|P2|COMPLETED|Overall Study||196
153732|NCT01066585|371222|P1|COMPLETED|Overall Study||210
153733|NCT01066585|371221|P2|STARTED|Overall Study||199
153734|NCT01066585|371222|P1|STARTED|Overall Study||211
153735|NCT01066546|371234|P1|NOT COMPLETED|Overall Study||5
153736|NCT01066546|371234|P1|COMPLETED|Overall Study||0
153737|NCT01066546|371234|P1|STARTED|Overall Study||5
153738|NCT01066520|371248|P3|NOT COMPLETED|Overall Study||0
153739|NCT01066520|371249|P2|NOT COMPLETED|Overall Study||0
153740|NCT01066520|371250|P1|NOT COMPLETED|Overall Study||0
153741|NCT01066520|371248|P3|COMPLETED|Overall Study||137
153742|NCT01066520|371249|P2|COMPLETED|Overall Study||140
153743|NCT01066520|371250|P1|COMPLETED|Overall Study||143
153744|NCT01066520|371248|P3|STARTED|Overall Study||137
153745|NCT01066520|371249|P2|STARTED|Overall Study||140
153746|NCT01066520|371250|P1|STARTED|Overall Study||143
153747|NCT01066156|371264|P1|NOT COMPLETED|Overall Study||10
153748|NCT01066156|371264|P1|COMPLETED|Overall Study||24
153749|NCT01066156|371264|P1|STARTED|Overall Study||34
153750|NCT01066143|371268|P1|NOT COMPLETED|Overall Study||8
153751|NCT01066143|371268|P1|COMPLETED|Overall Study||0
153752|NCT01066143|371268|P1|STARTED|Overall Study||8
153753|NCT01066104|371274|P2|NOT COMPLETED|Overall Study||1
153754|NCT01066104|371275|P1|NOT COMPLETED|Overall Study||2
153755|NCT01066104|371274|P2|COMPLETED|Overall Study||12
153756|NCT01066104|371275|P1|COMPLETED|Overall Study||12
153757|NCT01066104|371274|P2|STARTED|Overall Study||13
153758|NCT01066104|371275|P1|STARTED|Overall Study||14
153759|NCT01066039|371283|P1|NOT COMPLETED|Overall Study||44
153760|NCT01066039|371283|P1|COMPLETED|Overall Study||158
153761|NCT01066039|371283|P1|Treated|Overall Study||200
153762|NCT01066039|371283|P1|STARTED|Overall Study||202
153763|NCT01066000|371296|P1|NOT COMPLETED|Overall Study||9
153764|NCT01066000|371296|P1|COMPLETED|Overall Study||24
153765|NCT01066000|371296|P1|STARTED|Overall Study||33
153766|NCT01065844|371307|P1|NOT COMPLETED|Overall Study||5
153767|NCT01065844|371307|P1|COMPLETED|Overall Study||10
153768|NCT01065844|371307|P1|STARTED|Overall Study||15
153769|NCT01065818|371311|P1|NOT COMPLETED|Overall Study||2
153770|NCT01065818|371311|P1|COMPLETED|Overall Study||4
153771|NCT01065818|371311|P1|STARTED|Overall Study||6
153772|NCT01065779|371315|P1|NOT COMPLETED|Overall Study||82
153773|NCT01065779|371315|P1|COMPLETED|Overall Study||798
153774|NCT01065779|371315|P1|STARTED|Overall Study||880
153775|NCT01065766|371326|P1|NOT COMPLETED|Overall Study||32
153776|NCT01065766|371326|P1|COMPLETED|Overall Study||4033
153777|NCT01065766|371326|P1|STARTED|Overall Study||4065
153778|NCT01065714|371338|P1|NOT COMPLETED|Overall Study||0
153779|NCT01065714|371338|P1|COMPLETED|Overall Study||20
153780|NCT01065714|371338|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
153781|NCT01065597|371345|P1|NOT COMPLETED|Overall Study||1
153782|NCT01065597|371345|P1|COMPLETED|Overall Study||12
153783|NCT01065597|371345|P1|STARTED|Overall Study||13
153784|NCT01065558|371352|P1|NOT COMPLETED|Overall Study||0
153785|NCT01065558|371352|P1|COMPLETED|Overall Study||5
153786|NCT01065558|371352|P1|STARTED|Overall Study||5
153787|NCT01065506|371359|P2|NOT COMPLETED|Overall Study||38
153788|NCT01065506|371360|P1|NOT COMPLETED|Overall Study||32
153789|NCT01065506|371359|P2|COMPLETED|Overall Study||34
153790|NCT01065506|371360|P1|COMPLETED|Overall Study||32
153791|NCT01065506|371359|P2|4-Month Follow-Up|Overall Study||34
153792|NCT01065506|371360|P1|4-Month Follow-Up|Overall Study||35
153793|NCT01065506|371359|P2|End of Treatment|Overall Study||37
153794|NCT01065506|371360|P1|End of Treatment|Overall Study||44
153795|NCT01065506|371359|P2|STARTED|Overall Study||72
153796|NCT01065506|371360|P1|STARTED|Overall Study||64
153797|NCT01065480|371368|P2|NOT COMPLETED|Overall Study||0
153798|NCT01065480|371369|P1|NOT COMPLETED|Overall Study||0
153799|NCT01065480|371368|P2|COMPLETED|Overall Study||43
153800|NCT01065480|371369|P1|COMPLETED|Overall Study||48
153801|NCT01065480|371368|P2|STARTED|Overall Study||43
153802|NCT01065480|371369|P1|STARTED|Overall Study||48
153803|NCT01065454|371379|P4|NOT COMPLETED|Follow up||44
153804|NCT01065454|371380|P3|NOT COMPLETED|Follow up||17
153805|NCT01065454|371381|P2|NOT COMPLETED|Follow up||24
153806|NCT01065454|371382|P1|NOT COMPLETED|Follow up||39
153807|NCT01065454|371379|P4|COMPLETED|Follow up||13
153808|NCT01065454|371380|P3|COMPLETED|Follow up||6
153809|NCT01065454|371381|P2|COMPLETED|Follow up||4
153810|NCT01065454|371382|P1|COMPLETED|Follow up||15
153811|NCT01065454|371379|P4|Entering Follow-up|Follow up||51
153812|NCT01065454|371380|P3|Entering Follow-up|Follow up||23
153813|NCT01065454|371381|P2|Entering Follow-up|Follow up||27
153814|NCT01065454|371382|P1|Entering Follow-up|Follow up||49
153815|NCT01065454|371379|P4|STARTED|Follow up||57
153816|NCT01065454|371380|P3|STARTED|Follow up||23
153817|NCT01065454|371381|P2|STARTED|Follow up||28
153818|NCT01065454|371382|P1|STARTED|Follow up||54
153819|NCT01065454|371379|P4|NOT COMPLETED|Treatment||12
153820|NCT01065454|371380|P3|NOT COMPLETED|Treatment||9
153821|NCT01065454|371381|P2|NOT COMPLETED|Treatment||5
153822|NCT01065454|371382|P1|NOT COMPLETED|Treatment||13
153823|NCT01065454|371379|P4|COMPLETED|Treatment||57
153824|NCT01065454|371380|P3|COMPLETED|Treatment||23
153825|NCT01065454|371381|P2|COMPLETED|Treatment||28
153826|NCT01065454|371382|P1|COMPLETED|Treatment||54
153827|NCT01065454|371379|P4|STARTED|Treatment||69
153828|NCT01065454|371380|P3|STARTED|Treatment||32
153829|NCT01065454|371381|P2|STARTED|Treatment||33
153830|NCT01065454|371382|P1|STARTED|Treatment||67
153831|NCT01065428|371494|P2|NOT COMPLETED|Overall Study||0
153832|NCT01065428|371495|P1|NOT COMPLETED|Overall Study||0
153833|NCT01065428|371494|P2|COMPLETED|Overall Study||35
153834|NCT01065428|371495|P1|COMPLETED|Overall Study||17
153835|NCT01065428|371494|P2|STARTED|Overall Study||35
153836|NCT01065428|371495|P1|STARTED|Overall Study||17
153837|NCT01065350|371505|P2|NOT COMPLETED|Overall Study||1
153838|NCT01065350|371506|P1|NOT COMPLETED|Overall Study||0
153839|NCT01065350|371505|P2|COMPLETED|Overall Study||41
153840|NCT01065350|371506|P1|COMPLETED|Overall Study||43
153841|NCT01065350|371505|P2|STARTED|Overall Study||42
153842|NCT01065350|371506|P1|STARTED|Overall Study||43
153843|NCT01065051|371540|P2|NOT COMPLETED|Overall Study||0
153844|NCT01065051|371541|P1|NOT COMPLETED|Overall Study||0
153845|NCT01065051|371540|P2|COMPLETED|Overall Study||0
153846|NCT01065051|371541|P1|COMPLETED|Overall Study||1
153847|NCT01065051|371540|P2|STARTED|Overall Study||0
153848|NCT01065051|371541|P1|STARTED|Overall Study||1
153849|NCT01064947|371567|P1|NOT COMPLETED|Overall Study||41
153850|NCT01064947|371567|P1|COMPLETED|Overall Study||29
153851|NCT01064947|371567|P1|STARTED|Overall Study||70
153852|NCT01064882|371578|P3|NOT COMPLETED|Overall Study||2
153853|NCT01064882|371579|P2|NOT COMPLETED|Overall Study||2
153854|NCT01064882|371580|P1|NOT COMPLETED|Overall Study||2
153855|NCT01064882|371578|P3|COMPLETED|Overall Study||32
153856|NCT01064882|371579|P2|COMPLETED|Overall Study||32
153857|NCT01064882|371580|P1|COMPLETED|Overall Study||34
153858|NCT01064882|371578|P3|STARTED|Overall Study||34
153859|NCT01064882|371579|P2|STARTED|Overall Study||34
153860|NCT01064882|371580|P1|STARTED|Overall Study||36
153861|NCT01064856|371608|P4|NOT COMPLETED|Open-label (OL) Period||20
153862|NCT01064856|371609|P3|NOT COMPLETED|Open-label (OL) Period||26
153863|NCT01064856|371610|P2|NOT COMPLETED|Open-label (OL) Period||0
153864|NCT01064856|371611|P1|NOT COMPLETED|Open-label (OL) Period||0
153865|NCT01064856|371608|P4|COMPLETED|Open-label (OL) Period||61
153866|NCT01064856|371609|P3|COMPLETED|Open-label (OL) Period||56
153867|NCT01064856|371610|P2|COMPLETED|Open-label (OL) Period||0
153868|NCT01064856|371611|P1|COMPLETED|Open-label (OL) Period||0
153869|NCT01064856|371608|P4|STARTED|Open-label (OL) Period||81
153870|NCT01064856|371609|P3|STARTED|Open-label (OL) Period||82
153871|NCT01064856|371610|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
153872|NCT01064856|371611|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
153873|NCT01064856|371608|P4|NOT COMPLETED|Double-blind (DB) Period||0
153874|NCT01064856|371609|P3|NOT COMPLETED|Double-blind (DB) Period||0
153875|NCT01064856|371610|P2|NOT COMPLETED|Double-blind (DB) Period||0
153876|NCT01064856|371611|P1|NOT COMPLETED|Double-blind (DB) Period||2
153877|NCT01064856|371608|P4|COMPLETED|Double-blind (DB) Period||0
153878|NCT01064856|371609|P3|COMPLETED|Double-blind (DB) Period||0
153879|NCT01064856|371610|P2|COMPLETED|Double-blind (DB) Period||81
153880|NCT01064856|371611|P1|COMPLETED|Double-blind (DB) Period||82
153881|NCT01064856|371608|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
153882|NCT01064856|371609|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
153883|NCT01064856|371610|P2|STARTED|Double-blind (DB) Period||81
153884|NCT01064856|371611|P1|STARTED|Double-blind (DB) Period||84
153885|NCT01064830|371644|P2|NOT COMPLETED|Overall Study||4
153886|NCT01064830|371645|P1|NOT COMPLETED|Overall Study||2
153887|NCT01064830|371644|P2|COMPLETED|Overall Study||7
153888|NCT01064830|371645|P1|COMPLETED|Overall Study||8
153889|NCT01064830|371644|P2|STARTED|Overall Study||11
153890|NCT01064830|371645|P1|STARTED|Overall Study||10
153891|NCT01064817|371655|P2|NOT COMPLETED|Study Completion||0
153892|NCT01064817|371656|P1|NOT COMPLETED|Study Completion||2
153893|NCT01064817|371655|P2|COMPLETED|Study Completion||62
153894|NCT01064817|371656|P1|COMPLETED|Study Completion||60
153895|NCT01064817|371655|P2|STARTED|Study Completion||62
153896|NCT01064817|371656|P1|STARTED|Study Completion||62
153897|NCT01064817|371655|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
153898|NCT01064817|371656|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
153899|NCT01064817|371655|P2|COMPLETED|All Study Treatment Days 1-9||62
153900|NCT01064817|371656|P1|COMPLETED|All Study Treatment Days 1-9||62
153901|NCT01064817|371655|P2|STARTED|All Study Treatment Days 1-9||62
153902|NCT01064817|371656|P1|STARTED|All Study Treatment Days 1-9||62
153903|NCT01064739|371668|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
153904|NCT01064739|371668|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
153905|NCT01064739|371668|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
153906|NCT01064739|371668|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
153907|NCT01064739|371668|P1|COMPLETED|Fixed Sodium Study Diet||14
153908|NCT01064739|371668|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
153909|NCT01064687|371728|P4|NOT COMPLETED|Overall Study||17
153910|NCT01064687|371729|P3|NOT COMPLETED|Overall Study||41
153911|NCT01064687|371730|P2|NOT COMPLETED|Overall Study||26
153912|NCT01064687|371731|P1|NOT COMPLETED|Overall Study||34
153913|NCT01064687|371728|P4|COMPLETED|Overall Study||124
153914|NCT01064687|371729|P3|COMPLETED|Overall Study||237
153915|NCT01064687|371730|P2|COMPLETED|Overall Study||254
153916|NCT01064687|371731|P1|COMPLETED|Overall Study||245
153917|NCT01064687|371728|P4|Completed 26 Weeks|Overall Study||124
153918|NCT01064687|371729|P3|Completed 26 Weeks|Overall Study||252
153919|NCT01064687|371730|P2|Completed 26 Weeks|Overall Study||263
153920|NCT01064687|371731|P1|Completed 26 Weeks|Overall Study||260
153921|NCT01064687|371728|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
153922|NCT01064687|371729|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
153923|NCT01064687|371730|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
153924|NCT01064687|371731|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
153925|NCT01064687|371728|P4|STARTED|Overall Study||141
153926|NCT01064687|371729|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
153927|NCT01064687|371730|P2|STARTED|Overall Study||280
153928|NCT01064687|371731|P1|STARTED|Overall Study||279
153929|NCT01064622|371911|P2|NOT COMPLETED|Crossover of Arm I||0
153930|NCT01064622|371912|P1|NOT COMPLETED|Crossover of Arm I||0
153931|NCT01064622|371911|P2|COMPLETED|Crossover of Arm I||0
153932|NCT01064622|371912|P1|COMPLETED|Crossover of Arm I||22
153933|NCT01064622|371911|P2|STARTED|Crossover of Arm I||0
153934|NCT01064622|371912|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
153935|NCT01064622|371911|P2|NOT COMPLETED|Randomized Phase II||3
153936|NCT01064622|371912|P1|NOT COMPLETED|Randomized Phase II||2
153937|NCT01064622|371911|P2|COMPLETED|Randomized Phase II||53
153938|NCT01064622|371912|P1|COMPLETED|Randomized Phase II||53
153939|NCT01064622|371911|P2|STARTED|Randomized Phase II||56
153940|NCT01064622|371912|P1|STARTED|Randomized Phase II||55
153941|NCT01064622|371911|P2|NOT COMPLETED|Lead-in Phase I||0
153942|NCT01064622|371912|P1|NOT COMPLETED|Lead-in Phase I||0
153943|NCT01064622|371911|P2|COMPLETED|Lead-in Phase I||7
153944|NCT01064622|371912|P1|COMPLETED|Lead-in Phase I||0
153945|NCT01064622|371911|P2|STARTED|Lead-in Phase I||7
153946|NCT01064622|371912|P1|STARTED|Lead-in Phase I||0
153947|NCT01064414|371936|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
153948|NCT01064414|371937|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
153949|NCT01064414|371938|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
153950|NCT01064414|371936|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
153951|NCT01064414|371937|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
153952|NCT01064414|371938|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
153953|NCT01064414|371936|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
153954|NCT01064414|371937|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
153955|NCT01064414|371938|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
153956|NCT01064414|371936|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
153957|NCT01064414|371937|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
153958|NCT01064414|371938|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
153959|NCT01064414|371936|P3|COMPLETED|Core Period: Baseline to Week 26||82
153960|NCT01064414|371937|P2|COMPLETED|Core Period: Baseline to Week 26||75
153961|NCT01064414|371938|P1|COMPLETED|Core Period: Baseline to Week 26||77
153962|NCT01064414|371936|P3|STARTED|Core Period: Baseline to Week 26||89
153963|NCT01064414|371937|P2|STARTED|Core Period: Baseline to Week 26||90
153964|NCT01064414|371938|P1|STARTED|Core Period: Baseline to Week 26||90
153965|NCT01064401|371957|P2|NOT COMPLETED|Overall Study||195
153966|NCT01064401|371958|P1|NOT COMPLETED|Overall Study||228
153967|NCT01064401|371957|P2|COMPLETED|Overall Study||724
153968|NCT01064401|371958|P1|COMPLETED|Overall Study||694
153969|NCT01064401|371957|P2|STARTED|Overall Study||919
153970|NCT01064401|371958|P1|STARTED|Overall Study||922
153971|NCT01064362|371974|P2|NOT COMPLETED|Overall Study||0
153972|NCT01064362|371975|P1|NOT COMPLETED|Overall Study||0
153973|NCT01064362|371974|P2|COMPLETED|Overall Study||11883
153974|NCT01064362|371975|P1|COMPLETED|Overall Study||1559
153975|NCT01064362|371974|P2|STARTED|Overall Study||11883
153976|NCT01064362|371975|P1|STARTED|Overall Study||1559
153977|NCT01064323|371983|P1|NOT COMPLETED|Overall Study||0
153978|NCT01064323|371983|P1|COMPLETED|Overall Study||10
153979|NCT01064323|371983|P1|STARTED|Overall Study||10
153980|NCT01064310|372007|P3|NOT COMPLETED|Open Label Pazopinib||84
153981|NCT01064310|372008|P2|NOT COMPLETED|Open Label Pazopinib||0
153982|NCT01064310|372009|P1|NOT COMPLETED|Open Label Pazopinib||0
153983|NCT01064310|372007|P3|COMPLETED|Open Label Pazopinib||0
153984|NCT01064310|372008|P2|COMPLETED|Open Label Pazopinib||0
153985|NCT01064310|372009|P1|COMPLETED|Open Label Pazopinib||0
153986|NCT01064310|372007|P3|STARTED|Open Label Pazopinib||84
153987|NCT01064310|372008|P2|STARTED|Open Label Pazopinib||0
153988|NCT01064310|372009|P1|STARTED|Open Label Pazopinib||0
153989|NCT01064310|372007|P3|NOT COMPLETED|Period 2||0
153990|NCT01064310|372008|P2|NOT COMPLETED|Period 2||6
153991|NCT01064310|372009|P1|NOT COMPLETED|Period 2||4
153992|NCT01064310|372007|P3|COMPLETED|Period 2||0
153993|NCT01064310|372008|P2|COMPLETED|Period 2||62
153994|NCT01064310|372009|P1|COMPLETED|Period 2||64
153995|NCT01064310|372007|P3|STARTED|Period 2||0
153996|NCT01064310|372008|P2|STARTED|Period 2||68
153997|NCT01064310|372009|P1|STARTED|Period 2||68
153998|NCT01064310|372007|P3|NOT COMPLETED|Period 1||0
153999|NCT01064310|372008|P2|NOT COMPLETED|Period 1||18
154000|NCT01064310|372009|P1|NOT COMPLETED|Period 1||14
154001|NCT01064310|372007|P3|COMPLETED|Period 1||0
154002|NCT01064310|372008|P2|COMPLETED|Period 1||68
154003|NCT01064310|372009|P1|COMPLETED|Period 1||68
154004|NCT01064310|372007|P3|STARTED|Period 1||0
154005|NCT01064310|372008|P2|STARTED|Period 1||86
154006|NCT01064310|372009|P1|STARTED|Period 1||82
154007|NCT01064297|372039|P3|NOT COMPLETED|Overall Study||133
154008|NCT01064297|372040|P2|NOT COMPLETED|Overall Study||48
154009|NCT01064297|372041|P1|NOT COMPLETED|Overall Study||791
154010|NCT01064297|372039|P3|COMPLETED|Overall Study||497
154011|NCT01064297|372040|P2|COMPLETED|Overall Study||171
154012|NCT01064297|372041|P1|COMPLETED|Overall Study||1776
154013|NCT01064297|372039|P3|STARTED|Overall Study||630
154014|NCT01064297|372040|P2|STARTED|Overall Study||219
154015|NCT01064297|372041|P1|STARTED|Overall Study||2567
154016|NCT01064284|372087|P2|NOT COMPLETED|Overall Study||17
154017|NCT01064284|372088|P1|NOT COMPLETED|Overall Study||18
154018|NCT01064284|372087|P2|COMPLETED|Overall Study||109
154019|NCT01064284|372088|P1|COMPLETED|Overall Study||107
154020|NCT01064284|372087|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
154021|NCT01064284|372088|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
154022|NCT01064167|372110|P2|NOT COMPLETED|Overall Study||15
154023|NCT01064167|372111|P1|NOT COMPLETED|Overall Study||14
154024|NCT01064167|372110|P2|COMPLETED|Overall Study||115
154025|NCT01064167|372111|P1|COMPLETED|Overall Study||116
154026|NCT01064167|372110|P2|STARTED|Overall Study||130
154027|NCT01064167|372111|P1|STARTED|Overall Study||130
154028|NCT01064076|372119|P1|NOT COMPLETED|Overall Study||18
154029|NCT01064076|372119|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
154030|NCT01064076|372119|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
154031|NCT01063907|372124|P2|NOT COMPLETED|Overall Study||0
154032|NCT01063907|372125|P1|NOT COMPLETED|Overall Study||0
154033|NCT01063907|372124|P2|COMPLETED|Overall Study||80
154034|NCT01063907|372125|P1|COMPLETED|Overall Study||15
154035|NCT01063907|372124|P2|STARTED|Overall Study||80
154036|NCT01063907|372125|P1|STARTED|Overall Study||15
154037|NCT01063881|372158|P3|NOT COMPLETED|Overall Study||1
154038|NCT01063881|372159|P2|NOT COMPLETED|Overall Study||11
154039|NCT01063881|372160|P1|NOT COMPLETED|Overall Study||55
154040|NCT01063881|372158|P3|COMPLETED|Overall Study||12
154041|NCT01063881|372159|P2|COMPLETED|Overall Study||114
154042|NCT01063881|372160|P1|COMPLETED|Overall Study||92
154043|NCT01063881|372158|P3|STARTED|Overall Study||13
154044|NCT01063881|372159|P2|STARTED|Overall Study||125
154045|NCT01063881|372160|P1|STARTED|Overall Study||147
154046|NCT01063868|372184|P2|NOT COMPLETED|Overall Study||12
154047|NCT01063868|372185|P1|NOT COMPLETED|Overall Study||35
154048|NCT01063868|372184|P2|COMPLETED|Overall Study||0
154049|NCT01063868|372185|P1|COMPLETED|Overall Study||0
154050|NCT01063868|372184|P2|STARTED|Overall Study||12
154051|NCT01063868|372185|P1|STARTED|Overall Study||35
154052|NCT01063855|372193|P2|NOT COMPLETED|Overall Study||29
154053|NCT01063855|372194|P1|NOT COMPLETED|Overall Study||37
154054|NCT01063855|372193|P2|COMPLETED|Overall Study||221
154055|NCT01063855|372194|P1|COMPLETED|Overall Study||208
154056|NCT01063855|372193|P2|STARTED|Overall Study||250
154057|NCT01063855|372194|P1|STARTED|Overall Study||245
154058|NCT01063829|372220|P4|NOT COMPLETED|Overall Study||21
154059|NCT01063829|372221|P3|NOT COMPLETED|Overall Study||10
154060|NCT01063829|372222|P2|NOT COMPLETED|Overall Study||10
154061|NCT01063829|372223|P1|NOT COMPLETED|Overall Study||16
154062|NCT01063829|372220|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
154063|NCT01063829|372221|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
154064|NCT01063829|372222|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
154065|NCT01063829|372223|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
154066|NCT01063829|372220|P4|STARTED|Overall Study||33
154067|NCT01063829|372221|P3|STARTED|Overall Study||34
154068|NCT01063829|372222|P2|STARTED|Overall Study||31
154069|NCT01063829|372223|P1|STARTED|Overall Study||33
154070|NCT01063764|372241|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
154071|NCT01063764|372241|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
154072|NCT01063764|372241|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
154073|NCT01063764|372241|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
154074|NCT01063764|372241|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
154075|NCT01063764|372241|P1|STARTED|1st Period (From Week 8 to Week 22)||73
154076|NCT01063712|372255|P1|NOT COMPLETED|Overall Study||0
154077|NCT01063712|372255|P1|COMPLETED|Overall Study||29
154078|NCT01063712|372255|P1|STARTED|Overall Study||29
154079|NCT01063595|372260|P2|NOT COMPLETED|Second Intervention||0
154080|NCT01063595|372261|P1|NOT COMPLETED|Second Intervention||0
154081|NCT01063595|372260|P2|COMPLETED|Second Intervention||24
154082|NCT01063595|372261|P1|COMPLETED|Second Intervention||29
154083|NCT01063595|372260|P2|STARTED|Second Intervention||24
154084|NCT01063595|372261|P1|STARTED|Second Intervention||29
154085|NCT01063595|372260|P2|NOT COMPLETED|First Intervention||5
154086|NCT01063595|372261|P1|NOT COMPLETED|First Intervention||2
154087|NCT01063595|372260|P2|COMPLETED|First Intervention||24
154088|NCT01063595|372261|P1|COMPLETED|First Intervention||29
154089|NCT01063595|372260|P2|STARTED|First Intervention||29
154090|NCT01063595|372261|P1|STARTED|First Intervention||31
154091|NCT01063595|372260|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
154092|NCT01063595|372261|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
154093|NCT01063595|372260|P2|COMPLETED|Enrolled in Study and Randomized||29
154094|NCT01063595|372261|P1|COMPLETED|Enrolled in Study and Randomized||31
154095|NCT01063595|372260|P2|Received Treatment|Enrolled in Study and Randomized||29
154096|NCT01063595|372261|P1|Received Treatment|Enrolled in Study and Randomized||31
154097|NCT01063595|372260|P2|STARTED|Enrolled in Study and Randomized||31
154098|NCT01063595|372261|P1|STARTED|Enrolled in Study and Randomized||32
154099|NCT01063517|372273|P2|NOT COMPLETED|Overall Study||60
154100|NCT01063517|372274|P1|NOT COMPLETED|Overall Study||58
154101|NCT01063517|372273|P2|COMPLETED|Overall Study||2
154102|NCT01063517|372274|P1|COMPLETED|Overall Study||4
154103|NCT01063517|372273|P2|Received Randomised Treatment|Overall Study||62
154104|NCT01063517|372274|P1|Received Randomised Treatment|Overall Study||61
154105|NCT01063517|372273|P2|STARTED|Overall Study||62
154106|NCT01063517|372274|P1|STARTED|Overall Study||62
154107|NCT01063348|372314|P2|NOT COMPLETED|Overall Study||10
154108|NCT01063348|372315|P1|NOT COMPLETED|Overall Study||3
154109|NCT01063348|372314|P2|COMPLETED|Overall Study||21
154110|NCT01063348|372315|P1|COMPLETED|Overall Study||32
154111|NCT01063348|372314|P2|STARTED|Overall Study||31
154112|NCT01063348|372315|P1|STARTED|Overall Study||35
154113|NCT01063153|372325|P2|NOT COMPLETED|Overall Study||12
154114|NCT01063153|372326|P1|NOT COMPLETED|Overall Study||2
154115|NCT01063153|372325|P2|COMPLETED|Overall Study||26
154116|NCT01063153|372326|P1|COMPLETED|Overall Study||31
154117|NCT01063153|372325|P2|STARTED|Overall Study||38
154118|NCT01063153|372326|P1|STARTED|Overall Study||33
154119|NCT01063075|372336|P4|NOT COMPLETED|Overall Study||1
154120|NCT01063075|372337|P3|NOT COMPLETED|Overall Study||5
154121|NCT01063075|372338|P2|NOT COMPLETED|Overall Study||2
154122|NCT01063075|372339|P1|NOT COMPLETED|Overall Study||1
154123|NCT01063075|372336|P4|COMPLETED|Overall Study||14
154124|NCT01063075|372337|P3|COMPLETED|Overall Study||9
154125|NCT01063075|372338|P2|COMPLETED|Overall Study||1
154126|NCT01063075|372339|P1|COMPLETED|Overall Study||1
154127|NCT01063075|372336|P4|STARTED|Overall Study||15
154128|NCT01063075|372337|P3|STARTED|Overall Study||14
154129|NCT01063075|372338|P2|STARTED|Overall Study||3
154130|NCT01063075|372339|P1|STARTED|Overall Study||2
154131|NCT01063062|372357|P2|NOT COMPLETED|Overall Study||12
154132|NCT01063062|372358|P1|NOT COMPLETED|Overall Study||8
154133|NCT01063062|372357|P2|COMPLETED|Overall Study||65
154134|NCT01063062|372358|P1|COMPLETED|Overall Study||22
154135|NCT01063062|372357|P2|Received Study Drug|Overall Study||76
154136|NCT01063062|372358|P1|Received Study Drug|Overall Study||29
154137|NCT01063062|372357|P2|STARTED|Overall Study||77
154138|NCT01063062|372358|P1|STARTED|Overall Study||30
154139|NCT01063049|372399|P3|NOT COMPLETED|Overall Study||0
154140|NCT01063049|372400|P2|NOT COMPLETED|Overall Study||0
154141|NCT01063049|372401|P1|NOT COMPLETED|Overall Study||0
154142|NCT01063049|372399|P3|COMPLETED|Overall Study||200
154143|NCT01063049|372400|P2|COMPLETED|Overall Study||200
154144|NCT01063049|372401|P1|COMPLETED|Overall Study||200
154145|NCT01063049|372399|P3|STARTED|Overall Study||200
154146|NCT01063049|372400|P2|STARTED|Overall Study||200
154147|NCT01063049|372401|P1|STARTED|Overall Study||200
154148|NCT01063036|372412|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
154149|NCT01063036|372412|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
154150|NCT01063036|372412|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
154151|NCT01063036|372412|P1|NOT COMPLETED|Participants Treated With Study Drug||6
154152|NCT01063036|372412|P1|COMPLETED|Participants Treated With Study Drug||86
154153|NCT01063036|372412|P1|STARTED|Participants Treated With Study Drug||92
154154|NCT01062841|372428|P2|NOT COMPLETED|Overall Study||53
154155|NCT01062841|372429|P1|NOT COMPLETED|Overall Study||49
154156|NCT01062841|372428|P2|COMPLETED|Overall Study||162
154157|NCT01062841|372429|P1|COMPLETED|Overall Study||154
154158|NCT01062841|372428|P2|STARTED|Overall Study||215
154159|NCT01062841|372429|P1|STARTED|Overall Study||203
154160|NCT01062763|372459|P2|NOT COMPLETED|Overall Study||4
154161|NCT01062763|372460|P1|NOT COMPLETED|Overall Study||3
154162|NCT01062763|372459|P2|COMPLETED|Overall Study||57
154163|NCT01062763|372460|P1|COMPLETED|Overall Study||55
154164|NCT01062763|372459|P2|STARTED|Overall Study||61
154165|NCT01062763|372460|P1|STARTED|Overall Study|119 randomized.|58
154166|NCT01062425|372472|P2|NOT COMPLETED|Overall Study||6
154167|NCT01062425|372473|P1|NOT COMPLETED|Overall Study||3
154168|NCT01062425|372472|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
154169|NCT01062425|372473|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
154170|NCT01062425|372472|P2|STARTED|Overall Study||103
154171|NCT01062425|372473|P1|STARTED|Overall Study||55
154172|NCT01062399|372490|P5|NOT COMPLETED|Overall Study||4
154173|NCT01062399|372491|P4|NOT COMPLETED|Overall Study||6
154174|NCT01062399|372492|P3|NOT COMPLETED|Overall Study||0
154175|NCT01062399|372493|P2|NOT COMPLETED|Overall Study||1
154176|NCT01062399|372494|P1|NOT COMPLETED|Overall Study||0
154177|NCT01062399|372490|P5|COMPLETED|Overall Study||88
154178|NCT01062399|372491|P4|COMPLETED|Overall Study||83
154179|NCT01062399|372492|P3|COMPLETED|Overall Study||8
154180|NCT01062399|372493|P2|COMPLETED|Overall Study||9
154181|NCT01062399|372494|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
154182|NCT01062399|372490|P5|STARTED|Overall Study||92
154183|NCT01062399|372491|P4|STARTED|Overall Study||89
154184|NCT01062399|372492|P3|STARTED|Overall Study||8
154185|NCT01062399|372493|P2|STARTED|Overall Study||10
154186|NCT01062399|372494|P1|STARTED|Overall Study||8
154187|NCT01062308|372515|P2|NOT COMPLETED|Overall Study||10
154188|NCT01062308|372516|P1|NOT COMPLETED|Overall Study||16
154189|NCT01062308|372515|P2|COMPLETED|Overall Study||72
154190|NCT01062308|372516|P1|COMPLETED|Overall Study||64
154191|NCT01062308|372515|P2|STARTED|Overall Study||82
154192|NCT01062308|372516|P1|STARTED|Overall Study||80
154193|NCT01062269|372524|P1|NOT COMPLETED|Overall Study||0
154194|NCT01062269|372524|P1|COMPLETED|Overall Study||42
154195|NCT01062269|372524|P1|STARTED|Overall Study||42
154196|NCT01062256|372538|P3|NOT COMPLETED|Overall Study||4
154197|NCT01062256|372539|P2|NOT COMPLETED|Overall Study||7
154198|NCT01062256|372540|P1|NOT COMPLETED|Overall Study||3
154199|NCT01062256|372538|P3|COMPLETED|Overall Study||103
154200|NCT01062256|372539|P2|COMPLETED|Overall Study||96
154201|NCT01062256|372540|P1|COMPLETED|Overall Study||52
154202|NCT01062256|372538|P3|STARTED|Overall Study||107
154203|NCT01062256|372539|P2|STARTED|Overall Study||103
154204|NCT01062256|372540|P1|STARTED|Overall Study||55
154205|NCT01062230|372563|P1|NOT COMPLETED|Overall Study||0
154206|NCT01062230|372563|P1|COMPLETED|Overall Study||6
154207|NCT01062230|372563|P1|STARTED|Overall Study||6
154208|NCT01062165|372567|P1|NOT COMPLETED|Overall Study||0
154209|NCT01062165|372567|P1|COMPLETED|Overall Study||18
154210|NCT01062165|372567|P1|STARTED|Overall Study||18
154211|NCT01062113|372574|P3|NOT COMPLETED|Overall Study||31
154212|NCT01062113|372575|P2|NOT COMPLETED|Overall Study||22
154213|NCT01062113|372576|P1|NOT COMPLETED|Overall Study||40
154214|NCT01062113|372574|P3|COMPLETED|Overall Study||27
154215|NCT01062113|372575|P2|COMPLETED|Overall Study||42
154216|NCT01062113|372576|P1|COMPLETED|Overall Study||93
154217|NCT01062113|372574|P3|STARTED|Overall Study||58
154218|NCT01062113|372575|P2|STARTED|Overall Study||64
154219|NCT01062113|372576|P1|STARTED|Overall Study||133
154220|NCT01062074|372589|P1|NOT COMPLETED|Overall Study||0
154221|NCT01062074|372589|P1|COMPLETED|Overall Study||3605
154222|NCT01062074|372589|P1|STARTED|Overall Study||3605
154223|NCT01062061|372594|P1|NOT COMPLETED|Overall Study||27
154224|NCT01062061|372594|P1|COMPLETED|Overall Study||727
154225|NCT01062061|372594|P1|STARTED|Overall Study||754
154226|NCT01061866|372608|P1|NOT COMPLETED|Overall Study||2
154227|NCT01061866|372608|P1|COMPLETED|Overall Study||5
154228|NCT01061866|372608|P1|STARTED|Overall Study||7
154229|NCT01061775|372612|P1|NOT COMPLETED|Overall Study||3
154230|NCT01061775|372612|P1|COMPLETED|Overall Study||16
154231|NCT01061775|372612|P1|STARTED|Overall Study||19
154232|NCT01061736|372629|P10|NOT COMPLETED|Overall Study||74
154233|NCT01061736|372630|P9|NOT COMPLETED|Overall Study||97
154234|NCT01061736|372631|P8|NOT COMPLETED|Overall Study||94
154235|NCT01061736|372632|P7|NOT COMPLETED|Overall Study||84
154236|NCT01061736|372633|P6|NOT COMPLETED|Overall Study||3
154237|NCT01061736|372634|P5|NOT COMPLETED|Overall Study||7
154238|NCT01061736|372635|P4|NOT COMPLETED|Overall Study||3
154239|NCT01061736|372636|P3|NOT COMPLETED|Overall Study||6
154240|NCT01061736|372637|P2|NOT COMPLETED|Overall Study||4
154241|NCT01061736|372638|P1|NOT COMPLETED|Overall Study||13
154242|NCT01061736|372629|P10|COMPLETED|Overall Study||354
154243|NCT01061736|372630|P9|COMPLETED|Overall Study||330
154244|NCT01061736|372631|P8|COMPLETED|Overall Study||336
154245|NCT01061736|372632|P7|COMPLETED|Overall Study||0
154246|NCT01061736|372633|P6|COMPLETED|Overall Study||49
154247|NCT01061736|372634|P5|COMPLETED|Overall Study||45
154248|NCT01061736|372635|P4|COMPLETED|Overall Study||48
154249|NCT01061736|372636|P3|COMPLETED|Overall Study||45
154250|NCT01061736|372637|P2|COMPLETED|Overall Study||46
154251|NCT01061736|372638|P1|COMPLETED|Overall Study||37
154252|NCT01061736|372629|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
154253|NCT01061736|372630|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
154254|NCT01061736|372631|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
154255|NCT01061736|372632|P7|Rescued|Overall Study||0
154256|NCT01061736|372633|P6|Rescued|Overall Study||0
154257|NCT01061736|372634|P5|Rescued|Overall Study||0
154258|NCT01061736|372635|P4|Rescued|Overall Study||0
154259|NCT01061736|372636|P3|Rescued|Overall Study||0
154260|NCT01061736|372637|P2|Rescued|Overall Study||0
154261|NCT01061736|372638|P1|Rescued|Overall Study||0
154262|NCT01061736|372629|P10|Treated|Overall Study||428
154263|NCT01061736|372630|P9|Treated|Overall Study||426
154264|NCT01061736|372631|P8|Treated|Overall Study||428
154265|NCT01061736|372632|P7|Treated|Overall Study||84
154266|NCT01061736|372633|P6|Treated|Overall Study||52
154267|NCT01061736|372634|P5|Treated|Overall Study||51
154268|NCT01061736|372635|P4|Treated|Overall Study||51
154269|NCT01061736|372636|P3|Treated|Overall Study||51
154270|NCT01061736|372637|P2|Treated|Overall Study||50
154271|NCT01061736|372638|P1|Treated|Overall Study||50
154272|NCT01061736|372629|P10|STARTED|Overall Study||428
154273|NCT01061736|372630|P9|STARTED|Overall Study||427
154274|NCT01061736|372631|P8|STARTED|Overall Study||430
154275|NCT01061736|372632|P7|STARTED|Overall Study||84
154276|NCT01061736|372633|P6|STARTED|Overall Study||52
154277|NCT01061736|372634|P5|STARTED|Overall Study||52
154278|NCT01061736|372635|P4|STARTED|Overall Study||51
154279|NCT01061736|372636|P3|STARTED|Overall Study||51
154280|NCT01061736|372637|P2|STARTED|Overall Study||50
154281|NCT01061736|372638|P1|STARTED|Overall Study||50
154282|NCT01061723|372677|P6|NOT COMPLETED|Overall Study||9
154283|NCT01061723|372678|P5|NOT COMPLETED|Overall Study||3
154284|NCT01061723|372679|P4|NOT COMPLETED|Overall Study||8
154285|NCT01061723|372680|P3|NOT COMPLETED|Overall Study||10
154286|NCT01061723|372681|P2|NOT COMPLETED|Overall Study||6
154287|NCT01061723|372682|P1|NOT COMPLETED|Overall Study||4
154288|NCT01061723|372677|P6|COMPLETED|Overall Study||41
154289|NCT01061723|372678|P5|COMPLETED|Overall Study||47
154290|NCT01061723|372679|P4|COMPLETED|Overall Study||44
154291|NCT01061723|372680|P3|COMPLETED|Overall Study||40
154292|NCT01061723|372681|P2|COMPLETED|Overall Study||43
154293|NCT01061723|372682|P1|COMPLETED|Overall Study||46
154294|NCT01061723|372677|P6|Treated|Overall Study||49
154295|NCT01061723|372678|P5|Treated|Overall Study||50
154296|NCT01061723|372679|P4|Treated|Overall Study||52
154297|NCT01061723|372680|P3|Treated|Overall Study||50
154298|NCT01061723|372681|P2|Treated|Overall Study||49
154299|NCT01061723|372682|P1|Treated|Overall Study||50
154300|NCT01061723|372677|P6|STARTED|Overall Study||50
154301|NCT01061723|372678|P5|STARTED|Overall Study||50
154302|NCT01061723|372679|P4|STARTED|Overall Study||52
154303|NCT01061723|372680|P3|STARTED|Overall Study||50
154304|NCT01061723|372681|P2|STARTED|Overall Study||49
154305|NCT01061723|372682|P1|STARTED|Overall Study||50
154306|NCT01061710|372762|P1|NOT COMPLETED|Overall Study||14
154307|NCT01061710|372762|P1|COMPLETED|Overall Study||6
154308|NCT01061710|372762|P1|STARTED|Overall Study||20
154309|NCT01061671|372772|P2|NOT COMPLETED|Overall Study||55
154310|NCT01061671|372773|P1|NOT COMPLETED|Overall Study||47
154311|NCT01061671|372772|P2|COMPLETED|Overall Study||397
154312|NCT01061671|372773|P1|COMPLETED|Overall Study||386
154313|NCT01061671|372772|P2|STARTED|Overall Study||452
154314|NCT01061671|372773|P1|STARTED|Overall Study||433
154315|NCT01061606|372785|P1|NOT COMPLETED|Overall Study||8
154316|NCT01061606|372785|P1|COMPLETED|Overall Study||0
154317|NCT01061606|372785|P1|STARTED|Overall Study||8
154318|NCT01061567|372794|P1|NOT COMPLETED|Overall Study||76
154319|NCT01061567|372794|P1|COMPLETED|Overall Study||1738
154320|NCT01061567|372794|P1|STARTED|Overall Study||1814
154321|NCT01061476|372803|P1|NOT COMPLETED|Overall Study||0
154322|NCT01061476|372803|P1|COMPLETED|Overall Study||12
154323|NCT01061476|372803|P1|STARTED|Overall Study||12
154324|NCT01061385|372809|P2|NOT COMPLETED|Overall Study||1
154325|NCT01061385|372810|P1|NOT COMPLETED|Overall Study||1
154326|NCT01061385|372809|P2|COMPLETED|Overall Study||8
154327|NCT01061385|372810|P1|COMPLETED|Overall Study||20
154328|NCT01061385|372809|P2|STARTED|Overall Study||9
154329|NCT01061385|372810|P1|STARTED|Overall Study||21
154330|NCT01061359|372818|P1|NOT COMPLETED|Overall Study||1302
154331|NCT01061359|372818|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
154332|NCT01061359|372818|P1|STARTED|Overall Study||1972
154333|NCT01061333|372824|P2|NOT COMPLETED|Period 7: Mometasone||0
154334|NCT01061333|372825|P1|NOT COMPLETED|Period 7: Mometasone||0
154335|NCT01061333|372824|P2|COMPLETED|Period 7: Mometasone||7
154336|NCT01061333|372825|P1|COMPLETED|Period 7: Mometasone||8
154337|NCT01061333|372824|P2|STARTED|Period 7: Mometasone||7
154338|NCT01061333|372825|P1|STARTED|Period 7: Mometasone||8
154339|NCT01061333|372824|P2|NOT COMPLETED|Period 6: 20-day Washout||0
154340|NCT01061333|372825|P1|NOT COMPLETED|Period 6: 20-day Washout||0
154341|NCT01061333|372824|P2|COMPLETED|Period 6: 20-day Washout||7
154342|NCT01061333|372825|P1|COMPLETED|Period 6: 20-day Washout||8
154343|NCT01061333|372824|P2|STARTED|Period 6: 20-day Washout||7
154344|NCT01061333|372825|P1|STARTED|Period 6: 20-day Washout||8
154345|NCT01061333|372824|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
154346|NCT01061333|372825|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
154347|NCT01061333|372824|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
154348|NCT01061333|372825|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
154349|NCT01061333|372824|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
154350|NCT01061333|372825|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
154351|NCT01061333|372824|P2|NOT COMPLETED|Period 4: 20-day Washout||1
154352|NCT01061333|372825|P1|NOT COMPLETED|Period 4: 20-day Washout||0
154353|NCT01061333|372824|P2|COMPLETED|Period 4: 20-day Washout||7
154354|NCT01061333|372825|P1|COMPLETED|Period 4: 20-day Washout||8
154355|NCT01061333|372824|P2|STARTED|Period 4: 20-day Washout||8
154356|NCT01061333|372825|P1|STARTED|Period 4: 20-day Washout||8
154357|NCT01061333|372824|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
154358|NCT01061333|372825|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
154359|NCT01061333|372824|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
154360|NCT01061333|372825|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
154361|NCT01061333|372824|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
154362|NCT01061333|372825|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
154363|NCT01061333|372824|P2|NOT COMPLETED|Period 2: 20-day Washout||0
154364|NCT01061333|372825|P1|NOT COMPLETED|Period 2: 20-day Washout||0
154365|NCT01061333|372824|P2|COMPLETED|Period 2: 20-day Washout||8
154366|NCT01061333|372825|P1|COMPLETED|Period 2: 20-day Washout||8
154367|NCT01061333|372824|P2|STARTED|Period 2: 20-day Washout||8
154368|NCT01061333|372825|P1|STARTED|Period 2: 20-day Washout||8
154369|NCT01061333|372824|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
154370|NCT01061333|372825|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
154371|NCT01061333|372824|P2|COMPLETED|Period 1: Placebo Run-in||8
154372|NCT01061333|372825|P1|COMPLETED|Period 1: Placebo Run-in||8
154373|NCT01061333|372824|P2|STARTED|Period 1: Placebo Run-in||8
154374|NCT01061333|372825|P1|STARTED|Period 1: Placebo Run-in||8
154375|NCT01061177|372863|P1|NOT COMPLETED|Overall Study||208
154376|NCT01061177|372863|P1|COMPLETED|Overall Study||881
154377|NCT01061177|372863|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
154378|NCT01061177|372863|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
154379|NCT01061177|372863|P1|STARTED|Overall Study||1089
154380|NCT01061151|372886|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
154381|NCT01061151|372887|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
154382|NCT01061151|372888|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
154383|NCT01061151|372889|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
154384|NCT01061151|372886|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
154385|NCT01061151|372887|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
154386|NCT01061151|372888|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
154387|NCT01061151|372889|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
154388|NCT01061151|372886|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
154389|NCT01061151|372887|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
154390|NCT01061151|372888|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
154391|NCT01061151|372889|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
154392|NCT01061151|372886|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
154393|NCT01061151|372887|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
154394|NCT01061151|372888|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
154395|NCT01061151|372889|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
154396|NCT01061151|372886|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
154397|NCT01061151|372887|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
154398|NCT01061151|372888|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
154399|NCT01061151|372889|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
154400|NCT01061151|372886|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
154401|NCT01061151|372887|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
154402|NCT01061151|372888|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
154403|NCT01061151|372889|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
154404|NCT01061151|372886|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
154405|NCT01061151|372887|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
154406|NCT01061151|372888|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
154407|NCT01061151|372889|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
154408|NCT01061151|372886|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
154409|NCT01061151|372887|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
154410|NCT01061151|372888|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
154411|NCT01061151|372889|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
154412|NCT01061034|372941|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
154413|NCT01061034|372941|P1|COMPLETED|Aspirin Plus Omeprazole||9
154414|NCT01061034|372941|P1|STARTED|Aspirin Plus Omeprazole||9
154415|NCT01061034|372941|P1|NOT COMPLETED|Aspirin||0
154416|NCT01061034|372941|P1|COMPLETED|Aspirin||9
154417|NCT01061034|372941|P1|STARTED|Aspirin||9
154418|NCT01061008|372948|P2|NOT COMPLETED|Overall Study||6
154419|NCT01061008|372949|P1|NOT COMPLETED|Overall Study||6
154420|NCT01061008|372948|P2|COMPLETED|Overall Study||9
154421|NCT01061008|372949|P1|COMPLETED|Overall Study||10
154422|NCT01061008|372948|P2|STARTED|Overall Study||15
154423|NCT01061008|372949|P1|STARTED|Overall Study||16
154424|NCT01060670|372957|P2|NOT COMPLETED|Follow up Phase||35
154425|NCT01060670|372958|P1|NOT COMPLETED|Follow up Phase||22
154426|NCT01060670|372957|P2|COMPLETED|Follow up Phase||82
154427|NCT01060670|372958|P1|COMPLETED|Follow up Phase||106
154428|NCT01060670|372957|P2|Withdrew From Follow up Phase|Follow up Phase||35
154429|NCT01060670|372958|P1|Withdrew From Follow up Phase|Follow up Phase||22
154430|NCT01060670|372957|P2|Recurrence|Follow up Phase||9
154431|NCT01060670|372958|P1|Recurrence|Follow up Phase||14
154432|NCT01060670|372957|P2|STARTED|Follow up Phase||117
154433|NCT01060670|372958|P1|STARTED|Follow up Phase||128
154434|NCT01060670|372957|P2|NOT COMPLETED|Treatment Phase||36
154435|NCT01060670|372958|P1|NOT COMPLETED|Treatment Phase||26
154436|NCT01060670|372957|P2|COMPLETED|Treatment Phase||117
154437|NCT01060670|372958|P1|COMPLETED|Treatment Phase||128
154438|NCT01060670|372957|P2|Withdrew From Treatment|Treatment Phase||36
154439|NCT01060670|372958|P1|Withdrew From Treatment|Treatment Phase||26
154440|NCT01060670|372957|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
154441|NCT01060670|372958|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
154442|NCT01060670|372957|P2|Healed at End of Treatment Phase|Treatment Phase||49
154443|NCT01060670|372958|P1|Healed at End of Treatment Phase|Treatment Phase||79
154444|NCT01060670|372957|P2|STARTED|Treatment Phase||153
154445|NCT01060670|372958|P1|STARTED|Treatment Phase||154
154446|NCT01060670|372957|P2|NOT COMPLETED|Run In||238
154447|NCT01060670|372958|P1|NOT COMPLETED|Run In||0
154448|NCT01060670|372957|P2|COMPLETED|Run In||307
154449|NCT01060670|372958|P1|COMPLETED|Run In||0
154450|NCT01060670|372957|P2|STARTED|Run In||545
154451|NCT01060670|372958|P1|STARTED|Run In||0
154452|NCT01060592|372978|P2|NOT COMPLETED|12m||18
154453|NCT01060592|372979|P1|NOT COMPLETED|12m||0
154454|NCT01060592|372978|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
154455|NCT01060592|372979|P1|COMPLETED|12m||35
154456|NCT01060592|372978|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
154457|NCT01060592|372979|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
154458|NCT01060592|372978|P2|NOT COMPLETED|4-6w||10
154459|NCT01060592|372979|P1|NOT COMPLETED|4-6w||12
154460|NCT01060592|372978|P2|COMPLETED|4-6w||39
154461|NCT01060592|372979|P1|COMPLETED|4-6w||23
154462|NCT01060592|372978|P2|STARTED|4-6w||49
154463|NCT01060592|372979|P1|STARTED|4-6w||35
154464|NCT01060553|372993|P2|NOT COMPLETED|Overall Study||10
154465|NCT01060553|372994|P1|NOT COMPLETED|Overall Study||9
154466|NCT01060553|372993|P2|COMPLETED|Overall Study||5
154467|NCT01060553|372994|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
154468|NCT01060553|372993|P2|STARTED|Overall Study||15
154469|NCT01060553|372994|P1|STARTED|Overall Study||15
154470|NCT01060540|373001|P2|NOT COMPLETED|Overall Study||65
154471|NCT01060540|373002|P1|NOT COMPLETED|Overall Study||64
154472|NCT01060540|373001|P2|COMPLETED|Overall Study||233
154473|NCT01060540|373002|P1|COMPLETED|Overall Study||239
154474|NCT01060540|373001|P2|STARTED|Overall Study||298
154475|NCT01060540|373002|P1|STARTED|Overall Study||303
154476|NCT01060150|373016|P1|NOT COMPLETED|Overall Study||23
154477|NCT01060150|373016|P1|COMPLETED|Overall Study||92
154478|NCT01060150|373016|P1|Treated|Overall Study||113
154479|NCT01060150|373016|P1|STARTED|Overall Study||115
154480|NCT01060124|373031|P1|NOT COMPLETED|Overall Study||37
154481|NCT01060124|373031|P1|COMPLETED|Overall Study||66
154482|NCT01060124|373031|P1|STARTED|Overall Study||103
154483|NCT01060111|373042|P3|NOT COMPLETED|Overall Study||35
154484|NCT01060111|373043|P2|NOT COMPLETED|Overall Study||23
154485|NCT01060111|373044|P1|NOT COMPLETED|Overall Study||27
154486|NCT01060111|373042|P3|COMPLETED|Overall Study||45
154487|NCT01060111|373043|P2|COMPLETED|Overall Study||61
154488|NCT01060111|373044|P1|COMPLETED|Overall Study||54
154489|NCT01060111|373042|P3|Treated|Overall Study||79
154490|NCT01060111|373043|P2|Treated|Overall Study||83
154491|NCT01060111|373044|P1|Treated|Overall Study||81
154492|NCT01060111|373042|P3|STARTED|Overall Study||80
154493|NCT01060111|373043|P2|STARTED|Overall Study||84
154494|NCT01060111|373044|P1|STARTED|Overall Study||81
154495|NCT01060072|373063|P2|NOT COMPLETED|Overall Study||5
154496|NCT01060072|373064|P1|NOT COMPLETED|Overall Study||2
154497|NCT01060072|373063|P2|COMPLETED|Overall Study||196
154498|NCT01060072|373064|P1|COMPLETED|Overall Study||204
154499|NCT01060072|373063|P2|STARTED|Overall Study||201
154500|NCT01060072|373064|P1|STARTED|Overall Study||206
154501|NCT01060059|373080|P2|NOT COMPLETED|Overall Study||67
154502|NCT01060059|373081|P1|NOT COMPLETED|Overall Study||67
154503|NCT01060059|373080|P2|COMPLETED|Overall Study||371
154504|NCT01060059|373081|P1|COMPLETED|Overall Study||377
154505|NCT01060059|373080|P2|STARTED|Overall Study||438
154506|NCT01060059|373081|P1|STARTED|Overall Study||444
154507|NCT01060020|373131|P1|NOT COMPLETED|Overall Study||0
154508|NCT01060020|373131|P1|COMPLETED|Overall Study||20
154509|NCT01060020|373131|P1|STARTED|Overall Study||20
154510|NCT01060007|373139|P1|NOT COMPLETED|Overall Study||4
154511|NCT01060007|373139|P1|COMPLETED|Overall Study||76
154512|NCT01060007|373139|P1|STARTED|Overall Study||80
154513|NCT01059994|373157|P4|NOT COMPLETED|Overall Study||1
154514|NCT01059994|373158|P3|NOT COMPLETED|Overall Study||0
154515|NCT01059994|373159|P2|NOT COMPLETED|Overall Study||0
154516|NCT01059994|373160|P1|NOT COMPLETED|Overall Study||0
154517|NCT01059994|373157|P4|COMPLETED|Overall Study||3
154518|NCT01059994|373158|P3|COMPLETED|Overall Study||3
154519|NCT01059994|373159|P2|COMPLETED|Overall Study||2
154520|NCT01059994|373160|P1|COMPLETED|Overall Study||3
154521|NCT01059994|373157|P4|STARTED|Overall Study||4
154522|NCT01059994|373158|P3|STARTED|Overall Study||3
154523|NCT01059994|373159|P2|STARTED|Overall Study||2
154524|NCT01059994|373160|P1|STARTED|Overall Study||3
154525|NCT01059903|373176|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
154526|NCT01059903|373177|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
154527|NCT01059903|373176|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
154528|NCT01059903|373177|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
154529|NCT01059903|373176|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
154530|NCT01059903|373177|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
154531|NCT01059903|373176|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
154532|NCT01059903|373177|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
154533|NCT01059903|373176|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
154534|NCT01059903|373177|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
154535|NCT01059903|373176|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
154536|NCT01059903|373177|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
154537|NCT01059903|373176|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
154538|NCT01059903|373177|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
154539|NCT01059903|373176|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
154540|NCT01059903|373177|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
154541|NCT01059903|373176|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
154542|NCT01059903|373177|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
154543|NCT01059903|373176|P2|STARTED|Period 1: First Intervention- 24 Hours||25
154544|NCT01059903|373177|P1|STARTED|Period 1: First Intervention- 24 Hours||25
154545|NCT01059864|373211|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
154546|NCT01059864|373212|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
154547|NCT01059864|373213|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
154548|NCT01059864|373211|P3|COMPLETED|Double-Blind Treatment Phase||45
154549|NCT01059864|373212|P2|COMPLETED|Double-Blind Treatment Phase||47
154550|NCT01059864|373213|P1|COMPLETED|Double-Blind Treatment Phase||0
154551|NCT01059864|373211|P3|Treated|Double-Blind Treatment Phase||47
154552|NCT01059864|373212|P2|Treated|Double-Blind Treatment Phase||50
154553|NCT01059864|373213|P1|Treated|Double-Blind Treatment Phase||0
154554|NCT01059864|373211|P3|STARTED|Double-Blind Treatment Phase||48
154555|NCT01059864|373212|P2|STARTED|Double-Blind Treatment Phase||50
154556|NCT01059864|373213|P1|STARTED|Double-Blind Treatment Phase||0
154557|NCT01059864|373211|P3|NOT COMPLETED|Open-Label Run-In Phase||0
154558|NCT01059864|373212|P2|NOT COMPLETED|Open-Label Run-In Phase||0
154559|NCT01059864|373213|P1|NOT COMPLETED|Open-Label Run-In Phase||13
154560|NCT01059864|373211|P3|COMPLETED|Open-Label Run-In Phase||0
154561|NCT01059864|373212|P2|COMPLETED|Open-Label Run-In Phase||0
154562|NCT01059864|373213|P1|COMPLETED|Open-Label Run-In Phase||98
154563|NCT01059864|373211|P3|STARTED|Open-Label Run-In Phase||0
154564|NCT01059864|373212|P2|STARTED|Open-Label Run-In Phase||0
154565|NCT01059864|373213|P1|STARTED|Open-Label Run-In Phase||111
154566|NCT01059851|373262|P6|NOT COMPLETED|Overall Study||0
154567|NCT01059851|373263|P5|NOT COMPLETED|Overall Study||0
154568|NCT01059851|373264|P4|NOT COMPLETED|Overall Study||0
154569|NCT01059851|373265|P3|NOT COMPLETED|Overall Study||0
154570|NCT01059851|373266|P2|NOT COMPLETED|Overall Study||0
154571|NCT01059851|373267|P1|NOT COMPLETED|Overall Study||0
154572|NCT01059851|373262|P6|COMPLETED|Overall Study||0
154573|NCT01059851|373263|P5|COMPLETED|Overall Study||0
154574|NCT01059851|373264|P4|COMPLETED|Overall Study||0
154575|NCT01059851|373265|P3|COMPLETED|Overall Study||0
154576|NCT01059851|373266|P2|COMPLETED|Overall Study||8
154577|NCT01059851|373267|P1|COMPLETED|Overall Study||8
154578|NCT01059851|373262|P6|STARTED|Overall Study||0
154579|NCT01059851|373263|P5|STARTED|Overall Study||0
154580|NCT01059851|373264|P4|STARTED|Overall Study||0
154581|NCT01059851|373265|P3|STARTED|Overall Study||0
154582|NCT01059851|373266|P2|STARTED|Overall Study||8
154583|NCT01059851|373267|P1|STARTED|Overall Study||8
154584|NCT01059825|373287|P7|NOT COMPLETED|Treatment Period||0
154585|NCT01059825|373288|P6|NOT COMPLETED|Treatment Period||3
154586|NCT01059825|373289|P5|NOT COMPLETED|Treatment Period||8
154587|NCT01059825|373290|P4|NOT COMPLETED|Treatment Period||11
154588|NCT01059825|373291|P3|NOT COMPLETED|Treatment Period||6
154589|NCT01059825|373292|P2|NOT COMPLETED|Treatment Period||4
154590|NCT01059825|373293|P1|NOT COMPLETED|Treatment Period||10
154591|NCT01059825|373287|P7|COMPLETED|Treatment Period||0
154592|NCT01059825|373288|P6|COMPLETED|Treatment Period||52
154593|NCT01059825|373289|P5|COMPLETED|Treatment Period||47
154594|NCT01059825|373290|P4|COMPLETED|Treatment Period||44
154595|NCT01059825|373291|P3|COMPLETED|Treatment Period||49
154596|NCT01059825|373292|P2|COMPLETED|Treatment Period||50
154597|NCT01059825|373293|P1|COMPLETED|Treatment Period||44
154598|NCT01059825|373287|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
154599|NCT01059825|373288|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
154600|NCT01059825|373289|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
154601|NCT01059825|373290|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
154602|NCT01059825|373291|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
154603|NCT01059825|373292|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
154604|NCT01059825|373293|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
154605|NCT01059825|373287|P7|NOT COMPLETED|Enrolled, Run-in Period||47
154606|NCT01059825|373288|P6|NOT COMPLETED|Enrolled, Run-in Period||0
154607|NCT01059825|373289|P5|NOT COMPLETED|Enrolled, Run-in Period||0
154608|NCT01059825|373290|P4|NOT COMPLETED|Enrolled, Run-in Period||0
154609|NCT01059825|373291|P3|NOT COMPLETED|Enrolled, Run-in Period||0
154610|NCT01059825|373292|P2|NOT COMPLETED|Enrolled, Run-in Period||0
154611|NCT01059825|373293|P1|NOT COMPLETED|Enrolled, Run-in Period||0
154612|NCT01059825|373287|P7|COMPLETED|Enrolled, Run-in Period||328
154613|NCT01059825|373288|P6|COMPLETED|Enrolled, Run-in Period||0
154614|NCT01059825|373289|P5|COMPLETED|Enrolled, Run-in Period||0
154615|NCT01059825|373290|P4|COMPLETED|Enrolled, Run-in Period||0
154616|NCT01059825|373291|P3|COMPLETED|Enrolled, Run-in Period||0
154617|NCT01059825|373292|P2|COMPLETED|Enrolled, Run-in Period||0
154618|NCT01059825|373293|P1|COMPLETED|Enrolled, Run-in Period||0
154619|NCT01059825|373287|P7|STARTED|Enrolled, Run-in Period||375
154620|NCT01059825|373288|P6|STARTED|Enrolled, Run-in Period||0
154621|NCT01059825|373289|P5|STARTED|Enrolled, Run-in Period||0
154622|NCT01059825|373290|P4|STARTED|Enrolled, Run-in Period||0
154623|NCT01059825|373291|P3|STARTED|Enrolled, Run-in Period||0
154624|NCT01059825|373292|P2|STARTED|Enrolled, Run-in Period||0
154625|NCT01059825|373293|P1|STARTED|Enrolled, Run-in Period||0
154626|NCT01059812|373480|P2|NOT COMPLETED|Overall Study||16
154627|NCT01059812|373481|P1|NOT COMPLETED|Overall Study||37
154628|NCT01059812|373480|P2|COMPLETED|Overall Study||126
154629|NCT01059812|373481|P1|COMPLETED|Overall Study||245
154630|NCT01059812|373480|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
154631|NCT01059812|373481|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
154632|NCT01059812|373480|P2|STARTED|Overall Study||142
154633|NCT01059812|373481|P1|STARTED|Overall Study||282
154634|NCT01059799|373497|P2|NOT COMPLETED|Overall Study||10
154635|NCT01059799|373498|P1|NOT COMPLETED|Overall Study||31
154636|NCT01059799|373497|P2|COMPLETED|Overall Study||136
154637|NCT01059799|373498|P1|COMPLETED|Overall Study||258
154638|NCT01059799|373497|P2|Exposed|Overall Study||146
154639|NCT01059799|373498|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
154640|NCT01059799|373497|P2|STARTED|Overall Study||146
154641|NCT01059799|373498|P1|STARTED|Overall Study||289
154642|NCT01059773|373512|P2|NOT COMPLETED|Overall Study||24
154643|NCT01059773|373513|P1|NOT COMPLETED|Overall Study||20
154644|NCT01059773|373512|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
154645|NCT01059773|373513|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
154646|NCT01059773|373512|P2|STARTED|Overall Study||245
154647|NCT01059773|373513|P1|STARTED|Overall Study||244
154648|NCT01059760|373545|P2|NOT COMPLETED|Overall Study||0
154649|NCT01059760|373546|P1|NOT COMPLETED|Overall Study||0
154650|NCT01059760|373545|P2|COMPLETED|Overall Study||14
154651|NCT01059760|373546|P1|COMPLETED|Overall Study||16
154652|NCT01059760|373545|P2|STARTED|Overall Study||14
154653|NCT01059760|373546|P1|STARTED|Overall Study||16
154654|NCT01059643|373652|P1|NOT COMPLETED|Overall Study||6
154655|NCT01059643|373652|P1|COMPLETED|Overall Study||97
154656|NCT01059643|373652|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
154657|NCT01059643|373652|P1|STARTED|Overall Study||103
154658|NCT01059630|373667|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
154659|NCT01059630|373668|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
154660|NCT01059630|373667|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
154661|NCT01059630|373668|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
154662|NCT01059630|373667|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
154663|NCT01059630|373668|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
154664|NCT01059630|373667|P2|NOT COMPLETED|Induction Period (6 Months)||38
154665|NCT01059630|373668|P1|NOT COMPLETED|Induction Period (6 Months)||73
154666|NCT01059630|373667|P2|COMPLETED|Induction Period (6 Months)||156
154667|NCT01059630|373668|P1|COMPLETED|Induction Period (6 Months)||129
154668|NCT01059630|373667|P2|Treated|Induction Period (6 Months)||194
154669|NCT01059630|373668|P1|Treated|Induction Period (6 Months)||198
154670|NCT01059630|373667|P2|STARTED|Induction Period (6 Months)||194
154671|NCT01059630|373668|P1|STARTED|Induction Period (6 Months)||202
154672|NCT01059617|373728|P4|NOT COMPLETED|Overall Study||6
154673|NCT01059617|373729|P3|NOT COMPLETED|Overall Study||8
154674|NCT01059617|373730|P2|NOT COMPLETED|Overall Study||1
154675|NCT01059617|373731|P1|NOT COMPLETED|Overall Study||7
154676|NCT01059617|373728|P4|COMPLETED|Overall Study||27
154677|NCT01059617|373729|P3|COMPLETED|Overall Study||25
154678|NCT01059617|373730|P2|COMPLETED|Overall Study||33
154679|NCT01059617|373731|P1|COMPLETED|Overall Study||26
154680|NCT01059617|373728|P4|STARTED|Overall Study||33
154681|NCT01059617|373729|P3|STARTED|Overall Study||33
154682|NCT01059617|373730|P2|STARTED|Overall Study||34
154683|NCT01059617|373731|P1|STARTED|Overall Study||33
154684|NCT01059565|373901|P2|NOT COMPLETED|24-Week Open-Label Phase||3
154685|NCT01059565|373902|P1|NOT COMPLETED|24-Week Open-Label Phase||5
154686|NCT01059565|373901|P2|COMPLETED|24-Week Open-Label Phase||42
154687|NCT01059565|373902|P1|COMPLETED|24-Week Open-Label Phase||34
154688|NCT01059565|373901|P2|STARTED|24-Week Open-Label Phase||45
154689|NCT01059565|373902|P1|STARTED|24-Week Open-Label Phase||39
154690|NCT01059565|373901|P2|NOT COMPLETED|24-Week Randomized Phase||7
154691|NCT01059565|373902|P1|NOT COMPLETED|24-Week Randomized Phase||10
154692|NCT01059565|373901|P2|COMPLETED|24-Week Randomized Phase||45
154693|NCT01059565|373902|P1|COMPLETED|24-Week Randomized Phase||39
154694|NCT01059565|373901|P2|Randomized and Treated|24-Week Randomized Phase||52
154695|NCT01059565|373902|P1|Randomized and Treated|24-Week Randomized Phase||48
154696|NCT01059565|373901|P2|STARTED|24-Week Randomized Phase||52
154697|NCT01059565|373902|P1|STARTED|24-Week Randomized Phase||49
154698|NCT01059526|373938|P2|NOT COMPLETED|Overall Study||22
154699|NCT01059526|373939|P1|NOT COMPLETED|Overall Study||30
154700|NCT01059526|373938|P2|COMPLETED|Overall Study||18
154701|NCT01059526|373939|P1|COMPLETED|Overall Study||11
154702|NCT01059526|373938|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
154703|NCT01059526|373939|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
154704|NCT01059526|373938|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
154705|NCT01059526|373939|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
154706|NCT01059344|373949|P2|NOT COMPLETED|Overall Study||46
154707|NCT01059344|373950|P1|NOT COMPLETED|Overall Study||22
154708|NCT01059344|373949|P2|COMPLETED|Overall Study||95
154709|NCT01059344|373950|P1|COMPLETED|Overall Study||118
154710|NCT01059344|373949|P2|STARTED|Overall Study||141
154711|NCT01059344|373950|P1|STARTED|Overall Study||140
154712|NCT01059305|373968|P1|NOT COMPLETED|Overall Study||0
154713|NCT01059305|373968|P1|COMPLETED|Overall Study||10
154714|NCT01059305|373968|P1|STARTED|Overall Study||10
154715|NCT01059175|373974|P2|NOT COMPLETED|Overall Study||20
154716|NCT01059175|373975|P1|NOT COMPLETED|Overall Study||21
154717|NCT01059175|373974|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
154718|NCT01059175|373975|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
154719|NCT01059175|373974|P2|STARTED|Overall Study||41
154720|NCT01059175|373975|P1|STARTED|Overall Study||43
154721|NCT01059071|373997|P4|NOT COMPLETED|Overall Study||6
154722|NCT01059071|373998|P3|NOT COMPLETED|Overall Study||2
154723|NCT01059071|373999|P2|NOT COMPLETED|Overall Study||4
154724|NCT01059071|374000|P1|NOT COMPLETED|Overall Study||2
154725|NCT01059071|373997|P4|COMPLETED|Overall Study||3
154726|NCT01059071|373998|P3|COMPLETED|Overall Study||1
154727|NCT01059071|373999|P2|COMPLETED|Overall Study||1
154728|NCT01059071|374000|P1|COMPLETED|Overall Study||2
154729|NCT01059071|373997|P4|STARTED|Overall Study||9
154730|NCT01059071|373998|P3|STARTED|Overall Study||3
154731|NCT01059071|373999|P2|STARTED|Overall Study||5
154732|NCT01059071|374000|P1|STARTED|Overall Study||4
154733|NCT01058993|374012|P1|NOT COMPLETED|Overall Study||0
154734|NCT01058993|374012|P1|COMPLETED|Overall Study||6
154735|NCT01058993|374012|P1|STARTED|Overall Study||6
154736|NCT01058941|374018|P2|NOT COMPLETED|Overall Study||11
154737|NCT01058941|374019|P1|NOT COMPLETED|Overall Study||9
154738|NCT01058941|374018|P2|COMPLETED|Overall Study||22
154739|NCT01058941|374019|P1|COMPLETED|Overall Study||25
154740|NCT01058941|374018|P2|STARTED|Overall Study||33
154741|NCT01058941|374019|P1|STARTED|Overall Study||34
154742|NCT01058863|374027|P1|NOT COMPLETED|Overall Study||4
154743|NCT01058863|374027|P1|COMPLETED|Overall Study||68
154744|NCT01058863|374027|P1|Treated With Placebo Inhaler|Overall Study||69
154745|NCT01058863|374027|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
154746|NCT01058863|374027|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
154747|NCT01058863|374027|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
154748|NCT01058863|374027|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
154835|NCT01058421|374099|P2|NOT COMPLETED|3 Month Outcomes||26
154749|NCT01058863|374027|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
154750|NCT01058863|374027|P1|STARTED|Overall Study||72
154751|NCT01058668|374048|P3|NOT COMPLETED|Safety Follow-up||7
154752|NCT01058668|374049|P2|NOT COMPLETED|Safety Follow-up||0
154753|NCT01058668|374050|P1|NOT COMPLETED|Safety Follow-up||5
154754|NCT01058668|374048|P3|COMPLETED|Safety Follow-up||141
154755|NCT01058668|374049|P2|COMPLETED|Safety Follow-up||146
154756|NCT01058668|374050|P1|COMPLETED|Safety Follow-up||139
154757|NCT01058668|374048|P3|STARTED|Safety Follow-up||148
154758|NCT01058668|374049|P2|STARTED|Safety Follow-up||146
154759|NCT01058668|374050|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
154760|NCT01058668|374048|P3|NOT COMPLETED|Double-blind Treatment Phase||50
154761|NCT01058668|374049|P2|NOT COMPLETED|Double-blind Treatment Phase||38
154762|NCT01058668|374050|P1|NOT COMPLETED|Double-blind Treatment Phase||39
154763|NCT01058668|374048|P3|COMPLETED|Double-blind Treatment Phase||119
154764|NCT01058668|374049|P2|COMPLETED|Double-blind Treatment Phase||129
154765|NCT01058668|374050|P1|COMPLETED|Double-blind Treatment Phase||122
154766|NCT01058668|374048|P3|STARTED|Double-blind Treatment Phase||169
154767|NCT01058668|374049|P2|STARTED|Double-blind Treatment Phase||167
154768|NCT01058668|374050|P1|STARTED|Double-blind Treatment Phase||161
154769|NCT01058655|374065|P4|NOT COMPLETED|Overall Study||42
154770|NCT01058655|374066|P3|NOT COMPLETED|Overall Study||8
154771|NCT01058655|374067|P2|NOT COMPLETED|Overall Study||3
154772|NCT01058655|374068|P1|NOT COMPLETED|Overall Study||3
154773|NCT01058655|374065|P4|COMPLETED|Overall Study||0
154774|NCT01058655|374066|P3|COMPLETED|Overall Study||0
154775|NCT01058655|374067|P2|COMPLETED|Overall Study||0
154776|NCT01058655|374068|P1|COMPLETED|Overall Study||0
154777|NCT01058655|374065|P4|Evaluable|Overall Study||40
154778|NCT01058655|374066|P3|Evaluable|Overall Study||6
154779|NCT01058655|374067|P2|Evaluable|Overall Study||3
154780|NCT01058655|374068|P1|Evaluable|Overall Study||3
154781|NCT01058655|374065|P4|STARTED|Overall Study||42
154782|NCT01058655|374066|P3|STARTED|Overall Study||8
154783|NCT01058655|374067|P2|STARTED|Overall Study||3
154784|NCT01058655|374068|P1|STARTED|Overall Study||3
154785|NCT01058642|374086|P4|NOT COMPLETED|Treatment Period 2||0
154786|NCT01058642|374087|P3|NOT COMPLETED|Treatment Period 2||0
154787|NCT01058642|374088|P2|NOT COMPLETED|Treatment Period 2||0
154788|NCT01058642|374089|P1|NOT COMPLETED|Treatment Period 2||0
154789|NCT01058642|374086|P4|COMPLETED|Treatment Period 2||7
154790|NCT01058642|374087|P3|COMPLETED|Treatment Period 2||9
154791|NCT01058642|374088|P2|COMPLETED|Treatment Period 2||11
154792|NCT01058642|374089|P1|COMPLETED|Treatment Period 2||7
154793|NCT01058642|374086|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
154794|NCT01058642|374087|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
154795|NCT01058642|374088|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
154796|NCT01058642|374089|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
154797|NCT01058642|374086|P4|STARTED|Treatment Period 2||7
154798|NCT01058642|374087|P3|STARTED|Treatment Period 2||9
154799|NCT01058642|374088|P2|STARTED|Treatment Period 2||11
154800|NCT01058642|374089|P1|STARTED|Treatment Period 2||7
154801|NCT01058642|374086|P4|NOT COMPLETED|Washout Period||0
154802|NCT01058642|374087|P3|NOT COMPLETED|Washout Period||0
154803|NCT01058642|374088|P2|NOT COMPLETED|Washout Period||0
154804|NCT01058642|374089|P1|NOT COMPLETED|Washout Period||0
154805|NCT01058642|374086|P4|COMPLETED|Washout Period||7
154806|NCT01058642|374087|P3|COMPLETED|Washout Period||9
154807|NCT01058642|374088|P2|COMPLETED|Washout Period||11
154808|NCT01058642|374089|P1|COMPLETED|Washout Period||7
154809|NCT01058642|374086|P4|STARTED|Washout Period||7
154810|NCT01058642|374087|P3|STARTED|Washout Period||9
154811|NCT01058642|374088|P2|STARTED|Washout Period||11
154812|NCT01058642|374089|P1|STARTED|Washout Period||7
154813|NCT01058642|374086|P4|NOT COMPLETED|Treatment Period 1||2
154814|NCT01058642|374087|P3|NOT COMPLETED|Treatment Period 1||2
154815|NCT01058642|374088|P2|NOT COMPLETED|Treatment Period 1||1
154816|NCT01058642|374089|P1|NOT COMPLETED|Treatment Period 1||2
154817|NCT01058642|374086|P4|COMPLETED|Treatment Period 1||7
154818|NCT01058642|374087|P3|COMPLETED|Treatment Period 1||9
154819|NCT01058642|374088|P2|COMPLETED|Treatment Period 1||11
154820|NCT01058642|374089|P1|COMPLETED|Treatment Period 1||7
154821|NCT01058642|374086|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
154822|NCT01058642|374087|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
154823|NCT01058642|374088|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
154824|NCT01058642|374089|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
154825|NCT01058642|374086|P4|STARTED|Treatment Period 1||9
154826|NCT01058642|374087|P3|STARTED|Treatment Period 1||11
154827|NCT01058642|374088|P2|STARTED|Treatment Period 1||12
154828|NCT01058642|374089|P1|STARTED|Treatment Period 1||9
154829|NCT01058421|374099|P2|NOT COMPLETED|6 Month Outcomes||26
154830|NCT01058421|374100|P1|NOT COMPLETED|6 Month Outcomes||19
154831|NCT01058421|374099|P2|COMPLETED|6 Month Outcomes||24
154832|NCT01058421|374100|P1|COMPLETED|6 Month Outcomes||27
154833|NCT01058421|374099|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
154834|NCT01058421|374100|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
154836|NCT01058421|374100|P1|NOT COMPLETED|3 Month Outcomes||20
154837|NCT01058421|374099|P2|COMPLETED|3 Month Outcomes||29
154838|NCT01058421|374100|P1|COMPLETED|3 Month Outcomes||29
154839|NCT01058421|374099|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
154840|NCT01058421|374100|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
154841|NCT01058421|374099|P2|NOT COMPLETED|1 Month Outcomes||42
154842|NCT01058421|374100|P1|NOT COMPLETED|1 Month Outcomes||39
154843|NCT01058421|374099|P2|COMPLETED|1 Month Outcomes||19
154844|NCT01058421|374100|P1|COMPLETED|1 Month Outcomes||20
154845|NCT01058421|374099|P2|STARTED|1 Month Outcomes||61
154846|NCT01058421|374100|P1|STARTED|1 Month Outcomes||59
154847|NCT01058356|374122|P1|NOT COMPLETED|Overall Study||42
154848|NCT01058356|374122|P1|COMPLETED|Overall Study||172
154849|NCT01058356|374122|P1|STARTED|Overall Study||214
154850|NCT01058304|374129|P2|NOT COMPLETED|Overall Study||33
154851|NCT01058304|374130|P1|NOT COMPLETED|Overall Study||27
154852|NCT01058304|374129|P2|COMPLETED|Overall Study||128
154853|NCT01058304|374130|P1|COMPLETED|Overall Study||132
154854|NCT01058304|374129|P2|STARTED|Overall Study||161
154855|NCT01058304|374130|P1|STARTED|Overall Study||159
154856|NCT01058265|374140|P2|NOT COMPLETED|Overall Study||12
154857|NCT01058265|374141|P1|NOT COMPLETED|Overall Study||11
154858|NCT01058265|374140|P2|COMPLETED|Overall Study||13
154859|NCT01058265|374141|P1|COMPLETED|Overall Study||11
154860|NCT01058265|374140|P2|STARTED|Overall Study||25
154861|NCT01058265|374141|P1|STARTED|Overall Study||22
154862|NCT01058239|374149|P1|NOT COMPLETED|Overall Study||0
154863|NCT01058239|374149|P1|COMPLETED|Overall Study||7
154864|NCT01058239|374149|P1|STARTED|Overall Study||7
154865|NCT01058096|374160|P2|NOT COMPLETED|Safety Follow-up||4
154866|NCT01058096|374161|P1|NOT COMPLETED|Safety Follow-up||4
154867|NCT01058096|374160|P2|COMPLETED|Safety Follow-up||130
154868|NCT01058096|374161|P1|COMPLETED|Safety Follow-up||129
154869|NCT01058096|374160|P2|STARTED|Safety Follow-up||134
154870|NCT01058096|374161|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
154871|NCT01058096|374160|P2|NOT COMPLETED|Double-blind Treatment Phase||50
154872|NCT01058096|374161|P1|NOT COMPLETED|Double-blind Treatment Phase||48
154873|NCT01058096|374160|P2|COMPLETED|Double-blind Treatment Phase||108
154874|NCT01058096|374161|P1|COMPLETED|Double-blind Treatment Phase||106
154875|NCT01058096|374160|P2|STARTED|Double-blind Treatment Phase||158
154876|NCT01058096|374161|P1|STARTED|Double-blind Treatment Phase||154
154877|NCT01058070|374169|P1|NOT COMPLETED|Overall Study||11
154878|NCT01058070|374169|P1|COMPLETED|Overall Study||33
154879|NCT01058070|374169|P1|STARTED|Overall Study||44
154880|NCT01058005|374177|P3|NOT COMPLETED|Overall Study||20
154881|NCT01058005|374178|P2|NOT COMPLETED|Overall Study||25
154882|NCT01058005|374179|P1|NOT COMPLETED|Overall Study||38
154883|NCT01058005|374177|P3|COMPLETED|Overall Study||1
154884|NCT01058005|374178|P2|COMPLETED|Overall Study||0
154885|NCT01058005|374179|P1|COMPLETED|Overall Study||0
154886|NCT01058005|374177|P3|Dosed With Study Treatment|Overall Study||17
154887|NCT01058005|374178|P2|Dosed With Study Treatment|Overall Study||22
154888|NCT01058005|374179|P1|Dosed With Study Treatment|Overall Study||36
154889|NCT01058005|374177|P3|STARTED|Overall Study||21
154890|NCT01058005|374178|P2|STARTED|Overall Study||25
154891|NCT01058005|374179|P1|STARTED|Overall Study||38
154892|NCT01057901|374189|P2|NOT COMPLETED|Overall Study||246
154893|NCT01057901|374190|P1|NOT COMPLETED|Overall Study||260
154894|NCT01057901|374189|P2|COMPLETED|Overall Study||126
154895|NCT01057901|374190|P1|COMPLETED|Overall Study||116
154896|NCT01057901|374189|P2|STARTED|Overall Study||372
154897|NCT01057901|374190|P1|STARTED|Overall Study||376
154898|NCT01057888|374201|P3|NOT COMPLETED|Overall Study||0
154899|NCT01057888|374202|P2|NOT COMPLETED|Overall Study||0
154900|NCT01057888|374203|P1|NOT COMPLETED|Overall Study||0
154901|NCT01057888|374201|P3|COMPLETED|Overall Study||2494
154902|NCT01057888|374202|P2|COMPLETED|Overall Study||2406
154903|NCT01057888|374203|P1|COMPLETED|Overall Study||2504
154904|NCT01057888|374201|P3|STARTED|Overall Study||2494
154905|NCT01057888|374202|P2|STARTED|Overall Study||2406
154906|NCT01057888|374203|P1|STARTED|Overall Study||2504
154907|NCT01057862|374214|P2|NOT COMPLETED|Overall Study||2
154908|NCT01057862|374215|P1|NOT COMPLETED|Overall Study||1
154909|NCT01057862|374214|P2|COMPLETED|Overall Study||2
154910|NCT01057862|374215|P1|COMPLETED|Overall Study||4
154911|NCT01057862|374214|P2|STARTED|Overall Study||4
154912|NCT01057862|374215|P1|STARTED|Overall Study||5
154913|NCT01057810|374225|P2|NOT COMPLETED|Overall Study||398
154914|NCT01057810|374226|P1|NOT COMPLETED|Overall Study||198
154915|NCT01057810|374225|P2|COMPLETED|Overall Study||1
154916|NCT01057810|374226|P1|COMPLETED|Overall Study||1
154917|NCT01057810|374225|P2|STARTED|Overall Study||399
154918|NCT01057810|374226|P1|STARTED|Overall Study||199
154919|NCT01057693|374242|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
154920|NCT01057693|374243|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
154921|NCT01057693|374244|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
154922|NCT01057693|374242|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
154923|NCT01057693|374243|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
154924|NCT01057693|374244|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
155009|NCT01057121|374351|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
154925|NCT01057693|374242|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
154926|NCT01057693|374243|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
154927|NCT01057693|374244|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
154928|NCT01057693|374242|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
154929|NCT01057693|374243|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
154930|NCT01057693|374244|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
154931|NCT01057693|374242|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
154932|NCT01057693|374243|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
154933|NCT01057693|374244|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
154934|NCT01057693|374242|P3|COMPLETED|Between Single-Blind and Double-Blind||0
154935|NCT01057693|374243|P2|COMPLETED|Between Single-Blind and Double-Blind||0
154936|NCT01057693|374244|P1|COMPLETED|Between Single-Blind and Double-Blind||296
154937|NCT01057693|374242|P3|STARTED|Between Single-Blind and Double-Blind||0
154938|NCT01057693|374243|P2|STARTED|Between Single-Blind and Double-Blind||0
154939|NCT01057693|374244|P1|STARTED|Between Single-Blind and Double-Blind||566
154940|NCT01057693|374242|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
154941|NCT01057693|374243|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
154942|NCT01057693|374244|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
154943|NCT01057693|374242|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
154944|NCT01057693|374243|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
154945|NCT01057693|374244|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
154946|NCT01057693|374242|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
154947|NCT01057693|374243|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
154948|NCT01057693|374244|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
154949|NCT01057589|374290|P1|NOT COMPLETED|Overall Study||66
154950|NCT01057589|374290|P1|COMPLETED|Overall Study||0
154951|NCT01057589|374290|P1|STARTED|Overall Study||66
154952|NCT01057433|374299|P1|NOT COMPLETED|Overall Study||1
154953|NCT01057433|374299|P1|COMPLETED|Overall Study||23
154954|NCT01057433|374299|P1|STARTED|Overall Study||24
154955|NCT01057394|374303|P2|NOT COMPLETED|Overall Study||2
154956|NCT01057394|374304|P1|NOT COMPLETED|Overall Study||0
154957|NCT01057394|374303|P2|COMPLETED|Overall Study|19 treated participants|19
154958|NCT01057394|374304|P1|COMPLETED|Overall Study||0
154959|NCT01057394|374303|P2|STARTED|Overall Study|21 enrolled participants|21
154960|NCT01057394|374304|P1|STARTED|Overall Study||0
154961|NCT01057277|374308|P1|NOT COMPLETED|Overall Study||0
154962|NCT01057277|374308|P1|COMPLETED|Overall Study||3
154963|NCT01057277|374308|P1|STARTED|Overall Study||3
154964|NCT01057251|374314|P2|NOT COMPLETED|Overall Study||29
154965|NCT01057251|374315|P1|NOT COMPLETED|Overall Study||28
154966|NCT01057251|374314|P2|COMPLETED|Overall Study||114
154967|NCT01057251|374315|P1|COMPLETED|Overall Study||262
154968|NCT01057251|374314|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
154969|NCT01057251|374315|P1|STARTED|Overall Study||290
154970|NCT01057225|374323|P6|NOT COMPLETED|Overall Study||0
154971|NCT01057225|374324|P5|NOT COMPLETED|Overall Study||0
154972|NCT01057225|374325|P4|NOT COMPLETED|Overall Study||0
154973|NCT01057225|374326|P3|NOT COMPLETED|Overall Study||0
154974|NCT01057225|374327|P2|NOT COMPLETED|Overall Study||0
154975|NCT01057225|374328|P1|NOT COMPLETED|Overall Study||0
154976|NCT01057225|374323|P6|COMPLETED|Overall Study||23
154977|NCT01057225|374324|P5|COMPLETED|Overall Study||22
154978|NCT01057225|374325|P4|COMPLETED|Overall Study||7
154979|NCT01057225|374326|P3|COMPLETED|Overall Study||6
154980|NCT01057225|374327|P2|COMPLETED|Overall Study||3
154981|NCT01057225|374328|P1|COMPLETED|Overall Study||3
154982|NCT01057225|374323|P6|STARTED|Overall Study||23
154983|NCT01057225|374324|P5|STARTED|Overall Study||22
154984|NCT01057225|374325|P4|STARTED|Overall Study||7
154985|NCT01057225|374326|P3|STARTED|Overall Study||6
154986|NCT01057225|374327|P2|STARTED|Overall Study||3
154987|NCT01057225|374328|P1|STARTED|Overall Study||3
154988|NCT01057121|374350|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154989|NCT01057121|374351|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154990|NCT01057121|374352|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154991|NCT01057121|374353|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154992|NCT01057121|374354|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154993|NCT01057121|374350|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
154994|NCT01057121|374351|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154995|NCT01057121|374352|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154996|NCT01057121|374353|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154997|NCT01057121|374354|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
154998|NCT01057121|374350|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
154999|NCT01057121|374351|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
155000|NCT01057121|374352|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
155001|NCT01057121|374353|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
155002|NCT01057121|374354|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
155003|NCT01057121|374350|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155004|NCT01057121|374351|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155005|NCT01057121|374352|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155006|NCT01057121|374353|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155007|NCT01057121|374354|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155008|NCT01057121|374350|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155010|NCT01057121|374352|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155011|NCT01057121|374353|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155012|NCT01057121|374354|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
155013|NCT01057121|374350|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
155014|NCT01057121|374351|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
155015|NCT01057121|374352|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
155016|NCT01057121|374353|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
155017|NCT01057121|374354|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
155018|NCT01057121|374350|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155019|NCT01057121|374351|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155020|NCT01057121|374352|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155021|NCT01057121|374353|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155022|NCT01057121|374354|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155023|NCT01057121|374350|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155024|NCT01057121|374351|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155025|NCT01057121|374352|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
155026|NCT01057121|374353|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155027|NCT01057121|374354|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
155028|NCT01057121|374350|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
155029|NCT01057121|374351|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
155030|NCT01057121|374352|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
155031|NCT01057121|374353|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
155032|NCT01057121|374354|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
155033|NCT01057121|374350|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155034|NCT01057121|374351|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155035|NCT01057121|374352|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155036|NCT01057121|374353|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155037|NCT01057121|374354|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155038|NCT01057121|374350|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155039|NCT01057121|374351|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155040|NCT01057121|374352|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155041|NCT01057121|374353|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
155042|NCT01057121|374354|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
155043|NCT01057121|374350|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
155044|NCT01057121|374351|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
155045|NCT01057121|374352|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
155046|NCT01057121|374353|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
155047|NCT01057121|374354|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
155048|NCT01057121|374350|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155049|NCT01057121|374351|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155050|NCT01057121|374352|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155051|NCT01057121|374353|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155052|NCT01057121|374354|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155053|NCT01057121|374350|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155054|NCT01057121|374351|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155055|NCT01057121|374352|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155056|NCT01057121|374353|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
155057|NCT01057121|374354|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
155058|NCT01057121|374350|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
155059|NCT01057121|374351|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
155060|NCT01057121|374352|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
155061|NCT01057121|374353|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
155062|NCT01057121|374354|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
155063|NCT01057017|374383|P1|NOT COMPLETED|Overall Study||0
155064|NCT01057017|374383|P1|COMPLETED|Overall Study||5
155065|NCT01057017|374383|P1|STARTED|Overall Study||5
155066|NCT01056913|374387|P1|NOT COMPLETED|Overall Study||0
155067|NCT01056913|374387|P1|COMPLETED|Overall Study||62
155068|NCT01056913|374387|P1|STARTED|Overall Study||62
155069|NCT01056822|374393|P2|NOT COMPLETED|Overall Study||7
155070|NCT01056822|374394|P1|NOT COMPLETED|Overall Study||8
155071|NCT01056822|374393|P2|COMPLETED|Overall Study||35
155072|NCT01056822|374394|P1|COMPLETED|Overall Study||39
155073|NCT01056822|374393|P2|Safety (SAF) Population: NO|Overall Study||2
155074|NCT01056822|374394|P1|Safety (SAF) Population: NO|Overall Study||1
155075|NCT01056822|374393|P2|Safety (SAF) Population: YES|Overall Study||40
155076|NCT01056822|374394|P1|Safety (SAF) Population: YES|Overall Study||46
155077|NCT01056822|374393|P2|Per-protocol (PP) Population: NO|Overall Study||17
155078|NCT01056822|374394|P1|Per-protocol (PP) Population: NO|Overall Study||18
155079|NCT01056822|374393|P2|Per-protocol (PP) Population: YES|Overall Study||25
155080|NCT01056822|374394|P1|Per-protocol (PP) Population: YES|Overall Study||29
155081|NCT01056822|374393|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
155082|NCT01056822|374394|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
155083|NCT01056822|374393|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
155084|NCT01056822|374394|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
155085|NCT01056822|374393|P2|STARTED|Overall Study||42
155086|NCT01056822|374394|P1|STARTED|Overall Study||47
155087|NCT01056718|374443|P1|NOT COMPLETED|Overall Study||3
155088|NCT01056718|374443|P1|COMPLETED|Overall Study||50
155089|NCT01056718|374443|P1|STARTED|Overall Study||53
155090|NCT01056653|374476|P3|NOT COMPLETED|Overall Study||2
155091|NCT01056653|374477|P2|NOT COMPLETED|Overall Study||0
155092|NCT01056653|374478|P1|NOT COMPLETED|Overall Study||0
155093|NCT01056653|374476|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
155094|NCT01056653|374477|P2|COMPLETED|Overall Study||23
155095|NCT01056653|374478|P1|COMPLETED|Overall Study||46
155096|NCT01056653|374476|P3|STARTED|Overall Study||44
155097|NCT01056653|374477|P2|STARTED|Overall Study||23
155098|NCT01056653|374478|P1|STARTED|Overall Study||46
155099|NCT01056640|374494|P2|NOT COMPLETED|Overall Study||12
155100|NCT01056640|374495|P1|NOT COMPLETED|Overall Study||26
155101|NCT01056640|374494|P2|COMPLETED|Overall Study||91
155102|NCT01056640|374495|P1|COMPLETED|Overall Study||76
155103|NCT01056640|374494|P2|STARTED|Overall Study||103
155104|NCT01056640|374495|P1|STARTED|Overall Study||102
155105|NCT01056601|374501|P1|NOT COMPLETED|Overall Study||0
155106|NCT01056601|374501|P1|COMPLETED|Overall Study||7
155107|NCT01056601|374501|P1|STARTED|Overall Study||7
155108|NCT01056523|374507|P7|NOT COMPLETED|Overall Study||1
155109|NCT01056523|374508|P6|NOT COMPLETED|Overall Study||0
155110|NCT01056523|374509|P5|NOT COMPLETED|Overall Study||0
155111|NCT01056523|374510|P4|NOT COMPLETED|Overall Study||3
155112|NCT01056523|374511|P3|NOT COMPLETED|Overall Study||2
155113|NCT01056523|374512|P2|NOT COMPLETED|Overall Study||0
155114|NCT01056523|374513|P1|NOT COMPLETED|Overall Study||1
155115|NCT01056523|374507|P7|COMPLETED|Overall Study||4
155116|NCT01056523|374508|P6|COMPLETED|Overall Study||3
155117|NCT01056523|374509|P5|COMPLETED|Overall Study||3
155118|NCT01056523|374510|P4|COMPLETED|Overall Study||3
155119|NCT01056523|374511|P3|COMPLETED|Overall Study||3
155120|NCT01056523|374512|P2|COMPLETED|Overall Study||3
155121|NCT01056523|374513|P1|COMPLETED|Overall Study||3
155122|NCT01056523|374507|P7|STARTED|Overall Study||5
155123|NCT01056523|374508|P6|STARTED|Overall Study||3
155124|NCT01056523|374509|P5|STARTED|Overall Study||3
155125|NCT01056523|374510|P4|STARTED|Overall Study||6
155126|NCT01056523|374511|P3|STARTED|Overall Study||5
155127|NCT01056523|374512|P2|STARTED|Overall Study||3
155128|NCT01056523|374513|P1|STARTED|Overall Study||4
155129|NCT01056510|374523|P2|NOT COMPLETED|Overall Study||64
155130|NCT01056510|374524|P1|NOT COMPLETED|Overall Study||54
155131|NCT01056510|374523|P2|COMPLETED|Overall Study||115
155132|NCT01056510|374524|P1|COMPLETED|Overall Study||124
155133|NCT01056510|374523|P2|STARTED|Overall Study||179
155134|NCT01056510|374524|P1|STARTED|Overall Study||178
155135|NCT01056484|374570|P2|NOT COMPLETED|Follow up - Non-randomized||2
155136|NCT01056484|374571|P1|NOT COMPLETED|Follow up - Non-randomized||0
155137|NCT01056484|374570|P2|COMPLETED|Follow up - Non-randomized||56
155138|NCT01056484|374571|P1|COMPLETED|Follow up - Non-randomized||57
155139|NCT01056484|374570|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
155140|NCT01056484|374571|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
155141|NCT01056484|374570|P2|NOT COMPLETED|Randomized Controlled Trial||1
155142|NCT01056484|374571|P1|NOT COMPLETED|Randomized Controlled Trial||7
155143|NCT01056484|374570|P2|COMPLETED|Randomized Controlled Trial||58
155144|NCT01056484|374571|P1|COMPLETED|Randomized Controlled Trial||57
155145|NCT01056484|374570|P2|STARTED|Randomized Controlled Trial||59
155146|NCT01056484|374571|P1|STARTED|Randomized Controlled Trial||64
155147|NCT01056380|374587|P2|NOT COMPLETED|Overall Study||3
155148|NCT01056380|374588|P1|NOT COMPLETED|Overall Study||2
155149|NCT01056380|374587|P2|COMPLETED|Overall Study||39
155150|NCT01056380|374588|P1|COMPLETED|Overall Study||35
155151|NCT01056380|374587|P2|STARTED|Overall Study||42
155152|NCT01056380|374588|P1|STARTED|Overall Study||37
155153|NCT01056341|374615|P5|NOT COMPLETED|Overall Study||14
155154|NCT01056341|374616|P4|NOT COMPLETED|Overall Study||36
155155|NCT01056341|374617|P3|NOT COMPLETED|Overall Study||15
155156|NCT01056341|374618|P2|NOT COMPLETED|Overall Study||36
155157|NCT01056341|374619|P1|NOT COMPLETED|Overall Study||36
155158|NCT01056341|374615|P5|COMPLETED|Overall Study||88
155159|NCT01056341|374616|P4|COMPLETED|Overall Study||65
155160|NCT01056341|374617|P3|COMPLETED|Overall Study||88
155161|NCT01056341|374618|P2|COMPLETED|Overall Study||63
155162|NCT01056341|374619|P1|COMPLETED|Overall Study||19
155163|NCT01056341|374615|P5|Interim Analysis|Overall Study||43
155164|NCT01056341|374616|P4|Interim Analysis|Overall Study||40
155165|NCT01056341|374617|P3|Interim Analysis|Overall Study||41
155166|NCT01056341|374618|P2|Interim Analysis|Overall Study||41
155167|NCT01056341|374619|P1|Interim Analysis|Overall Study||25
155168|NCT01056341|374615|P5|STARTED|Overall Study||102
155169|NCT01056341|374616|P4|STARTED|Overall Study||101
155170|NCT01056341|374617|P3|STARTED|Overall Study||103
155171|NCT01056341|374618|P2|STARTED|Overall Study||99
155172|NCT01056341|374619|P1|STARTED|Overall Study||55
155173|NCT01056328|374640|P2|NOT COMPLETED|Overall Study||16
155174|NCT01056328|374641|P1|NOT COMPLETED|Overall Study||17
155175|NCT01056328|374640|P2|COMPLETED|Overall Study||144
155176|NCT01056328|374641|P1|COMPLETED|Overall Study||147
155177|NCT01056328|374640|P2|STARTED|Overall Study||160
155178|NCT01056328|374641|P1|STARTED|Overall Study||164
155179|NCT01056315|374657|P2|NOT COMPLETED|Overall Study||11
155180|NCT01056315|374658|P1|NOT COMPLETED|Overall Study||14
155181|NCT01056315|374657|P2|COMPLETED|Overall Study||12
155182|NCT01056315|374658|P1|COMPLETED|Overall Study||13
155183|NCT01056315|374657|P2|STARTED|Overall Study||23
155184|NCT01056315|374658|P1|STARTED|Overall Study||27
155185|NCT01056289|374692|P4|NOT COMPLETED|Double-blind Phase||10
155186|NCT01056289|374693|P3|NOT COMPLETED|Double-blind Phase||13
155187|NCT01056289|374694|P2|NOT COMPLETED|Double-blind Phase||4
155188|NCT01056289|374695|P1|NOT COMPLETED|Double-blind Phase||0
155189|NCT01056289|374692|P4|COMPLETED|Double-blind Phase||138
155190|NCT01056289|374693|P3|COMPLETED|Double-blind Phase||127
155191|NCT01056289|374694|P2|COMPLETED|Double-blind Phase||69
155192|NCT01056289|374695|P1|COMPLETED|Double-blind Phase||0
155193|NCT01056289|374692|P4|STARTED|Double-blind Phase||148
155194|NCT01056289|374693|P3|STARTED|Double-blind Phase||140
155195|NCT01056289|374694|P2|STARTED|Double-blind Phase||73
155196|NCT01056289|374695|P1|STARTED|Double-blind Phase||0
155197|NCT01056289|374692|P4|NOT COMPLETED|Open-label Phase||0
155198|NCT01056289|374693|P3|NOT COMPLETED|Open-label Phase||0
155199|NCT01056289|374694|P2|NOT COMPLETED|Open-label Phase||0
155200|NCT01056289|374695|P1|NOT COMPLETED|Open-label Phase||119
155201|NCT01056289|374692|P4|COMPLETED|Open-label Phase||0
155202|NCT01056289|374693|P3|COMPLETED|Open-label Phase||0
155203|NCT01056289|374694|P2|COMPLETED|Open-label Phase||0
155204|NCT01056289|374695|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
155205|NCT01056289|374692|P4|STARTED|Open-label Phase||0
155206|NCT01056289|374693|P3|STARTED|Open-label Phase||0
155207|NCT01056289|374694|P2|STARTED|Open-label Phase||0
155208|NCT01056289|374695|P1|STARTED|Open-label Phase||480
155209|NCT01056276|374712|P2|NOT COMPLETED|Maintenance Therapy||28
155210|NCT01056276|374713|P1|NOT COMPLETED|Maintenance Therapy||0
155211|NCT01056276|374712|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
155212|NCT01056276|374713|P1|COMPLETED|Maintenance Therapy||0
155213|NCT01056276|374712|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
155214|NCT01056276|374713|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
155215|NCT01056276|374712|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
155216|NCT01056276|374713|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
155217|NCT01056276|374712|P2|COMPLETED|Treatment Period-Cycles 1-8||33
155218|NCT01056276|374713|P1|COMPLETED|Treatment Period-Cycles 1-8||5
155219|NCT01056276|374712|P2|STARTED|Treatment Period-Cycles 1-8||41
155220|NCT01056276|374713|P1|STARTED|Treatment Period-Cycles 1-8||18
155221|NCT01056263|374727|P1|NOT COMPLETED|Overall Study||52
155222|NCT01056263|374727|P1|COMPLETED|Overall Study||0
155223|NCT01056263|374727|P1|STARTED|Overall Study||52
155224|NCT01056198|374733|P2|NOT COMPLETED|Overall Study||0
155225|NCT01056198|374734|P1|NOT COMPLETED|Overall Study||0
155226|NCT01056198|374733|P2|COMPLETED|Overall Study||24
155227|NCT01056198|374734|P1|COMPLETED|Overall Study||24
155228|NCT01056198|374733|P2|STARTED|Overall Study||24
155229|NCT01056198|374734|P1|STARTED|Overall Study||24
155230|NCT01056107|374750|P4|NOT COMPLETED|Overall Study||0
155231|NCT01056107|374751|P3|NOT COMPLETED|Overall Study||3
155232|NCT01056107|374752|P2|NOT COMPLETED|Overall Study||1
155233|NCT01056107|374753|P1|NOT COMPLETED|Overall Study||0
155234|NCT01056107|374750|P4|COMPLETED|Overall Study||12
155235|NCT01056107|374751|P3|COMPLETED|Overall Study||9
155236|NCT01056107|374752|P2|COMPLETED|Overall Study||10
155237|NCT01056107|374753|P1|COMPLETED|Overall Study||11
155238|NCT01056107|374750|P4|STARTED|Overall Study||12
155239|NCT01056107|374751|P3|STARTED|Overall Study||12
155240|NCT01056107|374752|P2|STARTED|Overall Study||11
155241|NCT01056107|374753|P1|STARTED|Overall Study||11
155242|NCT01056016|374801|P2|NOT COMPLETED|Overall Study||1
155243|NCT01056016|374802|P1|NOT COMPLETED|Overall Study||2
155244|NCT01056016|374801|P2|COMPLETED|Overall Study||26
155245|NCT01056016|374802|P1|COMPLETED|Overall Study||20
155246|NCT01056016|374801|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
155247|NCT01056016|374802|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
155248|NCT01055886|374810|P2|NOT COMPLETED|Overall Study||11
155249|NCT01055886|374811|P1|NOT COMPLETED|Overall Study||5
155250|NCT01055886|374810|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
155251|NCT01055886|374811|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
155252|NCT01055886|374810|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
155253|NCT01055886|374811|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
155254|NCT01055886|374810|P2|STARTED|Overall Study||32
155255|NCT01055886|374811|P1|STARTED|Overall Study||33
155256|NCT01055834|374823|P2|NOT COMPLETED|Treatment Period III||0
155257|NCT01055834|374824|P1|NOT COMPLETED|Treatment Period III||0
155258|NCT01055834|374823|P2|COMPLETED|Treatment Period III||14
155259|NCT01055834|374824|P1|COMPLETED|Treatment Period III||0
155260|NCT01055834|374823|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
155261|NCT01055834|374824|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
155262|NCT01055834|374823|P2|NOT COMPLETED|Treatment Period II||0
155263|NCT01055834|374824|P1|NOT COMPLETED|Treatment Period II||0
155264|NCT01055834|374823|P2|COMPLETED|Treatment Period II||21
155265|NCT01055834|374824|P1|COMPLETED|Treatment Period II||20
155266|NCT01055834|374823|P2|STARTED|Treatment Period II||21
155267|NCT01055834|374824|P1|STARTED|Treatment Period II||20
155268|NCT01055834|374823|P2|NOT COMPLETED|Treatment Period I||0
155269|NCT01055834|374824|P1|NOT COMPLETED|Treatment Period I||1
155270|NCT01055834|374823|P2|COMPLETED|Treatment Period I||21
155271|NCT01055834|374824|P1|COMPLETED|Treatment Period I||20
155272|NCT01055834|374823|P2|STARTED|Treatment Period I||21
155273|NCT01055834|374824|P1|STARTED|Treatment Period I||21
155274|NCT01055782|374838|P2|NOT COMPLETED|Overall Study||0
155275|NCT01055782|374839|P1|NOT COMPLETED|Overall Study||0
155276|NCT01055782|374838|P2|COMPLETED|Overall Study||449
155277|NCT01055782|374839|P1|COMPLETED|Overall Study||555
155278|NCT01055782|374838|P2|STARTED|Overall Study||449
155279|NCT01055782|374839|P1|STARTED|Overall Study||555
155280|NCT01055769|374847|P2|NOT COMPLETED|Second Intervention||0
155281|NCT01055769|374848|P1|NOT COMPLETED|Second Intervention||0
155282|NCT01055769|374847|P2|COMPLETED|Second Intervention||10
155283|NCT01055769|374848|P1|COMPLETED|Second Intervention||10
155284|NCT01055769|374847|P2|STARTED|Second Intervention||10
155285|NCT01055769|374848|P1|STARTED|Second Intervention||10
155286|NCT01055769|374847|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
155287|NCT01055769|374848|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
155288|NCT01055769|374847|P2|COMPLETED|Washout Period of Atleast 4 Days||10
155289|NCT01055769|374848|P1|COMPLETED|Washout Period of Atleast 4 Days||10
155290|NCT01055769|374847|P2|STARTED|Washout Period of Atleast 4 Days||10
155291|NCT01055769|374848|P1|STARTED|Washout Period of Atleast 4 Days||10
155292|NCT01055769|374847|P2|NOT COMPLETED|First Intervention||0
155293|NCT01055769|374848|P1|NOT COMPLETED|First Intervention||0
155294|NCT01055769|374847|P2|COMPLETED|First Intervention||10
155295|NCT01055769|374848|P1|COMPLETED|First Intervention||10
155296|NCT01055769|374847|P2|STARTED|First Intervention||10
155297|NCT01055769|374848|P1|STARTED|First Intervention||10
155298|NCT01055704|374866|P4|NOT COMPLETED|Overall Study||0
155299|NCT01055704|374867|P3|NOT COMPLETED|Overall Study||0
155300|NCT01055704|374868|P2|NOT COMPLETED|Overall Study||0
155301|NCT01055704|374869|P1|NOT COMPLETED|Overall Study||0
155302|NCT01055704|374866|P4|COMPLETED|Overall Study||8
155303|NCT01055704|374867|P3|COMPLETED|Overall Study||16
155304|NCT01055704|374868|P2|COMPLETED|Overall Study||8
155305|NCT01055704|374869|P1|COMPLETED|Overall Study||16
155306|NCT01055704|374866|P4|STARTED|Overall Study||8
155307|NCT01055704|374867|P3|STARTED|Overall Study||16
155308|NCT01055704|374868|P2|STARTED|Overall Study||8
155309|NCT01055704|374869|P1|STARTED|Overall Study||16
155310|NCT01055639|374909|P2|NOT COMPLETED|Overall Study||29
155311|NCT01055639|374910|P1|NOT COMPLETED|Overall Study||21
155312|NCT01055639|374909|P2|COMPLETED|Overall Study||31
155313|NCT01055639|374910|P1|COMPLETED|Overall Study||45
155314|NCT01055639|374909|P2|STARTED|Overall Study||60
155315|NCT01055639|374910|P1|STARTED|Overall Study||66
155316|NCT01055613|374934|P2|NOT COMPLETED|Overall Study||4
155317|NCT01055613|374935|P1|NOT COMPLETED|Overall Study||9
155318|NCT01055613|374934|P2|COMPLETED|Overall Study||96
155319|NCT01055613|374935|P1|COMPLETED|Overall Study||191
155320|NCT01055613|374934|P2|STARTED|Overall Study||100
155321|NCT01055613|374935|P1|STARTED|Overall Study||200
155322|NCT01055457|374953|P10|NOT COMPLETED|Overall Study||1
155323|NCT01055457|374954|P9|NOT COMPLETED|Overall Study||0
155324|NCT01055457|374955|P8|NOT COMPLETED|Overall Study||1
155325|NCT01055457|374956|P7|NOT COMPLETED|Overall Study||1
155326|NCT01055457|374957|P6|NOT COMPLETED|Overall Study||3
155327|NCT01055457|374958|P5|NOT COMPLETED|Overall Study||3
155328|NCT01055457|374959|P4|NOT COMPLETED|Overall Study||3
155329|NCT01055457|374960|P3|NOT COMPLETED|Overall Study||2
155330|NCT01055457|374961|P2|NOT COMPLETED|Overall Study||1
155331|NCT01055457|374962|P1|NOT COMPLETED|Overall Study||1
155332|NCT01055457|374953|P10|COMPLETED|Overall Study||19
155333|NCT01055457|374954|P9|COMPLETED|Overall Study||20
155334|NCT01055457|374955|P8|COMPLETED|Overall Study||18
155335|NCT01055457|374956|P7|COMPLETED|Overall Study||18
155336|NCT01055457|374957|P6|COMPLETED|Overall Study||15
155337|NCT01055457|374958|P5|COMPLETED|Overall Study||38
155338|NCT01055457|374959|P4|COMPLETED|Overall Study||37
155339|NCT01055457|374960|P3|COMPLETED|Overall Study||36
155340|NCT01055457|374961|P2|COMPLETED|Overall Study||39
155341|NCT01055457|374962|P1|COMPLETED|Overall Study||39
155342|NCT01055457|374953|P10|STARTED|Overall Study||20
155343|NCT01055457|374954|P9|STARTED|Overall Study||20
155344|NCT01055457|374955|P8|STARTED|Overall Study||19
155345|NCT01055457|374956|P7|STARTED|Overall Study||19
155346|NCT01055457|374957|P6|STARTED|Overall Study||18
155347|NCT01055457|374958|P5|STARTED|Overall Study||41
155348|NCT01055457|374959|P4|STARTED|Overall Study||40
155349|NCT01055457|374960|P3|STARTED|Overall Study||38
155350|NCT01055457|374961|P2|STARTED|Overall Study||40
155351|NCT01055457|374962|P1|STARTED|Overall Study||40
155352|NCT01055314|374996|P2|NOT COMPLETED|Overall Study||38
155353|NCT01055314|374997|P1|NOT COMPLETED|Overall Study||45
155354|NCT01055314|374996|P2|COMPLETED|Overall Study||37
155355|NCT01055314|374997|P1|COMPLETED|Overall Study||55
155356|NCT01055314|374996|P2|STARTED|Overall Study||75
155357|NCT01055314|374997|P1|STARTED|Overall Study||100
155358|NCT01055262|375009|P1|NOT COMPLETED|Overall Study||9
155359|NCT01055262|375009|P1|COMPLETED|Overall Study||160
155360|NCT01055262|375009|P1|STARTED|Overall Study||169
155361|NCT01055223|375020|P1|NOT COMPLETED|Overall Study||0
155362|NCT01055223|375020|P1|COMPLETED|Overall Study||98483
155363|NCT01055223|375020|P1|STARTED|Overall Study||98483
155364|NCT01055197|375050|P2|NOT COMPLETED|Overall Study||2
155365|NCT01055197|375051|P1|NOT COMPLETED|Overall Study||9
155366|NCT01055197|375050|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
155367|NCT01055197|375051|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
155368|NCT01055197|375050|P2|STARTED|Overall Study||46
155369|NCT01055197|375051|P1|STARTED|Overall Study||51
155370|NCT01055184|375057|P1|NOT COMPLETED|Overall Study||0
155371|NCT01055184|375057|P1|COMPLETED|Overall Study||34
155372|NCT01055184|375057|P1|STARTED|Overall Study||34
155373|NCT01055171|375063|P2|NOT COMPLETED|Overall Study||7
155374|NCT01055171|375064|P1|NOT COMPLETED|Overall Study||11
155375|NCT01055171|375063|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
155376|NCT01055171|375064|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
155377|NCT01055171|375063|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
155378|NCT01055171|375064|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
155379|NCT01055171|375063|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
155380|NCT01055171|375064|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
155381|NCT01055171|375063|P2|STARTED|Overall Study|Randomized to receive placebo.|28
155382|NCT01055171|375064|P1|STARTED|Overall Study|Randomized to receive medication.|29
155383|NCT01055132|375078|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
155384|NCT01055132|375079|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
155385|NCT01055132|375078|P2|COMPLETED|Period 2 (5-9 Days)||32
155386|NCT01055132|375079|P1|COMPLETED|Period 2 (5-9 Days)||35
155387|NCT01055132|375078|P2|STARTED|Period 2 (5-9 Days)||33
155388|NCT01055132|375079|P1|STARTED|Period 2 (5-9 Days)||35
155389|NCT01055132|375078|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
155390|NCT01055132|375079|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
155391|NCT01055132|375078|P2|COMPLETED|Period 1 (5-9 Days)||33
155392|NCT01055132|375079|P1|COMPLETED|Period 1 (5-9 Days)||35
155393|NCT01055132|375078|P2|STARTED|Period 1 (5-9 Days)||33
155394|NCT01055132|375079|P1|STARTED|Period 1 (5-9 Days)||36
155395|NCT01055028|375092|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
155396|NCT01055028|375093|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
155397|NCT01055028|375092|P2|COMPLETED|Treatment Cycles 4 to 6||2
155398|NCT01055028|375093|P1|COMPLETED|Treatment Cycles 4 to 6||6
155399|NCT01055028|375092|P2|STARTED|Treatment Cycles 4 to 6||2
155400|NCT01055028|375093|P1|STARTED|Treatment Cycles 4 to 6||6
155401|NCT01055028|375092|P2|NOT COMPLETED|Inter-treatment Period||3
155402|NCT01055028|375093|P1|NOT COMPLETED|Inter-treatment Period||0
155403|NCT01055028|375092|P2|COMPLETED|Inter-treatment Period||2
155404|NCT01055028|375093|P1|COMPLETED|Inter-treatment Period||6
155405|NCT01055028|375092|P2|STARTED|Inter-treatment Period||5
155406|NCT01055028|375093|P1|STARTED|Inter-treatment Period||6
155407|NCT01055028|375092|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
155408|NCT01055028|375093|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
155409|NCT01055028|375092|P2|COMPLETED|Treatment Cycles 1 to 3||5
155410|NCT01055028|375093|P1|COMPLETED|Treatment Cycles 1 to 3||6
155411|NCT01055028|375092|P2|STARTED|Treatment Cycles 1 to 3||8
155412|NCT01055028|375093|P1|STARTED|Treatment Cycles 1 to 3||8
155413|NCT01055028|375092|P2|NOT COMPLETED|Screening||1
155414|NCT01055028|375093|P1|NOT COMPLETED|Screening||1
155415|NCT01055028|375092|P2|COMPLETED|Screening||8
155416|NCT01055028|375093|P1|COMPLETED|Screening||8
155417|NCT01055028|375092|P2|STARTED|Screening||9
155418|NCT01055028|375093|P1|STARTED|Screening||9
155419|NCT01054976|375107|P1|NOT COMPLETED|Overall Study||35
155420|NCT01054976|375107|P1|COMPLETED|Overall Study||57
155421|NCT01054976|375107|P1|STARTED|Overall Study||92
155422|NCT01054911|375115|P1|NOT COMPLETED|Overall Study||0
155423|NCT01054911|375115|P1|COMPLETED|Overall Study||5
155424|NCT01054911|375115|P1|STARTED|Overall Study||5
155425|NCT01054885|375128|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
155426|NCT01054885|375129|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
155427|NCT01054885|375130|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
155428|NCT01054885|375131|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
155429|NCT01054885|375132|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
155430|NCT01054885|375133|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
155431|NCT01054885|375134|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
155432|NCT01054885|375128|P7|COMPLETED|24-week, Double-blind Treatment Period||158
155433|NCT01054885|375129|P6|COMPLETED|24-week, Double-blind Treatment Period||144
155434|NCT01054885|375130|P5|COMPLETED|24-week, Double-blind Treatment Period||161
155435|NCT01054885|375131|P4|COMPLETED|24-week, Double-blind Treatment Period||160
155436|NCT01054885|375132|P3|COMPLETED|24-week, Double-blind Treatment Period||155
155437|NCT01054885|375133|P2|COMPLETED|24-week, Double-blind Treatment Period||146
155438|NCT01054885|375134|P1|COMPLETED|24-week, Double-blind Treatment Period||0
155439|NCT01054885|375128|P7|STARTED|24-week, Double-blind Treatment Period||205
155440|NCT01054885|375129|P6|STARTED|24-week, Double-blind Treatment Period||204
155441|NCT01054885|375130|P5|STARTED|24-week, Double-blind Treatment Period||203
155442|NCT01054885|375131|P4|STARTED|24-week, Double-blind Treatment Period||203
155443|NCT01054885|375132|P3|STARTED|24-week, Double-blind Treatment Period||204
155444|NCT01054885|375133|P2|STARTED|24-week, Double-blind Treatment Period||205
155445|NCT01054885|375134|P1|STARTED|24-week, Double-blind Treatment Period||0
155446|NCT01054885|375128|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155447|NCT01054885|375129|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155448|NCT01054885|375130|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155449|NCT01054885|375131|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155450|NCT01054885|375132|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155451|NCT01054885|375133|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155452|NCT01054885|375134|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
155453|NCT01054885|375128|P7|COMPLETED|2-week, Single-blind Run-In Period||0
155454|NCT01054885|375129|P6|COMPLETED|2-week, Single-blind Run-In Period||0
155455|NCT01054885|375130|P5|COMPLETED|2-week, Single-blind Run-In Period||0
155456|NCT01054885|375131|P4|COMPLETED|2-week, Single-blind Run-In Period||0
155457|NCT01054885|375132|P3|COMPLETED|2-week, Single-blind Run-In Period||0
155458|NCT01054885|375133|P2|COMPLETED|2-week, Single-blind Run-In Period||0
155459|NCT01054885|375134|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
155460|NCT01054885|375128|P7|STARTED|2-week, Single-blind Run-In Period||0
155461|NCT01054885|375129|P6|STARTED|2-week, Single-blind Run-In Period||0
155462|NCT01054885|375130|P5|STARTED|2-week, Single-blind Run-In Period||0
155463|NCT01054885|375131|P4|STARTED|2-week, Single-blind Run-In Period||0
155464|NCT01054885|375132|P3|STARTED|2-week, Single-blind Run-In Period||0
155465|NCT01054885|375133|P2|STARTED|2-week, Single-blind Run-In Period||0
155466|NCT01054885|375134|P1|STARTED|2-week, Single-blind Run-In Period||1577
155467|NCT01054846|375174|P2|NOT COMPLETED|Overall Study||17
155468|NCT01054846|375175|P1|NOT COMPLETED|Overall Study||76
155469|NCT01054846|375174|P2|COMPLETED|Overall Study||51
155470|NCT01054846|375175|P1|COMPLETED|Overall Study||246
155471|NCT01054846|375174|P2|STARTED|Overall Study||68
155472|NCT01054846|375175|P1|STARTED|Overall Study||322
155473|NCT01054820|375182|P1|NOT COMPLETED|Overall Study||2
155474|NCT01054820|375182|P1|COMPLETED|Overall Study||121
155475|NCT01054820|375182|P1|STARTED|Overall Study||123
155476|NCT01054742|375196|P1|NOT COMPLETED|Overall Study||0
155477|NCT01054742|375196|P1|COMPLETED|Overall Study||2
155478|NCT01054742|375196|P1|STARTED|Overall Study||2
155479|NCT01054729|375204|P4|NOT COMPLETED|Overall Study||3
155480|NCT01054729|375205|P3|NOT COMPLETED|Overall Study||6
155481|NCT01054729|375206|P2|NOT COMPLETED|Overall Study||5
155482|NCT01054729|375207|P1|NOT COMPLETED|Overall Study||4
155483|NCT01054729|375204|P4|COMPLETED|Overall Study||11
155484|NCT01054729|375205|P3|COMPLETED|Overall Study||9
155485|NCT01054729|375206|P2|COMPLETED|Overall Study||14
155486|NCT01054729|375207|P1|COMPLETED|Overall Study||12
155487|NCT01054729|375204|P4|Randomized and Treated|Overall Study||14
155488|NCT01054729|375205|P3|Randomized and Treated|Overall Study||15
155489|NCT01054729|375206|P2|Randomized and Treated|Overall Study||18
155490|NCT01054729|375207|P1|Randomized and Treated|Overall Study||16
155491|NCT01054729|375204|P4|STARTED|Overall Study||14
155492|NCT01054729|375205|P3|STARTED|Overall Study||15
155493|NCT01054729|375206|P2|STARTED|Overall Study||19
155494|NCT01054729|375207|P1|STARTED|Overall Study||16
155495|NCT01054703|375268|P1|NOT COMPLETED|Overall Study||0
155496|NCT01054703|375268|P1|COMPLETED|Overall Study||14
155497|NCT01054703|375268|P1|STARTED|Overall Study||14
155498|NCT01054625|375275|P3|NOT COMPLETED|Overall Study||1
155499|NCT01054625|375276|P2|NOT COMPLETED|Overall Study||3
155500|NCT01054625|375277|P1|NOT COMPLETED|Overall Study||2
155501|NCT01054625|375275|P3|COMPLETED|Overall Study||9
155502|NCT01054625|375276|P2|COMPLETED|Overall Study||9
155503|NCT01054625|375277|P1|COMPLETED|Overall Study||6
155504|NCT01054625|375275|P3|STARTED|Overall Study||10
155505|NCT01054625|375276|P2|STARTED|Overall Study||12
155506|NCT01054625|375277|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
155507|NCT01054599|375305|P2|NOT COMPLETED|Overall Study||7
155508|NCT01054599|375306|P1|NOT COMPLETED|Overall Study||4
155509|NCT01054599|375305|P2|COMPLETED|Overall Study||9
155510|NCT01054599|375306|P1|COMPLETED|Overall Study||9
155511|NCT01054599|375305|P2|STARTED|Overall Study||16
155512|NCT01054599|375306|P1|STARTED|Overall Study||13
155513|NCT01054586|375318|P4|NOT COMPLETED|Overall Study||0
155514|NCT01054586|375319|P3|NOT COMPLETED|Overall Study||0
155515|NCT01054586|375320|P2|NOT COMPLETED|Overall Study||0
155516|NCT01054586|375321|P1|NOT COMPLETED|Overall Study||0
155517|NCT01054586|375318|P4|COMPLETED|Overall Study||101
155518|NCT01054586|375319|P3|COMPLETED|Overall Study||8
155519|NCT01054586|375320|P2|COMPLETED|Overall Study||15
155520|NCT01054586|375321|P1|COMPLETED|Overall Study||43
155521|NCT01054586|375318|P4|STARTED|Overall Study||101
155522|NCT01054586|375319|P3|STARTED|Overall Study||8
155523|NCT01054586|375320|P2|STARTED|Overall Study||15
155524|NCT01054586|375321|P1|STARTED|Overall Study||43
155525|NCT01054573|375413|P4|NOT COMPLETED|Overall Study||2
155526|NCT01054573|375414|P3|NOT COMPLETED|Overall Study||3
155527|NCT01054573|375415|P2|NOT COMPLETED|Overall Study||4
155528|NCT01054573|375416|P1|NOT COMPLETED|Overall Study||1
155529|NCT01054573|375413|P4|COMPLETED|Overall Study||25
155530|NCT01054573|375414|P3|COMPLETED|Overall Study||19
155531|NCT01054573|375415|P2|COMPLETED|Overall Study||28
155532|NCT01054573|375416|P1|COMPLETED|Overall Study||8
155533|NCT01054573|375413|P4|STARTED|Overall Study||27
155534|NCT01054573|375414|P3|STARTED|Overall Study||22
155535|NCT01054573|375415|P2|STARTED|Overall Study||32
155536|NCT01054573|375416|P1|STARTED|Overall Study||9
155537|NCT01054560|375462|P2|NOT COMPLETED|Overall Study||28
155538|NCT01054560|375463|P1|NOT COMPLETED|Overall Study||13
155539|NCT01054560|375462|P2|COMPLETED|Overall Study||27
155540|NCT01054560|375463|P1|COMPLETED|Overall Study||45
155541|NCT01054560|375462|P2|STARTED|Overall Study||55
155542|NCT01054560|375463|P1|STARTED|Overall Study||58
155543|NCT01054404|375487|P2|NOT COMPLETED|Overall Study||0
155544|NCT01054404|375488|P1|NOT COMPLETED|Overall Study||0
155545|NCT01054404|375487|P2|COMPLETED|Overall Study||13
155546|NCT01054404|375488|P1|COMPLETED|Overall Study||10
155547|NCT01054404|375487|P2|STARTED|Overall Study||13
155548|NCT01054404|375488|P1|STARTED|Overall Study||10
155549|NCT01054339|375497|P3|NOT COMPLETED|Overall Study||0
155550|NCT01054339|375498|P2|NOT COMPLETED|Overall Study||0
155551|NCT01054339|375499|P1|NOT COMPLETED|Overall Study||0
155552|NCT01054339|375497|P3|COMPLETED|Overall Study||3
155553|NCT01054339|375498|P2|COMPLETED|Overall Study||3
155554|NCT01054339|375499|P1|COMPLETED|Overall Study||3
155555|NCT01054339|375497|P3|STARTED|Overall Study||3
155556|NCT01054339|375498|P2|STARTED|Overall Study||3
155557|NCT01054339|375499|P1|STARTED|Overall Study||3
155558|NCT01054222|375513|P1|NOT COMPLETED|Overall Study||11
155559|NCT01054222|375513|P1|COMPLETED|Overall Study||20
155560|NCT01054222|375513|P1|STARTED|Overall Study||31
155561|NCT01054183|375534|P2|NOT COMPLETED|Overall Study||0
155562|NCT01054183|375535|P1|NOT COMPLETED|Overall Study||0
155563|NCT01054183|375534|P2|COMPLETED|Overall Study||12
155564|NCT01054183|375535|P1|COMPLETED|Overall Study||10
155565|NCT01054183|375534|P2|STARTED|Overall Study||12
155566|NCT01054183|375535|P1|STARTED|Overall Study||10
155567|NCT01054170|375545|P2|NOT COMPLETED|Overall Study||6
155568|NCT01054170|375546|P1|NOT COMPLETED|Overall Study||4
155569|NCT01054170|375545|P2|COMPLETED|Overall Study||21
155570|NCT01054170|375546|P1|COMPLETED|Overall Study||21
155571|NCT01054170|375545|P2|STARTED|Overall Study||27
155572|NCT01054170|375546|P1|STARTED|Overall Study||25
155573|NCT01054079|375598|P1|NOT COMPLETED|Overall Study||0
155574|NCT01054079|375598|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
155575|NCT01054079|375598|P1|# Recieved Proper PSA Testing|Overall Study||10
155576|NCT01054079|375598|P1|STARTED|Overall Study||20
155577|NCT01053988|375611|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
155578|NCT01053988|375612|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
155579|NCT01053988|375613|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
155580|NCT01053988|375614|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
155581|NCT01053988|375615|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
155582|NCT01053988|375616|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
155583|NCT01053988|375611|P6|COMPLETED|24-week, Double-blind Treatment Period||151
155584|NCT01053988|375612|P5|COMPLETED|24-week, Double-blind Treatment Period||147
155585|NCT01053988|375613|P4|COMPLETED|24-week, Double-blind Treatment Period||142
155586|NCT01053988|375614|P3|COMPLETED|24-week, Double-blind Treatment Period||145
155587|NCT01053988|375615|P2|COMPLETED|24-week, Double-blind Treatment Period||138
155588|NCT01053988|375616|P1|COMPLETED|24-week, Double-blind Treatment Period||0
155589|NCT01053988|375611|P6|STARTED|24-week, Double-blind Treatment Period||206
155590|NCT01053988|375612|P5|STARTED|24-week, Double-blind Treatment Period||206
155591|NCT01053988|375613|P4|STARTED|24-week, Double-blind Treatment Period||205
155592|NCT01053988|375614|P3|STARTED|24-week, Double-blind Treatment Period||206
155593|NCT01053988|375615|P2|STARTED|24-week, Double-blind Treatment Period||207
155594|NCT01053988|375616|P1|STARTED|24-week, Double-blind Treatment Period||0
155595|NCT01053988|375611|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155596|NCT01053988|375612|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155597|NCT01053988|375613|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155598|NCT01053988|375614|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155599|NCT01053988|375615|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
155600|NCT01053988|375616|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
155601|NCT01053988|375611|P6|COMPLETED|2-week, Single-blind Run-In Period||0
155602|NCT01053988|375612|P5|COMPLETED|2-week, Single-blind Run-In Period||0
155603|NCT01053988|375613|P4|COMPLETED|2-week, Single-blind Run-In Period||0
155604|NCT01053988|375614|P3|COMPLETED|2-week, Single-blind Run-In Period||0
155605|NCT01053988|375615|P2|COMPLETED|2-week, Single-blind Run-In Period||0
155606|NCT01053988|375616|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
155607|NCT01053988|375611|P6|STARTED|2-week, Single-blind Run-In Period||0
155608|NCT01053988|375612|P5|STARTED|2-week, Single-blind Run-In Period||0
155609|NCT01053988|375613|P4|STARTED|2-week, Single-blind Run-In Period||0
155610|NCT01053988|375614|P3|STARTED|2-week, Single-blind Run-In Period||0
155611|NCT01053988|375615|P2|STARTED|2-week, Single-blind Run-In Period||0
155612|NCT01053988|375616|P1|STARTED|2-week, Single-blind Run-In Period||1390
155613|NCT01053897|375648|P1|NOT COMPLETED|Overall Study||0
155614|NCT01053897|375648|P1|COMPLETED|Overall Study||5
155615|NCT01053897|375648|P1|STARTED|Overall Study||5
155616|NCT01053819|375660|P1|NOT COMPLETED|Overall Study||0
155617|NCT01053819|375660|P1|COMPLETED|Overall Study||6
155618|NCT01053819|375660|P1|STARTED|Overall Study||6
155619|NCT01053741|375667|P2|NOT COMPLETED|2nd Study Intervention||1
155620|NCT01053741|375668|P1|NOT COMPLETED|2nd Study Intervention||0
155621|NCT01053741|375667|P2|COMPLETED|2nd Study Intervention||5
155622|NCT01053741|375668|P1|COMPLETED|2nd Study Intervention||5
155623|NCT01053741|375667|P2|STARTED|2nd Study Intervention||6
155624|NCT01053741|375668|P1|STARTED|2nd Study Intervention||5
155625|NCT01053741|375667|P2|NOT COMPLETED|14 Day Washout||0
155626|NCT01053741|375668|P1|NOT COMPLETED|14 Day Washout||0
155627|NCT01053741|375667|P2|COMPLETED|14 Day Washout||6
155628|NCT01053741|375668|P1|COMPLETED|14 Day Washout||5
155629|NCT01053741|375667|P2|STARTED|14 Day Washout||6
155630|NCT01053741|375668|P1|STARTED|14 Day Washout||5
155631|NCT01053741|375667|P2|NOT COMPLETED|1st Intervention||0
155632|NCT01053741|375668|P1|NOT COMPLETED|1st Intervention||0
155633|NCT01053741|375667|P2|COMPLETED|1st Intervention||6
155634|NCT01053741|375668|P1|COMPLETED|1st Intervention||5
155635|NCT01053741|375667|P2|STARTED|1st Intervention||6
155636|NCT01053741|375668|P1|STARTED|1st Intervention||5
155637|NCT01053663|375677|P1|NOT COMPLETED|Overall Study||6
155638|NCT01053663|375677|P1|COMPLETED|Overall Study||3
155639|NCT01053663|375677|P1|STARTED|Overall Study||9
155640|NCT01053507|375720|P2|NOT COMPLETED|Overall Study||1
155641|NCT01053507|375721|P1|NOT COMPLETED|Overall Study||3
155642|NCT01053507|375720|P2|COMPLETED|Overall Study||11
155643|NCT01053507|375721|P1|COMPLETED|Overall Study||8
155644|NCT01053507|375720|P2|STARTED|Overall Study||12
155645|NCT01053507|375721|P1|STARTED|Overall Study||11
155646|NCT01053429|375735|P1|NOT COMPLETED|Overall Study||373
155647|NCT01053429|375735|P1|COMPLETED|Overall Study||3018
155648|NCT01053429|375735|P1|STARTED|Overall Study||3391
155649|NCT01053312|375744|P1|NOT COMPLETED|Overall Study||0
155650|NCT01053312|375744|P1|COMPLETED|Overall Study||7
155651|NCT01053312|375744|P1|STARTED|Overall Study||7
155652|NCT01053247|375765|P3|NOT COMPLETED|Overall Study||28
155653|NCT01053247|375766|P2|NOT COMPLETED|Overall Study||19
155654|NCT01053247|375767|P1|NOT COMPLETED|Overall Study||20
155655|NCT01053247|375765|P3|COMPLETED|Overall Study||236
155656|NCT01053247|375766|P2|COMPLETED|Overall Study||241
155657|NCT01053247|375767|P1|COMPLETED|Overall Study||249
155658|NCT01053247|375765|P3|STARTED|Overall Study||264
155659|NCT01053247|375766|P2|STARTED|Overall Study||260
155660|NCT01053247|375767|P1|STARTED|Overall Study||269
155661|NCT01053156|375777|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
155662|NCT01053156|375778|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
155663|NCT01053156|375777|P2|COMPLETED|Second Intervention (Week 13-24)||22
155664|NCT01053156|375778|P1|COMPLETED|Second Intervention (Week 13-24)||26
155665|NCT01053156|375777|P2|STARTED|Second Intervention (Week 13-24)||27
155666|NCT01053156|375778|P1|STARTED|Second Intervention (Week 13-24)||28
155667|NCT01053156|375777|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
155668|NCT01053156|375778|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
155669|NCT01053156|375777|P2|COMPLETED|First Intervention (Week 1-12)||27
155670|NCT01053156|375778|P1|COMPLETED|First Intervention (Week 1-12)||28
155671|NCT01053156|375777|P2|STARTED|First Intervention (Week 1-12)||33
155672|NCT01053156|375778|P1|STARTED|First Intervention (Week 1-12)||33
155673|NCT01053078|375816|P2|NOT COMPLETED|Overall Study||3
155674|NCT01053078|375817|P1|NOT COMPLETED|Overall Study||4
155675|NCT01053078|375816|P2|COMPLETED|Overall Study||12
155676|NCT01053078|375817|P1|COMPLETED|Overall Study||10
155677|NCT01053078|375816|P2|STARTED|Overall Study||15
155678|NCT01053078|375817|P1|STARTED|Overall Study||14
155679|NCT01053000|375823|P2|NOT COMPLETED|Overall Study||0
155680|NCT01053000|375824|P1|NOT COMPLETED|Overall Study||0
155681|NCT01053000|375823|P2|COMPLETED|Overall Study||5
155682|NCT01053000|375824|P1|COMPLETED|Overall Study||5
155683|NCT01053000|375823|P2|STARTED|Overall Study||5
155684|NCT01053000|375824|P1|STARTED|Overall Study||5
155685|NCT01052948|375834|P4|NOT COMPLETED|Overall Study||0
155686|NCT01052948|375835|P3|NOT COMPLETED|Overall Study||0
155687|NCT01052948|375836|P2|NOT COMPLETED|Overall Study||0
155688|NCT01052948|375837|P1|NOT COMPLETED|Overall Study||0
155689|NCT01052948|375834|P4|COMPLETED|Overall Study||29311
155690|NCT01052948|375835|P3|COMPLETED|Overall Study||15147
155691|NCT01052948|375836|P2|COMPLETED|Overall Study||14669
155692|NCT01052948|375837|P1|COMPLETED|Overall Study||27812
155693|NCT01052948|375834|P4|STARTED|Overall Study||29311
155694|NCT01052948|375835|P3|STARTED|Overall Study||15147
155695|NCT01052948|375836|P2|STARTED|Overall Study||14669
155696|NCT01052948|375837|P1|STARTED|Overall Study||27812
155697|NCT01052844|375861|P2|NOT COMPLETED|Overall Study||1
155698|NCT01052844|375862|P1|NOT COMPLETED|Overall Study||0
155699|NCT01052844|375861|P2|COMPLETED|Overall Study||39
155700|NCT01052844|375862|P1|COMPLETED|Overall Study||40
155701|NCT01052844|375861|P2|STARTED|Overall Study||40
155702|NCT01052844|375862|P1|STARTED|Overall Study||40
155703|NCT01052831|375872|P2|NOT COMPLETED|Overall Study||1
155704|NCT01052831|375873|P1|NOT COMPLETED|Overall Study||4
155705|NCT01052831|375872|P2|COMPLETED|Overall Study||23
155706|NCT01052831|375873|P1|COMPLETED|Overall Study||22
155707|NCT01052831|375872|P2|STARTED|Overall Study||24
155708|NCT01052831|375873|P1|STARTED|Overall Study||26
155709|NCT01052779|375883|P2|NOT COMPLETED|Overall Study||9
155710|NCT01052779|375884|P1|NOT COMPLETED|Overall Study||5
155711|NCT01052779|375883|P2|COMPLETED|Overall Study||73
155712|NCT01052779|375884|P1|COMPLETED|Overall Study||75
155713|NCT01052779|375883|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
155714|NCT01052779|375884|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
155715|NCT01052779|375883|P2|STARTED|Overall Study||82
155716|NCT01052779|375884|P1|STARTED|Overall Study||80
155717|NCT01052714|375894|P3|NOT COMPLETED|Overall Study||2
155718|NCT01052714|375895|P2|NOT COMPLETED|Overall Study||29
155719|NCT01052714|375896|P1|NOT COMPLETED|Overall Study||25
155720|NCT01052714|375894|P3|COMPLETED|Overall Study||15
155721|NCT01052714|375895|P2|COMPLETED|Overall Study||33
155722|NCT01052714|375896|P1|COMPLETED|Overall Study||17
155723|NCT01052714|375894|P3|STARTED|Overall Study||17
155724|NCT01052714|375895|P2|STARTED|Overall Study||62
155725|NCT01052714|375896|P1|STARTED|Overall Study||42
155726|NCT01052701|375938|P2|NOT COMPLETED|Overall Study||0
155727|NCT01052701|375939|P1|NOT COMPLETED|Overall Study||0
155728|NCT01052701|375938|P2|COMPLETED|Overall Study||12
155729|NCT01052701|375939|P1|COMPLETED|Overall Study||14
155730|NCT01052701|375938|P2|STARTED|Overall Study||12
155731|NCT01052701|375939|P1|STARTED|Overall Study||14
155732|NCT01052662|375950|P3|NOT COMPLETED|Overall Study||22
155733|NCT01052662|375951|P2|NOT COMPLETED|Overall Study||22
155734|NCT01052662|375952|P1|NOT COMPLETED|Overall Study||22
155735|NCT01052662|375950|P3|COMPLETED|Overall Study||10
155736|NCT01052662|375951|P2|COMPLETED|Overall Study||5
155737|NCT01052662|375952|P1|COMPLETED|Overall Study||6
155738|NCT01052662|375950|P3|Discontinuation Phase|Overall Study||10
155739|NCT01052662|375951|P2|Discontinuation Phase|Overall Study||5
155740|NCT01052662|375952|P1|Discontinuation Phase|Overall Study||6
155741|NCT01052662|375950|P3|Stabilization Phase|Overall Study||26
155742|NCT01052662|375951|P2|Stabilization Phase|Overall Study||21
155743|NCT01052662|375952|P1|Stabilization Phase|Overall Study||21
155744|NCT01052662|375950|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
155745|NCT01052662|375951|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
155746|NCT01052662|375952|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
155747|NCT01052545|375968|P2|NOT COMPLETED|Overall Study||0
155748|NCT01052545|375969|P1|NOT COMPLETED|Overall Study||0
155749|NCT01052545|375968|P2|COMPLETED|Overall Study||731
155750|NCT01052545|375969|P1|COMPLETED|Overall Study||867
155751|NCT01052545|375968|P2|STARTED|Overall Study||731
155752|NCT01052545|375969|P1|STARTED|Overall Study||867
155753|NCT01052480|375983|P2|NOT COMPLETED|Overall Study||17
155754|NCT01052480|375984|P1|NOT COMPLETED|Overall Study||8
155755|NCT01052480|375983|P2|COMPLETED|Overall Study||32
155756|NCT01052480|375984|P1|COMPLETED|Overall Study||41
155757|NCT01052480|375983|P2|STARTED|Overall Study||49
155758|NCT01052480|375984|P1|STARTED|Overall Study||49
155759|NCT01052428|376034|P2|NOT COMPLETED|Overall Study||1
155760|NCT01052428|376035|P1|NOT COMPLETED|Overall Study||1
155761|NCT01052428|376034|P2|COMPLETED|Overall Study||18
155762|NCT01052428|376035|P1|COMPLETED|Overall Study||18
155763|NCT01052428|376034|P2|STARTED|Overall Study||19
155764|NCT01052428|376035|P1|STARTED|Overall Study||19
155765|NCT01052272|376057|P4|NOT COMPLETED|Overall Study||7
155766|NCT01052272|376058|P3|NOT COMPLETED|Overall Study||8
155767|NCT01052272|376059|P2|NOT COMPLETED|Overall Study||7
155768|NCT01052272|376060|P1|NOT COMPLETED|Overall Study||5
155769|NCT01052272|376057|P4|COMPLETED|Overall Study||11
155770|NCT01052272|376058|P3|COMPLETED|Overall Study||10
155771|NCT01052272|376059|P2|COMPLETED|Overall Study||11
155772|NCT01052272|376060|P1|COMPLETED|Overall Study||13
155773|NCT01052272|376057|P4|STARTED|Overall Study||18
155774|NCT01052272|376058|P3|STARTED|Overall Study||18
155775|NCT01052272|376059|P2|STARTED|Overall Study||18
155776|NCT01052272|376060|P1|STARTED|Overall Study||18
155777|NCT01052207|376096|P2|NOT COMPLETED|Overall Study||0
155778|NCT01052207|376097|P1|NOT COMPLETED|Overall Study||0
155779|NCT01052207|376096|P2|COMPLETED|Overall Study||42
155780|NCT01052207|376097|P1|COMPLETED|Overall Study||60
155781|NCT01052207|376096|P2|STARTED|Overall Study||42
155782|NCT01052207|376097|P1|STARTED|Overall Study||60
155783|NCT01052116|376105|P2|NOT COMPLETED|Overall Study||27
155784|NCT01052116|376106|P1|NOT COMPLETED|Overall Study||14
155785|NCT01052116|376105|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
155786|NCT01052116|376106|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
155787|NCT01052116|376105|P2|STARTED|Overall Study||193
155788|NCT01052116|376106|P1|STARTED|Overall Study||193
155789|NCT01052077|376114|P4|NOT COMPLETED|Phase A+||21
155790|NCT01052077|376115|P3|NOT COMPLETED|Phase A+||0
155791|NCT01052077|376116|P2|NOT COMPLETED|Phase A+||0
155792|NCT01052077|376117|P1|NOT COMPLETED|Phase A+||0
155793|NCT01052077|376114|P4|COMPLETED|Phase A+||230
155794|NCT01052077|376115|P3|COMPLETED|Phase A+||0
155795|NCT01052077|376116|P2|COMPLETED|Phase A+||0
155796|NCT01052077|376117|P1|COMPLETED|Phase A+||0
155797|NCT01052077|376114|P4|STARTED|Phase A+||251
155798|NCT01052077|376115|P3|STARTED|Phase A+||0
155799|NCT01052077|376116|P2|STARTED|Phase A+||0
155800|NCT01052077|376117|P1|STARTED|Phase A+||0
155801|NCT01052077|376114|P4|NOT COMPLETED|Phase B||0
155802|NCT01052077|376115|P3|NOT COMPLETED|Phase B||16
155803|NCT01052077|376116|P2|NOT COMPLETED|Phase B||18
155804|NCT01052077|376117|P1|NOT COMPLETED|Phase B||0
155805|NCT01052077|376114|P4|COMPLETED|Phase B||0
155806|NCT01052077|376115|P3|COMPLETED|Phase B||171
155807|NCT01052077|376116|P2|COMPLETED|Phase B||167
155808|NCT01052077|376117|P1|COMPLETED|Phase B||0
155809|NCT01052077|376114|P4|STARTED|Phase B||0
155810|NCT01052077|376115|P3|STARTED|Phase B||187
155811|NCT01052077|376116|P2|STARTED|Phase B||185
155812|NCT01052077|376117|P1|STARTED|Phase B||0
155813|NCT01052077|376114|P4|NOT COMPLETED|Phase A||0
155814|NCT01052077|376115|P3|NOT COMPLETED|Phase A||0
155815|NCT01052077|376116|P2|NOT COMPLETED|Phase A||0
155816|NCT01052077|376117|P1|NOT COMPLETED|Phase A||146
155817|NCT01052077|376114|P4|COMPLETED|Phase A||0
155818|NCT01052077|376115|P3|COMPLETED|Phase A||0
155819|NCT01052077|376116|P2|COMPLETED|Phase A||0
155820|NCT01052077|376117|P1|COMPLETED|Phase A||623
155821|NCT01052077|376114|P4|STARTED|Phase A||0
155822|NCT01052077|376115|P3|STARTED|Phase A||0
155823|NCT01052077|376116|P2|STARTED|Phase A||0
155824|NCT01052077|376117|P1|STARTED|Phase A||769
155825|NCT01052038|376144|P3|NOT COMPLETED|Overall Study||4
155826|NCT01052038|376145|P2|NOT COMPLETED|Overall Study||6
155827|NCT01052038|376146|P1|NOT COMPLETED|Overall Study||4
155828|NCT01052038|376144|P3|COMPLETED|Overall Study||36
155829|NCT01052038|376145|P2|COMPLETED|Overall Study||34
155830|NCT01052038|376146|P1|COMPLETED|Overall Study||36
155831|NCT01052038|376144|P3|STARTED|Overall Study||40
155832|NCT01052038|376145|P2|STARTED|Overall Study||40
155833|NCT01052038|376146|P1|STARTED|Overall Study||40
155834|NCT01051986|376168|P2|NOT COMPLETED|Overall Study||4
155835|NCT01051986|376169|P1|NOT COMPLETED|Overall Study||5
155836|NCT01051986|376168|P2|COMPLETED|Overall Study||108
155837|NCT01051986|376169|P1|COMPLETED|Overall Study||107
155838|NCT01051986|376168|P2|STARTED|Overall Study||112
155839|NCT01051986|376169|P1|STARTED|Overall Study||112
155840|NCT01051921|376183|P1|NOT COMPLETED|Overall Study||30
155841|NCT01051921|376183|P1|COMPLETED|Overall Study||37
155842|NCT01051921|376183|P1|STARTED|Overall Study||67
155843|NCT01051856|376190|P2|NOT COMPLETED|Overall Study||0
155844|NCT01051856|376191|P1|NOT COMPLETED|Overall Study||1
155845|NCT01051856|376190|P2|COMPLETED|Overall Study||35
155846|NCT01051856|376191|P1|COMPLETED|Overall Study||32
155847|NCT01051856|376190|P2|STARTED|Overall Study||35
155848|NCT01051856|376191|P1|STARTED|Overall Study||33
155849|NCT01051817|376201|P2|NOT COMPLETED|Overall Study||9
155850|NCT01051817|376202|P1|NOT COMPLETED|Overall Study||3
155851|NCT01051817|376201|P2|COMPLETED|Overall Study||26
155852|NCT01051817|376202|P1|COMPLETED|Overall Study||35
155853|NCT01051817|376201|P2|STARTED|Overall Study||35
155854|NCT01051817|376202|P1|STARTED|Overall Study||38
155855|NCT01051791|376212|P1|NOT COMPLETED|Overall Study||4
155856|NCT01051791|376212|P1|COMPLETED|Overall Study||9
155857|NCT01051791|376212|P1|STARTED|Overall Study||13
155858|NCT01051778|376221|P2|NOT COMPLETED|Overall Study||0
155859|NCT01051778|376222|P1|NOT COMPLETED|Overall Study||0
155860|NCT01051778|376221|P2|COMPLETED|Overall Study|November 2009|30
155861|NCT01051778|376222|P1|COMPLETED|Overall Study|November 2009|30
155862|NCT01051778|376221|P2|STARTED|Overall Study|June 2006|30
155863|NCT01051778|376222|P1|STARTED|Overall Study|June 2006|30
155864|NCT01051739|376230|P2|NOT COMPLETED|Overall Study||13
155865|NCT01051739|376231|P1|NOT COMPLETED|Overall Study||28
155866|NCT01051739|376230|P2|COMPLETED|Overall Study||47
155867|NCT01051739|376231|P1|COMPLETED|Overall Study||92
155868|NCT01051739|376230|P2|STARTED|Overall Study||60
155869|NCT01051739|376231|P1|STARTED|Overall Study||120
155870|NCT01051570|376237|P1|NOT COMPLETED|Overall Study||0
155871|NCT01051570|376237|P1|COMPLETED|Overall Study||26
155872|NCT01051570|376237|P1|STARTED|Overall Study||26
155873|NCT01051557|376248|P7|NOT COMPLETED|Overall Study||6
155874|NCT01051557|376249|P6|NOT COMPLETED|Overall Study||6
155875|NCT01051557|376250|P5|NOT COMPLETED|Overall Study||7
155876|NCT01051557|376251|P4|NOT COMPLETED|Overall Study||3
155877|NCT01051557|376252|P3|NOT COMPLETED|Overall Study||6
155878|NCT01051557|376253|P2|NOT COMPLETED|Overall Study||3
155879|NCT01051557|376254|P1|NOT COMPLETED|Overall Study||4
155880|NCT01051557|376248|P7|COMPLETED|Overall Study||0
155881|NCT01051557|376249|P6|COMPLETED|Overall Study||0
155882|NCT01051557|376250|P5|COMPLETED|Overall Study||1
155883|NCT01051557|376251|P4|COMPLETED|Overall Study||0
155884|NCT01051557|376252|P3|COMPLETED|Overall Study||0
155885|NCT01051557|376253|P2|COMPLETED|Overall Study||0
155886|NCT01051557|376254|P1|COMPLETED|Overall Study||0
155887|NCT01051557|376248|P7|STARTED|Overall Study||6
155888|NCT01051557|376249|P6|STARTED|Overall Study||6
155889|NCT01051557|376250|P5|STARTED|Overall Study||8
155890|NCT01051557|376251|P4|STARTED|Overall Study||3
155891|NCT01051557|376252|P3|STARTED|Overall Study||6
155892|NCT01051557|376253|P2|STARTED|Overall Study||3
155893|NCT01051557|376254|P1|STARTED|Overall Study||4
155894|NCT01051466|376273|P2|NOT COMPLETED|Overall Study||5
155895|NCT01051466|376274|P1|NOT COMPLETED|Overall Study||8
155896|NCT01051466|376273|P2|COMPLETED|Overall Study||23
155897|NCT01051466|376274|P1|COMPLETED|Overall Study||24
155898|NCT01051466|376273|P2|STARTED|Overall Study||28
155899|NCT01051466|376274|P1|STARTED|Overall Study||32
155900|NCT01051440|376308|P2|NOT COMPLETED|Overall Study||0
155901|NCT01051440|376309|P1|NOT COMPLETED|Overall Study||0
155902|NCT01051440|376308|P2|COMPLETED|Overall Study||1
155903|NCT01051440|376309|P1|COMPLETED|Overall Study||1
155904|NCT01051440|376308|P2|STARTED|Overall Study||1
155905|NCT01051440|376309|P1|STARTED|Overall Study||1
155906|NCT01051323|376321|P1|NOT COMPLETED|Overall Study||539
155907|NCT01051323|376321|P1|COMPLETED|Overall Study||1041
155908|NCT01051323|376321|P1|Received at Least One Dose|Overall Study||1547
155909|NCT01051323|376321|P1|STARTED|Overall Study||1580
155910|NCT01050998|376348|P5|NOT COMPLETED|Overall Study||14
155911|NCT01050998|376349|P4|NOT COMPLETED|Overall Study||3
155912|NCT01050998|376350|P3|NOT COMPLETED|Overall Study||3
155913|NCT01050998|376351|P2|NOT COMPLETED|Overall Study||2
155914|NCT01050998|376352|P1|NOT COMPLETED|Overall Study||4
155915|NCT01050998|376348|P5|COMPLETED|Overall Study||82
155916|NCT01050998|376349|P4|COMPLETED|Overall Study||45
155917|NCT01050998|376350|P3|COMPLETED|Overall Study||46
155918|NCT01050998|376351|P2|COMPLETED|Overall Study||47
155919|NCT01050998|376352|P1|COMPLETED|Overall Study||44
155920|NCT01050998|376348|P5|STARTED|Overall Study||96
155921|NCT01050998|376349|P4|STARTED|Overall Study||48
155922|NCT01050998|376350|P3|STARTED|Overall Study||49
155923|NCT01050998|376351|P2|STARTED|Overall Study||49
155924|NCT01050998|376352|P1|STARTED|Overall Study||48
155925|NCT01050946|376676|P1|NOT COMPLETED|Overall Study||0
155926|NCT01050946|376676|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
155927|NCT01050946|376676|P1|STARTED|Overall Study||1
155928|NCT01050816|376686|P1|NOT COMPLETED|Overall Study||4
155929|NCT01050816|376686|P1|COMPLETED|Overall Study||26
155930|NCT01050816|376686|P1|STARTED|Overall Study||30
155931|NCT01050790|376692|P1|NOT COMPLETED|Overall Study||1
155932|NCT01050790|376692|P1|COMPLETED|Overall Study||16
155933|NCT01050790|376692|P1|STARTED|Overall Study||17
155934|NCT01050764|376702|P1|NOT COMPLETED|Overall Study||3
155935|NCT01050764|376702|P1|COMPLETED|Overall Study||7
155936|NCT01050764|376702|P1|Received Infusion of T-con Cells|Overall Study||7
155937|NCT01050764|376702|P1|Received Infusion of T-reg Cells|Overall Study||7
155938|NCT01050764|376702|P1|Received HSCT Graft|Overall Study||8
155939|NCT01050764|376702|P1|STARTED|Overall Study||10
155940|NCT01050673|376713|P2|NOT COMPLETED|Overall Study||5
155941|NCT01050673|376714|P1|NOT COMPLETED|Overall Study||4
155942|NCT01050673|376713|P2|COMPLETED|Overall Study||14
155943|NCT01050673|376714|P1|COMPLETED|Overall Study||17
155944|NCT01050673|376713|P2|STARTED|Overall Study||19
155945|NCT01050673|376714|P1|STARTED|Overall Study||21
155946|NCT01050660|376738|P2|NOT COMPLETED|Overall Study||0
155947|NCT01050660|376739|P1|NOT COMPLETED|Overall Study||0
155948|NCT01050660|376738|P2|COMPLETED|Overall Study||69
155949|NCT01050660|376739|P1|COMPLETED|Overall Study||67
155950|NCT01050660|376738|P2|STARTED|Overall Study||69
155951|NCT01050660|376739|P1|STARTED|Overall Study||67
155952|NCT01050647|376765|P2|NOT COMPLETED|Overall Study||0
155953|NCT01050647|376766|P1|NOT COMPLETED|Overall Study||0
155954|NCT01050647|376765|P2|COMPLETED|Overall Study||11
155955|NCT01050647|376766|P1|COMPLETED|Overall Study||10
155956|NCT01050647|376765|P2|STARTED|Overall Study||11
155957|NCT01050647|376766|P1|STARTED|Overall Study||10
155958|NCT01050634|376782|P1|NOT COMPLETED|Overall Study||128
155959|NCT01050634|376782|P1|COMPLETED|Overall Study||852
155960|NCT01050634|376782|P1|Received Treatment|Overall Study||924
155961|NCT01050634|376782|P1|STARTED|Overall Study||980
155962|NCT01050582|376792|P2|NOT COMPLETED|Overall Study||0
155963|NCT01050582|376793|P1|NOT COMPLETED|Overall Study||0
155964|NCT01050582|376792|P2|COMPLETED|Overall Study||51
155965|NCT01050582|376793|P1|COMPLETED|Overall Study||133
155966|NCT01050582|376792|P2|STARTED|Overall Study||51
155967|NCT01050582|376793|P1|STARTED|Overall Study||133
155968|NCT01050569|376806|P3|NOT COMPLETED|Overall Study||33
155969|NCT01050569|376807|P2|NOT COMPLETED|Overall Study||24
155970|NCT01050569|376808|P1|NOT COMPLETED|Overall Study||38
155971|NCT01050569|376806|P3|COMPLETED|Overall Study||47
155972|NCT01050569|376807|P2|COMPLETED|Overall Study||52
155973|NCT01050569|376808|P1|COMPLETED|Overall Study||41
155974|NCT01050569|376806|P3|STARTED|Overall Study||80
155975|NCT01050569|376807|P2|STARTED|Overall Study||76
155976|NCT01050569|376808|P1|STARTED|Overall Study||79
155977|NCT01050543|376827|P2|NOT COMPLETED|Overall Study||4
155978|NCT01050543|376828|P1|NOT COMPLETED|Overall Study||4
155979|NCT01050543|376827|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
155980|NCT01050543|376828|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
155981|NCT01050543|376827|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
155982|NCT01050543|376828|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
155983|NCT01050530|376836|P2|NOT COMPLETED|Overall Study||10
155984|NCT01050530|376837|P1|NOT COMPLETED|Overall Study||8
155985|NCT01050530|376836|P2|COMPLETED|Overall Study||70
155986|NCT01050530|376837|P1|COMPLETED|Overall Study||74
155987|NCT01050530|376836|P2|STARTED|Overall Study||80
155988|NCT01050530|376837|P1|STARTED|Overall Study||82
155989|NCT01050257|376848|P3|NOT COMPLETED|Overall Study||7
155990|NCT01050257|376849|P2|NOT COMPLETED|Overall Study||13
155991|NCT01050257|376850|P1|NOT COMPLETED|Overall Study||11
155992|NCT01050257|376848|P3|COMPLETED|Overall Study||8
155993|NCT01050257|376849|P2|COMPLETED|Overall Study||40
155994|NCT01050257|376850|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
155995|NCT01050257|376848|P3|Switched to Oral Treatment|Overall Study||3
155996|NCT01050257|376849|P2|Switched to Oral Treatment|Overall Study||31
155997|NCT01050257|376850|P1|Switched to Oral Treatment|Overall Study||28
155998|NCT01050257|376848|P3|Intent-to-treat Infected Confirmed|Overall Study||10
155999|NCT01050257|376849|P2|Intent-to-treat Infected Confirmed|Overall Study||32
156000|NCT01050257|376850|P1|Intent-to-treat Infected Confirmed|Overall Study||30
156001|NCT01050257|376848|P3|Safety Population: Actual Dose Received|Overall Study||14
156002|NCT01050257|376849|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
156003|NCT01050257|376850|P1|Safety Population: Actual Dose Received|Overall Study||48
156004|NCT01050257|376848|P3|Received Treatment|Overall Study||14
156005|NCT01050257|376849|P2|Received Treatment|Overall Study||50
156006|NCT01050257|376850|P1|Received Treatment|Overall Study||49
156007|NCT01050257|376848|P3|STARTED|Overall Study||15
156008|NCT01050257|376849|P2|STARTED|Overall Study||53
156009|NCT01050257|376850|P1|STARTED|Overall Study||50
156010|NCT01050218|376885|P1|NOT COMPLETED|Overall Study||95
156011|NCT01050218|376885|P1|COMPLETED|Overall Study||142
156012|NCT01050218|376885|P1|STARTED|Overall Study||237
156013|NCT01050205|376891|P2|NOT COMPLETED|Overall Study||4
156014|NCT01050205|376892|P1|NOT COMPLETED|Overall Study||11
156015|NCT01050205|376891|P2|COMPLETED|Overall Study||71
156016|NCT01050205|376892|P1|COMPLETED|Overall Study||137
156017|NCT01050205|376891|P2|STARTED|Overall Study||75
156018|NCT01050205|376892|P1|STARTED|Overall Study||148
156019|NCT01050153|376922|P2|NOT COMPLETED|Overall Study||0
156020|NCT01050153|376923|P1|NOT COMPLETED|Overall Study||0
156021|NCT01050153|376922|P2|COMPLETED|Overall Study||25
156022|NCT01050153|376923|P1|COMPLETED|Overall Study||25
156023|NCT01050153|376922|P2|STARTED|Overall Study||25
156024|NCT01050153|376923|P1|STARTED|Overall Study||25
156025|NCT01050062|376949|P2|NOT COMPLETED|Overall Study||112
156026|NCT01050062|376950|P1|NOT COMPLETED|Overall Study||271
156027|NCT01050062|376949|P2|COMPLETED|Overall Study||243
156028|NCT01050062|376950|P1|COMPLETED|Overall Study||799
156029|NCT01050062|376949|P2|STARTED|Overall Study||355
156030|NCT01050062|376950|P1|STARTED|Overall Study||1070
156031|NCT01049984|376972|P2|NOT COMPLETED|Overall Study||19
156032|NCT01049984|376973|P1|NOT COMPLETED|Overall Study||19
156033|NCT01049984|376972|P2|COMPLETED|Overall Study||146
156034|NCT01049984|376973|P1|COMPLETED|Overall Study||144
156035|NCT01049984|376972|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
156036|NCT01049984|376973|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
156037|NCT01049984|376972|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
156038|NCT01049984|376973|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
156039|NCT01049984|376972|P2|STARTED|Overall Study||165
156040|NCT01049984|376973|P1|STARTED|Overall Study||163
156041|NCT01049945|376991|P6|NOT COMPLETED|Overall Study||0
156042|NCT01049945|376992|P5|NOT COMPLETED|Overall Study||0
156043|NCT01049945|376993|P4|NOT COMPLETED|Overall Study||0
156044|NCT01049945|376994|P3|NOT COMPLETED|Overall Study||0
156045|NCT01049945|376995|P2|NOT COMPLETED|Overall Study||0
156046|NCT01049945|376996|P1|NOT COMPLETED|Overall Study||0
156047|NCT01049945|376991|P6|COMPLETED|Overall Study||49
156048|NCT01049945|376992|P5|COMPLETED|Overall Study||3
156049|NCT01049945|376993|P4|COMPLETED|Overall Study||6
156050|NCT01049945|376994|P3|COMPLETED|Overall Study||3
156051|NCT01049945|376995|P2|COMPLETED|Overall Study||6
156052|NCT01049945|376996|P1|COMPLETED|Overall Study||3
156053|NCT01049945|376991|P6|STARTED|Overall Study||49
156054|NCT01049945|376992|P5|STARTED|Overall Study||3
156055|NCT01049945|376993|P4|STARTED|Overall Study||6
156056|NCT01049945|376994|P3|STARTED|Overall Study||3
156057|NCT01049945|376995|P2|STARTED|Overall Study||6
156058|NCT01049945|376996|P1|STARTED|Overall Study||3
156059|NCT01049802|377012|P2|NOT COMPLETED|Overall Study||0
156060|NCT01049802|377013|P1|NOT COMPLETED|Overall Study||0
156061|NCT01049802|377012|P2|COMPLETED|Overall Study||10
156062|NCT01049802|377013|P1|COMPLETED|Overall Study||20
156063|NCT01049802|377012|P2|STARTED|Overall Study||10
156064|NCT01049802|377013|P1|STARTED|Overall Study||20
156065|NCT01049776|377027|P1|NOT COMPLETED|Overall Study||20
156066|NCT01049776|377027|P1|COMPLETED|Overall Study||12
156067|NCT01049776|377027|P1|STARTED|Overall Study||32
156068|NCT01049581|377033|P2|NOT COMPLETED|Overall Study||1
156069|NCT01049581|377034|P1|NOT COMPLETED|Overall Study||2
156070|NCT01049581|377033|P2|COMPLETED|Overall Study||13
156071|NCT01049581|377034|P1|COMPLETED|Overall Study||11
156072|NCT01049581|377033|P2|STARTED|Overall Study||14
156073|NCT01049581|377034|P1|STARTED|Overall Study||13
156074|NCT01049503|377049|P6|NOT COMPLETED|Overall Study||8
156075|NCT01049503|377050|P5|NOT COMPLETED|Overall Study||27
156076|NCT01049503|377051|P4|NOT COMPLETED|Overall Study||26
156077|NCT01049503|377052|P3|NOT COMPLETED|Overall Study||24
156078|NCT01049503|377053|P2|NOT COMPLETED|Overall Study||12
156079|NCT01049503|377054|P1|NOT COMPLETED|Overall Study||11
156080|NCT01049503|377049|P6|COMPLETED|Overall Study||40
156081|NCT01049503|377050|P5|COMPLETED|Overall Study||29
156082|NCT01049503|377051|P4|COMPLETED|Overall Study||29
156083|NCT01049503|377052|P3|COMPLETED|Overall Study||32
156084|NCT01049503|377053|P2|COMPLETED|Overall Study||36
156085|NCT01049503|377054|P1|COMPLETED|Overall Study||41
156086|NCT01049503|377049|P6|STARTED|Overall Study||48
156087|NCT01049503|377050|P5|STARTED|Overall Study||56
156088|NCT01049503|377051|P4|STARTED|Overall Study||55
156089|NCT01049503|377052|P3|STARTED|Overall Study||56
156090|NCT01049503|377053|P2|STARTED|Overall Study||48
156091|NCT01049503|377054|P1|STARTED|Overall Study||52
156092|NCT01049412|377085|P2|NOT COMPLETED|Period II||3
156093|NCT01049412|377086|P1|NOT COMPLETED|Period II||4
156094|NCT01049412|377085|P2|COMPLETED|Period II||52
156095|NCT01049412|377086|P1|COMPLETED|Period II||58
156096|NCT01049412|377085|P2|STARTED|Period II||55
156097|NCT01049412|377086|P1|STARTED|Period II||62
156098|NCT01049412|377085|P2|NOT COMPLETED|Period I||13
156099|NCT01049412|377086|P1|NOT COMPLETED|Period I||8
156100|NCT01049412|377085|P2|COMPLETED|Period I||55
156101|NCT01049412|377086|P1|COMPLETED|Period I||62
156102|NCT01049412|377085|P2|Took at Least One Dose of Study Drug|Period I||68
156103|NCT01049412|377086|P1|Took at Least One Dose of Study Drug|Period I||69
156104|NCT01049412|377085|P2|STARTED|Period I||68
156105|NCT01049412|377086|P1|STARTED|Period I||70
156106|NCT01049373|377115|P2|NOT COMPLETED|Overall Study||44
156107|NCT01049373|377116|P1|NOT COMPLETED|Overall Study||39
156108|NCT01049373|377115|P2|COMPLETED|Overall Study||65
156109|NCT01049373|377116|P1|COMPLETED|Overall Study||73
156110|NCT01049373|377115|P2|STARTED|Overall Study||109
156111|NCT01049373|377116|P1|STARTED|Overall Study||112
156112|NCT01049360|377130|P20|NOT COMPLETED|Period 4||0
156113|NCT01049360|377131|P19|NOT COMPLETED|Period 4||0
156114|NCT01049360|377132|P18|NOT COMPLETED|Period 4||1
156115|NCT01049360|377133|P17|NOT COMPLETED|Period 4||0
156116|NCT01049360|377134|P16|NOT COMPLETED|Period 4||0
156117|NCT01049360|377135|P15|NOT COMPLETED|Period 4||0
156118|NCT01049360|377136|P14|NOT COMPLETED|Period 4||0
156119|NCT01049360|377137|P13|NOT COMPLETED|Period 4||0
156120|NCT01049360|377138|P12|NOT COMPLETED|Period 4||0
156121|NCT01049360|377139|P11|NOT COMPLETED|Period 4||0
156122|NCT01049360|377140|P10|NOT COMPLETED|Period 4||0
156123|NCT01049360|377141|P9|NOT COMPLETED|Period 4||0
156124|NCT01049360|377142|P8|NOT COMPLETED|Period 4||0
156125|NCT01049360|377143|P7|NOT COMPLETED|Period 4||0
156126|NCT01049360|377144|P6|NOT COMPLETED|Period 4||0
156127|NCT01049360|377145|P5|NOT COMPLETED|Period 4||0
156128|NCT01049360|377146|P4|NOT COMPLETED|Period 4||1
156129|NCT01049360|377147|P3|NOT COMPLETED|Period 4||0
156130|NCT01049360|377148|P2|NOT COMPLETED|Period 4||0
156131|NCT01049360|377149|P1|NOT COMPLETED|Period 4||0
156132|NCT01049360|377130|P20|COMPLETED|Period 4||5
156133|NCT01049360|377131|P19|COMPLETED|Period 4||5
156134|NCT01049360|377132|P18|COMPLETED|Period 4||5
156135|NCT01049360|377133|P17|COMPLETED|Period 4||5
156136|NCT01049360|377134|P16|COMPLETED|Period 4||6
156137|NCT01049360|377135|P15|COMPLETED|Period 4||5
156138|NCT01049360|377136|P14|COMPLETED|Period 4||6
156139|NCT01049360|377137|P13|COMPLETED|Period 4||4
156140|NCT01049360|377138|P12|COMPLETED|Period 4||6
156141|NCT01049360|377139|P11|COMPLETED|Period 4||5
156142|NCT01049360|377140|P10|COMPLETED|Period 4||6
156143|NCT01049360|377141|P9|COMPLETED|Period 4||4
156144|NCT01049360|377142|P8|COMPLETED|Period 4||4
156145|NCT01049360|377143|P7|COMPLETED|Period 4||6
156146|NCT01049360|377144|P6|COMPLETED|Period 4||5
156147|NCT01049360|377145|P5|COMPLETED|Period 4||7
156148|NCT01049360|377146|P4|COMPLETED|Period 4||3
156149|NCT01049360|377147|P3|COMPLETED|Period 4||7
156150|NCT01049360|377148|P2|COMPLETED|Period 4||4
156151|NCT01049360|377149|P1|COMPLETED|Period 4||6
156152|NCT01049360|377130|P20|STARTED|Period 4||5
156153|NCT01049360|377131|P19|STARTED|Period 4||5
156154|NCT01049360|377132|P18|STARTED|Period 4||6
156155|NCT01049360|377133|P17|STARTED|Period 4||5
156156|NCT01049360|377134|P16|STARTED|Period 4||6
156157|NCT01049360|377135|P15|STARTED|Period 4||5
156158|NCT01049360|377136|P14|STARTED|Period 4||6
156159|NCT01049360|377137|P13|STARTED|Period 4||4
156160|NCT01049360|377138|P12|STARTED|Period 4||6
156161|NCT01049360|377139|P11|STARTED|Period 4||5
156162|NCT01049360|377140|P10|STARTED|Period 4||6
156163|NCT01049360|377141|P9|STARTED|Period 4||4
156164|NCT01049360|377142|P8|STARTED|Period 4||4
156165|NCT01049360|377143|P7|STARTED|Period 4||6
156166|NCT01049360|377144|P6|STARTED|Period 4||5
156167|NCT01049360|377145|P5|STARTED|Period 4||7
156168|NCT01049360|377146|P4|STARTED|Period 4||4
156169|NCT01049360|377147|P3|STARTED|Period 4||7
156170|NCT01049360|377148|P2|STARTED|Period 4||4
156171|NCT01049360|377149|P1|STARTED|Period 4||6
156172|NCT01049360|377130|P20|NOT COMPLETED|Period 3||0
156173|NCT01049360|377131|P19|NOT COMPLETED|Period 3||0
156174|NCT01049360|377132|P18|NOT COMPLETED|Period 3||0
156175|NCT01049360|377133|P17|NOT COMPLETED|Period 3||0
156176|NCT01049360|377134|P16|NOT COMPLETED|Period 3||0
156177|NCT01049360|377135|P15|NOT COMPLETED|Period 3||0
156178|NCT01049360|377136|P14|NOT COMPLETED|Period 3||0
156179|NCT01049360|377137|P13|NOT COMPLETED|Period 3||0
156180|NCT01049360|377138|P12|NOT COMPLETED|Period 3||0
156181|NCT01049360|377139|P11|NOT COMPLETED|Period 3||0
156182|NCT01049360|377140|P10|NOT COMPLETED|Period 3||0
156183|NCT01049360|377141|P9|NOT COMPLETED|Period 3||0
156184|NCT01049360|377142|P8|NOT COMPLETED|Period 3||0
156185|NCT01049360|377143|P7|NOT COMPLETED|Period 3||0
156186|NCT01049360|377144|P6|NOT COMPLETED|Period 3||0
156187|NCT01049360|377145|P5|NOT COMPLETED|Period 3||0
156188|NCT01049360|377146|P4|NOT COMPLETED|Period 3||0
156189|NCT01049360|377147|P3|NOT COMPLETED|Period 3||0
156190|NCT01049360|377148|P2|NOT COMPLETED|Period 3||0
156191|NCT01049360|377149|P1|NOT COMPLETED|Period 3||0
156192|NCT01049360|377130|P20|COMPLETED|Period 3||5
156193|NCT01049360|377131|P19|COMPLETED|Period 3||5
156194|NCT01049360|377132|P18|COMPLETED|Period 3||6
156195|NCT01049360|377133|P17|COMPLETED|Period 3||5
156196|NCT01049360|377134|P16|COMPLETED|Period 3||6
156197|NCT01049360|377135|P15|COMPLETED|Period 3||5
156198|NCT01049360|377136|P14|COMPLETED|Period 3||6
156199|NCT01049360|377137|P13|COMPLETED|Period 3||4
156200|NCT01049360|377138|P12|COMPLETED|Period 3||6
156201|NCT01049360|377139|P11|COMPLETED|Period 3||5
156202|NCT01049360|377140|P10|COMPLETED|Period 3||6
156203|NCT01049360|377141|P9|COMPLETED|Period 3||4
156204|NCT01049360|377142|P8|COMPLETED|Period 3||4
156205|NCT01049360|377143|P7|COMPLETED|Period 3||6
156206|NCT01049360|377144|P6|COMPLETED|Period 3||5
156207|NCT01049360|377145|P5|COMPLETED|Period 3||7
156208|NCT01049360|377146|P4|COMPLETED|Period 3||4
156209|NCT01049360|377147|P3|COMPLETED|Period 3||7
156210|NCT01049360|377148|P2|COMPLETED|Period 3||4
156211|NCT01049360|377149|P1|COMPLETED|Period 3||6
156212|NCT01049360|377130|P20|STARTED|Period 3||5
156213|NCT01049360|377131|P19|STARTED|Period 3||5
156214|NCT01049360|377132|P18|STARTED|Period 3||6
156215|NCT01049360|377133|P17|STARTED|Period 3||5
156216|NCT01049360|377134|P16|STARTED|Period 3||6
156217|NCT01049360|377135|P15|STARTED|Period 3||5
156218|NCT01049360|377136|P14|STARTED|Period 3||6
156219|NCT01049360|377137|P13|STARTED|Period 3||4
156220|NCT01049360|377138|P12|STARTED|Period 3||6
156221|NCT01049360|377139|P11|STARTED|Period 3||5
156222|NCT01049360|377140|P10|STARTED|Period 3||6
156223|NCT01049360|377141|P9|STARTED|Period 3||4
156224|NCT01049360|377142|P8|STARTED|Period 3||4
156225|NCT01049360|377143|P7|STARTED|Period 3||6
156226|NCT01049360|377144|P6|STARTED|Period 3||5
156227|NCT01049360|377145|P5|STARTED|Period 3||7
156228|NCT01049360|377146|P4|STARTED|Period 3||4
156229|NCT01049360|377147|P3|STARTED|Period 3||7
156230|NCT01049360|377148|P2|STARTED|Period 3||4
156231|NCT01049360|377149|P1|STARTED|Period 3||6
156232|NCT01049360|377130|P20|NOT COMPLETED|Period 2||2
156233|NCT01049360|377131|P19|NOT COMPLETED|Period 2||0
156234|NCT01049360|377132|P18|NOT COMPLETED|Period 2||0
156235|NCT01049360|377133|P17|NOT COMPLETED|Period 2||0
156236|NCT01049360|377134|P16|NOT COMPLETED|Period 2||1
156237|NCT01049360|377135|P15|NOT COMPLETED|Period 2||2
156238|NCT01049360|377136|P14|NOT COMPLETED|Period 2||0
156239|NCT01049360|377137|P13|NOT COMPLETED|Period 2||0
156240|NCT01049360|377138|P12|NOT COMPLETED|Period 2||0
156241|NCT01049360|377139|P11|NOT COMPLETED|Period 2||0
156242|NCT01049360|377140|P10|NOT COMPLETED|Period 2||0
156243|NCT01049360|377141|P9|NOT COMPLETED|Period 2||1
156244|NCT01049360|377142|P8|NOT COMPLETED|Period 2||0
156245|NCT01049360|377143|P7|NOT COMPLETED|Period 2||0
156246|NCT01049360|377144|P6|NOT COMPLETED|Period 2||1
156247|NCT01049360|377145|P5|NOT COMPLETED|Period 2||0
156248|NCT01049360|377146|P4|NOT COMPLETED|Period 2||2
156249|NCT01049360|377147|P3|NOT COMPLETED|Period 2||0
156250|NCT01049360|377148|P2|NOT COMPLETED|Period 2||1
156251|NCT01049360|377149|P1|NOT COMPLETED|Period 2||0
156252|NCT01049360|377130|P20|COMPLETED|Period 2||5
156253|NCT01049360|377131|P19|COMPLETED|Period 2||5
156254|NCT01049360|377132|P18|COMPLETED|Period 2||6
156255|NCT01049360|377133|P17|COMPLETED|Period 2||5
156256|NCT01049360|377134|P16|COMPLETED|Period 2||6
156257|NCT01049360|377135|P15|COMPLETED|Period 2||5
156258|NCT01049360|377136|P14|COMPLETED|Period 2||6
156259|NCT01049360|377137|P13|COMPLETED|Period 2||4
156260|NCT01049360|377138|P12|COMPLETED|Period 2||6
156261|NCT01049360|377139|P11|COMPLETED|Period 2||5
156262|NCT01049360|377140|P10|COMPLETED|Period 2||6
156263|NCT01049360|377141|P9|COMPLETED|Period 2||4
156264|NCT01049360|377142|P8|COMPLETED|Period 2||4
156265|NCT01049360|377143|P7|COMPLETED|Period 2||6
156266|NCT01049360|377144|P6|COMPLETED|Period 2||5
156267|NCT01049360|377145|P5|COMPLETED|Period 2||7
156268|NCT01049360|377146|P4|COMPLETED|Period 2||4
156269|NCT01049360|377147|P3|COMPLETED|Period 2||7
156270|NCT01049360|377148|P2|COMPLETED|Period 2||4
156271|NCT01049360|377149|P1|COMPLETED|Period 2||6
156272|NCT01049360|377130|P20|STARTED|Period 2||7
156273|NCT01049360|377131|P19|STARTED|Period 2||5
156274|NCT01049360|377132|P18|STARTED|Period 2||6
156275|NCT01049360|377133|P17|STARTED|Period 2||5
156276|NCT01049360|377134|P16|STARTED|Period 2||7
156277|NCT01049360|377135|P15|STARTED|Period 2||7
156278|NCT01049360|377136|P14|STARTED|Period 2||6
156279|NCT01049360|377137|P13|STARTED|Period 2||4
156280|NCT01049360|377138|P12|STARTED|Period 2||6
156281|NCT01049360|377139|P11|STARTED|Period 2||5
156282|NCT01049360|377140|P10|STARTED|Period 2||6
156283|NCT01049360|377141|P9|STARTED|Period 2||5
156284|NCT01049360|377142|P8|STARTED|Period 2||4
156285|NCT01049360|377143|P7|STARTED|Period 2||6
156286|NCT01049360|377144|P6|STARTED|Period 2||6
156287|NCT01049360|377145|P5|STARTED|Period 2||7
156288|NCT01049360|377146|P4|STARTED|Period 2||6
156289|NCT01049360|377147|P3|STARTED|Period 2||7
156290|NCT01049360|377148|P2|STARTED|Period 2||5
156291|NCT01049360|377149|P1|STARTED|Period 2||6
156292|NCT01049360|377130|P20|NOT COMPLETED|Period 1||0
156293|NCT01049360|377131|P19|NOT COMPLETED|Period 1||1
156294|NCT01049360|377132|P18|NOT COMPLETED|Period 1||0
156295|NCT01049360|377133|P17|NOT COMPLETED|Period 1||1
156296|NCT01049360|377134|P16|NOT COMPLETED|Period 1||0
156297|NCT01049360|377135|P15|NOT COMPLETED|Period 1||0
156298|NCT01049360|377136|P14|NOT COMPLETED|Period 1||1
156299|NCT01049360|377137|P13|NOT COMPLETED|Period 1||2
156300|NCT01049360|377138|P12|NOT COMPLETED|Period 1||0
156301|NCT01049360|377139|P11|NOT COMPLETED|Period 1||1
156302|NCT01049360|377140|P10|NOT COMPLETED|Period 1||0
156303|NCT01049360|377141|P9|NOT COMPLETED|Period 1||2
156304|NCT01049360|377142|P8|NOT COMPLETED|Period 1||2
156305|NCT01049360|377143|P7|NOT COMPLETED|Period 1||0
156306|NCT01049360|377144|P6|NOT COMPLETED|Period 1||0
156307|NCT01049360|377145|P5|NOT COMPLETED|Period 1||0
156308|NCT01049360|377146|P4|NOT COMPLETED|Period 1||1
156309|NCT01049360|377147|P3|NOT COMPLETED|Period 1||0
156310|NCT01049360|377148|P2|NOT COMPLETED|Period 1||1
156311|NCT01049360|377149|P1|NOT COMPLETED|Period 1||0
156312|NCT01049360|377130|P20|COMPLETED|Period 1||7
156313|NCT01049360|377131|P19|COMPLETED|Period 1||5
156314|NCT01049360|377132|P18|COMPLETED|Period 1||6
156315|NCT01049360|377133|P17|COMPLETED|Period 1||5
156316|NCT01049360|377134|P16|COMPLETED|Period 1||7
156317|NCT01049360|377135|P15|COMPLETED|Period 1||7
156318|NCT01049360|377136|P14|COMPLETED|Period 1||6
156319|NCT01049360|377137|P13|COMPLETED|Period 1||4
156320|NCT01049360|377138|P12|COMPLETED|Period 1||6
156321|NCT01049360|377139|P11|COMPLETED|Period 1||5
156322|NCT01049360|377140|P10|COMPLETED|Period 1||6
156323|NCT01049360|377141|P9|COMPLETED|Period 1||5
156324|NCT01049360|377142|P8|COMPLETED|Period 1||4
156325|NCT01049360|377143|P7|COMPLETED|Period 1||6
156326|NCT01049360|377144|P6|COMPLETED|Period 1||6
156327|NCT01049360|377145|P5|COMPLETED|Period 1||7
156328|NCT01049360|377146|P4|COMPLETED|Period 1||6
156329|NCT01049360|377147|P3|COMPLETED|Period 1||7
156330|NCT01049360|377148|P2|COMPLETED|Period 1||5
156331|NCT01049360|377149|P1|COMPLETED|Period 1||6
156332|NCT01049360|377130|P20|STARTED|Period 1||7
156333|NCT01049360|377131|P19|STARTED|Period 1||6
156334|NCT01049360|377132|P18|STARTED|Period 1||6
156335|NCT01049360|377133|P17|STARTED|Period 1||6
156336|NCT01049360|377134|P16|STARTED|Period 1||7
156337|NCT01049360|377135|P15|STARTED|Period 1||7
156338|NCT01049360|377136|P14|STARTED|Period 1||7
156339|NCT01049360|377137|P13|STARTED|Period 1||6
156340|NCT01049360|377138|P12|STARTED|Period 1||6
156341|NCT01049360|377139|P11|STARTED|Period 1||6
156342|NCT01049360|377140|P10|STARTED|Period 1||6
156343|NCT01049360|377141|P9|STARTED|Period 1||7
156344|NCT01049360|377142|P8|STARTED|Period 1||6
156345|NCT01049360|377143|P7|STARTED|Period 1||6
156346|NCT01049360|377144|P6|STARTED|Period 1||6
156347|NCT01049360|377145|P5|STARTED|Period 1||7
156348|NCT01049360|377146|P4|STARTED|Period 1||7
156349|NCT01049360|377147|P3|STARTED|Period 1||7
156350|NCT01049360|377148|P2|STARTED|Period 1||6
156351|NCT01049360|377149|P1|STARTED|Period 1||6
156352|NCT01049334|377173|P2|NOT COMPLETED|Overall Study||7
156353|NCT01049334|377174|P1|NOT COMPLETED|Overall Study||9
156354|NCT01049334|377173|P2|COMPLETED|Overall Study||95
156355|NCT01049334|377174|P1|COMPLETED|Overall Study||93
156356|NCT01049334|377173|P2|STARTED|Overall Study||102
156357|NCT01049334|377174|P1|STARTED|Overall Study||102
156358|NCT01049308|377210|P1|NOT COMPLETED|Pill Counts||83
156359|NCT01049308|377210|P1|COMPLETED|Pill Counts||168
156360|NCT01049308|377210|P1|STARTED|Pill Counts||251
156361|NCT01049308|377210|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
156362|NCT01049308|377210|P1|COMPLETED|Evaluation of Cognitive Impairment||251
156363|NCT01049308|377210|P1|STARTED|Evaluation of Cognitive Impairment||251
156364|NCT01049243|377217|P1|NOT COMPLETED|Overall Study||2
156365|NCT01049243|377217|P1|COMPLETED|Overall Study||18
156366|NCT01049243|377217|P1|STARTED|Overall Study||20
156367|NCT01049217|377224|P2|NOT COMPLETED|Overall Study||63
156368|NCT01049217|377225|P1|NOT COMPLETED|Overall Study||56
156369|NCT01049217|377224|P2|COMPLETED|Overall Study||131
156370|NCT01049217|377225|P1|COMPLETED|Overall Study||127
156371|NCT01049217|377224|P2|Treated|Overall Study||192
156372|NCT01049217|377225|P1|Treated|Overall Study||183
156373|NCT01049217|377224|P2|STARTED|Overall Study||194
156374|NCT01049217|377225|P1|STARTED|Overall Study||183
156375|NCT01049009|377297|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
156376|NCT01049009|377298|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
156377|NCT01049009|377297|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
156378|NCT01049009|377298|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
156379|NCT01049009|377297|P2|STARTED|Treatment Period 2 (12 Weeks)||18
156380|NCT01049009|377298|P1|STARTED|Treatment Period 2 (12 Weeks)||21
156381|NCT01049009|377297|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
156382|NCT01049009|377298|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
156383|NCT01049009|377297|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
156384|NCT01049009|377298|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
156385|NCT01049009|377297|P2|STARTED|Treatment Period 1 (12 Weeks)||21
156386|NCT01049009|377298|P1|STARTED|Treatment Period 1 (12 Weeks)||23
156387|NCT01048944|377310|P4|NOT COMPLETED|Overall Study||2
156388|NCT01048944|377311|P3|NOT COMPLETED|Overall Study||10
156389|NCT01048944|377312|P2|NOT COMPLETED|Overall Study||10
156390|NCT01048944|377313|P1|NOT COMPLETED|Overall Study||8
156391|NCT01048944|377310|P4|COMPLETED|Overall Study||19
156392|NCT01048944|377311|P3|COMPLETED|Overall Study||25
156393|NCT01048944|377312|P2|COMPLETED|Overall Study||28
156394|NCT01048944|377313|P1|COMPLETED|Overall Study||24
156395|NCT01048944|377310|P4|STARTED|Overall Study||21
156396|NCT01048944|377311|P3|STARTED|Overall Study||35
156397|NCT01048944|377312|P2|STARTED|Overall Study||38
156398|NCT01048944|377313|P1|STARTED|Overall Study||32
156399|NCT01048879|377330|P3|NOT COMPLETED|Overall Study||0
156400|NCT01048879|377331|P2|NOT COMPLETED|Overall Study||0
156401|NCT01048879|377332|P1|NOT COMPLETED|Overall Study||0
156402|NCT01048879|377330|P3|COMPLETED|Overall Study||5
156403|NCT01048879|377331|P2|COMPLETED|Overall Study||9
156404|NCT01048879|377332|P1|COMPLETED|Overall Study||1
156405|NCT01048879|377330|P3|STARTED|Overall Study||5
156406|NCT01048879|377331|P2|STARTED|Overall Study||9
156407|NCT01048879|377332|P1|STARTED|Overall Study||1
156408|NCT01048866|377345|P2|NOT COMPLETED|Overall Study||5
156409|NCT01048866|377346|P1|NOT COMPLETED|Overall Study||4
156410|NCT01048866|377345|P2|COMPLETED|Overall Study||92
156411|NCT01048866|377346|P1|COMPLETED|Overall Study||97
156412|NCT01048866|377345|P2|STARTED|Overall Study||97
156413|NCT01048866|377346|P1|STARTED|Overall Study||101
156414|NCT01048788|377391|P3|NOT COMPLETED|Overall Study||2
156415|NCT01048788|377392|P2|NOT COMPLETED|Overall Study||2
156416|NCT01048788|377393|P1|NOT COMPLETED|Overall Study||5
156417|NCT01048788|377391|P3|COMPLETED|Overall Study||11
156418|NCT01048788|377392|P2|COMPLETED|Overall Study||28
156419|NCT01048788|377393|P1|COMPLETED|Overall Study||3
156420|NCT01048788|377391|P3|STARTED|Overall Study||13
156421|NCT01048788|377392|P2|STARTED|Overall Study||30
156422|NCT01048788|377393|P1|STARTED|Overall Study||8
156423|NCT01048723|377401|P1|NOT COMPLETED|Overall Study||0
156424|NCT01048723|377401|P1|COMPLETED|Overall Study||2
156425|NCT01048723|377401|P1|STARTED|Overall Study||2
156426|NCT01048697|377408|P1|NOT COMPLETED|Overall Study||0
156427|NCT01048697|377408|P1|COMPLETED|Overall Study||18
156428|NCT01048697|377408|P1|STARTED|Overall Study||18
156429|NCT01048671|377415|P3|NOT COMPLETED|Overall Study||1
156430|NCT01048671|377416|P2|NOT COMPLETED|Overall Study||1
156431|NCT01048671|377417|P1|NOT COMPLETED|Overall Study||0
156432|NCT01048671|377415|P3|COMPLETED|Overall Study||151
156433|NCT01048671|377416|P2|COMPLETED|Overall Study||263
156434|NCT01048671|377417|P1|COMPLETED|Overall Study||66
156435|NCT01048671|377415|P3|STARTED|Overall Study||152
156436|NCT01048671|377416|P2|STARTED|Overall Study||264
156437|NCT01048671|377417|P1|STARTED|Overall Study||66
156438|NCT01048658|377440|P2|NOT COMPLETED|Overall Study||0
156439|NCT01048658|377441|P1|NOT COMPLETED|Overall Study||0
156440|NCT01048658|377440|P2|COMPLETED|Overall Study||80
156441|NCT01048658|377441|P1|COMPLETED|Overall Study||80
156442|NCT01048658|377440|P2|STARTED|Overall Study||80
156443|NCT01048658|377441|P1|STARTED|Overall Study||80
156444|NCT01048606|377459|P4|NOT COMPLETED|Overall Study||5
156445|NCT01048606|377460|P3|NOT COMPLETED|Overall Study||10
156446|NCT01048606|377461|P2|NOT COMPLETED|Overall Study||7
156447|NCT01048606|377462|P1|NOT COMPLETED|Overall Study||12
156448|NCT01048606|377459|P4|COMPLETED|Overall Study||5
156449|NCT01048606|377460|P3|COMPLETED|Overall Study||16
156450|NCT01048606|377461|P2|COMPLETED|Overall Study||8
156451|NCT01048606|377462|P1|COMPLETED|Overall Study||16
156452|NCT01048606|377459|P4|STARTED|Overall Study||10
156453|NCT01048606|377460|P3|STARTED|Overall Study||26
156454|NCT01048606|377461|P2|STARTED|Overall Study||15
156455|NCT01048606|377462|P1|STARTED|Overall Study||28
156456|NCT01048593|377475|P3|NOT COMPLETED|Overall Study||0
156457|NCT01048593|377476|P2|NOT COMPLETED|Overall Study||0
156458|NCT01048593|377477|P1|NOT COMPLETED|Overall Study||0
156459|NCT01048593|377475|P3|COMPLETED|Overall Study||1
156460|NCT01048593|377476|P2|COMPLETED|Overall Study||2
156461|NCT01048593|377477|P1|COMPLETED|Overall Study||3
156462|NCT01048593|377475|P3|STARTED|Overall Study||1
156463|NCT01048593|377476|P2|STARTED|Overall Study||2
156464|NCT01048593|377477|P1|STARTED|Overall Study||3
156465|NCT01048541|377485|P2|NOT COMPLETED|Overall Study||0
156466|NCT01048541|377486|P1|NOT COMPLETED|Overall Study||1
156467|NCT01048541|377485|P2|COMPLETED|Overall Study||19
156468|NCT01048541|377486|P1|COMPLETED|Overall Study||17
156469|NCT01048541|377485|P2|STARTED|Overall Study||19
156470|NCT01048541|377486|P1|STARTED|Overall Study||18
156471|NCT01048502|377496|P4|NOT COMPLETED|Overall Study||4
156472|NCT01048502|377497|P3|NOT COMPLETED|Overall Study||5
156473|NCT01048502|377498|P2|NOT COMPLETED|Overall Study||7
156474|NCT01048502|377499|P1|NOT COMPLETED|Overall Study||4
156475|NCT01048502|377496|P4|COMPLETED|Overall Study||21
156476|NCT01048502|377497|P3|COMPLETED|Overall Study||23
156477|NCT01048502|377498|P2|COMPLETED|Overall Study||16
156478|NCT01048502|377499|P1|COMPLETED|Overall Study||20
156479|NCT01048502|377496|P4|STARTED|Overall Study||25
156480|NCT01048502|377497|P3|STARTED|Overall Study||28
156481|NCT01048502|377498|P2|STARTED|Overall Study||23
156482|NCT01048502|377499|P1|STARTED|Overall Study||24
156483|NCT01048424|377512|P2|NOT COMPLETED|Overall Study||0
156484|NCT01048424|377513|P1|NOT COMPLETED|Overall Study||2
156485|NCT01048424|377512|P2|COMPLETED|Overall Study||10
156486|NCT01048424|377513|P1|COMPLETED|Overall Study||8
156487|NCT01048424|377512|P2|STARTED|Overall Study||10
156488|NCT01048424|377513|P1|STARTED|Overall Study||10
156489|NCT01048333|377535|P6|NOT COMPLETED|Treatment Period 3||0
156490|NCT01048333|377536|P5|NOT COMPLETED|Treatment Period 3||0
156491|NCT01048333|377537|P4|NOT COMPLETED|Treatment Period 3||0
156492|NCT01048333|377538|P3|NOT COMPLETED|Treatment Period 3||0
156493|NCT01048333|377539|P2|NOT COMPLETED|Treatment Period 3||0
156494|NCT01048333|377540|P1|NOT COMPLETED|Treatment Period 3||0
156495|NCT01048333|377535|P6|COMPLETED|Treatment Period 3||18
156496|NCT01048333|377536|P5|COMPLETED|Treatment Period 3||17
156497|NCT01048333|377537|P4|COMPLETED|Treatment Period 3||18
156498|NCT01048333|377538|P3|COMPLETED|Treatment Period 3||16
156499|NCT01048333|377539|P2|COMPLETED|Treatment Period 3||18
156500|NCT01048333|377540|P1|COMPLETED|Treatment Period 3||21
156501|NCT01048333|377535|P6|STARTED|Treatment Period 3||18
156502|NCT01048333|377536|P5|STARTED|Treatment Period 3||17
156503|NCT01048333|377537|P4|STARTED|Treatment Period 3||18
156504|NCT01048333|377538|P3|STARTED|Treatment Period 3||16
156505|NCT01048333|377539|P2|STARTED|Treatment Period 3||18
156506|NCT01048333|377540|P1|STARTED|Treatment Period 3||21
156507|NCT01048333|377535|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
156508|NCT01048333|377536|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
156509|NCT01048333|377537|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
156510|NCT01048333|377538|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
156511|NCT01048333|377539|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
156512|NCT01048333|377540|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
156513|NCT01048333|377535|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
156514|NCT01048333|377536|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
156515|NCT01048333|377537|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
156516|NCT01048333|377538|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
156517|NCT01048333|377539|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
156518|NCT01048333|377540|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
156519|NCT01048333|377535|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
156520|NCT01048333|377536|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
156521|NCT01048333|377537|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
156522|NCT01048333|377538|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
156523|NCT01048333|377539|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
156524|NCT01048333|377540|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
156525|NCT01048333|377535|P6|NOT COMPLETED|Treatment Period 2||0
156526|NCT01048333|377536|P5|NOT COMPLETED|Treatment Period 2||0
156527|NCT01048333|377537|P4|NOT COMPLETED|Treatment Period 2||0
156528|NCT01048333|377538|P3|NOT COMPLETED|Treatment Period 2||0
156529|NCT01048333|377539|P2|NOT COMPLETED|Treatment Period 2||0
156530|NCT01048333|377540|P1|NOT COMPLETED|Treatment Period 2||0
156531|NCT01048333|377535|P6|COMPLETED|Treatment Period 2||18
156532|NCT01048333|377536|P5|COMPLETED|Treatment Period 2||17
156533|NCT01048333|377537|P4|COMPLETED|Treatment Period 2||18
156534|NCT01048333|377538|P3|COMPLETED|Treatment Period 2||16
156535|NCT01048333|377539|P2|COMPLETED|Treatment Period 2||19
156536|NCT01048333|377540|P1|COMPLETED|Treatment Period 2||21
156537|NCT01048333|377535|P6|STARTED|Treatment Period 2||18
156538|NCT01048333|377536|P5|STARTED|Treatment Period 2||17
156539|NCT01048333|377537|P4|STARTED|Treatment Period 2||18
156540|NCT01048333|377538|P3|STARTED|Treatment Period 2||16
156541|NCT01048333|377539|P2|STARTED|Treatment Period 2||19
156542|NCT01048333|377540|P1|STARTED|Treatment Period 2||21
156543|NCT01048333|377535|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
156544|NCT01048333|377536|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
156545|NCT01048333|377537|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
156546|NCT01048333|377538|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
156547|NCT01048333|377539|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
156548|NCT01048333|377540|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
156549|NCT01048333|377535|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
156550|NCT01048333|377536|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
156551|NCT01048333|377537|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
156552|NCT01048333|377538|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
156553|NCT01048333|377539|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
156554|NCT01048333|377540|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
156555|NCT01048333|377535|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
156556|NCT01048333|377536|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
156557|NCT01048333|377537|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
156558|NCT01048333|377538|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
156559|NCT01048333|377539|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
156560|NCT01048333|377540|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
156561|NCT01048333|377535|P6|NOT COMPLETED|Treatment Period 1||0
156562|NCT01048333|377536|P5|NOT COMPLETED|Treatment Period 1||0
156563|NCT01048333|377537|P4|NOT COMPLETED|Treatment Period 1||0
156564|NCT01048333|377538|P3|NOT COMPLETED|Treatment Period 1||0
156565|NCT01048333|377539|P2|NOT COMPLETED|Treatment Period 1||0
156566|NCT01048333|377540|P1|NOT COMPLETED|Treatment Period 1||0
156567|NCT01048333|377535|P6|COMPLETED|Treatment Period 1||18
156568|NCT01048333|377536|P5|COMPLETED|Treatment Period 1||17
156569|NCT01048333|377537|P4|COMPLETED|Treatment Period 1||18
156570|NCT01048333|377538|P3|COMPLETED|Treatment Period 1||16
156571|NCT01048333|377539|P2|COMPLETED|Treatment Period 1||19
156572|NCT01048333|377540|P1|COMPLETED|Treatment Period 1||21
156573|NCT01048333|377535|P6|STARTED|Treatment Period 1||18
156574|NCT01048333|377536|P5|STARTED|Treatment Period 1||17
156575|NCT01048333|377537|P4|STARTED|Treatment Period 1||18
156576|NCT01048333|377538|P3|STARTED|Treatment Period 1||16
156577|NCT01048333|377539|P2|STARTED|Treatment Period 1||19
156578|NCT01048333|377540|P1|STARTED|Treatment Period 1||21
156579|NCT01048242|377562|P2|NOT COMPLETED|Overall Study||2
156580|NCT01048242|377563|P1|NOT COMPLETED|Overall Study||4
156581|NCT01048242|377562|P2|COMPLETED|Overall Study||13
156582|NCT01048242|377563|P1|COMPLETED|Overall Study||8
156583|NCT01048242|377562|P2|STARTED|Overall Study||15
156584|NCT01048242|377563|P1|STARTED|Overall Study||12
156585|NCT01048125|377571|P2|NOT COMPLETED|Overall Study||0
156586|NCT01048125|377572|P1|NOT COMPLETED|Overall Study||0
156587|NCT01048125|377571|P2|COMPLETED|Overall Study||0
156588|NCT01048125|377572|P1|COMPLETED|Overall Study||0
156589|NCT01048125|377571|P2|STARTED|Overall Study||0
156590|NCT01048125|377572|P1|STARTED|Overall Study||0
156591|NCT01048099|377578|P1|NOT COMPLETED|Treatment Per Protocol||14
156592|NCT01048099|377578|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
156593|NCT01048099|377578|P1|STARTED|Treatment Per Protocol||14
156594|NCT01048099|377578|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
156595|NCT01048099|377578|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
156596|NCT01048099|377578|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
156597|NCT01048099|377578|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
156598|NCT01048099|377578|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
156599|NCT01048099|377578|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
156600|NCT01048099|377578|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
156601|NCT01048099|377578|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
156602|NCT01048099|377578|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
156603|NCT01047839|377589|P3|NOT COMPLETED|Overall Study||6
156604|NCT01047839|377590|P2|NOT COMPLETED|Overall Study||0
156605|NCT01047839|377591|P1|NOT COMPLETED|Overall Study||2
156606|NCT01047839|377589|P3|COMPLETED|Overall Study||53
156607|NCT01047839|377590|P2|COMPLETED|Overall Study||29
156608|NCT01047839|377591|P1|COMPLETED|Overall Study||10
156609|NCT01047839|377589|P3|STARTED|Overall Study||59
156610|NCT01047839|377590|P2|STARTED|Overall Study||29
156611|NCT01047839|377591|P1|STARTED|Overall Study||12
156612|NCT01047709|377599|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
156613|NCT01047709|377600|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
156614|NCT01047709|377599|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
156615|NCT01047709|377600|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
156616|NCT01047709|377599|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
156617|NCT01047709|377600|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
156618|NCT01047709|377599|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
156619|NCT01047709|377600|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
156620|NCT01047709|377599|P2|COMPLETED|Positional Therapy (1 Night)||9
156621|NCT01047709|377600|P1|COMPLETED|Positional Therapy (1 Night)||9
156622|NCT01047709|377599|P2|STARTED|Positional Therapy (1 Night)||9
156623|NCT01047709|377600|P1|STARTED|Positional Therapy (1 Night)||9
156624|NCT01047553|377608|P2|NOT COMPLETED|Overall Study||9
156625|NCT01047553|377609|P1|NOT COMPLETED|Overall Study||17
156626|NCT01047553|377608|P2|COMPLETED|Overall Study||117
156627|NCT01047553|377609|P1|COMPLETED|Overall Study||108
156628|NCT01047553|377608|P2|STARTED|Overall Study||126
156629|NCT01047553|377609|P1|STARTED|Overall Study||125
156630|NCT01047527|377694|P3|NOT COMPLETED|Overall Study||65
156631|NCT01047527|377695|P2|NOT COMPLETED|Overall Study||61
156632|NCT01047527|377696|P1|NOT COMPLETED|Overall Study||85
156633|NCT01047527|377694|P3|COMPLETED|Overall Study||107
156634|NCT01047527|377695|P2|COMPLETED|Overall Study||112
156635|NCT01047527|377696|P1|COMPLETED|Overall Study||95
156636|NCT01047527|377694|P3|24 Weeks|Overall Study||119
156637|NCT01047527|377695|P2|24 Weeks|Overall Study||123
156638|NCT01047527|377696|P1|24 Weeks|Overall Study||111
156639|NCT01047527|377694|P3|8 Weeks|Overall Study||138
156640|NCT01047527|377695|P2|8 Weeks|Overall Study||142
156641|NCT01047527|377696|P1|8 Weeks|Overall Study||148
156642|NCT01047527|377694|P3|STARTED|Overall Study||172
156643|NCT01047527|377695|P2|STARTED|Overall Study||173
156644|NCT01047527|377696|P1|STARTED|Overall Study||180
156645|NCT01047475|377707|P2|NOT COMPLETED|Overall Study||7
156646|NCT01047475|377708|P1|NOT COMPLETED|Overall Study||5
156647|NCT01047475|377707|P2|COMPLETED|Overall Study||31
156648|NCT01047475|377708|P1|COMPLETED|Overall Study||29
156649|NCT01047475|377707|P2|STARTED|Overall Study||38
156650|NCT01047475|377708|P1|STARTED|Overall Study||34
156651|NCT01047436|377716|P2|NOT COMPLETED|Overall Study||0
156652|NCT01047436|377717|P1|NOT COMPLETED|Overall Study||1
156653|NCT01047436|377716|P2|COMPLETED|Overall Study||15
156654|NCT01047436|377717|P1|COMPLETED|Overall Study||15
156655|NCT01047436|377716|P2|STARTED|Overall Study||15
156656|NCT01047436|377717|P1|STARTED|Overall Study||16
156657|NCT01047358|377733|P1|NOT COMPLETED|Overall Study||0
156658|NCT01047358|377733|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
156659|NCT01047358|377733|P1|STARTED|Overall Study||206
156660|NCT01047345|377742|P3|NOT COMPLETED|Extension||6
156661|NCT01047345|377743|P2|NOT COMPLETED|Extension||0
156662|NCT01047345|377744|P1|NOT COMPLETED|Extension||0
156663|NCT01047345|377742|P3|COMPLETED|Extension||96
156664|NCT01047345|377743|P2|COMPLETED|Extension||0
156665|NCT01047345|377744|P1|COMPLETED|Extension||0
156666|NCT01047345|377742|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
156667|NCT01047345|377743|P2|Vaccination 6|Extension||0
156668|NCT01047345|377744|P1|Vaccination 6|Extension||0
156669|NCT01047345|377742|P3|Vaccination 5|Extension||99
156670|NCT01047345|377743|P2|Vaccination 5|Extension||0
156671|NCT01047345|377744|P1|Vaccination 5|Extension||0
156672|NCT01047345|377742|P3|Vaccination 4|Extension||102
156673|NCT01047345|377743|P2|Vaccination 4|Extension||0
156674|NCT01047345|377744|P1|Vaccination 4|Extension||0
156675|NCT01047345|377742|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
156676|NCT01047345|377743|P2|STARTED|Extension||0
156677|NCT01047345|377744|P1|STARTED|Extension||0
156678|NCT01047345|377742|P3|NOT COMPLETED|Base Study||0
156679|NCT01047345|377743|P2|NOT COMPLETED|Base Study||6
156680|NCT01047345|377744|P1|NOT COMPLETED|Base Study||22
156681|NCT01047345|377742|P3|COMPLETED|Base Study||0
156682|NCT01047345|377743|P2|COMPLETED|Base Study||300
156683|NCT01047345|377744|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
156684|NCT01047345|377742|P3|Vaccination 3|Base Study||0
156685|NCT01047345|377743|P2|Vaccination 3|Base Study||300
156686|NCT01047345|377744|P1|Vaccination 3|Base Study||597
156687|NCT01047345|377742|P3|Vaccination 2|Base Study||0
156688|NCT01047345|377743|P2|Vaccination 2|Base Study||304
156689|NCT01047345|377744|P1|Vaccination 2|Base Study||604
156690|NCT01047345|377742|P3|Vaccination 1|Base Study||0
156691|NCT01047345|377743|P2|Vaccination 1|Base Study||306
156692|NCT01047345|377744|P1|Vaccination 1|Base Study||615
156693|NCT01047345|377742|P3|STARTED|Base Study||0
156694|NCT01047345|377743|P2|STARTED|Base Study||306
156695|NCT01047345|377744|P1|STARTED|Base Study||618
156696|NCT01047332|377766|P2|NOT COMPLETED|Overall Study||64
156697|NCT01047332|377767|P1|NOT COMPLETED|Overall Study||57
156698|NCT01047332|377766|P2|COMPLETED|Overall Study|Alive at final follow-up|4
156699|NCT01047332|377767|P1|COMPLETED|Overall Study|Alive at final follow-up|4
156700|NCT01047332|377766|P2|STARTED|Overall Study||68
156701|NCT01047332|377767|P1|STARTED|Overall Study||61
156702|NCT01047306|377781|P2|NOT COMPLETED|Overall Study||0
156703|NCT01047306|377782|P1|NOT COMPLETED|Overall Study||3
156704|NCT01047306|377781|P2|COMPLETED|Overall Study||6
156705|NCT01047306|377782|P1|COMPLETED|Overall Study||16
156706|NCT01047306|377781|P2|Discontinued From the Study|Overall Study||0
156707|NCT01047306|377782|P1|Discontinued From the Study|Overall Study||3
156708|NCT01047306|377781|P2|STARTED|Overall Study||6
156709|NCT01047306|377782|P1|STARTED|Overall Study||19
156710|NCT01047293|377856|P4|NOT COMPLETED|Overall Study||0
156711|NCT01047293|377857|P3|NOT COMPLETED|Overall Study||0
156712|NCT01047293|377858|P2|NOT COMPLETED|Overall Study||1
156713|NCT01047293|377859|P1|NOT COMPLETED|Overall Study||1
156714|NCT01047293|377856|P4|COMPLETED|Overall Study||26
156715|NCT01047293|377857|P3|COMPLETED|Overall Study||9
156716|NCT01047293|377858|P2|COMPLETED|Overall Study||7
156717|NCT01047293|377859|P1|COMPLETED|Overall Study||3
156718|NCT01047293|377856|P4|STARTED|Overall Study||26
156719|NCT01047293|377857|P3|STARTED|Overall Study||9
156720|NCT01047293|377858|P2|STARTED|Overall Study||8
156721|NCT01047293|377859|P1|STARTED|Overall Study||4
156722|NCT01047241|377866|P1|NOT COMPLETED|Overall Study||0
156723|NCT01047241|377866|P1|COMPLETED|Overall Study||50
156724|NCT01047241|377866|P1|STARTED|Overall Study||50
156725|NCT01047189|377877|P2|NOT COMPLETED|Overall Study||0
156726|NCT01047189|377878|P1|NOT COMPLETED|Overall Study||4
156727|NCT01047189|377877|P2|COMPLETED|Overall Study||13
156728|NCT01047189|377878|P1|COMPLETED|Overall Study||9
156729|NCT01047189|377877|P2|STARTED|Overall Study||13
156730|NCT01047189|377878|P1|STARTED|Overall Study||13
156731|NCT01046903|377886|P1|NOT COMPLETED|Overall Study||28
156732|NCT01046903|377886|P1|COMPLETED|Overall Study||475
156733|NCT01046903|377886|P1|STARTED|Overall Study||503
156734|NCT01046877|377899|P1|NOT COMPLETED|Overall Study||18
156735|NCT01046877|377899|P1|COMPLETED|Overall Study||7
156736|NCT01046877|377899|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
156737|NCT01046877|377899|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
156738|NCT01046877|377899|P1|STARTED|Overall Study||25
156739|NCT01046695|377915|P2|NOT COMPLETED|Overall Study||2
156740|NCT01046695|377916|P1|NOT COMPLETED|Overall Study||0
156741|NCT01046695|377915|P2|COMPLETED|Overall Study||20
156742|NCT01046695|377916|P1|COMPLETED|Overall Study||20
156743|NCT01046695|377915|P2|STARTED|Overall Study||22
156744|NCT01046695|377916|P1|STARTED|Overall Study||20
156745|NCT01046682|377928|P2|NOT COMPLETED|Overall Study||0
156746|NCT01046682|377929|P1|NOT COMPLETED|Overall Study||2
156747|NCT01046682|377928|P2|COMPLETED|Overall Study||20
156748|NCT01046682|377929|P1|COMPLETED|Overall Study||18
156749|NCT01046682|377928|P2|STARTED|Overall Study||20
156750|NCT01046682|377929|P1|STARTED|Overall Study||20
156751|NCT01046643|377937|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
156752|NCT01046643|377938|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
156753|NCT01046643|377939|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
156754|NCT01046643|377940|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
156755|NCT01046643|377937|P4|COMPLETED|Second Period Treatment or Placebo||7
156756|NCT01046643|377938|P3|COMPLETED|Second Period Treatment or Placebo||7
156757|NCT01046643|377939|P2|COMPLETED|Second Period Treatment or Placebo||6
156758|NCT01046643|377940|P1|COMPLETED|Second Period Treatment or Placebo||9
156759|NCT01046643|377937|P4|STARTED|Second Period Treatment or Placebo||7
156760|NCT01046643|377938|P3|STARTED|Second Period Treatment or Placebo||7
156761|NCT01046643|377939|P2|STARTED|Second Period Treatment or Placebo||6
156762|NCT01046643|377940|P1|STARTED|Second Period Treatment or Placebo||9
156763|NCT01046643|377937|P4|NOT COMPLETED|Washout Period||0
156764|NCT01046643|377938|P3|NOT COMPLETED|Washout Period||0
156765|NCT01046643|377939|P2|NOT COMPLETED|Washout Period||0
156766|NCT01046643|377940|P1|NOT COMPLETED|Washout Period||0
156767|NCT01046643|377937|P4|COMPLETED|Washout Period||7
156768|NCT01046643|377938|P3|COMPLETED|Washout Period||7
156769|NCT01046643|377939|P2|COMPLETED|Washout Period||6
156770|NCT01046643|377940|P1|COMPLETED|Washout Period||9
156771|NCT01046643|377937|P4|STARTED|Washout Period||7
156772|NCT01046643|377938|P3|STARTED|Washout Period||7
156773|NCT01046643|377939|P2|STARTED|Washout Period||6
156774|NCT01046643|377940|P1|STARTED|Washout Period||9
156775|NCT01046643|377937|P4|NOT COMPLETED|First Period Treatment or Placebo||0
156776|NCT01046643|377938|P3|NOT COMPLETED|First Period Treatment or Placebo||0
156777|NCT01046643|377939|P2|NOT COMPLETED|First Period Treatment or Placebo||1
156778|NCT01046643|377940|P1|NOT COMPLETED|First Period Treatment or Placebo||0
156779|NCT01046643|377937|P4|COMPLETED|First Period Treatment or Placebo||7
156780|NCT01046643|377938|P3|COMPLETED|First Period Treatment or Placebo||7
156781|NCT01046643|377939|P2|COMPLETED|First Period Treatment or Placebo||6
156782|NCT01046643|377940|P1|COMPLETED|First Period Treatment or Placebo||9
156783|NCT01046643|377937|P4|STARTED|First Period Treatment or Placebo||7
156784|NCT01046643|377938|P3|STARTED|First Period Treatment or Placebo||7
156785|NCT01046643|377939|P2|STARTED|First Period Treatment or Placebo||7
156786|NCT01046643|377940|P1|STARTED|First Period Treatment or Placebo||9
156787|NCT01046565|377962|P1|NOT COMPLETED|Overall Study||9
156788|NCT01046565|377962|P1|COMPLETED|Overall Study||66
156789|NCT01046565|377962|P1|STARTED|Overall Study||75
156790|NCT01046396|377971|P1|NOT COMPLETED|Overall Study||5
156791|NCT01046396|377971|P1|COMPLETED|Overall Study||64
156792|NCT01046396|377971|P1|STARTED|Overall Study||69
156793|NCT01046253|377982|P2|NOT COMPLETED|Fourth Intervention||0
156794|NCT01046253|377983|P1|NOT COMPLETED|Fourth Intervention||0
156795|NCT01046253|377982|P2|COMPLETED|Fourth Intervention||23
156796|NCT01046253|377983|P1|COMPLETED|Fourth Intervention||25
156797|NCT01046253|377982|P2|STARTED|Fourth Intervention||23
156798|NCT01046253|377983|P1|STARTED|Fourth Intervention||25
156799|NCT01046253|377982|P2|NOT COMPLETED|Third Washout of 7 Days||0
156800|NCT01046253|377983|P1|NOT COMPLETED|Third Washout of 7 Days||0
156801|NCT01046253|377982|P2|COMPLETED|Third Washout of 7 Days||23
156802|NCT01046253|377983|P1|COMPLETED|Third Washout of 7 Days||25
156803|NCT01046253|377982|P2|STARTED|Third Washout of 7 Days||23
156804|NCT01046253|377983|P1|STARTED|Third Washout of 7 Days||25
156805|NCT01046253|377982|P2|NOT COMPLETED|Third Intervention||0
156806|NCT01046253|377983|P1|NOT COMPLETED|Third Intervention||0
156807|NCT01046253|377982|P2|COMPLETED|Third Intervention||23
156808|NCT01046253|377983|P1|COMPLETED|Third Intervention||25
156809|NCT01046253|377982|P2|STARTED|Third Intervention||23
156810|NCT01046253|377983|P1|STARTED|Third Intervention||25
156811|NCT01046253|377982|P2|NOT COMPLETED|Second Washout of 7 Days||0
156812|NCT01046253|377983|P1|NOT COMPLETED|Second Washout of 7 Days||0
156813|NCT01046253|377982|P2|COMPLETED|Second Washout of 7 Days||23
156814|NCT01046253|377983|P1|COMPLETED|Second Washout of 7 Days||25
156815|NCT01046253|377982|P2|STARTED|Second Washout of 7 Days||23
156816|NCT01046253|377983|P1|STARTED|Second Washout of 7 Days||25
156817|NCT01046253|377982|P2|NOT COMPLETED|Second Intervention||2
156818|NCT01046253|377983|P1|NOT COMPLETED|Second Intervention||0
156819|NCT01046253|377982|P2|COMPLETED|Second Intervention||23
156820|NCT01046253|377983|P1|COMPLETED|Second Intervention||25
156821|NCT01046253|377982|P2|STARTED|Second Intervention||25
156822|NCT01046253|377983|P1|STARTED|Second Intervention||25
156823|NCT01046253|377982|P2|NOT COMPLETED|First Washout of 7 Days||0
156824|NCT01046253|377983|P1|NOT COMPLETED|First Washout of 7 Days||0
156825|NCT01046253|377982|P2|COMPLETED|First Washout of 7 Days||25
156826|NCT01046253|377983|P1|COMPLETED|First Washout of 7 Days||25
156827|NCT01046253|377982|P2|STARTED|First Washout of 7 Days||25
156828|NCT01046253|377983|P1|STARTED|First Washout of 7 Days||25
156829|NCT01046253|377982|P2|NOT COMPLETED|First Intervention||0
156830|NCT01046253|377983|P1|NOT COMPLETED|First Intervention||0
156831|NCT01046253|377982|P2|COMPLETED|First Intervention||25
156832|NCT01046253|377983|P1|COMPLETED|First Intervention||25
156833|NCT01046253|377982|P2|STARTED|First Intervention||25
156834|NCT01046253|377983|P1|STARTED|First Intervention||25
156835|NCT01046136|377995|P2|NOT COMPLETED|Overall Study||8
156836|NCT01046136|377996|P1|NOT COMPLETED|Overall Study||4
156837|NCT01046136|377995|P2|COMPLETED|Overall Study||182
156838|NCT01046136|377996|P1|COMPLETED|Overall Study||184
156839|NCT01046136|377995|P2|STARTED|Overall Study||190
156840|NCT01046136|377996|P1|STARTED|Overall Study||188
156841|NCT01046110|378008|P2|NOT COMPLETED|Overall Study||55
156842|NCT01046110|378009|P1|NOT COMPLETED|Overall Study||55
156843|NCT01046110|378008|P2|COMPLETED|Overall Study||174
156844|NCT01046110|378009|P1|COMPLETED|Overall Study||174
156845|NCT01046110|378008|P2|Exposed|Overall Study|1 subject was randomised in error|228
156846|NCT01046110|378009|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
156847|NCT01046110|378008|P2|STARTED|Overall Study||229
156848|NCT01046110|378009|P1|STARTED|Overall Study||229
156849|NCT01046084|378019|P2|NOT COMPLETED|Fourth Intervention||0
156850|NCT01046084|378020|P1|NOT COMPLETED|Fourth Intervention||0
156851|NCT01046084|378019|P2|COMPLETED|Fourth Intervention||25
156852|NCT01046084|378020|P1|COMPLETED|Fourth Intervention||23
156853|NCT01046084|378019|P2|STARTED|Fourth Intervention||25
156854|NCT01046084|378020|P1|STARTED|Fourth Intervention||23
156855|NCT01046084|378019|P2|NOT COMPLETED|Third Washout of 7 Days||0
156856|NCT01046084|378020|P1|NOT COMPLETED|Third Washout of 7 Days||2
156857|NCT01046084|378019|P2|COMPLETED|Third Washout of 7 Days||25
156858|NCT01046084|378020|P1|COMPLETED|Third Washout of 7 Days||23
156859|NCT01046084|378019|P2|STARTED|Third Washout of 7 Days||25
156860|NCT01046084|378020|P1|STARTED|Third Washout of 7 Days||25
156861|NCT01046084|378019|P2|NOT COMPLETED|Third Intervention||0
156862|NCT01046084|378020|P1|NOT COMPLETED|Third Intervention||0
156863|NCT01046084|378019|P2|COMPLETED|Third Intervention||25
156864|NCT01046084|378020|P1|COMPLETED|Third Intervention||25
156865|NCT01046084|378019|P2|STARTED|Third Intervention||25
156866|NCT01046084|378020|P1|STARTED|Third Intervention||25
156867|NCT01046084|378019|P2|NOT COMPLETED|Second Washout of 7 Days||0
156868|NCT01046084|378020|P1|NOT COMPLETED|Second Washout of 7 Days||0
156869|NCT01046084|378019|P2|COMPLETED|Second Washout of 7 Days||25
156870|NCT01046084|378020|P1|COMPLETED|Second Washout of 7 Days||25
156871|NCT01046084|378019|P2|STARTED|Second Washout of 7 Days||25
156872|NCT01046084|378020|P1|STARTED|Second Washout of 7 Days||25
156873|NCT01046084|378019|P2|NOT COMPLETED|Second Intervention||0
156874|NCT01046084|378020|P1|NOT COMPLETED|Second Intervention||0
156875|NCT01046084|378019|P2|COMPLETED|Second Intervention||25
156876|NCT01046084|378020|P1|COMPLETED|Second Intervention||25
156877|NCT01046084|378019|P2|STARTED|Second Intervention||25
156878|NCT01046084|378020|P1|STARTED|Second Intervention||25
156879|NCT01046084|378019|P2|NOT COMPLETED|First Washout of 7 Days||0
156880|NCT01046084|378020|P1|NOT COMPLETED|First Washout of 7 Days||0
156881|NCT01046084|378019|P2|COMPLETED|First Washout of 7 Days||25
156882|NCT01046084|378020|P1|COMPLETED|First Washout of 7 Days||25
156883|NCT01046084|378019|P2|STARTED|First Washout of 7 Days||25
156884|NCT01046084|378020|P1|STARTED|First Washout of 7 Days||25
156885|NCT01046084|378019|P2|NOT COMPLETED|First Intervention||0
156886|NCT01046084|378020|P1|NOT COMPLETED|First Intervention||0
156887|NCT01046084|378019|P2|COMPLETED|First Intervention||25
156888|NCT01046084|378020|P1|COMPLETED|First Intervention||25
156889|NCT01046084|378019|P2|STARTED|First Intervention||25
156890|NCT01046084|378020|P1|STARTED|First Intervention||25
156891|NCT01045993|378034|P4|NOT COMPLETED|Overall Study||0
156892|NCT01045993|378035|P3|NOT COMPLETED|Overall Study||0
156893|NCT01045993|378036|P2|NOT COMPLETED|Overall Study||1
156894|NCT01045993|378037|P1|NOT COMPLETED|Overall Study||0
156895|NCT01045993|378034|P4|COMPLETED|Overall Study||25
156896|NCT01045993|378035|P3|COMPLETED|Overall Study||5
156897|NCT01045993|378036|P2|COMPLETED|Overall Study||4
156898|NCT01045993|378037|P1|COMPLETED|Overall Study||26
156899|NCT01045993|378034|P4|STARTED|Overall Study||25
156900|NCT01045993|378035|P3|STARTED|Overall Study||5
156901|NCT01045993|378036|P2|STARTED|Overall Study||5
156902|NCT01045993|378037|P1|STARTED|Overall Study||26
156903|NCT01045967|378113|P2|NOT COMPLETED|Second Intervention||1
156904|NCT01045967|378114|P1|NOT COMPLETED|Second Intervention||0
156905|NCT01045967|378113|P2|COMPLETED|Second Intervention||27
156906|NCT01045967|378114|P1|COMPLETED|Second Intervention||28
156907|NCT01045967|378113|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
156908|NCT01045967|378114|P1|STARTED|Second Intervention||28
156909|NCT01045967|378113|P2|NOT COMPLETED|Washout of 7 Days||0
156910|NCT01045967|378114|P1|NOT COMPLETED|Washout of 7 Days||0
156911|NCT01045967|378113|P2|COMPLETED|Washout of 7 Days||28
156912|NCT01045967|378114|P1|COMPLETED|Washout of 7 Days||28
156913|NCT01045967|378113|P2|STARTED|Washout of 7 Days||28
156914|NCT01045967|378114|P1|STARTED|Washout of 7 Days||28
156915|NCT01045967|378113|P2|NOT COMPLETED|First Intervention||0
156916|NCT01045967|378114|P1|NOT COMPLETED|First Intervention||0
156917|NCT01045967|378113|P2|COMPLETED|First Intervention||28
156918|NCT01045967|378114|P1|COMPLETED|First Intervention||28
156919|NCT01045967|378113|P2|STARTED|First Intervention||28
156920|NCT01045967|378114|P1|STARTED|First Intervention||28
156921|NCT01045798|378126|P2|NOT COMPLETED|Overall Study||4
156922|NCT01045798|378127|P1|NOT COMPLETED|Overall Study||2
156923|NCT01045798|378126|P2|COMPLETED|Overall Study||5
156924|NCT01045798|378127|P1|COMPLETED|Overall Study||4
156925|NCT01045798|378126|P2|STARTED|Overall Study||9
156926|NCT01045798|378127|P1|STARTED|Overall Study||6
156927|NCT01045707|378135|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
156928|NCT01045707|378136|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
156929|NCT01045707|378135|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
156930|NCT01045707|378136|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
156931|NCT01045707|378135|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
156932|NCT01045707|378136|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
156933|NCT01045707|378135|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
156934|NCT01045707|378136|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
156935|NCT01045707|378135|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
156936|NCT01045707|378136|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
156937|NCT01045707|378135|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
156938|NCT01045707|378136|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
156939|NCT01045707|378135|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
156940|NCT01045707|378136|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
156941|NCT01045694|378152|P1|NOT COMPLETED|Overall Study||2
156942|NCT01045694|378152|P1|COMPLETED|Overall Study||6
156943|NCT01045694|378152|P1|STARTED|Overall Study||8
156944|NCT01045551|378158|P1|NOT COMPLETED|Overall Study||0
156945|NCT01045551|378158|P1|COMPLETED|Overall Study||10
156946|NCT01045551|378158|P1|STARTED|Overall Study||10
156947|NCT01045447|378168|P2|NOT COMPLETED|Overall Study||28
156948|NCT01045447|378169|P1|NOT COMPLETED|Overall Study||36
156949|NCT01045447|378168|P2|COMPLETED|Overall Study||205
156950|NCT01045447|378169|P1|COMPLETED|Overall Study||196
156951|NCT01045447|378168|P2|Exposed|Overall Study||233
156952|NCT01045447|378169|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
156953|NCT01045447|378168|P2|STARTED|Overall Study||233
156954|NCT01045447|378169|P1|STARTED|Overall Study||232
156955|NCT01045421|378183|P11|NOT COMPLETED|Phase 2||2
156956|NCT01045421|378184|P10|NOT COMPLETED|Phase 2||3
156957|NCT01045421|378185|P9|NOT COMPLETED|Phase 2||2
156958|NCT01045421|378186|P8|NOT COMPLETED|Phase 2||5
156959|NCT01045421|378187|P7|NOT COMPLETED|Phase 2||0
156960|NCT01045421|378188|P6|NOT COMPLETED|Phase 2||0
156961|NCT01045421|378189|P5|NOT COMPLETED|Phase 2||0
156962|NCT01045421|378190|P4|NOT COMPLETED|Phase 2||0
156963|NCT01045421|378191|P3|NOT COMPLETED|Phase 2||0
156964|NCT01045421|378192|P2|NOT COMPLETED|Phase 2||0
156965|NCT01045421|378193|P1|NOT COMPLETED|Phase 2||0
156966|NCT01045421|378183|P11|COMPLETED|Phase 2||58
156967|NCT01045421|378184|P10|COMPLETED|Phase 2||23
156968|NCT01045421|378185|P9|COMPLETED|Phase 2||53
156969|NCT01045421|378186|P8|COMPLETED|Phase 2||50
156970|NCT01045421|378187|P7|COMPLETED|Phase 2||53
156971|NCT01045421|378188|P6|COMPLETED|Phase 2||0
156972|NCT01045421|378189|P5|COMPLETED|Phase 2||0
156973|NCT01045421|378190|P4|COMPLETED|Phase 2||0
156974|NCT01045421|378191|P3|COMPLETED|Phase 2||0
156975|NCT01045421|378192|P2|COMPLETED|Phase 2||0
156976|NCT01045421|378193|P1|COMPLETED|Phase 2||0
156977|NCT01045421|378183|P11|STARTED|Phase 2||60
156978|NCT01045421|378184|P10|STARTED|Phase 2||26
156979|NCT01045421|378185|P9|STARTED|Phase 2||55
156980|NCT01045421|378186|P8|STARTED|Phase 2||55
156981|NCT01045421|378187|P7|STARTED|Phase 2||53
156982|NCT01045421|378188|P6|STARTED|Phase 2||0
156983|NCT01045421|378189|P5|STARTED|Phase 2||0
156984|NCT01045421|378190|P4|STARTED|Phase 2||0
156985|NCT01045421|378191|P3|STARTED|Phase 2||0
156986|NCT01045421|378192|P2|STARTED|Phase 2||0
156987|NCT01045421|378193|P1|STARTED|Phase 2||0
156988|NCT01045421|378183|P11|NOT COMPLETED|Phase 1||0
156989|NCT01045421|378184|P10|NOT COMPLETED|Phase 1||0
156990|NCT01045421|378185|P9|NOT COMPLETED|Phase 1||0
156991|NCT01045421|378186|P8|NOT COMPLETED|Phase 1||0
156992|NCT01045421|378187|P7|NOT COMPLETED|Phase 1||0
156993|NCT01045421|378188|P6|NOT COMPLETED|Phase 1||0
156994|NCT01045421|378189|P5|NOT COMPLETED|Phase 1||1
156995|NCT01045421|378190|P4|NOT COMPLETED|Phase 1||1
156996|NCT01045421|378191|P3|NOT COMPLETED|Phase 1||0
156997|NCT01045421|378192|P2|NOT COMPLETED|Phase 1||0
156998|NCT01045421|378193|P1|NOT COMPLETED|Phase 1||0
156999|NCT01045421|378183|P11|COMPLETED|Phase 1||0
157000|NCT01045421|378184|P10|COMPLETED|Phase 1||0
157001|NCT01045421|378185|P9|COMPLETED|Phase 1||0
157002|NCT01045421|378186|P8|COMPLETED|Phase 1||0
157003|NCT01045421|378187|P7|COMPLETED|Phase 1||0
157004|NCT01045421|378188|P6|COMPLETED|Phase 1||1
157005|NCT01045421|378189|P5|COMPLETED|Phase 1||2
157006|NCT01045421|378190|P4|COMPLETED|Phase 1||11
157007|NCT01045421|378191|P3|COMPLETED|Phase 1||4
157008|NCT01045421|378192|P2|COMPLETED|Phase 1||3
157009|NCT01045421|378193|P1|COMPLETED|Phase 1||1
157010|NCT01045421|378183|P11|STARTED|Phase 1||0
157011|NCT01045421|378184|P10|STARTED|Phase 1||0
157012|NCT01045421|378185|P9|STARTED|Phase 1||0
157013|NCT01045421|378186|P8|STARTED|Phase 1||0
157014|NCT01045421|378187|P7|STARTED|Phase 1||0
157015|NCT01045421|378188|P6|STARTED|Phase 1||1
157016|NCT01045421|378189|P5|STARTED|Phase 1||3
157017|NCT01045421|378190|P4|STARTED|Phase 1||12
157018|NCT01045421|378191|P3|STARTED|Phase 1||4
157019|NCT01045421|378192|P2|STARTED|Phase 1||3
157020|NCT01045421|378193|P1|STARTED|Phase 1||1
157021|NCT01045265|378273|P1|NOT COMPLETED|Overall Study||0
157022|NCT01045265|378273|P1|COMPLETED|Overall Study||16
157023|NCT01045265|378273|P1|STARTED|Overall Study||16
157024|NCT01045187|378280|P1|NOT COMPLETED|Overall Study||0
157025|NCT01045187|378280|P1|COMPLETED|Overall Study||15
157026|NCT01045187|378280|P1|STARTED|Overall Study||15
157027|NCT01045161|378287|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
157028|NCT01045161|378288|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
157029|NCT01045161|378289|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
157030|NCT01045161|378287|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
157031|NCT01045161|378288|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
157032|NCT01045161|378289|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
157033|NCT01045161|378287|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
157034|NCT01045161|378288|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
157035|NCT01045161|378289|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
157036|NCT01045161|378287|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
157037|NCT01045161|378288|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
157038|NCT01045161|378289|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
157039|NCT01045161|378287|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
157040|NCT01045161|378288|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
157041|NCT01045161|378289|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
157042|NCT01045161|378287|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
157043|NCT01045161|378288|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
157044|NCT01045161|378289|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
157045|NCT01045122|378309|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
157046|NCT01045122|378310|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
157047|NCT01045122|378309|P2|COMPLETED|Propofol Then Dexmedetomidine||6
157048|NCT01045122|378310|P1|COMPLETED|Propofol Then Dexmedetomidine||5
157049|NCT01045122|378309|P2|STARTED|Propofol Then Dexmedetomidine||6
157050|NCT01045122|378310|P1|STARTED|Propofol Then Dexmedetomidine||5
157051|NCT01045122|378309|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
157052|NCT01045122|378310|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
157053|NCT01045122|378309|P2|COMPLETED|Dexmedetomidine Then Propofol||6
157054|NCT01045122|378310|P1|COMPLETED|Dexmedetomidine Then Propofol||5
157055|NCT01045122|378309|P2|STARTED|Dexmedetomidine Then Propofol||6
157056|NCT01045122|378310|P1|STARTED|Dexmedetomidine Then Propofol||5
157057|NCT01045096|378319|P3|NOT COMPLETED|Overall Study||0
157058|NCT01045096|378320|P2|NOT COMPLETED|Overall Study||0
157059|NCT01045096|378321|P1|NOT COMPLETED|Overall Study||3
157060|NCT01045096|378319|P3|COMPLETED|Overall Study||12
157061|NCT01045096|378320|P2|COMPLETED|Overall Study||12
157062|NCT01045096|378321|P1|COMPLETED|Overall Study||9
157063|NCT01045096|378319|P3|Pharmacokinetic Set|Overall Study||11
157064|NCT01045096|378320|P2|Pharmacokinetic Set|Overall Study||11
157065|NCT01045096|378321|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
157066|NCT01045096|378319|P3|STARTED|Overall Study||12
157067|NCT01045096|378320|P2|STARTED|Overall Study||12
157068|NCT01045096|378321|P1|STARTED|Overall Study||12
157069|NCT01045057|378347|P1|NOT COMPLETED|Overall Study||0
157070|NCT01045057|378347|P1|COMPLETED|Overall Study||27
157071|NCT01045057|378347|P1|STARTED|Overall Study||27
157072|NCT01045031|378356|P2|NOT COMPLETED|Overall Study||6
157073|NCT01045031|378357|P1|NOT COMPLETED|Overall Study||9
157074|NCT01045031|378356|P2|COMPLETED|Overall Study||50
157075|NCT01045031|378357|P1|COMPLETED|Overall Study||49
157076|NCT01045031|378356|P2|STARTED|Overall Study||56
157077|NCT01045031|378357|P1|STARTED|Overall Study||58
157078|NCT01044862|378370|P3|NOT COMPLETED|Overall Study||52
157079|NCT01044862|378371|P2|NOT COMPLETED|Overall Study||49
157080|NCT01044862|378372|P1|NOT COMPLETED|Overall Study||53
157081|NCT01044862|378370|P3|COMPLETED|Overall Study||249
157082|NCT01044862|378371|P2|COMPLETED|Overall Study||251
157083|NCT01044862|378372|P1|COMPLETED|Overall Study||246
157084|NCT01044862|378370|P3|STARTED|Overall Study||301
157085|NCT01044862|378371|P2|STARTED|Overall Study||300
157086|NCT01044862|378372|P1|STARTED|Overall Study||299
157087|NCT01044771|378389|P1|NOT COMPLETED|Overall Study||0
157088|NCT01044771|378389|P1|COMPLETED|Overall Study||20
157089|NCT01044771|378389|P1|STARTED|Overall Study||20
157090|NCT01044758|378401|P7|NOT COMPLETED|Overall Study||10
157091|NCT01044758|378402|P6|NOT COMPLETED|Overall Study||3
157092|NCT01044758|378403|P5|NOT COMPLETED|Overall Study||2
157093|NCT01044758|378404|P4|NOT COMPLETED|Overall Study||2
157094|NCT01044758|378405|P3|NOT COMPLETED|Overall Study||4
157095|NCT01044758|378406|P2|NOT COMPLETED|Overall Study||0
157096|NCT01044758|378407|P1|NOT COMPLETED|Overall Study||4
157097|NCT01044758|378401|P7|COMPLETED|Overall Study||17
157098|NCT01044758|378402|P6|COMPLETED|Overall Study||8
157099|NCT01044758|378403|P5|COMPLETED|Overall Study||9
157100|NCT01044758|378404|P4|COMPLETED|Overall Study||10
157101|NCT01044758|378405|P3|COMPLETED|Overall Study||7
157102|NCT01044758|378406|P2|COMPLETED|Overall Study||12
157103|NCT01044758|378407|P1|COMPLETED|Overall Study||8
157104|NCT01044758|378401|P7|STARTED|Overall Study||27
157105|NCT01044758|378402|P6|STARTED|Overall Study||11
157106|NCT01044758|378403|P5|STARTED|Overall Study||11
157107|NCT01044758|378404|P4|STARTED|Overall Study||12
157108|NCT01044758|378405|P3|STARTED|Overall Study||11
157109|NCT01044758|378406|P2|STARTED|Overall Study||12
157110|NCT01044758|378407|P1|STARTED|Overall Study||12
157111|NCT01044732|378432|P2|NOT COMPLETED|Overall Study||50
157112|NCT01044732|378433|P1|NOT COMPLETED|Overall Study||49
157113|NCT01044732|378432|P2|COMPLETED|Overall Study||176
157114|NCT01044732|378433|P1|COMPLETED|Overall Study||173
157115|NCT01044732|378432|P2|STARTED|Overall Study||226
157116|NCT01044732|378433|P1|STARTED|Overall Study||222
157117|NCT01044706|378443|P2|NOT COMPLETED|Overall Study||0
157118|NCT01044706|378444|P1|NOT COMPLETED|Overall Study||0
157119|NCT01044706|378443|P2|COMPLETED|Overall Study||30
157120|NCT01044706|378444|P1|COMPLETED|Overall Study||30
157121|NCT01044706|378443|P2|STARTED|Overall Study||30
157122|NCT01044706|378444|P1|STARTED|Overall Study||30
157123|NCT01044693|378452|P16|NOT COMPLETED|Overall Study||0
157124|NCT01044693|378453|P15|NOT COMPLETED|Overall Study||0
157125|NCT01044693|378454|P14|NOT COMPLETED|Overall Study||0
157126|NCT01044693|378455|P13|NOT COMPLETED|Overall Study||0
157127|NCT01044693|378456|P12|NOT COMPLETED|Overall Study||0
157128|NCT01044693|378457|P11|NOT COMPLETED|Overall Study||0
157129|NCT01044693|378458|P10|NOT COMPLETED|Overall Study||0
157130|NCT01044693|378459|P9|NOT COMPLETED|Overall Study||0
157131|NCT01044693|378460|P8|NOT COMPLETED|Overall Study||0
157132|NCT01044693|378461|P7|NOT COMPLETED|Overall Study||0
157133|NCT01044693|378462|P6|NOT COMPLETED|Overall Study||0
157134|NCT01044693|378463|P5|NOT COMPLETED|Overall Study||0
157135|NCT01044693|378464|P4|NOT COMPLETED|Overall Study||0
157136|NCT01044693|378465|P3|NOT COMPLETED|Overall Study||0
157137|NCT01044693|378466|P2|NOT COMPLETED|Overall Study||0
157138|NCT01044693|378467|P1|NOT COMPLETED|Overall Study||0
157139|NCT01044693|378452|P16|COMPLETED|Overall Study||1
157140|NCT01044693|378453|P15|COMPLETED|Overall Study||1
157141|NCT01044693|378454|P14|COMPLETED|Overall Study||1
157142|NCT01044693|378455|P13|COMPLETED|Overall Study||2
157143|NCT01044693|378456|P12|COMPLETED|Overall Study||1
157144|NCT01044693|378457|P11|COMPLETED|Overall Study||1
157145|NCT01044693|378458|P10|COMPLETED|Overall Study||1
157146|NCT01044693|378459|P9|COMPLETED|Overall Study||1
157147|NCT01044693|378460|P8|COMPLETED|Overall Study||1
157148|NCT01044693|378461|P7|COMPLETED|Overall Study||1
157149|NCT01044693|378462|P6|COMPLETED|Overall Study||2
157150|NCT01044693|378463|P5|COMPLETED|Overall Study||1
157151|NCT01044693|378464|P4|COMPLETED|Overall Study||1
157152|NCT01044693|378465|P3|COMPLETED|Overall Study||1
157153|NCT01044693|378466|P2|COMPLETED|Overall Study||1
157154|NCT01044693|378467|P1|COMPLETED|Overall Study||3
157155|NCT01044693|378452|P16|STARTED|Overall Study||1
157156|NCT01044693|378453|P15|STARTED|Overall Study||1
157157|NCT01044693|378454|P14|STARTED|Overall Study||1
157158|NCT01044693|378455|P13|STARTED|Overall Study||2
157159|NCT01044693|378456|P12|STARTED|Overall Study||1
157160|NCT01044693|378457|P11|STARTED|Overall Study||1
157161|NCT01044693|378458|P10|STARTED|Overall Study||1
157162|NCT01044693|378459|P9|STARTED|Overall Study||1
157163|NCT01044693|378460|P8|STARTED|Overall Study||1
157164|NCT01044693|378461|P7|STARTED|Overall Study||1
157165|NCT01044693|378462|P6|STARTED|Overall Study||2
157166|NCT01044693|378463|P5|STARTED|Overall Study||1
157167|NCT01044693|378464|P4|STARTED|Overall Study||1
157168|NCT01044693|378465|P3|STARTED|Overall Study||1
157169|NCT01044693|378466|P2|STARTED|Overall Study||1
157170|NCT01044693|378467|P1|STARTED|Overall Study||3
157171|NCT01044589|378491|P2|NOT COMPLETED|Overall Study||5
157172|NCT01044589|378492|P1|NOT COMPLETED|Overall Study||3
157173|NCT01044589|378491|P2|COMPLETED|Overall Study||2
157174|NCT01044589|378492|P1|COMPLETED|Overall Study||3
157175|NCT01044589|378491|P2|STARTED|Overall Study||7
157176|NCT01044589|378492|P1|STARTED|Overall Study||6
157177|NCT01044537|378507|P7|NOT COMPLETED|Overall Study||0
157178|NCT01044537|378508|P6|NOT COMPLETED|Overall Study||0
157179|NCT01044537|378509|P5|NOT COMPLETED|Overall Study||0
157180|NCT01044537|378510|P4|NOT COMPLETED|Overall Study||0
157181|NCT01044537|378511|P3|NOT COMPLETED|Overall Study||0
157182|NCT01044537|378512|P2|NOT COMPLETED|Overall Study||0
157183|NCT01044537|378513|P1|NOT COMPLETED|Overall Study||0
157184|NCT01044537|378507|P7|COMPLETED|Overall Study||16
157185|NCT01044537|378508|P6|COMPLETED|Overall Study||5
157186|NCT01044537|378509|P5|COMPLETED|Overall Study||5
157187|NCT01044537|378510|P4|COMPLETED|Overall Study||6
157188|NCT01044537|378511|P3|COMPLETED|Overall Study||6
157189|NCT01044537|378512|P2|COMPLETED|Overall Study||6
157190|NCT01044537|378513|P1|COMPLETED|Overall Study||6
157191|NCT01044537|378507|P7|STARTED|Overall Study||16
157192|NCT01044537|378508|P6|STARTED|Overall Study||5
157193|NCT01044537|378509|P5|STARTED|Overall Study||5
157194|NCT01044537|378510|P4|STARTED|Overall Study||6
157195|NCT01044537|378511|P3|STARTED|Overall Study||6
157196|NCT01044537|378512|P2|STARTED|Overall Study||6
157197|NCT01044537|378513|P1|STARTED|Overall Study||6
157198|NCT01044498|378622|P2|NOT COMPLETED|Overall Study||2
157199|NCT01044498|378623|P1|NOT COMPLETED|Overall Study||3
157200|NCT01044498|378622|P2|COMPLETED|Overall Study||21
157201|NCT01044498|378623|P1|COMPLETED|Overall Study||20
157202|NCT01044498|378622|P2|STARTED|Overall Study||23
157203|NCT01044498|378623|P1|STARTED|Overall Study||23
157204|NCT01044459|378649|P2|NOT COMPLETED|Overall Study||131
157205|NCT01044459|378650|P1|NOT COMPLETED|Overall Study||133
157206|NCT01044459|378649|P2|COMPLETED|Overall Study||162
157207|NCT01044459|378650|P1|COMPLETED|Overall Study||179
157208|NCT01044459|378649|P2|STARTED|Overall Study||293
157209|NCT01044459|378650|P1|STARTED|Overall Study||312
157210|NCT01044303|378658|P1|NOT COMPLETED|Overall Study||2
157211|NCT01044303|378658|P1|COMPLETED|Overall Study||30
157212|NCT01044303|378658|P1|STARTED|Overall Study||32
157213|NCT01044290|378668|P3|NOT COMPLETED|Follow-Up 2||2
157214|NCT01044290|378669|P2|NOT COMPLETED|Follow-Up 2||2
157215|NCT01044290|378670|P1|NOT COMPLETED|Follow-Up 2||0
157216|NCT01044290|378668|P3|COMPLETED|Follow-Up 2||69
157217|NCT01044290|378669|P2|COMPLETED|Follow-Up 2||67
157218|NCT01044290|378670|P1|COMPLETED|Follow-Up 2||70
157219|NCT01044290|378668|P3|Completed F2 Interview|Follow-Up 2||64
157220|NCT01044290|378669|P2|Completed F2 Interview|Follow-Up 2||57
157221|NCT01044290|378670|P1|Completed F2 Interview|Follow-Up 2||64
157222|NCT01044290|378668|P3|STARTED|Follow-Up 2||71
157223|NCT01044290|378669|P2|STARTED|Follow-Up 2||69
157224|NCT01044290|378670|P1|STARTED|Follow-Up 2||70
157225|NCT01044290|378668|P3|NOT COMPLETED|Follow-up 1||1
157226|NCT01044290|378669|P2|NOT COMPLETED|Follow-up 1||5
157227|NCT01044290|378670|P1|NOT COMPLETED|Follow-up 1||5
157228|NCT01044290|378668|P3|COMPLETED|Follow-up 1||71
157229|NCT01044290|378669|P2|COMPLETED|Follow-up 1||69
157230|NCT01044290|378670|P1|COMPLETED|Follow-up 1||70
157231|NCT01044290|378668|P3|Completed F1 Interview|Follow-up 1||61
157232|NCT01044290|378669|P2|Completed F1 Interview|Follow-up 1||60
157233|NCT01044290|378670|P1|Completed F1 Interview|Follow-up 1||61
157234|NCT01044290|378668|P3|STARTED|Follow-up 1||72
157235|NCT01044290|378669|P2|STARTED|Follow-up 1||74
157236|NCT01044290|378670|P1|STARTED|Follow-up 1||75
157237|NCT01044290|378668|P3|NOT COMPLETED|Randomization||0
157238|NCT01044290|378669|P2|NOT COMPLETED|Randomization||0
157239|NCT01044290|378670|P1|NOT COMPLETED|Randomization||0
157240|NCT01044290|378668|P3|COMPLETED|Randomization||72
157241|NCT01044290|378669|P2|COMPLETED|Randomization||74
157242|NCT01044290|378670|P1|COMPLETED|Randomization||75
157243|NCT01044290|378668|P3|Randomized|Randomization||72
157244|NCT01044290|378669|P2|Randomized|Randomization||74
157245|NCT01044290|378670|P1|Randomized|Randomization||75
157246|NCT01044290|378668|P3|STARTED|Randomization||72
157247|NCT01044290|378669|P2|STARTED|Randomization||74
157248|NCT01044290|378670|P1|STARTED|Randomization||75
157249|NCT01044264|378696|P3|NOT COMPLETED|Overall Study||92
157250|NCT01044264|378697|P2|NOT COMPLETED|Overall Study||94
157251|NCT01044264|378698|P1|NOT COMPLETED|Overall Study||90
157252|NCT01044264|378696|P3|COMPLETED|Overall Study||108
157253|NCT01044264|378697|P2|COMPLETED|Overall Study||108
157254|NCT01044264|378698|P1|COMPLETED|Overall Study||110
157255|NCT01044264|378696|P3|STARTED|Overall Study||200
157256|NCT01044264|378697|P2|STARTED|Overall Study||202
157257|NCT01044264|378698|P1|STARTED|Overall Study||200
157258|NCT01044212|378708|P2|NOT COMPLETED|Overall Study||7
157259|NCT01044212|378709|P1|NOT COMPLETED|Overall Study||5
157260|NCT01044212|378708|P2|COMPLETED|Overall Study||30
157261|NCT01044212|378709|P1|COMPLETED|Overall Study||30
157262|NCT01044212|378708|P2|STARTED|Overall Study||37
157263|NCT01044212|378709|P1|STARTED|Overall Study||35
157264|NCT01044056|378722|P3|NOT COMPLETED|Overall Study||0
157265|NCT01044056|378723|P2|NOT COMPLETED|Overall Study||0
157266|NCT01044056|378724|P1|NOT COMPLETED|Overall Study||0
157267|NCT01044056|378722|P3|COMPLETED|Overall Study||8
157268|NCT01044056|378723|P2|COMPLETED|Overall Study||8
157269|NCT01044056|378724|P1|COMPLETED|Overall Study||8
157270|NCT01044056|378722|P3|STARTED|Overall Study||8
157271|NCT01044056|378723|P2|STARTED|Overall Study||8
157272|NCT01044056|378724|P1|STARTED|Overall Study||8
157273|NCT01044030|378743|P2|NOT COMPLETED|Overall Study||20
157274|NCT01044030|378744|P1|NOT COMPLETED|Overall Study||19
157275|NCT01044030|378743|P2|COMPLETED|Overall Study||146
157276|NCT01044030|378744|P1|COMPLETED|Overall Study||141
157277|NCT01044030|378743|P2|STARTED|Overall Study||166
157278|NCT01044030|378744|P1|STARTED|Overall Study||160
157279|NCT01043939|378754|P2|NOT COMPLETED|Second Intervention||0
157280|NCT01043939|378755|P1|NOT COMPLETED|Second Intervention||0
157281|NCT01043939|378754|P2|COMPLETED|Second Intervention||12
157282|NCT01043939|378755|P1|COMPLETED|Second Intervention||12
157283|NCT01043939|378754|P2|STARTED|Second Intervention||12
157284|NCT01043939|378755|P1|STARTED|Second Intervention||12
157285|NCT01043939|378754|P2|NOT COMPLETED|Washout Period||0
157286|NCT01043939|378755|P1|NOT COMPLETED|Washout Period||0
157287|NCT01043939|378754|P2|COMPLETED|Washout Period||12
157288|NCT01043939|378755|P1|COMPLETED|Washout Period||12
157289|NCT01043939|378754|P2|STARTED|Washout Period||12
157290|NCT01043939|378755|P1|STARTED|Washout Period||12
157291|NCT01043939|378754|P2|NOT COMPLETED|First Intervention||0
157292|NCT01043939|378755|P1|NOT COMPLETED|First Intervention||0
157293|NCT01043939|378754|P2|COMPLETED|First Intervention||12
157294|NCT01043939|378755|P1|COMPLETED|First Intervention||12
157295|NCT01043939|378754|P2|STARTED|First Intervention||12
157296|NCT01043939|378755|P1|STARTED|First Intervention||12
157297|NCT01043926|378769|P4|NOT COMPLETED|Overall Study||0
157298|NCT01043926|378770|P3|NOT COMPLETED|Overall Study||0
157299|NCT01043926|378771|P2|NOT COMPLETED|Overall Study||0
157300|NCT01043926|378772|P1|NOT COMPLETED|Overall Study||0
157301|NCT01043926|378769|P4|COMPLETED|Overall Study||0
157302|NCT01043926|378770|P3|COMPLETED|Overall Study||0
157303|NCT01043926|378771|P2|COMPLETED|Overall Study||8
157304|NCT01043926|378772|P1|COMPLETED|Overall Study||8
157305|NCT01043926|378769|P4|STARTED|Overall Study||0
157306|NCT01043926|378770|P3|STARTED|Overall Study||0
157307|NCT01043926|378771|P2|STARTED|Overall Study||8
157308|NCT01043926|378772|P1|STARTED|Overall Study||8
157309|NCT01043874|378786|P1|NOT COMPLETED|Overall Study||6
157310|NCT01043874|378786|P1|COMPLETED|Overall Study||39
157311|NCT01043874|378786|P1|STARTED|Overall Study||45
157312|NCT01043705|378796|P3|NOT COMPLETED|Overall Study||80
157313|NCT01043705|378797|P2|NOT COMPLETED|Overall Study||131
157314|NCT01043705|378798|P1|NOT COMPLETED|Overall Study||107
157315|NCT01043705|378796|P3|COMPLETED|Overall Study||498
157316|NCT01043705|378797|P2|COMPLETED|Overall Study||447
157317|NCT01043705|378798|P1|COMPLETED|Overall Study||352
157318|NCT01043705|378796|P3|STARTED|Overall Study||578
157319|NCT01043705|378797|P2|STARTED|Overall Study||578
157320|NCT01043705|378798|P1|STARTED|Overall Study||459
157321|NCT01043653|378808|P1|NOT COMPLETED|Overall Study||64
157322|NCT01043653|378808|P1|COMPLETED|Overall Study||186
157323|NCT01043653|378808|P1|STARTED|Overall Study||250
157324|NCT01043640|378813|P1|NOT COMPLETED|Overall Study||0
157325|NCT01043640|378813|P1|COMPLETED|Overall Study||46
157326|NCT01043640|378813|P1|STARTED|Overall Study||46
157327|NCT01043562|378828|P1|NOT COMPLETED|Overall Study||0
157328|NCT01043562|378828|P1|COMPLETED|Overall Study||20
157329|NCT01043562|378828|P1|STARTED|Overall Study||20
157330|NCT01043523|378835|P1|NOT COMPLETED|Overall Study||0
157331|NCT01043523|378835|P1|COMPLETED|Overall Study||52
157332|NCT01043523|378835|P1|Participants With Unenhanced Images|Overall Study||51
157333|NCT01043523|378835|P1|STARTED|Overall Study||52
157334|NCT01043432|378864|P4|NOT COMPLETED|Overall Study||0
157335|NCT01043432|378865|P3|NOT COMPLETED|Overall Study||0
157336|NCT01043432|378866|P2|NOT COMPLETED|Overall Study||0
157337|NCT01043432|378867|P1|NOT COMPLETED|Overall Study||0
157338|NCT01043432|378864|P4|COMPLETED|Overall Study||48
157339|NCT01043432|378865|P3|COMPLETED|Overall Study||12
157340|NCT01043432|378866|P2|COMPLETED|Overall Study||51
157341|NCT01043432|378867|P1|COMPLETED|Overall Study||22
157342|NCT01043432|378864|P4|STARTED|Overall Study||48
157343|NCT01043432|378865|P3|STARTED|Overall Study||12
157344|NCT01043432|378866|P2|STARTED|Overall Study||51
157345|NCT01043432|378867|P1|STARTED|Overall Study||22
157346|NCT01043393|378876|P2|NOT COMPLETED|Overall Study||0
157347|NCT01043393|378877|P1|NOT COMPLETED|Overall Study||0
157348|NCT01043393|378876|P2|COMPLETED|Overall Study||12
157349|NCT01043393|378877|P1|COMPLETED|Overall Study||12
157350|NCT01043393|378876|P2|STARTED|Overall Study||12
157351|NCT01043393|378877|P1|STARTED|Overall Study||12
157352|NCT01043185|378887|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
157353|NCT01043185|378888|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
157354|NCT01043185|378889|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
157355|NCT01043185|378890|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
157356|NCT01043185|378891|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
157357|NCT01043185|378892|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
157358|NCT01043185|378893|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
157359|NCT01043185|378894|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
157360|NCT01043185|378895|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
157361|NCT01043185|378896|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
157362|NCT01043185|378887|P10|COMPLETED|Period 7 - Fourth Intervention||3
157363|NCT01043185|378888|P9|COMPLETED|Period 7 - Fourth Intervention||2
157364|NCT01043185|378889|P8|COMPLETED|Period 7 - Fourth Intervention||3
157365|NCT01043185|378890|P7|COMPLETED|Period 7 - Fourth Intervention||3
157366|NCT01043185|378891|P6|COMPLETED|Period 7 - Fourth Intervention||3
157367|NCT01043185|378892|P5|COMPLETED|Period 7 - Fourth Intervention||2
157368|NCT01043185|378893|P4|COMPLETED|Period 7 - Fourth Intervention||2
157369|NCT01043185|378894|P3|COMPLETED|Period 7 - Fourth Intervention||3
157370|NCT01043185|378895|P2|COMPLETED|Period 7 - Fourth Intervention||2
157371|NCT01043185|378896|P1|COMPLETED|Period 7 - Fourth Intervention||3
157372|NCT01043185|378887|P10|STARTED|Period 7 - Fourth Intervention||3
157373|NCT01043185|378888|P9|STARTED|Period 7 - Fourth Intervention||2
157374|NCT01043185|378889|P8|STARTED|Period 7 - Fourth Intervention||3
157375|NCT01043185|378890|P7|STARTED|Period 7 - Fourth Intervention||3
157376|NCT01043185|378891|P6|STARTED|Period 7 - Fourth Intervention||3
157377|NCT01043185|378892|P5|STARTED|Period 7 - Fourth Intervention||2
157378|NCT01043185|378893|P4|STARTED|Period 7 - Fourth Intervention||2
157379|NCT01043185|378894|P3|STARTED|Period 7 - Fourth Intervention||3
157380|NCT01043185|378895|P2|STARTED|Period 7 - Fourth Intervention||2
157381|NCT01043185|378896|P1|STARTED|Period 7 - Fourth Intervention||3
157382|NCT01043185|378887|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
157383|NCT01043185|378888|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
157384|NCT01043185|378889|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
157385|NCT01043185|378890|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
157386|NCT01043185|378891|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
157387|NCT01043185|378892|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
157388|NCT01043185|378893|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
157389|NCT01043185|378894|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
157390|NCT01043185|378895|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
157391|NCT01043185|378896|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
157392|NCT01043185|378887|P10|COMPLETED|Period 6 - Third Washout Period||3
157393|NCT01043185|378888|P9|COMPLETED|Period 6 - Third Washout Period||2
157394|NCT01043185|378889|P8|COMPLETED|Period 6 - Third Washout Period||3
157395|NCT01043185|378890|P7|COMPLETED|Period 6 - Third Washout Period||3
157396|NCT01043185|378891|P6|COMPLETED|Period 6 - Third Washout Period||3
157397|NCT01043185|378892|P5|COMPLETED|Period 6 - Third Washout Period||2
157398|NCT01043185|378893|P4|COMPLETED|Period 6 - Third Washout Period||2
157399|NCT01043185|378894|P3|COMPLETED|Period 6 - Third Washout Period||3
157400|NCT01043185|378895|P2|COMPLETED|Period 6 - Third Washout Period||2
157401|NCT01043185|378896|P1|COMPLETED|Period 6 - Third Washout Period||3
157402|NCT01043185|378887|P10|STARTED|Period 6 - Third Washout Period||3
157403|NCT01043185|378888|P9|STARTED|Period 6 - Third Washout Period||3
157404|NCT01043185|378889|P8|STARTED|Period 6 - Third Washout Period||3
157405|NCT01043185|378890|P7|STARTED|Period 6 - Third Washout Period||3
157406|NCT01043185|378891|P6|STARTED|Period 6 - Third Washout Period||3
157407|NCT01043185|378892|P5|STARTED|Period 6 - Third Washout Period||2
157408|NCT01043185|378893|P4|STARTED|Period 6 - Third Washout Period||2
157409|NCT01043185|378894|P3|STARTED|Period 6 - Third Washout Period||3
157410|NCT01043185|378895|P2|STARTED|Period 6 - Third Washout Period||2
157411|NCT01043185|378896|P1|STARTED|Period 6 - Third Washout Period||3
157412|NCT01043185|378887|P10|NOT COMPLETED|Period 5 - Third Intervention||0
157413|NCT01043185|378888|P9|NOT COMPLETED|Period 5 - Third Intervention||0
157414|NCT01043185|378889|P8|NOT COMPLETED|Period 5 - Third Intervention||0
157415|NCT01043185|378890|P7|NOT COMPLETED|Period 5 - Third Intervention||0
157416|NCT01043185|378891|P6|NOT COMPLETED|Period 5 - Third Intervention||0
157417|NCT01043185|378892|P5|NOT COMPLETED|Period 5 - Third Intervention||0
157418|NCT01043185|378893|P4|NOT COMPLETED|Period 5 - Third Intervention||0
157419|NCT01043185|378894|P3|NOT COMPLETED|Period 5 - Third Intervention||0
157420|NCT01043185|378895|P2|NOT COMPLETED|Period 5 - Third Intervention||0
157421|NCT01043185|378896|P1|NOT COMPLETED|Period 5 - Third Intervention||0
157422|NCT01043185|378887|P10|COMPLETED|Period 5 - Third Intervention||3
157423|NCT01043185|378888|P9|COMPLETED|Period 5 - Third Intervention||3
157424|NCT01043185|378889|P8|COMPLETED|Period 5 - Third Intervention||3
157425|NCT01043185|378890|P7|COMPLETED|Period 5 - Third Intervention||3
157426|NCT01043185|378891|P6|COMPLETED|Period 5 - Third Intervention||3
157427|NCT01043185|378892|P5|COMPLETED|Period 5 - Third Intervention||2
157428|NCT01043185|378893|P4|COMPLETED|Period 5 - Third Intervention||2
157429|NCT01043185|378894|P3|COMPLETED|Period 5 - Third Intervention||3
157430|NCT01043185|378895|P2|COMPLETED|Period 5 - Third Intervention||2
157431|NCT01043185|378896|P1|COMPLETED|Period 5 - Third Intervention||3
157432|NCT01043185|378887|P10|STARTED|Period 5 - Third Intervention||3
157433|NCT01043185|378888|P9|STARTED|Period 5 - Third Intervention||3
157434|NCT01043185|378889|P8|STARTED|Period 5 - Third Intervention||3
157435|NCT01043185|378890|P7|STARTED|Period 5 - Third Intervention||3
157436|NCT01043185|378891|P6|STARTED|Period 5 - Third Intervention||3
157437|NCT01043185|378892|P5|STARTED|Period 5 - Third Intervention||2
157438|NCT01043185|378893|P4|STARTED|Period 5 - Third Intervention||2
157439|NCT01043185|378894|P3|STARTED|Period 5 - Third Intervention||3
157440|NCT01043185|378895|P2|STARTED|Period 5 - Third Intervention||2
157441|NCT01043185|378896|P1|STARTED|Period 5 - Third Intervention||3
157442|NCT01043185|378887|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
157443|NCT01043185|378888|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
157444|NCT01043185|378889|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
157445|NCT01043185|378890|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
157446|NCT01043185|378891|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
157447|NCT01043185|378892|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
157448|NCT01043185|378893|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
157449|NCT01043185|378894|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
157450|NCT01043185|378895|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
157451|NCT01043185|378896|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
157452|NCT01043185|378887|P10|COMPLETED|Period 4 - Second Washout Period||3
157453|NCT01043185|378888|P9|COMPLETED|Period 4 - Second Washout Period||3
157454|NCT01043185|378889|P8|COMPLETED|Period 4 - Second Washout Period||3
157455|NCT01043185|378890|P7|COMPLETED|Period 4 - Second Washout Period||3
157456|NCT01043185|378891|P6|COMPLETED|Period 4 - Second Washout Period||3
157457|NCT01043185|378892|P5|COMPLETED|Period 4 - Second Washout Period||2
157458|NCT01043185|378893|P4|COMPLETED|Period 4 - Second Washout Period||2
157459|NCT01043185|378894|P3|COMPLETED|Period 4 - Second Washout Period||3
157460|NCT01043185|378895|P2|COMPLETED|Period 4 - Second Washout Period||2
157461|NCT01043185|378896|P1|COMPLETED|Period 4 - Second Washout Period||3
157462|NCT01043185|378887|P10|STARTED|Period 4 - Second Washout Period||3
157463|NCT01043185|378888|P9|STARTED|Period 4 - Second Washout Period||3
157464|NCT01043185|378889|P8|STARTED|Period 4 - Second Washout Period||3
157465|NCT01043185|378890|P7|STARTED|Period 4 - Second Washout Period||3
157466|NCT01043185|378891|P6|STARTED|Period 4 - Second Washout Period||3
157467|NCT01043185|378892|P5|STARTED|Period 4 - Second Washout Period||2
157468|NCT01043185|378893|P4|STARTED|Period 4 - Second Washout Period||2
157469|NCT01043185|378894|P3|STARTED|Period 4 - Second Washout Period||3
157470|NCT01043185|378895|P2|STARTED|Period 4 - Second Washout Period||2
157471|NCT01043185|378896|P1|STARTED|Period 4 - Second Washout Period||3
157472|NCT01043185|378887|P10|NOT COMPLETED|Period 3 - Second Intervention||0
157473|NCT01043185|378888|P9|NOT COMPLETED|Period 3 - Second Intervention||0
157474|NCT01043185|378889|P8|NOT COMPLETED|Period 3 - Second Intervention||0
157475|NCT01043185|378890|P7|NOT COMPLETED|Period 3 - Second Intervention||0
157476|NCT01043185|378891|P6|NOT COMPLETED|Period 3 - Second Intervention||0
157477|NCT01043185|378892|P5|NOT COMPLETED|Period 3 - Second Intervention||0
157478|NCT01043185|378893|P4|NOT COMPLETED|Period 3 - Second Intervention||0
157479|NCT01043185|378894|P3|NOT COMPLETED|Period 3 - Second Intervention||0
157480|NCT01043185|378895|P2|NOT COMPLETED|Period 3 - Second Intervention||0
157481|NCT01043185|378896|P1|NOT COMPLETED|Period 3 - Second Intervention||0
157482|NCT01043185|378887|P10|COMPLETED|Period 3 - Second Intervention||3
157483|NCT01043185|378888|P9|COMPLETED|Period 3 - Second Intervention||3
157484|NCT01043185|378889|P8|COMPLETED|Period 3 - Second Intervention||3
157485|NCT01043185|378890|P7|COMPLETED|Period 3 - Second Intervention||3
157486|NCT01043185|378891|P6|COMPLETED|Period 3 - Second Intervention||3
157487|NCT01043185|378892|P5|COMPLETED|Period 3 - Second Intervention||2
157488|NCT01043185|378893|P4|COMPLETED|Period 3 - Second Intervention||2
157489|NCT01043185|378894|P3|COMPLETED|Period 3 - Second Intervention||3
157490|NCT01043185|378895|P2|COMPLETED|Period 3 - Second Intervention||2
157491|NCT01043185|378896|P1|COMPLETED|Period 3 - Second Intervention||3
157492|NCT01043185|378887|P10|STARTED|Period 3 - Second Intervention||3
157493|NCT01043185|378888|P9|STARTED|Period 3 - Second Intervention||3
157494|NCT01043185|378889|P8|STARTED|Period 3 - Second Intervention||3
157495|NCT01043185|378890|P7|STARTED|Period 3 - Second Intervention||3
157496|NCT01043185|378891|P6|STARTED|Period 3 - Second Intervention||3
157497|NCT01043185|378892|P5|STARTED|Period 3 - Second Intervention||2
157498|NCT01043185|378893|P4|STARTED|Period 3 - Second Intervention||2
157499|NCT01043185|378894|P3|STARTED|Period 3 - Second Intervention||3
157500|NCT01043185|378895|P2|STARTED|Period 3 - Second Intervention||2
157501|NCT01043185|378896|P1|STARTED|Period 3 - Second Intervention||3
157502|NCT01043185|378887|P10|NOT COMPLETED|Period 2 - First Washout Period||0
157503|NCT01043185|378888|P9|NOT COMPLETED|Period 2 - First Washout Period||0
157504|NCT01043185|378889|P8|NOT COMPLETED|Period 2 - First Washout Period||0
157505|NCT01043185|378890|P7|NOT COMPLETED|Period 2 - First Washout Period||0
157506|NCT01043185|378891|P6|NOT COMPLETED|Period 2 - First Washout Period||0
157507|NCT01043185|378892|P5|NOT COMPLETED|Period 2 - First Washout Period||0
157508|NCT01043185|378893|P4|NOT COMPLETED|Period 2 - First Washout Period||0
157509|NCT01043185|378894|P3|NOT COMPLETED|Period 2 - First Washout Period||0
157510|NCT01043185|378895|P2|NOT COMPLETED|Period 2 - First Washout Period||0
157511|NCT01043185|378896|P1|NOT COMPLETED|Period 2 - First Washout Period||0
157512|NCT01043185|378887|P10|COMPLETED|Period 2 - First Washout Period||3
157513|NCT01043185|378888|P9|COMPLETED|Period 2 - First Washout Period||3
157514|NCT01043185|378889|P8|COMPLETED|Period 2 - First Washout Period||3
157515|NCT01043185|378890|P7|COMPLETED|Period 2 - First Washout Period||3
157516|NCT01043185|378891|P6|COMPLETED|Period 2 - First Washout Period||3
157517|NCT01043185|378892|P5|COMPLETED|Period 2 - First Washout Period||2
157518|NCT01043185|378893|P4|COMPLETED|Period 2 - First Washout Period||2
157519|NCT01043185|378894|P3|COMPLETED|Period 2 - First Washout Period||3
157520|NCT01043185|378895|P2|COMPLETED|Period 2 - First Washout Period||2
157521|NCT01043185|378896|P1|COMPLETED|Period 2 - First Washout Period||3
157522|NCT01043185|378887|P10|STARTED|Period 2 - First Washout Period||3
157523|NCT01043185|378888|P9|STARTED|Period 2 - First Washout Period||3
157524|NCT01043185|378889|P8|STARTED|Period 2 - First Washout Period||3
157525|NCT01043185|378890|P7|STARTED|Period 2 - First Washout Period||3
157526|NCT01043185|378891|P6|STARTED|Period 2 - First Washout Period||3
157527|NCT01043185|378892|P5|STARTED|Period 2 - First Washout Period||2
157528|NCT01043185|378893|P4|STARTED|Period 2 - First Washout Period||2
157529|NCT01043185|378894|P3|STARTED|Period 2 - First Washout Period||3
157530|NCT01043185|378895|P2|STARTED|Period 2 - First Washout Period||2
157531|NCT01043185|378896|P1|STARTED|Period 2 - First Washout Period||3
157532|NCT01043185|378887|P10|NOT COMPLETED|Period 1 - First Intervention||0
157533|NCT01043185|378888|P9|NOT COMPLETED|Period 1 - First Intervention||0
157534|NCT01043185|378889|P8|NOT COMPLETED|Period 1 - First Intervention||0
157535|NCT01043185|378890|P7|NOT COMPLETED|Period 1 - First Intervention||0
157536|NCT01043185|378891|P6|NOT COMPLETED|Period 1 - First Intervention||0
157537|NCT01043185|378892|P5|NOT COMPLETED|Period 1 - First Intervention||0
157538|NCT01043185|378893|P4|NOT COMPLETED|Period 1 - First Intervention||0
157539|NCT01043185|378894|P3|NOT COMPLETED|Period 1 - First Intervention||0
157540|NCT01043185|378895|P2|NOT COMPLETED|Period 1 - First Intervention||0
157541|NCT01043185|378896|P1|NOT COMPLETED|Period 1 - First Intervention||0
157542|NCT01043185|378887|P10|COMPLETED|Period 1 - First Intervention||3
157543|NCT01043185|378888|P9|COMPLETED|Period 1 - First Intervention||3
157544|NCT01043185|378889|P8|COMPLETED|Period 1 - First Intervention||3
157545|NCT01043185|378890|P7|COMPLETED|Period 1 - First Intervention||3
157546|NCT01043185|378891|P6|COMPLETED|Period 1 - First Intervention||3
157547|NCT01043185|378892|P5|COMPLETED|Period 1 - First Intervention||2
157548|NCT01043185|378893|P4|COMPLETED|Period 1 - First Intervention||2
157549|NCT01043185|378894|P3|COMPLETED|Period 1 - First Intervention||3
157550|NCT01043185|378895|P2|COMPLETED|Period 1 - First Intervention||2
157551|NCT01043185|378896|P1|COMPLETED|Period 1 - First Intervention||3
157552|NCT01043185|378887|P10|STARTED|Period 1 - First Intervention||3
157553|NCT01043185|378888|P9|STARTED|Period 1 - First Intervention||3
157554|NCT01043185|378889|P8|STARTED|Period 1 - First Intervention||3
157555|NCT01043185|378890|P7|STARTED|Period 1 - First Intervention||3
157556|NCT01043185|378891|P6|STARTED|Period 1 - First Intervention||3
157557|NCT01043185|378892|P5|STARTED|Period 1 - First Intervention||2
157558|NCT01043185|378893|P4|STARTED|Period 1 - First Intervention||2
157559|NCT01043185|378894|P3|STARTED|Period 1 - First Intervention||3
157560|NCT01043185|378895|P2|STARTED|Period 1 - First Intervention||2
157561|NCT01043185|378896|P1|STARTED|Period 1 - First Intervention||3
157562|NCT01043146|378929|P6|NOT COMPLETED|Overall Study||0
157563|NCT01043146|378930|P5|NOT COMPLETED|Overall Study||0
157564|NCT01043146|378931|P4|NOT COMPLETED|Overall Study||0
157565|NCT01043146|378932|P3|NOT COMPLETED|Overall Study||0
157566|NCT01043146|378933|P2|NOT COMPLETED|Overall Study||0
157567|NCT01043146|378934|P1|NOT COMPLETED|Overall Study||0
157568|NCT01043146|378929|P6|COMPLETED|Overall Study||8
157569|NCT01043146|378930|P5|COMPLETED|Overall Study||8
157570|NCT01043146|378931|P4|COMPLETED|Overall Study||8
157571|NCT01043146|378932|P3|COMPLETED|Overall Study||8
157572|NCT01043146|378933|P2|COMPLETED|Overall Study||8
157573|NCT01043146|378934|P1|COMPLETED|Overall Study||10
157574|NCT01043146|378929|P6|STARTED|Overall Study||8
157575|NCT01043146|378930|P5|STARTED|Overall Study||8
157576|NCT01043146|378931|P4|STARTED|Overall Study||8
157577|NCT01043146|378932|P3|STARTED|Overall Study||8
157578|NCT01043146|378933|P2|STARTED|Overall Study||8
157579|NCT01043146|378934|P1|STARTED|Overall Study||10
157580|NCT01043133|378950|P2|NOT COMPLETED|Overall Study||2
157581|NCT01043133|378951|P1|NOT COMPLETED|Overall Study||1
157582|NCT01043133|378950|P2|COMPLETED|Overall Study||78
157583|NCT01043133|378951|P1|COMPLETED|Overall Study||74
157584|NCT01043133|378950|P2|STARTED|Overall Study||80
157585|NCT01043133|378951|P1|STARTED|Overall Study||75
157586|NCT01043094|378961|P2|NOT COMPLETED|Overall Study||0
157587|NCT01043094|378962|P1|NOT COMPLETED|Overall Study||0
157588|NCT01043094|378961|P2|COMPLETED|Overall Study||8
157589|NCT01043094|378962|P1|COMPLETED|Overall Study||8
157590|NCT01043094|378961|P2|STARTED|Overall Study||8
157591|NCT01043094|378962|P1|STARTED|Overall Study||8
157592|NCT01042977|378972|P2|NOT COMPLETED|Overall Study||55
157593|NCT01042977|378973|P1|NOT COMPLETED|Overall Study||41
157594|NCT01042977|378972|P2|COMPLETED|Overall Study||428
157595|NCT01042977|378973|P1|COMPLETED|Overall Study||441
157596|NCT01042977|378972|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
157597|NCT01042977|378973|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
157598|NCT01042938|378993|P2|NOT COMPLETED|Overall Study||2
157599|NCT01042938|378994|P1|NOT COMPLETED|Overall Study||3
157600|NCT01042938|378993|P2|COMPLETED|Overall Study||16
157601|NCT01042938|378994|P1|COMPLETED|Overall Study||14
157602|NCT01042938|378993|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
157603|NCT01042938|378994|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
157604|NCT01042795|379006|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
157605|NCT01042795|379006|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
157606|NCT01042795|379006|P1|STARTED|Follow up - 22 Months After Drug Start||2
157607|NCT01042795|379006|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
157608|NCT01042795|379006|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
157609|NCT01042795|379006|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
157610|NCT01042678|379013|P6|NOT COMPLETED|Overall Study||0
157611|NCT01042678|379014|P5|NOT COMPLETED|Overall Study||0
157612|NCT01042678|379015|P4|NOT COMPLETED|Overall Study||0
157613|NCT01042678|379016|P3|NOT COMPLETED|Overall Study||0
157614|NCT01042678|379017|P2|NOT COMPLETED|Overall Study||0
157615|NCT01042678|379018|P1|NOT COMPLETED|Overall Study||1
157616|NCT01042678|379013|P6|COMPLETED|Overall Study||0
157617|NCT01042678|379014|P5|COMPLETED|Overall Study||0
157618|NCT01042678|379015|P4|COMPLETED|Overall Study||0
157619|NCT01042678|379016|P3|COMPLETED|Overall Study||6
157620|NCT01042678|379017|P2|COMPLETED|Overall Study||6
157621|NCT01042678|379018|P1|COMPLETED|Overall Study||5
157622|NCT01042678|379013|P6|STARTED|Overall Study||0
157623|NCT01042678|379014|P5|STARTED|Overall Study||0
157624|NCT01042678|379015|P4|STARTED|Overall Study||0
157625|NCT01042678|379016|P3|STARTED|Overall Study||6
157626|NCT01042678|379017|P2|STARTED|Overall Study||6
157627|NCT01042678|379018|P1|STARTED|Overall Study||6
157628|NCT01042613|379043|P2|NOT COMPLETED|Overall Study||0
157629|NCT01042613|379044|P1|NOT COMPLETED|Overall Study||0
157630|NCT01042613|379043|P2|COMPLETED|Overall Study||74
157631|NCT01042613|379044|P1|COMPLETED|Overall Study||72
157632|NCT01042613|379043|P2|STARTED|Overall Study||74
157633|NCT01042613|379044|P1|STARTED|Overall Study||72
157634|NCT01042600|379056|P2|NOT COMPLETED|Overall Study||0
157635|NCT01042600|379057|P1|NOT COMPLETED|Overall Study||1
157636|NCT01042600|379056|P2|COMPLETED|Overall Study||30
157637|NCT01042600|379057|P1|COMPLETED|Overall Study||30
157638|NCT01042600|379056|P2|STARTED|Overall Study||30
157639|NCT01042600|379057|P1|STARTED|Overall Study||31
157640|NCT01042535|379065|P1|NOT COMPLETED|Overall Study||8
157641|NCT01042535|379065|P1|COMPLETED|Overall Study||36
157642|NCT01042535|379065|P1|STARTED|Overall Study||44
157643|NCT01042509|379073|P1|NOT COMPLETED|Overall Study||0
157644|NCT01042509|379073|P1|COMPLETED|Overall Study||15
157645|NCT01042509|379073|P1|STARTED|Overall Study||15
157646|NCT01042496|379080|P2|NOT COMPLETED|Overall Study||0
157647|NCT01042496|379081|P1|NOT COMPLETED|Overall Study||0
157648|NCT01042496|379080|P2|COMPLETED|Overall Study||33
157649|NCT01042496|379081|P1|COMPLETED|Overall Study||29
157650|NCT01042496|379080|P2|STARTED|Overall Study||33
157651|NCT01042496|379081|P1|STARTED|Overall Study||29
157652|NCT01042392|379099|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
157653|NCT01042392|379100|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
157654|NCT01042392|379101|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
157655|NCT01042392|379102|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
157656|NCT01042392|379099|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
157657|NCT01042392|379100|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
157658|NCT01042392|379101|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
157659|NCT01042392|379102|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
157660|NCT01042392|379099|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
157661|NCT01042392|379100|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
157662|NCT01042392|379101|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
157663|NCT01042392|379102|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
157664|NCT01042392|379099|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
157665|NCT01042392|379100|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
157666|NCT01042392|379101|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
157667|NCT01042392|379102|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
157668|NCT01042392|379099|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
157669|NCT01042392|379100|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
157670|NCT01042392|379101|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
157671|NCT01042392|379102|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
157672|NCT01042392|379099|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
157673|NCT01042392|379100|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
157674|NCT01042392|379101|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
157675|NCT01042392|379102|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
157676|NCT01042392|379099|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
157677|NCT01042392|379100|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
157678|NCT01042392|379101|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
157679|NCT01042392|379102|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
157680|NCT01042392|379099|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
157681|NCT01042392|379100|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
157682|NCT01042392|379101|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
157683|NCT01042392|379102|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
157684|NCT01042366|379131|P3|NOT COMPLETED|Overall Study||0
157685|NCT01042366|379132|P2|NOT COMPLETED|Overall Study||0
157686|NCT01042366|379133|P1|NOT COMPLETED|Overall Study||0
157687|NCT01042366|379131|P3|COMPLETED|Overall Study||4
157688|NCT01042366|379132|P2|COMPLETED|Overall Study||6
157689|NCT01042366|379133|P1|COMPLETED|Overall Study||5
157690|NCT01042366|379131|P3|STARTED|Overall Study||4
157691|NCT01042366|379132|P2|STARTED|Overall Study||6
157692|NCT01042366|379133|P1|STARTED|Overall Study||5
157693|NCT01042288|379142|P1|NOT COMPLETED|Overall Study||69
157694|NCT01042288|379142|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
157695|NCT01042288|379142|P1|Maintenance|Overall Study||27
157696|NCT01042288|379142|P1|STARTED|Overall Study||69
157697|NCT01042236|379150|P6|NOT COMPLETED|Treatment Period 3||0
157698|NCT01042236|379151|P5|NOT COMPLETED|Treatment Period 3||0
157699|NCT01042236|379152|P4|NOT COMPLETED|Treatment Period 3||2
157700|NCT01042236|379153|P3|NOT COMPLETED|Treatment Period 3||0
157701|NCT01042236|379154|P2|NOT COMPLETED|Treatment Period 3||0
157702|NCT01042236|379155|P1|NOT COMPLETED|Treatment Period 3||0
157703|NCT01042236|379150|P6|COMPLETED|Treatment Period 3||3
157704|NCT01042236|379151|P5|COMPLETED|Treatment Period 3||3
157705|NCT01042236|379152|P4|COMPLETED|Treatment Period 3||3
157706|NCT01042236|379153|P3|COMPLETED|Treatment Period 3||3
157707|NCT01042236|379154|P2|COMPLETED|Treatment Period 3||3
157708|NCT01042236|379155|P1|COMPLETED|Treatment Period 3||3
157709|NCT01042236|379150|P6|STARTED|Treatment Period 3||3
157710|NCT01042236|379151|P5|STARTED|Treatment Period 3||3
157711|NCT01042236|379152|P4|STARTED|Treatment Period 3||5
157712|NCT01042236|379153|P3|STARTED|Treatment Period 3||3
157713|NCT01042236|379154|P2|STARTED|Treatment Period 3||3
157714|NCT01042236|379155|P1|STARTED|Treatment Period 3||3
157715|NCT01042236|379150|P6|NOT COMPLETED|Treatment Period 2||0
157716|NCT01042236|379151|P5|NOT COMPLETED|Treatment Period 2||0
157717|NCT01042236|379152|P4|NOT COMPLETED|Treatment Period 2||0
157718|NCT01042236|379153|P3|NOT COMPLETED|Treatment Period 2||0
157719|NCT01042236|379154|P2|NOT COMPLETED|Treatment Period 2||0
157720|NCT01042236|379155|P1|NOT COMPLETED|Treatment Period 2||0
157721|NCT01042236|379150|P6|COMPLETED|Treatment Period 2||3
157722|NCT01042236|379151|P5|COMPLETED|Treatment Period 2||3
157723|NCT01042236|379152|P4|COMPLETED|Treatment Period 2||5
157724|NCT01042236|379153|P3|COMPLETED|Treatment Period 2||3
157725|NCT01042236|379154|P2|COMPLETED|Treatment Period 2||3
157726|NCT01042236|379155|P1|COMPLETED|Treatment Period 2||3
157727|NCT01042236|379150|P6|STARTED|Treatment Period 2||3
157728|NCT01042236|379151|P5|STARTED|Treatment Period 2||3
157729|NCT01042236|379152|P4|STARTED|Treatment Period 2||5
157730|NCT01042236|379153|P3|STARTED|Treatment Period 2||3
157731|NCT01042236|379154|P2|STARTED|Treatment Period 2||3
157732|NCT01042236|379155|P1|STARTED|Treatment Period 2||3
157733|NCT01042236|379150|P6|NOT COMPLETED|Treatment Period 1||0
157734|NCT01042236|379151|P5|NOT COMPLETED|Treatment Period 1||1
157735|NCT01042236|379152|P4|NOT COMPLETED|Treatment Period 1||0
157736|NCT01042236|379153|P3|NOT COMPLETED|Treatment Period 1||0
157737|NCT01042236|379154|P2|NOT COMPLETED|Treatment Period 1||1
157738|NCT01042236|379155|P1|NOT COMPLETED|Treatment Period 1||0
157739|NCT01042236|379150|P6|COMPLETED|Treatment Period 1||3
157740|NCT01042236|379151|P5|COMPLETED|Treatment Period 1||3
157741|NCT01042236|379152|P4|COMPLETED|Treatment Period 1||5
157742|NCT01042236|379153|P3|COMPLETED|Treatment Period 1||3
157743|NCT01042236|379154|P2|COMPLETED|Treatment Period 1||3
157744|NCT01042236|379155|P1|COMPLETED|Treatment Period 1||3
157745|NCT01042236|379150|P6|STARTED|Treatment Period 1||3
157746|NCT01042236|379151|P5|STARTED|Treatment Period 1||4
157747|NCT01042236|379152|P4|STARTED|Treatment Period 1||5
157748|NCT01042236|379153|P3|STARTED|Treatment Period 1||3
157749|NCT01042236|379154|P2|STARTED|Treatment Period 1||4
157750|NCT01042236|379155|P1|STARTED|Treatment Period 1||3
157751|NCT01042158|379192|P1|NOT COMPLETED|Overall Study||1
157752|NCT01042158|379192|P1|COMPLETED|Overall Study||24
157753|NCT01042158|379192|P1|STARTED|Overall Study||25
157754|NCT01042145|379201|P2|NOT COMPLETED|Overall Study||1
157755|NCT01042145|379202|P1|NOT COMPLETED|Overall Study||1
157756|NCT01042145|379201|P2|COMPLETED|Overall Study||45
157757|NCT01042145|379202|P1|COMPLETED|Overall Study||40
157758|NCT01042145|379201|P2|STARTED|Overall Study||46
157759|NCT01042145|379202|P1|STARTED|Overall Study||41
157760|NCT01042093|379222|P4|NOT COMPLETED|Overall Study||4
157761|NCT01042093|379223|P3|NOT COMPLETED|Overall Study||2
157762|NCT01042093|379224|P2|NOT COMPLETED|Overall Study||2
157763|NCT01042093|379225|P1|NOT COMPLETED|Overall Study||2
157764|NCT01042093|379222|P4|COMPLETED|Overall Study||36
157765|NCT01042093|379223|P3|COMPLETED|Overall Study||38
157766|NCT01042093|379224|P2|COMPLETED|Overall Study||38
157767|NCT01042093|379225|P1|COMPLETED|Overall Study||38
157768|NCT01042093|379222|P4|STARTED|Overall Study||40
157769|NCT01042093|379223|P3|STARTED|Overall Study||40
157770|NCT01042093|379224|P2|STARTED|Overall Study||40
157771|NCT01042093|379225|P1|STARTED|Overall Study||40
157772|NCT01041976|379245|P2|NOT COMPLETED|Overall Study||4
157773|NCT01041976|379246|P1|NOT COMPLETED|Overall Study||5
157774|NCT01041976|379245|P2|COMPLETED|Overall Study||38
157775|NCT01041976|379246|P1|COMPLETED|Overall Study||37
157776|NCT01041976|379245|P2|18 Month Follow-up|Overall Study||38
157777|NCT01041976|379246|P1|18 Month Follow-up|Overall Study||37
157778|NCT01041976|379245|P2|12 Month Follow-up|Overall Study||38
157779|NCT01041976|379246|P1|12 Month Follow-up|Overall Study||37
157780|NCT01041976|379245|P2|6 Month Follow-up|Overall Study||41
157781|NCT01041976|379246|P1|6 Month Follow-up|Overall Study||39
157782|NCT01041976|379245|P2|STARTED|Overall Study||42
157783|NCT01041976|379246|P1|STARTED|Overall Study||42
157784|NCT01041859|379256|P3|NOT COMPLETED|Double-Blind Maintenance||45
157785|NCT01041859|379257|P2|NOT COMPLETED|Double-Blind Maintenance||46
157786|NCT01041859|379258|P1|NOT COMPLETED|Double-Blind Maintenance||0
157787|NCT01041859|379256|P3|COMPLETED|Double-Blind Maintenance||107
157788|NCT01041859|379257|P2|COMPLETED|Double-Blind Maintenance||120
157789|NCT01041859|379258|P1|COMPLETED|Double-Blind Maintenance||0
157790|NCT01041859|379256|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
157791|NCT01041859|379257|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
157792|NCT01041859|379258|P1|STARTED|Double-Blind Maintenance||0
157793|NCT01041859|379256|P3|NOT COMPLETED|Open-Label Titration||0
157794|NCT01041859|379257|P2|NOT COMPLETED|Open-Label Titration||0
157795|NCT01041859|379258|P1|NOT COMPLETED|Open-Label Titration||101
157796|NCT01041859|379256|P3|COMPLETED|Open-Label Titration||0
157797|NCT01041859|379257|P2|COMPLETED|Open-Label Titration||0
157798|NCT01041859|379258|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
157799|NCT01041859|379256|P3|STARTED|Open-Label Titration||0
157800|NCT01041859|379257|P2|STARTED|Open-Label Titration||0
157801|NCT01041859|379258|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
157802|NCT01041638|379273|P1|NOT COMPLETED|Overall Study||27
157803|NCT01041638|379273|P1|COMPLETED|Overall Study||78
157804|NCT01041638|379273|P1|STARTED|Overall Study||105
157805|NCT01041573|379281|P4|NOT COMPLETED|Overall Study||2
157806|NCT01041573|379282|P3|NOT COMPLETED|Overall Study||7
157807|NCT01041573|379283|P2|NOT COMPLETED|Overall Study||13
157808|NCT01041573|379284|P1|NOT COMPLETED|Overall Study||5
157809|NCT01041573|379281|P4|COMPLETED|Overall Study||62
157810|NCT01041573|379282|P3|COMPLETED|Overall Study||387
157811|NCT01041573|379283|P2|COMPLETED|Overall Study||858
157812|NCT01041573|379284|P1|COMPLETED|Overall Study||535
157813|NCT01041573|379281|P4|STARTED|Overall Study||64
157814|NCT01041573|379282|P3|STARTED|Overall Study||394
157815|NCT01041573|379283|P2|STARTED|Overall Study||871
157816|NCT01041573|379284|P1|STARTED|Overall Study||540
157817|NCT01041417|379296|P2|NOT COMPLETED|Overall Study||3
157818|NCT01041417|379297|P1|NOT COMPLETED|Overall Study||7
157819|NCT01041417|379296|P2|COMPLETED|Overall Study||76
157820|NCT01041417|379297|P1|COMPLETED|Overall Study||73
157821|NCT01041417|379296|P2|STARTED|Overall Study||79
157822|NCT01041417|379297|P1|STARTED|Overall Study||80
157823|NCT01041404|379335|P2|NOT COMPLETED|Overall Study||294
157824|NCT01041404|379336|P1|NOT COMPLETED|Overall Study||290
157825|NCT01041404|379335|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
157826|NCT01041404|379336|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
157827|NCT01041404|379335|P2|Alive in Follow-up|Overall Study||41
157828|NCT01041404|379336|P1|Alive in Follow-up|Overall Study||40
157829|NCT01041404|379335|P2|Lost to Follow-up|Overall Study||10
157830|NCT01041404|379336|P1|Lost to Follow-up|Overall Study||12
157831|NCT01041404|379335|P2|Died in Follow-up|Overall Study||200
157832|NCT01041404|379336|P1|Died in Follow-up|Overall Study||199
157833|NCT01041404|379335|P2|Entered Follow-Up|Overall Study||251
157834|NCT01041404|379336|P1|Entered Follow-Up|Overall Study||251
157835|NCT01041404|379335|P2|STARTED|Overall Study||294
157836|NCT01041404|379336|P1|STARTED|Overall Study||290
157837|NCT01041287|379377|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
157838|NCT01041287|379378|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
157839|NCT01041287|379377|P2|COMPLETED|Treatment Period 2 (3 Months)||14
157840|NCT01041287|379378|P1|COMPLETED|Treatment Period 2 (3 Months)||16
157841|NCT01041287|379377|P2|STARTED|Treatment Period 2 (3 Months)||19
157842|NCT01041287|379378|P1|STARTED|Treatment Period 2 (3 Months)||19
157843|NCT01041287|379377|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
157844|NCT01041287|379378|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
157845|NCT01041287|379377|P2|COMPLETED|Treatment Period 1 (3 Months)||19
157846|NCT01041287|379378|P1|COMPLETED|Treatment Period 1 (3 Months)||19
157847|NCT01041287|379377|P2|STARTED|Treatment Period 1 (3 Months)||19
157848|NCT01041287|379378|P1|STARTED|Treatment Period 1 (3 Months)||19
157849|NCT01041209|379390|P2|NOT COMPLETED|Overall Study||0
157850|NCT01041209|379391|P1|NOT COMPLETED|Overall Study||0
157851|NCT01041209|379390|P2|COMPLETED|Overall Study||60
157852|NCT01041209|379391|P1|COMPLETED|Overall Study||60
157853|NCT01041209|379390|P2|STARTED|Overall Study||60
157854|NCT01041209|379391|P1|STARTED|Overall Study||60
157855|NCT01040871|379401|P2|NOT COMPLETED|Overall Study||7
157856|NCT01040871|379402|P1|NOT COMPLETED|Overall Study||13
157857|NCT01040871|379401|P2|COMPLETED|Overall Study||73
157858|NCT01040871|379402|P1|COMPLETED|Overall Study||71
157859|NCT01040871|379401|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
157860|NCT01040871|379402|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
157861|NCT01040858|379422|P2|NOT COMPLETED|Overall Study||0
157862|NCT01040858|379423|P1|NOT COMPLETED|Overall Study||9
157863|NCT01040858|379422|P2|COMPLETED|Overall Study||69
157864|NCT01040858|379423|P1|COMPLETED|Overall Study||50
157865|NCT01040858|379422|P2|STARTED|Overall Study||69
157866|NCT01040858|379423|P1|STARTED|Overall Study||59
157867|NCT01040845|379453|P2|NOT COMPLETED|Overall Study||1
157868|NCT01040845|379454|P1|NOT COMPLETED|Overall Study||2
157869|NCT01040845|379453|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
157870|NCT01040845|379454|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
157871|NCT01040845|379453|P2|STARTED|Overall Study||15
157872|NCT01040845|379454|P1|STARTED|Overall Study||15
157873|NCT01040832|379469|P2|NOT COMPLETED|Overall Study||37
157874|NCT01040832|379470|P1|NOT COMPLETED|Overall Study||46
157875|NCT01040832|379469|P2|COMPLETED|Overall Study||16
157876|NCT01040832|379470|P1|COMPLETED|Overall Study||8
157877|NCT01040832|379469|P2|STARTED|Overall Study||53
157972|NCT01040169|379975|P1|NOT COMPLETED|Overall Study||3
157878|NCT01040832|379470|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
157879|NCT01040819|379486|P2|NOT COMPLETED|Overall Study||0
157880|NCT01040819|379487|P1|NOT COMPLETED|Overall Study||0
157881|NCT01040819|379486|P2|COMPLETED|Overall Study||12
157882|NCT01040819|379487|P1|COMPLETED|Overall Study||13
157883|NCT01040819|379486|P2|STARTED|Overall Study||12
157884|NCT01040819|379487|P1|STARTED|Overall Study||13
157885|NCT01040793|379493|P6|NOT COMPLETED|Overall Study||1
157886|NCT01040793|379494|P5|NOT COMPLETED|Overall Study||4
157887|NCT01040793|379495|P4|NOT COMPLETED|Overall Study||4
157888|NCT01040793|379496|P3|NOT COMPLETED|Overall Study||3
157889|NCT01040793|379497|P2|NOT COMPLETED|Overall Study||5
157890|NCT01040793|379498|P1|NOT COMPLETED|Overall Study||6
157891|NCT01040793|379493|P6|COMPLETED|Overall Study||26
157892|NCT01040793|379494|P5|COMPLETED|Overall Study||22
157893|NCT01040793|379495|P4|COMPLETED|Overall Study||22
157894|NCT01040793|379496|P3|COMPLETED|Overall Study||23
157895|NCT01040793|379497|P2|COMPLETED|Overall Study||21
157896|NCT01040793|379498|P1|COMPLETED|Overall Study||20
157897|NCT01040793|379493|P6|STARTED|Overall Study||27
157898|NCT01040793|379494|P5|STARTED|Overall Study||26
157899|NCT01040793|379495|P4|STARTED|Overall Study||26
157900|NCT01040793|379496|P3|STARTED|Overall Study||26
157901|NCT01040793|379497|P2|STARTED|Overall Study||26
157902|NCT01040793|379498|P1|STARTED|Overall Study|Entered and treated|26
157903|NCT01040780|379577|P2|NOT COMPLETED|Overall Study||3
157904|NCT01040780|379578|P1|NOT COMPLETED|Overall Study||1
157905|NCT01040780|379577|P2|COMPLETED|Overall Study||196
157906|NCT01040780|379578|P1|COMPLETED|Overall Study||199
157907|NCT01040780|379577|P2|STARTED|Overall Study||199
157908|NCT01040780|379578|P1|STARTED|Overall Study||200
157909|NCT01040728|379592|P4|NOT COMPLETED|Overall Study||6
157910|NCT01040728|379593|P3|NOT COMPLETED|Overall Study||1
157911|NCT01040728|379594|P2|NOT COMPLETED|Overall Study||11
157912|NCT01040728|379595|P1|NOT COMPLETED|Overall Study||4
157913|NCT01040728|379592|P4|COMPLETED|Overall Study||24
157914|NCT01040728|379593|P3|COMPLETED|Overall Study||30
157915|NCT01040728|379594|P2|COMPLETED|Overall Study||19
157916|NCT01040728|379595|P1|COMPLETED|Overall Study||27
157917|NCT01040728|379592|P4|STARTED|Overall Study||30
157918|NCT01040728|379593|P3|STARTED|Overall Study||31
157919|NCT01040728|379594|P2|STARTED|Overall Study||30
157920|NCT01040728|379595|P1|STARTED|Overall Study||31
157921|NCT01040689|379665|P4|NOT COMPLETED|Overall Study||4
157922|NCT01040689|379666|P3|NOT COMPLETED|Overall Study||4
157923|NCT01040689|379667|P2|NOT COMPLETED|Overall Study||2
157924|NCT01040689|379668|P1|NOT COMPLETED|Overall Study||3
157925|NCT01040689|379665|P4|COMPLETED|Overall Study||23
157926|NCT01040689|379666|P3|COMPLETED|Overall Study||23
157927|NCT01040689|379667|P2|COMPLETED|Overall Study||25
157928|NCT01040689|379668|P1|COMPLETED|Overall Study||24
157929|NCT01040689|379665|P4|STARTED|Overall Study||27
157930|NCT01040689|379666|P3|STARTED|Overall Study||27
157931|NCT01040689|379667|P2|STARTED|Overall Study||27
157932|NCT01040689|379668|P1|STARTED|Overall Study||27
157933|NCT01040624|379740|P2|NOT COMPLETED|Overall Study||0
157934|NCT01040624|379741|P1|NOT COMPLETED|Overall Study||0
157935|NCT01040624|379740|P2|COMPLETED|Overall Study||19
157936|NCT01040624|379741|P1|COMPLETED|Overall Study||58
157937|NCT01040624|379740|P2|STARTED|Overall Study||19
157938|NCT01040624|379741|P1|STARTED|Overall Study||58
157939|NCT01040403|379747|P1|NOT COMPLETED|Overall Study||20
157940|NCT01040403|379747|P1|COMPLETED|Overall Study|All treatment periods|213
157941|NCT01040403|379747|P1|Completed T+O 5/10|Overall Study||107
157942|NCT01040403|379747|P1|Completed T+O 2.5/10|Overall Study||110
157943|NCT01040403|379747|P1|Completed T+O 1.25/10|Overall Study||106
157944|NCT01040403|379747|P1|Completed Olo 10|Overall Study||109
157945|NCT01040403|379747|P1|Completed T+O 5/5|Overall Study||106
157946|NCT01040403|379747|P1|Completed T+O 2.5/5|Overall Study||111
157947|NCT01040403|379747|P1|Completed T+O 1.25/5|Overall Study||105
157948|NCT01040403|379747|P1|Completed Olo 5|Overall Study||106
157949|NCT01040403|379747|P1|STARTED|Overall Study||233
157950|NCT01040351|379935|P2|NOT COMPLETED|Overall Study||2
157951|NCT01040351|379936|P1|NOT COMPLETED|Overall Study||1
157952|NCT01040351|379935|P2|COMPLETED|Overall Study|May 2010|53
157953|NCT01040351|379936|P1|COMPLETED|Overall Study|May 2010|54
157954|NCT01040351|379935|P2|STARTED|Overall Study|October 2006|55
157955|NCT01040351|379936|P1|STARTED|Overall Study|October 2006|55
157956|NCT01040260|379946|P2|NOT COMPLETED|Overall Study||11
157957|NCT01040260|379947|P1|NOT COMPLETED|Overall Study||15
157958|NCT01040260|379946|P2|COMPLETED|Overall Study||39
157959|NCT01040260|379947|P1|COMPLETED|Overall Study||38
157960|NCT01040260|379946|P2|STARTED|Overall Study||50
157961|NCT01040260|379947|P1|STARTED|Overall Study||53
157962|NCT01040208|379956|P3|NOT COMPLETED|Overall Study||3
157963|NCT01040208|379957|P2|NOT COMPLETED|Overall Study||13
157964|NCT01040208|379958|P1|NOT COMPLETED|Overall Study||6
157965|NCT01040208|379956|P3|COMPLETED|Overall Study||35
157966|NCT01040208|379957|P2|COMPLETED|Overall Study||15
157967|NCT01040208|379958|P1|COMPLETED|Overall Study||39
157968|NCT01040208|379956|P3|STARTED|Overall Study||38
157969|NCT01040208|379957|P2|STARTED|Overall Study||28
157970|NCT01040208|379958|P1|STARTED|Overall Study||45
157971|NCT01040169|379974|P2|NOT COMPLETED|Overall Study||8
157973|NCT01040169|379974|P2|COMPLETED|Overall Study||36
157974|NCT01040169|379975|P1|COMPLETED|Overall Study||32
157975|NCT01040169|379974|P2|STARTED|Overall Study||44
157976|NCT01040169|379975|P1|STARTED|Overall Study||35
157977|NCT01040130|379983|P6|NOT COMPLETED|Overall Study||4
157978|NCT01040130|379984|P5|NOT COMPLETED|Overall Study||0
157979|NCT01040130|379985|P4|NOT COMPLETED|Overall Study||5
157980|NCT01040130|379986|P3|NOT COMPLETED|Overall Study||2
157981|NCT01040130|379987|P2|NOT COMPLETED|Overall Study||3
157982|NCT01040130|379988|P1|NOT COMPLETED|Overall Study||3
157983|NCT01040130|379983|P6|COMPLETED|Overall Study||22
157984|NCT01040130|379984|P5|COMPLETED|Overall Study||25
157985|NCT01040130|379985|P4|COMPLETED|Overall Study||20
157986|NCT01040130|379986|P3|COMPLETED|Overall Study||23
157987|NCT01040130|379987|P2|COMPLETED|Overall Study||22
157988|NCT01040130|379988|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
157989|NCT01040130|379983|P6|STARTED|Overall Study||26
157990|NCT01040130|379984|P5|STARTED|Overall Study||25
157991|NCT01040130|379985|P4|STARTED|Overall Study||25
157992|NCT01040130|379986|P3|STARTED|Overall Study||25
157993|NCT01040130|379987|P2|STARTED|Overall Study||25
157994|NCT01040130|379988|P1|STARTED|Overall Study|Number of patients entered and treated|25
157995|NCT01040052|380065|P1|NOT COMPLETED|Overall Study||0
157996|NCT01040052|380065|P1|COMPLETED|Overall Study||30
157997|NCT01040052|380065|P1|STARTED|Overall Study||30
157998|NCT01039792|380071|P2|NOT COMPLETED|Overall Study||1
157999|NCT01039792|380072|P1|NOT COMPLETED|Overall Study||6
158000|NCT01039792|380071|P2|COMPLETED|Overall Study||27
158001|NCT01039792|380072|P1|COMPLETED|Overall Study||23
158002|NCT01039792|380071|P2|STARTED|Overall Study||28
158003|NCT01039792|380072|P1|STARTED|Overall Study||29
158004|NCT01039688|380081|P3|NOT COMPLETED|Overall Study||80
158005|NCT01039688|380082|P2|NOT COMPLETED|Overall Study||111
158006|NCT01039688|380083|P1|NOT COMPLETED|Overall Study||107
158007|NCT01039688|380081|P3|COMPLETED|Overall Study||106
158008|NCT01039688|380082|P2|COMPLETED|Overall Study||286
158009|NCT01039688|380083|P1|COMPLETED|Overall Study||266
158010|NCT01039688|380081|P3|STARTED|Overall Study||186
158011|NCT01039688|380082|P2|STARTED|Overall Study||397
158012|NCT01039688|380083|P1|STARTED|Overall Study||373
158013|NCT01039675|380354|P2|NOT COMPLETED|Overall Study||7
158014|NCT01039675|380355|P1|NOT COMPLETED|Overall Study||0
158015|NCT01039675|380354|P2|COMPLETED|Overall Study||35
158016|NCT01039675|380355|P1|COMPLETED|Overall Study||9
158017|NCT01039675|380354|P2|STARTED|Overall Study||42
158018|NCT01039675|380355|P1|STARTED|Overall Study||9
158019|NCT01039584|380368|P3|NOT COMPLETED|Overall Study||57
158020|NCT01039584|380369|P2|NOT COMPLETED|Overall Study||97
158021|NCT01039584|380370|P1|NOT COMPLETED|Overall Study||103
158022|NCT01039584|380368|P3|COMPLETED|Overall Study||65
158023|NCT01039584|380369|P2|COMPLETED|Overall Study||146
158024|NCT01039584|380370|P1|COMPLETED|Overall Study||143
158025|NCT01039584|380368|P3|STARTED|Overall Study||122
158026|NCT01039584|380369|P2|STARTED|Overall Study||243
158027|NCT01039584|380370|P1|STARTED|Overall Study||246
158028|NCT01039519|380384|P1|NOT COMPLETED|Survival Follow-up||27
158029|NCT01039519|380384|P1|COMPLETED|Survival Follow-up||0
158030|NCT01039519|380384|P1|STARTED|Survival Follow-up||27
158031|NCT01039519|380384|P1|NOT COMPLETED|Treatment||27
158032|NCT01039519|380384|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
158033|NCT01039519|380384|P1|STARTED|Treatment||27
158034|NCT01039428|380395|P2|NOT COMPLETED|Overall Study||0
158035|NCT01039428|380396|P1|NOT COMPLETED|Overall Study||2
158036|NCT01039428|380395|P2|COMPLETED|Overall Study||28
158037|NCT01039428|380396|P1|COMPLETED|Overall Study||33
158038|NCT01039428|380395|P2|STARTED|Overall Study||28
158039|NCT01039428|380396|P1|STARTED|Overall Study||35
158040|NCT01039376|380420|P2|NOT COMPLETED|Overall Study||202
158041|NCT01039376|380421|P1|NOT COMPLETED|Overall Study||206
158042|NCT01039376|380420|P2|COMPLETED|Overall Study||34
158043|NCT01039376|380421|P1|COMPLETED|Overall Study||32
158044|NCT01039376|380420|P2|Ongoing|Overall Study||182
158045|NCT01039376|380421|P1|Ongoing|Overall Study||189
158046|NCT01039376|380420|P2|STARTED|Overall Study||236
158047|NCT01039376|380421|P1|STARTED|Overall Study||238
158048|NCT01039207|380479|P1|NOT COMPLETED|Overall Study||0
158049|NCT01039207|380479|P1|COMPLETED|Overall Study||31
158050|NCT01039207|380479|P1|STARTED|Overall Study||31
158051|NCT01038921|380489|P2|NOT COMPLETED|Overall Study||0
158052|NCT01038921|380490|P1|NOT COMPLETED|Overall Study||2
158053|NCT01038921|380489|P2|COMPLETED|Overall Study||20
158054|NCT01038921|380490|P1|COMPLETED|Overall Study|2 subjects withdrew|17
158055|NCT01038921|380489|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
158056|NCT01038921|380490|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
158057|NCT01038869|380496|P1|NOT COMPLETED|Overall Study||7
158058|NCT01038869|380496|P1|COMPLETED|Overall Study||13
158059|NCT01038869|380496|P1|STARTED|Overall Study||20
158060|NCT01038856|380504|P1|NOT COMPLETED|Overall Study||2
158061|NCT01038856|380504|P1|COMPLETED|Overall Study||3
158062|NCT01038856|380504|P1|STARTED|Overall Study||5
158063|NCT01038752|380513|P2|NOT COMPLETED|Overall Study||5
158064|NCT01038752|380514|P1|NOT COMPLETED|Overall Study||5
158065|NCT01038752|380513|P2|COMPLETED|Overall Study||1
158066|NCT01038752|380514|P1|COMPLETED|Overall Study||3
158067|NCT01038752|380513|P2|STARTED|Overall Study||6
158068|NCT01038752|380514|P1|STARTED|Overall Study||8
158069|NCT01038713|380537|P3|NOT COMPLETED|Overall Study||1
158070|NCT01038713|380538|P2|NOT COMPLETED|Overall Study||3
158071|NCT01038713|380539|P1|NOT COMPLETED|Overall Study||5
158072|NCT01038713|380537|P3|COMPLETED|Overall Study||16
158073|NCT01038713|380538|P2|COMPLETED|Overall Study||17
158074|NCT01038713|380539|P1|COMPLETED|Overall Study||21
158075|NCT01038713|380537|P3|STARTED|Overall Study||17
158076|NCT01038713|380538|P2|STARTED|Overall Study||20
158077|NCT01038713|380539|P1|STARTED|Overall Study||26
158078|NCT01038635|380568|P9|NOT COMPLETED|Overall Study||2
158079|NCT01038635|380569|P8|NOT COMPLETED|Overall Study||5
158080|NCT01038635|380570|P7|NOT COMPLETED|Overall Study||2
158081|NCT01038635|380571|P6|NOT COMPLETED|Overall Study||0
158082|NCT01038635|380572|P5|NOT COMPLETED|Overall Study||1
158083|NCT01038635|380573|P4|NOT COMPLETED|Overall Study||0
158084|NCT01038635|380574|P3|NOT COMPLETED|Overall Study||0
158085|NCT01038635|380575|P2|NOT COMPLETED|Overall Study||0
158086|NCT01038635|380576|P1|NOT COMPLETED|Overall Study||2
158087|NCT01038635|380568|P9|COMPLETED|Overall Study||38
158088|NCT01038635|380569|P8|COMPLETED|Overall Study||15
158089|NCT01038635|380570|P7|COMPLETED|Overall Study||5
158090|NCT01038635|380571|P6|COMPLETED|Overall Study||3
158091|NCT01038635|380572|P5|COMPLETED|Overall Study||3
158092|NCT01038635|380573|P4|COMPLETED|Overall Study||3
158093|NCT01038635|380574|P3|COMPLETED|Overall Study||3
158094|NCT01038635|380575|P2|COMPLETED|Overall Study||3
158095|NCT01038635|380576|P1|COMPLETED|Overall Study||3
158096|NCT01038635|380568|P9|STARTED|Overall Study||40
158097|NCT01038635|380569|P8|STARTED|Overall Study||20
158098|NCT01038635|380570|P7|STARTED|Overall Study||7
158099|NCT01038635|380571|P6|STARTED|Overall Study||3
158100|NCT01038635|380572|P5|STARTED|Overall Study||4
158101|NCT01038635|380573|P4|STARTED|Overall Study||3
158102|NCT01038635|380574|P3|STARTED|Overall Study||3
158103|NCT01038635|380575|P2|STARTED|Overall Study||3
158104|NCT01038635|380576|P1|STARTED|Overall Study||5
158105|NCT01038609|380602|P5|NOT COMPLETED|Overall Study||1
158106|NCT01038609|380603|P4|NOT COMPLETED|Overall Study||1
158107|NCT01038609|380604|P3|NOT COMPLETED|Overall Study||1
158108|NCT01038609|380605|P2|NOT COMPLETED|Overall Study||1
158109|NCT01038609|380606|P1|NOT COMPLETED|Overall Study||1
158110|NCT01038609|380602|P5|COMPLETED|Overall Study||50
158111|NCT01038609|380603|P4|COMPLETED|Overall Study||47
158112|NCT01038609|380604|P3|COMPLETED|Overall Study||48
158113|NCT01038609|380605|P2|COMPLETED|Overall Study||51
158114|NCT01038609|380606|P1|COMPLETED|Overall Study||49
158115|NCT01038609|380602|P5|STARTED|Overall Study||51
158116|NCT01038609|380603|P4|STARTED|Overall Study||48
158117|NCT01038609|380604|P3|STARTED|Overall Study||49
158118|NCT01038609|380605|P2|STARTED|Overall Study||52
158119|NCT01038609|380606|P1|STARTED|Overall Study||50
158120|NCT01038336|380651|P3|NOT COMPLETED|Overall Study||0
158121|NCT01038336|380652|P2|NOT COMPLETED|Overall Study||0
158122|NCT01038336|380653|P1|NOT COMPLETED|Overall Study||0
158123|NCT01038336|380651|P3|COMPLETED|Overall Study||44
158124|NCT01038336|380652|P2|COMPLETED|Overall Study||42
158125|NCT01038336|380653|P1|COMPLETED|Overall Study||43
158126|NCT01038336|380651|P3|STARTED|Overall Study||44
158127|NCT01038336|380652|P2|STARTED|Overall Study||42
158128|NCT01038336|380653|P1|STARTED|Overall Study||43
158129|NCT01038323|380685|P3|NOT COMPLETED|Overall Study||4
158130|NCT01038323|380686|P2|NOT COMPLETED|Overall Study||2
158131|NCT01038323|380687|P1|NOT COMPLETED|Overall Study||3
158132|NCT01038323|380685|P3|COMPLETED|Overall Study||15
158133|NCT01038323|380686|P2|COMPLETED|Overall Study||17
158134|NCT01038323|380687|P1|COMPLETED|Overall Study||17
158135|NCT01038323|380685|P3|STARTED|Overall Study||19
158136|NCT01038323|380686|P2|STARTED|Overall Study||19
158137|NCT01038323|380687|P1|STARTED|Overall Study||20
158138|NCT01038128|380701|P1|NOT COMPLETED|Overall Study||4
158139|NCT01038128|380701|P1|COMPLETED|Overall Study||1
158140|NCT01038128|380701|P1|Baseline Visit|Overall Study||3
158141|NCT01038128|380701|P1|STARTED|Overall Study||5
158142|NCT01037452|380713|P4|NOT COMPLETED|Overall Study||0
158143|NCT01037452|380714|P3|NOT COMPLETED|Overall Study||0
158144|NCT01037452|380715|P2|NOT COMPLETED|Overall Study||0
158145|NCT01037452|380716|P1|NOT COMPLETED|Overall Study||0
158146|NCT01037452|380713|P4|COMPLETED|Overall Study||30
158147|NCT01037452|380714|P3|COMPLETED|Overall Study||30
158148|NCT01037452|380715|P2|COMPLETED|Overall Study||30
158149|NCT01037452|380716|P1|COMPLETED|Overall Study||30
158150|NCT01037452|380713|P4|STARTED|Overall Study||30
158151|NCT01037452|380714|P3|STARTED|Overall Study||30
158152|NCT01037452|380715|P2|STARTED|Overall Study||30
158153|NCT01037452|380716|P1|STARTED|Overall Study||30
158154|NCT01037309|380744|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
158155|NCT01037309|380745|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
158156|NCT01037309|380746|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
158157|NCT01037309|380747|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
158158|NCT01037309|380748|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
158159|NCT01037309|380749|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
158160|NCT01037309|380750|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
158161|NCT01037309|380751|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
158162|NCT01037309|380752|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
158163|NCT01037309|380744|P9|COMPLETED|Intravenous Period 7 - 9||3
158164|NCT01037309|380745|P8|COMPLETED|Intravenous Period 7 - 9||3
158165|NCT01037309|380746|P7|COMPLETED|Intravenous Period 7 - 9||3
158166|NCT01037309|380747|P6|COMPLETED|Intravenous Period 7 - 9||0
158167|NCT01037309|380748|P5|COMPLETED|Intravenous Period 7 - 9||0
158168|NCT01037309|380749|P4|COMPLETED|Intravenous Period 7 - 9||0
158169|NCT01037309|380750|P3|COMPLETED|Intravenous Period 7 - 9||0
158170|NCT01037309|380751|P2|COMPLETED|Intravenous Period 7 - 9||0
158171|NCT01037309|380752|P1|COMPLETED|Intravenous Period 7 - 9||0
158172|NCT01037309|380744|P9|STARTED|Intravenous Period 7 - 9||3
158173|NCT01037309|380745|P8|STARTED|Intravenous Period 7 - 9||3
158174|NCT01037309|380746|P7|STARTED|Intravenous Period 7 - 9||3
158175|NCT01037309|380747|P6|STARTED|Intravenous Period 7 - 9||0
158176|NCT01037309|380748|P5|STARTED|Intravenous Period 7 - 9||0
158177|NCT01037309|380749|P4|STARTED|Intravenous Period 7 - 9||0
158178|NCT01037309|380750|P3|STARTED|Intravenous Period 7 - 9||0
158179|NCT01037309|380751|P2|STARTED|Intravenous Period 7 - 9||0
158180|NCT01037309|380752|P1|STARTED|Intravenous Period 7 - 9||0
158181|NCT01037309|380744|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158182|NCT01037309|380745|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158183|NCT01037309|380746|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158184|NCT01037309|380747|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158185|NCT01037309|380748|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158186|NCT01037309|380749|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158187|NCT01037309|380750|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158188|NCT01037309|380751|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158189|NCT01037309|380752|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
158190|NCT01037309|380744|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
158191|NCT01037309|380745|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
158192|NCT01037309|380746|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
158193|NCT01037309|380747|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
158194|NCT01037309|380748|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
158195|NCT01037309|380749|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
158196|NCT01037309|380750|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
158197|NCT01037309|380751|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
158198|NCT01037309|380752|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
158199|NCT01037309|380744|P9|STARTED|Subcutaneous Cohort 1 - 6||0
158200|NCT01037309|380745|P8|STARTED|Subcutaneous Cohort 1 - 6||0
158201|NCT01037309|380746|P7|STARTED|Subcutaneous Cohort 1 - 6||0
158202|NCT01037309|380747|P6|STARTED|Subcutaneous Cohort 1 - 6||3
158203|NCT01037309|380748|P5|STARTED|Subcutaneous Cohort 1 - 6||3
158204|NCT01037309|380749|P4|STARTED|Subcutaneous Cohort 1 - 6||3
158205|NCT01037309|380750|P3|STARTED|Subcutaneous Cohort 1 - 6||3
158206|NCT01037309|380751|P2|STARTED|Subcutaneous Cohort 1 - 6||3
158207|NCT01037309|380752|P1|STARTED|Subcutaneous Cohort 1 - 6||3
158208|NCT01037244|380785|P4|NOT COMPLETED|Overall Study||14
158209|NCT01037244|380786|P3|NOT COMPLETED|Overall Study||14
158210|NCT01037244|380787|P2|NOT COMPLETED|Overall Study||14
158211|NCT01037244|380788|P1|NOT COMPLETED|Overall Study||13
158212|NCT01037244|380785|P4|COMPLETED|Overall Study||140
158213|NCT01037244|380786|P3|COMPLETED|Overall Study||144
158214|NCT01037244|380787|P2|COMPLETED|Overall Study||138
158215|NCT01037244|380788|P1|COMPLETED|Overall Study||141
158216|NCT01037244|380785|P4|Safety Population|Overall Study||152
158217|NCT01037244|380786|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
158218|NCT01037244|380787|P2|Safety Population|Overall Study||150
158219|NCT01037244|380788|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
158220|NCT01037244|380785|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
158221|NCT01037244|380786|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
158222|NCT01037244|380787|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
158223|NCT01037244|380788|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
158224|NCT01037244|380785|P4|STARTED|Overall Study||154
158225|NCT01037244|380786|P3|STARTED|Overall Study||158
158226|NCT01037244|380787|P2|STARTED|Overall Study||152
158227|NCT01037244|380788|P1|STARTED|Overall Study||154
158228|NCT01037218|380850|P4|NOT COMPLETED|Overall Study||16
158229|NCT01037218|380851|P3|NOT COMPLETED|Overall Study||21
158230|NCT01037218|380852|P2|NOT COMPLETED|Overall Study||21
158231|NCT01037218|380853|P1|NOT COMPLETED|Overall Study||16
158232|NCT01037218|380850|P4|COMPLETED|Overall Study||134
158233|NCT01037218|380851|P3|COMPLETED|Overall Study||134
158234|NCT01037218|380852|P2|COMPLETED|Overall Study||128
158235|NCT01037218|380853|P1|COMPLETED|Overall Study||131
158236|NCT01037218|380850|P4|mITT Population|Overall Study||141
158237|NCT01037218|380851|P3|mITT Population|Overall Study||147
158238|NCT01037218|380852|P2|mITT Population|Overall Study||140
158239|NCT01037218|380853|P1|mITT Population|Overall Study||141
158240|NCT01037218|380850|P4|Safety Population|Overall Study||150
158241|NCT01037218|380851|P3|Safety Population|Overall Study||154
158242|NCT01037218|380852|P2|Safety Population|Overall Study||148
158243|NCT01037218|380853|P1|Safety Population|Overall Study||147
158244|NCT01037218|380850|P4|STARTED|Overall Study||150
158245|NCT01037218|380851|P3|STARTED|Overall Study||155
158246|NCT01037218|380852|P2|STARTED|Overall Study||149
158247|NCT01037218|380853|P1|STARTED|Overall Study||147
158248|NCT01037192|380913|P2|NOT COMPLETED|Overall Study||0
158249|NCT01037192|380914|P1|NOT COMPLETED|Overall Study||0
158250|NCT01037192|380913|P2|COMPLETED|Overall Study||1
158251|NCT01037192|380914|P1|COMPLETED|Overall Study||3
158252|NCT01037192|380913|P2|STARTED|Overall Study||1
158253|NCT01037192|380914|P1|STARTED|Overall Study||3
158254|NCT01037127|380924|P2|NOT COMPLETED|Overall Study||21
158255|NCT01037127|380925|P1|NOT COMPLETED|Overall Study||5
158256|NCT01037127|380924|P2|COMPLETED|Overall Study||36
158257|NCT01037127|380925|P1|COMPLETED|Overall Study||35
158258|NCT01037127|380924|P2|STARTED|Overall Study||57
158259|NCT01037127|380925|P1|STARTED|Overall Study||40
158260|NCT01037114|380957|P1|NOT COMPLETED|Year 20||1
158261|NCT01037114|380957|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
158262|NCT01037114|380957|P1|STARTED|Year 20||45
158263|NCT01037114|380957|P1|NOT COMPLETED|Year 19||0
158264|NCT01037114|380957|P1|COMPLETED|Year 19||45
158265|NCT01037114|380957|P1|STARTED|Year 19||45
158266|NCT01037114|380957|P1|NOT COMPLETED|Year 18||0
158267|NCT01037114|380957|P1|COMPLETED|Year 18||44
158268|NCT01037114|380957|P1|STARTED|Year 18||44
158269|NCT01037114|380957|P1|NOT COMPLETED|Year 17||0
158270|NCT01037114|380957|P1|COMPLETED|Year 17||48
158271|NCT01037114|380957|P1|STARTED|Year 17||48
158272|NCT01037114|380957|P1|NOT COMPLETED|Year 16||0
158273|NCT01037114|380957|P1|COMPLETED|Year 16||49
158274|NCT01037114|380957|P1|STARTED|Year 16||49
158275|NCT01037088|380970|P1|NOT COMPLETED|Overall Study||3
158276|NCT01037088|380970|P1|COMPLETED|Overall Study||36
158277|NCT01037088|380970|P1|Received Placebo|Overall Study||38
158278|NCT01037088|380970|P1|Received 1.29% THC|Overall Study||37
158279|NCT01037088|380970|P1|Received 3.53% THC|Overall Study||36
158280|NCT01037088|380970|P1|STARTED|Overall Study||39
158281|NCT01036802|380983|P2|NOT COMPLETED|Overall Study||0
158282|NCT01036802|380984|P1|NOT COMPLETED|Overall Study||0
158283|NCT01036802|380983|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
158284|NCT01036802|380984|P1|COMPLETED|Overall Study||2
158285|NCT01036802|380983|P2|STARTED|Overall Study||1
158286|NCT01036802|380984|P1|STARTED|Overall Study||2
158287|NCT01036763|381002|P1|NOT COMPLETED|Overall Study||93
158288|NCT01036763|381002|P1|COMPLETED|Overall Study||1171
158289|NCT01036763|381002|P1|STARTED|Overall Study||1264
158290|NCT01036724|381014|P2|NOT COMPLETED|Overall Study||8
158291|NCT01036724|381015|P1|NOT COMPLETED|Overall Study||6
158292|NCT01036724|381014|P2|COMPLETED|Overall Study||47
158293|NCT01036724|381015|P1|COMPLETED|Overall Study||46
158294|NCT01036724|381014|P2|STARTED|Overall Study||55
158295|NCT01036724|381015|P1|STARTED|Overall Study||52
158296|NCT01036529|381025|P2|NOT COMPLETED|Overall Study||15
158297|NCT01036529|381026|P1|NOT COMPLETED|Overall Study||13
158298|NCT01036529|381025|P2|COMPLETED|Overall Study||0
158299|NCT01036529|381026|P1|COMPLETED|Overall Study||0
158300|NCT01036529|381025|P2|Crossover to Other Group|Overall Study||1
158301|NCT01036529|381026|P1|Crossover to Other Group|Overall Study||1
158302|NCT01036529|381025|P2|Requested Crossover|Overall Study||2
158303|NCT01036529|381026|P1|Requested Crossover|Overall Study||1
158304|NCT01036529|381025|P2|12 Month Follow-up|Overall Study||3
158305|NCT01036529|381026|P1|12 Month Follow-up|Overall Study||4
158306|NCT01036529|381025|P2|6 Month Follow-up|Overall Study||7
158307|NCT01036529|381026|P1|6 Month Follow-up|Overall Study||6
158308|NCT01036529|381025|P2|3 Month Follow-up|Overall Study||9
158309|NCT01036529|381026|P1|3 Month Follow-up|Overall Study||7
158310|NCT01036529|381025|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
158311|NCT01036529|381026|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
158312|NCT01036529|381025|P2|Baseline Visit|Overall Study||13
158313|NCT01036529|381026|P1|Baseline Visit|Overall Study||10
158314|NCT01036529|381025|P2|STARTED|Overall Study||15
158315|NCT01036529|381026|P1|STARTED|Overall Study||13
158316|NCT01036490|381034|P2|NOT COMPLETED|Overall Study||0
158317|NCT01036490|381035|P1|NOT COMPLETED|Overall Study||4
158318|NCT01036490|381034|P2|COMPLETED|Overall Study||18
158319|NCT01036490|381035|P1|COMPLETED|Overall Study||14
158320|NCT01036490|381034|P2|STARTED|Overall Study||18
158321|NCT01036490|381035|P1|STARTED|Overall Study||18
158322|NCT01036438|381053|P2|NOT COMPLETED|Overall Study||10
158323|NCT01036438|381054|P1|NOT COMPLETED|Overall Study||10
158324|NCT01036438|381053|P2|COMPLETED|Overall Study||90
158325|NCT01036438|381054|P1|COMPLETED|Overall Study||91
158326|NCT01036438|381053|P2|STARTED|Overall Study||100
158327|NCT01036438|381054|P1|STARTED|Overall Study||101
158328|NCT01036321|381062|P2|NOT COMPLETED|Overall Study||4
158329|NCT01036321|381063|P1|NOT COMPLETED|Overall Study||5
158330|NCT01036321|381062|P2|COMPLETED|Overall Study||31
158331|NCT01036321|381063|P1|COMPLETED|Overall Study||31
158332|NCT01036321|381062|P2|STARTED|Overall Study||35
158333|NCT01036321|381063|P1|STARTED|Overall Study||36
158334|NCT01036165|381087|P1|NOT COMPLETED|Overall Study||15
158335|NCT01036165|381087|P1|COMPLETED|Overall Study||88
158336|NCT01036165|381087|P1|STARTED|Overall Study||103
158337|NCT01036022|381098|P6|NOT COMPLETED|Overall Study||3
158338|NCT01036022|381099|P5|NOT COMPLETED|Overall Study||3
158339|NCT01036022|381100|P4|NOT COMPLETED|Overall Study||2
158340|NCT01036022|381101|P3|NOT COMPLETED|Overall Study||4
158341|NCT01036022|381102|P2|NOT COMPLETED|Overall Study||4
158342|NCT01036022|381103|P1|NOT COMPLETED|Overall Study||2
158343|NCT01036022|381098|P6|COMPLETED|Overall Study||13
158344|NCT01036022|381099|P5|COMPLETED|Overall Study||9
158345|NCT01036022|381100|P4|COMPLETED|Overall Study||10
158346|NCT01036022|381101|P3|COMPLETED|Overall Study||8
158347|NCT01036022|381102|P2|COMPLETED|Overall Study||7
158348|NCT01036022|381103|P1|COMPLETED|Overall Study||13
158349|NCT01036022|381098|P6|STARTED|Overall Study||16
158350|NCT01036022|381099|P5|STARTED|Overall Study||12
158351|NCT01036022|381100|P4|STARTED|Overall Study||12
158352|NCT01036022|381101|P3|STARTED|Overall Study||12
158353|NCT01036022|381102|P2|STARTED|Overall Study||11
158354|NCT01036022|381103|P1|STARTED|Overall Study||15
158355|NCT01036009|381205|P2|NOT COMPLETED|Overall Study||0
158356|NCT01036009|381206|P1|NOT COMPLETED|Overall Study||0
158357|NCT01036009|381205|P2|COMPLETED|Overall Study||26
158358|NCT01036009|381206|P1|COMPLETED|Overall Study||17
158359|NCT01036009|381205|P2|STARTED|Overall Study||26
158360|NCT01036009|381206|P1|STARTED|Overall Study||17
158361|NCT01035944|381224|P4|NOT COMPLETED|Overall Study||0
158362|NCT01035944|381225|P3|NOT COMPLETED|Overall Study||1
158363|NCT01035944|381226|P2|NOT COMPLETED|Overall Study||1
158364|NCT01035944|381227|P1|NOT COMPLETED|Overall Study||3
158365|NCT01035944|381224|P4|COMPLETED|Overall Study||4
158366|NCT01035944|381225|P3|COMPLETED|Overall Study||4
158367|NCT01035944|381226|P2|COMPLETED|Overall Study||13
158368|NCT01035944|381227|P1|COMPLETED|Overall Study||11
158369|NCT01035944|381224|P4|STARTED|Overall Study||4
158370|NCT01035944|381225|P3|STARTED|Overall Study||5
158371|NCT01035944|381226|P2|STARTED|Overall Study||14
158372|NCT01035944|381227|P1|STARTED|Overall Study||14
158373|NCT01035905|381239|P2|NOT COMPLETED|Overall Study||1
158374|NCT01035905|381240|P1|NOT COMPLETED|Overall Study||1
158375|NCT01035905|381239|P2|COMPLETED|Overall Study||30
158376|NCT01035905|381240|P1|COMPLETED|Overall Study||31
158377|NCT01035905|381239|P2|STARTED|Overall Study||31
158378|NCT01035905|381240|P1|STARTED|Overall Study||32
158379|NCT01035788|381248|P2|NOT COMPLETED|Overall Study||14
158380|NCT01035788|381249|P1|NOT COMPLETED|Overall Study||6
158381|NCT01035788|381248|P2|COMPLETED|Overall Study||9
158382|NCT01035788|381249|P1|COMPLETED|Overall Study||17
158383|NCT01035788|381248|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
158384|NCT01035788|381249|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
158385|NCT01035749|381259|P4|NOT COMPLETED|Overall Study||0
158386|NCT01035749|381260|P3|NOT COMPLETED|Overall Study||0
158387|NCT01035749|381261|P2|NOT COMPLETED|Overall Study||0
158388|NCT01035749|381262|P1|NOT COMPLETED|Overall Study||0
158389|NCT01035749|381259|P4|COMPLETED|Overall Study||110
158390|NCT01035749|381260|P3|COMPLETED|Overall Study||68
158391|NCT01035749|381261|P2|COMPLETED|Overall Study||66
158392|NCT01035749|381262|P1|COMPLETED|Overall Study||66
158393|NCT01035749|381259|P4|STARTED|Overall Study||110
158394|NCT01035749|381260|P3|STARTED|Overall Study||68
158395|NCT01035749|381261|P2|STARTED|Overall Study||66
158396|NCT01035749|381262|P1|STARTED|Overall Study||66
158397|NCT01035658|381384|P4|NOT COMPLETED|Overall Study||0
158398|NCT01035658|381385|P3|NOT COMPLETED|Overall Study||0
158399|NCT01035658|381386|P2|NOT COMPLETED|Overall Study||0
158400|NCT01035658|381387|P1|NOT COMPLETED|Overall Study||0
158401|NCT01035658|381384|P4|COMPLETED|Overall Study||6
158402|NCT01035658|381385|P3|COMPLETED|Overall Study||3
158403|NCT01035658|381386|P2|COMPLETED|Overall Study||8
158404|NCT01035658|381387|P1|COMPLETED|Overall Study||5
158405|NCT01035658|381384|P4|STARTED|Overall Study||6
158406|NCT01035658|381385|P3|STARTED|Overall Study||3
158407|NCT01035658|381386|P2|STARTED|Overall Study||8
158408|NCT01035658|381387|P1|STARTED|Overall Study||5
158409|NCT01035606|381413|P3|NOT COMPLETED|Overall Study||4
158410|NCT01035606|381414|P2|NOT COMPLETED|Overall Study||3
158411|NCT01035606|381415|P1|NOT COMPLETED|Overall Study||3
158412|NCT01035606|381413|P3|COMPLETED|Overall Study||7
158413|NCT01035606|381414|P2|COMPLETED|Overall Study||16
158414|NCT01035606|381415|P1|COMPLETED|Overall Study||16
158415|NCT01035606|381413|P3|STARTED|Overall Study||11
158416|NCT01035606|381414|P2|STARTED|Overall Study||19
158417|NCT01035606|381415|P1|STARTED|Overall Study||19
158418|NCT01035346|381431|P2|NOT COMPLETED|Overall Study||0
158419|NCT01035346|381432|P1|NOT COMPLETED|Overall Study||0
158420|NCT01035346|381431|P2|COMPLETED|Overall Study||9
158421|NCT01035346|381432|P1|COMPLETED|Overall Study||7
158422|NCT01035346|381431|P2|STARTED|Overall Study||9
158423|NCT01035346|381432|P1|STARTED|Overall Study||7
158424|NCT01035333|381450|P1|NOT COMPLETED|Overall Study||10
158425|NCT01035333|381450|P1|COMPLETED|Overall Study||9
158426|NCT01035333|381450|P1|STARTED|Overall Study||19
158427|NCT01035255|381457|P2|NOT COMPLETED|Overall Study||862
158428|NCT01035255|381458|P1|NOT COMPLETED|Overall Study||741
158429|NCT01035255|381457|P2|COMPLETED|Overall Study||3371
158430|NCT01035255|381458|P1|COMPLETED|Overall Study||3468
158431|NCT01035255|381457|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
158432|NCT01035255|381458|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
158433|NCT01035255|381457|P2|Mis-randomized|Overall Study||2
158434|NCT01035255|381458|P1|Mis-randomized|Overall Study||4
158435|NCT01035255|381457|P2|GCP Violations|Overall Study||19
158436|NCT01035255|381458|P1|GCP Violations|Overall Study||18
158437|NCT01035255|381457|P2|STARTED|Overall Study||4233
158438|NCT01035255|381458|P1|STARTED|Overall Study||4209
158439|NCT01035229|381476|P2|NOT COMPLETED|Overall Study||184
158440|NCT01035229|381477|P1|NOT COMPLETED|Overall Study||362
158441|NCT01035229|381476|P2|COMPLETED|Overall Study||0
158442|NCT01035229|381477|P1|COMPLETED|Overall Study||0
158443|NCT01035229|381476|P2|STARTED|Overall Study||184
158444|NCT01035229|381477|P1|STARTED|Overall Study||362
158445|NCT01035138|381498|P3|NOT COMPLETED|Overall Study||47
158446|NCT01035138|381499|P2|NOT COMPLETED|Overall Study||60
158447|NCT01035138|381500|P1|NOT COMPLETED|Overall Study||73
158448|NCT01035138|381498|P3|COMPLETED|Overall Study||0
158449|NCT01035138|381499|P2|COMPLETED|Overall Study||0
158450|NCT01035138|381500|P1|COMPLETED|Overall Study||0
158451|NCT01035138|381498|P3|STARTED|Overall Study||47
158452|NCT01035138|381499|P2|STARTED|Overall Study||60
158453|NCT01035138|381500|P1|STARTED|Overall Study||73
158454|NCT01035060|381556|P2|NOT COMPLETED|Overall Study||14
158455|NCT01035060|381557|P1|NOT COMPLETED|Overall Study||24
158456|NCT01035060|381556|P2|COMPLETED|Overall Study||15
158457|NCT01035060|381557|P1|COMPLETED|Overall Study||15
158458|NCT01035060|381556|P2|STARTED|Overall Study||29
158459|NCT01035060|381557|P1|STARTED|Overall Study||39
158460|NCT01035047|381565|P2|NOT COMPLETED|Overall Study||0
158461|NCT01035047|381566|P1|NOT COMPLETED|Overall Study||0
158462|NCT01035047|381565|P2|COMPLETED|Overall Study||53
158463|NCT01035047|381566|P1|COMPLETED|Overall Study||52
158464|NCT01035047|381565|P2|STARTED|Overall Study||53
158465|NCT01035047|381566|P1|STARTED|Overall Study||52
158466|NCT01034709|381582|P2|NOT COMPLETED|Overall Study||16
158467|NCT01034709|381583|P1|NOT COMPLETED|Overall Study||9
158468|NCT01034709|381582|P2|COMPLETED|Overall Study||42
158469|NCT01034709|381583|P1|COMPLETED|Overall Study||44
158470|NCT01034709|381582|P2|STARTED|Overall Study||58
158471|NCT01034709|381583|P1|STARTED|Overall Study||53
158472|NCT01034657|381589|P3|NOT COMPLETED|Randomized Phase||1
158473|NCT01034657|381590|P2|NOT COMPLETED|Randomized Phase||6
158474|NCT01034657|381591|P1|NOT COMPLETED|Randomized Phase||5
158475|NCT01034657|381589|P3|COMPLETED|Randomized Phase||0
158476|NCT01034657|381590|P2|COMPLETED|Randomized Phase||0
158477|NCT01034657|381591|P1|COMPLETED|Randomized Phase||1
158478|NCT01034657|381589|P3|STARTED|Randomized Phase||1
158479|NCT01034657|381590|P2|STARTED|Randomized Phase||6
158480|NCT01034657|381591|P1|STARTED|Randomized Phase||6
158481|NCT01034657|381589|P3|NOT COMPLETED|Core Phase||0
158482|NCT01034657|381590|P2|NOT COMPLETED|Core Phase||0
158483|NCT01034657|381591|P1|NOT COMPLETED|Core Phase||14
158484|NCT01034657|381589|P3|COMPLETED|Core Phase||0
158485|NCT01034657|381590|P2|COMPLETED|Core Phase||0
158486|NCT01034657|381591|P1|COMPLETED|Core Phase||20
158487|NCT01034657|381589|P3|STARTED|Core Phase||0
158488|NCT01034657|381590|P2|STARTED|Core Phase||0
158489|NCT01034657|381591|P1|STARTED|Core Phase||34
158490|NCT01034631|381632|P3|NOT COMPLETED|Phase II||2
158491|NCT01034631|381633|P2|NOT COMPLETED|Phase II||1
158492|NCT01034631|381634|P1|NOT COMPLETED|Phase II||0
158493|NCT01034631|381632|P3|COMPLETED|Phase II||67
158494|NCT01034631|381633|P2|COMPLETED|Phase II||69
158495|NCT01034631|381634|P1|COMPLETED|Phase II||0
158496|NCT01034631|381632|P3|STARTED|Phase II||69
158497|NCT01034631|381633|P2|STARTED|Phase II||70
158498|NCT01034631|381634|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
158499|NCT01034631|381632|P3|NOT COMPLETED|Phase I||0
158500|NCT01034631|381633|P2|NOT COMPLETED|Phase I||0
158501|NCT01034631|381634|P1|NOT COMPLETED|Phase I||3
158502|NCT01034631|381632|P3|COMPLETED|Phase I||0
158503|NCT01034631|381633|P2|COMPLETED|Phase I||0
158504|NCT01034631|381634|P1|COMPLETED|Phase I||12
158505|NCT01034631|381632|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
158506|NCT01034631|381633|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
158507|NCT01034631|381634|P1|STARTED|Phase I||15
158508|NCT01034592|381653|P1|NOT COMPLETED|Overall Study||0
158509|NCT01034592|381653|P1|COMPLETED|Overall Study||2
158510|NCT01034592|381653|P1|STARTED|Overall Study||2
158511|NCT01034579|381665|P2|NOT COMPLETED|Overall Study||0
158512|NCT01034579|381666|P1|NOT COMPLETED|Overall Study||0
158513|NCT01034579|381665|P2|COMPLETED|Overall Study||166
158514|NCT01034579|381666|P1|COMPLETED|Overall Study||158
158515|NCT01034579|381665|P2|STARTED|Overall Study||166
158516|NCT01034579|381666|P1|STARTED|Overall Study||158
158517|NCT01034553|381680|P6|NOT COMPLETED|Overall Study||0
158518|NCT01034553|381681|P5|NOT COMPLETED|Overall Study||0
158519|NCT01034553|381682|P4|NOT COMPLETED|Overall Study||0
158520|NCT01034553|381683|P3|NOT COMPLETED|Overall Study||0
158521|NCT01034553|381684|P2|NOT COMPLETED|Overall Study||0
158522|NCT01034553|381685|P1|NOT COMPLETED|Overall Study||0
158523|NCT01034553|381680|P6|COMPLETED|Overall Study||7
158524|NCT01034553|381681|P5|COMPLETED|Overall Study||6
158525|NCT01034553|381682|P4|COMPLETED|Overall Study||3
158526|NCT01034553|381683|P3|COMPLETED|Overall Study||3
158527|NCT01034553|381684|P2|COMPLETED|Overall Study||4
158528|NCT01034553|381685|P1|COMPLETED|Overall Study||3
158529|NCT01034553|381680|P6|STARTED|Overall Study||7
158530|NCT01034553|381681|P5|STARTED|Overall Study||6
158531|NCT01034553|381682|P4|STARTED|Overall Study||3
158532|NCT01034553|381683|P3|STARTED|Overall Study||3
158533|NCT01034553|381684|P2|STARTED|Overall Study||4
158534|NCT01034553|381685|P1|STARTED|Overall Study||3
158535|NCT01034540|381701|P2|NOT COMPLETED|Overall Study||1
158536|NCT01034540|381702|P1|NOT COMPLETED|Overall Study||0
158537|NCT01034540|381701|P2|COMPLETED|Overall Study||11
158538|NCT01034540|381702|P1|COMPLETED|Overall Study||11
158539|NCT01034540|381701|P2|Completed 1st Treatment Intervention|Overall Study||11
158540|NCT01034540|381702|P1|Completed 1st Treatment Intervention|Overall Study||11
158541|NCT01034540|381701|P2|STARTED|Overall Study||12
158542|NCT01034540|381702|P1|STARTED|Overall Study||11
158543|NCT01034462|381712|P2|NOT COMPLETED|Overall Study||54
158544|NCT01034462|381713|P1|NOT COMPLETED|Overall Study||45
158545|NCT01034462|381712|P2|COMPLETED|Overall Study||163
158546|NCT01034462|381713|P1|COMPLETED|Overall Study||172
158547|NCT01034462|381712|P2|STARTED|Overall Study||217
158548|NCT01034462|381713|P1|STARTED|Overall Study||217
158549|NCT01034397|381723|P2|NOT COMPLETED|Overall Study||2
158550|NCT01034397|381724|P1|NOT COMPLETED|Overall Study||7
158551|NCT01034397|381723|P2|COMPLETED|Overall Study||17
158552|NCT01034397|381724|P1|COMPLETED|Overall Study||28
158553|NCT01034397|381723|P2|STARTED|Overall Study||19
158554|NCT01034397|381724|P1|STARTED|Overall Study||35
158555|NCT01034358|381873|P1|NOT COMPLETED|Overall Study||2
158556|NCT01034358|381873|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
158557|NCT01034358|381873|P1|STARTED|Overall Study||15
158558|NCT01034306|381879|P2|NOT COMPLETED|Overall Study||3
158559|NCT01034306|381880|P1|NOT COMPLETED|Overall Study||5
158560|NCT01034306|381879|P2|COMPLETED|Overall Study||34
158561|NCT01034306|381880|P1|COMPLETED|Overall Study||37
158562|NCT01034306|381879|P2|STARTED|Overall Study||37
158563|NCT01034306|381880|P1|STARTED|Overall Study||42
158564|NCT01034176|381888|P2|NOT COMPLETED|Overall Study||2
158565|NCT01034176|381889|P1|NOT COMPLETED|Overall Study||2
158566|NCT01034176|381888|P2|COMPLETED|Overall Study||19
158567|NCT01034176|381889|P1|COMPLETED|Overall Study||20
158568|NCT01034176|381888|P2|STARTED|Overall Study||21
158569|NCT01034176|381889|P1|STARTED|Overall Study||22
158570|NCT01034163|381899|P2|NOT COMPLETED|Overall Study||14
158571|NCT01034163|381900|P1|NOT COMPLETED|Overall Study||27
158572|NCT01034163|381899|P2|COMPLETED|Overall Study||0
158573|NCT01034163|381900|P1|COMPLETED|Overall Study||0
158574|NCT01034163|381899|P2|In Open Label Phase After Unblinding|Overall Study||0
158575|NCT01034163|381900|P1|In Open Label Phase After Unblinding|Overall Study||5
158576|NCT01034163|381899|P2|Safety Set|Overall Study||12
158577|NCT01034163|381900|P1|Safety Set|Overall Study||26
158578|NCT01034163|381899|P2|Untreated (Not in Safety Set)|Overall Study||2
158579|NCT01034163|381900|P1|Untreated (Not in Safety Set)|Overall Study||1
158580|NCT01034163|381899|P2|STARTED|Overall Study||14
158581|NCT01034163|381900|P1|STARTED|Overall Study||27
158582|NCT01034137|381909|P3|NOT COMPLETED|Overall Study||30
158583|NCT01034137|381910|P2|NOT COMPLETED|Overall Study||22
158584|NCT01034137|381911|P1|NOT COMPLETED|Overall Study||28
158585|NCT01034137|381909|P3|COMPLETED|Overall Study||78
158586|NCT01034137|381910|P2|COMPLETED|Overall Study||81
158587|NCT01034137|381911|P1|COMPLETED|Overall Study||78
158588|NCT01034137|381909|P3|STARTED|Overall Study||108
158589|NCT01034137|381910|P2|STARTED|Overall Study||103
158590|NCT01034137|381911|P1|STARTED|Overall Study||106
158591|NCT01034111|382042|P1|NOT COMPLETED|Overall Study||0
158592|NCT01034111|382042|P1|COMPLETED|Overall Study||30
158593|NCT01034111|382042|P1|STARTED|Overall Study||30
158594|NCT01033942|382050|P3|NOT COMPLETED|Overall Study||1
158595|NCT01033942|382051|P2|NOT COMPLETED|Overall Study||4
158596|NCT01033942|382052|P1|NOT COMPLETED|Overall Study||2
158597|NCT01033942|382050|P3|COMPLETED|Overall Study||18
158598|NCT01033942|382051|P2|COMPLETED|Overall Study||15
158599|NCT01033942|382052|P1|COMPLETED|Overall Study||18
158600|NCT01033942|382050|P3|STARTED|Overall Study||19
158601|NCT01033942|382051|P2|STARTED|Overall Study||19
158602|NCT01033942|382052|P1|STARTED|Overall Study||20
158603|NCT01033864|382324|P2|NOT COMPLETED|Overall Study||0
158604|NCT01033864|382325|P1|NOT COMPLETED|Overall Study||0
158605|NCT01033864|382324|P2|COMPLETED|Overall Study||11
158606|NCT01033864|382325|P1|COMPLETED|Overall Study||12
158607|NCT01033864|382324|P2|STARTED|Overall Study||11
158608|NCT01033864|382325|P1|STARTED|Overall Study||12
158609|NCT01033851|382350|P2|NOT COMPLETED|Overall Study||7
158610|NCT01033851|382351|P1|NOT COMPLETED|Overall Study||3
158611|NCT01033851|382350|P2|COMPLETED|Overall Study||34
158612|NCT01033851|382351|P1|COMPLETED|Overall Study||45
158613|NCT01033851|382350|P2|STARTED|Overall Study||41
158614|NCT01033851|382351|P1|STARTED|Overall Study||48
158615|NCT01033825|382366|P7|NOT COMPLETED|Overall Study||0
158616|NCT01033825|382367|P6|NOT COMPLETED|Overall Study||0
158617|NCT01033825|382368|P5|NOT COMPLETED|Overall Study||2
158618|NCT01033825|382369|P4|NOT COMPLETED|Overall Study||2
158619|NCT01033825|382370|P3|NOT COMPLETED|Overall Study||2
158620|NCT01033825|382371|P2|NOT COMPLETED|Overall Study||3
158621|NCT01033825|382372|P1|NOT COMPLETED|Overall Study||3
158622|NCT01033825|382366|P7|COMPLETED|Overall Study||18
158623|NCT01033825|382367|P6|COMPLETED|Overall Study||18
158624|NCT01033825|382368|P5|COMPLETED|Overall Study||56
158625|NCT01033825|382369|P4|COMPLETED|Overall Study||46
158626|NCT01033825|382370|P3|COMPLETED|Overall Study||55
158627|NCT01033825|382371|P2|COMPLETED|Overall Study||57
158628|NCT01033825|382372|P1|COMPLETED|Overall Study||48
158629|NCT01033825|382366|P7|STARTED|Overall Study||18
158630|NCT01033825|382367|P6|STARTED|Overall Study||18
158631|NCT01033825|382368|P5|STARTED|Overall Study||58
158632|NCT01033825|382369|P4|STARTED|Overall Study||48
158633|NCT01033825|382370|P3|STARTED|Overall Study||57
158634|NCT01033825|382371|P2|STARTED|Overall Study||60
158635|NCT01033825|382372|P1|STARTED|Overall Study||51
158636|NCT01033747|382593|P2|NOT COMPLETED|Overall Study||15
158637|NCT01033747|382594|P1|NOT COMPLETED|Overall Study||37
158638|NCT01033747|382593|P2|COMPLETED|Overall Study||4
158639|NCT01033747|382594|P1|COMPLETED|Overall Study||14
158640|NCT01033747|382593|P2|STARTED|Overall Study||19
158641|NCT01033747|382594|P1|STARTED|Overall Study||51
158642|NCT01033734|382602|P1|NOT COMPLETED|Overall Study||1
158643|NCT01033734|382602|P1|COMPLETED|Overall Study||7
158644|NCT01033734|382602|P1|STARTED|Overall Study||8
158645|NCT01033565|382654|P1|NOT COMPLETED|Overall Study||0
158646|NCT01033565|382654|P1|COMPLETED|Overall Study||1
158647|NCT01033565|382654|P1|STARTED|Overall Study||1
158648|NCT01033487|382658|P10|NOT COMPLETED|Fifth Intervention Period||0
158649|NCT01033487|382659|P9|NOT COMPLETED|Fifth Intervention Period||0
158650|NCT01033487|382660|P8|NOT COMPLETED|Fifth Intervention Period||0
158651|NCT01033487|382661|P7|NOT COMPLETED|Fifth Intervention Period||0
158652|NCT01033487|382662|P6|NOT COMPLETED|Fifth Intervention Period||0
158653|NCT01033487|382663|P5|NOT COMPLETED|Fifth Intervention Period||0
158654|NCT01033487|382664|P4|NOT COMPLETED|Fifth Intervention Period||0
158655|NCT01033487|382665|P3|NOT COMPLETED|Fifth Intervention Period||0
158656|NCT01033487|382666|P2|NOT COMPLETED|Fifth Intervention Period||0
158657|NCT01033487|382667|P1|NOT COMPLETED|Fifth Intervention Period||0
158658|NCT01033487|382658|P10|COMPLETED|Fifth Intervention Period||2
158659|NCT01033487|382659|P9|COMPLETED|Fifth Intervention Period||1
158660|NCT01033487|382660|P8|COMPLETED|Fifth Intervention Period||3
158661|NCT01033487|382661|P7|COMPLETED|Fifth Intervention Period||2
158662|NCT01033487|382662|P6|COMPLETED|Fifth Intervention Period||2
158663|NCT01033487|382663|P5|COMPLETED|Fifth Intervention Period||2
158664|NCT01033487|382664|P4|COMPLETED|Fifth Intervention Period||2
158665|NCT01033487|382665|P3|COMPLETED|Fifth Intervention Period||2
158666|NCT01033487|382666|P2|COMPLETED|Fifth Intervention Period||3
158667|NCT01033487|382667|P1|COMPLETED|Fifth Intervention Period||2
158668|NCT01033487|382658|P10|STARTED|Fifth Intervention Period||2
158669|NCT01033487|382659|P9|STARTED|Fifth Intervention Period||1
158670|NCT01033487|382660|P8|STARTED|Fifth Intervention Period||3
158671|NCT01033487|382661|P7|STARTED|Fifth Intervention Period||2
158672|NCT01033487|382662|P6|STARTED|Fifth Intervention Period||2
158673|NCT01033487|382663|P5|STARTED|Fifth Intervention Period||2
158674|NCT01033487|382664|P4|STARTED|Fifth Intervention Period||2
158675|NCT01033487|382665|P3|STARTED|Fifth Intervention Period||2
158676|NCT01033487|382666|P2|STARTED|Fifth Intervention Period||3
158677|NCT01033487|382667|P1|STARTED|Fifth Intervention Period||2
158678|NCT01033487|382658|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158679|NCT01033487|382659|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158680|NCT01033487|382660|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158681|NCT01033487|382661|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158682|NCT01033487|382662|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158683|NCT01033487|382663|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158684|NCT01033487|382664|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158685|NCT01033487|382665|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158686|NCT01033487|382666|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158687|NCT01033487|382667|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
158688|NCT01033487|382658|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
158689|NCT01033487|382659|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
158690|NCT01033487|382660|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
158691|NCT01033487|382661|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
158692|NCT01033487|382662|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
158693|NCT01033487|382663|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
158694|NCT01033487|382664|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
158695|NCT01033487|382665|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
158696|NCT01033487|382666|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
158697|NCT01033487|382667|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
158698|NCT01033487|382658|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
158699|NCT01033487|382659|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
158700|NCT01033487|382660|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
158701|NCT01033487|382661|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
158702|NCT01033487|382662|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
158703|NCT01033487|382663|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
158704|NCT01033487|382664|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
158705|NCT01033487|382665|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
158706|NCT01033487|382666|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
158707|NCT01033487|382667|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
158708|NCT01033487|382658|P10|NOT COMPLETED|Fourth Intervention Period||0
158709|NCT01033487|382659|P9|NOT COMPLETED|Fourth Intervention Period||1
158710|NCT01033487|382660|P8|NOT COMPLETED|Fourth Intervention Period||0
158711|NCT01033487|382661|P7|NOT COMPLETED|Fourth Intervention Period||0
158712|NCT01033487|382662|P6|NOT COMPLETED|Fourth Intervention Period||0
158713|NCT01033487|382663|P5|NOT COMPLETED|Fourth Intervention Period||0
158714|NCT01033487|382664|P4|NOT COMPLETED|Fourth Intervention Period||0
158715|NCT01033487|382665|P3|NOT COMPLETED|Fourth Intervention Period||0
158716|NCT01033487|382666|P2|NOT COMPLETED|Fourth Intervention Period||0
158717|NCT01033487|382667|P1|NOT COMPLETED|Fourth Intervention Period||0
158718|NCT01033487|382658|P10|COMPLETED|Fourth Intervention Period||2
158719|NCT01033487|382659|P9|COMPLETED|Fourth Intervention Period||1
158720|NCT01033487|382660|P8|COMPLETED|Fourth Intervention Period||3
158721|NCT01033487|382661|P7|COMPLETED|Fourth Intervention Period||2
158722|NCT01033487|382662|P6|COMPLETED|Fourth Intervention Period||2
158723|NCT01033487|382663|P5|COMPLETED|Fourth Intervention Period||2
158724|NCT01033487|382664|P4|COMPLETED|Fourth Intervention Period||2
158725|NCT01033487|382665|P3|COMPLETED|Fourth Intervention Period||2
158726|NCT01033487|382666|P2|COMPLETED|Fourth Intervention Period||3
158727|NCT01033487|382667|P1|COMPLETED|Fourth Intervention Period||2
158728|NCT01033487|382658|P10|STARTED|Fourth Intervention Period||2
158729|NCT01033487|382659|P9|STARTED|Fourth Intervention Period||2
158730|NCT01033487|382660|P8|STARTED|Fourth Intervention Period||3
158731|NCT01033487|382661|P7|STARTED|Fourth Intervention Period||2
158732|NCT01033487|382662|P6|STARTED|Fourth Intervention Period||2
158733|NCT01033487|382663|P5|STARTED|Fourth Intervention Period||2
158734|NCT01033487|382664|P4|STARTED|Fourth Intervention Period||2
158735|NCT01033487|382665|P3|STARTED|Fourth Intervention Period||2
158736|NCT01033487|382666|P2|STARTED|Fourth Intervention Period||3
158737|NCT01033487|382667|P1|STARTED|Fourth Intervention Period||2
158738|NCT01033487|382658|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158739|NCT01033487|382659|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158740|NCT01033487|382660|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158741|NCT01033487|382661|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158742|NCT01033487|382662|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158743|NCT01033487|382663|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158744|NCT01033487|382664|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158745|NCT01033487|382665|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158746|NCT01033487|382666|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158747|NCT01033487|382667|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
158748|NCT01033487|382658|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158749|NCT01033487|382659|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158750|NCT01033487|382660|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
158751|NCT01033487|382661|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158752|NCT01033487|382662|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158753|NCT01033487|382663|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158754|NCT01033487|382664|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158755|NCT01033487|382665|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158756|NCT01033487|382666|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
158757|NCT01033487|382667|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
158758|NCT01033487|382658|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158759|NCT01033487|382659|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158760|NCT01033487|382660|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
158761|NCT01033487|382661|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158762|NCT01033487|382662|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158763|NCT01033487|382663|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158764|NCT01033487|382664|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158765|NCT01033487|382665|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158766|NCT01033487|382666|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
158767|NCT01033487|382667|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
158768|NCT01033487|382658|P10|NOT COMPLETED|Third Intervention Period||0
158769|NCT01033487|382659|P9|NOT COMPLETED|Third Intervention Period||0
158770|NCT01033487|382660|P8|NOT COMPLETED|Third Intervention Period||0
158771|NCT01033487|382661|P7|NOT COMPLETED|Third Intervention Period||0
158772|NCT01033487|382662|P6|NOT COMPLETED|Third Intervention Period||0
158773|NCT01033487|382663|P5|NOT COMPLETED|Third Intervention Period||0
158774|NCT01033487|382664|P4|NOT COMPLETED|Third Intervention Period||0
158775|NCT01033487|382665|P3|NOT COMPLETED|Third Intervention Period||0
158776|NCT01033487|382666|P2|NOT COMPLETED|Third Intervention Period||0
158777|NCT01033487|382667|P1|NOT COMPLETED|Third Intervention Period||0
158778|NCT01033487|382658|P10|COMPLETED|Third Intervention Period||2
158779|NCT01033487|382659|P9|COMPLETED|Third Intervention Period||2
158780|NCT01033487|382660|P8|COMPLETED|Third Intervention Period||3
158781|NCT01033487|382661|P7|COMPLETED|Third Intervention Period||2
158782|NCT01033487|382662|P6|COMPLETED|Third Intervention Period||2
158783|NCT01033487|382663|P5|COMPLETED|Third Intervention Period||2
158784|NCT01033487|382664|P4|COMPLETED|Third Intervention Period||2
158785|NCT01033487|382665|P3|COMPLETED|Third Intervention Period||2
158786|NCT01033487|382666|P2|COMPLETED|Third Intervention Period||3
158787|NCT01033487|382667|P1|COMPLETED|Third Intervention Period||2
158788|NCT01033487|382658|P10|STARTED|Third Intervention Period||2
158789|NCT01033487|382659|P9|STARTED|Third Intervention Period||2
158790|NCT01033487|382660|P8|STARTED|Third Intervention Period||3
158791|NCT01033487|382661|P7|STARTED|Third Intervention Period||2
158792|NCT01033487|382662|P6|STARTED|Third Intervention Period||2
158793|NCT01033487|382663|P5|STARTED|Third Intervention Period||2
158794|NCT01033487|382664|P4|STARTED|Third Intervention Period||2
158795|NCT01033487|382665|P3|STARTED|Third Intervention Period||2
158796|NCT01033487|382666|P2|STARTED|Third Intervention Period||3
158797|NCT01033487|382667|P1|STARTED|Third Intervention Period||2
158798|NCT01033487|382658|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158799|NCT01033487|382659|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158800|NCT01033487|382660|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158801|NCT01033487|382661|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158802|NCT01033487|382662|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158803|NCT01033487|382663|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158804|NCT01033487|382664|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158805|NCT01033487|382665|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158806|NCT01033487|382666|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158807|NCT01033487|382667|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
158808|NCT01033487|382658|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158809|NCT01033487|382659|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158810|NCT01033487|382660|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
158811|NCT01033487|382661|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158812|NCT01033487|382662|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158813|NCT01033487|382663|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158814|NCT01033487|382664|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158815|NCT01033487|382665|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158816|NCT01033487|382666|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
158817|NCT01033487|382667|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
158818|NCT01033487|382658|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158819|NCT01033487|382659|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158820|NCT01033487|382660|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
158821|NCT01033487|382661|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158822|NCT01033487|382662|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158823|NCT01033487|382663|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158824|NCT01033487|382664|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158825|NCT01033487|382665|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158826|NCT01033487|382666|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
158827|NCT01033487|382667|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
158828|NCT01033487|382658|P10|NOT COMPLETED|Second Intervention Period||0
158829|NCT01033487|382659|P9|NOT COMPLETED|Second Intervention Period||0
158830|NCT01033487|382660|P8|NOT COMPLETED|Second Intervention Period||0
158831|NCT01033487|382661|P7|NOT COMPLETED|Second Intervention Period||0
158832|NCT01033487|382662|P6|NOT COMPLETED|Second Intervention Period||0
158833|NCT01033487|382663|P5|NOT COMPLETED|Second Intervention Period||0
158834|NCT01033487|382664|P4|NOT COMPLETED|Second Intervention Period||0
158835|NCT01033487|382665|P3|NOT COMPLETED|Second Intervention Period||0
158836|NCT01033487|382666|P2|NOT COMPLETED|Second Intervention Period||0
158837|NCT01033487|382667|P1|NOT COMPLETED|Second Intervention Period||0
158838|NCT01033487|382658|P10|COMPLETED|Second Intervention Period||2
158839|NCT01033487|382659|P9|COMPLETED|Second Intervention Period||2
158840|NCT01033487|382660|P8|COMPLETED|Second Intervention Period||3
158841|NCT01033487|382661|P7|COMPLETED|Second Intervention Period||2
158842|NCT01033487|382662|P6|COMPLETED|Second Intervention Period||2
158843|NCT01033487|382663|P5|COMPLETED|Second Intervention Period||2
158844|NCT01033487|382664|P4|COMPLETED|Second Intervention Period||2
158845|NCT01033487|382665|P3|COMPLETED|Second Intervention Period||2
158846|NCT01033487|382666|P2|COMPLETED|Second Intervention Period||3
158847|NCT01033487|382667|P1|COMPLETED|Second Intervention Period||2
158848|NCT01033487|382658|P10|STARTED|Second Intervention Period||2
158849|NCT01033487|382659|P9|STARTED|Second Intervention Period||2
158850|NCT01033487|382660|P8|STARTED|Second Intervention Period||3
158851|NCT01033487|382661|P7|STARTED|Second Intervention Period||2
158852|NCT01033487|382662|P6|STARTED|Second Intervention Period||2
158853|NCT01033487|382663|P5|STARTED|Second Intervention Period||2
158854|NCT01033487|382664|P4|STARTED|Second Intervention Period||2
158855|NCT01033487|382665|P3|STARTED|Second Intervention Period||2
158856|NCT01033487|382666|P2|STARTED|Second Intervention Period||3
158857|NCT01033487|382667|P1|STARTED|Second Intervention Period||2
158858|NCT01033487|382658|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158859|NCT01033487|382659|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158860|NCT01033487|382660|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158861|NCT01033487|382661|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158862|NCT01033487|382662|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158863|NCT01033487|382663|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158864|NCT01033487|382664|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158865|NCT01033487|382665|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158866|NCT01033487|382666|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158867|NCT01033487|382667|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
158868|NCT01033487|382658|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158869|NCT01033487|382659|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158870|NCT01033487|382660|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
158871|NCT01033487|382661|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158872|NCT01033487|382662|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158873|NCT01033487|382663|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158874|NCT01033487|382664|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158875|NCT01033487|382665|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158876|NCT01033487|382666|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
158877|NCT01033487|382667|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
158878|NCT01033487|382658|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158879|NCT01033487|382659|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158880|NCT01033487|382660|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
158881|NCT01033487|382661|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158882|NCT01033487|382662|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158883|NCT01033487|382663|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158884|NCT01033487|382664|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158885|NCT01033487|382665|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158886|NCT01033487|382666|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
158887|NCT01033487|382667|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
158888|NCT01033487|382658|P10|NOT COMPLETED|First Intervention Period||0
158889|NCT01033487|382659|P9|NOT COMPLETED|First Intervention Period||0
158890|NCT01033487|382660|P8|NOT COMPLETED|First Intervention Period||0
158891|NCT01033487|382661|P7|NOT COMPLETED|First Intervention Period||0
158892|NCT01033487|382662|P6|NOT COMPLETED|First Intervention Period||0
158893|NCT01033487|382663|P5|NOT COMPLETED|First Intervention Period||0
158894|NCT01033487|382664|P4|NOT COMPLETED|First Intervention Period||0
158895|NCT01033487|382665|P3|NOT COMPLETED|First Intervention Period||0
158896|NCT01033487|382666|P2|NOT COMPLETED|First Intervention Period||0
158897|NCT01033487|382667|P1|NOT COMPLETED|First Intervention Period||0
158898|NCT01033487|382658|P10|COMPLETED|First Intervention Period||2
158899|NCT01033487|382659|P9|COMPLETED|First Intervention Period||2
158900|NCT01033487|382660|P8|COMPLETED|First Intervention Period||3
158901|NCT01033487|382661|P7|COMPLETED|First Intervention Period||2
158902|NCT01033487|382662|P6|COMPLETED|First Intervention Period||2
158903|NCT01033487|382663|P5|COMPLETED|First Intervention Period||2
158904|NCT01033487|382664|P4|COMPLETED|First Intervention Period||2
158905|NCT01033487|382665|P3|COMPLETED|First Intervention Period||2
158906|NCT01033487|382666|P2|COMPLETED|First Intervention Period||3
158907|NCT01033487|382667|P1|COMPLETED|First Intervention Period||2
158908|NCT01033487|382658|P10|STARTED|First Intervention Period||2
158909|NCT01033487|382659|P9|STARTED|First Intervention Period||2
158910|NCT01033487|382660|P8|STARTED|First Intervention Period||3
158911|NCT01033487|382661|P7|STARTED|First Intervention Period||2
158912|NCT01033487|382662|P6|STARTED|First Intervention Period||2
158913|NCT01033487|382663|P5|STARTED|First Intervention Period||2
158914|NCT01033487|382664|P4|STARTED|First Intervention Period||2
158915|NCT01033487|382665|P3|STARTED|First Intervention Period||2
158916|NCT01033487|382666|P2|STARTED|First Intervention Period||3
158917|NCT01033487|382667|P1|STARTED|First Intervention Period||2
158918|NCT01033448|382721|P1|NOT COMPLETED|Overall Study||12
158919|NCT01033448|382721|P1|COMPLETED|Overall Study||47
158920|NCT01033448|382721|P1|STARTED|Overall Study||59
158921|NCT01033383|382733|P4|NOT COMPLETED|Overall Study||0
158922|NCT01033383|382734|P3|NOT COMPLETED|Overall Study||0
158923|NCT01033383|382735|P2|NOT COMPLETED|Overall Study||0
158924|NCT01033383|382736|P1|NOT COMPLETED|Overall Study||0
158925|NCT01033383|382733|P4|COMPLETED|Overall Study||20
158926|NCT01033383|382734|P3|COMPLETED|Overall Study||20
158927|NCT01033383|382735|P2|COMPLETED|Overall Study||20
158928|NCT01033383|382736|P1|COMPLETED|Overall Study||20
158929|NCT01033383|382733|P4|STARTED|Overall Study||20
158930|NCT01033383|382734|P3|STARTED|Overall Study||20
158931|NCT01033383|382735|P2|STARTED|Overall Study||20
158932|NCT01033383|382736|P1|STARTED|Overall Study||20
158933|NCT01033227|382756|P2|NOT COMPLETED|Overall Study||0
158934|NCT01033227|382757|P1|NOT COMPLETED|Overall Study||0
158935|NCT01033227|382756|P2|COMPLETED|Overall Study||2
158936|NCT01033227|382757|P1|COMPLETED|Overall Study||3
158937|NCT01033227|382756|P2|STARTED|Overall Study||2
158938|NCT01033227|382757|P1|STARTED|Overall Study||3
158939|NCT01033071|382768|P3|NOT COMPLETED|Overall Study||47
158940|NCT01033071|382769|P2|NOT COMPLETED|Overall Study||77
158941|NCT01033071|382770|P1|NOT COMPLETED|Overall Study||55
158942|NCT01033071|382768|P3|COMPLETED|Overall Study||317
158943|NCT01033071|382769|P2|COMPLETED|Overall Study||275
158944|NCT01033071|382770|P1|COMPLETED|Overall Study||300
158945|NCT01033071|382768|P3|STARTED|Overall Study||364
158946|NCT01033071|382769|P2|STARTED|Overall Study||352
158947|NCT01033071|382770|P1|STARTED|Overall Study||355
158948|NCT01033032|382829|P4|NOT COMPLETED|Phase II||0
158949|NCT01033032|382830|P3|NOT COMPLETED|Phase II||66
158950|NCT01033032|382831|P2|NOT COMPLETED|Phase II||0
158951|NCT01033032|382832|P1|NOT COMPLETED|Phase II||0
158952|NCT01033032|382829|P4|COMPLETED|Phase II||0
158953|NCT01033032|382830|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
158954|NCT01033032|382831|P2|COMPLETED|Phase II||0
158955|NCT01033032|382832|P1|COMPLETED|Phase II||0
158956|NCT01033032|382829|P4|STARTED|Phase II||0
158957|NCT01033032|382830|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
158958|NCT01033032|382831|P2|STARTED|Phase II||0
158959|NCT01033032|382832|P1|STARTED|Phase II||0
158960|NCT01033032|382829|P4|NOT COMPLETED|Phase I||6
158961|NCT01033032|382830|P3|NOT COMPLETED|Phase I||0
158962|NCT01033032|382831|P2|NOT COMPLETED|Phase I||3
158963|NCT01033032|382832|P1|NOT COMPLETED|Phase I||3
158964|NCT01033032|382829|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
158965|NCT01033032|382830|P3|COMPLETED|Phase I||3
158966|NCT01033032|382831|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
158967|NCT01033032|382832|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
158968|NCT01033032|382829|P4|STARTED|Phase I||6
158969|NCT01033032|382830|P3|STARTED|Phase I||3
158970|NCT01033032|382831|P2|STARTED|Phase I||3
158971|NCT01033032|382832|P1|STARTED|Phase I||3
158972|NCT01033019|382841|P2|NOT COMPLETED|Overall Study||0
158973|NCT01033019|382842|P1|NOT COMPLETED|Overall Study||1
158974|NCT01033019|382841|P2|COMPLETED|Overall Study||8
158975|NCT01033019|382842|P1|COMPLETED|Overall Study||15
158976|NCT01033019|382841|P2|STARTED|Overall Study||8
158977|NCT01033019|382842|P1|STARTED|Overall Study||16
158978|NCT01032993|382851|P2|NOT COMPLETED|Overall Study||0
158979|NCT01032993|382852|P1|NOT COMPLETED|Overall Study||0
158980|NCT01032993|382851|P2|COMPLETED|Overall Study||20
158981|NCT01032993|382852|P1|COMPLETED|Overall Study||19
158982|NCT01032993|382851|P2|STARTED|Overall Study||20
158983|NCT01032993|382852|P1|STARTED|Overall Study||19
158984|NCT01032928|382864|P1|NOT COMPLETED|Overall Study||0
158985|NCT01032928|382864|P1|COMPLETED|Overall Study||30
158986|NCT01032928|382864|P1|STARTED|Overall Study||30
158987|NCT01032915|382880|P4|NOT COMPLETED|Overall Study||7
158988|NCT01032915|382881|P3|NOT COMPLETED|Overall Study||7
158989|NCT01032915|382882|P2|NOT COMPLETED|Overall Study||11
158990|NCT01032915|382883|P1|NOT COMPLETED|Overall Study||8
158991|NCT01032915|382880|P4|COMPLETED|Overall Study||27
158992|NCT01032915|382881|P3|COMPLETED|Overall Study||24
158993|NCT01032915|382882|P2|COMPLETED|Overall Study||20
158994|NCT01032915|382883|P1|COMPLETED|Overall Study||21
158995|NCT01032915|382880|P4|STARTED|Overall Study||34
158996|NCT01032915|382881|P3|STARTED|Overall Study||31
158997|NCT01032915|382882|P2|STARTED|Overall Study||31
158998|NCT01032915|382883|P1|STARTED|Overall Study||29
158999|NCT01032889|382908|P3|NOT COMPLETED|Overall Study||3
159000|NCT01032889|382909|P2|NOT COMPLETED|Overall Study||15
159001|NCT01032889|382910|P1|NOT COMPLETED|Overall Study||8
159002|NCT01032889|382908|P3|COMPLETED|Overall Study||42
159003|NCT01032889|382909|P2|COMPLETED|Overall Study||28
159004|NCT01032889|382910|P1|COMPLETED|Overall Study||33
159005|NCT01032889|382908|P3|Received Treatment|Overall Study||45
159006|NCT01032889|382909|P2|Received Treatment|Overall Study||43
159007|NCT01032889|382910|P1|Received Treatment|Overall Study||41
159008|NCT01032889|382908|P3|STARTED|Overall Study||45
159009|NCT01032889|382909|P2|STARTED|Overall Study||43
159010|NCT01032889|382910|P1|STARTED|Overall Study||41
159011|NCT01032850|382930|P1|NOT COMPLETED|Overall Study||2
159012|NCT01032850|382930|P1|COMPLETED|Overall Study||13
159013|NCT01032850|382930|P1|STARTED|Overall Study||15
159014|NCT01032837|382941|P4|NOT COMPLETED|Overall Study||3
159015|NCT01032837|382942|P3|NOT COMPLETED|Overall Study||1
159016|NCT01032837|382943|P2|NOT COMPLETED|Overall Study||3
159017|NCT01032837|382944|P1|NOT COMPLETED|Overall Study||0
159018|NCT01032837|382941|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
159019|NCT01032837|382942|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
159020|NCT01032837|382943|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
159021|NCT01032837|382944|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
159022|NCT01032837|382941|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
159023|NCT01032837|382942|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
159024|NCT01032837|382943|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
159025|NCT01032837|382944|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
159026|NCT01032837|382941|P4|STARTED|Overall Study||25
159027|NCT01032837|382942|P3|STARTED|Overall Study||25
159028|NCT01032837|382943|P2|STARTED|Overall Study||26
159029|NCT01032837|382944|P1|STARTED|Overall Study||26
159030|NCT01032759|382992|P2|NOT COMPLETED|Overall Study||3
159031|NCT01032759|382993|P1|NOT COMPLETED|Overall Study||1
159032|NCT01032759|382992|P2|COMPLETED|Overall Study||28
159033|NCT01032759|382993|P1|COMPLETED|Overall Study||31
159034|NCT01032759|382992|P2|Completed 48 Hour Assessment|Overall Study||28
159035|NCT01032759|382993|P1|Completed 48 Hour Assessment|Overall Study||31
159036|NCT01032759|382992|P2|Completed 24 Hour Assessment|Overall Study||30
159037|NCT01032759|382993|P1|Completed 24 Hour Assessment|Overall Study||32
159038|NCT01032759|382992|P2|STARTED|Overall Study||31
159039|NCT01032759|382993|P1|STARTED|Overall Study||32
159040|NCT01032733|383013|P2|NOT COMPLETED|Overall Study||1
159041|NCT01032733|383014|P1|NOT COMPLETED|Overall Study||1
159042|NCT01032733|383013|P2|COMPLETED|Overall Study||16
159043|NCT01032733|383014|P1|COMPLETED|Overall Study||16
159044|NCT01032733|383013|P2|STARTED|Overall Study||17
159045|NCT01032733|383014|P1|STARTED|Overall Study||17
159046|NCT01032694|383030|P2|NOT COMPLETED|Overall Study||0
159047|NCT01032694|383031|P1|NOT COMPLETED|Overall Study||0
159048|NCT01032694|383030|P2|COMPLETED|Overall Study||10
159049|NCT01032694|383031|P1|COMPLETED|Overall Study||20
159050|NCT01032694|383030|P2|STARTED|Overall Study||10
159051|NCT01032694|383031|P1|STARTED|Overall Study||20
159052|NCT01032538|383041|P1|NOT COMPLETED|Overall Study||0
159053|NCT01032538|383041|P1|COMPLETED|Overall Study|Knees|99
159054|NCT01032538|383041|P1|STARTED|Overall Study|Knees|99
159055|NCT01032382|383049|P2|NOT COMPLETED|Overall Study||5
159056|NCT01032382|383050|P1|NOT COMPLETED|Overall Study||5
159057|NCT01032382|383049|P2|COMPLETED|Overall Study||9
159058|NCT01032382|383050|P1|COMPLETED|Overall Study||11
159059|NCT01032382|383049|P2|STARTED|Overall Study||14
159060|NCT01032382|383050|P1|STARTED|Overall Study||16
159061|NCT01032291|383079|P3|NOT COMPLETED|Proof of Concept||3
159062|NCT01032291|383080|P2|NOT COMPLETED|Proof of Concept||8
159063|NCT01032291|383081|P1|NOT COMPLETED|Proof of Concept||0
159064|NCT01032291|383079|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
159065|NCT01032291|383080|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
159066|NCT01032291|383081|P1|COMPLETED|Proof of Concept||0
159067|NCT01032291|383079|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
159068|NCT01032291|383080|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
159069|NCT01032291|383081|P1|Intent to Treat and Safety Populations|Proof of Concept||0
159070|NCT01032291|383079|P3|STARTED|Proof of Concept||21
159071|NCT01032291|383080|P2|STARTED|Proof of Concept||22
159072|NCT01032291|383081|P1|STARTED|Proof of Concept||0
159073|NCT01032291|383079|P3|NOT COMPLETED|Safety Lead-in||0
159074|NCT01032291|383080|P2|NOT COMPLETED|Safety Lead-in||0
159075|NCT01032291|383081|P1|NOT COMPLETED|Safety Lead-in||2
159076|NCT01032291|383079|P3|COMPLETED|Safety Lead-in||0
159077|NCT01032291|383080|P2|COMPLETED|Safety Lead-in||0
159078|NCT01032291|383081|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
159079|NCT01032291|383079|P3|STARTED|Safety Lead-in||0
159080|NCT01032291|383080|P2|STARTED|Safety Lead-in||0
159081|NCT01032291|383081|P1|STARTED|Safety Lead-in||8
159082|NCT01032265|383107|P2|NOT COMPLETED|Overall Study||17
159083|NCT01032265|383108|P1|NOT COMPLETED|Overall Study||13
159084|NCT01032265|383107|P2|COMPLETED|Overall Study||107
159085|NCT01032265|383108|P1|COMPLETED|Overall Study||113
159086|NCT01032265|383107|P2|STARTED|Overall Study||124
159087|NCT01032265|383108|P1|STARTED|Overall Study||126
159088|NCT01032239|383128|P2|NOT COMPLETED|Overall Study||5
159089|NCT01032239|383129|P1|NOT COMPLETED|Overall Study||7
159090|NCT01032239|383128|P2|COMPLETED|Overall Study||24
159091|NCT01032239|383129|P1|COMPLETED|Overall Study||24
159092|NCT01032239|383128|P2|Implant|Overall Study||0
159093|NCT01032239|383129|P1|Implant|Overall Study|implanted|25
159094|NCT01032239|383128|P2|STARTED|Overall Study|randomized to BMT arm|29
159095|NCT01032239|383129|P1|STARTED|Overall Study|randomized to ITB arm|31
159096|NCT01032200|383159|P2|NOT COMPLETED|Overall Study||7
159097|NCT01032200|383160|P1|NOT COMPLETED|Overall Study||4
159098|NCT01032200|383159|P2|COMPLETED|Overall Study||21
159099|NCT01032200|383160|P1|COMPLETED|Overall Study||22
159100|NCT01032200|383159|P2|STARTED|Overall Study||28
159101|NCT01032200|383160|P1|STARTED|Overall Study||26
159102|NCT01032174|383176|P2|NOT COMPLETED|Overall Study||1
159103|NCT01032174|383177|P1|NOT COMPLETED|Overall Study||0
159104|NCT01032174|383176|P2|COMPLETED|Overall Study||59
159105|NCT01032174|383177|P1|COMPLETED|Overall Study||63
159106|NCT01032174|383176|P2|STARTED|Overall Study||60
159107|NCT01032174|383177|P1|STARTED|Overall Study||63
159108|NCT01032135|383192|P7|NOT COMPLETED|8 Week Randomization||18
159109|NCT01032135|383193|P6|NOT COMPLETED|8 Week Randomization||17
159110|NCT01032135|383194|P5|NOT COMPLETED|8 Week Randomization||9
159111|NCT01032135|383195|P4|NOT COMPLETED|8 Week Randomization||11
159112|NCT01032135|383196|P3|NOT COMPLETED|8 Week Randomization||0
159113|NCT01032135|383197|P2|NOT COMPLETED|8 Week Randomization||0
159114|NCT01032135|383198|P1|NOT COMPLETED|8 Week Randomization||26
159115|NCT01032135|383192|P7|COMPLETED|8 Week Randomization||36
159116|NCT01032135|383193|P6|COMPLETED|8 Week Randomization||31
159117|NCT01032135|383194|P5|COMPLETED|8 Week Randomization||34
159118|NCT01032135|383195|P4|COMPLETED|8 Week Randomization||30
159119|NCT01032135|383196|P3|COMPLETED|8 Week Randomization||0
159120|NCT01032135|383197|P2|COMPLETED|8 Week Randomization||0
159121|NCT01032135|383198|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
159122|NCT01032135|383192|P7|12 Week Follow up|8 Week Randomization||41
159123|NCT01032135|383193|P6|12 Week Follow up|8 Week Randomization||36
159124|NCT01032135|383194|P5|12 Week Follow up|8 Week Randomization||38
159125|NCT01032135|383195|P4|12 Week Follow up|8 Week Randomization||34
159126|NCT01032135|383196|P3|12 Week Follow up|8 Week Randomization||0
159127|NCT01032135|383197|P2|12 Week Follow up|8 Week Randomization||0
159128|NCT01032135|383198|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
159129|NCT01032135|383192|P7|STARTED|8 Week Randomization||54
159130|NCT01032135|383193|P6|STARTED|8 Week Randomization||48
159131|NCT01032135|383194|P5|STARTED|8 Week Randomization||43
159132|NCT01032135|383195|P4|STARTED|8 Week Randomization||41
159133|NCT01032135|383196|P3|STARTED|8 Week Randomization||0
159134|NCT01032135|383197|P2|STARTED|8 Week Randomization||0
159135|NCT01032135|383198|P1|STARTED|8 Week Randomization||227
159136|NCT01032135|383192|P7|NOT COMPLETED|2 Week Randomization||0
159137|NCT01032135|383193|P6|NOT COMPLETED|2 Week Randomization||0
159138|NCT01032135|383194|P5|NOT COMPLETED|2 Week Randomization||0
159139|NCT01032135|383195|P4|NOT COMPLETED|2 Week Randomization||0
159140|NCT01032135|383196|P3|NOT COMPLETED|2 Week Randomization||0
159141|NCT01032135|383197|P2|NOT COMPLETED|2 Week Randomization||0
159142|NCT01032135|383198|P1|NOT COMPLETED|2 Week Randomization||0
159143|NCT01032135|383192|P7|COMPLETED|2 Week Randomization||0
159144|NCT01032135|383193|P6|COMPLETED|2 Week Randomization||0
159145|NCT01032135|383194|P5|COMPLETED|2 Week Randomization||0
159146|NCT01032135|383195|P4|COMPLETED|2 Week Randomization||0
159147|NCT01032135|383196|P3|COMPLETED|2 Week Randomization||96
159148|NCT01032135|383197|P2|COMPLETED|2 Week Randomization||93
159149|NCT01032135|383198|P1|COMPLETED|2 Week Randomization||311
159150|NCT01032135|383192|P7|STARTED|2 Week Randomization||0
159151|NCT01032135|383193|P6|STARTED|2 Week Randomization||0
159152|NCT01032135|383194|P5|STARTED|2 Week Randomization||0
159153|NCT01032135|383195|P4|STARTED|2 Week Randomization||0
159154|NCT01032135|383196|P3|STARTED|2 Week Randomization||96
159155|NCT01032135|383197|P2|STARTED|2 Week Randomization||93
159156|NCT01032135|383198|P1|STARTED|2 Week Randomization||311
159157|NCT01032070|383417|P2|NOT COMPLETED|Overall Study||12
159158|NCT01032070|383418|P1|NOT COMPLETED|Overall Study||13
159159|NCT01032070|383417|P2|COMPLETED|Overall Study||0
159160|NCT01032070|383418|P1|COMPLETED|Overall Study||0
159161|NCT01032070|383417|P2|STARTED|Overall Study||12
159162|NCT01032070|383418|P1|STARTED|Overall Study||13
159163|NCT01032044|383447|P2|NOT COMPLETED|Overall Study||20
159164|NCT01032044|383448|P1|NOT COMPLETED|Overall Study||25
159165|NCT01032044|383447|P2|COMPLETED|Overall Study||62
159166|NCT01032044|383448|P1|COMPLETED|Overall Study||57
159167|NCT01032044|383447|P2|Procedure|Overall Study||75
159168|NCT01032044|383448|P1|Procedure|Overall Study||74
159169|NCT01032044|383447|P2|STARTED|Overall Study||82
159170|NCT01032044|383448|P1|STARTED|Overall Study||82
159171|NCT01032018|383456|P2|NOT COMPLETED|Overall Study||6
159172|NCT01032018|383457|P1|NOT COMPLETED|Overall Study||6
159173|NCT01032018|383456|P2|COMPLETED|Overall Study||67
159174|NCT01032018|383457|P1|COMPLETED|Overall Study||71
159175|NCT01032018|383456|P2|STARTED|Overall Study||73
159176|NCT01032018|383457|P1|STARTED|Overall Study||77
159177|NCT01031979|383467|P2|NOT COMPLETED|Overall Study||4
159178|NCT01031979|383468|P1|NOT COMPLETED|Overall Study||5
159179|NCT01031979|383467|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
159180|NCT01031979|383468|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
159181|NCT01031979|383467|P2|Completed Primary Outcome Measure|Overall Study||12
159182|NCT01031979|383468|P1|Completed Primary Outcome Measure|Overall Study||12
159183|NCT01031979|383467|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
159184|NCT01031979|383468|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
159185|NCT01031953|383480|P1|NOT COMPLETED|Overall Study||0
159186|NCT01031953|383480|P1|COMPLETED|Overall Study||11
159187|NCT01031953|383480|P1|STARTED|Overall Study||11
159188|NCT01031914|383491|P1|NOT COMPLETED|Overall Study||0
159189|NCT01031914|383491|P1|COMPLETED|Overall Study||36
159190|NCT01031914|383491|P1|STARTED|Overall Study||36
159191|NCT01031810|383495|P1|NOT COMPLETED|Overall Study||4
159192|NCT01031810|383495|P1|COMPLETED|Overall Study||9
159193|NCT01031810|383495|P1|STARTED|Overall Study||13
159194|NCT01031706|383506|P2|NOT COMPLETED|Overall Study||1
159195|NCT01031706|383507|P1|NOT COMPLETED|Overall Study||2
159196|NCT01031706|383506|P2|COMPLETED|Overall Study||8
159197|NCT01031706|383507|P1|COMPLETED|Overall Study||12
159198|NCT01031706|383506|P2|STARTED|Overall Study||9
159199|NCT01031706|383507|P1|STARTED|Overall Study||14
159200|NCT01031680|383517|P2|NOT COMPLETED|Overall Study||58
159201|NCT01031680|383518|P1|NOT COMPLETED|Overall Study||57
159202|NCT01031680|383517|P2|COMPLETED|Overall Study||404
159203|NCT01031680|383518|P1|COMPLETED|Overall Study||403
159204|NCT01031680|383517|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
159205|NCT01031680|383518|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
159206|NCT01031628|383538|P4|NOT COMPLETED|Overall Study||0
159207|NCT01031628|383539|P3|NOT COMPLETED|Overall Study||3
159208|NCT01031628|383540|P2|NOT COMPLETED|Overall Study||1
159209|NCT01031628|383541|P1|NOT COMPLETED|Overall Study||0
159210|NCT01031628|383538|P4|COMPLETED|Overall Study||0
159211|NCT01031628|383539|P3|COMPLETED|Overall Study||0
159212|NCT01031628|383540|P2|COMPLETED|Overall Study||0
159213|NCT01031628|383541|P1|COMPLETED|Overall Study||0
159214|NCT01031628|383538|P4|STARTED|Overall Study||0
159215|NCT01031628|383539|P3|STARTED|Overall Study||3
159216|NCT01031628|383540|P2|STARTED|Overall Study||1
159217|NCT01031628|383541|P1|STARTED|Overall Study||0
159218|NCT01031550|383553|P2|NOT COMPLETED|Overall Study||0
159219|NCT01031550|383554|P1|NOT COMPLETED|Overall Study||0
159220|NCT01031550|383553|P2|COMPLETED|Overall Study||3
159221|NCT01031550|383554|P1|COMPLETED|Overall Study||5
159222|NCT01031550|383553|P2|STARTED|Overall Study||3
159223|NCT01031550|383554|P1|STARTED|Overall Study||5
159224|NCT01031498|383569|P3|NOT COMPLETED|Overall Study||2
159225|NCT01031498|383570|P2|NOT COMPLETED|Overall Study||3
159226|NCT01031498|383571|P1|NOT COMPLETED|Overall Study||2
159227|NCT01031498|383569|P3|COMPLETED|Overall Study||48
159228|NCT01031498|383570|P2|COMPLETED|Overall Study||48
159229|NCT01031498|383571|P1|COMPLETED|Overall Study||47
159230|NCT01031498|383569|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
159231|NCT01031498|383570|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
159232|NCT01031498|383571|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
159233|NCT01031446|383579|P1|NOT COMPLETED|Overall Study||55
159234|NCT01031446|383579|P1|COMPLETED|Overall Study||0
159235|NCT01031446|383579|P1|STARTED|Overall Study||55
159236|NCT01031381|383588|P1|NOT COMPLETED|Overall Study||9
159237|NCT01031381|383588|P1|COMPLETED|Overall Study||50
159238|NCT01031381|383588|P1|STARTED|Overall Study||59
159239|NCT01031134|383595|P2|NOT COMPLETED|Overall Study||10
159240|NCT01031134|383596|P1|NOT COMPLETED|Overall Study||11
159241|NCT01031134|383595|P2|COMPLETED|Overall Study||78
159242|NCT01031134|383596|P1|COMPLETED|Overall Study||103
159243|NCT01031134|383595|P2|STARTED|Overall Study||88
159244|NCT01031134|383596|P1|STARTED|Overall Study||114
159245|NCT01031095|383606|P2|NOT COMPLETED|Overall Study||0
159246|NCT01031095|383607|P1|NOT COMPLETED|Overall Study||0
159247|NCT01031095|383606|P2|COMPLETED|Overall Study||100
159248|NCT01031095|383607|P1|COMPLETED|Overall Study||100
159249|NCT01031095|383606|P2|STARTED|Overall Study||100
159250|NCT01031095|383607|P1|STARTED|Overall Study||100
159251|NCT01031043|383613|P1|NOT COMPLETED|Overall Study||1
159252|NCT01031043|383613|P1|COMPLETED|Overall Study||4
159253|NCT01031043|383613|P1|STARTED|Overall Study||5
159254|NCT01031004|383619|P2|NOT COMPLETED|Overall Study||1
159255|NCT01031004|383620|P1|NOT COMPLETED|Overall Study||1
159256|NCT01031004|383619|P2|COMPLETED|Overall Study||24
159257|NCT01031004|383620|P1|COMPLETED|Overall Study||24
159258|NCT01031004|383619|P2|STARTED|Overall Study||25
159259|NCT01031004|383620|P1|STARTED|Overall Study||25
159260|NCT01030965|383664|P4|NOT COMPLETED|Overall Study||7
159261|NCT01030965|383665|P3|NOT COMPLETED|Overall Study||4
159262|NCT01030965|383666|P2|NOT COMPLETED|Overall Study||6
159263|NCT01030965|383667|P1|NOT COMPLETED|Overall Study||4
159264|NCT01030965|383664|P4|COMPLETED|Overall Study||64
159265|NCT01030965|383665|P3|COMPLETED|Overall Study||68
159266|NCT01030965|383666|P2|COMPLETED|Overall Study||65
159267|NCT01030965|383667|P1|COMPLETED|Overall Study||67
159268|NCT01030965|383664|P4|STARTED|Overall Study||71
159269|NCT01030965|383665|P3|STARTED|Overall Study||72
159270|NCT01030965|383666|P2|STARTED|Overall Study||71
159271|NCT01030965|383667|P1|STARTED|Overall Study||71
159272|NCT01030952|383687|P2|NOT COMPLETED|Overall Study||3
159273|NCT01030952|383688|P1|NOT COMPLETED|Overall Study||2
159274|NCT01030952|383687|P2|COMPLETED|Overall Study||49
159275|NCT01030952|383688|P1|COMPLETED|Overall Study||49
159276|NCT01030952|383687|P2|STARTED|Overall Study||52
159277|NCT01030952|383688|P1|STARTED|Overall Study||51
159278|NCT01030822|383725|P3|NOT COMPLETED|Overall Study||26
159279|NCT01030822|383726|P2|NOT COMPLETED|Overall Study||24
159280|NCT01030822|383727|P1|NOT COMPLETED|Overall Study||31
159281|NCT01030822|383725|P3|COMPLETED|Overall Study||61
159282|NCT01030822|383726|P2|COMPLETED|Overall Study||71
159283|NCT01030822|383727|P1|COMPLETED|Overall Study||69
159284|NCT01030822|383725|P3|STARTED|Overall Study||87
159285|NCT01030822|383726|P2|STARTED|Overall Study||95
159286|NCT01030822|383727|P1|STARTED|Overall Study||100
159287|NCT01030757|383774|P1|NOT COMPLETED|Overall Study||0
159288|NCT01030757|383774|P1|COMPLETED|Overall Study||2
159289|NCT01030757|383774|P1|STARTED|Overall Study||2
159290|NCT01030718|383782|P3|NOT COMPLETED|Study CA180-036 Only||5
159291|NCT01030718|383783|P2|NOT COMPLETED|Study CA180-036 Only||7
159292|NCT01030718|383784|P1|NOT COMPLETED|Study CA180-036 Only||3
159293|NCT01030718|383782|P3|COMPLETED|Study CA180-036 Only||1
159294|NCT01030718|383783|P2|COMPLETED|Study CA180-036 Only||2
159295|NCT01030718|383784|P1|COMPLETED|Study CA180-036 Only||26
159296|NCT01030718|383782|P3|STARTED|Study CA180-036 Only||6
159297|NCT01030718|383783|P2|STARTED|Study CA180-036 Only||9
159298|NCT01030718|383784|P1|STARTED|Study CA180-036 Only||29
159299|NCT01030718|383782|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
159300|NCT01030718|383783|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
159301|NCT01030718|383784|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
159302|NCT01030718|383782|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
159303|NCT01030718|383783|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
159304|NCT01030718|383784|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
159305|NCT01030718|383782|P3|STARTED|Studies CA180-031 and -036 Combined||13
159306|NCT01030718|383783|P2|STARTED|Studies CA180-031 and -036 Combined||11
159307|NCT01030718|383784|P1|STARTED|Studies CA180-031 and -036 Combined||30
159308|NCT01030666|383845|P2|NOT COMPLETED|Overall Study||2
159309|NCT01030666|383846|P1|NOT COMPLETED|Overall Study||3
159310|NCT01030666|383845|P2|COMPLETED|Overall Study||31
159311|NCT01030666|383846|P1|COMPLETED|Overall Study||25
159312|NCT01030666|383845|P2|STARTED|Overall Study||33
159313|NCT01030666|383846|P1|STARTED|Overall Study||28
159314|NCT01030653|383856|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
159315|NCT01030653|383857|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
159316|NCT01030653|383856|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
159317|NCT01030653|383857|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
159318|NCT01030653|383856|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
159319|NCT01030653|383857|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
159320|NCT01030653|383856|P2|NOT COMPLETED|7-Day Washout Period||0
159321|NCT01030653|383857|P1|NOT COMPLETED|7-Day Washout Period||0
159322|NCT01030653|383856|P2|COMPLETED|7-Day Washout Period||4
159323|NCT01030653|383857|P1|COMPLETED|7-Day Washout Period||4
159324|NCT01030653|383856|P2|STARTED|7-Day Washout Period||4
159325|NCT01030653|383857|P1|STARTED|7-Day Washout Period||4
159326|NCT01030653|383856|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
159327|NCT01030653|383857|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
159328|NCT01030653|383856|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
159329|NCT01030653|383857|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
159330|NCT01030653|383856|P2|STARTED|Loading Dose & First Maintenance Regimen||4
159331|NCT01030653|383857|P1|STARTED|Loading Dose & First Maintenance Regimen||4
159332|NCT01030536|383871|P5|NOT COMPLETED|Overall Study||1
159333|NCT01030536|383872|P4|NOT COMPLETED|Overall Study||3
159334|NCT01030536|383873|P3|NOT COMPLETED|Overall Study||6
159335|NCT01030536|383874|P2|NOT COMPLETED|Overall Study||6
159336|NCT01030536|383875|P1|NOT COMPLETED|Overall Study||7
159337|NCT01030536|383871|P5|COMPLETED|Overall Study||0
159338|NCT01030536|383872|P4|COMPLETED|Overall Study||0
159339|NCT01030536|383873|P3|COMPLETED|Overall Study||0
159340|NCT01030536|383874|P2|COMPLETED|Overall Study||0
159341|NCT01030536|383875|P1|COMPLETED|Overall Study||0
159342|NCT01030536|383871|P5|STARTED|Overall Study||1
159343|NCT01030536|383872|P4|STARTED|Overall Study||3
159344|NCT01030536|383873|P3|STARTED|Overall Study||6
159345|NCT01030536|383874|P2|STARTED|Overall Study||6
159346|NCT01030536|383875|P1|STARTED|Overall Study||7
159347|NCT01030458|383980|P2|NOT COMPLETED|Overall Study||32
159348|NCT01030458|383981|P1|NOT COMPLETED|Overall Study||27
159349|NCT01030458|383980|P2|COMPLETED|Overall Study||57
159350|NCT01030458|383981|P1|COMPLETED|Overall Study||67
159351|NCT01030458|383980|P2|STARTED|Overall Study||89
159352|NCT01030458|383981|P1|STARTED|Overall Study||94
159353|NCT01029925|383993|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
159354|NCT01029925|383993|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
159355|NCT01029925|383993|P1|STARTED|Completion of Cycle 2 (56 Days)||3
159356|NCT01029925|383993|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
159357|NCT01029925|383993|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
159358|NCT01029925|383993|P1|STARTED|Completion of Cycle 1 (28 Days)||7
159359|NCT01029912|383999|P2|NOT COMPLETED|Overall Study||0
159360|NCT01029912|384000|P1|NOT COMPLETED|Overall Study||2
159361|NCT01029912|383999|P2|COMPLETED|Overall Study||12
159362|NCT01029912|384000|P1|COMPLETED|Overall Study||12
159363|NCT01029912|383999|P2|STARTED|Overall Study||12
159364|NCT01029912|384000|P1|STARTED|Overall Study||14
159365|NCT01029886|384012|P2|NOT COMPLETED|Overall Study||60
159366|NCT01029886|384013|P1|NOT COMPLETED|Overall Study||61
159367|NCT01029886|384012|P2|COMPLETED|Overall Study||391
159368|NCT01029886|384013|P1|COMPLETED|Overall Study||400
159369|NCT01029886|384012|P2|Intent to Treat (ITT)|Overall Study||450
159370|NCT01029886|384013|P1|Intent to Treat (ITT)|Overall Study||461
159371|NCT01029886|384012|P2|STARTED|Overall Study||451
159372|NCT01029886|384013|P1|STARTED|Overall Study||461
159373|NCT01029795|384041|P2|NOT COMPLETED|Overall Study||22
159374|NCT01029795|384042|P1|NOT COMPLETED|Overall Study||16
159375|NCT01029795|384041|P2|COMPLETED|Overall Study||0
159376|NCT01029795|384042|P1|COMPLETED|Overall Study||0
159377|NCT01029795|384041|P2|STARTED|Overall Study||22
159378|NCT01029795|384042|P1|STARTED|Overall Study||16
159379|NCT01029730|384094|P1|NOT COMPLETED|Maintenance Therapy||23
159380|NCT01029730|384094|P1|COMPLETED|Maintenance Therapy||14
159381|NCT01029730|384094|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
159382|NCT01029730|384094|P1|NOT COMPLETED|Combination Therapy||16
159383|NCT01029730|384094|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
159384|NCT01029730|384094|P1|STARTED|Combination Therapy||55
159385|NCT01029704|384106|P5|NOT COMPLETED|Overall Study||0
159386|NCT01029704|384107|P4|NOT COMPLETED|Overall Study||0
159387|NCT01029704|384108|P3|NOT COMPLETED|Overall Study||0
159388|NCT01029704|384109|P2|NOT COMPLETED|Overall Study||0
159389|NCT01029704|384110|P1|NOT COMPLETED|Overall Study||0
159390|NCT01029704|384106|P5|COMPLETED|Overall Study||26
159391|NCT01029704|384107|P4|COMPLETED|Overall Study||28
159392|NCT01029704|384108|P3|COMPLETED|Overall Study||23
159393|NCT01029704|384109|P2|COMPLETED|Overall Study||24
159394|NCT01029704|384110|P1|COMPLETED|Overall Study||28
159395|NCT01029704|384106|P5|STARTED|Overall Study||26
159396|NCT01029704|384107|P4|STARTED|Overall Study||28
159397|NCT01029704|384108|P3|STARTED|Overall Study||23
159398|NCT01029704|384109|P2|STARTED|Overall Study||24
159399|NCT01029704|384110|P1|STARTED|Overall Study||28
159400|NCT01029691|384140|P3|NOT COMPLETED|Continued APAP to Delivery||1
159401|NCT01029691|384141|P2|NOT COMPLETED|Continued APAP to Delivery||0
159402|NCT01029691|384142|P1|NOT COMPLETED|Continued APAP to Delivery||0
159403|NCT01029691|384140|P3|COMPLETED|Continued APAP to Delivery||76
159404|NCT01029691|384141|P2|COMPLETED|Continued APAP to Delivery||16
159405|NCT01029691|384142|P1|COMPLETED|Continued APAP to Delivery||20
159406|NCT01029691|384140|P3|STARTED|Continued APAP to Delivery||77
159407|NCT01029691|384141|P2|STARTED|Continued APAP to Delivery||16
159408|NCT01029691|384142|P1|STARTED|Continued APAP to Delivery||20
159409|NCT01029691|384140|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
159410|NCT01029691|384141|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
159411|NCT01029691|384142|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
159412|NCT01029691|384140|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
159413|NCT01029691|384141|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
159414|NCT01029691|384142|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
159415|NCT01029691|384140|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
159416|NCT01029691|384141|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
159417|NCT01029691|384142|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
159418|NCT01029691|384140|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
159419|NCT01029691|384141|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
159420|NCT01029691|384142|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
159421|NCT01029691|384140|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
159422|NCT01029691|384141|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
159423|NCT01029691|384142|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
159424|NCT01029652|384167|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
159425|NCT01029652|384168|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
159426|NCT01029652|384167|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
159427|NCT01029652|384168|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
159428|NCT01029652|384167|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
159429|NCT01029652|384168|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
159430|NCT01029652|384167|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
159431|NCT01029652|384168|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
159432|NCT01029652|384167|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
159433|NCT01029652|384168|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
159434|NCT01029652|384167|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
159435|NCT01029652|384168|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
159436|NCT01029652|384167|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
159437|NCT01029652|384168|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
159438|NCT01029652|384167|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
159439|NCT01029652|384168|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
159440|NCT01029652|384167|P2|COMPLETED|Core Study (0-12 Weeks)||105
159441|NCT01029652|384168|P1|COMPLETED|Core Study (0-12 Weeks)||109
159442|NCT01029652|384167|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
159443|NCT01029652|384168|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
159444|NCT01029652|384167|P2|STARTED|Core Study (0-12 Weeks)||115
159445|NCT01029652|384168|P1|STARTED|Core Study (0-12 Weeks)||115
159446|NCT01029535|384246|P1|NOT COMPLETED|Overall Study||31
159447|NCT01029535|384246|P1|COMPLETED|Overall Study||72
159448|NCT01029535|384246|P1|STARTED|Overall Study||103
159449|NCT01029405|384275|P4|NOT COMPLETED|Overall Study||5
159450|NCT01029405|384276|P3|NOT COMPLETED|Overall Study||4
159451|NCT01029405|384277|P2|NOT COMPLETED|Overall Study||3
159452|NCT01029405|384278|P1|NOT COMPLETED|Overall Study||2
159453|NCT01029405|384275|P4|COMPLETED|Overall Study||32
159454|NCT01029405|384276|P3|COMPLETED|Overall Study||31
159455|NCT01029405|384277|P2|COMPLETED|Overall Study||34
159456|NCT01029405|384278|P1|COMPLETED|Overall Study||34
159457|NCT01029405|384275|P4|STARTED|Overall Study||37
159458|NCT01029405|384276|P3|STARTED|Overall Study||35
159459|NCT01029405|384277|P2|STARTED|Overall Study||37
159460|NCT01029405|384278|P1|STARTED|Overall Study||36
159461|NCT01029392|384290|P2|NOT COMPLETED|Overall Study||11
159462|NCT01029392|384291|P1|NOT COMPLETED|Overall Study||20
159463|NCT01029392|384290|P2|COMPLETED|Overall Study||27
159464|NCT01029392|384291|P1|COMPLETED|Overall Study||17
159465|NCT01029392|384290|P2|STARTED|Overall Study||38
159466|NCT01029392|384291|P1|STARTED|Overall Study||37
159467|NCT01029366|384301|P2|NOT COMPLETED|Overall Study||2
159468|NCT01029366|384302|P1|NOT COMPLETED|Overall Study||4
159469|NCT01029366|384301|P2|COMPLETED|Overall Study||6
159470|NCT01029366|384302|P1|COMPLETED|Overall Study||14
159471|NCT01029366|384301|P2|STARTED|Overall Study||8
159472|NCT01029366|384302|P1|STARTED|Overall Study||18
159473|NCT01029340|384314|P6|NOT COMPLETED|Part C Follow up Period||0
159474|NCT01029340|384315|P5|NOT COMPLETED|Part C Follow up Period||0
159475|NCT01029340|384316|P4|NOT COMPLETED|Part C Follow up Period||0
159476|NCT01029340|384317|P3|NOT COMPLETED|Part C Follow up Period||0
159477|NCT01029340|384318|P2|NOT COMPLETED|Part C Follow up Period||0
159478|NCT01029340|384319|P1|NOT COMPLETED|Part C Follow up Period||0
159479|NCT01029340|384314|P6|COMPLETED|Part C Follow up Period||0
159480|NCT01029340|384315|P5|COMPLETED|Part C Follow up Period||5
159481|NCT01029340|384316|P4|COMPLETED|Part C Follow up Period||0
159482|NCT01029340|384317|P3|COMPLETED|Part C Follow up Period||0
159483|NCT01029340|384318|P2|COMPLETED|Part C Follow up Period||0
159484|NCT01029340|384319|P1|COMPLETED|Part C Follow up Period||0
159485|NCT01029340|384314|P6|STARTED|Part C Follow up Period||0
159486|NCT01029340|384315|P5|STARTED|Part C Follow up Period||5
159487|NCT01029340|384316|P4|STARTED|Part C Follow up Period||0
159488|NCT01029340|384317|P3|STARTED|Part C Follow up Period||0
159489|NCT01029340|384318|P2|STARTED|Part C Follow up Period||0
159490|NCT01029340|384319|P1|STARTED|Part C Follow up Period||0
159491|NCT01029340|384314|P6|NOT COMPLETED|Part C Treatment Period||0
159492|NCT01029340|384315|P5|NOT COMPLETED|Part C Treatment Period||0
159493|NCT01029340|384316|P4|NOT COMPLETED|Part C Treatment Period||0
159494|NCT01029340|384317|P3|NOT COMPLETED|Part C Treatment Period||0
159495|NCT01029340|384318|P2|NOT COMPLETED|Part C Treatment Period||0
159496|NCT01029340|384319|P1|NOT COMPLETED|Part C Treatment Period||0
159497|NCT01029340|384314|P6|COMPLETED|Part C Treatment Period||0
159498|NCT01029340|384315|P5|COMPLETED|Part C Treatment Period||5
159499|NCT01029340|384316|P4|COMPLETED|Part C Treatment Period||0
159500|NCT01029340|384317|P3|COMPLETED|Part C Treatment Period||0
159501|NCT01029340|384318|P2|COMPLETED|Part C Treatment Period||0
159502|NCT01029340|384319|P1|COMPLETED|Part C Treatment Period||0
159503|NCT01029340|384314|P6|Participants Received Treatment|Part C Treatment Period||0
159504|NCT01029340|384315|P5|Participants Received Treatment|Part C Treatment Period||5
159505|NCT01029340|384316|P4|Participants Received Treatment|Part C Treatment Period||0
159506|NCT01029340|384317|P3|Participants Received Treatment|Part C Treatment Period||0
159507|NCT01029340|384318|P2|Participants Received Treatment|Part C Treatment Period||0
159508|NCT01029340|384319|P1|Participants Received Treatment|Part C Treatment Period||0
159509|NCT01029340|384314|P6|STARTED|Part C Treatment Period||0
159510|NCT01029340|384315|P5|STARTED|Part C Treatment Period||5
159511|NCT01029340|384316|P4|STARTED|Part C Treatment Period||0
159512|NCT01029340|384317|P3|STARTED|Part C Treatment Period||0
159513|NCT01029340|384318|P2|STARTED|Part C Treatment Period||0
159514|NCT01029340|384319|P1|STARTED|Part C Treatment Period||0
159515|NCT01029340|384314|P6|NOT COMPLETED|Extension Period||12
159516|NCT01029340|384315|P5|NOT COMPLETED|Extension Period||0
159517|NCT01029340|384316|P4|NOT COMPLETED|Extension Period||0
159518|NCT01029340|384317|P3|NOT COMPLETED|Extension Period||0
159519|NCT01029340|384318|P2|NOT COMPLETED|Extension Period||0
159520|NCT01029340|384319|P1|NOT COMPLETED|Extension Period||0
159521|NCT01029340|384314|P6|COMPLETED|Extension Period||43
159522|NCT01029340|384315|P5|COMPLETED|Extension Period||0
159523|NCT01029340|384316|P4|COMPLETED|Extension Period||0
159524|NCT01029340|384317|P3|COMPLETED|Extension Period||0
159525|NCT01029340|384318|P2|COMPLETED|Extension Period||0
159526|NCT01029340|384319|P1|COMPLETED|Extension Period||0
159527|NCT01029340|384314|P6|STARTED|Extension Period||55
159528|NCT01029340|384315|P5|STARTED|Extension Period||0
159529|NCT01029340|384316|P4|STARTED|Extension Period||0
159530|NCT01029340|384317|P3|STARTED|Extension Period||0
159531|NCT01029340|384318|P2|STARTED|Extension Period||0
159532|NCT01029340|384319|P1|STARTED|Extension Period||0
159533|NCT01029340|384314|P6|NOT COMPLETED|Part B Follow up Period||0
159534|NCT01029340|384315|P5|NOT COMPLETED|Part B Follow up Period||0
159535|NCT01029340|384316|P4|NOT COMPLETED|Part B Follow up Period||0
159536|NCT01029340|384317|P3|NOT COMPLETED|Part B Follow up Period||0
159537|NCT01029340|384318|P2|NOT COMPLETED|Part B Follow up Period||0
159538|NCT01029340|384319|P1|NOT COMPLETED|Part B Follow up Period||0
159539|NCT01029340|384314|P6|COMPLETED|Part B Follow up Period||0
159540|NCT01029340|384315|P5|COMPLETED|Part B Follow up Period||0
159541|NCT01029340|384316|P4|COMPLETED|Part B Follow up Period||32
159542|NCT01029340|384317|P3|COMPLETED|Part B Follow up Period||29
159543|NCT01029340|384318|P2|COMPLETED|Part B Follow up Period||0
159544|NCT01029340|384319|P1|COMPLETED|Part B Follow up Period||0
159545|NCT01029340|384314|P6|STARTED|Part B Follow up Period||0
159546|NCT01029340|384315|P5|STARTED|Part B Follow up Period||0
159547|NCT01029340|384316|P4|STARTED|Part B Follow up Period||32
159548|NCT01029340|384317|P3|STARTED|Part B Follow up Period||29
159549|NCT01029340|384318|P2|STARTED|Part B Follow up Period||0
159550|NCT01029340|384319|P1|STARTED|Part B Follow up Period||0
159551|NCT01029340|384314|P6|NOT COMPLETED|Part B Treatment Period||0
159552|NCT01029340|384315|P5|NOT COMPLETED|Part B Treatment Period||0
159553|NCT01029340|384316|P4|NOT COMPLETED|Part B Treatment Period||0
159554|NCT01029340|384317|P3|NOT COMPLETED|Part B Treatment Period||2
159555|NCT01029340|384318|P2|NOT COMPLETED|Part B Treatment Period||0
159556|NCT01029340|384319|P1|NOT COMPLETED|Part B Treatment Period||0
159557|NCT01029340|384314|P6|COMPLETED|Part B Treatment Period||0
159558|NCT01029340|384315|P5|COMPLETED|Part B Treatment Period||0
159559|NCT01029340|384316|P4|COMPLETED|Part B Treatment Period||32
159560|NCT01029340|384317|P3|COMPLETED|Part B Treatment Period||29
159561|NCT01029340|384318|P2|COMPLETED|Part B Treatment Period||0
159562|NCT01029340|384319|P1|COMPLETED|Part B Treatment Period||0
159563|NCT01029340|384314|P6|Participants Received Treatment|Part B Treatment Period||0
159564|NCT01029340|384315|P5|Participants Received Treatment|Part B Treatment Period||0
159565|NCT01029340|384316|P4|Participants Received Treatment|Part B Treatment Period||32
159566|NCT01029340|384317|P3|Participants Received Treatment|Part B Treatment Period||30
159567|NCT01029340|384318|P2|Participants Received Treatment|Part B Treatment Period||0
159568|NCT01029340|384319|P1|Participants Received Treatment|Part B Treatment Period||0
159569|NCT01029340|384314|P6|STARTED|Part B Treatment Period||0
159570|NCT01029340|384315|P5|STARTED|Part B Treatment Period||0
159571|NCT01029340|384316|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
159572|NCT01029340|384317|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
159573|NCT01029340|384318|P2|STARTED|Part B Treatment Period||0
159574|NCT01029340|384319|P1|STARTED|Part B Treatment Period||0
159575|NCT01029340|384314|P6|NOT COMPLETED|Part A Follow up Period||0
159576|NCT01029340|384315|P5|NOT COMPLETED|Part A Follow up Period||0
159577|NCT01029340|384316|P4|NOT COMPLETED|Part A Follow up Period||0
159578|NCT01029340|384317|P3|NOT COMPLETED|Part A Follow up Period||0
159579|NCT01029340|384318|P2|NOT COMPLETED|Part A Follow up Period||0
159580|NCT01029340|384319|P1|NOT COMPLETED|Part A Follow up Period||0
159581|NCT01029340|384314|P6|COMPLETED|Part A Follow up Period||0
159582|NCT01029340|384315|P5|COMPLETED|Part A Follow up Period||0
159583|NCT01029340|384316|P4|COMPLETED|Part A Follow up Period||0
159584|NCT01029340|384317|P3|COMPLETED|Part A Follow up Period||0
159585|NCT01029340|384318|P2|COMPLETED|Part A Follow up Period||14
159586|NCT01029340|384319|P1|COMPLETED|Part A Follow up Period||14
159587|NCT01029340|384314|P6|STARTED|Part A Follow up Period||0
159588|NCT01029340|384315|P5|STARTED|Part A Follow up Period||0
159589|NCT01029340|384316|P4|STARTED|Part A Follow up Period||0
159590|NCT01029340|384317|P3|STARTED|Part A Follow up Period||0
159591|NCT01029340|384318|P2|STARTED|Part A Follow up Period||14
159592|NCT01029340|384319|P1|STARTED|Part A Follow up Period||14
159593|NCT01029340|384314|P6|NOT COMPLETED|Part A Treatment Period||0
159594|NCT01029340|384315|P5|NOT COMPLETED|Part A Treatment Period||0
159595|NCT01029340|384316|P4|NOT COMPLETED|Part A Treatment Period||0
159596|NCT01029340|384317|P3|NOT COMPLETED|Part A Treatment Period||0
159597|NCT01029340|384318|P2|NOT COMPLETED|Part A Treatment Period||0
159598|NCT01029340|384319|P1|NOT COMPLETED|Part A Treatment Period||0
159599|NCT01029340|384314|P6|COMPLETED|Part A Treatment Period||0
159600|NCT01029340|384315|P5|COMPLETED|Part A Treatment Period||0
159601|NCT01029340|384316|P4|COMPLETED|Part A Treatment Period||0
159602|NCT01029340|384317|P3|COMPLETED|Part A Treatment Period||0
159603|NCT01029340|384318|P2|COMPLETED|Part A Treatment Period||14
159604|NCT01029340|384319|P1|COMPLETED|Part A Treatment Period||14
159605|NCT01029340|384314|P6|Safety Population|Part A Treatment Period||0
159606|NCT01029340|384315|P5|Safety Population|Part A Treatment Period||0
159607|NCT01029340|384316|P4|Safety Population|Part A Treatment Period||0
159608|NCT01029340|384317|P3|Safety Population|Part A Treatment Period||0
159609|NCT01029340|384318|P2|Safety Population|Part A Treatment Period||14
159610|NCT01029340|384319|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
159611|NCT01029340|384314|P6|Participants Received Treatment|Part A Treatment Period||0
159612|NCT01029340|384315|P5|Participants Received Treatment|Part A Treatment Period||0
159613|NCT01029340|384316|P4|Participants Received Treatment|Part A Treatment Period||0
159614|NCT01029340|384317|P3|Participants Received Treatment|Part A Treatment Period||0
159615|NCT01029340|384318|P2|Participants Received Treatment|Part A Treatment Period||14
159616|NCT01029340|384319|P1|Participants Received Treatment|Part A Treatment Period||14
159617|NCT01029340|384314|P6|STARTED|Part A Treatment Period||0
159618|NCT01029340|384315|P5|STARTED|Part A Treatment Period||0
159619|NCT01029340|384316|P4|STARTED|Part A Treatment Period||0
159620|NCT01029340|384317|P3|STARTED|Part A Treatment Period||0
159621|NCT01029340|384318|P2|STARTED|Part A Treatment Period||14
159622|NCT01029340|384319|P1|STARTED|Part A Treatment Period||14
159623|NCT01029262|384350|P2|NOT COMPLETED|Overall Study||145
159624|NCT01029262|384351|P1|NOT COMPLETED|Overall Study||78
159625|NCT01029262|384350|P2|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|15
159626|NCT01029262|384351|P1|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|1
159627|NCT01029262|384350|P2|STARTED|Overall Study||160
159628|NCT01029262|384351|P1|STARTED|Overall Study||79
159629|NCT01029054|384407|P3|NOT COMPLETED|Phase II||0
159630|NCT01029054|384408|P2|NOT COMPLETED|Phase II||0
159631|NCT01029054|384409|P1|NOT COMPLETED|Phase II||0
159632|NCT01029054|384407|P3|COMPLETED|Phase II||18
159633|NCT01029054|384408|P2|COMPLETED|Phase II||0
159634|NCT01029054|384409|P1|COMPLETED|Phase II||0
159635|NCT01029054|384407|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
159636|NCT01029054|384408|P2|STARTED|Phase II||0
159637|NCT01029054|384409|P1|STARTED|Phase II||0
159638|NCT01029054|384407|P3|NOT COMPLETED|Phase I||0
159639|NCT01029054|384408|P2|NOT COMPLETED|Phase I||0
159640|NCT01029054|384409|P1|NOT COMPLETED|Phase I||0
159641|NCT01029054|384407|P3|COMPLETED|Phase I||18
159642|NCT01029054|384408|P2|COMPLETED|Phase I||13
159643|NCT01029054|384409|P1|COMPLETED|Phase I||4
159644|NCT01029054|384407|P3|STARTED|Phase I||18
159645|NCT01029054|384408|P2|STARTED|Phase I||13
159646|NCT01029054|384409|P1|STARTED|Phase I||4
159647|NCT01028911|384417|P2|NOT COMPLETED|Overall Study||0
159648|NCT01028911|384418|P1|NOT COMPLETED|Overall Study||0
159649|NCT01028911|384417|P2|COMPLETED|Overall Study||2
159650|NCT01028911|384418|P1|COMPLETED|Overall Study||7
159651|NCT01028911|384417|P2|STARTED|Overall Study||2
159652|NCT01028911|384418|P1|STARTED|Overall Study||7
159653|NCT01028820|384483|P1|NOT COMPLETED|Overall Study||1
159654|NCT01028820|384483|P1|COMPLETED|Overall Study||12
159655|NCT01028820|384483|P1|STARTED|Overall Study||13
159656|NCT01028677|384492|P2|NOT COMPLETED|Overall Study||1
159657|NCT01028677|384493|P1|NOT COMPLETED|Overall Study||2
159658|NCT01028677|384492|P2|COMPLETED|Overall Study||6
159659|NCT01028677|384493|P1|COMPLETED|Overall Study||8
159660|NCT01028677|384492|P2|STARTED|Overall Study||7
159661|NCT01028677|384493|P1|STARTED|Overall Study||10
159662|NCT01028651|384509|P1|NOT COMPLETED|Overall Study||3
159663|NCT01028651|384509|P1|COMPLETED|Overall Study||10
159664|NCT01028651|384509|P1|STARTED|Overall Study||13
159665|NCT01028391|384532|P2|NOT COMPLETED|Overall Study||11
159666|NCT01028391|384533|P1|NOT COMPLETED|Overall Study||14
159667|NCT01028391|384532|P2|COMPLETED|Overall Study||142
159668|NCT01028391|384533|P1|COMPLETED|Overall Study||150
159669|NCT01028391|384532|P2|STARTED|Overall Study||153
159670|NCT01028391|384533|P1|STARTED|Overall Study||164
159671|NCT01028378|384541|P1|NOT COMPLETED|Overall Study||17
159672|NCT01028378|384541|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
159673|NCT01028378|384541|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
159674|NCT01028352|384553|P1|NOT COMPLETED|Overall Study||6
159675|NCT01028352|384553|P1|COMPLETED|Overall Study||29
159676|NCT01028352|384553|P1|STARTED|Overall Study||35
159677|NCT01028300|384558|P1|NOT COMPLETED|Overall Study||4
159678|NCT01028300|384558|P1|COMPLETED|Overall Study||0
159679|NCT01028300|384558|P1|STARTED|Overall Study||4
159680|NCT01028222|384567|P2|NOT COMPLETED|Overall Study||13
159681|NCT01028222|384568|P1|NOT COMPLETED|Overall Study||38
159682|NCT01028222|384567|P2|COMPLETED|Overall Study||0
159683|NCT01028222|384568|P1|COMPLETED|Overall Study||4
159684|NCT01028222|384567|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
159685|NCT01028222|384568|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
159686|NCT01028222|384567|P2|STARTED|Overall Study||13
159687|NCT01028222|384568|P1|STARTED|Overall Study||42
159688|NCT01028131|384593|P4|NOT COMPLETED|Overall Study||4
159689|NCT01028131|384594|P3|NOT COMPLETED|Overall Study||6
159690|NCT01028131|384595|P2|NOT COMPLETED|Overall Study||3
159691|NCT01028131|384596|P1|NOT COMPLETED|Overall Study||3
159692|NCT01028131|384593|P4|COMPLETED|Overall Study||26
159693|NCT01028131|384594|P3|COMPLETED|Overall Study||22
159694|NCT01028131|384595|P2|COMPLETED|Overall Study||23
159695|NCT01028131|384596|P1|COMPLETED|Overall Study||23
159696|NCT01028131|384593|P4|Completed Intervention/Control Session|Overall Study||30
159697|NCT01028131|384594|P3|Completed Intervention/Control Session|Overall Study||28
159698|NCT01028131|384595|P2|Completed Intervention/Control Session|Overall Study||26
159699|NCT01028131|384596|P1|Completed Intervention/Control Session|Overall Study||26
159700|NCT01028131|384593|P4|STARTED|Overall Study||30
159701|NCT01028131|384594|P3|STARTED|Overall Study||28
159702|NCT01028131|384595|P2|STARTED|Overall Study||26
159703|NCT01028131|384596|P1|STARTED|Overall Study||26
159704|NCT01028053|384610|P1|NOT COMPLETED|Overall Study||133
159705|NCT01028053|384610|P1|COMPLETED|Overall Study||232
159706|NCT01028053|384610|P1|STARTED|Overall Study||365
159707|NCT01028027|384618|P2|NOT COMPLETED|Overall Study||13
159708|NCT01028027|384619|P1|NOT COMPLETED|Overall Study||16
159709|NCT01028027|384618|P2|COMPLETED|Overall Study||164
159710|NCT01028027|384619|P1|COMPLETED|Overall Study||164
159711|NCT01028027|384618|P2|STARTED|Overall Study||177
159712|NCT01028027|384619|P1|STARTED|Overall Study||180
159713|NCT01028014|384641|P6|NOT COMPLETED|Overall Study||2
159714|NCT01028014|384642|P5|NOT COMPLETED|Overall Study||1
159715|NCT01028014|384643|P4|NOT COMPLETED|Overall Study||1
159716|NCT01028014|384644|P3|NOT COMPLETED|Overall Study||0
159717|NCT01028014|384645|P2|NOT COMPLETED|Overall Study||2
159718|NCT01028014|384646|P1|NOT COMPLETED|Overall Study||1
159719|NCT01028014|384641|P6|COMPLETED|Overall Study||4
159720|NCT01028014|384642|P5|COMPLETED|Overall Study||9
159721|NCT01028014|384643|P4|COMPLETED|Overall Study||9
159722|NCT01028014|384644|P3|COMPLETED|Overall Study||10
159723|NCT01028014|384645|P2|COMPLETED|Overall Study||8
159724|NCT01028014|384646|P1|COMPLETED|Overall Study||9
159725|NCT01028014|384641|P6|STARTED|Overall Study||6
159726|NCT01028014|384642|P5|STARTED|Overall Study||10
159727|NCT01028014|384643|P4|STARTED|Overall Study||10
159728|NCT01028014|384644|P3|STARTED|Overall Study||10
159729|NCT01028014|384645|P2|STARTED|Overall Study||10
159730|NCT01028014|384646|P1|STARTED|Overall Study||10
159731|NCT01027910|384674|P2|NOT COMPLETED|Overall Study||0
159732|NCT01027910|384675|P1|NOT COMPLETED|Overall Study||0
159733|NCT01027910|384674|P2|COMPLETED|Overall Study||14
159734|NCT01027910|384675|P1|COMPLETED|Overall Study||6
159735|NCT01027910|384674|P2|STARTED|Overall Study||14
159736|NCT01027910|384675|P1|STARTED|Overall Study||6
159737|NCT01027897|384687|P1|NOT COMPLETED|Overall Study||2
159738|NCT01027897|384687|P1|COMPLETED|Overall Study||28
159739|NCT01027897|384687|P1|STARTED|Overall Study||30
159740|NCT01027884|384695|P2|NOT COMPLETED|Overall Study||7
159741|NCT01027884|384696|P1|NOT COMPLETED|Overall Study||4
159742|NCT01027884|384695|P2|COMPLETED|Overall Study||25
159743|NCT01027884|384696|P1|COMPLETED|Overall Study||30
159744|NCT01027884|384695|P2|STARTED|Overall Study||32
159745|NCT01027884|384696|P1|STARTED|Overall Study||34
159746|NCT01027819|384712|P2|NOT COMPLETED|Overall Study||0
159747|NCT01027819|384713|P1|NOT COMPLETED|Overall Study||0
159748|NCT01027819|384712|P2|COMPLETED|Overall Study||40
159749|NCT01027819|384713|P1|COMPLETED|Overall Study||40
159750|NCT01027819|384712|P2|STARTED|Overall Study||40
159751|NCT01027819|384713|P1|STARTED|Overall Study||40
159752|NCT01027780|384721|P2|NOT COMPLETED|Overall Study||1
159753|NCT01027780|384722|P1|NOT COMPLETED|Overall Study||0
159754|NCT01027780|384721|P2|COMPLETED|Overall Study||102
159755|NCT01027780|384722|P1|COMPLETED|Overall Study||105
159756|NCT01027780|384721|P2|STARTED|Overall Study||103
159757|NCT01027780|384722|P1|STARTED|Overall Study||105
159758|NCT01027702|384732|P7|NOT COMPLETED|Overall Study||1
159759|NCT01027702|384733|P6|NOT COMPLETED|Overall Study||0
159760|NCT01027702|384734|P5|NOT COMPLETED|Overall Study||1
159761|NCT01027702|384735|P4|NOT COMPLETED|Overall Study||4
159762|NCT01027702|384736|P3|NOT COMPLETED|Overall Study||1
159763|NCT01027702|384737|P2|NOT COMPLETED|Overall Study||2
159764|NCT01027702|384738|P1|NOT COMPLETED|Overall Study||1
159765|NCT01027702|384732|P7|COMPLETED|Overall Study||1
159766|NCT01027702|384733|P6|COMPLETED|Overall Study||1
159767|NCT01027702|384734|P5|COMPLETED|Overall Study||9
159768|NCT01027702|384735|P4|COMPLETED|Overall Study||10
159769|NCT01027702|384736|P3|COMPLETED|Overall Study||2
159770|NCT01027702|384737|P2|COMPLETED|Overall Study||2
159771|NCT01027702|384738|P1|COMPLETED|Overall Study||3
159772|NCT01027702|384732|P7|STARTED|Overall Study||2
159773|NCT01027702|384733|P6|STARTED|Overall Study||1
159774|NCT01027702|384734|P5|STARTED|Overall Study||10
159775|NCT01027702|384735|P4|STARTED|Overall Study||14
159776|NCT01027702|384736|P3|STARTED|Overall Study||3
159777|NCT01027702|384737|P2|STARTED|Overall Study||4
159778|NCT01027702|384738|P1|STARTED|Overall Study||4
159779|NCT01027650|384764|P8|NOT COMPLETED|Overall Study||0
159780|NCT01027650|384765|P7|NOT COMPLETED|Overall Study||1
159781|NCT01027650|384766|P6|NOT COMPLETED|Overall Study||2
159782|NCT01027650|384767|P5|NOT COMPLETED|Overall Study||2
159783|NCT01027650|384768|P4|NOT COMPLETED|Overall Study||0
159784|NCT01027650|384769|P3|NOT COMPLETED|Overall Study||0
159785|NCT01027650|384770|P2|NOT COMPLETED|Overall Study||0
159786|NCT01027650|384771|P1|NOT COMPLETED|Overall Study||0
159787|NCT01027650|384764|P8|COMPLETED|Overall Study||24
159788|NCT01027650|384765|P7|COMPLETED|Overall Study||24
159789|NCT01027650|384766|P6|COMPLETED|Overall Study||24
159790|NCT01027650|384767|P5|COMPLETED|Overall Study||23
159791|NCT01027650|384768|P4|COMPLETED|Overall Study||3
159792|NCT01027650|384769|P3|COMPLETED|Overall Study||6
159793|NCT01027650|384770|P2|COMPLETED|Overall Study||6
159794|NCT01027650|384771|P1|COMPLETED|Overall Study||6
159795|NCT01027650|384764|P8|STARTED|Overall Study||24
159796|NCT01027650|384765|P7|STARTED|Overall Study||25
159797|NCT01027650|384766|P6|STARTED|Overall Study||26
159798|NCT01027650|384767|P5|STARTED|Overall Study||25
159799|NCT01027650|384768|P4|STARTED|Overall Study||3
159800|NCT01027650|384769|P3|STARTED|Overall Study||6
159801|NCT01027650|384770|P2|STARTED|Overall Study||6
159802|NCT01027650|384771|P1|STARTED|Overall Study||6
159803|NCT01027598|384815|P2|NOT COMPLETED|Overall Study||67
159804|NCT01027598|384816|P1|NOT COMPLETED|Overall Study||134
159805|NCT01027598|384815|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
159806|NCT01027598|384816|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
159807|NCT01027598|384815|P2|STARTED|Overall Study||67
159808|NCT01027598|384816|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
159809|NCT01027468|384826|P1|NOT COMPLETED|Overall Study||0
159810|NCT01027468|384826|P1|COMPLETED|Overall Study||160
159811|NCT01027468|384826|P1|STARTED|Overall Study||160
159812|NCT01027416|384832|P2|NOT COMPLETED|Overall Study||5
159813|NCT01027416|384833|P1|NOT COMPLETED|Overall Study||1
159814|NCT01027416|384832|P2|COMPLETED|Overall Study||23
159815|NCT01027416|384833|P1|COMPLETED|Overall Study||30
159816|NCT01027416|384832|P2|STARTED|Overall Study||28
159817|NCT01027416|384833|P1|STARTED|Overall Study||31
159818|NCT01027364|384845|P4|NOT COMPLETED|Overall Study||1
159819|NCT01027364|384846|P3|NOT COMPLETED|Overall Study||1
159820|NCT01027364|384847|P2|NOT COMPLETED|Overall Study||2
159821|NCT01027364|384848|P1|NOT COMPLETED|Overall Study||4
159822|NCT01027364|384845|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
159823|NCT01027364|384846|P3|COMPLETED|Overall Study||26
159824|NCT01027364|384847|P2|COMPLETED|Overall Study||27
159825|NCT01027364|384848|P1|COMPLETED|Overall Study||59
159826|NCT01027364|384845|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
159827|NCT01027364|384846|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
159828|NCT01027364|384847|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
159829|NCT01027364|384848|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
159830|NCT01027364|384845|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
159831|NCT01027364|384846|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
159832|NCT01027364|384847|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
159833|NCT01027364|384848|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
159834|NCT01027364|384845|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
159835|NCT01027364|384846|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
159836|NCT01027364|384847|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
159837|NCT01027364|384848|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
159838|NCT01027364|384845|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
159839|NCT01027364|384846|P3|STARTED|Overall Study||27
159840|NCT01027364|384847|P2|STARTED|Overall Study||29
159841|NCT01027364|384848|P1|STARTED|Overall Study||63
159842|NCT01027351|384943|P6|NOT COMPLETED|Overall Study||5
159843|NCT01027351|384944|P5|NOT COMPLETED|Overall Study||11
159844|NCT01027351|384945|P4|NOT COMPLETED|Overall Study||2
159845|NCT01027351|384946|P3|NOT COMPLETED|Overall Study||1
159846|NCT01027351|384947|P2|NOT COMPLETED|Overall Study||1
159847|NCT01027351|384948|P1|NOT COMPLETED|Overall Study||3
159848|NCT01027351|384943|P6|COMPLETED|Overall Study||45
159849|NCT01027351|384944|P5|COMPLETED|Overall Study||32
159850|NCT01027351|384945|P4|COMPLETED|Overall Study||6
159851|NCT01027351|384946|P3|COMPLETED|Overall Study||13
159852|NCT01027351|384947|P2|COMPLETED|Overall Study||18
159853|NCT01027351|384948|P1|COMPLETED|Overall Study||26
159854|NCT01027351|384943|P6|STARTED|Overall Study||50
159855|NCT01027351|384944|P5|STARTED|Overall Study||43
159856|NCT01027351|384945|P4|STARTED|Overall Study||8
159857|NCT01027351|384946|P3|STARTED|Overall Study||14
159858|NCT01027351|384947|P2|STARTED|Overall Study||19
159859|NCT01027351|384948|P1|STARTED|Overall Study||29
159860|NCT01027286|385032|P2|NOT COMPLETED|Overall Study||1
159861|NCT01027286|385033|P1|NOT COMPLETED|Overall Study||1
159862|NCT01027286|385032|P2|COMPLETED|Overall Study||49
159863|NCT01027286|385033|P1|COMPLETED|Overall Study||49
159864|NCT01027286|385032|P2|12 Week Postoperative|Overall Study||49
159865|NCT01027286|385033|P1|12 Week Postoperative|Overall Study||49
159866|NCT01027286|385032|P2|4 Week Postoperative|Overall Study||50
159867|NCT01027286|385033|P1|4 Week Postoperative|Overall Study||49
159868|NCT01027286|385032|P2|Day of Surgery|Overall Study||50
159869|NCT01027286|385033|P1|Day of Surgery|Overall Study||50
159870|NCT01027286|385032|P2|Preoperative|Overall Study||50
159871|NCT01027286|385033|P1|Preoperative|Overall Study||50
159872|NCT01027286|385032|P2|STARTED|Overall Study||50
159873|NCT01027286|385033|P1|STARTED|Overall Study||50
159874|NCT01027273|385053|P2|NOT COMPLETED|Overall Study||33
159875|NCT01027273|385054|P1|NOT COMPLETED|Overall Study||59
159876|NCT01027273|385053|P2|COMPLETED|Overall Study||266
159877|NCT01027273|385054|P1|COMPLETED|Overall Study||242
159878|NCT01027273|385053|P2|STARTED|Overall Study||299
159879|NCT01027273|385054|P1|STARTED|Overall Study||301
159880|NCT01027195|385072|P2|NOT COMPLETED|Overall Study||0
159881|NCT01027195|385073|P1|NOT COMPLETED|Overall Study||0
159882|NCT01027195|385072|P2|COMPLETED|Overall Study||69
159883|NCT01027195|385073|P1|COMPLETED|Overall Study||71
159884|NCT01027195|385072|P2|STARTED|Overall Study||69
159885|NCT01027195|385073|P1|STARTED|Overall Study||71
159886|NCT01027000|385093|P1|NOT COMPLETED|Overall Study||0
159887|NCT01027000|385093|P1|COMPLETED|Overall Study||68
159888|NCT01027000|385093|P1|STARTED|Overall Study||68
159889|NCT01026974|385101|P4|NOT COMPLETED|Overall Study||3
159890|NCT01026974|385102|P3|NOT COMPLETED|Overall Study||12
159891|NCT01026974|385103|P2|NOT COMPLETED|Overall Study||2
159892|NCT01026974|385104|P1|NOT COMPLETED|Overall Study||1
159893|NCT01026974|385101|P4|COMPLETED|Overall Study||46
159894|NCT01026974|385102|P3|COMPLETED|Overall Study||29
159895|NCT01026974|385103|P2|COMPLETED|Overall Study||12
159896|NCT01026974|385104|P1|COMPLETED|Overall Study||15
159897|NCT01026974|385101|P4|STARTED|Overall Study||49
159898|NCT01026974|385102|P3|STARTED|Overall Study||41
159899|NCT01026974|385103|P2|STARTED|Overall Study||14
159900|NCT01026974|385104|P1|STARTED|Overall Study||16
159901|NCT01026948|385161|P1|NOT COMPLETED|Overall Study||8
159902|NCT01026948|385161|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
159903|NCT01026948|385161|P1|STARTED|Overall Study||70
159904|NCT01026909|385168|P2|NOT COMPLETED|Overall Study||0
159905|NCT01026909|385169|P1|NOT COMPLETED|Overall Study||0
159906|NCT01026909|385168|P2|COMPLETED|Overall Study||2
159907|NCT01026909|385169|P1|COMPLETED|Overall Study||1
159908|NCT01026909|385168|P2|STARTED|Overall Study||2
159909|NCT01026909|385169|P1|STARTED|Overall Study||1
159910|NCT01026844|385179|P2|NOT COMPLETED|Overall Study||0
159911|NCT01026844|385180|P1|NOT COMPLETED|Overall Study||0
159912|NCT01026844|385179|P2|COMPLETED|Overall Study||8
159913|NCT01026844|385180|P1|COMPLETED|Overall Study||19
159914|NCT01026844|385179|P2|STARTED|Overall Study||8
159915|NCT01026844|385180|P1|STARTED|Overall Study||19
159916|NCT01026831|385194|P2|NOT COMPLETED|Overall Study||11
159917|NCT01026831|385195|P1|NOT COMPLETED|Overall Study||14
159918|NCT01026831|385194|P2|COMPLETED|Overall Study||312
159919|NCT01026831|385195|P1|COMPLETED|Overall Study||306
159920|NCT01026831|385194|P2|STARTED|Overall Study|randomized|323
159921|NCT01026831|385195|P1|STARTED|Overall Study|randomized|320
159922|NCT01026818|385206|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
159923|NCT01026818|385207|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
159924|NCT01026818|385208|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
159925|NCT01026818|385209|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
159926|NCT01026818|385206|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
159927|NCT01026818|385207|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
159928|NCT01026818|385208|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
159929|NCT01026818|385209|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
159930|NCT01026818|385206|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
159931|NCT01026818|385207|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
159932|NCT01026818|385208|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
159933|NCT01026818|385209|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
159934|NCT01026818|385206|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
159935|NCT01026818|385207|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
159936|NCT01026818|385208|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
159937|NCT01026818|385209|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
159938|NCT01026818|385206|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
159939|NCT01026818|385207|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
159940|NCT01026818|385208|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
159941|NCT01026818|385209|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
159942|NCT01026818|385206|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
159943|NCT01026818|385207|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
159944|NCT01026818|385208|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
159945|NCT01026818|385209|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
159946|NCT01026818|385206|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
159947|NCT01026818|385207|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
159948|NCT01026818|385208|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
159949|NCT01026818|385209|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
159950|NCT01026818|385206|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
159951|NCT01026818|385207|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
159952|NCT01026818|385208|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
159953|NCT01026818|385209|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
159954|NCT01026818|385206|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
159955|NCT01026818|385207|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
159956|NCT01026818|385208|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
159957|NCT01026818|385209|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
159958|NCT01026818|385206|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
159959|NCT01026818|385207|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
159960|NCT01026818|385208|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
159961|NCT01026818|385209|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
159962|NCT01026818|385206|P4|NOT COMPLETED|Screening Period||0
159963|NCT01026818|385207|P3|NOT COMPLETED|Screening Period||0
159964|NCT01026818|385208|P2|NOT COMPLETED|Screening Period||0
159965|NCT01026818|385209|P1|NOT COMPLETED|Screening Period||160
159966|NCT01026818|385206|P4|COMPLETED|Screening Period||0
159967|NCT01026818|385207|P3|COMPLETED|Screening Period||0
159968|NCT01026818|385208|P2|COMPLETED|Screening Period||0
159969|NCT01026818|385209|P1|COMPLETED|Screening Period||423
159970|NCT01026818|385206|P4|STARTED|Screening Period||0
159971|NCT01026818|385207|P3|STARTED|Screening Period||0
159972|NCT01026818|385208|P2|STARTED|Screening Period||0
159973|NCT01026818|385209|P1|STARTED|Screening Period||583
159974|NCT01026805|385287|P1|NOT COMPLETED|Overall Study||0
159975|NCT01026805|385287|P1|COMPLETED|Overall Study||11
159976|NCT01026805|385287|P1|STARTED|Overall Study||11
159977|NCT01026792|385297|P1|NOT COMPLETED|Overall Study||1
159978|NCT01026792|385297|P1|COMPLETED|Overall Study||37
159979|NCT01026792|385297|P1|STARTED|Overall Study||38
159980|NCT01026493|385309|P8|NOT COMPLETED|Overall Study||1
159981|NCT01026493|385310|P7|NOT COMPLETED|Overall Study||4
159982|NCT01026493|385311|P6|NOT COMPLETED|Overall Study||3
159983|NCT01026493|385312|P5|NOT COMPLETED|Overall Study||2
159984|NCT01026493|385313|P4|NOT COMPLETED|Overall Study||0
159985|NCT01026493|385314|P3|NOT COMPLETED|Overall Study||0
159986|NCT01026493|385315|P2|NOT COMPLETED|Overall Study||1
159987|NCT01026493|385316|P1|NOT COMPLETED|Overall Study||0
159988|NCT01026493|385309|P8|COMPLETED|Overall Study||37
159989|NCT01026493|385310|P7|COMPLETED|Overall Study||32
159990|NCT01026493|385311|P6|COMPLETED|Overall Study||73
159991|NCT01026493|385312|P5|COMPLETED|Overall Study||73
159992|NCT01026493|385313|P4|COMPLETED|Overall Study||8
159993|NCT01026493|385314|P3|COMPLETED|Overall Study||9
159994|NCT01026493|385315|P2|COMPLETED|Overall Study||6
159995|NCT01026493|385316|P1|COMPLETED|Overall Study||8
159996|NCT01026493|385309|P8|STARTED|Overall Study||38
159997|NCT01026493|385310|P7|STARTED|Overall Study||36
159998|NCT01026493|385311|P6|STARTED|Overall Study||76
159999|NCT01026493|385312|P5|STARTED|Overall Study||75
160000|NCT01026493|385313|P4|STARTED|Overall Study||8
160001|NCT01026493|385314|P3|STARTED|Overall Study||9
160002|NCT01026493|385315|P2|STARTED|Overall Study||7
160003|NCT01026493|385316|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
160004|NCT01026454|385344|P2|NOT COMPLETED|Second Intervention||1
160005|NCT01026454|385345|P1|NOT COMPLETED|Second Intervention||1
160006|NCT01026454|385344|P2|COMPLETED|Second Intervention||13
160007|NCT01026454|385345|P1|COMPLETED|Second Intervention||16
160008|NCT01026454|385344|P2|STARTED|Second Intervention||14
160009|NCT01026454|385345|P1|STARTED|Second Intervention||17
160010|NCT01026454|385344|P2|NOT COMPLETED|Washout||0
160011|NCT01026454|385345|P1|NOT COMPLETED|Washout||0
160012|NCT01026454|385344|P2|COMPLETED|Washout||14
160013|NCT01026454|385345|P1|COMPLETED|Washout||18
160014|NCT01026454|385344|P2|STARTED|Washout||14
160015|NCT01026454|385345|P1|STARTED|Washout||18
160016|NCT01026454|385344|P2|NOT COMPLETED|First Intervention||0
160017|NCT01026454|385345|P1|NOT COMPLETED|First Intervention||0
160018|NCT01026454|385344|P2|COMPLETED|First Intervention||14
160019|NCT01026454|385345|P1|COMPLETED|First Intervention||18
160020|NCT01026454|385344|P2|STARTED|First Intervention||14
160021|NCT01026454|385345|P1|STARTED|First Intervention||18
160022|NCT01026402|385368|P17|NOT COMPLETED|Overall Study||0
160023|NCT01026402|385369|P16|NOT COMPLETED|Overall Study||0
160024|NCT01026402|385370|P15|NOT COMPLETED|Overall Study||0
160025|NCT01026402|385371|P14|NOT COMPLETED|Overall Study||0
160026|NCT01026402|385372|P13|NOT COMPLETED|Overall Study||0
160027|NCT01026402|385373|P12|NOT COMPLETED|Overall Study||0
160028|NCT01026402|385374|P11|NOT COMPLETED|Overall Study||0
160029|NCT01026402|385375|P10|NOT COMPLETED|Overall Study||0
160030|NCT01026402|385376|P9|NOT COMPLETED|Overall Study||0
160031|NCT01026402|385377|P8|NOT COMPLETED|Overall Study||0
160032|NCT01026402|385378|P7|NOT COMPLETED|Overall Study||0
160033|NCT01026402|385379|P6|NOT COMPLETED|Overall Study||0
160034|NCT01026402|385380|P5|NOT COMPLETED|Overall Study||0
160035|NCT01026402|385381|P4|NOT COMPLETED|Overall Study||0
160036|NCT01026402|385382|P3|NOT COMPLETED|Overall Study||0
160037|NCT01026402|385383|P2|NOT COMPLETED|Overall Study||0
160038|NCT01026402|385384|P1|NOT COMPLETED|Overall Study||0
160039|NCT01026402|385368|P17|COMPLETED|Overall Study||4
160040|NCT01026402|385369|P16|COMPLETED|Overall Study||5
160041|NCT01026402|385370|P15|COMPLETED|Overall Study||3
160042|NCT01026402|385371|P14|COMPLETED|Overall Study||6
160043|NCT01026402|385372|P13|COMPLETED|Overall Study||8
160044|NCT01026402|385373|P12|COMPLETED|Overall Study||8
160045|NCT01026402|385374|P11|COMPLETED|Overall Study||7
160046|NCT01026402|385375|P10|COMPLETED|Overall Study||3
160047|NCT01026402|385376|P9|COMPLETED|Overall Study||7
160048|NCT01026402|385377|P8|COMPLETED|Overall Study||3
160049|NCT01026402|385378|P7|COMPLETED|Overall Study||8
160050|NCT01026402|385379|P6|COMPLETED|Overall Study||5
160051|NCT01026402|385380|P5|COMPLETED|Overall Study||3
160052|NCT01026402|385381|P4|COMPLETED|Overall Study||18
160053|NCT01026402|385382|P3|COMPLETED|Overall Study||33
160054|NCT01026402|385383|P2|COMPLETED|Overall Study||8
160055|NCT01026402|385384|P1|COMPLETED|Overall Study||6
160056|NCT01026402|385368|P17|STARTED|Overall Study||4
160057|NCT01026402|385369|P16|STARTED|Overall Study||5
160058|NCT01026402|385370|P15|STARTED|Overall Study||3
160059|NCT01026402|385371|P14|STARTED|Overall Study||6
160060|NCT01026402|385372|P13|STARTED|Overall Study||8
160061|NCT01026402|385373|P12|STARTED|Overall Study||8
160062|NCT01026402|385374|P11|STARTED|Overall Study||7
160063|NCT01026402|385375|P10|STARTED|Overall Study||3
160064|NCT01026402|385376|P9|STARTED|Overall Study||7
160065|NCT01026402|385377|P8|STARTED|Overall Study||3
160066|NCT01026402|385378|P7|STARTED|Overall Study||8
160067|NCT01026402|385379|P6|STARTED|Overall Study||5
160068|NCT01026402|385380|P5|STARTED|Overall Study||3
160069|NCT01026402|385381|P4|STARTED|Overall Study||18
160070|NCT01026402|385382|P3|STARTED|Overall Study||33
160071|NCT01026402|385383|P2|STARTED|Overall Study||8
160072|NCT01026402|385384|P1|STARTED|Overall Study||6
160073|NCT01026389|385694|P2|NOT COMPLETED|Overall Study||5
160074|NCT01026389|385695|P1|NOT COMPLETED|Overall Study||5
160075|NCT01026389|385694|P2|COMPLETED|Overall Study||88
160076|NCT01026389|385695|P1|COMPLETED|Overall Study||88
160077|NCT01026389|385694|P2|STARTED|Overall Study||93
160078|NCT01026389|385695|P1|STARTED|Overall Study||93
160079|NCT01026324|385710|P3|NOT COMPLETED|Follow up/Survival||0
160080|NCT01026324|385711|P2|NOT COMPLETED|Follow up/Survival||0
160081|NCT01026324|385712|P1|NOT COMPLETED|Follow up/Survival||1
160082|NCT01026324|385710|P3|COMPLETED|Follow up/Survival||4
160083|NCT01026324|385711|P2|COMPLETED|Follow up/Survival||3
160084|NCT01026324|385712|P1|COMPLETED|Follow up/Survival||4
160085|NCT01026324|385710|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
160086|NCT01026324|385711|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
160087|NCT01026324|385712|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
160088|NCT01026324|385710|P3|STARTED|Follow up/Survival||4
160089|NCT01026324|385711|P2|STARTED|Follow up/Survival||3
160090|NCT01026324|385712|P1|STARTED|Follow up/Survival||5
160091|NCT01026324|385710|P3|NOT COMPLETED|Treatment Allocation||0
160092|NCT01026324|385711|P2|NOT COMPLETED|Treatment Allocation||0
160093|NCT01026324|385712|P1|NOT COMPLETED|Treatment Allocation||0
160094|NCT01026324|385710|P3|COMPLETED|Treatment Allocation||4
160095|NCT01026324|385711|P2|COMPLETED|Treatment Allocation||3
160096|NCT01026324|385712|P1|COMPLETED|Treatment Allocation||5
160097|NCT01026324|385710|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
160098|NCT01026324|385711|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
160099|NCT01026324|385712|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
160100|NCT01026324|385710|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
160101|NCT01026324|385711|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
160102|NCT01026324|385712|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
160103|NCT01026324|385710|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
160104|NCT01026324|385711|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
160105|NCT01026324|385712|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
160106|NCT01026324|385710|P3|STARTED|Treatment Allocation||4
160107|NCT01026324|385711|P2|STARTED|Treatment Allocation||3
160108|NCT01026324|385712|P1|STARTED|Treatment Allocation||5
160109|NCT01026220|385722|P3|NOT COMPLETED|Consolidation Maintenance||14
160110|NCT01026220|385723|P2|NOT COMPLETED|Consolidation Maintenance||6
160111|NCT01026220|385724|P1|NOT COMPLETED|Consolidation Maintenance||0
160112|NCT01026220|385722|P3|COMPLETED|Consolidation Maintenance||66
160113|NCT01026220|385723|P2|COMPLETED|Consolidation Maintenance||75
160114|NCT01026220|385724|P1|COMPLETED|Consolidation Maintenance||0
160115|NCT01026220|385722|P3|STARTED|Consolidation Maintenance||80
160116|NCT01026220|385723|P2|STARTED|Consolidation Maintenance||81
160117|NCT01026220|385724|P1|STARTED|Consolidation Maintenance||0
160118|NCT01026220|385722|P3|NOT COMPLETED|Induction||0
160119|NCT01026220|385723|P2|NOT COMPLETED|Induction||0
160120|NCT01026220|385724|P1|NOT COMPLETED|Induction||25
160121|NCT01026220|385722|P3|COMPLETED|Induction||0
160122|NCT01026220|385723|P2|COMPLETED|Induction||0
160123|NCT01026220|385724|P1|COMPLETED|Induction||141
160124|NCT01026220|385722|P3|STARTED|Induction||0
160125|NCT01026220|385723|P2|STARTED|Induction||0
160126|NCT01026220|385724|P1|STARTED|Induction||166
160127|NCT01026194|385748|P2|NOT COMPLETED|Period 2：Open-label Period||10
160128|NCT01026194|385749|P1|NOT COMPLETED|Period 2：Open-label Period||7
160129|NCT01026194|385748|P2|COMPLETED|Period 2：Open-label Period||88
160130|NCT01026194|385749|P1|COMPLETED|Period 2：Open-label Period||91
160131|NCT01026194|385748|P2|STARTED|Period 2：Open-label Period||98
160132|NCT01026194|385749|P1|STARTED|Period 2：Open-label Period||98
160133|NCT01026194|385748|P2|NOT COMPLETED|Period 1：Double Blind Period||5
160134|NCT01026194|385749|P1|NOT COMPLETED|Period 1：Double Blind Period||3
160135|NCT01026194|385748|P2|COMPLETED|Period 1：Double Blind Period||98
160136|NCT01026194|385749|P1|COMPLETED|Period 1：Double Blind Period||98
160137|NCT01026194|385748|P2|STARTED|Period 1：Double Blind Period||103
160138|NCT01026194|385749|P1|STARTED|Period 1：Double Blind Period||101
160139|NCT01026181|385766|P3|NOT COMPLETED|Overall Study||0
160140|NCT01026181|385767|P2|NOT COMPLETED|Overall Study||0
160141|NCT01026181|385768|P1|NOT COMPLETED|Overall Study||0
160142|NCT01026181|385766|P3|COMPLETED|Overall Study||48
160143|NCT01026181|385767|P2|COMPLETED|Overall Study||51
160144|NCT01026181|385768|P1|COMPLETED|Overall Study||51
160145|NCT01026181|385766|P3|STARTED|Overall Study||48
160146|NCT01026181|385767|P2|STARTED|Overall Study||51
160147|NCT01026181|385768|P1|STARTED|Overall Study||51
160148|NCT01026142|385781|P2|NOT COMPLETED|Overall Study||121
160149|NCT01026142|385782|P1|NOT COMPLETED|Overall Study||139
160150|NCT01026142|385781|P2|COMPLETED|Overall Study||107
160151|NCT01026142|385782|P1|COMPLETED|Overall Study||79
160152|NCT01026142|385781|P2|STARTED|Overall Study||228
160153|NCT01026142|385782|P1|STARTED|Overall Study||218
160154|NCT01026103|385804|P1|NOT COMPLETED|Overall Study||2
160155|NCT01026103|385804|P1|COMPLETED|Overall Study||28
160156|NCT01026103|385804|P1|Consented|Overall Study||30
160157|NCT01026103|385804|P1|STARTED|Overall Study||30
160158|NCT01026038|385814|P3|NOT COMPLETED|Overall Study||0
160159|NCT01026038|385815|P2|NOT COMPLETED|Overall Study||1
160160|NCT01026038|385816|P1|NOT COMPLETED|Overall Study||1
160161|NCT01026038|385814|P3|COMPLETED|Overall Study||67
160162|NCT01026038|385815|P2|COMPLETED|Overall Study||64
160163|NCT01026038|385816|P1|COMPLETED|Overall Study||129
160164|NCT01026038|385814|P3|STARTED|Overall Study||67
160165|NCT01026038|385815|P2|STARTED|Overall Study||65
160166|NCT01026038|385816|P1|STARTED|Overall Study||130
160167|NCT01026012|385851|P1|NOT COMPLETED|Overall Study||0
160168|NCT01026012|385851|P1|COMPLETED|Overall Study||40
160169|NCT01026012|385851|P1|STARTED|Overall Study||40
160170|NCT01025843|385865|P10|NOT COMPLETED|Period 5||0
160171|NCT01025843|385866|P9|NOT COMPLETED|Period 5||0
160172|NCT01025843|385867|P8|NOT COMPLETED|Period 5||0
160173|NCT01025843|385868|P7|NOT COMPLETED|Period 5||0
160174|NCT01025843|385869|P6|NOT COMPLETED|Period 5||0
160175|NCT01025843|385870|P5|NOT COMPLETED|Period 5||0
160176|NCT01025843|385871|P4|NOT COMPLETED|Period 5||0
160177|NCT01025843|385872|P3|NOT COMPLETED|Period 5||0
160178|NCT01025843|385873|P2|NOT COMPLETED|Period 5||0
160179|NCT01025843|385874|P1|NOT COMPLETED|Period 5||0
160180|NCT01025843|385865|P10|COMPLETED|Period 5||2
160181|NCT01025843|385866|P9|COMPLETED|Period 5||2
160182|NCT01025843|385867|P8|COMPLETED|Period 5||2
160183|NCT01025843|385868|P7|COMPLETED|Period 5||2
160184|NCT01025843|385869|P6|COMPLETED|Period 5||2
160185|NCT01025843|385870|P5|COMPLETED|Period 5||2
160186|NCT01025843|385871|P4|COMPLETED|Period 5||1
160187|NCT01025843|385872|P3|COMPLETED|Period 5||1
160188|NCT01025843|385873|P2|COMPLETED|Period 5||2
160189|NCT01025843|385874|P1|COMPLETED|Period 5||2
160190|NCT01025843|385865|P10|STARTED|Period 5||2
160191|NCT01025843|385866|P9|STARTED|Period 5||2
160192|NCT01025843|385867|P8|STARTED|Period 5||2
160193|NCT01025843|385868|P7|STARTED|Period 5||2
160194|NCT01025843|385869|P6|STARTED|Period 5||2
160195|NCT01025843|385870|P5|STARTED|Period 5||2
160196|NCT01025843|385871|P4|STARTED|Period 5||1
160197|NCT01025843|385872|P3|STARTED|Period 5||1
160198|NCT01025843|385873|P2|STARTED|Period 5||2
160199|NCT01025843|385874|P1|STARTED|Period 5||2
160200|NCT01025843|385865|P10|NOT COMPLETED|Washout 4||0
160201|NCT01025843|385866|P9|NOT COMPLETED|Washout 4||0
160202|NCT01025843|385867|P8|NOT COMPLETED|Washout 4||0
160203|NCT01025843|385868|P7|NOT COMPLETED|Washout 4||0
160204|NCT01025843|385869|P6|NOT COMPLETED|Washout 4||0
160205|NCT01025843|385870|P5|NOT COMPLETED|Washout 4||0
160206|NCT01025843|385871|P4|NOT COMPLETED|Washout 4||1
160207|NCT01025843|385872|P3|NOT COMPLETED|Washout 4||1
160208|NCT01025843|385873|P2|NOT COMPLETED|Washout 4||0
160209|NCT01025843|385874|P1|NOT COMPLETED|Washout 4||0
160210|NCT01025843|385865|P10|COMPLETED|Washout 4||2
160211|NCT01025843|385866|P9|COMPLETED|Washout 4||2
160212|NCT01025843|385867|P8|COMPLETED|Washout 4||2
160213|NCT01025843|385868|P7|COMPLETED|Washout 4||2
160214|NCT01025843|385869|P6|COMPLETED|Washout 4||2
160215|NCT01025843|385870|P5|COMPLETED|Washout 4||2
160216|NCT01025843|385871|P4|COMPLETED|Washout 4||1
160217|NCT01025843|385872|P3|COMPLETED|Washout 4||1
160218|NCT01025843|385873|P2|COMPLETED|Washout 4||2
160219|NCT01025843|385874|P1|COMPLETED|Washout 4||2
160220|NCT01025843|385865|P10|STARTED|Washout 4||2
160221|NCT01025843|385866|P9|STARTED|Washout 4||2
160222|NCT01025843|385867|P8|STARTED|Washout 4||2
160223|NCT01025843|385868|P7|STARTED|Washout 4||2
160224|NCT01025843|385869|P6|STARTED|Washout 4||2
160225|NCT01025843|385870|P5|STARTED|Washout 4||2
160226|NCT01025843|385871|P4|STARTED|Washout 4||2
160227|NCT01025843|385872|P3|STARTED|Washout 4||2
160228|NCT01025843|385873|P2|STARTED|Washout 4||2
160229|NCT01025843|385874|P1|STARTED|Washout 4||2
160230|NCT01025843|385865|P10|NOT COMPLETED|Period 4||0
160231|NCT01025843|385866|P9|NOT COMPLETED|Period 4||0
160232|NCT01025843|385867|P8|NOT COMPLETED|Period 4||0
160233|NCT01025843|385868|P7|NOT COMPLETED|Period 4||0
160234|NCT01025843|385869|P6|NOT COMPLETED|Period 4||0
160235|NCT01025843|385870|P5|NOT COMPLETED|Period 4||0
160236|NCT01025843|385871|P4|NOT COMPLETED|Period 4||0
160237|NCT01025843|385872|P3|NOT COMPLETED|Period 4||0
160238|NCT01025843|385873|P2|NOT COMPLETED|Period 4||0
160239|NCT01025843|385874|P1|NOT COMPLETED|Period 4||0
160240|NCT01025843|385865|P10|COMPLETED|Period 4||2
160241|NCT01025843|385866|P9|COMPLETED|Period 4||2
160242|NCT01025843|385867|P8|COMPLETED|Period 4||2
160243|NCT01025843|385868|P7|COMPLETED|Period 4||2
160244|NCT01025843|385869|P6|COMPLETED|Period 4||2
160245|NCT01025843|385870|P5|COMPLETED|Period 4||2
160246|NCT01025843|385871|P4|COMPLETED|Period 4||2
160247|NCT01025843|385872|P3|COMPLETED|Period 4||2
160248|NCT01025843|385873|P2|COMPLETED|Period 4||2
160249|NCT01025843|385874|P1|COMPLETED|Period 4||2
160250|NCT01025843|385865|P10|STARTED|Period 4||2
160251|NCT01025843|385866|P9|STARTED|Period 4||2
160252|NCT01025843|385867|P8|STARTED|Period 4||2
160253|NCT01025843|385868|P7|STARTED|Period 4||2
160254|NCT01025843|385869|P6|STARTED|Period 4||2
160255|NCT01025843|385870|P5|STARTED|Period 4||2
160256|NCT01025843|385871|P4|STARTED|Period 4||2
160257|NCT01025843|385872|P3|STARTED|Period 4||2
160258|NCT01025843|385873|P2|STARTED|Period 4||2
160259|NCT01025843|385874|P1|STARTED|Period 4||2
160260|NCT01025843|385865|P10|NOT COMPLETED|Washout 3||0
160261|NCT01025843|385866|P9|NOT COMPLETED|Washout 3||0
160262|NCT01025843|385867|P8|NOT COMPLETED|Washout 3||0
160263|NCT01025843|385868|P7|NOT COMPLETED|Washout 3||0
160264|NCT01025843|385869|P6|NOT COMPLETED|Washout 3||0
160265|NCT01025843|385870|P5|NOT COMPLETED|Washout 3||0
160266|NCT01025843|385871|P4|NOT COMPLETED|Washout 3||0
160267|NCT01025843|385872|P3|NOT COMPLETED|Washout 3||0
160268|NCT01025843|385873|P2|NOT COMPLETED|Washout 3||0
160269|NCT01025843|385874|P1|NOT COMPLETED|Washout 3||0
160270|NCT01025843|385865|P10|COMPLETED|Washout 3||2
160271|NCT01025843|385866|P9|COMPLETED|Washout 3||2
160272|NCT01025843|385867|P8|COMPLETED|Washout 3||2
160273|NCT01025843|385868|P7|COMPLETED|Washout 3||2
160274|NCT01025843|385869|P6|COMPLETED|Washout 3||2
160275|NCT01025843|385870|P5|COMPLETED|Washout 3||2
160276|NCT01025843|385871|P4|COMPLETED|Washout 3||2
160277|NCT01025843|385872|P3|COMPLETED|Washout 3||2
160278|NCT01025843|385873|P2|COMPLETED|Washout 3||2
160279|NCT01025843|385874|P1|COMPLETED|Washout 3||2
160280|NCT01025843|385865|P10|STARTED|Washout 3||2
160281|NCT01025843|385866|P9|STARTED|Washout 3||2
160282|NCT01025843|385867|P8|STARTED|Washout 3||2
160283|NCT01025843|385868|P7|STARTED|Washout 3||2
160284|NCT01025843|385869|P6|STARTED|Washout 3||2
160285|NCT01025843|385870|P5|STARTED|Washout 3||2
160286|NCT01025843|385871|P4|STARTED|Washout 3||2
160287|NCT01025843|385872|P3|STARTED|Washout 3||2
160288|NCT01025843|385873|P2|STARTED|Washout 3||2
160289|NCT01025843|385874|P1|STARTED|Washout 3||2
160290|NCT01025843|385865|P10|NOT COMPLETED|Period 3||0
160291|NCT01025843|385866|P9|NOT COMPLETED|Period 3||0
160292|NCT01025843|385867|P8|NOT COMPLETED|Period 3||0
160293|NCT01025843|385868|P7|NOT COMPLETED|Period 3||0
160294|NCT01025843|385869|P6|NOT COMPLETED|Period 3||0
160295|NCT01025843|385870|P5|NOT COMPLETED|Period 3||0
160296|NCT01025843|385871|P4|NOT COMPLETED|Period 3||0
160297|NCT01025843|385872|P3|NOT COMPLETED|Period 3||0
160298|NCT01025843|385873|P2|NOT COMPLETED|Period 3||0
160299|NCT01025843|385874|P1|NOT COMPLETED|Period 3||0
160300|NCT01025843|385865|P10|COMPLETED|Period 3||2
160301|NCT01025843|385866|P9|COMPLETED|Period 3||2
160302|NCT01025843|385867|P8|COMPLETED|Period 3||2
160303|NCT01025843|385868|P7|COMPLETED|Period 3||2
160304|NCT01025843|385869|P6|COMPLETED|Period 3||2
160305|NCT01025843|385870|P5|COMPLETED|Period 3||2
160306|NCT01025843|385871|P4|COMPLETED|Period 3||2
160307|NCT01025843|385872|P3|COMPLETED|Period 3||2
160308|NCT01025843|385873|P2|COMPLETED|Period 3||2
160309|NCT01025843|385874|P1|COMPLETED|Period 3||2
160310|NCT01025843|385865|P10|STARTED|Period 3||2
160311|NCT01025843|385866|P9|STARTED|Period 3||2
160312|NCT01025843|385867|P8|STARTED|Period 3||2
160313|NCT01025843|385868|P7|STARTED|Period 3||2
160314|NCT01025843|385869|P6|STARTED|Period 3||2
160315|NCT01025843|385870|P5|STARTED|Period 3||2
160316|NCT01025843|385871|P4|STARTED|Period 3||2
160317|NCT01025843|385872|P3|STARTED|Period 3||2
160318|NCT01025843|385873|P2|STARTED|Period 3||2
160319|NCT01025843|385874|P1|STARTED|Period 3||2
160320|NCT01025843|385865|P10|NOT COMPLETED|Washout 2||0
160321|NCT01025843|385866|P9|NOT COMPLETED|Washout 2||0
160322|NCT01025843|385867|P8|NOT COMPLETED|Washout 2||0
160323|NCT01025843|385868|P7|NOT COMPLETED|Washout 2||0
160324|NCT01025843|385869|P6|NOT COMPLETED|Washout 2||0
160325|NCT01025843|385870|P5|NOT COMPLETED|Washout 2||0
160326|NCT01025843|385871|P4|NOT COMPLETED|Washout 2||0
160327|NCT01025843|385872|P3|NOT COMPLETED|Washout 2||0
160328|NCT01025843|385873|P2|NOT COMPLETED|Washout 2||0
160329|NCT01025843|385874|P1|NOT COMPLETED|Washout 2||0
160330|NCT01025843|385865|P10|COMPLETED|Washout 2||2
160331|NCT01025843|385866|P9|COMPLETED|Washout 2||2
160332|NCT01025843|385867|P8|COMPLETED|Washout 2||2
160333|NCT01025843|385868|P7|COMPLETED|Washout 2||2
160334|NCT01025843|385869|P6|COMPLETED|Washout 2||2
160335|NCT01025843|385870|P5|COMPLETED|Washout 2||2
160336|NCT01025843|385871|P4|COMPLETED|Washout 2||2
160337|NCT01025843|385872|P3|COMPLETED|Washout 2||2
160338|NCT01025843|385873|P2|COMPLETED|Washout 2||2
160339|NCT01025843|385874|P1|COMPLETED|Washout 2||2
160340|NCT01025843|385865|P10|STARTED|Washout 2||2
160341|NCT01025843|385866|P9|STARTED|Washout 2||2
160342|NCT01025843|385867|P8|STARTED|Washout 2||2
160343|NCT01025843|385868|P7|STARTED|Washout 2||2
160344|NCT01025843|385869|P6|STARTED|Washout 2||2
160345|NCT01025843|385870|P5|STARTED|Washout 2||2
160346|NCT01025843|385871|P4|STARTED|Washout 2||2
160347|NCT01025843|385872|P3|STARTED|Washout 2||2
160348|NCT01025843|385873|P2|STARTED|Washout 2||2
160349|NCT01025843|385874|P1|STARTED|Washout 2||2
160350|NCT01025843|385865|P10|NOT COMPLETED|Period 2||0
160351|NCT01025843|385866|P9|NOT COMPLETED|Period 2||0
160352|NCT01025843|385867|P8|NOT COMPLETED|Period 2||0
160353|NCT01025843|385868|P7|NOT COMPLETED|Period 2||0
160354|NCT01025843|385869|P6|NOT COMPLETED|Period 2||0
160355|NCT01025843|385870|P5|NOT COMPLETED|Period 2||0
160356|NCT01025843|385871|P4|NOT COMPLETED|Period 2||0
160357|NCT01025843|385872|P3|NOT COMPLETED|Period 2||0
160358|NCT01025843|385873|P2|NOT COMPLETED|Period 2||0
160359|NCT01025843|385874|P1|NOT COMPLETED|Period 2||0
160360|NCT01025843|385865|P10|COMPLETED|Period 2||2
160361|NCT01025843|385866|P9|COMPLETED|Period 2||2
160362|NCT01025843|385867|P8|COMPLETED|Period 2||2
160363|NCT01025843|385868|P7|COMPLETED|Period 2||2
160364|NCT01025843|385869|P6|COMPLETED|Period 2||2
160365|NCT01025843|385870|P5|COMPLETED|Period 2||2
160366|NCT01025843|385871|P4|COMPLETED|Period 2||2
160367|NCT01025843|385872|P3|COMPLETED|Period 2||2
160368|NCT01025843|385873|P2|COMPLETED|Period 2||2
160369|NCT01025843|385874|P1|COMPLETED|Period 2||2
160370|NCT01025843|385865|P10|STARTED|Period 2||2
160371|NCT01025843|385866|P9|STARTED|Period 2||2
160372|NCT01025843|385867|P8|STARTED|Period 2||2
160373|NCT01025843|385868|P7|STARTED|Period 2||2
160374|NCT01025843|385869|P6|STARTED|Period 2||2
160375|NCT01025843|385870|P5|STARTED|Period 2||2
160376|NCT01025843|385871|P4|STARTED|Period 2||2
160377|NCT01025843|385872|P3|STARTED|Period 2||2
160378|NCT01025843|385873|P2|STARTED|Period 2||2
160379|NCT01025843|385874|P1|STARTED|Period 2||2
160380|NCT01025843|385865|P10|NOT COMPLETED|Washout 1||0
160381|NCT01025843|385866|P9|NOT COMPLETED|Washout 1||0
160382|NCT01025843|385867|P8|NOT COMPLETED|Washout 1||0
160383|NCT01025843|385868|P7|NOT COMPLETED|Washout 1||0
160384|NCT01025843|385869|P6|NOT COMPLETED|Washout 1||0
160385|NCT01025843|385870|P5|NOT COMPLETED|Washout 1||0
160386|NCT01025843|385871|P4|NOT COMPLETED|Washout 1||0
160387|NCT01025843|385872|P3|NOT COMPLETED|Washout 1||0
160388|NCT01025843|385873|P2|NOT COMPLETED|Washout 1||0
160389|NCT01025843|385874|P1|NOT COMPLETED|Washout 1||0
160390|NCT01025843|385865|P10|COMPLETED|Washout 1||2
160391|NCT01025843|385866|P9|COMPLETED|Washout 1||2
160392|NCT01025843|385867|P8|COMPLETED|Washout 1||2
160393|NCT01025843|385868|P7|COMPLETED|Washout 1||2
160394|NCT01025843|385869|P6|COMPLETED|Washout 1||2
160395|NCT01025843|385870|P5|COMPLETED|Washout 1||2
160396|NCT01025843|385871|P4|COMPLETED|Washout 1||2
160397|NCT01025843|385872|P3|COMPLETED|Washout 1||2
160398|NCT01025843|385873|P2|COMPLETED|Washout 1||2
160399|NCT01025843|385874|P1|COMPLETED|Washout 1||2
160400|NCT01025843|385865|P10|STARTED|Washout 1||2
160401|NCT01025843|385866|P9|STARTED|Washout 1||2
160402|NCT01025843|385867|P8|STARTED|Washout 1||2
160403|NCT01025843|385868|P7|STARTED|Washout 1||2
160404|NCT01025843|385869|P6|STARTED|Washout 1||2
160405|NCT01025843|385870|P5|STARTED|Washout 1||2
160406|NCT01025843|385871|P4|STARTED|Washout 1||2
160407|NCT01025843|385872|P3|STARTED|Washout 1||2
160408|NCT01025843|385873|P2|STARTED|Washout 1||2
160409|NCT01025843|385874|P1|STARTED|Washout 1||2
160410|NCT01025843|385865|P10|NOT COMPLETED|Period 1||0
160411|NCT01025843|385866|P9|NOT COMPLETED|Period 1||0
160412|NCT01025843|385867|P8|NOT COMPLETED|Period 1||0
160413|NCT01025843|385868|P7|NOT COMPLETED|Period 1||0
160414|NCT01025843|385869|P6|NOT COMPLETED|Period 1||0
160415|NCT01025843|385870|P5|NOT COMPLETED|Period 1||0
160416|NCT01025843|385871|P4|NOT COMPLETED|Period 1||0
160417|NCT01025843|385872|P3|NOT COMPLETED|Period 1||0
160418|NCT01025843|385873|P2|NOT COMPLETED|Period 1||0
160419|NCT01025843|385874|P1|NOT COMPLETED|Period 1||0
160420|NCT01025843|385865|P10|COMPLETED|Period 1||2
160421|NCT01025843|385866|P9|COMPLETED|Period 1||2
160422|NCT01025843|385867|P8|COMPLETED|Period 1||2
160423|NCT01025843|385868|P7|COMPLETED|Period 1||2
160424|NCT01025843|385869|P6|COMPLETED|Period 1||2
160425|NCT01025843|385870|P5|COMPLETED|Period 1||2
160426|NCT01025843|385871|P4|COMPLETED|Period 1||2
160427|NCT01025843|385872|P3|COMPLETED|Period 1||2
160428|NCT01025843|385873|P2|COMPLETED|Period 1||2
160429|NCT01025843|385874|P1|COMPLETED|Period 1||2
160430|NCT01025843|385865|P10|STARTED|Period 1||2
160431|NCT01025843|385866|P9|STARTED|Period 1||2
160432|NCT01025843|385867|P8|STARTED|Period 1||2
160433|NCT01025843|385868|P7|STARTED|Period 1||2
160434|NCT01025843|385869|P6|STARTED|Period 1||2
160435|NCT01025843|385870|P5|STARTED|Period 1||2
160436|NCT01025843|385871|P4|STARTED|Period 1||2
160437|NCT01025843|385872|P3|STARTED|Period 1||2
160438|NCT01025843|385873|P2|STARTED|Period 1||2
160439|NCT01025843|385874|P1|STARTED|Period 1||2
160440|NCT01025830|385948|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
160441|NCT01025830|385949|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
160442|NCT01025830|385948|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
160443|NCT01025830|385949|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
160444|NCT01025830|385948|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
160445|NCT01025830|385949|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
160446|NCT01025830|385948|P2|NOT COMPLETED|Washout Period of 30 Days||0
160447|NCT01025830|385949|P1|NOT COMPLETED|Washout Period of 30 Days||0
160448|NCT01025830|385948|P2|COMPLETED|Washout Period of 30 Days||12
160449|NCT01025830|385949|P1|COMPLETED|Washout Period of 30 Days||8
160450|NCT01025830|385948|P2|STARTED|Washout Period of 30 Days||12
160451|NCT01025830|385949|P1|STARTED|Washout Period of 30 Days||8
160452|NCT01025830|385948|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
160453|NCT01025830|385949|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
160454|NCT01025830|385948|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
160455|NCT01025830|385949|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
160456|NCT01025830|385948|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
160457|NCT01025830|385949|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
160458|NCT01025817|385968|P2|NOT COMPLETED|Completed Study||22
160459|NCT01025817|385969|P1|NOT COMPLETED|Completed Study||16
160460|NCT01025817|385968|P2|COMPLETED|Completed Study|Completed study phase|282
160461|NCT01025817|385969|P1|COMPLETED|Completed Study|Completed study phase|293
160462|NCT01025817|385968|P2|STARTED|Completed Study||304
160463|NCT01025817|385969|P1|STARTED|Completed Study||309
160464|NCT01025817|385968|P2|NOT COMPLETED|Completed Study Medication||72
160465|NCT01025817|385969|P1|NOT COMPLETED|Completed Study Medication||105
160466|NCT01025817|385968|P2|COMPLETED|Completed Study Medication||232
160467|NCT01025817|385969|P1|COMPLETED|Completed Study Medication||204
160468|NCT01025817|385968|P2|STARTED|Completed Study Medication||304
160469|NCT01025817|385969|P1|STARTED|Completed Study Medication||309
160470|NCT01025635|385989|P2|NOT COMPLETED|Overall Study||25
160471|NCT01025635|385990|P1|NOT COMPLETED|Overall Study||23
160472|NCT01025635|385989|P2|COMPLETED|Overall Study||178
160473|NCT01025635|385990|P1|COMPLETED|Overall Study||175
160474|NCT01025635|385989|P2|STARTED|Overall Study||203
160475|NCT01025635|385990|P1|STARTED|Overall Study||198
160476|NCT01025492|386002|P1|NOT COMPLETED|Overall Study||0
160477|NCT01025492|386002|P1|COMPLETED|Overall Study||24
160478|NCT01025492|386002|P1|STARTED|Overall Study||24
160479|NCT01025336|386011|P5|NOT COMPLETED|Overall Study||0
160480|NCT01025336|386012|P4|NOT COMPLETED|Overall Study||2
160481|NCT01025336|386013|P3|NOT COMPLETED|Overall Study||0
160482|NCT01025336|386014|P2|NOT COMPLETED|Overall Study||0
160483|NCT01025336|386015|P1|NOT COMPLETED|Overall Study||0
160484|NCT01025336|386011|P5|COMPLETED|Overall Study||222
160485|NCT01025336|386012|P4|COMPLETED|Overall Study||219
160486|NCT01025336|386013|P3|COMPLETED|Overall Study||179
160487|NCT01025336|386014|P2|COMPLETED|Overall Study||210
160488|NCT01025336|386015|P1|COMPLETED|Overall Study||130
160489|NCT01025336|386011|P5|STARTED|Overall Study||222
160490|NCT01025336|386012|P4|STARTED|Overall Study||221
160491|NCT01025336|386013|P3|STARTED|Overall Study||179
160492|NCT01025336|386014|P2|STARTED|Overall Study||210
160493|NCT01025336|386015|P1|STARTED|Overall Study||130
160494|NCT01025284|386070|P3|NOT COMPLETED|Overall Study||0
160495|NCT01025284|386071|P2|NOT COMPLETED|Overall Study||2
160496|NCT01025284|386072|P1|NOT COMPLETED|Overall Study||0
160497|NCT01025284|386070|P3|COMPLETED|Overall Study||8
160498|NCT01025284|386071|P2|COMPLETED|Overall Study||16
160499|NCT01025284|386072|P1|COMPLETED|Overall Study||38
160500|NCT01025284|386070|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
160501|NCT01025284|386071|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
160502|NCT01025284|386072|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
160503|NCT01025284|386070|P3|STARTED|Overall Study||8
160504|NCT01025284|386071|P2|STARTED|Overall Study||18
160505|NCT01025284|386072|P1|STARTED|Overall Study||38
160506|NCT01025271|386090|P1|NOT COMPLETED|Overall Study||0
160507|NCT01025271|386090|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
160508|NCT01025271|386090|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
160509|NCT01025232|386097|P2|NOT COMPLETED|Overall Study||6
160510|NCT01025232|386098|P1|NOT COMPLETED|Overall Study||3
160511|NCT01025232|386097|P2|COMPLETED|Overall Study||36
160512|NCT01025232|386098|P1|COMPLETED|Overall Study||43
160513|NCT01025232|386097|P2|STARTED|Overall Study||42
160514|NCT01025232|386098|P1|STARTED|Overall Study||46
160515|NCT01025193|386116|P1|NOT COMPLETED|Overall Study||4
160516|NCT01025193|386116|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
160517|NCT01025193|386116|P1|STARTED|Overall Study||8
160518|NCT01025154|386126|P1|NOT COMPLETED|Overall Study||2
160519|NCT01025154|386126|P1|COMPLETED|Overall Study||57
160520|NCT01025154|386126|P1|STARTED|Overall Study||59
160521|NCT01025076|386131|P1|NOT COMPLETED|Overall Study||0
160522|NCT01025076|386131|P1|COMPLETED|Overall Study||14
160523|NCT01025076|386131|P1|STARTED|Overall Study||14
160524|NCT01025037|386135|P1|NOT COMPLETED|Overall Study||11
160525|NCT01025037|386135|P1|COMPLETED|Overall Study||50
160526|NCT01025037|386135|P1|STARTED|Overall Study||61
160527|NCT01024972|386146|P2|NOT COMPLETED|Overall Study||0
160528|NCT01024972|386147|P1|NOT COMPLETED|Overall Study||0
160529|NCT01024972|386146|P2|COMPLETED|Overall Study||15
160530|NCT01024972|386147|P1|COMPLETED|Overall Study||16
160531|NCT01024972|386146|P2|STARTED|Overall Study||15
160532|NCT01024972|386147|P1|STARTED|Overall Study||16
160533|NCT01024959|386157|P1|NOT COMPLETED|Overall Study||41
160534|NCT01024959|386157|P1|COMPLETED|Overall Study||466
160535|NCT01024959|386157|P1|STARTED|Overall Study||507
160536|NCT01024946|386166|P1|NOT COMPLETED|Overall Study||5
160537|NCT01024946|386166|P1|COMPLETED|Overall Study||6
160538|NCT01024946|386166|P1|STARTED|Overall Study||11
160539|NCT01024855|386170|P1|NOT COMPLETED|Overall Study||1
160540|NCT01024855|386170|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
160541|NCT01024855|386170|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
160542|NCT01024751|386177|P2|NOT COMPLETED|Eligible Participants||3
160543|NCT01024751|386178|P1|NOT COMPLETED|Eligible Participants||0
160544|NCT01024751|386177|P2|COMPLETED|Eligible Participants||149
160545|NCT01024751|386178|P1|COMPLETED|Eligible Participants||153
160546|NCT01024751|386177|P2|STARTED|Eligible Participants||152
160547|NCT01024751|386178|P1|STARTED|Eligible Participants||153
160548|NCT01024751|386177|P2|NOT COMPLETED|Enrolled Participants||4
160549|NCT01024751|386178|P1|NOT COMPLETED|Enrolled Participants||3
160550|NCT01024751|386177|P2|COMPLETED|Enrolled Participants||152
160551|NCT01024751|386178|P1|COMPLETED|Enrolled Participants||153
160552|NCT01024751|386177|P2|STARTED|Enrolled Participants||156
160553|NCT01024751|386178|P1|STARTED|Enrolled Participants||156
160554|NCT01024738|386189|P3|NOT COMPLETED|Third Intervention:||0
160555|NCT01024738|386190|P2|NOT COMPLETED|Third Intervention:||0
160556|NCT01024738|386191|P1|NOT COMPLETED|Third Intervention:||0
160557|NCT01024738|386189|P3|COMPLETED|Third Intervention:||8
160558|NCT01024738|386190|P2|COMPLETED|Third Intervention:||7
160559|NCT01024738|386191|P1|COMPLETED|Third Intervention:||7
160560|NCT01024738|386189|P3|STARTED|Third Intervention:||8
160561|NCT01024738|386190|P2|STARTED|Third Intervention:||7
160562|NCT01024738|386191|P1|STARTED|Third Intervention:||7
160563|NCT01024738|386189|P3|NOT COMPLETED|Washout After 2nd Intervention||0
160564|NCT01024738|386190|P2|NOT COMPLETED|Washout After 2nd Intervention||0
160565|NCT01024738|386191|P1|NOT COMPLETED|Washout After 2nd Intervention||0
160566|NCT01024738|386189|P3|COMPLETED|Washout After 2nd Intervention||8
160567|NCT01024738|386190|P2|COMPLETED|Washout After 2nd Intervention||7
160568|NCT01024738|386191|P1|COMPLETED|Washout After 2nd Intervention||7
160569|NCT01024738|386189|P3|STARTED|Washout After 2nd Intervention||8
160570|NCT01024738|386190|P2|STARTED|Washout After 2nd Intervention||7
160571|NCT01024738|386191|P1|STARTED|Washout After 2nd Intervention||7
160572|NCT01024738|386189|P3|NOT COMPLETED|Second Intervention:||0
160573|NCT01024738|386190|P2|NOT COMPLETED|Second Intervention:||0
160574|NCT01024738|386191|P1|NOT COMPLETED|Second Intervention:||0
160575|NCT01024738|386189|P3|COMPLETED|Second Intervention:||8
160576|NCT01024738|386190|P2|COMPLETED|Second Intervention:||7
160577|NCT01024738|386191|P1|COMPLETED|Second Intervention:||7
160578|NCT01024738|386189|P3|STARTED|Second Intervention:||8
160579|NCT01024738|386190|P2|STARTED|Second Intervention:||7
160580|NCT01024738|386191|P1|STARTED|Second Intervention:||7
160581|NCT01024738|386189|P3|NOT COMPLETED|Washout After 1st Intervention||0
160582|NCT01024738|386190|P2|NOT COMPLETED|Washout After 1st Intervention||0
160583|NCT01024738|386191|P1|NOT COMPLETED|Washout After 1st Intervention||0
160584|NCT01024738|386189|P3|COMPLETED|Washout After 1st Intervention||8
160585|NCT01024738|386190|P2|COMPLETED|Washout After 1st Intervention||7
160586|NCT01024738|386191|P1|COMPLETED|Washout After 1st Intervention||7
160587|NCT01024738|386189|P3|STARTED|Washout After 1st Intervention||8
160588|NCT01024738|386190|P2|STARTED|Washout After 1st Intervention||7
160589|NCT01024738|386191|P1|STARTED|Washout After 1st Intervention||7
160590|NCT01024738|386189|P3|NOT COMPLETED|First Intervention:||0
160591|NCT01024738|386190|P2|NOT COMPLETED|First Intervention:||0
160592|NCT01024738|386191|P1|NOT COMPLETED|First Intervention:||0
160593|NCT01024738|386189|P3|COMPLETED|First Intervention:||8
160594|NCT01024738|386190|P2|COMPLETED|First Intervention:||7
160595|NCT01024738|386191|P1|COMPLETED|First Intervention:||7
160596|NCT01024738|386189|P3|STARTED|First Intervention:||8
160597|NCT01024738|386190|P2|STARTED|First Intervention:||7
160598|NCT01024738|386191|P1|STARTED|First Intervention:||7
160599|NCT01024608|386201|P2|NOT COMPLETED|Overall Study||4
160600|NCT01024608|386202|P1|NOT COMPLETED|Overall Study||4
160601|NCT01024608|386201|P2|COMPLETED|Overall Study||167
160602|NCT01024608|386202|P1|COMPLETED|Overall Study||165
160603|NCT01024608|386201|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
160604|NCT01024608|386202|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
160605|NCT01024608|386201|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
160606|NCT01024608|386202|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
160607|NCT01024608|386201|P2|STARTED|Overall Study||171
160608|NCT01024608|386202|P1|STARTED|Overall Study||169
160609|NCT01024465|386214|P1|NOT COMPLETED|Overall Study||3
160610|NCT01024465|386214|P1|COMPLETED|Overall Study||23
160611|NCT01024465|386214|P1|STARTED|Overall Study||26
160612|NCT01024387|386218|P1|NOT COMPLETED|Overall Study||60
160613|NCT01024387|386218|P1|COMPLETED|Overall Study||0
160614|NCT01024387|386218|P1|Evaluable for Response|Overall Study||53
160615|NCT01024387|386218|P1|Evaluable for PFS|Overall Study||54
160616|NCT01024387|386218|P1|STARTED|Overall Study||60
160617|NCT01024335|386228|P2|NOT COMPLETED|Overall Study||26
160618|NCT01024335|386229|P1|NOT COMPLETED|Overall Study||13
160619|NCT01024335|386228|P2|COMPLETED|Overall Study||14
160620|NCT01024335|386229|P1|COMPLETED|Overall Study||7
160621|NCT01024335|386228|P2|STARTED|Overall Study||40
160622|NCT01024335|386229|P1|STARTED|Overall Study||20
160623|NCT01024309|386239|P2|NOT COMPLETED|Overall Study||4
160624|NCT01024309|386240|P1|NOT COMPLETED|Overall Study||8
160625|NCT01024309|386239|P2|COMPLETED|Overall Study||27
160626|NCT01024309|386240|P1|COMPLETED|Overall Study||27
160627|NCT01024309|386239|P2|STARTED|Overall Study||31
160628|NCT01024309|386240|P1|STARTED|Overall Study||35
160629|NCT01024296|386262|P1|NOT COMPLETED|Overall Study||0
160630|NCT01024296|386262|P1|COMPLETED|Overall Study||4
160631|NCT01024296|386262|P1|STARTED|Overall Study||4
160632|NCT01024244|386272|P5|NOT COMPLETED|Overall Study||14
160633|NCT01024244|386273|P4|NOT COMPLETED|Overall Study||13
160634|NCT01024244|386274|P3|NOT COMPLETED|Overall Study||14
160635|NCT01024244|386275|P2|NOT COMPLETED|Overall Study||11
160636|NCT01024244|386276|P1|NOT COMPLETED|Overall Study||17
160637|NCT01024244|386272|P5|COMPLETED|Overall Study||1
160638|NCT01024244|386273|P4|COMPLETED|Overall Study||1
160639|NCT01024244|386274|P3|COMPLETED|Overall Study||1
160640|NCT01024244|386275|P2|COMPLETED|Overall Study||1
160641|NCT01024244|386276|P1|COMPLETED|Overall Study||5
160642|NCT01024244|386272|P5|STARTED|Overall Study||15
160643|NCT01024244|386273|P4|STARTED|Overall Study||14
160644|NCT01024244|386274|P3|STARTED|Overall Study||15
160645|NCT01024244|386275|P2|STARTED|Overall Study||12
160646|NCT01024244|386276|P1|STARTED|Overall Study||22
160647|NCT01024036|386390|P2|NOT COMPLETED|Follow-Up Period||3
160648|NCT01024036|386391|P1|NOT COMPLETED|Follow-Up Period||5
160649|NCT01024036|386390|P2|COMPLETED|Follow-Up Period||3
160650|NCT01024036|386391|P1|COMPLETED|Follow-Up Period||9
160651|NCT01024036|386390|P2|STARTED|Follow-Up Period||6
160652|NCT01024036|386391|P1|STARTED|Follow-Up Period||14
160653|NCT01024036|386390|P2|NOT COMPLETED|Unblinded Treatment||3
160654|NCT01024036|386391|P1|NOT COMPLETED|Unblinded Treatment||0
160655|NCT01024036|386390|P2|COMPLETED|Unblinded Treatment||10
160656|NCT01024036|386391|P1|COMPLETED|Unblinded Treatment||0
160657|NCT01024036|386390|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
160742|NCT01023581|386608|P2|NOT COMPLETED|Overall Study||23
160658|NCT01024036|386391|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
160659|NCT01024036|386390|P2|NOT COMPLETED|Blinded Treatment||20
160660|NCT01024036|386391|P1|NOT COMPLETED|Blinded Treatment||22
160661|NCT01024036|386390|P2|COMPLETED|Blinded Treatment||6
160662|NCT01024036|386391|P1|COMPLETED|Blinded Treatment||31
160663|NCT01024036|386390|P2|STARTED|Blinded Treatment||26
160664|NCT01024036|386391|P1|STARTED|Blinded Treatment||53
160665|NCT01023958|386422|P1|NOT COMPLETED|Overall Study||50
160666|NCT01023958|386422|P1|COMPLETED|Overall Study||0
160667|NCT01023958|386422|P1|STARTED|Overall Study||50
160668|NCT01023841|386451|P2|NOT COMPLETED|Overall Study||0
160669|NCT01023841|386452|P1|NOT COMPLETED|Overall Study||1
160670|NCT01023841|386451|P2|COMPLETED|Overall Study||23
160671|NCT01023841|386452|P1|COMPLETED|Overall Study||47
160672|NCT01023841|386451|P2|STARTED|Overall Study||23
160673|NCT01023841|386452|P1|STARTED|Overall Study||48
160674|NCT01023815|386470|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
160675|NCT01023815|386471|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
160676|NCT01023815|386472|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
160677|NCT01023815|386473|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
160678|NCT01023815|386470|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
160679|NCT01023815|386471|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
160680|NCT01023815|386472|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
160681|NCT01023815|386473|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
160682|NCT01023815|386470|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
160683|NCT01023815|386471|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
160684|NCT01023815|386472|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
160685|NCT01023815|386473|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
160686|NCT01023815|386470|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
160687|NCT01023815|386471|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
160688|NCT01023815|386472|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
160689|NCT01023815|386473|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
160690|NCT01023815|386470|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
160691|NCT01023815|386471|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
160692|NCT01023815|386472|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
160693|NCT01023815|386473|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
160694|NCT01023815|386470|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
160695|NCT01023815|386471|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
160696|NCT01023815|386472|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
160697|NCT01023815|386473|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
160698|NCT01023789|386492|P1|NOT COMPLETED|3 - Year Visit||43
160699|NCT01023789|386492|P1|COMPLETED|3 - Year Visit||769
160700|NCT01023789|386492|P1|STARTED|3 - Year Visit||812
160701|NCT01023789|386492|P1|NOT COMPLETED|2 - Year Visit||0
160702|NCT01023789|386492|P1|COMPLETED|2 - Year Visit||812
160703|NCT01023789|386492|P1|STARTED|2 - Year Visit||812
160704|NCT01023789|386492|P1|NOT COMPLETED|1 - Year Visit||0
160705|NCT01023789|386492|P1|COMPLETED|1 - Year Visit||812
160706|NCT01023789|386492|P1|STARTED|1 - Year Visit||812
160707|NCT01023789|386492|P1|NOT COMPLETED|180-day Clinical Follow-up||0
160708|NCT01023789|386492|P1|COMPLETED|180-day Clinical Follow-up||812
160709|NCT01023789|386492|P1|STARTED|180-day Clinical Follow-up||812
160710|NCT01023789|386492|P1|NOT COMPLETED|30-day Follow-up Visit||0
160711|NCT01023789|386492|P1|COMPLETED|30-day Follow-up Visit||812
160712|NCT01023789|386492|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
160713|NCT01023776|386559|P1|NOT COMPLETED|Overall Study||0
160714|NCT01023776|386559|P1|COMPLETED|Overall Study||20
160715|NCT01023776|386559|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
160716|NCT01023724|386566|P2|NOT COMPLETED|Overall Study||3
160717|NCT01023724|386567|P1|NOT COMPLETED|Overall Study||4
160718|NCT01023724|386566|P2|COMPLETED|Overall Study||22
160719|NCT01023724|386567|P1|COMPLETED|Overall Study||21
160720|NCT01023724|386566|P2|STARTED|Overall Study||25
160721|NCT01023724|386567|P1|STARTED|Overall Study||25
160722|NCT01023711|386573|P1|NOT COMPLETED|Overall Study||0
160723|NCT01023711|386573|P1|COMPLETED|Overall Study||107
160724|NCT01023711|386573|P1|STARTED|Overall Study||107
160725|NCT01023672|386578|P1|NOT COMPLETED|Overall Study||3
160726|NCT01023672|386578|P1|COMPLETED|Overall Study||17
160727|NCT01023672|386578|P1|STARTED|Overall Study||20
160728|NCT01023659|386585|P3|NOT COMPLETED|Overall Study||99
160729|NCT01023659|386586|P2|NOT COMPLETED|Overall Study||228
160730|NCT01023659|386587|P1|NOT COMPLETED|Overall Study||73
160731|NCT01023659|386585|P3|COMPLETED|Overall Study||165
160732|NCT01023659|386586|P2|COMPLETED|Overall Study||137
160733|NCT01023659|386587|P1|COMPLETED|Overall Study||185
160734|NCT01023659|386585|P3|STARTED|Overall Study||264
160735|NCT01023659|386586|P2|STARTED|Overall Study||365
160736|NCT01023659|386587|P1|STARTED|Overall Study||258
160737|NCT01023581|386603|P7|NOT COMPLETED|Overall Study||20
160738|NCT01023581|386604|P6|NOT COMPLETED|Overall Study||19
160739|NCT01023581|386605|P5|NOT COMPLETED|Overall Study||16
160740|NCT01023581|386606|P4|NOT COMPLETED|Overall Study||20
160741|NCT01023581|386607|P3|NOT COMPLETED|Overall Study||42
160743|NCT01023581|386609|P1|NOT COMPLETED|Overall Study||35
160744|NCT01023581|386603|P7|COMPLETED|Overall Study||94
160745|NCT01023581|386604|P6|COMPLETED|Overall Study||92
160746|NCT01023581|386605|P5|COMPLETED|Overall Study||95
160747|NCT01023581|386606|P4|COMPLETED|Overall Study||94
160748|NCT01023581|386607|P3|COMPLETED|Overall Study||71
160749|NCT01023581|386608|P2|COMPLETED|Overall Study||89
160750|NCT01023581|386609|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
160751|NCT01023581|386603|P7|Received Study Treatment|Overall Study||114
160752|NCT01023581|386604|P6|Received Study Treatment|Overall Study||106
160753|NCT01023581|386605|P5|Received Study Treatment|Overall Study||111
160754|NCT01023581|386606|P4|Received Study Treatment|Overall Study||109
160755|NCT01023581|386607|P3|Received Study Treatment|Overall Study||110
160756|NCT01023581|386608|P2|Received Study Treatment|Overall Study||112
160757|NCT01023581|386609|P1|Received Study Treatment|Overall Study||106
160758|NCT01023581|386603|P7|STARTED|Overall Study||114
160759|NCT01023581|386604|P6|STARTED|Overall Study||111
160760|NCT01023581|386605|P5|STARTED|Overall Study||111
160761|NCT01023581|386606|P4|STARTED|Overall Study||114
160762|NCT01023581|386607|P3|STARTED|Overall Study||113
160763|NCT01023581|386608|P2|STARTED|Overall Study||112
160764|NCT01023581|386609|P1|STARTED|Overall Study||109
160765|NCT01023568|386642|P3|NOT COMPLETED|Overall Study||0
160766|NCT01023568|386643|P2|NOT COMPLETED|Overall Study||0
160767|NCT01023568|386644|P1|NOT COMPLETED|Overall Study||0
160768|NCT01023568|386642|P3|COMPLETED|Overall Study||45
160769|NCT01023568|386643|P2|COMPLETED|Overall Study||44
160770|NCT01023568|386644|P1|COMPLETED|Overall Study||45
160771|NCT01023568|386642|P3|STARTED|Overall Study||45
160772|NCT01023568|386643|P2|STARTED|Overall Study||44
160773|NCT01023568|386644|P1|STARTED|Overall Study||45
160774|NCT01023516|386666|P2|NOT COMPLETED|Overall Study||18
160775|NCT01023516|386667|P1|NOT COMPLETED|Overall Study||24
160776|NCT01023516|386666|P2|COMPLETED|Overall Study||284
160777|NCT01023516|386667|P1|COMPLETED|Overall Study||289
160778|NCT01023516|386666|P2|STARTED|Overall Study||302
160779|NCT01023516|386667|P1|STARTED|Overall Study||313
160780|NCT01023308|386749|P2|NOT COMPLETED|Overall Study||279
160781|NCT01023308|386750|P1|NOT COMPLETED|Overall Study||285
160782|NCT01023308|386749|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
160783|NCT01023308|386750|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
160784|NCT01023308|386749|P2|STARTED|Overall Study||381
160785|NCT01023308|386750|P1|STARTED|Overall Study||387
160786|NCT01023256|386780|P4|NOT COMPLETED|Overall Study||5
160787|NCT01023256|386781|P3|NOT COMPLETED|Overall Study||1
160788|NCT01023256|386782|P2|NOT COMPLETED|Overall Study||3
160789|NCT01023256|386783|P1|NOT COMPLETED|Overall Study||4
160790|NCT01023256|386780|P4|COMPLETED|Overall Study||22
160791|NCT01023256|386781|P3|COMPLETED|Overall Study||23
160792|NCT01023256|386782|P2|COMPLETED|Overall Study||19
160793|NCT01023256|386783|P1|COMPLETED|Overall Study||21
160794|NCT01023256|386780|P4|STARTED|Overall Study||27
160795|NCT01023256|386781|P3|STARTED|Overall Study||24
160796|NCT01023256|386782|P2|STARTED|Overall Study||22
160797|NCT01023256|386783|P1|STARTED|Overall Study||25
160798|NCT01023217|386825|P2|NOT COMPLETED|Overall Study||0
160799|NCT01023217|386826|P1|NOT COMPLETED|Overall Study||1
160800|NCT01023217|386825|P2|COMPLETED|Overall Study||45
160801|NCT01023217|386826|P1|COMPLETED|Overall Study||44
160802|NCT01023217|386825|P2|STARTED|Overall Study||45
160803|NCT01023217|386826|P1|STARTED|Overall Study||45
160804|NCT01023178|386835|P3|NOT COMPLETED|Overall Study||3
160805|NCT01023178|386836|P2|NOT COMPLETED|Overall Study||2
160806|NCT01023178|386837|P1|NOT COMPLETED|Overall Study||2
160807|NCT01023178|386835|P3|COMPLETED|Overall Study||4
160808|NCT01023178|386836|P2|COMPLETED|Overall Study||6
160809|NCT01023178|386837|P1|COMPLETED|Overall Study||3
160810|NCT01023178|386835|P3|STARTED|Overall Study||7
160811|NCT01023178|386836|P2|STARTED|Overall Study||8
160812|NCT01023178|386837|P1|STARTED|Overall Study||5
160813|NCT01023074|386848|P3|NOT COMPLETED|Overall Study||0
160814|NCT01023074|386849|P2|NOT COMPLETED|Overall Study||0
160815|NCT01023074|386850|P1|NOT COMPLETED|Overall Study||0
160816|NCT01023074|386848|P3|COMPLETED|Overall Study||13
160817|NCT01023074|386849|P2|COMPLETED|Overall Study||13
160818|NCT01023074|386850|P1|COMPLETED|Overall Study||26
160819|NCT01023074|386848|P3|STARTED|Overall Study||13
160820|NCT01023074|386849|P2|STARTED|Overall Study||13
160821|NCT01023074|386850|P1|STARTED|Overall Study||26
160822|NCT01023061|386864|P1|NOT COMPLETED|Overall Study||2
160823|NCT01023061|386864|P1|COMPLETED|Overall Study||22
160824|NCT01023061|386864|P1|STARTED|Overall Study||24
160825|NCT01023035|386873|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
160826|NCT01023035|386874|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
160827|NCT01023035|386875|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
160828|NCT01023035|386873|P3|COMPLETED|Follow-up Period (up to Week 72)||108
160829|NCT01023035|386874|P2|COMPLETED|Follow-up Period (up to Week 72)||207
160830|NCT01023035|386875|P1|COMPLETED|Follow-up Period (up to Week 72)||210
160831|NCT01023035|386873|P3|STARTED|Follow-up Period (up to Week 72)||147
160832|NCT01023035|386874|P2|STARTED|Follow-up Period (up to Week 72)||235
160833|NCT01023035|386875|P1|STARTED|Follow-up Period (up to Week 72)||238
160834|NCT01023035|386873|P3|NOT COMPLETED|Treatment Period||118
160835|NCT01023035|386874|P2|NOT COMPLETED|Treatment Period||85
160836|NCT01023035|386875|P1|NOT COMPLETED|Treatment Period||72
160837|NCT01023035|386873|P3|COMPLETED|Treatment Period||69
160838|NCT01023035|386874|P2|COMPLETED|Treatment Period||166
160839|NCT01023035|386875|P1|COMPLETED|Treatment Period||177
160840|NCT01023035|386873|P3|STARTED|Treatment Period||187
160841|NCT01023035|386874|P2|STARTED|Treatment Period||251
160842|NCT01023035|386875|P1|STARTED|Treatment Period||249
160843|NCT01023022|386885|P1|NOT COMPLETED|Overall Study||14
160844|NCT01023022|386885|P1|COMPLETED|Overall Study||162
160845|NCT01023022|386885|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
160846|NCT01022996|386891|P1|NOT COMPLETED|Overall Study||57
160847|NCT01022996|386891|P1|COMPLETED|Overall Study||0
160848|NCT01022996|386891|P1|STARTED|Overall Study||57
160849|NCT01022762|386902|P2|NOT COMPLETED|Overall Study||28
160850|NCT01022762|386903|P1|NOT COMPLETED|Overall Study||22
160851|NCT01022762|386902|P2|COMPLETED|Overall Study||194
160852|NCT01022762|386903|P1|COMPLETED|Overall Study||196
160853|NCT01022762|386902|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
160854|NCT01022762|386903|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
160855|NCT01022762|386902|P2|STARTED|Overall Study||222
160856|NCT01022762|386903|P1|STARTED|Overall Study||218
160857|NCT01022567|386931|P2|NOT COMPLETED|Overall Study||15
160858|NCT01022567|386932|P1|NOT COMPLETED|Overall Study||1
160859|NCT01022567|386931|P2|COMPLETED|Overall Study||242
160860|NCT01022567|386932|P1|COMPLETED|Overall Study||272
160861|NCT01022567|386931|P2|STARTED|Overall Study||257
160862|NCT01022567|386932|P1|STARTED|Overall Study||273
160863|NCT01022502|386938|P1|NOT COMPLETED|Overall Study||3
160864|NCT01022502|386938|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
160865|NCT01022502|386938|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
160866|NCT01022398|386954|P2|NOT COMPLETED|Overall Study||2
160867|NCT01022398|386955|P1|NOT COMPLETED|Overall Study||2
160868|NCT01022398|386954|P2|COMPLETED|Overall Study||0
160869|NCT01022398|386955|P1|COMPLETED|Overall Study||0
160870|NCT01022398|386954|P2|STARTED|Overall Study||2
160871|NCT01022398|386955|P1|STARTED|Overall Study||2
160872|NCT01022307|386962|P2|NOT COMPLETED|Overall Study||4
160873|NCT01022307|386963|P1|NOT COMPLETED|Overall Study||0
160874|NCT01022307|386962|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
160875|NCT01022307|386963|P1|COMPLETED|Overall Study||184
160876|NCT01022307|386962|P2|STARTED|Overall Study||28
160877|NCT01022307|386963|P1|STARTED|Overall Study||184
160878|NCT01022242|386971|P2|NOT COMPLETED|Overall Study||19
160879|NCT01022242|386972|P1|NOT COMPLETED|Overall Study||21
160880|NCT01022242|386971|P2|COMPLETED|Overall Study||46
160881|NCT01022242|386972|P1|COMPLETED|Overall Study||49
160882|NCT01022242|386971|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
160883|NCT01022242|386972|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
160884|NCT01022203|386980|P2|NOT COMPLETED|Follow-Up Assessment||2
160885|NCT01022203|386981|P1|NOT COMPLETED|Follow-Up Assessment||2
160886|NCT01022203|386980|P2|COMPLETED|Follow-Up Assessment||40
160887|NCT01022203|386981|P1|COMPLETED|Follow-Up Assessment||42
160888|NCT01022203|386980|P2|STARTED|Follow-Up Assessment||42
160889|NCT01022203|386981|P1|STARTED|Follow-Up Assessment||44
160890|NCT01022203|386980|P2|NOT COMPLETED|Post Treatment Assessment||14
160891|NCT01022203|386981|P1|NOT COMPLETED|Post Treatment Assessment||14
160892|NCT01022203|386980|P2|COMPLETED|Post Treatment Assessment||42
160893|NCT01022203|386981|P1|COMPLETED|Post Treatment Assessment||44
160894|NCT01022203|386980|P2|STARTED|Post Treatment Assessment||56
160895|NCT01022203|386981|P1|STARTED|Post Treatment Assessment||58
160896|NCT01022203|386980|P2|NOT COMPLETED|PreTreatment Assessment||0
160897|NCT01022203|386981|P1|NOT COMPLETED|PreTreatment Assessment||0
160898|NCT01022203|386980|P2|COMPLETED|PreTreatment Assessment||56
160899|NCT01022203|386981|P1|COMPLETED|PreTreatment Assessment||58
160900|NCT01022203|386980|P2|STARTED|PreTreatment Assessment||56
160901|NCT01022203|386981|P1|STARTED|PreTreatment Assessment||58
160902|NCT01022190|386991|P1|NOT COMPLETED|Overall Study||0
160903|NCT01022190|386991|P1|COMPLETED|Overall Study||42
160904|NCT01022190|386991|P1|STARTED|Overall Study||42
160905|NCT01022112|387000|P5|NOT COMPLETED|Overall Study||10
160906|NCT01022112|387001|P4|NOT COMPLETED|Overall Study||3
160907|NCT01022112|387002|P3|NOT COMPLETED|Overall Study||3
160908|NCT01022112|387003|P2|NOT COMPLETED|Overall Study||3
160909|NCT01022112|387004|P1|NOT COMPLETED|Overall Study||3
160910|NCT01022112|387000|P5|COMPLETED|Overall Study||65
160911|NCT01022112|387001|P4|COMPLETED|Overall Study||72
160912|NCT01022112|387002|P3|COMPLETED|Overall Study||74
160913|NCT01022112|387003|P2|COMPLETED|Overall Study||71
160914|NCT01022112|387004|P1|COMPLETED|Overall Study||79
160915|NCT01022112|387000|P5|STARTED|Overall Study||75
160916|NCT01022112|387001|P4|STARTED|Overall Study||75
160917|NCT01022112|387002|P3|STARTED|Overall Study||77
160918|NCT01022112|387003|P2|STARTED|Overall Study||74
160919|NCT01022112|387004|P1|STARTED|Overall Study||82
160920|NCT01022073|387018|P2|NOT COMPLETED|Overall Study||18
160921|NCT01022073|387019|P1|NOT COMPLETED|Overall Study||19
160922|NCT01022073|387018|P2|COMPLETED|Overall Study||52
160923|NCT01022073|387019|P1|COMPLETED|Overall Study||67
160924|NCT01022073|387018|P2|STARTED|Overall Study||70
160925|NCT01022073|387019|P1|STARTED|Overall Study||86
160926|NCT01021878|387027|P2|NOT COMPLETED|Overall Study||10
160927|NCT01021878|387028|P1|NOT COMPLETED|Overall Study||16
160928|NCT01021878|387027|P2|COMPLETED|Overall Study||17
160929|NCT01021878|387028|P1|COMPLETED|Overall Study||17
160930|NCT01021878|387027|P2|Completed Follow-up|Overall Study||17
160931|NCT01021878|387028|P1|Completed Follow-up|Overall Study||17
160932|NCT01021878|387027|P2|STARTED|Overall Study||27
160933|NCT01021878|387028|P1|STARTED|Overall Study||33
160934|NCT01021852|387050|P8|NOT COMPLETED|Treatment Period 2||2
160935|NCT01021852|387051|P7|NOT COMPLETED|Treatment Period 2||3
160936|NCT01021852|387052|P6|NOT COMPLETED|Treatment Period 2||1
160937|NCT01021852|387053|P5|NOT COMPLETED|Treatment Period 2||2
160938|NCT01021852|387054|P4|NOT COMPLETED|Treatment Period 2||0
160939|NCT01021852|387055|P3|NOT COMPLETED|Treatment Period 2||1
160940|NCT01021852|387056|P2|NOT COMPLETED|Treatment Period 2||1
160941|NCT01021852|387057|P1|NOT COMPLETED|Treatment Period 2||0
160942|NCT01021852|387050|P8|COMPLETED|Treatment Period 2||38
160943|NCT01021852|387051|P7|COMPLETED|Treatment Period 2||37
160944|NCT01021852|387052|P6|COMPLETED|Treatment Period 2||37
160945|NCT01021852|387053|P5|COMPLETED|Treatment Period 2||37
160946|NCT01021852|387054|P4|COMPLETED|Treatment Period 2||37
160947|NCT01021852|387055|P3|COMPLETED|Treatment Period 2||38
160948|NCT01021852|387056|P2|COMPLETED|Treatment Period 2||38
160949|NCT01021852|387057|P1|COMPLETED|Treatment Period 2||37
160950|NCT01021852|387050|P8|STARTED|Treatment Period 2||40
160951|NCT01021852|387051|P7|STARTED|Treatment Period 2||40
160952|NCT01021852|387052|P6|STARTED|Treatment Period 2||38
160953|NCT01021852|387053|P5|STARTED|Treatment Period 2||39
160954|NCT01021852|387054|P4|STARTED|Treatment Period 2||37
160955|NCT01021852|387055|P3|STARTED|Treatment Period 2||39
160956|NCT01021852|387056|P2|STARTED|Treatment Period 2||39
160957|NCT01021852|387057|P1|STARTED|Treatment Period 2||37
160958|NCT01021852|387050|P8|NOT COMPLETED|Washout Period-No Drug||0
160959|NCT01021852|387051|P7|NOT COMPLETED|Washout Period-No Drug||0
160960|NCT01021852|387052|P6|NOT COMPLETED|Washout Period-No Drug||1
160961|NCT01021852|387053|P5|NOT COMPLETED|Washout Period-No Drug||0
160962|NCT01021852|387054|P4|NOT COMPLETED|Washout Period-No Drug||0
160963|NCT01021852|387055|P3|NOT COMPLETED|Washout Period-No Drug||0
160964|NCT01021852|387056|P2|NOT COMPLETED|Washout Period-No Drug||0
160965|NCT01021852|387057|P1|NOT COMPLETED|Washout Period-No Drug||1
160966|NCT01021852|387050|P8|COMPLETED|Washout Period-No Drug||40
160967|NCT01021852|387051|P7|COMPLETED|Washout Period-No Drug||40
160968|NCT01021852|387052|P6|COMPLETED|Washout Period-No Drug||38
160969|NCT01021852|387053|P5|COMPLETED|Washout Period-No Drug||39
160970|NCT01021852|387054|P4|COMPLETED|Washout Period-No Drug||37
160971|NCT01021852|387055|P3|COMPLETED|Washout Period-No Drug||39
160972|NCT01021852|387056|P2|COMPLETED|Washout Period-No Drug||39
160973|NCT01021852|387057|P1|COMPLETED|Washout Period-No Drug||37
160974|NCT01021852|387050|P8|STARTED|Washout Period-No Drug||40
160975|NCT01021852|387051|P7|STARTED|Washout Period-No Drug||40
160976|NCT01021852|387052|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
160977|NCT01021852|387053|P5|STARTED|Washout Period-No Drug||39
160978|NCT01021852|387054|P4|STARTED|Washout Period-No Drug||37
160979|NCT01021852|387055|P3|STARTED|Washout Period-No Drug||39
160980|NCT01021852|387056|P2|STARTED|Washout Period-No Drug||39
160981|NCT01021852|387057|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
160982|NCT01021852|387050|P8|NOT COMPLETED|Washout Period-Placebo||0
160983|NCT01021852|387051|P7|NOT COMPLETED|Washout Period-Placebo||1
160984|NCT01021852|387052|P6|NOT COMPLETED|Washout Period-Placebo||1
160985|NCT01021852|387053|P5|NOT COMPLETED|Washout Period-Placebo||1
160986|NCT01021852|387054|P4|NOT COMPLETED|Washout Period-Placebo||1
160987|NCT01021852|387055|P3|NOT COMPLETED|Washout Period-Placebo||0
160988|NCT01021852|387056|P2|NOT COMPLETED|Washout Period-Placebo||0
160989|NCT01021852|387057|P1|NOT COMPLETED|Washout Period-Placebo||0
160990|NCT01021852|387050|P8|COMPLETED|Washout Period-Placebo||40
160991|NCT01021852|387051|P7|COMPLETED|Washout Period-Placebo||40
160992|NCT01021852|387052|P6|COMPLETED|Washout Period-Placebo||38
160993|NCT01021852|387053|P5|COMPLETED|Washout Period-Placebo||39
160994|NCT01021852|387054|P4|COMPLETED|Washout Period-Placebo||37
160995|NCT01021852|387055|P3|COMPLETED|Washout Period-Placebo||39
160996|NCT01021852|387056|P2|COMPLETED|Washout Period-Placebo||39
160997|NCT01021852|387057|P1|COMPLETED|Washout Period-Placebo||37
160998|NCT01021852|387050|P8|STARTED|Washout Period-Placebo||40
160999|NCT01021852|387051|P7|STARTED|Washout Period-Placebo||41
161000|NCT01021852|387052|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
161001|NCT01021852|387053|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
161002|NCT01021852|387054|P4|STARTED|Washout Period-Placebo||38
161003|NCT01021852|387055|P3|STARTED|Washout Period-Placebo||39
161004|NCT01021852|387056|P2|STARTED|Washout Period-Placebo||39
161005|NCT01021852|387057|P1|STARTED|Washout Period-Placebo||37
161006|NCT01021852|387050|P8|NOT COMPLETED|Treatment Period 1||1
161007|NCT01021852|387051|P7|NOT COMPLETED|Treatment Period 1||0
161008|NCT01021852|387052|P6|NOT COMPLETED|Treatment Period 1||2
161009|NCT01021852|387053|P5|NOT COMPLETED|Treatment Period 1||3
161010|NCT01021852|387054|P4|NOT COMPLETED|Treatment Period 1||2
161011|NCT01021852|387055|P3|NOT COMPLETED|Treatment Period 1||2
161012|NCT01021852|387056|P2|NOT COMPLETED|Treatment Period 1||1
161013|NCT01021852|387057|P1|NOT COMPLETED|Treatment Period 1||3
161014|NCT01021852|387050|P8|COMPLETED|Treatment Period 1||40
161015|NCT01021852|387051|P7|COMPLETED|Treatment Period 1||41
161016|NCT01021852|387052|P6|COMPLETED|Treatment Period 1||39
161017|NCT01021852|387053|P5|COMPLETED|Treatment Period 1||39
161018|NCT01021852|387054|P4|COMPLETED|Treatment Period 1||38
161019|NCT01021852|387055|P3|COMPLETED|Treatment Period 1||39
161020|NCT01021852|387056|P2|COMPLETED|Treatment Period 1||39
161021|NCT01021852|387057|P1|COMPLETED|Treatment Period 1||37
161022|NCT01021852|387050|P8|Treated|Treatment Period 1||41
161023|NCT01021852|387051|P7|Treated|Treatment Period 1||41
161024|NCT01021852|387052|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
161025|NCT01021852|387053|P5|Treated|Treatment Period 1||42
161026|NCT01021852|387054|P4|Treated|Treatment Period 1||38
161027|NCT01021852|387055|P3|Treated|Treatment Period 1||41
161028|NCT01021852|387056|P2|Treated|Treatment Period 1||40
161029|NCT01021852|387057|P1|Treated|Treatment Period 1||40
161030|NCT01021852|387050|P8|STARTED|Treatment Period 1||41
161031|NCT01021852|387051|P7|STARTED|Treatment Period 1||41
161032|NCT01021852|387052|P6|STARTED|Treatment Period 1||41
161033|NCT01021852|387053|P5|STARTED|Treatment Period 1||42
161034|NCT01021852|387054|P4|STARTED|Treatment Period 1||40
161035|NCT01021852|387055|P3|STARTED|Treatment Period 1||41
161036|NCT01021852|387056|P2|STARTED|Treatment Period 1||40
161037|NCT01021852|387057|P1|STARTED|Treatment Period 1||40
161038|NCT01021813|387093|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
161039|NCT01021813|387094|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
161040|NCT01021813|387095|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
161041|NCT01021813|387096|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
161042|NCT01021813|387097|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
161043|NCT01021813|387093|P5|COMPLETED|DB Randomized Discontinuation Phase||157
161044|NCT01021813|387094|P4|COMPLETED|DB Randomized Discontinuation Phase||161
161045|NCT01021813|387095|P3|COMPLETED|DB Randomized Discontinuation Phase||152
161046|NCT01021813|387096|P2|COMPLETED|DB Randomized Discontinuation Phase||0
161047|NCT01021813|387097|P1|COMPLETED|DB Randomized Discontinuation Phase||0
161048|NCT01021813|387093|P5|STARTED|DB Randomized Discontinuation Phase||162
161049|NCT01021813|387094|P4|STARTED|DB Randomized Discontinuation Phase||166
161050|NCT01021813|387095|P3|STARTED|DB Randomized Discontinuation Phase||156
161051|NCT01021813|387096|P2|STARTED|DB Randomized Discontinuation Phase||0
161052|NCT01021813|387097|P1|STARTED|DB Randomized Discontinuation Phase||0
161053|NCT01021813|387093|P5|NOT COMPLETED|DB Treatment Phase||0
161054|NCT01021813|387094|P4|NOT COMPLETED|DB Treatment Phase||0
161055|NCT01021813|387095|P3|NOT COMPLETED|DB Treatment Phase||0
161056|NCT01021813|387096|P2|NOT COMPLETED|DB Treatment Phase||97
161057|NCT01021813|387097|P1|NOT COMPLETED|DB Treatment Phase||200
161058|NCT01021813|387093|P5|COMPLETED|DB Treatment Phase||0
161059|NCT01021813|387094|P4|COMPLETED|DB Treatment Phase||0
161060|NCT01021813|387095|P3|COMPLETED|DB Treatment Phase||0
161061|NCT01021813|387096|P2|COMPLETED|DB Treatment Phase||162
161062|NCT01021813|387097|P1|COMPLETED|DB Treatment Phase||322
161063|NCT01021813|387093|P5|Treated|DB Treatment Phase||0
161064|NCT01021813|387094|P4|Treated|DB Treatment Phase||0
161065|NCT01021813|387095|P3|Treated|DB Treatment Phase||0
161066|NCT01021813|387096|P2|Treated|DB Treatment Phase||258
161067|NCT01021813|387097|P1|Treated|DB Treatment Phase||521
161068|NCT01021813|387093|P5|STARTED|DB Treatment Phase||0
161069|NCT01021813|387094|P4|STARTED|DB Treatment Phase||0
161070|NCT01021813|387095|P3|STARTED|DB Treatment Phase||0
161071|NCT01021813|387096|P2|STARTED|DB Treatment Phase||259
161072|NCT01021813|387097|P1|STARTED|DB Treatment Phase||522
161073|NCT01021761|387139|P3|NOT COMPLETED|Overall Study||0
161074|NCT01021761|387140|P2|NOT COMPLETED|Overall Study||4
161075|NCT01021761|387141|P1|NOT COMPLETED|Overall Study||1
161076|NCT01021761|387139|P3|COMPLETED|Overall Study||42
161077|NCT01021761|387140|P2|COMPLETED|Overall Study||38
161078|NCT01021761|387141|P1|COMPLETED|Overall Study||41
161079|NCT01021761|387139|P3|STARTED|Overall Study||42
161080|NCT01021761|387140|P2|STARTED|Overall Study||42
161081|NCT01021761|387141|P1|STARTED|Overall Study||42
161082|NCT01021683|387149|P1|NOT COMPLETED|Overall Study||71
161083|NCT01021683|387149|P1|COMPLETED|Overall Study||132
161084|NCT01021683|387149|P1|STARTED|Overall Study||203
161085|NCT01021618|387163|P2|NOT COMPLETED|Overall Study||0
161086|NCT01021618|387164|P1|NOT COMPLETED|Overall Study||0
161087|NCT01021618|387163|P2|COMPLETED|Overall Study||96
161088|NCT01021618|387164|P1|COMPLETED|Overall Study||44
161089|NCT01021618|387163|P2|STARTED|Overall Study||96
161090|NCT01021618|387164|P1|STARTED|Overall Study||44
161091|NCT01021553|387175|P3|NOT COMPLETED|Overall Study||3
161092|NCT01021553|387176|P2|NOT COMPLETED|Overall Study||5
161093|NCT01021553|387177|P1|NOT COMPLETED|Overall Study||4
161094|NCT01021553|387175|P3|COMPLETED|Overall Study||25
161095|NCT01021553|387176|P2|COMPLETED|Overall Study||17
161096|NCT01021553|387177|P1|COMPLETED|Overall Study||23
161097|NCT01021553|387175|P3|STARTED|Overall Study||28
161098|NCT01021553|387176|P2|STARTED|Overall Study||22
161099|NCT01021553|387177|P1|STARTED|Overall Study||27
161100|NCT01021423|387231|P2|NOT COMPLETED|Overall Study||5
161101|NCT01021423|387232|P1|NOT COMPLETED|Overall Study||4
161102|NCT01021423|387231|P2|COMPLETED|Overall Study||0
161103|NCT01021423|387232|P1|COMPLETED|Overall Study||0
161104|NCT01021423|387231|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
161105|NCT01021423|387232|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
161106|NCT01021332|387248|P1|NOT COMPLETED|Overall Study||106
161107|NCT01021332|387248|P1|COMPLETED|Overall Study||960
161108|NCT01021332|387248|P1|Full Analysis Set (FAS)|Overall Study||1009
161109|NCT01021332|387248|P1|Safety Analysis Set (SAF)|Overall Study||1066
161110|NCT01021332|387248|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
161111|NCT01021306|387286|P4|NOT COMPLETED|6 Month (Follow-up)||3
161112|NCT01021306|387287|P3|NOT COMPLETED|6 Month (Follow-up)||0
161113|NCT01021306|387288|P2|NOT COMPLETED|6 Month (Follow-up)||1
161114|NCT01021306|387289|P1|NOT COMPLETED|6 Month (Follow-up)||3
161115|NCT01021306|387286|P4|COMPLETED|6 Month (Follow-up)||14
161116|NCT01021306|387287|P3|COMPLETED|6 Month (Follow-up)||14
161117|NCT01021306|387288|P2|COMPLETED|6 Month (Follow-up)||13
161118|NCT01021306|387289|P1|COMPLETED|6 Month (Follow-up)||11
161119|NCT01021306|387286|P4|STARTED|6 Month (Follow-up)||17
161120|NCT01021306|387287|P3|STARTED|6 Month (Follow-up)||14
161121|NCT01021306|387288|P2|STARTED|6 Month (Follow-up)||14
161122|NCT01021306|387289|P1|STARTED|6 Month (Follow-up)||14
161123|NCT01021306|387286|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
161124|NCT01021306|387287|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
161125|NCT01021306|387288|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
161126|NCT01021306|387289|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
161127|NCT01021306|387286|P4|COMPLETED|2 Month (Primary Outcome)||17
161128|NCT01021306|387287|P3|COMPLETED|2 Month (Primary Outcome)||14
161129|NCT01021306|387288|P2|COMPLETED|2 Month (Primary Outcome)||14
161130|NCT01021306|387289|P1|COMPLETED|2 Month (Primary Outcome)||14
161131|NCT01021306|387286|P4|STARTED|2 Month (Primary Outcome)||21
161132|NCT01021306|387287|P3|STARTED|2 Month (Primary Outcome)||19
161133|NCT01021306|387288|P2|STARTED|2 Month (Primary Outcome)||20
161134|NCT01021306|387289|P1|STARTED|2 Month (Primary Outcome)||20
161135|NCT01021293|387309|P2|NOT COMPLETED|Overall Study||24
161136|NCT01021293|387310|P1|NOT COMPLETED|Overall Study||12
161137|NCT01021293|387309|P2|COMPLETED|Overall Study||526
161138|NCT01021293|387310|P1|COMPLETED|Overall Study||538
161139|NCT01021293|387309|P2|STARTED|Overall Study||550
161140|NCT01021293|387310|P1|STARTED|Overall Study||550
161141|NCT01021215|387329|P2|NOT COMPLETED|Overall Study||0
161142|NCT01021215|387330|P1|NOT COMPLETED|Overall Study||3
161143|NCT01021215|387329|P2|COMPLETED|Overall Study||20
161144|NCT01021215|387330|P1|COMPLETED|Overall Study||57
161145|NCT01021215|387329|P2|Received Allocated Intervention|Overall Study||20
161146|NCT01021215|387330|P1|Received Allocated Intervention|Overall Study||60
161147|NCT01021215|387329|P2|STARTED|Overall Study||20
161148|NCT01021215|387330|P1|STARTED|Overall Study||60
161149|NCT01021111|387340|P1|NOT COMPLETED|Overall Study||0
161150|NCT01021111|387340|P1|COMPLETED|Overall Study||17
161151|NCT01021111|387340|P1|STARTED|Overall Study||17
161152|NCT01021020|387345|P1|NOT COMPLETED|Period III||0
161153|NCT01021020|387345|P1|COMPLETED|Period III||25
161154|NCT01021020|387345|P1|STARTED|Period III||25
161155|NCT01021020|387345|P1|NOT COMPLETED|14 Day Washout Period B||0
161156|NCT01021020|387345|P1|COMPLETED|14 Day Washout Period B||25
161157|NCT01021020|387345|P1|STARTED|14 Day Washout Period B||25
161158|NCT01021020|387345|P1|NOT COMPLETED|Period II||0
161159|NCT01021020|387345|P1|COMPLETED|Period II||25
161160|NCT01021020|387345|P1|STARTED|Period II||25
161161|NCT01021020|387345|P1|NOT COMPLETED|14 Day Washout Period A||1
161162|NCT01021020|387345|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
161163|NCT01021020|387345|P1|STARTED|14 Day Washout Period A||26
161164|NCT01021020|387345|P1|NOT COMPLETED|Period I||2
161165|NCT01021020|387345|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
161166|NCT01021020|387345|P1|STARTED|Period I||28
161167|NCT01021007|387361|P2|NOT COMPLETED|Overall Study||4
161168|NCT01021007|387362|P1|NOT COMPLETED|Overall Study||2
161169|NCT01021007|387361|P2|COMPLETED|Overall Study||33
161170|NCT01021007|387362|P1|COMPLETED|Overall Study||34
161171|NCT01021007|387361|P2|STARTED|Overall Study||37
161172|NCT01021007|387362|P1|STARTED|Overall Study||36
161173|NCT01020981|387374|P2|NOT COMPLETED|Overall Study||90
161174|NCT01020981|387375|P1|NOT COMPLETED|Overall Study||84
161175|NCT01020981|387374|P2|COMPLETED|Overall Study||60
161176|NCT01020981|387375|P1|COMPLETED|Overall Study||66
161177|NCT01020981|387374|P2|STARTED|Overall Study||150
161178|NCT01020981|387375|P1|STARTED|Overall Study||150
161179|NCT01020903|387387|P2|NOT COMPLETED|Overall Study||0
161180|NCT01020903|387388|P1|NOT COMPLETED|Overall Study||0
161181|NCT01020903|387387|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
161182|NCT01020903|387388|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
161183|NCT01020903|387387|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
161184|NCT01020903|387388|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
161185|NCT01020877|387396|P2|NOT COMPLETED|Second Intervention||0
161186|NCT01020877|387397|P1|NOT COMPLETED|Second Intervention||1
161187|NCT01020877|387396|P2|COMPLETED|Second Intervention||19
161188|NCT01020877|387397|P1|COMPLETED|Second Intervention||18
161189|NCT01020877|387396|P2|STARTED|Second Intervention||19
161190|NCT01020877|387397|P1|STARTED|Second Intervention||19
161191|NCT01020877|387396|P2|NOT COMPLETED|Washout of 7 Days||0
161192|NCT01020877|387397|P1|NOT COMPLETED|Washout of 7 Days||0
161193|NCT01020877|387396|P2|COMPLETED|Washout of 7 Days||19
161194|NCT01020877|387397|P1|COMPLETED|Washout of 7 Days||19
161195|NCT01020877|387396|P2|STARTED|Washout of 7 Days||19
161196|NCT01020877|387397|P1|STARTED|Washout of 7 Days||19
161197|NCT01020877|387396|P2|NOT COMPLETED|First Intervention||0
161198|NCT01020877|387397|P1|NOT COMPLETED|First Intervention||0
161199|NCT01020877|387396|P2|COMPLETED|First Intervention||19
161200|NCT01020877|387397|P1|COMPLETED|First Intervention||19
161201|NCT01020877|387396|P2|STARTED|First Intervention||19
161202|NCT01020877|387397|P1|STARTED|First Intervention||19
161203|NCT01020838|387407|P1|NOT COMPLETED|Overall Study||183
161204|NCT01020838|387407|P1|COMPLETED|Overall Study||35
161205|NCT01020838|387407|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
161206|NCT01020838|387407|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
161207|NCT01020838|387407|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
161208|NCT01020838|387407|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
161209|NCT01020838|387407|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
161210|NCT01020838|387407|P1|STARTED|Overall Study||218
161211|NCT01020812|387422|P1|NOT COMPLETED|Overall Study||3
161212|NCT01020812|387422|P1|COMPLETED|Overall Study||8
161213|NCT01020812|387422|P1|STARTED|Overall Study||11
161214|NCT01020799|387432|P3|NOT COMPLETED|Overall Study||7
161215|NCT01020799|387433|P2|NOT COMPLETED|Overall Study||14
161216|NCT01020799|387434|P1|NOT COMPLETED|Overall Study||19
161217|NCT01020799|387432|P3|COMPLETED|Overall Study||43
161218|NCT01020799|387433|P2|COMPLETED|Overall Study||85
161219|NCT01020799|387434|P1|COMPLETED|Overall Study||79
161220|NCT01020799|387432|P3|Full Analysis Set|Overall Study||49
161221|NCT01020799|387433|P2|Full Analysis Set|Overall Study||94
161222|NCT01020799|387434|P1|Full Analysis Set|Overall Study||91
161223|NCT01020799|387432|P3|Patients Received Treatment|Overall Study||50
161224|NCT01020799|387433|P2|Patients Received Treatment|Overall Study||99
161225|NCT01020799|387434|P1|Patients Received Treatment|Overall Study||96
161226|NCT01020799|387432|P3|STARTED|Overall Study||50
161227|NCT01020799|387433|P2|STARTED|Overall Study||99
161228|NCT01020799|387434|P1|STARTED|Overall Study||98
161229|NCT01020786|387457|P1|NOT COMPLETED|Maintenance Period||60
161230|NCT01020786|387457|P1|COMPLETED|Maintenance Period||0
161231|NCT01020786|387457|P1|STARTED|Maintenance Period||60
161232|NCT01020786|387457|P1|NOT COMPLETED|Induction Period||49
161233|NCT01020786|387457|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
161234|NCT01020786|387457|P1|STARTED|Induction Period||109
161235|NCT01020773|387471|P2|NOT COMPLETED|Overall Study||3
161236|NCT01020773|387472|P1|NOT COMPLETED|Overall Study||4
161237|NCT01020773|387471|P2|COMPLETED|Overall Study||29
161238|NCT01020773|387472|P1|COMPLETED|Overall Study||31
161239|NCT01020773|387471|P2|STARTED|Overall Study||32
161240|NCT01020773|387472|P1|STARTED|Overall Study||35
161241|NCT01020747|387478|P1|NOT COMPLETED|Overall Study||1
161242|NCT01020747|387478|P1|COMPLETED|Overall Study||19
161243|NCT01020747|387478|P1|STARTED|Overall Study||20
161244|NCT01020591|387485|P2|NOT COMPLETED|Overall Study||0
161245|NCT01020591|387486|P1|NOT COMPLETED|Overall Study||0
161246|NCT01020591|387485|P2|COMPLETED|Overall Study||15
161247|NCT01020591|387486|P1|COMPLETED|Overall Study||15
161248|NCT01020591|387485|P2|STARTED|Overall Study||15
161249|NCT01020591|387486|P1|STARTED|Overall Study||15
161250|NCT01020526|387494|P1|NOT COMPLETED|Overall Study||14
161251|NCT01020526|387494|P1|COMPLETED|Overall Study||49
161252|NCT01020526|387494|P1|STARTED|Overall Study||63
161253|NCT01020474|387500|P2|NOT COMPLETED|Overall Study||17
161254|NCT01020474|387501|P1|NOT COMPLETED|Overall Study||10
161255|NCT01020474|387500|P2|COMPLETED|Overall Study||36
161256|NCT01020474|387501|P1|COMPLETED|Overall Study||44
161257|NCT01020474|387500|P2|STARTED|Overall Study||53
161258|NCT01020474|387501|P1|STARTED|Overall Study||54
161259|NCT01020448|387521|P1|NOT COMPLETED|Treatment||26
161260|NCT01020448|387521|P1|COMPLETED|Treatment||299
161261|NCT01020448|387521|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
161262|NCT01020448|387521|P1|NOT COMPLETED|Pre-assignment||13
161263|NCT01020448|387521|P1|COMPLETED|Pre-assignment||326
161264|NCT01020448|387521|P1|STARTED|Pre-assignment||339
161265|NCT01020435|387532|P2|NOT COMPLETED|Overall Study||1
161266|NCT01020435|387533|P1|NOT COMPLETED|Overall Study||0
161267|NCT01020435|387532|P2|COMPLETED|Overall Study||26
161268|NCT01020435|387533|P1|COMPLETED|Overall Study||24
161269|NCT01020435|387532|P2|STARTED|Overall Study||27
161270|NCT01020435|387533|P1|STARTED|Overall Study||24
161271|NCT01020305|387541|P1|NOT COMPLETED|Overall Study||2
161272|NCT01020305|387541|P1|COMPLETED|Overall Study||3
161273|NCT01020305|387541|P1|STARTED|Overall Study||5
161274|NCT01020123|387552|P7|NOT COMPLETED|Extention Period||1
161275|NCT01020123|387553|P6|NOT COMPLETED|Extention Period||2
161276|NCT01020123|387554|P5|NOT COMPLETED|Extention Period||0
161277|NCT01020123|387555|P4|NOT COMPLETED|Extention Period||1
161278|NCT01020123|387556|P3|NOT COMPLETED|Extention Period||2
161279|NCT01020123|387557|P2|NOT COMPLETED|Extention Period||2
161280|NCT01020123|387558|P1|NOT COMPLETED|Extention Period||3
161281|NCT01020123|387552|P7|COMPLETED|Extention Period||18
161282|NCT01020123|387553|P6|COMPLETED|Extention Period||36
161283|NCT01020123|387554|P5|COMPLETED|Extention Period||31
161284|NCT01020123|387555|P4|COMPLETED|Extention Period||12
161285|NCT01020123|387556|P3|COMPLETED|Extention Period||17
161286|NCT01020123|387557|P2|COMPLETED|Extention Period||33
161287|NCT01020123|387558|P1|COMPLETED|Extention Period||37
161288|NCT01020123|387552|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
161289|NCT01020123|387553|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
161290|NCT01020123|387554|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
161291|NCT01020123|387555|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
161292|NCT01020123|387556|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
161293|NCT01020123|387557|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
161294|NCT01020123|387558|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
161295|NCT01020123|387552|P7|NOT COMPLETED|Main Period||11
161296|NCT01020123|387553|P6|NOT COMPLETED|Main Period||11
161297|NCT01020123|387554|P5|NOT COMPLETED|Main Period||11
161298|NCT01020123|387555|P4|NOT COMPLETED|Main Period||7
161299|NCT01020123|387556|P3|NOT COMPLETED|Main Period||8
161300|NCT01020123|387557|P2|NOT COMPLETED|Main Period||14
161301|NCT01020123|387558|P1|NOT COMPLETED|Main Period||17
161302|NCT01020123|387552|P7|COMPLETED|Main Period||61
161303|NCT01020123|387553|P6|COMPLETED|Main Period||83
161304|NCT01020123|387554|P5|COMPLETED|Main Period||77
161305|NCT01020123|387555|P4|COMPLETED|Main Period||33
161306|NCT01020123|387556|P3|COMPLETED|Main Period||44
161307|NCT01020123|387557|P2|COMPLETED|Main Period||77
161308|NCT01020123|387558|P1|COMPLETED|Main Period||76
161309|NCT01020123|387552|P7|STARTED|Main Period||72
161310|NCT01020123|387553|P6|STARTED|Main Period||94
161311|NCT01020123|387554|P5|STARTED|Main Period||88
161312|NCT01020123|387555|P4|STARTED|Main Period||40
161313|NCT01020123|387556|P3|STARTED|Main Period||52
161314|NCT01020123|387557|P2|STARTED|Main Period||91
161315|NCT01020123|387558|P1|STARTED|Main Period||93
161316|NCT01020019|387753|P2|NOT COMPLETED|Overall Study||29
161317|NCT01020019|387754|P1|NOT COMPLETED|Overall Study||26
161318|NCT01020019|387753|P2|COMPLETED|Overall Study||32
161319|NCT01020019|387754|P1|COMPLETED|Overall Study||35
161320|NCT01020019|387753|P2|STARTED|Overall Study||61
161321|NCT01020019|387754|P1|STARTED|Overall Study||61
161322|NCT01020006|387763|P3|NOT COMPLETED|Overall Study||16
161323|NCT01020006|387764|P2|NOT COMPLETED|Overall Study||18
161324|NCT01020006|387765|P1|NOT COMPLETED|Overall Study||8
161325|NCT01020006|387763|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
161326|NCT01020006|387764|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
161327|NCT01020006|387765|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
161328|NCT01020006|387763|P3|STARTED|Overall Study||16
161329|NCT01020006|387764|P2|STARTED|Overall Study||18
161330|NCT01020006|387765|P1|STARTED|Overall Study||8
161331|NCT01019980|387775|P2|NOT COMPLETED|Overall Study||0
161332|NCT01019980|387776|P1|NOT COMPLETED|Overall Study||2
161333|NCT01019980|387775|P2|COMPLETED|Overall Study||0
161334|NCT01019980|387776|P1|COMPLETED|Overall Study||0
161335|NCT01019980|387775|P2|Discontinued|Overall Study||0
161336|NCT01019980|387776|P1|Discontinued|Overall Study||2
161337|NCT01019980|387775|P2|STARTED|Overall Study||0
161338|NCT01019980|387776|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
161339|NCT01019928|387784|P2|NOT COMPLETED|Period 3||0
161340|NCT01019928|387785|P1|NOT COMPLETED|Period 3||0
161341|NCT01019928|387784|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
161342|NCT01019928|387785|P1|COMPLETED|Period 3||7
161343|NCT01019928|387784|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
161344|NCT01019928|387785|P1|STARTED|Period 3||7
161345|NCT01019928|387784|P2|NOT COMPLETED|Period 2||1
161346|NCT01019928|387785|P1|NOT COMPLETED|Period 2||0
161347|NCT01019928|387784|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
161348|NCT01019928|387785|P1|COMPLETED|Period 2||7
161349|NCT01019928|387784|P2|STARTED|Period 2||7
161350|NCT01019928|387785|P1|STARTED|Period 2||7
161351|NCT01019928|387784|P2|NOT COMPLETED|Period 1||0
161352|NCT01019928|387785|P1|NOT COMPLETED|Period 1||0
161353|NCT01019928|387784|P2|COMPLETED|Period 1||7
161354|NCT01019928|387785|P1|COMPLETED|Period 1||7
161355|NCT01019928|387784|P2|STARTED|Period 1||7
161356|NCT01019928|387785|P1|STARTED|Period 1||7
161357|NCT01019707|387825|P2|NOT COMPLETED|Second Phase||0
161358|NCT01019707|387826|P1|NOT COMPLETED|Second Phase||0
161359|NCT01019707|387825|P2|COMPLETED|Second Phase||1
161360|NCT01019707|387826|P1|COMPLETED|Second Phase||3
161361|NCT01019707|387825|P2|STARTED|Second Phase||1
161362|NCT01019707|387826|P1|STARTED|Second Phase||3
161363|NCT01019707|387825|P2|NOT COMPLETED|Washout||2
161364|NCT01019707|387826|P1|NOT COMPLETED|Washout||0
161365|NCT01019707|387825|P2|COMPLETED|Washout||1
161366|NCT01019707|387826|P1|COMPLETED|Washout||3
161367|NCT01019707|387825|P2|STARTED|Washout||3
161368|NCT01019707|387826|P1|STARTED|Washout||3
161369|NCT01019707|387825|P2|NOT COMPLETED|First Phase||0
161370|NCT01019707|387826|P1|NOT COMPLETED|First Phase||0
161371|NCT01019707|387825|P2|COMPLETED|First Phase||3
161372|NCT01019707|387826|P1|COMPLETED|First Phase||3
161373|NCT01019707|387825|P2|STARTED|First Phase||3
161374|NCT01019707|387826|P1|STARTED|First Phase||3
161375|NCT01019694|387839|P3|NOT COMPLETED|Overall Study||47
161376|NCT01019694|387840|P2|NOT COMPLETED|Overall Study||38
161377|NCT01019694|387841|P1|NOT COMPLETED|Overall Study||24
161378|NCT01019694|387839|P3|COMPLETED|Overall Study||110
161379|NCT01019694|387840|P2|COMPLETED|Overall Study||118
161380|NCT01019694|387841|P1|COMPLETED|Overall Study||133
161381|NCT01019694|387839|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
161382|NCT01019694|387840|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
161383|NCT01019694|387841|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
161384|NCT01019486|387966|P3|NOT COMPLETED|Overall Study||1
161385|NCT01019486|387967|P2|NOT COMPLETED|Overall Study||1
161386|NCT01019486|387968|P1|NOT COMPLETED|Overall Study||1
161387|NCT01019486|387966|P3|COMPLETED|Overall Study||15
161388|NCT01019486|387967|P2|COMPLETED|Overall Study||4
161389|NCT01019486|387968|P1|COMPLETED|Overall Study||4
161390|NCT01019486|387966|P3|STARTED|Overall Study||16
161391|NCT01019486|387967|P2|STARTED|Overall Study||5
161392|NCT01019486|387968|P1|STARTED|Overall Study||5
161393|NCT01019369|387982|P2|NOT COMPLETED|Overall Study||7
161394|NCT01019369|387983|P1|NOT COMPLETED|Overall Study||10
161395|NCT01019369|387982|P2|COMPLETED|Overall Study||39
161396|NCT01019369|387983|P1|COMPLETED|Overall Study||76
161397|NCT01019369|387982|P2|STARTED|Overall Study||46
161398|NCT01019369|387983|P1|STARTED|Overall Study||86
161399|NCT01019317|387989|P1|NOT COMPLETED|Overall Study||4
161400|NCT01019317|387989|P1|COMPLETED|Overall Study||147
161401|NCT01019317|387989|P1|STARTED|Overall Study||151
161402|NCT01019135|387996|P3|NOT COMPLETED|Overall Study||31
161403|NCT01019135|387997|P2|NOT COMPLETED|Overall Study||19
161404|NCT01019135|387998|P1|NOT COMPLETED|Overall Study||20
161405|NCT01019135|387996|P3|COMPLETED|Overall Study||24
161406|NCT01019135|387997|P2|COMPLETED|Overall Study||40
161407|NCT01019135|387998|P1|COMPLETED|Overall Study||35
161408|NCT01019135|387996|P3|STARTED|Overall Study||55
161409|NCT01019135|387997|P2|STARTED|Overall Study||59
161410|NCT01019135|387998|P1|STARTED|Overall Study||55
161411|NCT01018992|388026|P2|NOT COMPLETED|Overall Study||16
161412|NCT01018992|388027|P1|NOT COMPLETED|Overall Study||16
161413|NCT01018992|388026|P2|COMPLETED|Overall Study||49
161414|NCT01018992|388027|P1|COMPLETED|Overall Study||47
161415|NCT01018992|388026|P2|STARTED|Overall Study||65
161416|NCT01018992|388027|P1|STARTED|Overall Study||63
161417|NCT01018979|388041|P2|NOT COMPLETED|Overall Study||10
161418|NCT01018979|388042|P1|NOT COMPLETED|Overall Study||3
161419|NCT01018979|388041|P2|COMPLETED|Overall Study||3
161420|NCT01018979|388042|P1|COMPLETED|Overall Study||4
161421|NCT01018979|388041|P2|Received at Least One Dose|Overall Study||12
161422|NCT01018979|388042|P1|Received at Least One Dose|Overall Study||7
161423|NCT01018979|388041|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
161424|NCT01018979|388042|P1|STARTED|Overall Study||7
161425|NCT01018953|388072|P1|NOT COMPLETED|Overall Study||8
161426|NCT01018953|388072|P1|COMPLETED|Overall Study||0
161427|NCT01018953|388072|P1|BIM 23A760 4 mg|Overall Study||3
161428|NCT01018953|388072|P1|BIM 23A760 2 mg|Overall Study||2
161429|NCT01018953|388072|P1|BIM 23A760 1 mg|Overall Study||3
161430|NCT01018953|388072|P1|STARTED|Overall Study||8
161431|NCT01018862|388085|P3|NOT COMPLETED|Overall Study||16
161432|NCT01018862|388086|P2|NOT COMPLETED|Overall Study||10
161433|NCT01018862|388087|P1|NOT COMPLETED|Overall Study||13
161434|NCT01018862|388085|P3|COMPLETED|Overall Study||146
161435|NCT01018862|388086|P2|COMPLETED|Overall Study||156
161436|NCT01018862|388087|P1|COMPLETED|Overall Study||148
161437|NCT01018862|388085|P3|STARTED|Overall Study||162
161438|NCT01018862|388086|P2|STARTED|Overall Study||166
161439|NCT01018862|388087|P1|STARTED|Overall Study||161
161440|NCT01018810|388109|P5|NOT COMPLETED|Overall Study||1
161441|NCT01018810|388110|P4|NOT COMPLETED|Overall Study||1
161442|NCT01018810|388111|P3|NOT COMPLETED|Overall Study||1
161443|NCT01018810|388112|P2|NOT COMPLETED|Overall Study||1
161444|NCT01018810|388113|P1|NOT COMPLETED|Overall Study||2
161445|NCT01018810|388109|P5|COMPLETED|Overall Study||0
161446|NCT01018810|388110|P4|COMPLETED|Overall Study||0
161447|NCT01018810|388111|P3|COMPLETED|Overall Study||0
161448|NCT01018810|388112|P2|COMPLETED|Overall Study||0
161449|NCT01018810|388113|P1|COMPLETED|Overall Study||2
161450|NCT01018810|388109|P5|STARTED|Overall Study||1
161451|NCT01018810|388110|P4|STARTED|Overall Study||1
161452|NCT01018810|388111|P3|STARTED|Overall Study||1
161453|NCT01018810|388112|P2|STARTED|Overall Study||1
161454|NCT01018810|388113|P1|STARTED|Overall Study||4
161455|NCT01018732|388173|P3|NOT COMPLETED|Overall Study||4
161456|NCT01018732|388174|P2|NOT COMPLETED|Overall Study||2
161457|NCT01018732|388175|P1|NOT COMPLETED|Overall Study||1
161458|NCT01018732|388173|P3|COMPLETED|Overall Study||50
161459|NCT01018732|388174|P2|COMPLETED|Overall Study||49
161460|NCT01018732|388175|P1|COMPLETED|Overall Study||49
161461|NCT01018732|388173|P3|STARTED|Overall Study||54
161462|NCT01018732|388174|P2|STARTED|Overall Study||51
161463|NCT01018732|388175|P1|STARTED|Overall Study||50
161464|NCT01018680|388209|P2|NOT COMPLETED|Overall Study||75
161465|NCT01018680|388210|P1|NOT COMPLETED|Overall Study||61
161466|NCT01018680|388209|P2|COMPLETED|Overall Study||189
161467|NCT01018680|388210|P1|COMPLETED|Overall Study||199
161468|NCT01018680|388209|P2|STARTED|Overall Study||264
161469|NCT01018680|388210|P1|STARTED|Overall Study||260
161470|NCT01020487|388253|P3|NOT COMPLETED|Part 2 Open-label Period||1
161471|NCT01020487|388254|P2|NOT COMPLETED|Part 2 Open-label Period||4
161472|NCT01020487|388255|P1|NOT COMPLETED|Part 2 Open-label Period||0
161473|NCT01020487|388253|P3|COMPLETED|Part 2 Open-label Period||12
161474|NCT01020487|388254|P2|COMPLETED|Part 2 Open-label Period||12
161475|NCT01020487|388255|P1|COMPLETED|Part 2 Open-label Period||0
161476|NCT01020487|388253|P3|STARTED|Part 2 Open-label Period||13
161477|NCT01020487|388254|P2|STARTED|Part 2 Open-label Period||16
161478|NCT01020487|388255|P1|STARTED|Part 2 Open-label Period||0
161479|NCT01020487|388253|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
161480|NCT01020487|388254|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
161481|NCT01020487|388255|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
161482|NCT01020487|388253|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
161483|NCT01020487|388254|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
161484|NCT01020487|388255|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
161485|NCT01020487|388253|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
161486|NCT01020487|388254|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
161487|NCT01020487|388255|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
161488|NCT01020487|388253|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
161489|NCT01020487|388254|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
161490|NCT01020487|388255|P1|STARTED|Part 2 Double-blind Treatment Period||0
161491|NCT01020487|388253|P3|NOT COMPLETED|Part 1||0
161492|NCT01020487|388254|P2|NOT COMPLETED|Part 1||0
161493|NCT01020487|388255|P1|NOT COMPLETED|Part 1||0
161494|NCT01020487|388253|P3|COMPLETED|Part 1||0
161495|NCT01020487|388254|P2|COMPLETED|Part 1||0
161496|NCT01020487|388255|P1|COMPLETED|Part 1||12
161497|NCT01020487|388253|P3|STARTED|Part 1||0
161498|NCT01020487|388254|P2|STARTED|Part 1||0
161499|NCT01020487|388255|P1|STARTED|Part 1||12
161500|NCT01018511|388280|P4|NOT COMPLETED|Overall Study||33
161501|NCT01018511|388281|P3|NOT COMPLETED|Overall Study||40
161502|NCT01018511|388282|P2|NOT COMPLETED|Overall Study||32
161503|NCT01018511|388283|P1|NOT COMPLETED|Overall Study||26
161504|NCT01018511|388280|P4|COMPLETED|Overall Study||294
161505|NCT01018511|388281|P3|COMPLETED|Overall Study||299
161506|NCT01018511|388282|P2|COMPLETED|Overall Study||295
161507|NCT01018511|388283|P1|COMPLETED|Overall Study||315
161508|NCT01018511|388280|P4|Randomized and Treated|Overall Study||324
161509|NCT01018511|388281|P3|Randomized and Treated|Overall Study||338
161510|NCT01018511|388282|P2|Randomized and Treated|Overall Study||326
161511|NCT01018511|388283|P1|Randomized and Treated|Overall Study||341
161512|NCT01018511|388280|P4|STARTED|Overall Study||327
161513|NCT01018511|388281|P3|STARTED|Overall Study||339
161514|NCT01018511|388282|P2|STARTED|Overall Study||327
161515|NCT01018511|388283|P1|STARTED|Overall Study||341
161516|NCT01018420|388452|P2|NOT COMPLETED|Overall Study||0
161517|NCT01018420|388453|P1|NOT COMPLETED|Overall Study||0
161518|NCT01018420|388452|P2|COMPLETED|Overall Study||3
161519|NCT01018420|388453|P1|COMPLETED|Overall Study||15
161520|NCT01018420|388452|P2|STARTED|Overall Study||3
161521|NCT01018420|388453|P1|STARTED|Overall Study||15
161522|NCT01018394|388480|P2|NOT COMPLETED|Overall Study||8
161523|NCT01018394|388481|P1|NOT COMPLETED|Overall Study||9
161524|NCT01018394|388480|P2|COMPLETED|Overall Study||33
161525|NCT01018394|388481|P1|COMPLETED|Overall Study||31
161526|NCT01018394|388480|P2|STARTED|Overall Study||41
161527|NCT01018394|388481|P1|STARTED|Overall Study||40
161528|NCT01018264|388491|P2|NOT COMPLETED|Overall Study||1
161529|NCT01018264|388492|P1|NOT COMPLETED|Overall Study||1
161530|NCT01018264|388491|P2|COMPLETED|Overall Study||12
161531|NCT01018264|388492|P1|COMPLETED|Overall Study||9
161532|NCT01018264|388491|P2|STARTED|Overall Study||13
161533|NCT01018264|388492|P1|STARTED|Overall Study||10
161534|NCT01018186|388509|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
161535|NCT01018186|388510|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
161536|NCT01018186|388511|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
161537|NCT01018186|388512|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
161538|NCT01018186|388509|P4|COMPLETED|52-week Double-blind Treatment Period||71
161539|NCT01018186|388510|P3|COMPLETED|52-week Double-blind Treatment Period||161
161540|NCT01018186|388511|P2|COMPLETED|52-week Double-blind Treatment Period||161
161541|NCT01018186|388512|P1|COMPLETED|52-week Double-blind Treatment Period||0
161542|NCT01018186|388509|P4|STARTED|52-week Double-blind Treatment Period||100
161543|NCT01018186|388510|P3|STARTED|52-week Double-blind Treatment Period||202
161544|NCT01018186|388511|P2|STARTED|52-week Double-blind Treatment Period||201
161545|NCT01018186|388512|P1|STARTED|52-week Double-blind Treatment Period||0
161546|NCT01018186|388509|P4|NOT COMPLETED|2-week Run-in Period||0
161547|NCT01018186|388510|P3|NOT COMPLETED|2-week Run-in Period||0
161548|NCT01018186|388511|P2|NOT COMPLETED|2-week Run-in Period||0
161549|NCT01018186|388512|P1|NOT COMPLETED|2-week Run-in Period||114
161550|NCT01018186|388509|P4|COMPLETED|2-week Run-in Period||0
161551|NCT01018186|388510|P3|COMPLETED|2-week Run-in Period||0
161552|NCT01018186|388511|P2|COMPLETED|2-week Run-in Period||0
161553|NCT01018186|388512|P1|COMPLETED|2-week Run-in Period||503
161554|NCT01018186|388509|P4|STARTED|2-week Run-in Period||0
161555|NCT01018186|388510|P3|STARTED|2-week Run-in Period||0
161556|NCT01018186|388511|P2|STARTED|2-week Run-in Period||0
161557|NCT01018186|388512|P1|STARTED|2-week Run-in Period||617
161558|NCT01018134|388604|P6|NOT COMPLETED|Overall Study||0
161559|NCT01018134|388605|P5|NOT COMPLETED|Overall Study||0
161560|NCT01018134|388606|P4|NOT COMPLETED|Overall Study||0
161561|NCT01018134|388607|P3|NOT COMPLETED|Overall Study||1
161562|NCT01018134|388608|P2|NOT COMPLETED|Overall Study||1
161563|NCT01018134|388609|P1|NOT COMPLETED|Overall Study||0
161564|NCT01018134|388604|P6|COMPLETED|Overall Study||15
161565|NCT01018134|388605|P5|COMPLETED|Overall Study||15
161566|NCT01018134|388606|P4|COMPLETED|Overall Study||29
161567|NCT01018134|388607|P3|COMPLETED|Overall Study||29
161568|NCT01018134|388608|P2|COMPLETED|Overall Study||30
161569|NCT01018134|388609|P1|COMPLETED|Overall Study||30
161570|NCT01018134|388604|P6|STARTED|Overall Study||15
161571|NCT01018134|388605|P5|STARTED|Overall Study||15
161572|NCT01018134|388606|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
161573|NCT01018134|388607|P3|STARTED|Overall Study||30
161574|NCT01018134|388608|P2|STARTED|Overall Study||31
161575|NCT01018134|388609|P1|STARTED|Overall Study||30
161576|NCT01018095|388649|P2|NOT COMPLETED|Overall Study||62
161577|NCT01018095|388650|P1|NOT COMPLETED|Overall Study||56
161578|NCT01018095|388649|P2|COMPLETED|Overall Study||73
161579|NCT01018095|388650|P1|COMPLETED|Overall Study||79
161580|NCT01018095|388649|P2|STARTED|Overall Study||135
161581|NCT01018095|388650|P1|STARTED|Overall Study||135
161582|NCT01018056|388661|P3|NOT COMPLETED|Overall Study||1
161583|NCT01018056|388662|P2|NOT COMPLETED|Overall Study||2
161584|NCT01018056|388663|P1|NOT COMPLETED|Overall Study||3
161585|NCT01018056|388661|P3|COMPLETED|Overall Study||5
161586|NCT01018056|388662|P2|COMPLETED|Overall Study||10
161587|NCT01018056|388663|P1|COMPLETED|Overall Study||9
161588|NCT01018056|388661|P3|STARTED|Overall Study||6
161589|NCT01018056|388662|P2|STARTED|Overall Study||12
161590|NCT01018056|388663|P1|STARTED|Overall Study||12
161591|NCT01018030|388713|P3|NOT COMPLETED|Overall Study||13
161592|NCT01018030|388714|P2|NOT COMPLETED|Overall Study||11
161593|NCT01018030|388715|P1|NOT COMPLETED|Overall Study||19
161594|NCT01018030|388713|P3|COMPLETED|Overall Study||239
161595|NCT01018030|388714|P2|COMPLETED|Overall Study||232
161596|NCT01018030|388715|P1|COMPLETED|Overall Study||227
161597|NCT01018030|388713|P3|STARTED|Overall Study||252
161598|NCT01018030|388714|P2|STARTED|Overall Study||243
161599|NCT01018030|388715|P1|STARTED|Overall Study||246
161600|NCT01017952|388766|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
161601|NCT01017952|388767|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
161602|NCT01017952|388768|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
161603|NCT01017952|388769|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
161604|NCT01017952|388770|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
161605|NCT01017952|388766|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
161606|NCT01017952|388767|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
161607|NCT01017952|388768|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
161608|NCT01017952|388769|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
161609|NCT01017952|388770|P1|COMPLETED|52-week, Double-blind Treatment Period||0
161610|NCT01017952|388766|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
161611|NCT01017952|388767|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
161695|NCT01017237|388968|P2|COMPLETED|Overall Study||6
161612|NCT01017952|388768|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
161613|NCT01017952|388769|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
161614|NCT01017952|388770|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
161615|NCT01017952|388766|P5|STARTED|52-week, Double-blind Treatment Period||409
161616|NCT01017952|388767|P4|STARTED|52-week, Double-blind Treatment Period||403
161617|NCT01017952|388768|P3|STARTED|52-week, Double-blind Treatment Period||412
161618|NCT01017952|388769|P2|STARTED|52-week, Double-blind Treatment Period||409
161619|NCT01017952|388770|P1|STARTED|52-week, Double-blind Treatment Period||0
161620|NCT01017952|388766|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
161621|NCT01017952|388767|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
161622|NCT01017952|388768|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
161623|NCT01017952|388769|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
161624|NCT01017952|388770|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
161625|NCT01017952|388766|P5|COMPLETED|4-week, Open-label Run-In Period||0
161626|NCT01017952|388767|P4|COMPLETED|4-week, Open-label Run-In Period||0
161627|NCT01017952|388768|P3|COMPLETED|4-week, Open-label Run-In Period||0
161628|NCT01017952|388769|P2|COMPLETED|4-week, Open-label Run-In Period||0
161629|NCT01017952|388770|P1|COMPLETED|4-week, Open-label Run-In Period||1633
161630|NCT01017952|388766|P5|STARTED|4-week, Open-label Run-In Period||0
161631|NCT01017952|388767|P4|STARTED|4-week, Open-label Run-In Period||0
161632|NCT01017952|388768|P3|STARTED|4-week, Open-label Run-In Period||0
161633|NCT01017952|388769|P2|STARTED|4-week, Open-label Run-In Period||0
161634|NCT01017952|388770|P1|STARTED|4-week, Open-label Run-In Period||2092
161635|NCT01017874|388794|P2|NOT COMPLETED|Overall Study||26
161636|NCT01017874|388795|P1|NOT COMPLETED|Overall Study||30
161637|NCT01017874|388794|P2|COMPLETED|Overall Study||92
161638|NCT01017874|388795|P1|COMPLETED|Overall Study||88
161639|NCT01017874|388794|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
161640|NCT01017874|388795|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
161641|NCT01017874|388794|P2|STARTED|Overall Study||118
161642|NCT01017874|388795|P1|STARTED|Overall Study||118
161643|NCT01017731|388813|P1|NOT COMPLETED|Overall Study||8
161644|NCT01017731|388813|P1|COMPLETED|Overall Study||60
161645|NCT01017731|388813|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
161646|NCT01017731|388813|P1|STARTED|Overall Study||68
161647|NCT01017653|388830|P1|NOT COMPLETED|Overall Study||0
161648|NCT01017653|388830|P1|COMPLETED|Overall Study||16
161649|NCT01017653|388830|P1|STARTED|Overall Study||16
161650|NCT01017601|388842|P2|NOT COMPLETED|Overall Study||13
161651|NCT01017601|388843|P1|NOT COMPLETED|Overall Study||12
161652|NCT01017601|388842|P2|COMPLETED|Overall Study||11
161653|NCT01017601|388843|P1|COMPLETED|Overall Study||14
161654|NCT01017601|388842|P2|STARTED|Overall Study||24
161655|NCT01017601|388843|P1|STARTED|Overall Study||26
161656|NCT01017575|388870|P5|NOT COMPLETED|Overall Study||3
161657|NCT01017575|388871|P4|NOT COMPLETED|Overall Study||1
161658|NCT01017575|388872|P3|NOT COMPLETED|Overall Study||0
161659|NCT01017575|388873|P2|NOT COMPLETED|Overall Study||2
161660|NCT01017575|388874|P1|NOT COMPLETED|Overall Study||1
161661|NCT01017575|388870|P5|COMPLETED|Overall Study||6
161662|NCT01017575|388871|P4|COMPLETED|Overall Study||7
161663|NCT01017575|388872|P3|COMPLETED|Overall Study||8
161664|NCT01017575|388873|P2|COMPLETED|Overall Study||7
161665|NCT01017575|388874|P1|COMPLETED|Overall Study||7
161666|NCT01017575|388870|P5|STARTED|Overall Study||9
161667|NCT01017575|388871|P4|STARTED|Overall Study||8
161668|NCT01017575|388872|P3|STARTED|Overall Study||8
161669|NCT01017575|388873|P2|STARTED|Overall Study||9
161670|NCT01017575|388874|P1|STARTED|Overall Study||8
161671|NCT01017549|388911|P1|NOT COMPLETED|One-year Follow-up||7
161672|NCT01017549|388911|P1|COMPLETED|One-year Follow-up||36
161673|NCT01017549|388911|P1|STARTED|One-year Follow-up||43
161674|NCT01017549|388911|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
161675|NCT01017549|388911|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
161676|NCT01017549|388911|P1|STARTED|Eligibility Through 6 Month Follow-up||44
161677|NCT01017536|388918|P2|NOT COMPLETED|Overall Study||0
161678|NCT01017536|388919|P1|NOT COMPLETED|Overall Study||0
161679|NCT01017536|388918|P2|COMPLETED|Overall Study||13
161680|NCT01017536|388919|P1|COMPLETED|Overall Study||13
161681|NCT01017536|388918|P2|STARTED|Overall Study||13
161682|NCT01017536|388919|P1|STARTED|Overall Study||13
161683|NCT01017497|388929|P1|NOT COMPLETED|Overall Study||0
161684|NCT01017497|388929|P1|COMPLETED|Overall Study||49
161685|NCT01017497|388929|P1|STARTED|Overall Study||49
161686|NCT01017263|388942|P1|NOT COMPLETED|Overall Study||12
161687|NCT01017263|388942|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
161688|NCT01017263|388942|P1|STARTED|Overall Study||14
161689|NCT01017250|388946|P1|NOT COMPLETED|Overall Study||0
161690|NCT01017250|388946|P1|COMPLETED|Overall Study||15
161691|NCT01017250|388946|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
161692|NCT01017250|388946|P1|STARTED|Overall Study||15
161693|NCT01017237|388968|P2|NOT COMPLETED|Overall Study||2
161694|NCT01017237|388969|P1|NOT COMPLETED|Overall Study||5
161696|NCT01017237|388969|P1|COMPLETED|Overall Study||5
161697|NCT01017237|388968|P2|STARTED|Overall Study||8
161698|NCT01017237|388969|P1|STARTED|Overall Study||10
161699|NCT01017146|389023|P2|NOT COMPLETED|Overall Study||39
161700|NCT01017146|389024|P1|NOT COMPLETED|Overall Study||66
161701|NCT01017146|389023|P2|COMPLETED|Overall Study||333
161702|NCT01017146|389024|P1|COMPLETED|Overall Study||306
161703|NCT01017146|389023|P2|STARTED|Overall Study||372
161704|NCT01017146|389024|P1|STARTED|Overall Study||372
161705|NCT01017120|389062|P2|NOT COMPLETED|Overall Study||35
161706|NCT01017120|389063|P1|NOT COMPLETED|Overall Study||66
161707|NCT01017120|389062|P2|COMPLETED|Overall Study||334
161708|NCT01017120|389063|P1|COMPLETED|Overall Study||307
161709|NCT01017120|389062|P2|STARTED|Overall Study||369
161710|NCT01017120|389063|P1|STARTED|Overall Study||373
161711|NCT01017042|389111|P1|NOT COMPLETED|Overall Study||0
161712|NCT01017042|389111|P1|COMPLETED|Overall Study||13
161713|NCT01017042|389111|P1|STARTED|Overall Study||13
161714|NCT01017029|389124|P2|NOT COMPLETED|Overall Study||2
161715|NCT01017029|389125|P1|NOT COMPLETED|Overall Study||4
161716|NCT01017029|389124|P2|COMPLETED|Overall Study||90
161717|NCT01017029|389125|P1|COMPLETED|Overall Study||85
161718|NCT01017029|389124|P2|STARTED|Overall Study||92
161719|NCT01017029|389125|P1|STARTED|Overall Study||89
161720|NCT01017003|389141|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
161721|NCT01017003|389141|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
161722|NCT01017003|389141|P1|STARTED|Colchicine 0.6 mg Final Dose||13
161723|NCT01017003|389141|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
161724|NCT01017003|389141|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
161725|NCT01017003|389141|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
161726|NCT01017003|389141|P1|NOT COMPLETED|14 Day Washout Period||0
161727|NCT01017003|389141|P1|COMPLETED|14 Day Washout Period||13
161728|NCT01017003|389141|P1|STARTED|14 Day Washout Period||13
161729|NCT01017003|389141|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
161730|NCT01017003|389141|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
161731|NCT01017003|389141|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
161732|NCT01016977|389153|P2|NOT COMPLETED|Overall Study||2
161733|NCT01016977|389154|P1|NOT COMPLETED|Overall Study||3
161734|NCT01016977|389153|P2|COMPLETED|Overall Study||18
161735|NCT01016977|389154|P1|COMPLETED|Overall Study||17
161736|NCT01016977|389153|P2|STARTED|Overall Study||20
161737|NCT01016977|389154|P1|STARTED|Overall Study||20
161738|NCT01016964|389190|P2|NOT COMPLETED|Overall Study||3
161739|NCT01016964|389191|P1|NOT COMPLETED|Overall Study||3
161740|NCT01016964|389190|P2|COMPLETED|Overall Study||39
161741|NCT01016964|389191|P1|COMPLETED|Overall Study||18
161742|NCT01016964|389190|P2|STARTED|Overall Study||42
161743|NCT01016964|389191|P1|STARTED|Overall Study||21
161744|NCT01016938|389197|P1|NOT COMPLETED|Overall Study||9
161745|NCT01016938|389197|P1|COMPLETED|Overall Study||7
161746|NCT01016938|389197|P1|STARTED|Overall Study||16
161747|NCT01016912|389207|P5|NOT COMPLETED|Follow-up Period||0
161748|NCT01016912|389208|P4|NOT COMPLETED|Follow-up Period||1
161749|NCT01016912|389209|P3|NOT COMPLETED|Follow-up Period||1
161750|NCT01016912|389210|P2|NOT COMPLETED|Follow-up Period||0
161751|NCT01016912|389211|P1|NOT COMPLETED|Follow-up Period||0
161752|NCT01016912|389207|P5|COMPLETED|Follow-up Period||9
161753|NCT01016912|389208|P4|COMPLETED|Follow-up Period||8
161754|NCT01016912|389209|P3|COMPLETED|Follow-up Period||9
161755|NCT01016912|389210|P2|COMPLETED|Follow-up Period||9
161756|NCT01016912|389211|P1|COMPLETED|Follow-up Period||8
161757|NCT01016912|389207|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
161758|NCT01016912|389208|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
161759|NCT01016912|389209|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
161760|NCT01016912|389210|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
161761|NCT01016912|389211|P1|STARTED|Follow-up Period||8
161762|NCT01016912|389207|P5|NOT COMPLETED|End of Treatment Period||4
161763|NCT01016912|389208|P4|NOT COMPLETED|End of Treatment Period||4
161764|NCT01016912|389209|P3|NOT COMPLETED|End of Treatment Period||1
161765|NCT01016912|389210|P2|NOT COMPLETED|End of Treatment Period||3
161766|NCT01016912|389211|P1|NOT COMPLETED|End of Treatment Period||0
161767|NCT01016912|389207|P5|COMPLETED|End of Treatment Period||5
161768|NCT01016912|389208|P4|COMPLETED|End of Treatment Period||5
161769|NCT01016912|389209|P3|COMPLETED|End of Treatment Period||9
161770|NCT01016912|389210|P2|COMPLETED|End of Treatment Period||6
161771|NCT01016912|389211|P1|COMPLETED|End of Treatment Period||8
161772|NCT01016912|389207|P5|Received Treatment|End of Treatment Period||9
161773|NCT01016912|389208|P4|Received Treatment|End of Treatment Period||9
161774|NCT01016912|389209|P3|Received Treatment|End of Treatment Period||10
161775|NCT01016912|389210|P2|Received Treatment|End of Treatment Period||9
161776|NCT01016912|389211|P1|Received Treatment|End of Treatment Period||8
161777|NCT01016912|389207|P5|STARTED|End of Treatment Period||9
161778|NCT01016912|389208|P4|STARTED|End of Treatment Period||9
161779|NCT01016912|389209|P3|STARTED|End of Treatment Period||10
161780|NCT01016912|389210|P2|STARTED|End of Treatment Period||9
161781|NCT01016912|389211|P1|STARTED|End of Treatment Period||8
161782|NCT01016873|389256|P3|NOT COMPLETED|36 Months||6
161783|NCT01016873|389257|P2|NOT COMPLETED|36 Months||4
161784|NCT01016873|389258|P1|NOT COMPLETED|36 Months||11
161785|NCT01016873|389256|P3|COMPLETED|36 Months||67
161786|NCT01016873|389257|P2|COMPLETED|36 Months||64
161787|NCT01016873|389258|P1|COMPLETED|36 Months||58
161788|NCT01016873|389256|P3|STARTED|36 Months||73
161789|NCT01016873|389257|P2|STARTED|36 Months||68
161790|NCT01016873|389258|P1|STARTED|36 Months||69
161791|NCT01016873|389256|P3|NOT COMPLETED|24 Months||6
161792|NCT01016873|389257|P2|NOT COMPLETED|24 Months||4
161793|NCT01016873|389258|P1|NOT COMPLETED|24 Months||5
161794|NCT01016873|389256|P3|COMPLETED|24 Months||73
161795|NCT01016873|389257|P2|COMPLETED|24 Months||68
161796|NCT01016873|389258|P1|COMPLETED|24 Months||69
161797|NCT01016873|389256|P3|STARTED|24 Months||79
161798|NCT01016873|389257|P2|STARTED|24 Months||72
161799|NCT01016873|389258|P1|STARTED|24 Months||74
161800|NCT01016873|389256|P3|NOT COMPLETED|12 Months||1
161801|NCT01016873|389257|P2|NOT COMPLETED|12 Months||3
161802|NCT01016873|389258|P1|NOT COMPLETED|12 Months||1
161803|NCT01016873|389256|P3|COMPLETED|12 Months||79
161804|NCT01016873|389257|P2|COMPLETED|12 Months||72
161805|NCT01016873|389258|P1|COMPLETED|12 Months||74
161806|NCT01016873|389256|P3|STARTED|12 Months||80
161807|NCT01016873|389257|P2|STARTED|12 Months||75
161808|NCT01016873|389258|P1|STARTED|12 Months||75
161809|NCT01016847|389289|P2|NOT COMPLETED|Overall Study||0
161810|NCT01016847|389290|P1|NOT COMPLETED|Overall Study||0
161811|NCT01016847|389289|P2|COMPLETED|Overall Study||2
161812|NCT01016847|389290|P1|COMPLETED|Overall Study||1
161813|NCT01016847|389289|P2|STARTED|Overall Study||2
161814|NCT01016847|389290|P1|STARTED|Overall Study||1
161815|NCT01016834|389306|P1|NOT COMPLETED|Overall Study||22
161816|NCT01016834|389306|P1|COMPLETED|Overall Study||220
161817|NCT01016834|389306|P1|STARTED|Overall Study||242
161818|NCT01016691|389315|P3|NOT COMPLETED|Overall Study||0
161819|NCT01016691|389316|P2|NOT COMPLETED|Overall Study||0
161820|NCT01016691|389317|P1|NOT COMPLETED|Overall Study||0
161821|NCT01016691|389315|P3|COMPLETED|Overall Study||18
161822|NCT01016691|389316|P2|COMPLETED|Overall Study||12
161823|NCT01016691|389317|P1|COMPLETED|Overall Study||17
161824|NCT01016691|389315|P3|STARTED|Overall Study||18
161825|NCT01016691|389316|P2|STARTED|Overall Study||12
161826|NCT01016691|389317|P1|STARTED|Overall Study||17
161827|NCT01016678|389325|P5|NOT COMPLETED|Overall Study||6
161828|NCT01016678|389326|P4|NOT COMPLETED|Overall Study||0
161829|NCT01016678|389327|P3|NOT COMPLETED|Overall Study||4
161830|NCT01016678|389328|P2|NOT COMPLETED|Overall Study||3
161831|NCT01016678|389329|P1|NOT COMPLETED|Overall Study||2
161832|NCT01016678|389325|P5|COMPLETED|Overall Study||13
161833|NCT01016678|389326|P4|COMPLETED|Overall Study||19
161834|NCT01016678|389327|P3|COMPLETED|Overall Study||15
161835|NCT01016678|389328|P2|COMPLETED|Overall Study||14
161836|NCT01016678|389329|P1|COMPLETED|Overall Study||18
161837|NCT01016678|389325|P5|STARTED|Overall Study||19
161838|NCT01016678|389326|P4|STARTED|Overall Study||19
161839|NCT01016678|389327|P3|STARTED|Overall Study||19
161840|NCT01016678|389328|P2|STARTED|Overall Study||17
161841|NCT01016678|389329|P1|STARTED|Overall Study||20
161842|NCT01016652|389351|P2|NOT COMPLETED|Period 2||0
161843|NCT01016652|389352|P1|NOT COMPLETED|Period 2||0
161844|NCT01016652|389351|P2|COMPLETED|Period 2||24
161845|NCT01016652|389352|P1|COMPLETED|Period 2||25
161846|NCT01016652|389351|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
161847|NCT01016652|389352|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
161848|NCT01016652|389351|P2|NOT COMPLETED|Period 1||0
161849|NCT01016652|389352|P1|NOT COMPLETED|Period 1||0
161850|NCT01016652|389351|P2|COMPLETED|Period 1||24
161851|NCT01016652|389352|P1|COMPLETED|Period 1||25
161852|NCT01016652|389351|P2|STARTED|Period 1||24
161853|NCT01016652|389352|P1|STARTED|Period 1||25
161854|NCT01016600|389372|P4|NOT COMPLETED|Overall Study||0
161855|NCT01016600|389373|P3|NOT COMPLETED|Overall Study||0
161856|NCT01016600|389374|P2|NOT COMPLETED|Overall Study||0
161857|NCT01016600|389375|P1|NOT COMPLETED|Overall Study||1
161858|NCT01016600|389372|P4|COMPLETED|Overall Study||12
161859|NCT01016600|389373|P3|COMPLETED|Overall Study||6
161860|NCT01016600|389374|P2|COMPLETED|Overall Study||4
161861|NCT01016600|389375|P1|COMPLETED|Overall Study||8
161862|NCT01016600|389372|P4|STARTED|Overall Study||12
161863|NCT01016600|389373|P3|STARTED|Overall Study||6
161864|NCT01016600|389374|P2|STARTED|Overall Study||4
161865|NCT01016600|389375|P1|STARTED|Overall Study||9
161866|NCT01016483|389442|P4|NOT COMPLETED|Phase II||0
161867|NCT01016483|389443|P3|NOT COMPLETED|Phase II||0
161868|NCT01016483|389444|P2|NOT COMPLETED|Phase II||0
161869|NCT01016483|389445|P1|NOT COMPLETED|Phase II||0
161870|NCT01016483|389442|P4|COMPLETED|Phase II||44
161871|NCT01016483|389443|P3|COMPLETED|Phase II||44
161872|NCT01016483|389444|P2|COMPLETED|Phase II||0
161873|NCT01016483|389445|P1|COMPLETED|Phase II||0
161874|NCT01016483|389442|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
161875|NCT01016483|389443|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
161876|NCT01016483|389444|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
161972|NCT01015677|389677|P3|STARTED|Overall Study||33
161877|NCT01016483|389445|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
161878|NCT01016483|389442|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
161879|NCT01016483|389443|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
161880|NCT01016483|389444|P2|STARTED|Phase II||0
161881|NCT01016483|389445|P1|STARTED|Phase II||0
161882|NCT01016483|389442|P4|NOT COMPLETED|Safety Run-in Part||0
161883|NCT01016483|389443|P3|NOT COMPLETED|Safety Run-in Part||0
161884|NCT01016483|389444|P2|NOT COMPLETED|Safety Run-in Part||0
161885|NCT01016483|389445|P1|NOT COMPLETED|Safety Run-in Part||0
161886|NCT01016483|389442|P4|COMPLETED|Safety Run-in Part||0
161887|NCT01016483|389443|P3|COMPLETED|Safety Run-in Part||0
161888|NCT01016483|389444|P2|COMPLETED|Safety Run-in Part||26
161889|NCT01016483|389445|P1|COMPLETED|Safety Run-in Part||27
161890|NCT01016483|389442|P4|STARTED|Safety Run-in Part||0
161891|NCT01016483|389443|P3|STARTED|Safety Run-in Part||0
161892|NCT01016483|389444|P2|STARTED|Safety Run-in Part||26
161893|NCT01016483|389445|P1|STARTED|Safety Run-in Part||27
161894|NCT01016353|389553|P2|NOT COMPLETED|Overall Study||1
161895|NCT01016353|389554|P1|NOT COMPLETED|Overall Study||2
161896|NCT01016353|389553|P2|COMPLETED|Overall Study||102
161897|NCT01016353|389554|P1|COMPLETED|Overall Study||178
161898|NCT01016353|389553|P2|STARTED|Overall Study||103
161899|NCT01016353|389554|P1|STARTED|Overall Study||180
161900|NCT01016132|389560|P1|NOT COMPLETED|Overall Study||1
161901|NCT01016132|389560|P1|COMPLETED|Overall Study||151
161902|NCT01016132|389560|P1|STARTED|Overall Study||152
161903|NCT01016106|389566|P2|NOT COMPLETED|Overall Study||0
161904|NCT01016106|389567|P1|NOT COMPLETED|Overall Study||0
161905|NCT01016106|389566|P2|COMPLETED|Overall Study||18
161906|NCT01016106|389567|P1|COMPLETED|Overall Study||17
161907|NCT01016106|389566|P2|STARTED|Overall Study||18
161908|NCT01016106|389567|P1|STARTED|Overall Study||17
161909|NCT01016067|389575|P2|NOT COMPLETED|Overall Study||4
161910|NCT01016067|389576|P1|NOT COMPLETED|Overall Study||2
161911|NCT01016067|389575|P2|COMPLETED|Overall Study||8
161912|NCT01016067|389576|P1|COMPLETED|Overall Study||9
161913|NCT01016067|389575|P2|STARTED|Overall Study||12
161914|NCT01016067|389576|P1|STARTED|Overall Study||11
161915|NCT01016015|389594|P1|NOT COMPLETED|Overall Study||19
161916|NCT01016015|389594|P1|COMPLETED|Overall Study||159
161917|NCT01016015|389594|P1|STARTED|Overall Study||178
161918|NCT01015976|389598|P2|NOT COMPLETED|Overall Study||0
161919|NCT01015976|389599|P1|NOT COMPLETED|Overall Study||0
161920|NCT01015976|389598|P2|COMPLETED|Overall Study||5
161921|NCT01015976|389599|P1|COMPLETED|Overall Study||5
161922|NCT01015976|389598|P2|STARTED|Overall Study||5
161923|NCT01015976|389599|P1|STARTED|Overall Study||5
161924|NCT01015833|389605|P2|NOT COMPLETED|Overall Study||5
161925|NCT01015833|389606|P1|NOT COMPLETED|Overall Study||13
161926|NCT01015833|389605|P2|COMPLETED|Overall Study||171
161927|NCT01015833|389606|P1|COMPLETED|Overall Study||167
161928|NCT01015833|389605|P2|STARTED|Overall Study||176
161929|NCT01015833|389606|P1|STARTED|Overall Study||180
161930|NCT01015820|389622|P2|NOT COMPLETED|Overall Study||0
161931|NCT01015820|389623|P1|NOT COMPLETED|Overall Study||1
161932|NCT01015820|389622|P2|COMPLETED|Overall Study||15
161933|NCT01015820|389623|P1|COMPLETED|Overall Study||14
161934|NCT01015820|389622|P2|STARTED|Overall Study||15
161935|NCT01015820|389623|P1|STARTED|Overall Study||15
161936|NCT01015807|389634|P3|NOT COMPLETED|Overall Study||0
161937|NCT01015807|389635|P2|NOT COMPLETED|Overall Study||0
161938|NCT01015807|389636|P1|NOT COMPLETED|Overall Study||0
161939|NCT01015807|389634|P3|COMPLETED|Overall Study||30
161940|NCT01015807|389635|P2|COMPLETED|Overall Study||30
161941|NCT01015807|389636|P1|COMPLETED|Overall Study||30
161942|NCT01015807|389634|P3|STARTED|Overall Study||30
161943|NCT01015807|389635|P2|STARTED|Overall Study||30
161944|NCT01015807|389636|P1|STARTED|Overall Study||30
161945|NCT01015781|389646|P2|NOT COMPLETED|Overall Study||29
161946|NCT01015781|389647|P1|NOT COMPLETED|Overall Study||37
161947|NCT01015781|389646|P2|COMPLETED|Overall Study||121
161948|NCT01015781|389647|P1|COMPLETED|Overall Study||113
161949|NCT01015781|389646|P2|STARTED|Overall Study||150
161950|NCT01015781|389647|P1|STARTED|Overall Study||150
161951|NCT01015703|389658|P5|NOT COMPLETED|Overall Study||0
161952|NCT01015703|389659|P4|NOT COMPLETED|Overall Study||0
161953|NCT01015703|389660|P3|NOT COMPLETED|Overall Study||0
161954|NCT01015703|389661|P2|NOT COMPLETED|Overall Study||1
161955|NCT01015703|389662|P1|NOT COMPLETED|Overall Study||2
161956|NCT01015703|389658|P5|COMPLETED|Overall Study||10
161957|NCT01015703|389659|P4|COMPLETED|Overall Study||10
161958|NCT01015703|389660|P3|COMPLETED|Overall Study||10
161959|NCT01015703|389661|P2|COMPLETED|Overall Study||9
161960|NCT01015703|389662|P1|COMPLETED|Overall Study||8
161961|NCT01015703|389658|P5|STARTED|Overall Study||10
161962|NCT01015703|389659|P4|STARTED|Overall Study||10
161963|NCT01015703|389660|P3|STARTED|Overall Study||10
161964|NCT01015703|389661|P2|STARTED|Overall Study||10
161965|NCT01015703|389662|P1|STARTED|Overall Study||10
161966|NCT01015677|389677|P3|NOT COMPLETED|Overall Study||0
161967|NCT01015677|389678|P2|NOT COMPLETED|Overall Study||4
161968|NCT01015677|389679|P1|NOT COMPLETED|Overall Study||1
161969|NCT01015677|389677|P3|COMPLETED|Overall Study||33
161970|NCT01015677|389678|P2|COMPLETED|Overall Study||28
161971|NCT01015677|389679|P1|COMPLETED|Overall Study||33
161973|NCT01015677|389678|P2|STARTED|Overall Study||32
161974|NCT01015677|389679|P1|STARTED|Overall Study||34
161975|NCT01015638|389701|P2|NOT COMPLETED|Overall Study||0
161976|NCT01015638|389702|P1|NOT COMPLETED|Overall Study||1
161977|NCT01015638|389701|P2|COMPLETED|Overall Study||19
161978|NCT01015638|389702|P1|COMPLETED|Overall Study||16
161979|NCT01015638|389701|P2|STARTED|Overall Study||19
161980|NCT01015638|389702|P1|STARTED|Overall Study||17
161981|NCT01015560|389730|P1|NOT COMPLETED|Overall Study||3
161982|NCT01015560|389730|P1|COMPLETED|Overall Study||41
161983|NCT01015560|389730|P1|Eligible and Analyzable|Overall Study||43
161984|NCT01015560|389730|P1|STARTED|Overall Study||44
161985|NCT01015534|389736|P2|NOT COMPLETED|Overall Study||0
161986|NCT01015534|389737|P1|NOT COMPLETED|Overall Study||1
161987|NCT01015534|389736|P2|COMPLETED|Overall Study||27
161988|NCT01015534|389737|P1|COMPLETED|Overall Study||27
161989|NCT01015534|389736|P2|STARTED|Overall Study||27
161990|NCT01015534|389737|P1|STARTED|Overall Study||28
161991|NCT01015443|389751|P2|NOT COMPLETED|Overall Study||0
161992|NCT01015443|389752|P1|NOT COMPLETED|Overall Study||0
161993|NCT01015443|389751|P2|COMPLETED|Overall Study||94
161994|NCT01015443|389752|P1|COMPLETED|Overall Study||191
161995|NCT01015443|389751|P2|Treated|Overall Study||93
161996|NCT01015443|389752|P1|Treated|Overall Study||191
161997|NCT01015443|389751|P2|STARTED|Overall Study||94
161998|NCT01015443|389752|P1|STARTED|Overall Study||191
161999|NCT01015326|389770|P2|NOT COMPLETED|Overall Study||2
162000|NCT01015326|389771|P1|NOT COMPLETED|Overall Study||1
162001|NCT01015326|389770|P2|COMPLETED|Overall Study||18
162002|NCT01015326|389771|P1|COMPLETED|Overall Study||11
162003|NCT01015326|389770|P2|STARTED|Overall Study||20
162004|NCT01015326|389771|P1|STARTED|Overall Study||12
162005|NCT01015287|389779|P2|NOT COMPLETED|Overall Study||79
162006|NCT01015287|389780|P1|NOT COMPLETED|Overall Study||72
162007|NCT01015287|389779|P2|COMPLETED|Overall Study||1958
162008|NCT01015287|389780|P1|COMPLETED|Overall Study||1924
162009|NCT01015287|389779|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
162010|NCT01015287|389780|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
162011|NCT01015287|389779|P2|STARTED|Overall Study||2037
162012|NCT01015287|389780|P1|STARTED|Overall Study||1996
162013|NCT01015170|389806|P1|NOT COMPLETED|Overall Study||239
162014|NCT01015170|389806|P1|COMPLETED|Overall Study||215
162015|NCT01015170|389806|P1|STARTED|Overall Study||454
162016|NCT01015131|389812|P1|NOT COMPLETED|Overall Study||8
162017|NCT01015131|389812|P1|COMPLETED|Overall Study||36
162018|NCT01015131|389812|P1|STARTED|Overall Study||44
162019|NCT01015118|389828|P2|NOT COMPLETED|Overall Study||327
162020|NCT01015118|389829|P1|NOT COMPLETED|Overall Study||669
162021|NCT01015118|389828|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
162022|NCT01015118|389829|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
162023|NCT01015118|389828|P2|STARTED|Overall Study||455
162024|NCT01015118|389829|P1|STARTED|Overall Study||911
162025|NCT01014988|389857|P6|NOT COMPLETED|Overall Study||3
162026|NCT01014988|389858|P5|NOT COMPLETED|Overall Study||1
162027|NCT01014988|389859|P4|NOT COMPLETED|Overall Study||0
162028|NCT01014988|389860|P3|NOT COMPLETED|Overall Study||2
162029|NCT01014988|389861|P2|NOT COMPLETED|Overall Study||0
162030|NCT01014988|389862|P1|NOT COMPLETED|Overall Study||23
162031|NCT01014988|389857|P6|COMPLETED|Overall Study||11
162032|NCT01014988|389858|P5|COMPLETED|Overall Study||26
162033|NCT01014988|389859|P4|COMPLETED|Overall Study||12
162034|NCT01014988|389860|P3|COMPLETED|Overall Study||9
162035|NCT01014988|389861|P2|COMPLETED|Overall Study||7
162036|NCT01014988|389862|P1|COMPLETED|Overall Study||107
162037|NCT01014988|389857|P6|STARTED|Overall Study||14
162038|NCT01014988|389858|P5|STARTED|Overall Study||27
162039|NCT01014988|389859|P4|STARTED|Overall Study||12
162040|NCT01014988|389860|P3|STARTED|Overall Study||11
162041|NCT01014988|389861|P2|STARTED|Overall Study||7
162042|NCT01014988|389862|P1|STARTED|Overall Study||130
162043|NCT01014975|390034|P3|NOT COMPLETED|Overall Study||6
162044|NCT01014975|390035|P2|NOT COMPLETED|Overall Study||3
162045|NCT01014975|390036|P1|NOT COMPLETED|Overall Study||4
162046|NCT01014975|390034|P3|COMPLETED|Overall Study||10
162047|NCT01014975|390035|P2|COMPLETED|Overall Study||13
162048|NCT01014975|390036|P1|COMPLETED|Overall Study||4
162049|NCT01014975|390034|P3|STARTED|Overall Study||16
162050|NCT01014975|390035|P2|STARTED|Overall Study||16
162051|NCT01014975|390036|P1|STARTED|Overall Study||8
162052|NCT01014936|390047|P3|NOT COMPLETED|Overall Study||0
162053|NCT01014936|390048|P2|NOT COMPLETED|Overall Study||0
162054|NCT01014936|390049|P1|NOT COMPLETED|Overall Study||0
162055|NCT01014936|390047|P3|COMPLETED|Overall Study||62
162056|NCT01014936|390048|P2|COMPLETED|Overall Study||45
162057|NCT01014936|390049|P1|COMPLETED|Overall Study||42
162058|NCT01014936|390047|P3|STARTED|Overall Study||62
162059|NCT01014936|390048|P2|STARTED|Overall Study||45
162060|NCT01014936|390049|P1|STARTED|Overall Study||42
162061|NCT01014910|390541|P2|NOT COMPLETED|Overall Study||2
162062|NCT01014910|390542|P1|NOT COMPLETED|Overall Study||0
162063|NCT01014910|390541|P2|COMPLETED|Overall Study||79
162064|NCT01014910|390542|P1|COMPLETED|Overall Study||80
162065|NCT01014910|390541|P2|STARTED|Overall Study||81
162066|NCT01014910|390542|P1|STARTED|Overall Study||80
162067|NCT01014871|390550|P1|NOT COMPLETED|Overall Study||0
162068|NCT01014871|390550|P1|COMPLETED|Overall Study||30
162069|NCT01014871|390550|P1|STARTED|Overall Study||30
162070|NCT01014741|390558|P2|NOT COMPLETED|Overall Study||5
162071|NCT01014741|390559|P1|NOT COMPLETED|Overall Study||11
162072|NCT01014741|390558|P2|COMPLETED|Overall Study||90
162073|NCT01014741|390559|P1|COMPLETED|Overall Study||94
162074|NCT01014741|390558|P2|STARTED|Overall Study||95
162075|NCT01014741|390559|P1|STARTED|Overall Study||105
162076|NCT01014728|390573|P2|NOT COMPLETED|Overall Study||0
162077|NCT01014728|390574|P1|NOT COMPLETED|Overall Study||0
162078|NCT01014728|390573|P2|COMPLETED|Overall Study||15
162079|NCT01014728|390574|P1|COMPLETED|Overall Study||18
162080|NCT01014728|390573|P2|STARTED|Overall Study||15
162081|NCT01014728|390574|P1|STARTED|Overall Study||18
162082|NCT01014689|390586|P2|NOT COMPLETED|Overall Study||13
162083|NCT01014689|390587|P1|NOT COMPLETED|Overall Study||13
162084|NCT01014689|390586|P2|COMPLETED|Overall Study||174
162085|NCT01014689|390587|P1|COMPLETED|Overall Study||178
162086|NCT01014689|390586|P2|STARTED|Overall Study||187
162087|NCT01014689|390587|P1|STARTED|Overall Study||191
162088|NCT01014624|390597|P2|NOT COMPLETED|Overall Study||1
162089|NCT01014624|390598|P1|NOT COMPLETED|Overall Study||2
162090|NCT01014624|390597|P2|COMPLETED|Overall Study||26
162091|NCT01014624|390598|P1|COMPLETED|Overall Study||27
162092|NCT01014624|390597|P2|STARTED|Overall Study||27
162093|NCT01014624|390598|P1|STARTED|Overall Study||29
162094|NCT01014585|390622|P4|NOT COMPLETED|Overall Study||30
162095|NCT01014585|390623|P3|NOT COMPLETED|Overall Study||23
162096|NCT01014585|390624|P2|NOT COMPLETED|Overall Study||25
162097|NCT01014585|390625|P1|NOT COMPLETED|Overall Study||20
162098|NCT01014585|390622|P4|COMPLETED|Overall Study||99
162099|NCT01014585|390623|P3|COMPLETED|Overall Study||37
162100|NCT01014585|390624|P2|COMPLETED|Overall Study||75
162101|NCT01014585|390625|P1|COMPLETED|Overall Study||31
162102|NCT01014585|390622|P4|STARTED|Overall Study||129
162103|NCT01014585|390623|P3|STARTED|Overall Study||60
162104|NCT01014585|390624|P2|STARTED|Overall Study||100
162105|NCT01014585|390625|P1|STARTED|Overall Study||51
162106|NCT01014533|390645|P2|NOT COMPLETED|Overall Study||5
162107|NCT01014533|390646|P1|NOT COMPLETED|Overall Study||5
162108|NCT01014533|390645|P2|COMPLETED|Overall Study||25
162109|NCT01014533|390646|P1|COMPLETED|Overall Study||24
162110|NCT01014533|390645|P2|STARTED|Overall Study||30
162111|NCT01014533|390646|P1|STARTED|Overall Study||29
162112|NCT01014455|390658|P2|NOT COMPLETED|Overall Study||0
162113|NCT01014455|390659|P1|NOT COMPLETED|Overall Study||0
162114|NCT01014455|390658|P2|COMPLETED|Overall Study||87
162115|NCT01014455|390659|P1|COMPLETED|Overall Study||82
162116|NCT01014455|390658|P2|STARTED|Overall Study||87
162117|NCT01014455|390659|P1|STARTED|Overall Study||82
162118|NCT01014442|390667|P2|NOT COMPLETED|Overall Study||19
162119|NCT01014442|390668|P1|NOT COMPLETED|Overall Study||7
162120|NCT01014442|390667|P2|COMPLETED|Overall Study||16
162121|NCT01014442|390668|P1|COMPLETED|Overall Study||26
162122|NCT01014442|390667|P2|STARTED|Overall Study||35
162123|NCT01014442|390668|P1|STARTED|Overall Study||33
162124|NCT01014351|390780|P1|NOT COMPLETED|Overall Study||37
162125|NCT01014351|390780|P1|COMPLETED|Overall Study||33
162126|NCT01014351|390780|P1|STARTED|Overall Study||70
162127|NCT01014208|390788|P2|NOT COMPLETED|Overall Study||100
162128|NCT01014208|390789|P1|NOT COMPLETED|Overall Study||94
162129|NCT01014208|390788|P2|COMPLETED|Overall Study||122
162130|NCT01014208|390789|P1|COMPLETED|Overall Study||131
162131|NCT01014208|390788|P2|Intent-to-Treat Population|Overall Study||222
162132|NCT01014208|390789|P1|Intent-to-Treat Population|Overall Study||223
162133|NCT01014208|390788|P2|STARTED|Overall Study||222
162134|NCT01014208|390789|P1|STARTED|Overall Study||225
162135|NCT01014169|390817|P2|NOT COMPLETED|Overall Study||13
162136|NCT01014169|390818|P1|NOT COMPLETED|Overall Study||7
162137|NCT01014169|390817|P2|COMPLETED|Overall Study||48
162138|NCT01014169|390818|P1|COMPLETED|Overall Study||58
162139|NCT01014169|390817|P2|STARTED|Overall Study||61
162140|NCT01014169|390818|P1|STARTED|Overall Study||65
162141|NCT01014143|390831|P3|NOT COMPLETED|Third Intervention||0
162142|NCT01014143|390832|P2|NOT COMPLETED|Third Intervention||0
162143|NCT01014143|390833|P1|NOT COMPLETED|Third Intervention||0
162144|NCT01014143|390831|P3|COMPLETED|Third Intervention||9
162145|NCT01014143|390832|P2|COMPLETED|Third Intervention||9
162146|NCT01014143|390833|P1|COMPLETED|Third Intervention||8
162147|NCT01014143|390831|P3|STARTED|Third Intervention||9
162148|NCT01014143|390832|P2|STARTED|Third Intervention||9
162149|NCT01014143|390833|P1|STARTED|Third Intervention||8
162150|NCT01014143|390831|P3|NOT COMPLETED|Washout After 2nd Intervention||0
162151|NCT01014143|390832|P2|NOT COMPLETED|Washout After 2nd Intervention||0
162152|NCT01014143|390833|P1|NOT COMPLETED|Washout After 2nd Intervention||0
162153|NCT01014143|390831|P3|COMPLETED|Washout After 2nd Intervention||9
162154|NCT01014143|390832|P2|COMPLETED|Washout After 2nd Intervention||9
162155|NCT01014143|390833|P1|COMPLETED|Washout After 2nd Intervention||8
162156|NCT01014143|390831|P3|STARTED|Washout After 2nd Intervention||9
162157|NCT01014143|390832|P2|STARTED|Washout After 2nd Intervention||9
162158|NCT01014143|390833|P1|STARTED|Washout After 2nd Intervention||8
162159|NCT01014143|390831|P3|NOT COMPLETED|Second Intervention||0
162160|NCT01014143|390832|P2|NOT COMPLETED|Second Intervention||0
162161|NCT01014143|390833|P1|NOT COMPLETED|Second Intervention||2
162162|NCT01014143|390831|P3|COMPLETED|Second Intervention||9
162163|NCT01014143|390832|P2|COMPLETED|Second Intervention||9
162164|NCT01014143|390833|P1|COMPLETED|Second Intervention||8
162165|NCT01014143|390831|P3|STARTED|Second Intervention||9
162166|NCT01014143|390832|P2|STARTED|Second Intervention||9
162167|NCT01014143|390833|P1|STARTED|Second Intervention||10
162168|NCT01014143|390831|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
162169|NCT01014143|390832|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
162170|NCT01014143|390833|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
162171|NCT01014143|390831|P3|COMPLETED|Washout Period After 1st Intervention||9
162172|NCT01014143|390832|P2|COMPLETED|Washout Period After 1st Intervention||9
162173|NCT01014143|390833|P1|COMPLETED|Washout Period After 1st Intervention||10
162174|NCT01014143|390831|P3|STARTED|Washout Period After 1st Intervention||9
162175|NCT01014143|390832|P2|STARTED|Washout Period After 1st Intervention||9
162176|NCT01014143|390833|P1|STARTED|Washout Period After 1st Intervention||10
162177|NCT01014143|390831|P3|NOT COMPLETED|First Intervention||0
162178|NCT01014143|390832|P2|NOT COMPLETED|First Intervention||0
162179|NCT01014143|390833|P1|NOT COMPLETED|First Intervention||0
162180|NCT01014143|390831|P3|COMPLETED|First Intervention||9
162181|NCT01014143|390832|P2|COMPLETED|First Intervention||9
162182|NCT01014143|390833|P1|COMPLETED|First Intervention||10
162183|NCT01014143|390831|P3|STARTED|First Intervention||9
162184|NCT01014143|390832|P2|STARTED|First Intervention||9
162185|NCT01014143|390833|P1|STARTED|First Intervention||10
162186|NCT01014091|390847|P6|NOT COMPLETED|Overall Study||0
162187|NCT01014091|390848|P5|NOT COMPLETED|Overall Study||0
162188|NCT01014091|390849|P4|NOT COMPLETED|Overall Study||0
162189|NCT01014091|390850|P3|NOT COMPLETED|Overall Study||0
162190|NCT01014091|390851|P2|NOT COMPLETED|Overall Study||0
162191|NCT01014091|390852|P1|NOT COMPLETED|Overall Study||0
162192|NCT01014091|390847|P6|COMPLETED|Overall Study||12
162193|NCT01014091|390848|P5|COMPLETED|Overall Study||6
162194|NCT01014091|390849|P4|COMPLETED|Overall Study||15
162195|NCT01014091|390850|P3|COMPLETED|Overall Study||5
162196|NCT01014091|390851|P2|COMPLETED|Overall Study||13
162197|NCT01014091|390852|P1|COMPLETED|Overall Study||7
162198|NCT01014091|390847|P6|STARTED|Overall Study||12
162199|NCT01014091|390848|P5|STARTED|Overall Study||6
162200|NCT01014091|390849|P4|STARTED|Overall Study||15
162201|NCT01014091|390850|P3|STARTED|Overall Study||5
162202|NCT01014091|390851|P2|STARTED|Overall Study||13
162203|NCT01014091|390852|P1|STARTED|Overall Study||7
162204|NCT01014013|390928|P2|NOT COMPLETED|Overall Study||56
162205|NCT01014013|390929|P1|NOT COMPLETED|Overall Study||51
162206|NCT01014013|390928|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
162207|NCT01014013|390929|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
162208|NCT01014013|390928|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
162209|NCT01014013|390929|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
162210|NCT01014013|390928|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
162211|NCT01014013|390929|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
162212|NCT01014013|390928|P2|STARTED|Overall Study||136
162213|NCT01014013|390929|P1|STARTED|Overall Study||135
162214|NCT01013961|390941|P2|NOT COMPLETED|Overall Study||3
162215|NCT01013961|390942|P1|NOT COMPLETED|Overall Study||3
162216|NCT01013961|390941|P2|COMPLETED|Overall Study||12
162217|NCT01013961|390942|P1|COMPLETED|Overall Study||13
162218|NCT01013961|390941|P2|STARTED|Overall Study||15
162219|NCT01013961|390942|P1|STARTED|Overall Study||16
162220|NCT01013883|390960|P2|NOT COMPLETED|Overall Study||2
162221|NCT01013883|390961|P1|NOT COMPLETED|Overall Study||2
162222|NCT01013883|390960|P2|COMPLETED|Overall Study||241
162223|NCT01013883|390961|P1|COMPLETED|Overall Study||268
162224|NCT01013883|390960|P2|STARTED|Overall Study||243
162225|NCT01013883|390961|P1|STARTED|Overall Study||270
162226|NCT01013870|390973|P2|NOT COMPLETED|Overall Study||3
162227|NCT01013870|390974|P1|NOT COMPLETED|Overall Study||1
162228|NCT01013870|390973|P2|COMPLETED|Overall Study||21
162229|NCT01013870|390974|P1|COMPLETED|Overall Study||27
162230|NCT01013870|390973|P2|STARTED|Overall Study||24
162231|NCT01013870|390974|P1|STARTED|Overall Study||28
162232|NCT01013844|390998|P2|NOT COMPLETED|Overall Study||0
162233|NCT01013844|390999|P1|NOT COMPLETED|Overall Study||0
162234|NCT01013844|390998|P2|COMPLETED|Overall Study||65
162235|NCT01013844|390999|P1|COMPLETED|Overall Study||65
162236|NCT01013844|390998|P2|STARTED|Overall Study||65
162237|NCT01013844|390999|P1|STARTED|Overall Study||65
162238|NCT01013792|391023|P2|NOT COMPLETED|Overall Study||5
162239|NCT01013792|391024|P1|NOT COMPLETED|Overall Study||2
162240|NCT01013792|391023|P2|COMPLETED|Overall Study||11
162241|NCT01013792|391024|P1|COMPLETED|Overall Study||12
162242|NCT01013792|391023|P2|STARTED|Overall Study||16
162243|NCT01013792|391024|P1|STARTED|Overall Study||14
162244|NCT01013753|391030|P1|NOT COMPLETED|Overall Study||16
162245|NCT01013753|391030|P1|COMPLETED|Overall Study||182
162246|NCT01013753|391030|P1|Received Form 12 mcg Bid|Overall Study||125
162247|NCT01013753|391030|P1|Received Olo 20 mcg qd|Overall Study||124
162248|NCT01013753|391030|P1|Received Olo 10 mcg qd|Overall Study||127
162249|NCT01013753|391030|P1|Received Olo 5 mcg qd|Overall Study||130
162250|NCT01013753|391030|P1|Received Olo 2 mcg qd|Overall Study||121
162251|NCT01013753|391030|P1|Received Placebo|Overall Study||125
162252|NCT01013753|391030|P1|STARTED|Overall Study|Entered and treated|198
162253|NCT01013740|391226|P2|NOT COMPLETED|Overall Study||19
162254|NCT01013740|391227|P1|NOT COMPLETED|Overall Study||11
162255|NCT01013740|391226|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
162256|NCT01013740|391227|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
162257|NCT01013740|391226|P2|Ongoing|Overall Study||0
162258|NCT01013740|391227|P1|Ongoing|Overall Study||0
162259|NCT01013740|391226|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
162260|NCT01013740|391227|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
162261|NCT01013701|391251|P1|NOT COMPLETED|Overall Study||7
162262|NCT01013701|391251|P1|COMPLETED|Overall Study||0
162263|NCT01013701|391251|P1|STARTED|Overall Study||7
162264|NCT01013597|391258|P1|NOT COMPLETED|Overall Study||1
162265|NCT01013597|391258|P1|COMPLETED|Overall Study||12
162266|NCT01013597|391258|P1|STARTED|Overall Study||13
162267|NCT01013207|391268|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
162268|NCT01013207|391268|P1|COMPLETED|CPAP Post Nexus (S9)||44
162269|NCT01013207|391268|P1|STARTED|CPAP Post Nexus (S9)||50
162270|NCT01013207|391268|P1|NOT COMPLETED|Nexus (S9)||0
162271|NCT01013207|391268|P1|COMPLETED|Nexus (S9)||50
162272|NCT01013207|391268|P1|STARTED|Nexus (S9)||50
162273|NCT01013207|391268|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
162274|NCT01013207|391268|P1|COMPLETED|CPAP Pre Nexus (S9)||50
162275|NCT01013207|391268|P1|STARTED|CPAP Pre Nexus (S9)||50
162276|NCT01013194|391275|P2|NOT COMPLETED|Overall Study||0
162277|NCT01013194|391276|P1|NOT COMPLETED|Overall Study||0
162278|NCT01013194|391275|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
162279|NCT01013194|391276|P1|COMPLETED|Overall Study|Consecutive patients|9
162280|NCT01013194|391275|P2|STARTED|Overall Study||16
162281|NCT01013194|391276|P1|STARTED|Overall Study||9
162282|NCT01012999|391286|P1|NOT COMPLETED|Overall Study||1
162283|NCT01012999|391286|P1|COMPLETED|Overall Study||15
162284|NCT01012999|391286|P1|STARTED|Overall Study||16
162285|NCT01012973|391292|P2|NOT COMPLETED|Overall Study||19
162286|NCT01012973|391293|P1|NOT COMPLETED|Overall Study||16
162287|NCT01012973|391292|P2|COMPLETED|Overall Study||52
162288|NCT01012973|391293|P1|COMPLETED|Overall Study||90
162289|NCT01012973|391292|P2|Completed Week 52, From FAS|Overall Study||52
162290|NCT01012973|391293|P1|Completed Week 52, From FAS|Overall Study||91
162291|NCT01012973|391292|P2|Completed Week 24, From FAS|Overall Study||57
162292|NCT01012973|391293|P1|Completed Week 24, From FAS|Overall Study||97
162293|NCT01012973|391292|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
162294|NCT01012973|391293|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
162295|NCT01012973|391292|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
162296|NCT01012973|391293|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
162297|NCT01012973|391292|P2|STARTED|Overall Study||71
162298|NCT01012973|391293|P1|STARTED|Overall Study||106
162299|NCT01012947|391318|P5|NOT COMPLETED|Overall Study||142
162300|NCT01012947|391319|P4|NOT COMPLETED|Overall Study||118
162301|NCT01012947|391320|P3|NOT COMPLETED|Overall Study||130
162302|NCT01012947|391321|P2|NOT COMPLETED|Overall Study||135
162303|NCT01012947|391322|P1|NOT COMPLETED|Overall Study||131
162304|NCT01012947|391318|P5|COMPLETED|Overall Study||94
162305|NCT01012947|391319|P4|COMPLETED|Overall Study||93
162306|NCT01012947|391320|P3|COMPLETED|Overall Study||111
162307|NCT01012947|391321|P2|COMPLETED|Overall Study||80
162308|NCT01012947|391322|P1|COMPLETED|Overall Study||81
162309|NCT01012947|391318|P5|STARTED|Overall Study||236
162310|NCT01012947|391319|P4|STARTED|Overall Study||211
162311|NCT01012947|391320|P3|STARTED|Overall Study||241
162312|NCT01012947|391321|P2|STARTED|Overall Study||215
162313|NCT01012947|391322|P1|STARTED|Overall Study||212
162314|NCT01012921|391336|P2|NOT COMPLETED|Overall Study||13
162315|NCT01012921|391337|P1|NOT COMPLETED|Overall Study||10
162316|NCT01012921|391336|P2|COMPLETED|Overall Study||47
162317|NCT01012921|391337|P1|COMPLETED|Overall Study||47
162318|NCT01012921|391336|P2|STARTED|Overall Study||60
162319|NCT01012921|391337|P1|STARTED|Overall Study||57
162320|NCT01012765|391343|P6|NOT COMPLETED|Treatment Period 3||0
162321|NCT01012765|391344|P5|NOT COMPLETED|Treatment Period 3||0
162322|NCT01012765|391345|P4|NOT COMPLETED|Treatment Period 3||0
162323|NCT01012765|391346|P3|NOT COMPLETED|Treatment Period 3||0
162324|NCT01012765|391347|P2|NOT COMPLETED|Treatment Period 3||0
162325|NCT01012765|391348|P1|NOT COMPLETED|Treatment Period 3||0
162326|NCT01012765|391343|P6|COMPLETED|Treatment Period 3||24
162327|NCT01012765|391344|P5|COMPLETED|Treatment Period 3||18
162328|NCT01012765|391345|P4|COMPLETED|Treatment Period 3||15
162329|NCT01012765|391346|P3|COMPLETED|Treatment Period 3||18
162330|NCT01012765|391347|P2|COMPLETED|Treatment Period 3||19
162331|NCT01012765|391348|P1|COMPLETED|Treatment Period 3||16
162332|NCT01012765|391343|P6|STARTED|Treatment Period 3||24
162333|NCT01012765|391344|P5|STARTED|Treatment Period 3||18
162334|NCT01012765|391345|P4|STARTED|Treatment Period 3||15
162335|NCT01012765|391346|P3|STARTED|Treatment Period 3||18
162336|NCT01012765|391347|P2|STARTED|Treatment Period 3||19
162337|NCT01012765|391348|P1|STARTED|Treatment Period 3||16
162338|NCT01012765|391343|P6|NOT COMPLETED|Treatment Period 2||1
162339|NCT01012765|391344|P5|NOT COMPLETED|Treatment Period 2||1
162340|NCT01012765|391345|P4|NOT COMPLETED|Treatment Period 2||0
162341|NCT01012765|391346|P3|NOT COMPLETED|Treatment Period 2||3
162342|NCT01012765|391347|P2|NOT COMPLETED|Treatment Period 2||2
162343|NCT01012765|391348|P1|NOT COMPLETED|Treatment Period 2||1
162344|NCT01012765|391343|P6|COMPLETED|Treatment Period 2||24
162345|NCT01012765|391344|P5|COMPLETED|Treatment Period 2||18
162346|NCT01012765|391345|P4|COMPLETED|Treatment Period 2||15
162347|NCT01012765|391346|P3|COMPLETED|Treatment Period 2||18
162348|NCT01012765|391347|P2|COMPLETED|Treatment Period 2||19
162349|NCT01012765|391348|P1|COMPLETED|Treatment Period 2||16
162350|NCT01012765|391343|P6|STARTED|Treatment Period 2||25
162351|NCT01012765|391344|P5|STARTED|Treatment Period 2||19
162352|NCT01012765|391345|P4|STARTED|Treatment Period 2||15
162353|NCT01012765|391346|P3|STARTED|Treatment Period 2||21
162354|NCT01012765|391347|P2|STARTED|Treatment Period 2||21
162355|NCT01012765|391348|P1|STARTED|Treatment Period 2||17
162356|NCT01012765|391343|P6|NOT COMPLETED|Treatment Period 1||0
162357|NCT01012765|391344|P5|NOT COMPLETED|Treatment Period 1||3
162358|NCT01012765|391345|P4|NOT COMPLETED|Treatment Period 1||3
162359|NCT01012765|391346|P3|NOT COMPLETED|Treatment Period 1||2
162360|NCT01012765|391347|P2|NOT COMPLETED|Treatment Period 1||0
162361|NCT01012765|391348|P1|NOT COMPLETED|Treatment Period 1||3
162362|NCT01012765|391343|P6|COMPLETED|Treatment Period 1||25
162363|NCT01012765|391344|P5|COMPLETED|Treatment Period 1||19
162364|NCT01012765|391345|P4|COMPLETED|Treatment Period 1||15
162365|NCT01012765|391346|P3|COMPLETED|Treatment Period 1||21
162366|NCT01012765|391347|P2|COMPLETED|Treatment Period 1||21
162367|NCT01012765|391348|P1|COMPLETED|Treatment Period 1||17
162368|NCT01012765|391343|P6|STARTED|Treatment Period 1||25
162369|NCT01012765|391344|P5|STARTED|Treatment Period 1||22
162370|NCT01012765|391345|P4|STARTED|Treatment Period 1||18
162371|NCT01012765|391346|P3|STARTED|Treatment Period 1||23
162372|NCT01012765|391347|P2|STARTED|Treatment Period 1||21
162373|NCT01012765|391348|P1|STARTED|Treatment Period 1||20
162374|NCT01012739|391377|P4|NOT COMPLETED|Treatment Period 4||0
162375|NCT01012739|391378|P3|NOT COMPLETED|Treatment Period 4||0
162376|NCT01012739|391379|P2|NOT COMPLETED|Treatment Period 4||0
162377|NCT01012739|391380|P1|NOT COMPLETED|Treatment Period 4||0
162378|NCT01012739|391377|P4|COMPLETED|Treatment Period 4||7
162379|NCT01012739|391378|P3|COMPLETED|Treatment Period 4||9
162380|NCT01012739|391379|P2|COMPLETED|Treatment Period 4||8
162381|NCT01012739|391380|P1|COMPLETED|Treatment Period 4||9
162382|NCT01012739|391377|P4|STARTED|Treatment Period 4||7
162383|NCT01012739|391378|P3|STARTED|Treatment Period 4||9
162384|NCT01012739|391379|P2|STARTED|Treatment Period 4||8
162385|NCT01012739|391380|P1|STARTED|Treatment Period 4||9
162386|NCT01012739|391377|P4|NOT COMPLETED|Treatment Period 3||0
162387|NCT01012739|391378|P3|NOT COMPLETED|Treatment Period 3||0
162388|NCT01012739|391379|P2|NOT COMPLETED|Treatment Period 3||0
162389|NCT01012739|391380|P1|NOT COMPLETED|Treatment Period 3||0
162390|NCT01012739|391377|P4|COMPLETED|Treatment Period 3||7
162391|NCT01012739|391378|P3|COMPLETED|Treatment Period 3||9
162392|NCT01012739|391379|P2|COMPLETED|Treatment Period 3||8
162393|NCT01012739|391380|P1|COMPLETED|Treatment Period 3||9
162394|NCT01012739|391377|P4|STARTED|Treatment Period 3||7
162395|NCT01012739|391378|P3|STARTED|Treatment Period 3||9
162396|NCT01012739|391379|P2|STARTED|Treatment Period 3||8
162397|NCT01012739|391380|P1|STARTED|Treatment Period 3||9
162398|NCT01012739|391377|P4|NOT COMPLETED|Treatment Period 2||1
162399|NCT01012739|391378|P3|NOT COMPLETED|Treatment Period 2||0
162400|NCT01012739|391379|P2|NOT COMPLETED|Treatment Period 2||0
162401|NCT01012739|391380|P1|NOT COMPLETED|Treatment Period 2||0
162402|NCT01012739|391377|P4|COMPLETED|Treatment Period 2||7
162403|NCT01012739|391378|P3|COMPLETED|Treatment Period 2||9
162404|NCT01012739|391379|P2|COMPLETED|Treatment Period 2||8
162405|NCT01012739|391380|P1|COMPLETED|Treatment Period 2||9
162406|NCT01012739|391377|P4|STARTED|Treatment Period 2||8
162407|NCT01012739|391378|P3|STARTED|Treatment Period 2||9
162408|NCT01012739|391379|P2|STARTED|Treatment Period 2||8
162409|NCT01012739|391380|P1|STARTED|Treatment Period 2||9
162410|NCT01012739|391377|P4|NOT COMPLETED|Treatment Period 1||1
162411|NCT01012739|391378|P3|NOT COMPLETED|Treatment Period 1||0
162412|NCT01012739|391379|P2|NOT COMPLETED|Treatment Period 1||0
162413|NCT01012739|391380|P1|NOT COMPLETED|Treatment Period 1||0
162414|NCT01012739|391377|P4|COMPLETED|Treatment Period 1||8
162415|NCT01012739|391378|P3|COMPLETED|Treatment Period 1||9
162416|NCT01012739|391379|P2|COMPLETED|Treatment Period 1||8
162417|NCT01012739|391380|P1|COMPLETED|Treatment Period 1||9
162418|NCT01012739|391377|P4|STARTED|Treatment Period 1||9
162419|NCT01012739|391378|P3|STARTED|Treatment Period 1||9
162420|NCT01012739|391379|P2|STARTED|Treatment Period 1||8
162421|NCT01012739|391380|P1|STARTED|Treatment Period 1||9
162422|NCT01012713|391408|P1|NOT COMPLETED|Overall Study||3
162423|NCT01012713|391408|P1|COMPLETED|Overall Study||27
162424|NCT01012713|391408|P1|STARTED|Overall Study||30
162425|NCT01012674|391414|P1|NOT COMPLETED|Overall Study||24
162426|NCT01012674|391414|P1|COMPLETED|Overall Study||187
162427|NCT01012674|391414|P1|STARTED|Overall Study||211
162428|NCT01012661|391426|P1|NOT COMPLETED|Overall Study||0
162429|NCT01012661|391426|P1|COMPLETED|Overall Study||50
162430|NCT01012661|391426|P1|STARTED|Overall Study||50
162431|NCT01012622|391434|P1|NOT COMPLETED|Overall Study||31
162432|NCT01012622|391434|P1|COMPLETED|Overall Study||111
162433|NCT01012622|391434|P1|STARTED|Overall Study||142
162434|NCT01012492|391453|P1|NOT COMPLETED|Overall Study||0
162435|NCT01012492|391453|P1|COMPLETED|Overall Study||10
162436|NCT01012492|391453|P1|STARTED|Overall Study||10
162437|NCT01012440|391458|P1|NOT COMPLETED|Overall Study||2
162438|NCT01012440|391458|P1|COMPLETED|Overall Study||3
162439|NCT01012440|391458|P1|STARTED|Overall Study||5
162440|NCT01012414|391462|P1|NOT COMPLETED|Overall Study||10
162441|NCT01012414|391462|P1|COMPLETED|Overall Study|No subjects completed the study.|0
162442|NCT01012414|391462|P1|STARTED|Overall Study||10
162443|NCT01012388|391469|P1|NOT COMPLETED|Overall Study||0
162444|NCT01012388|391469|P1|COMPLETED|Overall Study||100
162445|NCT01012388|391469|P1|STARTED|Overall Study||100
162446|NCT01012362|391479|P5|NOT COMPLETED|Overall Study||0
162447|NCT01012362|391480|P4|NOT COMPLETED|Overall Study||0
162448|NCT01012362|391481|P3|NOT COMPLETED|Overall Study||0
162449|NCT01012362|391482|P2|NOT COMPLETED|Overall Study||0
162450|NCT01012362|391483|P1|NOT COMPLETED|Overall Study||0
162451|NCT01012362|391479|P5|COMPLETED|Overall Study||9
162452|NCT01012362|391480|P4|COMPLETED|Overall Study||4
162453|NCT01012362|391481|P3|COMPLETED|Overall Study||3
162454|NCT01012362|391482|P2|COMPLETED|Overall Study||6
162455|NCT01012362|391483|P1|COMPLETED|Overall Study||9
162456|NCT01012362|391479|P5|STARTED|Overall Study||9
162457|NCT01012362|391480|P4|STARTED|Overall Study||4
162458|NCT01012362|391481|P3|STARTED|Overall Study||3
162459|NCT01012362|391482|P2|STARTED|Overall Study||6
162460|NCT01012362|391483|P1|STARTED|Overall Study||9
162461|NCT01012336|391499|P1|NOT COMPLETED|Overall Study||0
162462|NCT01012336|391499|P1|COMPLETED|Overall Study||85
162463|NCT01012336|391499|P1|STARTED|Overall Study||85
162464|NCT01012323|391503|P1|NOT COMPLETED|Overall Study||1
162465|NCT01012323|391503|P1|COMPLETED|Overall Study||50
162466|NCT01012323|391503|P1|STARTED|Overall Study||51
162467|NCT01012297|391527|P2|NOT COMPLETED|Overall Study||0
162468|NCT01012297|391528|P1|NOT COMPLETED|Overall Study||0
162469|NCT01012297|391527|P2|COMPLETED|Overall Study||53
162470|NCT01012297|391528|P1|COMPLETED|Overall Study||54
162471|NCT01012297|391527|P2|STARTED|Overall Study||53
162472|NCT01012297|391528|P1|STARTED|Overall Study||54
162473|NCT01012258|391540|P1|NOT COMPLETED|Overall Study||66
162474|NCT01012258|391540|P1|COMPLETED|Overall Study||0
162475|NCT01012258|391540|P1|STARTED|Overall Study||66
162476|NCT01012245|391550|P1|NOT COMPLETED|Overall Study||2427
162477|NCT01012245|391550|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
162478|NCT01012245|391550|P1|STARTED|Overall Study||28812
162479|NCT01012219|391587|P1|NOT COMPLETED|Period 3||0
162480|NCT01012219|391587|P1|COMPLETED|Period 3||20
162481|NCT01012219|391587|P1|STARTED|Period 3|of the 36 who started Period 1|20
162482|NCT01012219|391587|P1|NOT COMPLETED|Period 2||1
162483|NCT01012219|391587|P1|COMPLETED|Period 2||34
162484|NCT01012219|391587|P1|STARTED|Period 2|Number who completed Period 1|35
162485|NCT01012219|391587|P1|NOT COMPLETED|Period 1||1
162486|NCT01012219|391587|P1|COMPLETED|Period 1||35
162487|NCT01012219|391587|P1|STARTED|Period 1|Number randomized|36
162488|NCT01012167|391597|P3|NOT COMPLETED|Overall Study||4
162489|NCT01012167|391598|P2|NOT COMPLETED|Overall Study||2
162490|NCT01012167|391599|P1|NOT COMPLETED|Overall Study||2
162491|NCT01012167|391597|P3|COMPLETED|Overall Study||17
162492|NCT01012167|391598|P2|COMPLETED|Overall Study||18
162493|NCT01012167|391599|P1|COMPLETED|Overall Study||15
162494|NCT01012167|391597|P3|Exposed to Study Drug|Overall Study||20
162495|NCT01012167|391598|P2|Exposed to Study Drug|Overall Study||20
162496|NCT01012167|391599|P1|Exposed to Study Drug|Overall Study||16
162497|NCT01012167|391597|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
162498|NCT01012167|391598|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
162499|NCT01012167|391599|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
162500|NCT01012167|391597|P3|STARTED|Overall Study||21
162501|NCT01012167|391598|P2|STARTED|Overall Study||20
162502|NCT01012167|391599|P1|STARTED|Overall Study||17
162503|NCT01012037|391856|P3|NOT COMPLETED|Overall Study||10
162504|NCT01012037|391857|P2|NOT COMPLETED|Overall Study||16
162505|NCT01012037|391858|P1|NOT COMPLETED|Overall Study||1
162506|NCT01012037|391856|P3|COMPLETED|Overall Study||214
162507|NCT01012037|391857|P2|COMPLETED|Overall Study||207
162508|NCT01012037|391858|P1|COMPLETED|Overall Study||43
162509|NCT01012037|391856|P3|STARTED|Overall Study||224
162510|NCT01012037|391857|P2|STARTED|Overall Study||223
162511|NCT01012037|391858|P1|STARTED|Overall Study||44
162512|NCT01011946|391893|P1|NOT COMPLETED|Overall Study||3
162513|NCT01011946|391893|P1|COMPLETED|Overall Study||33
162514|NCT01011946|391893|P1|STARTED|Overall Study||36
162515|NCT01011933|391897|P1|NOT COMPLETED|Overall Study||4
162516|NCT01011933|391897|P1|COMPLETED|Overall Study|total eligible and evaluable|50
162517|NCT01011933|391897|P1|STARTED|Overall Study|total enrolled|54
162518|NCT01011907|391914|P2|NOT COMPLETED|Overall Study||15
162519|NCT01011907|391915|P1|NOT COMPLETED|Overall Study||14
162520|NCT01011907|391914|P2|COMPLETED|Overall Study||18
162521|NCT01011907|391915|P1|COMPLETED|Overall Study||17
162522|NCT01011907|391914|P2|STARTED|Overall Study||33
162523|NCT01011907|391915|P1|STARTED|Overall Study||31
162524|NCT01011894|391925|P1|NOT COMPLETED|Overall Study||0
162525|NCT01011894|391925|P1|COMPLETED|Overall Study||26
162526|NCT01011894|391925|P1|STARTED|Overall Study||26
162527|NCT01011868|391932|P3|NOT COMPLETED|After Week 78 Follow-up||44
162528|NCT01011868|391933|P2|NOT COMPLETED|After Week 78 Follow-up||38
162529|NCT01011868|391934|P1|NOT COMPLETED|After Week 78 Follow-up||52
162530|NCT01011868|391932|P3|COMPLETED|After Week 78 Follow-up||111
162531|NCT01011868|391933|P2|COMPLETED|After Week 78 Follow-up||131
162532|NCT01011868|391934|P1|COMPLETED|After Week 78 Follow-up||118
162533|NCT01011868|391932|P3|STARTED|After Week 78 Follow-up||155
162534|NCT01011868|391933|P2|STARTED|After Week 78 Follow-up||169
162535|NCT01011868|391934|P1|STARTED|After Week 78 Follow-up||170
162536|NCT01011868|391932|P3|NOT COMPLETED|After Week 18 Follow-up||26
162537|NCT01011868|391933|P2|NOT COMPLETED|After Week 18 Follow-up||16
162538|NCT01011868|391934|P1|NOT COMPLETED|After Week 18 Follow-up||23
162539|NCT01011868|391932|P3|COMPLETED|After Week 18 Follow-up||129
162540|NCT01011868|391933|P2|COMPLETED|After Week 18 Follow-up||153
162541|NCT01011868|391934|P1|COMPLETED|After Week 18 Follow-up||147
162542|NCT01011868|391932|P3|STARTED|After Week 18 Follow-up||155
162543|NCT01011868|391933|P2|STARTED|After Week 18 Follow-up||169
162544|NCT01011868|391934|P1|STARTED|After Week 18 Follow-up||170
162545|NCT01011829|391971|P2|NOT COMPLETED|Overall Study||9
162546|NCT01011829|391972|P1|NOT COMPLETED|Overall Study||4
162547|NCT01011829|391971|P2|COMPLETED|Overall Study||1
162548|NCT01011829|391972|P1|COMPLETED|Overall Study||6
162549|NCT01011829|391971|P2|STARTED|Overall Study||10
162550|NCT01011829|391972|P1|STARTED|Overall Study||10
162551|NCT01011816|391982|P2|NOT COMPLETED|78-Week Extended Follow-up||28
162552|NCT01011816|391983|P1|NOT COMPLETED|78-Week Extended Follow-up||72
162553|NCT01011816|391982|P2|COMPLETED|78-Week Extended Follow-up||26
162554|NCT01011816|391983|P1|COMPLETED|78-Week Extended Follow-up||85
162555|NCT01011816|391982|P2|STARTED|78-Week Extended Follow-up||54
162556|NCT01011816|391983|P1|STARTED|78-Week Extended Follow-up||157
162557|NCT01011816|391982|P2|NOT COMPLETED|26-Week Primary Endpoint||2
162558|NCT01011816|391983|P1|NOT COMPLETED|26-Week Primary Endpoint||7
162559|NCT01011816|391982|P2|COMPLETED|26-Week Primary Endpoint||54
162560|NCT01011816|391983|P1|COMPLETED|26-Week Primary Endpoint||157
162561|NCT01011816|391982|P2|STARTED|26-Week Primary Endpoint||56
162562|NCT01011816|391983|P1|STARTED|26-Week Primary Endpoint||164
162563|NCT01011738|391996|P3|NOT COMPLETED|Overall Study||17
162564|NCT01011738|391997|P2|NOT COMPLETED|Overall Study||294
162565|NCT01011738|391998|P1|NOT COMPLETED|Overall Study||324
162566|NCT01011738|391996|P3|COMPLETED|Overall Study||36
162567|NCT01011738|391997|P2|COMPLETED|Overall Study||618
162568|NCT01011738|391998|P1|COMPLETED|Overall Study||553
162569|NCT01011738|391996|P3|STARTED|Overall Study||53
162570|NCT01011738|391997|P2|STARTED|Overall Study||912
162571|NCT01011738|391998|P1|STARTED|Overall Study||877
162572|NCT01011673|392038|P2|NOT COMPLETED|24 Hour Follow-up||3
162573|NCT01011673|392039|P1|NOT COMPLETED|24 Hour Follow-up||3
162574|NCT01011673|392038|P2|COMPLETED|24 Hour Follow-up||57
162575|NCT01011673|392039|P1|COMPLETED|24 Hour Follow-up||57
162576|NCT01011673|392038|P2|STARTED|24 Hour Follow-up||60
162577|NCT01011673|392039|P1|STARTED|24 Hour Follow-up||60
162578|NCT01011673|392038|P2|NOT COMPLETED|Emergency Department Portion||0
162579|NCT01011673|392039|P1|NOT COMPLETED|Emergency Department Portion||0
162580|NCT01011673|392038|P2|COMPLETED|Emergency Department Portion||60
162581|NCT01011673|392039|P1|COMPLETED|Emergency Department Portion||60
162582|NCT01011673|392038|P2|STARTED|Emergency Department Portion||60
162583|NCT01011673|392039|P1|STARTED|Emergency Department Portion||60
162584|NCT01011673|392038|P2|NOT COMPLETED|Randomized||1
162585|NCT01011673|392039|P1|NOT COMPLETED|Randomized||2
162586|NCT01011673|392038|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
162587|NCT01011673|392039|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
162588|NCT01011673|392038|P2|STARTED|Randomized||61
162589|NCT01011673|392039|P1|STARTED|Randomized||62
162590|NCT01011634|392049|P2|NOT COMPLETED|Overall Study||1
162591|NCT01011634|392050|P1|NOT COMPLETED|Overall Study||0
162592|NCT01011634|392049|P2|COMPLETED|Overall Study||8
162593|NCT01011634|392050|P1|COMPLETED|Overall Study||9
162594|NCT01011634|392049|P2|STARTED|Overall Study||9
162595|NCT01011634|392050|P1|STARTED|Overall Study||9
162596|NCT01011556|392062|P4|NOT COMPLETED|Overall Study||13
162597|NCT01011556|392063|P3|NOT COMPLETED|Overall Study||10
162598|NCT01011556|392064|P2|NOT COMPLETED|Overall Study||8
162599|NCT01011556|392065|P1|NOT COMPLETED|Overall Study||6
162600|NCT01011556|392062|P4|COMPLETED|Overall Study||51
162601|NCT01011556|392063|P3|COMPLETED|Overall Study||45
162602|NCT01011556|392064|P2|COMPLETED|Overall Study||48
162603|NCT01011556|392065|P1|COMPLETED|Overall Study||52
162604|NCT01011556|392062|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
162605|NCT01011556|392063|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
162606|NCT01011556|392064|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
162607|NCT01011556|392065|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
162608|NCT01011556|392062|P4|STARTED|Overall Study||64
162609|NCT01011556|392063|P3|STARTED|Overall Study||55
162610|NCT01011556|392064|P2|STARTED|Overall Study||56
162611|NCT01011556|392065|P1|STARTED|Overall Study||58
162612|NCT01011465|392143|P8|NOT COMPLETED|Overall Study||0
162613|NCT01011465|392144|P7|NOT COMPLETED|Overall Study||1
162614|NCT01011465|392145|P6|NOT COMPLETED|Overall Study||0
162615|NCT01011465|392146|P5|NOT COMPLETED|Overall Study||1
162616|NCT01011465|392147|P4|NOT COMPLETED|Overall Study||0
162617|NCT01011465|392148|P3|NOT COMPLETED|Overall Study||0
162618|NCT01011465|392149|P2|NOT COMPLETED|Overall Study||1
162619|NCT01011465|392150|P1|NOT COMPLETED|Overall Study||2
162620|NCT01011465|392143|P8|COMPLETED|Overall Study||32
162621|NCT01011465|392144|P7|COMPLETED|Overall Study||51
162622|NCT01011465|392145|P6|COMPLETED|Overall Study||29
162623|NCT01011465|392146|P5|COMPLETED|Overall Study||46
162624|NCT01011465|392147|P4|COMPLETED|Overall Study||18
162625|NCT01011465|392148|P3|COMPLETED|Overall Study||36
162626|NCT01011465|392149|P2|COMPLETED|Overall Study||19
162627|NCT01011465|392150|P1|COMPLETED|Overall Study||34
162628|NCT01011465|392143|P8|STARTED|Overall Study||32
162629|NCT01011465|392144|P7|STARTED|Overall Study||52
162630|NCT01011465|392145|P6|STARTED|Overall Study||29
162631|NCT01011465|392146|P5|STARTED|Overall Study||47
162632|NCT01011465|392147|P4|STARTED|Overall Study||18
162633|NCT01011465|392148|P3|STARTED|Overall Study||36
162634|NCT01011465|392149|P2|STARTED|Overall Study||20
162635|NCT01011465|392150|P1|STARTED|Overall Study||36
162636|NCT01011387|392178|P1|NOT COMPLETED|Overall Study||6
162637|NCT01011387|392178|P1|COMPLETED|Overall Study||10
162638|NCT01011387|392178|P1|STARTED|Overall Study||16
162639|NCT01011335|392186|P13|NOT COMPLETED|Overall Study||3
162640|NCT01011335|392187|P12|NOT COMPLETED|Overall Study||1
162641|NCT01011335|392188|P11|NOT COMPLETED|Overall Study||6
162642|NCT01011335|392189|P10|NOT COMPLETED|Overall Study||0
162643|NCT01011335|392190|P9|NOT COMPLETED|Overall Study||2
162644|NCT01011335|392191|P8|NOT COMPLETED|Overall Study||2
162645|NCT01011335|392192|P7|NOT COMPLETED|Overall Study||3
162646|NCT01011335|392193|P6|NOT COMPLETED|Overall Study||1
162647|NCT01011335|392194|P5|NOT COMPLETED|Overall Study||1
162648|NCT01011335|392195|P4|NOT COMPLETED|Overall Study||2
162649|NCT01011335|392196|P3|NOT COMPLETED|Overall Study||1
162650|NCT01011335|392197|P2|NOT COMPLETED|Overall Study||1
162651|NCT01011335|392198|P1|NOT COMPLETED|Overall Study||1
162652|NCT01011335|392186|P13|COMPLETED|Overall Study||19
162653|NCT01011335|392187|P12|COMPLETED|Overall Study||21
162654|NCT01011335|392188|P11|COMPLETED|Overall Study||6
162655|NCT01011335|392189|P10|COMPLETED|Overall Study||12
162656|NCT01011335|392190|P9|COMPLETED|Overall Study||10
162657|NCT01011335|392191|P8|COMPLETED|Overall Study||10
162658|NCT01011335|392192|P7|COMPLETED|Overall Study||9
162659|NCT01011335|392193|P6|COMPLETED|Overall Study||11
162660|NCT01011335|392194|P5|COMPLETED|Overall Study||12
162661|NCT01011335|392195|P4|COMPLETED|Overall Study||10
162662|NCT01011335|392196|P3|COMPLETED|Overall Study||11
162663|NCT01011335|392197|P2|COMPLETED|Overall Study||11
162664|NCT01011335|392198|P1|COMPLETED|Overall Study||10
162665|NCT01011335|392186|P13|STARTED|Overall Study||22
162666|NCT01011335|392187|P12|STARTED|Overall Study||22
162667|NCT01011335|392188|P11|STARTED|Overall Study||12
162668|NCT01011335|392189|P10|STARTED|Overall Study||12
162669|NCT01011335|392190|P9|STARTED|Overall Study||12
162670|NCT01011335|392191|P8|STARTED|Overall Study||12
162671|NCT01011335|392192|P7|STARTED|Overall Study||12
162672|NCT01011335|392193|P6|STARTED|Overall Study||12
162673|NCT01011335|392194|P5|STARTED|Overall Study||13
162674|NCT01011335|392195|P4|STARTED|Overall Study||12
162675|NCT01011335|392196|P3|STARTED|Overall Study||12
162676|NCT01011335|392197|P2|STARTED|Overall Study||12
162677|NCT01011335|392198|P1|STARTED|Overall Study||11
162678|NCT01011309|392238|P3|NOT COMPLETED|Overall Study||5
162679|NCT01011309|392239|P2|NOT COMPLETED|Overall Study||3
162680|NCT01011309|392240|P1|NOT COMPLETED|Overall Study||2
162681|NCT01011309|392238|P3|COMPLETED|Overall Study||16
162682|NCT01011309|392239|P2|COMPLETED|Overall Study||7
162683|NCT01011309|392240|P1|COMPLETED|Overall Study||12
162684|NCT01011309|392238|P3|STARTED|Overall Study||21
162685|NCT01011309|392239|P2|STARTED|Overall Study||10
162686|NCT01011309|392240|P1|STARTED|Overall Study||14
162687|NCT01011283|392256|P2|NOT COMPLETED|Overall Study||11
162688|NCT01011283|392257|P1|NOT COMPLETED|Overall Study||11
162689|NCT01011283|392256|P2|COMPLETED|Overall Study||2
162690|NCT01011283|392257|P1|COMPLETED|Overall Study||2
162691|NCT01011283|392256|P2|STARTED|Overall Study||13
162692|NCT01011283|392257|P1|STARTED|Overall Study||13
162693|NCT01011179|392267|P2|NOT COMPLETED|Overall Study||2
162694|NCT01011179|392268|P1|NOT COMPLETED|Overall Study||4
162695|NCT01011179|392267|P2|COMPLETED|Overall Study||20
162696|NCT01011179|392268|P1|COMPLETED|Overall Study||20
162697|NCT01011179|392267|P2|STARTED|Overall Study||22
162698|NCT01011179|392268|P1|STARTED|Overall Study||24
162699|NCT01011153|392277|P3|NOT COMPLETED|Overall Study||9
162700|NCT01011153|392278|P2|NOT COMPLETED|Overall Study||11
162701|NCT01011153|392279|P1|NOT COMPLETED|Overall Study||8
162702|NCT01011153|392277|P3|COMPLETED|Overall Study||45
162703|NCT01011153|392278|P2|COMPLETED|Overall Study||64
162704|NCT01011153|392279|P1|COMPLETED|Overall Study||46
162705|NCT01011153|392277|P3|STARTED|Overall Study||54
162706|NCT01011153|392278|P2|STARTED|Overall Study||75
162707|NCT01011153|392279|P1|STARTED|Overall Study||54
162708|NCT01011075|392297|P1|NOT COMPLETED|Overall Study||0
162709|NCT01011075|392297|P1|COMPLETED|Overall Study||34
162710|NCT01011075|392297|P1|STARTED|Overall Study||34
162711|NCT01011049|392308|P4|NOT COMPLETED|Overall Study||0
162712|NCT01011049|392309|P3|NOT COMPLETED|Overall Study||4
162713|NCT01011049|392310|P2|NOT COMPLETED|Overall Study||2
162714|NCT01011049|392311|P1|NOT COMPLETED|Overall Study||1
162715|NCT01011049|392308|P4|COMPLETED|Overall Study||246
162716|NCT01011049|392309|P3|COMPLETED|Overall Study||239
162717|NCT01011049|392310|P2|COMPLETED|Overall Study||250
162718|NCT01011049|392311|P1|COMPLETED|Overall Study||506
162719|NCT01011049|392308|P4|STARTED|Overall Study||246
162720|NCT01011049|392309|P3|STARTED|Overall Study||243
162721|NCT01011049|392310|P2|STARTED|Overall Study||252
162722|NCT01011049|392311|P1|STARTED|Overall Study||507
162723|NCT01010971|392336|P3|NOT COMPLETED|Overall Study||13
162724|NCT01010971|392337|P2|NOT COMPLETED|Overall Study||8
162725|NCT01010971|392338|P1|NOT COMPLETED|Overall Study||3
162726|NCT01010971|392336|P3|COMPLETED|Overall Study||207
162727|NCT01010971|392337|P2|COMPLETED|Overall Study||218
162728|NCT01010971|392338|P1|COMPLETED|Overall Study||222
162729|NCT01010971|392336|P3|STARTED|Overall Study||220
162730|NCT01010971|392337|P2|STARTED|Overall Study||226
162731|NCT01010971|392338|P1|STARTED|Overall Study||225
162732|NCT01010932|392423|P1|NOT COMPLETED|Overall Study||22
162733|NCT01010932|392423|P1|COMPLETED|Overall Study||200
162734|NCT01010932|392423|P1|STARTED|Overall Study||222
162735|NCT01010906|392441|P6|NOT COMPLETED|Overall Study||0
162736|NCT01010906|392442|P5|NOT COMPLETED|Overall Study||0
162737|NCT01010906|392443|P4|NOT COMPLETED|Overall Study||0
162738|NCT01010906|392444|P3|NOT COMPLETED|Overall Study||0
162739|NCT01010906|392445|P2|NOT COMPLETED|Overall Study||0
162740|NCT01010906|392446|P1|NOT COMPLETED|Overall Study||0
162741|NCT01010906|392441|P6|COMPLETED|Overall Study||10
162742|NCT01010906|392442|P5|COMPLETED|Overall Study||10
162743|NCT01010906|392443|P4|COMPLETED|Overall Study||10
162744|NCT01010906|392444|P3|COMPLETED|Overall Study||10
162745|NCT01010906|392445|P2|COMPLETED|Overall Study||10
162746|NCT01010906|392446|P1|COMPLETED|Overall Study||10
162747|NCT01010906|392441|P6|STARTED|Overall Study||10
162748|NCT01010906|392442|P5|STARTED|Overall Study||10
162749|NCT01010906|392443|P4|STARTED|Overall Study||10
162750|NCT01010906|392444|P3|STARTED|Overall Study||10
162751|NCT01010906|392445|P2|STARTED|Overall Study||10
162752|NCT01010906|392446|P1|STARTED|Overall Study||10
162753|NCT01010867|392466|P1|NOT COMPLETED|Overall Study||1
162754|NCT01010867|392466|P1|COMPLETED|Overall Study||30
162755|NCT01010867|392466|P1|STARTED|Overall Study||31
162756|NCT01010854|392473|P1|NOT COMPLETED|Overall Study||0
162757|NCT01010854|392473|P1|COMPLETED|Overall Study||6
162758|NCT01010854|392473|P1|STARTED|Overall Study||6
162759|NCT01010776|392478|P1|NOT COMPLETED|Extension Phase||3
162760|NCT01010776|392478|P1|COMPLETED|Extension Phase||156
162761|NCT01010776|392478|P1|STARTED|Extension Phase||159
162762|NCT01010776|392478|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
162763|NCT01010776|392478|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
162764|NCT01010776|392478|P1|STARTED|In-Between Main Phase & Extension Phase||174
162765|NCT01010776|392478|P1|NOT COMPLETED|Main Phase||49
162766|NCT01010776|392478|P1|COMPLETED|Main Phase||174
162767|NCT01010776|392478|P1|Treated|Main Phase||218
162768|NCT01010776|392478|P1|STARTED|Main Phase||223
162769|NCT01010750|392506|P6|NOT COMPLETED|Third Intervention||0
162770|NCT01010750|392507|P5|NOT COMPLETED|Third Intervention||0
162771|NCT01010750|392508|P4|NOT COMPLETED|Third Intervention||0
162772|NCT01010750|392509|P3|NOT COMPLETED|Third Intervention||0
162773|NCT01010750|392510|P2|NOT COMPLETED|Third Intervention||0
162774|NCT01010750|392511|P1|NOT COMPLETED|Third Intervention||0
162775|NCT01010750|392506|P6|COMPLETED|Third Intervention||3
162776|NCT01010750|392507|P5|COMPLETED|Third Intervention||2
162777|NCT01010750|392508|P4|COMPLETED|Third Intervention||3
162778|NCT01010750|392509|P3|COMPLETED|Third Intervention||3
162779|NCT01010750|392510|P2|COMPLETED|Third Intervention||3
162780|NCT01010750|392511|P1|COMPLETED|Third Intervention||3
162781|NCT01010750|392506|P6|STARTED|Third Intervention||3
162782|NCT01010750|392507|P5|STARTED|Third Intervention||2
162783|NCT01010750|392508|P4|STARTED|Third Intervention||3
162784|NCT01010750|392509|P3|STARTED|Third Intervention||3
162785|NCT01010750|392510|P2|STARTED|Third Intervention||3
162786|NCT01010750|392511|P1|STARTED|Third Intervention||3
162787|NCT01010750|392506|P6|NOT COMPLETED|Second Intervention||0
162788|NCT01010750|392507|P5|NOT COMPLETED|Second Intervention||0
162789|NCT01010750|392508|P4|NOT COMPLETED|Second Intervention||0
162790|NCT01010750|392509|P3|NOT COMPLETED|Second Intervention||0
162791|NCT01010750|392510|P2|NOT COMPLETED|Second Intervention||1
162792|NCT01010750|392511|P1|NOT COMPLETED|Second Intervention||0
162793|NCT01010750|392506|P6|COMPLETED|Second Intervention||3
162794|NCT01010750|392507|P5|COMPLETED|Second Intervention||2
162795|NCT01010750|392508|P4|COMPLETED|Second Intervention||3
162796|NCT01010750|392509|P3|COMPLETED|Second Intervention||3
162797|NCT01010750|392510|P2|COMPLETED|Second Intervention||3
162798|NCT01010750|392511|P1|COMPLETED|Second Intervention||3
162799|NCT01010750|392506|P6|STARTED|Second Intervention||3
162800|NCT01010750|392507|P5|STARTED|Second Intervention||2
162801|NCT01010750|392508|P4|STARTED|Second Intervention||3
162802|NCT01010750|392509|P3|STARTED|Second Intervention||3
162803|NCT01010750|392510|P2|STARTED|Second Intervention||4
162804|NCT01010750|392511|P1|STARTED|Second Intervention||3
162805|NCT01010750|392506|P6|NOT COMPLETED|First Intervention||0
162806|NCT01010750|392507|P5|NOT COMPLETED|First Intervention||0
162807|NCT01010750|392508|P4|NOT COMPLETED|First Intervention||0
162808|NCT01010750|392509|P3|NOT COMPLETED|First Intervention||0
162809|NCT01010750|392510|P2|NOT COMPLETED|First Intervention||0
162810|NCT01010750|392511|P1|NOT COMPLETED|First Intervention||0
162811|NCT01010750|392506|P6|COMPLETED|First Intervention||3
162812|NCT01010750|392507|P5|COMPLETED|First Intervention||2
162813|NCT01010750|392508|P4|COMPLETED|First Intervention||3
162814|NCT01010750|392509|P3|COMPLETED|First Intervention||3
162815|NCT01010750|392510|P2|COMPLETED|First Intervention||4
162816|NCT01010750|392511|P1|COMPLETED|First Intervention||3
162817|NCT01010750|392506|P6|STARTED|First Intervention||3
162818|NCT01010750|392507|P5|STARTED|First Intervention||2
162819|NCT01010750|392508|P4|STARTED|First Intervention||3
162820|NCT01010750|392509|P3|STARTED|First Intervention||3
162821|NCT01010750|392510|P2|STARTED|First Intervention||4
162822|NCT01010750|392511|P1|STARTED|First Intervention||3
162823|NCT01010633|392536|P2|NOT COMPLETED|Overall Study||5
162824|NCT01010633|392537|P1|NOT COMPLETED|Overall Study||4
162825|NCT01010633|392536|P2|COMPLETED|Overall Study||198
162826|NCT01010633|392537|P1|COMPLETED|Overall Study||199
162827|NCT01010633|392536|P2|STARTED|Overall Study||203
162828|NCT01010633|392537|P1|STARTED|Overall Study||203
162829|NCT01010568|392547|P1|NOT COMPLETED|Overall Study||5
162830|NCT01010568|392547|P1|COMPLETED|Overall Study||5
162831|NCT01010568|392547|P1|STARTED|Overall Study||10
162832|NCT01010555|392553|P2|NOT COMPLETED|Second Four Weeks of Wear||0
162833|NCT01010555|392554|P1|NOT COMPLETED|Second Four Weeks of Wear||0
162834|NCT01010555|392553|P2|COMPLETED|Second Four Weeks of Wear||9
162835|NCT01010555|392554|P1|COMPLETED|Second Four Weeks of Wear||10
162836|NCT01010555|392553|P2|STARTED|Second Four Weeks of Wear||9
162837|NCT01010555|392554|P1|STARTED|Second Four Weeks of Wear||10
162838|NCT01010555|392553|P2|NOT COMPLETED|First Four Weeks of Wear||0
162839|NCT01010555|392554|P1|NOT COMPLETED|First Four Weeks of Wear||0
162840|NCT01010555|392553|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
162841|NCT01010555|392554|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
162842|NCT01010555|392553|P2|STARTED|First Four Weeks of Wear||10
162843|NCT01010555|392554|P1|STARTED|First Four Weeks of Wear||11
162844|NCT01010503|392564|P1|NOT COMPLETED|Overall Study||2
162845|NCT01010503|392564|P1|COMPLETED|Overall Study||30
162846|NCT01010503|392564|P1|STARTED|Overall Study||32
162847|NCT01010477|392584|P2|NOT COMPLETED|Overall Study||3
162848|NCT01010477|392585|P1|NOT COMPLETED|Overall Study||6
162849|NCT01010477|392584|P2|COMPLETED|Overall Study||22
162850|NCT01010477|392585|P1|COMPLETED|Overall Study||21
162851|NCT01010477|392584|P2|STARTED|Overall Study||25
162852|NCT01010477|392585|P1|STARTED|Overall Study||27
162853|NCT01010399|392591|P1|NOT COMPLETED|Overall Study||5
162854|NCT01010399|392591|P1|COMPLETED|Overall Study||31
162855|NCT01010399|392591|P1|STARTED|Overall Study||36
162856|NCT01010282|392599|P3|NOT COMPLETED|Overall Study||19
162857|NCT01010282|392600|P2|NOT COMPLETED|Overall Study||7
162858|NCT01010282|392601|P1|NOT COMPLETED|Overall Study||6
162859|NCT01010282|392599|P3|COMPLETED|Overall Study||77
162860|NCT01010282|392600|P2|COMPLETED|Overall Study||88
162861|NCT01010282|392601|P1|COMPLETED|Overall Study||91
162862|NCT01010282|392599|P3|STARTED|Overall Study||96
162863|NCT01010282|392600|P2|STARTED|Overall Study||95
162864|NCT01010282|392601|P1|STARTED|Overall Study||97
162865|NCT01010230|392623|P2|NOT COMPLETED|Overall Study||7
162866|NCT01010230|392624|P1|NOT COMPLETED|Overall Study||10
162867|NCT01010230|392623|P2|COMPLETED|Overall Study||26
162868|NCT01010230|392624|P1|COMPLETED|Overall Study||22
162869|NCT01010230|392623|P2|STARTED|Overall Study||33
162870|NCT01010230|392624|P1|STARTED|Overall Study||32
162871|NCT01010204|392656|P2|NOT COMPLETED|Overall Study||9
162872|NCT01010204|392657|P1|NOT COMPLETED|Overall Study||7
162873|NCT01010204|392656|P2|COMPLETED|Overall Study||20
162874|NCT01010204|392657|P1|COMPLETED|Overall Study||24
162875|NCT01010204|392656|P2|STARTED|Overall Study||29
162876|NCT01010204|392657|P1|STARTED|Overall Study||31
162877|NCT01010061|392669|P2|NOT COMPLETED|Overall Study||95
162878|NCT01010061|392670|P1|NOT COMPLETED|Overall Study||133
162879|NCT01010061|392669|P2|COMPLETED|Overall Study||23
162880|NCT01010061|392670|P1|COMPLETED|Overall Study|Completed=Completed treatment.|105
162881|NCT01010061|392669|P2|Received Study Drug|Overall Study||116
162882|NCT01010061|392670|P1|Received Study Drug|Overall Study||236
162883|NCT01010061|392669|P2|STARTED|Overall Study||118
162884|NCT01010061|392670|P1|STARTED|Overall Study||238
162885|NCT01010009|392704|P3|NOT COMPLETED|Overall Study||0
162886|NCT01010009|392705|P2|NOT COMPLETED|Overall Study||0
162887|NCT01010009|392706|P1|NOT COMPLETED|Overall Study||0
162888|NCT01010009|392704|P3|COMPLETED|Overall Study||8
162889|NCT01010009|392705|P2|COMPLETED|Overall Study||8
162890|NCT01010009|392706|P1|COMPLETED|Overall Study||8
162891|NCT01010009|392704|P3|STARTED|Overall Study||8
162892|NCT01010009|392705|P2|STARTED|Overall Study||8
162893|NCT01010009|392706|P1|STARTED|Overall Study||8
162894|NCT01009983|392720|P1|NOT COMPLETED|Overall Study||1
162895|NCT01009983|392720|P1|COMPLETED|Overall Study||13
162896|NCT01009983|392720|P1|STARTED|Overall Study||14
162897|NCT01009931|392727|P1|NOT COMPLETED|Overall Study||1
162898|NCT01009931|392727|P1|COMPLETED|Overall Study||0
162899|NCT01009931|392727|P1|STARTED|Overall Study||1
162900|NCT01009840|392733|P1|NOT COMPLETED|Overall Study||14
162901|NCT01009840|392733|P1|COMPLETED|Overall Study||16
162902|NCT01009840|392733|P1|STARTED|Overall Study||30
162903|NCT01009762|392748|P2|NOT COMPLETED|Overall Study||0
162904|NCT01009762|392749|P1|NOT COMPLETED|Overall Study||0
162905|NCT01009762|392748|P2|COMPLETED|Overall Study|10 participants received vaccine|10
162906|NCT01009762|392749|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
162907|NCT01009762|392748|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
162908|NCT01009762|392749|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
162909|NCT01009762|392748|P2|STARTED|Overall Study||10
162910|NCT01009762|392749|P1|STARTED|Overall Study||1
162911|NCT01009645|392763|P4|NOT COMPLETED|Overall Study||5
162912|NCT01009645|392764|P3|NOT COMPLETED|Overall Study||4
162913|NCT01009645|392765|P2|NOT COMPLETED|Overall Study||8
162914|NCT01009645|392766|P1|NOT COMPLETED|Overall Study||2
162915|NCT01009645|392763|P4|COMPLETED|Overall Study||26
162916|NCT01009645|392764|P3|COMPLETED|Overall Study||28
162917|NCT01009645|392765|P2|COMPLETED|Overall Study||23
162918|NCT01009645|392766|P1|COMPLETED|Overall Study||29
162919|NCT01009645|392763|P4|STARTED|Overall Study||31
162920|NCT01009645|392764|P3|STARTED|Overall Study||32
162921|NCT01009645|392765|P2|STARTED|Overall Study||31
162922|NCT01009645|392766|P1|STARTED|Overall Study||31
162923|NCT01009619|392782|P2|NOT COMPLETED|Overall Study||0
162924|NCT01009619|392783|P1|NOT COMPLETED|Overall Study||0
162925|NCT01009619|392782|P2|COMPLETED|Overall Study||43
162926|NCT01009619|392783|P1|COMPLETED|Overall Study||40
162927|NCT01009619|392782|P2|STARTED|Overall Study||43
162928|NCT01009619|392783|P1|STARTED|Overall Study||40
162929|NCT01009580|392803|P2|NOT COMPLETED|Overall Study||35
162930|NCT01009580|392804|P1|NOT COMPLETED|Overall Study||27
162931|NCT01009580|392803|P2|COMPLETED|Overall Study||188
162932|NCT01009580|392804|P1|COMPLETED|Overall Study||197
162933|NCT01009580|392803|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
162934|NCT01009580|392804|P1|Exposed|Overall Study||224
162935|NCT01009580|392803|P2|STARTED|Overall Study||223
162936|NCT01009580|392804|P1|STARTED|Overall Study||224
162937|NCT01009554|392818|P2|NOT COMPLETED|Overall Study||7
162938|NCT01009554|392819|P1|NOT COMPLETED|Overall Study||2
162939|NCT01009554|392818|P2|COMPLETED|Overall Study||41
162940|NCT01009554|392819|P1|COMPLETED|Overall Study||46
162941|NCT01009554|392818|P2|STARTED|Overall Study||48
162942|NCT01009554|392819|P1|STARTED|Overall Study||48
162943|NCT01009515|392951|P1|NOT COMPLETED|Overall Study||3
162944|NCT01009515|392951|P1|COMPLETED|Overall Study||16
162945|NCT01009515|392951|P1|STARTED|Overall Study||19
162946|NCT01009463|392962|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
162947|NCT01009463|392963|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
162948|NCT01009463|392964|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
162949|NCT01009463|392965|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
162950|NCT01009463|392966|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
162951|NCT01009463|392962|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
162952|NCT01009463|392963|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
162953|NCT01009463|392964|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
162954|NCT01009463|392965|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
162955|NCT01009463|392966|P1|COMPLETED|52-week, Double-blind Treatment Period||0
162956|NCT01009463|392962|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
162957|NCT01009463|392963|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
162958|NCT01009463|392964|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
162959|NCT01009463|392965|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
162960|NCT01009463|392966|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
162961|NCT01009463|392962|P5|STARTED|52-week, Double-blind Treatment Period||402
163056|NCT01009086|393062|P2|NOT COMPLETED|Overall Study||47
162962|NCT01009463|392963|P4|STARTED|52-week, Double-blind Treatment Period||403
162963|NCT01009463|392964|P3|STARTED|52-week, Double-blind Treatment Period||408
162964|NCT01009463|392965|P2|STARTED|52-week, Double-blind Treatment Period||409
162965|NCT01009463|392966|P1|STARTED|52-week, Double-blind Treatment Period||0
162966|NCT01009463|392962|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
162967|NCT01009463|392963|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
162968|NCT01009463|392964|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
162969|NCT01009463|392965|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
162970|NCT01009463|392966|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
162971|NCT01009463|392962|P5|COMPLETED|4-week, Open-label Run-In Period||0
162972|NCT01009463|392963|P4|COMPLETED|4-week, Open-label Run-In Period||0
162973|NCT01009463|392964|P3|COMPLETED|4-week, Open-label Run-In Period||0
162974|NCT01009463|392965|P2|COMPLETED|4-week, Open-label Run-In Period||0
162975|NCT01009463|392966|P1|COMPLETED|4-week, Open-label Run-In Period||1622
162976|NCT01009463|392962|P5|STARTED|4-week, Open-label Run-In Period||0
162977|NCT01009463|392963|P4|STARTED|4-week, Open-label Run-In Period||0
162978|NCT01009463|392964|P3|STARTED|4-week, Open-label Run-In Period||0
162979|NCT01009463|392965|P2|STARTED|4-week, Open-label Run-In Period||0
162980|NCT01009463|392966|P1|STARTED|4-week, Open-label Run-In Period||2071
162981|NCT01009346|392988|P1|NOT COMPLETED|Overall Study||4
162982|NCT01009346|392988|P1|COMPLETED|Overall Study||5
162983|NCT01009346|392988|P1|Toxicity|Overall Study||8
162984|NCT01009346|392988|P1|STARTED|Overall Study||9
162985|NCT01009333|392992|P6|NOT COMPLETED|Week 3||0
162986|NCT01009333|392993|P5|NOT COMPLETED|Week 3||0
162987|NCT01009333|392994|P4|NOT COMPLETED|Week 3||0
162988|NCT01009333|392995|P3|NOT COMPLETED|Week 3||0
162989|NCT01009333|392996|P2|NOT COMPLETED|Week 3||0
162990|NCT01009333|392997|P1|NOT COMPLETED|Week 3||0
162991|NCT01009333|392992|P6|COMPLETED|Week 3||2
162992|NCT01009333|392993|P5|COMPLETED|Week 3||2
162993|NCT01009333|392994|P4|COMPLETED|Week 3||2
162994|NCT01009333|392995|P3|COMPLETED|Week 3||2
162995|NCT01009333|392996|P2|COMPLETED|Week 3||2
162996|NCT01009333|392997|P1|COMPLETED|Week 3||2
162997|NCT01009333|392992|P6|STARTED|Week 3||2
162998|NCT01009333|392993|P5|STARTED|Week 3||2
162999|NCT01009333|392994|P4|STARTED|Week 3||2
163000|NCT01009333|392995|P3|STARTED|Week 3||2
163001|NCT01009333|392996|P2|STARTED|Week 3||2
163002|NCT01009333|392997|P1|STARTED|Week 3||2
163003|NCT01009333|392992|P6|NOT COMPLETED|Week 2||0
163004|NCT01009333|392993|P5|NOT COMPLETED|Week 2||0
163005|NCT01009333|392994|P4|NOT COMPLETED|Week 2||0
163006|NCT01009333|392995|P3|NOT COMPLETED|Week 2||0
163007|NCT01009333|392996|P2|NOT COMPLETED|Week 2||0
163008|NCT01009333|392997|P1|NOT COMPLETED|Week 2||0
163009|NCT01009333|392992|P6|COMPLETED|Week 2||2
163010|NCT01009333|392993|P5|COMPLETED|Week 2||2
163011|NCT01009333|392994|P4|COMPLETED|Week 2||2
163012|NCT01009333|392995|P3|COMPLETED|Week 2||2
163013|NCT01009333|392996|P2|COMPLETED|Week 2||2
163014|NCT01009333|392997|P1|COMPLETED|Week 2||2
163015|NCT01009333|392992|P6|STARTED|Week 2||2
163016|NCT01009333|392993|P5|STARTED|Week 2||2
163017|NCT01009333|392994|P4|STARTED|Week 2||2
163018|NCT01009333|392995|P3|STARTED|Week 2||2
163019|NCT01009333|392996|P2|STARTED|Week 2||2
163020|NCT01009333|392997|P1|STARTED|Week 2||2
163021|NCT01009333|392992|P6|NOT COMPLETED|Week 1||0
163022|NCT01009333|392993|P5|NOT COMPLETED|Week 1||0
163023|NCT01009333|392994|P4|NOT COMPLETED|Week 1||0
163024|NCT01009333|392995|P3|NOT COMPLETED|Week 1||0
163025|NCT01009333|392996|P2|NOT COMPLETED|Week 1||0
163026|NCT01009333|392997|P1|NOT COMPLETED|Week 1||0
163027|NCT01009333|392992|P6|COMPLETED|Week 1||2
163028|NCT01009333|392993|P5|COMPLETED|Week 1||2
163029|NCT01009333|392994|P4|COMPLETED|Week 1||2
163030|NCT01009333|392995|P3|COMPLETED|Week 1||2
163031|NCT01009333|392996|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
163032|NCT01009333|392997|P1|COMPLETED|Week 1||2
163033|NCT01009333|392992|P6|STARTED|Week 1||2
163034|NCT01009333|392993|P5|STARTED|Week 1||2
163035|NCT01009333|392994|P4|STARTED|Week 1||2
163036|NCT01009333|392995|P3|STARTED|Week 1||2
163037|NCT01009333|392996|P2|STARTED|Week 1||3
163038|NCT01009333|392997|P1|STARTED|Week 1||2
163039|NCT01009203|393011|P1|NOT COMPLETED|Overall Study||7
163040|NCT01009203|393011|P1|COMPLETED|Overall Study||6
163041|NCT01009203|393011|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
163042|NCT01009203|393011|P1|STARTED|Overall Study||13
163043|NCT01009138|393020|P2|NOT COMPLETED|Overall Study||20
163044|NCT01009138|393021|P1|NOT COMPLETED|Overall Study||13
163045|NCT01009138|393020|P2|COMPLETED|Overall Study||88
163046|NCT01009138|393021|P1|COMPLETED|Overall Study||93
163047|NCT01009138|393020|P2|STARTED|Overall Study||108
163048|NCT01009138|393021|P1|STARTED|Overall Study||106
163049|NCT01009099|393051|P2|NOT COMPLETED|Overall Study||4
163050|NCT01009099|393052|P1|NOT COMPLETED|Overall Study||5
163051|NCT01009099|393051|P2|COMPLETED|Overall Study||57
163052|NCT01009099|393052|P1|COMPLETED|Overall Study||53
163053|NCT01009099|393051|P2|STARTED|Overall Study||61
163054|NCT01009099|393052|P1|STARTED|Overall Study||58
163055|NCT01009086|393061|P3|NOT COMPLETED|Overall Study||34
163057|NCT01009086|393063|P1|NOT COMPLETED|Overall Study||44
163058|NCT01009086|393061|P3|COMPLETED|Overall Study||170
163059|NCT01009086|393062|P2|COMPLETED|Overall Study||158
163060|NCT01009086|393063|P1|COMPLETED|Overall Study||162
163061|NCT01009086|393061|P3|STARTED|Overall Study||204
163062|NCT01009086|393062|P2|STARTED|Overall Study||205
163063|NCT01009086|393063|P1|STARTED|Overall Study||206
163064|NCT01009060|393098|P2|NOT COMPLETED|Overall Study||5
163065|NCT01009060|393099|P1|NOT COMPLETED|Overall Study||4
163066|NCT01009060|393098|P2|COMPLETED|Overall Study||20
163067|NCT01009060|393099|P1|COMPLETED|Overall Study||21
163068|NCT01009060|393098|P2|STARTED|Overall Study||25
163069|NCT01009060|393099|P1|STARTED|Overall Study||25
163070|NCT01009047|393137|P2|NOT COMPLETED|Overall Study||26
163071|NCT01009047|393138|P1|NOT COMPLETED|Overall Study||28
163072|NCT01009047|393137|P2|COMPLETED|Overall Study||89
163073|NCT01009047|393138|P1|COMPLETED|Overall Study||85
163074|NCT01009047|393137|P2|STARTED|Overall Study||115
163075|NCT01009047|393138|P1|STARTED|Overall Study||113
163076|NCT01009034|393160|P1|NOT COMPLETED|Overall Study||4
163077|NCT01009034|393160|P1|COMPLETED|Overall Study||10
163078|NCT01009034|393160|P1|STARTED|Overall Study||14
163079|NCT01008995|393168|P4|NOT COMPLETED|After Controlled Period||1
163080|NCT01008995|393169|P3|NOT COMPLETED|After Controlled Period||2
163081|NCT01008995|393170|P2|NOT COMPLETED|After Controlled Period||0
163082|NCT01008995|393171|P1|NOT COMPLETED|After Controlled Period||0
163083|NCT01008995|393168|P4|COMPLETED|After Controlled Period||156
163084|NCT01008995|393169|P3|COMPLETED|After Controlled Period||156
163085|NCT01008995|393170|P2|COMPLETED|After Controlled Period||0
163086|NCT01008995|393171|P1|COMPLETED|After Controlled Period||0
163087|NCT01008995|393168|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
163088|NCT01008995|393169|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
163089|NCT01008995|393170|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
163090|NCT01008995|393171|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
163091|NCT01008995|393168|P4|NOT COMPLETED|Controlled Period||0
163092|NCT01008995|393169|P3|NOT COMPLETED|Controlled Period||0
163093|NCT01008995|393170|P2|NOT COMPLETED|Controlled Period||3
163094|NCT01008995|393171|P1|NOT COMPLETED|Controlled Period||3
163095|NCT01008995|393168|P4|COMPLETED|Controlled Period||0
163096|NCT01008995|393169|P3|COMPLETED|Controlled Period||0
163097|NCT01008995|393170|P2|COMPLETED|Controlled Period||157
163098|NCT01008995|393171|P1|COMPLETED|Controlled Period||159
163099|NCT01008995|393168|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
163100|NCT01008995|393169|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
163101|NCT01008995|393170|P2|STARTED|Controlled Period||160
163102|NCT01008995|393171|P1|STARTED|Controlled Period||162
163103|NCT01008969|393183|P1|NOT COMPLETED|Overall Study||0
163104|NCT01008969|393183|P1|COMPLETED|Overall Study||10
163105|NCT01008969|393183|P1|STARTED|Overall Study||10
163106|NCT01008943|393188|P1|NOT COMPLETED|Overall Study||1
163107|NCT01008943|393188|P1|COMPLETED|Overall Study||15
163108|NCT01008943|393188|P1|STARTED|Overall Study||16
163109|NCT01008904|393195|P1|NOT COMPLETED|Overall Study||4
163110|NCT01008904|393195|P1|COMPLETED|Overall Study||25
163111|NCT01008904|393195|P1|STARTED|Overall Study||29
163112|NCT01008722|393202|P2|NOT COMPLETED|Overall Study||0
163113|NCT01008722|393203|P1|NOT COMPLETED|Overall Study||0
163114|NCT01008722|393202|P2|COMPLETED|Overall Study||71
163115|NCT01008722|393203|P1|COMPLETED|Overall Study||36
163116|NCT01008722|393202|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
163117|NCT01008722|393203|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
163118|NCT01008696|393213|P2|NOT COMPLETED|Overall Study||17
163119|NCT01008696|393214|P1|NOT COMPLETED|Overall Study||17
163120|NCT01008696|393213|P2|COMPLETED|Overall Study||92
163121|NCT01008696|393214|P1|COMPLETED|Overall Study||91
163122|NCT01008696|393213|P2|STARTED|Overall Study||109
163123|NCT01008696|393214|P1|STARTED|Overall Study||108
163124|NCT01008618|393224|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
163125|NCT01008618|393225|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
163126|NCT01008618|393226|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
163127|NCT01008618|393224|P3|COMPLETED|Period 2 (Double-Blind Period)||39
163128|NCT01008618|393225|P2|COMPLETED|Period 2 (Double-Blind Period)||37
163129|NCT01008618|393226|P1|COMPLETED|Period 2 (Double-Blind Period)||0
163130|NCT01008618|393224|P3|STARTED|Period 2 (Double-Blind Period)||77
163131|NCT01008618|393225|P2|STARTED|Period 2 (Double-Blind Period)||73
163132|NCT01008618|393226|P1|STARTED|Period 2 (Double-Blind Period)||0
163133|NCT01008618|393224|P3|NOT COMPLETED|Period 1 (Titration Period)||0
163134|NCT01008618|393225|P2|NOT COMPLETED|Period 1 (Titration Period)||0
163135|NCT01008618|393226|P1|NOT COMPLETED|Period 1 (Titration Period)||68
163136|NCT01008618|393224|P3|COMPLETED|Period 1 (Titration Period)||0
163137|NCT01008618|393225|P2|COMPLETED|Period 1 (Titration Period)||0
163138|NCT01008618|393226|P1|COMPLETED|Period 1 (Titration Period)||150
163139|NCT01008618|393224|P3|STARTED|Period 1 (Titration Period)||0
163140|NCT01008618|393225|P2|STARTED|Period 1 (Titration Period)||0
163141|NCT01008618|393226|P1|STARTED|Period 1 (Titration Period)||218
163142|NCT01008605|393251|P1|NOT COMPLETED|Overall Study||0
163143|NCT01008605|393251|P1|COMPLETED|Overall Study||48
163144|NCT01008605|393251|P1|STARTED|Overall Study||48
163145|NCT01008553|393275|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
163146|NCT01008553|393276|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
163147|NCT01008553|393277|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
163148|NCT01008553|393275|P3|COMPLETED|Period 2 (Double-Blind Period)||28
163149|NCT01008553|393276|P2|COMPLETED|Period 2 (Double-Blind Period)||47
163150|NCT01008553|393277|P1|COMPLETED|Period 2 (Double-Blind Period)||0
163151|NCT01008553|393275|P3|STARTED|Period 2 (Double-Blind Period)||79
163152|NCT01008553|393276|P2|STARTED|Period 2 (Double-Blind Period)||84
163153|NCT01008553|393277|P1|STARTED|Period 2 (Double-Blind Period)||0
163154|NCT01008553|393275|P3|NOT COMPLETED|Period 1 (Titration Period)||0
163155|NCT01008553|393276|P2|NOT COMPLETED|Period 1 (Titration Period)||0
163156|NCT01008553|393277|P1|NOT COMPLETED|Period 1 (Titration Period)||95
163157|NCT01008553|393275|P3|COMPLETED|Period 1 (Titration Period)||0
163158|NCT01008553|393276|P2|COMPLETED|Period 1 (Titration Period)||0
163159|NCT01008553|393277|P1|COMPLETED|Period 1 (Titration Period)||163
163160|NCT01008553|393275|P3|STARTED|Period 1 (Titration Period)||0
163161|NCT01008553|393276|P2|STARTED|Period 1 (Titration Period)||0
163162|NCT01008553|393277|P1|STARTED|Period 1 (Titration Period)||258
163163|NCT01008475|393309|P7|NOT COMPLETED|Overall Study||4
163164|NCT01008475|393310|P6|NOT COMPLETED|Overall Study||6
163165|NCT01008475|393311|P5|NOT COMPLETED|Overall Study||5
163166|NCT01008475|393312|P4|NOT COMPLETED|Overall Study||0
163167|NCT01008475|393313|P3|NOT COMPLETED|Overall Study||0
163168|NCT01008475|393314|P2|NOT COMPLETED|Overall Study||0
163169|NCT01008475|393315|P1|NOT COMPLETED|Overall Study||0
163170|NCT01008475|393309|P7|COMPLETED|Overall Study||67
163171|NCT01008475|393310|P6|COMPLETED|Overall Study||67
163172|NCT01008475|393311|P5|COMPLETED|Overall Study||67
163173|NCT01008475|393312|P4|COMPLETED|Overall Study||3
163174|NCT01008475|393313|P3|COMPLETED|Overall Study||7
163175|NCT01008475|393314|P2|COMPLETED|Overall Study||3
163176|NCT01008475|393315|P1|COMPLETED|Overall Study||3
163177|NCT01008475|393309|P7|Safety Analysis Set|Overall Study||69
163178|NCT01008475|393310|P6|Safety Analysis Set|Overall Study||72
163179|NCT01008475|393311|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
163180|NCT01008475|393312|P4|Safety Analysis Set|Overall Study||3
163181|NCT01008475|393313|P3|Safety Analysis Set|Overall Study||7
163182|NCT01008475|393314|P2|Safety Analysis Set|Overall Study||3
163183|NCT01008475|393315|P1|Safety Analysis Set|Overall Study||3
163184|NCT01008475|393309|P7|STARTED|Overall Study||71
163185|NCT01008475|393310|P6|STARTED|Overall Study||73
163186|NCT01008475|393311|P5|STARTED|Overall Study||72
163187|NCT01008475|393312|P4|STARTED|Overall Study||3
163188|NCT01008475|393313|P3|STARTED|Overall Study||7
163189|NCT01008475|393314|P2|STARTED|Overall Study||3
163190|NCT01008475|393315|P1|STARTED|Overall Study||3
163191|NCT01008449|393345|P2|NOT COMPLETED|Overall Study||19
163192|NCT01008449|393346|P1|NOT COMPLETED|Overall Study||29
163193|NCT01008449|393345|P2|COMPLETED|Overall Study||179
163194|NCT01008449|393346|P1|COMPLETED|Overall Study||171
163195|NCT01008449|393345|P2|STARTED|Overall Study||198
163196|NCT01008449|393346|P1|STARTED|Overall Study||200
163197|NCT01008319|393368|P2|NOT COMPLETED|Overall Study||0
163198|NCT01008319|393369|P1|NOT COMPLETED|Overall Study||0
163199|NCT01008319|393368|P2|COMPLETED|Overall Study||60
163200|NCT01008319|393369|P1|COMPLETED|Overall Study||60
163201|NCT01008319|393368|P2|STARTED|Overall Study||60
163202|NCT01008319|393369|P1|STARTED|Overall Study||60
163203|NCT01008280|393381|P2|NOT COMPLETED|Overall Study||19
163204|NCT01008280|393382|P1|NOT COMPLETED|Overall Study||21
163205|NCT01008280|393381|P2|COMPLETED|Overall Study||73
163206|NCT01008280|393382|P1|COMPLETED|Overall Study||67
163207|NCT01008280|393381|P2|STARTED|Overall Study||92
163208|NCT01008280|393382|P1|STARTED|Overall Study||88
163209|NCT01007916|393392|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
163210|NCT01007916|393393|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
163211|NCT01007916|393392|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
163212|NCT01007916|393393|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
163213|NCT01007916|393392|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
163214|NCT01007916|393393|P1|STARTED|Period 2, 4 Weeks of Wear||22
163215|NCT01007916|393392|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
163216|NCT01007916|393393|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
163217|NCT01007916|393392|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
163218|NCT01007916|393393|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
163219|NCT01007916|393392|P2|STARTED|Period 1, 4 Weeks of Wear||26
163220|NCT01007916|393393|P1|STARTED|Period 1, 4 Weeks of Wear||23
163221|NCT01007942|393401|P2|NOT COMPLETED|Overall Study||278
163222|NCT01007942|393402|P1|NOT COMPLETED|Overall Study||281
163223|NCT01007942|393401|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
163224|NCT01007942|393402|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
163225|NCT01007942|393401|P2|STARTED|Overall Study||285
163226|NCT01007942|393402|P1|STARTED|Overall Study||284
163227|NCT01007838|393428|P4|NOT COMPLETED|Overall Study||0
163228|NCT01007838|393429|P3|NOT COMPLETED|Overall Study||0
163229|NCT01007838|393430|P2|NOT COMPLETED|Overall Study||0
163230|NCT01007838|393431|P1|NOT COMPLETED|Overall Study||3
163231|NCT01007838|393428|P4|COMPLETED|Overall Study||4
163232|NCT01007838|393429|P3|COMPLETED|Overall Study||5
163233|NCT01007838|393430|P2|COMPLETED|Overall Study||11
163234|NCT01007838|393431|P1|COMPLETED|Overall Study||9
163235|NCT01007838|393428|P4|STARTED|Overall Study||4
163236|NCT01007838|393429|P3|STARTED|Overall Study||5
163237|NCT01007838|393430|P2|STARTED|Overall Study||11
163238|NCT01007838|393431|P1|STARTED|Overall Study||12
163239|NCT01007812|393441|P2|NOT COMPLETED|Period 2, One Week||0
163240|NCT01007812|393442|P1|NOT COMPLETED|Period 2, One Week||0
163241|NCT01007812|393441|P2|COMPLETED|Period 2, One Week||24
163242|NCT01007812|393442|P1|COMPLETED|Period 2, One Week||24
163243|NCT01007812|393441|P2|STARTED|Period 2, One Week||24
163244|NCT01007812|393442|P1|STARTED|Period 2, One Week||24
163245|NCT01007812|393441|P2|NOT COMPLETED|Period 1, One Week||1
163246|NCT01007812|393442|P1|NOT COMPLETED|Period 1, One Week||1
163247|NCT01007812|393441|P2|COMPLETED|Period 1, One Week||24
163248|NCT01007812|393442|P1|COMPLETED|Period 1, One Week||24
163249|NCT01007812|393441|P2|STARTED|Period 1, One Week||25
163250|NCT01007812|393442|P1|STARTED|Period 1, One Week||25
163251|NCT01007656|393448|P1|NOT COMPLETED|Overall Study||0
163252|NCT01007656|393448|P1|COMPLETED|Overall Study||31
163253|NCT01007656|393448|P1|STARTED|Overall Study||31
163254|NCT01007643|393468|P2|NOT COMPLETED|Overall Study||0
163255|NCT01007643|393469|P1|NOT COMPLETED|Overall Study||0
163256|NCT01007643|393468|P2|COMPLETED|Overall Study||14
163257|NCT01007643|393469|P1|COMPLETED|Overall Study||8
163258|NCT01007643|393468|P2|STARTED|Overall Study||14
163259|NCT01007643|393469|P1|STARTED|Overall Study||8
163260|NCT01007552|393475|P1|NOT COMPLETED|Overall Study||1
163261|NCT01007552|393475|P1|COMPLETED|Overall Study||49
163262|NCT01007552|393475|P1|STARTED|Overall Study||50
163263|NCT01007435|393489|P4|NOT COMPLETED|Overall Study||56
163264|NCT01007435|393490|P3|NOT COMPLETED|Overall Study||64
163265|NCT01007435|393491|P2|NOT COMPLETED|Overall Study||59
163266|NCT01007435|393492|P1|NOT COMPLETED|Overall Study||63
163267|NCT01007435|393489|P4|COMPLETED|Overall Study||236
163268|NCT01007435|393490|P3|COMPLETED|Overall Study||227
163269|NCT01007435|393491|P2|COMPLETED|Overall Study||231
163270|NCT01007435|393492|P1|COMPLETED|Overall Study||226
163271|NCT01007435|393489|P4|STARTED|Overall Study||292
163272|NCT01007435|393490|P3|STARTED|Overall Study||291
163273|NCT01007435|393491|P2|STARTED|Overall Study||290
163274|NCT01007435|393492|P1|STARTED|Overall Study||289
163275|NCT01007396|393534|P1|NOT COMPLETED|Overall Study||47
163276|NCT01007396|393534|P1|COMPLETED|Overall Study||275
163277|NCT01007396|393534|P1|STARTED|Overall Study||322
163278|NCT01007253|393539|P4|NOT COMPLETED|Fourth Intervention||0
163279|NCT01007253|393540|P3|NOT COMPLETED|Fourth Intervention||0
163280|NCT01007253|393541|P2|NOT COMPLETED|Fourth Intervention||0
163281|NCT01007253|393542|P1|NOT COMPLETED|Fourth Intervention||0
163282|NCT01007253|393539|P4|COMPLETED|Fourth Intervention||5
163283|NCT01007253|393540|P3|COMPLETED|Fourth Intervention||5
163284|NCT01007253|393541|P2|COMPLETED|Fourth Intervention||5
163285|NCT01007253|393542|P1|COMPLETED|Fourth Intervention||5
163286|NCT01007253|393539|P4|STARTED|Fourth Intervention||5
163287|NCT01007253|393540|P3|STARTED|Fourth Intervention||5
163288|NCT01007253|393541|P2|STARTED|Fourth Intervention||5
163289|NCT01007253|393542|P1|STARTED|Fourth Intervention||5
163290|NCT01007253|393539|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
163291|NCT01007253|393540|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
163292|NCT01007253|393541|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
163293|NCT01007253|393542|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
163294|NCT01007253|393539|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
163295|NCT01007253|393540|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
163296|NCT01007253|393541|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
163297|NCT01007253|393542|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
163298|NCT01007253|393539|P4|STARTED|Washout Period (2 Weeks) # 3||5
163299|NCT01007253|393540|P3|STARTED|Washout Period (2 Weeks) # 3||5
163300|NCT01007253|393541|P2|STARTED|Washout Period (2 Weeks) # 3||5
163301|NCT01007253|393542|P1|STARTED|Washout Period (2 Weeks) # 3||6
163302|NCT01007253|393539|P4|NOT COMPLETED|Third Intervention||0
163303|NCT01007253|393540|P3|NOT COMPLETED|Third Intervention||0
163304|NCT01007253|393541|P2|NOT COMPLETED|Third Intervention||0
163305|NCT01007253|393542|P1|NOT COMPLETED|Third Intervention||0
163306|NCT01007253|393539|P4|COMPLETED|Third Intervention||5
163307|NCT01007253|393540|P3|COMPLETED|Third Intervention||5
163308|NCT01007253|393541|P2|COMPLETED|Third Intervention||5
163309|NCT01007253|393542|P1|COMPLETED|Third Intervention||6
163310|NCT01007253|393539|P4|STARTED|Third Intervention||5
163311|NCT01007253|393540|P3|STARTED|Third Intervention||5
163312|NCT01007253|393541|P2|STARTED|Third Intervention||5
163313|NCT01007253|393542|P1|STARTED|Third Intervention||6
163314|NCT01007253|393539|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
163315|NCT01007253|393540|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
163316|NCT01007253|393541|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
163317|NCT01007253|393542|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
163318|NCT01007253|393539|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
163319|NCT01007253|393540|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
163320|NCT01007253|393541|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
163321|NCT01007253|393542|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
163322|NCT01007253|393539|P4|STARTED|Washout Period (2 Weeks) # 2||5
163323|NCT01007253|393540|P3|STARTED|Washout Period (2 Weeks) # 2||5
163324|NCT01007253|393541|P2|STARTED|Washout Period (2 Weeks) # 2||5
163325|NCT01007253|393542|P1|STARTED|Washout Period (2 Weeks) # 2||6
163326|NCT01007253|393539|P4|NOT COMPLETED|Second Intervention||0
163327|NCT01007253|393540|P3|NOT COMPLETED|Second Intervention||0
163328|NCT01007253|393541|P2|NOT COMPLETED|Second Intervention||0
163329|NCT01007253|393542|P1|NOT COMPLETED|Second Intervention||0
163330|NCT01007253|393539|P4|COMPLETED|Second Intervention||5
163331|NCT01007253|393540|P3|COMPLETED|Second Intervention||5
163332|NCT01007253|393541|P2|COMPLETED|Second Intervention||5
163333|NCT01007253|393542|P1|COMPLETED|Second Intervention||6
163334|NCT01007253|393539|P4|STARTED|Second Intervention||5
163335|NCT01007253|393540|P3|STARTED|Second Intervention||5
163336|NCT01007253|393541|P2|STARTED|Second Intervention||5
163337|NCT01007253|393542|P1|STARTED|Second Intervention||6
163338|NCT01007253|393539|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
163339|NCT01007253|393540|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
163340|NCT01007253|393541|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
163341|NCT01007253|393542|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
163342|NCT01007253|393539|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
163343|NCT01007253|393540|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
163344|NCT01007253|393541|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
163345|NCT01007253|393542|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
163346|NCT01007253|393539|P4|STARTED|Washout Period (2 Weeks) # 1||5
163347|NCT01007253|393540|P3|STARTED|Washout Period (2 Weeks) # 1||5
163348|NCT01007253|393541|P2|STARTED|Washout Period (2 Weeks) # 1||5
163349|NCT01007253|393542|P1|STARTED|Washout Period (2 Weeks) # 1||6
163350|NCT01007253|393539|P4|NOT COMPLETED|First Intervention||0
163351|NCT01007253|393540|P3|NOT COMPLETED|First Intervention||0
163352|NCT01007253|393541|P2|NOT COMPLETED|First Intervention||0
163353|NCT01007253|393542|P1|NOT COMPLETED|First Intervention||0
163354|NCT01007253|393539|P4|COMPLETED|First Intervention||5
163355|NCT01007253|393540|P3|COMPLETED|First Intervention||5
163356|NCT01007253|393541|P2|COMPLETED|First Intervention||5
163357|NCT01007253|393542|P1|COMPLETED|First Intervention||6
163358|NCT01007253|393539|P4|STARTED|First Intervention||5
163359|NCT01007253|393540|P3|STARTED|First Intervention||5
163360|NCT01007253|393541|P2|STARTED|First Intervention||5
163361|NCT01007253|393542|P1|STARTED|First Intervention||6
163362|NCT01007149|393574|P2|NOT COMPLETED|Overall Study||1
163363|NCT01007149|393575|P1|NOT COMPLETED|Overall Study||0
163364|NCT01007149|393574|P2|COMPLETED|Overall Study||20
163365|NCT01007149|393575|P1|COMPLETED|Overall Study||20
163366|NCT01007149|393574|P2|STARTED|Overall Study||21
163367|NCT01007149|393575|P1|STARTED|Overall Study||20
163368|NCT01007123|393601|P4|NOT COMPLETED|Overall Study||6
163369|NCT01007123|393602|P3|NOT COMPLETED|Overall Study||11
163370|NCT01007123|393603|P2|NOT COMPLETED|Overall Study||6
163371|NCT01007123|393604|P1|NOT COMPLETED|Overall Study||6
163372|NCT01007123|393601|P4|COMPLETED|Overall Study||41
163373|NCT01007123|393602|P3|COMPLETED|Overall Study||37
163374|NCT01007123|393603|P2|COMPLETED|Overall Study||41
163375|NCT01007123|393604|P1|COMPLETED|Overall Study||42
163376|NCT01007123|393601|P4|STARTED|Overall Study||47
163377|NCT01007123|393602|P3|STARTED|Overall Study||48
163378|NCT01007123|393603|P2|STARTED|Overall Study||47
163379|NCT01007123|393604|P1|STARTED|Overall Study||48
163380|NCT01007110|393635|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
163381|NCT01007110|393636|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
163382|NCT01007110|393635|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
163383|NCT01007110|393636|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
163384|NCT01007110|393635|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
163385|NCT01007110|393636|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
163386|NCT01007110|393635|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
163387|NCT01007110|393636|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
163388|NCT01007110|393635|P2|COMPLETED|Follow-Up at 36 Weeks||20
163389|NCT01007110|393636|P1|COMPLETED|Follow-Up at 36 Weeks||24
163390|NCT01007110|393635|P2|STARTED|Follow-Up at 36 Weeks||22
163391|NCT01007110|393636|P1|STARTED|Follow-Up at 36 Weeks||24
163392|NCT01007110|393635|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
163393|NCT01007110|393636|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
163394|NCT01007110|393635|P2|COMPLETED|Follow-Up at 32 Weeks||22
163395|NCT01007110|393636|P1|COMPLETED|Follow-Up at 32 Weeks||24
163396|NCT01007110|393635|P2|STARTED|Follow-Up at 32 Weeks||23
163397|NCT01007110|393636|P1|STARTED|Follow-Up at 32 Weeks||25
163398|NCT01007110|393635|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
163399|NCT01007110|393636|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
163400|NCT01007110|393635|P2|COMPLETED|Follow-Up at 24 Weeks||23
163401|NCT01007110|393636|P1|COMPLETED|Follow-Up at 24 Weeks||25
163402|NCT01007110|393635|P2|STARTED|Follow-Up at 24 Weeks||27
163403|NCT01007110|393636|P1|STARTED|Follow-Up at 24 Weeks||25
163404|NCT01007110|393635|P2|NOT COMPLETED|Allocation||8
163405|NCT01007110|393636|P1|NOT COMPLETED|Allocation||7
163406|NCT01007110|393635|P2|COMPLETED|Allocation||27
163407|NCT01007110|393636|P1|COMPLETED|Allocation||25
163408|NCT01007110|393635|P2|STARTED|Allocation||35
163409|NCT01007110|393636|P1|STARTED|Allocation||32
163410|NCT01007071|393652|P2|NOT COMPLETED|Overall Study||0
163411|NCT01007071|393653|P1|NOT COMPLETED|Overall Study||0
163412|NCT01007071|393652|P2|COMPLETED|Overall Study||5
163413|NCT01007071|393653|P1|COMPLETED|Overall Study||6
163414|NCT01007071|393652|P2|STARTED|Overall Study||5
163415|NCT01007071|393653|P1|STARTED|Overall Study||6
163416|NCT01006980|393663|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
163417|NCT01006980|393664|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
163418|NCT01006980|393663|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
163419|NCT01006980|393664|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
163420|NCT01006980|393663|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
163421|NCT01006980|393664|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
163422|NCT01006980|393663|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
163423|NCT01006980|393664|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
163424|NCT01006980|393663|P2|COMPLETED|Vemurafenib and Dacarbazine||0
163425|NCT01006980|393664|P1|COMPLETED|Vemurafenib and Dacarbazine||0
163426|NCT01006980|393663|P2|Treated|Vemurafenib and Dacarbazine||293
163427|NCT01006980|393664|P1|Treated|Vemurafenib and Dacarbazine||336
163428|NCT01006980|393663|P2|STARTED|Vemurafenib and Dacarbazine||338
163429|NCT01006980|393664|P1|STARTED|Vemurafenib and Dacarbazine||337
163430|NCT01006889|393684|P1|NOT COMPLETED|Overall Study||3
163431|NCT01006889|393684|P1|COMPLETED|Overall Study||17
163432|NCT01006889|393684|P1|STARTED|Overall Study||20
163433|NCT01006707|393695|P3|NOT COMPLETED|Study Session 3||0
163434|NCT01006707|393696|P2|NOT COMPLETED|Study Session 3||0
163435|NCT01006707|393697|P1|NOT COMPLETED|Study Session 3||0
163436|NCT01006707|393695|P3|COMPLETED|Study Session 3||6
163437|NCT01006707|393696|P2|COMPLETED|Study Session 3||4
163438|NCT01006707|393697|P1|COMPLETED|Study Session 3||0
163439|NCT01006707|393695|P3|STARTED|Study Session 3||6
163440|NCT01006707|393696|P2|STARTED|Study Session 3||4
163441|NCT01006707|393697|P1|STARTED|Study Session 3||0
163442|NCT01006707|393695|P3|NOT COMPLETED|Study Session 2||0
163443|NCT01006707|393696|P2|NOT COMPLETED|Study Session 2||0
163444|NCT01006707|393697|P1|NOT COMPLETED|Study Session 2||0
163445|NCT01006707|393695|P3|COMPLETED|Study Session 2||6
163446|NCT01006707|393696|P2|COMPLETED|Study Session 2||4
163447|NCT01006707|393697|P1|COMPLETED|Study Session 2||0
163448|NCT01006707|393695|P3|STARTED|Study Session 2||6
163449|NCT01006707|393696|P2|STARTED|Study Session 2||4
163450|NCT01006707|393697|P1|STARTED|Study Session 2||0
163451|NCT01006707|393695|P3|NOT COMPLETED|Study Session 1||0
163452|NCT01006707|393696|P2|NOT COMPLETED|Study Session 1||0
163453|NCT01006707|393697|P1|NOT COMPLETED|Study Session 1||5
163454|NCT01006707|393695|P3|COMPLETED|Study Session 1||0
163455|NCT01006707|393696|P2|COMPLETED|Study Session 1||0
163456|NCT01006707|393697|P1|COMPLETED|Study Session 1||10
163457|NCT01006707|393695|P3|STARTED|Study Session 1||0
163458|NCT01006707|393696|P2|STARTED|Study Session 1||0
163459|NCT01006707|393697|P1|STARTED|Study Session 1||15
163460|NCT01006655|393710|P2|NOT COMPLETED|Second Intervention||0
163461|NCT01006655|393711|P1|NOT COMPLETED|Second Intervention||0
163462|NCT01006655|393710|P2|COMPLETED|Second Intervention||10
163463|NCT01006655|393711|P1|COMPLETED|Second Intervention||11
163464|NCT01006655|393710|P2|STARTED|Second Intervention||10
163465|NCT01006655|393711|P1|STARTED|Second Intervention||11
163466|NCT01006655|393710|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
163467|NCT01006655|393711|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
163468|NCT01006655|393710|P2|COMPLETED|Washout Period of 2 Weeks||10
163469|NCT01006655|393711|P1|COMPLETED|Washout Period of 2 Weeks||11
163470|NCT01006655|393710|P2|STARTED|Washout Period of 2 Weeks||10
163471|NCT01006655|393711|P1|STARTED|Washout Period of 2 Weeks||11
163472|NCT01006655|393710|P2|NOT COMPLETED|First Intervention||0
163473|NCT01006655|393711|P1|NOT COMPLETED|First Intervention||0
163474|NCT01006655|393710|P2|COMPLETED|First Intervention||10
163475|NCT01006655|393711|P1|COMPLETED|First Intervention||11
163476|NCT01006655|393710|P2|STARTED|First Intervention||10
163477|NCT01006655|393711|P1|STARTED|First Intervention||11
163478|NCT01006629|393717|P1|NOT COMPLETED|Overall Study||6
163479|NCT01006629|393717|P1|COMPLETED|Overall Study||94
163480|NCT01006629|393717|P1|STARTED|Overall Study||100
163481|NCT01006616|393732|P4|NOT COMPLETED|Period 2 (18 Months)||82
163482|NCT01006616|393733|P3|NOT COMPLETED|Period 2 (18 Months)||55
163483|NCT01006616|393734|P2|NOT COMPLETED|Period 2 (18 Months)||63
163484|NCT01006616|393735|P1|NOT COMPLETED|Period 2 (18 Months)||75
163485|NCT01006616|393732|P4|COMPLETED|Period 2 (18 Months)||0
163486|NCT01006616|393733|P3|COMPLETED|Period 2 (18 Months)||0
163487|NCT01006616|393734|P2|COMPLETED|Period 2 (18 Months)||0
163488|NCT01006616|393735|P1|COMPLETED|Period 2 (18 Months)||0
163489|NCT01006616|393732|P4|Treated|Period 2 (18 Months)||82
163490|NCT01006616|393733|P3|Treated|Period 2 (18 Months)||55
163491|NCT01006616|393734|P2|Treated|Period 2 (18 Months)||63
163492|NCT01006616|393735|P1|Treated|Period 2 (18 Months)||75
163493|NCT01006616|393732|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
163494|NCT01006616|393733|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
163495|NCT01006616|393734|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
163496|NCT01006616|393735|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
163497|NCT01006616|393732|P4|NOT COMPLETED|Period 1 (6 Months)||27
163498|NCT01006616|393733|P3|NOT COMPLETED|Period 1 (6 Months)||51
163499|NCT01006616|393734|P2|NOT COMPLETED|Period 1 (6 Months)||54
163500|NCT01006616|393735|P1|NOT COMPLETED|Period 1 (6 Months)||26
163501|NCT01006616|393732|P4|COMPLETED|Period 1 (6 Months)||128
163502|NCT01006616|393733|P3|COMPLETED|Period 1 (6 Months)||102
163503|NCT01006616|393734|P2|COMPLETED|Period 1 (6 Months)||102
163504|NCT01006616|393735|P1|COMPLETED|Period 1 (6 Months)||126
163505|NCT01006616|393732|P4|Treated|Period 1 (6 Months)||154
163506|NCT01006616|393733|P3|Treated|Period 1 (6 Months)||152
163507|NCT01006616|393734|P2|Treated|Period 1 (6 Months)||156
163508|NCT01006616|393735|P1|Treated|Period 1 (6 Months)||152
163509|NCT01006616|393732|P4|STARTED|Period 1 (6 Months)||155
163510|NCT01006616|393733|P3|STARTED|Period 1 (6 Months)||153
163511|NCT01006616|393734|P2|STARTED|Period 1 (6 Months)||156
163512|NCT01006616|393735|P1|STARTED|Period 1 (6 Months)||152
163513|NCT01006603|393871|P2|NOT COMPLETED|Overall Study||75
163514|NCT01006603|393872|P1|NOT COMPLETED|Overall Study||71
163515|NCT01006603|393871|P2|COMPLETED|Overall Study||285
163516|NCT01006603|393872|P1|COMPLETED|Overall Study||289
163517|NCT01006603|393871|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
163518|NCT01006603|393872|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
163519|NCT01006590|393892|P2|NOT COMPLETED|Overall Study||32
163520|NCT01006590|393893|P1|NOT COMPLETED|Overall Study||28
163521|NCT01006590|393892|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
163522|NCT01006590|393893|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
163523|NCT01006590|393892|P2|STARTED|Overall Study|Randomised and treated|139
163524|NCT01006590|393893|P1|STARTED|Overall Study|Randomised and treated|147
163525|NCT01006356|393909|P1|NOT COMPLETED|Overall Study||42
163526|NCT01006356|393909|P1|COMPLETED|Overall Study||99
163527|NCT01006356|393909|P1|STARTED|Overall Study||141
163528|NCT01006291|393924|P3|NOT COMPLETED|Overall Study||27
163529|NCT01006291|393925|P2|NOT COMPLETED|Overall Study||24
163530|NCT01006291|393926|P1|NOT COMPLETED|Overall Study||26
163531|NCT01006291|393924|P3|COMPLETED|Overall Study||203
163532|NCT01006291|393925|P2|COMPLETED|Overall Study||204
163533|NCT01006291|393926|P1|COMPLETED|Overall Study||203
163534|NCT01006291|393924|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
163535|NCT01006291|393925|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
163536|NCT01006291|393926|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
163537|NCT01006291|393924|P3|STARTED|Overall Study||230
163538|NCT01006291|393925|P2|STARTED|Overall Study||228
163539|NCT01006291|393926|P1|STARTED|Overall Study||229
163540|NCT01006135|393943|P1|NOT COMPLETED|Overall Study||140
163541|NCT01006135|393943|P1|COMPLETED|Overall Study||4712
163542|NCT01006135|393943|P1|STARTED|Overall Study||4852
163543|NCT01006122|393950|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
163544|NCT01006122|393951|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
163545|NCT01006122|393950|P2|COMPLETED|Second Double-blind Intervention Period||24
163546|NCT01006122|393951|P1|COMPLETED|Second Double-blind Intervention Period||29
163547|NCT01006122|393950|P2|STARTED|Second Double-blind Intervention Period||31
163548|NCT01006122|393951|P1|STARTED|Second Double-blind Intervention Period||31
163549|NCT01006122|393950|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
163550|NCT01006122|393951|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
163551|NCT01006122|393950|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
163552|NCT01006122|393951|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
163553|NCT01006122|393950|P2|STARTED|Wash-out Period (at Least 7 Days)||31
163554|NCT01006122|393951|P1|STARTED|Wash-out Period (at Least 7 Days)||31
163555|NCT01006122|393950|P2|NOT COMPLETED|First Double-blind Intervention Period||17
163556|NCT01006122|393951|P1|NOT COMPLETED|First Double-blind Intervention Period||16
163557|NCT01006122|393950|P2|COMPLETED|First Double-blind Intervention Period||31
163558|NCT01006122|393951|P1|COMPLETED|First Double-blind Intervention Period||31
163559|NCT01006122|393950|P2|STARTED|First Double-blind Intervention Period||48
163560|NCT01006122|393951|P1|STARTED|First Double-blind Intervention Period||47
163561|NCT01006018|393992|P3|NOT COMPLETED|Overall Study||0
163562|NCT01006018|393993|P2|NOT COMPLETED|Overall Study||0
163563|NCT01006018|393994|P1|NOT COMPLETED|Overall Study||0
163564|NCT01006018|393992|P3|COMPLETED|Overall Study||0
163565|NCT01006018|393993|P2|COMPLETED|Overall Study||0
163566|NCT01006018|393994|P1|COMPLETED|Overall Study||0
163567|NCT01006018|393992|P3|STARTED|Overall Study||0
163568|NCT01006018|393993|P2|STARTED|Overall Study||0
163569|NCT01006018|393994|P1|STARTED|Overall Study||0
163570|NCT01005966|394002|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
163571|NCT01005966|394003|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
163572|NCT01005966|394004|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
163573|NCT01005966|394005|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
163574|NCT01005966|394006|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
163575|NCT01005966|394002|P5|COMPLETED|Treatment Period 5 (14 Days)||10
163576|NCT01005966|394003|P4|COMPLETED|Treatment Period 5 (14 Days)||11
163577|NCT01005966|394004|P3|COMPLETED|Treatment Period 5 (14 Days)||11
163578|NCT01005966|394005|P2|COMPLETED|Treatment Period 5 (14 Days)||12
163579|NCT01005966|394006|P1|COMPLETED|Treatment Period 5 (14 Days)||9
163580|NCT01005966|394002|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
163581|NCT01005966|394003|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
163582|NCT01005966|394004|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
163583|NCT01005966|394005|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
163584|NCT01005966|394006|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
163585|NCT01005966|394002|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
163586|NCT01005966|394003|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
163587|NCT01005966|394004|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
163588|NCT01005966|394005|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
163589|NCT01005966|394006|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
163590|NCT01005966|394002|P5|COMPLETED|Washout Period 4 (4 Days)||12
163591|NCT01005966|394003|P4|COMPLETED|Washout Period 4 (4 Days)||10
163592|NCT01005966|394004|P3|COMPLETED|Washout Period 4 (4 Days)||11
163593|NCT01005966|394005|P2|COMPLETED|Washout Period 4 (4 Days)||10
163594|NCT01005966|394006|P1|COMPLETED|Washout Period 4 (4 Days)||10
163595|NCT01005966|394002|P5|STARTED|Washout Period 4 (4 Days)||12
163596|NCT01005966|394003|P4|STARTED|Washout Period 4 (4 Days)||10
163597|NCT01005966|394004|P3|STARTED|Washout Period 4 (4 Days)||11
163598|NCT01005966|394005|P2|STARTED|Washout Period 4 (4 Days)||10
163599|NCT01005966|394006|P1|STARTED|Washout Period 4 (4 Days)||10
163600|NCT01005966|394002|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
163601|NCT01005966|394003|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
163602|NCT01005966|394004|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
163603|NCT01005966|394005|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
163604|NCT01005966|394006|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
163605|NCT01005966|394002|P5|COMPLETED|Treatment Period 4 (14 Days)||12
163606|NCT01005966|394003|P4|COMPLETED|Treatment Period 4 (14 Days)||10
163607|NCT01005966|394004|P3|COMPLETED|Treatment Period 4 (14 Days)||11
163608|NCT01005966|394005|P2|COMPLETED|Treatment Period 4 (14 Days)||10
163609|NCT01005966|394006|P1|COMPLETED|Treatment Period 4 (14 Days)||10
163610|NCT01005966|394002|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
163611|NCT01005966|394003|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
163612|NCT01005966|394004|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
163613|NCT01005966|394005|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
163614|NCT01005966|394006|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
163615|NCT01005966|394002|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
163616|NCT01005966|394003|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
163617|NCT01005966|394004|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
163618|NCT01005966|394005|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
163619|NCT01005966|394006|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
163620|NCT01005966|394002|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
163621|NCT01005966|394003|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
163622|NCT01005966|394004|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
163623|NCT01005966|394005|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
163624|NCT01005966|394006|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
163625|NCT01005966|394002|P5|STARTED|Washout Period 3 ( 4 Days)||11
163626|NCT01005966|394003|P4|STARTED|Washout Period 3 ( 4 Days)||13
163627|NCT01005966|394004|P3|STARTED|Washout Period 3 ( 4 Days)||12
163628|NCT01005966|394005|P2|STARTED|Washout Period 3 ( 4 Days)||7
163629|NCT01005966|394006|P1|STARTED|Washout Period 3 ( 4 Days)||12
163630|NCT01005966|394002|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
163631|NCT01005966|394003|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
163632|NCT01005966|394004|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
163633|NCT01005966|394005|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
163634|NCT01005966|394006|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
163635|NCT01005966|394002|P5|COMPLETED|Treatment Period 3 (14 Days)||11
163636|NCT01005966|394003|P4|COMPLETED|Treatment Period 3 (14 Days)||13
163637|NCT01005966|394004|P3|COMPLETED|Treatment Period 3 (14 Days)||12
163638|NCT01005966|394005|P2|COMPLETED|Treatment Period 3 (14 Days)||7
163639|NCT01005966|394006|P1|COMPLETED|Treatment Period 3 (14 Days)||12
163640|NCT01005966|394002|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
163641|NCT01005966|394003|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
163642|NCT01005966|394004|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
163643|NCT01005966|394005|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
163723|NCT01005888|394076|P1|STARTED|Second Intervention||11
163644|NCT01005966|394006|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
163645|NCT01005966|394002|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
163646|NCT01005966|394003|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
163647|NCT01005966|394004|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
163648|NCT01005966|394005|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
163649|NCT01005966|394006|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
163650|NCT01005966|394002|P5|COMPLETED|Washout Period 2 (4 Days)||11
163651|NCT01005966|394003|P4|COMPLETED|Washout Period 2 (4 Days)||11
163652|NCT01005966|394004|P3|COMPLETED|Washout Period 2 (4 Days)||10
163653|NCT01005966|394005|P2|COMPLETED|Washout Period 2 (4 Days)||12
163654|NCT01005966|394006|P1|COMPLETED|Washout Period 2 (4 Days)||13
163655|NCT01005966|394002|P5|STARTED|Washout Period 2 (4 Days)||11
163656|NCT01005966|394003|P4|STARTED|Washout Period 2 (4 Days)||11
163657|NCT01005966|394004|P3|STARTED|Washout Period 2 (4 Days)||10
163658|NCT01005966|394005|P2|STARTED|Washout Period 2 (4 Days)||12
163659|NCT01005966|394006|P1|STARTED|Washout Period 2 (4 Days)||13
163660|NCT01005966|394002|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
163661|NCT01005966|394003|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
163662|NCT01005966|394004|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
163663|NCT01005966|394005|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
163664|NCT01005966|394006|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
163665|NCT01005966|394002|P5|COMPLETED|Treatment Period 2 (14 Days)||11
163666|NCT01005966|394003|P4|COMPLETED|Treatment Period 2 (14 Days)||11
163667|NCT01005966|394004|P3|COMPLETED|Treatment Period 2 (14 Days)||10
163668|NCT01005966|394005|P2|COMPLETED|Treatment Period 2 (14 Days)||12
163669|NCT01005966|394006|P1|COMPLETED|Treatment Period 2 (14 Days)||13
163670|NCT01005966|394002|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
163671|NCT01005966|394003|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
163672|NCT01005966|394004|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
163673|NCT01005966|394005|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
163674|NCT01005966|394006|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
163675|NCT01005966|394002|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
163676|NCT01005966|394003|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
163677|NCT01005966|394004|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
163678|NCT01005966|394005|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
163679|NCT01005966|394006|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
163680|NCT01005966|394002|P5|COMPLETED|Washout Period 1 (4 Days)||13
163681|NCT01005966|394003|P4|COMPLETED|Washout Period 1 (4 Days)||12
163682|NCT01005966|394004|P3|COMPLETED|Washout Period 1 (4 Days)||12
163683|NCT01005966|394005|P2|COMPLETED|Washout Period 1 (4 Days)||13
163684|NCT01005966|394006|P1|COMPLETED|Washout Period 1 (4 Days)||11
163685|NCT01005966|394002|P5|STARTED|Washout Period 1 (4 Days)||13
163686|NCT01005966|394003|P4|STARTED|Washout Period 1 (4 Days)||13
163687|NCT01005966|394004|P3|STARTED|Washout Period 1 (4 Days)||12
163688|NCT01005966|394005|P2|STARTED|Washout Period 1 (4 Days)||13
163689|NCT01005966|394006|P1|STARTED|Washout Period 1 (4 Days)||11
163690|NCT01005966|394002|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
163691|NCT01005966|394003|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
163692|NCT01005966|394004|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
163693|NCT01005966|394005|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
163694|NCT01005966|394006|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
163695|NCT01005966|394002|P5|COMPLETED|Treatment Period 1 (14 Days)||13
163696|NCT01005966|394003|P4|COMPLETED|Treatment Period 1 (14 Days)||13
163697|NCT01005966|394004|P3|COMPLETED|Treatment Period 1 (14 Days)||12
163698|NCT01005966|394005|P2|COMPLETED|Treatment Period 1 (14 Days)||13
163699|NCT01005966|394006|P1|COMPLETED|Treatment Period 1 (14 Days)||11
163700|NCT01005966|394002|P5|STARTED|Treatment Period 1 (14 Days)||13
163701|NCT01005966|394003|P4|STARTED|Treatment Period 1 (14 Days)||13
163702|NCT01005966|394004|P3|STARTED|Treatment Period 1 (14 Days)||13
163703|NCT01005966|394005|P2|STARTED|Treatment Period 1 (14 Days)||13
163704|NCT01005966|394006|P1|STARTED|Treatment Period 1 (14 Days)||13
163705|NCT01005914|394026|P1|NOT COMPLETED|Overall Study||10
163706|NCT01005914|394026|P1|COMPLETED|Overall Study||1
163707|NCT01005914|394026|P1|STARTED|Overall Study||11
163708|NCT01005901|394032|P2|NOT COMPLETED|Overall Study||58
163709|NCT01005901|394033|P1|NOT COMPLETED|Overall Study||102
163710|NCT01005901|394032|P2|COMPLETED|Overall Study||212
163711|NCT01005901|394033|P1|COMPLETED|Overall Study||450
163712|NCT01005901|394032|P2|Full Analysis Set|Overall Study||260
163713|NCT01005901|394033|P1|Full Analysis Set|Overall Study||534
163714|NCT01005901|394032|P2|Safety Population|Overall Study||267
163715|NCT01005901|394033|P1|Safety Population|Overall Study||550
163716|NCT01005901|394032|P2|STARTED|Overall Study||270
163717|NCT01005901|394033|P1|STARTED|Overall Study||552
163718|NCT01005888|394075|P2|NOT COMPLETED|Second Intervention||1
163719|NCT01005888|394076|P1|NOT COMPLETED|Second Intervention||1
163720|NCT01005888|394075|P2|COMPLETED|Second Intervention||10
163721|NCT01005888|394076|P1|COMPLETED|Second Intervention||10
163722|NCT01005888|394075|P2|STARTED|Second Intervention||11
163724|NCT01005888|394075|P2|NOT COMPLETED|First Intervention||1
163725|NCT01005888|394076|P1|NOT COMPLETED|First Intervention||1
163726|NCT01005888|394075|P2|COMPLETED|First Intervention||11
163727|NCT01005888|394076|P1|COMPLETED|First Intervention||11
163728|NCT01005888|394075|P2|STARTED|First Intervention||12
163729|NCT01005888|394076|P1|STARTED|First Intervention||12
163730|NCT01005875|394096|P1|NOT COMPLETED|Overall Study||3
163731|NCT01005875|394096|P1|COMPLETED|Overall Study||2
163732|NCT01005875|394096|P1|STARTED|Overall Study||5
163733|NCT01005745|394104|P1|NOT COMPLETED|Overall Study||6
163734|NCT01005745|394104|P1|COMPLETED|Overall Study||13
163735|NCT01005745|394104|P1|STARTED|Overall Study||19
163736|NCT01005732|394109|P1|NOT COMPLETED|Overall Study||11
163737|NCT01005732|394109|P1|COMPLETED|Overall Study||43
163738|NCT01005732|394109|P1|STARTED|Overall Study||54
163739|NCT01005719|394125|P6|NOT COMPLETED|Period 3||0
163740|NCT01005719|394126|P5|NOT COMPLETED|Period 3||0
163741|NCT01005719|394127|P4|NOT COMPLETED|Period 3||0
163742|NCT01005719|394128|P3|NOT COMPLETED|Period 3||0
163743|NCT01005719|394129|P2|NOT COMPLETED|Period 3||0
163744|NCT01005719|394130|P1|NOT COMPLETED|Period 3||0
163745|NCT01005719|394125|P6|COMPLETED|Period 3||9
163746|NCT01005719|394126|P5|COMPLETED|Period 3||10
163747|NCT01005719|394127|P4|COMPLETED|Period 3||10
163748|NCT01005719|394128|P3|COMPLETED|Period 3||10
163749|NCT01005719|394129|P2|COMPLETED|Period 3||10
163750|NCT01005719|394130|P1|COMPLETED|Period 3||10
163751|NCT01005719|394125|P6|STARTED|Period 3||9
163752|NCT01005719|394126|P5|STARTED|Period 3||10
163753|NCT01005719|394127|P4|STARTED|Period 3||10
163754|NCT01005719|394128|P3|STARTED|Period 3||10
163755|NCT01005719|394129|P2|STARTED|Period 3||10
163756|NCT01005719|394130|P1|STARTED|Period 3||10
163757|NCT01005719|394125|P6|NOT COMPLETED|Period 2||1
163758|NCT01005719|394126|P5|NOT COMPLETED|Period 2||1
163759|NCT01005719|394127|P4|NOT COMPLETED|Period 2||0
163760|NCT01005719|394128|P3|NOT COMPLETED|Period 2||0
163761|NCT01005719|394129|P2|NOT COMPLETED|Period 2||0
163762|NCT01005719|394130|P1|NOT COMPLETED|Period 2||0
163763|NCT01005719|394125|P6|COMPLETED|Period 2||9
163764|NCT01005719|394126|P5|COMPLETED|Period 2||10
163765|NCT01005719|394127|P4|COMPLETED|Period 2||10
163766|NCT01005719|394128|P3|COMPLETED|Period 2||10
163767|NCT01005719|394129|P2|COMPLETED|Period 2||10
163768|NCT01005719|394130|P1|COMPLETED|Period 2||10
163769|NCT01005719|394125|P6|STARTED|Period 2||10
163770|NCT01005719|394126|P5|STARTED|Period 2||11
163771|NCT01005719|394127|P4|STARTED|Period 2||10
163772|NCT01005719|394128|P3|STARTED|Period 2||10
163773|NCT01005719|394129|P2|STARTED|Period 2||10
163774|NCT01005719|394130|P1|STARTED|Period 2||10
163775|NCT01005719|394125|P6|NOT COMPLETED|Period 1||1
163776|NCT01005719|394126|P5|NOT COMPLETED|Period 1||0
163777|NCT01005719|394127|P4|NOT COMPLETED|Period 1||1
163778|NCT01005719|394128|P3|NOT COMPLETED|Period 1||0
163779|NCT01005719|394129|P2|NOT COMPLETED|Period 1||0
163780|NCT01005719|394130|P1|NOT COMPLETED|Period 1||0
163781|NCT01005719|394125|P6|COMPLETED|Period 1||10
163782|NCT01005719|394126|P5|COMPLETED|Period 1||11
163783|NCT01005719|394127|P4|COMPLETED|Period 1||10
163784|NCT01005719|394128|P3|COMPLETED|Period 1||10
163785|NCT01005719|394129|P2|COMPLETED|Period 1||10
163786|NCT01005719|394130|P1|COMPLETED|Period 1||10
163787|NCT01005719|394125|P6|STARTED|Period 1||11
163788|NCT01005719|394126|P5|STARTED|Period 1||11
163789|NCT01005719|394127|P4|STARTED|Period 1||11
163790|NCT01005719|394128|P3|STARTED|Period 1||10
163791|NCT01005719|394129|P2|STARTED|Period 1||10
163792|NCT01005719|394130|P1|STARTED|Period 1||10
163793|NCT01005706|394188|P2|NOT COMPLETED|Overall Study||0
163794|NCT01005706|394189|P1|NOT COMPLETED|Overall Study||0
163795|NCT01005706|394188|P2|COMPLETED|Overall Study||17
163796|NCT01005706|394189|P1|COMPLETED|Overall Study||23
163797|NCT01005706|394188|P2|STARTED|Overall Study||17
163798|NCT01005706|394189|P1|STARTED|Overall Study||23
163799|NCT01005680|394197|P2|NOT COMPLETED|Overall Study||11
163800|NCT01005680|394198|P1|NOT COMPLETED|Overall Study||6
163801|NCT01005680|394197|P2|COMPLETED|Overall Study||119
163802|NCT01005680|394198|P1|COMPLETED|Overall Study||120
163803|NCT01005680|394197|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
163804|NCT01005680|394198|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
163805|NCT01005680|394197|P2|STARTED|Overall Study||130
163806|NCT01005680|394198|P1|STARTED|Overall Study||126
163807|NCT01005602|394222|P2|NOT COMPLETED|Overall Study||0
163808|NCT01005602|394223|P1|NOT COMPLETED|Overall Study||1
163809|NCT01005602|394222|P2|COMPLETED|Overall Study||66
163810|NCT01005602|394223|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
163811|NCT01005602|394222|P2|STARTED|Overall Study||66
163812|NCT01005602|394223|P1|STARTED|Overall Study||66
163813|NCT01005576|394243|P1|NOT COMPLETED|Overall Study||0
163814|NCT01005576|394243|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
163815|NCT01005576|394243|P1|STARTED|Overall Study||21
163816|NCT01005459|394253|P2|NOT COMPLETED|Overall Study||0
163817|NCT01005459|394254|P1|NOT COMPLETED|Overall Study||0
163818|NCT01005459|394253|P2|COMPLETED|Overall Study||23
163819|NCT01005459|394254|P1|COMPLETED|Overall Study||23
163820|NCT01005459|394253|P2|STARTED|Overall Study||23
163821|NCT01005459|394254|P1|STARTED|Overall Study||23
163822|NCT01005407|394262|P2|NOT COMPLETED|Overall Study||32
163823|NCT01005407|394263|P1|NOT COMPLETED|Overall Study||151
163824|NCT01005407|394262|P2|COMPLETED|Overall Study||451
163825|NCT01005407|394263|P1|COMPLETED|Overall Study||1818
163826|NCT01005407|394262|P2|STARTED|Overall Study||483
163827|NCT01005407|394263|P1|STARTED|Overall Study||1969
163828|NCT01005355|394274|P3|NOT COMPLETED|Overall Study||0
163829|NCT01005355|394275|P2|NOT COMPLETED|Overall Study||0
163830|NCT01005355|394276|P1|NOT COMPLETED|Overall Study||0
163831|NCT01005355|394274|P3|COMPLETED|Overall Study||6
163832|NCT01005355|394275|P2|COMPLETED|Overall Study||6
163833|NCT01005355|394276|P1|COMPLETED|Overall Study||3
163834|NCT01005355|394274|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
163835|NCT01005355|394275|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
163836|NCT01005355|394276|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
163837|NCT01005355|394274|P3|STARTED|Overall Study||6
163838|NCT01005355|394275|P2|STARTED|Overall Study||6
163839|NCT01005355|394276|P1|STARTED|Overall Study||3
163840|NCT01005329|394311|P1|NOT COMPLETED|Overall Study||4
163841|NCT01005329|394311|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
163842|NCT01005329|394311|P1|STARTED|Overall Study||34
163843|NCT01005316|394324|P4|NOT COMPLETED|Overall Study||108
163844|NCT01005316|394325|P3|NOT COMPLETED|Overall Study||11
163845|NCT01005316|394326|P2|NOT COMPLETED|Overall Study||76
163846|NCT01005316|394327|P1|NOT COMPLETED|Overall Study||50
163847|NCT01005316|394324|P4|COMPLETED|Overall Study||19
163848|NCT01005316|394325|P3|COMPLETED|Overall Study||5
163849|NCT01005316|394326|P2|COMPLETED|Overall Study||21
163850|NCT01005316|394327|P1|COMPLETED|Overall Study||0
163851|NCT01005316|394324|P4|STARTED|Overall Study||127
163852|NCT01005316|394325|P3|STARTED|Overall Study||16
163853|NCT01005316|394326|P2|STARTED|Overall Study||97
163854|NCT01005316|394327|P1|STARTED|Overall Study||50
163855|NCT01005290|394379|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
163856|NCT01005290|394380|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
163857|NCT01005290|394381|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
163858|NCT01005290|394379|P3|COMPLETED|Period 2 (5 Weeks)||7
163859|NCT01005290|394380|P2|COMPLETED|Period 2 (5 Weeks)||13
163860|NCT01005290|394381|P1|COMPLETED|Period 2 (5 Weeks)||0
163861|NCT01005290|394379|P3|STARTED|Period 2 (5 Weeks)||9
163862|NCT01005290|394380|P2|STARTED|Period 2 (5 Weeks)||13
163863|NCT01005290|394381|P1|STARTED|Period 2 (5 Weeks)||0
163864|NCT01005290|394379|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
163865|NCT01005290|394380|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
163866|NCT01005290|394381|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
163867|NCT01005290|394379|P3|COMPLETED|Washout Period (2 Weeks)||9
163868|NCT01005290|394380|P2|COMPLETED|Washout Period (2 Weeks)||13
163869|NCT01005290|394381|P1|COMPLETED|Washout Period (2 Weeks)||0
163870|NCT01005290|394379|P3|STARTED|Washout Period (2 Weeks)||9
163871|NCT01005290|394380|P2|STARTED|Washout Period (2 Weeks)||13
163872|NCT01005290|394381|P1|STARTED|Washout Period (2 Weeks)||0
163873|NCT01005290|394379|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
163874|NCT01005290|394380|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
163875|NCT01005290|394381|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
163876|NCT01005290|394379|P3|COMPLETED|Period 1 (5 Weeks)||9
163877|NCT01005290|394380|P2|COMPLETED|Period 1 (5 Weeks)||13
163878|NCT01005290|394381|P1|COMPLETED|Period 1 (5 Weeks)||0
163879|NCT01005290|394379|P3|STARTED|Period 1 (5 Weeks)||18
163880|NCT01005290|394380|P2|STARTED|Period 1 (5 Weeks)||20
163881|NCT01005290|394381|P1|STARTED|Period 1 (5 Weeks)||0
163882|NCT01005290|394379|P3|NOT COMPLETED|Run-In||0
163883|NCT01005290|394380|P2|NOT COMPLETED|Run-In||0
163884|NCT01005290|394381|P1|NOT COMPLETED|Run-In||14
163885|NCT01005290|394379|P3|COMPLETED|Run-In||0
163886|NCT01005290|394380|P2|COMPLETED|Run-In||0
163887|NCT01005290|394381|P1|COMPLETED|Run-In||38
163888|NCT01005290|394379|P3|STARTED|Run-In||0
163889|NCT01005290|394380|P2|STARTED|Run-In||0
163890|NCT01005290|394381|P1|STARTED|Run-In||52
163891|NCT01005251|394394|P5|NOT COMPLETED|Overall Study||18
163892|NCT01005251|394395|P4|NOT COMPLETED|Overall Study||12
163893|NCT01005251|394396|P3|NOT COMPLETED|Overall Study||22
163894|NCT01005251|394397|P2|NOT COMPLETED|Overall Study||16
163895|NCT01005251|394398|P1|NOT COMPLETED|Overall Study||13
163896|NCT01005251|394394|P5|COMPLETED|Overall Study||122
163897|NCT01005251|394395|P4|COMPLETED|Overall Study||114
163898|NCT01005251|394396|P3|COMPLETED|Overall Study||114
163899|NCT01005251|394397|P2|COMPLETED|Overall Study||109
163900|NCT01005251|394398|P1|COMPLETED|Overall Study||121
163901|NCT01005251|394394|P5|STARTED|Overall Study||140
163902|NCT01005251|394395|P4|STARTED|Overall Study||126
163903|NCT01005251|394396|P3|STARTED|Overall Study||136
163904|NCT01005251|394397|P2|STARTED|Overall Study||125
163905|NCT01005251|394398|P1|STARTED|Overall Study||134
163906|NCT01004991|394415|P1|NOT COMPLETED|Overall Study||0
163907|NCT01004991|394415|P1|COMPLETED|Overall Study||12
163908|NCT01004991|394415|P1|STARTED|Overall Study||12
163909|NCT01004939|394419|P1|NOT COMPLETED|Overall Study||0
163910|NCT01004939|394419|P1|COMPLETED|Overall Study||120
163911|NCT01004939|394419|P1|STARTED|Overall Study||120
163912|NCT01004874|394460|P1|NOT COMPLETED|Overall Study||0
163913|NCT01004874|394460|P1|COMPLETED|Overall Study||80
163914|NCT01004874|394460|P1|STARTED|Overall Study||80
163915|NCT01004848|394471|P2|NOT COMPLETED|Overall Study||45
163916|NCT01004848|394472|P1|NOT COMPLETED|Overall Study||55
163917|NCT01004848|394471|P2|COMPLETED|Overall Study||147
163918|NCT01004848|394472|P1|COMPLETED|Overall Study||155
163919|NCT01004848|394471|P2|STARTED|Overall Study||192
163920|NCT01004848|394472|P1|STARTED|Overall Study||210
163921|NCT01004822|394510|P8|NOT COMPLETED|Overall Study||5
163922|NCT01004822|394511|P7|NOT COMPLETED|Overall Study||4
163923|NCT01004822|394512|P6|NOT COMPLETED|Overall Study||4
163924|NCT01004822|394513|P5|NOT COMPLETED|Overall Study||4
163925|NCT01004822|394514|P4|NOT COMPLETED|Overall Study||4
163926|NCT01004822|394515|P3|NOT COMPLETED|Overall Study||4
163927|NCT01004822|394516|P2|NOT COMPLETED|Overall Study||3
163928|NCT01004822|394517|P1|NOT COMPLETED|Overall Study||3
163929|NCT01004822|394510|P8|COMPLETED|Overall Study||0
163930|NCT01004822|394511|P7|COMPLETED|Overall Study||0
163931|NCT01004822|394512|P6|COMPLETED|Overall Study||0
163932|NCT01004822|394513|P5|COMPLETED|Overall Study||0
163933|NCT01004822|394514|P4|COMPLETED|Overall Study||0
163934|NCT01004822|394515|P3|COMPLETED|Overall Study||0
163935|NCT01004822|394516|P2|COMPLETED|Overall Study||0
163936|NCT01004822|394517|P1|COMPLETED|Overall Study||0
163937|NCT01004822|394510|P8|Treated|Overall Study||5
163938|NCT01004822|394511|P7|Treated|Overall Study||4
163939|NCT01004822|394512|P6|Treated|Overall Study||4
163940|NCT01004822|394513|P5|Treated|Overall Study||4
163941|NCT01004822|394514|P4|Treated|Overall Study||4
163942|NCT01004822|394515|P3|Treated|Overall Study||3
163943|NCT01004822|394516|P2|Treated|Overall Study||3
163944|NCT01004822|394517|P1|Treated|Overall Study||3
163945|NCT01004822|394510|P8|STARTED|Overall Study||5
163946|NCT01004822|394511|P7|STARTED|Overall Study||4
163947|NCT01004822|394512|P6|STARTED|Overall Study||4
163948|NCT01004822|394513|P5|STARTED|Overall Study||4
163949|NCT01004822|394514|P4|STARTED|Overall Study||4
163950|NCT01004822|394515|P3|STARTED|Overall Study||4
163951|NCT01004822|394516|P2|STARTED|Overall Study||3
163952|NCT01004822|394517|P1|STARTED|Overall Study||3
163953|NCT01004770|394631|P5|NOT COMPLETED|Overall Study||0
163954|NCT01004770|394632|P4|NOT COMPLETED|Overall Study||0
163955|NCT01004770|394633|P3|NOT COMPLETED|Overall Study||0
163956|NCT01004770|394634|P2|NOT COMPLETED|Overall Study||0
163957|NCT01004770|394635|P1|NOT COMPLETED|Overall Study||0
163958|NCT01004770|394631|P5|COMPLETED|Overall Study||10
163959|NCT01004770|394632|P4|COMPLETED|Overall Study||10
163960|NCT01004770|394633|P3|COMPLETED|Overall Study||10
163961|NCT01004770|394634|P2|COMPLETED|Overall Study||10
163962|NCT01004770|394635|P1|COMPLETED|Overall Study||10
163963|NCT01004770|394631|P5|STARTED|Overall Study||10
163964|NCT01004770|394632|P4|STARTED|Overall Study||10
163965|NCT01004770|394633|P3|STARTED|Overall Study||10
163966|NCT01004770|394634|P2|STARTED|Overall Study||10
163967|NCT01004770|394635|P1|STARTED|Overall Study||10
163968|NCT01004705|394667|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
163969|NCT01004705|394668|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
163970|NCT01004705|394669|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
163971|NCT01004705|394667|P3|COMPLETED|Period 2 (12 Weeks)||9
163972|NCT01004705|394668|P2|COMPLETED|Period 2 (12 Weeks)||13
163973|NCT01004705|394669|P1|COMPLETED|Period 2 (12 Weeks)||0
163974|NCT01004705|394667|P3|STARTED|Period 2 (12 Weeks)||13
163975|NCT01004705|394668|P2|STARTED|Period 2 (12 Weeks)||13
163976|NCT01004705|394669|P1|STARTED|Period 2 (12 Weeks)||0
163977|NCT01004705|394667|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
163978|NCT01004705|394668|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
163979|NCT01004705|394669|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
163980|NCT01004705|394667|P3|COMPLETED|Washout Period (6 Weeks)||13
163981|NCT01004705|394668|P2|COMPLETED|Washout Period (6 Weeks)||13
163982|NCT01004705|394669|P1|COMPLETED|Washout Period (6 Weeks)||0
163983|NCT01004705|394667|P3|STARTED|Washout Period (6 Weeks)||13
163984|NCT01004705|394668|P2|STARTED|Washout Period (6 Weeks)||13
163985|NCT01004705|394669|P1|STARTED|Washout Period (6 Weeks)||0
163986|NCT01004705|394667|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
163987|NCT01004705|394668|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
163988|NCT01004705|394669|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
163989|NCT01004705|394667|P3|COMPLETED|Period 1 (12 Weeks)||13
163990|NCT01004705|394668|P2|COMPLETED|Period 1 (12 Weeks)||13
163991|NCT01004705|394669|P1|COMPLETED|Period 1 (12 Weeks)||0
163992|NCT01004705|394667|P3|STARTED|Period 1 (12 Weeks)||18
163993|NCT01004705|394668|P2|STARTED|Period 1 (12 Weeks)||18
163994|NCT01004705|394669|P1|STARTED|Period 1 (12 Weeks)||0
163995|NCT01004705|394667|P3|NOT COMPLETED|Run-In||0
163996|NCT01004705|394668|P2|NOT COMPLETED|Run-In||0
163997|NCT01004705|394669|P1|NOT COMPLETED|Run-In||8
163998|NCT01004705|394667|P3|COMPLETED|Run-In||0
163999|NCT01004705|394668|P2|COMPLETED|Run-In||0
164000|NCT01004705|394669|P1|COMPLETED|Run-In||36
164001|NCT01004705|394667|P3|STARTED|Run-In||0
164002|NCT01004705|394668|P2|STARTED|Run-In||0
164003|NCT01004705|394669|P1|STARTED|Run-In||44
164004|NCT01004614|394682|P4|NOT COMPLETED|Second Intervention||0
164005|NCT01004614|394683|P3|NOT COMPLETED|Second Intervention||0
164006|NCT01004614|394684|P2|NOT COMPLETED|Second Intervention||0
164007|NCT01004614|394685|P1|NOT COMPLETED|Second Intervention||0
164008|NCT01004614|394682|P4|COMPLETED|Second Intervention||12
164009|NCT01004614|394683|P3|COMPLETED|Second Intervention||12
164010|NCT01004614|394684|P2|COMPLETED|Second Intervention||11
164011|NCT01004614|394685|P1|COMPLETED|Second Intervention||12
164012|NCT01004614|394682|P4|STARTED|Second Intervention||12
164013|NCT01004614|394683|P3|STARTED|Second Intervention||12
164014|NCT01004614|394684|P2|STARTED|Second Intervention||11
164015|NCT01004614|394685|P1|STARTED|Second Intervention||12
164016|NCT01004614|394682|P4|NOT COMPLETED|Washout||0
164017|NCT01004614|394683|P3|NOT COMPLETED|Washout||0
164018|NCT01004614|394684|P2|NOT COMPLETED|Washout||1
164019|NCT01004614|394685|P1|NOT COMPLETED|Washout||0
164020|NCT01004614|394682|P4|COMPLETED|Washout||12
164021|NCT01004614|394683|P3|COMPLETED|Washout||12
164022|NCT01004614|394684|P2|COMPLETED|Washout||11
164023|NCT01004614|394685|P1|COMPLETED|Washout||12
164024|NCT01004614|394682|P4|STARTED|Washout||12
164025|NCT01004614|394683|P3|STARTED|Washout||12
164026|NCT01004614|394684|P2|STARTED|Washout||12
164027|NCT01004614|394685|P1|STARTED|Washout||12
164028|NCT01004614|394682|P4|NOT COMPLETED|First Intervention||0
164029|NCT01004614|394683|P3|NOT COMPLETED|First Intervention||0
164030|NCT01004614|394684|P2|NOT COMPLETED|First Intervention||0
164031|NCT01004614|394685|P1|NOT COMPLETED|First Intervention||0
164032|NCT01004614|394682|P4|COMPLETED|First Intervention||12
164033|NCT01004614|394683|P3|COMPLETED|First Intervention||12
164034|NCT01004614|394684|P2|COMPLETED|First Intervention||12
164035|NCT01004614|394685|P1|COMPLETED|First Intervention||12
164036|NCT01004614|394682|P4|STARTED|First Intervention||12
164037|NCT01004614|394683|P3|STARTED|First Intervention||12
164038|NCT01004614|394684|P2|STARTED|First Intervention||12
164039|NCT01004614|394685|P1|STARTED|First Intervention||12
164040|NCT01004510|394719|P1|NOT COMPLETED|Overall Study||1
164041|NCT01004510|394719|P1|COMPLETED|Overall Study||2
164042|NCT01004510|394719|P1|STARTED|Overall Study||3
164043|NCT01004432|394723|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
164044|NCT01004432|394724|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
164045|NCT01004432|394725|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
164046|NCT01004432|394726|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
164047|NCT01004432|394727|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
164048|NCT01004432|394723|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
164049|NCT01004432|394724|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
164050|NCT01004432|394725|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
164051|NCT01004432|394726|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
164052|NCT01004432|394727|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
164053|NCT01004432|394723|P5|STARTED|OL Study Extension (Week 52 - 76)||212
164054|NCT01004432|394724|P4|STARTED|OL Study Extension (Week 52 - 76)||0
164055|NCT01004432|394725|P3|STARTED|OL Study Extension (Week 52 - 76)||0
164056|NCT01004432|394726|P2|STARTED|OL Study Extension (Week 52 - 76)||0
164057|NCT01004432|394727|P1|STARTED|OL Study Extension (Week 52 - 76)||0
164058|NCT01004432|394723|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
164059|NCT01004432|394724|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
164060|NCT01004432|394725|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
164061|NCT01004432|394726|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
164062|NCT01004432|394727|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
164063|NCT01004432|394723|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
164064|NCT01004432|394724|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
164065|NCT01004432|394725|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
164066|NCT01004432|394726|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
164067|NCT01004432|394727|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
164068|NCT01004432|394723|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
164069|NCT01004432|394724|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
164070|NCT01004432|394725|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
164071|NCT01004432|394726|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
164072|NCT01004432|394727|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
164073|NCT01004432|394723|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164074|NCT01004432|394724|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164075|NCT01004432|394725|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164076|NCT01004432|394726|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164077|NCT01004432|394727|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
164078|NCT01004432|394723|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164079|NCT01004432|394724|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164080|NCT01004432|394725|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164081|NCT01004432|394726|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
164082|NCT01004432|394727|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
164083|NCT01004432|394723|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
164084|NCT01004432|394724|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
164085|NCT01004432|394725|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
164086|NCT01004432|394726|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
164087|NCT01004432|394727|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
164088|NCT01004393|394747|P1|NOT COMPLETED|Overall Study||0
164089|NCT01004393|394747|P1|COMPLETED|Overall Study||12
164090|NCT01004393|394747|P1|STARTED|Overall Study||12
164091|NCT01004354|394758|P1|NOT COMPLETED|Overall Study||0
164092|NCT01004354|394758|P1|COMPLETED|Overall Study||12
164093|NCT01004354|394758|P1|STARTED|Overall Study||12
164094|NCT01004263|394770|P1|NOT COMPLETED|Overall Study||179
164095|NCT01004263|394770|P1|COMPLETED|Overall Study||427
164096|NCT01004263|394770|P1|STARTED|Overall Study|Participants who took study drug|606
164097|NCT01004250|394778|P1|NOT COMPLETED|Follow-Up (FU) Period||1
164098|NCT01004250|394778|P1|COMPLETED|Follow-Up (FU) Period||100
164099|NCT01004250|394778|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
164100|NCT01004250|394778|P1|NOT COMPLETED|Maintenance Therapy Period||26
164101|NCT01004250|394778|P1|COMPLETED|Maintenance Therapy Period||46
164102|NCT01004250|394778|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
164103|NCT01004250|394778|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
164104|NCT01004250|394778|P1|NOT COMPLETED|Induction Therapy Period||15
164105|NCT01004250|394778|P1|COMPLETED|Induction Therapy Period||94
164106|NCT01004250|394778|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
164107|NCT01004250|394778|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
164108|NCT01004250|394778|P1|STARTED|Induction Therapy Period||109
164109|NCT01004185|394790|P2|NOT COMPLETED|Overall Study||9
164110|NCT01004185|394791|P1|NOT COMPLETED|Overall Study||9
164111|NCT01004185|394790|P2|COMPLETED|Overall Study||11
164112|NCT01004185|394791|P1|COMPLETED|Overall Study||10
164113|NCT01004185|394790|P2|STARTED|Overall Study||20
164114|NCT01004185|394791|P1|STARTED|Overall Study||19
164115|NCT01004172|394799|P1|NOT COMPLETED|Overall Study||38
164116|NCT01004172|394799|P1|COMPLETED|Overall Study||0
164117|NCT01004172|394799|P1|STARTED|Overall Study||38
164118|NCT01004159|394805|P1|NOT COMPLETED|Overall Study||20
164119|NCT01004159|394805|P1|COMPLETED|Overall Study||0
164120|NCT01004159|394805|P1|STARTED|Overall Study||20
164121|NCT01004146|394812|P2|NOT COMPLETED|Overall Study||5
164122|NCT01004146|394813|P1|NOT COMPLETED|Overall Study||4
164123|NCT01004146|394812|P2|COMPLETED|Overall Study||20
164124|NCT01004146|394813|P1|COMPLETED|Overall Study||21
164125|NCT01004146|394812|P2|Have Incentive Spirometry Data|Overall Study||20
164126|NCT01004146|394813|P1|Have Incentive Spirometry Data|Overall Study||21
164127|NCT01004146|394812|P2|STARTED|Overall Study||25
164128|NCT01004146|394813|P1|STARTED|Overall Study||25
164129|NCT01004003|394828|P9|NOT COMPLETED|Overall Study||30
164130|NCT01004003|394829|P8|NOT COMPLETED|Overall Study||60
164131|NCT01004003|394830|P7|NOT COMPLETED|Overall Study||8
164132|NCT01004003|394831|P6|NOT COMPLETED|Overall Study||4
164133|NCT01004003|394832|P5|NOT COMPLETED|Overall Study||4
164134|NCT01004003|394833|P4|NOT COMPLETED|Overall Study||3
164135|NCT01004003|394834|P3|NOT COMPLETED|Overall Study||4
164136|NCT01004003|394835|P2|NOT COMPLETED|Overall Study||3
164137|NCT01004003|394836|P1|NOT COMPLETED|Overall Study||6
164138|NCT01004003|394828|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
164139|NCT01004003|394829|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
164140|NCT01004003|394830|P7|COMPLETED|Overall Study||0
164141|NCT01004003|394831|P6|COMPLETED|Overall Study||0
164142|NCT01004003|394832|P5|COMPLETED|Overall Study||0
164143|NCT01004003|394833|P4|COMPLETED|Overall Study||0
164144|NCT01004003|394834|P3|COMPLETED|Overall Study||0
164145|NCT01004003|394835|P2|COMPLETED|Overall Study||0
164146|NCT01004003|394836|P1|COMPLETED|Overall Study||0
164147|NCT01004003|394828|P9|STARTED|Overall Study||31
164148|NCT01004003|394829|P8|STARTED|Overall Study||62
164149|NCT01004003|394830|P7|STARTED|Overall Study||8
164150|NCT01004003|394831|P6|STARTED|Overall Study||4
164151|NCT01004003|394832|P5|STARTED|Overall Study||4
164152|NCT01004003|394833|P4|STARTED|Overall Study||3
164153|NCT01004003|394834|P3|STARTED|Overall Study||4
164154|NCT01004003|394835|P2|STARTED|Overall Study||3
164155|NCT01004003|394836|P1|STARTED|Overall Study||6
164156|NCT01003990|394867|P3|NOT COMPLETED|Overall Study||43
164157|NCT01003990|394868|P2|NOT COMPLETED|Overall Study||51
164158|NCT01003990|394869|P1|NOT COMPLETED|Overall Study||92
164159|NCT01003990|394867|P3|COMPLETED|Overall Study||53
164160|NCT01003990|394868|P2|COMPLETED|Overall Study||103
164161|NCT01003990|394869|P1|COMPLETED|Overall Study||367
164162|NCT01003990|394867|P3|STARTED|Overall Study||96
164163|NCT01003990|394868|P2|STARTED|Overall Study||154
164164|NCT01003990|394869|P1|STARTED|Overall Study||459
164165|NCT01003938|394877|P1|NOT COMPLETED|Overall Study||0
164166|NCT01003938|394877|P1|COMPLETED|Overall Study||6
164167|NCT01003938|394877|P1|STARTED|Overall Study||6
164168|NCT01003899|394886|P1|NOT COMPLETED|Overall Study||47
164169|NCT01003899|394886|P1|COMPLETED|Overall Study||0
164170|NCT01003899|394886|P1|STARTED|Overall Study|enrolled|47
164171|NCT01003886|394895|P1|NOT COMPLETED|Overall Study||230
164172|NCT01003886|394895|P1|COMPLETED|Overall Study||759
164173|NCT01003886|394895|P1|STARTED|Overall Study||989
164174|NCT01003301|394906|P2|NOT COMPLETED|Overall Study||0
164175|NCT01003301|394907|P1|NOT COMPLETED|Overall Study||0
164176|NCT01003301|394906|P2|COMPLETED|Overall Study||9
164177|NCT01003301|394907|P1|COMPLETED|Overall Study||10
164178|NCT01003301|394906|P2|STARTED|Overall Study||9
164179|NCT01003301|394907|P1|STARTED|Overall Study||10
164180|NCT01003288|394915|P1|NOT COMPLETED|Overall Study||0
164181|NCT01003288|394915|P1|COMPLETED|Overall Study||255
164182|NCT01003288|394915|P1|STARTED|Overall Study||255
164183|NCT01003275|394922|P2|NOT COMPLETED|Overall Study||0
164184|NCT01003275|394923|P1|NOT COMPLETED|Overall Study||1
164185|NCT01003275|394922|P2|COMPLETED|Overall Study||11
164186|NCT01003275|394923|P1|COMPLETED|Overall Study||10
164187|NCT01003275|394922|P2|STARTED|Overall Study||11
164188|NCT01003275|394923|P1|STARTED|Overall Study||11
164189|NCT01003249|394929|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
164190|NCT01003249|394930|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
164191|NCT01003249|394929|P2|COMPLETED|Second Intervention (4 Weeks)||2
164192|NCT01003249|394930|P1|COMPLETED|Second Intervention (4 Weeks)||3
164193|NCT01003249|394929|P2|STARTED|Second Intervention (4 Weeks)||3
164194|NCT01003249|394930|P1|STARTED|Second Intervention (4 Weeks)||4
164195|NCT01003249|394929|P2|NOT COMPLETED|Washout (3 Weeks)||0
164196|NCT01003249|394930|P1|NOT COMPLETED|Washout (3 Weeks)||0
164197|NCT01003249|394929|P2|COMPLETED|Washout (3 Weeks)||3
164198|NCT01003249|394930|P1|COMPLETED|Washout (3 Weeks)||4
164199|NCT01003249|394929|P2|STARTED|Washout (3 Weeks)||3
164200|NCT01003249|394930|P1|STARTED|Washout (3 Weeks)||4
164201|NCT01003249|394929|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
164202|NCT01003249|394930|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
164203|NCT01003249|394929|P2|COMPLETED|First Intervention (4 Weeks)||3
164204|NCT01003249|394930|P1|COMPLETED|First Intervention (4 Weeks)||5
164205|NCT01003249|394929|P2|Received Intervention|First Intervention (4 Weeks)||5
164206|NCT01003249|394930|P1|Received Intervention|First Intervention (4 Weeks)||7
164207|NCT01003249|394929|P2|STARTED|First Intervention (4 Weeks)||5
164208|NCT01003249|394930|P1|STARTED|First Intervention (4 Weeks)||7
164209|NCT01003210|394948|P2|NOT COMPLETED|Overall Study||3
164210|NCT01003210|394949|P1|NOT COMPLETED|Overall Study||1
164211|NCT01003210|394948|P2|COMPLETED|Overall Study||102
164212|NCT01003210|394949|P1|COMPLETED|Overall Study||104
164213|NCT01003210|394948|P2|STARTED|Overall Study||105
164214|NCT01003210|394949|P1|STARTED|Overall Study||105
164215|NCT01003184|394959|P2|NOT COMPLETED|Overall Study||12
164216|NCT01003184|394960|P1|NOT COMPLETED|Overall Study||19
164217|NCT01003184|394959|P2|COMPLETED|Overall Study||99
164218|NCT01003184|394960|P1|COMPLETED|Overall Study||92
164219|NCT01003184|394959|P2|Full Analysis Set (FAS)|Overall Study||105
164220|NCT01003184|394960|P1|Full Analysis Set (FAS)|Overall Study||111
164221|NCT01003184|394959|P2|STARTED|Overall Study||111
164222|NCT01003184|394960|P1|STARTED|Overall Study||111
164223|NCT01003106|394996|P8|NOT COMPLETED|Month 6-Month 36||0
164224|NCT01003106|394997|P7|NOT COMPLETED|Month 6-Month 36||1
164225|NCT01003106|394998|P6|NOT COMPLETED|Month 6-Month 36||0
164226|NCT01003106|394999|P5|NOT COMPLETED|Month 6-Month 36||0
164227|NCT01003106|395000|P4|NOT COMPLETED|Month 6-Month 36||0
164228|NCT01003106|395001|P3|NOT COMPLETED|Month 6-Month 36||1
164229|NCT01003106|395002|P2|NOT COMPLETED|Month 6-Month 36||0
164230|NCT01003106|395003|P1|NOT COMPLETED|Month 6-Month 36||0
164231|NCT01003106|394996|P8|COMPLETED|Month 6-Month 36||18
164232|NCT01003106|394997|P7|COMPLETED|Month 6-Month 36||19
164233|NCT01003106|394998|P6|COMPLETED|Month 6-Month 36||0
164234|NCT01003106|394999|P5|COMPLETED|Month 6-Month 36||0
164235|NCT01003106|395000|P4|COMPLETED|Month 6-Month 36||20
164236|NCT01003106|395001|P3|COMPLETED|Month 6-Month 36||18
164237|NCT01003106|395002|P2|COMPLETED|Month 6-Month 36||0
164238|NCT01003106|395003|P1|COMPLETED|Month 6-Month 36||0
164239|NCT01003106|394996|P8|STARTED|Month 6-Month 36||18
164240|NCT01003106|394997|P7|STARTED|Month 6-Month 36||20
164241|NCT01003106|394998|P6|STARTED|Month 6-Month 36||0
164242|NCT01003106|394999|P5|STARTED|Month 6-Month 36||0
164243|NCT01003106|395000|P4|STARTED|Month 6-Month 36||20
164244|NCT01003106|395001|P3|STARTED|Month 6-Month 36||19
164245|NCT01003106|395002|P2|STARTED|Month 6-Month 36||0
164246|NCT01003106|395003|P1|STARTED|Month 6-Month 36||0
164247|NCT01003106|394996|P8|NOT COMPLETED|Baseline to Month 6||0
164248|NCT01003106|394997|P7|NOT COMPLETED|Baseline to Month 6||0
164249|NCT01003106|394998|P6|NOT COMPLETED|Baseline to Month 6||0
164250|NCT01003106|394999|P5|NOT COMPLETED|Baseline to Month 6||0
164251|NCT01003106|395000|P4|NOT COMPLETED|Baseline to Month 6||0
164252|NCT01003106|395001|P3|NOT COMPLETED|Baseline to Month 6||0
164253|NCT01003106|395002|P2|NOT COMPLETED|Baseline to Month 6||0
164254|NCT01003106|395003|P1|NOT COMPLETED|Baseline to Month 6||0
164255|NCT01003106|394996|P8|COMPLETED|Baseline to Month 6||0
164256|NCT01003106|394997|P7|COMPLETED|Baseline to Month 6||0
164257|NCT01003106|394998|P6|COMPLETED|Baseline to Month 6||20
164258|NCT01003106|394999|P5|COMPLETED|Baseline to Month 6||19
164259|NCT01003106|395000|P4|COMPLETED|Baseline to Month 6||0
164260|NCT01003106|395001|P3|COMPLETED|Baseline to Month 6||0
164261|NCT01003106|395002|P2|COMPLETED|Baseline to Month 6||20
164262|NCT01003106|395003|P1|COMPLETED|Baseline to Month 6||22
164263|NCT01003106|394996|P8|STARTED|Baseline to Month 6||0
164264|NCT01003106|394997|P7|STARTED|Baseline to Month 6||0
164265|NCT01003106|394998|P6|STARTED|Baseline to Month 6||20
164266|NCT01003106|394999|P5|STARTED|Baseline to Month 6||19
164267|NCT01003106|395000|P4|STARTED|Baseline to Month 6||0
164268|NCT01003106|395001|P3|STARTED|Baseline to Month 6||0
164269|NCT01003106|395002|P2|STARTED|Baseline to Month 6||20
164270|NCT01003106|395003|P1|STARTED|Baseline to Month 6||22
164271|NCT01003080|395027|P2|NOT COMPLETED|Overall Study||0
164272|NCT01003080|395028|P1|NOT COMPLETED|Overall Study||0
164273|NCT01003080|395027|P2|COMPLETED|Overall Study||61
164274|NCT01003080|395028|P1|COMPLETED|Overall Study||50
164275|NCT01003080|395027|P2|STARTED|Overall Study||61
164276|NCT01003080|395028|P1|STARTED|Overall Study||50
164277|NCT01003067|395036|P2|NOT COMPLETED|Overall Study||24
164278|NCT01003067|395037|P1|NOT COMPLETED|Overall Study||33
164279|NCT01003067|395036|P2|COMPLETED|Overall Study||107
164280|NCT01003067|395037|P1|COMPLETED|Overall Study||103
164281|NCT01003067|395036|P2|STARTED|Overall Study||131
164282|NCT01003067|395037|P1|STARTED|Overall Study||136
164283|NCT01002989|395043|P1|NOT COMPLETED|Overall Study||5
164284|NCT01002989|395043|P1|COMPLETED|Overall Study||93
164285|NCT01002989|395043|P1|STARTED|Overall Study||98
164286|NCT01002742|395052|P2|NOT COMPLETED|Overall Study||1
164287|NCT01002742|395053|P1|NOT COMPLETED|Overall Study||0
164288|NCT01002742|395052|P2|COMPLETED|Overall Study||116
164289|NCT01002742|395053|P1|COMPLETED|Overall Study||119
164290|NCT01002742|395052|P2|STARTED|Overall Study||117
164291|NCT01002742|395053|P1|STARTED|Overall Study||119
164292|NCT01002573|395089|P2|NOT COMPLETED|Overall Study||7
164293|NCT01002573|395090|P1|NOT COMPLETED|Overall Study||11
164294|NCT01002573|395089|P2|COMPLETED|Overall Study||53
164295|NCT01002573|395090|P1|COMPLETED|Overall Study||47
164296|NCT01002573|395089|P2|STARTED|Overall Study||60
164297|NCT01002573|395090|P1|STARTED|Overall Study||58
164298|NCT01002482|395110|P2|NOT COMPLETED|Overall Study||21
164299|NCT01002482|395111|P1|NOT COMPLETED|Overall Study||15
164300|NCT01002482|395110|P2|COMPLETED|Overall Study||1312
164301|NCT01002482|395111|P1|COMPLETED|Overall Study||1336
164302|NCT01002482|395110|P2|STARTED|Overall Study||1333
164303|NCT01002482|395111|P1|STARTED|Overall Study||1351
164304|NCT01002456|395133|P2|NOT COMPLETED|Overall Study||0
164305|NCT01002456|395134|P1|NOT COMPLETED|Overall Study||0
164306|NCT01002456|395133|P2|COMPLETED|Overall Study||122
164307|NCT01002456|395134|P1|COMPLETED|Overall Study||98
164308|NCT01002456|395133|P2|STARTED|Overall Study||122
164309|NCT01002456|395134|P1|STARTED|Overall Study||98
164310|NCT01002339|395145|P3|NOT COMPLETED|Overall Study||5
164311|NCT01002339|395146|P2|NOT COMPLETED|Overall Study||1
164312|NCT01002339|395147|P1|NOT COMPLETED|Overall Study||0
164313|NCT01002339|395145|P3|COMPLETED|Overall Study||42
164314|NCT01002339|395146|P2|COMPLETED|Overall Study||42
164315|NCT01002339|395147|P1|COMPLETED|Overall Study||44
164316|NCT01002339|395145|P3|STARTED|Overall Study||47
164317|NCT01002339|395146|P2|STARTED|Overall Study||43
164318|NCT01002339|395147|P1|STARTED|Overall Study||44
164319|NCT01002287|395202|P2|NOT COMPLETED|Overall Study||0
164320|NCT01002287|395203|P1|NOT COMPLETED|Overall Study||0
164321|NCT01002287|395202|P2|COMPLETED|Overall Study||3
164322|NCT01002287|395203|P1|COMPLETED|Overall Study||8
164323|NCT01002287|395202|P2|STARTED|Overall Study||3
164324|NCT01002287|395203|P1|STARTED|Overall Study||8
164325|NCT01002118|395215|P1|NOT COMPLETED|Overall Study||0
164326|NCT01002118|395215|P1|COMPLETED|Overall Study||1
164327|NCT01002118|395215|P1|Randomized Only Patient|Overall Study||1
164328|NCT01002118|395215|P1|STARTED|Overall Study||1
164329|NCT01002105|395223|P2|NOT COMPLETED|Overall Study||21
164330|NCT01002105|395224|P1|NOT COMPLETED|Overall Study||19
164331|NCT01002105|395223|P2|COMPLETED|Overall Study||11
164332|NCT01002105|395224|P1|COMPLETED|Overall Study||13
164333|NCT01002105|395223|P2|STARTED|Overall Study||32
164334|NCT01002105|395224|P1|STARTED|Overall Study||32
164335|NCT01001988|395240|P1|NOT COMPLETED|Overall Study||117
164336|NCT01001988|395240|P1|COMPLETED|Overall Study||479
164337|NCT01001988|395240|P1|STARTED|Overall Study||596
164338|NCT01001975|395247|P2|NOT COMPLETED|Overall Study||0
164339|NCT01001975|395248|P1|NOT COMPLETED|Overall Study||0
164340|NCT01001975|395247|P2|COMPLETED|Overall Study||5
164341|NCT01001975|395248|P1|COMPLETED|Overall Study||5
164342|NCT01001975|395247|P2|STARTED|Overall Study||5
164343|NCT01001975|395248|P1|STARTED|Overall Study||5
164344|NCT01001832|395258|P2|NOT COMPLETED|Follow-up Period||21
164345|NCT01001832|395259|P1|NOT COMPLETED|Follow-up Period||18
164346|NCT01001832|395258|P2|COMPLETED|Follow-up Period||30
164347|NCT01001832|395259|P1|COMPLETED|Follow-up Period||34
164348|NCT01001832|395258|P2|STARTED|Follow-up Period||51
164349|NCT01001832|395259|P1|STARTED|Follow-up Period||52
164350|NCT01001832|395258|P2|NOT COMPLETED|Long-term Period||5
164351|NCT01001832|395259|P1|NOT COMPLETED|Long-term Period||4
164352|NCT01001832|395258|P2|COMPLETED|Long-term Period||51
164353|NCT01001832|395259|P1|COMPLETED|Long-term Period||52
164354|NCT01001832|395258|P2|STARTED|Long-term Period||56
164355|NCT01001832|395259|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
164356|NCT01001832|395258|P2|NOT COMPLETED|Short-term Period||3
164357|NCT01001832|395259|P1|NOT COMPLETED|Short-term Period||2
164358|NCT01001832|395258|P2|COMPLETED|Short-term Period||56
164359|NCT01001832|395259|P1|COMPLETED|Short-term Period||57
164360|NCT01001832|395258|P2|STARTED|Short-term Period||59
164361|NCT01001832|395259|P1|STARTED|Short-term Period||59
164362|NCT01001806|395305|P3|NOT COMPLETED|Overall Study||4
164363|NCT01001806|395306|P2|NOT COMPLETED|Overall Study||1
164364|NCT01001806|395307|P1|NOT COMPLETED|Overall Study||0
164365|NCT01001806|395305|P3|COMPLETED|Overall Study||38
164366|NCT01001806|395306|P2|COMPLETED|Overall Study||41
164367|NCT01001806|395307|P1|COMPLETED|Overall Study||42
164368|NCT01001806|395305|P3|STARTED|Overall Study||42
164369|NCT01001806|395306|P2|STARTED|Overall Study||42
164370|NCT01001806|395307|P1|STARTED|Overall Study||42
164371|NCT01001767|395317|P2|NOT COMPLETED|Overall Study||0
164372|NCT01001767|395318|P1|NOT COMPLETED|Overall Study||4
164373|NCT01001767|395317|P2|COMPLETED|Overall Study||17
164374|NCT01001767|395318|P1|COMPLETED|Overall Study||14
164375|NCT01001767|395317|P2|STARTED|Overall Study||17
164376|NCT01001767|395318|P1|STARTED|Overall Study||18
164377|NCT01001702|395324|P1|NOT COMPLETED|Overall Study||72
164378|NCT01001702|395324|P1|COMPLETED|Overall Study||13
164379|NCT01001702|395324|P1|STARTED|Overall Study||85
164380|NCT01001572|395337|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
164381|NCT01001572|395338|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
164382|NCT01001572|395339|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
164383|NCT01001572|395337|P3|COMPLETED|Double-Blind Treatment Phase||306
164384|NCT01001572|395338|P2|COMPLETED|Double-Blind Treatment Phase||319
164385|NCT01001572|395339|P1|COMPLETED|Double-Blind Treatment Phase||0
164386|NCT01001572|395337|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
164387|NCT01001572|395338|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
164388|NCT01001572|395339|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
164389|NCT01001572|395337|P3|STARTED|Double-Blind Treatment Phase||325
164390|NCT01001572|395338|P2|STARTED|Double-Blind Treatment Phase||329
164391|NCT01001572|395339|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
164392|NCT01001572|395337|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
164393|NCT01001572|395338|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
164394|NCT01001572|395339|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
164395|NCT01001572|395337|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
164396|NCT01001572|395338|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
164397|NCT01001572|395339|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
164398|NCT01001572|395337|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
164399|NCT01001572|395338|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
164400|NCT01001572|395339|P1|STARTED|Single-Blind Valsartan 160 mg||932
164401|NCT01001559|395355|P2|NOT COMPLETED|Overall Study||0
164402|NCT01001559|395356|P1|NOT COMPLETED|Overall Study||0
164403|NCT01001559|395355|P2|COMPLETED|Overall Study||147
164404|NCT01001559|395356|P1|COMPLETED|Overall Study||95
164405|NCT01001559|395355|P2|STARTED|Overall Study||147
164406|NCT01001559|395356|P1|STARTED|Overall Study||95
164407|NCT01001546|395370|P2|NOT COMPLETED|Overall Study||0
164408|NCT01001546|395371|P1|NOT COMPLETED|Overall Study||0
164409|NCT01001546|395370|P2|COMPLETED|Overall Study||207
164410|NCT01001546|395371|P1|COMPLETED|Overall Study||206
164411|NCT01001546|395370|P2|STARTED|Overall Study||207
164412|NCT01001546|395371|P1|STARTED|Overall Study||206
164413|NCT01001520|395377|P2|NOT COMPLETED|Medication Period 2||3
164414|NCT01001520|395378|P1|NOT COMPLETED|Medication Period 2||0
164415|NCT01001520|395377|P2|COMPLETED|Medication Period 2||13
164416|NCT01001520|395378|P1|COMPLETED|Medication Period 2||16
164417|NCT01001520|395377|P2|STARTED|Medication Period 2||16
164418|NCT01001520|395378|P1|STARTED|Medication Period 2||16
164419|NCT01001520|395377|P2|NOT COMPLETED|Washout Period||1
164420|NCT01001520|395378|P1|NOT COMPLETED|Washout Period||2
164421|NCT01001520|395377|P2|COMPLETED|Washout Period||16
164422|NCT01001520|395378|P1|COMPLETED|Washout Period||16
164423|NCT01001520|395377|P2|STARTED|Washout Period||17
164424|NCT01001520|395378|P1|STARTED|Washout Period||18
164425|NCT01001520|395377|P2|NOT COMPLETED|Medication Period 1||7
164426|NCT01001520|395378|P1|NOT COMPLETED|Medication Period 1||4
164427|NCT01001520|395377|P2|COMPLETED|Medication Period 1||17
164428|NCT01001520|395378|P1|COMPLETED|Medication Period 1||18
164429|NCT01001520|395377|P2|STARTED|Medication Period 1||24
164430|NCT01001520|395378|P1|STARTED|Medication Period 1||22
164431|NCT01001494|395405|P3|NOT COMPLETED|Overall Study||41
164432|NCT01001494|395406|P2|NOT COMPLETED|Overall Study||17
164433|NCT01001494|395407|P1|NOT COMPLETED|Overall Study||24
164434|NCT01001494|395405|P3|COMPLETED|Overall Study||232
164435|NCT01001494|395406|P2|COMPLETED|Overall Study||252
164436|NCT01001494|395407|P1|COMPLETED|Overall Study||253
164437|NCT01001494|395405|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
164438|NCT01001494|395406|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
164439|NCT01001494|395407|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
164440|NCT01001442|395435|P8|NOT COMPLETED|Overall Study||2
164441|NCT01001442|395436|P7|NOT COMPLETED|Overall Study||4
164442|NCT01001442|395437|P6|NOT COMPLETED|Overall Study||0
164443|NCT01001442|395438|P5|NOT COMPLETED|Overall Study||2
164444|NCT01001442|395439|P4|NOT COMPLETED|Overall Study||0
164445|NCT01001442|395440|P3|NOT COMPLETED|Overall Study||0
164446|NCT01001442|395441|P2|NOT COMPLETED|Overall Study||0
164447|NCT01001442|395442|P1|NOT COMPLETED|Overall Study||0
164448|NCT01001442|395435|P8|COMPLETED|Overall Study||2
164449|NCT01001442|395436|P7|COMPLETED|Overall Study||6
164450|NCT01001442|395437|P6|COMPLETED|Overall Study||3
164451|NCT01001442|395438|P5|COMPLETED|Overall Study||2
164452|NCT01001442|395439|P4|COMPLETED|Overall Study||3
164453|NCT01001442|395440|P3|COMPLETED|Overall Study||4
164454|NCT01001442|395441|P2|COMPLETED|Overall Study||3
164455|NCT01001442|395442|P1|COMPLETED|Overall Study||4
164456|NCT01001442|395435|P8|STARTED|Overall Study||4
164457|NCT01001442|395436|P7|STARTED|Overall Study||10
164458|NCT01001442|395437|P6|STARTED|Overall Study||3
164459|NCT01001442|395438|P5|STARTED|Overall Study||4
164460|NCT01001442|395439|P4|STARTED|Overall Study||3
164461|NCT01001442|395440|P3|STARTED|Overall Study||4
164462|NCT01001442|395441|P2|STARTED|Overall Study||3
164463|NCT01001442|395442|P1|STARTED|Overall Study||4
164464|NCT01001429|395492|P2|NOT COMPLETED|Overall Study||1
164465|NCT01001429|395493|P1|NOT COMPLETED|Overall Study||0
164466|NCT01001429|395492|P2|COMPLETED|Overall Study||37
164467|NCT01001429|395493|P1|COMPLETED|Overall Study||39
164468|NCT01001429|395492|P2|STARTED|Overall Study||38
164469|NCT01001429|395493|P1|STARTED|Overall Study||39
164470|NCT01001403|395525|P2|NOT COMPLETED|Overall Study||0
164471|NCT01001403|395526|P1|NOT COMPLETED|Overall Study||0
164472|NCT01001403|395525|P2|COMPLETED|Overall Study||31
164473|NCT01001403|395526|P1|COMPLETED|Overall Study||31
164474|NCT01001403|395525|P2|STARTED|Overall Study||31
164475|NCT01001403|395526|P1|STARTED|Overall Study||31
164476|NCT01001390|395532|P2|NOT COMPLETED|Overall Study||0
164477|NCT01001390|395533|P1|NOT COMPLETED|Overall Study||2
164478|NCT01001390|395532|P2|COMPLETED|Overall Study||0
164479|NCT01001390|395533|P1|COMPLETED|Overall Study||0
164480|NCT01001390|395532|P2|STARTED|Overall Study||0
164481|NCT01001390|395533|P1|STARTED|Overall Study||2
164482|NCT01001377|395541|P2|NOT COMPLETED|Overall Study||421
164483|NCT01001377|395542|P1|NOT COMPLETED|Overall Study||426
164484|NCT01001377|395541|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
164485|NCT01001377|395542|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
164486|NCT01001377|395541|P2|Received Treatment|Overall Study||499
164487|NCT01001377|395542|P1|Received Treatment|Overall Study||500
164488|NCT01001377|395541|P2|STARTED|Overall Study||506
164489|NCT01001377|395542|P1|STARTED|Overall Study||504
164490|NCT01001325|395572|P2|NOT COMPLETED|Overall Study||10
164491|NCT01001325|395573|P1|NOT COMPLETED|Overall Study||18
164492|NCT01001325|395572|P2|COMPLETED|Overall Study||224
164493|NCT01001325|395573|P1|COMPLETED|Overall Study||216
164494|NCT01001325|395572|P2|STARTED|Overall Study||234
164495|NCT01001325|395573|P1|STARTED|Overall Study||234
164496|NCT01001299|395579|P1|NOT COMPLETED|Overall Study||25
164497|NCT01001299|395579|P1|COMPLETED|Overall Study||0
164498|NCT01001299|395579|P1|STARTED|Overall Study||25
164499|NCT01001234|395608|P5|NOT COMPLETED|Overall Study||0
164500|NCT01001234|395609|P4|NOT COMPLETED|Overall Study||25
164501|NCT01001234|395610|P3|NOT COMPLETED|Overall Study||32
164502|NCT01001234|395611|P2|NOT COMPLETED|Overall Study||26
164503|NCT01001234|395612|P1|NOT COMPLETED|Overall Study||405
164504|NCT01001234|395608|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
164505|NCT01001234|395609|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
164506|NCT01001234|395610|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
164507|NCT01001234|395611|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
164508|NCT01001234|395612|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
164509|NCT01001234|395608|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
164510|NCT01001234|395609|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
164511|NCT01001234|395610|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
164512|NCT01001234|395611|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
164513|NCT01001234|395612|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
164514|NCT01001234|395608|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
164515|NCT01001234|395609|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
164516|NCT01001234|395610|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
164517|NCT01001234|395611|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
164518|NCT01001234|395612|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
164519|NCT01001234|395608|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
164520|NCT01001234|395609|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
164521|NCT01001234|395610|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
164522|NCT01001234|395611|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
164523|NCT01001234|395612|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
164524|NCT01001221|395628|P5|NOT COMPLETED|Overall Study||0
164525|NCT01001221|395629|P4|NOT COMPLETED|Overall Study||6
164526|NCT01001221|395630|P3|NOT COMPLETED|Overall Study||3
164527|NCT01001221|395631|P2|NOT COMPLETED|Overall Study||5
164528|NCT01001221|395632|P1|NOT COMPLETED|Overall Study||5
164529|NCT01001221|395628|P5|COMPLETED|Overall Study||0
164530|NCT01001221|395629|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
164531|NCT01001221|395630|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
164532|NCT01001221|395631|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
164533|NCT01001221|395632|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
164534|NCT01001221|395628|P5|Completed 1st Treatment Cycle|Overall Study||0
164535|NCT01001221|395629|P4|Completed 1st Treatment Cycle|Overall Study||6
164536|NCT01001221|395630|P3|Completed 1st Treatment Cycle|Overall Study||2
164537|NCT01001221|395631|P2|Completed 1st Treatment Cycle|Overall Study||5
164538|NCT01001221|395632|P1|Completed 1st Treatment Cycle|Overall Study||5
164539|NCT01001221|395628|P5|Treated|Overall Study||0
164540|NCT01001221|395629|P4|Treated|Overall Study||6
164541|NCT01001221|395630|P3|Treated|Overall Study||2
164542|NCT01001221|395631|P2|Treated|Overall Study||5
164543|NCT01001221|395632|P1|Treated|Overall Study||5
164544|NCT01001221|395628|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
164545|NCT01001221|395629|P4|STARTED|Overall Study||6
164546|NCT01001221|395630|P3|STARTED|Overall Study||3
164547|NCT01001221|395631|P2|STARTED|Overall Study||5
164548|NCT01001221|395632|P1|STARTED|Overall Study||5
164549|NCT01001208|395807|P2|NOT COMPLETED|Overall Study||33
164550|NCT01001208|395808|P1|NOT COMPLETED|Overall Study||28
164551|NCT01001208|395807|P2|COMPLETED|Overall Study||206
164552|NCT01001208|395808|P1|COMPLETED|Overall Study||211
164553|NCT01001208|395807|P2|STARTED|Overall Study||239
164554|NCT01001208|395808|P1|STARTED|Overall Study||239
164555|NCT01001195|395836|P4|NOT COMPLETED|Overall Study||0
164556|NCT01001195|395837|P3|NOT COMPLETED|Overall Study||0
164557|NCT01001195|395838|P2|NOT COMPLETED|Overall Study||2
164558|NCT01001195|395839|P1|NOT COMPLETED|Overall Study||2
164559|NCT01001195|395836|P4|COMPLETED|Overall Study||41
164560|NCT01001195|395837|P3|COMPLETED|Overall Study||44
164561|NCT01001195|395838|P2|COMPLETED|Overall Study||39
164562|NCT01001195|395839|P1|COMPLETED|Overall Study||37
164563|NCT01001195|395836|P4|STARTED|Overall Study||41
164564|NCT01001195|395837|P3|STARTED|Overall Study||44
164565|NCT01001195|395838|P2|STARTED|Overall Study||41
164566|NCT01001195|395839|P1|STARTED|Overall Study||39
164567|NCT01001169|395851|P2|NOT COMPLETED|Overall Study||1
164568|NCT01001169|395852|P1|NOT COMPLETED|Overall Study||2
164569|NCT01001169|395851|P2|COMPLETED|Overall Study||29
164570|NCT01001169|395852|P1|COMPLETED|Overall Study||28
164571|NCT01001169|395851|P2|STARTED|Overall Study||30
164572|NCT01001169|395852|P1|STARTED|Overall Study||30
164573|NCT01001104|395960|P4|NOT COMPLETED|Overall Study||3
164574|NCT01001104|395961|P3|NOT COMPLETED|Overall Study||1
164575|NCT01001104|395962|P2|NOT COMPLETED|Overall Study||1
164576|NCT01001104|395963|P1|NOT COMPLETED|Overall Study||2
164577|NCT01001104|395960|P4|COMPLETED|Overall Study||34
164578|NCT01001104|395961|P3|COMPLETED|Overall Study||35
164579|NCT01001104|395962|P2|COMPLETED|Overall Study||36
164580|NCT01001104|395963|P1|COMPLETED|Overall Study||33
164581|NCT01001104|395960|P4|STARTED|Overall Study||37
164582|NCT01001104|395961|P3|STARTED|Overall Study||36
164583|NCT01001104|395962|P2|STARTED|Overall Study||37
164584|NCT01001104|395963|P1|STARTED|Overall Study||35
164585|NCT01001078|396010|P2|NOT COMPLETED|Overall Study||0
164586|NCT01001078|396011|P1|NOT COMPLETED|Overall Study||0
164587|NCT01001078|396010|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
164588|NCT01001078|396011|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
164589|NCT01001078|396010|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
164590|NCT01001078|396011|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
164591|NCT01001078|396010|P2|Intubated|Overall Study||1
164592|NCT01001078|396011|P1|Intubated|Overall Study||2
164593|NCT01001078|396010|P2|Received Crossover|Overall Study||3
164594|NCT01001078|396011|P1|Received Crossover|Overall Study||2
164595|NCT01001078|396010|P2|Received Allocated Intervention|Overall Study||46
164596|NCT01001078|396011|P1|Received Allocated Intervention|Overall Study||46
164597|NCT01001078|396010|P2|STARTED|Overall Study||50
164598|NCT01001078|396011|P1|STARTED|Overall Study||50
164599|NCT01001052|396027|P2|NOT COMPLETED|Overall Study||0
164600|NCT01001052|396028|P1|NOT COMPLETED|Overall Study||0
164601|NCT01001052|396027|P2|COMPLETED|Overall Study||18
164602|NCT01001052|396028|P1|COMPLETED|Overall Study||20
164603|NCT01001052|396027|P2|STARTED|Overall Study||18
164604|NCT01001052|396028|P1|STARTED|Overall Study||20
164605|NCT01000987|396041|P3|NOT COMPLETED|Overall Study||0
164606|NCT01000987|396042|P2|NOT COMPLETED|Overall Study||0
164607|NCT01000987|396043|P1|NOT COMPLETED|Overall Study||0
164608|NCT01000987|396041|P3|COMPLETED|Overall Study||17
164609|NCT01000987|396042|P2|COMPLETED|Overall Study||15
164610|NCT01000987|396043|P1|COMPLETED|Overall Study||12
164611|NCT01000987|396041|P3|STARTED|Overall Study||17
164612|NCT01000987|396042|P2|STARTED|Overall Study||15
164613|NCT01000987|396043|P1|STARTED|Overall Study||12
164614|NCT01000974|396054|P3|NOT COMPLETED|Booster Vaccination Phase||14
164615|NCT01000974|396055|P2|NOT COMPLETED|Booster Vaccination Phase||12
164616|NCT01000974|396056|P1|NOT COMPLETED|Booster Vaccination Phase||67
164617|NCT01000974|396054|P3|COMPLETED|Booster Vaccination Phase||386
164618|NCT01000974|396055|P2|COMPLETED|Booster Vaccination Phase||423
164619|NCT01000974|396056|P1|COMPLETED|Booster Vaccination Phase||2270
164620|NCT01000974|396054|P3|STARTED|Booster Vaccination Phase||400
164621|NCT01000974|396055|P2|STARTED|Booster Vaccination Phase||435
164622|NCT01000974|396056|P1|STARTED|Booster Vaccination Phase||2337
164623|NCT01000974|396054|P3|NOT COMPLETED|Primary Vaccination Phase||63
164624|NCT01000974|396055|P2|NOT COMPLETED|Primary Vaccination Phase||50
164625|NCT01000974|396056|P1|NOT COMPLETED|Primary Vaccination Phase||338
164626|NCT01000974|396054|P3|COMPLETED|Primary Vaccination Phase||457
164627|NCT01000974|396055|P2|COMPLETED|Primary Vaccination Phase||470
164628|NCT01000974|396056|P1|COMPLETED|Primary Vaccination Phase||2625
164629|NCT01000974|396054|P3|STARTED|Primary Vaccination Phase||520
164630|NCT01000974|396055|P2|STARTED|Primary Vaccination Phase||520
164631|NCT01000974|396056|P1|STARTED|Primary Vaccination Phase||2963
164632|NCT01000961|396163|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
164633|NCT01000961|396164|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
164634|NCT01000961|396163|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
164635|NCT01000961|396164|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
164636|NCT01000961|396163|P2|STARTED|Second Intervention (3 Weeks)||20
164637|NCT01000961|396164|P1|STARTED|Second Intervention (3 Weeks)||21
164638|NCT01000961|396163|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
164639|NCT01000961|396164|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
164640|NCT01000961|396163|P2|COMPLETED|First Intervention (3 Weeks)||20
164641|NCT01000961|396164|P1|COMPLETED|First Intervention (3 Weeks)||21
164642|NCT01000961|396163|P2|STARTED|First Intervention (3 Weeks)||22
164643|NCT01000961|396164|P1|STARTED|First Intervention (3 Weeks)||21
164644|NCT01000961|396163|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
164645|NCT01000961|396164|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
164646|NCT01000961|396163|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
164647|NCT01000961|396164|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
164648|NCT01000961|396163|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
164649|NCT01000961|396164|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
164650|NCT01000818|396176|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
164651|NCT01000818|396176|P1|COMPLETED|Omeprazole + Raltegravir||18
164652|NCT01000818|396176|P1|STARTED|Omeprazole + Raltegravir||18
164653|NCT01000818|396176|P1|NOT COMPLETED|Famotidine + Raltegravir||0
164654|NCT01000818|396176|P1|COMPLETED|Famotidine + Raltegravir||18
164655|NCT01000818|396176|P1|STARTED|Famotidine + Raltegravir||18
164656|NCT01000818|396176|P1|NOT COMPLETED|Raltegravir||0
164657|NCT01000818|396176|P1|COMPLETED|Raltegravir||18
164658|NCT01000818|396176|P1|STARTED|Raltegravir||18
164659|NCT01000805|396187|P2|NOT COMPLETED|Overall Study||62
164660|NCT01000805|396188|P1|NOT COMPLETED|Overall Study||70
164661|NCT01000805|396187|P2|COMPLETED|Overall Study||204
164662|NCT01000805|396188|P1|COMPLETED|Overall Study||192
164663|NCT01000805|396187|P2|STARTED|Overall Study||266
164664|NCT01000805|396188|P1|STARTED|Overall Study||262
164665|NCT01000727|396222|P2|NOT COMPLETED|Overall Study||176
164666|NCT01000727|396223|P1|NOT COMPLETED|Overall Study||175
164667|NCT01000727|396222|P2|COMPLETED|Overall Study||6328
164668|NCT01000727|396223|P1|COMPLETED|Overall Study||6347
164669|NCT01000727|396222|P2|STARTED|Overall Study||6504
164670|NCT01000727|396223|P1|STARTED|Overall Study||6522
164671|NCT01000662|396253|P2|NOT COMPLETED|Overall Study||8
164672|NCT01000662|396254|P1|NOT COMPLETED|Overall Study||4
164673|NCT01000662|396253|P2|COMPLETED|Overall Study||198
164674|NCT01000662|396254|P1|COMPLETED|Overall Study||202
164675|NCT01000662|396253|P2|STARTED|Overall Study||206
164676|NCT01000662|396254|P1|STARTED|Overall Study||206
164677|NCT01000649|396264|P4|NOT COMPLETED|Overall Study||6
164678|NCT01000649|396265|P3|NOT COMPLETED|Overall Study||2
164679|NCT01000649|396266|P2|NOT COMPLETED|Overall Study||3
164680|NCT01000649|396267|P1|NOT COMPLETED|Overall Study||5
164681|NCT01000649|396264|P4|COMPLETED|Overall Study||15
164682|NCT01000649|396265|P3|COMPLETED|Overall Study||0
164683|NCT01000649|396266|P2|COMPLETED|Overall Study||16
164684|NCT01000649|396267|P1|COMPLETED|Overall Study||5
164685|NCT01000649|396264|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
164686|NCT01000649|396265|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
164687|NCT01000649|396266|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
164688|NCT01000649|396267|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
164689|NCT01000649|396264|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
164690|NCT01000649|396265|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
164691|NCT01000649|396266|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
164692|NCT01000649|396267|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
164693|NCT01000610|396348|P1|NOT COMPLETED|Overall Study||6
164694|NCT01000610|396348|P1|COMPLETED|Overall Study||12
164695|NCT01000610|396348|P1|STARTED|Overall Study||18
164696|NCT01000506|396359|P4|NOT COMPLETED|Overall Study||23
164697|NCT01000506|396360|P3|NOT COMPLETED|Overall Study||21
164698|NCT01000506|396361|P2|NOT COMPLETED|Overall Study||24
164699|NCT01000506|396362|P1|NOT COMPLETED|Overall Study||28
164700|NCT01000506|396359|P4|COMPLETED|Overall Study||133
164701|NCT01000506|396360|P3|COMPLETED|Overall Study||131
164702|NCT01000506|396361|P2|COMPLETED|Overall Study||129
164703|NCT01000506|396362|P1|COMPLETED|Overall Study||127
164704|NCT01000506|396359|P4|STARTED|Overall Study||156
164705|NCT01000506|396360|P3|STARTED|Overall Study||152
164706|NCT01000506|396361|P2|STARTED|Overall Study||153
164707|NCT01000506|396362|P1|STARTED|Overall Study||155
164708|NCT01000493|396406|P2|NOT COMPLETED|Overall Study||55
164709|NCT01000493|396407|P1|NOT COMPLETED|Overall Study||39
164710|NCT01000493|396406|P2|COMPLETED|Overall Study||14
164711|NCT01000493|396407|P1|COMPLETED|Overall Study||21
164712|NCT01000493|396406|P2|STARTED|Overall Study||69
164713|NCT01000493|396407|P1|STARTED|Overall Study||60
164714|NCT01000480|396457|P1|NOT COMPLETED|Follow-Up Period||0
164715|NCT01000480|396457|P1|COMPLETED|Follow-Up Period||88
164716|NCT01000480|396457|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
164717|NCT01000480|396457|P1|NOT COMPLETED|Concurrent Therapy Phase||10
164718|NCT01000480|396457|P1|COMPLETED|Concurrent Therapy Phase||65
164719|NCT01000480|396457|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
164720|NCT01000480|396457|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
164721|NCT01000480|396457|P1|NOT COMPLETED|Induction Phase||7
164722|NCT01000480|396457|P1|COMPLETED|Induction Phase||83
164723|NCT01000480|396457|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
164724|NCT01000480|396457|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
164725|NCT01000480|396457|P1|STARTED|Induction Phase||90
164726|NCT01000376|396465|P2|NOT COMPLETED|Cycle 1 Day 15||0
164727|NCT01000376|396466|P1|NOT COMPLETED|Cycle 1 Day 15||0
164728|NCT01000376|396465|P2|COMPLETED|Cycle 1 Day 15||6
164729|NCT01000376|396466|P1|COMPLETED|Cycle 1 Day 15||4
164730|NCT01000376|396465|P2|STARTED|Cycle 1 Day 15||6
164731|NCT01000376|396466|P1|STARTED|Cycle 1 Day 15||4
164732|NCT01000376|396465|P2|NOT COMPLETED|Cycle 1 Day 1||0
164733|NCT01000376|396466|P1|NOT COMPLETED|Cycle 1 Day 1||2
164734|NCT01000376|396465|P2|COMPLETED|Cycle 1 Day 1||6
164735|NCT01000376|396466|P1|COMPLETED|Cycle 1 Day 1||4
164736|NCT01000376|396465|P2|STARTED|Cycle 1 Day 1||6
164737|NCT01000376|396466|P1|STARTED|Cycle 1 Day 1||6
164738|NCT01000337|396476|P2|NOT COMPLETED|Overall Study||3
164739|NCT01000337|396477|P1|NOT COMPLETED|Overall Study||4
164740|NCT01000337|396476|P2|COMPLETED|Overall Study||30
164741|NCT01000337|396477|P1|COMPLETED|Overall Study||30
164742|NCT01000337|396476|P2|STARTED|Overall Study||33
164743|NCT01000337|396477|P1|STARTED|Overall Study||34
164744|NCT01000324|396483|P1|NOT COMPLETED|Year 20||0
164745|NCT01000324|396483|P1|COMPLETED|Year 20||28
164746|NCT01000324|396483|P1|STARTED|Year 20||28
164747|NCT01000324|396483|P1|NOT COMPLETED|Year 19||0
164748|NCT01000324|396483|P1|COMPLETED|Year 19||28
164749|NCT01000324|396483|P1|STARTED|Year 19||28
164750|NCT01000324|396483|P1|NOT COMPLETED|Year 18||0
164751|NCT01000324|396483|P1|COMPLETED|Year 18||29
164752|NCT01000324|396483|P1|STARTED|Year 18||29
164753|NCT01000324|396483|P1|NOT COMPLETED|Year 17||0
164754|NCT01000324|396483|P1|COMPLETED|Year 17||32
164755|NCT01000324|396483|P1|STARTED|Year 17||32
164756|NCT01000324|396483|P1|NOT COMPLETED|Year 16||0
164757|NCT01000324|396483|P1|COMPLETED|Year 16||40
164758|NCT01000324|396483|P1|STARTED|Year 16||40
164759|NCT01000311|396495|P2|NOT COMPLETED|Overall Study||70
164760|NCT01000311|396496|P1|NOT COMPLETED|Overall Study||45
164761|NCT01000311|396495|P2|COMPLETED|Overall Study||201
164762|NCT01000311|396496|P1|COMPLETED|Overall Study||213
164763|NCT01000311|396495|P2|STARTED|Overall Study||271
164764|NCT01000311|396496|P1|STARTED|Overall Study||258
164765|NCT01000285|396526|P1|NOT COMPLETED|Overall Study||0
164766|NCT01000285|396526|P1|COMPLETED|Overall Study||18
164767|NCT01000285|396526|P1|STARTED|Overall Study||18
164768|NCT01000155|396546|P1|NOT COMPLETED|Overall Study||2
164769|NCT01000155|396546|P1|COMPLETED|Overall Study||3
164770|NCT01000155|396546|P1|STARTED|Overall Study||5
164771|NCT01000064|396552|P2|NOT COMPLETED|Overall Study||1
164772|NCT01000064|396553|P1|NOT COMPLETED|Overall Study||1
164773|NCT01000064|396552|P2|COMPLETED|Overall Study||5
164774|NCT01000064|396553|P1|COMPLETED|Overall Study||6
164775|NCT01000064|396552|P2|STARTED|Overall Study||6
164776|NCT01000064|396553|P1|STARTED|Overall Study||7
164777|NCT01000025|396576|P2|NOT COMPLETED|Overall Study||238
164778|NCT01000025|396577|P1|NOT COMPLETED|Overall Study||468
164779|NCT01000025|396576|P2|COMPLETED|Overall Study||2
164780|NCT01000025|396577|P1|COMPLETED|Overall Study||12
164781|NCT01000025|396576|P2|STARTED|Overall Study||240
164782|NCT01000025|396577|P1|STARTED|Overall Study||480
164783|NCT00999921|396595|P2|NOT COMPLETED|Overall Study||19
164784|NCT00999921|396596|P1|NOT COMPLETED|Overall Study||10
164785|NCT00999921|396595|P2|COMPLETED|Overall Study||110
164786|NCT00999921|396596|P1|COMPLETED|Overall Study||117
164787|NCT00999921|396595|P2|STARTED|Overall Study||129
164788|NCT00999921|396596|P1|STARTED|Overall Study||127
164789|NCT00999908|396606|P3|NOT COMPLETED|Treatment Period 3||0
164790|NCT00999908|396607|P2|NOT COMPLETED|Treatment Period 3||0
164791|NCT00999908|396608|P1|NOT COMPLETED|Treatment Period 3||0
164792|NCT00999908|396606|P3|COMPLETED|Treatment Period 3||19
164793|NCT00999908|396607|P2|COMPLETED|Treatment Period 3||16
164794|NCT00999908|396608|P1|COMPLETED|Treatment Period 3||16
164795|NCT00999908|396606|P3|STARTED|Treatment Period 3||19
164796|NCT00999908|396607|P2|STARTED|Treatment Period 3||16
164797|NCT00999908|396608|P1|STARTED|Treatment Period 3||16
164798|NCT00999908|396606|P3|NOT COMPLETED|Treatment Period 2||0
164799|NCT00999908|396607|P2|NOT COMPLETED|Treatment Period 2||0
164800|NCT00999908|396608|P1|NOT COMPLETED|Treatment Period 2||1
164801|NCT00999908|396606|P3|COMPLETED|Treatment Period 2||19
164802|NCT00999908|396607|P2|COMPLETED|Treatment Period 2||16
164803|NCT00999908|396608|P1|COMPLETED|Treatment Period 2||16
164804|NCT00999908|396606|P3|STARTED|Treatment Period 2||19
164805|NCT00999908|396607|P2|STARTED|Treatment Period 2||16
164806|NCT00999908|396608|P1|STARTED|Treatment Period 2||17
164807|NCT00999908|396606|P3|NOT COMPLETED|Treatment Period 1||0
164808|NCT00999908|396607|P2|NOT COMPLETED|Treatment Period 1||0
164809|NCT00999908|396608|P1|NOT COMPLETED|Treatment Period 1||2
164810|NCT00999908|396606|P3|COMPLETED|Treatment Period 1||19
164811|NCT00999908|396607|P2|COMPLETED|Treatment Period 1||16
164812|NCT00999908|396608|P1|COMPLETED|Treatment Period 1||17
164813|NCT00999908|396606|P3|STARTED|Treatment Period 1||19
164814|NCT00999908|396607|P2|STARTED|Treatment Period 1||16
164815|NCT00999908|396608|P1|STARTED|Treatment Period 1||19
164816|NCT00999830|396624|P2|NOT COMPLETED|Overall Study||0
164817|NCT00999830|396625|P1|NOT COMPLETED|Overall Study||0
164818|NCT00999830|396624|P2|COMPLETED|Overall Study||13
164819|NCT00999830|396625|P1|COMPLETED|Overall Study||14
164820|NCT00999830|396624|P2|STARTED|Overall Study||13
164821|NCT00999830|396625|P1|STARTED|Overall Study||14
164822|NCT00999804|396637|P2|NOT COMPLETED|Overall Study||5
164823|NCT00999804|396638|P1|NOT COMPLETED|Overall Study||21
164824|NCT00999804|396637|P2|COMPLETED|Overall Study||38
164825|NCT00999804|396638|P1|COMPLETED|Overall Study||64
164826|NCT00999804|396637|P2|STARTED|Overall Study||43
164827|NCT00999804|396638|P1|STARTED|Overall Study||85
164828|NCT00999713|396652|P2|NOT COMPLETED|Overall Study||0
164829|NCT00999713|396653|P1|NOT COMPLETED|Overall Study||2
164830|NCT00999713|396652|P2|COMPLETED|Overall Study||17
164831|NCT00999713|396653|P1|COMPLETED|Overall Study||24
164832|NCT00999713|396652|P2|STARTED|Overall Study||17
164833|NCT00999713|396653|P1|STARTED|Overall Study||26
164834|NCT00999687|396667|P1|NOT COMPLETED|Second Intervention||3
164835|NCT00999687|396667|P1|COMPLETED|Second Intervention||27
164836|NCT00999687|396667|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
164837|NCT00999687|396667|P1|NOT COMPLETED|First Intervention||1
164838|NCT00999687|396667|P1|COMPLETED|First Intervention||30
164839|NCT00999687|396667|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
164840|NCT00999661|396674|P1|NOT COMPLETED|Overall Study||70
164841|NCT00999661|396674|P1|COMPLETED|Overall Study||161
164842|NCT00999661|396674|P1|STARTED|Overall Study||231
164843|NCT00999609|396682|P2|NOT COMPLETED|Overall Study||1
164844|NCT00999609|396683|P1|NOT COMPLETED|Overall Study||1
164845|NCT00999609|396682|P2|COMPLETED|Overall Study|1 year post intervention|9
164846|NCT00999609|396683|P1|COMPLETED|Overall Study|1 year post intervention|20
164847|NCT00999609|396682|P2|STARTED|Overall Study||10
164848|NCT00999609|396683|P1|STARTED|Overall Study|Before intervention|21
164849|NCT00999596|396695|P1|NOT COMPLETED|Overall Study||101
164850|NCT00999596|396695|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
164851|NCT00999596|396695|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
164852|NCT00999596|396695|P1|STARTED|Overall Study||107
164853|NCT00999544|396700|P1|NOT COMPLETED|Overall Study||1
164854|NCT00999544|396700|P1|COMPLETED|Overall Study||8
164855|NCT00999544|396700|P1|STARTED|Overall Study||9
164856|NCT00999466|396736|P3|NOT COMPLETED|Main Part||4
164857|NCT00999466|396737|P2|NOT COMPLETED|Main Part||4
164858|NCT00999466|396738|P1|NOT COMPLETED|Main Part||0
164859|NCT00999466|396736|P3|COMPLETED|Main Part||21
164860|NCT00999466|396737|P2|COMPLETED|Main Part||22
164861|NCT00999466|396738|P1|COMPLETED|Main Part||0
164862|NCT00999466|396736|P3|STARTED|Main Part||25
164863|NCT00999466|396737|P2|STARTED|Main Part||26
164864|NCT00999466|396738|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
164865|NCT00999466|396736|P3|NOT COMPLETED|Pilot Part||0
164866|NCT00999466|396737|P2|NOT COMPLETED|Pilot Part||0
164867|NCT00999466|396738|P1|NOT COMPLETED|Pilot Part||0
164868|NCT00999466|396736|P3|COMPLETED|Pilot Part||3
164869|NCT00999466|396737|P2|COMPLETED|Pilot Part||0
164870|NCT00999466|396738|P1|COMPLETED|Pilot Part||6
164871|NCT00999466|396736|P3|STARTED|Pilot Part||3
164872|NCT00999466|396737|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
164873|NCT00999466|396738|P1|STARTED|Pilot Part||6
164874|NCT00999167|397015|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
164875|NCT00999167|397016|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
164876|NCT00999167|397017|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
164877|NCT00999167|397015|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
164878|NCT00999167|397016|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
164879|NCT00999167|397017|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
164880|NCT00999167|397015|P3|STARTED|Part B: Randomized, Placebo Controlled||88
164881|NCT00999167|397016|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
164882|NCT00999167|397017|P1|STARTED|Part B: Randomized, Placebo Controlled||0
164883|NCT00999167|397015|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
164884|NCT00999167|397016|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
164885|NCT00999167|397017|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
164886|NCT00999167|397015|P3|COMPLETED|Part A: Open Label Safety run-in||0
164887|NCT00999167|397016|P2|COMPLETED|Part A: Open Label Safety run-in||0
164888|NCT00999167|397017|P1|COMPLETED|Part A: Open Label Safety run-in||8
164889|NCT00999167|397015|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
164890|NCT00999167|397016|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
164891|NCT00999167|397017|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
164892|NCT00999167|397015|P3|STARTED|Part A: Open Label Safety run-in||0
164893|NCT00999167|397016|P2|STARTED|Part A: Open Label Safety run-in||0
164894|NCT00999167|397017|P1|STARTED|Part A: Open Label Safety run-in||15
164895|NCT00999141|397031|P1|NOT COMPLETED|Overall Study||0
164896|NCT00999141|397031|P1|COMPLETED|Overall Study||75
164897|NCT00999141|397031|P1|STARTED|Overall Study|Randomized and treated|75
164898|NCT00999037|397115|P2|NOT COMPLETED|Overall Study||0
164899|NCT00999037|397116|P1|NOT COMPLETED|Overall Study||0
164900|NCT00999037|397115|P2|COMPLETED|Overall Study||9
164901|NCT00999037|397116|P1|COMPLETED|Overall Study||9
164902|NCT00999037|397115|P2|STARTED|Overall Study|20|9
164903|NCT00999037|397116|P1|STARTED|Overall Study||9
164904|NCT00998985|397140|P14|NOT COMPLETED|Overall Study||0
164905|NCT00998985|397141|P13|NOT COMPLETED|Overall Study||0
164906|NCT00998985|397142|P12|NOT COMPLETED|Overall Study||0
164907|NCT00998985|397143|P11|NOT COMPLETED|Overall Study||0
164908|NCT00998985|397144|P10|NOT COMPLETED|Overall Study||0
164909|NCT00998985|397145|P9|NOT COMPLETED|Overall Study||1
164910|NCT00998985|397146|P8|NOT COMPLETED|Overall Study||0
164911|NCT00998985|397147|P7|NOT COMPLETED|Overall Study||0
164912|NCT00998985|397148|P6|NOT COMPLETED|Overall Study||1
164913|NCT00998985|397149|P5|NOT COMPLETED|Overall Study||0
164914|NCT00998985|397150|P4|NOT COMPLETED|Overall Study||0
164915|NCT00998985|397151|P3|NOT COMPLETED|Overall Study||0
164916|NCT00998985|397152|P2|NOT COMPLETED|Overall Study||0
164917|NCT00998985|397153|P1|NOT COMPLETED|Overall Study||0
164918|NCT00998985|397140|P14|COMPLETED|Overall Study||15
164919|NCT00998985|397141|P13|COMPLETED|Overall Study||5
164920|NCT00998985|397142|P12|COMPLETED|Overall Study||5
164921|NCT00998985|397143|P11|COMPLETED|Overall Study||5
164922|NCT00998985|397144|P10|COMPLETED|Overall Study||5
164923|NCT00998985|397145|P9|COMPLETED|Overall Study||5
164924|NCT00998985|397146|P8|COMPLETED|Overall Study||5
164925|NCT00998985|397147|P7|COMPLETED|Overall Study||5
164926|NCT00998985|397148|P6|COMPLETED|Overall Study||4
164927|NCT00998985|397149|P5|COMPLETED|Overall Study||5
164928|NCT00998985|397150|P4|COMPLETED|Overall Study||5
164929|NCT00998985|397151|P3|COMPLETED|Overall Study||15
164930|NCT00998985|397152|P2|COMPLETED|Overall Study||5
164931|NCT00998985|397153|P1|COMPLETED|Overall Study||5
164932|NCT00998985|397140|P14|STARTED|Overall Study||15
164933|NCT00998985|397141|P13|STARTED|Overall Study||5
164934|NCT00998985|397142|P12|STARTED|Overall Study||5
164935|NCT00998985|397143|P11|STARTED|Overall Study||5
164936|NCT00998985|397144|P10|STARTED|Overall Study||5
164937|NCT00998985|397145|P9|STARTED|Overall Study||6
164938|NCT00998985|397146|P8|STARTED|Overall Study||5
164939|NCT00998985|397147|P7|STARTED|Overall Study||5
164940|NCT00998985|397148|P6|STARTED|Overall Study||5
164941|NCT00998985|397149|P5|STARTED|Overall Study||5
164942|NCT00998985|397150|P4|STARTED|Overall Study||5
164943|NCT00998985|397151|P3|STARTED|Overall Study||15
164944|NCT00998985|397152|P2|STARTED|Overall Study||5
164945|NCT00998985|397153|P1|STARTED|Overall Study||5
164946|NCT00998881|397221|P2|NOT COMPLETED|Overall Study||2
164947|NCT00998881|397222|P1|NOT COMPLETED|Overall Study||8
164948|NCT00998881|397221|P2|COMPLETED|Overall Study||97
164949|NCT00998881|397222|P1|COMPLETED|Overall Study||96
164950|NCT00998881|397221|P2|STARTED|Overall Study||99
164951|NCT00998881|397222|P1|STARTED|Overall Study||104
164952|NCT00998868|397234|P1|NOT COMPLETED|Overall Study||0
164953|NCT00998868|397234|P1|COMPLETED|Overall Study||51
164954|NCT00998868|397234|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
164955|NCT00998764|397243|P2|NOT COMPLETED|Overall Study||274
164956|NCT00998764|397244|P1|NOT COMPLETED|Overall Study||216
164957|NCT00998764|397243|P2|COMPLETED|Overall Study||2
164958|NCT00998764|397244|P1|COMPLETED|Overall Study||0
164959|NCT00998764|397243|P2|Treated|Overall Study||275
164960|NCT00998764|397244|P1|Treated|Overall Study||215
164961|NCT00998764|397243|P2|STARTED|Overall Study||276
164962|NCT00998764|397244|P1|STARTED|Overall Study||216
164963|NCT00998738|397266|P1|NOT COMPLETED|Overall Study||1
164964|NCT00998738|397266|P1|COMPLETED|Overall Study||0
164965|NCT00998738|397266|P1|STARTED|Overall Study||1
164966|NCT00998660|397281|P1|NOT COMPLETED|Overall Study||13
164967|NCT00998660|397281|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
164968|NCT00998660|397281|P1|Month 3 Visit|Overall Study||87
164969|NCT00998660|397281|P1|Implanted|Overall Study||93
164970|NCT00998660|397281|P1|STARTED|Overall Study||100
164971|NCT00998582|397287|P2|NOT COMPLETED|Overall Study||0
164972|NCT00998582|397288|P1|NOT COMPLETED|Overall Study||0
164973|NCT00998582|397287|P2|COMPLETED|Overall Study||14
164974|NCT00998582|397288|P1|COMPLETED|Overall Study||13
164975|NCT00998582|397287|P2|STARTED|Overall Study||14
164976|NCT00998582|397288|P1|STARTED|Overall Study||13
164977|NCT00998517|397299|P3|NOT COMPLETED|Overall Study||0
164978|NCT00998517|397300|P2|NOT COMPLETED|Overall Study||0
164979|NCT00998517|397301|P1|NOT COMPLETED|Overall Study||0
164980|NCT00998517|397299|P3|COMPLETED|Overall Study||918
164981|NCT00998517|397300|P2|COMPLETED|Overall Study||906
164982|NCT00998517|397301|P1|COMPLETED|Overall Study||888
164983|NCT00998517|397299|P3|STARTED|Overall Study||918
164984|NCT00998517|397300|P2|STARTED|Overall Study||906
164985|NCT00998517|397301|P1|STARTED|Overall Study||888
164986|NCT00998426|397327|P1|NOT COMPLETED|Overall Study||0
164987|NCT00998426|397327|P1|COMPLETED|Overall Study||5
164988|NCT00998426|397327|P1|Blood Glucose Monitoring|Overall Study||5
164989|NCT00998426|397327|P1|STARTED|Overall Study||5
164990|NCT00998374|397334|P2|NOT COMPLETED|Overall Study||11
164991|NCT00998374|397335|P1|NOT COMPLETED|Overall Study||12
164992|NCT00998374|397334|P2|COMPLETED|Overall Study||12
164993|NCT00998374|397335|P1|COMPLETED|Overall Study||27
164994|NCT00998374|397334|P2|STARTED|Overall Study||23
164995|NCT00998374|397335|P1|STARTED|Overall Study||39
164996|NCT00998335|397349|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
164997|NCT00998335|397350|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
164998|NCT00998335|397349|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
164999|NCT00998335|397350|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
165000|NCT00998335|397349|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
165001|NCT00998335|397350|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
165002|NCT00998335|397349|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
165003|NCT00998335|397350|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
165004|NCT00998335|397349|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
165005|NCT00998335|397350|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
165006|NCT00998335|397349|P2|STARTED|Initial Treatment (Months 0 - 3)||0
165007|NCT00998335|397350|P1|STARTED|Initial Treatment (Months 0 - 3)||30
165008|NCT00998309|397378|P1|NOT COMPLETED|Overall Study||4
165009|NCT00998309|397378|P1|COMPLETED|Overall Study||498
165010|NCT00998309|397378|P1|STARTED|Overall Study||502
165011|NCT00998296|397445|P11|NOT COMPLETED|Overall Study||7
165012|NCT00998296|397446|P10|NOT COMPLETED|Overall Study||18
165013|NCT00998296|397447|P9|NOT COMPLETED|Overall Study||2
165014|NCT00998296|397448|P8|NOT COMPLETED|Overall Study||2
165015|NCT00998296|397449|P7|NOT COMPLETED|Overall Study||1
165016|NCT00998296|397450|P6|NOT COMPLETED|Overall Study||0
165017|NCT00998296|397451|P5|NOT COMPLETED|Overall Study||2
165018|NCT00998296|397452|P4|NOT COMPLETED|Overall Study||0
165019|NCT00998296|397453|P3|NOT COMPLETED|Overall Study||0
165020|NCT00998296|397454|P2|NOT COMPLETED|Overall Study||1
165021|NCT00998296|397455|P1|NOT COMPLETED|Overall Study||0
165022|NCT00998296|397445|P11|COMPLETED|Overall Study||0
165023|NCT00998296|397446|P10|COMPLETED|Overall Study||0
165024|NCT00998296|397447|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
165025|NCT00998296|397448|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
165026|NCT00998296|397449|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
165027|NCT00998296|397450|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
165028|NCT00998296|397451|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
165029|NCT00998296|397452|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
165030|NCT00998296|397453|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
165031|NCT00998296|397454|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
165032|NCT00998296|397455|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
165033|NCT00998296|397445|P11|STARTED|Overall Study||7
165034|NCT00998296|397446|P10|STARTED|Overall Study||18
165035|NCT00998296|397447|P9|STARTED|Overall Study||6
165036|NCT00998296|397448|P8|STARTED|Overall Study||6
165037|NCT00998296|397449|P7|STARTED|Overall Study||7
165038|NCT00998296|397450|P6|STARTED|Overall Study||3
165039|NCT00998296|397451|P5|STARTED|Overall Study||8
165040|NCT00998296|397452|P4|STARTED|Overall Study||3
165041|NCT00998296|397453|P3|STARTED|Overall Study||3
165042|NCT00998296|397454|P2|STARTED|Overall Study||3
165043|NCT00998296|397455|P1|STARTED|Overall Study||6
165044|NCT00998205|397522|P1|NOT COMPLETED|Overall Study||0
165045|NCT00998205|397522|P1|COMPLETED|Overall Study||16
165046|NCT00998205|397522|P1|STARTED|Overall Study||16
165047|NCT00998049|397527|P1|NOT COMPLETED|Overall Study||0
165048|NCT00998049|397527|P1|COMPLETED|Overall Study||39
165049|NCT00998049|397527|P1|STARTED|Overall Study||39
165050|NCT00998023|397538|P2|NOT COMPLETED|Overall Study||0
165051|NCT00998023|397539|P1|NOT COMPLETED|Overall Study||0
165052|NCT00998023|397538|P2|COMPLETED|Overall Study||32
165053|NCT00998023|397539|P1|COMPLETED|Overall Study||32
165054|NCT00998023|397538|P2|STARTED|Overall Study||32
165055|NCT00998023|397539|P1|STARTED|Overall Study||32
165056|NCT00997984|397550|P3|NOT COMPLETED|Overall Study||26
165057|NCT00997984|397551|P2|NOT COMPLETED|Overall Study||34
165058|NCT00997984|397552|P1|NOT COMPLETED|Overall Study||37
165059|NCT00997984|397550|P3|COMPLETED|Overall Study||88
165060|NCT00997984|397551|P2|COMPLETED|Overall Study||79
165061|NCT00997984|397552|P1|COMPLETED|Overall Study||76
165062|NCT00997984|397550|P3|STARTED|Overall Study||114
165063|NCT00997984|397551|P2|STARTED|Overall Study||113
165064|NCT00997984|397552|P1|STARTED|Overall Study||113
165065|NCT00997932|397618|P1|NOT COMPLETED|Overall Study||2
165066|NCT00997932|397618|P1|COMPLETED|Overall Study||27
165067|NCT00997932|397618|P1|STARTED|Overall Study||29
165068|NCT00997672|397625|P2|NOT COMPLETED|Overall Study||4
165069|NCT00997672|397626|P1|NOT COMPLETED|Overall Study||4
165070|NCT00997672|397625|P2|COMPLETED|Overall Study||1
165071|NCT00997672|397626|P1|COMPLETED|Overall Study||0
165072|NCT00997672|397625|P2|STARTED|Overall Study||5
165073|NCT00997672|397626|P1|STARTED|Overall Study||4
165074|NCT00997620|397634|P2|NOT COMPLETED|Overall Study||0
165075|NCT00997620|397635|P1|NOT COMPLETED|Overall Study||0
165076|NCT00997620|397634|P2|COMPLETED|Overall Study||21
165077|NCT00997620|397635|P1|COMPLETED|Overall Study||19
165078|NCT00997620|397634|P2|STARTED|Overall Study||21
165079|NCT00997620|397635|P1|STARTED|Overall Study||19
165080|NCT00997594|397653|P2|NOT COMPLETED|Overall Study||0
165081|NCT00997594|397654|P1|NOT COMPLETED|Overall Study||0
165082|NCT00997594|397653|P2|COMPLETED|Overall Study||9
165083|NCT00997594|397654|P1|COMPLETED|Overall Study||9
165084|NCT00997594|397653|P2|Completion of Ablation Procedure|Overall Study||9
165085|NCT00997594|397654|P1|Completion of Ablation Procedure|Overall Study||9
165086|NCT00997594|397653|P2|STARTED|Overall Study||9
165087|NCT00997594|397654|P1|STARTED|Overall Study||9
165088|NCT00997555|397662|P2|NOT COMPLETED|Overall Study||0
165089|NCT00997555|397663|P1|NOT COMPLETED|Overall Study||0
165090|NCT00997555|397662|P2|COMPLETED|Overall Study||15
165091|NCT00997555|397663|P1|COMPLETED|Overall Study||13
165092|NCT00997555|397662|P2|STARTED|Overall Study||15
165093|NCT00997555|397663|P1|STARTED|Overall Study||13
165094|NCT00997516|397681|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
165095|NCT00997516|397682|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
165096|NCT00997516|397681|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
165097|NCT00997516|397682|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
165098|NCT00997516|397681|P2|STARTED|Long-term Follow-up (After 6 Months)||38
165099|NCT00997516|397682|P1|STARTED|Long-term Follow-up (After 6 Months)||37
165100|NCT00997516|397681|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
165101|NCT00997516|397682|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
165102|NCT00997516|397681|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
165103|NCT00997516|397682|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
165104|NCT00997516|397681|P2|STARTED|Short-term Follow-up (Post Operative)||38
165105|NCT00997516|397682|P1|STARTED|Short-term Follow-up (Post Operative)||37
165106|NCT00997503|397710|P1|NOT COMPLETED|Overall Study||273
165107|NCT00997503|397710|P1|COMPLETED|Overall Study||3926
165108|NCT00997503|397710|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
165109|NCT00997503|397710|P1|STARTED|Overall Study||4199
165110|NCT00997438|397753|P3|NOT COMPLETED|Overall Study||4
165111|NCT00997438|397754|P2|NOT COMPLETED|Overall Study||3
165112|NCT00997438|397755|P1|NOT COMPLETED|Overall Study||5
165113|NCT00997438|397753|P3|COMPLETED|Overall Study||20
165114|NCT00997438|397754|P2|COMPLETED|Overall Study||21
165115|NCT00997438|397755|P1|COMPLETED|Overall Study||16
165116|NCT00997438|397753|P3|STARTED|Overall Study||24
165117|NCT00997438|397754|P2|STARTED|Overall Study||24
165118|NCT00997438|397755|P1|STARTED|Overall Study||21
165119|NCT00997425|397790|P1|NOT COMPLETED|Overall Study||0
165120|NCT00997425|397790|P1|COMPLETED|Overall Study||19
165121|NCT00997425|397790|P1|STARTED|Overall Study||19
165122|NCT00997373|397797|P2|NOT COMPLETED|Overall Study||0
165123|NCT00997373|397798|P1|NOT COMPLETED|Overall Study||15
165124|NCT00997373|397797|P2|COMPLETED|Overall Study||15
165125|NCT00997373|397798|P1|COMPLETED|Overall Study||13
165126|NCT00997373|397797|P2|Completed Hysterectomy|Overall Study||15
165127|NCT00997373|397798|P1|Completed Hysterectomy|Overall Study||17
165128|NCT00997373|397797|P2|Received Letrozole|Overall Study||0
165129|NCT00997373|397798|P1|Received Letrozole|Overall Study||23
165130|NCT00997373|397797|P2|STARTED|Overall Study||15
165131|NCT00997373|397798|P1|STARTED|Overall Study||28
165132|NCT00997334|397804|P1|NOT COMPLETED|Overall Study||25
165133|NCT00997334|397804|P1|COMPLETED|Overall Study||35
165134|NCT00997334|397804|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
165135|NCT00997334|397804|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
165136|NCT00997334|397804|P1|STARTED|Overall Study||60
165137|NCT00997321|397813|P2|NOT COMPLETED|Overall Study||3
165138|NCT00997321|397814|P1|NOT COMPLETED|Overall Study||0
165139|NCT00997321|397813|P2|COMPLETED|Overall Study||47
165140|NCT00997321|397814|P1|COMPLETED|Overall Study||50
165141|NCT00997321|397813|P2|STARTED|Overall Study||50
165142|NCT00997321|397814|P1|STARTED|Overall Study||50
165143|NCT00997243|397826|P1|NOT COMPLETED|Overall Study||7
165144|NCT00997243|397826|P1|COMPLETED|Overall Study||0
165145|NCT00997243|397826|P1|STARTED|Overall Study||7
165146|NCT00997204|397838|P2|NOT COMPLETED|Self-administration Phase||1
165147|NCT00997204|397839|P1|NOT COMPLETED|Self-administration Phase||0
165148|NCT00997204|397838|P2|COMPLETED|Self-administration Phase||77
165149|NCT00997204|397839|P1|COMPLETED|Self-administration Phase||19
165150|NCT00997204|397838|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
165151|NCT00997204|397839|P1|STARTED|Self-administration Phase||19
165152|NCT00997204|397838|P2|NOT COMPLETED|Naive Treatment Phase||79
165153|NCT00997204|397839|P1|NOT COMPLETED|Naive Treatment Phase||6
165154|NCT00997204|397838|P2|COMPLETED|Naive Treatment Phase||0
165155|NCT00997204|397839|P1|COMPLETED|Naive Treatment Phase||19
165156|NCT00997204|397838|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
165157|NCT00997204|397839|P1|STARTED|Naive Treatment Phase||25
165158|NCT00997139|397850|P1|NOT COMPLETED|Overall Study||186
165159|NCT00997139|397850|P1|COMPLETED|Overall Study||30
165160|NCT00997139|397850|P1|Treated for Positive Baseline Culture|Overall Study||30
165161|NCT00997139|397850|P1|STARTED|Overall Study||216
165162|NCT00997126|397858|P2|NOT COMPLETED|Overall Study||11
165163|NCT00997126|397859|P1|NOT COMPLETED|Overall Study||7
165164|NCT00997126|397858|P2|COMPLETED|Overall Study||52
165165|NCT00997126|397859|P1|COMPLETED|Overall Study||56
165166|NCT00997126|397858|P2|STARTED|Overall Study||63
165167|NCT00997126|397859|P1|STARTED|Overall Study||63
165168|NCT00997113|397875|P2|NOT COMPLETED|Overall Study||0
165169|NCT00997113|397876|P1|NOT COMPLETED|Overall Study||0
165170|NCT00997113|397875|P2|COMPLETED|Overall Study||10
165171|NCT00997113|397876|P1|COMPLETED|Overall Study||10
165172|NCT00997113|397875|P2|STARTED|Overall Study||10
165173|NCT00997113|397876|P1|STARTED|Overall Study||10
165174|NCT00997035|397888|P2|NOT COMPLETED|3-month Follow-up Visit||6
165175|NCT00997035|397889|P1|NOT COMPLETED|3-month Follow-up Visit||12
165176|NCT00997035|397888|P2|COMPLETED|3-month Follow-up Visit||107
165177|NCT00997035|397889|P1|COMPLETED|3-month Follow-up Visit||100
165178|NCT00997035|397888|P2|STARTED|3-month Follow-up Visit||113
165179|NCT00997035|397889|P1|STARTED|3-month Follow-up Visit||112
165180|NCT00997035|397888|P2|NOT COMPLETED|3-week Followup Visit||6
165181|NCT00997035|397889|P1|NOT COMPLETED|3-week Followup Visit||9
165182|NCT00997035|397888|P2|COMPLETED|3-week Followup Visit||113
165183|NCT00997035|397889|P1|COMPLETED|3-week Followup Visit||112
165184|NCT00997035|397888|P2|STARTED|3-week Followup Visit||119
165185|NCT00997035|397889|P1|STARTED|3-week Followup Visit||121
165186|NCT00996996|397909|P1|NOT COMPLETED|Overall Study||33
165187|NCT00996996|397909|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
165188|NCT00996996|397909|P1|STARTED|Overall Study||77
165189|NCT00996944|397943|P2|NOT COMPLETED|Long-term Treatment Period||5
165190|NCT00996944|397944|P1|NOT COMPLETED|Long-term Treatment Period||12
165191|NCT00996944|397943|P2|COMPLETED|Long-term Treatment Period||0
165192|NCT00996944|397944|P1|COMPLETED|Long-term Treatment Period||0
165193|NCT00996944|397943|P2|STARTED|Long-term Treatment Period||5
165194|NCT00996944|397944|P1|STARTED|Long-term Treatment Period||12
165195|NCT00996944|397943|P2|NOT COMPLETED|Double-blind Treatment Period||7
165196|NCT00996944|397944|P1|NOT COMPLETED|Double-blind Treatment Period||10
165197|NCT00996944|397943|P2|COMPLETED|Double-blind Treatment Period||5
165198|NCT00996944|397944|P1|COMPLETED|Double-blind Treatment Period||12
165199|NCT00996944|397943|P2|STARTED|Double-blind Treatment Period||12
165200|NCT00996944|397944|P1|STARTED|Double-blind Treatment Period||22
165201|NCT00996931|397986|P1|NOT COMPLETED|Overall Study||0
165202|NCT00996931|397986|P1|COMPLETED|Overall Study||6
165203|NCT00996931|397986|P1|STARTED|Overall Study||6
165204|NCT00996918|397996|P5|NOT COMPLETED|Overall Study||4
165205|NCT00996918|397997|P4|NOT COMPLETED|Overall Study||56
165206|NCT00996918|397998|P3|NOT COMPLETED|Overall Study||37
165207|NCT00996918|397999|P2|NOT COMPLETED|Overall Study||66
165208|NCT00996918|398000|P1|NOT COMPLETED|Overall Study||39
165209|NCT00996918|397996|P5|COMPLETED|Overall Study||0
165210|NCT00996918|397997|P4|COMPLETED|Overall Study||0
165211|NCT00996918|397998|P3|COMPLETED|Overall Study||0
165212|NCT00996918|397999|P2|COMPLETED|Overall Study||0
165213|NCT00996918|398000|P1|COMPLETED|Overall Study||0
165214|NCT00996918|397996|P5|Treated|Overall Study||4
165215|NCT00996918|397997|P4|Treated|Overall Study||56
165216|NCT00996918|397998|P3|Treated|Overall Study||37
165217|NCT00996918|397999|P2|Treated|Overall Study||66
165218|NCT00996918|398000|P1|Treated|Overall Study||39
165219|NCT00996918|397996|P5|STARTED|Overall Study||4
165220|NCT00996918|397997|P4|STARTED|Overall Study||56
165221|NCT00996918|397998|P3|STARTED|Overall Study||37
165222|NCT00996918|397999|P2|STARTED|Overall Study||66
165223|NCT00996918|398000|P1|STARTED|Overall Study||39
165224|NCT00996892|398044|P20|NOT COMPLETED|Expansion Stage 2A||45
165225|NCT00996892|398045|P19|NOT COMPLETED|Expansion Stage 2A||0
165226|NCT00996892|398046|P18|NOT COMPLETED|Expansion Stage 2A||0
165227|NCT00996892|398047|P17|NOT COMPLETED|Expansion Stage 2A||0
165228|NCT00996892|398048|P16|NOT COMPLETED|Expansion Stage 2A||0
165229|NCT00996892|398049|P15|NOT COMPLETED|Expansion Stage 2A||0
165230|NCT00996892|398050|P14|NOT COMPLETED|Expansion Stage 2A||0
165231|NCT00996892|398051|P13|NOT COMPLETED|Expansion Stage 2A||0
165232|NCT00996892|398052|P12|NOT COMPLETED|Expansion Stage 2A||0
165233|NCT00996892|398053|P11|NOT COMPLETED|Expansion Stage 2A||0
165234|NCT00996892|398054|P10|NOT COMPLETED|Expansion Stage 2A||0
165235|NCT00996892|398055|P9|NOT COMPLETED|Expansion Stage 2A||0
165236|NCT00996892|398056|P8|NOT COMPLETED|Expansion Stage 2A||0
165237|NCT00996892|398057|P7|NOT COMPLETED|Expansion Stage 2A||0
165238|NCT00996892|398058|P6|NOT COMPLETED|Expansion Stage 2A||0
165239|NCT00996892|398059|P5|NOT COMPLETED|Expansion Stage 2A||0
165240|NCT00996892|398060|P4|NOT COMPLETED|Expansion Stage 2A||0
165241|NCT00996892|398061|P3|NOT COMPLETED|Expansion Stage 2A||0
165242|NCT00996892|398062|P2|NOT COMPLETED|Expansion Stage 2A||0
165243|NCT00996892|398063|P1|NOT COMPLETED|Expansion Stage 2A||0
165244|NCT00996892|398044|P20|COMPLETED|Expansion Stage 2A||0
165245|NCT00996892|398045|P19|COMPLETED|Expansion Stage 2A||0
165246|NCT00996892|398046|P18|COMPLETED|Expansion Stage 2A||0
165247|NCT00996892|398047|P17|COMPLETED|Expansion Stage 2A||0
165248|NCT00996892|398048|P16|COMPLETED|Expansion Stage 2A||0
165249|NCT00996892|398049|P15|COMPLETED|Expansion Stage 2A||0
165250|NCT00996892|398050|P14|COMPLETED|Expansion Stage 2A||0
165251|NCT00996892|398051|P13|COMPLETED|Expansion Stage 2A||0
165252|NCT00996892|398052|P12|COMPLETED|Expansion Stage 2A||0
165253|NCT00996892|398053|P11|COMPLETED|Expansion Stage 2A||0
165254|NCT00996892|398054|P10|COMPLETED|Expansion Stage 2A||0
165255|NCT00996892|398055|P9|COMPLETED|Expansion Stage 2A||0
165256|NCT00996892|398056|P8|COMPLETED|Expansion Stage 2A||0
165257|NCT00996892|398057|P7|COMPLETED|Expansion Stage 2A||0
165258|NCT00996892|398058|P6|COMPLETED|Expansion Stage 2A||0
165259|NCT00996892|398059|P5|COMPLETED|Expansion Stage 2A||0
165260|NCT00996892|398060|P4|COMPLETED|Expansion Stage 2A||0
165261|NCT00996892|398061|P3|COMPLETED|Expansion Stage 2A||0
165262|NCT00996892|398062|P2|COMPLETED|Expansion Stage 2A||0
165263|NCT00996892|398063|P1|COMPLETED|Expansion Stage 2A||0
165264|NCT00996892|398044|P20|STARTED|Expansion Stage 2A||45
165265|NCT00996892|398045|P19|STARTED|Expansion Stage 2A||0
165266|NCT00996892|398046|P18|STARTED|Expansion Stage 2A||0
165267|NCT00996892|398047|P17|STARTED|Expansion Stage 2A||0
165268|NCT00996892|398048|P16|STARTED|Expansion Stage 2A||0
165269|NCT00996892|398049|P15|STARTED|Expansion Stage 2A||0
165270|NCT00996892|398050|P14|STARTED|Expansion Stage 2A||0
165271|NCT00996892|398051|P13|STARTED|Expansion Stage 2A||0
165272|NCT00996892|398052|P12|STARTED|Expansion Stage 2A||0
165273|NCT00996892|398053|P11|STARTED|Expansion Stage 2A||0
165274|NCT00996892|398054|P10|STARTED|Expansion Stage 2A||0
165275|NCT00996892|398055|P9|STARTED|Expansion Stage 2A||0
165276|NCT00996892|398056|P8|STARTED|Expansion Stage 2A||0
165277|NCT00996892|398057|P7|STARTED|Expansion Stage 2A||0
165278|NCT00996892|398058|P6|STARTED|Expansion Stage 2A||0
165279|NCT00996892|398059|P5|STARTED|Expansion Stage 2A||0
165280|NCT00996892|398060|P4|STARTED|Expansion Stage 2A||0
165281|NCT00996892|398061|P3|STARTED|Expansion Stage 2A||0
165282|NCT00996892|398062|P2|STARTED|Expansion Stage 2A||0
165283|NCT00996892|398063|P1|STARTED|Expansion Stage 2A||0
165284|NCT00996892|398044|P20|NOT COMPLETED|Expansion Stage 2||0
165285|NCT00996892|398045|P19|NOT COMPLETED|Expansion Stage 2||35
165286|NCT00996892|398046|P18|NOT COMPLETED|Expansion Stage 2||0
165287|NCT00996892|398047|P17|NOT COMPLETED|Expansion Stage 2||0
165288|NCT00996892|398048|P16|NOT COMPLETED|Expansion Stage 2||0
165289|NCT00996892|398049|P15|NOT COMPLETED|Expansion Stage 2||0
165290|NCT00996892|398050|P14|NOT COMPLETED|Expansion Stage 2||0
165291|NCT00996892|398051|P13|NOT COMPLETED|Expansion Stage 2||0
165292|NCT00996892|398052|P12|NOT COMPLETED|Expansion Stage 2||0
165293|NCT00996892|398053|P11|NOT COMPLETED|Expansion Stage 2||0
165294|NCT00996892|398054|P10|NOT COMPLETED|Expansion Stage 2||0
165295|NCT00996892|398055|P9|NOT COMPLETED|Expansion Stage 2||0
165296|NCT00996892|398056|P8|NOT COMPLETED|Expansion Stage 2||0
165297|NCT00996892|398057|P7|NOT COMPLETED|Expansion Stage 2||0
165298|NCT00996892|398058|P6|NOT COMPLETED|Expansion Stage 2||0
165299|NCT00996892|398059|P5|NOT COMPLETED|Expansion Stage 2||0
165300|NCT00996892|398060|P4|NOT COMPLETED|Expansion Stage 2||0
165301|NCT00996892|398061|P3|NOT COMPLETED|Expansion Stage 2||0
165302|NCT00996892|398062|P2|NOT COMPLETED|Expansion Stage 2||0
165303|NCT00996892|398063|P1|NOT COMPLETED|Expansion Stage 2||0
165304|NCT00996892|398044|P20|COMPLETED|Expansion Stage 2||0
165305|NCT00996892|398045|P19|COMPLETED|Expansion Stage 2||0
165306|NCT00996892|398046|P18|COMPLETED|Expansion Stage 2||0
165307|NCT00996892|398047|P17|COMPLETED|Expansion Stage 2||0
165308|NCT00996892|398048|P16|COMPLETED|Expansion Stage 2||0
165309|NCT00996892|398049|P15|COMPLETED|Expansion Stage 2||0
165310|NCT00996892|398050|P14|COMPLETED|Expansion Stage 2||0
165311|NCT00996892|398051|P13|COMPLETED|Expansion Stage 2||0
165312|NCT00996892|398052|P12|COMPLETED|Expansion Stage 2||0
165313|NCT00996892|398053|P11|COMPLETED|Expansion Stage 2||0
165314|NCT00996892|398054|P10|COMPLETED|Expansion Stage 2||0
165315|NCT00996892|398055|P9|COMPLETED|Expansion Stage 2||0
165316|NCT00996892|398056|P8|COMPLETED|Expansion Stage 2||0
165317|NCT00996892|398057|P7|COMPLETED|Expansion Stage 2||0
165318|NCT00996892|398058|P6|COMPLETED|Expansion Stage 2||0
165319|NCT00996892|398059|P5|COMPLETED|Expansion Stage 2||0
165320|NCT00996892|398060|P4|COMPLETED|Expansion Stage 2||0
165321|NCT00996892|398061|P3|COMPLETED|Expansion Stage 2||0
165322|NCT00996892|398062|P2|COMPLETED|Expansion Stage 2||0
165323|NCT00996892|398063|P1|COMPLETED|Expansion Stage 2||0
165324|NCT00996892|398044|P20|STARTED|Expansion Stage 2||0
165325|NCT00996892|398045|P19|STARTED|Expansion Stage 2||35
165326|NCT00996892|398046|P18|STARTED|Expansion Stage 2||0
165327|NCT00996892|398047|P17|STARTED|Expansion Stage 2||0
165328|NCT00996892|398048|P16|STARTED|Expansion Stage 2||0
165329|NCT00996892|398049|P15|STARTED|Expansion Stage 2||0
165330|NCT00996892|398050|P14|STARTED|Expansion Stage 2||0
165331|NCT00996892|398051|P13|STARTED|Expansion Stage 2||0
165332|NCT00996892|398052|P12|STARTED|Expansion Stage 2||0
165333|NCT00996892|398053|P11|STARTED|Expansion Stage 2||0
165334|NCT00996892|398054|P10|STARTED|Expansion Stage 2||0
165335|NCT00996892|398055|P9|STARTED|Expansion Stage 2||0
165336|NCT00996892|398056|P8|STARTED|Expansion Stage 2||0
165337|NCT00996892|398057|P7|STARTED|Expansion Stage 2||0
165338|NCT00996892|398058|P6|STARTED|Expansion Stage 2||0
165339|NCT00996892|398059|P5|STARTED|Expansion Stage 2||0
165340|NCT00996892|398060|P4|STARTED|Expansion Stage 2||0
165341|NCT00996892|398061|P3|STARTED|Expansion Stage 2||0
165342|NCT00996892|398062|P2|STARTED|Expansion Stage 2||0
165343|NCT00996892|398063|P1|STARTED|Expansion Stage 2||0
165344|NCT00996892|398044|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
165345|NCT00996892|398045|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
165346|NCT00996892|398046|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
165347|NCT00996892|398047|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
165348|NCT00996892|398048|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
165349|NCT00996892|398049|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
165350|NCT00996892|398050|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
165351|NCT00996892|398051|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
165352|NCT00996892|398052|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
165353|NCT00996892|398053|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
165354|NCT00996892|398054|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
165355|NCT00996892|398055|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
165356|NCT00996892|398056|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
165357|NCT00996892|398057|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
165358|NCT00996892|398058|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
165359|NCT00996892|398059|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
165360|NCT00996892|398060|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
165361|NCT00996892|398061|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
165362|NCT00996892|398062|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
165363|NCT00996892|398063|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
165364|NCT00996892|398044|P20|COMPLETED|Dose-Escalation Stage 1B||0
165365|NCT00996892|398045|P19|COMPLETED|Dose-Escalation Stage 1B||0
165366|NCT00996892|398046|P18|COMPLETED|Dose-Escalation Stage 1B||0
165367|NCT00996892|398047|P17|COMPLETED|Dose-Escalation Stage 1B||0
165368|NCT00996892|398048|P16|COMPLETED|Dose-Escalation Stage 1B||0
165369|NCT00996892|398049|P15|COMPLETED|Dose-Escalation Stage 1B||0
165370|NCT00996892|398050|P14|COMPLETED|Dose-Escalation Stage 1B||0
165371|NCT00996892|398051|P13|COMPLETED|Dose-Escalation Stage 1B||0
165372|NCT00996892|398052|P12|COMPLETED|Dose-Escalation Stage 1B||0
165373|NCT00996892|398053|P11|COMPLETED|Dose-Escalation Stage 1B||0
165374|NCT00996892|398054|P10|COMPLETED|Dose-Escalation Stage 1B||0
165375|NCT00996892|398055|P9|COMPLETED|Dose-Escalation Stage 1B||0
165376|NCT00996892|398056|P8|COMPLETED|Dose-Escalation Stage 1B||0
165377|NCT00996892|398057|P7|COMPLETED|Dose-Escalation Stage 1B||0
165378|NCT00996892|398058|P6|COMPLETED|Dose-Escalation Stage 1B||0
165379|NCT00996892|398059|P5|COMPLETED|Dose-Escalation Stage 1B||0
165380|NCT00996892|398060|P4|COMPLETED|Dose-Escalation Stage 1B||0
165381|NCT00996892|398061|P3|COMPLETED|Dose-Escalation Stage 1B||0
165382|NCT00996892|398062|P2|COMPLETED|Dose-Escalation Stage 1B||0
165383|NCT00996892|398063|P1|COMPLETED|Dose-Escalation Stage 1B||0
165384|NCT00996892|398044|P20|STARTED|Dose-Escalation Stage 1B||0
165385|NCT00996892|398045|P19|STARTED|Dose-Escalation Stage 1B||0
165386|NCT00996892|398046|P18|STARTED|Dose-Escalation Stage 1B||5
165387|NCT00996892|398047|P17|STARTED|Dose-Escalation Stage 1B||3
165388|NCT00996892|398048|P16|STARTED|Dose-Escalation Stage 1B||3
165389|NCT00996892|398049|P15|STARTED|Dose-Escalation Stage 1B||4
165390|NCT00996892|398050|P14|STARTED|Dose-Escalation Stage 1B||0
165391|NCT00996892|398051|P13|STARTED|Dose-Escalation Stage 1B||0
165392|NCT00996892|398052|P12|STARTED|Dose-Escalation Stage 1B||0
165393|NCT00996892|398053|P11|STARTED|Dose-Escalation Stage 1B||0
165394|NCT00996892|398054|P10|STARTED|Dose-Escalation Stage 1B||0
165395|NCT00996892|398055|P9|STARTED|Dose-Escalation Stage 1B||0
165396|NCT00996892|398056|P8|STARTED|Dose-Escalation Stage 1B||0
165397|NCT00996892|398057|P7|STARTED|Dose-Escalation Stage 1B||0
165398|NCT00996892|398058|P6|STARTED|Dose-Escalation Stage 1B||0
165399|NCT00996892|398059|P5|STARTED|Dose-Escalation Stage 1B||0
165400|NCT00996892|398060|P4|STARTED|Dose-Escalation Stage 1B||0
165401|NCT00996892|398061|P3|STARTED|Dose-Escalation Stage 1B||0
165402|NCT00996892|398062|P2|STARTED|Dose-Escalation Stage 1B||0
165403|NCT00996892|398063|P1|STARTED|Dose-Escalation Stage 1B||0
165404|NCT00996892|398044|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
165405|NCT00996892|398045|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
165406|NCT00996892|398046|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
165407|NCT00996892|398047|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
165408|NCT00996892|398048|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
165409|NCT00996892|398049|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
165410|NCT00996892|398050|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
165411|NCT00996892|398051|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
165412|NCT00996892|398052|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
165413|NCT00996892|398053|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
165414|NCT00996892|398054|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
165415|NCT00996892|398055|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
165416|NCT00996892|398056|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
165417|NCT00996892|398057|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
165418|NCT00996892|398058|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
165419|NCT00996892|398059|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
165420|NCT00996892|398060|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
165421|NCT00996892|398061|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
165422|NCT00996892|398062|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
165423|NCT00996892|398063|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
165424|NCT00996892|398044|P20|COMPLETED|Dose-Escalation Stage 1A||0
165425|NCT00996892|398045|P19|COMPLETED|Dose-Escalation Stage 1A||0
165426|NCT00996892|398046|P18|COMPLETED|Dose-Escalation Stage 1A||0
165427|NCT00996892|398047|P17|COMPLETED|Dose-Escalation Stage 1A||0
165428|NCT00996892|398048|P16|COMPLETED|Dose-Escalation Stage 1A||0
165429|NCT00996892|398049|P15|COMPLETED|Dose-Escalation Stage 1A||0
165430|NCT00996892|398050|P14|COMPLETED|Dose-Escalation Stage 1A||0
165431|NCT00996892|398051|P13|COMPLETED|Dose-Escalation Stage 1A||0
165432|NCT00996892|398052|P12|COMPLETED|Dose-Escalation Stage 1A||0
165433|NCT00996892|398053|P11|COMPLETED|Dose-Escalation Stage 1A||0
165434|NCT00996892|398054|P10|COMPLETED|Dose-Escalation Stage 1A||0
165435|NCT00996892|398055|P9|COMPLETED|Dose-Escalation Stage 1A||0
165436|NCT00996892|398056|P8|COMPLETED|Dose-Escalation Stage 1A||0
165437|NCT00996892|398057|P7|COMPLETED|Dose-Escalation Stage 1A||0
165438|NCT00996892|398058|P6|COMPLETED|Dose-Escalation Stage 1A||0
165439|NCT00996892|398059|P5|COMPLETED|Dose-Escalation Stage 1A||0
165440|NCT00996892|398060|P4|COMPLETED|Dose-Escalation Stage 1A||0
165441|NCT00996892|398061|P3|COMPLETED|Dose-Escalation Stage 1A||0
165442|NCT00996892|398062|P2|COMPLETED|Dose-Escalation Stage 1A||0
165443|NCT00996892|398063|P1|COMPLETED|Dose-Escalation Stage 1A||0
165444|NCT00996892|398044|P20|STARTED|Dose-Escalation Stage 1A||0
165445|NCT00996892|398045|P19|STARTED|Dose-Escalation Stage 1A||0
165446|NCT00996892|398046|P18|STARTED|Dose-Escalation Stage 1A||0
165447|NCT00996892|398047|P17|STARTED|Dose-Escalation Stage 1A||0
165448|NCT00996892|398048|P16|STARTED|Dose-Escalation Stage 1A||0
165449|NCT00996892|398049|P15|STARTED|Dose-Escalation Stage 1A||0
165450|NCT00996892|398050|P14|STARTED|Dose-Escalation Stage 1A||5
165451|NCT00996892|398051|P13|STARTED|Dose-Escalation Stage 1A||8
165452|NCT00996892|398052|P12|STARTED|Dose-Escalation Stage 1A||9
165453|NCT00996892|398053|P11|STARTED|Dose-Escalation Stage 1A||7
165454|NCT00996892|398054|P10|STARTED|Dose-Escalation Stage 1A||4
165455|NCT00996892|398055|P9|STARTED|Dose-Escalation Stage 1A||3
165456|NCT00996892|398056|P8|STARTED|Dose-Escalation Stage 1A||3
165457|NCT00996892|398057|P7|STARTED|Dose-Escalation Stage 1A||0
165458|NCT00996892|398058|P6|STARTED|Dose-Escalation Stage 1A||0
165459|NCT00996892|398059|P5|STARTED|Dose-Escalation Stage 1A||0
165460|NCT00996892|398060|P4|STARTED|Dose-Escalation Stage 1A||0
165461|NCT00996892|398061|P3|STARTED|Dose-Escalation Stage 1A||0
165462|NCT00996892|398062|P2|STARTED|Dose-Escalation Stage 1A||0
165463|NCT00996892|398063|P1|STARTED|Dose-Escalation Stage 1A||0
165464|NCT00996892|398044|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
165465|NCT00996892|398045|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
165466|NCT00996892|398046|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
165467|NCT00996892|398047|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
165468|NCT00996892|398048|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
165469|NCT00996892|398049|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
165470|NCT00996892|398050|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
165471|NCT00996892|398051|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
165472|NCT00996892|398052|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
165473|NCT00996892|398053|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
165474|NCT00996892|398054|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
165475|NCT00996892|398055|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
165476|NCT00996892|398056|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
165477|NCT00996892|398057|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
165478|NCT00996892|398058|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
165479|NCT00996892|398059|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
165480|NCT00996892|398060|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
165481|NCT00996892|398061|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
165482|NCT00996892|398062|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
165483|NCT00996892|398063|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
165484|NCT00996892|398044|P20|COMPLETED|Dose-Escalation Stage 1||0
165485|NCT00996892|398045|P19|COMPLETED|Dose-Escalation Stage 1||0
165486|NCT00996892|398046|P18|COMPLETED|Dose-Escalation Stage 1||0
165487|NCT00996892|398047|P17|COMPLETED|Dose-Escalation Stage 1||0
165488|NCT00996892|398048|P16|COMPLETED|Dose-Escalation Stage 1||0
165489|NCT00996892|398049|P15|COMPLETED|Dose-Escalation Stage 1||0
165490|NCT00996892|398050|P14|COMPLETED|Dose-Escalation Stage 1||0
165491|NCT00996892|398051|P13|COMPLETED|Dose-Escalation Stage 1||0
165492|NCT00996892|398052|P12|COMPLETED|Dose-Escalation Stage 1||0
165493|NCT00996892|398053|P11|COMPLETED|Dose-Escalation Stage 1||0
165494|NCT00996892|398054|P10|COMPLETED|Dose-Escalation Stage 1||0
165495|NCT00996892|398055|P9|COMPLETED|Dose-Escalation Stage 1||0
165496|NCT00996892|398056|P8|COMPLETED|Dose-Escalation Stage 1||0
165497|NCT00996892|398057|P7|COMPLETED|Dose-Escalation Stage 1||0
165498|NCT00996892|398058|P6|COMPLETED|Dose-Escalation Stage 1||0
165499|NCT00996892|398059|P5|COMPLETED|Dose-Escalation Stage 1||0
165500|NCT00996892|398060|P4|COMPLETED|Dose-Escalation Stage 1||0
165501|NCT00996892|398061|P3|COMPLETED|Dose-Escalation Stage 1||0
165502|NCT00996892|398062|P2|COMPLETED|Dose-Escalation Stage 1||0
165503|NCT00996892|398063|P1|COMPLETED|Dose-Escalation Stage 1||0
165504|NCT00996892|398044|P20|STARTED|Dose-Escalation Stage 1||0
165505|NCT00996892|398045|P19|STARTED|Dose-Escalation Stage 1||0
165506|NCT00996892|398046|P18|STARTED|Dose-Escalation Stage 1||0
165507|NCT00996892|398047|P17|STARTED|Dose-Escalation Stage 1||0
165508|NCT00996892|398048|P16|STARTED|Dose-Escalation Stage 1||0
165509|NCT00996892|398049|P15|STARTED|Dose-Escalation Stage 1||0
165510|NCT00996892|398050|P14|STARTED|Dose-Escalation Stage 1||0
165511|NCT00996892|398051|P13|STARTED|Dose-Escalation Stage 1||0
165512|NCT00996892|398052|P12|STARTED|Dose-Escalation Stage 1||0
165513|NCT00996892|398053|P11|STARTED|Dose-Escalation Stage 1||0
165514|NCT00996892|398054|P10|STARTED|Dose-Escalation Stage 1||0
165515|NCT00996892|398055|P9|STARTED|Dose-Escalation Stage 1||0
165516|NCT00996892|398056|P8|STARTED|Dose-Escalation Stage 1||0
165517|NCT00996892|398057|P7|STARTED|Dose-Escalation Stage 1||4
165518|NCT00996892|398058|P6|STARTED|Dose-Escalation Stage 1||10
165519|NCT00996892|398059|P5|STARTED|Dose-Escalation Stage 1||11
165520|NCT00996892|398060|P4|STARTED|Dose-Escalation Stage 1||9
165521|NCT00996892|398061|P3|STARTED|Dose-Escalation Stage 1||3
165522|NCT00996892|398062|P2|STARTED|Dose-Escalation Stage 1||3
165523|NCT00996892|398063|P1|STARTED|Dose-Escalation Stage 1||4
165524|NCT00996840|398657|P5|NOT COMPLETED|Overall Study||2
165525|NCT00996840|398658|P4|NOT COMPLETED|Overall Study||1
165526|NCT00996840|398659|P3|NOT COMPLETED|Overall Study||1
165527|NCT00996840|398660|P2|NOT COMPLETED|Overall Study||2
165528|NCT00996840|398661|P1|NOT COMPLETED|Overall Study||1
165529|NCT00996840|398657|P5|COMPLETED|Overall Study||16
165530|NCT00996840|398658|P4|COMPLETED|Overall Study||17
165531|NCT00996840|398659|P3|COMPLETED|Overall Study||11
165532|NCT00996840|398660|P2|COMPLETED|Overall Study||7
165533|NCT00996840|398661|P1|COMPLETED|Overall Study||19
165534|NCT00996840|398657|P5|STARTED|Overall Study||18
165535|NCT00996840|398658|P4|STARTED|Overall Study||18
165536|NCT00996840|398659|P3|STARTED|Overall Study||12
165537|NCT00996840|398660|P2|STARTED|Overall Study||9
165538|NCT00996840|398661|P1|STARTED|Overall Study||20
165539|NCT00996801|398811|P6|NOT COMPLETED|Overall Study||19
165540|NCT00996801|398812|P5|NOT COMPLETED|Overall Study||88
165541|NCT00996801|398813|P4|NOT COMPLETED|Overall Study||31
165542|NCT00996801|398814|P3|NOT COMPLETED|Overall Study||23
165543|NCT00996801|398815|P2|NOT COMPLETED|Overall Study||16
165544|NCT00996801|398816|P1|NOT COMPLETED|Overall Study||20
165545|NCT00996801|398811|P6|COMPLETED|Overall Study||68
165546|NCT00996801|398812|P5|COMPLETED|Overall Study||0
165547|NCT00996801|398813|P4|COMPLETED|Overall Study||56
165548|NCT00996801|398814|P3|COMPLETED|Overall Study||65
165549|NCT00996801|398815|P2|COMPLETED|Overall Study||72
165550|NCT00996801|398816|P1|COMPLETED|Overall Study||68
165551|NCT00996801|398811|P6|STARTED|Overall Study||87
165552|NCT00996801|398812|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
165553|NCT00996801|398813|P4|STARTED|Overall Study||87
165554|NCT00996801|398814|P3|STARTED|Overall Study||88
165555|NCT00996801|398815|P2|STARTED|Overall Study||88
165556|NCT00996801|398816|P1|STARTED|Overall Study||88
165557|NCT00996775|398919|P2|NOT COMPLETED|Overall Study||14
165558|NCT00996775|398920|P1|NOT COMPLETED|Overall Study||11
165559|NCT00996775|398919|P2|COMPLETED|Overall Study||75
165560|NCT00996775|398920|P1|COMPLETED|Overall Study||67
165561|NCT00996775|398919|P2|STARTED|Overall Study||89
165562|NCT00996775|398920|P1|STARTED|Overall Study||78
165563|NCT00996736|398928|P2|NOT COMPLETED|Overall Study||18
165564|NCT00996736|398929|P1|NOT COMPLETED|Overall Study||21
165565|NCT00996736|398928|P2|COMPLETED|Overall Study||143
165566|NCT00996736|398929|P1|COMPLETED|Overall Study||141
165567|NCT00996736|398928|P2|3-month Visit|Overall Study||146
165568|NCT00996736|398929|P1|3-month Visit|Overall Study||146
165569|NCT00996736|398928|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
165570|NCT00996736|398929|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
165571|NCT00996736|398928|P2|STARTED|Overall Study||161
165572|NCT00996736|398929|P1|STARTED|Overall Study||162
165573|NCT00996658|398949|P2|NOT COMPLETED|Overall Study||21
165574|NCT00996658|398950|P1|NOT COMPLETED|Overall Study||16
165575|NCT00996658|398949|P2|COMPLETED|Overall Study||165
165576|NCT00996658|398950|P1|COMPLETED|Overall Study||76
165577|NCT00996658|398949|P2|STARTED|Overall Study||186
165578|NCT00996658|398950|P1|STARTED|Overall Study||92
165579|NCT00996632|398978|P2|NOT COMPLETED|Overall Study||0
165580|NCT00996632|398979|P1|NOT COMPLETED|Overall Study||0
165581|NCT00996632|398978|P2|COMPLETED|Overall Study||56
165582|NCT00996632|398979|P1|COMPLETED|Overall Study||38
165583|NCT00996632|398978|P2|STARTED|Overall Study||56
165584|NCT00996632|398979|P1|STARTED|Overall Study||38
165585|NCT00996606|398987|P1|NOT COMPLETED|Overall Study||8
165586|NCT00996606|398987|P1|COMPLETED|Overall Study||50
165587|NCT00996606|398987|P1|STARTED|Overall Study||58
165588|NCT00996593|399081|P1|NOT COMPLETED|Long-Term Follow-Up||3
165589|NCT00996593|399081|P1|COMPLETED|Long-Term Follow-Up||6
165590|NCT00996593|399081|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
165591|NCT00996593|399081|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
165592|NCT00996593|399081|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
165593|NCT00996593|399081|P1|STARTED|Dosimetric and Therapeutic Treatment||43
165594|NCT00996580|399109|P1|NOT COMPLETED|Overall Study||1453
165595|NCT00996580|399109|P1|COMPLETED|Overall Study||2144
165596|NCT00996580|399109|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
165597|NCT00996580|399109|P1|STARTED|Overall Study||3597
165598|NCT00996502|399137|P1|NOT COMPLETED|Overall Study||0
165599|NCT00996502|399137|P1|COMPLETED|Overall Study||4
165600|NCT00996502|399137|P1|STARTED|Overall Study||4
165601|NCT00996476|399146|P5|NOT COMPLETED|Overall Study||2
165602|NCT00996476|399147|P4|NOT COMPLETED|Overall Study||0
165603|NCT00996476|399148|P3|NOT COMPLETED|Overall Study||1
165604|NCT00996476|399149|P2|NOT COMPLETED|Overall Study||3
165605|NCT00996476|399150|P1|NOT COMPLETED|Overall Study||1
165606|NCT00996476|399146|P5|COMPLETED|Overall Study||11
165607|NCT00996476|399147|P4|COMPLETED|Overall Study||13
165608|NCT00996476|399148|P3|COMPLETED|Overall Study||12
165609|NCT00996476|399149|P2|COMPLETED|Overall Study||23
165610|NCT00996476|399150|P1|COMPLETED|Overall Study||26
165611|NCT00996476|399146|P5|STARTED|Overall Study||13
165612|NCT00996476|399147|P4|STARTED|Overall Study||13
165613|NCT00996476|399148|P3|STARTED|Overall Study||13
165614|NCT00996476|399149|P2|STARTED|Overall Study||26
165615|NCT00996476|399150|P1|STARTED|Overall Study||27
165616|NCT00996437|399218|P2|NOT COMPLETED|Overall Study||7
165617|NCT00996437|399219|P1|NOT COMPLETED|Overall Study||5
165618|NCT00996437|399218|P2|COMPLETED|Overall Study||129
165619|NCT00996437|399219|P1|COMPLETED|Overall Study||120
165620|NCT00996437|399218|P2|STARTED|Overall Study||136
165621|NCT00996437|399219|P1|STARTED|Overall Study||125
165622|NCT00996372|399241|P2|NOT COMPLETED|Overall Study||84
165623|NCT00996372|399242|P1|NOT COMPLETED|Overall Study||103
165624|NCT00996372|399241|P2|COMPLETED|Overall Study||397
165625|NCT00996372|399242|P1|COMPLETED|Overall Study||365
165626|NCT00996372|399241|P2|STARTED|Overall Study||481
165627|NCT00996372|399242|P1|STARTED|Overall Study||468
165628|NCT00996346|399255|P3|NOT COMPLETED|Overall Study||0
165629|NCT00996346|399256|P2|NOT COMPLETED|Overall Study||0
165630|NCT00996346|399257|P1|NOT COMPLETED|Overall Study||0
165631|NCT00996346|399255|P3|COMPLETED|Overall Study||3
165632|NCT00996346|399256|P2|COMPLETED|Overall Study||8
165633|NCT00996346|399257|P1|COMPLETED|Overall Study||6
165634|NCT00996346|399255|P3|STARTED|Overall Study||3
165635|NCT00996346|399256|P2|STARTED|Overall Study||8
165636|NCT00996346|399257|P1|STARTED|Overall Study||6
165637|NCT00996333|399264|P1|NOT COMPLETED|Overall Study||13
165638|NCT00996333|399264|P1|COMPLETED|Overall Study||33
165639|NCT00996333|399264|P1|STARTED|Overall Study||46
165640|NCT00996307|399274|P4|NOT COMPLETED|Overall Study||21
165641|NCT00996307|399275|P3|NOT COMPLETED|Overall Study||14
165642|NCT00996307|399276|P2|NOT COMPLETED|Overall Study||17
165643|NCT00996307|399277|P1|NOT COMPLETED|Overall Study||20
165644|NCT00996307|399274|P4|COMPLETED|Overall Study||144
165645|NCT00996307|399275|P3|COMPLETED|Overall Study||146
165646|NCT00996307|399276|P2|COMPLETED|Overall Study||148
165647|NCT00996307|399277|P1|COMPLETED|Overall Study||144
165648|NCT00996307|399274|P4|STARTED|Overall Study||165
165649|NCT00996307|399275|P3|STARTED|Overall Study||160
165650|NCT00996307|399276|P2|STARTED|Overall Study||165
165651|NCT00996307|399277|P1|STARTED|Overall Study||164
165652|NCT00996281|399337|P2|NOT COMPLETED|Overall Study||89
165653|NCT00996281|399338|P1|NOT COMPLETED|Overall Study||131
165654|NCT00996281|399337|P2|COMPLETED|Overall Study||330
165655|NCT00996281|399338|P1|COMPLETED|Overall Study||287
165656|NCT00996281|399337|P2|STARTED|Overall Study||419
165657|NCT00996281|399338|P1|STARTED|Overall Study||418
165658|NCT00996216|399346|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
165659|NCT00996216|399346|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
165660|NCT00996216|399346|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
165661|NCT00996216|399346|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
165662|NCT00996216|399346|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
165663|NCT00996216|399346|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
165664|NCT00996203|399362|P1|NOT COMPLETED|Overall Study||7
165665|NCT00996203|399362|P1|COMPLETED|Overall Study||194
165666|NCT00996203|399362|P1|STARTED|Overall Study||201
165667|NCT00996164|399383|P2|NOT COMPLETED|Overall Study||101
165668|NCT00996164|399384|P1|NOT COMPLETED|Overall Study||135
165669|NCT00996164|399383|P2|COMPLETED|Overall Study||446
165670|NCT00996164|399384|P1|COMPLETED|Overall Study||408
165671|NCT00996164|399383|P2|STARTED|Overall Study||547
165672|NCT00996164|399384|P1|STARTED|Overall Study||543
165673|NCT00996125|399394|P2|NOT COMPLETED|Overall Study||11
165674|NCT00996125|399395|P1|NOT COMPLETED|Overall Study||5
165675|NCT00996125|399394|P2|COMPLETED|Overall Study||365
165676|NCT00996125|399395|P1|COMPLETED|Overall Study||369
165677|NCT00996125|399394|P2|STARTED|Overall Study||376
165678|NCT00996125|399395|P1|STARTED|Overall Study||374
165679|NCT00996034|399415|P1|NOT COMPLETED|Overall Study||3
165680|NCT00996034|399415|P1|COMPLETED|Overall Study||11
165681|NCT00996034|399415|P1|STARTED|Overall Study||14
165682|NCT00995930|399421|P2|NOT COMPLETED|Overall Study||28
165683|NCT00995930|399422|P1|NOT COMPLETED|Overall Study||21
165684|NCT00995930|399421|P2|COMPLETED|Overall Study||67
165685|NCT00995930|399422|P1|COMPLETED|Overall Study||73
165686|NCT00995930|399421|P2|Imaging Analysis Set|Overall Study||92
165687|NCT00995930|399422|P1|Imaging Analysis Set|Overall Study||92
165688|NCT00995930|399421|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
165689|NCT00995930|399422|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
165690|NCT00995930|399421|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
165691|NCT00995930|399422|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
165692|NCT00995930|399421|P2|Safety Analysis Set|Overall Study||95
165693|NCT00995930|399422|P1|Safety Analysis Set|Overall Study||94
165694|NCT00995930|399421|P2|STARTED|Overall Study||95
165695|NCT00995930|399422|P1|STARTED|Overall Study||94
165696|NCT00995904|399451|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
165697|NCT00995904|399452|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
165698|NCT00995904|399453|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
165699|NCT00995904|399454|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
165700|NCT00995904|399455|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
165701|NCT00995904|399456|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
165702|NCT00995904|399451|P6|COMPLETED|Follow-up Visit (Final Visit)||3
165703|NCT00995904|399452|P5|COMPLETED|Follow-up Visit (Final Visit)||5
165704|NCT00995904|399453|P4|COMPLETED|Follow-up Visit (Final Visit)||5
165705|NCT00995904|399454|P3|COMPLETED|Follow-up Visit (Final Visit)||4
165706|NCT00995904|399455|P2|COMPLETED|Follow-up Visit (Final Visit)||3
165707|NCT00995904|399456|P1|COMPLETED|Follow-up Visit (Final Visit)||4
165708|NCT00995904|399451|P6|STARTED|Follow-up Visit (Final Visit)||3
165709|NCT00995904|399452|P5|STARTED|Follow-up Visit (Final Visit)||5
165710|NCT00995904|399453|P4|STARTED|Follow-up Visit (Final Visit)||5
165711|NCT00995904|399454|P3|STARTED|Follow-up Visit (Final Visit)||4
165712|NCT00995904|399455|P2|STARTED|Follow-up Visit (Final Visit)||3
165713|NCT00995904|399456|P1|STARTED|Follow-up Visit (Final Visit)||4
165714|NCT00995904|399451|P6|NOT COMPLETED|Visit 4||0
165715|NCT00995904|399452|P5|NOT COMPLETED|Visit 4||0
165716|NCT00995904|399453|P4|NOT COMPLETED|Visit 4||0
165717|NCT00995904|399454|P3|NOT COMPLETED|Visit 4||0
165718|NCT00995904|399455|P2|NOT COMPLETED|Visit 4||0
165719|NCT00995904|399456|P1|NOT COMPLETED|Visit 4||0
165720|NCT00995904|399451|P6|COMPLETED|Visit 4||3
165721|NCT00995904|399452|P5|COMPLETED|Visit 4||5
165722|NCT00995904|399453|P4|COMPLETED|Visit 4||5
165723|NCT00995904|399454|P3|COMPLETED|Visit 4||4
165724|NCT00995904|399455|P2|COMPLETED|Visit 4||3
165725|NCT00995904|399456|P1|COMPLETED|Visit 4||4
165726|NCT00995904|399451|P6|STARTED|Visit 4||3
165727|NCT00995904|399452|P5|STARTED|Visit 4||5
165728|NCT00995904|399453|P4|STARTED|Visit 4||5
165729|NCT00995904|399454|P3|STARTED|Visit 4||4
165730|NCT00995904|399455|P2|STARTED|Visit 4||3
165731|NCT00995904|399456|P1|STARTED|Visit 4||4
165732|NCT00995904|399451|P6|NOT COMPLETED|Visit 3||0
165733|NCT00995904|399452|P5|NOT COMPLETED|Visit 3||0
165734|NCT00995904|399453|P4|NOT COMPLETED|Visit 3||0
165735|NCT00995904|399454|P3|NOT COMPLETED|Visit 3||0
165736|NCT00995904|399455|P2|NOT COMPLETED|Visit 3||0
165737|NCT00995904|399456|P1|NOT COMPLETED|Visit 3||0
165738|NCT00995904|399451|P6|COMPLETED|Visit 3||3
165739|NCT00995904|399452|P5|COMPLETED|Visit 3||5
165740|NCT00995904|399453|P4|COMPLETED|Visit 3||5
165741|NCT00995904|399454|P3|COMPLETED|Visit 3||4
165742|NCT00995904|399455|P2|COMPLETED|Visit 3||3
165743|NCT00995904|399456|P1|COMPLETED|Visit 3||4
165744|NCT00995904|399451|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
165745|NCT00995904|399452|P5|STARTED|Visit 3||5
165746|NCT00995904|399453|P4|STARTED|Visit 3||5
165747|NCT00995904|399454|P3|STARTED|Visit 3||4
165748|NCT00995904|399455|P2|STARTED|Visit 3||3
165749|NCT00995904|399456|P1|STARTED|Visit 3||4
165750|NCT00995904|399451|P6|NOT COMPLETED|Visit 2 (Randomization)||0
165751|NCT00995904|399452|P5|NOT COMPLETED|Visit 2 (Randomization)||0
165752|NCT00995904|399453|P4|NOT COMPLETED|Visit 2 (Randomization)||0
165753|NCT00995904|399454|P3|NOT COMPLETED|Visit 2 (Randomization)||0
165754|NCT00995904|399455|P2|NOT COMPLETED|Visit 2 (Randomization)||0
165755|NCT00995904|399456|P1|NOT COMPLETED|Visit 2 (Randomization)||0
165756|NCT00995904|399451|P6|COMPLETED|Visit 2 (Randomization)||4
165757|NCT00995904|399452|P5|COMPLETED|Visit 2 (Randomization)||5
165758|NCT00995904|399453|P4|COMPLETED|Visit 2 (Randomization)||5
165759|NCT00995904|399454|P3|COMPLETED|Visit 2 (Randomization)||4
165760|NCT00995904|399455|P2|COMPLETED|Visit 2 (Randomization)||3
165761|NCT00995904|399456|P1|COMPLETED|Visit 2 (Randomization)||4
165762|NCT00995904|399451|P6|STARTED|Visit 2 (Randomization)||4
165763|NCT00995904|399452|P5|STARTED|Visit 2 (Randomization)||5
165764|NCT00995904|399453|P4|STARTED|Visit 2 (Randomization)||5
165765|NCT00995904|399454|P3|STARTED|Visit 2 (Randomization)||4
165766|NCT00995904|399455|P2|STARTED|Visit 2 (Randomization)||3
165767|NCT00995904|399456|P1|STARTED|Visit 2 (Randomization)||4
165768|NCT00995865|399473|P3|NOT COMPLETED|Overall Study||1
165769|NCT00995865|399474|P2|NOT COMPLETED|Overall Study||0
165770|NCT00995865|399475|P1|NOT COMPLETED|Overall Study||2
165771|NCT00995865|399473|P3|COMPLETED|Overall Study||11
165772|NCT00995865|399474|P2|COMPLETED|Overall Study||24
165773|NCT00995865|399475|P1|COMPLETED|Overall Study||22
165774|NCT00995865|399473|P3|STARTED|Overall Study||12
165775|NCT00995865|399474|P2|STARTED|Overall Study||24
165776|NCT00995865|399475|P1|STARTED|Overall Study||24
165777|NCT00995774|399497|P2|NOT COMPLETED|Training Period 2||0
165778|NCT00995774|399498|P1|NOT COMPLETED|Training Period 2||2
165779|NCT00995774|399497|P2|COMPLETED|Training Period 2||5
165780|NCT00995774|399498|P1|COMPLETED|Training Period 2||5
165781|NCT00995774|399497|P2|STARTED|Training Period 2||5
165782|NCT00995774|399498|P1|STARTED|Training Period 2||7
165783|NCT00995774|399497|P2|NOT COMPLETED|Washout Period||0
165784|NCT00995774|399498|P1|NOT COMPLETED|Washout Period||0
165785|NCT00995774|399497|P2|COMPLETED|Washout Period||5
165786|NCT00995774|399498|P1|COMPLETED|Washout Period||7
165787|NCT00995774|399497|P2|STARTED|Washout Period||5
165788|NCT00995774|399498|P1|STARTED|Washout Period||7
165789|NCT00995774|399497|P2|NOT COMPLETED|Training Period 1||0
165790|NCT00995774|399498|P1|NOT COMPLETED|Training Period 1||0
165791|NCT00995774|399497|P2|COMPLETED|Training Period 1||5
165792|NCT00995774|399498|P1|COMPLETED|Training Period 1||7
165793|NCT00995774|399497|P2|STARTED|Training Period 1||5
165794|NCT00995774|399498|P1|STARTED|Training Period 1||7
165795|NCT00995761|399506|P1|NOT COMPLETED|Overall Study||0
165796|NCT00995761|399506|P1|COMPLETED|Overall Study||48
165797|NCT00995761|399506|P1|STARTED|Overall Study||48
165798|NCT00995722|399512|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
165799|NCT00995722|399513|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
165800|NCT00995722|399512|P2|COMPLETED|Overall Study: 36 Weeks||2
165801|NCT00995722|399513|P1|COMPLETED|Overall Study: 36 Weeks||3
165802|NCT00995722|399512|P2|STARTED|Overall Study: 36 Weeks||4
165803|NCT00995722|399513|P1|STARTED|Overall Study: 36 Weeks||5
165804|NCT00995722|399512|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
165805|NCT00995722|399513|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
165806|NCT00995722|399512|P2|COMPLETED|Double Blinded: 16 Weeks||4
165807|NCT00995722|399513|P1|COMPLETED|Double Blinded: 16 Weeks||5
165808|NCT00995722|399512|P2|STARTED|Double Blinded: 16 Weeks||5
165809|NCT00995722|399513|P1|STARTED|Double Blinded: 16 Weeks||6
165810|NCT00995709|399530|P3|NOT COMPLETED|Overall Study||5
165811|NCT00995709|399531|P2|NOT COMPLETED|Overall Study||9
165812|NCT00995709|399532|P1|NOT COMPLETED|Overall Study||7
165813|NCT00995709|399530|P3|COMPLETED|Overall Study||34
165814|NCT00995709|399531|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
165815|NCT00995709|399532|P1|COMPLETED|Overall Study||32
165816|NCT00995709|399530|P3|STARTED|Overall Study||39
165817|NCT00995709|399531|P2|STARTED|Overall Study||40
165818|NCT00995709|399532|P1|STARTED|Overall Study||39
165819|NCT00995670|399558|P3|NOT COMPLETED|Overall Study||3
165820|NCT00995670|399559|P2|NOT COMPLETED|Overall Study||0
165821|NCT00995670|399560|P1|NOT COMPLETED|Overall Study||1
165822|NCT00995670|399558|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
165823|NCT00995670|399559|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
165824|NCT00995670|399560|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
165825|NCT00995670|399558|P3|STARTED|Overall Study||17
165826|NCT00995670|399559|P2|STARTED|Overall Study||16
165827|NCT00995670|399560|P1|STARTED|Overall Study||26
165828|NCT00995566|399568|P1|NOT COMPLETED|Overall Study||54
165829|NCT00995566|399568|P1|COMPLETED|Overall Study||0
165830|NCT00995566|399568|P1|STARTED|Overall Study||54
165831|NCT00995553|399582|P2|NOT COMPLETED|Overall Study||6
165832|NCT00995553|399583|P1|NOT COMPLETED|Overall Study||2
165833|NCT00995553|399582|P2|COMPLETED|Overall Study||35
165834|NCT00995553|399583|P1|COMPLETED|Overall Study||38
165835|NCT00995553|399582|P2|STARTED|Overall Study||41
165836|NCT00995553|399583|P1|STARTED|Overall Study||40
165837|NCT00995501|399599|P8|NOT COMPLETED|Overall Study||0
165838|NCT00995501|399600|P7|NOT COMPLETED|Overall Study||0
165839|NCT00995501|399601|P6|NOT COMPLETED|Overall Study||0
165840|NCT00995501|399602|P5|NOT COMPLETED|Overall Study||0
165841|NCT00995501|399603|P4|NOT COMPLETED|Overall Study||0
165842|NCT00995501|399604|P3|NOT COMPLETED|Overall Study||0
165843|NCT00995501|399605|P2|NOT COMPLETED|Overall Study||0
165844|NCT00995501|399606|P1|NOT COMPLETED|Overall Study||0
165845|NCT00995501|399599|P8|COMPLETED|Overall Study||46
165846|NCT00995501|399600|P7|COMPLETED|Overall Study||49
165847|NCT00995501|399601|P6|COMPLETED|Overall Study||44
165848|NCT00995501|399602|P5|COMPLETED|Overall Study||46
165849|NCT00995501|399603|P4|COMPLETED|Overall Study||46
165850|NCT00995501|399604|P3|COMPLETED|Overall Study||47
165851|NCT00995501|399605|P2|COMPLETED|Overall Study||51
165852|NCT00995501|399606|P1|COMPLETED|Overall Study||52
165853|NCT00995501|399599|P8|STARTED|Overall Study||46
165854|NCT00995501|399600|P7|STARTED|Overall Study||49
165855|NCT00995501|399601|P6|STARTED|Overall Study||44
165856|NCT00995501|399602|P5|STARTED|Overall Study||46
165857|NCT00995501|399603|P4|STARTED|Overall Study||46
165858|NCT00995501|399604|P3|STARTED|Overall Study||47
165859|NCT00995501|399605|P2|STARTED|Overall Study||51
165860|NCT00995501|399606|P1|STARTED|Overall Study||52
165861|NCT00995488|399632|P1|NOT COMPLETED|Overall Study||1
165862|NCT00995488|399632|P1|COMPLETED|Overall Study||15
165863|NCT00995488|399632|P1|STARTED|Overall Study||16
165864|NCT00995449|399641|P4|NOT COMPLETED|Overall Study||0
165865|NCT00995449|399642|P3|NOT COMPLETED|Overall Study||2
165866|NCT00995449|399643|P2|NOT COMPLETED|Overall Study||0
165867|NCT00995449|399644|P1|NOT COMPLETED|Overall Study||0
165868|NCT00995449|399641|P4|COMPLETED|Overall Study||2
165869|NCT00995449|399642|P3|COMPLETED|Overall Study||5
165870|NCT00995449|399643|P2|COMPLETED|Overall Study||0
165871|NCT00995449|399644|P1|COMPLETED|Overall Study||0
165872|NCT00995449|399641|P4|STARTED|Overall Study||2
165873|NCT00995449|399642|P3|STARTED|Overall Study||7
165874|NCT00995449|399643|P2|STARTED|Overall Study||0
165875|NCT00995449|399644|P1|STARTED|Overall Study||0
165876|NCT00995436|399655|P3|NOT COMPLETED|Overall Study||0
165877|NCT00995436|399656|P2|NOT COMPLETED|Overall Study||5
165878|NCT00995436|399657|P1|NOT COMPLETED|Overall Study||2
165879|NCT00995436|399655|P3|COMPLETED|Overall Study||26
165880|NCT00995436|399656|P2|COMPLETED|Overall Study||22
165881|NCT00995436|399657|P1|COMPLETED|Overall Study||23
165882|NCT00995436|399655|P3|STARTED|Overall Study||26
165883|NCT00995436|399656|P2|STARTED|Overall Study||27
165884|NCT00995436|399657|P1|STARTED|Overall Study|25|25
165885|NCT00995410|399665|P1|NOT COMPLETED|Overall Study||88
165886|NCT00995410|399665|P1|COMPLETED|Overall Study||292
165887|NCT00995410|399665|P1|Treated|Overall Study||379
165888|NCT00995410|399665|P1|STARTED|Overall Study||380
165889|NCT00995371|399672|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
165890|NCT00995371|399673|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
165891|NCT00995371|399672|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
165892|NCT00995371|399673|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
165893|NCT00995371|399672|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
165894|NCT00995371|399673|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
165895|NCT00995371|399672|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
165896|NCT00995371|399673|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
165897|NCT00995371|399672|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
165898|NCT00995371|399673|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
165899|NCT00995371|399672|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
165900|NCT00995371|399673|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
165901|NCT00995345|399691|P5|NOT COMPLETED|Overall Study||5
165902|NCT00995345|399692|P4|NOT COMPLETED|Overall Study||5
165903|NCT00995345|399693|P3|NOT COMPLETED|Overall Study||7
165904|NCT00995345|399694|P2|NOT COMPLETED|Overall Study||7
165905|NCT00995345|399695|P1|NOT COMPLETED|Overall Study||11
165906|NCT00995345|399691|P5|COMPLETED|Overall Study||75
165907|NCT00995345|399692|P4|COMPLETED|Overall Study||76
165908|NCT00995345|399693|P3|COMPLETED|Overall Study||73
165909|NCT00995345|399694|P2|COMPLETED|Overall Study||74
165910|NCT00995345|399695|P1|COMPLETED|Overall Study||70
165911|NCT00995345|399691|P5|STARTED|Overall Study||80
165912|NCT00995345|399692|P4|STARTED|Overall Study||81
165913|NCT00995345|399693|P3|STARTED|Overall Study||80
165914|NCT00995345|399694|P2|STARTED|Overall Study||81
165915|NCT00995345|399695|P1|STARTED|Overall Study||81
165916|NCT00995085|399722|P1|NOT COMPLETED|Overall Study||5
165917|NCT00995085|399722|P1|COMPLETED|Overall Study||38
165918|NCT00995085|399722|P1|STARTED|Overall Study||43
165919|NCT00995020|399728|P2|NOT COMPLETED|Overall Study||7
165920|NCT00995020|399729|P1|NOT COMPLETED|Overall Study||3
165921|NCT00995020|399728|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
165922|NCT00995020|399729|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
165923|NCT00995020|399728|P2|STARTED|Overall Study||52
165924|NCT00995020|399729|P1|STARTED|Overall Study||51
165925|NCT00995007|399739|P2|NOT COMPLETED|Overall Study||2
165926|NCT00995007|399740|P1|NOT COMPLETED|Overall Study||17
165927|NCT00995007|399739|P2|COMPLETED|Overall Study||54
165928|NCT00995007|399740|P1|COMPLETED|Overall Study||39
165929|NCT00995007|399739|P2|Crossover to Vandetanib|Overall Study||0
165930|NCT00995007|399740|P1|Crossover to Vandetanib|Overall Study||42
165931|NCT00995007|399739|P2|STARTED|Overall Study||56
165932|NCT00995007|399740|P1|STARTED|Overall Study||56
165933|NCT00994929|399756|P1|NOT COMPLETED|Overall Study||0
165934|NCT00994929|399756|P1|COMPLETED|Overall Study||9
165935|NCT00994929|399756|P1|STARTED|Overall Study||9
165936|NCT00994760|399762|P1|NOT COMPLETED|Overall Study||24
165937|NCT00994760|399762|P1|COMPLETED|Overall Study||107
165938|NCT00994760|399762|P1|STARTED|Overall Study||131
165939|NCT00994682|399803|P2|NOT COMPLETED|Pioglitazone Open Label||7
165940|NCT00994682|399804|P1|NOT COMPLETED|Pioglitazone Open Label||13
165941|NCT00994682|399803|P2|COMPLETED|Pioglitazone Open Label||34
165942|NCT00994682|399804|P1|COMPLETED|Pioglitazone Open Label||29
165943|NCT00994682|399803|P2|STARTED|Pioglitazone Open Label||41
165944|NCT00994682|399804|P1|STARTED|Pioglitazone Open Label||42
165945|NCT00994682|399803|P2|NOT COMPLETED|Double Bilnd||9
165946|NCT00994682|399804|P1|NOT COMPLETED|Double Bilnd||9
165947|NCT00994682|399803|P2|COMPLETED|Double Bilnd||41
165948|NCT00994682|399804|P1|COMPLETED|Double Bilnd||42
165949|NCT00994682|399803|P2|STARTED|Double Bilnd||50
165950|NCT00994682|399804|P1|STARTED|Double Bilnd||51
165951|NCT00994643|399848|P1|NOT COMPLETED|Overall Study||1
165952|NCT00994643|399848|P1|COMPLETED|Overall Study||10
165953|NCT00994643|399848|P1|STARTED|Overall Study||11
165954|NCT00994604|399852|P1|NOT COMPLETED|Overall Study||6
165955|NCT00994604|399852|P1|COMPLETED|Overall Study||45
165956|NCT00994604|399852|P1|STARTED|Overall Study||51
165957|NCT00994461|399862|P3|NOT COMPLETED|Overall Study||0
165958|NCT00994461|399863|P2|NOT COMPLETED|Overall Study||1
165959|NCT00994461|399864|P1|NOT COMPLETED|Overall Study||2
165960|NCT00994461|399862|P3|COMPLETED|Overall Study||37
165961|NCT00994461|399863|P2|COMPLETED|Overall Study||75
165962|NCT00994461|399864|P1|COMPLETED|Overall Study||74
165963|NCT00994461|399862|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
165964|NCT00994461|399863|P2|STARTED|Overall Study||76
165965|NCT00994461|399864|P1|STARTED|Overall Study||76
165966|NCT00994448|399892|P2|NOT COMPLETED|Overall Study||2
165967|NCT00994448|399893|P1|NOT COMPLETED|Overall Study||8
165968|NCT00994448|399892|P2|COMPLETED|Overall Study||5
165969|NCT00994448|399893|P1|COMPLETED|Overall Study||4
165970|NCT00994448|399892|P2|STARTED|Overall Study||7
165971|NCT00994448|399893|P1|STARTED|Overall Study||12
165972|NCT00994422|399901|P2|NOT COMPLETED|Overall Study||1
165973|NCT00994422|399902|P1|NOT COMPLETED|Overall Study||7
165974|NCT00994422|399901|P2|COMPLETED|Overall Study||54
165975|NCT00994422|399902|P1|COMPLETED|Overall Study||185
165976|NCT00994422|399901|P2|STARTED|Overall Study||55
165977|NCT00994422|399902|P1|STARTED|Overall Study||192
165978|NCT00994318|399915|P3|NOT COMPLETED|Overall Study||67
165979|NCT00994318|399916|P2|NOT COMPLETED|Overall Study||18
165980|NCT00994318|399917|P1|NOT COMPLETED|Overall Study||22
165981|NCT00994318|399915|P3|COMPLETED|Overall Study||250
165982|NCT00994318|399916|P2|COMPLETED|Overall Study||136
165983|NCT00994318|399917|P1|COMPLETED|Overall Study||133
165984|NCT00994318|399915|P3|STARTED|Overall Study||317
165985|NCT00994318|399916|P2|STARTED|Overall Study||154
165986|NCT00994318|399917|P1|STARTED|Overall Study||155
165987|NCT00994279|399927|P2|NOT COMPLETED|Overall Study||5
165988|NCT00994279|399928|P1|NOT COMPLETED|Overall Study||4
165989|NCT00994279|399927|P2|COMPLETED|Overall Study||13
165990|NCT00994279|399928|P1|COMPLETED|Overall Study||18
165991|NCT00994279|399927|P2|STARTED|Overall Study||18
165992|NCT00994279|399928|P1|STARTED|Overall Study||22
165993|NCT00994240|399938|P2|NOT COMPLETED|Overall Study||5
165994|NCT00994240|399939|P1|NOT COMPLETED|Overall Study||6
165995|NCT00994240|399938|P2|COMPLETED|Overall Study||39
165996|NCT00994240|399939|P1|COMPLETED|Overall Study||35
165997|NCT00994240|399938|P2|STARTED|Overall Study||44
165998|NCT00994240|399939|P1|STARTED|Overall Study||41
165999|NCT00994214|399949|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
166000|NCT00994214|399950|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
166001|NCT00994214|399951|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
166002|NCT00994214|399952|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
166003|NCT00994214|399949|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
166004|NCT00994214|399950|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
166005|NCT00994214|399951|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
166006|NCT00994214|399952|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
166007|NCT00994214|399949|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
166008|NCT00994214|399950|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
166009|NCT00994214|399951|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
166010|NCT00994214|399952|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
166011|NCT00994214|399949|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
166012|NCT00994214|399950|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
166013|NCT00994214|399951|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
166014|NCT00994214|399952|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
166015|NCT00994214|399949|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
166016|NCT00994214|399950|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
166017|NCT00994214|399951|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
166018|NCT00994214|399952|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
166019|NCT00994214|399949|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
166020|NCT00994214|399950|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
166021|NCT00994214|399951|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
166022|NCT00994214|399952|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
166023|NCT00994214|399949|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
166024|NCT00994214|399950|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
166025|NCT00994214|399951|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
166026|NCT00994214|399952|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
166027|NCT00994214|399949|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
166028|NCT00994214|399950|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
166029|NCT00994214|399951|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
166030|NCT00994214|399952|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
166031|NCT00994214|399949|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
166032|NCT00994214|399950|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
166033|NCT00994214|399951|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
166034|NCT00994214|399952|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
166035|NCT00994214|399949|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
166036|NCT00994214|399950|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
166037|NCT00994214|399951|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
166038|NCT00994214|399952|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
166039|NCT00994175|399996|P2|NOT COMPLETED|Second Intervention||0
166040|NCT00994175|399997|P1|NOT COMPLETED|Second Intervention||0
166041|NCT00994175|399996|P2|COMPLETED|Second Intervention||8
166042|NCT00994175|399997|P1|COMPLETED|Second Intervention||4
166043|NCT00994175|399996|P2|STARTED|Second Intervention||8
166044|NCT00994175|399997|P1|STARTED|Second Intervention||4
166045|NCT00994175|399996|P2|NOT COMPLETED|First Intervention||1
166046|NCT00994175|399997|P1|NOT COMPLETED|First Intervention||2
166047|NCT00994175|399996|P2|COMPLETED|First Intervention||8
166048|NCT00994175|399997|P1|COMPLETED|First Intervention||4
166049|NCT00994175|399996|P2|STARTED|First Intervention||9
166050|NCT00994175|399997|P1|STARTED|First Intervention||6
166051|NCT00994123|400008|P3|NOT COMPLETED|Overall Study||0
166052|NCT00994123|400009|P2|NOT COMPLETED|Overall Study||0
166053|NCT00994123|400010|P1|NOT COMPLETED|Overall Study||0
166054|NCT00994123|400008|P3|COMPLETED|Overall Study||44
166055|NCT00994123|400009|P2|COMPLETED|Overall Study||85
166056|NCT00994123|400010|P1|COMPLETED|Overall Study||33
166057|NCT00994123|400008|P3|STARTED|Overall Study||44
166058|NCT00994123|400009|P2|STARTED|Overall Study||85
166059|NCT00994123|400010|P1|STARTED|Overall Study||33
166060|NCT00994110|400031|P2|NOT COMPLETED|Overall Study||74
166061|NCT00994110|400032|P1|NOT COMPLETED|Overall Study||65
166062|NCT00994110|400031|P2|COMPLETED|Overall Study||148
166063|NCT00994110|400032|P1|COMPLETED|Overall Study||152
166064|NCT00994110|400031|P2|STARTED|Overall Study||222
166065|NCT00994110|400032|P1|STARTED|Overall Study||217
166066|NCT00993967|400038|P1|NOT COMPLETED|Overall Study||61
166067|NCT00993967|400038|P1|COMPLETED|Overall Study||139
166068|NCT00993967|400038|P1|STARTED|Overall Study||200
166069|NCT00993954|400045|P2|NOT COMPLETED|Overall Study||2
166070|NCT00993954|400046|P1|NOT COMPLETED|Overall Study||21
166071|NCT00993954|400045|P2|COMPLETED|Overall Study||121
166072|NCT00993954|400046|P1|COMPLETED|Overall Study||124
166073|NCT00993954|400045|P2|STARTED|Overall Study||123
166074|NCT00993954|400046|P1|STARTED|Overall Study||145
166075|NCT00993928|400059|P2|NOT COMPLETED|Overall Study||7
166076|NCT00993928|400060|P1|NOT COMPLETED|Overall Study||5
166077|NCT00993928|400059|P2|COMPLETED|Overall Study||38
166078|NCT00993928|400060|P1|COMPLETED|Overall Study||43
166079|NCT00993928|400059|P2|STARTED|Overall Study||45
166080|NCT00993928|400060|P1|STARTED|Overall Study||48
166081|NCT00993915|400074|P1|NOT COMPLETED|Overall Study||9
166082|NCT00993915|400074|P1|COMPLETED|Overall Study||678
166083|NCT00993915|400074|P1|STARTED|Overall Study||687
166084|NCT00993824|400085|P2|NOT COMPLETED|Overall Study||0
166085|NCT00993824|400086|P1|NOT COMPLETED|Overall Study||0
166086|NCT00993824|400085|P2|COMPLETED|Overall Study||10
166087|NCT00993824|400086|P1|COMPLETED|Overall Study||11
166088|NCT00993824|400085|P2|STARTED|Overall Study||10
166089|NCT00993824|400086|P1|STARTED|Overall Study||11
166090|NCT00993668|400100|P2|NOT COMPLETED|Open-Label Period||15
166091|NCT00993668|400101|P1|NOT COMPLETED|Open-Label Period||23
166092|NCT00993668|400100|P2|COMPLETED|Open-Label Period||91
166093|NCT00993668|400101|P1|COMPLETED|Open-Label Period||86
166094|NCT00993668|400100|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
166095|NCT00993668|400101|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
166096|NCT00993668|400100|P2|NOT COMPLETED|Single-Blind Period||3
166097|NCT00993668|400101|P1|NOT COMPLETED|Single-Blind Period||4
166098|NCT00993668|400100|P2|COMPLETED|Single-Blind Period||107
166099|NCT00993668|400101|P1|COMPLETED|Single-Blind Period||110
166100|NCT00993668|400100|P2|STARTED|Single-Blind Period||110
166101|NCT00993668|400101|P1|STARTED|Single-Blind Period||114
166102|NCT00993655|400129|P3|NOT COMPLETED|Overall Study||0
166103|NCT00993655|400130|P2|NOT COMPLETED|Overall Study||0
166104|NCT00993655|400131|P1|NOT COMPLETED|Overall Study||0
166105|NCT00993655|400129|P3|COMPLETED|Overall Study||102
166106|NCT00993655|400130|P2|COMPLETED|Overall Study||72
166107|NCT00993655|400131|P1|COMPLETED|Overall Study||101
166108|NCT00993655|400129|P3|STARTED|Overall Study||102
166109|NCT00993655|400130|P2|STARTED|Overall Study||72
166110|NCT00993655|400131|P1|STARTED|Overall Study||101
166111|NCT00993616|400145|P1|NOT COMPLETED|Overall Study||2
166112|NCT00993616|400145|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
166113|NCT00993616|400145|P1|STARTED|Overall Study||29
166114|NCT00993499|400163|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
166197|NCT00993421|400330|P4|STARTED|Overall Study||49
166115|NCT00993499|400164|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
166116|NCT00993499|400165|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
166117|NCT00993499|400166|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
166118|NCT00993499|400167|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
166119|NCT00993499|400168|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
166120|NCT00993499|400163|P6|COMPLETED|Discontinued After Starting Course 3||0
166121|NCT00993499|400164|P5|COMPLETED|Discontinued After Starting Course 3||0
166122|NCT00993499|400165|P4|COMPLETED|Discontinued After Starting Course 3||1
166123|NCT00993499|400166|P3|COMPLETED|Discontinued After Starting Course 3||3
166124|NCT00993499|400167|P2|COMPLETED|Discontinued After Starting Course 3||4
166125|NCT00993499|400168|P1|COMPLETED|Discontinued After Starting Course 3||4
166126|NCT00993499|400163|P6|STARTED|Discontinued After Starting Course 3||3
166127|NCT00993499|400164|P5|STARTED|Discontinued After Starting Course 3||3
166128|NCT00993499|400165|P4|STARTED|Discontinued After Starting Course 3||3
166129|NCT00993499|400166|P3|STARTED|Discontinued After Starting Course 3||9
166130|NCT00993499|400167|P2|STARTED|Discontinued After Starting Course 3||9
166131|NCT00993499|400168|P1|STARTED|Discontinued After Starting Course 3||12
166132|NCT00993499|400163|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
166133|NCT00993499|400164|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
166134|NCT00993499|400165|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
166135|NCT00993499|400166|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
166136|NCT00993499|400167|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
166137|NCT00993499|400168|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
166138|NCT00993499|400163|P6|COMPLETED|Discontinued Before Starting Course 3||3
166139|NCT00993499|400164|P5|COMPLETED|Discontinued Before Starting Course 3||3
166140|NCT00993499|400165|P4|COMPLETED|Discontinued Before Starting Course 3||2
166141|NCT00993499|400166|P3|COMPLETED|Discontinued Before Starting Course 3||6
166142|NCT00993499|400167|P2|COMPLETED|Discontinued Before Starting Course 3||5
166143|NCT00993499|400168|P1|COMPLETED|Discontinued Before Starting Course 3||8
166144|NCT00993499|400163|P6|STARTED|Discontinued Before Starting Course 3||3
166145|NCT00993499|400164|P5|STARTED|Discontinued Before Starting Course 3||3
166146|NCT00993499|400165|P4|STARTED|Discontinued Before Starting Course 3||3
166147|NCT00993499|400166|P3|STARTED|Discontinued Before Starting Course 3||9
166148|NCT00993499|400167|P2|STARTED|Discontinued Before Starting Course 3||9
166149|NCT00993499|400168|P1|STARTED|Discontinued Before Starting Course 3||12
166150|NCT00993499|400163|P6|NOT COMPLETED|Run-in Period (8 Days)||0
166151|NCT00993499|400164|P5|NOT COMPLETED|Run-in Period (8 Days)||0
166152|NCT00993499|400165|P4|NOT COMPLETED|Run-in Period (8 Days)||0
166153|NCT00993499|400166|P3|NOT COMPLETED|Run-in Period (8 Days)||1
166154|NCT00993499|400167|P2|NOT COMPLETED|Run-in Period (8 Days)||3
166155|NCT00993499|400168|P1|NOT COMPLETED|Run-in Period (8 Days)||1
166156|NCT00993499|400163|P6|COMPLETED|Run-in Period (8 Days)||3
166157|NCT00993499|400164|P5|COMPLETED|Run-in Period (8 Days)||3
166158|NCT00993499|400165|P4|COMPLETED|Run-in Period (8 Days)||3
166159|NCT00993499|400166|P3|COMPLETED|Run-in Period (8 Days)||9
166160|NCT00993499|400167|P2|COMPLETED|Run-in Period (8 Days)||9
166161|NCT00993499|400168|P1|COMPLETED|Run-in Period (8 Days)||12
166162|NCT00993499|400163|P6|STARTED|Run-in Period (8 Days)||3
166163|NCT00993499|400164|P5|STARTED|Run-in Period (8 Days)||3
166164|NCT00993499|400165|P4|STARTED|Run-in Period (8 Days)||3
166165|NCT00993499|400166|P3|STARTED|Run-in Period (8 Days)||10
166166|NCT00993499|400167|P2|STARTED|Run-in Period (8 Days)||12
166167|NCT00993499|400168|P1|STARTED|Run-in Period (8 Days)||13
166168|NCT00993473|400250|P2|NOT COMPLETED|Overall Study||10
166169|NCT00993473|400251|P1|NOT COMPLETED|Overall Study||4
166170|NCT00993473|400250|P2|COMPLETED|Overall Study||54
166171|NCT00993473|400251|P1|COMPLETED|Overall Study||57
166172|NCT00993473|400250|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
166173|NCT00993473|400251|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
166174|NCT00993447|400289|P2|NOT COMPLETED|Overall Study||19
166175|NCT00993447|400290|P1|NOT COMPLETED|Overall Study||37
166176|NCT00993447|400289|P2|COMPLETED|Overall Study||180
166177|NCT00993447|400290|P1|COMPLETED|Overall Study||364
166178|NCT00993447|400289|P2|STARTED|Overall Study||199
166179|NCT00993447|400290|P1|STARTED|Overall Study||401
166180|NCT00993421|400327|P7|NOT COMPLETED|Overall Study||42
166181|NCT00993421|400328|P6|NOT COMPLETED|Overall Study||46
166182|NCT00993421|400329|P5|NOT COMPLETED|Overall Study||46
166183|NCT00993421|400330|P4|NOT COMPLETED|Overall Study||45
166184|NCT00993421|400331|P3|NOT COMPLETED|Overall Study||43
166185|NCT00993421|400332|P2|NOT COMPLETED|Overall Study||45
166186|NCT00993421|400333|P1|NOT COMPLETED|Overall Study||44
166187|NCT00993421|400327|P7|COMPLETED|Overall Study||4
166188|NCT00993421|400328|P6|COMPLETED|Overall Study||4
166189|NCT00993421|400329|P5|COMPLETED|Overall Study||6
166190|NCT00993421|400330|P4|COMPLETED|Overall Study||4
166191|NCT00993421|400331|P3|COMPLETED|Overall Study||5
166192|NCT00993421|400332|P2|COMPLETED|Overall Study||4
166193|NCT00993421|400333|P1|COMPLETED|Overall Study||5
166194|NCT00993421|400327|P7|STARTED|Overall Study||46
166195|NCT00993421|400328|P6|STARTED|Overall Study||50
166196|NCT00993421|400329|P5|STARTED|Overall Study||52
166198|NCT00993421|400331|P3|STARTED|Overall Study||48
166199|NCT00993421|400332|P2|STARTED|Overall Study||49
166200|NCT00993421|400333|P1|STARTED|Overall Study||49
166201|NCT00993317|400484|P2|NOT COMPLETED|Overall Study||25
166202|NCT00993317|400485|P1|NOT COMPLETED|Overall Study||21
166203|NCT00993317|400484|P2|COMPLETED|Overall Study||60
166204|NCT00993317|400485|P1|COMPLETED|Overall Study||21
166205|NCT00993317|400484|P2|STARTED|Overall Study||85
166206|NCT00993317|400485|P1|STARTED|Overall Study||42
166207|NCT00993291|400503|P1|NOT COMPLETED|Overall Study||1
166208|NCT00993291|400503|P1|COMPLETED|Overall Study||19
166209|NCT00993291|400503|P1|STARTED|Overall Study||20
166210|NCT00993265|400509|P2|NOT COMPLETED|Overall Study||0
166211|NCT00993265|400510|P1|NOT COMPLETED|Overall Study||4
166212|NCT00993265|400509|P2|COMPLETED|Overall Study||19
166213|NCT00993265|400510|P1|COMPLETED|Overall Study||16
166214|NCT00993265|400509|P2|STARTED|Overall Study||19
166215|NCT00993265|400510|P1|STARTED|Overall Study||20
166216|NCT00993200|400530|P2|NOT COMPLETED|Overall Study||0
166217|NCT00993200|400531|P1|NOT COMPLETED|Overall Study||0
166218|NCT00993200|400530|P2|COMPLETED|Overall Study||13
166219|NCT00993200|400531|P1|COMPLETED|Overall Study||13
166220|NCT00993200|400530|P2|STARTED|Overall Study||13
166221|NCT00993200|400531|P1|STARTED|Overall Study||13
166222|NCT00993187|400543|P2|NOT COMPLETED|Overall Study||37
166223|NCT00993187|400544|P1|NOT COMPLETED|Overall Study||26
166224|NCT00993187|400543|P2|COMPLETED|Overall Study||108
166225|NCT00993187|400544|P1|COMPLETED|Overall Study||121
166226|NCT00993187|400543|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
166227|NCT00993187|400544|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
166228|NCT00993187|400543|P2|STARTED|Overall Study||145
166229|NCT00993187|400544|P1|STARTED|Overall Study||147
166230|NCT00993148|400562|P1|NOT COMPLETED|Overall Study||3
166231|NCT00993148|400562|P1|COMPLETED|Overall Study||22
166232|NCT00993148|400562|P1|STARTED|Overall Study||25
166233|NCT00993044|400574|P1|NOT COMPLETED|Irinotecan 50 mg||1
166234|NCT00993044|400574|P1|COMPLETED|Irinotecan 50 mg||6
166235|NCT00993044|400574|P1|STARTED|Irinotecan 50 mg||7
166236|NCT00993044|400574|P1|NOT COMPLETED|Irinotecan 30 mg||0
166237|NCT00993044|400574|P1|COMPLETED|Irinotecan 30 mg||6
166238|NCT00993044|400574|P1|STARTED|Irinotecan 30 mg||6
166239|NCT00993031|400581|P2|NOT COMPLETED|Overall Study||19
166240|NCT00993031|400582|P1|NOT COMPLETED|Overall Study||22
166241|NCT00993031|400581|P2|COMPLETED|Overall Study||175
166242|NCT00993031|400582|P1|COMPLETED|Overall Study||173
166243|NCT00993031|400581|P2|Delivered|Overall Study||190
166244|NCT00993031|400582|P1|Delivered|Overall Study||187
166245|NCT00993031|400581|P2|STARTED|Overall Study||194
166246|NCT00993031|400582|P1|STARTED|Overall Study||195
166247|NCT00992992|400600|P1|NOT COMPLETED|Overall Study||25
166248|NCT00992992|400600|P1|COMPLETED|Overall Study||0
166249|NCT00992992|400600|P1|STARTED|Overall Study||25
166250|NCT00992927|400622|P2|NOT COMPLETED|Overall Study||0
166251|NCT00992927|400623|P1|NOT COMPLETED|Overall Study||0
166252|NCT00992927|400622|P2|COMPLETED|Overall Study||22
166253|NCT00992927|400623|P1|COMPLETED|Overall Study||32
166254|NCT00992927|400622|P2|STARTED|Overall Study||22
166255|NCT00992927|400623|P1|STARTED|Overall Study||32
166256|NCT00992836|400631|P1|NOT COMPLETED|Overall Study||5
166257|NCT00992836|400631|P1|COMPLETED|Overall Study||150
166258|NCT00992836|400631|P1|Received Both Study Vaccinations|Overall Study||150
166259|NCT00992836|400631|P1|STARTED|Overall Study||155
166260|NCT00992784|400646|P3|NOT COMPLETED|Overall Study||1
166261|NCT00992784|400647|P2|NOT COMPLETED|Overall Study||2
166262|NCT00992784|400648|P1|NOT COMPLETED|Overall Study||3
166263|NCT00992784|400646|P3|COMPLETED|Overall Study||85
166264|NCT00992784|400647|P2|COMPLETED|Overall Study||102
166265|NCT00992784|400648|P1|COMPLETED|Overall Study||177
166266|NCT00992784|400646|P3|STARTED|Overall Study||86
166267|NCT00992784|400647|P2|STARTED|Overall Study||104
166268|NCT00992784|400648|P1|STARTED|Overall Study||180
166269|NCT00992719|400719|P3|NOT COMPLETED|Overall Study||0
166270|NCT00992719|400720|P2|NOT COMPLETED|Overall Study||1
166271|NCT00992719|400721|P1|NOT COMPLETED|Overall Study||1
166272|NCT00992719|400719|P3|COMPLETED|Overall Study||28
166273|NCT00992719|400720|P2|COMPLETED|Overall Study||27
166274|NCT00992719|400721|P1|COMPLETED|Overall Study||27
166275|NCT00992719|400719|P3|STARTED|Overall Study||28
166276|NCT00992719|400720|P2|STARTED|Overall Study||28
166277|NCT00992719|400721|P1|STARTED|Overall Study||28
166278|NCT00992602|400755|P1|NOT COMPLETED|Overall Study||3
166279|NCT00992602|400755|P1|COMPLETED|Overall Study||0
166280|NCT00992602|400755|P1|STARTED|Overall Study||3
166281|NCT00992589|400760|P4|NOT COMPLETED|Double-Blind Phase||10
166282|NCT00992589|400761|P3|NOT COMPLETED|Double-Blind Phase||13
166283|NCT00992589|400762|P2|NOT COMPLETED|Double-Blind Phase||13
166284|NCT00992589|400763|P1|NOT COMPLETED|Double-Blind Phase||0
166285|NCT00992589|400760|P4|COMPLETED|Double-Blind Phase||78
166286|NCT00992589|400761|P3|COMPLETED|Double-Blind Phase||77
166287|NCT00992589|400762|P2|COMPLETED|Double-Blind Phase||76
166288|NCT00992589|400763|P1|COMPLETED|Double-Blind Phase||0
166289|NCT00992589|400760|P4|STARTED|Double-Blind Phase||88
166290|NCT00992589|400761|P3|STARTED|Double-Blind Phase||90
166291|NCT00992589|400762|P2|STARTED|Double-Blind Phase||89
166292|NCT00992589|400763|P1|STARTED|Double-Blind Phase||0
166293|NCT00992589|400760|P4|NOT COMPLETED|Open-Label Phase||0
166294|NCT00992589|400761|P3|NOT COMPLETED|Open-Label Phase||0
166295|NCT00992589|400762|P2|NOT COMPLETED|Open-Label Phase||0
166296|NCT00992589|400763|P1|NOT COMPLETED|Open-Label Phase||77
166297|NCT00992589|400760|P4|COMPLETED|Open-Label Phase||0
166298|NCT00992589|400761|P3|COMPLETED|Open-Label Phase||0
166299|NCT00992589|400762|P2|COMPLETED|Open-Label Phase||0
166300|NCT00992589|400763|P1|COMPLETED|Open-Label Phase||267
166301|NCT00992589|400760|P4|STARTED|Open-Label Phase||0
166302|NCT00992589|400761|P3|STARTED|Open-Label Phase||0
166303|NCT00992589|400762|P2|STARTED|Open-Label Phase||0
166304|NCT00992589|400763|P1|STARTED|Open-Label Phase||344
166305|NCT00992459|400807|P2|NOT COMPLETED|Overall Study||1
166306|NCT00992459|400808|P1|NOT COMPLETED|Overall Study||1
166307|NCT00992459|400807|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
166308|NCT00992459|400808|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
166309|NCT00992459|400807|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
166310|NCT00992459|400808|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
166311|NCT00992446|400832|P1|NOT COMPLETED|Overall Study||8
166312|NCT00992446|400832|P1|COMPLETED|Overall Study||19
166313|NCT00992446|400832|P1|STARTED|Overall Study||27
166314|NCT00992433|400839|P2|NOT COMPLETED|Overall Study||7
166315|NCT00992433|400840|P1|NOT COMPLETED|Overall Study||4
166316|NCT00992433|400839|P2|COMPLETED|Overall Study||90
166317|NCT00992433|400840|P1|COMPLETED|Overall Study||91
166318|NCT00992433|400839|P2|STARTED|Overall Study||97
166319|NCT00992433|400840|P1|STARTED|Overall Study||95
166320|NCT00992407|400904|P2|NOT COMPLETED|Overall Study||24
166321|NCT00992407|400905|P1|NOT COMPLETED|Overall Study||31
166322|NCT00992407|400904|P2|COMPLETED|Overall Study||14
166323|NCT00992407|400905|P1|COMPLETED|Overall Study||6
166324|NCT00992407|400904|P2|Treated|Overall Study||25
166325|NCT00992407|400905|P1|Treated|Overall Study||20
166326|NCT00992407|400904|P2|STARTED|Overall Study||38
166327|NCT00992407|400905|P1|STARTED|Overall Study||37
166328|NCT00992394|400955|P2|NOT COMPLETED|Overall Study||14
166329|NCT00992394|400956|P1|NOT COMPLETED|Overall Study||24
166330|NCT00992394|400955|P2|COMPLETED|Overall Study||72
166331|NCT00992394|400956|P1|COMPLETED|Overall Study||64
166332|NCT00992394|400955|P2|mITT Population|Overall Study||84
166333|NCT00992394|400956|P1|mITT Population|Overall Study||86
166334|NCT00992394|400955|P2|Safety Population|Overall Study||84
166335|NCT00992394|400956|P1|Safety Population|Overall Study||87
166336|NCT00992394|400955|P2|STARTED|Overall Study||86
166337|NCT00992394|400956|P1|STARTED|Overall Study||88
166338|NCT00992264|401014|P16|NOT COMPLETED|Overall Study||0
166339|NCT00992264|401015|P15|NOT COMPLETED|Overall Study||0
166340|NCT00992264|401016|P14|NOT COMPLETED|Overall Study||0
166341|NCT00992264|401017|P13|NOT COMPLETED|Overall Study||0
166342|NCT00992264|401018|P12|NOT COMPLETED|Overall Study||0
166343|NCT00992264|401019|P11|NOT COMPLETED|Overall Study||0
166344|NCT00992264|401020|P10|NOT COMPLETED|Overall Study||0
166345|NCT00992264|401021|P9|NOT COMPLETED|Overall Study||0
166346|NCT00992264|401022|P8|NOT COMPLETED|Overall Study||0
166347|NCT00992264|401023|P7|NOT COMPLETED|Overall Study||0
166348|NCT00992264|401024|P6|NOT COMPLETED|Overall Study||0
166349|NCT00992264|401025|P5|NOT COMPLETED|Overall Study||0
166350|NCT00992264|401026|P4|NOT COMPLETED|Overall Study||0
166351|NCT00992264|401027|P3|NOT COMPLETED|Overall Study||0
166352|NCT00992264|401028|P2|NOT COMPLETED|Overall Study||0
166353|NCT00992264|401029|P1|NOT COMPLETED|Overall Study||0
166354|NCT00992264|401014|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
166355|NCT00992264|401015|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166356|NCT00992264|401016|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166357|NCT00992264|401017|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
166358|NCT00992264|401018|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166359|NCT00992264|401019|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166360|NCT00992264|401020|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
166361|NCT00992264|401021|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
166362|NCT00992264|401022|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166363|NCT00992264|401023|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
166364|NCT00992264|401024|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166365|NCT00992264|401025|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166366|NCT00992264|401026|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166367|NCT00992264|401027|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
166368|NCT00992264|401028|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
166369|NCT00992264|401029|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
166370|NCT00992264|401014|P16|STARTED|Overall Study||116
166371|NCT00992264|401015|P15|STARTED|Overall Study||117
166372|NCT00992264|401016|P14|STARTED|Overall Study||117
166373|NCT00992264|401017|P13|STARTED|Overall Study||116
166374|NCT00992264|401018|P12|STARTED|Overall Study||117
166375|NCT00992264|401019|P11|STARTED|Overall Study||117
166376|NCT00992264|401020|P10|STARTED|Overall Study||116
166377|NCT00992264|401021|P9|STARTED|Overall Study||116
166378|NCT00992264|401022|P8|STARTED|Overall Study||117
166379|NCT00992264|401023|P7|STARTED|Overall Study||116
166380|NCT00992264|401024|P6|STARTED|Overall Study||117
166381|NCT00992264|401025|P5|STARTED|Overall Study||117
166382|NCT00992264|401026|P4|STARTED|Overall Study||117
166383|NCT00992264|401027|P3|STARTED|Overall Study||117
166384|NCT00992264|401028|P2|STARTED|Overall Study||116
166385|NCT00992264|401029|P1|STARTED|Overall Study||116
166386|NCT00992186|401043|P1|NOT COMPLETED|Overall Study||46
166387|NCT00992186|401043|P1|COMPLETED|Overall Study||0
166388|NCT00992186|401043|P1|STARTED|Overall Study||46
166389|NCT00992108|401062|P2|NOT COMPLETED|Overall Study||1
166390|NCT00992108|401063|P1|NOT COMPLETED|Overall Study||0
166391|NCT00992108|401062|P2|COMPLETED|Overall Study||9
166392|NCT00992108|401063|P1|COMPLETED|Overall Study||7
166393|NCT00992108|401062|P2|STARTED|Overall Study||10
166394|NCT00992108|401063|P1|STARTED|Overall Study||7
166395|NCT00992056|401077|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
166396|NCT00992056|401078|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
166397|NCT00992056|401077|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
166398|NCT00992056|401078|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
166399|NCT00992056|401077|P2|STARTED|Treatment Period 2 (6 Weeks)||10
166400|NCT00992056|401078|P1|STARTED|Treatment Period 2 (6 Weeks)||10
166401|NCT00992056|401077|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
166402|NCT00992056|401078|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
166403|NCT00992056|401077|P2|COMPLETED|Washout Period (2 Weeks)||10
166404|NCT00992056|401078|P1|COMPLETED|Washout Period (2 Weeks)||10
166405|NCT00992056|401077|P2|STARTED|Washout Period (2 Weeks)||10
166406|NCT00992056|401078|P1|STARTED|Washout Period (2 Weeks)||11
166407|NCT00992056|401077|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
166408|NCT00992056|401078|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
166409|NCT00992056|401077|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
166410|NCT00992056|401078|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
166411|NCT00992056|401077|P2|STARTED|Treatment Period 1 (6 Weeks)||12
166412|NCT00992056|401078|P1|STARTED|Treatment Period 1 (6 Weeks)||12
166413|NCT00992017|401084|P1|NOT COMPLETED|Overall Study||10
166414|NCT00992017|401084|P1|COMPLETED|Overall Study||118
166415|NCT00992017|401084|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
166416|NCT00992017|401084|P1|Received Both Study Vaccinations|Overall Study||124
166417|NCT00992017|401084|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
166418|NCT00991952|401099|P2|NOT COMPLETED|Overall Study||1
166419|NCT00991952|401100|P1|NOT COMPLETED|Overall Study||0
166420|NCT00991952|401099|P2|COMPLETED|Overall Study||5
166421|NCT00991952|401100|P1|COMPLETED|Overall Study||13
166422|NCT00991952|401099|P2|STARTED|Overall Study||6
166423|NCT00991952|401100|P1|STARTED|Overall Study||13
166424|NCT00991939|401108|P2|NOT COMPLETED|Overall Study||2
166425|NCT00991939|401109|P1|NOT COMPLETED|Overall Study||5
166426|NCT00991939|401108|P2|COMPLETED|Overall Study||1
166427|NCT00991939|401109|P1|COMPLETED|Overall Study||0
166428|NCT00991939|401108|P2|STARTED|Overall Study||3
166429|NCT00991939|401109|P1|STARTED|Overall Study||5
166430|NCT00991887|401143|P2|NOT COMPLETED|Overall Study||1
166431|NCT00991887|401144|P1|NOT COMPLETED|Overall Study||2
166432|NCT00991887|401143|P2|COMPLETED|Overall Study||21
166433|NCT00991887|401144|P1|COMPLETED|Overall Study||24
166434|NCT00991887|401143|P2|STARTED|Overall Study||22
166435|NCT00991887|401144|P1|STARTED|Overall Study||26
166436|NCT00991809|401152|P2|NOT COMPLETED|Overall Study||6
166437|NCT00991809|401153|P1|NOT COMPLETED|Overall Study||4
166438|NCT00991809|401152|P2|COMPLETED|Overall Study||4
166439|NCT00991809|401153|P1|COMPLETED|Overall Study||8
166440|NCT00991809|401152|P2|STARTED|Overall Study||10
166441|NCT00991809|401153|P1|STARTED|Overall Study||12
166442|NCT00991510|401163|P2|NOT COMPLETED|Period III (Days 29-112)||1
166443|NCT00991510|401164|P1|NOT COMPLETED|Period III (Days 29-112)||1
166444|NCT00991510|401163|P2|COMPLETED|Period III (Days 29-112)||20
166445|NCT00991510|401164|P1|COMPLETED|Period III (Days 29-112)||20
166446|NCT00991510|401163|P2|STARTED|Period III (Days 29-112)||21
166447|NCT00991510|401164|P1|STARTED|Period III (Days 29-112)||21
166448|NCT00991510|401163|P2|NOT COMPLETED|Period II (Days 15-28)||0
166449|NCT00991510|401164|P1|NOT COMPLETED|Period II (Days 15-28)||0
166450|NCT00991510|401163|P2|COMPLETED|Period II (Days 15-28)||21
166451|NCT00991510|401164|P1|COMPLETED|Period II (Days 15-28)||21
166452|NCT00991510|401163|P2|STARTED|Period II (Days 15-28)||21
166453|NCT00991510|401164|P1|STARTED|Period II (Days 15-28)||21
166454|NCT00991510|401163|P2|NOT COMPLETED|Period I (Days 1-14)||0
166455|NCT00991510|401164|P1|NOT COMPLETED|Period I (Days 1-14)||1
166456|NCT00991510|401163|P2|COMPLETED|Period I (Days 1-14)||21
166457|NCT00991510|401164|P1|COMPLETED|Period I (Days 1-14)||21
166458|NCT00991510|401163|P2|STARTED|Period I (Days 1-14)||21
166459|NCT00991510|401164|P1|STARTED|Period I (Days 1-14)||22
166460|NCT00991458|401189|P3|NOT COMPLETED|Overall Study||25
166461|NCT00991458|401190|P2|NOT COMPLETED|Overall Study||28
166462|NCT00991458|401191|P1|NOT COMPLETED|Overall Study||20
166463|NCT00991458|401189|P3|COMPLETED|Overall Study||180
166464|NCT00991458|401190|P2|COMPLETED|Overall Study||181
166465|NCT00991458|401191|P1|COMPLETED|Overall Study||187
166466|NCT00991458|401189|P3|STARTED|Overall Study||205
166467|NCT00991458|401190|P2|STARTED|Overall Study||209
166468|NCT00991458|401191|P1|STARTED|Overall Study||207
166469|NCT00991341|401210|P2|NOT COMPLETED|Overall Study||179
166470|NCT00991341|401211|P1|NOT COMPLETED|Overall Study||204
166471|NCT00991341|401210|P2|COMPLETED|Overall Study||560
166472|NCT00991341|401211|P1|COMPLETED|Overall Study||538
166473|NCT00991341|401210|P2|STARTED|Overall Study||739
166474|NCT00991341|401211|P1|STARTED|Overall Study||742
166475|NCT00991302|401249|P2|NOT COMPLETED|Overall Study||13
166476|NCT00991302|401250|P1|NOT COMPLETED|Overall Study||14
166477|NCT00991302|401249|P2|COMPLETED|Overall Study||73
166478|NCT00991302|401250|P1|COMPLETED|Overall Study||72
166479|NCT00991302|401249|P2|STARTED|Overall Study||86
166480|NCT00991302|401250|P1|STARTED|Overall Study||86
166481|NCT00991289|401266|P1|NOT COMPLETED|Overall Study||12
166482|NCT00991289|401266|P1|COMPLETED|Overall Study|Completed study.|55
166483|NCT00991289|401266|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
166484|NCT00991289|401266|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
166485|NCT00991276|401286|P6|NOT COMPLETED|Third Intervention Period||1
166486|NCT00991276|401287|P5|NOT COMPLETED|Third Intervention Period||0
166487|NCT00991276|401288|P4|NOT COMPLETED|Third Intervention Period||1
166488|NCT00991276|401289|P3|NOT COMPLETED|Third Intervention Period||1
166489|NCT00991276|401290|P2|NOT COMPLETED|Third Intervention Period||0
166490|NCT00991276|401291|P1|NOT COMPLETED|Third Intervention Period||1
166491|NCT00991276|401286|P6|COMPLETED|Third Intervention Period||10
166492|NCT00991276|401287|P5|COMPLETED|Third Intervention Period||10
166493|NCT00991276|401288|P4|COMPLETED|Third Intervention Period||8
166494|NCT00991276|401289|P3|COMPLETED|Third Intervention Period||13
166495|NCT00991276|401290|P2|COMPLETED|Third Intervention Period||8
166496|NCT00991276|401291|P1|COMPLETED|Third Intervention Period||13
166497|NCT00991276|401286|P6|STARTED|Third Intervention Period||11
166498|NCT00991276|401287|P5|STARTED|Third Intervention Period||10
166499|NCT00991276|401288|P4|STARTED|Third Intervention Period||9
166500|NCT00991276|401289|P3|STARTED|Third Intervention Period||14
166501|NCT00991276|401290|P2|STARTED|Third Intervention Period||8
166502|NCT00991276|401291|P1|STARTED|Third Intervention Period||14
166503|NCT00991276|401286|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166504|NCT00991276|401287|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166505|NCT00991276|401288|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166506|NCT00991276|401289|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166507|NCT00991276|401290|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166508|NCT00991276|401291|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166509|NCT00991276|401286|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
166510|NCT00991276|401287|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
166511|NCT00991276|401288|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
166512|NCT00991276|401289|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
166513|NCT00991276|401290|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
166514|NCT00991276|401291|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
166515|NCT00991276|401286|P6|STARTED|Placebo Wash-out Period (7 Days)||11
166516|NCT00991276|401287|P5|STARTED|Placebo Wash-out Period (7 Days)||10
166517|NCT00991276|401288|P4|STARTED|Placebo Wash-out Period (7 Days)||9
166518|NCT00991276|401289|P3|STARTED|Placebo Wash-out Period (7 Days)||14
166519|NCT00991276|401290|P2|STARTED|Placebo Wash-out Period (7 Days)||8
166520|NCT00991276|401291|P1|STARTED|Placebo Wash-out Period (7 Days)||14
166521|NCT00991276|401286|P6|NOT COMPLETED|Second Intervention Period||1
166522|NCT00991276|401287|P5|NOT COMPLETED|Second Intervention Period||1
166523|NCT00991276|401288|P4|NOT COMPLETED|Second Intervention Period||2
166524|NCT00991276|401289|P3|NOT COMPLETED|Second Intervention Period||0
166525|NCT00991276|401290|P2|NOT COMPLETED|Second Intervention Period||2
166526|NCT00991276|401291|P1|NOT COMPLETED|Second Intervention Period||1
166527|NCT00991276|401286|P6|COMPLETED|Second Intervention Period||11
166528|NCT00991276|401287|P5|COMPLETED|Second Intervention Period||10
166529|NCT00991276|401288|P4|COMPLETED|Second Intervention Period||9
166530|NCT00991276|401289|P3|COMPLETED|Second Intervention Period||14
166531|NCT00991276|401290|P2|COMPLETED|Second Intervention Period||8
166532|NCT00991276|401291|P1|COMPLETED|Second Intervention Period||14
166533|NCT00991276|401286|P6|STARTED|Second Intervention Period||12
166534|NCT00991276|401287|P5|STARTED|Second Intervention Period||11
166535|NCT00991276|401288|P4|STARTED|Second Intervention Period||11
166536|NCT00991276|401289|P3|STARTED|Second Intervention Period||14
166537|NCT00991276|401290|P2|STARTED|Second Intervention Period||10
166538|NCT00991276|401291|P1|STARTED|Second Intervention Period||15
166539|NCT00991276|401286|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166540|NCT00991276|401287|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166541|NCT00991276|401288|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166542|NCT00991276|401289|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166543|NCT00991276|401290|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166544|NCT00991276|401291|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
166545|NCT00991276|401286|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
166546|NCT00991276|401287|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
166547|NCT00991276|401288|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
166548|NCT00991276|401289|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
166549|NCT00991276|401290|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
166550|NCT00991276|401291|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
166551|NCT00991276|401286|P6|STARTED|Placebo Wash-out Period (7 Days)||12
166552|NCT00991276|401287|P5|STARTED|Placebo Wash-out Period (7 Days)||11
166553|NCT00991276|401288|P4|STARTED|Placebo Wash-out Period (7 Days)||11
166554|NCT00991276|401289|P3|STARTED|Placebo Wash-out Period (7 Days)||14
166555|NCT00991276|401290|P2|STARTED|Placebo Wash-out Period (7 Days)||10
166556|NCT00991276|401291|P1|STARTED|Placebo Wash-out Period (7 Days)||15
166557|NCT00991276|401286|P6|NOT COMPLETED|First Intervention Period||1
166558|NCT00991276|401287|P5|NOT COMPLETED|First Intervention Period||4
166559|NCT00991276|401288|P4|NOT COMPLETED|First Intervention Period||4
166560|NCT00991276|401289|P3|NOT COMPLETED|First Intervention Period||0
166561|NCT00991276|401290|P2|NOT COMPLETED|First Intervention Period||3
166562|NCT00991276|401291|P1|NOT COMPLETED|First Intervention Period||0
166563|NCT00991276|401286|P6|COMPLETED|First Intervention Period||12
166564|NCT00991276|401287|P5|COMPLETED|First Intervention Period||11
166565|NCT00991276|401288|P4|COMPLETED|First Intervention Period||11
166566|NCT00991276|401289|P3|COMPLETED|First Intervention Period||14
166567|NCT00991276|401290|P2|COMPLETED|First Intervention Period||10
166568|NCT00991276|401291|P1|COMPLETED|First Intervention Period||15
166569|NCT00991276|401286|P6|STARTED|First Intervention Period||13
166570|NCT00991276|401287|P5|STARTED|First Intervention Period||15
166571|NCT00991276|401288|P4|STARTED|First Intervention Period||15
166572|NCT00991276|401289|P3|STARTED|First Intervention Period||14
166573|NCT00991276|401290|P2|STARTED|First Intervention Period||13
166574|NCT00991276|401291|P1|STARTED|First Intervention Period||15
166575|NCT00991185|401389|P1|NOT COMPLETED|Overall Study||0
166576|NCT00991185|401389|P1|COMPLETED|Overall Study||8
166577|NCT00991185|401389|P1|STARTED|Overall Study||8
166578|NCT00991081|401395|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
166579|NCT00991081|401396|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
166580|NCT00991081|401397|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
166581|NCT00991081|401395|P3|COMPLETED|Phase II, Randomized Control Trial||15
166582|NCT00991081|401396|P2|COMPLETED|Phase II, Randomized Control Trial||15
166583|NCT00991081|401397|P1|COMPLETED|Phase II, Randomized Control Trial||0
166584|NCT00991081|401395|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
166585|NCT00991081|401396|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
166586|NCT00991081|401397|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
166587|NCT00991081|401395|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
166588|NCT00991081|401396|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
166589|NCT00991081|401397|P1|STARTED|Phase II, Randomized Control Trial||0
166590|NCT00991081|401395|P3|NOT COMPLETED|Phase I, Formative Research||0
166591|NCT00991081|401396|P2|NOT COMPLETED|Phase I, Formative Research||0
166592|NCT00991081|401397|P1|NOT COMPLETED|Phase I, Formative Research||0
166593|NCT00991081|401395|P3|COMPLETED|Phase I, Formative Research||0
166594|NCT00991081|401396|P2|COMPLETED|Phase I, Formative Research||0
166595|NCT00991081|401397|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
166596|NCT00991081|401395|P3|STARTED|Phase I, Formative Research||0
166597|NCT00991081|401396|P2|STARTED|Phase I, Formative Research||0
166598|NCT00991081|401397|P1|STARTED|Phase I, Formative Research||20
166599|NCT00990964|401429|P1|NOT COMPLETED|Overall Study||212
166600|NCT00990964|401429|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
166601|NCT00990964|401429|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
166602|NCT00990964|401429|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
166603|NCT00990821|401448|P14|NOT COMPLETED|Overall Study||1
166604|NCT00990821|401449|P13|NOT COMPLETED|Overall Study||2
166605|NCT00990821|401450|P12|NOT COMPLETED|Overall Study||5
166606|NCT00990821|401451|P11|NOT COMPLETED|Overall Study||3
166607|NCT00990821|401452|P10|NOT COMPLETED|Overall Study||1
166608|NCT00990821|401453|P9|NOT COMPLETED|Overall Study||0
166609|NCT00990821|401454|P8|NOT COMPLETED|Overall Study||0
166610|NCT00990821|401455|P7|NOT COMPLETED|Overall Study||1
166611|NCT00990821|401456|P6|NOT COMPLETED|Overall Study||3
166612|NCT00990821|401457|P5|NOT COMPLETED|Overall Study||3
166613|NCT00990821|401458|P4|NOT COMPLETED|Overall Study||0
166614|NCT00990821|401459|P3|NOT COMPLETED|Overall Study||0
166615|NCT00990821|401460|P2|NOT COMPLETED|Overall Study||2
166616|NCT00990821|401461|P1|NOT COMPLETED|Overall Study||0
166617|NCT00990821|401448|P14|COMPLETED|Overall Study||11
166618|NCT00990821|401449|P13|COMPLETED|Overall Study||10
166619|NCT00990821|401450|P12|COMPLETED|Overall Study||9
166620|NCT00990821|401451|P11|COMPLETED|Overall Study||9
166621|NCT00990821|401452|P10|COMPLETED|Overall Study||13
166622|NCT00990821|401453|P9|COMPLETED|Overall Study||12
166623|NCT00990821|401454|P8|COMPLETED|Overall Study||14
166624|NCT00990821|401455|P7|COMPLETED|Overall Study||11
166625|NCT00990821|401456|P6|COMPLETED|Overall Study||14
166626|NCT00990821|401457|P5|COMPLETED|Overall Study||14
166627|NCT00990821|401458|P4|COMPLETED|Overall Study||8
166628|NCT00990821|401459|P3|COMPLETED|Overall Study||14
166629|NCT00990821|401460|P2|COMPLETED|Overall Study||14
166630|NCT00990821|401461|P1|COMPLETED|Overall Study||14
166631|NCT00990821|401448|P14|STARTED|Overall Study||12
166632|NCT00990821|401449|P13|STARTED|Overall Study||12
166633|NCT00990821|401450|P12|STARTED|Overall Study||14
166634|NCT00990821|401451|P11|STARTED|Overall Study||12
166635|NCT00990821|401452|P10|STARTED|Overall Study||14
166636|NCT00990821|401453|P9|STARTED|Overall Study||12
166637|NCT00990821|401454|P8|STARTED|Overall Study||14
166638|NCT00990821|401455|P7|STARTED|Overall Study||12
166639|NCT00990821|401456|P6|STARTED|Overall Study||17
166640|NCT00990821|401457|P5|STARTED|Overall Study||17
166641|NCT00990821|401458|P4|STARTED|Overall Study||8
166642|NCT00990821|401459|P3|STARTED|Overall Study||14
166643|NCT00990821|401460|P2|STARTED|Overall Study||16
166644|NCT00990821|401461|P1|STARTED|Overall Study||14
166645|NCT00990782|401478|P1|NOT COMPLETED|Overall Study||5
166646|NCT00990782|401478|P1|COMPLETED|Overall Study||88
166647|NCT00990782|401478|P1|STARTED|Overall Study||93
166648|NCT00990769|401485|P2|NOT COMPLETED|Overall Study||0
166649|NCT00990769|401486|P1|NOT COMPLETED|Overall Study||0
166650|NCT00990769|401485|P2|COMPLETED|Overall Study||18
166651|NCT00990769|401486|P1|COMPLETED|Overall Study||22
166652|NCT00990769|401485|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
166653|NCT00990769|401486|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
166654|NCT00990704|401498|P2|NOT COMPLETED|Overall Study||2
166655|NCT00990704|401499|P1|NOT COMPLETED|Overall Study||1
166656|NCT00990704|401498|P2|COMPLETED|Overall Study||31
166657|NCT00990704|401499|P1|COMPLETED|Overall Study||13
166658|NCT00990704|401498|P2|STARTED|Overall Study||33
166659|NCT00990704|401499|P1|STARTED|Overall Study||14
166660|NCT00990652|401519|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
166661|NCT00990652|401519|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
166662|NCT00990652|401519|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
166663|NCT00990652|401519|P1|NOT COMPLETED|Surgical Resection||0
166664|NCT00990652|401519|P1|COMPLETED|Surgical Resection||9
166665|NCT00990652|401519|P1|STARTED|Surgical Resection||9
166666|NCT00990652|401519|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
166667|NCT00990652|401519|P1|COMPLETED|Pre-surgical Bortezomib||9
166668|NCT00990652|401519|P1|STARTED|Pre-surgical Bortezomib||10
166669|NCT00990561|401529|P4|NOT COMPLETED|Period 2||2
166670|NCT00990561|401530|P3|NOT COMPLETED|Period 2||0
166671|NCT00990561|401531|P2|NOT COMPLETED|Period 2||0
166672|NCT00990561|401532|P1|NOT COMPLETED|Period 2||0
166673|NCT00990561|401529|P4|COMPLETED|Period 2||17
166674|NCT00990561|401530|P3|COMPLETED|Period 2||20
166675|NCT00990561|401531|P2|COMPLETED|Period 2||0
166676|NCT00990561|401532|P1|COMPLETED|Period 2||0
166677|NCT00990561|401529|P4|STARTED|Period 2||19
166678|NCT00990561|401530|P3|STARTED|Period 2||20
166679|NCT00990561|401531|P2|STARTED|Period 2||0
166680|NCT00990561|401532|P1|STARTED|Period 2||0
166681|NCT00990561|401529|P4|NOT COMPLETED|Period 1||0
166682|NCT00990561|401530|P3|NOT COMPLETED|Period 1||0
166683|NCT00990561|401531|P2|NOT COMPLETED|Period 1||1
166684|NCT00990561|401532|P1|NOT COMPLETED|Period 1||0
166685|NCT00990561|401529|P4|COMPLETED|Period 1||0
166686|NCT00990561|401530|P3|COMPLETED|Period 1||0
166687|NCT00990561|401531|P2|COMPLETED|Period 1||19
166688|NCT00990561|401532|P1|COMPLETED|Period 1||20
166689|NCT00990561|401529|P4|STARTED|Period 1||0
166690|NCT00990561|401530|P3|STARTED|Period 1||0
166691|NCT00990561|401531|P2|STARTED|Period 1||20
166692|NCT00990561|401532|P1|STARTED|Period 1||20
166693|NCT00990509|401540|P2|NOT COMPLETED|Overall Study||1
166694|NCT00990509|401541|P1|NOT COMPLETED|Overall Study||0
166695|NCT00990509|401540|P2|COMPLETED|Overall Study||8
166696|NCT00990509|401541|P1|COMPLETED|Overall Study||5
166697|NCT00990509|401540|P2|STARTED|Overall Study||9
166698|NCT00990509|401541|P1|STARTED|Overall Study||5
166699|NCT00990340|401553|P2|NOT COMPLETED|Second 14-day Treatment||0
166700|NCT00990340|401554|P1|NOT COMPLETED|Second 14-day Treatment||0
166701|NCT00990340|401553|P2|COMPLETED|Second 14-day Treatment||21
166702|NCT00990340|401554|P1|COMPLETED|Second 14-day Treatment||21
166703|NCT00990340|401553|P2|STARTED|Second 14-day Treatment||21
166704|NCT00990340|401554|P1|STARTED|Second 14-day Treatment||21
166705|NCT00990340|401553|P2|NOT COMPLETED|First 14-day Treatment||4
166706|NCT00990340|401554|P1|NOT COMPLETED|First 14-day Treatment||6
166707|NCT00990340|401553|P2|COMPLETED|First 14-day Treatment||21
166708|NCT00990340|401554|P1|COMPLETED|First 14-day Treatment||21
166709|NCT00990340|401553|P2|STARTED|First 14-day Treatment||25
166710|NCT00990340|401554|P1|STARTED|First 14-day Treatment||27
166711|NCT00990288|401570|P2|NOT COMPLETED|Overall Study||0
166712|NCT00990288|401571|P1|NOT COMPLETED|Overall Study||0
166713|NCT00990288|401570|P2|COMPLETED|Overall Study||99
166714|NCT00990288|401571|P1|COMPLETED|Overall Study||97
166715|NCT00990288|401570|P2|STARTED|Overall Study||99
166716|NCT00990288|401571|P1|STARTED|Overall Study||97
166717|NCT00990184|401601|P1|NOT COMPLETED|Overall Study||1
166718|NCT00990184|401601|P1|COMPLETED|Overall Study||20
166719|NCT00990184|401601|P1|STARTED|Overall Study||21
166720|NCT00990106|401609|P2|NOT COMPLETED|Overall Study||12
166721|NCT00990106|401610|P1|NOT COMPLETED|Overall Study||9
166722|NCT00990106|401609|P2|COMPLETED|Overall Study||23
166723|NCT00990106|401610|P1|COMPLETED|Overall Study||23
166724|NCT00990106|401609|P2|STARTED|Overall Study||35
166725|NCT00990106|401610|P1|STARTED|Overall Study||32
166726|NCT00990093|401620|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
166727|NCT00990093|401621|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
166728|NCT00990093|401620|P2|COMPLETED|Test Period 2 (15-28 Days)||14
166729|NCT00990093|401621|P1|COMPLETED|Test Period 2 (15-28 Days)||13
166730|NCT00990093|401620|P2|STARTED|Test Period 2 (15-28 Days)||15
166731|NCT00990093|401621|P1|STARTED|Test Period 2 (15-28 Days)||15
166732|NCT00990093|401620|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
166733|NCT00990093|401621|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
166734|NCT00990093|401620|P2|COMPLETED|Test Period 1 (1-14 Days)||15
166735|NCT00990093|401621|P1|COMPLETED|Test Period 1 (1-14 Days)||15
166736|NCT00990093|401620|P2|STARTED|Test Period 1 (1-14 Days)||17
166737|NCT00990093|401621|P1|STARTED|Test Period 1 (1-14 Days)||19
166738|NCT00989989|401630|P3|NOT COMPLETED|Overall Study||23
166739|NCT00989989|401631|P2|NOT COMPLETED|Overall Study||10
166740|NCT00989989|401632|P1|NOT COMPLETED|Overall Study||18
166741|NCT00989989|401630|P3|COMPLETED|Overall Study||108
166742|NCT00989989|401631|P2|COMPLETED|Overall Study||123
166743|NCT00989989|401632|P1|COMPLETED|Overall Study||114
166744|NCT00989989|401630|P3|STARTED|Overall Study||131
166745|NCT00989989|401631|P2|STARTED|Overall Study||133
166746|NCT00989989|401632|P1|STARTED|Overall Study||132
166747|NCT00989950|401674|P4|NOT COMPLETED|Randomized Phase||0
166748|NCT00989950|401675|P3|NOT COMPLETED|Randomized Phase||0
166749|NCT00989950|401676|P2|NOT COMPLETED|Randomized Phase||1
166750|NCT00989950|401677|P1|NOT COMPLETED|Randomized Phase||1
166751|NCT00989950|401674|P4|COMPLETED|Randomized Phase||7
166752|NCT00989950|401675|P3|COMPLETED|Randomized Phase||4
166753|NCT00989950|401676|P2|COMPLETED|Randomized Phase||8
166754|NCT00989950|401677|P1|COMPLETED|Randomized Phase||5
166755|NCT00989950|401674|P4|STARTED|Randomized Phase||7
166756|NCT00989950|401675|P3|STARTED|Randomized Phase||4
166757|NCT00989950|401676|P2|STARTED|Randomized Phase||9
166758|NCT00989950|401677|P1|STARTED|Randomized Phase||6
166759|NCT00989950|401674|P4|NOT COMPLETED|Open Label Dose Optimization||0
166760|NCT00989950|401675|P3|NOT COMPLETED|Open Label Dose Optimization||0
166761|NCT00989950|401676|P2|NOT COMPLETED|Open Label Dose Optimization||0
166762|NCT00989950|401677|P1|NOT COMPLETED|Open Label Dose Optimization||0
166763|NCT00989950|401674|P4|COMPLETED|Open Label Dose Optimization||7
166764|NCT00989950|401675|P3|COMPLETED|Open Label Dose Optimization||4
166765|NCT00989950|401676|P2|COMPLETED|Open Label Dose Optimization||9
166766|NCT00989950|401677|P1|COMPLETED|Open Label Dose Optimization||6
166767|NCT00989950|401674|P4|STARTED|Open Label Dose Optimization||7
166768|NCT00989950|401675|P3|STARTED|Open Label Dose Optimization||4
166769|NCT00989950|401676|P2|STARTED|Open Label Dose Optimization||9
166770|NCT00989950|401677|P1|STARTED|Open Label Dose Optimization||6
166771|NCT00989911|401687|P1|NOT COMPLETED|Overall Study||3
166772|NCT00989911|401687|P1|COMPLETED|Overall Study||7
166773|NCT00989911|401687|P1|STARTED|Overall Study||10
166774|NCT00989833|401694|P3|NOT COMPLETED|Overall Study||2
166775|NCT00989833|401695|P2|NOT COMPLETED|Overall Study||3
166776|NCT00989833|401696|P1|NOT COMPLETED|Overall Study||2
166777|NCT00989833|401694|P3|COMPLETED|Overall Study||21
166778|NCT00989833|401695|P2|COMPLETED|Overall Study||19
166779|NCT00989833|401696|P1|COMPLETED|Overall Study||19
166780|NCT00989833|401694|P3|STARTED|Overall Study||23
166781|NCT00989833|401695|P2|STARTED|Overall Study||22
166782|NCT00989833|401696|P1|STARTED|Overall Study||21
166783|NCT00989781|401727|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
166784|NCT00989781|401728|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
166785|NCT00989781|401727|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
166786|NCT00989781|401728|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
166787|NCT00989781|401727|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
166788|NCT00989781|401728|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
166789|NCT00989781|401727|P2|NOT COMPLETED|Ovarian Response to hCG||2
166790|NCT00989781|401728|P1|NOT COMPLETED|Ovarian Response to hCG||3
166791|NCT00989781|401727|P2|COMPLETED|Ovarian Response to hCG||18
166792|NCT00989781|401728|P1|COMPLETED|Ovarian Response to hCG||18
166793|NCT00989781|401727|P2|STARTED|Ovarian Response to hCG||20
166794|NCT00989781|401728|P1|STARTED|Ovarian Response to hCG||21
166795|NCT00989768|401744|P1|NOT COMPLETED|Overall Study||1
166796|NCT00989768|401744|P1|COMPLETED|Overall Study||28
166797|NCT00989768|401744|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
166798|NCT00989664|401755|P1|NOT COMPLETED|Long-Term Follow-Up||3
166799|NCT00989664|401755|P1|COMPLETED|Long-Term Follow-Up||11
166800|NCT00989664|401755|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
166801|NCT00989664|401755|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
166802|NCT00989664|401755|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
166803|NCT00989664|401755|P1|STARTED|Dosimetric and Therapeutic Treatment||61
166804|NCT00989586|401785|P2|NOT COMPLETED|Overall Study||0
166805|NCT00989586|401786|P1|NOT COMPLETED|Overall Study||0
166806|NCT00989586|401785|P2|COMPLETED|Overall Study||17
166807|NCT00989586|401786|P1|COMPLETED|Overall Study||18
166808|NCT00989586|401785|P2|STARTED|Overall Study||17
166809|NCT00989586|401786|P1|STARTED|Overall Study||18
166810|NCT00989287|401801|P2|NOT COMPLETED|Overall Study||1
166811|NCT00989287|401802|P1|NOT COMPLETED|Overall Study||1
166812|NCT00989287|401801|P2|COMPLETED|Overall Study||65
166813|NCT00989287|401802|P1|COMPLETED|Overall Study||64
166814|NCT00989287|401801|P2|STARTED|Overall Study||66
166815|NCT00989287|401802|P1|STARTED|Overall Study||65
166816|NCT00989235|401904|P2|NOT COMPLETED|Overall Study||6
166817|NCT00989235|401905|P1|NOT COMPLETED|Overall Study||3
166818|NCT00989235|401904|P2|COMPLETED|Overall Study||44
166819|NCT00989235|401905|P1|COMPLETED|Overall Study||55
166820|NCT00989235|401904|P2|Number Completing Double-Blind Treatment|Overall Study||41
166821|NCT00989235|401905|P1|Number Completing Double-Blind Treatment|Overall Study||51
166822|NCT00989235|401904|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
166823|NCT00989235|401905|P1|Number Rescued to Open-Label Treatment|Overall Study||4
166824|NCT00989235|401904|P2|STARTED|Overall Study||50
166825|NCT00989235|401905|P1|STARTED|Overall Study||58
166826|NCT00989196|401950|P2|NOT COMPLETED|Treatment Period||0
166827|NCT00989196|401951|P1|NOT COMPLETED|Treatment Period||1
166828|NCT00989196|401950|P2|COMPLETED|Treatment Period||12
166829|NCT00989196|401951|P1|COMPLETED|Treatment Period||9
166830|NCT00989196|401950|P2|STARTED|Treatment Period||12
166831|NCT00989196|401951|P1|STARTED|Treatment Period||10
166832|NCT00989196|401950|P2|NOT COMPLETED|PK Crossover Period||0
166833|NCT00989196|401951|P1|NOT COMPLETED|PK Crossover Period||0
166834|NCT00989196|401950|P2|COMPLETED|PK Crossover Period||12
166835|NCT00989196|401951|P1|COMPLETED|PK Crossover Period||10
166836|NCT00989196|401950|P2|STARTED|PK Crossover Period||12
166837|NCT00989196|401951|P1|STARTED|PK Crossover Period||10
166838|NCT00989157|401972|P2|NOT COMPLETED|Overall Study||0
166839|NCT00989157|401973|P1|NOT COMPLETED|Overall Study||0
166840|NCT00989157|401972|P2|COMPLETED|Overall Study||10
166841|NCT00989157|401973|P1|COMPLETED|Overall Study||10
166842|NCT00989157|401972|P2|STARTED|Overall Study||10
166843|NCT00989157|401973|P1|STARTED|Overall Study||10
166844|NCT00989092|401989|P2|NOT COMPLETED|Overall Study||28
166845|NCT00989092|401990|P1|NOT COMPLETED|Overall Study||90
166846|NCT00989092|401989|P2|COMPLETED|Overall Study||31
166847|NCT00989092|401990|P1|COMPLETED|Overall Study||138
166848|NCT00989092|401989|P2|Treated With Darbepoetin Alfa|Overall Study||33
166849|NCT00989092|401990|P1|Treated With Darbepoetin Alfa|Overall Study||226
166850|NCT00989092|401989|P2|STARTED|Overall Study||59
166851|NCT00989092|401990|P1|STARTED|Overall Study||228
166852|NCT00989014|402027|P4|NOT COMPLETED|Overall Study||0
166853|NCT00989014|402028|P3|NOT COMPLETED|Overall Study||0
166854|NCT00989014|402029|P2|NOT COMPLETED|Overall Study||0
166855|NCT00989014|402030|P1|NOT COMPLETED|Overall Study||0
166856|NCT00989014|402027|P4|COMPLETED|Overall Study||32
166857|NCT00989014|402028|P3|COMPLETED|Overall Study||28
166858|NCT00989014|402029|P2|COMPLETED|Overall Study||31
166859|NCT00989014|402030|P1|COMPLETED|Overall Study||31
166860|NCT00989014|402027|P4|STARTED|Overall Study||32
166861|NCT00989014|402028|P3|STARTED|Overall Study||28
166862|NCT00989014|402029|P2|STARTED|Overall Study||31
166863|NCT00989014|402030|P1|STARTED|Overall Study||31
166864|NCT00988884|402042|P2|NOT COMPLETED|Overall Study||36
166865|NCT00988884|402043|P1|NOT COMPLETED|Overall Study||35
166866|NCT00988884|402042|P2|COMPLETED|Overall Study||584
166867|NCT00988884|402043|P1|COMPLETED|Overall Study||586
166868|NCT00988884|402042|P2|STARTED|Overall Study||620
166869|NCT00988884|402043|P1|STARTED|Overall Study||621
166870|NCT00988858|402065|P1|NOT COMPLETED|Overall Study||10
166871|NCT00988858|402065|P1|COMPLETED|Overall Study||45
166872|NCT00988858|402065|P1|STARTED|Overall Study||55
166873|NCT00988832|402077|P1|NOT COMPLETED|Overall Study||0
166874|NCT00988832|402077|P1|COMPLETED|Overall Study||380
166875|NCT00988832|402077|P1|STARTED|Overall Study||380
166876|NCT00988637|402114|P2|NOT COMPLETED|Overall Study||3
166877|NCT00988637|402115|P1|NOT COMPLETED|Overall Study||3
166878|NCT00988637|402114|P2|COMPLETED|Overall Study||65
166879|NCT00988637|402115|P1|COMPLETED|Overall Study||67
166880|NCT00988637|402114|P2|STARTED|Overall Study||68
166881|NCT00988637|402115|P1|STARTED|Overall Study||70
166882|NCT00988533|402145|P1|NOT COMPLETED|Overall Study||3
166883|NCT00988533|402145|P1|COMPLETED|Overall Study||27
166884|NCT00988533|402145|P1|STARTED|Overall Study||30
166885|NCT00988442|402159|P2|NOT COMPLETED|Overall Study||28
166886|NCT00988442|402160|P1|NOT COMPLETED|Overall Study||30
166887|NCT00988442|402159|P2|COMPLETED|Overall Study||1
166888|NCT00988442|402160|P1|COMPLETED|Overall Study||0
166889|NCT00988442|402159|P2|STARTED|Overall Study||29
166890|NCT00988442|402160|P1|STARTED|Overall Study||30
166891|NCT00988429|402223|P3|NOT COMPLETED|Overall Study||69
166892|NCT00988429|402224|P2|NOT COMPLETED|Overall Study||43
166893|NCT00988429|402225|P1|NOT COMPLETED|Overall Study||37
166894|NCT00988429|402223|P3|COMPLETED|Overall Study||142
166895|NCT00988429|402224|P2|COMPLETED|Overall Study||173
166896|NCT00988429|402225|P1|COMPLETED|Overall Study||189
166897|NCT00988429|402223|P3|Intention-to-treat (ITT) Population|Overall Study||205
166898|NCT00988429|402224|P2|Intention-to-treat (ITT) Population|Overall Study||215
166899|NCT00988429|402225|P1|Intention-to-treat (ITT) Population|Overall Study||220
166900|NCT00988429|402223|P3|Safety Population|Overall Study||210
166901|NCT00988429|402224|P2|Safety Population|Overall Study||216
166902|NCT00988429|402225|P1|Safety Population|Overall Study||224
166903|NCT00988429|402223|P3|STARTED|Overall Study||211
166904|NCT00988429|402224|P2|STARTED|Overall Study||216
166905|NCT00988429|402225|P1|STARTED|Overall Study||226
166906|NCT00988351|402238|P2|NOT COMPLETED|Overall Study||12
166907|NCT00988351|402239|P1|NOT COMPLETED|Overall Study||19
166908|NCT00988351|402238|P2|COMPLETED|Overall Study||66
166909|NCT00988351|402239|P1|COMPLETED|Overall Study||59
166910|NCT00988351|402238|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
166911|NCT00988351|402239|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
166912|NCT00988351|402238|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
166913|NCT00988351|402239|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
166914|NCT00988351|402238|P2|PAP Setup|Overall Study|APAP treatment started|78
166915|NCT00988351|402239|P1|PAP Setup|Overall Study|CPAP treatment started|70
166916|NCT00988351|402238|P2|CPAP Titration|Overall Study|no titration needed|78
166917|NCT00988351|402239|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
166918|NCT00988351|402238|P2|STARTED|Overall Study||78
166919|NCT00988351|402239|P1|STARTED|Overall Study||78
166920|NCT00988325|402256|P3|NOT COMPLETED|Overall Study||0
166921|NCT00988325|402257|P2|NOT COMPLETED|Overall Study||0
166922|NCT00988325|402258|P1|NOT COMPLETED|Overall Study||0
166923|NCT00988325|402256|P3|COMPLETED|Overall Study||5
166924|NCT00988325|402257|P2|COMPLETED|Overall Study||20
166925|NCT00988325|402258|P1|COMPLETED|Overall Study||40
166926|NCT00988325|402256|P3|STARTED|Overall Study||5
166927|NCT00988325|402257|P2|STARTED|Overall Study||20
166928|NCT00988325|402258|P1|STARTED|Overall Study||40
166929|NCT00988247|402316|P2|NOT COMPLETED|Overall Study||26
166930|NCT00988247|402317|P1|NOT COMPLETED|Overall Study||83
166931|NCT00988247|402316|P2|COMPLETED|Overall Study||85
166932|NCT00988247|402317|P1|COMPLETED|Overall Study||335
166933|NCT00988247|402316|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
166934|NCT00988247|402317|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
166935|NCT00988247|402316|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
166936|NCT00988247|402317|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
166937|NCT00988247|402316|P2|STARTED|Overall Study||111
166938|NCT00988247|402317|P1|STARTED|Overall Study||418
166939|NCT00988221|402336|P4|NOT COMPLETED|Part III||0
166940|NCT00988221|402337|P3|NOT COMPLETED|Part III||3
166941|NCT00988221|402338|P2|NOT COMPLETED|Part III||1
166942|NCT00988221|402339|P1|NOT COMPLETED|Part III||1
166943|NCT00988221|402336|P4|COMPLETED|Part III||0
166944|NCT00988221|402337|P3|COMPLETED|Part III||103
166945|NCT00988221|402338|P2|COMPLETED|Part III||23
166946|NCT00988221|402339|P1|COMPLETED|Part III||29
166947|NCT00988221|402336|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
166948|NCT00988221|402337|P3|STARTED|Part III||106
166949|NCT00988221|402338|P2|STARTED|Part III||24
166950|NCT00988221|402339|P1|STARTED|Part III||30
166951|NCT00988221|402336|P4|NOT COMPLETED|Part II||3
166952|NCT00988221|402337|P3|NOT COMPLETED|Part II||3
166953|NCT00988221|402338|P2|NOT COMPLETED|Part II||0
166954|NCT00988221|402339|P1|NOT COMPLETED|Part II||1
166955|NCT00988221|402336|P4|COMPLETED|Part II||81
166956|NCT00988221|402337|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
166957|NCT00988221|402338|P2|COMPLETED|Part II||11
166958|NCT00988221|402339|P1|COMPLETED|Part II||15
166959|NCT00988221|402336|P4|STARTED|Part II||84
166960|NCT00988221|402337|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
166961|NCT00988221|402338|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
166962|NCT00988221|402339|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
166963|NCT00988221|402336|P4|NOT COMPLETED|Part I||0
166964|NCT00988221|402337|P3|NOT COMPLETED|Part I||8
166965|NCT00988221|402338|P2|NOT COMPLETED|Part I||10
166966|NCT00988221|402339|P1|NOT COMPLETED|Part I||4
166967|NCT00988221|402336|P4|COMPLETED|Part I||0
166968|NCT00988221|402337|P3|COMPLETED|Part I||111
166969|NCT00988221|402338|P2|COMPLETED|Part I||24
166970|NCT00988221|402339|P1|COMPLETED|Part I||31
166971|NCT00988221|402336|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
166972|NCT00988221|402337|P3|STARTED|Part I||119
166973|NCT00988221|402338|P2|STARTED|Part I||34
166974|NCT00988221|402339|P1|STARTED|Part I||35
166975|NCT00988208|402512|P2|NOT COMPLETED|Overall Study||438
166976|NCT00988208|402513|P1|NOT COMPLETED|Overall Study||431
166977|NCT00988208|402512|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
166978|NCT00988208|402513|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
166979|NCT00988208|402512|P2|Treated|Overall Study||525
166980|NCT00988208|402513|P1|Treated|Overall Study||521
166981|NCT00988208|402512|P2|STARTED|Overall Study||533
166982|NCT00988208|402513|P1|STARTED|Overall Study||526
166983|NCT00988169|402531|P1|NOT COMPLETED|Overall Study||1
166984|NCT00988169|402531|P1|COMPLETED|Overall Study||5
166985|NCT00988169|402531|P1|STARTED|Overall Study||6
166986|NCT00988156|402537|P2|NOT COMPLETED|Overall Study||20
166987|NCT00988156|402538|P1|NOT COMPLETED|Overall Study||17
166988|NCT00988156|402537|P2|COMPLETED|Overall Study||135
166989|NCT00988156|402538|P1|COMPLETED|Overall Study||132
166990|NCT00988156|402537|P2|Safety Set|Overall Study||134
166991|NCT00988156|402538|P1|Safety Set|Overall Study||129
166992|NCT00988156|402537|P2|Per Protocol Set (PP)|Overall Study||97
166993|NCT00988156|402538|P1|Per Protocol Set (PP)|Overall Study||101
166994|NCT00988156|402537|P2|Intention-to-Treat Set (ITT)|Overall Study||134
166995|NCT00988156|402538|P1|Intention-to-Treat Set (ITT)|Overall Study||129
166996|NCT00988156|402537|P2|STARTED|Overall Study||155
166997|NCT00988156|402538|P1|STARTED|Overall Study||149
166998|NCT00988143|402549|P3|NOT COMPLETED|Overall Study||0
166999|NCT00988143|402550|P2|NOT COMPLETED|Overall Study||0
167000|NCT00988143|402551|P1|NOT COMPLETED|Overall Study||0
167001|NCT00988143|402549|P3|COMPLETED|Overall Study||190
167002|NCT00988143|402550|P2|COMPLETED|Overall Study||190
167003|NCT00988143|402551|P1|COMPLETED|Overall Study||220
167004|NCT00988143|402549|P3|STARTED|Overall Study||190
167005|NCT00988143|402550|P2|STARTED|Overall Study||190
167006|NCT00988143|402551|P1|STARTED|Overall Study||220
167007|NCT00988117|402583|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
167008|NCT00988117|402583|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
167009|NCT00988117|402583|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
167010|NCT00988117|402583|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
167011|NCT00988117|402583|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
167012|NCT00988117|402583|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
167013|NCT00988091|402592|P2|NOT COMPLETED|Open-label Period||33
167014|NCT00988091|402593|P1|NOT COMPLETED|Open-label Period||21
167015|NCT00988091|402592|P2|COMPLETED|Open-label Period||192
167016|NCT00988091|402593|P1|COMPLETED|Open-label Period||208
167017|NCT00988091|402592|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
167018|NCT00988091|402593|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
167019|NCT00988091|402592|P2|NOT COMPLETED|Double-blind Period||47
167020|NCT00988091|402593|P1|NOT COMPLETED|Double-blind Period||43
167021|NCT00988091|402592|P2|COMPLETED|Double-blind Period||251
167022|NCT00988091|402593|P1|COMPLETED|Double-blind Period||255
167023|NCT00988091|402592|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
167024|NCT00988091|402593|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
167025|NCT00988091|402592|P2|STARTED|Double-blind Period||298
167026|NCT00988091|402593|P1|STARTED|Double-blind Period||298
167027|NCT00988065|402615|P3|NOT COMPLETED|Overall Study||15
167028|NCT00988065|402616|P2|NOT COMPLETED|Overall Study||23
167029|NCT00988065|402617|P1|NOT COMPLETED|Overall Study||13
167030|NCT00988065|402615|P3|COMPLETED|Overall Study||135
167031|NCT00988065|402616|P2|COMPLETED|Overall Study||127
167032|NCT00988065|402617|P1|COMPLETED|Overall Study||135
167033|NCT00988065|402615|P3|Received Third Randomized Dose|Overall Study||135
167034|NCT00988065|402616|P2|Received Third Randomized Dose|Overall Study||127
167035|NCT00988065|402617|P1|Received Third Randomized Dose|Overall Study||135
167036|NCT00988065|402615|P3|Received Second Randomized Dose|Overall Study||145
167037|NCT00988065|402616|P2|Received Second Randomized Dose|Overall Study||135
167038|NCT00988065|402617|P1|Received Second Randomized Dose|Overall Study||139
167039|NCT00988065|402615|P3|Received First Randomized Dose|Overall Study||150
167040|NCT00988065|402616|P2|Received First Randomized Dose|Overall Study||150
167041|NCT00988065|402617|P1|Received First Randomized Dose|Overall Study||148
167042|NCT00988065|402615|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
167043|NCT00988065|402616|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
167044|NCT00988065|402617|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
167045|NCT00987948|402637|P1|NOT COMPLETED|Overall Study||3
167046|NCT00987948|402637|P1|COMPLETED|Overall Study||12
167047|NCT00987948|402637|P1|STARTED|Overall Study||15
167048|NCT00987935|402651|P9|NOT COMPLETED|Overall Study||32
167049|NCT00987935|402652|P8|NOT COMPLETED|Overall Study||62
167050|NCT00987935|402653|P7|NOT COMPLETED|Overall Study||15
167051|NCT00987935|402654|P6|NOT COMPLETED|Overall Study||3
167052|NCT00987935|402655|P5|NOT COMPLETED|Overall Study||7
167053|NCT00987935|402656|P4|NOT COMPLETED|Overall Study||3
167054|NCT00987935|402657|P3|NOT COMPLETED|Overall Study||3
167055|NCT00987935|402658|P2|NOT COMPLETED|Overall Study||3
167056|NCT00987935|402659|P1|NOT COMPLETED|Overall Study||4
167057|NCT00987935|402651|P9|COMPLETED|Overall Study||0
167058|NCT00987935|402652|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
167059|NCT00987935|402653|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
167060|NCT00987935|402654|P6|COMPLETED|Overall Study||0
167061|NCT00987935|402655|P5|COMPLETED|Overall Study||0
167062|NCT00987935|402656|P4|COMPLETED|Overall Study||0
167063|NCT00987935|402657|P3|COMPLETED|Overall Study||0
167064|NCT00987935|402658|P2|COMPLETED|Overall Study||0
167065|NCT00987935|402659|P1|COMPLETED|Overall Study||0
167066|NCT00987935|402651|P9|STARTED|Overall Study||32
167067|NCT00987935|402652|P8|STARTED|Overall Study||63
167068|NCT00987935|402653|P7|STARTED|Overall Study||16
167069|NCT00987935|402654|P6|STARTED|Overall Study||3
167070|NCT00987935|402655|P5|STARTED|Overall Study||7
167071|NCT00987935|402656|P4|STARTED|Overall Study||3
167072|NCT00987935|402657|P3|STARTED|Overall Study||3
167073|NCT00987935|402658|P2|STARTED|Overall Study||3
167074|NCT00987935|402659|P1|STARTED|Overall Study||4
167075|NCT00987831|402715|P3|NOT COMPLETED|Overall Study||0
167076|NCT00987831|402716|P2|NOT COMPLETED|Overall Study||3
167077|NCT00987831|402717|P1|NOT COMPLETED|Overall Study||1
167078|NCT00987831|402715|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
167079|NCT00987831|402716|P2|COMPLETED|Overall Study|all controls returned for two visits|52
167080|NCT00987831|402717|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
167081|NCT00987831|402715|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
167082|NCT00987831|402716|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
167083|NCT00987831|402717|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
167084|NCT00987727|402728|P2|NOT COMPLETED|Overall Study||7
167085|NCT00987727|402729|P1|NOT COMPLETED|Overall Study||5
167086|NCT00987727|402728|P2|COMPLETED|Overall Study||34
167087|NCT00987727|402729|P1|COMPLETED|Overall Study||36
167088|NCT00987727|402728|P2|STARTED|Overall Study||41
167089|NCT00987727|402729|P1|STARTED|Overall Study||41
167090|NCT00987623|402739|P2|NOT COMPLETED|Overall Study||3
167091|NCT00987623|402740|P1|NOT COMPLETED|Overall Study||5
167092|NCT00987623|402739|P2|COMPLETED|Overall Study||151
167093|NCT00987623|402740|P1|COMPLETED|Overall Study||140
167094|NCT00987623|402739|P2|STARTED|Overall Study||154
167095|NCT00987623|402740|P1|STARTED|Overall Study||145
167096|NCT00987558|402746|P2|NOT COMPLETED|Overall Study||5
167097|NCT00987558|402747|P1|NOT COMPLETED|Overall Study||1
167098|NCT00987558|402746|P2|COMPLETED|Overall Study||12
167099|NCT00987558|402747|P1|COMPLETED|Overall Study||12
167100|NCT00987558|402746|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
167101|NCT00987558|402747|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
167102|NCT00987558|402746|P2|Washout|Overall Study||12
167103|NCT00987558|402747|P1|Washout|Overall Study||13
167104|NCT00987558|402746|P2|Simvastatin|Overall Study||12
167105|NCT00987558|402747|P1|Simvastatin|Overall Study||13
167106|NCT00987558|402746|P2|STARTED|Overall Study||17
167107|NCT00987558|402747|P1|STARTED|Overall Study||13
167108|NCT00987467|402760|P1|NOT COMPLETED|Overall Study||2
167109|NCT00987467|402760|P1|COMPLETED|Overall Study||10
167110|NCT00987467|402760|P1|STARTED|Overall Study||12
167111|NCT00987415|402767|P2|NOT COMPLETED|Overall Study||9
167112|NCT00987415|402768|P1|NOT COMPLETED|Overall Study||9
167113|NCT00987415|402767|P2|COMPLETED|Overall Study||116
167114|NCT00987415|402768|P1|COMPLETED|Overall Study||119
167115|NCT00987415|402767|P2|STARTED|Overall Study||125
167116|NCT00987415|402768|P1|STARTED|Overall Study||128
167117|NCT00987402|402784|P2|NOT COMPLETED|Overall Study||98
167118|NCT00987402|402785|P1|NOT COMPLETED|Overall Study||86
167119|NCT00987402|402784|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
167120|NCT00987402|402785|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
167121|NCT00987402|402784|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
167122|NCT00987402|402785|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
167123|NCT00987337|402794|P3|NOT COMPLETED|Overall Study||51
167124|NCT00987337|402795|P2|NOT COMPLETED|Overall Study||55
167125|NCT00987337|402796|P1|NOT COMPLETED|Overall Study||57
167126|NCT00987337|402794|P3|COMPLETED|Overall Study||45
167127|NCT00987337|402795|P2|COMPLETED|Overall Study||41
167128|NCT00987337|402796|P1|COMPLETED|Overall Study||39
167129|NCT00987337|402794|P3|STARTED|Overall Study||96
167130|NCT00987337|402795|P2|STARTED|Overall Study||96
167131|NCT00987337|402796|P1|STARTED|Overall Study||96
167132|NCT00986999|402840|P1|NOT COMPLETED|Overall Study||1
167133|NCT00986999|402840|P1|COMPLETED|Overall Study||6
167134|NCT00986999|402840|P1|STARTED|Overall Study||7
167135|NCT00986986|402851|P2|NOT COMPLETED|Overall Study||1
167136|NCT00986986|402852|P1|NOT COMPLETED|Overall Study||0
167137|NCT00986986|402851|P2|COMPLETED|Overall Study||9
167138|NCT00986986|402852|P1|COMPLETED|Overall Study||10
167139|NCT00986986|402851|P2|STARTED|Overall Study||10
167140|NCT00986986|402852|P1|STARTED|Overall Study||10
167141|NCT00986973|402862|P1|NOT COMPLETED|Overall Study||1
167142|NCT00986973|402862|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
167143|NCT00986973|402862|P1|STARTED|Overall Study||6
167144|NCT00986960|402874|P2|NOT COMPLETED|Overall Study||0
167145|NCT00986960|402875|P1|NOT COMPLETED|Overall Study||0
167146|NCT00986960|402874|P2|COMPLETED|Overall Study||0
167147|NCT00986960|402875|P1|COMPLETED|Overall Study||0
167148|NCT00986960|402874|P2|STARTED|Overall Study||0
167149|NCT00986960|402875|P1|STARTED|Overall Study||0
167150|NCT00986947|402881|P1|NOT COMPLETED|Overall Study||20
167151|NCT00986947|402881|P1|COMPLETED|Overall Study||0
167152|NCT00986947|402881|P1|STARTED|Overall Study||20
167153|NCT00986921|402888|P2|NOT COMPLETED|Overall Study||0
167154|NCT00986921|402889|P1|NOT COMPLETED|Overall Study||1
167155|NCT00986921|402888|P2|COMPLETED|Overall Study||25
167156|NCT00986921|402889|P1|COMPLETED|Overall Study||24
167157|NCT00986921|402888|P2|STARTED|Overall Study||25
167158|NCT00986921|402889|P1|STARTED|Overall Study||25
167159|NCT00986856|402901|P2|NOT COMPLETED|Overall Study||0
167160|NCT00986856|402902|P1|NOT COMPLETED|Overall Study||0
167161|NCT00986856|402901|P2|COMPLETED|Overall Study||16
167162|NCT00986856|402902|P1|COMPLETED|Overall Study||42
167163|NCT00986856|402901|P2|STARTED|Overall Study||16
167164|NCT00986856|402902|P1|STARTED|Overall Study||42
167165|NCT00986674|402925|P3|NOT COMPLETED|Overall Study||48
167166|NCT00986674|402926|P2|NOT COMPLETED|Overall Study||45
167167|NCT00986674|402927|P1|NOT COMPLETED|Overall Study||47
167168|NCT00986674|402925|P3|COMPLETED|Overall Study||0
167169|NCT00986674|402926|P2|COMPLETED|Overall Study||0
167170|NCT00986674|402927|P1|COMPLETED|Overall Study||0
167171|NCT00986674|402925|P3|Eligible and Treated|Overall Study||47
167172|NCT00986674|402926|P2|Eligible and Treated|Overall Study||41
167173|NCT00986674|402927|P1|Eligible and Treated|Overall Study||39
167174|NCT00986674|402925|P3|Treated|Overall Study||47
167175|NCT00986674|402926|P2|Treated|Overall Study||42
167176|NCT00986674|402927|P1|Treated|Overall Study||43
167177|NCT00986674|402925|P3|STARTED|Overall Study||48
167178|NCT00986674|402926|P2|STARTED|Overall Study||45
167179|NCT00986674|402927|P1|STARTED|Overall Study||47
167180|NCT00986583|402943|P2|NOT COMPLETED|Overall Study||0
167181|NCT00986583|402944|P1|NOT COMPLETED|Overall Study||0
167182|NCT00986583|402943|P2|COMPLETED|Overall Study||32
167183|NCT00986583|402944|P1|COMPLETED|Overall Study||38
167184|NCT00986583|402943|P2|STARTED|Overall Study||32
167185|NCT00986583|402944|P1|STARTED|Overall Study||38
167186|NCT00986570|402960|P1|NOT COMPLETED|Overall Study||7
167187|NCT00986570|402960|P1|COMPLETED|Overall Study||114
167188|NCT00986570|402960|P1|STARTED|Overall Study||121
167189|NCT00986544|402966|P2|NOT COMPLETED|Overall Study||0
167190|NCT00986544|402967|P1|NOT COMPLETED|Overall Study||0
167191|NCT00986544|402966|P2|COMPLETED|Overall Study||53
167192|NCT00986544|402967|P1|COMPLETED|Overall Study||53
167193|NCT00986544|402966|P2|STARTED|Overall Study||53
167194|NCT00986544|402967|P1|STARTED|Overall Study||53
167195|NCT00986479|402977|P2|NOT COMPLETED|Period 2||0
167196|NCT00986479|402978|P1|NOT COMPLETED|Period 2||0
167197|NCT00986479|402977|P2|COMPLETED|Period 2||10
167198|NCT00986479|402978|P1|COMPLETED|Period 2||10
167199|NCT00986479|402977|P2|STARTED|Period 2||10
167200|NCT00986479|402978|P1|STARTED|Period 2||10
167201|NCT00986479|402977|P2|NOT COMPLETED|Period 1||0
167202|NCT00986479|402978|P1|NOT COMPLETED|Period 1||2
167203|NCT00986479|402977|P2|COMPLETED|Period 1||10
167204|NCT00986479|402978|P1|COMPLETED|Period 1||10
167205|NCT00986479|402977|P2|STARTED|Period 1||10
167206|NCT00986479|402978|P1|STARTED|Period 1||12
167207|NCT00986453|403008|P1|NOT COMPLETED|Overall Study||2
167208|NCT00986453|403008|P1|COMPLETED|Overall Study||43
167209|NCT00986453|403008|P1|STARTED|Overall Study||45
167210|NCT00986427|403024|P2|NOT COMPLETED|Overall Study||0
167211|NCT00986427|403025|P1|NOT COMPLETED|Overall Study||4
167212|NCT00986427|403024|P2|COMPLETED|Overall Study||12
167213|NCT00986427|403025|P1|COMPLETED|Overall Study||8
167214|NCT00986427|403024|P2|STARTED|Overall Study||12
167215|NCT00986427|403025|P1|STARTED|Overall Study||12
167216|NCT00986401|403041|P2|NOT COMPLETED|Period 2||0
167217|NCT00986401|403042|P1|NOT COMPLETED|Period 2||0
167218|NCT00986401|403041|P2|COMPLETED|Period 2||21
167219|NCT00986401|403042|P1|COMPLETED|Period 2||22
167220|NCT00986401|403041|P2|STARTED|Period 2||21
167221|NCT00986401|403042|P1|STARTED|Period 2||22
167222|NCT00986401|403041|P2|NOT COMPLETED|Period 1||1
167223|NCT00986401|403042|P1|NOT COMPLETED|Period 1||0
167224|NCT00986401|403041|P2|COMPLETED|Period 1||21
167225|NCT00986401|403042|P1|COMPLETED|Period 1||22
167226|NCT00986401|403041|P2|STARTED|Period 1||22
167227|NCT00986401|403042|P1|STARTED|Period 1||22
167228|NCT00986362|403053|P2|NOT COMPLETED|Overall Study||1
167229|NCT00986362|403054|P1|NOT COMPLETED|Overall Study||2
167230|NCT00986362|403053|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
167231|NCT00986362|403054|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
167232|NCT00986362|403053|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
167233|NCT00986362|403054|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
167234|NCT00986349|403060|P1|NOT COMPLETED|Overall Study||7
167235|NCT00986349|403060|P1|COMPLETED|Overall Study||16
167236|NCT00986349|403060|P1|Early Explant|Overall Study||4
167237|NCT00986349|403060|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
167238|NCT00986349|403060|P1|STARTED|Overall Study|attempted implant procedures|23
167239|NCT00986258|403073|P1|NOT COMPLETED|Maintenance Period||9
167240|NCT00986258|403073|P1|COMPLETED|Maintenance Period||93
167241|NCT00986258|403073|P1|STARTED|Maintenance Period||102
167242|NCT00986258|403073|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
167243|NCT00986258|403073|P1|COMPLETED|Titration and Optimal Dose Period||102
167244|NCT00986258|403073|P1|STARTED|Titration and Optimal Dose Period||125
167245|NCT00986258|403073|P1|NOT COMPLETED|Observation Period||11
167246|NCT00986258|403073|P1|COMPLETED|Observation Period||125
167247|NCT00986258|403073|P1|STARTED|Observation Period||136
167248|NCT00986245|403101|P2|NOT COMPLETED|Second Intervention||1
167249|NCT00986245|403102|P1|NOT COMPLETED|Second Intervention||2
167250|NCT00986245|403101|P2|COMPLETED|Second Intervention||32
167251|NCT00986245|403102|P1|COMPLETED|Second Intervention||29
167252|NCT00986245|403101|P2|STARTED|Second Intervention||33
167253|NCT00986245|403102|P1|STARTED|Second Intervention||31
167254|NCT00986245|403101|P2|NOT COMPLETED|First Intervention||8
167255|NCT00986245|403102|P1|NOT COMPLETED|First Intervention||10
167256|NCT00986245|403101|P2|COMPLETED|First Intervention||33
167257|NCT00986245|403102|P1|COMPLETED|First Intervention||31
167258|NCT00986245|403101|P2|STARTED|First Intervention||41
167259|NCT00986245|403102|P1|STARTED|First Intervention||41
167260|NCT00986232|403139|P4|NOT COMPLETED|Overall Study||20
167261|NCT00986232|403140|P3|NOT COMPLETED|Overall Study||35
167262|NCT00986232|403141|P2|NOT COMPLETED|Overall Study||50
167263|NCT00986232|403142|P1|NOT COMPLETED|Overall Study||51
167264|NCT00986232|403139|P4|COMPLETED|Overall Study||370
167265|NCT00986232|403140|P3|COMPLETED|Overall Study||346
167266|NCT00986232|403141|P2|COMPLETED|Overall Study||343
167267|NCT00986232|403142|P1|COMPLETED|Overall Study||336
167268|NCT00986232|403139|P4|Vaccination Visit 2|Overall Study||0
167269|NCT00986232|403140|P3|Vaccination Visit 2|Overall Study||360
167270|NCT00986232|403141|P2|Vaccination Visit 2|Overall Study||365
167271|NCT00986232|403142|P1|Vaccination Visit 2|Overall Study||360
167272|NCT00986232|403139|P4|Vaccination Visit 1|Overall Study||390
167273|NCT00986232|403140|P3|Vaccination Visit 1|Overall Study||381
167274|NCT00986232|403141|P2|Vaccination Visit 1|Overall Study||393
167275|NCT00986232|403142|P1|Vaccination Visit 1|Overall Study||387
167276|NCT00986232|403139|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
167277|NCT00986232|403140|P3|STARTED|Overall Study||381
167278|NCT00986232|403141|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
167279|NCT00986232|403142|P1|STARTED|Overall Study||387
167280|NCT00986180|403216|P2|NOT COMPLETED|Overall Study||56
167281|NCT00986180|403217|P1|NOT COMPLETED|Overall Study||44
167282|NCT00986180|403216|P2|COMPLETED|Overall Study||268
167283|NCT00986180|403217|P1|COMPLETED|Overall Study||277
167284|NCT00986180|403216|P2|STARTED|Overall Study||324
167285|NCT00986180|403217|P1|STARTED|Overall Study||321
167286|NCT00986154|403295|P2|NOT COMPLETED|Overall Study||194
167287|NCT00986154|403296|P1|NOT COMPLETED|Overall Study||206
167288|NCT00986154|403295|P2|COMPLETED|Overall Study||3955
167289|NCT00986154|403296|P1|COMPLETED|Overall Study||3937
167290|NCT00986154|403295|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
167291|NCT00986154|403296|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
167292|NCT00986154|403295|P2|STARTED|Overall Study||4149
167293|NCT00986154|403296|P1|STARTED|Overall Study||4143
167294|NCT00986102|403310|P4|NOT COMPLETED|Overall Study||1
167295|NCT00986102|403311|P3|NOT COMPLETED|Overall Study||0
167296|NCT00986102|403312|P2|NOT COMPLETED|Overall Study||2
167297|NCT00986102|403313|P1|NOT COMPLETED|Overall Study||1
167298|NCT00986102|403310|P4|COMPLETED|Overall Study||66
167299|NCT00986102|403311|P3|COMPLETED|Overall Study||19
167300|NCT00986102|403312|P2|COMPLETED|Overall Study||75
167301|NCT00986102|403313|P1|COMPLETED|Overall Study||52
167302|NCT00986102|403310|P4|STARTED|Overall Study|Number of participants who received study medication|67
167303|NCT00986102|403311|P3|STARTED|Overall Study|Number of participants who received study medication|19
167304|NCT00986102|403312|P2|STARTED|Overall Study|Number of participants who received study medication|77
167305|NCT00986102|403313|P1|STARTED|Overall Study|Number of participants who received study medication|53
167306|NCT00985985|403363|P4|NOT COMPLETED|Overall Study||13
167307|NCT00985985|403364|P3|NOT COMPLETED|Overall Study||11
167308|NCT00985985|403365|P2|NOT COMPLETED|Overall Study||24
167309|NCT00985985|403366|P1|NOT COMPLETED|Overall Study||24
167310|NCT00985985|403363|P4|COMPLETED|Overall Study||107
167311|NCT00985985|403364|P3|COMPLETED|Overall Study||109
167312|NCT00985985|403365|P2|COMPLETED|Overall Study||218
167313|NCT00985985|403366|P1|COMPLETED|Overall Study||217
167314|NCT00985985|403363|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
167315|NCT00985985|403364|P3|Full Analysis Set (FAS) Population|Overall Study||120
167316|NCT00985985|403365|P2|Full Analysis Set (FAS) Population|Overall Study||242
167317|NCT00985985|403366|P1|Full Analysis Set (FAS) Population|Overall Study||241
167318|NCT00985985|403363|P4|Safety Population|Overall Study||118
167319|NCT00985985|403364|P3|Safety Population|Overall Study||119
167320|NCT00985985|403365|P2|Safety Population|Overall Study||242
167321|NCT00985985|403366|P1|Safety Population|Overall Study||241
167322|NCT00985985|403363|P4|STARTED|Overall Study||120
167323|NCT00985985|403364|P3|STARTED|Overall Study||120
167324|NCT00985985|403365|P2|STARTED|Overall Study||242
167325|NCT00985985|403366|P1|STARTED|Overall Study||241
167326|NCT00985959|403407|P3|NOT COMPLETED|Overall Study||59
167327|NCT00985959|403408|P2|NOT COMPLETED|Overall Study||3
167328|NCT00985959|403409|P1|NOT COMPLETED|Overall Study||3
167329|NCT00985959|403407|P3|COMPLETED|Overall Study||28
167330|NCT00985959|403408|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
167331|NCT00985959|403409|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
167332|NCT00985959|403407|P3|STARTED|Overall Study|Number of participants treated|87
167333|NCT00985959|403408|P2|STARTED|Overall Study|Number of participants treated|6
167334|NCT00985959|403409|P1|STARTED|Overall Study|Number of participants treated|6
167335|NCT00985946|403432|P1|NOT COMPLETED|Overall Study||7
167336|NCT00985946|403432|P1|COMPLETED|Overall Study||8
167337|NCT00985946|403432|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
167338|NCT00985829|403440|P1|NOT COMPLETED|Overall Study||0
167339|NCT00985829|403440|P1|COMPLETED|Overall Study||28
167340|NCT00985829|403440|P1|STARTED|Overall Study||28
167341|NCT00985790|403451|P2|NOT COMPLETED|Overall Study||8
167342|NCT00985790|403452|P1|NOT COMPLETED|Overall Study||7
167343|NCT00985790|403451|P2|COMPLETED|Overall Study||293
167344|NCT00985790|403452|P1|COMPLETED|Overall Study||291
167345|NCT00985790|403451|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
167346|NCT00985790|403452|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
167347|NCT00985751|403493|P5|NOT COMPLETED|Overall Study||1
167348|NCT00985751|403494|P4|NOT COMPLETED|Overall Study||0
167349|NCT00985751|403495|P3|NOT COMPLETED|Overall Study||0
167350|NCT00985751|403496|P2|NOT COMPLETED|Overall Study||0
167351|NCT00985751|403497|P1|NOT COMPLETED|Overall Study||0
167352|NCT00985751|403493|P5|COMPLETED|Overall Study||50
167353|NCT00985751|403494|P4|COMPLETED|Overall Study||51
167354|NCT00985751|403495|P3|COMPLETED|Overall Study||52
167355|NCT00985751|403496|P2|COMPLETED|Overall Study||52
167356|NCT00985751|403497|P1|COMPLETED|Overall Study||51
167357|NCT00985751|403493|P5|STARTED|Overall Study||51
167358|NCT00985751|403494|P4|STARTED|Overall Study||51
167359|NCT00985751|403495|P3|STARTED|Overall Study||52
167360|NCT00985751|403496|P2|STARTED|Overall Study||52
167361|NCT00985751|403497|P1|STARTED|Overall Study||51
167362|NCT00985738|403560|P2|NOT COMPLETED|Overall Study||8
167363|NCT00985738|403561|P1|NOT COMPLETED|Overall Study||8
167364|NCT00985738|403560|P2|COMPLETED|Overall Study||0
167365|NCT00985738|403561|P1|COMPLETED|Overall Study||0
167366|NCT00985738|403560|P2|STARTED|Overall Study||8
167367|NCT00985738|403561|P1|STARTED|Overall Study||8
167368|NCT00985725|403569|P2|NOT COMPLETED|Overall Study||13
167369|NCT00985725|403570|P1|NOT COMPLETED|Overall Study||11
167370|NCT00985725|403569|P2|COMPLETED|Overall Study||59
167371|NCT00985725|403570|P1|COMPLETED|Overall Study||60
167372|NCT00985725|403569|P2|STARTED|Overall Study||72
167373|NCT00985725|403570|P1|STARTED|Overall Study||71
167374|NCT00985712|403606|P2|NOT COMPLETED|Overall Study||7
167375|NCT00985712|403607|P1|NOT COMPLETED|Overall Study||6
167376|NCT00985712|403606|P2|COMPLETED|Overall Study||123
167377|NCT00985712|403607|P1|COMPLETED|Overall Study||127
167378|NCT00985712|403606|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
167379|NCT00985712|403607|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
167380|NCT00985712|403606|P2|Received at Least One Dose of Study Drug|Overall Study||130
167381|NCT00985712|403607|P1|Received at Least One Dose of Study Drug|Overall Study||131
167382|NCT00985712|403606|P2|STARTED|Overall Study||130
167383|NCT00985712|403607|P1|STARTED|Overall Study||133
167384|NCT00985686|403625|P4|NOT COMPLETED|Overall Study||2
167385|NCT00985686|403626|P3|NOT COMPLETED|Overall Study||0
167386|NCT00985686|403627|P2|NOT COMPLETED|Overall Study||1
167387|NCT00985686|403628|P1|NOT COMPLETED|Overall Study||1
167388|NCT00985686|403625|P4|COMPLETED|Overall Study||14
167389|NCT00985686|403626|P3|COMPLETED|Overall Study||13
167390|NCT00985686|403627|P2|COMPLETED|Overall Study||15
167391|NCT00985686|403628|P1|COMPLETED|Overall Study||17
167392|NCT00985686|403625|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
167393|NCT00985686|403626|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
167394|NCT00985686|403627|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
167395|NCT00985686|403628|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
167396|NCT00985686|403625|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
167397|NCT00985686|403626|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
167398|NCT00985686|403627|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
167399|NCT00985686|403628|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
167400|NCT00985686|403625|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
167401|NCT00985686|403626|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
167402|NCT00985686|403627|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
167403|NCT00985686|403628|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
167404|NCT00985686|403625|P4|Visit 1: Baseline Data Collection|Overall Study||16
167405|NCT00985686|403626|P3|Visit 1: Baseline Data Collection|Overall Study||13
167406|NCT00985686|403627|P2|Visit 1: Baseline Data Collection|Overall Study||15
167407|NCT00985686|403628|P1|Visit 1: Baseline Data Collection|Overall Study||18
167408|NCT00985686|403625|P4|STARTED|Overall Study||16
167409|NCT00985686|403626|P3|STARTED|Overall Study||13
167410|NCT00985686|403627|P2|STARTED|Overall Study||16
167411|NCT00985686|403628|P1|STARTED|Overall Study||18
167412|NCT00985673|403642|P6|NOT COMPLETED|Overall Study||6
167413|NCT00985673|403643|P5|NOT COMPLETED|Overall Study||8
167414|NCT00985673|403644|P4|NOT COMPLETED|Overall Study||12
167415|NCT00985673|403645|P3|NOT COMPLETED|Overall Study||12
167416|NCT00985673|403646|P2|NOT COMPLETED|Overall Study||11
167417|NCT00985673|403647|P1|NOT COMPLETED|Overall Study||7
167418|NCT00985673|403642|P6|COMPLETED|Overall Study||96
167419|NCT00985673|403643|P5|COMPLETED|Overall Study||93
167420|NCT00985673|403644|P4|COMPLETED|Overall Study||88
167421|NCT00985673|403645|P3|COMPLETED|Overall Study||90
167422|NCT00985673|403646|P2|COMPLETED|Overall Study||93
167423|NCT00985673|403647|P1|COMPLETED|Overall Study||95
167424|NCT00985673|403642|P6|STARTED|Overall Study||102
167425|NCT00985673|403643|P5|STARTED|Overall Study||101
167426|NCT00985673|403644|P4|STARTED|Overall Study||100
167427|NCT00985673|403645|P3|STARTED|Overall Study||102
167428|NCT00985673|403646|P2|STARTED|Overall Study||104
167429|NCT00985673|403647|P1|STARTED|Overall Study||102
167430|NCT00985543|403898|P1|NOT COMPLETED|Overall Study||0
167431|NCT00985543|403898|P1|COMPLETED|Overall Study||22
167432|NCT00985543|403898|P1|STARTED|Overall Study||22
167433|NCT00985504|403909|P2|NOT COMPLETED|Optimization Period||23
167434|NCT00985504|403910|P1|NOT COMPLETED|Optimization Period||26
167435|NCT00985504|403909|P2|COMPLETED|Optimization Period||204
167436|NCT00985504|403910|P1|COMPLETED|Optimization Period||203
167437|NCT00985504|403909|P2|STARTED|Optimization Period||227
167438|NCT00985504|403910|P1|STARTED|Optimization Period||229
167439|NCT00985504|403909|P2|NOT COMPLETED|Acute Treatment Period||12
167440|NCT00985504|403910|P1|NOT COMPLETED|Acute Treatment Period||15
167441|NCT00985504|403909|P2|COMPLETED|Acute Treatment Period||227
167442|NCT00985504|403910|P1|COMPLETED|Acute Treatment Period||229
167443|NCT00985504|403909|P2|STARTED|Acute Treatment Period||239
167444|NCT00985504|403910|P1|STARTED|Acute Treatment Period||244
167445|NCT00985491|403936|P1|NOT COMPLETED|Overall Study||19
167446|NCT00985491|403936|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
167447|NCT00985491|403936|P1|Received Device|Overall Study||43
167448|NCT00985491|403936|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
167449|NCT00985439|403945|P4|NOT COMPLETED|Overall Study||0
167450|NCT00985439|403946|P3|NOT COMPLETED|Overall Study||1
167451|NCT00985439|403947|P2|NOT COMPLETED|Overall Study||0
167452|NCT00985439|403948|P1|NOT COMPLETED|Overall Study||0
167453|NCT00985439|403945|P4|COMPLETED|Overall Study||51
167454|NCT00985439|403946|P3|COMPLETED|Overall Study||50
167455|NCT00985439|403947|P2|COMPLETED|Overall Study||51
167456|NCT00985439|403948|P1|COMPLETED|Overall Study||49
167457|NCT00985439|403945|P4|STARTED|Overall Study||51
167458|NCT00985439|403946|P3|STARTED|Overall Study||51
167459|NCT00985439|403947|P2|STARTED|Overall Study||51
167460|NCT00985439|403948|P1|STARTED|Overall Study||49
167461|NCT00985257|403958|P1|NOT COMPLETED|Overall Study||0
167462|NCT00985257|403958|P1|COMPLETED|Overall Study||123
167463|NCT00985257|403958|P1|STARTED|Overall Study||123
167464|NCT00985231|403964|P2|NOT COMPLETED|Overall Study||3
167465|NCT00985231|403965|P1|NOT COMPLETED|Overall Study||3
167466|NCT00985231|403964|P2|COMPLETED|Overall Study||129
167467|NCT00985231|403965|P1|COMPLETED|Overall Study||130
167468|NCT00985231|403964|P2|STARTED|Overall Study||132
167469|NCT00985231|403965|P1|STARTED|Overall Study||133
167470|NCT00985192|403973|P1|NOT COMPLETED|Overall Study||4
167471|NCT00985192|403973|P1|COMPLETED|Overall Study||45
167472|NCT00985192|403973|P1|STARTED|Overall Study||49
167473|NCT00985166|403985|P3|NOT COMPLETED|Overall Study||7
167474|NCT00985166|403986|P2|NOT COMPLETED|Overall Study||4
167475|NCT00985166|403987|P1|NOT COMPLETED|Overall Study||9
167476|NCT00985166|403985|P3|COMPLETED|Overall Study||188
167477|NCT00985166|403986|P2|COMPLETED|Overall Study||201
167478|NCT00985166|403987|P1|COMPLETED|Overall Study||392
167479|NCT00985166|403985|P3|Vaccinated at Visit 1|Overall Study||195
167480|NCT00985166|403986|P2|Vaccinated at Visit 1|Overall Study||205
167481|NCT00985166|403987|P1|Vaccinated at Visit 1|Overall Study||399
167482|NCT00985166|403985|P3|STARTED|Overall Study||195
167483|NCT00985166|403986|P2|STARTED|Overall Study||205
167484|NCT00985166|403987|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
167485|NCT00985153|404007|P4|NOT COMPLETED|Overall Study||47
167486|NCT00985153|404008|P3|NOT COMPLETED|Overall Study||44
167487|NCT00985153|404009|P2|NOT COMPLETED|Overall Study||44
167488|NCT00985153|404010|P1|NOT COMPLETED|Overall Study||35
167489|NCT00985153|404007|P4|COMPLETED|Overall Study||965
167490|NCT00985153|404008|P3|COMPLETED|Overall Study||918
167491|NCT00985153|404009|P2|COMPLETED|Overall Study||924
167492|NCT00985153|404010|P1|COMPLETED|Overall Study||950
167493|NCT00985153|404007|P4|Vaccinated at Visit 1|Overall Study||1012
167494|NCT00985153|404008|P3|Vaccinated at Visit 1|Overall Study||962
167495|NCT00985153|404009|P2|Vaccinated at Visit 1|Overall Study||968
167496|NCT00985153|404010|P1|Vaccinated at Visit 1|Overall Study||985
167497|NCT00985153|404007|P4|STARTED|Overall Study||1012
167498|NCT00985153|404008|P3|STARTED|Overall Study||962
167499|NCT00985153|404009|P2|STARTED|Overall Study||968
167500|NCT00985153|404010|P1|STARTED|Overall Study||985
167501|NCT00985140|404052|P1|NOT COMPLETED|Overall Study||0
167502|NCT00985140|404052|P1|COMPLETED|Overall Study||15
167503|NCT00985140|404052|P1|STARTED|Overall Study||15
167504|NCT00985114|404058|P2|NOT COMPLETED|Overall Study||2
167505|NCT00985114|404059|P1|NOT COMPLETED|Overall Study||1
167506|NCT00985114|404058|P2|COMPLETED|Overall Study||37
167507|NCT00985114|404059|P1|COMPLETED|Overall Study||33
167595|NCT00984568|404476|P2|COMPLETED|Overall Study||7
167508|NCT00985114|404058|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
167509|NCT00985114|404059|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
167510|NCT00985114|404058|P2|STARTED|Overall Study||39
167511|NCT00985114|404059|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
167512|NCT00985088|404073|P8|NOT COMPLETED|Overall Study||6
167513|NCT00985088|404074|P7|NOT COMPLETED|Overall Study||4
167514|NCT00985088|404075|P6|NOT COMPLETED|Overall Study||7
167515|NCT00985088|404076|P5|NOT COMPLETED|Overall Study||9
167516|NCT00985088|404077|P4|NOT COMPLETED|Overall Study||7
167517|NCT00985088|404078|P3|NOT COMPLETED|Overall Study||4
167518|NCT00985088|404079|P2|NOT COMPLETED|Overall Study||2
167519|NCT00985088|404080|P1|NOT COMPLETED|Overall Study||11
167520|NCT00985088|404073|P8|COMPLETED|Overall Study||216
167521|NCT00985088|404074|P7|COMPLETED|Overall Study||107
167522|NCT00985088|404075|P6|COMPLETED|Overall Study||108
167523|NCT00985088|404076|P5|COMPLETED|Overall Study||214
167524|NCT00985088|404077|P4|COMPLETED|Overall Study||214
167525|NCT00985088|404078|P3|COMPLETED|Overall Study||108
167526|NCT00985088|404079|P2|COMPLETED|Overall Study||112
167527|NCT00985088|404080|P1|COMPLETED|Overall Study||211
167528|NCT00985088|404073|P8|STARTED|Overall Study||222
167529|NCT00985088|404074|P7|STARTED|Overall Study||111
167530|NCT00985088|404075|P6|STARTED|Overall Study||115
167531|NCT00985088|404076|P5|STARTED|Overall Study||223
167532|NCT00985088|404077|P4|STARTED|Overall Study||221
167533|NCT00985088|404078|P3|STARTED|Overall Study||112
167534|NCT00985088|404079|P2|STARTED|Overall Study||114
167535|NCT00985088|404080|P1|STARTED|Overall Study||222
167536|NCT00985010|404338|P2|NOT COMPLETED|Overall Study||0
167537|NCT00985010|404339|P1|NOT COMPLETED|Overall Study||0
167538|NCT00985010|404338|P2|COMPLETED|Overall Study||5
167539|NCT00985010|404339|P1|COMPLETED|Overall Study||4
167540|NCT00985010|404338|P2|STARTED|Overall Study||5
167541|NCT00985010|404339|P1|STARTED|Overall Study||4
167542|NCT00984867|404349|P2|NOT COMPLETED|Overall Study||17
167543|NCT00984867|404350|P1|NOT COMPLETED|Overall Study||23
167544|NCT00984867|404349|P2|COMPLETED|Overall Study||208
167545|NCT00984867|404350|P1|COMPLETED|Overall Study||203
167546|NCT00984867|404349|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
167547|NCT00984867|404350|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
167548|NCT00984815|404368|P1|NOT COMPLETED|Overall Study||30
167549|NCT00984815|404368|P1|COMPLETED|Overall Study||56
167550|NCT00984815|404368|P1|STARTED|Overall Study||86
167551|NCT00984698|404377|P2|NOT COMPLETED|Overall Study||8
167552|NCT00984698|404378|P1|NOT COMPLETED|Overall Study||3
167553|NCT00984698|404377|P2|COMPLETED|Overall Study||14
167554|NCT00984698|404378|P1|COMPLETED|Overall Study||18
167555|NCT00984698|404377|P2|STARTED|Overall Study||22
167556|NCT00984698|404378|P1|STARTED|Overall Study||21
167557|NCT00984659|404390|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
167558|NCT00984659|404391|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
167559|NCT00984659|404392|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
167560|NCT00984659|404393|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
167561|NCT00984659|404390|P4|COMPLETED|6-week Double-blind Treatment Period||126
167562|NCT00984659|404391|P3|COMPLETED|6-week Double-blind Treatment Period||141
167563|NCT00984659|404392|P2|COMPLETED|6-week Double-blind Treatment Period||69
167564|NCT00984659|404393|P1|COMPLETED|6-week Double-blind Treatment Period||0
167565|NCT00984659|404390|P4|STARTED|6-week Double-blind Treatment Period||139
167566|NCT00984659|404391|P3|STARTED|6-week Double-blind Treatment Period||152
167567|NCT00984659|404392|P2|STARTED|6-week Double-blind Treatment Period||75
167568|NCT00984659|404393|P1|STARTED|6-week Double-blind Treatment Period||0
167569|NCT00984659|404390|P4|NOT COMPLETED|2-week Run-in Period||0
167570|NCT00984659|404391|P3|NOT COMPLETED|2-week Run-in Period||0
167571|NCT00984659|404392|P2|NOT COMPLETED|2-week Run-in Period||0
167572|NCT00984659|404393|P1|NOT COMPLETED|2-week Run-in Period||52
167573|NCT00984659|404390|P4|COMPLETED|2-week Run-in Period||0
167574|NCT00984659|404391|P3|COMPLETED|2-week Run-in Period||0
167575|NCT00984659|404392|P2|COMPLETED|2-week Run-in Period||0
167576|NCT00984659|404393|P1|COMPLETED|2-week Run-in Period||366
167577|NCT00984659|404390|P4|STARTED|2-week Run-in Period||0
167578|NCT00984659|404391|P3|STARTED|2-week Run-in Period||0
167579|NCT00984659|404392|P2|STARTED|2-week Run-in Period||0
167580|NCT00984659|404393|P1|STARTED|2-week Run-in Period||418
167581|NCT00984620|404420|P2|NOT COMPLETED|Overall Study||12
167582|NCT00984620|404421|P1|NOT COMPLETED|Overall Study||6
167583|NCT00984620|404420|P2|COMPLETED|Overall Study||67
167584|NCT00984620|404421|P1|COMPLETED|Overall Study||75
167585|NCT00984620|404420|P2|STARTED|Overall Study||79
167586|NCT00984620|404421|P1|STARTED|Overall Study||81
167587|NCT00984594|404459|P2|NOT COMPLETED|Overall Study||1
167588|NCT00984594|404460|P1|NOT COMPLETED|Overall Study||1
167589|NCT00984594|404459|P2|COMPLETED|Overall Study||1
167590|NCT00984594|404460|P1|COMPLETED|Overall Study||1
167591|NCT00984594|404459|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
167592|NCT00984594|404460|P1|STARTED|Overall Study||2
167593|NCT00984568|404476|P2|NOT COMPLETED|Overall Study||6
167594|NCT00984568|404477|P1|NOT COMPLETED|Overall Study||8
167596|NCT00984568|404477|P1|COMPLETED|Overall Study||7
167597|NCT00984568|404476|P2|STARTED|Overall Study||13
167598|NCT00984568|404477|P1|STARTED|Overall Study||15
167599|NCT00984542|404485|P1|NOT COMPLETED|Overall Study||41
167600|NCT00984542|404485|P1|COMPLETED|Overall Study||9
167601|NCT00984542|404485|P1|STARTED|Overall Study||50
167602|NCT00984490|404493|P1|NOT COMPLETED|Overall Study||0
167603|NCT00984490|404493|P1|COMPLETED|Overall Study||5
167604|NCT00984490|404493|P1|STARTED|Overall Study||5
167605|NCT00984334|404503|P5|NOT COMPLETED|Overall Study||1
167606|NCT00984334|404504|P4|NOT COMPLETED|Overall Study||1
167607|NCT00984334|404505|P3|NOT COMPLETED|Overall Study||0
167608|NCT00984334|404506|P2|NOT COMPLETED|Overall Study||1
167609|NCT00984334|404507|P1|NOT COMPLETED|Overall Study||1
167610|NCT00984334|404503|P5|COMPLETED|Overall Study||7
167611|NCT00984334|404504|P4|COMPLETED|Overall Study||7
167612|NCT00984334|404505|P3|COMPLETED|Overall Study||8
167613|NCT00984334|404506|P2|COMPLETED|Overall Study||7
167614|NCT00984334|404507|P1|COMPLETED|Overall Study||7
167615|NCT00984334|404503|P5|STARTED|Overall Study||8
167616|NCT00984334|404504|P4|STARTED|Overall Study||8
167617|NCT00984334|404505|P3|STARTED|Overall Study||8
167618|NCT00984334|404506|P2|STARTED|Overall Study||8
167619|NCT00984334|404507|P1|STARTED|Overall Study||8
167620|NCT00984308|404521|P2|NOT COMPLETED|Overall Study||6
167621|NCT00984308|404522|P1|NOT COMPLETED|Overall Study||18
167622|NCT00984308|404521|P2|COMPLETED|Overall Study||109
167623|NCT00984308|404522|P1|COMPLETED|Overall Study||92
167624|NCT00984308|404521|P2|STARTED|Overall Study||115
167625|NCT00984308|404522|P1|STARTED|Overall Study||110
167626|NCT00984295|404535|P3|NOT COMPLETED|Overall Study||37
167627|NCT00984295|404536|P2|NOT COMPLETED|Overall Study||32
167628|NCT00984295|404537|P1|NOT COMPLETED|Overall Study||65
167629|NCT00984295|404535|P3|COMPLETED|Overall Study||442
167630|NCT00984295|404536|P2|COMPLETED|Overall Study||453
167631|NCT00984295|404537|P1|COMPLETED|Overall Study||884
167632|NCT00984295|404535|P3|Visit 2|Overall Study||453
167633|NCT00984295|404536|P2|Visit 2|Overall Study||468
167634|NCT00984295|404537|P1|Visit 2|Overall Study||909
167635|NCT00984295|404535|P3|Visit 1|Overall Study||479
167636|NCT00984295|404536|P2|Visit 1|Overall Study||485
167637|NCT00984295|404537|P1|Visit 1|Overall Study||949
167638|NCT00984295|404535|P3|STARTED|Overall Study||479
167639|NCT00984295|404536|P2|STARTED|Overall Study||485
167640|NCT00984295|404537|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
167641|NCT00984282|404604|P2|NOT COMPLETED|Long Term Follow-up||117
167642|NCT00984282|404605|P1|NOT COMPLETED|Long Term Follow-up||114
167643|NCT00984282|404604|P2|COMPLETED|Long Term Follow-up||0
167644|NCT00984282|404605|P1|COMPLETED|Long Term Follow-up||0
167645|NCT00984282|404604|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|117
167646|NCT00984282|404605|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|114
167647|NCT00984282|404604|P2|NOT COMPLETED|Open-label Treatment||161
167648|NCT00984282|404605|P1|NOT COMPLETED|Open-label Treatment||86
167649|NCT00984282|404604|P2|COMPLETED|Open-label Treatment||0
167650|NCT00984282|404605|P1|COMPLETED|Open-label Treatment||0
167651|NCT00984282|404604|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
167652|NCT00984282|404605|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
167653|NCT00984282|404604|P2|STARTED|Open-label Treatment||161
167654|NCT00984282|404605|P1|STARTED|Open-label Treatment||86
167655|NCT00984282|404604|P2|NOT COMPLETED|Double Blind Treatment||38
167656|NCT00984282|404605|P1|NOT COMPLETED|Double Blind Treatment||104
167657|NCT00984282|404604|P2|COMPLETED|Double Blind Treatment||172
167658|NCT00984282|404605|P1|COMPLETED|Double Blind Treatment||103
167659|NCT00984282|404604|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
167660|NCT00984282|404605|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
167661|NCT00984282|404604|P2|STARTED|Double Blind Treatment||210
167662|NCT00984282|404605|P1|STARTED|Double Blind Treatment||207
167663|NCT00984256|404628|P2|NOT COMPLETED|Overall Study||1
167664|NCT00984256|404629|P1|NOT COMPLETED|Overall Study||0
167665|NCT00984256|404628|P2|COMPLETED|Overall Study||29
167666|NCT00984256|404629|P1|COMPLETED|Overall Study||6
167667|NCT00984256|404628|P2|STARTED|Overall Study||30
167668|NCT00984256|404629|P1|STARTED|Overall Study||6
167669|NCT00984204|404649|P1|NOT COMPLETED|Overall Study||15
167670|NCT00984204|404649|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
167671|NCT00984204|404649|P1|STARTED|Overall Study||188
167672|NCT00984165|404659|P4|NOT COMPLETED|Overall Study||4
167673|NCT00984165|404660|P3|NOT COMPLETED|Overall Study||0
167674|NCT00984165|404661|P2|NOT COMPLETED|Overall Study||1
167675|NCT00984165|404662|P1|NOT COMPLETED|Overall Study||7
167676|NCT00984165|404659|P4|COMPLETED|Overall Study||0
167677|NCT00984165|404660|P3|COMPLETED|Overall Study||4
167678|NCT00984165|404661|P2|COMPLETED|Overall Study||0
167679|NCT00984165|404662|P1|COMPLETED|Overall Study||2
167680|NCT00984165|404659|P4|STARTED|Overall Study||4
167681|NCT00984165|404660|P3|STARTED|Overall Study||4
167682|NCT00984165|404661|P2|STARTED|Overall Study||1
167683|NCT00984165|404662|P1|STARTED|Overall Study||9
167684|NCT00984139|404675|P1|NOT COMPLETED|Overall Study||0
167685|NCT00984139|404675|P1|COMPLETED|Overall Study||306
167686|NCT00984139|404675|P1|STARTED|Overall Study||306
167687|NCT00984126|404691|P4|NOT COMPLETED|Overall Study||59
167688|NCT00984126|404692|P3|NOT COMPLETED|Overall Study||7
167689|NCT00984126|404693|P2|NOT COMPLETED|Overall Study||8
167690|NCT00984126|404694|P1|NOT COMPLETED|Overall Study||7
167691|NCT00984126|404691|P4|COMPLETED|Overall Study||76
167692|NCT00984126|404692|P3|COMPLETED|Overall Study||16
167693|NCT00984126|404693|P2|COMPLETED|Overall Study||20
167694|NCT00984126|404694|P1|COMPLETED|Overall Study||20
167695|NCT00984126|404691|P4|STARTED|Overall Study||135
167696|NCT00984126|404692|P3|STARTED|Overall Study||23
167697|NCT00984126|404693|P2|STARTED|Overall Study||28
167698|NCT00984126|404694|P1|STARTED|Overall Study||27
167699|NCT00984061|404719|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
167700|NCT00984061|404719|P1|COMPLETED|Colchicine With Clarithromycin||23
167701|NCT00984061|404719|P1|STARTED|Colchicine With Clarithromycin||23
167702|NCT00984061|404719|P1|NOT COMPLETED|Clarithromycin Alone||1
167703|NCT00984061|404719|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
167704|NCT00984061|404719|P1|STARTED|Clarithromycin Alone||24
167705|NCT00984061|404719|P1|NOT COMPLETED|21 Day Washout Period||0
167706|NCT00984061|404719|P1|COMPLETED|21 Day Washout Period||24
167707|NCT00984061|404719|P1|STARTED|21 Day Washout Period||24
167708|NCT00984061|404719|P1|NOT COMPLETED|Colchicine Alone||0
167709|NCT00984061|404719|P1|COMPLETED|Colchicine Alone||24
167710|NCT00984061|404719|P1|STARTED|Colchicine Alone||24
167711|NCT00984022|404732|P2|NOT COMPLETED|Overall Study||14
167712|NCT00984022|404733|P1|NOT COMPLETED|Overall Study||10
167713|NCT00984022|404732|P2|COMPLETED|Overall Study||35
167714|NCT00984022|404733|P1|COMPLETED|Overall Study||33
167715|NCT00984022|404732|P2|STARTED|Overall Study||49
167716|NCT00984022|404733|P1|STARTED|Overall Study||43
167717|NCT00984009|404743|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
167718|NCT00984009|404743|P1|COMPLETED|Colchicine With Grapefruit Juice||21
167719|NCT00984009|404743|P1|STARTED|Colchicine With Grapefruit Juice||21
167720|NCT00984009|404743|P1|NOT COMPLETED|Grapefruit Juice Alone||1
167721|NCT00984009|404743|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
167722|NCT00984009|404743|P1|STARTED|Grapefruit Juice Alone||22
167723|NCT00984009|404743|P1|NOT COMPLETED|14 Day Washout Period||0
167724|NCT00984009|404743|P1|COMPLETED|14 Day Washout Period||22
167725|NCT00984009|404743|P1|STARTED|14 Day Washout Period||22
167726|NCT00984009|404743|P1|NOT COMPLETED|Colchicine Alone||0
167727|NCT00984009|404743|P1|COMPLETED|Colchicine Alone||22
167728|NCT00984009|404743|P1|STARTED|Colchicine Alone||22
167729|NCT00983983|404757|P3|NOT COMPLETED|Overall Study||1
167730|NCT00983983|404758|P2|NOT COMPLETED|Overall Study||1
167731|NCT00983983|404759|P1|NOT COMPLETED|Overall Study||2
167732|NCT00983983|404757|P3|COMPLETED|Overall Study||6
167733|NCT00983983|404758|P2|COMPLETED|Overall Study||8
167734|NCT00983983|404759|P1|COMPLETED|Overall Study||6
167735|NCT00983983|404757|P3|STARTED|Overall Study||7
167736|NCT00983983|404758|P2|STARTED|Overall Study||9
167737|NCT00983983|404759|P1|STARTED|Overall Study||8
167738|NCT00983957|404776|P1|NOT COMPLETED|Overall Study||2
167739|NCT00983957|404776|P1|COMPLETED|Overall Study||18
167740|NCT00983957|404776|P1|Treatment C|Overall Study||18
167741|NCT00983957|404776|P1|Treatment B|Overall Study||20
167742|NCT00983957|404776|P1|Treatment A|Overall Study||20
167743|NCT00983957|404776|P1|STARTED|Overall Study||20
167744|NCT00983931|404810|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
167745|NCT00983931|404810|P1|COMPLETED|Colchicine With Cyclosporine||23
167746|NCT00983931|404810|P1|STARTED|Colchicine With Cyclosporine||23
167747|NCT00983931|404810|P1|NOT COMPLETED|14 Day Washout Period||1
167748|NCT00983931|404810|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
167749|NCT00983931|404810|P1|STARTED|14 Day Washout Period||24
167750|NCT00983931|404810|P1|NOT COMPLETED|Colchicine Alone||0
167751|NCT00983931|404810|P1|COMPLETED|Colchicine Alone||24
167752|NCT00983931|404810|P1|STARTED|Colchicine Alone||24
167753|NCT00983918|404824|P4|NOT COMPLETED|Overall Study||2
167754|NCT00983918|404825|P3|NOT COMPLETED|Overall Study||2
167755|NCT00983918|404826|P2|NOT COMPLETED|Overall Study||2
167756|NCT00983918|404827|P1|NOT COMPLETED|Overall Study||0
167757|NCT00983918|404824|P4|COMPLETED|Overall Study||18
167758|NCT00983918|404825|P3|COMPLETED|Overall Study||18
167759|NCT00983918|404826|P2|COMPLETED|Overall Study||18
167760|NCT00983918|404827|P1|COMPLETED|Overall Study||20
167761|NCT00983918|404824|P4|STARTED|Overall Study||20
167762|NCT00983918|404825|P3|STARTED|Overall Study||20
167763|NCT00983918|404826|P2|STARTED|Overall Study||20
167764|NCT00983918|404827|P1|STARTED|Overall Study||20
167765|NCT00983905|404837|P1|NOT COMPLETED|Theophylline With Colchicine||0
167766|NCT00983905|404837|P1|COMPLETED|Theophylline With Colchicine||27
167767|NCT00983905|404837|P1|STARTED|Theophylline With Colchicine||27
167768|NCT00983905|404837|P1|NOT COMPLETED|Colchicine Alone||2
167769|NCT00983905|404837|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
167770|NCT00983905|404837|P1|STARTED|Colchicine Alone||29
167771|NCT00983905|404837|P1|NOT COMPLETED|4 Day Washout Period||0
167772|NCT00983905|404837|P1|COMPLETED|4 Day Washout Period||29
167773|NCT00983905|404837|P1|STARTED|4 Day Washout Period||29
167774|NCT00983905|404837|P1|NOT COMPLETED|Theophylline Alone||1
167775|NCT00983905|404837|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
167776|NCT00983905|404837|P1|STARTED|Theophylline Alone||30
167777|NCT00983892|404850|P2|NOT COMPLETED|Overall Study||12
167778|NCT00983892|404851|P1|NOT COMPLETED|Overall Study||10
167779|NCT00983892|404850|P2|COMPLETED|Overall Study||56
167780|NCT00983892|404851|P1|COMPLETED|Overall Study||56
167781|NCT00983892|404850|P2|STARTED|Overall Study||68
167782|NCT00983892|404851|P1|STARTED|Overall Study||66
167783|NCT00983853|404863|P6|NOT COMPLETED|Overall Study||1
167784|NCT00983853|404864|P5|NOT COMPLETED|Overall Study||3
167785|NCT00983853|404865|P4|NOT COMPLETED|Overall Study||2
167786|NCT00983853|404866|P3|NOT COMPLETED|Overall Study||3
167787|NCT00983853|404867|P2|NOT COMPLETED|Overall Study||2
167788|NCT00983853|404868|P1|NOT COMPLETED|Overall Study||1
167789|NCT00983853|404863|P6|COMPLETED|Overall Study||7
167790|NCT00983853|404864|P5|COMPLETED|Overall Study||12
167791|NCT00983853|404865|P4|COMPLETED|Overall Study||6
167792|NCT00983853|404866|P3|COMPLETED|Overall Study||14
167793|NCT00983853|404867|P2|COMPLETED|Overall Study||5
167794|NCT00983853|404868|P1|COMPLETED|Overall Study||6
167795|NCT00983853|404863|P6|STARTED|Overall Study||8
167796|NCT00983853|404864|P5|STARTED|Overall Study||15
167797|NCT00983853|404865|P4|STARTED|Overall Study||8
167798|NCT00983853|404866|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
167799|NCT00983853|404867|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
167800|NCT00983853|404868|P1|STARTED|Overall Study||7
167801|NCT00983827|404896|P1|NOT COMPLETED|Overall Study||1
167802|NCT00983827|404896|P1|COMPLETED|Overall Study||7
167803|NCT00983827|404896|P1|STARTED|Overall Study||8
167804|NCT00983801|404900|P1|NOT COMPLETED|Overall Study||0
167805|NCT00983801|404900|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
167806|NCT00983801|404900|P1|STARTED|Overall Study|Participants who received treatment.|52
167807|NCT00983749|404914|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
167808|NCT00983749|404915|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
167809|NCT00983749|404914|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
167810|NCT00983749|404915|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
167811|NCT00983749|404914|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
167812|NCT00983749|404915|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
167813|NCT00983749|404914|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
167814|NCT00983749|404915|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
167815|NCT00983749|404914|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
167816|NCT00983749|404915|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
167817|NCT00983749|404914|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
167818|NCT00983749|404915|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
167819|NCT00983645|404925|P2|NOT COMPLETED|Overall Study||0
167820|NCT00983645|404926|P1|NOT COMPLETED|Overall Study||0
167821|NCT00983645|404925|P2|COMPLETED|Overall Study||7
167822|NCT00983645|404926|P1|COMPLETED|Overall Study||8
167823|NCT00983645|404925|P2|STARTED|Overall Study||7
167824|NCT00983645|404926|P1|STARTED|Overall Study||8
167825|NCT00983580|404940|P2|NOT COMPLETED|Overall Study||4
167826|NCT00983580|404941|P1|NOT COMPLETED|Overall Study||5
167827|NCT00983580|404940|P2|COMPLETED|Overall Study||49
167828|NCT00983580|404941|P1|COMPLETED|Overall Study||49
167829|NCT00983580|404940|P2|STARTED|Overall Study||53
167830|NCT00983580|404941|P1|STARTED|Overall Study||54
167831|NCT00983541|404957|P1|NOT COMPLETED|Overall Study||0
167832|NCT00983541|404957|P1|COMPLETED|Overall Study||1
167833|NCT00983541|404957|P1|STARTED|Overall Study||1
167834|NCT00983515|404967|P1|NOT COMPLETED|Colchicine With Ritonavir||1
167835|NCT00983515|404967|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
167836|NCT00983515|404967|P1|STARTED|Colchicine With Ritonavir||18
167837|NCT00983515|404967|P1|NOT COMPLETED|Ritonavir Alone||6
167838|NCT00983515|404967|P1|COMPLETED|Ritonavir Alone||18
167839|NCT00983515|404967|P1|STARTED|Ritonavir Alone||24
167840|NCT00983515|404967|P1|NOT COMPLETED|14 Day Washout Period||0
167841|NCT00983515|404967|P1|COMPLETED|14 Day Washout Period||24
167842|NCT00983515|404967|P1|STARTED|14 Day Washout Period||24
167843|NCT00983515|404967|P1|NOT COMPLETED|Colchicine Alone||0
167844|NCT00983515|404967|P1|COMPLETED|Colchicine Alone||24
167845|NCT00983515|404967|P1|STARTED|Colchicine Alone||24
167846|NCT00983489|404981|P3|NOT COMPLETED|Overall Study||312
167847|NCT00983489|404982|P2|NOT COMPLETED|Overall Study||285
167848|NCT00983489|404983|P1|NOT COMPLETED|Overall Study||185
167849|NCT00983489|404981|P3|COMPLETED|Overall Study||135
167850|NCT00983489|404982|P2|COMPLETED|Overall Study||168
167851|NCT00983489|404983|P1|COMPLETED|Overall Study||326
167852|NCT00983489|404981|P3|STARTED|Overall Study||447
167853|NCT00983489|404982|P2|STARTED|Overall Study||453
167854|NCT00983489|404983|P1|STARTED|Overall Study||511
167855|NCT00983476|404994|P3|NOT COMPLETED|Overall Study||0
167856|NCT00983476|404995|P2|NOT COMPLETED|Overall Study||22
167857|NCT00983476|404996|P1|NOT COMPLETED|Overall Study||17
167858|NCT00983476|404994|P3|COMPLETED|Overall Study||88
167859|NCT00983476|404995|P2|COMPLETED|Overall Study||71
167860|NCT00983476|404996|P1|COMPLETED|Overall Study||78
167861|NCT00983476|404994|P3|6 Month Follow up Assessment|Overall Study||74
167862|NCT00983476|404995|P2|6 Month Follow up Assessment|Overall Study||62
167863|NCT00983476|404996|P1|6 Month Follow up Assessment|Overall Study||71
167864|NCT00983476|404994|P3|STARTED|Overall Study||88
167865|NCT00983476|404995|P2|STARTED|Overall Study||93
167866|NCT00983476|404996|P1|STARTED|Overall Study||95
167867|NCT00983437|405028|P1|NOT COMPLETED|Overall Study||47
167868|NCT00983437|405028|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
167869|NCT00983437|405028|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
167870|NCT00983437|405028|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
167871|NCT00983437|405028|P1|STARTED|Overall Study||47
167872|NCT00983385|405047|P1|NOT COMPLETED|Maintenance Period||23
167873|NCT00983385|405047|P1|COMPLETED|Maintenance Period||117
167874|NCT00983385|405047|P1|STARTED|Maintenance Period||140
167875|NCT00983385|405047|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
167876|NCT00983385|405047|P1|COMPLETED|Titration and Optimal Dose Period||140
167877|NCT00983385|405047|P1|STARTED|Titration and Optimal Dose Period||176
167878|NCT00983385|405047|P1|NOT COMPLETED|Observation Period||32
167879|NCT00983385|405047|P1|COMPLETED|Observation Period||176
167880|NCT00983385|405047|P1|STARTED|Observation Period||208
167881|NCT00983372|405092|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
167882|NCT00983372|405092|P1|COMPLETED|Colchicine With Diltiazem ER||20
167883|NCT00983372|405092|P1|STARTED|Colchicine With Diltiazem ER||20
167884|NCT00983372|405092|P1|NOT COMPLETED|Diltiazem ER Alone||3
167885|NCT00983372|405092|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
167886|NCT00983372|405092|P1|STARTED|Diltiazem ER Alone||23
167887|NCT00983372|405092|P1|NOT COMPLETED|14 Day Washout Period||1
167888|NCT00983372|405092|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
167889|NCT00983372|405092|P1|STARTED|14 Day Washout Period||24
167890|NCT00983372|405092|P1|NOT COMPLETED|Colchicine Alone||0
167891|NCT00983372|405092|P1|COMPLETED|Colchicine Alone||24
167892|NCT00983372|405092|P1|STARTED|Colchicine Alone||24
167893|NCT00983359|405103|P1|NOT COMPLETED|Overall Study||1
167894|NCT00983359|405103|P1|COMPLETED|Overall Study||39
167895|NCT00983359|405103|P1|Not Eligible for Analysis|Overall Study||1
167896|NCT00983359|405103|P1|STARTED|Overall Study||40
167897|NCT00983346|405111|P1|NOT COMPLETED|Overall Study||0
167898|NCT00983346|405111|P1|COMPLETED|Overall Study||17
167899|NCT00983346|405111|P1|STARTED|Overall Study||17
167900|NCT00983307|405115|P1|NOT COMPLETED|Overall Study||0
167901|NCT00983307|405115|P1|COMPLETED|Overall Study||17
167902|NCT00983307|405115|P1|STARTED|Overall Study||17
167903|NCT00983294|405119|P1|NOT COMPLETED|Colchicine With Azithromycin||1
167904|NCT00983294|405119|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
167905|NCT00983294|405119|P1|STARTED|Colchicine With Azithromycin||22
167906|NCT00983294|405119|P1|NOT COMPLETED|Azithromycin Alone||0
167907|NCT00983294|405119|P1|COMPLETED|Azithromycin Alone||22
167908|NCT00983294|405119|P1|STARTED|Azithromycin Alone||22
167909|NCT00983294|405119|P1|NOT COMPLETED|14 Day Washout Period||2
167910|NCT00983294|405119|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
167911|NCT00983294|405119|P1|STARTED|14 Day Washout Period||24
167912|NCT00983294|405119|P1|NOT COMPLETED|Colchicine Alone||0
167913|NCT00983294|405119|P1|COMPLETED|Colchicine Alone||24
167914|NCT00983294|405119|P1|STARTED|Colchicine Alone||24
167915|NCT00983281|405132|P2|NOT COMPLETED|Overall Study||0
167916|NCT00983281|405133|P1|NOT COMPLETED|Overall Study||0
167917|NCT00983281|405132|P2|COMPLETED|Overall Study||909
167918|NCT00983281|405133|P1|COMPLETED|Overall Study||805
167919|NCT00983281|405132|P2|STARTED|Overall Study||909
167920|NCT00983281|405133|P1|STARTED|Overall Study||805
167921|NCT00983242|405139|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
167922|NCT00983242|405139|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
167923|NCT00983242|405139|P1|STARTED|Colchicine With Verapamil HCl ER||24
167924|NCT00983242|405139|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
167925|NCT00983242|405139|P1|COMPLETED|Verapamil HCl ER Alone||24
167926|NCT00983242|405139|P1|STARTED|Verapamil HCl ER Alone||24
167927|NCT00983242|405139|P1|NOT COMPLETED|14 Day Washout Period||0
167928|NCT00983242|405139|P1|COMPLETED|14 Day Washout Period||24
167929|NCT00983242|405139|P1|STARTED|14 Day Washout Period||24
167930|NCT00983242|405139|P1|NOT COMPLETED|Colchicine Alone||0
167931|NCT00983242|405139|P1|COMPLETED|Colchicine Alone||24
167932|NCT00983242|405139|P1|STARTED|Colchicine Alone||24
167933|NCT00983216|405150|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
167934|NCT00983216|405150|P1|COMPLETED|Colchicine With Ketoconazole||24
167935|NCT00983216|405150|P1|STARTED|Colchicine With Ketoconazole||24
167936|NCT00983216|405150|P1|NOT COMPLETED|Ketoconazole Alone||0
167937|NCT00983216|405150|P1|COMPLETED|Ketoconazole Alone||24
167938|NCT00983216|405150|P1|STARTED|Ketoconazole Alone||24
167939|NCT00983216|405150|P1|NOT COMPLETED|14 Day Washout Period||0
167940|NCT00983216|405150|P1|COMPLETED|14 Day Washout Period||24
167941|NCT00983216|405150|P1|STARTED|14 Day Washout Period||24
167942|NCT00983216|405150|P1|NOT COMPLETED|Colchicine Alone||0
167943|NCT00983216|405150|P1|COMPLETED|Colchicine Alone||24
167944|NCT00983216|405150|P1|STARTED|Colchicine Alone||24
167945|NCT00983073|405161|P1|NOT COMPLETED|Maintenance Period||16
167946|NCT00983073|405161|P1|COMPLETED|Maintenance Period||144
167947|NCT00983073|405161|P1|STARTED|Maintenance Period||160
167948|NCT00983073|405161|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
167949|NCT00983073|405161|P1|COMPLETED|Titration and Optimal Dose Period||160
167950|NCT00983073|405161|P1|STARTED|Titration and Optimal Dose Period||200
167951|NCT00983073|405161|P1|NOT COMPLETED|Observation Period||24
167952|NCT00983073|405161|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
167953|NCT00983073|405161|P1|STARTED|Observation Period||224
167954|NCT00982995|405182|P1|NOT COMPLETED|Overall Study||0
167955|NCT00982995|405182|P1|COMPLETED|Overall Study||3
167956|NCT00982995|405182|P1|STARTED|Overall Study||3
167957|NCT00982735|405187|P1|NOT COMPLETED|Overall Study||230
167958|NCT00982735|405187|P1|COMPLETED|Overall Study||757
167959|NCT00982735|405187|P1|STARTED|Overall Study||987
167960|NCT00982657|405197|P4|NOT COMPLETED|Overall Study||9
167961|NCT00982657|405198|P3|NOT COMPLETED|Overall Study||2
167962|NCT00982657|405199|P2|NOT COMPLETED|Overall Study||0
167963|NCT00982657|405200|P1|NOT COMPLETED|Overall Study||1
167964|NCT00982657|405197|P4|COMPLETED|Overall Study||7
167965|NCT00982657|405198|P3|COMPLETED|Overall Study||1
167966|NCT00982657|405199|P2|COMPLETED|Overall Study||3
167967|NCT00982657|405200|P1|COMPLETED|Overall Study||11
167968|NCT00982657|405197|P4|STARTED|Overall Study||16
167969|NCT00982657|405198|P3|STARTED|Overall Study||3
167970|NCT00982657|405199|P2|STARTED|Overall Study||3
167971|NCT00982657|405200|P1|STARTED|Overall Study||12
167972|NCT00982644|405241|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
167973|NCT00982644|405242|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
167974|NCT00982644|405241|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
167975|NCT00982644|405242|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
167976|NCT00982644|405241|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
167977|NCT00982644|405242|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
167978|NCT00982644|405241|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
167979|NCT00982644|405242|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
167980|NCT00982644|405241|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
167981|NCT00982644|405242|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
167982|NCT00982644|405241|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
167983|NCT00982644|405242|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
167984|NCT00982644|405241|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
167985|NCT00982644|405242|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
167986|NCT00982644|405241|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
167987|NCT00982644|405242|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
167988|NCT00982592|405266|P2|NOT COMPLETED|Overall Study||33
167989|NCT00982592|405267|P1|NOT COMPLETED|Overall Study||31
167990|NCT00982592|405266|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
167991|NCT00982592|405267|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
167992|NCT00982592|405266|P2|Treatment Received|Overall Study||52
167993|NCT00982592|405267|P1|Treatment Received|Overall Study||63
167994|NCT00982592|405266|P2|STARTED|Overall Study||60
167995|NCT00982592|405267|P1|STARTED|Overall Study||64
167996|NCT00982553|405281|P1|NOT COMPLETED|Overall Study||0
167997|NCT00982553|405281|P1|COMPLETED|Overall Study||14
167998|NCT00982553|405281|P1|STARTED|Overall Study||14
167999|NCT00982488|405293|P5|NOT COMPLETED|Overall Study||1
168000|NCT00982488|405294|P4|NOT COMPLETED|Overall Study||3
168001|NCT00982488|405295|P3|NOT COMPLETED|Overall Study||34
168002|NCT00982488|405296|P2|NOT COMPLETED|Overall Study||14
168003|NCT00982488|405297|P1|NOT COMPLETED|Overall Study||185
168004|NCT00982488|405293|P5|COMPLETED|Overall Study|Still receiving treatment|0
168005|NCT00982488|405294|P4|COMPLETED|Overall Study|Still receiving treatment|0
168006|NCT00982488|405295|P3|COMPLETED|Overall Study|Still receiving treatment|0
168007|NCT00982488|405296|P2|COMPLETED|Overall Study|Still receiving treatment|0
168008|NCT00982488|405297|P1|COMPLETED|Overall Study|Still receiving treatment|0
168009|NCT00982488|405293|P5|STARTED|Overall Study|Received treatment|1
168010|NCT00982488|405294|P4|STARTED|Overall Study|Received treatment|3
168011|NCT00982488|405295|P3|STARTED|Overall Study|Received treatment|34
168012|NCT00982488|405296|P2|STARTED|Overall Study|Received treatment|14
168013|NCT00982488|405297|P1|STARTED|Overall Study|Received treatment|185
168014|NCT00982423|405311|P2|NOT COMPLETED|Overall Study||0
168015|NCT00982423|405312|P1|NOT COMPLETED|Overall Study||0
168016|NCT00982423|405311|P2|COMPLETED|Overall Study||19
168017|NCT00982423|405312|P1|COMPLETED|Overall Study||13
168018|NCT00982423|405311|P2|STARTED|Overall Study||19
168019|NCT00982423|405312|P1|STARTED|Overall Study||13
168020|NCT00982410|405330|P2|NOT COMPLETED|12-month Follow-up Assessment||9
168021|NCT00982410|405331|P1|NOT COMPLETED|12-month Follow-up Assessment||9
168022|NCT00982410|405330|P2|COMPLETED|12-month Follow-up Assessment||55
168023|NCT00982410|405331|P1|COMPLETED|12-month Follow-up Assessment||56
168024|NCT00982410|405330|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
168025|NCT00982410|405331|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
168026|NCT00982410|405330|P2|NOT COMPLETED|6-month Follow-up Assessment||11
168027|NCT00982410|405331|P1|NOT COMPLETED|6-month Follow-up Assessment||6
168028|NCT00982410|405330|P2|COMPLETED|6-month Follow-up Assessment||53
168029|NCT00982410|405331|P1|COMPLETED|6-month Follow-up Assessment||59
168030|NCT00982410|405330|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
168031|NCT00982410|405331|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
168032|NCT00982410|405330|P2|NOT COMPLETED|3-month Follow-up Assessment||13
168033|NCT00982410|405331|P1|NOT COMPLETED|3-month Follow-up Assessment||9
168034|NCT00982410|405330|P2|COMPLETED|3-month Follow-up Assessment||53
168035|NCT00982410|405331|P1|COMPLETED|3-month Follow-up Assessment||56
168036|NCT00982410|405330|P2|STARTED|3-month Follow-up Assessment||66
168037|NCT00982410|405331|P1|STARTED|3-month Follow-up Assessment||65
168038|NCT00982397|405355|P2|NOT COMPLETED|Phase II/Overall Study||0
168039|NCT00982397|405356|P1|NOT COMPLETED|Phase II/Overall Study||0
168040|NCT00982397|405355|P2|COMPLETED|Phase II/Overall Study||751
168041|NCT00982397|405356|P1|COMPLETED|Phase II/Overall Study||2019
168042|NCT00982397|405355|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
168043|NCT00982397|405356|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
168044|NCT00982397|405355|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
168045|NCT00982397|405356|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
168046|NCT00982397|405355|P2|STARTED|Phase II/Overall Study||751
168047|NCT00982397|405356|P1|STARTED|Phase II/Overall Study||2019
168048|NCT00982397|405355|P2|NOT COMPLETED|Phase I||0
168049|NCT00982397|405356|P1|NOT COMPLETED|Phase I||0
168050|NCT00982397|405355|P2|COMPLETED|Phase I||0
168051|NCT00982397|405356|P1|COMPLETED|Phase I||236
168052|NCT00982397|405355|P2|STARTED|Phase I||0
168053|NCT00982397|405356|P1|STARTED|Phase I||236
168054|NCT00982345|405366|P1|NOT COMPLETED|Overall Study||2
168055|NCT00982345|405366|P1|COMPLETED|Overall Study||18
168056|NCT00982345|405366|P1|STARTED|Overall Study||20
168057|NCT00982280|405370|P1|NOT COMPLETED|Maintenance Period||1
168058|NCT00982280|405370|P1|COMPLETED|Maintenance Period||54
168059|NCT00982280|405370|P1|STARTED|Maintenance Period||55
168060|NCT00982280|405370|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
168061|NCT00982280|405370|P1|COMPLETED|Titration and Optimal Dose Period||55
168062|NCT00982280|405370|P1|STARTED|Titration and Optimal Dose Period||63
168063|NCT00982280|405370|P1|NOT COMPLETED|Observation Period||19
168064|NCT00982280|405370|P1|COMPLETED|Observation Period||63
168065|NCT00982280|405370|P1|STARTED|Observation Period||82
168066|NCT00982228|405395|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
168067|NCT00982228|405396|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
168068|NCT00982228|405395|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
168069|NCT00982228|405396|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
168070|NCT00982228|405395|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
168071|NCT00982228|405396|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
168072|NCT00982228|405395|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
168073|NCT00982228|405396|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
168074|NCT00982228|405395|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
168075|NCT00982228|405396|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
168076|NCT00982228|405395|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
168077|NCT00982228|405396|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
168078|NCT00982228|405395|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
168079|NCT00982228|405396|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
168080|NCT00982228|405395|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
168081|NCT00982228|405396|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
168082|NCT00982189|405424|P4|NOT COMPLETED|Overall Study||0
168083|NCT00982189|405425|P3|NOT COMPLETED|Overall Study||0
168084|NCT00982189|405426|P2|NOT COMPLETED|Overall Study||0
168085|NCT00982189|405427|P1|NOT COMPLETED|Overall Study||0
168086|NCT00982189|405424|P4|COMPLETED|Overall Study||9
168087|NCT00982189|405425|P3|COMPLETED|Overall Study||9
168088|NCT00982189|405426|P2|COMPLETED|Overall Study||9
168089|NCT00982189|405427|P1|COMPLETED|Overall Study||10
168090|NCT00982189|405424|P4|STARTED|Overall Study||9
168091|NCT00982189|405425|P3|STARTED|Overall Study||9
168092|NCT00982189|405426|P2|STARTED|Overall Study||9
168093|NCT00982189|405427|P1|STARTED|Overall Study||10
168094|NCT00982137|405455|P4|NOT COMPLETED|Overall Study||1
168095|NCT00982137|405456|P3|NOT COMPLETED|Overall Study||0
168096|NCT00982137|405457|P2|NOT COMPLETED|Overall Study||1
168097|NCT00982137|405458|P1|NOT COMPLETED|Overall Study||0
168098|NCT00982137|405455|P4|COMPLETED|Overall Study||17
168099|NCT00982137|405456|P3|COMPLETED|Overall Study||18
168100|NCT00982137|405457|P2|COMPLETED|Overall Study||35
168101|NCT00982137|405458|P1|COMPLETED|Overall Study||36
168102|NCT00982137|405455|P4|STARTED|Overall Study||18
168103|NCT00982137|405456|P3|STARTED|Overall Study||18
168104|NCT00982137|405457|P2|STARTED|Overall Study||36
168105|NCT00982137|405458|P1|STARTED|Overall Study||36
168106|NCT00982111|405490|P2|NOT COMPLETED|Overall Study||66
168107|NCT00982111|405491|P1|NOT COMPLETED|Overall Study||75
168108|NCT00982111|405490|P2|COMPLETED|Overall Study||252
168109|NCT00982111|405491|P1|COMPLETED|Overall Study||240
168110|NCT00982111|405490|P2|On Study at Conclusion, Off Treatment|Overall Study||6
168111|NCT00982111|405491|P1|On Study at Conclusion, Off Treatment|Overall Study||4
168112|NCT00982111|405490|P2|Death Due to Any Cause|Overall Study||246
168113|NCT00982111|405491|P1|Death Due to Any Cause|Overall Study||236
168114|NCT00982111|405490|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
168115|NCT00982111|405491|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
168116|NCT00982111|405490|P2|STARTED|Overall Study||318
168117|NCT00982111|405491|P1|STARTED|Overall Study||315
168118|NCT00982033|405515|P2|NOT COMPLETED|Overall Study||0
168119|NCT00982033|405516|P1|NOT COMPLETED|Overall Study||0
168120|NCT00982033|405515|P2|COMPLETED|Overall Study||27
168121|NCT00982033|405516|P1|COMPLETED|Overall Study||25
168122|NCT00982033|405515|P2|STARTED|Overall Study||27
168123|NCT00982033|405516|P1|STARTED|Overall Study||25
168124|NCT00982020|405524|P2|NOT COMPLETED|Overall Study||64
168125|NCT00982020|405525|P1|NOT COMPLETED|Overall Study||57
168126|NCT00982020|405524|P2|COMPLETED|Overall Study||37
168127|NCT00982020|405525|P1|COMPLETED|Overall Study||45
168128|NCT00982020|405524|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
168129|NCT00982020|405525|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
168130|NCT00982020|405524|P2|STARTED|Overall Study||101
168131|NCT00982020|405525|P1|STARTED|Overall Study||102
168132|NCT00982007|405549|P4|NOT COMPLETED|Overall Study||6
168133|NCT00982007|405550|P3|NOT COMPLETED|Overall Study||0
168134|NCT00982007|405551|P2|NOT COMPLETED|Overall Study||4
168135|NCT00982007|405552|P1|NOT COMPLETED|Overall Study||4
168136|NCT00982007|405549|P4|COMPLETED|Overall Study||245
168137|NCT00982007|405550|P3|COMPLETED|Overall Study||253
168138|NCT00982007|405551|P2|COMPLETED|Overall Study||253
168139|NCT00982007|405552|P1|COMPLETED|Overall Study||246
168140|NCT00982007|405549|P4|STARTED|Overall Study||251
168141|NCT00982007|405550|P3|STARTED|Overall Study||253
168142|NCT00982007|405551|P2|STARTED|Overall Study||257
168143|NCT00982007|405552|P1|STARTED|Overall Study||250
168144|NCT00981825|405564|P2|NOT COMPLETED|Second Intervention||0
168145|NCT00981825|405565|P1|NOT COMPLETED|Second Intervention||0
168146|NCT00981825|405564|P2|COMPLETED|Second Intervention||11
168147|NCT00981825|405565|P1|COMPLETED|Second Intervention||11
168148|NCT00981825|405564|P2|STARTED|Second Intervention||11
168149|NCT00981825|405565|P1|STARTED|Second Intervention||11
168150|NCT00981825|405564|P2|NOT COMPLETED|Washout After 1st Intervention||0
168151|NCT00981825|405565|P1|NOT COMPLETED|Washout After 1st Intervention||0
168152|NCT00981825|405564|P2|COMPLETED|Washout After 1st Intervention||11
168153|NCT00981825|405565|P1|COMPLETED|Washout After 1st Intervention||11
168154|NCT00981825|405564|P2|STARTED|Washout After 1st Intervention||11
168155|NCT00981825|405565|P1|STARTED|Washout After 1st Intervention||11
168156|NCT00981825|405564|P2|NOT COMPLETED|First Intervention||0
168157|NCT00981825|405565|P1|NOT COMPLETED|First Intervention||0
168158|NCT00981825|405564|P2|COMPLETED|First Intervention||11
168159|NCT00981825|405565|P1|COMPLETED|First Intervention||11
168160|NCT00981825|405564|P2|STARTED|First Intervention||11
168161|NCT00981825|405565|P1|STARTED|First Intervention||11
168162|NCT00981812|405571|P1|NOT COMPLETED|Overall Study||0
168163|NCT00981812|405571|P1|COMPLETED|Overall Study||20
168164|NCT00981812|405571|P1|STARTED|Overall Study||20
168165|NCT00981669|405577|P2|NOT COMPLETED|Overall Study||0
168166|NCT00981669|405578|P1|NOT COMPLETED|Overall Study||1
168167|NCT00981669|405577|P2|COMPLETED|Overall Study||40
168168|NCT00981669|405578|P1|COMPLETED|Overall Study||39
168169|NCT00981669|405577|P2|STARTED|Overall Study||40
168170|NCT00981669|405578|P1|STARTED|Overall Study||40
168171|NCT00981630|405590|P4|NOT COMPLETED|Overall Study||0
168172|NCT00981630|405591|P3|NOT COMPLETED|Overall Study||0
168173|NCT00981630|405592|P2|NOT COMPLETED|Overall Study||0
168174|NCT00981630|405593|P1|NOT COMPLETED|Overall Study||0
168175|NCT00981630|405590|P4|COMPLETED|Overall Study||32
168176|NCT00981630|405591|P3|COMPLETED|Overall Study||32
168177|NCT00981630|405592|P2|COMPLETED|Overall Study||32
168178|NCT00981630|405593|P1|COMPLETED|Overall Study||32
168179|NCT00981630|405590|P4|STARTED|Overall Study||32
168180|NCT00981630|405591|P3|STARTED|Overall Study||32
168181|NCT00981630|405592|P2|STARTED|Overall Study||32
168182|NCT00981630|405593|P1|STARTED|Overall Study||32
168183|NCT00981461|405625|P2|NOT COMPLETED|Overall Study||2
168184|NCT00981461|405626|P1|NOT COMPLETED|Overall Study||5
168185|NCT00981461|405625|P2|COMPLETED|Overall Study||22
168186|NCT00981461|405626|P1|COMPLETED|Overall Study||43
168187|NCT00981461|405625|P2|STARTED|Overall Study||24
168188|NCT00981461|405626|P1|STARTED|Overall Study||48
168189|NCT00981435|405635|P3|NOT COMPLETED|Overall Study||0
168190|NCT00981435|405636|P2|NOT COMPLETED|Overall Study||0
168191|NCT00981435|405637|P1|NOT COMPLETED|Overall Study||0
168192|NCT00981435|405635|P3|COMPLETED|Overall Study||37
168193|NCT00981435|405636|P2|COMPLETED|Overall Study||29
168194|NCT00981435|405637|P1|COMPLETED|Overall Study||31
168195|NCT00981435|405635|P3|STARTED|Overall Study||37
168196|NCT00981435|405636|P2|STARTED|Overall Study||29
168197|NCT00981435|405637|P1|STARTED|Overall Study||31
168198|NCT00981409|405650|P2|NOT COMPLETED|Overall Study||1
168199|NCT00981409|405651|P1|NOT COMPLETED|Overall Study||6
168200|NCT00981409|405650|P2|COMPLETED|Overall Study||10
168201|NCT00981409|405651|P1|COMPLETED|Overall Study||24
168202|NCT00981409|405650|P2|STARTED|Overall Study||11
168203|NCT00981409|405651|P1|STARTED|Overall Study||30
168204|NCT00981370|405665|P1|NOT COMPLETED|Overall Study||0
168205|NCT00981370|405665|P1|COMPLETED|Overall Study||0
168206|NCT00981370|405665|P1|STARTED|Overall Study||0
168207|NCT00981305|405671|P2|NOT COMPLETED|Overall Study||10
168208|NCT00981305|405672|P1|NOT COMPLETED|Overall Study||19
168209|NCT00981305|405671|P2|COMPLETED|Overall Study||57
168210|NCT00981305|405672|P1|COMPLETED|Overall Study||50
168211|NCT00981305|405671|P2|STARTED|Overall Study||67
168212|NCT00981305|405672|P1|STARTED|Overall Study||69
168213|NCT00981292|405690|P6|NOT COMPLETED|Day 3||1
168214|NCT00981292|405691|P5|NOT COMPLETED|Day 3||0
168215|NCT00981292|405692|P4|NOT COMPLETED|Day 3||0
168216|NCT00981292|405693|P3|NOT COMPLETED|Day 3||0
168217|NCT00981292|405694|P2|NOT COMPLETED|Day 3||0
168218|NCT00981292|405695|P1|NOT COMPLETED|Day 3||0
168219|NCT00981292|405690|P6|COMPLETED|Day 3||4
168220|NCT00981292|405691|P5|COMPLETED|Day 3||4
168221|NCT00981292|405692|P4|COMPLETED|Day 3||4
168222|NCT00981292|405693|P3|COMPLETED|Day 3||6
168223|NCT00981292|405694|P2|COMPLETED|Day 3||4
168224|NCT00981292|405695|P1|COMPLETED|Day 3||4
168225|NCT00981292|405690|P6|STARTED|Day 3||5
168226|NCT00981292|405691|P5|STARTED|Day 3||4
168227|NCT00981292|405692|P4|STARTED|Day 3||4
168228|NCT00981292|405693|P3|STARTED|Day 3||6
168229|NCT00981292|405694|P2|STARTED|Day 3||4
168230|NCT00981292|405695|P1|STARTED|Day 3||4
168231|NCT00981292|405690|P6|NOT COMPLETED|Day 2||0
168232|NCT00981292|405691|P5|NOT COMPLETED|Day 2||0
168233|NCT00981292|405692|P4|NOT COMPLETED|Day 2||0
168234|NCT00981292|405693|P3|NOT COMPLETED|Day 2||0
168235|NCT00981292|405694|P2|NOT COMPLETED|Day 2||0
168236|NCT00981292|405695|P1|NOT COMPLETED|Day 2||2
168237|NCT00981292|405690|P6|COMPLETED|Day 2||5
168238|NCT00981292|405691|P5|COMPLETED|Day 2||4
168239|NCT00981292|405692|P4|COMPLETED|Day 2||4
168240|NCT00981292|405693|P3|COMPLETED|Day 2||6
168241|NCT00981292|405694|P2|COMPLETED|Day 2||4
168242|NCT00981292|405695|P1|COMPLETED|Day 2||4
168243|NCT00981292|405690|P6|STARTED|Day 2||5
168244|NCT00981292|405691|P5|STARTED|Day 2||4
168245|NCT00981292|405692|P4|STARTED|Day 2||4
168246|NCT00981292|405693|P3|STARTED|Day 2||6
168247|NCT00981292|405694|P2|STARTED|Day 2||4
168248|NCT00981292|405695|P1|STARTED|Day 2||6
168249|NCT00981292|405690|P6|NOT COMPLETED|Day 1||2
168250|NCT00981292|405691|P5|NOT COMPLETED|Day 1||0
168251|NCT00981292|405692|P4|NOT COMPLETED|Day 1||0
168252|NCT00981292|405693|P3|NOT COMPLETED|Day 1||0
168253|NCT00981292|405694|P2|NOT COMPLETED|Day 1||0
168254|NCT00981292|405695|P1|NOT COMPLETED|Day 1||1
168255|NCT00981292|405690|P6|COMPLETED|Day 1||5
168256|NCT00981292|405691|P5|COMPLETED|Day 1||4
168257|NCT00981292|405692|P4|COMPLETED|Day 1||4
168258|NCT00981292|405693|P3|COMPLETED|Day 1||6
168259|NCT00981292|405694|P2|COMPLETED|Day 1||4
168260|NCT00981292|405695|P1|COMPLETED|Day 1||6
168261|NCT00981292|405690|P6|STARTED|Day 1||7
168262|NCT00981292|405691|P5|STARTED|Day 1||4
168263|NCT00981292|405692|P4|STARTED|Day 1||4
168264|NCT00981292|405693|P3|STARTED|Day 1||6
168265|NCT00981292|405694|P2|STARTED|Day 1||4
168266|NCT00981292|405695|P1|STARTED|Day 1||7
168267|NCT00981253|405714|P2|NOT COMPLETED|Overall Study||3
168268|NCT00981253|405715|P1|NOT COMPLETED|Overall Study||3
168269|NCT00981253|405714|P2|COMPLETED|Overall Study||72
168270|NCT00981253|405715|P1|COMPLETED|Overall Study||73
168271|NCT00981253|405714|P2|STARTED|Overall Study||75
168272|NCT00981253|405715|P1|STARTED|Overall Study||76
168273|NCT00981227|405739|P6|NOT COMPLETED|Overall Study||18
168274|NCT00981227|405740|P5|NOT COMPLETED|Overall Study||30
168275|NCT00981227|405741|P4|NOT COMPLETED|Overall Study||21
168276|NCT00981227|405742|P3|NOT COMPLETED|Overall Study||21
168277|NCT00981227|405743|P2|NOT COMPLETED|Overall Study||19
168278|NCT00981227|405744|P1|NOT COMPLETED|Overall Study||22
168279|NCT00981227|405739|P6|COMPLETED|Overall Study||75
168280|NCT00981227|405740|P5|COMPLETED|Overall Study||60
168281|NCT00981227|405741|P4|COMPLETED|Overall Study||73
168282|NCT00981227|405742|P3|COMPLETED|Overall Study||73
168283|NCT00981227|405743|P2|COMPLETED|Overall Study||75
168284|NCT00981227|405744|P1|COMPLETED|Overall Study||80
168285|NCT00981227|405739|P6|Per–Protocol|Overall Study||70
168286|NCT00981227|405740|P5|Per–Protocol|Overall Study||50
168287|NCT00981227|405741|P4|Per–Protocol|Overall Study||68
168288|NCT00981227|405742|P3|Per–Protocol|Overall Study||67
168289|NCT00981227|405743|P2|Per–Protocol|Overall Study||72
168290|NCT00981227|405744|P1|Per–Protocol|Overall Study||69
168291|NCT00981227|405739|P6|Safety Population|Overall Study||93
168292|NCT00981227|405740|P5|Safety Population|Overall Study||90
168293|NCT00981227|405741|P4|Safety Population|Overall Study||94
168294|NCT00981227|405742|P3|Safety Population|Overall Study||94
168295|NCT00981227|405743|P2|Safety Population|Overall Study||94
168296|NCT00981227|405744|P1|Safety Population|Overall Study||102
168297|NCT00981227|405739|P6|Randomized|Overall Study||93
168298|NCT00981227|405740|P5|Randomized|Overall Study||90
168299|NCT00981227|405741|P4|Randomized|Overall Study||94
168300|NCT00981227|405742|P3|Randomized|Overall Study||94
168301|NCT00981227|405743|P2|Randomized|Overall Study||94
168302|NCT00981227|405744|P1|Randomized|Overall Study||102
168303|NCT00981227|405739|P6|STARTED|Overall Study||93
168304|NCT00981227|405740|P5|STARTED|Overall Study||90
168305|NCT00981227|405741|P4|STARTED|Overall Study||94
168306|NCT00981227|405742|P3|STARTED|Overall Study||94
168307|NCT00981227|405743|P2|STARTED|Overall Study||94
168308|NCT00981227|405744|P1|STARTED|Overall Study||102
168309|NCT00981214|405762|P1|NOT COMPLETED|Overall Study||0
168310|NCT00981214|405762|P1|COMPLETED|Overall Study||19
168311|NCT00981214|405762|P1|STARTED|Overall Study||19
168312|NCT00981175|405779|P2|NOT COMPLETED|Booster Dose Vaccination||3
168313|NCT00981175|405780|P1|NOT COMPLETED|Booster Dose Vaccination||2
168314|NCT00981175|405779|P2|COMPLETED|Booster Dose Vaccination||40
168315|NCT00981175|405780|P1|COMPLETED|Booster Dose Vaccination||53
168316|NCT00981175|405779|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
168317|NCT00981175|405780|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
168318|NCT00981175|405779|P2|NOT COMPLETED|Primary Dose Vaccination||2
168319|NCT00981175|405780|P1|NOT COMPLETED|Primary Dose Vaccination||3
168320|NCT00981175|405779|P2|COMPLETED|Primary Dose Vaccination||99
168321|NCT00981175|405780|P1|COMPLETED|Primary Dose Vaccination||98
168322|NCT00981175|405779|P2|STARTED|Primary Dose Vaccination||101
168323|NCT00981175|405780|P1|STARTED|Primary Dose Vaccination||101
168324|NCT00981149|405805|P2|NOT COMPLETED|Overall Study||3
168325|NCT00981149|405806|P1|NOT COMPLETED|Overall Study||2
168326|NCT00981149|405805|P2|COMPLETED|Overall Study||9
168327|NCT00981149|405806|P1|COMPLETED|Overall Study||10
168328|NCT00981149|405805|P2|STARTED|Overall Study||12
168329|NCT00981149|405806|P1|STARTED|Overall Study||12
168330|NCT00981084|405816|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
168331|NCT00981084|405817|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
168332|NCT00981084|405816|P2|COMPLETED|Post Intervention (Data Analysis)||16
168333|NCT00981084|405817|P1|COMPLETED|Post Intervention (Data Analysis)||14
168334|NCT00981084|405816|P2|STARTED|Post Intervention (Data Analysis)||17
168335|NCT00981084|405817|P1|STARTED|Post Intervention (Data Analysis)||16
168336|NCT00981084|405816|P2|NOT COMPLETED|Second Intervention (One Day)||0
168337|NCT00981084|405817|P1|NOT COMPLETED|Second Intervention (One Day)||0
168338|NCT00981084|405816|P2|COMPLETED|Second Intervention (One Day)||17
168339|NCT00981084|405817|P1|COMPLETED|Second Intervention (One Day)||16
168340|NCT00981084|405816|P2|STARTED|Second Intervention (One Day)||17
168341|NCT00981084|405817|P1|STARTED|Second Intervention (One Day)||16
168342|NCT00981084|405816|P2|NOT COMPLETED|Washout Period (7 Days)||0
168343|NCT00981084|405817|P1|NOT COMPLETED|Washout Period (7 Days)||0
168344|NCT00981084|405816|P2|COMPLETED|Washout Period (7 Days)||17
168345|NCT00981084|405817|P1|COMPLETED|Washout Period (7 Days)||16
168346|NCT00981084|405816|P2|STARTED|Washout Period (7 Days)||17
168347|NCT00981084|405817|P1|STARTED|Washout Period (7 Days)||16
168348|NCT00981084|405816|P2|NOT COMPLETED|First Intervention (One Day)||0
168349|NCT00981084|405817|P1|NOT COMPLETED|First Intervention (One Day)||0
168350|NCT00981084|405816|P2|COMPLETED|First Intervention (One Day)||17
168351|NCT00981084|405817|P1|COMPLETED|First Intervention (One Day)||16
168352|NCT00981084|405816|P2|STARTED|First Intervention (One Day)||17
168353|NCT00981084|405817|P1|STARTED|First Intervention (One Day)||16
168354|NCT00981058|405833|P2|NOT COMPLETED|Overall Study||97
168355|NCT00981058|405834|P1|NOT COMPLETED|Overall Study||120
168356|NCT00981058|405833|P2|COMPLETED|Overall Study||451
168357|NCT00981058|405834|P1|COMPLETED|Overall Study||425
168358|NCT00981058|405833|P2|Death Due to Any Cause|Overall Study||442
168359|NCT00981058|405834|P1|Death Due to Any Cause|Overall Study||418
168360|NCT00981058|405833|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
168361|NCT00981058|405834|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
168362|NCT00981058|405833|P2|STARTED|Overall Study||548
168363|NCT00981058|405834|P1|STARTED|Overall Study||545
168364|NCT00981045|405856|P2|NOT COMPLETED|Overall Study||9
168365|NCT00981045|405857|P1|NOT COMPLETED|Overall Study||14
168366|NCT00981045|405856|P2|COMPLETED|Overall Study||1285
168367|NCT00981045|405857|P1|COMPLETED|Overall Study||1276
168368|NCT00981045|405856|P2|STARTED|Overall Study||1294
168369|NCT00981045|405857|P1|STARTED|Overall Study||1290
168370|NCT00981019|405865|P1|NOT COMPLETED|Overall Study||477
168371|NCT00981019|405865|P1|COMPLETED|Overall Study||301
168372|NCT00981019|405865|P1|STARTED|Overall Study||778
168373|NCT00980980|405872|P3|NOT COMPLETED|Overall Study||0
168374|NCT00980980|405873|P2|NOT COMPLETED|Overall Study||1
168375|NCT00980980|405874|P1|NOT COMPLETED|Overall Study||0
168376|NCT00980980|405872|P3|COMPLETED|Overall Study||13
168377|NCT00980980|405873|P2|COMPLETED|Overall Study||13
168378|NCT00980980|405874|P1|COMPLETED|Overall Study||16
168379|NCT00980980|405872|P3|STARTED|Overall Study||13
168380|NCT00980980|405873|P2|STARTED|Overall Study||14
168381|NCT00980980|405874|P1|STARTED|Overall Study||16
168382|NCT00980798|405905|P2|NOT COMPLETED|Overall Study||55
168383|NCT00980798|405906|P1|NOT COMPLETED|Overall Study||33
168384|NCT00980798|405905|P2|COMPLETED|Overall Study||84
168385|NCT00980798|405906|P1|COMPLETED|Overall Study||116
168386|NCT00980798|405905|P2|STARTED|Overall Study||139
168387|NCT00980798|405906|P1|STARTED|Overall Study||149
168388|NCT00980746|405920|P6|NOT COMPLETED|Overall Study||18
168389|NCT00980746|405921|P5|NOT COMPLETED|Overall Study||17
168390|NCT00980746|405922|P4|NOT COMPLETED|Overall Study||36
168391|NCT00980746|405923|P3|NOT COMPLETED|Overall Study||20
168392|NCT00980746|405924|P2|NOT COMPLETED|Overall Study||22
168393|NCT00980746|405925|P1|NOT COMPLETED|Overall Study||27
168394|NCT00980746|405920|P6|COMPLETED|Overall Study||78
168395|NCT00980746|405921|P5|COMPLETED|Overall Study||75
168396|NCT00980746|405922|P4|COMPLETED|Overall Study||64
168397|NCT00980746|405923|P3|COMPLETED|Overall Study||75
168398|NCT00980746|405924|P2|COMPLETED|Overall Study||67
168399|NCT00980746|405925|P1|COMPLETED|Overall Study||58
168400|NCT00980746|405920|P6|Per-protocol|Overall Study||74
168401|NCT00980746|405921|P5|Per-protocol|Overall Study||73
168402|NCT00980746|405922|P4|Per-protocol|Overall Study||62
168403|NCT00980746|405923|P3|Per-protocol|Overall Study||73
168404|NCT00980746|405924|P2|Per-protocol|Overall Study||66
168405|NCT00980746|405925|P1|Per-protocol|Overall Study||55
168406|NCT00980746|405920|P6|Safety Population|Overall Study||96
168407|NCT00980746|405921|P5|Safety Population|Overall Study||92
168408|NCT00980746|405922|P4|Safety Population|Overall Study||100
168409|NCT00980746|405923|P3|Safety Population|Overall Study||95
168410|NCT00980746|405924|P2|Safety Population|Overall Study||89
168411|NCT00980746|405925|P1|Safety Population|Overall Study||85
168412|NCT00980746|405920|P6|Randomized|Overall Study||96
168413|NCT00980746|405921|P5|Randomized|Overall Study||92
168414|NCT00980746|405922|P4|Randomized|Overall Study||100
168415|NCT00980746|405923|P3|Randomized|Overall Study||95
168416|NCT00980746|405924|P2|Randomized|Overall Study||89
168417|NCT00980746|405925|P1|Randomized|Overall Study||85
168418|NCT00980746|405920|P6|STARTED|Overall Study||96
168419|NCT00980746|405921|P5|STARTED|Overall Study||92
168420|NCT00980746|405922|P4|STARTED|Overall Study||100
168421|NCT00980746|405923|P3|STARTED|Overall Study||95
168422|NCT00980746|405924|P2|STARTED|Overall Study||89
168423|NCT00980746|405925|P1|STARTED|Overall Study||85
168424|NCT00980681|405939|P1|NOT COMPLETED|Dotarem MRA||0
168425|NCT00980681|405939|P1|COMPLETED|Dotarem MRA||10
168426|NCT00980681|405939|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
168427|NCT00980681|405939|P1|NOT COMPLETED|TOF MRA||0
168428|NCT00980681|405939|P1|COMPLETED|TOF MRA||10
168429|NCT00980681|405939|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
168430|NCT00980655|405947|P2|NOT COMPLETED|Overall Study||51
168431|NCT00980655|405948|P1|NOT COMPLETED|Overall Study||16
168432|NCT00980655|405947|P2|COMPLETED|Overall Study||139
168433|NCT00980655|405948|P1|COMPLETED|Overall Study||45
168434|NCT00980655|405947|P2|Vaccinated 23vPS Dose|Overall Study||140
168435|NCT00980655|405948|P1|Vaccinated 23vPS Dose|Overall Study||45
168436|NCT00980655|405947|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
168437|NCT00980655|405948|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
168438|NCT00980655|405947|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
168439|NCT00980655|405948|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
168440|NCT00980655|405947|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
168441|NCT00980655|405948|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
168442|NCT00980655|405947|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
168443|NCT00980655|405948|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
168444|NCT00980655|405947|P2|STARTED|Overall Study||190
168445|NCT00980655|405948|P1|STARTED|Overall Study||61
168446|NCT00980642|405996|P2|NOT COMPLETED|Overall Study||0
168447|NCT00980642|405997|P1|NOT COMPLETED|Overall Study||0
168448|NCT00980642|405996|P2|COMPLETED|Overall Study||20
168449|NCT00980642|405997|P1|COMPLETED|Overall Study||36
168450|NCT00980642|405996|P2|STARTED|Overall Study||20
168451|NCT00980642|405997|P1|STARTED|Overall Study||36
168452|NCT00980590|406009|P2|NOT COMPLETED|Overall Study||0
168453|NCT00980590|406010|P1|NOT COMPLETED|Overall Study||0
168454|NCT00980590|406009|P2|COMPLETED|Overall Study||50
168455|NCT00980590|406010|P1|COMPLETED|Overall Study||50
168456|NCT00980590|406009|P2|STARTED|Overall Study||50
168457|NCT00980590|406010|P1|STARTED|Overall Study||50
168458|NCT00980343|406024|P2|NOT COMPLETED|Overall Study||3
168459|NCT00980343|406025|P1|NOT COMPLETED|Overall Study||1
168460|NCT00980343|406024|P2|COMPLETED|Overall Study||20
168461|NCT00980343|406025|P1|COMPLETED|Overall Study||20
168462|NCT00980343|406024|P2|STARTED|Overall Study||23
168463|NCT00980343|406025|P1|STARTED|Overall Study||21
168464|NCT00980330|406049|P7|NOT COMPLETED|Overall Study||7
168465|NCT00980330|406050|P6|NOT COMPLETED|Overall Study||4
168466|NCT00980330|406051|P5|NOT COMPLETED|Overall Study||5
168467|NCT00980330|406052|P4|NOT COMPLETED|Overall Study||5
168468|NCT00980330|406053|P3|NOT COMPLETED|Overall Study||8
168469|NCT00980330|406054|P2|NOT COMPLETED|Overall Study||5
168470|NCT00980330|406055|P1|NOT COMPLETED|Overall Study||5
168471|NCT00980330|406049|P7|COMPLETED|Overall Study||59
168472|NCT00980330|406050|P6|COMPLETED|Overall Study||61
168473|NCT00980330|406051|P5|COMPLETED|Overall Study||63
168474|NCT00980330|406052|P4|COMPLETED|Overall Study||61
168475|NCT00980330|406053|P3|COMPLETED|Overall Study||58
168476|NCT00980330|406054|P2|COMPLETED|Overall Study||60
168477|NCT00980330|406055|P1|COMPLETED|Overall Study||61
168478|NCT00980330|406049|P7|STARTED|Overall Study||66
168479|NCT00980330|406050|P6|STARTED|Overall Study||65
168480|NCT00980330|406051|P5|STARTED|Overall Study||68
168481|NCT00980330|406052|P4|STARTED|Overall Study||66
168482|NCT00980330|406053|P3|STARTED|Overall Study||66
168483|NCT00980330|406054|P2|STARTED|Overall Study||65
168484|NCT00980330|406055|P1|STARTED|Overall Study||66
168485|NCT00980278|406155|P2|NOT COMPLETED|Overall Study||0
168486|NCT00980278|406156|P1|NOT COMPLETED|Overall Study||2
168487|NCT00980278|406155|P2|COMPLETED|Overall Study||13
168488|NCT00980278|406156|P1|COMPLETED|Overall Study||11
168489|NCT00980278|406155|P2|STARTED|Overall Study||13
168490|NCT00980278|406156|P1|STARTED|Overall Study||13
168491|NCT00980200|406170|P5|NOT COMPLETED|7-day Treatment Period 5||0
168492|NCT00980200|406171|P4|NOT COMPLETED|7-day Treatment Period 5||0
168493|NCT00980200|406172|P3|NOT COMPLETED|7-day Treatment Period 5||0
168494|NCT00980200|406173|P2|NOT COMPLETED|7-day Treatment Period 5||0
168495|NCT00980200|406174|P1|NOT COMPLETED|7-day Treatment Period 5||0
168496|NCT00980200|406170|P5|COMPLETED|7-day Treatment Period 5||14
168497|NCT00980200|406171|P4|COMPLETED|7-day Treatment Period 5||16
168498|NCT00980200|406172|P3|COMPLETED|7-day Treatment Period 5||15
168499|NCT00980200|406173|P2|COMPLETED|7-day Treatment Period 5||12
168500|NCT00980200|406174|P1|COMPLETED|7-day Treatment Period 5||15
168501|NCT00980200|406170|P5|STARTED|7-day Treatment Period 5||14
168502|NCT00980200|406171|P4|STARTED|7-day Treatment Period 5||16
168503|NCT00980200|406172|P3|STARTED|7-day Treatment Period 5||15
168504|NCT00980200|406173|P2|STARTED|7-day Treatment Period 5||12
168505|NCT00980200|406174|P1|STARTED|7-day Treatment Period 5||15
168506|NCT00980200|406170|P5|NOT COMPLETED|7-day Washout Period 4||0
168507|NCT00980200|406171|P4|NOT COMPLETED|7-day Washout Period 4||0
168508|NCT00980200|406172|P3|NOT COMPLETED|7-day Washout Period 4||0
168509|NCT00980200|406173|P2|NOT COMPLETED|7-day Washout Period 4||0
168510|NCT00980200|406174|P1|NOT COMPLETED|7-day Washout Period 4||0
168511|NCT00980200|406170|P5|COMPLETED|7-day Washout Period 4||14
168512|NCT00980200|406171|P4|COMPLETED|7-day Washout Period 4||16
168513|NCT00980200|406172|P3|COMPLETED|7-day Washout Period 4||15
168514|NCT00980200|406173|P2|COMPLETED|7-day Washout Period 4||12
168515|NCT00980200|406174|P1|COMPLETED|7-day Washout Period 4||15
168516|NCT00980200|406170|P5|STARTED|7-day Washout Period 4||14
168517|NCT00980200|406171|P4|STARTED|7-day Washout Period 4||16
168518|NCT00980200|406172|P3|STARTED|7-day Washout Period 4||15
168519|NCT00980200|406173|P2|STARTED|7-day Washout Period 4||12
168520|NCT00980200|406174|P1|STARTED|7-day Washout Period 4||15
168521|NCT00980200|406170|P5|NOT COMPLETED|7-day Treatment Period 4||0
168522|NCT00980200|406171|P4|NOT COMPLETED|7-day Treatment Period 4||0
168523|NCT00980200|406172|P3|NOT COMPLETED|7-day Treatment Period 4||0
168524|NCT00980200|406173|P2|NOT COMPLETED|7-day Treatment Period 4||0
168525|NCT00980200|406174|P1|NOT COMPLETED|7-day Treatment Period 4||0
168526|NCT00980200|406170|P5|COMPLETED|7-day Treatment Period 4||14
168527|NCT00980200|406171|P4|COMPLETED|7-day Treatment Period 4||16
168528|NCT00980200|406172|P3|COMPLETED|7-day Treatment Period 4||15
168529|NCT00980200|406173|P2|COMPLETED|7-day Treatment Period 4||12
168530|NCT00980200|406174|P1|COMPLETED|7-day Treatment Period 4||15
168531|NCT00980200|406170|P5|STARTED|7-day Treatment Period 4||14
168532|NCT00980200|406171|P4|STARTED|7-day Treatment Period 4||16
168533|NCT00980200|406172|P3|STARTED|7-day Treatment Period 4||15
168534|NCT00980200|406173|P2|STARTED|7-day Treatment Period 4||12
168535|NCT00980200|406174|P1|STARTED|7-day Treatment Period 4||15
168536|NCT00980200|406170|P5|NOT COMPLETED|7-day Washout Period 3||0
168537|NCT00980200|406171|P4|NOT COMPLETED|7-day Washout Period 3||0
168538|NCT00980200|406172|P3|NOT COMPLETED|7-day Washout Period 3||0
168539|NCT00980200|406173|P2|NOT COMPLETED|7-day Washout Period 3||0
168540|NCT00980200|406174|P1|NOT COMPLETED|7-day Washout Period 3||0
168541|NCT00980200|406170|P5|COMPLETED|7-day Washout Period 3||14
168542|NCT00980200|406171|P4|COMPLETED|7-day Washout Period 3||16
168543|NCT00980200|406172|P3|COMPLETED|7-day Washout Period 3||15
168544|NCT00980200|406173|P2|COMPLETED|7-day Washout Period 3||12
168545|NCT00980200|406174|P1|COMPLETED|7-day Washout Period 3||15
168546|NCT00980200|406170|P5|STARTED|7-day Washout Period 3||14
168547|NCT00980200|406171|P4|STARTED|7-day Washout Period 3||16
168548|NCT00980200|406172|P3|STARTED|7-day Washout Period 3||15
168549|NCT00980200|406173|P2|STARTED|7-day Washout Period 3||12
168550|NCT00980200|406174|P1|STARTED|7-day Washout Period 3||15
168551|NCT00980200|406170|P5|NOT COMPLETED|7-day Treatment Period 3||1
168552|NCT00980200|406171|P4|NOT COMPLETED|7-day Treatment Period 3||0
168553|NCT00980200|406172|P3|NOT COMPLETED|7-day Treatment Period 3||0
168554|NCT00980200|406173|P2|NOT COMPLETED|7-day Treatment Period 3||1
168555|NCT00980200|406174|P1|NOT COMPLETED|7-day Treatment Period 3||0
168556|NCT00980200|406170|P5|COMPLETED|7-day Treatment Period 3||14
168557|NCT00980200|406171|P4|COMPLETED|7-day Treatment Period 3||16
168558|NCT00980200|406172|P3|COMPLETED|7-day Treatment Period 3||15
168559|NCT00980200|406173|P2|COMPLETED|7-day Treatment Period 3||12
168560|NCT00980200|406174|P1|COMPLETED|7-day Treatment Period 3||15
168561|NCT00980200|406170|P5|STARTED|7-day Treatment Period 3||15
168562|NCT00980200|406171|P4|STARTED|7-day Treatment Period 3||16
168563|NCT00980200|406172|P3|STARTED|7-day Treatment Period 3||15
168564|NCT00980200|406173|P2|STARTED|7-day Treatment Period 3||13
168565|NCT00980200|406174|P1|STARTED|7-day Treatment Period 3||15
168566|NCT00980200|406170|P5|NOT COMPLETED|7-day Washout Period 2||0
168567|NCT00980200|406171|P4|NOT COMPLETED|7-day Washout Period 2||0
168568|NCT00980200|406172|P3|NOT COMPLETED|7-day Washout Period 2||0
168569|NCT00980200|406173|P2|NOT COMPLETED|7-day Washout Period 2||0
168570|NCT00980200|406174|P1|NOT COMPLETED|7-day Washout Period 2||0
168571|NCT00980200|406170|P5|COMPLETED|7-day Washout Period 2||15
168572|NCT00980200|406171|P4|COMPLETED|7-day Washout Period 2||16
168573|NCT00980200|406172|P3|COMPLETED|7-day Washout Period 2||15
168574|NCT00980200|406173|P2|COMPLETED|7-day Washout Period 2||13
168575|NCT00980200|406174|P1|COMPLETED|7-day Washout Period 2||15
168576|NCT00980200|406170|P5|STARTED|7-day Washout Period 2||15
168577|NCT00980200|406171|P4|STARTED|7-day Washout Period 2||16
168578|NCT00980200|406172|P3|STARTED|7-day Washout Period 2||15
168579|NCT00980200|406173|P2|STARTED|7-day Washout Period 2||13
168580|NCT00980200|406174|P1|STARTED|7-day Washout Period 2||15
168581|NCT00980200|406170|P5|NOT COMPLETED|7-day Treatment Period 2||0
168582|NCT00980200|406171|P4|NOT COMPLETED|7-day Treatment Period 2||0
168583|NCT00980200|406172|P3|NOT COMPLETED|7-day Treatment Period 2||0
168584|NCT00980200|406173|P2|NOT COMPLETED|7-day Treatment Period 2||0
168585|NCT00980200|406174|P1|NOT COMPLETED|7-day Treatment Period 2||0
168586|NCT00980200|406170|P5|COMPLETED|7-day Treatment Period 2||15
168587|NCT00980200|406171|P4|COMPLETED|7-day Treatment Period 2||16
168588|NCT00980200|406172|P3|COMPLETED|7-day Treatment Period 2||15
168589|NCT00980200|406173|P2|COMPLETED|7-day Treatment Period 2||13
168590|NCT00980200|406174|P1|COMPLETED|7-day Treatment Period 2||15
168591|NCT00980200|406170|P5|STARTED|7-day Treatment Period 2||15
168592|NCT00980200|406171|P4|STARTED|7-day Treatment Period 2||16
168593|NCT00980200|406172|P3|STARTED|7-day Treatment Period 2||15
168594|NCT00980200|406173|P2|STARTED|7-day Treatment Period 2||13
168595|NCT00980200|406174|P1|STARTED|7-day Treatment Period 2||15
168596|NCT00980200|406170|P5|NOT COMPLETED|7-day Washout Period 1||0
168597|NCT00980200|406171|P4|NOT COMPLETED|7-day Washout Period 1||0
168598|NCT00980200|406172|P3|NOT COMPLETED|7-day Washout Period 1||0
168599|NCT00980200|406173|P2|NOT COMPLETED|7-day Washout Period 1||0
168600|NCT00980200|406174|P1|NOT COMPLETED|7-day Washout Period 1||0
168601|NCT00980200|406170|P5|COMPLETED|7-day Washout Period 1||15
168602|NCT00980200|406171|P4|COMPLETED|7-day Washout Period 1||16
168603|NCT00980200|406172|P3|COMPLETED|7-day Washout Period 1||15
168604|NCT00980200|406173|P2|COMPLETED|7-day Washout Period 1||13
168605|NCT00980200|406174|P1|COMPLETED|7-day Washout Period 1||15
168606|NCT00980200|406170|P5|STARTED|7-day Washout Period 1||15
168607|NCT00980200|406171|P4|STARTED|7-day Washout Period 1||16
168608|NCT00980200|406172|P3|STARTED|7-day Washout Period 1||15
168609|NCT00980200|406173|P2|STARTED|7-day Washout Period 1||13
168610|NCT00980200|406174|P1|STARTED|7-day Washout Period 1||15
168611|NCT00980200|406170|P5|NOT COMPLETED|7-day Treatment Period 1||0
168612|NCT00980200|406171|P4|NOT COMPLETED|7-day Treatment Period 1||0
168613|NCT00980200|406172|P3|NOT COMPLETED|7-day Treatment Period 1||0
168614|NCT00980200|406173|P2|NOT COMPLETED|7-day Treatment Period 1||1
168615|NCT00980200|406174|P1|NOT COMPLETED|7-day Treatment Period 1||0
168616|NCT00980200|406170|P5|COMPLETED|7-day Treatment Period 1||15
168617|NCT00980200|406171|P4|COMPLETED|7-day Treatment Period 1||16
168618|NCT00980200|406172|P3|COMPLETED|7-day Treatment Period 1||15
168619|NCT00980200|406173|P2|COMPLETED|7-day Treatment Period 1||13
168620|NCT00980200|406174|P1|COMPLETED|7-day Treatment Period 1||15
168621|NCT00980200|406170|P5|STARTED|7-day Treatment Period 1||15
168622|NCT00980200|406171|P4|STARTED|7-day Treatment Period 1||16
168623|NCT00980200|406172|P3|STARTED|7-day Treatment Period 1||15
168624|NCT00980200|406173|P2|STARTED|7-day Treatment Period 1||14
168625|NCT00980200|406174|P1|STARTED|7-day Treatment Period 1||15
168626|NCT00980174|406193|P2|NOT COMPLETED|Overall Study||10
168627|NCT00980174|406194|P1|NOT COMPLETED|Overall Study||4
168628|NCT00980174|406193|P2|COMPLETED|Overall Study||111
168629|NCT00980174|406194|P1|COMPLETED|Overall Study||117
168630|NCT00980174|406193|P2|STARTED|Overall Study||121
168631|NCT00980174|406194|P1|STARTED|Overall Study||121
168632|NCT00980148|406212|P2|NOT COMPLETED|Overall Study||128
168633|NCT00980148|406213|P1|NOT COMPLETED|Overall Study||129
168634|NCT00980148|406212|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
168635|NCT00980148|406213|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
168636|NCT00980148|406212|P2|STARTED|Overall Study||283
168637|NCT00980148|406213|P1|STARTED|Overall Study||284
168638|NCT00980044|406222|P3|NOT COMPLETED|Overall Study||5
168639|NCT00980044|406223|P2|NOT COMPLETED|Overall Study||7
168640|NCT00980044|406224|P1|NOT COMPLETED|Overall Study||5
168641|NCT00980044|406222|P3|COMPLETED|Overall Study||12
168642|NCT00980044|406223|P2|COMPLETED|Overall Study||12
168643|NCT00980044|406224|P1|COMPLETED|Overall Study||12
168644|NCT00980044|406222|P3|STARTED|Overall Study||17
168645|NCT00980044|406223|P2|STARTED|Overall Study||19
168646|NCT00980044|406224|P1|STARTED|Overall Study||17
168647|NCT00980005|406243|P2|NOT COMPLETED|Overall Study||63
168648|NCT00980005|406244|P1|NOT COMPLETED|Overall Study||47
168649|NCT00980005|406243|P2|COMPLETED|Overall Study||998
168650|NCT00980005|406244|P1|COMPLETED|Overall Study||1008
168651|NCT00980005|406243|P2|STARTED|Overall Study||1061
168652|NCT00980005|406244|P1|STARTED|Overall Study||1055
168653|NCT00979992|406284|P1|NOT COMPLETED|Overall Study||5
168654|NCT00979992|406284|P1|COMPLETED|Overall Study||30
168655|NCT00979992|406284|P1|STARTED|Overall Study||35
168656|NCT00979953|406296|P4|NOT COMPLETED|Overall Study||7
168657|NCT00979953|406297|P3|NOT COMPLETED|Overall Study||22
168658|NCT00979953|406298|P2|NOT COMPLETED|Overall Study||5
168659|NCT00979953|406299|P1|NOT COMPLETED|Overall Study||8
168660|NCT00979953|406296|P4|COMPLETED|Overall Study||97
168661|NCT00979953|406297|P3|COMPLETED|Overall Study||82
168662|NCT00979953|406298|P2|COMPLETED|Overall Study||94
168663|NCT00979953|406299|P1|COMPLETED|Overall Study||93
168664|NCT00979953|406296|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
168665|NCT00979953|406297|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
168666|NCT00979953|406298|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
168667|NCT00979953|406299|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
168668|NCT00979953|406296|P4|STARTED|Overall Study||104
168669|NCT00979953|406297|P3|STARTED|Overall Study||104
168670|NCT00979953|406298|P2|STARTED|Overall Study||99
168671|NCT00979953|406299|P1|STARTED|Overall Study||101
168672|NCT00979940|406311|P2|NOT COMPLETED|Overall Study||0
168673|NCT00979940|406312|P1|NOT COMPLETED|Overall Study||0
168674|NCT00979940|406311|P2|COMPLETED|Overall Study||28
168675|NCT00979940|406312|P1|COMPLETED|Overall Study||32
168676|NCT00979940|406311|P2|STARTED|Overall Study||28
168677|NCT00979940|406312|P1|STARTED|Overall Study||32
168678|NCT00979901|406322|P4|NOT COMPLETED|Overall Study||116
168679|NCT00979901|406323|P3|NOT COMPLETED|Overall Study||29
168680|NCT00979901|406324|P2|NOT COMPLETED|Overall Study||12
168681|NCT00979901|406325|P1|NOT COMPLETED|Overall Study||18
168682|NCT00979901|406322|P4|COMPLETED|Overall Study||159
168683|NCT00979901|406323|P3|COMPLETED|Overall Study||573
168684|NCT00979901|406324|P2|COMPLETED|Overall Study||336
168685|NCT00979901|406325|P1|COMPLETED|Overall Study||334
168686|NCT00979901|406322|P4|STARTED|Overall Study||275
168687|NCT00979901|406323|P3|STARTED|Overall Study||602
168688|NCT00979901|406324|P2|STARTED|Overall Study||348
168689|NCT00979901|406325|P1|STARTED|Overall Study||352
168690|NCT00979875|406349|P6|NOT COMPLETED|Intervention 3||0
168691|NCT00979875|406350|P5|NOT COMPLETED|Intervention 3||0
168692|NCT00979875|406351|P4|NOT COMPLETED|Intervention 3||0
168693|NCT00979875|406352|P3|NOT COMPLETED|Intervention 3||0
168694|NCT00979875|406353|P2|NOT COMPLETED|Intervention 3||0
168695|NCT00979875|406354|P1|NOT COMPLETED|Intervention 3||0
168696|NCT00979875|406349|P6|COMPLETED|Intervention 3||2
168697|NCT00979875|406350|P5|COMPLETED|Intervention 3||3
168698|NCT00979875|406351|P4|COMPLETED|Intervention 3||2
168699|NCT00979875|406352|P3|COMPLETED|Intervention 3||3
168700|NCT00979875|406353|P2|COMPLETED|Intervention 3||2
168701|NCT00979875|406354|P1|COMPLETED|Intervention 3||2
168702|NCT00979875|406349|P6|STARTED|Intervention 3||2
168703|NCT00979875|406350|P5|STARTED|Intervention 3||3
168704|NCT00979875|406351|P4|STARTED|Intervention 3||2
168705|NCT00979875|406352|P3|STARTED|Intervention 3||3
168706|NCT00979875|406353|P2|STARTED|Intervention 3||2
168707|NCT00979875|406354|P1|STARTED|Intervention 3||2
168708|NCT00979875|406349|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
168709|NCT00979875|406350|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
168710|NCT00979875|406351|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
168711|NCT00979875|406352|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
168712|NCT00979875|406353|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
168713|NCT00979875|406354|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
168714|NCT00979875|406349|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
168715|NCT00979875|406350|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
168716|NCT00979875|406351|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
168717|NCT00979875|406352|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
168718|NCT00979875|406353|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
168719|NCT00979875|406354|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
168720|NCT00979875|406349|P6|STARTED|Washout 2 (3 to 14 Days)||2
168721|NCT00979875|406350|P5|STARTED|Washout 2 (3 to 14 Days)||3
168722|NCT00979875|406351|P4|STARTED|Washout 2 (3 to 14 Days)||2
168723|NCT00979875|406352|P3|STARTED|Washout 2 (3 to 14 Days)||3
168724|NCT00979875|406353|P2|STARTED|Washout 2 (3 to 14 Days)||2
168725|NCT00979875|406354|P1|STARTED|Washout 2 (3 to 14 Days)||2
168726|NCT00979875|406349|P6|NOT COMPLETED|Intervention 2||0
168727|NCT00979875|406350|P5|NOT COMPLETED|Intervention 2||0
168728|NCT00979875|406351|P4|NOT COMPLETED|Intervention 2||0
168729|NCT00979875|406352|P3|NOT COMPLETED|Intervention 2||0
168730|NCT00979875|406353|P2|NOT COMPLETED|Intervention 2||0
168731|NCT00979875|406354|P1|NOT COMPLETED|Intervention 2||0
168732|NCT00979875|406349|P6|COMPLETED|Intervention 2||2
168733|NCT00979875|406350|P5|COMPLETED|Intervention 2||3
168734|NCT00979875|406351|P4|COMPLETED|Intervention 2||2
168735|NCT00979875|406352|P3|COMPLETED|Intervention 2||3
168736|NCT00979875|406353|P2|COMPLETED|Intervention 2||2
168737|NCT00979875|406354|P1|COMPLETED|Intervention 2||2
168738|NCT00979875|406349|P6|STARTED|Intervention 2||2
168739|NCT00979875|406350|P5|STARTED|Intervention 2||3
168740|NCT00979875|406351|P4|STARTED|Intervention 2||2
168741|NCT00979875|406352|P3|STARTED|Intervention 2||3
168742|NCT00979875|406353|P2|STARTED|Intervention 2||2
168743|NCT00979875|406354|P1|STARTED|Intervention 2||2
168744|NCT00979875|406349|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
168745|NCT00979875|406350|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
168746|NCT00979875|406351|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
168747|NCT00979875|406352|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
168748|NCT00979875|406353|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
168749|NCT00979875|406354|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
168750|NCT00979875|406349|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
168751|NCT00979875|406350|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
168752|NCT00979875|406351|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
168753|NCT00979875|406352|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
168754|NCT00979875|406353|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
168755|NCT00979875|406354|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
168756|NCT00979875|406349|P6|STARTED|Washout 1 (3 to 14 Days)||2
168757|NCT00979875|406350|P5|STARTED|Washout 1 (3 to 14 Days)||3
168758|NCT00979875|406351|P4|STARTED|Washout 1 (3 to 14 Days)||2
168759|NCT00979875|406352|P3|STARTED|Washout 1 (3 to 14 Days)||3
168760|NCT00979875|406353|P2|STARTED|Washout 1 (3 to 14 Days)||2
168761|NCT00979875|406354|P1|STARTED|Washout 1 (3 to 14 Days)||2
168762|NCT00979875|406349|P6|NOT COMPLETED|Intervention 1||0
168763|NCT00979875|406350|P5|NOT COMPLETED|Intervention 1||0
168764|NCT00979875|406351|P4|NOT COMPLETED|Intervention 1||0
168765|NCT00979875|406352|P3|NOT COMPLETED|Intervention 1||0
168766|NCT00979875|406353|P2|NOT COMPLETED|Intervention 1||0
168767|NCT00979875|406354|P1|NOT COMPLETED|Intervention 1||0
168768|NCT00979875|406349|P6|COMPLETED|Intervention 1||2
168769|NCT00979875|406350|P5|COMPLETED|Intervention 1||3
168770|NCT00979875|406351|P4|COMPLETED|Intervention 1||2
168771|NCT00979875|406352|P3|COMPLETED|Intervention 1||3
168772|NCT00979875|406353|P2|COMPLETED|Intervention 1||2
168773|NCT00979875|406354|P1|COMPLETED|Intervention 1||2
168774|NCT00979875|406349|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
168775|NCT00979875|406350|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
168776|NCT00979875|406351|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
168777|NCT00979875|406352|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
168778|NCT00979875|406353|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
168779|NCT00979875|406354|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
168780|NCT00979875|406349|P6|STARTED|Intervention 1||2
168781|NCT00979875|406350|P5|STARTED|Intervention 1||3
168782|NCT00979875|406351|P4|STARTED|Intervention 1||2
168783|NCT00979875|406352|P3|STARTED|Intervention 1||3
168784|NCT00979875|406353|P2|STARTED|Intervention 1||2
168785|NCT00979875|406354|P1|STARTED|Intervention 1||2
168786|NCT00979654|406398|P1|NOT COMPLETED|Overall Study||36
168787|NCT00979654|406398|P1|COMPLETED|Overall Study||67
168788|NCT00979654|406398|P1|STARTED|Overall Study||103
168789|NCT00979628|406413|P3|NOT COMPLETED|Overall Study||6
168790|NCT00979628|406414|P2|NOT COMPLETED|Overall Study||9
168791|NCT00979628|406415|P1|NOT COMPLETED|Overall Study||9
168792|NCT00979628|406413|P3|COMPLETED|Overall Study||74
168793|NCT00979628|406414|P2|COMPLETED|Overall Study||133
168794|NCT00979628|406415|P1|COMPLETED|Overall Study||144
168795|NCT00979628|406413|P3|STARTED|Overall Study||80
168796|NCT00979628|406414|P2|STARTED|Overall Study||142
168797|NCT00979628|406415|P1|STARTED|Overall Study||153
168798|NCT00979615|406425|P2|NOT COMPLETED|Overall Study||8
168799|NCT00979615|406426|P1|NOT COMPLETED|Overall Study||6
168800|NCT00979615|406425|P2|COMPLETED|Overall Study||58
168801|NCT00979615|406426|P1|COMPLETED|Overall Study||57
168802|NCT00979615|406425|P2|STARTED|Overall Study||66
168803|NCT00979615|406426|P1|STARTED|Overall Study||63
168804|NCT00979602|406442|P2|NOT COMPLETED|Overall Study||133
168805|NCT00979602|406443|P1|NOT COMPLETED|Overall Study||145
168806|NCT00979602|406442|P2|COMPLETED|Overall Study||1890
168807|NCT00979602|406443|P1|COMPLETED|Overall Study||1880
168808|NCT00979602|406442|P2|STARTED|Overall Study||2023
168809|NCT00979602|406443|P1|STARTED|Overall Study||2025
168810|NCT00979576|406614|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
168811|NCT00979576|406615|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
168812|NCT00979576|406616|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
168813|NCT00979576|406614|P3|COMPLETED|Combination Followed by Monotherapy||0
168814|NCT00979576|406615|P2|COMPLETED|Combination Followed by Monotherapy||0
168815|NCT00979576|406616|P1|COMPLETED|Combination Followed by Monotherapy||0
168816|NCT00979576|406614|P3|STARTED|Combination Followed by Monotherapy||1
168817|NCT00979576|406615|P2|STARTED|Combination Followed by Monotherapy||2
168818|NCT00979576|406616|P1|STARTED|Combination Followed by Monotherapy||0
168819|NCT00979576|406614|P3|NOT COMPLETED|Combination Treatment Phase||9
168820|NCT00979576|406615|P2|NOT COMPLETED|Combination Treatment Phase||6
168821|NCT00979576|406616|P1|NOT COMPLETED|Combination Treatment Phase||3
168822|NCT00979576|406614|P3|COMPLETED|Combination Treatment Phase||0
168823|NCT00979576|406615|P2|COMPLETED|Combination Treatment Phase||0
168824|NCT00979576|406616|P1|COMPLETED|Combination Treatment Phase||0
168825|NCT00979576|406614|P3|STARTED|Combination Treatment Phase||9
168826|NCT00979576|406615|P2|STARTED|Combination Treatment Phase||6
168827|NCT00979576|406616|P1|STARTED|Combination Treatment Phase||3
168828|NCT00979550|406649|P2|NOT COMPLETED|Overall Study||0
168829|NCT00979550|406650|P1|NOT COMPLETED|Overall Study||0
168830|NCT00979550|406649|P2|COMPLETED|Overall Study||3
168831|NCT00979550|406650|P1|COMPLETED|Overall Study||4
168832|NCT00979550|406649|P2|STARTED|Overall Study||3
168833|NCT00979550|406650|P1|STARTED|Overall Study||4
168834|NCT00979459|406656|P2|NOT COMPLETED|Second Intervention||0
168835|NCT00979459|406657|P1|NOT COMPLETED|Second Intervention||0
168836|NCT00979459|406656|P2|COMPLETED|Second Intervention||6
168837|NCT00979459|406657|P1|COMPLETED|Second Intervention||6
168838|NCT00979459|406656|P2|STARTED|Second Intervention||6
168839|NCT00979459|406657|P1|STARTED|Second Intervention||6
168840|NCT00979459|406656|P2|NOT COMPLETED|7-day Washout Period||0
168841|NCT00979459|406657|P1|NOT COMPLETED|7-day Washout Period||0
168842|NCT00979459|406656|P2|COMPLETED|7-day Washout Period||6
168843|NCT00979459|406657|P1|COMPLETED|7-day Washout Period||6
168844|NCT00979459|406656|P2|STARTED|7-day Washout Period||6
168845|NCT00979459|406657|P1|STARTED|7-day Washout Period||6
168846|NCT00979459|406656|P2|NOT COMPLETED|First Intervention||0
168847|NCT00979459|406657|P1|NOT COMPLETED|First Intervention||0
168848|NCT00979459|406656|P2|COMPLETED|First Intervention||6
168849|NCT00979459|406657|P1|COMPLETED|First Intervention||6
168850|NCT00979459|406656|P2|STARTED|First Intervention||6
168851|NCT00979459|406657|P1|STARTED|First Intervention||6
168852|NCT00979420|406673|P4|NOT COMPLETED|Overall Study||2
168853|NCT00979420|406674|P3|NOT COMPLETED|Overall Study||1
168854|NCT00979420|406675|P2|NOT COMPLETED|Overall Study||0
168855|NCT00979420|406676|P1|NOT COMPLETED|Overall Study||7
168856|NCT00979420|406673|P4|COMPLETED|Overall Study||59
168857|NCT00979420|406674|P3|COMPLETED|Overall Study||59
168858|NCT00979420|406675|P2|COMPLETED|Overall Study||57
168859|NCT00979420|406676|P1|COMPLETED|Overall Study||171
168860|NCT00979420|406673|P4|STARTED|Overall Study||61
168861|NCT00979420|406674|P3|STARTED|Overall Study||60
168862|NCT00979420|406675|P2|STARTED|Overall Study||57
168863|NCT00979420|406676|P1|STARTED|Overall Study||178
168864|NCT00979303|406746|P2|NOT COMPLETED|Overall Study||0
168865|NCT00979303|406747|P1|NOT COMPLETED|Overall Study||0
168866|NCT00979303|406746|P2|COMPLETED|Overall Study||37
168867|NCT00979303|406747|P1|COMPLETED|Overall Study||37
168868|NCT00979303|406746|P2|STARTED|Overall Study||37
168869|NCT00979303|406747|P1|STARTED|Overall Study||37
168870|NCT00979212|406757|P2|NOT COMPLETED|Overall Study||8
168871|NCT00979212|406758|P1|NOT COMPLETED|Overall Study||2
168872|NCT00979212|406757|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
168873|NCT00979212|406758|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
168874|NCT00979212|406757|P2|STARTED|Overall Study||47
168875|NCT00979212|406758|P1|STARTED|Overall Study||24
168876|NCT00979199|406776|P1|NOT COMPLETED|Overall Study||222
168877|NCT00979199|406776|P1|COMPLETED|Overall Study||475
168878|NCT00979199|406776|P1|STARTED|Overall Study||697
168879|NCT00979121|406782|P2|NOT COMPLETED|Overall Study||0
168880|NCT00979121|406783|P1|NOT COMPLETED|Overall Study||0
168881|NCT00979121|406782|P2|COMPLETED|Overall Study||366
168882|NCT00979121|406783|P1|COMPLETED|Overall Study||379
168883|NCT00979121|406782|P2|STARTED|Overall Study||366
168884|NCT00979121|406783|P1|STARTED|Overall Study||379
168885|NCT00979069|406801|P2|NOT COMPLETED|Overall Study||2
168886|NCT00979069|406802|P1|NOT COMPLETED|Overall Study||0
168887|NCT00979069|406801|P2|COMPLETED|Overall Study||8
168888|NCT00979069|406802|P1|COMPLETED|Overall Study||10
168889|NCT00979069|406801|P2|STARTED|Overall Study||10
168890|NCT00979069|406802|P1|STARTED|Overall Study||10
168891|NCT00979017|406808|P1|NOT COMPLETED|Overall Study||0
168892|NCT00979017|406808|P1|COMPLETED|Overall Study||41
168893|NCT00979017|406808|P1|STARTED|Overall Study||41
168894|NCT00978757|406818|P2|NOT COMPLETED|Overall Study||3
168895|NCT00978757|406819|P1|NOT COMPLETED|Overall Study||1
168896|NCT00978757|406818|P2|COMPLETED|Overall Study|Junio 2008|17
168897|NCT00978757|406819|P1|COMPLETED|Overall Study|Junio 2008|21
168898|NCT00978757|406818|P2|STARTED|Overall Study|Junio 2001|20
168899|NCT00978757|406819|P1|STARTED|Overall Study|Junio 2001|22
168900|NCT00978731|406829|P4|NOT COMPLETED|Overall Study||4
168901|NCT00978731|406830|P3|NOT COMPLETED|Overall Study||5
168902|NCT00978731|406831|P2|NOT COMPLETED|Overall Study||15
168903|NCT00978731|406832|P1|NOT COMPLETED|Overall Study||22
168904|NCT00978731|406829|P4|COMPLETED|Overall Study||0
168905|NCT00978731|406830|P3|COMPLETED|Overall Study||0
168906|NCT00978731|406831|P2|COMPLETED|Overall Study||0
168907|NCT00978731|406832|P1|COMPLETED|Overall Study||0
168908|NCT00978731|406829|P4|STARTED|Overall Study||4
168909|NCT00978731|406830|P3|STARTED|Overall Study||5
168910|NCT00978731|406831|P2|STARTED|Overall Study||15
168911|NCT00978731|406832|P1|STARTED|Overall Study||22
168912|NCT00978627|406872|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
168913|NCT00978627|406873|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
168914|NCT00978627|406872|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
168915|NCT00978627|406873|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
168916|NCT00978627|406872|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
168917|NCT00978627|406873|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
168918|NCT00978627|406872|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
168919|NCT00978627|406873|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
168920|NCT00978627|406872|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
168921|NCT00978627|406873|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
168922|NCT00978627|406872|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
168923|NCT00978627|406873|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
168924|NCT00978627|406872|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
168925|NCT00978627|406873|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
168926|NCT00978562|406895|P1|NOT COMPLETED|Overall Study||0
168927|NCT00978562|406895|P1|COMPLETED|Overall Study||7
168928|NCT00978562|406895|P1|STARTED|Overall Study||7
168929|NCT00978445|406900|P2|NOT COMPLETED|Overall Study||1
168930|NCT00978445|406901|P1|NOT COMPLETED|Overall Study||2
168931|NCT00978445|406900|P2|COMPLETED|Overall Study||12
168932|NCT00978445|406901|P1|COMPLETED|Overall Study||10
168933|NCT00978445|406900|P2|STARTED|Overall Study||13
168934|NCT00978445|406901|P1|STARTED|Overall Study||12
168935|NCT00978432|406911|P3|NOT COMPLETED|Overall Study||5
168936|NCT00978432|406912|P2|NOT COMPLETED|Overall Study||1
168937|NCT00978432|406913|P1|NOT COMPLETED|Overall Study||3
168938|NCT00978432|406911|P3|COMPLETED|Overall Study||13
168939|NCT00978432|406912|P2|COMPLETED|Overall Study||4
168940|NCT00978432|406913|P1|COMPLETED|Overall Study||7
168941|NCT00978432|406911|P3|STARTED|Overall Study||18
168942|NCT00978432|406912|P2|STARTED|Overall Study||5
168943|NCT00978432|406913|P1|STARTED|Overall Study||10
168944|NCT00978380|406933|P1|NOT COMPLETED|Overall Study||19
168945|NCT00978380|406933|P1|COMPLETED|Overall Study||44
168946|NCT00978380|406933|P1|STARTED|Overall Study||63
168947|NCT00978341|406939|P2|NOT COMPLETED|Second Intervention||0
168948|NCT00978341|406940|P1|NOT COMPLETED|Second Intervention||0
168949|NCT00978341|406939|P2|COMPLETED|Second Intervention||7
168950|NCT00978341|406940|P1|COMPLETED|Second Intervention||7
168951|NCT00978341|406939|P2|STARTED|Second Intervention||7
168952|NCT00978341|406940|P1|STARTED|Second Intervention||7
168953|NCT00978341|406939|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
168954|NCT00978341|406940|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
168955|NCT00978341|406939|P2|COMPLETED|Washout Period of 2 Weeks||7
168956|NCT00978341|406940|P1|COMPLETED|Washout Period of 2 Weeks||7
168957|NCT00978341|406939|P2|STARTED|Washout Period of 2 Weeks||7
168958|NCT00978341|406940|P1|STARTED|Washout Period of 2 Weeks||8
168959|NCT00978341|406939|P2|NOT COMPLETED|First Intervention||0
168960|NCT00978341|406940|P1|NOT COMPLETED|First Intervention||0
168961|NCT00978341|406939|P2|COMPLETED|First Intervention||7
168962|NCT00978341|406940|P1|COMPLETED|First Intervention||8
168963|NCT00978341|406939|P2|STARTED|First Intervention||7
168964|NCT00978341|406940|P1|STARTED|First Intervention||8
168965|NCT00978120|406962|P4|NOT COMPLETED|Overall Study||2
168966|NCT00978120|406963|P3|NOT COMPLETED|Overall Study||3
168967|NCT00978120|406964|P2|NOT COMPLETED|Overall Study||0
168968|NCT00978120|406965|P1|NOT COMPLETED|Overall Study||2
168969|NCT00978120|406962|P4|COMPLETED|Overall Study||84
168970|NCT00978120|406963|P3|COMPLETED|Overall Study||84
168971|NCT00978120|406964|P2|COMPLETED|Overall Study||107
168972|NCT00978120|406965|P1|COMPLETED|Overall Study||108
168973|NCT00978120|406962|P4|STARTED|Overall Study||86
168974|NCT00978120|406963|P3|STARTED|Overall Study||87
168975|NCT00978120|406964|P2|STARTED|Overall Study||107
168976|NCT00978120|406965|P1|STARTED|Overall Study||110
168977|NCT00978042|407017|P2|NOT COMPLETED|Received Repeat Treatment||3
168978|NCT00978042|407018|P1|NOT COMPLETED|Received Repeat Treatment||43
168979|NCT00978042|407017|P2|COMPLETED|Received Repeat Treatment||23
168980|NCT00978042|407018|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
168981|NCT00978042|407017|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
168982|NCT00978042|407018|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
168983|NCT00978042|407017|P2|NOT COMPLETED|Initial Treatment Period||15
168984|NCT00978042|407018|P1|NOT COMPLETED|Initial Treatment Period||61
168985|NCT00978042|407017|P2|COMPLETED|Initial Treatment Period||32
168986|NCT00978042|407018|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
168987|NCT00978042|407017|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
168988|NCT00978042|407018|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
168989|NCT00978042|407017|P2|STARTED|Initial Treatment Period||47
168990|NCT00978042|407018|P1|STARTED|Initial Treatment Period||235
168991|NCT00978029|407031|P3|NOT COMPLETED|Overall Study||6
168992|NCT00978029|407032|P2|NOT COMPLETED|Overall Study||3
168993|NCT00978029|407033|P1|NOT COMPLETED|Overall Study||1
168994|NCT00978029|407031|P3|COMPLETED|Overall Study||59
168995|NCT00978029|407032|P2|COMPLETED|Overall Study||63
168996|NCT00978029|407033|P1|COMPLETED|Overall Study||64
168997|NCT00978029|407031|P3|STARTED|Overall Study||65
168998|NCT00978029|407032|P2|STARTED|Overall Study||66
168999|NCT00978029|407033|P1|STARTED|Overall Study||65
169000|NCT00977938|407060|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
169001|NCT00977938|407061|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
169002|NCT00977938|407062|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
169003|NCT00977938|407063|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
169004|NCT00977938|407060|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
169005|NCT00977938|407061|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
169006|NCT00977938|407062|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
169007|NCT00977938|407063|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
169008|NCT00977938|407060|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
169009|NCT00977938|407061|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
169010|NCT00977938|407062|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
169011|NCT00977938|407063|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
169012|NCT00977938|407060|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
169013|NCT00977938|407061|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
169014|NCT00977938|407062|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
169015|NCT00977938|407063|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
169016|NCT00977938|407060|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
169017|NCT00977938|407061|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
169018|NCT00977938|407062|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
169019|NCT00977938|407063|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
169020|NCT00977938|407060|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
169021|NCT00977938|407061|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
169022|NCT00977938|407062|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
169023|NCT00977938|407063|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
169024|NCT00977808|407097|P1|NOT COMPLETED|Overall Study||1
169025|NCT00977808|407097|P1|COMPLETED|Overall Study||11
169026|NCT00977808|407097|P1|Completion of Closed-Loop Admission|Overall Study||11
169027|NCT00977808|407097|P1|Completion of Open-Loop Admission|Overall Study||12
169028|NCT00977808|407097|P1|STARTED|Overall Study||12
169029|NCT00977769|407105|P3|NOT COMPLETED|Overall Study||0
169030|NCT00977769|407106|P2|NOT COMPLETED|Overall Study||0
169031|NCT00977769|407107|P1|NOT COMPLETED|Overall Study||0
169032|NCT00977769|407105|P3|COMPLETED|Overall Study||25
169033|NCT00977769|407106|P2|COMPLETED|Overall Study||26
169034|NCT00977769|407107|P1|COMPLETED|Overall Study||25
169035|NCT00977769|407105|P3|STARTED|Overall Study||25
169036|NCT00977769|407106|P2|STARTED|Overall Study||26
169037|NCT00977769|407107|P1|STARTED|Overall Study||25
169038|NCT00977704|407121|P1|NOT COMPLETED|Overall Study||0
169039|NCT00977704|407121|P1|COMPLETED|Overall Study||20
169040|NCT00977704|407121|P1|STARTED|Overall Study||20
169041|NCT00977665|407127|P2|NOT COMPLETED|Overall Study||15
169042|NCT00977665|407128|P1|NOT COMPLETED|Overall Study||21
169043|NCT00977665|407127|P2|COMPLETED|Overall Study||75
169044|NCT00977665|407128|P1|COMPLETED|Overall Study||63
169045|NCT00977665|407127|P2|STARTED|Overall Study||90
169046|NCT00977665|407128|P1|STARTED|Overall Study||84
169047|NCT00977613|407160|P1|NOT COMPLETED|Overall Study||16
169048|NCT00977613|407160|P1|COMPLETED|Overall Study||34
169049|NCT00977613|407160|P1|STARTED|Overall Study||50
169050|NCT00977574|407167|P3|NOT COMPLETED|Overall Study||4
169051|NCT00977574|407168|P2|NOT COMPLETED|Overall Study||2
169052|NCT00977574|407169|P1|NOT COMPLETED|Overall Study||4
169053|NCT00977574|407167|P3|COMPLETED|Overall Study||114
169054|NCT00977574|407168|P2|COMPLETED|Overall Study||113
169055|NCT00977574|407169|P1|COMPLETED|Overall Study||112
169056|NCT00977574|407167|P3|STARTED|Overall Study||118
169057|NCT00977574|407168|P2|STARTED|Overall Study||115
169058|NCT00977574|407169|P1|STARTED|Overall Study||116
169059|NCT00977561|407188|P2|NOT COMPLETED|Overall Study||4
169060|NCT00977561|407189|P1|NOT COMPLETED|Overall Study||5
169061|NCT00977561|407188|P2|COMPLETED|Overall Study||0
169062|NCT00977561|407189|P1|COMPLETED|Overall Study||0
169063|NCT00977561|407188|P2|STARTED|Overall Study||4
169064|NCT00977561|407189|P1|STARTED|Overall Study||5
169065|NCT00977548|407216|P1|NOT COMPLETED|Overall Study||13
169066|NCT00977548|407216|P1|COMPLETED|Overall Study||26
169067|NCT00977548|407216|P1|STARTED|Overall Study||39
169068|NCT00977470|407225|P2|NOT COMPLETED|Overall Study||38
169069|NCT00977470|407226|P1|NOT COMPLETED|Overall Study||38
169070|NCT00977470|407225|P2|COMPLETED|Overall Study||0
169071|NCT00977470|407226|P1|COMPLETED|Overall Study||0
169072|NCT00977470|407225|P2|STARTED|Overall Study||38
169073|NCT00977470|407226|P1|STARTED|Overall Study||38
169074|NCT00977379|407246|P2|NOT COMPLETED|Overall Study||12
169075|NCT00977379|407247|P1|NOT COMPLETED|Overall Study||12
169076|NCT00977379|407246|P2|COMPLETED|Overall Study||0
169077|NCT00977379|407247|P1|COMPLETED|Overall Study||0
169078|NCT00977379|407246|P2|Treated|Overall Study||11
169079|NCT00977379|407247|P1|Treated|Overall Study||12
169080|NCT00977379|407246|P2|STARTED|Overall Study|Randomized|12
169081|NCT00977379|407247|P1|STARTED|Overall Study|Randomized|12
169082|NCT00977314|407283|P2|NOT COMPLETED|Overall Study||0
169083|NCT00977314|407284|P1|NOT COMPLETED|Overall Study||2
169084|NCT00977314|407283|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
169085|NCT00977314|407284|P1|COMPLETED|Overall Study||28
169086|NCT00977314|407283|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
169087|NCT00977314|407284|P1|STARTED|Overall Study||30
169088|NCT00977197|407292|P2|NOT COMPLETED|Overall Study||9
169089|NCT00977197|407293|P1|NOT COMPLETED|Overall Study||9
169090|NCT00977197|407292|P2|COMPLETED|Overall Study||35
169091|NCT00977197|407293|P1|COMPLETED|Overall Study||32
169092|NCT00977197|407292|P2|STARTED|Overall Study||44
169093|NCT00977197|407293|P1|STARTED|Overall Study||41
169094|NCT00977184|407323|P2|NOT COMPLETED|Overall Study||0
169095|NCT00977184|407324|P1|NOT COMPLETED|Overall Study||0
169096|NCT00977184|407323|P2|COMPLETED|Overall Study||13
169097|NCT00977184|407324|P1|COMPLETED|Overall Study||13
169098|NCT00977184|407323|P2|STARTED|Overall Study||13
169099|NCT00977184|407324|P1|STARTED|Overall Study||13
169100|NCT00977171|407350|P1|NOT COMPLETED|Overall Study||0
169101|NCT00977171|407350|P1|COMPLETED|Overall Study||3
169102|NCT00977171|407350|P1|STARTED|Overall Study||3
169103|NCT00977106|407356|P2|NOT COMPLETED|Overall Study||11
169104|NCT00977106|407357|P1|NOT COMPLETED|Overall Study||10
169105|NCT00977106|407356|P2|COMPLETED|Overall Study||45
169106|NCT00977106|407357|P1|COMPLETED|Overall Study||37
169107|NCT00977106|407356|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
169108|NCT00977106|407357|P1|STARTED|Overall Study||47
169109|NCT00977080|407449|P4|NOT COMPLETED|Overall Study||17
169110|NCT00977080|407450|P3|NOT COMPLETED|Overall Study||16
169111|NCT00977080|407451|P2|NOT COMPLETED|Overall Study||20
169112|NCT00977080|407452|P1|NOT COMPLETED|Overall Study||12
169113|NCT00977080|407449|P4|COMPLETED|Overall Study||53
169114|NCT00977080|407450|P3|COMPLETED|Overall Study||56
169115|NCT00977080|407451|P2|COMPLETED|Overall Study||44
169116|NCT00977080|407452|P1|COMPLETED|Overall Study||50
169117|NCT00977080|407449|P4|STARTED|Overall Study||70
169118|NCT00977080|407450|P3|STARTED|Overall Study||72
169119|NCT00977080|407451|P2|STARTED|Overall Study||64
169120|NCT00977080|407452|P1|STARTED|Overall Study||62
169121|NCT00976989|407485|P3|NOT COMPLETED|Overall Study||17
169122|NCT00976989|407486|P2|NOT COMPLETED|Overall Study||12
169123|NCT00976989|407487|P1|NOT COMPLETED|Overall Study||13
169124|NCT00976989|407485|P3|COMPLETED|Overall Study||60
169125|NCT00976989|407486|P2|COMPLETED|Overall Study||63
169126|NCT00976989|407487|P1|COMPLETED|Overall Study||60
169127|NCT00976989|407485|P3|STARTED|Overall Study||77
169128|NCT00976989|407486|P2|STARTED|Overall Study||75
169129|NCT00976989|407487|P1|STARTED|Overall Study||73
169130|NCT00976950|407528|P1|NOT COMPLETED|Overall Study||6
169131|NCT00976950|407528|P1|COMPLETED|Overall Study||36
169132|NCT00976950|407528|P1|STARTED|Overall Study||42
169133|NCT00976937|407536|P2|NOT COMPLETED|Overall Study||11
169134|NCT00976937|407537|P1|NOT COMPLETED|Overall Study||16
169135|NCT00976937|407536|P2|COMPLETED|Overall Study||150
169136|NCT00976937|407537|P1|COMPLETED|Overall Study||142
169137|NCT00976937|407536|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
169138|NCT00976937|407537|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
169139|NCT00976937|407536|P2|Treated/Safety Population|Overall Study||161
169140|NCT00976937|407537|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
169141|NCT00976937|407536|P2|STARTED|Overall Study||161
169142|NCT00976937|407537|P1|STARTED|Overall Study|Randomized|158
169143|NCT00976911|407579|P2|NOT COMPLETED|Overall Study||179
169144|NCT00976911|407580|P1|NOT COMPLETED|Overall Study||182
169145|NCT00976911|407579|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
169146|NCT00976911|407580|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
169147|NCT00976911|407579|P2|STARTED|Overall Study||179
169148|NCT00976911|407580|P1|STARTED|Overall Study||182
169149|NCT00976898|407598|P1|NOT COMPLETED|Overall Study||5
169150|NCT00976898|407598|P1|COMPLETED|Overall Study||78
169151|NCT00976898|407598|P1|STARTED|Overall Study||83
169152|NCT00976820|407609|P4|NOT COMPLETED|Overall Study||7
169153|NCT00976820|407610|P3|NOT COMPLETED|Overall Study||4
169154|NCT00976820|407611|P2|NOT COMPLETED|Overall Study||20
169155|NCT00976820|407612|P1|NOT COMPLETED|Overall Study||8
169156|NCT00976820|407609|P4|COMPLETED|Overall Study||56
169157|NCT00976820|407610|P3|COMPLETED|Overall Study||60
169158|NCT00976820|407611|P2|COMPLETED|Overall Study||108
169159|NCT00976820|407612|P1|COMPLETED|Overall Study||59
169160|NCT00976820|407609|P4|STARTED|Overall Study||63
169161|NCT00976820|407610|P3|STARTED|Overall Study||64
169162|NCT00976820|407611|P2|STARTED|Overall Study||128
169163|NCT00976820|407612|P1|STARTED|Overall Study||67
169164|NCT00976716|407948|P1|NOT COMPLETED|Overall Study||1
169165|NCT00976716|407948|P1|COMPLETED|Overall Study||79
169166|NCT00976716|407948|P1|STARTED|Overall Study||80
169167|NCT00976703|407966|P2|NOT COMPLETED|Overall Study||3
169168|NCT00976703|407967|P1|NOT COMPLETED|Overall Study||3
169169|NCT00976703|407966|P2|COMPLETED|Overall Study||95
169170|NCT00976703|407967|P1|COMPLETED|Overall Study||96
169171|NCT00976703|407966|P2|STARTED|Overall Study||98
169172|NCT00976703|407967|P1|STARTED|Overall Study||99
169173|NCT00976677|407981|P2|NOT COMPLETED|Overall Study||5
169174|NCT00976677|407982|P1|NOT COMPLETED|Overall Study||5
169175|NCT00976677|407981|P2|COMPLETED|Overall Study||0
169176|NCT00976677|407982|P1|COMPLETED|Overall Study||0
169177|NCT00976677|407981|P2|STARTED|Overall Study||5
169178|NCT00976677|407982|P1|STARTED|Overall Study||5
169179|NCT00976664|407990|P2|NOT COMPLETED|Overall Study||1
169180|NCT00976664|407991|P1|NOT COMPLETED|Overall Study||3
169181|NCT00976664|407990|P2|COMPLETED|Overall Study||24
169182|NCT00976664|407991|P1|COMPLETED|Overall Study||22
169183|NCT00976664|407990|P2|STARTED|Overall Study||25
169184|NCT00976664|407991|P1|STARTED|Overall Study||25
169185|NCT00976599|408001|P2|NOT COMPLETED|Overall Study||0
169186|NCT00976599|408002|P1|NOT COMPLETED|Overall Study||0
169187|NCT00976599|408001|P2|COMPLETED|Overall Study||14
169188|NCT00976599|408002|P1|COMPLETED|Overall Study||15
169189|NCT00976599|408001|P2|STARTED|Overall Study||14
169190|NCT00976599|408002|P1|STARTED|Overall Study||15
169191|NCT00976573|408190|P2|NOT COMPLETED|Overall Study||3
169192|NCT00976573|408191|P1|NOT COMPLETED|Overall Study||4
169193|NCT00976573|408190|P2|COMPLETED|Overall Study||71
169194|NCT00976573|408191|P1|COMPLETED|Overall Study||71
169195|NCT00976573|408190|P2|STARTED|Overall Study||74
169196|NCT00976573|408191|P1|STARTED|Overall Study||75
169197|NCT00976560|408205|P2|NOT COMPLETED|Overall Study||13
169198|NCT00976560|408206|P1|NOT COMPLETED|Overall Study||14
169199|NCT00976560|408205|P2|COMPLETED|Overall Study||51
169200|NCT00976560|408206|P1|COMPLETED|Overall Study||50
169201|NCT00976560|408205|P2|STARTED|Overall Study||64
169202|NCT00976560|408206|P1|STARTED|Overall Study||64
169203|NCT00976521|408258|P4|NOT COMPLETED|Overall Study||19
169204|NCT00976521|408259|P3|NOT COMPLETED|Overall Study||9
169205|NCT00976521|408260|P2|NOT COMPLETED|Overall Study||12
169206|NCT00976521|408261|P1|NOT COMPLETED|Overall Study||9
169207|NCT00976521|408258|P4|COMPLETED|Overall Study||93
169208|NCT00976521|408259|P3|COMPLETED|Overall Study||102
169209|NCT00976521|408260|P2|COMPLETED|Overall Study||99
169210|NCT00976521|408261|P1|COMPLETED|Overall Study||109
169211|NCT00976521|408258|P4|STARTED|Overall Study||112
169212|NCT00976521|408259|P3|STARTED|Overall Study||111
169213|NCT00976521|408260|P2|STARTED|Overall Study||111
169214|NCT00976521|408261|P1|STARTED|Overall Study||118
169215|NCT00976508|408275|P2|NOT COMPLETED|Overall Study||6
169216|NCT00976508|408276|P1|NOT COMPLETED|Overall Study||14
169217|NCT00976508|408275|P2|COMPLETED|Overall Study||0
169218|NCT00976508|408276|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
169219|NCT00976508|408275|P2|STARTED|Overall Study||6
169220|NCT00976508|408276|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
169221|NCT00976495|408309|P3|NOT COMPLETED|Overall Study||0
169222|NCT00976495|408310|P2|NOT COMPLETED|Overall Study||1
169223|NCT00976495|408311|P1|NOT COMPLETED|Overall Study||0
169224|NCT00976495|408309|P3|COMPLETED|Overall Study||26
169225|NCT00976495|408310|P2|COMPLETED|Overall Study||23
169226|NCT00976495|408311|P1|COMPLETED|Overall Study||25
169227|NCT00976495|408309|P3|STARTED|Overall Study||26
169228|NCT00976495|408310|P2|STARTED|Overall Study||24
169229|NCT00976495|408311|P1|STARTED|Overall Study||25
169230|NCT00976482|408328|P1|NOT COMPLETED|Overall Study||259
169231|NCT00976482|408328|P1|COMPLETED|Overall Study||1486
169232|NCT00976482|408328|P1|Eligible for Last Follow up|Overall Study||1487
169233|NCT00976482|408328|P1|STARTED|Overall Study||1745
169234|NCT00976456|408334|P2|NOT COMPLETED|Overall Study||38
169235|NCT00976456|408335|P1|NOT COMPLETED|Overall Study||43
169236|NCT00976456|408334|P2|COMPLETED|Overall Study||98
169237|NCT00976456|408335|P1|COMPLETED|Overall Study||92
169238|NCT00976456|408334|P2|STARTED|Overall Study||136
169239|NCT00976456|408335|P1|STARTED|Overall Study||135
169240|NCT00976404|408345|P2|NOT COMPLETED|Overall Study||0
169241|NCT00976404|408346|P1|NOT COMPLETED|Overall Study||0
169242|NCT00976404|408345|P2|COMPLETED|Overall Study||14
169243|NCT00976404|408346|P1|COMPLETED|Overall Study||14
169244|NCT00976404|408345|P2|STARTED|Overall Study||14
169245|NCT00976404|408346|P1|STARTED|Overall Study||14
169246|NCT00976391|408362|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
169247|NCT00976391|408363|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
169248|NCT00976391|408362|P2|COMPLETED|Follow-up Period (8 Weeks)||247
169249|NCT00976391|408363|P1|COMPLETED|Follow-up Period (8 Weeks)||256
169250|NCT00976391|408362|P2|STARTED|Follow-up Period (8 Weeks)||281
169251|NCT00976391|408363|P1|STARTED|Follow-up Period (8 Weeks)||285
169252|NCT00976391|408362|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
169253|NCT00976391|408363|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
169254|NCT00976391|408362|P2|COMPLETED|Treatment Period (52 Weeks)||242
169255|NCT00976391|408363|P1|COMPLETED|Treatment Period (52 Weeks)||243
169256|NCT00976391|408362|P2|STARTED|Treatment Period (52 Weeks)||281
169257|NCT00976391|408363|P1|STARTED|Treatment Period (52 Weeks)||285
169258|NCT00976352|408385|P2|NOT COMPLETED|Overall Study||4
169259|NCT00976352|408386|P1|NOT COMPLETED|Overall Study||0
169260|NCT00976352|408385|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
169261|NCT00976352|408386|P1|COMPLETED|Overall Study||3
169262|NCT00976352|408385|P2|STARTED|Overall Study||10
169263|NCT00976352|408386|P1|STARTED|Overall Study||3
169264|NCT00976339|408400|P2|NOT COMPLETED|Overall Study||0
169265|NCT00976339|408401|P1|NOT COMPLETED|Overall Study||0
169266|NCT00976339|408400|P2|COMPLETED|Overall Study||10
169267|NCT00976339|408401|P1|COMPLETED|Overall Study||10
169268|NCT00976339|408400|P2|STARTED|Overall Study||10
169269|NCT00976339|408401|P1|STARTED|Overall Study||10
169270|NCT00976274|408411|P2|NOT COMPLETED|Overall Study||8
169271|NCT00976274|408412|P1|NOT COMPLETED|Overall Study||7
169272|NCT00976274|408411|P2|COMPLETED|Overall Study||21
169273|NCT00976274|408412|P1|COMPLETED|Overall Study||24
169274|NCT00976274|408411|P2|STARTED|Overall Study||29
169275|NCT00976274|408412|P1|STARTED|Overall Study||31
169276|NCT00976248|408420|P1|NOT COMPLETED|Overall Study||0
169277|NCT00976248|408420|P1|COMPLETED|Overall Study||33
169278|NCT00976248|408420|P1|STARTED|Overall Study||33
169279|NCT00976209|408428|P2|NOT COMPLETED|Treatment Period 2||2
169280|NCT00976209|408429|P1|NOT COMPLETED|Treatment Period 2||0
169281|NCT00976209|408428|P2|COMPLETED|Treatment Period 2||161
169282|NCT00976209|408429|P1|COMPLETED|Treatment Period 2||158
169283|NCT00976209|408428|P2|STARTED|Treatment Period 2||163
169284|NCT00976209|408429|P1|STARTED|Treatment Period 2||158
169285|NCT00976209|408428|P2|NOT COMPLETED|Wash-out Period||2
169286|NCT00976209|408429|P1|NOT COMPLETED|Wash-out Period||4
169287|NCT00976209|408428|P2|COMPLETED|Wash-out Period||163
169288|NCT00976209|408429|P1|COMPLETED|Wash-out Period||158
169289|NCT00976209|408428|P2|STARTED|Wash-out Period||165
169290|NCT00976209|408429|P1|STARTED|Wash-out Period||162
169291|NCT00976209|408428|P2|NOT COMPLETED|Treatment Period 1||1
169292|NCT00976209|408429|P1|NOT COMPLETED|Treatment Period 1||3
169293|NCT00976209|408428|P2|COMPLETED|Treatment Period 1||165
169294|NCT00976209|408429|P1|COMPLETED|Treatment Period 1||162
169295|NCT00976209|408428|P2|STARTED|Treatment Period 1||166
169296|NCT00976209|408429|P1|STARTED|Treatment Period 1||165
169297|NCT00976183|408435|P1|NOT COMPLETED|Overall Study||0
169298|NCT00976183|408435|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
169299|NCT00976183|408435|P1|STARTED|Overall Study||18
169300|NCT00976027|408442|P2|NOT COMPLETED|Overall Study||215
169301|NCT00976027|408443|P1|NOT COMPLETED|Overall Study||411
169302|NCT00976027|408442|P2|COMPLETED|Overall Study||2835
169303|NCT00976027|408443|P1|COMPLETED|Overall Study||5697
169304|NCT00976027|408442|P2|STARTED|Overall Study||3050
169305|NCT00976027|408443|P1|STARTED|Overall Study||6108
169306|NCT00975975|408455|P1|NOT COMPLETED|Overall Study||6
169307|NCT00975975|408455|P1|COMPLETED|Overall Study||11
169308|NCT00975975|408455|P1|STARTED|Overall Study||17
169309|NCT00975923|408463|P2|NOT COMPLETED|Overall Study||1
169310|NCT00975923|408464|P1|NOT COMPLETED|Overall Study||0
169311|NCT00975923|408463|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
169312|NCT00975923|408464|P1|COMPLETED|Overall Study||30
169313|NCT00975923|408463|P2|STARTED|Overall Study||30
169314|NCT00975923|408464|P1|STARTED|Overall Study||30
169315|NCT00975806|408475|P3|NOT COMPLETED|Overall Study||4
169316|NCT00975806|408476|P2|NOT COMPLETED|Overall Study||7
169317|NCT00975806|408477|P1|NOT COMPLETED|Overall Study||5
169318|NCT00975806|408475|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
169319|NCT00975806|408476|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
169320|NCT00975806|408477|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
169321|NCT00975806|408475|P3|STARTED|Overall Study||4
169322|NCT00975806|408476|P2|STARTED|Overall Study||7
169323|NCT00975806|408477|P1|STARTED|Overall Study||5
169324|NCT00975780|408501|P2|NOT COMPLETED|Follow Up||157
169325|NCT00975780|408502|P1|NOT COMPLETED|Follow Up||102
169326|NCT00975780|408501|P2|COMPLETED|Follow Up||277
169327|NCT00975780|408502|P1|COMPLETED|Follow Up||298
169328|NCT00975780|408501|P2|STARTED|Follow Up||434
169329|NCT00975780|408502|P1|STARTED|Follow Up||400
169330|NCT00975780|408501|P2|NOT COMPLETED|Allocation||0
169331|NCT00975780|408502|P1|NOT COMPLETED|Allocation||0
169332|NCT00975780|408501|P2|COMPLETED|Allocation||434
169333|NCT00975780|408502|P1|COMPLETED|Allocation||400
169334|NCT00975780|408501|P2|STARTED|Allocation||434
169335|NCT00975780|408502|P1|STARTED|Allocation||400
169336|NCT00975715|408512|P2|NOT COMPLETED|Maintenance Period||1
169337|NCT00975715|408513|P1|NOT COMPLETED|Maintenance Period||2
169338|NCT00975715|408512|P2|COMPLETED|Maintenance Period||50
169339|NCT00975715|408513|P1|COMPLETED|Maintenance Period||39
169340|NCT00975715|408512|P2|STARTED|Maintenance Period||51
169341|NCT00975715|408513|P1|STARTED|Maintenance Period||41
169342|NCT00975715|408512|P2|NOT COMPLETED|Titration Period||0
169343|NCT00975715|408513|P1|NOT COMPLETED|Titration Period||7
169344|NCT00975715|408512|P2|COMPLETED|Titration Period||51
169345|NCT00975715|408513|P1|COMPLETED|Titration Period||41
169346|NCT00975715|408512|P2|STARTED|Titration Period||51
169347|NCT00975715|408513|P1|STARTED|Titration Period||48
169348|NCT00975689|408529|P2|NOT COMPLETED|Overall Study||3
169349|NCT00975689|408530|P1|NOT COMPLETED|Overall Study||2
169350|NCT00975689|408529|P2|COMPLETED|Overall Study||15
169351|NCT00975689|408530|P1|COMPLETED|Overall Study||15
169352|NCT00975689|408529|P2|STARTED|Overall Study||18
169353|NCT00975689|408530|P1|STARTED|Overall Study||17
169354|NCT00975637|408541|P5|NOT COMPLETED|Overall Study||2
169355|NCT00975637|408542|P4|NOT COMPLETED|Overall Study||6
169356|NCT00975637|408543|P3|NOT COMPLETED|Overall Study||2
169357|NCT00975637|408544|P2|NOT COMPLETED|Overall Study||1
169358|NCT00975637|408545|P1|NOT COMPLETED|Overall Study||3
169359|NCT00975637|408541|P5|COMPLETED|Overall Study||37
169360|NCT00975637|408542|P4|COMPLETED|Overall Study||32
169361|NCT00975637|408543|P3|COMPLETED|Overall Study||40
169362|NCT00975637|408544|P2|COMPLETED|Overall Study||38
169363|NCT00975637|408545|P1|COMPLETED|Overall Study||37
169364|NCT00975637|408541|P5|STARTED|Overall Study||39
169365|NCT00975637|408542|P4|STARTED|Overall Study||38
169366|NCT00975637|408543|P3|STARTED|Overall Study||42
169367|NCT00975637|408544|P2|STARTED|Overall Study||39
169368|NCT00975637|408545|P1|STARTED|Overall Study||40
169369|NCT00975611|408562|P1|NOT COMPLETED|Overall Study||17
169370|NCT00975611|408562|P1|COMPLETED|Overall Study||5
169371|NCT00975611|408562|P1|STARTED|Overall Study||22
169372|NCT00975585|408568|P2|NOT COMPLETED|Overall Study||12
169373|NCT00975585|408569|P1|NOT COMPLETED|Overall Study||7
169374|NCT00975585|408568|P2|COMPLETED|Overall Study||183
169375|NCT00975585|408569|P1|COMPLETED|Overall Study||177
169376|NCT00975585|408568|P2|STARTED|Overall Study||195
169377|NCT00975585|408569|P1|STARTED|Overall Study||184
169378|NCT00975507|408589|P2|NOT COMPLETED|Overall Study||4
169379|NCT00975507|408590|P1|NOT COMPLETED|Overall Study||20
169380|NCT00975507|408589|P2|COMPLETED|Overall Study||153
169381|NCT00975507|408590|P1|COMPLETED|Overall Study||303
169382|NCT00975507|408589|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
169383|NCT00975507|408590|P1|Vaccinated at Visit 2|Overall Study||310
169384|NCT00975507|408589|P2|Vaccinated at Visit 1|Overall Study||157
169385|NCT00975507|408590|P1|Vaccinated at Visit 1|Overall Study||323
169386|NCT00975507|408589|P2|STARTED|Overall Study||157
169387|NCT00975507|408590|P1|STARTED|Overall Study||323
169388|NCT00975481|408610|P6|NOT COMPLETED|Sixth Intervention Period||0
169389|NCT00975481|408611|P5|NOT COMPLETED|Sixth Intervention Period||0
169390|NCT00975481|408612|P4|NOT COMPLETED|Sixth Intervention Period||0
169391|NCT00975481|408613|P3|NOT COMPLETED|Sixth Intervention Period||0
169392|NCT00975481|408614|P2|NOT COMPLETED|Sixth Intervention Period||0
169393|NCT00975481|408615|P1|NOT COMPLETED|Sixth Intervention Period||0
169394|NCT00975481|408610|P6|COMPLETED|Sixth Intervention Period||6
169395|NCT00975481|408611|P5|COMPLETED|Sixth Intervention Period||5
169396|NCT00975481|408612|P4|COMPLETED|Sixth Intervention Period||5
169397|NCT00975481|408613|P3|COMPLETED|Sixth Intervention Period||4
169398|NCT00975481|408614|P2|COMPLETED|Sixth Intervention Period||5
169399|NCT00975481|408615|P1|COMPLETED|Sixth Intervention Period||4
169400|NCT00975481|408610|P6|STARTED|Sixth Intervention Period||6
169401|NCT00975481|408611|P5|STARTED|Sixth Intervention Period||5
169402|NCT00975481|408612|P4|STARTED|Sixth Intervention Period||5
169403|NCT00975481|408613|P3|STARTED|Sixth Intervention Period||4
169404|NCT00975481|408614|P2|STARTED|Sixth Intervention Period||5
169405|NCT00975481|408615|P1|STARTED|Sixth Intervention Period||4
169406|NCT00975481|408610|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169407|NCT00975481|408611|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169408|NCT00975481|408612|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169409|NCT00975481|408613|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169410|NCT00975481|408614|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169411|NCT00975481|408615|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169412|NCT00975481|408610|P6|COMPLETED|Washout Period (at Least 7 Days)||6
169413|NCT00975481|408611|P5|COMPLETED|Washout Period (at Least 7 Days)||5
169414|NCT00975481|408612|P4|COMPLETED|Washout Period (at Least 7 Days)||5
169415|NCT00975481|408613|P3|COMPLETED|Washout Period (at Least 7 Days)||4
169416|NCT00975481|408614|P2|COMPLETED|Washout Period (at Least 7 Days)||5
169417|NCT00975481|408615|P1|COMPLETED|Washout Period (at Least 7 Days)||4
169418|NCT00975481|408610|P6|STARTED|Washout Period (at Least 7 Days)||6
169419|NCT00975481|408611|P5|STARTED|Washout Period (at Least 7 Days)||5
169420|NCT00975481|408612|P4|STARTED|Washout Period (at Least 7 Days)||5
169421|NCT00975481|408613|P3|STARTED|Washout Period (at Least 7 Days)||4
169422|NCT00975481|408614|P2|STARTED|Washout Period (at Least 7 Days)||5
169423|NCT00975481|408615|P1|STARTED|Washout Period (at Least 7 Days)||4
169424|NCT00975481|408610|P6|NOT COMPLETED|Fifth Intervention Period||0
169425|NCT00975481|408611|P5|NOT COMPLETED|Fifth Intervention Period||1
169426|NCT00975481|408612|P4|NOT COMPLETED|Fifth Intervention Period||0
169427|NCT00975481|408613|P3|NOT COMPLETED|Fifth Intervention Period||0
169428|NCT00975481|408614|P2|NOT COMPLETED|Fifth Intervention Period||0
169429|NCT00975481|408615|P1|NOT COMPLETED|Fifth Intervention Period||0
169430|NCT00975481|408610|P6|COMPLETED|Fifth Intervention Period||6
169431|NCT00975481|408611|P5|COMPLETED|Fifth Intervention Period||5
169432|NCT00975481|408612|P4|COMPLETED|Fifth Intervention Period||5
169433|NCT00975481|408613|P3|COMPLETED|Fifth Intervention Period||4
169434|NCT00975481|408614|P2|COMPLETED|Fifth Intervention Period||5
169435|NCT00975481|408615|P1|COMPLETED|Fifth Intervention Period||4
169436|NCT00975481|408610|P6|STARTED|Fifth Intervention Period||6
169437|NCT00975481|408611|P5|STARTED|Fifth Intervention Period||6
169438|NCT00975481|408612|P4|STARTED|Fifth Intervention Period||5
169439|NCT00975481|408613|P3|STARTED|Fifth Intervention Period||4
169440|NCT00975481|408614|P2|STARTED|Fifth Intervention Period||5
169441|NCT00975481|408615|P1|STARTED|Fifth Intervention Period||4
169442|NCT00975481|408610|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169443|NCT00975481|408611|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169444|NCT00975481|408612|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169445|NCT00975481|408613|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169446|NCT00975481|408614|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169447|NCT00975481|408615|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169448|NCT00975481|408610|P6|COMPLETED|Washout Period (at Least 7 Days)||6
169449|NCT00975481|408611|P5|COMPLETED|Washout Period (at Least 7 Days)||6
169450|NCT00975481|408612|P4|COMPLETED|Washout Period (at Least 7 Days)||5
169451|NCT00975481|408613|P3|COMPLETED|Washout Period (at Least 7 Days)||4
169452|NCT00975481|408614|P2|COMPLETED|Washout Period (at Least 7 Days)||5
169453|NCT00975481|408615|P1|COMPLETED|Washout Period (at Least 7 Days)||4
169454|NCT00975481|408610|P6|STARTED|Washout Period (at Least 7 Days)||6
169455|NCT00975481|408611|P5|STARTED|Washout Period (at Least 7 Days)||6
169456|NCT00975481|408612|P4|STARTED|Washout Period (at Least 7 Days)||5
169457|NCT00975481|408613|P3|STARTED|Washout Period (at Least 7 Days)||4
169458|NCT00975481|408614|P2|STARTED|Washout Period (at Least 7 Days)||5
169459|NCT00975481|408615|P1|STARTED|Washout Period (at Least 7 Days)||4
169460|NCT00975481|408610|P6|NOT COMPLETED|Fourth Intervention Period||0
169461|NCT00975481|408611|P5|NOT COMPLETED|Fourth Intervention Period||0
169462|NCT00975481|408612|P4|NOT COMPLETED|Fourth Intervention Period||1
169463|NCT00975481|408613|P3|NOT COMPLETED|Fourth Intervention Period||1
169464|NCT00975481|408614|P2|NOT COMPLETED|Fourth Intervention Period||0
169465|NCT00975481|408615|P1|NOT COMPLETED|Fourth Intervention Period||0
169466|NCT00975481|408610|P6|COMPLETED|Fourth Intervention Period||6
169467|NCT00975481|408611|P5|COMPLETED|Fourth Intervention Period||6
169468|NCT00975481|408612|P4|COMPLETED|Fourth Intervention Period||5
169469|NCT00975481|408613|P3|COMPLETED|Fourth Intervention Period||4
169470|NCT00975481|408614|P2|COMPLETED|Fourth Intervention Period||5
169471|NCT00975481|408615|P1|COMPLETED|Fourth Intervention Period||4
169472|NCT00975481|408610|P6|STARTED|Fourth Intervention Period||6
169473|NCT00975481|408611|P5|STARTED|Fourth Intervention Period||6
169474|NCT00975481|408612|P4|STARTED|Fourth Intervention Period||6
169475|NCT00975481|408613|P3|STARTED|Fourth Intervention Period||5
169476|NCT00975481|408614|P2|STARTED|Fourth Intervention Period||5
169477|NCT00975481|408615|P1|STARTED|Fourth Intervention Period||4
169478|NCT00975481|408610|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169479|NCT00975481|408611|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169480|NCT00975481|408612|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169481|NCT00975481|408613|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169482|NCT00975481|408614|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169483|NCT00975481|408615|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169484|NCT00975481|408610|P6|COMPLETED|Washout Period (at Least 7 Days)||6
169485|NCT00975481|408611|P5|COMPLETED|Washout Period (at Least 7 Days)||6
169486|NCT00975481|408612|P4|COMPLETED|Washout Period (at Least 7 Days)||6
169487|NCT00975481|408613|P3|COMPLETED|Washout Period (at Least 7 Days)||5
169488|NCT00975481|408614|P2|COMPLETED|Washout Period (at Least 7 Days)||5
169489|NCT00975481|408615|P1|COMPLETED|Washout Period (at Least 7 Days)||4
169490|NCT00975481|408610|P6|STARTED|Washout Period (at Least 7 Days)||6
169491|NCT00975481|408611|P5|STARTED|Washout Period (at Least 7 Days)||6
169492|NCT00975481|408612|P4|STARTED|Washout Period (at Least 7 Days)||6
169493|NCT00975481|408613|P3|STARTED|Washout Period (at Least 7 Days)||5
169494|NCT00975481|408614|P2|STARTED|Washout Period (at Least 7 Days)||5
169495|NCT00975481|408615|P1|STARTED|Washout Period (at Least 7 Days)||4
169496|NCT00975481|408610|P6|NOT COMPLETED|Third Intervention Period||0
169497|NCT00975481|408611|P5|NOT COMPLETED|Third Intervention Period||0
169498|NCT00975481|408612|P4|NOT COMPLETED|Third Intervention Period||0
169499|NCT00975481|408613|P3|NOT COMPLETED|Third Intervention Period||0
169500|NCT00975481|408614|P2|NOT COMPLETED|Third Intervention Period||0
169501|NCT00975481|408615|P1|NOT COMPLETED|Third Intervention Period||0
169502|NCT00975481|408610|P6|COMPLETED|Third Intervention Period||6
169503|NCT00975481|408611|P5|COMPLETED|Third Intervention Period||6
169504|NCT00975481|408612|P4|COMPLETED|Third Intervention Period||6
169505|NCT00975481|408613|P3|COMPLETED|Third Intervention Period||5
169506|NCT00975481|408614|P2|COMPLETED|Third Intervention Period||5
169507|NCT00975481|408615|P1|COMPLETED|Third Intervention Period||4
169508|NCT00975481|408610|P6|STARTED|Third Intervention Period||6
169509|NCT00975481|408611|P5|STARTED|Third Intervention Period||6
169510|NCT00975481|408612|P4|STARTED|Third Intervention Period||6
169511|NCT00975481|408613|P3|STARTED|Third Intervention Period||5
169512|NCT00975481|408614|P2|STARTED|Third Intervention Period||5
169513|NCT00975481|408615|P1|STARTED|Third Intervention Period||4
169514|NCT00975481|408610|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169515|NCT00975481|408611|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169516|NCT00975481|408612|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169517|NCT00975481|408613|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169518|NCT00975481|408614|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169519|NCT00975481|408615|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169520|NCT00975481|408610|P6|COMPLETED|Washout Period (at Least 7 Days)||6
169521|NCT00975481|408611|P5|COMPLETED|Washout Period (at Least 7 Days)||6
169522|NCT00975481|408612|P4|COMPLETED|Washout Period (at Least 7 Days)||6
169523|NCT00975481|408613|P3|COMPLETED|Washout Period (at Least 7 Days)||5
169524|NCT00975481|408614|P2|COMPLETED|Washout Period (at Least 7 Days)||5
169525|NCT00975481|408615|P1|COMPLETED|Washout Period (at Least 7 Days)||4
169526|NCT00975481|408610|P6|STARTED|Washout Period (at Least 7 Days)||6
169527|NCT00975481|408611|P5|STARTED|Washout Period (at Least 7 Days)||6
169528|NCT00975481|408612|P4|STARTED|Washout Period (at Least 7 Days)||6
169529|NCT00975481|408613|P3|STARTED|Washout Period (at Least 7 Days)||5
169530|NCT00975481|408614|P2|STARTED|Washout Period (at Least 7 Days)||5
169531|NCT00975481|408615|P1|STARTED|Washout Period (at Least 7 Days)||4
169532|NCT00975481|408610|P6|NOT COMPLETED|Second Intervention Period||0
169533|NCT00975481|408611|P5|NOT COMPLETED|Second Intervention Period||0
169534|NCT00975481|408612|P4|NOT COMPLETED|Second Intervention Period||0
169535|NCT00975481|408613|P3|NOT COMPLETED|Second Intervention Period||1
169536|NCT00975481|408614|P2|NOT COMPLETED|Second Intervention Period||1
169537|NCT00975481|408615|P1|NOT COMPLETED|Second Intervention Period||2
169538|NCT00975481|408610|P6|COMPLETED|Second Intervention Period||6
169539|NCT00975481|408611|P5|COMPLETED|Second Intervention Period||6
169540|NCT00975481|408612|P4|COMPLETED|Second Intervention Period||6
169541|NCT00975481|408613|P3|COMPLETED|Second Intervention Period||5
169542|NCT00975481|408614|P2|COMPLETED|Second Intervention Period||5
169543|NCT00975481|408615|P1|COMPLETED|Second Intervention Period||4
169544|NCT00975481|408610|P6|STARTED|Second Intervention Period||6
169545|NCT00975481|408611|P5|STARTED|Second Intervention Period||6
169546|NCT00975481|408612|P4|STARTED|Second Intervention Period||6
169547|NCT00975481|408613|P3|STARTED|Second Intervention Period||6
169548|NCT00975481|408614|P2|STARTED|Second Intervention Period||6
169549|NCT00975481|408615|P1|STARTED|Second Intervention Period||6
169550|NCT00975481|408610|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169551|NCT00975481|408611|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169552|NCT00975481|408612|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169553|NCT00975481|408613|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169554|NCT00975481|408614|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169555|NCT00975481|408615|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
169556|NCT00975481|408610|P6|COMPLETED|Washout Period (at Least 7 Days)||6
169557|NCT00975481|408611|P5|COMPLETED|Washout Period (at Least 7 Days)||6
169558|NCT00975481|408612|P4|COMPLETED|Washout Period (at Least 7 Days)||6
169559|NCT00975481|408613|P3|COMPLETED|Washout Period (at Least 7 Days)||6
169560|NCT00975481|408614|P2|COMPLETED|Washout Period (at Least 7 Days)||6
169561|NCT00975481|408615|P1|COMPLETED|Washout Period (at Least 7 Days)||6
169562|NCT00975481|408610|P6|STARTED|Washout Period (at Least 7 Days)||6
169563|NCT00975481|408611|P5|STARTED|Washout Period (at Least 7 Days)||6
169564|NCT00975481|408612|P4|STARTED|Washout Period (at Least 7 Days)||6
169565|NCT00975481|408613|P3|STARTED|Washout Period (at Least 7 Days)||6
169566|NCT00975481|408614|P2|STARTED|Washout Period (at Least 7 Days)||6
169567|NCT00975481|408615|P1|STARTED|Washout Period (at Least 7 Days)||6
169568|NCT00975481|408610|P6|NOT COMPLETED|First Intervention Period||0
169569|NCT00975481|408611|P5|NOT COMPLETED|First Intervention Period||0
169570|NCT00975481|408612|P4|NOT COMPLETED|First Intervention Period||0
169571|NCT00975481|408613|P3|NOT COMPLETED|First Intervention Period||0
169572|NCT00975481|408614|P2|NOT COMPLETED|First Intervention Period||0
169573|NCT00975481|408615|P1|NOT COMPLETED|First Intervention Period||0
169574|NCT00975481|408610|P6|COMPLETED|First Intervention Period||6
169575|NCT00975481|408611|P5|COMPLETED|First Intervention Period||6
169576|NCT00975481|408612|P4|COMPLETED|First Intervention Period||6
169577|NCT00975481|408613|P3|COMPLETED|First Intervention Period||6
169578|NCT00975481|408614|P2|COMPLETED|First Intervention Period||6
169579|NCT00975481|408615|P1|COMPLETED|First Intervention Period||6
169580|NCT00975481|408610|P6|STARTED|First Intervention Period||6
169581|NCT00975481|408611|P5|STARTED|First Intervention Period||6
169582|NCT00975481|408612|P4|STARTED|First Intervention Period||6
169583|NCT00975481|408613|P3|STARTED|First Intervention Period||6
169584|NCT00975481|408614|P2|STARTED|First Intervention Period||6
169585|NCT00975481|408615|P1|STARTED|First Intervention Period||6
169586|NCT00975416|408715|P2|NOT COMPLETED|Overall Study||5
169587|NCT00975416|408716|P1|NOT COMPLETED|Overall Study||3
169588|NCT00975416|408715|P2|COMPLETED|Overall Study||11
169589|NCT00975416|408716|P1|COMPLETED|Overall Study||11
169590|NCT00975416|408715|P2|STARTED|Overall Study||16
169591|NCT00975416|408716|P1|STARTED|Overall Study||14
169592|NCT00975286|408725|P2|NOT COMPLETED|Overall Study||29
169593|NCT00975286|408726|P1|NOT COMPLETED|Overall Study||12
169594|NCT00975286|408725|P2|COMPLETED|Overall Study||194
169595|NCT00975286|408726|P1|COMPLETED|Overall Study||211
169596|NCT00975286|408725|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
169597|NCT00975286|408726|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
169598|NCT00975286|408725|P2|Safety Population|Overall Study||223
169599|NCT00975286|408726|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
169600|NCT00975286|408725|P2|STARTED|Overall Study||223
169601|NCT00975286|408726|P1|STARTED|Overall Study|Randomized.|223
169602|NCT00975221|408758|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
169603|NCT00975221|408759|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
169604|NCT00975221|408758|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
169605|NCT00975221|408759|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
169606|NCT00975221|408758|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
169607|NCT00975221|408759|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
169608|NCT00975221|408758|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
169609|NCT00975221|408759|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
169610|NCT00975221|408758|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
169611|NCT00975221|408759|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
169612|NCT00975221|408758|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
169613|NCT00975221|408759|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
169614|NCT00975221|408758|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
169615|NCT00975221|408759|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
169616|NCT00975221|408758|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
169617|NCT00975221|408759|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
169618|NCT00975221|408758|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
169619|NCT00975221|408759|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
169620|NCT00975221|408758|P2|STARTED|Titration Phase (Weeks 1-12)||33
169621|NCT00975221|408759|P1|STARTED|Titration Phase (Weeks 1-12)||34
169622|NCT00975195|408775|P2|NOT COMPLETED|Overall Study||233
169623|NCT00975195|408776|P1|NOT COMPLETED|Overall Study||228
169624|NCT00975195|408775|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
169625|NCT00975195|408776|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
169626|NCT00975195|408775|P2|STARTED|Overall Study||1244
169627|NCT00975195|408776|P1|STARTED|Overall Study||1244
169628|NCT00975156|408836|P2|NOT COMPLETED|Overall Study||1
169629|NCT00975156|408837|P1|NOT COMPLETED|Overall Study||0
169630|NCT00975156|408836|P2|COMPLETED|Overall Study||9
169631|NCT00975156|408837|P1|COMPLETED|Overall Study||11
169632|NCT00975156|408836|P2|STARTED|Overall Study||10
169633|NCT00975156|408837|P1|STARTED|Overall Study||11
169634|NCT00975143|408849|P2|NOT COMPLETED|Overall Study||60
169635|NCT00975143|408850|P1|NOT COMPLETED|Overall Study||70
169636|NCT00975143|408849|P2|COMPLETED|Overall Study||401
169637|NCT00975143|408850|P1|COMPLETED|Overall Study||394
169638|NCT00975143|408849|P2|Completed Treatment (Week 20)|Overall Study||410
169639|NCT00975143|408850|P1|Completed Treatment (Week 20)|Overall Study||403
169640|NCT00975143|408849|P2|STARTED|Overall Study||461
169641|NCT00975143|408850|P1|STARTED|Overall Study||464
169642|NCT00975130|408860|P3|NOT COMPLETED|Study Part 2||17
169643|NCT00975130|408861|P2|NOT COMPLETED|Study Part 2||38
169644|NCT00975130|408862|P1|NOT COMPLETED|Study Part 2||0
169645|NCT00975130|408860|P3|COMPLETED|Study Part 2||238
169646|NCT00975130|408861|P2|COMPLETED|Study Part 2||212
169647|NCT00975130|408862|P1|COMPLETED|Study Part 2||0
169648|NCT00975130|408860|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
169649|NCT00975130|408861|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
169650|NCT00975130|408862|P1|STARTED|Study Part 2||0
169651|NCT00975130|408860|P3|NOT COMPLETED|Study Part 1||0
169652|NCT00975130|408861|P2|NOT COMPLETED|Study Part 1||0
169653|NCT00975130|408862|P1|NOT COMPLETED|Study Part 1||280
169654|NCT00975130|408860|P3|COMPLETED|Study Part 1||0
169655|NCT00975130|408861|P2|COMPLETED|Study Part 1||0
169656|NCT00975130|408862|P1|COMPLETED|Study Part 1||3086
169657|NCT00975130|408860|P3|STARTED|Study Part 1||0
169658|NCT00975130|408861|P2|STARTED|Study Part 1||0
169659|NCT00975130|408862|P1|STARTED|Study Part 1||3366
169660|NCT00975000|409046|P2|NOT COMPLETED|Overall Study||5
169661|NCT00975000|409047|P1|NOT COMPLETED|Overall Study||5
169662|NCT00975000|409046|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
169663|NCT00975000|409047|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
169664|NCT00975000|409046|P2|Completed Maintenance Phase|Overall Study||52
169665|NCT00975000|409047|P1|Completed Maintenance Phase|Overall Study||52
169666|NCT00975000|409046|P2|Completed Efficacy Assessment Phase|Overall Study||54
169667|NCT00975000|409047|P1|Completed Efficacy Assessment Phase|Overall Study||54
169668|NCT00975000|409046|P2|Completed Titration Phase|Overall Study||55
169669|NCT00975000|409047|P1|Completed Titration Phase|Overall Study||54
169670|NCT00975000|409046|P2|STARTED|Overall Study||57
169671|NCT00975000|409047|P1|STARTED|Overall Study||57
169672|NCT00974974|409071|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
169673|NCT00974974|409072|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
169674|NCT00974974|409071|P2|COMPLETED|Maintenance - Double Blind Treatment||182
169675|NCT00974974|409072|P1|COMPLETED|Maintenance - Double Blind Treatment||186
169676|NCT00974974|409071|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
169677|NCT00974974|409072|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
169678|NCT00974974|409071|P2|NOT COMPLETED|IPX066 Dose Conversion||0
169679|NCT00974974|409072|P1|NOT COMPLETED|IPX066 Dose Conversion||57
169680|NCT00974974|409071|P2|COMPLETED|IPX066 Dose Conversion||0
169681|NCT00974974|409072|P1|COMPLETED|IPX066 Dose Conversion||393
169682|NCT00974974|409071|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
169683|NCT00974974|409072|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
169684|NCT00974974|409071|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
169685|NCT00974974|409072|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
169686|NCT00974974|409071|P2|COMPLETED|IR CD-LD Dose Adjustment||450
169687|NCT00974974|409072|P1|COMPLETED|IR CD-LD Dose Adjustment||0
169688|NCT00974974|409071|P2|STARTED|IR CD-LD Dose Adjustment||471
169689|NCT00974974|409072|P1|STARTED|IR CD-LD Dose Adjustment||0
169690|NCT00974922|409082|P1|NOT COMPLETED|Overall Study||24
169691|NCT00974922|409082|P1|COMPLETED|Overall Study||16
169692|NCT00974922|409082|P1|STARTED|Overall Study||40
169693|NCT00974818|409089|P2|NOT COMPLETED|Overall Study||0
169694|NCT00974818|409090|P1|NOT COMPLETED|Overall Study||0
169695|NCT00974818|409089|P2|COMPLETED|Overall Study||25
169696|NCT00974818|409090|P1|COMPLETED|Overall Study||25
169697|NCT00974818|409089|P2|STARTED|Overall Study||25
169698|NCT00974818|409090|P1|STARTED|Overall Study||25
169699|NCT00974675|409100|P4|NOT COMPLETED|Overall Study||2
169700|NCT00974675|409101|P3|NOT COMPLETED|Overall Study||2
169701|NCT00974675|409102|P2|NOT COMPLETED|Overall Study||1
169702|NCT00974675|409103|P1|NOT COMPLETED|Overall Study||2
169703|NCT00974675|409100|P4|COMPLETED|Overall Study||2
169704|NCT00974675|409101|P3|COMPLETED|Overall Study||1
169705|NCT00974675|409102|P2|COMPLETED|Overall Study||7
169706|NCT00974675|409103|P1|COMPLETED|Overall Study||6
169707|NCT00974675|409100|P4|STARTED|Overall Study||4
169708|NCT00974675|409101|P3|STARTED|Overall Study||3
169709|NCT00974675|409102|P2|STARTED|Overall Study||8
169710|NCT00974675|409103|P1|STARTED|Overall Study||8
169711|NCT00974571|409152|P3|NOT COMPLETED|Overall Study||83
169712|NCT00974571|409153|P2|NOT COMPLETED|Overall Study||16
169713|NCT00974571|409154|P1|NOT COMPLETED|Overall Study||68
169714|NCT00974571|409152|P3|COMPLETED|Overall Study||530
169715|NCT00974571|409153|P2|COMPLETED|Overall Study||106
169716|NCT00974571|409154|P1|COMPLETED|Overall Study||562
169717|NCT00974571|409152|P3|STARTED|Overall Study||613
169718|NCT00974571|409153|P2|STARTED|Overall Study||122
169719|NCT00974571|409154|P1|STARTED|Overall Study||630
169720|NCT00974480|409177|P3|NOT COMPLETED|Overall Study||10
169721|NCT00974480|409178|P2|NOT COMPLETED|Overall Study||7
169722|NCT00974480|409179|P1|NOT COMPLETED|Overall Study||11
169723|NCT00974480|409177|P3|COMPLETED|Overall Study||30
169724|NCT00974480|409178|P2|COMPLETED|Overall Study||33
169725|NCT00974480|409179|P1|COMPLETED|Overall Study||29
169726|NCT00974480|409177|P3|STARTED|Overall Study||40
169727|NCT00974480|409178|P2|STARTED|Overall Study||40
169728|NCT00974480|409179|P1|STARTED|Overall Study||40
169729|NCT00974376|409219|P2|NOT COMPLETED|Overall Study||33
169730|NCT00974376|409220|P1|NOT COMPLETED|Overall Study||34
169731|NCT00974376|409219|P2|COMPLETED|Overall Study||42
169732|NCT00974376|409220|P1|COMPLETED|Overall Study||41
169733|NCT00974376|409219|P2|STARTED|Overall Study||75
169734|NCT00974376|409220|P1|STARTED|Overall Study||75
169735|NCT00974363|409228|P2|NOT COMPLETED|Overall Study||0
169736|NCT00974363|409229|P1|NOT COMPLETED|Overall Study||0
169737|NCT00974363|409228|P2|COMPLETED|Overall Study||168
169738|NCT00974363|409229|P1|COMPLETED|Overall Study||521
169739|NCT00974363|409228|P2|STARTED|Overall Study||168
169740|NCT00974363|409229|P1|STARTED|Overall Study||521
169741|NCT00974311|409251|P2|NOT COMPLETED|Overall Study||236
169742|NCT00974311|409252|P1|NOT COMPLETED|Overall Study||546
169743|NCT00974311|409251|P2|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|163
169744|NCT00974311|409252|P1|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|254
169745|NCT00974311|409251|P2|STARTED|Overall Study||399
169746|NCT00974311|409252|P1|STARTED|Overall Study||800
169747|NCT00974246|409276|P1|NOT COMPLETED|Overall Study||0
169748|NCT00974246|409276|P1|COMPLETED|Overall Study||27
169749|NCT00974246|409276|P1|STARTED|Overall Study||27
169750|NCT00974233|409282|P1|NOT COMPLETED|Maintenance Lenalidomide||13
169751|NCT00974233|409282|P1|COMPLETED|Maintenance Lenalidomide||6
169752|NCT00974233|409282|P1|STARTED|Maintenance Lenalidomide||19
169753|NCT00974233|409282|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
169754|NCT00974233|409282|P1|COMPLETED|Induction Chemoimmunotherapy||19
169755|NCT00974233|409282|P1|STARTED|Induction Chemoimmunotherapy||34
169756|NCT00974220|409297|P2|NOT COMPLETED|Treatment Period 2||0
169757|NCT00974220|409298|P1|NOT COMPLETED|Treatment Period 2||0
169758|NCT00974220|409297|P2|COMPLETED|Treatment Period 2||5
169759|NCT00974220|409298|P1|COMPLETED|Treatment Period 2||7
169760|NCT00974220|409297|P2|STARTED|Treatment Period 2||5
169761|NCT00974220|409298|P1|STARTED|Treatment Period 2||7
169762|NCT00974220|409297|P2|NOT COMPLETED|Treatment Period 1||2
169763|NCT00974220|409298|P1|NOT COMPLETED|Treatment Period 1||2
169764|NCT00974220|409297|P2|COMPLETED|Treatment Period 1||5
169765|NCT00974220|409298|P1|COMPLETED|Treatment Period 1||7
169766|NCT00974220|409297|P2|STARTED|Treatment Period 1||7
169767|NCT00974220|409298|P1|STARTED|Treatment Period 1||9
169768|NCT00974142|409308|P2|NOT COMPLETED|Overall Study||0
169769|NCT00974142|409309|P1|NOT COMPLETED|Overall Study||0
169770|NCT00974142|409308|P2|COMPLETED|Overall Study||9
169771|NCT00974142|409309|P1|COMPLETED|Overall Study||8
169772|NCT00974142|409308|P2|STARTED|Overall Study||9
169773|NCT00974142|409309|P1|STARTED|Overall Study||8
169774|NCT00974090|409343|P2|NOT COMPLETED|Period 2: Open-label Period||10
169775|NCT00974090|409344|P1|NOT COMPLETED|Period 2: Open-label Period||8
169776|NCT00974090|409343|P2|COMPLETED|Period 2: Open-label Period||85
169777|NCT00974090|409344|P1|COMPLETED|Period 2: Open-label Period||87
169778|NCT00974090|409343|P2|STARTED|Period 2: Open-label Period||95
169779|NCT00974090|409344|P1|STARTED|Period 2: Open-label Period||95
169780|NCT00974090|409343|P2|NOT COMPLETED|Period 1: Double Blind Period||1
169781|NCT00974090|409344|P1|NOT COMPLETED|Period 1: Double Blind Period||3
169782|NCT00974090|409343|P2|COMPLETED|Period 1: Double Blind Period||95
169783|NCT00974090|409344|P1|COMPLETED|Period 1: Double Blind Period||95
169784|NCT00974090|409343|P2|STARTED|Period 1: Double Blind Period||96
169785|NCT00974090|409344|P1|STARTED|Period 1: Double Blind Period||98
169786|NCT00974051|409358|P3|NOT COMPLETED|Overall Study||0
169787|NCT00974051|409359|P2|NOT COMPLETED|Overall Study||0
169788|NCT00974051|409360|P1|NOT COMPLETED|Overall Study||0
169789|NCT00974051|409358|P3|COMPLETED|Overall Study||6
169790|NCT00974051|409359|P2|COMPLETED|Overall Study||4
169791|NCT00974051|409360|P1|COMPLETED|Overall Study||6
169792|NCT00974051|409358|P3|STARTED|Overall Study||6
169793|NCT00974051|409359|P2|STARTED|Overall Study||4
169794|NCT00974051|409360|P1|STARTED|Overall Study||6
169795|NCT00973921|409378|P1|NOT COMPLETED|Overall Study||9
169796|NCT00973921|409378|P1|COMPLETED|Overall Study||31
169797|NCT00973921|409378|P1|STARTED|Overall Study||40
169798|NCT00973765|409387|P2|NOT COMPLETED|Overall Study||14
169799|NCT00973765|409388|P1|NOT COMPLETED|Overall Study||8
169800|NCT00973765|409387|P2|COMPLETED|Overall Study|102|102
169801|NCT00973765|409388|P1|COMPLETED|Overall Study|88|88
169802|NCT00973765|409387|P2|STARTED|Overall Study|116|116
169803|NCT00973765|409388|P1|STARTED|Overall Study|96|96
169804|NCT00973752|409394|P1|NOT COMPLETED|Overall Study||0
169805|NCT00973752|409394|P1|COMPLETED|Overall Study||30
169806|NCT00973752|409394|P1|STARTED|Overall Study||30
169807|NCT00973739|409398|P1|NOT COMPLETED|Overall Study||4
169808|NCT00973739|409398|P1|COMPLETED|Overall Study||17
169809|NCT00973739|409398|P1|STARTED|Overall Study||21
169810|NCT00973700|409410|P5|NOT COMPLETED|Overall Study||10
169811|NCT00973700|409411|P4|NOT COMPLETED|Overall Study||18
169812|NCT00973700|409412|P3|NOT COMPLETED|Overall Study||10
169813|NCT00973700|409413|P2|NOT COMPLETED|Overall Study||2
169814|NCT00973700|409414|P1|NOT COMPLETED|Overall Study||7
169815|NCT00973700|409410|P5|COMPLETED|Overall Study||158
169816|NCT00973700|409411|P4|COMPLETED|Overall Study||318
169817|NCT00973700|409412|P3|COMPLETED|Overall Study||158
169818|NCT00973700|409413|P2|COMPLETED|Overall Study||54
169819|NCT00973700|409414|P1|COMPLETED|Overall Study||49
169820|NCT00973700|409410|P5|STARTED|Overall Study||168
169821|NCT00973700|409411|P4|STARTED|Overall Study||336
169822|NCT00973700|409412|P3|STARTED|Overall Study||168
169823|NCT00973700|409413|P2|STARTED|Overall Study||56
169824|NCT00973700|409414|P1|STARTED|Overall Study||56
169825|NCT00973622|409463|P2|NOT COMPLETED|Overall Study||5
169826|NCT00973622|409464|P1|NOT COMPLETED|Overall Study||31
169827|NCT00973622|409463|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
169828|NCT00973622|409464|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
169829|NCT00973622|409463|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
169830|NCT00973622|409464|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
169831|NCT00973479|409472|P2|NOT COMPLETED|Overall Study||69
169832|NCT00973479|409473|P1|NOT COMPLETED|Overall Study||37
169833|NCT00973479|409472|P2|COMPLETED|Overall Study||326
169834|NCT00973479|409473|P1|COMPLETED|Overall Study||160
169835|NCT00973479|409472|P2|STARTED|Overall Study||395
169836|NCT00973479|409473|P1|STARTED|Overall Study||197
169837|NCT00973362|409491|P2|NOT COMPLETED|3-Year Follow-up||0
169838|NCT00973362|409492|P1|NOT COMPLETED|3-Year Follow-up||17
169839|NCT00973362|409491|P2|COMPLETED|3-Year Follow-up||0
169840|NCT00973362|409492|P1|COMPLETED|3-Year Follow-up||10854
169841|NCT00973362|409491|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
169842|NCT00973362|409492|P1|STARTED|3-Year Follow-up||10871
169843|NCT00973362|409491|P2|NOT COMPLETED|Baseline Evaluation||223
169844|NCT00973362|409492|P1|NOT COMPLETED|Baseline Evaluation||773
169845|NCT00973362|409491|P2|COMPLETED|Baseline Evaluation||1029
169846|NCT00973362|409492|P1|COMPLETED|Baseline Evaluation||10871
169847|NCT00973362|409491|P2|Conclusive Disease Status|Baseline Evaluation||939
169848|NCT00973362|409492|P1|Conclusive Disease Status|Baseline Evaluation||819
169849|NCT00973362|409491|P2|Evaluable for Analysis|Baseline Evaluation||958
169850|NCT00973362|409492|P1|Evaluable for Analysis|Baseline Evaluation||10871
169851|NCT00973362|409491|P2|STARTED|Baseline Evaluation||1252
169852|NCT00973362|409492|P1|STARTED|Baseline Evaluation||11644
169853|NCT00973349|409517|P16|NOT COMPLETED|Overall Study||2
169854|NCT00973349|409518|P15|NOT COMPLETED|Overall Study||2
169855|NCT00973349|409519|P14|NOT COMPLETED|Overall Study||0
169856|NCT00973349|409520|P13|NOT COMPLETED|Overall Study||1
169857|NCT00973349|409521|P12|NOT COMPLETED|Overall Study||2
169858|NCT00973349|409522|P11|NOT COMPLETED|Overall Study||0
169859|NCT00973349|409523|P10|NOT COMPLETED|Overall Study||6
169860|NCT00973349|409524|P9|NOT COMPLETED|Overall Study||4
169861|NCT00973349|409525|P8|NOT COMPLETED|Overall Study||3
169862|NCT00973349|409526|P7|NOT COMPLETED|Overall Study||2
169863|NCT00973349|409527|P6|NOT COMPLETED|Overall Study||4
169864|NCT00973349|409528|P5|NOT COMPLETED|Overall Study||5
169865|NCT00973349|409529|P4|NOT COMPLETED|Overall Study||5
169866|NCT00973349|409530|P3|NOT COMPLETED|Overall Study||5
169867|NCT00973349|409531|P2|NOT COMPLETED|Overall Study||3
169868|NCT00973349|409532|P1|NOT COMPLETED|Overall Study||4
169869|NCT00973349|409517|P16|COMPLETED|Overall Study||165
169870|NCT00973349|409518|P15|COMPLETED|Overall Study||168
169871|NCT00973349|409519|P14|COMPLETED|Overall Study||171
169872|NCT00973349|409520|P13|COMPLETED|Overall Study||168
169873|NCT00973349|409521|P12|COMPLETED|Overall Study||167
169874|NCT00973349|409522|P11|COMPLETED|Overall Study||174
169875|NCT00973349|409523|P10|COMPLETED|Overall Study||163
169876|NCT00973349|409524|P9|COMPLETED|Overall Study||167
169877|NCT00973349|409525|P8|COMPLETED|Overall Study||166
169878|NCT00973349|409526|P7|COMPLETED|Overall Study||172
169879|NCT00973349|409527|P6|COMPLETED|Overall Study||165
169880|NCT00973349|409528|P5|COMPLETED|Overall Study||165
169881|NCT00973349|409529|P4|COMPLETED|Overall Study||163
169882|NCT00973349|409530|P3|COMPLETED|Overall Study||166
169883|NCT00973349|409531|P2|COMPLETED|Overall Study||165
169884|NCT00973349|409532|P1|COMPLETED|Overall Study||166
169885|NCT00973349|409517|P16|STARTED|Overall Study||167
169886|NCT00973349|409518|P15|STARTED|Overall Study||170
169887|NCT00973349|409519|P14|STARTED|Overall Study||171
169888|NCT00973349|409520|P13|STARTED|Overall Study||169
169889|NCT00973349|409521|P12|STARTED|Overall Study||169
169890|NCT00973349|409522|P11|STARTED|Overall Study||174
169891|NCT00973349|409523|P10|STARTED|Overall Study||169
169892|NCT00973349|409524|P9|STARTED|Overall Study||171
169893|NCT00973349|409525|P8|STARTED|Overall Study||169
169894|NCT00973349|409526|P7|STARTED|Overall Study||174
169895|NCT00973349|409527|P6|STARTED|Overall Study||169
169896|NCT00973349|409528|P5|STARTED|Overall Study||170
169897|NCT00973349|409529|P4|STARTED|Overall Study||168
169898|NCT00973349|409530|P3|STARTED|Overall Study||171
169899|NCT00973349|409531|P2|STARTED|Overall Study||168
169900|NCT00973349|409532|P1|STARTED|Overall Study||170
169901|NCT00972959|409630|P1|NOT COMPLETED|Overall Study||0
169902|NCT00972959|409630|P1|COMPLETED|Overall Study||17
169903|NCT00972959|409630|P1|STARTED|Overall Study||17
169904|NCT00972816|409653|P8|NOT COMPLETED|Overall Study||9
169905|NCT00972816|409654|P7|NOT COMPLETED|Overall Study||10
169906|NCT00972816|409655|P6|NOT COMPLETED|Overall Study||11
169907|NCT00972816|409656|P5|NOT COMPLETED|Overall Study||12
169908|NCT00972816|409657|P4|NOT COMPLETED|Overall Study||8
169909|NCT00972816|409658|P3|NOT COMPLETED|Overall Study||9
169910|NCT00972816|409659|P2|NOT COMPLETED|Overall Study||11
169911|NCT00972816|409660|P1|NOT COMPLETED|Overall Study||17
169912|NCT00972816|409653|P8|COMPLETED|Overall Study||161
169913|NCT00972816|409654|P7|COMPLETED|Overall Study||159
169914|NCT00972816|409655|P6|COMPLETED|Overall Study||158
169915|NCT00972816|409656|P5|COMPLETED|Overall Study||157
169916|NCT00972816|409657|P4|COMPLETED|Overall Study||161
169917|NCT00972816|409658|P3|COMPLETED|Overall Study||160
169918|NCT00972816|409659|P2|COMPLETED|Overall Study||158
169919|NCT00972816|409660|P1|COMPLETED|Overall Study||156
169920|NCT00972816|409653|P8|STARTED|Overall Study||170
169921|NCT00972816|409654|P7|STARTED|Overall Study||169
169922|NCT00972816|409655|P6|STARTED|Overall Study||169
169923|NCT00972816|409656|P5|STARTED|Overall Study||169
169924|NCT00972816|409657|P4|STARTED|Overall Study||169
169925|NCT00972816|409658|P3|STARTED|Overall Study||169
169926|NCT00972816|409659|P2|STARTED|Overall Study||169
169927|NCT00972816|409660|P1|STARTED|Overall Study||173
169928|NCT00972777|409744|P2|NOT COMPLETED|Overall Study||14
169929|NCT00972777|409745|P1|NOT COMPLETED|Overall Study||14
169930|NCT00972777|409744|P2|COMPLETED|Overall Study||229
169931|NCT00972777|409745|P1|COMPLETED|Overall Study||217
169932|NCT00972777|409744|P2|STARTED|Overall Study||243
169933|NCT00972777|409745|P1|STARTED|Overall Study||231
169934|NCT00972738|409760|P3|NOT COMPLETED|Overall Study||29
169935|NCT00972738|409761|P2|NOT COMPLETED|Overall Study||6
169936|NCT00972738|409762|P1|NOT COMPLETED|Overall Study||21
169937|NCT00972738|409760|P3|COMPLETED|Overall Study||492
169938|NCT00972738|409761|P2|COMPLETED|Overall Study||165
169939|NCT00972738|409762|P1|COMPLETED|Overall Study||501
169940|NCT00972738|409760|P3|STARTED|Overall Study||521
169941|NCT00972738|409761|P2|STARTED|Overall Study||171
169942|NCT00972738|409762|P1|STARTED|Overall Study||522
169943|NCT00972725|409787|P2|NOT COMPLETED|Overall Study||0
169944|NCT00972725|409788|P1|NOT COMPLETED|Overall Study||0
169945|NCT00972725|409787|P2|COMPLETED|Overall Study||15
169946|NCT00972725|409788|P1|COMPLETED|Overall Study||13
169947|NCT00972725|409787|P2|STARTED|Overall Study||15
169948|NCT00972725|409788|P1|STARTED|Overall Study||13
169949|NCT00972621|409870|P2|NOT COMPLETED|Overall Study||1
169950|NCT00972621|409871|P1|NOT COMPLETED|Overall Study||0
169951|NCT00972621|409870|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
169952|NCT00972621|409871|P1|COMPLETED|Overall Study||200
169953|NCT00972621|409870|P2|STARTED|Overall Study||200
169954|NCT00972621|409871|P1|STARTED|Overall Study||200
169955|NCT00972595|409879|P2|NOT COMPLETED|Period 2||0
169956|NCT00972595|409880|P1|NOT COMPLETED|Period 2||0
169957|NCT00972595|409879|P2|COMPLETED|Period 2||22
169958|NCT00972595|409880|P1|COMPLETED|Period 2||22
169959|NCT00972595|409879|P2|STARTED|Period 2||22
169960|NCT00972595|409880|P1|STARTED|Period 2||22
169961|NCT00972595|409879|P2|NOT COMPLETED|Period 1||0
169962|NCT00972595|409880|P1|NOT COMPLETED|Period 1||1
169963|NCT00972595|409879|P2|COMPLETED|Period 1||22
169964|NCT00972595|409880|P1|COMPLETED|Period 1||22
169965|NCT00972595|409879|P2|STARTED|Period 1||22
169966|NCT00972595|409880|P1|STARTED|Period 1||23
169967|NCT00972543|409890|P2|NOT COMPLETED|Overall Study||1
169968|NCT00972543|409891|P1|NOT COMPLETED|Overall Study||5
169969|NCT00972543|409890|P2|COMPLETED|Overall Study||0
169970|NCT00972543|409891|P1|COMPLETED|Overall Study||0
169971|NCT00972543|409890|P2|STARTED|Overall Study||1
169972|NCT00972543|409891|P1|STARTED|Overall Study||5
169973|NCT00972530|409967|P2|NOT COMPLETED|Overall Study||0
169974|NCT00972530|409968|P1|NOT COMPLETED|Overall Study||0
169975|NCT00972530|409967|P2|COMPLETED|Overall Study||46
169976|NCT00972530|409968|P1|COMPLETED|Overall Study||44
169977|NCT00972530|409967|P2|STARTED|Overall Study||46
169978|NCT00972530|409968|P1|STARTED|Overall Study||44
169979|NCT00972504|409974|P1|NOT COMPLETED|Overall Study||3
169980|NCT00972504|409974|P1|COMPLETED|Overall Study||51
169981|NCT00972504|409974|P1|STARTED|Overall Study||54
169982|NCT00972478|410006|P2|NOT COMPLETED|Overall Study||38
169983|NCT00972478|410007|P1|NOT COMPLETED|Overall Study||7
169984|NCT00972478|410006|P2|COMPLETED|Overall Study||34
169985|NCT00972478|410007|P1|COMPLETED|Overall Study||4
169986|NCT00972478|410006|P2|Eligible and Began Protocol Therapy|Overall Study||63
169987|NCT00972478|410007|P1|Eligible and Began Protocol Therapy|Overall Study||9
169988|NCT00972478|410006|P2|STARTED|Overall Study||72
169989|NCT00972478|410007|P1|STARTED|Overall Study||11
169990|NCT00972439|410019|P2|NOT COMPLETED|Overall Study||0
169991|NCT00972439|410020|P1|NOT COMPLETED|Overall Study||0
169992|NCT00972439|410019|P2|COMPLETED|Overall Study||16
169993|NCT00972439|410020|P1|COMPLETED|Overall Study||17
169994|NCT00972439|410019|P2|STARTED|Overall Study||16
169995|NCT00972439|410020|P1|STARTED|Overall Study||17
169996|NCT00972374|410029|P3|NOT COMPLETED|Overall Study||1
169997|NCT00972374|410030|P2|NOT COMPLETED|Overall Study||0
169998|NCT00972374|410031|P1|NOT COMPLETED|Overall Study||2
169999|NCT00972374|410029|P3|COMPLETED|Overall Study||13
170000|NCT00972374|410030|P2|COMPLETED|Overall Study||15
170001|NCT00972374|410031|P1|COMPLETED|Overall Study||13
170002|NCT00972374|410029|P3|STARTED|Overall Study||14
170003|NCT00972374|410030|P2|STARTED|Overall Study||15
170004|NCT00972374|410031|P1|STARTED|Overall Study||15
170005|NCT00972335|410045|P1|NOT COMPLETED|Overall Study||17
170006|NCT00972335|410045|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
170007|NCT00972335|410045|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
170008|NCT00972322|410052|P2|NOT COMPLETED|Overall Study||3
170009|NCT00972322|410053|P1|NOT COMPLETED|Overall Study||3
170010|NCT00972322|410052|P2|COMPLETED|Overall Study||25
170011|NCT00972322|410053|P1|COMPLETED|Overall Study||25
170012|NCT00972322|410052|P2|STARTED|Overall Study||28
170013|NCT00972322|410053|P1|STARTED|Overall Study||28
170014|NCT00972283|410065|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
170015|NCT00972283|410066|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
170016|NCT00972283|410065|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
170017|NCT00972283|410066|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
170018|NCT00972283|410065|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
170019|NCT00972283|410066|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
170020|NCT00972283|410065|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
170021|NCT00972283|410066|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
170022|NCT00972283|410065|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
170023|NCT00972283|410066|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
170024|NCT00972283|410065|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
170025|NCT00972283|410066|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
170026|NCT00972283|410065|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
170027|NCT00972283|410066|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
170028|NCT00972283|410065|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
170029|NCT00972283|410066|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
170030|NCT00972244|410093|P5|NOT COMPLETED|Overall Study||9
170031|NCT00972244|410094|P4|NOT COMPLETED|Overall Study||0
170032|NCT00972244|410095|P3|NOT COMPLETED|Overall Study||2
170033|NCT00972244|410096|P2|NOT COMPLETED|Overall Study||5
170034|NCT00972244|410097|P1|NOT COMPLETED|Overall Study||5
170035|NCT00972244|410093|P5|COMPLETED|Overall Study||45
170036|NCT00972244|410094|P4|COMPLETED|Overall Study||52
170037|NCT00972244|410095|P3|COMPLETED|Overall Study||56
170038|NCT00972244|410096|P2|COMPLETED|Overall Study||51
170039|NCT00972244|410097|P1|COMPLETED|Overall Study||54
170040|NCT00972244|410093|P5|STARTED|Overall Study||54
170041|NCT00972244|410094|P4|STARTED|Overall Study||52
170042|NCT00972244|410095|P3|STARTED|Overall Study||58
170043|NCT00972244|410096|P2|STARTED|Overall Study||56
170044|NCT00972244|410097|P1|STARTED|Overall Study||59
170045|NCT00972205|410119|P1|NOT COMPLETED|Overall Study||0
170046|NCT00972205|410119|P1|COMPLETED|Overall Study||12
170047|NCT00972205|410119|P1|STARTED|Overall Study||12
170048|NCT00972153|410129|P3|NOT COMPLETED|Overall Study||0
170049|NCT00972153|410130|P2|NOT COMPLETED|Overall Study||1
170050|NCT00972153|410131|P1|NOT COMPLETED|Overall Study||0
170051|NCT00972153|410129|P3|COMPLETED|Overall Study||12
170052|NCT00972153|410130|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
170053|NCT00972153|410131|P1|COMPLETED|Overall Study||12
170054|NCT00972153|410129|P3|STARTED|Overall Study||12
170055|NCT00972153|410130|P2|STARTED|Overall Study||12
170056|NCT00972153|410131|P1|STARTED|Overall Study||12
170057|NCT00972088|410142|P1|NOT COMPLETED|Overall Study||0
170058|NCT00972088|410142|P1|COMPLETED|Overall Study||26
170059|NCT00972088|410142|P1|STARTED|Overall Study||26
170060|NCT00972023|410146|P1|NOT COMPLETED|Overall Study||1
170061|NCT00972023|410146|P1|COMPLETED|Overall Study||0
170062|NCT00972023|410146|P1|STARTED|Overall Study||1
170063|NCT00971997|410153|P1|NOT COMPLETED|Overall Study||19
170064|NCT00971997|410153|P1|COMPLETED|Overall Study||116
170065|NCT00971997|410153|P1|STARTED|Overall Study||135
170066|NCT00971932|410171|P1|NOT COMPLETED|Overall Study||7
170067|NCT00971932|410171|P1|COMPLETED|Overall Study||26
170068|NCT00971932|410171|P1|STARTED|Overall Study|Number of participants treated.|33
170069|NCT00971841|410181|P1|NOT COMPLETED|Overall Study||0
170070|NCT00971841|410181|P1|COMPLETED|Overall Study||1
170071|NCT00971841|410181|P1|STARTED|Overall Study||1
170072|NCT00971789|410186|P1|NOT COMPLETED|Overall Study||0
170073|NCT00971789|410186|P1|COMPLETED|Overall Study||18
170074|NCT00971789|410186|P1|STARTED|Overall Study||18
170075|NCT00971750|410191|P1|NOT COMPLETED|Overall Study||0
170076|NCT00971750|410191|P1|COMPLETED|Overall Study||253
170077|NCT00971750|410191|P1|STARTED|Overall Study||253
170078|NCT00971633|410200|P6|NOT COMPLETED|Period 3||0
170079|NCT00971633|410201|P5|NOT COMPLETED|Period 3||0
170080|NCT00971633|410202|P4|NOT COMPLETED|Period 3||0
170081|NCT00971633|410203|P3|NOT COMPLETED|Period 3||0
170082|NCT00971633|410204|P2|NOT COMPLETED|Period 3||0
170083|NCT00971633|410205|P1|NOT COMPLETED|Period 3||0
170084|NCT00971633|410200|P6|COMPLETED|Period 3||2
170085|NCT00971633|410201|P5|COMPLETED|Period 3||2
170086|NCT00971633|410202|P4|COMPLETED|Period 3||2
170087|NCT00971633|410203|P3|COMPLETED|Period 3||2
170088|NCT00971633|410204|P2|COMPLETED|Period 3||2
170089|NCT00971633|410205|P1|COMPLETED|Period 3||2
170090|NCT00971633|410200|P6|STARTED|Period 3||2
170091|NCT00971633|410201|P5|STARTED|Period 3||2
170092|NCT00971633|410202|P4|STARTED|Period 3||2
170093|NCT00971633|410203|P3|STARTED|Period 3||2
170094|NCT00971633|410204|P2|STARTED|Period 3||2
170095|NCT00971633|410205|P1|STARTED|Period 3||2
170096|NCT00971633|410200|P6|NOT COMPLETED|Period 2||0
170097|NCT00971633|410201|P5|NOT COMPLETED|Period 2||0
170098|NCT00971633|410202|P4|NOT COMPLETED|Period 2||0
170099|NCT00971633|410203|P3|NOT COMPLETED|Period 2||0
170100|NCT00971633|410204|P2|NOT COMPLETED|Period 2||0
170101|NCT00971633|410205|P1|NOT COMPLETED|Period 2||0
170102|NCT00971633|410200|P6|COMPLETED|Period 2||2
170103|NCT00971633|410201|P5|COMPLETED|Period 2||2
170104|NCT00971633|410202|P4|COMPLETED|Period 2||2
170105|NCT00971633|410203|P3|COMPLETED|Period 2||2
170106|NCT00971633|410204|P2|COMPLETED|Period 2||2
170107|NCT00971633|410205|P1|COMPLETED|Period 2||2
170108|NCT00971633|410200|P6|STARTED|Period 2||2
170109|NCT00971633|410201|P5|STARTED|Period 2||2
170110|NCT00971633|410202|P4|STARTED|Period 2||2
170111|NCT00971633|410203|P3|STARTED|Period 2||2
170112|NCT00971633|410204|P2|STARTED|Period 2||2
170113|NCT00971633|410205|P1|STARTED|Period 2||2
170114|NCT00971633|410200|P6|NOT COMPLETED|Period 1||0
170115|NCT00971633|410201|P5|NOT COMPLETED|Period 1||0
170116|NCT00971633|410202|P4|NOT COMPLETED|Period 1||0
170117|NCT00971633|410203|P3|NOT COMPLETED|Period 1||0
170118|NCT00971633|410204|P2|NOT COMPLETED|Period 1||0
170119|NCT00971633|410205|P1|NOT COMPLETED|Period 1||0
170120|NCT00971633|410200|P6|COMPLETED|Period 1||2
170121|NCT00971633|410201|P5|COMPLETED|Period 1||2
170122|NCT00971633|410202|P4|COMPLETED|Period 1||2
170123|NCT00971633|410203|P3|COMPLETED|Period 1||2
170124|NCT00971633|410204|P2|COMPLETED|Period 1||2
170125|NCT00971633|410205|P1|COMPLETED|Period 1||2
170126|NCT00971633|410200|P6|STARTED|Period 1||2
170127|NCT00971633|410201|P5|STARTED|Period 1||2
170128|NCT00971633|410202|P4|STARTED|Period 1||2
170129|NCT00971633|410203|P3|STARTED|Period 1||2
170130|NCT00971633|410204|P2|STARTED|Period 1||2
170131|NCT00971633|410205|P1|STARTED|Period 1||2
170132|NCT00971620|410218|P2|NOT COMPLETED|Overall Study||0
170133|NCT00971620|410219|P1|NOT COMPLETED|Overall Study||0
170134|NCT00971620|410218|P2|COMPLETED|Overall Study||9
170135|NCT00971620|410219|P1|COMPLETED|Overall Study||9
170136|NCT00971620|410218|P2|STARTED|Overall Study||9
170137|NCT00971620|410219|P1|STARTED|Overall Study||9
170138|NCT00971425|410251|P2|NOT COMPLETED|Overall Study||2
170139|NCT00971425|410252|P1|NOT COMPLETED|Overall Study||1
170140|NCT00971425|410251|P2|COMPLETED|Overall Study||71
170141|NCT00971425|410252|P1|COMPLETED|Overall Study||71
170142|NCT00971425|410251|P2|STARTED|Overall Study||73
170143|NCT00971425|410252|P1|STARTED|Overall Study||72
170144|NCT00971295|410286|P2|NOT COMPLETED|Overall Study||1
170145|NCT00971295|410287|P1|NOT COMPLETED|Overall Study||0
170146|NCT00971295|410286|P2|COMPLETED|Overall Study||9
170147|NCT00971295|410287|P1|COMPLETED|Overall Study||10
170148|NCT00971295|410286|P2|STARTED|Overall Study||10
170149|NCT00971295|410287|P1|STARTED|Overall Study||10
170150|NCT00971282|410297|P1|NOT COMPLETED|Overall Study||0
170151|NCT00971282|410297|P1|COMPLETED|Overall Study||30
170152|NCT00971282|410297|P1|STARTED|Overall Study||30
170153|NCT00971243|410316|P5|NOT COMPLETED|Open-label Period||6
170154|NCT00971243|410317|P4|NOT COMPLETED|Open-label Period||10
170155|NCT00971243|410318|P3|NOT COMPLETED|Open-label Period||5
170156|NCT00971243|410319|P2|NOT COMPLETED|Open-label Period||10
170157|NCT00971243|410320|P1|NOT COMPLETED|Open-label Period||8
170158|NCT00971243|410316|P5|COMPLETED|Open-label Period||64
170159|NCT00971243|410317|P4|COMPLETED|Open-label Period||64
170160|NCT00971243|410318|P3|COMPLETED|Open-label Period||66
170161|NCT00971243|410319|P2|COMPLETED|Open-label Period||71
170162|NCT00971243|410320|P1|COMPLETED|Open-label Period||60
170163|NCT00971243|410316|P5|STARTED|Open-label Period||70
170164|NCT00971243|410317|P4|STARTED|Open-label Period||74
170165|NCT00971243|410318|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
170166|NCT00971243|410319|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
170167|NCT00971243|410320|P1|STARTED|Open-label Period||68
170168|NCT00971243|410316|P5|NOT COMPLETED|Double Blind Period||18
170169|NCT00971243|410317|P4|NOT COMPLETED|Double Blind Period||14
170170|NCT00971243|410318|P3|NOT COMPLETED|Double Blind Period||19
170171|NCT00971243|410319|P2|NOT COMPLETED|Double Blind Period||11
170172|NCT00971243|410320|P1|NOT COMPLETED|Double Blind Period||19
170173|NCT00971243|410316|P5|COMPLETED|Double Blind Period||70
170174|NCT00971243|410317|P4|COMPLETED|Double Blind Period||74
170175|NCT00971243|410318|P3|COMPLETED|Double Blind Period||72
170176|NCT00971243|410319|P2|COMPLETED|Double Blind Period||82
170177|NCT00971243|410320|P1|COMPLETED|Double Blind Period||68
170178|NCT00971243|410316|P5|STARTED|Double Blind Period||88
170179|NCT00971243|410317|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
170180|NCT00971243|410318|P3|STARTED|Double Blind Period||91
170181|NCT00971243|410319|P2|STARTED|Double Blind Period||93
170182|NCT00971243|410320|P1|STARTED|Double Blind Period||87
170183|NCT00971204|410337|P1|NOT COMPLETED|Overall Study||24
170184|NCT00971204|410337|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
170185|NCT00971204|410337|P1|Treated|Overall Study||86
170186|NCT00971204|410337|P1|STARTED|Overall Study|100 enrolled participants|100
170187|NCT00971048|410345|P4|NOT COMPLETED|Overall Study||2
170188|NCT00971048|410346|P3|NOT COMPLETED|Overall Study||1
170189|NCT00971048|410347|P2|NOT COMPLETED|Overall Study||2
170190|NCT00971048|410348|P1|NOT COMPLETED|Overall Study||1
170191|NCT00971048|410345|P4|COMPLETED|Overall Study||11
170192|NCT00971048|410346|P3|COMPLETED|Overall Study||11
170193|NCT00971048|410347|P2|COMPLETED|Overall Study||31
170194|NCT00971048|410348|P1|COMPLETED|Overall Study||29
170195|NCT00971048|410345|P4|STARTED|Overall Study||13
170196|NCT00971048|410346|P3|STARTED|Overall Study||12
170197|NCT00971048|410347|P2|STARTED|Overall Study||33
170198|NCT00971048|410348|P1|STARTED|Overall Study||30
170199|NCT00970944|410372|P2|NOT COMPLETED|Overall Study||2
170200|NCT00970944|410373|P1|NOT COMPLETED|Overall Study||1
170201|NCT00970944|410372|P2|COMPLETED|Overall Study||95
170202|NCT00970944|410373|P1|COMPLETED|Overall Study||86
170203|NCT00970944|410372|P2|STARTED|Overall Study||97
170204|NCT00970944|410373|P1|STARTED|Overall Study||87
170205|NCT00970853|410383|P2|NOT COMPLETED|Overall Study||0
170206|NCT00970853|410384|P1|NOT COMPLETED|Overall Study||0
170207|NCT00970853|410383|P2|COMPLETED|Overall Study||98
170208|NCT00970853|410384|P1|COMPLETED|Overall Study||89
170209|NCT00970853|410383|P2|STARTED|Overall Study||98
170210|NCT00970853|410384|P1|STARTED|Overall Study||89
170211|NCT00970814|410408|P2|NOT COMPLETED|Overall Study||14
170212|NCT00970814|410409|P1|NOT COMPLETED|Overall Study||8
170213|NCT00970814|410408|P2|COMPLETED|Overall Study||50
170214|NCT00970814|410409|P1|COMPLETED|Overall Study||58
170215|NCT00970814|410408|P2|STARTED|Overall Study||64
170216|NCT00970814|410409|P1|STARTED|Overall Study||66
170217|NCT00970736|410419|P1|NOT COMPLETED|Overall Study||2
170218|NCT00970736|410419|P1|COMPLETED|Overall Study||18
170219|NCT00970736|410419|P1|STARTED|Overall Study||20
170220|NCT00970684|410425|P1|NOT COMPLETED|Overall Study||10
170221|NCT00970684|410425|P1|COMPLETED|Overall Study||3
170222|NCT00970684|410425|P1|STARTED|Overall Study||13
170223|NCT00970632|410434|P3|NOT COMPLETED|Overall Study||18
170224|NCT00970632|410435|P2|NOT COMPLETED|Overall Study||15
170225|NCT00970632|410436|P1|NOT COMPLETED|Overall Study||24
170226|NCT00970632|410434|P3|COMPLETED|Overall Study||150
170227|NCT00970632|410435|P2|COMPLETED|Overall Study||156
170228|NCT00970632|410436|P1|COMPLETED|Overall Study||148
170229|NCT00970632|410434|P3|STARTED|Overall Study||168
170230|NCT00970632|410435|P2|STARTED|Overall Study||171
170231|NCT00970632|410436|P1|STARTED|Overall Study||172
170232|NCT00970606|410494|P2|NOT COMPLETED|Overall Study||0
170233|NCT00970606|410495|P1|NOT COMPLETED|Overall Study||0
170234|NCT00970606|410494|P2|COMPLETED|Overall Study||3
170235|NCT00970606|410495|P1|COMPLETED|Overall Study||4
170236|NCT00970606|410494|P2|STARTED|Overall Study||3
170237|NCT00970606|410495|P1|STARTED|Overall Study||4
170238|NCT00970502|410501|P1|NOT COMPLETED|Overall Study||1
170239|NCT00970502|410501|P1|COMPLETED|Overall Study||14
170240|NCT00970502|410501|P1|STARTED|Overall Study||15
170241|NCT00970489|410512|P2|NOT COMPLETED|Overall Study||41
170242|NCT00970489|410513|P1|NOT COMPLETED|Overall Study||54
170243|NCT00970489|410512|P2|COMPLETED|Overall Study||717
170244|NCT00970489|410513|P1|COMPLETED|Overall Study||704
170245|NCT00970489|410512|P2|STARTED|Overall Study||758
170246|NCT00970489|410513|P1|STARTED|Overall Study||758
170247|NCT00970359|410525|P1|NOT COMPLETED|Overall Study||4
170248|NCT00970359|410525|P1|COMPLETED|Overall Study||20
170249|NCT00970359|410525|P1|STARTED|Overall Study||24
170250|NCT00970320|410536|P5|NOT COMPLETED|Overall Study||540
170251|NCT00970320|410537|P4|NOT COMPLETED|Overall Study||14
170252|NCT00970320|410538|P3|NOT COMPLETED|Overall Study||13
170253|NCT00970320|410539|P2|NOT COMPLETED|Overall Study||11
170254|NCT00970320|410540|P1|NOT COMPLETED|Overall Study||0
170255|NCT00970320|410536|P5|COMPLETED|Overall Study||1031
170256|NCT00970320|410537|P4|COMPLETED|Overall Study||36
170257|NCT00970320|410538|P3|COMPLETED|Overall Study||35
170258|NCT00970320|410539|P2|COMPLETED|Overall Study||13
170259|NCT00970320|410540|P1|COMPLETED|Overall Study||25
170260|NCT00970320|410536|P5|STARTED|Overall Study||1571
170261|NCT00970320|410537|P4|STARTED|Overall Study||50
170262|NCT00970320|410538|P3|STARTED|Overall Study||48
170263|NCT00970320|410539|P2|STARTED|Overall Study||24
170264|NCT00970320|410540|P1|STARTED|Overall Study||25
170265|NCT00970307|410555|P3|NOT COMPLETED|Overall Study||2
170266|NCT00970307|410556|P2|NOT COMPLETED|Overall Study||3
170267|NCT00970307|410557|P1|NOT COMPLETED|Overall Study||3
170268|NCT00970307|410555|P3|COMPLETED|Overall Study||139
170269|NCT00970307|410556|P2|COMPLETED|Overall Study||136
170270|NCT00970307|410557|P1|COMPLETED|Overall Study||138
170271|NCT00970307|410555|P3|STARTED|Overall Study||141
170272|NCT00970307|410556|P2|STARTED|Overall Study||139
170273|NCT00970307|410557|P1|STARTED|Overall Study||141
170274|NCT00970294|410631|P1|NOT COMPLETED|Overall Study||5
170275|NCT00970294|410631|P1|COMPLETED|Overall Study||6
170276|NCT00970294|410631|P1|STARTED|Overall Study||11
170277|NCT00970281|410639|P2|NOT COMPLETED|Overall Study||16
170278|NCT00970281|410640|P1|NOT COMPLETED|Overall Study||2
170279|NCT00970281|410639|P2|COMPLETED|Overall Study||29
170280|NCT00970281|410640|P1|COMPLETED|Overall Study||44
170281|NCT00970281|410639|P2|Full Analysis Set|Overall Study||45
170282|NCT00970281|410640|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
170283|NCT00970281|410639|P2|STARTED|Overall Study||45
170284|NCT00970281|410640|P1|STARTED|Overall Study||46
170285|NCT00970268|410658|P2|NOT COMPLETED|Overall Study||49
170286|NCT00970268|410659|P1|NOT COMPLETED|Overall Study||43
170287|NCT00970268|410658|P2|COMPLETED|Overall Study||103
170288|NCT00970268|410659|P1|COMPLETED|Overall Study||96
170289|NCT00970268|410658|P2|STARTED|Overall Study||152
170290|NCT00970268|410659|P1|STARTED|Overall Study||139
170291|NCT00970216|410673|P1|NOT COMPLETED|Overall Study||80
170292|NCT00970216|410673|P1|COMPLETED|Overall Study||80
170293|NCT00970216|410673|P1|STARTED|Overall Study||160
170294|NCT00969878|410679|P2|NOT COMPLETED|Overall Study||26
170295|NCT00969878|410680|P1|NOT COMPLETED|Overall Study||30
170296|NCT00969878|410679|P2|COMPLETED|Overall Study||126
170297|NCT00969878|410680|P1|COMPLETED|Overall Study||118
170298|NCT00969878|410679|P2|STARTED|Overall Study||152
170299|NCT00969878|410680|P1|STARTED|Overall Study||148
170300|NCT00969709|410692|P4|NOT COMPLETED|Overall Study||63
170301|NCT00969709|410693|P3|NOT COMPLETED|Overall Study||58
170302|NCT00969709|410694|P2|NOT COMPLETED|Overall Study||48
170303|NCT00969709|410695|P1|NOT COMPLETED|Overall Study||38
170304|NCT00969709|410692|P4|COMPLETED|Overall Study||117
170305|NCT00969709|410693|P3|COMPLETED|Overall Study||121
170306|NCT00969709|410694|P2|COMPLETED|Overall Study||130
170307|NCT00969709|410695|P1|COMPLETED|Overall Study||138
170308|NCT00969709|410692|P4|STARTED|Overall Study||180
170309|NCT00969709|410693|P3|STARTED|Overall Study||179
170310|NCT00969709|410694|P2|STARTED|Overall Study||178
170311|NCT00969709|410695|P1|STARTED|Overall Study||176
170312|NCT00969618|410709|P1|NOT COMPLETED|Overall Study||78
170313|NCT00969618|410709|P1|COMPLETED|Overall Study||133
170314|NCT00969618|410709|P1|STARTED|Overall Study||211
170315|NCT00969540|410722|P2|NOT COMPLETED|Overall Study||1
170316|NCT00969540|410723|P1|NOT COMPLETED|Overall Study||1
170317|NCT00969540|410722|P2|COMPLETED|Overall Study||3
170318|NCT00969540|410723|P1|COMPLETED|Overall Study||3
170319|NCT00969540|410722|P2|STARTED|Overall Study||4
170320|NCT00969540|410723|P1|STARTED|Overall Study||4
170321|NCT00969501|410741|P1|NOT COMPLETED|Overall Study||5
170322|NCT00969501|410741|P1|COMPLETED|Overall Study||27
170323|NCT00969501|410741|P1|STARTED|Overall Study||32
170324|NCT00969436|410748|P3|NOT COMPLETED|Overall Study||11
170325|NCT00969436|410749|P2|NOT COMPLETED|Overall Study||21
170326|NCT00969436|410750|P1|NOT COMPLETED|Overall Study||25
170327|NCT00969436|410748|P3|COMPLETED|Overall Study||79
170328|NCT00969436|410749|P2|COMPLETED|Overall Study||159
170329|NCT00969436|410750|P1|COMPLETED|Overall Study||155
170330|NCT00969436|410748|P3|STARTED|Overall Study||90
170331|NCT00969436|410749|P2|STARTED|Overall Study||180
170332|NCT00969436|410750|P1|STARTED|Overall Study||180
170333|NCT00969280|410784|P2|NOT COMPLETED|Overall Study||3
170334|NCT00969280|410785|P1|NOT COMPLETED|Overall Study||2
170335|NCT00969280|410784|P2|COMPLETED|Overall Study||18
170336|NCT00969280|410785|P1|COMPLETED|Overall Study||19
170337|NCT00969280|410784|P2|STARTED|Overall Study||21
170338|NCT00969280|410785|P1|STARTED|Overall Study||21
170339|NCT00969228|410793|P2|NOT COMPLETED|Overall Study||14
170340|NCT00969228|410794|P1|NOT COMPLETED|Overall Study||43
170341|NCT00969228|410793|P2|COMPLETED|Overall Study||162
170342|NCT00969228|410794|P1|COMPLETED|Overall Study||465
170343|NCT00969228|410793|P2|STARTED|Overall Study||176
170344|NCT00969228|410794|P1|STARTED|Overall Study||508
170345|NCT00969150|410812|P2|NOT COMPLETED|Overall Study||40
170346|NCT00969150|410813|P1|NOT COMPLETED|Overall Study||33
170347|NCT00969150|410812|P2|COMPLETED|Overall Study||135
170348|NCT00969150|410813|P1|COMPLETED|Overall Study||149
170349|NCT00969150|410812|P2|STARTED|Overall Study||175
170350|NCT00969150|410813|P1|STARTED|Overall Study||182
170351|NCT00969124|410821|P1|NOT COMPLETED|Overall Study||30
170352|NCT00969124|410821|P1|COMPLETED|Overall Study||298
170353|NCT00969124|410821|P1|STARTED|Overall Study||328
170354|NCT00968981|410830|P3|NOT COMPLETED|Overall Study||22
170355|NCT00968981|410831|P2|NOT COMPLETED|Overall Study||22
170356|NCT00968981|410832|P1|NOT COMPLETED|Overall Study||22
170357|NCT00968981|410830|P3|COMPLETED|Overall Study||0
170358|NCT00968981|410831|P2|COMPLETED|Overall Study||0
170359|NCT00968981|410832|P1|COMPLETED|Overall Study||1
170360|NCT00968981|410830|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
170361|NCT00968981|410831|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
170362|NCT00968981|410832|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
170363|NCT00968981|410830|P3|STARTED|Overall Study||22
170364|NCT00968981|410831|P2|STARTED|Overall Study||22
170365|NCT00968981|410832|P1|STARTED|Overall Study||23
170366|NCT00968890|410870|P2|NOT COMPLETED|Overall Study||0
170367|NCT00968890|410871|P1|NOT COMPLETED|Overall Study||0
170368|NCT00968890|410870|P2|COMPLETED|Overall Study||84
170369|NCT00968890|410871|P1|COMPLETED|Overall Study||84
170370|NCT00968890|410870|P2|STARTED|Overall Study||84
170371|NCT00968890|410871|P1|STARTED|Overall Study||84
170372|NCT00968864|410899|P1|NOT COMPLETED|Overall Study||1
170373|NCT00968864|410899|P1|COMPLETED|Overall Study||52
170374|NCT00968864|410899|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
170375|NCT00968838|410917|P2|NOT COMPLETED|Overall Study||0
170376|NCT00968838|410918|P1|NOT COMPLETED|Overall Study||0
170377|NCT00968838|410917|P2|COMPLETED|Overall Study||58
170378|NCT00968838|410918|P1|COMPLETED|Overall Study||50
170379|NCT00968838|410917|P2|STARTED|Overall Study||58
170380|NCT00968838|410918|P1|STARTED|Overall Study||50
170381|NCT00968812|410927|P3|NOT COMPLETED|Overall Study||168
170382|NCT00968812|410928|P2|NOT COMPLETED|Overall Study||162
170383|NCT00968812|410929|P1|NOT COMPLETED|Overall Study||140
170384|NCT00968812|410927|P3|COMPLETED|Overall Study||314
170385|NCT00968812|410928|P2|COMPLETED|Overall Study||323
170386|NCT00968812|410929|P1|COMPLETED|Overall Study||343
170387|NCT00968812|410927|P3|STARTED|Overall Study||482
170388|NCT00968812|410928|P2|STARTED|Overall Study||485
170389|NCT00968812|410929|P1|STARTED|Overall Study||483
170390|NCT00968799|410949|P1|NOT COMPLETED|Overall Study||2
170391|NCT00968799|410949|P1|COMPLETED|Overall Study||4
170392|NCT00968799|410949|P1|STARTED|Overall Study||6
170393|NCT00968708|410959|P2|NOT COMPLETED|Overall Study||298
170394|NCT00968708|410960|P1|NOT COMPLETED|Overall Study||318
170395|NCT00968708|410959|P2|COMPLETED|Overall Study||2403
170396|NCT00968708|410960|P1|COMPLETED|Overall Study||2361
170397|NCT00968708|410959|P2|Treated|Overall Study||2698
170398|NCT00968708|410960|P1|Treated|Overall Study||2676
170399|NCT00968708|410959|P2|STARTED|Overall Study||2701
170400|NCT00968708|410960|P1|STARTED|Overall Study||2679
170401|NCT00968669|410972|P4|NOT COMPLETED|Overall Study||9
170402|NCT00968669|410973|P3|NOT COMPLETED|Overall Study||11
170403|NCT00968669|410974|P2|NOT COMPLETED|Overall Study||18
170404|NCT00968669|410975|P1|NOT COMPLETED|Overall Study||18
170405|NCT00968669|410972|P4|COMPLETED|Overall Study||72
170406|NCT00968669|410973|P3|COMPLETED|Overall Study||72
170407|NCT00968669|410974|P2|COMPLETED|Overall Study||63
170408|NCT00968669|410975|P1|COMPLETED|Overall Study||64
170409|NCT00968669|410972|P4|STARTED|Overall Study||81
170410|NCT00968669|410973|P3|STARTED|Overall Study||83
170411|NCT00968669|410974|P2|STARTED|Overall Study||81
170412|NCT00968669|410975|P1|STARTED|Overall Study||82
170413|NCT00968617|411065|P1|NOT COMPLETED|Overall Study||6
170414|NCT00968617|411065|P1|COMPLETED|Overall Study||1
170415|NCT00968617|411065|P1|STARTED|Overall Study||7
170416|NCT00968539|411079|P2|NOT COMPLETED|Overall Study||0
170417|NCT00968539|411080|P1|NOT COMPLETED|Overall Study||1
170418|NCT00968539|411079|P2|COMPLETED|Overall Study||66
170419|NCT00968539|411080|P1|COMPLETED|Overall Study||63
170420|NCT00968539|411079|P2|STARTED|Overall Study||66
170421|NCT00968539|411080|P1|STARTED|Overall Study||64
170422|NCT00968253|411141|P3|NOT COMPLETED|Overall Study||7
170423|NCT00968253|411142|P2|NOT COMPLETED|Overall Study||3
170424|NCT00968253|411143|P1|NOT COMPLETED|Overall Study||0
170425|NCT00968253|411141|P3|COMPLETED|Overall Study||5
170426|NCT00968253|411142|P2|COMPLETED|Overall Study||6
170427|NCT00968253|411143|P1|COMPLETED|Overall Study||3
170428|NCT00968253|411141|P3|STARTED|Overall Study||12
170429|NCT00968253|411142|P2|STARTED|Overall Study||9
170430|NCT00968253|411143|P1|STARTED|Overall Study||3
170431|NCT00968227|411157|P1|NOT COMPLETED|Overall Study||0
170432|NCT00968227|411157|P1|COMPLETED|Overall Study||56
170433|NCT00968227|411157|P1|STARTED|Overall Study||56
170434|NCT00968201|411164|P3|NOT COMPLETED|Extension Study - (Period III)||280
170435|NCT00968201|411165|P2|NOT COMPLETED|Extension Study - (Period III)||124
170436|NCT00968201|411166|P1|NOT COMPLETED|Extension Study - (Period III)||0
170437|NCT00968201|411164|P3|COMPLETED|Extension Study - (Period III)||84
170438|NCT00968201|411165|P2|COMPLETED|Extension Study - (Period III)||33
170439|NCT00968201|411166|P1|COMPLETED|Extension Study - (Period III)||0
170440|NCT00968201|411164|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
170441|NCT00968201|411165|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
170442|NCT00968201|411166|P1|STARTED|Extension Study - (Period III)||0
170443|NCT00968201|411164|P3|NOT COMPLETED|Base Study - (Period II)||45
170444|NCT00968201|411165|P2|NOT COMPLETED|Base Study - (Period II)||0
170445|NCT00968201|411166|P1|NOT COMPLETED|Base Study - (Period II)||26
170446|NCT00968201|411164|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
170447|NCT00968201|411165|P2|COMPLETED|Base Study - (Period II)||0
170448|NCT00968201|411166|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
170449|NCT00968201|411164|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
170450|NCT00968201|411165|P2|STARTED|Base Study - (Period II)||0
170451|NCT00968201|411166|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
170452|NCT00968149|411227|P2|NOT COMPLETED|Overall Study||6
170453|NCT00968149|411228|P1|NOT COMPLETED|Overall Study||11
170454|NCT00968149|411227|P2|COMPLETED|Overall Study||127
170455|NCT00968149|411228|P1|COMPLETED|Overall Study||269
170456|NCT00968149|411227|P2|STARTED|Overall Study||133
170457|NCT00968149|411228|P1|STARTED|Overall Study||280
170458|NCT00968071|411248|P1|NOT COMPLETED|Overall Study||0
170459|NCT00968071|411248|P1|COMPLETED|Overall Study||71
170460|NCT00968071|411248|P1|STARTED|Overall Study||71
170461|NCT00968032|411252|P1|NOT COMPLETED|Overall Study||2
170462|NCT00968032|411252|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
170463|NCT00968032|411252|P1|STARTED|Overall Study||63
170464|NCT00968019|411256|P1|NOT COMPLETED|Overall Study||15
170465|NCT00968019|411256|P1|COMPLETED|Overall Study||303
170466|NCT00968019|411256|P1|STARTED|Overall Study||318
170467|NCT00967993|411277|P1|NOT COMPLETED|Overall Study||4
170468|NCT00967993|411277|P1|COMPLETED|Overall Study||18
170469|NCT00967993|411277|P1|STARTED|Overall Study||22
170470|NCT00967694|411281|P1|NOT COMPLETED|Overall Study||6
170471|NCT00967694|411281|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
170472|NCT00967694|411281|P1|STARTED|Overall Study||26
170473|NCT00967668|411288|P3|NOT COMPLETED|Overall Study||69
170474|NCT00967668|411289|P2|NOT COMPLETED|Overall Study||56
170475|NCT00967668|411290|P1|NOT COMPLETED|Overall Study||71
170476|NCT00967668|411288|P3|COMPLETED|Overall Study||90
170477|NCT00967668|411289|P2|COMPLETED|Overall Study||104
170478|NCT00967668|411290|P1|COMPLETED|Overall Study||91
170479|NCT00967668|411288|P3|18-mo Assessment|Overall Study||92
170480|NCT00967668|411289|P2|18-mo Assessment|Overall Study||102
170481|NCT00967668|411290|P1|18-mo Assessment|Overall Study||95
170482|NCT00967668|411288|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
170483|NCT00967668|411289|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
170484|NCT00967668|411290|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
170485|NCT00967668|411288|P3|3-mo Assessment|Overall Study||115
170486|NCT00967668|411289|P2|3-mo Assessment|Overall Study||127
170487|NCT00967668|411290|P1|3-mo Assessment|Overall Study||131
170488|NCT00967668|411288|P3|STARTED|Overall Study||159
170489|NCT00967668|411289|P2|STARTED|Overall Study||160
170490|NCT00967668|411290|P1|STARTED|Overall Study||162
170491|NCT00967551|411303|P2|NOT COMPLETED|Overall Study||0
170492|NCT00967551|411304|P1|NOT COMPLETED|Overall Study||0
170493|NCT00967551|411303|P2|COMPLETED|Overall Study||75
170494|NCT00967551|411304|P1|COMPLETED|Overall Study||68
170495|NCT00967551|411303|P2|STARTED|Overall Study||75
170496|NCT00967551|411304|P1|STARTED|Overall Study||68
170497|NCT00967486|411314|P2|NOT COMPLETED|Overall Study||0
170498|NCT00967486|411315|P1|NOT COMPLETED|Overall Study||0
170499|NCT00967486|411314|P2|COMPLETED|Overall Study||102
170500|NCT00967486|411315|P1|COMPLETED|Overall Study||98
170501|NCT00967486|411314|P2|STARTED|Overall Study||102
170502|NCT00967486|411315|P1|STARTED|Overall Study||98
170503|NCT00967473|411321|P1|NOT COMPLETED|Overall Study||0
170504|NCT00967473|411321|P1|COMPLETED|Overall Study||15
170505|NCT00967473|411321|P1|STARTED|Overall Study||15
170506|NCT00967447|411327|P1|NOT COMPLETED|Overall Study||0
170507|NCT00967447|411327|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
170508|NCT00967447|411327|P1|STARTED|Overall Study|there are no collected data in CRF|2
170509|NCT00967330|411336|P2|NOT COMPLETED|Overall Study||60
170510|NCT00967330|411337|P1|NOT COMPLETED|Overall Study||122
170511|NCT00967330|411336|P2|COMPLETED|Overall Study||0
170512|NCT00967330|411337|P1|COMPLETED|Overall Study||0
170513|NCT00967330|411336|P2|STARTED|Overall Study||60
170514|NCT00967330|411337|P1|STARTED|Overall Study||122
170515|NCT00967226|411367|P2|NOT COMPLETED|Overall Study||6
170516|NCT00967226|411368|P1|NOT COMPLETED|Overall Study||2
170517|NCT00967226|411367|P2|COMPLETED|Overall Study||2
170518|NCT00967226|411368|P1|COMPLETED|Overall Study||9
170519|NCT00967226|411367|P2|STARTED|Overall Study||8
170520|NCT00967226|411368|P1|STARTED|Overall Study||11
170521|NCT00967044|411398|P1|NOT COMPLETED|Overall Study||0
170522|NCT00967044|411398|P1|COMPLETED|Overall Study||30
170523|NCT00967044|411398|P1|STARTED|Overall Study||30
170524|NCT00967018|411402|P1|NOT COMPLETED|Overall Study||21
170525|NCT00967018|411402|P1|COMPLETED|Overall Study||56
170526|NCT00967018|411402|P1|STARTED|Overall Study||77
170527|NCT00967005|411411|P2|NOT COMPLETED|Overall Study||10
170528|NCT00967005|411412|P1|NOT COMPLETED|Overall Study||7
170529|NCT00967005|411411|P2|COMPLETED|Overall Study||5
170530|NCT00967005|411412|P1|COMPLETED|Overall Study||6
170531|NCT00967005|411411|P2|Treatment Completion|Overall Study||10
170532|NCT00967005|411412|P1|Treatment Completion|Overall Study||10
170533|NCT00967005|411411|P2|STARTED|Overall Study||15
170534|NCT00967005|411412|P1|STARTED|Overall Study||13
170535|NCT00966992|411466|P2|NOT COMPLETED|Overall Study||0
170536|NCT00966992|411467|P1|NOT COMPLETED|Overall Study||0
170537|NCT00966992|411466|P2|COMPLETED|Overall Study||0
170538|NCT00966992|411467|P1|COMPLETED|Overall Study||3
170539|NCT00966992|411466|P2|STARTED|Overall Study||0
170540|NCT00966992|411467|P1|STARTED|Overall Study||3
170541|NCT00966953|411487|P4|NOT COMPLETED|4th Intervention Order||0
170542|NCT00966953|411488|P3|NOT COMPLETED|4th Intervention Order||0
170543|NCT00966953|411489|P2|NOT COMPLETED|4th Intervention Order||0
170544|NCT00966953|411490|P1|NOT COMPLETED|4th Intervention Order||0
170545|NCT00966953|411487|P4|COMPLETED|4th Intervention Order||7
170546|NCT00966953|411488|P3|COMPLETED|4th Intervention Order||6
170547|NCT00966953|411489|P2|COMPLETED|4th Intervention Order||6
170548|NCT00966953|411490|P1|COMPLETED|4th Intervention Order||6
170549|NCT00966953|411487|P4|STARTED|4th Intervention Order||7
170550|NCT00966953|411488|P3|STARTED|4th Intervention Order||6
170551|NCT00966953|411489|P2|STARTED|4th Intervention Order||6
170552|NCT00966953|411490|P1|STARTED|4th Intervention Order||6
170553|NCT00966953|411487|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
170554|NCT00966953|411488|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
170555|NCT00966953|411489|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
170556|NCT00966953|411490|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
170557|NCT00966953|411487|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
170558|NCT00966953|411488|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
170559|NCT00966953|411489|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
170560|NCT00966953|411490|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
170561|NCT00966953|411487|P4|STARTED|1 Week Washout After 3rd Intervention||7
170562|NCT00966953|411488|P3|STARTED|1 Week Washout After 3rd Intervention||6
170563|NCT00966953|411489|P2|STARTED|1 Week Washout After 3rd Intervention||6
170564|NCT00966953|411490|P1|STARTED|1 Week Washout After 3rd Intervention||6
170565|NCT00966953|411487|P4|NOT COMPLETED|3rd Intervention Order||0
170566|NCT00966953|411488|P3|NOT COMPLETED|3rd Intervention Order||0
170567|NCT00966953|411489|P2|NOT COMPLETED|3rd Intervention Order||0
170568|NCT00966953|411490|P1|NOT COMPLETED|3rd Intervention Order||0
170569|NCT00966953|411487|P4|COMPLETED|3rd Intervention Order||7
170570|NCT00966953|411488|P3|COMPLETED|3rd Intervention Order||6
170571|NCT00966953|411489|P2|COMPLETED|3rd Intervention Order||6
170572|NCT00966953|411490|P1|COMPLETED|3rd Intervention Order||6
170573|NCT00966953|411487|P4|STARTED|3rd Intervention Order||7
170574|NCT00966953|411488|P3|STARTED|3rd Intervention Order||6
170575|NCT00966953|411489|P2|STARTED|3rd Intervention Order||6
170576|NCT00966953|411490|P1|STARTED|3rd Intervention Order||6
170577|NCT00966953|411487|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
170578|NCT00966953|411488|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
170579|NCT00966953|411489|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
170580|NCT00966953|411490|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
170581|NCT00966953|411487|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
170582|NCT00966953|411488|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
170583|NCT00966953|411489|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
170584|NCT00966953|411490|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
170585|NCT00966953|411487|P4|STARTED|1 Week Washout After 2nd Intervention||7
170586|NCT00966953|411488|P3|STARTED|1 Week Washout After 2nd Intervention||6
170587|NCT00966953|411489|P2|STARTED|1 Week Washout After 2nd Intervention||6
170588|NCT00966953|411490|P1|STARTED|1 Week Washout After 2nd Intervention||6
170589|NCT00966953|411487|P4|NOT COMPLETED|2nd Intervention||0
170590|NCT00966953|411488|P3|NOT COMPLETED|2nd Intervention||0
170591|NCT00966953|411489|P2|NOT COMPLETED|2nd Intervention||0
170592|NCT00966953|411490|P1|NOT COMPLETED|2nd Intervention||0
170593|NCT00966953|411487|P4|COMPLETED|2nd Intervention||7
170594|NCT00966953|411488|P3|COMPLETED|2nd Intervention||6
170595|NCT00966953|411489|P2|COMPLETED|2nd Intervention||6
170596|NCT00966953|411490|P1|COMPLETED|2nd Intervention||6
170597|NCT00966953|411487|P4|STARTED|2nd Intervention||7
170598|NCT00966953|411488|P3|STARTED|2nd Intervention||6
170599|NCT00966953|411489|P2|STARTED|2nd Intervention||6
170600|NCT00966953|411490|P1|STARTED|2nd Intervention||6
170601|NCT00966953|411487|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
170602|NCT00966953|411488|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
170603|NCT00966953|411489|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
170604|NCT00966953|411490|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
170605|NCT00966953|411487|P4|COMPLETED|1 Week Washout After 1st Intervention||7
170606|NCT00966953|411488|P3|COMPLETED|1 Week Washout After 1st Intervention||6
170607|NCT00966953|411489|P2|COMPLETED|1 Week Washout After 1st Intervention||6
170608|NCT00966953|411490|P1|COMPLETED|1 Week Washout After 1st Intervention||6
170609|NCT00966953|411487|P4|STARTED|1 Week Washout After 1st Intervention||7
170610|NCT00966953|411488|P3|STARTED|1 Week Washout After 1st Intervention||6
170611|NCT00966953|411489|P2|STARTED|1 Week Washout After 1st Intervention||6
170612|NCT00966953|411490|P1|STARTED|1 Week Washout After 1st Intervention||6
170613|NCT00966953|411487|P4|NOT COMPLETED|1st Intervention||0
170614|NCT00966953|411488|P3|NOT COMPLETED|1st Intervention||0
170615|NCT00966953|411489|P2|NOT COMPLETED|1st Intervention||0
170616|NCT00966953|411490|P1|NOT COMPLETED|1st Intervention||0
170617|NCT00966953|411487|P4|COMPLETED|1st Intervention||7
170618|NCT00966953|411488|P3|COMPLETED|1st Intervention||6
170619|NCT00966953|411489|P2|COMPLETED|1st Intervention||6
170620|NCT00966953|411490|P1|COMPLETED|1st Intervention||6
170621|NCT00966953|411487|P4|STARTED|1st Intervention||7
170622|NCT00966953|411488|P3|STARTED|1st Intervention||6
170623|NCT00966953|411489|P2|STARTED|1st Intervention||6
170624|NCT00966953|411490|P1|STARTED|1st Intervention||6
170625|NCT00966940|411498|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
170626|NCT00966940|411499|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
170627|NCT00966940|411498|P2|COMPLETED|Period 2, Second 6 Weeks||23
170628|NCT00966940|411499|P1|COMPLETED|Period 2, Second 6 Weeks||25
170629|NCT00966940|411498|P2|STARTED|Period 2, Second 6 Weeks||23
170630|NCT00966940|411499|P1|STARTED|Period 2, Second 6 Weeks||25
170631|NCT00966940|411498|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
170632|NCT00966940|411499|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
170633|NCT00966940|411498|P2|COMPLETED|Period 1, First 6 Weeks||23
170634|NCT00966940|411499|P1|COMPLETED|Period 1, First 6 Weeks||25
170635|NCT00966940|411498|P2|STARTED|Period 1, First 6 Weeks||23
170636|NCT00966940|411499|P1|STARTED|Period 1, First 6 Weeks||28
170637|NCT00966875|411526|P9|NOT COMPLETED|Part B||18
170638|NCT00966875|411527|P8|NOT COMPLETED|Part B||19
170639|NCT00966875|411528|P7|NOT COMPLETED|Part B||22
170640|NCT00966875|411529|P6|NOT COMPLETED|Part B||6
170641|NCT00966875|411530|P5|NOT COMPLETED|Part B||7
170642|NCT00966875|411531|P4|NOT COMPLETED|Part B||3
170643|NCT00966875|411532|P3|NOT COMPLETED|Part B||6
170644|NCT00966875|411533|P2|NOT COMPLETED|Part B||3
170645|NCT00966875|411534|P1|NOT COMPLETED|Part B||5
170646|NCT00966875|411526|P9|COMPLETED|Part B||32
170647|NCT00966875|411527|P8|COMPLETED|Part B||38
170648|NCT00966875|411528|P7|COMPLETED|Part B||29
170649|NCT00966875|411529|P6|COMPLETED|Part B||26
170650|NCT00966875|411530|P5|COMPLETED|Part B||44
170651|NCT00966875|411531|P4|COMPLETED|Part B||31
170652|NCT00966875|411532|P3|COMPLETED|Part B||27
170653|NCT00966875|411533|P2|COMPLETED|Part B||33
170654|NCT00966875|411534|P1|COMPLETED|Part B||41
170655|NCT00966875|411526|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
170656|NCT00966875|411527|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
170657|NCT00966875|411528|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
170658|NCT00966875|411529|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
170659|NCT00966875|411530|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
170660|NCT00966875|411531|P4|STARTED|Part B||34
170661|NCT00966875|411532|P3|STARTED|Part B||33
170662|NCT00966875|411533|P2|STARTED|Part B||36
170663|NCT00966875|411534|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
170664|NCT00966875|411526|P9|NOT COMPLETED|Part A||8
170665|NCT00966875|411527|P8|NOT COMPLETED|Part A||7
170666|NCT00966875|411528|P7|NOT COMPLETED|Part A||12
170667|NCT00966875|411529|P6|NOT COMPLETED|Part A||4
170668|NCT00966875|411530|P5|NOT COMPLETED|Part A||5
170669|NCT00966875|411531|P4|NOT COMPLETED|Part A||3
170670|NCT00966875|411532|P3|NOT COMPLETED|Part A||2
170671|NCT00966875|411533|P2|NOT COMPLETED|Part A||4
170672|NCT00966875|411534|P1|NOT COMPLETED|Part A||6
170673|NCT00966875|411526|P9|COMPLETED|Part A||51
170674|NCT00966875|411527|P8|COMPLETED|Part A||58
170675|NCT00966875|411528|P7|COMPLETED|Part A||52
170676|NCT00966875|411529|P6|COMPLETED|Part A||33
170677|NCT00966875|411530|P5|COMPLETED|Part A||52
170678|NCT00966875|411531|P4|COMPLETED|Part A||34
170679|NCT00966875|411532|P3|COMPLETED|Part A||33
170680|NCT00966875|411533|P2|COMPLETED|Part A||36
170681|NCT00966875|411534|P1|COMPLETED|Part A||48
170682|NCT00966875|411526|P9|Received ≥1 Doses of Study Drug|Part A||59
170683|NCT00966875|411527|P8|Received ≥1 Doses of Study Drug|Part A||65
170684|NCT00966875|411528|P7|Received ≥1 Doses of Study Drug|Part A||64
170685|NCT00966875|411529|P6|Received ≥1 Doses of Study Drug|Part A||37
170686|NCT00966875|411530|P5|Received ≥1 Doses of Study Drug|Part A||57
170687|NCT00966875|411531|P4|Received ≥1 Doses of Study Drug|Part A||37
170688|NCT00966875|411532|P3|Received ≥1 Doses of Study Drug|Part A||35
170689|NCT00966875|411533|P2|Received ≥1 Doses of Study Drug|Part A||40
170690|NCT00966875|411534|P1|Received ≥1 Doses of Study Drug|Part A||54
170691|NCT00966875|411526|P9|STARTED|Part A||59
170692|NCT00966875|411527|P8|STARTED|Part A||65
170693|NCT00966875|411528|P7|STARTED|Part A||64
170694|NCT00966875|411529|P6|STARTED|Part A||37
170695|NCT00966875|411530|P5|STARTED|Part A||57
170696|NCT00966875|411531|P4|STARTED|Part A||37
170697|NCT00966875|411532|P3|STARTED|Part A||35
170698|NCT00966875|411533|P2|STARTED|Part A||40
170699|NCT00966875|411534|P1|STARTED|Part A||54
170700|NCT00966823|411853|P1|NOT COMPLETED|Overall Study||1
170701|NCT00966823|411853|P1|COMPLETED|Overall Study||2
170702|NCT00966823|411853|P1|STARTED|Overall Study||3
170703|NCT00966654|411861|P1|NOT COMPLETED|Overall Study||12
170704|NCT00966654|411861|P1|COMPLETED|Overall Study||0
170705|NCT00966654|411861|P1|STARTED|Overall Study||12
170706|NCT00966641|411869|P2|NOT COMPLETED|Second Intervention||0
170707|NCT00966641|411870|P1|NOT COMPLETED|Second Intervention||0
170708|NCT00966641|411869|P2|COMPLETED|Second Intervention||17
170709|NCT00966641|411870|P1|COMPLETED|Second Intervention||17
170710|NCT00966641|411869|P2|STARTED|Second Intervention||17
170711|NCT00966641|411870|P1|STARTED|Second Intervention||17
170712|NCT00966641|411869|P2|NOT COMPLETED|First Intervention||0
170713|NCT00966641|411870|P1|NOT COMPLETED|First Intervention||0
170714|NCT00966641|411869|P2|COMPLETED|First Intervention||17
170715|NCT00966641|411870|P1|COMPLETED|First Intervention||17
170716|NCT00966641|411869|P2|STARTED|First Intervention||17
170717|NCT00966641|411870|P1|STARTED|First Intervention||17
170718|NCT00966550|411878|P2|NOT COMPLETED|Overall Study||0
170719|NCT00966550|411879|P1|NOT COMPLETED|Overall Study||0
170720|NCT00966550|411878|P2|COMPLETED|Overall Study||12
170721|NCT00966550|411879|P1|COMPLETED|Overall Study||13
170722|NCT00966550|411878|P2|STARTED|Overall Study||12
170723|NCT00966550|411879|P1|STARTED|Overall Study||13
170724|NCT00966446|411888|P3|NOT COMPLETED|Overall Study||21
170725|NCT00966446|411889|P2|NOT COMPLETED|Overall Study||25
170726|NCT00966446|411890|P1|NOT COMPLETED|Overall Study||28
170727|NCT00966446|411888|P3|COMPLETED|Overall Study||52
170728|NCT00966446|411889|P2|COMPLETED|Overall Study||49
170729|NCT00966446|411890|P1|COMPLETED|Overall Study||48
170730|NCT00966446|411888|P3|STARTED|Overall Study||73
170731|NCT00966446|411889|P2|STARTED|Overall Study||74
170732|NCT00966446|411890|P1|STARTED|Overall Study||76
170733|NCT00966355|411907|P3|NOT COMPLETED|Overall Study||84
170734|NCT00966355|411908|P2|NOT COMPLETED|Overall Study||86
170735|NCT00966355|411909|P1|NOT COMPLETED|Overall Study||84
170736|NCT00966355|411907|P3|COMPLETED|Overall Study||261
170737|NCT00966355|411908|P2|COMPLETED|Overall Study||259
170738|NCT00966355|411909|P1|COMPLETED|Overall Study||260
170739|NCT00966355|411907|P3|STARTED|Overall Study||345
170740|NCT00966355|411908|P2|STARTED|Overall Study||345
170741|NCT00966355|411909|P1|STARTED|Overall Study||344
170742|NCT00966277|411922|P2|NOT COMPLETED|Overall Study||4
170743|NCT00966277|411923|P1|NOT COMPLETED|Overall Study||4
170744|NCT00966277|411922|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
170745|NCT00966277|411923|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
170746|NCT00966277|411922|P2|STARTED|Overall Study||37
170747|NCT00966277|411923|P1|STARTED|Overall Study||38
170748|NCT00966264|411931|P2|NOT COMPLETED|Overall Study||3
170749|NCT00966264|411932|P1|NOT COMPLETED|Overall Study||4
170750|NCT00966264|411931|P2|COMPLETED|Overall Study|5 years results|114
170751|NCT00966264|411932|P1|COMPLETED|Overall Study|5 years results|115
170752|NCT00966264|411931|P2|STARTED|Overall Study||117
170753|NCT00966264|411932|P1|STARTED|Overall Study||119
170754|NCT00966238|411944|P6|NOT COMPLETED|Overall Study||0
170755|NCT00966238|411945|P5|NOT COMPLETED|Overall Study||0
170756|NCT00966238|411946|P4|NOT COMPLETED|Overall Study||0
170757|NCT00966238|411947|P3|NOT COMPLETED|Overall Study||0
170758|NCT00966238|411948|P2|NOT COMPLETED|Overall Study||0
170759|NCT00966238|411949|P1|NOT COMPLETED|Overall Study||0
170760|NCT00966238|411944|P6|COMPLETED|Overall Study||20
170761|NCT00966238|411945|P5|COMPLETED|Overall Study||20
170762|NCT00966238|411946|P4|COMPLETED|Overall Study||20
170763|NCT00966238|411947|P3|COMPLETED|Overall Study||20
170764|NCT00966238|411948|P2|COMPLETED|Overall Study||20
170765|NCT00966238|411949|P1|COMPLETED|Overall Study||20
170766|NCT00966238|411944|P6|STARTED|Overall Study||20
170767|NCT00966238|411945|P5|STARTED|Overall Study||20
170768|NCT00966238|411946|P4|STARTED|Overall Study||20
170769|NCT00966238|411947|P3|STARTED|Overall Study||20
170770|NCT00966238|411948|P2|STARTED|Overall Study||20
170771|NCT00966238|411949|P1|STARTED|Overall Study||20
170772|NCT00966186|411971|P2|NOT COMPLETED|Overall Study||0
170773|NCT00966186|411972|P1|NOT COMPLETED|Overall Study||0
170774|NCT00966186|411971|P2|COMPLETED|Overall Study||60
170775|NCT00966186|411972|P1|COMPLETED|Overall Study||60
170776|NCT00966186|411971|P2|STARTED|Overall Study||60
170777|NCT00966186|411972|P1|STARTED|Overall Study||60
170778|NCT00965848|411978|P3|NOT COMPLETED|Overall Study||10
170779|NCT00965848|411979|P2|NOT COMPLETED|Overall Study||2
170780|NCT00965848|411980|P1|NOT COMPLETED|Overall Study||29
170781|NCT00965848|411978|P3|COMPLETED|Overall Study||117
170782|NCT00965848|411979|P2|COMPLETED|Overall Study||32
170783|NCT00965848|411980|P1|COMPLETED|Overall Study||78
170784|NCT00965848|411978|P3|STARTED|Overall Study||127
170785|NCT00965848|411979|P2|STARTED|Overall Study||34
170786|NCT00965848|411980|P1|STARTED|Overall Study||107
170787|NCT00965757|411999|P4|NOT COMPLETED|Extension Phase||24
170788|NCT00965757|412000|P3|NOT COMPLETED|Extension Phase||33
170789|NCT00965757|412001|P2|NOT COMPLETED|Extension Phase||0
170790|NCT00965757|412002|P1|NOT COMPLETED|Extension Phase||0
170791|NCT00965757|411999|P4|COMPLETED|Extension Phase||64
170792|NCT00965757|412000|P3|COMPLETED|Extension Phase||132
170793|NCT00965757|412001|P2|COMPLETED|Extension Phase||0
170794|NCT00965757|412002|P1|COMPLETED|Extension Phase||0
170795|NCT00965757|411999|P4|STARTED|Extension Phase||88
170796|NCT00965757|412000|P3|STARTED|Extension Phase||165
170797|NCT00965757|412001|P2|STARTED|Extension Phase||0
170798|NCT00965757|412002|P1|STARTED|Extension Phase||0
170799|NCT00965757|411999|P4|NOT COMPLETED|Double-blind Phase||0
170800|NCT00965757|412000|P3|NOT COMPLETED|Double-blind Phase||0
170801|NCT00965757|412001|P2|NOT COMPLETED|Double-blind Phase||18
170802|NCT00965757|412002|P1|NOT COMPLETED|Double-blind Phase||17
170803|NCT00965757|411999|P4|COMPLETED|Double-blind Phase||0
170804|NCT00965757|412000|P3|COMPLETED|Double-blind Phase||0
170805|NCT00965757|412001|P2|COMPLETED|Double-blind Phase||70
170806|NCT00965757|412002|P1|COMPLETED|Double-blind Phase||148
170807|NCT00965757|411999|P4|STARTED|Double-blind Phase||0
170808|NCT00965757|412000|P3|STARTED|Double-blind Phase||0
170809|NCT00965757|412001|P2|STARTED|Double-blind Phase||88
170810|NCT00965757|412002|P1|STARTED|Double-blind Phase||165
170811|NCT00965731|412036|P2|NOT COMPLETED|Overall Study||20
170812|NCT00965731|412037|P1|NOT COMPLETED|Overall Study||7
170813|NCT00965731|412036|P2|COMPLETED|Overall Study||0
170814|NCT00965731|412037|P1|COMPLETED|Overall Study||0
170815|NCT00965731|412036|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
170816|NCT00965731|412037|P1|STARTED|Overall Study||7
170817|NCT00965718|412101|P1|NOT COMPLETED|Overall Study||4
170818|NCT00965718|412101|P1|COMPLETED|Overall Study||16
170819|NCT00965718|412101|P1|STARTED|Overall Study||20
170820|NCT00965562|412114|P3|NOT COMPLETED|Overall Study||3
170821|NCT00965562|412115|P2|NOT COMPLETED|Overall Study||4
170822|NCT00965562|412116|P1|NOT COMPLETED|Overall Study||3
170823|NCT00965562|412114|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
170824|NCT00965562|412115|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
170825|NCT00965562|412116|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
170826|NCT00965562|412114|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
170827|NCT00965562|412115|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
170828|NCT00965562|412116|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
170829|NCT00965562|412114|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
170830|NCT00965562|412115|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
170831|NCT00965562|412116|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
170832|NCT00965562|412114|P3|STARTED|Overall Study||16
170833|NCT00965562|412115|P2|STARTED|Overall Study||17
170834|NCT00965562|412116|P1|STARTED|Overall Study||16
170835|NCT00965523|412154|P1|NOT COMPLETED|Study 224||6
170836|NCT00965523|412154|P1|COMPLETED|Study 224||0
170837|NCT00965523|412154|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
170838|NCT00965523|412154|P1|NOT COMPLETED|Study 221||7
170839|NCT00965523|412154|P1|COMPLETED|Study 221||74
170840|NCT00965523|412154|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
170841|NCT00965497|412159|P1|NOT COMPLETED|Overall Study||1
170842|NCT00965497|412159|P1|COMPLETED|Overall Study||13
170843|NCT00965497|412159|P1|STARTED|Overall Study||14
170844|NCT00965484|412164|P1|NOT COMPLETED|Overall Study||2
170845|NCT00965484|412164|P1|COMPLETED|Overall Study||134
170846|NCT00965484|412164|P1|STARTED|Overall Study||136
170847|NCT00965458|412173|P2|NOT COMPLETED|Overall Study||4
170848|NCT00965458|412174|P1|NOT COMPLETED|Overall Study||2
170849|NCT00965458|412173|P2|COMPLETED|Overall Study||12
170850|NCT00965458|412174|P1|COMPLETED|Overall Study||31
170851|NCT00965458|412173|P2|STARTED|Overall Study||16
170852|NCT00965458|412174|P1|STARTED|Overall Study||33
170853|NCT00965419|412190|P1|NOT COMPLETED|Follow-up Phase||62
170854|NCT00965419|412190|P1|COMPLETED|Follow-up Phase||18
170855|NCT00965419|412190|P1|STARTED|Follow-up Phase||80
170856|NCT00965419|412190|P1|NOT COMPLETED|Open Label Treatment for Responders||247
170857|NCT00965419|412190|P1|COMPLETED|Open Label Treatment for Responders||20
170858|NCT00965419|412190|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
170859|NCT00965419|412190|P1|STARTED|Open Label Treatment for Responders||267
170860|NCT00965341|412236|P2|NOT COMPLETED|Overall Study||8
170861|NCT00965341|412237|P1|NOT COMPLETED|Overall Study||6
170862|NCT00965341|412236|P2|COMPLETED|Overall Study||16
170863|NCT00965341|412237|P1|COMPLETED|Overall Study||13
170864|NCT00965341|412236|P2|STARTED|Overall Study||24
170865|NCT00965341|412237|P1|STARTED|Overall Study||19
170866|NCT00965263|412247|P2|NOT COMPLETED|Overall Study||3
170867|NCT00965263|412248|P1|NOT COMPLETED|Overall Study||2
170868|NCT00965263|412247|P2|COMPLETED|Overall Study||6
170869|NCT00965263|412248|P1|COMPLETED|Overall Study||4
170870|NCT00965263|412247|P2|STARTED|Overall Study||9
170871|NCT00965263|412248|P1|STARTED|Overall Study||6
170872|NCT00965250|412280|P2|NOT COMPLETED|Overall Study||0
170873|NCT00965250|412281|P1|NOT COMPLETED|Overall Study||0
170874|NCT00965250|412280|P2|COMPLETED|Overall Study||12
170875|NCT00965250|412281|P1|COMPLETED|Overall Study||37
170876|NCT00965250|412280|P2|STARTED|Overall Study||12
170877|NCT00965250|412281|P1|STARTED|Overall Study||37
170878|NCT00965237|412299|P2|NOT COMPLETED|Period 2, One Week of Wear||0
170879|NCT00965237|412300|P1|NOT COMPLETED|Period 2, One Week of Wear||0
170880|NCT00965237|412299|P2|COMPLETED|Period 2, One Week of Wear||8
170881|NCT00965237|412300|P1|COMPLETED|Period 2, One Week of Wear||8
170882|NCT00965237|412299|P2|STARTED|Period 2, One Week of Wear||8
170883|NCT00965237|412300|P1|STARTED|Period 2, One Week of Wear||8
170884|NCT00965237|412299|P2|NOT COMPLETED|Period 1, One Week of Wear||0
170885|NCT00965237|412300|P1|NOT COMPLETED|Period 1, One Week of Wear||0
170886|NCT00965237|412299|P2|COMPLETED|Period 1, One Week of Wear||8
170887|NCT00965237|412300|P1|COMPLETED|Period 1, One Week of Wear||8
170888|NCT00965237|412299|P2|STARTED|Period 1, One Week of Wear||8
170889|NCT00965237|412300|P1|STARTED|Period 1, One Week of Wear||8
170890|NCT00965185|412308|P2|NOT COMPLETED|Overall Study||1
170891|NCT00965185|412309|P1|NOT COMPLETED|Overall Study||2
170892|NCT00965185|412308|P2|COMPLETED|Overall Study||20
170893|NCT00965185|412309|P1|COMPLETED|Overall Study||17
170894|NCT00965185|412308|P2|9 Month Visit|Overall Study||21
170895|NCT00965185|412309|P1|9 Month Visit|Overall Study||18
170896|NCT00965185|412308|P2|6 Month Visit|Overall Study||21
170897|NCT00965185|412309|P1|6 Month Visit|Overall Study||18
170898|NCT00965185|412308|P2|3 Month Visit|Overall Study||21
170899|NCT00965185|412309|P1|3 Month Visit|Overall Study||18
170900|NCT00965185|412308|P2|1 Month Visit|Overall Study||21
170901|NCT00965185|412309|P1|1 Month Visit|Overall Study||18
170902|NCT00965185|412308|P2|STARTED|Overall Study||21
170903|NCT00965185|412309|P1|STARTED|Overall Study||19
170904|NCT00965146|412329|P1|NOT COMPLETED|Overall Study||210
170905|NCT00965146|412329|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
170906|NCT00965146|412329|P1|STARTED|Overall Study||210
170907|NCT00965094|412336|P2|NOT COMPLETED|Overall Study||1
170908|NCT00965094|412337|P1|NOT COMPLETED|Overall Study||5
170909|NCT00965094|412336|P2|COMPLETED|Overall Study||16
170910|NCT00965094|412337|P1|COMPLETED|Overall Study||14
170911|NCT00965094|412336|P2|STARTED|Overall Study||17
170912|NCT00965094|412337|P1|STARTED|Overall Study||19
170913|NCT00965081|412353|P2|NOT COMPLETED|Overall Study||43
170914|NCT00965081|412354|P1|NOT COMPLETED|Overall Study||34
170915|NCT00965081|412353|P2|COMPLETED|Overall Study||110
170916|NCT00965081|412354|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
170917|NCT00965081|412353|P2|STARTED|Overall Study||153
170918|NCT00965081|412354|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
170919|NCT00964886|412381|P4|NOT COMPLETED|Overall Study||9
170920|NCT00964886|412382|P3|NOT COMPLETED|Overall Study||16
170921|NCT00964886|412383|P2|NOT COMPLETED|Overall Study||7
170922|NCT00964886|412384|P1|NOT COMPLETED|Overall Study||11
170923|NCT00964886|412381|P4|COMPLETED|Overall Study||24
170924|NCT00964886|412382|P3|COMPLETED|Overall Study||21
170925|NCT00964886|412383|P2|COMPLETED|Overall Study||27
170926|NCT00964886|412384|P1|COMPLETED|Overall Study||27
170927|NCT00964886|412381|P4|STARTED|Overall Study||33
170928|NCT00964886|412382|P3|STARTED|Overall Study||37
170929|NCT00964886|412383|P2|STARTED|Overall Study||34
170930|NCT00964886|412384|P1|STARTED|Overall Study||38
170931|NCT00964860|412400|P2|NOT COMPLETED|Overall Study||1
170932|NCT00964860|412401|P1|NOT COMPLETED|Overall Study||0
170933|NCT00964860|412400|P2|COMPLETED|Overall Study||29
170934|NCT00964860|412401|P1|COMPLETED|Overall Study||30
170935|NCT00964860|412400|P2|STARTED|Overall Study||30
170936|NCT00964860|412401|P1|STARTED|Overall Study||30
170937|NCT00964795|412409|P1|NOT COMPLETED|Overall Study||307
170938|NCT00964795|412409|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
170939|NCT00964795|412409|P1|Number of Participants Treated|Overall Study||320
170940|NCT00964795|412409|P1|STARTED|Overall Study|randomized|323
170941|NCT00964743|412416|P1|NOT COMPLETED|Overall Study||2
170942|NCT00964743|412416|P1|COMPLETED|Overall Study||0
170943|NCT00964743|412416|P1|STARTED|Overall Study||2
170944|NCT00964678|412424|P1|NOT COMPLETED|Overall Study||4
170945|NCT00964678|412424|P1|COMPLETED|Overall Study||6
170946|NCT00964678|412424|P1|STARTED|Overall Study||10
170947|NCT00964548|412433|P2|NOT COMPLETED|Overall Study||0
170948|NCT00964548|412434|P1|NOT COMPLETED|Overall Study||0
170949|NCT00964548|412433|P2|COMPLETED|Overall Study||5
170950|NCT00964548|412434|P1|COMPLETED|Overall Study||5
170951|NCT00964548|412433|P2|STARTED|Overall Study||5
170952|NCT00964548|412434|P1|STARTED|Overall Study||5
170953|NCT00964496|412446|P2|NOT COMPLETED|Overall Study||1
170954|NCT00964496|412447|P1|NOT COMPLETED|Overall Study||2
170955|NCT00964496|412446|P2|COMPLETED|Overall Study||26
170956|NCT00964496|412447|P1|COMPLETED|Overall Study||26
170957|NCT00964496|412446|P2|STARTED|Overall Study||27
170958|NCT00964496|412447|P1|STARTED|Overall Study||28
170959|NCT00964444|412465|P1|NOT COMPLETED|Overall Study||0
170960|NCT00964444|412465|P1|COMPLETED|Overall Study||10
170961|NCT00964444|412465|P1|STARTED|Overall Study||10
170962|NCT00964431|412473|P4|NOT COMPLETED|Overall Study||0
170963|NCT00964431|412474|P3|NOT COMPLETED|Overall Study||0
170964|NCT00964431|412475|P2|NOT COMPLETED|Overall Study||0
170965|NCT00964431|412476|P1|NOT COMPLETED|Overall Study||0
170966|NCT00964431|412473|P4|COMPLETED|Overall Study||51
170967|NCT00964431|412474|P3|COMPLETED|Overall Study||51
170968|NCT00964431|412475|P2|COMPLETED|Overall Study||51
170969|NCT00964431|412476|P1|COMPLETED|Overall Study||50
170970|NCT00964431|412473|P4|STARTED|Overall Study||51
170971|NCT00964431|412474|P3|STARTED|Overall Study||51
170972|NCT00964431|412475|P2|STARTED|Overall Study||51
170973|NCT00964431|412476|P1|STARTED|Overall Study||50
170974|NCT00964392|412488|P2|NOT COMPLETED|Overall Study||190
170975|NCT00964392|412489|P1|NOT COMPLETED|Overall Study||53
170976|NCT00964392|412488|P2|COMPLETED|Overall Study||92
170977|NCT00964392|412489|P1|COMPLETED|Overall Study||72
170978|NCT00964392|412488|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
170979|NCT00964392|412489|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
170980|NCT00964366|412499|P2|NOT COMPLETED|Overall Study||1
170981|NCT00964366|412500|P1|NOT COMPLETED|Overall Study||1
170982|NCT00964366|412499|P2|COMPLETED|Overall Study||24
170983|NCT00964366|412500|P1|COMPLETED|Overall Study||27
170984|NCT00964366|412499|P2|STARTED|Overall Study||25
170985|NCT00964366|412500|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
170986|NCT00964223|412514|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
170987|NCT00964223|412514|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
170988|NCT00964223|412514|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
170989|NCT00964223|412514|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
170990|NCT00964223|412514|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
170991|NCT00964223|412514|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
170992|NCT00964158|412582|P3|NOT COMPLETED|Overall Study||8
170993|NCT00964158|412583|P2|NOT COMPLETED|Overall Study||1
170994|NCT00964158|412584|P1|NOT COMPLETED|Overall Study||0
170995|NCT00964158|412582|P3|COMPLETED|Overall Study||92
170996|NCT00964158|412583|P2|COMPLETED|Overall Study||56
170997|NCT00964158|412584|P1|COMPLETED|Overall Study||53
170998|NCT00964158|412582|P3|STARTED|Overall Study||100
170999|NCT00964158|412583|P2|STARTED|Overall Study||57
171000|NCT00964158|412584|P1|STARTED|Overall Study||53
171001|NCT00964119|412653|P1|NOT COMPLETED|Overall Study||0
171002|NCT00964119|412653|P1|COMPLETED|Overall Study||15
171003|NCT00964119|412653|P1|STARTED|Overall Study||15
171004|NCT00964028|412659|P2|NOT COMPLETED|Overall Study||1
171005|NCT00964028|412660|P1|NOT COMPLETED|Overall Study||0
171006|NCT00964028|412659|P2|COMPLETED|Overall Study||24
171007|NCT00964028|412660|P1|COMPLETED|Overall Study||25
171008|NCT00964028|412659|P2|STARTED|Overall Study||25
171009|NCT00964028|412660|P1|STARTED|Overall Study||25
171010|NCT00963937|412675|P3|NOT COMPLETED|Overall Study||4
171011|NCT00963937|412676|P2|NOT COMPLETED|Overall Study||11
171012|NCT00963937|412677|P1|NOT COMPLETED|Overall Study||19
171013|NCT00963937|412675|P3|COMPLETED|Overall Study||41
171014|NCT00963937|412676|P2|COMPLETED|Overall Study||33
171015|NCT00963937|412677|P1|COMPLETED|Overall Study||70
171016|NCT00963937|412675|P3|STARTED|Overall Study||45
171017|NCT00963937|412676|P2|STARTED|Overall Study||44
171018|NCT00963937|412677|P1|STARTED|Overall Study||89
171019|NCT00963924|412715|P2|NOT COMPLETED|Overall Study||3
171020|NCT00963924|412716|P1|NOT COMPLETED|Overall Study||1
171021|NCT00963924|412715|P2|COMPLETED|Overall Study||15
171022|NCT00963924|412716|P1|COMPLETED|Overall Study||17
171023|NCT00963924|412715|P2|STARTED|Overall Study||18
171024|NCT00963924|412716|P1|STARTED|Overall Study||18
171025|NCT00963872|412740|P2|NOT COMPLETED|Overall Study||1
171026|NCT00963872|412741|P1|NOT COMPLETED|Overall Study||1
171027|NCT00963872|412740|P2|COMPLETED|Overall Study||5
171028|NCT00963872|412741|P1|COMPLETED|Overall Study||24
171029|NCT00963872|412740|P2|STARTED|Overall Study||6
171030|NCT00963872|412741|P1|STARTED|Overall Study||25
171031|NCT00963859|412785|P1|NOT COMPLETED|Overall Study||0
171032|NCT00963859|412785|P1|COMPLETED|Overall Study||11
171033|NCT00963859|412785|P1|STARTED|Overall Study||11
171034|NCT00963820|412790|P12|NOT COMPLETED|Expansion Phase||4
171035|NCT00963820|412791|P11|NOT COMPLETED|Expansion Phase||5
171036|NCT00963820|412792|P10|NOT COMPLETED|Expansion Phase||9
171037|NCT00963820|412793|P9|NOT COMPLETED|Expansion Phase||10
171038|NCT00963820|412794|P8|NOT COMPLETED|Expansion Phase||0
171039|NCT00963820|412795|P7|NOT COMPLETED|Expansion Phase||0
171040|NCT00963820|412796|P6|NOT COMPLETED|Expansion Phase||0
171041|NCT00963820|412797|P5|NOT COMPLETED|Expansion Phase||0
171042|NCT00963820|412798|P4|NOT COMPLETED|Expansion Phase||0
171043|NCT00963820|412799|P3|NOT COMPLETED|Expansion Phase||0
171044|NCT00963820|412800|P2|NOT COMPLETED|Expansion Phase||0
171045|NCT00963820|412801|P1|NOT COMPLETED|Expansion Phase||0
171046|NCT00963820|412790|P12|COMPLETED|Expansion Phase||0
171047|NCT00963820|412791|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
171048|NCT00963820|412792|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
171049|NCT00963820|412793|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
171050|NCT00963820|412794|P8|COMPLETED|Expansion Phase||0
171051|NCT00963820|412795|P7|COMPLETED|Expansion Phase||0
171052|NCT00963820|412796|P6|COMPLETED|Expansion Phase||0
171053|NCT00963820|412797|P5|COMPLETED|Expansion Phase||0
171054|NCT00963820|412798|P4|COMPLETED|Expansion Phase||0
171055|NCT00963820|412799|P3|COMPLETED|Expansion Phase||0
171056|NCT00963820|412800|P2|COMPLETED|Expansion Phase||0
171057|NCT00963820|412801|P1|COMPLETED|Expansion Phase||0
171058|NCT00963820|412790|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
171059|NCT00963820|412791|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
171060|NCT00963820|412792|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
171061|NCT00963820|412793|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
171062|NCT00963820|412794|P8|STARTED|Expansion Phase||0
171063|NCT00963820|412795|P7|STARTED|Expansion Phase||0
171064|NCT00963820|412796|P6|STARTED|Expansion Phase||0
171065|NCT00963820|412797|P5|STARTED|Expansion Phase||0
171066|NCT00963820|412798|P4|STARTED|Expansion Phase||0
171067|NCT00963820|412799|P3|STARTED|Expansion Phase||0
171068|NCT00963820|412800|P2|STARTED|Expansion Phase||0
171069|NCT00963820|412801|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
171070|NCT00963820|412790|P12|NOT COMPLETED|Dose Escalation Phase||0
171071|NCT00963820|412791|P11|NOT COMPLETED|Dose Escalation Phase||0
171072|NCT00963820|412792|P10|NOT COMPLETED|Dose Escalation Phase||0
171073|NCT00963820|412793|P9|NOT COMPLETED|Dose Escalation Phase||0
171074|NCT00963820|412794|P8|NOT COMPLETED|Dose Escalation Phase||5
171075|NCT00963820|412795|P7|NOT COMPLETED|Dose Escalation Phase||8
171076|NCT00963820|412796|P6|NOT COMPLETED|Dose Escalation Phase||3
171077|NCT00963820|412797|P5|NOT COMPLETED|Dose Escalation Phase||4
171078|NCT00963820|412798|P4|NOT COMPLETED|Dose Escalation Phase||3
171079|NCT00963820|412799|P3|NOT COMPLETED|Dose Escalation Phase||3
171080|NCT00963820|412800|P2|NOT COMPLETED|Dose Escalation Phase||3
171081|NCT00963820|412801|P1|NOT COMPLETED|Dose Escalation Phase||3
171082|NCT00963820|412790|P12|COMPLETED|Dose Escalation Phase||0
171083|NCT00963820|412791|P11|COMPLETED|Dose Escalation Phase||0
171084|NCT00963820|412792|P10|COMPLETED|Dose Escalation Phase||0
171085|NCT00963820|412793|P9|COMPLETED|Dose Escalation Phase||0
171086|NCT00963820|412794|P8|COMPLETED|Dose Escalation Phase||0
171087|NCT00963820|412795|P7|COMPLETED|Dose Escalation Phase||0
171088|NCT00963820|412796|P6|COMPLETED|Dose Escalation Phase||0
171089|NCT00963820|412797|P5|COMPLETED|Dose Escalation Phase||0
171090|NCT00963820|412798|P4|COMPLETED|Dose Escalation Phase||0
171091|NCT00963820|412799|P3|COMPLETED|Dose Escalation Phase||0
171092|NCT00963820|412800|P2|COMPLETED|Dose Escalation Phase||0
171093|NCT00963820|412801|P1|COMPLETED|Dose Escalation Phase||0
171094|NCT00963820|412790|P12|STARTED|Dose Escalation Phase||0
171095|NCT00963820|412791|P11|STARTED|Dose Escalation Phase||0
171096|NCT00963820|412792|P10|STARTED|Dose Escalation Phase||0
171097|NCT00963820|412793|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
171098|NCT00963820|412794|P8|STARTED|Dose Escalation Phase||5
171099|NCT00963820|412795|P7|STARTED|Dose Escalation Phase||8
171100|NCT00963820|412796|P6|STARTED|Dose Escalation Phase||3
171101|NCT00963820|412797|P5|STARTED|Dose Escalation Phase||4
171102|NCT00963820|412798|P4|STARTED|Dose Escalation Phase||3
171103|NCT00963820|412799|P3|STARTED|Dose Escalation Phase||3
171104|NCT00963820|412800|P2|STARTED|Dose Escalation Phase||3
171105|NCT00963820|412801|P1|STARTED|Dose Escalation Phase||3
171106|NCT00963807|412937|P1|NOT COMPLETED|Overall Study||18
171107|NCT00963807|412937|P1|COMPLETED|Overall Study||8
171108|NCT00963807|412937|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
171109|NCT00963807|412937|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
171110|NCT00963807|412937|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
171111|NCT00963807|412937|P1|Completed Baseline Imaging|Overall Study||11
171112|NCT00963807|412937|P1|STARTED|Overall Study||26
171113|NCT00963677|412948|P2|NOT COMPLETED|Overall Study||2
171114|NCT00963677|412949|P1|NOT COMPLETED|Overall Study||0
171115|NCT00963677|412948|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
171116|NCT00963677|412949|P1|COMPLETED|Overall Study||35
171117|NCT00963677|412948|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
171118|NCT00963677|412949|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
171119|NCT00963638|412959|P2|NOT COMPLETED|Overall Study||0
171120|NCT00963638|412960|P1|NOT COMPLETED|Overall Study||0
171121|NCT00963638|412959|P2|COMPLETED|Overall Study||20
171122|NCT00963638|412960|P1|COMPLETED|Overall Study||20
171123|NCT00963638|412959|P2|STARTED|Overall Study||20
171124|NCT00963638|412960|P1|STARTED|Overall Study||20
171125|NCT00963599|412970|P4|NOT COMPLETED|Overall Study||14
171126|NCT00963599|412971|P3|NOT COMPLETED|Overall Study||9
171127|NCT00963599|412972|P2|NOT COMPLETED|Overall Study||6
171128|NCT00963599|412973|P1|NOT COMPLETED|Overall Study||6
171129|NCT00963599|412970|P4|COMPLETED|Overall Study||288
171130|NCT00963599|412971|P3|COMPLETED|Overall Study||292
171131|NCT00963599|412972|P2|COMPLETED|Overall Study||149
171132|NCT00963599|412973|P1|COMPLETED|Overall Study||143
171133|NCT00963599|412970|P4|STARTED|Overall Study||302
171134|NCT00963599|412971|P3|STARTED|Overall Study||301
171135|NCT00963599|412972|P2|STARTED|Overall Study||155
171136|NCT00963599|412973|P1|STARTED|Overall Study||149
171137|NCT00963560|413030|P3|NOT COMPLETED|Overall Study||0
171138|NCT00963560|413031|P2|NOT COMPLETED|Overall Study||3
171139|NCT00963560|413032|P1|NOT COMPLETED|Overall Study||3
171140|NCT00963560|413030|P3|COMPLETED|Overall Study||41
171141|NCT00963560|413031|P2|COMPLETED|Overall Study||41
171142|NCT00963560|413032|P1|COMPLETED|Overall Study||44
171143|NCT00963560|413030|P3|STARTED|Overall Study||41
171144|NCT00963560|413031|P2|STARTED|Overall Study||44
171145|NCT00963560|413032|P1|STARTED|Overall Study||47
171146|NCT00963508|413042|P2|NOT COMPLETED|Overall Study||28
171147|NCT00963508|413043|P1|NOT COMPLETED|Overall Study||10
171148|NCT00963508|413042|P2|COMPLETED|Overall Study||169
171149|NCT00963508|413043|P1|COMPLETED|Overall Study||196
171150|NCT00963508|413042|P2|STARTED|Overall Study||197
171151|NCT00963508|413043|P1|STARTED|Overall Study||206
171152|NCT00963482|413053|P2|NOT COMPLETED|Overall Study||17
171153|NCT00963482|413054|P1|NOT COMPLETED|Overall Study||28
171154|NCT00963482|413053|P2|COMPLETED|Overall Study||33
171155|NCT00963482|413054|P1|COMPLETED|Overall Study||25
171156|NCT00963482|413053|P2|STARTED|Overall Study||50
171157|NCT00963482|413054|P1|STARTED|Overall Study||53
171158|NCT00963469|413063|P3|NOT COMPLETED|Overall Study||10
171159|NCT00963469|413064|P2|NOT COMPLETED|Overall Study||28
171160|NCT00963469|413065|P1|NOT COMPLETED|Overall Study||41
171161|NCT00963469|413063|P3|COMPLETED|Overall Study||170
171162|NCT00963469|413064|P2|COMPLETED|Overall Study||420
171163|NCT00963469|413065|P1|COMPLETED|Overall Study||410
171164|NCT00963469|413063|P3|STARTED|Overall Study||180
171165|NCT00963469|413064|P2|STARTED|Overall Study||448
171166|NCT00963469|413065|P1|STARTED|Overall Study||451
171167|NCT00963430|413093|P2|NOT COMPLETED|Overall Study||3
171168|NCT00963430|413094|P1|NOT COMPLETED|Overall Study||1
171169|NCT00963430|413093|P2|COMPLETED|Overall Study||57
171170|NCT00963430|413094|P1|COMPLETED|Overall Study||59
171171|NCT00963430|413093|P2|STARTED|Overall Study||60
171172|NCT00963430|413094|P1|STARTED|Overall Study||60
171173|NCT00963235|413132|P1|NOT COMPLETED|Overall Study||60
171174|NCT00963235|413132|P1|COMPLETED|Overall Study||271
171175|NCT00963235|413132|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
171176|NCT00963235|413132|P1|Vaccinated Dose 3|Overall Study||279
171177|NCT00963235|413132|P1|Vaccinated Dose 2|Overall Study||300
171178|NCT00963235|413132|P1|Vaccinated Dose 1|Overall Study||329
171179|NCT00963235|413132|P1|STARTED|Overall Study||331
171180|NCT00963157|413156|P5|NOT COMPLETED|Overall Study||2
171181|NCT00963157|413157|P4|NOT COMPLETED|Overall Study||7
171182|NCT00963157|413158|P3|NOT COMPLETED|Overall Study||5
171183|NCT00963157|413159|P2|NOT COMPLETED|Overall Study||4
171184|NCT00963157|413160|P1|NOT COMPLETED|Overall Study||5
171185|NCT00963157|413156|P5|COMPLETED|Overall Study||151
171186|NCT00963157|413157|P4|COMPLETED|Overall Study||150
171187|NCT00963157|413158|P3|COMPLETED|Overall Study||155
171188|NCT00963157|413159|P2|COMPLETED|Overall Study||159
171189|NCT00963157|413160|P1|COMPLETED|Overall Study||151
171190|NCT00963157|413156|P5|STARTED|Overall Study||153
171191|NCT00963157|413157|P4|STARTED|Overall Study||157
171192|NCT00963157|413158|P3|STARTED|Overall Study||160
171193|NCT00963157|413159|P2|STARTED|Overall Study||163
171194|NCT00963157|413160|P1|STARTED|Overall Study||156
171195|NCT00962871|413356|P4|NOT COMPLETED|Overall Study||0
171196|NCT00962871|413357|P3|NOT COMPLETED|Overall Study||0
171197|NCT00962871|413358|P2|NOT COMPLETED|Overall Study||0
171198|NCT00962871|413359|P1|NOT COMPLETED|Overall Study||0
171199|NCT00962871|413356|P4|COMPLETED|Overall Study||6
171200|NCT00962871|413357|P3|COMPLETED|Overall Study||12
171201|NCT00962871|413358|P2|COMPLETED|Overall Study||6
171202|NCT00962871|413359|P1|COMPLETED|Overall Study||6
171203|NCT00962871|413356|P4|STARTED|Overall Study||6
171204|NCT00962871|413357|P3|STARTED|Overall Study||12
171205|NCT00962871|413358|P2|STARTED|Overall Study||6
171206|NCT00962871|413359|P1|STARTED|Overall Study||6
171207|NCT00962780|413375|P2|NOT COMPLETED|Overall Study||14
171208|NCT00962780|413376|P1|NOT COMPLETED|Overall Study||10
171209|NCT00962780|413375|P2|COMPLETED|Overall Study||138
171210|NCT00962780|413376|P1|COMPLETED|Overall Study||141
171211|NCT00962780|413375|P2|Vaccinated 23vPS Dose|Overall Study||139
171212|NCT00962780|413376|P1|Vaccinated 23vPS Dose|Overall Study||143
171213|NCT00962780|413375|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
171214|NCT00962780|413376|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
171215|NCT00962780|413375|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
171216|NCT00962780|413376|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
171217|NCT00962780|413375|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
171218|NCT00962780|413376|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
171219|NCT00962780|413375|P2|STARTED|Overall Study||152
171220|NCT00962780|413376|P1|STARTED|Overall Study||151
171221|NCT00962754|413440|P2|NOT COMPLETED|Overall Study||0
171222|NCT00962754|413441|P1|NOT COMPLETED|Overall Study||0
171223|NCT00962754|413440|P2|COMPLETED|Overall Study||84
171224|NCT00962754|413441|P1|COMPLETED|Overall Study||86
171225|NCT00962754|413440|P2|STARTED|Overall Study||84
171226|NCT00962754|413441|P1|STARTED|Overall Study||86
171227|NCT00962741|413451|P1|NOT COMPLETED|Overall Study||8
171228|NCT00962741|413451|P1|COMPLETED|Overall Study||119
171229|NCT00962741|413451|P1|STARTED|Overall Study||127
171230|NCT00962650|413542|P1|NOT COMPLETED|Overall Study||2
171231|NCT00962650|413542|P1|COMPLETED|Overall Study||8
171232|NCT00962650|413542|P1|STARTED|Overall Study||10
171233|NCT00962598|413548|P2|NOT COMPLETED|Overall Study||0
171234|NCT00962598|413549|P1|NOT COMPLETED|Overall Study||0
171235|NCT00962598|413548|P2|COMPLETED|Overall Study||9
171236|NCT00962598|413549|P1|COMPLETED|Overall Study||7
171237|NCT00962598|413548|P2|STARTED|Overall Study||9
171238|NCT00962598|413549|P1|STARTED|Overall Study||7
171239|NCT00962585|413561|P4|NOT COMPLETED|Overall Study||0
171240|NCT00962585|413562|P3|NOT COMPLETED|Overall Study||3
171241|NCT00962585|413563|P2|NOT COMPLETED|Overall Study||2
171242|NCT00962585|413564|P1|NOT COMPLETED|Overall Study||6
171243|NCT00962585|413561|P4|COMPLETED|Overall Study||42
171244|NCT00962585|413562|P3|COMPLETED|Overall Study||39
171245|NCT00962585|413563|P2|COMPLETED|Overall Study||40
171246|NCT00962585|413564|P1|COMPLETED|Overall Study||37
171247|NCT00962585|413561|P4|STARTED|Overall Study||42
171248|NCT00962585|413562|P3|STARTED|Overall Study||42
171249|NCT00962585|413563|P2|STARTED|Overall Study||42
171250|NCT00962585|413564|P1|STARTED|Overall Study||43
171251|NCT00962390|413626|P4|NOT COMPLETED|Overall Study||1
171252|NCT00962390|413627|P3|NOT COMPLETED|Overall Study||4
171253|NCT00962390|413628|P2|NOT COMPLETED|Overall Study||3
171254|NCT00962390|413629|P1|NOT COMPLETED|Overall Study||4
171255|NCT00962390|413626|P4|COMPLETED|Overall Study||28
171256|NCT00962390|413627|P3|COMPLETED|Overall Study||25
171257|NCT00962390|413628|P2|COMPLETED|Overall Study||26
171258|NCT00962390|413629|P1|COMPLETED|Overall Study||25
171259|NCT00962390|413626|P4|STARTED|Overall Study||29
171260|NCT00962390|413627|P3|STARTED|Overall Study||29
171261|NCT00962390|413628|P2|STARTED|Overall Study||29
171262|NCT00962390|413629|P1|STARTED|Overall Study||29
171263|NCT00962247|413691|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
171264|NCT00962247|413691|P1|COMPLETED|50% Reduction of Sedentary Activity||56
171265|NCT00962247|413691|P1|STARTED|50% Reduction of Sedentary Activity||56
171266|NCT00962247|413691|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
171267|NCT00962247|413691|P1|COMPLETED|25% Reduction of Sedentary Activity||56
171268|NCT00962247|413691|P1|STARTED|25% Reduction of Sedentary Activity||61
171269|NCT00962247|413691|P1|NOT COMPLETED|Usual Sedentary||18
171270|NCT00962247|413691|P1|COMPLETED|Usual Sedentary||61
171271|NCT00962247|413691|P1|STARTED|Usual Sedentary||79
171272|NCT00962208|413702|P2|NOT COMPLETED|Overall Study||10
171273|NCT00962208|413703|P1|NOT COMPLETED|Overall Study||14
171274|NCT00962208|413702|P2|COMPLETED|Overall Study||41
171275|NCT00962208|413703|P1|COMPLETED|Overall Study||37
171276|NCT00962208|413702|P2|STARTED|Overall Study||51
171277|NCT00962208|413703|P1|STARTED|Overall Study||51
171278|NCT00962104|413711|P2|NOT COMPLETED|Overall Study||25
171279|NCT00962104|413712|P1|NOT COMPLETED|Overall Study||40
171280|NCT00962104|413711|P2|COMPLETED|Overall Study||171
171281|NCT00962104|413712|P1|COMPLETED|Overall Study||155
171282|NCT00962104|413711|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
171283|NCT00962104|413712|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
171284|NCT00962104|413711|P2|STARTED|Overall Study||196
171285|NCT00962104|413712|P1|STARTED|Overall Study||195
171286|NCT00962065|413741|P3|NOT COMPLETED|Overall Study||0
171287|NCT00962065|413742|P2|NOT COMPLETED|Overall Study||0
171288|NCT00962065|413743|P1|NOT COMPLETED|Overall Study||0
171289|NCT00962065|413741|P3|COMPLETED|Overall Study||12
171290|NCT00962065|413742|P2|COMPLETED|Overall Study||12
171291|NCT00962065|413743|P1|COMPLETED|Overall Study||12
171292|NCT00962065|413741|P3|STARTED|Overall Study||12
171293|NCT00962065|413742|P2|STARTED|Overall Study||12
171294|NCT00962065|413743|P1|STARTED|Overall Study||12
171295|NCT00962013|413766|P1|NOT COMPLETED|Overall Study||68
171296|NCT00962013|413766|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
171297|NCT00962013|413766|P1|STARTED|Overall Study||120
171298|NCT00962000|413775|P2|NOT COMPLETED|Period 4 - 1 Week||0
171299|NCT00962000|413776|P1|NOT COMPLETED|Period 4 - 1 Week||0
171300|NCT00962000|413775|P2|COMPLETED|Period 4 - 1 Week||21
171301|NCT00962000|413776|P1|COMPLETED|Period 4 - 1 Week||21
171302|NCT00962000|413775|P2|STARTED|Period 4 - 1 Week||21
171303|NCT00962000|413776|P1|STARTED|Period 4 - 1 Week||21
171304|NCT00962000|413775|P2|NOT COMPLETED|Period 3 - 1 Week||0
171305|NCT00962000|413776|P1|NOT COMPLETED|Period 3 - 1 Week||0
171306|NCT00962000|413775|P2|COMPLETED|Period 3 - 1 Week||21
171307|NCT00962000|413776|P1|COMPLETED|Period 3 - 1 Week||21
171308|NCT00962000|413775|P2|STARTED|Period 3 - 1 Week||21
171309|NCT00962000|413776|P1|STARTED|Period 3 - 1 Week||21
171310|NCT00962000|413775|P2|NOT COMPLETED|Period 2 - 1 Week||0
171311|NCT00962000|413776|P1|NOT COMPLETED|Period 2 - 1 Week||0
171312|NCT00962000|413775|P2|COMPLETED|Period 2 - 1 Week||21
171313|NCT00962000|413776|P1|COMPLETED|Period 2 - 1 Week||21
171314|NCT00962000|413775|P2|STARTED|Period 2 - 1 Week||21
171315|NCT00962000|413776|P1|STARTED|Period 2 - 1 Week||21
171316|NCT00962000|413775|P2|NOT COMPLETED|Period 1 - 1 Week||0
171317|NCT00962000|413776|P1|NOT COMPLETED|Period 1 - 1 Week||0
171318|NCT00962000|413775|P2|COMPLETED|Period 1 - 1 Week||21
171319|NCT00962000|413776|P1|COMPLETED|Period 1 - 1 Week||21
171320|NCT00962000|413775|P2|STARTED|Period 1 - 1 Week||21
171321|NCT00962000|413776|P1|STARTED|Period 1 - 1 Week||21
171322|NCT00961896|413789|P3|NOT COMPLETED|Overall Study||1
171323|NCT00961896|413790|P2|NOT COMPLETED|Overall Study||0
171324|NCT00961896|413791|P1|NOT COMPLETED|Overall Study||0
171325|NCT00961896|413789|P3|COMPLETED|Overall Study||6
171326|NCT00961896|413790|P2|COMPLETED|Overall Study||3
171327|NCT00961896|413791|P1|COMPLETED|Overall Study||8
171328|NCT00961896|413789|P3|STARTED|Overall Study||7
171329|NCT00961896|413790|P2|STARTED|Overall Study||3
171330|NCT00961896|413791|P1|STARTED|Overall Study||8
171331|NCT00961805|413812|P2|NOT COMPLETED|Overall Study||0
171332|NCT00961805|413813|P1|NOT COMPLETED|Overall Study||0
171333|NCT00961805|413812|P2|COMPLETED|Overall Study||40
171334|NCT00961805|413813|P1|COMPLETED|Overall Study||40
171335|NCT00961805|413812|P2|STARTED|Overall Study||40
171336|NCT00961805|413813|P1|STARTED|Overall Study||40
171337|NCT00961662|413844|P3|NOT COMPLETED|Overall Study||19
171338|NCT00961662|413845|P2|NOT COMPLETED|Overall Study||19
171339|NCT00961662|413846|P1|NOT COMPLETED|Overall Study||22
171340|NCT00961662|413844|P3|COMPLETED|Overall Study||34
171341|NCT00961662|413845|P2|COMPLETED|Overall Study||32
171342|NCT00961662|413846|P1|COMPLETED|Overall Study||35
171343|NCT00961662|413844|P3|STARTED|Overall Study||53
171344|NCT00961662|413845|P2|STARTED|Overall Study||51
171345|NCT00961662|413846|P1|STARTED|Overall Study||57
171346|NCT00961649|413858|P4|NOT COMPLETED|Overall Study||4
171347|NCT00961649|413859|P3|NOT COMPLETED|Overall Study||5
171348|NCT00961649|413860|P2|NOT COMPLETED|Overall Study||4
171349|NCT00961649|413861|P1|NOT COMPLETED|Overall Study||9
171350|NCT00961649|413858|P4|COMPLETED|Overall Study||37
171351|NCT00961649|413859|P3|COMPLETED|Overall Study||39
171352|NCT00961649|413860|P2|COMPLETED|Overall Study||40
171353|NCT00961649|413861|P1|COMPLETED|Overall Study||32
171354|NCT00961649|413858|P4|STARTED|Overall Study||41
171355|NCT00961649|413859|P3|STARTED|Overall Study||44
171356|NCT00961649|413860|P2|STARTED|Overall Study||44
171357|NCT00961649|413861|P1|STARTED|Overall Study||41
171358|NCT00961636|413875|P3|NOT COMPLETED|Overall Study||32
171359|NCT00961636|413876|P2|NOT COMPLETED|Overall Study||131
171360|NCT00961636|413877|P1|NOT COMPLETED|Overall Study||107
171361|NCT00961636|413875|P3|COMPLETED|Overall Study||201
171362|NCT00961636|413876|P2|COMPLETED|Overall Study||325
171363|NCT00961636|413877|P1|COMPLETED|Overall Study||356
171364|NCT00961636|413875|P3|STARTED|Overall Study||233
171365|NCT00961636|413876|P2|STARTED|Overall Study||456
171366|NCT00961636|413877|P1|STARTED|Overall Study||463
171367|NCT00961571|413888|P1|NOT COMPLETED|Overall Study||39
171368|NCT00961571|413888|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
171369|NCT00961571|413888|P1|STARTED|Overall Study||50
171370|NCT00961532|413892|P1|NOT COMPLETED|Overall Study||0
171371|NCT00961532|413892|P1|COMPLETED|Overall Study||14
171372|NCT00961532|413892|P1|STARTED|Overall Study||14
171373|NCT00961441|413899|P2|NOT COMPLETED|Overall Study||0
171374|NCT00961441|413900|P1|NOT COMPLETED|Overall Study||0
171375|NCT00961441|413899|P2|COMPLETED|Overall Study||13
171376|NCT00961441|413900|P1|COMPLETED|Overall Study||12
171377|NCT00961441|413899|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
171378|NCT00961441|413900|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
171379|NCT00961441|413899|P2|STARTED|Overall Study||13
171380|NCT00961441|413900|P1|STARTED|Overall Study||12
171381|NCT00961415|413916|P3|NOT COMPLETED|Maintenance Treatment Phase||45
171382|NCT00961415|413917|P2|NOT COMPLETED|Maintenance Treatment Phase||48
171383|NCT00961415|413918|P1|NOT COMPLETED|Maintenance Treatment Phase||0
171384|NCT00961415|413916|P3|COMPLETED|Maintenance Treatment Phase||83
171385|NCT00961415|413917|P2|COMPLETED|Maintenance Treatment Phase||77
171386|NCT00961415|413918|P1|COMPLETED|Maintenance Treatment Phase||0
171387|NCT00961415|413916|P3|STARTED|Maintenance Treatment Phase||128
171388|NCT00961415|413917|P2|STARTED|Maintenance Treatment Phase||125
171389|NCT00961415|413918|P1|STARTED|Maintenance Treatment Phase||0
171390|NCT00961415|413916|P3|NOT COMPLETED|Induction Treatment Phase||0
171391|NCT00961415|413917|P2|NOT COMPLETED|Induction Treatment Phase||0
171392|NCT00961415|413918|P1|NOT COMPLETED|Induction Treatment Phase||123
171393|NCT00961415|413916|P3|COMPLETED|Induction Treatment Phase||0
171394|NCT00961415|413917|P2|COMPLETED|Induction Treatment Phase||0
171395|NCT00961415|413918|P1|COMPLETED|Induction Treatment Phase||253
171396|NCT00961415|413916|P3|STARTED|Induction Treatment Phase||0
171397|NCT00961415|413917|P2|STARTED|Induction Treatment Phase||0
171398|NCT00961415|413918|P1|STARTED|Induction Treatment Phase||376
171399|NCT00961402|413943|P2|NOT COMPLETED|Overall Study||5
171400|NCT00961402|413944|P1|NOT COMPLETED|Overall Study||1
171401|NCT00961402|413943|P2|COMPLETED|Overall Study||61
171402|NCT00961402|413944|P1|COMPLETED|Overall Study||63
171403|NCT00961402|413943|P2|Randomized|Overall Study||66
171404|NCT00961402|413944|P1|Randomized|Overall Study||64
171405|NCT00961402|413943|P2|STARTED|Overall Study||66
171406|NCT00961402|413944|P1|STARTED|Overall Study||64
171407|NCT00961350|413958|P2|NOT COMPLETED|Overall Study||67
171408|NCT00961350|413959|P1|NOT COMPLETED|Overall Study||47
171409|NCT00961350|413958|P2|COMPLETED|Overall Study||198
171410|NCT00961350|413959|P1|COMPLETED|Overall Study||218
171411|NCT00961350|413958|P2|Safety Population|Overall Study||265
171412|NCT00961350|413959|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
171413|NCT00961350|413958|P2|Intent-to-Treat Population (ITT)|Overall Study||265
171414|NCT00961350|413959|P1|Intent-to-Treat Population (ITT)|Overall Study||265
171415|NCT00961350|413958|P2|STARTED|Overall Study||265
171416|NCT00961350|413959|P1|STARTED|Overall Study||265
171417|NCT00961311|413973|P1|NOT COMPLETED|Overall Study||0
171418|NCT00961311|413973|P1|COMPLETED|Overall Study||51
171419|NCT00961311|413973|P1|STARTED|Overall Study||51
171420|NCT00961298|413980|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
171421|NCT00961298|413980|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
171422|NCT00961298|413980|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
171423|NCT00961298|413980|P1|NOT COMPLETED|Two Week Placebo Run in||1
171424|NCT00961298|413980|P1|COMPLETED|Two Week Placebo Run in||14
171425|NCT00961298|413980|P1|STARTED|Two Week Placebo Run in||15
171426|NCT00961259|413987|P3|NOT COMPLETED|Third Intervention||0
171427|NCT00961259|413988|P2|NOT COMPLETED|Third Intervention||0
171428|NCT00961259|413989|P1|NOT COMPLETED|Third Intervention||0
171429|NCT00961259|413987|P3|COMPLETED|Third Intervention||18
171430|NCT00961259|413988|P2|COMPLETED|Third Intervention||17
171431|NCT00961259|413989|P1|COMPLETED|Third Intervention||18
171432|NCT00961259|413987|P3|STARTED|Third Intervention||18
171433|NCT00961259|413988|P2|STARTED|Third Intervention||17
171434|NCT00961259|413989|P1|STARTED|Third Intervention||18
171435|NCT00961259|413987|P3|NOT COMPLETED|Washout Period of 7 Days||0
171436|NCT00961259|413988|P2|NOT COMPLETED|Washout Period of 7 Days||0
171437|NCT00961259|413989|P1|NOT COMPLETED|Washout Period of 7 Days||0
171438|NCT00961259|413987|P3|COMPLETED|Washout Period of 7 Days||18
171439|NCT00961259|413988|P2|COMPLETED|Washout Period of 7 Days||17
171440|NCT00961259|413989|P1|COMPLETED|Washout Period of 7 Days||18
171441|NCT00961259|413987|P3|STARTED|Washout Period of 7 Days||18
171442|NCT00961259|413988|P2|STARTED|Washout Period of 7 Days||17
171443|NCT00961259|413989|P1|STARTED|Washout Period of 7 Days||18
171444|NCT00961259|413987|P3|NOT COMPLETED|Second Intervention||0
171445|NCT00961259|413988|P2|NOT COMPLETED|Second Intervention||0
171446|NCT00961259|413989|P1|NOT COMPLETED|Second Intervention||0
171447|NCT00961259|413987|P3|COMPLETED|Second Intervention||18
171448|NCT00961259|413988|P2|COMPLETED|Second Intervention||17
171449|NCT00961259|413989|P1|COMPLETED|Second Intervention||18
171450|NCT00961259|413987|P3|STARTED|Second Intervention||18
171451|NCT00961259|413988|P2|STARTED|Second Intervention||17
171452|NCT00961259|413989|P1|STARTED|Second Intervention||18
171453|NCT00961259|413987|P3|NOT COMPLETED|Washout Period of 7 Days||0
171454|NCT00961259|413988|P2|NOT COMPLETED|Washout Period of 7 Days||1
171455|NCT00961259|413989|P1|NOT COMPLETED|Washout Period of 7 Days||0
171456|NCT00961259|413987|P3|COMPLETED|Washout Period of 7 Days||18
171457|NCT00961259|413988|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
171458|NCT00961259|413989|P1|COMPLETED|Washout Period of 7 Days||18
171459|NCT00961259|413987|P3|STARTED|Washout Period of 7 Days||18
171460|NCT00961259|413988|P2|STARTED|Washout Period of 7 Days||18
171461|NCT00961259|413989|P1|STARTED|Washout Period of 7 Days||18
171462|NCT00961259|413987|P3|NOT COMPLETED|First Intervention||0
171463|NCT00961259|413988|P2|NOT COMPLETED|First Intervention||0
171464|NCT00961259|413989|P1|NOT COMPLETED|First Intervention||0
171465|NCT00961259|413987|P3|COMPLETED|First Intervention||18
171466|NCT00961259|413988|P2|COMPLETED|First Intervention||18
171467|NCT00961259|413989|P1|COMPLETED|First Intervention||18
171468|NCT00961259|413987|P3|STARTED|First Intervention||18
171469|NCT00961259|413988|P2|STARTED|First Intervention||18
171470|NCT00961259|413989|P1|STARTED|First Intervention||18
171471|NCT00961233|414008|P2|NOT COMPLETED|Overall Study||1
171472|NCT00961233|414009|P1|NOT COMPLETED|Overall Study||2
171473|NCT00961233|414008|P2|COMPLETED|Overall Study||11
171474|NCT00961233|414009|P1|COMPLETED|Overall Study||11
171475|NCT00961233|414008|P2|STARTED|Overall Study||12
171476|NCT00961233|414009|P1|STARTED|Overall Study||13
171477|NCT00961220|414017|P1|NOT COMPLETED|Overall Study||7
171478|NCT00961220|414017|P1|COMPLETED|Overall Study||10
171479|NCT00961220|414017|P1|STARTED|Overall Study||17
171480|NCT00961181|414033|P1|NOT COMPLETED|Overall Study||5
171481|NCT00961181|414033|P1|COMPLETED|Overall Study||76
171482|NCT00961181|414033|P1|STARTED|Overall Study||81
171483|NCT00961116|414046|P2|NOT COMPLETED|Second Intervention||0
171484|NCT00961116|414047|P1|NOT COMPLETED|Second Intervention||0
171485|NCT00961116|414046|P2|COMPLETED|Second Intervention||24
171486|NCT00961116|414047|P1|COMPLETED|Second Intervention||25
171487|NCT00961116|414046|P2|STARTED|Second Intervention||24
171488|NCT00961116|414047|P1|STARTED|Second Intervention||25
171489|NCT00961116|414046|P2|NOT COMPLETED|Washout Period of 7 Days||3
171490|NCT00961116|414047|P1|NOT COMPLETED|Washout Period of 7 Days||2
171491|NCT00961116|414046|P2|COMPLETED|Washout Period of 7 Days||24
171492|NCT00961116|414047|P1|COMPLETED|Washout Period of 7 Days||25
171493|NCT00961116|414046|P2|STARTED|Washout Period of 7 Days||27
171494|NCT00961116|414047|P1|STARTED|Washout Period of 7 Days||27
171495|NCT00961116|414046|P2|NOT COMPLETED|First Intervention||0
171496|NCT00961116|414047|P1|NOT COMPLETED|First Intervention||0
171497|NCT00961116|414046|P2|COMPLETED|First Intervention||27
171498|NCT00961116|414047|P1|COMPLETED|First Intervention||27
171499|NCT00961116|414046|P2|STARTED|First Intervention||27
171500|NCT00961116|414047|P1|STARTED|First Intervention||27
171501|NCT00961051|414059|P2|NOT COMPLETED|Overall Study||14
171502|NCT00961051|414060|P1|NOT COMPLETED|Overall Study||12
171503|NCT00961051|414059|P2|COMPLETED|Overall Study||79
171504|NCT00961051|414060|P1|COMPLETED|Overall Study||165
171505|NCT00961051|414059|P2|STARTED|Overall Study||93
171506|NCT00961051|414060|P1|STARTED|Overall Study||177
171507|NCT00960999|414070|P2|NOT COMPLETED|Overall Study||2
171508|NCT00960999|414071|P1|NOT COMPLETED|Overall Study||8
171509|NCT00960999|414070|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
171510|NCT00960999|414071|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
171511|NCT00960999|414070|P2|STARTED|Overall Study||47
171512|NCT00960999|414071|P1|STARTED|Overall Study||47
171513|NCT00960986|414081|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
171514|NCT00960986|414082|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
171515|NCT00960986|414083|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
171516|NCT00960986|414084|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
171517|NCT00960986|414081|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
171518|NCT00960986|414082|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
171519|NCT00960986|414083|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
171520|NCT00960986|414084|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
171521|NCT00960986|414081|P4|STARTED|Period 3 (7-week Therapy Period)||61
171522|NCT00960986|414082|P3|STARTED|Period 3 (7-week Therapy Period)||59
171523|NCT00960986|414083|P2|STARTED|Period 3 (7-week Therapy Period)||59
171524|NCT00960986|414084|P1|STARTED|Period 3 (7-week Therapy Period)||56
171525|NCT00960986|414081|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
171526|NCT00960986|414082|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
171527|NCT00960986|414083|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
171528|NCT00960986|414084|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
171529|NCT00960986|414081|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
171530|NCT00960986|414082|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
171531|NCT00960986|414083|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
171532|NCT00960986|414084|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
171533|NCT00960986|414081|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
171534|NCT00960986|414082|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
171535|NCT00960986|414083|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
171536|NCT00960986|414084|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
171537|NCT00960986|414081|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
171538|NCT00960986|414082|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
171539|NCT00960986|414083|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
171540|NCT00960986|414084|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
171541|NCT00960986|414081|P4|COMPLETED|Period 1 (Screening and Washout)||61
171542|NCT00960986|414082|P3|COMPLETED|Period 1 (Screening and Washout)||59
171543|NCT00960986|414083|P2|COMPLETED|Period 1 (Screening and Washout)||59
171544|NCT00960986|414084|P1|COMPLETED|Period 1 (Screening and Washout)||56
171545|NCT00960986|414081|P4|STARTED|Period 1 (Screening and Washout)||64
171546|NCT00960986|414082|P3|STARTED|Period 1 (Screening and Washout)||63
171547|NCT00960986|414083|P2|STARTED|Period 1 (Screening and Washout)||63
171548|NCT00960986|414084|P1|STARTED|Period 1 (Screening and Washout)||59
171549|NCT00960934|414160|P6|NOT COMPLETED|Overall Study||64
171550|NCT00960934|414161|P5|NOT COMPLETED|Overall Study||64
171551|NCT00960934|414162|P4|NOT COMPLETED|Overall Study||64
171552|NCT00960934|414163|P3|NOT COMPLETED|Overall Study||64
171553|NCT00960934|414164|P2|NOT COMPLETED|Overall Study||63
171554|NCT00960934|414165|P1|NOT COMPLETED|Overall Study||64
171555|NCT00960934|414160|P6|COMPLETED|Overall Study||0
171556|NCT00960934|414161|P5|COMPLETED|Overall Study||0
171557|NCT00960934|414162|P4|COMPLETED|Overall Study||0
171558|NCT00960934|414163|P3|COMPLETED|Overall Study||0
171559|NCT00960934|414164|P2|COMPLETED|Overall Study||0
171560|NCT00960934|414165|P1|COMPLETED|Overall Study||0
171561|NCT00960934|414160|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
171562|NCT00960934|414161|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
171563|NCT00960934|414162|P4|Number Treated|Overall Study||64
171564|NCT00960934|414163|P3|Number Treated|Overall Study||64
171565|NCT00960934|414164|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
171566|NCT00960934|414165|P1|Number Treated|Overall Study||64
171567|NCT00960934|414160|P6|STARTED|Overall Study||64
171568|NCT00960934|414161|P5|STARTED|Overall Study||64
171569|NCT00960934|414162|P4|STARTED|Overall Study||64
171570|NCT00960934|414163|P3|STARTED|Overall Study||64
171571|NCT00960934|414164|P2|STARTED|Overall Study||63
171572|NCT00960934|414165|P1|STARTED|Overall Study||64
171573|NCT00960869|414277|P2|NOT COMPLETED|Overall Study||62
171574|NCT00960869|414278|P1|NOT COMPLETED|Overall Study||53
171575|NCT00960869|414277|P2|COMPLETED|Overall Study||198
171576|NCT00960869|414278|P1|COMPLETED|Overall Study||206
171577|NCT00960869|414277|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
171578|NCT00960869|414278|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
171579|NCT00960869|414277|P2|Intent-to-Treat Population (ITT)|Overall Study||260
171580|NCT00960869|414278|P1|Intent-to-Treat Population (ITT)|Overall Study||259
171581|NCT00960869|414277|P2|STARTED|Overall Study||260
171582|NCT00960869|414278|P1|STARTED|Overall Study||259
171583|NCT00960856|414292|P4|NOT COMPLETED|Period IV||0
171584|NCT00960856|414293|P3|NOT COMPLETED|Period IV||0
171585|NCT00960856|414294|P2|NOT COMPLETED|Period IV||0
171586|NCT00960856|414295|P1|NOT COMPLETED|Period IV||0
171587|NCT00960856|414292|P4|COMPLETED|Period IV||9
171588|NCT00960856|414293|P3|COMPLETED|Period IV||8
171589|NCT00960856|414294|P2|COMPLETED|Period IV||7
171590|NCT00960856|414295|P1|COMPLETED|Period IV||10
171591|NCT00960856|414292|P4|STARTED|Period IV||9
171592|NCT00960856|414293|P3|STARTED|Period IV||8
171593|NCT00960856|414294|P2|STARTED|Period IV||7
171594|NCT00960856|414295|P1|STARTED|Period IV||10
171595|NCT00960856|414292|P4|NOT COMPLETED|Washout Period of 7 Days||0
171596|NCT00960856|414293|P3|NOT COMPLETED|Washout Period of 7 Days||1
171597|NCT00960856|414294|P2|NOT COMPLETED|Washout Period of 7 Days||0
171598|NCT00960856|414295|P1|NOT COMPLETED|Washout Period of 7 Days||0
171599|NCT00960856|414292|P4|COMPLETED|Washout Period of 7 Days||9
171600|NCT00960856|414293|P3|COMPLETED|Washout Period of 7 Days||8
171601|NCT00960856|414294|P2|COMPLETED|Washout Period of 7 Days||7
171602|NCT00960856|414295|P1|COMPLETED|Washout Period of 7 Days||10
171603|NCT00960856|414292|P4|STARTED|Washout Period of 7 Days||9
171604|NCT00960856|414293|P3|STARTED|Washout Period of 7 Days||9
171605|NCT00960856|414294|P2|STARTED|Washout Period of 7 Days||7
171606|NCT00960856|414295|P1|STARTED|Washout Period of 7 Days||10
171607|NCT00960856|414292|P4|NOT COMPLETED|Period III||0
171608|NCT00960856|414293|P3|NOT COMPLETED|Period III||0
171609|NCT00960856|414294|P2|NOT COMPLETED|Period III||0
171610|NCT00960856|414295|P1|NOT COMPLETED|Period III||0
171611|NCT00960856|414292|P4|COMPLETED|Period III||9
171612|NCT00960856|414293|P3|COMPLETED|Period III||9
171613|NCT00960856|414294|P2|COMPLETED|Period III||7
171614|NCT00960856|414295|P1|COMPLETED|Period III||10
171615|NCT00960856|414292|P4|STARTED|Period III||9
171616|NCT00960856|414293|P3|STARTED|Period III||9
171617|NCT00960856|414294|P2|STARTED|Period III||7
171618|NCT00960856|414295|P1|STARTED|Period III||10
171619|NCT00960856|414292|P4|NOT COMPLETED|Washout Period of 7 Days||0
171620|NCT00960856|414293|P3|NOT COMPLETED|Washout Period of 7 Days||0
171621|NCT00960856|414294|P2|NOT COMPLETED|Washout Period of 7 Days||0
171622|NCT00960856|414295|P1|NOT COMPLETED|Washout Period of 7 Days||0
171623|NCT00960856|414292|P4|COMPLETED|Washout Period of 7 Days||9
171624|NCT00960856|414293|P3|COMPLETED|Washout Period of 7 Days||9
171625|NCT00960856|414294|P2|COMPLETED|Washout Period of 7 Days||7
171626|NCT00960856|414295|P1|COMPLETED|Washout Period of 7 Days||10
171627|NCT00960856|414292|P4|STARTED|Washout Period of 7 Days||9
171628|NCT00960856|414293|P3|STARTED|Washout Period of 7 Days||9
171629|NCT00960856|414294|P2|STARTED|Washout Period of 7 Days||7
171630|NCT00960856|414295|P1|STARTED|Washout Period of 7 Days||10
171631|NCT00960856|414292|P4|NOT COMPLETED|Period II||0
171632|NCT00960856|414293|P3|NOT COMPLETED|Period II||0
171633|NCT00960856|414294|P2|NOT COMPLETED|Period II||0
171634|NCT00960856|414295|P1|NOT COMPLETED|Period II||0
171635|NCT00960856|414292|P4|COMPLETED|Period II||9
171636|NCT00960856|414293|P3|COMPLETED|Period II||9
171637|NCT00960856|414294|P2|COMPLETED|Period II||7
171638|NCT00960856|414295|P1|COMPLETED|Period II||10
171639|NCT00960856|414292|P4|STARTED|Period II||9
171640|NCT00960856|414293|P3|STARTED|Period II||9
171641|NCT00960856|414294|P2|STARTED|Period II||7
171642|NCT00960856|414295|P1|STARTED|Period II||10
171643|NCT00960856|414292|P4|NOT COMPLETED|Washout Period of 7 Days||0
171644|NCT00960856|414293|P3|NOT COMPLETED|Washout Period of 7 Days||0
171645|NCT00960856|414294|P2|NOT COMPLETED|Washout Period of 7 Days||2
171646|NCT00960856|414295|P1|NOT COMPLETED|Washout Period of 7 Days||0
171647|NCT00960856|414292|P4|COMPLETED|Washout Period of 7 Days||9
171648|NCT00960856|414293|P3|COMPLETED|Washout Period of 7 Days||9
171649|NCT00960856|414294|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
171650|NCT00960856|414295|P1|COMPLETED|Washout Period of 7 Days||10
171651|NCT00960856|414292|P4|STARTED|Washout Period of 7 Days||9
171652|NCT00960856|414293|P3|STARTED|Washout Period of 7 Days||9
171653|NCT00960856|414294|P2|STARTED|Washout Period of 7 Days||9
171654|NCT00960856|414295|P1|STARTED|Washout Period of 7 Days||10
171655|NCT00960856|414292|P4|NOT COMPLETED|Period I||0
171656|NCT00960856|414293|P3|NOT COMPLETED|Period I||0
171657|NCT00960856|414294|P2|NOT COMPLETED|Period I||0
171658|NCT00960856|414295|P1|NOT COMPLETED|Period I||0
171659|NCT00960856|414292|P4|COMPLETED|Period I||9
171660|NCT00960856|414293|P3|COMPLETED|Period I||9
171661|NCT00960856|414294|P2|COMPLETED|Period I||9
171662|NCT00960856|414295|P1|COMPLETED|Period I||10
171663|NCT00960856|414292|P4|STARTED|Period I||9
171664|NCT00960856|414293|P3|STARTED|Period I||9
171665|NCT00960856|414294|P2|STARTED|Period I||9
171666|NCT00960856|414295|P1|STARTED|Period I||10
171667|NCT00960843|414315|P2|NOT COMPLETED|Overall Study||5
171668|NCT00960843|414316|P1|NOT COMPLETED|Overall Study||2
171669|NCT00960843|414315|P2|COMPLETED|Overall Study||21
171670|NCT00960843|414316|P1|COMPLETED|Overall Study||23
171671|NCT00960843|414315|P2|STARTED|Overall Study||26
171672|NCT00960843|414316|P1|STARTED|Overall Study||25
171673|NCT00960687|414326|P2|NOT COMPLETED|Second Intervention||0
171674|NCT00960687|414327|P1|NOT COMPLETED|Second Intervention||0
171675|NCT00960687|414326|P2|COMPLETED|Second Intervention||24
171676|NCT00960687|414327|P1|COMPLETED|Second Intervention||23
171677|NCT00960687|414326|P2|STARTED|Second Intervention||24
171678|NCT00960687|414327|P1|STARTED|Second Intervention||23
171679|NCT00960687|414326|P2|NOT COMPLETED|Washout Period of 7 Days||3
171680|NCT00960687|414327|P1|NOT COMPLETED|Washout Period of 7 Days||4
171681|NCT00960687|414326|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
171682|NCT00960687|414327|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
171683|NCT00960687|414326|P2|STARTED|Washout Period of 7 Days||27
171684|NCT00960687|414327|P1|STARTED|Washout Period of 7 Days||27
171685|NCT00960687|414326|P2|NOT COMPLETED|First Intervention||0
171686|NCT00960687|414327|P1|NOT COMPLETED|First Intervention||0
171687|NCT00960687|414326|P2|COMPLETED|First Intervention||27
171688|NCT00960687|414327|P1|COMPLETED|First Intervention||27
171689|NCT00960687|414326|P2|STARTED|First Intervention||27
171690|NCT00960687|414327|P1|STARTED|First Intervention||27
171691|NCT00960661|414339|P3|NOT COMPLETED|Interventional Phase||46
171692|NCT00960661|414340|P2|NOT COMPLETED|Interventional Phase||52
171693|NCT00960661|414341|P1|NOT COMPLETED|Interventional Phase||0
171694|NCT00960661|414339|P3|COMPLETED|Interventional Phase||275
171695|NCT00960661|414340|P2|COMPLETED|Interventional Phase||264
171696|NCT00960661|414341|P1|COMPLETED|Interventional Phase||0
171697|NCT00960661|414339|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
171698|NCT00960661|414340|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
171699|NCT00960661|414341|P1|Per Protocol Population|Interventional Phase||0
171700|NCT00960661|414339|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
171701|NCT00960661|414340|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
171702|NCT00960661|414341|P1|Intent to Treat Population|Interventional Phase||0
171703|NCT00960661|414339|P3|STARTED|Interventional Phase||321
171704|NCT00960661|414340|P2|STARTED|Interventional Phase||316
171705|NCT00960661|414341|P1|STARTED|Interventional Phase||0
171706|NCT00960661|414339|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
171707|NCT00960661|414340|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
171708|NCT00960661|414341|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
171709|NCT00960661|414339|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
171710|NCT00960661|414340|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
171711|NCT00960661|414341|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
171712|NCT00960661|414339|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
171713|NCT00960661|414340|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
171714|NCT00960661|414341|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
171715|NCT00960622|414373|P2|NOT COMPLETED|Overall Study||3
171716|NCT00960622|414374|P1|NOT COMPLETED|Overall Study||0
171717|NCT00960622|414373|P2|COMPLETED|Overall Study||7
171718|NCT00960622|414374|P1|COMPLETED|Overall Study||10
171719|NCT00960622|414373|P2|STARTED|Overall Study||10
171720|NCT00960622|414374|P1|STARTED|Overall Study||10
171721|NCT00960570|414380|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
171722|NCT00960570|414380|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
171723|NCT00960570|414380|P1|STARTED|Efavirenz and Fenofibric Acid||25
171724|NCT00960570|414380|P1|NOT COMPLETED|1 Day Period Between Dosing||3
171725|NCT00960570|414380|P1|COMPLETED|1 Day Period Between Dosing||25
171726|NCT00960570|414380|P1|STARTED|1 Day Period Between Dosing||28
171727|NCT00960570|414380|P1|NOT COMPLETED|Fenofibric Acid Alone||0
171728|NCT00960570|414380|P1|COMPLETED|Fenofibric Acid Alone||28
171729|NCT00960570|414380|P1|STARTED|Fenofibric Acid Alone||28
171730|NCT00960570|414380|P1|NOT COMPLETED|21 Day Washout Period||2
171731|NCT00960570|414380|P1|COMPLETED|21 Day Washout Period||28
171732|NCT00960570|414380|P1|STARTED|21 Day Washout Period||30
171733|NCT00960570|414380|P1|NOT COMPLETED|Efavirenz Alone||0
171734|NCT00960570|414380|P1|COMPLETED|Efavirenz Alone||30
171735|NCT00960570|414380|P1|STARTED|Efavirenz Alone||30
171736|NCT00960531|414401|P10|NOT COMPLETED|Overall Study||1
171737|NCT00960531|414402|P9|NOT COMPLETED|Overall Study||14
171738|NCT00960531|414403|P8|NOT COMPLETED|Overall Study||4
171739|NCT00960531|414404|P7|NOT COMPLETED|Overall Study||24
171740|NCT00960531|414405|P6|NOT COMPLETED|Overall Study||3
171741|NCT00960531|414406|P5|NOT COMPLETED|Overall Study||2
171742|NCT00960531|414407|P4|NOT COMPLETED|Overall Study||8
171743|NCT00960531|414408|P3|NOT COMPLETED|Overall Study||26
171744|NCT00960531|414409|P2|NOT COMPLETED|Overall Study||1
171745|NCT00960531|414410|P1|NOT COMPLETED|Overall Study||10
171746|NCT00960531|414401|P10|COMPLETED|Overall Study|Completed study|3
171747|NCT00960531|414402|P9|COMPLETED|Overall Study|Completed study|2
171748|NCT00960531|414403|P8|COMPLETED|Overall Study|Completed study|2
171749|NCT00960531|414404|P7|COMPLETED|Overall Study|Completed study|3
171750|NCT00960531|414405|P6|COMPLETED|Overall Study|Completed study|6
171751|NCT00960531|414406|P5|COMPLETED|Overall Study|Completed study|3
171752|NCT00960531|414407|P4|COMPLETED|Overall Study|Completed study|17
171753|NCT00960531|414408|P3|COMPLETED|Overall Study|Completed study|15
171754|NCT00960531|414409|P2|COMPLETED|Overall Study|Completed study|5
171755|NCT00960531|414410|P1|COMPLETED|Overall Study|Completed study|11
171756|NCT00960531|414401|P10|Completed Treatment|Overall Study||4
171757|NCT00960531|414402|P9|Completed Treatment|Overall Study||2
171758|NCT00960531|414403|P8|Completed Treatment|Overall Study||3
171759|NCT00960531|414404|P7|Completed Treatment|Overall Study||4
171760|NCT00960531|414405|P6|Completed Treatment|Overall Study||7
171761|NCT00960531|414406|P5|Completed Treatment|Overall Study||3
171762|NCT00960531|414407|P4|Completed Treatment|Overall Study||17
171763|NCT00960531|414408|P3|Completed Treatment|Overall Study||15
171764|NCT00960531|414409|P2|Completed Treatment|Overall Study||5
171765|NCT00960531|414410|P1|Completed Treatment|Overall Study||12
171766|NCT00960531|414401|P10|Treated|Overall Study||4
171767|NCT00960531|414402|P9|Treated|Overall Study||16
171768|NCT00960531|414403|P8|Treated|Overall Study||6
171769|NCT00960531|414404|P7|Treated|Overall Study||27
171770|NCT00960531|414405|P6|Treated|Overall Study||9
171771|NCT00960531|414406|P5|Treated|Overall Study||5
171772|NCT00960531|414407|P4|Treated|Overall Study||24
171773|NCT00960531|414408|P3|Treated|Overall Study||41
171774|NCT00960531|414409|P2|Treated|Overall Study||6
171775|NCT00960531|414410|P1|Treated|Overall Study||21
171776|NCT00960531|414401|P10|STARTED|Overall Study|Started=Randomized|4
171777|NCT00960531|414402|P9|STARTED|Overall Study|Started=Randomized|16
171778|NCT00960531|414403|P8|STARTED|Overall Study|Started=Randomized|6
171779|NCT00960531|414404|P7|STARTED|Overall Study|Started=Randomized|27
171780|NCT00960531|414405|P6|STARTED|Overall Study|Started=Randomized|9
171781|NCT00960531|414406|P5|STARTED|Overall Study|Started=Randomized|5
171782|NCT00960531|414407|P4|STARTED|Overall Study|Started=Randomized.|25
171783|NCT00960531|414408|P3|STARTED|Overall Study|Started=Randomized|41
171784|NCT00960531|414409|P2|STARTED|Overall Study|Started=Randomized|6
171785|NCT00960531|414410|P1|STARTED|Overall Study|Started=Randomized|21
171786|NCT00960440|414458|P4|NOT COMPLETED|Overall Study||18
171787|NCT00960440|414459|P3|NOT COMPLETED|Overall Study||13
171788|NCT00960440|414460|P2|NOT COMPLETED|Overall Study||31
171789|NCT00960440|414461|P1|NOT COMPLETED|Overall Study||26
171790|NCT00960440|414458|P4|COMPLETED|Overall Study||48
171791|NCT00960440|414459|P3|COMPLETED|Overall Study||53
171792|NCT00960440|414460|P2|COMPLETED|Overall Study||103
171793|NCT00960440|414461|P1|COMPLETED|Overall Study||107
171794|NCT00960440|414458|P4|STARTED|Overall Study||66
171795|NCT00960440|414459|P3|STARTED|Overall Study||66
171796|NCT00960440|414460|P2|STARTED|Overall Study||134
171797|NCT00960440|414461|P1|STARTED|Overall Study||133
171798|NCT00960375|414633|P2|NOT COMPLETED|Overall Study||22
171799|NCT00960375|414634|P1|NOT COMPLETED|Overall Study||20
171800|NCT00960375|414633|P2|COMPLETED|Overall Study||65
171801|NCT00960375|414634|P1|COMPLETED|Overall Study||72
171802|NCT00960375|414633|P2|STARTED|Overall Study||87
171803|NCT00960375|414634|P1|STARTED|Overall Study||92
171804|NCT00960323|414642|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
171805|NCT00960323|414642|P1|COMPLETED|Colchicine and Atorvastatin||23
171806|NCT00960323|414642|P1|STARTED|Colchicine and Atorvastatin||23
171807|NCT00960323|414642|P1|NOT COMPLETED|Atorvastatin Alone||1
171808|NCT00960323|414642|P1|COMPLETED|Atorvastatin Alone||23
171809|NCT00960323|414642|P1|STARTED|Atorvastatin Alone||24
171810|NCT00960323|414642|P1|NOT COMPLETED|14 Day Washout Period||0
171811|NCT00960323|414642|P1|COMPLETED|14 Day Washout Period||24
171812|NCT00960323|414642|P1|STARTED|14 Day Washout Period||24
171813|NCT00960323|414642|P1|NOT COMPLETED|Colchicine Alone||0
171814|NCT00960323|414642|P1|COMPLETED|Colchicine Alone||24
171815|NCT00960323|414642|P1|STARTED|Colchicine Alone||24
171816|NCT00960297|414653|P1|NOT COMPLETED|Overall Study||3
171817|NCT00960297|414653|P1|COMPLETED|Overall Study||1
171818|NCT00960297|414653|P1|STARTED|Overall Study||4
171819|NCT00960206|414660|P3|NOT COMPLETED|Overall Study||12
171820|NCT00960206|414661|P2|NOT COMPLETED|Overall Study||27
171821|NCT00960206|414662|P1|NOT COMPLETED|Overall Study||40
171822|NCT00960206|414660|P3|COMPLETED|Overall Study||77
171823|NCT00960206|414661|P2|COMPLETED|Overall Study||158
171824|NCT00960206|414662|P1|COMPLETED|Overall Study||150
171825|NCT00960206|414660|P3|STARTED|Overall Study||89
171826|NCT00960206|414661|P2|STARTED|Overall Study||185
171827|NCT00960206|414662|P1|STARTED|Overall Study||190
171828|NCT00960193|414680|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
171829|NCT00960193|414680|P1|COMPLETED|Colchicine With Seville Orange Juice||23
171830|NCT00960193|414680|P1|STARTED|Colchicine With Seville Orange Juice||23
171831|NCT00960193|414680|P1|NOT COMPLETED|Seville Orange Juice Alone||0
171832|NCT00960193|414680|P1|COMPLETED|Seville Orange Juice Alone||23
171833|NCT00960193|414680|P1|STARTED|Seville Orange Juice Alone||23
171834|NCT00960193|414680|P1|NOT COMPLETED|14 Day Washout Period||1
171835|NCT00960193|414680|P1|COMPLETED|14 Day Washout Period||23
171836|NCT00960193|414680|P1|STARTED|14 Day Washout Period||24
171837|NCT00960193|414680|P1|NOT COMPLETED|Colchicine Alone||0
171838|NCT00960193|414680|P1|COMPLETED|Colchicine Alone||24
171839|NCT00960193|414680|P1|STARTED|Colchicine Alone||24
171840|NCT00960154|414693|P2|NOT COMPLETED|Overall Study||25
171841|NCT00960154|414694|P1|NOT COMPLETED|Overall Study||25
171842|NCT00960154|414693|P2|COMPLETED|Overall Study||0
171843|NCT00960154|414694|P1|COMPLETED|Overall Study||0
171844|NCT00960154|414693|P2|STARTED|Overall Study||25
171845|NCT00960154|414694|P1|STARTED|Overall Study||25
171846|NCT00960141|414705|P3|NOT COMPLETED|Overall Study||7
171847|NCT00960141|414706|P2|NOT COMPLETED|Overall Study||17
171848|NCT00960141|414707|P1|NOT COMPLETED|Overall Study||10
171849|NCT00960141|414705|P3|COMPLETED|Overall Study||163
171850|NCT00960141|414706|P2|COMPLETED|Overall Study||309
171851|NCT00960141|414707|P1|COMPLETED|Overall Study||323
171852|NCT00960141|414705|P3|STARTED|Overall Study||170
171853|NCT00960141|414706|P2|STARTED|Overall Study||326
171854|NCT00960141|414707|P1|STARTED|Overall Study||333
171855|NCT00960115|414732|P2|NOT COMPLETED|Overall Study||15
171856|NCT00960115|414733|P1|NOT COMPLETED|Overall Study||19
171857|NCT00960115|414732|P2|COMPLETED|Overall Study||43
171858|NCT00960115|414733|P1|COMPLETED|Overall Study||95
171859|NCT00960115|414732|P2|STARTED|Overall Study||58
171860|NCT00960115|414733|P1|STARTED|Overall Study||114
171861|NCT00960076|414747|P2|NOT COMPLETED|Overall Study||25
171862|NCT00960076|414748|P1|NOT COMPLETED|Overall Study||8
171863|NCT00960076|414747|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
171864|NCT00960076|414748|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
171865|NCT00960076|414747|P2|STARTED|Overall Study|Randomized and treated|144
171866|NCT00960076|414748|P1|STARTED|Overall Study|Randomized and treated|138
171867|NCT00960063|414763|P3|NOT COMPLETED|Overall Study||3
171868|NCT00960063|414764|P2|NOT COMPLETED|Overall Study||0
171869|NCT00960063|414765|P1|NOT COMPLETED|Overall Study||1
171870|NCT00960063|414763|P3|COMPLETED|Overall Study||0
171871|NCT00960063|414764|P2|COMPLETED|Overall Study||0
171872|NCT00960063|414765|P1|COMPLETED|Overall Study||0
171873|NCT00960063|414763|P3|STARTED|Overall Study||3
171874|NCT00960063|414764|P2|STARTED|Overall Study||0
171875|NCT00960063|414765|P1|STARTED|Overall Study||1
171876|NCT00959985|414807|P4|NOT COMPLETED|Overall Study||0
171877|NCT00959985|414808|P3|NOT COMPLETED|Overall Study||0
171878|NCT00959985|414809|P2|NOT COMPLETED|Overall Study||0
171879|NCT00959985|414810|P1|NOT COMPLETED|Overall Study||0
171880|NCT00959985|414807|P4|COMPLETED|Overall Study||4
171881|NCT00959985|414808|P3|COMPLETED|Overall Study||4
171882|NCT00959985|414809|P2|COMPLETED|Overall Study||7
171883|NCT00959985|414810|P1|COMPLETED|Overall Study||8
171884|NCT00959985|414807|P4|STARTED|Overall Study||4
171885|NCT00959985|414808|P3|STARTED|Overall Study||4
171886|NCT00959985|414809|P2|STARTED|Overall Study||7
171887|NCT00959985|414810|P1|STARTED|Overall Study||8
171888|NCT00959946|414856|P8|NOT COMPLETED|Overall Study||2
171889|NCT00959946|414857|P7|NOT COMPLETED|Overall Study||2
171890|NCT00959946|414858|P6|NOT COMPLETED|Overall Study||9
171891|NCT00959946|414859|P5|NOT COMPLETED|Overall Study||4
171892|NCT00959946|414860|P4|NOT COMPLETED|Overall Study||5
171893|NCT00959946|414861|P3|NOT COMPLETED|Overall Study||4
171894|NCT00959946|414862|P2|NOT COMPLETED|Overall Study||4
171895|NCT00959946|414863|P1|NOT COMPLETED|Overall Study||2
171896|NCT00959946|414856|P8|COMPLETED|Overall Study||0
171897|NCT00959946|414857|P7|COMPLETED|Overall Study||0
171898|NCT00959946|414858|P6|COMPLETED|Overall Study||0
171899|NCT00959946|414859|P5|COMPLETED|Overall Study||0
171900|NCT00959946|414860|P4|COMPLETED|Overall Study||0
171901|NCT00959946|414861|P3|COMPLETED|Overall Study||0
171902|NCT00959946|414862|P2|COMPLETED|Overall Study||0
171903|NCT00959946|414863|P1|COMPLETED|Overall Study||0
171904|NCT00959946|414856|P8|STARTED|Overall Study||2
171905|NCT00959946|414857|P7|STARTED|Overall Study||2
171906|NCT00959946|414858|P6|STARTED|Overall Study||9
171907|NCT00959946|414859|P5|STARTED|Overall Study||4
171908|NCT00959946|414860|P4|STARTED|Overall Study||5
171909|NCT00959946|414861|P3|STARTED|Overall Study||4
171910|NCT00959946|414862|P2|STARTED|Overall Study||4
171911|NCT00959946|414863|P1|STARTED|Overall Study||2
171912|NCT00959920|414916|P2|NOT COMPLETED|Overall Study||1
171913|NCT00959920|414917|P1|NOT COMPLETED|Overall Study||0
171914|NCT00959920|414916|P2|COMPLETED|Overall Study||66
171915|NCT00959920|414917|P1|COMPLETED|Overall Study||72
171916|NCT00959920|414916|P2|STARTED|Overall Study||67
171917|NCT00959920|414917|P1|STARTED|Overall Study||72
171918|NCT00959907|414927|P2|NOT COMPLETED|Overall Study||1
171919|NCT00959907|414928|P1|NOT COMPLETED|Overall Study||3
171920|NCT00959907|414927|P2|COMPLETED|Overall Study||28
171921|NCT00959907|414928|P1|COMPLETED|Overall Study||27
171922|NCT00959907|414927|P2|STARTED|Overall Study||29
171923|NCT00959907|414928|P1|STARTED|Overall Study||30
171924|NCT00959894|414938|P1|NOT COMPLETED|Overall Study||16
171925|NCT00959894|414938|P1|COMPLETED|Overall Study||63
171926|NCT00959894|414938|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
171927|NCT00959764|414969|P3|NOT COMPLETED|Overall Study||36
171928|NCT00959764|414970|P2|NOT COMPLETED|Overall Study||57
171929|NCT00959764|414971|P1|NOT COMPLETED|Overall Study||95
171930|NCT00959764|414969|P3|COMPLETED|Overall Study||73
171931|NCT00959764|414970|P2|COMPLETED|Overall Study||128
171932|NCT00959764|414971|P1|COMPLETED|Overall Study||176
171933|NCT00959764|414969|P3|STARTED|Overall Study||109
171934|NCT00959764|414970|P2|STARTED|Overall Study||185
171935|NCT00959764|414971|P1|STARTED|Overall Study||271
171936|NCT00959751|414987|P2|NOT COMPLETED|Overall Study||12
171937|NCT00959751|414988|P1|NOT COMPLETED|Overall Study||9
171938|NCT00959751|414987|P2|COMPLETED|Overall Study||86
171939|NCT00959751|414988|P1|COMPLETED|Overall Study||88
171940|NCT00959751|414987|P2|STARTED|Overall Study||98
171941|NCT00959751|414988|P1|STARTED|Overall Study||97
171942|NCT00959699|415010|P2|NOT COMPLETED|Follow-up Period||6
171943|NCT00959699|415011|P1|NOT COMPLETED|Follow-up Period||6
171944|NCT00959699|415010|P2|COMPLETED|Follow-up Period||56
171945|NCT00959699|415011|P1|COMPLETED|Follow-up Period||27
171946|NCT00959699|415010|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
171947|NCT00959699|415011|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
171948|NCT00959699|415010|P2|NOT COMPLETED|Treatment Period||25
171949|NCT00959699|415011|P1|NOT COMPLETED|Treatment Period||23
171950|NCT00959699|415010|P2|COMPLETED|Treatment Period||40
171951|NCT00959699|415011|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
171952|NCT00959699|415010|P2|Treated|Treatment Period||64
171953|NCT00959699|415011|P1|Treated|Treatment Period||34
171954|NCT00959699|415010|P2|STARTED|Treatment Period||65
171955|NCT00959699|415011|P1|STARTED|Treatment Period||34
171956|NCT00959660|415032|P4|NOT COMPLETED|Overall Study||3
171957|NCT00959660|415033|P3|NOT COMPLETED|Overall Study||3
171958|NCT00959660|415034|P2|NOT COMPLETED|Overall Study||0
171959|NCT00959660|415035|P1|NOT COMPLETED|Overall Study||2
171960|NCT00959660|415032|P4|COMPLETED|Overall Study||22
171961|NCT00959660|415033|P3|COMPLETED|Overall Study||22
171962|NCT00959660|415034|P2|COMPLETED|Overall Study||24
171963|NCT00959660|415035|P1|COMPLETED|Overall Study||24
171964|NCT00959660|415032|P4|STARTED|Overall Study||25
171965|NCT00959660|415033|P3|STARTED|Overall Study||25
171966|NCT00959660|415034|P2|STARTED|Overall Study||24
171967|NCT00959660|415035|P1|STARTED|Overall Study||26
171968|NCT00959647|415057|P1|NOT COMPLETED|Overall Study||19
171969|NCT00959647|415057|P1|COMPLETED|Overall Study||0
171970|NCT00959647|415057|P1|STARTED|Overall Study||19
171971|NCT00959374|415062|P1|NOT COMPLETED|Overall Study||23
171972|NCT00959374|415062|P1|COMPLETED|Overall Study||218
171973|NCT00959374|415062|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
171974|NCT00959192|415076|P4|NOT COMPLETED|Overall Study||1
171975|NCT00959192|415077|P3|NOT COMPLETED|Overall Study||3
171976|NCT00959192|415078|P2|NOT COMPLETED|Overall Study||1
171977|NCT00959192|415079|P1|NOT COMPLETED|Overall Study||2
171978|NCT00959192|415076|P4|COMPLETED|Overall Study||7
171979|NCT00959192|415077|P3|COMPLETED|Overall Study||6
171980|NCT00959192|415078|P2|COMPLETED|Overall Study||8
171981|NCT00959192|415079|P1|COMPLETED|Overall Study||4
171982|NCT00959192|415076|P4|STARTED|Overall Study||8
171983|NCT00959192|415077|P3|STARTED|Overall Study||9
171984|NCT00959192|415078|P2|STARTED|Overall Study||9
171985|NCT00959192|415079|P1|STARTED|Overall Study||6
171986|NCT00959049|415127|P6|NOT COMPLETED|Overall Study||1
171987|NCT00959049|415128|P5|NOT COMPLETED|Overall Study||9
171988|NCT00959049|415129|P4|NOT COMPLETED|Overall Study||11
171989|NCT00959049|415130|P3|NOT COMPLETED|Overall Study||1
171990|NCT00959049|415131|P2|NOT COMPLETED|Overall Study||7
171991|NCT00959049|415132|P1|NOT COMPLETED|Overall Study||18
171992|NCT00959049|415127|P6|COMPLETED|Overall Study||249
171993|NCT00959049|415128|P5|COMPLETED|Overall Study||248
171994|NCT00959049|415129|P4|COMPLETED|Overall Study||217
171995|NCT00959049|415130|P3|COMPLETED|Overall Study||253
171996|NCT00959049|415131|P2|COMPLETED|Overall Study||247
171997|NCT00959049|415132|P1|COMPLETED|Overall Study||213
171998|NCT00959049|415127|P6|STARTED|Overall Study||250
171999|NCT00959049|415128|P5|STARTED|Overall Study||257
172000|NCT00959049|415129|P4|STARTED|Overall Study||228
172001|NCT00959049|415130|P3|STARTED|Overall Study||254
172002|NCT00959049|415131|P2|STARTED|Overall Study||254
172003|NCT00959049|415132|P1|STARTED|Overall Study||231
172004|NCT00958919|415182|P2|NOT COMPLETED|Second Intervention||0
172005|NCT00958919|415183|P1|NOT COMPLETED|Second Intervention||0
172006|NCT00958919|415182|P2|COMPLETED|Second Intervention||7
172007|NCT00958919|415183|P1|COMPLETED|Second Intervention||7
172008|NCT00958919|415182|P2|STARTED|Second Intervention||7
172009|NCT00958919|415183|P1|STARTED|Second Intervention||7
172010|NCT00958919|415182|P2|NOT COMPLETED|First Intervention||0
172011|NCT00958919|415183|P1|NOT COMPLETED|First Intervention||0
172012|NCT00958919|415182|P2|COMPLETED|First Intervention||7
172013|NCT00958919|415183|P1|COMPLETED|First Intervention||7
172014|NCT00958919|415182|P2|STARTED|First Intervention||7
172015|NCT00958919|415183|P1|STARTED|First Intervention||7
172016|NCT00958893|415197|P1|NOT COMPLETED|Overall Study||4
172017|NCT00958893|415197|P1|COMPLETED|Overall Study||0
172018|NCT00958893|415197|P1|STARTED|Overall Study||4
172019|NCT00958880|415203|P2|NOT COMPLETED|Overall Study||2
172020|NCT00958880|415204|P1|NOT COMPLETED|Overall Study||2
172021|NCT00958880|415203|P2|COMPLETED|Overall Study||18
172022|NCT00958880|415204|P1|COMPLETED|Overall Study||18
172023|NCT00958880|415203|P2|STARTED|Overall Study||20
172024|NCT00958880|415204|P1|STARTED|Overall Study||20
172025|NCT00958841|415212|P1|NOT COMPLETED|Overall Study||96
172026|NCT00958841|415212|P1|COMPLETED|Overall Study|Completed = Completed extension|22
172027|NCT00958841|415212|P1|Entered in Extension|Overall Study||63
172028|NCT00958841|415212|P1|Completed Month 6 (M6)|Overall Study||90
172029|NCT00958841|415212|P1|STARTED|Overall Study||118
172030|NCT00958828|415230|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
172031|NCT00958828|415231|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
172032|NCT00958828|415230|P2|COMPLETED|Period 2, 1 Week of Wear||87
172033|NCT00958828|415231|P1|COMPLETED|Period 2, 1 Week of Wear||89
172034|NCT00958828|415230|P2|STARTED|Period 2, 1 Week of Wear||88
172035|NCT00958828|415231|P1|STARTED|Period 2, 1 Week of Wear||89
172036|NCT00958828|415230|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
172037|NCT00958828|415231|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
172038|NCT00958828|415230|P2|COMPLETED|Period 1, 1 Week of Wear||88
172039|NCT00958828|415231|P1|COMPLETED|Period 1, 1 Week of Wear||89
172040|NCT00958828|415230|P2|STARTED|Period 1, 1 Week of Wear||89
172041|NCT00958828|415231|P1|STARTED|Period 1, 1 Week of Wear||89
172042|NCT00958789|415237|P1|NOT COMPLETED|Overall Study||51
172043|NCT00958789|415237|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
172044|NCT00958789|415237|P1|STARTED|Overall Study||181
172045|NCT00958776|415243|P2|NOT COMPLETED|Overall Study||29
172046|NCT00958776|415244|P1|NOT COMPLETED|Overall Study||16
172047|NCT00958776|415243|P2|COMPLETED|Overall Study||239
172048|NCT00958776|415244|P1|COMPLETED|Overall Study||121
172049|NCT00958776|415243|P2|STARTED|Overall Study||268
172050|NCT00958776|415244|P1|STARTED|Overall Study||137
172051|NCT00958724|415274|P1|NOT COMPLETED|Overall Study||6
172052|NCT00958724|415274|P1|COMPLETED|Overall Study||0
172053|NCT00958724|415274|P1|STARTED|Overall Study||6
172054|NCT00958581|415287|P3|NOT COMPLETED|Overall Study||0
172055|NCT00958581|415288|P2|NOT COMPLETED|Overall Study||0
172056|NCT00958581|415289|P1|NOT COMPLETED|Overall Study||0
172057|NCT00958581|415287|P3|COMPLETED|Overall Study||55
172058|NCT00958581|415288|P2|COMPLETED|Overall Study||61
172059|NCT00958581|415289|P1|COMPLETED|Overall Study||61
172060|NCT00958581|415287|P3|STARTED|Overall Study||55
172061|NCT00958581|415288|P2|STARTED|Overall Study||61
172062|NCT00958581|415289|P1|STARTED|Overall Study||61
172063|NCT00958568|415303|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
172064|NCT00958568|415304|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
172065|NCT00958568|415305|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
172066|NCT00958568|415306|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
172067|NCT00958568|415303|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
172068|NCT00958568|415304|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
172069|NCT00958568|415305|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
172070|NCT00958568|415306|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
172071|NCT00958568|415303|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
172072|NCT00958568|415304|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
172073|NCT00958568|415305|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
172074|NCT00958568|415306|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
172075|NCT00958568|415303|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
172076|NCT00958568|415304|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
172077|NCT00958568|415305|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
172078|NCT00958568|415306|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
172079|NCT00958568|415303|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
172080|NCT00958568|415304|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
172081|NCT00958568|415305|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
172082|NCT00958568|415306|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
172083|NCT00958568|415303|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
172084|NCT00958568|415304|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
172085|NCT00958568|415305|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
172086|NCT00958568|415306|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
172087|NCT00958568|415303|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
172088|NCT00958568|415304|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
172089|NCT00958568|415305|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
172090|NCT00958568|415306|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
172091|NCT00958568|415303|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
172092|NCT00958568|415304|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
172093|NCT00958568|415305|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
172094|NCT00958568|415306|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
172095|NCT00958568|415303|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
172096|NCT00958568|415304|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
172097|NCT00958568|415305|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
172098|NCT00958568|415306|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
172099|NCT00958477|415391|P4|NOT COMPLETED|Overall Study||0
172100|NCT00958477|415392|P3|NOT COMPLETED|Overall Study||0
172101|NCT00958477|415393|P2|NOT COMPLETED|Overall Study||0
172102|NCT00958477|415394|P1|NOT COMPLETED|Overall Study||0
172103|NCT00958477|415391|P4|COMPLETED|Overall Study||6
172104|NCT00958477|415392|P3|COMPLETED|Overall Study||6
172105|NCT00958477|415393|P2|COMPLETED|Overall Study||6
172106|NCT00958477|415394|P1|COMPLETED|Overall Study||8
172107|NCT00958477|415391|P4|STARTED|Overall Study||6
172108|NCT00958477|415392|P3|STARTED|Overall Study||6
172109|NCT00958477|415393|P2|STARTED|Overall Study||6
172110|NCT00958477|415394|P1|STARTED|Overall Study||8
172111|NCT00958438|415543|P3|NOT COMPLETED|Overall Study||6
172112|NCT00958438|415544|P2|NOT COMPLETED|Overall Study||10
172113|NCT00958438|415545|P1|NOT COMPLETED|Overall Study||10
172114|NCT00958438|415543|P3|COMPLETED|Overall Study||78
172115|NCT00958438|415544|P2|COMPLETED|Overall Study||72
172116|NCT00958438|415545|P1|COMPLETED|Overall Study||72
172117|NCT00958438|415543|P3|STARTED|Overall Study||84
172118|NCT00958438|415544|P2|STARTED|Overall Study||82
172119|NCT00958438|415545|P1|STARTED|Overall Study||82
172120|NCT00958360|415570|P2|NOT COMPLETED|Overall Study||10
172121|NCT00958360|415571|P1|NOT COMPLETED|Overall Study||11
172122|NCT00958360|415570|P2|COMPLETED|Overall Study||150
172123|NCT00958360|415571|P1|COMPLETED|Overall Study||152
172124|NCT00958360|415570|P2|STARTED|Overall Study||160
172125|NCT00958360|415571|P1|STARTED|Overall Study||163
172126|NCT00958347|415585|P1|NOT COMPLETED|Overall Study||226
172127|NCT00958347|415585|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
172128|NCT00958347|415585|P1|STARTED|Overall Study||226
172129|NCT00958334|415592|P3|NOT COMPLETED|Overall Study||13
172130|NCT00958334|415593|P2|NOT COMPLETED|Overall Study||17
172131|NCT00958334|415594|P1|NOT COMPLETED|Overall Study||14
172132|NCT00958334|415592|P3|COMPLETED|Overall Study||8
172133|NCT00958334|415593|P2|COMPLETED|Overall Study||5
172134|NCT00958334|415594|P1|COMPLETED|Overall Study||8
172135|NCT00958334|415592|P3|STARTED|Overall Study||21
172136|NCT00958334|415593|P2|STARTED|Overall Study||22
172137|NCT00958334|415594|P1|STARTED|Overall Study||22
172138|NCT00958308|415605|P3|NOT COMPLETED|Overall Study||0
172139|NCT00958308|415606|P2|NOT COMPLETED|Overall Study||0
172140|NCT00958308|415607|P1|NOT COMPLETED|Overall Study||0
172141|NCT00958308|415605|P3|COMPLETED|Overall Study||86
172142|NCT00958308|415606|P2|COMPLETED|Overall Study||85
172143|NCT00958308|415607|P1|COMPLETED|Overall Study||84
172144|NCT00958308|415605|P3|STARTED|Overall Study||86
172145|NCT00958308|415606|P2|STARTED|Overall Study||85
172146|NCT00958308|415607|P1|STARTED|Overall Study||84
172147|NCT00958282|415617|P2|NOT COMPLETED|Overall Study||6
172148|NCT00958282|415618|P1|NOT COMPLETED|Overall Study||10
172149|NCT00958282|415617|P2|COMPLETED|Overall Study||15
172150|NCT00958282|415618|P1|COMPLETED|Overall Study||12
172151|NCT00958282|415617|P2|STARTED|Overall Study||21
172152|NCT00958282|415618|P1|STARTED|Overall Study||22
172153|NCT00958256|415626|P1|NOT COMPLETED|Overall Study||3
172154|NCT00958256|415626|P1|COMPLETED|Overall Study||18
172155|NCT00958256|415626|P1|STARTED|Overall Study||21
172156|NCT00958243|415636|P6|NOT COMPLETED|Overall Study||10
172157|NCT00958243|415637|P5|NOT COMPLETED|Overall Study||9
172158|NCT00958243|415638|P4|NOT COMPLETED|Overall Study||3
172159|NCT00958243|415639|P3|NOT COMPLETED|Overall Study||14
172160|NCT00958243|415640|P2|NOT COMPLETED|Overall Study||6
172161|NCT00958243|415641|P1|NOT COMPLETED|Overall Study||2
172162|NCT00958243|415636|P6|COMPLETED|Overall Study||99
172163|NCT00958243|415637|P5|COMPLETED|Overall Study||100
172164|NCT00958243|415638|P4|COMPLETED|Overall Study||25
172165|NCT00958243|415639|P3|COMPLETED|Overall Study||82
172166|NCT00958243|415640|P2|COMPLETED|Overall Study||99
172167|NCT00958243|415641|P1|COMPLETED|Overall Study||24
172168|NCT00958243|415636|P6|STARTED|Overall Study||109
172169|NCT00958243|415637|P5|STARTED|Overall Study||109
172170|NCT00958243|415638|P4|STARTED|Overall Study||28
172171|NCT00958243|415639|P3|STARTED|Overall Study||96
172172|NCT00958243|415640|P2|STARTED|Overall Study||105
172173|NCT00958243|415641|P1|STARTED|Overall Study||26
172174|NCT00958217|415699|P2|NOT COMPLETED|Overall Study||25
172175|NCT00958217|415700|P1|NOT COMPLETED|Overall Study||24
172176|NCT00958217|415699|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
172177|NCT00958217|415700|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
172178|NCT00958217|415699|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
172179|NCT00958217|415700|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
172180|NCT00958217|415699|P2|STARTED|Overall Study||62
172181|NCT00958217|415700|P1|STARTED|Overall Study||61
172182|NCT00958191|415711|P1|NOT COMPLETED|Overall Study||111
172183|NCT00958191|415711|P1|COMPLETED|Overall Study||110
172184|NCT00958191|415711|P1|STARTED|Overall Study||221
172185|NCT00958165|415726|P1|NOT COMPLETED|Overall Study||14
172186|NCT00958165|415726|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
172187|NCT00958165|415726|P1|Treated|Overall Study||72
172188|NCT00958165|415726|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
172189|NCT00958126|415738|P8|NOT COMPLETED|Overall Study||0
172190|NCT00958126|415739|P7|NOT COMPLETED|Overall Study||1
172191|NCT00958126|415740|P6|NOT COMPLETED|Overall Study||1
172192|NCT00958126|415741|P5|NOT COMPLETED|Overall Study||0
172193|NCT00958126|415742|P4|NOT COMPLETED|Overall Study||11
172194|NCT00958126|415743|P3|NOT COMPLETED|Overall Study||10
172195|NCT00958126|415744|P2|NOT COMPLETED|Overall Study||9
172196|NCT00958126|415745|P1|NOT COMPLETED|Overall Study||1
172197|NCT00958126|415738|P8|COMPLETED|Overall Study||202
172198|NCT00958126|415739|P7|COMPLETED|Overall Study||199
172199|NCT00958126|415740|P6|COMPLETED|Overall Study||202
172200|NCT00958126|415741|P5|COMPLETED|Overall Study||50
172201|NCT00958126|415742|P4|COMPLETED|Overall Study||192
172202|NCT00958126|415743|P3|COMPLETED|Overall Study||191
172203|NCT00958126|415744|P2|COMPLETED|Overall Study||196
172204|NCT00958126|415745|P1|COMPLETED|Overall Study||48
172205|NCT00958126|415738|P8|STARTED|Overall Study||202
172206|NCT00958126|415739|P7|STARTED|Overall Study||200
172207|NCT00958126|415740|P6|STARTED|Overall Study||203
172208|NCT00958126|415741|P5|STARTED|Overall Study||50
172209|NCT00958126|415742|P4|STARTED|Overall Study||203
172210|NCT00958126|415743|P3|STARTED|Overall Study||201
172211|NCT00958126|415744|P2|STARTED|Overall Study||205
172212|NCT00958126|415745|P1|STARTED|Overall Study||49
172213|NCT00958074|415817|P2|NOT COMPLETED|Overall Study||1
172214|NCT00958074|415818|P1|NOT COMPLETED|Overall Study||0
172215|NCT00958074|415817|P2|COMPLETED|Overall Study||6
172216|NCT00958074|415818|P1|COMPLETED|Overall Study||4
172217|NCT00958074|415817|P2|STARTED|Overall Study||7
172218|NCT00958074|415818|P1|STARTED|Overall Study||4
172219|NCT00958035|415826|P2|NOT COMPLETED|Overall Study||4
172220|NCT00958035|415827|P1|NOT COMPLETED|Overall Study||3
172221|NCT00958035|415826|P2|COMPLETED|Overall Study||39
172222|NCT00958035|415827|P1|COMPLETED|Overall Study||43
172223|NCT00958035|415826|P2|STARTED|Overall Study||43
172224|NCT00958035|415827|P1|STARTED|Overall Study||46
172225|NCT00958009|415833|P1|NOT COMPLETED|Overall Study||2
172226|NCT00958009|415833|P1|COMPLETED|Overall Study||107
172227|NCT00958009|415833|P1|STARTED|Overall Study||109
172228|NCT00957996|415840|P2|NOT COMPLETED|Overall Study||28
172229|NCT00957996|415841|P1|NOT COMPLETED|Overall Study||26
172230|NCT00957996|415840|P2|COMPLETED|Overall Study||89
172231|NCT00957996|415841|P1|COMPLETED|Overall Study||91
172232|NCT00957996|415840|P2|STARTED|Overall Study||117
172233|NCT00957996|415841|P1|STARTED|Overall Study||117
172234|NCT00957944|415873|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
172235|NCT00957944|415874|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
172236|NCT00957944|415873|P2|COMPLETED|Second Intervention- 24 Hours||19
172237|NCT00957944|415874|P1|COMPLETED|Second Intervention- 24 Hours||20
172238|NCT00957944|415873|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
172239|NCT00957944|415874|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
172240|NCT00957944|415873|P2|STARTED|Second Intervention- 24 Hours||19
172241|NCT00957944|415874|P1|STARTED|Second Intervention- 24 Hours||20
172242|NCT00957944|415873|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
172243|NCT00957944|415874|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
172244|NCT00957944|415873|P2|COMPLETED|Washout Period of at Least 5 Days||19
172245|NCT00957944|415874|P1|COMPLETED|Washout Period of at Least 5 Days||20
172246|NCT00957944|415873|P2|STARTED|Washout Period of at Least 5 Days||19
172247|NCT00957944|415874|P1|STARTED|Washout Period of at Least 5 Days||20
172248|NCT00957944|415873|P2|NOT COMPLETED|First Intervention- 24 Hours||1
172249|NCT00957944|415874|P1|NOT COMPLETED|First Intervention- 24 Hours||0
172250|NCT00957944|415873|P2|COMPLETED|First Intervention- 24 Hours||19
172251|NCT00957944|415874|P1|COMPLETED|First Intervention- 24 Hours||20
172252|NCT00957944|415873|P2|STARTED|First Intervention- 24 Hours||20
172253|NCT00957944|415874|P1|STARTED|First Intervention- 24 Hours||20
172254|NCT00957905|415910|P2|NOT COMPLETED|Part B||4
172255|NCT00957905|415911|P1|NOT COMPLETED|Part B||0
172256|NCT00957905|415910|P2|COMPLETED|Part B||25
172257|NCT00957905|415911|P1|COMPLETED|Part B||0
172258|NCT00957905|415910|P2|STARTED|Part B||29
172259|NCT00957905|415911|P1|STARTED|Part B||0
172260|NCT00957905|415910|P2|NOT COMPLETED|Part A||0
172261|NCT00957905|415911|P1|NOT COMPLETED|Part A||0
172262|NCT00957905|415910|P2|COMPLETED|Part A||0
172263|NCT00957905|415911|P1|COMPLETED|Part A||7
172264|NCT00957905|415910|P2|STARTED|Part A||0
172265|NCT00957905|415911|P1|STARTED|Part A||7
172266|NCT00957801|415921|P4|NOT COMPLETED|Overall Study||1
172267|NCT00957801|415922|P3|NOT COMPLETED|Overall Study||0
172268|NCT00957801|415923|P2|NOT COMPLETED|Overall Study||0
172269|NCT00957801|415924|P1|NOT COMPLETED|Overall Study||0
172270|NCT00957801|415921|P4|COMPLETED|Overall Study||7
172271|NCT00957801|415922|P3|COMPLETED|Overall Study||7
172272|NCT00957801|415923|P2|COMPLETED|Overall Study||7
172273|NCT00957801|415924|P1|COMPLETED|Overall Study||7
172274|NCT00957801|415921|P4|STARTED|Overall Study||8
172275|NCT00957801|415922|P3|STARTED|Overall Study||7
172276|NCT00957801|415923|P2|STARTED|Overall Study||7
172277|NCT00957801|415924|P1|STARTED|Overall Study||7
172278|NCT00957723|416090|P1|NOT COMPLETED|Overall Study||121
172279|NCT00957723|416090|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
172280|NCT00957723|416090|P1|STARTED|Overall Study||419
172281|NCT00957684|416105|P5|NOT COMPLETED|PART II||75
172282|NCT00957684|416106|P4|NOT COMPLETED|PART II||0
172283|NCT00957684|416107|P3|NOT COMPLETED|PART II||0
172284|NCT00957684|416108|P2|NOT COMPLETED|PART II||0
172285|NCT00957684|416109|P1|NOT COMPLETED|PART II||0
172286|NCT00957684|416105|P5|COMPLETED|PART II||239
172287|NCT00957684|416106|P4|COMPLETED|PART II||0
172288|NCT00957684|416107|P3|COMPLETED|PART II||0
172289|NCT00957684|416108|P2|COMPLETED|PART II||0
172290|NCT00957684|416109|P1|COMPLETED|PART II||0
172291|NCT00957684|416105|P5|Patients Entered Part II|PART II||314
172292|NCT00957684|416106|P4|Patients Entered Part II|PART II||0
172293|NCT00957684|416107|P3|Patients Entered Part II|PART II||0
172294|NCT00957684|416108|P2|Patients Entered Part II|PART II||0
172295|NCT00957684|416109|P1|Patients Entered Part II|PART II||0
172296|NCT00957684|416105|P5|STARTED|PART II||314
172297|NCT00957684|416106|P4|STARTED|PART II||0
172298|NCT00957684|416107|P3|STARTED|PART II||0
172299|NCT00957684|416108|P2|STARTED|PART II||0
172300|NCT00957684|416109|P1|STARTED|PART II||0
172301|NCT00957684|416105|P5|NOT COMPLETED|PART I||0
172302|NCT00957684|416106|P4|NOT COMPLETED|PART I||18
172303|NCT00957684|416107|P3|NOT COMPLETED|PART I||10
172304|NCT00957684|416108|P2|NOT COMPLETED|PART I||13
172305|NCT00957684|416109|P1|NOT COMPLETED|PART I||31
172306|NCT00957684|416105|P5|COMPLETED|PART I||0
172307|NCT00957684|416106|P4|COMPLETED|PART I||84
172308|NCT00957684|416107|P3|COMPLETED|PART I||90
172309|NCT00957684|416108|P2|COMPLETED|PART I||85
172310|NCT00957684|416109|P1|COMPLETED|PART I||71
172311|NCT00957684|416105|P5|Per-protocol (PP)Population|PART I||0
172312|NCT00957684|416106|P4|Per-protocol (PP)Population|PART I||91
172313|NCT00957684|416107|P3|Per-protocol (PP)Population|PART I||94
172314|NCT00957684|416108|P2|Per-protocol (PP)Population|PART I||86
172315|NCT00957684|416109|P1|Per-protocol (PP)Population|PART I||72
172316|NCT00957684|416105|P5|Intention-to-treat (ITT) Population|PART I||0
172317|NCT00957684|416106|P4|Intention-to-treat (ITT) Population|PART I||102
172318|NCT00957684|416107|P3|Intention-to-treat (ITT) Population|PART I||99
172319|NCT00957684|416108|P2|Intention-to-treat (ITT) Population|PART I||98
172320|NCT00957684|416109|P1|Intention-to-treat (ITT) Population|PART I||98
172321|NCT00957684|416105|P5|Randomised (Safety Population)|PART I||0
172322|NCT00957684|416106|P4|Randomised (Safety Population)|PART I||102
172323|NCT00957684|416107|P3|Randomised (Safety Population)|PART I||100
172324|NCT00957684|416108|P2|Randomised (Safety Population)|PART I||98
172325|NCT00957684|416109|P1|Randomised (Safety Population)|PART I||102
172326|NCT00957684|416105|P5|STARTED|PART I||0
172327|NCT00957684|416106|P4|STARTED|PART I||102
172328|NCT00957684|416107|P3|STARTED|PART I||100
172329|NCT00957684|416108|P2|STARTED|PART I||98
172330|NCT00957684|416109|P1|STARTED|PART I||102
172331|NCT00957671|416119|P1|NOT COMPLETED|Overall Study||0
172332|NCT00957671|416119|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
172333|NCT00957671|416119|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
172334|NCT00957658|416176|P1|NOT COMPLETED|Overall Study||65
172335|NCT00957658|416176|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
172336|NCT00957658|416176|P1|STARTED|Overall Study||234
172337|NCT00957593|416191|P2|NOT COMPLETED|Overall Study||0
172338|NCT00957593|416192|P1|NOT COMPLETED|Overall Study||0
172339|NCT00957593|416191|P2|COMPLETED|Overall Study||125
172340|NCT00957593|416192|P1|COMPLETED|Overall Study||127
172341|NCT00957593|416191|P2|STARTED|Overall Study||125
172342|NCT00957593|416192|P1|STARTED|Overall Study||127
172343|NCT00957580|416201|P3|NOT COMPLETED|Overall Study||0
172344|NCT00957580|416202|P2|NOT COMPLETED|Overall Study||2
172345|NCT00957580|416203|P1|NOT COMPLETED|Overall Study||0
172346|NCT00957580|416201|P3|COMPLETED|Overall Study||15
172347|NCT00957580|416202|P2|COMPLETED|Overall Study||31
172348|NCT00957580|416203|P1|COMPLETED|Overall Study||33
172349|NCT00957580|416201|P3|Treated|Overall Study||15
172350|NCT00957580|416202|P2|Treated|Overall Study||32
172351|NCT00957580|416203|P1|Treated|Overall Study||33
172352|NCT00957580|416201|P3|STARTED|Overall Study||15
172353|NCT00957580|416202|P2|STARTED|Overall Study||33
172354|NCT00957580|416203|P1|STARTED|Overall Study||33
172355|NCT00957528|416350|P3|NOT COMPLETED|Overall Study||1
172356|NCT00957528|416351|P2|NOT COMPLETED|Overall Study||1
172357|NCT00957528|416352|P1|NOT COMPLETED|Overall Study||0
172358|NCT00957528|416350|P3|COMPLETED|Overall Study||8
172359|NCT00957528|416351|P2|COMPLETED|Overall Study||8
172360|NCT00957528|416352|P1|COMPLETED|Overall Study||8
172361|NCT00957528|416350|P3|STARTED|Overall Study||9
172362|NCT00957528|416351|P2|STARTED|Overall Study||9
172363|NCT00957528|416352|P1|STARTED|Overall Study||8
172364|NCT00957424|416375|P1|NOT COMPLETED|Overall Study||23
172365|NCT00957424|416375|P1|COMPLETED|Overall Study||44
172366|NCT00957424|416375|P1|Follow-up #2|Overall Study||50
172367|NCT00957424|416375|P1|Follow-up #1|Overall Study||59
172368|NCT00957424|416375|P1|STARTED|Overall Study||67
172369|NCT00957372|416385|P4|NOT COMPLETED|PART II||44
172370|NCT00957372|416386|P3|NOT COMPLETED|PART II||0
172371|NCT00957372|416387|P2|NOT COMPLETED|PART II||0
172372|NCT00957372|416388|P1|NOT COMPLETED|PART II||0
172373|NCT00957372|416385|P4|COMPLETED|PART II||150
172374|NCT00957372|416386|P3|COMPLETED|PART II||0
172375|NCT00957372|416387|P2|COMPLETED|PART II||0
172376|NCT00957372|416388|P1|COMPLETED|PART II||0
172377|NCT00957372|416385|P4|Per-Protocol Population|PART II||108
172378|NCT00957372|416386|P3|Per-Protocol Population|PART II||0
172379|NCT00957372|416387|P2|Per-Protocol Population|PART II||0
172380|NCT00957372|416388|P1|Per-Protocol Population|PART II||0
172381|NCT00957372|416385|P4|Intention-to-treat (ITT) Population|PART II||191
172382|NCT00957372|416386|P3|Intention-to-treat (ITT) Population|PART II||0
172383|NCT00957372|416387|P2|Intention-to-treat (ITT) Population|PART II||0
172384|NCT00957372|416388|P1|Intention-to-treat (ITT) Population|PART II||0
172385|NCT00957372|416385|P4|Safety Population|PART II||194
172386|NCT00957372|416386|P3|Safety Population|PART II||0
172387|NCT00957372|416387|P2|Safety Population|PART II||0
172388|NCT00957372|416388|P1|Safety Population|PART II||0
172389|NCT00957372|416385|P4|STARTED|PART II||194
172390|NCT00957372|416386|P3|STARTED|PART II||0
172391|NCT00957372|416387|P2|STARTED|PART II||0
172392|NCT00957372|416388|P1|STARTED|PART II||0
172393|NCT00957372|416385|P4|NOT COMPLETED|PART I||0
172394|NCT00957372|416386|P3|NOT COMPLETED|PART I||1
172395|NCT00957372|416387|P2|NOT COMPLETED|PART I||0
172396|NCT00957372|416388|P1|NOT COMPLETED|PART I||0
172397|NCT00957372|416385|P4|COMPLETED|PART I||0
172398|NCT00957372|416386|P3|COMPLETED|PART I||87
172399|NCT00957372|416387|P2|COMPLETED|PART I||85
172400|NCT00957372|416388|P1|COMPLETED|PART I||80
172401|NCT00957372|416385|P4|Randomized But Not Treated|PART I||0
172402|NCT00957372|416386|P3|Randomized But Not Treated|PART I||1
172403|NCT00957372|416387|P2|Randomized But Not Treated|PART I||0
172404|NCT00957372|416388|P1|Randomized But Not Treated|PART I||0
172405|NCT00957372|416385|P4|Per-Protocol Population|PART I||0
172406|NCT00957372|416386|P3|Per-Protocol Population|PART I||51
172407|NCT00957372|416387|P2|Per-Protocol Population|PART I||47
172408|NCT00957372|416388|P1|Per-Protocol Population|PART I||35
172409|NCT00957372|416385|P4|Intention-to-Treat Population|PART I||0
172410|NCT00957372|416386|P3|Intention-to-Treat Population|PART I||84
172411|NCT00957372|416387|P2|Intention-to-Treat Population|PART I||84
172412|NCT00957372|416388|P1|Intention-to-Treat Population|PART I||77
172413|NCT00957372|416385|P4|Safety Population|PART I||0
172414|NCT00957372|416386|P3|Safety Population|PART I||87
172415|NCT00957372|416387|P2|Safety Population|PART I||85
172416|NCT00957372|416388|P1|Safety Population|PART I||80
172417|NCT00957372|416385|P4|STARTED|PART I||0
172418|NCT00957372|416386|P3|STARTED|PART I||88
172419|NCT00957372|416387|P2|STARTED|PART I||85
172420|NCT00957372|416388|P1|STARTED|PART I||80
172421|NCT00957333|416404|P1|NOT COMPLETED|Overall Study||0
172422|NCT00957333|416404|P1|COMPLETED|Overall Study||44
172423|NCT00957333|416404|P1|STARTED|Overall Study||44
172424|NCT00957268|416413|P5|NOT COMPLETED|Overall Study||0
172425|NCT00957268|416414|P4|NOT COMPLETED|Overall Study||0
172426|NCT00957268|416415|P3|NOT COMPLETED|Overall Study||1
172427|NCT00957268|416416|P2|NOT COMPLETED|Overall Study||0
172428|NCT00957268|416417|P1|NOT COMPLETED|Overall Study||0
172429|NCT00957268|416413|P5|COMPLETED|Overall Study||22
172430|NCT00957268|416414|P4|COMPLETED|Overall Study||7
172431|NCT00957268|416415|P3|COMPLETED|Overall Study||7
172432|NCT00957268|416416|P2|COMPLETED|Overall Study||4
172433|NCT00957268|416417|P1|COMPLETED|Overall Study||5
172434|NCT00957268|416413|P5|STARTED|Overall Study||22
172435|NCT00957268|416414|P4|STARTED|Overall Study||7
172436|NCT00957268|416415|P3|STARTED|Overall Study||8
172437|NCT00957268|416416|P2|STARTED|Overall Study||4
172438|NCT00957268|416417|P1|STARTED|Overall Study||5
172439|NCT00957242|416481|P2|NOT COMPLETED|Overall Study||0
172440|NCT00957242|416482|P1|NOT COMPLETED|Overall Study||0
172441|NCT00957242|416481|P2|COMPLETED|Overall Study||72
172442|NCT00957242|416482|P1|COMPLETED|Overall Study||73
172443|NCT00957242|416481|P2|STARTED|Overall Study||72
172444|NCT00957242|416482|P1|STARTED|Overall Study||73
172445|NCT00957047|416514|P5|NOT COMPLETED|PART II||102
172446|NCT00957047|416515|P4|NOT COMPLETED|PART II||0
172447|NCT00957047|416516|P3|NOT COMPLETED|PART II||0
172448|NCT00957047|416517|P2|NOT COMPLETED|PART II||0
172449|NCT00957047|416518|P1|NOT COMPLETED|PART II||0
172450|NCT00957047|416514|P5|COMPLETED|PART II||223
172451|NCT00957047|416515|P4|COMPLETED|PART II||0
172452|NCT00957047|416516|P3|COMPLETED|PART II||0
172453|NCT00957047|416517|P2|COMPLETED|PART II||0
172454|NCT00957047|416518|P1|COMPLETED|PART II||0
172455|NCT00957047|416514|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
172456|NCT00957047|416515|P4|Terminated Prematurely|PART II||0
172457|NCT00957047|416516|P3|Terminated Prematurely|PART II||0
172458|NCT00957047|416517|P2|Terminated Prematurely|PART II||0
172459|NCT00957047|416518|P1|Terminated Prematurely|PART II||0
172460|NCT00957047|416514|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
172461|NCT00957047|416515|P4|STARTED|PART II||0
172462|NCT00957047|416516|P3|STARTED|PART II||0
172463|NCT00957047|416517|P2|STARTED|PART II||0
172464|NCT00957047|416518|P1|STARTED|PART II||0
172465|NCT00957047|416514|P5|NOT COMPLETED|PART I||0
172466|NCT00957047|416515|P4|NOT COMPLETED|PART I||30
172467|NCT00957047|416516|P3|NOT COMPLETED|PART I||21
172468|NCT00957047|416517|P2|NOT COMPLETED|PART I||13
172469|NCT00957047|416518|P1|NOT COMPLETED|PART I||6
172470|NCT00957047|416514|P5|COMPLETED|PART I||0
172471|NCT00957047|416515|P4|COMPLETED|PART I||68
172472|NCT00957047|416516|P3|COMPLETED|PART I||80
172473|NCT00957047|416517|P2|COMPLETED|PART I||83
172474|NCT00957047|416518|P1|COMPLETED|PART I||94
172475|NCT00957047|416514|P5|Per-Protocol Population|PART I||0
172476|NCT00957047|416515|P4|Per-Protocol Population|PART I||54
172477|NCT00957047|416516|P3|Per-Protocol Population|PART I||75
172478|NCT00957047|416517|P2|Per-Protocol Population|PART I||70
172479|NCT00957047|416518|P1|Per-Protocol Population|PART I||81
172480|NCT00957047|416514|P5|Intention-to-treat (ITT) Population|PART I||0
172481|NCT00957047|416515|P4|Intention-to-treat (ITT) Population|PART I||97
172482|NCT00957047|416516|P3|Intention-to-treat (ITT) Population|PART I||100
172483|NCT00957047|416517|P2|Intention-to-treat (ITT) Population|PART I||96
172484|NCT00957047|416518|P1|Intention-to-treat (ITT) Population|PART I||100
172485|NCT00957047|416514|P5|Randomized/Safety Population|PART I||0
172486|NCT00957047|416515|P4|Randomized/Safety Population|PART I||98
172487|NCT00957047|416516|P3|Randomized/Safety Population|PART I||101
172488|NCT00957047|416517|P2|Randomized/Safety Population|PART I||96
172489|NCT00957047|416518|P1|Randomized/Safety Population|PART I||100
172490|NCT00957047|416514|P5|STARTED|PART I||0
172491|NCT00957047|416515|P4|STARTED|PART I||98
172492|NCT00957047|416516|P3|STARTED|PART I||101
172493|NCT00957047|416517|P2|STARTED|PART I||96
172494|NCT00957047|416518|P1|STARTED|PART I||100
172495|NCT00957034|416539|P3|NOT COMPLETED|Overall Study||6
172496|NCT00957034|416540|P2|NOT COMPLETED|Overall Study||4
172497|NCT00957034|416541|P1|NOT COMPLETED|Overall Study||6
172498|NCT00957034|416539|P3|COMPLETED|Overall Study||1
172499|NCT00957034|416540|P2|COMPLETED|Overall Study||0
172500|NCT00957034|416541|P1|COMPLETED|Overall Study||0
172501|NCT00957034|416539|P3|STARTED|Overall Study||7
172502|NCT00957034|416540|P2|STARTED|Overall Study||4
172503|NCT00957034|416541|P1|STARTED|Overall Study||6
172504|NCT00957021|416564|P1|NOT COMPLETED|Overall Study||117
172505|NCT00957021|416564|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
172506|NCT00957021|416564|P1|STARTED|Overall Study||354
172507|NCT00957008|416577|P4|NOT COMPLETED|Overall Study||24
172508|NCT00957008|416578|P3|NOT COMPLETED|Overall Study||17
172509|NCT00957008|416579|P2|NOT COMPLETED|Overall Study||12
172510|NCT00957008|416580|P1|NOT COMPLETED|Overall Study||21
172511|NCT00957008|416577|P4|COMPLETED|Overall Study||26
172512|NCT00957008|416578|P3|COMPLETED|Overall Study||32
172513|NCT00957008|416579|P2|COMPLETED|Overall Study||37
172514|NCT00957008|416580|P1|COMPLETED|Overall Study||28
172515|NCT00957008|416577|P4|STARTED|Overall Study||50
172516|NCT00957008|416578|P3|STARTED|Overall Study||49
172517|NCT00957008|416579|P2|STARTED|Overall Study||49
172518|NCT00957008|416580|P1|STARTED|Overall Study||49
172519|NCT00956943|416608|P2|NOT COMPLETED|Overall Study||10
172520|NCT00956943|416609|P1|NOT COMPLETED|Overall Study||9
172521|NCT00956943|416608|P2|COMPLETED|Overall Study||34
172522|NCT00956943|416609|P1|COMPLETED|Overall Study||34
172523|NCT00956943|416608|P2|Baseline|Overall Study||44
172524|NCT00956943|416609|P1|Baseline|Overall Study||43
172525|NCT00956943|416608|P2|STARTED|Overall Study||44
172526|NCT00956943|416609|P1|STARTED|Overall Study||43
172527|NCT00956839|416620|P3|NOT COMPLETED|Overall Study||3
172528|NCT00956839|416621|P2|NOT COMPLETED|Overall Study||0
172529|NCT00956839|416622|P1|NOT COMPLETED|Overall Study||3
172530|NCT00956839|416620|P3|COMPLETED|Overall Study||10
172531|NCT00956839|416621|P2|COMPLETED|Overall Study||13
172532|NCT00956839|416622|P1|COMPLETED|Overall Study||11
172533|NCT00956839|416620|P3|STARTED|Overall Study||13
172534|NCT00956839|416621|P2|STARTED|Overall Study||13
172535|NCT00956839|416622|P1|STARTED|Overall Study||14
172536|NCT00956813|416635|P2|NOT COMPLETED|Continuation Phase||0
172537|NCT00956813|416636|P1|NOT COMPLETED|Continuation Phase||0
172538|NCT00956813|416635|P2|COMPLETED|Continuation Phase||0
172539|NCT00956813|416636|P1|COMPLETED|Continuation Phase||80
172540|NCT00956813|416635|P2|STARTED|Continuation Phase||0
172541|NCT00956813|416636|P1|STARTED|Continuation Phase||80
172542|NCT00956813|416635|P2|NOT COMPLETED|Flaxseed and Placebo||5
172543|NCT00956813|416636|P1|NOT COMPLETED|Flaxseed and Placebo||8
172544|NCT00956813|416635|P2|COMPLETED|Flaxseed and Placebo||100
172545|NCT00956813|416636|P1|COMPLETED|Flaxseed and Placebo||97
172546|NCT00956813|416635|P2|STARTED|Flaxseed and Placebo||105
172547|NCT00956813|416636|P1|STARTED|Flaxseed and Placebo||105
172548|NCT00956761|416651|P1|NOT COMPLETED|Overall Study||0
172549|NCT00956761|416651|P1|COMPLETED|Overall Study||63
172550|NCT00956761|416651|P1|STARTED|Overall Study||63
172551|NCT00956709|416660|P2|NOT COMPLETED|Overall Study||0
172552|NCT00956709|416661|P1|NOT COMPLETED|Overall Study||0
172553|NCT00956709|416660|P2|COMPLETED|Overall Study||19
172554|NCT00956709|416661|P1|COMPLETED|Overall Study||16
172555|NCT00956709|416660|P2|STARTED|Overall Study||19
172556|NCT00956709|416661|P1|STARTED|Overall Study||16
172557|NCT00956657|416673|P2|NOT COMPLETED|Overall Study||0
172558|NCT00956657|416674|P1|NOT COMPLETED|Overall Study||0
172559|NCT00956657|416673|P2|COMPLETED|Overall Study||13
172560|NCT00956657|416674|P1|COMPLETED|Overall Study||18
172561|NCT00956657|416673|P2|STARTED|Overall Study||13
172562|NCT00956657|416674|P1|STARTED|Overall Study||18
172563|NCT00956631|416680|P1|NOT COMPLETED|Overall Study||16
172564|NCT00956631|416680|P1|COMPLETED|Overall Study||62
172565|NCT00956631|416680|P1|STARTED|Overall Study||78
172566|NCT00956592|416688|P2|NOT COMPLETED|Overall Study||3
172567|NCT00956592|416689|P1|NOT COMPLETED|Overall Study||1
172568|NCT00956592|416688|P2|COMPLETED|Overall Study||147
172569|NCT00956592|416689|P1|COMPLETED|Overall Study||149
172570|NCT00956592|416688|P2|STARTED|Overall Study||150
172571|NCT00956592|416689|P1|STARTED|Overall Study||150
172572|NCT00956540|416709|P4|NOT COMPLETED|Overall Study||4
172573|NCT00956540|416710|P3|NOT COMPLETED|Overall Study||3
172574|NCT00956540|416711|P2|NOT COMPLETED|Overall Study||4
172575|NCT00956540|416712|P1|NOT COMPLETED|Overall Study||3
172576|NCT00956540|416709|P4|COMPLETED|Overall Study||41
172577|NCT00956540|416710|P3|COMPLETED|Overall Study||43
172578|NCT00956540|416711|P2|COMPLETED|Overall Study||46
172579|NCT00956540|416712|P1|COMPLETED|Overall Study||51
172580|NCT00956540|416709|P4|STARTED|Overall Study||45
172581|NCT00956540|416710|P3|STARTED|Overall Study||46
172582|NCT00956540|416711|P2|STARTED|Overall Study||50
172583|NCT00956540|416712|P1|STARTED|Overall Study||54
172584|NCT00956293|416724|P3|NOT COMPLETED|Follow-up Period||0
172585|NCT00956293|416725|P2|NOT COMPLETED|Follow-up Period||32
172586|NCT00956293|416726|P1|NOT COMPLETED|Follow-up Period||20
172587|NCT00956293|416724|P3|COMPLETED|Follow-up Period||0
172588|NCT00956293|416725|P2|COMPLETED|Follow-up Period||0
172589|NCT00956293|416726|P1|COMPLETED|Follow-up Period||0
172590|NCT00956293|416724|P3|STARTED|Follow-up Period||0
172591|NCT00956293|416725|P2|STARTED|Follow-up Period||32
172592|NCT00956293|416726|P1|STARTED|Follow-up Period||20
172593|NCT00956293|416724|P3|NOT COMPLETED|Main Period (Randomization)||0
172594|NCT00956293|416725|P2|NOT COMPLETED|Main Period (Randomization)||27
172595|NCT00956293|416726|P1|NOT COMPLETED|Main Period (Randomization)||1
172596|NCT00956293|416724|P3|COMPLETED|Main Period (Randomization)||0
172597|NCT00956293|416725|P2|COMPLETED|Main Period (Randomization)||26
172598|NCT00956293|416726|P1|COMPLETED|Main Period (Randomization)||23
172599|NCT00956293|416724|P3|Randomized Safety Set|Main Period (Randomization)||0
172600|NCT00956293|416725|P2|Randomized Safety Set|Main Period (Randomization)||51
172601|NCT00956293|416726|P1|Randomized Safety Set|Main Period (Randomization)||24
172602|NCT00956293|416724|P3|Full Analysis Set|Main Period (Randomization)||0
172603|NCT00956293|416725|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
172604|NCT00956293|416726|P1|Full Analysis Set|Main Period (Randomization)||24
172605|NCT00956293|416724|P3|STARTED|Main Period (Randomization)||0
172606|NCT00956293|416725|P2|STARTED|Main Period (Randomization)||53
172607|NCT00956293|416726|P1|STARTED|Main Period (Randomization)||24
172608|NCT00956293|416724|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
172609|NCT00956293|416725|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
172610|NCT00956293|416726|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
172611|NCT00956293|416724|P3|COMPLETED|Main Period (Pre-randomization)||77
172612|NCT00956293|416725|P2|COMPLETED|Main Period (Pre-randomization)||0
172613|NCT00956293|416726|P1|COMPLETED|Main Period (Pre-randomization)||0
172614|NCT00956293|416724|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
172615|NCT00956293|416725|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
172616|NCT00956293|416726|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
172617|NCT00956293|416724|P3|STARTED|Main Period (Pre-randomization)||207
172618|NCT00956293|416725|P2|STARTED|Main Period (Pre-randomization)||0
172619|NCT00956293|416726|P1|STARTED|Main Period (Pre-randomization)||0
172620|NCT00956254|416750|P1|NOT COMPLETED|Overall Study||0
172621|NCT00956254|416750|P1|COMPLETED|Overall Study||18
172622|NCT00956254|416750|P1|STARTED|Overall Study||18
172623|NCT00956085|416760|P1|NOT COMPLETED|Overall Study||0
172624|NCT00956085|416760|P1|COMPLETED|Overall Study||12
172625|NCT00956085|416760|P1|STARTED|Overall Study||12
172626|NCT00956020|416764|P1|NOT COMPLETED|Overall Study||0
172627|NCT00956020|416764|P1|COMPLETED|Overall Study||4
172628|NCT00956020|416764|P1|STARTED|Overall Study||4
172629|NCT00955968|416781|P2|NOT COMPLETED|Overall Study||126
172630|NCT00955968|416782|P1|NOT COMPLETED|Overall Study||137
172631|NCT00955968|416781|P2|COMPLETED|Overall Study||699
172632|NCT00955968|416782|P1|COMPLETED|Overall Study||691
172633|NCT00955968|416781|P2|STARTED|Overall Study||825
172634|NCT00955968|416782|P1|STARTED|Overall Study||828
172635|NCT00955955|416816|P3|NOT COMPLETED|Overall Study||0
172636|NCT00955955|416817|P2|NOT COMPLETED|Overall Study||0
172637|NCT00955955|416818|P1|NOT COMPLETED|Overall Study||2
172638|NCT00955955|416816|P3|COMPLETED|Overall Study||28
172639|NCT00955955|416817|P2|COMPLETED|Overall Study||28
172640|NCT00955955|416818|P1|COMPLETED|Overall Study||17
172641|NCT00955955|416816|P3|STARTED|Overall Study||28
172642|NCT00955955|416817|P2|STARTED|Overall Study||28
172643|NCT00955955|416818|P1|STARTED|Overall Study||19
172644|NCT00955916|416832|P1|NOT COMPLETED|Overall Study||0
172645|NCT00955916|416832|P1|COMPLETED|Overall Study||38
172646|NCT00955916|416832|P1|STARTED|Overall Study||38
172647|NCT00955903|416841|P3|NOT COMPLETED|Overall Study||7
172648|NCT00955903|416842|P2|NOT COMPLETED|Overall Study||3
172649|NCT00955903|416843|P1|NOT COMPLETED|Overall Study||6
172650|NCT00955903|416841|P3|COMPLETED|Overall Study||48
172651|NCT00955903|416842|P2|COMPLETED|Overall Study||51
172652|NCT00955903|416843|P1|COMPLETED|Overall Study||49
172653|NCT00955903|416841|P3|STARTED|Overall Study||55
172654|NCT00955903|416842|P2|STARTED|Overall Study||54
172655|NCT00955903|416843|P1|STARTED|Overall Study||55
172656|NCT00955825|416859|P2|NOT COMPLETED|Overall Study||17
172657|NCT00955825|416860|P1|NOT COMPLETED|Overall Study||26
172658|NCT00955825|416859|P2|COMPLETED|Overall Study||223
172659|NCT00955825|416860|P1|COMPLETED|Overall Study||207
172660|NCT00955825|416859|P2|STARTED|Overall Study||240
172661|NCT00955825|416860|P1|STARTED|Overall Study||233
172662|NCT00955747|416868|P2|NOT COMPLETED|Overall Study||69
172663|NCT00955747|416869|P1|NOT COMPLETED|Overall Study||69
172664|NCT00955747|416868|P2|COMPLETED|Overall Study||172
172665|NCT00955747|416869|P1|COMPLETED|Overall Study||184
172666|NCT00955747|416868|P2|STARTED|Overall Study||241
172667|NCT00955747|416869|P1|STARTED|Overall Study||253
172668|NCT00955721|416877|P2|NOT COMPLETED|Overall Study||0
172669|NCT00955721|416878|P1|NOT COMPLETED|Overall Study||3
172670|NCT00955721|416877|P2|COMPLETED|Overall Study||0
172671|NCT00955721|416878|P1|COMPLETED|Overall Study||6
172672|NCT00955721|416877|P2|STARTED|Overall Study||0
172673|NCT00955721|416878|P1|STARTED|Overall Study||9
172674|NCT00955617|416888|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
172675|NCT00955617|416889|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
172676|NCT00955617|416888|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
172677|NCT00955617|416889|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
172678|NCT00955617|416888|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
172679|NCT00955617|416889|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
172680|NCT00955617|416888|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
172681|NCT00955617|416889|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
172682|NCT00955617|416888|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
172683|NCT00955617|416889|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
172684|NCT00955617|416888|P2|STARTED|First MRA (Between Day0 and Day21)||10
172685|NCT00955617|416889|P1|STARTED|First MRA (Between Day0 and Day21)||10
172686|NCT00955513|416902|P3|NOT COMPLETED|Overall Study||3
172687|NCT00955513|416903|P2|NOT COMPLETED|Overall Study||2
172688|NCT00955513|416904|P1|NOT COMPLETED|Overall Study||1
172689|NCT00955513|416902|P3|COMPLETED|Overall Study||79
172690|NCT00955513|416903|P2|COMPLETED|Overall Study||78
172691|NCT00955513|416904|P1|COMPLETED|Overall Study||79
172692|NCT00955513|416902|P3|STARTED|Overall Study||82
172693|NCT00955513|416903|P2|STARTED|Overall Study||80
172694|NCT00955513|416904|P1|STARTED|Overall Study||80
172695|NCT00955487|416914|P6|NOT COMPLETED|Overall Study||0
172696|NCT00955487|416915|P5|NOT COMPLETED|Overall Study||0
172697|NCT00955487|416916|P4|NOT COMPLETED|Overall Study||0
172698|NCT00955487|416917|P3|NOT COMPLETED|Overall Study||0
172699|NCT00955487|416918|P2|NOT COMPLETED|Overall Study||0
172700|NCT00955487|416919|P1|NOT COMPLETED|Overall Study||0
172701|NCT00955487|416914|P6|COMPLETED|Overall Study||35
172702|NCT00955487|416915|P5|COMPLETED|Overall Study||32
172703|NCT00955487|416916|P4|COMPLETED|Overall Study||21
172704|NCT00955487|416917|P3|COMPLETED|Overall Study||17
172705|NCT00955487|416918|P2|COMPLETED|Overall Study||9
172706|NCT00955487|416919|P1|COMPLETED|Overall Study||10
172707|NCT00955487|416914|P6|STARTED|Overall Study||35
172708|NCT00955487|416915|P5|STARTED|Overall Study||32
172709|NCT00955487|416916|P4|STARTED|Overall Study||21
172710|NCT00955487|416917|P3|STARTED|Overall Study||17
172711|NCT00955487|416918|P2|STARTED|Overall Study||9
172712|NCT00955487|416919|P1|STARTED|Overall Study||10
172713|NCT00955474|416953|P2|NOT COMPLETED|Overall Study||5
172714|NCT00955474|416954|P1|NOT COMPLETED|Overall Study||7
172715|NCT00955474|416953|P2|COMPLETED|Overall Study||8
172716|NCT00955474|416954|P1|COMPLETED|Overall Study||5
172717|NCT00955474|416953|P2|STARTED|Overall Study||13
172718|NCT00955474|416954|P1|STARTED|Overall Study||12
172719|NCT00955357|416990|P2|NOT COMPLETED|Maintenance Phase||45
172720|NCT00955357|416991|P1|NOT COMPLETED|Maintenance Phase||12
172721|NCT00955357|416990|P2|COMPLETED|Maintenance Phase||249
172722|NCT00955357|416991|P1|COMPLETED|Maintenance Phase||68
172723|NCT00955357|416990|P2|STARTED|Maintenance Phase||294
172724|NCT00955357|416991|P1|STARTED|Maintenance Phase||80
172725|NCT00955357|416990|P2|NOT COMPLETED|Titration Phase||66
172726|NCT00955357|416991|P1|NOT COMPLETED|Titration Phase||16
172727|NCT00955357|416990|P2|COMPLETED|Titration Phase||294
172728|NCT00955357|416991|P1|COMPLETED|Titration Phase||80
172729|NCT00955357|416990|P2|STARTED|Titration Phase||360
172730|NCT00955357|416991|P1|STARTED|Titration Phase||96
172731|NCT00955305|416999|P2|NOT COMPLETED|Overall Study||87
172732|NCT00955305|417000|P1|NOT COMPLETED|Overall Study||88
172733|NCT00955305|416999|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
172734|NCT00955305|417000|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
172735|NCT00955305|416999|P2|Eligible and Treated|Overall Study||75
172736|NCT00955305|417000|P1|Eligible and Treated|Overall Study||78
172737|NCT00955305|416999|P2|Treated|Overall Study||82
172738|NCT00955305|417000|P1|Treated|Overall Study||83
172739|NCT00955305|416999|P2|STARTED|Overall Study||87
172740|NCT00955305|417000|P1|STARTED|Overall Study||88
172741|NCT00955279|417013|P3|NOT COMPLETED|Overall Study||8
172742|NCT00955279|417014|P2|NOT COMPLETED|Overall Study||4
172743|NCT00955279|417015|P1|NOT COMPLETED|Overall Study||3
172744|NCT00955279|417013|P3|COMPLETED|Overall Study||52
172745|NCT00955279|417014|P2|COMPLETED|Overall Study||51
172746|NCT00955279|417015|P1|COMPLETED|Overall Study||55
172747|NCT00955279|417013|P3|STARTED|Overall Study||60
172748|NCT00955279|417014|P2|STARTED|Overall Study||55
172749|NCT00955279|417015|P1|STARTED|Overall Study||58
172750|NCT00955266|417037|P2|NOT COMPLETED|Overall Study||0
172751|NCT00955266|417038|P1|NOT COMPLETED|Overall Study||0
172752|NCT00955266|417037|P2|COMPLETED|Overall Study||4
172753|NCT00955266|417038|P1|COMPLETED|Overall Study||4
172754|NCT00955266|417037|P2|STARTED|Overall Study||4
172755|NCT00955266|417038|P1|STARTED|Overall Study||4
172756|NCT00955110|417052|P1|NOT COMPLETED|Treatment Phase||6
172757|NCT00955110|417052|P1|COMPLETED|Treatment Phase||35
172758|NCT00955110|417052|P1|Oxycodone CR 60 mg|Treatment Phase||40
172759|NCT00955110|417052|P1|Oxycodone CR 30 mg|Treatment Phase||40
172760|NCT00955110|417052|P1|Oxymorphone ER 30 mg|Treatment Phase||38
172761|NCT00955110|417052|P1|Oxymorphone ER 15 mg|Treatment Phase||37
172762|NCT00955110|417052|P1|Placebo|Treatment Phase||38
172763|NCT00955110|417052|P1|STARTED|Treatment Phase||41
172764|NCT00955110|417052|P1|NOT COMPLETED|Qualification Phase||24
172765|NCT00955110|417052|P1|COMPLETED|Qualification Phase||54
172766|NCT00955110|417052|P1|STARTED|Qualification Phase||78
172767|NCT00955032|417066|P2|NOT COMPLETED|Overall Study||0
172768|NCT00955032|417067|P1|NOT COMPLETED|Overall Study||0
172769|NCT00955032|417066|P2|COMPLETED|Overall Study||8
172770|NCT00955032|417067|P1|COMPLETED|Overall Study||16
172771|NCT00955032|417066|P2|STARTED|Overall Study||8
172772|NCT00955032|417067|P1|STARTED|Overall Study||16
172773|NCT00954993|417087|P1|NOT COMPLETED|Period 2||0
172774|NCT00954993|417087|P1|COMPLETED|Period 2||3
172775|NCT00954993|417087|P1|STARTED|Period 2||3
172776|NCT00954993|417087|P1|NOT COMPLETED|Washout||0
172777|NCT00954993|417087|P1|COMPLETED|Washout||3
172778|NCT00954993|417087|P1|STARTED|Washout||3
172779|NCT00954993|417087|P1|NOT COMPLETED|Period 1||0
172780|NCT00954993|417087|P1|COMPLETED|Period 1||3
172781|NCT00954993|417087|P1|STARTED|Period 1||3
172782|NCT00954941|417099|P2|NOT COMPLETED|Overall Study||7
172783|NCT00954941|417100|P1|NOT COMPLETED|Overall Study||8
172784|NCT00954941|417099|P2|COMPLETED|Overall Study||41
172785|NCT00954941|417100|P1|COMPLETED|Overall Study||42
172786|NCT00954941|417099|P2|STARTED|Overall Study||48
172787|NCT00954941|417100|P1|STARTED|Overall Study||50
172788|NCT00954915|417108|P1|NOT COMPLETED|Overall Study||0
172789|NCT00954915|417108|P1|COMPLETED|Overall Study||1
172790|NCT00954915|417108|P1|STARTED|Overall Study||1
172791|NCT00954824|417112|P1|NOT COMPLETED|Overall Study||50
172792|NCT00954824|417112|P1|COMPLETED|Overall Study||50
172793|NCT00954824|417112|P1|STARTED|Overall Study||100
172794|NCT00954733|417116|P1|NOT COMPLETED|Overall Study||1
172795|NCT00954733|417116|P1|COMPLETED|Overall Study||39
172796|NCT00954733|417116|P1|STARTED|Overall Study||40
172797|NCT00954707|417120|P1|NOT COMPLETED|Overall Study||167
172798|NCT00954707|417120|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
172799|NCT00954707|417120|P1|STARTED|Overall Study||2509
172800|NCT00954681|417136|P1|NOT COMPLETED|Overall Study||5
172801|NCT00954681|417136|P1|COMPLETED|Overall Study||10
172802|NCT00954681|417136|P1|STARTED|Overall Study||15
172803|NCT00954538|417142|P6|NOT COMPLETED|Part III||0
172804|NCT00954538|417143|P5|NOT COMPLETED|Part III||1
172805|NCT00954538|417144|P4|NOT COMPLETED|Part III||0
172806|NCT00954538|417145|P3|NOT COMPLETED|Part III||0
172807|NCT00954538|417146|P2|NOT COMPLETED|Part III||0
172808|NCT00954538|417147|P1|NOT COMPLETED|Part III||0
172809|NCT00954538|417142|P6|COMPLETED|Part III||2
172810|NCT00954538|417143|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
172811|NCT00954538|417144|P4|COMPLETED|Part III||4
172812|NCT00954538|417145|P3|COMPLETED|Part III||0
172813|NCT00954538|417146|P2|COMPLETED|Part III||0
172814|NCT00954538|417147|P1|COMPLETED|Part III||0
172815|NCT00954538|417142|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
172816|NCT00954538|417143|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
172817|NCT00954538|417144|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
172818|NCT00954538|417145|P3|STARTED|Part III||0
172819|NCT00954538|417146|P2|STARTED|Part III||0
172820|NCT00954538|417147|P1|STARTED|Part III||0
172821|NCT00954538|417142|P6|NOT COMPLETED|Part II||0
172822|NCT00954538|417143|P5|NOT COMPLETED|Part II||0
172823|NCT00954538|417144|P4|NOT COMPLETED|Part II||0
172824|NCT00954538|417145|P3|NOT COMPLETED|Part II||0
172825|NCT00954538|417146|P2|NOT COMPLETED|Part II||0
172826|NCT00954538|417147|P1|NOT COMPLETED|Part II||0
172827|NCT00954538|417142|P6|COMPLETED|Part II||2
172828|NCT00954538|417143|P5|COMPLETED|Part II||0
172829|NCT00954538|417144|P4|COMPLETED|Part II||0
172830|NCT00954538|417145|P3|COMPLETED|Part II||3
172831|NCT00954538|417146|P2|COMPLETED|Part II||1
172832|NCT00954538|417147|P1|COMPLETED|Part II||0
172833|NCT00954538|417142|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
172834|NCT00954538|417143|P5|STARTED|Part II||0
172835|NCT00954538|417144|P4|STARTED|Part II||0
172836|NCT00954538|417145|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
172837|NCT00954538|417146|P2|STARTED|Part II|This subject did not participate in Part I or III|1
172838|NCT00954538|417147|P1|STARTED|Part II||0
172839|NCT00954538|417142|P6|NOT COMPLETED|Part I||0
172840|NCT00954538|417143|P5|NOT COMPLETED|Part I||0
172841|NCT00954538|417144|P4|NOT COMPLETED|Part I||0
172842|NCT00954538|417145|P3|NOT COMPLETED|Part I||0
172843|NCT00954538|417146|P2|NOT COMPLETED|Part I||0
172844|NCT00954538|417147|P1|NOT COMPLETED|Part I||0
172845|NCT00954538|417142|P6|COMPLETED|Part I||0
172846|NCT00954538|417143|P5|COMPLETED|Part I||0
172847|NCT00954538|417144|P4|COMPLETED|Part I||0
172848|NCT00954538|417145|P3|COMPLETED|Part I||0
172849|NCT00954538|417146|P2|COMPLETED|Part I||0
172850|NCT00954538|417147|P1|COMPLETED|Part I||3
172851|NCT00954538|417142|P6|STARTED|Part I||0
172852|NCT00954538|417143|P5|STARTED|Part I||0
172853|NCT00954538|417144|P4|STARTED|Part I||0
172854|NCT00954538|417145|P3|STARTED|Part I||0
172855|NCT00954538|417146|P2|STARTED|Part I||0
172856|NCT00954538|417147|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
172857|NCT00954512|417164|P6|NOT COMPLETED|Overall Study||4
172858|NCT00954512|417165|P5|NOT COMPLETED|Overall Study||4
172859|NCT00954512|417166|P4|NOT COMPLETED|Overall Study||2
172860|NCT00954512|417167|P3|NOT COMPLETED|Overall Study||0
172861|NCT00954512|417168|P2|NOT COMPLETED|Overall Study||3
172862|NCT00954512|417169|P1|NOT COMPLETED|Overall Study||2
172863|NCT00954512|417164|P6|COMPLETED|Overall Study||0
172864|NCT00954512|417165|P5|COMPLETED|Overall Study||0
172865|NCT00954512|417166|P4|COMPLETED|Overall Study||0
172866|NCT00954512|417167|P3|COMPLETED|Overall Study||0
172867|NCT00954512|417168|P2|COMPLETED|Overall Study||0
172868|NCT00954512|417169|P1|COMPLETED|Overall Study||0
172869|NCT00954512|417164|P6|STARTED|Overall Study||4
172870|NCT00954512|417165|P5|STARTED|Overall Study||4
172871|NCT00954512|417166|P4|STARTED|Overall Study||2
172872|NCT00954512|417167|P3|STARTED|Overall Study||0
172873|NCT00954512|417168|P2|STARTED|Overall Study||3
172874|NCT00954512|417169|P1|STARTED|Overall Study||2
172875|NCT00954447|417190|P2|NOT COMPLETED|Overall Study||88
172876|NCT00954447|417191|P1|NOT COMPLETED|Overall Study||110
172877|NCT00954447|417190|P2|COMPLETED|Overall Study||543
172878|NCT00954447|417191|P1|COMPLETED|Overall Study||520
172879|NCT00954447|417190|P2|STARTED|Overall Study||631
172880|NCT00954447|417191|P1|STARTED|Overall Study||630
172881|NCT00954421|417227|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
172882|NCT00954421|417227|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
172883|NCT00954421|417227|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
172884|NCT00954421|417227|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
172885|NCT00954421|417227|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
172886|NCT00954421|417227|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
172887|NCT00954421|417227|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
172888|NCT00954421|417227|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
172889|NCT00954421|417227|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
172890|NCT00954421|417227|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
172891|NCT00954421|417227|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
172892|NCT00954421|417227|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
172893|NCT00954421|417227|P1|NOT COMPLETED|6 Months of DBS||1
172894|NCT00954421|417227|P1|COMPLETED|6 Months of DBS||12
172895|NCT00954421|417227|P1|STARTED|6 Months of DBS||13
172896|NCT00954421|417227|P1|NOT COMPLETED|Baseline||0
172897|NCT00954421|417227|P1|COMPLETED|Baseline||13
172898|NCT00954421|417227|P1|STARTED|Baseline||13
172899|NCT00954421|417227|P1|NOT COMPLETED|Screening||3
172900|NCT00954421|417227|P1|COMPLETED|Screening||13
172901|NCT00954421|417227|P1|STARTED|Screening||16
172902|NCT00954356|417235|P2|NOT COMPLETED|Overall Study||0
172903|NCT00954356|417236|P1|NOT COMPLETED|Overall Study||0
172904|NCT00954356|417235|P2|COMPLETED|Overall Study||20
172905|NCT00954356|417236|P1|COMPLETED|Overall Study||41
172906|NCT00954356|417235|P2|STARTED|Overall Study||20
172907|NCT00954356|417236|P1|STARTED|Overall Study||41
172908|NCT00954187|417266|P2|NOT COMPLETED|Overall Study||0
172909|NCT00954187|417267|P1|NOT COMPLETED|Overall Study||0
172910|NCT00954187|417266|P2|COMPLETED|Overall Study||0
172911|NCT00954187|417267|P1|COMPLETED|Overall Study||0
172912|NCT00954187|417266|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
172913|NCT00954187|417267|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
172914|NCT00954122|417273|P1|NOT COMPLETED|Overall Study||7
172915|NCT00954122|417273|P1|COMPLETED|Overall Study||28
172916|NCT00954122|417273|P1|STARTED|Overall Study||35
172917|NCT00954109|417283|P1|NOT COMPLETED|Overall Study||0
172918|NCT00954109|417283|P1|COMPLETED|Overall Study||11
172919|NCT00954109|417283|P1|STARTED|Overall Study||11
172920|NCT00953927|417290|P2|NOT COMPLETED|Overall Study||95
172921|NCT00953927|417291|P1|NOT COMPLETED|Overall Study||105
172922|NCT00953927|417290|P2|COMPLETED|Overall Study||1303
172923|NCT00953927|417291|P1|COMPLETED|Overall Study||1294
172924|NCT00953927|417290|P2|STARTED|Overall Study||1398
172925|NCT00953927|417291|P1|STARTED|Overall Study||1399
172926|NCT00953862|417309|P1|NOT COMPLETED|Overall Study||6
172927|NCT00953862|417309|P1|COMPLETED|Overall Study||12
172928|NCT00953862|417309|P1|STARTED|Overall Study||18
172929|NCT00953849|417319|P4|NOT COMPLETED|Overall Study||0
172930|NCT00953849|417320|P3|NOT COMPLETED|Overall Study||0
172931|NCT00953849|417321|P2|NOT COMPLETED|Overall Study||0
172932|NCT00953849|417322|P1|NOT COMPLETED|Overall Study||0
172933|NCT00953849|417319|P4|COMPLETED|Overall Study||5
172934|NCT00953849|417320|P3|COMPLETED|Overall Study||4
172935|NCT00953849|417321|P2|COMPLETED|Overall Study||6
172936|NCT00953849|417322|P1|COMPLETED|Overall Study||6
172937|NCT00953849|417319|P4|STARTED|Overall Study||5
172938|NCT00953849|417320|P3|STARTED|Overall Study||4
172939|NCT00953849|417321|P2|STARTED|Overall Study||6
172940|NCT00953849|417322|P1|STARTED|Overall Study||6
172941|NCT00953745|417346|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
172942|NCT00953745|417347|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
172943|NCT00953745|417346|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
172944|NCT00953745|417347|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
172945|NCT00953745|417346|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
172946|NCT00953745|417347|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
172947|NCT00953745|417346|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
172948|NCT00953745|417347|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
172949|NCT00953745|417346|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
172950|NCT00953745|417347|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
172951|NCT00953745|417346|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
172952|NCT00953745|417347|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
172953|NCT00953745|417346|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
172954|NCT00953745|417347|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
172955|NCT00953745|417346|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
172956|NCT00953745|417347|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
172957|NCT00953745|417346|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
172958|NCT00953745|417347|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
172959|NCT00953719|417357|P2|NOT COMPLETED|Overall Study||5
172960|NCT00953719|417358|P1|NOT COMPLETED|Overall Study||19
172961|NCT00953719|417357|P2|COMPLETED|Overall Study||69
172962|NCT00953719|417358|P1|COMPLETED|Overall Study||150
172963|NCT00953719|417357|P2|STARTED|Overall Study||74
172964|NCT00953719|417358|P1|STARTED|Overall Study||169
172965|NCT00953706|417380|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
172966|NCT00953706|417381|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
172967|NCT00953706|417382|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
172968|NCT00953706|417383|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
172969|NCT00953706|417380|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
172970|NCT00953706|417381|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
172971|NCT00953706|417382|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
172972|NCT00953706|417383|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
172973|NCT00953706|417380|P4|STARTED|Part B (96-Week Open-Label Extension)||33
172974|NCT00953706|417381|P3|STARTED|Part B (96-Week Open-Label Extension)||5
172975|NCT00953706|417382|P2|STARTED|Part B (96-Week Open-Label Extension)||0
172976|NCT00953706|417383|P1|STARTED|Part B (96-Week Open-Label Extension)||0
172977|NCT00953706|417380|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
172978|NCT00953706|417381|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
172979|NCT00953706|417382|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
172980|NCT00953706|417383|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
172981|NCT00953706|417380|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
172982|NCT00953706|417381|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
172983|NCT00953706|417382|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
172984|NCT00953706|417383|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
172985|NCT00953706|417380|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
172986|NCT00953706|417381|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
172987|NCT00953706|417382|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
172988|NCT00953706|417383|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
172989|NCT00953680|417415|P2|NOT COMPLETED|Period 2||0
172990|NCT00953680|417416|P1|NOT COMPLETED|Period 2||0
172991|NCT00953680|417415|P2|COMPLETED|Period 2||38
172992|NCT00953680|417416|P1|COMPLETED|Period 2||38
172993|NCT00953680|417415|P2|STARTED|Period 2||38
172994|NCT00953680|417416|P1|STARTED|Period 2||38
172995|NCT00953680|417415|P2|NOT COMPLETED|Period 1||1
172996|NCT00953680|417416|P1|NOT COMPLETED|Period 1||0
172997|NCT00953680|417415|P2|COMPLETED|Period 1||38
172998|NCT00953680|417416|P1|COMPLETED|Period 1||38
172999|NCT00953680|417415|P2|STARTED|Period 1||39
173000|NCT00953680|417416|P1|STARTED|Period 1||38
173001|NCT00953667|417428|P1|NOT COMPLETED|Overall Study||123
173002|NCT00953667|417428|P1|COMPLETED|Overall Study||277
173003|NCT00953667|417428|P1|STARTED|Overall Study||400
173004|NCT00953654|417436|P3|NOT COMPLETED|Overall Study||0
173005|NCT00953654|417437|P2|NOT COMPLETED|Overall Study||0
173006|NCT00953654|417438|P1|NOT COMPLETED|Overall Study||0
173007|NCT00953654|417436|P3|COMPLETED|Overall Study||10
173008|NCT00953654|417437|P2|COMPLETED|Overall Study||10
173009|NCT00953654|417438|P1|COMPLETED|Overall Study||10
173010|NCT00953654|417436|P3|STARTED|Overall Study||10
173011|NCT00953654|417437|P2|STARTED|Overall Study||10
173012|NCT00953654|417438|P1|STARTED|Overall Study||10
173013|NCT00953615|417449|P1|NOT COMPLETED|Overall Study||1
173014|NCT00953615|417449|P1|COMPLETED|Overall Study||0
173015|NCT00953615|417449|P1|STARTED|Overall Study||1
173016|NCT00953524|417460|P4|NOT COMPLETED|Overall Study||8
173017|NCT00953524|417461|P3|NOT COMPLETED|Overall Study||14
173018|NCT00953524|417462|P2|NOT COMPLETED|Overall Study||15
173019|NCT00953524|417463|P1|NOT COMPLETED|Overall Study||22
173020|NCT00953524|417460|P4|COMPLETED|Overall Study||91
173021|NCT00953524|417461|P3|COMPLETED|Overall Study||233
173022|NCT00953524|417462|P2|COMPLETED|Overall Study||239
173023|NCT00953524|417463|P1|COMPLETED|Overall Study||227
173024|NCT00953524|417460|P4|STARTED|Overall Study||99
173025|NCT00953524|417461|P3|STARTED|Overall Study||247
173026|NCT00953524|417462|P2|STARTED|Overall Study||254
173027|NCT00953524|417463|P1|STARTED|Overall Study||249
173028|NCT00953407|417506|P5|NOT COMPLETED|Overall Study||1
173029|NCT00953407|417507|P4|NOT COMPLETED|Overall Study||2
173030|NCT00953407|417508|P3|NOT COMPLETED|Overall Study||1
173031|NCT00953407|417509|P2|NOT COMPLETED|Overall Study||1
173032|NCT00953407|417510|P1|NOT COMPLETED|Overall Study||1
173033|NCT00953407|417506|P5|COMPLETED|Overall Study||23
173034|NCT00953407|417507|P4|COMPLETED|Overall Study||23
173035|NCT00953407|417508|P3|COMPLETED|Overall Study||25
173036|NCT00953407|417509|P2|COMPLETED|Overall Study||24
173037|NCT00953407|417510|P1|COMPLETED|Overall Study||25
173038|NCT00953407|417506|P5|STARTED|Overall Study||24
173039|NCT00953407|417507|P4|STARTED|Overall Study||25
173040|NCT00953407|417508|P3|STARTED|Overall Study||26
173041|NCT00953407|417509|P2|STARTED|Overall Study||25
173042|NCT00953407|417510|P1|STARTED|Overall Study||26
173043|NCT00953329|417522|P1|NOT COMPLETED|Overall Study||1
173044|NCT00953329|417522|P1|COMPLETED|Overall Study||0
173045|NCT00953329|417522|P1|STARTED|Overall Study||1
173046|NCT00953290|417526|P1|NOT COMPLETED|Overall Study||0
173047|NCT00953290|417526|P1|COMPLETED|Overall Study||4
173048|NCT00953290|417526|P1|STARTED|Overall Study||4
173049|NCT00953225|417535|P2|NOT COMPLETED|Overall Study||0
173050|NCT00953225|417536|P1|NOT COMPLETED|Overall Study||2
173051|NCT00953225|417535|P2|COMPLETED|Overall Study||37
173052|NCT00953225|417536|P1|COMPLETED|Overall Study||44
173053|NCT00953225|417535|P2|STARTED|Overall Study||37
173054|NCT00953225|417536|P1|STARTED|Overall Study||46
173055|NCT00953212|417548|P4|NOT COMPLETED|Overall Study||0
173056|NCT00953212|417549|P3|NOT COMPLETED|Overall Study||0
173057|NCT00953212|417550|P2|NOT COMPLETED|Overall Study||0
173058|NCT00953212|417551|P1|NOT COMPLETED|Overall Study||0
173059|NCT00953212|417548|P4|COMPLETED|Overall Study||76
173060|NCT00953212|417549|P3|COMPLETED|Overall Study||78
173061|NCT00953212|417550|P2|COMPLETED|Overall Study||74
173062|NCT00953212|417551|P1|COMPLETED|Overall Study||76
173063|NCT00953212|417548|P4|STARTED|Overall Study||76
173064|NCT00953212|417549|P3|STARTED|Overall Study||78
173065|NCT00953212|417550|P2|STARTED|Overall Study||74
173066|NCT00953212|417551|P1|STARTED|Overall Study||76
173067|NCT00953199|417607|P2|NOT COMPLETED|Overall Study||0
173068|NCT00953199|417608|P1|NOT COMPLETED|Overall Study||0
173069|NCT00953199|417607|P2|COMPLETED|Overall Study||252
173070|NCT00953199|417608|P1|COMPLETED|Overall Study||254
173071|NCT00953199|417607|P2|STARTED|Overall Study||252
173072|NCT00953199|417608|P1|STARTED|Overall Study||254
173073|NCT00953173|417616|P1|NOT COMPLETED|Overall Study||282
173074|NCT00953173|417616|P1|COMPLETED|Overall Study||389
173075|NCT00953173|417616|P1|STARTED|Overall Study||671
173076|NCT00953160|417620|P1|NOT COMPLETED|Overall Study||27
173077|NCT00953160|417620|P1|COMPLETED|Overall Study||49
173078|NCT00953160|417620|P1|STARTED|Overall Study||76
173079|NCT00953147|417629|P3|NOT COMPLETED|Overall Study||42
173080|NCT00953147|417630|P2|NOT COMPLETED|Overall Study||66
173081|NCT00953147|417631|P1|NOT COMPLETED|Overall Study||37
173082|NCT00953147|417629|P3|COMPLETED|Overall Study||265
173083|NCT00953147|417630|P2|COMPLETED|Overall Study||439
173084|NCT00953147|417631|P1|COMPLETED|Overall Study||261
173085|NCT00953147|417629|P3|STARTED|Overall Study||307
173086|NCT00953147|417630|P2|STARTED|Overall Study||505
173087|NCT00953147|417631|P1|STARTED|Overall Study||298
173088|NCT00953121|417681|P3|NOT COMPLETED|Overall Study||0
173089|NCT00953121|417682|P2|NOT COMPLETED|Overall Study||0
173090|NCT00953121|417683|P1|NOT COMPLETED|Overall Study||0
173091|NCT00953121|417681|P3|COMPLETED|Overall Study||25
173092|NCT00953121|417682|P2|COMPLETED|Overall Study||39
173093|NCT00953121|417683|P1|COMPLETED|Overall Study||40
173094|NCT00953121|417681|P3|STARTED|Overall Study||25
173095|NCT00953121|417682|P2|STARTED|Overall Study||39
173096|NCT00953121|417683|P1|STARTED|Overall Study||40
173097|NCT00953056|417709|P6|NOT COMPLETED|Overall Study||4
173098|NCT00953056|417710|P5|NOT COMPLETED|Overall Study||2
173099|NCT00953056|417711|P4|NOT COMPLETED|Overall Study||0
173100|NCT00953056|417712|P3|NOT COMPLETED|Overall Study||0
173101|NCT00953056|417713|P2|NOT COMPLETED|Overall Study||0
173102|NCT00953056|417714|P1|NOT COMPLETED|Overall Study||0
173103|NCT00953056|417709|P6|COMPLETED|Overall Study||20
173104|NCT00953056|417710|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
173105|NCT00953056|417711|P4|COMPLETED|Overall Study||24
173106|NCT00953056|417712|P3|COMPLETED|Overall Study||24
173107|NCT00953056|417713|P2|COMPLETED|Overall Study||24
173108|NCT00953056|417714|P1|COMPLETED|Overall Study||24
173109|NCT00953056|417709|P6|STARTED|Overall Study||24
173110|NCT00953056|417710|P5|STARTED|Overall Study||24
173111|NCT00953056|417711|P4|STARTED|Overall Study||24
173112|NCT00953056|417712|P3|STARTED|Overall Study||24
173113|NCT00953056|417713|P2|STARTED|Overall Study||24
173114|NCT00953056|417714|P1|STARTED|Overall Study||24
173115|NCT00953043|417738|P2|NOT COMPLETED|Overall Study||2
173116|NCT00953043|417739|P1|NOT COMPLETED|Overall Study||4
173117|NCT00953043|417738|P2|COMPLETED|Overall Study||28
173118|NCT00953043|417739|P1|COMPLETED|Overall Study||26
173119|NCT00953043|417738|P2|STARTED|Overall Study||30
173120|NCT00953043|417739|P1|STARTED|Overall Study||30
173121|NCT00953017|417763|P4|NOT COMPLETED|Overall Study||5
173122|NCT00953017|417764|P3|NOT COMPLETED|Overall Study||6
173123|NCT00953017|417765|P2|NOT COMPLETED|Overall Study||6
173124|NCT00953017|417766|P1|NOT COMPLETED|Overall Study||5
173125|NCT00953017|417763|P4|COMPLETED|Overall Study||101
173126|NCT00953017|417764|P3|COMPLETED|Overall Study||100
173127|NCT00953017|417765|P2|COMPLETED|Overall Study||101
173128|NCT00953017|417766|P1|COMPLETED|Overall Study||101
173129|NCT00953017|417763|P4|STARTED|Overall Study||106
173130|NCT00953017|417764|P3|STARTED|Overall Study||106
173131|NCT00953017|417765|P2|STARTED|Overall Study||107
173132|NCT00953017|417766|P1|STARTED|Overall Study||106
173133|NCT00952848|417788|P1|NOT COMPLETED|Overall Study||4
173134|NCT00952848|417788|P1|COMPLETED|Overall Study||14
173135|NCT00952848|417788|P1|STARTED|Overall Study||18
173136|NCT00952822|417795|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
173137|NCT00952822|417796|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
173138|NCT00952822|417797|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
173139|NCT00952822|417798|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
173140|NCT00952822|417795|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
173141|NCT00952822|417796|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
173142|NCT00952822|417797|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
173143|NCT00952822|417798|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
173144|NCT00952822|417795|P4|STARTED|2nd Pharmacokinetic Evaluation||4
173145|NCT00952822|417796|P3|STARTED|2nd Pharmacokinetic Evaluation||11
173146|NCT00952822|417797|P2|STARTED|2nd Pharmacokinetic Evaluation||17
173147|NCT00952822|417798|P1|STARTED|2nd Pharmacokinetic Evaluation||9
173148|NCT00952822|417795|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
173149|NCT00952822|417796|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
173150|NCT00952822|417797|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
173151|NCT00952822|417798|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
173152|NCT00952822|417795|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
173153|NCT00952822|417796|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
173154|NCT00952822|417797|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
173155|NCT00952822|417798|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
173156|NCT00952822|417795|P4|STARTED|1st Pharmacokinetic Evaluation||4
173157|NCT00952822|417796|P3|STARTED|1st Pharmacokinetic Evaluation||11
173158|NCT00952822|417797|P2|STARTED|1st Pharmacokinetic Evaluation||18
173159|NCT00952822|417798|P1|STARTED|1st Pharmacokinetic Evaluation||9
173160|NCT00952731|417830|P2|NOT COMPLETED|Overall Study||0
173161|NCT00952731|417831|P1|NOT COMPLETED|Overall Study||1
173162|NCT00952731|417830|P2|COMPLETED|Overall Study||14
173163|NCT00952731|417831|P1|COMPLETED|Overall Study||12
173164|NCT00952731|417830|P2|Follow-up|Overall Study||14
173165|NCT00952731|417831|P1|Follow-up|Overall Study||12
173166|NCT00952731|417830|P2|Surgery|Overall Study||14
173167|NCT00952731|417831|P1|Surgery|Overall Study||12
173168|NCT00952731|417830|P2|Treatment & Pre-Surgery|Overall Study||14
173169|NCT00952731|417831|P1|Treatment & Pre-Surgery|Overall Study||12
173170|NCT00952731|417830|P2|Randomization|Overall Study||14
173171|NCT00952731|417831|P1|Randomization|Overall Study||13
173172|NCT00952731|417830|P2|STARTED|Overall Study||14
173173|NCT00952731|417831|P1|STARTED|Overall Study||13
173174|NCT00952705|417850|P3|NOT COMPLETED|Overall Study||10
173175|NCT00952705|417851|P2|NOT COMPLETED|Overall Study||10
173176|NCT00952705|417852|P1|NOT COMPLETED|Overall Study||33
173177|NCT00952705|417850|P3|COMPLETED|Overall Study||288
173178|NCT00952705|417851|P2|COMPLETED|Overall Study||290
173179|NCT00952705|417852|P1|COMPLETED|Overall Study||1169
173180|NCT00952705|417850|P3|STARTED|Overall Study||298
173181|NCT00952705|417851|P2|STARTED|Overall Study||300
173182|NCT00952705|417852|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
173183|NCT00952653|417914|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
173184|NCT00952653|417914|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
173185|NCT00952653|417914|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
173186|NCT00952653|417914|P1|NOT COMPLETED|Period 1: MDZ Alone||0
173187|NCT00952653|417914|P1|COMPLETED|Period 1: MDZ Alone||28
173188|NCT00952653|417914|P1|STARTED|Period 1: MDZ Alone||28
173189|NCT00952614|417939|P1|NOT COMPLETED|Overall Study||7
173190|NCT00952614|417939|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
173191|NCT00952614|417939|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
173192|NCT00952614|417939|P1|STARTED|Overall Study||30
173193|NCT00952588|417946|P2|NOT COMPLETED|Overall Study||24
173194|NCT00952588|417947|P1|NOT COMPLETED|Overall Study||36
173195|NCT00952588|417946|P2|COMPLETED|Overall Study||2
173196|NCT00952588|417947|P1|COMPLETED|Overall Study||12
173197|NCT00952588|417946|P2|STARTED|Overall Study||26
173198|NCT00952588|417947|P1|STARTED|Overall Study||48
173199|NCT00952523|417965|P1|NOT COMPLETED|Overall Study||7
173200|NCT00952523|417965|P1|COMPLETED|Overall Study||155
173201|NCT00952523|417965|P1|STARTED|Overall Study||162
173202|NCT00952484|417974|P3|NOT COMPLETED|Overall Study||0
173203|NCT00952484|417975|P2|NOT COMPLETED|Overall Study||1
173204|NCT00952484|417976|P1|NOT COMPLETED|Overall Study||0
173205|NCT00952484|417974|P3|COMPLETED|Overall Study||16
173206|NCT00952484|417975|P2|COMPLETED|Overall Study||6
173207|NCT00952484|417976|P1|COMPLETED|Overall Study||6
173208|NCT00952484|417974|P3|STARTED|Overall Study||16
173209|NCT00952484|417975|P2|STARTED|Overall Study||7
173210|NCT00952484|417976|P1|STARTED|Overall Study||6
173211|NCT00952419|418003|P3|NOT COMPLETED|Overall Study||0
173212|NCT00952419|418004|P2|NOT COMPLETED|Overall Study||10
173213|NCT00952419|418005|P1|NOT COMPLETED|Overall Study||6
173214|NCT00952419|418003|P3|COMPLETED|Overall Study||51
173215|NCT00952419|418004|P2|COMPLETED|Overall Study||198
173216|NCT00952419|418005|P1|COMPLETED|Overall Study||209
173217|NCT00952419|418003|P3|STARTED|Overall Study||51
173218|NCT00952419|418004|P2|STARTED|Overall Study||208
173219|NCT00952419|418005|P1|STARTED|Overall Study||215
173220|NCT00952393|418037|P1|NOT COMPLETED|Overall Study||0
173221|NCT00952393|418037|P1|COMPLETED|Overall Study||10
173222|NCT00952393|418037|P1|STARTED|Overall Study|10|10
173223|NCT00952367|418041|P1|NOT COMPLETED|Overall Study||6
173224|NCT00952367|418041|P1|COMPLETED|Overall Study||3635
173225|NCT00952367|418041|P1|STARTED|Overall Study||3641
173226|NCT00952341|418056|P2|NOT COMPLETED|Cycle 2||12
173227|NCT00952341|418057|P1|NOT COMPLETED|Cycle 2||9
173228|NCT00952341|418056|P2|COMPLETED|Cycle 2||118
173229|NCT00952341|418057|P1|COMPLETED|Cycle 2||101
173230|NCT00952341|418056|P2|STARTED|Cycle 2||130
173231|NCT00952341|418057|P1|STARTED|Cycle 2||110
173232|NCT00952341|418056|P2|NOT COMPLETED|Cycle 1||13
173233|NCT00952341|418057|P1|NOT COMPLETED|Cycle 1||20
173234|NCT00952341|418056|P2|COMPLETED|Cycle 1||199
173235|NCT00952341|418057|P1|COMPLETED|Cycle 1||189
173236|NCT00952341|418056|P2|STARTED|Cycle 1||212
173237|NCT00952341|418057|P1|STARTED|Cycle 1||209
173238|NCT00952289|418079|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
173239|NCT00952289|418080|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
173240|NCT00952289|418079|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
173241|NCT00952289|418080|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
173242|NCT00952289|418079|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
173243|NCT00952289|418080|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
173244|NCT00952289|418079|P2|NOT COMPLETED|All Participants||40
173245|NCT00952289|418080|P1|NOT COMPLETED|All Participants||21
173246|NCT00952289|418079|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
173247|NCT00952289|418080|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
173248|NCT00952289|418079|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
173249|NCT00952289|418080|P1|Safety Population|All Participants||155
173250|NCT00952289|418079|P2|STARTED|All Participants||154
173251|NCT00952289|418080|P1|STARTED|All Participants||155
173252|NCT00952276|418109|P5|NOT COMPLETED|Overall Study||0
173253|NCT00952276|418110|P4|NOT COMPLETED|Overall Study||1
173254|NCT00952276|418111|P3|NOT COMPLETED|Overall Study||0
173255|NCT00952276|418112|P2|NOT COMPLETED|Overall Study||0
173256|NCT00952276|418113|P1|NOT COMPLETED|Overall Study||1
173257|NCT00952276|418109|P5|COMPLETED|Overall Study||63
173258|NCT00952276|418110|P4|COMPLETED|Overall Study||120
173259|NCT00952276|418111|P3|COMPLETED|Overall Study||122
173260|NCT00952276|418112|P2|COMPLETED|Overall Study||115
173261|NCT00952276|418113|P1|COMPLETED|Overall Study||126
173262|NCT00952276|418109|P5|STARTED|Overall Study||63
173263|NCT00952276|418110|P4|STARTED|Overall Study||121
173264|NCT00952276|418111|P3|STARTED|Overall Study||122
173265|NCT00952276|418112|P2|STARTED|Overall Study||115
173266|NCT00952276|418113|P1|STARTED|Overall Study||127
173267|NCT00952211|418162|P2|NOT COMPLETED|Overall Study||0
173268|NCT00952211|418163|P1|NOT COMPLETED|Overall Study||0
173269|NCT00952211|418162|P2|COMPLETED|Overall Study||0
173270|NCT00952211|418163|P1|COMPLETED|Overall Study||3
173271|NCT00952211|418162|P2|STARTED|Overall Study||0
173272|NCT00952211|418163|P1|STARTED|Overall Study||3
173273|NCT00952133|418173|P2|NOT COMPLETED|Overall Study||0
173274|NCT00952133|418174|P1|NOT COMPLETED|Overall Study||0
173275|NCT00952133|418173|P2|COMPLETED|Overall Study||59
173276|NCT00952133|418174|P1|COMPLETED|Overall Study||59
173277|NCT00952133|418173|P2|STARTED|Overall Study||59
173278|NCT00952133|418174|P1|STARTED|Overall Study||59
173279|NCT00952120|418185|P3|NOT COMPLETED|Overall Study||0
173280|NCT00952120|418186|P2|NOT COMPLETED|Overall Study||0
173281|NCT00952120|418187|P1|NOT COMPLETED|Overall Study||0
173282|NCT00952120|418185|P3|COMPLETED|Overall Study||5
173283|NCT00952120|418186|P2|COMPLETED|Overall Study||47
173284|NCT00952120|418187|P1|COMPLETED|Overall Study||52
173285|NCT00952120|418185|P3|STARTED|Overall Study||5
173286|NCT00952120|418186|P2|STARTED|Overall Study||47
173287|NCT00952120|418187|P1|STARTED|Overall Study||52
173288|NCT00952081|418195|P1|NOT COMPLETED|Overall Study||0
173289|NCT00952081|418195|P1|COMPLETED|Overall Study||22
173290|NCT00952081|418195|P1|STARTED|Overall Study||22
173291|NCT00952068|418199|P1|NOT COMPLETED|Overall Study||7
173292|NCT00952068|418199|P1|COMPLETED|Overall Study||40
173293|NCT00952068|418199|P1|STARTED|Overall Study||47
173294|NCT00951912|418210|P3|NOT COMPLETED|Overall Study||2
173295|NCT00951912|418211|P2|NOT COMPLETED|Overall Study||5
173296|NCT00951912|418212|P1|NOT COMPLETED|Overall Study||7
173297|NCT00951912|418210|P3|COMPLETED|Overall Study||54
173298|NCT00951912|418211|P2|COMPLETED|Overall Study||50
173299|NCT00951912|418212|P1|COMPLETED|Overall Study||47
173300|NCT00951912|418210|P3|STARTED|Overall Study||56
173301|NCT00951912|418211|P2|STARTED|Overall Study||55
173302|NCT00951912|418212|P1|STARTED|Overall Study||54
173303|NCT00951899|418264|P2|NOT COMPLETED|Overall Study||0
173304|NCT00951899|418265|P1|NOT COMPLETED|Overall Study||0
173305|NCT00951899|418264|P2|COMPLETED|Overall Study||19
173306|NCT00951899|418265|P1|COMPLETED|Overall Study||19
173307|NCT00951899|418264|P2|STARTED|Overall Study||19
173308|NCT00951899|418265|P1|STARTED|Overall Study||19
173309|NCT00951821|418289|P2|NOT COMPLETED|Overall Study||0
173310|NCT00951821|418290|P1|NOT COMPLETED|Overall Study||0
173311|NCT00951821|418289|P2|COMPLETED|Overall Study||8
173312|NCT00951821|418290|P1|COMPLETED|Overall Study||16
173313|NCT00951821|418289|P2|STARTED|Overall Study||8
173314|NCT00951821|418290|P1|STARTED|Overall Study||16
173315|NCT00951808|418298|P3|NOT COMPLETED|Overall Study||4
173316|NCT00951808|418299|P2|NOT COMPLETED|Overall Study||0
173317|NCT00951808|418300|P1|NOT COMPLETED|Overall Study||0
173318|NCT00951808|418298|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
173319|NCT00951808|418299|P2|COMPLETED|Overall Study||6
173320|NCT00951808|418300|P1|COMPLETED|Overall Study||4
173321|NCT00951808|418298|P3|STARTED|Overall Study||227
173322|NCT00951808|418299|P2|STARTED|Overall Study||6
173323|NCT00951808|418300|P1|STARTED|Overall Study||4
173324|NCT00951665|418312|P6|NOT COMPLETED|Phase 2a||7
173325|NCT00951665|418313|P5|NOT COMPLETED|Phase 2a||12
173326|NCT00951665|418314|P4|NOT COMPLETED|Phase 2a||0
173327|NCT00951665|418315|P3|NOT COMPLETED|Phase 2a||0
173328|NCT00951665|418316|P2|NOT COMPLETED|Phase 2a||0
173329|NCT00951665|418317|P1|NOT COMPLETED|Phase 2a||0
173330|NCT00951665|418312|P6|COMPLETED|Phase 2a||15
173331|NCT00951665|418313|P5|COMPLETED|Phase 2a||10
173332|NCT00951665|418314|P4|COMPLETED|Phase 2a||0
173333|NCT00951665|418315|P3|COMPLETED|Phase 2a||0
173334|NCT00951665|418316|P2|COMPLETED|Phase 2a||0
173335|NCT00951665|418317|P1|COMPLETED|Phase 2a||0
173336|NCT00951665|418312|P6|STARTED|Phase 2a||22
173337|NCT00951665|418313|P5|STARTED|Phase 2a||22
173338|NCT00951665|418314|P4|STARTED|Phase 2a||0
173339|NCT00951665|418315|P3|STARTED|Phase 2a||0
173340|NCT00951665|418316|P2|STARTED|Phase 2a||0
173341|NCT00951665|418317|P1|STARTED|Phase 2a||0
173342|NCT00951665|418312|P6|NOT COMPLETED|Phase 1b||0
173343|NCT00951665|418313|P5|NOT COMPLETED|Phase 1b||0
173344|NCT00951665|418314|P4|NOT COMPLETED|Phase 1b||1
173345|NCT00951665|418315|P3|NOT COMPLETED|Phase 1b||17
173346|NCT00951665|418316|P2|NOT COMPLETED|Phase 1b||4
173347|NCT00951665|418317|P1|NOT COMPLETED|Phase 1b||22
173348|NCT00951665|418312|P6|COMPLETED|Phase 1b||0
173349|NCT00951665|418313|P5|COMPLETED|Phase 1b||0
173350|NCT00951665|418314|P4|COMPLETED|Phase 1b||2
173351|NCT00951665|418315|P3|COMPLETED|Phase 1b||4
173352|NCT00951665|418316|P2|COMPLETED|Phase 1b||6
173353|NCT00951665|418317|P1|COMPLETED|Phase 1b||7
173354|NCT00951665|418312|P6|Started Treatment|Phase 1b||0
173355|NCT00951665|418313|P5|Started Treatment|Phase 1b||0
173356|NCT00951665|418314|P4|Started Treatment|Phase 1b||3
173357|NCT00951665|418315|P3|Started Treatment|Phase 1b||21
173358|NCT00951665|418316|P2|Started Treatment|Phase 1b||10
173359|NCT00951665|418317|P1|Started Treatment|Phase 1b||26
173360|NCT00951665|418312|P6|STARTED|Phase 1b||0
173361|NCT00951665|418313|P5|STARTED|Phase 1b||0
173362|NCT00951665|418314|P4|STARTED|Phase 1b||3
173363|NCT00951665|418315|P3|STARTED|Phase 1b||21
173364|NCT00951665|418316|P2|STARTED|Phase 1b||10
173365|NCT00951665|418317|P1|STARTED|Phase 1b||29
173366|NCT00951561|418418|P4|NOT COMPLETED|Overall Study||1
173367|NCT00951561|418419|P3|NOT COMPLETED|Overall Study||3
173368|NCT00951561|418420|P2|NOT COMPLETED|Overall Study||0
173369|NCT00951561|418421|P1|NOT COMPLETED|Overall Study||0
173370|NCT00951561|418418|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
173371|NCT00951561|418419|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
173372|NCT00951561|418420|P2|COMPLETED|Overall Study||29
173373|NCT00951561|418421|P1|COMPLETED|Overall Study||25
173374|NCT00951561|418418|P4|STARTED|Overall Study||27
173375|NCT00951561|418419|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
173376|NCT00951561|418420|P2|STARTED|Overall Study||29
173377|NCT00951561|418421|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
173378|NCT00951509|418426|P1|NOT COMPLETED|Overall Study||2
173379|NCT00951509|418426|P1|COMPLETED|Overall Study||29
173380|NCT00951509|418426|P1|Driving Condition 5|Overall Study||30
173381|NCT00951509|418426|P1|Driving Condition 4|Overall Study||28
173382|NCT00951509|418426|P1|Driving Condition 3|Overall Study||25
173383|NCT00951509|418426|P1|Driving Condition 2|Overall Study||29
173384|NCT00951509|418426|P1|Driving Condition 1|Overall Study||29
173385|NCT00951509|418426|P1|STARTED|Overall Study||31
173386|NCT00951496|418437|P3|NOT COMPLETED|Overall Study||13
173387|NCT00951496|418438|P2|NOT COMPLETED|Overall Study||8
173388|NCT00951496|418439|P1|NOT COMPLETED|Overall Study||10
173389|NCT00951496|418437|P3|COMPLETED|Overall Study||508
173390|NCT00951496|418438|P2|COMPLETED|Overall Study||510
173391|NCT00951496|418439|P1|COMPLETED|Overall Study||511
173392|NCT00951496|418437|P3|STARTED|Overall Study||521
173393|NCT00951496|418438|P2|STARTED|Overall Study||518
173394|NCT00951496|418439|P1|STARTED|Overall Study||521
173395|NCT00951483|418467|P2|NOT COMPLETED|Overall Study||0
173396|NCT00951483|418468|P1|NOT COMPLETED|Overall Study||19
173397|NCT00951483|418467|P2|COMPLETED|Overall Study||44
173398|NCT00951483|418468|P1|COMPLETED|Overall Study||28
173399|NCT00951483|418467|P2|STARTED|Overall Study||44
173400|NCT00951483|418468|P1|STARTED|Overall Study||47
173401|NCT00951379|418488|P2|NOT COMPLETED|Overall Study||2
173402|NCT00951379|418489|P1|NOT COMPLETED|Overall Study||6
173403|NCT00951379|418488|P2|COMPLETED|Overall Study||23
173404|NCT00951379|418489|P1|COMPLETED|Overall Study||21
173405|NCT00951379|418488|P2|STARTED|Overall Study||25
173406|NCT00951379|418489|P1|STARTED|Overall Study||27
173407|NCT00951275|418531|P1|NOT COMPLETED|Overall Study||13
173408|NCT00951275|418531|P1|COMPLETED|Overall Study||92
173409|NCT00951275|418531|P1|STARTED|Overall Study||105
173410|NCT00951171|418563|P2|NOT COMPLETED|Overall Study||0
173411|NCT00951171|418564|P1|NOT COMPLETED|Overall Study||2
173412|NCT00951171|418563|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
173413|NCT00951171|418564|P1|COMPLETED|Overall Study||38
173414|NCT00951171|418563|P2|Pregnancy|Overall Study||7
173415|NCT00951171|418564|P1|Pregnancy|Overall Study||1
173416|NCT00951171|418563|P2|STARTED|Overall Study||55
173417|NCT00951171|418564|P1|STARTED|Overall Study||40
173418|NCT00951093|418570|P1|NOT COMPLETED|6 Months After GBP||0
173419|NCT00951093|418570|P1|COMPLETED|6 Months After GBP||53
173420|NCT00951093|418570|P1|STARTED|6 Months After GBP||53
173421|NCT00951093|418570|P1|NOT COMPLETED|Before GBP||0
173422|NCT00951093|418570|P1|COMPLETED|Before GBP||53
173423|NCT00951093|418570|P1|STARTED|Before GBP||53
173424|NCT00951015|418598|P5|NOT COMPLETED|Open-label Phase||50
173425|NCT00951015|418599|P4|NOT COMPLETED|Open-label Phase||0
173426|NCT00951015|418600|P3|NOT COMPLETED|Open-label Phase||0
173427|NCT00951015|418601|P2|NOT COMPLETED|Open-label Phase||0
173428|NCT00951015|418602|P1|NOT COMPLETED|Open-label Phase||0
173429|NCT00951015|418598|P5|COMPLETED|Open-label Phase||88
173430|NCT00951015|418599|P4|COMPLETED|Open-label Phase||0
173431|NCT00951015|418600|P3|COMPLETED|Open-label Phase||0
173432|NCT00951015|418601|P2|COMPLETED|Open-label Phase||0
173433|NCT00951015|418602|P1|COMPLETED|Open-label Phase||0
173434|NCT00951015|418598|P5|STARTED|Open-label Phase||138
173435|NCT00951015|418599|P4|STARTED|Open-label Phase||0
173436|NCT00951015|418600|P3|STARTED|Open-label Phase||0
173437|NCT00951015|418601|P2|STARTED|Open-label Phase||0
173438|NCT00951015|418602|P1|STARTED|Open-label Phase||0
173439|NCT00951015|418598|P5|NOT COMPLETED|Randomization Phase 96 Week||0
173440|NCT00951015|418599|P4|NOT COMPLETED|Randomization Phase 96 Week||10
173441|NCT00951015|418600|P3|NOT COMPLETED|Randomization Phase 96 Week||5
173442|NCT00951015|418601|P2|NOT COMPLETED|Randomization Phase 96 Week||7
173443|NCT00951015|418602|P1|NOT COMPLETED|Randomization Phase 96 Week||5
173444|NCT00951015|418598|P5|COMPLETED|Randomization Phase 96 Week||0
173445|NCT00951015|418599|P4|COMPLETED|Randomization Phase 96 Week||40
173446|NCT00951015|418600|P3|COMPLETED|Randomization Phase 96 Week||46
173447|NCT00951015|418601|P2|COMPLETED|Randomization Phase 96 Week||44
173448|NCT00951015|418602|P1|COMPLETED|Randomization Phase 96 Week||48
173449|NCT00951015|418598|P5|STARTED|Randomization Phase 96 Week||0
173450|NCT00951015|418599|P4|STARTED|Randomization Phase 96 Week||50
173451|NCT00951015|418600|P3|STARTED|Randomization Phase 96 Week||51
173452|NCT00951015|418601|P2|STARTED|Randomization Phase 96 Week||51
173453|NCT00951015|418602|P1|STARTED|Randomization Phase 96 Week||53
173454|NCT00950963|418699|P2|NOT COMPLETED|Overall Study||24
173455|NCT00950963|418700|P1|NOT COMPLETED|Overall Study||29
173456|NCT00950963|418699|P2|COMPLETED|Overall Study||357
173457|NCT00950963|418700|P1|COMPLETED|Overall Study||352
173458|NCT00950963|418699|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
173459|NCT00950963|418700|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
173460|NCT00950937|418716|P2|NOT COMPLETED|Overall Study||0
173461|NCT00950937|418717|P1|NOT COMPLETED|Overall Study||0
173462|NCT00950937|418716|P2|COMPLETED|Overall Study||14
173463|NCT00950937|418717|P1|COMPLETED|Overall Study||14
173464|NCT00950937|418716|P2|STARTED|Overall Study||14
173465|NCT00950937|418717|P1|STARTED|Overall Study||14
173466|NCT00950911|418735|P2|NOT COMPLETED|Overall Study||15
173467|NCT00950911|418736|P1|NOT COMPLETED|Overall Study||12
173468|NCT00950911|418735|P2|COMPLETED|Overall Study||3
173469|NCT00950911|418736|P1|COMPLETED|Overall Study||5
173470|NCT00950911|418735|P2|STARTED|Overall Study||18
173471|NCT00950911|418736|P1|STARTED|Overall Study||17
173472|NCT00950872|418742|P1|NOT COMPLETED|Overall Study||3
173473|NCT00950872|418742|P1|COMPLETED|Overall Study||26
173474|NCT00950872|418742|P1|STARTED|Overall Study||29
173475|NCT00950859|418751|P2|NOT COMPLETED|Overall Study||10
173476|NCT00950859|418752|P1|NOT COMPLETED|Overall Study||16
173477|NCT00950859|418751|P2|COMPLETED|Overall Study||14
173478|NCT00950859|418752|P1|COMPLETED|Overall Study||11
173479|NCT00950859|418751|P2|STARTED|Overall Study||24
173480|NCT00950859|418752|P1|STARTED|Overall Study||27
173481|NCT00950833|418795|P3|NOT COMPLETED|Overall Study||0
173482|NCT00950833|418796|P2|NOT COMPLETED|Overall Study||0
173483|NCT00950833|418797|P1|NOT COMPLETED|Overall Study||0
173484|NCT00950833|418795|P3|COMPLETED|Overall Study||223
173485|NCT00950833|418796|P2|COMPLETED|Overall Study||108
173486|NCT00950833|418797|P1|COMPLETED|Overall Study||112
173487|NCT00950833|418795|P3|STARTED|Overall Study||223
173488|NCT00950833|418796|P2|STARTED|Overall Study||108
173489|NCT00950833|418797|P1|STARTED|Overall Study||112
173490|NCT00950807|418851|P10|NOT COMPLETED|Treatment Period 3||1
173491|NCT00950807|418852|P9|NOT COMPLETED|Treatment Period 3||0
173492|NCT00950807|418853|P8|NOT COMPLETED|Treatment Period 3||1
173493|NCT00950807|418854|P7|NOT COMPLETED|Treatment Period 3||1
173494|NCT00950807|418855|P6|NOT COMPLETED|Treatment Period 3||0
173495|NCT00950807|418856|P5|NOT COMPLETED|Treatment Period 3||0
173496|NCT00950807|418857|P4|NOT COMPLETED|Treatment Period 3||0
173497|NCT00950807|418858|P3|NOT COMPLETED|Treatment Period 3||0
173498|NCT00950807|418859|P2|NOT COMPLETED|Treatment Period 3||0
173499|NCT00950807|418860|P1|NOT COMPLETED|Treatment Period 3||1
173500|NCT00950807|418851|P10|COMPLETED|Treatment Period 3||10
173501|NCT00950807|418852|P9|COMPLETED|Treatment Period 3||9
173502|NCT00950807|418853|P8|COMPLETED|Treatment Period 3||9
173503|NCT00950807|418854|P7|COMPLETED|Treatment Period 3||11
173504|NCT00950807|418855|P6|COMPLETED|Treatment Period 3||9
173505|NCT00950807|418856|P5|COMPLETED|Treatment Period 3||12
173506|NCT00950807|418857|P4|COMPLETED|Treatment Period 3||11
173507|NCT00950807|418858|P3|COMPLETED|Treatment Period 3||10
173508|NCT00950807|418859|P2|COMPLETED|Treatment Period 3||9
173509|NCT00950807|418860|P1|COMPLETED|Treatment Period 3||45
173510|NCT00950807|418851|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
173511|NCT00950807|418852|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
173512|NCT00950807|418853|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
173513|NCT00950807|418854|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
173514|NCT00950807|418855|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
173515|NCT00950807|418856|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
173516|NCT00950807|418857|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
173517|NCT00950807|418858|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
173518|NCT00950807|418859|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
173519|NCT00950807|418860|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
173520|NCT00950807|418851|P10|NOT COMPLETED|Washout Period 2||0
173521|NCT00950807|418852|P9|NOT COMPLETED|Washout Period 2||0
173522|NCT00950807|418853|P8|NOT COMPLETED|Washout Period 2||1
173523|NCT00950807|418854|P7|NOT COMPLETED|Washout Period 2||1
173524|NCT00950807|418855|P6|NOT COMPLETED|Washout Period 2||0
173525|NCT00950807|418856|P5|NOT COMPLETED|Washout Period 2||1
173526|NCT00950807|418857|P4|NOT COMPLETED|Washout Period 2||1
173527|NCT00950807|418858|P3|NOT COMPLETED|Washout Period 2||0
173528|NCT00950807|418859|P2|NOT COMPLETED|Washout Period 2||1
173529|NCT00950807|418860|P1|NOT COMPLETED|Washout Period 2||4
173530|NCT00950807|418851|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
173531|NCT00950807|418852|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
173532|NCT00950807|418853|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
173533|NCT00950807|418854|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
173534|NCT00950807|418855|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
173535|NCT00950807|418856|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
173536|NCT00950807|418857|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
173537|NCT00950807|418858|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
173538|NCT00950807|418859|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
173539|NCT00950807|418860|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
173540|NCT00950807|418851|P10|STARTED|Washout Period 2||11
173541|NCT00950807|418852|P9|STARTED|Washout Period 2||11
173542|NCT00950807|418853|P8|STARTED|Washout Period 2||10
173543|NCT00950807|418854|P7|STARTED|Washout Period 2||9
173544|NCT00950807|418855|P6|STARTED|Washout Period 2||9
173545|NCT00950807|418856|P5|STARTED|Washout Period 2||13
173546|NCT00950807|418857|P4|STARTED|Washout Period 2||12
173547|NCT00950807|418858|P3|STARTED|Washout Period 2||10
173548|NCT00950807|418859|P2|STARTED|Washout Period 2||12
173549|NCT00950807|418860|P1|STARTED|Washout Period 2||51
173550|NCT00950807|418851|P10|NOT COMPLETED|Treatment Period 2||0
173551|NCT00950807|418852|P9|NOT COMPLETED|Treatment Period 2||0
173552|NCT00950807|418853|P8|NOT COMPLETED|Treatment Period 2||3
173553|NCT00950807|418854|P7|NOT COMPLETED|Treatment Period 2||1
173554|NCT00950807|418855|P6|NOT COMPLETED|Treatment Period 2||1
173555|NCT00950807|418856|P5|NOT COMPLETED|Treatment Period 2||0
173556|NCT00950807|418857|P4|NOT COMPLETED|Treatment Period 2||1
173557|NCT00950807|418858|P3|NOT COMPLETED|Treatment Period 2||0
173558|NCT00950807|418859|P2|NOT COMPLETED|Treatment Period 2||1
173559|NCT00950807|418860|P1|NOT COMPLETED|Treatment Period 2||2
173560|NCT00950807|418851|P10|COMPLETED|Treatment Period 2||11
173561|NCT00950807|418852|P9|COMPLETED|Treatment Period 2||11
173562|NCT00950807|418853|P8|COMPLETED|Treatment Period 2||10
173563|NCT00950807|418854|P7|COMPLETED|Treatment Period 2||9
173564|NCT00950807|418855|P6|COMPLETED|Treatment Period 2||9
173565|NCT00950807|418856|P5|COMPLETED|Treatment Period 2||13
173566|NCT00950807|418857|P4|COMPLETED|Treatment Period 2||12
173567|NCT00950807|418858|P3|COMPLETED|Treatment Period 2||10
173568|NCT00950807|418859|P2|COMPLETED|Treatment Period 2||12
173569|NCT00950807|418860|P1|COMPLETED|Treatment Period 2||51
173570|NCT00950807|418851|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
173571|NCT00950807|418852|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
173572|NCT00950807|418853|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
173573|NCT00950807|418854|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
173574|NCT00950807|418855|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
173575|NCT00950807|418856|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
173576|NCT00950807|418857|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
173577|NCT00950807|418858|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
173578|NCT00950807|418859|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
173579|NCT00950807|418860|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
173580|NCT00950807|418851|P10|NOT COMPLETED|Washout Period 1||0
173581|NCT00950807|418852|P9|NOT COMPLETED|Washout Period 1||1
173582|NCT00950807|418853|P8|NOT COMPLETED|Washout Period 1||1
173583|NCT00950807|418854|P7|NOT COMPLETED|Washout Period 1||2
173584|NCT00950807|418855|P6|NOT COMPLETED|Washout Period 1||0
173585|NCT00950807|418856|P5|NOT COMPLETED|Washout Period 1||1
173586|NCT00950807|418857|P4|NOT COMPLETED|Washout Period 1||1
173587|NCT00950807|418858|P3|NOT COMPLETED|Washout Period 1||0
173588|NCT00950807|418859|P2|NOT COMPLETED|Washout Period 1||0
173589|NCT00950807|418860|P1|NOT COMPLETED|Washout Period 1||5
173590|NCT00950807|418851|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
173591|NCT00950807|418852|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
173592|NCT00950807|418853|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
173593|NCT00950807|418854|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
173594|NCT00950807|418855|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
173595|NCT00950807|418856|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
173596|NCT00950807|418857|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
173597|NCT00950807|418858|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
173598|NCT00950807|418859|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
173599|NCT00950807|418860|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
173600|NCT00950807|418851|P10|STARTED|Washout Period 1||13
173601|NCT00950807|418852|P9|STARTED|Washout Period 1||12
173602|NCT00950807|418853|P8|STARTED|Washout Period 1||14
173603|NCT00950807|418854|P7|STARTED|Washout Period 1||12
173604|NCT00950807|418855|P6|STARTED|Washout Period 1||11
173605|NCT00950807|418856|P5|STARTED|Washout Period 1||12
173606|NCT00950807|418857|P4|STARTED|Washout Period 1||12
173607|NCT00950807|418858|P3|STARTED|Washout Period 1||13
173608|NCT00950807|418859|P2|STARTED|Washout Period 1||13
173609|NCT00950807|418860|P1|STARTED|Washout Period 1||56
173610|NCT00950807|418851|P10|NOT COMPLETED|Treatment Period 1||0
173611|NCT00950807|418852|P9|NOT COMPLETED|Treatment Period 1||1
173612|NCT00950807|418853|P8|NOT COMPLETED|Treatment Period 1||0
173613|NCT00950807|418854|P7|NOT COMPLETED|Treatment Period 1||0
173614|NCT00950807|418855|P6|NOT COMPLETED|Treatment Period 1||2
173615|NCT00950807|418856|P5|NOT COMPLETED|Treatment Period 1||1
173616|NCT00950807|418857|P4|NOT COMPLETED|Treatment Period 1||0
173617|NCT00950807|418858|P3|NOT COMPLETED|Treatment Period 1||1
173618|NCT00950807|418859|P2|NOT COMPLETED|Treatment Period 1||0
173619|NCT00950807|418860|P1|NOT COMPLETED|Treatment Period 1||3
173620|NCT00950807|418851|P10|COMPLETED|Treatment Period 1||13
173621|NCT00950807|418852|P9|COMPLETED|Treatment Period 1||12
173622|NCT00950807|418853|P8|COMPLETED|Treatment Period 1||14
173623|NCT00950807|418854|P7|COMPLETED|Treatment Period 1||12
173624|NCT00950807|418855|P6|COMPLETED|Treatment Period 1||11
173625|NCT00950807|418856|P5|COMPLETED|Treatment Period 1||12
173626|NCT00950807|418857|P4|COMPLETED|Treatment Period 1||12
173627|NCT00950807|418858|P3|COMPLETED|Treatment Period 1||13
173628|NCT00950807|418859|P2|COMPLETED|Treatment Period 1||13
173629|NCT00950807|418860|P1|COMPLETED|Treatment Period 1||56
173630|NCT00950807|418851|P10|STARTED|Treatment Period 1||13
173631|NCT00950807|418852|P9|STARTED|Treatment Period 1||13
173632|NCT00950807|418853|P8|STARTED|Treatment Period 1||14
173633|NCT00950807|418854|P7|STARTED|Treatment Period 1||12
173634|NCT00950807|418855|P6|STARTED|Treatment Period 1||13
173635|NCT00950807|418856|P5|STARTED|Treatment Period 1||13
173636|NCT00950807|418857|P4|STARTED|Treatment Period 1||12
173637|NCT00950807|418858|P3|STARTED|Treatment Period 1||14
173638|NCT00950807|418859|P2|STARTED|Treatment Period 1||13
173639|NCT00950807|418860|P1|STARTED|Treatment Period 1||59
173640|NCT00950755|418902|P1|NOT COMPLETED|Long-Term Follow-Up||9
173641|NCT00950755|418902|P1|COMPLETED|Long-Term Follow-Up||9
173642|NCT00950755|418902|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
173643|NCT00950755|418902|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
173644|NCT00950755|418902|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
173645|NCT00950755|418902|P1|STARTED|Dosimetric and Therapeutic Treatment||41
173646|NCT00950742|418928|P2|NOT COMPLETED|Overall Study||2
173647|NCT00950742|418929|P1|NOT COMPLETED|Overall Study||16
173648|NCT00950742|418928|P2|COMPLETED|Overall Study||0
173649|NCT00950742|418929|P1|COMPLETED|Overall Study||0
173650|NCT00950742|418928|P2|STARTED|Overall Study|entered and treated|2
173651|NCT00950742|418929|P1|STARTED|Overall Study|entered and treated|16
173652|NCT00950729|418945|P1|NOT COMPLETED|Driving With Aircast||0
173653|NCT00950729|418945|P1|COMPLETED|Driving With Aircast||48
173654|NCT00950729|418945|P1|STARTED|Driving With Aircast||48
173655|NCT00950729|418945|P1|NOT COMPLETED|Driving With Plaster Cast||0
173656|NCT00950729|418945|P1|COMPLETED|Driving With Plaster Cast||48
173657|NCT00950729|418945|P1|STARTED|Driving With Plaster Cast||48
173658|NCT00950729|418945|P1|NOT COMPLETED|Driving With Running Shoes||0
173659|NCT00950729|418945|P1|COMPLETED|Driving With Running Shoes|June 2007|48
173660|NCT00950729|418945|P1|STARTED|Driving With Running Shoes|March 2007|48
173661|NCT00950690|418950|P1|NOT COMPLETED|Overall Study||244
173662|NCT00950690|418950|P1|COMPLETED|Overall Study||1105
173663|NCT00950690|418950|P1|STARTED|Overall Study||1349
173664|NCT00950664|418957|P2|NOT COMPLETED|Second Intervention||48
173665|NCT00950664|418958|P1|NOT COMPLETED|Second Intervention||46
173666|NCT00950664|418957|P2|COMPLETED|Second Intervention||0
173667|NCT00950664|418958|P1|COMPLETED|Second Intervention||0
173668|NCT00950664|418957|P2|STARTED|Second Intervention||48
173669|NCT00950664|418958|P1|STARTED|Second Intervention||46
173670|NCT00950664|418957|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
173671|NCT00950664|418958|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
173672|NCT00950664|418957|P2|COMPLETED|Washout Period of 4 Weeks||48
173673|NCT00950664|418958|P1|COMPLETED|Washout Period of 4 Weeks||46
173674|NCT00950664|418957|P2|STARTED|Washout Period of 4 Weeks||48
173675|NCT00950664|418958|P1|STARTED|Washout Period of 4 Weeks||46
173676|NCT00950664|418957|P2|NOT COMPLETED|First Intervention||5
173677|NCT00950664|418958|P1|NOT COMPLETED|First Intervention||3
173678|NCT00950664|418957|P2|COMPLETED|First Intervention||48
173679|NCT00950664|418958|P1|COMPLETED|First Intervention||46
173680|NCT00950664|418957|P2|STARTED|First Intervention||53
173681|NCT00950664|418958|P1|STARTED|First Intervention||49
173682|NCT00950651|418978|P2|NOT COMPLETED|Overall Study||35
173683|NCT00950651|418979|P1|NOT COMPLETED|Overall Study||31
173684|NCT00950651|418978|P2|COMPLETED|Overall Study||181
173685|NCT00950651|418979|P1|COMPLETED|Overall Study||184
173686|NCT00950651|418978|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
173687|NCT00950651|418979|P1|STARTED|Overall Study||215
173688|NCT00950612|419027|P2|NOT COMPLETED|Overall Study||0
173689|NCT00950612|419028|P1|NOT COMPLETED|Overall Study||0
173690|NCT00950612|419027|P2|COMPLETED|Overall Study||20
173691|NCT00950612|419028|P1|COMPLETED|Overall Study||40
173692|NCT00950612|419027|P2|STARTED|Overall Study||20
173693|NCT00950612|419028|P1|STARTED|Overall Study||40
173694|NCT00950599|419072|P10|NOT COMPLETED|Follow-Up Period||2
173695|NCT00950599|419073|P9|NOT COMPLETED|Follow-Up Period||13
173696|NCT00950599|419074|P8|NOT COMPLETED|Follow-Up Period||0
173697|NCT00950599|419075|P7|NOT COMPLETED|Follow-Up Period||0
173698|NCT00950599|419076|P6|NOT COMPLETED|Follow-Up Period||0
173699|NCT00950599|419077|P5|NOT COMPLETED|Follow-Up Period||0
173700|NCT00950599|419078|P4|NOT COMPLETED|Follow-Up Period||0
173701|NCT00950599|419079|P3|NOT COMPLETED|Follow-Up Period||0
173702|NCT00950599|419080|P2|NOT COMPLETED|Follow-Up Period||0
173703|NCT00950599|419081|P1|NOT COMPLETED|Follow-Up Period||0
173704|NCT00950599|419072|P10|COMPLETED|Follow-Up Period||78
173705|NCT00950599|419073|P9|COMPLETED|Follow-Up Period||296
173706|NCT00950599|419074|P8|COMPLETED|Follow-Up Period||0
173707|NCT00950599|419075|P7|COMPLETED|Follow-Up Period||0
173708|NCT00950599|419076|P6|COMPLETED|Follow-Up Period||0
173709|NCT00950599|419077|P5|COMPLETED|Follow-Up Period||0
173710|NCT00950599|419078|P4|COMPLETED|Follow-Up Period||0
173711|NCT00950599|419079|P3|COMPLETED|Follow-Up Period||0
173712|NCT00950599|419080|P2|COMPLETED|Follow-Up Period||0
173713|NCT00950599|419081|P1|COMPLETED|Follow-Up Period||0
173714|NCT00950599|419072|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
173715|NCT00950599|419073|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
173716|NCT00950599|419074|P8|STARTED|Follow-Up Period||0
173717|NCT00950599|419075|P7|STARTED|Follow-Up Period||0
173718|NCT00950599|419076|P6|STARTED|Follow-Up Period||0
173719|NCT00950599|419077|P5|STARTED|Follow-Up Period||0
173720|NCT00950599|419078|P4|STARTED|Follow-Up Period||0
173721|NCT00950599|419079|P3|STARTED|Follow-Up Period||0
173722|NCT00950599|419080|P2|STARTED|Follow-Up Period||0
173723|NCT00950599|419081|P1|STARTED|Follow-Up Period||0
173724|NCT00950599|419072|P10|NOT COMPLETED|Double-Blind Treatment Period||0
173725|NCT00950599|419073|P9|NOT COMPLETED|Double-Blind Treatment Period||0
173726|NCT00950599|419074|P8|NOT COMPLETED|Double-Blind Treatment Period||6
173727|NCT00950599|419075|P7|NOT COMPLETED|Double-Blind Treatment Period||0
173728|NCT00950599|419076|P6|NOT COMPLETED|Double-Blind Treatment Period||12
173729|NCT00950599|419077|P5|NOT COMPLETED|Double-Blind Treatment Period||7
173730|NCT00950599|419078|P4|NOT COMPLETED|Double-Blind Treatment Period||11
173731|NCT00950599|419079|P3|NOT COMPLETED|Double-Blind Treatment Period||9
173732|NCT00950599|419080|P2|NOT COMPLETED|Double-Blind Treatment Period||10
173733|NCT00950599|419081|P1|NOT COMPLETED|Double-Blind Treatment Period||7
173734|NCT00950599|419072|P10|COMPLETED|Double-Blind Treatment Period||0
173735|NCT00950599|419073|P9|COMPLETED|Double-Blind Treatment Period||0
173736|NCT00950599|419074|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
173737|NCT00950599|419075|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
173738|NCT00950599|419076|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
173739|NCT00950599|419077|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
173740|NCT00950599|419078|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
173741|NCT00950599|419079|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
173742|NCT00950599|419080|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
173743|NCT00950599|419081|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
173744|NCT00950599|419072|P10|STARTED|Double-Blind Treatment Period||0
173745|NCT00950599|419073|P9|STARTED|Double-Blind Treatment Period||0
173746|NCT00950599|419074|P8|STARTED|Double-Blind Treatment Period||41
173747|NCT00950599|419075|P7|STARTED|Double-Blind Treatment Period||44
173748|NCT00950599|419076|P6|STARTED|Double-Blind Treatment Period||67
173749|NCT00950599|419077|P5|STARTED|Double-Blind Treatment Period||52
173750|NCT00950599|419078|P4|STARTED|Double-Blind Treatment Period||54
173751|NCT00950599|419079|P3|STARTED|Double-Blind Treatment Period||63
173752|NCT00950599|419080|P2|STARTED|Double-Blind Treatment Period||47
173753|NCT00950599|419081|P1|STARTED|Double-Blind Treatment Period||55
173754|NCT00950352|419645|P2|NOT COMPLETED|Overall Study||11
173755|NCT00950352|419646|P1|NOT COMPLETED|Overall Study||42
173756|NCT00950352|419645|P2|COMPLETED|Overall Study||21
173757|NCT00950352|419646|P1|COMPLETED|Overall Study||30
173758|NCT00950352|419645|P2|STARTED|Overall Study||32
173759|NCT00950352|419646|P1|STARTED|Overall Study||72
173760|NCT00950300|419654|P2|NOT COMPLETED|SFU Period||78
173761|NCT00950300|419655|P1|NOT COMPLETED|SFU Period||78
173762|NCT00950300|419654|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
173763|NCT00950300|419655|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
173764|NCT00950300|419654|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
173765|NCT00950300|419655|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
173766|NCT00950300|419654|P2|NOT COMPLETED|TFFU Period||107
173767|NCT00950300|419655|P1|NOT COMPLETED|TFFU Period||100
173768|NCT00950300|419654|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
173769|NCT00950300|419655|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
173770|NCT00950300|419654|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
173771|NCT00950300|419655|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
173772|NCT00950300|419654|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
173773|NCT00950300|419655|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
173774|NCT00950300|419654|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
173775|NCT00950300|419655|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
173776|NCT00950300|419654|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
173777|NCT00950300|419655|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
173778|NCT00950300|419654|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
173779|NCT00950300|419655|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
173780|NCT00950300|419654|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
173781|NCT00950300|419655|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
173782|NCT00950300|419654|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
173783|NCT00950300|419655|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
173784|NCT00950235|419704|P2|NOT COMPLETED|Overall Study||4
173785|NCT00950235|419705|P1|NOT COMPLETED|Overall Study||2
173786|NCT00950235|419704|P2|COMPLETED|Overall Study||54
173787|NCT00950235|419705|P1|COMPLETED|Overall Study||58
173788|NCT00950235|419704|P2|STARTED|Overall Study||58
173789|NCT00950235|419705|P1|STARTED|Overall Study||60
173790|NCT00950183|419715|P1|NOT COMPLETED|Overall Study||36
173791|NCT00950183|419715|P1|COMPLETED|Overall Study||0
173792|NCT00950183|419715|P1|STARTED|Overall Study||36
173793|NCT00949975|419727|P4|NOT COMPLETED|Overall Study||28
173794|NCT00949975|419728|P3|NOT COMPLETED|Overall Study||19
173795|NCT00949975|419729|P2|NOT COMPLETED|Overall Study||29
173796|NCT00949975|419730|P1|NOT COMPLETED|Overall Study||27
173797|NCT00949975|419727|P4|COMPLETED|Overall Study||190
173798|NCT00949975|419728|P3|COMPLETED|Overall Study||183
173799|NCT00949975|419729|P2|COMPLETED|Overall Study||177
173800|NCT00949975|419730|P1|COMPLETED|Overall Study||185
173801|NCT00949975|419727|P4|STARTED|Overall Study||218
173802|NCT00949975|419728|P3|STARTED|Overall Study||202
173803|NCT00949975|419729|P2|STARTED|Overall Study||206
173804|NCT00949975|419730|P1|STARTED|Overall Study||212
173805|NCT00949910|419848|P1|NOT COMPLETED|Overall Study||6576
173806|NCT00949910|419848|P1|COMPLETED|Overall Study||10
173807|NCT00949910|419848|P1|STARTED|Overall Study||6586
173808|NCT00949884|419861|P3|NOT COMPLETED|Overall Study||58
173809|NCT00949884|419862|P2|NOT COMPLETED|Overall Study||15
173810|NCT00949884|419863|P1|NOT COMPLETED|Overall Study||50
173811|NCT00949884|419861|P3|COMPLETED|Overall Study||411
173812|NCT00949884|419862|P2|COMPLETED|Overall Study||37
173813|NCT00949884|419863|P1|COMPLETED|Overall Study||370
173814|NCT00949884|419861|P3|STARTED|Overall Study||469
173815|NCT00949884|419862|P2|STARTED|Overall Study||52
173816|NCT00949884|419863|P1|STARTED|Overall Study||420
173817|NCT00949715|419918|P2|NOT COMPLETED|Overall Study||0
173818|NCT00949715|419919|P1|NOT COMPLETED|Overall Study||4
173819|NCT00949715|419918|P2|COMPLETED|Overall Study||33
173820|NCT00949715|419919|P1|COMPLETED|Overall Study||28
173821|NCT00949715|419918|P2|STARTED|Overall Study||33
173822|NCT00949715|419919|P1|STARTED|Overall Study||32
173823|NCT00949702|419930|P1|NOT COMPLETED|Overall Study||48
173824|NCT00949702|419930|P1|COMPLETED|Overall Study||84
173825|NCT00949702|419930|P1|STARTED|Overall Study||132
173826|NCT00949650|419947|P2|NOT COMPLETED|Overall Study||115
173827|NCT00949650|419948|P1|NOT COMPLETED|Overall Study||230
173828|NCT00949650|419947|P2|COMPLETED|Overall Study||0
173829|NCT00949650|419948|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
173830|NCT00949650|419947|P2|STARTED|Overall Study|Treated patients.|115
173831|NCT00949650|419948|P1|STARTED|Overall Study|Treated patients.|230
173832|NCT00949533|419986|P2|NOT COMPLETED|Overall Study||1
173833|NCT00949533|419987|P1|NOT COMPLETED|Overall Study||0
173834|NCT00949533|419986|P2|COMPLETED|Overall Study||17
173835|NCT00949533|419987|P1|COMPLETED|Overall Study||19
173836|NCT00949533|419986|P2|STARTED|Overall Study||18
173837|NCT00949533|419987|P1|STARTED|Overall Study||19
173838|NCT00949234|419999|P1|NOT COMPLETED|Overall Study||42
173839|NCT00949234|419999|P1|COMPLETED|Overall Study||225
173840|NCT00949234|419999|P1|STARTED|Overall Study||267
173841|NCT00949117|420005|P2|NOT COMPLETED|Overall Study||5
173842|NCT00949117|420006|P1|NOT COMPLETED|Overall Study||3
173843|NCT00949117|420005|P2|COMPLETED|Overall Study||0
173844|NCT00949117|420006|P1|COMPLETED|Overall Study||1
173845|NCT00949117|420005|P2|STARTED|Overall Study||5
173846|NCT00949117|420006|P1|STARTED|Overall Study||4
173847|NCT00949078|420022|P2|NOT COMPLETED|Overall Study||0
173848|NCT00949078|420023|P1|NOT COMPLETED|Overall Study||0
173849|NCT00949078|420022|P2|COMPLETED|Overall Study||9
173850|NCT00949078|420023|P1|COMPLETED|Overall Study||5
173851|NCT00949078|420022|P2|STARTED|Overall Study||9
173852|NCT00949078|420023|P1|STARTED|Overall Study||5
173853|NCT00948896|420053|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
173854|NCT00948896|420054|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
173855|NCT00948896|420055|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
173856|NCT00948896|420056|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
173857|NCT00948896|420057|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
173858|NCT00948896|420058|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
173859|NCT00948896|420059|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
173860|NCT00948896|420060|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
173861|NCT00948896|420053|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
173862|NCT00948896|420054|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
173863|NCT00948896|420055|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
173864|NCT00948896|420056|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
173865|NCT00948896|420057|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
173866|NCT00948896|420058|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
173867|NCT00948896|420059|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
173868|NCT00948896|420060|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
173869|NCT00948896|420053|P8|STARTED|24 Months of Age to 36 Months of Age||45
173870|NCT00948896|420054|P7|STARTED|24 Months of Age to 36 Months of Age||43
173871|NCT00948896|420055|P6|STARTED|24 Months of Age to 36 Months of Age||42
173872|NCT00948896|420056|P5|STARTED|24 Months of Age to 36 Months of Age||44
173873|NCT00948896|420057|P4|STARTED|24 Months of Age to 36 Months of Age||87
173874|NCT00948896|420058|P3|STARTED|24 Months of Age to 36 Months of Age||90
173875|NCT00948896|420059|P2|STARTED|24 Months of Age to 36 Months of Age||85
173876|NCT00948896|420060|P1|STARTED|24 Months of Age to 36 Months of Age||90
173877|NCT00948896|420053|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
173878|NCT00948896|420054|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
173879|NCT00948896|420055|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
173880|NCT00948896|420056|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
173881|NCT00948896|420057|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
173882|NCT00948896|420058|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
173883|NCT00948896|420059|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
173884|NCT00948896|420060|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
173885|NCT00948896|420053|P8|COMPLETED|Randomization to 24 Months of Age||45
173886|NCT00948896|420054|P7|COMPLETED|Randomization to 24 Months of Age||43
173887|NCT00948896|420055|P6|COMPLETED|Randomization to 24 Months of Age||42
173888|NCT00948896|420056|P5|COMPLETED|Randomization to 24 Months of Age||44
173889|NCT00948896|420057|P4|COMPLETED|Randomization to 24 Months of Age||87
173890|NCT00948896|420058|P3|COMPLETED|Randomization to 24 Months of Age||90
173891|NCT00948896|420059|P2|COMPLETED|Randomization to 24 Months of Age||85
173892|NCT00948896|420060|P1|COMPLETED|Randomization to 24 Months of Age||90
173893|NCT00948896|420053|P8|STARTED|Randomization to 24 Months of Age||47
173894|NCT00948896|420054|P7|STARTED|Randomization to 24 Months of Age||47
173895|NCT00948896|420055|P6|STARTED|Randomization to 24 Months of Age||46
173896|NCT00948896|420056|P5|STARTED|Randomization to 24 Months of Age||46
173897|NCT00948896|420057|P4|STARTED|Randomization to 24 Months of Age||98
173898|NCT00948896|420058|P3|STARTED|Randomization to 24 Months of Age||99
173899|NCT00948896|420059|P2|STARTED|Randomization to 24 Months of Age||98
173900|NCT00948896|420060|P1|STARTED|Randomization to 24 Months of Age||98
173901|NCT00948857|420096|P2|NOT COMPLETED|Overall Study||0
173902|NCT00948857|420097|P1|NOT COMPLETED|Overall Study||1
173903|NCT00948857|420096|P2|COMPLETED|Overall Study||2
173904|NCT00948857|420097|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
173905|NCT00948857|420096|P2|STARTED|Overall Study||2
173906|NCT00948857|420097|P1|STARTED|Overall Study||3
173907|NCT00948818|420105|P2|NOT COMPLETED|Overall Study||94
173908|NCT00948818|420106|P1|NOT COMPLETED|Overall Study||62
173909|NCT00948818|420105|P2|COMPLETED|Overall Study||312
173910|NCT00948818|420106|P1|COMPLETED|Overall Study||335
173911|NCT00948818|420105|P2|STARTED|Overall Study||406
173912|NCT00948818|420106|P1|STARTED|Overall Study||397
173913|NCT00948792|420141|P1|NOT COMPLETED|Overall Study||0
173914|NCT00948792|420141|P1|COMPLETED|Overall Study||21
173915|NCT00948792|420141|P1|STARTED|Overall Study||21
173916|NCT00948766|420153|P2|NOT COMPLETED|Extension Study||0
173917|NCT00948766|420154|P1|NOT COMPLETED|Extension Study||91
173918|NCT00948766|420153|P2|COMPLETED|Extension Study||0
173919|NCT00948766|420154|P1|COMPLETED|Extension Study||306
173920|NCT00948766|420153|P2|Exposed to Study Medication|Extension Study||0
173921|NCT00948766|420154|P1|Exposed to Study Medication|Extension Study||396
173922|NCT00948766|420153|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
173923|NCT00948766|420154|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
173924|NCT00948766|420153|P2|NOT COMPLETED|Core Study||126
173925|NCT00948766|420154|P1|NOT COMPLETED|Core Study||127
173926|NCT00948766|420153|P2|COMPLETED|Core Study||234
173927|NCT00948766|420154|P1|COMPLETED|Core Study||229
173928|NCT00948766|420153|P2|Exposed to Study Medication|Core Study||359
173929|NCT00948766|420154|P1|Exposed to Study Medication|Core Study||355
173930|NCT00948766|420153|P2|STARTED|Core Study||360
173931|NCT00948766|420154|P1|STARTED|Core Study||356
173932|NCT00948688|420170|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
173933|NCT00948688|420171|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
173934|NCT00948688|420170|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
173935|NCT00948688|420171|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
173936|NCT00948688|420170|P2|STARTED|Period 2: 100 mg Vorinostat||6
173937|NCT00948688|420171|P1|STARTED|Period 2: 100 mg Vorinostat||0
173938|NCT00948688|420170|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
173939|NCT00948688|420171|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
173940|NCT00948688|420170|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
173941|NCT00948688|420171|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
173942|NCT00948688|420170|P2|STARTED|Period 1: 200 mg Vorinostat||0
173943|NCT00948688|420171|P1|STARTED|Period 1: 200 mg Vorinostat||4
173944|NCT00948675|420185|P2|NOT COMPLETED|Overall Study||4
173945|NCT00948675|420186|P1|NOT COMPLETED|Overall Study||7
173946|NCT00948675|420185|P2|COMPLETED|Overall Study||175
173947|NCT00948675|420186|P1|COMPLETED|Overall Study||175
173948|NCT00948675|420185|P2|STARTED|Overall Study||179
173949|NCT00948675|420186|P1|STARTED|Overall Study||182
173950|NCT00948610|420202|P2|NOT COMPLETED|Overall Study||1
173951|NCT00948610|420203|P1|NOT COMPLETED|Overall Study||1
173952|NCT00948610|420202|P2|COMPLETED|Overall Study||9
173953|NCT00948610|420203|P1|COMPLETED|Overall Study||9
173954|NCT00948610|420202|P2|STARTED|Overall Study||10
173955|NCT00948610|420203|P1|STARTED|Overall Study||10
173956|NCT00948506|420213|P2|NOT COMPLETED|Overall Study||1
173957|NCT00948506|420214|P1|NOT COMPLETED|Overall Study||3
173958|NCT00948506|420213|P2|COMPLETED|Overall Study||8
173959|NCT00948506|420214|P1|COMPLETED|Overall Study||8
173960|NCT00948506|420213|P2|STARTED|Overall Study||9
173961|NCT00948506|420214|P1|STARTED|Overall Study||11
173962|NCT00948441|420225|P2|NOT COMPLETED|Overall Study||4
173963|NCT00948441|420226|P1|NOT COMPLETED|Overall Study||1
173964|NCT00948441|420225|P2|COMPLETED|Overall Study||4
173965|NCT00948441|420226|P1|COMPLETED|Overall Study||7
173966|NCT00948441|420225|P2|STARTED|Overall Study||8
173967|NCT00948441|420226|P1|STARTED|Overall Study||8
173968|NCT00948389|420239|P5|NOT COMPLETED|Overall Study||1
173969|NCT00948389|420240|P4|NOT COMPLETED|Overall Study||9
173970|NCT00948389|420241|P3|NOT COMPLETED|Overall Study||7
173971|NCT00948389|420242|P2|NOT COMPLETED|Overall Study||3
173972|NCT00948389|420243|P1|NOT COMPLETED|Overall Study||6
173973|NCT00948389|420239|P5|COMPLETED|Overall Study||0
173974|NCT00948389|420240|P4|COMPLETED|Overall Study||0
173975|NCT00948389|420241|P3|COMPLETED|Overall Study||0
173976|NCT00948389|420242|P2|COMPLETED|Overall Study||0
173977|NCT00948389|420243|P1|COMPLETED|Overall Study||0
173978|NCT00948389|420239|P5|STARTED|Overall Study||1
173979|NCT00948389|420240|P4|STARTED|Overall Study||9
173980|NCT00948389|420241|P3|STARTED|Overall Study||7
173981|NCT00948389|420242|P2|STARTED|Overall Study||3
173982|NCT00948389|420243|P1|STARTED|Overall Study||6
173983|NCT00948246|420280|P1|NOT COMPLETED|Overall Study||24
173984|NCT00948246|420280|P1|COMPLETED|Overall Study||86
173985|NCT00948246|420280|P1|STARTED|Overall Study||110
173986|NCT00948155|420289|P2|NOT COMPLETED|Second Intervention 21 Days||3
173987|NCT00948155|420290|P1|NOT COMPLETED|Second Intervention 21 Days||2
173988|NCT00948155|420289|P2|COMPLETED|Second Intervention 21 Days||8
173989|NCT00948155|420290|P1|COMPLETED|Second Intervention 21 Days||9
173990|NCT00948155|420289|P2|STARTED|Second Intervention 21 Days||11
173991|NCT00948155|420290|P1|STARTED|Second Intervention 21 Days||11
173992|NCT00948155|420289|P2|NOT COMPLETED|Washout 14 Days||2
173993|NCT00948155|420290|P1|NOT COMPLETED|Washout 14 Days||1
173994|NCT00948155|420289|P2|COMPLETED|Washout 14 Days||11
173995|NCT00948155|420290|P1|COMPLETED|Washout 14 Days||11
173996|NCT00948155|420289|P2|STARTED|Washout 14 Days||13
173997|NCT00948155|420290|P1|STARTED|Washout 14 Days||12
173998|NCT00948155|420289|P2|NOT COMPLETED|First Intervention 21 Days||2
173999|NCT00948155|420290|P1|NOT COMPLETED|First Intervention 21 Days||2
174000|NCT00948155|420289|P2|COMPLETED|First Intervention 21 Days||13
174001|NCT00948155|420290|P1|COMPLETED|First Intervention 21 Days||12
174002|NCT00948155|420289|P2|STARTED|First Intervention 21 Days||15
174003|NCT00948155|420290|P1|STARTED|First Intervention 21 Days||14
174004|NCT00948090|420312|P4|NOT COMPLETED|Overall Study||11
174005|NCT00948090|420313|P3|NOT COMPLETED|Overall Study||56
174006|NCT00948090|420314|P2|NOT COMPLETED|Overall Study||1
174007|NCT00948090|420315|P1|NOT COMPLETED|Overall Study||43
174008|NCT00948090|420312|P4|COMPLETED|Overall Study||7
174009|NCT00948090|420313|P3|COMPLETED|Overall Study||67
174010|NCT00948090|420314|P2|COMPLETED|Overall Study||0
174011|NCT00948090|420315|P1|COMPLETED|Overall Study||22
174012|NCT00948090|420312|P4|STARTED|Overall Study||18
174013|NCT00948090|420313|P3|STARTED|Overall Study||123
174014|NCT00948090|420314|P2|STARTED|Overall Study||1
174015|NCT00948090|420315|P1|STARTED|Overall Study||65
174016|NCT00948064|420337|P3|NOT COMPLETED|Phase II||1
174017|NCT00948064|420338|P2|NOT COMPLETED|Phase II||1
174018|NCT00948064|420339|P1|NOT COMPLETED|Phase II||0
174019|NCT00948064|420337|P3|COMPLETED|Phase II||26
174020|NCT00948064|420338|P2|COMPLETED|Phase II||51
174021|NCT00948064|420339|P1|COMPLETED|Phase II||0
174022|NCT00948064|420337|P3|STARTED|Phase II||27
174023|NCT00948064|420338|P2|STARTED|Phase II||52
174024|NCT00948064|420339|P1|STARTED|Phase II||0
174025|NCT00948064|420337|P3|NOT COMPLETED|Phase I||0
174026|NCT00948064|420338|P2|NOT COMPLETED|Phase I||0
174027|NCT00948064|420339|P1|NOT COMPLETED|Phase I||1
174028|NCT00948064|420337|P3|COMPLETED|Phase I||0
174029|NCT00948064|420338|P2|COMPLETED|Phase I||0
174030|NCT00948064|420339|P1|COMPLETED|Phase I||30
174031|NCT00948064|420337|P3|STARTED|Phase I||0
174032|NCT00948064|420338|P2|STARTED|Phase I||0
174033|NCT00948064|420339|P1|STARTED|Phase I||31
174034|NCT00947882|420354|P4|NOT COMPLETED|Overall Study||82
174035|NCT00947882|420355|P3|NOT COMPLETED|Overall Study||79
174036|NCT00947882|420356|P2|NOT COMPLETED|Overall Study||77
174037|NCT00947882|420357|P1|NOT COMPLETED|Overall Study||74
174038|NCT00947882|420354|P4|COMPLETED|Overall Study||20
174039|NCT00947882|420355|P3|COMPLETED|Overall Study||22
174040|NCT00947882|420356|P2|COMPLETED|Overall Study||24
174041|NCT00947882|420357|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
174042|NCT00947882|420354|P4|Visit 12, Month 6|Overall Study||95
174043|NCT00947882|420355|P3|Visit 12, Month 6|Overall Study||90
174044|NCT00947882|420356|P2|Visit 12, Month 6|Overall Study||91
174045|NCT00947882|420357|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
174046|NCT00947882|420354|P4|Safety Analysis Set|Overall Study||105
174047|NCT00947882|420355|P3|Safety Analysis Set|Overall Study||100
174048|NCT00947882|420356|P2|Safety Analysis Set|Overall Study||101
174049|NCT00947882|420357|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
174050|NCT00947882|420354|P4|Actual Treatment|Overall Study||105
174051|NCT00947882|420355|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
174052|NCT00947882|420356|P2|Actual Treatment|Overall Study||101
174053|NCT00947882|420357|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
174054|NCT00947882|420354|P4|Full Analysis Set (FAS)|Overall Study||102
174055|NCT00947882|420355|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
174056|NCT00947882|420356|P2|Full Analysis Set (FAS)|Overall Study||101
174140|NCT00947505|420528|P1|COMPLETED|Overall Study||24
174057|NCT00947882|420357|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
174058|NCT00947882|420354|P4|STARTED|Overall Study||102
174059|NCT00947882|420355|P3|STARTED|Overall Study||101
174060|NCT00947882|420356|P2|STARTED|Overall Study||101
174061|NCT00947882|420357|P1|STARTED|Overall Study|Started: Randomised.|100
174062|NCT00947856|420385|P2|NOT COMPLETED|Follow-up Period||23
174063|NCT00947856|420386|P1|NOT COMPLETED|Follow-up Period||51
174064|NCT00947856|420385|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
174065|NCT00947856|420386|P1|COMPLETED|Follow-up Period||27
174066|NCT00947856|420385|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
174067|NCT00947856|420386|P1|STARTED|Follow-up Period||78
174068|NCT00947856|420385|P2|NOT COMPLETED|Treatment Period||32
174069|NCT00947856|420386|P1|NOT COMPLETED|Treatment Period||78
174070|NCT00947856|420385|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
174071|NCT00947856|420386|P1|COMPLETED|Treatment Period||0
174072|NCT00947856|420385|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
174073|NCT00947856|420386|P1|STARTED|Treatment Period||78
174074|NCT00947791|420415|P2|NOT COMPLETED|Overall Study||0
174075|NCT00947791|420416|P1|NOT COMPLETED|Overall Study||0
174076|NCT00947791|420415|P2|COMPLETED|Overall Study||1
174077|NCT00947791|420416|P1|COMPLETED|Overall Study||0
174078|NCT00947791|420415|P2|STARTED|Overall Study||1
174079|NCT00947791|420416|P1|STARTED|Overall Study||0
174080|NCT00947765|420434|P2|NOT COMPLETED|Overall Study||0
174081|NCT00947765|420435|P1|NOT COMPLETED|Overall Study||0
174082|NCT00947765|420434|P2|COMPLETED|Overall Study||30
174083|NCT00947765|420435|P1|COMPLETED|Overall Study||30
174084|NCT00947765|420434|P2|STARTED|Overall Study||30
174085|NCT00947765|420435|P1|STARTED|Overall Study||30
174086|NCT00947752|420457|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
174087|NCT00947752|420458|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
174088|NCT00947752|420457|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
174089|NCT00947752|420458|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
174090|NCT00947752|420457|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
174091|NCT00947752|420458|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
174092|NCT00947752|420457|P2|NOT COMPLETED|1st 14-day Treatment Period||0
174093|NCT00947752|420458|P1|NOT COMPLETED|1st 14-day Treatment Period||0
174094|NCT00947752|420457|P2|COMPLETED|1st 14-day Treatment Period||71
174095|NCT00947752|420458|P1|COMPLETED|1st 14-day Treatment Period||76
174096|NCT00947752|420457|P2|STARTED|1st 14-day Treatment Period||71
174097|NCT00947752|420458|P1|STARTED|1st 14-day Treatment Period||76
174098|NCT00947752|420457|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
174099|NCT00947752|420458|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
174100|NCT00947752|420457|P2|COMPLETED|7-Day Run-in Treatment Period||0
174101|NCT00947752|420458|P1|COMPLETED|7-Day Run-in Treatment Period||147
174102|NCT00947752|420457|P2|STARTED|7-Day Run-in Treatment Period||0
174103|NCT00947752|420458|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
174104|NCT00947661|420468|P2|NOT COMPLETED|Overall Study||15
174105|NCT00947661|420469|P1|NOT COMPLETED|Overall Study||13
174106|NCT00947661|420468|P2|COMPLETED|Overall Study||274
174107|NCT00947661|420469|P1|COMPLETED|Overall Study||276
174108|NCT00947661|420468|P2|STARTED|Overall Study||289
174109|NCT00947661|420469|P1|STARTED|Overall Study||289
174110|NCT00947544|420475|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
174111|NCT00947544|420476|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
174112|NCT00947544|420475|P2|COMPLETED|Safety-Extension Period (12 Months)||6
174113|NCT00947544|420476|P1|COMPLETED|Safety-Extension Period (12 Months)||10
174114|NCT00947544|420475|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
174115|NCT00947544|420476|P1|STARTED|Safety-Extension Period (12 Months)||11
174116|NCT00947544|420475|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
174117|NCT00947544|420476|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
174118|NCT00947544|420475|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
174119|NCT00947544|420476|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
174120|NCT00947544|420475|P2|STARTED|Switch-Over Period (2 Weeks)||0
174121|NCT00947544|420476|P1|STARTED|Switch-Over Period (2 Weeks)||11
174122|NCT00947531|420502|P2|NOT COMPLETED|Overall Study||11
174123|NCT00947531|420503|P1|NOT COMPLETED|Overall Study||14
174124|NCT00947531|420502|P2|COMPLETED|Overall Study||110
174125|NCT00947531|420503|P1|COMPLETED|Overall Study||107
174126|NCT00947531|420502|P2|STARTED|Overall Study||121
174127|NCT00947531|420503|P1|STARTED|Overall Study||121
174128|NCT00947518|420512|P3|NOT COMPLETED|Overall Study||0
174129|NCT00947518|420513|P2|NOT COMPLETED|Overall Study||0
174130|NCT00947518|420514|P1|NOT COMPLETED|Overall Study||0
174131|NCT00947518|420512|P3|COMPLETED|Overall Study||20
174132|NCT00947518|420513|P2|COMPLETED|Overall Study||20
174133|NCT00947518|420514|P1|COMPLETED|Overall Study||20
174134|NCT00947518|420512|P3|STARTED|Overall Study||20
174135|NCT00947518|420513|P2|STARTED|Overall Study||20
174136|NCT00947518|420514|P1|STARTED|Overall Study||20
174137|NCT00947505|420527|P2|NOT COMPLETED|Overall Study||2
174138|NCT00947505|420528|P1|NOT COMPLETED|Overall Study||9
174139|NCT00947505|420527|P2|COMPLETED|Overall Study||14
174141|NCT00947505|420527|P2|STARTED|Overall Study||16
174142|NCT00947505|420528|P1|STARTED|Overall Study||33
174143|NCT00947427|420536|P2|NOT COMPLETED|Overall Study||4
174144|NCT00947427|420537|P1|NOT COMPLETED|Overall Study||1
174145|NCT00947427|420536|P2|COMPLETED|Overall Study||45
174146|NCT00947427|420537|P1|COMPLETED|Overall Study||21
174147|NCT00947427|420536|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
174148|NCT00947427|420537|P1|STARTED|Overall Study||22
174149|NCT00947349|420547|P4|NOT COMPLETED|Overall Study Standard of Care||2
174150|NCT00947349|420548|P3|NOT COMPLETED|Overall Study Standard of Care||2
174151|NCT00947349|420549|P2|NOT COMPLETED|Overall Study Standard of Care||0
174152|NCT00947349|420550|P1|NOT COMPLETED|Overall Study Standard of Care||0
174153|NCT00947349|420547|P4|COMPLETED|Overall Study Standard of Care||4
174154|NCT00947349|420548|P3|COMPLETED|Overall Study Standard of Care||4
174155|NCT00947349|420549|P2|COMPLETED|Overall Study Standard of Care||5
174156|NCT00947349|420550|P1|COMPLETED|Overall Study Standard of Care||4
174157|NCT00947349|420547|P4|STARTED|Overall Study Standard of Care||6
174158|NCT00947349|420548|P3|STARTED|Overall Study Standard of Care||6
174159|NCT00947349|420549|P2|STARTED|Overall Study Standard of Care||5
174160|NCT00947349|420550|P1|STARTED|Overall Study Standard of Care||4
174161|NCT00947349|420547|P4|NOT COMPLETED|Triple Treatment Combination Period||0
174162|NCT00947349|420548|P3|NOT COMPLETED|Triple Treatment Combination Period||0
174163|NCT00947349|420549|P2|NOT COMPLETED|Triple Treatment Combination Period||1
174164|NCT00947349|420550|P1|NOT COMPLETED|Triple Treatment Combination Period||0
174165|NCT00947349|420547|P4|COMPLETED|Triple Treatment Combination Period||6
174166|NCT00947349|420548|P3|COMPLETED|Triple Treatment Combination Period||6
174167|NCT00947349|420549|P2|COMPLETED|Triple Treatment Combination Period||5
174168|NCT00947349|420550|P1|COMPLETED|Triple Treatment Combination Period||4
174169|NCT00947349|420547|P4|STARTED|Triple Treatment Combination Period||6
174170|NCT00947349|420548|P3|STARTED|Triple Treatment Combination Period||6
174171|NCT00947349|420549|P2|STARTED|Triple Treatment Combination Period||6
174172|NCT00947349|420550|P1|STARTED|Triple Treatment Combination Period||4
174173|NCT00947310|420685|P3|NOT COMPLETED|Overall Study||0
174174|NCT00947310|420686|P2|NOT COMPLETED|Overall Study||0
174175|NCT00947310|420687|P1|NOT COMPLETED|Overall Study||0
174176|NCT00947310|420685|P3|COMPLETED|Overall Study||486
174177|NCT00947310|420686|P2|COMPLETED|Overall Study||500
174178|NCT00947310|420687|P1|COMPLETED|Overall Study||514
174179|NCT00947310|420685|P3|STARTED|Overall Study||486
174180|NCT00947310|420686|P2|STARTED|Overall Study||500
174181|NCT00947310|420687|P1|STARTED|Overall Study||514
174182|NCT00947297|420701|P1|NOT COMPLETED|Overall Study||7
174183|NCT00947297|420701|P1|COMPLETED|Overall Study||53
174184|NCT00947297|420701|P1|STARTED|Overall Study||60
174185|NCT00947284|420708|P2|NOT COMPLETED|Overall Study||3
174186|NCT00947284|420709|P1|NOT COMPLETED|Overall Study||0
174187|NCT00947284|420708|P2|COMPLETED|Overall Study||0
174188|NCT00947284|420709|P1|COMPLETED|Overall Study||0
174189|NCT00947284|420708|P2|STARTED|Overall Study||3
174190|NCT00947284|420709|P1|STARTED|Overall Study||0
174191|NCT00947271|420717|P4|NOT COMPLETED|12 Months Post Intervention||62
174192|NCT00947271|420718|P3|NOT COMPLETED|12 Months Post Intervention||59
174193|NCT00947271|420719|P2|NOT COMPLETED|12 Months Post Intervention||60
174194|NCT00947271|420720|P1|NOT COMPLETED|12 Months Post Intervention||71
174195|NCT00947271|420717|P4|COMPLETED|12 Months Post Intervention||188
174196|NCT00947271|420718|P3|COMPLETED|12 Months Post Intervention||195
174197|NCT00947271|420719|P2|COMPLETED|12 Months Post Intervention||192
174198|NCT00947271|420720|P1|COMPLETED|12 Months Post Intervention||183
174199|NCT00947271|420717|P4|STARTED|12 Months Post Intervention||250
174200|NCT00947271|420718|P3|STARTED|12 Months Post Intervention||254
174201|NCT00947271|420719|P2|STARTED|12 Months Post Intervention||252
174202|NCT00947271|420720|P1|STARTED|12 Months Post Intervention||254
174203|NCT00947271|420717|P4|NOT COMPLETED|9 Months Post Intervention||59
174204|NCT00947271|420718|P3|NOT COMPLETED|9 Months Post Intervention||61
174205|NCT00947271|420719|P2|NOT COMPLETED|9 Months Post Intervention||60
174206|NCT00947271|420720|P1|NOT COMPLETED|9 Months Post Intervention||70
174207|NCT00947271|420717|P4|COMPLETED|9 Months Post Intervention||191
174208|NCT00947271|420718|P3|COMPLETED|9 Months Post Intervention||193
174209|NCT00947271|420719|P2|COMPLETED|9 Months Post Intervention||192
174210|NCT00947271|420720|P1|COMPLETED|9 Months Post Intervention||184
174211|NCT00947271|420717|P4|STARTED|9 Months Post Intervention||250
174212|NCT00947271|420718|P3|STARTED|9 Months Post Intervention||254
174213|NCT00947271|420719|P2|STARTED|9 Months Post Intervention||252
174214|NCT00947271|420720|P1|STARTED|9 Months Post Intervention||254
174215|NCT00947271|420717|P4|NOT COMPLETED|6 Months Post Intervention||54
174216|NCT00947271|420718|P3|NOT COMPLETED|6 Months Post Intervention||58
174217|NCT00947271|420719|P2|NOT COMPLETED|6 Months Post Intervention||53
174218|NCT00947271|420720|P1|NOT COMPLETED|6 Months Post Intervention||55
174219|NCT00947271|420717|P4|COMPLETED|6 Months Post Intervention||196
174220|NCT00947271|420718|P3|COMPLETED|6 Months Post Intervention||196
174221|NCT00947271|420719|P2|COMPLETED|6 Months Post Intervention||199
174222|NCT00947271|420720|P1|COMPLETED|6 Months Post Intervention||199
174223|NCT00947271|420717|P4|STARTED|6 Months Post Intervention||250
174224|NCT00947271|420718|P3|STARTED|6 Months Post Intervention||254
174225|NCT00947271|420719|P2|STARTED|6 Months Post Intervention||252
174226|NCT00947271|420720|P1|STARTED|6 Months Post Intervention||254
174227|NCT00947271|420717|P4|NOT COMPLETED|3 Months Post Intervention||44
174228|NCT00947271|420718|P3|NOT COMPLETED|3 Months Post Intervention||36
174229|NCT00947271|420719|P2|NOT COMPLETED|3 Months Post Intervention||48
174230|NCT00947271|420720|P1|NOT COMPLETED|3 Months Post Intervention||52
174231|NCT00947271|420717|P4|COMPLETED|3 Months Post Intervention||206
174232|NCT00947271|420718|P3|COMPLETED|3 Months Post Intervention||218
174233|NCT00947271|420719|P2|COMPLETED|3 Months Post Intervention||204
174234|NCT00947271|420720|P1|COMPLETED|3 Months Post Intervention||202
174235|NCT00947271|420717|P4|STARTED|3 Months Post Intervention||250
174236|NCT00947271|420718|P3|STARTED|3 Months Post Intervention||254
174237|NCT00947271|420719|P2|STARTED|3 Months Post Intervention||252
174238|NCT00947271|420720|P1|STARTED|3 Months Post Intervention||254
174239|NCT00947219|420749|P3|NOT COMPLETED|Overall Study||4
174240|NCT00947219|420750|P2|NOT COMPLETED|Overall Study||4
174241|NCT00947219|420751|P1|NOT COMPLETED|Overall Study||6
174242|NCT00947219|420749|P3|COMPLETED|Overall Study||22
174243|NCT00947219|420750|P2|COMPLETED|Overall Study||21
174244|NCT00947219|420751|P1|COMPLETED|Overall Study||22
174245|NCT00947219|420749|P3|STARTED|Overall Study||26
174246|NCT00947219|420750|P2|STARTED|Overall Study||25
174247|NCT00947219|420751|P1|STARTED|Overall Study||28
174248|NCT00947167|420759|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
174249|NCT00947167|420759|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
174250|NCT00947167|420759|P1|STARTED|Erlotinib Added to Pertuzumab||3
174251|NCT00947167|420759|P1|NOT COMPLETED|Pertuzumab Alone||0
174252|NCT00947167|420759|P1|COMPLETED|Pertuzumab Alone||4
174253|NCT00947167|420759|P1|STARTED|Pertuzumab Alone||4
174254|NCT00947154|420764|P1|NOT COMPLETED|Overall Study||1
174255|NCT00947154|420764|P1|COMPLETED|Overall Study||11
174256|NCT00947154|420764|P1|STARTED|Overall Study||12
174257|NCT00947115|420774|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
174258|NCT00947115|420775|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
174259|NCT00947115|420776|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
174260|NCT00947115|420774|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
174261|NCT00947115|420775|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
174262|NCT00947115|420776|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
174263|NCT00947115|420774|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
174264|NCT00947115|420775|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
174265|NCT00947115|420776|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
174266|NCT00947115|420774|P3|NOT COMPLETED|Year 10 (Month 120)||0
174267|NCT00947115|420775|P2|NOT COMPLETED|Year 10 (Month 120)||0
174268|NCT00947115|420776|P1|NOT COMPLETED|Year 10 (Month 120)||0
174269|NCT00947115|420774|P3|COMPLETED|Year 10 (Month 120)||156
174270|NCT00947115|420775|P2|COMPLETED|Year 10 (Month 120)||172
174271|NCT00947115|420776|P1|COMPLETED|Year 10 (Month 120)||142
174272|NCT00947115|420774|P3|STARTED|Year 10 (Month 120)||156
174273|NCT00947115|420775|P2|STARTED|Year 10 (Month 120)||172
174274|NCT00947115|420776|P1|STARTED|Year 10 (Month 120)||142
174275|NCT00947115|420774|P3|NOT COMPLETED|Year 9 (Month 108)||0
174276|NCT00947115|420775|P2|NOT COMPLETED|Year 9 (Month 108)||0
174277|NCT00947115|420776|P1|NOT COMPLETED|Year 9 (Month 108)||0
174278|NCT00947115|420774|P3|COMPLETED|Year 9 (Month 108)||157
174279|NCT00947115|420775|P2|COMPLETED|Year 9 (Month 108)||180
174280|NCT00947115|420776|P1|COMPLETED|Year 9 (Month 108)||146
174281|NCT00947115|420774|P3|STARTED|Year 9 (Month 108)||157
174282|NCT00947115|420775|P2|STARTED|Year 9 (Month 108)||180
174283|NCT00947115|420776|P1|STARTED|Year 9 (Month 108)||146
174284|NCT00947115|420774|P3|NOT COMPLETED|Year 8 (Month 96)||0
174285|NCT00947115|420775|P2|NOT COMPLETED|Year 8 (Month 96)||0
174286|NCT00947115|420776|P1|NOT COMPLETED|Year 8 (Month 96)||0
174287|NCT00947115|420774|P3|COMPLETED|Year 8 (Month 96)||141
174288|NCT00947115|420775|P2|COMPLETED|Year 8 (Month 96)||152
174289|NCT00947115|420776|P1|COMPLETED|Year 8 (Month 96)||137
174290|NCT00947115|420774|P3|STARTED|Year 8 (Month 96)||141
174291|NCT00947115|420775|P2|STARTED|Year 8 (Month 96)||152
174292|NCT00947115|420776|P1|STARTED|Year 8 (Month 96)||137
174293|NCT00947115|420774|P3|NOT COMPLETED|Year 7 (Month 84)||0
174294|NCT00947115|420775|P2|NOT COMPLETED|Year 7 (Month 84)||0
174295|NCT00947115|420776|P1|NOT COMPLETED|Year 7 (Month 84)||0
174296|NCT00947115|420774|P3|COMPLETED|Year 7 (Month 84)||160
174297|NCT00947115|420775|P2|COMPLETED|Year 7 (Month 84)||165
174298|NCT00947115|420776|P1|COMPLETED|Year 7 (Month 84)||149
174299|NCT00947115|420774|P3|STARTED|Year 7 (Month 84)||160
174300|NCT00947115|420775|P2|STARTED|Year 7 (Month 84)||165
174301|NCT00947115|420776|P1|STARTED|Year 7 (Month 84)||149
174302|NCT00947115|420774|P3|NOT COMPLETED|Year 6 (Month 72)||0
174303|NCT00947115|420775|P2|NOT COMPLETED|Year 6 (Month 72)||0
174304|NCT00947115|420776|P1|NOT COMPLETED|Year 6 (Month 72)||0
174305|NCT00947115|420774|P3|COMPLETED|Year 6 (Month 72)||164
174306|NCT00947115|420775|P2|COMPLETED|Year 6 (Month 72)||177
174307|NCT00947115|420776|P1|COMPLETED|Year 6 (Month 72)||147
174308|NCT00947115|420774|P3|STARTED|Year 6 (Month 72)||164
174309|NCT00947115|420775|P2|STARTED|Year 6 (Month 72)||177
174310|NCT00947115|420776|P1|STARTED|Year 6 (Month 72)||147
174311|NCT00947115|420774|P3|NOT COMPLETED|Year 5 (Month 60)||0
174312|NCT00947115|420775|P2|NOT COMPLETED|Year 5 (Month 60)||0
174313|NCT00947115|420776|P1|NOT COMPLETED|Year 5 (Month 60)||0
174314|NCT00947115|420774|P3|COMPLETED|Year 5 (Month 60)||170
174315|NCT00947115|420775|P2|COMPLETED|Year 5 (Month 60)||184
174316|NCT00947115|420776|P1|COMPLETED|Year 5 (Month 60)||153
174317|NCT00947115|420774|P3|STARTED|Year 5 (Month 60)||170
174318|NCT00947115|420775|P2|STARTED|Year 5 (Month 60)||184
174319|NCT00947115|420776|P1|STARTED|Year 5 (Month 60)||153
174320|NCT00947011|420838|P1|NOT COMPLETED|Overall Study||12
174321|NCT00947011|420838|P1|COMPLETED|Overall Study||0
174322|NCT00947011|420838|P1|STARTED|Overall Study||12
174323|NCT00946998|420848|P2|NOT COMPLETED|Overall Study||3
174324|NCT00946998|420849|P1|NOT COMPLETED|Overall Study||5
174325|NCT00946998|420848|P2|COMPLETED|Overall Study||96
174326|NCT00946998|420849|P1|COMPLETED|Overall Study||97
174327|NCT00946998|420848|P2|Received Treatment as Randomized|Overall Study||99
174328|NCT00946998|420849|P1|Received Treatment as Randomized|Overall Study||102
174329|NCT00946998|420848|P2|STARTED|Overall Study||99
174330|NCT00946998|420849|P1|STARTED|Overall Study||102
174331|NCT00946985|420863|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
174332|NCT00946985|420863|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
174333|NCT00946985|420863|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
174334|NCT00946985|420863|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
174335|NCT00946985|420863|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
174336|NCT00946985|420863|P1|STARTED|Stabilization Phase (25 Weeks)||162
174337|NCT00946920|420869|P2|NOT COMPLETED|Overall Study||44
174338|NCT00946920|420870|P1|NOT COMPLETED|Overall Study||110
174339|NCT00946920|420869|P2|COMPLETED|Overall Study||239
174340|NCT00946920|420870|P1|COMPLETED|Overall Study||455
174341|NCT00946920|420869|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
174342|NCT00946920|420870|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
174343|NCT00946920|420869|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
174344|NCT00946920|420870|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
174345|NCT00946881|420885|P1|NOT COMPLETED|Retreatment||1
174346|NCT00946881|420885|P1|COMPLETED|Retreatment||7
174347|NCT00946881|420885|P1|STARTED|Retreatment|This part concerns the number of patients who were retreated ,not the same number as previous period|8
174348|NCT00946881|420885|P1|NOT COMPLETED|First Treatment||2
174349|NCT00946881|420885|P1|COMPLETED|First Treatment||28
174350|NCT00946881|420885|P1|STARTED|First Treatment||30
174351|NCT00946530|420918|P4|NOT COMPLETED|Overall Study||4
174352|NCT00946530|420919|P3|NOT COMPLETED|Overall Study||1
174353|NCT00946530|420920|P2|NOT COMPLETED|Overall Study||4
174354|NCT00946530|420921|P1|NOT COMPLETED|Overall Study||1
174355|NCT00946530|420918|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
174356|NCT00946530|420919|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
174357|NCT00946530|420920|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
174358|NCT00946530|420921|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
174359|NCT00946530|420918|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
174360|NCT00946530|420919|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
174361|NCT00946530|420920|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
174362|NCT00946530|420921|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
174363|NCT00946478|420937|P2|NOT COMPLETED|Overall Study||0
174364|NCT00946478|420938|P1|NOT COMPLETED|Overall Study||0
174365|NCT00946478|420937|P2|COMPLETED|Overall Study||20
174366|NCT00946478|420938|P1|COMPLETED|Overall Study||20
174367|NCT00946478|420937|P2|STARTED|Overall Study||20
174368|NCT00946478|420938|P1|STARTED|Overall Study||20
174369|NCT00946348|420946|P2|NOT COMPLETED|Overall Study||0
174370|NCT00946348|420947|P1|NOT COMPLETED|Overall Study||0
174371|NCT00946348|420946|P2|COMPLETED|Overall Study||6
174372|NCT00946348|420947|P1|COMPLETED|Overall Study||6
174373|NCT00946348|420946|P2|STARTED|Overall Study||6
174374|NCT00946348|420947|P1|STARTED|Overall Study||6
174375|NCT00946322|420953|P1|NOT COMPLETED|Post-treatment||2
174376|NCT00946322|420953|P1|COMPLETED|Post-treatment||9
174377|NCT00946322|420953|P1|STARTED|Post-treatment||11
174378|NCT00946322|420953|P1|NOT COMPLETED|Pre-treatment||1
174379|NCT00946322|420953|P1|COMPLETED|Pre-treatment||11
174380|NCT00946322|420953|P1|STARTED|Pre-treatment||12
174381|NCT00946309|420966|P2|NOT COMPLETED|Overall Study||4
174382|NCT00946309|420967|P1|NOT COMPLETED|Overall Study||1
174383|NCT00946309|420966|P2|COMPLETED|Overall Study||19
174384|NCT00946309|420967|P1|COMPLETED|Overall Study||21
174385|NCT00946309|420966|P2|STARTED|Overall Study||23
174386|NCT00946309|420967|P1|STARTED|Overall Study||22
174387|NCT00946296|420985|P2|NOT COMPLETED|Overall Study||0
174388|NCT00946296|420986|P1|NOT COMPLETED|Overall Study||3
174389|NCT00946296|420985|P2|COMPLETED|Overall Study||15
174390|NCT00946296|420986|P1|COMPLETED|Overall Study||18
174391|NCT00946296|420985|P2|STARTED|Overall Study||15
174392|NCT00946296|420986|P1|STARTED|Overall Study||21
174393|NCT00946114|420994|P2|NOT COMPLETED|Overall Study||2
174394|NCT00946114|420995|P1|NOT COMPLETED|Overall Study||8
174395|NCT00946114|420994|P2|COMPLETED|Overall Study||10
174396|NCT00946114|420995|P1|COMPLETED|Overall Study||12
174397|NCT00946114|420994|P2|STARTED|Overall Study||12
174398|NCT00946114|420995|P1|STARTED|Overall Study||20
174399|NCT00946101|421003|P2|NOT COMPLETED|Overall Study||2
174400|NCT00946101|421004|P1|NOT COMPLETED|Overall Study||4
174401|NCT00946101|421003|P2|COMPLETED|Overall Study||63
174402|NCT00946101|421004|P1|COMPLETED|Overall Study||257
174403|NCT00946101|421003|P2|Day 15 Post Dose 2|Overall Study||63
174404|NCT00946101|421004|P1|Day 15 Post Dose 2|Overall Study||254
174405|NCT00946101|421003|P2|Day 15 Post Dose 1|Overall Study||64
174406|NCT00946101|421004|P1|Day 15 Post Dose 1|Overall Study||260
174407|NCT00946101|421003|P2|STARTED|Overall Study||65
174408|NCT00946101|421004|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
174409|NCT00946088|421070|P2|NOT COMPLETED|Overall Study||1
174410|NCT00946088|421071|P1|NOT COMPLETED|Overall Study||0
174411|NCT00946088|421070|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
174412|NCT00946088|421071|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
174413|NCT00946088|421070|P2|STARTED|Overall Study||3
174414|NCT00946088|421071|P1|STARTED|Overall Study||4
174415|NCT00945958|421093|P1|NOT COMPLETED|Overall Study||12
174416|NCT00945958|421093|P1|COMPLETED|Overall Study||149
174417|NCT00945958|421093|P1|STARTED|Overall Study||161
174418|NCT00945945|421100|P2|NOT COMPLETED|Overall Study||55
174419|NCT00945945|421101|P1|NOT COMPLETED|Overall Study||36
174420|NCT00945945|421100|P2|COMPLETED|Overall Study||162
174421|NCT00945945|421101|P1|COMPLETED|Overall Study||171
174422|NCT00945945|421100|P2|STARTED|Overall Study||217
174423|NCT00945945|421101|P1|STARTED|Overall Study||207
174424|NCT00945906|421127|P1|NOT COMPLETED|Overall Study||7
174425|NCT00945906|421127|P1|COMPLETED|Overall Study||54
174426|NCT00945906|421127|P1|STARTED|Overall Study||61
174427|NCT00945893|421138|P2|NOT COMPLETED|Overall Study||10
174428|NCT00945893|421139|P1|NOT COMPLETED|Overall Study||3
174429|NCT00945893|421138|P2|COMPLETED|Overall Study||230
174430|NCT00945893|421139|P1|COMPLETED|Overall Study||57
174431|NCT00945893|421138|P2|Day 15 Post Dose 2|Overall Study||226
174432|NCT00945893|421139|P1|Day 15 Post Dose 2|Overall Study||54
174433|NCT00945893|421138|P2|Day 15 Post Dose 1|Overall Study||238
174434|NCT00945893|421139|P1|Day 15 Post Dose 1|Overall Study||60
174435|NCT00945893|421138|P2|STARTED|Overall Study||240
174436|NCT00945893|421139|P1|STARTED|Overall Study||60
174437|NCT00945854|421205|P2|NOT COMPLETED|Overall Study||4
174438|NCT00945854|421206|P1|NOT COMPLETED|Overall Study||2
174439|NCT00945854|421205|P2|COMPLETED|Overall Study||26
174440|NCT00945854|421206|P1|COMPLETED|Overall Study||28
174441|NCT00945854|421205|P2|STARTED|Overall Study||30
174442|NCT00945854|421206|P1|STARTED|Overall Study||30
174443|NCT00945815|421216|P1|NOT COMPLETED|Overall Study||8
174444|NCT00945815|421216|P1|COMPLETED|Overall Study||27
174445|NCT00945815|421216|P1|Eligible and Began Protocol Therapy|Overall Study||31
174446|NCT00945815|421216|P1|Eligible|Overall Study||32
174447|NCT00945815|421216|P1|STARTED|Overall Study||35
174448|NCT00945750|421227|P6|NOT COMPLETED|Period III||0
174449|NCT00945750|421228|P5|NOT COMPLETED|Period III||0
174450|NCT00945750|421229|P4|NOT COMPLETED|Period III||0
174451|NCT00945750|421230|P3|NOT COMPLETED|Period III||0
174452|NCT00945750|421231|P2|NOT COMPLETED|Period III||0
174453|NCT00945750|421232|P1|NOT COMPLETED|Period III||0
174454|NCT00945750|421227|P6|COMPLETED|Period III||5
174455|NCT00945750|421228|P5|COMPLETED|Period III||5
174456|NCT00945750|421229|P4|COMPLETED|Period III||5
174457|NCT00945750|421230|P3|COMPLETED|Period III||5
174458|NCT00945750|421231|P2|COMPLETED|Period III||5
174459|NCT00945750|421232|P1|COMPLETED|Period III||5
174460|NCT00945750|421227|P6|STARTED|Period III||5
174461|NCT00945750|421228|P5|STARTED|Period III||5
174462|NCT00945750|421229|P4|STARTED|Period III||5
174463|NCT00945750|421230|P3|STARTED|Period III||5
174464|NCT00945750|421231|P2|STARTED|Period III||5
174465|NCT00945750|421232|P1|STARTED|Period III||5
174466|NCT00945750|421227|P6|NOT COMPLETED|Period II||0
174467|NCT00945750|421228|P5|NOT COMPLETED|Period II||0
174468|NCT00945750|421229|P4|NOT COMPLETED|Period II||0
174469|NCT00945750|421230|P3|NOT COMPLETED|Period II||0
174470|NCT00945750|421231|P2|NOT COMPLETED|Period II||0
174471|NCT00945750|421232|P1|NOT COMPLETED|Period II||0
174472|NCT00945750|421227|P6|COMPLETED|Period II||5
174473|NCT00945750|421228|P5|COMPLETED|Period II||5
174474|NCT00945750|421229|P4|COMPLETED|Period II||5
174475|NCT00945750|421230|P3|COMPLETED|Period II||5
174476|NCT00945750|421231|P2|COMPLETED|Period II||5
174477|NCT00945750|421232|P1|COMPLETED|Period II||5
174478|NCT00945750|421227|P6|STARTED|Period II||5
174479|NCT00945750|421228|P5|STARTED|Period II||5
174480|NCT00945750|421229|P4|STARTED|Period II||5
174481|NCT00945750|421230|P3|STARTED|Period II||5
174482|NCT00945750|421231|P2|STARTED|Period II||5
174483|NCT00945750|421232|P1|STARTED|Period II||5
174484|NCT00945750|421227|P6|NOT COMPLETED|Period I||0
174485|NCT00945750|421228|P5|NOT COMPLETED|Period I||0
174486|NCT00945750|421229|P4|NOT COMPLETED|Period I||0
174487|NCT00945750|421230|P3|NOT COMPLETED|Period I||0
174488|NCT00945750|421231|P2|NOT COMPLETED|Period I||0
174489|NCT00945750|421232|P1|NOT COMPLETED|Period I||0
174490|NCT00945750|421227|P6|COMPLETED|Period I||5
174491|NCT00945750|421228|P5|COMPLETED|Period I||5
174492|NCT00945750|421229|P4|COMPLETED|Period I||5
174493|NCT00945750|421230|P3|COMPLETED|Period I||5
174494|NCT00945750|421231|P2|COMPLETED|Period I||5
174495|NCT00945750|421232|P1|COMPLETED|Period I||5
174496|NCT00945750|421227|P6|STARTED|Period I||5
174497|NCT00945750|421228|P5|STARTED|Period I||5
174498|NCT00945750|421229|P4|STARTED|Period I||5
174499|NCT00945750|421230|P3|STARTED|Period I||5
174500|NCT00945750|421231|P2|STARTED|Period I||5
174501|NCT00945750|421232|P1|STARTED|Period I||5
174502|NCT00945555|421245|P1|NOT COMPLETED|Overall Study||28
174503|NCT00945555|421245|P1|COMPLETED|Overall Study||236
174504|NCT00945555|421245|P1|STARTED|Overall Study||264
174505|NCT00945477|421256|P1|NOT COMPLETED|Overall Study||6
174506|NCT00945477|421256|P1|COMPLETED|Overall Study||5
174507|NCT00945477|421256|P1|STARTED|Overall Study||11
174508|NCT00945334|421263|P2|NOT COMPLETED|Overall Study||3
174509|NCT00945334|421264|P1|NOT COMPLETED|Overall Study||3
174510|NCT00945334|421263|P2|COMPLETED|Overall Study||15
174511|NCT00945334|421264|P1|COMPLETED|Overall Study||16
174512|NCT00945334|421263|P2|STARTED|Overall Study||18
174513|NCT00945334|421264|P1|STARTED|Overall Study||19
174514|NCT00945321|421272|P6|NOT COMPLETED|Period 4||1
174515|NCT00945321|421273|P5|NOT COMPLETED|Period 4||0
174516|NCT00945321|421274|P4|NOT COMPLETED|Period 4||0
174517|NCT00945321|421275|P3|NOT COMPLETED|Period 4||0
174518|NCT00945321|421276|P2|NOT COMPLETED|Period 4||0
174519|NCT00945321|421277|P1|NOT COMPLETED|Period 4||0
174520|NCT00945321|421272|P6|COMPLETED|Period 4||6
174521|NCT00945321|421273|P5|COMPLETED|Period 4||6
174522|NCT00945321|421274|P4|COMPLETED|Period 4||7
174523|NCT00945321|421275|P3|COMPLETED|Period 4||7
174524|NCT00945321|421276|P2|COMPLETED|Period 4||7
174525|NCT00945321|421277|P1|COMPLETED|Period 4||7
174526|NCT00945321|421272|P6|STARTED|Period 4||7
174527|NCT00945321|421273|P5|STARTED|Period 4||6
174528|NCT00945321|421274|P4|STARTED|Period 4||7
174529|NCT00945321|421275|P3|STARTED|Period 4||7
174530|NCT00945321|421276|P2|STARTED|Period 4||7
174531|NCT00945321|421277|P1|STARTED|Period 4||7
174532|NCT00945321|421272|P6|NOT COMPLETED|Period 3||0
174533|NCT00945321|421273|P5|NOT COMPLETED|Period 3||0
174534|NCT00945321|421274|P4|NOT COMPLETED|Period 3||0
174535|NCT00945321|421275|P3|NOT COMPLETED|Period 3||0
174536|NCT00945321|421276|P2|NOT COMPLETED|Period 3||0
174537|NCT00945321|421277|P1|NOT COMPLETED|Period 3||0
174538|NCT00945321|421272|P6|COMPLETED|Period 3||7
174539|NCT00945321|421273|P5|COMPLETED|Period 3||6
174540|NCT00945321|421274|P4|COMPLETED|Period 3||7
174541|NCT00945321|421275|P3|COMPLETED|Period 3||7
174542|NCT00945321|421276|P2|COMPLETED|Period 3||7
174543|NCT00945321|421277|P1|COMPLETED|Period 3||7
174544|NCT00945321|421272|P6|STARTED|Period 3||7
174545|NCT00945321|421273|P5|STARTED|Period 3||6
174546|NCT00945321|421274|P4|STARTED|Period 3||7
174547|NCT00945321|421275|P3|STARTED|Period 3||7
174548|NCT00945321|421276|P2|STARTED|Period 3||7
174549|NCT00945321|421277|P1|STARTED|Period 3||7
174550|NCT00945321|421272|P6|NOT COMPLETED|Period 2||0
174551|NCT00945321|421273|P5|NOT COMPLETED|Period 2||0
174552|NCT00945321|421274|P4|NOT COMPLETED|Period 2||0
174553|NCT00945321|421275|P3|NOT COMPLETED|Period 2||0
174554|NCT00945321|421276|P2|NOT COMPLETED|Period 2||0
174555|NCT00945321|421277|P1|NOT COMPLETED|Period 2||0
174556|NCT00945321|421272|P6|COMPLETED|Period 2||7
174557|NCT00945321|421273|P5|COMPLETED|Period 2||6
174558|NCT00945321|421274|P4|COMPLETED|Period 2||7
174559|NCT00945321|421275|P3|COMPLETED|Period 2||7
174560|NCT00945321|421276|P2|COMPLETED|Period 2||7
174561|NCT00945321|421277|P1|COMPLETED|Period 2||7
174562|NCT00945321|421272|P6|STARTED|Period 2||7
174563|NCT00945321|421273|P5|STARTED|Period 2||6
174564|NCT00945321|421274|P4|STARTED|Period 2||7
174565|NCT00945321|421275|P3|STARTED|Period 2||7
174566|NCT00945321|421276|P2|STARTED|Period 2||7
174567|NCT00945321|421277|P1|STARTED|Period 2||7
174568|NCT00945321|421272|P6|NOT COMPLETED|Period 1||0
174569|NCT00945321|421273|P5|NOT COMPLETED|Period 1||1
174570|NCT00945321|421274|P4|NOT COMPLETED|Period 1||0
174571|NCT00945321|421275|P3|NOT COMPLETED|Period 1||0
174572|NCT00945321|421276|P2|NOT COMPLETED|Period 1||0
174573|NCT00945321|421277|P1|NOT COMPLETED|Period 1||0
174574|NCT00945321|421272|P6|COMPLETED|Period 1||7
174575|NCT00945321|421273|P5|COMPLETED|Period 1||6
174576|NCT00945321|421274|P4|COMPLETED|Period 1||7
174577|NCT00945321|421275|P3|COMPLETED|Period 1||7
174578|NCT00945321|421276|P2|COMPLETED|Period 1||7
174579|NCT00945321|421277|P1|COMPLETED|Period 1||7
174580|NCT00945321|421272|P6|STARTED|Period 1||7
174581|NCT00945321|421273|P5|STARTED|Period 1||7
174582|NCT00945321|421274|P4|STARTED|Period 1||7
174583|NCT00945321|421275|P3|STARTED|Period 1||7
174584|NCT00945321|421276|P2|STARTED|Period 1||7
174585|NCT00945321|421277|P1|STARTED|Period 1||7
174586|NCT00945295|421299|P2|NOT COMPLETED|Overall Study||2
174587|NCT00945295|421300|P1|NOT COMPLETED|Overall Study||0
174588|NCT00945295|421299|P2|COMPLETED|Overall Study||14
174589|NCT00945295|421300|P1|COMPLETED|Overall Study||15
174590|NCT00945295|421299|P2|STARTED|Overall Study||16
174591|NCT00945295|421300|P1|STARTED|Overall Study||15
174592|NCT00945256|421313|P5|NOT COMPLETED|Overall Study||1
174593|NCT00945256|421314|P4|NOT COMPLETED|Overall Study||9
174594|NCT00945256|421315|P3|NOT COMPLETED|Overall Study||8
174595|NCT00945256|421316|P2|NOT COMPLETED|Overall Study||2
174596|NCT00945256|421317|P1|NOT COMPLETED|Overall Study||4
174597|NCT00945256|421313|P5|COMPLETED|Overall Study||7
174598|NCT00945256|421314|P4|COMPLETED|Overall Study||7
174599|NCT00945256|421315|P3|COMPLETED|Overall Study||7
174600|NCT00945256|421316|P2|COMPLETED|Overall Study||8
174601|NCT00945256|421317|P1|COMPLETED|Overall Study||9
174602|NCT00945256|421313|P5|STARTED|Overall Study||8
174603|NCT00945256|421314|P4|STARTED|Overall Study||16
174604|NCT00945256|421315|P3|STARTED|Overall Study||15
174605|NCT00945256|421316|P2|STARTED|Overall Study||10
174606|NCT00945256|421317|P1|STARTED|Overall Study||13
174607|NCT00945243|421329|P1|NOT COMPLETED|Overall Study||3
174608|NCT00945243|421329|P1|COMPLETED|Overall Study||8
174609|NCT00945243|421329|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
174610|NCT00945139|421335|P1|NOT COMPLETED|Overall Study||0
174611|NCT00945139|421335|P1|COMPLETED|Overall Study||46
174612|NCT00945139|421335|P1|STARTED|Overall Study||46
174613|NCT00945100|421346|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
174614|NCT00945100|421347|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
174615|NCT00945100|421346|P2|COMPLETED|Post-10 Week Primary Outcome||56
174616|NCT00945100|421347|P1|COMPLETED|Post-10 Week Primary Outcome||51
174617|NCT00945100|421346|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
174618|NCT00945100|421347|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
174619|NCT00945100|421346|P2|NOT COMPLETED|10-week Primary Outcome||3
174620|NCT00945100|421347|P1|NOT COMPLETED|10-week Primary Outcome||1
174621|NCT00945100|421346|P2|COMPLETED|10-week Primary Outcome||83
174622|NCT00945100|421347|P1|COMPLETED|10-week Primary Outcome||82
174623|NCT00945100|421346|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
174624|NCT00945100|421347|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
174625|NCT00945100|421346|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
174626|NCT00945100|421347|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
174627|NCT00945100|421346|P2|STARTED|10-week Primary Outcome||86
174628|NCT00945100|421347|P1|STARTED|10-week Primary Outcome||83
174629|NCT00945035|421411|P2|NOT COMPLETED|Period 2||0
174630|NCT00945035|421412|P1|NOT COMPLETED|Period 2||0
174631|NCT00945035|421411|P2|COMPLETED|Period 2||18
174632|NCT00945035|421412|P1|COMPLETED|Period 2||18
174633|NCT00945035|421411|P2|STARTED|Period 2||18
174634|NCT00945035|421412|P1|STARTED|Period 2||18
174635|NCT00945035|421411|P2|NOT COMPLETED|Period 1||0
174636|NCT00945035|421412|P1|NOT COMPLETED|Period 1||0
174637|NCT00945035|421411|P2|COMPLETED|Period 1||18
174638|NCT00945035|421412|P1|COMPLETED|Period 1||18
174639|NCT00945035|421411|P2|STARTED|Period 1||18
174640|NCT00945035|421412|P1|STARTED|Period 1||18
174641|NCT00944749|421420|P1|NOT COMPLETED|Overall Study||1
174642|NCT00944749|421420|P1|COMPLETED|Overall Study||22
174643|NCT00944749|421420|P1|STARTED|Overall Study||23
174644|NCT00944710|421427|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
174645|NCT00944710|421428|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
174646|NCT00944710|421427|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
174647|NCT00944710|421428|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
174648|NCT00944710|421427|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
174649|NCT00944710|421428|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
174650|NCT00944710|421427|P2|STARTED|Additional Post 10-week Primary Outcome||33
174651|NCT00944710|421428|P1|STARTED|Additional Post 10-week Primary Outcome||40
174652|NCT00944710|421427|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
174653|NCT00944710|421428|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
174654|NCT00944710|421427|P2|COMPLETED|12-week Visit (Off-treatment)||33
174655|NCT00944710|421428|P1|COMPLETED|12-week Visit (Off-treatment)||40
174656|NCT00944710|421427|P2|STARTED|12-week Visit (Off-treatment)||33
174657|NCT00944710|421428|P1|STARTED|12-week Visit (Off-treatment)||40
174658|NCT00944710|421427|P2|NOT COMPLETED|10-week Primary Outcome||0
174659|NCT00944710|421428|P1|NOT COMPLETED|10-week Primary Outcome||0
174660|NCT00944710|421427|P2|COMPLETED|10-week Primary Outcome||33
174661|NCT00944710|421428|P1|COMPLETED|10-week Primary Outcome||40
174662|NCT00944710|421427|P2|STARTED|10-week Primary Outcome||33
174663|NCT00944710|421428|P1|STARTED|10-week Primary Outcome||40
174664|NCT00944697|421486|P2|NOT COMPLETED|Overall Study||5
174665|NCT00944697|421487|P1|NOT COMPLETED|Overall Study||2
174666|NCT00944697|421486|P2|COMPLETED|Overall Study||43
174667|NCT00944697|421487|P1|COMPLETED|Overall Study||48
174668|NCT00944697|421486|P2|STARTED|Overall Study||48
174669|NCT00944697|421487|P1|STARTED|Overall Study||50
174670|NCT00944671|421499|P6|NOT COMPLETED|Period III||0
174671|NCT00944671|421500|P5|NOT COMPLETED|Period III||0
174672|NCT00944671|421501|P4|NOT COMPLETED|Period III||0
174673|NCT00944671|421502|P3|NOT COMPLETED|Period III||0
174674|NCT00944671|421503|P2|NOT COMPLETED|Period III||0
174675|NCT00944671|421504|P1|NOT COMPLETED|Period III||0
174676|NCT00944671|421499|P6|COMPLETED|Period III||4
174677|NCT00944671|421500|P5|COMPLETED|Period III||4
174678|NCT00944671|421501|P4|COMPLETED|Period III||4
174679|NCT00944671|421502|P3|COMPLETED|Period III||4
174680|NCT00944671|421503|P2|COMPLETED|Period III||4
174681|NCT00944671|421504|P1|COMPLETED|Period III||4
174682|NCT00944671|421499|P6|STARTED|Period III||4
174683|NCT00944671|421500|P5|STARTED|Period III||4
174684|NCT00944671|421501|P4|STARTED|Period III||4
174685|NCT00944671|421502|P3|STARTED|Period III||4
174686|NCT00944671|421503|P2|STARTED|Period III||4
174687|NCT00944671|421504|P1|STARTED|Period III||4
174688|NCT00944671|421499|P6|NOT COMPLETED|Period II||0
174689|NCT00944671|421500|P5|NOT COMPLETED|Period II||0
174690|NCT00944671|421501|P4|NOT COMPLETED|Period II||0
174691|NCT00944671|421502|P3|NOT COMPLETED|Period II||0
174692|NCT00944671|421503|P2|NOT COMPLETED|Period II||0
174693|NCT00944671|421504|P1|NOT COMPLETED|Period II||0
174694|NCT00944671|421499|P6|COMPLETED|Period II||4
174695|NCT00944671|421500|P5|COMPLETED|Period II||4
174696|NCT00944671|421501|P4|COMPLETED|Period II||4
174697|NCT00944671|421502|P3|COMPLETED|Period II||4
174698|NCT00944671|421503|P2|COMPLETED|Period II||4
174699|NCT00944671|421504|P1|COMPLETED|Period II||4
174700|NCT00944671|421499|P6|STARTED|Period II||4
174701|NCT00944671|421500|P5|STARTED|Period II||4
174702|NCT00944671|421501|P4|STARTED|Period II||4
174703|NCT00944671|421502|P3|STARTED|Period II||4
174704|NCT00944671|421503|P2|STARTED|Period II||4
174705|NCT00944671|421504|P1|STARTED|Period II||4
174706|NCT00944671|421499|P6|NOT COMPLETED|Period I||0
174707|NCT00944671|421500|P5|NOT COMPLETED|Period I||0
174708|NCT00944671|421501|P4|NOT COMPLETED|Period I||0
174709|NCT00944671|421502|P3|NOT COMPLETED|Period I||0
174710|NCT00944671|421503|P2|NOT COMPLETED|Period I||0
174711|NCT00944671|421504|P1|NOT COMPLETED|Period I||0
174712|NCT00944671|421499|P6|COMPLETED|Period I||4
174713|NCT00944671|421500|P5|COMPLETED|Period I||4
174714|NCT00944671|421501|P4|COMPLETED|Period I||4
174715|NCT00944671|421502|P3|COMPLETED|Period I||4
174716|NCT00944671|421503|P2|COMPLETED|Period I||4
174717|NCT00944671|421504|P1|COMPLETED|Period I||4
174718|NCT00944671|421499|P6|STARTED|Period I||4
174719|NCT00944671|421500|P5|STARTED|Period I||4
174720|NCT00944671|421501|P4|STARTED|Period I||4
174721|NCT00944671|421502|P3|STARTED|Period I||4
174722|NCT00944671|421503|P2|STARTED|Period I||4
174723|NCT00944671|421504|P1|STARTED|Period I||4
174724|NCT00944645|421517|P2|NOT COMPLETED|Period 2||9
174725|NCT00944645|421518|P1|NOT COMPLETED|Period 2||8
174726|NCT00944645|421517|P2|COMPLETED|Period 2||85
174727|NCT00944645|421518|P1|COMPLETED|Period 2||86
174728|NCT00944645|421517|P2|STARTED|Period 2||94
174729|NCT00944645|421518|P1|STARTED|Period 2||94
174730|NCT00944645|421517|P2|NOT COMPLETED|Period 1||0
174731|NCT00944645|421518|P1|NOT COMPLETED|Period 1||0
174732|NCT00944645|421517|P2|COMPLETED|Period 1||94
174733|NCT00944645|421518|P1|COMPLETED|Period 1||94
174734|NCT00944645|421517|P2|STARTED|Period 1||94
174735|NCT00944645|421518|P1|STARTED|Period 1||94
174736|NCT00944554|421532|P2|NOT COMPLETED|Overall Study||29
174737|NCT00944554|421533|P1|NOT COMPLETED|Overall Study||28
174738|NCT00944554|421532|P2|COMPLETED|Overall Study||25
174739|NCT00944554|421533|P1|COMPLETED|Overall Study||22
174740|NCT00944554|421532|P2|STARTED|Overall Study||54
174741|NCT00944554|421533|P1|STARTED|Overall Study||50
174742|NCT00944450|421539|P2|NOT COMPLETED|Period 2||0
174743|NCT00944450|421540|P1|NOT COMPLETED|Period 2||0
174744|NCT00944450|421539|P2|COMPLETED|Period 2||6
174745|NCT00944450|421540|P1|COMPLETED|Period 2||6
174746|NCT00944450|421539|P2|STARTED|Period 2||6
174747|NCT00944450|421540|P1|STARTED|Period 2||6
174748|NCT00944450|421539|P2|NOT COMPLETED|Period 1||0
174749|NCT00944450|421540|P1|NOT COMPLETED|Period 1||0
174750|NCT00944450|421539|P2|COMPLETED|Period 1||6
174751|NCT00944450|421540|P1|COMPLETED|Period 1||6
174752|NCT00944450|421539|P2|STARTED|Period 1||6
174753|NCT00944450|421540|P1|STARTED|Period 1||6
174754|NCT00944229|421548|P1|NOT COMPLETED|Overall Study||25
174755|NCT00944229|421548|P1|COMPLETED|Overall Study||33
174756|NCT00944229|421548|P1|STARTED|Overall Study||58
174757|NCT00944125|421554|P2|NOT COMPLETED|6 Months to Study Completion||2
174758|NCT00944125|421555|P1|NOT COMPLETED|6 Months to Study Completion||0
174759|NCT00944125|421554|P2|COMPLETED|6 Months to Study Completion||18
174760|NCT00944125|421555|P1|COMPLETED|6 Months to Study Completion||19
174761|NCT00944125|421554|P2|STARTED|6 Months to Study Completion||20
174762|NCT00944125|421555|P1|STARTED|6 Months to Study Completion||19
174763|NCT00944125|421554|P2|NOT COMPLETED|3 to 6 Months||2
174764|NCT00944125|421555|P1|NOT COMPLETED|3 to 6 Months||0
174765|NCT00944125|421554|P2|COMPLETED|3 to 6 Months||20
174766|NCT00944125|421555|P1|COMPLETED|3 to 6 Months||19
174767|NCT00944125|421554|P2|STARTED|3 to 6 Months||22
174768|NCT00944125|421555|P1|STARTED|3 to 6 Months||19
174769|NCT00944125|421554|P2|NOT COMPLETED|Baseline to 3 Months||0
174770|NCT00944125|421555|P1|NOT COMPLETED|Baseline to 3 Months||0
174771|NCT00944125|421554|P2|COMPLETED|Baseline to 3 Months||22
174772|NCT00944125|421555|P1|COMPLETED|Baseline to 3 Months||19
174773|NCT00944125|421554|P2|STARTED|Baseline to 3 Months||22
174774|NCT00944125|421555|P1|STARTED|Baseline to 3 Months||19
174775|NCT00944073|421563|P2|NOT COMPLETED|Overall Study||4
174776|NCT00944073|421564|P1|NOT COMPLETED|Overall Study||5
174777|NCT00944073|421563|P2|COMPLETED|Overall Study||287
174778|NCT00944073|421564|P1|COMPLETED|Overall Study||287
174779|NCT00944073|421563|P2|STARTED|Overall Study||291
174780|NCT00944073|421564|P1|STARTED|Overall Study||292
174781|NCT00944047|421642|P1|NOT COMPLETED|Overall Study||5
174782|NCT00944047|421642|P1|COMPLETED|Overall Study||27
174783|NCT00944047|421642|P1|STARTED|Overall Study||32
174784|NCT00944034|421658|P12|NOT COMPLETED|Overall Study||4
174785|NCT00944034|421659|P11|NOT COMPLETED|Overall Study||1
174786|NCT00944034|421660|P10|NOT COMPLETED|Overall Study||10
174787|NCT00944034|421661|P9|NOT COMPLETED|Overall Study||10
174788|NCT00944034|421662|P8|NOT COMPLETED|Overall Study||5
174789|NCT00944034|421663|P7|NOT COMPLETED|Overall Study||4
174790|NCT00944034|421664|P6|NOT COMPLETED|Overall Study||20
174791|NCT00944034|421665|P5|NOT COMPLETED|Overall Study||14
174792|NCT00944034|421666|P4|NOT COMPLETED|Overall Study||4
174793|NCT00944034|421667|P3|NOT COMPLETED|Overall Study||9
174794|NCT00944034|421668|P2|NOT COMPLETED|Overall Study||7
174795|NCT00944034|421669|P1|NOT COMPLETED|Overall Study||5
174796|NCT00944034|421658|P12|COMPLETED|Overall Study||52
174797|NCT00944034|421659|P11|COMPLETED|Overall Study||50
174798|NCT00944034|421660|P10|COMPLETED|Overall Study||236
174799|NCT00944034|421661|P9|COMPLETED|Overall Study||63
174800|NCT00944034|421662|P8|COMPLETED|Overall Study||73
174801|NCT00944034|421663|P7|COMPLETED|Overall Study||102
174802|NCT00944034|421664|P6|COMPLETED|Overall Study||123
174803|NCT00944034|421665|P5|COMPLETED|Overall Study||150
174804|NCT00944034|421666|P4|COMPLETED|Overall Study||170
174805|NCT00944034|421667|P3|COMPLETED|Overall Study||143
174806|NCT00944034|421668|P2|COMPLETED|Overall Study||150
174807|NCT00944034|421669|P1|COMPLETED|Overall Study||183
174808|NCT00944034|421658|P12|STARTED|Overall Study||56
174809|NCT00944034|421659|P11|STARTED|Overall Study||51
174810|NCT00944034|421660|P10|STARTED|Overall Study||246
174811|NCT00944034|421661|P9|STARTED|Overall Study||73
174812|NCT00944034|421662|P8|STARTED|Overall Study||78
174813|NCT00944034|421663|P7|STARTED|Overall Study||106
174814|NCT00944034|421664|P6|STARTED|Overall Study||143
174815|NCT00944034|421665|P5|STARTED|Overall Study||164
174816|NCT00944034|421666|P4|STARTED|Overall Study||174
174817|NCT00944034|421667|P3|STARTED|Overall Study||152
174818|NCT00944034|421668|P2|STARTED|Overall Study||157
174819|NCT00944034|421669|P1|STARTED|Overall Study||188
174820|NCT00944021|421739|P5|NOT COMPLETED|Overall Study||0
174821|NCT00944021|421740|P4|NOT COMPLETED|Overall Study||0
174822|NCT00944021|421741|P3|NOT COMPLETED|Overall Study||0
174823|NCT00944021|421742|P2|NOT COMPLETED|Overall Study||0
174824|NCT00944021|421743|P1|NOT COMPLETED|Overall Study||1
174825|NCT00944021|421739|P5|COMPLETED|Overall Study||8
174826|NCT00944021|421740|P4|COMPLETED|Overall Study||16
174827|NCT00944021|421741|P3|COMPLETED|Overall Study||15
174828|NCT00944021|421742|P2|COMPLETED|Overall Study||15
174829|NCT00944021|421743|P1|COMPLETED|Overall Study||14
174830|NCT00944021|421739|P5|STARTED|Overall Study||8
174831|NCT00944021|421740|P4|STARTED|Overall Study||16
174832|NCT00944021|421741|P3|STARTED|Overall Study||15
174833|NCT00944021|421742|P2|STARTED|Overall Study||15
174834|NCT00944021|421743|P1|STARTED|Overall Study||15
174835|NCT00943917|421815|P15|NOT COMPLETED|Stage II Continuation||4
174836|NCT00943917|421816|P14|NOT COMPLETED|Stage II Continuation||3
174837|NCT00943917|421817|P13|NOT COMPLETED|Stage II Continuation||3
174838|NCT00943917|421818|P12|NOT COMPLETED|Stage II Continuation||2
174839|NCT00943917|421819|P11|NOT COMPLETED|Stage II Continuation||0
174840|NCT00943917|421820|P10|NOT COMPLETED|Stage II Continuation||1
174841|NCT00943917|421821|P9|NOT COMPLETED|Stage II Continuation||0
174842|NCT00943917|421822|P8|NOT COMPLETED|Stage II Continuation||0
174843|NCT00943917|421823|P7|NOT COMPLETED|Stage II Continuation||0
174844|NCT00943917|421824|P6|NOT COMPLETED|Stage II Continuation||0
174845|NCT00943917|421825|P5|NOT COMPLETED|Stage II Continuation||0
174846|NCT00943917|421826|P4|NOT COMPLETED|Stage II Continuation||0
174847|NCT00943917|421827|P3|NOT COMPLETED|Stage II Continuation||0
174848|NCT00943917|421828|P2|NOT COMPLETED|Stage II Continuation||0
174849|NCT00943917|421829|P1|NOT COMPLETED|Stage II Continuation||0
174850|NCT00943917|421815|P15|COMPLETED|Stage II Continuation||8
174851|NCT00943917|421816|P14|COMPLETED|Stage II Continuation||12
174852|NCT00943917|421817|P13|COMPLETED|Stage II Continuation||13
174853|NCT00943917|421818|P12|COMPLETED|Stage II Continuation||11
174854|NCT00943917|421819|P11|COMPLETED|Stage II Continuation||15
174855|NCT00943917|421820|P10|COMPLETED|Stage II Continuation||14
174856|NCT00943917|421821|P9|COMPLETED|Stage II Continuation||0
174857|NCT00943917|421822|P8|COMPLETED|Stage II Continuation||0
174858|NCT00943917|421823|P7|COMPLETED|Stage II Continuation||0
174859|NCT00943917|421824|P6|COMPLETED|Stage II Continuation||0
174860|NCT00943917|421825|P5|COMPLETED|Stage II Continuation||0
174861|NCT00943917|421826|P4|COMPLETED|Stage II Continuation||0
174862|NCT00943917|421827|P3|COMPLETED|Stage II Continuation||0
174863|NCT00943917|421828|P2|COMPLETED|Stage II Continuation||0
174864|NCT00943917|421829|P1|COMPLETED|Stage II Continuation||0
174865|NCT00943917|421815|P15|STARTED|Stage II Continuation||12
174866|NCT00943917|421816|P14|STARTED|Stage II Continuation||15
174867|NCT00943917|421817|P13|STARTED|Stage II Continuation||16
174868|NCT00943917|421818|P12|STARTED|Stage II Continuation||13
174869|NCT00943917|421819|P11|STARTED|Stage II Continuation||15
174870|NCT00943917|421820|P10|STARTED|Stage II Continuation||15
174871|NCT00943917|421821|P9|STARTED|Stage II Continuation||0
174872|NCT00943917|421822|P8|STARTED|Stage II Continuation||0
174873|NCT00943917|421823|P7|STARTED|Stage II Continuation||0
174874|NCT00943917|421824|P6|STARTED|Stage II Continuation||0
174875|NCT00943917|421825|P5|STARTED|Stage II Continuation||0
174876|NCT00943917|421826|P4|STARTED|Stage II Continuation||0
174877|NCT00943917|421827|P3|STARTED|Stage II Continuation||0
174878|NCT00943917|421828|P2|STARTED|Stage II Continuation||0
174879|NCT00943917|421829|P1|STARTED|Stage II Continuation||0
174880|NCT00943917|421815|P15|NOT COMPLETED|Stage II||0
174881|NCT00943917|421816|P14|NOT COMPLETED|Stage II||0
174882|NCT00943917|421817|P13|NOT COMPLETED|Stage II||0
174883|NCT00943917|421818|P12|NOT COMPLETED|Stage II||0
174884|NCT00943917|421819|P11|NOT COMPLETED|Stage II||0
174885|NCT00943917|421820|P10|NOT COMPLETED|Stage II||0
174886|NCT00943917|421821|P9|NOT COMPLETED|Stage II||1
174887|NCT00943917|421822|P8|NOT COMPLETED|Stage II||0
174888|NCT00943917|421823|P7|NOT COMPLETED|Stage II||3
174889|NCT00943917|421824|P6|NOT COMPLETED|Stage II||3
174890|NCT00943917|421825|P5|NOT COMPLETED|Stage II||0
174891|NCT00943917|421826|P4|NOT COMPLETED|Stage II||0
174892|NCT00943917|421827|P3|NOT COMPLETED|Stage II||0
174893|NCT00943917|421828|P2|NOT COMPLETED|Stage II||0
174894|NCT00943917|421829|P1|NOT COMPLETED|Stage II||0
174895|NCT00943917|421815|P15|COMPLETED|Stage II||0
174896|NCT00943917|421816|P14|COMPLETED|Stage II||0
174897|NCT00943917|421817|P13|COMPLETED|Stage II||0
174898|NCT00943917|421818|P12|COMPLETED|Stage II||0
174899|NCT00943917|421819|P11|COMPLETED|Stage II||0
174900|NCT00943917|421820|P10|COMPLETED|Stage II||0
174901|NCT00943917|421821|P9|COMPLETED|Stage II||20
174902|NCT00943917|421822|P8|COMPLETED|Stage II||23
174903|NCT00943917|421823|P7|COMPLETED|Stage II||20
174904|NCT00943917|421824|P6|COMPLETED|Stage II||20
174905|NCT00943917|421825|P5|COMPLETED|Stage II||21
174906|NCT00943917|421826|P4|COMPLETED|Stage II||20
174907|NCT00943917|421827|P3|COMPLETED|Stage II||0
174908|NCT00943917|421828|P2|COMPLETED|Stage II||0
174909|NCT00943917|421829|P1|COMPLETED|Stage II||0
174910|NCT00943917|421815|P15|STARTED|Stage II||0
174911|NCT00943917|421816|P14|STARTED|Stage II||0
174912|NCT00943917|421817|P13|STARTED|Stage II||0
174913|NCT00943917|421818|P12|STARTED|Stage II||0
174914|NCT00943917|421819|P11|STARTED|Stage II||0
174915|NCT00943917|421820|P10|STARTED|Stage II||0
174916|NCT00943917|421821|P9|STARTED|Stage II||21
174917|NCT00943917|421822|P8|STARTED|Stage II||23
174918|NCT00943917|421823|P7|STARTED|Stage II||23
174919|NCT00943917|421824|P6|STARTED|Stage II||23
174920|NCT00943917|421825|P5|STARTED|Stage II||21
174921|NCT00943917|421826|P4|STARTED|Stage II||20
174922|NCT00943917|421827|P3|STARTED|Stage II||0
174923|NCT00943917|421828|P2|STARTED|Stage II||0
174924|NCT00943917|421829|P1|STARTED|Stage II||0
174925|NCT00943917|421815|P15|NOT COMPLETED|Stage I||0
174926|NCT00943917|421816|P14|NOT COMPLETED|Stage I||0
174927|NCT00943917|421817|P13|NOT COMPLETED|Stage I||0
174928|NCT00943917|421818|P12|NOT COMPLETED|Stage I||0
174929|NCT00943917|421819|P11|NOT COMPLETED|Stage I||0
174930|NCT00943917|421820|P10|NOT COMPLETED|Stage I||0
174931|NCT00943917|421821|P9|NOT COMPLETED|Stage I||0
174932|NCT00943917|421822|P8|NOT COMPLETED|Stage I||0
174933|NCT00943917|421823|P7|NOT COMPLETED|Stage I||0
174934|NCT00943917|421824|P6|NOT COMPLETED|Stage I||0
174935|NCT00943917|421825|P5|NOT COMPLETED|Stage I||0
174936|NCT00943917|421826|P4|NOT COMPLETED|Stage I||0
174937|NCT00943917|421827|P3|NOT COMPLETED|Stage I||6
174938|NCT00943917|421828|P2|NOT COMPLETED|Stage I||3
174939|NCT00943917|421829|P1|NOT COMPLETED|Stage I||4
174940|NCT00943917|421815|P15|COMPLETED|Stage I||0
174941|NCT00943917|421816|P14|COMPLETED|Stage I||0
174942|NCT00943917|421817|P13|COMPLETED|Stage I||0
174943|NCT00943917|421818|P12|COMPLETED|Stage I||0
174944|NCT00943917|421819|P11|COMPLETED|Stage I||0
174945|NCT00943917|421820|P10|COMPLETED|Stage I||0
174946|NCT00943917|421821|P9|COMPLETED|Stage I||0
174947|NCT00943917|421822|P8|COMPLETED|Stage I||0
174948|NCT00943917|421823|P7|COMPLETED|Stage I||0
174949|NCT00943917|421824|P6|COMPLETED|Stage I||0
174950|NCT00943917|421825|P5|COMPLETED|Stage I||0
174951|NCT00943917|421826|P4|COMPLETED|Stage I||0
174952|NCT00943917|421827|P3|COMPLETED|Stage I||47
174953|NCT00943917|421828|P2|COMPLETED|Stage I||48
174954|NCT00943917|421829|P1|COMPLETED|Stage I||47
174955|NCT00943917|421815|P15|STARTED|Stage I||0
174956|NCT00943917|421816|P14|STARTED|Stage I||0
174957|NCT00943917|421817|P13|STARTED|Stage I||0
174958|NCT00943917|421818|P12|STARTED|Stage I||0
174959|NCT00943917|421819|P11|STARTED|Stage I||0
174960|NCT00943917|421820|P10|STARTED|Stage I||0
174961|NCT00943917|421821|P9|STARTED|Stage I||0
174962|NCT00943917|421822|P8|STARTED|Stage I||0
174963|NCT00943917|421823|P7|STARTED|Stage I||0
174964|NCT00943917|421824|P6|STARTED|Stage I||0
174965|NCT00943917|421825|P5|STARTED|Stage I||0
174966|NCT00943917|421826|P4|STARTED|Stage I||0
174967|NCT00943917|421827|P3|STARTED|Stage I||53
174968|NCT00943917|421828|P2|STARTED|Stage I||51
174969|NCT00943917|421829|P1|STARTED|Stage I||51
174970|NCT00943878|421880|P4|NOT COMPLETED|Overall Study||2
174971|NCT00943878|421881|P3|NOT COMPLETED|Overall Study||6
174972|NCT00943878|421882|P2|NOT COMPLETED|Overall Study||2
174973|NCT00943878|421883|P1|NOT COMPLETED|Overall Study||2
174974|NCT00943878|421880|P4|COMPLETED|Overall Study||198
174975|NCT00943878|421881|P3|COMPLETED|Overall Study||197
174976|NCT00943878|421882|P2|COMPLETED|Overall Study||198
174977|NCT00943878|421883|P1|COMPLETED|Overall Study||200
174978|NCT00943878|421880|P4|STARTED|Overall Study||200
174979|NCT00943878|421881|P3|STARTED|Overall Study||203
174980|NCT00943878|421882|P2|STARTED|Overall Study||200
174981|NCT00943878|421883|P1|STARTED|Overall Study||202
174982|NCT00943852|422005|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174983|NCT00943852|422006|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174984|NCT00943852|422007|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174985|NCT00943852|422008|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174986|NCT00943852|422009|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174987|NCT00943852|422010|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174988|NCT00943852|422011|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174989|NCT00943852|422012|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174990|NCT00943852|422013|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174991|NCT00943852|422014|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
174992|NCT00943852|422005|P10|COMPLETED|Fifth Period of Treatment Intervention||1
174993|NCT00943852|422006|P9|COMPLETED|Fifth Period of Treatment Intervention||1
174994|NCT00943852|422007|P8|COMPLETED|Fifth Period of Treatment Intervention||0
174995|NCT00943852|422008|P7|COMPLETED|Fifth Period of Treatment Intervention||0
174996|NCT00943852|422009|P6|COMPLETED|Fifth Period of Treatment Intervention||0
174997|NCT00943852|422010|P5|COMPLETED|Fifth Period of Treatment Intervention||1
174998|NCT00943852|422011|P4|COMPLETED|Fifth Period of Treatment Intervention||0
174999|NCT00943852|422012|P3|COMPLETED|Fifth Period of Treatment Intervention||0
175000|NCT00943852|422013|P2|COMPLETED|Fifth Period of Treatment Intervention||1
175001|NCT00943852|422014|P1|COMPLETED|Fifth Period of Treatment Intervention||1
175002|NCT00943852|422005|P10|STARTED|Fifth Period of Treatment Intervention||1
175003|NCT00943852|422006|P9|STARTED|Fifth Period of Treatment Intervention||1
175004|NCT00943852|422007|P8|STARTED|Fifth Period of Treatment Intervention||0
175005|NCT00943852|422008|P7|STARTED|Fifth Period of Treatment Intervention||0
175006|NCT00943852|422009|P6|STARTED|Fifth Period of Treatment Intervention||0
175007|NCT00943852|422010|P5|STARTED|Fifth Period of Treatment Intervention||1
175008|NCT00943852|422011|P4|STARTED|Fifth Period of Treatment Intervention||0
175009|NCT00943852|422012|P3|STARTED|Fifth Period of Treatment Intervention||0
175010|NCT00943852|422013|P2|STARTED|Fifth Period of Treatment Intervention||1
175011|NCT00943852|422014|P1|STARTED|Fifth Period of Treatment Intervention||1
175012|NCT00943852|422005|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
175013|NCT00943852|422006|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
175014|NCT00943852|422007|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
175015|NCT00943852|422008|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
175016|NCT00943852|422009|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
175017|NCT00943852|422010|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
175018|NCT00943852|422011|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
175019|NCT00943852|422012|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
175020|NCT00943852|422013|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
175021|NCT00943852|422014|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
175022|NCT00943852|422005|P10|COMPLETED|Washout Period After Period 4 Treatment||1
175023|NCT00943852|422006|P9|COMPLETED|Washout Period After Period 4 Treatment||1
175024|NCT00943852|422007|P8|COMPLETED|Washout Period After Period 4 Treatment||0
175025|NCT00943852|422008|P7|COMPLETED|Washout Period After Period 4 Treatment||0
175026|NCT00943852|422009|P6|COMPLETED|Washout Period After Period 4 Treatment||0
175027|NCT00943852|422010|P5|COMPLETED|Washout Period After Period 4 Treatment||1
175028|NCT00943852|422011|P4|COMPLETED|Washout Period After Period 4 Treatment||0
175029|NCT00943852|422012|P3|COMPLETED|Washout Period After Period 4 Treatment||0
175030|NCT00943852|422013|P2|COMPLETED|Washout Period After Period 4 Treatment||1
175031|NCT00943852|422014|P1|COMPLETED|Washout Period After Period 4 Treatment||1
175032|NCT00943852|422005|P10|STARTED|Washout Period After Period 4 Treatment||1
175033|NCT00943852|422006|P9|STARTED|Washout Period After Period 4 Treatment||1
175034|NCT00943852|422007|P8|STARTED|Washout Period After Period 4 Treatment||1
175035|NCT00943852|422008|P7|STARTED|Washout Period After Period 4 Treatment||1
175036|NCT00943852|422009|P6|STARTED|Washout Period After Period 4 Treatment||0
175037|NCT00943852|422010|P5|STARTED|Washout Period After Period 4 Treatment||1
175038|NCT00943852|422011|P4|STARTED|Washout Period After Period 4 Treatment||1
175039|NCT00943852|422012|P3|STARTED|Washout Period After Period 4 Treatment||1
175040|NCT00943852|422013|P2|STARTED|Washout Period After Period 4 Treatment||1
175041|NCT00943852|422014|P1|STARTED|Washout Period After Period 4 Treatment||2
175042|NCT00943852|422005|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175043|NCT00943852|422006|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175044|NCT00943852|422007|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175045|NCT00943852|422008|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175046|NCT00943852|422009|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175047|NCT00943852|422010|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175048|NCT00943852|422011|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175049|NCT00943852|422012|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175050|NCT00943852|422013|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175051|NCT00943852|422014|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
175052|NCT00943852|422005|P10|COMPLETED|Fourth Period of Treatment Intervention||1
175053|NCT00943852|422006|P9|COMPLETED|Fourth Period of Treatment Intervention||1
175054|NCT00943852|422007|P8|COMPLETED|Fourth Period of Treatment Intervention||1
175055|NCT00943852|422008|P7|COMPLETED|Fourth Period of Treatment Intervention||1
175056|NCT00943852|422009|P6|COMPLETED|Fourth Period of Treatment Intervention||0
175057|NCT00943852|422010|P5|COMPLETED|Fourth Period of Treatment Intervention||1
175058|NCT00943852|422011|P4|COMPLETED|Fourth Period of Treatment Intervention||1
175059|NCT00943852|422012|P3|COMPLETED|Fourth Period of Treatment Intervention||1
175060|NCT00943852|422013|P2|COMPLETED|Fourth Period of Treatment Intervention||1
175061|NCT00943852|422014|P1|COMPLETED|Fourth Period of Treatment Intervention||2
175062|NCT00943852|422005|P10|STARTED|Fourth Period of Treatment Intervention||1
175063|NCT00943852|422006|P9|STARTED|Fourth Period of Treatment Intervention||1
175064|NCT00943852|422007|P8|STARTED|Fourth Period of Treatment Intervention||1
175065|NCT00943852|422008|P7|STARTED|Fourth Period of Treatment Intervention||1
175066|NCT00943852|422009|P6|STARTED|Fourth Period of Treatment Intervention||0
175067|NCT00943852|422010|P5|STARTED|Fourth Period of Treatment Intervention||1
175068|NCT00943852|422011|P4|STARTED|Fourth Period of Treatment Intervention||1
175069|NCT00943852|422012|P3|STARTED|Fourth Period of Treatment Intervention||1
175070|NCT00943852|422013|P2|STARTED|Fourth Period of Treatment Intervention||1
175071|NCT00943852|422014|P1|STARTED|Fourth Period of Treatment Intervention||2
175072|NCT00943852|422005|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175073|NCT00943852|422006|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175074|NCT00943852|422007|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175075|NCT00943852|422008|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
175076|NCT00943852|422009|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175077|NCT00943852|422010|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175078|NCT00943852|422011|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175079|NCT00943852|422012|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175080|NCT00943852|422013|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175081|NCT00943852|422014|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
175082|NCT00943852|422005|P10|COMPLETED|Washout Period After Period 3 Treatment||1
175083|NCT00943852|422006|P9|COMPLETED|Washout Period After Period 3 Treatment||1
175084|NCT00943852|422007|P8|COMPLETED|Washout Period After Period 3 Treatment||1
175085|NCT00943852|422008|P7|COMPLETED|Washout Period After Period 3 Treatment||1
175086|NCT00943852|422009|P6|COMPLETED|Washout Period After Period 3 Treatment||0
175087|NCT00943852|422010|P5|COMPLETED|Washout Period After Period 3 Treatment||1
175088|NCT00943852|422011|P4|COMPLETED|Washout Period After Period 3 Treatment||1
175089|NCT00943852|422012|P3|COMPLETED|Washout Period After Period 3 Treatment||1
175090|NCT00943852|422013|P2|COMPLETED|Washout Period After Period 3 Treatment||1
175091|NCT00943852|422014|P1|COMPLETED|Washout Period After Period 3 Treatment||2
175092|NCT00943852|422005|P10|STARTED|Washout Period After Period 3 Treatment||1
175093|NCT00943852|422006|P9|STARTED|Washout Period After Period 3 Treatment||1
175094|NCT00943852|422007|P8|STARTED|Washout Period After Period 3 Treatment||1
175095|NCT00943852|422008|P7|STARTED|Washout Period After Period 3 Treatment||2
175096|NCT00943852|422009|P6|STARTED|Washout Period After Period 3 Treatment||0
175097|NCT00943852|422010|P5|STARTED|Washout Period After Period 3 Treatment||1
175098|NCT00943852|422011|P4|STARTED|Washout Period After Period 3 Treatment||1
175099|NCT00943852|422012|P3|STARTED|Washout Period After Period 3 Treatment||1
175100|NCT00943852|422013|P2|STARTED|Washout Period After Period 3 Treatment||1
175101|NCT00943852|422014|P1|STARTED|Washout Period After Period 3 Treatment||2
175102|NCT00943852|422005|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
175103|NCT00943852|422006|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
175104|NCT00943852|422007|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
175105|NCT00943852|422008|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
175106|NCT00943852|422009|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
175107|NCT00943852|422010|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
175108|NCT00943852|422011|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
175109|NCT00943852|422012|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
175110|NCT00943852|422013|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
175111|NCT00943852|422014|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
175112|NCT00943852|422005|P10|COMPLETED|Third Period of Treatment Intervention||1
175113|NCT00943852|422006|P9|COMPLETED|Third Period of Treatment Intervention||1
175114|NCT00943852|422007|P8|COMPLETED|Third Period of Treatment Intervention||1
175115|NCT00943852|422008|P7|COMPLETED|Third Period of Treatment Intervention||2
175116|NCT00943852|422009|P6|COMPLETED|Third Period of Treatment Intervention||0
175117|NCT00943852|422010|P5|COMPLETED|Third Period of Treatment Intervention||1
175118|NCT00943852|422011|P4|COMPLETED|Third Period of Treatment Intervention||1
175119|NCT00943852|422012|P3|COMPLETED|Third Period of Treatment Intervention||1
175120|NCT00943852|422013|P2|COMPLETED|Third Period of Treatment Intervention||1
175121|NCT00943852|422014|P1|COMPLETED|Third Period of Treatment Intervention||2
175122|NCT00943852|422005|P10|STARTED|Third Period of Treatment Intervention||1
175123|NCT00943852|422006|P9|STARTED|Third Period of Treatment Intervention||1
175124|NCT00943852|422007|P8|STARTED|Third Period of Treatment Intervention||1
175125|NCT00943852|422008|P7|STARTED|Third Period of Treatment Intervention||2
175126|NCT00943852|422009|P6|STARTED|Third Period of Treatment Intervention||0
175127|NCT00943852|422010|P5|STARTED|Third Period of Treatment Intervention||1
175128|NCT00943852|422011|P4|STARTED|Third Period of Treatment Intervention||1
175129|NCT00943852|422012|P3|STARTED|Third Period of Treatment Intervention||1
175130|NCT00943852|422013|P2|STARTED|Third Period of Treatment Intervention||1
175131|NCT00943852|422014|P1|STARTED|Third Period of Treatment Intervention||2
175132|NCT00943852|422005|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175133|NCT00943852|422006|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175134|NCT00943852|422007|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175135|NCT00943852|422008|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175136|NCT00943852|422009|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
175137|NCT00943852|422010|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175138|NCT00943852|422011|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175139|NCT00943852|422012|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175140|NCT00943852|422013|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175141|NCT00943852|422014|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
175142|NCT00943852|422005|P10|COMPLETED|Washout Period After Period 2 Treatment||1
175143|NCT00943852|422006|P9|COMPLETED|Washout Period After Period 2 Treatment||1
175144|NCT00943852|422007|P8|COMPLETED|Washout Period After Period 2 Treatment||1
175145|NCT00943852|422008|P7|COMPLETED|Washout Period After Period 2 Treatment||2
175146|NCT00943852|422009|P6|COMPLETED|Washout Period After Period 2 Treatment||0
175147|NCT00943852|422010|P5|COMPLETED|Washout Period After Period 2 Treatment||1
175148|NCT00943852|422011|P4|COMPLETED|Washout Period After Period 2 Treatment||1
175149|NCT00943852|422012|P3|COMPLETED|Washout Period After Period 2 Treatment||1
175150|NCT00943852|422013|P2|COMPLETED|Washout Period After Period 2 Treatment||1
175151|NCT00943852|422014|P1|COMPLETED|Washout Period After Period 2 Treatment||2
175152|NCT00943852|422005|P10|STARTED|Washout Period After Period 2 Treatment||1
175153|NCT00943852|422006|P9|STARTED|Washout Period After Period 2 Treatment||1
175154|NCT00943852|422007|P8|STARTED|Washout Period After Period 2 Treatment||1
175155|NCT00943852|422008|P7|STARTED|Washout Period After Period 2 Treatment||2
175156|NCT00943852|422009|P6|STARTED|Washout Period After Period 2 Treatment||1
175157|NCT00943852|422010|P5|STARTED|Washout Period After Period 2 Treatment||1
175158|NCT00943852|422011|P4|STARTED|Washout Period After Period 2 Treatment||1
175159|NCT00943852|422012|P3|STARTED|Washout Period After Period 2 Treatment||1
175160|NCT00943852|422013|P2|STARTED|Washout Period After Period 2 Treatment||1
175161|NCT00943852|422014|P1|STARTED|Washout Period After Period 2 Treatment||2
175162|NCT00943852|422005|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
175163|NCT00943852|422006|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
175164|NCT00943852|422007|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
175165|NCT00943852|422008|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
175166|NCT00943852|422009|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
175167|NCT00943852|422010|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
175168|NCT00943852|422011|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
175169|NCT00943852|422012|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
175170|NCT00943852|422013|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
175171|NCT00943852|422014|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
175172|NCT00943852|422005|P10|COMPLETED|Second Period of Treatment Intervention||1
175173|NCT00943852|422006|P9|COMPLETED|Second Period of Treatment Intervention||1
175174|NCT00943852|422007|P8|COMPLETED|Second Period of Treatment Intervention||1
175175|NCT00943852|422008|P7|COMPLETED|Second Period of Treatment Intervention||2
175176|NCT00943852|422009|P6|COMPLETED|Second Period of Treatment Intervention||1
175177|NCT00943852|422010|P5|COMPLETED|Second Period of Treatment Intervention||1
175178|NCT00943852|422011|P4|COMPLETED|Second Period of Treatment Intervention||1
175179|NCT00943852|422012|P3|COMPLETED|Second Period of Treatment Intervention||1
175180|NCT00943852|422013|P2|COMPLETED|Second Period of Treatment Intervention||1
175181|NCT00943852|422014|P1|COMPLETED|Second Period of Treatment Intervention||2
175182|NCT00943852|422005|P10|STARTED|Second Period of Treatment Intervention||1
175183|NCT00943852|422006|P9|STARTED|Second Period of Treatment Intervention||1
175184|NCT00943852|422007|P8|STARTED|Second Period of Treatment Intervention||1
175185|NCT00943852|422008|P7|STARTED|Second Period of Treatment Intervention||2
175186|NCT00943852|422009|P6|STARTED|Second Period of Treatment Intervention||1
175187|NCT00943852|422010|P5|STARTED|Second Period of Treatment Intervention||1
175188|NCT00943852|422011|P4|STARTED|Second Period of Treatment Intervention||1
175189|NCT00943852|422012|P3|STARTED|Second Period of Treatment Intervention||1
175190|NCT00943852|422013|P2|STARTED|Second Period of Treatment Intervention||1
175191|NCT00943852|422014|P1|STARTED|Second Period of Treatment Intervention||2
175192|NCT00943852|422005|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175193|NCT00943852|422006|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175266|NCT00943826|422027|P2|COMPLETED|Maintenance Phase||331
175194|NCT00943852|422007|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175195|NCT00943852|422008|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175196|NCT00943852|422009|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175197|NCT00943852|422010|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175198|NCT00943852|422011|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
175199|NCT00943852|422012|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175200|NCT00943852|422013|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175201|NCT00943852|422014|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
175202|NCT00943852|422005|P10|COMPLETED|Washout Period After Period 1 Treatment||1
175203|NCT00943852|422006|P9|COMPLETED|Washout Period After Period 1 Treatment||1
175204|NCT00943852|422007|P8|COMPLETED|Washout Period After Period 1 Treatment||1
175205|NCT00943852|422008|P7|COMPLETED|Washout Period After Period 1 Treatment||2
175206|NCT00943852|422009|P6|COMPLETED|Washout Period After Period 1 Treatment||1
175207|NCT00943852|422010|P5|COMPLETED|Washout Period After Period 1 Treatment||1
175208|NCT00943852|422011|P4|COMPLETED|Washout Period After Period 1 Treatment||1
175209|NCT00943852|422012|P3|COMPLETED|Washout Period After Period 1 Treatment||1
175210|NCT00943852|422013|P2|COMPLETED|Washout Period After Period 1 Treatment||1
175211|NCT00943852|422014|P1|COMPLETED|Washout Period After Period 1 Treatment||2
175212|NCT00943852|422005|P10|STARTED|Washout Period After Period 1 Treatment||1
175213|NCT00943852|422006|P9|STARTED|Washout Period After Period 1 Treatment||1
175214|NCT00943852|422007|P8|STARTED|Washout Period After Period 1 Treatment||1
175215|NCT00943852|422008|P7|STARTED|Washout Period After Period 1 Treatment||2
175216|NCT00943852|422009|P6|STARTED|Washout Period After Period 1 Treatment||1
175217|NCT00943852|422010|P5|STARTED|Washout Period After Period 1 Treatment||1
175218|NCT00943852|422011|P4|STARTED|Washout Period After Period 1 Treatment||2
175219|NCT00943852|422012|P3|STARTED|Washout Period After Period 1 Treatment||1
175220|NCT00943852|422013|P2|STARTED|Washout Period After Period 1 Treatment||1
175221|NCT00943852|422014|P1|STARTED|Washout Period After Period 1 Treatment||2
175222|NCT00943852|422005|P10|NOT COMPLETED|First Period of Treatment Intervention||0
175223|NCT00943852|422006|P9|NOT COMPLETED|First Period of Treatment Intervention||0
175224|NCT00943852|422007|P8|NOT COMPLETED|First Period of Treatment Intervention||0
175225|NCT00943852|422008|P7|NOT COMPLETED|First Period of Treatment Intervention||0
175226|NCT00943852|422009|P6|NOT COMPLETED|First Period of Treatment Intervention||0
175227|NCT00943852|422010|P5|NOT COMPLETED|First Period of Treatment Intervention||0
175228|NCT00943852|422011|P4|NOT COMPLETED|First Period of Treatment Intervention||0
175229|NCT00943852|422012|P3|NOT COMPLETED|First Period of Treatment Intervention||0
175230|NCT00943852|422013|P2|NOT COMPLETED|First Period of Treatment Intervention||0
175231|NCT00943852|422014|P1|NOT COMPLETED|First Period of Treatment Intervention||0
175232|NCT00943852|422005|P10|COMPLETED|First Period of Treatment Intervention||1
175233|NCT00943852|422006|P9|COMPLETED|First Period of Treatment Intervention||1
175234|NCT00943852|422007|P8|COMPLETED|First Period of Treatment Intervention||1
175235|NCT00943852|422008|P7|COMPLETED|First Period of Treatment Intervention||2
175236|NCT00943852|422009|P6|COMPLETED|First Period of Treatment Intervention||1
175237|NCT00943852|422010|P5|COMPLETED|First Period of Treatment Intervention||1
175238|NCT00943852|422011|P4|COMPLETED|First Period of Treatment Intervention||2
175239|NCT00943852|422012|P3|COMPLETED|First Period of Treatment Intervention||1
175240|NCT00943852|422013|P2|COMPLETED|First Period of Treatment Intervention||1
175241|NCT00943852|422014|P1|COMPLETED|First Period of Treatment Intervention||2
175242|NCT00943852|422005|P10|STARTED|First Period of Treatment Intervention||1
175243|NCT00943852|422006|P9|STARTED|First Period of Treatment Intervention||1
175244|NCT00943852|422007|P8|STARTED|First Period of Treatment Intervention||1
175245|NCT00943852|422008|P7|STARTED|First Period of Treatment Intervention||2
175246|NCT00943852|422009|P6|STARTED|First Period of Treatment Intervention||1
175247|NCT00943852|422010|P5|STARTED|First Period of Treatment Intervention||1
175248|NCT00943852|422011|P4|STARTED|First Period of Treatment Intervention||2
175249|NCT00943852|422012|P3|STARTED|First Period of Treatment Intervention||1
175250|NCT00943852|422013|P2|STARTED|First Period of Treatment Intervention||1
175251|NCT00943852|422014|P1|STARTED|First Period of Treatment Intervention||2
175252|NCT00943826|422027|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
175253|NCT00943826|422028|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
175254|NCT00943826|422027|P2|COMPLETED|After Primary Overall Survival Analysis||0
175255|NCT00943826|422028|P1|COMPLETED|After Primary Overall Survival Analysis||0
175256|NCT00943826|422027|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
175257|NCT00943826|422028|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
175258|NCT00943826|422027|P2|NOT COMPLETED|Monotherapy Phase||16
175259|NCT00943826|422028|P1|NOT COMPLETED|Monotherapy Phase||65
175260|NCT00943826|422027|P2|COMPLETED|Monotherapy Phase||143
175261|NCT00943826|422028|P1|COMPLETED|Monotherapy Phase||204
175262|NCT00943826|422027|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
175263|NCT00943826|422028|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
175264|NCT00943826|422027|P2|NOT COMPLETED|Maintenance Phase||39
175265|NCT00943826|422028|P1|NOT COMPLETED|Maintenance Phase||43
175267|NCT00943826|422028|P1|COMPLETED|Maintenance Phase||353
175268|NCT00943826|422027|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
175269|NCT00943826|422028|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
175270|NCT00943826|422027|P2|NOT COMPLETED|Concurrent Phase||42
175271|NCT00943826|422028|P1|NOT COMPLETED|Concurrent Phase||61
175272|NCT00943826|422027|P2|COMPLETED|Concurrent Phase||421
175273|NCT00943826|422028|P1|COMPLETED|Concurrent Phase||397
175274|NCT00943826|422027|P2|Treated|Concurrent Phase||459
175275|NCT00943826|422028|P1|Treated|Concurrent Phase||452
175276|NCT00943826|422027|P2|STARTED|Concurrent Phase||463
175277|NCT00943826|422028|P1|STARTED|Concurrent Phase||458
175278|NCT00943787|422046|P1|NOT COMPLETED|Overall Study||7
175279|NCT00943787|422046|P1|COMPLETED|Overall Study||34
175280|NCT00943787|422046|P1|STARTED|Overall Study||41
175281|NCT00943761|422053|P2|NOT COMPLETED|Overall Study||1
175282|NCT00943761|422054|P1|NOT COMPLETED|Overall Study||4
175283|NCT00943761|422053|P2|COMPLETED|Overall Study||23
175284|NCT00943761|422054|P1|COMPLETED|Overall Study||17
175285|NCT00943761|422053|P2|STARTED|Overall Study||24
175286|NCT00943761|422054|P1|STARTED|Overall Study||21
175287|NCT00943735|422066|P1|NOT COMPLETED|Overall Study||32
175288|NCT00943735|422066|P1|COMPLETED|Overall Study||742
175289|NCT00943735|422066|P1|Per Protocol Population|Overall Study||500
175290|NCT00943735|422066|P1|STARTED|Overall Study||774
175291|NCT00943722|422104|P5|NOT COMPLETED|Overall Study||22
175292|NCT00943722|422105|P4|NOT COMPLETED|Overall Study||22
175293|NCT00943722|422106|P3|NOT COMPLETED|Overall Study||13
175294|NCT00943722|422107|P2|NOT COMPLETED|Overall Study||22
175295|NCT00943722|422108|P1|NOT COMPLETED|Overall Study||25
175296|NCT00943722|422104|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
175297|NCT00943722|422105|P4|COMPLETED|Overall Study||647
175298|NCT00943722|422106|P3|COMPLETED|Overall Study||631
175299|NCT00943722|422107|P2|COMPLETED|Overall Study||621
175300|NCT00943722|422108|P1|COMPLETED|Overall Study||623
175301|NCT00943722|422104|P5|Vaccination 3|Overall Study||455
175302|NCT00943722|422105|P4|Vaccination 3|Overall Study||653
175303|NCT00943722|422106|P3|Vaccination 3|Overall Study||637
175304|NCT00943722|422107|P2|Vaccination 3|Overall Study||627
175305|NCT00943722|422108|P1|Vaccination 3|Overall Study||635
175306|NCT00943722|422104|P5|Vaccination 2|Overall Study||462
175307|NCT00943722|422105|P4|Vaccination 2|Overall Study||658
175308|NCT00943722|422106|P3|Vaccination 2|Overall Study||638
175309|NCT00943722|422107|P2|Vaccination 2|Overall Study||633
175310|NCT00943722|422108|P1|Vaccination 2|Overall Study||637
175311|NCT00943722|422104|P5|Vaccination 1|Overall Study||468
175312|NCT00943722|422105|P4|Vaccination 1|Overall Study||666
175313|NCT00943722|422106|P3|Vaccination 1|Overall Study||644
175314|NCT00943722|422107|P2|Vaccination 1|Overall Study||642
175315|NCT00943722|422108|P1|Vaccination 1|Overall Study||646
175316|NCT00943722|422104|P5|STARTED|Overall Study||470
175317|NCT00943722|422105|P4|STARTED|Overall Study||669
175318|NCT00943722|422106|P3|STARTED|Overall Study||644
175319|NCT00943722|422107|P2|STARTED|Overall Study||643
175320|NCT00943722|422108|P1|STARTED|Overall Study||648
175321|NCT00943683|422138|P2|NOT COMPLETED|Overall Study||6
175322|NCT00943683|422139|P1|NOT COMPLETED|Overall Study||7
175323|NCT00943683|422138|P2|COMPLETED|Overall Study||169
175324|NCT00943683|422139|P1|COMPLETED|Overall Study||74
175325|NCT00943683|422138|P2|STARTED|Overall Study||175
175326|NCT00943683|422139|P1|STARTED|Overall Study||81
175327|NCT00943670|422145|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
175328|NCT00943670|422145|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
175329|NCT00943670|422145|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
175330|NCT00943670|422145|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
175331|NCT00943670|422145|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
175332|NCT00943670|422145|P1|Treated|Single-agent Trastuzumab Emtansine||51
175333|NCT00943670|422145|P1|STARTED|Single-agent Trastuzumab Emtansine||51
175334|NCT00943631|422181|P2|NOT COMPLETED|Overall Study||2
175335|NCT00943631|422182|P1|NOT COMPLETED|Overall Study||4
175336|NCT00943631|422181|P2|COMPLETED|Overall Study||202
175337|NCT00943631|422182|P1|COMPLETED|Overall Study||198
175338|NCT00943631|422181|P2|STARTED|Overall Study||204
175339|NCT00943631|422182|P1|STARTED|Overall Study||202
175340|NCT00943605|422234|P2|NOT COMPLETED|Overall Study||30
175341|NCT00943605|422235|P1|NOT COMPLETED|Overall Study||30
175342|NCT00943605|422234|P2|COMPLETED|Overall Study||0
175343|NCT00943605|422235|P1|COMPLETED|Overall Study||0
175344|NCT00943605|422234|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
175345|NCT00943605|422235|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
175346|NCT00943592|422245|P1|NOT COMPLETED|Overall Study||3
175347|NCT00943592|422245|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
175348|NCT00943592|422245|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
175349|NCT00943592|422245|P1|STARTED|Overall Study||82
175350|NCT00943579|422258|P2|NOT COMPLETED|Overall Study||5
175351|NCT00943579|422259|P1|NOT COMPLETED|Overall Study||6
175352|NCT00943579|422258|P2|COMPLETED|Overall Study||15
175353|NCT00943579|422259|P1|COMPLETED|Overall Study||15
175354|NCT00943579|422258|P2|STARTED|Overall Study||20
175355|NCT00943579|422259|P1|STARTED|Overall Study||21
175356|NCT00943488|422280|P2|NOT COMPLETED|Overall Study||2
175357|NCT00943488|422281|P1|NOT COMPLETED|Overall Study||1
175358|NCT00943488|422280|P2|COMPLETED|Overall Study||202
175359|NCT00943488|422281|P1|COMPLETED|Overall Study||203
175360|NCT00943488|422280|P2|STARTED|Overall Study||204
175361|NCT00943488|422281|P1|STARTED|Overall Study||204
175362|NCT00943436|422337|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
175363|NCT00943436|422338|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
175364|NCT00943436|422337|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
175365|NCT00943436|422338|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
175366|NCT00943436|422337|P2|STARTED|Rest Session: 45 Minutes of Reading||10
175367|NCT00943436|422338|P1|STARTED|Rest Session: 45 Minutes of Reading||10
175368|NCT00943436|422337|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
175369|NCT00943436|422338|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
175370|NCT00943436|422337|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
175371|NCT00943436|422338|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
175372|NCT00943436|422337|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
175373|NCT00943436|422338|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
175374|NCT00943397|422360|P2|NOT COMPLETED|Overall Study||72
175375|NCT00943397|422361|P1|NOT COMPLETED|Overall Study||15
175376|NCT00943397|422360|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
175377|NCT00943397|422361|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
175378|NCT00943397|422360|P2|STARTED|Overall Study||158
175379|NCT00943397|422361|P1|STARTED|Overall Study||32
175380|NCT00943384|422367|P1|NOT COMPLETED|Overall Study||49
175381|NCT00943384|422367|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
175382|NCT00943384|422367|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
175383|NCT00943384|422367|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
175384|NCT00943384|422367|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
175385|NCT00943306|422381|P1|NOT COMPLETED|Overall Study||3
175386|NCT00943306|422381|P1|COMPLETED|Overall Study||16
175387|NCT00943306|422381|P1|STARTED|Overall Study||19
175388|NCT00943202|422442|P4|NOT COMPLETED|Overall Study||1
175389|NCT00943202|422443|P3|NOT COMPLETED|Overall Study||0
175390|NCT00943202|422444|P2|NOT COMPLETED|Overall Study||2
175391|NCT00943202|422445|P1|NOT COMPLETED|Overall Study||1
175392|NCT00943202|422442|P4|COMPLETED|Overall Study||131
175393|NCT00943202|422443|P3|COMPLETED|Overall Study||133
175394|NCT00943202|422444|P2|COMPLETED|Overall Study||131
175395|NCT00943202|422445|P1|COMPLETED|Overall Study||132
175396|NCT00943202|422442|P4|STARTED|Overall Study||132
175397|NCT00943202|422443|P3|STARTED|Overall Study||133
175398|NCT00943202|422444|P2|STARTED|Overall Study||133
175399|NCT00943202|422445|P1|STARTED|Overall Study||133
175400|NCT00943150|422661|P2|NOT COMPLETED|Overall Study||0
175401|NCT00943150|422662|P1|NOT COMPLETED|Overall Study||0
175402|NCT00943150|422661|P2|COMPLETED|Overall Study||10
175403|NCT00943150|422662|P1|COMPLETED|Overall Study||10
175404|NCT00943150|422661|P2|STARTED|Overall Study||10
175405|NCT00943150|422662|P1|STARTED|Overall Study||10
175406|NCT00943124|422683|P2|NOT COMPLETED|Period 2||0
175407|NCT00943124|422684|P1|NOT COMPLETED|Period 2||0
175408|NCT00943124|422683|P2|COMPLETED|Period 2||108
175409|NCT00943124|422684|P1|COMPLETED|Period 2||108
175410|NCT00943124|422683|P2|STARTED|Period 2||108
175411|NCT00943124|422684|P1|STARTED|Period 2||108
175412|NCT00943124|422683|P2|NOT COMPLETED|Period 1||2
175413|NCT00943124|422684|P1|NOT COMPLETED|Period 1||2
175414|NCT00943124|422683|P2|COMPLETED|Period 1||108
175415|NCT00943124|422684|P1|COMPLETED|Period 1||108
175416|NCT00943124|422683|P2|STARTED|Period 1||110
175417|NCT00943124|422684|P1|STARTED|Period 1||110
175418|NCT00943111|422706|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
175419|NCT00943111|422707|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
175420|NCT00943111|422708|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
175421|NCT00943111|422706|P3|COMPLETED|5 Years Long-term Treatment Period||77
175422|NCT00943111|422707|P2|COMPLETED|5 Years Long-term Treatment Period||0
175423|NCT00943111|422708|P1|COMPLETED|5 Years Long-term Treatment Period||0
175424|NCT00943111|422706|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
175425|NCT00943111|422707|P2|STARTED|5 Years Long-term Treatment Period||0
175426|NCT00943111|422708|P1|STARTED|5 Years Long-term Treatment Period||0
175427|NCT00943111|422706|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
175428|NCT00943111|422707|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
175429|NCT00943111|422708|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
175430|NCT00943111|422706|P3|COMPLETED|52-Weeks Primary Analysis Period||0
175431|NCT00943111|422707|P2|COMPLETED|52-Weeks Primary Analysis Period||52
175432|NCT00943111|422708|P1|COMPLETED|52-Weeks Primary Analysis Period||104
175433|NCT00943111|422706|P3|Treated|52-Weeks Primary Analysis Period||0
175434|NCT00943111|422707|P2|Treated|52-Weeks Primary Analysis Period||53
175435|NCT00943111|422708|P1|Treated|52-Weeks Primary Analysis Period||106
175436|NCT00943111|422706|P3|STARTED|52-Weeks Primary Analysis Period||0
175437|NCT00943111|422707|P2|STARTED|52-Weeks Primary Analysis Period||54
175438|NCT00943111|422708|P1|STARTED|52-Weeks Primary Analysis Period||106
175439|NCT00943098|422741|P2|NOT COMPLETED|Overall Study||0
175440|NCT00943098|422742|P1|NOT COMPLETED|Overall Study||0
175441|NCT00943098|422741|P2|COMPLETED|Overall Study||72
175442|NCT00943098|422742|P1|COMPLETED|Overall Study||70
175443|NCT00943098|422741|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
175444|NCT00943098|422742|P1|STARTED|Overall Study||70
175445|NCT00943072|422776|P2|NOT COMPLETED|Overall Study||14
175446|NCT00943072|422777|P1|NOT COMPLETED|Overall Study||5
175447|NCT00943072|422776|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
175448|NCT00943072|422777|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
175449|NCT00943072|422776|P2|Full Analysis Set (FAS) Population|Overall Study||73
175450|NCT00943072|422777|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
175451|NCT00943072|422776|P2|Participants Received Treatment|Overall Study||74
175452|NCT00943072|422777|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
175453|NCT00943072|422776|P2|STARTED|Overall Study||74
175454|NCT00943072|422777|P1|STARTED|Overall Study||115
175455|NCT00942994|422795|P2|NOT COMPLETED|Overall Study||19
175456|NCT00942994|422796|P1|NOT COMPLETED|Overall Study||16
175457|NCT00942994|422795|P2|COMPLETED|Overall Study||190
175458|NCT00942994|422796|P1|COMPLETED|Overall Study||187
175459|NCT00942994|422795|P2|STARTED|Overall Study||209
175460|NCT00942994|422796|P1|STARTED|Overall Study||203
175461|NCT00942968|422812|P1|NOT COMPLETED|Overall Study||229
175462|NCT00942968|422812|P1|COMPLETED|Overall Study||109
175463|NCT00942968|422812|P1|Treated|Overall Study||334
175464|NCT00942968|422812|P1|STARTED|Overall Study||338
175465|NCT00942903|422833|P1|NOT COMPLETED|Overall Study||0
175466|NCT00942903|422833|P1|COMPLETED|Overall Study||20
175467|NCT00942903|422833|P1|STARTED|Overall Study||20
175468|NCT00942890|422840|P2|NOT COMPLETED|Overall Study||0
175469|NCT00942890|422841|P1|NOT COMPLETED|Overall Study||0
175470|NCT00942890|422840|P2|COMPLETED|Overall Study||23
175471|NCT00942890|422841|P1|COMPLETED|Overall Study||21
175472|NCT00942890|422840|P2|STARTED|Overall Study||23
175473|NCT00942890|422841|P1|STARTED|Overall Study||21
175474|NCT00942851|422863|P2|NOT COMPLETED|Overall Study||1
175475|NCT00942851|422864|P1|NOT COMPLETED|Overall Study||0
175476|NCT00942851|422863|P2|COMPLETED|Overall Study||11
175477|NCT00942851|422864|P1|COMPLETED|Overall Study||12
175478|NCT00942851|422863|P2|STARTED|Overall Study||12
175479|NCT00942851|422864|P1|STARTED|Overall Study||12
175480|NCT00942825|422876|P2|NOT COMPLETED|Overall Study||0
175481|NCT00942825|422877|P1|NOT COMPLETED|Overall Study||0
175482|NCT00942825|422876|P2|COMPLETED|Overall Study||98
175483|NCT00942825|422877|P1|COMPLETED|Overall Study||97
175484|NCT00942825|422876|P2|STARTED|Overall Study||98
175485|NCT00942825|422877|P1|STARTED|Overall Study||97
175486|NCT00942786|422883|P1|NOT COMPLETED|Overall Study||0
175487|NCT00942786|422883|P1|COMPLETED|Overall Study|date of last follow-up|297
175488|NCT00942786|422883|P1|STARTED|Overall Study||297
175489|NCT00942734|422890|P1|NOT COMPLETED|Overall Study||8
175490|NCT00942734|422890|P1|COMPLETED|Overall Study||35
175491|NCT00942734|422890|P1|STARTED|Overall Study||43
175492|NCT00942604|422896|P2|NOT COMPLETED|Overall Study||4
175493|NCT00942604|422897|P1|NOT COMPLETED|Overall Study||2
175494|NCT00942604|422896|P2|COMPLETED|Overall Study||99
175495|NCT00942604|422897|P1|COMPLETED|Overall Study||98
175496|NCT00942604|422896|P2|STARTED|Overall Study||103
175497|NCT00942604|422897|P1|STARTED|Overall Study||100
175498|NCT00942448|422909|P4|NOT COMPLETED|Overall Study||0
175499|NCT00942448|422910|P3|NOT COMPLETED|Overall Study||0
175500|NCT00942448|422911|P2|NOT COMPLETED|Overall Study||0
175501|NCT00942448|422912|P1|NOT COMPLETED|Overall Study||0
175502|NCT00942448|422909|P4|COMPLETED|Overall Study||75
175503|NCT00942448|422910|P3|COMPLETED|Overall Study||78
175504|NCT00942448|422911|P2|COMPLETED|Overall Study||76
175505|NCT00942448|422912|P1|COMPLETED|Overall Study||77
175506|NCT00942448|422909|P4|STARTED|Overall Study||75
175507|NCT00942448|422910|P3|STARTED|Overall Study||78
175508|NCT00942448|422911|P2|STARTED|Overall Study||76
175509|NCT00942448|422912|P1|STARTED|Overall Study||77
175510|NCT00942422|422974|P1|NOT COMPLETED|Overall Study||3
175511|NCT00942422|422974|P1|COMPLETED|Overall Study||5
175512|NCT00942422|422974|P1|STARTED|Overall Study||8
175513|NCT00942409|422978|P1|NOT COMPLETED|Overall Study||3
175514|NCT00942409|422978|P1|COMPLETED|Overall Study||2
175515|NCT00942409|422978|P1|STARTED|Overall Study||5
175516|NCT00942266|422984|P2|NOT COMPLETED|Overall Study||15
175517|NCT00942266|422985|P1|NOT COMPLETED|Overall Study||43
175518|NCT00942266|422984|P2|COMPLETED|Overall Study||0
175519|NCT00942266|422985|P1|COMPLETED|Overall Study||0
175520|NCT00942266|422984|P2|STARTED|Overall Study||15
175521|NCT00942266|422985|P1|STARTED|Overall Study||43
175522|NCT00942188|423007|P4|NOT COMPLETED|Overall Study||4
175523|NCT00942188|423008|P3|NOT COMPLETED|Overall Study||9
175524|NCT00942188|423009|P2|NOT COMPLETED|Overall Study||10
175525|NCT00942188|423010|P1|NOT COMPLETED|Overall Study||4
175526|NCT00942188|423007|P4|COMPLETED|Overall Study||23
175527|NCT00942188|423008|P3|COMPLETED|Overall Study||18
175528|NCT00942188|423009|P2|COMPLETED|Overall Study||16
175529|NCT00942188|423010|P1|COMPLETED|Overall Study||22
175530|NCT00942188|423007|P4|STARTED|Overall Study||27
175531|NCT00942188|423008|P3|STARTED|Overall Study||27
175532|NCT00942188|423009|P2|STARTED|Overall Study||26
175533|NCT00942188|423010|P1|STARTED|Overall Study||26
175534|NCT00942175|423049|P4|NOT COMPLETED|Overall Study||2
175535|NCT00942175|423050|P3|NOT COMPLETED|Overall Study||2
175536|NCT00942175|423051|P2|NOT COMPLETED|Overall Study||4
175537|NCT00942175|423052|P1|NOT COMPLETED|Overall Study||2
175538|NCT00942175|423049|P4|COMPLETED|Overall Study||38
175539|NCT00942175|423050|P3|COMPLETED|Overall Study||38
175540|NCT00942175|423051|P2|COMPLETED|Overall Study||36
175541|NCT00942175|423052|P1|COMPLETED|Overall Study||38
175542|NCT00942175|423049|P4|STARTED|Overall Study||40
175543|NCT00942175|423050|P3|STARTED|Overall Study||40
175544|NCT00942175|423051|P2|STARTED|Overall Study||40
175545|NCT00942175|423052|P1|STARTED|Overall Study||40
175546|NCT00942149|423102|P1|NOT COMPLETED|Overall Study||0
175547|NCT00942149|423102|P1|COMPLETED|Overall Study||20
175548|NCT00942149|423102|P1|STARTED|Overall Study||20
175549|NCT00942084|423106|P1|NOT COMPLETED|Overall Study||2
175550|NCT00942084|423106|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
175551|NCT00942084|423106|P1|STARTED|Overall Study||32
175552|NCT00941993|423115|P1|NOT COMPLETED|Overall Study||0
175553|NCT00941993|423115|P1|COMPLETED|Overall Study||109
175554|NCT00941993|423115|P1|STARTED|Overall Study||109
175555|NCT00941928|423123|P1|NOT COMPLETED|Overall Study||2
175556|NCT00941928|423123|P1|COMPLETED|Overall Study||0
175557|NCT00941928|423123|P1|STARTED|Overall Study||2
175558|NCT00941889|423129|P2|NOT COMPLETED|Overall Study||12
175559|NCT00941889|423130|P1|NOT COMPLETED|Overall Study||12
175560|NCT00941889|423129|P2|COMPLETED|Overall Study||3
175561|NCT00941889|423130|P1|COMPLETED|Overall Study||5
175562|NCT00941889|423129|P2|STARTED|Overall Study||15
175563|NCT00941889|423130|P1|STARTED|Overall Study||17
175564|NCT00941863|423141|P5|NOT COMPLETED|Continued After PCD||19
175565|NCT00941863|423142|P4|NOT COMPLETED|Continued After PCD||0
175566|NCT00941863|423143|P3|NOT COMPLETED|Continued After PCD||0
175567|NCT00941863|423144|P2|NOT COMPLETED|Continued After PCD||0
175568|NCT00941863|423145|P1|NOT COMPLETED|Continued After PCD||0
175569|NCT00941863|423141|P5|COMPLETED|Continued After PCD||6
175570|NCT00941863|423142|P4|COMPLETED|Continued After PCD||0
175571|NCT00941863|423143|P3|COMPLETED|Continued After PCD||0
175572|NCT00941863|423144|P2|COMPLETED|Continued After PCD||0
175573|NCT00941863|423145|P1|COMPLETED|Continued After PCD||0
175574|NCT00941863|423141|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
175575|NCT00941863|423142|P4|STARTED|Continued After PCD||0
175576|NCT00941863|423143|P3|STARTED|Continued After PCD||0
175577|NCT00941863|423144|P2|STARTED|Continued After PCD||0
175578|NCT00941863|423145|P1|STARTED|Continued After PCD||0
175579|NCT00941863|423141|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
175580|NCT00941863|423142|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
175581|NCT00941863|423143|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
175582|NCT00941863|423144|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
175583|NCT00941863|423145|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
175584|NCT00941863|423141|P5|COMPLETED|Until Primary Completion Date (PCD)||25
175585|NCT00941863|423142|P4|COMPLETED|Until Primary Completion Date (PCD)||0
175586|NCT00941863|423143|P3|COMPLETED|Until Primary Completion Date (PCD)||0
175587|NCT00941863|423144|P2|COMPLETED|Until Primary Completion Date (PCD)||0
175588|NCT00941863|423145|P1|COMPLETED|Until Primary Completion Date (PCD)||0
175589|NCT00941863|423141|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
175590|NCT00941863|423142|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
175591|NCT00941863|423143|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
175592|NCT00941863|423144|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
175593|NCT00941863|423145|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
175594|NCT00941863|423141|P5|STARTED|Until Primary Completion Date (PCD)||119
175595|NCT00941863|423142|P4|STARTED|Until Primary Completion Date (PCD)||17
175596|NCT00941863|423143|P3|STARTED|Until Primary Completion Date (PCD)||12
175597|NCT00941863|423144|P2|STARTED|Until Primary Completion Date (PCD)||3
175598|NCT00941863|423145|P1|STARTED|Until Primary Completion Date (PCD)||7
175599|NCT00941798|423172|P2|NOT COMPLETED|Overall Study||185
175600|NCT00941798|423173|P1|NOT COMPLETED|Overall Study||194
175601|NCT00941798|423172|P2|COMPLETED|Overall Study||578
175602|NCT00941798|423173|P1|COMPLETED|Overall Study||561
175603|NCT00941798|423172|P2|Full Analysis Set|Overall Study||759
175604|NCT00941798|423173|P1|Full Analysis Set|Overall Study||749
175605|NCT00941798|423172|P2|STARTED|Overall Study||763
175606|NCT00941798|423173|P1|STARTED|Overall Study||755
175607|NCT00941733|423203|P2|NOT COMPLETED|Overall Study||28
175608|NCT00941733|423204|P1|NOT COMPLETED|Overall Study||74
175609|NCT00941733|423203|P2|COMPLETED|Overall Study|1 year follow-up|91
175610|NCT00941733|423204|P1|COMPLETED|Overall Study|1 year follow-up|165
175611|NCT00941733|423203|P2|STARTED|Overall Study||119
175612|NCT00941733|423204|P1|STARTED|Overall Study||239
175613|NCT00941720|423244|P1|NOT COMPLETED|Overall Study||14
175614|NCT00941720|423244|P1|COMPLETED|Overall Study||57
175615|NCT00941720|423244|P1|STARTED|Overall Study||71
175616|NCT00941681|423253|P3|NOT COMPLETED|Overall Study||0
175617|NCT00941681|423254|P2|NOT COMPLETED|Overall Study||1
175618|NCT00941681|423255|P1|NOT COMPLETED|Overall Study||0
175619|NCT00941681|423253|P3|COMPLETED|Overall Study||12
175620|NCT00941681|423254|P2|COMPLETED|Overall Study||10
175621|NCT00941681|423255|P1|COMPLETED|Overall Study||12
175622|NCT00941681|423253|P3|STARTED|Overall Study||12
175623|NCT00941681|423254|P2|STARTED|Overall Study||11
175624|NCT00941681|423255|P1|STARTED|Overall Study||12
175625|NCT00941668|423280|P2|NOT COMPLETED|Overall Study||25
175626|NCT00941668|423281|P1|NOT COMPLETED|Overall Study||24
175627|NCT00941668|423280|P2|COMPLETED|Overall Study||0
175628|NCT00941668|423281|P1|COMPLETED|Overall Study||0
175629|NCT00941668|423280|P2|STARTED|Overall Study||25
175630|NCT00941668|423281|P1|STARTED|Overall Study||24
175631|NCT00941655|423291|P2|NOT COMPLETED|Overall Study||5
175632|NCT00941655|423292|P1|NOT COMPLETED|Overall Study||5
175633|NCT00941655|423291|P2|COMPLETED|Overall Study||2
175634|NCT00941655|423292|P1|COMPLETED|Overall Study||3
175635|NCT00941655|423291|P2|STARTED|Overall Study||7
175636|NCT00941655|423292|P1|STARTED|Overall Study||8
175637|NCT00941603|423317|P6|NOT COMPLETED|Overall Study||3
175638|NCT00941603|423318|P5|NOT COMPLETED|Overall Study||4
175639|NCT00941603|423319|P4|NOT COMPLETED|Overall Study||4
175640|NCT00941603|423320|P3|NOT COMPLETED|Overall Study||5
175641|NCT00941603|423321|P2|NOT COMPLETED|Overall Study||16
175642|NCT00941603|423322|P1|NOT COMPLETED|Overall Study||11
175643|NCT00941603|423317|P6|COMPLETED|Overall Study||94
175644|NCT00941603|423318|P5|COMPLETED|Overall Study||101
175645|NCT00941603|423319|P4|COMPLETED|Overall Study||100
175646|NCT00941603|423320|P3|COMPLETED|Overall Study||99
175647|NCT00941603|423321|P2|COMPLETED|Overall Study||89
175648|NCT00941603|423322|P1|COMPLETED|Overall Study||93
175649|NCT00941603|423317|P6|STARTED|Overall Study||97
175650|NCT00941603|423318|P5|STARTED|Overall Study||105
175651|NCT00941603|423319|P4|STARTED|Overall Study||104
175652|NCT00941603|423320|P3|STARTED|Overall Study||104
175653|NCT00941603|423321|P2|STARTED|Overall Study||105
175654|NCT00941603|423322|P1|STARTED|Overall Study||104
175655|NCT00941330|423344|P2|NOT COMPLETED|Overall Study||2
175656|NCT00941330|423345|P1|NOT COMPLETED|Overall Study||1
175657|NCT00941330|423344|P2|COMPLETED|Overall Study||9
175658|NCT00941330|423345|P1|COMPLETED|Overall Study||14
175659|NCT00941330|423344|P2|STARTED|Overall Study||11
175660|NCT00941330|423345|P1|STARTED|Overall Study||15
175661|NCT00941304|423358|P5|NOT COMPLETED|Overall Study||0
175662|NCT00941304|423359|P4|NOT COMPLETED|Overall Study||0
175663|NCT00941304|423360|P3|NOT COMPLETED|Overall Study||0
175664|NCT00941304|423361|P2|NOT COMPLETED|Overall Study||0
175665|NCT00941304|423362|P1|NOT COMPLETED|Overall Study||1
175666|NCT00941304|423358|P5|COMPLETED|Overall Study||31
175667|NCT00941304|423359|P4|COMPLETED|Overall Study||30
175668|NCT00941304|423360|P3|COMPLETED|Overall Study||31
175669|NCT00941304|423361|P2|COMPLETED|Overall Study||30
175670|NCT00941304|423362|P1|COMPLETED|Overall Study||30
175671|NCT00941304|423358|P5|STARTED|Overall Study||31
175672|NCT00941304|423359|P4|STARTED|Overall Study||30
175673|NCT00941304|423360|P3|STARTED|Overall Study||31
175674|NCT00941304|423361|P2|STARTED|Overall Study||30
175675|NCT00941304|423362|P1|STARTED|Overall Study||31
175676|NCT00941070|423424|P1|NOT COMPLETED|Overall Study||1
175677|NCT00941070|423424|P1|COMPLETED|Overall Study||25
175678|NCT00941070|423424|P1|STARTED|Overall Study||26
175679|NCT00941031|423444|P7|NOT COMPLETED|Maintenance Period||43
175680|NCT00941031|423445|P6|NOT COMPLETED|Maintenance Period||6
175681|NCT00941031|423446|P5|NOT COMPLETED|Maintenance Period||9
175682|NCT00941031|423447|P4|NOT COMPLETED|Maintenance Period||0
175683|NCT00941031|423448|P3|NOT COMPLETED|Maintenance Period||0
175684|NCT00941031|423449|P2|NOT COMPLETED|Maintenance Period||0
175685|NCT00941031|423450|P1|NOT COMPLETED|Maintenance Period||0
175686|NCT00941031|423444|P7|COMPLETED|Maintenance Period||204
175687|NCT00941031|423445|P6|COMPLETED|Maintenance Period||61
175688|NCT00941031|423446|P5|COMPLETED|Maintenance Period||56
175689|NCT00941031|423447|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
175690|NCT00941031|423448|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
175691|NCT00941031|423449|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
175692|NCT00941031|423450|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
175693|NCT00941031|423444|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
175694|NCT00941031|423445|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
175695|NCT00941031|423446|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
175696|NCT00941031|423447|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
175697|NCT00941031|423448|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
175787|NCT00940446|423602|P1|COMPLETED|Overall Study||30
175698|NCT00941031|423449|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
175699|NCT00941031|423450|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
175700|NCT00941031|423444|P7|NOT COMPLETED|Induction Period||0
175701|NCT00941031|423445|P6|NOT COMPLETED|Induction Period||0
175702|NCT00941031|423446|P5|NOT COMPLETED|Induction Period||0
175703|NCT00941031|423447|P4|NOT COMPLETED|Induction Period||9
175704|NCT00941031|423448|P3|NOT COMPLETED|Induction Period||6
175705|NCT00941031|423449|P2|NOT COMPLETED|Induction Period||4
175706|NCT00941031|423450|P1|NOT COMPLETED|Induction Period||5
175707|NCT00941031|423444|P7|COMPLETED|Induction Period||0
175708|NCT00941031|423445|P6|COMPLETED|Induction Period||0
175709|NCT00941031|423446|P5|COMPLETED|Induction Period||0
175710|NCT00941031|423447|P4|COMPLETED|Induction Period||58
175711|NCT00941031|423448|P3|COMPLETED|Induction Period||127
175712|NCT00941031|423449|P2|COMPLETED|Induction Period||134
175713|NCT00941031|423450|P1|COMPLETED|Induction Period||61
175714|NCT00941031|423444|P7|STARTED|Induction Period||0
175715|NCT00941031|423445|P6|STARTED|Induction Period||0
175716|NCT00941031|423446|P5|STARTED|Induction Period||0
175717|NCT00941031|423447|P4|STARTED|Induction Period||67
175718|NCT00941031|423448|P3|STARTED|Induction Period||133
175719|NCT00941031|423449|P2|STARTED|Induction Period||138
175720|NCT00941031|423450|P1|STARTED|Induction Period||66
175721|NCT00940992|423476|P3|NOT COMPLETED|Overall Study||2
175722|NCT00940992|423477|P2|NOT COMPLETED|Overall Study||2
175723|NCT00940992|423478|P1|NOT COMPLETED|Overall Study||4
175724|NCT00940992|423476|P3|COMPLETED|Overall Study||28
175725|NCT00940992|423477|P2|COMPLETED|Overall Study||28
175726|NCT00940992|423478|P1|COMPLETED|Overall Study||28
175727|NCT00940992|423476|P3|STARTED|Overall Study||30
175728|NCT00940992|423477|P2|STARTED|Overall Study||30
175729|NCT00940992|423478|P1|STARTED|Overall Study||32
175730|NCT00940927|423489|P1|NOT COMPLETED|Overall Study||0
175731|NCT00940927|423489|P1|COMPLETED|Overall Study||81
175732|NCT00940927|423489|P1|STARTED|Overall Study||81
175733|NCT00940901|423496|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
175734|NCT00940901|423497|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
175735|NCT00940901|423496|P2|COMPLETED|Week 9-16 (Phase 2)||4
175736|NCT00940901|423497|P1|COMPLETED|Week 9-16 (Phase 2)||4
175737|NCT00940901|423496|P2|STARTED|Week 9-16 (Phase 2)||7
175738|NCT00940901|423497|P1|STARTED|Week 9-16 (Phase 2)||6
175739|NCT00940901|423496|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
175740|NCT00940901|423497|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
175741|NCT00940901|423496|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
175742|NCT00940901|423497|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
175743|NCT00940901|423496|P2|STARTED|Weeks 1-8 (Phase 1)||7
175744|NCT00940901|423497|P1|STARTED|Weeks 1-8 (Phase 1)||6
175745|NCT00940888|423507|P1|NOT COMPLETED|Overall Study||835
175746|NCT00940888|423507|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
175747|NCT00940888|423507|P1|STARTED|Overall Study|Total number of subjects consented|1701
175748|NCT00940875|423514|P2|NOT COMPLETED|Post-Study Treatment||3
175749|NCT00940875|423515|P1|NOT COMPLETED|Post-Study Treatment||0
175750|NCT00940875|423514|P2|COMPLETED|Post-Study Treatment||1
175751|NCT00940875|423515|P1|COMPLETED|Post-Study Treatment||0
175752|NCT00940875|423514|P2|STARTED|Post-Study Treatment||4
175753|NCT00940875|423515|P1|STARTED|Post-Study Treatment||0
175754|NCT00940875|423514|P2|NOT COMPLETED|Treatment Phase||19
175755|NCT00940875|423515|P1|NOT COMPLETED|Treatment Phase||26
175756|NCT00940875|423514|P2|COMPLETED|Treatment Phase||4
175757|NCT00940875|423515|P1|COMPLETED|Treatment Phase||5
175758|NCT00940875|423514|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
175759|NCT00940875|423515|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
175760|NCT00940823|423535|P2|NOT COMPLETED|Overall Study||32
175761|NCT00940823|423536|P1|NOT COMPLETED|Overall Study||35
175762|NCT00940823|423535|P2|COMPLETED|Overall Study||82
175763|NCT00940823|423536|P1|COMPLETED|Overall Study||89
175764|NCT00940823|423535|P2|STARTED|Overall Study||114
175765|NCT00940823|423536|P1|STARTED|Overall Study||124
175766|NCT00940576|423552|P2|NOT COMPLETED|Overall Study||0
175767|NCT00940576|423553|P1|NOT COMPLETED|Overall Study||0
175768|NCT00940576|423552|P2|COMPLETED|Overall Study||9
175769|NCT00940576|423553|P1|COMPLETED|Overall Study||8
175770|NCT00940576|423552|P2|STARTED|Overall Study||9
175771|NCT00940576|423553|P1|STARTED|Overall Study||8
175772|NCT00940537|423562|P2|NOT COMPLETED|Overall Study||0
175773|NCT00940537|423563|P1|NOT COMPLETED|Overall Study||0
175774|NCT00940537|423562|P2|COMPLETED|Overall Study||9
175775|NCT00940537|423563|P1|COMPLETED|Overall Study||5
175776|NCT00940537|423562|P2|STARTED|Overall Study||9
175777|NCT00940537|423563|P1|STARTED|Overall Study||5
175778|NCT00940485|423574|P2|NOT COMPLETED|Overall Study||7
175779|NCT00940485|423575|P1|NOT COMPLETED|Overall Study||15
175780|NCT00940485|423574|P2|COMPLETED|Overall Study||93
175781|NCT00940485|423575|P1|COMPLETED|Overall Study||82
175782|NCT00940485|423574|P2|STARTED|Overall Study||100
175783|NCT00940485|423575|P1|STARTED|Overall Study||97
175784|NCT00940446|423601|P2|NOT COMPLETED|Overall Study||0
175785|NCT00940446|423602|P1|NOT COMPLETED|Overall Study||0
175786|NCT00940446|423601|P2|COMPLETED|Overall Study||30
175788|NCT00940446|423601|P2|STARTED|Overall Study||30
175789|NCT00940446|423602|P1|STARTED|Overall Study||30
175790|NCT00940290|423614|P4|NOT COMPLETED|Overall Study||0
175791|NCT00940290|423615|P3|NOT COMPLETED|Overall Study||0
175792|NCT00940290|423616|P2|NOT COMPLETED|Overall Study||0
175793|NCT00940290|423617|P1|NOT COMPLETED|Overall Study||0
175794|NCT00940290|423614|P4|COMPLETED|Overall Study||54
175795|NCT00940290|423615|P3|COMPLETED|Overall Study||55
175796|NCT00940290|423616|P2|COMPLETED|Overall Study||53
175797|NCT00940290|423617|P1|COMPLETED|Overall Study||54
175798|NCT00940290|423614|P4|STARTED|Overall Study||54
175799|NCT00940290|423615|P3|STARTED|Overall Study||55
175800|NCT00940290|423616|P2|STARTED|Overall Study||53
175801|NCT00940290|423617|P1|STARTED|Overall Study||54
175802|NCT00940108|423631|P4|NOT COMPLETED|Overall Study||5
175803|NCT00940108|423632|P3|NOT COMPLETED|Overall Study||3
175804|NCT00940108|423633|P2|NOT COMPLETED|Overall Study||9
175805|NCT00940108|423634|P1|NOT COMPLETED|Overall Study||5
175806|NCT00940108|423631|P4|COMPLETED|Overall Study||99
175807|NCT00940108|423632|P3|COMPLETED|Overall Study||100
175808|NCT00940108|423633|P2|COMPLETED|Overall Study||71
175809|NCT00940108|423634|P1|COMPLETED|Overall Study||77
175810|NCT00940108|423631|P4|STARTED|Overall Study||104
175811|NCT00940108|423632|P3|STARTED|Overall Study||103
175812|NCT00940108|423633|P2|STARTED|Overall Study||80
175813|NCT00940108|423634|P1|STARTED|Overall Study||82
175814|NCT00940017|423684|P1|NOT COMPLETED|Overall Study||4
175815|NCT00940017|423684|P1|COMPLETED|Overall Study||20
175816|NCT00940017|423684|P1|Subjects Treated|Overall Study||21
175817|NCT00940017|423684|P1|STARTED|Overall Study||24
175818|NCT00939991|423705|P2|NOT COMPLETED|Overall Study||0
175819|NCT00939991|423706|P1|NOT COMPLETED|Overall Study||0
175820|NCT00939991|423705|P2|COMPLETED|Overall Study||39
175821|NCT00939991|423706|P1|COMPLETED|Overall Study||9
175822|NCT00939991|423705|P2|STARTED|Overall Study||39
175823|NCT00939991|423706|P1|STARTED|Overall Study||9
175824|NCT00939952|423716|P1|NOT COMPLETED|Overall Study||0
175825|NCT00939952|423716|P1|COMPLETED|Overall Study||7
175826|NCT00939952|423716|P1|STARTED|Overall Study||7
175827|NCT00939900|423728|P2|NOT COMPLETED|Overall Study||7
175828|NCT00939900|423729|P1|NOT COMPLETED|Overall Study||2
175829|NCT00939900|423728|P2|COMPLETED|Overall Study||48
175830|NCT00939900|423729|P1|COMPLETED|Overall Study||53
175831|NCT00939900|423728|P2|STARTED|Overall Study||55
175832|NCT00939900|423729|P1|STARTED|Overall Study||55
175833|NCT00939874|423735|P1|NOT COMPLETED|Overall Study||20
175834|NCT00939874|423735|P1|COMPLETED|Overall Study||32
175835|NCT00939874|423735|P1|Completed Week 48|Overall Study||37
175836|NCT00939874|423735|P1|STARTED|Overall Study||52
175837|NCT00939809|423740|P1|NOT COMPLETED|Overall Study||3
175838|NCT00939809|423740|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
175839|NCT00939809|423740|P1|STARTED|Overall Study||31
175840|NCT00939796|423748|P1|NOT COMPLETED|Overall Study||0
175841|NCT00939796|423748|P1|COMPLETED|Overall Study||16
175842|NCT00939796|423748|P1|STARTED|Overall Study||16
175843|NCT00939783|423754|P1|NOT COMPLETED|Overall Study||649
175844|NCT00939783|423754|P1|COMPLETED|Overall Study||0
175845|NCT00939783|423754|P1|Treated|Overall Study||648
175846|NCT00939783|423754|P1|STARTED|Overall Study||649
175847|NCT00939731|423761|P2|NOT COMPLETED|Second Intervention Period||0
175848|NCT00939731|423762|P1|NOT COMPLETED|Second Intervention Period||0
175849|NCT00939731|423761|P2|COMPLETED|Second Intervention Period||12
175850|NCT00939731|423762|P1|COMPLETED|Second Intervention Period||12
175851|NCT00939731|423761|P2|STARTED|Second Intervention Period||12
175852|NCT00939731|423762|P1|STARTED|Second Intervention Period||12
175853|NCT00939731|423761|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
175854|NCT00939731|423762|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
175855|NCT00939731|423761|P2|COMPLETED|Washout Period (at Least 14 Days)||12
175856|NCT00939731|423762|P1|COMPLETED|Washout Period (at Least 14 Days)||12
175857|NCT00939731|423761|P2|STARTED|Washout Period (at Least 14 Days)||12
175858|NCT00939731|423762|P1|STARTED|Washout Period (at Least 14 Days)||12
175859|NCT00939731|423761|P2|NOT COMPLETED|First Intervention Period||0
175860|NCT00939731|423762|P1|NOT COMPLETED|First Intervention Period||0
175861|NCT00939731|423761|P2|COMPLETED|First Intervention Period||12
175862|NCT00939731|423762|P1|COMPLETED|First Intervention Period||12
175863|NCT00939731|423761|P2|STARTED|First Intervention Period||12
175864|NCT00939731|423762|P1|STARTED|First Intervention Period||12
175865|NCT00939705|423782|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
175866|NCT00939705|423783|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
175867|NCT00939705|423782|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
175868|NCT00939705|423783|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
175869|NCT00939705|423782|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
175870|NCT00939705|423783|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
175871|NCT00939705|423782|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
175872|NCT00939705|423783|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
175873|NCT00939705|423782|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
175874|NCT00939705|423783|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
175875|NCT00939705|423782|P2|STARTED|Period 2 - Washout Period - 21 Days||9
175876|NCT00939705|423783|P1|STARTED|Period 2 - Washout Period - 21 Days||9
175877|NCT00939705|423782|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
175878|NCT00939705|423783|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
175879|NCT00939705|423782|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
175880|NCT00939705|423783|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
175881|NCT00939705|423782|P2|STARTED|Period 1 - First Intervention - 5 Days||9
175882|NCT00939705|423783|P1|STARTED|Period 1 - First Intervention - 5 Days||9
175883|NCT00939692|423795|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
175884|NCT00939692|423796|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
175885|NCT00939692|423795|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
175886|NCT00939692|423796|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
175887|NCT00939692|423795|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
175888|NCT00939692|423796|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
175889|NCT00939692|423795|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
175890|NCT00939692|423796|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
175891|NCT00939692|423795|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
175892|NCT00939692|423796|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
175893|NCT00939692|423795|P2|STARTED|Period 1 - First Intervention - 5 Days||13
175894|NCT00939692|423796|P1|STARTED|Period 1 - First Intervention - 5 Days||13
175895|NCT00939627|423808|P3|NOT COMPLETED|Overall Study||0
175896|NCT00939627|423809|P2|NOT COMPLETED|Overall Study||28
175897|NCT00939627|423810|P1|NOT COMPLETED|Overall Study||27
175898|NCT00939627|423808|P3|COMPLETED|Overall Study||0
175899|NCT00939627|423809|P2|COMPLETED|Overall Study||0
175900|NCT00939627|423810|P1|COMPLETED|Overall Study||0
175901|NCT00939627|423808|P3|STARTED|Overall Study||0
175902|NCT00939627|423809|P2|STARTED|Overall Study||28
175903|NCT00939627|423810|P1|STARTED|Overall Study||27
175904|NCT00939562|423828|P2|NOT COMPLETED|Period 2||0
175905|NCT00939562|423829|P1|NOT COMPLETED|Period 2||0
175906|NCT00939562|423828|P2|COMPLETED|Period 2||12
175907|NCT00939562|423829|P1|COMPLETED|Period 2||12
175908|NCT00939562|423828|P2|STARTED|Period 2||12
175909|NCT00939562|423829|P1|STARTED|Period 2||12
175910|NCT00939562|423828|P2|NOT COMPLETED|Period 1||0
175911|NCT00939562|423829|P1|NOT COMPLETED|Period 1||0
175912|NCT00939562|423828|P2|COMPLETED|Period 1||12
175913|NCT00939562|423829|P1|COMPLETED|Period 1||12
175914|NCT00939562|423828|P2|STARTED|Period 1||12
175915|NCT00939562|423829|P1|STARTED|Period 1||12
175916|NCT00939536|423839|P2|NOT COMPLETED|Second Intervention||0
175917|NCT00939536|423840|P1|NOT COMPLETED|Second Intervention||0
175918|NCT00939536|423839|P2|COMPLETED|Second Intervention||12
175919|NCT00939536|423840|P1|COMPLETED|Second Intervention||12
175920|NCT00939536|423839|P2|STARTED|Second Intervention||12
175921|NCT00939536|423840|P1|STARTED|Second Intervention||12
175922|NCT00939536|423839|P2|NOT COMPLETED|First Intervention||0
175923|NCT00939536|423840|P1|NOT COMPLETED|First Intervention||0
175924|NCT00939536|423839|P2|COMPLETED|First Intervention||12
175925|NCT00939536|423840|P1|COMPLETED|First Intervention||12
175926|NCT00939536|423839|P2|STARTED|First Intervention||12
175927|NCT00939536|423840|P1|STARTED|First Intervention||12
175928|NCT00939510|423850|P1|NOT COMPLETED|Overall Study||1
175929|NCT00939510|423850|P1|COMPLETED|Overall Study||31
175930|NCT00939510|423850|P1|STARTED|Overall Study||32
175931|NCT00939484|423859|P3|NOT COMPLETED|Overall Study||3
175932|NCT00939484|423860|P2|NOT COMPLETED|Overall Study||20
175933|NCT00939484|423861|P1|NOT COMPLETED|Overall Study||8
175934|NCT00939484|423859|P3|COMPLETED|Overall Study||0
175935|NCT00939484|423860|P2|COMPLETED|Overall Study||0
175936|NCT00939484|423861|P1|COMPLETED|Overall Study||0
175937|NCT00939484|423859|P3|STARTED|Overall Study||3
175938|NCT00939484|423860|P2|STARTED|Overall Study||20
175939|NCT00939484|423861|P1|STARTED|Overall Study||8
175940|NCT00939471|423874|P1|NOT COMPLETED|Overall Study||11
175941|NCT00939471|423874|P1|COMPLETED|Overall Study||33
175942|NCT00939471|423874|P1|STARTED|Overall Study||44
175943|NCT00939393|423887|P2|NOT COMPLETED|Overall Study||0
175944|NCT00939393|423888|P1|NOT COMPLETED|Overall Study||4
175945|NCT00939393|423887|P2|COMPLETED|Overall Study||35
175946|NCT00939393|423888|P1|COMPLETED|Overall Study||33
175947|NCT00939393|423887|P2|STARTED|Overall Study||35
175948|NCT00939393|423888|P1|STARTED|Overall Study||37
175949|NCT00939367|423908|P2|NOT COMPLETED|Second Intervention||0
175950|NCT00939367|423909|P1|NOT COMPLETED|Second Intervention||0
175951|NCT00939367|423908|P2|COMPLETED|Second Intervention||15
175952|NCT00939367|423909|P1|COMPLETED|Second Intervention||15
175953|NCT00939367|423908|P2|STARTED|Second Intervention||15
175954|NCT00939367|423909|P1|STARTED|Second Intervention||15
175955|NCT00939367|423908|P2|NOT COMPLETED|First Intervention||0
175956|NCT00939367|423909|P1|NOT COMPLETED|First Intervention||0
175957|NCT00939367|423908|P2|COMPLETED|First Intervention||15
175958|NCT00939367|423909|P1|COMPLETED|First Intervention||15
175959|NCT00939367|423908|P2|STARTED|First Intervention||15
175960|NCT00939367|423909|P1|STARTED|First Intervention||15
175961|NCT00939341|423919|P1|NOT COMPLETED|Overall Study||66
175962|NCT00939341|423919|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
175963|NCT00939341|423919|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
175964|NCT00939211|423939|P1|NOT COMPLETED|Placebo||0
175965|NCT00939211|423939|P1|COMPLETED|Placebo||28
175966|NCT00939211|423939|P1|STARTED|Placebo||28
175967|NCT00939211|423939|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
175968|NCT00939211|423939|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
175969|NCT00939211|423939|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
175970|NCT00939211|423939|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
175971|NCT00939211|423939|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
175972|NCT00939211|423939|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
175973|NCT00939211|423939|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
175974|NCT00939211|423939|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
175975|NCT00939211|423939|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
175976|NCT00939211|423939|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
175977|NCT00939211|423939|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
175978|NCT00939211|423939|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
175979|NCT00939185|424001|P1|NOT COMPLETED|Overall Study||25
175980|NCT00939185|424001|P1|COMPLETED|Overall Study||375
175981|NCT00939185|424001|P1|Received Treatment|Overall Study||390
175982|NCT00939185|424001|P1|STARTED|Overall Study||400
175983|NCT00939159|424008|P1|NOT COMPLETED|Overall Study||0
175984|NCT00939159|424008|P1|COMPLETED|Overall Study||13
175985|NCT00939159|424008|P1|STARTED|Overall Study||13
175986|NCT00939120|424014|P2|NOT COMPLETED|Overall Study||5
175987|NCT00939120|424015|P1|NOT COMPLETED|Overall Study||8
175988|NCT00939120|424014|P2|COMPLETED|Overall Study||18
175989|NCT00939120|424015|P1|COMPLETED|Overall Study||15
175990|NCT00939120|424014|P2|STARTED|Overall Study||23
175991|NCT00939120|424015|P1|STARTED|Overall Study||23
175992|NCT00939107|424039|P2|NOT COMPLETED|Overall Study||12
175993|NCT00939107|424040|P1|NOT COMPLETED|Overall Study||14
175994|NCT00939107|424039|P2|COMPLETED|Overall Study||163
175995|NCT00939107|424040|P1|COMPLETED|Overall Study||161
175996|NCT00939107|424039|P2|12 Months Follow-up|Overall Study||163
175997|NCT00939107|424040|P1|12 Months Follow-up|Overall Study||161
175998|NCT00939107|424039|P2|STARTED|Overall Study||175
175999|NCT00939107|424040|P1|STARTED|Overall Study||175
176000|NCT00939094|424054|P2|NOT COMPLETED|Overall Study||10
176001|NCT00939094|424055|P1|NOT COMPLETED|Overall Study||14
176002|NCT00939094|424054|P2|COMPLETED|Overall Study||35
176003|NCT00939094|424055|P1|COMPLETED|Overall Study||28
176004|NCT00939094|424054|P2|STARTED|Overall Study||45
176005|NCT00939094|424055|P1|STARTED|Overall Study||42
176006|NCT00939055|424077|P2|NOT COMPLETED|Overall Study||0
176007|NCT00939055|424078|P1|NOT COMPLETED|Overall Study||4
176008|NCT00939055|424077|P2|COMPLETED|Overall Study||39
176009|NCT00939055|424078|P1|COMPLETED|Overall Study||69
176010|NCT00939055|424077|P2|STARTED|Overall Study||39
176011|NCT00939055|424078|P1|STARTED|Overall Study||73
176012|NCT00939029|424088|P2|NOT COMPLETED|Overall Study||12
176013|NCT00939029|424089|P1|NOT COMPLETED|Overall Study||6
176014|NCT00939029|424088|P2|COMPLETED|Overall Study||15
176015|NCT00939029|424089|P1|COMPLETED|Overall Study||19
176016|NCT00939029|424088|P2|STARTED|Overall Study||27
176017|NCT00939029|424089|P1|STARTED|Overall Study||25
176018|NCT00939003|424101|P2|NOT COMPLETED|Open-label Treatment Period||29
176019|NCT00939003|424102|P1|NOT COMPLETED|Open-label Treatment Period||29
176020|NCT00939003|424101|P2|COMPLETED|Open-label Treatment Period||62
176021|NCT00939003|424102|P1|COMPLETED|Open-label Treatment Period||66
176022|NCT00939003|424101|P2|STARTED|Open-label Treatment Period||91
176023|NCT00939003|424102|P1|STARTED|Open-label Treatment Period||95
176024|NCT00939003|424101|P2|NOT COMPLETED|Double-blind Treatment Period||4
176025|NCT00939003|424102|P1|NOT COMPLETED|Double-blind Treatment Period||2
176026|NCT00939003|424101|P2|COMPLETED|Double-blind Treatment Period||91
176027|NCT00939003|424102|P1|COMPLETED|Double-blind Treatment Period||95
176028|NCT00939003|424101|P2|STARTED|Double-blind Treatment Period||95
176029|NCT00939003|424102|P1|STARTED|Double-blind Treatment Period||97
176030|NCT00938964|424139|P2|NOT COMPLETED|Overall Study||28
176031|NCT00938964|424140|P1|NOT COMPLETED|Overall Study||30
176032|NCT00938964|424139|P2|COMPLETED|Overall Study||209
176033|NCT00938964|424140|P1|COMPLETED|Overall Study||211
176034|NCT00938964|424139|P2|STARTED|Overall Study||237
176035|NCT00938964|424140|P1|STARTED|Overall Study||241
176036|NCT00938886|424180|P2|NOT COMPLETED|Overall Study||10
176037|NCT00938886|424181|P1|NOT COMPLETED|Overall Study||7
176038|NCT00938886|424180|P2|COMPLETED|Overall Study||65
176039|NCT00938886|424181|P1|COMPLETED|Overall Study||68
176040|NCT00938886|424180|P2|Attended 1 Counseling Session|Overall Study||70
176041|NCT00938886|424181|P1|Attended 1 Counseling Session|Overall Study||70
176042|NCT00938886|424180|P2|STARTED|Overall Study||75
176043|NCT00938886|424181|P1|STARTED|Overall Study||75
176044|NCT00938860|424191|P2|NOT COMPLETED|Overall Study||17
176045|NCT00938860|424192|P1|NOT COMPLETED|Overall Study||25
176046|NCT00938860|424191|P2|COMPLETED|Overall Study||25
176047|NCT00938860|424192|P1|COMPLETED|Overall Study||25
176048|NCT00938860|424191|P2|Efficacy Population|Overall Study||41
176049|NCT00938860|424192|P1|Efficacy Population|Overall Study||40
176050|NCT00938860|424191|P2|STARTED|Overall Study||42
176051|NCT00938860|424192|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
176052|NCT00938782|424216|P2|NOT COMPLETED|Overall Study||0
176053|NCT00938782|424217|P1|NOT COMPLETED|Overall Study||0
176152|NCT00938041|424537|P1|COMPLETED|Overall Study||5
176054|NCT00938782|424216|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
176055|NCT00938782|424217|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
176056|NCT00938782|424216|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
176057|NCT00938782|424217|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
176058|NCT00938717|424225|P2|NOT COMPLETED|Overall Study||108
176059|NCT00938717|424226|P1|NOT COMPLETED|Overall Study||98
176060|NCT00938717|424225|P2|COMPLETED|Overall Study||294
176061|NCT00938717|424226|P1|COMPLETED|Overall Study||305
176062|NCT00938717|424225|P2|STARTED|Overall Study||402
176063|NCT00938717|424226|P1|STARTED|Overall Study||403
176064|NCT00938704|424260|P2|NOT COMPLETED|Overall Study||0
176065|NCT00938704|424261|P1|NOT COMPLETED|Overall Study||0
176066|NCT00938704|424260|P2|COMPLETED|Overall Study||37
176067|NCT00938704|424261|P1|COMPLETED|Overall Study||33
176068|NCT00938704|424260|P2|STARTED|Overall Study||37
176069|NCT00938704|424261|P1|STARTED|Overall Study||33
176070|NCT00938639|424277|P2|NOT COMPLETED|Overall Study||4
176071|NCT00938639|424278|P1|NOT COMPLETED|Overall Study||3
176072|NCT00938639|424277|P2|COMPLETED|Overall Study||116
176073|NCT00938639|424278|P1|COMPLETED|Overall Study||117
176074|NCT00938639|424277|P2|STARTED|Overall Study||120
176075|NCT00938639|424278|P1|STARTED|Overall Study||120
176076|NCT00938548|424348|P2|NOT COMPLETED|Overall Study||0
176077|NCT00938548|424349|P1|NOT COMPLETED|Overall Study||0
176078|NCT00938548|424348|P2|COMPLETED|Overall Study||35
176079|NCT00938548|424349|P1|COMPLETED|Overall Study||35
176080|NCT00938548|424348|P2|STARTED|Overall Study||35
176081|NCT00938548|424349|P1|STARTED|Overall Study||35
176082|NCT00938470|424361|P2|NOT COMPLETED|Overall Study||3
176083|NCT00938470|424362|P1|NOT COMPLETED|Overall Study||7
176084|NCT00938470|424361|P2|COMPLETED|Overall Study||25
176085|NCT00938470|424362|P1|COMPLETED|Overall Study||27
176086|NCT00938470|424361|P2|STARTED|Overall Study||28
176087|NCT00938470|424362|P1|STARTED|Overall Study||34
176088|NCT00938457|424376|P1|NOT COMPLETED|Overall Study||0
176089|NCT00938457|424376|P1|COMPLETED|Overall Study||3
176090|NCT00938457|424376|P1|STARTED|Overall Study||3
176091|NCT00938431|424392|P3|NOT COMPLETED|Overall Study||8
176092|NCT00938431|424393|P2|NOT COMPLETED|Overall Study||9
176093|NCT00938431|424394|P1|NOT COMPLETED|Overall Study||6
176094|NCT00938431|424392|P3|COMPLETED|Overall Study||1
176095|NCT00938431|424393|P2|COMPLETED|Overall Study||14
176096|NCT00938431|424394|P1|COMPLETED|Overall Study||9
176097|NCT00938431|424392|P3|STARTED|Overall Study||9
176098|NCT00938431|424393|P2|STARTED|Overall Study||23
176099|NCT00938431|424394|P1|STARTED|Overall Study||15
176100|NCT00938392|424421|P2|NOT COMPLETED|Overall Study||4
176101|NCT00938392|424422|P1|NOT COMPLETED|Overall Study||2
176102|NCT00938392|424421|P2|COMPLETED|Overall Study||358
176103|NCT00938392|424422|P1|COMPLETED|Overall Study||360
176104|NCT00938392|424421|P2|STARTED|Overall Study||362
176105|NCT00938392|424422|P1|STARTED|Overall Study||362
176106|NCT00938366|424448|P2|NOT COMPLETED|Overall Study||0
176107|NCT00938366|424449|P1|NOT COMPLETED|Overall Study||1
176108|NCT00938366|424448|P2|COMPLETED|Overall Study||9
176109|NCT00938366|424449|P1|COMPLETED|Overall Study||8
176110|NCT00938366|424448|P2|STARTED|Overall Study||9
176111|NCT00938366|424449|P1|STARTED|Overall Study||9
176112|NCT00938327|424469|P1|NOT COMPLETED|Overall Study||60
176113|NCT00938327|424469|P1|COMPLETED|Overall Study||272
176114|NCT00938327|424469|P1|STARTED|Overall Study||332
176115|NCT00938314|424480|P4|NOT COMPLETED|Cohort 3||1
176116|NCT00938314|424481|P3|NOT COMPLETED|Cohort 3||4
176117|NCT00938314|424482|P2|NOT COMPLETED|Cohort 3||0
176118|NCT00938314|424483|P1|NOT COMPLETED|Cohort 3||0
176119|NCT00938314|424480|P4|COMPLETED|Cohort 3||7
176120|NCT00938314|424481|P3|COMPLETED|Cohort 3||20
176121|NCT00938314|424482|P2|COMPLETED|Cohort 3||0
176122|NCT00938314|424483|P1|COMPLETED|Cohort 3||0
176123|NCT00938314|424480|P4|STARTED|Cohort 3||8
176124|NCT00938314|424481|P3|STARTED|Cohort 3||24
176125|NCT00938314|424482|P2|STARTED|Cohort 3||0
176126|NCT00938314|424483|P1|STARTED|Cohort 3||0
176127|NCT00938314|424480|P4|NOT COMPLETED|Cohort 2||2
176128|NCT00938314|424481|P3|NOT COMPLETED|Cohort 2||0
176129|NCT00938314|424482|P2|NOT COMPLETED|Cohort 2||6
176130|NCT00938314|424483|P1|NOT COMPLETED|Cohort 2||0
176131|NCT00938314|424480|P4|COMPLETED|Cohort 2||6
176132|NCT00938314|424481|P3|COMPLETED|Cohort 2||0
176133|NCT00938314|424482|P2|COMPLETED|Cohort 2||18
176134|NCT00938314|424483|P1|COMPLETED|Cohort 2||0
176135|NCT00938314|424480|P4|STARTED|Cohort 2||8
176136|NCT00938314|424481|P3|STARTED|Cohort 2||0
176137|NCT00938314|424482|P2|STARTED|Cohort 2||24
176138|NCT00938314|424483|P1|STARTED|Cohort 2||0
176139|NCT00938314|424480|P4|NOT COMPLETED|Cohort 1||2
176140|NCT00938314|424481|P3|NOT COMPLETED|Cohort 1||0
176141|NCT00938314|424482|P2|NOT COMPLETED|Cohort 1||0
176142|NCT00938314|424483|P1|NOT COMPLETED|Cohort 1||2
176143|NCT00938314|424480|P4|COMPLETED|Cohort 1||6
176144|NCT00938314|424481|P3|COMPLETED|Cohort 1||0
176145|NCT00938314|424482|P2|COMPLETED|Cohort 1||0
176146|NCT00938314|424483|P1|COMPLETED|Cohort 1||22
176147|NCT00938314|424480|P4|STARTED|Cohort 1||8
176148|NCT00938314|424481|P3|STARTED|Cohort 1||0
176149|NCT00938314|424482|P2|STARTED|Cohort 1||0
176150|NCT00938314|424483|P1|STARTED|Cohort 1||24
176151|NCT00938041|424537|P1|NOT COMPLETED|Overall Study||27
176153|NCT00938041|424537|P1|STARTED|Overall Study||32
176154|NCT00938015|424546|P1|NOT COMPLETED|Overall Study||147
176155|NCT00938015|424546|P1|COMPLETED|Overall Study||156
176156|NCT00938015|424546|P1|STARTED|Overall Study||303
176157|NCT00937950|424562|P1|NOT COMPLETED|Overall Study||216
176158|NCT00937950|424562|P1|COMPLETED|Overall Study||1787
176159|NCT00937950|424562|P1|STARTED|Overall Study||2003
176160|NCT00937937|424578|P1|NOT COMPLETED|Overall Study||72
176161|NCT00937937|424578|P1|COMPLETED|Overall Study||0
176162|NCT00937937|424578|P1|STARTED|Overall Study||72
176163|NCT00937833|424587|P2|NOT COMPLETED|Overall Study||17
176164|NCT00937833|424588|P1|NOT COMPLETED|Overall Study||15
176165|NCT00937833|424587|P2|COMPLETED|Overall Study||60
176166|NCT00937833|424588|P1|COMPLETED|Overall Study||58
176167|NCT00937833|424587|P2|STARTED|Overall Study||77
176168|NCT00937833|424588|P1|STARTED|Overall Study||73
176169|NCT00937794|424594|P1|NOT COMPLETED|Overall Study||0
176170|NCT00937794|424594|P1|COMPLETED|Overall Study||33
176171|NCT00937794|424594|P1|STARTED|Overall Study||33
176172|NCT00937768|424601|P2|NOT COMPLETED|Overall Study||8
176173|NCT00937768|424602|P1|NOT COMPLETED|Overall Study||8
176174|NCT00937768|424601|P2|COMPLETED|Overall Study||0
176175|NCT00937768|424602|P1|COMPLETED|Overall Study||0
176176|NCT00937768|424601|P2|STARTED|Overall Study||8
176177|NCT00937768|424602|P1|STARTED|Overall Study||8
176178|NCT00937560|424608|P1|NOT COMPLETED|Maintenance Treatment||18
176179|NCT00937560|424608|P1|COMPLETED|Maintenance Treatment||150
176180|NCT00937560|424608|P1|STARTED|Maintenance Treatment||168
176181|NCT00937560|424608|P1|NOT COMPLETED|Initial Treatment||21
176182|NCT00937560|424608|P1|COMPLETED|Initial Treatment||168
176183|NCT00937560|424608|P1|Received Treatment|Initial Treatment||189
176184|NCT00937560|424608|P1|STARTED|Initial Treatment||189
176185|NCT00937547|424619|P3|NOT COMPLETED|Overall Study||7
176186|NCT00937547|424620|P2|NOT COMPLETED|Overall Study||6
176187|NCT00937547|424621|P1|NOT COMPLETED|Overall Study||1
176188|NCT00937547|424619|P3|COMPLETED|Overall Study||142
176189|NCT00937547|424620|P2|COMPLETED|Overall Study||78
176190|NCT00937547|424621|P1|COMPLETED|Overall Study||95
176191|NCT00937547|424619|P3|Histological Samples|Overall Study||142
176192|NCT00937547|424620|P2|Histological Samples|Overall Study||78
176193|NCT00937547|424621|P1|Histological Samples|Overall Study||95
176194|NCT00937547|424619|P3|STARTED|Overall Study||149
176195|NCT00937547|424620|P2|STARTED|Overall Study||84
176196|NCT00937547|424621|P1|STARTED|Overall Study||96
176197|NCT00937521|424658|P8|NOT COMPLETED|Booster Phase||2
176198|NCT00937521|424659|P7|NOT COMPLETED|Booster Phase||5
176199|NCT00937521|424660|P6|NOT COMPLETED|Booster Phase||5
176200|NCT00937521|424661|P5|NOT COMPLETED|Booster Phase||5
176201|NCT00937521|424662|P4|NOT COMPLETED|Booster Phase||3
176202|NCT00937521|424663|P3|NOT COMPLETED|Booster Phase||5
176203|NCT00937521|424664|P2|NOT COMPLETED|Booster Phase||2
176204|NCT00937521|424665|P1|NOT COMPLETED|Booster Phase||3
176205|NCT00937521|424658|P8|COMPLETED|Booster Phase||159
176206|NCT00937521|424659|P7|COMPLETED|Booster Phase||160
176207|NCT00937521|424660|P6|COMPLETED|Booster Phase||160
176208|NCT00937521|424661|P5|COMPLETED|Booster Phase||163
176209|NCT00937521|424662|P4|COMPLETED|Booster Phase||167
176210|NCT00937521|424663|P3|COMPLETED|Booster Phase||164
176211|NCT00937521|424664|P2|COMPLETED|Booster Phase||161
176212|NCT00937521|424665|P1|COMPLETED|Booster Phase||152
176213|NCT00937521|424658|P8|Premature Withdrawal|Booster Phase||2
176214|NCT00937521|424659|P7|Premature Withdrawal|Booster Phase||5
176215|NCT00937521|424660|P6|Premature Withdrawal|Booster Phase||5
176216|NCT00937521|424661|P5|Premature Withdrawal|Booster Phase||5
176217|NCT00937521|424662|P4|Premature Withdrawal|Booster Phase||3
176218|NCT00937521|424663|P3|Premature Withdrawal|Booster Phase||5
176219|NCT00937521|424664|P2|Premature Withdrawal|Booster Phase||2
176220|NCT00937521|424665|P1|Premature Withdrawal|Booster Phase||3
176221|NCT00937521|424658|P8|STARTED|Booster Phase||161
176222|NCT00937521|424659|P7|STARTED|Booster Phase||165
176223|NCT00937521|424660|P6|STARTED|Booster Phase||165
176224|NCT00937521|424661|P5|STARTED|Booster Phase||168
176225|NCT00937521|424662|P4|STARTED|Booster Phase||170
176226|NCT00937521|424663|P3|STARTED|Booster Phase||169
176227|NCT00937521|424664|P2|STARTED|Booster Phase||163
176228|NCT00937521|424665|P1|STARTED|Booster Phase||155
176229|NCT00937521|424658|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
176230|NCT00937521|424659|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
176231|NCT00937521|424660|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
176232|NCT00937521|424661|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
176233|NCT00937521|424662|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
176234|NCT00937521|424663|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
176235|NCT00937521|424664|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
176236|NCT00937521|424665|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
176237|NCT00937521|424658|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
176238|NCT00937521|424659|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
176239|NCT00937521|424660|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
176240|NCT00937521|424661|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
176241|NCT00937521|424662|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
176242|NCT00937521|424663|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
176243|NCT00937521|424664|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
176244|NCT00937521|424665|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
176245|NCT00937521|424658|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
176246|NCT00937521|424659|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
176247|NCT00937521|424660|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
176248|NCT00937521|424661|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
176249|NCT00937521|424662|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
176250|NCT00937521|424663|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
176251|NCT00937521|424664|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
176252|NCT00937521|424665|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
176253|NCT00937521|424658|P8|STARTED|Overall Study - Prior to Booster Dose||184
176254|NCT00937521|424659|P7|STARTED|Overall Study - Prior to Booster Dose||186
176255|NCT00937521|424660|P6|STARTED|Overall Study - Prior to Booster Dose||188
176256|NCT00937521|424661|P5|STARTED|Overall Study - Prior to Booster Dose||191
176257|NCT00937521|424662|P4|STARTED|Overall Study - Prior to Booster Dose||188
176258|NCT00937521|424663|P3|STARTED|Overall Study - Prior to Booster Dose||192
176259|NCT00937521|424664|P2|STARTED|Overall Study - Prior to Booster Dose||190
176260|NCT00937521|424665|P1|STARTED|Overall Study - Prior to Booster Dose||188
176261|NCT00937495|424771|P1|NOT COMPLETED|Overall Study||2
176262|NCT00937495|424771|P1|COMPLETED|Overall Study||14
176263|NCT00937495|424771|P1|STARTED|Overall Study||16
176264|NCT00937391|424779|P1|NOT COMPLETED|Stage 2||1
176265|NCT00937391|424779|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
176266|NCT00937391|424779|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
176267|NCT00937391|424779|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
176268|NCT00937391|424779|P1|NOT COMPLETED|Stage 1||0
176269|NCT00937391|424779|P1|COMPLETED|Stage 1||20
176270|NCT00937391|424779|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
176271|NCT00937391|424779|P1|STARTED|Stage 1||20
176272|NCT00937326|424835|P5|NOT COMPLETED|Overall Study||5
176273|NCT00937326|424836|P4|NOT COMPLETED|Overall Study||5
176274|NCT00937326|424837|P3|NOT COMPLETED|Overall Study||4
176275|NCT00937326|424838|P2|NOT COMPLETED|Overall Study||7
176276|NCT00937326|424839|P1|NOT COMPLETED|Overall Study||3
176277|NCT00937326|424835|P5|COMPLETED|Overall Study||40
176278|NCT00937326|424836|P4|COMPLETED|Overall Study||40
176279|NCT00937326|424837|P3|COMPLETED|Overall Study||42
176280|NCT00937326|424838|P2|COMPLETED|Overall Study||38
176281|NCT00937326|424839|P1|COMPLETED|Overall Study||43
176282|NCT00937326|424835|P5|STARTED|Overall Study||45
176283|NCT00937326|424836|P4|STARTED|Overall Study||45
176284|NCT00937326|424837|P3|STARTED|Overall Study||46
176285|NCT00937326|424838|P2|STARTED|Overall Study||45
176286|NCT00937326|424839|P1|STARTED|Overall Study||46
176287|NCT00937235|425067|P2|NOT COMPLETED|Overall Study||0
176288|NCT00937235|425068|P1|NOT COMPLETED|Overall Study||0
176289|NCT00937235|425067|P2|COMPLETED|Overall Study||70
176290|NCT00937235|425068|P1|COMPLETED|Overall Study||72
176291|NCT00937235|425067|P2|STARTED|Overall Study||70
176292|NCT00937235|425068|P1|STARTED|Overall Study||72
176293|NCT00937157|425088|P1|NOT COMPLETED|Overall Study||4
176294|NCT00937157|425088|P1|COMPLETED|Overall Study||8
176295|NCT00937157|425088|P1|STARTED|Overall Study||12
176296|NCT00937118|425092|P1|NOT COMPLETED|Overall Study||0
176297|NCT00937118|425092|P1|COMPLETED|Overall Study||41
176298|NCT00937118|425092|P1|STARTED|Overall Study||41
176299|NCT00937105|425101|P2|NOT COMPLETED|Overall Study||39
176300|NCT00937105|425102|P1|NOT COMPLETED|Overall Study||40
176301|NCT00937105|425101|P2|COMPLETED|Overall Study||70
176302|NCT00937105|425102|P1|COMPLETED|Overall Study||69
176303|NCT00937105|425101|P2|STARTED|Overall Study||109
176304|NCT00937105|425102|P1|STARTED|Overall Study||109
176305|NCT00937040|425119|P2|NOT COMPLETED|Overall Study||37
176306|NCT00937040|425120|P1|NOT COMPLETED|Overall Study||41
176307|NCT00937040|425119|P2|COMPLETED|Overall Study||141
176308|NCT00937040|425120|P1|COMPLETED|Overall Study||138
176309|NCT00937040|425119|P2|STARTED|Overall Study||178
176310|NCT00937040|425120|P1|STARTED|Overall Study||179
176311|NCT00936975|425162|P1|NOT COMPLETED|Overall Study||6
176312|NCT00936975|425162|P1|COMPLETED|Overall Study||12
176313|NCT00936975|425162|P1|STARTED|Overall Study||18
176314|NCT00936910|425171|P1|NOT COMPLETED|Overall Study||3
176315|NCT00936910|425171|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
176316|NCT00936910|425171|P1|STARTED|Overall Study||13
176317|NCT00936897|425180|P2|NOT COMPLETED|Overall Study||60
176318|NCT00936897|425181|P1|NOT COMPLETED|Overall Study||19
176319|NCT00936897|425180|P2|COMPLETED|Overall Study||356
176320|NCT00936897|425181|P1|COMPLETED|Overall Study||398
176321|NCT00936897|425180|P2|STARTED|Overall Study|Randomized|416
176322|NCT00936897|425181|P1|STARTED|Overall Study|Randomized|417
176323|NCT00936741|425193|P1|NOT COMPLETED|Overall Study||9
176324|NCT00936741|425193|P1|COMPLETED|Overall Study||21
176325|NCT00936741|425193|P1|STARTED|Overall Study||30
176326|NCT00936715|425198|P1|NOT COMPLETED|Overall Study||6
176327|NCT00936715|425198|P1|COMPLETED|Overall Study||18
176328|NCT00936715|425198|P1|STARTED|Overall Study||24
176329|NCT00936702|425202|P1|NOT COMPLETED|Overall Study||46
176330|NCT00936702|425202|P1|COMPLETED|Overall Study||0
176331|NCT00936702|425202|P1|STARTED|Overall Study||46
176332|NCT00936663|425212|P2|NOT COMPLETED|Overall Study||0
176333|NCT00936663|425213|P1|NOT COMPLETED|Overall Study||0
176334|NCT00936663|425212|P2|COMPLETED|Overall Study||2
176335|NCT00936663|425213|P1|COMPLETED|Overall Study||1
176336|NCT00936663|425212|P2|STARTED|Overall Study||2
176337|NCT00936663|425213|P1|STARTED|Overall Study||1
176338|NCT00936598|425235|P2|NOT COMPLETED|Overall Study||0
176339|NCT00936598|425236|P1|NOT COMPLETED|Overall Study||2
176340|NCT00936598|425235|P2|COMPLETED|Overall Study||1
176341|NCT00936598|425236|P1|COMPLETED|Overall Study||2
176342|NCT00936598|425235|P2|STARTED|Overall Study||1
176343|NCT00936598|425236|P1|STARTED|Overall Study||4
176344|NCT00936585|425246|P1|NOT COMPLETED|Overall Study||0
176345|NCT00936585|425246|P1|COMPLETED|Overall Study||2
176346|NCT00936585|425246|P1|STARTED|Overall Study||2
176347|NCT00936481|425252|P2|NOT COMPLETED|Overall Study||0
176348|NCT00936481|425253|P1|NOT COMPLETED|Overall Study||0
176349|NCT00936481|425252|P2|COMPLETED|Overall Study||17
176350|NCT00936481|425253|P1|COMPLETED|Overall Study||17
176351|NCT00936481|425252|P2|STARTED|Overall Study||17
176352|NCT00936481|425253|P1|STARTED|Overall Study||17
176353|NCT00936455|425263|P2|NOT COMPLETED|Overall Study||0
176354|NCT00936455|425264|P1|NOT COMPLETED|Overall Study||0
176355|NCT00936455|425263|P2|COMPLETED|Overall Study||38
176356|NCT00936455|425264|P1|COMPLETED|Overall Study||37
176357|NCT00936455|425263|P2|STARTED|Overall Study||38
176358|NCT00936455|425264|P1|STARTED|Overall Study||37
176359|NCT00936377|425279|P3|NOT COMPLETED|Overall Study||0
176360|NCT00936377|425280|P2|NOT COMPLETED|Overall Study||0
176361|NCT00936377|425281|P1|NOT COMPLETED|Overall Study||0
176362|NCT00936377|425279|P3|COMPLETED|Overall Study||8
176363|NCT00936377|425280|P2|COMPLETED|Overall Study||8
176364|NCT00936377|425281|P1|COMPLETED|Overall Study||8
176365|NCT00936377|425279|P3|STARTED|Overall Study||8
176366|NCT00936377|425280|P2|STARTED|Overall Study||8
176367|NCT00936377|425281|P1|STARTED|Overall Study||8
176368|NCT00936351|425312|P2|NOT COMPLETED|Overall Study||2
176369|NCT00936351|425313|P1|NOT COMPLETED|Overall Study||3
176370|NCT00936351|425312|P2|COMPLETED|Overall Study||14
176371|NCT00936351|425313|P1|COMPLETED|Overall Study||15
176372|NCT00936351|425312|P2|STARTED|Overall Study||16
176373|NCT00936351|425313|P1|STARTED|Overall Study||18
176374|NCT00936221|425325|P2|NOT COMPLETED|Overall Study||1
176375|NCT00936221|425326|P1|NOT COMPLETED|Overall Study||1
176376|NCT00936221|425325|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
176377|NCT00936221|425326|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
176378|NCT00936221|425325|P2|Received Treatment|Overall Study||45
176379|NCT00936221|425326|P1|Received Treatment|Overall Study||44
176380|NCT00936221|425325|P2|STARTED|Overall Study||46
176381|NCT00936221|425326|P1|STARTED|Overall Study||45
176382|NCT00936208|425340|P2|NOT COMPLETED|Overall Study||22
176383|NCT00936208|425341|P1|NOT COMPLETED|Overall Study||37
176384|NCT00936208|425340|P2|COMPLETED|Overall Study||1574
176385|NCT00936208|425341|P1|COMPLETED|Overall Study||1462
176386|NCT00936208|425340|P2|STARTED|Overall Study||1596
176387|NCT00936208|425341|P1|STARTED|Overall Study||1499
176388|NCT00936117|425359|P1|NOT COMPLETED|Overall Study||10
176389|NCT00936117|425359|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
176390|NCT00936117|425359|P1|STARTED|Overall Study||20
176391|NCT00936065|425367|P3|NOT COMPLETED|Overall Study||7
176392|NCT00936065|425368|P2|NOT COMPLETED|Overall Study||4
176393|NCT00936065|425369|P1|NOT COMPLETED|Overall Study||4
176394|NCT00936065|425367|P3|COMPLETED|Overall Study||12
176395|NCT00936065|425368|P2|COMPLETED|Overall Study||16
176396|NCT00936065|425369|P1|COMPLETED|Overall Study||17
176397|NCT00936065|425367|P3|Study Assessments Performed|Overall Study||18
176398|NCT00936065|425368|P2|Study Assessments Performed|Overall Study||19
176399|NCT00936065|425369|P1|Study Assessments Performed|Overall Study||21
176400|NCT00936065|425367|P3|Received Treatment|Overall Study||18
176401|NCT00936065|425368|P2|Received Treatment|Overall Study||20
176402|NCT00936065|425369|P1|Received Treatment|Overall Study||21
176403|NCT00936065|425367|P3|STARTED|Overall Study||19
176404|NCT00936065|425368|P2|STARTED|Overall Study||20
176405|NCT00936065|425369|P1|STARTED|Overall Study||21
176406|NCT00935883|425475|P2|NOT COMPLETED|Follow-Up Period||0
176407|NCT00935883|425476|P1|NOT COMPLETED|Follow-Up Period||0
176408|NCT00935883|425475|P2|COMPLETED|Follow-Up Period||38
176409|NCT00935883|425476|P1|COMPLETED|Follow-Up Period||19
176410|NCT00935883|425475|P2|STARTED|Follow-Up Period||38
176411|NCT00935883|425476|P1|STARTED|Follow-Up Period||19
176412|NCT00935883|425475|P2|NOT COMPLETED|Treatment Period||2
176413|NCT00935883|425476|P1|NOT COMPLETED|Treatment Period||1
176414|NCT00935883|425475|P2|COMPLETED|Treatment Period||38
176415|NCT00935883|425476|P1|COMPLETED|Treatment Period||19
176416|NCT00935883|425475|P2|STARTED|Treatment Period||40
176417|NCT00935883|425476|P1|STARTED|Treatment Period||20
176418|NCT00935857|425490|P2|NOT COMPLETED|Overall Study||0
176419|NCT00935857|425491|P1|NOT COMPLETED|Overall Study||0
176420|NCT00935857|425490|P2|COMPLETED|Overall Study||16
176421|NCT00935857|425491|P1|COMPLETED|Overall Study||14
176422|NCT00935857|425490|P2|STARTED|Overall Study||16
176423|NCT00935857|425491|P1|STARTED|Overall Study||14
176424|NCT00935818|425503|P2|NOT COMPLETED|Overall Study||100
176425|NCT00935818|425504|P1|NOT COMPLETED|Overall Study||91
176426|NCT00935818|425503|P2|COMPLETED|Overall Study||157
176427|NCT00935818|425504|P1|COMPLETED|Overall Study||158
176428|NCT00935818|425503|P2|End of Medication Phase|Overall Study||184
176429|NCT00935818|425504|P1|End of Medication Phase|Overall Study||182
176430|NCT00935818|425503|P2|STARTED|Overall Study||257
176431|NCT00935818|425504|P1|STARTED|Overall Study||249
176432|NCT00935792|425525|P3|NOT COMPLETED|Overall Study||0
176433|NCT00935792|425526|P2|NOT COMPLETED|Overall Study||3
176434|NCT00935792|425527|P1|NOT COMPLETED|Overall Study||1
176435|NCT00935792|425525|P3|COMPLETED|Overall Study||12
176436|NCT00935792|425526|P2|COMPLETED|Overall Study||6
176437|NCT00935792|425527|P1|COMPLETED|Overall Study||6
176438|NCT00935792|425525|P3|STARTED|Overall Study||12
176439|NCT00935792|425526|P2|STARTED|Overall Study||9
176440|NCT00935792|425527|P1|STARTED|Overall Study||7
176441|NCT00935766|425544|P2|NOT COMPLETED|Overall Study||7
176442|NCT00935766|425545|P1|NOT COMPLETED|Overall Study||7
176443|NCT00935766|425544|P2|COMPLETED|Overall Study||27
176444|NCT00935766|425545|P1|COMPLETED|Overall Study||35
176445|NCT00935766|425544|P2|STARTED|Overall Study||34
176446|NCT00935766|425545|P1|STARTED|Overall Study||42
176447|NCT00935701|425555|P1|NOT COMPLETED|Overall Study||1
176448|NCT00935701|425555|P1|COMPLETED|Overall Study||9
176449|NCT00935701|425555|P1|Transition Acupressure to Acupuncture|Overall Study||9
176450|NCT00935701|425555|P1|STARTED|Overall Study||10
176451|NCT00935649|425562|P1|NOT COMPLETED|Overall Study||5
176452|NCT00935649|425562|P1|COMPLETED|Overall Study||134
176453|NCT00935649|425562|P1|STARTED|Overall Study||139
176454|NCT00935584|425572|P2|NOT COMPLETED|Overall Study||4
176455|NCT00935584|425573|P1|NOT COMPLETED|Overall Study||49
176456|NCT00935584|425572|P2|COMPLETED|Overall Study||19
176457|NCT00935584|425573|P1|COMPLETED|Overall Study||77
176458|NCT00935584|425572|P2|STARTED|Overall Study||23
176459|NCT00935584|425573|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
176460|NCT00935532|425585|P2|NOT COMPLETED|Overall Study||11
176461|NCT00935532|425586|P1|NOT COMPLETED|Overall Study||22
176462|NCT00935532|425585|P2|COMPLETED|Overall Study||201
176463|NCT00935532|425586|P1|COMPLETED|Overall Study||193
176464|NCT00935532|425585|P2|STARTED|Overall Study||212
176465|NCT00935532|425586|P1|STARTED|Overall Study||215
176466|NCT00935493|425615|P3|NOT COMPLETED|Overall Study||1
176467|NCT00935493|425616|P2|NOT COMPLETED|Overall Study||2
176468|NCT00935493|425617|P1|NOT COMPLETED|Overall Study||1
176469|NCT00935493|425615|P3|COMPLETED|Overall Study||40
176470|NCT00935493|425616|P2|COMPLETED|Overall Study||39
176471|NCT00935493|425617|P1|COMPLETED|Overall Study||40
176472|NCT00935493|425615|P3|STARTED|Overall Study||41
176473|NCT00935493|425616|P2|STARTED|Overall Study||41
176474|NCT00935493|425617|P1|STARTED|Overall Study||41
176475|NCT00935311|425634|P3|NOT COMPLETED|Overall Study||0
176476|NCT00935311|425635|P2|NOT COMPLETED|Overall Study||0
176477|NCT00935311|425636|P1|NOT COMPLETED|Overall Study||0
176478|NCT00935311|425634|P3|COMPLETED|Overall Study||40
176479|NCT00935311|425635|P2|COMPLETED|Overall Study||39
176480|NCT00935311|425636|P1|COMPLETED|Overall Study||43
176481|NCT00935311|425634|P3|STARTED|Overall Study||40
176482|NCT00935311|425635|P2|STARTED|Overall Study||39
176483|NCT00935311|425636|P1|STARTED|Overall Study||43
176484|NCT00935272|425655|P2|NOT COMPLETED|Overall Study||6
176485|NCT00935272|425656|P1|NOT COMPLETED|Overall Study||19
176486|NCT00935272|425655|P2|COMPLETED|Overall Study||39
176487|NCT00935272|425656|P1|COMPLETED|Overall Study||116
176488|NCT00935272|425655|P2|STARTED|Overall Study||45
176489|NCT00935272|425656|P1|STARTED|Overall Study||135
176490|NCT00935259|425665|P2|NOT COMPLETED|Period 2||0
176491|NCT00935259|425666|P1|NOT COMPLETED|Period 2||0
176492|NCT00935259|425665|P2|COMPLETED|Period 2||14
176493|NCT00935259|425666|P1|COMPLETED|Period 2||15
176494|NCT00935259|425665|P2|STARTED|Period 2||14
176495|NCT00935259|425666|P1|STARTED|Period 2||15
176496|NCT00935259|425665|P2|NOT COMPLETED|Period 1||1
176497|NCT00935259|425666|P1|NOT COMPLETED|Period 1||1
176498|NCT00935259|425665|P2|COMPLETED|Period 1||14
176499|NCT00935259|425666|P1|COMPLETED|Period 1||15
176500|NCT00935259|425665|P2|STARTED|Period 1||15
176501|NCT00935259|425666|P1|STARTED|Period 1||16
176502|NCT00935220|425680|P1|NOT COMPLETED|Overall Study||2
176503|NCT00935220|425680|P1|COMPLETED|Overall Study||39
176504|NCT00935220|425680|P1|STARTED|Overall Study||41
176505|NCT00935064|425694|P2|NOT COMPLETED|Overall Study||0
176506|NCT00935064|425695|P1|NOT COMPLETED|Overall Study||0
176507|NCT00935064|425694|P2|COMPLETED|Overall Study||30
176508|NCT00935064|425695|P1|COMPLETED|Overall Study||30
176509|NCT00935064|425694|P2|STARTED|Overall Study||30
176510|NCT00935064|425695|P1|STARTED|Overall Study||30
176511|NCT00934947|425711|P2|NOT COMPLETED|Overall Study||2
176512|NCT00934947|425712|P1|NOT COMPLETED|Overall Study||0
176513|NCT00934947|425711|P2|COMPLETED|Overall Study||20
176514|NCT00934947|425712|P1|COMPLETED|Overall Study||23
176515|NCT00934947|425711|P2|STARTED|Overall Study||22
176516|NCT00934947|425712|P1|STARTED|Overall Study||23
176517|NCT00934921|425726|P2|NOT COMPLETED|Second Intervention||0
176518|NCT00934921|425727|P1|NOT COMPLETED|Second Intervention||0
176519|NCT00934921|425726|P2|COMPLETED|Second Intervention||12
176520|NCT00934921|425727|P1|COMPLETED|Second Intervention||12
176521|NCT00934921|425726|P2|STARTED|Second Intervention||12
176522|NCT00934921|425727|P1|STARTED|Second Intervention||12
176523|NCT00934921|425726|P2|NOT COMPLETED|First Intervention||0
176524|NCT00934921|425727|P1|NOT COMPLETED|First Intervention||0
176525|NCT00934921|425726|P2|COMPLETED|First Intervention||12
176526|NCT00934921|425727|P1|COMPLETED|First Intervention||12
176527|NCT00934921|425726|P2|STARTED|First Intervention||12
176528|NCT00934921|425727|P1|STARTED|First Intervention||12
176529|NCT00934856|425741|P6|NOT COMPLETED|Extension Part||5
176530|NCT00934856|425742|P5|NOT COMPLETED|Extension Part||4
176531|NCT00934856|425743|P4|NOT COMPLETED|Extension Part||2
176532|NCT00934856|425744|P3|NOT COMPLETED|Extension Part||0
176533|NCT00934856|425745|P2|NOT COMPLETED|Extension Part||0
176534|NCT00934856|425746|P1|NOT COMPLETED|Extension Part||0
176535|NCT00934856|425741|P6|COMPLETED|Extension Part||19
176536|NCT00934856|425742|P5|COMPLETED|Extension Part||24
176537|NCT00934856|425743|P4|COMPLETED|Extension Part||2
176538|NCT00934856|425744|P3|COMPLETED|Extension Part||0
176539|NCT00934856|425745|P2|COMPLETED|Extension Part||0
176540|NCT00934856|425746|P1|COMPLETED|Extension Part||0
176541|NCT00934856|425741|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
176542|NCT00934856|425742|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
176543|NCT00934856|425743|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
176544|NCT00934856|425744|P3|STARTED|Extension Part||0
176545|NCT00934856|425745|P2|STARTED|Extension Part||0
176546|NCT00934856|425746|P1|STARTED|Extension Part||0
176547|NCT00934856|425741|P6|NOT COMPLETED|Feasibility Part||3
176548|NCT00934856|425742|P5|NOT COMPLETED|Feasibility Part||0
176549|NCT00934856|425743|P4|NOT COMPLETED|Feasibility Part||5
176550|NCT00934856|425744|P3|NOT COMPLETED|Feasibility Part||3
176551|NCT00934856|425745|P2|NOT COMPLETED|Feasibility Part||5
176552|NCT00934856|425746|P1|NOT COMPLETED|Feasibility Part||5
176553|NCT00934856|425741|P6|COMPLETED|Feasibility Part||6
176554|NCT00934856|425742|P5|COMPLETED|Feasibility Part||12
176555|NCT00934856|425743|P4|COMPLETED|Feasibility Part||1
176556|NCT00934856|425744|P3|COMPLETED|Feasibility Part||0
176557|NCT00934856|425745|P2|COMPLETED|Feasibility Part||1
176558|NCT00934856|425746|P1|COMPLETED|Feasibility Part||1
176559|NCT00934856|425741|P6|STARTED|Feasibility Part||9
176560|NCT00934856|425742|P5|STARTED|Feasibility Part||12
176561|NCT00934856|425743|P4|STARTED|Feasibility Part||6
176562|NCT00934856|425744|P3|STARTED|Feasibility Part||3
176563|NCT00934856|425745|P2|STARTED|Feasibility Part||6
176564|NCT00934856|425746|P1|STARTED|Feasibility Part||6
176565|NCT00934843|425844|P2|NOT COMPLETED|Overall Study||1
176566|NCT00934843|425845|P1|NOT COMPLETED|Overall Study||0
176567|NCT00934843|425844|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
176568|NCT00934843|425845|P1|COMPLETED|Overall Study||37
176569|NCT00934843|425844|P2|STARTED|Overall Study||40
176570|NCT00934843|425845|P1|STARTED|Overall Study||37
176571|NCT00934791|425861|P2|NOT COMPLETED|Overall Study||0
176572|NCT00934791|425862|P1|NOT COMPLETED|Overall Study||1
176573|NCT00934791|425861|P2|COMPLETED|Overall Study||0
176574|NCT00934791|425862|P1|COMPLETED|Overall Study||0
176575|NCT00934791|425861|P2|STARTED|Overall Study||0
176576|NCT00934791|425862|P1|STARTED|Overall Study||1
176577|NCT00934661|425870|P2|NOT COMPLETED|Overall Study||0
176578|NCT00934661|425871|P1|NOT COMPLETED|Overall Study||1
176579|NCT00934661|425870|P2|COMPLETED|Overall Study||20
176580|NCT00934661|425871|P1|COMPLETED|Overall Study||19
176581|NCT00934661|425870|P2|STARTED|Overall Study||20
176582|NCT00934661|425871|P1|STARTED|Overall Study||20
176583|NCT00934648|425891|P1|NOT COMPLETED|Overall Study||9
176584|NCT00934648|425891|P1|COMPLETED|Overall Study||6
176585|NCT00934648|425891|P1|STARTED|Overall Study||15
176586|NCT00934635|425907|P9|NOT COMPLETED|Overall Study||0
176587|NCT00934635|425908|P8|NOT COMPLETED|Overall Study||0
176588|NCT00934635|425909|P7|NOT COMPLETED|Overall Study||0
176589|NCT00934635|425910|P6|NOT COMPLETED|Overall Study||0
176590|NCT00934635|425911|P5|NOT COMPLETED|Overall Study||0
176591|NCT00934635|425912|P4|NOT COMPLETED|Overall Study||0
176592|NCT00934635|425913|P3|NOT COMPLETED|Overall Study||0
176593|NCT00934635|425914|P2|NOT COMPLETED|Overall Study||0
176594|NCT00934635|425915|P1|NOT COMPLETED|Overall Study||0
176595|NCT00934635|425907|P9|COMPLETED|Overall Study||1
176596|NCT00934635|425908|P8|COMPLETED|Overall Study||0
176597|NCT00934635|425909|P7|COMPLETED|Overall Study||0
176598|NCT00934635|425910|P6|COMPLETED|Overall Study||0
176599|NCT00934635|425911|P5|COMPLETED|Overall Study||0
176600|NCT00934635|425912|P4|COMPLETED|Overall Study||0
176601|NCT00934635|425913|P3|COMPLETED|Overall Study||0
176602|NCT00934635|425914|P2|COMPLETED|Overall Study||1
176603|NCT00934635|425915|P1|COMPLETED|Overall Study||0
176604|NCT00934635|425907|P9|STARTED|Overall Study||1
176605|NCT00934635|425908|P8|STARTED|Overall Study||0
176606|NCT00934635|425909|P7|STARTED|Overall Study||0
176607|NCT00934635|425910|P6|STARTED|Overall Study||0
176608|NCT00934635|425911|P5|STARTED|Overall Study||0
176609|NCT00934635|425912|P4|STARTED|Overall Study||0
176610|NCT00934635|425913|P3|STARTED|Overall Study||0
176611|NCT00934635|425914|P2|STARTED|Overall Study||1
176612|NCT00934635|425915|P1|STARTED|Overall Study||0
176613|NCT00934622|425935|P1|NOT COMPLETED|Overall Study||8
176614|NCT00934622|425935|P1|COMPLETED|Overall Study||68
176615|NCT00934622|425935|P1|STARTED|Overall Study||76
176616|NCT00934596|425942|P2|NOT COMPLETED|Overall Study||0
176617|NCT00934596|425943|P1|NOT COMPLETED|Overall Study||0
176618|NCT00934596|425942|P2|COMPLETED|Overall Study||10
176619|NCT00934596|425943|P1|COMPLETED|Overall Study||10
176620|NCT00934596|425942|P2|STARTED|Overall Study||10
176621|NCT00934596|425943|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
176622|NCT00934544|425973|P2|NOT COMPLETED|Overall Study||42
176623|NCT00934544|425974|P1|NOT COMPLETED|Overall Study||55
176624|NCT00934544|425973|P2|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for the BAT group|31
176625|NCT00934544|425974|P1|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for INC424/INCB018424 group|91
176626|NCT00934544|425973|P2|STARTED|Overall Study||73
176627|NCT00934544|425974|P1|STARTED|Overall Study||146
176628|NCT00934440|425988|P1|NOT COMPLETED|Overall Study||1
176629|NCT00934440|425988|P1|COMPLETED|Overall Study||10
176630|NCT00934440|425988|P1|STARTED|Overall Study||11
176631|NCT00934375|425995|P2|NOT COMPLETED|Overall Study||22
176632|NCT00934375|425996|P1|NOT COMPLETED|Overall Study||13
176633|NCT00934375|425995|P2|COMPLETED|Overall Study||55
176634|NCT00934375|425996|P1|COMPLETED|Overall Study||55
176635|NCT00934375|425995|P2|STARTED|Overall Study||77
176636|NCT00934375|425996|P1|STARTED|Overall Study||68
176637|NCT00934362|426004|P2|NOT COMPLETED|Overall Study||0
176638|NCT00934362|426005|P1|NOT COMPLETED|Overall Study||1
176639|NCT00934362|426004|P2|COMPLETED|Overall Study||8
176640|NCT00934362|426005|P1|COMPLETED|Overall Study||7
176641|NCT00934362|426004|P2|STARTED|Overall Study||8
176642|NCT00934362|426005|P1|STARTED|Overall Study||8
176643|NCT00934180|426015|P2|NOT COMPLETED|Second Intervention||0
176644|NCT00934180|426016|P1|NOT COMPLETED|Second Intervention||0
176645|NCT00934180|426015|P2|COMPLETED|Second Intervention||12
176646|NCT00934180|426016|P1|COMPLETED|Second Intervention||12
176647|NCT00934180|426015|P2|STARTED|Second Intervention||12
176648|NCT00934180|426016|P1|STARTED|Second Intervention||12
176649|NCT00934180|426015|P2|NOT COMPLETED|First Intervention||0
176650|NCT00934180|426016|P1|NOT COMPLETED|First Intervention||0
176651|NCT00934180|426015|P2|COMPLETED|First Intervention||12
176652|NCT00934180|426016|P1|COMPLETED|First Intervention||12
176653|NCT00934180|426015|P2|STARTED|First Intervention||12
176654|NCT00934180|426016|P1|STARTED|First Intervention||12
176655|NCT00934141|426028|P4|NOT COMPLETED|Overall Study||3
176656|NCT00934141|426029|P3|NOT COMPLETED|Overall Study||0
176657|NCT00934141|426030|P2|NOT COMPLETED|Overall Study||3
176658|NCT00934141|426031|P1|NOT COMPLETED|Overall Study||4
176659|NCT00934141|426028|P4|COMPLETED|Overall Study||51
176660|NCT00934141|426029|P3|COMPLETED|Overall Study||48
176661|NCT00934141|426030|P2|COMPLETED|Overall Study||47
176662|NCT00934141|426031|P1|COMPLETED|Overall Study||45
176663|NCT00934141|426028|P4|STARTED|Overall Study||54
176664|NCT00934141|426029|P3|STARTED|Overall Study||48
176665|NCT00934141|426030|P2|STARTED|Overall Study||50
176666|NCT00934141|426031|P1|STARTED|Overall Study||49
176667|NCT00934128|426055|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
176668|NCT00934128|426056|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
176669|NCT00934128|426055|P2|COMPLETED|Second Intervention (2 Hours)||5
176670|NCT00934128|426056|P1|COMPLETED|Second Intervention (2 Hours)||3
176671|NCT00934128|426055|P2|STARTED|Second Intervention (2 Hours)||8
176672|NCT00934128|426056|P1|STARTED|Second Intervention (2 Hours)||3
176673|NCT00934128|426055|P2|NOT COMPLETED|Washout Period (1 Hour)||5
176674|NCT00934128|426056|P1|NOT COMPLETED|Washout Period (1 Hour)||7
176675|NCT00934128|426055|P2|COMPLETED|Washout Period (1 Hour)||8
176676|NCT00934128|426056|P1|COMPLETED|Washout Period (1 Hour)||3
176677|NCT00934128|426055|P2|STARTED|Washout Period (1 Hour)||13
176678|NCT00934128|426056|P1|STARTED|Washout Period (1 Hour)||10
176679|NCT00934128|426055|P2|NOT COMPLETED|First Intervention (2 Hours)||2
176680|NCT00934128|426056|P1|NOT COMPLETED|First Intervention (2 Hours)||5
176681|NCT00934128|426055|P2|COMPLETED|First Intervention (2 Hours)||13
176682|NCT00934128|426056|P1|COMPLETED|First Intervention (2 Hours)||10
176683|NCT00934128|426055|P2|STARTED|First Intervention (2 Hours)||15
176684|NCT00934128|426056|P1|STARTED|First Intervention (2 Hours)||15
176685|NCT00934102|426064|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
176686|NCT00934102|426065|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
176687|NCT00934102|426066|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
176688|NCT00934102|426064|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
176689|NCT00934102|426065|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
176690|NCT00934102|426066|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
176691|NCT00934102|426064|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
176692|NCT00934102|426065|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
176693|NCT00934102|426066|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
176694|NCT00934102|426064|P3|NOT COMPLETED|Period 1, One Night of Wear||0
176695|NCT00934102|426065|P2|NOT COMPLETED|Period 1, One Night of Wear||0
176696|NCT00934102|426066|P1|NOT COMPLETED|Period 1, One Night of Wear||1
176697|NCT00934102|426064|P3|COMPLETED|Period 1, One Night of Wear||15
176698|NCT00934102|426065|P2|COMPLETED|Period 1, One Night of Wear||15
176699|NCT00934102|426066|P1|COMPLETED|Period 1, One Night of Wear||15
176700|NCT00934102|426064|P3|STARTED|Period 1, One Night of Wear||15
176701|NCT00934102|426065|P2|STARTED|Period 1, One Night of Wear||15
176702|NCT00934102|426066|P1|STARTED|Period 1, One Night of Wear||16
176703|NCT00934050|426080|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
176704|NCT00934050|426081|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
176705|NCT00934050|426082|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
176706|NCT00934050|426083|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
176707|NCT00934050|426084|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
176708|NCT00934050|426085|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
176709|NCT00934050|426080|P6|COMPLETED|Enrolled After 15 Dec 2009||23
176710|NCT00934050|426081|P5|COMPLETED|Enrolled After 15 Dec 2009||19
176711|NCT00934050|426082|P4|COMPLETED|Enrolled After 15 Dec 2009||0
176712|NCT00934050|426083|P3|COMPLETED|Enrolled After 15 Dec 2009||0
176713|NCT00934050|426084|P2|COMPLETED|Enrolled After 15 Dec 2009||0
176714|NCT00934050|426085|P1|COMPLETED|Enrolled After 15 Dec 2009||0
176715|NCT00934050|426080|P6|STARTED|Enrolled After 15 Dec 2009||27
176716|NCT00934050|426081|P5|STARTED|Enrolled After 15 Dec 2009||26
176717|NCT00934050|426082|P4|STARTED|Enrolled After 15 Dec 2009||0
176718|NCT00934050|426083|P3|STARTED|Enrolled After 15 Dec 2009||0
176719|NCT00934050|426084|P2|STARTED|Enrolled After 15 Dec 2009||0
176720|NCT00934050|426085|P1|STARTED|Enrolled After 15 Dec 2009||0
176721|NCT00934050|426080|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
176722|NCT00934050|426081|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
176723|NCT00934050|426082|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
176724|NCT00934050|426083|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
176725|NCT00934050|426084|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
176726|NCT00934050|426085|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
176727|NCT00934050|426080|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
176728|NCT00934050|426081|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
176729|NCT00934050|426082|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
176730|NCT00934050|426083|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
176731|NCT00934050|426084|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
176732|NCT00934050|426085|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
176733|NCT00934050|426080|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
176734|NCT00934050|426081|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
176735|NCT00934050|426082|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
176736|NCT00934050|426083|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
176737|NCT00934050|426084|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
176738|NCT00934050|426085|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
176739|NCT00933933|426100|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
176740|NCT00933933|426101|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
176741|NCT00933933|426102|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
176742|NCT00933933|426100|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
176743|NCT00933933|426101|P2|COMPLETED|Pediatric From 2 to 21 Years||64
176744|NCT00933933|426102|P1|COMPLETED|Pediatric From 2 to 21 Years||588
176745|NCT00933933|426100|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
176746|NCT00933933|426101|P2|STARTED|Pediatric From 2 to 21 Years||64
176747|NCT00933933|426102|P1|STARTED|Pediatric From 2 to 21 Years||588
176748|NCT00933933|426100|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
176749|NCT00933933|426101|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
176750|NCT00933933|426102|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
176751|NCT00933933|426100|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
176752|NCT00933933|426101|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
176753|NCT00933933|426102|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
176754|NCT00933933|426100|P3|STARTED|Pregnant Females Between 16-44 Years||203
176755|NCT00933933|426101|P2|STARTED|Pregnant Females Between 16-44 Years||67
176756|NCT00933933|426102|P1|STARTED|Pregnant Females Between 16-44 Years||448
176757|NCT00933933|426100|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
176758|NCT00933933|426101|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
176759|NCT00933933|426102|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
176760|NCT00933933|426100|P3|COMPLETED|General Population From 16 to 89 Years||1206
176761|NCT00933933|426101|P2|COMPLETED|General Population From 16 to 89 Years||1267
176762|NCT00933933|426102|P1|COMPLETED|General Population From 16 to 89 Years||6164
176763|NCT00933933|426100|P3|STARTED|General Population From 16 to 89 Years||1206
176764|NCT00933933|426101|P2|STARTED|General Population From 16 to 89 Years||1287
176765|NCT00933933|426102|P1|STARTED|General Population From 16 to 89 Years||6164
176766|NCT00933686|426120|P2|NOT COMPLETED|Overall Study||11
176767|NCT00933686|426121|P1|NOT COMPLETED|Overall Study||10
176768|NCT00933686|426120|P2|COMPLETED|Overall Study||47
176769|NCT00933686|426121|P1|COMPLETED|Overall Study||45
176770|NCT00933686|426120|P2|STARTED|Overall Study||58
176771|NCT00933686|426121|P1|STARTED|Overall Study||55
176772|NCT00933608|426141|P2|NOT COMPLETED|Overall Study||2
176773|NCT00933608|426142|P1|NOT COMPLETED|Overall Study||5
176774|NCT00933608|426141|P2|COMPLETED|Overall Study||8
176775|NCT00933608|426142|P1|COMPLETED|Overall Study||2
176776|NCT00933608|426141|P2|STARTED|Overall Study||10
176777|NCT00933608|426142|P1|STARTED|Overall Study||7
176778|NCT00933543|426150|P2|NOT COMPLETED|Overall Study||7
176779|NCT00933543|426151|P1|NOT COMPLETED|Overall Study||3
176780|NCT00933543|426150|P2|COMPLETED|Overall Study||46
176781|NCT00933543|426151|P1|COMPLETED|Overall Study||51
176782|NCT00933543|426150|P2|STARTED|Overall Study||53
176783|NCT00933543|426151|P1|STARTED|Overall Study||54
176784|NCT00933491|426209|P2|NOT COMPLETED|Overall Study||0
176785|NCT00933491|426210|P1|NOT COMPLETED|Overall Study||0
176786|NCT00933491|426209|P2|COMPLETED|Overall Study||18
176787|NCT00933491|426210|P1|COMPLETED|Overall Study||14
176788|NCT00933491|426209|P2|STARTED|Overall Study||18
176789|NCT00933491|426210|P1|STARTED|Overall Study||14
176790|NCT00933335|426220|P2|NOT COMPLETED|Overall Study||16
176791|NCT00933335|426221|P1|NOT COMPLETED|Overall Study||2
176792|NCT00933335|426220|P2|COMPLETED|Overall Study||20
176793|NCT00933335|426221|P1|COMPLETED|Overall Study||0
176794|NCT00933335|426220|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
176795|NCT00933335|426221|P1|STARTED|Overall Study||2
176796|NCT00933270|426291|P1|NOT COMPLETED|Overall Study||87
176797|NCT00933270|426291|P1|COMPLETED|Overall Study||177
176798|NCT00933270|426291|P1|STARTED|Overall Study|ITT population|264
176799|NCT00933244|426385|P3|NOT COMPLETED|Overall Study||3
176800|NCT00933244|426386|P2|NOT COMPLETED|Overall Study||1
176801|NCT00933244|426387|P1|NOT COMPLETED|Overall Study||5
176802|NCT00933244|426385|P3|COMPLETED|Overall Study||73
176803|NCT00933244|426386|P2|COMPLETED|Overall Study||74
176804|NCT00933244|426387|P1|COMPLETED|Overall Study||74
176805|NCT00933244|426385|P3|STARTED|Overall Study||76
176806|NCT00933244|426386|P2|STARTED|Overall Study||75
176807|NCT00933244|426387|P1|STARTED|Overall Study||79
176808|NCT00933166|426404|P1|NOT COMPLETED|Overall Study||18
176809|NCT00933166|426404|P1|COMPLETED|Overall Study||151
176810|NCT00933166|426404|P1|STARTED|Overall Study||169
176811|NCT00932893|426410|P2|NOT COMPLETED|Overall Study||170
176812|NCT00932893|426411|P1|NOT COMPLETED|Overall Study||133
176813|NCT00932893|426410|P2|COMPLETED|Overall Study||4
176814|NCT00932893|426411|P1|COMPLETED|Overall Study||40
176815|NCT00932893|426410|P2|Treated|Overall Study||171
176816|NCT00932893|426411|P1|Treated|Overall Study||172
176817|NCT00932893|426410|P2|STARTED|Overall Study||174
176818|NCT00932893|426411|P1|STARTED|Overall Study||173
176819|NCT00932828|426442|P1|NOT COMPLETED|Overall Study||5
176820|NCT00932828|426442|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
176821|NCT00932828|426442|P1|STARTED|Overall Study||37
176822|NCT00932659|426448|P1|NOT COMPLETED|Overall Study||0
176823|NCT00932659|426448|P1|COMPLETED|Overall Study||8
176824|NCT00932659|426448|P1|STARTED|Overall Study||8
176825|NCT00932646|426453|P4|NOT COMPLETED|Overall Study||1
176826|NCT00932646|426454|P3|NOT COMPLETED|Overall Study||4
176827|NCT00932646|426455|P2|NOT COMPLETED|Overall Study||3
176828|NCT00932646|426456|P1|NOT COMPLETED|Overall Study||5
176829|NCT00932646|426453|P4|COMPLETED|Overall Study||24
176830|NCT00932646|426454|P3|COMPLETED|Overall Study||21
176831|NCT00932646|426455|P2|COMPLETED|Overall Study||22
176832|NCT00932646|426456|P1|COMPLETED|Overall Study||20
176833|NCT00932646|426453|P4|STARTED|Overall Study||25
176834|NCT00932646|426454|P3|STARTED|Overall Study||25
176835|NCT00932646|426455|P2|STARTED|Overall Study||25
176836|NCT00932646|426456|P1|STARTED|Overall Study||25
176837|NCT00932620|426512|P2|NOT COMPLETED|Overall Study||0
176838|NCT00932620|426513|P1|NOT COMPLETED|Overall Study||0
176839|NCT00932620|426512|P2|COMPLETED|Overall Study||50
176840|NCT00932620|426513|P1|COMPLETED|Overall Study||50
176841|NCT00932620|426512|P2|STARTED|Overall Study||50
176842|NCT00932620|426513|P1|STARTED|Overall Study||50
176843|NCT00932477|426521|P6|NOT COMPLETED|Treatment 3||0
176844|NCT00932477|426522|P5|NOT COMPLETED|Treatment 3||0
176845|NCT00932477|426523|P4|NOT COMPLETED|Treatment 3||0
176846|NCT00932477|426524|P3|NOT COMPLETED|Treatment 3||0
176847|NCT00932477|426525|P2|NOT COMPLETED|Treatment 3||0
176848|NCT00932477|426526|P1|NOT COMPLETED|Treatment 3||0
176849|NCT00932477|426521|P6|COMPLETED|Treatment 3||8
176850|NCT00932477|426522|P5|COMPLETED|Treatment 3||8
176851|NCT00932477|426523|P4|COMPLETED|Treatment 3||7
176852|NCT00932477|426524|P3|COMPLETED|Treatment 3||9
176853|NCT00932477|426525|P2|COMPLETED|Treatment 3||8
176854|NCT00932477|426526|P1|COMPLETED|Treatment 3||7
176855|NCT00932477|426521|P6|STARTED|Treatment 3||8
176856|NCT00932477|426522|P5|STARTED|Treatment 3||8
176857|NCT00932477|426523|P4|STARTED|Treatment 3||7
176858|NCT00932477|426524|P3|STARTED|Treatment 3||9
176859|NCT00932477|426525|P2|STARTED|Treatment 3||8
176860|NCT00932477|426526|P1|STARTED|Treatment 3||7
176861|NCT00932477|426521|P6|NOT COMPLETED|Treatment 2||0
176862|NCT00932477|426522|P5|NOT COMPLETED|Treatment 2||0
176863|NCT00932477|426523|P4|NOT COMPLETED|Treatment 2||0
176864|NCT00932477|426524|P3|NOT COMPLETED|Treatment 2||0
176865|NCT00932477|426525|P2|NOT COMPLETED|Treatment 2||0
176866|NCT00932477|426526|P1|NOT COMPLETED|Treatment 2||0
176867|NCT00932477|426521|P6|COMPLETED|Treatment 2||8
176868|NCT00932477|426522|P5|COMPLETED|Treatment 2||8
176869|NCT00932477|426523|P4|COMPLETED|Treatment 2||7
176870|NCT00932477|426524|P3|COMPLETED|Treatment 2||9
176871|NCT00932477|426525|P2|COMPLETED|Treatment 2||8
176872|NCT00932477|426526|P1|COMPLETED|Treatment 2||7
176873|NCT00932477|426521|P6|STARTED|Treatment 2||8
176874|NCT00932477|426522|P5|STARTED|Treatment 2||8
176875|NCT00932477|426523|P4|STARTED|Treatment 2||7
176876|NCT00932477|426524|P3|STARTED|Treatment 2||9
176877|NCT00932477|426525|P2|STARTED|Treatment 2||8
176878|NCT00932477|426526|P1|STARTED|Treatment 2||7
176879|NCT00932477|426521|P6|NOT COMPLETED|Treatment 1||0
176880|NCT00932477|426522|P5|NOT COMPLETED|Treatment 1||0
176881|NCT00932477|426523|P4|NOT COMPLETED|Treatment 1||0
176882|NCT00932477|426524|P3|NOT COMPLETED|Treatment 1||0
176883|NCT00932477|426525|P2|NOT COMPLETED|Treatment 1||0
176884|NCT00932477|426526|P1|NOT COMPLETED|Treatment 1||0
176885|NCT00932477|426521|P6|COMPLETED|Treatment 1||8
176886|NCT00932477|426522|P5|COMPLETED|Treatment 1||8
176887|NCT00932477|426523|P4|COMPLETED|Treatment 1||7
176888|NCT00932477|426524|P3|COMPLETED|Treatment 1||9
176889|NCT00932477|426525|P2|COMPLETED|Treatment 1||8
176890|NCT00932477|426526|P1|COMPLETED|Treatment 1||7
176891|NCT00932477|426521|P6|STARTED|Treatment 1||8
176892|NCT00932477|426522|P5|STARTED|Treatment 1||8
176893|NCT00932477|426523|P4|STARTED|Treatment 1||7
176894|NCT00932477|426524|P3|STARTED|Treatment 1||9
176895|NCT00932477|426525|P2|STARTED|Treatment 1||8
176896|NCT00932477|426526|P1|STARTED|Treatment 1||7
176897|NCT00932451|426543|P1|NOT COMPLETED|Overall Study||822
176898|NCT00932451|426543|P1|COMPLETED|Overall Study||244
176899|NCT00932451|426543|P1|STARTED|Overall Study||1066
176900|NCT00932425|426567|P2|NOT COMPLETED|Overall Study||2
176901|NCT00932425|426568|P1|NOT COMPLETED|Overall Study||0
176902|NCT00932425|426567|P2|COMPLETED|Overall Study||18
176903|NCT00932425|426568|P1|COMPLETED|Overall Study||20
176904|NCT00932425|426567|P2|STARTED|Overall Study||20
176905|NCT00932425|426568|P1|STARTED|Overall Study||20
176906|NCT00932399|426583|P2|NOT COMPLETED|Overall Study||0
176907|NCT00932399|426584|P1|NOT COMPLETED|Overall Study||0
176908|NCT00932399|426583|P2|COMPLETED|Overall Study||3790
176909|NCT00932399|426584|P1|COMPLETED|Overall Study||759
176910|NCT00932399|426583|P2|STARTED|Overall Study||3790
176911|NCT00932399|426584|P1|STARTED|Overall Study||759
176912|NCT00932373|426601|P11|NOT COMPLETED|Overall Study||3
176913|NCT00932373|426602|P10|NOT COMPLETED|Overall Study||13
176914|NCT00932373|426603|P9|NOT COMPLETED|Overall Study||2
176915|NCT00932373|426604|P8|NOT COMPLETED|Overall Study||3
176916|NCT00932373|426605|P7|NOT COMPLETED|Overall Study||1
176917|NCT00932373|426606|P6|NOT COMPLETED|Overall Study||3
176918|NCT00932373|426607|P5|NOT COMPLETED|Overall Study||14
176919|NCT00932373|426608|P4|NOT COMPLETED|Overall Study||0
176920|NCT00932373|426609|P3|NOT COMPLETED|Overall Study||1
176921|NCT00932373|426610|P2|NOT COMPLETED|Overall Study||1
176922|NCT00932373|426611|P1|NOT COMPLETED|Overall Study||3
176923|NCT00932373|426601|P11|COMPLETED|Overall Study||0
176924|NCT00932373|426602|P10|COMPLETED|Overall Study||3
176925|NCT00932373|426603|P9|COMPLETED|Overall Study||1
176926|NCT00932373|426604|P8|COMPLETED|Overall Study||0
176927|NCT00932373|426605|P7|COMPLETED|Overall Study||2
176928|NCT00932373|426606|P6|COMPLETED|Overall Study||0
176929|NCT00932373|426607|P5|COMPLETED|Overall Study||1
176930|NCT00932373|426608|P4|COMPLETED|Overall Study||1
176931|NCT00932373|426609|P3|COMPLETED|Overall Study||0
176932|NCT00932373|426610|P2|COMPLETED|Overall Study||0
176933|NCT00932373|426611|P1|COMPLETED|Overall Study||0
176934|NCT00932373|426601|P11|STARTED|Overall Study||3
176935|NCT00932373|426602|P10|STARTED|Overall Study||16
176936|NCT00932373|426603|P9|STARTED|Overall Study||3
176937|NCT00932373|426604|P8|STARTED|Overall Study||3
176938|NCT00932373|426605|P7|STARTED|Overall Study||3
176939|NCT00932373|426606|P6|STARTED|Overall Study||3
176940|NCT00932373|426607|P5|STARTED|Overall Study||15
176941|NCT00932373|426608|P4|STARTED|Overall Study||1
176942|NCT00932373|426609|P3|STARTED|Overall Study||1
176943|NCT00932373|426610|P2|STARTED|Overall Study||1
176944|NCT00932373|426611|P1|STARTED|Overall Study||3
176945|NCT00932321|426713|P2|NOT COMPLETED|Overall Study||46
176946|NCT00932321|426714|P1|NOT COMPLETED|Overall Study||171
176947|NCT00932321|426713|P2|COMPLETED|Overall Study||141
176948|NCT00932321|426714|P1|COMPLETED|Overall Study||580
176949|NCT00932321|426713|P2|MITT Population|Overall Study||181
176950|NCT00932321|426714|P1|MITT Population|Overall Study||705
176951|NCT00932321|426713|P2|STARTED|Overall Study||187
176952|NCT00932321|426714|P1|STARTED|Overall Study||751
176953|NCT00932282|426724|P2|NOT COMPLETED|OIT Maintenance Phase||2
176954|NCT00932282|426725|P1|NOT COMPLETED|OIT Maintenance Phase||1
176955|NCT00932282|426724|P2|COMPLETED|OIT Maintenance Phase||2
176956|NCT00932282|426725|P1|COMPLETED|OIT Maintenance Phase||4
176957|NCT00932282|426724|P2|STARTED|OIT Maintenance Phase||4
176958|NCT00932282|426725|P1|STARTED|OIT Maintenance Phase||5
176959|NCT00932282|426724|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
176960|NCT00932282|426725|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
176961|NCT00932282|426724|P2|COMPLETED|Biweekly OIT Buildup Phase||4
176962|NCT00932282|426725|P1|COMPLETED|Biweekly OIT Buildup Phase||5
176963|NCT00932282|426724|P2|STARTED|Biweekly OIT Buildup Phase||5
176964|NCT00932282|426725|P1|STARTED|Biweekly OIT Buildup Phase||6
176965|NCT00932282|426724|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
176966|NCT00932282|426725|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
176967|NCT00932282|426724|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
176968|NCT00932282|426725|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
176969|NCT00932282|426724|P2|STARTED|Modified OIT Rush Desensitization Phase||5
176970|NCT00932282|426725|P1|STARTED|Modified OIT Rush Desensitization Phase||6
176971|NCT00932282|426724|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
176972|NCT00932282|426725|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
176973|NCT00932282|426724|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
176974|NCT00932282|426725|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
176975|NCT00932282|426724|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
176976|NCT00932282|426725|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
176977|NCT00932165|426739|P1|NOT COMPLETED|Overall Study||1
176978|NCT00932165|426739|P1|COMPLETED|Overall Study||450
176979|NCT00932165|426739|P1|STARTED|Overall Study||451
176980|NCT00932152|426752|P2|NOT COMPLETED|Overall Study||2
176981|NCT00932152|426753|P1|NOT COMPLETED|Overall Study||1
176982|NCT00932152|426752|P2|COMPLETED|Overall Study||0
176983|NCT00932152|426753|P1|COMPLETED|Overall Study||0
176984|NCT00932152|426752|P2|STARTED|Overall Study||2
176985|NCT00932152|426753|P1|STARTED|Overall Study||1
176986|NCT00932126|426763|P8|NOT COMPLETED|Overall Study||10
176987|NCT00932126|426764|P7|NOT COMPLETED|Overall Study||5
176988|NCT00932126|426765|P6|NOT COMPLETED|Overall Study||3
176989|NCT00932126|426766|P5|NOT COMPLETED|Overall Study||5
176990|NCT00932126|426767|P4|NOT COMPLETED|Overall Study||3
176991|NCT00932126|426768|P3|NOT COMPLETED|Overall Study||3
176992|NCT00932126|426769|P2|NOT COMPLETED|Overall Study||3
176993|NCT00932126|426770|P1|NOT COMPLETED|Overall Study||3
176994|NCT00932126|426763|P8|COMPLETED|Overall Study||0
176995|NCT00932126|426764|P7|COMPLETED|Overall Study||0
176996|NCT00932126|426765|P6|COMPLETED|Overall Study||0
176997|NCT00932126|426766|P5|COMPLETED|Overall Study||0
176998|NCT00932126|426767|P4|COMPLETED|Overall Study||0
176999|NCT00932126|426768|P3|COMPLETED|Overall Study||0
177000|NCT00932126|426769|P2|COMPLETED|Overall Study||0
177001|NCT00932126|426770|P1|COMPLETED|Overall Study||0
177002|NCT00932126|426763|P8|STARTED|Overall Study||10
177003|NCT00932126|426764|P7|STARTED|Overall Study||5
177004|NCT00932126|426765|P6|STARTED|Overall Study||3
177005|NCT00932126|426766|P5|STARTED|Overall Study||5
177006|NCT00932126|426767|P4|STARTED|Overall Study||3
177007|NCT00932126|426768|P3|STARTED|Overall Study||3
177008|NCT00932126|426769|P2|STARTED|Overall Study||3
177009|NCT00932126|426770|P1|STARTED|Overall Study||3
177010|NCT00932113|426808|P2|NOT COMPLETED|Overall Study||0
177011|NCT00932113|426809|P1|NOT COMPLETED|Overall Study||1
177012|NCT00932113|426808|P2|COMPLETED|Overall Study||15
177013|NCT00932113|426809|P1|COMPLETED|Overall Study||14
177014|NCT00932113|426808|P2|STARTED|Overall Study||15
177015|NCT00932113|426809|P1|STARTED|Overall Study||15
177016|NCT00932035|426827|P2|NOT COMPLETED|Overall Study||0
177017|NCT00932035|426828|P1|NOT COMPLETED|Overall Study||0
177018|NCT00932035|426827|P2|COMPLETED|Overall Study||21
177019|NCT00932035|426828|P1|COMPLETED|Overall Study||18
177020|NCT00932035|426827|P2|STARTED|Overall Study||21
177021|NCT00932035|426828|P1|STARTED|Overall Study||18
177022|NCT00932022|426840|P2|NOT COMPLETED|Overall Study||4
177023|NCT00932022|426841|P1|NOT COMPLETED|Overall Study||5
177024|NCT00932022|426840|P2|COMPLETED|Overall Study||59
177025|NCT00932022|426841|P1|COMPLETED|Overall Study||59
177026|NCT00932022|426840|P2|STARTED|Overall Study||63
177027|NCT00932022|426841|P1|STARTED|Overall Study||64
177028|NCT00931996|426855|P1|NOT COMPLETED|Overall Study||7
177029|NCT00931996|426855|P1|COMPLETED|Overall Study||5
177030|NCT00931996|426855|P1|STARTED|Overall Study||12
177031|NCT00931918|426861|P2|NOT COMPLETED|Overall Study||17
177032|NCT00931918|426862|P1|NOT COMPLETED|Overall Study||17
177033|NCT00931918|426861|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
177034|NCT00931918|426862|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
177035|NCT00931918|426861|P2|Safety Population: Received Study Drug|Overall Study||101
177036|NCT00931918|426862|P1|Safety Population: Received Study Drug|Overall Study||100
177037|NCT00931918|426861|P2|STARTED|Overall Study||103
177038|NCT00931918|426862|P1|STARTED|Overall Study||103
177039|NCT00931879|426888|P2|NOT COMPLETED|Overall Study||3
177040|NCT00931879|426889|P1|NOT COMPLETED|Overall Study||3
177041|NCT00931879|426888|P2|COMPLETED|Overall Study||19
177042|NCT00931879|426889|P1|COMPLETED|Overall Study||19
177043|NCT00931879|426888|P2|STARTED|Overall Study||22
177044|NCT00931879|426889|P1|STARTED|Overall Study||22
177045|NCT00931801|426914|P3|NOT COMPLETED|Overall Study||4
177046|NCT00931801|426915|P2|NOT COMPLETED|Overall Study||1
177047|NCT00931801|426916|P1|NOT COMPLETED|Overall Study||1
177048|NCT00931801|426914|P3|COMPLETED|Overall Study||10
177049|NCT00931801|426915|P2|COMPLETED|Overall Study||14
177050|NCT00931801|426916|P1|COMPLETED|Overall Study||13
177051|NCT00931801|426914|P3|STARTED|Overall Study||14
177052|NCT00931801|426915|P2|STARTED|Overall Study||15
177053|NCT00931801|426916|P1|STARTED|Overall Study||14
177054|NCT00931723|426939|P2|NOT COMPLETED|Overall Study||39
177055|NCT00931723|426940|P1|NOT COMPLETED|Overall Study||26
177056|NCT00931723|426939|P2|COMPLETED|Overall Study||144
177057|NCT00931723|426940|P1|COMPLETED|Overall Study||147
177058|NCT00931723|426939|P2|STARTED|Overall Study||183
177059|NCT00931723|426940|P1|STARTED|Overall Study||173
177060|NCT00931710|426988|P2|NOT COMPLETED|Overall Study||38
177061|NCT00931710|426989|P1|NOT COMPLETED|Overall Study||34
177062|NCT00931710|426988|P2|COMPLETED|Overall Study||209
177063|NCT00931710|426989|P1|COMPLETED|Overall Study||207
177064|NCT00931710|426988|P2|STARTED|Overall Study||247
177065|NCT00931710|426989|P1|STARTED|Overall Study||241
177066|NCT00931632|427007|P2|NOT COMPLETED|Overall Study||18
177067|NCT00931632|427008|P1|NOT COMPLETED|Overall Study||21
177068|NCT00931632|427007|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
177069|NCT00931632|427008|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
177070|NCT00931632|427007|P2|STARTED|Overall Study|Randomized|222
177071|NCT00931632|427008|P1|STARTED|Overall Study|Randomized|229
177072|NCT00931528|427030|P2|NOT COMPLETED|Overall Study||60
177073|NCT00931528|427031|P1|NOT COMPLETED|Overall Study||41
177074|NCT00931528|427030|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
177075|NCT00931528|427031|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
177076|NCT00931528|427030|P2|STARTED|Overall Study||121
177077|NCT00931528|427031|P1|STARTED|Overall Study||121
177078|NCT00931515|427051|P2|NOT COMPLETED|Overall Study||5
177079|NCT00931515|427052|P1|NOT COMPLETED|Overall Study||2
177080|NCT00931515|427051|P2|COMPLETED|Overall Study||10
177081|NCT00931515|427052|P1|COMPLETED|Overall Study||13
177082|NCT00931515|427051|P2|STARTED|Overall Study||15
177083|NCT00931515|427052|P1|STARTED|Overall Study||15
177084|NCT00931489|427063|P5|NOT COMPLETED|Overall Study||0
177085|NCT00931489|427064|P4|NOT COMPLETED|Overall Study||0
177086|NCT00931489|427065|P3|NOT COMPLETED|Overall Study||0
177087|NCT00931489|427066|P2|NOT COMPLETED|Overall Study||0
177088|NCT00931489|427067|P1|NOT COMPLETED|Overall Study||0
177089|NCT00931489|427063|P5|COMPLETED|Overall Study||7
177090|NCT00931489|427064|P4|COMPLETED|Overall Study||39
177091|NCT00931489|427065|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
177092|NCT00931489|427066|P2|COMPLETED|Overall Study||40
177093|NCT00931489|427067|P1|COMPLETED|Overall Study||40
177094|NCT00931489|427063|P5|STARTED|Overall Study||7
177095|NCT00931489|427064|P4|STARTED|Overall Study||39
177096|NCT00931489|427065|P3|STARTED|Overall Study||5
177097|NCT00931489|427066|P2|STARTED|Overall Study||40
177098|NCT00931489|427067|P1|STARTED|Overall Study||40
177099|NCT00931463|427082|P2|NOT COMPLETED|Overall Study||5
177100|NCT00931463|427083|P1|NOT COMPLETED|Overall Study||17
177101|NCT00931463|427082|P2|COMPLETED|Overall Study||265
177102|NCT00931463|427083|P1|COMPLETED|Overall Study||254
177103|NCT00931463|427082|P2|STARTED|Overall Study||270
177104|NCT00931463|427083|P1|STARTED|Overall Study||271
177105|NCT00931411|427099|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
177106|NCT00931411|427100|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
177107|NCT00931411|427099|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
177108|NCT00931411|427100|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
177109|NCT00931411|427099|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
177110|NCT00931411|427100|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
177111|NCT00931411|427099|P2|NOT COMPLETED|First Intervention - 42 Days||3
177112|NCT00931411|427100|P1|NOT COMPLETED|First Intervention - 42 Days||4
177113|NCT00931411|427099|P2|COMPLETED|First Intervention - 42 Days||35
177114|NCT00931411|427100|P1|COMPLETED|First Intervention - 42 Days||31
177115|NCT00931411|427099|P2|STARTED|First Intervention - 42 Days||38
177116|NCT00931411|427100|P1|STARTED|First Intervention - 42 Days||35
177117|NCT00931385|427121|P4|NOT COMPLETED|Overall Study||5
177118|NCT00931385|427122|P3|NOT COMPLETED|Overall Study||1
177119|NCT00931385|427123|P2|NOT COMPLETED|Overall Study||2
177120|NCT00931385|427124|P1|NOT COMPLETED|Overall Study||2
177121|NCT00931385|427121|P4|COMPLETED|Overall Study||21
177122|NCT00931385|427122|P3|COMPLETED|Overall Study||24
177123|NCT00931385|427123|P2|COMPLETED|Overall Study||21
177124|NCT00931385|427124|P1|COMPLETED|Overall Study||23
177125|NCT00931385|427121|P4|STARTED|Overall Study||26
177126|NCT00931385|427122|P3|STARTED|Overall Study||25
177127|NCT00931385|427123|P2|STARTED|Overall Study||23
177128|NCT00931385|427124|P1|STARTED|Overall Study||25
177129|NCT00931359|427180|P2|NOT COMPLETED|Overall Study||13
177130|NCT00931359|427181|P1|NOT COMPLETED|Overall Study||6
177131|NCT00931359|427180|P2|COMPLETED|Overall Study||68
177132|NCT00931359|427181|P1|COMPLETED|Overall Study||33
177133|NCT00931359|427180|P2|STARTED|Overall Study||81
177134|NCT00931359|427181|P1|STARTED|Overall Study||39
177135|NCT00931307|427193|P1|NOT COMPLETED|Overall Study||13
177136|NCT00931307|427193|P1|COMPLETED|Overall Study||9
177137|NCT00931307|427193|P1|STARTED|Overall Study||22
177138|NCT00931268|427197|P1|NOT COMPLETED|Overall Study||6
177139|NCT00931268|427197|P1|COMPLETED|Overall Study||4
177140|NCT00931268|427197|P1|STARTED|Overall Study||10
177141|NCT00931255|427209|P2|NOT COMPLETED|Overall Study||3
177142|NCT00931255|427210|P1|NOT COMPLETED|Overall Study||2
177143|NCT00931255|427209|P2|COMPLETED|Overall Study||12
177144|NCT00931255|427210|P1|COMPLETED|Overall Study||15
177145|NCT00931255|427209|P2|STARTED|Overall Study||15
177146|NCT00931255|427210|P1|STARTED|Overall Study||17
177147|NCT00931242|427234|P2|NOT COMPLETED|Overall Study||2
177148|NCT00931242|427235|P1|NOT COMPLETED|Overall Study||5
177149|NCT00931242|427234|P2|COMPLETED|Overall Study||0
177150|NCT00931242|427235|P1|COMPLETED|Overall Study||5
177151|NCT00931242|427234|P2|STARTED|Overall Study||2
177152|NCT00931242|427235|P1|STARTED|Overall Study||10
177153|NCT00931164|427241|P1|NOT COMPLETED|Overall Study||0
177154|NCT00931164|427241|P1|COMPLETED|Overall Study||6
177155|NCT00931164|427241|P1|STARTED|Overall Study||6
177156|NCT00930982|427247|P2|NOT COMPLETED|Overall Study||29
177157|NCT00930982|427248|P1|NOT COMPLETED|Overall Study||21
177158|NCT00930982|427247|P2|COMPLETED|Overall Study||35
177159|NCT00930982|427248|P1|COMPLETED|Overall Study||39
177160|NCT00930982|427247|P2|STARTED|Overall Study||64
177161|NCT00930982|427248|P1|STARTED|Overall Study||60
177162|NCT00930969|427282|P1|NOT COMPLETED|Overall Study||38
177163|NCT00930969|427282|P1|COMPLETED|Overall Study||137
177164|NCT00930969|427282|P1|STARTED|Overall Study||175
177165|NCT00930930|427292|P2|NOT COMPLETED|Overall Study||9
177166|NCT00930930|427293|P1|NOT COMPLETED|Overall Study||21
177167|NCT00930930|427292|P2|COMPLETED|Overall Study||40
177168|NCT00930930|427293|P1|COMPLETED|Overall Study||75
177169|NCT00930930|427292|P2|STARTED|Overall Study||49
177170|NCT00930930|427293|P1|STARTED|Overall Study||96
177171|NCT00930813|427307|P2|NOT COMPLETED|Overall Study||14
177172|NCT00930813|427308|P1|NOT COMPLETED|Overall Study||8
177173|NCT00930813|427307|P2|COMPLETED|Overall Study||38
177174|NCT00930813|427308|P1|COMPLETED|Overall Study||41
177175|NCT00930813|427307|P2|STARTED|Overall Study||52
177176|NCT00930813|427308|P1|STARTED|Overall Study||49
177177|NCT00930787|427318|P2|NOT COMPLETED|Overall Study||0
177178|NCT00930787|427319|P1|NOT COMPLETED|Overall Study||0
177179|NCT00930787|427318|P2|COMPLETED|Overall Study||9
177180|NCT00930787|427319|P1|COMPLETED|Overall Study||14
177181|NCT00930787|427318|P2|STARTED|Overall Study||9
177182|NCT00930787|427319|P1|STARTED|Overall Study||14
177183|NCT00930774|427329|P4|NOT COMPLETED|Overall Study||0
177184|NCT00930774|427330|P3|NOT COMPLETED|Overall Study||2
177185|NCT00930774|427331|P2|NOT COMPLETED|Overall Study||9
177186|NCT00930774|427332|P1|NOT COMPLETED|Overall Study||1
177187|NCT00930774|427329|P4|COMPLETED|Overall Study||25
177188|NCT00930774|427330|P3|COMPLETED|Overall Study||22
177189|NCT00930774|427331|P2|COMPLETED|Overall Study||16
177190|NCT00930774|427332|P1|COMPLETED|Overall Study||24
177191|NCT00930774|427329|P4|STARTED|Overall Study||25
177192|NCT00930774|427330|P3|STARTED|Overall Study||24
177193|NCT00930774|427331|P2|STARTED|Overall Study||25
177194|NCT00930774|427332|P1|STARTED|Overall Study||25
177195|NCT00930761|427372|P2|NOT COMPLETED|Overall Study||3
177196|NCT00930761|427373|P1|NOT COMPLETED|Overall Study||4
177197|NCT00930761|427372|P2|COMPLETED|Overall Study||48
177198|NCT00930761|427373|P1|COMPLETED|Overall Study||46
177199|NCT00930761|427372|P2|STARTED|Overall Study||51
177200|NCT00930761|427373|P1|STARTED|Overall Study||50
177201|NCT00930722|427385|P1|NOT COMPLETED|Overall Study||27
177202|NCT00930722|427385|P1|COMPLETED|Overall Study||302
177203|NCT00930722|427385|P1|STARTED|Overall Study||329
177204|NCT00930644|427400|P1|NOT COMPLETED|Overall Study||23
177205|NCT00930644|427400|P1|COMPLETED|Overall Study||65
177206|NCT00930644|427400|P1|STARTED|Overall Study||88
177207|NCT00930553|427413|P1|NOT COMPLETED|Overall Study||223
177208|NCT00930553|427413|P1|COMPLETED|Overall Study||1091
177209|NCT00930553|427413|P1|Participants Entered From CAMMS324|Overall Study||685
177210|NCT00930553|427413|P1|Participants Entered From CAMMS323|Overall Study||488
177211|NCT00930553|427413|P1|Participants Entered From CAMMS223|Overall Study||141
177212|NCT00930553|427413|P1|STARTED|Overall Study||1314
177213|NCT00930293|427481|P2|NOT COMPLETED|Overall Study||7
177214|NCT00930293|427482|P1|NOT COMPLETED|Overall Study||7
177215|NCT00930293|427481|P2|COMPLETED|Overall Study||19
177216|NCT00930293|427482|P1|COMPLETED|Overall Study||17
177217|NCT00930293|427481|P2|STARTED|Overall Study||26
177218|NCT00930293|427482|P1|STARTED|Overall Study||24
177219|NCT00930176|427490|P1|NOT COMPLETED|Overall Study||1
177220|NCT00930176|427490|P1|COMPLETED|Overall Study||15
177221|NCT00930176|427490|P1|STARTED|Overall Study||16
177222|NCT00929981|427495|P1|NOT COMPLETED|Overall Study||0
177223|NCT00929981|427495|P1|COMPLETED|Overall Study||80
177224|NCT00929981|427495|P1|STARTED|Overall Study||80
177225|NCT00929864|427507|P2|NOT COMPLETED|Overall Study||83
177226|NCT00929864|427508|P1|NOT COMPLETED|Overall Study||66
177227|NCT00929864|427507|P2|COMPLETED|Overall Study||245
177228|NCT00929864|427508|P1|COMPLETED|Overall Study||252
177229|NCT00929864|427507|P2|STARTED|Overall Study||328
177230|NCT00929864|427508|P1|STARTED|Overall Study||318
177231|NCT00929773|427528|P2|NOT COMPLETED|Overall Study||0
177232|NCT00929773|427529|P1|NOT COMPLETED|Overall Study||0
177233|NCT00929773|427528|P2|COMPLETED|Overall Study||50
177234|NCT00929773|427529|P1|COMPLETED|Overall Study||50
177235|NCT00929773|427528|P2|STARTED|Overall Study||50
177236|NCT00929773|427529|P1|STARTED|Overall Study||50
177237|NCT00929734|427547|P2|NOT COMPLETED|Overall Study||3
177238|NCT00929734|427548|P1|NOT COMPLETED|Overall Study||2
177239|NCT00929734|427547|P2|COMPLETED|Overall Study||47
177240|NCT00929734|427548|P1|COMPLETED|Overall Study||47
177241|NCT00929734|427547|P2|STARTED|Overall Study||50
177242|NCT00929734|427548|P1|STARTED|Overall Study||49
177243|NCT00929708|427565|P5|NOT COMPLETED|Overall Study||6
177244|NCT00929708|427566|P4|NOT COMPLETED|Overall Study||6
177245|NCT00929708|427567|P3|NOT COMPLETED|Overall Study||3
177246|NCT00929708|427568|P2|NOT COMPLETED|Overall Study||3
177247|NCT00929708|427569|P1|NOT COMPLETED|Overall Study||4
177248|NCT00929708|427565|P5|COMPLETED|Overall Study||57
177249|NCT00929708|427566|P4|COMPLETED|Overall Study||61
177250|NCT00929708|427567|P3|COMPLETED|Overall Study||62
177251|NCT00929708|427568|P2|COMPLETED|Overall Study||66
177252|NCT00929708|427569|P1|COMPLETED|Overall Study||61
177253|NCT00929708|427565|P5|STARTED|Overall Study||63
177254|NCT00929708|427566|P4|STARTED|Overall Study||67
177255|NCT00929708|427567|P3|STARTED|Overall Study||65
177256|NCT00929708|427568|P2|STARTED|Overall Study||69
177257|NCT00929708|427569|P1|STARTED|Overall Study||65
177258|NCT00929695|427623|P2|NOT COMPLETED|Overall Study||6
177259|NCT00929695|427624|P1|NOT COMPLETED|Overall Study||8
177260|NCT00929695|427623|P2|COMPLETED|Overall Study||77
177261|NCT00929695|427624|P1|COMPLETED|Overall Study||73
177262|NCT00929695|427623|P2|STARTED|Overall Study||83
177263|NCT00929695|427624|P1|STARTED|Overall Study||81
177264|NCT00929669|427654|P1|NOT COMPLETED|Overall Study||1
177265|NCT00929669|427654|P1|COMPLETED|Overall Study||1
177266|NCT00929669|427654|P1|STARTED|Overall Study||2
177267|NCT00929656|427661|P2|NOT COMPLETED|Overall Study||1
177268|NCT00929656|427662|P1|NOT COMPLETED|Overall Study||0
177269|NCT00929656|427661|P2|COMPLETED|Overall Study||8
177270|NCT00929656|427662|P1|COMPLETED|Overall Study||13
177271|NCT00929656|427661|P2|STARTED|Overall Study||9
177272|NCT00929656|427662|P1|STARTED|Overall Study||13
177273|NCT00929643|427676|P1|NOT COMPLETED|Overall Study||2
177274|NCT00929643|427676|P1|COMPLETED|Overall Study||201
177275|NCT00929643|427676|P1|STARTED|Overall Study||203
177276|NCT00929578|427685|P1|NOT COMPLETED|Overall Study||0
177277|NCT00929578|427685|P1|COMPLETED|Overall Study||15
177278|NCT00929578|427685|P1|STARTED|Overall Study||15
177279|NCT00929526|427698|P2|NOT COMPLETED|Overall Study||29
177280|NCT00929526|427699|P1|NOT COMPLETED|Overall Study||17
177281|NCT00929526|427698|P2|COMPLETED|Overall Study||348
177282|NCT00929526|427699|P1|COMPLETED|Overall Study||358
177283|NCT00929526|427698|P2|STARTED|Overall Study||377
177284|NCT00929526|427699|P1|STARTED|Overall Study||375
177285|NCT00929500|427735|P2|NOT COMPLETED|Overall Study||0
177286|NCT00929500|427736|P1|NOT COMPLETED|Overall Study||4
177287|NCT00929500|427735|P2|COMPLETED|Overall Study||4
177288|NCT00929500|427736|P1|COMPLETED|Overall Study||4
177289|NCT00929500|427735|P2|STARTED|Overall Study||4
177290|NCT00929500|427736|P1|STARTED|Overall Study||8
177291|NCT00929474|427750|P2|NOT COMPLETED|Overall Study||9
177292|NCT00929474|427751|P1|NOT COMPLETED|Overall Study||8
177293|NCT00929474|427750|P2|COMPLETED|Overall Study||0
177294|NCT00929474|427751|P1|COMPLETED|Overall Study||0
177295|NCT00929474|427750|P2|STARTED|Overall Study||9
177296|NCT00929474|427751|P1|STARTED|Overall Study||8
177297|NCT00929383|427757|P1|NOT COMPLETED|Overall Study||15
177298|NCT00929383|427757|P1|COMPLETED|Overall Study||67
177299|NCT00929383|427757|P1|STARTED|Overall Study||82
177300|NCT00929357|427767|P2|NOT COMPLETED|Overall Study||0
177301|NCT00929357|427768|P1|NOT COMPLETED|Overall Study||0
177302|NCT00929357|427767|P2|COMPLETED|Overall Study||64
177303|NCT00929357|427768|P1|COMPLETED|Overall Study||92
177304|NCT00929357|427767|P2|STARTED|Overall Study||64
177305|NCT00929357|427768|P1|STARTED|Overall Study||92
177306|NCT00929344|427791|P3|NOT COMPLETED|Overall Study||21
177307|NCT00929344|427792|P2|NOT COMPLETED|Overall Study||13
177308|NCT00929344|427793|P1|NOT COMPLETED|Overall Study||22
177309|NCT00929344|427791|P3|COMPLETED|Overall Study||29
177310|NCT00929344|427792|P2|COMPLETED|Overall Study||37
177311|NCT00929344|427793|P1|COMPLETED|Overall Study||28
177312|NCT00929344|427791|P3|STARTED|Overall Study||50
177313|NCT00929344|427792|P2|STARTED|Overall Study||50
177314|NCT00929344|427793|P1|STARTED|Overall Study||50
177315|NCT00929331|427809|P2|NOT COMPLETED|Overall Study||0
177316|NCT00929331|427810|P1|NOT COMPLETED|Overall Study||0
177317|NCT00929331|427809|P2|COMPLETED|Overall Study||55
177318|NCT00929331|427810|P1|COMPLETED|Overall Study||55
177319|NCT00929331|427809|P2|STARTED|Overall Study||55
177320|NCT00929331|427810|P1|STARTED|Overall Study||55
177321|NCT00929305|427844|P2|NOT COMPLETED|Overall Study||0
177322|NCT00929305|427845|P1|NOT COMPLETED|Overall Study||0
177323|NCT00929305|427844|P2|COMPLETED|Overall Study||43
177324|NCT00929305|427845|P1|COMPLETED|Overall Study||43
177325|NCT00929305|427844|P2|STARTED|Overall Study||43
177326|NCT00929305|427845|P1|STARTED|Overall Study||43
177327|NCT00929240|427853|P3|NOT COMPLETED|Maintenance Phase||91
177328|NCT00929240|427854|P2|NOT COMPLETED|Maintenance Phase||94
177329|NCT00929240|427855|P1|NOT COMPLETED|Maintenance Phase||0
177330|NCT00929240|427853|P3|COMPLETED|Maintenance Phase||0
177331|NCT00929240|427854|P2|COMPLETED|Maintenance Phase||0
177332|NCT00929240|427855|P1|COMPLETED|Maintenance Phase||0
177333|NCT00929240|427853|P3|STARTED|Maintenance Phase||91
177334|NCT00929240|427854|P2|STARTED|Maintenance Phase||94
177335|NCT00929240|427855|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
177336|NCT00929240|427853|P3|NOT COMPLETED|Initial Treatment Phase||0
177337|NCT00929240|427854|P2|NOT COMPLETED|Initial Treatment Phase||0
177338|NCT00929240|427855|P1|NOT COMPLETED|Initial Treatment Phase||99
177339|NCT00929240|427853|P3|COMPLETED|Initial Treatment Phase||0
177340|NCT00929240|427854|P2|COMPLETED|Initial Treatment Phase||0
177341|NCT00929240|427855|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
177342|NCT00929240|427853|P3|STARTED|Initial Treatment Phase||0
177343|NCT00929240|427854|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
177344|NCT00929240|427855|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
177345|NCT00929201|427882|P2|NOT COMPLETED|Period 2||0
177346|NCT00929201|427883|P1|NOT COMPLETED|Period 2||0
177347|NCT00929201|427882|P2|COMPLETED|Period 2||30
177348|NCT00929201|427883|P1|COMPLETED|Period 2||30
177349|NCT00929201|427882|P2|STARTED|Period 2||30
177350|NCT00929201|427883|P1|STARTED|Period 2||30
177351|NCT00929201|427882|P2|NOT COMPLETED|7-day Washout||0
177352|NCT00929201|427883|P1|NOT COMPLETED|7-day Washout||0
177353|NCT00929201|427882|P2|COMPLETED|7-day Washout||30
177354|NCT00929201|427883|P1|COMPLETED|7-day Washout||30
177355|NCT00929201|427882|P2|STARTED|7-day Washout||30
177356|NCT00929201|427883|P1|STARTED|7-day Washout||30
177357|NCT00929201|427882|P2|NOT COMPLETED|Period 1||1
177358|NCT00929201|427883|P1|NOT COMPLETED|Period 1||0
177359|NCT00929201|427882|P2|COMPLETED|Period 1||30
177360|NCT00929201|427883|P1|COMPLETED|Period 1||30
177361|NCT00929201|427882|P2|STARTED|Period 1||31
177362|NCT00929201|427883|P1|STARTED|Period 1||30
177363|NCT00929162|427893|P2|NOT COMPLETED|Overall Study||42
177364|NCT00929162|427894|P1|NOT COMPLETED|Overall Study||48
177365|NCT00929162|427893|P2|COMPLETED|Overall Study||19
177366|NCT00929162|427894|P1|COMPLETED|Overall Study||11
177367|NCT00929162|427893|P2|Patients Who Received Treatment|Overall Study||58
177368|NCT00929162|427894|P1|Patients Who Received Treatment|Overall Study||58
177369|NCT00929162|427893|P2|STARTED|Overall Study||61
177370|NCT00929162|427894|P1|STARTED|Overall Study||59
177371|NCT00929110|427907|P3|NOT COMPLETED|Overall Study||62
177372|NCT00929110|427908|P2|NOT COMPLETED|Overall Study||76
177373|NCT00929110|427909|P1|NOT COMPLETED|Overall Study||118
177374|NCT00929110|427907|P3|COMPLETED|Overall Study||206
177375|NCT00929110|427908|P2|COMPLETED|Overall Study||193
177376|NCT00929110|427909|P1|COMPLETED|Overall Study||411
177377|NCT00929110|427907|P3|STARTED|Overall Study||268
177378|NCT00929110|427908|P2|STARTED|Overall Study||269
177379|NCT00929110|427909|P1|STARTED|Overall Study||529
177380|NCT00929071|427974|P1|NOT COMPLETED|Overall Study||0
177381|NCT00929071|427974|P1|COMPLETED|Overall Study||10
177382|NCT00929071|427974|P1|STARTED|Overall Study||10
177383|NCT00928954|427981|P2|NOT COMPLETED|Overall Study||0
177384|NCT00928954|427982|P1|NOT COMPLETED|Overall Study||0
177385|NCT00928954|427981|P2|COMPLETED|Overall Study||6
177386|NCT00928954|427982|P1|COMPLETED|Overall Study||4
177387|NCT00928954|427981|P2|STARTED|Overall Study||6
177388|NCT00928954|427982|P1|STARTED|Overall Study||4
177389|NCT00928889|427992|P2|NOT COMPLETED|Overall Study||2
177390|NCT00928889|427993|P1|NOT COMPLETED|Overall Study||5
177391|NCT00928889|427992|P2|COMPLETED|Overall Study||78
177392|NCT00928889|427993|P1|COMPLETED|Overall Study||75
177393|NCT00928889|427992|P2|STARTED|Overall Study||80
177394|NCT00928889|427993|P1|STARTED|Overall Study||80
177395|NCT00928772|428020|P3|NOT COMPLETED|Overall Study||0
177396|NCT00928772|428021|P2|NOT COMPLETED|Overall Study||0
177397|NCT00928772|428022|P1|NOT COMPLETED|Overall Study||0
177398|NCT00928772|428020|P3|COMPLETED|Overall Study||38
177399|NCT00928772|428021|P2|COMPLETED|Overall Study||38
177400|NCT00928772|428022|P1|COMPLETED|Overall Study||39
177401|NCT00928772|428020|P3|STARTED|Overall Study||38
177402|NCT00928772|428021|P2|STARTED|Overall Study||38
177403|NCT00928772|428022|P1|STARTED|Overall Study||39
177404|NCT00928746|428039|P1|NOT COMPLETED|Overall Study||6
177405|NCT00928746|428039|P1|COMPLETED|Overall Study||136
177406|NCT00928746|428039|P1|STARTED|Overall Study||142
177407|NCT00928720|428062|P3|NOT COMPLETED|Overall Study||3
177408|NCT00928720|428063|P2|NOT COMPLETED|Overall Study||6
177409|NCT00928720|428064|P1|NOT COMPLETED|Overall Study||2
177410|NCT00928720|428062|P3|COMPLETED|Overall Study||15
177411|NCT00928720|428063|P2|COMPLETED|Overall Study||14
177412|NCT00928720|428064|P1|COMPLETED|Overall Study||17
177413|NCT00928720|428062|P3|STARTED|Overall Study||18
177414|NCT00928720|428063|P2|STARTED|Overall Study||20
177415|NCT00928720|428064|P1|STARTED|Overall Study||19
177416|NCT00928694|428072|P2|NOT COMPLETED|Second Intervention||0
177417|NCT00928694|428073|P1|NOT COMPLETED|Second Intervention||0
177418|NCT00928694|428072|P2|COMPLETED|Second Intervention||7
177419|NCT00928694|428073|P1|COMPLETED|Second Intervention||7
177420|NCT00928694|428072|P2|STARTED|Second Intervention||7
177421|NCT00928694|428073|P1|STARTED|Second Intervention||7
177422|NCT00928694|428072|P2|NOT COMPLETED|First Intervention||0
177423|NCT00928694|428073|P1|NOT COMPLETED|First Intervention||0
177424|NCT00928694|428072|P2|COMPLETED|First Intervention||7
177425|NCT00928694|428073|P1|COMPLETED|First Intervention||7
177426|NCT00928694|428072|P2|STARTED|First Intervention||7
177427|NCT00928694|428073|P1|STARTED|First Intervention||7
177428|NCT00928668|428081|P5|NOT COMPLETED|Overall Study||1
177429|NCT00928668|428082|P4|NOT COMPLETED|Overall Study||1
177430|NCT00928668|428083|P3|NOT COMPLETED|Overall Study||1
177431|NCT00928668|428084|P2|NOT COMPLETED|Overall Study||1
177432|NCT00928668|428085|P1|NOT COMPLETED|Overall Study||1
177433|NCT00928668|428081|P5|COMPLETED|Overall Study||5
177434|NCT00928668|428082|P4|COMPLETED|Overall Study||3
177435|NCT00928668|428083|P3|COMPLETED|Overall Study||6
177436|NCT00928668|428084|P2|COMPLETED|Overall Study||6
177437|NCT00928668|428085|P1|COMPLETED|Overall Study||6
177438|NCT00928668|428081|P5|STARTED|Overall Study||6
177439|NCT00928668|428082|P4|STARTED|Overall Study||4
177440|NCT00928668|428083|P3|STARTED|Overall Study||7
177441|NCT00928668|428084|P2|STARTED|Overall Study||7
177442|NCT00928668|428085|P1|STARTED|Overall Study||7
177443|NCT00928642|428127|P1|NOT COMPLETED|Overall Study||0
177444|NCT00928642|428127|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
177445|NCT00928642|428127|P1|STARTED|Overall Study||8
177446|NCT00928512|428141|P5|NOT COMPLETED|Overall Study||15
177447|NCT00928512|428142|P4|NOT COMPLETED|Overall Study||21
177448|NCT00928512|428143|P3|NOT COMPLETED|Overall Study||11
177449|NCT00928512|428144|P2|NOT COMPLETED|Overall Study||6
177450|NCT00928512|428145|P1|NOT COMPLETED|Overall Study||10
177451|NCT00928512|428141|P5|COMPLETED|Overall Study||35
177452|NCT00928512|428142|P4|COMPLETED|Overall Study||33
177453|NCT00928512|428143|P3|COMPLETED|Overall Study||38
177454|NCT00928512|428144|P2|COMPLETED|Overall Study||37
177455|NCT00928512|428145|P1|COMPLETED|Overall Study||31
177456|NCT00928512|428141|P5|Entered/Continued to Week 20 (All)|Overall Study||45
177457|NCT00928512|428142|P4|Entered/Continued to Week 20 (All)|Overall Study||45
177458|NCT00928512|428143|P3|Entered/Continued to Week 20 (All)|Overall Study||46
177459|NCT00928512|428144|P2|Entered/Continued to Week 20 (All)|Overall Study||43
177460|NCT00928512|428145|P1|Entered/Continued to Week 20 (All)|Overall Study||37
177461|NCT00928512|428141|P5|Completed Week 16|Overall Study||45
177462|NCT00928512|428142|P4|Completed Week 16|Overall Study||48
177463|NCT00928512|428143|P3|Completed Week 16|Overall Study||47
177464|NCT00928512|428144|P2|Completed Week 16|Overall Study||43
177465|NCT00928512|428145|P1|Completed Week 16|Overall Study||38
177466|NCT00928512|428141|P5|New Groups After Reassignment|Overall Study||0
177467|NCT00928512|428142|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
177468|NCT00928512|428143|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
177469|NCT00928512|428144|P2|New Groups After Reassignment|Overall Study||115
177470|NCT00928512|428145|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
177471|NCT00928512|428141|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
177472|NCT00928512|428142|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
177473|NCT00928512|428143|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
177474|NCT00928512|428144|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
177475|NCT00928512|428145|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
177476|NCT00928512|428141|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
177477|NCT00928512|428142|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
177478|NCT00928512|428143|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
177479|NCT00928512|428144|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
177480|NCT00928512|428145|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
177481|NCT00928512|428141|P5|Discontinued Prior to Week 16|Overall Study||5
177482|NCT00928512|428142|P4|Discontinued Prior to Week 16|Overall Study||6
177483|NCT00928512|428143|P3|Discontinued Prior to Week 16|Overall Study||2
177484|NCT00928512|428144|P2|Discontinued Prior to Week 16|Overall Study||0
177485|NCT00928512|428145|P1|Discontinued Prior to Week 16|Overall Study||3
177486|NCT00928512|428141|P5|STARTED|Overall Study||50
177487|NCT00928512|428142|P4|STARTED|Overall Study||54
177488|NCT00928512|428143|P3|STARTED|Overall Study||49
177489|NCT00928512|428144|P2|STARTED|Overall Study||43
177490|NCT00928512|428145|P1|STARTED|Overall Study||41
177491|NCT00928486|428246|P1|NOT COMPLETED|Overall Study||10
177492|NCT00928486|428246|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
177493|NCT00928486|428246|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
177494|NCT00928486|428246|P1|STARTED|Overall Study||25
177495|NCT00928434|428255|P3|NOT COMPLETED|Overall Study||44
177496|NCT00928434|428256|P2|NOT COMPLETED|Overall Study||14
177497|NCT00928434|428257|P1|NOT COMPLETED|Overall Study||44
177498|NCT00928434|428255|P3|COMPLETED|Overall Study||134
177499|NCT00928434|428256|P2|COMPLETED|Overall Study||36
177500|NCT00928434|428257|P1|COMPLETED|Overall Study||131
177501|NCT00928434|428255|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
177502|NCT00928434|428256|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
177503|NCT00928434|428257|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
177504|NCT00928434|428255|P3|STARTED|Overall Study|Full Analysis Set Patients|178
177505|NCT00928434|428256|P2|STARTED|Overall Study|Full Analysis Set Patients|50
177506|NCT00928434|428257|P1|STARTED|Overall Study|Full Analysis Set Patients|175
177507|NCT00928421|428329|P1|NOT COMPLETED|Overall Study||0
177508|NCT00928421|428329|P1|COMPLETED|Overall Study||16
177509|NCT00928421|428329|P1|Treated With Study Drug|Overall Study||16
177510|NCT00928421|428329|P1|STARTED|Overall Study||16
177511|NCT00928408|428333|P1|NOT COMPLETED|Overall Study||23
177512|NCT00928408|428333|P1|COMPLETED|Overall Study||282
177513|NCT00928408|428333|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
177514|NCT00928408|428333|P1|STARTED|Overall Study|Number Enrolled|305
177515|NCT00928395|428362|P1|NOT COMPLETED|Overall Study||21
177516|NCT00928395|428362|P1|COMPLETED|Overall Study||29
177517|NCT00928395|428362|P1|STARTED|Overall Study||50
177518|NCT00928304|428366|P2|NOT COMPLETED|Overall Study||0
177519|NCT00928304|428367|P1|NOT COMPLETED|Overall Study||0
177520|NCT00928304|428366|P2|COMPLETED|Overall Study||70
177521|NCT00928304|428367|P1|COMPLETED|Overall Study||39
177522|NCT00928304|428366|P2|STARTED|Overall Study||70
177523|NCT00928304|428367|P1|STARTED|Overall Study||39
177524|NCT00928252|428379|P1|NOT COMPLETED|Overall Study||3
177525|NCT00928252|428379|P1|COMPLETED|Overall Study||42
177526|NCT00928252|428379|P1|STARTED|Overall Study||45
177527|NCT00928187|428388|P3|NOT COMPLETED|Overall Study||5
177528|NCT00928187|428389|P2|NOT COMPLETED|Overall Study||6
177529|NCT00928187|428390|P1|NOT COMPLETED|Overall Study||2
177530|NCT00928187|428388|P3|COMPLETED|Overall Study||150
177531|NCT00928187|428389|P2|COMPLETED|Overall Study||141
177532|NCT00928187|428390|P1|COMPLETED|Overall Study||150
177533|NCT00928187|428388|P3|Analysed|Overall Study||154
177534|NCT00928187|428389|P2|Analysed|Overall Study||145
177535|NCT00928187|428390|P1|Analysed|Overall Study||152
177536|NCT00928187|428388|P3|STARTED|Overall Study||155
177537|NCT00928187|428389|P2|STARTED|Overall Study||147
177538|NCT00928187|428390|P1|STARTED|Overall Study||152
177539|NCT00928174|428434|P1|NOT COMPLETED|Overall Study||5
177540|NCT00928174|428434|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
177541|NCT00928174|428434|P1|STARTED|Overall Study||27
177542|NCT00928083|428441|P9|NOT COMPLETED|Overall Study||0
177543|NCT00928083|428442|P8|NOT COMPLETED|Overall Study||0
177544|NCT00928083|428443|P7|NOT COMPLETED|Overall Study||0
177545|NCT00928083|428444|P6|NOT COMPLETED|Overall Study||0
177546|NCT00928083|428445|P5|NOT COMPLETED|Overall Study||1
177547|NCT00928083|428446|P4|NOT COMPLETED|Overall Study||1
177548|NCT00928083|428447|P3|NOT COMPLETED|Overall Study||0
177549|NCT00928083|428448|P2|NOT COMPLETED|Overall Study||0
177550|NCT00928083|428449|P1|NOT COMPLETED|Overall Study||4
177551|NCT00928083|428441|P9|COMPLETED|Overall Study||6
177552|NCT00928083|428442|P8|COMPLETED|Overall Study||6
177553|NCT00928083|428443|P7|COMPLETED|Overall Study||6
177554|NCT00928083|428444|P6|COMPLETED|Overall Study||6
177555|NCT00928083|428445|P5|COMPLETED|Overall Study||6
177556|NCT00928083|428446|P4|COMPLETED|Overall Study||5
177557|NCT00928083|428447|P3|COMPLETED|Overall Study||8
177558|NCT00928083|428448|P2|COMPLETED|Overall Study||8
177559|NCT00928083|428449|P1|COMPLETED|Overall Study||6
177560|NCT00928083|428441|P9|STARTED|Overall Study||6
177561|NCT00928083|428442|P8|STARTED|Overall Study||6
177562|NCT00928083|428443|P7|STARTED|Overall Study||6
177563|NCT00928083|428444|P6|STARTED|Overall Study||6
177564|NCT00928083|428445|P5|STARTED|Overall Study||7
177565|NCT00928083|428446|P4|STARTED|Overall Study||6
177566|NCT00928083|428447|P3|STARTED|Overall Study||8
177567|NCT00928083|428448|P2|STARTED|Overall Study||8
177568|NCT00928083|428449|P1|STARTED|Overall Study||10
177569|NCT00928070|428560|P2|NOT COMPLETED|Overall Study||57
177570|NCT00928070|428561|P1|NOT COMPLETED|Overall Study||63
177571|NCT00928070|428560|P2|COMPLETED|Overall Study||226
177572|NCT00928070|428561|P1|COMPLETED|Overall Study||220
177573|NCT00928070|428560|P2|Treated|Overall Study||281
177574|NCT00928070|428561|P1|Treated|Overall Study||281
177575|NCT00928070|428560|P2|STARTED|Overall Study||283
177576|NCT00928070|428561|P1|STARTED|Overall Study||283
177577|NCT00928057|428619|P2|NOT COMPLETED|Overall Study||4
177578|NCT00928057|428620|P1|NOT COMPLETED|Overall Study||2
177579|NCT00928057|428619|P2|COMPLETED|Overall Study||85
177580|NCT00928057|428620|P1|COMPLETED|Overall Study||82
177581|NCT00928057|428619|P2|STARTED|Overall Study||89
177582|NCT00928057|428620|P1|STARTED|Overall Study||84
177583|NCT00928018|428645|P2|NOT COMPLETED|Overall Study||0
177584|NCT00928018|428646|P1|NOT COMPLETED|Overall Study||1
177585|NCT00928018|428645|P2|COMPLETED|Overall Study||73
177586|NCT00928018|428646|P1|COMPLETED|Overall Study||65
177587|NCT00928018|428645|P2|STARTED|Overall Study||73
177588|NCT00928018|428646|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
177589|NCT00927992|428664|P1|NOT COMPLETED|Overall Study||0
177590|NCT00927992|428664|P1|COMPLETED|Overall Study||11
177591|NCT00927992|428664|P1|STARTED|Overall Study||11
177592|NCT00927953|428676|P2|NOT COMPLETED|Overall Study||1
177593|NCT00927953|428677|P1|NOT COMPLETED|Overall Study||2
177594|NCT00927953|428676|P2|COMPLETED|Overall Study||6
177595|NCT00927953|428677|P1|COMPLETED|Overall Study||4
177596|NCT00927953|428676|P2|STARTED|Overall Study||7
177597|NCT00927953|428677|P1|STARTED|Overall Study||6
177598|NCT00927940|428691|P1|NOT COMPLETED|Overall Study||1
177599|NCT00927940|428691|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
177600|NCT00927940|428691|P1|STARTED|Overall Study||100
177601|NCT00927927|428711|P15|NOT COMPLETED|Overall Study||0
177602|NCT00927927|428712|P14|NOT COMPLETED|Overall Study||0
177603|NCT00927927|428713|P13|NOT COMPLETED|Overall Study||0
177604|NCT00927927|428714|P12|NOT COMPLETED|Overall Study||2
177605|NCT00927927|428715|P11|NOT COMPLETED|Overall Study||0
177606|NCT00927927|428716|P10|NOT COMPLETED|Overall Study||0
177607|NCT00927927|428717|P9|NOT COMPLETED|Overall Study||0
177608|NCT00927927|428718|P8|NOT COMPLETED|Overall Study||2
177609|NCT00927927|428719|P7|NOT COMPLETED|Overall Study||0
177610|NCT00927927|428720|P6|NOT COMPLETED|Overall Study||0
177611|NCT00927927|428721|P5|NOT COMPLETED|Overall Study||0
177612|NCT00927927|428722|P4|NOT COMPLETED|Overall Study||0
177613|NCT00927927|428723|P3|NOT COMPLETED|Overall Study||0
177614|NCT00927927|428724|P2|NOT COMPLETED|Overall Study||0
177615|NCT00927927|428725|P1|NOT COMPLETED|Overall Study||0
177616|NCT00927927|428711|P15|COMPLETED|Overall Study||9
177617|NCT00927927|428712|P14|COMPLETED|Overall Study||5
177618|NCT00927927|428713|P13|COMPLETED|Overall Study||5
177619|NCT00927927|428714|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
177620|NCT00927927|428715|P11|COMPLETED|Overall Study||5
177621|NCT00927927|428716|P10|COMPLETED|Overall Study||3
177622|NCT00927927|428717|P9|COMPLETED|Overall Study||8
177623|NCT00927927|428718|P8|COMPLETED|Overall Study||1
177624|NCT00927927|428719|P7|COMPLETED|Overall Study||3
177625|NCT00927927|428720|P6|COMPLETED|Overall Study||3
177626|NCT00927927|428721|P5|COMPLETED|Overall Study||3
177627|NCT00927927|428722|P4|COMPLETED|Overall Study||3
177628|NCT00927927|428723|P3|COMPLETED|Overall Study||3
177629|NCT00927927|428724|P2|COMPLETED|Overall Study||3
177630|NCT00927927|428725|P1|COMPLETED|Overall Study||3
177631|NCT00927927|428711|P15|Exposed|Overall Study||9
177632|NCT00927927|428712|P14|Exposed|Overall Study||5
177633|NCT00927927|428713|P13|Exposed|Overall Study||5
177634|NCT00927927|428714|P12|Exposed|Overall Study||5
177635|NCT00927927|428715|P11|Exposed|Overall Study||5
177636|NCT00927927|428716|P10|Exposed|Overall Study||3
177637|NCT00927927|428717|P9|Exposed|Overall Study||8
177638|NCT00927927|428718|P8|Exposed|Overall Study||3
177639|NCT00927927|428719|P7|Exposed|Overall Study||3
177640|NCT00927927|428720|P6|Exposed|Overall Study||3
177641|NCT00927927|428721|P5|Exposed|Overall Study||3
177642|NCT00927927|428722|P4|Exposed|Overall Study||3
177643|NCT00927927|428723|P3|Exposed|Overall Study||3
177644|NCT00927927|428724|P2|Exposed|Overall Study||3
177645|NCT00927927|428725|P1|Exposed|Overall Study||3
177646|NCT00927927|428711|P15|STARTED|Overall Study||9
177647|NCT00927927|428712|P14|STARTED|Overall Study||5
177648|NCT00927927|428713|P13|STARTED|Overall Study||5
177649|NCT00927927|428714|P12|STARTED|Overall Study||6
177650|NCT00927927|428715|P11|STARTED|Overall Study||5
177651|NCT00927927|428716|P10|STARTED|Overall Study||3
177652|NCT00927927|428717|P9|STARTED|Overall Study||8
177653|NCT00927927|428718|P8|STARTED|Overall Study||3
177654|NCT00927927|428719|P7|STARTED|Overall Study||3
177655|NCT00927927|428720|P6|STARTED|Overall Study||3
177656|NCT00927927|428721|P5|STARTED|Overall Study||3
177657|NCT00927927|428722|P4|STARTED|Overall Study||3
177658|NCT00927927|428723|P3|STARTED|Overall Study||3
177659|NCT00927927|428724|P2|STARTED|Overall Study||3
177660|NCT00927927|428725|P1|STARTED|Overall Study||3
177661|NCT00927901|428772|P4|NOT COMPLETED|Treatment Period 4||1
177662|NCT00927901|428773|P3|NOT COMPLETED|Treatment Period 4||1
177663|NCT00927901|428774|P2|NOT COMPLETED|Treatment Period 4||0
177664|NCT00927901|428775|P1|NOT COMPLETED|Treatment Period 4||0
177665|NCT00927901|428772|P4|COMPLETED|Treatment Period 4||8
177666|NCT00927901|428773|P3|COMPLETED|Treatment Period 4||5
177667|NCT00927901|428774|P2|COMPLETED|Treatment Period 4||7
177668|NCT00927901|428775|P1|COMPLETED|Treatment Period 4||7
177669|NCT00927901|428772|P4|STARTED|Treatment Period 4||9
177670|NCT00927901|428773|P3|STARTED|Treatment Period 4||6
177671|NCT00927901|428774|P2|STARTED|Treatment Period 4||7
177672|NCT00927901|428775|P1|STARTED|Treatment Period 4||7
177673|NCT00927901|428772|P4|NOT COMPLETED|Treatment Period 3||0
177674|NCT00927901|428773|P3|NOT COMPLETED|Treatment Period 3||0
177675|NCT00927901|428774|P2|NOT COMPLETED|Treatment Period 3||0
177676|NCT00927901|428775|P1|NOT COMPLETED|Treatment Period 3||0
177677|NCT00927901|428772|P4|COMPLETED|Treatment Period 3||9
177678|NCT00927901|428773|P3|COMPLETED|Treatment Period 3||6
177679|NCT00927901|428774|P2|COMPLETED|Treatment Period 3||7
177680|NCT00927901|428775|P1|COMPLETED|Treatment Period 3||7
177681|NCT00927901|428772|P4|STARTED|Treatment Period 3||9
177682|NCT00927901|428773|P3|STARTED|Treatment Period 3||6
177683|NCT00927901|428774|P2|STARTED|Treatment Period 3||7
177684|NCT00927901|428775|P1|STARTED|Treatment Period 3||7
177685|NCT00927901|428772|P4|NOT COMPLETED|Treatment Period 2||0
177686|NCT00927901|428773|P3|NOT COMPLETED|Treatment Period 2||0
177687|NCT00927901|428774|P2|NOT COMPLETED|Treatment Period 2||0
177688|NCT00927901|428775|P1|NOT COMPLETED|Treatment Period 2||0
177689|NCT00927901|428772|P4|COMPLETED|Treatment Period 2||9
177690|NCT00927901|428773|P3|COMPLETED|Treatment Period 2||6
177691|NCT00927901|428774|P2|COMPLETED|Treatment Period 2||7
177692|NCT00927901|428775|P1|COMPLETED|Treatment Period 2||7
177693|NCT00927901|428772|P4|STARTED|Treatment Period 2||9
177694|NCT00927901|428773|P3|STARTED|Treatment Period 2||6
177695|NCT00927901|428774|P2|STARTED|Treatment Period 2||7
177696|NCT00927901|428775|P1|STARTED|Treatment Period 2||7
177697|NCT00927901|428772|P4|NOT COMPLETED|Treatment Period 1||0
177698|NCT00927901|428773|P3|NOT COMPLETED|Treatment Period 1||1
177699|NCT00927901|428774|P2|NOT COMPLETED|Treatment Period 1||0
177700|NCT00927901|428775|P1|NOT COMPLETED|Treatment Period 1||0
177701|NCT00927901|428772|P4|COMPLETED|Treatment Period 1||9
177702|NCT00927901|428773|P3|COMPLETED|Treatment Period 1||6
177703|NCT00927901|428774|P2|COMPLETED|Treatment Period 1||7
177704|NCT00927901|428775|P1|COMPLETED|Treatment Period 1||7
177705|NCT00927901|428772|P4|STARTED|Treatment Period 1||9
177706|NCT00927901|428773|P3|STARTED|Treatment Period 1||7
177707|NCT00927901|428774|P2|STARTED|Treatment Period 1||7
177708|NCT00927901|428775|P1|STARTED|Treatment Period 1||7
177709|NCT00927888|428805|P2|NOT COMPLETED|Overall Study||0
177710|NCT00927888|428806|P1|NOT COMPLETED|Overall Study||0
177711|NCT00927888|428805|P2|COMPLETED|Overall Study||27
177712|NCT00927888|428806|P1|COMPLETED|Overall Study||29
177713|NCT00927888|428805|P2|STARTED|Overall Study||27
177714|NCT00927888|428806|P1|STARTED|Overall Study||29
177715|NCT00927862|428816|P2|NOT COMPLETED|Overall Study||45
177716|NCT00927862|428817|P1|NOT COMPLETED|Overall Study||27
177717|NCT00927862|428816|P2|COMPLETED|Overall Study||1866
177718|NCT00927862|428817|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
177719|NCT00927862|428816|P2|STARTED|Overall Study||1911
177720|NCT00927862|428817|P1|STARTED|Overall Study||504
177721|NCT00927849|428842|P3|NOT COMPLETED|Overall Study||0
177722|NCT00927849|428843|P2|NOT COMPLETED|Overall Study||0
177723|NCT00927849|428844|P1|NOT COMPLETED|Overall Study||0
177724|NCT00927849|428842|P3|COMPLETED|Overall Study||21
177725|NCT00927849|428843|P2|COMPLETED|Overall Study||21
177726|NCT00927849|428844|P1|COMPLETED|Overall Study||21
177727|NCT00927849|428842|P3|STARTED|Overall Study||21
177728|NCT00927849|428843|P2|STARTED|Overall Study||21
177729|NCT00927849|428844|P1|STARTED|Overall Study||21
177730|NCT00927823|428852|P4|NOT COMPLETED|Continuous Dosing Period||5
177731|NCT00927823|428853|P3|NOT COMPLETED|Continuous Dosing Period||26
177732|NCT00927823|428854|P2|NOT COMPLETED|Continuous Dosing Period||3
177733|NCT00927823|428855|P1|NOT COMPLETED|Continuous Dosing Period||3
177734|NCT00927823|428852|P4|COMPLETED|Continuous Dosing Period||0
177735|NCT00927823|428853|P3|COMPLETED|Continuous Dosing Period||0
177736|NCT00927823|428854|P2|COMPLETED|Continuous Dosing Period||0
177737|NCT00927823|428855|P1|COMPLETED|Continuous Dosing Period||0
177738|NCT00927823|428852|P4|Treated|Continuous Dosing Period||5
177739|NCT00927823|428853|P3|Treated|Continuous Dosing Period||23
177740|NCT00927823|428854|P2|Treated|Continuous Dosing Period||3
177741|NCT00927823|428855|P1|Treated|Continuous Dosing Period||3
177742|NCT00927823|428852|P4|STARTED|Continuous Dosing Period||5
177743|NCT00927823|428853|P3|STARTED|Continuous Dosing Period||26
177744|NCT00927823|428854|P2|STARTED|Continuous Dosing Period||3
177745|NCT00927823|428855|P1|STARTED|Continuous Dosing Period||3
177746|NCT00927823|428852|P4|NOT COMPLETED|Lead-In Period||0
177747|NCT00927823|428853|P3|NOT COMPLETED|Lead-In Period||0
177748|NCT00927823|428854|P2|NOT COMPLETED|Lead-In Period||0
177749|NCT00927823|428855|P1|NOT COMPLETED|Lead-In Period||0
177750|NCT00927823|428852|P4|COMPLETED|Lead-In Period||5
177751|NCT00927823|428853|P3|COMPLETED|Lead-In Period||26
177752|NCT00927823|428854|P2|COMPLETED|Lead-In Period||3
177753|NCT00927823|428855|P1|COMPLETED|Lead-In Period||3
177754|NCT00927823|428852|P4|STARTED|Lead-In Period||5
177755|NCT00927823|428853|P3|STARTED|Lead-In Period||26
177756|NCT00927823|428854|P2|STARTED|Lead-In Period||3
177757|NCT00927823|428855|P1|STARTED|Lead-In Period||3
177758|NCT00927758|428919|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
177759|NCT00927758|428920|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
177760|NCT00927758|428921|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
177761|NCT00927758|428922|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
177762|NCT00927758|428923|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
177763|NCT00927758|428924|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
177764|NCT00927758|428919|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
177765|NCT00927758|428920|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
177766|NCT00927758|428921|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
177767|NCT00927758|428922|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
177768|NCT00927758|428923|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
177769|NCT00927758|428924|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
177770|NCT00927758|428919|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
177771|NCT00927758|428920|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
177772|NCT00927758|428921|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
177773|NCT00927758|428922|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
177774|NCT00927758|428923|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
177775|NCT00927758|428924|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
177776|NCT00927758|428919|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
177777|NCT00927758|428920|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
177778|NCT00927758|428921|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
177779|NCT00927758|428922|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
177780|NCT00927758|428923|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
177781|NCT00927758|428924|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
177782|NCT00927758|428919|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
177783|NCT00927758|428920|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
177784|NCT00927758|428921|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
177785|NCT00927758|428922|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
177786|NCT00927758|428923|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
177787|NCT00927758|428924|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
177788|NCT00927758|428919|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
177789|NCT00927758|428920|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
177790|NCT00927758|428921|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
177791|NCT00927758|428922|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
177792|NCT00927758|428923|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
177793|NCT00927758|428924|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
177794|NCT00927758|428919|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
177795|NCT00927758|428920|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
177796|NCT00927758|428921|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
177797|NCT00927758|428922|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
177798|NCT00927758|428923|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
177799|NCT00927758|428924|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
177800|NCT00927758|428919|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
177801|NCT00927758|428920|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
177802|NCT00927758|428921|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
177803|NCT00927758|428922|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
177804|NCT00927758|428923|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
177805|NCT00927758|428924|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
177806|NCT00927758|428919|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
177807|NCT00927758|428920|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
177808|NCT00927758|428921|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
177809|NCT00927758|428922|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
177810|NCT00927758|428923|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
177811|NCT00927758|428924|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
177812|NCT00927758|428919|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
177813|NCT00927758|428920|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
177814|NCT00927758|428921|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
177815|NCT00927758|428922|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
177816|NCT00927758|428923|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
177817|NCT00927758|428924|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
177818|NCT00927758|428919|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
177819|NCT00927758|428920|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
177820|NCT00927758|428921|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
177821|NCT00927758|428922|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
177822|NCT00927758|428923|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
177823|NCT00927758|428924|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
177824|NCT00927589|428932|P1|NOT COMPLETED|Overall Study||16
177825|NCT00927589|428932|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
177826|NCT00927589|428932|P1|STARTED|Overall Study||59
177827|NCT00927576|428956|P2|NOT COMPLETED|Overall Study||0
177828|NCT00927576|428957|P1|NOT COMPLETED|Overall Study||0
177829|NCT00927576|428956|P2|COMPLETED|Overall Study||28
177830|NCT00927576|428957|P1|COMPLETED|Overall Study||237
177831|NCT00927576|428956|P2|Cognitive Testing|Overall Study||28
177832|NCT00927576|428957|P1|Cognitive Testing|Overall Study||237
177833|NCT00927576|428956|P2|STARTED|Overall Study||28
177834|NCT00927576|428957|P1|STARTED|Overall Study||237
177835|NCT00927563|428962|P1|NOT COMPLETED|Overall Study||2
177836|NCT00927563|428962|P1|COMPLETED|Overall Study||22
177837|NCT00927563|428962|P1|STARTED|Overall Study||24
177838|NCT00927472|428970|P2|NOT COMPLETED|Overall Study||22
177839|NCT00927472|428971|P1|NOT COMPLETED|Overall Study||11
177840|NCT00927472|428970|P2|COMPLETED|Overall Study||106
177841|NCT00927472|428971|P1|COMPLETED|Overall Study||115
177842|NCT00927472|428970|P2|STARTED|Overall Study||128
177843|NCT00927472|428971|P1|STARTED|Overall Study||126
177844|NCT00927394|428997|P2|NOT COMPLETED|Overall Study||85
177845|NCT00927394|428998|P1|NOT COMPLETED|Overall Study||77
177846|NCT00927394|428997|P2|COMPLETED|Overall Study||483
177847|NCT00927394|428998|P1|COMPLETED|Overall Study||498
177848|NCT00927394|428997|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
177849|NCT00927394|428998|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
177850|NCT00927394|428997|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
177851|NCT00927394|428998|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
177852|NCT00927394|428997|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
177853|NCT00927394|428998|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
177854|NCT00927394|428997|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
178031|NCT00926328|429519|P1|COMPLETED|Overall Study||48
178032|NCT00926328|429518|P2|STARTED|Overall Study||60
177855|NCT00927394|428998|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
177856|NCT00927394|428997|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
177857|NCT00927394|428998|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
177858|NCT00927394|428997|P2|Cohort 2 (Randomized)|Overall Study||403
177859|NCT00927394|428998|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
177860|NCT00927394|428997|P2|Cohort 1 (Randomized)|Overall Study||165
177861|NCT00927394|428998|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
177862|NCT00927394|428997|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
177863|NCT00927394|428998|P1|STARTED|Overall Study||575
177864|NCT00927368|429029|P3|NOT COMPLETED|Overall Study||5
177865|NCT00927368|429030|P2|NOT COMPLETED|Overall Study||5
177866|NCT00927368|429031|P1|NOT COMPLETED|Overall Study||6
177867|NCT00927368|429029|P3|COMPLETED|Overall Study||138
177868|NCT00927368|429030|P2|COMPLETED|Overall Study||152
177869|NCT00927368|429031|P1|COMPLETED|Overall Study||147
177870|NCT00927368|429029|P3|STARTED|Overall Study||143
177871|NCT00927368|429030|P2|STARTED|Overall Study||157
177872|NCT00927368|429031|P1|STARTED|Overall Study||153
177873|NCT00927355|429050|P2|NOT COMPLETED|Overall Study||1
177874|NCT00927355|429051|P1|NOT COMPLETED|Overall Study||1
177875|NCT00927355|429050|P2|COMPLETED|Overall Study||4
177876|NCT00927355|429051|P1|COMPLETED|Overall Study||4
177877|NCT00927355|429050|P2|STARTED|Overall Study||5
177878|NCT00927355|429051|P1|STARTED|Overall Study||5
177879|NCT00927264|429071|P2|NOT COMPLETED|Overall Study||25
177880|NCT00927264|429072|P1|NOT COMPLETED|Overall Study||56
177881|NCT00927264|429071|P2|COMPLETED|Overall Study||140
177882|NCT00927264|429072|P1|COMPLETED|Overall Study||109
177883|NCT00927264|429071|P2|STARTED|Overall Study||165
177884|NCT00927264|429072|P1|STARTED|Overall Study||165
177885|NCT00927251|429086|P1|NOT COMPLETED|Overall Study||8
177886|NCT00927251|429086|P1|COMPLETED|Overall Study||82
177887|NCT00927251|429086|P1|STARTED|Overall Study||90
177888|NCT00927186|429092|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
177889|NCT00927186|429093|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
177890|NCT00927186|429092|P2|COMPLETED|12 - 24 Months Extension Treatment||11
177891|NCT00927186|429093|P1|COMPLETED|12 - 24 Months Extension Treatment||10
177892|NCT00927186|429092|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
177893|NCT00927186|429093|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
177894|NCT00927186|429092|P2|NOT COMPLETED|12 Months Primary Study||4
177895|NCT00927186|429093|P1|NOT COMPLETED|12 Months Primary Study||7
177896|NCT00927186|429092|P2|COMPLETED|12 Months Primary Study||31
177897|NCT00927186|429093|P1|COMPLETED|12 Months Primary Study||27
177898|NCT00927186|429092|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
177899|NCT00927186|429093|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
177900|NCT00927186|429092|P2|STARTED|12 Months Primary Study||35
177901|NCT00927186|429093|P1|STARTED|12 Months Primary Study||34
177902|NCT00927160|429211|P2|NOT COMPLETED|Overall Study||0
177903|NCT00927160|429212|P1|NOT COMPLETED|Overall Study||0
177904|NCT00927160|429211|P2|COMPLETED|Overall Study||173
177905|NCT00927160|429212|P1|COMPLETED|Overall Study||173
177906|NCT00927160|429211|P2|STARTED|Overall Study||173
177907|NCT00927160|429212|P1|STARTED|Overall Study||173
177908|NCT00927095|429223|P3|NOT COMPLETED|Overall Study||2
177909|NCT00927095|429224|P2|NOT COMPLETED|Overall Study||4
177910|NCT00927095|429225|P1|NOT COMPLETED|Overall Study||6
177911|NCT00927095|429223|P3|COMPLETED|Overall Study||22
177912|NCT00927095|429224|P2|COMPLETED|Overall Study||17
177913|NCT00927095|429225|P1|COMPLETED|Overall Study||16
177914|NCT00927095|429223|P3|STARTED|Overall Study||24
177915|NCT00927095|429224|P2|STARTED|Overall Study||21
177916|NCT00927095|429225|P1|STARTED|Overall Study||22
177917|NCT00927082|429237|P4|NOT COMPLETED|Overall Study||19
177918|NCT00927082|429238|P3|NOT COMPLETED|Overall Study||22
177919|NCT00927082|429239|P2|NOT COMPLETED|Overall Study||10
177920|NCT00927082|429240|P1|NOT COMPLETED|Overall Study||12
177921|NCT00927082|429237|P4|COMPLETED|Overall Study||78
177922|NCT00927082|429238|P3|COMPLETED|Overall Study||86
177923|NCT00927082|429239|P2|COMPLETED|Overall Study||77
177924|NCT00927082|429240|P1|COMPLETED|Overall Study||79
177925|NCT00927082|429237|P4|STARTED|Overall Study||97
177926|NCT00927082|429238|P3|STARTED|Overall Study||108
177927|NCT00927082|429239|P2|STARTED|Overall Study||87
177928|NCT00927082|429240|P1|STARTED|Overall Study||91
177929|NCT00927069|429304|P4|NOT COMPLETED|Week 12 to Week 24||3
177930|NCT00927069|429305|P3|NOT COMPLETED|Week 12 to Week 24||3
177931|NCT00927069|429306|P2|NOT COMPLETED|Week 12 to Week 24||0
177932|NCT00927069|429307|P1|NOT COMPLETED|Week 12 to Week 24||2
177933|NCT00927069|429304|P4|COMPLETED|Week 12 to Week 24||20
177934|NCT00927069|429305|P3|COMPLETED|Week 12 to Week 24||28
177935|NCT00927069|429306|P2|COMPLETED|Week 12 to Week 24||11
177936|NCT00927069|429307|P1|COMPLETED|Week 12 to Week 24||16
177937|NCT00927069|429304|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
178033|NCT00926328|429519|P1|STARTED|Overall Study||60
177938|NCT00927069|429305|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
177939|NCT00927069|429306|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
177940|NCT00927069|429307|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
177941|NCT00927069|429304|P4|NOT COMPLETED|Week 0 to Week 12||0
177942|NCT00927069|429305|P3|NOT COMPLETED|Week 0 to Week 12||0
177943|NCT00927069|429306|P2|NOT COMPLETED|Week 0 to Week 12||1
177944|NCT00927069|429307|P1|NOT COMPLETED|Week 0 to Week 12||1
177945|NCT00927069|429304|P4|COMPLETED|Week 0 to Week 12||0
177946|NCT00927069|429305|P3|COMPLETED|Week 0 to Week 12||0
177947|NCT00927069|429306|P2|COMPLETED|Week 0 to Week 12||34
177948|NCT00927069|429307|P1|COMPLETED|Week 0 to Week 12||49
177949|NCT00927069|429304|P4|STARTED|Week 0 to Week 12||0
177950|NCT00927069|429305|P3|STARTED|Week 0 to Week 12||0
177951|NCT00927069|429306|P2|STARTED|Week 0 to Week 12||35
177952|NCT00927069|429307|P1|STARTED|Week 0 to Week 12||50
177953|NCT00926952|429317|P1|NOT COMPLETED|Overall Study||0
177954|NCT00926952|429317|P1|COMPLETED|Overall Study||20
177955|NCT00926952|429317|P1|STARTED|Overall Study||20
177956|NCT00926887|429331|P2|NOT COMPLETED|Overall Study||0
177957|NCT00926887|429332|P1|NOT COMPLETED|Overall Study||0
177958|NCT00926887|429331|P2|COMPLETED|Overall Study||50
177959|NCT00926887|429332|P1|COMPLETED|Overall Study||54
177960|NCT00926887|429331|P2|STARTED|Overall Study||50
177961|NCT00926887|429332|P1|STARTED|Overall Study||54
177962|NCT00926796|429344|P2|NOT COMPLETED|Overall Study||106
177963|NCT00926796|429345|P1|NOT COMPLETED|Overall Study||107
177964|NCT00926796|429344|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
177965|NCT00926796|429345|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
177966|NCT00926796|429344|P2|STARTED|Overall Study|Number randomized|305
177967|NCT00926796|429345|P1|STARTED|Overall Study|Number randomized|309
177968|NCT00926783|429366|P2|NOT COMPLETED|Overall Study||3
177969|NCT00926783|429367|P1|NOT COMPLETED|Overall Study||3
177970|NCT00926783|429366|P2|COMPLETED|Overall Study||38
177971|NCT00926783|429367|P1|COMPLETED|Overall Study||39
177972|NCT00926783|429366|P2|STARTED|Overall Study||41
177973|NCT00926783|429367|P1|STARTED|Overall Study||42
177974|NCT00926588|429385|P2|NOT COMPLETED|Overall Study||4
177975|NCT00926588|429386|P1|NOT COMPLETED|Overall Study||8
177976|NCT00926588|429385|P2|COMPLETED|Overall Study||122
177977|NCT00926588|429386|P1|COMPLETED|Overall Study||116
177978|NCT00926588|429385|P2|STARTED|Overall Study||126
177979|NCT00926588|429386|P1|STARTED|Overall Study||124
177980|NCT00926575|429394|P2|NOT COMPLETED|Overall Study||17
177981|NCT00926575|429395|P1|NOT COMPLETED|Overall Study||16
177982|NCT00926575|429394|P2|COMPLETED|Overall Study||53
177983|NCT00926575|429395|P1|COMPLETED|Overall Study||54
177984|NCT00926575|429394|P2|STARTED|Overall Study||70
177985|NCT00926575|429395|P1|STARTED|Overall Study||70
177986|NCT00926536|429407|P2|NOT COMPLETED|Overall Study||2
177987|NCT00926536|429408|P1|NOT COMPLETED|Overall Study||1
177988|NCT00926536|429407|P2|COMPLETED|Overall Study||41
177989|NCT00926536|429408|P1|COMPLETED|Overall Study||43
177990|NCT00926536|429407|P2|STARTED|Overall Study||43
177991|NCT00926536|429408|P1|STARTED|Overall Study||44
177992|NCT00926497|429418|P2|NOT COMPLETED|Overall Study||0
177993|NCT00926497|429419|P1|NOT COMPLETED|Overall Study||0
177994|NCT00926497|429418|P2|COMPLETED|Overall Study||61
177995|NCT00926497|429419|P1|COMPLETED|Overall Study||60
177996|NCT00926497|429418|P2|STARTED|Overall Study||61
177997|NCT00926497|429419|P1|STARTED|Overall Study||60
177998|NCT00926393|429429|P2|NOT COMPLETED|Overall Study||3
177999|NCT00926393|429430|P1|NOT COMPLETED|Overall Study||2
178000|NCT00926393|429429|P2|COMPLETED|Overall Study||67
178001|NCT00926393|429430|P1|COMPLETED|Overall Study||67
178002|NCT00926393|429429|P2|STARTED|Overall Study||70
178003|NCT00926393|429430|P1|STARTED|Overall Study||69
178004|NCT00926380|429463|P3|NOT COMPLETED|Year 2||5
178005|NCT00926380|429464|P2|NOT COMPLETED|Year 2||2
178006|NCT00926380|429465|P1|NOT COMPLETED|Year 2||2
178007|NCT00926380|429463|P3|COMPLETED|Year 2||24
178008|NCT00926380|429464|P2|COMPLETED|Year 2||28
178009|NCT00926380|429465|P1|COMPLETED|Year 2||31
178010|NCT00926380|429463|P3|STARTED|Year 2||29
178011|NCT00926380|429464|P2|STARTED|Year 2||30
178012|NCT00926380|429465|P1|STARTED|Year 2||33
178013|NCT00926380|429463|P3|NOT COMPLETED|Year 1||1
178014|NCT00926380|429464|P2|NOT COMPLETED|Year 1||1
178015|NCT00926380|429465|P1|NOT COMPLETED|Year 1||0
178016|NCT00926380|429463|P3|COMPLETED|Year 1||29
178017|NCT00926380|429464|P2|COMPLETED|Year 1||30
178018|NCT00926380|429465|P1|COMPLETED|Year 1||33
178019|NCT00926380|429463|P3|STARTED|Year 1||30
178020|NCT00926380|429464|P2|STARTED|Year 1||31
178021|NCT00926380|429465|P1|STARTED|Year 1||33
178022|NCT00926367|429475|P2|NOT COMPLETED|Overall Study||3
178023|NCT00926367|429476|P1|NOT COMPLETED|Overall Study||2
178024|NCT00926367|429475|P2|COMPLETED|Overall Study||24
178025|NCT00926367|429476|P1|COMPLETED|Overall Study||23
178026|NCT00926367|429475|P2|STARTED|Overall Study||27
178027|NCT00926367|429476|P1|STARTED|Overall Study||25
178028|NCT00926328|429518|P2|NOT COMPLETED|Overall Study||14
178029|NCT00926328|429519|P1|NOT COMPLETED|Overall Study||12
178030|NCT00926328|429518|P2|COMPLETED|Overall Study||46
178034|NCT00926289|429529|P2|NOT COMPLETED|Overall Study||36
178035|NCT00926289|429530|P1|NOT COMPLETED|Overall Study||25
178036|NCT00926289|429529|P2|COMPLETED|Overall Study||558
178037|NCT00926289|429530|P1|COMPLETED|Overall Study||269
178038|NCT00926289|429529|P2|STARTED|Overall Study|Number of treated patients|594
178039|NCT00926289|429530|P1|STARTED|Overall Study|Number of treated patients|294
178040|NCT00926263|429566|P2|NOT COMPLETED|Overall Study||0
178041|NCT00926263|429567|P1|NOT COMPLETED|Overall Study||0
178042|NCT00926263|429566|P2|COMPLETED|Overall Study||12
178043|NCT00926263|429567|P1|COMPLETED|Overall Study||16
178044|NCT00926263|429566|P2|STARTED|Overall Study||12
178045|NCT00926263|429567|P1|STARTED|Overall Study||16
178046|NCT00926211|429598|P1|NOT COMPLETED|Overall Study||1
178047|NCT00926211|429598|P1|COMPLETED|Overall Study||35
178048|NCT00926211|429598|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
178049|NCT00926185|429609|P4|NOT COMPLETED|Overall Study||10
178050|NCT00926185|429610|P3|NOT COMPLETED|Overall Study||10
178051|NCT00926185|429611|P2|NOT COMPLETED|Overall Study||6
178052|NCT00926185|429612|P1|NOT COMPLETED|Overall Study||3
178053|NCT00926185|429609|P4|COMPLETED|Overall Study||48
178054|NCT00926185|429610|P3|COMPLETED|Overall Study||48
178055|NCT00926185|429611|P2|COMPLETED|Overall Study||51
178056|NCT00926185|429612|P1|COMPLETED|Overall Study||54
178057|NCT00926185|429609|P4|STARTED|Overall Study||58
178058|NCT00926185|429610|P3|STARTED|Overall Study||58
178059|NCT00926185|429611|P2|STARTED|Overall Study||57
178060|NCT00926185|429612|P1|STARTED|Overall Study||57
178061|NCT00926029|429629|P3|NOT COMPLETED|Overall Study||1
178062|NCT00926029|429630|P2|NOT COMPLETED|Overall Study||1
178063|NCT00926029|429631|P1|NOT COMPLETED|Overall Study||2
178064|NCT00926029|429629|P3|COMPLETED|Overall Study||33
178065|NCT00926029|429630|P2|COMPLETED|Overall Study||33
178066|NCT00926029|429631|P1|COMPLETED|Overall Study||32
178067|NCT00926029|429629|P3|STARTED|Overall Study||34
178068|NCT00926029|429630|P2|STARTED|Overall Study||34
178069|NCT00926029|429631|P1|STARTED|Overall Study||34
178070|NCT00925990|429644|P2|NOT COMPLETED|Overall Study||11
178071|NCT00925990|429645|P1|NOT COMPLETED|Overall Study||5
178072|NCT00925990|429644|P2|COMPLETED|Overall Study||24
178073|NCT00925990|429645|P1|COMPLETED|Overall Study||30
178074|NCT00925990|429644|P2|STARTED|Overall Study||35
178075|NCT00925990|429645|P1|STARTED|Overall Study||35
178076|NCT00925938|429656|P3|NOT COMPLETED|Overall Study||0
178077|NCT00925938|429657|P2|NOT COMPLETED|Overall Study||0
178078|NCT00925938|429658|P1|NOT COMPLETED|Overall Study||0
178079|NCT00925938|429656|P3|COMPLETED|Overall Study||17
178080|NCT00925938|429657|P2|COMPLETED|Overall Study||25
178081|NCT00925938|429658|P1|COMPLETED|Overall Study||9
178082|NCT00925938|429656|P3|STARTED|Overall Study||17
178083|NCT00925938|429657|P2|STARTED|Overall Study||25
178084|NCT00925938|429658|P1|STARTED|Overall Study||9
178085|NCT00925899|429680|P2|NOT COMPLETED|Part 2||12
178086|NCT00925899|429681|P1|NOT COMPLETED|Part 2||6
178087|NCT00925899|429680|P2|COMPLETED|Part 2||9
178088|NCT00925899|429681|P1|COMPLETED|Part 2||9
178089|NCT00925899|429680|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
178090|NCT00925899|429681|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
178091|NCT00925899|429680|P2|NOT COMPLETED|Part 1||11
178092|NCT00925899|429681|P1|NOT COMPLETED|Part 1||11
178093|NCT00925899|429680|P2|COMPLETED|Part 1||27
178094|NCT00925899|429681|P1|COMPLETED|Part 1||23
178095|NCT00925899|429680|P2|STARTED|Part 1||38
178096|NCT00925899|429681|P1|STARTED|Part 1||34
178097|NCT00925782|429699|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
178098|NCT00925782|429700|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
178099|NCT00925782|429699|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
178100|NCT00925782|429700|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
178101|NCT00925782|429699|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
178102|NCT00925782|429700|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
178103|NCT00925782|429699|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
178104|NCT00925782|429700|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
178105|NCT00925782|429699|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
178106|NCT00925782|429700|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
178107|NCT00925782|429699|P2|STARTED|Study Period (Day -3 to Day 0)||12
178108|NCT00925782|429700|P1|STARTED|Study Period (Day -3 to Day 0)||12
178109|NCT00925782|429699|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
178110|NCT00925782|429700|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
178111|NCT00925782|429699|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
178112|NCT00925782|429700|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
178113|NCT00925782|429699|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
178114|NCT00925782|429700|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
178115|NCT00925769|429709|P6|NOT COMPLETED|Overall Study||3
178116|NCT00925769|429710|P5|NOT COMPLETED|Overall Study||3
178117|NCT00925769|429711|P4|NOT COMPLETED|Overall Study||6
178118|NCT00925769|429712|P3|NOT COMPLETED|Overall Study||6
178119|NCT00925769|429713|P2|NOT COMPLETED|Overall Study||6
178120|NCT00925769|429714|P1|NOT COMPLETED|Overall Study||6
178121|NCT00925769|429709|P6|COMPLETED|Overall Study||0
178122|NCT00925769|429710|P5|COMPLETED|Overall Study||0
178123|NCT00925769|429711|P4|COMPLETED|Overall Study||0
178124|NCT00925769|429712|P3|COMPLETED|Overall Study||0
178125|NCT00925769|429713|P2|COMPLETED|Overall Study||0
178126|NCT00925769|429714|P1|COMPLETED|Overall Study||0
178127|NCT00925769|429709|P6|STARTED|Overall Study||3
178128|NCT00925769|429710|P5|STARTED|Overall Study||3
178129|NCT00925769|429711|P4|STARTED|Overall Study||6
178130|NCT00925769|429712|P3|STARTED|Overall Study||6
178131|NCT00925769|429713|P2|STARTED|Overall Study||6
178132|NCT00925769|429714|P1|STARTED|Overall Study||6
178133|NCT00925704|429782|P6|NOT COMPLETED|Third Intervention||1
178134|NCT00925704|429783|P5|NOT COMPLETED|Third Intervention||0
178135|NCT00925704|429784|P4|NOT COMPLETED|Third Intervention||0
178136|NCT00925704|429785|P3|NOT COMPLETED|Third Intervention||0
178137|NCT00925704|429786|P2|NOT COMPLETED|Third Intervention||0
178138|NCT00925704|429787|P1|NOT COMPLETED|Third Intervention||0
178139|NCT00925704|429782|P6|COMPLETED|Third Intervention||6
178140|NCT00925704|429783|P5|COMPLETED|Third Intervention||5
178141|NCT00925704|429784|P4|COMPLETED|Third Intervention||6
178142|NCT00925704|429785|P3|COMPLETED|Third Intervention||7
178143|NCT00925704|429786|P2|COMPLETED|Third Intervention||7
178144|NCT00925704|429787|P1|COMPLETED|Third Intervention||5
178145|NCT00925704|429782|P6|STARTED|Third Intervention||7
178146|NCT00925704|429783|P5|STARTED|Third Intervention||5
178147|NCT00925704|429784|P4|STARTED|Third Intervention||6
178148|NCT00925704|429785|P3|STARTED|Third Intervention||7
178149|NCT00925704|429786|P2|STARTED|Third Intervention||7
178150|NCT00925704|429787|P1|STARTED|Third Intervention||5
178151|NCT00925704|429782|P6|NOT COMPLETED|Washout||0
178152|NCT00925704|429783|P5|NOT COMPLETED|Washout||0
178153|NCT00925704|429784|P4|NOT COMPLETED|Washout||0
178154|NCT00925704|429785|P3|NOT COMPLETED|Washout||0
178155|NCT00925704|429786|P2|NOT COMPLETED|Washout||0
178156|NCT00925704|429787|P1|NOT COMPLETED|Washout||0
178157|NCT00925704|429782|P6|COMPLETED|Washout||7
178158|NCT00925704|429783|P5|COMPLETED|Washout||5
178159|NCT00925704|429784|P4|COMPLETED|Washout||6
178160|NCT00925704|429785|P3|COMPLETED|Washout||7
178161|NCT00925704|429786|P2|COMPLETED|Washout||7
178162|NCT00925704|429787|P1|COMPLETED|Washout||5
178163|NCT00925704|429782|P6|STARTED|Washout||7
178164|NCT00925704|429783|P5|STARTED|Washout||5
178165|NCT00925704|429784|P4|STARTED|Washout||6
178166|NCT00925704|429785|P3|STARTED|Washout||7
178167|NCT00925704|429786|P2|STARTED|Washout||7
178168|NCT00925704|429787|P1|STARTED|Washout||5
178169|NCT00925704|429782|P6|NOT COMPLETED|Second Intervention||0
178170|NCT00925704|429783|P5|NOT COMPLETED|Second Intervention||1
178171|NCT00925704|429784|P4|NOT COMPLETED|Second Intervention||0
178172|NCT00925704|429785|P3|NOT COMPLETED|Second Intervention||0
178173|NCT00925704|429786|P2|NOT COMPLETED|Second Intervention||0
178174|NCT00925704|429787|P1|NOT COMPLETED|Second Intervention||1
178175|NCT00925704|429782|P6|COMPLETED|Second Intervention||7
178176|NCT00925704|429783|P5|COMPLETED|Second Intervention||5
178177|NCT00925704|429784|P4|COMPLETED|Second Intervention||6
178178|NCT00925704|429785|P3|COMPLETED|Second Intervention||7
178179|NCT00925704|429786|P2|COMPLETED|Second Intervention||7
178180|NCT00925704|429787|P1|COMPLETED|Second Intervention||5
178181|NCT00925704|429782|P6|STARTED|Second Intervention||7
178182|NCT00925704|429783|P5|STARTED|Second Intervention||6
178183|NCT00925704|429784|P4|STARTED|Second Intervention||6
178184|NCT00925704|429785|P3|STARTED|Second Intervention||7
178185|NCT00925704|429786|P2|STARTED|Second Intervention||7
178186|NCT00925704|429787|P1|STARTED|Second Intervention||6
178187|NCT00925704|429782|P6|NOT COMPLETED|Washout||0
178188|NCT00925704|429783|P5|NOT COMPLETED|Washout||0
178189|NCT00925704|429784|P4|NOT COMPLETED|Washout||0
178190|NCT00925704|429785|P3|NOT COMPLETED|Washout||0
178191|NCT00925704|429786|P2|NOT COMPLETED|Washout||0
178192|NCT00925704|429787|P1|NOT COMPLETED|Washout||0
178193|NCT00925704|429782|P6|COMPLETED|Washout||7
178194|NCT00925704|429783|P5|COMPLETED|Washout||6
178195|NCT00925704|429784|P4|COMPLETED|Washout||6
178196|NCT00925704|429785|P3|COMPLETED|Washout||7
178197|NCT00925704|429786|P2|COMPLETED|Washout||7
178198|NCT00925704|429787|P1|COMPLETED|Washout||6
178199|NCT00925704|429782|P6|STARTED|Washout||7
178200|NCT00925704|429783|P5|STARTED|Washout||6
178201|NCT00925704|429784|P4|STARTED|Washout||6
178202|NCT00925704|429785|P3|STARTED|Washout||7
178203|NCT00925704|429786|P2|STARTED|Washout||7
178204|NCT00925704|429787|P1|STARTED|Washout||6
178205|NCT00925704|429782|P6|NOT COMPLETED|First Intervention||0
178206|NCT00925704|429783|P5|NOT COMPLETED|First Intervention||1
178207|NCT00925704|429784|P4|NOT COMPLETED|First Intervention||1
178208|NCT00925704|429785|P3|NOT COMPLETED|First Intervention||0
178209|NCT00925704|429786|P2|NOT COMPLETED|First Intervention||0
178210|NCT00925704|429787|P1|NOT COMPLETED|First Intervention||0
178211|NCT00925704|429782|P6|COMPLETED|First Intervention||7
178212|NCT00925704|429783|P5|COMPLETED|First Intervention||6
178213|NCT00925704|429784|P4|COMPLETED|First Intervention||6
178214|NCT00925704|429785|P3|COMPLETED|First Intervention||7
178215|NCT00925704|429786|P2|COMPLETED|First Intervention||7
178216|NCT00925704|429787|P1|COMPLETED|First Intervention||6
178217|NCT00925704|429782|P6|STARTED|First Intervention||7
178218|NCT00925704|429783|P5|STARTED|First Intervention||7
178219|NCT00925704|429784|P4|STARTED|First Intervention||7
178220|NCT00925704|429785|P3|STARTED|First Intervention||7
178221|NCT00925704|429786|P2|STARTED|First Intervention||7
178222|NCT00925704|429787|P1|STARTED|First Intervention||6
178223|NCT00925600|429800|P2|NOT COMPLETED|Overall Study||28
178224|NCT00925600|429801|P1|NOT COMPLETED|Overall Study||32
178225|NCT00925600|429800|P2|COMPLETED|Overall Study||355
178226|NCT00925600|429801|P1|COMPLETED|Overall Study||354
178227|NCT00925600|429800|P2|Received Treatment|Overall Study||382
178228|NCT00925600|429801|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
178229|NCT00925600|429800|P2|STARTED|Overall Study||383
178230|NCT00925600|429801|P1|STARTED|Overall Study||386
178231|NCT00925587|429823|P2|NOT COMPLETED|Overall Study||25
178232|NCT00925587|429824|P1|NOT COMPLETED|Overall Study||36
178233|NCT00925587|429823|P2|COMPLETED|Overall Study||155
178234|NCT00925587|429824|P1|COMPLETED|Overall Study||142
178235|NCT00925587|429823|P2|STARTED|Overall Study||180
178236|NCT00925587|429824|P1|STARTED|Overall Study||178
178237|NCT00925548|429938|P2|NOT COMPLETED|Overall Study||5
178238|NCT00925548|429939|P1|NOT COMPLETED|Overall Study||10
178239|NCT00925548|429938|P2|COMPLETED|Overall Study||0
178240|NCT00925548|429939|P1|COMPLETED|Overall Study||1
178241|NCT00925548|429938|P2|STARTED|Overall Study||5
178242|NCT00925548|429939|P1|STARTED|Overall Study||11
178243|NCT00925522|429965|P1|NOT COMPLETED|Overall Study||0
178244|NCT00925522|429965|P1|COMPLETED|Overall Study||20
178245|NCT00925522|429965|P1|STARTED|Overall Study||20
178246|NCT00925353|429969|P1|NOT COMPLETED|Overall Study||3
178247|NCT00925353|429969|P1|COMPLETED|Overall Study||10
178248|NCT00925353|429969|P1|STARTED|Overall Study||13
178249|NCT00925288|429975|P2|NOT COMPLETED|Overall Study||7
178250|NCT00925288|429976|P1|NOT COMPLETED|Overall Study||9
178251|NCT00925288|429975|P2|COMPLETED|Overall Study||93
178252|NCT00925288|429976|P1|COMPLETED|Overall Study||91
178253|NCT00925288|429975|P2|STARTED|Overall Study||100
178254|NCT00925288|429976|P1|STARTED|Overall Study||100
178255|NCT00925132|429988|P5|NOT COMPLETED|Overall Study||5
178256|NCT00925132|429989|P4|NOT COMPLETED|Overall Study||0
178257|NCT00925132|429990|P3|NOT COMPLETED|Overall Study||0
178258|NCT00925132|429991|P2|NOT COMPLETED|Overall Study||0
178259|NCT00925132|429992|P1|NOT COMPLETED|Overall Study||2
178260|NCT00925132|429988|P5|COMPLETED|Overall Study||17
178261|NCT00925132|429989|P4|COMPLETED|Overall Study||4
178262|NCT00925132|429990|P3|COMPLETED|Overall Study||4
178263|NCT00925132|429991|P2|COMPLETED|Overall Study||4
178264|NCT00925132|429992|P1|COMPLETED|Overall Study||3
178265|NCT00925132|429988|P5|STARTED|Overall Study||22
178266|NCT00925132|429989|P4|STARTED|Overall Study||4
178267|NCT00925132|429990|P3|STARTED|Overall Study||4
178268|NCT00925132|429991|P2|STARTED|Overall Study||4
178269|NCT00925132|429992|P1|STARTED|Overall Study||5
178270|NCT00925119|429998|P1|NOT COMPLETED|Overall Study||12
178271|NCT00925119|429998|P1|COMPLETED|Overall Study||19
178272|NCT00925119|429998|P1|STARTED|Overall Study||31
178273|NCT00925015|430011|P3|NOT COMPLETED|Overall Study||6
178274|NCT00925015|430012|P2|NOT COMPLETED|Overall Study||6
178275|NCT00925015|430013|P1|NOT COMPLETED|Overall Study||8
178276|NCT00925015|430011|P3|COMPLETED|Overall Study||0
178277|NCT00925015|430012|P2|COMPLETED|Overall Study||0
178278|NCT00925015|430013|P1|COMPLETED|Overall Study||0
178279|NCT00925015|430011|P3|STARTED|Overall Study||6
178280|NCT00925015|430012|P2|STARTED|Overall Study||6
178281|NCT00925015|430013|P1|STARTED|Overall Study||8
178282|NCT00924950|430069|P1|NOT COMPLETED|Overall Study||2
178283|NCT00924950|430069|P1|COMPLETED|Overall Study||28
178284|NCT00924950|430069|P1|STARTED|Overall Study||30
178285|NCT00924898|430074|P1|NOT COMPLETED|Overall Study||2
178286|NCT00924898|430074|P1|COMPLETED|Overall Study||90
178287|NCT00924898|430074|P1|STARTED|Overall Study||92
178288|NCT00924833|430086|P3|NOT COMPLETED|Overall Study||0
178289|NCT00924833|430087|P2|NOT COMPLETED|Overall Study||0
178290|NCT00924833|430088|P1|NOT COMPLETED|Overall Study||0
178291|NCT00924833|430086|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
178292|NCT00924833|430087|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
178293|NCT00924833|430088|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
178294|NCT00924833|430086|P3|STARTED|Overall Study||9
178295|NCT00924833|430087|P2|STARTED|Overall Study||9
178296|NCT00924833|430088|P1|STARTED|Overall Study||9
178297|NCT00924807|430102|P1|NOT COMPLETED|Overall Study||0
178298|NCT00924807|430102|P1|COMPLETED|Overall Study||4
178299|NCT00924807|430102|P1|STARTED|Overall Study||4
178300|NCT00924781|430110|P2|NOT COMPLETED|Overall Study||10
178301|NCT00924781|430111|P1|NOT COMPLETED|Overall Study||12
178302|NCT00924781|430110|P2|COMPLETED|Overall Study||9
178303|NCT00924781|430111|P1|COMPLETED|Overall Study||8
178304|NCT00924781|430110|P2|STARTED|Overall Study||19
178305|NCT00924781|430111|P1|STARTED|Overall Study||20
178306|NCT00924729|430145|P2|NOT COMPLETED|Overall Study||0
178307|NCT00924729|430146|P1|NOT COMPLETED|Overall Study||2
178308|NCT00924729|430145|P2|COMPLETED|Overall Study||25
178309|NCT00924729|430146|P1|COMPLETED|Overall Study||23
178310|NCT00924729|430145|P2|STARTED|Overall Study||25
178311|NCT00924729|430146|P1|STARTED|Overall Study||25
178312|NCT00924651|430156|P2|NOT COMPLETED|Overall Study||25
178313|NCT00924651|430157|P1|NOT COMPLETED|Overall Study||25
178314|NCT00924651|430156|P2|COMPLETED|Overall Study||312
178315|NCT00924651|430157|P1|COMPLETED|Overall Study||331
178316|NCT00924651|430156|P2|STARTED|Overall Study||337
178317|NCT00924651|430157|P1|STARTED|Overall Study||356
178318|NCT00924638|430165|P2|NOT COMPLETED|Overall Study||13
178319|NCT00924638|430166|P1|NOT COMPLETED|Overall Study||12
178320|NCT00924638|430165|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
178321|NCT00924638|430166|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
178322|NCT00924638|430165|P2|STARTED|Overall Study|Randomized to Control Arm|220
178323|NCT00924638|430166|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
178324|NCT00924560|430188|P3|NOT COMPLETED|Overall Study||83
178325|NCT00924560|430189|P2|NOT COMPLETED|Overall Study||208
178326|NCT00924560|430190|P1|NOT COMPLETED|Overall Study||211
178327|NCT00924560|430188|P3|COMPLETED|Overall Study||372
178328|NCT00924560|430189|P2|COMPLETED|Overall Study||240
178329|NCT00924560|430190|P1|COMPLETED|Overall Study||247
178330|NCT00924560|430188|P3|Received Treatment|Overall Study||0
178331|NCT00924560|430189|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
178332|NCT00924560|430190|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
178333|NCT00924560|430188|P3|STARTED|Overall Study||455
178334|NCT00924560|430189|P2|STARTED|Overall Study||448
178335|NCT00924560|430190|P1|STARTED|Overall Study||458
178336|NCT00924508|430234|P1|NOT COMPLETED|Overall Study||3
178337|NCT00924508|430234|P1|COMPLETED|Overall Study||20
178338|NCT00924508|430234|P1|STARTED|Overall Study||23
178339|NCT00924482|430241|P1|NOT COMPLETED|Overall Study||0
178340|NCT00924482|430241|P1|COMPLETED|Overall Study||261
178341|NCT00924482|430241|P1|STARTED|Overall Study||261
178342|NCT00924469|430248|P2|NOT COMPLETED|Overall Study||2
178343|NCT00924469|430249|P1|NOT COMPLETED|Overall Study||2
178344|NCT00924469|430248|P2|COMPLETED|Overall Study||26
178345|NCT00924469|430249|P1|COMPLETED|Overall Study||28
178346|NCT00924469|430248|P2|STARTED|Overall Study||28
178347|NCT00924469|430249|P1|STARTED|Overall Study||30
178348|NCT00924443|430271|P1|NOT COMPLETED|Overall Study||3
178349|NCT00924443|430271|P1|COMPLETED|Overall Study||66
178350|NCT00924443|430271|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
178351|NCT00924443|430271|P1|STARTED|Overall Study||69
178352|NCT00924404|430281|P2|NOT COMPLETED|Overall Study||4
178353|NCT00924404|430282|P1|NOT COMPLETED|Overall Study||6
178354|NCT00924404|430281|P2|COMPLETED|Overall Study||22
178355|NCT00924404|430282|P1|COMPLETED|Overall Study||21
178356|NCT00924404|430281|P2|STARTED|Overall Study||26
178357|NCT00924404|430282|P1|STARTED|Overall Study||27
178358|NCT00924352|430290|P2|NOT COMPLETED|Overall Study||0
178359|NCT00924352|430291|P1|NOT COMPLETED|Overall Study||0
178360|NCT00924352|430290|P2|COMPLETED|Overall Study||44
178361|NCT00924352|430291|P1|COMPLETED|Overall Study||12
178362|NCT00924352|430290|P2|STARTED|Overall Study||44
178363|NCT00924352|430291|P1|STARTED|Overall Study||12
178364|NCT00924313|430304|P1|NOT COMPLETED|Overall Study||1
178365|NCT00924313|430304|P1|COMPLETED|Overall Study||39
178366|NCT00924313|430304|P1|STARTED|Overall Study||40
178367|NCT00924287|430316|P1|NOT COMPLETED|Overall Study||1
178368|NCT00924287|430316|P1|COMPLETED|Overall Study||0
178369|NCT00924287|430316|P1|STARTED|Overall Study||1
178370|NCT00924209|430322|P1|NOT COMPLETED|Overall Study||0
178371|NCT00924209|430322|P1|COMPLETED|Overall Study||7
178372|NCT00924209|430322|P1|STARTED|Overall Study||7
178373|NCT00924170|430329|P2|NOT COMPLETED|Overall Study||8
178374|NCT00924170|430330|P1|NOT COMPLETED|Overall Study||7
178375|NCT00924170|430329|P2|COMPLETED|Overall Study||0
178376|NCT00924170|430330|P1|COMPLETED|Overall Study||3
178377|NCT00924170|430329|P2|STARTED|Overall Study||8
178378|NCT00924170|430330|P1|STARTED|Overall Study||10
178379|NCT00924118|430370|P2|NOT COMPLETED|Overall Study||0
178380|NCT00924118|430371|P1|NOT COMPLETED|Overall Study||0
178381|NCT00924118|430370|P2|COMPLETED|Overall Study||15
178382|NCT00924118|430371|P1|COMPLETED|Overall Study||15
178383|NCT00924118|430370|P2|STARTED|Overall Study||15
178384|NCT00924118|430371|P1|STARTED|Overall Study||15
178385|NCT00924066|430379|P1|NOT COMPLETED|Overall Study||0
178386|NCT00924066|430379|P1|COMPLETED|Overall Study||41
178387|NCT00924066|430379|P1|STARTED|Overall Study||41
178388|NCT00924053|430388|P4|NOT COMPLETED|Overall Study||0
178389|NCT00924053|430389|P3|NOT COMPLETED|Overall Study||0
178390|NCT00924053|430390|P2|NOT COMPLETED|Overall Study||0
178391|NCT00924053|430391|P1|NOT COMPLETED|Overall Study||0
178392|NCT00924053|430388|P4|COMPLETED|Overall Study||6
178393|NCT00924053|430389|P3|COMPLETED|Overall Study||6
178394|NCT00924053|430390|P2|COMPLETED|Overall Study||6
178395|NCT00924053|430391|P1|COMPLETED|Overall Study||6
178396|NCT00924053|430388|P4|STARTED|Overall Study||6
178397|NCT00924053|430389|P3|STARTED|Overall Study||6
178398|NCT00924053|430390|P2|STARTED|Overall Study||6
178399|NCT00924053|430391|P1|STARTED|Overall Study||6
178400|NCT00924040|430437|P1|NOT COMPLETED|Overall Study||0
178401|NCT00924040|430437|P1|COMPLETED|Overall Study||1
178402|NCT00924040|430437|P1|STARTED|Overall Study||1
178403|NCT00924001|430449|P1|NOT COMPLETED|Overall Study||0
178404|NCT00924001|430449|P1|COMPLETED|Overall Study||1
178405|NCT00924001|430449|P1|STARTED|Overall Study||1
178406|NCT00923975|430455|P1|NOT COMPLETED|Overall Study||1
178407|NCT00923975|430455|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
178408|NCT00923975|430455|P1|STARTED|Overall Study||51
178409|NCT00923949|430462|P1|NOT COMPLETED|Overall Study||0
178410|NCT00923949|430462|P1|COMPLETED|Overall Study||1
178411|NCT00923949|430462|P1|STARTED|Overall Study||1
178412|NCT00923936|430474|P2|NOT COMPLETED|Overall Study||3
178413|NCT00923936|430475|P1|NOT COMPLETED|Overall Study||8
178414|NCT00923936|430474|P2|COMPLETED|Overall Study||3
178415|NCT00923936|430475|P1|COMPLETED|Overall Study||2
178416|NCT00923936|430474|P2|STARTED|Overall Study||6
178417|NCT00923936|430475|P1|STARTED|Overall Study||10
178418|NCT00923910|430491|P2|NOT COMPLETED|Period 2||0
178419|NCT00923910|430492|P1|NOT COMPLETED|Period 2||0
178420|NCT00923910|430491|P2|COMPLETED|Period 2||5
178421|NCT00923910|430492|P1|COMPLETED|Period 2||5
178422|NCT00923910|430491|P2|STARTED|Period 2||5
178423|NCT00923910|430492|P1|STARTED|Period 2||5
178424|NCT00923910|430491|P2|NOT COMPLETED|Period 1||0
178425|NCT00923910|430492|P1|NOT COMPLETED|Period 1||0
178426|NCT00923910|430491|P2|COMPLETED|Period 1||5
178427|NCT00923910|430492|P1|COMPLETED|Period 1||5
178428|NCT00923910|430491|P2|STARTED|Period 1||5
178429|NCT00923910|430492|P1|STARTED|Period 1||5
178430|NCT00923845|430504|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
178431|NCT00923845|430505|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
178432|NCT00923845|430504|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
178433|NCT00923845|430505|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
178434|NCT00923845|430504|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
178435|NCT00923845|430505|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
178436|NCT00923845|430504|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
178437|NCT00923845|430505|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
178438|NCT00923845|430504|P2|STARTED|Allogeneic Stem Cell Therapy||10
178439|NCT00923845|430505|P1|STARTED|Allogeneic Stem Cell Therapy||0
178440|NCT00923845|430504|P2|NOT COMPLETED|Induction Therapy||2
178441|NCT00923845|430505|P1|NOT COMPLETED|Induction Therapy||0
178442|NCT00923845|430504|P2|COMPLETED|Induction Therapy||10
178443|NCT00923845|430505|P1|COMPLETED|Induction Therapy||0
178444|NCT00923845|430504|P2|STARTED|Induction Therapy||12
178445|NCT00923845|430505|P1|STARTED|Induction Therapy||0
178446|NCT00923845|430504|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
178447|NCT00923845|430505|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
178448|NCT00923845|430504|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
178449|NCT00923845|430505|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
178450|NCT00923845|430504|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
178451|NCT00923845|430505|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
178452|NCT00923845|430504|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
178453|NCT00923845|430505|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
178454|NCT00923845|430504|P2|COMPLETED|Donor Lymphocyte Harvest||0
178455|NCT00923845|430505|P1|COMPLETED|Donor Lymphocyte Harvest||13
178456|NCT00923845|430504|P2|STARTED|Donor Lymphocyte Harvest||0
178457|NCT00923845|430505|P1|STARTED|Donor Lymphocyte Harvest||13
178458|NCT00923481|430526|P1|NOT COMPLETED|Overall Study||0
178459|NCT00923481|430526|P1|COMPLETED|Overall Study||37
178460|NCT00923481|430526|P1|STARTED|Overall Study||37
178461|NCT00923364|430531|P2|NOT COMPLETED|Overall Study||0
178462|NCT00923364|430532|P1|NOT COMPLETED|Overall Study||4
178463|NCT00923364|430531|P2|COMPLETED|Overall Study||5
178464|NCT00923364|430532|P1|COMPLETED|Overall Study||10
178465|NCT00923364|430531|P2|STARTED|Overall Study||5
178466|NCT00923364|430532|P1|STARTED|Overall Study||14
178467|NCT00923351|430544|P3|NOT COMPLETED|Overall Study||12
178468|NCT00923351|430545|P2|NOT COMPLETED|Overall Study||0
178469|NCT00923351|430546|P1|NOT COMPLETED|Overall Study||0
178470|NCT00923351|430544|P3|COMPLETED|Overall Study||0
178471|NCT00923351|430545|P2|COMPLETED|Overall Study||26
178472|NCT00923351|430546|P1|COMPLETED|Overall Study||6
178473|NCT00923351|430544|P3|STARTED|Overall Study||12
178474|NCT00923351|430545|P2|STARTED|Overall Study||26
178475|NCT00923351|430546|P1|STARTED|Overall Study||6
178476|NCT00923273|430561|P5|NOT COMPLETED|Phase II Treatment Period||0
178477|NCT00923273|430562|P4|NOT COMPLETED|Phase II Treatment Period||7
178478|NCT00923273|430563|P3|NOT COMPLETED|Phase II Treatment Period||0
178479|NCT00923273|430564|P2|NOT COMPLETED|Phase II Treatment Period||0
178480|NCT00923273|430565|P1|NOT COMPLETED|Phase II Treatment Period||0
178481|NCT00923273|430561|P5|COMPLETED|Phase II Treatment Period||0
178482|NCT00923273|430562|P4|COMPLETED|Phase II Treatment Period||20
178483|NCT00923273|430563|P3|COMPLETED|Phase II Treatment Period||0
178484|NCT00923273|430564|P2|COMPLETED|Phase II Treatment Period||0
178485|NCT00923273|430565|P1|COMPLETED|Phase II Treatment Period||0
178486|NCT00923273|430561|P5|STARTED|Phase II Treatment Period||0
178487|NCT00923273|430562|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
178488|NCT00923273|430563|P3|STARTED|Phase II Treatment Period||0
178489|NCT00923273|430564|P2|STARTED|Phase II Treatment Period||0
178490|NCT00923273|430565|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
178491|NCT00923273|430561|P5|NOT COMPLETED|Phase I Treatment Period||0
178492|NCT00923273|430562|P4|NOT COMPLETED|Phase I Treatment Period||0
178493|NCT00923273|430563|P3|NOT COMPLETED|Phase I Treatment Period||0
178494|NCT00923273|430564|P2|NOT COMPLETED|Phase I Treatment Period||0
178495|NCT00923273|430565|P1|NOT COMPLETED|Phase I Treatment Period||0
178496|NCT00923273|430561|P5|COMPLETED|Phase I Treatment Period||5
178497|NCT00923273|430562|P4|COMPLETED|Phase I Treatment Period||7
178498|NCT00923273|430563|P3|COMPLETED|Phase I Treatment Period||3
178499|NCT00923273|430564|P2|COMPLETED|Phase I Treatment Period||3
178500|NCT00923273|430565|P1|COMPLETED|Phase I Treatment Period||4
178501|NCT00923273|430561|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
178502|NCT00923273|430562|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
178503|NCT00923273|430563|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
178504|NCT00923273|430564|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
178505|NCT00923273|430565|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
178506|NCT00923260|430590|P2|NOT COMPLETED|Overall Study||1
178507|NCT00923260|430591|P1|NOT COMPLETED|Overall Study||1
178508|NCT00923260|430590|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
178509|NCT00923260|430591|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
178510|NCT00923260|430590|P2|STARTED|Overall Study||12
178511|NCT00923260|430591|P1|STARTED|Overall Study||12
178512|NCT00923247|430725|P2|NOT COMPLETED|Overall Study||0
178513|NCT00923247|430726|P1|NOT COMPLETED|Overall Study||0
178514|NCT00923247|430725|P2|COMPLETED|Overall Study||1
178515|NCT00923247|430726|P1|COMPLETED|Overall Study||21
178516|NCT00923247|430725|P2|STARTED|Overall Study||1
178517|NCT00923247|430726|P1|STARTED|Overall Study||21
178518|NCT00923195|430754|P2|NOT COMPLETED|Overall Study||1
178519|NCT00923195|430755|P1|NOT COMPLETED|Overall Study||0
178520|NCT00923195|430754|P2|COMPLETED|Overall Study||1
178521|NCT00923195|430755|P1|COMPLETED|Overall Study||2
178522|NCT00923195|430754|P2|STARTED|Overall Study||2
178523|NCT00923195|430755|P1|STARTED|Overall Study||2
178524|NCT00923156|430766|P3|NOT COMPLETED|Overall Study||3
178525|NCT00923156|430767|P2|NOT COMPLETED|Overall Study||4
178526|NCT00923156|430768|P1|NOT COMPLETED|Overall Study||0
178527|NCT00923156|430766|P3|COMPLETED|Overall Study||38
178528|NCT00923156|430767|P2|COMPLETED|Overall Study||38
178529|NCT00923156|430768|P1|COMPLETED|Overall Study||40
178530|NCT00923156|430766|P3|STARTED|Overall Study||41
178531|NCT00923156|430767|P2|STARTED|Overall Study||42
178532|NCT00923156|430768|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
178533|NCT00923130|430794|P1|NOT COMPLETED|Overall Study||25
178534|NCT00923130|430794|P1|COMPLETED|Overall Study||5
178535|NCT00923130|430794|P1|STARTED|Overall Study||30
178536|NCT00923117|430812|P2|NOT COMPLETED|Overall Study||0
178537|NCT00923117|430813|P1|NOT COMPLETED|Overall Study||0
178538|NCT00923117|430812|P2|COMPLETED|Overall Study||43
178539|NCT00923117|430813|P1|COMPLETED|Overall Study||44
178540|NCT00923117|430812|P2|STARTED|Overall Study||43
178541|NCT00923117|430813|P1|STARTED|Overall Study||44
178542|NCT00923091|430829|P13|NOT COMPLETED|Period VI (Open-Label)||0
178543|NCT00923091|430830|P12|NOT COMPLETED|Period VI (Open-Label)||0
178544|NCT00923091|430831|P11|NOT COMPLETED|Period VI (Open-Label)||0
178545|NCT00923091|430832|P10|NOT COMPLETED|Period VI (Open-Label)||0
178546|NCT00923091|430833|P9|NOT COMPLETED|Period VI (Open-Label)||0
178547|NCT00923091|430834|P8|NOT COMPLETED|Period VI (Open-Label)||0
178548|NCT00923091|430835|P7|NOT COMPLETED|Period VI (Open-Label)||0
178549|NCT00923091|430836|P6|NOT COMPLETED|Period VI (Open-Label)||0
178550|NCT00923091|430837|P5|NOT COMPLETED|Period VI (Open-Label)||7
178551|NCT00923091|430838|P4|NOT COMPLETED|Period VI (Open-Label)||3
178552|NCT00923091|430839|P3|NOT COMPLETED|Period VI (Open-Label)||13
178553|NCT00923091|430840|P2|NOT COMPLETED|Period VI (Open-Label)||8
178554|NCT00923091|430841|P1|NOT COMPLETED|Period VI (Open-Label)||39
178555|NCT00923091|430829|P13|COMPLETED|Period VI (Open-Label)||0
178556|NCT00923091|430830|P12|COMPLETED|Period VI (Open-Label)||0
178557|NCT00923091|430831|P11|COMPLETED|Period VI (Open-Label)||0
178558|NCT00923091|430832|P10|COMPLETED|Period VI (Open-Label)||0
178559|NCT00923091|430833|P9|COMPLETED|Period VI (Open-Label)||0
178560|NCT00923091|430834|P8|COMPLETED|Period VI (Open-Label)||0
178561|NCT00923091|430835|P7|COMPLETED|Period VI (Open-Label)||0
178562|NCT00923091|430836|P6|COMPLETED|Period VI (Open-Label)||0
178563|NCT00923091|430837|P5|COMPLETED|Period VI (Open-Label)||157
178564|NCT00923091|430838|P4|COMPLETED|Period VI (Open-Label)||143
178565|NCT00923091|430839|P3|COMPLETED|Period VI (Open-Label)||467
178566|NCT00923091|430840|P2|COMPLETED|Period VI (Open-Label)||264
178567|NCT00923091|430841|P1|COMPLETED|Period VI (Open-Label)||1408
178568|NCT00923091|430829|P13|STARTED|Period VI (Open-Label)||0
178569|NCT00923091|430830|P12|STARTED|Period VI (Open-Label)||0
178570|NCT00923091|430831|P11|STARTED|Period VI (Open-Label)||0
178571|NCT00923091|430832|P10|STARTED|Period VI (Open-Label)||0
178572|NCT00923091|430833|P9|STARTED|Period VI (Open-Label)||0
178573|NCT00923091|430834|P8|STARTED|Period VI (Open-Label)||0
178574|NCT00923091|430835|P7|STARTED|Period VI (Open-Label)||0
178575|NCT00923091|430836|P6|STARTED|Period VI (Open-Label)||0
178576|NCT00923091|430837|P5|STARTED|Period VI (Open-Label)||164
178577|NCT00923091|430838|P4|STARTED|Period VI (Open-Label)||146
178578|NCT00923091|430839|P3|STARTED|Period VI (Open-Label)||480
178579|NCT00923091|430840|P2|STARTED|Period VI (Open-Label)||272
178580|NCT00923091|430841|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
178581|NCT00923091|430829|P13|NOT COMPLETED|Period V (Double -Blind)||2
178582|NCT00923091|430830|P12|NOT COMPLETED|Period V (Double -Blind)||0
178583|NCT00923091|430831|P11|NOT COMPLETED|Period V (Double -Blind)||1
178584|NCT00923091|430832|P10|NOT COMPLETED|Period V (Double -Blind)||0
178585|NCT00923091|430833|P9|NOT COMPLETED|Period V (Double -Blind)||1
178586|NCT00923091|430834|P8|NOT COMPLETED|Period V (Double -Blind)||0
178587|NCT00923091|430835|P7|NOT COMPLETED|Period V (Double -Blind)||0
178588|NCT00923091|430836|P6|NOT COMPLETED|Period V (Double -Blind)||0
178589|NCT00923091|430837|P5|NOT COMPLETED|Period V (Double -Blind)||0
178590|NCT00923091|430838|P4|NOT COMPLETED|Period V (Double -Blind)||0
178591|NCT00923091|430839|P3|NOT COMPLETED|Period V (Double -Blind)||0
178592|NCT00923091|430840|P2|NOT COMPLETED|Period V (Double -Blind)||0
178593|NCT00923091|430841|P1|NOT COMPLETED|Period V (Double -Blind)||0
178594|NCT00923091|430829|P13|COMPLETED|Period V (Double -Blind)||73
178595|NCT00923091|430830|P12|COMPLETED|Period V (Double -Blind)||151
178596|NCT00923091|430831|P11|COMPLETED|Period V (Double -Blind)||193
178597|NCT00923091|430832|P10|COMPLETED|Period V (Double -Blind)||119
178598|NCT00923091|430833|P9|COMPLETED|Period V (Double -Blind)||134
178599|NCT00923091|430834|P8|COMPLETED|Period V (Double -Blind)||0
178600|NCT00923091|430835|P7|COMPLETED|Period V (Double -Blind)||0
178601|NCT00923091|430836|P6|COMPLETED|Period V (Double -Blind)||0
178602|NCT00923091|430837|P5|COMPLETED|Period V (Double -Blind)||0
178603|NCT00923091|430838|P4|COMPLETED|Period V (Double -Blind)||0
178604|NCT00923091|430839|P3|COMPLETED|Period V (Double -Blind)||0
178605|NCT00923091|430840|P2|COMPLETED|Period V (Double -Blind)||0
178606|NCT00923091|430841|P1|COMPLETED|Period V (Double -Blind)||0
178607|NCT00923091|430829|P13|STARTED|Period V (Double -Blind)||75
178608|NCT00923091|430830|P12|STARTED|Period V (Double -Blind)||151
178609|NCT00923091|430831|P11|STARTED|Period V (Double -Blind)||194
178610|NCT00923091|430832|P10|STARTED|Period V (Double -Blind)||119
178611|NCT00923091|430833|P9|STARTED|Period V (Double -Blind)||135
178612|NCT00923091|430834|P8|STARTED|Period V (Double -Blind)||0
178613|NCT00923091|430835|P7|STARTED|Period V (Double -Blind)||0
178614|NCT00923091|430836|P6|STARTED|Period V (Double -Blind)||0
178615|NCT00923091|430837|P5|STARTED|Period V (Double -Blind)||0
178616|NCT00923091|430838|P4|STARTED|Period V (Double -Blind)||0
178617|NCT00923091|430839|P3|STARTED|Period V (Double -Blind)||0
178618|NCT00923091|430840|P2|STARTED|Period V (Double -Blind)||0
178619|NCT00923091|430841|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
178620|NCT00923091|430829|P13|NOT COMPLETED|Period IV (Double-Blind)||0
178621|NCT00923091|430830|P12|NOT COMPLETED|Period IV (Double-Blind)||0
178622|NCT00923091|430831|P11|NOT COMPLETED|Period IV (Double-Blind)||0
178623|NCT00923091|430832|P10|NOT COMPLETED|Period IV (Double-Blind)||0
178624|NCT00923091|430833|P9|NOT COMPLETED|Period IV (Double-Blind)||0
178625|NCT00923091|430834|P8|NOT COMPLETED|Period IV (Double-Blind)||0
178626|NCT00923091|430835|P7|NOT COMPLETED|Period IV (Double-Blind)||0
178627|NCT00923091|430836|P6|NOT COMPLETED|Period IV (Double-Blind)||0
178628|NCT00923091|430837|P5|NOT COMPLETED|Period IV (Double-Blind)||0
178629|NCT00923091|430838|P4|NOT COMPLETED|Period IV (Double-Blind)||0
178630|NCT00923091|430839|P3|NOT COMPLETED|Period IV (Double-Blind)||0
178631|NCT00923091|430840|P2|NOT COMPLETED|Period IV (Double-Blind)||2
178632|NCT00923091|430841|P1|NOT COMPLETED|Period IV (Double-Blind)||2
178633|NCT00923091|430829|P13|COMPLETED|Period IV (Double-Blind)||0
178634|NCT00923091|430830|P12|COMPLETED|Period IV (Double-Blind)||0
178635|NCT00923091|430831|P11|COMPLETED|Period IV (Double-Blind)||0
178636|NCT00923091|430832|P10|COMPLETED|Period IV (Double-Blind)||0
178637|NCT00923091|430833|P9|COMPLETED|Period IV (Double-Blind)||0
178638|NCT00923091|430834|P8|COMPLETED|Period IV (Double-Blind)||0
178639|NCT00923091|430835|P7|COMPLETED|Period IV (Double-Blind)||0
178640|NCT00923091|430836|P6|COMPLETED|Period IV (Double-Blind)||0
178641|NCT00923091|430837|P5|COMPLETED|Period IV (Double-Blind)||0
178642|NCT00923091|430838|P4|COMPLETED|Period IV (Double-Blind)||0
178643|NCT00923091|430839|P3|COMPLETED|Period IV (Double-Blind)||0
178644|NCT00923091|430840|P2|COMPLETED|Period IV (Double-Blind)||451
178645|NCT00923091|430841|P1|COMPLETED|Period IV (Double-Blind)||226
178646|NCT00923091|430829|P13|STARTED|Period IV (Double-Blind)||0
178647|NCT00923091|430830|P12|STARTED|Period IV (Double-Blind)||0
178648|NCT00923091|430831|P11|STARTED|Period IV (Double-Blind)||0
178649|NCT00923091|430832|P10|STARTED|Period IV (Double-Blind)||0
178650|NCT00923091|430833|P9|STARTED|Period IV (Double-Blind)||0
178651|NCT00923091|430834|P8|STARTED|Period IV (Double-Blind)||0
178652|NCT00923091|430835|P7|STARTED|Period IV (Double-Blind)||0
178653|NCT00923091|430836|P6|STARTED|Period IV (Double-Blind)||0
178654|NCT00923091|430837|P5|STARTED|Period IV (Double-Blind)||0
178655|NCT00923091|430838|P4|STARTED|Period IV (Double-Blind)||0
178656|NCT00923091|430839|P3|STARTED|Period IV (Double-Blind)||0
178657|NCT00923091|430840|P2|STARTED|Period IV (Double-Blind)||453
178658|NCT00923091|430841|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
178659|NCT00923091|430829|P13|NOT COMPLETED|Period III (Single-Blind)||0
178660|NCT00923091|430830|P12|NOT COMPLETED|Period III (Single-Blind)||0
178661|NCT00923091|430831|P11|NOT COMPLETED|Period III (Single-Blind)||0
178662|NCT00923091|430832|P10|NOT COMPLETED|Period III (Single-Blind)||0
178663|NCT00923091|430833|P9|NOT COMPLETED|Period III (Single-Blind)||0
178664|NCT00923091|430834|P8|NOT COMPLETED|Period III (Single-Blind)||0
178665|NCT00923091|430835|P7|NOT COMPLETED|Period III (Single-Blind)||0
178666|NCT00923091|430836|P6|NOT COMPLETED|Period III (Single-Blind)||0
178667|NCT00923091|430837|P5|NOT COMPLETED|Period III (Single-Blind)||0
178668|NCT00923091|430838|P4|NOT COMPLETED|Period III (Single-Blind)||0
178669|NCT00923091|430839|P3|NOT COMPLETED|Period III (Single-Blind)||0
178670|NCT00923091|430840|P2|NOT COMPLETED|Period III (Single-Blind)||0
178671|NCT00923091|430841|P1|NOT COMPLETED|Period III (Single-Blind)||20
178672|NCT00923091|430829|P13|COMPLETED|Period III (Single-Blind)||0
178673|NCT00923091|430830|P12|COMPLETED|Period III (Single-Blind)||0
178674|NCT00923091|430831|P11|COMPLETED|Period III (Single-Blind)||0
178675|NCT00923091|430832|P10|COMPLETED|Period III (Single-Blind)||0
178676|NCT00923091|430833|P9|COMPLETED|Period III (Single-Blind)||0
178677|NCT00923091|430834|P8|COMPLETED|Period III (Single-Blind)||0
178678|NCT00923091|430835|P7|COMPLETED|Period III (Single-Blind)||0
178679|NCT00923091|430836|P6|COMPLETED|Period III (Single-Blind)||0
178680|NCT00923091|430837|P5|COMPLETED|Period III (Single-Blind)||0
178681|NCT00923091|430838|P4|COMPLETED|Period III (Single-Blind)||0
178682|NCT00923091|430839|P3|COMPLETED|Period III (Single-Blind)||0
178683|NCT00923091|430840|P2|COMPLETED|Period III (Single-Blind)||0
178684|NCT00923091|430841|P1|COMPLETED|Period III (Single-Blind)||2520
178685|NCT00923091|430829|P13|STARTED|Period III (Single-Blind)||0
178686|NCT00923091|430830|P12|STARTED|Period III (Single-Blind)||0
178687|NCT00923091|430831|P11|STARTED|Period III (Single-Blind)||0
178688|NCT00923091|430832|P10|STARTED|Period III (Single-Blind)||0
178689|NCT00923091|430833|P9|STARTED|Period III (Single-Blind)||0
178690|NCT00923091|430834|P8|STARTED|Period III (Single-Blind)||0
178691|NCT00923091|430835|P7|STARTED|Period III (Single-Blind)||0
178692|NCT00923091|430836|P6|STARTED|Period III (Single-Blind)||0
178693|NCT00923091|430837|P5|STARTED|Period III (Single-Blind)||0
178694|NCT00923091|430838|P4|STARTED|Period III (Single-Blind)||0
178695|NCT00923091|430839|P3|STARTED|Period III (Single-Blind)||0
178696|NCT00923091|430840|P2|STARTED|Period III (Single-Blind)||0
178697|NCT00923091|430841|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
178698|NCT00923091|430829|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178699|NCT00923091|430830|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178700|NCT00923091|430831|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178701|NCT00923091|430832|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178702|NCT00923091|430833|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178703|NCT00923091|430834|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
178704|NCT00923091|430835|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
178705|NCT00923091|430836|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
178706|NCT00923091|430837|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
178707|NCT00923091|430838|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
178708|NCT00923091|430839|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
178709|NCT00923091|430840|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
178710|NCT00923091|430841|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
178711|NCT00923091|430829|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178712|NCT00923091|430830|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178713|NCT00923091|430831|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178714|NCT00923091|430832|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178715|NCT00923091|430833|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
178716|NCT00923091|430834|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
178717|NCT00923091|430835|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
178718|NCT00923091|430836|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
178719|NCT00923091|430837|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
178720|NCT00923091|430838|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
178721|NCT00923091|430839|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
178722|NCT00923091|430840|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
178723|NCT00923091|430841|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
178724|NCT00923091|430829|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
178725|NCT00923091|430830|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
178726|NCT00923091|430831|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
178727|NCT00923091|430832|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
178728|NCT00923091|430833|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
178729|NCT00923091|430834|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
178730|NCT00923091|430835|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
178731|NCT00923091|430836|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
178732|NCT00923091|430837|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
178733|NCT00923091|430838|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
178734|NCT00923091|430839|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
178735|NCT00923091|430840|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
178736|NCT00923091|430841|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
178737|NCT00923078|430891|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
178738|NCT00923078|430892|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
178739|NCT00923078|430893|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
178740|NCT00923078|430891|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
178741|NCT00923078|430892|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
178742|NCT00923078|430893|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
178743|NCT00923078|430891|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
178744|NCT00923078|430892|P2|STARTED|Second Intervention (Weeks 5-8)||19
178745|NCT00923078|430893|P1|STARTED|Second Intervention (Weeks 5-8)||19
178746|NCT00923078|430891|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
178747|NCT00923078|430892|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
178748|NCT00923078|430893|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
178749|NCT00923078|430891|P3|COMPLETED|First Intervention (Weeks 1-4)||0
178750|NCT00923078|430892|P2|COMPLETED|First Intervention (Weeks 1-4)||19
178751|NCT00923078|430893|P1|COMPLETED|First Intervention (Weeks 1-4)||19
178752|NCT00923078|430891|P3|STARTED|First Intervention (Weeks 1-4)||20
178753|NCT00923078|430892|P2|STARTED|First Intervention (Weeks 1-4)||20
178754|NCT00923078|430893|P1|STARTED|First Intervention (Weeks 1-4)||20
178755|NCT00922987|430912|P1|NOT COMPLETED|Overall Study||4
178756|NCT00922987|430912|P1|COMPLETED|Overall Study||277
178757|NCT00922987|430912|P1|STARTED|Overall Study||281
178758|NCT00922935|430927|P3|NOT COMPLETED|Overall Study||0
178759|NCT00922935|430928|P2|NOT COMPLETED|Overall Study||5
178760|NCT00922935|430929|P1|NOT COMPLETED|Overall Study||1
178761|NCT00922935|430927|P3|COMPLETED|Overall Study||10
178762|NCT00922935|430928|P2|COMPLETED|Overall Study||11
178763|NCT00922935|430929|P1|COMPLETED|Overall Study||9
178764|NCT00922935|430927|P3|STARTED|Overall Study||10
178765|NCT00922935|430928|P2|STARTED|Overall Study||16
178766|NCT00922935|430929|P1|STARTED|Overall Study||10
178767|NCT00922779|430937|P1|NOT COMPLETED|Overall Study||2327
178768|NCT00922779|430937|P1|COMPLETED|Overall Study||4334
178769|NCT00922779|430937|P1|STARTED|Overall Study||6661
178770|NCT00922766|430944|P1|NOT COMPLETED|Overall Study||7
178771|NCT00922766|430944|P1|COMPLETED|Overall Study||610
178772|NCT00922766|430944|P1|STARTED|Overall Study||617
178773|NCT00922701|430953|P1|NOT COMPLETED|Overall Study||0
178774|NCT00922701|430953|P1|COMPLETED|Overall Study||4
178775|NCT00922701|430953|P1|STARTED|Overall Study||4
178776|NCT00922636|430962|P5|NOT COMPLETED|Overall Study||16
178777|NCT00922636|430963|P4|NOT COMPLETED|Overall Study||17
178778|NCT00922636|430964|P3|NOT COMPLETED|Overall Study||20
178779|NCT00922636|430965|P2|NOT COMPLETED|Overall Study||16
178780|NCT00922636|430966|P1|NOT COMPLETED|Overall Study||7
178781|NCT00922636|430962|P5|COMPLETED|Overall Study||59
178782|NCT00922636|430963|P4|COMPLETED|Overall Study||58
178783|NCT00922636|430964|P3|COMPLETED|Overall Study||56
178784|NCT00922636|430965|P2|COMPLETED|Overall Study||62
178785|NCT00922636|430966|P1|COMPLETED|Overall Study||29
178786|NCT00922636|430962|P5|Entered Optional Taper Phase|Overall Study||12
178787|NCT00922636|430963|P4|Entered Optional Taper Phase|Overall Study||7
178788|NCT00922636|430964|P3|Entered Optional Taper Phase|Overall Study||15
178789|NCT00922636|430965|P2|Entered Optional Taper Phase|Overall Study||10
178790|NCT00922636|430966|P1|Entered Optional Taper Phase|Overall Study||4
178791|NCT00922636|430962|P5|STARTED|Overall Study||75
178792|NCT00922636|430963|P4|STARTED|Overall Study||75
178793|NCT00922636|430964|P3|STARTED|Overall Study||76
178794|NCT00922636|430965|P2|STARTED|Overall Study||78
178795|NCT00922636|430966|P1|STARTED|Overall Study||36
178796|NCT00922623|431113|P1|NOT COMPLETED|Overall Study||5
178797|NCT00922623|431113|P1|COMPLETED|Overall Study||88
178798|NCT00922623|431113|P1|STARTED|Overall Study||93
178799|NCT00922480|431121|P2|NOT COMPLETED|Extension Study||3
178800|NCT00922480|431122|P1|NOT COMPLETED|Extension Study||5
178801|NCT00922480|431121|P2|COMPLETED|Extension Study||82
178802|NCT00922480|431122|P1|COMPLETED|Extension Study||68
178803|NCT00922480|431121|P2|STARTED|Extension Study||85
178804|NCT00922480|431122|P1|STARTED|Extension Study||73
178805|NCT00922480|431121|P2|NOT COMPLETED|Main Study||29
178806|NCT00922480|431122|P1|NOT COMPLETED|Main Study||37
178807|NCT00922480|431121|P2|COMPLETED|Main Study||226
178808|NCT00922480|431122|P1|COMPLETED|Main Study||213
178809|NCT00922480|431121|P2|STARTED|Main Study||255
178810|NCT00922480|431122|P1|STARTED|Main Study||250
178811|NCT00922441|431133|P3|NOT COMPLETED|Overall Study||3
178812|NCT00922441|431134|P2|NOT COMPLETED|Overall Study||0
178813|NCT00922441|431135|P1|NOT COMPLETED|Overall Study||0
178814|NCT00922441|431133|P3|COMPLETED|Overall Study||29
178815|NCT00922441|431134|P2|COMPLETED|Overall Study||30
178816|NCT00922441|431135|P1|COMPLETED|Overall Study||30
178817|NCT00922441|431133|P3|STARTED|Overall Study||32
178818|NCT00922441|431134|P2|STARTED|Overall Study||30
178819|NCT00922441|431135|P1|STARTED|Overall Study||30
178820|NCT00922428|431143|P1|NOT COMPLETED|Overall Study||15
178821|NCT00922428|431143|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
178822|NCT00922428|431143|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
178823|NCT00922272|431172|P2|NOT COMPLETED|Double-blind Phase||6
178824|NCT00922272|431173|P1|NOT COMPLETED|Double-blind Phase||7
178825|NCT00922272|431172|P2|COMPLETED|Double-blind Phase||29
178826|NCT00922272|431173|P1|COMPLETED|Double-blind Phase||27
178827|NCT00922272|431172|P2|STARTED|Double-blind Phase||35
178828|NCT00922272|431173|P1|STARTED|Double-blind Phase||34
178829|NCT00922272|431172|P2|NOT COMPLETED|Open-label Phase||0
178830|NCT00922272|431173|P1|NOT COMPLETED|Open-label Phase||23
178831|NCT00922272|431172|P2|COMPLETED|Open-label Phase||0
178832|NCT00922272|431173|P1|COMPLETED|Open-label Phase||69
178833|NCT00922272|431172|P2|STARTED|Open-label Phase||0
178834|NCT00922272|431173|P1|STARTED|Open-label Phase||92
178835|NCT00922233|431229|P1|NOT COMPLETED|Overall Study||4
178836|NCT00922233|431229|P1|COMPLETED|Overall Study||68
178837|NCT00922233|431229|P1|STARTED|Overall Study||72
178838|NCT00922207|431238|P3|NOT COMPLETED|Overall Study||4
178839|NCT00922207|431239|P2|NOT COMPLETED|Overall Study||7
178840|NCT00922207|431240|P1|NOT COMPLETED|Overall Study||6
178841|NCT00922207|431238|P3|COMPLETED|Overall Study||90
178842|NCT00922207|431239|P2|COMPLETED|Overall Study||88
178843|NCT00922207|431240|P1|COMPLETED|Overall Study||85
178844|NCT00922207|431238|P3|STARTED|Overall Study||94
178845|NCT00922207|431239|P2|STARTED|Overall Study||95
178846|NCT00922207|431240|P1|STARTED|Overall Study||91
178847|NCT00922194|431266|P1|NOT COMPLETED|Metformin for 12 Months or More||0
178848|NCT00922194|431266|P1|COMPLETED|Metformin for 12 Months or More||102
178849|NCT00922194|431266|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
178850|NCT00922194|431266|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
178851|NCT00922194|431266|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
178852|NCT00922194|431266|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
178853|NCT00922116|431276|P1|NOT COMPLETED|Overall Study||15
178854|NCT00922116|431276|P1|COMPLETED|Overall Study||176
178855|NCT00922116|431276|P1|STARTED|Overall Study||191
178856|NCT00921947|431287|P2|NOT COMPLETED|Day 28||0
178857|NCT00921947|431288|P1|NOT COMPLETED|Day 28||0
178858|NCT00921947|431287|P2|COMPLETED|Day 28||30
178859|NCT00921947|431288|P1|COMPLETED|Day 28||28
178860|NCT00921947|431287|P2|STARTED|Day 28||30
178861|NCT00921947|431288|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
178862|NCT00921947|431287|P2|NOT COMPLETED|Day 0||0
178863|NCT00921947|431288|P1|NOT COMPLETED|Day 0||0
178864|NCT00921947|431287|P2|COMPLETED|Day 0||30
178865|NCT00921947|431288|P1|COMPLETED|Day 0||30
178866|NCT00921947|431287|P2|STARTED|Day 0||30
178867|NCT00921947|431288|P1|STARTED|Day 0||30
178868|NCT00921934|431298|P1|NOT COMPLETED|Overall Study||0
178869|NCT00921934|431298|P1|COMPLETED|Overall Study||68
178870|NCT00921934|431298|P1|STARTED|Overall Study||68
178871|NCT00921895|431302|P1|NOT COMPLETED|Overall Study||0
178872|NCT00921895|431302|P1|COMPLETED|Overall Study||128
178873|NCT00921895|431302|P1|STARTED|Overall Study||128
178874|NCT00921687|431309|P2|NOT COMPLETED|Overall Study||0
178875|NCT00921687|431310|P1|NOT COMPLETED|Overall Study||0
178876|NCT00921687|431309|P2|COMPLETED|Overall Study||363
178877|NCT00921687|431310|P1|COMPLETED|Overall Study||418
178878|NCT00921687|431309|P2|STARTED|Overall Study||363
178879|NCT00921687|431310|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
178880|NCT00921557|431321|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
178881|NCT00921557|431322|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
178882|NCT00921557|431323|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
178883|NCT00921557|431321|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
178884|NCT00921557|431322|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
178885|NCT00921557|431323|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
178886|NCT00921557|431321|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
178887|NCT00921557|431322|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
178888|NCT00921557|431323|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
178889|NCT00921557|431321|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
178890|NCT00921557|431322|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
178891|NCT00921557|431323|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
178892|NCT00921557|431321|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
178893|NCT00921557|431322|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
178894|NCT00921557|431323|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
178895|NCT00921557|431321|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
178896|NCT00921557|431322|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
178897|NCT00921557|431323|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
178898|NCT00921557|431321|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
178899|NCT00921557|431322|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
178900|NCT00921557|431323|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
178901|NCT00921557|431321|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
178902|NCT00921557|431322|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
178903|NCT00921557|431323|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
178904|NCT00921557|431321|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
178905|NCT00921557|431322|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
178906|NCT00921557|431323|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
178907|NCT00921518|431383|P2|NOT COMPLETED|Overall Study||0
178908|NCT00921518|431384|P1|NOT COMPLETED|Overall Study||0
178909|NCT00921518|431383|P2|COMPLETED|Overall Study||44
178910|NCT00921518|431384|P1|COMPLETED|Overall Study||48
178911|NCT00921518|431383|P2|STARTED|Overall Study||44
178912|NCT00921518|431384|P1|STARTED|Overall Study||48
178913|NCT00921310|431392|P3|NOT COMPLETED|Overall Study||0
178914|NCT00921310|431393|P2|NOT COMPLETED|Overall Study||0
178915|NCT00921310|431394|P1|NOT COMPLETED|Overall Study||0
178916|NCT00921310|431392|P3|COMPLETED|Overall Study||4
178917|NCT00921310|431393|P2|COMPLETED|Overall Study||6
178918|NCT00921310|431394|P1|COMPLETED|Overall Study||2
178919|NCT00921310|431392|P3|STARTED|Overall Study||4
178920|NCT00921310|431393|P2|STARTED|Overall Study||6
178921|NCT00921310|431394|P1|STARTED|Overall Study||2
178922|NCT00921115|431419|P1|NOT COMPLETED|Overall Study||0
178923|NCT00921115|431419|P1|COMPLETED|Overall Study||42
178924|NCT00921115|431419|P1|STARTED|Overall Study||42
178925|NCT00921024|431425|P2|NOT COMPLETED|Overall Study||3
178926|NCT00921024|431426|P1|NOT COMPLETED|Overall Study||4
178927|NCT00921024|431425|P2|COMPLETED|Overall Study||39
178928|NCT00921024|431426|P1|COMPLETED|Overall Study||81
178929|NCT00921024|431425|P2|STARTED|Overall Study||42
178930|NCT00921024|431426|P1|STARTED|Overall Study||85
178931|NCT00920907|431436|P2|NOT COMPLETED|Maintenance Period||13
178932|NCT00920907|431437|P1|NOT COMPLETED|Maintenance Period||12
178933|NCT00920907|431436|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
178934|NCT00920907|431437|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
178935|NCT00920907|431436|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
178936|NCT00920907|431437|P1|STARTED|Maintenance Period||15
178937|NCT00920907|431436|P2|NOT COMPLETED|Induction Period||22
178938|NCT00920907|431437|P1|NOT COMPLETED|Induction Period||22
178939|NCT00920907|431436|P2|COMPLETED|Induction Period||16
178940|NCT00920907|431437|P1|COMPLETED|Induction Period||15
178941|NCT00920907|431436|P2|STARTED|Induction Period||38
178942|NCT00920907|431437|P1|STARTED|Induction Period||37
178943|NCT00920855|431478|P3|NOT COMPLETED|Overall Study||22
178944|NCT00920855|431479|P2|NOT COMPLETED|Overall Study||3
178945|NCT00920855|431480|P1|NOT COMPLETED|Overall Study||5
178946|NCT00920855|431478|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
178947|NCT00920855|431479|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
178948|NCT00920855|431480|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
178949|NCT00920855|431478|P3|Safety and Efficacy Populations|Overall Study||31
178950|NCT00920855|431479|P2|Safety and Efficacy Populations|Overall Study||4
178951|NCT00920855|431480|P1|Safety and Efficacy Populations|Overall Study||5
178952|NCT00920855|431478|P3|STARTED|Overall Study||31
178953|NCT00920855|431479|P2|STARTED|Overall Study||4
178954|NCT00920855|431480|P1|STARTED|Overall Study||5
178955|NCT00920816|431506|P4|NOT COMPLETED|Overall Study||69
178956|NCT00920816|431507|P3|NOT COMPLETED|Overall Study||135
178957|NCT00920816|431508|P2|NOT COMPLETED|Overall Study||96
178958|NCT00920816|431509|P1|NOT COMPLETED|Overall Study||192
178959|NCT00920816|431506|P4|COMPLETED|Overall Study||0
178960|NCT00920816|431507|P3|COMPLETED|Overall Study||0
178961|NCT00920816|431508|P2|COMPLETED|Overall Study||0
178962|NCT00920816|431509|P1|COMPLETED|Overall Study||0
178963|NCT00920816|431506|P4|Treated|Overall Study||69
178964|NCT00920816|431507|P3|Treated|Overall Study||135
178965|NCT00920816|431508|P2|Treated|Overall Study||96
178966|NCT00920816|431509|P1|Treated|Overall Study||189
178967|NCT00920816|431506|P4|STARTED|Overall Study||69
178968|NCT00920816|431507|P3|STARTED|Overall Study||135
178969|NCT00920816|431508|P2|STARTED|Overall Study||96
178970|NCT00920816|431509|P1|STARTED|Overall Study||192
178971|NCT00920790|431547|P1|NOT COMPLETED|Overall Study||14
178972|NCT00920790|431547|P1|COMPLETED|Overall Study||13
178973|NCT00920790|431547|P1|STARTED|Overall Study||27
178974|NCT00920699|431559|P3|NOT COMPLETED|Overall Study||4
178975|NCT00920699|431560|P2|NOT COMPLETED|Overall Study||1
178976|NCT00920699|431561|P1|NOT COMPLETED|Overall Study||2
178977|NCT00920699|431559|P3|COMPLETED|Overall Study||28
178978|NCT00920699|431560|P2|COMPLETED|Overall Study||29
178979|NCT00920699|431561|P1|COMPLETED|Overall Study||27
178980|NCT00920699|431559|P3|STARTED|Overall Study||32
178981|NCT00920699|431560|P2|STARTED|Overall Study||30
178982|NCT00920699|431561|P1|STARTED|Overall Study||29
178983|NCT00920686|431578|P3|NOT COMPLETED|Overall Study||13
178984|NCT00920686|431579|P2|NOT COMPLETED|Overall Study||22
178985|NCT00920686|431580|P1|NOT COMPLETED|Overall Study||19
178986|NCT00920686|431578|P3|COMPLETED|Overall Study||62
178987|NCT00920686|431579|P2|COMPLETED|Overall Study||60
178988|NCT00920686|431580|P1|COMPLETED|Overall Study||63
178989|NCT00920686|431578|P3|STARTED|Overall Study||75
178990|NCT00920686|431579|P2|STARTED|Overall Study||82
178991|NCT00920686|431580|P1|STARTED|Overall Study||82
178992|NCT00920647|431604|P4|NOT COMPLETED|Overall Study||0
178993|NCT00920647|431605|P3|NOT COMPLETED|Overall Study||0
178994|NCT00920647|431606|P2|NOT COMPLETED|Overall Study||0
178995|NCT00920647|431607|P1|NOT COMPLETED|Overall Study||0
178996|NCT00920647|431604|P4|COMPLETED|Overall Study||4
178997|NCT00920647|431605|P3|COMPLETED|Overall Study||4
178998|NCT00920647|431606|P2|COMPLETED|Overall Study||4
178999|NCT00920647|431607|P1|COMPLETED|Overall Study||4
179000|NCT00920647|431604|P4|STARTED|Overall Study||4
179001|NCT00920647|431605|P3|STARTED|Overall Study||4
179002|NCT00920647|431606|P2|STARTED|Overall Study||4
179003|NCT00920647|431607|P1|STARTED|Overall Study||4
179004|NCT00920621|431659|P4|NOT COMPLETED|Overall Study||35
179005|NCT00920621|431660|P3|NOT COMPLETED|Overall Study||35
179006|NCT00920621|431661|P2|NOT COMPLETED|Overall Study||45
179007|NCT00920621|431662|P1|NOT COMPLETED|Overall Study||54
179008|NCT00920621|431659|P4|COMPLETED|Overall Study||401
179009|NCT00920621|431660|P3|COMPLETED|Overall Study||405
179010|NCT00920621|431661|P2|COMPLETED|Overall Study||391
179011|NCT00920621|431662|P1|COMPLETED|Overall Study||386
179012|NCT00920621|431659|P4|STARTED|Overall Study||436
179013|NCT00920621|431660|P3|STARTED|Overall Study||440
179014|NCT00920621|431661|P2|STARTED|Overall Study||436
179015|NCT00920621|431662|P1|STARTED|Overall Study||440
179016|NCT00920439|431686|P1|NOT COMPLETED|Overall Study||0
179017|NCT00920439|431686|P1|COMPLETED|Overall Study||25
179018|NCT00920439|431686|P1|STARTED|Overall Study||25
179019|NCT00920426|431696|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
179020|NCT00920426|431697|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
179021|NCT00920426|431698|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
179022|NCT00920426|431699|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
179023|NCT00920426|431696|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
179024|NCT00920426|431697|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
179025|NCT00920426|431698|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
179026|NCT00920426|431699|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
179027|NCT00920426|431696|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
179028|NCT00920426|431697|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
179029|NCT00920426|431698|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
179030|NCT00920426|431699|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
179031|NCT00920426|431696|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
179032|NCT00920426|431697|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
179033|NCT00920426|431698|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
179034|NCT00920426|431699|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
179035|NCT00920426|431696|P4|COMPLETED|ITZ112929: Randomized Regimen||0
179036|NCT00920426|431697|P3|COMPLETED|ITZ112929: Randomized Regimen||2
179037|NCT00920426|431698|P2|COMPLETED|ITZ112929: Randomized Regimen||7
179038|NCT00920426|431699|P1|COMPLETED|ITZ112929: Randomized Regimen||0
179039|NCT00920426|431696|P4|STARTED|ITZ112929: Randomized Regimen||0
179040|NCT00920426|431697|P3|STARTED|ITZ112929: Randomized Regimen||2
179041|NCT00920426|431698|P2|STARTED|ITZ112929: Randomized Regimen||7
179042|NCT00920426|431699|P1|STARTED|ITZ112929: Randomized Regimen||0
179043|NCT00920426|431696|P4|NOT COMPLETED|ITZ111451||0
179044|NCT00920426|431697|P3|NOT COMPLETED|ITZ111451||0
179045|NCT00920426|431698|P2|NOT COMPLETED|ITZ111451||0
179046|NCT00920426|431699|P1|NOT COMPLETED|ITZ111451||1
179047|NCT00920426|431696|P4|COMPLETED|ITZ111451||0
179048|NCT00920426|431697|P3|COMPLETED|ITZ111451||0
179049|NCT00920426|431698|P2|COMPLETED|ITZ111451||0
179050|NCT00920426|431699|P1|COMPLETED|ITZ111451||7
179051|NCT00920426|431696|P4|STARTED|ITZ111451||0
179052|NCT00920426|431697|P3|STARTED|ITZ111451||0
179053|NCT00920426|431698|P2|STARTED|ITZ111451||0
179054|NCT00920426|431699|P1|STARTED|ITZ111451||8
179055|NCT00920374|431768|P2|NOT COMPLETED|Overall Study||0
179056|NCT00920374|431769|P1|NOT COMPLETED|Overall Study||0
179057|NCT00920374|431768|P2|COMPLETED|Overall Study||57
179058|NCT00920374|431769|P1|COMPLETED|Overall Study||61
179059|NCT00920374|431768|P2|STARTED|Overall Study||57
179060|NCT00920374|431769|P1|STARTED|Overall Study||61
179061|NCT00920309|431795|P2|NOT COMPLETED|Overall Study||0
179062|NCT00920309|431796|P1|NOT COMPLETED|Overall Study||0
179063|NCT00920309|431795|P2|COMPLETED|Overall Study||7
179064|NCT00920309|431796|P1|COMPLETED|Overall Study||14
179065|NCT00920309|431795|P2|STARTED|Overall Study||7
179066|NCT00920309|431796|P1|STARTED|Overall Study||14
179067|NCT00920231|431806|P2|NOT COMPLETED|Overall Study||0
179068|NCT00920231|431807|P1|NOT COMPLETED|Overall Study||0
179069|NCT00920231|431806|P2|COMPLETED|Overall Study||8
179070|NCT00920231|431807|P1|COMPLETED|Overall Study||8
179071|NCT00920231|431806|P2|STARTED|Overall Study||8
179072|NCT00920231|431807|P1|STARTED|Overall Study||8
179073|NCT00920218|431819|P4|NOT COMPLETED|Overall Study||7
179074|NCT00920218|431820|P3|NOT COMPLETED|Overall Study||8
179075|NCT00920218|431821|P2|NOT COMPLETED|Overall Study||5
179076|NCT00920218|431822|P1|NOT COMPLETED|Overall Study||2
179077|NCT00920218|431819|P4|COMPLETED|Overall Study||23
179078|NCT00920218|431820|P3|COMPLETED|Overall Study||23
179079|NCT00920218|431821|P2|COMPLETED|Overall Study||24
179080|NCT00920218|431822|P1|COMPLETED|Overall Study||28
179081|NCT00920218|431819|P4|STARTED|Overall Study||30
179082|NCT00920218|431820|P3|STARTED|Overall Study||31
179083|NCT00920218|431821|P2|STARTED|Overall Study||29
179084|NCT00920218|431822|P1|STARTED|Overall Study||30
179085|NCT00920140|431925|P5|NOT COMPLETED|Phase 2||11
179086|NCT00920140|431926|P4|NOT COMPLETED|Phase 2||22
179087|NCT00920140|431927|P3|NOT COMPLETED|Phase 2||50
179088|NCT00920140|431928|P2|NOT COMPLETED|Phase 2||0
179089|NCT00920140|431929|P1|NOT COMPLETED|Phase 2||0
179090|NCT00920140|431925|P5|COMPLETED|Phase 2||0
179091|NCT00920140|431926|P4|COMPLETED|Phase 2||0
179092|NCT00920140|431927|P3|COMPLETED|Phase 2||0
179093|NCT00920140|431928|P2|COMPLETED|Phase 2||0
179094|NCT00920140|431929|P1|COMPLETED|Phase 2||0
179095|NCT00920140|431925|P5|STARTED|Phase 2||11
179096|NCT00920140|431926|P4|STARTED|Phase 2||22
179097|NCT00920140|431927|P3|STARTED|Phase 2||50
179098|NCT00920140|431928|P2|STARTED|Phase 2||0
179099|NCT00920140|431929|P1|STARTED|Phase 2||0
179100|NCT00920140|431925|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
179101|NCT00920140|431926|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
179102|NCT00920140|431927|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
179103|NCT00920140|431928|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
179104|NCT00920140|431929|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
179105|NCT00920140|431925|P5|COMPLETED|Phase 1 (Dose Escalation)||0
179106|NCT00920140|431926|P4|COMPLETED|Phase 1 (Dose Escalation)||0
179107|NCT00920140|431927|P3|COMPLETED|Phase 1 (Dose Escalation)||0
179108|NCT00920140|431928|P2|COMPLETED|Phase 1 (Dose Escalation)||0
179109|NCT00920140|431929|P1|COMPLETED|Phase 1 (Dose Escalation)||0
179110|NCT00920140|431925|P5|STARTED|Phase 1 (Dose Escalation)||0
179111|NCT00920140|431926|P4|STARTED|Phase 1 (Dose Escalation)||0
179112|NCT00920140|431927|P3|STARTED|Phase 1 (Dose Escalation)||0
179113|NCT00920140|431928|P2|STARTED|Phase 1 (Dose Escalation)||9
179114|NCT00920140|431929|P1|STARTED|Phase 1 (Dose Escalation)||5
179115|NCT00920075|431967|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
179116|NCT00920075|431967|P1|COMPLETED|Post Study, 11 Pts Responded||11
179117|NCT00920075|431967|P1|STARTED|Post Study, 11 Pts Responded||11
179118|NCT00920075|431967|P1|NOT COMPLETED|Last Study,25 Pts Invited,11 Responded||0
179119|NCT00920075|431967|P1|COMPLETED|Last Study,25 Pts Invited,11 Responded||11
179120|NCT00920075|431967|P1|STARTED|Last Study,25 Pts Invited,11 Responded||11
179121|NCT00920023|431973|P1|NOT COMPLETED|Overall Study||0
179122|NCT00920023|431973|P1|COMPLETED|Overall Study||15
179123|NCT00920023|431973|P1|STARTED|Overall Study||15
179124|NCT00919932|431980|P2|NOT COMPLETED|Overall Study||0
179125|NCT00919932|431981|P1|NOT COMPLETED|Overall Study||0
179126|NCT00919932|431980|P2|COMPLETED|Overall Study||5
179127|NCT00919932|431981|P1|COMPLETED|Overall Study||4
179128|NCT00919932|431980|P2|STARTED|Overall Study||5
179129|NCT00919932|431981|P1|STARTED|Overall Study||4
179130|NCT00919893|431991|P2|NOT COMPLETED|Overall Study||9
179131|NCT00919893|431992|P1|NOT COMPLETED|Overall Study||19
179132|NCT00919893|431991|P2|COMPLETED|Overall Study||60
179133|NCT00919893|431992|P1|COMPLETED|Overall Study||51
179134|NCT00919893|431991|P2|STARTED|Overall Study||69
179135|NCT00919893|431992|P1|STARTED|Overall Study||70
179136|NCT00919867|432004|P6|NOT COMPLETED|Third Intervention||0
179137|NCT00919867|432005|P5|NOT COMPLETED|Third Intervention||0
179138|NCT00919867|432006|P4|NOT COMPLETED|Third Intervention||0
179139|NCT00919867|432007|P3|NOT COMPLETED|Third Intervention||0
179140|NCT00919867|432008|P2|NOT COMPLETED|Third Intervention||0
179141|NCT00919867|432009|P1|NOT COMPLETED|Third Intervention||0
179142|NCT00919867|432004|P6|COMPLETED|Third Intervention||6
179143|NCT00919867|432005|P5|COMPLETED|Third Intervention||7
179144|NCT00919867|432006|P4|COMPLETED|Third Intervention||7
179145|NCT00919867|432007|P3|COMPLETED|Third Intervention||6
179146|NCT00919867|432008|P2|COMPLETED|Third Intervention||7
179147|NCT00919867|432009|P1|COMPLETED|Third Intervention||7
179148|NCT00919867|432004|P6|STARTED|Third Intervention||6
179149|NCT00919867|432005|P5|STARTED|Third Intervention||7
179150|NCT00919867|432006|P4|STARTED|Third Intervention||7
179151|NCT00919867|432007|P3|STARTED|Third Intervention||6
179152|NCT00919867|432008|P2|STARTED|Third Intervention||7
179153|NCT00919867|432009|P1|STARTED|Third Intervention||7
179154|NCT00919867|432004|P6|NOT COMPLETED|Washout||0
179155|NCT00919867|432005|P5|NOT COMPLETED|Washout||0
179156|NCT00919867|432006|P4|NOT COMPLETED|Washout||0
179157|NCT00919867|432007|P3|NOT COMPLETED|Washout||0
179158|NCT00919867|432008|P2|NOT COMPLETED|Washout||0
179159|NCT00919867|432009|P1|NOT COMPLETED|Washout||0
179160|NCT00919867|432004|P6|COMPLETED|Washout||6
179161|NCT00919867|432005|P5|COMPLETED|Washout||7
179162|NCT00919867|432006|P4|COMPLETED|Washout||7
179163|NCT00919867|432007|P3|COMPLETED|Washout||6
179164|NCT00919867|432008|P2|COMPLETED|Washout||7
179165|NCT00919867|432009|P1|COMPLETED|Washout||7
179166|NCT00919867|432004|P6|STARTED|Washout||6
179167|NCT00919867|432005|P5|STARTED|Washout||7
179168|NCT00919867|432006|P4|STARTED|Washout||7
179169|NCT00919867|432007|P3|STARTED|Washout||6
179170|NCT00919867|432008|P2|STARTED|Washout||7
179171|NCT00919867|432009|P1|STARTED|Washout||7
179172|NCT00919867|432004|P6|NOT COMPLETED|Second Intervention||0
179173|NCT00919867|432005|P5|NOT COMPLETED|Second Intervention||0
179174|NCT00919867|432006|P4|NOT COMPLETED|Second Intervention||0
179175|NCT00919867|432007|P3|NOT COMPLETED|Second Intervention||0
179176|NCT00919867|432008|P2|NOT COMPLETED|Second Intervention||0
179177|NCT00919867|432009|P1|NOT COMPLETED|Second Intervention||0
179178|NCT00919867|432004|P6|COMPLETED|Second Intervention||6
179179|NCT00919867|432005|P5|COMPLETED|Second Intervention||7
179180|NCT00919867|432006|P4|COMPLETED|Second Intervention||7
179181|NCT00919867|432007|P3|COMPLETED|Second Intervention||6
179182|NCT00919867|432008|P2|COMPLETED|Second Intervention||7
179183|NCT00919867|432009|P1|COMPLETED|Second Intervention||7
179184|NCT00919867|432004|P6|STARTED|Second Intervention||6
179185|NCT00919867|432005|P5|STARTED|Second Intervention||7
179186|NCT00919867|432006|P4|STARTED|Second Intervention||7
179187|NCT00919867|432007|P3|STARTED|Second Intervention||6
179188|NCT00919867|432008|P2|STARTED|Second Intervention||7
179189|NCT00919867|432009|P1|STARTED|Second Intervention||7
179190|NCT00919867|432004|P6|NOT COMPLETED|Washout||0
179191|NCT00919867|432005|P5|NOT COMPLETED|Washout||0
179192|NCT00919867|432006|P4|NOT COMPLETED|Washout||0
179193|NCT00919867|432007|P3|NOT COMPLETED|Washout||0
179194|NCT00919867|432008|P2|NOT COMPLETED|Washout||0
179195|NCT00919867|432009|P1|NOT COMPLETED|Washout||0
179196|NCT00919867|432004|P6|COMPLETED|Washout||6
179197|NCT00919867|432005|P5|COMPLETED|Washout||7
179198|NCT00919867|432006|P4|COMPLETED|Washout||7
179199|NCT00919867|432007|P3|COMPLETED|Washout||6
179200|NCT00919867|432008|P2|COMPLETED|Washout||7
179201|NCT00919867|432009|P1|COMPLETED|Washout||7
179202|NCT00919867|432004|P6|STARTED|Washout||6
179203|NCT00919867|432005|P5|STARTED|Washout||7
179204|NCT00919867|432006|P4|STARTED|Washout||7
179205|NCT00919867|432007|P3|STARTED|Washout||6
179206|NCT00919867|432008|P2|STARTED|Washout||7
179207|NCT00919867|432009|P1|STARTED|Washout||7
179208|NCT00919867|432004|P6|NOT COMPLETED|First Intervention||1
179209|NCT00919867|432005|P5|NOT COMPLETED|First Intervention||0
179210|NCT00919867|432006|P4|NOT COMPLETED|First Intervention||0
179211|NCT00919867|432007|P3|NOT COMPLETED|First Intervention||1
179212|NCT00919867|432008|P2|NOT COMPLETED|First Intervention||0
179213|NCT00919867|432009|P1|NOT COMPLETED|First Intervention||0
179214|NCT00919867|432004|P6|COMPLETED|First Intervention||6
179215|NCT00919867|432005|P5|COMPLETED|First Intervention||7
179216|NCT00919867|432006|P4|COMPLETED|First Intervention||7
179217|NCT00919867|432007|P3|COMPLETED|First Intervention||6
179218|NCT00919867|432008|P2|COMPLETED|First Intervention||7
179219|NCT00919867|432009|P1|COMPLETED|First Intervention||7
179220|NCT00919867|432004|P6|STARTED|First Intervention||7
179221|NCT00919867|432005|P5|STARTED|First Intervention||7
179222|NCT00919867|432006|P4|STARTED|First Intervention||7
179223|NCT00919867|432007|P3|STARTED|First Intervention||7
179224|NCT00919867|432008|P2|STARTED|First Intervention||7
179225|NCT00919867|432009|P1|STARTED|First Intervention||7
179226|NCT00919854|432030|P1|NOT COMPLETED|Overall Study||1
179227|NCT00919854|432030|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
179228|NCT00919854|432030|P1|STARTED|Overall Study||21
179229|NCT00919802|432039|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
179230|NCT00919802|432040|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
179231|NCT00919802|432039|P2|COMPLETED|Second Intervention - (24 Hours)||13
179232|NCT00919802|432040|P1|COMPLETED|Second Intervention - (24 Hours)||12
179233|NCT00919802|432039|P2|STARTED|Second Intervention - (24 Hours)||13
179234|NCT00919802|432040|P1|STARTED|Second Intervention - (24 Hours)||12
179235|NCT00919802|432039|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
179236|NCT00919802|432040|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
179237|NCT00919802|432039|P2|COMPLETED|First Intervention - (24 Hours)||13
179238|NCT00919802|432040|P1|COMPLETED|First Intervention - (24 Hours)||12
179239|NCT00919802|432039|P2|STARTED|First Intervention - (24 Hours)||13
179240|NCT00919802|432040|P1|STARTED|First Intervention - (24 Hours)||12
179241|NCT00919763|432050|P2|NOT COMPLETED|Overall Study||4
179242|NCT00919763|432051|P1|NOT COMPLETED|Overall Study||12
179243|NCT00919763|432050|P2|COMPLETED|Overall Study||45
179244|NCT00919763|432051|P1|COMPLETED|Overall Study||41
179245|NCT00919763|432050|P2|STARTED|Overall Study||49
179246|NCT00919763|432051|P1|STARTED|Overall Study||53
179247|NCT00919724|432059|P2|NOT COMPLETED|Overall Study||0
179248|NCT00919724|432060|P1|NOT COMPLETED|Overall Study||0
179249|NCT00919724|432059|P2|COMPLETED|Overall Study||44
179250|NCT00919724|432060|P1|COMPLETED|Overall Study||45
179251|NCT00919724|432059|P2|STARTED|Overall Study||44
179252|NCT00919724|432060|P1|STARTED|Overall Study||45
179253|NCT00919711|432068|P2|NOT COMPLETED|Overall Study||13
179254|NCT00919711|432069|P1|NOT COMPLETED|Overall Study||33
179255|NCT00919711|432068|P2|COMPLETED|Overall Study||422
179256|NCT00919711|432069|P1|COMPLETED|Overall Study||402
179257|NCT00919711|432068|P2|STARTED|Overall Study||435
179258|NCT00919711|432069|P1|STARTED|Overall Study||435
179259|NCT00919633|432085|P4|NOT COMPLETED|Overall Study||21
179260|NCT00919633|432086|P3|NOT COMPLETED|Overall Study||23
179261|NCT00919633|432087|P2|NOT COMPLETED|Overall Study||15
179262|NCT00919633|432088|P1|NOT COMPLETED|Overall Study||22
179263|NCT00919633|432085|P4|COMPLETED|Overall Study||5
179264|NCT00919633|432086|P3|COMPLETED|Overall Study||4
179265|NCT00919633|432087|P2|COMPLETED|Overall Study||10
179266|NCT00919633|432088|P1|COMPLETED|Overall Study||6
179267|NCT00919633|432085|P4|STARTED|Overall Study||26
179268|NCT00919633|432086|P3|STARTED|Overall Study||27
179269|NCT00919633|432087|P2|STARTED|Overall Study||25
179270|NCT00919633|432088|P1|STARTED|Overall Study||28
179271|NCT00919191|432106|P1|NOT COMPLETED|Overall Study||0
179272|NCT00919191|432106|P1|COMPLETED|Overall Study||26
179273|NCT00919191|432106|P1|STARTED|Overall Study||26
179274|NCT00919126|432116|P3|NOT COMPLETED|Overall Study||1
179275|NCT00919126|432117|P2|NOT COMPLETED|Overall Study||5
179276|NCT00919126|432118|P1|NOT COMPLETED|Overall Study||1
179277|NCT00919126|432116|P3|COMPLETED|Overall Study||32
179278|NCT00919126|432117|P2|COMPLETED|Overall Study||32
179279|NCT00919126|432118|P1|COMPLETED|Overall Study||31
179280|NCT00919126|432116|P3|STARTED|Overall Study||33
179281|NCT00919126|432117|P2|STARTED|Overall Study||37
179282|NCT00919126|432118|P1|STARTED|Overall Study||32
179283|NCT00919113|432164|P2|NOT COMPLETED|Overall Study||8
179284|NCT00919113|432165|P1|NOT COMPLETED|Overall Study||9
179285|NCT00919113|432164|P2|COMPLETED|Overall Study||40
179286|NCT00919113|432165|P1|COMPLETED|Overall Study||41
179287|NCT00919113|432164|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
179288|NCT00919113|432165|P1|Received Placebo|Overall Study||0
179289|NCT00919113|432164|P2|Received Uracyst|Overall Study||0
179290|NCT00919113|432165|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
179291|NCT00919113|432164|P2|STARTED|Overall Study||48
179292|NCT00919113|432165|P1|STARTED|Overall Study||50
179293|NCT00919061|432173|P1|NOT COMPLETED|Overall Study||2
179294|NCT00919061|432173|P1|COMPLETED|Overall Study||37
179295|NCT00919061|432173|P1|STARTED|Overall Study||39
179296|NCT00919035|432178|P1|NOT COMPLETED|Overall Study||0
179297|NCT00919035|432178|P1|COMPLETED|Overall Study||21
179298|NCT00919035|432178|P1|STARTED|Overall Study||21
179299|NCT00918957|432186|P2|NOT COMPLETED|Overall Study||0
179300|NCT00918957|432187|P1|NOT COMPLETED|Overall Study||3
179301|NCT00918957|432186|P2|COMPLETED|Overall Study||30
179302|NCT00918957|432187|P1|COMPLETED|Overall Study||29
179303|NCT00918957|432186|P2|STARTED|Overall Study||30
179304|NCT00918957|432187|P1|STARTED|Overall Study||32
179305|NCT00918931|432214|P1|NOT COMPLETED|Overall Study||0
179306|NCT00918931|432214|P1|COMPLETED|Overall Study||3
179307|NCT00918931|432214|P1|STARTED|Overall Study||3
179308|NCT00918879|432220|P2|NOT COMPLETED|Overall Study||6
179309|NCT00918879|432221|P1|NOT COMPLETED|Overall Study||6
179310|NCT00918879|432220|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
179311|NCT00918879|432221|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
179312|NCT00918879|432220|P2|STARTED|Overall Study|Randomized and treated|106
179313|NCT00918879|432221|P1|STARTED|Overall Study|Randomized and treated|107
179314|NCT00918866|432235|P2|NOT COMPLETED|Overall Study||0
179315|NCT00918866|432236|P1|NOT COMPLETED|Overall Study||0
179316|NCT00918866|432235|P2|COMPLETED|Overall Study||16
179317|NCT00918866|432236|P1|COMPLETED|Overall Study||16
179318|NCT00918866|432235|P2|STARTED|Overall Study||16
179319|NCT00918866|432236|P1|STARTED|Overall Study||16
179320|NCT00918749|432253|P3|NOT COMPLETED|Overall Study||7
179321|NCT00918749|432254|P2|NOT COMPLETED|Overall Study||3
179322|NCT00918749|432255|P1|NOT COMPLETED|Overall Study||7
179323|NCT00918749|432253|P3|COMPLETED|Overall Study||62
179324|NCT00918749|432254|P2|COMPLETED|Overall Study||63
179325|NCT00918749|432255|P1|COMPLETED|Overall Study||63
179326|NCT00918749|432253|P3|ITT (Intent to Treat) Population|Overall Study||69
179327|NCT00918749|432254|P2|ITT (Intent to Treat) Population|Overall Study||66
179328|NCT00918749|432255|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
179329|NCT00918749|432253|P3|STARTED|Overall Study||69
179330|NCT00918749|432254|P2|STARTED|Overall Study||66
179331|NCT00918749|432255|P1|STARTED|Overall Study||70
179332|NCT00918736|432287|P1|NOT COMPLETED|Overall Study||4
179333|NCT00918736|432287|P1|COMPLETED|Overall Study|October, 2008|46
179334|NCT00918736|432287|P1|STARTED|Overall Study|October, 2007|50
179335|NCT00918723|432291|P1|NOT COMPLETED|Overall Study||0
179336|NCT00918723|432291|P1|COMPLETED|Overall Study||40
179337|NCT00918723|432291|P1|STARTED|Overall Study||40
179338|NCT00918684|432300|P1|NOT COMPLETED|Treatment Phase||25
179339|NCT00918684|432300|P1|COMPLETED|Treatment Phase||65
179340|NCT00918684|432300|P1|STARTED|Treatment Phase||90
179341|NCT00918684|432300|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
179342|NCT00918684|432300|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
179343|NCT00918684|432300|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
179344|NCT00918671|432306|P1|NOT COMPLETED|Overall Study||0
179345|NCT00918671|432306|P1|COMPLETED|Overall Study||60
179346|NCT00918671|432306|P1|STARTED|Overall Study||60
179347|NCT00918645|432311|P1|NOT COMPLETED|Overall Study||1
179348|NCT00918645|432311|P1|COMPLETED|Overall Study||12
179349|NCT00918645|432311|P1|STARTED|Overall Study||13
179350|NCT00918580|432317|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
179351|NCT00918580|432317|P1|COMPLETED|After 6-month FU to 1-year FU||87
179352|NCT00918580|432317|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
179353|NCT00918580|432317|P1|STARTED|After 6-month FU to 1-year FU||147
179354|NCT00918580|432317|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
179355|NCT00918580|432317|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
179356|NCT00918580|432317|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
179357|NCT00918580|432317|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
179358|NCT00918580|432317|P1|STARTED|Up to 6-month Follow-up(FU)||158
179359|NCT00918385|432337|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
179360|NCT00918385|432338|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
179361|NCT00918385|432337|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
179362|NCT00918385|432338|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
179363|NCT00918385|432337|P2|STARTED|Combination Nilutamide and Dasatinib||11
179364|NCT00918385|432338|P1|STARTED|Combination Nilutamide and Dasatinib||12
179365|NCT00918385|432337|P2|NOT COMPLETED|Monotherapy||6
179366|NCT00918385|432338|P1|NOT COMPLETED|Monotherapy||2
179367|NCT00918385|432337|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
179368|NCT00918385|432338|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
179369|NCT00918385|432337|P2|STARTED|Monotherapy||17
179370|NCT00918385|432338|P1|STARTED|Monotherapy||14
179371|NCT00918346|432347|P2|NOT COMPLETED|Post Study Period||0
179372|NCT00918346|432348|P1|NOT COMPLETED|Post Study Period||0
179373|NCT00918346|432347|P2|COMPLETED|Post Study Period||21
179374|NCT00918346|432348|P1|COMPLETED|Post Study Period||21
179375|NCT00918346|432347|P2|STARTED|Post Study Period||21
179376|NCT00918346|432348|P1|STARTED|Post Study Period||21
179377|NCT00918346|432347|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
179378|NCT00918346|432348|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
179379|NCT00918346|432347|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
179380|NCT00918346|432348|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
179381|NCT00918346|432347|P2|STARTED|Second Treatment Period (4 Weeks)||21
179382|NCT00918346|432348|P1|STARTED|Second Treatment Period (4 Weeks)||21
179383|NCT00918346|432347|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
179384|NCT00918346|432348|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
179385|NCT00918346|432347|P2|COMPLETED|Washout (at Least 4 Weeks)||21
179386|NCT00918346|432348|P1|COMPLETED|Washout (at Least 4 Weeks)||21
179387|NCT00918346|432347|P2|STARTED|Washout (at Least 4 Weeks)||21
179388|NCT00918346|432348|P1|STARTED|Washout (at Least 4 Weeks)||21
179389|NCT00918346|432347|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
179390|NCT00918346|432348|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
179391|NCT00918346|432347|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
179392|NCT00918346|432348|P1|COMPLETED|First Treatment Period (4 Weeks)||21
179393|NCT00918346|432347|P2|STARTED|First Treatment Period (4 Weeks)||22
179394|NCT00918346|432348|P1|STARTED|First Treatment Period (4 Weeks)||21
179395|NCT00918333|432364|P2|NOT COMPLETED|Overall Study||5
179396|NCT00918333|432365|P1|NOT COMPLETED|Overall Study||3
179397|NCT00918333|432364|P2|COMPLETED|Overall Study||93
179398|NCT00918333|432365|P1|COMPLETED|Overall Study||23
179399|NCT00918333|432364|P2|STARTED|Overall Study||98
179400|NCT00918333|432365|P1|STARTED|Overall Study||26
179401|NCT00918281|432385|P1|NOT COMPLETED|Overall Study||29
179402|NCT00918281|432385|P1|COMPLETED|Overall Study||41
179403|NCT00918281|432385|P1|STARTED|Overall Study||70
179404|NCT00918255|432395|P3|NOT COMPLETED|Overall Study||5
179405|NCT00918255|432396|P2|NOT COMPLETED|Overall Study||0
179406|NCT00918255|432397|P1|NOT COMPLETED|Overall Study||6
179407|NCT00918255|432395|P3|COMPLETED|Overall Study||46
179408|NCT00918255|432396|P2|COMPLETED|Overall Study||52
179409|NCT00918255|432397|P1|COMPLETED|Overall Study||45
179410|NCT00918255|432395|P3|STARTED|Overall Study||51
179411|NCT00918255|432396|P2|STARTED|Overall Study||52
179412|NCT00918255|432397|P1|STARTED|Overall Study||51
179413|NCT00918203|432425|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||3
179414|NCT00918203|432426|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
179415|NCT00918203|432427|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
179416|NCT00918203|432425|P3|COMPLETED|Crossover to Olaratumab Monotherapy||14
179417|NCT00918203|432426|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
179418|NCT00918203|432427|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
179419|NCT00918203|432425|P3|STARTED|Crossover to Olaratumab Monotherapy|16 participants crossed over to olaratumab after PD and 1 participant of symptomatic deterioration.|17
179420|NCT00918203|432426|P2|STARTED|Crossover to Olaratumab Monotherapy||0
179421|NCT00918203|432427|P1|STARTED|Crossover to Olaratumab Monotherapy||0
179422|NCT00918203|432425|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
179423|NCT00918203|432426|P2|NOT COMPLETED|Treatment With or Without Olaratumab||14
179424|NCT00918203|432427|P1|NOT COMPLETED|Treatment With or Without Olaratumab||7
179425|NCT00918203|432425|P3|COMPLETED|Treatment With or Without Olaratumab||0
179426|NCT00918203|432426|P2|COMPLETED|Treatment With or Without Olaratumab||53
179427|NCT00918203|432427|P1|COMPLETED|Treatment With or Without Olaratumab||63
179428|NCT00918203|432425|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
179429|NCT00918203|432426|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
179430|NCT00918203|432427|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
179431|NCT00918203|432425|P3|STARTED|Treatment With or Without Olaratumab||0
179432|NCT00918203|432426|P2|STARTED|Treatment With or Without Olaratumab||67
179433|NCT00918203|432427|P1|STARTED|Treatment With or Without Olaratumab||70
179434|NCT00918138|432458|P2|NOT COMPLETED|Overall Study||1
179435|NCT00918138|432459|P1|NOT COMPLETED|Overall Study||2
179436|NCT00918138|432458|P2|COMPLETED|Overall Study||46
179437|NCT00918138|432459|P1|COMPLETED|Overall Study||44
179438|NCT00918138|432458|P2|STARTED|Overall Study||47
179439|NCT00918138|432459|P1|STARTED|Overall Study||46
179440|NCT00918125|432475|P2|NOT COMPLETED|Overall Study||0
179441|NCT00918125|432476|P1|NOT COMPLETED|Overall Study||0
179442|NCT00918125|432475|P2|COMPLETED|Overall Study||39
179443|NCT00918125|432476|P1|COMPLETED|Overall Study||20
179444|NCT00918125|432475|P2|STARTED|Overall Study||39
179445|NCT00918125|432476|P1|STARTED|Overall Study||20
179446|NCT00917865|432487|P1|NOT COMPLETED|Overall Study||0
179447|NCT00917865|432487|P1|COMPLETED|Overall Study||11
179448|NCT00917865|432487|P1|STARTED|Overall Study||11
179449|NCT00917852|432498|P1|NOT COMPLETED|Overall Study||6
179450|NCT00917852|432498|P1|COMPLETED|Overall Study||45
179451|NCT00917852|432498|P1|STARTED|Overall Study||51
179452|NCT00917735|432505|P2|NOT COMPLETED|Overall Study||63
179453|NCT00917735|432506|P1|NOT COMPLETED|Overall Study||75
179454|NCT00917735|432505|P2|COMPLETED|Overall Study||474
179455|NCT00917735|432506|P1|COMPLETED|Overall Study||463
179456|NCT00917735|432505|P2|STARTED|Overall Study||537
179457|NCT00917735|432506|P1|STARTED|Overall Study||538
179458|NCT00917644|432516|P2|NOT COMPLETED|Period 2: Second Intervention||0
179459|NCT00917644|432517|P1|NOT COMPLETED|Period 2: Second Intervention||1
179460|NCT00917644|432516|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
179461|NCT00917644|432517|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
179462|NCT00917644|432516|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
179463|NCT00917644|432517|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
179464|NCT00917644|432516|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
179465|NCT00917644|432517|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
179466|NCT00917644|432516|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
179467|NCT00917644|432517|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
179468|NCT00917644|432516|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
179469|NCT00917644|432517|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
179470|NCT00917644|432516|P2|NOT COMPLETED|Period 1: First Intervention||0
179471|NCT00917644|432517|P1|NOT COMPLETED|Period 1: First Intervention||0
179472|NCT00917644|432516|P2|COMPLETED|Period 1: First Intervention||37
179473|NCT00917644|432517|P1|COMPLETED|Period 1: First Intervention||39
179474|NCT00917644|432516|P2|STARTED|Period 1: First Intervention||37
179475|NCT00917644|432517|P1|STARTED|Period 1: First Intervention||39
179476|NCT00917579|432531|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
179477|NCT00917579|432532|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
179478|NCT00917579|432531|P2|COMPLETED|Period 2: 2nd Intervention||37
179479|NCT00917579|432532|P1|COMPLETED|Period 2: 2nd Intervention||37
179480|NCT00917579|432531|P2|STARTED|Period 2: 2nd Intervention||37
179481|NCT00917579|432532|P1|STARTED|Period 2: 2nd Intervention||37
179482|NCT00917579|432531|P2|NOT COMPLETED|Washout >= 2 Weeks||0
179483|NCT00917579|432532|P1|NOT COMPLETED|Washout >= 2 Weeks||2
179484|NCT00917579|432531|P2|COMPLETED|Washout >= 2 Weeks||37
179485|NCT00917579|432532|P1|COMPLETED|Washout >= 2 Weeks||37
179486|NCT00917579|432531|P2|STARTED|Washout >= 2 Weeks||37
179487|NCT00917579|432532|P1|STARTED|Washout >= 2 Weeks||39
179488|NCT00917579|432531|P2|NOT COMPLETED|Period 1: 1st Intervention||0
179489|NCT00917579|432532|P1|NOT COMPLETED|Period 1: 1st Intervention||0
179490|NCT00917579|432531|P2|COMPLETED|Period 1: 1st Intervention||37
179491|NCT00917579|432532|P1|COMPLETED|Period 1: 1st Intervention||39
179492|NCT00917579|432531|P2|STARTED|Period 1: 1st Intervention||37
179493|NCT00917579|432532|P1|STARTED|Period 1: 1st Intervention||39
179494|NCT00917501|432548|P2|NOT COMPLETED|Overall Study||5
179495|NCT00917501|432549|P1|NOT COMPLETED|Overall Study||8
179496|NCT00917501|432548|P2|COMPLETED|Overall Study||21
179497|NCT00917501|432549|P1|COMPLETED|Overall Study||21
179498|NCT00917501|432548|P2|STARTED|Overall Study||26
179499|NCT00917501|432549|P1|STARTED|Overall Study||29
179500|NCT00917384|432557|P2|NOT COMPLETED|Overall Study||4
179501|NCT00917384|432558|P1|NOT COMPLETED|Overall Study||14
179502|NCT00917384|432557|P2|COMPLETED|Overall Study||113
179503|NCT00917384|432558|P1|COMPLETED|Overall Study||224
179504|NCT00917384|432557|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
179505|NCT00917384|432558|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
179506|NCT00917384|432557|P2|STARTED|Overall Study||117
179507|NCT00917384|432558|P1|STARTED|Overall Study||238
179508|NCT00917267|432582|P2|NOT COMPLETED|Overall Study||79
179509|NCT00917267|432583|P1|NOT COMPLETED|Overall Study||39
179510|NCT00917267|432582|P2|COMPLETED|Overall Study||266
179511|NCT00917267|432583|P1|COMPLETED|Overall Study||307
179512|NCT00917267|432582|P2|Intent to Treat (ITT)|Overall Study||338
179513|NCT00917267|432583|P1|Intent to Treat (ITT)|Overall Study||340
179514|NCT00917267|432582|P2|STARTED|Overall Study||345
179515|NCT00917267|432583|P1|STARTED|Overall Study||346
179516|NCT00917124|432611|P2|NOT COMPLETED|Overall Study||6
179517|NCT00917124|432612|P1|NOT COMPLETED|Overall Study||4
179518|NCT00917124|432611|P2|COMPLETED|Overall Study||94
179519|NCT00917124|432612|P1|COMPLETED|Overall Study||96
179520|NCT00917124|432611|P2|STARTED|Overall Study||100
179521|NCT00917124|432612|P1|STARTED|Overall Study||100
179522|NCT00916929|432622|P2|NOT COMPLETED|Overall Study||29
179523|NCT00916929|432623|P1|NOT COMPLETED|Overall Study||10
179524|NCT00916929|432622|P2|COMPLETED|Overall Study||53
179525|NCT00916929|432623|P1|COMPLETED|Overall Study||70
179526|NCT00916929|432622|P2|STARTED|Overall Study||82
179527|NCT00916929|432623|P1|STARTED|Overall Study||80
179528|NCT00916721|432633|P2|NOT COMPLETED|Overall Study||10
179529|NCT00916721|432634|P1|NOT COMPLETED|Overall Study||10
179530|NCT00916721|432633|P2|COMPLETED|Overall Study||29
179531|NCT00916721|432634|P1|COMPLETED|Overall Study||25
179532|NCT00916721|432633|P2|STARTED|Overall Study||39
179533|NCT00916721|432634|P1|STARTED|Overall Study||35
179534|NCT00916643|432646|P1|NOT COMPLETED|Overall Study||0
179535|NCT00916643|432646|P1|COMPLETED|Overall Study||113
179536|NCT00916643|432646|P1|STARTED|Overall Study||113
179537|NCT00916617|432657|P4|NOT COMPLETED|Overall Study||7
179538|NCT00916617|432658|P3|NOT COMPLETED|Overall Study||10
179539|NCT00916617|432659|P2|NOT COMPLETED|Overall Study||21
179540|NCT00916617|432660|P1|NOT COMPLETED|Overall Study||23
179541|NCT00916617|432657|P4|COMPLETED|Overall Study||0
179542|NCT00916617|432658|P3|COMPLETED|Overall Study||0
179543|NCT00916617|432659|P2|COMPLETED|Overall Study||0
179544|NCT00916617|432660|P1|COMPLETED|Overall Study||1
179545|NCT00916617|432657|P4|STARTED|Overall Study||7
179546|NCT00916617|432658|P3|STARTED|Overall Study||10
179547|NCT00916617|432659|P2|STARTED|Overall Study||21
179548|NCT00916617|432660|P1|STARTED|Overall Study||24
179549|NCT00916539|432676|P2|NOT COMPLETED|Overall Study||0
179550|NCT00916539|432677|P1|NOT COMPLETED|Overall Study||0
179551|NCT00916539|432676|P2|COMPLETED|Overall Study||31
179552|NCT00916539|432677|P1|COMPLETED|Overall Study||31
179553|NCT00916539|432676|P2|STARTED|Overall Study||31
179554|NCT00916539|432677|P1|STARTED|Overall Study||31
179555|NCT00916383|432699|P1|NOT COMPLETED|Overall Study||3
179556|NCT00916383|432699|P1|COMPLETED|Overall Study||46
179557|NCT00916383|432699|P1|STARTED|Overall Study||49
179558|NCT00916370|432727|P2|NOT COMPLETED|Overall Study||2
179559|NCT00916370|432728|P1|NOT COMPLETED|Overall Study||5
179560|NCT00916370|432727|P2|COMPLETED|Overall Study||102
179561|NCT00916370|432728|P1|COMPLETED|Overall Study||396
179562|NCT00916370|432727|P2|STARTED|Overall Study||104
179563|NCT00916370|432728|P1|STARTED|Overall Study||401
179564|NCT00916357|432902|P6|NOT COMPLETED|Period 3||0
179565|NCT00916357|432903|P5|NOT COMPLETED|Period 3||0
179566|NCT00916357|432904|P4|NOT COMPLETED|Period 3||0
179567|NCT00916357|432905|P3|NOT COMPLETED|Period 3||0
179568|NCT00916357|432906|P2|NOT COMPLETED|Period 3||0
179569|NCT00916357|432907|P1|NOT COMPLETED|Period 3||0
179570|NCT00916357|432902|P6|COMPLETED|Period 3||4
179571|NCT00916357|432903|P5|COMPLETED|Period 3||3
179572|NCT00916357|432904|P4|COMPLETED|Period 3||3
179573|NCT00916357|432905|P3|COMPLETED|Period 3||4
179574|NCT00916357|432906|P2|COMPLETED|Period 3||4
179575|NCT00916357|432907|P1|COMPLETED|Period 3||3
179576|NCT00916357|432902|P6|STARTED|Period 3||4
179577|NCT00916357|432903|P5|STARTED|Period 3||3
179578|NCT00916357|432904|P4|STARTED|Period 3||3
179579|NCT00916357|432905|P3|STARTED|Period 3||4
179580|NCT00916357|432906|P2|STARTED|Period 3||4
179581|NCT00916357|432907|P1|STARTED|Period 3||3
179582|NCT00916357|432902|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
179583|NCT00916357|432903|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
179584|NCT00916357|432904|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
179585|NCT00916357|432905|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
179586|NCT00916357|432906|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
179587|NCT00916357|432907|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
179588|NCT00916357|432902|P6|COMPLETED|Washout (3 to 14 Days)||4
179589|NCT00916357|432903|P5|COMPLETED|Washout (3 to 14 Days)||3
179590|NCT00916357|432904|P4|COMPLETED|Washout (3 to 14 Days)||3
179591|NCT00916357|432905|P3|COMPLETED|Washout (3 to 14 Days)||4
179592|NCT00916357|432906|P2|COMPLETED|Washout (3 to 14 Days)||4
179593|NCT00916357|432907|P1|COMPLETED|Washout (3 to 14 Days)||3
179594|NCT00916357|432902|P6|STARTED|Washout (3 to 14 Days)||4
179595|NCT00916357|432903|P5|STARTED|Washout (3 to 14 Days)||3
179596|NCT00916357|432904|P4|STARTED|Washout (3 to 14 Days)||3
179597|NCT00916357|432905|P3|STARTED|Washout (3 to 14 Days)||4
179598|NCT00916357|432906|P2|STARTED|Washout (3 to 14 Days)||4
179599|NCT00916357|432907|P1|STARTED|Washout (3 to 14 Days)||3
179600|NCT00916357|432902|P6|NOT COMPLETED|Period 2||0
179601|NCT00916357|432903|P5|NOT COMPLETED|Period 2||0
179602|NCT00916357|432904|P4|NOT COMPLETED|Period 2||1
179603|NCT00916357|432905|P3|NOT COMPLETED|Period 2||0
179604|NCT00916357|432906|P2|NOT COMPLETED|Period 2||0
179605|NCT00916357|432907|P1|NOT COMPLETED|Period 2||0
179606|NCT00916357|432902|P6|COMPLETED|Period 2||4
179607|NCT00916357|432903|P5|COMPLETED|Period 2||3
179608|NCT00916357|432904|P4|COMPLETED|Period 2||3
179609|NCT00916357|432905|P3|COMPLETED|Period 2||4
179610|NCT00916357|432906|P2|COMPLETED|Period 2||4
179611|NCT00916357|432907|P1|COMPLETED|Period 2||3
179612|NCT00916357|432902|P6|STARTED|Period 2||4
179613|NCT00916357|432903|P5|STARTED|Period 2||3
179614|NCT00916357|432904|P4|STARTED|Period 2||4
179615|NCT00916357|432905|P3|STARTED|Period 2||4
179616|NCT00916357|432906|P2|STARTED|Period 2||4
179617|NCT00916357|432907|P1|STARTED|Period 2||3
179618|NCT00916357|432902|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
179619|NCT00916357|432903|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
179620|NCT00916357|432904|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
179621|NCT00916357|432905|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
179622|NCT00916357|432906|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
179623|NCT00916357|432907|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
179624|NCT00916357|432902|P6|COMPLETED|Washout (3 to 14 Days)||4
179625|NCT00916357|432903|P5|COMPLETED|Washout (3 to 14 Days)||3
179626|NCT00916357|432904|P4|COMPLETED|Washout (3 to 14 Days)||4
179627|NCT00916357|432905|P3|COMPLETED|Washout (3 to 14 Days)||4
179628|NCT00916357|432906|P2|COMPLETED|Washout (3 to 14 Days)||4
179629|NCT00916357|432907|P1|COMPLETED|Washout (3 to 14 Days)||3
179630|NCT00916357|432902|P6|STARTED|Washout (3 to 14 Days)||4
179631|NCT00916357|432903|P5|STARTED|Washout (3 to 14 Days)||3
179632|NCT00916357|432904|P4|STARTED|Washout (3 to 14 Days)||4
179633|NCT00916357|432905|P3|STARTED|Washout (3 to 14 Days)||4
179634|NCT00916357|432906|P2|STARTED|Washout (3 to 14 Days)||4
179635|NCT00916357|432907|P1|STARTED|Washout (3 to 14 Days)||3
179636|NCT00916357|432902|P6|NOT COMPLETED|Period 1||0
179637|NCT00916357|432903|P5|NOT COMPLETED|Period 1||0
179638|NCT00916357|432904|P4|NOT COMPLETED|Period 1||0
179639|NCT00916357|432905|P3|NOT COMPLETED|Period 1||0
179640|NCT00916357|432906|P2|NOT COMPLETED|Period 1||0
179641|NCT00916357|432907|P1|NOT COMPLETED|Period 1||1
179642|NCT00916357|432902|P6|COMPLETED|Period 1||4
179643|NCT00916357|432903|P5|COMPLETED|Period 1||3
179644|NCT00916357|432904|P4|COMPLETED|Period 1||4
179645|NCT00916357|432905|P3|COMPLETED|Period 1||4
179646|NCT00916357|432906|P2|COMPLETED|Period 1||4
179647|NCT00916357|432907|P1|COMPLETED|Period 1||3
179648|NCT00916357|432902|P6|Received at Least 1 Dose of Study Drug|Period 1||4
179649|NCT00916357|432903|P5|Received at Least 1 Dose of Study Drug|Period 1||3
179650|NCT00916357|432904|P4|Received at Least 1 Dose of Study Drug|Period 1||4
179651|NCT00916357|432905|P3|Received at Least 1 Dose of Study Drug|Period 1||4
179652|NCT00916357|432906|P2|Received at Least 1 Dose of Study Drug|Period 1||4
179653|NCT00916357|432907|P1|Received at Least 1 Dose of Study Drug|Period 1||4
179654|NCT00916357|432902|P6|STARTED|Period 1||4
179655|NCT00916357|432903|P5|STARTED|Period 1||3
179656|NCT00916357|432904|P4|STARTED|Period 1||4
179657|NCT00916357|432905|P3|STARTED|Period 1||4
179658|NCT00916357|432906|P2|STARTED|Period 1||4
179659|NCT00916357|432907|P1|STARTED|Period 1||4
179660|NCT00916344|432945|P1|NOT COMPLETED|Overall Study||8
179661|NCT00916344|432945|P1|COMPLETED|Overall Study||167
179662|NCT00916344|432945|P1|STARTED|Overall Study||175
179663|NCT00916305|432952|P2|NOT COMPLETED|Overall Study||28
179664|NCT00916305|432953|P1|NOT COMPLETED|Overall Study||21
179665|NCT00916305|432952|P2|COMPLETED|Overall Study||9
179666|NCT00916305|432953|P1|COMPLETED|Overall Study||7
179667|NCT00916305|432952|P2|STARTED|Overall Study||37
179668|NCT00916305|432953|P1|STARTED|Overall Study||28
179669|NCT00916279|432961|P1|NOT COMPLETED|Overall Study||4
179670|NCT00916279|432961|P1|COMPLETED|Overall Study||37
179671|NCT00916279|432961|P1|24 Months|Overall Study||37
179672|NCT00916279|432961|P1|6 Months|Overall Study||41
179673|NCT00916279|432961|P1|30 Days|Overall Study||41
179674|NCT00916279|432961|P1|STARTED|Overall Study||41
179675|NCT00916136|432971|P2|NOT COMPLETED|Overall Study||0
179676|NCT00916136|432972|P1|NOT COMPLETED|Overall Study||0
179677|NCT00916136|432971|P2|COMPLETED|Overall Study||29
179678|NCT00916136|432972|P1|COMPLETED|Overall Study||37
179679|NCT00916136|432971|P2|STARTED|Overall Study||29
179680|NCT00916136|432972|P1|STARTED|Overall Study||37
179681|NCT00916032|432980|P2|NOT COMPLETED|Overall Study||0
179682|NCT00916032|432981|P1|NOT COMPLETED|Overall Study||0
179683|NCT00916032|432980|P2|COMPLETED|Overall Study||11
179684|NCT00916032|432981|P1|COMPLETED|Overall Study||12
179685|NCT00916032|432980|P2|STARTED|Overall Study||11
179686|NCT00916032|432981|P1|STARTED|Overall Study||12
179687|NCT00916006|433023|P2|NOT COMPLETED|Overall Study||7
179688|NCT00916006|433024|P1|NOT COMPLETED|Overall Study||3
179689|NCT00916006|433023|P2|COMPLETED|Overall Study||127
179690|NCT00916006|433024|P1|COMPLETED|Overall Study||132
179691|NCT00916006|433023|P2|STARTED|Overall Study||134
179692|NCT00916006|433024|P1|STARTED|Overall Study||135
179693|NCT00915902|433034|P2|NOT COMPLETED|2nd Treatment Period||1
179694|NCT00915902|433035|P1|NOT COMPLETED|2nd Treatment Period||0
179695|NCT00915902|433034|P2|COMPLETED|2nd Treatment Period||20
179696|NCT00915902|433035|P1|COMPLETED|2nd Treatment Period||19
179697|NCT00915902|433034|P2|STARTED|2nd Treatment Period||21
179698|NCT00915902|433035|P1|STARTED|2nd Treatment Period||19
179699|NCT00915902|433034|P2|NOT COMPLETED|Washout (4 Weeks)||1
179700|NCT00915902|433035|P1|NOT COMPLETED|Washout (4 Weeks)||0
179701|NCT00915902|433034|P2|COMPLETED|Washout (4 Weeks)||21
179702|NCT00915902|433035|P1|COMPLETED|Washout (4 Weeks)||19
179703|NCT00915902|433034|P2|STARTED|Washout (4 Weeks)||22
179704|NCT00915902|433035|P1|STARTED|Washout (4 Weeks)||19
179705|NCT00915902|433034|P2|NOT COMPLETED|1st Treatment Period||0
179706|NCT00915902|433035|P1|NOT COMPLETED|1st Treatment Period||1
179707|NCT00915902|433034|P2|COMPLETED|1st Treatment Period||22
179708|NCT00915902|433035|P1|COMPLETED|1st Treatment Period||19
179709|NCT00915902|433034|P2|STARTED|1st Treatment Period||22
179710|NCT00915902|433035|P1|STARTED|1st Treatment Period||20
179711|NCT00915876|433045|P2|NOT COMPLETED|Overall Study||1
179712|NCT00915876|433046|P1|NOT COMPLETED|Overall Study||0
179713|NCT00915876|433045|P2|COMPLETED|Overall Study||20
179714|NCT00915876|433046|P1|COMPLETED|Overall Study||20
179715|NCT00915876|433045|P2|Moving Beyond First Dose|Overall Study||20
179716|NCT00915876|433046|P1|Moving Beyond First Dose|Overall Study||20
179717|NCT00915876|433045|P2|STARTED|Overall Study||21
179718|NCT00915876|433046|P1|STARTED|Overall Study||20
179719|NCT00915798|433056|P4|NOT COMPLETED|Overall Study||0
179720|NCT00915798|433057|P3|NOT COMPLETED|Overall Study||0
179721|NCT00915798|433058|P2|NOT COMPLETED|Overall Study||0
179722|NCT00915798|433059|P1|NOT COMPLETED|Overall Study||0
179723|NCT00915798|433056|P4|COMPLETED|Overall Study||26
179724|NCT00915798|433057|P3|COMPLETED|Overall Study||23
179725|NCT00915798|433058|P2|COMPLETED|Overall Study||21
179726|NCT00915798|433059|P1|COMPLETED|Overall Study||19
179727|NCT00915798|433056|P4|STARTED|Overall Study||26
179728|NCT00915798|433057|P3|STARTED|Overall Study||23
179729|NCT00915798|433058|P2|STARTED|Overall Study||21
179730|NCT00915798|433059|P1|STARTED|Overall Study||19
179731|NCT00915772|433082|P3|NOT COMPLETED|Overall Study||29
179732|NCT00915772|433083|P2|NOT COMPLETED|Overall Study||46
179733|NCT00915772|433084|P1|NOT COMPLETED|Overall Study||36
179734|NCT00915772|433082|P3|COMPLETED|Overall Study||142
179735|NCT00915772|433083|P2|COMPLETED|Overall Study||179
179736|NCT00915772|433084|P1|COMPLETED|Overall Study||134
179737|NCT00915772|433082|P3|STARTED|Overall Study||171
179738|NCT00915772|433083|P2|STARTED|Overall Study||225
179739|NCT00915772|433084|P1|STARTED|Overall Study||170
179740|NCT00915759|433129|P1|NOT COMPLETED|Overall Study||0
179741|NCT00915759|433129|P1|COMPLETED|Overall Study|number of participants|40
179742|NCT00915759|433129|P1|STARTED|Overall Study|number of participants|40
179743|NCT00915655|433139|P1|NOT COMPLETED|Overall Study||0
179744|NCT00915655|433139|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
179745|NCT00915655|433139|P1|STARTED|Overall Study||12
179746|NCT00915603|433146|P2|NOT COMPLETED|Overall Study||55
179747|NCT00915603|433147|P1|NOT COMPLETED|Overall Study||56
179748|NCT00915603|433146|P2|COMPLETED|Overall Study||0
179749|NCT00915603|433147|P1|COMPLETED|Overall Study||0
179750|NCT00915603|433146|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
179751|NCT00915603|433147|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
179752|NCT00915590|433163|P2|NOT COMPLETED|Overall Study||1
179753|NCT00915590|433164|P1|NOT COMPLETED|Overall Study||2
179754|NCT00915590|433163|P2|COMPLETED|Overall Study||4
179755|NCT00915590|433164|P1|COMPLETED|Overall Study||3
179756|NCT00915590|433163|P2|STARTED|Overall Study||5
179757|NCT00915590|433164|P1|STARTED|Overall Study||5
179758|NCT00915551|433183|P2|NOT COMPLETED|Overall Study||1
179759|NCT00915551|433184|P1|NOT COMPLETED|Overall Study||0
179760|NCT00915551|433183|P2|COMPLETED|Overall Study||135
179761|NCT00915551|433184|P1|COMPLETED|Overall Study||142
179762|NCT00915551|433183|P2|STARTED|Overall Study||136
179763|NCT00915551|433184|P1|STARTED|Overall Study||142
179764|NCT00915525|433194|P2|NOT COMPLETED|Overall Study||135
179765|NCT00915525|433195|P1|NOT COMPLETED|Overall Study||265
179766|NCT00915525|433194|P2|COMPLETED|Overall Study||151
179767|NCT00915525|433195|P1|COMPLETED|Overall Study||278
179768|NCT00915525|433194|P2|STARTED|Overall Study||286
179769|NCT00915525|433195|P1|STARTED|Overall Study||543
179770|NCT00915499|433298|P2|NOT COMPLETED|Overall Study||2
179771|NCT00915499|433299|P1|NOT COMPLETED|Overall Study||4
179772|NCT00915499|433298|P2|COMPLETED|Overall Study||31
179773|NCT00915499|433299|P1|COMPLETED|Overall Study||29
179774|NCT00915499|433298|P2|STARTED|Overall Study||33
179775|NCT00915499|433299|P1|STARTED|Overall Study||33
179776|NCT00915473|433309|P2|NOT COMPLETED|4-week Follow Up||5
179777|NCT00915473|433310|P1|NOT COMPLETED|4-week Follow Up||1
179778|NCT00915473|433309|P2|COMPLETED|4-week Follow Up||30
179779|NCT00915473|433310|P1|COMPLETED|4-week Follow Up||33
179780|NCT00915473|433309|P2|STARTED|4-week Follow Up||35
179781|NCT00915473|433310|P1|STARTED|4-week Follow Up||34
179782|NCT00915473|433309|P2|NOT COMPLETED|Injection||0
179783|NCT00915473|433310|P1|NOT COMPLETED|Injection||0
179784|NCT00915473|433309|P2|COMPLETED|Injection||35
179785|NCT00915473|433310|P1|COMPLETED|Injection||34
179786|NCT00915473|433309|P2|STARTED|Injection||35
179787|NCT00915473|433310|P1|STARTED|Injection||34
179788|NCT00915473|433309|P2|NOT COMPLETED|Screening||0
179789|NCT00915473|433310|P1|NOT COMPLETED|Screening||1
179790|NCT00915473|433309|P2|COMPLETED|Screening||35
179791|NCT00915473|433310|P1|COMPLETED|Screening||34
179792|NCT00915473|433309|P2|STARTED|Screening||35
179793|NCT00915473|433310|P1|STARTED|Screening||35
179794|NCT00915356|433327|P5|NOT COMPLETED|Overall Study||0
179795|NCT00915356|433328|P4|NOT COMPLETED|Overall Study||0
179796|NCT00915356|433329|P3|NOT COMPLETED|Overall Study||0
179797|NCT00915356|433330|P2|NOT COMPLETED|Overall Study||0
179798|NCT00915356|433331|P1|NOT COMPLETED|Overall Study||1
179799|NCT00915356|433327|P5|COMPLETED|Overall Study||43
179800|NCT00915356|433328|P4|COMPLETED|Overall Study||12
179801|NCT00915356|433329|P3|COMPLETED|Overall Study||45
179802|NCT00915356|433330|P2|COMPLETED|Overall Study||45
179803|NCT00915356|433331|P1|COMPLETED|Overall Study||25
179804|NCT00915356|433327|P5|STARTED|Overall Study||43
179805|NCT00915356|433328|P4|STARTED|Overall Study||12
179806|NCT00915356|433329|P3|STARTED|Overall Study||45
179807|NCT00915356|433330|P2|STARTED|Overall Study||45
179808|NCT00915356|433331|P1|STARTED|Overall Study||26
179809|NCT00915343|433393|P3|NOT COMPLETED|Part B - Open Label Period||2
179810|NCT00915343|433394|P2|NOT COMPLETED|Part B - Open Label Period||0
179811|NCT00915343|433395|P1|NOT COMPLETED|Part B - Open Label Period||0
179812|NCT00915343|433393|P3|COMPLETED|Part B - Open Label Period||57
179813|NCT00915343|433394|P2|COMPLETED|Part B - Open Label Period||0
179814|NCT00915343|433395|P1|COMPLETED|Part B - Open Label Period||0
179815|NCT00915343|433393|P3|STARTED|Part B - Open Label Period||59
179816|NCT00915343|433394|P2|STARTED|Part B - Open Label Period||0
179817|NCT00915343|433395|P1|STARTED|Part B - Open Label Period||0
179818|NCT00915343|433393|P3|NOT COMPLETED|Part A - Second Intervention Period||0
179819|NCT00915343|433394|P2|NOT COMPLETED|Part A - Second Intervention Period||0
179820|NCT00915343|433395|P1|NOT COMPLETED|Part A - Second Intervention Period||0
179821|NCT00915343|433393|P3|COMPLETED|Part A - Second Intervention Period||0
179822|NCT00915343|433394|P2|COMPLETED|Part A - Second Intervention Period||32
179823|NCT00915343|433395|P1|COMPLETED|Part A - Second Intervention Period||32
179824|NCT00915343|433393|P3|STARTED|Part A - Second Intervention Period||0
179825|NCT00915343|433394|P2|STARTED|Part A - Second Intervention Period||32
179826|NCT00915343|433395|P1|STARTED|Part A - Second Intervention Period||32
179827|NCT00915343|433393|P3|NOT COMPLETED|Part A - First Intervention Period||0
179828|NCT00915343|433394|P2|NOT COMPLETED|Part A - First Intervention Period||0
179829|NCT00915343|433395|P1|NOT COMPLETED|Part A - First Intervention Period||0
179830|NCT00915343|433393|P3|COMPLETED|Part A - First Intervention Period||0
179831|NCT00915343|433394|P2|COMPLETED|Part A - First Intervention Period||32
179832|NCT00915343|433395|P1|COMPLETED|Part A - First Intervention Period||32
179833|NCT00915343|433393|P3|STARTED|Part A - First Intervention Period||0
179834|NCT00915343|433394|P2|STARTED|Part A - First Intervention Period||32
179835|NCT00915343|433395|P1|STARTED|Part A - First Intervention Period||32
179836|NCT00915278|433480|P6|NOT COMPLETED|Overall Study||8
179837|NCT00915278|433481|P5|NOT COMPLETED|Overall Study||2
179838|NCT00915278|433482|P4|NOT COMPLETED|Overall Study||3
179839|NCT00915278|433483|P3|NOT COMPLETED|Overall Study||1
179840|NCT00915278|433484|P2|NOT COMPLETED|Overall Study||3
179841|NCT00915278|433485|P1|NOT COMPLETED|Overall Study||5
179842|NCT00915278|433480|P6|COMPLETED|Overall Study||1
179843|NCT00915278|433481|P5|COMPLETED|Overall Study||1
179844|NCT00915278|433482|P4|COMPLETED|Overall Study||2
179845|NCT00915278|433483|P3|COMPLETED|Overall Study||2
179846|NCT00915278|433484|P2|COMPLETED|Overall Study||2
179847|NCT00915278|433485|P1|COMPLETED|Overall Study||3
179848|NCT00915278|433480|P6|STARTED|Overall Study||9
179849|NCT00915278|433481|P5|STARTED|Overall Study||3
179850|NCT00915278|433482|P4|STARTED|Overall Study||5
179851|NCT00915278|433483|P3|STARTED|Overall Study||3
179852|NCT00915278|433484|P2|STARTED|Overall Study||5
179853|NCT00915278|433485|P1|STARTED|Overall Study||8
179854|NCT00915148|433631|P1|NOT COMPLETED|Overall Study||0
179855|NCT00915148|433631|P1|COMPLETED|Overall Study|August 2010|110
179856|NCT00915148|433631|P1|STARTED|Overall Study|October 2009|110
179857|NCT00915018|433638|P2|NOT COMPLETED|Overall Study||207
179858|NCT00915018|433639|P1|NOT COMPLETED|Overall Study||215
179859|NCT00915018|433638|P2|COMPLETED|Overall Study||30
179860|NCT00915018|433639|P1|COMPLETED|Overall Study||27
179861|NCT00915018|433638|P2|Received Treatment|Overall Study||234
179862|NCT00915018|433639|P1|Received Treatment|Overall Study||240
179863|NCT00915018|433638|P2|STARTED|Overall Study||237
179864|NCT00915018|433639|P1|STARTED|Overall Study||242
179865|NCT00914966|433653|P1|NOT COMPLETED|Step 3: 2500 Units||0
179866|NCT00914966|433653|P1|COMPLETED|Step 3: 2500 Units||12
179867|NCT00914966|433653|P1|STARTED|Step 3: 2500 Units||12
179868|NCT00914966|433653|P1|NOT COMPLETED|Step 2: 2000 Units||1
179869|NCT00914966|433653|P1|COMPLETED|Step 2: 2000 Units||12
179870|NCT00914966|433653|P1|STARTED|Step 2: 2000 Units||13
179871|NCT00914966|433653|P1|NOT COMPLETED|Step 1: 1500 Units||2
179872|NCT00914966|433653|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
179873|NCT00914966|433653|P1|STARTED|Step 1: 1500 Units||20
179874|NCT00914927|433672|P7|NOT COMPLETED|Overall Study||0
179875|NCT00914927|433673|P6|NOT COMPLETED|Overall Study||0
179876|NCT00914927|433674|P5|NOT COMPLETED|Overall Study||2
179877|NCT00914927|433675|P4|NOT COMPLETED|Overall Study||2
179878|NCT00914927|433676|P3|NOT COMPLETED|Overall Study||0
179879|NCT00914927|433677|P2|NOT COMPLETED|Overall Study||2
179880|NCT00914927|433678|P1|NOT COMPLETED|Overall Study||2
179881|NCT00914927|433672|P7|COMPLETED|Overall Study||21
179882|NCT00914927|433673|P6|COMPLETED|Overall Study||21
179883|NCT00914927|433674|P5|COMPLETED|Overall Study||19
179884|NCT00914927|433675|P4|COMPLETED|Overall Study||14
179885|NCT00914927|433676|P3|COMPLETED|Overall Study||17
179886|NCT00914927|433677|P2|COMPLETED|Overall Study||14
179887|NCT00914927|433678|P1|COMPLETED|Overall Study||16
179888|NCT00914927|433672|P7|STARTED|Overall Study||21
179889|NCT00914927|433673|P6|STARTED|Overall Study||21
179890|NCT00914927|433674|P5|STARTED|Overall Study||21
179891|NCT00914927|433675|P4|STARTED|Overall Study||16
179892|NCT00914927|433676|P3|STARTED|Overall Study||17
179893|NCT00914927|433677|P2|STARTED|Overall Study||16
179894|NCT00914927|433678|P1|STARTED|Overall Study||18
179895|NCT00914862|433727|P5|NOT COMPLETED|Overall Study||0
179896|NCT00914862|433728|P4|NOT COMPLETED|Overall Study||0
179897|NCT00914862|433729|P3|NOT COMPLETED|Overall Study||0
179898|NCT00914862|433730|P2|NOT COMPLETED|Overall Study||0
179899|NCT00914862|433731|P1|NOT COMPLETED|Overall Study||0
179900|NCT00914862|433727|P5|COMPLETED|Overall Study||28
179901|NCT00914862|433728|P4|COMPLETED|Overall Study||8
179902|NCT00914862|433729|P3|COMPLETED|Overall Study||8
179903|NCT00914862|433730|P2|COMPLETED|Overall Study||6
179904|NCT00914862|433731|P1|COMPLETED|Overall Study||6
179905|NCT00914862|433727|P5|STARTED|Overall Study||28
179906|NCT00914862|433728|P4|STARTED|Overall Study||8
179907|NCT00914862|433729|P3|STARTED|Overall Study||8
179908|NCT00914862|433730|P2|STARTED|Overall Study||6
179909|NCT00914862|433731|P1|STARTED|Overall Study||6
179910|NCT00914849|433805|P2|NOT COMPLETED|Overall Study||1
179911|NCT00914849|433806|P1|NOT COMPLETED|Overall Study||1
179912|NCT00914849|433805|P2|COMPLETED|Overall Study||33
179913|NCT00914849|433806|P1|COMPLETED|Overall Study||33
179914|NCT00914849|433805|P2|STARTED|Overall Study||34
179915|NCT00914849|433806|P1|STARTED|Overall Study||34
179916|NCT00914810|433840|P2|NOT COMPLETED|Overall Study||1
179917|NCT00914810|433841|P1|NOT COMPLETED|Overall Study||2
179918|NCT00914810|433840|P2|COMPLETED|Overall Study||18
179919|NCT00914810|433841|P1|COMPLETED|Overall Study||18
179920|NCT00914810|433840|P2|STARTED|Overall Study||19
179921|NCT00914810|433841|P1|STARTED|Overall Study||20
179922|NCT00914589|433852|P3|NOT COMPLETED|Overall Study||12
179923|NCT00914589|433853|P2|NOT COMPLETED|Overall Study||16
179924|NCT00914589|433854|P1|NOT COMPLETED|Overall Study||25
179925|NCT00914589|433852|P3|COMPLETED|Overall Study||126
179926|NCT00914589|433853|P2|COMPLETED|Overall Study||127
179927|NCT00914589|433854|P1|COMPLETED|Overall Study||103
179928|NCT00914589|433852|P3|STARTED|Overall Study||138
179929|NCT00914589|433853|P2|STARTED|Overall Study||143
179930|NCT00914589|433854|P1|STARTED|Overall Study||128
179931|NCT00914485|433874|P1|NOT COMPLETED|Overall Study||0
179932|NCT00914485|433874|P1|COMPLETED|Overall Study||369
179933|NCT00914485|433874|P1|STARTED|Overall Study||369
179934|NCT00914459|433880|P2|NOT COMPLETED|Overall Study||1
179935|NCT00914459|433881|P1|NOT COMPLETED|Overall Study||1
179936|NCT00914459|433880|P2|COMPLETED|Overall Study||18
179937|NCT00914459|433881|P1|COMPLETED|Overall Study||17
179938|NCT00914459|433880|P2|STARTED|Overall Study||19
179939|NCT00914459|433881|P1|STARTED|Overall Study||18
179940|NCT00914316|433911|P4|NOT COMPLETED|Phase 2||0
179941|NCT00914316|433912|P3|NOT COMPLETED|Phase 2||1
179942|NCT00914316|433913|P2|NOT COMPLETED|Phase 2||0
179943|NCT00914316|433914|P1|NOT COMPLETED|Phase 2||1
179944|NCT00914316|433911|P4|COMPLETED|Phase 2||6
179945|NCT00914316|433912|P3|COMPLETED|Phase 2||2
179946|NCT00914316|433913|P2|COMPLETED|Phase 2||4
179947|NCT00914316|433914|P1|COMPLETED|Phase 2||1
179948|NCT00914316|433911|P4|STARTED|Phase 2||6
179949|NCT00914316|433912|P3|STARTED|Phase 2||3
179950|NCT00914316|433913|P2|STARTED|Phase 2||4
179951|NCT00914316|433914|P1|STARTED|Phase 2||2
179952|NCT00914316|433911|P4|NOT COMPLETED|Phase 1||2
179953|NCT00914316|433912|P3|NOT COMPLETED|Phase 1||5
179954|NCT00914316|433913|P2|NOT COMPLETED|Phase 1||2
179955|NCT00914316|433914|P1|NOT COMPLETED|Phase 1||5
179956|NCT00914316|433911|P4|COMPLETED|Phase 1||6
179957|NCT00914316|433912|P3|COMPLETED|Phase 1||3
179958|NCT00914316|433913|P2|COMPLETED|Phase 1||4
179959|NCT00914316|433914|P1|COMPLETED|Phase 1||2
179960|NCT00914316|433911|P4|STARTED|Phase 1||8
179961|NCT00914316|433912|P3|STARTED|Phase 1||8
179962|NCT00914316|433913|P2|STARTED|Phase 1||6
179963|NCT00914316|433914|P1|STARTED|Phase 1||7
179964|NCT00914186|433932|P4|NOT COMPLETED|Overall Study||10
179965|NCT00914186|433933|P3|NOT COMPLETED|Overall Study||2
179966|NCT00914186|433934|P2|NOT COMPLETED|Overall Study||2
179967|NCT00914186|433935|P1|NOT COMPLETED|Overall Study||3
179968|NCT00914186|433932|P4|COMPLETED|Overall Study||20
179969|NCT00914186|433933|P3|COMPLETED|Overall Study||29
179970|NCT00914186|433934|P2|COMPLETED|Overall Study||28
179971|NCT00914186|433935|P1|COMPLETED|Overall Study||28
179972|NCT00914186|433932|P4|STARTED|Overall Study||30
179973|NCT00914186|433933|P3|STARTED|Overall Study||31
179974|NCT00914186|433934|P2|STARTED|Overall Study||30
179975|NCT00914186|433935|P1|STARTED|Overall Study||31
179976|NCT00914069|433969|P2|NOT COMPLETED|Overall Study||0
179977|NCT00914069|433970|P1|NOT COMPLETED|Overall Study||0
179978|NCT00914069|433969|P2|COMPLETED|Overall Study||88
179979|NCT00914069|433970|P1|COMPLETED|Overall Study||84
179980|NCT00914069|433969|P2|STARTED|Overall Study||88
179981|NCT00914069|433970|P1|STARTED|Overall Study||84
179982|NCT00913913|433984|P1|NOT COMPLETED|Overall Study||8
179983|NCT00913913|433984|P1|COMPLETED|Overall Study||0
179984|NCT00913913|433984|P1|STARTED|Overall Study||8
179985|NCT00913835|433993|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
179986|NCT00913835|433994|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
179987|NCT00913835|433993|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
179988|NCT00913835|433994|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
179989|NCT00913835|433993|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
179990|NCT00913835|433994|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
179991|NCT00913835|433993|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
179992|NCT00913835|433994|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
179993|NCT00913835|433993|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
179994|NCT00913835|433994|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
179995|NCT00913835|433993|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
179996|NCT00913835|433994|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
179997|NCT00913835|433993|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
179998|NCT00913835|433994|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
179999|NCT00913835|433993|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
180000|NCT00913835|433994|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
180001|NCT00913770|434033|P3|NOT COMPLETED|Overall Study||21
180002|NCT00913770|434034|P2|NOT COMPLETED|Overall Study||29
180003|NCT00913770|434035|P1|NOT COMPLETED|Overall Study||35
180004|NCT00913770|434033|P3|COMPLETED|Overall Study||93
180005|NCT00913770|434034|P2|COMPLETED|Overall Study||82
180006|NCT00913770|434035|P1|COMPLETED|Overall Study||69
180007|NCT00913770|434033|P3|STARTED|Overall Study||114
180008|NCT00913770|434034|P2|STARTED|Overall Study||111
180009|NCT00913770|434035|P1|STARTED|Overall Study||104
180010|NCT00913744|434048|P2|NOT COMPLETED|Overall Study||1
180011|NCT00913744|434049|P1|NOT COMPLETED|Overall Study||5
180012|NCT00913744|434048|P2|COMPLETED|Overall Study||24
180013|NCT00913744|434049|P1|COMPLETED|Overall Study||70
180014|NCT00913744|434048|P2|STARTED|Overall Study||25
180015|NCT00913744|434049|P1|STARTED|Overall Study||75
180016|NCT00913692|434055|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
180017|NCT00913692|434055|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
180018|NCT00913692|434055|P1|STARTED|Treatment Phase 2 (5 Months)||1
180019|NCT00913692|434055|P1|NOT COMPLETED|Washout (2 Weeks)||0
180020|NCT00913692|434055|P1|COMPLETED|Washout (2 Weeks)||1
180021|NCT00913692|434055|P1|STARTED|Washout (2 Weeks)||1
180022|NCT00913692|434055|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
180023|NCT00913692|434055|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
180024|NCT00913692|434055|P1|STARTED|Treatment Phase 1 (5 Months)||2
180025|NCT00913692|434055|P1|NOT COMPLETED|Screening (4 Months)||9
180026|NCT00913692|434055|P1|COMPLETED|Screening (4 Months)||2
180027|NCT00913692|434055|P1|STARTED|Screening (4 Months)||11
180028|NCT00913627|434069|P4|NOT COMPLETED|Overall Study||0
180029|NCT00913627|434070|P3|NOT COMPLETED|Overall Study||0
180030|NCT00913627|434071|P2|NOT COMPLETED|Overall Study||0
180031|NCT00913627|434072|P1|NOT COMPLETED|Overall Study||0
180032|NCT00913627|434069|P4|COMPLETED|Overall Study||58
180033|NCT00913627|434070|P3|COMPLETED|Overall Study||56
180034|NCT00913627|434071|P2|COMPLETED|Overall Study||53
180035|NCT00913627|434072|P1|COMPLETED|Overall Study||29
180036|NCT00913627|434069|P4|STARTED|Overall Study||58
180037|NCT00913627|434070|P3|STARTED|Overall Study||56
180038|NCT00913627|434071|P2|STARTED|Overall Study||53
180039|NCT00913627|434072|P1|STARTED|Overall Study||29
180040|NCT00913523|434149|P3|NOT COMPLETED|Overall Study||14
180041|NCT00913523|434150|P2|NOT COMPLETED|Overall Study||16
180042|NCT00913523|434151|P1|NOT COMPLETED|Overall Study||18
180043|NCT00913523|434149|P3|COMPLETED|Overall Study||147
180044|NCT00913523|434150|P2|COMPLETED|Overall Study||143
180045|NCT00913523|434151|P1|COMPLETED|Overall Study||144
180046|NCT00913523|434149|P3|STARTED|Overall Study||161
180047|NCT00913523|434150|P2|STARTED|Overall Study||159
180048|NCT00913523|434151|P1|STARTED|Overall Study||162
180049|NCT00913510|434176|P2|NOT COMPLETED|Overall Study||4
180050|NCT00913510|434177|P1|NOT COMPLETED|Overall Study||8
180051|NCT00913510|434176|P2|COMPLETED|Overall Study||3
180052|NCT00913510|434177|P1|COMPLETED|Overall Study||5
180053|NCT00913510|434176|P2|STARTED|Overall Study||7
180054|NCT00913510|434177|P1|STARTED|Overall Study||13
180055|NCT00913458|434183|P7|NOT COMPLETED|Phase 3||8
180056|NCT00913458|434184|P6|NOT COMPLETED|Phase 3||18
180057|NCT00913458|434185|P5|NOT COMPLETED|Phase 3||22
180058|NCT00913458|434186|P4|NOT COMPLETED|Phase 3||0
180059|NCT00913458|434187|P3|NOT COMPLETED|Phase 3||0
180060|NCT00913458|434188|P2|NOT COMPLETED|Phase 3||0
180061|NCT00913458|434189|P1|NOT COMPLETED|Phase 3||0
180062|NCT00913458|434183|P7|COMPLETED|Phase 3||24
180063|NCT00913458|434184|P6|COMPLETED|Phase 3||28
180064|NCT00913458|434185|P5|COMPLETED|Phase 3||31
180065|NCT00913458|434186|P4|COMPLETED|Phase 3||0
180066|NCT00913458|434187|P3|COMPLETED|Phase 3||0
180067|NCT00913458|434188|P2|COMPLETED|Phase 3||0
180068|NCT00913458|434189|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
180069|NCT00913458|434183|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
180070|NCT00913458|434184|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
180071|NCT00913458|434185|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
180072|NCT00913458|434186|P4|STARTED|Phase 3||0
180073|NCT00913458|434187|P3|STARTED|Phase 3||0
180074|NCT00913458|434188|P2|STARTED|Phase 3||0
180075|NCT00913458|434189|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
180076|NCT00913458|434183|P7|NOT COMPLETED|Phase 2||0
180077|NCT00913458|434184|P6|NOT COMPLETED|Phase 2||0
180078|NCT00913458|434185|P5|NOT COMPLETED|Phase 2||0
180079|NCT00913458|434186|P4|NOT COMPLETED|Phase 2||33
180080|NCT00913458|434187|P3|NOT COMPLETED|Phase 2||19
180081|NCT00913458|434188|P2|NOT COMPLETED|Phase 2||10
180082|NCT00913458|434189|P1|NOT COMPLETED|Phase 2||0
180083|NCT00913458|434183|P7|COMPLETED|Phase 2||0
180084|NCT00913458|434184|P6|COMPLETED|Phase 2||0
180085|NCT00913458|434185|P5|COMPLETED|Phase 2||0
180086|NCT00913458|434186|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
180087|NCT00913458|434187|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
180088|NCT00913458|434188|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
180089|NCT00913458|434189|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
180090|NCT00913458|434183|P7|STARTED|Phase 2||0
180091|NCT00913458|434184|P6|STARTED|Phase 2||0
180092|NCT00913458|434185|P5|STARTED|Phase 2||0
180093|NCT00913458|434186|P4|STARTED|Phase 2||65
180094|NCT00913458|434187|P3|STARTED|Phase 2||65
180095|NCT00913458|434188|P2|STARTED|Phase 2||63
180096|NCT00913458|434189|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
180097|NCT00913458|434183|P7|NOT COMPLETED|Phase 1||0
180098|NCT00913458|434184|P6|NOT COMPLETED|Phase 1||0
180099|NCT00913458|434185|P5|NOT COMPLETED|Phase 1||0
180100|NCT00913458|434186|P4|NOT COMPLETED|Phase 1||0
180101|NCT00913458|434187|P3|NOT COMPLETED|Phase 1||0
180102|NCT00913458|434188|P2|NOT COMPLETED|Phase 1||0
180103|NCT00913458|434189|P1|NOT COMPLETED|Phase 1||112
180104|NCT00913458|434183|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
180105|NCT00913458|434184|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
180106|NCT00913458|434185|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
180107|NCT00913458|434186|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
180108|NCT00913458|434187|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
180109|NCT00913458|434188|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
180110|NCT00913458|434189|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
180111|NCT00913458|434183|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
180112|NCT00913458|434184|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
180113|NCT00913458|434185|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
180114|NCT00913458|434186|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
180115|NCT00913458|434187|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
180116|NCT00913458|434188|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
180117|NCT00913458|434189|P1|STARTED|Phase 1||306
180118|NCT00913380|434282|P2|NOT COMPLETED|Clinical Outcomes||6
180119|NCT00913380|434283|P1|NOT COMPLETED|Clinical Outcomes||6
180120|NCT00913380|434282|P2|COMPLETED|Clinical Outcomes||441
180121|NCT00913380|434283|P1|COMPLETED|Clinical Outcomes||438
180122|NCT00913380|434282|P2|STARTED|Clinical Outcomes||447
180123|NCT00913380|434283|P1|STARTED|Clinical Outcomes||444
180124|NCT00913380|434282|P2|NOT COMPLETED|CT Examination||0
180125|NCT00913380|434283|P1|NOT COMPLETED|CT Examination||0
180126|NCT00913380|434282|P2|COMPLETED|CT Examination||447
180127|NCT00913380|434283|P1|COMPLETED|CT Examination||444
180128|NCT00913380|434282|P2|STARTED|CT Examination||447
180129|NCT00913380|434283|P1|STARTED|CT Examination||444
180130|NCT00913263|434309|P1|NOT COMPLETED|Overall Study||0
180131|NCT00913263|434309|P1|COMPLETED|Overall Study||24
180132|NCT00913263|434309|P1|STARTED|Overall Study||24
180133|NCT00913133|434318|P1|NOT COMPLETED|Overall Study||0
180134|NCT00913133|434318|P1|COMPLETED|Overall Study||516
180135|NCT00913133|434318|P1|STARTED|Overall Study||516
180136|NCT00913081|434323|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
180137|NCT00913081|434323|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
180138|NCT00913081|434323|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
180139|NCT00913081|434323|P1|NOT COMPLETED|Washout #3 (7days)||0
180140|NCT00913081|434323|P1|COMPLETED|Washout #3 (7days)||17
180141|NCT00913081|434323|P1|STARTED|Washout #3 (7days)||17
180142|NCT00913081|434323|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
180143|NCT00913081|434323|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
180144|NCT00913081|434323|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
180145|NCT00913081|434323|P1|NOT COMPLETED|Washout #2 (7 Days)||0
180146|NCT00913081|434323|P1|COMPLETED|Washout #2 (7 Days)||17
180147|NCT00913081|434323|P1|STARTED|Washout #2 (7 Days)||17
180148|NCT00913081|434323|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
180149|NCT00913081|434323|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
180150|NCT00913081|434323|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
180151|NCT00913081|434323|P1|NOT COMPLETED|Washout #1 (7 Days)||0
180152|NCT00913081|434323|P1|COMPLETED|Washout #1 (7 Days)||17
180153|NCT00913081|434323|P1|STARTED|Washout #1 (7 Days)||17
180154|NCT00913081|434323|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
180155|NCT00913081|434323|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
180156|NCT00913081|434323|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
180157|NCT00913003|434335|P2|NOT COMPLETED|Overall Study||0
180158|NCT00913003|434336|P1|NOT COMPLETED|Overall Study||0
180159|NCT00913003|434335|P2|COMPLETED|Overall Study||11
180160|NCT00913003|434336|P1|COMPLETED|Overall Study||11
180161|NCT00913003|434335|P2|STARTED|Overall Study||11
180162|NCT00913003|434336|P1|STARTED|Overall Study||11
180163|NCT00912964|434349|P3|NOT COMPLETED|Overall Study||54
180164|NCT00912964|434350|P2|NOT COMPLETED|Overall Study||46
180165|NCT00912964|434351|P1|NOT COMPLETED|Overall Study||66
180166|NCT00912964|434349|P3|COMPLETED|Overall Study||386
180167|NCT00912964|434350|P2|COMPLETED|Overall Study||387
180168|NCT00912964|434351|P1|COMPLETED|Overall Study||367
180169|NCT00912964|434349|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
180170|NCT00912964|434350|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
180171|NCT00912964|434351|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
180172|NCT00912964|434349|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
180173|NCT00912964|434350|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
180174|NCT00912964|434351|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
180175|NCT00912964|434349|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
180176|NCT00912964|434350|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
180177|NCT00912964|434351|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
180178|NCT00912964|434349|P3|STARTED|Overall Study||440
180179|NCT00912964|434350|P2|STARTED|Overall Study||433
180180|NCT00912964|434351|P1|STARTED|Overall Study||433
180181|NCT00912925|434475|P2|NOT COMPLETED|Overall Study||0
180182|NCT00912925|434476|P1|NOT COMPLETED|Overall Study||0
180183|NCT00912925|434475|P2|COMPLETED|Overall Study||22
180184|NCT00912925|434476|P1|COMPLETED|Overall Study||23
180185|NCT00912925|434475|P2|STARTED|Overall Study||22
180186|NCT00912925|434476|P1|STARTED|Overall Study||23
180187|NCT00912912|434494|P1|NOT COMPLETED|Overall Study||4
180188|NCT00912912|434494|P1|COMPLETED|Overall Study||1
180189|NCT00912912|434494|P1|STARTED|Overall Study||5
180190|NCT00912808|434500|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
180191|NCT00912808|434501|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
180192|NCT00912808|434500|P2|COMPLETED|Second Intervention (6 Weeks)||9
180193|NCT00912808|434501|P1|COMPLETED|Second Intervention (6 Weeks)||8
180194|NCT00912808|434500|P2|Received Intervention|Second Intervention (6 Weeks)||10
180195|NCT00912808|434501|P1|Received Intervention|Second Intervention (6 Weeks)||9
180196|NCT00912808|434500|P2|STARTED|Second Intervention (6 Weeks)||10
180197|NCT00912808|434501|P1|STARTED|Second Intervention (6 Weeks)||9
180198|NCT00912808|434500|P2|NOT COMPLETED|Washout||1
180199|NCT00912808|434501|P1|NOT COMPLETED|Washout||0
180200|NCT00912808|434500|P2|COMPLETED|Washout||10
180201|NCT00912808|434501|P1|COMPLETED|Washout||9
180202|NCT00912808|434500|P2|STARTED|Washout||11
180203|NCT00912808|434501|P1|STARTED|Washout||9
180204|NCT00912808|434500|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
180205|NCT00912808|434501|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
180206|NCT00912808|434500|P2|COMPLETED|First Intervention (6 Weeks)||11
180207|NCT00912808|434501|P1|COMPLETED|First Intervention (6 Weeks)||9
180208|NCT00912808|434500|P2|Received Intervention|First Intervention (6 Weeks)||12
180209|NCT00912808|434501|P1|Received Intervention|First Intervention (6 Weeks)||11
180210|NCT00912808|434500|P2|STARTED|First Intervention (6 Weeks)||12
180211|NCT00912808|434501|P1|STARTED|First Intervention (6 Weeks)||11
180212|NCT00912795|434511|P2|NOT COMPLETED|Overall Study||58
180213|NCT00912795|434512|P1|NOT COMPLETED|Overall Study||47
180214|NCT00912795|434511|P2|COMPLETED|Overall Study||17
180215|NCT00912795|434512|P1|COMPLETED|Overall Study||29
180216|NCT00912795|434511|P2|STARTED|Overall Study||75
180217|NCT00912795|434512|P1|STARTED|Overall Study||76
180218|NCT00912782|434526|P2|NOT COMPLETED|Overall Study||5
180219|NCT00912782|434527|P1|NOT COMPLETED|Overall Study||3
180220|NCT00912782|434526|P2|COMPLETED|Overall Study||20
180221|NCT00912782|434527|P1|COMPLETED|Overall Study||24
180222|NCT00912782|434526|P2|STARTED|Overall Study||25
180223|NCT00912782|434527|P1|STARTED|Overall Study||27
180224|NCT00912743|434537|P2|NOT COMPLETED|Overall Study||20
180225|NCT00912743|434538|P1|NOT COMPLETED|Overall Study||13
180226|NCT00912743|434537|P2|COMPLETED|Overall Study||0
180227|NCT00912743|434538|P1|COMPLETED|Overall Study||0
180228|NCT00912743|434537|P2|STARTED|Overall Study||20
180229|NCT00912743|434538|P1|STARTED|Overall Study||13
180230|NCT00912509|434550|P2|NOT COMPLETED|Overall Study||3
180231|NCT00912509|434551|P1|NOT COMPLETED|Overall Study||5
180232|NCT00912509|434550|P2|COMPLETED|Overall Study||7
180233|NCT00912509|434551|P1|COMPLETED|Overall Study||15
180234|NCT00912509|434550|P2|STARTED|Overall Study||10
180235|NCT00912509|434551|P1|STARTED|Overall Study||20
180236|NCT00912405|434559|P1|NOT COMPLETED|Overall Study||5
180237|NCT00912405|434559|P1|COMPLETED|Overall Study||45
180238|NCT00912405|434559|P1|STARTED|Overall Study||50
180239|NCT00912301|434569|P3|NOT COMPLETED|Overall Study||0
180240|NCT00912301|434570|P2|NOT COMPLETED|Overall Study||0
180241|NCT00912301|434571|P1|NOT COMPLETED|Overall Study||0
180242|NCT00912301|434569|P3|COMPLETED|Overall Study||13
180243|NCT00912301|434570|P2|COMPLETED|Overall Study||12
180244|NCT00912301|434571|P1|COMPLETED|Overall Study||11
180245|NCT00912301|434569|P3|STARTED|Overall Study||13
180246|NCT00912301|434570|P2|STARTED|Overall Study||12
180247|NCT00912301|434571|P1|STARTED|Overall Study||11
180248|NCT00912288|434593|P2|NOT COMPLETED|Overall Study||40
180249|NCT00912288|434594|P1|NOT COMPLETED|Overall Study||41
180250|NCT00912288|434593|P2|COMPLETED|Overall Study||2
180251|NCT00912288|434594|P1|COMPLETED|Overall Study||3
180252|NCT00912288|434593|P2|STARTED|Overall Study||42
180253|NCT00912288|434594|P1|STARTED|Overall Study||44
180254|NCT00912223|434616|P1|NOT COMPLETED|Overall Study||3
180255|NCT00912223|434616|P1|COMPLETED|Overall Study||62
180256|NCT00912223|434616|P1|STARTED|Overall Study||65
180257|NCT00912158|434635|P3|NOT COMPLETED|Overall Study||0
180258|NCT00912158|434636|P2|NOT COMPLETED|Overall Study||0
180259|NCT00912158|434637|P1|NOT COMPLETED|Overall Study||0
180260|NCT00912158|434635|P3|COMPLETED|Overall Study||41
180261|NCT00912158|434636|P2|COMPLETED|Overall Study||44
180262|NCT00912158|434637|P1|COMPLETED|Overall Study||44
180263|NCT00912158|434635|P3|STARTED|Overall Study||41
180264|NCT00912158|434636|P2|STARTED|Overall Study||44
180265|NCT00912158|434637|P1|STARTED|Overall Study||44
180266|NCT00912093|434647|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
180267|NCT00912093|434648|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
180268|NCT00912093|434649|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
180269|NCT00912093|434650|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
180270|NCT00912093|434651|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
180271|NCT00912093|434647|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
180272|NCT00912093|434648|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
180273|NCT00912093|434649|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
180274|NCT00912093|434650|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
180275|NCT00912093|434651|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
180276|NCT00912093|434647|P5|STARTED|The Open Label Extension (OLE) Phase||4
180277|NCT00912093|434648|P4|STARTED|The Open Label Extension (OLE) Phase||2
180278|NCT00912093|434649|P3|STARTED|The Open Label Extension (OLE) Phase||3
180279|NCT00912093|434650|P2|STARTED|The Open Label Extension (OLE) Phase||35
180280|NCT00912093|434651|P1|STARTED|The Open Label Extension (OLE) Phase||38
180281|NCT00912093|434647|P5|NOT COMPLETED|The Controlled Phase||1
180282|NCT00912093|434648|P4|NOT COMPLETED|The Controlled Phase||0
180283|NCT00912093|434649|P3|NOT COMPLETED|The Controlled Phase||0
180284|NCT00912093|434650|P2|NOT COMPLETED|The Controlled Phase||2
180285|NCT00912093|434651|P1|NOT COMPLETED|The Controlled Phase||0
180286|NCT00912093|434647|P5|COMPLETED|The Controlled Phase||4
180287|NCT00912093|434648|P4|COMPLETED|The Controlled Phase||2
180288|NCT00912093|434649|P3|COMPLETED|The Controlled Phase||3
180289|NCT00912093|434650|P2|COMPLETED|The Controlled Phase||43
180290|NCT00912093|434651|P1|COMPLETED|The Controlled Phase||43
180291|NCT00912093|434647|P5|STARTED|The Controlled Phase||5
180292|NCT00912093|434648|P4|STARTED|The Controlled Phase||2
180293|NCT00912093|434649|P3|STARTED|The Controlled Phase||3
180294|NCT00912093|434650|P2|STARTED|The Controlled Phase||45
180295|NCT00912093|434651|P1|STARTED|The Controlled Phase||43
180296|NCT00912028|434670|P5|NOT COMPLETED|Overall Study||3
180297|NCT00912028|434671|P4|NOT COMPLETED|Overall Study||1
180298|NCT00912028|434672|P3|NOT COMPLETED|Overall Study||0
180299|NCT00912028|434673|P2|NOT COMPLETED|Overall Study||3
180300|NCT00912028|434674|P1|NOT COMPLETED|Overall Study||5
180301|NCT00912028|434670|P5|COMPLETED|Overall Study||0
180302|NCT00912028|434671|P4|COMPLETED|Overall Study||16
180303|NCT00912028|434672|P3|COMPLETED|Overall Study||13
180304|NCT00912028|434673|P2|COMPLETED|Overall Study||0
180305|NCT00912028|434674|P1|COMPLETED|Overall Study||30
180306|NCT00912028|434670|P5|STARTED|Overall Study||3
180307|NCT00912028|434671|P4|STARTED|Overall Study||17
180308|NCT00912028|434672|P3|STARTED|Overall Study||13
180309|NCT00912028|434673|P2|STARTED|Overall Study||3
180310|NCT00912028|434674|P1|STARTED|Overall Study||35
180311|NCT00912015|434703|P4|NOT COMPLETED|Overall Study||2
180312|NCT00912015|434704|P3|NOT COMPLETED|Overall Study||3
180313|NCT00912015|434705|P2|NOT COMPLETED|Overall Study||8
180314|NCT00912015|434706|P1|NOT COMPLETED|Overall Study||16
180315|NCT00912015|434703|P4|COMPLETED|Overall Study||0
180316|NCT00912015|434704|P3|COMPLETED|Overall Study||22
180317|NCT00912015|434705|P2|COMPLETED|Overall Study||62
180318|NCT00912015|434706|P1|COMPLETED|Overall Study||125
180319|NCT00912015|434703|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
180320|NCT00912015|434704|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
180321|NCT00912015|434705|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
180322|NCT00912015|434706|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
180323|NCT00912002|434716|P1|NOT COMPLETED|Overall Study||0
180324|NCT00912002|434716|P1|COMPLETED|Overall Study||6
180325|NCT00912002|434716|P1|STARTED|Overall Study||6
180326|NCT00911989|434722|P1|NOT COMPLETED|Overall Study||1
180327|NCT00911989|434722|P1|COMPLETED|Overall Study||3
180328|NCT00911989|434722|P1|STARTED|Overall Study||4
180329|NCT00911937|434728|P2|NOT COMPLETED|Overall Study||95
180330|NCT00911937|434729|P1|NOT COMPLETED|Overall Study||87
180331|NCT00911937|434728|P2|COMPLETED|Overall Study||381
180332|NCT00911937|434729|P1|COMPLETED|Overall Study||400
180333|NCT00911937|434728|P2|Treated|Overall Study||463
180334|NCT00911937|434729|P1|Treated|Overall Study||474
180335|NCT00911937|434728|P2|STARTED|Overall Study||476
180336|NCT00911937|434729|P1|STARTED|Overall Study||487
180337|NCT00911898|434789|P1|NOT COMPLETED|Overall Study||0
180338|NCT00911898|434789|P1|COMPLETED|Overall Study||20
180339|NCT00911898|434789|P1|STARTED|Overall Study||20
180340|NCT00911859|434796|P3|NOT COMPLETED|Follow-up Period||41
180341|NCT00911859|434797|P2|NOT COMPLETED|Follow-up Period||46
180342|NCT00911859|434798|P1|NOT COMPLETED|Follow-up Period||11
180343|NCT00911859|434796|P3|COMPLETED|Follow-up Period||11
180344|NCT00911859|434797|P2|COMPLETED|Follow-up Period||7
180345|NCT00911859|434798|P1|COMPLETED|Follow-up Period||1
180346|NCT00911859|434796|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
180347|NCT00911859|434797|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
180348|NCT00911859|434798|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
180349|NCT00911859|434796|P3|NOT COMPLETED|Maintainance Period||21
180350|NCT00911859|434797|P2|NOT COMPLETED|Maintainance Period||0
180351|NCT00911859|434798|P1|NOT COMPLETED|Maintainance Period||0
180352|NCT00911859|434796|P3|COMPLETED|Maintainance Period||0
180353|NCT00911859|434797|P2|COMPLETED|Maintainance Period||0
180354|NCT00911859|434798|P1|COMPLETED|Maintainance Period||0
180355|NCT00911859|434796|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
180356|NCT00911859|434797|P2|STARTED|Maintainance Period||0
180357|NCT00911859|434798|P1|STARTED|Maintainance Period||0
180358|NCT00911859|434796|P3|NOT COMPLETED|Treatment Period||25
180359|NCT00911859|434797|P2|NOT COMPLETED|Treatment Period||21
180360|NCT00911859|434798|P1|NOT COMPLETED|Treatment Period||8
180361|NCT00911859|434796|P3|COMPLETED|Treatment Period||27
180362|NCT00911859|434797|P2|COMPLETED|Treatment Period||33
180363|NCT00911859|434798|P1|COMPLETED|Treatment Period||4
180364|NCT00911859|434796|P3|Received Treatment|Treatment Period||52
180365|NCT00911859|434797|P2|Received Treatment|Treatment Period||53
180366|NCT00911859|434798|P1|Received Treatment|Treatment Period||12
180367|NCT00911859|434796|P3|STARTED|Treatment Period||52
180368|NCT00911859|434797|P2|STARTED|Treatment Period||54
180369|NCT00911859|434798|P1|STARTED|Treatment Period||12
180370|NCT00911820|434824|P2|NOT COMPLETED|Overall Study||43
180371|NCT00911820|434825|P1|NOT COMPLETED|Overall Study||45
180372|NCT00911820|434824|P2|COMPLETED|Overall Study||0
180373|NCT00911820|434825|P1|COMPLETED|Overall Study||0
180374|NCT00911820|434824|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
180375|NCT00911820|434825|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
180376|NCT00911820|434824|P2|STARTED|Overall Study||43
180377|NCT00911820|434825|P1|STARTED|Overall Study||45
180378|NCT00911807|434842|P3|NOT COMPLETED|Overall Study||23
180379|NCT00911807|434843|P2|NOT COMPLETED|Overall Study||18
180380|NCT00911807|434844|P1|NOT COMPLETED|Overall Study||17
180381|NCT00911807|434842|P3|COMPLETED|Overall Study||52
180382|NCT00911807|434843|P2|COMPLETED|Overall Study||52
180383|NCT00911807|434844|P1|COMPLETED|Overall Study||55
180384|NCT00911807|434842|P3|STARTED|Overall Study||75
180385|NCT00911807|434843|P2|STARTED|Overall Study||70
180386|NCT00911807|434844|P1|STARTED|Overall Study||72
180387|NCT00911768|434854|P2|NOT COMPLETED|Overall Study||4
180388|NCT00911768|434855|P1|NOT COMPLETED|Overall Study||6
180389|NCT00911768|434854|P2|COMPLETED|Overall Study||46
180390|NCT00911768|434855|P1|COMPLETED|Overall Study||44
180391|NCT00911768|434854|P2|STARTED|Overall Study||50
180392|NCT00911768|434855|P1|STARTED|Overall Study||50
180393|NCT00911742|434867|P2|NOT COMPLETED|Treatment Phase II||0
180394|NCT00911742|434868|P1|NOT COMPLETED|Treatment Phase II||0
180395|NCT00911742|434867|P2|COMPLETED|Treatment Phase II||13
180396|NCT00911742|434868|P1|COMPLETED|Treatment Phase II||13
180397|NCT00911742|434867|P2|STARTED|Treatment Phase II||13
180398|NCT00911742|434868|P1|STARTED|Treatment Phase II||13
180399|NCT00911742|434867|P2|NOT COMPLETED|Treatment Phase I||0
180400|NCT00911742|434868|P1|NOT COMPLETED|Treatment Phase I||0
180401|NCT00911742|434867|P2|COMPLETED|Treatment Phase I||13
180402|NCT00911742|434868|P1|COMPLETED|Treatment Phase I||13
180403|NCT00911742|434867|P2|STARTED|Treatment Phase I||13
180404|NCT00911742|434868|P1|STARTED|Treatment Phase I||13
180405|NCT00911625|434884|P2|NOT COMPLETED|Overall Study||0
180406|NCT00911625|434885|P1|NOT COMPLETED|Overall Study||7
180407|NCT00911625|434884|P2|COMPLETED|Overall Study||57
180408|NCT00911625|434885|P1|COMPLETED|Overall Study||50
180409|NCT00911625|434884|P2|STARTED|Overall Study||57
180410|NCT00911625|434885|P1|STARTED|Overall Study||57
180411|NCT00911612|434895|P2|NOT COMPLETED|Overall Study||0
180412|NCT00911612|434896|P1|NOT COMPLETED|Overall Study||0
180413|NCT00911612|434895|P2|COMPLETED|Overall Study||12
180414|NCT00911612|434896|P1|COMPLETED|Overall Study||12
180415|NCT00911612|434895|P2|STARTED|Overall Study||12
180416|NCT00911612|434896|P1|STARTED|Overall Study||12
180417|NCT00911547|434914|P4|NOT COMPLETED|Overall Study||16
180418|NCT00911547|434915|P3|NOT COMPLETED|Overall Study||22
180419|NCT00911547|434916|P2|NOT COMPLETED|Overall Study||42
180420|NCT00911547|434917|P1|NOT COMPLETED|Overall Study||11
180421|NCT00911547|434914|P4|COMPLETED|Overall Study||177
180422|NCT00911547|434915|P3|COMPLETED|Overall Study||178
180423|NCT00911547|434916|P2|COMPLETED|Overall Study||159
180424|NCT00911547|434917|P1|COMPLETED|Overall Study||37
180425|NCT00911547|434914|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
180426|NCT00911547|434915|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
180427|NCT00911547|434916|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
180428|NCT00911547|434917|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
180429|NCT00911534|434945|P2|NOT COMPLETED|Overall Study||16
180430|NCT00911534|434946|P1|NOT COMPLETED|Overall Study||15
180431|NCT00911534|434945|P2|COMPLETED|Overall Study||137
180432|NCT00911534|434946|P1|COMPLETED|Overall Study||132
180433|NCT00911534|434945|P2|STARTED|Overall Study|Randomized (treated)|153
180434|NCT00911534|434946|P1|STARTED|Overall Study|Randomized (treated)|147
180435|NCT00911495|434958|P1|NOT COMPLETED|Overall Study||1
180436|NCT00911495|434958|P1|COMPLETED|Overall Study||14
180437|NCT00911495|434958|P1|STARTED|Overall Study||15
180438|NCT00911443|434971|P5|NOT COMPLETED|Overall Study||0
180439|NCT00911443|434972|P4|NOT COMPLETED|Overall Study||0
180440|NCT00911443|434973|P3|NOT COMPLETED|Overall Study||0
180441|NCT00911443|434974|P2|NOT COMPLETED|Overall Study||0
180442|NCT00911443|434975|P1|NOT COMPLETED|Overall Study||0
180443|NCT00911443|434971|P5|COMPLETED|Overall Study||97
180444|NCT00911443|434972|P4|COMPLETED|Overall Study||99
180445|NCT00911443|434973|P3|COMPLETED|Overall Study||98
180446|NCT00911443|434974|P2|COMPLETED|Overall Study||97
180447|NCT00911443|434975|P1|COMPLETED|Overall Study||97
180448|NCT00911443|434971|P5|STARTED|Overall Study||97
180449|NCT00911443|434972|P4|STARTED|Overall Study||99
180450|NCT00911443|434973|P3|STARTED|Overall Study||98
180451|NCT00911443|434974|P2|STARTED|Overall Study||97
180452|NCT00911443|434975|P1|STARTED|Overall Study||97
180453|NCT00911326|434992|P1|NOT COMPLETED|Overall Study||16
180454|NCT00911326|434992|P1|COMPLETED|Overall Study||85
180455|NCT00911326|434992|P1|STARTED|Overall Study||101
180456|NCT00911300|435001|P2|NOT COMPLETED|Overall Study||43
180457|NCT00911300|435002|P1|NOT COMPLETED|Overall Study||35
180458|NCT00911300|435001|P2|COMPLETED|Overall Study||131
180459|NCT00911300|435002|P1|COMPLETED|Overall Study||140
180460|NCT00911300|435001|P2|STARTED|Overall Study||174
180461|NCT00911300|435002|P1|STARTED|Overall Study||175
180462|NCT00911274|435028|P2|NOT COMPLETED|Period 2||0
180463|NCT00911274|435029|P1|NOT COMPLETED|Period 2||0
180464|NCT00911274|435028|P2|COMPLETED|Period 2||26
180465|NCT00911274|435029|P1|COMPLETED|Period 2||27
180466|NCT00911274|435028|P2|STARTED|Period 2||26
180467|NCT00911274|435029|P1|STARTED|Period 2||27
180468|NCT00911274|435028|P2|NOT COMPLETED|Period 1||0
180469|NCT00911274|435029|P1|NOT COMPLETED|Period 1||0
180470|NCT00911274|435028|P2|COMPLETED|Period 1||26
180471|NCT00911274|435029|P1|COMPLETED|Period 1||27
180472|NCT00911274|435028|P2|STARTED|Period 1||26
180473|NCT00911274|435029|P1|STARTED|Period 1||27
180474|NCT00911170|435039|P2|NOT COMPLETED|Long Term Follow-Up||422
180475|NCT00911170|435040|P1|NOT COMPLETED|Long Term Follow-Up||423
180476|NCT00911170|435039|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
180477|NCT00911170|435040|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
180478|NCT00911170|435039|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
180479|NCT00911170|435040|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
180480|NCT00911170|435039|P2|NOT COMPLETED|Treatment Period||37
180481|NCT00911170|435040|P1|NOT COMPLETED|Treatment Period||27
180482|NCT00911170|435039|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
180483|NCT00911170|435040|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
180484|NCT00911170|435039|P2|Received Investigational Product|Treatment Period||419
180485|NCT00911170|435040|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
180486|NCT00911170|435039|P2|Received Bevacizumab|Treatment Period||420
180487|NCT00911170|435040|P1|Received Bevacizumab|Treatment Period||423
180488|NCT00911170|435039|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
180489|NCT00911170|435040|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
180490|NCT00911170|435039|P2|STARTED|Treatment Period||423
180491|NCT00911170|435040|P1|STARTED|Treatment Period||424
180492|NCT00911157|435064|P2|NOT COMPLETED|Overall Study||2
180493|NCT00911157|435065|P1|NOT COMPLETED|Overall Study||7
180494|NCT00911157|435064|P2|COMPLETED|Overall Study||8
180495|NCT00911157|435065|P1|COMPLETED|Overall Study||22
180496|NCT00911157|435064|P2|STARTED|Overall Study||10
180497|NCT00911157|435065|P1|STARTED|Overall Study||29
180498|NCT00911144|435081|P2|NOT COMPLETED|Overall Study||5
180499|NCT00911144|435082|P1|NOT COMPLETED|Overall Study||16
180500|NCT00911144|435081|P2|COMPLETED|Overall Study||108
180501|NCT00911144|435082|P1|COMPLETED|Overall Study||319
180502|NCT00911144|435081|P2|STARTED|Overall Study||113
180503|NCT00911144|435082|P1|STARTED|Overall Study||335
180504|NCT00910988|435110|P4|NOT COMPLETED|Overall Study||0
180505|NCT00910988|435111|P3|NOT COMPLETED|Overall Study||3
180506|NCT00910988|435112|P2|NOT COMPLETED|Overall Study||4
180507|NCT00910988|435113|P1|NOT COMPLETED|Overall Study||2
180508|NCT00910988|435110|P4|COMPLETED|Overall Study||6
180509|NCT00910988|435111|P3|COMPLETED|Overall Study||5
180510|NCT00910988|435112|P2|COMPLETED|Overall Study||12
180511|NCT00910988|435113|P1|COMPLETED|Overall Study||14
180512|NCT00910988|435110|P4|STARTED|Overall Study||6
180513|NCT00910988|435111|P3|STARTED|Overall Study||8
180514|NCT00910988|435112|P2|STARTED|Overall Study||16
180515|NCT00910988|435113|P1|STARTED|Overall Study||16
180516|NCT00910962|435158|P3|NOT COMPLETED|Overall Study||76
180517|NCT00910962|435159|P2|NOT COMPLETED|Overall Study||78
180518|NCT00910962|435160|P1|NOT COMPLETED|Overall Study||43
180519|NCT00910962|435158|P3|COMPLETED|Overall Study||116
180520|NCT00910962|435159|P2|COMPLETED|Overall Study||121
180521|NCT00910962|435160|P1|COMPLETED|Overall Study||92
180522|NCT00910962|435158|P3|STARTED|Overall Study||192
180523|NCT00910962|435159|P2|STARTED|Overall Study||199
180524|NCT00910962|435160|P1|STARTED|Overall Study||135
180525|NCT00910910|435252|P2|NOT COMPLETED|Overall Study||224
180526|NCT00910910|435253|P1|NOT COMPLETED|Overall Study||225
180527|NCT00910910|435252|P2|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|1
180528|NCT00910910|435253|P1|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|0
180529|NCT00910910|435252|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
180530|NCT00910910|435253|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
180531|NCT00910910|435252|P2|STARTED|Overall Study||225
180532|NCT00910910|435253|P1|STARTED|Overall Study||225
180533|NCT00910871|435287|P1|NOT COMPLETED|Overall Study||54
180534|NCT00910871|435287|P1|COMPLETED|Overall Study||179
180535|NCT00910871|435287|P1|STARTED|Overall Study||233
180536|NCT00910858|435295|P3|NOT COMPLETED|Combined Treatment Phase||4
180537|NCT00910858|435296|P2|NOT COMPLETED|Combined Treatment Phase||10
180538|NCT00910858|435297|P1|NOT COMPLETED|Combined Treatment Phase||9
180539|NCT00910858|435295|P3|COMPLETED|Combined Treatment Phase||0
180540|NCT00910858|435296|P2|COMPLETED|Combined Treatment Phase||0
180541|NCT00910858|435297|P1|COMPLETED|Combined Treatment Phase||0
180542|NCT00910858|435295|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
180543|NCT00910858|435296|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
180544|NCT00910858|435297|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
180545|NCT00910858|435295|P3|NOT COMPLETED|Monotherapy Phase||7
180546|NCT00910858|435296|P2|NOT COMPLETED|Monotherapy Phase||15
180547|NCT00910858|435297|P1|NOT COMPLETED|Monotherapy Phase||17
180548|NCT00910858|435295|P3|COMPLETED|Monotherapy Phase||0
180549|NCT00910858|435296|P2|COMPLETED|Monotherapy Phase||0
180550|NCT00910858|435297|P1|COMPLETED|Monotherapy Phase||0
180551|NCT00910858|435295|P3|Pharmacokinetic Population|Monotherapy Phase||7
180552|NCT00910858|435296|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
180553|NCT00910858|435297|P1|Pharmacokinetic Population|Monotherapy Phase||17
180554|NCT00910858|435295|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
180555|NCT00910858|435296|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
180556|NCT00910858|435297|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
180557|NCT00910858|435295|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
180558|NCT00910858|435296|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
180559|NCT00910858|435297|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
180560|NCT00910858|435295|P3|NOT COMPLETED|Pharmacokinetic Phase||0
180561|NCT00910858|435296|P2|NOT COMPLETED|Pharmacokinetic Phase||0
180562|NCT00910858|435297|P1|NOT COMPLETED|Pharmacokinetic Phase||1
180563|NCT00910858|435295|P3|COMPLETED|Pharmacokinetic Phase||3
180564|NCT00910858|435296|P2|COMPLETED|Pharmacokinetic Phase||0
180565|NCT00910858|435297|P1|COMPLETED|Pharmacokinetic Phase||8
180566|NCT00910858|435295|P3|STARTED|Pharmacokinetic Phase||3
180567|NCT00910858|435296|P2|STARTED|Pharmacokinetic Phase||0
180568|NCT00910858|435297|P1|STARTED|Pharmacokinetic Phase||9
180569|NCT00910845|435322|P2|NOT COMPLETED|Treatment Cycle 2||9
180570|NCT00910845|435323|P1|NOT COMPLETED|Treatment Cycle 2||5
180571|NCT00910845|435322|P2|COMPLETED|Treatment Cycle 2||203
180572|NCT00910845|435323|P1|COMPLETED|Treatment Cycle 2||136
180573|NCT00910845|435322|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
180574|NCT00910845|435323|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
180575|NCT00910845|435322|P2|NOT COMPLETED|Treatment Cycle 1||34
180576|NCT00910845|435323|P1|NOT COMPLETED|Treatment Cycle 1||31
180577|NCT00910845|435322|P2|COMPLETED|Treatment Cycle 1||243
180578|NCT00910845|435323|P1|COMPLETED|Treatment Cycle 1||249
180579|NCT00910845|435322|P2|STARTED|Treatment Cycle 1||277
180580|NCT00910845|435323|P1|STARTED|Treatment Cycle 1||280
180581|NCT00910728|435342|P9|NOT COMPLETED|Overall Study||3
180582|NCT00910728|435343|P8|NOT COMPLETED|Overall Study||3
180583|NCT00910728|435344|P7|NOT COMPLETED|Overall Study||6
180584|NCT00910728|435345|P6|NOT COMPLETED|Overall Study||1
180585|NCT00910728|435346|P5|NOT COMPLETED|Overall Study||5
180586|NCT00910728|435347|P4|NOT COMPLETED|Overall Study||3
180587|NCT00910728|435348|P3|NOT COMPLETED|Overall Study||3
180588|NCT00910728|435349|P2|NOT COMPLETED|Overall Study||3
180589|NCT00910728|435350|P1|NOT COMPLETED|Overall Study||6
180590|NCT00910728|435342|P9|COMPLETED|Overall Study||0
180591|NCT00910728|435343|P8|COMPLETED|Overall Study||1
180592|NCT00910728|435344|P7|COMPLETED|Overall Study||0
180593|NCT00910728|435345|P6|COMPLETED|Overall Study||0
180594|NCT00910728|435346|P5|COMPLETED|Overall Study||1
180595|NCT00910728|435347|P4|COMPLETED|Overall Study||0
180596|NCT00910728|435348|P3|COMPLETED|Overall Study||0
180597|NCT00910728|435349|P2|COMPLETED|Overall Study||0
180598|NCT00910728|435350|P1|COMPLETED|Overall Study||0
180599|NCT00910728|435342|P9|STARTED|Overall Study||3
180600|NCT00910728|435343|P8|STARTED|Overall Study||4
180601|NCT00910728|435344|P7|STARTED|Overall Study||6
180602|NCT00910728|435345|P6|STARTED|Overall Study||1
180603|NCT00910728|435346|P5|STARTED|Overall Study||6
180604|NCT00910728|435347|P4|STARTED|Overall Study||3
180605|NCT00910728|435348|P3|STARTED|Overall Study||3
180606|NCT00910728|435349|P2|STARTED|Overall Study||3
180607|NCT00910728|435350|P1|STARTED|Overall Study||6
180608|NCT00910715|435472|P3|NOT COMPLETED|Overall Study||0
180609|NCT00910715|435473|P2|NOT COMPLETED|Overall Study||26
180610|NCT00910715|435474|P1|NOT COMPLETED|Overall Study||22
180611|NCT00910715|435472|P3|COMPLETED|Overall Study||81
180612|NCT00910715|435473|P2|COMPLETED|Overall Study||91
180613|NCT00910715|435474|P1|COMPLETED|Overall Study||86
180614|NCT00910715|435472|P3|STARTED|Overall Study||81
180615|NCT00910715|435473|P2|STARTED|Overall Study||117
180616|NCT00910715|435474|P1|STARTED|Overall Study||108
180617|NCT00910689|435488|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
180618|NCT00910689|435489|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
180619|NCT00910689|435490|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
180620|NCT00910689|435491|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
180621|NCT00910689|435488|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
180622|NCT00910689|435489|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
180623|NCT00910689|435490|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
180624|NCT00910689|435491|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
180625|NCT00910689|435488|P4|STARTED|Months 11- 16: Evaluation Period II||41
180626|NCT00910689|435489|P3|STARTED|Months 11- 16: Evaluation Period II||35
180627|NCT00910689|435490|P2|STARTED|Months 11- 16: Evaluation Period II||35
180628|NCT00910689|435491|P1|STARTED|Months 11- 16: Evaluation Period II||40
180629|NCT00910689|435488|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
180630|NCT00910689|435489|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
180631|NCT00910689|435490|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
180632|NCT00910689|435491|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
180633|NCT00910689|435488|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
180634|NCT00910689|435489|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
180635|NCT00910689|435490|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
180636|NCT00910689|435491|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
180637|NCT00910689|435488|P4|STARTED|Months 5 - 10: Evaluation Period I||48
180638|NCT00910689|435489|P3|STARTED|Months 5 - 10: Evaluation Period I||42
180639|NCT00910689|435490|P2|STARTED|Months 5 - 10: Evaluation Period I||42
180640|NCT00910689|435491|P1|STARTED|Months 5 - 10: Evaluation Period I||44
180641|NCT00910689|435488|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
180642|NCT00910689|435489|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
180643|NCT00910689|435490|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
180644|NCT00910689|435491|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
180645|NCT00910689|435488|P4|COMPLETED|Month 2- 4: Treatment Period||48
180646|NCT00910689|435489|P3|COMPLETED|Month 2- 4: Treatment Period||42
180647|NCT00910689|435490|P2|COMPLETED|Month 2- 4: Treatment Period||42
180648|NCT00910689|435491|P1|COMPLETED|Month 2- 4: Treatment Period||44
180649|NCT00910689|435488|P4|STARTED|Month 2- 4: Treatment Period||59
180650|NCT00910689|435489|P3|STARTED|Month 2- 4: Treatment Period||50
180651|NCT00910689|435490|P2|STARTED|Month 2- 4: Treatment Period||52
180652|NCT00910689|435491|P1|STARTED|Month 2- 4: Treatment Period||53
180653|NCT00910689|435488|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
180654|NCT00910689|435489|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
180655|NCT00910689|435490|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
180656|NCT00910689|435491|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
180657|NCT00910689|435488|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
180658|NCT00910689|435489|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
180659|NCT00910689|435490|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
180660|NCT00910689|435491|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
180661|NCT00910689|435488|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
180662|NCT00910689|435489|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
180663|NCT00910689|435490|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
180664|NCT00910689|435491|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
180665|NCT00910663|435523|P2|NOT COMPLETED|Period 2||0
180666|NCT00910663|435524|P1|NOT COMPLETED|Period 2||0
180667|NCT00910663|435523|P2|COMPLETED|Period 2||29
180668|NCT00910663|435524|P1|COMPLETED|Period 2||30
180669|NCT00910663|435523|P2|STARTED|Period 2||29
180670|NCT00910663|435524|P1|STARTED|Period 2||30
180671|NCT00910663|435523|P2|NOT COMPLETED|Period 1||1
180672|NCT00910663|435524|P1|NOT COMPLETED|Period 1||0
180673|NCT00910663|435523|P2|COMPLETED|Period 1||29
180674|NCT00910663|435524|P1|COMPLETED|Period 1||30
180675|NCT00910663|435523|P2|STARTED|Period 1||30
180676|NCT00910663|435524|P1|STARTED|Period 1||30
180677|NCT00910624|435538|P4|NOT COMPLETED|Follow-Up Phase||0
180678|NCT00910624|435539|P3|NOT COMPLETED|Follow-Up Phase||4
180679|NCT00910624|435540|P2|NOT COMPLETED|Follow-Up Phase||4
180680|NCT00910624|435541|P1|NOT COMPLETED|Follow-Up Phase||6
180681|NCT00910624|435538|P4|COMPLETED|Follow-Up Phase||2
180682|NCT00910624|435539|P3|COMPLETED|Follow-Up Phase||25
180683|NCT00910624|435540|P2|COMPLETED|Follow-Up Phase||76
180684|NCT00910624|435541|P1|COMPLETED|Follow-Up Phase||42
180685|NCT00910624|435538|P4|STARTED|Follow-Up Phase||2
180686|NCT00910624|435539|P3|STARTED|Follow-Up Phase||29
180687|NCT00910624|435540|P2|STARTED|Follow-Up Phase||80
180688|NCT00910624|435541|P1|STARTED|Follow-Up Phase||48
180689|NCT00910624|435538|P4|NOT COMPLETED|Treatment Phase||0
180690|NCT00910624|435539|P3|NOT COMPLETED|Treatment Phase||9
180691|NCT00910624|435540|P2|NOT COMPLETED|Treatment Phase||21
180692|NCT00910624|435541|P1|NOT COMPLETED|Treatment Phase||30
180693|NCT00910624|435538|P4|COMPLETED|Treatment Phase||2
180694|NCT00910624|435539|P3|COMPLETED|Treatment Phase||20
180695|NCT00910624|435540|P2|COMPLETED|Treatment Phase||64
180696|NCT00910624|435541|P1|COMPLETED|Treatment Phase||22
180697|NCT00910624|435538|P4|STARTED|Treatment Phase||2
180698|NCT00910624|435539|P3|STARTED|Treatment Phase||29
180699|NCT00910624|435540|P2|STARTED|Treatment Phase||85
180700|NCT00910624|435541|P1|STARTED|Treatment Phase||52
180701|NCT00910520|435555|P2|NOT COMPLETED|Treatment Cycle 2||8
180702|NCT00910520|435556|P1|NOT COMPLETED|Treatment Cycle 2||7
180703|NCT00910520|435555|P2|COMPLETED|Treatment Cycle 2||215
180704|NCT00910520|435556|P1|COMPLETED|Treatment Cycle 2||156
180705|NCT00910520|435555|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
180706|NCT00910520|435556|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
180707|NCT00910520|435555|P2|NOT COMPLETED|Treatment Cycle 1||24
180708|NCT00910520|435556|P1|NOT COMPLETED|Treatment Cycle 1||20
180709|NCT00910520|435555|P2|COMPLETED|Treatment Cycle 1||247
180710|NCT00910520|435556|P1|COMPLETED|Treatment Cycle 1||257
180711|NCT00910520|435555|P2|STARTED|Treatment Cycle 1||271
180712|NCT00910520|435556|P1|STARTED|Treatment Cycle 1||277
180713|NCT00910299|435568|P2|NOT COMPLETED|Overall Study||74
180714|NCT00910299|435569|P1|NOT COMPLETED|Overall Study||76
180715|NCT00910299|435568|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
180716|NCT00910299|435569|P1|COMPLETED|Overall Study||136
180717|NCT00910299|435568|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
180718|NCT00910299|435569|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
180719|NCT00910299|435568|P2|STARTED|Overall Study||211
180720|NCT00910299|435569|P1|STARTED|Overall Study||212
180721|NCT00910273|435581|P2|NOT COMPLETED|Overall Study||13
180722|NCT00910273|435582|P1|NOT COMPLETED|Overall Study||18
180723|NCT00910273|435581|P2|COMPLETED|Overall Study||3
180724|NCT00910273|435582|P1|COMPLETED|Overall Study||0
180725|NCT00910273|435581|P2|STARTED|Overall Study||16
180726|NCT00910273|435582|P1|STARTED|Overall Study||18
180727|NCT00910091|435634|P2|NOT COMPLETED|Treatment and Survival||4
180728|NCT00910091|435635|P1|NOT COMPLETED|Treatment and Survival||4
180729|NCT00910091|435634|P2|COMPLETED|Treatment and Survival||31
180730|NCT00910091|435635|P1|COMPLETED|Treatment and Survival||32
180731|NCT00910091|435634|P2|STARTED|Treatment and Survival||35
180732|NCT00910091|435635|P1|STARTED|Treatment and Survival||36
180733|NCT00910091|435634|P2|NOT COMPLETED|Pre-assignment||2
180734|NCT00910091|435635|P1|NOT COMPLETED|Pre-assignment||0
180735|NCT00910091|435634|P2|COMPLETED|Pre-assignment||35
180736|NCT00910091|435635|P1|COMPLETED|Pre-assignment||36
180737|NCT00910091|435634|P2|STARTED|Pre-assignment||37
180738|NCT00910091|435635|P1|STARTED|Pre-assignment||36
180739|NCT00910039|435663|P1|NOT COMPLETED|Overall Study||1
180740|NCT00910039|435663|P1|COMPLETED|Overall Study||13
180741|NCT00910039|435663|P1|STARTED|Overall Study||14
180742|NCT00910000|435680|P6|NOT COMPLETED|Overall Study||1
180743|NCT00910000|435681|P5|NOT COMPLETED|Overall Study||1
180744|NCT00910000|435682|P4|NOT COMPLETED|Overall Study||2
180745|NCT00910000|435683|P3|NOT COMPLETED|Overall Study||3
180746|NCT00910000|435684|P2|NOT COMPLETED|Overall Study||3
180747|NCT00910000|435685|P1|NOT COMPLETED|Overall Study||0
180748|NCT00910000|435680|P6|COMPLETED|Overall Study||0
180749|NCT00910000|435681|P5|COMPLETED|Overall Study||2
180750|NCT00910000|435682|P4|COMPLETED|Overall Study||0
180751|NCT00910000|435683|P3|COMPLETED|Overall Study||0
180752|NCT00910000|435684|P2|COMPLETED|Overall Study||0
180753|NCT00910000|435685|P1|COMPLETED|Overall Study||3
180754|NCT00910000|435680|P6|STARTED|Overall Study||1
180755|NCT00910000|435681|P5|STARTED|Overall Study||3
180756|NCT00910000|435682|P4|STARTED|Overall Study||2
180757|NCT00910000|435683|P3|STARTED|Overall Study||3
180758|NCT00910000|435684|P2|STARTED|Overall Study||3
180759|NCT00910000|435685|P1|STARTED|Overall Study||3
180760|NCT00909870|435703|P2|NOT COMPLETED|Overall Study||27
180761|NCT00909870|435704|P1|NOT COMPLETED|Overall Study||23
180762|NCT00909870|435703|P2|COMPLETED|Overall Study||236
180763|NCT00909870|435704|P1|COMPLETED|Overall Study||251
180764|NCT00909870|435703|P2|STARTED|Overall Study||263
180765|NCT00909870|435704|P1|STARTED|Overall Study||274
180766|NCT00909857|435716|P2|NOT COMPLETED|Overall Study||45
180767|NCT00909857|435717|P1|NOT COMPLETED|Overall Study||36
180768|NCT00909857|435716|P2|COMPLETED|Overall Study||209
180769|NCT00909857|435717|P1|COMPLETED|Overall Study||217
180770|NCT00909857|435716|P2|Treated|Overall Study||230
180771|NCT00909857|435717|P1|Treated|Overall Study||234
180772|NCT00909857|435716|P2|STARTED|Overall Study||254
180773|NCT00909857|435717|P1|STARTED|Overall Study||253
180774|NCT00909844|435857|P1|NOT COMPLETED|Overall Study||4
180775|NCT00909844|435857|P1|COMPLETED|Overall Study||31
180776|NCT00909844|435857|P1|STARTED|Overall Study||35
180777|NCT00909792|435875|P2|NOT COMPLETED|Period 2||1
180778|NCT00909792|435876|P1|NOT COMPLETED|Period 2||1
180779|NCT00909792|435875|P2|COMPLETED|Period 2||124
180780|NCT00909792|435876|P1|COMPLETED|Period 2||128
180781|NCT00909792|435875|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
180782|NCT00909792|435876|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
180783|NCT00909792|435875|P2|NOT COMPLETED|Period 1||1
180784|NCT00909792|435876|P1|NOT COMPLETED|Period 1||0
180785|NCT00909792|435875|P2|COMPLETED|Period 1||127
180786|NCT00909792|435876|P1|COMPLETED|Period 1||130
180787|NCT00909792|435875|P2|STARTED|Period 1||128
180788|NCT00909792|435876|P1|STARTED|Period 1||130
180789|NCT00909779|435884|P2|NOT COMPLETED|Overall Study||165
180790|NCT00909779|435885|P1|NOT COMPLETED|Overall Study||210
180791|NCT00909779|435884|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
180792|NCT00909779|435885|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
180793|NCT00909779|435884|P2|STARTED|Overall Study||420
180794|NCT00909779|435885|P1|STARTED|Overall Study||421
180795|NCT00909753|435909|P2|NOT COMPLETED|Period: Second Intervention||0
180796|NCT00909753|435910|P1|NOT COMPLETED|Period: Second Intervention||1
180797|NCT00909753|435909|P2|COMPLETED|Period: Second Intervention||43
180798|NCT00909753|435910|P1|COMPLETED|Period: Second Intervention||43
180799|NCT00909753|435909|P2|STARTED|Period: Second Intervention||43
180800|NCT00909753|435910|P1|STARTED|Period: Second Intervention||44
180801|NCT00909753|435909|P2|NOT COMPLETED|Period: Washout of 28 Days||3
180802|NCT00909753|435910|P1|NOT COMPLETED|Period: Washout of 28 Days||2
180803|NCT00909753|435909|P2|COMPLETED|Period: Washout of 28 Days||43
180804|NCT00909753|435910|P1|COMPLETED|Period: Washout of 28 Days||44
180805|NCT00909753|435909|P2|STARTED|Period: Washout of 28 Days||46
180806|NCT00909753|435910|P1|STARTED|Period: Washout of 28 Days||46
180807|NCT00909753|435909|P2|NOT COMPLETED|Period: First Intervention||0
180808|NCT00909753|435910|P1|NOT COMPLETED|Period: First Intervention||0
180809|NCT00909753|435909|P2|COMPLETED|Period: First Intervention||46
180810|NCT00909753|435910|P1|COMPLETED|Period: First Intervention||46
180811|NCT00909753|435909|P2|STARTED|Period: First Intervention||46
180812|NCT00909753|435910|P1|STARTED|Period: First Intervention||46
180813|NCT00909727|435930|P2|NOT COMPLETED|Overall Study||0
180814|NCT00909727|435931|P1|NOT COMPLETED|Overall Study||4
180815|NCT00909727|435930|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
180816|NCT00909727|435931|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
180817|NCT00909727|435930|P2|Completed Treatment Period, Week 24|Overall Study||26
180818|NCT00909727|435931|P1|Completed Treatment Period, Week 24|Overall Study||23
180819|NCT00909727|435930|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
180820|NCT00909727|435931|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
180821|NCT00909649|435947|P2|NOT COMPLETED|Overall Study||0
180822|NCT00909649|435948|P1|NOT COMPLETED|Overall Study||0
180823|NCT00909649|435947|P2|COMPLETED|Overall Study||25
180824|NCT00909649|435948|P1|COMPLETED|Overall Study||25
180825|NCT00909649|435947|P2|STARTED|Overall Study||25
180826|NCT00909649|435948|P1|STARTED|Overall Study||25
180827|NCT00909610|435954|P2|NOT COMPLETED|Period: Second Intervention||0
180828|NCT00909610|435955|P1|NOT COMPLETED|Period: Second Intervention||1
180829|NCT00909610|435954|P2|COMPLETED|Period: Second Intervention||33
180830|NCT00909610|435955|P1|COMPLETED|Period: Second Intervention||36
180831|NCT00909610|435954|P2|STARTED|Period: Second Intervention||33
180832|NCT00909610|435955|P1|STARTED|Period: Second Intervention||37
180833|NCT00909610|435954|P2|NOT COMPLETED|Period: Washout of 28 Days||6
180834|NCT00909610|435955|P1|NOT COMPLETED|Period: Washout of 28 Days||3
180835|NCT00909610|435954|P2|COMPLETED|Period: Washout of 28 Days||33
180836|NCT00909610|435955|P1|COMPLETED|Period: Washout of 28 Days||37
180837|NCT00909610|435954|P2|STARTED|Period: Washout of 28 Days||39
180838|NCT00909610|435955|P1|STARTED|Period: Washout of 28 Days||40
180839|NCT00909610|435954|P2|NOT COMPLETED|Period: First Intervention||1
180840|NCT00909610|435955|P1|NOT COMPLETED|Period: First Intervention||0
180841|NCT00909610|435954|P2|COMPLETED|Period: First Intervention||39
180842|NCT00909610|435955|P1|COMPLETED|Period: First Intervention||40
180843|NCT00909610|435954|P2|STARTED|Period: First Intervention||40
180844|NCT00909610|435955|P1|STARTED|Period: First Intervention||40
180845|NCT00909545|435977|P4|NOT COMPLETED|Overall Study||5
180846|NCT00909545|435978|P3|NOT COMPLETED|Overall Study||1
180847|NCT00909545|435979|P2|NOT COMPLETED|Overall Study||1
180848|NCT00909545|435980|P1|NOT COMPLETED|Overall Study||1
180849|NCT00909545|435977|P4|COMPLETED|Overall Study||19
180850|NCT00909545|435978|P3|COMPLETED|Overall Study||25
180851|NCT00909545|435979|P2|COMPLETED|Overall Study||22
180852|NCT00909545|435980|P1|COMPLETED|Overall Study||25
180853|NCT00909545|435977|P4|STARTED|Overall Study||24
180854|NCT00909545|435978|P3|STARTED|Overall Study||26
180855|NCT00909545|435979|P2|STARTED|Overall Study||23
180856|NCT00909545|435980|P1|STARTED|Overall Study||26
180857|NCT00909532|436116|P2|NOT COMPLETED|Overall Study||6
180858|NCT00909532|436117|P1|NOT COMPLETED|Overall Study||10
180859|NCT00909532|436116|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
180860|NCT00909532|436117|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
180861|NCT00909532|436116|P2|Completed Treatment Period, Week 24|Overall Study||80
180862|NCT00909532|436117|P1|Completed Treatment Period, Week 24|Overall Study||71
180863|NCT00909532|436116|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
180864|NCT00909532|436117|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
180865|NCT00909480|436135|P2|NOT COMPLETED|Overall Study||41
180866|NCT00909480|436136|P1|NOT COMPLETED|Overall Study||38
180867|NCT00909480|436135|P2|COMPLETED|Overall Study||188
180868|NCT00909480|436136|P1|COMPLETED|Overall Study||190
180869|NCT00909480|436135|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
180870|NCT00909480|436136|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
180871|NCT00909480|436135|P2|STARTED|Overall Study||229
180872|NCT00909480|436136|P1|STARTED|Overall Study||228
180873|NCT00909428|436171|P3|NOT COMPLETED|Overall Study||9
180874|NCT00909428|436172|P2|NOT COMPLETED|Overall Study||10
180875|NCT00909428|436173|P1|NOT COMPLETED|Overall Study||13
180876|NCT00909428|436171|P3|COMPLETED|Overall Study||0
180877|NCT00909428|436172|P2|COMPLETED|Overall Study||5
180878|NCT00909428|436173|P1|COMPLETED|Overall Study||5
180879|NCT00909428|436171|P3|STARTED|Overall Study||9
180880|NCT00909428|436172|P2|STARTED|Overall Study||15
180881|NCT00909428|436173|P1|STARTED|Overall Study||18
180882|NCT00909389|436180|P1|NOT COMPLETED|Overall Study||133
180883|NCT00909389|436180|P1|COMPLETED|Overall Study||4615
180884|NCT00909389|436180|P1|STARTED|Overall Study||4748
180885|NCT00909324|436186|P2|NOT COMPLETED|Overall Study||0
180886|NCT00909324|436187|P1|NOT COMPLETED|Overall Study||0
180887|NCT00909324|436186|P2|COMPLETED|Overall Study||90
180888|NCT00909324|436187|P1|COMPLETED|Overall Study||72
180889|NCT00909324|436186|P2|STARTED|Overall Study||90
180890|NCT00909324|436187|P1|STARTED|Overall Study||72
180891|NCT00909220|436199|P2|NOT COMPLETED|Overall Study||0
180892|NCT00909220|436200|P1|NOT COMPLETED|Overall Study||0
180893|NCT00909220|436199|P2|COMPLETED|Overall Study||36
180894|NCT00909220|436200|P1|COMPLETED|Overall Study||41
180895|NCT00909220|436199|P2|Submission for Publication|Overall Study||36
180896|NCT00909220|436200|P1|Submission for Publication|Overall Study||41
180897|NCT00909220|436199|P2|Data Analyses|Overall Study||36
180898|NCT00909220|436200|P1|Data Analyses|Overall Study||41
180899|NCT00909220|436199|P2|Data Entry|Overall Study||36
180900|NCT00909220|436200|P1|Data Entry|Overall Study||41
180901|NCT00909220|436199|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
180902|NCT00909220|436200|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
180903|NCT00909181|436214|P3|NOT COMPLETED|Overall Study||33
180904|NCT00909181|436215|P2|NOT COMPLETED|Overall Study||18
180905|NCT00909181|436216|P1|NOT COMPLETED|Overall Study||39
180906|NCT00909181|436214|P3|COMPLETED|Overall Study||169
180907|NCT00909181|436215|P2|COMPLETED|Overall Study||196
180908|NCT00909181|436216|P1|COMPLETED|Overall Study||171
180909|NCT00909181|436214|P3|STARTED|Overall Study||202
180910|NCT00909181|436215|P2|STARTED|Overall Study||214
180911|NCT00909181|436216|P1|STARTED|Overall Study||210
180912|NCT00909155|436227|P3|NOT COMPLETED|Overall Study||7
180913|NCT00909155|436228|P2|NOT COMPLETED|Overall Study||5
180914|NCT00909155|436229|P1|NOT COMPLETED|Overall Study||3
180915|NCT00909155|436227|P3|COMPLETED|Overall Study||14
180916|NCT00909155|436228|P2|COMPLETED|Overall Study||9
180917|NCT00909155|436229|P1|COMPLETED|Overall Study||12
180918|NCT00909155|436227|P3|STARTED|Overall Study||21
180919|NCT00909155|436228|P2|STARTED|Overall Study||14
180920|NCT00909155|436229|P1|STARTED|Overall Study||15
180921|NCT00909064|436237|P1|NOT COMPLETED|Overall Study||0
180922|NCT00909064|436237|P1|COMPLETED|Overall Study||114
180923|NCT00909064|436237|P1|STARTED|Overall Study||114
180924|NCT00909038|436243|P1|NOT COMPLETED|Overall Study||417
180925|NCT00909038|436243|P1|COMPLETED|Overall Study||1994
180926|NCT00909038|436243|P1|STARTED|Overall Study||2411
180927|NCT00908960|436255|P3|NOT COMPLETED|Overall Study||2
180928|NCT00908960|436256|P2|NOT COMPLETED|Overall Study||1
180929|NCT00908960|436257|P1|NOT COMPLETED|Overall Study||1
180930|NCT00908960|436255|P3|COMPLETED|Overall Study||32
180931|NCT00908960|436256|P2|COMPLETED|Overall Study||11
180932|NCT00908960|436257|P1|COMPLETED|Overall Study||23
180933|NCT00908960|436255|P3|Evaluable|Overall Study||32
180934|NCT00908960|436256|P2|Evaluable|Overall Study||11
180935|NCT00908960|436257|P1|Evaluable|Overall Study||23
180936|NCT00908960|436255|P3|STARTED|Overall Study||34
180937|NCT00908960|436256|P2|STARTED|Overall Study||12
180938|NCT00908960|436257|P1|STARTED|Overall Study||24
180939|NCT00908908|436271|P1|NOT COMPLETED|Overall Study||0
180940|NCT00908908|436271|P1|COMPLETED|Overall Study||6
180941|NCT00908908|436271|P1|Physician Decision|Overall Study||0
180942|NCT00908908|436271|P1|Administrative/Other|Overall Study||0
180943|NCT00908908|436271|P1|Withdrawl by Subject|Overall Study||0
180944|NCT00908908|436271|P1|Adverse Event|Overall Study||0
180945|NCT00908908|436271|P1|STARTED|Overall Study||6
180946|NCT00908895|436279|P2|NOT COMPLETED|Overall Study||6
180947|NCT00908895|436280|P1|NOT COMPLETED|Overall Study||4
180948|NCT00908895|436279|P2|COMPLETED|Overall Study||57
180949|NCT00908895|436280|P1|COMPLETED|Overall Study||53
180950|NCT00908895|436279|P2|STARTED|Overall Study||63
180951|NCT00908895|436280|P1|STARTED|Overall Study||57
180952|NCT00908882|436290|P2|NOT COMPLETED|Overall Study||30
180953|NCT00908882|436291|P1|NOT COMPLETED|Overall Study||28
180954|NCT00908882|436290|P2|COMPLETED|Overall Study||59
180955|NCT00908882|436291|P1|COMPLETED|Overall Study||61
180956|NCT00908882|436290|P2|STARTED|Overall Study||89
180957|NCT00908882|436291|P1|STARTED|Overall Study||89
180958|NCT00908687|436321|P6|NOT COMPLETED|Overall Study||6
180959|NCT00908687|436322|P5|NOT COMPLETED|Overall Study||4
180960|NCT00908687|436323|P4|NOT COMPLETED|Overall Study||3
180961|NCT00908687|436324|P3|NOT COMPLETED|Overall Study||3
180962|NCT00908687|436325|P2|NOT COMPLETED|Overall Study||1
180963|NCT00908687|436326|P1|NOT COMPLETED|Overall Study||1
180964|NCT00908687|436321|P6|COMPLETED|Overall Study||94
180965|NCT00908687|436322|P5|COMPLETED|Overall Study||94
180966|NCT00908687|436323|P4|COMPLETED|Overall Study||47
180967|NCT00908687|436324|P3|COMPLETED|Overall Study||99
180968|NCT00908687|436325|P2|COMPLETED|Overall Study||99
180969|NCT00908687|436326|P1|COMPLETED|Overall Study||49
180970|NCT00908687|436321|P6|STARTED|Overall Study||100
180971|NCT00908687|436322|P5|STARTED|Overall Study||98
180972|NCT00908687|436323|P4|STARTED|Overall Study||50
180973|NCT00908687|436324|P3|STARTED|Overall Study||102
180974|NCT00908687|436325|P2|STARTED|Overall Study||100
180975|NCT00908687|436326|P1|STARTED|Overall Study||50
180976|NCT00908648|436342|P2|NOT COMPLETED|Overall Study||0
180977|NCT00908648|436343|P1|NOT COMPLETED|Overall Study||0
180978|NCT00908648|436342|P2|COMPLETED|Overall Study||103
180979|NCT00908648|436343|P1|COMPLETED|Overall Study||108
180980|NCT00908648|436342|P2|STARTED|Overall Study||103
180981|NCT00908648|436343|P1|STARTED|Overall Study||108
180982|NCT00908596|436353|P4|NOT COMPLETED|Overall Study||37
180983|NCT00908596|436354|P3|NOT COMPLETED|Overall Study||74
180984|NCT00908596|436355|P2|NOT COMPLETED|Overall Study||13
180985|NCT00908596|436356|P1|NOT COMPLETED|Overall Study||47
180986|NCT00908596|436353|P4|COMPLETED|Overall Study||48
180987|NCT00908596|436354|P3|COMPLETED|Overall Study||119
180988|NCT00908596|436355|P2|COMPLETED|Overall Study||19
180989|NCT00908596|436356|P1|COMPLETED|Overall Study||0
180990|NCT00908596|436353|P4|STARTED|Overall Study||85
180991|NCT00908596|436354|P3|STARTED|Overall Study||193
180992|NCT00908596|436355|P2|STARTED|Overall Study||32
180993|NCT00908596|436356|P1|STARTED|Overall Study||47
180994|NCT00908583|436386|P1|NOT COMPLETED|Phase 5||3
180995|NCT00908583|436386|P1|COMPLETED|Phase 5||2
180996|NCT00908583|436386|P1|STARTED|Phase 5||5
180997|NCT00908583|436386|P1|NOT COMPLETED|Phase 4||2
180998|NCT00908583|436386|P1|COMPLETED|Phase 4||3
180999|NCT00908583|436386|P1|STARTED|Phase 4||5
181000|NCT00908583|436386|P1|NOT COMPLETED|Phase 3||2
181001|NCT00908583|436386|P1|COMPLETED|Phase 3||8
181002|NCT00908583|436386|P1|STARTED|Phase 3||10
181003|NCT00908583|436386|P1|NOT COMPLETED|Phase 2||2
181004|NCT00908583|436386|P1|COMPLETED|Phase 2||10
181005|NCT00908583|436386|P1|STARTED|Phase 2||12
181006|NCT00908583|436386|P1|NOT COMPLETED|Phase 1||5
181007|NCT00908583|436386|P1|COMPLETED|Phase 1||15
181008|NCT00908583|436386|P1|STARTED|Phase 1||20
181009|NCT00908388|436404|P1|NOT COMPLETED|Overall Study||10
181010|NCT00908388|436404|P1|COMPLETED|Overall Study||40
181011|NCT00908388|436404|P1|STARTED|Overall Study||50
181012|NCT00908375|436414|P2|NOT COMPLETED|Overall Study||10
181013|NCT00908375|436415|P1|NOT COMPLETED|Overall Study||10
181014|NCT00908375|436414|P2|COMPLETED|Overall Study||9
181015|NCT00908375|436415|P1|COMPLETED|Overall Study||10
181016|NCT00908375|436414|P2|STARTED|Overall Study||19
181017|NCT00908375|436415|P1|STARTED|Overall Study||20
181018|NCT00908349|436425|P1|NOT COMPLETED|Overall Study||35
181019|NCT00908349|436425|P1|COMPLETED|Overall Study||179
181020|NCT00908349|436425|P1|STARTED|Overall Study||214
181021|NCT00908310|436429|P1|NOT COMPLETED|Overall Study||60
181022|NCT00908310|436429|P1|COMPLETED|Overall Study||153
181023|NCT00908310|436429|P1|STARTED|Overall Study||213
181024|NCT00908232|436433|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
181025|NCT00908232|436434|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
181026|NCT00908232|436435|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
181027|NCT00908232|436436|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
181028|NCT00908232|436433|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
181029|NCT00908232|436434|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
181030|NCT00908232|436435|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
181031|NCT00908232|436436|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
181032|NCT00908232|436433|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
181033|NCT00908232|436434|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
181034|NCT00908232|436435|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
181035|NCT00908232|436436|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
181036|NCT00908232|436433|P4|NOT COMPLETED|Cycle 1 to 4||0
181037|NCT00908232|436434|P3|NOT COMPLETED|Cycle 1 to 4||0
181038|NCT00908232|436435|P2|NOT COMPLETED|Cycle 1 to 4||0
181039|NCT00908232|436436|P1|NOT COMPLETED|Cycle 1 to 4||28
181040|NCT00908232|436433|P4|COMPLETED|Cycle 1 to 4||0
181041|NCT00908232|436434|P3|COMPLETED|Cycle 1 to 4||0
181042|NCT00908232|436435|P2|COMPLETED|Cycle 1 to 4||0
181043|NCT00908232|436436|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
181044|NCT00908232|436433|P4|STARTED|Cycle 1 to 4||0
181045|NCT00908232|436434|P3|STARTED|Cycle 1 to 4||0
181046|NCT00908232|436435|P2|STARTED|Cycle 1 to 4||0
181207|NCT00907907|436663|P2|NOT COMPLETED|Period 3||0
181047|NCT00908232|436436|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
181048|NCT00908141|436454|P2|NOT COMPLETED|Overall Study||1
181049|NCT00908141|436455|P1|NOT COMPLETED|Overall Study||0
181050|NCT00908141|436454|P2|COMPLETED|Overall Study||8
181051|NCT00908141|436455|P1|COMPLETED|Overall Study||8
181052|NCT00908141|436454|P2|STARTED|Overall Study||9
181053|NCT00908141|436455|P1|STARTED|Overall Study||8
181054|NCT00908128|436463|P2|NOT COMPLETED|Period 4||0
181055|NCT00908128|436464|P1|NOT COMPLETED|Period 4||0
181056|NCT00908128|436463|P2|COMPLETED|Period 4||19
181057|NCT00908128|436464|P1|COMPLETED|Period 4||20
181058|NCT00908128|436463|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
181059|NCT00908128|436464|P1|STARTED|Period 4||20
181060|NCT00908128|436463|P2|NOT COMPLETED|Period 3||0
181061|NCT00908128|436464|P1|NOT COMPLETED|Period 3||0
181062|NCT00908128|436463|P2|COMPLETED|Period 3||20
181063|NCT00908128|436464|P1|COMPLETED|Period 3||20
181064|NCT00908128|436463|P2|STARTED|Period 3||20
181065|NCT00908128|436464|P1|STARTED|Period 3||20
181066|NCT00908128|436463|P2|NOT COMPLETED|Period 2||0
181067|NCT00908128|436464|P1|NOT COMPLETED|Period 2||0
181068|NCT00908128|436463|P2|COMPLETED|Period 2||20
181069|NCT00908128|436464|P1|COMPLETED|Period 2||20
181070|NCT00908128|436463|P2|STARTED|Period 2||20
181071|NCT00908128|436464|P1|STARTED|Period 2||20
181072|NCT00908128|436463|P2|NOT COMPLETED|Period 1||0
181073|NCT00908128|436464|P1|NOT COMPLETED|Period 1||0
181074|NCT00908128|436463|P2|COMPLETED|Period 1||20
181075|NCT00908128|436464|P1|COMPLETED|Period 1||20
181076|NCT00908128|436463|P2|STARTED|Period 1||20
181077|NCT00908128|436464|P1|STARTED|Period 1||20
181078|NCT00908115|436472|P1|NOT COMPLETED|Overall Study||14
181079|NCT00908115|436472|P1|COMPLETED|Overall Study||1244
181080|NCT00908115|436472|P1|STARTED|Overall Study||1258
181081|NCT00908076|436480|P2|NOT COMPLETED|Overall Study||1
181082|NCT00908076|436481|P1|NOT COMPLETED|Overall Study||1
181083|NCT00908076|436480|P2|COMPLETED|Overall Study||26
181084|NCT00908076|436481|P1|COMPLETED|Overall Study||26
181085|NCT00908076|436480|P2|STARTED|Overall Study||27
181086|NCT00908076|436481|P1|STARTED|Overall Study||27
181087|NCT00908037|436494|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
181088|NCT00908037|436495|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
181089|NCT00908037|436496|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
181090|NCT00908037|436497|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181091|NCT00908037|436498|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181092|NCT00908037|436499|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181093|NCT00908037|436500|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181094|NCT00908037|436501|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181095|NCT00908037|436502|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181096|NCT00908037|436503|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181097|NCT00908037|436504|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181098|NCT00908037|436505|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181099|NCT00908037|436494|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
181100|NCT00908037|436495|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
181101|NCT00908037|436496|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
181102|NCT00908037|436497|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181103|NCT00908037|436498|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181104|NCT00908037|436499|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181105|NCT00908037|436500|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181106|NCT00908037|436501|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181107|NCT00908037|436502|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181108|NCT00908037|436503|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181109|NCT00908037|436504|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181110|NCT00908037|436505|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
181111|NCT00908037|436494|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
181112|NCT00908037|436495|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
181113|NCT00908037|436496|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
181114|NCT00908037|436497|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181115|NCT00908037|436498|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181116|NCT00908037|436499|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181117|NCT00908037|436500|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181118|NCT00908037|436501|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181119|NCT00908037|436502|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181120|NCT00908037|436503|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181121|NCT00908037|436504|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181122|NCT00908037|436505|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
181123|NCT00908037|436494|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181124|NCT00908037|436495|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181125|NCT00908037|436496|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181126|NCT00908037|436497|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
181127|NCT00908037|436498|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181128|NCT00908037|436499|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
181129|NCT00908037|436500|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181130|NCT00908037|436501|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
181131|NCT00908037|436502|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
181132|NCT00908037|436503|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181133|NCT00908037|436504|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181134|NCT00908037|436505|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
181135|NCT00908037|436494|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
181136|NCT00908037|436495|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
181137|NCT00908037|436496|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
181138|NCT00908037|436497|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
181139|NCT00908037|436498|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
181140|NCT00908037|436499|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
181141|NCT00908037|436500|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
181142|NCT00908037|436501|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
181143|NCT00908037|436502|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
181144|NCT00908037|436503|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
181145|NCT00908037|436504|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
181146|NCT00908037|436505|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
181147|NCT00908037|436494|P12|STARTED|Part 2 (7 Week Randomized Period)||0
181148|NCT00908037|436495|P11|STARTED|Part 2 (7 Week Randomized Period)||0
181149|NCT00908037|436496|P10|STARTED|Part 2 (7 Week Randomized Period)||0
181150|NCT00908037|436497|P9|STARTED|Part 2 (7 Week Randomized Period)||10
181151|NCT00908037|436498|P8|STARTED|Part 2 (7 Week Randomized Period)||5
181152|NCT00908037|436499|P7|STARTED|Part 2 (7 Week Randomized Period)||19
181153|NCT00908037|436500|P6|STARTED|Part 2 (7 Week Randomized Period)||9
181154|NCT00908037|436501|P5|STARTED|Part 2 (7 Week Randomized Period)||16
181155|NCT00908037|436502|P4|STARTED|Part 2 (7 Week Randomized Period)||8
181156|NCT00908037|436503|P3|STARTED|Part 2 (7 Week Randomized Period)||0
181157|NCT00908037|436504|P2|STARTED|Part 2 (7 Week Randomized Period)||0
181158|NCT00908037|436505|P1|STARTED|Part 2 (7 Week Randomized Period)||0
181159|NCT00908037|436494|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181160|NCT00908037|436495|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181161|NCT00908037|436496|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181162|NCT00908037|436497|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181163|NCT00908037|436498|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181164|NCT00908037|436499|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181165|NCT00908037|436500|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181166|NCT00908037|436501|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181167|NCT00908037|436502|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181168|NCT00908037|436503|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181169|NCT00908037|436504|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181170|NCT00908037|436505|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181171|NCT00908037|436494|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181172|NCT00908037|436495|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181173|NCT00908037|436496|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181174|NCT00908037|436497|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181175|NCT00908037|436498|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181176|NCT00908037|436499|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181177|NCT00908037|436500|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181178|NCT00908037|436501|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181179|NCT00908037|436502|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
181180|NCT00908037|436503|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
181181|NCT00908037|436504|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
181182|NCT00908037|436505|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
181183|NCT00908037|436494|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
181184|NCT00908037|436495|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
181185|NCT00908037|436496|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
181186|NCT00908037|436497|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
181187|NCT00908037|436498|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
181188|NCT00908037|436499|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
181189|NCT00908037|436500|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
181190|NCT00908037|436501|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
181191|NCT00908037|436502|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
181192|NCT00908037|436503|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
181193|NCT00908037|436504|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
181194|NCT00908037|436505|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
181195|NCT00908011|436654|P2|NOT COMPLETED|Overall Study||2
181196|NCT00908011|436655|P1|NOT COMPLETED|Overall Study||2
181197|NCT00908011|436654|P2|COMPLETED|Overall Study||18
181198|NCT00908011|436655|P1|COMPLETED|Overall Study||21
181199|NCT00908011|436654|P2|STARTED|Overall Study||20
181200|NCT00908011|436655|P1|STARTED|Overall Study||23
181201|NCT00907907|436663|P2|NOT COMPLETED|Period 4||0
181202|NCT00907907|436664|P1|NOT COMPLETED|Period 4||0
181203|NCT00907907|436663|P2|COMPLETED|Period 4||18
181204|NCT00907907|436664|P1|COMPLETED|Period 4||19
181205|NCT00907907|436663|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
181206|NCT00907907|436664|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
181208|NCT00907907|436664|P1|NOT COMPLETED|Period 3||0
181209|NCT00907907|436663|P2|COMPLETED|Period 3||20
181210|NCT00907907|436664|P1|COMPLETED|Period 3||20
181211|NCT00907907|436663|P2|STARTED|Period 3||20
181212|NCT00907907|436664|P1|STARTED|Period 3||20
181213|NCT00907907|436663|P2|NOT COMPLETED|Period 2||0
181214|NCT00907907|436664|P1|NOT COMPLETED|Period 2||0
181215|NCT00907907|436663|P2|COMPLETED|Period 2||20
181216|NCT00907907|436664|P1|COMPLETED|Period 2||20
181217|NCT00907907|436663|P2|STARTED|Period 2||20
181218|NCT00907907|436664|P1|STARTED|Period 2||20
181219|NCT00907907|436663|P2|NOT COMPLETED|Period 1||0
181220|NCT00907907|436664|P1|NOT COMPLETED|Period 1||0
181221|NCT00907907|436663|P2|COMPLETED|Period 1||20
181222|NCT00907907|436664|P1|COMPLETED|Period 1||20
181223|NCT00907907|436663|P2|STARTED|Period 1||20
181224|NCT00907907|436664|P1|STARTED|Period 1||20
181225|NCT00907881|436672|P1|NOT COMPLETED|Overall Study||85
181226|NCT00907881|436672|P1|COMPLETED|Overall Study||984
181227|NCT00907881|436672|P1|STARTED|Overall Study||1069
181228|NCT00907803|436682|P3|NOT COMPLETED|Overall Study||0
181229|NCT00907803|436683|P2|NOT COMPLETED|Overall Study||3
181230|NCT00907803|436684|P1|NOT COMPLETED|Overall Study||3
181231|NCT00907803|436682|P3|COMPLETED|Overall Study||16
181232|NCT00907803|436683|P2|COMPLETED|Overall Study||43
181233|NCT00907803|436684|P1|COMPLETED|Overall Study||42
181234|NCT00907803|436682|P3|STARTED|Overall Study||16
181235|NCT00907803|436683|P2|STARTED|Overall Study||46
181236|NCT00907803|436684|P1|STARTED|Overall Study||45
181237|NCT00907777|436715|P2|NOT COMPLETED|Overall Study||1
181238|NCT00907777|436716|P1|NOT COMPLETED|Overall Study||0
181239|NCT00907777|436715|P2|COMPLETED|Overall Study||26
181240|NCT00907777|436716|P1|COMPLETED|Overall Study||25
181241|NCT00907777|436715|P2|STARTED|Overall Study||27
181242|NCT00907777|436716|P1|STARTED|Overall Study||25
181243|NCT00907738|436743|P5|NOT COMPLETED|Overall Study||2
181244|NCT00907738|436744|P4|NOT COMPLETED|Overall Study||4
181245|NCT00907738|436745|P3|NOT COMPLETED|Overall Study||7
181246|NCT00907738|436746|P2|NOT COMPLETED|Overall Study||1
181247|NCT00907738|436747|P1|NOT COMPLETED|Overall Study||13
181248|NCT00907738|436743|P5|COMPLETED|Overall Study||0
181249|NCT00907738|436744|P4|COMPLETED|Overall Study||0
181250|NCT00907738|436745|P3|COMPLETED|Overall Study||0
181251|NCT00907738|436746|P2|COMPLETED|Overall Study||0
181252|NCT00907738|436747|P1|COMPLETED|Overall Study||0
181253|NCT00907738|436743|P5|STARTED|Overall Study||2
181254|NCT00907738|436744|P4|STARTED|Overall Study||4
181255|NCT00907738|436745|P3|STARTED|Overall Study||7
181256|NCT00907738|436746|P2|STARTED|Overall Study||1
181257|NCT00907738|436747|P1|STARTED|Overall Study||13
181258|NCT00907621|436765|P2|NOT COMPLETED|Overall Study||4
181259|NCT00907621|436766|P1|NOT COMPLETED|Overall Study||7
181260|NCT00907621|436765|P2|COMPLETED|Overall Study||41
181261|NCT00907621|436766|P1|COMPLETED|Overall Study||38
181262|NCT00907621|436765|P2|STARTED|Overall Study||45
181263|NCT00907621|436766|P1|STARTED|Overall Study||45
181264|NCT00907517|436779|P5|NOT COMPLETED|Overall Study||5
181265|NCT00907517|436780|P4|NOT COMPLETED|Overall Study||4
181266|NCT00907517|436781|P3|NOT COMPLETED|Overall Study||4
181267|NCT00907517|436782|P2|NOT COMPLETED|Overall Study||3
181268|NCT00907517|436783|P1|NOT COMPLETED|Overall Study||3
181269|NCT00907517|436779|P5|COMPLETED|Overall Study||1
181270|NCT00907517|436780|P4|COMPLETED|Overall Study||2
181271|NCT00907517|436781|P3|COMPLETED|Overall Study||2
181272|NCT00907517|436782|P2|COMPLETED|Overall Study||0
181273|NCT00907517|436783|P1|COMPLETED|Overall Study||0
181274|NCT00907517|436779|P5|STARTED|Overall Study||6
181275|NCT00907517|436780|P4|STARTED|Overall Study||6
181276|NCT00907517|436781|P3|STARTED|Overall Study||6
181277|NCT00907517|436782|P2|STARTED|Overall Study||3
181278|NCT00907517|436783|P1|STARTED|Overall Study||3
181279|NCT00907478|436808|P3|NOT COMPLETED|Overall Study||22
181280|NCT00907478|436809|P2|NOT COMPLETED|Overall Study||17
181281|NCT00907478|436810|P1|NOT COMPLETED|Overall Study||27
181282|NCT00907478|436808|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
181283|NCT00907478|436809|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
181284|NCT00907478|436810|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
181285|NCT00907478|436808|P3|STARTED|Overall Study||69
181286|NCT00907478|436809|P2|STARTED|Overall Study||50
181287|NCT00907478|436810|P1|STARTED|Overall Study||50
181288|NCT00907426|436841|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
181289|NCT00907426|436842|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
181290|NCT00907426|436843|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
181291|NCT00907426|436841|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
181292|NCT00907426|436842|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
181293|NCT00907426|436843|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
181294|NCT00907426|436841|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
181295|NCT00907426|436842|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
181296|NCT00907426|436843|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
181297|NCT00907426|436841|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
181298|NCT00907426|436842|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
181299|NCT00907426|436843|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
181300|NCT00907426|436841|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
181301|NCT00907426|436842|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
181302|NCT00907426|436843|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
181303|NCT00907426|436841|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
181304|NCT00907426|436842|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
181305|NCT00907426|436843|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
181306|NCT00907374|436860|P2|NOT COMPLETED|Overall Study||2
181307|NCT00907374|436861|P1|NOT COMPLETED|Overall Study||2
181308|NCT00907374|436860|P2|COMPLETED|Overall Study||11
181309|NCT00907374|436861|P1|COMPLETED|Overall Study||12
181310|NCT00907374|436860|P2|STARTED|Overall Study||13
181311|NCT00907374|436861|P1|STARTED|Overall Study||14
181312|NCT00907335|436875|P2|NOT COMPLETED|Overall Study||1
181313|NCT00907335|436876|P1|NOT COMPLETED|Overall Study||8
181314|NCT00907335|436875|P2|COMPLETED|Overall Study||54
181315|NCT00907335|436876|P1|COMPLETED|Overall Study||47
181316|NCT00907335|436875|P2|STARTED|Overall Study||55
181317|NCT00907335|436876|P1|STARTED|Overall Study||55
181318|NCT00907257|436894|P2|NOT COMPLETED|Overall Study||12
181319|NCT00907257|436895|P1|NOT COMPLETED|Overall Study||13
181320|NCT00907257|436894|P2|COMPLETED|Overall Study||112
181321|NCT00907257|436895|P1|COMPLETED|Overall Study||110
181322|NCT00907257|436894|P2|STARTED|Overall Study||124
181323|NCT00907257|436895|P1|STARTED|Overall Study||123
181324|NCT00907218|436905|P1|NOT COMPLETED|Overall Study||0
181325|NCT00907218|436905|P1|COMPLETED|Overall Study||2
181326|NCT00907218|436905|P1|STARTED|Overall Study||2
181327|NCT00907153|436917|P2|NOT COMPLETED|Overall Study||4
181328|NCT00907153|436918|P1|NOT COMPLETED|Overall Study||2
181329|NCT00907153|436917|P2|COMPLETED|Overall Study||11
181330|NCT00907153|436918|P1|COMPLETED|Overall Study||11
181331|NCT00907153|436917|P2|STARTED|Overall Study||15
181332|NCT00907153|436918|P1|STARTED|Overall Study||13
181333|NCT00907101|436960|P1|NOT COMPLETED|Overall Study||0
181334|NCT00907101|436960|P1|COMPLETED|Overall Study||30
181335|NCT00907101|436960|P1|STARTED|Overall Study||30
181336|NCT00907088|436970|P2|NOT COMPLETED|Overall Study||30
181337|NCT00907088|436971|P1|NOT COMPLETED|Overall Study||20
181338|NCT00907088|436970|P2|COMPLETED|Overall Study||99
181339|NCT00907088|436971|P1|COMPLETED|Overall Study||102
181340|NCT00907088|436970|P2|STARTED|Overall Study||129
181341|NCT00907088|436971|P1|STARTED|Overall Study||122
181342|NCT00906971|436979|P2|NOT COMPLETED|Overall Study||3
181343|NCT00906971|436980|P1|NOT COMPLETED|Overall Study||8
181344|NCT00906971|436979|P2|COMPLETED|Overall Study||33
181345|NCT00906971|436980|P1|COMPLETED|Overall Study||28
181346|NCT00906971|436979|P2|STARTED|Overall Study||36
181347|NCT00906971|436980|P1|STARTED|Overall Study||36
181348|NCT00906945|436993|P6|NOT COMPLETED|Overall Study||2
181349|NCT00906945|436994|P5|NOT COMPLETED|Overall Study||1
181350|NCT00906945|436995|P4|NOT COMPLETED|Overall Study||1
181351|NCT00906945|436996|P3|NOT COMPLETED|Overall Study||0
181352|NCT00906945|436997|P2|NOT COMPLETED|Overall Study||0
181353|NCT00906945|436998|P1|NOT COMPLETED|Overall Study||0
181354|NCT00906945|436993|P6|COMPLETED|Overall Study||14
181355|NCT00906945|436994|P5|COMPLETED|Overall Study||6
181356|NCT00906945|436995|P4|COMPLETED|Overall Study||6
181357|NCT00906945|436996|P3|COMPLETED|Overall Study||3
181358|NCT00906945|436997|P2|COMPLETED|Overall Study||3
181359|NCT00906945|436998|P1|COMPLETED|Overall Study||3
181360|NCT00906945|436993|P6|STARTED|Overall Study||16
181361|NCT00906945|436994|P5|STARTED|Overall Study||7
181362|NCT00906945|436995|P4|STARTED|Overall Study||7
181363|NCT00906945|436996|P3|STARTED|Overall Study||3
181364|NCT00906945|436997|P2|STARTED|Overall Study||3
181365|NCT00906945|436998|P1|STARTED|Overall Study||3
181366|NCT00906789|437025|P1|NOT COMPLETED|Overall Study||0
181367|NCT00906789|437025|P1|COMPLETED|Overall Study||15
181368|NCT00906789|437025|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
181369|NCT00906776|437035|P2|NOT COMPLETED|Overall Study||0
181370|NCT00906776|437036|P1|NOT COMPLETED|Overall Study||0
181371|NCT00906776|437035|P2|COMPLETED|Overall Study||8
181372|NCT00906776|437036|P1|COMPLETED|Overall Study||11
181373|NCT00906776|437035|P2|STARTED|Overall Study||8
181374|NCT00906776|437036|P1|STARTED|Overall Study||11
181375|NCT00906698|437058|P6|NOT COMPLETED|Overall Study||5
181376|NCT00906698|437059|P5|NOT COMPLETED|Overall Study||18
181377|NCT00906698|437060|P4|NOT COMPLETED|Overall Study||4
181378|NCT00906698|437061|P3|NOT COMPLETED|Overall Study||6
181379|NCT00906698|437062|P2|NOT COMPLETED|Overall Study||19
181380|NCT00906698|437063|P1|NOT COMPLETED|Overall Study||3
181381|NCT00906698|437058|P6|COMPLETED|Overall Study||0
181382|NCT00906698|437059|P5|COMPLETED|Overall Study||0
181383|NCT00906698|437060|P4|COMPLETED|Overall Study||0
181384|NCT00906698|437061|P3|COMPLETED|Overall Study||0
181385|NCT00906698|437062|P2|COMPLETED|Overall Study||0
181386|NCT00906698|437063|P1|COMPLETED|Overall Study||0
181387|NCT00906698|437058|P6|STARTED|Overall Study||5
181388|NCT00906698|437059|P5|STARTED|Overall Study||18
181389|NCT00906698|437060|P4|STARTED|Overall Study||4
181390|NCT00906698|437061|P3|STARTED|Overall Study||6
181391|NCT00906698|437062|P2|STARTED|Overall Study||19
181392|NCT00906698|437063|P1|STARTED|Overall Study||3
181393|NCT00906503|437145|P1|NOT COMPLETED|Overall Study||0
181394|NCT00906503|437145|P1|COMPLETED|Overall Study||9
181395|NCT00906503|437145|P1|STARTED|Overall Study||9
181396|NCT00906425|437151|P2|NOT COMPLETED|Overall Study||72
181397|NCT00906425|437152|P1|NOT COMPLETED|Overall Study||73
181398|NCT00906425|437151|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
181399|NCT00906425|437152|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
181400|NCT00906425|437151|P2|2 Year|Overall Study|ITT population|58
181401|NCT00906425|437152|P1|2 Year|Overall Study|ITT population|62
181402|NCT00906425|437151|P2|1 Year|Overall Study|ITT population|60
181403|NCT00906425|437152|P1|1 Year|Overall Study|ITT population|67
181404|NCT00906425|437151|P2|6 Months|Overall Study|ITT population|64
181405|NCT00906425|437152|P1|6 Months|Overall Study|ITT population|69
181406|NCT00906425|437151|P2|STARTED|Overall Study||72
181407|NCT00906425|437152|P1|STARTED|Overall Study||73
181408|NCT00906399|437165|P7|NOT COMPLETED|Year 2||29
181409|NCT00906399|437166|P6|NOT COMPLETED|Year 2||47
181410|NCT00906399|437167|P5|NOT COMPLETED|Year 2||35
181411|NCT00906399|437168|P4|NOT COMPLETED|Year 2||30
181412|NCT00906399|437169|P3|NOT COMPLETED|Year 2||0
181413|NCT00906399|437170|P2|NOT COMPLETED|Year 2||0
181414|NCT00906399|437171|P1|NOT COMPLETED|Year 2||0
181415|NCT00906399|437165|P7|COMPLETED|Year 2||409
181416|NCT00906399|437166|P6|COMPLETED|Year 2||391
181417|NCT00906399|437167|P5|COMPLETED|Year 2||193
181418|NCT00906399|437168|P4|COMPLETED|Year 2||198
181419|NCT00906399|437169|P3|COMPLETED|Year 2||0
181420|NCT00906399|437170|P2|COMPLETED|Year 2||0
181421|NCT00906399|437171|P1|COMPLETED|Year 2||0
181422|NCT00906399|437165|P7|Completed Year 2 Study Treatment|Year 2||411
181423|NCT00906399|437166|P6|Completed Year 2 Study Treatment|Year 2||391
181424|NCT00906399|437167|P5|Completed Year 2 Study Treatment|Year 2||196
181425|NCT00906399|437168|P4|Completed Year 2 Study Treatment|Year 2||200
181426|NCT00906399|437169|P3|Completed Year 2 Study Treatment|Year 2||0
181427|NCT00906399|437170|P2|Completed Year 2 Study Treatment|Year 2||0
181428|NCT00906399|437171|P1|Completed Year 2 Study Treatment|Year 2||0
181429|NCT00906399|437165|P7|STARTED|Year 2||438
181430|NCT00906399|437166|P6|STARTED|Year 2||438
181431|NCT00906399|437167|P5|STARTED|Year 2||228
181432|NCT00906399|437168|P4|STARTED|Year 2||228
181433|NCT00906399|437169|P3|STARTED|Year 2||0
181434|NCT00906399|437170|P2|STARTED|Year 2||0
181435|NCT00906399|437171|P1|STARTED|Year 2||0
181436|NCT00906399|437165|P7|NOT COMPLETED|Year 1||0
181437|NCT00906399|437166|P6|NOT COMPLETED|Year 1||0
181438|NCT00906399|437167|P5|NOT COMPLETED|Year 1||0
181439|NCT00906399|437168|P4|NOT COMPLETED|Year 1||0
181440|NCT00906399|437169|P3|NOT COMPLETED|Year 1||76
181441|NCT00906399|437170|P2|NOT COMPLETED|Year 1||63
181442|NCT00906399|437171|P1|NOT COMPLETED|Year 1||44
181443|NCT00906399|437165|P7|COMPLETED|Year 1||0
181444|NCT00906399|437166|P6|COMPLETED|Year 1||0
181445|NCT00906399|437167|P5|COMPLETED|Year 1||0
181446|NCT00906399|437168|P4|COMPLETED|Year 1||0
181447|NCT00906399|437169|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
181448|NCT00906399|437170|P2|COMPLETED|Year 1||438
181449|NCT00906399|437171|P1|COMPLETED|Year 1||456
181450|NCT00906399|437165|P7|Completed Year 1 Study Treatment|Year 1||0
181451|NCT00906399|437166|P6|Completed Year 1 Study Treatment|Year 1||0
181452|NCT00906399|437167|P5|Completed Year 1 Study Treatment|Year 1||0
181453|NCT00906399|437168|P4|Completed Year 1 Study Treatment|Year 1||0
181454|NCT00906399|437169|P3|Completed Year 1 Study Treatment|Year 1||438
181455|NCT00906399|437170|P2|Completed Year 1 Study Treatment|Year 1||438
181456|NCT00906399|437171|P1|Completed Year 1 Study Treatment|Year 1||456
181457|NCT00906399|437165|P7|STARTED|Year 1||0
181458|NCT00906399|437166|P6|STARTED|Year 1||0
181459|NCT00906399|437167|P5|STARTED|Year 1||0
181460|NCT00906399|437168|P4|STARTED|Year 1||0
181461|NCT00906399|437169|P3|STARTED|Year 1||515
181462|NCT00906399|437170|P2|STARTED|Year 1||501
181463|NCT00906399|437171|P1|STARTED|Year 1||500
181464|NCT00906347|437194|P2|NOT COMPLETED|Received Study Drug||31
181465|NCT00906347|437195|P1|NOT COMPLETED|Received Study Drug||40
181466|NCT00906347|437194|P2|COMPLETED|Received Study Drug||143
181467|NCT00906347|437195|P1|COMPLETED|Received Study Drug||136
181468|NCT00906347|437194|P2|STARTED|Received Study Drug||174
181469|NCT00906347|437195|P1|STARTED|Received Study Drug||176
181470|NCT00906347|437194|P2|NOT COMPLETED|Randomized||0
181471|NCT00906347|437195|P1|NOT COMPLETED|Randomized||0
181472|NCT00906347|437194|P2|COMPLETED|Randomized||174
181473|NCT00906347|437195|P1|COMPLETED|Randomized||176
181474|NCT00906347|437194|P2|STARTED|Randomized||174
181475|NCT00906347|437195|P1|STARTED|Randomized||176
181476|NCT00906282|437215|P1|NOT COMPLETED|Surgical Resection||0
181477|NCT00906282|437215|P1|COMPLETED|Surgical Resection||27
181478|NCT00906282|437215|P1|STARTED|Surgical Resection||27
181479|NCT00906282|437215|P1|NOT COMPLETED|Preoperative Chemotherapy||19
181480|NCT00906282|437215|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
181481|NCT00906282|437215|P1|STARTED|Preoperative Chemotherapy||46
181482|NCT00906243|437223|P1|NOT COMPLETED|Overall Study||0
181483|NCT00906243|437223|P1|COMPLETED|Overall Study||6
181484|NCT00906243|437223|P1|STARTED|Overall Study||6
181485|NCT00906204|437229|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
181486|NCT00906204|437230|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
181487|NCT00906204|437229|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
181488|NCT00906204|437230|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
181489|NCT00906204|437229|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
181490|NCT00906204|437230|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
181491|NCT00906204|437229|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
181492|NCT00906204|437230|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
181493|NCT00906204|437229|P2|COMPLETED|Primary Endpoint (Early Safety)||51
181494|NCT00906204|437230|P1|COMPLETED|Primary Endpoint (Early Safety)||43
181495|NCT00906204|437229|P2|STARTED|Primary Endpoint (Early Safety)||52
181496|NCT00906204|437230|P1|STARTED|Primary Endpoint (Early Safety)||45
181497|NCT00906178|437248|P2|NOT COMPLETED|Overall Study||16
181498|NCT00906178|437249|P1|NOT COMPLETED|Overall Study||15
181499|NCT00906178|437248|P2|COMPLETED|Overall Study||167
181500|NCT00906178|437249|P1|COMPLETED|Overall Study||168
181501|NCT00906178|437248|P2|STARTED|Overall Study||183
181502|NCT00906178|437249|P1|STARTED|Overall Study||183
181503|NCT00906087|437261|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
181504|NCT00906087|437261|P1|COMPLETED|Final Washout Period 4 Weeks||12
181505|NCT00906087|437261|P1|STARTED|Final Washout Period 4 Weeks||12
181506|NCT00906087|437261|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
181507|NCT00906087|437261|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
181508|NCT00906087|437261|P1|STARTED|Cosopt Treatment 6 Weeks||12
181509|NCT00906087|437261|P1|NOT COMPLETED|Initial Washout||2
181510|NCT00906087|437261|P1|COMPLETED|Initial Washout||12
181511|NCT00906087|437261|P1|Completed Washout and Continue Protocol|Initial Washout||12
181512|NCT00906087|437261|P1|Begin Washout|Initial Washout||13
181513|NCT00906087|437261|P1|Completed Screening|Initial Washout||14
181514|NCT00906087|437261|P1|STARTED|Initial Washout||14
181515|NCT00906074|437270|P2|NOT COMPLETED|Overall Study||0
181516|NCT00906074|437271|P1|NOT COMPLETED|Overall Study||0
181517|NCT00906074|437270|P2|COMPLETED|Overall Study||90
181518|NCT00906074|437271|P1|COMPLETED|Overall Study||90
181519|NCT00906074|437270|P2|STARTED|Overall Study||90
181520|NCT00906074|437271|P1|STARTED|Overall Study||90
181521|NCT00906035|437298|P3|NOT COMPLETED|Overall Study||0
181522|NCT00906035|437299|P2|NOT COMPLETED|Overall Study||3
181523|NCT00906035|437300|P1|NOT COMPLETED|Overall Study||2
181524|NCT00906035|437298|P3|COMPLETED|Overall Study||8
181525|NCT00906035|437299|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
181526|NCT00906035|437300|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
181527|NCT00906035|437298|P3|STARTED|Overall Study||8
181528|NCT00906035|437299|P2|STARTED|Overall Study||9
181529|NCT00906035|437300|P1|STARTED|Overall Study||8
181530|NCT00905840|437314|P1|NOT COMPLETED|Overall Study||16
181531|NCT00905840|437314|P1|COMPLETED|Overall Study||75
181532|NCT00905840|437314|P1|STARTED|Overall Study||91
181533|NCT00905827|437326|P3|NOT COMPLETED|Overall Study||0
181534|NCT00905827|437327|P2|NOT COMPLETED|Overall Study||0
181535|NCT00905827|437328|P1|NOT COMPLETED|Overall Study||0
181536|NCT00905827|437326|P3|COMPLETED|Overall Study||73
181537|NCT00905827|437327|P2|COMPLETED|Overall Study||69
181538|NCT00905827|437328|P1|COMPLETED|Overall Study||70
181539|NCT00905827|437326|P3|STARTED|Overall Study||73
181540|NCT00905827|437327|P2|STARTED|Overall Study||69
181541|NCT00905827|437328|P1|STARTED|Overall Study||70
181542|NCT00905632|437345|P7|NOT COMPLETED|Overall Study||4
181543|NCT00905632|437346|P6|NOT COMPLETED|Overall Study||1
181544|NCT00905632|437347|P5|NOT COMPLETED|Overall Study||0
181545|NCT00905632|437348|P4|NOT COMPLETED|Overall Study||0
181546|NCT00905632|437349|P3|NOT COMPLETED|Overall Study||0
181547|NCT00905632|437350|P2|NOT COMPLETED|Overall Study||0
181548|NCT00905632|437351|P1|NOT COMPLETED|Overall Study||0
181549|NCT00905632|437345|P7|COMPLETED|Overall Study||7
181550|NCT00905632|437346|P6|COMPLETED|Overall Study||8
181551|NCT00905632|437347|P5|COMPLETED|Overall Study||10
181552|NCT00905632|437348|P4|COMPLETED|Overall Study||6
181553|NCT00905632|437349|P3|COMPLETED|Overall Study||7
181554|NCT00905632|437350|P2|COMPLETED|Overall Study||6
181555|NCT00905632|437351|P1|COMPLETED|Overall Study||8
181556|NCT00905632|437345|P7|STARTED|Overall Study||11
181557|NCT00905632|437346|P6|STARTED|Overall Study||9
181558|NCT00905632|437347|P5|STARTED|Overall Study||10
181559|NCT00905632|437348|P4|STARTED|Overall Study||6
181560|NCT00905632|437349|P3|STARTED|Overall Study||7
181561|NCT00905632|437350|P2|STARTED|Overall Study||6
181562|NCT00905632|437351|P1|STARTED|Overall Study||8
181563|NCT00905606|437489|P2|NOT COMPLETED|Period 2||0
181564|NCT00905606|437490|P1|NOT COMPLETED|Period 2||0
181565|NCT00905606|437489|P2|COMPLETED|Period 2||14
181566|NCT00905606|437490|P1|COMPLETED|Period 2||14
181567|NCT00905606|437489|P2|STARTED|Period 2||14
181568|NCT00905606|437490|P1|STARTED|Period 2||14
181569|NCT00905606|437489|P2|NOT COMPLETED|Washout||0
181570|NCT00905606|437490|P1|NOT COMPLETED|Washout||1
181571|NCT00905606|437489|P2|COMPLETED|Washout||14
181572|NCT00905606|437490|P1|COMPLETED|Washout||14
181573|NCT00905606|437489|P2|STARTED|Washout||14
181574|NCT00905606|437490|P1|STARTED|Washout||15
181575|NCT00905606|437489|P2|NOT COMPLETED|Period 1||1
181576|NCT00905606|437490|P1|NOT COMPLETED|Period 1||0
181577|NCT00905606|437489|P2|COMPLETED|Period 1||14
181578|NCT00905606|437490|P1|COMPLETED|Period 1||15
181579|NCT00905606|437489|P2|STARTED|Period 1||15
181580|NCT00905606|437490|P1|STARTED|Period 1||15
181581|NCT00905580|437500|P2|NOT COMPLETED|Overall Study||3
181582|NCT00905580|437501|P1|NOT COMPLETED|Overall Study||2
181583|NCT00905580|437500|P2|COMPLETED|Overall Study||47
181584|NCT00905580|437501|P1|COMPLETED|Overall Study||47
181585|NCT00905580|437500|P2|STARTED|Overall Study||50
181586|NCT00905580|437501|P1|STARTED|Overall Study||49
181587|NCT00905567|437515|P2|NOT COMPLETED|Period 2||0
181588|NCT00905567|437516|P1|NOT COMPLETED|Period 2||0
181589|NCT00905567|437515|P2|COMPLETED|Period 2||11
181590|NCT00905567|437516|P1|COMPLETED|Period 2||12
181591|NCT00905567|437515|P2|STARTED|Period 2||11
181592|NCT00905567|437516|P1|STARTED|Period 2||12
181593|NCT00905567|437515|P2|NOT COMPLETED|Washout||1
181594|NCT00905567|437516|P1|NOT COMPLETED|Washout||0
181595|NCT00905567|437515|P2|COMPLETED|Washout||11
181596|NCT00905567|437516|P1|COMPLETED|Washout||12
181597|NCT00905567|437515|P2|STARTED|Washout||12
181598|NCT00905567|437516|P1|STARTED|Washout||12
181599|NCT00905567|437515|P2|NOT COMPLETED|Period 1||0
181600|NCT00905567|437516|P1|NOT COMPLETED|Period 1||0
181601|NCT00905567|437515|P2|COMPLETED|Period 1||12
181602|NCT00905567|437516|P1|COMPLETED|Period 1||12
181603|NCT00905567|437515|P2|STARTED|Period 1||12
181604|NCT00905567|437516|P1|STARTED|Period 1||12
181605|NCT00905554|437526|P2|NOT COMPLETED|Overall Study||0
181606|NCT00905554|437527|P1|NOT COMPLETED|Overall Study||0
181607|NCT00905554|437526|P2|COMPLETED|Overall Study||114
181608|NCT00905554|437527|P1|COMPLETED|Overall Study||116
181609|NCT00905554|437526|P2|STARTED|Overall Study||114
181610|NCT00905554|437527|P1|STARTED|Overall Study||116
181611|NCT00905515|437538|P3|NOT COMPLETED|Overall Study||2
181612|NCT00905515|437539|P2|NOT COMPLETED|Overall Study||0
181613|NCT00905515|437540|P1|NOT COMPLETED|Overall Study||2
181614|NCT00905515|437538|P3|COMPLETED|Overall Study||20
181615|NCT00905515|437539|P2|COMPLETED|Overall Study||20
181616|NCT00905515|437540|P1|COMPLETED|Overall Study||19
181617|NCT00905515|437538|P3|STARTED|Overall Study||22
181618|NCT00905515|437539|P2|STARTED|Overall Study||20
181619|NCT00905515|437540|P1|STARTED|Overall Study||21
181620|NCT00905489|437548|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
181621|NCT00905489|437548|P1|COMPLETED|Optional Extension Phase (OEP)||39
181622|NCT00905489|437548|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
181623|NCT00905489|437548|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
181624|NCT00905489|437548|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
181625|NCT00905489|437548|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
181626|NCT00905437|437597|P2|NOT COMPLETED|Overall Study||10
181627|NCT00905437|437598|P1|NOT COMPLETED|Overall Study||8
181628|NCT00905437|437597|P2|COMPLETED|Overall Study||27
181629|NCT00905437|437598|P1|COMPLETED|Overall Study||27
181630|NCT00905437|437597|P2|STARTED|Overall Study||37
181631|NCT00905437|437598|P1|STARTED|Overall Study||35
181632|NCT00905424|437618|P2|NOT COMPLETED|Overall Study||9
181633|NCT00905424|437619|P1|NOT COMPLETED|Overall Study||11
181634|NCT00905424|437618|P2|COMPLETED|Overall Study||79
181635|NCT00905424|437619|P1|COMPLETED|Overall Study||78
181636|NCT00905424|437618|P2|STARTED|Overall Study||88
181637|NCT00905424|437619|P1|STARTED|Overall Study||89
181638|NCT00905359|437661|P2|NOT COMPLETED|Overall Study||16
181639|NCT00905359|437662|P1|NOT COMPLETED|Overall Study||24
181640|NCT00905359|437661|P2|COMPLETED|Overall Study||65
181641|NCT00905359|437662|P1|COMPLETED|Overall Study||58
181642|NCT00905359|437661|P2|24 Months Follow up|Overall Study||65
181643|NCT00905359|437662|P1|24 Months Follow up|Overall Study||58
181644|NCT00905359|437661|P2|12 Months Follow up|Overall Study||72
181645|NCT00905359|437662|P1|12 Months Follow up|Overall Study||68
181646|NCT00905359|437661|P2|STARTED|Overall Study||81
181647|NCT00905359|437662|P1|STARTED|Overall Study||82
181648|NCT00905346|437698|P2|NOT COMPLETED|Period 2||0
181649|NCT00905346|437699|P1|NOT COMPLETED|Period 2||0
181650|NCT00905346|437698|P2|COMPLETED|Period 2||11
181651|NCT00905346|437699|P1|COMPLETED|Period 2||10
181652|NCT00905346|437698|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
181653|NCT00905346|437699|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
181654|NCT00905346|437698|P2|NOT COMPLETED|Period 1||0
181655|NCT00905346|437699|P1|NOT COMPLETED|Period 1||1
181656|NCT00905346|437698|P2|COMPLETED|Period 1||12
181657|NCT00905346|437699|P1|COMPLETED|Period 1||11
181658|NCT00905346|437698|P2|STARTED|Period 1||12
181659|NCT00905346|437699|P1|STARTED|Period 1||12
181660|NCT00905307|437713|P6|NOT COMPLETED|Overall Study||42
181661|NCT00905307|437714|P5|NOT COMPLETED|Overall Study||16
181662|NCT00905307|437715|P4|NOT COMPLETED|Overall Study||37
181663|NCT00905307|437716|P3|NOT COMPLETED|Overall Study||37
181664|NCT00905307|437717|P2|NOT COMPLETED|Overall Study||37
181665|NCT00905307|437718|P1|NOT COMPLETED|Overall Study||22
181666|NCT00905307|437713|P6|COMPLETED|Overall Study||53
181667|NCT00905307|437714|P5|COMPLETED|Overall Study||34
181668|NCT00905307|437715|P4|COMPLETED|Overall Study||56
181669|NCT00905307|437716|P3|COMPLETED|Overall Study||53
181670|NCT00905307|437717|P2|COMPLETED|Overall Study||52
181671|NCT00905307|437718|P1|COMPLETED|Overall Study||20
181672|NCT00905307|437713|P6|STARTED|Overall Study||95
181673|NCT00905307|437714|P5|STARTED|Overall Study||50
181674|NCT00905307|437715|P4|STARTED|Overall Study||93
181675|NCT00905307|437716|P3|STARTED|Overall Study||90
181676|NCT00905307|437717|P2|STARTED|Overall Study||89
181677|NCT00905307|437718|P1|STARTED|Overall Study||42
181678|NCT00905268|437778|P4|NOT COMPLETED|Overall Study||2
181679|NCT00905268|437779|P3|NOT COMPLETED|Overall Study||0
181680|NCT00905268|437780|P2|NOT COMPLETED|Overall Study||1
181681|NCT00905268|437781|P1|NOT COMPLETED|Overall Study||4
181682|NCT00905268|437778|P4|COMPLETED|Overall Study||57
181683|NCT00905268|437779|P3|COMPLETED|Overall Study||59
181684|NCT00905268|437780|P2|COMPLETED|Overall Study||56
181685|NCT00905268|437781|P1|COMPLETED|Overall Study||53
181686|NCT00905268|437778|P4|STARTED|Overall Study||59
181687|NCT00905268|437779|P3|STARTED|Overall Study||59
181688|NCT00905268|437780|P2|STARTED|Overall Study||57
181689|NCT00905268|437781|P1|STARTED|Overall Study||57
181690|NCT00905255|437813|P2|NOT COMPLETED|Overall Study||9
181691|NCT00905255|437814|P1|NOT COMPLETED|Overall Study||13
181692|NCT00905255|437813|P2|COMPLETED|Overall Study||27
181693|NCT00905255|437814|P1|COMPLETED|Overall Study||20
181694|NCT00905255|437813|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
181695|NCT00905255|437814|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
181696|NCT00905255|437813|P2|Safety Population|Overall Study||36
181697|NCT00905255|437814|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
181698|NCT00905255|437813|P2|STARTED|Overall Study||36
181699|NCT00905255|437814|P1|STARTED|Overall Study|Randomized.|33
181700|NCT00905164|437832|P2|NOT COMPLETED|Period 2||0
181701|NCT00905164|437833|P1|NOT COMPLETED|Period 2||0
181702|NCT00905164|437832|P2|COMPLETED|Period 2||11
181703|NCT00905164|437833|P1|COMPLETED|Period 2||12
181704|NCT00905164|437832|P2|STARTED|Period 2||11
181705|NCT00905164|437833|P1|STARTED|Period 2||12
181706|NCT00905164|437832|P2|NOT COMPLETED|Period 1||1
181707|NCT00905164|437833|P1|NOT COMPLETED|Period 1||0
181708|NCT00905164|437832|P2|COMPLETED|Period 1||11
181709|NCT00905164|437833|P1|COMPLETED|Period 1||12
181710|NCT00905164|437832|P2|STARTED|Period 1||12
181711|NCT00905164|437833|P1|STARTED|Period 1||12
181712|NCT00905151|437841|P1|NOT COMPLETED|Overall Study||6
181713|NCT00905151|437841|P1|COMPLETED|Overall Study||200
181714|NCT00905151|437841|P1|STARTED|Overall Study||206
181715|NCT00905125|437847|P2|NOT COMPLETED|Overall Study||3
181716|NCT00905125|437848|P1|NOT COMPLETED|Overall Study||4
181717|NCT00905125|437847|P2|COMPLETED|Overall Study||53
181718|NCT00905125|437848|P1|COMPLETED|Overall Study||42
181719|NCT00905125|437847|P2|STARTED|Overall Study||56
181720|NCT00905125|437848|P1|STARTED|Overall Study||46
181721|NCT00905034|437880|P1|NOT COMPLETED|Overall Study||1
181722|NCT00905034|437880|P1|COMPLETED|Overall Study||36
181723|NCT00905034|437880|P1|STARTED|Overall Study||37
181724|NCT00905021|437884|P1|NOT COMPLETED|Overall Study||2
181725|NCT00905021|437884|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
181726|NCT00905021|437884|P1|STARTED|Overall Study||4
181727|NCT00904995|437891|P2|NOT COMPLETED|Overall Study||0
181728|NCT00904995|437892|P1|NOT COMPLETED|Overall Study||0
181729|NCT00904995|437891|P2|COMPLETED|Overall Study||11
181730|NCT00904995|437892|P1|COMPLETED|Overall Study||10
181731|NCT00904995|437891|P2|STARTED|Overall Study||11
181732|NCT00904995|437892|P1|STARTED|Overall Study||10
181733|NCT00904982|437902|P4|NOT COMPLETED|Overall Study||0
181734|NCT00904982|437903|P3|NOT COMPLETED|Overall Study||0
181735|NCT00904982|437904|P2|NOT COMPLETED|Overall Study||0
181736|NCT00904982|437905|P1|NOT COMPLETED|Overall Study||2
181737|NCT00904982|437902|P4|COMPLETED|Overall Study||68
181738|NCT00904982|437903|P3|COMPLETED|Overall Study||67
181739|NCT00904982|437904|P2|COMPLETED|Overall Study||67
181740|NCT00904982|437905|P1|COMPLETED|Overall Study||66
181741|NCT00904982|437902|P4|STARTED|Overall Study||68
181742|NCT00904982|437903|P3|STARTED|Overall Study||67
181743|NCT00904982|437904|P2|STARTED|Overall Study||67
181744|NCT00904982|437905|P1|STARTED|Overall Study||68
181745|NCT00904969|437915|P1|NOT COMPLETED|Overall Study||19
181746|NCT00904969|437915|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
181747|NCT00904969|437915|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
181748|NCT00904943|437967|P2|NOT COMPLETED|Period 2||0
181749|NCT00904943|437968|P1|NOT COMPLETED|Period 2||0
181750|NCT00904943|437967|P2|COMPLETED|Period 2||8
181751|NCT00904943|437968|P1|COMPLETED|Period 2||9
181752|NCT00904943|437967|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
181753|NCT00904943|437968|P1|STARTED|Period 2||9
181754|NCT00904943|437967|P2|NOT COMPLETED|Period 1||0
181755|NCT00904943|437968|P1|NOT COMPLETED|Period 1||0
181756|NCT00904943|437967|P2|COMPLETED|Period 1||9
181757|NCT00904943|437968|P1|COMPLETED|Period 1||9
181758|NCT00904943|437967|P2|STARTED|Period 1||9
181759|NCT00904943|437968|P1|STARTED|Period 1||9
181760|NCT00904917|437980|P4|NOT COMPLETED|Overall Study||2
181761|NCT00904917|437981|P3|NOT COMPLETED|Overall Study||2
181762|NCT00904917|437982|P2|NOT COMPLETED|Overall Study||2
181763|NCT00904917|437983|P1|NOT COMPLETED|Overall Study||2
181764|NCT00904917|437980|P4|COMPLETED|Overall Study||6
181765|NCT00904917|437981|P3|COMPLETED|Overall Study||6
181766|NCT00904917|437982|P2|COMPLETED|Overall Study||9
181767|NCT00904917|437983|P1|COMPLETED|Overall Study||5
181768|NCT00904917|437980|P4|STARTED|Overall Study||8
181769|NCT00904917|437981|P3|STARTED|Overall Study||8
181770|NCT00904917|437982|P2|STARTED|Overall Study||11
181771|NCT00904917|437983|P1|STARTED|Overall Study||7
181772|NCT00904839|438001|P3|NOT COMPLETED|Overall Study||15
181773|NCT00904839|438002|P2|NOT COMPLETED|Overall Study||18
181774|NCT00904839|438003|P1|NOT COMPLETED|Overall Study||1
181775|NCT00904839|438001|P3|COMPLETED|Overall Study||27
181776|NCT00904839|438002|P2|COMPLETED|Overall Study||64
181777|NCT00904839|438003|P1|COMPLETED|Overall Study||3
181778|NCT00904839|438001|P3|STARTED|Overall Study|Randomised|42
181779|NCT00904839|438002|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
181780|NCT00904839|438003|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
181781|NCT00904826|438037|P1|NOT COMPLETED|Overall Study||0
181782|NCT00904826|438037|P1|COMPLETED|Overall Study||14
181783|NCT00904826|438037|P1|STARTED|Overall Study||14
181784|NCT00904748|438049|P6|NOT COMPLETED|Overall Study||0
181785|NCT00904748|438050|P5|NOT COMPLETED|Overall Study||1
181786|NCT00904748|438051|P4|NOT COMPLETED|Overall Study||2
181787|NCT00904748|438052|P3|NOT COMPLETED|Overall Study||1
181788|NCT00904748|438053|P2|NOT COMPLETED|Overall Study||1
181789|NCT00904748|438054|P1|NOT COMPLETED|Overall Study||1
181790|NCT00904748|438049|P6|COMPLETED|Overall Study||8
181791|NCT00904748|438050|P5|COMPLETED|Overall Study||7
181792|NCT00904748|438051|P4|COMPLETED|Overall Study||6
181793|NCT00904748|438052|P3|COMPLETED|Overall Study||7
181794|NCT00904748|438053|P2|COMPLETED|Overall Study||7
181795|NCT00904748|438054|P1|COMPLETED|Overall Study||7
181796|NCT00904748|438049|P6|Received Treatment|Overall Study||8
181797|NCT00904748|438050|P5|Received Treatment|Overall Study||7
181798|NCT00904748|438051|P4|Received Treatment|Overall Study||8
181799|NCT00904748|438052|P3|Received Treatment|Overall Study||8
181800|NCT00904748|438053|P2|Received Treatment|Overall Study||8
181801|NCT00904748|438054|P1|Received Treatment|Overall Study||8
181802|NCT00904748|438049|P6|STARTED|Overall Study||8
181803|NCT00904748|438050|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
181804|NCT00904748|438051|P4|STARTED|Overall Study||8
181805|NCT00904748|438052|P3|STARTED|Overall Study||8
181806|NCT00904748|438053|P2|STARTED|Overall Study||8
181807|NCT00904748|438054|P1|STARTED|Overall Study||8
181808|NCT00904722|438078|P1|NOT COMPLETED|Overall Study||1
181809|NCT00904722|438078|P1|COMPLETED|Overall Study||29
181810|NCT00904722|438078|P1|STARTED|Overall Study||30
181811|NCT00904670|438083|P2|NOT COMPLETED|Second Intervention Period||0
181812|NCT00904670|438084|P1|NOT COMPLETED|Second Intervention Period||0
181813|NCT00904670|438083|P2|COMPLETED|Second Intervention Period||22
181814|NCT00904670|438084|P1|COMPLETED|Second Intervention Period||17
181815|NCT00904670|438083|P2|STARTED|Second Intervention Period||22
181816|NCT00904670|438084|P1|STARTED|Second Intervention Period||17
181817|NCT00904670|438083|P2|NOT COMPLETED|First Intervention Period||0
181818|NCT00904670|438084|P1|NOT COMPLETED|First Intervention Period||0
181819|NCT00904670|438083|P2|COMPLETED|First Intervention Period||22
181820|NCT00904670|438084|P1|COMPLETED|First Intervention Period||17
181821|NCT00904670|438083|P2|STARTED|First Intervention Period||22
181822|NCT00904670|438084|P1|STARTED|First Intervention Period||17
181823|NCT00904670|438083|P2|NOT COMPLETED|Open Label Phase||0
181824|NCT00904670|438084|P1|NOT COMPLETED|Open Label Phase||6
181825|NCT00904670|438083|P2|COMPLETED|Open Label Phase||22
181826|NCT00904670|438084|P1|COMPLETED|Open Label Phase||17
181827|NCT00904670|438083|P2|STARTED|Open Label Phase||22
181828|NCT00904670|438084|P1|STARTED|Open Label Phase||23
181829|NCT00904618|438105|P1|NOT COMPLETED|Overall Study||0
181830|NCT00904618|438105|P1|COMPLETED|Overall Study||48
181831|NCT00904618|438105|P1|STARTED|Overall Study||48
181832|NCT00904488|438115|P2|NOT COMPLETED|Overall Study||0
181833|NCT00904488|438116|P1|NOT COMPLETED|Overall Study||0
181834|NCT00904488|438115|P2|COMPLETED|Overall Study||6
181835|NCT00904488|438116|P1|COMPLETED|Overall Study||5
181836|NCT00904488|438115|P2|STARTED|Overall Study||6
181837|NCT00904488|438116|P1|STARTED|Overall Study||5
181838|NCT00904423|438146|P1|NOT COMPLETED|Overall Study||0
181839|NCT00904423|438146|P1|COMPLETED|Overall Study||8
181840|NCT00904423|438146|P1|STARTED|Overall Study||8
181841|NCT00904371|438154|P1|NOT COMPLETED|Overall Study||9
181842|NCT00904371|438154|P1|COMPLETED|Overall Study||202
181843|NCT00904371|438154|P1|STARTED|Overall Study||211
181844|NCT00904215|438168|P1|NOT COMPLETED|Overall Study||135
181845|NCT00904215|438168|P1|COMPLETED|Overall Study||960
181846|NCT00904215|438168|P1|STARTED|Overall Study||1095
181847|NCT00904189|438175|P1|NOT COMPLETED|Overall Study||0
181848|NCT00904189|438175|P1|COMPLETED|Overall Study||2
181849|NCT00904189|438175|P1|STARTED|Overall Study||2
181850|NCT00904150|438182|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
181851|NCT00904150|438183|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
181852|NCT00904150|438182|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
181853|NCT00904150|438183|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
181854|NCT00904150|438182|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
181855|NCT00904150|438183|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
181856|NCT00904150|438182|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
181857|NCT00904150|438183|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
181858|NCT00904150|438182|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
181859|NCT00904150|438183|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
181860|NCT00904150|438182|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
181861|NCT00904150|438183|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
181862|NCT00904150|438182|P2|NOT COMPLETED|Saliva Samples (DNA)||145
181863|NCT00904150|438183|P1|NOT COMPLETED|Saliva Samples (DNA)||3
181864|NCT00904150|438182|P2|COMPLETED|Saliva Samples (DNA)||155
181865|NCT00904150|438183|P1|COMPLETED|Saliva Samples (DNA)||282
181866|NCT00904150|438182|P2|STARTED|Saliva Samples (DNA)||300
181867|NCT00904150|438183|P1|STARTED|Saliva Samples (DNA)||285
181868|NCT00904007|438203|P2|NOT COMPLETED|Overall Study||0
181869|NCT00904007|438204|P1|NOT COMPLETED|Overall Study||0
181870|NCT00904007|438203|P2|COMPLETED|Overall Study||56
181871|NCT00904007|438204|P1|COMPLETED|Overall Study||55
181872|NCT00904007|438203|P2|STARTED|Overall Study||56
181873|NCT00904007|438204|P1|STARTED|Overall Study||55
181874|NCT00903968|438212|P8|NOT COMPLETED|Overall Study||33
181875|NCT00903968|438213|P7|NOT COMPLETED|Overall Study||3
181876|NCT00903968|438214|P6|NOT COMPLETED|Overall Study||6
181877|NCT00903968|438215|P5|NOT COMPLETED|Overall Study||4
181878|NCT00903968|438216|P4|NOT COMPLETED|Overall Study||3
181879|NCT00903968|438217|P3|NOT COMPLETED|Overall Study||3
181880|NCT00903968|438218|P2|NOT COMPLETED|Overall Study||3
181881|NCT00903968|438219|P1|NOT COMPLETED|Overall Study||3
181882|NCT00903968|438212|P8|COMPLETED|Overall Study||0
181883|NCT00903968|438213|P7|COMPLETED|Overall Study||0
181884|NCT00903968|438214|P6|COMPLETED|Overall Study||0
181885|NCT00903968|438215|P5|COMPLETED|Overall Study||0
181886|NCT00903968|438216|P4|COMPLETED|Overall Study||0
181887|NCT00903968|438217|P3|COMPLETED|Overall Study||0
181888|NCT00903968|438218|P2|COMPLETED|Overall Study||0
181889|NCT00903968|438219|P1|COMPLETED|Overall Study||0
181890|NCT00903968|438212|P8|STARTED|Overall Study||33
181891|NCT00903968|438213|P7|STARTED|Overall Study||3
181892|NCT00903968|438214|P6|STARTED|Overall Study||6
181893|NCT00903968|438215|P5|STARTED|Overall Study||4
181894|NCT00903968|438216|P4|STARTED|Overall Study||3
181895|NCT00903968|438217|P3|STARTED|Overall Study||3
181896|NCT00903968|438218|P2|STARTED|Overall Study||3
181897|NCT00903968|438219|P1|STARTED|Overall Study||3
181898|NCT00903929|438249|P4|NOT COMPLETED|Overall Study||3
181899|NCT00903929|438250|P3|NOT COMPLETED|Overall Study||1
181900|NCT00903929|438251|P2|NOT COMPLETED|Overall Study||0
181901|NCT00903929|438252|P1|NOT COMPLETED|Overall Study||0
181902|NCT00903929|438249|P4|COMPLETED|Overall Study||6
181903|NCT00903929|438250|P3|COMPLETED|Overall Study||3
181904|NCT00903929|438251|P2|COMPLETED|Overall Study||3
181905|NCT00903929|438252|P1|COMPLETED|Overall Study||3
181906|NCT00903929|438249|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
181907|NCT00903929|438250|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
181908|NCT00903929|438251|P2|STARTED|Overall Study||3
181909|NCT00903929|438252|P1|STARTED|Overall Study||3
181910|NCT00903877|438258|P1|NOT COMPLETED|Overall Study||43
181911|NCT00903877|438258|P1|COMPLETED|Overall Study||8
181912|NCT00903877|438258|P1|STARTED|Overall Study||51
181913|NCT00903695|438264|P2|NOT COMPLETED|Overall Study||0
181914|NCT00903695|438265|P1|NOT COMPLETED|Overall Study||2
181915|NCT00903695|438264|P2|COMPLETED|Overall Study||2
181916|NCT00903695|438265|P1|COMPLETED|Overall Study||6
181917|NCT00903695|438264|P2|STARTED|Overall Study||2
181918|NCT00903695|438265|P1|STARTED|Overall Study||8
181919|NCT00903682|438287|P2|NOT COMPLETED|Overall Study||15
181920|NCT00903682|438288|P1|NOT COMPLETED|Overall Study||16
181921|NCT00903682|438287|P2|COMPLETED|Overall Study||63
181922|NCT00903682|438288|P1|COMPLETED|Overall Study||63
181923|NCT00903682|438287|P2|STARTED|Overall Study||78
181924|NCT00903682|438288|P1|STARTED|Overall Study||79
181925|NCT00903630|438309|P3|NOT COMPLETED|Phase 2||1
181926|NCT00903630|438310|P2|NOT COMPLETED|Phase 2||0
181927|NCT00903630|438311|P1|NOT COMPLETED|Phase 2||0
181928|NCT00903630|438309|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
181929|NCT00903630|438310|P2|COMPLETED|Phase 2||0
181930|NCT00903630|438311|P1|COMPLETED|Phase 2||6
181931|NCT00903630|438309|P3|STARTED|Phase 2||4
181932|NCT00903630|438310|P2|STARTED|Phase 2||0
181933|NCT00903630|438311|P1|STARTED|Phase 2||6
181934|NCT00903630|438309|P3|NOT COMPLETED|Phase l||0
181935|NCT00903630|438310|P2|NOT COMPLETED|Phase l||0
181936|NCT00903630|438311|P1|NOT COMPLETED|Phase l||0
181937|NCT00903630|438309|P3|COMPLETED|Phase l||0
181938|NCT00903630|438310|P2|COMPLETED|Phase l||5
181939|NCT00903630|438311|P1|COMPLETED|Phase l||6
181940|NCT00903630|438309|P3|STARTED|Phase l||0
181941|NCT00903630|438310|P2|STARTED|Phase l||5
181942|NCT00903630|438311|P1|STARTED|Phase l||6
181943|NCT00903617|438329|P4|NOT COMPLETED|Overall Study||1
181944|NCT00903617|438330|P3|NOT COMPLETED|Overall Study||5
181945|NCT00903617|438331|P2|NOT COMPLETED|Overall Study||5
181946|NCT00903617|438332|P1|NOT COMPLETED|Overall Study||3
181947|NCT00903617|438329|P4|COMPLETED|Overall Study||20
181948|NCT00903617|438330|P3|COMPLETED|Overall Study||15
181949|NCT00903617|438331|P2|COMPLETED|Overall Study||15
181950|NCT00903617|438332|P1|COMPLETED|Overall Study||16
181951|NCT00903617|438329|P4|STARTED|Overall Study||21
181952|NCT00903617|438330|P3|STARTED|Overall Study||20
181953|NCT00903617|438331|P2|STARTED|Overall Study||20
181954|NCT00903617|438332|P1|STARTED|Overall Study||19
181955|NCT00903448|438426|P2|NOT COMPLETED|Period 3: 5 Days||0
181956|NCT00903448|438427|P1|NOT COMPLETED|Period 3: 5 Days||0
181957|NCT00903448|438426|P2|COMPLETED|Period 3: 5 Days||20
181958|NCT00903448|438427|P1|COMPLETED|Period 3: 5 Days||20
181959|NCT00903448|438426|P2|STARTED|Period 3: 5 Days||20
181960|NCT00903448|438427|P1|STARTED|Period 3: 5 Days||20
181961|NCT00903448|438426|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
181962|NCT00903448|438427|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
181963|NCT00903448|438426|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
181964|NCT00903448|438427|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
181965|NCT00903448|438426|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
181966|NCT00903448|438427|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
181967|NCT00903448|438426|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
181968|NCT00903448|438427|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
181969|NCT00903448|438426|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
181970|NCT00903448|438427|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
181971|NCT00903448|438426|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
181972|NCT00903448|438427|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
181973|NCT00903409|438435|P2|NOT COMPLETED|Overall Study||27
181974|NCT00903409|438436|P1|NOT COMPLETED|Overall Study||26
181975|NCT00903409|438435|P2|COMPLETED|Overall Study||73
181976|NCT00903409|438436|P1|COMPLETED|Overall Study||62
181977|NCT00903409|438435|P2|STARTED|Overall Study||100
181978|NCT00903409|438436|P1|STARTED|Overall Study||88
181979|NCT00903396|438454|P4|NOT COMPLETED|Overall Study||0
181980|NCT00903396|438455|P3|NOT COMPLETED|Overall Study||0
181981|NCT00903396|438456|P2|NOT COMPLETED|Overall Study||0
181982|NCT00903396|438457|P1|NOT COMPLETED|Overall Study||0
181983|NCT00903396|438454|P4|COMPLETED|Overall Study||1
181984|NCT00903396|438455|P3|COMPLETED|Overall Study||3
181985|NCT00903396|438456|P2|COMPLETED|Overall Study||1
181986|NCT00903396|438457|P1|COMPLETED|Overall Study||2
181987|NCT00903396|438454|P4|STARTED|Overall Study||1
181988|NCT00903396|438455|P3|STARTED|Overall Study||3
181989|NCT00903396|438456|P2|STARTED|Overall Study||1
181990|NCT00903396|438457|P1|STARTED|Overall Study||2
181991|NCT00903383|438487|P4|NOT COMPLETED|Overall Study||5
181992|NCT00903383|438488|P3|NOT COMPLETED|Overall Study||3
181993|NCT00903383|438489|P2|NOT COMPLETED|Overall Study||6
181994|NCT00903383|438490|P1|NOT COMPLETED|Overall Study||7
181995|NCT00903383|438487|P4|COMPLETED|Overall Study||44
181996|NCT00903383|438488|P3|COMPLETED|Overall Study||47
181997|NCT00903383|438489|P2|COMPLETED|Overall Study||48
181998|NCT00903383|438490|P1|COMPLETED|Overall Study||48
181999|NCT00903383|438487|P4|STARTED|Overall Study||49
182000|NCT00903383|438488|P3|STARTED|Overall Study||50
182001|NCT00903383|438489|P2|STARTED|Overall Study||54
182002|NCT00903383|438490|P1|STARTED|Overall Study||55
182003|NCT00903370|438522|P2|NOT COMPLETED|Overall Study||24
182004|NCT00903370|438523|P1|NOT COMPLETED|Overall Study||28
182005|NCT00903370|438522|P2|COMPLETED|Overall Study||109
182006|NCT00903370|438523|P1|COMPLETED|Overall Study||99
182007|NCT00903370|438522|P2|STARTED|Overall Study||133
182008|NCT00903370|438523|P1|STARTED|Overall Study||127
182009|NCT00903357|438531|P2|NOT COMPLETED|Second Intervention||0
182010|NCT00903357|438532|P1|NOT COMPLETED|Second Intervention||1
182011|NCT00903357|438531|P2|COMPLETED|Second Intervention||22
182012|NCT00903357|438532|P1|COMPLETED|Second Intervention||21
182013|NCT00903357|438531|P2|STARTED|Second Intervention||22
182014|NCT00903357|438532|P1|STARTED|Second Intervention||22
182015|NCT00903357|438531|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
182016|NCT00903357|438532|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
182017|NCT00903357|438531|P2|COMPLETED|Wash Out Period of 2 Weeks||22
182018|NCT00903357|438532|P1|COMPLETED|Wash Out Period of 2 Weeks||22
182019|NCT00903357|438531|P2|STARTED|Wash Out Period of 2 Weeks||23
182020|NCT00903357|438532|P1|STARTED|Wash Out Period of 2 Weeks||22
182021|NCT00903357|438531|P2|NOT COMPLETED|First Intervention||4
182022|NCT00903357|438532|P1|NOT COMPLETED|First Intervention||5
182023|NCT00903357|438531|P2|COMPLETED|First Intervention||23
182024|NCT00903357|438532|P1|COMPLETED|First Intervention||22
182025|NCT00903357|438531|P2|STARTED|First Intervention||27
182026|NCT00903357|438532|P1|STARTED|First Intervention||27
182027|NCT00903344|438544|P2|NOT COMPLETED|Overall Study||3
182028|NCT00903344|438545|P1|NOT COMPLETED|Overall Study||5
182029|NCT00903344|438544|P2|COMPLETED|Overall Study||7
182030|NCT00903344|438545|P1|COMPLETED|Overall Study||7
182031|NCT00903344|438544|P2|6 Month Visit|Overall Study||10
182032|NCT00903344|438545|P1|6 Month Visit|Overall Study||9
182033|NCT00903344|438544|P2|3 Month Visit|Overall Study||10
182034|NCT00903344|438545|P1|3 Month Visit|Overall Study||10
182035|NCT00903344|438544|P2|STARTED|Overall Study||10
182036|NCT00903344|438545|P1|STARTED|Overall Study||12
182037|NCT00903331|438563|P2|NOT COMPLETED|Overall Study||18
182038|NCT00903331|438564|P1|NOT COMPLETED|Overall Study||5
182039|NCT00903331|438563|P2|COMPLETED|Overall Study||101
182040|NCT00903331|438564|P1|COMPLETED|Overall Study||54
182041|NCT00903331|438563|P2|STARTED|Overall Study||119
182042|NCT00903331|438564|P1|STARTED|Overall Study||59
182043|NCT00903201|438575|P3|NOT COMPLETED|Overall Study||2
182044|NCT00903201|438576|P2|NOT COMPLETED|Overall Study||6
182045|NCT00903201|438577|P1|NOT COMPLETED|Overall Study||5
182046|NCT00903201|438575|P3|COMPLETED|Overall Study||39
182047|NCT00903201|438576|P2|COMPLETED|Overall Study||38
182048|NCT00903201|438577|P1|COMPLETED|Overall Study||56
182049|NCT00903201|438575|P3|STARTED|Overall Study||41
182050|NCT00903201|438576|P2|STARTED|Overall Study||44
182051|NCT00903201|438577|P1|STARTED|Overall Study||61
182052|NCT00903175|438635|P2|NOT COMPLETED|Period 2 - Second Line||36
182053|NCT00903175|438636|P1|NOT COMPLETED|Period 2 - Second Line||49
182054|NCT00903175|438635|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
182055|NCT00903175|438636|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
182056|NCT00903175|438635|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
182057|NCT00903175|438636|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
182058|NCT00903175|438635|P2|NOT COMPLETED|Period 1 - First Line||89
182059|NCT00903175|438636|P1|NOT COMPLETED|Period 1 - First Line||77
182060|NCT00903175|438635|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
182061|NCT00903175|438636|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
182062|NCT00903175|438635|P2|STARTED|Period 1 - First Line||231
182063|NCT00903175|438636|P1|STARTED|Period 1 - First Line||238
182064|NCT00903162|438666|P1|NOT COMPLETED|Overall Study||4
182065|NCT00903162|438666|P1|COMPLETED|Overall Study||12
182066|NCT00903162|438666|P1|STARTED|Overall Study||16
182067|NCT00903032|438674|P2|NOT COMPLETED|Overall Study||5
182068|NCT00903032|438675|P1|NOT COMPLETED|Overall Study||7
182069|NCT00903032|438674|P2|COMPLETED|Overall Study||119
182070|NCT00903032|438675|P1|COMPLETED|Overall Study||122
182071|NCT00903032|438674|P2|STARTED|Overall Study||124
182072|NCT00903032|438675|P1|STARTED|Overall Study||129
182073|NCT00903006|438685|P4|NOT COMPLETED|Overall Study||0
182074|NCT00903006|438686|P3|NOT COMPLETED|Overall Study||1
182075|NCT00903006|438687|P2|NOT COMPLETED|Overall Study||3
182076|NCT00903006|438688|P1|NOT COMPLETED|Overall Study||2
182077|NCT00903006|438685|P4|COMPLETED|Overall Study||0
182078|NCT00903006|438686|P3|COMPLETED|Overall Study||0
182079|NCT00903006|438687|P2|COMPLETED|Overall Study||0
182080|NCT00903006|438688|P1|COMPLETED|Overall Study||0
182081|NCT00903006|438685|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
182082|NCT00903006|438686|P3|STARTED|Overall Study||1
182083|NCT00903006|438687|P2|STARTED|Overall Study||3
182084|NCT00903006|438688|P1|STARTED|Overall Study||2
182085|NCT00902850|438700|P2|NOT COMPLETED|Overall Study||2
182086|NCT00902850|438701|P1|NOT COMPLETED|Overall Study||2
182087|NCT00902850|438700|P2|COMPLETED|Overall Study||12
182088|NCT00902850|438701|P1|COMPLETED|Overall Study||12
182089|NCT00902850|438700|P2|STARTED|Overall Study||14
182090|NCT00902850|438701|P1|STARTED|Overall Study||14
182091|NCT00902746|438707|P1|NOT COMPLETED|Overall Study||36
182092|NCT00902746|438707|P1|COMPLETED|Overall Study||113
182093|NCT00902746|438707|P1|Transfer to Step 2|Overall Study||133
182094|NCT00902746|438707|P1|Initiation of Study Drug Administration|Overall Study||148
182095|NCT00902746|438707|P1|STARTED|Overall Study||149
182096|NCT00902668|438712|P1|NOT COMPLETED|Overall Study||3
182097|NCT00902668|438712|P1|COMPLETED|Overall Study||0
182098|NCT00902668|438712|P1|STARTED|Overall Study||3
182099|NCT00902564|438716|P1|NOT COMPLETED|Overall Study||2
182100|NCT00902564|438716|P1|COMPLETED|Overall Study||28
182101|NCT00902564|438716|P1|STARTED|Overall Study||30
182102|NCT00902538|438731|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
182103|NCT00902538|438732|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
182104|NCT00902538|438733|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
182105|NCT00902538|438734|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
182106|NCT00902538|438735|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
182107|NCT00902538|438736|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
182108|NCT00902538|438731|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
182109|NCT00902538|438732|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
182110|NCT00902538|438733|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
182111|NCT00902538|438734|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
182112|NCT00902538|438735|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
182113|NCT00902538|438736|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
182114|NCT00902538|438731|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
182115|NCT00902538|438732|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
182116|NCT00902538|438733|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
182117|NCT00902538|438734|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
182118|NCT00902538|438735|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
182119|NCT00902538|438736|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
182120|NCT00902538|438731|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
182121|NCT00902538|438732|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
182122|NCT00902538|438733|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
182123|NCT00902538|438734|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
182124|NCT00902538|438735|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
182125|NCT00902538|438736|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
182126|NCT00902538|438731|P6|COMPLETED|3-Single-blind, Single Treatment||0
182127|NCT00902538|438732|P5|COMPLETED|3-Single-blind, Single Treatment||0
182128|NCT00902538|438733|P4|COMPLETED|3-Single-blind, Single Treatment||0
182129|NCT00902538|438734|P3|COMPLETED|3-Single-blind, Single Treatment||0
182130|NCT00902538|438735|P2|COMPLETED|3-Single-blind, Single Treatment||767
182131|NCT00902538|438736|P1|COMPLETED|3-Single-blind, Single Treatment||0
182132|NCT00902538|438731|P6|STARTED|3-Single-blind, Single Treatment||0
182133|NCT00902538|438732|P5|STARTED|3-Single-blind, Single Treatment||0
182134|NCT00902538|438733|P4|STARTED|3-Single-blind, Single Treatment||0
182135|NCT00902538|438734|P3|STARTED|3-Single-blind, Single Treatment||0
182136|NCT00902538|438735|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
182137|NCT00902538|438736|P1|STARTED|3-Single-blind, Single Treatment||0
182138|NCT00902538|438731|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
182139|NCT00902538|438732|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
182140|NCT00902538|438733|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
182141|NCT00902538|438734|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
182142|NCT00902538|438735|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
182143|NCT00902538|438736|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
182144|NCT00902538|438731|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
182145|NCT00902538|438732|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
182146|NCT00902538|438733|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
182147|NCT00902538|438734|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
182148|NCT00902538|438735|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
182149|NCT00902538|438736|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
182150|NCT00902538|438731|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
182151|NCT00902538|438732|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
182152|NCT00902538|438733|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
182153|NCT00902538|438734|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
182154|NCT00902538|438735|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
182155|NCT00902538|438736|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
182156|NCT00902538|438731|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182157|NCT00902538|438732|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182158|NCT00902538|438733|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182159|NCT00902538|438734|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182160|NCT00902538|438735|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182161|NCT00902538|438736|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
182162|NCT00902538|438731|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182163|NCT00902538|438732|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182164|NCT00902538|438733|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182165|NCT00902538|438734|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182166|NCT00902538|438735|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
182167|NCT00902538|438736|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
182168|NCT00902538|438731|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
182169|NCT00902538|438732|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
182170|NCT00902538|438733|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
182171|NCT00902538|438734|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
182172|NCT00902538|438735|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
182173|NCT00902538|438736|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
182174|NCT00902330|438768|P2|NOT COMPLETED|Overall Study||5
182175|NCT00902330|438769|P1|NOT COMPLETED|Overall Study||4
182176|NCT00902330|438768|P2|COMPLETED|Overall Study||75
182177|NCT00902330|438769|P1|COMPLETED|Overall Study||77
182178|NCT00902330|438768|P2|STARTED|Overall Study||80
182179|NCT00902330|438769|P1|STARTED|Overall Study||81
182180|NCT00902304|438806|P3|NOT COMPLETED|Overall Study||110
182181|NCT00902304|438807|P2|NOT COMPLETED|Overall Study||71
182182|NCT00902304|438808|P1|NOT COMPLETED|Overall Study||58
182183|NCT00902304|438806|P3|COMPLETED|Overall Study||568
182184|NCT00902304|438807|P2|COMPLETED|Overall Study||289
182185|NCT00902304|438808|P1|COMPLETED|Overall Study||466
182186|NCT00902304|438806|P3|STARTED|Overall Study||678
182187|NCT00902304|438807|P2|STARTED|Overall Study||360
182188|NCT00902304|438808|P1|STARTED|Overall Study||524
182189|NCT00902278|438858|P5|NOT COMPLETED|Overall Study||2
182190|NCT00902278|438859|P4|NOT COMPLETED|Overall Study||0
182191|NCT00902278|438860|P3|NOT COMPLETED|Overall Study||5
182192|NCT00902278|438861|P2|NOT COMPLETED|Overall Study||2
182193|NCT00902278|438862|P1|NOT COMPLETED|Overall Study||4
182194|NCT00902278|438858|P5|COMPLETED|Overall Study||35
182195|NCT00902278|438859|P4|COMPLETED|Overall Study||12
182196|NCT00902278|438860|P3|COMPLETED|Overall Study||49
182197|NCT00902278|438861|P2|COMPLETED|Overall Study||34
182198|NCT00902278|438862|P1|COMPLETED|Overall Study||50
182199|NCT00902278|438858|P5|STARTED|Overall Study||37
182200|NCT00902278|438859|P4|STARTED|Overall Study||12
182201|NCT00902278|438860|P3|STARTED|Overall Study||54
182202|NCT00902278|438861|P2|STARTED|Overall Study||36
182203|NCT00902278|438862|P1|STARTED|Overall Study||54
182204|NCT00902265|438879|P1|NOT COMPLETED|Overall Study||6
182205|NCT00902265|438879|P1|COMPLETED|Overall Study||132
182206|NCT00902265|438879|P1|Participants Who Received Treatment|Overall Study||137
182207|NCT00902265|438879|P1|STARTED|Overall Study||138
182208|NCT00902226|438891|P1|NOT COMPLETED|Overall Study||0
182209|NCT00902226|438891|P1|COMPLETED|Overall Study||30
182210|NCT00902226|438891|P1|STARTED|Overall Study||30
182211|NCT00902174|438903|P2|NOT COMPLETED|Overall Study||18
182212|NCT00902174|438904|P1|NOT COMPLETED|Overall Study||34
182213|NCT00902174|438903|P2|COMPLETED|Overall Study||81
182214|NCT00902174|438904|P1|COMPLETED|Overall Study||69
182215|NCT00902174|438903|P2|STARTED|Overall Study||99
182216|NCT00902174|438904|P1|STARTED|Overall Study||103
182217|NCT00902161|438942|P3|NOT COMPLETED|Period 2||0
182218|NCT00902161|438943|P2|NOT COMPLETED|Period 2||0
182219|NCT00902161|438944|P1|NOT COMPLETED|Period 2||0
182220|NCT00902161|438942|P3|COMPLETED|Period 2||0
182221|NCT00902161|438943|P2|COMPLETED|Period 2||9
182222|NCT00902161|438944|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
182223|NCT00902161|438942|P3|STARTED|Period 2||0
182224|NCT00902161|438943|P2|STARTED|Period 2||9
182225|NCT00902161|438944|P1|STARTED|Period 2||8
182226|NCT00902161|438942|P3|NOT COMPLETED|Post-clamp Washout||0
182227|NCT00902161|438943|P2|NOT COMPLETED|Post-clamp Washout||0
182228|NCT00902161|438944|P1|NOT COMPLETED|Post-clamp Washout||0
182229|NCT00902161|438942|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
182230|NCT00902161|438943|P2|COMPLETED|Post-clamp Washout||0
182231|NCT00902161|438944|P1|COMPLETED|Post-clamp Washout||0
182232|NCT00902161|438942|P3|STARTED|Post-clamp Washout||22
182233|NCT00902161|438943|P2|STARTED|Post-clamp Washout||0
182234|NCT00902161|438944|P1|STARTED|Post-clamp Washout||0
182235|NCT00902161|438942|P3|NOT COMPLETED|Period 1||0
182236|NCT00902161|438943|P2|NOT COMPLETED|Period 1||0
182237|NCT00902161|438944|P1|NOT COMPLETED|Period 1||0
182238|NCT00902161|438942|P3|COMPLETED|Period 1||0
182239|NCT00902161|438943|P2|COMPLETED|Period 1||10
182240|NCT00902161|438944|P1|COMPLETED|Period 1||12
182241|NCT00902161|438942|P3|STARTED|Period 1||0
182242|NCT00902161|438943|P2|STARTED|Period 1||10
182243|NCT00902161|438944|P1|STARTED|Period 1||12
182244|NCT00902161|438942|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
182245|NCT00902161|438943|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
182246|NCT00902161|438944|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
182247|NCT00902161|438942|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
182248|NCT00902161|438943|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
182249|NCT00902161|438944|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
182250|NCT00902161|438942|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
182251|NCT00902161|438943|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
182252|NCT00902161|438944|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
182253|NCT00901901|438961|P2|NOT COMPLETED|Follow-up Period||259
182254|NCT00901901|438962|P1|NOT COMPLETED|Follow-up Period||246
182255|NCT00901901|438961|P2|COMPLETED|Follow-up Period|These participants are ongoing.|65
182256|NCT00901901|438962|P1|COMPLETED|Follow-up Period|These participants are ongoing.|76
182257|NCT00901901|438961|P2|STARTED|Follow-up Period||324
182258|NCT00901901|438962|P1|STARTED|Follow-up Period||322
182259|NCT00901901|438961|P2|NOT COMPLETED|Treatment Period||168
182260|NCT00901901|438962|P1|NOT COMPLETED|Treatment Period||157
182261|NCT00901901|438961|P2|COMPLETED|Treatment Period|17 of these participants are ongoing|190
182262|NCT00901901|438962|P1|COMPLETED|Treatment Period|19 of these participants are ongoing|205
182263|NCT00901901|438961|P2|Participants Received Treatment|Treatment Period||355
182264|NCT00901901|438962|P1|Participants Received Treatment|Treatment Period||362
182265|NCT00901901|438961|P2|STARTED|Treatment Period||358
182266|NCT00901901|438962|P1|STARTED|Treatment Period||362
182267|NCT00901628|438984|P2|NOT COMPLETED|Overall Study||10
182268|NCT00901628|438985|P1|NOT COMPLETED|Overall Study||4
182269|NCT00901628|438984|P2|COMPLETED|Overall Study||42
182270|NCT00901628|438985|P1|COMPLETED|Overall Study||45
182271|NCT00901628|438984|P2|STARTED|Overall Study||52
182272|NCT00901628|438985|P1|STARTED|Overall Study||49
182273|NCT00901576|439007|P6|NOT COMPLETED|Third Intervention||0
182274|NCT00901576|439008|P5|NOT COMPLETED|Third Intervention||0
182275|NCT00901576|439009|P4|NOT COMPLETED|Third Intervention||0
182276|NCT00901576|439010|P3|NOT COMPLETED|Third Intervention||0
182277|NCT00901576|439011|P2|NOT COMPLETED|Third Intervention||0
182278|NCT00901576|439012|P1|NOT COMPLETED|Third Intervention||0
182279|NCT00901576|439007|P6|COMPLETED|Third Intervention||5
182280|NCT00901576|439008|P5|COMPLETED|Third Intervention||6
182281|NCT00901576|439009|P4|COMPLETED|Third Intervention||5
182282|NCT00901576|439010|P3|COMPLETED|Third Intervention||7
182283|NCT00901576|439011|P2|COMPLETED|Third Intervention||7
182284|NCT00901576|439012|P1|COMPLETED|Third Intervention||5
182285|NCT00901576|439007|P6|STARTED|Third Intervention||5
182286|NCT00901576|439008|P5|STARTED|Third Intervention||6
182287|NCT00901576|439009|P4|STARTED|Third Intervention||5
182288|NCT00901576|439010|P3|STARTED|Third Intervention||7
182289|NCT00901576|439011|P2|STARTED|Third Intervention||7
182290|NCT00901576|439012|P1|STARTED|Third Intervention||5
182291|NCT00901576|439007|P6|NOT COMPLETED|Washout||0
182292|NCT00901576|439008|P5|NOT COMPLETED|Washout||0
182293|NCT00901576|439009|P4|NOT COMPLETED|Washout||0
182294|NCT00901576|439010|P3|NOT COMPLETED|Washout||0
182295|NCT00901576|439011|P2|NOT COMPLETED|Washout||0
182296|NCT00901576|439012|P1|NOT COMPLETED|Washout||0
182297|NCT00901576|439007|P6|COMPLETED|Washout||5
182298|NCT00901576|439008|P5|COMPLETED|Washout||6
182299|NCT00901576|439009|P4|COMPLETED|Washout||5
182300|NCT00901576|439010|P3|COMPLETED|Washout||7
182301|NCT00901576|439011|P2|COMPLETED|Washout||7
182302|NCT00901576|439012|P1|COMPLETED|Washout||5
182303|NCT00901576|439007|P6|STARTED|Washout||5
182304|NCT00901576|439008|P5|STARTED|Washout||6
182305|NCT00901576|439009|P4|STARTED|Washout||5
182306|NCT00901576|439010|P3|STARTED|Washout||7
182307|NCT00901576|439011|P2|STARTED|Washout||7
182308|NCT00901576|439012|P1|STARTED|Washout||5
182309|NCT00901576|439007|P6|NOT COMPLETED|Second Intervention||1
182310|NCT00901576|439008|P5|NOT COMPLETED|Second Intervention||0
182311|NCT00901576|439009|P4|NOT COMPLETED|Second Intervention||1
182312|NCT00901576|439010|P3|NOT COMPLETED|Second Intervention||0
182313|NCT00901576|439011|P2|NOT COMPLETED|Second Intervention||0
182314|NCT00901576|439012|P1|NOT COMPLETED|Second Intervention||1
182315|NCT00901576|439007|P6|COMPLETED|Second Intervention||5
182316|NCT00901576|439008|P5|COMPLETED|Second Intervention||6
182317|NCT00901576|439009|P4|COMPLETED|Second Intervention||5
182318|NCT00901576|439010|P3|COMPLETED|Second Intervention||7
182319|NCT00901576|439011|P2|COMPLETED|Second Intervention||7
182320|NCT00901576|439012|P1|COMPLETED|Second Intervention||5
182321|NCT00901576|439007|P6|STARTED|Second Intervention||6
182322|NCT00901576|439008|P5|STARTED|Second Intervention||6
182323|NCT00901576|439009|P4|STARTED|Second Intervention||6
182324|NCT00901576|439010|P3|STARTED|Second Intervention||7
182325|NCT00901576|439011|P2|STARTED|Second Intervention||7
182326|NCT00901576|439012|P1|STARTED|Second Intervention||6
182327|NCT00901576|439007|P6|NOT COMPLETED|Washout||0
182328|NCT00901576|439008|P5|NOT COMPLETED|Washout||0
182329|NCT00901576|439009|P4|NOT COMPLETED|Washout||0
182330|NCT00901576|439010|P3|NOT COMPLETED|Washout||0
182331|NCT00901576|439011|P2|NOT COMPLETED|Washout||0
182332|NCT00901576|439012|P1|NOT COMPLETED|Washout||0
182333|NCT00901576|439007|P6|COMPLETED|Washout||6
182334|NCT00901576|439008|P5|COMPLETED|Washout||6
182335|NCT00901576|439009|P4|COMPLETED|Washout||6
182336|NCT00901576|439010|P3|COMPLETED|Washout||7
182337|NCT00901576|439011|P2|COMPLETED|Washout||7
182338|NCT00901576|439012|P1|COMPLETED|Washout||6
182339|NCT00901576|439007|P6|STARTED|Washout||6
182340|NCT00901576|439008|P5|STARTED|Washout||6
182341|NCT00901576|439009|P4|STARTED|Washout||6
182342|NCT00901576|439010|P3|STARTED|Washout||7
182343|NCT00901576|439011|P2|STARTED|Washout||7
182344|NCT00901576|439012|P1|STARTED|Washout||6
182345|NCT00901576|439007|P6|NOT COMPLETED|First Intervention||0
182346|NCT00901576|439008|P5|NOT COMPLETED|First Intervention||0
182347|NCT00901576|439009|P4|NOT COMPLETED|First Intervention||0
182348|NCT00901576|439010|P3|NOT COMPLETED|First Intervention||0
182349|NCT00901576|439011|P2|NOT COMPLETED|First Intervention||0
182350|NCT00901576|439012|P1|NOT COMPLETED|First Intervention||0
182351|NCT00901576|439007|P6|COMPLETED|First Intervention||6
182352|NCT00901576|439008|P5|COMPLETED|First Intervention||6
182353|NCT00901576|439009|P4|COMPLETED|First Intervention||6
182354|NCT00901576|439010|P3|COMPLETED|First Intervention||7
182355|NCT00901576|439011|P2|COMPLETED|First Intervention||7
182356|NCT00901576|439012|P1|COMPLETED|First Intervention||6
182357|NCT00901576|439007|P6|STARTED|First Intervention||6
182358|NCT00901576|439008|P5|STARTED|First Intervention||6
182359|NCT00901576|439009|P4|STARTED|First Intervention||6
182360|NCT00901576|439010|P3|STARTED|First Intervention||7
182361|NCT00901576|439011|P2|STARTED|First Intervention||7
182362|NCT00901576|439012|P1|STARTED|First Intervention||6
182363|NCT00901459|439033|P1|NOT COMPLETED|Overall Study||6
182364|NCT00901459|439033|P1|COMPLETED|Overall Study||15
182365|NCT00901459|439033|P1|STARTED|Overall Study||21
182366|NCT00901342|439044|P1|NOT COMPLETED|Overall Study||15
182367|NCT00901342|439044|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
182368|NCT00901342|439044|P1|Received at Least 1 Infusion|Overall Study||98
182369|NCT00901342|439044|P1|STARTED|Overall Study||104
182370|NCT00901316|439050|P2|NOT COMPLETED|Overall Study||0
182371|NCT00901316|439051|P1|NOT COMPLETED|Overall Study||0
182372|NCT00901316|439050|P2|COMPLETED|Overall Study||495
182373|NCT00901316|439051|P1|COMPLETED|Overall Study||492
182374|NCT00901316|439050|P2|STARTED|Overall Study||495
182375|NCT00901316|439051|P1|STARTED|Overall Study||492
182376|NCT00901225|439057|P1|NOT COMPLETED|Overall Study||1
182377|NCT00901225|439057|P1|COMPLETED|Overall Study||20
182378|NCT00901225|439057|P1|STARTED|Overall Study||21
182379|NCT00901186|439068|P2|NOT COMPLETED|Overall Study||11
182380|NCT00901186|439069|P1|NOT COMPLETED|Overall Study||9
182381|NCT00901186|439068|P2|COMPLETED|Overall Study||32
182382|NCT00901186|439069|P1|COMPLETED|Overall Study||31
182468|NCT00900159|439210|P1|STARTED|First Intervention||11
182383|NCT00901186|439068|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
182384|NCT00901186|439069|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
182385|NCT00901186|439068|P2|Safety Set|Overall Study||43
182386|NCT00901186|439069|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
182387|NCT00901186|439068|P2|STARTED|Overall Study||43
182388|NCT00901186|439069|P1|STARTED|Overall Study||40
182389|NCT00901017|439085|P1|NOT COMPLETED|Overall Study||0
182390|NCT00901017|439085|P1|COMPLETED|Overall Study||14
182391|NCT00901017|439085|P1|STARTED|Overall Study||14
182392|NCT00900822|439099|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
182393|NCT00900822|439099|P1|COMPLETED|12 Months Clinical Evaluation||11
182394|NCT00900822|439099|P1|STARTED|12 Months Clinical Evaluation||11
182395|NCT00900822|439099|P1|NOT COMPLETED|9 Months Histological Evaluation||0
182396|NCT00900822|439099|P1|COMPLETED|9 Months Histological Evaluation||11
182397|NCT00900822|439099|P1|STARTED|9 Months Histological Evaluation||11
182398|NCT00900796|439109|P1|NOT COMPLETED|Phase 2||5
182399|NCT00900796|439109|P1|COMPLETED|Phase 2||6
182400|NCT00900796|439109|P1|STARTED|Phase 2||11
182401|NCT00900796|439109|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
182402|NCT00900796|439109|P1|COMPLETED|Between Phase 1 and Phase 2||11
182403|NCT00900796|439109|P1|STARTED|Between Phase 1 and Phase 2||121
182404|NCT00900796|439109|P1|NOT COMPLETED|Phase 1||11
182405|NCT00900796|439109|P1|COMPLETED|Phase 1||121
182406|NCT00900796|439109|P1|STARTED|Phase 1||132
182407|NCT00900757|439119|P1|NOT COMPLETED|Overall Study||19
182408|NCT00900757|439119|P1|COMPLETED|Overall Study||38
182409|NCT00900757|439119|P1|STARTED|Overall Study||57
182410|NCT00900731|439129|P2|NOT COMPLETED|Overall Study||61
182411|NCT00900731|439130|P1|NOT COMPLETED|Overall Study||60
182412|NCT00900731|439129|P2|COMPLETED|Overall Study||740
182413|NCT00900731|439130|P1|COMPLETED|Overall Study||737
182414|NCT00900731|439129|P2|Safety Set: Received Study Drug|Overall Study||799
182415|NCT00900731|439130|P1|Safety Set: Received Study Drug|Overall Study||794
182416|NCT00900731|439129|P2|STARTED|Overall Study||801
182417|NCT00900731|439130|P1|STARTED|Overall Study|Randomized participants|797
182418|NCT00900666|439152|P2|NOT COMPLETED|Overall Study||0
182419|NCT00900666|439153|P1|NOT COMPLETED|Overall Study||0
182420|NCT00900666|439152|P2|COMPLETED|Overall Study||9
182421|NCT00900666|439153|P1|COMPLETED|Overall Study||10
182422|NCT00900666|439152|P2|STARTED|Overall Study||9
182423|NCT00900666|439153|P1|STARTED|Overall Study||10
182424|NCT00900627|439167|P6|NOT COMPLETED|Overall Study||26
182425|NCT00900627|439168|P5|NOT COMPLETED|Overall Study||29
182426|NCT00900627|439169|P4|NOT COMPLETED|Overall Study||6
182427|NCT00900627|439170|P3|NOT COMPLETED|Overall Study||6
182428|NCT00900627|439171|P2|NOT COMPLETED|Overall Study||2
182429|NCT00900627|439172|P1|NOT COMPLETED|Overall Study||6
182430|NCT00900627|439167|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
182431|NCT00900627|439168|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
182432|NCT00900627|439169|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
182433|NCT00900627|439170|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
182434|NCT00900627|439171|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
182435|NCT00900627|439172|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
182436|NCT00900627|439167|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
182437|NCT00900627|439168|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
182438|NCT00900627|439169|P4|STARTED|Overall Study||6
182439|NCT00900627|439170|P3|STARTED|Overall Study||6
182440|NCT00900627|439171|P2|STARTED|Overall Study||2
182441|NCT00900627|439172|P1|STARTED|Overall Study||6
182442|NCT00900601|439190|P1|NOT COMPLETED|Overall Study||1
182443|NCT00900601|439190|P1|COMPLETED|Overall Study||8
182444|NCT00900601|439190|P1|STARTED|Overall Study||9
182445|NCT00900237|439198|P2|NOT COMPLETED|Overall Study||0
182446|NCT00900237|439199|P1|NOT COMPLETED|Overall Study||0
182447|NCT00900237|439198|P2|COMPLETED|Overall Study||7
182448|NCT00900237|439199|P1|COMPLETED|Overall Study||7
182449|NCT00900237|439198|P2|STARTED|Overall Study||7
182450|NCT00900237|439199|P1|STARTED|Overall Study||7
182451|NCT00900159|439209|P2|NOT COMPLETED|Second Intervention||0
182452|NCT00900159|439210|P1|NOT COMPLETED|Second Intervention||1
182453|NCT00900159|439209|P2|COMPLETED|Second Intervention||13
182454|NCT00900159|439210|P1|COMPLETED|Second Intervention||10
182455|NCT00900159|439209|P2|STARTED|Second Intervention||13
182456|NCT00900159|439210|P1|STARTED|Second Intervention||11
182457|NCT00900159|439209|P2|NOT COMPLETED|Washout||0
182458|NCT00900159|439210|P1|NOT COMPLETED|Washout||0
182459|NCT00900159|439209|P2|COMPLETED|Washout||13
182460|NCT00900159|439210|P1|COMPLETED|Washout||11
182461|NCT00900159|439209|P2|STARTED|Washout||13
182462|NCT00900159|439210|P1|STARTED|Washout||11
182463|NCT00900159|439209|P2|NOT COMPLETED|First Intervention||0
182464|NCT00900159|439210|P1|NOT COMPLETED|First Intervention||0
182465|NCT00900159|439209|P2|COMPLETED|First Intervention||13
182466|NCT00900159|439210|P1|COMPLETED|First Intervention||11
182467|NCT00900159|439209|P2|STARTED|First Intervention||13
182469|NCT00900146|439229|P5|NOT COMPLETED|Intermediate: Period III||167
182470|NCT00900146|439230|P4|NOT COMPLETED|Intermediate: Period III||90
182471|NCT00900146|439231|P3|NOT COMPLETED|Intermediate: Period III||84
182472|NCT00900146|439232|P2|NOT COMPLETED|Intermediate: Period III||93
182473|NCT00900146|439233|P1|NOT COMPLETED|Intermediate: Period III||87
182474|NCT00900146|439229|P5|COMPLETED|Intermediate: Period III||0
182475|NCT00900146|439230|P4|COMPLETED|Intermediate: Period III||0
182476|NCT00900146|439231|P3|COMPLETED|Intermediate: Period III||0
182477|NCT00900146|439232|P2|COMPLETED|Intermediate: Period III||0
182478|NCT00900146|439233|P1|COMPLETED|Intermediate: Period III||0
182479|NCT00900146|439229|P5|Safety Set|Intermediate: Period III||166
182480|NCT00900146|439230|P4|Safety Set|Intermediate: Period III||90
182481|NCT00900146|439231|P3|Safety Set|Intermediate: Period III||84
182482|NCT00900146|439232|P2|Safety Set|Intermediate: Period III||92
182483|NCT00900146|439233|P1|Safety Set|Intermediate: Period III||86
182484|NCT00900146|439229|P5|STARTED|Intermediate: Period III||167
182485|NCT00900146|439230|P4|STARTED|Intermediate: Period III||90
182486|NCT00900146|439231|P3|STARTED|Intermediate: Period III||84
182487|NCT00900146|439232|P2|STARTED|Intermediate: Period III||93
182488|NCT00900146|439233|P1|STARTED|Intermediate: Period III||87
182489|NCT00900146|439229|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
182490|NCT00900146|439230|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
182491|NCT00900146|439231|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
182492|NCT00900146|439232|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
182493|NCT00900146|439233|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
182494|NCT00900146|439229|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
182495|NCT00900146|439230|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
182496|NCT00900146|439231|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
182497|NCT00900146|439232|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
182498|NCT00900146|439233|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
182499|NCT00900146|439229|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
182500|NCT00900146|439230|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
182501|NCT00900146|439231|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
182502|NCT00900146|439232|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
182503|NCT00900146|439233|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
182504|NCT00900146|439229|P5|STARTED|Dose Finding: Period II (4 Months)||179
182505|NCT00900146|439230|P4|STARTED|Dose Finding: Period II (4 Months)||92
182506|NCT00900146|439231|P3|STARTED|Dose Finding: Period II (4 Months)||92
182507|NCT00900146|439232|P2|STARTED|Dose Finding: Period II (4 Months)||95
182508|NCT00900146|439233|P1|STARTED|Dose Finding: Period II (4 Months)||93
182509|NCT00900029|439350|P5|NOT COMPLETED|Overall Study||6
182510|NCT00900029|439351|P4|NOT COMPLETED|Overall Study||7
182511|NCT00900029|439352|P3|NOT COMPLETED|Overall Study||3
182512|NCT00900029|439353|P2|NOT COMPLETED|Overall Study||4
182513|NCT00900029|439354|P1|NOT COMPLETED|Overall Study||3
182514|NCT00900029|439350|P5|COMPLETED|Overall Study||38
182515|NCT00900029|439351|P4|COMPLETED|Overall Study||35
182516|NCT00900029|439352|P3|COMPLETED|Overall Study||38
182517|NCT00900029|439353|P2|COMPLETED|Overall Study||37
182518|NCT00900029|439354|P1|COMPLETED|Overall Study||35
182519|NCT00900029|439350|P5|STARTED|Overall Study||44
182520|NCT00900029|439351|P4|STARTED|Overall Study||42
182521|NCT00900029|439352|P3|STARTED|Overall Study||41
182522|NCT00900029|439353|P2|STARTED|Overall Study||41
182523|NCT00900029|439354|P1|STARTED|Overall Study||38
182524|NCT00899847|439371|P1|NOT COMPLETED|Overall Study||2
182525|NCT00899847|439371|P1|COMPLETED|Overall Study||7
182526|NCT00899847|439371|P1|STARTED|Overall Study||9
182527|NCT00899717|439384|P2|NOT COMPLETED|Overall Study||0
182528|NCT00899717|439385|P1|NOT COMPLETED|Overall Study||0
182529|NCT00899717|439384|P2|COMPLETED|Overall Study||11
182530|NCT00899717|439385|P1|COMPLETED|Overall Study||10
182531|NCT00899717|439384|P2|STARTED|Overall Study||11
182532|NCT00899717|439385|P1|STARTED|Overall Study||10
182533|NCT00899678|439402|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
182534|NCT00899678|439403|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
182535|NCT00899678|439404|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
182536|NCT00899678|439402|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
182537|NCT00899678|439403|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
182538|NCT00899678|439404|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
182539|NCT00899678|439402|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
182540|NCT00899678|439403|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
182541|NCT00899678|439404|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
182542|NCT00899678|439402|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
182543|NCT00899678|439403|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
182544|NCT00899678|439404|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
182545|NCT00899678|439402|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
182546|NCT00899678|439403|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
182547|NCT00899678|439404|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
182548|NCT00899678|439402|P3|STARTED|Induction Period (Weeks 0 to 6)||35
182549|NCT00899678|439403|P2|STARTED|Induction Period (Weeks 0 to 6)||37
182550|NCT00899678|439404|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
182551|NCT00899600|439434|P2|NOT COMPLETED|Overall Study||0
182552|NCT00899600|439435|P1|NOT COMPLETED|Overall Study||0
182553|NCT00899600|439434|P2|COMPLETED|Overall Study||52
182554|NCT00899600|439435|P1|COMPLETED|Overall Study||50
182555|NCT00899600|439434|P2|STARTED|Overall Study||52
182556|NCT00899600|439435|P1|STARTED|Overall Study||50
182557|NCT00899574|439441|P1|NOT COMPLETED|Overall Study||0
182558|NCT00899574|439441|P1|COMPLETED|Overall Study||10
182559|NCT00899574|439441|P1|STARTED|Overall Study||10
182560|NCT00899470|439446|P4|NOT COMPLETED|Fourth Therapy||0
182561|NCT00899470|439447|P3|NOT COMPLETED|Fourth Therapy||0
182562|NCT00899470|439448|P2|NOT COMPLETED|Fourth Therapy||0
182563|NCT00899470|439449|P1|NOT COMPLETED|Fourth Therapy||0
182564|NCT00899470|439446|P4|COMPLETED|Fourth Therapy||6
182565|NCT00899470|439447|P3|COMPLETED|Fourth Therapy||6
182566|NCT00899470|439448|P2|COMPLETED|Fourth Therapy||6
182567|NCT00899470|439449|P1|COMPLETED|Fourth Therapy||6
182568|NCT00899470|439446|P4|STARTED|Fourth Therapy||6
182569|NCT00899470|439447|P3|STARTED|Fourth Therapy||6
182570|NCT00899470|439448|P2|STARTED|Fourth Therapy||6
182571|NCT00899470|439449|P1|STARTED|Fourth Therapy||6
182572|NCT00899470|439446|P4|NOT COMPLETED|Third Washout||0
182573|NCT00899470|439447|P3|NOT COMPLETED|Third Washout||0
182574|NCT00899470|439448|P2|NOT COMPLETED|Third Washout||0
182575|NCT00899470|439449|P1|NOT COMPLETED|Third Washout||0
182576|NCT00899470|439446|P4|COMPLETED|Third Washout||6
182577|NCT00899470|439447|P3|COMPLETED|Third Washout||6
182578|NCT00899470|439448|P2|COMPLETED|Third Washout||6
182579|NCT00899470|439449|P1|COMPLETED|Third Washout||6
182580|NCT00899470|439446|P4|STARTED|Third Washout||6
182581|NCT00899470|439447|P3|STARTED|Third Washout||6
182582|NCT00899470|439448|P2|STARTED|Third Washout||6
182583|NCT00899470|439449|P1|STARTED|Third Washout||6
182584|NCT00899470|439446|P4|NOT COMPLETED|Third Therapy||0
182585|NCT00899470|439447|P3|NOT COMPLETED|Third Therapy||0
182586|NCT00899470|439448|P2|NOT COMPLETED|Third Therapy||0
182587|NCT00899470|439449|P1|NOT COMPLETED|Third Therapy||0
182588|NCT00899470|439446|P4|COMPLETED|Third Therapy||6
182589|NCT00899470|439447|P3|COMPLETED|Third Therapy||6
182590|NCT00899470|439448|P2|COMPLETED|Third Therapy||6
182591|NCT00899470|439449|P1|COMPLETED|Third Therapy||6
182592|NCT00899470|439446|P4|STARTED|Third Therapy||6
182593|NCT00899470|439447|P3|STARTED|Third Therapy||6
182594|NCT00899470|439448|P2|STARTED|Third Therapy||6
182595|NCT00899470|439449|P1|STARTED|Third Therapy||6
182596|NCT00899470|439446|P4|NOT COMPLETED|Second Washout||0
182597|NCT00899470|439447|P3|NOT COMPLETED|Second Washout||0
182598|NCT00899470|439448|P2|NOT COMPLETED|Second Washout||0
182599|NCT00899470|439449|P1|NOT COMPLETED|Second Washout||0
182600|NCT00899470|439446|P4|COMPLETED|Second Washout||6
182601|NCT00899470|439447|P3|COMPLETED|Second Washout||6
182602|NCT00899470|439448|P2|COMPLETED|Second Washout||6
182603|NCT00899470|439449|P1|COMPLETED|Second Washout||6
182604|NCT00899470|439446|P4|STARTED|Second Washout||6
182605|NCT00899470|439447|P3|STARTED|Second Washout||6
182606|NCT00899470|439448|P2|STARTED|Second Washout||6
182607|NCT00899470|439449|P1|STARTED|Second Washout||6
182608|NCT00899470|439446|P4|NOT COMPLETED|Second Therapy||0
182609|NCT00899470|439447|P3|NOT COMPLETED|Second Therapy||0
182610|NCT00899470|439448|P2|NOT COMPLETED|Second Therapy||0
182611|NCT00899470|439449|P1|NOT COMPLETED|Second Therapy||0
182612|NCT00899470|439446|P4|COMPLETED|Second Therapy||6
182613|NCT00899470|439447|P3|COMPLETED|Second Therapy||6
182614|NCT00899470|439448|P2|COMPLETED|Second Therapy||6
182615|NCT00899470|439449|P1|COMPLETED|Second Therapy||6
182616|NCT00899470|439446|P4|STARTED|Second Therapy||6
182617|NCT00899470|439447|P3|STARTED|Second Therapy||6
182618|NCT00899470|439448|P2|STARTED|Second Therapy||6
182619|NCT00899470|439449|P1|STARTED|Second Therapy||6
182620|NCT00899470|439446|P4|NOT COMPLETED|First Washout Period||0
182621|NCT00899470|439447|P3|NOT COMPLETED|First Washout Period||0
182622|NCT00899470|439448|P2|NOT COMPLETED|First Washout Period||0
182623|NCT00899470|439449|P1|NOT COMPLETED|First Washout Period||0
182624|NCT00899470|439446|P4|COMPLETED|First Washout Period||6
182625|NCT00899470|439447|P3|COMPLETED|First Washout Period||6
182626|NCT00899470|439448|P2|COMPLETED|First Washout Period||6
182627|NCT00899470|439449|P1|COMPLETED|First Washout Period||6
182628|NCT00899470|439446|P4|STARTED|First Washout Period||6
182629|NCT00899470|439447|P3|STARTED|First Washout Period||6
182630|NCT00899470|439448|P2|STARTED|First Washout Period||6
182631|NCT00899470|439449|P1|STARTED|First Washout Period||6
182632|NCT00899470|439446|P4|NOT COMPLETED|First Therapy||0
182633|NCT00899470|439447|P3|NOT COMPLETED|First Therapy||0
182634|NCT00899470|439448|P2|NOT COMPLETED|First Therapy||0
182635|NCT00899470|439449|P1|NOT COMPLETED|First Therapy||0
182636|NCT00899470|439446|P4|COMPLETED|First Therapy||6
182637|NCT00899470|439447|P3|COMPLETED|First Therapy||6
182638|NCT00899470|439448|P2|COMPLETED|First Therapy||6
182639|NCT00899470|439449|P1|COMPLETED|First Therapy||6
182640|NCT00899470|439446|P4|STARTED|First Therapy||6
182641|NCT00899470|439447|P3|STARTED|First Therapy||6
182642|NCT00899470|439448|P2|STARTED|First Therapy||6
182643|NCT00899470|439449|P1|STARTED|First Therapy||6
182644|NCT00899392|439527|P2|NOT COMPLETED|Overall Study||24
182645|NCT00899392|439528|P1|NOT COMPLETED|Overall Study||21
182646|NCT00899392|439527|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
182647|NCT00899392|439528|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
182648|NCT00899392|439527|P2|STARTED|Overall Study||74
182649|NCT00899392|439528|P1|STARTED|Overall Study||68
182650|NCT00899379|439545|P5|NOT COMPLETED|Overall Study||31
182651|NCT00899379|439546|P4|NOT COMPLETED|Overall Study||37
182652|NCT00899379|439547|P3|NOT COMPLETED|Overall Study||29
182653|NCT00899379|439548|P2|NOT COMPLETED|Overall Study||29
182654|NCT00899379|439549|P1|NOT COMPLETED|Overall Study||34
182655|NCT00899379|439545|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
182656|NCT00899379|439546|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
182657|NCT00899379|439547|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
182658|NCT00899379|439548|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
182659|NCT00899379|439549|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
182660|NCT00899379|439545|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
182661|NCT00899379|439546|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
182662|NCT00899379|439547|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
182663|NCT00899379|439548|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
182664|NCT00899379|439549|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
182665|NCT00899379|439545|P5|Patients Treated|Overall Study|Patients who took study drug|81
182666|NCT00899379|439546|P4|Patients Treated|Overall Study|Patients who took study drug|77
182667|NCT00899379|439547|P3|Patients Treated|Overall Study|Patients who took study drug|84
182668|NCT00899379|439548|P2|Patients Treated|Overall Study|Patients who took study drug|82
182669|NCT00899379|439549|P1|Patients Treated|Overall Study|Patients who took study drug|83
182670|NCT00899379|439545|P5|STARTED|Overall Study|Patients who were allocated study drug|94
182671|NCT00899379|439546|P4|STARTED|Overall Study|Patients who were allocated study drug|94
182672|NCT00899379|439547|P3|STARTED|Overall Study|Patients who were allocated study drug|95
182673|NCT00899379|439548|P2|STARTED|Overall Study|Patients who were allocated study drug|95
182674|NCT00899379|439549|P1|STARTED|Overall Study|Patients who were allocated study drug|95
182675|NCT00899353|439561|P1|NOT COMPLETED|Overall Study||5
182676|NCT00899353|439561|P1|COMPLETED|Overall Study||11
182677|NCT00899353|439561|P1|STARTED|Overall Study||16
182678|NCT00898937|439585|P3|NOT COMPLETED|Overall Study||0
182679|NCT00898937|439586|P2|NOT COMPLETED|Overall Study||0
182680|NCT00898937|439587|P1|NOT COMPLETED|Overall Study||0
182681|NCT00898937|439585|P3|COMPLETED|Overall Study||9
182682|NCT00898937|439586|P2|COMPLETED|Overall Study||21
182683|NCT00898937|439587|P1|COMPLETED|Overall Study||25
182684|NCT00898937|439585|P3|STARTED|Overall Study||9
182685|NCT00898937|439586|P2|STARTED|Overall Study||21
182686|NCT00898937|439587|P1|STARTED|Overall Study||25
182687|NCT00898807|439597|P2|NOT COMPLETED|Overall Study||9
182688|NCT00898807|439598|P1|NOT COMPLETED|Overall Study||8
182689|NCT00898807|439597|P2|COMPLETED|Overall Study||83
182690|NCT00898807|439598|P1|COMPLETED|Overall Study||86
182691|NCT00898807|439597|P2|STARTED|Overall Study||92
182692|NCT00898807|439598|P1|STARTED|Overall Study||94
182693|NCT00898677|439614|P4|NOT COMPLETED|Overall Study||19
182694|NCT00898677|439615|P3|NOT COMPLETED|Overall Study||72
182695|NCT00898677|439616|P2|NOT COMPLETED|Overall Study||69
182696|NCT00898677|439617|P1|NOT COMPLETED|Overall Study||17
182697|NCT00898677|439614|P4|COMPLETED|Overall Study||159
182698|NCT00898677|439615|P3|COMPLETED|Overall Study||383
182699|NCT00898677|439616|P2|COMPLETED|Overall Study||386
182700|NCT00898677|439617|P1|COMPLETED|Overall Study||163
182701|NCT00898677|439614|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
182702|NCT00898677|439615|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
182703|NCT00898677|439616|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
182704|NCT00898677|439617|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
182705|NCT00898677|439614|P4|STARTED|Overall Study||178
182706|NCT00898677|439615|P3|STARTED|Overall Study||455
182707|NCT00898677|439616|P2|STARTED|Overall Study||455
182708|NCT00898677|439617|P1|STARTED|Overall Study||180
182709|NCT00898560|439643|P1|NOT COMPLETED|Overall Study||1
182710|NCT00898560|439643|P1|COMPLETED|Overall Study||19
182711|NCT00898560|439643|P1|STARTED|Overall Study||20
182712|NCT00898443|439655|P2|NOT COMPLETED|Overall Study||0
182713|NCT00898443|439656|P1|NOT COMPLETED|Overall Study||1
182714|NCT00898443|439655|P2|COMPLETED|Overall Study||8
182715|NCT00898443|439656|P1|COMPLETED|Overall Study||9
182716|NCT00898443|439655|P2|STARTED|Overall Study||8
182717|NCT00898443|439656|P1|STARTED|Overall Study||10
182718|NCT00898222|439664|P1|NOT COMPLETED|Overall Study||0
182719|NCT00898222|439664|P1|COMPLETED|Overall Study||4
182720|NCT00898222|439664|P1|STARTED|Overall Study||4
182721|NCT00897949|439671|P3|NOT COMPLETED|Overall Study||69
182722|NCT00897949|439672|P2|NOT COMPLETED|Overall Study||103
182723|NCT00897949|439673|P1|NOT COMPLETED|Overall Study||104
182724|NCT00897949|439671|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
182806|NCT00896363|439905|P2|COMPLETED|Overall Study||25
182725|NCT00897949|439672|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
182726|NCT00897949|439673|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
182727|NCT00897949|439671|P3|Patients Treated|Overall Study|Patients who took study drug|304
182728|NCT00897949|439672|P2|Patients Treated|Overall Study|Patients who took study drug|456
182729|NCT00897949|439673|P1|Patients Treated|Overall Study|Patients who took study drug|458
182730|NCT00897949|439671|P3|STARTED|Overall Study|Patients who were allocated study drug|370
182731|NCT00897949|439672|P2|STARTED|Overall Study|Patients who were allocated study drug|549
182732|NCT00897949|439673|P1|STARTED|Overall Study|Patients who were allocated study drug|554
182733|NCT00897910|439696|P1|NOT COMPLETED|Overall Study||0
182734|NCT00897910|439696|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
182735|NCT00897910|439696|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
182736|NCT00897897|439700|P1|NOT COMPLETED|Overall Study||0
182737|NCT00897897|439700|P1|COMPLETED|Overall Study||33
182738|NCT00897897|439700|P1|STARTED|Overall Study||33
182739|NCT00897715|439707|P2|NOT COMPLETED|Overall Study||1
182740|NCT00897715|439708|P1|NOT COMPLETED|Overall Study||2
182741|NCT00897715|439707|P2|COMPLETED|Overall Study||6
182742|NCT00897715|439708|P1|COMPLETED|Overall Study||6
182743|NCT00897715|439707|P2|STARTED|Overall Study||7
182744|NCT00897715|439708|P1|STARTED|Overall Study||8
182745|NCT00897676|439716|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
182746|NCT00897676|439717|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
182747|NCT00897676|439716|P2|COMPLETED|Intervention 2(6 Hours)||7
182748|NCT00897676|439717|P1|COMPLETED|Intervention 2(6 Hours)||9
182749|NCT00897676|439716|P2|STARTED|Intervention 2(6 Hours)||7
182750|NCT00897676|439717|P1|STARTED|Intervention 2(6 Hours)||9
182751|NCT00897676|439716|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
182752|NCT00897676|439717|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
182753|NCT00897676|439716|P2|COMPLETED|Intervention 1(6 Hours)||7
182754|NCT00897676|439717|P1|COMPLETED|Intervention 1(6 Hours)||9
182755|NCT00897676|439716|P2|STARTED|Intervention 1(6 Hours)||7
182756|NCT00897676|439717|P1|STARTED|Intervention 1(6 Hours)||9
182757|NCT00897390|439733|P1|NOT COMPLETED|Overall Study||6
182758|NCT00897390|439733|P1|COMPLETED|Overall Study||18
182759|NCT00897390|439733|P1|STARTED|Overall Study||24
182760|NCT00897104|439823|P3|NOT COMPLETED|Overall Study||8
182761|NCT00897104|439824|P2|NOT COMPLETED|Overall Study||71
182762|NCT00897104|439825|P1|NOT COMPLETED|Overall Study||64
182763|NCT00897104|439823|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
182764|NCT00897104|439824|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
182765|NCT00897104|439825|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
182766|NCT00897104|439823|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
182767|NCT00897104|439824|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
182768|NCT00897104|439825|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
182769|NCT00897104|439823|P3|Participants Treated|Overall Study|Participants who took study drug|80
182770|NCT00897104|439824|P2|Participants Treated|Overall Study|Participants who took study drug|357
182771|NCT00897104|439825|P1|Participants Treated|Overall Study|Participants who took study drug|355
182772|NCT00897104|439823|P3|STARTED|Overall Study|Participants who were allocated study drug|87
182773|NCT00897104|439824|P2|STARTED|Overall Study|Participants who were allocated study drug|428
182774|NCT00897104|439825|P1|STARTED|Overall Study|Participants who were allocated study drug|418
182775|NCT00896779|439853|P2|NOT COMPLETED|Overall Study||1
182776|NCT00896779|439854|P1|NOT COMPLETED|Overall Study||0
182777|NCT00896779|439853|P2|COMPLETED|Overall Study||11
182778|NCT00896779|439854|P1|COMPLETED|Overall Study||8
182779|NCT00896779|439853|P2|STARTED|Overall Study||12
182780|NCT00896779|439854|P1|STARTED|Overall Study||8
182781|NCT00896649|439860|P1|NOT COMPLETED|Overall Study||5
182782|NCT00896649|439860|P1|COMPLETED|Overall Study||188
182783|NCT00896649|439860|P1|STARTED|Overall Study||193
182784|NCT00896454|439865|P1|NOT COMPLETED|Overall Study||33
182785|NCT00896454|439865|P1|COMPLETED|Overall Study||0
182786|NCT00896454|439865|P1|STARTED|Overall Study||33
182787|NCT00896441|439879|P2|NOT COMPLETED|Overall Study||0
182788|NCT00896441|439880|P1|NOT COMPLETED|Overall Study||2
182789|NCT00896441|439879|P2|COMPLETED|Overall Study||9
182790|NCT00896441|439880|P1|COMPLETED|Overall Study||15
182791|NCT00896441|439879|P2|STARTED|Overall Study||9
182792|NCT00896441|439880|P1|STARTED|Overall Study||17
182793|NCT00896389|439887|P1|NOT COMPLETED|HCTZ High Dose||0
182794|NCT00896389|439887|P1|COMPLETED|HCTZ High Dose||25
182795|NCT00896389|439887|P1|STARTED|HCTZ High Dose||25
182796|NCT00896389|439887|P1|NOT COMPLETED|HCTZ Low Dose||0
182797|NCT00896389|439887|P1|COMPLETED|HCTZ Low Dose||28
182798|NCT00896389|439887|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
182799|NCT00896389|439887|P1|NOT COMPLETED|Salt Loading||0
182800|NCT00896389|439887|P1|COMPLETED|Salt Loading||124
182801|NCT00896389|439887|P1|STARTED|Salt Loading||124
182802|NCT00896363|439904|P3|NOT COMPLETED|Overall Study||8
182803|NCT00896363|439905|P2|NOT COMPLETED|Overall Study||11
182804|NCT00896363|439906|P1|NOT COMPLETED|Overall Study||6
182805|NCT00896363|439904|P3|COMPLETED|Overall Study||24
182807|NCT00896363|439906|P1|COMPLETED|Overall Study||25
182808|NCT00896363|439904|P3|STARTED|Overall Study||32
182809|NCT00896363|439905|P2|STARTED|Overall Study||36
182810|NCT00896363|439906|P1|STARTED|Overall Study||31
182811|NCT00896337|439958|P1|NOT COMPLETED|Overall Study||25
182812|NCT00896337|439958|P1|COMPLETED|Overall Study||100
182813|NCT00896337|439958|P1|STARTED|Overall Study||125
182814|NCT00896233|440025|P1|NOT COMPLETED|Overall Study||1
182815|NCT00896233|440025|P1|COMPLETED|Overall Study||9
182816|NCT00896233|440025|P1|STARTED|Overall Study||10
182817|NCT00896168|440038|P2|NOT COMPLETED|Overall Study||19
182818|NCT00896168|440039|P1|NOT COMPLETED|Overall Study||14
182819|NCT00896168|440038|P2|COMPLETED|Overall Study||111
182820|NCT00896168|440039|P1|COMPLETED|Overall Study||90
182821|NCT00896168|440038|P2|STARTED|Overall Study||130
182822|NCT00896168|440039|P1|STARTED|Overall Study||104
182823|NCT00896064|440069|P2|NOT COMPLETED|Overall Study||0
182824|NCT00896064|440070|P1|NOT COMPLETED|Overall Study||0
182825|NCT00896064|440069|P2|COMPLETED|Overall Study||21
182826|NCT00896064|440070|P1|COMPLETED|Overall Study||22
182827|NCT00896064|440069|P2|STARTED|Overall Study||21
182828|NCT00896064|440070|P1|STARTED|Overall Study||22
182829|NCT00896051|440100|P2|NOT COMPLETED|Overall Study||9
182830|NCT00896051|440101|P1|NOT COMPLETED|Overall Study||10
182831|NCT00896051|440100|P2|COMPLETED|Overall Study||16
182832|NCT00896051|440101|P1|COMPLETED|Overall Study||15
182833|NCT00896051|440100|P2|STARTED|Overall Study||25
182834|NCT00896051|440101|P1|STARTED|Overall Study||25
182835|NCT00896038|440143|P2|NOT COMPLETED|Overall Study||1
182836|NCT00896038|440144|P1|NOT COMPLETED|Overall Study||4
182837|NCT00896038|440143|P2|COMPLETED|Overall Study||27
182838|NCT00896038|440144|P1|COMPLETED|Overall Study||26
182839|NCT00896038|440143|P2|STARTED|Overall Study||28
182840|NCT00896038|440144|P1|STARTED|Overall Study||30
182841|NCT00896025|440182|P1|NOT COMPLETED|Overall Study||0
182842|NCT00896025|440182|P1|COMPLETED|Overall Study||8
182843|NCT00896025|440182|P1|STARTED|Overall Study||8
182844|NCT00895947|440188|P2|NOT COMPLETED|Overall Study||10
182845|NCT00895947|440189|P1|NOT COMPLETED|Overall Study||12
182846|NCT00895947|440188|P2|COMPLETED|Overall Study||90
182847|NCT00895947|440189|P1|COMPLETED|Overall Study||88
182848|NCT00895947|440188|P2|STARTED|Overall Study||100
182849|NCT00895947|440189|P1|STARTED|Overall Study||100
182850|NCT00895934|440207|P2|NOT COMPLETED|Overall Study||25
182851|NCT00895934|440208|P1|NOT COMPLETED|Overall Study||6
182852|NCT00895934|440207|P2|COMPLETED|Overall Study||18
182853|NCT00895934|440208|P1|COMPLETED|Overall Study||4
182854|NCT00895934|440207|P2|STARTED|Overall Study||43
182855|NCT00895934|440208|P1|STARTED|Overall Study||10
182856|NCT00895895|440219|P5|NOT COMPLETED|Period 2||49
182857|NCT00895895|440220|P4|NOT COMPLETED|Period 2||54
182858|NCT00895895|440221|P3|NOT COMPLETED|Period 2||49
182859|NCT00895895|440222|P2|NOT COMPLETED|Period 2||53
182860|NCT00895895|440223|P1|NOT COMPLETED|Period 2||56
182861|NCT00895895|440219|P5|COMPLETED|Period 2||35
182862|NCT00895895|440220|P4|COMPLETED|Period 2||37
182863|NCT00895895|440221|P3|COMPLETED|Period 2||33
182864|NCT00895895|440222|P2|COMPLETED|Period 2||31
182865|NCT00895895|440223|P1|COMPLETED|Period 2||30
182866|NCT00895895|440219|P5|STARTED|Period 2||84
182867|NCT00895895|440220|P4|STARTED|Period 2||91
182868|NCT00895895|440221|P3|STARTED|Period 2||82
182869|NCT00895895|440222|P2|STARTED|Period 2||84
182870|NCT00895895|440223|P1|STARTED|Period 2||86
182871|NCT00895895|440219|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
182872|NCT00895895|440220|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
182873|NCT00895895|440221|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
182874|NCT00895895|440222|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
182875|NCT00895895|440223|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
182876|NCT00895895|440219|P5|COMPLETED|After Period 1, Prior to Period 2||84
182877|NCT00895895|440220|P4|COMPLETED|After Period 1, Prior to Period 2||91
182878|NCT00895895|440221|P3|COMPLETED|After Period 1, Prior to Period 2||82
182879|NCT00895895|440222|P2|COMPLETED|After Period 1, Prior to Period 2||84
182880|NCT00895895|440223|P1|COMPLETED|After Period 1, Prior to Period 2||86
182881|NCT00895895|440219|P5|STARTED|After Period 1, Prior to Period 2||86
182882|NCT00895895|440220|P4|STARTED|After Period 1, Prior to Period 2||91
182883|NCT00895895|440221|P3|STARTED|After Period 1, Prior to Period 2||84
182884|NCT00895895|440222|P2|STARTED|After Period 1, Prior to Period 2||84
182885|NCT00895895|440223|P1|STARTED|After Period 1, Prior to Period 2||86
182886|NCT00895895|440219|P5|NOT COMPLETED|Period 1||20
182887|NCT00895895|440220|P4|NOT COMPLETED|Period 1||13
182888|NCT00895895|440221|P3|NOT COMPLETED|Period 1||20
182889|NCT00895895|440222|P2|NOT COMPLETED|Period 1||21
182890|NCT00895895|440223|P1|NOT COMPLETED|Period 1||21
182891|NCT00895895|440219|P5|COMPLETED|Period 1||86
182892|NCT00895895|440220|P4|COMPLETED|Period 1||91
182893|NCT00895895|440221|P3|COMPLETED|Period 1||84
182894|NCT00895895|440222|P2|COMPLETED|Period 1||84
182895|NCT00895895|440223|P1|COMPLETED|Period 1||86
182896|NCT00895895|440219|P5|Randomized But Not Treated|Period 1||2
182897|NCT00895895|440220|P4|Randomized But Not Treated|Period 1||1
182898|NCT00895895|440221|P3|Randomized But Not Treated|Period 1||1
182899|NCT00895895|440222|P2|Randomized But Not Treated|Period 1||3
182900|NCT00895895|440223|P1|Randomized But Not Treated|Period 1||1
182901|NCT00895895|440219|P5|STARTED|Period 1||106
182902|NCT00895895|440220|P4|STARTED|Period 1||104
182903|NCT00895895|440221|P3|STARTED|Period 1||104
182904|NCT00895895|440222|P2|STARTED|Period 1||105
182905|NCT00895895|440223|P1|STARTED|Period 1||107
182906|NCT00895843|440337|P2|NOT COMPLETED|Overall Study||12
182907|NCT00895843|440338|P1|NOT COMPLETED|Overall Study||12
182908|NCT00895843|440337|P2|COMPLETED|Overall Study||50
182909|NCT00895843|440338|P1|COMPLETED|Overall Study||48
182910|NCT00895843|440337|P2|STARTED|Overall Study||62
182911|NCT00895843|440338|P1|STARTED|Overall Study||60
182912|NCT00895830|440349|P5|NOT COMPLETED|Overall Study||0
182913|NCT00895830|440350|P4|NOT COMPLETED|Overall Study||0
182914|NCT00895830|440351|P3|NOT COMPLETED|Overall Study||0
182915|NCT00895830|440352|P2|NOT COMPLETED|Overall Study||0
182916|NCT00895830|440353|P1|NOT COMPLETED|Overall Study||0
182917|NCT00895830|440349|P5|COMPLETED|Overall Study||55
182918|NCT00895830|440350|P4|COMPLETED|Overall Study||52
182919|NCT00895830|440351|P3|COMPLETED|Overall Study||49
182920|NCT00895830|440352|P2|COMPLETED|Overall Study||50
182921|NCT00895830|440353|P1|COMPLETED|Overall Study||51
182922|NCT00895830|440349|P5|STARTED|Overall Study||55
182923|NCT00895830|440350|P4|STARTED|Overall Study||52
182924|NCT00895830|440351|P3|STARTED|Overall Study||49
182925|NCT00895830|440352|P2|STARTED|Overall Study||50
182926|NCT00895830|440353|P1|STARTED|Overall Study||51
182927|NCT00895817|440367|P2|NOT COMPLETED|Overall Study||0
182928|NCT00895817|440368|P1|NOT COMPLETED|Overall Study||0
182929|NCT00895817|440367|P2|COMPLETED|Overall Study||21
182930|NCT00895817|440368|P1|COMPLETED|Overall Study||21
182931|NCT00895817|440367|P2|STARTED|Overall Study||21
182932|NCT00895817|440368|P1|STARTED|Overall Study||21
182933|NCT00895752|440374|P1|NOT COMPLETED|Overall Study||0
182934|NCT00895752|440374|P1|COMPLETED|Overall Study||6
182935|NCT00895752|440374|P1|STARTED|Overall Study||6
182936|NCT00895661|440385|P1|NOT COMPLETED|Overall Study||3
182937|NCT00895661|440385|P1|COMPLETED|Overall Study||37
182938|NCT00895661|440385|P1|STARTED|Overall Study||40
182939|NCT00895622|440395|P3|NOT COMPLETED|Overall Study||4
182940|NCT00895622|440396|P2|NOT COMPLETED|Overall Study||4
182941|NCT00895622|440397|P1|NOT COMPLETED|Overall Study||5
182942|NCT00895622|440395|P3|COMPLETED|Overall Study||53
182943|NCT00895622|440396|P2|COMPLETED|Overall Study||52
182944|NCT00895622|440397|P1|COMPLETED|Overall Study||60
182945|NCT00895622|440395|P3|STARTED|Overall Study||57
182946|NCT00895622|440396|P2|STARTED|Overall Study||56
182947|NCT00895622|440397|P1|STARTED|Overall Study||65
182948|NCT00895583|440420|P2|NOT COMPLETED|Overall Study||12
182949|NCT00895583|440421|P1|NOT COMPLETED|Overall Study||44
182950|NCT00895583|440420|P2|COMPLETED|Overall Study||111
182951|NCT00895583|440421|P1|COMPLETED|Overall Study||87
182952|NCT00895583|440420|P2|STARTED|Overall Study||123
182953|NCT00895583|440421|P1|STARTED|Overall Study||131
182954|NCT00895531|440501|P2|NOT COMPLETED|Overall Study||0
182955|NCT00895531|440502|P1|NOT COMPLETED|Overall Study||0
182956|NCT00895531|440501|P2|COMPLETED|Overall Study||37
182957|NCT00895531|440502|P1|COMPLETED|Overall Study||38
182958|NCT00895531|440501|P2|STARTED|Overall Study||37
182959|NCT00895531|440502|P1|STARTED|Overall Study||38
182960|NCT00895453|440511|P3|NOT COMPLETED|Overall Study||23
182961|NCT00895453|440512|P2|NOT COMPLETED|Overall Study||25
182962|NCT00895453|440513|P1|NOT COMPLETED|Overall Study||25
182963|NCT00895453|440511|P3|COMPLETED|Overall Study||23
182964|NCT00895453|440512|P2|COMPLETED|Overall Study||25
182965|NCT00895453|440513|P1|COMPLETED|Overall Study||23
182966|NCT00895453|440511|P3|STARTED|Overall Study||46
182967|NCT00895453|440512|P2|STARTED|Overall Study||50
182968|NCT00895453|440513|P1|STARTED|Overall Study||48
182969|NCT00895310|440521|P1|NOT COMPLETED|Overall Study||1
182970|NCT00895310|440521|P1|COMPLETED|Overall Study||29
182971|NCT00895310|440521|P1|STARTED|Overall Study||30
182972|NCT00895284|440530|P2|NOT COMPLETED|Overall Study||0
182973|NCT00895284|440531|P1|NOT COMPLETED|Overall Study||0
182974|NCT00895284|440530|P2|COMPLETED|Overall Study||0
182975|NCT00895284|440531|P1|COMPLETED|Overall Study||3
182976|NCT00895284|440530|P2|STARTED|Overall Study||0
182977|NCT00895284|440531|P1|STARTED|Overall Study||3
182978|NCT00895245|440537|P1|NOT COMPLETED|Overall Study||6
182979|NCT00895245|440537|P1|COMPLETED|Overall Study||0
182980|NCT00895245|440537|P1|STARTED|Overall Study||6
182981|NCT00895232|440547|P3|NOT COMPLETED|Overall Study||5
182982|NCT00895232|440548|P2|NOT COMPLETED|Overall Study||4
182983|NCT00895232|440549|P1|NOT COMPLETED|Overall Study||3
182984|NCT00895232|440547|P3|COMPLETED|Overall Study||3
182985|NCT00895232|440548|P2|COMPLETED|Overall Study||2
182986|NCT00895232|440549|P1|COMPLETED|Overall Study||4
182987|NCT00895232|440547|P3|STARTED|Overall Study||8
182988|NCT00895232|440548|P2|STARTED|Overall Study||6
182989|NCT00895232|440549|P1|STARTED|Overall Study||7
182990|NCT00895193|440567|P4|NOT COMPLETED|Overall Study||0
182991|NCT00895193|440568|P3|NOT COMPLETED|Overall Study||0
182992|NCT00895193|440569|P2|NOT COMPLETED|Overall Study||0
182993|NCT00895193|440570|P1|NOT COMPLETED|Overall Study||0
182994|NCT00895193|440567|P4|COMPLETED|Overall Study||25
182995|NCT00895193|440568|P3|COMPLETED|Overall Study||25
182996|NCT00895193|440569|P2|COMPLETED|Overall Study||25
182997|NCT00895193|440570|P1|COMPLETED|Overall Study||25
182998|NCT00895193|440567|P4|STARTED|Overall Study||25
182999|NCT00895193|440568|P3|STARTED|Overall Study||25
183000|NCT00895193|440569|P2|STARTED|Overall Study||25
183001|NCT00895193|440570|P1|STARTED|Overall Study||25
183002|NCT00895180|440594|P2|NOT COMPLETED|Overall Study||0
183003|NCT00895180|440595|P1|NOT COMPLETED|Overall Study||0
183004|NCT00895180|440594|P2|COMPLETED|Overall Study||40
183005|NCT00895180|440595|P1|COMPLETED|Overall Study||40
183006|NCT00895180|440594|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
183007|NCT00895180|440595|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
183008|NCT00895180|440594|P2|STARTED|Overall Study||40
183009|NCT00895180|440595|P1|STARTED|Overall Study||40
183010|NCT00895011|440616|P3|NOT COMPLETED|Overall Study||8
183011|NCT00895011|440617|P2|NOT COMPLETED|Overall Study||14
183012|NCT00895011|440618|P1|NOT COMPLETED|Overall Study||24
183013|NCT00895011|440616|P3|COMPLETED|Overall Study||91
183014|NCT00895011|440617|P2|COMPLETED|Overall Study||85
183015|NCT00895011|440618|P1|COMPLETED|Overall Study||76
183016|NCT00895011|440616|P3|STARTED|Overall Study||99
183017|NCT00895011|440617|P2|STARTED|Overall Study||99
183018|NCT00895011|440618|P1|STARTED|Overall Study||100
183019|NCT00894933|440632|P1|NOT COMPLETED|Overall Study||4
183020|NCT00894933|440632|P1|COMPLETED|Overall Study||29
183021|NCT00894933|440632|P1|STARTED|Overall Study||33
183022|NCT00894803|440650|P2|NOT COMPLETED|Overall Study||5
183023|NCT00894803|440651|P1|NOT COMPLETED|Overall Study||20
183024|NCT00894803|440650|P2|COMPLETED|Overall Study||20
183025|NCT00894803|440651|P1|COMPLETED|Overall Study||81
183026|NCT00894803|440650|P2|STARTED|Overall Study||25
183027|NCT00894803|440651|P1|STARTED|Overall Study||101
183028|NCT00894790|440687|P2|NOT COMPLETED|Overall Study||2
183029|NCT00894790|440688|P1|NOT COMPLETED|Overall Study||1
183030|NCT00894790|440687|P2|COMPLETED|Overall Study||2
183031|NCT00894790|440688|P1|COMPLETED|Overall Study||3
183032|NCT00894790|440687|P2|STARTED|Overall Study||4
183033|NCT00894790|440688|P1|STARTED|Overall Study||4
183034|NCT00894699|440712|P2|NOT COMPLETED|Overall Study||0
183035|NCT00894699|440713|P1|NOT COMPLETED|Overall Study||0
183036|NCT00894699|440712|P2|COMPLETED|Overall Study||19
183037|NCT00894699|440713|P1|COMPLETED|Overall Study||21
183038|NCT00894699|440712|P2|STARTED|Overall Study||19
183039|NCT00894699|440713|P1|STARTED|Overall Study||21
183040|NCT00894647|440721|P2|NOT COMPLETED|Overall Study||14
183041|NCT00894647|440722|P1|NOT COMPLETED|Overall Study||10
183042|NCT00894647|440721|P2|COMPLETED|Overall Study||112
183043|NCT00894647|440722|P1|COMPLETED|Overall Study||111
183044|NCT00894647|440721|P2|STARTED|Overall Study||126
183045|NCT00894647|440722|P1|STARTED|Overall Study||121
183046|NCT00894556|440735|P4|NOT COMPLETED|Treatment Phase||0
183047|NCT00894556|440736|P3|NOT COMPLETED|Treatment Phase||1
183048|NCT00894556|440737|P2|NOT COMPLETED|Treatment Phase||4
183049|NCT00894556|440738|P1|NOT COMPLETED|Treatment Phase||4
183050|NCT00894556|440735|P4|COMPLETED|Treatment Phase||0
183051|NCT00894556|440736|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
183052|NCT00894556|440737|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
183053|NCT00894556|440738|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
183054|NCT00894556|440735|P4|STARTED|Treatment Phase||0
183055|NCT00894556|440736|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
183056|NCT00894556|440737|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
183057|NCT00894556|440738|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
183058|NCT00894556|440735|P4|NOT COMPLETED|Baseline Phase||85
183059|NCT00894556|440736|P3|NOT COMPLETED|Baseline Phase||0
183060|NCT00894556|440737|P2|NOT COMPLETED|Baseline Phase||0
183061|NCT00894556|440738|P1|NOT COMPLETED|Baseline Phase||0
183062|NCT00894556|440735|P4|COMPLETED|Baseline Phase||109
183063|NCT00894556|440736|P3|COMPLETED|Baseline Phase||0
183064|NCT00894556|440737|P2|COMPLETED|Baseline Phase||0
183065|NCT00894556|440738|P1|COMPLETED|Baseline Phase||0
183066|NCT00894556|440735|P4|STARTED|Baseline Phase||194
183067|NCT00894556|440736|P3|STARTED|Baseline Phase||0
183068|NCT00894556|440737|P2|STARTED|Baseline Phase||0
183069|NCT00894556|440738|P1|STARTED|Baseline Phase||0
183070|NCT00894543|440749|P2|NOT COMPLETED|Week 4 to Week 8||2
183071|NCT00894543|440750|P1|NOT COMPLETED|Week 4 to Week 8||4
183072|NCT00894543|440749|P2|COMPLETED|Week 4 to Week 8||97
183073|NCT00894543|440750|P1|COMPLETED|Week 4 to Week 8||97
183074|NCT00894543|440749|P2|STARTED|Week 4 to Week 8||99
183075|NCT00894543|440750|P1|STARTED|Week 4 to Week 8||101
183076|NCT00894543|440749|P2|NOT COMPLETED|Baseline to Week 4||2
183077|NCT00894543|440750|P1|NOT COMPLETED|Baseline to Week 4||3
183078|NCT00894543|440749|P2|COMPLETED|Baseline to Week 4||99
183079|NCT00894543|440750|P1|COMPLETED|Baseline to Week 4||101
183080|NCT00894543|440749|P2|STARTED|Baseline to Week 4||101
183081|NCT00894543|440750|P1|STARTED|Baseline to Week 4||104
183082|NCT00894543|440749|P2|NOT COMPLETED|Baseline||0
183083|NCT00894543|440750|P1|NOT COMPLETED|Baseline||0
183084|NCT00894543|440749|P2|COMPLETED|Baseline||101
183085|NCT00894543|440750|P1|COMPLETED|Baseline||104
183086|NCT00894543|440749|P2|STARTED|Baseline||101
183087|NCT00894543|440750|P1|STARTED|Baseline||104
183088|NCT00894517|440774|P2|NOT COMPLETED|Overall Study||5
183089|NCT00894517|440775|P1|NOT COMPLETED|Overall Study||2
183090|NCT00894517|440774|P2|COMPLETED|Overall Study||26
183091|NCT00894517|440775|P1|COMPLETED|Overall Study||28
183092|NCT00894517|440774|P2|STARTED|Overall Study||31
183093|NCT00894517|440775|P1|STARTED|Overall Study||30
183094|NCT00894504|440789|P1|NOT COMPLETED|Overall Study||71
183095|NCT00894504|440789|P1|COMPLETED|Overall Study||0
183096|NCT00894504|440789|P1|STARTED|Overall Study||71
183097|NCT00894465|440805|P2|NOT COMPLETED|Overall Study||0
183098|NCT00894465|440806|P1|NOT COMPLETED|Overall Study||0
183099|NCT00894465|440805|P2|COMPLETED|Overall Study||22
183100|NCT00894465|440806|P1|COMPLETED|Overall Study||22
183101|NCT00894465|440805|P2|STARTED|Overall Study||22
183102|NCT00894465|440806|P1|STARTED|Overall Study||22
183103|NCT00894387|440816|P2|NOT COMPLETED|Overall Study||175
183104|NCT00894387|440817|P1|NOT COMPLETED|Overall Study||175
183105|NCT00894387|440816|P2|COMPLETED|Overall Study||643
183106|NCT00894387|440817|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
183107|NCT00894387|440816|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
183108|NCT00894387|440817|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
183109|NCT00894387|440816|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
183110|NCT00894387|440817|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
183111|NCT00894387|440816|P2|Full Analysis Set|Overall Study||807
183112|NCT00894387|440817|P1|Full Analysis Set|Overall Study||808
183113|NCT00894387|440816|P2|Safety Set|Overall Study||810
183114|NCT00894387|440817|P1|Safety Set|Overall Study||808
183115|NCT00894387|440816|P2|STARTED|Overall Study||818
183116|NCT00894387|440817|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
183117|NCT00894361|440837|P2|NOT COMPLETED|Overall Study||64
183118|NCT00894361|440838|P1|NOT COMPLETED|Overall Study||24
183119|NCT00894361|440837|P2|COMPLETED|Overall Study||136
183120|NCT00894361|440838|P1|COMPLETED|Overall Study||176
183121|NCT00894361|440837|P2|STARTED|Overall Study||200
183122|NCT00894361|440838|P1|STARTED|Overall Study||200
183123|NCT00894322|440847|P3|NOT COMPLETED|Overall Study||0
183124|NCT00894322|440848|P2|NOT COMPLETED|Overall Study||0
183125|NCT00894322|440849|P1|NOT COMPLETED|Overall Study||1
183126|NCT00894322|440847|P3|COMPLETED|Overall Study||12
183127|NCT00894322|440848|P2|COMPLETED|Overall Study||23
183128|NCT00894322|440849|P1|COMPLETED|Overall Study||29
183129|NCT00894322|440847|P3|STARTED|Overall Study||12
183130|NCT00894322|440848|P2|STARTED|Overall Study||23
183131|NCT00894322|440849|P1|STARTED|Overall Study||30
183132|NCT00894244|440888|P1|NOT COMPLETED|Overall Study||1
183133|NCT00894244|440888|P1|COMPLETED|Overall Study||24
183134|NCT00894244|440888|P1|STARTED|Overall Study||25
183135|NCT00894166|440900|P8|NOT COMPLETED|Overall Study||34
183136|NCT00894166|440901|P7|NOT COMPLETED|Overall Study||16
183137|NCT00894166|440902|P6|NOT COMPLETED|Overall Study||16
183138|NCT00894166|440903|P5|NOT COMPLETED|Overall Study||24
183139|NCT00894166|440904|P4|NOT COMPLETED|Overall Study||69
183140|NCT00894166|440905|P3|NOT COMPLETED|Overall Study||62
183141|NCT00894166|440906|P2|NOT COMPLETED|Overall Study||63
183142|NCT00894166|440907|P1|NOT COMPLETED|Overall Study||61
183143|NCT00894166|440900|P8|COMPLETED|Overall Study||0
183144|NCT00894166|440901|P7|COMPLETED|Overall Study||19
183145|NCT00894166|440902|P6|COMPLETED|Overall Study||20
183146|NCT00894166|440903|P5|COMPLETED|Overall Study||10
183147|NCT00894166|440904|P4|COMPLETED|Overall Study||45
183148|NCT00894166|440905|P3|COMPLETED|Overall Study||50
183149|NCT00894166|440906|P2|COMPLETED|Overall Study||46
183150|NCT00894166|440907|P1|COMPLETED|Overall Study||71
183151|NCT00894166|440900|P8|STARTED|Overall Study||34
183152|NCT00894166|440901|P7|STARTED|Overall Study||35
183153|NCT00894166|440902|P6|STARTED|Overall Study||36
183154|NCT00894166|440903|P5|STARTED|Overall Study||34
183155|NCT00894166|440904|P4|STARTED|Overall Study||114
183156|NCT00894166|440905|P3|STARTED|Overall Study||112
183157|NCT00894166|440906|P2|STARTED|Overall Study||109
183158|NCT00894166|440907|P1|STARTED|Overall Study||132
183159|NCT00894127|440937|P1|NOT COMPLETED|Overall Study||0
183160|NCT00894127|440937|P1|COMPLETED|Overall Study||128
183161|NCT00894127|440937|P1|STARTED|Overall Study||128
183162|NCT00893997|440941|P1|NOT COMPLETED|Overall Study||0
183163|NCT00893997|440941|P1|COMPLETED|Overall Study||10
183164|NCT00893997|440941|P1|STARTED|Overall Study||10
183165|NCT00893971|440946|P1|NOT COMPLETED|Overall Study||3
183166|NCT00893971|440946|P1|COMPLETED|Overall Study||13
183167|NCT00893971|440946|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
183168|NCT00893971|440946|P1|Placebo + FF MDI (PT005)|Overall Study||13
183169|NCT00893971|440946|P1|Placebo + GFF MDI (PT003)|Overall Study||15
183170|NCT00893971|440946|P1|Placebo + GP MDI (PT001)|Overall Study||15
183171|NCT00893971|440946|P1|STARTED|Overall Study||16
183172|NCT00893789|441064|P4|NOT COMPLETED|Overall Study||13
183173|NCT00893789|441065|P3|NOT COMPLETED|Overall Study||7
183174|NCT00893789|441066|P2|NOT COMPLETED|Overall Study||4
183175|NCT00893789|441067|P1|NOT COMPLETED|Overall Study||6
183176|NCT00893789|441064|P4|COMPLETED|Overall Study||16
183177|NCT00893789|441065|P3|COMPLETED|Overall Study||22
183178|NCT00893789|441066|P2|COMPLETED|Overall Study||26
183179|NCT00893789|441067|P1|COMPLETED|Overall Study||23
183180|NCT00893789|441064|P4|Full Analysis Set (FAS)|Overall Study||27
183181|NCT00893789|441065|P3|Full Analysis Set (FAS)|Overall Study||28
183182|NCT00893789|441066|P2|Full Analysis Set (FAS)|Overall Study||29
183183|NCT00893789|441067|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
183184|NCT00893789|441064|P4|Safety Analysis Set (SAS)|Overall Study||29
183185|NCT00893789|441065|P3|Safety Analysis Set (SAS)|Overall Study||29
183186|NCT00893789|441066|P2|Safety Analysis Set (SAS)|Overall Study||30
183187|NCT00893789|441067|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
183188|NCT00893789|441064|P4|STARTED|Overall Study||29
183189|NCT00893789|441065|P3|STARTED|Overall Study||29
183190|NCT00893789|441066|P2|STARTED|Overall Study||30
183191|NCT00893789|441067|P1|STARTED|Overall Study||29
183192|NCT00893763|441151|P2|NOT COMPLETED|Overall Study||110
183193|NCT00893763|441152|P1|NOT COMPLETED|Overall Study||110
183194|NCT00893763|441151|P2|COMPLETED|Overall Study||47
183195|NCT00893763|441152|P1|COMPLETED|Overall Study||47
183196|NCT00893763|441151|P2|STARTED|Overall Study||157
183197|NCT00893763|441152|P1|STARTED|Overall Study||157
183198|NCT00893737|441160|P1|NOT COMPLETED|Overall Study||12
183199|NCT00893737|441160|P1|COMPLETED|Overall Study||135
183200|NCT00893737|441160|P1|STARTED|Overall Study||147
183201|NCT00893464|441174|P8|NOT COMPLETED|Overall Study||2
183202|NCT00893464|441175|P7|NOT COMPLETED|Overall Study||2
183203|NCT00893464|441176|P6|NOT COMPLETED|Overall Study||0
183204|NCT00893464|441177|P5|NOT COMPLETED|Overall Study||0
183205|NCT00893464|441178|P4|NOT COMPLETED|Overall Study||0
183206|NCT00893464|441179|P3|NOT COMPLETED|Overall Study||0
183207|NCT00893464|441180|P2|NOT COMPLETED|Overall Study||0
183208|NCT00893464|441181|P1|NOT COMPLETED|Overall Study||0
183209|NCT00893464|441174|P8|COMPLETED|Overall Study||3
183210|NCT00893464|441175|P7|COMPLETED|Overall Study||8
183211|NCT00893464|441176|P6|COMPLETED|Overall Study||7
183212|NCT00893464|441177|P5|COMPLETED|Overall Study||4
183213|NCT00893464|441178|P4|COMPLETED|Overall Study||1
183214|NCT00893464|441179|P3|COMPLETED|Overall Study||1
183215|NCT00893464|441180|P2|COMPLETED|Overall Study||1
183216|NCT00893464|441181|P1|COMPLETED|Overall Study||1
183217|NCT00893464|441174|P8|STARTED|Overall Study||5
183218|NCT00893464|441175|P7|STARTED|Overall Study||10
183219|NCT00893464|441176|P6|STARTED|Overall Study||7
183220|NCT00893464|441177|P5|STARTED|Overall Study||4
183221|NCT00893464|441178|P4|STARTED|Overall Study||1
183222|NCT00893464|441179|P3|STARTED|Overall Study||1
183223|NCT00893464|441180|P2|STARTED|Overall Study||1
183224|NCT00893464|441181|P1|STARTED|Overall Study||1
183225|NCT00893152|441299|P2|NOT COMPLETED|Overall Study||0
183226|NCT00893152|441300|P1|NOT COMPLETED|Overall Study||0
183227|NCT00893152|441299|P2|COMPLETED|Overall Study||36
183228|NCT00893152|441300|P1|COMPLETED|Overall Study||47
183229|NCT00893152|441299|P2|STARTED|Overall Study||36
183230|NCT00893152|441300|P1|STARTED|Overall Study||47
183231|NCT00893113|441308|P2|NOT COMPLETED|Overall Study||16
183232|NCT00893113|441309|P1|NOT COMPLETED|Overall Study||13
183233|NCT00893113|441308|P2|COMPLETED|Overall Study||22
183234|NCT00893113|441309|P1|COMPLETED|Overall Study||23
183235|NCT00893113|441308|P2|STARTED|Overall Study||38
183236|NCT00893113|441309|P1|STARTED|Overall Study||36
183237|NCT00893074|441319|P1|NOT COMPLETED|Overall Study||11
183238|NCT00893074|441319|P1|COMPLETED|Overall Study||13
183239|NCT00893074|441319|P1|STARTED|Overall Study||24
183240|NCT00892957|441339|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
183241|NCT00892957|441340|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
183242|NCT00892957|441339|P2|COMPLETED|Postoperative Day 30 Assessment||66
183243|NCT00892957|441340|P1|COMPLETED|Postoperative Day 30 Assessment||70
183244|NCT00892957|441339|P2|STARTED|Postoperative Day 30 Assessment||66
183245|NCT00892957|441340|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
183246|NCT00892957|441339|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
183247|NCT00892957|441340|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
183248|NCT00892957|441339|P2|COMPLETED|Postoperative Day 14 Assessment||66
183249|NCT00892957|441340|P1|COMPLETED|Postoperative Day 14 Assessment||68
183250|NCT00892957|441339|P2|STARTED|Postoperative Day 14 Assessment||66
183251|NCT00892957|441340|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
183252|NCT00892957|441339|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
183253|NCT00892957|441340|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
183254|NCT00892957|441339|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
183255|NCT00892957|441340|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
183256|NCT00892957|441339|P2|STARTED|Between Postoperative Day 1 and Day 14||70
183257|NCT00892957|441340|P1|STARTED|Between Postoperative Day 1 and Day 14||70
183258|NCT00892957|441339|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
183259|NCT00892957|441340|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
183260|NCT00892957|441339|P2|COMPLETED|Postoperative Day 1 Assessment||70
183261|NCT00892957|441340|P1|COMPLETED|Postoperative Day 1 Assessment||70
183262|NCT00892957|441339|P2|STARTED|Postoperative Day 1 Assessment||70
183263|NCT00892957|441340|P1|STARTED|Postoperative Day 1 Assessment||70
183264|NCT00892957|441339|P2|NOT COMPLETED|Intraoperative Day 0||0
183265|NCT00892957|441340|P1|NOT COMPLETED|Intraoperative Day 0||0
183266|NCT00892957|441339|P2|COMPLETED|Intraoperative Day 0||70
183267|NCT00892957|441340|P1|COMPLETED|Intraoperative Day 0||70
183268|NCT00892957|441339|P2|STARTED|Intraoperative Day 0||70
183269|NCT00892957|441340|P1|STARTED|Intraoperative Day 0||70
183270|NCT00892775|441428|P2|NOT COMPLETED|Overall Study||1
183271|NCT00892775|441429|P1|NOT COMPLETED|Overall Study||5
183272|NCT00892775|441428|P2|COMPLETED|Overall Study||165
183273|NCT00892775|441429|P1|COMPLETED|Overall Study||327
183274|NCT00892775|441428|P2|STARTED|Overall Study||166
183275|NCT00892775|441429|P1|STARTED|Overall Study||332
183276|NCT00892723|441456|P3|NOT COMPLETED|Overall Study||2
183277|NCT00892723|441457|P2|NOT COMPLETED|Overall Study||4
183278|NCT00892723|441458|P1|NOT COMPLETED|Overall Study||2
183279|NCT00892723|441456|P3|COMPLETED|Overall Study||17
183280|NCT00892723|441457|P2|COMPLETED|Overall Study||15
183281|NCT00892723|441458|P1|COMPLETED|Overall Study||19
183282|NCT00892723|441456|P3|STARTED|Overall Study||19
183283|NCT00892723|441457|P2|STARTED|Overall Study||19
183284|NCT00892723|441458|P1|STARTED|Overall Study||21
183285|NCT00892710|441502|P3|NOT COMPLETED|Overall Study||55
183286|NCT00892710|441503|P2|NOT COMPLETED|Overall Study||59
183287|NCT00892710|441504|P1|NOT COMPLETED|Overall Study||48
183288|NCT00892710|441502|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
183289|NCT00892710|441503|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
183290|NCT00892710|441504|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
183291|NCT00892710|441502|P3|STARTED|Overall Study||55
183292|NCT00892710|441503|P2|STARTED|Overall Study||59
183293|NCT00892710|441504|P1|STARTED|Overall Study||48
183294|NCT00892697|441527|P1|NOT COMPLETED|Overall Study||0
183295|NCT00892697|441527|P1|COMPLETED|Overall Study||15
183296|NCT00892697|441527|P1|STARTED|Overall Study||15
183297|NCT00892606|441534|P2|NOT COMPLETED|Overall Study||4
183298|NCT00892606|441535|P1|NOT COMPLETED|Overall Study||5
183299|NCT00892606|441534|P2|COMPLETED|Overall Study||33
183300|NCT00892606|441535|P1|COMPLETED|Overall Study||33
183301|NCT00892606|441534|P2|STARTED|Overall Study||37
183302|NCT00892606|441535|P1|STARTED|Overall Study||38
183303|NCT00892437|441547|P2|NOT COMPLETED|Open-Label Extension Phase||4
183304|NCT00892437|441548|P1|NOT COMPLETED|Open-Label Extension Phase||12
183305|NCT00892437|441547|P2|COMPLETED|Open-Label Extension Phase||15
183306|NCT00892437|441548|P1|COMPLETED|Open-Label Extension Phase||32
183307|NCT00892437|441547|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
183308|NCT00892437|441548|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
183309|NCT00892437|441547|P2|NOT COMPLETED|Randomized Phase||5
183310|NCT00892437|441548|P1|NOT COMPLETED|Randomized Phase||11
183311|NCT00892437|441547|P2|COMPLETED|Randomized Phase||24
183312|NCT00892437|441548|P1|COMPLETED|Randomized Phase||45
183313|NCT00892437|441547|P2|Randomized and Treated|Randomized Phase||29
183314|NCT00892437|441548|P1|Randomized and Treated|Randomized Phase||50
183315|NCT00892437|441547|P2|STARTED|Randomized Phase||29
183316|NCT00892437|441548|P1|STARTED|Randomized Phase||56
183317|NCT00892281|441567|P2|NOT COMPLETED|Overall Study||37
183318|NCT00892281|441568|P1|NOT COMPLETED|Overall Study||267
183319|NCT00892281|441567|P2|COMPLETED|Overall Study||187
183320|NCT00892281|441568|P1|COMPLETED|Overall Study||930
183321|NCT00892281|441567|P2|STARTED|Overall Study||224
183322|NCT00892281|441568|P1|STARTED|Overall Study||1197
183323|NCT00892177|441581|P6|NOT COMPLETED|Phase II||2
183324|NCT00892177|441582|P5|NOT COMPLETED|Phase II||5
183325|NCT00892177|441583|P4|NOT COMPLETED|Phase II||0
183326|NCT00892177|441584|P3|NOT COMPLETED|Phase II||0
183327|NCT00892177|441585|P2|NOT COMPLETED|Phase II||0
183328|NCT00892177|441586|P1|NOT COMPLETED|Phase II||0
183329|NCT00892177|441581|P6|COMPLETED|Phase II||38
183330|NCT00892177|441582|P5|COMPLETED|Phase II||83
183331|NCT00892177|441583|P4|COMPLETED|Phase II||0
183332|NCT00892177|441584|P3|COMPLETED|Phase II||0
183333|NCT00892177|441585|P2|COMPLETED|Phase II||0
183334|NCT00892177|441586|P1|COMPLETED|Phase II||0
183335|NCT00892177|441581|P6|STARTED|Phase II||40
183336|NCT00892177|441582|P5|STARTED|Phase II||88
183337|NCT00892177|441583|P4|STARTED|Phase II||0
183338|NCT00892177|441584|P3|STARTED|Phase II||0
183339|NCT00892177|441585|P2|STARTED|Phase II||0
183340|NCT00892177|441586|P1|STARTED|Phase II||0
183341|NCT00892177|441581|P6|NOT COMPLETED|Phase I: Dose Level 3||0
183342|NCT00892177|441582|P5|NOT COMPLETED|Phase I: Dose Level 3||0
183343|NCT00892177|441583|P4|NOT COMPLETED|Phase I: Dose Level 3||0
183344|NCT00892177|441584|P3|NOT COMPLETED|Phase I: Dose Level 3||0
183345|NCT00892177|441585|P2|NOT COMPLETED|Phase I: Dose Level 3||0
183346|NCT00892177|441586|P1|NOT COMPLETED|Phase I: Dose Level 3||0
183347|NCT00892177|441581|P6|COMPLETED|Phase I: Dose Level 3||0
183348|NCT00892177|441582|P5|COMPLETED|Phase I: Dose Level 3||0
183349|NCT00892177|441583|P4|COMPLETED|Phase I: Dose Level 3||6
183350|NCT00892177|441584|P3|COMPLETED|Phase I: Dose Level 3||0
183351|NCT00892177|441585|P2|COMPLETED|Phase I: Dose Level 3||0
183352|NCT00892177|441586|P1|COMPLETED|Phase I: Dose Level 3||0
183353|NCT00892177|441581|P6|STARTED|Phase I: Dose Level 3||0
183354|NCT00892177|441582|P5|STARTED|Phase I: Dose Level 3||0
183355|NCT00892177|441583|P4|STARTED|Phase I: Dose Level 3||6
183356|NCT00892177|441584|P3|STARTED|Phase I: Dose Level 3||0
183357|NCT00892177|441585|P2|STARTED|Phase I: Dose Level 3||0
183358|NCT00892177|441586|P1|STARTED|Phase I: Dose Level 3||0
183359|NCT00892177|441581|P6|NOT COMPLETED|Phase I: Dose Level 2||0
183360|NCT00892177|441582|P5|NOT COMPLETED|Phase I: Dose Level 2||0
183361|NCT00892177|441583|P4|NOT COMPLETED|Phase I: Dose Level 2||0
183362|NCT00892177|441584|P3|NOT COMPLETED|Phase I: Dose Level 2||0
183363|NCT00892177|441585|P2|NOT COMPLETED|Phase I: Dose Level 2||0
183364|NCT00892177|441586|P1|NOT COMPLETED|Phase I: Dose Level 2||0
183365|NCT00892177|441581|P6|COMPLETED|Phase I: Dose Level 2||0
183366|NCT00892177|441582|P5|COMPLETED|Phase I: Dose Level 2||0
183367|NCT00892177|441583|P4|COMPLETED|Phase I: Dose Level 2||0
183368|NCT00892177|441584|P3|COMPLETED|Phase I: Dose Level 2||3
183369|NCT00892177|441585|P2|COMPLETED|Phase I: Dose Level 2||0
183370|NCT00892177|441586|P1|COMPLETED|Phase I: Dose Level 2||0
183371|NCT00892177|441581|P6|STARTED|Phase I: Dose Level 2||0
183372|NCT00892177|441582|P5|STARTED|Phase I: Dose Level 2||0
183373|NCT00892177|441583|P4|STARTED|Phase I: Dose Level 2||0
183374|NCT00892177|441584|P3|STARTED|Phase I: Dose Level 2||3
183375|NCT00892177|441585|P2|STARTED|Phase I: Dose Level 2||0
183376|NCT00892177|441586|P1|STARTED|Phase I: Dose Level 2||0
183377|NCT00892177|441581|P6|NOT COMPLETED|Phase I: Dose Level 1||0
183378|NCT00892177|441582|P5|NOT COMPLETED|Phase I: Dose Level 1||0
183379|NCT00892177|441583|P4|NOT COMPLETED|Phase I: Dose Level 1||0
183380|NCT00892177|441584|P3|NOT COMPLETED|Phase I: Dose Level 1||0
183381|NCT00892177|441585|P2|NOT COMPLETED|Phase I: Dose Level 1||0
183382|NCT00892177|441586|P1|NOT COMPLETED|Phase I: Dose Level 1||0
183383|NCT00892177|441581|P6|COMPLETED|Phase I: Dose Level 1||0
183384|NCT00892177|441582|P5|COMPLETED|Phase I: Dose Level 1||0
183385|NCT00892177|441583|P4|COMPLETED|Phase I: Dose Level 1||0
183386|NCT00892177|441584|P3|COMPLETED|Phase I: Dose Level 1||0
183387|NCT00892177|441585|P2|COMPLETED|Phase I: Dose Level 1||4
183388|NCT00892177|441586|P1|COMPLETED|Phase I: Dose Level 1||0
183389|NCT00892177|441581|P6|STARTED|Phase I: Dose Level 1||0
183390|NCT00892177|441582|P5|STARTED|Phase I: Dose Level 1||0
183391|NCT00892177|441583|P4|STARTED|Phase I: Dose Level 1||0
183392|NCT00892177|441584|P3|STARTED|Phase I: Dose Level 1||0
183393|NCT00892177|441585|P2|STARTED|Phase I: Dose Level 1||4
183394|NCT00892177|441586|P1|STARTED|Phase I: Dose Level 1||0
183395|NCT00892177|441581|P6|NOT COMPLETED|Phase I: Dose Level 0||0
183396|NCT00892177|441582|P5|NOT COMPLETED|Phase I: Dose Level 0||0
183397|NCT00892177|441583|P4|NOT COMPLETED|Phase I: Dose Level 0||0
183398|NCT00892177|441584|P3|NOT COMPLETED|Phase I: Dose Level 0||0
183399|NCT00892177|441585|P2|NOT COMPLETED|Phase I: Dose Level 0||0
183400|NCT00892177|441586|P1|NOT COMPLETED|Phase I: Dose Level 0||0
183401|NCT00892177|441581|P6|COMPLETED|Phase I: Dose Level 0||0
183402|NCT00892177|441582|P5|COMPLETED|Phase I: Dose Level 0||0
183403|NCT00892177|441583|P4|COMPLETED|Phase I: Dose Level 0||0
183404|NCT00892177|441584|P3|COMPLETED|Phase I: Dose Level 0||0
183405|NCT00892177|441585|P2|COMPLETED|Phase I: Dose Level 0||0
183406|NCT00892177|441586|P1|COMPLETED|Phase I: Dose Level 0||3
183407|NCT00892177|441581|P6|STARTED|Phase I: Dose Level 0||0
183408|NCT00892177|441582|P5|STARTED|Phase I: Dose Level 0||0
183409|NCT00892177|441583|P4|STARTED|Phase I: Dose Level 0||0
183410|NCT00892177|441584|P3|STARTED|Phase I: Dose Level 0||0
183411|NCT00892177|441585|P2|STARTED|Phase I: Dose Level 0||0
183412|NCT00892177|441586|P1|STARTED|Phase I: Dose Level 0||3
183413|NCT00892151|441611|P1|NOT COMPLETED|Overall Study||1
183414|NCT00892151|441611|P1|COMPLETED|Overall Study||50
183415|NCT00892151|441611|P1|STARTED|Overall Study||51
183416|NCT00892099|441620|P3|NOT COMPLETED|Overall Study||7
183417|NCT00892099|441621|P2|NOT COMPLETED|Overall Study||1
183418|NCT00892099|441622|P1|NOT COMPLETED|Overall Study||5
183419|NCT00892099|441620|P3|COMPLETED|Overall Study||29
183420|NCT00892099|441621|P2|COMPLETED|Overall Study||32
183421|NCT00892099|441622|P1|COMPLETED|Overall Study||31
183422|NCT00892099|441620|P3|STARTED|Overall Study||36
183423|NCT00892099|441621|P2|STARTED|Overall Study||33
183424|NCT00892099|441622|P1|STARTED|Overall Study||36
183425|NCT00892047|441647|P2|NOT COMPLETED|Overall Study||7
183426|NCT00892047|441648|P1|NOT COMPLETED|Overall Study||4
183427|NCT00892047|441647|P2|COMPLETED|Overall Study||83
183428|NCT00892047|441648|P1|COMPLETED|Overall Study||87
183429|NCT00892047|441647|P2|STARTED|Overall Study||90
183430|NCT00892047|441648|P1|STARTED|Overall Study||91
183431|NCT00892008|441664|P1|NOT COMPLETED|Overall Study||565
183432|NCT00892008|441664|P1|COMPLETED|Overall Study||1713
183433|NCT00892008|441664|P1|STARTED|Overall Study||2278
183434|NCT00891995|441680|P2|NOT COMPLETED|Overall Study||0
183435|NCT00891995|441681|P1|NOT COMPLETED|Overall Study||0
183436|NCT00891995|441680|P2|COMPLETED|Overall Study||21
183437|NCT00891995|441681|P1|COMPLETED|Overall Study||50
183438|NCT00891995|441680|P2|STARTED|Overall Study||21
183439|NCT00891995|441681|P1|STARTED|Overall Study||50
183440|NCT00891982|441705|P2|NOT COMPLETED|Overall Study||1
183441|NCT00891982|441706|P1|NOT COMPLETED|Overall Study||2
183442|NCT00891982|441705|P2|COMPLETED|Overall Study||30
183443|NCT00891982|441706|P1|COMPLETED|Overall Study||28
183444|NCT00891982|441705|P2|STARTED|Overall Study||31
183445|NCT00891982|441706|P1|STARTED|Overall Study||30
183446|NCT00891930|441750|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
183447|NCT00891930|441750|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
183448|NCT00891930|441750|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
183449|NCT00891930|441750|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
183450|NCT00891930|441750|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
183451|NCT00891930|441750|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
183452|NCT00891930|441750|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
183453|NCT00891904|441771|P1|NOT COMPLETED|Overall Study||2
183454|NCT00891904|441771|P1|COMPLETED|Overall Study||0
183455|NCT00891904|441771|P1|STARTED|Overall Study||2
183456|NCT00891839|441778|P1|NOT COMPLETED|Overall Study||7
183457|NCT00891839|441778|P1|COMPLETED|Overall Study|completed treatment|38
183458|NCT00891839|441778|P1|STARTED|Overall Study||45
183459|NCT00891813|441787|P1|NOT COMPLETED|Overall Study||12
183460|NCT00891813|441787|P1|COMPLETED|Overall Study||88
183461|NCT00891813|441787|P1|STARTED|Overall Study||100
183462|NCT00891774|441793|P1|NOT COMPLETED|Overall Study||14
183463|NCT00891774|441793|P1|COMPLETED|Overall Study||158
183464|NCT00891774|441793|P1|STARTED|Overall Study||172
183465|NCT00891735|441801|P4|NOT COMPLETED|Overall Study||15
183466|NCT00891735|441802|P3|NOT COMPLETED|Overall Study||12
183467|NCT00891735|441803|P2|NOT COMPLETED|Overall Study||16
183468|NCT00891735|441804|P1|NOT COMPLETED|Overall Study||17
183469|NCT00891735|441801|P4|COMPLETED|Overall Study||258
183470|NCT00891735|441802|P3|COMPLETED|Overall Study||263
183471|NCT00891735|441803|P2|COMPLETED|Overall Study||258
183472|NCT00891735|441804|P1|COMPLETED|Overall Study||258
183473|NCT00891735|441801|P4|STARTED|Overall Study||273
183474|NCT00891735|441802|P3|STARTED|Overall Study||275
183475|NCT00891735|441803|P2|STARTED|Overall Study||274
183476|NCT00891735|441804|P1|STARTED|Overall Study||275
183477|NCT00891657|441844|P2|NOT COMPLETED|Overall Study||1
183478|NCT00891657|441845|P1|NOT COMPLETED|Overall Study||1
183479|NCT00891657|441844|P2|COMPLETED|Overall Study||5
183480|NCT00891657|441845|P1|COMPLETED|Overall Study||8
183481|NCT00891657|441844|P2|STARTED|Overall Study||6
183482|NCT00891657|441845|P1|STARTED|Overall Study||9
183483|NCT00891618|441857|P1|NOT COMPLETED|Overall Study||1
183484|NCT00891618|441857|P1|COMPLETED|Overall Study||20
183485|NCT00891618|441857|P1|STARTED|Overall Study||21
183486|NCT00891527|441861|P1|NOT COMPLETED|Overall Study||2
183487|NCT00891527|441861|P1|COMPLETED|Overall Study||48
183488|NCT00891527|441861|P1|STARTED|Overall Study||50
183489|NCT00891462|441870|P3|NOT COMPLETED|Overall Study||24
183490|NCT00891462|441871|P2|NOT COMPLETED|Overall Study||33
183491|NCT00891462|441872|P1|NOT COMPLETED|Overall Study||37
183492|NCT00891462|441870|P3|COMPLETED|Overall Study||166
183493|NCT00891462|441871|P2|COMPLETED|Overall Study||152
183494|NCT00891462|441872|P1|COMPLETED|Overall Study||149
183495|NCT00891462|441870|P3|STARTED|Overall Study||190
183496|NCT00891462|441871|P2|STARTED|Overall Study||185
183497|NCT00891462|441872|P1|STARTED|Overall Study||186
183498|NCT00891436|441885|P2|NOT COMPLETED|Overall Study||0
183499|NCT00891436|441886|P1|NOT COMPLETED|Overall Study||0
183500|NCT00891436|441885|P2|COMPLETED|Overall Study||10
183501|NCT00891436|441886|P1|COMPLETED|Overall Study||10
183502|NCT00891436|441885|P2|STARTED|Overall Study||10
183503|NCT00891436|441886|P1|STARTED|Overall Study||10
183504|NCT00891371|441894|P1|NOT COMPLETED|Treatment||9
183505|NCT00891371|441894|P1|COMPLETED|Treatment||27
183506|NCT00891371|441894|P1|STARTED|Treatment||36
183507|NCT00891371|441894|P1|NOT COMPLETED|Pre-assignment||6
183508|NCT00891371|441894|P1|COMPLETED|Pre-assignment||36
183509|NCT00891371|441894|P1|STARTED|Pre-assignment||42
183510|NCT00891319|441905|P2|NOT COMPLETED|Overall Study||0
183511|NCT00891319|441906|P1|NOT COMPLETED|Overall Study||8
183512|NCT00891319|441905|P2|COMPLETED|Overall Study||40
183513|NCT00891319|441906|P1|COMPLETED|Overall Study||32
183514|NCT00891319|441905|P2|STARTED|Overall Study||40
183515|NCT00891319|441906|P1|STARTED|Overall Study||40
183516|NCT00891293|441916|P1|NOT COMPLETED|Overall Study||84
183517|NCT00891293|441916|P1|COMPLETED|Overall Study||9
183518|NCT00891293|441916|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
183519|NCT00891228|441931|P3|NOT COMPLETED|Overall Study||15
183520|NCT00891228|441932|P2|NOT COMPLETED|Overall Study||13
183521|NCT00891228|441933|P1|NOT COMPLETED|Overall Study||11
183522|NCT00891228|441931|P3|COMPLETED|Overall Study||19
183523|NCT00891228|441932|P2|COMPLETED|Overall Study||20
183524|NCT00891228|441933|P1|COMPLETED|Overall Study||21
183525|NCT00891228|441931|P3|STARTED|Overall Study||34
183526|NCT00891228|441932|P2|STARTED|Overall Study||33
183527|NCT00891228|441933|P1|STARTED|Overall Study||32
183528|NCT00891202|441955|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
183529|NCT00891202|441956|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
183530|NCT00891202|441957|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
183531|NCT00891202|441958|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
183532|NCT00891202|441955|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
183533|NCT00891202|441956|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
183534|NCT00891202|441957|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
183535|NCT00891202|441958|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
183536|NCT00891202|441955|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
183537|NCT00891202|441956|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
183538|NCT00891202|441957|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
183539|NCT00891202|441958|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
183540|NCT00891202|441955|P4|NOT COMPLETED|PAP (Up To Week 39)||0
183541|NCT00891202|441956|P3|NOT COMPLETED|PAP (Up To Week 39)||0
183542|NCT00891202|441957|P2|NOT COMPLETED|PAP (Up To Week 39)||0
183543|NCT00891202|441958|P1|NOT COMPLETED|PAP (Up To Week 39)||1
183544|NCT00891202|441955|P4|COMPLETED|PAP (Up To Week 39)||0
183545|NCT00891202|441956|P3|COMPLETED|PAP (Up To Week 39)||0
183546|NCT00891202|441957|P2|COMPLETED|PAP (Up To Week 39)||20
183547|NCT00891202|441958|P1|COMPLETED|PAP (Up To Week 39)||19
183548|NCT00891202|441955|P4|STARTED|PAP (Up To Week 39)||0
183549|NCT00891202|441956|P3|STARTED|PAP (Up To Week 39)||0
183550|NCT00891202|441957|P2|STARTED|PAP (Up To Week 39)||20
183551|NCT00891202|441958|P1|STARTED|PAP (Up To Week 39)||20
183552|NCT00891176|441984|P4|NOT COMPLETED|At 6 Years of Age||0
183553|NCT00891176|441985|P3|NOT COMPLETED|At 6 Years of Age||0
183554|NCT00891176|441986|P2|NOT COMPLETED|At 6 Years of Age||0
183555|NCT00891176|441987|P1|NOT COMPLETED|At 6 Years of Age||0
183556|NCT00891176|441984|P4|COMPLETED|At 6 Years of Age||135
183557|NCT00891176|441985|P3|COMPLETED|At 6 Years of Age||135
183558|NCT00891176|441986|P2|COMPLETED|At 6 Years of Age||138
183559|NCT00891176|441987|P1|COMPLETED|At 6 Years of Age||131
183560|NCT00891176|441984|P4|STARTED|At 6 Years of Age||135
183561|NCT00891176|441985|P3|STARTED|At 6 Years of Age||135
183562|NCT00891176|441986|P2|STARTED|At 6 Years of Age||138
183563|NCT00891176|441987|P1|STARTED|At 6 Years of Age||131
183564|NCT00891176|441984|P4|NOT COMPLETED|At 4 Years of Age||0
183565|NCT00891176|441985|P3|NOT COMPLETED|At 4 Years of Age||0
183566|NCT00891176|441986|P2|NOT COMPLETED|At 4 Years of Age||0
183567|NCT00891176|441987|P1|NOT COMPLETED|At 4 Years of Age||0
183568|NCT00891176|441984|P4|COMPLETED|At 4 Years of Age||137
183569|NCT00891176|441985|P3|COMPLETED|At 4 Years of Age||142
183570|NCT00891176|441986|P2|COMPLETED|At 4 Years of Age||142
183571|NCT00891176|441987|P1|COMPLETED|At 4 Years of Age||140
183572|NCT00891176|441984|P4|STARTED|At 4 Years of Age||137
183573|NCT00891176|441985|P3|STARTED|At 4 Years of Age||142
183574|NCT00891176|441986|P2|STARTED|At 4 Years of Age||142
183575|NCT00891176|441987|P1|STARTED|At 4 Years of Age||140
183576|NCT00891176|441984|P4|NOT COMPLETED|At 3 Years of Age||0
183577|NCT00891176|441985|P3|NOT COMPLETED|At 3 Years of Age||0
183578|NCT00891176|441986|P2|NOT COMPLETED|At 3 Years of Age||0
183579|NCT00891176|441987|P1|NOT COMPLETED|At 3 Years of Age||0
183580|NCT00891176|441984|P4|COMPLETED|At 3 Years of Age||141
183581|NCT00891176|441985|P3|COMPLETED|At 3 Years of Age||149
183582|NCT00891176|441986|P2|COMPLETED|At 3 Years of Age||147
183583|NCT00891176|441987|P1|COMPLETED|At 3 Years of Age||144
183584|NCT00891176|441984|P4|STARTED|At 3 Years of Age||141
183585|NCT00891176|441985|P3|STARTED|At 3 Years of Age||149
183586|NCT00891176|441986|P2|STARTED|At 3 Years of Age||147
183587|NCT00891176|441987|P1|STARTED|At 3 Years of Age||144
183588|NCT00891046|442134|P5|NOT COMPLETED|Overall Study||39
183589|NCT00891046|442135|P4|NOT COMPLETED|Overall Study||3
183590|NCT00891046|442136|P3|NOT COMPLETED|Overall Study||23
183591|NCT00891046|442137|P2|NOT COMPLETED|Overall Study||9
183592|NCT00891046|442138|P1|NOT COMPLETED|Overall Study||12
183593|NCT00891046|442134|P5|COMPLETED|Overall Study||84
183594|NCT00891046|442135|P4|COMPLETED|Overall Study||8
183595|NCT00891046|442136|P3|COMPLETED|Overall Study||17
183596|NCT00891046|442137|P2|COMPLETED|Overall Study||54
183597|NCT00891046|442138|P1|COMPLETED|Overall Study||21
183598|NCT00891046|442134|P5|STARTED|Overall Study||123
183599|NCT00891046|442135|P4|STARTED|Overall Study||11
183600|NCT00891046|442136|P3|STARTED|Overall Study||40
183601|NCT00891046|442137|P2|STARTED|Overall Study||63
183602|NCT00891046|442138|P1|STARTED|Overall Study||33
183603|NCT00891020|442214|P3|NOT COMPLETED|Long-term Extension Period||23
183604|NCT00891020|442215|P2|NOT COMPLETED|Long-term Extension Period||24
183605|NCT00891020|442216|P1|NOT COMPLETED|Long-term Extension Period||6
183606|NCT00891020|442214|P3|COMPLETED|Long-term Extension Period||170
183607|NCT00891020|442215|P2|COMPLETED|Long-term Extension Period||172
183608|NCT00891020|442216|P1|COMPLETED|Long-term Extension Period||49
183609|NCT00891020|442214|P3|STARTED|Long-term Extension Period||193
183610|NCT00891020|442215|P2|STARTED|Long-term Extension Period||196
183611|NCT00891020|442216|P1|STARTED|Long-term Extension Period||55
183612|NCT00891020|442214|P3|NOT COMPLETED|24 Week Treatment Period||58
183613|NCT00891020|442215|P2|NOT COMPLETED|24 Week Treatment Period||60
183614|NCT00891020|442216|P1|NOT COMPLETED|24 Week Treatment Period||37
183615|NCT00891020|442214|P3|COMPLETED|24 Week Treatment Period||302
183616|NCT00891020|442215|P2|COMPLETED|24 Week Treatment Period||303
183617|NCT00891020|442216|P1|COMPLETED|24 Week Treatment Period||126
183618|NCT00891020|442214|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
183619|NCT00891020|442215|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
183620|NCT00891020|442216|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
183621|NCT00891020|442214|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
183622|NCT00891020|442215|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
183623|NCT00891020|442216|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
183624|NCT00891020|442214|P3|STARTED|24 Week Treatment Period||360
183625|NCT00891020|442215|P2|STARTED|24 Week Treatment Period||363
183626|NCT00891020|442216|P1|STARTED|24 Week Treatment Period||163
183627|NCT00890981|442249|P2|NOT COMPLETED|Overall Study||0
183628|NCT00890981|442250|P1|NOT COMPLETED|Overall Study||0
183629|NCT00890981|442249|P2|COMPLETED|Overall Study||40
183630|NCT00890981|442250|P1|COMPLETED|Overall Study||39
183631|NCT00890981|442249|P2|STARTED|Overall Study||40
183632|NCT00890981|442250|P1|STARTED|Overall Study||39
183633|NCT00890929|442280|P1|NOT COMPLETED|Overall Study||6
183634|NCT00890929|442280|P1|COMPLETED|Overall Study||39
183635|NCT00890929|442280|P1|Initiated Treatment|Overall Study||43
183636|NCT00890929|442280|P1|Consented & Enrolled|Overall Study||45
183637|NCT00890929|442280|P1|STARTED|Overall Study||45
183638|NCT00890916|442292|P1|NOT COMPLETED|"Rehab - NP Off"||0
183639|NCT00890916|442292|P1|COMPLETED|"Rehab - NP Off"||10
183640|NCT00890916|442292|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
183641|NCT00890916|442292|P1|STARTED|"Rehab - NP Off"||10
183642|NCT00890916|442292|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
183643|NCT00890916|442292|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
183644|NCT00890916|442292|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
183645|NCT00890916|442292|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
183646|NCT00890721|442298|P2|NOT COMPLETED|Overall Study||1
183647|NCT00890721|442299|P1|NOT COMPLETED|Overall Study||1
183648|NCT00890721|442298|P2|COMPLETED|Overall Study||93
183649|NCT00890721|442299|P1|COMPLETED|Overall Study||94
183650|NCT00890721|442298|P2|STARTED|Overall Study||94
183651|NCT00890721|442299|P1|STARTED|Overall Study||95
183652|NCT00890695|442307|P2|NOT COMPLETED|Overall Study||0
183653|NCT00890695|442308|P1|NOT COMPLETED|Overall Study||1
183654|NCT00890695|442307|P2|COMPLETED|Overall Study||33
183655|NCT00890695|442308|P1|COMPLETED|Overall Study||31
183656|NCT00890695|442307|P2|STARTED|Overall Study||33
183657|NCT00890695|442308|P1|STARTED|Overall Study||32
183658|NCT00890682|442326|P2|NOT COMPLETED|Overall Study||2
183659|NCT00890682|442327|P1|NOT COMPLETED|Overall Study||4
183660|NCT00890682|442326|P2|COMPLETED|Overall Study||94
183661|NCT00890682|442327|P1|COMPLETED|Overall Study||93
183662|NCT00890682|442326|P2|STARTED|Overall Study||96
183663|NCT00890682|442327|P1|STARTED|Overall Study||97
183664|NCT00890656|442333|P1|NOT COMPLETED|Overall Study||0
183665|NCT00890656|442333|P1|COMPLETED|Overall Study||90
183666|NCT00890656|442333|P1|STARTED|Overall Study||90
183667|NCT00890591|442337|P1|NOT COMPLETED|Overall Study||20
183668|NCT00890591|442337|P1|COMPLETED|Overall Study||124
183669|NCT00890591|442337|P1|STARTED|Overall Study||144
183670|NCT00890552|442343|P1|NOT COMPLETED|On-treatment||10
183671|NCT00890552|442343|P1|COMPLETED|On-treatment||14
183672|NCT00890552|442343|P1|STARTED|On-treatment||24
183673|NCT00890552|442343|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
183674|NCT00890552|442343|P1|COMPLETED|Enrollment and Pre-treatment||24
183675|NCT00890552|442343|P1|STARTED|Enrollment and Pre-treatment||25
183676|NCT00890409|442352|P2|NOT COMPLETED|Overall Study||21
183677|NCT00890409|442353|P1|NOT COMPLETED|Overall Study||20
183678|NCT00890409|442352|P2|COMPLETED|Overall Study||119
183679|NCT00890409|442353|P1|COMPLETED|Overall Study||96
183680|NCT00890409|442352|P2|STARTED|Overall Study||140
183681|NCT00890409|442353|P1|STARTED|Overall Study||116
183682|NCT00890201|442363|P2|NOT COMPLETED|Overall Study||56
183683|NCT00890201|442364|P1|NOT COMPLETED|Overall Study||5
183684|NCT00890201|442363|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
183685|NCT00890201|442364|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
183686|NCT00890201|442363|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
183687|NCT00890201|442364|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
183688|NCT00890097|442373|P3|NOT COMPLETED|Overall Study||77
183689|NCT00890097|442374|P2|NOT COMPLETED|Overall Study||86
183690|NCT00890097|442375|P1|NOT COMPLETED|Overall Study||68
183691|NCT00890097|442373|P3|COMPLETED|Overall Study||184
183692|NCT00890097|442374|P2|COMPLETED|Overall Study||173
183693|NCT00890097|442375|P1|COMPLETED|Overall Study||184
183694|NCT00890097|442373|P3|STARTED|Overall Study||261
183695|NCT00890097|442374|P2|STARTED|Overall Study||259
183696|NCT00890097|442375|P1|STARTED|Overall Study||252
183697|NCT00890084|442383|P1|NOT COMPLETED|Overall Study||142
183698|NCT00890084|442383|P1|COMPLETED|Overall Study||2771
183699|NCT00890084|442383|P1|STARTED|Overall Study||2913
183700|NCT00889928|442394|P1|NOT COMPLETED|Overall Study||0
183701|NCT00889928|442394|P1|COMPLETED|Overall Study||7
183702|NCT00889928|442394|P1|STARTED|Overall Study||7
183703|NCT00889915|442402|P4|NOT COMPLETED|Overall Study||8
183704|NCT00889915|442403|P3|NOT COMPLETED|Overall Study||13
183705|NCT00889915|442404|P2|NOT COMPLETED|Overall Study||5
183706|NCT00889915|442405|P1|NOT COMPLETED|Overall Study||2
183707|NCT00889915|442402|P4|COMPLETED|Overall Study||40
183708|NCT00889915|442403|P3|COMPLETED|Overall Study||54
183709|NCT00889915|442404|P2|COMPLETED|Overall Study||71
183710|NCT00889915|442405|P1|COMPLETED|Overall Study||35
183711|NCT00889915|442402|P4|STARTED|Overall Study||48
183712|NCT00889915|442403|P3|STARTED|Overall Study||67
183713|NCT00889915|442404|P2|STARTED|Overall Study||76
183714|NCT00889915|442405|P1|STARTED|Overall Study||37
183715|NCT00889863|442423|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
183716|NCT00889863|442424|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
183717|NCT00889863|442423|P2|COMPLETED|Part II: Randomized Double Blind||24
183718|NCT00889863|442424|P1|COMPLETED|Part II: Randomized Double Blind||39
183719|NCT00889863|442423|P2|STARTED|Part II: Randomized Double Blind||50
183720|NCT00889863|442424|P1|STARTED|Part II: Randomized Double Blind||50
183721|NCT00889863|442423|P2|NOT COMPLETED|Part I: Open Label||0
183722|NCT00889863|442424|P1|NOT COMPLETED|Part I: Open Label||77
183723|NCT00889863|442423|P2|COMPLETED|Part I: Open Label||0
183724|NCT00889863|442424|P1|COMPLETED|Part I: Open Label||100
183725|NCT00889863|442423|P2|Entered Part 1d|Part I: Open Label||0
183726|NCT00889863|442424|P1|Entered Part 1d|Part I: Open Label||103
183727|NCT00889863|442423|P2|Entered Part Ic|Part I: Open Label||0
183728|NCT00889863|442424|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
183729|NCT00889863|442423|P2|Entered Part Ib|Part I: Open Label||0
183730|NCT00889863|442424|P1|Entered Part Ib|Part I: Open Label||142
183731|NCT00889863|442423|P2|Entered Part Ia|Part I: Open Label||0
183732|NCT00889863|442424|P1|Entered Part Ia|Part I: Open Label||145
183733|NCT00889863|442423|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
183734|NCT00889863|442424|P1|STARTED|Part I: Open Label||177
183735|NCT00889824|442446|P1|NOT COMPLETED|Overall Study||0
183736|NCT00889824|442446|P1|COMPLETED|Overall Study||5
183737|NCT00889824|442446|P1|STARTED|Overall Study||5
183738|NCT00889720|442450|P1|NOT COMPLETED|Overall Study||8
183739|NCT00889720|442450|P1|COMPLETED|Overall Study||8
183740|NCT00889720|442450|P1|Surgical Population|Overall Study||12
183741|NCT00889720|442450|P1|STARTED|Overall Study||16
183742|NCT00889707|442477|P2|NOT COMPLETED|Overall Study||10
183743|NCT00889707|442478|P1|NOT COMPLETED|Overall Study||7
183744|NCT00889707|442477|P2|COMPLETED|Overall Study||21
183745|NCT00889707|442478|P1|COMPLETED|Overall Study||54
183746|NCT00889707|442477|P2|STARTED|Overall Study||31
183747|NCT00889707|442478|P1|STARTED|Overall Study||61
183748|NCT00889681|442486|P1|NOT COMPLETED|Overall Study||3
183749|NCT00889681|442486|P1|COMPLETED|Overall Study||78
183750|NCT00889681|442486|P1|Received Treatment|Overall Study||78
183751|NCT00889681|442486|P1|STARTED|Overall Study||81
183752|NCT00889603|442493|P1|NOT COMPLETED|Overall Study||37
183753|NCT00889603|442493|P1|COMPLETED|Overall Study||333
183754|NCT00889603|442493|P1|STARTED|Overall Study||370
183755|NCT00889512|442508|P2|NOT COMPLETED|Overall Study||0
183756|NCT00889512|442509|P1|NOT COMPLETED|Overall Study||0
183757|NCT00889512|442508|P2|COMPLETED|Overall Study||9
183758|NCT00889512|442509|P1|COMPLETED|Overall Study||5
183759|NCT00889512|442508|P2|STARTED|Overall Study||9
183760|NCT00889512|442509|P1|STARTED|Overall Study||5
183761|NCT00889421|442515|P1|NOT COMPLETED|Overall Study||3
183762|NCT00889421|442515|P1|COMPLETED|Overall Study||0
183763|NCT00889421|442515|P1|STARTED|Overall Study||3
183764|NCT00889330|442525|P2|NOT COMPLETED|Overall Study||0
183765|NCT00889330|442526|P1|NOT COMPLETED|Overall Study||0
183766|NCT00889330|442525|P2|COMPLETED|Overall Study||30
183767|NCT00889330|442526|P1|COMPLETED|Overall Study||30
183768|NCT00889330|442525|P2|STARTED|Overall Study||30
183769|NCT00889330|442526|P1|STARTED|Overall Study||30
183770|NCT00889265|442556|P1|NOT COMPLETED|Overall Study||7
183771|NCT00889265|442556|P1|COMPLETED|Overall Study||44
183772|NCT00889265|442556|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
183773|NCT00889252|442563|P2|NOT COMPLETED|Overall Study||4
183774|NCT00889252|442564|P1|NOT COMPLETED|Overall Study||7
183775|NCT00889252|442563|P2|COMPLETED|Overall Study||78
183776|NCT00889252|442564|P1|COMPLETED|Overall Study||161
183777|NCT00889252|442563|P2|STARTED|Overall Study||82
183778|NCT00889252|442564|P1|STARTED|Overall Study||168
183779|NCT00889200|442606|P1|NOT COMPLETED|Overall Study||0
183780|NCT00889200|442606|P1|COMPLETED|Overall Study||12
183781|NCT00889200|442606|P1|STARTED|Overall Study||12
183782|NCT00889187|442610|P4|NOT COMPLETED|Overall Study||0
183783|NCT00889187|442611|P3|NOT COMPLETED|Overall Study||0
183784|NCT00889187|442612|P2|NOT COMPLETED|Overall Study||0
183785|NCT00889187|442613|P1|NOT COMPLETED|Overall Study||0
183786|NCT00889187|442610|P4|COMPLETED|Overall Study||0
183787|NCT00889187|442611|P3|COMPLETED|Overall Study||4
183788|NCT00889187|442612|P2|COMPLETED|Overall Study||3
183789|NCT00889187|442613|P1|COMPLETED|Overall Study||3
183790|NCT00889187|442610|P4|STARTED|Overall Study||0
183791|NCT00889187|442611|P3|STARTED|Overall Study||4
183792|NCT00889187|442612|P2|STARTED|Overall Study||3
183793|NCT00889187|442613|P1|STARTED|Overall Study||3
183794|NCT00888979|442628|P1|NOT COMPLETED|Overall Study||4
183795|NCT00888979|442628|P1|COMPLETED|Overall Study||6
183796|NCT00888979|442628|P1|Received the Inhaler/Counseling|Overall Study||8
183797|NCT00888979|442628|P1|STARTED|Overall Study||10
183798|NCT00888940|442636|P2|NOT COMPLETED|Overall Study||21
183799|NCT00888940|442637|P1|NOT COMPLETED|Overall Study||28
183800|NCT00888940|442636|P2|COMPLETED|Overall Study||101
183801|NCT00888940|442637|P1|COMPLETED|Overall Study||92
183802|NCT00888940|442636|P2|Completed Therapy|Overall Study||106
183803|NCT00888940|442637|P1|Completed Therapy|Overall Study||107
183804|NCT00888940|442636|P2|STARTED|Overall Study||122
183805|NCT00888940|442637|P1|STARTED|Overall Study||120
183806|NCT00888849|442647|P2|NOT COMPLETED|Overall Study||9
183807|NCT00888849|442648|P1|NOT COMPLETED|Overall Study||5
183808|NCT00888849|442647|P2|COMPLETED|Overall Study||129
183809|NCT00888849|442648|P1|COMPLETED|Overall Study||137
183810|NCT00888849|442647|P2|STARTED|Overall Study||138
183811|NCT00888849|442648|P1|STARTED|Overall Study||142
183812|NCT00888654|442658|P1|NOT COMPLETED|Overall Study||10
183813|NCT00888654|442658|P1|COMPLETED|Overall Study||31
183814|NCT00888654|442658|P1|STARTED|Overall Study||41
183815|NCT00888628|442664|P1|NOT COMPLETED|Overall Study||3
183816|NCT00888628|442664|P1|COMPLETED|Overall Study||4
183817|NCT00888628|442664|P1|Transplanted|Overall Study||4
183818|NCT00888628|442664|P1|Withdrawn|Overall Study||1
183819|NCT00888628|442664|P1|Screen Failure|Overall Study||2
183820|NCT00888628|442664|P1|Enrolled|Overall Study||7
183821|NCT00888628|442664|P1|STARTED|Overall Study||7
183822|NCT00888459|442678|P2|NOT COMPLETED|Overall Study||0
183823|NCT00888459|442679|P1|NOT COMPLETED|Overall Study||0
183824|NCT00888459|442678|P2|COMPLETED|Overall Study||30
183825|NCT00888459|442679|P1|COMPLETED|Overall Study||30
183826|NCT00888459|442678|P2|STARTED|Overall Study||30
183827|NCT00888459|442679|P1|STARTED|Overall Study||30
183828|NCT00888433|442687|P2|NOT COMPLETED|Overall Study||3
183829|NCT00888433|442688|P1|NOT COMPLETED|Overall Study||3
183830|NCT00888433|442687|P2|COMPLETED|Overall Study||51
183831|NCT00888433|442688|P1|COMPLETED|Overall Study||49
183832|NCT00888433|442687|P2|STARTED|Overall Study||54
183833|NCT00888433|442688|P1|STARTED|Overall Study||52
183834|NCT00888381|442696|P2|NOT COMPLETED|Overall Study||1
183835|NCT00888381|442697|P1|NOT COMPLETED|Overall Study||0
183836|NCT00888381|442696|P2|COMPLETED|Overall Study||59
183837|NCT00888381|442697|P1|COMPLETED|Overall Study||60
183838|NCT00888381|442696|P2|STARTED|Overall Study||60
183839|NCT00888381|442697|P1|STARTED|Overall Study||60
183840|NCT00888355|442717|P4|NOT COMPLETED|Overall Study||10
183841|NCT00888355|442718|P3|NOT COMPLETED|Overall Study||12
183842|NCT00888355|442719|P2|NOT COMPLETED|Overall Study||9
183843|NCT00888355|442720|P1|NOT COMPLETED|Overall Study||22
183844|NCT00888355|442717|P4|COMPLETED|Overall Study||96
183845|NCT00888355|442718|P3|COMPLETED|Overall Study||94
183846|NCT00888355|442719|P2|COMPLETED|Overall Study||99
183847|NCT00888355|442720|P1|COMPLETED|Overall Study||86
183848|NCT00888355|442717|P4|STARTED|Overall Study||106
183849|NCT00888355|442718|P3|STARTED|Overall Study||106
183850|NCT00888355|442719|P2|STARTED|Overall Study||108
183851|NCT00888355|442720|P1|STARTED|Overall Study||108
183852|NCT00888329|442776|P2|NOT COMPLETED|Overall Study||9
183853|NCT00888329|442777|P1|NOT COMPLETED|Overall Study||6
183854|NCT00888329|442776|P2|COMPLETED|Overall Study||122
183855|NCT00888329|442777|P1|COMPLETED|Overall Study||119
183856|NCT00888329|442776|P2|STARTED|Overall Study||131
183857|NCT00888329|442777|P1|STARTED|Overall Study||125
183858|NCT00888238|442783|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
183859|NCT00888238|442784|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
183860|NCT00888238|442785|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
183861|NCT00888238|442783|P3|COMPLETED|Third Period of Treatment Intervention||3
183862|NCT00888238|442784|P2|COMPLETED|Third Period of Treatment Intervention||4
183863|NCT00888238|442785|P1|COMPLETED|Third Period of Treatment Intervention||4
183864|NCT00888238|442783|P3|STARTED|Third Period of Treatment Intervention||3
183865|NCT00888238|442784|P2|STARTED|Third Period of Treatment Intervention||4
183866|NCT00888238|442785|P1|STARTED|Third Period of Treatment Intervention||4
183867|NCT00888238|442783|P3|NOT COMPLETED|Washout Period After Period 2||1
183868|NCT00888238|442784|P2|NOT COMPLETED|Washout Period After Period 2||0
183869|NCT00888238|442785|P1|NOT COMPLETED|Washout Period After Period 2||0
183870|NCT00888238|442783|P3|COMPLETED|Washout Period After Period 2||3
183871|NCT00888238|442784|P2|COMPLETED|Washout Period After Period 2||4
183872|NCT00888238|442785|P1|COMPLETED|Washout Period After Period 2||4
183873|NCT00888238|442783|P3|STARTED|Washout Period After Period 2||4
183874|NCT00888238|442784|P2|STARTED|Washout Period After Period 2||4
183875|NCT00888238|442785|P1|STARTED|Washout Period After Period 2||4
183876|NCT00888238|442783|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
183877|NCT00888238|442784|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
183878|NCT00888238|442785|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
183879|NCT00888238|442783|P3|COMPLETED|Second Period of Treatment Intervention||4
183880|NCT00888238|442784|P2|COMPLETED|Second Period of Treatment Intervention||4
183881|NCT00888238|442785|P1|COMPLETED|Second Period of Treatment Intervention||4
183882|NCT00888238|442783|P3|STARTED|Second Period of Treatment Intervention||4
183883|NCT00888238|442784|P2|STARTED|Second Period of Treatment Intervention||4
183884|NCT00888238|442785|P1|STARTED|Second Period of Treatment Intervention||4
183885|NCT00888238|442783|P3|NOT COMPLETED|Washout Period After Period 1||0
183886|NCT00888238|442784|P2|NOT COMPLETED|Washout Period After Period 1||0
183887|NCT00888238|442785|P1|NOT COMPLETED|Washout Period After Period 1||0
183888|NCT00888238|442783|P3|COMPLETED|Washout Period After Period 1||4
183889|NCT00888238|442784|P2|COMPLETED|Washout Period After Period 1||4
183890|NCT00888238|442785|P1|COMPLETED|Washout Period After Period 1||4
183891|NCT00888238|442783|P3|STARTED|Washout Period After Period 1||4
183892|NCT00888238|442784|P2|STARTED|Washout Period After Period 1||4
183893|NCT00888238|442785|P1|STARTED|Washout Period After Period 1||4
183894|NCT00888238|442783|P3|NOT COMPLETED|First Period of Treatment Intervention||0
183895|NCT00888238|442784|P2|NOT COMPLETED|First Period of Treatment Intervention||0
183896|NCT00888238|442785|P1|NOT COMPLETED|First Period of Treatment Intervention||0
183897|NCT00888238|442783|P3|COMPLETED|First Period of Treatment Intervention||4
183898|NCT00888238|442784|P2|COMPLETED|First Period of Treatment Intervention||4
183899|NCT00888238|442785|P1|COMPLETED|First Period of Treatment Intervention||4
183900|NCT00888238|442783|P3|STARTED|First Period of Treatment Intervention||4
183901|NCT00888238|442784|P2|STARTED|First Period of Treatment Intervention||4
183902|NCT00888238|442785|P1|STARTED|First Period of Treatment Intervention||4
183903|NCT00888173|442793|P1|NOT COMPLETED|Overall Study||2
183904|NCT00888173|442793|P1|COMPLETED|Overall Study||43
183905|NCT00888173|442793|P1|STARTED|Overall Study||45
183906|NCT00888134|442801|P1|NOT COMPLETED|Follow-up||1
183907|NCT00888134|442801|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
183908|NCT00888134|442801|P1|STARTED|Follow-up||27
183909|NCT00888134|442801|P1|NOT COMPLETED|Treatment With Study Drug||1
183910|NCT00888134|442801|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
183911|NCT00888134|442801|P1|STARTED|Treatment With Study Drug||28
183912|NCT00887978|442811|P2|NOT COMPLETED|Overall Study||15
183913|NCT00887978|442812|P1|NOT COMPLETED|Overall Study||25
183914|NCT00887978|442811|P2|COMPLETED|Overall Study||138
183915|NCT00887978|442812|P1|COMPLETED|Overall Study||132
183916|NCT00887978|442811|P2|STARTED|Overall Study||153
183917|NCT00887978|442812|P1|STARTED|Overall Study||157
183918|NCT00887965|442848|P1|NOT COMPLETED|Overall Study||0
183919|NCT00887965|442848|P1|COMPLETED|Overall Study||15
183920|NCT00887965|442848|P1|STARTED|Overall Study||15
183921|NCT00887913|442878|P1|NOT COMPLETED|Overall Study||6
183922|NCT00887913|442878|P1|COMPLETED|Overall Study||63
183923|NCT00887913|442878|P1|STARTED|Overall Study||69
183924|NCT00887822|442886|P2|NOT COMPLETED|Overall Study||102
183925|NCT00887822|442887|P1|NOT COMPLETED|Overall Study||97
183926|NCT00887822|442886|P2|COMPLETED|Overall Study||0
183927|NCT00887822|442887|P1|COMPLETED|Overall Study||3
183928|NCT00887822|442886|P2|Treated (Safety Population)|Overall Study||101
183929|NCT00887822|442887|P1|Treated (Safety Population)|Overall Study||100
183930|NCT00887822|442886|P2|STARTED|Overall Study||102
183931|NCT00887822|442887|P1|STARTED|Overall Study||100
183932|NCT00887809|442919|P2|NOT COMPLETED|Overall Study||0
183933|NCT00887809|442920|P1|NOT COMPLETED|Overall Study||4
183934|NCT00887809|442919|P2|COMPLETED|Overall Study||10
183935|NCT00887809|442920|P1|COMPLETED|Overall Study||33
183936|NCT00887809|442919|P2|STARTED|Overall Study||10
183937|NCT00887809|442920|P1|STARTED|Overall Study||37
183938|NCT00887744|442926|P1|NOT COMPLETED|Overall Study||34
183939|NCT00887744|442926|P1|COMPLETED|Overall Study||128
183940|NCT00887744|442926|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
183941|NCT00887679|442935|P1|NOT COMPLETED|Overall Study||10
183942|NCT00887679|442935|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
183943|NCT00887679|442935|P1|STARTED|Overall Study||30
183944|NCT00887653|442944|P1|NOT COMPLETED|Overall Study||0
183945|NCT00887653|442944|P1|COMPLETED|Overall Study||20
183946|NCT00887653|442944|P1|STARTED|Overall Study||20
183947|NCT00887640|442950|P1|NOT COMPLETED|Overall Study||0
183948|NCT00887640|442950|P1|COMPLETED|Overall Study||11
183949|NCT00887640|442950|P1|STARTED|Overall Study||11
183950|NCT00887588|442965|P2|NOT COMPLETED|Extension Period||5
183951|NCT00887588|442966|P1|NOT COMPLETED|Extension Period||6
183952|NCT00887588|442965|P2|COMPLETED|Extension Period||120
183953|NCT00887588|442966|P1|COMPLETED|Extension Period||121
183954|NCT00887588|442965|P2|Arterial Stiffness Set|Extension Period||94
183955|NCT00887588|442966|P1|Arterial Stiffness Set|Extension Period||86
183956|NCT00887588|442965|P2|STARTED|Extension Period||125
183957|NCT00887588|442966|P1|STARTED|Extension Period||127
183958|NCT00887588|442965|P2|NOT COMPLETED|Core Period||21
183959|NCT00887588|442966|P1|NOT COMPLETED|Core Period||19
183960|NCT00887588|442965|P2|COMPLETED|Core Period||131
183961|NCT00887588|442966|P1|COMPLETED|Core Period||130
183962|NCT00887588|442965|P2|Arterial Stiffness Set|Core Period||94
183963|NCT00887588|442966|P1|Arterial Stiffness Set|Core Period||86
183964|NCT00887588|442965|P2|Full Analysis Set|Core Period||146
183965|NCT00887588|442966|P1|Full Analysis Set|Core Period||148
183966|NCT00887588|442965|P2|Extension Efficacy Set|Core Period||125
183967|NCT00887588|442966|P1|Extension Efficacy Set|Core Period||127
183968|NCT00887588|442965|P2|STARTED|Core Period||152
183969|NCT00887588|442966|P1|STARTED|Core Period||149
183970|NCT00887575|443018|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
183971|NCT00887575|443019|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
183972|NCT00887575|443020|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
183973|NCT00887575|443018|P3|COMPLETED|Phase II - Maintenance Therapy||0
183974|NCT00887575|443019|P2|COMPLETED|Phase II - Maintenance Therapy||0
183975|NCT00887575|443020|P1|COMPLETED|Phase II - Maintenance Therapy||6
183976|NCT00887575|443018|P3|STARTED|Phase II - Maintenance Therapy||0
183977|NCT00887575|443019|P2|STARTED|Phase II - Maintenance Therapy||0
183978|NCT00887575|443020|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
183979|NCT00887575|443018|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
183980|NCT00887575|443019|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
183981|NCT00887575|443020|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
183982|NCT00887575|443018|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
183983|NCT00887575|443019|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
183984|NCT00887575|443020|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
183985|NCT00887575|443018|P3|STARTED|Phase II - Neoadjuvant Therapy||0
183986|NCT00887575|443019|P2|STARTED|Phase II - Neoadjuvant Therapy||0
183987|NCT00887575|443020|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
183988|NCT00887575|443018|P3|NOT COMPLETED|Phase I||3
183989|NCT00887575|443019|P2|NOT COMPLETED|Phase I||6
183990|NCT00887575|443020|P1|NOT COMPLETED|Phase I||0
183991|NCT00887575|443018|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
183992|NCT00887575|443019|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
183993|NCT00887575|443020|P1|COMPLETED|Phase I||6
183994|NCT00887575|443018|P3|STARTED|Phase I||3
183995|NCT00887575|443019|P2|STARTED|Phase I||6
183996|NCT00887575|443020|P1|STARTED|Phase I||6
183997|NCT00887562|443031|P3|NOT COMPLETED|Overall Study||1
183998|NCT00887562|443032|P2|NOT COMPLETED|Overall Study||2
183999|NCT00887562|443033|P1|NOT COMPLETED|Overall Study||3
184000|NCT00887562|443031|P3|COMPLETED|Overall Study||7
184001|NCT00887562|443032|P2|COMPLETED|Overall Study||7
184002|NCT00887562|443033|P1|COMPLETED|Overall Study||7
184003|NCT00887562|443031|P3|STARTED|Overall Study||8
184004|NCT00887562|443032|P2|STARTED|Overall Study||9
184005|NCT00887562|443033|P1|STARTED|Overall Study||10
184006|NCT00887549|443047|P1|NOT COMPLETED|Maintenance Therapy||43
184007|NCT00887549|443047|P1|COMPLETED|Maintenance Therapy||0
184008|NCT00887549|443047|P1|STARTED|Maintenance Therapy||43
184009|NCT00887549|443047|P1|NOT COMPLETED|Induction Therapy||27
184010|NCT00887549|443047|P1|COMPLETED|Induction Therapy||43
184011|NCT00887549|443047|P1|STARTED|Induction Therapy||70
184012|NCT00887510|443056|P2|NOT COMPLETED|Overall Study||0
184013|NCT00887510|443057|P1|NOT COMPLETED|Overall Study||0
184014|NCT00887510|443056|P2|COMPLETED|Overall Study||12
184015|NCT00887510|443057|P1|COMPLETED|Overall Study||12
184016|NCT00887510|443056|P2|STARTED|Overall Study||12
184017|NCT00887510|443057|P1|STARTED|Overall Study||12
184018|NCT00887484|443065|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
184019|NCT00887484|443065|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
184020|NCT00887484|443065|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
184021|NCT00887484|443065|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
184022|NCT00887484|443065|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
184023|NCT00887484|443065|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
184024|NCT00887471|443131|P2|NOT COMPLETED|Overall Study||0
184025|NCT00887471|443132|P1|NOT COMPLETED|Overall Study||0
184026|NCT00887471|443131|P2|COMPLETED|Overall Study||15
184027|NCT00887471|443132|P1|COMPLETED|Overall Study||15
184028|NCT00887471|443131|P2|STARTED|Overall Study||15
184029|NCT00887471|443132|P1|STARTED|Overall Study||15
184030|NCT00887458|443142|P2|NOT COMPLETED|Overall Study||4
184031|NCT00887458|443143|P1|NOT COMPLETED|Overall Study||0
184032|NCT00887458|443142|P2|COMPLETED|Overall Study||25
184033|NCT00887458|443143|P1|COMPLETED|Overall Study||17
184034|NCT00887458|443142|P2|STARTED|Overall Study||29
184035|NCT00887458|443143|P1|STARTED|Overall Study||17
184036|NCT00887354|443153|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
184037|NCT00887354|443154|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
184038|NCT00887354|443153|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
184039|NCT00887354|443154|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
184040|NCT00887354|443153|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
184041|NCT00887354|443154|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
184042|NCT00887354|443153|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
184043|NCT00887354|443154|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
184044|NCT00887354|443153|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
184045|NCT00887354|443154|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
184046|NCT00887354|443153|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
184047|NCT00887354|443154|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
184048|NCT00887354|443153|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
184049|NCT00887354|443154|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
184050|NCT00887354|443153|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
184051|NCT00887354|443154|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
184052|NCT00887341|443174|P2|NOT COMPLETED|Overall Study||3
184053|NCT00887341|443175|P1|NOT COMPLETED|Overall Study||2
184054|NCT00887341|443174|P2|COMPLETED|Overall Study||36
184055|NCT00887341|443175|P1|COMPLETED|Overall Study||35
184056|NCT00887341|443174|P2|STARTED|Overall Study||39
184057|NCT00887341|443175|P1|STARTED|Overall Study||37
184058|NCT00887315|443211|P2|NOT COMPLETED|Overall Study||4
184059|NCT00887315|443212|P1|NOT COMPLETED|Overall Study||7
184060|NCT00887315|443211|P2|COMPLETED|Overall Study||0
184061|NCT00887315|443212|P1|COMPLETED|Overall Study||0
184062|NCT00887315|443211|P2|STARTED|Overall Study||4
184063|NCT00887315|443212|P1|STARTED|Overall Study||7
184064|NCT00887289|443220|P1|NOT COMPLETED|Overall Study||95
184065|NCT00887289|443220|P1|COMPLETED|Overall Study||1409
184066|NCT00887289|443220|P1|STARTED|Overall Study||1504
184067|NCT00887250|443232|P3|NOT COMPLETED|Overall Study||13
184068|NCT00887250|443233|P2|NOT COMPLETED|Overall Study||12
184069|NCT00887250|443234|P1|NOT COMPLETED|Overall Study||18
184070|NCT00887250|443232|P3|COMPLETED|Overall Study||110
184071|NCT00887250|443233|P2|COMPLETED|Overall Study||115
184072|NCT00887250|443234|P1|COMPLETED|Overall Study||98
184073|NCT00887250|443232|P3|STARTED|Overall Study||123
184074|NCT00887250|443233|P2|STARTED|Overall Study||127
184075|NCT00887250|443234|P1|STARTED|Overall Study||116
184076|NCT00887224|443257|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
184077|NCT00887224|443258|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
184078|NCT00887224|443259|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
184079|NCT00887224|443257|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
184080|NCT00887224|443258|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
184081|NCT00887224|443259|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
184082|NCT00887224|443257|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
184083|NCT00887224|443258|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
184084|NCT00887224|443259|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
184085|NCT00887224|443257|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
184086|NCT00887224|443258|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
184087|NCT00887224|443259|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
184088|NCT00887224|443257|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
184089|NCT00887224|443258|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
184090|NCT00887224|443259|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
184091|NCT00887224|443257|P3|NOT COMPLETED|Double-blind (DB) Phase||62
184092|NCT00887224|443258|P2|NOT COMPLETED|Double-blind (DB) Phase||100
184093|NCT00887224|443259|P1|NOT COMPLETED|Double-blind (DB) Phase||0
184094|NCT00887224|443257|P3|COMPLETED|Double-blind (DB) Phase||210
184095|NCT00887224|443258|P2|COMPLETED|Double-blind (DB) Phase||176
184096|NCT00887224|443259|P1|COMPLETED|Double-blind (DB) Phase||0
184097|NCT00887224|443257|P3|STARTED|Double-blind (DB) Phase||272
184098|NCT00887224|443258|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
184099|NCT00887224|443259|P1|STARTED|Double-blind (DB) Phase||0
184100|NCT00887224|443257|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
184101|NCT00887224|443258|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
184102|NCT00887224|443259|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
184103|NCT00887224|443257|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
184104|NCT00887224|443258|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
184105|NCT00887224|443259|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
184106|NCT00887224|443257|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
184107|NCT00887224|443258|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
184108|NCT00887224|443259|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
184109|NCT00887224|443257|P3|STARTED|OL Taper Phase / OL Follow Up||0
184110|NCT00887224|443258|P2|STARTED|OL Taper Phase / OL Follow Up||0
184111|NCT00887224|443259|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
184112|NCT00887224|443257|P3|NOT COMPLETED|Between OLS and DB Phases||0
184113|NCT00887224|443258|P2|NOT COMPLETED|Between OLS and DB Phases||0
184114|NCT00887224|443259|P1|NOT COMPLETED|Between OLS and DB Phases||28
184115|NCT00887224|443257|P3|COMPLETED|Between OLS and DB Phases||0
184116|NCT00887224|443258|P2|COMPLETED|Between OLS and DB Phases||0
184117|NCT00887224|443259|P1|COMPLETED|Between OLS and DB Phases||548
184118|NCT00887224|443257|P3|STARTED|Between OLS and DB Phases||0
184119|NCT00887224|443258|P2|STARTED|Between OLS and DB Phases||0
184120|NCT00887224|443259|P1|STARTED|Between OLS and DB Phases||576
184121|NCT00887224|443257|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
184122|NCT00887224|443258|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
184123|NCT00887224|443259|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
184124|NCT00887224|443257|P3|COMPLETED|Open-label Stability (OLS) Phase||0
184125|NCT00887224|443258|P2|COMPLETED|Open-label Stability (OLS) Phase||0
184126|NCT00887224|443259|P1|COMPLETED|Open-label Stability (OLS) Phase||576
184127|NCT00887224|443257|P3|STARTED|Open-label Stability (OLS) Phase||0
184128|NCT00887224|443258|P2|STARTED|Open-label Stability (OLS) Phase||0
184129|NCT00887224|443259|P1|STARTED|Open-label Stability (OLS) Phase||659
184130|NCT00887224|443257|P3|NOT COMPLETED|Between OLR and OLS Phases||0
184131|NCT00887224|443258|P2|NOT COMPLETED|Between OLR and OLS Phases||0
184132|NCT00887224|443259|P1|NOT COMPLETED|Between OLR and OLS Phases||93
184133|NCT00887224|443257|P3|COMPLETED|Between OLR and OLS Phases||0
184134|NCT00887224|443258|P2|COMPLETED|Between OLR and OLS Phases||0
184135|NCT00887224|443259|P1|COMPLETED|Between OLR and OLS Phases||659
184136|NCT00887224|443257|P3|STARTED|Between OLR and OLS Phases||0
184137|NCT00887224|443258|P2|STARTED|Between OLR and OLS Phases||0
184138|NCT00887224|443259|P1|STARTED|Between OLR and OLS Phases||752
184139|NCT00887224|443257|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
184140|NCT00887224|443258|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
184141|NCT00887224|443259|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
184142|NCT00887224|443257|P3|COMPLETED|Open-label Response (OLR) Phase||0
184143|NCT00887224|443258|P2|COMPLETED|Open-label Response (OLR) Phase||0
184144|NCT00887224|443259|P1|COMPLETED|Open-label Response (OLR) Phase||752
184145|NCT00887224|443257|P3|STARTED|Open-label Response (OLR) Phase||0
184146|NCT00887224|443258|P2|STARTED|Open-label Response (OLR) Phase||0
184147|NCT00887224|443259|P1|STARTED|Open-label Response (OLR) Phase||874
184148|NCT00887198|443286|P2|NOT COMPLETED|Overall Study||431
184149|NCT00887198|443287|P1|NOT COMPLETED|Overall Study||384
184150|NCT00887198|443286|P2|COMPLETED|Overall Study||111
184151|NCT00887198|443287|P1|COMPLETED|Overall Study||162
184152|NCT00887198|443286|P2|STARTED|Overall Study||542
184153|NCT00887198|443287|P1|STARTED|Overall Study||546
184154|NCT00887159|443318|P3|NOT COMPLETED|Overall Study||56
184155|NCT00887159|443319|P2|NOT COMPLETED|Overall Study||56
184156|NCT00887159|443320|P1|NOT COMPLETED|Overall Study||29
184157|NCT00887159|443318|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
184158|NCT00887159|443319|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
184159|NCT00887159|443320|P1|COMPLETED|Overall Study||27
184160|NCT00887159|443318|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
184161|NCT00887159|443319|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
184162|NCT00887159|443320|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
184163|NCT00887159|443318|P3|Eligible and Treated Patients|Overall Study||52
184164|NCT00887159|443319|P2|Eligible and Treated Patients|Overall Study||52
184165|NCT00887159|443320|P1|Eligible and Treated Patients|Overall Study||48
184166|NCT00887159|443318|P3|Patients Who Started Assigned Treatment|Overall Study||52
184167|NCT00887159|443319|P2|Patients Who Started Assigned Treatment|Overall Study||53
184168|NCT00887159|443320|P1|Patients Who Started Assigned Treatment|Overall Study||53
184169|NCT00887159|443318|P3|STARTED|Overall Study||56
184170|NCT00887159|443319|P2|STARTED|Overall Study||56
184171|NCT00887159|443320|P1|STARTED|Overall Study||56
184172|NCT00886938|443336|P1|NOT COMPLETED|Overall Study||2
184173|NCT00886938|443336|P1|COMPLETED|Overall Study||10
184174|NCT00886938|443336|P1|STARTED|Overall Study||12
184175|NCT00886899|443340|P1|NOT COMPLETED|Overall Study||0
184176|NCT00886899|443340|P1|COMPLETED|Overall Study||147
184177|NCT00886899|443340|P1|STARTED|Overall Study||147
184178|NCT00886834|443349|P2|NOT COMPLETED|Overall Study||3
184179|NCT00886834|443350|P1|NOT COMPLETED|Overall Study||0
184180|NCT00886834|443349|P2|COMPLETED|Overall Study||51
184181|NCT00886834|443350|P1|COMPLETED|Overall Study||54
184182|NCT00886834|443349|P2|STARTED|Overall Study||54
184183|NCT00886834|443350|P1|STARTED|Overall Study||54
184184|NCT00886821|443372|P14|NOT COMPLETED|Stage 2||1
184185|NCT00886821|443373|P13|NOT COMPLETED|Stage 2||5
184186|NCT00886821|443374|P12|NOT COMPLETED|Stage 2||1
184187|NCT00886821|443375|P11|NOT COMPLETED|Stage 2||0
184188|NCT00886821|443376|P10|NOT COMPLETED|Stage 2||0
184189|NCT00886821|443377|P9|NOT COMPLETED|Stage 2||0
184190|NCT00886821|443378|P8|NOT COMPLETED|Stage 2||0
184191|NCT00886821|443379|P7|NOT COMPLETED|Stage 2||0
184192|NCT00886821|443380|P6|NOT COMPLETED|Stage 2||0
184193|NCT00886821|443381|P5|NOT COMPLETED|Stage 2||0
184194|NCT00886821|443382|P4|NOT COMPLETED|Stage 2||0
184195|NCT00886821|443383|P3|NOT COMPLETED|Stage 2||0
184196|NCT00886821|443384|P2|NOT COMPLETED|Stage 2||0
184197|NCT00886821|443385|P1|NOT COMPLETED|Stage 2||0
184198|NCT00886821|443372|P14|COMPLETED|Stage 2||8
184199|NCT00886821|443373|P13|COMPLETED|Stage 2||8
184200|NCT00886821|443374|P12|COMPLETED|Stage 2||8
184201|NCT00886821|443375|P11|COMPLETED|Stage 2||9
184202|NCT00886821|443376|P10|COMPLETED|Stage 2||0
184203|NCT00886821|443377|P9|COMPLETED|Stage 2||0
184204|NCT00886821|443378|P8|COMPLETED|Stage 2||0
184205|NCT00886821|443379|P7|COMPLETED|Stage 2||0
184206|NCT00886821|443380|P6|COMPLETED|Stage 2||0
184207|NCT00886821|443381|P5|COMPLETED|Stage 2||0
184208|NCT00886821|443382|P4|COMPLETED|Stage 2||0
184209|NCT00886821|443383|P3|COMPLETED|Stage 2||0
184210|NCT00886821|443384|P2|COMPLETED|Stage 2||0
184211|NCT00886821|443385|P1|COMPLETED|Stage 2||0
184212|NCT00886821|443372|P14|STARTED|Stage 2||9
184213|NCT00886821|443373|P13|STARTED|Stage 2||13
184214|NCT00886821|443374|P12|STARTED|Stage 2||9
184215|NCT00886821|443375|P11|STARTED|Stage 2||9
184216|NCT00886821|443376|P10|STARTED|Stage 2||0
184217|NCT00886821|443377|P9|STARTED|Stage 2||0
184218|NCT00886821|443378|P8|STARTED|Stage 2||0
184219|NCT00886821|443379|P7|STARTED|Stage 2||0
184220|NCT00886821|443380|P6|STARTED|Stage 2||0
184221|NCT00886821|443381|P5|STARTED|Stage 2||0
184222|NCT00886821|443382|P4|STARTED|Stage 2||0
184223|NCT00886821|443383|P3|STARTED|Stage 2||0
184224|NCT00886821|443384|P2|STARTED|Stage 2||0
184225|NCT00886821|443385|P1|STARTED|Stage 2||0
184226|NCT00886821|443372|P14|NOT COMPLETED|Stage 1||0
184227|NCT00886821|443373|P13|NOT COMPLETED|Stage 1||0
184228|NCT00886821|443374|P12|NOT COMPLETED|Stage 1||0
184229|NCT00886821|443375|P11|NOT COMPLETED|Stage 1||0
184230|NCT00886821|443376|P10|NOT COMPLETED|Stage 1||0
184231|NCT00886821|443377|P9|NOT COMPLETED|Stage 1||0
184232|NCT00886821|443378|P8|NOT COMPLETED|Stage 1||0
184233|NCT00886821|443379|P7|NOT COMPLETED|Stage 1||0
184234|NCT00886821|443380|P6|NOT COMPLETED|Stage 1||0
184235|NCT00886821|443381|P5|NOT COMPLETED|Stage 1||0
184236|NCT00886821|443382|P4|NOT COMPLETED|Stage 1||0
184237|NCT00886821|443383|P3|NOT COMPLETED|Stage 1||0
184238|NCT00886821|443384|P2|NOT COMPLETED|Stage 1||0
184239|NCT00886821|443385|P1|NOT COMPLETED|Stage 1||0
184240|NCT00886821|443372|P14|COMPLETED|Stage 1||0
184241|NCT00886821|443373|P13|COMPLETED|Stage 1||0
184242|NCT00886821|443374|P12|COMPLETED|Stage 1||0
184243|NCT00886821|443375|P11|COMPLETED|Stage 1||0
184244|NCT00886821|443376|P10|COMPLETED|Stage 1||18
184245|NCT00886821|443377|P9|COMPLETED|Stage 1||6
184246|NCT00886821|443378|P8|COMPLETED|Stage 1||6
184247|NCT00886821|443379|P7|COMPLETED|Stage 1||6
184248|NCT00886821|443380|P6|COMPLETED|Stage 1||6
184249|NCT00886821|443381|P5|COMPLETED|Stage 1||6
184250|NCT00886821|443382|P4|COMPLETED|Stage 1||7
184251|NCT00886821|443383|P3|COMPLETED|Stage 1||6
184252|NCT00886821|443384|P2|COMPLETED|Stage 1||6
184253|NCT00886821|443385|P1|COMPLETED|Stage 1||7
184254|NCT00886821|443372|P14|STARTED|Stage 1||0
184255|NCT00886821|443373|P13|STARTED|Stage 1||0
184256|NCT00886821|443374|P12|STARTED|Stage 1||0
184257|NCT00886821|443375|P11|STARTED|Stage 1||0
184258|NCT00886821|443376|P10|STARTED|Stage 1||18
184259|NCT00886821|443377|P9|STARTED|Stage 1||6
184260|NCT00886821|443378|P8|STARTED|Stage 1||6
184261|NCT00886821|443379|P7|STARTED|Stage 1||6
184262|NCT00886821|443380|P6|STARTED|Stage 1||6
184263|NCT00886821|443381|P5|STARTED|Stage 1||6
184264|NCT00886821|443382|P4|STARTED|Stage 1||7
184265|NCT00886821|443383|P3|STARTED|Stage 1||6
184266|NCT00886821|443384|P2|STARTED|Stage 1||6
184267|NCT00886821|443385|P1|STARTED|Stage 1||7
184268|NCT00886795|443610|P1|NOT COMPLETED|Overall Study||1
184269|NCT00886795|443610|P1|COMPLETED|Overall Study||3
184270|NCT00886795|443610|P1|STARTED|Overall Study||4
184271|NCT00886769|443617|P2|NOT COMPLETED|Overall Study||37
184272|NCT00886769|443618|P1|NOT COMPLETED|Overall Study||6
184273|NCT00886769|443617|P2|COMPLETED|Overall Study||4
184274|NCT00886769|443618|P1|COMPLETED|Overall Study||37
184275|NCT00886769|443617|P2|STARTED|Overall Study||41
184276|NCT00886769|443618|P1|STARTED|Overall Study||43
184277|NCT00886743|443642|P1|NOT COMPLETED|Overall Study||4
184278|NCT00886743|443642|P1|COMPLETED|Overall Study||15
184279|NCT00886743|443642|P1|STARTED|Overall Study|Received treatment|19
184280|NCT00886704|443652|P2|NOT COMPLETED|Overall Study||0
184281|NCT00886704|443653|P1|NOT COMPLETED|Overall Study||0
184282|NCT00886704|443652|P2|COMPLETED|Overall Study||10
184283|NCT00886704|443653|P1|COMPLETED|Overall Study||40
184284|NCT00886704|443652|P2|STARTED|Overall Study||10
184285|NCT00886704|443653|P1|STARTED|Overall Study||40
184286|NCT00886639|443661|P1|NOT COMPLETED|Overall Study||16
184287|NCT00886639|443661|P1|COMPLETED|Overall Study||111
184288|NCT00886639|443661|P1|STARTED|Overall Study||127
184289|NCT00886626|443665|P2|NOT COMPLETED|Period 2 (90 Days)||0
184290|NCT00886626|443666|P1|NOT COMPLETED|Period 2 (90 Days)||0
184291|NCT00886626|443665|P2|COMPLETED|Period 2 (90 Days)||6
184292|NCT00886626|443666|P1|COMPLETED|Period 2 (90 Days)||5
184293|NCT00886626|443665|P2|STARTED|Period 2 (90 Days)||6
184294|NCT00886626|443666|P1|STARTED|Period 2 (90 Days)||5
184295|NCT00886626|443665|P2|NOT COMPLETED|Period 1 (90 Days)||0
184296|NCT00886626|443666|P1|NOT COMPLETED|Period 1 (90 Days)||1
184297|NCT00886626|443665|P2|COMPLETED|Period 1 (90 Days)||6
184298|NCT00886626|443666|P1|COMPLETED|Period 1 (90 Days)||5
184299|NCT00886626|443665|P2|STARTED|Period 1 (90 Days)||6
184300|NCT00886626|443666|P1|STARTED|Period 1 (90 Days)||6
184301|NCT00886613|443675|P3|NOT COMPLETED|Overall Study||3
184302|NCT00886613|443676|P2|NOT COMPLETED|Overall Study||0
184303|NCT00886613|443677|P1|NOT COMPLETED|Overall Study||2
184304|NCT00886613|443675|P3|COMPLETED|Overall Study||37
184305|NCT00886613|443676|P2|COMPLETED|Overall Study||39
184306|NCT00886613|443677|P1|COMPLETED|Overall Study||39
184307|NCT00886613|443675|P3|STARTED|Overall Study||40
184308|NCT00886613|443676|P2|STARTED|Overall Study||39
184309|NCT00886613|443677|P1|STARTED|Overall Study||41
184310|NCT00886600|443699|P4|NOT COMPLETED|Combination Therapy Period||0
184311|NCT00886600|443700|P3|NOT COMPLETED|Combination Therapy Period||2
184312|NCT00886600|443701|P2|NOT COMPLETED|Combination Therapy Period||0
184313|NCT00886600|443702|P1|NOT COMPLETED|Combination Therapy Period||0
184314|NCT00886600|443699|P4|COMPLETED|Combination Therapy Period||23
184315|NCT00886600|443700|P3|COMPLETED|Combination Therapy Period||19
184316|NCT00886600|443701|P2|COMPLETED|Combination Therapy Period||21
184317|NCT00886600|443702|P1|COMPLETED|Combination Therapy Period||28
184318|NCT00886600|443699|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
184319|NCT00886600|443700|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
184320|NCT00886600|443701|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
184321|NCT00886600|443702|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
184322|NCT00886600|443699|P4|NOT COMPLETED|Double-blind Monotherapy||2
184323|NCT00886600|443700|P3|NOT COMPLETED|Double-blind Monotherapy||1
184324|NCT00886600|443701|P2|NOT COMPLETED|Double-blind Monotherapy||1
184325|NCT00886600|443702|P1|NOT COMPLETED|Double-blind Monotherapy||2
184326|NCT00886600|443699|P4|COMPLETED|Double-blind Monotherapy||29
184327|NCT00886600|443700|P3|COMPLETED|Double-blind Monotherapy||29
184328|NCT00886600|443701|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
184329|NCT00886600|443702|P1|COMPLETED|Double-blind Monotherapy||30
184330|NCT00886600|443699|P4|STARTED|Double-blind Monotherapy||31
184331|NCT00886600|443700|P3|STARTED|Double-blind Monotherapy||30
184332|NCT00886600|443701|P2|STARTED|Double-blind Monotherapy||29
184333|NCT00886600|443702|P1|STARTED|Double-blind Monotherapy||32
184334|NCT00886587|443726|P2|NOT COMPLETED|Overall Study||2
184335|NCT00886587|443727|P1|NOT COMPLETED|Overall Study||4
184336|NCT00886587|443726|P2|COMPLETED|Overall Study||39
184337|NCT00886587|443727|P1|COMPLETED|Overall Study||37
184338|NCT00886587|443726|P2|STARTED|Overall Study||41
184339|NCT00886587|443727|P1|STARTED|Overall Study||41
184340|NCT00886483|443741|P2|NOT COMPLETED|Overall Study||3
184341|NCT00886483|443742|P1|NOT COMPLETED|Overall Study||2
184342|NCT00886483|443741|P2|COMPLETED|Overall Study||10
184343|NCT00886483|443742|P1|COMPLETED|Overall Study||24
184344|NCT00886483|443741|P2|Completed 20 Treatments|Overall Study||11
184345|NCT00886483|443742|P1|Completed 20 Treatments|Overall Study||25
184346|NCT00886483|443741|P2|STARTED|Overall Study||13
184347|NCT00886483|443742|P1|STARTED|Overall Study||26
184348|NCT00886340|443760|P2|NOT COMPLETED|Overall Study||7
184349|NCT00886340|443761|P1|NOT COMPLETED|Overall Study||0
184350|NCT00886340|443760|P2|COMPLETED|Overall Study||24
184351|NCT00886340|443761|P1|COMPLETED|Overall Study||27
184352|NCT00886340|443760|P2|STARTED|Overall Study||31
184353|NCT00886340|443761|P1|STARTED|Overall Study||27
184354|NCT00886288|443769|P2|NOT COMPLETED|Overall Study||227
184355|NCT00886288|443770|P1|NOT COMPLETED|Overall Study||743
184356|NCT00886288|443769|P2|COMPLETED|Overall Study||457
184357|NCT00886288|443770|P1|COMPLETED|Overall Study||1284
184358|NCT00886288|443769|P2|STARTED|Overall Study|Baseline Population|684
184359|NCT00886288|443770|P1|STARTED|Overall Study|Baseline Population|2027
184360|NCT00886145|443786|P1|NOT COMPLETED|Overall Study||0
184361|NCT00886145|443786|P1|COMPLETED|Overall Study||1
184362|NCT00886145|443786|P1|STARTED|Overall Study||1
184363|NCT00886119|443792|P2|NOT COMPLETED|Period 2||0
184364|NCT00886119|443793|P1|NOT COMPLETED|Period 2||0
184365|NCT00886119|443792|P2|COMPLETED|Period 2||22
184366|NCT00886119|443793|P1|COMPLETED|Period 2||23
184367|NCT00886119|443792|P2|STARTED|Period 2||22
184368|NCT00886119|443793|P1|STARTED|Period 2||23
184369|NCT00886119|443792|P2|NOT COMPLETED|Period 1||0
184370|NCT00886119|443793|P1|NOT COMPLETED|Period 1||1
184371|NCT00886119|443792|P2|COMPLETED|Period 1||22
184372|NCT00886119|443793|P1|COMPLETED|Period 1||23
184373|NCT00886119|443792|P2|STARTED|Period 1||22
184374|NCT00886119|443793|P1|STARTED|Period 1||24
184375|NCT00886015|443801|P2|NOT COMPLETED|Overall Study||2
184376|NCT00886015|443802|P1|NOT COMPLETED|Overall Study||0
184377|NCT00886015|443801|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
184378|NCT00886015|443802|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
184379|NCT00886015|443801|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
184380|NCT00886015|443802|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
184381|NCT00885846|443821|P3|NOT COMPLETED|Overall Study||2
184382|NCT00885846|443822|P2|NOT COMPLETED|Overall Study||5
184383|NCT00885846|443823|P1|NOT COMPLETED|Overall Study||2
184384|NCT00885846|443821|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
184385|NCT00885846|443822|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
184386|NCT00885846|443823|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
184387|NCT00885846|443821|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
184388|NCT00885846|443822|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
184389|NCT00885846|443823|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
184390|NCT00885768|443831|P1|NOT COMPLETED|Overall Study||0
184391|NCT00885768|443831|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
184392|NCT00885768|443831|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
184393|NCT00885755|443838|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
184394|NCT00885755|443839|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
184395|NCT00885755|443840|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
184396|NCT00885755|443838|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
184397|NCT00885755|443839|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
184398|NCT00885755|443840|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
184399|NCT00885755|443838|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
184400|NCT00885755|443839|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
184401|NCT00885755|443840|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
184402|NCT00885755|443838|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
184403|NCT00885755|443839|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
184404|NCT00885755|443840|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
184405|NCT00885755|443838|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
184406|NCT00885755|443839|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
184407|NCT00885755|443840|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
184408|NCT00885755|443838|P3|STARTED|Part I: Trastuzumab+Taxane||1
184409|NCT00885755|443839|P2|STARTED|Part I: Trastuzumab+Taxane||1
184410|NCT00885755|443840|P1|STARTED|Part I: Trastuzumab+Taxane||31
184411|NCT00885742|443865|P1|NOT COMPLETED|Overall Study||0
184412|NCT00885742|443865|P1|COMPLETED|Overall Study||41
184413|NCT00885742|443865|P1|STARTED|Overall Study||41
184414|NCT00885703|443883|P7|NOT COMPLETED|Overall Study||6
184415|NCT00885703|443884|P6|NOT COMPLETED|Overall Study||13
184416|NCT00885703|443885|P5|NOT COMPLETED|Overall Study||12
184417|NCT00885703|443886|P4|NOT COMPLETED|Overall Study||9
184418|NCT00885703|443887|P3|NOT COMPLETED|Overall Study||11
184419|NCT00885703|443888|P2|NOT COMPLETED|Overall Study||10
184420|NCT00885703|443889|P1|NOT COMPLETED|Overall Study||10
184421|NCT00885703|443883|P7|COMPLETED|Overall Study||18
184422|NCT00885703|443884|P6|COMPLETED|Overall Study||11
184423|NCT00885703|443885|P5|COMPLETED|Overall Study||12
184424|NCT00885703|443886|P4|COMPLETED|Overall Study||15
184425|NCT00885703|443887|P3|COMPLETED|Overall Study||13
184426|NCT00885703|443888|P2|COMPLETED|Overall Study||16
184427|NCT00885703|443889|P1|COMPLETED|Overall Study||12
184428|NCT00885703|443883|P7|STARTED|Overall Study||24
184429|NCT00885703|443884|P6|STARTED|Overall Study||24
184430|NCT00885703|443885|P5|STARTED|Overall Study||24
184431|NCT00885703|443886|P4|STARTED|Overall Study||24
184432|NCT00885703|443887|P3|STARTED|Overall Study||24
184433|NCT00885703|443888|P2|STARTED|Overall Study||26
184434|NCT00885703|443889|P1|STARTED|Overall Study||22
184435|NCT00885677|443947|P2|NOT COMPLETED|Overall Study||178
184436|NCT00885677|443948|P1|NOT COMPLETED|Overall Study||183
184437|NCT00885677|443947|P2|COMPLETED|Overall Study||277
184438|NCT00885677|443948|P1|COMPLETED|Overall Study||279
184439|NCT00885677|443947|P2|Intention To Treat|Overall Study||428
184440|NCT00885677|443948|P1|Intention To Treat|Overall Study||437
184441|NCT00885677|443947|P2|STARTED|Overall Study||455
184442|NCT00885677|443948|P1|STARTED|Overall Study||462
184443|NCT00885638|443956|P2|NOT COMPLETED|Overall Study||0
184444|NCT00885638|443957|P1|NOT COMPLETED|Overall Study||0
184445|NCT00885638|443956|P2|COMPLETED|Overall Study||6
184446|NCT00885638|443957|P1|COMPLETED|Overall Study||6
184447|NCT00885638|443956|P2|STARTED|Overall Study||6
184448|NCT00885638|443957|P1|STARTED|Overall Study||6
184449|NCT00885534|443964|P1|NOT COMPLETED|Overall Study||1
184450|NCT00885534|443964|P1|COMPLETED|Overall Study||6
184451|NCT00885534|443964|P1|STARTED|Overall Study||7
184452|NCT00885482|443968|P1|NOT COMPLETED|Overall Study||4
184453|NCT00885482|443968|P1|COMPLETED|Overall Study||36
184454|NCT00885482|443968|P1|STARTED|Overall Study||40
184455|NCT00885378|443974|P2|NOT COMPLETED|Overall Study||8
184456|NCT00885378|443975|P1|NOT COMPLETED|Overall Study||8
184457|NCT00885378|443974|P2|COMPLETED|Overall Study||78
184458|NCT00885378|443975|P1|COMPLETED|Overall Study||66
184459|NCT00885378|443974|P2|STARTED|Overall Study|Number randomized.|86
184460|NCT00885378|443975|P1|STARTED|Overall Study|Number randomized.|74
184461|NCT00885365|444005|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
184462|NCT00885365|444006|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
184463|NCT00885365|444005|P2|COMPLETED|4 Weeks OFF Treatment||159
184464|NCT00885365|444006|P1|COMPLETED|4 Weeks OFF Treatment||155
184465|NCT00885365|444005|P2|STARTED|4 Weeks OFF Treatment||159
184466|NCT00885365|444006|P1|STARTED|4 Weeks OFF Treatment||155
184467|NCT00885365|444005|P2|NOT COMPLETED|4 Weeks ON Treatment||6
184468|NCT00885365|444006|P1|NOT COMPLETED|4 Weeks ON Treatment||4
184469|NCT00885365|444005|P2|COMPLETED|4 Weeks ON Treatment||159
184470|NCT00885365|444006|P1|COMPLETED|4 Weeks ON Treatment||155
184471|NCT00885365|444005|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
184472|NCT00885365|444006|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
184473|NCT00885365|444005|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
184474|NCT00885365|444006|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
184475|NCT00885365|444005|P2|STARTED|4 Weeks ON Treatment||165
184476|NCT00885365|444006|P1|STARTED|4 Weeks ON Treatment||159
184477|NCT00885352|444042|P2|NOT COMPLETED|Overall Study||20
184478|NCT00885352|444043|P1|NOT COMPLETED|Overall Study||8
184479|NCT00885352|444042|P2|COMPLETED|Overall Study||136
184480|NCT00885352|444043|P1|COMPLETED|Overall Study||149
184481|NCT00885352|444042|P2|STARTED|Overall Study||156
184482|NCT00885352|444043|P1|STARTED|Overall Study||157
184483|NCT00885170|444055|P2|NOT COMPLETED|Overall Study||23
184484|NCT00885170|444056|P1|NOT COMPLETED|Overall Study||38
184485|NCT00885170|444055|P2|COMPLETED|Overall Study||99
184486|NCT00885170|444056|P1|COMPLETED|Overall Study||86
184487|NCT00885170|444055|P2|Treated|Overall Study||121
184488|NCT00885170|444056|P1|Treated|Overall Study||122
184489|NCT00885170|444055|P2|STARTED|Overall Study||122
184490|NCT00885170|444056|P1|STARTED|Overall Study||124
184491|NCT00885118|444115|P5|NOT COMPLETED|Overall Study||1
184492|NCT00885118|444116|P4|NOT COMPLETED|Overall Study||0
184493|NCT00885118|444117|P3|NOT COMPLETED|Overall Study||1
184494|NCT00885118|444118|P2|NOT COMPLETED|Overall Study||0
184495|NCT00885118|444119|P1|NOT COMPLETED|Overall Study||1
184496|NCT00885118|444115|P5|COMPLETED|Overall Study||18
184497|NCT00885118|444116|P4|COMPLETED|Overall Study||20
184498|NCT00885118|444117|P3|COMPLETED|Overall Study||20
184499|NCT00885118|444118|P2|COMPLETED|Overall Study||19
184500|NCT00885118|444119|P1|COMPLETED|Overall Study||20
184501|NCT00885118|444115|P5|STARTED|Overall Study||19
184502|NCT00885118|444116|P4|STARTED|Overall Study||20
184503|NCT00885118|444117|P3|STARTED|Overall Study||21
184504|NCT00885118|444118|P2|STARTED|Overall Study||19
184505|NCT00885118|444119|P1|STARTED|Overall Study||21
184506|NCT00885105|444258|P2|NOT COMPLETED|Overall Study||10
184507|NCT00885105|444259|P1|NOT COMPLETED|Overall Study||1
184508|NCT00885105|444258|P2|COMPLETED|Overall Study||120
184509|NCT00885105|444259|P1|COMPLETED|Overall Study||111
184510|NCT00885105|444258|P2|STARTED|Overall Study||130
184511|NCT00885105|444259|P1|STARTED|Overall Study||112
184512|NCT00885092|444277|P2|NOT COMPLETED|Period 2, 7 Days||0
184513|NCT00885092|444278|P1|NOT COMPLETED|Period 2, 7 Days||0
184514|NCT00885092|444277|P2|COMPLETED|Period 2, 7 Days||20
184515|NCT00885092|444278|P1|COMPLETED|Period 2, 7 Days||20
184516|NCT00885092|444277|P2|STARTED|Period 2, 7 Days||20
184517|NCT00885092|444278|P1|STARTED|Period 2, 7 Days||20
184518|NCT00885092|444277|P2|NOT COMPLETED|Period 1, 7 Days||0
184519|NCT00885092|444278|P1|NOT COMPLETED|Period 1, 7 Days||0
184520|NCT00885092|444277|P2|COMPLETED|Period 1, 7 Days||20
184521|NCT00885092|444278|P1|COMPLETED|Period 1, 7 Days||20
184522|NCT00885092|444277|P2|STARTED|Period 1, 7 Days||20
184523|NCT00885092|444278|P1|STARTED|Period 1, 7 Days||20
184524|NCT00885079|444290|P2|NOT COMPLETED|Overall Study||4
184525|NCT00885079|444291|P1|NOT COMPLETED|Overall Study||2
184526|NCT00885079|444290|P2|COMPLETED|Overall Study||91
184527|NCT00885079|444291|P1|COMPLETED|Overall Study||91
184528|NCT00885079|444290|P2|STARTED|Overall Study||95
184529|NCT00885079|444291|P1|STARTED|Overall Study||93
184530|NCT00884949|444299|P1|NOT COMPLETED|Continuation Period||0
184531|NCT00884949|444299|P1|COMPLETED|Continuation Period||18
184532|NCT00884949|444299|P1|STARTED|Continuation Period||18
184533|NCT00884949|444299|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
184534|NCT00884949|444299|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
184535|NCT00884949|444299|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
184536|NCT00884949|444299|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
184537|NCT00884949|444299|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
184538|NCT00884949|444299|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
184539|NCT00884949|444299|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
184540|NCT00884949|444299|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
184541|NCT00884949|444299|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
184542|NCT00884910|444316|P1|NOT COMPLETED|Overall Study||1
184543|NCT00884910|444316|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
184544|NCT00884910|444316|P1|STARTED|Overall Study||33
184545|NCT00884897|444323|P2|NOT COMPLETED|Overall Study||0
184546|NCT00884897|444324|P1|NOT COMPLETED|Overall Study||0
184547|NCT00884897|444323|P2|COMPLETED|Overall Study||15
184548|NCT00884897|444324|P1|COMPLETED|Overall Study||13
184549|NCT00884897|444323|P2|STARTED|Overall Study||15
184550|NCT00884897|444324|P1|STARTED|Overall Study||13
184551|NCT00884832|444334|P2|NOT COMPLETED|Overall Study||1
184552|NCT00884832|444335|P1|NOT COMPLETED|Overall Study||0
184553|NCT00884832|444334|P2|COMPLETED|Overall Study||21
184554|NCT00884832|444335|P1|COMPLETED|Overall Study||22
184555|NCT00884832|444334|P2|STARTED|Overall Study||22
184556|NCT00884832|444335|P1|STARTED|Overall Study||22
184557|NCT00884806|444365|P1|NOT COMPLETED|Overall Study||0
184558|NCT00884806|444365|P1|COMPLETED|Overall Study||110
184559|NCT00884806|444365|P1|STARTED|Overall Study||110
184560|NCT00884793|444370|P1|NOT COMPLETED|Overall Study||1
184561|NCT00884793|444370|P1|COMPLETED|Overall Study||7
184562|NCT00884793|444370|P1|STARTED|Overall Study||8
184563|NCT00884754|444379|P2|NOT COMPLETED|Overall Study||0
184564|NCT00884754|444380|P1|NOT COMPLETED|Overall Study||0
184565|NCT00884754|444379|P2|COMPLETED|Overall Study||30
184566|NCT00884754|444380|P1|COMPLETED|Overall Study||30
184567|NCT00884754|444379|P2|STARTED|Overall Study||30
184568|NCT00884754|444380|P1|STARTED|Overall Study||30
184569|NCT00884741|444389|P4|NOT COMPLETED|Randomization||8
184570|NCT00884741|444390|P3|NOT COMPLETED|Randomization||8
184571|NCT00884741|444391|P2|NOT COMPLETED|Randomization||0
184572|NCT00884741|444392|P1|NOT COMPLETED|Randomization||0
184573|NCT00884741|444389|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
184574|NCT00884741|444390|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
184575|NCT00884741|444391|P2|COMPLETED|Randomization||0
184576|NCT00884741|444392|P1|COMPLETED|Randomization||0
184577|NCT00884741|444389|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
184578|NCT00884741|444390|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
184579|NCT00884741|444391|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
184580|NCT00884741|444392|P1|STARTED|Randomization||0
184581|NCT00884741|444389|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
184582|NCT00884741|444390|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
184583|NCT00884741|444391|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
184584|NCT00884741|444392|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
184585|NCT00884741|444389|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
184586|NCT00884741|444390|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
184587|NCT00884741|444391|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
184588|NCT00884741|444392|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
184589|NCT00884741|444389|P4|STARTED|Step 2 Registration: Tissue Analysis||0
184590|NCT00884741|444390|P3|STARTED|Step 2 Registration: Tissue Analysis||0
184591|NCT00884741|444391|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
184592|NCT00884741|444392|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
184593|NCT00884741|444389|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
184594|NCT00884741|444390|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
184595|NCT00884741|444391|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
184596|NCT00884741|444392|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
184597|NCT00884741|444389|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
184598|NCT00884741|444390|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
184599|NCT00884741|444391|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
184600|NCT00884741|444392|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
184601|NCT00884741|444389|P4|STARTED|Step 1 Registration: Tissue Screening||0
184602|NCT00884741|444390|P3|STARTED|Step 1 Registration: Tissue Screening||0
184603|NCT00884741|444391|P2|STARTED|Step 1 Registration: Tissue Screening||0
184604|NCT00884741|444392|P1|STARTED|Step 1 Registration: Tissue Screening||978
184605|NCT00884611|444403|P1|NOT COMPLETED|Overall Study||1
184606|NCT00884611|444403|P1|COMPLETED|Overall Study||19
184607|NCT00884611|444403|P1|Enrolled, Not Treated|Overall Study||1
184608|NCT00884611|444403|P1|STARTED|Overall Study||20
184609|NCT00884585|444427|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
184610|NCT00884585|444428|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
184611|NCT00884585|444427|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
184612|NCT00884585|444428|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
184613|NCT00884585|444427|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
184614|NCT00884585|444428|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
184615|NCT00884585|444427|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
184616|NCT00884585|444428|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
184617|NCT00884585|444427|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
184618|NCT00884585|444428|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
184619|NCT00884585|444427|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
184620|NCT00884585|444428|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
184621|NCT00884585|444427|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
184622|NCT00884585|444428|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
184623|NCT00884585|444427|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
184624|NCT00884585|444428|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
184625|NCT00884585|444427|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
184626|NCT00884585|444428|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
184627|NCT00884390|444442|P2|NOT COMPLETED|Overall Study||8
184628|NCT00884390|444443|P1|NOT COMPLETED|Overall Study||23
184629|NCT00884390|444442|P2|COMPLETED|Overall Study||54
184630|NCT00884390|444443|P1|COMPLETED|Overall Study||123
184631|NCT00884390|444442|P2|STARTED|Overall Study||62
184632|NCT00884390|444443|P1|STARTED|Overall Study||146
184633|NCT00884377|444461|P2|NOT COMPLETED|Overall Study||1
184634|NCT00884377|444462|P1|NOT COMPLETED|Overall Study||2
184635|NCT00884377|444461|P2|COMPLETED|Overall Study||27
184636|NCT00884377|444462|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
184637|NCT00884377|444461|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
184638|NCT00884377|444462|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
184639|NCT00884325|444484|P2|NOT COMPLETED|Overall Study||4
184640|NCT00884325|444485|P1|NOT COMPLETED|Overall Study||3
184641|NCT00884325|444484|P2|COMPLETED|Overall Study||16
184642|NCT00884325|444485|P1|COMPLETED|Overall Study||17
184643|NCT00884325|444484|P2|STARTED|Overall Study||20
184644|NCT00884325|444485|P1|STARTED|Overall Study||20
184645|NCT00884312|444495|P2|NOT COMPLETED|Overall Study||25
184646|NCT00884312|444496|P1|NOT COMPLETED|Overall Study||2
184647|NCT00884312|444495|P2|COMPLETED|Overall Study||67
184648|NCT00884312|444496|P1|COMPLETED|Overall Study||7
184649|NCT00884312|444495|P2|Received Treatment|Overall Study||91
184650|NCT00884312|444496|P1|Received Treatment|Overall Study||9
184651|NCT00884312|444495|P2|STARTED|Overall Study||92
184652|NCT00884312|444496|P1|STARTED|Overall Study||9
184653|NCT00884286|444512|P2|NOT COMPLETED|Overall Study||33
184654|NCT00884286|444513|P1|NOT COMPLETED|Overall Study||32
184655|NCT00884286|444512|P2|COMPLETED|Overall Study||0
184656|NCT00884286|444513|P1|COMPLETED|Overall Study||2
184657|NCT00884286|444512|P2|STARTED|Overall Study||33
184658|NCT00884286|444513|P1|STARTED|Overall Study||34
184659|NCT00884273|444527|P2|NOT COMPLETED|Overall Study||5
184660|NCT00884273|444528|P1|NOT COMPLETED|Overall Study||2
184661|NCT00884273|444527|P2|COMPLETED|Overall Study||93
184662|NCT00884273|444528|P1|COMPLETED|Overall Study||82
184663|NCT00884273|444527|P2|Safety Analysis Set|Overall Study||98
184664|NCT00884273|444528|P1|Safety Analysis Set|Overall Study||84
184665|NCT00884273|444527|P2|Per Protocol (PP) Analysis Set|Overall Study||92
184666|NCT00884273|444528|P1|Per Protocol (PP) Analysis Set|Overall Study||81
184667|NCT00884273|444527|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
184668|NCT00884273|444528|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
184669|NCT00884273|444527|P2|STARTED|Overall Study|ITT population.|98
184670|NCT00884273|444528|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
184671|NCT00884221|444554|P2|NOT COMPLETED|Overall Study||32
184672|NCT00884221|444555|P1|NOT COMPLETED|Overall Study||34
184673|NCT00884221|444554|P2|COMPLETED|Overall Study||343
184674|NCT00884221|444555|P1|COMPLETED|Overall Study||340
184675|NCT00884221|444554|P2|STARTED|Overall Study||375
184676|NCT00884221|444555|P1|STARTED|Overall Study||374
184677|NCT00884117|444591|P1|NOT COMPLETED|Overall Study||249
184678|NCT00884117|444591|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
184679|NCT00884117|444591|P1|STARTED|Overall Study||4561
184680|NCT00884065|444635|P2|NOT COMPLETED|Overall Study||0
184681|NCT00884065|444636|P1|NOT COMPLETED|Overall Study||0
184682|NCT00884065|444635|P2|COMPLETED|Overall Study||25
184683|NCT00884065|444636|P1|COMPLETED|Overall Study||25
184684|NCT00884065|444635|P2|STARTED|Overall Study||25
184685|NCT00884065|444636|P1|STARTED|Overall Study||25
184686|NCT00884039|444654|P2|NOT COMPLETED|Overall Study||1
184687|NCT00884039|444655|P1|NOT COMPLETED|Overall Study||2
184688|NCT00884039|444654|P2|COMPLETED|Overall Study||1
184689|NCT00884039|444655|P1|COMPLETED|Overall Study||3
184690|NCT00884039|444654|P2|STARTED|Overall Study||2
184691|NCT00884039|444655|P1|STARTED|Overall Study||5
184692|NCT00883779|444663|P2|NOT COMPLETED|Off-study Phase||202
184693|NCT00883779|444664|P1|NOT COMPLETED|Off-study Phase||209
184694|NCT00883779|444663|P2|COMPLETED|Off-study Phase||0
184695|NCT00883779|444664|P1|COMPLETED|Off-study Phase||0
184696|NCT00883779|444663|P2|STARTED|Off-study Phase||202
184697|NCT00883779|444664|P1|STARTED|Off-study Phase||209
184698|NCT00883779|444663|P2|NOT COMPLETED|Post-Study Treatment Phase||135
184699|NCT00883779|444664|P1|NOT COMPLETED|Post-Study Treatment Phase||112
184700|NCT00883779|444663|P2|COMPLETED|Post-Study Treatment Phase||0
184701|NCT00883779|444664|P1|COMPLETED|Post-Study Treatment Phase||0
184702|NCT00883779|444663|P2|STARTED|Post-Study Treatment Phase||135
184703|NCT00883779|444664|P1|STARTED|Post-Study Treatment Phase||112
184704|NCT00883779|444663|P2|NOT COMPLETED|Primary Study Treatment Phase||86
184705|NCT00883779|444664|P1|NOT COMPLETED|Primary Study Treatment Phase||105
184706|NCT00883779|444663|P2|COMPLETED|Primary Study Treatment Phase||140
184707|NCT00883779|444664|P1|COMPLETED|Primary Study Treatment Phase||120
184708|NCT00883779|444663|P2|STARTED|Primary Study Treatment Phase||226
184709|NCT00883779|444664|P1|STARTED|Primary Study Treatment Phase||225
184710|NCT00883753|444700|P1|NOT COMPLETED|Overall Study||107
184711|NCT00883753|444700|P1|COMPLETED|Overall Study||827
184712|NCT00883753|444700|P1|STARTED|Overall Study||934
184713|NCT00883740|444740|P2|NOT COMPLETED|Second Intervention||1
184714|NCT00883740|444741|P1|NOT COMPLETED|Second Intervention||1
184715|NCT00883740|444740|P2|COMPLETED|Second Intervention||50
184716|NCT00883740|444741|P1|COMPLETED|Second Intervention||52
184717|NCT00883740|444740|P2|STARTED|Second Intervention||51
184718|NCT00883740|444741|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
184719|NCT00883740|444740|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
184720|NCT00883740|444741|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
184721|NCT00883740|444740|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
184722|NCT00883740|444741|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
184723|NCT00883740|444740|P2|STARTED|Taper and Washout Period (2 Weeks)||51
184724|NCT00883740|444741|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
184725|NCT00883740|444740|P2|NOT COMPLETED|First Intervention||8
184726|NCT00883740|444741|P1|NOT COMPLETED|First Intervention||7
184727|NCT00883740|444740|P2|COMPLETED|First Intervention||51
184728|NCT00883740|444741|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
184729|NCT00883740|444740|P2|STARTED|First Intervention||59
184730|NCT00883740|444741|P1|STARTED|First Intervention||60
184731|NCT00883675|444781|P1|NOT COMPLETED|Overall Study||0
184732|NCT00883675|444781|P1|COMPLETED|Overall Study||133
184733|NCT00883675|444781|P1|STARTED|Overall Study||133
184734|NCT00883558|444785|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
184735|NCT00883558|444786|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
184736|NCT00883558|444787|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
184737|NCT00883558|444785|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
184738|NCT00883558|444786|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
184739|NCT00883558|444787|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
184740|NCT00883558|444785|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
184741|NCT00883558|444786|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
184742|NCT00883558|444787|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
184743|NCT00883558|444785|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
184744|NCT00883558|444786|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
184745|NCT00883558|444787|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
184746|NCT00883558|444785|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
184747|NCT00883558|444786|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
184748|NCT00883558|444787|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
184749|NCT00883558|444785|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
184750|NCT00883558|444786|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
184751|NCT00883558|444787|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
184752|NCT00883558|444785|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
184753|NCT00883558|444786|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
184754|NCT00883558|444787|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
184755|NCT00883558|444785|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
184756|NCT00883558|444786|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
184757|NCT00883558|444787|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
184758|NCT00883558|444785|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
184759|NCT00883558|444786|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
184760|NCT00883558|444787|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
184761|NCT00883558|444785|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
184762|NCT00883558|444786|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
184763|NCT00883558|444787|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
184764|NCT00883558|444785|P3|STARTED|Titration Period (Weeks 0 to 4)||0
184765|NCT00883558|444786|P2|STARTED|Titration Period (Weeks 0 to 4)||0
184766|NCT00883558|444787|P1|STARTED|Titration Period (Weeks 0 to 4)||48
184767|NCT00883493|444799|P2|NOT COMPLETED|Overall Study||50
184768|NCT00883493|444800|P1|NOT COMPLETED|Overall Study||46
184769|NCT00883493|444799|P2|COMPLETED|Overall Study||159
184770|NCT00883493|444800|P1|COMPLETED|Overall Study||166
184771|NCT00883493|444799|P2|Per Protocol Analysis Population|Overall Study||155
184772|NCT00883493|444800|P1|Per Protocol Analysis Population|Overall Study||162
184773|NCT00883493|444799|P2|Intention To Treat Analysis Population|Overall Study||195
184774|NCT00883493|444800|P1|Intention To Treat Analysis Population|Overall Study||204
184775|NCT00883493|444799|P2|STARTED|Overall Study||209
184776|NCT00883493|444800|P1|STARTED|Overall Study||212
184777|NCT00883389|444824|P1|NOT COMPLETED|Overall Study||0
184778|NCT00883389|444824|P1|COMPLETED|Overall Study||26
184779|NCT00883389|444824|P1|STARTED|Overall Study||26
184780|NCT00883337|444831|P3|NOT COMPLETED|Extension Treatment Period||19
184781|NCT00883337|444832|P2|NOT COMPLETED|Extension Treatment Period||23
184782|NCT00883337|444833|P1|NOT COMPLETED|Extension Treatment Period||28
184783|NCT00883337|444831|P3|COMPLETED|Extension Treatment Period||40
184784|NCT00883337|444832|P2|COMPLETED|Extension Treatment Period||66
184785|NCT00883337|444833|P1|COMPLETED|Extension Treatment Period||61
184786|NCT00883337|444831|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
184787|NCT00883337|444832|P2|STARTED|Extension Treatment Period||89
184788|NCT00883337|444833|P1|STARTED|Extension Treatment Period||89
184789|NCT00883337|444831|P3|NOT COMPLETED|Core Treatment Period||33
184790|NCT00883337|444832|P2|NOT COMPLETED|Core Treatment Period||22
184791|NCT00883337|444833|P1|NOT COMPLETED|Core Treatment Period||20
184792|NCT00883337|444831|P3|COMPLETED|Core Treatment Period||71
184793|NCT00883337|444832|P2|COMPLETED|Core Treatment Period||89
184794|NCT00883337|444833|P1|COMPLETED|Core Treatment Period||89
184795|NCT00883337|444831|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
184796|NCT00883337|444832|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
184797|NCT00883337|444833|P1|Treated|Core Treatment Period||109
184798|NCT00883337|444831|P3|STARTED|Core Treatment Period||104
184799|NCT00883337|444832|P2|STARTED|Core Treatment Period||111
184800|NCT00883337|444833|P1|STARTED|Core Treatment Period||109
184801|NCT00883246|444865|P1|NOT COMPLETED|Overall Study||173
184802|NCT00883246|444865|P1|COMPLETED|Overall Study||626
184803|NCT00883246|444865|P1|STARTED|Overall Study||799
184804|NCT00883233|444887|P4|NOT COMPLETED|Overall Study||5
184805|NCT00883233|444888|P3|NOT COMPLETED|Overall Study||4
184806|NCT00883233|444889|P2|NOT COMPLETED|Overall Study||4
184807|NCT00883233|444890|P1|NOT COMPLETED|Overall Study||5
184808|NCT00883233|444887|P4|COMPLETED|Overall Study||25
184809|NCT00883233|444888|P3|COMPLETED|Overall Study||25
184810|NCT00883233|444889|P2|COMPLETED|Overall Study||28
184811|NCT00883233|444890|P1|COMPLETED|Overall Study||27
184812|NCT00883233|444887|P4|STARTED|Overall Study||30
184813|NCT00883233|444888|P3|STARTED|Overall Study||29
184814|NCT00883233|444889|P2|STARTED|Overall Study||32
184815|NCT00883233|444890|P1|STARTED|Overall Study||32
184816|NCT00883181|444900|P1|NOT COMPLETED|Overall Study||278
184817|NCT00883181|444900|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
184818|NCT00883181|444900|P1|STARTED|Overall Study|Full analysis set|1347
184819|NCT00883168|445113|P4|NOT COMPLETED|Overall Study||15
184820|NCT00883168|445114|P3|NOT COMPLETED|Overall Study||19
184821|NCT00883168|445115|P2|NOT COMPLETED|Overall Study||15
184822|NCT00883168|445116|P1|NOT COMPLETED|Overall Study||14
184823|NCT00883168|445113|P4|COMPLETED|Overall Study||433
184824|NCT00883168|445114|P3|COMPLETED|Overall Study||431
184825|NCT00883168|445115|P2|COMPLETED|Overall Study||430
184826|NCT00883168|445116|P1|COMPLETED|Overall Study||434
184827|NCT00883168|445113|P4|STARTED|Overall Study||448
184828|NCT00883168|445114|P3|STARTED|Overall Study||450
184829|NCT00883168|445115|P2|STARTED|Overall Study||445
184830|NCT00883168|445116|P1|STARTED|Overall Study||448
184831|NCT00883129|445136|P2|NOT COMPLETED|Overall Study||36
184832|NCT00883129|445137|P1|NOT COMPLETED|Overall Study||20
184833|NCT00883129|445136|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
184834|NCT00883129|445137|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
184835|NCT00883129|445136|P2|STARTED|Overall Study||73
184836|NCT00883129|445137|P1|STARTED|Overall Study||69
184837|NCT00883116|445161|P2|NOT COMPLETED|Overall Study||219
184838|NCT00883116|445162|P1|NOT COMPLETED|Overall Study||209
184839|NCT00883116|445161|P2|COMPLETED|Overall Study||29
184840|NCT00883116|445162|P1|COMPLETED|Overall Study||39
184841|NCT00883116|445161|P2|Received Treatment|Overall Study||239
184842|NCT00883116|445162|P1|Received Treatment|Overall Study||248
184843|NCT00883116|445161|P2|STARTED|Overall Study||248
184844|NCT00883116|445162|P1|STARTED|Overall Study||248
184845|NCT00883103|445177|P2|NOT COMPLETED|Overall Study||0
184846|NCT00883103|445178|P1|NOT COMPLETED|Overall Study||0
184847|NCT00883103|445177|P2|COMPLETED|Overall Study||68
184848|NCT00883103|445178|P1|COMPLETED|Overall Study||69
184849|NCT00883103|445177|P2|STARTED|Overall Study||68
184850|NCT00883103|445178|P1|STARTED|Overall Study||69
184851|NCT00883090|445184|P1|NOT COMPLETED|Overall Study||2
184852|NCT00883090|445184|P1|COMPLETED|Overall Study||13
184853|NCT00883090|445184|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
184854|NCT00882921|445199|P1|NOT COMPLETED|Overall Study||11
184855|NCT00882921|445199|P1|COMPLETED|Overall Study||15
184856|NCT00882921|445199|P1|STARTED|Overall Study||26
184857|NCT00882908|445209|P5|NOT COMPLETED|Overall Study||6
184858|NCT00882908|445210|P4|NOT COMPLETED|Overall Study||7
184859|NCT00882908|445211|P3|NOT COMPLETED|Overall Study||7
184860|NCT00882908|445212|P2|NOT COMPLETED|Overall Study||6
184861|NCT00882908|445213|P1|NOT COMPLETED|Overall Study||3
184862|NCT00882908|445209|P5|COMPLETED|Overall Study||71
184863|NCT00882908|445210|P4|COMPLETED|Overall Study||72
184864|NCT00882908|445211|P3|COMPLETED|Overall Study||70
184865|NCT00882908|445212|P2|COMPLETED|Overall Study||69
184866|NCT00882908|445213|P1|COMPLETED|Overall Study||75
184867|NCT00882908|445209|P5|STARTED|Overall Study||77
184868|NCT00882908|445210|P4|STARTED|Overall Study||79
184869|NCT00882908|445211|P3|STARTED|Overall Study||77
184870|NCT00882908|445212|P2|STARTED|Overall Study||75
184871|NCT00882908|445213|P1|STARTED|Overall Study||78
184872|NCT00882778|445288|P1|NOT COMPLETED|Overall Study||0
184873|NCT00882778|445288|P1|COMPLETED|Overall Study||86
184874|NCT00882778|445288|P1|STARTED|Overall Study||86
184875|NCT00882713|445319|P1|NOT COMPLETED|Overall Study||22
184876|NCT00882713|445319|P1|COMPLETED|Overall Study||172
184877|NCT00882713|445319|P1|STARTED|Overall Study||194
184878|NCT00882687|445345|P4|NOT COMPLETED|Overall Study||2
184879|NCT00882687|445346|P3|NOT COMPLETED|Overall Study||3
184880|NCT00882687|445347|P2|NOT COMPLETED|Overall Study||2
184881|NCT00882687|445348|P1|NOT COMPLETED|Overall Study||2
184882|NCT00882687|445345|P4|COMPLETED|Overall Study||13
184883|NCT00882687|445346|P3|COMPLETED|Overall Study||12
184884|NCT00882687|445347|P2|COMPLETED|Overall Study||13
184885|NCT00882687|445348|P1|COMPLETED|Overall Study||13
184886|NCT00882687|445345|P4|STARTED|Overall Study||15
184887|NCT00882687|445346|P3|STARTED|Overall Study||15
184888|NCT00882687|445347|P2|STARTED|Overall Study||15
184889|NCT00882687|445348|P1|STARTED|Overall Study||15
184890|NCT00882661|445381|P2|NOT COMPLETED|Treatment||26
184891|NCT00882661|445382|P1|NOT COMPLETED|Treatment||10
184892|NCT00882661|445381|P2|COMPLETED|Treatment||114
184893|NCT00882661|445382|P1|COMPLETED|Treatment||141
184894|NCT00882661|445381|P2|STARTED|Treatment||140
184895|NCT00882661|445382|P1|STARTED|Treatment||151
184896|NCT00882661|445381|P2|NOT COMPLETED|Investigational Training||0
184897|NCT00882661|445382|P1|NOT COMPLETED|Investigational Training||10
184898|NCT00882661|445381|P2|COMPLETED|Investigational Training||0
184899|NCT00882661|445382|P1|COMPLETED|Investigational Training||79
184900|NCT00882661|445381|P2|STARTED|Investigational Training||0
184901|NCT00882661|445382|P1|STARTED|Investigational Training||89
184902|NCT00882583|445412|P2|NOT COMPLETED|Overall Study||1
184903|NCT00882583|445413|P1|NOT COMPLETED|Overall Study||1
184904|NCT00882583|445412|P2|COMPLETED|Overall Study||11
184905|NCT00882583|445413|P1|COMPLETED|Overall Study||6
184906|NCT00882583|445412|P2|STARTED|Overall Study||12
184907|NCT00882583|445413|P1|STARTED|Overall Study||7
184908|NCT00882557|445421|P2|NOT COMPLETED|Overall Study||1
184909|NCT00882557|445422|P1|NOT COMPLETED|Overall Study||2
184910|NCT00882557|445421|P2|COMPLETED|Overall Study||7
184911|NCT00882557|445422|P1|COMPLETED|Overall Study||6
184912|NCT00882557|445421|P2|Completed Dose 2|Overall Study||7
184913|NCT00882557|445422|P1|Completed Dose 2|Overall Study||6
184914|NCT00882557|445421|P2|Completed Dose 1|Overall Study||7
184915|NCT00882557|445422|P1|Completed Dose 1|Overall Study||8
184916|NCT00882557|445421|P2|STARTED|Overall Study||8
184917|NCT00882557|445422|P1|STARTED|Overall Study||8
184918|NCT00882518|445442|P2|NOT COMPLETED|Overall Study||44
184919|NCT00882518|445443|P1|NOT COMPLETED|Overall Study||38
184920|NCT00882518|445442|P2|COMPLETED|Overall Study||148
184921|NCT00882518|445443|P1|COMPLETED|Overall Study||158
184922|NCT00882518|445442|P2|STARTED|Overall Study||192
184923|NCT00882518|445443|P1|STARTED|Overall Study||196
184924|NCT00882440|445472|P7|NOT COMPLETED|Overall Study||4
184925|NCT00882440|445473|P6|NOT COMPLETED|Overall Study||7
184926|NCT00882440|445474|P5|NOT COMPLETED|Overall Study||10
184927|NCT00882440|445475|P4|NOT COMPLETED|Overall Study||3
184928|NCT00882440|445476|P3|NOT COMPLETED|Overall Study||7
184929|NCT00882440|445477|P2|NOT COMPLETED|Overall Study||8
184930|NCT00882440|445478|P1|NOT COMPLETED|Overall Study||11
184931|NCT00882440|445472|P7|COMPLETED|Overall Study||79
184932|NCT00882440|445473|P6|COMPLETED|Overall Study||77
184933|NCT00882440|445474|P5|COMPLETED|Overall Study||80
184934|NCT00882440|445475|P4|COMPLETED|Overall Study||76
184935|NCT00882440|445476|P3|COMPLETED|Overall Study||75
184936|NCT00882440|445477|P2|COMPLETED|Overall Study||72
184937|NCT00882440|445478|P1|COMPLETED|Overall Study||67
184938|NCT00882440|445472|P7|STARTED|Overall Study||83
184939|NCT00882440|445473|P6|STARTED|Overall Study||84
184940|NCT00882440|445474|P5|STARTED|Overall Study||90
184941|NCT00882440|445475|P4|STARTED|Overall Study||79
184942|NCT00882440|445476|P3|STARTED|Overall Study||82
184943|NCT00882440|445477|P2|STARTED|Overall Study||80
184944|NCT00882440|445478|P1|STARTED|Overall Study||78
184945|NCT00882362|445503|P2|NOT COMPLETED|Overall Study||23
184946|NCT00882362|445504|P1|NOT COMPLETED|Overall Study||49
184947|NCT00882362|445503|P2|COMPLETED|Overall Study||10
184948|NCT00882362|445504|P1|COMPLETED|Overall Study||73
184949|NCT00882362|445503|P2|STARTED|Overall Study||33
184950|NCT00882362|445504|P1|STARTED|Overall Study||122
184951|NCT00882310|445510|P1|NOT COMPLETED|Overall Study||22
184952|NCT00882310|445510|P1|COMPLETED|Overall Study||15
184953|NCT00882310|445510|P1|STARTED|Overall Study||37
184954|NCT00882206|445516|P1|NOT COMPLETED|Overall Study||0
184955|NCT00882206|445516|P1|COMPLETED|Overall Study||13
184956|NCT00882206|445516|P1|STARTED|Overall Study||13
184957|NCT00882102|445523|P1|NOT COMPLETED|Overall Study||0
184958|NCT00882102|445523|P1|COMPLETED|Overall Study||40
184959|NCT00882102|445523|P1|STARTED|Overall Study||40
184960|NCT00881959|445529|P2|NOT COMPLETED|Overall Study||4
184961|NCT00881959|445530|P1|NOT COMPLETED|Overall Study||2
184962|NCT00881959|445529|P2|COMPLETED|Overall Study||38
184963|NCT00881959|445530|P1|COMPLETED|Overall Study||36
184964|NCT00881959|445529|P2|STARTED|Overall Study||42
184965|NCT00881959|445530|P1|STARTED|Overall Study||38
184966|NCT00881894|445538|P2|NOT COMPLETED|Overall Study||3
184967|NCT00881894|445539|P1|NOT COMPLETED|Overall Study||1
184968|NCT00881894|445538|P2|COMPLETED|Overall Study||23
184969|NCT00881894|445539|P1|COMPLETED|Overall Study||25
184970|NCT00881894|445538|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
184971|NCT00881894|445539|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
184972|NCT00881894|445538|P2|STARTED|Overall Study||26
184973|NCT00881894|445539|P1|STARTED|Overall Study||26
184974|NCT00881868|445571|P2|NOT COMPLETED|Overall Study||2
184975|NCT00881868|445572|P1|NOT COMPLETED|Overall Study||8
184976|NCT00881868|445571|P2|COMPLETED|Overall Study||38
184977|NCT00881868|445572|P1|COMPLETED|Overall Study||33
184978|NCT00881868|445571|P2|STARTED|Overall Study||40
184979|NCT00881868|445572|P1|STARTED|Overall Study||41
184980|NCT00881751|445586|P2|NOT COMPLETED|Overall Study||5
184981|NCT00881751|445587|P1|NOT COMPLETED|Overall Study||0
184982|NCT00881751|445586|P2|COMPLETED|Overall Study||43
184983|NCT00881751|445587|P1|COMPLETED|Overall Study||47
184984|NCT00881751|445586|P2|STARTED|Overall Study||48
184985|NCT00881751|445587|P1|STARTED|Overall Study||47
184986|NCT00881712|445602|P3|NOT COMPLETED|Overall Study||0
184987|NCT00881712|445603|P2|NOT COMPLETED|Overall Study||0
184988|NCT00881712|445604|P1|NOT COMPLETED|Overall Study||2
184989|NCT00881712|445602|P3|COMPLETED|Overall Study||0
184990|NCT00881712|445603|P2|COMPLETED|Overall Study||0
184991|NCT00881712|445604|P1|COMPLETED|Overall Study||13
184992|NCT00881712|445602|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
184993|NCT00881712|445603|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
184994|NCT00881712|445604|P1|STARTED|Overall Study||15
184995|NCT00881647|445626|P2|NOT COMPLETED|Overall Study||1
184996|NCT00881647|445627|P1|NOT COMPLETED|Overall Study||2
184997|NCT00881647|445626|P2|COMPLETED|Overall Study||15
184998|NCT00881647|445627|P1|COMPLETED|Overall Study||27
184999|NCT00881647|445626|P2|STARTED|Overall Study||16
185000|NCT00881647|445627|P1|STARTED|Overall Study||29
185001|NCT00881621|445637|P1|NOT COMPLETED|Overall Study||34
185002|NCT00881621|445637|P1|COMPLETED|Overall Study||17
185003|NCT00881621|445637|P1|STARTED|Overall Study||51
185004|NCT00881608|445649|P1|NOT COMPLETED|Overall Study||11
185005|NCT00881608|445649|P1|COMPLETED|Overall Study||0
185006|NCT00881608|445649|P1|STARTED|Overall Study||11
185007|NCT00881530|445672|P6|NOT COMPLETED|Overall Study||5
185008|NCT00881530|445673|P5|NOT COMPLETED|Overall Study||14
185009|NCT00881530|445674|P4|NOT COMPLETED|Overall Study||9
185010|NCT00881530|445675|P3|NOT COMPLETED|Overall Study||5
185011|NCT00881530|445676|P2|NOT COMPLETED|Overall Study||5
185012|NCT00881530|445677|P1|NOT COMPLETED|Overall Study||14
185013|NCT00881530|445672|P6|COMPLETED|Overall Study||51
185014|NCT00881530|445673|P5|COMPLETED|Overall Study||152
185015|NCT00881530|445674|P4|COMPLETED|Overall Study||157
185016|NCT00881530|445675|P3|COMPLETED|Overall Study||51
185017|NCT00881530|445676|P2|COMPLETED|Overall Study||104
185018|NCT00881530|445677|P1|COMPLETED|Overall Study||92
185019|NCT00881530|445672|P6|STARTED|Overall Study||56
185020|NCT00881530|445673|P5|STARTED|Overall Study||166
185021|NCT00881530|445674|P4|STARTED|Overall Study||166
185022|NCT00881530|445675|P3|STARTED|Overall Study||56
185023|NCT00881530|445676|P2|STARTED|Overall Study||109
185024|NCT00881530|445677|P1|STARTED|Overall Study||106
185025|NCT00881504|445733|P1|NOT COMPLETED|Overall Study||1
185026|NCT00881504|445733|P1|COMPLETED|Overall Study||8
185027|NCT00881504|445733|P1|STARTED|Overall Study||9
185028|NCT00881465|445740|P2|NOT COMPLETED|Overall Study||0
185029|NCT00881465|445741|P1|NOT COMPLETED|Overall Study||2
185030|NCT00881465|445740|P2|COMPLETED|Overall Study||15
185031|NCT00881465|445741|P1|COMPLETED|Overall Study||14
185032|NCT00881465|445740|P2|STARTED|Overall Study||15
185033|NCT00881465|445741|P1|STARTED|Overall Study||16
185034|NCT00881335|445753|P2|NOT COMPLETED|Overall Study||2
185035|NCT00881335|445754|P1|NOT COMPLETED|Overall Study||3
185036|NCT00881335|445753|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
185037|NCT00881335|445754|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
185038|NCT00881335|445753|P2|STARTED|Overall Study||30
185039|NCT00881335|445754|P1|STARTED|Overall Study||30
185040|NCT00881205|445774|P2|NOT COMPLETED|Overall Study||7
185041|NCT00881205|445775|P1|NOT COMPLETED|Overall Study||11
185042|NCT00881205|445774|P2|COMPLETED|Overall Study||34
185043|NCT00881205|445775|P1|COMPLETED|Overall Study||34
185044|NCT00881205|445774|P2|STARTED|Overall Study||41
185045|NCT00881205|445775|P1|STARTED|Overall Study||45
185046|NCT00880919|445785|P3|NOT COMPLETED|Overall Study||6
185047|NCT00880919|445786|P2|NOT COMPLETED|Overall Study||14
185048|NCT00880919|445787|P1|NOT COMPLETED|Overall Study||15
185049|NCT00880919|445785|P3|COMPLETED|Overall Study||23
185050|NCT00880919|445786|P2|COMPLETED|Overall Study||19
185051|NCT00880919|445787|P1|COMPLETED|Overall Study||18
185052|NCT00880919|445785|P3|STARTED|Overall Study||29
185053|NCT00880919|445786|P2|STARTED|Overall Study||33
185054|NCT00880919|445787|P1|STARTED|Overall Study||33
185055|NCT00880906|445821|P2|NOT COMPLETED|Overall Study||7
185056|NCT00880906|445822|P1|NOT COMPLETED|Overall Study||12
185057|NCT00880906|445821|P2|COMPLETED|Overall Study||14
185058|NCT00880906|445822|P1|COMPLETED|Overall Study||17
185059|NCT00880906|445821|P2|STARTED|Overall Study||21
185060|NCT00880906|445822|P1|STARTED|Overall Study||29
185061|NCT00880763|445834|P4|NOT COMPLETED|Extension Period (Part 2)||3
185062|NCT00880763|445835|P3|NOT COMPLETED|Extension Period (Part 2)||3
185063|NCT00880763|445836|P2|NOT COMPLETED|Extension Period (Part 2)||3
185064|NCT00880763|445837|P1|NOT COMPLETED|Extension Period (Part 2)||0
185065|NCT00880763|445834|P4|COMPLETED|Extension Period (Part 2)||19
185066|NCT00880763|445835|P3|COMPLETED|Extension Period (Part 2)||20
185067|NCT00880763|445836|P2|COMPLETED|Extension Period (Part 2)||19
185068|NCT00880763|445837|P1|COMPLETED|Extension Period (Part 2)||23
185069|NCT00880763|445834|P4|STARTED|Extension Period (Part 2)||22
185070|NCT00880763|445835|P3|STARTED|Extension Period (Part 2)||23
185071|NCT00880763|445836|P2|STARTED|Extension Period (Part 2)||22
185072|NCT00880763|445837|P1|STARTED|Extension Period (Part 2)||23
185073|NCT00880763|445834|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
185074|NCT00880763|445835|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
185075|NCT00880763|445836|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
185076|NCT00880763|445837|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
185077|NCT00880763|445834|P4|COMPLETED|Initial Treatment Period (Part 1)||22
185078|NCT00880763|445835|P3|COMPLETED|Initial Treatment Period (Part 1)||23
185079|NCT00880763|445836|P2|COMPLETED|Initial Treatment Period (Part 1)||22
185080|NCT00880763|445837|P1|COMPLETED|Initial Treatment Period (Part 1)||23
185081|NCT00880763|445834|P4|STARTED|Initial Treatment Period (Part 1)||22
185082|NCT00880763|445835|P3|STARTED|Initial Treatment Period (Part 1)||23
185083|NCT00880763|445836|P2|STARTED|Initial Treatment Period (Part 1)||22
185084|NCT00880763|445837|P1|STARTED|Initial Treatment Period (Part 1)||23
185085|NCT00880750|445869|P2|NOT COMPLETED|Second Intervention||2
185086|NCT00880750|445870|P1|NOT COMPLETED|Second Intervention||4
185087|NCT00880750|445869|P2|COMPLETED|Second Intervention||30
185088|NCT00880750|445870|P1|COMPLETED|Second Intervention||26
185089|NCT00880750|445869|P2|STARTED|Second Intervention||32
185090|NCT00880750|445870|P1|STARTED|Second Intervention||30
185091|NCT00880750|445869|P2|NOT COMPLETED|Washout Period||0
185092|NCT00880750|445870|P1|NOT COMPLETED|Washout Period||0
185093|NCT00880750|445869|P2|COMPLETED|Washout Period||32
185094|NCT00880750|445870|P1|COMPLETED|Washout Period||30
185095|NCT00880750|445869|P2|STARTED|Washout Period||32
185096|NCT00880750|445870|P1|STARTED|Washout Period||30
185097|NCT00880750|445869|P2|NOT COMPLETED|First Intervention||1
185098|NCT00880750|445870|P1|NOT COMPLETED|First Intervention||9
185099|NCT00880750|445869|P2|COMPLETED|First Intervention||32
185100|NCT00880750|445870|P1|COMPLETED|First Intervention||30
185101|NCT00880750|445869|P2|STARTED|First Intervention||33
185102|NCT00880750|445870|P1|STARTED|First Intervention||39
185103|NCT00880698|445888|P4|NOT COMPLETED|Overall Study||3
185104|NCT00880698|445889|P3|NOT COMPLETED|Overall Study||1
185105|NCT00880698|445890|P2|NOT COMPLETED|Overall Study||3
185106|NCT00880698|445891|P1|NOT COMPLETED|Overall Study||1
185107|NCT00880698|445888|P4|COMPLETED|Overall Study||36
185108|NCT00880698|445889|P3|COMPLETED|Overall Study||36
185109|NCT00880698|445890|P2|COMPLETED|Overall Study||61
185110|NCT00880698|445891|P1|COMPLETED|Overall Study||61
185111|NCT00880698|445888|P4|STARTED|Overall Study||39
185112|NCT00880698|445889|P3|STARTED|Overall Study||37
185113|NCT00880698|445890|P2|STARTED|Overall Study||64
185114|NCT00880698|445891|P1|STARTED|Overall Study||62
185115|NCT00880685|445917|P1|NOT COMPLETED|Memantine 30mg||0
185116|NCT00880685|445917|P1|COMPLETED|Memantine 30mg||9
185117|NCT00880685|445917|P1|STARTED|Memantine 30mg||9
185118|NCT00880685|445917|P1|NOT COMPLETED|Memantine 20mg||1
185119|NCT00880685|445917|P1|COMPLETED|Memantine 20mg||9
185120|NCT00880685|445917|P1|STARTED|Memantine 20mg||10
185121|NCT00880685|445917|P1|NOT COMPLETED|Memantine 10mg||2
185122|NCT00880685|445917|P1|COMPLETED|Memantine 10mg||10
185123|NCT00880685|445917|P1|STARTED|Memantine 10mg||12
185124|NCT00880620|445929|P4|NOT COMPLETED|Overall Study||24
185125|NCT00880620|445930|P3|NOT COMPLETED|Overall Study||21
185126|NCT00880620|445931|P2|NOT COMPLETED|Overall Study||15
185127|NCT00880620|445932|P1|NOT COMPLETED|Overall Study||21
185128|NCT00880620|445929|P4|COMPLETED|Overall Study||74
185129|NCT00880620|445930|P3|COMPLETED|Overall Study||83
185130|NCT00880620|445931|P2|COMPLETED|Overall Study||72
185131|NCT00880620|445932|P1|COMPLETED|Overall Study||71
185132|NCT00880620|445929|P4|Week 23|Overall Study||74
185133|NCT00880620|445930|P3|Week 23|Overall Study||85
185134|NCT00880620|445931|P2|Week 23|Overall Study||72
185135|NCT00880620|445932|P1|Week 23|Overall Study||71
185136|NCT00880620|445929|P4|Week 16|Overall Study||74
185137|NCT00880620|445930|P3|Week 16|Overall Study||87
185138|NCT00880620|445931|P2|Week 16|Overall Study||73
185139|NCT00880620|445932|P1|Week 16|Overall Study||74
185140|NCT00880620|445929|P4|Week 9|Overall Study||78
185141|NCT00880620|445930|P3|Week 9|Overall Study||88
185142|NCT00880620|445931|P2|Week 9|Overall Study||73
185143|NCT00880620|445932|P1|Week 9|Overall Study||80
185144|NCT00880620|445929|P4|Week 4|Overall Study||86
185145|NCT00880620|445930|P3|Week 4|Overall Study||94
185146|NCT00880620|445931|P2|Week 4|Overall Study||79
185147|NCT00880620|445932|P1|Week 4|Overall Study||88
185148|NCT00880620|445929|P4|STARTED|Overall Study||98
185149|NCT00880620|445930|P3|STARTED|Overall Study||104
185150|NCT00880620|445931|P2|STARTED|Overall Study||87
185151|NCT00880620|445932|P1|STARTED|Overall Study||92
185152|NCT00880581|445946|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
185153|NCT00880581|445946|P1|COMPLETED|Cycle 2 Re-treatment||24
185154|NCT00880581|445946|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
185155|NCT00880581|445946|P1|NOT COMPLETED|Cycle 1||0
185156|NCT00880581|445946|P1|COMPLETED|Cycle 1||30
185157|NCT00880581|445946|P1|STARTED|Cycle 1||30
185158|NCT00880568|445960|P9|NOT COMPLETED|Overall Study||3
185159|NCT00880568|445961|P8|NOT COMPLETED|Overall Study||2
185160|NCT00880568|445962|P7|NOT COMPLETED|Overall Study||6
185161|NCT00880568|445963|P6|NOT COMPLETED|Overall Study||3
185162|NCT00880568|445964|P5|NOT COMPLETED|Overall Study||3
185163|NCT00880568|445965|P4|NOT COMPLETED|Overall Study||1
185164|NCT00880568|445966|P3|NOT COMPLETED|Overall Study||3
185165|NCT00880568|445967|P2|NOT COMPLETED|Overall Study||3
185166|NCT00880568|445968|P1|NOT COMPLETED|Overall Study||3
185167|NCT00880568|445960|P9|COMPLETED|Overall Study||0
185168|NCT00880568|445961|P8|COMPLETED|Overall Study||0
185169|NCT00880568|445962|P7|COMPLETED|Overall Study||0
185170|NCT00880568|445963|P6|COMPLETED|Overall Study||0
185171|NCT00880568|445964|P5|COMPLETED|Overall Study||0
185172|NCT00880568|445965|P4|COMPLETED|Overall Study||0
185173|NCT00880568|445966|P3|COMPLETED|Overall Study||0
185174|NCT00880568|445967|P2|COMPLETED|Overall Study||0
185175|NCT00880568|445968|P1|COMPLETED|Overall Study||0
185176|NCT00880568|445960|P9|STARTED|Overall Study||3
185177|NCT00880568|445961|P8|STARTED|Overall Study||2
185178|NCT00880568|445962|P7|STARTED|Overall Study||6
185179|NCT00880568|445963|P6|STARTED|Overall Study||3
185180|NCT00880568|445964|P5|STARTED|Overall Study||3
185181|NCT00880568|445965|P4|STARTED|Overall Study||1
185182|NCT00880568|445966|P3|STARTED|Overall Study||3
185183|NCT00880568|445967|P2|STARTED|Overall Study||3
185184|NCT00880568|445968|P1|STARTED|Overall Study||3
185185|NCT00880555|446014|P6|NOT COMPLETED|Overall Study||1
185186|NCT00880555|446015|P5|NOT COMPLETED|Overall Study||1
185187|NCT00880555|446016|P4|NOT COMPLETED|Overall Study||2
185188|NCT00880555|446017|P3|NOT COMPLETED|Overall Study||5
185189|NCT00880555|446018|P2|NOT COMPLETED|Overall Study||17
185190|NCT00880555|446019|P1|NOT COMPLETED|Overall Study||10
185191|NCT00880555|446014|P6|COMPLETED|Overall Study||0
185192|NCT00880555|446015|P5|COMPLETED|Overall Study||0
185193|NCT00880555|446016|P4|COMPLETED|Overall Study||0
185194|NCT00880555|446017|P3|COMPLETED|Overall Study||6
185195|NCT00880555|446018|P2|COMPLETED|Overall Study||23
185196|NCT00880555|446019|P1|COMPLETED|Overall Study||13
185197|NCT00880555|446014|P6|STARTED|Overall Study||1
185198|NCT00880555|446015|P5|STARTED|Overall Study||1
185199|NCT00880555|446016|P4|STARTED|Overall Study||2
185200|NCT00880555|446017|P3|STARTED|Overall Study||11
185201|NCT00880555|446018|P2|STARTED|Overall Study||40
185202|NCT00880555|446019|P1|STARTED|Overall Study||23
185203|NCT00880542|446030|P1|NOT COMPLETED|Follow-up Period||0
185204|NCT00880542|446030|P1|COMPLETED|Follow-up Period||7
185205|NCT00880542|446030|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
185206|NCT00880542|446030|P1|NOT COMPLETED|Continued Treatment Period||0
185207|NCT00880542|446030|P1|COMPLETED|Continued Treatment Period||0
185208|NCT00880542|446030|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
185209|NCT00880542|446030|P1|NOT COMPLETED|Post Surgical Evaluation||0
185210|NCT00880542|446030|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
185211|NCT00880542|446030|P1|STARTED|Post Surgical Evaluation||3
185212|NCT00880542|446030|P1|NOT COMPLETED|REP: Surgical Resection||1
185213|NCT00880542|446030|P1|COMPLETED|REP: Surgical Resection||3
185214|NCT00880542|446030|P1|STARTED|REP: Surgical Resection||4
185215|NCT00880542|446030|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
185216|NCT00880542|446030|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
185217|NCT00880542|446030|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
185218|NCT00880542|446030|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
185219|NCT00880542|446030|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
185220|NCT00880542|446030|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
185221|NCT00880425|446035|P2|NOT COMPLETED|Overall Study||0
185222|NCT00880425|446036|P1|NOT COMPLETED|Overall Study||0
185223|NCT00880425|446035|P2|COMPLETED|Overall Study||27
185224|NCT00880425|446036|P1|COMPLETED|Overall Study||18
185225|NCT00880425|446035|P2|STARTED|Overall Study||27
185226|NCT00880425|446036|P1|STARTED|Overall Study||18
185227|NCT00880399|446047|P3|NOT COMPLETED|Overall Study||26
185228|NCT00880399|446048|P2|NOT COMPLETED|Overall Study||29
185229|NCT00880399|446049|P1|NOT COMPLETED|Overall Study||31
185230|NCT00880399|446047|P3|COMPLETED|Overall Study||81
185231|NCT00880399|446048|P2|COMPLETED|Overall Study||84
185232|NCT00880399|446049|P1|COMPLETED|Overall Study||77
185233|NCT00880399|446047|P3|STARTED|Overall Study||107
185234|NCT00880399|446048|P2|STARTED|Overall Study||113
185235|NCT00880399|446049|P1|STARTED|Overall Study||108
185236|NCT00880360|446105|P1|NOT COMPLETED|Overall Study||0
185237|NCT00880360|446105|P1|COMPLETED|Overall Study||19
185238|NCT00880360|446105|P1|STARTED|Overall Study||19
185239|NCT00880334|446112|P2|NOT COMPLETED|Overall Study||3
185240|NCT00880334|446113|P1|NOT COMPLETED|Overall Study||4
185241|NCT00880334|446112|P2|COMPLETED|Overall Study||72
185242|NCT00880334|446113|P1|COMPLETED|Overall Study||70
185243|NCT00880334|446112|P2|Eligible & Treated|Overall Study||72
185244|NCT00880334|446113|P1|Eligible & Treated|Overall Study||70
185245|NCT00880334|446112|P2|STARTED|Overall Study||75
185246|NCT00880334|446113|P1|STARTED|Overall Study||74
185247|NCT00880269|446129|P2|NOT COMPLETED|Overall Study||27
185248|NCT00880269|446130|P1|NOT COMPLETED|Overall Study||32
185249|NCT00880269|446129|P2|COMPLETED|Overall Study||0
185250|NCT00880269|446130|P1|COMPLETED|Overall Study||0
185251|NCT00880269|446129|P2|Discontinued Treatment|Overall Study||27
185252|NCT00880269|446130|P1|Discontinued Treatment|Overall Study||32
185253|NCT00880269|446129|P2|STARTED|Overall Study||27
185254|NCT00880269|446130|P1|STARTED|Overall Study||32
185255|NCT00880256|446146|P1|NOT COMPLETED|Overall Study||28
185256|NCT00880256|446146|P1|COMPLETED|Overall Study||65
185257|NCT00880256|446146|P1|STARTED|Overall Study||93
185258|NCT00880230|446151|P1|NOT COMPLETED|Overall Study||7
185259|NCT00880230|446151|P1|COMPLETED|Overall Study||134
185260|NCT00880230|446151|P1|STARTED|Overall Study||141
185261|NCT00880191|446173|P2|NOT COMPLETED|Overall Study||8
185262|NCT00880191|446174|P1|NOT COMPLETED|Overall Study||13
185263|NCT00880191|446173|P2|COMPLETED|Overall Study||198
185264|NCT00880191|446174|P1|COMPLETED|Overall Study||194
185265|NCT00880191|446173|P2|Available for Primary Endpoint Analysis|Overall Study||206
185266|NCT00880191|446174|P1|Available for Primary Endpoint Analysis|Overall Study||207
185267|NCT00880191|446173|P2|STARTED|Overall Study||206
185268|NCT00880191|446174|P1|STARTED|Overall Study||207
185269|NCT00880165|446194|P2|NOT COMPLETED|Overall Study||50
185270|NCT00880165|446195|P1|NOT COMPLETED|Overall Study||62
185271|NCT00880165|446194|P2|COMPLETED|Overall Study||98
185272|NCT00880165|446195|P1|COMPLETED|Overall Study||86
185273|NCT00880165|446194|P2|STARTED|Overall Study||148
185274|NCT00880165|446195|P1|STARTED|Overall Study||148
185275|NCT00880100|446205|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
185276|NCT00880100|446205|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
185277|NCT00880100|446205|P1|STARTED|Treatment Phase With Ultrase® MT12||48
185278|NCT00880100|446205|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
185279|NCT00880100|446205|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
185280|NCT00880100|446205|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
185281|NCT00880048|446219|P3|NOT COMPLETED|Overall Study||35
185282|NCT00880048|446220|P2|NOT COMPLETED|Overall Study||33
185283|NCT00880048|446221|P1|NOT COMPLETED|Overall Study||28
185284|NCT00880048|446219|P3|COMPLETED|Overall Study||77
185285|NCT00880048|446220|P2|COMPLETED|Overall Study||82
185286|NCT00880048|446221|P1|COMPLETED|Overall Study||88
185287|NCT00880048|446219|P3|STARTED|Overall Study||112
185288|NCT00880048|446220|P2|STARTED|Overall Study||115
185289|NCT00880048|446221|P1|STARTED|Overall Study||116
185290|NCT00880022|446279|P2|NOT COMPLETED|Overall Study||3
185291|NCT00880022|446280|P1|NOT COMPLETED|Overall Study||2
185292|NCT00880022|446279|P2|COMPLETED|Overall Study||21
185293|NCT00880022|446280|P1|COMPLETED|Overall Study||21
185294|NCT00880022|446279|P2|STARTED|Overall Study||24
185295|NCT00880022|446280|P1|STARTED|Overall Study||23
185296|NCT00880009|446288|P1|NOT COMPLETED|Overall Study||16
185297|NCT00880009|446288|P1|COMPLETED|Overall Study||0
185298|NCT00880009|446288|P1|STARTED|Overall Study||16
185299|NCT00879996|446312|P2|NOT COMPLETED|Overall Study||13
185300|NCT00879996|446313|P1|NOT COMPLETED|Overall Study||15
185301|NCT00879996|446312|P2|COMPLETED|Overall Study||13
185302|NCT00879996|446313|P1|COMPLETED|Overall Study||13
185303|NCT00879996|446312|P2|STARTED|Overall Study||26
185304|NCT00879996|446313|P1|STARTED|Overall Study||28
185305|NCT00879970|446328|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
185306|NCT00879970|446329|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
185307|NCT00879970|446330|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
185308|NCT00879970|446331|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
185309|NCT00879970|446332|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
185310|NCT00879970|446328|P5|COMPLETED|Period 2 Vitamin D Randomization||600
185311|NCT00879970|446329|P4|COMPLETED|Period 2 Vitamin D Randomization||610
185312|NCT00879970|446330|P3|COMPLETED|Period 2 Vitamin D Randomization||0
185313|NCT00879970|446331|P2|COMPLETED|Period 2 Vitamin D Randomization||0
185314|NCT00879970|446332|P1|COMPLETED|Period 2 Vitamin D Randomization||0
185315|NCT00879970|446328|P5|STARTED|Period 2 Vitamin D Randomization||607
185316|NCT00879970|446329|P4|STARTED|Period 2 Vitamin D Randomization||614
185317|NCT00879970|446330|P3|STARTED|Period 2 Vitamin D Randomization||0
185318|NCT00879970|446331|P2|STARTED|Period 2 Vitamin D Randomization||0
185319|NCT00879970|446332|P1|STARTED|Period 2 Vitamin D Randomization||0
185320|NCT00879970|446328|P5|NOT COMPLETED|Period 1 TZD Randomization||0
185321|NCT00879970|446329|P4|NOT COMPLETED|Period 1 TZD Randomization||0
185322|NCT00879970|446330|P3|NOT COMPLETED|Period 1 TZD Randomization||6
185323|NCT00879970|446331|P2|NOT COMPLETED|Period 1 TZD Randomization||4
185324|NCT00879970|446332|P1|NOT COMPLETED|Period 1 TZD Randomization||8
185325|NCT00879970|446328|P5|COMPLETED|Period 1 TZD Randomization||0
185326|NCT00879970|446329|P4|COMPLETED|Period 1 TZD Randomization||0
185327|NCT00879970|446330|P3|COMPLETED|Period 1 TZD Randomization||393
185328|NCT00879970|446331|P2|COMPLETED|Period 1 TZD Randomization||388
185329|NCT00879970|446332|P1|COMPLETED|Period 1 TZD Randomization||533
185330|NCT00879970|446328|P5|STARTED|Period 1 TZD Randomization||0
185331|NCT00879970|446329|P4|STARTED|Period 1 TZD Randomization||0
185332|NCT00879970|446330|P3|STARTED|Period 1 TZD Randomization||399
185333|NCT00879970|446331|P2|STARTED|Period 1 TZD Randomization||392
185334|NCT00879970|446332|P1|STARTED|Period 1 TZD Randomization||541
185335|NCT00879879|446414|P1|NOT COMPLETED|Overall Study||3
185336|NCT00879879|446414|P1|COMPLETED|Overall Study||17
185337|NCT00879879|446414|P1|STARTED|Overall Study||20
185338|NCT00879814|446422|P4|NOT COMPLETED|Overall Study||5
185339|NCT00879814|446423|P3|NOT COMPLETED|Overall Study||3
185340|NCT00879814|446424|P2|NOT COMPLETED|Overall Study||2
185341|NCT00879814|446425|P1|NOT COMPLETED|Overall Study||4
185342|NCT00879814|446422|P4|COMPLETED|Overall Study||7
185343|NCT00879814|446423|P3|COMPLETED|Overall Study||9
185344|NCT00879814|446424|P2|COMPLETED|Overall Study||10
185345|NCT00879814|446425|P1|COMPLETED|Overall Study||8
185346|NCT00879814|446422|P4|STARTED|Overall Study||12
185347|NCT00879814|446423|P3|STARTED|Overall Study||12
185348|NCT00879814|446424|P2|STARTED|Overall Study||12
185349|NCT00879814|446425|P1|STARTED|Overall Study||12
185350|NCT00879775|446533|P2|NOT COMPLETED|Overall Study||1
185351|NCT00879775|446534|P1|NOT COMPLETED|Overall Study||2
185352|NCT00879775|446533|P2|COMPLETED|Overall Study||20
185353|NCT00879775|446534|P1|COMPLETED|Overall Study||18
185354|NCT00879775|446533|P2|STARTED|Overall Study||21
185355|NCT00879775|446534|P1|STARTED|Overall Study||20
185356|NCT00879710|446550|P4|NOT COMPLETED|Phase 2 6 Weeks||0
185357|NCT00879710|446551|P3|NOT COMPLETED|Phase 2 6 Weeks||0
185358|NCT00879710|446552|P2|NOT COMPLETED|Phase 2 6 Weeks||0
185359|NCT00879710|446553|P1|NOT COMPLETED|Phase 2 6 Weeks||0
185360|NCT00879710|446550|P4|COMPLETED|Phase 2 6 Weeks||13
185361|NCT00879710|446551|P3|COMPLETED|Phase 2 6 Weeks||10
185362|NCT00879710|446552|P2|COMPLETED|Phase 2 6 Weeks||14
185363|NCT00879710|446553|P1|COMPLETED|Phase 2 6 Weeks||10
185364|NCT00879710|446550|P4|STARTED|Phase 2 6 Weeks||13
185365|NCT00879710|446551|P3|STARTED|Phase 2 6 Weeks||10
185366|NCT00879710|446552|P2|STARTED|Phase 2 6 Weeks||14
185367|NCT00879710|446553|P1|STARTED|Phase 2 6 Weeks||10
185368|NCT00879710|446550|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
185369|NCT00879710|446551|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
185370|NCT00879710|446552|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
185371|NCT00879710|446553|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
185372|NCT00879710|446550|P4|COMPLETED|Wash Out Period of 4 Weeks||13
185373|NCT00879710|446551|P3|COMPLETED|Wash Out Period of 4 Weeks||10
185374|NCT00879710|446552|P2|COMPLETED|Wash Out Period of 4 Weeks||14
185375|NCT00879710|446553|P1|COMPLETED|Wash Out Period of 4 Weeks||10
185376|NCT00879710|446550|P4|STARTED|Wash Out Period of 4 Weeks||13
185462|NCT00879359|446688|P1|COMPLETED|Overall Study||15
185377|NCT00879710|446551|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
185378|NCT00879710|446552|P2|STARTED|Wash Out Period of 4 Weeks||14
185379|NCT00879710|446553|P1|STARTED|Wash Out Period of 4 Weeks||10
185380|NCT00879710|446550|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
185381|NCT00879710|446551|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
185382|NCT00879710|446552|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
185383|NCT00879710|446553|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
185384|NCT00879710|446550|P4|COMPLETED|Phase 1 - 6 Weeks||13
185385|NCT00879710|446551|P3|COMPLETED|Phase 1 - 6 Weeks||9
185386|NCT00879710|446552|P2|COMPLETED|Phase 1 - 6 Weeks||14
185387|NCT00879710|446553|P1|COMPLETED|Phase 1 - 6 Weeks||10
185388|NCT00879710|446550|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
185389|NCT00879710|446551|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
185390|NCT00879710|446552|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
185391|NCT00879710|446553|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
185392|NCT00879697|446563|P2|NOT COMPLETED|Overall Study||2
185393|NCT00879697|446564|P1|NOT COMPLETED|Overall Study||2
185394|NCT00879697|446563|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
185395|NCT00879697|446564|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
185396|NCT00879697|446563|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
185397|NCT00879697|446564|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
185398|NCT00879684|446570|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
185399|NCT00879684|446571|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
185400|NCT00879684|446572|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
185401|NCT00879684|446573|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
185402|NCT00879684|446574|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
185403|NCT00879684|446575|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
185404|NCT00879684|446576|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
185405|NCT00879684|446570|P7|COMPLETED|Stage 2: Expanded Cohort||0
185406|NCT00879684|446571|P6|COMPLETED|Stage 2: Expanded Cohort||0
185407|NCT00879684|446572|P5|COMPLETED|Stage 2: Expanded Cohort||0
185408|NCT00879684|446573|P4|COMPLETED|Stage 2: Expanded Cohort||0
185409|NCT00879684|446574|P3|COMPLETED|Stage 2: Expanded Cohort||0
185410|NCT00879684|446575|P2|COMPLETED|Stage 2: Expanded Cohort||0
185411|NCT00879684|446576|P1|COMPLETED|Stage 2: Expanded Cohort||0
185412|NCT00879684|446570|P7|STARTED|Stage 2: Expanded Cohort||13
185413|NCT00879684|446571|P6|STARTED|Stage 2: Expanded Cohort||0
185414|NCT00879684|446572|P5|STARTED|Stage 2: Expanded Cohort||0
185415|NCT00879684|446573|P4|STARTED|Stage 2: Expanded Cohort||0
185416|NCT00879684|446574|P3|STARTED|Stage 2: Expanded Cohort||0
185417|NCT00879684|446575|P2|STARTED|Stage 2: Expanded Cohort||0
185418|NCT00879684|446576|P1|STARTED|Stage 2: Expanded Cohort||0
185419|NCT00879684|446570|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
185420|NCT00879684|446571|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
185421|NCT00879684|446572|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
185422|NCT00879684|446573|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
185423|NCT00879684|446574|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
185424|NCT00879684|446575|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
185425|NCT00879684|446576|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
185426|NCT00879684|446570|P7|COMPLETED|Stage 1: Dose Escalation||0
185427|NCT00879684|446571|P6|COMPLETED|Stage 1: Dose Escalation||0
185428|NCT00879684|446572|P5|COMPLETED|Stage 1: Dose Escalation||0
185429|NCT00879684|446573|P4|COMPLETED|Stage 1: Dose Escalation||0
185430|NCT00879684|446574|P3|COMPLETED|Stage 1: Dose Escalation||0
185431|NCT00879684|446575|P2|COMPLETED|Stage 1: Dose Escalation||0
185432|NCT00879684|446576|P1|COMPLETED|Stage 1: Dose Escalation||0
185433|NCT00879684|446570|P7|STARTED|Stage 1: Dose Escalation||0
185434|NCT00879684|446571|P6|STARTED|Stage 1: Dose Escalation||3
185435|NCT00879684|446572|P5|STARTED|Stage 1: Dose Escalation||3
185436|NCT00879684|446573|P4|STARTED|Stage 1: Dose Escalation||6
185437|NCT00879684|446574|P3|STARTED|Stage 1: Dose Escalation||3
185438|NCT00879684|446575|P2|STARTED|Stage 1: Dose Escalation||3
185439|NCT00879684|446576|P1|STARTED|Stage 1: Dose Escalation||3
185440|NCT00879645|446642|P4|NOT COMPLETED|Overall Study||0
185441|NCT00879645|446643|P3|NOT COMPLETED|Overall Study||0
185442|NCT00879645|446644|P2|NOT COMPLETED|Overall Study||0
185443|NCT00879645|446645|P1|NOT COMPLETED|Overall Study||1
185444|NCT00879645|446642|P4|COMPLETED|Overall Study||7
185445|NCT00879645|446643|P3|COMPLETED|Overall Study||6
185446|NCT00879645|446644|P2|COMPLETED|Overall Study||6
185447|NCT00879645|446645|P1|COMPLETED|Overall Study||8
185448|NCT00879645|446642|P4|STARTED|Overall Study||7
185449|NCT00879645|446643|P3|STARTED|Overall Study||6
185450|NCT00879645|446644|P2|STARTED|Overall Study||6
185451|NCT00879645|446645|P1|STARTED|Overall Study||9
185452|NCT00879619|446663|P1|NOT COMPLETED|Overall Study||0
185453|NCT00879619|446663|P1|COMPLETED|Overall Study||4
185454|NCT00879619|446663|P1|STARTED|Overall Study||4
185455|NCT00879411|446672|P1|NOT COMPLETED|Overall Study||162
185456|NCT00879411|446672|P1|COMPLETED|Overall Study||539
185457|NCT00879411|446672|P1|STARTED|Overall Study||701
185458|NCT00879398|446678|P1|NOT COMPLETED|Overall Study||675
185459|NCT00879398|446678|P1|COMPLETED|Overall Study||2434
185460|NCT00879398|446678|P1|STARTED|Overall Study||3109
185461|NCT00879359|446688|P1|NOT COMPLETED|Overall Study||0
185463|NCT00879359|446688|P1|STARTED|Overall Study||15
185464|NCT00879333|446696|P2|NOT COMPLETED|Overall Study||217
185465|NCT00879333|446697|P1|NOT COMPLETED|Overall Study||428
185466|NCT00879333|446696|P2|COMPLETED|Overall Study||0
185467|NCT00879333|446697|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
185468|NCT00879333|446696|P2|Discontinued Study Treatment|Overall Study||217
185469|NCT00879333|446697|P1|Discontinued Study Treatment|Overall Study||428
185470|NCT00879333|446696|P2|STARTED|Overall Study||217
185471|NCT00879333|446697|P1|STARTED|Overall Study||439
185472|NCT00879255|446717|P2|NOT COMPLETED|Overall Study||19
185473|NCT00879255|446718|P1|NOT COMPLETED|Overall Study||16
185474|NCT00879255|446717|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
185475|NCT00879255|446718|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
185476|NCT00879255|446717|P2|Completed 3-mo Follow-up|Overall Study||49
185477|NCT00879255|446718|P1|Completed 3-mo Follow-up|Overall Study||48
185478|NCT00879255|446717|P2|Completed Posttreatment Follow-up|Overall Study||55
185479|NCT00879255|446718|P1|Completed Posttreatment Follow-up|Overall Study||50
185480|NCT00879255|446717|P2|Received Allocated Intervention:|Overall Study||56
185481|NCT00879255|446718|P1|Received Allocated Intervention:|Overall Study||51
185482|NCT00879255|446717|P2|STARTED|Overall Study||64
185483|NCT00879255|446718|P1|STARTED|Overall Study||61
185484|NCT00879229|446730|P2|NOT COMPLETED|Overall Study||14
185485|NCT00879229|446731|P1|NOT COMPLETED|Overall Study||22
185486|NCT00879229|446730|P2|COMPLETED|Overall Study||1
185487|NCT00879229|446731|P1|COMPLETED|Overall Study||3
185488|NCT00879229|446730|P2|STARTED|Overall Study||15
185489|NCT00879229|446731|P1|STARTED|Overall Study||25
185490|NCT00879190|446757|P2|NOT COMPLETED|Overall Study||0
185491|NCT00879190|446758|P1|NOT COMPLETED|Overall Study||0
185492|NCT00879190|446757|P2|COMPLETED|Overall Study||49
185493|NCT00879190|446758|P1|COMPLETED|Overall Study||43
185494|NCT00879190|446757|P2|STARTED|Overall Study||49
185495|NCT00879190|446758|P1|STARTED|Overall Study||43
185496|NCT00879034|446768|P1|NOT COMPLETED|Overall Study||0
185497|NCT00879034|446768|P1|COMPLETED|Overall Study||5
185498|NCT00879034|446768|P1|Received Treatment|Overall Study||4
185499|NCT00879034|446768|P1|STARTED|Overall Study||5
185500|NCT00878995|446779|P2|NOT COMPLETED|Midpoint Study - Post Study||0
185501|NCT00878995|446780|P1|NOT COMPLETED|Midpoint Study - Post Study||0
185502|NCT00878995|446779|P2|COMPLETED|Midpoint Study - Post Study||10
185503|NCT00878995|446780|P1|COMPLETED|Midpoint Study - Post Study||12
185504|NCT00878995|446779|P2|STARTED|Midpoint Study - Post Study||10
185505|NCT00878995|446780|P1|STARTED|Midpoint Study - Post Study||12
185506|NCT00878995|446779|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
185507|NCT00878995|446780|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
185508|NCT00878995|446779|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
185509|NCT00878995|446780|P1|COMPLETED|Baseline Study - Midpoint Study||12
185510|NCT00878995|446779|P2|Baseline Study|Baseline Study - Midpoint Study||12
185511|NCT00878995|446780|P1|Baseline Study|Baseline Study - Midpoint Study||12
185512|NCT00878995|446779|P2|STARTED|Baseline Study - Midpoint Study||12
185513|NCT00878995|446780|P1|STARTED|Baseline Study - Midpoint Study||12
185514|NCT00878969|446881|P3|NOT COMPLETED|Overall Study||11
185515|NCT00878969|446882|P2|NOT COMPLETED|Overall Study||15
185516|NCT00878969|446883|P1|NOT COMPLETED|Overall Study||15
185517|NCT00878969|446881|P3|COMPLETED|Overall Study||15
185518|NCT00878969|446882|P2|COMPLETED|Overall Study||12
185519|NCT00878969|446883|P1|COMPLETED|Overall Study||10
185520|NCT00878969|446881|P3|STARTED|Overall Study||26
185521|NCT00878969|446882|P2|STARTED|Overall Study||27
185522|NCT00878969|446883|P1|STARTED|Overall Study||25
185523|NCT00878878|446893|P2|NOT COMPLETED|Overall Study||0
185524|NCT00878878|446894|P1|NOT COMPLETED|Overall Study||0
185525|NCT00878878|446893|P2|COMPLETED|Overall Study||15
185526|NCT00878878|446894|P1|COMPLETED|Overall Study||15
185527|NCT00878878|446893|P2|STARTED|Overall Study||15
185528|NCT00878878|446894|P1|STARTED|Overall Study||15
185529|NCT00878826|446907|P3|NOT COMPLETED|Overall Study||0
185530|NCT00878826|446908|P2|NOT COMPLETED|Overall Study||0
185531|NCT00878826|446909|P1|NOT COMPLETED|Overall Study||0
185532|NCT00878826|446907|P3|COMPLETED|Overall Study||2
185533|NCT00878826|446908|P2|COMPLETED|Overall Study||6
185534|NCT00878826|446909|P1|COMPLETED|Overall Study||3
185535|NCT00878826|446907|P3|STARTED|Overall Study||2
185536|NCT00878826|446908|P2|STARTED|Overall Study||6
185537|NCT00878826|446909|P1|STARTED|Overall Study||3
185538|NCT00878800|446931|P5|NOT COMPLETED|Overall Study||16
185539|NCT00878800|446932|P4|NOT COMPLETED|Overall Study||6
185540|NCT00878800|446933|P3|NOT COMPLETED|Overall Study||9
185541|NCT00878800|446934|P2|NOT COMPLETED|Overall Study||7
185542|NCT00878800|446935|P1|NOT COMPLETED|Overall Study||3
185543|NCT00878800|446931|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
185544|NCT00878800|446932|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
185545|NCT00878800|446933|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
185546|NCT00878800|446934|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
185547|NCT00878800|446935|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
185548|NCT00878800|446931|P5|STARTED|Overall Study||16
185549|NCT00878800|446932|P4|STARTED|Overall Study||6
185550|NCT00878800|446933|P3|STARTED|Overall Study||9
185551|NCT00878800|446934|P2|STARTED|Overall Study||7
185552|NCT00878800|446935|P1|STARTED|Overall Study||3
185553|NCT00878722|446970|P8|NOT COMPLETED|Overall Study||7
185554|NCT00878722|446971|P7|NOT COMPLETED|Overall Study||6
185555|NCT00878722|446972|P6|NOT COMPLETED|Overall Study||2
185556|NCT00878722|446973|P5|NOT COMPLETED|Overall Study||7
185557|NCT00878722|446974|P4|NOT COMPLETED|Overall Study||9
185558|NCT00878722|446975|P3|NOT COMPLETED|Overall Study||3
185559|NCT00878722|446976|P2|NOT COMPLETED|Overall Study||3
185560|NCT00878722|446977|P1|NOT COMPLETED|Overall Study||3
185561|NCT00878722|446970|P8|COMPLETED|Overall Study||0
185562|NCT00878722|446971|P7|COMPLETED|Overall Study||0
185563|NCT00878722|446972|P6|COMPLETED|Overall Study||1
185564|NCT00878722|446973|P5|COMPLETED|Overall Study||0
185565|NCT00878722|446974|P4|COMPLETED|Overall Study||0
185566|NCT00878722|446975|P3|COMPLETED|Overall Study||0
185567|NCT00878722|446976|P2|COMPLETED|Overall Study||0
185568|NCT00878722|446977|P1|COMPLETED|Overall Study||0
185569|NCT00878722|446970|P8|STARTED|Overall Study||7
185570|NCT00878722|446971|P7|STARTED|Overall Study||6
185571|NCT00878722|446972|P6|STARTED|Overall Study||3
185572|NCT00878722|446973|P5|STARTED|Overall Study||7
185573|NCT00878722|446974|P4|STARTED|Overall Study||9
185574|NCT00878722|446975|P3|STARTED|Overall Study||3
185575|NCT00878722|446976|P2|STARTED|Overall Study||3
185576|NCT00878722|446977|P1|STARTED|Overall Study||3
185577|NCT00878709|447062|P2|NOT COMPLETED|Overall Study||237
185578|NCT00878709|447063|P1|NOT COMPLETED|Overall Study||325
185579|NCT00878709|447062|P2|COMPLETED|Overall Study||1183
185580|NCT00878709|447063|P1|COMPLETED|Overall Study||1095
185581|NCT00878709|447062|P2|STARTED|Overall Study||1420
185582|NCT00878709|447063|P1|STARTED|Overall Study||1420
185583|NCT00878644|447089|P2|NOT COMPLETED|Overall Study||4
185584|NCT00878644|447090|P1|NOT COMPLETED|Overall Study||4
185585|NCT00878644|447089|P2|COMPLETED|Overall Study||136
185586|NCT00878644|447090|P1|COMPLETED|Overall Study||151
185587|NCT00878644|447089|P2|STARTED|Overall Study||140
185588|NCT00878644|447090|P1|STARTED|Overall Study||155
185589|NCT00878605|447106|P4|NOT COMPLETED|Overall Study||3
185590|NCT00878605|447107|P3|NOT COMPLETED|Overall Study||1
185591|NCT00878605|447108|P2|NOT COMPLETED|Overall Study||3
185592|NCT00878605|447109|P1|NOT COMPLETED|Overall Study||3
185593|NCT00878605|447106|P4|COMPLETED|Overall Study||6
185594|NCT00878605|447107|P3|COMPLETED|Overall Study||8
185595|NCT00878605|447108|P2|COMPLETED|Overall Study||7
185596|NCT00878605|447109|P1|COMPLETED|Overall Study||7
185597|NCT00878605|447106|P4|STARTED|Overall Study||9
185598|NCT00878605|447107|P3|STARTED|Overall Study||9
185599|NCT00878605|447108|P2|STARTED|Overall Study||10
185600|NCT00878605|447109|P1|STARTED|Overall Study||10
185601|NCT00878553|447123|P5|NOT COMPLETED|PK Study||0
185602|NCT00878553|447124|P4|NOT COMPLETED|PK Study||1
185603|NCT00878553|447125|P3|NOT COMPLETED|PK Study||0
185604|NCT00878553|447126|P2|NOT COMPLETED|PK Study||0
185605|NCT00878553|447127|P1|NOT COMPLETED|PK Study||0
185606|NCT00878553|447123|P5|COMPLETED|PK Study||15
185607|NCT00878553|447124|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
185608|NCT00878553|447125|P3|COMPLETED|PK Study||17
185609|NCT00878553|447126|P2|COMPLETED|PK Study||16
185610|NCT00878553|447127|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
185611|NCT00878553|447123|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
185612|NCT00878553|447124|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
185613|NCT00878553|447125|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
185614|NCT00878553|447126|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
185615|NCT00878553|447127|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
185616|NCT00878553|447123|P5|NOT COMPLETED|Sleep Study||0
185617|NCT00878553|447124|P4|NOT COMPLETED|Sleep Study||0
185618|NCT00878553|447125|P3|NOT COMPLETED|Sleep Study||0
185619|NCT00878553|447126|P2|NOT COMPLETED|Sleep Study||0
185620|NCT00878553|447127|P1|NOT COMPLETED|Sleep Study||5
185621|NCT00878553|447123|P5|COMPLETED|Sleep Study||0
185622|NCT00878553|447124|P4|COMPLETED|Sleep Study||0
185623|NCT00878553|447125|P3|COMPLETED|Sleep Study||0
185624|NCT00878553|447126|P2|COMPLETED|Sleep Study||0
185625|NCT00878553|447127|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
185626|NCT00878553|447123|P5|Number of Patients Receiving 20mg|Sleep Study||0
185627|NCT00878553|447124|P4|Number of Patients Receiving 20mg|Sleep Study||0
185628|NCT00878553|447125|P3|Number of Patients Receiving 20mg|Sleep Study||0
185629|NCT00878553|447126|P2|Number of Patients Receiving 20mg|Sleep Study||0
185630|NCT00878553|447127|P1|Number of Patients Receiving 20mg|Sleep Study||65
185631|NCT00878553|447123|P5|Number of Patients Receiving 15mg|Sleep Study||0
185632|NCT00878553|447124|P4|Number of Patients Receiving 15mg|Sleep Study||0
185633|NCT00878553|447125|P3|Number of Patients Receiving 15mg|Sleep Study||0
185634|NCT00878553|447126|P2|Number of Patients Receiving 15mg|Sleep Study||0
185635|NCT00878553|447127|P1|Number of Patients Receiving 15mg|Sleep Study||65
185636|NCT00878553|447123|P5|Number of Patients Receiving 10mg|Sleep Study||0
185637|NCT00878553|447124|P4|Number of Patients Receiving 10mg|Sleep Study||0
185638|NCT00878553|447125|P3|Number of Patients Receiving 10mg|Sleep Study||0
185639|NCT00878553|447126|P2|Number of Patients Receiving 10mg|Sleep Study||0
185640|NCT00878553|447127|P1|Number of Patients Receiving 10mg|Sleep Study||65
185641|NCT00878553|447123|P5|Number of Patients Receiving Placebo|Sleep Study||0
185642|NCT00878553|447124|P4|Number of Patients Receiving Placebo|Sleep Study||0
185643|NCT00878553|447125|P3|Number of Patients Receiving Placebo|Sleep Study||0
185644|NCT00878553|447126|P2|Number of Patients Receiving Placebo|Sleep Study||0
185645|NCT00878553|447127|P1|Number of Patients Receiving Placebo|Sleep Study||66
185646|NCT00878553|447123|P5|STARTED|Sleep Study||0
185647|NCT00878553|447124|P4|STARTED|Sleep Study||0
185648|NCT00878553|447125|P3|STARTED|Sleep Study||0
185649|NCT00878553|447126|P2|STARTED|Sleep Study||0
185650|NCT00878553|447127|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
185651|NCT00878501|447186|P3|NOT COMPLETED|Overall Study||8
185652|NCT00878501|447187|P2|NOT COMPLETED|Overall Study||7
185653|NCT00878501|447188|P1|NOT COMPLETED|Overall Study||17
185654|NCT00878501|447186|P3|COMPLETED|Overall Study||85
185655|NCT00878501|447187|P2|COMPLETED|Overall Study||37
185656|NCT00878501|447188|P1|COMPLETED|Overall Study||87
185657|NCT00878501|447186|P3|Interim Analysis|Overall Study||81
185658|NCT00878501|447187|P2|Interim Analysis|Overall Study||37
185659|NCT00878501|447188|P1|Interim Analysis|Overall Study||83
185660|NCT00878501|447186|P3|STARTED|Overall Study||93
185661|NCT00878501|447187|P2|STARTED|Overall Study||44
185662|NCT00878501|447188|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
185663|NCT00878436|447207|P2|NOT COMPLETED|Overall Study||24
185664|NCT00878436|447208|P1|NOT COMPLETED|Overall Study||23
185665|NCT00878436|447207|P2|COMPLETED|Overall Study||0
185666|NCT00878436|447208|P1|COMPLETED|Overall Study||5
185667|NCT00878436|447207|P2|6 Months|Overall Study||0
185668|NCT00878436|447208|P1|6 Months|Overall Study||8
185669|NCT00878436|447207|P2|Completed 2 Cycles|Overall Study||20
185670|NCT00878436|447208|P1|Completed 2 Cycles|Overall Study||21
185671|NCT00878436|447207|P2|STARTED|Overall Study||24
185672|NCT00878436|447208|P1|STARTED|Overall Study||28
185673|NCT00878228|447222|P2|NOT COMPLETED|Overall Study||12
185674|NCT00878228|447223|P1|NOT COMPLETED|Overall Study||10
185675|NCT00878228|447222|P2|COMPLETED|Overall Study||37
185676|NCT00878228|447223|P1|COMPLETED|Overall Study||39
185677|NCT00878228|447222|P2|STARTED|Overall Study||49
185678|NCT00878228|447223|P1|STARTED|Overall Study||49
185679|NCT00878215|447237|P4|NOT COMPLETED|Overall Study||0
185680|NCT00878215|447238|P3|NOT COMPLETED|Overall Study||0
185681|NCT00878215|447239|P2|NOT COMPLETED|Overall Study||10
185682|NCT00878215|447240|P1|NOT COMPLETED|Overall Study||0
185683|NCT00878215|447237|P4|COMPLETED|Overall Study||0
185684|NCT00878215|447238|P3|COMPLETED|Overall Study||0
185685|NCT00878215|447239|P2|COMPLETED|Overall Study||9
185686|NCT00878215|447240|P1|COMPLETED|Overall Study||21
185687|NCT00878215|447237|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
185688|NCT00878215|447238|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
185689|NCT00878215|447239|P2|STARTED|Overall Study||19
185690|NCT00878215|447240|P1|STARTED|Overall Study||21
185691|NCT00877929|447252|P2|NOT COMPLETED|Overall Study||35
185692|NCT00877929|447253|P1|NOT COMPLETED|Overall Study||20
185693|NCT00877929|447252|P2|COMPLETED|Overall Study||319
185694|NCT00877929|447253|P1|COMPLETED|Overall Study||332
185695|NCT00877929|447252|P2|STARTED|Overall Study||354
185696|NCT00877929|447253|P1|STARTED|Overall Study||352
185697|NCT00877890|447341|P2|NOT COMPLETED|Overall Study||30
185698|NCT00877890|447342|P1|NOT COMPLETED|Overall Study||20
185699|NCT00877890|447341|P2|COMPLETED|Overall Study||95
185700|NCT00877890|447342|P1|COMPLETED|Overall Study||109
185701|NCT00877890|447341|P2|Intent to Treat (ITT)|Overall Study||123
185702|NCT00877890|447342|P1|Intent to Treat (ITT)|Overall Study||129
185703|NCT00877890|447341|P2|STARTED|Overall Study||125
185704|NCT00877890|447342|P1|STARTED|Overall Study||129
185705|NCT00877877|447376|P1|NOT COMPLETED|Year 10||0
185706|NCT00877877|447376|P1|COMPLETED|Year 10||495
185707|NCT00877877|447376|P1|STARTED|Year 10||495
185708|NCT00877877|447376|P1|NOT COMPLETED|Year 9||0
185709|NCT00877877|447376|P1|COMPLETED|Year 9||507
185710|NCT00877877|447376|P1|STARTED|Year 9||507
185711|NCT00877877|447376|P1|NOT COMPLETED|Year 8||0
185712|NCT00877877|447376|P1|COMPLETED|Year 8||522
185713|NCT00877877|447376|P1|STARTED|Year 8||522
185714|NCT00877877|447376|P1|NOT COMPLETED|Year 7||0
185715|NCT00877877|447376|P1|COMPLETED|Year 7||523
185716|NCT00877877|447376|P1|STARTED|Year 7||523
185717|NCT00877877|447376|P1|NOT COMPLETED|Year 6||0
185718|NCT00877877|447376|P1|COMPLETED|Year 6||529
185719|NCT00877877|447376|P1|STARTED|Year 6||529
185720|NCT00877877|447376|P1|NOT COMPLETED|Year 5||0
185721|NCT00877877|447376|P1|COMPLETED|Year 5||397
185722|NCT00877877|447376|P1|STARTED|Year 5||397
185723|NCT00877799|447407|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
185724|NCT00877799|447408|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
185725|NCT00877799|447409|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
185726|NCT00877799|447410|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
185727|NCT00877799|447411|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
185728|NCT00877799|447407|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
185729|NCT00877799|447408|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
185730|NCT00877799|447409|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
185731|NCT00877799|447410|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
185732|NCT00877799|447411|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
185733|NCT00877799|447407|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
185734|NCT00877799|447408|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
185735|NCT00877799|447409|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
185736|NCT00877799|447410|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
185737|NCT00877799|447411|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
185738|NCT00877799|447407|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
185739|NCT00877799|447408|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
185740|NCT00877799|447409|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
185741|NCT00877799|447410|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
185742|NCT00877799|447411|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
185743|NCT00877799|447407|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
185744|NCT00877799|447408|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
185745|NCT00877799|447409|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
185746|NCT00877799|447410|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
185747|NCT00877799|447411|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
185748|NCT00877799|447407|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
185749|NCT00877799|447408|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
185750|NCT00877799|447409|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
185751|NCT00877799|447410|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
185752|NCT00877799|447411|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
185753|NCT00877773|447426|P1|NOT COMPLETED|Overall Study||44
185754|NCT00877773|447426|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
185755|NCT00877773|447426|P1|STARTED|Overall Study||44
185756|NCT00877604|447432|P2|NOT COMPLETED|Overall Study||3
185757|NCT00877604|447433|P1|NOT COMPLETED|Overall Study||2
185758|NCT00877604|447432|P2|COMPLETED|Overall Study||14
185759|NCT00877604|447433|P1|COMPLETED|Overall Study||15
185760|NCT00877604|447432|P2|STARTED|Overall Study||17
185761|NCT00877604|447433|P1|STARTED|Overall Study||17
185762|NCT00877487|447439|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
185763|NCT00877487|447440|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
185764|NCT00877487|447439|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
185765|NCT00877487|447440|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
185766|NCT00877487|447439|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
185767|NCT00877487|447440|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
185768|NCT00877487|447439|P2|NOT COMPLETED|Open-label Treatment Phase||0
185769|NCT00877487|447440|P1|NOT COMPLETED|Open-label Treatment Phase||7
185770|NCT00877487|447439|P2|COMPLETED|Open-label Treatment Phase||0
185771|NCT00877487|447440|P1|COMPLETED|Open-label Treatment Phase||116
185772|NCT00877487|447439|P2|STARTED|Open-label Treatment Phase||0
185773|NCT00877487|447440|P1|STARTED|Open-label Treatment Phase||123
185774|NCT00877448|447457|P7|NOT COMPLETED|Overall Study||0
185775|NCT00877448|447458|P6|NOT COMPLETED|Overall Study||1
185776|NCT00877448|447459|P5|NOT COMPLETED|Overall Study||0
185777|NCT00877448|447460|P4|NOT COMPLETED|Overall Study||1
185778|NCT00877448|447461|P3|NOT COMPLETED|Overall Study||0
185779|NCT00877448|447462|P2|NOT COMPLETED|Overall Study||1
185780|NCT00877448|447463|P1|NOT COMPLETED|Overall Study||0
185781|NCT00877448|447457|P7|COMPLETED|Overall Study||3
185782|NCT00877448|447458|P6|COMPLETED|Overall Study||9
185783|NCT00877448|447459|P5|COMPLETED|Overall Study||10
185784|NCT00877448|447460|P4|COMPLETED|Overall Study||9
185785|NCT00877448|447461|P3|COMPLETED|Overall Study||10
185786|NCT00877448|447462|P2|COMPLETED|Overall Study||9
185787|NCT00877448|447463|P1|COMPLETED|Overall Study||10
185788|NCT00877448|447457|P7|STARTED|Overall Study||3
185789|NCT00877448|447458|P6|STARTED|Overall Study||10
185790|NCT00877448|447459|P5|STARTED|Overall Study||10
185791|NCT00877448|447460|P4|STARTED|Overall Study||10
185792|NCT00877448|447461|P3|STARTED|Overall Study||10
185793|NCT00877448|447462|P2|STARTED|Overall Study||10
185794|NCT00877448|447463|P1|STARTED|Overall Study||10
185795|NCT00877383|447488|P2|NOT COMPLETED|Overall Study||37
185796|NCT00877383|447489|P1|NOT COMPLETED|Overall Study||29
185797|NCT00877383|447488|P2|COMPLETED|Overall Study||533
185798|NCT00877383|447489|P1|COMPLETED|Overall Study||543
185799|NCT00877383|447488|P2|STARTED|Overall Study||570
185800|NCT00877383|447489|P1|STARTED|Overall Study||572
185801|NCT00877370|447505|P1|NOT COMPLETED|Overall Study||0
185802|NCT00877370|447505|P1|COMPLETED|Overall Study||8
185803|NCT00877370|447505|P1|STARTED|Overall Study||8
185804|NCT00877071|447509|P1|NOT COMPLETED|Overall Study||2
185805|NCT00877071|447509|P1|COMPLETED|Overall Study||0
185806|NCT00877071|447509|P1|STARTED|Overall Study||2
185807|NCT00877058|447519|P3|NOT COMPLETED|Overall Study||39
185808|NCT00877058|447520|P2|NOT COMPLETED|Overall Study||40
185809|NCT00877058|447521|P1|NOT COMPLETED|Overall Study||37
185810|NCT00877058|447519|P3|COMPLETED|Overall Study||75
185811|NCT00877058|447520|P2|COMPLETED|Overall Study||131
185812|NCT00877058|447521|P1|COMPLETED|Overall Study||137
185813|NCT00877058|447519|P3|STARTED|Overall Study||114
185814|NCT00877058|447520|P2|STARTED|Overall Study||171
185815|NCT00877058|447521|P1|STARTED|Overall Study||174
185816|NCT00877032|447542|P7|NOT COMPLETED|Overall Study||2
185817|NCT00877032|447543|P6|NOT COMPLETED|Overall Study||0
185818|NCT00877032|447544|P5|NOT COMPLETED|Overall Study||0
185819|NCT00877032|447545|P4|NOT COMPLETED|Overall Study||1
185820|NCT00877032|447546|P3|NOT COMPLETED|Overall Study||0
185821|NCT00877032|447547|P2|NOT COMPLETED|Overall Study||0
185822|NCT00877032|447548|P1|NOT COMPLETED|Overall Study||0
185823|NCT00877032|447542|P7|COMPLETED|Overall Study||18
185824|NCT00877032|447543|P6|COMPLETED|Overall Study||6
185825|NCT00877032|447544|P5|COMPLETED|Overall Study||6
185826|NCT00877032|447545|P4|COMPLETED|Overall Study||6
185827|NCT00877032|447546|P3|COMPLETED|Overall Study||6
185828|NCT00877032|447547|P2|COMPLETED|Overall Study||6
185829|NCT00877032|447548|P1|COMPLETED|Overall Study||6
185830|NCT00877032|447542|P7|Treated|Overall Study||18
185831|NCT00877032|447543|P6|Treated|Overall Study||6
185832|NCT00877032|447544|P5|Treated|Overall Study||6
185833|NCT00877032|447545|P4|Treated|Overall Study||6
185834|NCT00877032|447546|P3|Treated|Overall Study||6
185835|NCT00877032|447547|P2|Treated|Overall Study||6
185836|NCT00877032|447548|P1|Treated|Overall Study||6
185837|NCT00877032|447542|P7|STARTED|Overall Study||20
185838|NCT00877032|447543|P6|STARTED|Overall Study||6
185839|NCT00877032|447544|P5|STARTED|Overall Study||6
185840|NCT00877032|447545|P4|STARTED|Overall Study||7
185841|NCT00877032|447546|P3|STARTED|Overall Study||6
185842|NCT00877032|447547|P2|STARTED|Overall Study||6
185843|NCT00877032|447548|P1|STARTED|Overall Study||6
185844|NCT00877006|447649|P2|NOT COMPLETED|Long-Term Follow-up Period||55
185845|NCT00877006|447650|P1|NOT COMPLETED|Long-Term Follow-up Period||53
185846|NCT00877006|447649|P2|COMPLETED|Long-Term Follow-up Period||154
185847|NCT00877006|447650|P1|COMPLETED|Long-Term Follow-up Period||157
185848|NCT00877006|447649|P2|STARTED|Long-Term Follow-up Period||209
185849|NCT00877006|447650|P1|STARTED|Long-Term Follow-up Period||210
185850|NCT00877006|447649|P2|NOT COMPLETED|Treatment Period||27
185851|NCT00877006|447650|P1|NOT COMPLETED|Treatment Period||25
185852|NCT00877006|447649|P2|COMPLETED|Treatment Period||196
185853|NCT00877006|447650|P1|COMPLETED|Treatment Period||199
185854|NCT00877006|447649|P2|STARTED|Treatment Period||223
185855|NCT00877006|447650|P1|STARTED|Treatment Period||224
185856|NCT00876928|447690|P2|NOT COMPLETED|Overall Study||5
185857|NCT00876928|447691|P1|NOT COMPLETED|Overall Study||3
185858|NCT00876928|447690|P2|COMPLETED|Overall Study||56
185859|NCT00876928|447691|P1|COMPLETED|Overall Study||53
185860|NCT00876928|447690|P2|STARTED|Overall Study||61
185861|NCT00876928|447691|P1|STARTED|Overall Study||56
185862|NCT00876915|447702|P3|NOT COMPLETED|Overall Study||0
185863|NCT00876915|447703|P2|NOT COMPLETED|Overall Study||14
185864|NCT00876915|447704|P1|NOT COMPLETED|Overall Study||19
185865|NCT00876915|447702|P3|COMPLETED|Overall Study||101
185866|NCT00876915|447703|P2|COMPLETED|Overall Study||34
185867|NCT00876915|447704|P1|COMPLETED|Overall Study||31
185868|NCT00876915|447702|P3|Week 8|Overall Study||0
185869|NCT00876915|447703|P2|Week 8|Overall Study||36
185870|NCT00876915|447704|P1|Week 8|Overall Study||33
185871|NCT00876915|447702|P3|Week 4|Overall Study||0
185872|NCT00876915|447703|P2|Week 4|Overall Study||45
185873|NCT00876915|447704|P1|Week 4|Overall Study||38
185874|NCT00876915|447702|P3|STARTED|Overall Study||101
185875|NCT00876915|447703|P2|STARTED|Overall Study||48
185876|NCT00876915|447704|P1|STARTED|Overall Study||50
185877|NCT00876733|447728|P4|NOT COMPLETED|Overall Study||7
185878|NCT00876733|447729|P3|NOT COMPLETED|Overall Study||30
185879|NCT00876733|447730|P2|NOT COMPLETED|Overall Study||42
185880|NCT00876733|447731|P1|NOT COMPLETED|Overall Study||91
185881|NCT00876733|447728|P4|COMPLETED|Overall Study||14
185882|NCT00876733|447729|P3|COMPLETED|Overall Study||63
185883|NCT00876733|447730|P2|COMPLETED|Overall Study||161
185884|NCT00876733|447731|P1|COMPLETED|Overall Study||197
185885|NCT00876733|447728|P4|STARTED|Overall Study||21
185886|NCT00876733|447729|P3|STARTED|Overall Study||93
185887|NCT00876733|447730|P2|STARTED|Overall Study||203
185888|NCT00876733|447731|P1|STARTED|Overall Study||288
185889|NCT00876694|447839|P2|NOT COMPLETED|Overall Study||12
185890|NCT00876694|447840|P1|NOT COMPLETED|Overall Study||21
185891|NCT00876694|447839|P2|COMPLETED|Overall Study||49
185892|NCT00876694|447840|P1|COMPLETED|Overall Study||104
185893|NCT00876694|447839|P2|STARTED|Overall Study||61
185894|NCT00876694|447840|P1|STARTED|Overall Study||125
185895|NCT00876460|447866|P8|NOT COMPLETED|Mono Therapy Phase||3
185896|NCT00876460|447867|P7|NOT COMPLETED|Mono Therapy Phase||1
185897|NCT00876460|447868|P6|NOT COMPLETED|Mono Therapy Phase||0
185898|NCT00876460|447869|P5|NOT COMPLETED|Mono Therapy Phase||2
185899|NCT00876460|447870|P4|NOT COMPLETED|Mono Therapy Phase||1
185900|NCT00876460|447871|P3|NOT COMPLETED|Mono Therapy Phase||0
185901|NCT00876460|447872|P2|NOT COMPLETED|Mono Therapy Phase||1
185902|NCT00876460|447873|P1|NOT COMPLETED|Mono Therapy Phase||0
185903|NCT00876460|447866|P8|COMPLETED|Mono Therapy Phase||0
185904|NCT00876460|447867|P7|COMPLETED|Mono Therapy Phase||0
185905|NCT00876460|447868|P6|COMPLETED|Mono Therapy Phase||0
185906|NCT00876460|447869|P5|COMPLETED|Mono Therapy Phase||0
185907|NCT00876460|447870|P4|COMPLETED|Mono Therapy Phase||0
185908|NCT00876460|447871|P3|COMPLETED|Mono Therapy Phase||0
185909|NCT00876460|447872|P2|COMPLETED|Mono Therapy Phase||0
185910|NCT00876460|447873|P1|COMPLETED|Mono Therapy Phase||0
185911|NCT00876460|447866|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
185912|NCT00876460|447867|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
185913|NCT00876460|447868|P6|STARTED|Mono Therapy Phase||0
185914|NCT00876460|447869|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
185915|NCT00876460|447870|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
185916|NCT00876460|447871|P3|STARTED|Mono Therapy Phase||0
185917|NCT00876460|447872|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
185918|NCT00876460|447873|P1|STARTED|Mono Therapy Phase||0
185919|NCT00876460|447866|P8|NOT COMPLETED|Combination Therapy Phase||6
185920|NCT00876460|447867|P7|NOT COMPLETED|Combination Therapy Phase||8
185921|NCT00876460|447868|P6|NOT COMPLETED|Combination Therapy Phase||3
185922|NCT00876460|447869|P5|NOT COMPLETED|Combination Therapy Phase||7
185923|NCT00876460|447870|P4|NOT COMPLETED|Combination Therapy Phase||6
185924|NCT00876460|447871|P3|NOT COMPLETED|Combination Therapy Phase||3
185925|NCT00876460|447872|P2|NOT COMPLETED|Combination Therapy Phase||7
185926|NCT00876460|447873|P1|NOT COMPLETED|Combination Therapy Phase||3
185927|NCT00876460|447866|P8|COMPLETED|Combination Therapy Phase||0
185928|NCT00876460|447867|P7|COMPLETED|Combination Therapy Phase||0
185929|NCT00876460|447868|P6|COMPLETED|Combination Therapy Phase||0
185930|NCT00876460|447869|P5|COMPLETED|Combination Therapy Phase||0
185931|NCT00876460|447870|P4|COMPLETED|Combination Therapy Phase||0
185932|NCT00876460|447871|P3|COMPLETED|Combination Therapy Phase||0
185933|NCT00876460|447872|P2|COMPLETED|Combination Therapy Phase||0
185934|NCT00876460|447873|P1|COMPLETED|Combination Therapy Phase||0
185935|NCT00876460|447866|P8|STARTED|Combination Therapy Phase||6
185936|NCT00876460|447867|P7|STARTED|Combination Therapy Phase||8
185937|NCT00876460|447868|P6|STARTED|Combination Therapy Phase||3
185938|NCT00876460|447869|P5|STARTED|Combination Therapy Phase||7
185939|NCT00876460|447870|P4|STARTED|Combination Therapy Phase||6
185940|NCT00876460|447871|P3|STARTED|Combination Therapy Phase||3
185941|NCT00876460|447872|P2|STARTED|Combination Therapy Phase||7
185942|NCT00876460|447873|P1|STARTED|Combination Therapy Phase||3
185943|NCT00876447|447945|P2|NOT COMPLETED|Overall Study||81
185944|NCT00876447|447946|P1|NOT COMPLETED|Overall Study||80
185945|NCT00876447|447945|P2|COMPLETED|Overall Study||122
185946|NCT00876447|447946|P1|COMPLETED|Overall Study||105
185947|NCT00876447|447945|P2|STARTED|Overall Study||203
185948|NCT00876447|447946|P1|STARTED|Overall Study||185
185949|NCT00876343|448007|P3|NOT COMPLETED|Overall Study||12
185950|NCT00876343|448008|P2|NOT COMPLETED|Overall Study||17
185951|NCT00876343|448009|P1|NOT COMPLETED|Overall Study||17
185952|NCT00876343|448007|P3|COMPLETED|Overall Study||183
185953|NCT00876343|448008|P2|COMPLETED|Overall Study||180
185954|NCT00876343|448009|P1|COMPLETED|Overall Study||177
185955|NCT00876343|448007|P3|STARTED|Overall Study||195
185956|NCT00876343|448008|P2|STARTED|Overall Study||197
185957|NCT00876343|448009|P1|STARTED|Overall Study||194
185958|NCT00876265|448023|P1|NOT COMPLETED|Overall Study||12
185959|NCT00876265|448023|P1|COMPLETED|Overall Study||106
185960|NCT00876265|448023|P1|STARTED|Overall Study||118
185961|NCT00876018|448032|P3|NOT COMPLETED|Overall Study||3
185962|NCT00876018|448033|P2|NOT COMPLETED|Overall Study||5
185963|NCT00876018|448034|P1|NOT COMPLETED|Overall Study||5
185964|NCT00876018|448032|P3|COMPLETED|Overall Study||97
185965|NCT00876018|448033|P2|COMPLETED|Overall Study||95
185966|NCT00876018|448034|P1|COMPLETED|Overall Study||95
185967|NCT00876018|448032|P3|STARTED|Overall Study||100
185968|NCT00876018|448033|P2|STARTED|Overall Study||100
185969|NCT00876018|448034|P1|STARTED|Overall Study||100
185970|NCT00875979|448089|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
185971|NCT00875979|448090|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
185972|NCT00875979|448089|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
185973|NCT00875979|448090|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
185974|NCT00875979|448089|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
185975|NCT00875979|448090|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
185976|NCT00875979|448089|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
185977|NCT00875979|448090|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
185978|NCT00875979|448089|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
185979|NCT00875979|448090|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
185980|NCT00875979|448089|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
185981|NCT00875979|448090|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
185982|NCT00875979|448089|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
185983|NCT00875979|448090|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
185984|NCT00875979|448089|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
185985|NCT00875979|448090|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
185986|NCT00875979|448089|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
185987|NCT00875979|448090|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
185988|NCT00875836|448102|P2|NOT COMPLETED|Overall Study||40
185989|NCT00875836|448103|P1|NOT COMPLETED|Overall Study||43
185990|NCT00875836|448102|P2|COMPLETED|Overall Study||47
185991|NCT00875836|448103|P1|COMPLETED|Overall Study||45
185992|NCT00875836|448102|P2|STARTED|Overall Study||87
185993|NCT00875836|448103|P1|STARTED|Overall Study||88
185994|NCT00875810|448113|P1|NOT COMPLETED|Overall Study||46
185995|NCT00875810|448113|P1|COMPLETED|Overall Study||148
185996|NCT00875810|448113|P1|24 Months Follow up|Overall Study||148
185997|NCT00875810|448113|P1|12 Months Follow up|Overall Study||112
185998|NCT00875810|448113|P1|6 Months Follow up|Overall Study||80
185999|NCT00875810|448113|P1|3 Months Follow up|Overall Study||175
186000|NCT00875810|448113|P1|Discharged|Overall Study||177
186001|NCT00875810|448113|P1|Implanted|Overall Study||190
186002|NCT00875810|448113|P1|STARTED|Overall Study||194
186003|NCT00875797|448122|P2|NOT COMPLETED|Overall Study||3
186004|NCT00875797|448123|P1|NOT COMPLETED|Overall Study||6
186005|NCT00875797|448122|P2|COMPLETED|Overall Study||42
186006|NCT00875797|448123|P1|COMPLETED|Overall Study||39
186007|NCT00875797|448122|P2|STARTED|Overall Study||45
186008|NCT00875797|448123|P1|STARTED|Overall Study||45
186009|NCT00875706|448136|P3|NOT COMPLETED|Overall Study||0
186010|NCT00875706|448137|P2|NOT COMPLETED|Overall Study||0
186011|NCT00875706|448138|P1|NOT COMPLETED|Overall Study||1
186012|NCT00875706|448136|P3|COMPLETED|Overall Study||13
186013|NCT00875706|448137|P2|COMPLETED|Overall Study||24
186014|NCT00875706|448138|P1|COMPLETED|Overall Study||7
186015|NCT00875706|448136|P3|STARTED|Overall Study||13
186016|NCT00875706|448137|P2|STARTED|Overall Study||24
186017|NCT00875706|448138|P1|STARTED|Overall Study||8
186018|NCT00875615|448155|P1|NOT COMPLETED|Overall Study||1
186019|NCT00875615|448155|P1|COMPLETED|Overall Study||10
186020|NCT00875615|448155|P1|STARTED|Overall Study||11
186021|NCT00875589|448162|P2|NOT COMPLETED|Overall Study||0
186022|NCT00875589|448163|P1|NOT COMPLETED|Overall Study||0
186023|NCT00875589|448162|P2|COMPLETED|Overall Study||11
186024|NCT00875589|448163|P1|COMPLETED|Overall Study||15
186025|NCT00875589|448162|P2|STARTED|Overall Study||11
186026|NCT00875589|448163|P1|STARTED|Overall Study||15
186027|NCT00875563|448169|P1|NOT COMPLETED|Overall Study||24
186028|NCT00875563|448169|P1|COMPLETED|Overall Study||18
186029|NCT00875563|448169|P1|STARTED|Overall Study||42
186030|NCT00875550|448175|P2|NOT COMPLETED|Overall Study||10
186031|NCT00875550|448176|P1|NOT COMPLETED|Overall Study||12
186032|NCT00875550|448175|P2|COMPLETED|Overall Study||76
186033|NCT00875550|448176|P1|COMPLETED|Overall Study||77
186034|NCT00875550|448175|P2|STARTED|Overall Study||86
186035|NCT00875550|448176|P1|STARTED|Overall Study||89
186036|NCT00875485|448194|P2|NOT COMPLETED|Challenge Dose Epoch||0
186037|NCT00875485|448195|P1|NOT COMPLETED|Challenge Dose Epoch||1
186038|NCT00875485|448194|P2|COMPLETED|Challenge Dose Epoch||11
186039|NCT00875485|448195|P1|COMPLETED|Challenge Dose Epoch||7
186040|NCT00875485|448194|P2|STARTED|Challenge Dose Epoch||11
186041|NCT00875485|448195|P1|STARTED|Challenge Dose Epoch||8
186042|NCT00875485|448194|P2|NOT COMPLETED|Year 15||0
186043|NCT00875485|448195|P1|NOT COMPLETED|Year 15||0
186044|NCT00875485|448194|P2|COMPLETED|Year 15||111
186045|NCT00875485|448195|P1|COMPLETED|Year 15||98
186046|NCT00875485|448194|P2|STARTED|Year 15||111
186047|NCT00875485|448195|P1|STARTED|Year 15||98
186048|NCT00875485|448194|P2|NOT COMPLETED|Year 14||0
186049|NCT00875485|448195|P1|NOT COMPLETED|Year 14||0
186050|NCT00875485|448194|P2|COMPLETED|Year 14||113
186051|NCT00875485|448195|P1|COMPLETED|Year 14||100
186052|NCT00875485|448194|P2|STARTED|Year 14||113
186053|NCT00875485|448195|P1|STARTED|Year 14||100
186054|NCT00875485|448194|P2|NOT COMPLETED|Year 13||0
186055|NCT00875485|448195|P1|NOT COMPLETED|Year 13||0
186056|NCT00875485|448194|P2|COMPLETED|Year 13||113
186057|NCT00875485|448195|P1|COMPLETED|Year 13||102
186058|NCT00875485|448194|P2|STARTED|Year 13||113
186059|NCT00875485|448195|P1|STARTED|Year 13||102
186060|NCT00875485|448194|P2|NOT COMPLETED|Year 12||0
186061|NCT00875485|448195|P1|NOT COMPLETED|Year 12||0
186062|NCT00875485|448194|P2|COMPLETED|Year 12||109
186063|NCT00875485|448195|P1|COMPLETED|Year 12||101
186064|NCT00875485|448194|P2|STARTED|Year 12||109
186065|NCT00875485|448195|P1|STARTED|Year 12||101
186066|NCT00875485|448194|P2|NOT COMPLETED|Year 11||0
186067|NCT00875485|448195|P1|NOT COMPLETED|Year 11||0
186068|NCT00875485|448194|P2|COMPLETED|Year 11||111
186069|NCT00875485|448195|P1|COMPLETED|Year 11||99
186070|NCT00875485|448194|P2|STARTED|Year 11||111
186071|NCT00875485|448195|P1|STARTED|Year 11||99
186072|NCT00875433|448235|P1|NOT COMPLETED|Overall Study||60
186073|NCT00875433|448235|P1|COMPLETED|Overall Study||0
186074|NCT00875433|448235|P1|STARTED|Overall Study|Treated|60
186075|NCT00875420|448265|P5|NOT COMPLETED|Overall Study||2
186076|NCT00875420|448266|P4|NOT COMPLETED|Overall Study||2
186077|NCT00875420|448267|P3|NOT COMPLETED|Overall Study||3
186078|NCT00875420|448268|P2|NOT COMPLETED|Overall Study||2
186079|NCT00875420|448269|P1|NOT COMPLETED|Overall Study||2
186080|NCT00875420|448265|P5|COMPLETED|Overall Study||17
186081|NCT00875420|448266|P4|COMPLETED|Overall Study||16
186082|NCT00875420|448267|P3|COMPLETED|Overall Study||18
186083|NCT00875420|448268|P2|COMPLETED|Overall Study||18
186084|NCT00875420|448269|P1|COMPLETED|Overall Study||20
186085|NCT00875420|448265|P5|STARTED|Overall Study||19
186086|NCT00875420|448266|P4|STARTED|Overall Study||18
186087|NCT00875420|448267|P3|STARTED|Overall Study||21
186088|NCT00875420|448268|P2|STARTED|Overall Study||20
186089|NCT00875420|448269|P1|STARTED|Overall Study||22
186090|NCT00875394|448299|P3|NOT COMPLETED|Overall Study||0
186091|NCT00875394|448300|P2|NOT COMPLETED|Overall Study||0
186092|NCT00875394|448301|P1|NOT COMPLETED|Overall Study||0
186093|NCT00875394|448299|P3|COMPLETED|Overall Study||9
186094|NCT00875394|448300|P2|COMPLETED|Overall Study||23
186095|NCT00875394|448301|P1|COMPLETED|Overall Study||36
186096|NCT00875394|448299|P3|STARTED|Overall Study||9
186097|NCT00875394|448300|P2|STARTED|Overall Study||23
186098|NCT00875394|448301|P1|STARTED|Overall Study||36
186099|NCT00875329|448309|P1|NOT COMPLETED|Overall Study||0
186100|NCT00875329|448309|P1|COMPLETED|Overall Study||97
186101|NCT00875329|448309|P1|STARTED|Overall Study||97
186102|NCT00875212|448313|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
186103|NCT00875212|448313|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
186104|NCT00875212|448313|P1|STARTED|CaGP and Fluoride Dentifrice||12
186105|NCT00875212|448313|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
186106|NCT00875212|448313|P1|COMPLETED|Fluoride Only Dentifrice||12
186107|NCT00875212|448313|P1|STARTED|Fluoride Only Dentifrice||12
186108|NCT00875212|448313|P1|NOT COMPLETED|CaGP Only Dentifrice||0
186109|NCT00875212|448313|P1|COMPLETED|CaGP Only Dentifrice||12
186110|NCT00875212|448313|P1|STARTED|CaGP Only Dentifrice||12
186111|NCT00875212|448313|P1|NOT COMPLETED|Placebo Dentifrice||0
186112|NCT00875212|448313|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
186113|NCT00875212|448313|P1|STARTED|Placebo Dentifrice||12
186114|NCT00875017|448330|P6|NOT COMPLETED|Fourth Intervention||1
186115|NCT00875017|448331|P5|NOT COMPLETED|Fourth Intervention||0
186116|NCT00875017|448332|P4|NOT COMPLETED|Fourth Intervention||0
186117|NCT00875017|448333|P3|NOT COMPLETED|Fourth Intervention||0
186118|NCT00875017|448334|P2|NOT COMPLETED|Fourth Intervention||0
186119|NCT00875017|448335|P1|NOT COMPLETED|Fourth Intervention||0
186120|NCT00875017|448330|P6|COMPLETED|Fourth Intervention||4
186121|NCT00875017|448331|P5|COMPLETED|Fourth Intervention||3
186122|NCT00875017|448332|P4|COMPLETED|Fourth Intervention||4
186123|NCT00875017|448333|P3|COMPLETED|Fourth Intervention||2
186124|NCT00875017|448334|P2|COMPLETED|Fourth Intervention||3
186125|NCT00875017|448335|P1|COMPLETED|Fourth Intervention||3
186126|NCT00875017|448330|P6|STARTED|Fourth Intervention||5
186127|NCT00875017|448331|P5|STARTED|Fourth Intervention||3
186128|NCT00875017|448332|P4|STARTED|Fourth Intervention||4
186129|NCT00875017|448333|P3|STARTED|Fourth Intervention||2
186130|NCT00875017|448334|P2|STARTED|Fourth Intervention||3
186131|NCT00875017|448335|P1|STARTED|Fourth Intervention||3
186132|NCT00875017|448330|P6|NOT COMPLETED|Washout||0
186133|NCT00875017|448331|P5|NOT COMPLETED|Washout||1
186134|NCT00875017|448332|P4|NOT COMPLETED|Washout||0
186135|NCT00875017|448333|P3|NOT COMPLETED|Washout||0
186136|NCT00875017|448334|P2|NOT COMPLETED|Washout||0
186137|NCT00875017|448335|P1|NOT COMPLETED|Washout||0
186138|NCT00875017|448330|P6|COMPLETED|Washout||5
186139|NCT00875017|448331|P5|COMPLETED|Washout||3
186140|NCT00875017|448332|P4|COMPLETED|Washout||4
186141|NCT00875017|448333|P3|COMPLETED|Washout||2
186142|NCT00875017|448334|P2|COMPLETED|Washout||3
186143|NCT00875017|448335|P1|COMPLETED|Washout||3
186144|NCT00875017|448330|P6|STARTED|Washout||5
186145|NCT00875017|448331|P5|STARTED|Washout||4
186146|NCT00875017|448332|P4|STARTED|Washout||4
186147|NCT00875017|448333|P3|STARTED|Washout||2
186148|NCT00875017|448334|P2|STARTED|Washout||3
186149|NCT00875017|448335|P1|STARTED|Washout||3
186150|NCT00875017|448330|P6|NOT COMPLETED|Third Intervention||0
186151|NCT00875017|448331|P5|NOT COMPLETED|Third Intervention||0
186152|NCT00875017|448332|P4|NOT COMPLETED|Third Intervention||0
186153|NCT00875017|448333|P3|NOT COMPLETED|Third Intervention||1
186154|NCT00875017|448334|P2|NOT COMPLETED|Third Intervention||1
186155|NCT00875017|448335|P1|NOT COMPLETED|Third Intervention||0
186156|NCT00875017|448330|P6|COMPLETED|Third Intervention||5
186157|NCT00875017|448331|P5|COMPLETED|Third Intervention||4
186158|NCT00875017|448332|P4|COMPLETED|Third Intervention||4
186159|NCT00875017|448333|P3|COMPLETED|Third Intervention||2
186160|NCT00875017|448334|P2|COMPLETED|Third Intervention||3
186161|NCT00875017|448335|P1|COMPLETED|Third Intervention||3
186162|NCT00875017|448330|P6|STARTED|Third Intervention||5
186163|NCT00875017|448331|P5|STARTED|Third Intervention||4
186164|NCT00875017|448332|P4|STARTED|Third Intervention||4
186165|NCT00875017|448333|P3|STARTED|Third Intervention||3
186166|NCT00875017|448334|P2|STARTED|Third Intervention||4
186167|NCT00875017|448335|P1|STARTED|Third Intervention||3
186168|NCT00875017|448330|P6|NOT COMPLETED|Washout||0
186169|NCT00875017|448331|P5|NOT COMPLETED|Washout||0
186170|NCT00875017|448332|P4|NOT COMPLETED|Washout||0
186171|NCT00875017|448333|P3|NOT COMPLETED|Washout||0
186172|NCT00875017|448334|P2|NOT COMPLETED|Washout||1
186173|NCT00875017|448335|P1|NOT COMPLETED|Washout||0
186174|NCT00875017|448330|P6|COMPLETED|Washout||5
186175|NCT00875017|448331|P5|COMPLETED|Washout||4
186176|NCT00875017|448332|P4|COMPLETED|Washout||4
186177|NCT00875017|448333|P3|COMPLETED|Washout||3
186178|NCT00875017|448334|P2|COMPLETED|Washout||4
186179|NCT00875017|448335|P1|COMPLETED|Washout||3
186180|NCT00875017|448330|P6|STARTED|Washout||5
186181|NCT00875017|448331|P5|STARTED|Washout||4
186182|NCT00875017|448332|P4|STARTED|Washout||4
186183|NCT00875017|448333|P3|STARTED|Washout||3
186184|NCT00875017|448334|P2|STARTED|Washout||5
186185|NCT00875017|448335|P1|STARTED|Washout||3
186186|NCT00875017|448330|P6|NOT COMPLETED|Second Intervention||0
186187|NCT00875017|448331|P5|NOT COMPLETED|Second Intervention||0
186188|NCT00875017|448332|P4|NOT COMPLETED|Second Intervention||1
186189|NCT00875017|448333|P3|NOT COMPLETED|Second Intervention||0
186190|NCT00875017|448334|P2|NOT COMPLETED|Second Intervention||0
186191|NCT00875017|448335|P1|NOT COMPLETED|Second Intervention||0
186192|NCT00875017|448330|P6|COMPLETED|Second Intervention||5
186193|NCT00875017|448331|P5|COMPLETED|Second Intervention||4
186194|NCT00875017|448332|P4|COMPLETED|Second Intervention||4
186195|NCT00875017|448333|P3|COMPLETED|Second Intervention||3
186196|NCT00875017|448334|P2|COMPLETED|Second Intervention||5
186197|NCT00875017|448335|P1|COMPLETED|Second Intervention||3
186198|NCT00875017|448330|P6|STARTED|Second Intervention||5
186199|NCT00875017|448331|P5|STARTED|Second Intervention||4
186200|NCT00875017|448332|P4|STARTED|Second Intervention||5
186201|NCT00875017|448333|P3|STARTED|Second Intervention||3
186202|NCT00875017|448334|P2|STARTED|Second Intervention||5
186203|NCT00875017|448335|P1|STARTED|Second Intervention||3
186204|NCT00875017|448330|P6|NOT COMPLETED|Washout||0
186205|NCT00875017|448331|P5|NOT COMPLETED|Washout||0
186206|NCT00875017|448332|P4|NOT COMPLETED|Washout||0
186207|NCT00875017|448333|P3|NOT COMPLETED|Washout||1
186208|NCT00875017|448334|P2|NOT COMPLETED|Washout||0
186209|NCT00875017|448335|P1|NOT COMPLETED|Washout||0
186210|NCT00875017|448330|P6|COMPLETED|Washout||5
186211|NCT00875017|448331|P5|COMPLETED|Washout||4
186212|NCT00875017|448332|P4|COMPLETED|Washout||5
186213|NCT00875017|448333|P3|COMPLETED|Washout||3
186214|NCT00875017|448334|P2|COMPLETED|Washout||5
186215|NCT00875017|448335|P1|COMPLETED|Washout||3
186216|NCT00875017|448330|P6|STARTED|Washout||5
186217|NCT00875017|448331|P5|STARTED|Washout||4
186218|NCT00875017|448332|P4|STARTED|Washout||5
186219|NCT00875017|448333|P3|STARTED|Washout||4
186220|NCT00875017|448334|P2|STARTED|Washout||5
186221|NCT00875017|448335|P1|STARTED|Washout||3
186222|NCT00875017|448330|P6|NOT COMPLETED|First Intervention||0
186223|NCT00875017|448331|P5|NOT COMPLETED|First Intervention||1
186224|NCT00875017|448332|P4|NOT COMPLETED|First Intervention||1
186225|NCT00875017|448333|P3|NOT COMPLETED|First Intervention||1
186226|NCT00875017|448334|P2|NOT COMPLETED|First Intervention||0
186227|NCT00875017|448335|P1|NOT COMPLETED|First Intervention||2
186228|NCT00875017|448330|P6|COMPLETED|First Intervention||5
186229|NCT00875017|448331|P5|COMPLETED|First Intervention||4
186230|NCT00875017|448332|P4|COMPLETED|First Intervention||5
186231|NCT00875017|448333|P3|COMPLETED|First Intervention||4
186232|NCT00875017|448334|P2|COMPLETED|First Intervention||5
186233|NCT00875017|448335|P1|COMPLETED|First Intervention||3
186234|NCT00875017|448330|P6|STARTED|First Intervention||5
186235|NCT00875017|448331|P5|STARTED|First Intervention||5
186236|NCT00875017|448332|P4|STARTED|First Intervention||6
186237|NCT00875017|448333|P3|STARTED|First Intervention||5
186238|NCT00875017|448334|P2|STARTED|First Intervention||5
186239|NCT00875017|448335|P1|STARTED|First Intervention||5
186240|NCT00874939|448349|P1|NOT COMPLETED|Overall Study||4
186241|NCT00874939|448349|P1|COMPLETED|Overall Study||0
186242|NCT00874939|448349|P1|Treated|Overall Study||0
186243|NCT00874939|448349|P1|STARTED|Overall Study||4
186244|NCT00874887|448365|P2|NOT COMPLETED|Overall Study||0
186245|NCT00874887|448366|P1|NOT COMPLETED|Overall Study||0
186246|NCT00874887|448365|P2|COMPLETED|Overall Study||34
186247|NCT00874887|448366|P1|COMPLETED|Overall Study||32
186248|NCT00874887|448365|P2|STARTED|Overall Study||34
186249|NCT00874887|448366|P1|STARTED|Overall Study||32
186250|NCT00874848|448382|P2|NOT COMPLETED|Overall Study||28
186251|NCT00874848|448383|P1|NOT COMPLETED|Overall Study||59
186252|NCT00874848|448382|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
186253|NCT00874848|448383|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
186254|NCT00874848|448382|P2|Discontinued|Overall Study||28
186255|NCT00874848|448383|P1|Discontinued|Overall Study||59
186256|NCT00874848|448382|P2|STARTED|Overall Study||29
186257|NCT00874848|448383|P1|STARTED|Overall Study||59
186258|NCT00874822|448399|P1|NOT COMPLETED|Overall Study||8
186259|NCT00874822|448399|P1|COMPLETED|Overall Study||208
186260|NCT00874822|448399|P1|STARTED|Overall Study||216
186261|NCT00874770|448407|P4|NOT COMPLETED|Overall Study||5
186262|NCT00874770|448408|P3|NOT COMPLETED|Overall Study||4
186263|NCT00874770|448409|P2|NOT COMPLETED|Overall Study||1
186264|NCT00874770|448410|P1|NOT COMPLETED|Overall Study||5
186265|NCT00874770|448407|P4|COMPLETED|Overall Study||7
186266|NCT00874770|448408|P3|COMPLETED|Overall Study||8
186267|NCT00874770|448409|P2|COMPLETED|Overall Study||11
186268|NCT00874770|448410|P1|COMPLETED|Overall Study||7
186269|NCT00874770|448407|P4|STARTED|Overall Study||12
186270|NCT00874770|448408|P3|STARTED|Overall Study||12
186271|NCT00874770|448409|P2|STARTED|Overall Study||12
186272|NCT00874770|448410|P1|STARTED|Overall Study||12
186273|NCT00874549|448448|P4|NOT COMPLETED|Overall Study||2
186274|NCT00874549|448449|P3|NOT COMPLETED|Overall Study||4
186275|NCT00874549|448450|P2|NOT COMPLETED|Overall Study||1
186276|NCT00874549|448451|P1|NOT COMPLETED|Overall Study||1
186277|NCT00874549|448448|P4|COMPLETED|Overall Study||56
186278|NCT00874549|448449|P3|COMPLETED|Overall Study||47
186279|NCT00874549|448450|P2|COMPLETED|Overall Study||55
186280|NCT00874549|448451|P1|COMPLETED|Overall Study||50
186281|NCT00874549|448448|P4|STARTED|Overall Study||58
186282|NCT00874549|448449|P3|STARTED|Overall Study||51
186283|NCT00874549|448450|P2|STARTED|Overall Study||56
186284|NCT00874549|448451|P1|STARTED|Overall Study||51
186285|NCT00874510|448519|P2|NOT COMPLETED|Year 2||0
186286|NCT00874510|448520|P1|NOT COMPLETED|Year 2||0
186287|NCT00874510|448519|P2|COMPLETED|Year 2||87
186288|NCT00874510|448520|P1|COMPLETED|Year 2||92
186289|NCT00874510|448519|P2|STARTED|Year 2||87
186290|NCT00874510|448520|P1|STARTED|Year 2||92
186291|NCT00874510|448519|P2|NOT COMPLETED|Year 1||0
186292|NCT00874510|448520|P1|NOT COMPLETED|Year 1||0
186293|NCT00874510|448519|P2|COMPLETED|Year 1||85
186294|NCT00874510|448520|P1|COMPLETED|Year 1||88
186295|NCT00874510|448519|P2|STARTED|Year 1||85
186296|NCT00874510|448520|P1|STARTED|Year 1||88
186297|NCT00874497|448528|P2|NOT COMPLETED|Overall Study||18
186298|NCT00874497|448529|P1|NOT COMPLETED|Overall Study||28
186299|NCT00874497|448528|P2|COMPLETED|Overall Study||15
186300|NCT00874497|448529|P1|COMPLETED|Overall Study||23
186301|NCT00874497|448528|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
186302|NCT00874497|448529|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
186303|NCT00874276|448569|P2|NOT COMPLETED|Overall Study||1
186304|NCT00874276|448570|P1|NOT COMPLETED|Overall Study||1
186305|NCT00874276|448569|P2|COMPLETED|Overall Study||7
186306|NCT00874276|448570|P1|COMPLETED|Overall Study||5
186307|NCT00874276|448569|P2|STARTED|Overall Study||8
186308|NCT00874276|448570|P1|STARTED|Overall Study||6
186309|NCT00874250|448578|P1|NOT COMPLETED|Overall Study||51
186310|NCT00874250|448578|P1|COMPLETED|Overall Study||0
186311|NCT00874250|448578|P1|STARTED|Overall Study||51
186312|NCT00874120|448592|P2|NOT COMPLETED|Second Intervention||0
186313|NCT00874120|448593|P1|NOT COMPLETED|Second Intervention||2
186314|NCT00874120|448592|P2|COMPLETED|Second Intervention||56
186315|NCT00874120|448593|P1|COMPLETED|Second Intervention||50
186316|NCT00874120|448592|P2|STARTED|Second Intervention||56
186317|NCT00874120|448593|P1|STARTED|Second Intervention||52
186318|NCT00874120|448592|P2|NOT COMPLETED|Wash-out Period||0
186319|NCT00874120|448593|P1|NOT COMPLETED|Wash-out Period||0
186320|NCT00874120|448592|P2|COMPLETED|Wash-out Period||56
186321|NCT00874120|448593|P1|COMPLETED|Wash-out Period||52
186322|NCT00874120|448592|P2|STARTED|Wash-out Period||56
186323|NCT00874120|448593|P1|STARTED|Wash-out Period||52
186324|NCT00874120|448592|P2|NOT COMPLETED|First Intervention||2
186325|NCT00874120|448593|P1|NOT COMPLETED|First Intervention||6
186326|NCT00874120|448592|P2|COMPLETED|First Intervention||56
186327|NCT00874120|448593|P1|COMPLETED|First Intervention||52
186328|NCT00874120|448592|P2|STARTED|First Intervention||58
186329|NCT00874120|448593|P1|STARTED|First Intervention||58
186330|NCT00874094|448599|P1|NOT COMPLETED|Overall Study||0
186331|NCT00874094|448599|P1|COMPLETED|Overall Study||15
186332|NCT00874094|448599|P1|STARTED|Overall Study||15
186333|NCT00874029|448606|P1|NOT COMPLETED|Overall Study||21
186334|NCT00874029|448606|P1|COMPLETED|Overall Study||116
186335|NCT00874029|448606|P1|STARTED|Overall Study||137
186336|NCT00873912|448622|P2|NOT COMPLETED|Overall Study||0
186337|NCT00873912|448623|P1|NOT COMPLETED|Overall Study||3
186338|NCT00873912|448622|P2|COMPLETED|Overall Study||60
186339|NCT00873912|448623|P1|COMPLETED|Overall Study||237
186340|NCT00873912|448622|P2|STARTED|Overall Study||60
186341|NCT00873912|448623|P1|STARTED|Overall Study||240
186342|NCT00873873|448641|P4|NOT COMPLETED|Overall Study||0
186343|NCT00873873|448642|P3|NOT COMPLETED|Overall Study||0
186344|NCT00873873|448643|P2|NOT COMPLETED|Overall Study||0
186345|NCT00873873|448644|P1|NOT COMPLETED|Overall Study||0
186346|NCT00873873|448641|P4|COMPLETED|Overall Study||18
186347|NCT00873873|448642|P3|COMPLETED|Overall Study||9
186348|NCT00873873|448643|P2|COMPLETED|Overall Study||8
186349|NCT00873873|448644|P1|COMPLETED|Overall Study||20
186350|NCT00873873|448641|P4|STARTED|Overall Study||18
186351|NCT00873873|448642|P3|STARTED|Overall Study||9
186352|NCT00873873|448643|P2|STARTED|Overall Study||8
186353|NCT00873873|448644|P1|STARTED|Overall Study||20
186354|NCT00873860|448662|P4|NOT COMPLETED|Overall Study||1
186355|NCT00873860|448663|P3|NOT COMPLETED|Overall Study||3
186356|NCT00873860|448664|P2|NOT COMPLETED|Overall Study||0
186357|NCT00873860|448665|P1|NOT COMPLETED|Overall Study||4
186358|NCT00873860|448662|P4|COMPLETED|Overall Study||47
186359|NCT00873860|448663|P3|COMPLETED|Overall Study||48
186360|NCT00873860|448664|P2|COMPLETED|Overall Study||47
186361|NCT00873860|448665|P1|COMPLETED|Overall Study||44
186362|NCT00873860|448662|P4|Treated|Overall Study||48
186363|NCT00873860|448663|P3|Treated|Overall Study||51
186364|NCT00873860|448664|P2|Treated|Overall Study||47
186365|NCT00873860|448665|P1|Treated|Overall Study||47
186366|NCT00873860|448662|P4|STARTED|Overall Study||48
186367|NCT00873860|448663|P3|STARTED|Overall Study||51
186368|NCT00873860|448664|P2|STARTED|Overall Study||47
186369|NCT00873860|448665|P1|STARTED|Overall Study||48
186370|NCT00873821|448736|P2|NOT COMPLETED|Overall Study||0
186371|NCT00873821|448737|P1|NOT COMPLETED|Overall Study||0
186372|NCT00873821|448736|P2|COMPLETED|Overall Study||22
186373|NCT00873821|448737|P1|COMPLETED|Overall Study||22
186374|NCT00873821|448736|P2|STARTED|Overall Study||22
186375|NCT00873821|448737|P1|STARTED|Overall Study||22
186376|NCT00873782|448747|P1|NOT COMPLETED|Overall Study||0
186377|NCT00873782|448747|P1|COMPLETED|Overall Study||16
186378|NCT00873782|448747|P1|STARTED|Overall Study||16
186379|NCT00873730|448753|P2|NOT COMPLETED|Overall Study||5
186380|NCT00873730|448754|P1|NOT COMPLETED|Overall Study||6
186381|NCT00873730|448753|P2|COMPLETED|Overall Study||49
186382|NCT00873730|448754|P1|COMPLETED|Overall Study||48
186383|NCT00873730|448753|P2|STARTED|Overall Study||54
186384|NCT00873730|448754|P1|STARTED|Overall Study||54
186385|NCT00873457|448790|P1|NOT COMPLETED|Overall Study||0
186386|NCT00873457|448790|P1|COMPLETED|Overall Study||16
186387|NCT00873457|448790|P1|STARTED|Overall Study||16
186388|NCT00873366|448797|P1|NOT COMPLETED|Overall Study||6
186389|NCT00873366|448797|P1|COMPLETED|Overall Study||71
186390|NCT00873366|448797|P1|STARTED|Overall Study||77
186391|NCT00873327|448816|P1|NOT COMPLETED|Overall Study||0
186392|NCT00873327|448816|P1|COMPLETED|Overall Study||32
186393|NCT00873327|448816|P1|STARTED|Overall Study||32
186394|NCT00873119|448822|P2|NOT COMPLETED|Overall Study||26
186395|NCT00873119|448823|P1|NOT COMPLETED|Overall Study||44
186396|NCT00873119|448822|P2|COMPLETED|Overall Study||19
186397|NCT00873119|448823|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
186398|NCT00873119|448822|P2|STARTED|Overall Study||45
186399|NCT00873119|448823|P1|STARTED|Overall Study||44
186400|NCT00873093|448844|P5|NOT COMPLETED|Overall Study||2
186401|NCT00873093|448845|P4|NOT COMPLETED|Overall Study||11
186402|NCT00873093|448846|P3|NOT COMPLETED|Overall Study||16
186403|NCT00873093|448847|P2|NOT COMPLETED|Overall Study||27
186404|NCT00873093|448848|P1|NOT COMPLETED|Overall Study||1
186405|NCT00873093|448844|P5|COMPLETED|Overall Study||8
186406|NCT00873093|448845|P4|COMPLETED|Overall Study||12
186407|NCT00873093|448846|P3|COMPLETED|Overall Study||33
186408|NCT00873093|448847|P2|COMPLETED|Overall Study||35
186409|NCT00873093|448848|P1|COMPLETED|Overall Study||3
186410|NCT00873093|448844|P5|STARTED|Overall Study||10
186411|NCT00873093|448845|P4|STARTED|Overall Study||23
186412|NCT00873093|448846|P3|STARTED|Overall Study||49
186413|NCT00873093|448847|P2|STARTED|Overall Study||62
186414|NCT00873093|448848|P1|STARTED|Overall Study||4
186415|NCT00873041|448905|P3|NOT COMPLETED|Extension Study||2
186416|NCT00873041|448906|P2|NOT COMPLETED|Extension Study||0
186417|NCT00873041|448907|P1|NOT COMPLETED|Extension Study||1
186418|NCT00873041|448905|P3|COMPLETED|Extension Study||46
186419|NCT00873041|448906|P2|COMPLETED|Extension Study||44
186420|NCT00873041|448907|P1|COMPLETED|Extension Study||40
186421|NCT00873041|448905|P3|STARTED|Extension Study||48
186422|NCT00873041|448906|P2|STARTED|Extension Study||44
186423|NCT00873041|448907|P1|STARTED|Extension Study||41
186424|NCT00873041|448905|P3|NOT COMPLETED|Core Study||5
186425|NCT00873041|448906|P2|NOT COMPLETED|Core Study||6
186426|NCT00873041|448907|P1|NOT COMPLETED|Core Study||7
186427|NCT00873041|448905|P3|COMPLETED|Core Study||51
186428|NCT00873041|448906|P2|COMPLETED|Core Study||49
186429|NCT00873041|448907|P1|COMPLETED|Core Study||48
186430|NCT00873041|448905|P3|STARTED|Core Study||56
186431|NCT00873041|448906|P2|STARTED|Core Study||55
186432|NCT00873041|448907|P1|STARTED|Core Study||55
186433|NCT00873015|448965|P4|NOT COMPLETED|Overall Study||0
186434|NCT00873015|448966|P3|NOT COMPLETED|Overall Study||0
186435|NCT00873015|448967|P2|NOT COMPLETED|Overall Study||1
186436|NCT00873015|448968|P1|NOT COMPLETED|Overall Study||0
186437|NCT00873015|448965|P4|COMPLETED|Overall Study||3
186438|NCT00873015|448966|P3|COMPLETED|Overall Study||3
186439|NCT00873015|448967|P2|COMPLETED|Overall Study||3
186440|NCT00873015|448968|P1|COMPLETED|Overall Study||9
186441|NCT00873015|448965|P4|STARTED|Overall Study||3
186442|NCT00873015|448966|P3|STARTED|Overall Study||3
186443|NCT00873015|448967|P2|STARTED|Overall Study||4
186444|NCT00873015|448968|P1|STARTED|Overall Study||9
186445|NCT00872989|448977|P2|NOT COMPLETED|Overall Study||63
186446|NCT00872989|448978|P1|NOT COMPLETED|Overall Study||65
186447|NCT00872989|448977|P2|COMPLETED|Overall Study||0
186448|NCT00872989|448978|P1|COMPLETED|Overall Study||1
186449|NCT00872989|448977|P2|STARTED|Overall Study||63
186450|NCT00872989|448978|P1|STARTED|Overall Study||66
186451|NCT00872898|448997|P2|NOT COMPLETED|Part Two - Double Blind||6
186452|NCT00872898|448998|P1|NOT COMPLETED|Part Two - Double Blind||11
186453|NCT00872898|448997|P2|COMPLETED|Part Two - Double Blind||54
186454|NCT00872898|448998|P1|COMPLETED|Part Two - Double Blind||50
186455|NCT00872898|448997|P2|STARTED|Part Two - Double Blind||60
186456|NCT00872898|448998|P1|STARTED|Part Two - Double Blind||61
186457|NCT00872898|448997|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
186458|NCT00872898|448998|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
186459|NCT00872898|448997|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
186460|NCT00872898|448998|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
186461|NCT00872898|448997|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
186462|NCT00872898|448998|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
186463|NCT00872833|449032|P2|NOT COMPLETED|Overall Study||0
186464|NCT00872833|449033|P1|NOT COMPLETED|Overall Study||0
186465|NCT00872833|449032|P2|COMPLETED|Overall Study||17
186466|NCT00872833|449033|P1|COMPLETED|Overall Study||15
186467|NCT00872833|449032|P2|STARTED|Overall Study||17
186468|NCT00872833|449033|P1|STARTED|Overall Study||15
186469|NCT00872729|449042|P1|NOT COMPLETED|Overall Study||0
186470|NCT00872729|449042|P1|COMPLETED|Overall Study||9
186471|NCT00872729|449042|P1|STARTED|Overall Study||9
186472|NCT00872599|449072|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
186473|NCT00872599|449073|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
186474|NCT00872599|449072|P2|COMPLETED|Second Drug During High Salt Intake||16
186475|NCT00872599|449073|P1|COMPLETED|Second Drug During High Salt Intake||15
186476|NCT00872599|449072|P2|STARTED|Second Drug During High Salt Intake||16
186477|NCT00872599|449073|P1|STARTED|Second Drug During High Salt Intake||15
186478|NCT00872599|449072|P2|NOT COMPLETED|Second Washout Period||1
186479|NCT00872599|449073|P1|NOT COMPLETED|Second Washout Period||1
186480|NCT00872599|449072|P2|COMPLETED|Second Washout Period||16
186481|NCT00872599|449073|P1|COMPLETED|Second Washout Period||15
186482|NCT00872599|449072|P2|STARTED|Second Washout Period||17
186483|NCT00872599|449073|P1|STARTED|Second Washout Period||16
186484|NCT00872599|449072|P2|NOT COMPLETED|First Drug During High Salt Intake||0
186485|NCT00872599|449073|P1|NOT COMPLETED|First Drug During High Salt Intake||0
186486|NCT00872599|449072|P2|COMPLETED|First Drug During High Salt Intake||17
186487|NCT00872599|449073|P1|COMPLETED|First Drug During High Salt Intake||16
186488|NCT00872599|449072|P2|STARTED|First Drug During High Salt Intake||17
186489|NCT00872599|449073|P1|STARTED|First Drug During High Salt Intake||16
186490|NCT00872599|449072|P2|NOT COMPLETED|First Washout Period After Low Salt||0
186491|NCT00872599|449073|P1|NOT COMPLETED|First Washout Period After Low Salt||0
186492|NCT00872599|449072|P2|COMPLETED|First Washout Period After Low Salt||17
186493|NCT00872599|449073|P1|COMPLETED|First Washout Period After Low Salt||16
186494|NCT00872599|449072|P2|STARTED|First Washout Period After Low Salt||17
186495|NCT00872599|449073|P1|STARTED|First Washout Period After Low Salt||16
186496|NCT00872534|449083|P2|NOT COMPLETED|Overall Study||3
186497|NCT00872534|449084|P1|NOT COMPLETED|Overall Study||3
186498|NCT00872534|449083|P2|COMPLETED|Overall Study||101
186499|NCT00872534|449084|P1|COMPLETED|Overall Study||97
186500|NCT00872534|449083|P2|STARTED|Overall Study||104
186501|NCT00872534|449084|P1|STARTED|Overall Study||100
186502|NCT00872521|449093|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
186503|NCT00872521|449094|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
186504|NCT00872521|449095|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
186505|NCT00872521|449093|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
186506|NCT00872521|449094|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
186507|NCT00872521|449095|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
186508|NCT00872521|449093|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
186509|NCT00872521|449094|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
186510|NCT00872521|449095|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
186511|NCT00872521|449093|P3|NOT COMPLETED|Completed 3-month Follow up||0
186512|NCT00872521|449094|P2|NOT COMPLETED|Completed 3-month Follow up||3
186513|NCT00872521|449095|P1|NOT COMPLETED|Completed 3-month Follow up||0
186514|NCT00872521|449093|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
186515|NCT00872521|449094|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
186516|NCT00872521|449095|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
186517|NCT00872521|449093|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
186518|NCT00872521|449094|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
186519|NCT00872521|449095|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
186520|NCT00872521|449093|P3|NOT COMPLETED|Primary Endpoint Analysis||1
186521|NCT00872521|449094|P2|NOT COMPLETED|Primary Endpoint Analysis||5
186522|NCT00872521|449095|P1|NOT COMPLETED|Primary Endpoint Analysis||1
186523|NCT00872521|449093|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
186524|NCT00872521|449094|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
186525|NCT00872521|449095|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
186526|NCT00872521|449093|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
186527|NCT00872521|449094|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
186528|NCT00872521|449095|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
186529|NCT00872521|449093|P3|NOT COMPLETED|Completed PAD Induction||0
186530|NCT00872521|449094|P2|NOT COMPLETED|Completed PAD Induction||4
186531|NCT00872521|449095|P1|NOT COMPLETED|Completed PAD Induction||5
186532|NCT00872521|449093|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
186533|NCT00872521|449094|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
186534|NCT00872521|449095|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
186535|NCT00872521|449093|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
186536|NCT00872521|449094|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
186537|NCT00872521|449095|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
186538|NCT00872430|449143|P2|NOT COMPLETED|Second Intervention||0
186539|NCT00872430|449144|P1|NOT COMPLETED|Second Intervention||0
186540|NCT00872430|449143|P2|COMPLETED|Second Intervention||10
186541|NCT00872430|449144|P1|COMPLETED|Second Intervention||10
186542|NCT00872430|449143|P2|STARTED|Second Intervention||10
186543|NCT00872430|449144|P1|STARTED|Second Intervention||10
186544|NCT00872430|449143|P2|NOT COMPLETED|Washout Period||0
186545|NCT00872430|449144|P1|NOT COMPLETED|Washout Period||0
186546|NCT00872430|449143|P2|COMPLETED|Washout Period||10
186547|NCT00872430|449144|P1|COMPLETED|Washout Period||10
186548|NCT00872430|449143|P2|STARTED|Washout Period||10
186549|NCT00872430|449144|P1|STARTED|Washout Period||10
186550|NCT00872430|449143|P2|NOT COMPLETED|First Intervention||0
186551|NCT00872430|449144|P1|NOT COMPLETED|First Intervention||0
186552|NCT00872430|449143|P2|COMPLETED|First Intervention||10
186553|NCT00872430|449144|P1|COMPLETED|First Intervention||10
186554|NCT00872430|449143|P2|STARTED|First Intervention||10
186555|NCT00872430|449144|P1|STARTED|First Intervention||10
186556|NCT00872339|449153|P3|NOT COMPLETED|Overall Study||0
186557|NCT00872339|449154|P2|NOT COMPLETED|Overall Study||0
186558|NCT00872339|449155|P1|NOT COMPLETED|Overall Study||0
186559|NCT00872339|449153|P3|COMPLETED|Overall Study||37
186560|NCT00872339|449154|P2|COMPLETED|Overall Study||14
186561|NCT00872339|449155|P1|COMPLETED|Overall Study||201
186562|NCT00872339|449153|P3|STARTED|Overall Study||37
186563|NCT00872339|449154|P2|STARTED|Overall Study||14
186564|NCT00872339|449155|P1|STARTED|Overall Study||201
186565|NCT00872170|449166|P2|NOT COMPLETED|Overall Study||0
186566|NCT00872170|449167|P1|NOT COMPLETED|Overall Study||1
186567|NCT00872170|449166|P2|COMPLETED|Overall Study||13
186568|NCT00872170|449167|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
186569|NCT00872170|449166|P2|STARTED|Overall Study||13
186570|NCT00872170|449167|P1|STARTED|Overall Study||14
186571|NCT00872079|449182|P1|NOT COMPLETED|Overall Study||0
186572|NCT00872079|449182|P1|COMPLETED|Overall Study||175
186573|NCT00872079|449182|P1|STARTED|Overall Study||175
186574|NCT00872027|449188|P2|NOT COMPLETED|Overall Study||0
186575|NCT00872027|449189|P1|NOT COMPLETED|Overall Study||0
186576|NCT00872027|449188|P2|COMPLETED|Overall Study||8
186577|NCT00872027|449189|P1|COMPLETED|Overall Study||7
186578|NCT00872027|449188|P2|STARTED|Overall Study||8
186579|NCT00872027|449189|P1|STARTED|Overall Study||7
186580|NCT00872001|449197|P2|NOT COMPLETED|Overall Study||131
186581|NCT00872001|449198|P1|NOT COMPLETED|Overall Study||136
186582|NCT00872001|449197|P2|COMPLETED|Overall Study||1413
186583|NCT00872001|449198|P1|COMPLETED|Overall Study||1400
186584|NCT00872001|449197|P2|STARTED|Overall Study||1544
186585|NCT00872001|449198|P1|STARTED|Overall Study||1536
186586|NCT00871975|449206|P1|NOT COMPLETED|Overall Study||22
186587|NCT00871975|449206|P1|COMPLETED|Overall Study||133
186588|NCT00871975|449206|P1|STARTED|Overall Study||155
186589|NCT00871871|449212|P4|NOT COMPLETED|Part II||4
186590|NCT00871871|449213|P3|NOT COMPLETED|Part II||4
186591|NCT00871871|449214|P2|NOT COMPLETED|Part II||0
186592|NCT00871871|449215|P1|NOT COMPLETED|Part II||0
186593|NCT00871871|449212|P4|COMPLETED|Part II||11
186594|NCT00871871|449213|P3|COMPLETED|Part II||9
186595|NCT00871871|449214|P2|COMPLETED|Part II||0
186596|NCT00871871|449215|P1|COMPLETED|Part II||0
186597|NCT00871871|449212|P4|STARTED|Part II||15
186598|NCT00871871|449213|P3|STARTED|Part II||13
186599|NCT00871871|449214|P2|STARTED|Part II||0
186600|NCT00871871|449215|P1|STARTED|Part II||0
186601|NCT00871871|449212|P4|NOT COMPLETED|Part I||0
186602|NCT00871871|449213|P3|NOT COMPLETED|Part I||0
186603|NCT00871871|449214|P2|NOT COMPLETED|Part I||3
186604|NCT00871871|449215|P1|NOT COMPLETED|Part I||3
186605|NCT00871871|449212|P4|COMPLETED|Part I||0
186606|NCT00871871|449213|P3|COMPLETED|Part I||0
186607|NCT00871871|449214|P2|COMPLETED|Part I||15
186608|NCT00871871|449215|P1|COMPLETED|Part I||15
186609|NCT00871871|449212|P4|STARTED|Part I||0
186610|NCT00871871|449213|P3|STARTED|Part I||0
186611|NCT00871871|449214|P2|STARTED|Part I||18
186612|NCT00871871|449215|P1|STARTED|Part I||18
186613|NCT00871819|449235|P1|NOT COMPLETED|Overall Study||0
186614|NCT00871819|449235|P1|COMPLETED|Overall Study||20
186615|NCT00871819|449235|P1|STARTED|Overall Study||20
186616|NCT00871780|449239|P1|NOT COMPLETED|Overall Study||27
186617|NCT00871780|449239|P1|COMPLETED|Overall Study||197
186618|NCT00871780|449239|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
186619|NCT00871780|449239|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
186620|NCT00871780|449239|P1|STARTED|Overall Study|number enrolled|224
186621|NCT00871741|449259|P2|NOT COMPLETED|Overall Study||7
186622|NCT00871741|449260|P1|NOT COMPLETED|Overall Study||9
186623|NCT00871741|449259|P2|COMPLETED|Overall Study||0
186624|NCT00871741|449260|P1|COMPLETED|Overall Study||0
186625|NCT00871741|449259|P2|STARTED|Overall Study||7
186626|NCT00871741|449260|P1|STARTED|Overall Study||9
186627|NCT00871728|449274|P1|NOT COMPLETED|Overall Study||20
186628|NCT00871728|449274|P1|COMPLETED|Overall Study||112
186629|NCT00871728|449274|P1|Treated|Overall Study||130
186630|NCT00871728|449274|P1|STARTED|Overall Study||132
186631|NCT00871715|449287|P3|NOT COMPLETED|Overall Study||26
186632|NCT00871715|449288|P2|NOT COMPLETED|Overall Study||16
186633|NCT00871715|449289|P1|NOT COMPLETED|Overall Study||15
186634|NCT00871715|449287|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
186635|NCT00871715|449288|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
186636|NCT00871715|449289|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
186637|NCT00871715|449287|P3|6-mo Follow-up|Overall Study||112
186638|NCT00871715|449288|P2|6-mo Follow-up|Overall Study||113
186639|NCT00871715|449289|P1|6-mo Follow-up|Overall Study||110
186640|NCT00871715|449287|P3|Post-Intervention|Overall Study||115
186641|NCT00871715|449288|P2|Post-Intervention|Overall Study||115
186642|NCT00871715|449289|P1|Post-Intervention|Overall Study||112
186643|NCT00871715|449287|P3|STARTED|Overall Study||122
186644|NCT00871715|449288|P2|STARTED|Overall Study||120
186645|NCT00871715|449289|P1|STARTED|Overall Study||119
186646|NCT00871689|449307|P1|NOT COMPLETED|Overall Study||0
186647|NCT00871689|449307|P1|COMPLETED|Overall Study||2
186648|NCT00871689|449307|P1|STARTED|Overall Study||2
186649|NCT00871624|449320|P2|NOT COMPLETED|Overall Study||1
186650|NCT00871624|449321|P1|NOT COMPLETED|Overall Study||2
186651|NCT00871624|449320|P2|COMPLETED|Overall Study||17
186652|NCT00871624|449321|P1|COMPLETED|Overall Study||16
186653|NCT00871624|449320|P2|STARTED|Overall Study||18
186654|NCT00871624|449321|P1|STARTED|Overall Study||18
186655|NCT00871572|449333|P4|NOT COMPLETED|Overall Study||7
186656|NCT00871572|449334|P3|NOT COMPLETED|Overall Study||4
186657|NCT00871572|449335|P2|NOT COMPLETED|Overall Study||6
186658|NCT00871572|449336|P1|NOT COMPLETED|Overall Study||2
186659|NCT00871572|449333|P4|COMPLETED|Overall Study||19
186660|NCT00871572|449334|P3|COMPLETED|Overall Study||30
186661|NCT00871572|449335|P2|COMPLETED|Overall Study||11
186662|NCT00871572|449336|P1|COMPLETED|Overall Study||8
186663|NCT00871572|449333|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
186664|NCT00871572|449334|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
186665|NCT00871572|449335|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
186666|NCT00871572|449336|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
186667|NCT00871572|449333|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
186668|NCT00871572|449334|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
186669|NCT00871572|449335|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
186670|NCT00871572|449336|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
186671|NCT00871572|449333|P4|STARTED|Overall Study||26
186672|NCT00871572|449334|P3|STARTED|Overall Study||34
186673|NCT00871572|449335|P2|STARTED|Overall Study||17
186674|NCT00871572|449336|P1|STARTED|Overall Study||10
186675|NCT00871494|449406|P1|NOT COMPLETED|Overall Study||14
186676|NCT00871494|449406|P1|COMPLETED|Overall Study||62
186677|NCT00871494|449406|P1|STARTED|Overall Study||76
186678|NCT00871429|449413|P1|NOT COMPLETED|Overall Study||24
186679|NCT00871429|449413|P1|COMPLETED|Overall Study||75
186680|NCT00871429|449413|P1|STARTED|Overall Study||99
186681|NCT00871403|449424|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
186682|NCT00871403|449425|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
186683|NCT00871403|449426|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
186684|NCT00871403|449424|P3|COMPLETED|Monotherapy Treatment Phase||0
186685|NCT00871403|449425|P2|COMPLETED|Monotherapy Treatment Phase||0
186686|NCT00871403|449426|P1|COMPLETED|Monotherapy Treatment Phase||0
186687|NCT00871403|449424|P3|STARTED|Monotherapy Treatment Phase||1
186688|NCT00871403|449425|P2|STARTED|Monotherapy Treatment Phase||13
186689|NCT00871403|449426|P1|STARTED|Monotherapy Treatment Phase||0
186690|NCT00871403|449424|P3|NOT COMPLETED|Combination Treatment Phase||12
186691|NCT00871403|449425|P2|NOT COMPLETED|Combination Treatment Phase||49
186692|NCT00871403|449426|P1|NOT COMPLETED|Combination Treatment Phase||9
186693|NCT00871403|449424|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
186694|NCT00871403|449425|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
186695|NCT00871403|449426|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
186696|NCT00871403|449424|P3|STARTED|Combination Treatment Phase||35
186697|NCT00871403|449425|P2|STARTED|Combination Treatment Phase||62
186698|NCT00871403|449426|P1|STARTED|Combination Treatment Phase||9
186699|NCT00871377|449439|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
186700|NCT00871377|449440|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
186701|NCT00871377|449441|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
186702|NCT00871377|449442|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
186703|NCT00871377|449443|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
186704|NCT00871377|449444|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
186705|NCT00871377|449439|P6|COMPLETED|Third Intervention (10 Weeks)||3
186706|NCT00871377|449440|P5|COMPLETED|Third Intervention (10 Weeks)||4
186707|NCT00871377|449441|P4|COMPLETED|Third Intervention (10 Weeks)||3
186708|NCT00871377|449442|P3|COMPLETED|Third Intervention (10 Weeks)||3
186709|NCT00871377|449443|P2|COMPLETED|Third Intervention (10 Weeks)||4
186710|NCT00871377|449444|P1|COMPLETED|Third Intervention (10 Weeks)||2
186711|NCT00871377|449439|P6|STARTED|Third Intervention (10 Weeks)||3
186712|NCT00871377|449440|P5|STARTED|Third Intervention (10 Weeks)||4
186713|NCT00871377|449441|P4|STARTED|Third Intervention (10 Weeks)||4
186714|NCT00871377|449442|P3|STARTED|Third Intervention (10 Weeks)||3
186715|NCT00871377|449443|P2|STARTED|Third Intervention (10 Weeks)||4
186716|NCT00871377|449444|P1|STARTED|Third Intervention (10 Weeks)||2
186717|NCT00871377|449439|P6|NOT COMPLETED|Washout (6 Weeks)||1
186718|NCT00871377|449440|P5|NOT COMPLETED|Washout (6 Weeks)||0
186719|NCT00871377|449441|P4|NOT COMPLETED|Washout (6 Weeks)||0
186720|NCT00871377|449442|P3|NOT COMPLETED|Washout (6 Weeks)||0
186721|NCT00871377|449443|P2|NOT COMPLETED|Washout (6 Weeks)||0
186722|NCT00871377|449444|P1|NOT COMPLETED|Washout (6 Weeks)||0
186723|NCT00871377|449439|P6|COMPLETED|Washout (6 Weeks)||3
186724|NCT00871377|449440|P5|COMPLETED|Washout (6 Weeks)||4
186725|NCT00871377|449441|P4|COMPLETED|Washout (6 Weeks)||4
186726|NCT00871377|449442|P3|COMPLETED|Washout (6 Weeks)||3
186727|NCT00871377|449443|P2|COMPLETED|Washout (6 Weeks)||4
186728|NCT00871377|449444|P1|COMPLETED|Washout (6 Weeks)||2
186729|NCT00871377|449439|P6|STARTED|Washout (6 Weeks)||4
186730|NCT00871377|449440|P5|STARTED|Washout (6 Weeks)||4
186731|NCT00871377|449441|P4|STARTED|Washout (6 Weeks)||4
186732|NCT00871377|449442|P3|STARTED|Washout (6 Weeks)||3
186733|NCT00871377|449443|P2|STARTED|Washout (6 Weeks)||4
186734|NCT00871377|449444|P1|STARTED|Washout (6 Weeks)||2
186735|NCT00871377|449439|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
186736|NCT00871377|449440|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
186737|NCT00871377|449441|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
186738|NCT00871377|449442|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
186739|NCT00871377|449443|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
186740|NCT00871377|449444|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
186741|NCT00871377|449439|P6|COMPLETED|Second Intervention (10 Weeks)||4
186742|NCT00871377|449440|P5|COMPLETED|Second Intervention (10 Weeks)||4
186743|NCT00871377|449441|P4|COMPLETED|Second Intervention (10 Weeks)||4
186744|NCT00871377|449442|P3|COMPLETED|Second Intervention (10 Weeks)||3
186745|NCT00871377|449443|P2|COMPLETED|Second Intervention (10 Weeks)||4
186746|NCT00871377|449444|P1|COMPLETED|Second Intervention (10 Weeks)||2
186747|NCT00871377|449439|P6|STARTED|Second Intervention (10 Weeks)||4
186748|NCT00871377|449440|P5|STARTED|Second Intervention (10 Weeks)||4
186749|NCT00871377|449441|P4|STARTED|Second Intervention (10 Weeks)||4
186750|NCT00871377|449442|P3|STARTED|Second Intervention (10 Weeks)||3
186751|NCT00871377|449443|P2|STARTED|Second Intervention (10 Weeks)||4
186752|NCT00871377|449444|P1|STARTED|Second Intervention (10 Weeks)||2
186753|NCT00871377|449439|P6|NOT COMPLETED|Washout (6 Weeks)||0
186754|NCT00871377|449440|P5|NOT COMPLETED|Washout (6 Weeks)||0
186755|NCT00871377|449441|P4|NOT COMPLETED|Washout (6 Weeks)||0
186756|NCT00871377|449442|P3|NOT COMPLETED|Washout (6 Weeks)||0
186757|NCT00871377|449443|P2|NOT COMPLETED|Washout (6 Weeks)||0
186758|NCT00871377|449444|P1|NOT COMPLETED|Washout (6 Weeks)||1
186759|NCT00871377|449439|P6|COMPLETED|Washout (6 Weeks)||4
186760|NCT00871377|449440|P5|COMPLETED|Washout (6 Weeks)||4
186761|NCT00871377|449441|P4|COMPLETED|Washout (6 Weeks)||4
186762|NCT00871377|449442|P3|COMPLETED|Washout (6 Weeks)||3
186763|NCT00871377|449443|P2|COMPLETED|Washout (6 Weeks)||4
186764|NCT00871377|449444|P1|COMPLETED|Washout (6 Weeks)||2
186765|NCT00871377|449439|P6|STARTED|Washout (6 Weeks)||4
186766|NCT00871377|449440|P5|STARTED|Washout (6 Weeks)||4
186767|NCT00871377|449441|P4|STARTED|Washout (6 Weeks)||4
186768|NCT00871377|449442|P3|STARTED|Washout (6 Weeks)||3
186769|NCT00871377|449443|P2|STARTED|Washout (6 Weeks)||4
186770|NCT00871377|449444|P1|STARTED|Washout (6 Weeks)||3
186771|NCT00871377|449439|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
186772|NCT00871377|449440|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
186773|NCT00871377|449441|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
186774|NCT00871377|449442|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
186775|NCT00871377|449443|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
186776|NCT00871377|449444|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
186777|NCT00871377|449439|P6|COMPLETED|First Intervention (10 Weeks)||4
186778|NCT00871377|449440|P5|COMPLETED|First Intervention (10 Weeks)||4
186779|NCT00871377|449441|P4|COMPLETED|First Intervention (10 Weeks)||4
186780|NCT00871377|449442|P3|COMPLETED|First Intervention (10 Weeks)||3
186781|NCT00871377|449443|P2|COMPLETED|First Intervention (10 Weeks)||4
186782|NCT00871377|449444|P1|COMPLETED|First Intervention (10 Weeks)||3
186783|NCT00871377|449439|P6|STARTED|First Intervention (10 Weeks)||5
186784|NCT00871377|449440|P5|STARTED|First Intervention (10 Weeks)||4
186785|NCT00871377|449441|P4|STARTED|First Intervention (10 Weeks)||4
186786|NCT00871377|449442|P3|STARTED|First Intervention (10 Weeks)||4
186787|NCT00871377|449443|P2|STARTED|First Intervention (10 Weeks)||4
186788|NCT00871377|449444|P1|STARTED|First Intervention (10 Weeks)||3
186789|NCT00871351|449455|P3|NOT COMPLETED|Overall Study||0
186790|NCT00871351|449456|P2|NOT COMPLETED|Overall Study||1
186791|NCT00871351|449457|P1|NOT COMPLETED|Overall Study||4
186792|NCT00871351|449455|P3|COMPLETED|Overall Study||32
186793|NCT00871351|449456|P2|COMPLETED|Overall Study||45
186794|NCT00871351|449457|P1|COMPLETED|Overall Study||43
186795|NCT00871351|449455|P3|STARTED|Overall Study||32
186796|NCT00871351|449456|P2|STARTED|Overall Study||46
186797|NCT00871351|449457|P1|STARTED|Overall Study||47
186798|NCT00871338|449479|P2|NOT COMPLETED|After Booster||0
186799|NCT00871338|449480|P1|NOT COMPLETED|After Booster||0
186800|NCT00871338|449479|P2|COMPLETED|After Booster||135
186801|NCT00871338|449480|P1|COMPLETED|After Booster||139
186802|NCT00871338|449479|P2|STARTED|After Booster||135
186803|NCT00871338|449480|P1|STARTED|After Booster||139
186804|NCT00871338|449479|P2|NOT COMPLETED|Prior to Booster||3
186805|NCT00871338|449480|P1|NOT COMPLETED|Prior to Booster||2
186806|NCT00871338|449479|P2|COMPLETED|Prior to Booster||139
186807|NCT00871338|449480|P1|COMPLETED|Prior to Booster||140
186808|NCT00871338|449479|P2|STARTED|Prior to Booster||142
186809|NCT00871338|449480|P1|STARTED|Prior to Booster||142
186810|NCT00871286|449560|P2|NOT COMPLETED|Overall Study||6
186811|NCT00871286|449561|P1|NOT COMPLETED|Overall Study||0
186812|NCT00871286|449560|P2|COMPLETED|Overall Study||14
186813|NCT00871286|449561|P1|COMPLETED|Overall Study||20
186814|NCT00871286|449560|P2|STARTED|Overall Study||20
186815|NCT00871286|449561|P1|STARTED|Overall Study||20
186816|NCT00871234|449569|P1|NOT COMPLETED|Overall Study||5
186817|NCT00871234|449569|P1|COMPLETED|Overall Study||23
186818|NCT00871234|449569|P1|STARTED|Overall Study||28
186819|NCT00871169|449573|P1|NOT COMPLETED|Overall Study||3
186820|NCT00871169|449573|P1|COMPLETED|Overall Study||58
186821|NCT00871169|449573|P1|STARTED|Overall Study||61
186822|NCT00871143|449580|P2|NOT COMPLETED|Overall Study||0
186823|NCT00871143|449581|P1|NOT COMPLETED|Overall Study||0
186824|NCT00871143|449580|P2|COMPLETED|Overall Study||25
186825|NCT00871143|449581|P1|COMPLETED|Overall Study||21
186826|NCT00871143|449580|P2|STARTED|Overall Study||25
186827|NCT00871143|449581|P1|STARTED|Overall Study||21
186828|NCT00871117|449601|P2|NOT COMPLETED|Overall Study||10
186829|NCT00871117|449602|P1|NOT COMPLETED|Overall Study||5
186830|NCT00871117|449601|P2|COMPLETED|Overall Study||227
186831|NCT00871117|449602|P1|COMPLETED|Overall Study||234
186832|NCT00871117|449601|P2|STARTED|Overall Study||237
186833|NCT00871117|449602|P1|STARTED|Overall Study||239
186834|NCT00871000|449634|P2|NOT COMPLETED|Overall Study||0
186835|NCT00871000|449635|P1|NOT COMPLETED|Overall Study||1
186836|NCT00871000|449634|P2|COMPLETED|Overall Study||152
186837|NCT00871000|449635|P1|COMPLETED|Overall Study||150
186838|NCT00871000|449634|P2|STARTED|Overall Study||152
186839|NCT00871000|449635|P1|STARTED|Overall Study||151
186840|NCT00870896|449677|P1|NOT COMPLETED|Overall Study||0
186841|NCT00870896|449677|P1|COMPLETED|Overall Study||5
186842|NCT00870896|449677|P1|STARTED|Overall Study||5
186843|NCT00870740|449689|P6|NOT COMPLETED|Overall Study||17
186844|NCT00870740|449690|P5|NOT COMPLETED|Overall Study||11
186845|NCT00870740|449691|P4|NOT COMPLETED|Overall Study||12
186846|NCT00870740|449692|P3|NOT COMPLETED|Overall Study||10
186847|NCT00870740|449693|P2|NOT COMPLETED|Overall Study||9
186848|NCT00870740|449694|P1|NOT COMPLETED|Overall Study||12
186849|NCT00870740|449689|P6|COMPLETED|Overall Study||70
186850|NCT00870740|449690|P5|COMPLETED|Overall Study||77
186851|NCT00870740|449691|P4|COMPLETED|Overall Study||74
186852|NCT00870740|449692|P3|COMPLETED|Overall Study||76
186853|NCT00870740|449693|P2|COMPLETED|Overall Study||75
186854|NCT00870740|449694|P1|COMPLETED|Overall Study||74
186855|NCT00870740|449689|P6|STARTED|Overall Study|number randomized and dosed|87
186856|NCT00870740|449690|P5|STARTED|Overall Study|number randomized and dosed|88
186857|NCT00870740|449691|P4|STARTED|Overall Study|number randomized and dosed|86
186858|NCT00870740|449692|P3|STARTED|Overall Study|number randomized and dosed|86
186859|NCT00870740|449693|P2|STARTED|Overall Study|number randomized and dosed|84
186860|NCT00870740|449694|P1|STARTED|Overall Study|number randomized and dosed|86
186861|NCT00870688|449768|P1|NOT COMPLETED|Overall Study||4
186862|NCT00870688|449768|P1|COMPLETED|Overall Study||78
186863|NCT00870688|449768|P1|STARTED|Overall Study||82
186864|NCT00870584|449773|P2|NOT COMPLETED|Overall Study||13
186865|NCT00870584|449774|P1|NOT COMPLETED|Overall Study||16
186866|NCT00870584|449773|P2|COMPLETED|Overall Study||122
186867|NCT00870584|449774|P1|COMPLETED|Overall Study||120
186868|NCT00870584|449773|P2|STARTED|Overall Study||135
186869|NCT00870584|449774|P1|STARTED|Overall Study||136
186870|NCT00870545|449782|P1|NOT COMPLETED|Overall Study||17
186871|NCT00870545|449782|P1|COMPLETED|Overall Study||69
186872|NCT00870545|449782|P1|STARTED|Overall Study||86
186873|NCT00870467|449793|P6|NOT COMPLETED|Open-label||3
186874|NCT00870467|449794|P5|NOT COMPLETED|Open-label||5
186875|NCT00870467|449795|P4|NOT COMPLETED|Open-label||7
186876|NCT00870467|449796|P3|NOT COMPLETED|Open-label||13
186877|NCT00870467|449797|P2|NOT COMPLETED|Open-label||0
186878|NCT00870467|449798|P1|NOT COMPLETED|Open-label||0
186879|NCT00870467|449793|P6|COMPLETED|Open-label||21
186880|NCT00870467|449794|P5|COMPLETED|Open-label||5
186881|NCT00870467|449795|P4|COMPLETED|Open-label||120
186882|NCT00870467|449796|P3|COMPLETED|Open-label||132
186883|NCT00870467|449797|P2|COMPLETED|Open-label||0
186884|NCT00870467|449798|P1|COMPLETED|Open-label||0
186885|NCT00870467|449793|P6|STARTED|Open-label||24
186886|NCT00870467|449794|P5|STARTED|Open-label||10
186887|NCT00870467|449795|P4|STARTED|Open-label||127
186888|NCT00870467|449796|P3|STARTED|Open-label||145
186889|NCT00870467|449797|P2|STARTED|Open-label||0
186890|NCT00870467|449798|P1|STARTED|Open-label||0
186891|NCT00870467|449793|P6|NOT COMPLETED|Double-blind||0
186892|NCT00870467|449794|P5|NOT COMPLETED|Double-blind||0
186893|NCT00870467|449795|P4|NOT COMPLETED|Double-blind||0
186894|NCT00870467|449796|P3|NOT COMPLETED|Double-blind||0
186895|NCT00870467|449797|P2|NOT COMPLETED|Double-blind||12
186896|NCT00870467|449798|P1|NOT COMPLETED|Double-blind||16
186897|NCT00870467|449793|P6|COMPLETED|Double-blind||0
186898|NCT00870467|449794|P5|COMPLETED|Double-blind||0
186899|NCT00870467|449795|P4|COMPLETED|Double-blind||0
186900|NCT00870467|449796|P3|COMPLETED|Double-blind||0
186901|NCT00870467|449797|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
186902|NCT00870467|449798|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
186903|NCT00870467|449793|P6|STARTED|Double-blind||0
186904|NCT00870467|449794|P5|STARTED|Double-blind||0
186905|NCT00870467|449795|P4|STARTED|Double-blind||0
186906|NCT00870467|449796|P3|STARTED|Double-blind||0
186907|NCT00870467|449797|P2|STARTED|Double-blind||163
186908|NCT00870467|449798|P1|STARTED|Double-blind||171
186909|NCT00870363|449846|P4|NOT COMPLETED|Overall Study||0
186910|NCT00870363|449847|P3|NOT COMPLETED|Overall Study||3
186911|NCT00870363|449848|P2|NOT COMPLETED|Overall Study||3
186912|NCT00870363|449849|P1|NOT COMPLETED|Overall Study||0
186913|NCT00870363|449846|P4|COMPLETED|Overall Study||12
186914|NCT00870363|449847|P3|COMPLETED|Overall Study||8
186915|NCT00870363|449848|P2|COMPLETED|Overall Study||8
186916|NCT00870363|449849|P1|COMPLETED|Overall Study||10
186917|NCT00870363|449846|P4|STARTED|Overall Study||12
186918|NCT00870363|449847|P3|STARTED|Overall Study||11
186919|NCT00870363|449848|P2|STARTED|Overall Study||11
186920|NCT00870363|449849|P1|STARTED|Overall Study||10
186921|NCT00870194|449885|P2|NOT COMPLETED|Overall Study||14
186922|NCT00870194|449886|P1|NOT COMPLETED|Overall Study||26
186923|NCT00870194|449885|P2|COMPLETED|Overall Study||114
186924|NCT00870194|449886|P1|COMPLETED|Overall Study||101
186925|NCT00870194|449885|P2|Per Protocol Set|Overall Study||111
186926|NCT00870194|449886|P1|Per Protocol Set|Overall Study||97
186927|NCT00870194|449885|P2|STARTED|Overall Study||128
186928|NCT00870194|449886|P1|STARTED|Overall Study||127
186929|NCT00870103|449924|P1|NOT COMPLETED|Overall Study||4
186930|NCT00870103|449924|P1|COMPLETED|Overall Study||60
186931|NCT00870103|449924|P1|STARTED|Overall Study||64
186932|NCT00869999|449929|P1|NOT COMPLETED|Overall Study||2
186933|NCT00869999|449929|P1|COMPLETED|Overall Study||24
186934|NCT00869999|449929|P1|STARTED|Overall Study||26
186935|NCT00869960|449935|P1|NOT COMPLETED|Overall Study||2
186936|NCT00869960|449935|P1|COMPLETED|Overall Study||22
186937|NCT00869960|449935|P1|STARTED|Overall Study||24
186938|NCT00869947|449948|P2|NOT COMPLETED|Overall Study||0
186939|NCT00869947|449949|P1|NOT COMPLETED|Overall Study||0
186940|NCT00869947|449948|P2|COMPLETED|Overall Study||8
186941|NCT00869947|449949|P1|COMPLETED|Overall Study||8
186942|NCT00869947|449948|P2|STARTED|Overall Study||8
186943|NCT00869947|449949|P1|STARTED|Overall Study||8
186944|NCT00869791|449962|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
186945|NCT00869791|449963|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
186946|NCT00869791|449962|P2|COMPLETED|Period 2 Treatment for 7 Days||13
186947|NCT00869791|449963|P1|COMPLETED|Period 2 Treatment for 7 Days||14
186948|NCT00869791|449962|P2|STARTED|Period 2 Treatment for 7 Days||13
186949|NCT00869791|449963|P1|STARTED|Period 2 Treatment for 7 Days||14
186950|NCT00869791|449962|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
186951|NCT00869791|449963|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
186952|NCT00869791|449962|P2|COMPLETED|Period 1 Treatment for 7 Days||13
186953|NCT00869791|449963|P1|COMPLETED|Period 1 Treatment for 7 Days||14
186954|NCT00869791|449962|P2|STARTED|Period 1 Treatment for 7 Days||13
186955|NCT00869791|449963|P1|STARTED|Period 1 Treatment for 7 Days||14
186956|NCT00869778|449984|P3|NOT COMPLETED|Overall Study||10
186957|NCT00869778|449985|P2|NOT COMPLETED|Overall Study||7
186958|NCT00869778|449986|P1|NOT COMPLETED|Overall Study||12
186959|NCT00869778|449984|P3|COMPLETED|Overall Study||110
186960|NCT00869778|449985|P2|COMPLETED|Overall Study||113
186961|NCT00869778|449986|P1|COMPLETED|Overall Study||108
186962|NCT00869778|449984|P3|STARTED|Overall Study||120
186963|NCT00869778|449985|P2|STARTED|Overall Study||120
186964|NCT00869778|449986|P1|STARTED|Overall Study||120
186965|NCT00869622|450023|P2|NOT COMPLETED|Overall Study||14
186966|NCT00869622|450024|P1|NOT COMPLETED|Overall Study||13
186967|NCT00869622|450023|P2|COMPLETED|Overall Study||26
186968|NCT00869622|450024|P1|COMPLETED|Overall Study||27
186969|NCT00869622|450023|P2|STARTED|Overall Study||40
186970|NCT00869622|450024|P1|STARTED|Overall Study||40
186971|NCT00869609|450034|P2|NOT COMPLETED|Overall Study||3
186972|NCT00869609|450035|P1|NOT COMPLETED|Overall Study||6
186973|NCT00869609|450034|P2|COMPLETED|Overall Study||26
186974|NCT00869609|450035|P1|COMPLETED|Overall Study||25
186975|NCT00869609|450034|P2|STARTED|Overall Study||29
186976|NCT00869609|450035|P1|STARTED|Overall Study||31
186977|NCT00869557|450061|P2|NOT COMPLETED|Extension Phase||3
186978|NCT00869557|450062|P1|NOT COMPLETED|Extension Phase||10
186979|NCT00869557|450061|P2|COMPLETED|Extension Phase||11
186980|NCT00869557|450062|P1|COMPLETED|Extension Phase||35
186981|NCT00869557|450061|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
186982|NCT00869557|450062|P1|STARTED|Extension Phase||45
186983|NCT00869557|450061|P2|NOT COMPLETED|Randomized Phase||2
186984|NCT00869557|450062|P1|NOT COMPLETED|Randomized Phase||3
186985|NCT00869557|450061|P2|COMPLETED|Randomized Phase||21
186986|NCT00869557|450062|P1|COMPLETED|Randomized Phase||45
186987|NCT00869557|450061|P2|STARTED|Randomized Phase||23
186988|NCT00869557|450062|P1|STARTED|Randomized Phase||48
186989|NCT00869518|450081|P2|NOT COMPLETED|Overall Study||1
186990|NCT00869518|450082|P1|NOT COMPLETED|Overall Study||1
186991|NCT00869518|450081|P2|COMPLETED|Overall Study||5
186992|NCT00869518|450082|P1|COMPLETED|Overall Study||5
186993|NCT00869518|450081|P2|STARTED|Overall Study||6
186994|NCT00869518|450082|P1|STARTED|Overall Study||6
186995|NCT00869414|450094|P3|NOT COMPLETED|Overall Study||0
186996|NCT00869414|450095|P2|NOT COMPLETED|Overall Study||0
186997|NCT00869414|450096|P1|NOT COMPLETED|Overall Study||0
186998|NCT00869414|450094|P3|COMPLETED|Overall Study||0
186999|NCT00869414|450095|P2|COMPLETED|Overall Study||0
187000|NCT00869414|450096|P1|COMPLETED|Overall Study||0
187001|NCT00869414|450094|P3|STARTED|Overall Study||0
187002|NCT00869414|450095|P2|STARTED|Overall Study||0
187003|NCT00869414|450096|P1|STARTED|Overall Study||0
187004|NCT00869401|450110|P5|NOT COMPLETED|Overall Study||3
187005|NCT00869401|450111|P4|NOT COMPLETED|Overall Study||5
187006|NCT00869401|450112|P3|NOT COMPLETED|Overall Study||0
187007|NCT00869401|450113|P2|NOT COMPLETED|Overall Study||0
187008|NCT00869401|450114|P1|NOT COMPLETED|Overall Study||0
187009|NCT00869401|450110|P5|COMPLETED|Overall Study||63
187010|NCT00869401|450111|P4|COMPLETED|Overall Study||133
187011|NCT00869401|450112|P3|COMPLETED|Overall Study||7
187012|NCT00869401|450113|P2|COMPLETED|Overall Study||3
187013|NCT00869401|450114|P1|COMPLETED|Overall Study||3
187014|NCT00869401|450110|P5|STARTED|Overall Study||66
187015|NCT00869401|450111|P4|STARTED|Overall Study||138
187016|NCT00869401|450112|P3|STARTED|Overall Study||7
187017|NCT00869401|450113|P2|STARTED|Overall Study||3
187018|NCT00869401|450114|P1|STARTED|Overall Study||3
187019|NCT00869375|450132|P2|NOT COMPLETED|Overall Study||0
187020|NCT00869375|450133|P1|NOT COMPLETED|Overall Study||0
187021|NCT00869375|450132|P2|COMPLETED|Overall Study||3
187022|NCT00869375|450133|P1|COMPLETED|Overall Study||3
187023|NCT00869375|450132|P2|STARTED|Overall Study||3
187024|NCT00869375|450133|P1|STARTED|Overall Study||3
187025|NCT00869362|450143|P2|NOT COMPLETED|Overall Study||5
187026|NCT00869362|450144|P1|NOT COMPLETED|Overall Study||1
187027|NCT00869362|450143|P2|COMPLETED|Overall Study||11
187028|NCT00869362|450144|P1|COMPLETED|Overall Study||14
187029|NCT00869362|450143|P2|STARTED|Overall Study||16
187030|NCT00869362|450144|P1|STARTED|Overall Study||15
187031|NCT00869349|450154|P2|NOT COMPLETED|Overall Study||4
187032|NCT00869349|450155|P1|NOT COMPLETED|Overall Study||7
187033|NCT00869349|450154|P2|COMPLETED|Overall Study||36
187034|NCT00869349|450155|P1|COMPLETED|Overall Study||32
187035|NCT00869349|450154|P2|STARTED|Overall Study||40
187036|NCT00869349|450155|P1|STARTED|Overall Study||39
187037|NCT00869323|450165|P1|NOT COMPLETED|Maintenance Therapy||1
187038|NCT00869323|450165|P1|COMPLETED|Maintenance Therapy||1
187039|NCT00869323|450165|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
187040|NCT00869323|450165|P1|NOT COMPLETED|Induction Therapy||0
187041|NCT00869323|450165|P1|COMPLETED|Induction Therapy||3
187042|NCT00869323|450165|P1|STARTED|Induction Therapy||3
187043|NCT00869258|450173|P1|NOT COMPLETED|Overall Study||1
187044|NCT00869258|450173|P1|COMPLETED|Overall Study||31
187045|NCT00869258|450173|P1|STARTED|Overall Study||32
187046|NCT00869167|450179|P2|NOT COMPLETED|Overall Study||1
187047|NCT00869167|450180|P1|NOT COMPLETED|Overall Study||0
187048|NCT00869167|450179|P2|COMPLETED|Overall Study||0
187049|NCT00869167|450180|P1|COMPLETED|Overall Study||2
187050|NCT00869167|450179|P2|STARTED|Overall Study||1
187051|NCT00869167|450180|P1|STARTED|Overall Study||2
187052|NCT00869141|450196|P2|NOT COMPLETED|Overall Study||0
187053|NCT00869141|450197|P1|NOT COMPLETED|Overall Study||0
187054|NCT00869141|450196|P2|COMPLETED|Overall Study||26
187055|NCT00869141|450197|P1|COMPLETED|Overall Study||26
187056|NCT00869141|450196|P2|STARTED|Overall Study||26
187057|NCT00869141|450197|P1|STARTED|Overall Study||26
187058|NCT00869128|450207|P2|NOT COMPLETED|Overall Study||6
187059|NCT00869128|450208|P1|NOT COMPLETED|Overall Study||6
187060|NCT00869128|450207|P2|COMPLETED|Overall Study||12
187061|NCT00869128|450208|P1|COMPLETED|Overall Study||12
187062|NCT00869128|450207|P2|STARTED|Overall Study||18
187063|NCT00869128|450208|P1|STARTED|Overall Study||18
187064|NCT00869089|450212|P1|NOT COMPLETED|Overall Study||3
187065|NCT00869089|450212|P1|COMPLETED|Overall Study||2
187066|NCT00869089|450212|P1|STARTED|Overall Study||5
187067|NCT00869050|450216|P1|NOT COMPLETED|Overall Study||3
187068|NCT00869050|450216|P1|COMPLETED|Overall Study||38
187069|NCT00869050|450216|P1|STARTED|Overall Study||41
187070|NCT00868998|450221|P1|NOT COMPLETED|Overall Study||5
187071|NCT00868998|450221|P1|COMPLETED|Overall Study||0
187072|NCT00868998|450221|P1|STARTED|Overall Study||5
187073|NCT00868959|450226|P1|NOT COMPLETED|Overall Study||258
187074|NCT00868959|450226|P1|COMPLETED|Overall Study||559
187075|NCT00868959|450226|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
187076|NCT00868790|450232|P14|NOT COMPLETED|Post-study||0
187077|NCT00868790|450233|P13|NOT COMPLETED|Post-study||0
187078|NCT00868790|450234|P12|NOT COMPLETED|Post-study||0
187079|NCT00868790|450235|P11|NOT COMPLETED|Post-study||0
187080|NCT00868790|450236|P10|NOT COMPLETED|Post-study||1
187081|NCT00868790|450237|P9|NOT COMPLETED|Post-study||0
187082|NCT00868790|450238|P8|NOT COMPLETED|Post-study||2
187083|NCT00868790|450239|P7|NOT COMPLETED|Post-study||0
187084|NCT00868790|450240|P6|NOT COMPLETED|Post-study||0
187085|NCT00868790|450241|P5|NOT COMPLETED|Post-study||1
187086|NCT00868790|450242|P4|NOT COMPLETED|Post-study||0
187087|NCT00868790|450243|P3|NOT COMPLETED|Post-study||0
187088|NCT00868790|450244|P2|NOT COMPLETED|Post-study||0
187089|NCT00868790|450245|P1|NOT COMPLETED|Post-study||0
187090|NCT00868790|450232|P14|COMPLETED|Post-study||7
187091|NCT00868790|450233|P13|COMPLETED|Post-study||6
187092|NCT00868790|450234|P12|COMPLETED|Post-study||3
187093|NCT00868790|450235|P11|COMPLETED|Post-study||5
187094|NCT00868790|450236|P10|COMPLETED|Post-study||1
187095|NCT00868790|450237|P9|COMPLETED|Post-study||6
187096|NCT00868790|450238|P8|COMPLETED|Post-study||12
187097|NCT00868790|450239|P7|COMPLETED|Post-study||4
187098|NCT00868790|450240|P6|COMPLETED|Post-study||1
187099|NCT00868790|450241|P5|COMPLETED|Post-study||17
187100|NCT00868790|450242|P4|COMPLETED|Post-study||3
187101|NCT00868790|450243|P3|COMPLETED|Post-study||3
187102|NCT00868790|450244|P2|COMPLETED|Post-study||6
187103|NCT00868790|450245|P1|COMPLETED|Post-study||7
187104|NCT00868790|450232|P14|STARTED|Post-study||7
187105|NCT00868790|450233|P13|STARTED|Post-study||6
187106|NCT00868790|450234|P12|STARTED|Post-study||3
187107|NCT00868790|450235|P11|STARTED|Post-study||5
187108|NCT00868790|450236|P10|STARTED|Post-study||2
187109|NCT00868790|450237|P9|STARTED|Post-study||6
187110|NCT00868790|450238|P8|STARTED|Post-study||14
187111|NCT00868790|450239|P7|STARTED|Post-study||4
187112|NCT00868790|450240|P6|STARTED|Post-study||1
187113|NCT00868790|450241|P5|STARTED|Post-study||18
187114|NCT00868790|450242|P4|STARTED|Post-study||3
187115|NCT00868790|450243|P3|STARTED|Post-study||3
187116|NCT00868790|450244|P2|STARTED|Post-study||6
187117|NCT00868790|450245|P1|STARTED|Post-study||7
187118|NCT00868790|450232|P14|NOT COMPLETED|Period 4||1
187119|NCT00868790|450233|P13|NOT COMPLETED|Period 4||1
187120|NCT00868790|450234|P12|NOT COMPLETED|Period 4||1
187121|NCT00868790|450235|P11|NOT COMPLETED|Period 4||3
187122|NCT00868790|450236|P10|NOT COMPLETED|Period 4||0
187123|NCT00868790|450237|P9|NOT COMPLETED|Period 4||2
187124|NCT00868790|450238|P8|NOT COMPLETED|Period 4||3
187125|NCT00868790|450239|P7|NOT COMPLETED|Period 4||0
187126|NCT00868790|450240|P6|NOT COMPLETED|Period 4||0
187127|NCT00868790|450241|P5|NOT COMPLETED|Period 4||0
187128|NCT00868790|450242|P4|NOT COMPLETED|Period 4||0
187129|NCT00868790|450243|P3|NOT COMPLETED|Period 4||1
187130|NCT00868790|450244|P2|NOT COMPLETED|Period 4||0
187131|NCT00868790|450245|P1|NOT COMPLETED|Period 4||2
187132|NCT00868790|450232|P14|COMPLETED|Period 4||7
187133|NCT00868790|450233|P13|COMPLETED|Period 4||6
187134|NCT00868790|450234|P12|COMPLETED|Period 4||3
187135|NCT00868790|450235|P11|COMPLETED|Period 4||5
187136|NCT00868790|450236|P10|COMPLETED|Period 4||2
187137|NCT00868790|450237|P9|COMPLETED|Period 4||6
187138|NCT00868790|450238|P8|COMPLETED|Period 4||14
187139|NCT00868790|450239|P7|COMPLETED|Period 4||4
187140|NCT00868790|450240|P6|COMPLETED|Period 4||1
187141|NCT00868790|450241|P5|COMPLETED|Period 4||18
187142|NCT00868790|450242|P4|COMPLETED|Period 4||3
187143|NCT00868790|450243|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
187144|NCT00868790|450244|P2|COMPLETED|Period 4||6
187145|NCT00868790|450245|P1|COMPLETED|Period 4||7
187146|NCT00868790|450232|P14|STARTED|Period 4||8
187147|NCT00868790|450233|P13|STARTED|Period 4||7
187148|NCT00868790|450234|P12|STARTED|Period 4||4
187149|NCT00868790|450235|P11|STARTED|Period 4||8
187150|NCT00868790|450236|P10|STARTED|Period 4||2
187151|NCT00868790|450237|P9|STARTED|Period 4||8
187152|NCT00868790|450238|P8|STARTED|Period 4||17
187153|NCT00868790|450239|P7|STARTED|Period 4||4
187154|NCT00868790|450240|P6|STARTED|Period 4||1
187155|NCT00868790|450241|P5|STARTED|Period 4||18
187156|NCT00868790|450242|P4|STARTED|Period 4||3
187157|NCT00868790|450243|P3|STARTED|Period 4||4
187158|NCT00868790|450244|P2|STARTED|Period 4||6
187159|NCT00868790|450245|P1|STARTED|Period 4||9
187160|NCT00868790|450232|P14|NOT COMPLETED|Period 3||0
187161|NCT00868790|450233|P13|NOT COMPLETED|Period 3||0
187162|NCT00868790|450234|P12|NOT COMPLETED|Period 3||0
187163|NCT00868790|450235|P11|NOT COMPLETED|Period 3||1
187164|NCT00868790|450236|P10|NOT COMPLETED|Period 3||1
187165|NCT00868790|450237|P9|NOT COMPLETED|Period 3||0
187166|NCT00868790|450238|P8|NOT COMPLETED|Period 3||0
187167|NCT00868790|450239|P7|NOT COMPLETED|Period 3||0
187168|NCT00868790|450240|P6|NOT COMPLETED|Period 3||0
187169|NCT00868790|450241|P5|NOT COMPLETED|Period 3||0
187170|NCT00868790|450242|P4|NOT COMPLETED|Period 3||1
187171|NCT00868790|450243|P3|NOT COMPLETED|Period 3||0
187172|NCT00868790|450244|P2|NOT COMPLETED|Period 3||0
187173|NCT00868790|450245|P1|NOT COMPLETED|Period 3||0
187174|NCT00868790|450232|P14|COMPLETED|Period 3||8
187175|NCT00868790|450233|P13|COMPLETED|Period 3||7
187176|NCT00868790|450234|P12|COMPLETED|Period 3||4
187177|NCT00868790|450235|P11|COMPLETED|Period 3||8
187178|NCT00868790|450236|P10|COMPLETED|Period 3||2
187179|NCT00868790|450237|P9|COMPLETED|Period 3||8
187180|NCT00868790|450238|P8|COMPLETED|Period 3||17
187181|NCT00868790|450239|P7|COMPLETED|Period 3||4
187182|NCT00868790|450240|P6|COMPLETED|Period 3||1
187183|NCT00868790|450241|P5|COMPLETED|Period 3||18
187184|NCT00868790|450242|P4|COMPLETED|Period 3||3
187185|NCT00868790|450243|P3|COMPLETED|Period 3||4
187186|NCT00868790|450244|P2|COMPLETED|Period 3||6
187187|NCT00868790|450245|P1|COMPLETED|Period 3||9
187188|NCT00868790|450232|P14|STARTED|Period 3||8
187189|NCT00868790|450233|P13|STARTED|Period 3||7
187190|NCT00868790|450234|P12|STARTED|Period 3||4
187191|NCT00868790|450235|P11|STARTED|Period 3||9
187192|NCT00868790|450236|P10|STARTED|Period 3||3
187193|NCT00868790|450237|P9|STARTED|Period 3||8
187194|NCT00868790|450238|P8|STARTED|Period 3||17
187195|NCT00868790|450239|P7|STARTED|Period 3||4
187196|NCT00868790|450240|P6|STARTED|Period 3||1
187197|NCT00868790|450241|P5|STARTED|Period 3||18
187198|NCT00868790|450242|P4|STARTED|Period 3||4
187199|NCT00868790|450243|P3|STARTED|Period 3||4
187200|NCT00868790|450244|P2|STARTED|Period 3||6
187201|NCT00868790|450245|P1|STARTED|Period 3||9
187202|NCT00868790|450232|P14|NOT COMPLETED|Period 2||1
187203|NCT00868790|450233|P13|NOT COMPLETED|Period 2||0
187204|NCT00868790|450234|P12|NOT COMPLETED|Period 2||0
187205|NCT00868790|450235|P11|NOT COMPLETED|Period 2||0
187206|NCT00868790|450236|P10|NOT COMPLETED|Period 2||0
187207|NCT00868790|450237|P9|NOT COMPLETED|Period 2||2
187208|NCT00868790|450238|P8|NOT COMPLETED|Period 2||0
187209|NCT00868790|450239|P7|NOT COMPLETED|Period 2||0
187210|NCT00868790|450240|P6|NOT COMPLETED|Period 2||1
187211|NCT00868790|450241|P5|NOT COMPLETED|Period 2||0
187212|NCT00868790|450242|P4|NOT COMPLETED|Period 2||0
187213|NCT00868790|450243|P3|NOT COMPLETED|Period 2||0
187214|NCT00868790|450244|P2|NOT COMPLETED|Period 2||1
187215|NCT00868790|450245|P1|NOT COMPLETED|Period 2||0
187216|NCT00868790|450232|P14|COMPLETED|Period 2||8
187217|NCT00868790|450233|P13|COMPLETED|Period 2||7
187218|NCT00868790|450234|P12|COMPLETED|Period 2||4
187219|NCT00868790|450235|P11|COMPLETED|Period 2||9
187220|NCT00868790|450236|P10|COMPLETED|Period 2||3
187221|NCT00868790|450237|P9|COMPLETED|Period 2||8
187222|NCT00868790|450238|P8|COMPLETED|Period 2||17
187223|NCT00868790|450239|P7|COMPLETED|Period 2||4
187224|NCT00868790|450240|P6|COMPLETED|Period 2||1
187225|NCT00868790|450241|P5|COMPLETED|Period 2||18
187226|NCT00868790|450242|P4|COMPLETED|Period 2||4
187227|NCT00868790|450243|P3|COMPLETED|Period 2||4
187228|NCT00868790|450244|P2|COMPLETED|Period 2||6
187229|NCT00868790|450245|P1|COMPLETED|Period 2||9
187230|NCT00868790|450232|P14|STARTED|Period 2||9
187231|NCT00868790|450233|P13|STARTED|Period 2||7
187232|NCT00868790|450234|P12|STARTED|Period 2||4
187233|NCT00868790|450235|P11|STARTED|Period 2||9
187234|NCT00868790|450236|P10|STARTED|Period 2||3
187235|NCT00868790|450237|P9|STARTED|Period 2||10
187236|NCT00868790|450238|P8|STARTED|Period 2||17
187237|NCT00868790|450239|P7|STARTED|Period 2||4
187238|NCT00868790|450240|P6|STARTED|Period 2||2
187239|NCT00868790|450241|P5|STARTED|Period 2||18
187240|NCT00868790|450242|P4|STARTED|Period 2||4
187241|NCT00868790|450243|P3|STARTED|Period 2||4
187242|NCT00868790|450244|P2|STARTED|Period 2||7
187243|NCT00868790|450245|P1|STARTED|Period 2||9
187244|NCT00868790|450232|P14|NOT COMPLETED|Period 1||2
187245|NCT00868790|450233|P13|NOT COMPLETED|Period 1||0
187246|NCT00868790|450234|P12|NOT COMPLETED|Period 1||0
187247|NCT00868790|450235|P11|NOT COMPLETED|Period 1||0
187248|NCT00868790|450236|P10|NOT COMPLETED|Period 1||0
187249|NCT00868790|450237|P9|NOT COMPLETED|Period 1||1
187250|NCT00868790|450238|P8|NOT COMPLETED|Period 1||3
187251|NCT00868790|450239|P7|NOT COMPLETED|Period 1||0
187252|NCT00868790|450240|P6|NOT COMPLETED|Period 1||1
187253|NCT00868790|450241|P5|NOT COMPLETED|Period 1||1
187254|NCT00868790|450242|P4|NOT COMPLETED|Period 1||0
187255|NCT00868790|450243|P3|NOT COMPLETED|Period 1||0
187256|NCT00868790|450244|P2|NOT COMPLETED|Period 1||1
187257|NCT00868790|450245|P1|NOT COMPLETED|Period 1||2
187258|NCT00868790|450232|P14|COMPLETED|Period 1||9
187259|NCT00868790|450233|P13|COMPLETED|Period 1||7
187260|NCT00868790|450234|P12|COMPLETED|Period 1||4
187261|NCT00868790|450235|P11|COMPLETED|Period 1||9
187262|NCT00868790|450236|P10|COMPLETED|Period 1||3
187263|NCT00868790|450237|P9|COMPLETED|Period 1||10
187264|NCT00868790|450238|P8|COMPLETED|Period 1||17
187265|NCT00868790|450239|P7|COMPLETED|Period 1||4
187266|NCT00868790|450240|P6|COMPLETED|Period 1||2
187267|NCT00868790|450241|P5|COMPLETED|Period 1||18
187268|NCT00868790|450242|P4|COMPLETED|Period 1||4
187269|NCT00868790|450243|P3|COMPLETED|Period 1||4
187270|NCT00868790|450244|P2|COMPLETED|Period 1||7
187271|NCT00868790|450245|P1|COMPLETED|Period 1||9
187272|NCT00868790|450232|P14|STARTED|Period 1||11
187273|NCT00868790|450233|P13|STARTED|Period 1||7
187274|NCT00868790|450234|P12|STARTED|Period 1||4
187275|NCT00868790|450235|P11|STARTED|Period 1||9
187276|NCT00868790|450236|P10|STARTED|Period 1||3
187277|NCT00868790|450237|P9|STARTED|Period 1||11
187278|NCT00868790|450238|P8|STARTED|Period 1||20
187279|NCT00868790|450239|P7|STARTED|Period 1||4
187280|NCT00868790|450240|P6|STARTED|Period 1||3
187281|NCT00868790|450241|P5|STARTED|Period 1||19
187282|NCT00868790|450242|P4|STARTED|Period 1||4
187283|NCT00868790|450243|P3|STARTED|Period 1||4
187284|NCT00868790|450244|P2|STARTED|Period 1||8
187285|NCT00868790|450245|P1|STARTED|Period 1||11
187286|NCT00868751|450282|P1|NOT COMPLETED|Overall Study||1
187287|NCT00868751|450282|P1|COMPLETED|Overall Study||0
187288|NCT00868751|450282|P1|STARTED|Overall Study||1
187289|NCT00868712|450293|P3|NOT COMPLETED|Overall Study||0
187290|NCT00868712|450294|P2|NOT COMPLETED|Overall Study||0
187291|NCT00868712|450295|P1|NOT COMPLETED|Overall Study||0
187292|NCT00868712|450293|P3|COMPLETED|Overall Study||28
187293|NCT00868712|450294|P2|COMPLETED|Overall Study||11
187294|NCT00868712|450295|P1|COMPLETED|Overall Study||31
187295|NCT00868712|450293|P3|STARTED|Overall Study||28
187296|NCT00868712|450294|P2|STARTED|Overall Study||11
187297|NCT00868712|450295|P1|STARTED|Overall Study||31
187298|NCT00868699|450309|P3|NOT COMPLETED|Overall Study||43
187299|NCT00868699|450310|P2|NOT COMPLETED|Overall Study||45
187300|NCT00868699|450311|P1|NOT COMPLETED|Overall Study||43
187301|NCT00868699|450309|P3|COMPLETED|Overall Study||123
187302|NCT00868699|450310|P2|COMPLETED|Overall Study||124
187303|NCT00868699|450311|P1|COMPLETED|Overall Study||127
187304|NCT00868699|450309|P3|Safety Population|Overall Study||164
187305|NCT00868699|450310|P2|Safety Population|Overall Study||167
187306|NCT00868699|450311|P1|Safety Population|Overall Study||168
187307|NCT00868699|450309|P3|Intent-to-Treat Population|Overall Study||161
187308|NCT00868699|450310|P2|Intent-to-Treat Population|Overall Study||162
187309|NCT00868699|450311|P1|Intent-to-Treat Population|Overall Study||162
187310|NCT00868699|450309|P3|STARTED|Overall Study||166
187311|NCT00868699|450310|P2|STARTED|Overall Study||169
187312|NCT00868699|450311|P1|STARTED|Overall Study||170
187313|NCT00868608|450328|P3|NOT COMPLETED|Overall Study||5
187314|NCT00868608|450329|P2|NOT COMPLETED|Overall Study||3
187315|NCT00868608|450330|P1|NOT COMPLETED|Overall Study||23
187316|NCT00868608|450328|P3|COMPLETED|Overall Study||0
187317|NCT00868608|450329|P2|COMPLETED|Overall Study||1
187318|NCT00868608|450330|P1|COMPLETED|Overall Study||49
187319|NCT00868608|450328|P3|STARTED|Overall Study||5
187320|NCT00868608|450329|P2|STARTED|Overall Study||4
187321|NCT00868608|450330|P1|STARTED|Overall Study||72
187322|NCT00868530|450354|P1|NOT COMPLETED|Overall Study||4
187323|NCT00868530|450354|P1|COMPLETED|Overall Study||49
187324|NCT00868530|450354|P1|STARTED|Overall Study||53
187325|NCT00868517|450369|P3|NOT COMPLETED|Overall Study||2
187326|NCT00868517|450370|P2|NOT COMPLETED|Overall Study||4
187327|NCT00868517|450371|P1|NOT COMPLETED|Overall Study||4
187328|NCT00868517|450369|P3|COMPLETED|Overall Study||9
187329|NCT00868517|450370|P2|COMPLETED|Overall Study||8
187330|NCT00868517|450371|P1|COMPLETED|Overall Study||8
187331|NCT00868517|450369|P3|STARTED|Overall Study||11
187332|NCT00868517|450370|P2|STARTED|Overall Study||12
187333|NCT00868517|450371|P1|STARTED|Overall Study||12
187334|NCT00868452|450396|P2|NOT COMPLETED|Overall Study||29
187335|NCT00868452|450397|P1|NOT COMPLETED|Overall Study||40
187336|NCT00868452|450396|P2|COMPLETED|Overall Study||136
187337|NCT00868452|450397|P1|COMPLETED|Overall Study||143
187338|NCT00868452|450396|P2|STARTED|Overall Study||165
187339|NCT00868452|450397|P1|STARTED|Overall Study||183
187340|NCT00868439|450409|P2|NOT COMPLETED|Overall Study||9
187341|NCT00868439|450410|P1|NOT COMPLETED|Overall Study||8
187342|NCT00868439|450409|P2|COMPLETED|Overall Study||40
187343|NCT00868439|450410|P1|COMPLETED|Overall Study||48
187344|NCT00868439|450409|P2|STARTED|Overall Study||49
187345|NCT00868439|450410|P1|STARTED|Overall Study||56
187346|NCT00868374|450428|P2|NOT COMPLETED|Overall Study||7
187347|NCT00868374|450429|P1|NOT COMPLETED|Overall Study||7
187348|NCT00868374|450428|P2|COMPLETED|Overall Study||4
187349|NCT00868374|450429|P1|COMPLETED|Overall Study||5
187350|NCT00868374|450428|P2|STARTED|Overall Study||11
187351|NCT00868374|450429|P1|STARTED|Overall Study||12
187352|NCT00868348|450437|P2|NOT COMPLETED|Overall Study||0
187353|NCT00868348|450438|P1|NOT COMPLETED|Overall Study||0
187354|NCT00868348|450437|P2|COMPLETED|Overall Study||30
187355|NCT00868348|450438|P1|COMPLETED|Overall Study||30
187356|NCT00868348|450437|P2|STARTED|Overall Study||30
187357|NCT00868348|450438|P1|STARTED|Overall Study||30
187358|NCT00868309|450456|P2|NOT COMPLETED|Overall Study||0
187359|NCT00868309|450457|P1|NOT COMPLETED|Overall Study||0
187360|NCT00868309|450456|P2|COMPLETED|Overall Study||6
187361|NCT00868309|450457|P1|COMPLETED|Overall Study||6
187362|NCT00868309|450456|P2|STARTED|Overall Study||6
187363|NCT00868309|450457|P1|STARTED|Overall Study||6
187364|NCT00868296|450467|P2|NOT COMPLETED|Overall Study||3
187365|NCT00868296|450468|P1|NOT COMPLETED|Overall Study||0
187366|NCT00868296|450467|P2|COMPLETED|Overall Study||43
187367|NCT00868296|450468|P1|COMPLETED|Overall Study||12
187368|NCT00868296|450467|P2|STARTED|Overall Study||46
187369|NCT00868296|450468|P1|STARTED|Overall Study||12
187370|NCT00868231|450476|P6|NOT COMPLETED|Treatment Period 3||0
187371|NCT00868231|450477|P5|NOT COMPLETED|Treatment Period 3||0
187372|NCT00868231|450478|P4|NOT COMPLETED|Treatment Period 3||0
187373|NCT00868231|450479|P3|NOT COMPLETED|Treatment Period 3||1
187374|NCT00868231|450480|P2|NOT COMPLETED|Treatment Period 3||0
187375|NCT00868231|450481|P1|NOT COMPLETED|Treatment Period 3||0
187376|NCT00868231|450476|P6|COMPLETED|Treatment Period 3||5
187377|NCT00868231|450477|P5|COMPLETED|Treatment Period 3||4
187378|NCT00868231|450478|P4|COMPLETED|Treatment Period 3||5
187379|NCT00868231|450479|P3|COMPLETED|Treatment Period 3||4
187380|NCT00868231|450480|P2|COMPLETED|Treatment Period 3||5
187381|NCT00868231|450481|P1|COMPLETED|Treatment Period 3||4
187382|NCT00868231|450476|P6|STARTED|Treatment Period 3||5
187383|NCT00868231|450477|P5|STARTED|Treatment Period 3||4
187384|NCT00868231|450478|P4|STARTED|Treatment Period 3||5
187385|NCT00868231|450479|P3|STARTED|Treatment Period 3||5
187386|NCT00868231|450480|P2|STARTED|Treatment Period 3||5
187387|NCT00868231|450481|P1|STARTED|Treatment Period 3||4
187388|NCT00868231|450476|P6|NOT COMPLETED|Treatment Period 2||0
187389|NCT00868231|450477|P5|NOT COMPLETED|Treatment Period 2||0
187390|NCT00868231|450478|P4|NOT COMPLETED|Treatment Period 2||0
187391|NCT00868231|450479|P3|NOT COMPLETED|Treatment Period 2||0
187392|NCT00868231|450480|P2|NOT COMPLETED|Treatment Period 2||0
187393|NCT00868231|450481|P1|NOT COMPLETED|Treatment Period 2||1
187394|NCT00868231|450476|P6|COMPLETED|Treatment Period 2||5
187395|NCT00868231|450477|P5|COMPLETED|Treatment Period 2||4
187396|NCT00868231|450478|P4|COMPLETED|Treatment Period 2||5
187397|NCT00868231|450479|P3|COMPLETED|Treatment Period 2||5
187398|NCT00868231|450480|P2|COMPLETED|Treatment Period 2||5
187399|NCT00868231|450481|P1|COMPLETED|Treatment Period 2||4
187400|NCT00868231|450476|P6|STARTED|Treatment Period 2||5
187401|NCT00868231|450477|P5|STARTED|Treatment Period 2||4
187402|NCT00868231|450478|P4|STARTED|Treatment Period 2||5
187403|NCT00868231|450479|P3|STARTED|Treatment Period 2||5
187404|NCT00868231|450480|P2|STARTED|Treatment Period 2||5
187405|NCT00868231|450481|P1|STARTED|Treatment Period 2||5
187406|NCT00868231|450476|P6|NOT COMPLETED|Treatment Period 1||0
187407|NCT00868231|450477|P5|NOT COMPLETED|Treatment Period 1||1
187408|NCT00868231|450478|P4|NOT COMPLETED|Treatment Period 1||0
187409|NCT00868231|450479|P3|NOT COMPLETED|Treatment Period 1||0
187410|NCT00868231|450480|P2|NOT COMPLETED|Treatment Period 1||0
187411|NCT00868231|450481|P1|NOT COMPLETED|Treatment Period 1||0
187412|NCT00868231|450476|P6|COMPLETED|Treatment Period 1||5
187413|NCT00868231|450477|P5|COMPLETED|Treatment Period 1||4
187414|NCT00868231|450478|P4|COMPLETED|Treatment Period 1||5
187415|NCT00868231|450479|P3|COMPLETED|Treatment Period 1||5
187416|NCT00868231|450480|P2|COMPLETED|Treatment Period 1||5
187417|NCT00868231|450481|P1|COMPLETED|Treatment Period 1||5
187418|NCT00868231|450476|P6|STARTED|Treatment Period 1||5
187419|NCT00868231|450477|P5|STARTED|Treatment Period 1||5
187420|NCT00868231|450478|P4|STARTED|Treatment Period 1||5
187421|NCT00868231|450479|P3|STARTED|Treatment Period 1||5
187422|NCT00868231|450480|P2|STARTED|Treatment Period 1||5
187423|NCT00868231|450481|P1|STARTED|Treatment Period 1||5
187424|NCT00868218|450526|P4|NOT COMPLETED|Overall Study||0
187425|NCT00868218|450527|P3|NOT COMPLETED|Overall Study||0
187426|NCT00868218|450528|P2|NOT COMPLETED|Overall Study||0
187427|NCT00868218|450529|P1|NOT COMPLETED|Overall Study||0
187428|NCT00868218|450526|P4|COMPLETED|Overall Study||15
187429|NCT00868218|450527|P3|COMPLETED|Overall Study||15
187430|NCT00868218|450528|P2|COMPLETED|Overall Study||15
187431|NCT00868218|450529|P1|COMPLETED|Overall Study||15
187432|NCT00868218|450526|P4|STARTED|Overall Study||15
187433|NCT00868218|450527|P3|STARTED|Overall Study||15
187434|NCT00868218|450528|P2|STARTED|Overall Study||15
187435|NCT00868218|450529|P1|STARTED|Overall Study||15
187436|NCT00868192|450547|P1|NOT COMPLETED|Overall Study||4
187437|NCT00868192|450547|P1|COMPLETED|Overall Study||34
187438|NCT00868192|450547|P1|STARTED|Overall Study||38
187439|NCT00868140|450564|P2|NOT COMPLETED|Overall Study||0
187440|NCT00868140|450565|P1|NOT COMPLETED|Overall Study||0
187441|NCT00868140|450564|P2|COMPLETED|Overall Study||25
187442|NCT00868140|450565|P1|COMPLETED|Overall Study||26
187443|NCT00868140|450564|P2|STARTED|Overall Study||25
187444|NCT00868140|450565|P1|STARTED|Overall Study||26
187445|NCT00868101|450583|P2|NOT COMPLETED|Overall Study||0
187446|NCT00868101|450584|P1|NOT COMPLETED|Overall Study||0
187447|NCT00868101|450583|P2|COMPLETED|Overall Study||10
187448|NCT00868101|450584|P1|COMPLETED|Overall Study||12
187449|NCT00868101|450583|P2|STARTED|Overall Study||10
187450|NCT00868101|450584|P1|STARTED|Overall Study||12
187451|NCT00867659|450596|P1|NOT COMPLETED|Overall Study||0
187452|NCT00867659|450596|P1|COMPLETED|Overall Study|January 2010|20
187453|NCT00867659|450596|P1|STARTED|Overall Study|October 2009|20
187454|NCT00867568|450601|P1|NOT COMPLETED|Overall Study||15
187455|NCT00867568|450601|P1|COMPLETED|Overall Study||3
187456|NCT00867568|450601|P1|STARTED|Overall Study||18
187457|NCT00867529|450610|P1|NOT COMPLETED|Overall Study||0
187458|NCT00867529|450610|P1|COMPLETED|Overall Study||63
187459|NCT00867529|450610|P1|STARTED|Overall Study||63
187460|NCT00867503|450618|P1|NOT COMPLETED|Overall Study||1
187461|NCT00867503|450618|P1|COMPLETED|Overall Study||9
187462|NCT00867503|450618|P1|STARTED|Overall Study||10
187463|NCT00867490|450624|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
187464|NCT00867490|450624|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
187465|NCT00867490|450624|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
187466|NCT00867490|450624|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
187467|NCT00867490|450624|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
187468|NCT00867490|450624|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
187469|NCT00867490|450624|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
187470|NCT00867490|450624|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
187471|NCT00867490|450624|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
187472|NCT00867451|450643|P2|NOT COMPLETED|Overall Study||0
187473|NCT00867451|450644|P1|NOT COMPLETED|Overall Study||0
187474|NCT00867451|450643|P2|COMPLETED|Overall Study||4
187475|NCT00867451|450644|P1|COMPLETED|Overall Study||4
187476|NCT00867451|450643|P2|STARTED|Overall Study||4
187477|NCT00867451|450644|P1|STARTED|Overall Study||4
187478|NCT00867360|450666|P2|NOT COMPLETED|Overall Study||1
187479|NCT00867360|450667|P1|NOT COMPLETED|Overall Study||1
187480|NCT00867360|450666|P2|COMPLETED|Overall Study||5
187481|NCT00867360|450667|P1|COMPLETED|Overall Study||3
187482|NCT00867360|450666|P2|STARTED|Overall Study||6
187483|NCT00867360|450667|P1|STARTED|Overall Study||4
187484|NCT00867321|450680|P6|NOT COMPLETED|Overall Study||0
187485|NCT00867321|450681|P5|NOT COMPLETED|Overall Study||0
187486|NCT00867321|450682|P4|NOT COMPLETED|Overall Study||0
187487|NCT00867321|450683|P3|NOT COMPLETED|Overall Study||0
187488|NCT00867321|450684|P2|NOT COMPLETED|Overall Study||1
187489|NCT00867321|450685|P1|NOT COMPLETED|Overall Study||0
187490|NCT00867321|450680|P6|COMPLETED|Overall Study||3
187491|NCT00867321|450681|P5|COMPLETED|Overall Study||5
187492|NCT00867321|450682|P4|COMPLETED|Overall Study||6
187493|NCT00867321|450683|P3|COMPLETED|Overall Study||3
187494|NCT00867321|450684|P2|COMPLETED|Overall Study||2
187495|NCT00867321|450685|P1|COMPLETED|Overall Study||4
187496|NCT00867321|450680|P6|STARTED|Overall Study||3
187497|NCT00867321|450681|P5|STARTED|Overall Study||5
187498|NCT00867321|450682|P4|STARTED|Overall Study||6
187499|NCT00867321|450683|P3|STARTED|Overall Study||3
187500|NCT00867321|450684|P2|STARTED|Overall Study||3
187501|NCT00867321|450685|P1|STARTED|Overall Study||4
187502|NCT00867217|450705|P2|NOT COMPLETED|Overall Study||10
187503|NCT00867217|450706|P1|NOT COMPLETED|Overall Study||3
187504|NCT00867217|450705|P2|COMPLETED|Overall Study||70
187505|NCT00867217|450706|P1|COMPLETED|Overall Study||77
187506|NCT00867217|450705|P2|STARTED|Overall Study||80
187507|NCT00867217|450706|P1|STARTED|Overall Study||80
187508|NCT00867165|450714|P2|NOT COMPLETED|Overall Study||0
187509|NCT00867165|450715|P1|NOT COMPLETED|Overall Study||4
187510|NCT00867165|450714|P2|COMPLETED|Overall Study||45
187511|NCT00867165|450715|P1|COMPLETED|Overall Study||89
187512|NCT00867165|450714|P2|STARTED|Overall Study||45
187513|NCT00867165|450715|P1|STARTED|Overall Study||93
187514|NCT00867139|450820|P3|NOT COMPLETED|Overall Study||1
187515|NCT00867139|450821|P2|NOT COMPLETED|Overall Study||0
187516|NCT00867139|450822|P1|NOT COMPLETED|Overall Study||0
187517|NCT00867139|450820|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
187518|NCT00867139|450821|P2|COMPLETED|Overall Study||1
187519|NCT00867139|450822|P1|COMPLETED|Overall Study||2
187520|NCT00867139|450820|P3|STARTED|Overall Study||4
187521|NCT00867139|450821|P2|STARTED|Overall Study||1
187522|NCT00867139|450822|P1|STARTED|Overall Study||2
187523|NCT00867113|450863|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
187524|NCT00867113|450863|P1|COMPLETED|Post Treatment After Survival Follow-up||57
187525|NCT00867113|450863|P1|STARTED|Post Treatment After Survival Follow-up||68
187526|NCT00867113|450863|P1|NOT COMPLETED|Treatment Period||45
187527|NCT00867113|450863|P1|COMPLETED|Treatment Period||46
187528|NCT00867113|450863|P1|Full Analysis Set (FAS)|Treatment Period||91
187529|NCT00867113|450863|P1|Safety Set|Treatment Period||91
187530|NCT00867113|450863|P1|STARTED|Treatment Period||91
187531|NCT00867087|450870|P1|NOT COMPLETED|Overall Study||42
187532|NCT00867087|450870|P1|COMPLETED|Overall Study||21
187533|NCT00867087|450870|P1|STARTED|Overall Study||63
187534|NCT00867035|450886|P2|NOT COMPLETED|Baseline to 1 Week||0
187535|NCT00867035|450887|P1|NOT COMPLETED|Baseline to 1 Week||1
187536|NCT00867035|450886|P2|COMPLETED|Baseline to 1 Week||8
187537|NCT00867035|450887|P1|COMPLETED|Baseline to 1 Week||11
187538|NCT00867035|450886|P2|STARTED|Baseline to 1 Week||8
187539|NCT00867035|450887|P1|STARTED|Baseline to 1 Week||12
187540|NCT00867035|450886|P2|NOT COMPLETED|Baseline to 4 Hours||0
187541|NCT00867035|450887|P1|NOT COMPLETED|Baseline to 4 Hours||0
187542|NCT00867035|450886|P2|COMPLETED|Baseline to 4 Hours||8
187543|NCT00867035|450887|P1|COMPLETED|Baseline to 4 Hours||12
187544|NCT00867035|450886|P2|STARTED|Baseline to 4 Hours||8
187545|NCT00867035|450887|P1|STARTED|Baseline to 4 Hours||12
187546|NCT00867035|450886|P2|NOT COMPLETED|Baseline to 2 Hours||0
187547|NCT00867035|450887|P1|NOT COMPLETED|Baseline to 2 Hours||0
187548|NCT00867035|450886|P2|COMPLETED|Baseline to 2 Hours||8
187549|NCT00867035|450887|P1|COMPLETED|Baseline to 2 Hours||12
187550|NCT00867035|450886|P2|STARTED|Baseline to 2 Hours||8
187551|NCT00867035|450887|P1|STARTED|Baseline to 2 Hours||12
187552|NCT00867035|450886|P2|NOT COMPLETED|Baseline to 1 Hour||1
187553|NCT00867035|450887|P1|NOT COMPLETED|Baseline to 1 Hour||1
187554|NCT00867035|450886|P2|COMPLETED|Baseline to 1 Hour||8
187555|NCT00867035|450887|P1|COMPLETED|Baseline to 1 Hour||12
187556|NCT00867035|450886|P2|STARTED|Baseline to 1 Hour||9
187557|NCT00867035|450887|P1|STARTED|Baseline to 1 Hour||13
187558|NCT00867009|450913|P1|NOT COMPLETED|Maintenance Period||4
187559|NCT00867009|450913|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
187560|NCT00867009|450913|P1|STARTED|Maintenance Period||51
187561|NCT00867009|450913|P1|NOT COMPLETED|Induction Period||62
187562|NCT00867009|450913|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
187563|NCT00867009|450913|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
187564|NCT00867009|450913|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
187565|NCT00867009|450913|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
187566|NCT00866918|450922|P2|NOT COMPLETED|Overall Study||12
187567|NCT00866918|450923|P1|NOT COMPLETED|Overall Study||16
187568|NCT00866918|450922|P2|COMPLETED|Overall Study||27
187569|NCT00866918|450923|P1|COMPLETED|Overall Study||53
187570|NCT00866918|450922|P2|STARTED|Overall Study||39
187571|NCT00866918|450923|P1|STARTED|Overall Study||69
187572|NCT00866905|450935|P1|NOT COMPLETED|Overall Study||33
187573|NCT00866905|450935|P1|COMPLETED|Overall Study||135
187574|NCT00866905|450935|P1|STARTED|Overall Study||168
187575|NCT00866814|450940|P1|NOT COMPLETED|Overall Study||20
187576|NCT00866814|450940|P1|COMPLETED|Overall Study||99
187577|NCT00866814|450940|P1|STARTED|Overall Study||119
187578|NCT00866788|450953|P4|NOT COMPLETED|Overall Study||5
187579|NCT00866788|450954|P3|NOT COMPLETED|Overall Study||2
187580|NCT00866788|450955|P2|NOT COMPLETED|Overall Study||6
187581|NCT00866788|450956|P1|NOT COMPLETED|Overall Study||6
187582|NCT00866788|450953|P4|COMPLETED|Overall Study||16
187583|NCT00866788|450954|P3|COMPLETED|Overall Study||23
187584|NCT00866788|450955|P2|COMPLETED|Overall Study||17
187585|NCT00866788|450956|P1|COMPLETED|Overall Study||15
187586|NCT00866788|450953|P4|STARTED|Overall Study||21
187587|NCT00866788|450954|P3|STARTED|Overall Study||25
187588|NCT00866788|450955|P2|STARTED|Overall Study||23
187589|NCT00866788|450956|P1|STARTED|Overall Study||21
187590|NCT00866775|451004|P2|NOT COMPLETED|Overall Study||52
187591|NCT00866775|451005|P1|NOT COMPLETED|Overall Study||36
187592|NCT00866775|451004|P2|COMPLETED|Overall Study||76
187593|NCT00866775|451005|P1|COMPLETED|Overall Study||29
187594|NCT00866775|451004|P2|STARTED|Overall Study||128
187595|NCT00866775|451005|P1|STARTED|Overall Study||65
187596|NCT00866723|451041|P1|NOT COMPLETED|Overall Study||5
187597|NCT00866723|451041|P1|COMPLETED|Overall Study||0
187598|NCT00866723|451041|P1|STARTED|Overall Study||5
187599|NCT00866697|451048|P2|NOT COMPLETED|Overall Study||377
187600|NCT00866697|451049|P1|NOT COMPLETED|Overall Study||373
187601|NCT00866697|451048|P2|COMPLETED|Overall Study||95
187602|NCT00866697|451049|P1|COMPLETED|Overall Study||95
187603|NCT00866697|451048|P2|Ongoing|Overall Study||312
187604|NCT00866697|451049|P1|Ongoing|Overall Study||335
187605|NCT00866697|451048|P2|STARTED|Overall Study||472
187606|NCT00866697|451049|P1|STARTED|Overall Study||468
187607|NCT00866658|451093|P2|NOT COMPLETED|Overall Study||21
187608|NCT00866658|451094|P1|NOT COMPLETED|Overall Study||13
187609|NCT00866658|451093|P2|COMPLETED|Overall Study||133
187610|NCT00866658|451094|P1|COMPLETED|Overall Study||144
187611|NCT00866658|451093|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
187612|NCT00866658|451094|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
187613|NCT00866658|451093|P2|Safety Population|Overall Study||154
187614|NCT00866658|451094|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
187615|NCT00866658|451093|P2|STARTED|Overall Study||154
187616|NCT00866658|451094|P1|STARTED|Overall Study|Randomized.|157
187617|NCT00866606|451122|P1|NOT COMPLETED|Overall Study||4
187618|NCT00866606|451122|P1|COMPLETED|Overall Study||31
187619|NCT00866606|451122|P1|STARTED|Overall Study||35
187620|NCT00866359|451136|P4|NOT COMPLETED|Observational Follow-Up Phase||0
187621|NCT00866359|451137|P3|NOT COMPLETED|Observational Follow-Up Phase||0
187622|NCT00866359|451138|P2|NOT COMPLETED|Observational Follow-Up Phase||0
187623|NCT00866359|451139|P1|NOT COMPLETED|Observational Follow-Up Phase||0
187624|NCT00866359|451136|P4|COMPLETED|Observational Follow-Up Phase||54
187625|NCT00866359|451137|P3|COMPLETED|Observational Follow-Up Phase||54
187626|NCT00866359|451138|P2|COMPLETED|Observational Follow-Up Phase||0
187627|NCT00866359|451139|P1|COMPLETED|Observational Follow-Up Phase||0
187628|NCT00866359|451136|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
187629|NCT00866359|451137|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
187630|NCT00866359|451138|P2|STARTED|Observational Follow-Up Phase||0
187631|NCT00866359|451139|P1|STARTED|Observational Follow-Up Phase||0
187632|NCT00866359|451136|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
187633|NCT00866359|451137|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
187634|NCT00866359|451138|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
187635|NCT00866359|451139|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
187636|NCT00866359|451136|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
187637|NCT00866359|451137|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
187638|NCT00866359|451138|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
187639|NCT00866359|451139|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
187640|NCT00866359|451136|P4|STARTED|Extension Phase (Day 86 to 169)||50
187641|NCT00866359|451137|P3|STARTED|Extension Phase (Day 86 to 169)||45
187642|NCT00866359|451138|P2|STARTED|Extension Phase (Day 86 to 169)||0
187643|NCT00866359|451139|P1|STARTED|Extension Phase (Day 86 to 169)||0
187644|NCT00866359|451136|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
187645|NCT00866359|451137|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
187646|NCT00866359|451138|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
187647|NCT00866359|451139|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
187648|NCT00866359|451136|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
187649|NCT00866359|451137|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
187650|NCT00866359|451138|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
187651|NCT00866359|451139|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
187652|NCT00866359|451136|P4|STARTED|Treatment Phase (Days 1 to 85)||0
187653|NCT00866359|451137|P3|STARTED|Treatment Phase (Days 1 to 85)||0
187654|NCT00866359|451138|P2|STARTED|Treatment Phase (Days 1 to 85)||55
187655|NCT00866359|451139|P1|STARTED|Treatment Phase (Days 1 to 85)||56
187656|NCT00866320|451192|P1|NOT COMPLETED|Overall Study||6
187657|NCT00866320|451192|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
187658|NCT00866320|451192|P1|STARTED|Overall Study||49
187659|NCT00866307|451199|P3|NOT COMPLETED|Consolidation/Maintenance||16
187660|NCT00866307|451200|P2|NOT COMPLETED|Consolidation/Maintenance||9
187661|NCT00866307|451201|P1|NOT COMPLETED|Consolidation/Maintenance||0
187662|NCT00866307|451199|P3|COMPLETED|Consolidation/Maintenance||14
187663|NCT00866307|451200|P2|COMPLETED|Consolidation/Maintenance||45
187664|NCT00866307|451201|P1|COMPLETED|Consolidation/Maintenance||0
187665|NCT00866307|451199|P3|STARTED|Consolidation/Maintenance||30
187666|NCT00866307|451200|P2|STARTED|Consolidation/Maintenance||54
187667|NCT00866307|451201|P1|STARTED|Consolidation/Maintenance||0
187668|NCT00866307|451199|P3|NOT COMPLETED|Induction||0
187669|NCT00866307|451200|P2|NOT COMPLETED|Induction||0
187670|NCT00866307|451201|P1|NOT COMPLETED|Induction||20
187671|NCT00866307|451199|P3|COMPLETED|Induction||0
187672|NCT00866307|451200|P2|COMPLETED|Induction||0
187673|NCT00866307|451201|P1|COMPLETED|Induction||84
187674|NCT00866307|451199|P3|STARTED|Induction||0
187675|NCT00866307|451200|P2|STARTED|Induction||0
187676|NCT00866307|451201|P1|STARTED|Induction||104
187677|NCT00866294|451211|P3|NOT COMPLETED|Overall Study||11
187678|NCT00866294|451212|P2|NOT COMPLETED|Overall Study||20
187679|NCT00866294|451213|P1|NOT COMPLETED|Overall Study||33
187680|NCT00866294|451211|P3|COMPLETED|Overall Study||72
187681|NCT00866294|451212|P2|COMPLETED|Overall Study||141
187682|NCT00866294|451213|P1|COMPLETED|Overall Study||139
187683|NCT00866294|451211|P3|STARTED|Overall Study||83
187684|NCT00866294|451212|P2|STARTED|Overall Study||161
187685|NCT00866294|451213|P1|STARTED|Overall Study||172
187686|NCT00866281|451242|P2|NOT COMPLETED|Overall Study||15
187687|NCT00866281|451243|P1|NOT COMPLETED|Overall Study||7
187688|NCT00866281|451242|P2|COMPLETED|Overall Study||0
187689|NCT00866281|451243|P1|COMPLETED|Overall Study||0
187690|NCT00866281|451242|P2|STARTED|Overall Study||15
187691|NCT00866281|451243|P1|STARTED|Overall Study||7
187692|NCT00866177|451259|P1|NOT COMPLETED|Overall Study||152
187693|NCT00866177|451259|P1|COMPLETED|Overall Study||15
187694|NCT00866177|451259|P1|STARTED|Overall Study||167
187695|NCT00866047|451263|P1|NOT COMPLETED|Follow-up Period||5
187696|NCT00866047|451263|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
187697|NCT00866047|451263|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
187698|NCT00866047|451263|P1|NOT COMPLETED|Treatment Period||48
187699|NCT00866047|451263|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
187700|NCT00866047|451263|P1|STARTED|Treatment Period||58
187701|NCT00866034|451281|P2|NOT COMPLETED|Overall Study||8
187702|NCT00866034|451282|P1|NOT COMPLETED|Overall Study||16
187703|NCT00866034|451281|P2|COMPLETED|Overall Study||301
187704|NCT00866034|451282|P1|COMPLETED|Overall Study||292
187705|NCT00866034|451281|P2|STARTED|Overall Study||309
187706|NCT00866034|451282|P1|STARTED|Overall Study||308
187707|NCT00865904|451295|P5|NOT COMPLETED|Overall Study||1
187708|NCT00865904|451296|P4|NOT COMPLETED|Overall Study||1
187709|NCT00865904|451297|P3|NOT COMPLETED|Overall Study||0
187710|NCT00865904|451298|P2|NOT COMPLETED|Overall Study||0
187711|NCT00865904|451299|P1|NOT COMPLETED|Overall Study||2
187712|NCT00865904|451295|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
187713|NCT00865904|451296|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
187714|NCT00865904|451297|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
187715|NCT00865904|451298|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
187716|NCT00865904|451299|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
187717|NCT00865904|451295|P5|STARTED|Overall Study|Randomized.|20
187718|NCT00865904|451296|P4|STARTED|Overall Study|Randomized.|18
187719|NCT00865904|451297|P3|STARTED|Overall Study|Randomized.|18
187720|NCT00865904|451298|P2|STARTED|Overall Study|Randomized.|18
187721|NCT00865904|451299|P1|STARTED|Overall Study|Randomized.|19
187722|NCT00865709|451356|P2|NOT COMPLETED|Long Term Follow-up||49
187723|NCT00865709|451357|P1|NOT COMPLETED|Long Term Follow-up||46
187724|NCT00865709|451356|P2|COMPLETED|Long Term Follow-up||33
187725|NCT00865709|451357|P1|COMPLETED|Long Term Follow-up||24
187726|NCT00865709|451356|P2|STARTED|Long Term Follow-up||82
187727|NCT00865709|451357|P1|STARTED|Long Term Follow-up||70
187728|NCT00865709|451356|P2|NOT COMPLETED|Active Follow-up||1
187729|NCT00865709|451357|P1|NOT COMPLETED|Active Follow-up||8
187730|NCT00865709|451356|P2|COMPLETED|Active Follow-up||15
187731|NCT00865709|451357|P1|COMPLETED|Active Follow-up||17
187732|NCT00865709|451356|P2|STARTED|Active Follow-up||16
187733|NCT00865709|451357|P1|STARTED|Active Follow-up||25
187734|NCT00865709|451356|P2|NOT COMPLETED|Treatment||18
187735|NCT00865709|451357|P1|NOT COMPLETED|Treatment||30
187736|NCT00865709|451356|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
187737|NCT00865709|451357|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
187738|NCT00865709|451356|P2|Received Treatment|Treatment|Safety population|101
187739|NCT00865709|451357|P1|Received Treatment|Treatment|Safety population|97
187740|NCT00865709|451356|P2|STARTED|Treatment||101
187741|NCT00865709|451357|P1|STARTED|Treatment||97
187742|NCT00865514|451373|P1|NOT COMPLETED|Overall Study||2
187743|NCT00865514|451373|P1|COMPLETED|Overall Study||0
187744|NCT00865514|451373|P1|STARTED|Overall Study||2
187745|NCT00865345|451378|P1|NOT COMPLETED|Overall Study||2
187746|NCT00865345|451378|P1|COMPLETED|Overall Study||61
187747|NCT00865345|451378|P1|STARTED|Overall Study||63
187748|NCT00865306|451385|P2|NOT COMPLETED|One-Year Follow-Up||0
187749|NCT00865306|451386|P1|NOT COMPLETED|One-Year Follow-Up||0
187750|NCT00865306|451385|P2|COMPLETED|One-Year Follow-Up||15
187751|NCT00865306|451386|P1|COMPLETED|One-Year Follow-Up||29
187752|NCT00865306|451385|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
187753|NCT00865306|451386|P1|STARTED|One-Year Follow-Up||29
187754|NCT00865306|451385|P2|NOT COMPLETED|Controlled Trial||2
187755|NCT00865306|451386|P1|NOT COMPLETED|Controlled Trial||5
187756|NCT00865306|451385|P2|COMPLETED|Controlled Trial||28
187757|NCT00865306|451386|P1|COMPLETED|Controlled Trial||29
187758|NCT00865306|451385|P2|STARTED|Controlled Trial||30
187759|NCT00865306|451386|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
187760|NCT00865202|451398|P2|NOT COMPLETED|Overall Study||0
187761|NCT00865202|451399|P1|NOT COMPLETED|Overall Study||0
187762|NCT00865202|451398|P2|COMPLETED|Overall Study||149
187763|NCT00865202|451399|P1|COMPLETED|Overall Study||152
187764|NCT00865202|451398|P2|STARTED|Overall Study||149
187765|NCT00865202|451399|P1|STARTED|Overall Study||152
187766|NCT00865189|451415|P2|NOT COMPLETED|Overall Study||19
187767|NCT00865189|451416|P1|NOT COMPLETED|Overall Study||12
187768|NCT00865189|451415|P2|COMPLETED|Overall Study||26
187769|NCT00865189|451416|P1|COMPLETED|Overall Study||34
187770|NCT00865189|451415|P2|STARTED|Overall Study||45
187771|NCT00865189|451416|P1|STARTED|Overall Study||46
187772|NCT00865124|451444|P3|NOT COMPLETED|Overall Study||0
187773|NCT00865124|451445|P2|NOT COMPLETED|Overall Study||1
187774|NCT00865124|451446|P1|NOT COMPLETED|Overall Study||4
187775|NCT00865124|451444|P3|COMPLETED|Overall Study||17
187776|NCT00865124|451445|P2|COMPLETED|Overall Study||24
187777|NCT00865124|451446|P1|COMPLETED|Overall Study||23
187778|NCT00865124|451444|P3|STARTED|Overall Study||17
187779|NCT00865124|451445|P2|STARTED|Overall Study||25
187780|NCT00865124|451446|P1|STARTED|Overall Study||27
187781|NCT00865098|451463|P1|NOT COMPLETED|Overall Study||1
187782|NCT00865098|451463|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
187783|NCT00865098|451463|P1|STARTED|Overall Study||22
187784|NCT00865046|451475|P3|NOT COMPLETED|Overall Study||1
187785|NCT00865046|451476|P2|NOT COMPLETED|Overall Study||5
187786|NCT00865046|451477|P1|NOT COMPLETED|Overall Study||6
187787|NCT00865046|451475|P3|COMPLETED|Overall Study||62
187788|NCT00865046|451476|P2|COMPLETED|Overall Study||59
187789|NCT00865046|451477|P1|COMPLETED|Overall Study||57
187790|NCT00865046|451475|P3|STARTED|Overall Study||63
187791|NCT00865046|451476|P2|STARTED|Overall Study||64
187792|NCT00865046|451477|P1|STARTED|Overall Study||63
187793|NCT00865020|451487|P2|NOT COMPLETED|Overall Study||51
187794|NCT00865020|451488|P1|NOT COMPLETED|Overall Study||49
187795|NCT00865020|451487|P2|COMPLETED|Overall Study||357
187796|NCT00865020|451488|P1|COMPLETED|Overall Study||365
187797|NCT00865020|451487|P2|STARTED|Overall Study||408
187798|NCT00865020|451488|P1|STARTED|Overall Study||414
187799|NCT00864916|451504|P2|NOT COMPLETED|Overall Study||4
187800|NCT00864916|451505|P1|NOT COMPLETED|Overall Study||6
187801|NCT00864916|451504|P2|COMPLETED|Overall Study||5
187802|NCT00864916|451505|P1|COMPLETED|Overall Study||4
187803|NCT00864916|451504|P2|STARTED|Overall Study||9
187804|NCT00864916|451505|P1|STARTED|Overall Study||10
187805|NCT00864851|451514|P3|NOT COMPLETED|Overall Study||0
187806|NCT00864851|451515|P2|NOT COMPLETED|Overall Study||1
187807|NCT00864851|451516|P1|NOT COMPLETED|Overall Study||3
187808|NCT00864851|451514|P3|COMPLETED|Overall Study||5
187809|NCT00864851|451515|P2|COMPLETED|Overall Study||18
187810|NCT00864851|451516|P1|COMPLETED|Overall Study||17
187811|NCT00864851|451514|P3|STARTED|Overall Study||5
187812|NCT00864851|451515|P2|STARTED|Overall Study||19
187813|NCT00864851|451516|P1|STARTED|Overall Study||20
187814|NCT00864708|451550|P1|NOT COMPLETED|Overall Study||0
187815|NCT00864708|451550|P1|COMPLETED|Overall Study||1
187816|NCT00864708|451550|P1|STARTED|Overall Study||1
187817|NCT00864682|451562|P3|NOT COMPLETED|Overall Study||2
187818|NCT00864682|451563|P2|NOT COMPLETED|Overall Study||1
187819|NCT00864682|451564|P1|NOT COMPLETED|Overall Study||2
187820|NCT00864682|451562|P3|COMPLETED|Overall Study||51
187821|NCT00864682|451563|P2|COMPLETED|Overall Study||50
187822|NCT00864682|451564|P1|COMPLETED|Overall Study||50
187823|NCT00864682|451562|P3|STARTED|Overall Study||53
187824|NCT00864682|451563|P2|STARTED|Overall Study||51
187825|NCT00864682|451564|P1|STARTED|Overall Study||52
187826|NCT00864539|451584|P6|NOT COMPLETED|Overall Study||14
187827|NCT00864539|451585|P5|NOT COMPLETED|Overall Study||22
187828|NCT00864539|451586|P4|NOT COMPLETED|Overall Study||7
187829|NCT00864539|451587|P3|NOT COMPLETED|Overall Study||10
187830|NCT00864539|451588|P2|NOT COMPLETED|Overall Study||23
187831|NCT00864539|451589|P1|NOT COMPLETED|Overall Study||9
187832|NCT00864539|451584|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
187833|NCT00864539|451585|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
187834|NCT00864539|451586|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
187835|NCT00864539|451587|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
187836|NCT00864539|451588|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
187837|NCT00864539|451589|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
187838|NCT00864539|451584|P6|STARTED|Overall Study||85
187839|NCT00864539|451585|P5|STARTED|Overall Study||103
187840|NCT00864539|451586|P4|STARTED|Overall Study||96
187841|NCT00864539|451587|P3|STARTED|Overall Study||102
187842|NCT00864539|451588|P2|STARTED|Overall Study||95
187843|NCT00864539|451589|P1|STARTED|Overall Study||104
187844|NCT00864513|451603|P1|NOT COMPLETED|Overall Study||3
187845|NCT00864513|451603|P1|COMPLETED|Overall Study||12
187846|NCT00864513|451603|P1|STARTED|Overall Study||15
187847|NCT00864383|451613|P3|NOT COMPLETED|Modified Intent to Treat||85
187848|NCT00864383|451614|P2|NOT COMPLETED|Modified Intent to Treat||87
187849|NCT00864383|451615|P1|NOT COMPLETED|Modified Intent to Treat||85
187850|NCT00864383|451613|P3|COMPLETED|Modified Intent to Treat||551
187851|NCT00864383|451614|P2|COMPLETED|Modified Intent to Treat||568
187852|NCT00864383|451615|P1|COMPLETED|Modified Intent to Treat||555
187853|NCT00864383|451613|P3|STARTED|Modified Intent to Treat||636
187854|NCT00864383|451614|P2|STARTED|Modified Intent to Treat||655
187855|NCT00864383|451615|P1|STARTED|Modified Intent to Treat||640
187856|NCT00864383|451613|P3|NOT COMPLETED|Per- Protocol||112
187857|NCT00864383|451614|P2|NOT COMPLETED|Per- Protocol||141
187858|NCT00864383|451615|P1|NOT COMPLETED|Per- Protocol||130
187859|NCT00864383|451613|P3|COMPLETED|Per- Protocol||524
187860|NCT00864383|451614|P2|COMPLETED|Per- Protocol||514
187861|NCT00864383|451615|P1|COMPLETED|Per- Protocol||510
187862|NCT00864383|451613|P3|STARTED|Per- Protocol||636
187863|NCT00864383|451614|P2|STARTED|Per- Protocol||655
187864|NCT00864383|451615|P1|STARTED|Per- Protocol||640
187865|NCT00864253|451649|P2|NOT COMPLETED|Overall Study||58
187866|NCT00864253|451650|P1|NOT COMPLETED|Overall Study||99
187867|NCT00864253|451649|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
187868|NCT00864253|451650|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
187869|NCT00864253|451649|P2|Treated|Overall Study||258
187870|NCT00864253|451650|P1|Treated|Overall Study||257
187871|NCT00864253|451649|P2|STARTED|Overall Study||265
187872|NCT00864253|451650|P1|STARTED|Overall Study||264
187873|NCT00864227|451680|P1|NOT COMPLETED|Overall Study||4
187874|NCT00864227|451680|P1|COMPLETED|Overall Study||50
187875|NCT00864227|451680|P1|STARTED|Overall Study||54
187876|NCT00864123|451697|P2|NOT COMPLETED|Overall Study||0
187877|NCT00864123|451698|P1|NOT COMPLETED|Overall Study||0
187878|NCT00864123|451697|P2|COMPLETED|Overall Study||15
187879|NCT00864123|451698|P1|COMPLETED|Overall Study||15
187880|NCT00864123|451697|P2|STARTED|Overall Study||15
187881|NCT00864123|451698|P1|STARTED|Overall Study||15
187882|NCT00864084|451708|P1|NOT COMPLETED|Overall Study||3
187883|NCT00864084|451708|P1|COMPLETED|Overall Study||11
187884|NCT00864084|451708|P1|STARTED|Overall Study||14
187885|NCT00864032|451731|P3|NOT COMPLETED|Overall Study||0
187886|NCT00864032|451732|P2|NOT COMPLETED|Overall Study||0
187887|NCT00864032|451733|P1|NOT COMPLETED|Overall Study||0
187888|NCT00864032|451731|P3|COMPLETED|Overall Study||0
187889|NCT00864032|451732|P2|COMPLETED|Overall Study||5
187890|NCT00864032|451733|P1|COMPLETED|Overall Study||3
187891|NCT00864032|451731|P3|STARTED|Overall Study||0
187892|NCT00864032|451732|P2|STARTED|Overall Study||5
187893|NCT00864032|451733|P1|STARTED|Overall Study||3
187894|NCT00863798|451742|P3|NOT COMPLETED|Overall Study||25
187895|NCT00863798|451743|P2|NOT COMPLETED|Overall Study||30
187896|NCT00863798|451744|P1|NOT COMPLETED|Overall Study||32
187897|NCT00863798|451742|P3|COMPLETED|Overall Study||202
187898|NCT00863798|451743|P2|COMPLETED|Overall Study||198
187899|NCT00863798|451744|P1|COMPLETED|Overall Study||195
187900|NCT00863798|451742|P3|Treated|Overall Study||224
187901|NCT00863798|451743|P2|Treated|Overall Study||226
187902|NCT00863798|451744|P1|Treated|Overall Study||223
187903|NCT00863798|451742|P3|STARTED|Overall Study||227
187904|NCT00863798|451743|P2|STARTED|Overall Study||228
187905|NCT00863798|451744|P1|STARTED|Overall Study||227
187906|NCT00863746|451796|P2|NOT COMPLETED|Survival Follow up||280
187907|NCT00863746|451797|P1|NOT COMPLETED|Survival Follow up||253
187908|NCT00863746|451796|P2|COMPLETED|Survival Follow up||51
187909|NCT00863746|451797|P1|COMPLETED|Survival Follow up||45
187910|NCT00863746|451796|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
187911|NCT00863746|451797|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
187912|NCT00863746|451796|P2|NOT COMPLETED|Treatment||35
187913|NCT00863746|451797|P1|NOT COMPLETED|Treatment||71
187914|NCT00863746|451796|P2|COMPLETED|Treatment||318
187915|NCT00863746|451797|P1|COMPLETED|Treatment||279
187916|NCT00863746|451796|P2|Participants Received Treatment|Treatment|Safety population|351
187917|NCT00863746|451797|P1|Participants Received Treatment|Treatment|Safety population|346
187918|NCT00863746|451796|P2|STARTED|Treatment||353
187919|NCT00863746|451797|P1|STARTED|Treatment||350
187920|NCT00863707|451823|P2|NOT COMPLETED|Overall Study||3
187921|NCT00863707|451824|P1|NOT COMPLETED|Overall Study||4
187922|NCT00863707|451823|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
187923|NCT00863707|451824|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
187924|NCT00863707|451823|P2|STARTED|Overall Study||337
187925|NCT00863707|451824|P1|STARTED|Overall Study||174
187926|NCT00863655|451832|P2|NOT COMPLETED|Overall Study||239
187927|NCT00863655|451833|P1|NOT COMPLETED|Overall Study||485
187928|NCT00863655|451832|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
187929|NCT00863655|451833|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
187930|NCT00863655|451832|P2|STARTED|Overall Study||239
187931|NCT00863655|451833|P1|STARTED|Overall Study||485
187932|NCT00863551|451860|P1|NOT COMPLETED|Overall Study||0
187933|NCT00863551|451860|P1|COMPLETED|Overall Study||12
187934|NCT00863551|451860|P1|STARTED|Overall Study||12
187935|NCT00863512|451870|P2|NOT COMPLETED|Overall Study||0
187936|NCT00863512|451871|P1|NOT COMPLETED|Overall Study||14
187937|NCT00863512|451870|P2|COMPLETED|Overall Study||17
187938|NCT00863512|451871|P1|COMPLETED|Overall Study||3
187939|NCT00863512|451870|P2|STARTED|Overall Study||17
187940|NCT00863512|451871|P1|STARTED|Overall Study||17
187941|NCT00863434|451877|P1|NOT COMPLETED|Overall Study||0
187942|NCT00863434|451877|P1|COMPLETED|Overall Study||2
187943|NCT00863434|451877|P1|STARTED|Overall Study||2
187944|NCT00863356|451883|P1|NOT COMPLETED|Overall Study||0
187945|NCT00863356|451883|P1|COMPLETED|Overall Study||20
187946|NCT00863356|451883|P1|STARTED|Overall Study||20
187947|NCT00863343|451889|P2|NOT COMPLETED|Overall Study||0
187948|NCT00863343|451890|P1|NOT COMPLETED|Overall Study||0
187949|NCT00863343|451889|P2|COMPLETED|Overall Study||374
187950|NCT00863343|451890|P1|COMPLETED|Overall Study||17
187951|NCT00863343|451889|P2|STARTED|Overall Study||374
187952|NCT00863343|451890|P1|STARTED|Overall Study||17
187953|NCT00863330|451902|P1|NOT COMPLETED|Overall Study||6
187954|NCT00863330|451902|P1|COMPLETED|Overall Study||0
187955|NCT00863330|451902|P1|STARTED|Overall Study||6
187956|NCT00863317|451908|P2|NOT COMPLETED|Overall Study||9
187957|NCT00863317|451909|P1|NOT COMPLETED|Overall Study||8
187958|NCT00863317|451908|P2|COMPLETED|Overall Study||64
187959|NCT00863317|451909|P1|COMPLETED|Overall Study||60
187960|NCT00863317|451908|P2|STARTED|Overall Study||73
187961|NCT00863317|451909|P1|STARTED|Overall Study||68
187962|NCT00863109|451915|P1|NOT COMPLETED|Follow-up Period||11
187963|NCT00863109|451915|P1|COMPLETED|Follow-up Period||48
187964|NCT00863109|451915|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
187965|NCT00863109|451915|P1|NOT COMPLETED|Treatment Period||77
187966|NCT00863109|451915|P1|COMPLETED|Treatment Period||53
187967|NCT00863109|451915|P1|STARTED|Treatment Period||130
187968|NCT00863057|451932|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
187969|NCT00863057|451933|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
187970|NCT00863057|451934|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
187971|NCT00863057|451935|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
187972|NCT00863057|451932|P4|COMPLETED|Period 4 (Weeks 16-20)||2
187973|NCT00863057|451933|P3|COMPLETED|Period 4 (Weeks 16-20)||2
187974|NCT00863057|451934|P2|COMPLETED|Period 4 (Weeks 16-20)||1
187975|NCT00863057|451935|P1|COMPLETED|Period 4 (Weeks 16-20)||3
187976|NCT00863057|451932|P4|STARTED|Period 4 (Weeks 16-20)||2
187977|NCT00863057|451933|P3|STARTED|Period 4 (Weeks 16-20)||2
187978|NCT00863057|451934|P2|STARTED|Period 4 (Weeks 16-20)||1
187979|NCT00863057|451935|P1|STARTED|Period 4 (Weeks 16-20)||3
187980|NCT00863057|451932|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
187981|NCT00863057|451933|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
187982|NCT00863057|451934|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
187983|NCT00863057|451935|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
187984|NCT00863057|451932|P4|COMPLETED|Period 3 (Weeks 11-15)||2
187985|NCT00863057|451933|P3|COMPLETED|Period 3 (Weeks 11-15)||2
187986|NCT00863057|451934|P2|COMPLETED|Period 3 (Weeks 11-15)||1
187987|NCT00863057|451935|P1|COMPLETED|Period 3 (Weeks 11-15)||3
187988|NCT00863057|451932|P4|STARTED|Period 3 (Weeks 11-15)||2
187989|NCT00863057|451933|P3|STARTED|Period 3 (Weeks 11-15)||2
187990|NCT00863057|451934|P2|STARTED|Period 3 (Weeks 11-15)||1
187991|NCT00863057|451935|P1|STARTED|Period 3 (Weeks 11-15)||3
187992|NCT00863057|451932|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
187993|NCT00863057|451933|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
187994|NCT00863057|451934|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
187995|NCT00863057|451935|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
187996|NCT00863057|451932|P4|COMPLETED|Period 2 (Weeks 6-10)||2
187997|NCT00863057|451933|P3|COMPLETED|Period 2 (Weeks 6-10)||2
187998|NCT00863057|451934|P2|COMPLETED|Period 2 (Weeks 6-10)||1
187999|NCT00863057|451935|P1|COMPLETED|Period 2 (Weeks 6-10)||3
188000|NCT00863057|451932|P4|STARTED|Period 2 (Weeks 6-10)||3
188001|NCT00863057|451933|P3|STARTED|Period 2 (Weeks 6-10)||3
188002|NCT00863057|451934|P2|STARTED|Period 2 (Weeks 6-10)||2
188003|NCT00863057|451935|P1|STARTED|Period 2 (Weeks 6-10)||3
188004|NCT00863057|451932|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
188005|NCT00863057|451933|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
188006|NCT00863057|451934|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
188007|NCT00863057|451935|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
188008|NCT00863057|451932|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
188009|NCT00863057|451933|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
188010|NCT00863057|451934|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
188011|NCT00863057|451935|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
188012|NCT00863057|451932|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
188013|NCT00863057|451933|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
188014|NCT00863057|451934|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
188015|NCT00863057|451935|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
188016|NCT00862940|451985|P2|NOT COMPLETED|Overall Study||30
188017|NCT00862940|451986|P1|NOT COMPLETED|Overall Study||30
188018|NCT00862940|451985|P2|COMPLETED|Overall Study||114
188019|NCT00862940|451986|P1|COMPLETED|Overall Study||103
188020|NCT00862940|451985|P2|STARTED|Overall Study||144
188021|NCT00862940|451986|P1|STARTED|Overall Study||133
188022|NCT00862849|451998|P6|NOT COMPLETED|Intervention 6||0
188023|NCT00862849|451999|P5|NOT COMPLETED|Intervention 6||0
188024|NCT00862849|452000|P4|NOT COMPLETED|Intervention 6||0
188025|NCT00862849|452001|P3|NOT COMPLETED|Intervention 6||0
188026|NCT00862849|452002|P2|NOT COMPLETED|Intervention 6||0
188027|NCT00862849|452003|P1|NOT COMPLETED|Intervention 6||0
188028|NCT00862849|451998|P6|COMPLETED|Intervention 6||3
188029|NCT00862849|451999|P5|COMPLETED|Intervention 6||4
188030|NCT00862849|452000|P4|COMPLETED|Intervention 6||4
188031|NCT00862849|452001|P3|COMPLETED|Intervention 6||3
188032|NCT00862849|452002|P2|COMPLETED|Intervention 6||3
188033|NCT00862849|452003|P1|COMPLETED|Intervention 6||3
188034|NCT00862849|451998|P6|STARTED|Intervention 6||3
188035|NCT00862849|451999|P5|STARTED|Intervention 6||4
188036|NCT00862849|452000|P4|STARTED|Intervention 6||4
188037|NCT00862849|452001|P3|STARTED|Intervention 6||3
188038|NCT00862849|452002|P2|STARTED|Intervention 6||3
188039|NCT00862849|452003|P1|STARTED|Intervention 6||3
188040|NCT00862849|451998|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
188041|NCT00862849|451999|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
188042|NCT00862849|452000|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
188043|NCT00862849|452001|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
188044|NCT00862849|452002|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
188045|NCT00862849|452003|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
188046|NCT00862849|451998|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
188047|NCT00862849|451999|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
188048|NCT00862849|452000|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
188049|NCT00862849|452001|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
188050|NCT00862849|452002|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
188051|NCT00862849|452003|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
188052|NCT00862849|451998|P6|STARTED|Washout 5 (3 to 14 Days)||3
188053|NCT00862849|451999|P5|STARTED|Washout 5 (3 to 14 Days)||4
188054|NCT00862849|452000|P4|STARTED|Washout 5 (3 to 14 Days)||4
188055|NCT00862849|452001|P3|STARTED|Washout 5 (3 to 14 Days)||3
188056|NCT00862849|452002|P2|STARTED|Washout 5 (3 to 14 Days)||3
188057|NCT00862849|452003|P1|STARTED|Washout 5 (3 to 14 Days)||3
188058|NCT00862849|451998|P6|NOT COMPLETED|Intervention 5||0
188059|NCT00862849|451999|P5|NOT COMPLETED|Intervention 5||0
188060|NCT00862849|452000|P4|NOT COMPLETED|Intervention 5||0
188061|NCT00862849|452001|P3|NOT COMPLETED|Intervention 5||0
188062|NCT00862849|452002|P2|NOT COMPLETED|Intervention 5||0
188063|NCT00862849|452003|P1|NOT COMPLETED|Intervention 5||0
188064|NCT00862849|451998|P6|COMPLETED|Intervention 5||3
188065|NCT00862849|451999|P5|COMPLETED|Intervention 5||4
188066|NCT00862849|452000|P4|COMPLETED|Intervention 5||4
188067|NCT00862849|452001|P3|COMPLETED|Intervention 5||3
188068|NCT00862849|452002|P2|COMPLETED|Intervention 5||3
188069|NCT00862849|452003|P1|COMPLETED|Intervention 5||3
188070|NCT00862849|451998|P6|STARTED|Intervention 5||3
188071|NCT00862849|451999|P5|STARTED|Intervention 5||4
188072|NCT00862849|452000|P4|STARTED|Intervention 5||4
188073|NCT00862849|452001|P3|STARTED|Intervention 5||3
188074|NCT00862849|452002|P2|STARTED|Intervention 5||3
188075|NCT00862849|452003|P1|STARTED|Intervention 5||3
188076|NCT00862849|451998|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
188077|NCT00862849|451999|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
188078|NCT00862849|452000|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
188079|NCT00862849|452001|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
188080|NCT00862849|452002|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
188081|NCT00862849|452003|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
188082|NCT00862849|451998|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
188083|NCT00862849|451999|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
188084|NCT00862849|452000|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
188085|NCT00862849|452001|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
188086|NCT00862849|452002|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
188087|NCT00862849|452003|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
188088|NCT00862849|451998|P6|STARTED|Washout 4 (3 to 14 Days)||3
188089|NCT00862849|451999|P5|STARTED|Washout 4 (3 to 14 Days)||4
188090|NCT00862849|452000|P4|STARTED|Washout 4 (3 to 14 Days)||4
188091|NCT00862849|452001|P3|STARTED|Washout 4 (3 to 14 Days)||3
188092|NCT00862849|452002|P2|STARTED|Washout 4 (3 to 14 Days)||3
188093|NCT00862849|452003|P1|STARTED|Washout 4 (3 to 14 Days)||3
188094|NCT00862849|451998|P6|NOT COMPLETED|Intervention 4||0
188095|NCT00862849|451999|P5|NOT COMPLETED|Intervention 4||0
188096|NCT00862849|452000|P4|NOT COMPLETED|Intervention 4||0
188097|NCT00862849|452001|P3|NOT COMPLETED|Intervention 4||0
188098|NCT00862849|452002|P2|NOT COMPLETED|Intervention 4||0
188099|NCT00862849|452003|P1|NOT COMPLETED|Intervention 4||0
188100|NCT00862849|451998|P6|COMPLETED|Intervention 4||3
188101|NCT00862849|451999|P5|COMPLETED|Intervention 4||4
188102|NCT00862849|452000|P4|COMPLETED|Intervention 4||4
188103|NCT00862849|452001|P3|COMPLETED|Intervention 4||3
188104|NCT00862849|452002|P2|COMPLETED|Intervention 4||3
188105|NCT00862849|452003|P1|COMPLETED|Intervention 4||3
188106|NCT00862849|451998|P6|STARTED|Intervention 4||3
188107|NCT00862849|451999|P5|STARTED|Intervention 4||4
188108|NCT00862849|452000|P4|STARTED|Intervention 4||4
188109|NCT00862849|452001|P3|STARTED|Intervention 4||3
188110|NCT00862849|452002|P2|STARTED|Intervention 4||3
188111|NCT00862849|452003|P1|STARTED|Intervention 4||3
188112|NCT00862849|451998|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
188113|NCT00862849|451999|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
188114|NCT00862849|452000|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
188115|NCT00862849|452001|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
188116|NCT00862849|452002|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
188117|NCT00862849|452003|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
188118|NCT00862849|451998|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
188119|NCT00862849|451999|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
188120|NCT00862849|452000|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
188121|NCT00862849|452001|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
188122|NCT00862849|452002|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
188123|NCT00862849|452003|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
188124|NCT00862849|451998|P6|STARTED|Washout 3 (3 to 14 Days)||3
188125|NCT00862849|451999|P5|STARTED|Washout 3 (3 to 14 Days)||4
188126|NCT00862849|452000|P4|STARTED|Washout 3 (3 to 14 Days)||4
188127|NCT00862849|452001|P3|STARTED|Washout 3 (3 to 14 Days)||3
188128|NCT00862849|452002|P2|STARTED|Washout 3 (3 to 14 Days)||3
188129|NCT00862849|452003|P1|STARTED|Washout 3 (3 to 14 Days)||3
188130|NCT00862849|451998|P6|NOT COMPLETED|Intervention 3||0
188131|NCT00862849|451999|P5|NOT COMPLETED|Intervention 3||0
188132|NCT00862849|452000|P4|NOT COMPLETED|Intervention 3||0
188133|NCT00862849|452001|P3|NOT COMPLETED|Intervention 3||0
188134|NCT00862849|452002|P2|NOT COMPLETED|Intervention 3||0
188135|NCT00862849|452003|P1|NOT COMPLETED|Intervention 3||0
188136|NCT00862849|451998|P6|COMPLETED|Intervention 3||3
188137|NCT00862849|451999|P5|COMPLETED|Intervention 3||4
188138|NCT00862849|452000|P4|COMPLETED|Intervention 3||4
188139|NCT00862849|452001|P3|COMPLETED|Intervention 3||3
188140|NCT00862849|452002|P2|COMPLETED|Intervention 3||3
188141|NCT00862849|452003|P1|COMPLETED|Intervention 3||3
188142|NCT00862849|451998|P6|STARTED|Intervention 3||3
188143|NCT00862849|451999|P5|STARTED|Intervention 3||4
188144|NCT00862849|452000|P4|STARTED|Intervention 3||4
188145|NCT00862849|452001|P3|STARTED|Intervention 3||3
188146|NCT00862849|452002|P2|STARTED|Intervention 3||3
188147|NCT00862849|452003|P1|STARTED|Intervention 3||3
188148|NCT00862849|451998|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
188149|NCT00862849|451999|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
188150|NCT00862849|452000|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
188151|NCT00862849|452001|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
188152|NCT00862849|452002|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
188153|NCT00862849|452003|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
188154|NCT00862849|451998|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
188155|NCT00862849|451999|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
188156|NCT00862849|452000|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
188157|NCT00862849|452001|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
188158|NCT00862849|452002|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
188159|NCT00862849|452003|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
188160|NCT00862849|451998|P6|STARTED|Washout 2 (3 to 14 Days)||3
188161|NCT00862849|451999|P5|STARTED|Washout 2 (3 to 14 Days)||4
188162|NCT00862849|452000|P4|STARTED|Washout 2 (3 to 14 Days)||4
188163|NCT00862849|452001|P3|STARTED|Washout 2 (3 to 14 Days)||3
188164|NCT00862849|452002|P2|STARTED|Washout 2 (3 to 14 Days)||4
188165|NCT00862849|452003|P1|STARTED|Washout 2 (3 to 14 Days)||3
188166|NCT00862849|451998|P6|NOT COMPLETED|Intervention 2||0
188167|NCT00862849|451999|P5|NOT COMPLETED|Intervention 2||0
188168|NCT00862849|452000|P4|NOT COMPLETED|Intervention 2||0
188169|NCT00862849|452001|P3|NOT COMPLETED|Intervention 2||0
188170|NCT00862849|452002|P2|NOT COMPLETED|Intervention 2||0
188171|NCT00862849|452003|P1|NOT COMPLETED|Intervention 2||0
188172|NCT00862849|451998|P6|COMPLETED|Intervention 2||3
188173|NCT00862849|451999|P5|COMPLETED|Intervention 2||4
188174|NCT00862849|452000|P4|COMPLETED|Intervention 2||4
188175|NCT00862849|452001|P3|COMPLETED|Intervention 2||3
188176|NCT00862849|452002|P2|COMPLETED|Intervention 2||4
188177|NCT00862849|452003|P1|COMPLETED|Intervention 2||3
188178|NCT00862849|451998|P6|STARTED|Intervention 2||3
188179|NCT00862849|451999|P5|STARTED|Intervention 2||4
188180|NCT00862849|452000|P4|STARTED|Intervention 2||4
188181|NCT00862849|452001|P3|STARTED|Intervention 2||3
188182|NCT00862849|452002|P2|STARTED|Intervention 2||4
188183|NCT00862849|452003|P1|STARTED|Intervention 2||3
188184|NCT00862849|451998|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
188185|NCT00862849|451999|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
188186|NCT00862849|452000|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
188187|NCT00862849|452001|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
188188|NCT00862849|452002|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
188189|NCT00862849|452003|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
188190|NCT00862849|451998|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
188191|NCT00862849|451999|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
188192|NCT00862849|452000|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
188193|NCT00862849|452001|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
188194|NCT00862849|452002|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
188195|NCT00862849|452003|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
188196|NCT00862849|451998|P6|STARTED|Washout 1 (3 to 14 Days)||3
188197|NCT00862849|451999|P5|STARTED|Washout 1 (3 to 14 Days)||4
188198|NCT00862849|452000|P4|STARTED|Washout 1 (3 to 14 Days)||4
188199|NCT00862849|452001|P3|STARTED|Washout 1 (3 to 14 Days)||3
188200|NCT00862849|452002|P2|STARTED|Washout 1 (3 to 14 Days)||5
188201|NCT00862849|452003|P1|STARTED|Washout 1 (3 to 14 Days)||3
188202|NCT00862849|451998|P6|NOT COMPLETED|Intervention 1||0
188203|NCT00862849|451999|P5|NOT COMPLETED|Intervention 1||0
188204|NCT00862849|452000|P4|NOT COMPLETED|Intervention 1||0
188205|NCT00862849|452001|P3|NOT COMPLETED|Intervention 1||0
188206|NCT00862849|452002|P2|NOT COMPLETED|Intervention 1||0
188207|NCT00862849|452003|P1|NOT COMPLETED|Intervention 1||0
188208|NCT00862849|451998|P6|COMPLETED|Intervention 1||3
188209|NCT00862849|451999|P5|COMPLETED|Intervention 1||4
188210|NCT00862849|452000|P4|COMPLETED|Intervention 1||4
188211|NCT00862849|452001|P3|COMPLETED|Intervention 1||3
188212|NCT00862849|452002|P2|COMPLETED|Intervention 1||5
188213|NCT00862849|452003|P1|COMPLETED|Intervention 1||3
188214|NCT00862849|451998|P6|Received at Least One Dose of Study Drug|Intervention 1||3
188215|NCT00862849|451999|P5|Received at Least One Dose of Study Drug|Intervention 1||4
188216|NCT00862849|452000|P4|Received at Least One Dose of Study Drug|Intervention 1||4
188217|NCT00862849|452001|P3|Received at Least One Dose of Study Drug|Intervention 1||3
188218|NCT00862849|452002|P2|Received at Least One Dose of Study Drug|Intervention 1||5
188219|NCT00862849|452003|P1|Received at Least One Dose of Study Drug|Intervention 1||3
188220|NCT00862849|451998|P6|STARTED|Intervention 1||3
188221|NCT00862849|451999|P5|STARTED|Intervention 1||4
188222|NCT00862849|452000|P4|STARTED|Intervention 1||4
188223|NCT00862849|452001|P3|STARTED|Intervention 1||3
188224|NCT00862849|452002|P2|STARTED|Intervention 1||5
188225|NCT00862849|452003|P1|STARTED|Intervention 1||3
188226|NCT00862836|452026|P1|NOT COMPLETED|Overall Study||1
188227|NCT00862836|452026|P1|COMPLETED|Overall Study||14
188228|NCT00862836|452026|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
188229|NCT00862836|452026|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
188230|NCT00862836|452026|P1|STARTED|Overall Study||15
188231|NCT00862823|452037|P2|NOT COMPLETED|Second Intervention||0
188232|NCT00862823|452038|P1|NOT COMPLETED|Second Intervention||0
188233|NCT00862823|452037|P2|COMPLETED|Second Intervention||9
188234|NCT00862823|452038|P1|COMPLETED|Second Intervention||5
188235|NCT00862823|452037|P2|STARTED|Second Intervention||9
188236|NCT00862823|452038|P1|STARTED|Second Intervention||5
188237|NCT00862823|452037|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
188238|NCT00862823|452038|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
188239|NCT00862823|452037|P2|COMPLETED|Washout Period of 2 Weeks||9
188240|NCT00862823|452038|P1|COMPLETED|Washout Period of 2 Weeks||5
188241|NCT00862823|452037|P2|STARTED|Washout Period of 2 Weeks||9
188242|NCT00862823|452038|P1|STARTED|Washout Period of 2 Weeks||5
188243|NCT00862823|452037|P2|NOT COMPLETED|First Intervention||1
188244|NCT00862823|452038|P1|NOT COMPLETED|First Intervention||1
188245|NCT00862823|452037|P2|COMPLETED|First Intervention||9
188246|NCT00862823|452038|P1|COMPLETED|First Intervention||5
188247|NCT00862823|452037|P2|STARTED|First Intervention||10
188248|NCT00862823|452038|P1|STARTED|First Intervention||6
188249|NCT00862810|452047|P2|NOT COMPLETED|Overall Study||4
188250|NCT00862810|452048|P1|NOT COMPLETED|Overall Study||4
188251|NCT00862810|452047|P2|COMPLETED|Overall Study||35
188252|NCT00862810|452048|P1|COMPLETED|Overall Study||29
188253|NCT00862810|452047|P2|STARTED|Overall Study||39
188254|NCT00862810|452048|P1|STARTED|Overall Study||33
188255|NCT00862784|452054|P1|NOT COMPLETED|Overall Study||0
188256|NCT00862784|452054|P1|COMPLETED|Overall Study||48
188257|NCT00862784|452054|P1|Received Any Amount of Study Drug|Overall Study||48
188258|NCT00862784|452054|P1|STARTED|Overall Study||48
188259|NCT00862745|452076|P2|NOT COMPLETED|Open-label Follow-up||49
188260|NCT00862745|452077|P1|NOT COMPLETED|Open-label Follow-up||39
188261|NCT00862745|452076|P2|COMPLETED|Open-label Follow-up||225
188262|NCT00862745|452077|P1|COMPLETED|Open-label Follow-up||229
188263|NCT00862745|452076|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
188264|NCT00862745|452077|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
188265|NCT00862745|452076|P2|NOT COMPLETED|Randomized Control Trial||39
188266|NCT00862745|452077|P1|NOT COMPLETED|Randomized Control Trial||38
188267|NCT00862745|452076|P2|COMPLETED|Randomized Control Trial||284
188268|NCT00862745|452077|P1|COMPLETED|Randomized Control Trial||284
188269|NCT00862745|452076|P2|STARTED|Randomized Control Trial||323
188270|NCT00862745|452077|P1|STARTED|Randomized Control Trial||322
188271|NCT00862719|452087|P4|NOT COMPLETED|Overall Study||1
188272|NCT00862719|452088|P3|NOT COMPLETED|Overall Study||4
188273|NCT00862719|452089|P2|NOT COMPLETED|Overall Study||6
188274|NCT00862719|452090|P1|NOT COMPLETED|Overall Study||10
188275|NCT00862719|452087|P4|COMPLETED|Overall Study||0
188276|NCT00862719|452088|P3|COMPLETED|Overall Study||0
188277|NCT00862719|452089|P2|COMPLETED|Overall Study||1
188278|NCT00862719|452090|P1|COMPLETED|Overall Study||7
188279|NCT00862719|452087|P4|STARTED|Overall Study||1
188280|NCT00862719|452088|P3|STARTED|Overall Study||4
188281|NCT00862719|452089|P2|STARTED|Overall Study||7
188282|NCT00862719|452090|P1|STARTED|Overall Study||17
188283|NCT00862654|452113|P4|NOT COMPLETED|Overall Study||6
188284|NCT00862654|452114|P3|NOT COMPLETED|Overall Study||6
188285|NCT00862654|452115|P2|NOT COMPLETED|Overall Study||8
188286|NCT00862654|452116|P1|NOT COMPLETED|Overall Study||6
188287|NCT00862654|452113|P4|COMPLETED|Overall Study||74
188288|NCT00862654|452114|P3|COMPLETED|Overall Study||76
188289|NCT00862654|452115|P2|COMPLETED|Overall Study||74
188290|NCT00862654|452116|P1|COMPLETED|Overall Study||76
188291|NCT00862654|452113|P4|STARTED|Overall Study||80
188292|NCT00862654|452114|P3|STARTED|Overall Study||82
188293|NCT00862654|452115|P2|STARTED|Overall Study||82
188294|NCT00862654|452116|P1|STARTED|Overall Study||82
188295|NCT00862641|452130|P4|NOT COMPLETED|Overall Study||4
188296|NCT00862641|452131|P3|NOT COMPLETED|Overall Study||1
188297|NCT00862641|452132|P2|NOT COMPLETED|Overall Study||4
188298|NCT00862641|452133|P1|NOT COMPLETED|Overall Study||1
188299|NCT00862641|452130|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
188300|NCT00862641|452131|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
188301|NCT00862641|452132|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
188302|NCT00862641|452133|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
188303|NCT00862641|452130|P4|STARTED|Overall Study||320
188304|NCT00862641|452131|P3|STARTED|Overall Study||152
188305|NCT00862641|452132|P2|STARTED|Overall Study||360
188306|NCT00862641|452133|P1|STARTED|Overall Study||177
188307|NCT00862563|452179|P4|NOT COMPLETED|Overall Study||5
188308|NCT00862563|452180|P3|NOT COMPLETED|Overall Study||6
188309|NCT00862563|452181|P2|NOT COMPLETED|Overall Study||4
188310|NCT00862563|452182|P1|NOT COMPLETED|Overall Study||4
188311|NCT00862563|452179|P4|COMPLETED|Overall Study||19
188312|NCT00862563|452180|P3|COMPLETED|Overall Study||15
188313|NCT00862563|452181|P2|COMPLETED|Overall Study||17
188314|NCT00862563|452182|P1|COMPLETED|Overall Study||15
188315|NCT00862563|452179|P4|STARTED|Overall Study||24
188316|NCT00862563|452180|P3|STARTED|Overall Study||21
188317|NCT00862563|452181|P2|STARTED|Overall Study||21
188318|NCT00862563|452182|P1|STARTED|Overall Study||19
188319|NCT00862537|452220|P1|NOT COMPLETED|Overall Study||7
188320|NCT00862537|452220|P1|COMPLETED|Overall Study||11
188321|NCT00862537|452220|P1|STARTED|Overall Study||18
188322|NCT00862459|452227|P3|NOT COMPLETED|Overall Study||6
188323|NCT00862459|452228|P2|NOT COMPLETED|Overall Study||8
188324|NCT00862459|452229|P1|NOT COMPLETED|Overall Study||6
188325|NCT00862459|452227|P3|COMPLETED|Overall Study||66
188326|NCT00862459|452228|P2|COMPLETED|Overall Study||85
188327|NCT00862459|452229|P1|COMPLETED|Overall Study||66
188328|NCT00862459|452227|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
188329|NCT00862459|452228|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
188330|NCT00862459|452229|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
188331|NCT00862459|452227|P3|STARTED|Overall Study||72
188332|NCT00862459|452228|P2|STARTED|Overall Study||93
188333|NCT00862459|452229|P1|STARTED|Overall Study||72
188334|NCT00862277|452376|P3|NOT COMPLETED|Overall Study||5
188335|NCT00862277|452377|P2|NOT COMPLETED|Overall Study||2
188336|NCT00862277|452378|P1|NOT COMPLETED|Overall Study||1
188337|NCT00862277|452376|P3|COMPLETED|Overall Study||100
188338|NCT00862277|452377|P2|COMPLETED|Overall Study||94
188339|NCT00862277|452378|P1|COMPLETED|Overall Study||560
188340|NCT00862277|452376|P3|STARTED|Overall Study||105
188341|NCT00862277|452377|P2|STARTED|Overall Study||96
188342|NCT00862277|452378|P1|STARTED|Overall Study||561
188343|NCT00862251|452392|P3|NOT COMPLETED|Overall Study||9
188344|NCT00862251|452393|P2|NOT COMPLETED|Overall Study||5
188345|NCT00862251|452394|P1|NOT COMPLETED|Overall Study||19
188346|NCT00862251|452392|P3|COMPLETED|Overall Study||315
188347|NCT00862251|452393|P2|COMPLETED|Overall Study||157
188348|NCT00862251|452394|P1|COMPLETED|Overall Study||303
188349|NCT00862251|452392|P3|STARTED|Overall Study||324
188350|NCT00862251|452393|P2|STARTED|Overall Study||162
188351|NCT00862251|452394|P1|STARTED|Overall Study||322
188352|NCT00862186|452447|P1|NOT COMPLETED|Overall Study||0
188353|NCT00862186|452447|P1|COMPLETED|Overall Study||15
188354|NCT00862186|452447|P1|STARTED|Overall Study||15
188355|NCT00862134|452454|P2|NOT COMPLETED|Overall Study||12
188356|NCT00862134|452455|P1|NOT COMPLETED|Overall Study||11
188357|NCT00862134|452454|P2|COMPLETED|Overall Study||11
188358|NCT00862134|452455|P1|COMPLETED|Overall Study||8
188359|NCT00862134|452454|P2|STARTED|Overall Study||23
188360|NCT00862134|452455|P1|STARTED|Overall Study||19
188361|NCT00862121|452467|P2|NOT COMPLETED|Overall Study||8
188362|NCT00862121|452468|P1|NOT COMPLETED|Overall Study||1
188363|NCT00862121|452467|P2|COMPLETED|Overall Study||4
188364|NCT00862121|452468|P1|COMPLETED|Overall Study||7
188365|NCT00862121|452467|P2|Safety Analysis Set|Overall Study||11
188366|NCT00862121|452468|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
188367|NCT00862121|452467|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
188368|NCT00862121|452468|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
188369|NCT00862121|452467|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
188370|NCT00862121|452468|P1|STARTED|Overall Study||8
188371|NCT00862082|452486|P2|NOT COMPLETED|Overall Study||1
188372|NCT00862082|452487|P1|NOT COMPLETED|Overall Study||5
188373|NCT00862082|452486|P2|COMPLETED|Overall Study||5
188374|NCT00862082|452487|P1|COMPLETED|Overall Study||3
188375|NCT00862082|452486|P2|STARTED|Overall Study||6
188376|NCT00862082|452487|P1|STARTED|Overall Study||8
188377|NCT00861913|452530|P1|NOT COMPLETED|Overall Study||0
188378|NCT00861913|452530|P1|COMPLETED|Overall Study||13
188379|NCT00861913|452530|P1|STARTED|Overall Study||13
188380|NCT00861757|452542|P4|NOT COMPLETED|Overall Study||9
188381|NCT00861757|452543|P3|NOT COMPLETED|Overall Study||18
188382|NCT00861757|452544|P2|NOT COMPLETED|Overall Study||15
188383|NCT00861757|452545|P1|NOT COMPLETED|Overall Study||9
188384|NCT00861757|452542|P4|COMPLETED|Overall Study||143
188385|NCT00861757|452543|P3|COMPLETED|Overall Study||137
188386|NCT00861757|452544|P2|COMPLETED|Overall Study||136
188387|NCT00861757|452545|P1|COMPLETED|Overall Study||145
188388|NCT00861757|452542|P4|STARTED|Overall Study||152
188389|NCT00861757|452543|P3|STARTED|Overall Study||155
188390|NCT00861757|452544|P2|STARTED|Overall Study||151
188391|NCT00861757|452545|P1|STARTED|Overall Study||154
188392|NCT00861744|452603|P4|NOT COMPLETED|Overall Study||33
188393|NCT00861744|452604|P3|NOT COMPLETED|Overall Study||24
188394|NCT00861744|452605|P2|NOT COMPLETED|Overall Study||29
188395|NCT00861744|452606|P1|NOT COMPLETED|Overall Study||17
188396|NCT00861744|452603|P4|COMPLETED|Overall Study||275
188397|NCT00861744|452604|P3|COMPLETED|Overall Study||280
188398|NCT00861744|452605|P2|COMPLETED|Overall Study||275
188399|NCT00861744|452606|P1|COMPLETED|Overall Study||287
188400|NCT00861744|452603|P4|STARTED|Overall Study||308
188401|NCT00861744|452604|P3|STARTED|Overall Study||304
188402|NCT00861744|452605|P2|STARTED|Overall Study||304
188403|NCT00861744|452606|P1|STARTED|Overall Study||304
188404|NCT00861705|452788|P4|NOT COMPLETED|Overall Study||1
188405|NCT00861705|452789|P3|NOT COMPLETED|Overall Study||0
188406|NCT00861705|452790|P2|NOT COMPLETED|Overall Study||3
188407|NCT00861705|452791|P1|NOT COMPLETED|Overall Study||7
188408|NCT00861705|452788|P4|COMPLETED|Overall Study||112
188409|NCT00861705|452789|P3|COMPLETED|Overall Study||113
188410|NCT00861705|452790|P2|COMPLETED|Overall Study||110
188411|NCT00861705|452791|P1|COMPLETED|Overall Study||108
188412|NCT00861705|452788|P4|STARTED|Overall Study||113
188413|NCT00861705|452789|P3|STARTED|Overall Study||113
188414|NCT00861705|452790|P2|STARTED|Overall Study||113
188415|NCT00861705|452791|P1|STARTED|Overall Study||115
188416|NCT00861692|452807|P1|NOT COMPLETED|Overall Study||6
188417|NCT00861692|452807|P1|COMPLETED|Overall Study||14
188418|NCT00861692|452807|P1|STARTED|Overall Study||20
188419|NCT00861614|452819|P2|NOT COMPLETED|Overall Study||368
188420|NCT00861614|452820|P1|NOT COMPLETED|Overall Study||371
188421|NCT00861614|452819|P2|COMPLETED|Overall Study||28
188422|NCT00861614|452820|P1|COMPLETED|Overall Study||22
188423|NCT00861614|452819|P2|STARTED|Overall Study||396
188424|NCT00861614|452820|P1|STARTED|Overall Study||393
188425|NCT00861601|452853|P3|NOT COMPLETED|Overall Study||0
188426|NCT00861601|452854|P2|NOT COMPLETED|Overall Study||0
188427|NCT00861601|452855|P1|NOT COMPLETED|Overall Study||0
188428|NCT00861601|452853|P3|COMPLETED|Overall Study||12
188429|NCT00861601|452854|P2|COMPLETED|Overall Study||14
188430|NCT00861601|452855|P1|COMPLETED|Overall Study||12
188431|NCT00861601|452853|P3|STARTED|Overall Study||12
188432|NCT00861601|452854|P2|STARTED|Overall Study||14
188433|NCT00861601|452855|P1|STARTED|Overall Study||12
188434|NCT00861471|452905|P1|NOT COMPLETED|Overall Study||9
188435|NCT00861471|452905|P1|COMPLETED|Overall Study||3
188436|NCT00861471|452905|P1|STARTED|Overall Study||12
188437|NCT00861341|452913|P1|NOT COMPLETED|Overall Study||2
188438|NCT00861341|452913|P1|COMPLETED|Overall Study||38
188439|NCT00861341|452913|P1|STARTED|Overall Study||40
188440|NCT00861263|452918|P1|NOT COMPLETED|Overall Study||0
188441|NCT00861263|452918|P1|COMPLETED|Overall Study||193
188442|NCT00861263|452918|P1|STARTED|Overall Study||193
188443|NCT00861198|452922|P1|NOT COMPLETED|Overall Study||5
188444|NCT00861198|452922|P1|COMPLETED|Overall Study||70
188445|NCT00861198|452922|P1|STARTED|Overall Study||75
188446|NCT00861146|452928|P2|NOT COMPLETED|Overall Study||8
188447|NCT00861146|452929|P1|NOT COMPLETED|Overall Study||20
188448|NCT00861146|452928|P2|COMPLETED|Overall Study||38
188449|NCT00861146|452929|P1|COMPLETED|Overall Study||85
188450|NCT00861146|452928|P2|Week 13 Assessment|Overall Study||38
188451|NCT00861146|452929|P1|Week 13 Assessment|Overall Study||85
188452|NCT00861146|452928|P2|Week 2 Assessment|Overall Study||45
188453|NCT00861146|452929|P1|Week 2 Assessment|Overall Study||97
188454|NCT00861146|452928|P2|STARTED|Overall Study||46
188455|NCT00861146|452929|P1|STARTED|Overall Study||105
188456|NCT00860951|452939|P1|NOT COMPLETED|Overall Study||7
188457|NCT00860951|452939|P1|COMPLETED|Overall Study||22
188458|NCT00860951|452939|P1|STARTED|Overall Study||29
188459|NCT00860847|452947|P2|NOT COMPLETED|Overall Study||5
188460|NCT00860847|452948|P1|NOT COMPLETED|Overall Study||4
188461|NCT00860847|452947|P2|COMPLETED|Overall Study||28
188462|NCT00860847|452948|P1|COMPLETED|Overall Study||28
188463|NCT00860847|452947|P2|STARTED|Overall Study||33
188464|NCT00860847|452948|P1|STARTED|Overall Study||32
188465|NCT00860795|452956|P2|NOT COMPLETED|Overall Study||0
188466|NCT00860795|452957|P1|NOT COMPLETED|Overall Study||0
188467|NCT00860795|452956|P2|COMPLETED|Overall Study||10
188468|NCT00860795|452957|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
188469|NCT00860795|452956|P2|Number to Complete Study Medication|Overall Study||10
188470|NCT00860795|452957|P1|Number to Complete Study Medication|Overall Study||9
188471|NCT00860795|452956|P2|STARTED|Overall Study||10
188472|NCT00860795|452957|P1|STARTED|Overall Study||10
188473|NCT00860743|452981|P2|NOT COMPLETED|Overall Study||0
188474|NCT00860743|452982|P1|NOT COMPLETED|Overall Study||3
188475|NCT00860743|452981|P2|COMPLETED|Overall Study||23
188476|NCT00860743|452982|P1|COMPLETED|Overall Study||37
188477|NCT00860743|452981|P2|STARTED|Overall Study||23
188478|NCT00860743|452982|P1|STARTED|Overall Study||40
188479|NCT00860535|452988|P1|NOT COMPLETED|Overall Study||1
188480|NCT00860535|452988|P1|COMPLETED|Overall Study||8
188481|NCT00860535|452988|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
188482|NCT00860535|452988|P1|STARTED|Overall Study||9
188483|NCT00860470|452995|P2|NOT COMPLETED|Overall Study||59
188484|NCT00860470|452996|P1|NOT COMPLETED|Overall Study||48
188485|NCT00860470|452995|P2|COMPLETED|Overall Study||22346
188486|NCT00860470|452996|P1|COMPLETED|Overall Study||22114
188487|NCT00860470|452995|P2|STARTED|Overall Study||22405
188488|NCT00860470|452996|P1|STARTED|Overall Study||22162
188489|NCT00860457|453020|P1|NOT COMPLETED|Overall Study||11
188490|NCT00860457|453020|P1|COMPLETED|Overall Study||11
188491|NCT00860457|453020|P1|STARTED|Overall Study||22
188492|NCT00860405|453026|P2|NOT COMPLETED|Overall Study||4
188493|NCT00860405|453027|P1|NOT COMPLETED|Overall Study||5
188494|NCT00860405|453026|P2|COMPLETED|Overall Study||26
188495|NCT00860405|453027|P1|COMPLETED|Overall Study|completed overall study|26
188496|NCT00860405|453026|P2|Day 28 Follow-up Performed|Overall Study||29
188497|NCT00860405|453027|P1|Day 28 Follow-up Performed|Overall Study||31
188498|NCT00860405|453026|P2|Completed Treatment|Overall Study||29
188499|NCT00860405|453027|P1|Completed Treatment|Overall Study||31
188500|NCT00860405|453026|P2|STARTED|Overall Study||30
188501|NCT00860405|453027|P1|STARTED|Overall Study||31
188502|NCT00860314|453051|P2|NOT COMPLETED|Overall Study||0
188503|NCT00860314|453052|P1|NOT COMPLETED|Overall Study||0
188504|NCT00860314|453051|P2|COMPLETED|Overall Study||48
188505|NCT00860314|453052|P1|COMPLETED|Overall Study||48
188506|NCT00860314|453051|P2|STARTED|Overall Study||48
188507|NCT00860314|453052|P1|STARTED|Overall Study||48
188508|NCT00860262|453067|P3|NOT COMPLETED|Overall Study||18
188509|NCT00860262|453068|P2|NOT COMPLETED|Overall Study||22
188510|NCT00860262|453069|P1|NOT COMPLETED|Overall Study||20
188511|NCT00860262|453067|P3|COMPLETED|Overall Study||202
188512|NCT00860262|453068|P2|COMPLETED|Overall Study||195
188513|NCT00860262|453069|P1|COMPLETED|Overall Study||401
188514|NCT00860262|453067|P3|STARTED|Overall Study||220
188515|NCT00860262|453068|P2|STARTED|Overall Study||217
188516|NCT00860262|453069|P1|STARTED|Overall Study||421
188517|NCT00860249|453182|P3|NOT COMPLETED|Overall Study||21
188518|NCT00860249|453183|P2|NOT COMPLETED|Overall Study||18
188519|NCT00860249|453184|P1|NOT COMPLETED|Overall Study||21
188520|NCT00860249|453182|P3|COMPLETED|Overall Study||0
188521|NCT00860249|453183|P2|COMPLETED|Overall Study||0
188522|NCT00860249|453184|P1|COMPLETED|Overall Study||0
188523|NCT00860249|453182|P3|STARTED|Overall Study||21
188524|NCT00860249|453183|P2|STARTED|Overall Study||18
188525|NCT00860249|453184|P1|STARTED|Overall Study||21
188526|NCT00860171|453195|P1|NOT COMPLETED|Overall Study||0
188527|NCT00860171|453195|P1|COMPLETED|Overall Study||16
188528|NCT00860171|453195|P1|STARTED|Overall Study||16
188529|NCT00860158|453202|P1|NOT COMPLETED|Overall Study||1
188530|NCT00860158|453202|P1|COMPLETED|Overall Study||0
188531|NCT00860158|453202|P1|STARTED|Overall Study||1
188532|NCT00860067|453214|P3|NOT COMPLETED|Overall Study||9
188533|NCT00860067|453215|P2|NOT COMPLETED|Overall Study||9
188534|NCT00860067|453216|P1|NOT COMPLETED|Overall Study||51
188535|NCT00860067|453214|P3|COMPLETED|Overall Study||292
188536|NCT00860067|453215|P2|COMPLETED|Overall Study||290
188537|NCT00860067|453216|P1|COMPLETED|Overall Study||1149
188538|NCT00860067|453214|P3|STARTED|Overall Study||301
188539|NCT00860067|453215|P2|STARTED|Overall Study||299
188540|NCT00860067|453216|P1|STARTED|Overall Study||1200
188541|NCT00860028|453276|P2|NOT COMPLETED|Smoking Cessation Phase||2
188542|NCT00860028|453277|P1|NOT COMPLETED|Smoking Cessation Phase||0
188543|NCT00860028|453276|P2|COMPLETED|Smoking Cessation Phase||12
188544|NCT00860028|453277|P1|COMPLETED|Smoking Cessation Phase||13
188545|NCT00860028|453276|P2|STARTED|Smoking Cessation Phase||14
188546|NCT00860028|453277|P1|STARTED|Smoking Cessation Phase||13
188547|NCT00860028|453276|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
188548|NCT00860028|453277|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
188549|NCT00860028|453276|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
188550|NCT00860028|453277|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
188551|NCT00860028|453276|P2|STARTED|Placebo Controlled Pretreatment Period||15
188552|NCT00860028|453277|P1|STARTED|Placebo Controlled Pretreatment Period||15
188553|NCT00859950|453289|P2|NOT COMPLETED|Overall Study||0
188554|NCT00859950|453290|P1|NOT COMPLETED|Overall Study||0
188555|NCT00859950|453289|P2|COMPLETED|Overall Study||21
188556|NCT00859950|453290|P1|COMPLETED|Overall Study||49
188557|NCT00859950|453289|P2|STARTED|Overall Study||21
188558|NCT00859950|453290|P1|STARTED|Overall Study||49
188559|NCT00859937|453298|P2|NOT COMPLETED|Overall Study||0
188560|NCT00859937|453299|P1|NOT COMPLETED|Overall Study||1
188561|NCT00859937|453298|P2|COMPLETED|Overall Study||14
188562|NCT00859937|453299|P1|COMPLETED|Overall Study||40
188563|NCT00859937|453298|P2|STARTED|Overall Study||14
188564|NCT00859937|453299|P1|STARTED|Overall Study||41
188565|NCT00859898|453314|P3|NOT COMPLETED|Overall Study||27
188566|NCT00859898|453315|P2|NOT COMPLETED|Overall Study||31
188567|NCT00859898|453316|P1|NOT COMPLETED|Overall Study||28
188568|NCT00859898|453314|P3|COMPLETED|Overall Study||181
188569|NCT00859898|453315|P2|COMPLETED|Overall Study||188
188570|NCT00859898|453316|P1|COMPLETED|Overall Study||183
188571|NCT00859898|453314|P3|STARTED|Overall Study||208
188572|NCT00859898|453315|P2|STARTED|Overall Study||219
188573|NCT00859898|453316|P1|STARTED|Overall Study||211
188574|NCT00859833|453357|P1|NOT COMPLETED|Overall Study||0
188575|NCT00859833|453357|P1|COMPLETED|Overall Study||30
188576|NCT00859833|453357|P1|STARTED|Overall Study||30
188577|NCT00859651|453364|P2|NOT COMPLETED|Overall Study||0
188578|NCT00859651|453365|P1|NOT COMPLETED|Overall Study||0
188579|NCT00859651|453364|P2|COMPLETED|Overall Study||22
188580|NCT00859651|453365|P1|COMPLETED|Overall Study||18
188581|NCT00859651|453364|P2|STARTED|Overall Study||22
188582|NCT00859651|453365|P1|STARTED|Overall Study||18
188583|NCT00859638|453375|P2|NOT COMPLETED|Overall Study||4
188584|NCT00859638|453376|P1|NOT COMPLETED|Overall Study||10
188585|NCT00859638|453375|P2|COMPLETED|Overall Study||55
188586|NCT00859638|453376|P1|COMPLETED|Overall Study||55
188587|NCT00859638|453375|P2|STARTED|Overall Study||59
188588|NCT00859638|453376|P1|STARTED|Overall Study||65
188589|NCT00859586|453382|P1|NOT COMPLETED|Overall Study||4
188590|NCT00859586|453382|P1|COMPLETED|Overall Study||4
188591|NCT00859586|453382|P1|STARTED|Overall Study||8
188592|NCT00859573|453388|P2|NOT COMPLETED|Overall Study||2
188593|NCT00859573|453389|P1|NOT COMPLETED|Overall Study||5
188594|NCT00859573|453388|P2|COMPLETED|Overall Study||1
188595|NCT00859573|453389|P1|COMPLETED|Overall Study||1
188596|NCT00859573|453388|P2|STARTED|Overall Study||3
188597|NCT00859573|453389|P1|STARTED|Overall Study||6
188598|NCT00859547|453395|P1|NOT COMPLETED|Overall Study||2
188599|NCT00859547|453395|P1|COMPLETED|Overall Study||28
188600|NCT00859547|453395|P1|STARTED|Overall Study||30
188601|NCT00859521|453408|P2|NOT COMPLETED|Second Intervention||0
188602|NCT00859521|453409|P1|NOT COMPLETED|Second Intervention||0
188603|NCT00859521|453408|P2|COMPLETED|Second Intervention||14
188604|NCT00859521|453409|P1|COMPLETED|Second Intervention||15
188605|NCT00859521|453408|P2|STARTED|Second Intervention||14
188606|NCT00859521|453409|P1|STARTED|Second Intervention||15
188607|NCT00859521|453408|P2|NOT COMPLETED|Washout||1
188608|NCT00859521|453409|P1|NOT COMPLETED|Washout||0
188609|NCT00859521|453408|P2|COMPLETED|Washout||14
188610|NCT00859521|453409|P1|COMPLETED|Washout||15
188611|NCT00859521|453408|P2|STARTED|Washout||15
188612|NCT00859521|453409|P1|STARTED|Washout||15
188613|NCT00859521|453408|P2|NOT COMPLETED|First Intervention||0
188614|NCT00859521|453409|P1|NOT COMPLETED|First Intervention||0
188615|NCT00859521|453408|P2|COMPLETED|First Intervention||15
188616|NCT00859521|453409|P1|COMPLETED|First Intervention||15
188617|NCT00859521|453408|P2|STARTED|First Intervention||15
188618|NCT00859521|453409|P1|STARTED|First Intervention||15
188619|NCT00859508|453419|P2|NOT COMPLETED|Overall Study||0
188620|NCT00859508|453420|P1|NOT COMPLETED|Overall Study||6
188621|NCT00859508|453419|P2|COMPLETED|Overall Study||37
188622|NCT00859508|453420|P1|COMPLETED|Overall Study||62
188623|NCT00859508|453419|P2|STARTED|Overall Study||37
188624|NCT00859508|453420|P1|STARTED|Overall Study||68
188625|NCT00859469|453426|P1|NOT COMPLETED|Overall Study||28
188626|NCT00859469|453426|P1|COMPLETED|Overall Study||1
188627|NCT00859469|453426|P1|6 Cycles|Overall Study||16
188628|NCT00859469|453426|P1|STARTED|Overall Study||29
188629|NCT00859430|453434|P2|NOT COMPLETED|Second Intervention||0
188630|NCT00859430|453435|P1|NOT COMPLETED|Second Intervention||0
188631|NCT00859430|453434|P2|COMPLETED|Second Intervention||10
188632|NCT00859430|453435|P1|COMPLETED|Second Intervention||11
188633|NCT00859430|453434|P2|STARTED|Second Intervention||10
188634|NCT00859430|453435|P1|STARTED|Second Intervention||11
188635|NCT00859430|453434|P2|NOT COMPLETED|First Intervention||1
188636|NCT00859430|453435|P1|NOT COMPLETED|First Intervention||0
188637|NCT00859430|453434|P2|COMPLETED|First Intervention||10
188638|NCT00859430|453435|P1|COMPLETED|First Intervention||11
188639|NCT00859430|453434|P2|STARTED|First Intervention||11
188640|NCT00859430|453435|P1|STARTED|First Intervention||11
188641|NCT00859339|453443|P1|NOT COMPLETED|Overall Study||0
188642|NCT00859339|453443|P1|COMPLETED|Overall Study||9
188643|NCT00859339|453443|P1|STARTED|Overall Study||9
188644|NCT00859313|453451|P1|NOT COMPLETED|Overall Study||4
188645|NCT00859313|453451|P1|COMPLETED|Overall Study||26
188646|NCT00859313|453451|P1|STARTED|Overall Study||30
188647|NCT00859222|453458|P5|NOT COMPLETED|Overall Study||15
188648|NCT00859222|453459|P4|NOT COMPLETED|Overall Study||24
188649|NCT00859222|453460|P3|NOT COMPLETED|Overall Study||6
188650|NCT00859222|453461|P2|NOT COMPLETED|Overall Study||3
188651|NCT00859222|453462|P1|NOT COMPLETED|Overall Study||3
188652|NCT00859222|453458|P5|COMPLETED|Overall Study||0
188653|NCT00859222|453459|P4|COMPLETED|Overall Study||0
188654|NCT00859222|453460|P3|COMPLETED|Overall Study||0
188655|NCT00859222|453461|P2|COMPLETED|Overall Study||0
188656|NCT00859222|453462|P1|COMPLETED|Overall Study||0
188657|NCT00859222|453458|P5|STARTED|Overall Study||15
188658|NCT00859222|453459|P4|STARTED|Overall Study||24
188659|NCT00859222|453460|P3|STARTED|Overall Study||6
188660|NCT00859222|453461|P2|STARTED|Overall Study||3
188661|NCT00859222|453462|P1|STARTED|Overall Study||3
188662|NCT00859131|453489|P2|NOT COMPLETED|Overall Study||0
188663|NCT00859131|453490|P1|NOT COMPLETED|Overall Study||0
188664|NCT00859131|453489|P2|COMPLETED|Overall Study||98
188665|NCT00859131|453490|P1|COMPLETED|Overall Study||102
188666|NCT00859131|453489|P2|STARTED|Overall Study||98
188667|NCT00859131|453490|P1|STARTED|Overall Study||102
188668|NCT00859053|453512|P4|NOT COMPLETED|Overall Study||0
188669|NCT00859053|453513|P3|NOT COMPLETED|Overall Study||0
188670|NCT00859053|453514|P2|NOT COMPLETED|Overall Study||0
188671|NCT00859053|453515|P1|NOT COMPLETED|Overall Study||0
188672|NCT00859053|453512|P4|COMPLETED|Overall Study||12
188673|NCT00859053|453513|P3|COMPLETED|Overall Study||6
188674|NCT00859053|453514|P2|COMPLETED|Overall Study||6
188675|NCT00859053|453515|P1|COMPLETED|Overall Study||6
188676|NCT00859053|453512|P4|STARTED|Overall Study||12
188677|NCT00859053|453513|P3|STARTED|Overall Study||6
188678|NCT00859053|453514|P2|STARTED|Overall Study||6
188679|NCT00859053|453515|P1|STARTED|Overall Study||6
188680|NCT00859040|453559|P2|NOT COMPLETED|Overall Study||0
188681|NCT00859040|453560|P1|NOT COMPLETED|Overall Study||0
188682|NCT00859040|453559|P2|COMPLETED|Overall Study||16
188683|NCT00859040|453560|P1|COMPLETED|Overall Study||18
188684|NCT00859040|453559|P2|STARTED|Overall Study||16
188685|NCT00859040|453560|P1|STARTED|Overall Study||18
188686|NCT00859027|453575|P2|NOT COMPLETED|Overall Study||5
188687|NCT00859027|453576|P1|NOT COMPLETED|Overall Study||5
188688|NCT00859027|453575|P2|COMPLETED|Overall Study||20
188689|NCT00859027|453576|P1|COMPLETED|Overall Study||20
188690|NCT00859027|453575|P2|STARTED|Overall Study||25
188691|NCT00859027|453576|P1|STARTED|Overall Study||25
188692|NCT00859014|453584|P1|NOT COMPLETED|Overall Study||5
188693|NCT00859014|453584|P1|COMPLETED|Overall Study||20
188694|NCT00859014|453584|P1|STARTED|Overall Study||25
188695|NCT00858962|453589|P1|NOT COMPLETED|Overall Study||0
188696|NCT00858962|453589|P1|COMPLETED|Overall Study||12
188697|NCT00858962|453589|P1|STARTED|Overall Study||12
188698|NCT00858858|453593|P1|NOT COMPLETED|Overall Study||18
188699|NCT00858858|453593|P1|COMPLETED|Overall Study||42
188700|NCT00858858|453593|P1|STARTED|Overall Study||60
188701|NCT00858845|453599|P2|NOT COMPLETED|Overall Study||1
188702|NCT00858845|453600|P1|NOT COMPLETED|Overall Study||0
188703|NCT00858845|453599|P2|COMPLETED|Overall Study||5
188704|NCT00858845|453600|P1|COMPLETED|Overall Study||5
188705|NCT00858845|453599|P2|STARTED|Overall Study||6
188706|NCT00858845|453600|P1|STARTED|Overall Study||5
188707|NCT00858832|453612|P2|NOT COMPLETED|Overall Study||1
188708|NCT00858832|453613|P1|NOT COMPLETED|Overall Study||1
188709|NCT00858832|453612|P2|COMPLETED|Overall Study||22
188710|NCT00858832|453613|P1|COMPLETED|Overall Study||20
188711|NCT00858832|453612|P2|STARTED|Overall Study||23
188712|NCT00858832|453613|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
188713|NCT00858780|453619|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
188714|NCT00858780|453620|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188715|NCT00858780|453621|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188716|NCT00858780|453622|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188717|NCT00858780|453623|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188718|NCT00858780|453619|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
188719|NCT00858780|453620|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188720|NCT00858780|453621|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188721|NCT00858780|453622|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188722|NCT00858780|453623|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
188723|NCT00858780|453619|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
188724|NCT00858780|453620|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
188725|NCT00858780|453621|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
188726|NCT00858780|453622|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
188727|NCT00858780|453623|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
188728|NCT00858780|453619|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
188729|NCT00858780|453620|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
188730|NCT00858780|453621|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
188731|NCT00858780|453622|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
188732|NCT00858780|453623|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
188733|NCT00858780|453619|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
188734|NCT00858780|453620|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
188735|NCT00858780|453621|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
188736|NCT00858780|453622|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
188737|NCT00858780|453623|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
188738|NCT00858780|453619|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
188739|NCT00858780|453620|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
188740|NCT00858780|453621|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
188741|NCT00858780|453622|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
188742|NCT00858780|453623|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
188743|NCT00858780|453619|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188744|NCT00858780|453620|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188745|NCT00858780|453621|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188746|NCT00858780|453622|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188747|NCT00858780|453623|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
188748|NCT00858780|453619|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188749|NCT00858780|453620|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188750|NCT00858780|453621|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188751|NCT00858780|453622|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188752|NCT00858780|453623|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
188753|NCT00858780|453619|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188754|NCT00858780|453620|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188755|NCT00858780|453621|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188756|NCT00858780|453622|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
188757|NCT00858780|453623|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
188758|NCT00858702|453698|P2|NOT COMPLETED|Overall Study||2
188759|NCT00858702|453699|P1|NOT COMPLETED|Overall Study||5
188760|NCT00858702|453698|P2|COMPLETED|Overall Study||50
188761|NCT00858702|453699|P1|COMPLETED|Overall Study||48
188762|NCT00858702|453698|P2|STARTED|Overall Study||52
188763|NCT00858702|453699|P1|STARTED|Overall Study||53
188764|NCT00858689|453707|P1|NOT COMPLETED|Overall Study||1
188765|NCT00858689|453707|P1|COMPLETED|Overall Study||19
188766|NCT00858689|453707|P1|STARTED|Overall Study||20
188767|NCT00858637|453714|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
188768|NCT00858637|453715|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
188769|NCT00858637|453716|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
188770|NCT00858637|453717|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
188771|NCT00858637|453718|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
188772|NCT00858637|453719|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
188773|NCT00858637|453714|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
188774|NCT00858637|453715|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
188775|NCT00858637|453716|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
188776|NCT00858637|453717|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
188777|NCT00858637|453718|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
188778|NCT00858637|453719|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
188779|NCT00858637|453714|P6|STARTED|Placebo-controlled Withdrawal Phase||59
188780|NCT00858637|453715|P5|STARTED|Placebo-controlled Withdrawal Phase||56
188781|NCT00858637|453716|P4|STARTED|Placebo-controlled Withdrawal Phase||0
188782|NCT00858637|453717|P3|STARTED|Placebo-controlled Withdrawal Phase||54
188783|NCT00858637|453718|P2|STARTED|Placebo-controlled Withdrawal Phase||49
188784|NCT00858637|453719|P1|STARTED|Placebo-controlled Withdrawal Phase||0
188785|NCT00858637|453714|P6|NOT COMPLETED|Active Comparison Phase||0
188786|NCT00858637|453715|P5|NOT COMPLETED|Active Comparison Phase||0
188787|NCT00858637|453716|P4|NOT COMPLETED|Active Comparison Phase||18
188788|NCT00858637|453717|P3|NOT COMPLETED|Active Comparison Phase||0
188789|NCT00858637|453718|P2|NOT COMPLETED|Active Comparison Phase||0
188790|NCT00858637|453719|P1|NOT COMPLETED|Active Comparison Phase||24
188791|NCT00858637|453714|P6|COMPLETED|Active Comparison Phase||0
188792|NCT00858637|453715|P5|COMPLETED|Active Comparison Phase||0
188793|NCT00858637|453716|P4|COMPLETED|Active Comparison Phase||115
188794|NCT00858637|453717|P3|COMPLETED|Active Comparison Phase||0
188795|NCT00858637|453718|P2|COMPLETED|Active Comparison Phase||0
188796|NCT00858637|453719|P1|COMPLETED|Active Comparison Phase||103
188797|NCT00858637|453714|P6|STARTED|Active Comparison Phase||0
188798|NCT00858637|453715|P5|STARTED|Active Comparison Phase||0
188799|NCT00858637|453716|P4|STARTED|Active Comparison Phase||133
188800|NCT00858637|453717|P3|STARTED|Active Comparison Phase||0
188801|NCT00858637|453718|P2|STARTED|Active Comparison Phase||0
188802|NCT00858637|453719|P1|STARTED|Active Comparison Phase||127
188803|NCT00858507|453731|P2|NOT COMPLETED|Overall Study||15
188804|NCT00858507|453732|P1|NOT COMPLETED|Overall Study||22
188805|NCT00858507|453731|P2|COMPLETED|Overall Study||101
188806|NCT00858507|453732|P1|COMPLETED|Overall Study||83
188807|NCT00858507|453731|P2|STARTED|Overall Study||116
188808|NCT00858507|453732|P1|STARTED|Overall Study||105
188809|NCT00858494|453738|P1|NOT COMPLETED|Overall Study||4
188810|NCT00858494|453738|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
188811|NCT00858494|453738|P1|STARTED|Overall Study||49
188812|NCT00858468|453745|P2|NOT COMPLETED|Overall Study||0
188813|NCT00858468|453746|P1|NOT COMPLETED|Overall Study||0
188814|NCT00858468|453745|P2|COMPLETED|Overall Study||192
188815|NCT00858468|453746|P1|COMPLETED|Overall Study||201
188816|NCT00858468|453745|P2|STARTED|Overall Study||192
188817|NCT00858468|453746|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
188818|NCT00858442|453760|P2|NOT COMPLETED|Compression:Start to Finish||3
188819|NCT00858442|453761|P1|NOT COMPLETED|Compression:Start to Finish||1
188820|NCT00858442|453760|P2|COMPLETED|Compression:Start to Finish||20
188821|NCT00858442|453761|P1|COMPLETED|Compression:Start to Finish||20
188822|NCT00858442|453760|P2|STARTED|Compression:Start to Finish||23
188823|NCT00858442|453761|P1|STARTED|Compression:Start to Finish||21
188824|NCT00858442|453760|P2|NOT COMPLETED|From Surgery to Start Compression;||0
188825|NCT00858442|453761|P1|NOT COMPLETED|From Surgery to Start Compression;||0
188826|NCT00858442|453760|P2|COMPLETED|From Surgery to Start Compression;||23
188827|NCT00858442|453761|P1|COMPLETED|From Surgery to Start Compression;||21
188828|NCT00858442|453760|P2|STARTED|From Surgery to Start Compression;||23
188829|NCT00858442|453761|P1|STARTED|From Surgery to Start Compression;||21
188830|NCT00858403|453771|P1|NOT COMPLETED|Overall Study||5
188831|NCT00858403|453771|P1|COMPLETED|Overall Study||2
188832|NCT00858403|453771|P1|STARTED|Overall Study||7
188833|NCT00858390|453783|P2|NOT COMPLETED|Overall Study||0
188834|NCT00858390|453784|P1|NOT COMPLETED|Overall Study||0
188835|NCT00858390|453783|P2|COMPLETED|Overall Study||18
188836|NCT00858390|453784|P1|COMPLETED|Overall Study||18
188837|NCT00858390|453783|P2|STARTED|Overall Study||18
188838|NCT00858390|453784|P1|STARTED|Overall Study||18
188839|NCT00858247|453792|P2|NOT COMPLETED|Week 12 Follow-up||1
188840|NCT00858247|453793|P1|NOT COMPLETED|Week 12 Follow-up||0
188841|NCT00858247|453792|P2|COMPLETED|Week 12 Follow-up||23
188842|NCT00858247|453793|P1|COMPLETED|Week 12 Follow-up||23
188843|NCT00858247|453792|P2|STARTED|Week 12 Follow-up||24
188844|NCT00858247|453793|P1|STARTED|Week 12 Follow-up||23
188845|NCT00858247|453792|P2|NOT COMPLETED|Baseline Assessment||2
188846|NCT00858247|453793|P1|NOT COMPLETED|Baseline Assessment||2
188847|NCT00858247|453792|P2|COMPLETED|Baseline Assessment||24
188848|NCT00858247|453793|P1|COMPLETED|Baseline Assessment||23
188849|NCT00858247|453792|P2|STARTED|Baseline Assessment||26
188850|NCT00858247|453793|P1|STARTED|Baseline Assessment||25
188851|NCT00858208|453809|P1|NOT COMPLETED|Overall Study||79
188852|NCT00858208|453809|P1|COMPLETED|Overall Study||6
188853|NCT00858208|453809|P1|STARTED|Overall Study||85
188854|NCT00858143|453826|P1|NOT COMPLETED|Overall Study||50
188855|NCT00858143|453826|P1|COMPLETED|Overall Study||261
188856|NCT00858143|453826|P1|STARTED|Overall Study|Baseline|311
188857|NCT00858130|453875|P1|NOT COMPLETED|Overall Study||0
188858|NCT00858130|453875|P1|COMPLETED|Overall Study||12
188859|NCT00858130|453875|P1|STARTED|Overall Study||12
188860|NCT00858013|453885|P2|NOT COMPLETED|Overall Study||19
188861|NCT00858013|453886|P1|NOT COMPLETED|Overall Study||22
188862|NCT00858013|453885|P2|COMPLETED|Overall Study||23
188863|NCT00858013|453886|P1|COMPLETED|Overall Study||24
188864|NCT00858013|453885|P2|STARTED|Overall Study||42
188865|NCT00858013|453886|P1|STARTED|Overall Study||46
188866|NCT00857961|453900|P1|NOT COMPLETED|Overall Study||0
188867|NCT00857961|453900|P1|COMPLETED|Overall Study||21
188868|NCT00857961|453900|P1|STARTED|Overall Study||21
188869|NCT00857948|453938|P4|NOT COMPLETED|Overall Study||0
188870|NCT00857948|453939|P3|NOT COMPLETED|Overall Study||1
188871|NCT00857948|453940|P2|NOT COMPLETED|Overall Study||0
188872|NCT00857948|453941|P1|NOT COMPLETED|Overall Study||3
188873|NCT00857948|453938|P4|COMPLETED|Overall Study||23
188874|NCT00857948|453939|P3|COMPLETED|Overall Study||18
188875|NCT00857948|453940|P2|COMPLETED|Overall Study||18
188876|NCT00857948|453941|P1|COMPLETED|Overall Study||15
188877|NCT00857948|453938|P4|STARTED|Overall Study||23
188878|NCT00857948|453939|P3|STARTED|Overall Study||19
188879|NCT00857948|453940|P2|STARTED|Overall Study||18
188880|NCT00857948|453941|P1|STARTED|Overall Study||18
188881|NCT00857896|453963|P1|NOT COMPLETED|Week 5 to Week 8||0
188882|NCT00857896|453963|P1|COMPLETED|Week 5 to Week 8||20
188883|NCT00857896|453963|P1|STARTED|Week 5 to Week 8||20
188884|NCT00857896|453963|P1|NOT COMPLETED|Baseline to Week 4||1
188885|NCT00857896|453963|P1|COMPLETED|Baseline to Week 4||20
188886|NCT00857896|453963|P1|STARTED|Baseline to Week 4||21
188887|NCT00857857|453975|P1|NOT COMPLETED|Overall Study||0
188888|NCT00857857|453975|P1|COMPLETED|Overall Study||24
188889|NCT00857857|453975|P1|STARTED|Overall Study||24
188890|NCT00857818|454119|P2|NOT COMPLETED|Overall Study||8
188891|NCT00857818|454120|P1|NOT COMPLETED|Overall Study||11
188892|NCT00857818|454119|P2|COMPLETED|Overall Study||6
188893|NCT00857818|454120|P1|COMPLETED|Overall Study||3
188894|NCT00857818|454119|P2|Received Treatment|Overall Study||12
188895|NCT00857818|454120|P1|Received Treatment|Overall Study||14
188896|NCT00857818|454119|P2|STARTED|Overall Study||14
188897|NCT00857818|454120|P1|STARTED|Overall Study||14
188898|NCT00857792|454148|P1|NOT COMPLETED|Overall Study||12
188899|NCT00857792|454148|P1|COMPLETED|Overall Study||108
188900|NCT00857792|454148|P1|STARTED|Overall Study||120
188901|NCT00857766|454154|P2|NOT COMPLETED|Overall Study||30
188902|NCT00857766|454155|P1|NOT COMPLETED|Overall Study||31
188903|NCT00857766|454154|P2|COMPLETED|Overall Study||96
188904|NCT00857766|454155|P1|COMPLETED|Overall Study||92
188905|NCT00857766|454154|P2|STARTED|Overall Study||126
188906|NCT00857766|454155|P1|STARTED|Overall Study||123
188907|NCT00857714|454165|P1|NOT COMPLETED|Overall Study||0
188908|NCT00857714|454165|P1|COMPLETED|Overall Study||1
188909|NCT00857714|454165|P1|STARTED|Overall Study||1
188910|NCT00857649|454172|P2|NOT COMPLETED|Overall Study||32
188911|NCT00857649|454173|P1|NOT COMPLETED|Overall Study||31
188912|NCT00857649|454172|P2|COMPLETED|Overall Study||155
188913|NCT00857649|454173|P1|COMPLETED|Overall Study||151
188914|NCT00857649|454172|P2|STARTED|Overall Study||187
188915|NCT00857649|454173|P1|STARTED|Overall Study||182
188916|NCT00857623|454189|P2|NOT COMPLETED|Overall Study||10
188917|NCT00857623|454190|P1|NOT COMPLETED|Overall Study||14
188918|NCT00857623|454189|P2|COMPLETED|Overall Study||55
188919|NCT00857623|454190|P1|COMPLETED|Overall Study||48
188920|NCT00857623|454189|P2|STARTED|Overall Study||65
188921|NCT00857623|454190|P1|STARTED|Overall Study||62
188922|NCT00857584|454214|P2|NOT COMPLETED|Overall Study||5
188923|NCT00857584|454215|P1|NOT COMPLETED|Overall Study||4
188924|NCT00857584|454214|P2|COMPLETED|Overall Study||8
188925|NCT00857584|454215|P1|COMPLETED|Overall Study||10
188926|NCT00857584|454214|P2|Week 8|Overall Study||8
188927|NCT00857584|454215|P1|Week 8|Overall Study||10
188928|NCT00857584|454214|P2|Week 4|Overall Study||9
188929|NCT00857584|454215|P1|Week 4|Overall Study||11
188930|NCT00857584|454214|P2|Week 2|Overall Study||11
188931|NCT00857584|454215|P1|Week 2|Overall Study||14
188932|NCT00857584|454214|P2|Week 1|Overall Study||13
188933|NCT00857584|454215|P1|Week 1|Overall Study||14
188934|NCT00857584|454214|P2|STARTED|Overall Study||13
188935|NCT00857584|454215|P1|STARTED|Overall Study||14
188936|NCT00857545|454257|P2|NOT COMPLETED|Overall Study||0
188937|NCT00857545|454258|P1|NOT COMPLETED|Overall Study||0
188938|NCT00857545|454257|P2|COMPLETED|Overall Study||85
188939|NCT00857545|454258|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
188940|NCT00857545|454257|P2|STARTED|Overall Study||85
188941|NCT00857545|454258|P1|STARTED|Overall Study||86
188942|NCT00857532|454268|P1|NOT COMPLETED|Overall Study||0
188943|NCT00857532|454268|P1|COMPLETED|Overall Study||31
188944|NCT00857532|454268|P1|STARTED|Overall Study||31
188945|NCT00857506|454279|P3|NOT COMPLETED|Overall Study||18
188946|NCT00857506|454280|P2|NOT COMPLETED|Overall Study||15
188947|NCT00857506|454281|P1|NOT COMPLETED|Overall Study||15
188948|NCT00857506|454279|P3|COMPLETED|Overall Study||51
188949|NCT00857506|454280|P2|COMPLETED|Overall Study||37
188950|NCT00857506|454281|P1|COMPLETED|Overall Study||16
188951|NCT00857506|454279|P3|STARTED|Overall Study||69
188952|NCT00857506|454280|P2|STARTED|Overall Study||52
188953|NCT00857506|454281|P1|STARTED|Overall Study||31
188954|NCT00857454|454307|P1|NOT COMPLETED|Overall Study||20
188955|NCT00857454|454307|P1|COMPLETED|Overall Study||51
188956|NCT00857454|454307|P1|STARTED|Overall Study||71
188957|NCT00857415|454320|P2|NOT COMPLETED|Overall Study||0
188958|NCT00857415|454321|P1|NOT COMPLETED|Overall Study||117
188959|NCT00857415|454320|P2|COMPLETED|Overall Study||74
188960|NCT00857415|454321|P1|COMPLETED|Overall Study||35
188961|NCT00857415|454320|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
188962|NCT00857415|454321|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
188963|NCT00857415|454320|P2|STARTED|Overall Study||74
188964|NCT00857415|454321|P1|STARTED|Overall Study||152
188965|NCT00857311|454332|P4|NOT COMPLETED|Overall Study||0
188966|NCT00857311|454333|P3|NOT COMPLETED|Overall Study||0
188967|NCT00857311|454334|P2|NOT COMPLETED|Overall Study||0
188968|NCT00857311|454335|P1|NOT COMPLETED|Overall Study||1
188969|NCT00857311|454332|P4|COMPLETED|Overall Study||0
188970|NCT00857311|454333|P3|COMPLETED|Overall Study||8
188971|NCT00857311|454334|P2|COMPLETED|Overall Study||0
188972|NCT00857311|454335|P1|COMPLETED|Overall Study||8
188973|NCT00857311|454332|P4|STARTED|Overall Study||0
188974|NCT00857311|454333|P3|STARTED|Overall Study||8
188975|NCT00857311|454334|P2|STARTED|Overall Study||0
188976|NCT00857311|454335|P1|STARTED|Overall Study||9
188977|NCT00857285|454347|P2|NOT COMPLETED|Overall Study||6
188978|NCT00857285|454348|P1|NOT COMPLETED|Overall Study||12
188979|NCT00857285|454347|P2|COMPLETED|Overall Study||59
188980|NCT00857285|454348|P1|COMPLETED|Overall Study||53
188981|NCT00857285|454347|P2|STARTED|Overall Study||65
188982|NCT00857285|454348|P1|STARTED|Overall Study||65
188983|NCT00857272|454354|P2|NOT COMPLETED|Overall Study||9
188984|NCT00857272|454355|P1|NOT COMPLETED|Overall Study||9
188985|NCT00857272|454354|P2|COMPLETED|Overall Study||145
188986|NCT00857272|454355|P1|COMPLETED|Overall Study||145
188987|NCT00857272|454354|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
188988|NCT00857272|454355|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
188989|NCT00857259|454364|P3|NOT COMPLETED|Overall Study||1
188990|NCT00857259|454365|P2|NOT COMPLETED|Overall Study||0
188991|NCT00857259|454366|P1|NOT COMPLETED|Overall Study||1
188992|NCT00857259|454364|P3|COMPLETED|Overall Study||6
188993|NCT00857259|454365|P2|COMPLETED|Overall Study||1
188994|NCT00857259|454366|P1|COMPLETED|Overall Study||7
188995|NCT00857259|454364|P3|STARTED|Overall Study||7
188996|NCT00857259|454365|P2|STARTED|Overall Study||1
188997|NCT00857259|454366|P1|STARTED|Overall Study||8
188998|NCT00857246|454376|P1|NOT COMPLETED|ChemoRT||3
188999|NCT00857246|454376|P1|COMPLETED|ChemoRT||12
189000|NCT00857246|454376|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
189001|NCT00857246|454376|P1|NOT COMPLETED|Surgery (Curative)||6
189002|NCT00857246|454376|P1|COMPLETED|Surgery (Curative)||21
189003|NCT00857246|454376|P1|STARTED|Surgery (Curative)||27
189004|NCT00857246|454376|P1|NOT COMPLETED|Induction Regimen||3
189005|NCT00857246|454376|P1|COMPLETED|Induction Regimen||27
189006|NCT00857246|454376|P1|STARTED|Induction Regimen||30
189007|NCT00857233|454386|P1|NOT COMPLETED|Overall Study||55
189008|NCT00857233|454386|P1|COMPLETED|Overall Study||242
189009|NCT00857233|454386|P1|STARTED|Overall Study||297
189010|NCT00857220|454395|P1|NOT COMPLETED|Overall Study||183
189011|NCT00857220|454395|P1|COMPLETED|Overall Study||121
189012|NCT00857220|454395|P1|STARTED|Overall Study||304
189013|NCT00856986|454417|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
189014|NCT00856986|454418|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
189015|NCT00856986|454419|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
189016|NCT00856986|454420|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
189017|NCT00856986|454421|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
189018|NCT00856986|454417|P5|COMPLETED|Extension Period, Weeks 26-52||0
189019|NCT00856986|454418|P4|COMPLETED|Extension Period, Weeks 26-52||0
189020|NCT00856986|454419|P3|COMPLETED|Extension Period, Weeks 26-52||432
189021|NCT00856986|454420|P2|COMPLETED|Extension Period, Weeks 26-52||130
189022|NCT00856986|454421|P1|COMPLETED|Extension Period, Weeks 26-52||108
189023|NCT00856986|454417|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
189024|NCT00856986|454418|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
189025|NCT00856986|454419|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
189026|NCT00856986|454420|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
189027|NCT00856986|454421|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
189028|NCT00856986|454417|P5|STARTED|Extension Period, Weeks 26-52||0
189029|NCT00856986|454418|P4|STARTED|Extension Period, Weeks 26-52||0
189030|NCT00856986|454419|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
189031|NCT00856986|454420|P2|STARTED|Extension Period, Weeks 26-52||144
189032|NCT00856986|454421|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
189033|NCT00856986|454417|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
189034|NCT00856986|454418|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
189035|NCT00856986|454419|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
189036|NCT00856986|454420|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
189037|NCT00856986|454421|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
189038|NCT00856986|454417|P5|COMPLETED|Main Period, Weeks 0-26||0
189039|NCT00856986|454418|P4|COMPLETED|Main Period, Weeks 0-26||0
189040|NCT00856986|454419|P3|COMPLETED|Main Period, Weeks 0-26||470
189041|NCT00856986|454420|P2|COMPLETED|Main Period, Weeks 0-26||144
189042|NCT00856986|454421|P1|COMPLETED|Main Period, Weeks 0-26||127
189043|NCT00856986|454417|P5|STARTED|Main Period, Weeks 0-26||0
189044|NCT00856986|454418|P4|STARTED|Main Period, Weeks 0-26||0
189045|NCT00856986|454419|P3|STARTED|Main Period, Weeks 0-26||498
189046|NCT00856986|454420|P2|STARTED|Main Period, Weeks 0-26||162
189047|NCT00856986|454421|P1|STARTED|Main Period, Weeks 0-26||161
189048|NCT00856986|454417|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
189049|NCT00856986|454418|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
189050|NCT00856986|454419|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
189051|NCT00856986|454420|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
189052|NCT00856986|454421|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
189053|NCT00856986|454417|P5|COMPLETED|Run-in Period, Weeks -12-0||0
189054|NCT00856986|454418|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
189055|NCT00856986|454419|P3|COMPLETED|Run-in Period, Weeks -12-0||498
189056|NCT00856986|454420|P2|COMPLETED|Run-in Period, Weeks -12-0||162
189057|NCT00856986|454421|P1|COMPLETED|Run-in Period, Weeks -12-0||161
189058|NCT00856986|454417|P5|STARTED|Run-in Period, Weeks -12-0||0
189059|NCT00856986|454418|P4|STARTED|Run-in Period, Weeks -12-0||167
189060|NCT00856986|454419|P3|STARTED|Run-in Period, Weeks -12-0||498
189061|NCT00856986|454420|P2|STARTED|Run-in Period, Weeks -12-0||162
189062|NCT00856986|454421|P1|STARTED|Run-in Period, Weeks -12-0||161
189063|NCT00856973|454591|P3|NOT COMPLETED|Overall Study||38
189064|NCT00856973|454592|P2|NOT COMPLETED|Overall Study||41
189065|NCT00856973|454593|P1|NOT COMPLETED|Overall Study||36
189066|NCT00856973|454591|P3|COMPLETED|Overall Study||123
189067|NCT00856973|454592|P2|COMPLETED|Overall Study||122
189068|NCT00856973|454593|P1|COMPLETED|Overall Study||126
189069|NCT00856973|454591|P3|STARTED|Overall Study||161
189070|NCT00856973|454592|P2|STARTED|Overall Study||163
189071|NCT00856973|454593|P1|STARTED|Overall Study||162
189072|NCT00856934|454661|P3|NOT COMPLETED|Overall Study||0
189073|NCT00856934|454662|P2|NOT COMPLETED|Overall Study||0
189074|NCT00856934|454663|P1|NOT COMPLETED|Overall Study||0
189075|NCT00856934|454661|P3|COMPLETED|Overall Study||15
189076|NCT00856934|454662|P2|COMPLETED|Overall Study||15
189077|NCT00856934|454663|P1|COMPLETED|Overall Study||15
189078|NCT00856934|454661|P3|STARTED|Overall Study||15
189079|NCT00856934|454662|P2|STARTED|Overall Study||15
189080|NCT00856934|454663|P1|STARTED|Overall Study||15
189081|NCT00856908|454673|P2|NOT COMPLETED|Overall Study||0
189082|NCT00856908|454674|P1|NOT COMPLETED|Overall Study||1
189083|NCT00856908|454673|P2|COMPLETED|Overall Study||5
189084|NCT00856908|454674|P1|COMPLETED|Overall Study||14
189085|NCT00856908|454673|P2|STARTED|Overall Study||5
189086|NCT00856908|454674|P1|STARTED|Overall Study||15
189087|NCT00856843|454701|P2|NOT COMPLETED|Overall Study||5
189088|NCT00856843|454702|P1|NOT COMPLETED|Overall Study||2
189089|NCT00856843|454701|P2|COMPLETED|Overall Study||63
189090|NCT00856843|454702|P1|COMPLETED|Overall Study||66
189091|NCT00856843|454701|P2|STARTED|Overall Study||68
189092|NCT00856843|454702|P1|STARTED|Overall Study||68
189093|NCT00856830|454738|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
189094|NCT00856830|454739|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
189095|NCT00856830|454740|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
189096|NCT00856830|454741|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
189097|NCT00856830|454738|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
189098|NCT00856830|454739|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
189099|NCT00856830|454740|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
189100|NCT00856830|454741|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
189101|NCT00856830|454738|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
189102|NCT00856830|454739|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
189103|NCT00856830|454740|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
189104|NCT00856830|454741|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
189105|NCT00856830|454738|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
189106|NCT00856830|454739|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
189107|NCT00856830|454740|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
189108|NCT00856830|454741|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
189109|NCT00856830|454738|P4|COMPLETED|Irinotecan & Bendamustine||12
189110|NCT00856830|454739|P3|COMPLETED|Irinotecan & Bendamustine||6
189111|NCT00856830|454740|P2|COMPLETED|Irinotecan & Bendamustine||6
189112|NCT00856830|454741|P1|COMPLETED|Irinotecan & Bendamustine||3
189113|NCT00856830|454738|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
189114|NCT00856830|454739|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
189115|NCT00856830|454740|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
189116|NCT00856830|454741|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
189117|NCT00856830|454738|P4|STARTED|Irinotecan & Bendamustine||15
189118|NCT00856830|454739|P3|STARTED|Irinotecan & Bendamustine||6
189119|NCT00856830|454740|P2|STARTED|Irinotecan & Bendamustine||6
189120|NCT00856830|454741|P1|STARTED|Irinotecan & Bendamustine||3
189121|NCT00856791|454747|P1|NOT COMPLETED|Overall Study||0
189122|NCT00856791|454747|P1|COMPLETED|Overall Study||1
189123|NCT00856791|454747|P1|STARTED|Overall Study||1
189124|NCT00856778|454752|P1|NOT COMPLETED|Overall Study||24
189125|NCT00856778|454752|P1|COMPLETED|Overall Study||74
189126|NCT00856778|454752|P1|STARTED|Overall Study||98
189127|NCT00856739|454771|P3|NOT COMPLETED|Overall Study||0
189128|NCT00856739|454772|P2|NOT COMPLETED|Overall Study||0
189129|NCT00856739|454773|P1|NOT COMPLETED|Overall Study||0
189130|NCT00856739|454771|P3|COMPLETED|Overall Study||55
189131|NCT00856739|454772|P2|COMPLETED|Overall Study||52
189132|NCT00856739|454773|P1|COMPLETED|Overall Study||70
189133|NCT00856739|454771|P3|STARTED|Overall Study||55
189134|NCT00856739|454772|P2|STARTED|Overall Study||52
189135|NCT00856739|454773|P1|STARTED|Overall Study||70
189136|NCT00856726|454784|P1|NOT COMPLETED|Overall Study||0
189137|NCT00856726|454784|P1|COMPLETED|Overall Study||26
189138|NCT00856726|454784|P1|STARTED|Overall Study||26
189139|NCT00856661|454795|P2|NOT COMPLETED|Overall Study||29
189140|NCT00856661|454796|P1|NOT COMPLETED|Overall Study||27
189141|NCT00856661|454795|P2|COMPLETED|Overall Study||106
189142|NCT00856661|454796|P1|COMPLETED|Overall Study||108
189143|NCT00856661|454795|P2|Randomized Not Treated|Overall Study||4
189144|NCT00856661|454796|P1|Randomized Not Treated|Overall Study||9
189145|NCT00856661|454795|P2|Treated|Overall Study||131
189146|NCT00856661|454796|P1|Treated|Overall Study||126
189147|NCT00856661|454795|P2|STARTED|Overall Study|Randomised|135
189148|NCT00856661|454796|P1|STARTED|Overall Study|Randomised|135
189149|NCT00856635|454810|P2|NOT COMPLETED|Overall Study||8
189150|NCT00856635|454811|P1|NOT COMPLETED|Overall Study||10
189151|NCT00856635|454810|P2|COMPLETED|Overall Study||14
189152|NCT00856635|454811|P1|COMPLETED|Overall Study||12
189153|NCT00856635|454810|P2|Received Study Drug|Overall Study||20
189154|NCT00856635|454811|P1|Received Study Drug|Overall Study||20
189155|NCT00856635|454810|P2|STARTED|Overall Study||22
189156|NCT00856635|454811|P1|STARTED|Overall Study||22
189157|NCT00856609|454821|P2|NOT COMPLETED|Overall Study||0
189158|NCT00856609|454822|P1|NOT COMPLETED|Overall Study||1
189159|NCT00856609|454821|P2|COMPLETED|Overall Study||39
189160|NCT00856609|454822|P1|COMPLETED|Overall Study||40
189161|NCT00856609|454821|P2|STARTED|Overall Study||39
189162|NCT00856609|454822|P1|STARTED|Overall Study||41
189163|NCT00856583|454834|P2|NOT COMPLETED|Overall Study||2597
189164|NCT00856583|454835|P1|NOT COMPLETED|Overall Study||3137
189165|NCT00856583|454834|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
189166|NCT00856583|454835|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
189167|NCT00856583|454834|P2|STARTED|Overall Study|Patients treated|4904
189168|NCT00856583|454835|P1|STARTED|Overall Study|Patients treated|4905
189169|NCT00856557|454865|P2|NOT COMPLETED|Overall Study||16
189170|NCT00856557|454866|P1|NOT COMPLETED|Overall Study||12
189171|NCT00856557|454865|P2|COMPLETED|Overall Study||60
189172|NCT00856557|454866|P1|COMPLETED|Overall Study||50
189173|NCT00856557|454865|P2|With Patients With Contextual Flags|Overall Study||60
189174|NCT00856557|454866|P1|With Patients With Contextual Flags|Overall Study||50
189175|NCT00856557|454865|P2|Tested With Standardized Patients|Overall Study||76
189176|NCT00856557|454866|P1|Tested With Standardized Patients|Overall Study||62
189177|NCT00856557|454865|P2|Received Intervention/Control|Overall Study||76
189178|NCT00856557|454866|P1|Received Intervention/Control|Overall Study||62
189179|NCT00856557|454865|P2|STARTED|Overall Study||76
189180|NCT00856557|454866|P1|STARTED|Overall Study||62
189181|NCT00856544|454880|P4|NOT COMPLETED|Overall Study||13
189182|NCT00856544|454881|P3|NOT COMPLETED|Overall Study||8
189183|NCT00856544|454882|P2|NOT COMPLETED|Overall Study||66
189184|NCT00856544|454883|P1|NOT COMPLETED|Overall Study||57
189185|NCT00856544|454880|P4|COMPLETED|Overall Study||67
189186|NCT00856544|454881|P3|COMPLETED|Overall Study||71
189187|NCT00856544|454882|P2|COMPLETED|Overall Study||252
189188|NCT00856544|454883|P1|COMPLETED|Overall Study||261
189189|NCT00856544|454880|P4|Treated|Overall Study||80
189190|NCT00856544|454881|P3|Treated|Overall Study||79
189191|NCT00856544|454882|P2|Treated|Overall Study||318
189192|NCT00856544|454883|P1|Treated|Overall Study||315
189193|NCT00856544|454880|P4|STARTED|Overall Study||80
189194|NCT00856544|454881|P3|STARTED|Overall Study||79
189195|NCT00856544|454882|P2|STARTED|Overall Study||318
189196|NCT00856544|454883|P1|STARTED|Overall Study||318
189197|NCT00856518|455062|P2|NOT COMPLETED|Overall Study||2
189198|NCT00856518|455063|P1|NOT COMPLETED|Overall Study||4
189199|NCT00856518|455062|P2|COMPLETED|Overall Study||16
189200|NCT00856518|455063|P1|COMPLETED|Overall Study||20
189201|NCT00856518|455062|P2|STARTED|Overall Study||18
189202|NCT00856518|455063|P1|STARTED|Overall Study||24
189203|NCT00856492|455076|P3|NOT COMPLETED|Overall Study||2
189204|NCT00856492|455077|P2|NOT COMPLETED|Overall Study||1
189205|NCT00856492|455078|P1|NOT COMPLETED|Overall Study||1
189206|NCT00856492|455076|P3|COMPLETED|Overall Study||51
189207|NCT00856492|455077|P2|COMPLETED|Overall Study||62
189208|NCT00856492|455078|P1|COMPLETED|Overall Study||98
189209|NCT00856492|455076|P3|Toxicity Eval|Overall Study||51
189210|NCT00856492|455077|P2|Toxicity Eval|Overall Study||60
189211|NCT00856492|455078|P1|Toxicity Eval|Overall Study||96
189212|NCT00856492|455076|P3|STARTED|Overall Study||53
189213|NCT00856492|455077|P2|STARTED|Overall Study||63
189214|NCT00856492|455078|P1|STARTED|Overall Study||99
189215|NCT00856414|455092|P1|NOT COMPLETED|Overall Study||0
189216|NCT00856414|455092|P1|COMPLETED|Overall Study||45
189217|NCT00856414|455092|P1|STARTED|Overall Study||45
189218|NCT00856388|455100|P1|NOT COMPLETED|Overall Study||1
189219|NCT00856388|455100|P1|COMPLETED|Overall Study||61
189220|NCT00856388|455100|P1|STARTED|Overall Study||62
189221|NCT00856349|455111|P1|NOT COMPLETED|Overall Study||1021
189222|NCT00856349|455111|P1|COMPLETED|Overall Study||3111
189223|NCT00856349|455111|P1|24 Month Follow-up|Overall Study||1698
189224|NCT00856349|455111|P1|18 Month Follow-up|Overall Study||2467
189225|NCT00856349|455111|P1|12 Month Follow-up|Overall Study||3228
189226|NCT00856349|455111|P1|STARTED|Overall Study||4132
189227|NCT00856323|455120|P1|NOT COMPLETED|Overall Study||2
189228|NCT00856323|455120|P1|COMPLETED|Overall Study||51
189229|NCT00856323|455120|P1|STARTED|Overall Study||53
189230|NCT00856297|455132|P5|NOT COMPLETED|Overall Study||0
189231|NCT00856297|455133|P4|NOT COMPLETED|Overall Study||0
189232|NCT00856297|455134|P3|NOT COMPLETED|Overall Study||0
189233|NCT00856297|455135|P2|NOT COMPLETED|Overall Study||0
189234|NCT00856297|455136|P1|NOT COMPLETED|Overall Study||2
189235|NCT00856297|455132|P5|COMPLETED|Overall Study||31
189236|NCT00856297|455133|P4|COMPLETED|Overall Study||44
189237|NCT00856297|455134|P3|COMPLETED|Overall Study||107
189238|NCT00856297|455135|P2|COMPLETED|Overall Study||76
189239|NCT00856297|455136|P1|COMPLETED|Overall Study||129
189240|NCT00856297|455132|P5|STARTED|Overall Study||31
189241|NCT00856297|455133|P4|STARTED|Overall Study||44
189242|NCT00856297|455134|P3|STARTED|Overall Study||107
189243|NCT00856297|455135|P2|STARTED|Overall Study||76
189244|NCT00856297|455136|P1|STARTED|Overall Study||131
189245|NCT00856284|455169|P3|NOT COMPLETED|Overall Study||447
189246|NCT00856284|455170|P2|NOT COMPLETED|Overall Study||392
189247|NCT00856284|455171|P1|NOT COMPLETED|Overall Study||408
189248|NCT00856284|455169|P3|COMPLETED|Overall Study||427
189249|NCT00856284|455170|P2|COMPLETED|Overall Study||493
189250|NCT00856284|455171|P1|COMPLETED|Overall Study||472
189251|NCT00856284|455169|P3|Received Study Drug|Overall Study||869
189252|NCT00856284|455170|P2|Received Study Drug|Overall Study||878
189253|NCT00856284|455171|P1|Received Study Drug|Overall Study||873
189254|NCT00856284|455169|P3|STARTED|Overall Study||874
189255|NCT00856284|455170|P2|STARTED|Overall Study||885
189256|NCT00856284|455171|P1|STARTED|Overall Study||880
189257|NCT00856245|455197|P1|NOT COMPLETED|Overall Study||5
189258|NCT00856245|455197|P1|COMPLETED|Overall Study||14
189259|NCT00856245|455197|P1|STARTED|Overall Study||19
189260|NCT00856232|455205|P3|NOT COMPLETED|Overall Study||0
189261|NCT00856232|455206|P2|NOT COMPLETED|Overall Study||0
189262|NCT00856232|455207|P1|NOT COMPLETED|Overall Study||0
189263|NCT00856232|455205|P3|COMPLETED|Overall Study||36
189264|NCT00856232|455206|P2|COMPLETED|Overall Study||29
189265|NCT00856232|455207|P1|COMPLETED|Overall Study||26
189266|NCT00856232|455205|P3|STARTED|Overall Study||36
189267|NCT00856232|455206|P2|STARTED|Overall Study||29
189268|NCT00856232|455207|P1|STARTED|Overall Study||26
189269|NCT00856206|455220|P2|NOT COMPLETED|Overall Study||161
189270|NCT00856206|455221|P1|NOT COMPLETED|Overall Study||54
189271|NCT00856206|455220|P2|COMPLETED|Overall Study||824
189272|NCT00856206|455221|P1|COMPLETED|Overall Study||276
189273|NCT00856206|455220|P2|STARTED|Overall Study||985
189274|NCT00856206|455221|P1|STARTED|Overall Study||330
189275|NCT00856193|455235|P2|NOT COMPLETED|Period 2||2
189276|NCT00856193|455236|P1|NOT COMPLETED|Period 2||0
189277|NCT00856193|455235|P2|COMPLETED|Period 2||15
189278|NCT00856193|455236|P1|COMPLETED|Period 2||16
189279|NCT00856193|455235|P2|STARTED|Period 2||17
189280|NCT00856193|455236|P1|STARTED|Period 2||16
189281|NCT00856193|455235|P2|NOT COMPLETED|Period 1||0
189282|NCT00856193|455236|P1|NOT COMPLETED|Period 1||0
189283|NCT00856193|455235|P2|COMPLETED|Period 1||17
189284|NCT00856193|455236|P1|COMPLETED|Period 1||16
189285|NCT00856193|455235|P2|STARTED|Period 1||17
189286|NCT00856193|455236|P1|STARTED|Period 1||16
189287|NCT00856180|455248|P1|NOT COMPLETED|Overall Study||20
189288|NCT00856180|455248|P1|COMPLETED|Overall Study||0
189289|NCT00856180|455248|P1|STARTED|Overall Study||20
189290|NCT00856050|455257|P1|NOT COMPLETED|Overall Study||0
189291|NCT00856050|455257|P1|COMPLETED|Overall Study||26
189292|NCT00856050|455257|P1|STARTED|Overall Study||26
189293|NCT00856024|455261|P1|NOT COMPLETED|Overall Study||0
189294|NCT00856024|455261|P1|COMPLETED|Overall Study||902
189295|NCT00856024|455261|P1|STARTED|Overall Study||902
189296|NCT00855959|455273|P1|NOT COMPLETED|Overall Study||9
189297|NCT00855959|455273|P1|COMPLETED|Overall Study||99
189298|NCT00855959|455273|P1|Patients Who Received Pulmicort Respules|Overall Study||105
189299|NCT00855959|455273|P1|STARTED|Overall Study||108
189300|NCT00855933|455290|P2|NOT COMPLETED|Overall Study||1
189301|NCT00855933|455291|P1|NOT COMPLETED|Overall Study||0
189302|NCT00855933|455290|P2|COMPLETED|Overall Study||29
189303|NCT00855933|455291|P1|COMPLETED|Overall Study||30
189304|NCT00855933|455290|P2|STARTED|Overall Study||30
189305|NCT00855933|455291|P1|STARTED|Overall Study||30
189306|NCT00855920|455300|P3|NOT COMPLETED|Overall Study||11
189307|NCT00855920|455301|P2|NOT COMPLETED|Overall Study||9
189308|NCT00855920|455302|P1|NOT COMPLETED|Overall Study||8
189309|NCT00855920|455300|P3|COMPLETED|Overall Study||64
189310|NCT00855920|455301|P2|COMPLETED|Overall Study||65
189311|NCT00855920|455302|P1|COMPLETED|Overall Study||68
189312|NCT00855920|455300|P3|Safety Population|Overall Study||75
189313|NCT00855920|455301|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
189314|NCT00855920|455302|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
189315|NCT00855920|455300|P3|STARTED|Overall Study||75
189316|NCT00855920|455301|P2|STARTED|Overall Study||74
189317|NCT00855920|455302|P1|STARTED|Overall Study||76
189318|NCT00855894|455319|P1|NOT COMPLETED|Overall Study||33
189319|NCT00855894|455319|P1|COMPLETED|Overall Study||8
189320|NCT00855894|455319|P1|STARTED|Overall Study||41
189321|NCT00855868|455329|P2|NOT COMPLETED|Overall Study||1
189322|NCT00855868|455330|P1|NOT COMPLETED|Overall Study||1
189323|NCT00855868|455329|P2|COMPLETED|Overall Study||14
189324|NCT00855868|455330|P1|COMPLETED|Overall Study||12
189325|NCT00855868|455329|P2|STARTED|Overall Study||15
189326|NCT00855868|455330|P1|STARTED|Overall Study||13
189327|NCT00855842|455336|P1|NOT COMPLETED|Overall Study||0
189328|NCT00855842|455336|P1|COMPLETED|Overall Study||4
189329|NCT00855842|455336|P1|STARTED|Overall Study||4
189330|NCT00855816|455342|P2|NOT COMPLETED|Overall Study||21
189331|NCT00855816|455343|P1|NOT COMPLETED|Overall Study||26
189332|NCT00855816|455342|P2|COMPLETED|Overall Study||12
189333|NCT00855816|455343|P1|COMPLETED|Overall Study||21
189334|NCT00855816|455342|P2|STARTED|Overall Study||33
189335|NCT00855816|455343|P1|STARTED|Overall Study||47
189336|NCT00855738|455349|P1|NOT COMPLETED|Overall Study||5
189337|NCT00855738|455349|P1|COMPLETED|Overall Study||106
189338|NCT00855738|455349|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
189339|NCT00855738|455349|P1|STARTED|Overall Study||111
189340|NCT00855595|455377|P2|NOT COMPLETED|Overall Study||7
189341|NCT00855595|455378|P1|NOT COMPLETED|Overall Study||6
189342|NCT00855595|455377|P2|COMPLETED|Overall Study||94
189343|NCT00855595|455378|P1|COMPLETED|Overall Study||100
189344|NCT00855595|455377|P2|STARTED|Overall Study||101
189345|NCT00855595|455378|P1|STARTED|Overall Study||106
189346|NCT00855582|455417|P3|NOT COMPLETED|Overall Study||30
189347|NCT00855582|455418|P2|NOT COMPLETED|Overall Study||24
189348|NCT00855582|455419|P1|NOT COMPLETED|Overall Study||26
189349|NCT00855582|455417|P3|COMPLETED|Overall Study||170
189350|NCT00855582|455418|P2|COMPLETED|Overall Study||184
189351|NCT00855582|455419|P1|COMPLETED|Overall Study||172
189352|NCT00855582|455417|P3|STARTED|Overall Study||200
189353|NCT00855582|455418|P2|STARTED|Overall Study||208
189354|NCT00855582|455419|P1|STARTED|Overall Study||198
189355|NCT00855465|455508|P2|NOT COMPLETED|Follow-up Period (FUP)||2
189356|NCT00855465|455509|P1|NOT COMPLETED|Follow-up Period (FUP)||8
189357|NCT00855465|455508|P2|COMPLETED|Follow-up Period (FUP)||2
189358|NCT00855465|455509|P1|COMPLETED|Follow-up Period (FUP)||9
189359|NCT00855465|455508|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
189360|NCT00855465|455509|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
189361|NCT00855465|455508|P2|NOT COMPLETED|Treatment Period||5
189362|NCT00855465|455509|P1|NOT COMPLETED|Treatment Period||14
189363|NCT00855465|455508|P2|COMPLETED|Treatment Period||83
189364|NCT00855465|455509|P1|COMPLETED|Treatment Period||160
189365|NCT00855465|455508|P2|Participants Received Treatment|Treatment Period||88
189366|NCT00855465|455509|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
189367|NCT00855465|455508|P2|STARTED|Treatment Period||88
189368|NCT00855465|455509|P1|STARTED|Treatment Period||174
189369|NCT00855439|455599|P2|NOT COMPLETED|Overall Study||0
189370|NCT00855439|455600|P1|NOT COMPLETED|Overall Study||3
189371|NCT00855439|455599|P2|COMPLETED|Overall Study||24
189372|NCT00855439|455600|P1|COMPLETED|Overall Study||19
189373|NCT00855439|455599|P2|STARTED|Overall Study||24
189374|NCT00855439|455600|P1|STARTED|Overall Study||22
189375|NCT00855413|455612|P1|NOT COMPLETED|Overall Study||0
189376|NCT00855413|455612|P1|COMPLETED|Overall Study||15
189377|NCT00855413|455612|P1|STARTED|Overall Study||15
189378|NCT00855335|455658|P5|NOT COMPLETED|Overall Study||1
189379|NCT00855335|455659|P4|NOT COMPLETED|Overall Study||7
189380|NCT00855335|455660|P3|NOT COMPLETED|Overall Study||5
189381|NCT00855335|455661|P2|NOT COMPLETED|Overall Study||2
189382|NCT00855335|455662|P1|NOT COMPLETED|Overall Study||5
189383|NCT00855335|455658|P5|COMPLETED|Overall Study||6
189384|NCT00855335|455659|P4|COMPLETED|Overall Study||12
189385|NCT00855335|455660|P3|COMPLETED|Overall Study||10
189386|NCT00855335|455661|P2|COMPLETED|Overall Study||15
189387|NCT00855335|455662|P1|COMPLETED|Overall Study||12
189388|NCT00855335|455658|P5|STARTED|Overall Study||7
189389|NCT00855335|455659|P4|STARTED|Overall Study||19
189390|NCT00855335|455660|P3|STARTED|Overall Study||15
189391|NCT00855335|455661|P2|STARTED|Overall Study||17
189392|NCT00855335|455662|P1|STARTED|Overall Study||17
189393|NCT00855309|455749|P2|NOT COMPLETED|Overall Study||0
189394|NCT00855309|455750|P1|NOT COMPLETED|Overall Study||1
189395|NCT00855309|455749|P2|COMPLETED|Overall Study||55
189396|NCT00855309|455750|P1|COMPLETED|Overall Study||56
189397|NCT00855309|455749|P2|STARTED|Overall Study||55
189398|NCT00855309|455750|P1|STARTED|Overall Study||57
189399|NCT00855218|455758|P2|NOT COMPLETED|Overall Study||153
189400|NCT00855218|455759|P1|NOT COMPLETED|Overall Study||154
189401|NCT00855218|455758|P2|COMPLETED|Overall Study||0
189402|NCT00855218|455759|P1|COMPLETED|Overall Study||0
189403|NCT00855218|455758|P2|Participants Received Treatment|Overall Study||151
189404|NCT00855218|455759|P1|Participants Received Treatment|Overall Study||153
189405|NCT00855218|455758|P2|STARTED|Overall Study||153
189406|NCT00855218|455759|P1|STARTED|Overall Study||154
189407|NCT00855166|455777|P2|NOT COMPLETED|Overall Study||8
189408|NCT00855166|455778|P1|NOT COMPLETED|Overall Study||5
189409|NCT00855166|455777|P2|COMPLETED|Overall Study||83
189410|NCT00855166|455778|P1|COMPLETED|Overall Study||86
189411|NCT00855166|455777|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
189412|NCT00855166|455778|P1|STARTED|Overall Study||91
189413|NCT00855062|455798|P2|NOT COMPLETED|Step2||6
189414|NCT00855062|455799|P1|NOT COMPLETED|Step2||6
189415|NCT00855062|455798|P2|COMPLETED|Step2||15
189416|NCT00855062|455799|P1|COMPLETED|Step2||13
189417|NCT00855062|455798|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
189418|NCT00855062|455799|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
189419|NCT00855062|455798|P2|NOT COMPLETED|Step1||11
189420|NCT00855062|455799|P1|NOT COMPLETED|Step1||10
189421|NCT00855062|455798|P2|COMPLETED|Step1||26
189422|NCT00855062|455799|P1|COMPLETED|Step1||26
189423|NCT00855062|455798|P2|STARTED|Step1||37
189424|NCT00855062|455799|P1|STARTED|Step1||36
189425|NCT00855010|455825|P2|NOT COMPLETED|Overall Study||1
189426|NCT00855010|455826|P1|NOT COMPLETED|Overall Study||4
189427|NCT00855010|455825|P2|COMPLETED|Overall Study||18
189428|NCT00855010|455826|P1|COMPLETED|Overall Study||19
189429|NCT00855010|455825|P2|STARTED|Overall Study||19
189430|NCT00855010|455826|P1|STARTED|Overall Study||23
189431|NCT00854906|455848|P1|NOT COMPLETED|Overall Study||1
189432|NCT00854906|455848|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
189433|NCT00854906|455848|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
189434|NCT00854724|455857|P2|NOT COMPLETED|Second Intervention||1
189435|NCT00854724|455858|P1|NOT COMPLETED|Second Intervention||1
189436|NCT00854724|455857|P2|COMPLETED|Second Intervention||5
189437|NCT00854724|455858|P1|COMPLETED|Second Intervention||5
189438|NCT00854724|455857|P2|STARTED|Second Intervention||6
189439|NCT00854724|455858|P1|STARTED|Second Intervention||6
189440|NCT00854724|455857|P2|NOT COMPLETED|Washout||1
189441|NCT00854724|455858|P1|NOT COMPLETED|Washout||1
189442|NCT00854724|455857|P2|COMPLETED|Washout||6
189443|NCT00854724|455858|P1|COMPLETED|Washout||6
189444|NCT00854724|455857|P2|STARTED|Washout||7
189445|NCT00854724|455858|P1|STARTED|Washout||7
189446|NCT00854724|455857|P2|NOT COMPLETED|First Intervention||1
189447|NCT00854724|455858|P1|NOT COMPLETED|First Intervention||1
189448|NCT00854724|455857|P2|COMPLETED|First Intervention||7
189449|NCT00854724|455858|P1|COMPLETED|First Intervention||7
189450|NCT00854724|455857|P2|STARTED|First Intervention||8
189451|NCT00854724|455858|P1|STARTED|First Intervention||8
189452|NCT00854620|455864|P1|NOT COMPLETED|Overall Study||1
189453|NCT00854620|455864|P1|COMPLETED|Overall Study||8
189454|NCT00854620|455864|P1|STARTED|Overall Study||9
189455|NCT00854607|455868|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
189456|NCT00854607|455868|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
189457|NCT00854607|455868|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
189458|NCT00854607|455868|P1|NOT COMPLETED|Enrollment||0
189459|NCT00854607|455868|P1|COMPLETED|Enrollment||116
189460|NCT00854607|455868|P1|STARTED|Enrollment||116
189461|NCT00854594|455903|P2|NOT COMPLETED|Overall Study||0
189462|NCT00854594|455904|P1|NOT COMPLETED|Overall Study||0
189463|NCT00854594|455903|P2|COMPLETED|Overall Study||69
189464|NCT00854594|455904|P1|COMPLETED|Overall Study||48
189465|NCT00854594|455903|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
189466|NCT00854594|455904|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
189467|NCT00854581|455916|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
189468|NCT00854581|455916|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
189469|NCT00854581|455916|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
189470|NCT00854581|455916|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
189471|NCT00854581|455916|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
189472|NCT00854581|455916|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
189473|NCT00854581|455916|P1|NOT COMPLETED|Induction (Up to Day 21)||6
189474|NCT00854581|455916|P1|COMPLETED|Induction (Up to Day 21)||7
189475|NCT00854581|455916|P1|STARTED|Induction (Up to Day 21)||13
189476|NCT00854373|455931|P2|NOT COMPLETED|Overall Study||4
189477|NCT00854373|455932|P1|NOT COMPLETED|Overall Study||2
189478|NCT00854373|455931|P2|COMPLETED|Overall Study||89
189479|NCT00854373|455932|P1|COMPLETED|Overall Study||93
189480|NCT00854373|455931|P2|STARTED|Overall Study||93
189481|NCT00854373|455932|P1|STARTED|Overall Study||95
189482|NCT00854360|455946|P4|NOT COMPLETED|Overall Study||10
189483|NCT00854360|455947|P3|NOT COMPLETED|Overall Study||2
189484|NCT00854360|455948|P2|NOT COMPLETED|Overall Study||3
189485|NCT00854360|455949|P1|NOT COMPLETED|Overall Study||2
189486|NCT00854360|455946|P4|COMPLETED|Overall Study||114
189487|NCT00854360|455947|P3|COMPLETED|Overall Study||120
189488|NCT00854360|455948|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
189489|NCT00854360|455949|P1|COMPLETED|Overall Study||116
189490|NCT00854360|455946|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
189491|NCT00854360|455947|P3|Intent to Treat / Safety Population|Overall Study||122
189492|NCT00854360|455948|P2|Intent to Treat / Safety Population|Overall Study||123
189493|NCT00854360|455949|P1|Intent to Treat / Safety Population|Overall Study||118
189494|NCT00854360|455946|P4|STARTED|Overall Study||124
189495|NCT00854360|455947|P3|STARTED|Overall Study||122
189496|NCT00854360|455948|P2|STARTED|Overall Study||123
189497|NCT00854360|455949|P1|STARTED|Overall Study||118
189498|NCT00854308|455981|P2|NOT COMPLETED|Overall Study||67
189499|NCT00854308|455982|P1|NOT COMPLETED|Overall Study||62
189500|NCT00854308|455981|P2|COMPLETED|Overall Study||1
189501|NCT00854308|455982|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
189502|NCT00854308|455981|P2|Received Study Drug|Overall Study||67
189503|NCT00854308|455982|P1|Received Study Drug|Overall Study||69
189504|NCT00854308|455981|P2|STARTED|Overall Study||68
189505|NCT00854308|455982|P1|STARTED|Overall Study||69
189506|NCT00854113|456007|P11|NOT COMPLETED|Overall Study||0
189507|NCT00854113|456008|P10|NOT COMPLETED|Overall Study||0
189508|NCT00854113|456009|P9|NOT COMPLETED|Overall Study||1
189509|NCT00854113|456010|P8|NOT COMPLETED|Overall Study||3
189510|NCT00854113|456011|P7|NOT COMPLETED|Overall Study||0
189511|NCT00854113|456012|P6|NOT COMPLETED|Overall Study||0
189512|NCT00854113|456013|P5|NOT COMPLETED|Overall Study||0
189513|NCT00854113|456014|P4|NOT COMPLETED|Overall Study||0
189514|NCT00854113|456015|P3|NOT COMPLETED|Overall Study||0
189515|NCT00854113|456016|P2|NOT COMPLETED|Overall Study||0
189516|NCT00854113|456017|P1|NOT COMPLETED|Overall Study||0
189517|NCT00854113|456007|P11|COMPLETED|Overall Study||6
189518|NCT00854113|456008|P10|COMPLETED|Overall Study||8
189519|NCT00854113|456009|P9|COMPLETED|Overall Study||7
189520|NCT00854113|456010|P8|COMPLETED|Overall Study||5
189521|NCT00854113|456011|P7|COMPLETED|Overall Study||12
189522|NCT00854113|456012|P6|COMPLETED|Overall Study||6
189523|NCT00854113|456013|P5|COMPLETED|Overall Study||6
189524|NCT00854113|456014|P4|COMPLETED|Overall Study||6
189525|NCT00854113|456015|P3|COMPLETED|Overall Study||6
189526|NCT00854113|456016|P2|COMPLETED|Overall Study||6
189527|NCT00854113|456017|P1|COMPLETED|Overall Study||6
189528|NCT00854113|456007|P11|STARTED|Overall Study||6
189529|NCT00854113|456008|P10|STARTED|Overall Study||8
189530|NCT00854113|456009|P9|STARTED|Overall Study||8
189531|NCT00854113|456010|P8|STARTED|Overall Study||8
189532|NCT00854113|456011|P7|STARTED|Overall Study||12
189533|NCT00854113|456012|P6|STARTED|Overall Study||6
189534|NCT00854113|456013|P5|STARTED|Overall Study||6
189535|NCT00854113|456014|P4|STARTED|Overall Study||6
189536|NCT00854113|456015|P3|STARTED|Overall Study||6
189537|NCT00854113|456016|P2|STARTED|Overall Study||6
189538|NCT00854113|456017|P1|STARTED|Overall Study||6
189539|NCT00854087|456120|P2|NOT COMPLETED|Overall Study||19
189540|NCT00854087|456121|P1|NOT COMPLETED|Overall Study||19
189541|NCT00854087|456120|P2|COMPLETED|Overall Study||40
189542|NCT00854087|456121|P1|COMPLETED|Overall Study||40
189543|NCT00854087|456120|P2|STARTED|Overall Study||59
189544|NCT00854087|456121|P1|STARTED|Overall Study||59
189545|NCT00853996|456127|P1|NOT COMPLETED|Overall Study||0
189546|NCT00853996|456127|P1|COMPLETED|Overall Study||25
189547|NCT00853996|456127|P1|STARTED|Overall Study||25
189548|NCT00853970|456139|P2|NOT COMPLETED|Overall Study||3
189549|NCT00853970|456140|P1|NOT COMPLETED|Overall Study||6
189550|NCT00853970|456139|P2|COMPLETED|Overall Study||144
189551|NCT00853970|456140|P1|COMPLETED|Overall Study||146
189552|NCT00853970|456139|P2|STARTED|Overall Study||147
189553|NCT00853970|456140|P1|STARTED|Overall Study||152
189554|NCT00853957|456150|P2|NOT COMPLETED|Overall Study||19
189555|NCT00853957|456151|P1|NOT COMPLETED|Overall Study||14
189556|NCT00853957|456150|P2|COMPLETED|Overall Study||204
189557|NCT00853957|456151|P1|COMPLETED|Overall Study||206
189558|NCT00853957|456150|P2|STARTED|Overall Study||223
189559|NCT00853957|456151|P1|STARTED|Overall Study||220
189560|NCT00853905|456169|P2|NOT COMPLETED|Overall Study||4
189561|NCT00853905|456170|P1|NOT COMPLETED|Overall Study||2
189562|NCT00853905|456169|P2|COMPLETED|Overall Study||36
189563|NCT00853905|456170|P1|COMPLETED|Overall Study||35
189564|NCT00853905|456169|P2|STARTED|Overall Study||40
189565|NCT00853905|456170|P1|STARTED|Overall Study||37
189566|NCT00853840|456176|P2|NOT COMPLETED|Period 2||0
189567|NCT00853840|456177|P1|NOT COMPLETED|Period 2||0
189568|NCT00853840|456176|P2|COMPLETED|Period 2||9
189569|NCT00853840|456177|P1|COMPLETED|Period 2||9
189570|NCT00853840|456176|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
189571|NCT00853840|456177|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
189572|NCT00853840|456176|P2|Maraviroc (Days 1 - 3)|Period 2||9
189573|NCT00853840|456177|P1|Maraviroc (Days 1 - 3)|Period 2||9
189574|NCT00853840|456176|P2|STARTED|Period 2||9
189575|NCT00853840|456177|P1|STARTED|Period 2||9
189576|NCT00853840|456176|P2|NOT COMPLETED|Period 1||0
189577|NCT00853840|456177|P1|NOT COMPLETED|Period 1||0
189578|NCT00853840|456176|P2|COMPLETED|Period 1||9
189579|NCT00853840|456177|P1|COMPLETED|Period 1||9
189580|NCT00853840|456176|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
189581|NCT00853840|456177|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
189582|NCT00853840|456176|P2|Maraviroc (Days 1 - 4)|Period 1||9
189583|NCT00853840|456177|P1|Maraviroc (Days 1 - 4)|Period 1||9
189584|NCT00853840|456176|P2|STARTED|Period 1||9
189585|NCT00853840|456177|P1|STARTED|Period 1||9
189586|NCT00853827|456194|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
189587|NCT00853827|456195|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
189588|NCT00853827|456194|P2|COMPLETED|Double Blind Period (103 Weeks)||199
189589|NCT00853827|456195|P1|COMPLETED|Double Blind Period (103 Weeks)||201
189590|NCT00853827|456194|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
189591|NCT00853827|456195|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
189592|NCT00853827|456194|P2|STARTED|Double Blind Period (103 Weeks)||308
189593|NCT00853827|456195|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
189594|NCT00853827|456194|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
189595|NCT00853827|456195|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
189596|NCT00853827|456194|P2|COMPLETED|Single Blind Period (1 Week)||0
189597|NCT00853827|456195|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
189598|NCT00853827|456194|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
189599|NCT00853827|456195|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
189600|NCT00853762|456211|P4|NOT COMPLETED|Overall Study||22
189601|NCT00853762|456212|P3|NOT COMPLETED|Overall Study||17
189602|NCT00853762|456213|P2|NOT COMPLETED|Overall Study||19
189603|NCT00853762|456214|P1|NOT COMPLETED|Overall Study||16
189604|NCT00853762|456211|P4|COMPLETED|Overall Study||0
189605|NCT00853762|456212|P3|COMPLETED|Overall Study||0
189606|NCT00853762|456213|P2|COMPLETED|Overall Study||0
189607|NCT00853762|456214|P1|COMPLETED|Overall Study||0
189608|NCT00853762|456211|P4|STARTED|Overall Study||22
189609|NCT00853762|456212|P3|STARTED|Overall Study||17
189610|NCT00853762|456213|P2|STARTED|Overall Study||19
189611|NCT00853762|456214|P1|STARTED|Overall Study||16
189612|NCT00853749|456282|P2|NOT COMPLETED|Overall Study||1
189613|NCT00853749|456283|P1|NOT COMPLETED|Overall Study||0
189614|NCT00853749|456282|P2|COMPLETED|Overall Study||38
189615|NCT00853749|456283|P1|COMPLETED|Overall Study||50
189616|NCT00853749|456282|P2|Vaccinated|Overall Study||39
189617|NCT00853749|456283|P1|Vaccinated|Overall Study||50
189618|NCT00853749|456282|P2|STARTED|Overall Study||39
189619|NCT00853749|456283|P1|STARTED|Overall Study||50
189620|NCT00853723|456304|P3|NOT COMPLETED|Overall Study||2
189621|NCT00853723|456305|P2|NOT COMPLETED|Overall Study||7
189622|NCT00853723|456306|P1|NOT COMPLETED|Overall Study||6
189623|NCT00853723|456304|P3|COMPLETED|Overall Study||33
189624|NCT00853723|456305|P2|COMPLETED|Overall Study||28
189625|NCT00853723|456306|P1|COMPLETED|Overall Study||29
189626|NCT00853723|456304|P3|STARTED|Overall Study||35
189627|NCT00853723|456305|P2|STARTED|Overall Study||35
189628|NCT00853723|456306|P1|STARTED|Overall Study||35
189629|NCT00853658|456353|P3|NOT COMPLETED|Overall Study||815
189630|NCT00853658|456354|P2|NOT COMPLETED|Overall Study||832
189631|NCT00853658|456355|P1|NOT COMPLETED|Overall Study||787
189632|NCT00853658|456353|P3|COMPLETED|Overall Study||1539
189633|NCT00853658|456354|P2|COMPLETED|Overall Study||1524
189634|NCT00853658|456355|P1|COMPLETED|Overall Study||1567
189635|NCT00853658|456353|P3|Safety Set|Overall Study||2345
189636|NCT00853658|456354|P2|Safety Set|Overall Study||2348
189637|NCT00853658|456355|P1|Safety Set|Overall Study||2347
189638|NCT00853658|456353|P3|Full Analysis Set (FAS)|Overall Study||2336
189639|NCT00853658|456354|P2|Full Analysis Set (FAS)|Overall Study||2340
189640|NCT00853658|456355|P1|Full Analysis Set (FAS)|Overall Study||2340
189641|NCT00853658|456353|P3|STARTED|Overall Study||2354
189642|NCT00853658|456354|P2|STARTED|Overall Study||2356
189643|NCT00853658|456355|P1|STARTED|Overall Study||2354
189644|NCT00853606|456369|P1|NOT COMPLETED|Overall Study||220
189645|NCT00853606|456369|P1|COMPLETED|Overall Study||492
189646|NCT00853606|456369|P1|STARTED|Overall Study||712
189647|NCT00853593|456375|P1|NOT COMPLETED|Overall Study||45
189648|NCT00853593|456375|P1|COMPLETED|Overall Study||152
189649|NCT00853593|456375|P1|Model 4396 Lead Attempted|Overall Study||164
189650|NCT00853593|456375|P1|Implant Attempted|Overall Study||193
189651|NCT00853593|456375|P1|STARTED|Overall Study||197
189652|NCT00853580|456402|P2|NOT COMPLETED|Overall Study||16
189653|NCT00853580|456403|P1|NOT COMPLETED|Overall Study||7
189654|NCT00853580|456402|P2|COMPLETED|Overall Study||56
189655|NCT00853580|456403|P1|COMPLETED|Overall Study||67
189656|NCT00853580|456402|P2|STARTED|Overall Study||72
189657|NCT00853580|456403|P1|STARTED|Overall Study||74
189658|NCT00853567|456450|P1|NOT COMPLETED|Overall Study||71
189659|NCT00853567|456450|P1|COMPLETED|Overall Study||0
189660|NCT00853567|456450|P1|STARTED|Overall Study||71
189661|NCT00853489|456460|P2|NOT COMPLETED|Overall Study||2
189662|NCT00853489|456461|P1|NOT COMPLETED|Overall Study||5
189663|NCT00853489|456460|P2|COMPLETED|Overall Study||12
189664|NCT00853489|456461|P1|COMPLETED|Overall Study||11
189665|NCT00853489|456460|P2|STARTED|Overall Study||14
189666|NCT00853489|456461|P1|STARTED|Overall Study||16
189667|NCT00853385|456476|P5|NOT COMPLETED|Overall Study||42
189668|NCT00853385|456477|P4|NOT COMPLETED|Overall Study||13
189669|NCT00853385|456478|P3|NOT COMPLETED|Overall Study||9
189670|NCT00853385|456479|P2|NOT COMPLETED|Overall Study||43
189671|NCT00853385|456480|P1|NOT COMPLETED|Overall Study||54
189672|NCT00853385|456476|P5|COMPLETED|Overall Study||162
189673|NCT00853385|456477|P4|COMPLETED|Overall Study||39
189674|NCT00853385|456478|P3|COMPLETED|Overall Study||47
189675|NCT00853385|456479|P2|COMPLETED|Overall Study||158
189676|NCT00853385|456480|P1|COMPLETED|Overall Study||150
189677|NCT00853385|456476|P5|STARTED|Overall Study||204
189678|NCT00853385|456477|P4|STARTED|Overall Study||52
189679|NCT00853385|456478|P3|STARTED|Overall Study||56
189680|NCT00853385|456479|P2|STARTED|Overall Study||201
189681|NCT00853385|456480|P1|STARTED|Overall Study||204
189682|NCT00853333|456696|P3|NOT COMPLETED|Overall Study||0
189683|NCT00853333|456697|P2|NOT COMPLETED|Overall Study||0
189684|NCT00853333|456698|P1|NOT COMPLETED|Overall Study||0
189685|NCT00853333|456696|P3|COMPLETED|Overall Study||31
189686|NCT00853333|456697|P2|COMPLETED|Overall Study||27
189687|NCT00853333|456698|P1|COMPLETED|Overall Study||28
189688|NCT00853333|456696|P3|STARTED|Overall Study||31
189689|NCT00853333|456697|P2|STARTED|Overall Study||27
189690|NCT00853333|456698|P1|STARTED|Overall Study||28
189691|NCT00853307|456708|P2|NOT COMPLETED|Overall Study||5
189692|NCT00853307|456709|P1|NOT COMPLETED|Overall Study||2
189693|NCT00853307|456708|P2|COMPLETED|Overall Study||20
189694|NCT00853307|456709|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
189695|NCT00853307|456708|P2|STARTED|Overall Study||25
189696|NCT00853307|456709|P1|STARTED|Overall Study||6
189697|NCT00853242|456736|P7|NOT COMPLETED|Overall Study||5
189698|NCT00853242|456737|P6|NOT COMPLETED|Overall Study||2
189699|NCT00853242|456738|P5|NOT COMPLETED|Overall Study||4
189700|NCT00853242|456739|P4|NOT COMPLETED|Overall Study||4
189701|NCT00853242|456740|P3|NOT COMPLETED|Overall Study||3
189702|NCT00853242|456741|P2|NOT COMPLETED|Overall Study||3
189703|NCT00853242|456742|P1|NOT COMPLETED|Overall Study||3
189704|NCT00853242|456736|P7|COMPLETED|Overall Study||44
189705|NCT00853242|456737|P6|COMPLETED|Overall Study||49
189706|NCT00853242|456738|P5|COMPLETED|Overall Study||46
189707|NCT00853242|456739|P4|COMPLETED|Overall Study||46
189708|NCT00853242|456740|P3|COMPLETED|Overall Study||46
189709|NCT00853242|456741|P2|COMPLETED|Overall Study||47
189710|NCT00853242|456742|P1|COMPLETED|Overall Study||47
189711|NCT00853242|456736|P7|Treated|Overall Study||48
189712|NCT00853242|456737|P6|Treated|Overall Study||51
189713|NCT00853242|456738|P5|Treated|Overall Study||50
189714|NCT00853242|456739|P4|Treated|Overall Study||50
189715|NCT00853242|456740|P3|Treated|Overall Study||48
189716|NCT00853242|456741|P2|Treated|Overall Study||49
189717|NCT00853242|456742|P1|Treated|Overall Study||50
189718|NCT00853242|456736|P7|STARTED|Overall Study||49
189719|NCT00853242|456737|P6|STARTED|Overall Study||51
189720|NCT00853242|456738|P5|STARTED|Overall Study||50
189721|NCT00853242|456739|P4|STARTED|Overall Study||50
189722|NCT00853242|456740|P3|STARTED|Overall Study||49
189723|NCT00853242|456741|P2|STARTED|Overall Study||50
189724|NCT00853242|456742|P1|STARTED|Overall Study||50
189725|NCT00853229|456784|P2|NOT COMPLETED|Phase 2: Cross Over||0
189726|NCT00853229|456785|P1|NOT COMPLETED|Phase 2: Cross Over||0
189727|NCT00853229|456784|P2|COMPLETED|Phase 2: Cross Over||0
189728|NCT00853229|456785|P1|COMPLETED|Phase 2: Cross Over||0
189729|NCT00853229|456784|P2|STARTED|Phase 2: Cross Over||0
189730|NCT00853229|456785|P1|STARTED|Phase 2: Cross Over||0
189731|NCT00853229|456784|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
189732|NCT00853229|456785|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
189733|NCT00853229|456784|P2|COMPLETED|Phase 1: Initial Intervention||0
189734|NCT00853229|456785|P1|COMPLETED|Phase 1: Initial Intervention||0
189735|NCT00853229|456784|P2|STARTED|Phase 1: Initial Intervention||8
189736|NCT00853229|456785|P1|STARTED|Phase 1: Initial Intervention||8
189737|NCT00853151|456795|P4|NOT COMPLETED|Overall Study||3
189738|NCT00853151|456796|P3|NOT COMPLETED|Overall Study||8
189739|NCT00853151|456797|P2|NOT COMPLETED|Overall Study||13
189740|NCT00853151|456798|P1|NOT COMPLETED|Overall Study||10
189741|NCT00853151|456795|P4|COMPLETED|Overall Study||15
189742|NCT00853151|456796|P3|COMPLETED|Overall Study||30
189743|NCT00853151|456797|P2|COMPLETED|Overall Study||24
189744|NCT00853151|456798|P1|COMPLETED|Overall Study||28
189745|NCT00853151|456795|P4|STARTED|Overall Study||18
189746|NCT00853151|456796|P3|STARTED|Overall Study||38
189747|NCT00853151|456797|P2|STARTED|Overall Study||37
189748|NCT00853151|456798|P1|STARTED|Overall Study||38
189749|NCT00853112|456947|P7|NOT COMPLETED|Overall Study||1
189750|NCT00853112|456948|P6|NOT COMPLETED|Overall Study||0
189751|NCT00853112|456949|P5|NOT COMPLETED|Overall Study||0
189752|NCT00853112|456950|P4|NOT COMPLETED|Overall Study||2
189753|NCT00853112|456951|P3|NOT COMPLETED|Overall Study||0
189754|NCT00853112|456952|P2|NOT COMPLETED|Overall Study||1
189755|NCT00853112|456953|P1|NOT COMPLETED|Overall Study||0
189756|NCT00853112|456947|P7|COMPLETED|Overall Study||6
189757|NCT00853112|456948|P6|COMPLETED|Overall Study||7
189758|NCT00853112|456949|P5|COMPLETED|Overall Study||6
189759|NCT00853112|456950|P4|COMPLETED|Overall Study||6
189760|NCT00853112|456951|P3|COMPLETED|Overall Study||7
189761|NCT00853112|456952|P2|COMPLETED|Overall Study||6
189762|NCT00853112|456953|P1|COMPLETED|Overall Study||6
189763|NCT00853112|456947|P7|Treated|Overall Study||6
189764|NCT00853112|456948|P6|Treated|Overall Study||7
189765|NCT00853112|456949|P5|Treated|Overall Study||6
189766|NCT00853112|456950|P4|Treated|Overall Study||6
189767|NCT00853112|456951|P3|Treated|Overall Study||7
189768|NCT00853112|456952|P2|Treated|Overall Study||6
189769|NCT00853112|456953|P1|Treated|Overall Study||6
189770|NCT00853112|456947|P7|STARTED|Overall Study||7
189771|NCT00853112|456948|P6|STARTED|Overall Study||7
189772|NCT00853112|456949|P5|STARTED|Overall Study||6
189773|NCT00853112|456950|P4|STARTED|Overall Study||8
189774|NCT00853112|456951|P3|STARTED|Overall Study||7
189775|NCT00853112|456952|P2|STARTED|Overall Study||7
189776|NCT00853112|456953|P1|STARTED|Overall Study||6
189777|NCT00853099|457063|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
189778|NCT00853099|457064|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
189779|NCT00853099|457065|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
189780|NCT00853099|457066|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
189781|NCT00853099|457063|P4|COMPLETED|Double-blind + Open-label Periods||119
189782|NCT00853099|457064|P3|COMPLETED|Double-blind + Open-label Periods||0
189783|NCT00853099|457065|P2|COMPLETED|Double-blind + Open-label Periods||0
189784|NCT00853099|457066|P1|COMPLETED|Double-blind + Open-label Periods||0
189785|NCT00853099|457063|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
189786|NCT00853099|457064|P3|STARTED|Double-blind + Open-label Periods||0
189787|NCT00853099|457065|P2|STARTED|Double-blind + Open-label Periods||0
189788|NCT00853099|457066|P1|STARTED|Double-blind + Open-label Periods||0
189789|NCT00853099|457063|P4|NOT COMPLETED|Double-blind Period||0
189790|NCT00853099|457064|P3|NOT COMPLETED|Double-blind Period||31
189791|NCT00853099|457065|P2|NOT COMPLETED|Double-blind Period||29
189792|NCT00853099|457066|P1|NOT COMPLETED|Double-blind Period||23
189793|NCT00853099|457063|P4|COMPLETED|Double-blind Period||0
189794|NCT00853099|457064|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
189795|NCT00853099|457065|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
189796|NCT00853099|457066|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
189797|NCT00853099|457063|P4|Completed Week 8|Double-blind Period||0
189798|NCT00853099|457064|P3|Completed Week 8|Double-blind Period||86
189799|NCT00853099|457065|P2|Completed Week 8|Double-blind Period||85
189800|NCT00853099|457066|P1|Completed Week 8|Double-blind Period||92
189801|NCT00853099|457063|P4|Treated|Double-blind Period||0
189802|NCT00853099|457064|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
189803|NCT00853099|457065|P2|Treated|Double-blind Period||87
189804|NCT00853099|457066|P1|Treated|Double-blind Period||96
189805|NCT00853099|457063|P4|STARTED|Double-blind Period||0
189806|NCT00853099|457064|P3|STARTED|Double-blind Period||91
189807|NCT00853099|457065|P2|STARTED|Double-blind Period||87
189808|NCT00853099|457066|P1|STARTED|Double-blind Period||96
189809|NCT00853073|457108|P2|NOT COMPLETED|Overall Study||2
189810|NCT00853073|457109|P1|NOT COMPLETED|Overall Study||3
189811|NCT00853073|457108|P2|COMPLETED|Overall Study||29
189812|NCT00853073|457109|P1|COMPLETED|Overall Study||29
189813|NCT00853073|457108|P2|STARTED|Overall Study||31
189814|NCT00853073|457109|P1|STARTED|Overall Study||32
189815|NCT00853021|457117|P1|NOT COMPLETED|Overall Study||5
189816|NCT00853021|457117|P1|COMPLETED|Overall Study||21
189817|NCT00853021|457117|P1|STARTED|Overall Study||26
189818|NCT00852995|457129|P5|NOT COMPLETED|Overall Study||4
189819|NCT00852995|457130|P4|NOT COMPLETED|Overall Study||5
189820|NCT00852995|457131|P3|NOT COMPLETED|Overall Study||5
189821|NCT00852995|457132|P2|NOT COMPLETED|Overall Study||1
189822|NCT00852995|457133|P1|NOT COMPLETED|Overall Study||8
189823|NCT00852995|457129|P5|COMPLETED|Overall Study||46
189824|NCT00852995|457130|P4|COMPLETED|Overall Study||40
189825|NCT00852995|457131|P3|COMPLETED|Overall Study||39
189826|NCT00852995|457132|P2|COMPLETED|Overall Study||42
189827|NCT00852995|457133|P1|COMPLETED|Overall Study||38
189828|NCT00852995|457129|P5|STARTED|Overall Study||50
189829|NCT00852995|457130|P4|STARTED|Overall Study||45
189830|NCT00852995|457131|P3|STARTED|Overall Study||44
189831|NCT00852995|457132|P2|STARTED|Overall Study||43
189832|NCT00852995|457133|P1|STARTED|Overall Study||46
189833|NCT00852969|457177|P2|NOT COMPLETED|Overall Study||2
189834|NCT00852969|457178|P1|NOT COMPLETED|Overall Study||0
189835|NCT00852969|457177|P2|COMPLETED|Overall Study||13
189836|NCT00852969|457178|P1|COMPLETED|Overall Study||15
189837|NCT00852969|457177|P2|STARTED|Overall Study||15
189838|NCT00852969|457178|P1|STARTED|Overall Study||15
189839|NCT00852930|457189|P3|NOT COMPLETED|Overall Study||2
189840|NCT00852930|457190|P2|NOT COMPLETED|Overall Study||1
189841|NCT00852930|457191|P1|NOT COMPLETED|Overall Study||1
189842|NCT00852930|457189|P3|COMPLETED|Overall Study||15
189843|NCT00852930|457190|P2|COMPLETED|Overall Study||16
189844|NCT00852930|457191|P1|COMPLETED|Overall Study||15
189845|NCT00852930|457189|P3|STARTED|Overall Study||17
189846|NCT00852930|457190|P2|STARTED|Overall Study||17
189847|NCT00852930|457191|P1|STARTED|Overall Study||16
189848|NCT00852917|457212|P4|NOT COMPLETED|Overall Study||93
189849|NCT00852917|457213|P3|NOT COMPLETED|Overall Study||58
189850|NCT00852917|457214|P2|NOT COMPLETED|Overall Study||46
189851|NCT00852917|457215|P1|NOT COMPLETED|Overall Study||44
189852|NCT00852917|457212|P4|COMPLETED|Overall Study||134
189853|NCT00852917|457213|P3|COMPLETED|Overall Study||50
189854|NCT00852917|457214|P2|COMPLETED|Overall Study||65
189855|NCT00852917|457215|P1|COMPLETED|Overall Study||62
189856|NCT00852917|457212|P4|STARTED|Overall Study||227
189857|NCT00852917|457213|P3|STARTED|Overall Study||108
189858|NCT00852917|457214|P2|STARTED|Overall Study||111
189859|NCT00852917|457215|P1|STARTED|Overall Study||106
189860|NCT00852761|457255|P2|NOT COMPLETED|Overall Study||0
189861|NCT00852761|457256|P1|NOT COMPLETED|Overall Study||0
189862|NCT00852761|457255|P2|COMPLETED|Overall Study||17
189863|NCT00852761|457256|P1|COMPLETED|Overall Study||17
189864|NCT00852761|457255|P2|STARTED|Overall Study||17
189865|NCT00852761|457256|P1|STARTED|Overall Study||17
189866|NCT00852644|457298|P6|NOT COMPLETED|Overall Study||0
189867|NCT00852644|457299|P5|NOT COMPLETED|Overall Study||0
189868|NCT00852644|457300|P4|NOT COMPLETED|Overall Study||0
189869|NCT00852644|457301|P3|NOT COMPLETED|Overall Study||0
189870|NCT00852644|457302|P2|NOT COMPLETED|Overall Study||0
189871|NCT00852644|457303|P1|NOT COMPLETED|Overall Study||0
189872|NCT00852644|457298|P6|COMPLETED|Overall Study||0
189873|NCT00852644|457299|P5|COMPLETED|Overall Study||0
189874|NCT00852644|457300|P4|COMPLETED|Overall Study||3
189875|NCT00852644|457301|P3|COMPLETED|Overall Study||0
189876|NCT00852644|457302|P2|COMPLETED|Overall Study||3
189877|NCT00852644|457303|P1|COMPLETED|Overall Study||3
189878|NCT00852644|457298|P6|STARTED|Overall Study||0
189879|NCT00852644|457299|P5|STARTED|Overall Study||0
189880|NCT00852644|457300|P4|STARTED|Overall Study||3
189881|NCT00852644|457301|P3|STARTED|Overall Study||0
189882|NCT00852644|457302|P2|STARTED|Overall Study||3
189883|NCT00852644|457303|P1|STARTED|Overall Study||3
189884|NCT00852631|457324|P1|NOT COMPLETED|Overall Study||11
189885|NCT00852631|457324|P1|COMPLETED|Overall Study||17
189886|NCT00852631|457324|P1|STARTED|Overall Study||28
189887|NCT00852592|457332|P2|NOT COMPLETED|Overall Study||4
189888|NCT00852592|457333|P1|NOT COMPLETED|Overall Study||3
189889|NCT00852592|457332|P2|COMPLETED|Overall Study||19
189890|NCT00852592|457333|P1|COMPLETED|Overall Study||20
189891|NCT00852592|457332|P2|STARTED|Overall Study||23
189892|NCT00852592|457333|P1|STARTED|Overall Study||23
189893|NCT00852540|457343|P2|NOT COMPLETED|Overall Study||18
189894|NCT00852540|457344|P1|NOT COMPLETED|Overall Study||36
189895|NCT00852540|457343|P2|COMPLETED|Overall Study||122
189896|NCT00852540|457344|P1|COMPLETED|Overall Study||234
189897|NCT00852540|457343|P2|STARTED|Overall Study||140
189898|NCT00852540|457344|P1|STARTED|Overall Study||270
189899|NCT00852527|457370|P2|NOT COMPLETED|Overall Study||0
189900|NCT00852527|457371|P1|NOT COMPLETED|Overall Study||0
189901|NCT00852527|457370|P2|COMPLETED|Overall Study||242
189902|NCT00852527|457371|P1|COMPLETED|Overall Study||196
189903|NCT00852527|457370|P2|STARTED|Overall Study||242
189904|NCT00852527|457371|P1|STARTED|Overall Study||196
189905|NCT00852475|457378|P2|NOT COMPLETED|Overall Study||4
189906|NCT00852475|457379|P1|NOT COMPLETED|Overall Study||3
189907|NCT00852475|457378|P2|COMPLETED|Overall Study||16
189908|NCT00852475|457379|P1|COMPLETED|Overall Study||23
189909|NCT00852475|457378|P2|STARTED|Overall Study||20
189910|NCT00852475|457379|P1|STARTED|Overall Study||26
189911|NCT00852397|457390|P3|NOT COMPLETED|Overall Study||14
189912|NCT00852397|457391|P2|NOT COMPLETED|Overall Study||8
189913|NCT00852397|457392|P1|NOT COMPLETED|Overall Study||11
189914|NCT00852397|457390|P3|COMPLETED|Overall Study||36
189915|NCT00852397|457391|P2|COMPLETED|Overall Study||41
189916|NCT00852397|457392|P1|COMPLETED|Overall Study||41
189917|NCT00852397|457390|P3|Treated Participants|Overall Study||49
189918|NCT00852397|457391|P2|Treated Participants|Overall Study||49
189919|NCT00852397|457392|P1|Treated Participants|Overall Study||51
189920|NCT00852397|457390|P3|STARTED|Overall Study||50
189921|NCT00852397|457391|P2|STARTED|Overall Study||49
189922|NCT00852397|457392|P1|STARTED|Overall Study||52
189923|NCT00852241|457421|P1|NOT COMPLETED|Overall Study||18
189924|NCT00852241|457421|P1|COMPLETED|Overall Study||0
189925|NCT00852241|457421|P1|STARTED|Overall Study||18
189926|NCT00852137|457427|P2|NOT COMPLETED|Overall Study||0
189927|NCT00852137|457428|P1|NOT COMPLETED|Overall Study||0
189928|NCT00852137|457427|P2|COMPLETED|Overall Study||3
189929|NCT00852137|457428|P1|COMPLETED|Overall Study||13
189930|NCT00852137|457427|P2|STARTED|Overall Study||3
189931|NCT00852137|457428|P1|STARTED|Overall Study||13
189932|NCT00852124|457450|P2|NOT COMPLETED|Overall Study||0
189933|NCT00852124|457451|P1|NOT COMPLETED|Overall Study||0
189934|NCT00852124|457450|P2|COMPLETED|Overall Study||0
189935|NCT00852124|457451|P1|COMPLETED|Overall Study||3
189936|NCT00852124|457450|P2|STARTED|Overall Study||0
189937|NCT00852124|457451|P1|STARTED|Overall Study||3
189938|NCT00851903|457456|P1|NOT COMPLETED|Overall Study||2
189939|NCT00851903|457456|P1|COMPLETED|Overall Study||110
189940|NCT00851903|457456|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
189941|NCT00851903|457456|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
189942|NCT00851903|457456|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
189943|NCT00851903|457456|P1|STARTED|Overall Study||112
189944|NCT00851890|457470|P4|NOT COMPLETED|Overall Study||1
189945|NCT00851890|457471|P3|NOT COMPLETED|Overall Study||0
189946|NCT00851890|457472|P2|NOT COMPLETED|Overall Study||1
189947|NCT00851890|457473|P1|NOT COMPLETED|Overall Study||0
189948|NCT00851890|457470|P4|COMPLETED|Overall Study||5
189949|NCT00851890|457471|P3|COMPLETED|Overall Study||8
189950|NCT00851890|457472|P2|COMPLETED|Overall Study||7
189951|NCT00851890|457473|P1|COMPLETED|Overall Study||8
189952|NCT00851890|457470|P4|STARTED|Overall Study||6
189953|NCT00851890|457471|P3|STARTED|Overall Study||8
189954|NCT00851890|457472|P2|STARTED|Overall Study||8
189955|NCT00851890|457473|P1|STARTED|Overall Study||8
189956|NCT00851799|457533|P3|NOT COMPLETED|Overall Study||24
189957|NCT00851799|457534|P2|NOT COMPLETED|Overall Study||13
189958|NCT00851799|457535|P1|NOT COMPLETED|Overall Study||16
189959|NCT00851799|457533|P3|COMPLETED|Overall Study||89
189960|NCT00851799|457534|P2|COMPLETED|Overall Study||93
189961|NCT00851799|457535|P1|COMPLETED|Overall Study||93
189962|NCT00851799|457533|P3|STARTED|Overall Study||113
189963|NCT00851799|457534|P2|STARTED|Overall Study||106
189964|NCT00851799|457535|P1|STARTED|Overall Study||109
189965|NCT00851786|457623|P2|NOT COMPLETED|Overall Study||2
189966|NCT00851786|457624|P1|NOT COMPLETED|Overall Study||5
189967|NCT00851786|457623|P2|COMPLETED|Overall Study||97
189968|NCT00851786|457624|P1|COMPLETED|Overall Study||291
189969|NCT00851786|457623|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
189970|NCT00851786|457624|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
189971|NCT00851747|457637|P3|NOT COMPLETED|Overall Study||6
189972|NCT00851747|457638|P2|NOT COMPLETED|Overall Study||6
189973|NCT00851747|457639|P1|NOT COMPLETED|Overall Study||6
189974|NCT00851747|457637|P3|COMPLETED|Overall Study||0
189975|NCT00851747|457638|P2|COMPLETED|Overall Study||0
189976|NCT00851747|457639|P1|COMPLETED|Overall Study||0
189977|NCT00851747|457637|P3|STARTED|Overall Study||6
189978|NCT00851747|457638|P2|STARTED|Overall Study||6
189979|NCT00851747|457639|P1|STARTED|Overall Study||6
189980|NCT00851721|457648|P2|NOT COMPLETED|Overall Study||1
189981|NCT00851721|457649|P1|NOT COMPLETED|Overall Study||2
189982|NCT00851721|457648|P2|COMPLETED|Overall Study||16
189983|NCT00851721|457649|P1|COMPLETED|Overall Study||17
189984|NCT00851721|457648|P2|STARTED|Overall Study||17
189985|NCT00851721|457649|P1|STARTED|Overall Study||19
189986|NCT00851682|457739|P2|NOT COMPLETED|Overall Study||0
189987|NCT00851682|457740|P1|NOT COMPLETED|Overall Study||5
189988|NCT00851682|457739|P2|COMPLETED|Overall Study||5
189989|NCT00851682|457740|P1|COMPLETED|Overall Study||55
189990|NCT00851682|457739|P2|STARTED|Overall Study||5
189991|NCT00851682|457740|P1|STARTED|Overall Study||60
189992|NCT00851643|457754|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
189993|NCT00851643|457755|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
189994|NCT00851643|457756|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
189995|NCT00851643|457757|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
189996|NCT00851643|457758|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
189997|NCT00851643|457759|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
189998|NCT00851643|457754|P6|COMPLETED|Extension Study (Up to 36 Months)||14
189999|NCT00851643|457755|P5|COMPLETED|Extension Study (Up to 36 Months)||19
190000|NCT00851643|457756|P4|COMPLETED|Extension Study (Up to 36 Months)||5
190001|NCT00851643|457757|P3|COMPLETED|Extension Study (Up to 36 Months)||14
190002|NCT00851643|457758|P2|COMPLETED|Extension Study (Up to 36 Months)||15
190003|NCT00851643|457759|P1|COMPLETED|Extension Study (Up to 36 Months)||6
190004|NCT00851643|457754|P6|STARTED|Extension Study (Up to 36 Months)||15
190005|NCT00851643|457755|P5|STARTED|Extension Study (Up to 36 Months)||21
190006|NCT00851643|457756|P4|STARTED|Extension Study (Up to 36 Months)||7
190007|NCT00851643|457757|P3|STARTED|Extension Study (Up to 36 Months)||19
190008|NCT00851643|457758|P2|STARTED|Extension Study (Up to 36 Months)||19
190009|NCT00851643|457759|P1|STARTED|Extension Study (Up to 36 Months)||10
190010|NCT00851643|457754|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
190011|NCT00851643|457755|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
190012|NCT00851643|457756|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
190013|NCT00851643|457757|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
190014|NCT00851643|457758|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
190015|NCT00851643|457759|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
190016|NCT00851643|457754|P6|COMPLETED|Base Study (Up to 12 Months)||29
190017|NCT00851643|457755|P5|COMPLETED|Base Study (Up to 12 Months)||30
190018|NCT00851643|457756|P4|COMPLETED|Base Study (Up to 12 Months)||15
190019|NCT00851643|457757|P3|COMPLETED|Base Study (Up to 12 Months)||30
190020|NCT00851643|457758|P2|COMPLETED|Base Study (Up to 12 Months)||30
190021|NCT00851643|457759|P1|COMPLETED|Base Study (Up to 12 Months)||14
190022|NCT00851643|457754|P6|STARTED|Base Study (Up to 12 Months)||30
190023|NCT00851643|457755|P5|STARTED|Base Study (Up to 12 Months)||30
190024|NCT00851643|457756|P4|STARTED|Base Study (Up to 12 Months)||15
190025|NCT00851643|457757|P3|STARTED|Base Study (Up to 12 Months)||30
190026|NCT00851643|457758|P2|STARTED|Base Study (Up to 12 Months)||30
190027|NCT00851643|457759|P1|STARTED|Base Study (Up to 12 Months)||15
190028|NCT00851630|457780|P2|NOT COMPLETED|Overall Study||2
190029|NCT00851630|457781|P1|NOT COMPLETED|Overall Study||2
190030|NCT00851630|457780|P2|COMPLETED|Overall Study||33
190031|NCT00851630|457781|P1|COMPLETED|Overall Study||33
190032|NCT00851630|457780|P2|STARTED|Overall Study||35
190033|NCT00851630|457781|P1|STARTED|Overall Study||35
190034|NCT00851591|457795|P2|NOT COMPLETED|Overall Study||0
190035|NCT00851591|457796|P1|NOT COMPLETED|Overall Study||2
190036|NCT00851591|457795|P2|COMPLETED|Overall Study||1
190037|NCT00851591|457796|P1|COMPLETED|Overall Study||0
190038|NCT00851591|457795|P2|STARTED|Overall Study|One received treatment.|1
190039|NCT00851591|457796|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
190040|NCT00851552|457802|P1|NOT COMPLETED|Overall Study||7
190041|NCT00851552|457802|P1|COMPLETED|Overall Study||2
190042|NCT00851552|457802|P1|STARTED|Overall Study||9
190043|NCT00851409|457807|P1|NOT COMPLETED|Overall Study||0
190044|NCT00851409|457807|P1|COMPLETED|Overall Study||25
190045|NCT00851409|457807|P1|STARTED|Overall Study||25
190046|NCT00851318|457816|P4|NOT COMPLETED|Overall Study||19
190047|NCT00851318|457817|P3|NOT COMPLETED|Overall Study||21
190048|NCT00851318|457818|P2|NOT COMPLETED|Overall Study||5
190049|NCT00851318|457819|P1|NOT COMPLETED|Overall Study||30
190050|NCT00851318|457816|P4|COMPLETED|Overall Study||73
190051|NCT00851318|457817|P3|COMPLETED|Overall Study||72
190052|NCT00851318|457818|P2|COMPLETED|Overall Study||14
190053|NCT00851318|457819|P1|COMPLETED|Overall Study||51
190054|NCT00851318|457816|P4|Completed Week 52|Overall Study||85
190055|NCT00851318|457817|P3|Completed Week 52|Overall Study||87
190056|NCT00851318|457818|P2|Completed Week 52|Overall Study||16
190057|NCT00851318|457819|P1|Completed Week 52|Overall Study||64
190058|NCT00851318|457816|P4|Completed Week 24|Overall Study||87
190059|NCT00851318|457817|P3|Completed Week 24|Overall Study||90
190060|NCT00851318|457818|P2|Completed Week 24|Overall Study||17
190061|NCT00851318|457819|P1|Completed Week 24|Overall Study||69
190062|NCT00851318|457816|P4|STARTED|Overall Study||92
190063|NCT00851318|457817|P3|STARTED|Overall Study||93
190064|NCT00851318|457818|P2|STARTED|Overall Study||19
190065|NCT00851318|457819|P1|STARTED|Overall Study||81
190066|NCT00851279|457849|P1|NOT COMPLETED|Overall Study||0
190067|NCT00851279|457849|P1|COMPLETED|Overall Study||53
190068|NCT00851279|457849|P1|STARTED|Overall Study||53
190069|NCT00851253|457855|P2|NOT COMPLETED|Overall Study||0
190070|NCT00851253|457856|P1|NOT COMPLETED|Overall Study||1
190071|NCT00851253|457855|P2|COMPLETED|Overall Study||10
190072|NCT00851253|457856|P1|COMPLETED|Overall Study||1
190073|NCT00851253|457855|P2|STARTED|Overall Study||10
190074|NCT00851253|457856|P1|STARTED|Overall Study||2
190075|NCT00851084|457866|P2|NOT COMPLETED|Overall Study||119
190076|NCT00851084|457867|P1|NOT COMPLETED|Overall Study||117
190077|NCT00851084|457866|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
190078|NCT00851084|457867|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
190079|NCT00851084|457866|P2|STARTED|Overall Study||119
190080|NCT00851084|457867|P1|STARTED|Overall Study||117
190081|NCT00851006|457883|P2|NOT COMPLETED|Overall Study||0
190082|NCT00851006|457884|P1|NOT COMPLETED|Overall Study||0
190083|NCT00851006|457883|P2|COMPLETED|Overall Study||6
190084|NCT00851006|457884|P1|COMPLETED|Overall Study||7
190085|NCT00851006|457883|P2|STARTED|Overall Study||6
190086|NCT00851006|457884|P1|STARTED|Overall Study||7
190087|NCT00850993|457895|P4|NOT COMPLETED|Overall Study||0
190088|NCT00850993|457896|P3|NOT COMPLETED|Overall Study||0
190089|NCT00850993|457897|P2|NOT COMPLETED|Overall Study||1
190090|NCT00850993|457898|P1|NOT COMPLETED|Overall Study||0
190091|NCT00850993|457895|P4|COMPLETED|Overall Study||8
190092|NCT00850993|457896|P3|COMPLETED|Overall Study||18
190093|NCT00850993|457897|P2|COMPLETED|Overall Study||16
190094|NCT00850993|457898|P1|COMPLETED|Overall Study||15
190095|NCT00850993|457895|P4|STARTED|Overall Study||8
190096|NCT00850993|457896|P3|STARTED|Overall Study||18
190097|NCT00850993|457897|P2|STARTED|Overall Study||17
190098|NCT00850993|457898|P1|STARTED|Overall Study||15
190099|NCT00850889|457912|P1|NOT COMPLETED|Overall Study||0
190100|NCT00850889|457912|P1|COMPLETED|Overall Study||32
190101|NCT00850889|457912|P1|STARTED|Overall Study||32
190102|NCT00850759|457927|P4|NOT COMPLETED|Overall Study||3
190103|NCT00850759|457928|P3|NOT COMPLETED|Overall Study||5
190104|NCT00850759|457929|P2|NOT COMPLETED|Overall Study||5
190105|NCT00850759|457930|P1|NOT COMPLETED|Overall Study||7
190106|NCT00850759|457927|P4|COMPLETED|Overall Study||55
190107|NCT00850759|457928|P3|COMPLETED|Overall Study||52
190108|NCT00850759|457929|P2|COMPLETED|Overall Study||52
190109|NCT00850759|457930|P1|COMPLETED|Overall Study||52
190110|NCT00850759|457927|P4|STARTED|Overall Study||58
190111|NCT00850759|457928|P3|STARTED|Overall Study||57
190112|NCT00850759|457929|P2|STARTED|Overall Study||57
190113|NCT00850759|457930|P1|STARTED|Overall Study||59
190114|NCT00850720|457940|P1|NOT COMPLETED|Overall Study||0
190115|NCT00850720|457940|P1|COMPLETED|Overall Study||0
190116|NCT00850720|457940|P1|STARTED|Overall Study||0
190117|NCT00850642|457946|P2|NOT COMPLETED|Overall Study||0
190118|NCT00850642|457947|P1|NOT COMPLETED|Overall Study||0
190119|NCT00850642|457946|P2|COMPLETED|Overall Study||4
190120|NCT00850642|457947|P1|COMPLETED|Overall Study||3
190121|NCT00850642|457946|P2|STARTED|Overall Study||4
190122|NCT00850642|457947|P1|STARTED|Overall Study||3
190123|NCT00850603|457985|P5|NOT COMPLETED|Overall Study||0
190124|NCT00850603|457986|P4|NOT COMPLETED|Overall Study||0
190125|NCT00850603|457987|P3|NOT COMPLETED|Overall Study||0
190126|NCT00850603|457988|P2|NOT COMPLETED|Overall Study||0
190127|NCT00850603|457989|P1|NOT COMPLETED|Overall Study||0
190128|NCT00850603|457985|P5|COMPLETED|Overall Study||34
190129|NCT00850603|457986|P4|COMPLETED|Overall Study||34
190130|NCT00850603|457987|P3|COMPLETED|Overall Study||34
190131|NCT00850603|457988|P2|COMPLETED|Overall Study||34
190132|NCT00850603|457989|P1|COMPLETED|Overall Study||34
190133|NCT00850603|457985|P5|STARTED|Overall Study||34
190134|NCT00850603|457986|P4|STARTED|Overall Study||34
190135|NCT00850603|457987|P3|STARTED|Overall Study||34
190136|NCT00850603|457988|P2|STARTED|Overall Study||34
190137|NCT00850603|457989|P1|STARTED|Overall Study||34
190138|NCT00850564|458011|P1|NOT COMPLETED|Overall Study||2
190139|NCT00850564|458011|P1|COMPLETED|Overall Study||13
190140|NCT00850564|458011|P1|STARTED|Overall Study||15
190141|NCT00850538|458016|P1|NOT COMPLETED|Overall Study||41
190142|NCT00850538|458016|P1|COMPLETED|Overall Study||60
190143|NCT00850538|458016|P1|STARTED|Overall Study||101
190144|NCT00850499|458022|P2|NOT COMPLETED|Overall Study||2
190145|NCT00850499|458023|P1|NOT COMPLETED|Overall Study||3
190146|NCT00850499|458022|P2|COMPLETED|Overall Study||6
190147|NCT00850499|458023|P1|COMPLETED|Overall Study||1
190148|NCT00850499|458022|P2|STARTED|Overall Study||8
190149|NCT00850499|458023|P1|STARTED|Overall Study||4
190150|NCT00850460|458033|P2|NOT COMPLETED|Overall Study||4
190151|NCT00850460|458034|P1|NOT COMPLETED|Overall Study||4
190152|NCT00850460|458033|P2|COMPLETED|Overall Study||3
190153|NCT00850460|458034|P1|COMPLETED|Overall Study||3
190154|NCT00850460|458033|P2|Completion - Week 8|Overall Study||3
190155|NCT00850460|458034|P1|Completion - Week 8|Overall Study||3
190156|NCT00850460|458033|P2|Started - Week 0|Overall Study||7
190157|NCT00850460|458034|P1|Started - Week 0|Overall Study||7
190158|NCT00850460|458033|P2|STARTED|Overall Study||7
190159|NCT00850460|458034|P1|STARTED|Overall Study||7
190160|NCT00850421|458042|P1|NOT COMPLETED|Overall Study||17
190161|NCT00850421|458042|P1|COMPLETED|Overall Study||18
190162|NCT00850421|458042|P1|STARTED|Overall Study||35
190163|NCT00850395|458046|P1|NOT COMPLETED|Overall Study||10
190164|NCT00850395|458046|P1|COMPLETED|Overall Study||69
190165|NCT00850395|458046|P1|STARTED|Overall Study||79
190166|NCT00850343|458066|P4|NOT COMPLETED|Overall Study||13
190167|NCT00850343|458067|P3|NOT COMPLETED|Overall Study||14
190168|NCT00850343|458068|P2|NOT COMPLETED|Overall Study||3
190169|NCT00850343|458069|P1|NOT COMPLETED|Overall Study||46
190170|NCT00850343|458066|P4|COMPLETED|Overall Study||30
190171|NCT00850343|458067|P3|COMPLETED|Overall Study||29
190172|NCT00850343|458068|P2|COMPLETED|Overall Study||9
190173|NCT00850343|458069|P1|COMPLETED|Overall Study||64
190174|NCT00850343|458066|P4|Completed Week 52|Overall Study||37
190175|NCT00850343|458067|P3|Completed Week 52|Overall Study||37
190176|NCT00850343|458068|P2|Completed Week 52|Overall Study||11
190177|NCT00850343|458069|P1|Completed Week 52|Overall Study||88
190178|NCT00850343|458066|P4|Completed Week 24|Overall Study||39
190179|NCT00850343|458067|P3|Completed Week 24|Overall Study||39
190180|NCT00850343|458068|P2|Completed Week 24|Overall Study||12
190181|NCT00850343|458069|P1|Completed Week 24|Overall Study||94
190182|NCT00850343|458066|P4|STARTED|Overall Study||43
190183|NCT00850343|458067|P3|STARTED|Overall Study||43
190184|NCT00850343|458068|P2|STARTED|Overall Study||12
190185|NCT00850343|458069|P1|STARTED|Overall Study||110
190186|NCT00850200|458099|P1|NOT COMPLETED|Overall Study||1
190187|NCT00850200|458099|P1|COMPLETED|Overall Study||19
190188|NCT00850200|458099|P1|STARTED|Overall Study||20
190189|NCT00850174|458107|P2|NOT COMPLETED|Second Intervention||0
190190|NCT00850174|458108|P1|NOT COMPLETED|Second Intervention||1
190191|NCT00850174|458107|P2|COMPLETED|Second Intervention||28
190192|NCT00850174|458108|P1|COMPLETED|Second Intervention||29
190193|NCT00850174|458107|P2|STARTED|Second Intervention||28
190194|NCT00850174|458108|P1|STARTED|Second Intervention||30
190195|NCT00850174|458107|P2|NOT COMPLETED|Washout: One Week||2
190196|NCT00850174|458108|P1|NOT COMPLETED|Washout: One Week||0
190197|NCT00850174|458107|P2|COMPLETED|Washout: One Week||28
190198|NCT00850174|458108|P1|COMPLETED|Washout: One Week||30
190199|NCT00850174|458107|P2|STARTED|Washout: One Week||30
190200|NCT00850174|458108|P1|STARTED|Washout: One Week||30
190201|NCT00850174|458107|P2|NOT COMPLETED|First Intervention||0
190202|NCT00850174|458108|P1|NOT COMPLETED|First Intervention||0
190203|NCT00850174|458107|P2|COMPLETED|First Intervention||30
190204|NCT00850174|458108|P1|COMPLETED|First Intervention||30
190205|NCT00850174|458107|P2|STARTED|First Intervention||30
190206|NCT00850174|458108|P1|STARTED|First Intervention||30
190207|NCT00850135|458122|P1|NOT COMPLETED|Overall Study||1
190208|NCT00850135|458122|P1|COMPLETED|Overall Study||56
190209|NCT00850135|458122|P1|STARTED|Overall Study||57
190210|NCT00850096|458130|P2|NOT COMPLETED|Overall Study||2
190211|NCT00850096|458131|P1|NOT COMPLETED|Overall Study||3
190212|NCT00850096|458130|P2|COMPLETED|Overall Study||45
190213|NCT00850096|458131|P1|COMPLETED|Overall Study||44
190214|NCT00850096|458130|P2|STARTED|Overall Study||47
190215|NCT00850096|458131|P1|STARTED|Overall Study||47
190216|NCT00850070|458141|P2|NOT COMPLETED|Overall Study||1
190217|NCT00850070|458142|P1|NOT COMPLETED|Overall Study||3
190218|NCT00850070|458141|P2|COMPLETED|Overall Study||22
190219|NCT00850070|458142|P1|COMPLETED|Overall Study||20
190220|NCT00850070|458141|P2|STARTED|Overall Study||23
190221|NCT00850070|458142|P1|STARTED|Overall Study||23
190222|NCT00850031|458166|P1|NOT COMPLETED|Overall Study||17
190223|NCT00850031|458166|P1|COMPLETED|Overall Study||101
190224|NCT00850031|458166|P1|STARTED|Overall Study||118
190225|NCT00849940|458171|P1|NOT COMPLETED|Overall Study||4
190226|NCT00849940|458171|P1|COMPLETED|Overall Study||68
190227|NCT00849940|458171|P1|STARTED|Overall Study||72
190228|NCT00849901|458182|P3|NOT COMPLETED|Extension Phase||17
190229|NCT00849901|458183|P2|NOT COMPLETED|Extension Phase||26
190230|NCT00849901|458184|P1|NOT COMPLETED|Extension Phase||27
190231|NCT00849901|458182|P3|COMPLETED|Extension Phase||69
190232|NCT00849901|458183|P2|COMPLETED|Extension Phase||65
190233|NCT00849901|458184|P1|COMPLETED|Extension Phase||56
190234|NCT00849901|458182|P3|STARTED|Extension Phase||86
190235|NCT00849901|458183|P2|STARTED|Extension Phase||91
190236|NCT00849901|458184|P1|STARTED|Extension Phase||83
190237|NCT00849901|458182|P3|NOT COMPLETED|Acute Treatment Phase||16
190238|NCT00849901|458183|P2|NOT COMPLETED|Acute Treatment Phase||26
190239|NCT00849901|458184|P1|NOT COMPLETED|Acute Treatment Phase||30
190240|NCT00849901|458182|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
190241|NCT00849901|458183|P2|COMPLETED|Acute Treatment Phase||91
190242|NCT00849901|458184|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
190243|NCT00849901|458182|P3|STARTED|Acute Treatment Phase||103
190244|NCT00849901|458183|P2|STARTED|Acute Treatment Phase||117
190245|NCT00849901|458184|P1|STARTED|Acute Treatment Phase||117
190246|NCT00849875|458231|P1|NOT COMPLETED|Overall Study||47
190247|NCT00849875|458231|P1|COMPLETED|Overall Study||1
190248|NCT00849875|458231|P1|STARTED|Overall Study||48
190249|NCT00849862|458313|P2|NOT COMPLETED|Second Intervention||0
190250|NCT00849862|458314|P1|NOT COMPLETED|Second Intervention||0
190251|NCT00849862|458313|P2|COMPLETED|Second Intervention||11
190252|NCT00849862|458314|P1|COMPLETED|Second Intervention||11
190253|NCT00849862|458313|P2|STARTED|Second Intervention||11
190254|NCT00849862|458314|P1|STARTED|Second Intervention||11
190255|NCT00849862|458313|P2|NOT COMPLETED|Washout: 7 Days||0
190256|NCT00849862|458314|P1|NOT COMPLETED|Washout: 7 Days||0
190257|NCT00849862|458313|P2|COMPLETED|Washout: 7 Days||11
190258|NCT00849862|458314|P1|COMPLETED|Washout: 7 Days||11
190259|NCT00849862|458313|P2|STARTED|Washout: 7 Days||11
190260|NCT00849862|458314|P1|STARTED|Washout: 7 Days||11
190261|NCT00849862|458313|P2|NOT COMPLETED|First Intervention||0
190262|NCT00849862|458314|P1|NOT COMPLETED|First Intervention||0
190263|NCT00849862|458313|P2|COMPLETED|First Intervention||11
190264|NCT00849862|458314|P1|COMPLETED|First Intervention||11
190265|NCT00849862|458313|P2|STARTED|First Intervention||11
190266|NCT00849862|458314|P1|STARTED|First Intervention||11
190267|NCT00849810|458322|P1|NOT COMPLETED|Overall Study||0
190268|NCT00849810|458322|P1|COMPLETED|Overall Study||1
190269|NCT00849810|458322|P1|STARTED|Overall Study||1
190270|NCT00849797|458328|P2|NOT COMPLETED|Second Intervention||0
190271|NCT00849797|458329|P1|NOT COMPLETED|Second Intervention||0
190272|NCT00849797|458328|P2|COMPLETED|Second Intervention||57
190273|NCT00849797|458329|P1|COMPLETED|Second Intervention||59
190274|NCT00849797|458328|P2|STARTED|Second Intervention||57
190275|NCT00849797|458329|P1|STARTED|Second Intervention||59
190276|NCT00849797|458328|P2|NOT COMPLETED|Washout: One Week||2
190277|NCT00849797|458329|P1|NOT COMPLETED|Washout: One Week||0
190278|NCT00849797|458328|P2|COMPLETED|Washout: One Week||57
190279|NCT00849797|458329|P1|COMPLETED|Washout: One Week||59
190280|NCT00849797|458328|P2|STARTED|Washout: One Week||59
190281|NCT00849797|458329|P1|STARTED|Washout: One Week||59
190282|NCT00849797|458328|P2|NOT COMPLETED|First Intervention||1
190283|NCT00849797|458329|P1|NOT COMPLETED|First Intervention||1
190284|NCT00849797|458328|P2|COMPLETED|First Intervention||59
190285|NCT00849797|458329|P1|COMPLETED|First Intervention||59
190286|NCT00849797|458328|P2|STARTED|First Intervention||60
190287|NCT00849797|458329|P1|STARTED|First Intervention||60
190288|NCT00849693|458347|P4|NOT COMPLETED|Extension Phase||38
190289|NCT00849693|458348|P3|NOT COMPLETED|Extension Phase||35
190290|NCT00849693|458349|P2|NOT COMPLETED|Extension Phase||30
190291|NCT00849693|458350|P1|NOT COMPLETED|Extension Phase||30
190292|NCT00849693|458347|P4|COMPLETED|Extension Phase||44
190293|NCT00849693|458348|P3|COMPLETED|Extension Phase||49
190294|NCT00849693|458349|P2|COMPLETED|Extension Phase||50
190295|NCT00849693|458350|P1|COMPLETED|Extension Phase||43
190296|NCT00849693|458347|P4|STARTED|Extension Phase||82
190297|NCT00849693|458348|P3|STARTED|Extension Phase||84
190298|NCT00849693|458349|P2|STARTED|Extension Phase||80
190299|NCT00849693|458350|P1|STARTED|Extension Phase||73
190300|NCT00849693|458347|P4|NOT COMPLETED|Acute Treatment Phase||37
190301|NCT00849693|458348|P3|NOT COMPLETED|Acute Treatment Phase||33
190302|NCT00849693|458349|P2|NOT COMPLETED|Acute Treatment Phase||35
190303|NCT00849693|458350|P1|NOT COMPLETED|Acute Treatment Phase||33
190304|NCT00849693|458347|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
190305|NCT00849693|458348|P3|COMPLETED|Acute Treatment Phase||84
190306|NCT00849693|458349|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
190307|NCT00849693|458350|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
190308|NCT00849693|458347|P4|STARTED|Acute Treatment Phase||122
190309|NCT00849693|458348|P3|STARTED|Acute Treatment Phase||117
190310|NCT00849693|458349|P2|STARTED|Acute Treatment Phase||116
190311|NCT00849693|458350|P1|STARTED|Acute Treatment Phase||108
190312|NCT00849680|458417|P8|NOT COMPLETED|Overall Study||8
190313|NCT00849680|458418|P7|NOT COMPLETED|Overall Study||17
190314|NCT00849680|458419|P6|NOT COMPLETED|Overall Study||15
190315|NCT00849680|458420|P5|NOT COMPLETED|Overall Study||10
190316|NCT00849680|458421|P4|NOT COMPLETED|Overall Study||14
190317|NCT00849680|458422|P3|NOT COMPLETED|Overall Study||15
190318|NCT00849680|458423|P2|NOT COMPLETED|Overall Study||3
190319|NCT00849680|458424|P1|NOT COMPLETED|Overall Study||11
190320|NCT00849680|458417|P8|COMPLETED|Overall Study||23
190321|NCT00849680|458418|P7|COMPLETED|Overall Study||61
190322|NCT00849680|458419|P6|COMPLETED|Overall Study||27
190323|NCT00849680|458420|P5|COMPLETED|Overall Study||32
190324|NCT00849680|458421|P4|COMPLETED|Overall Study||28
190325|NCT00849680|458422|P3|COMPLETED|Overall Study||27
190326|NCT00849680|458423|P2|COMPLETED|Overall Study||10
190327|NCT00849680|458424|P1|COMPLETED|Overall Study||16
190328|NCT00849680|458417|P8|STARTED|Overall Study||31
190329|NCT00849680|458418|P7|STARTED|Overall Study||78
190330|NCT00849680|458419|P6|STARTED|Overall Study||42
190331|NCT00849680|458420|P5|STARTED|Overall Study||42
190332|NCT00849680|458421|P4|STARTED|Overall Study||42
190333|NCT00849680|458422|P3|STARTED|Overall Study||42
190334|NCT00849680|458423|P2|STARTED|Overall Study||13
190335|NCT00849680|458424|P1|STARTED|Overall Study||27
190336|NCT00849524|458466|P1|NOT COMPLETED|Overall Study||3
190337|NCT00849524|458466|P1|COMPLETED|Overall Study||3
190338|NCT00849524|458466|P1|STARTED|Overall Study||6
190339|NCT00849485|458474|P2|NOT COMPLETED|Second Intervention||0
190340|NCT00849485|458475|P1|NOT COMPLETED|Second Intervention||0
190341|NCT00849485|458474|P2|COMPLETED|Second Intervention||11
190342|NCT00849485|458475|P1|COMPLETED|Second Intervention||11
190343|NCT00849485|458474|P2|STARTED|Second Intervention||11
190344|NCT00849485|458475|P1|STARTED|Second Intervention||11
190345|NCT00849485|458474|P2|NOT COMPLETED|Washout: 7 Days||0
190346|NCT00849485|458475|P1|NOT COMPLETED|Washout: 7 Days||0
190347|NCT00849485|458474|P2|COMPLETED|Washout: 7 Days||11
190348|NCT00849485|458475|P1|COMPLETED|Washout: 7 Days||11
190349|NCT00849485|458474|P2|STARTED|Washout: 7 Days||11
190350|NCT00849485|458475|P1|STARTED|Washout: 7 Days||11
190351|NCT00849485|458474|P2|NOT COMPLETED|First Intervention||0
190352|NCT00849485|458475|P1|NOT COMPLETED|First Intervention||0
190353|NCT00849485|458474|P2|COMPLETED|First Intervention||11
190354|NCT00849485|458475|P1|COMPLETED|First Intervention||11
190355|NCT00849485|458474|P2|STARTED|First Intervention||11
190356|NCT00849485|458475|P1|STARTED|First Intervention||11
190357|NCT00849472|458483|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
190358|NCT00849472|458483|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
190359|NCT00849472|458483|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
190360|NCT00849472|458483|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
190361|NCT00849472|458483|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
190362|NCT00849472|458483|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
190363|NCT00849472|458483|P1|NOT COMPLETED|Weekly Paclitaxel||16
190364|NCT00849472|458483|P1|COMPLETED|Weekly Paclitaxel||78
190365|NCT00849472|458483|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
190366|NCT00849472|458483|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
190367|NCT00849472|458483|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
190368|NCT00849472|458483|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
190369|NCT00849381|458497|P1|NOT COMPLETED|Overall Study||145
190370|NCT00849381|458497|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
190371|NCT00849381|458497|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
190372|NCT00849290|458503|P1|NOT COMPLETED|Overall Study||55
190373|NCT00849290|458503|P1|COMPLETED|Overall Study||58
190374|NCT00849290|458503|P1|STARTED|Overall Study||113
190375|NCT00849251|458507|P2|NOT COMPLETED|Overall Study||1
190376|NCT00849251|458508|P1|NOT COMPLETED|Overall Study||1
190377|NCT00849251|458507|P2|COMPLETED|Overall Study||24
190378|NCT00849251|458508|P1|COMPLETED|Overall Study||5
190379|NCT00849251|458507|P2|STARTED|Overall Study||25
190380|NCT00849251|458508|P1|STARTED|Overall Study||6
190381|NCT00849212|458514|P1|NOT COMPLETED|Overall Study||7
190382|NCT00849212|458514|P1|COMPLETED|Overall Study||23
190383|NCT00849212|458514|P1|STARTED|Overall Study||30
190384|NCT00849186|458519|P1|NOT COMPLETED|Overall Study||10
190385|NCT00849186|458519|P1|COMPLETED|Overall Study||16
190386|NCT00849186|458519|P1|STARTED|Overall Study||26
190387|NCT00849147|458525|P1|NOT COMPLETED|Overall Study||5
190388|NCT00849147|458525|P1|COMPLETED|Overall Study||50
190389|NCT00849147|458525|P1|STARTED|Overall Study||55
190390|NCT00849121|458542|P2|NOT COMPLETED|Overall Study||0
190391|NCT00849121|458543|P1|NOT COMPLETED|Overall Study||0
190392|NCT00849121|458542|P2|COMPLETED|Overall Study||9
190393|NCT00849121|458543|P1|COMPLETED|Overall Study||8
190394|NCT00849121|458542|P2|STARTED|Overall Study||9
190395|NCT00849121|458543|P1|STARTED|Overall Study||8
190396|NCT00849108|458558|P2|NOT COMPLETED|Cohort 2 Efficacy||10
190397|NCT00849108|458559|P1|NOT COMPLETED|Cohort 2 Efficacy||0
190398|NCT00849108|458558|P2|COMPLETED|Cohort 2 Efficacy||133
190399|NCT00849108|458559|P1|COMPLETED|Cohort 2 Efficacy||0
190400|NCT00849108|458558|P2|STARTED|Cohort 2 Efficacy||143
190401|NCT00849108|458559|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
190402|NCT00849108|458558|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
190403|NCT00849108|458559|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
190404|NCT00849108|458558|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
190405|NCT00849108|458559|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
190406|NCT00849108|458558|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
190407|NCT00849108|458559|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
190408|NCT00849056|458569|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
190409|NCT00849056|458570|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
190410|NCT00849056|458569|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
190411|NCT00849056|458570|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
190412|NCT00849056|458569|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
190413|NCT00849056|458570|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
190414|NCT00849056|458569|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
190415|NCT00849056|458570|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
190416|NCT00849056|458569|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
190417|NCT00849056|458570|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
190418|NCT00849056|458569|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
190419|NCT00849056|458570|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
190420|NCT00849017|458595|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
190421|NCT00849017|458596|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
190422|NCT00849017|458597|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
190423|NCT00849017|458595|P3|COMPLETED|Follow-up Period (8 Weeks)||74
190424|NCT00849017|458596|P2|COMPLETED|Follow-up Period (8 Weeks)||83
190425|NCT00849017|458597|P1|COMPLETED|Follow-up Period (8 Weeks)||76
190426|NCT00849017|458595|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
190427|NCT00849017|458596|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
190511|NCT00848484|458821|P2|COMPLETED|Washout Period of Two Weeks||21
190428|NCT00849017|458597|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
190429|NCT00849017|458595|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
190430|NCT00849017|458596|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
190431|NCT00849017|458597|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
190432|NCT00849017|458595|P3|COMPLETED|Treatment Period (156 Weeks)||57
190433|NCT00849017|458596|P2|COMPLETED|Treatment Period (156 Weeks)||68
190434|NCT00849017|458597|P1|COMPLETED|Treatment Period (156 Weeks)||58
190435|NCT00849017|458595|P3|STARTED|Treatment Period (156 Weeks)||99
190436|NCT00849017|458596|P2|STARTED|Treatment Period (156 Weeks)||101
190437|NCT00849017|458597|P1|STARTED|Treatment Period (156 Weeks)||101
190438|NCT00848965|458640|P1|NOT COMPLETED|Overall Study||2
190439|NCT00848965|458640|P1|COMPLETED|Overall Study||57
190440|NCT00848965|458640|P1|STARTED|Overall Study||59
190441|NCT00848926|458682|P1|NOT COMPLETED|Follow-up Period||12
190442|NCT00848926|458682|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
190443|NCT00848926|458682|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
190444|NCT00848926|458682|P1|NOT COMPLETED|Treatment Period||84
190445|NCT00848926|458682|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
190446|NCT00848926|458682|P1|STARTED|Treatment Period||102
190447|NCT00848783|458701|P3|NOT COMPLETED|Overall Study||0
190448|NCT00848783|458702|P2|NOT COMPLETED|Overall Study||2
190449|NCT00848783|458703|P1|NOT COMPLETED|Overall Study||3
190450|NCT00848783|458701|P3|COMPLETED|Overall Study||1
190451|NCT00848783|458702|P2|COMPLETED|Overall Study||1
190452|NCT00848783|458703|P1|COMPLETED|Overall Study||1
190453|NCT00848783|458701|P3|STARTED|Overall Study||1
190454|NCT00848783|458702|P2|STARTED|Overall Study||3
190455|NCT00848783|458703|P1|STARTED|Overall Study||4
190456|NCT00848744|458712|P1|NOT COMPLETED|Overall Study||0
190457|NCT00848744|458712|P1|COMPLETED|Overall Study||10
190458|NCT00848744|458712|P1|STARTED|Overall Study||10
190459|NCT00848549|458721|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
190460|NCT00848549|458722|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
190461|NCT00848549|458721|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
190462|NCT00848549|458722|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
190463|NCT00848549|458721|P2|STARTED|E2090-E044-314 (Extension Study)||158
190464|NCT00848549|458722|P1|STARTED|E2090-E044-314 (Extension Study)||137
190465|NCT00848549|458721|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
190466|NCT00848549|458722|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
190467|NCT00848549|458721|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
190468|NCT00848549|458722|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
190469|NCT00848549|458721|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
190470|NCT00848549|458722|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
190471|NCT00848549|458721|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
190472|NCT00848549|458722|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
190473|NCT00848549|458721|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
190474|NCT00848549|458722|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
190475|NCT00848549|458721|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
190476|NCT00848549|458722|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
190477|NCT00848536|458740|P2|NOT COMPLETED|Overall Study||7
190478|NCT00848536|458741|P1|NOT COMPLETED|Overall Study||4
190479|NCT00848536|458740|P2|COMPLETED|Overall Study||179
190480|NCT00848536|458741|P1|COMPLETED|Overall Study||181
190481|NCT00848536|458740|P2|STARTED|Overall Study||186
190482|NCT00848536|458741|P1|STARTED|Overall Study||185
190483|NCT00848510|458755|P4|NOT COMPLETED|Overall Study||0
190484|NCT00848510|458756|P3|NOT COMPLETED|Overall Study||0
190485|NCT00848510|458757|P2|NOT COMPLETED|Overall Study||0
190486|NCT00848510|458758|P1|NOT COMPLETED|Overall Study||0
190487|NCT00848510|458755|P4|COMPLETED|Overall Study||10
190488|NCT00848510|458756|P3|COMPLETED|Overall Study||8
190489|NCT00848510|458757|P2|COMPLETED|Overall Study||13
190490|NCT00848510|458758|P1|COMPLETED|Overall Study||10
190491|NCT00848510|458755|P4|STARTED|Overall Study||10
190492|NCT00848510|458756|P3|STARTED|Overall Study||8
190493|NCT00848510|458757|P2|STARTED|Overall Study||13
190494|NCT00848510|458758|P1|STARTED|Overall Study||10
190495|NCT00848497|458806|P2|NOT COMPLETED|Overall Study||1
190496|NCT00848497|458807|P1|NOT COMPLETED|Overall Study||2
190497|NCT00848497|458806|P2|COMPLETED|Overall Study||0
190498|NCT00848497|458807|P1|COMPLETED|Overall Study||0
190499|NCT00848497|458806|P2|STARTED|Overall Study|Completed Visit 4|1
190500|NCT00848497|458807|P1|STARTED|Overall Study||2
190501|NCT00848484|458821|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
190502|NCT00848484|458822|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
190503|NCT00848484|458821|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
190504|NCT00848484|458822|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
190505|NCT00848484|458821|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
190506|NCT00848484|458822|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
190507|NCT00848484|458821|P2|STARTED|Second Intervention (Treatment Period 2)||21
190508|NCT00848484|458822|P1|STARTED|Second Intervention (Treatment Period 2)||25
190509|NCT00848484|458821|P2|NOT COMPLETED|Washout Period of Two Weeks||3
190510|NCT00848484|458822|P1|NOT COMPLETED|Washout Period of Two Weeks||0
190512|NCT00848484|458822|P1|COMPLETED|Washout Period of Two Weeks||25
190513|NCT00848484|458821|P2|STARTED|Washout Period of Two Weeks||24
190514|NCT00848484|458822|P1|STARTED|Washout Period of Two Weeks||25
190515|NCT00848484|458821|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
190516|NCT00848484|458822|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
190517|NCT00848484|458821|P2|COMPLETED|First Intervention (Treatment Period 1)||24
190518|NCT00848484|458822|P1|COMPLETED|First Intervention (Treatment Period 1)||25
190519|NCT00848484|458821|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
190520|NCT00848484|458822|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
190521|NCT00848484|458821|P2|STARTED|First Intervention (Treatment Period 1)||27
190522|NCT00848484|458822|P1|STARTED|First Intervention (Treatment Period 1)||27
190523|NCT00848367|458840|P2|NOT COMPLETED|Overall Study||9
190524|NCT00848367|458841|P1|NOT COMPLETED|Overall Study||9
190525|NCT00848367|458840|P2|COMPLETED|Overall Study||41
190526|NCT00848367|458841|P1|COMPLETED|Overall Study||43
190527|NCT00848367|458840|P2|STARTED|Overall Study||50
190528|NCT00848367|458841|P1|STARTED|Overall Study||52
190529|NCT00848354|458851|P2|NOT COMPLETED|Phase 2 Year 2||7
190530|NCT00848354|458852|P1|NOT COMPLETED|Phase 2 Year 2||23
190531|NCT00848354|458851|P2|COMPLETED|Phase 2 Year 2||113
190532|NCT00848354|458852|P1|COMPLETED|Phase 2 Year 2||218
190533|NCT00848354|458851|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
190534|NCT00848354|458852|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
190535|NCT00848354|458851|P2|NOT COMPLETED|Phase 2 Year 1||6
190536|NCT00848354|458852|P1|NOT COMPLETED|Phase 2 Year 1||18
190537|NCT00848354|458851|P2|COMPLETED|Phase 2 Year 1||120
190538|NCT00848354|458852|P1|COMPLETED|Phase 2 Year 1||242
190539|NCT00848354|458851|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
190540|NCT00848354|458852|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
190541|NCT00848354|458851|P2|NOT COMPLETED|Phase 1||14
190542|NCT00848354|458852|P1|NOT COMPLETED|Phase 1||12
190543|NCT00848354|458851|P2|COMPLETED|Phase 1||129
190544|NCT00848354|458852|P1|COMPLETED|Phase 1||269
190545|NCT00848354|458851|P2|STARTED|Phase 1||143
190546|NCT00848354|458852|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
190547|NCT00848250|459004|P2|NOT COMPLETED|Overall Study||1
190548|NCT00848250|459005|P1|NOT COMPLETED|Overall Study||0
190549|NCT00848250|459004|P2|COMPLETED|Overall Study||9
190550|NCT00848250|459005|P1|COMPLETED|Overall Study||11
190551|NCT00848250|459004|P2|STARTED|Overall Study||10
190552|NCT00848250|459005|P1|STARTED|Overall Study||11
190553|NCT00848237|459023|P1|NOT COMPLETED|Overall Study||539
190554|NCT00848237|459023|P1|COMPLETED|Overall Study||4982
190555|NCT00848237|459023|P1|STARTED|Overall Study||5521
190556|NCT00848211|459036|P4|NOT COMPLETED|Overall Study||0
190557|NCT00848211|459037|P3|NOT COMPLETED|Overall Study||1
190558|NCT00848211|459038|P2|NOT COMPLETED|Overall Study||1
190559|NCT00848211|459039|P1|NOT COMPLETED|Overall Study||0
190560|NCT00848211|459036|P4|COMPLETED|Overall Study||5
190561|NCT00848211|459037|P3|COMPLETED|Overall Study||5
190562|NCT00848211|459038|P2|COMPLETED|Overall Study||6
190563|NCT00848211|459039|P1|COMPLETED|Overall Study||6
190564|NCT00848211|459036|P4|STARTED|Overall Study||5
190565|NCT00848211|459037|P3|STARTED|Overall Study||6
190566|NCT00848211|459038|P2|STARTED|Overall Study||7
190567|NCT00848211|459039|P1|STARTED|Overall Study||6
190568|NCT00848198|459057|P1|NOT COMPLETED|Overall Study||15
190569|NCT00848198|459057|P1|COMPLETED|Overall Study||299
190570|NCT00848198|459057|P1|STARTED|Overall Study||314
190571|NCT00848185|459098|P3|NOT COMPLETED|Overall Study||0
190572|NCT00848185|459099|P2|NOT COMPLETED|Overall Study||0
190573|NCT00848185|459100|P1|NOT COMPLETED|Overall Study||0
190574|NCT00848185|459098|P3|COMPLETED|Overall Study||32
190575|NCT00848185|459099|P2|COMPLETED|Overall Study||32
190576|NCT00848185|459100|P1|COMPLETED|Overall Study||32
190577|NCT00848185|459098|P3|STARTED|Overall Study||32
190578|NCT00848185|459099|P2|STARTED|Overall Study||32
190579|NCT00848185|459100|P1|STARTED|Overall Study||32
190580|NCT00848172|459110|P2|NOT COMPLETED|Visit 3 - Follow Up||0
190581|NCT00848172|459111|P1|NOT COMPLETED|Visit 3 - Follow Up||0
190582|NCT00848172|459110|P2|COMPLETED|Visit 3 - Follow Up||8
190583|NCT00848172|459111|P1|COMPLETED|Visit 3 - Follow Up||10
190584|NCT00848172|459110|P2|STARTED|Visit 3 - Follow Up||8
190585|NCT00848172|459111|P1|STARTED|Visit 3 - Follow Up||10
190586|NCT00848172|459110|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
190587|NCT00848172|459111|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
190588|NCT00848172|459110|P2|COMPLETED|Visit 2 - Drug Administration||8
190589|NCT00848172|459111|P1|COMPLETED|Visit 2 - Drug Administration||10
190590|NCT00848172|459110|P2|STARTED|Visit 2 - Drug Administration||9
190591|NCT00848172|459111|P1|STARTED|Visit 2 - Drug Administration||10
190592|NCT00848120|459122|P1|NOT COMPLETED|Overall Study||1
190593|NCT00848120|459122|P1|COMPLETED|Overall Study||28
190594|NCT00848120|459122|P1|STARTED|Overall Study||29
190595|NCT00848107|459134|P1|NOT COMPLETED|Overall Study||21
190596|NCT00848107|459134|P1|COMPLETED|Overall Study||94
190597|NCT00848107|459134|P1|STARTED|Overall Study||115
190598|NCT00848081|459144|P2|NOT COMPLETED|Overall Study||18
190599|NCT00848081|459145|P1|NOT COMPLETED|Overall Study||20
190600|NCT00848081|459144|P2|COMPLETED|Overall Study||140
190601|NCT00848081|459145|P1|COMPLETED|Overall Study||140
190602|NCT00848081|459144|P2|STARTED|Overall Study||158
190603|NCT00848081|459145|P1|STARTED|Overall Study||160
190604|NCT00848042|459162|P3|NOT COMPLETED|Overall Study||0
190605|NCT00848042|459163|P2|NOT COMPLETED|Overall Study||2
190606|NCT00848042|459164|P1|NOT COMPLETED|Overall Study||4
190607|NCT00848042|459162|P3|COMPLETED|Overall Study||1
190608|NCT00848042|459163|P2|COMPLETED|Overall Study||3
190609|NCT00848042|459164|P1|COMPLETED|Overall Study||1
190610|NCT00848042|459162|P3|Month 6|Overall Study||1
190611|NCT00848042|459163|P2|Month 6|Overall Study||3
190612|NCT00848042|459164|P1|Month 6|Overall Study||1
190613|NCT00848042|459162|P3|Month 5|Overall Study||1
190614|NCT00848042|459163|P2|Month 5|Overall Study||3
190615|NCT00848042|459164|P1|Month 5|Overall Study||1
190616|NCT00848042|459162|P3|Month 4|Overall Study||1
190617|NCT00848042|459163|P2|Month 4|Overall Study||4
190618|NCT00848042|459164|P1|Month 4|Overall Study||1
190619|NCT00848042|459162|P3|Month 3|Overall Study||1
190620|NCT00848042|459163|P2|Month 3|Overall Study||4
190621|NCT00848042|459164|P1|Month 3|Overall Study||1
190622|NCT00848042|459162|P3|Month 2|Overall Study||1
190623|NCT00848042|459163|P2|Month 2|Overall Study||5
190624|NCT00848042|459164|P1|Month 2|Overall Study||1
190625|NCT00848042|459162|P3|Month 1|Overall Study||1
190626|NCT00848042|459163|P2|Month 1|Overall Study||5
190627|NCT00848042|459164|P1|Month 1|Overall Study||4
190628|NCT00848042|459162|P3|Day 15|Overall Study||1
190629|NCT00848042|459163|P2|Day 15|Overall Study||5
190630|NCT00848042|459164|P1|Day 15|Overall Study||4
190631|NCT00848042|459162|P3|Day 8|Overall Study||1
190632|NCT00848042|459163|P2|Day 8|Overall Study||5
190633|NCT00848042|459164|P1|Day 8|Overall Study||5
190634|NCT00848042|459162|P3|Day 3|Overall Study||1
190635|NCT00848042|459163|P2|Day 3|Overall Study||5
190636|NCT00848042|459164|P1|Day 3|Overall Study||5
190637|NCT00848042|459162|P3|Day 2|Overall Study||1
190638|NCT00848042|459163|P2|Day 2|Overall Study||5
190639|NCT00848042|459164|P1|Day 2|Overall Study||5
190640|NCT00848042|459162|P3|Day 1|Overall Study||1
190641|NCT00848042|459163|P2|Day 1|Overall Study||5
190642|NCT00848042|459164|P1|Day 1|Overall Study||5
190643|NCT00848042|459162|P3|STARTED|Overall Study||1
190644|NCT00848042|459163|P2|STARTED|Overall Study||5
190645|NCT00848042|459164|P1|STARTED|Overall Study||5
190646|NCT00848016|459175|P1|NOT COMPLETED|Overall Study||0
190647|NCT00848016|459175|P1|COMPLETED|Overall Study||29
190648|NCT00848016|459175|P1|STARTED|Overall Study||29
190649|NCT00847912|459183|P2|NOT COMPLETED|Overall Study||13
190650|NCT00847912|459184|P1|NOT COMPLETED|Overall Study||9
190651|NCT00847912|459183|P2|COMPLETED|Overall Study||464
190652|NCT00847912|459184|P1|COMPLETED|Overall Study||468
190653|NCT00847912|459183|P2|STARTED|Overall Study||477
190654|NCT00847912|459184|P1|STARTED|Overall Study||477
190655|NCT00847886|459194|P2|NOT COMPLETED|Overall Study||1
190656|NCT00847886|459195|P1|NOT COMPLETED|Overall Study||0
190657|NCT00847886|459194|P2|COMPLETED|Overall Study||3
190658|NCT00847886|459195|P1|COMPLETED|Overall Study||12
190659|NCT00847886|459194|P2|STARTED|Overall Study||4
190660|NCT00847886|459195|P1|STARTED|Overall Study||12
190661|NCT00847808|459221|P1|NOT COMPLETED|Overall Study||15
190662|NCT00847808|459221|P1|COMPLETED|Overall Study||163
190663|NCT00847808|459221|P1|STARTED|Overall Study||178
190664|NCT00847704|459238|P1|NOT COMPLETED|Overall Study||1
190665|NCT00847704|459238|P1|COMPLETED|Overall Study||2
190666|NCT00847704|459238|P1|STARTED|Overall Study||3
190667|NCT00847665|459249|P2|NOT COMPLETED|Overall Study||0
190668|NCT00847665|459250|P1|NOT COMPLETED|Overall Study||1
190669|NCT00847665|459249|P2|COMPLETED|Overall Study||165
190670|NCT00847665|459250|P1|COMPLETED|Overall Study||164
190671|NCT00847665|459249|P2|STARTED|Overall Study||165
190672|NCT00847665|459250|P1|STARTED|Overall Study||165
190673|NCT00847626|459273|P11|NOT COMPLETED|Overall Study||20
190674|NCT00847626|459274|P10|NOT COMPLETED|Overall Study||14
190675|NCT00847626|459275|P9|NOT COMPLETED|Overall Study||14
190676|NCT00847626|459276|P8|NOT COMPLETED|Overall Study||19
190677|NCT00847626|459277|P7|NOT COMPLETED|Overall Study||22
190678|NCT00847626|459278|P6|NOT COMPLETED|Overall Study||37
190679|NCT00847626|459279|P5|NOT COMPLETED|Overall Study||28
190680|NCT00847626|459280|P4|NOT COMPLETED|Overall Study||31
190681|NCT00847626|459281|P3|NOT COMPLETED|Overall Study||16
190682|NCT00847626|459282|P2|NOT COMPLETED|Overall Study||23
190683|NCT00847626|459283|P1|NOT COMPLETED|Overall Study||21
190684|NCT00847626|459273|P11|COMPLETED|Overall Study||142
190685|NCT00847626|459274|P10|COMPLETED|Overall Study||139
190686|NCT00847626|459275|P9|COMPLETED|Overall Study||141
190687|NCT00847626|459276|P8|COMPLETED|Overall Study||141
190688|NCT00847626|459277|P7|COMPLETED|Overall Study||135
190689|NCT00847626|459278|P6|COMPLETED|Overall Study||125
190690|NCT00847626|459279|P5|COMPLETED|Overall Study||125
190691|NCT00847626|459280|P4|COMPLETED|Overall Study||125
190692|NCT00847626|459281|P3|COMPLETED|Overall Study||131
190693|NCT00847626|459282|P2|COMPLETED|Overall Study||131
190694|NCT00847626|459283|P1|COMPLETED|Overall Study||135
190695|NCT00847626|459273|P11|STARTED|Overall Study||162
190696|NCT00847626|459274|P10|STARTED|Overall Study||153
190697|NCT00847626|459275|P9|STARTED|Overall Study||155
190698|NCT00847626|459276|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
190699|NCT00847626|459277|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
190700|NCT00847626|459278|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
190701|NCT00847626|459279|P5|STARTED|Overall Study||153
190702|NCT00847626|459280|P4|STARTED|Overall Study||156
190703|NCT00847626|459281|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
190704|NCT00847626|459282|P2|STARTED|Overall Study||154
190705|NCT00847626|459283|P1|STARTED|Overall Study||156
190706|NCT00847613|459482|P4|NOT COMPLETED|Overall Study||79
190707|NCT00847613|459483|P3|NOT COMPLETED|Overall Study||81
190708|NCT00847613|459484|P2|NOT COMPLETED|Overall Study||319
190709|NCT00847613|459485|P1|NOT COMPLETED|Overall Study||321
190710|NCT00847613|459482|P4|COMPLETED|Overall Study||0
190711|NCT00847613|459483|P3|COMPLETED|Overall Study||0
190712|NCT00847613|459484|P2|COMPLETED|Overall Study||0
190713|NCT00847613|459485|P1|COMPLETED|Overall Study||0
190714|NCT00847613|459482|P4|Treated|Overall Study||79
190715|NCT00847613|459483|P3|Treated|Overall Study||81
190716|NCT00847613|459484|P2|Treated|Overall Study||316
190717|NCT00847613|459485|P1|Treated|Overall Study||321
190718|NCT00847613|459482|P4|STARTED|Overall Study||79
190719|NCT00847613|459483|P3|STARTED|Overall Study||81
190720|NCT00847613|459484|P2|STARTED|Overall Study||319
190721|NCT00847613|459485|P1|STARTED|Overall Study||321
190722|NCT00847587|459725|P2|NOT COMPLETED|Overall Study||0
190723|NCT00847587|459726|P1|NOT COMPLETED|Overall Study||1
190724|NCT00847587|459725|P2|COMPLETED|Overall Study||34
190725|NCT00847587|459726|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
190726|NCT00847587|459725|P2|STARTED|Overall Study||34
190727|NCT00847587|459726|P1|STARTED|Overall Study||35
190728|NCT00847561|459736|P2|NOT COMPLETED|Overall Study||4
190729|NCT00847561|459737|P1|NOT COMPLETED|Overall Study||13
190730|NCT00847561|459736|P2|COMPLETED|Overall Study||62
190731|NCT00847561|459737|P1|COMPLETED|Overall Study||57
190732|NCT00847561|459736|P2|STARTED|Overall Study||66
190733|NCT00847561|459737|P1|STARTED|Overall Study||70
190734|NCT00847535|459743|P3|NOT COMPLETED|Overall Study||1
190735|NCT00847535|459744|P2|NOT COMPLETED|Overall Study||2
190736|NCT00847535|459745|P1|NOT COMPLETED|Overall Study||2
190737|NCT00847535|459743|P3|COMPLETED|Overall Study||15
190738|NCT00847535|459744|P2|COMPLETED|Overall Study||22
190739|NCT00847535|459745|P1|COMPLETED|Overall Study||22
190740|NCT00847535|459743|P3|200 Million AMDC|Overall Study||8
190741|NCT00847535|459744|P2|200 Million AMDC|Overall Study||0
190742|NCT00847535|459745|P1|200 Million AMDC|Overall Study||0
190743|NCT00847535|459743|P3|100 Million AMDC|Overall Study||8
190744|NCT00847535|459744|P2|100 Million AMDC|Overall Study||8
190745|NCT00847535|459745|P1|100 Million AMDC|Overall Study||8
190746|NCT00847535|459743|P3|50 Million AMDC|Overall Study||0
190747|NCT00847535|459744|P2|50 Million AMDC|Overall Study||8
190748|NCT00847535|459745|P1|50 Million AMDC|Overall Study||8
190749|NCT00847535|459743|P3|10 Million AMDC|Overall Study||0
190750|NCT00847535|459744|P2|10 Million AMDC|Overall Study||8
190751|NCT00847535|459745|P1|10 Million AMDC|Overall Study||8
190752|NCT00847535|459743|P3|STARTED|Overall Study||16
190753|NCT00847535|459744|P2|STARTED|Overall Study||24
190754|NCT00847535|459745|P1|STARTED|Overall Study||24
190755|NCT00847522|459753|P1|NOT COMPLETED|Overall Study||0
190756|NCT00847522|459753|P1|COMPLETED|Overall Study||90
190757|NCT00847522|459753|P1|Phase II|Overall Study||80
190758|NCT00847522|459753|P1|Phase I|Overall Study||10
190759|NCT00847522|459753|P1|STARTED|Overall Study||90
190760|NCT00847509|459758|P1|NOT COMPLETED|Overall Study||11
190761|NCT00847509|459758|P1|COMPLETED|Overall Study||38
190762|NCT00847509|459758|P1|STARTED|Overall Study||49
190763|NCT00847405|459764|P2|NOT COMPLETED|Second Intervention||0
190764|NCT00847405|459765|P1|NOT COMPLETED|Second Intervention||0
190765|NCT00847405|459764|P2|COMPLETED|Second Intervention||13
190766|NCT00847405|459765|P1|COMPLETED|Second Intervention||13
190767|NCT00847405|459764|P2|STARTED|Second Intervention||13
190768|NCT00847405|459765|P1|STARTED|Second Intervention||13
190769|NCT00847405|459764|P2|NOT COMPLETED|Washout of 7 Days||0
190770|NCT00847405|459765|P1|NOT COMPLETED|Washout of 7 Days||1
190771|NCT00847405|459764|P2|COMPLETED|Washout of 7 Days||13
190772|NCT00847405|459765|P1|COMPLETED|Washout of 7 Days||13
190773|NCT00847405|459764|P2|STARTED|Washout of 7 Days||13
190774|NCT00847405|459765|P1|STARTED|Washout of 7 Days||14
190775|NCT00847405|459764|P2|NOT COMPLETED|First Intervention||1
190776|NCT00847405|459765|P1|NOT COMPLETED|First Intervention||0
190777|NCT00847405|459764|P2|COMPLETED|First Intervention||13
190778|NCT00847405|459765|P1|COMPLETED|First Intervention||14
190779|NCT00847405|459764|P2|STARTED|First Intervention||14
190780|NCT00847405|459765|P1|STARTED|First Intervention||14
190781|NCT00847301|459773|P1|NOT COMPLETED|Overall Study||54
190782|NCT00847301|459773|P1|COMPLETED|Overall Study||374
190783|NCT00847301|459773|P1|STARTED|Overall Study||428
190784|NCT00847288|459783|P2|NOT COMPLETED|Overall Study||47
190785|NCT00847288|459784|P1|NOT COMPLETED|Overall Study||30
190786|NCT00847288|459783|P2|COMPLETED|Overall Study||780
190787|NCT00847288|459784|P1|COMPLETED|Overall Study||811
190788|NCT00847288|459783|P2|STARTED|Overall Study||827
190789|NCT00847288|459784|P1|STARTED|Overall Study||841
190790|NCT00847210|459798|P2|NOT COMPLETED|Overall Study||0
190791|NCT00847210|459799|P1|NOT COMPLETED|Overall Study||0
190792|NCT00847210|459798|P2|COMPLETED|Overall Study||18
190793|NCT00847210|459799|P1|COMPLETED|Overall Study||18
190794|NCT00847210|459798|P2|STARTED|Overall Study||18
190795|NCT00847210|459799|P1|STARTED|Overall Study||18
190796|NCT00847197|459821|P2|NOT COMPLETED|Overall Study||5
190797|NCT00847197|459822|P1|NOT COMPLETED|Overall Study||24
190798|NCT00847197|459821|P2|COMPLETED|Overall Study||70
190799|NCT00847197|459822|P1|COMPLETED|Overall Study||92
190800|NCT00847197|459821|P2|STARTED|Overall Study||75
190801|NCT00847197|459822|P1|STARTED|Overall Study||116
190802|NCT00847145|459840|P8|NOT COMPLETED|Overall Study||4
190803|NCT00847145|459841|P7|NOT COMPLETED|Overall Study||9
190804|NCT00847145|459842|P6|NOT COMPLETED|Overall Study||4
190805|NCT00847145|459843|P5|NOT COMPLETED|Overall Study||6
190806|NCT00847145|459844|P4|NOT COMPLETED|Overall Study||1
190807|NCT00847145|459845|P3|NOT COMPLETED|Overall Study||11
190808|NCT00847145|459846|P2|NOT COMPLETED|Overall Study||6
190809|NCT00847145|459847|P1|NOT COMPLETED|Overall Study||6
190810|NCT00847145|459840|P8|COMPLETED|Overall Study||136
190811|NCT00847145|459841|P7|COMPLETED|Overall Study||143
190812|NCT00847145|459842|P6|COMPLETED|Overall Study||152
190813|NCT00847145|459843|P5|COMPLETED|Overall Study||131
190814|NCT00847145|459844|P4|COMPLETED|Overall Study||116
190815|NCT00847145|459845|P3|COMPLETED|Overall Study||274
190816|NCT00847145|459846|P2|COMPLETED|Overall Study||627
190817|NCT00847145|459847|P1|COMPLETED|Overall Study||623
190818|NCT00847145|459840|P8|STARTED|Overall Study||140
190819|NCT00847145|459841|P7|STARTED|Overall Study||152
190820|NCT00847145|459842|P6|STARTED|Overall Study||156
190821|NCT00847145|459843|P5|STARTED|Overall Study||137
190822|NCT00847145|459844|P4|STARTED|Overall Study||117
190823|NCT00847145|459845|P3|STARTED|Overall Study||285
190824|NCT00847145|459846|P2|STARTED|Overall Study||633
190825|NCT00847145|459847|P1|STARTED|Overall Study||629
190826|NCT00847132|459897|P2|NOT COMPLETED|Overall Study||1
190827|NCT00847132|459898|P1|NOT COMPLETED|Overall Study||1
190828|NCT00847132|459897|P2|COMPLETED|Overall Study||84
190829|NCT00847132|459898|P1|COMPLETED|Overall Study||89
190830|NCT00847132|459897|P2|STARTED|Overall Study||85
190831|NCT00847132|459898|P1|STARTED|Overall Study||90
190832|NCT00847015|459906|P1|NOT COMPLETED|Overall Study||3
190833|NCT00847015|459906|P1|COMPLETED|Overall Study||15
190834|NCT00847015|459906|P1|STARTED|Overall Study||18
190835|NCT00847002|459914|P2|NOT COMPLETED|Overall Study||0
190836|NCT00847002|459915|P1|NOT COMPLETED|Overall Study||0
190837|NCT00847002|459914|P2|COMPLETED|Overall Study||4
190838|NCT00847002|459915|P1|COMPLETED|Overall Study||4
190839|NCT00847002|459914|P2|STARTED|Overall Study||4
190840|NCT00847002|459915|P1|STARTED|Overall Study||4
190841|NCT00846885|459925|P2|NOT COMPLETED|Second Intervention||0
190842|NCT00846885|459926|P1|NOT COMPLETED|Second Intervention||0
190843|NCT00846885|459925|P2|COMPLETED|Second Intervention||14
190844|NCT00846885|459926|P1|COMPLETED|Second Intervention||14
190845|NCT00846885|459925|P2|STARTED|Second Intervention||14
190846|NCT00846885|459926|P1|STARTED|Second Intervention||14
190847|NCT00846885|459925|P2|NOT COMPLETED|Washout of 7 Days||0
190848|NCT00846885|459926|P1|NOT COMPLETED|Washout of 7 Days||0
190849|NCT00846885|459925|P2|COMPLETED|Washout of 7 Days||14
190850|NCT00846885|459926|P1|COMPLETED|Washout of 7 Days||14
190851|NCT00846885|459925|P2|STARTED|Washout of 7 Days||14
190852|NCT00846885|459926|P1|STARTED|Washout of 7 Days||14
190853|NCT00846885|459925|P2|NOT COMPLETED|First Intervention||0
190854|NCT00846885|459926|P1|NOT COMPLETED|First Intervention||0
190855|NCT00846885|459925|P2|COMPLETED|First Intervention||14
190856|NCT00846885|459926|P1|COMPLETED|First Intervention||14
190857|NCT00846885|459925|P2|STARTED|First Intervention||14
190858|NCT00846885|459926|P1|STARTED|First Intervention||14
190859|NCT00846846|459934|P1|NOT COMPLETED|Overall Study||75
190860|NCT00846846|459934|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
190861|NCT00846846|459934|P1|STARTED|Overall Study||1018
190862|NCT00846807|459939|P1|NOT COMPLETED|Overall Study||632
190863|NCT00846807|459939|P1|COMPLETED|Overall Study|Completed treatment.|4660
190864|NCT00846807|459939|P1|STARTED|Overall Study|Entered and treated.|5292
190865|NCT00846768|459947|P4|NOT COMPLETED|Overall Study||0
190866|NCT00846768|459948|P3|NOT COMPLETED|Overall Study||0
190867|NCT00846768|459949|P2|NOT COMPLETED|Overall Study||1
190868|NCT00846768|459950|P1|NOT COMPLETED|Overall Study||0
190869|NCT00846768|459947|P4|COMPLETED|Overall Study||12
190870|NCT00846768|459948|P3|COMPLETED|Overall Study||12
190871|NCT00846768|459949|P2|COMPLETED|Overall Study||11
190872|NCT00846768|459950|P1|COMPLETED|Overall Study||11
190873|NCT00846768|459947|P4|STARTED|Overall Study||12
190874|NCT00846768|459948|P3|STARTED|Overall Study||12
190875|NCT00846768|459949|P2|STARTED|Overall Study||12
190876|NCT00846768|459950|P1|STARTED|Overall Study||11
190877|NCT00846651|460022|P2|NOT COMPLETED|Overall Study||4
190878|NCT00846651|460023|P1|NOT COMPLETED|Overall Study||4
190879|NCT00846651|460022|P2|COMPLETED|Overall Study||37
190880|NCT00846651|460023|P1|COMPLETED|Overall Study||37
190881|NCT00846651|460022|P2|STARTED|Overall Study||41
190882|NCT00846651|460023|P1|STARTED|Overall Study||41
190883|NCT00846586|460041|P2|NOT COMPLETED|Overall Study||35
190884|NCT00846586|460042|P1|NOT COMPLETED|Overall Study||39
190885|NCT00846586|460041|P2|COMPLETED|Overall Study||529
190886|NCT00846586|460042|P1|COMPLETED|Overall Study||531
190887|NCT00846586|460041|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
190888|NCT00846586|460042|P1|Received Study Drug|Overall Study||570
190889|NCT00846586|460041|P2|STARTED|Overall Study||564
190890|NCT00846586|460042|P1|STARTED|Overall Study||570
190891|NCT00846573|460061|P4|NOT COMPLETED|Overall Study||0
190892|NCT00846573|460062|P3|NOT COMPLETED|Overall Study||0
190893|NCT00846573|460063|P2|NOT COMPLETED|Overall Study||0
190894|NCT00846573|460064|P1|NOT COMPLETED|Overall Study||0
190895|NCT00846573|460061|P4|COMPLETED|Overall Study||0
190896|NCT00846573|460062|P3|COMPLETED|Overall Study||7
190897|NCT00846573|460063|P2|COMPLETED|Overall Study||2
190898|NCT00846573|460064|P1|COMPLETED|Overall Study||5
190899|NCT00846573|460061|P4|STARTED|Overall Study||0
190900|NCT00846573|460062|P3|STARTED|Overall Study||7
190901|NCT00846573|460063|P2|STARTED|Overall Study||2
190902|NCT00846573|460064|P1|STARTED|Overall Study||5
190903|NCT00846547|460072|P1|NOT COMPLETED|Overall Study||7
190904|NCT00846547|460072|P1|COMPLETED|Overall Study||25
190905|NCT00846547|460072|P1|STARTED|Overall Study||32
190906|NCT00846521|460076|P1|NOT COMPLETED|Overall Study||11
190907|NCT00846521|460076|P1|COMPLETED|Overall Study||12
190908|NCT00846521|460076|P1|STARTED|Overall Study||23
190909|NCT00846495|460083|P2|NOT COMPLETED|Overall Study||3
190910|NCT00846495|460084|P1|NOT COMPLETED|Overall Study||8
190911|NCT00846495|460083|P2|COMPLETED|Overall Study||24
190912|NCT00846495|460084|P1|COMPLETED|Overall Study||20
190913|NCT00846495|460083|P2|STARTED|Overall Study||27
190914|NCT00846495|460084|P1|STARTED|Overall Study||28
190915|NCT00846391|460107|P3|NOT COMPLETED|Overall Study||3
190916|NCT00846391|460108|P2|NOT COMPLETED|Overall Study||2
190917|NCT00846391|460109|P1|NOT COMPLETED|Overall Study||1
190918|NCT00846391|460107|P3|COMPLETED|Overall Study||3
190919|NCT00846391|460108|P2|COMPLETED|Overall Study||2
190920|NCT00846391|460109|P1|COMPLETED|Overall Study||3
190921|NCT00846391|460107|P3|STARTED|Overall Study||6
190922|NCT00846391|460108|P2|STARTED|Overall Study||4
190923|NCT00846391|460109|P1|STARTED|Overall Study||4
190924|NCT00846365|460120|P3|NOT COMPLETED|Overall Study||33
190925|NCT00846365|460121|P2|NOT COMPLETED|Overall Study||49
190926|NCT00846365|460122|P1|NOT COMPLETED|Overall Study||55
190927|NCT00846365|460120|P3|COMPLETED|Overall Study||323
190928|NCT00846365|460121|P2|COMPLETED|Overall Study||308
190929|NCT00846365|460122|P1|COMPLETED|Overall Study||317
190930|NCT00846365|460120|P3|STARTED|Overall Study||356
190931|NCT00846365|460121|P2|STARTED|Overall Study||357
190932|NCT00846365|460122|P1|STARTED|Overall Study||372
190933|NCT00846287|460177|P2|NOT COMPLETED|Overall Study||5
190934|NCT00846287|460178|P1|NOT COMPLETED|Overall Study||10
190935|NCT00846287|460177|P2|COMPLETED|Overall Study||10
190936|NCT00846287|460178|P1|COMPLETED|Overall Study||6
190937|NCT00846287|460177|P2|STARTED|Overall Study||15
190938|NCT00846287|460178|P1|STARTED|Overall Study||16
190939|NCT00846066|460188|P2|NOT COMPLETED|Overall Study||0
190940|NCT00846066|460189|P1|NOT COMPLETED|Overall Study||0
190941|NCT00846066|460188|P2|COMPLETED|Overall Study||29
190942|NCT00846066|460189|P1|COMPLETED|Overall Study||27
190943|NCT00846066|460188|P2|STARTED|Overall Study||29
190944|NCT00846066|460189|P1|STARTED|Overall Study||27
190945|NCT00846027|460201|P1|NOT COMPLETED|Overall Study||90
190946|NCT00846027|460201|P1|COMPLETED|Overall Study||0
190947|NCT00846027|460201|P1|Received Treatment|Overall Study||83
190948|NCT00846027|460201|P1|STARTED|Overall Study||90
190949|NCT00845975|460210|P2|NOT COMPLETED|Overall Study||0
190950|NCT00845975|460211|P1|NOT COMPLETED|Overall Study||0
190951|NCT00845975|460210|P2|COMPLETED|Overall Study||9
190952|NCT00845975|460211|P1|COMPLETED|Overall Study||9
190953|NCT00845975|460210|P2|STARTED|Overall Study||9
190954|NCT00845975|460211|P1|STARTED|Overall Study||9
190955|NCT00845897|460224|P3|NOT COMPLETED|Overall Study||3
190956|NCT00845897|460225|P2|NOT COMPLETED|Overall Study||5
190957|NCT00845897|460226|P1|NOT COMPLETED|Overall Study||2
190958|NCT00845897|460224|P3|COMPLETED|Overall Study||2
190959|NCT00845897|460225|P2|COMPLETED|Overall Study||2
190960|NCT00845897|460226|P1|COMPLETED|Overall Study||3
190961|NCT00845897|460224|P3|STARTED|Overall Study||5
190962|NCT00845897|460225|P2|STARTED|Overall Study||7
190963|NCT00845897|460226|P1|STARTED|Overall Study||5
190964|NCT00845858|460240|P3|NOT COMPLETED|Overall Study||8
190965|NCT00845858|460241|P2|NOT COMPLETED|Overall Study||12
190966|NCT00845858|460242|P1|NOT COMPLETED|Overall Study||8
190967|NCT00845858|460240|P3|COMPLETED|Overall Study||87
190968|NCT00845858|460241|P2|COMPLETED|Overall Study||84
190969|NCT00845858|460242|P1|COMPLETED|Overall Study||88
190970|NCT00845858|460240|P3|STARTED|Overall Study||95
190971|NCT00845858|460241|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
190972|NCT00845858|460242|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
190973|NCT00845845|460255|P2|NOT COMPLETED|Overall Study||4
190974|NCT00845845|460256|P1|NOT COMPLETED|Overall Study||0
190975|NCT00845845|460255|P2|COMPLETED|Overall Study||2
190976|NCT00845845|460256|P1|COMPLETED|Overall Study||3
190977|NCT00845845|460255|P2|STARTED|Overall Study||6
190978|NCT00845845|460256|P1|STARTED|Overall Study||3
190979|NCT00845832|460267|P3|NOT COMPLETED|Extended Safety Follow-Up||7
190980|NCT00845832|460268|P2|NOT COMPLETED|Extended Safety Follow-Up||0
190981|NCT00845832|460269|P1|NOT COMPLETED|Extended Safety Follow-Up||0
190982|NCT00845832|460267|P3|COMPLETED|Extended Safety Follow-Up||0
190983|NCT00845832|460268|P2|COMPLETED|Extended Safety Follow-Up||5
190984|NCT00845832|460269|P1|COMPLETED|Extended Safety Follow-Up||2
190985|NCT00845832|460267|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
190986|NCT00845832|460268|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
190987|NCT00845832|460269|P1|STARTED|Extended Safety Follow-Up||2
190988|NCT00845832|460267|P3|NOT COMPLETED|Safety Follow-Up||0
190989|NCT00845832|460268|P2|NOT COMPLETED|Safety Follow-Up||0
190990|NCT00845832|460269|P1|NOT COMPLETED|Safety Follow-Up||1
190991|NCT00845832|460267|P3|COMPLETED|Safety Follow-Up||12
190992|NCT00845832|460268|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
190993|NCT00845832|460269|P1|COMPLETED|Safety Follow-Up||2
190994|NCT00845832|460267|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
190995|NCT00845832|460268|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
190996|NCT00845832|460269|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
190997|NCT00845832|460267|P3|NOT COMPLETED|Treatment Period||0
190998|NCT00845832|460268|P2|NOT COMPLETED|Treatment Period||3
190999|NCT00845832|460269|P1|NOT COMPLETED|Treatment Period||1
191000|NCT00845832|460267|P3|COMPLETED|Treatment Period||10
191001|NCT00845832|460268|P2|COMPLETED|Treatment Period||7
191002|NCT00845832|460269|P1|COMPLETED|Treatment Period||3
191003|NCT00845832|460267|P3|STARTED|Treatment Period||10
191004|NCT00845832|460268|P2|STARTED|Treatment Period||10
191005|NCT00845832|460269|P1|STARTED|Treatment Period||4
191006|NCT00845728|460315|P2|NOT COMPLETED|Overall Study||342
191007|NCT00845728|460316|P1|NOT COMPLETED|Overall Study||386
191008|NCT00845728|460315|P2|COMPLETED|Overall Study||1379
191009|NCT00845728|460316|P1|COMPLETED|Overall Study||1337
191010|NCT00845728|460315|P2|Exposed|Overall Study||1718
191011|NCT00845728|460316|P1|Exposed|Overall Study||1721
191012|NCT00845728|460315|P2|STARTED|Overall Study||1721
191013|NCT00845728|460316|P1|STARTED|Overall Study||1723
191014|NCT00845702|460324|P1|NOT COMPLETED|Dotarem MRA||0
191015|NCT00845702|460324|P1|COMPLETED|Dotarem MRA||32
191016|NCT00845702|460324|P1|STARTED|Dotarem MRA||32
191017|NCT00845702|460324|P1|NOT COMPLETED|TOF MRA||1
191018|NCT00845702|460324|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
191019|NCT00845702|460324|P1|STARTED|TOF MRA||33
191020|NCT00845676|460330|P1|NOT COMPLETED|Overall Study||2
191021|NCT00845676|460330|P1|COMPLETED|Overall Study||19
191022|NCT00845676|460330|P1|STARTED|Overall Study||21
191023|NCT00845663|460336|P2|NOT COMPLETED|Overall Study||0
191024|NCT00845663|460337|P1|NOT COMPLETED|Overall Study||0
191025|NCT00845663|460336|P2|COMPLETED|Overall Study||49
191026|NCT00845663|460337|P1|COMPLETED|Overall Study||49
191027|NCT00845663|460336|P2|STARTED|Overall Study||49
191028|NCT00845663|460337|P1|STARTED|Overall Study||49
191029|NCT00845507|460387|P2|NOT COMPLETED|Overall Study||1
191030|NCT00845507|460388|P1|NOT COMPLETED|Overall Study||2
191031|NCT00845507|460387|P2|COMPLETED|Overall Study||29
191032|NCT00845507|460388|P1|COMPLETED|Overall Study||22
191033|NCT00845507|460387|P2|STARTED|Overall Study||30
191034|NCT00845507|460388|P1|STARTED|Overall Study||24
191035|NCT00845481|460396|P1|NOT COMPLETED|Overall Study||0
191036|NCT00845481|460396|P1|COMPLETED|Overall Study||24
191037|NCT00845481|460396|P1|STARTED|Overall Study||24
191038|NCT00845429|460408|P3|NOT COMPLETED|Overall Study||20
191039|NCT00845429|460409|P2|NOT COMPLETED|Overall Study||15
191040|NCT00845429|460410|P1|NOT COMPLETED|Overall Study||14
191041|NCT00845429|460408|P3|COMPLETED|Overall Study||224
191042|NCT00845429|460409|P2|COMPLETED|Overall Study||226
191043|NCT00845429|460410|P1|COMPLETED|Overall Study||230
191044|NCT00845429|460408|P3|STARTED|Overall Study||244
191045|NCT00845429|460409|P2|STARTED|Overall Study||241
191046|NCT00845429|460410|P1|STARTED|Overall Study||244
191047|NCT00845195|460429|P2|NOT COMPLETED|Overall Study||0
191048|NCT00845195|460430|P1|NOT COMPLETED|Overall Study||0
191049|NCT00845195|460429|P2|COMPLETED|Overall Study||75
191050|NCT00845195|460430|P1|COMPLETED|Overall Study||75
191051|NCT00845195|460429|P2|STARTED|Overall Study||75
191052|NCT00845195|460430|P1|STARTED|Overall Study||75
191053|NCT00845182|460445|P3|NOT COMPLETED|Overall Study||6
191054|NCT00845182|460446|P2|NOT COMPLETED|Overall Study||4
191055|NCT00845182|460447|P1|NOT COMPLETED|Overall Study||3
191056|NCT00845182|460445|P3|COMPLETED|Overall Study||9
191057|NCT00845182|460446|P2|COMPLETED|Overall Study||11
191058|NCT00845182|460447|P1|COMPLETED|Overall Study||10
191059|NCT00845182|460445|P3|STARTED|Overall Study||15
191060|NCT00845182|460446|P2|STARTED|Overall Study||15
191061|NCT00845182|460447|P1|STARTED|Overall Study||13
191062|NCT00845130|460461|P2|NOT COMPLETED|Overall Study||3
191063|NCT00845130|460462|P1|NOT COMPLETED|Overall Study||4
191064|NCT00845130|460461|P2|COMPLETED|Overall Study||19
191065|NCT00845130|460462|P1|COMPLETED|Overall Study||16
191066|NCT00845130|460461|P2|STARTED|Overall Study||22
191067|NCT00845130|460462|P1|STARTED|Overall Study||20
191068|NCT00845065|460472|P2|NOT COMPLETED|Overall Study||55
191069|NCT00845065|460473|P1|NOT COMPLETED|Overall Study||47
191070|NCT00845065|460472|P2|COMPLETED|Overall Study||79
191071|NCT00845065|460473|P1|COMPLETED|Overall Study||20
191072|NCT00845065|460472|P2|STARTED|Overall Study||134
191073|NCT00845065|460473|P1|STARTED|Overall Study||67
191074|NCT00845000|460493|P6|NOT COMPLETED|Period 3||0
191075|NCT00845000|460494|P5|NOT COMPLETED|Period 3||0
191076|NCT00845000|460495|P4|NOT COMPLETED|Period 3||0
191077|NCT00845000|460496|P3|NOT COMPLETED|Period 3||0
191078|NCT00845000|460497|P2|NOT COMPLETED|Period 3||0
191079|NCT00845000|460498|P1|NOT COMPLETED|Period 3||0
191080|NCT00845000|460493|P6|COMPLETED|Period 3||2
191081|NCT00845000|460494|P5|COMPLETED|Period 3||2
191082|NCT00845000|460495|P4|COMPLETED|Period 3||2
191083|NCT00845000|460496|P3|COMPLETED|Period 3||2
191084|NCT00845000|460497|P2|COMPLETED|Period 3||2
191085|NCT00845000|460498|P1|COMPLETED|Period 3||2
191086|NCT00845000|460493|P6|STARTED|Period 3||2
191087|NCT00845000|460494|P5|STARTED|Period 3||2
191088|NCT00845000|460495|P4|STARTED|Period 3||2
191089|NCT00845000|460496|P3|STARTED|Period 3||2
191090|NCT00845000|460497|P2|STARTED|Period 3||2
191091|NCT00845000|460498|P1|STARTED|Period 3||2
191092|NCT00845000|460493|P6|NOT COMPLETED|Period 2||0
191093|NCT00845000|460494|P5|NOT COMPLETED|Period 2||0
191094|NCT00845000|460495|P4|NOT COMPLETED|Period 2||0
191095|NCT00845000|460496|P3|NOT COMPLETED|Period 2||0
191096|NCT00845000|460497|P2|NOT COMPLETED|Period 2||0
191097|NCT00845000|460498|P1|NOT COMPLETED|Period 2||0
191098|NCT00845000|460493|P6|COMPLETED|Period 2||2
191099|NCT00845000|460494|P5|COMPLETED|Period 2||2
191100|NCT00845000|460495|P4|COMPLETED|Period 2||2
191101|NCT00845000|460496|P3|COMPLETED|Period 2||2
191102|NCT00845000|460497|P2|COMPLETED|Period 2||2
191103|NCT00845000|460498|P1|COMPLETED|Period 2||2
191104|NCT00845000|460493|P6|STARTED|Period 2||2
191105|NCT00845000|460494|P5|STARTED|Period 2||2
191106|NCT00845000|460495|P4|STARTED|Period 2||2
191107|NCT00845000|460496|P3|STARTED|Period 2||2
191108|NCT00845000|460497|P2|STARTED|Period 2||2
191109|NCT00845000|460498|P1|STARTED|Period 2||2
191110|NCT00845000|460493|P6|NOT COMPLETED|Period 1||0
191111|NCT00845000|460494|P5|NOT COMPLETED|Period 1||0
191112|NCT00845000|460495|P4|NOT COMPLETED|Period 1||0
191113|NCT00845000|460496|P3|NOT COMPLETED|Period 1||0
191114|NCT00845000|460497|P2|NOT COMPLETED|Period 1||0
191115|NCT00845000|460498|P1|NOT COMPLETED|Period 1||0
191116|NCT00845000|460493|P6|COMPLETED|Period 1||2
191117|NCT00845000|460494|P5|COMPLETED|Period 1||2
191118|NCT00845000|460495|P4|COMPLETED|Period 1||2
191119|NCT00845000|460496|P3|COMPLETED|Period 1||2
191120|NCT00845000|460497|P2|COMPLETED|Period 1||2
191121|NCT00845000|460498|P1|COMPLETED|Period 1||2
191122|NCT00845000|460493|P6|STARTED|Period 1||2
191123|NCT00845000|460494|P5|STARTED|Period 1||2
191124|NCT00845000|460495|P4|STARTED|Period 1||2
191125|NCT00845000|460496|P3|STARTED|Period 1||2
191126|NCT00845000|460497|P2|STARTED|Period 1||2
191127|NCT00845000|460498|P1|STARTED|Period 1||2
191128|NCT00844896|460517|P2|NOT COMPLETED|Overall Study||17
191129|NCT00844896|460518|P1|NOT COMPLETED|Overall Study||12
191130|NCT00844896|460517|P2|COMPLETED|Overall Study||11
191131|NCT00844896|460518|P1|COMPLETED|Overall Study||17
191132|NCT00844896|460517|P2|STARTED|Overall Study||28
191133|NCT00844896|460518|P1|STARTED|Overall Study||29
191134|NCT00844883|460540|P1|NOT COMPLETED|Overall Study||4
191135|NCT00844883|460540|P1|COMPLETED|Overall Study||46
191136|NCT00844883|460540|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
191137|NCT00844883|460540|P1|STARTED|Overall Study||50
191138|NCT00844857|460552|P2|NOT COMPLETED|Overall Study||37
191139|NCT00844857|460553|P1|NOT COMPLETED|Overall Study||78
191140|NCT00844857|460552|P2|COMPLETED|Overall Study||60
191141|NCT00844857|460553|P1|COMPLETED|Overall Study||116
191142|NCT00844857|460552|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
191143|NCT00844857|460553|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
191144|NCT00844857|460552|P2|STARTED|Overall Study||97
191145|NCT00844857|460553|P1|STARTED|Overall Study||194
191146|NCT00844844|460597|P1|NOT COMPLETED|Post Treatment Period||1
191147|NCT00844844|460597|P1|COMPLETED|Post Treatment Period||5
191148|NCT00844844|460597|P1|STARTED|Post Treatment Period||6
191149|NCT00844844|460597|P1|NOT COMPLETED|Extension Treatment Period||2
191150|NCT00844844|460597|P1|COMPLETED|Extension Treatment Period||11
191151|NCT00844844|460597|P1|STARTED|Extension Treatment Period||13
191152|NCT00844844|460597|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
191153|NCT00844844|460597|P1|COMPLETED|Treatment Period (26 Weeks)||15
191154|NCT00844844|460597|P1|STARTED|Treatment Period (26 Weeks)||17
191155|NCT00844844|460597|P1|NOT COMPLETED|Screening Period||0
191156|NCT00844844|460597|P1|COMPLETED|Screening Period||17
191157|NCT00844844|460597|P1|STARTED|Screening Period||17
191158|NCT00844831|460611|P1|NOT COMPLETED|Overall Study||6
191159|NCT00844831|460611|P1|COMPLETED|Overall Study||19
191160|NCT00844831|460611|P1|STARTED|Overall Study||25
191161|NCT00844805|460621|P4|NOT COMPLETED|Follow-Up Phase||9
191162|NCT00844805|460622|P3|NOT COMPLETED|Follow-Up Phase||9
191163|NCT00844805|460623|P2|NOT COMPLETED|Follow-Up Phase||0
191164|NCT00844805|460624|P1|NOT COMPLETED|Follow-Up Phase||0
191165|NCT00844805|460621|P4|COMPLETED|Follow-Up Phase||32
191166|NCT00844805|460622|P3|COMPLETED|Follow-Up Phase||32
191167|NCT00844805|460623|P2|COMPLETED|Follow-Up Phase||0
191168|NCT00844805|460624|P1|COMPLETED|Follow-Up Phase||0
191169|NCT00844805|460621|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
191170|NCT00844805|460622|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
191171|NCT00844805|460623|P2|STARTED|Follow-Up Phase||0
191172|NCT00844805|460624|P1|STARTED|Follow-Up Phase||0
191173|NCT00844805|460621|P4|NOT COMPLETED|Treatment Phase||0
191174|NCT00844805|460622|P3|NOT COMPLETED|Treatment Phase||0
191175|NCT00844805|460623|P2|NOT COMPLETED|Treatment Phase||7
191176|NCT00844805|460624|P1|NOT COMPLETED|Treatment Phase||10
191177|NCT00844805|460621|P4|COMPLETED|Treatment Phase||0
191178|NCT00844805|460622|P3|COMPLETED|Treatment Phase||0
191179|NCT00844805|460623|P2|COMPLETED|Treatment Phase||45
191180|NCT00844805|460624|P1|COMPLETED|Treatment Phase||96
191181|NCT00844805|460621|P4|STARTED|Treatment Phase||0
191182|NCT00844805|460622|P3|STARTED|Treatment Phase||0
191183|NCT00844805|460623|P2|STARTED|Treatment Phase||52
191184|NCT00844805|460624|P1|STARTED|Treatment Phase||106
191185|NCT00844753|460668|P4|NOT COMPLETED|Overall Study||11
191186|NCT00844753|460669|P3|NOT COMPLETED|Overall Study||7
191187|NCT00844753|460670|P2|NOT COMPLETED|Overall Study||3
191188|NCT00844753|460671|P1|NOT COMPLETED|Overall Study||8
191189|NCT00844753|460668|P4|COMPLETED|Overall Study||21
191190|NCT00844753|460669|P3|COMPLETED|Overall Study||25
191191|NCT00844753|460670|P2|COMPLETED|Overall Study||29
191192|NCT00844753|460671|P1|COMPLETED|Overall Study||24
191193|NCT00844753|460668|P4|STARTED|Overall Study||32
191194|NCT00844753|460669|P3|STARTED|Overall Study||32
191195|NCT00844753|460670|P2|STARTED|Overall Study||32
191196|NCT00844753|460671|P1|STARTED|Overall Study||32
191197|NCT00844714|460683|P1|NOT COMPLETED|Overall Study||0
191198|NCT00844714|460683|P1|COMPLETED|Overall Study||20
191199|NCT00844714|460683|P1|STARTED|Overall Study||20
191200|NCT00844649|460689|P2|NOT COMPLETED|Overall Study||418
191201|NCT00844649|460690|P1|NOT COMPLETED|Overall Study||405
191202|NCT00844649|460689|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
191203|NCT00844649|460690|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
191204|NCT00844649|460689|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
191205|NCT00844649|460690|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
191206|NCT00844649|460689|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
191207|NCT00844649|460690|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
191208|NCT00844597|460714|P6|NOT COMPLETED|Overall Study||0
191209|NCT00844597|460715|P5|NOT COMPLETED|Overall Study||0
191210|NCT00844597|460716|P4|NOT COMPLETED|Overall Study||1
191211|NCT00844597|460717|P3|NOT COMPLETED|Overall Study||0
191212|NCT00844597|460718|P2|NOT COMPLETED|Overall Study||0
191213|NCT00844597|460719|P1|NOT COMPLETED|Overall Study||0
191214|NCT00844597|460714|P6|COMPLETED|Overall Study||4
191215|NCT00844597|460715|P5|COMPLETED|Overall Study||4
191216|NCT00844597|460716|P4|COMPLETED|Overall Study||2
191217|NCT00844597|460717|P3|COMPLETED|Overall Study||2
191218|NCT00844597|460718|P2|COMPLETED|Overall Study||2
191219|NCT00844597|460719|P1|COMPLETED|Overall Study||4
191220|NCT00844597|460714|P6|STARTED|Overall Study||4
191221|NCT00844597|460715|P5|STARTED|Overall Study||4
191222|NCT00844597|460716|P4|STARTED|Overall Study||3
191223|NCT00844597|460717|P3|STARTED|Overall Study||2
191224|NCT00844597|460718|P2|STARTED|Overall Study||2
191225|NCT00844597|460719|P1|STARTED|Overall Study||4
191226|NCT00844558|460739|P2|NOT COMPLETED|Overall Study||4
191227|NCT00844558|460740|P1|NOT COMPLETED|Overall Study||12
191228|NCT00844558|460739|P2|COMPLETED|Overall Study||18
191229|NCT00844558|460740|P1|COMPLETED|Overall Study||24
191230|NCT00844558|460739|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
191231|NCT00844558|460740|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
191232|NCT00844558|460739|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
191233|NCT00844558|460740|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
191234|NCT00844558|460739|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
191235|NCT00844558|460740|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
191236|NCT00844558|460739|P2|Received Allocated Intervention|Overall Study||21
191237|NCT00844558|460740|P1|Received Allocated Intervention|Overall Study||33
191238|NCT00844558|460739|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
191239|NCT00844558|460740|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
191240|NCT00844545|460756|P1|NOT COMPLETED|Post Treatment Period||1
191241|NCT00844545|460756|P1|COMPLETED|Post Treatment Period||5
191242|NCT00844545|460756|P1|STARTED|Post Treatment Period||6
191243|NCT00844545|460756|P1|NOT COMPLETED|Extension Treatment Period||2
191244|NCT00844545|460756|P1|COMPLETED|Extension Treatment Period||11
191245|NCT00844545|460756|P1|STARTED|Extension Treatment Period||13
191246|NCT00844545|460756|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
191247|NCT00844545|460756|P1|COMPLETED|Treatment Period (26 Weeks)||15
191248|NCT00844545|460756|P1|STARTED|Treatment Period (26 Weeks)||17
191249|NCT00844545|460756|P1|NOT COMPLETED|Screening Period||0
191250|NCT00844545|460756|P1|COMPLETED|Screening Period||17
191251|NCT00844545|460756|P1|STARTED|Screening Period||17
191252|NCT00844532|460770|P1|NOT COMPLETED|Overall Study||39
191253|NCT00844532|460770|P1|COMPLETED|Overall Study||112
191254|NCT00844532|460770|P1|STARTED|Overall Study||151
191255|NCT00844519|460856|P2|NOT COMPLETED|Overall Study||1
191256|NCT00844519|460857|P1|NOT COMPLETED|Overall Study||2
191257|NCT00844519|460856|P2|COMPLETED|Overall Study||25
191258|NCT00844519|460857|P1|COMPLETED|Overall Study||24
191259|NCT00844519|460856|P2|STARTED|Overall Study||26
191260|NCT00844519|460857|P1|STARTED|Overall Study||26
191261|NCT00844480|460865|P2|NOT COMPLETED|Overall Study||3
191262|NCT00844480|460866|P1|NOT COMPLETED|Overall Study||2
191263|NCT00844480|460865|P2|COMPLETED|Overall Study||6
191264|NCT00844480|460866|P1|COMPLETED|Overall Study||6
191265|NCT00844480|460865|P2|STARTED|Overall Study||9
191266|NCT00844480|460866|P1|STARTED|Overall Study||8
191267|NCT00844428|460874|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
191268|NCT00844428|460874|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
191269|NCT00844428|460874|P1|STARTED|Post Treatment Period (Patients Who Disc||5
191270|NCT00844428|460874|P1|NOT COMPLETED|Extension Treatment Period||1
191271|NCT00844428|460874|P1|COMPLETED|Extension Treatment Period||18
191272|NCT00844428|460874|P1|STARTED|Extension Treatment Period||19
191273|NCT00844428|460874|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
191274|NCT00844428|460874|P1|COMPLETED|Treatment Period (26 Weeks)||20
191275|NCT00844428|460874|P1|STARTED|Treatment Period (26 Weeks)||20
191276|NCT00844428|460874|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
191277|NCT00844428|460874|P1|COMPLETED|Observation Period (8 Weeks)||20
191278|NCT00844428|460874|P1|STARTED|Observation Period (8 Weeks)||20
191279|NCT00844428|460874|P1|NOT COMPLETED|Screening Period||3
191280|NCT00844428|460874|P1|COMPLETED|Screening Period||20
191281|NCT00844428|460874|P1|STARTED|Screening Period||23
191282|NCT00844415|460890|P1|NOT COMPLETED|Overall Study||1
191283|NCT00844415|460890|P1|COMPLETED|Overall Study|Completed.|8
191284|NCT00844415|460890|P1|Pat. Received Single Dose 75mg|Overall Study||1
191285|NCT00844415|460890|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
191286|NCT00844415|460890|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
191287|NCT00844415|460890|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
191288|NCT00844415|460890|P1|STARTED|Overall Study|Entered and treated.|9
191289|NCT00844376|460904|P2|NOT COMPLETED|Period 2: Second Intervention||0
191290|NCT00844376|460905|P1|NOT COMPLETED|Period 2: Second Intervention||0
191291|NCT00844376|460904|P2|COMPLETED|Period 2: Second Intervention||6
191292|NCT00844376|460905|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
191293|NCT00844376|460904|P2|STARTED|Period 2: Second Intervention||6
191294|NCT00844376|460905|P1|STARTED|Period 2: Second Intervention||5
191295|NCT00844376|460904|P2|NOT COMPLETED|Period 1: First Intervention||0
191296|NCT00844376|460905|P1|NOT COMPLETED|Period 1: First Intervention||1
191297|NCT00844376|460904|P2|COMPLETED|Period 1: First Intervention||6
191298|NCT00844376|460905|P1|COMPLETED|Period 1: First Intervention||5
191299|NCT00844376|460904|P2|STARTED|Period 1: First Intervention||6
191300|NCT00844376|460905|P1|STARTED|Period 1: First Intervention||6
191301|NCT00844298|460923|P1|NOT COMPLETED|Overall Study||0
191302|NCT00844298|460923|P1|COMPLETED|Overall Study||91
191303|NCT00844298|460923|P1|STARTED|Overall Study||91
191304|NCT00844194|460929|P2|NOT COMPLETED|Overall Study||8
191305|NCT00844194|460930|P1|NOT COMPLETED|Overall Study||25
191306|NCT00844194|460929|P2|COMPLETED|Overall Study||22
191307|NCT00844194|460930|P1|COMPLETED|Overall Study||53
191308|NCT00844194|460929|P2|STARTED|Overall Study||30
191309|NCT00844194|460930|P1|STARTED|Overall Study||78
191310|NCT00844090|461136|P2|NOT COMPLETED|Overall Study||8
191311|NCT00844090|461137|P1|NOT COMPLETED|Overall Study||6
191312|NCT00844090|461136|P2|COMPLETED|Overall Study||46
191313|NCT00844090|461137|P1|COMPLETED|Overall Study||46
191314|NCT00844090|461136|P2|STARTED|Overall Study||54
191315|NCT00844090|461137|P1|STARTED|Overall Study||52
191316|NCT00844051|461145|P2|NOT COMPLETED|Overall Study||0
191317|NCT00844051|461146|P1|NOT COMPLETED|Overall Study||0
191318|NCT00844051|461145|P2|COMPLETED|Overall Study||2368
191319|NCT00844051|461146|P1|COMPLETED|Overall Study||2087
191320|NCT00844051|461145|P2|STARTED|Overall Study||2368
191321|NCT00844051|461146|P1|STARTED|Overall Study||2087
191322|NCT00843986|461156|P2|NOT COMPLETED|Overall Study||1
191323|NCT00843986|461157|P1|NOT COMPLETED|Overall Study||1
191324|NCT00843986|461156|P2|COMPLETED|Overall Study||5
191325|NCT00843986|461157|P1|COMPLETED|Overall Study||2
191326|NCT00843986|461156|P2|Completed Treatment (Infusion)|Overall Study||6
191327|NCT00843986|461157|P1|Completed Treatment (Infusion)|Overall Study||2
191328|NCT00843986|461156|P2|STARTED|Overall Study||6
191329|NCT00843986|461157|P1|STARTED|Overall Study||3
191330|NCT00843843|461185|P2|NOT COMPLETED|Overall Study||2
191331|NCT00843843|461186|P1|NOT COMPLETED|Overall Study||2
191332|NCT00843843|461185|P2|COMPLETED|Overall Study||6
191333|NCT00843843|461186|P1|COMPLETED|Overall Study||6
191334|NCT00843843|461185|P2|STARTED|Overall Study||8
191335|NCT00843843|461186|P1|STARTED|Overall Study||8
191336|NCT00843830|461194|P1|NOT COMPLETED|Overall Study||0
191337|NCT00843830|461194|P1|COMPLETED|Overall Study||4
191338|NCT00843830|461194|P1|STARTED|Overall Study||4
191339|NCT00843778|461199|P1|NOT COMPLETED|Overall Study||35
191340|NCT00843778|461199|P1|COMPLETED|Overall Study||96
191341|NCT00843778|461199|P1|STARTED|Overall Study||131
191342|NCT00843713|461234|P2|NOT COMPLETED|Overall Study||0
191343|NCT00843713|461235|P1|NOT COMPLETED|Overall Study||0
191344|NCT00843713|461234|P2|COMPLETED|Overall Study||26
191345|NCT00843713|461235|P1|COMPLETED|Overall Study||30
191346|NCT00843713|461234|P2|STARTED|Overall Study||26
191347|NCT00843713|461235|P1|STARTED|Overall Study||30
191348|NCT00843635|461244|P3|NOT COMPLETED|Overall Study||0
191349|NCT00843635|461245|P2|NOT COMPLETED|Overall Study||2
191350|NCT00843635|461246|P1|NOT COMPLETED|Overall Study||2
191351|NCT00843635|461244|P3|COMPLETED|Overall Study||5
191352|NCT00843635|461245|P2|COMPLETED|Overall Study||13
191353|NCT00843635|461246|P1|COMPLETED|Overall Study||13
191354|NCT00843635|461244|P3|STARTED|Overall Study||5
191355|NCT00843635|461245|P2|STARTED|Overall Study||15
191356|NCT00843635|461246|P1|STARTED|Overall Study||15
191357|NCT00843622|461266|P2|NOT COMPLETED|Overall Study||55
191358|NCT00843622|461267|P1|NOT COMPLETED|Overall Study||43
191359|NCT00843622|461266|P2|COMPLETED|Overall Study||70
191360|NCT00843622|461267|P1|COMPLETED|Overall Study||82
191361|NCT00843622|461266|P2|STARTED|Overall Study||125
191362|NCT00843622|461267|P1|STARTED|Overall Study||125
191363|NCT00843518|461275|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
191364|NCT00843518|461276|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
191365|NCT00843518|461275|P2|COMPLETED|Period 3 (Single-blind Washout)||49
191366|NCT00843518|461276|P1|COMPLETED|Period 3 (Single-blind Washout)||42
191367|NCT00843518|461275|P2|STARTED|Period 3 (Single-blind Washout)||49
191368|NCT00843518|461276|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
191369|NCT00843518|461275|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
191370|NCT00843518|461276|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
191371|NCT00843518|461275|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
191372|NCT00843518|461276|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
191373|NCT00843518|461275|P2|STARTED|Period 2 (Double-blind Treatment)||69
191374|NCT00843518|461276|P1|STARTED|Period 2 (Double-blind Treatment)||63
191375|NCT00843492|461306|P2|NOT COMPLETED|Overall Study||14
191376|NCT00843492|461307|P1|NOT COMPLETED|Overall Study||8
191377|NCT00843492|461306|P2|COMPLETED|Overall Study||607
191378|NCT00843492|461307|P1|COMPLETED|Overall Study||614
191379|NCT00843492|461306|P2|STARTED|Overall Study||621
191380|NCT00843492|461307|P1|STARTED|Overall Study||622
191381|NCT00843479|461327|P2|NOT COMPLETED|Overall Study||0
191382|NCT00843479|461328|P1|NOT COMPLETED|Overall Study||0
191383|NCT00843479|461327|P2|COMPLETED|Overall Study||12
191384|NCT00843479|461328|P1|COMPLETED|Overall Study||12
191385|NCT00843479|461327|P2|STARTED|Overall Study||12
191386|NCT00843479|461328|P1|STARTED|Overall Study||12
191387|NCT00843466|461346|P2|NOT COMPLETED|Overall Study||0
191388|NCT00843466|461347|P1|NOT COMPLETED|Overall Study||0
191389|NCT00843466|461346|P2|COMPLETED|Overall Study||18
191390|NCT00843466|461347|P1|COMPLETED|Overall Study||24
191391|NCT00843466|461346|P2|STARTED|Overall Study||18
191392|NCT00843466|461347|P1|STARTED|Overall Study||24
191393|NCT00843349|461357|P4|NOT COMPLETED|Overall Study||1
191394|NCT00843349|461358|P3|NOT COMPLETED|Overall Study||0
191395|NCT00843349|461359|P2|NOT COMPLETED|Overall Study||0
191396|NCT00843349|461360|P1|NOT COMPLETED|Overall Study||3
191397|NCT00843349|461357|P4|COMPLETED|Overall Study||10
191398|NCT00843349|461358|P3|COMPLETED|Overall Study||10
191399|NCT00843349|461359|P2|COMPLETED|Overall Study||11
191400|NCT00843349|461360|P1|COMPLETED|Overall Study||8
191401|NCT00843349|461357|P4|STARTED|Overall Study||11
191402|NCT00843349|461358|P3|STARTED|Overall Study||10
191403|NCT00843349|461359|P2|STARTED|Overall Study||11
191404|NCT00843349|461360|P1|STARTED|Overall Study||11
191405|NCT00843310|461374|P1|NOT COMPLETED|Overall Study||7
191406|NCT00843310|461374|P1|COMPLETED|Overall Study||1
191407|NCT00843310|461374|P1|STARTED|Overall Study||8
191408|NCT00843284|461378|P1|NOT COMPLETED|Overall Study||72
191409|NCT00843284|461378|P1|COMPLETED|Overall Study||619
191410|NCT00843284|461378|P1|STARTED|Overall Study||691
191411|NCT00843193|461388|P2|NOT COMPLETED|Overall Study||11
191412|NCT00843193|461389|P1|NOT COMPLETED|Overall Study||8
191413|NCT00843193|461388|P2|COMPLETED|Overall Study||88
191414|NCT00843193|461389|P1|COMPLETED|Overall Study||91
191415|NCT00843193|461388|P2|STARTED|Overall Study||99
191416|NCT00843193|461389|P1|STARTED|Overall Study||99
191417|NCT00843180|461425|P2|NOT COMPLETED|Overall Study||0
191418|NCT00843180|461426|P1|NOT COMPLETED|Overall Study||0
191419|NCT00843180|461425|P2|COMPLETED|Overall Study||7
191420|NCT00843180|461426|P1|COMPLETED|Overall Study||16
191421|NCT00843180|461425|P2|STARTED|Overall Study||7
191422|NCT00843180|461426|P1|STARTED|Overall Study||16
191423|NCT00843167|461440|P2|NOT COMPLETED|Follow-up||0
191424|NCT00843167|461441|P1|NOT COMPLETED|Follow-up||0
191425|NCT00843167|461440|P2|COMPLETED|Follow-up||24
191426|NCT00843167|461441|P1|COMPLETED|Follow-up||24
191427|NCT00843167|461440|P2|Completed Final Visit|Follow-up||24
191428|NCT00843167|461441|P1|Completed Final Visit|Follow-up||24
191429|NCT00843167|461440|P2|STARTED|Follow-up||24
191430|NCT00843167|461441|P1|STARTED|Follow-up||24
191431|NCT00843167|461440|P2|NOT COMPLETED|Treatment Period||8
191432|NCT00843167|461441|P1|NOT COMPLETED|Treatment Period||3
191433|NCT00843167|461440|P2|COMPLETED|Treatment Period||19
191434|NCT00843167|461441|P1|COMPLETED|Treatment Period||24
191435|NCT00843167|461440|P2|STARTED|Treatment Period||27
191436|NCT00843167|461441|P1|STARTED|Treatment Period||27
191437|NCT00843115|461454|P1|NOT COMPLETED|Overall Study||66
191438|NCT00843115|461454|P1|COMPLETED|Overall Study||304
191439|NCT00843115|461454|P1|STARTED|Overall Study||370
191440|NCT00843050|461500|P1|NOT COMPLETED|Overall Study||13
191441|NCT00843050|461500|P1|COMPLETED|Overall Study||0
191442|NCT00843050|461500|P1|STARTED|Overall Study||13
191443|NCT00843024|461510|P6|NOT COMPLETED|Double-blind Treatment Phase||25
191444|NCT00843024|461511|P5|NOT COMPLETED|Double-blind Treatment Phase||20
191445|NCT00843024|461512|P4|NOT COMPLETED|Double-blind Treatment Phase||23
191446|NCT00843024|461513|P3|NOT COMPLETED|Double-blind Treatment Phase||31
191447|NCT00843024|461514|P2|NOT COMPLETED|Double-blind Treatment Phase||0
191448|NCT00843024|461515|P1|NOT COMPLETED|Double-blind Treatment Phase||0
191449|NCT00843024|461510|P6|COMPLETED|Double-blind Treatment Phase||152
191450|NCT00843024|461511|P5|COMPLETED|Double-blind Treatment Phase||97
191451|NCT00843024|461512|P4|COMPLETED|Double-blind Treatment Phase||96
191452|NCT00843024|461513|P3|COMPLETED|Double-blind Treatment Phase||145
191453|NCT00843024|461514|P2|COMPLETED|Double-blind Treatment Phase||0
191454|NCT00843024|461515|P1|COMPLETED|Double-blind Treatment Phase||0
191455|NCT00843024|461510|P6|STARTED|Double-blind Treatment Phase||177
191456|NCT00843024|461511|P5|STARTED|Double-blind Treatment Phase||117
191457|NCT00843024|461512|P4|STARTED|Double-blind Treatment Phase||119
191458|NCT00843024|461513|P3|STARTED|Double-blind Treatment Phase||176
191459|NCT00843024|461514|P2|STARTED|Double-blind Treatment Phase||0
191460|NCT00843024|461515|P1|STARTED|Double-blind Treatment Phase||0
191461|NCT00843024|461510|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
191462|NCT00843024|461511|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
191463|NCT00843024|461512|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
191464|NCT00843024|461513|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
191465|NCT00843024|461514|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
191466|NCT00843024|461515|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
191467|NCT00843024|461510|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
191468|NCT00843024|461511|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
191469|NCT00843024|461512|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
191470|NCT00843024|461513|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
191471|NCT00843024|461514|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
191472|NCT00843024|461515|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
191473|NCT00843024|461510|P6|STARTED|Single-blind Placebo Run-In Phase||0
191474|NCT00843024|461511|P5|STARTED|Single-blind Placebo Run-In Phase||0
191475|NCT00843024|461512|P4|STARTED|Single-blind Placebo Run-In Phase||0
191476|NCT00843024|461513|P3|STARTED|Single-blind Placebo Run-In Phase||0
191477|NCT00843024|461514|P2|STARTED|Single-blind Placebo Run-In Phase||457
191478|NCT00843024|461515|P1|STARTED|Single-blind Placebo Run-In Phase||408
191479|NCT00842985|461580|P1|NOT COMPLETED|Fourth Intervention||0
191480|NCT00842985|461580|P1|COMPLETED|Fourth Intervention||15
191481|NCT00842985|461580|P1|STARTED|Fourth Intervention||15
191482|NCT00842985|461580|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
191483|NCT00842985|461580|P1|COMPLETED|Washout Period of GE 4 Days||15
191484|NCT00842985|461580|P1|STARTED|Washout Period of GE 4 Days||15
191485|NCT00842985|461580|P1|NOT COMPLETED|Third Intervention||0
191486|NCT00842985|461580|P1|COMPLETED|Third Intervention||15
191487|NCT00842985|461580|P1|STARTED|Third Intervention||15
191488|NCT00842985|461580|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
191489|NCT00842985|461580|P1|COMPLETED|Washout Period of GE 4 Days||15
191490|NCT00842985|461580|P1|STARTED|Washout Period of GE 4 Days||17
191491|NCT00842985|461580|P1|NOT COMPLETED|Second Intervention||1
191492|NCT00842985|461580|P1|COMPLETED|Second Intervention||17
191493|NCT00842985|461580|P1|STARTED|Second Intervention||18
191494|NCT00842985|461580|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
191495|NCT00842985|461580|P1|COMPLETED|Washout Period of GE 4 Days||18
191496|NCT00842985|461580|P1|STARTED|Washout Period of GE 4 Days||20
191497|NCT00842985|461580|P1|NOT COMPLETED|First Intervention||6
191498|NCT00842985|461580|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
191499|NCT00842985|461580|P1|STARTED|First Intervention|Signed Consent|26
191500|NCT00842985|461580|P1|NOT COMPLETED|Screening||27
191501|NCT00842985|461580|P1|COMPLETED|Screening||26
191502|NCT00842985|461580|P1|STARTED|Screening||53
191503|NCT00842946|461589|P2|NOT COMPLETED|Overall Study||5
191504|NCT00842946|461590|P1|NOT COMPLETED|Overall Study||5
191505|NCT00842946|461589|P2|COMPLETED|Overall Study||19
191506|NCT00842946|461590|P1|COMPLETED|Overall Study||16
191507|NCT00842946|461589|P2|STARTED|Overall Study||24
191508|NCT00842946|461590|P1|STARTED|Overall Study||21
191509|NCT00842829|461598|P3|NOT COMPLETED|Continuation Period||61
191510|NCT00842829|461599|P2|NOT COMPLETED|Continuation Period||0
191511|NCT00842829|461600|P1|NOT COMPLETED|Continuation Period||0
191512|NCT00842829|461598|P3|COMPLETED|Continuation Period||27
191513|NCT00842829|461599|P2|COMPLETED|Continuation Period||0
191514|NCT00842829|461600|P1|COMPLETED|Continuation Period||0
191515|NCT00842829|461598|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
191516|NCT00842829|461599|P2|Continuation Safety Analysis Set|Continuation Period||0
191517|NCT00842829|461600|P1|Continuation Safety Analysis Set|Continuation Period||0
191518|NCT00842829|461598|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
191519|NCT00842829|461599|P2|STARTED|Continuation Period||0
191520|NCT00842829|461600|P1|STARTED|Continuation Period||0
191521|NCT00842829|461598|P3|NOT COMPLETED|Treatment Period||63
191522|NCT00842829|461599|P2|NOT COMPLETED|Treatment Period||0
191523|NCT00842829|461600|P1|NOT COMPLETED|Treatment Period||0
191524|NCT00842829|461598|P3|COMPLETED|Treatment Period||218
191525|NCT00842829|461599|P2|COMPLETED|Treatment Period||0
191526|NCT00842829|461600|P1|COMPLETED|Treatment Period||0
191527|NCT00842829|461598|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
191528|NCT00842829|461599|P2|Safety Analysis Set|Treatment Period||0
191529|NCT00842829|461600|P1|Safety Analysis Set|Treatment Period||0
191530|NCT00842829|461598|P3|STARTED|Treatment Period||281
191531|NCT00842829|461599|P2|STARTED|Treatment Period||0
191532|NCT00842829|461600|P1|STARTED|Treatment Period||0
191533|NCT00842829|461598|P3|NOT COMPLETED|Dose Titration Period||0
191534|NCT00842829|461599|P2|NOT COMPLETED|Dose Titration Period||23
191535|NCT00842829|461600|P1|NOT COMPLETED|Dose Titration Period||26
191536|NCT00842829|461598|P3|COMPLETED|Dose Titration Period||0
191537|NCT00842829|461599|P2|COMPLETED|Dose Titration Period||151
191538|NCT00842829|461600|P1|COMPLETED|Dose Titration Period||130
191539|NCT00842829|461598|P3|Titration Safety Analysis Set|Dose Titration Period||0
191540|NCT00842829|461599|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
191541|NCT00842829|461600|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
191542|NCT00842829|461598|P3|STARTED|Dose Titration Period||0
191543|NCT00842829|461599|P2|STARTED|Dose Titration Period||174
191544|NCT00842829|461600|P1|STARTED|Dose Titration Period||156
191545|NCT00842751|461634|P1|NOT COMPLETED|Overall Study||0
191546|NCT00842751|461634|P1|COMPLETED|Overall Study||11
191547|NCT00842751|461634|P1|STARTED|Overall Study||11
191548|NCT00842712|461655|P7|NOT COMPLETED|Randomized Part||6
191549|NCT00842712|461656|P6|NOT COMPLETED|Randomized Part||1
191550|NCT00842712|461657|P5|NOT COMPLETED|Randomized Part||0
191551|NCT00842712|461658|P4|NOT COMPLETED|Randomized Part||0
191552|NCT00842712|461659|P3|NOT COMPLETED|Randomized Part||0
191553|NCT00842712|461660|P2|NOT COMPLETED|Randomized Part||0
191554|NCT00842712|461661|P1|NOT COMPLETED|Randomized Part||0
191555|NCT00842712|461655|P7|COMPLETED|Randomized Part||78
191556|NCT00842712|461656|P6|COMPLETED|Randomized Part||50
191557|NCT00842712|461657|P5|COMPLETED|Randomized Part||85
191558|NCT00842712|461658|P4|COMPLETED|Randomized Part||0
191559|NCT00842712|461659|P3|COMPLETED|Randomized Part||0
191560|NCT00842712|461660|P2|COMPLETED|Randomized Part||0
191561|NCT00842712|461661|P1|COMPLETED|Randomized Part||0
191562|NCT00842712|461655|P7|Treated|Randomized Part||80
191563|NCT00842712|461656|P6|Treated|Randomized Part||50
191564|NCT00842712|461657|P5|Treated|Randomized Part||85
191565|NCT00842712|461658|P4|Treated|Randomized Part||0
191566|NCT00842712|461659|P3|Treated|Randomized Part||0
191567|NCT00842712|461660|P2|Treated|Randomized Part||0
191568|NCT00842712|461661|P1|Treated|Randomized Part||0
191569|NCT00842712|461655|P7|STARTED|Randomized Part||84
191570|NCT00842712|461656|P6|STARTED|Randomized Part||51
191571|NCT00842712|461657|P5|STARTED|Randomized Part||85
191572|NCT00842712|461658|P4|STARTED|Randomized Part||0
191573|NCT00842712|461659|P3|STARTED|Randomized Part||0
191574|NCT00842712|461660|P2|STARTED|Randomized Part||0
191575|NCT00842712|461661|P1|STARTED|Randomized Part||0
191576|NCT00842712|461655|P7|NOT COMPLETED|Safety Run-in Part||0
191577|NCT00842712|461656|P6|NOT COMPLETED|Safety Run-in Part||0
191578|NCT00842712|461657|P5|NOT COMPLETED|Safety Run-in Part||0
191579|NCT00842712|461658|P4|NOT COMPLETED|Safety Run-in Part||1
191580|NCT00842712|461659|P3|NOT COMPLETED|Safety Run-in Part||0
191581|NCT00842712|461660|P2|NOT COMPLETED|Safety Run-in Part||2
191582|NCT00842712|461661|P1|NOT COMPLETED|Safety Run-in Part||3
191583|NCT00842712|461655|P7|COMPLETED|Safety Run-in Part||0
191584|NCT00842712|461656|P6|COMPLETED|Safety Run-in Part||0
191585|NCT00842712|461657|P5|COMPLETED|Safety Run-in Part||0
191586|NCT00842712|461658|P4|COMPLETED|Safety Run-in Part||2
191587|NCT00842712|461659|P3|COMPLETED|Safety Run-in Part||3
191588|NCT00842712|461660|P2|COMPLETED|Safety Run-in Part||1
191589|NCT00842712|461661|P1|COMPLETED|Safety Run-in Part||0
191590|NCT00842712|461655|P7|STARTED|Safety Run-in Part||0
191591|NCT00842712|461656|P6|STARTED|Safety Run-in Part||0
191592|NCT00842712|461657|P5|STARTED|Safety Run-in Part||0
191593|NCT00842712|461658|P4|STARTED|Safety Run-in Part||3
191594|NCT00842712|461659|P3|STARTED|Safety Run-in Part||3
191595|NCT00842712|461660|P2|STARTED|Safety Run-in Part||3
191596|NCT00842712|461661|P1|STARTED|Safety Run-in Part||3
191597|NCT00842608|461693|P4|NOT COMPLETED|Overall Study||0
191598|NCT00842608|461694|P3|NOT COMPLETED|Overall Study||0
191599|NCT00842608|461695|P2|NOT COMPLETED|Overall Study||0
191600|NCT00842608|461696|P1|NOT COMPLETED|Overall Study||0
191601|NCT00842608|461693|P4|COMPLETED|Overall Study||100
191602|NCT00842608|461694|P3|COMPLETED|Overall Study||99
191603|NCT00842608|461695|P2|COMPLETED|Overall Study||176
191604|NCT00842608|461696|P1|COMPLETED|Overall Study||170
191605|NCT00842608|461693|P4|STARTED|Overall Study||100
191606|NCT00842608|461694|P3|STARTED|Overall Study||99
191607|NCT00842608|461695|P2|STARTED|Overall Study||176
191608|NCT00842608|461696|P1|STARTED|Overall Study||170
191609|NCT00842543|461718|P4|NOT COMPLETED|Overall Study||4
191610|NCT00842543|461719|P3|NOT COMPLETED|Overall Study||3
191611|NCT00842543|461720|P2|NOT COMPLETED|Overall Study||0
191612|NCT00842543|461721|P1|NOT COMPLETED|Overall Study||2
191613|NCT00842543|461718|P4|COMPLETED|Overall Study||4
191614|NCT00842543|461719|P3|COMPLETED|Overall Study||10
191615|NCT00842543|461720|P2|COMPLETED|Overall Study||5
191616|NCT00842543|461721|P1|COMPLETED|Overall Study||11
191617|NCT00842543|461718|P4|STARTED|Overall Study||8
191618|NCT00842543|461719|P3|STARTED|Overall Study||13
191619|NCT00842543|461720|P2|STARTED|Overall Study||5
191620|NCT00842543|461721|P1|STARTED|Overall Study||13
191621|NCT00842361|461735|P2|NOT COMPLETED|Overall Study||2
191622|NCT00842361|461736|P1|NOT COMPLETED|Overall Study||1
191623|NCT00842361|461735|P2|COMPLETED|Overall Study||31
191624|NCT00842361|461736|P1|COMPLETED|Overall Study||32
191625|NCT00842361|461735|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
191626|NCT00842361|461736|P1|Exposed|Overall Study||33
191627|NCT00842361|461735|P2|STARTED|Overall Study||33
191628|NCT00842361|461736|P1|STARTED|Overall Study||33
191629|NCT00842348|461756|P2|NOT COMPLETED|Study 729||38
191630|NCT00842348|461757|P1|NOT COMPLETED|Study 729||26
191631|NCT00842348|461756|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
191632|NCT00842348|461757|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
191633|NCT00842348|461756|P2|STARTED|Study 729||47
191634|NCT00842348|461757|P1|STARTED|Study 729||42
191635|NCT00842348|461756|P2|NOT COMPLETED|Patients Randomised in Study 726||56
191636|NCT00842348|461757|P1|NOT COMPLETED|Patients Randomised in Study 726||59
191637|NCT00842348|461756|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
191638|NCT00842348|461757|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
191639|NCT00842348|461756|P2|STARTED|Patients Randomised in Study 726||103
191640|NCT00842348|461757|P1|STARTED|Patients Randomised in Study 726||101
191641|NCT00842335|461767|P1|NOT COMPLETED|Overall Study||0
191642|NCT00842335|461767|P1|COMPLETED|Overall Study||18
191643|NCT00842335|461767|P1|STARTED|Overall Study||18
191644|NCT00842296|461774|P1|NOT COMPLETED|Overall Study||0
191645|NCT00842296|461774|P1|COMPLETED|Overall Study||326
191646|NCT00842296|461774|P1|STARTED|Overall Study||326
191647|NCT00842257|461800|P1|NOT COMPLETED|Overall Study||1
191648|NCT00842257|461800|P1|COMPLETED|Overall Study||19
191649|NCT00842257|461800|P1|STARTED|Overall Study||20
191650|NCT00842244|461807|P1|NOT COMPLETED|Overall Study||21
191651|NCT00842244|461807|P1|COMPLETED|Overall Study||1
191652|NCT00842244|461807|P1|STARTED|Overall Study||22
191653|NCT00842231|461826|P1|NOT COMPLETED|Overall Study||0
191654|NCT00842231|461826|P1|COMPLETED|Overall Study||40
191655|NCT00842231|461826|P1|STARTED|Overall Study||40
191656|NCT00842153|461834|P2|NOT COMPLETED|Overall Study||3
191657|NCT00842153|461835|P1|NOT COMPLETED|Overall Study||1
191658|NCT00842153|461834|P2|COMPLETED|Overall Study||27
191659|NCT00842153|461835|P1|COMPLETED|Overall Study||27
191660|NCT00842153|461834|P2|STARTED|Overall Study||30
191661|NCT00842153|461835|P1|STARTED|Overall Study||28
191662|NCT00842075|461875|P2|NOT COMPLETED|Overall Study||0
191663|NCT00842075|461876|P1|NOT COMPLETED|Overall Study||0
191664|NCT00842075|461875|P2|COMPLETED|Overall Study||5
191665|NCT00842075|461876|P1|COMPLETED|Overall Study||5
191666|NCT00842075|461875|P2|STARTED|Overall Study||5
191667|NCT00842075|461876|P1|STARTED|Overall Study||5
191668|NCT00842023|461886|P2|NOT COMPLETED|Overall Study||0
191669|NCT00842023|461887|P1|NOT COMPLETED|Overall Study||0
191670|NCT00842023|461886|P2|COMPLETED|Overall Study||44
191671|NCT00842023|461887|P1|COMPLETED|Overall Study||45
191672|NCT00842023|461886|P2|STARTED|Overall Study||44
191673|NCT00842023|461887|P1|STARTED|Overall Study||45
191674|NCT00841971|461899|P2|NOT COMPLETED|Overall Study||1
191675|NCT00841971|461900|P1|NOT COMPLETED|Overall Study||2
191676|NCT00841971|461899|P2|COMPLETED|Overall Study||99
191677|NCT00841971|461900|P1|COMPLETED|Overall Study||98
191678|NCT00841971|461899|P2|STARTED|Overall Study||100
191679|NCT00841971|461900|P1|STARTED|Overall Study||100
191680|NCT00841906|461910|P2|NOT COMPLETED|Overall Study||0
191681|NCT00841906|461911|P1|NOT COMPLETED|Overall Study||2
191682|NCT00841906|461910|P2|COMPLETED|Overall Study||15
191683|NCT00841906|461911|P1|COMPLETED|Overall Study||15
191684|NCT00841906|461910|P2|STARTED|Overall Study||15
191685|NCT00841906|461911|P1|STARTED|Overall Study||17
191686|NCT00841815|461925|P2|NOT COMPLETED|Period 2||0
191687|NCT00841815|461926|P1|NOT COMPLETED|Period 2||0
191688|NCT00841815|461925|P2|COMPLETED|Period 2||13
191689|NCT00841815|461926|P1|COMPLETED|Period 2||14
191690|NCT00841815|461925|P2|STARTED|Period 2||13
191691|NCT00841815|461926|P1|STARTED|Period 2||14
191692|NCT00841815|461925|P2|NOT COMPLETED|Washout||1
191693|NCT00841815|461926|P1|NOT COMPLETED|Washout||0
191694|NCT00841815|461925|P2|COMPLETED|Washout||13
191695|NCT00841815|461926|P1|COMPLETED|Washout||14
191696|NCT00841815|461925|P2|STARTED|Washout||14
191697|NCT00841815|461926|P1|STARTED|Washout||14
191698|NCT00841815|461925|P2|NOT COMPLETED|Period 1||0
191699|NCT00841815|461926|P1|NOT COMPLETED|Period 1||0
191700|NCT00841815|461925|P2|COMPLETED|Period 1||14
191701|NCT00841815|461926|P1|COMPLETED|Period 1||14
191702|NCT00841815|461925|P2|STARTED|Period 1||14
191703|NCT00841815|461926|P1|STARTED|Period 1||14
191704|NCT00841776|461936|P2|NOT COMPLETED|Overall Study||3
191705|NCT00841776|461937|P1|NOT COMPLETED|Overall Study||2
191706|NCT00841776|461936|P2|COMPLETED|Overall Study||24
191707|NCT00841776|461937|P1|COMPLETED|Overall Study||25
191708|NCT00841776|461936|P2|STARTED|Overall Study||27
191709|NCT00841776|461937|P1|STARTED|Overall Study||27
191710|NCT00841763|461955|P4|NOT COMPLETED|Overall Study||3
191711|NCT00841763|461956|P3|NOT COMPLETED|Overall Study||8
191712|NCT00841763|461957|P2|NOT COMPLETED|Overall Study||57
191713|NCT00841763|461958|P1|NOT COMPLETED|Overall Study||162
191714|NCT00841763|461955|P4|COMPLETED|Overall Study||53
191715|NCT00841763|461956|P3|COMPLETED|Overall Study||211
191716|NCT00841763|461957|P2|COMPLETED|Overall Study||624
191717|NCT00841763|461958|P1|COMPLETED|Overall Study||2529
191718|NCT00841763|461955|P4|STARTED|Overall Study||56
191719|NCT00841763|461956|P3|STARTED|Overall Study||219
191720|NCT00841763|461957|P2|STARTED|Overall Study||681
191721|NCT00841763|461958|P1|STARTED|Overall Study||2691
191722|NCT00841698|462020|P2|NOT COMPLETED|Second Intervention||0
191723|NCT00841698|462021|P1|NOT COMPLETED|Second Intervention||0
191724|NCT00841698|462020|P2|COMPLETED|Second Intervention||25
191725|NCT00841698|462021|P1|COMPLETED|Second Intervention||24
191726|NCT00841698|462020|P2|STARTED|Second Intervention||25
191727|NCT00841698|462021|P1|STARTED|Second Intervention||24
191728|NCT00841698|462020|P2|NOT COMPLETED|Washout: 2 Weeks||0
191729|NCT00841698|462021|P1|NOT COMPLETED|Washout: 2 Weeks||0
191730|NCT00841698|462020|P2|COMPLETED|Washout: 2 Weeks||25
191731|NCT00841698|462021|P1|COMPLETED|Washout: 2 Weeks||24
191732|NCT00841698|462020|P2|STARTED|Washout: 2 Weeks||25
191733|NCT00841698|462021|P1|STARTED|Washout: 2 Weeks||24
191734|NCT00841698|462020|P2|NOT COMPLETED|First Intervention||0
191735|NCT00841698|462021|P1|NOT COMPLETED|First Intervention||1
191736|NCT00841698|462020|P2|COMPLETED|First Intervention||25
191737|NCT00841698|462021|P1|COMPLETED|First Intervention||24
191738|NCT00841698|462020|P2|STARTED|First Intervention||25
191739|NCT00841698|462021|P1|STARTED|First Intervention||25
191740|NCT00841672|462031|P2|NOT COMPLETED|Overall Study||32
191741|NCT00841672|462032|P1|NOT COMPLETED|Overall Study||20
191742|NCT00841672|462031|P2|COMPLETED|Overall Study||209
191743|NCT00841672|462032|P1|COMPLETED|Overall Study||224
191744|NCT00841672|462031|P2|STARTED|Overall Study||241
191745|NCT00841672|462032|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
191746|NCT00841659|462048|P2|NOT COMPLETED|Second Intervention||0
191747|NCT00841659|462049|P1|NOT COMPLETED|Second Intervention||0
191748|NCT00841659|462048|P2|COMPLETED|Second Intervention||12
191749|NCT00841659|462049|P1|COMPLETED|Second Intervention||11
191750|NCT00841659|462048|P2|STARTED|Second Intervention||12
191751|NCT00841659|462049|P1|STARTED|Second Intervention||11
191752|NCT00841659|462048|P2|NOT COMPLETED|Washout: 2 Weeks||0
191753|NCT00841659|462049|P1|NOT COMPLETED|Washout: 2 Weeks||1
191754|NCT00841659|462048|P2|COMPLETED|Washout: 2 Weeks||12
191755|NCT00841659|462049|P1|COMPLETED|Washout: 2 Weeks||11
191756|NCT00841659|462048|P2|STARTED|Washout: 2 Weeks||12
191757|NCT00841659|462049|P1|STARTED|Washout: 2 Weeks||12
191758|NCT00841659|462048|P2|NOT COMPLETED|First Intervention||0
191759|NCT00841659|462049|P1|NOT COMPLETED|First Intervention||0
191760|NCT00841659|462048|P2|COMPLETED|First Intervention||12
191761|NCT00841659|462049|P1|COMPLETED|First Intervention||12
191762|NCT00841659|462048|P2|STARTED|First Intervention||12
191763|NCT00841659|462049|P1|STARTED|First Intervention||12
191764|NCT00841555|462060|P3|NOT COMPLETED|Overall Study||0
191765|NCT00841555|462061|P2|NOT COMPLETED|Overall Study||0
191766|NCT00841555|462062|P1|NOT COMPLETED|Overall Study||0
191767|NCT00841555|462060|P3|COMPLETED|Overall Study||3
191768|NCT00841555|462061|P2|COMPLETED|Overall Study||3
191769|NCT00841555|462062|P1|COMPLETED|Overall Study||3
191770|NCT00841555|462060|P3|STARTED|Overall Study||3
191771|NCT00841555|462061|P2|STARTED|Overall Study||3
191772|NCT00841555|462062|P1|STARTED|Overall Study||3
191773|NCT00841542|462072|P2|NOT COMPLETED|Period 2||0
191774|NCT00841542|462073|P1|NOT COMPLETED|Period 2||0
191775|NCT00841542|462072|P2|COMPLETED|Period 2||14
191776|NCT00841542|462073|P1|COMPLETED|Period 2||13
191777|NCT00841542|462072|P2|STARTED|Period 2||14
191778|NCT00841542|462073|P1|STARTED|Period 2||13
191779|NCT00841542|462072|P2|NOT COMPLETED|Period 1||0
191780|NCT00841542|462073|P1|NOT COMPLETED|Period 1||1
191781|NCT00841542|462072|P2|COMPLETED|Period 1||14
191782|NCT00841542|462073|P1|COMPLETED|Period 1||13
191783|NCT00841542|462072|P2|STARTED|Period 1||14
191784|NCT00841542|462073|P1|STARTED|Period 1||14
191785|NCT00841412|462081|P2|NOT COMPLETED|Overall Study||30
191786|NCT00841412|462082|P1|NOT COMPLETED|Overall Study||40
191787|NCT00841412|462081|P2|COMPLETED|Overall Study||50
191788|NCT00841412|462082|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
191789|NCT00841412|462081|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
191790|NCT00841412|462082|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
191791|NCT00841321|462088|P2|NOT COMPLETED|Overall Study||3
191792|NCT00841321|462089|P1|NOT COMPLETED|Overall Study||1
191793|NCT00841321|462088|P2|COMPLETED|Overall Study||58
191794|NCT00841321|462089|P1|COMPLETED|Overall Study||58
191795|NCT00841321|462088|P2|STARTED|Overall Study||61
191796|NCT00841321|462089|P1|STARTED|Overall Study||59
191797|NCT00841269|462103|P2|NOT COMPLETED|Overall Study||9
191798|NCT00841269|462104|P1|NOT COMPLETED|Overall Study||8
191799|NCT00841269|462103|P2|COMPLETED|Overall Study||13
191800|NCT00841269|462104|P1|COMPLETED|Overall Study||12
191801|NCT00841269|462103|P2|STARTED|Overall Study||22
191802|NCT00841269|462104|P1|STARTED|Overall Study||20
191803|NCT00841204|462115|P2|NOT COMPLETED|Overall Study||0
191804|NCT00841204|462116|P1|NOT COMPLETED|Overall Study||0
191805|NCT00841204|462115|P2|COMPLETED|Overall Study||25
191806|NCT00841204|462116|P1|COMPLETED|Overall Study||25
191807|NCT00841204|462115|P2|STARTED|Overall Study||25
191808|NCT00841204|462116|P1|STARTED|Overall Study||25
191809|NCT00841087|462138|P2|NOT COMPLETED|Overall Study||0
191810|NCT00841087|462139|P1|NOT COMPLETED|Overall Study||0
191811|NCT00841087|462138|P2|COMPLETED|Overall Study||32
191812|NCT00841087|462139|P1|COMPLETED|Overall Study||33
191813|NCT00841087|462138|P2|STARTED|Overall Study||32
191814|NCT00841087|462139|P1|STARTED|Overall Study||33
191815|NCT00841035|462157|P1|NOT COMPLETED|Phase 2 of Overall Study||0
191816|NCT00841035|462157|P1|COMPLETED|Phase 2 of Overall Study||6
191817|NCT00841035|462157|P1|STARTED|Phase 2 of Overall Study||6
191818|NCT00841035|462157|P1|NOT COMPLETED|Phase 1 Overall Study||13
191819|NCT00841035|462157|P1|COMPLETED|Phase 1 Overall Study||6
191820|NCT00841035|462157|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
191821|NCT00840996|462164|P2|NOT COMPLETED|Overall Study||0
191822|NCT00840996|462165|P1|NOT COMPLETED|Overall Study||1
191823|NCT00840996|462164|P2|COMPLETED|Overall Study||58
191824|NCT00840996|462165|P1|COMPLETED|Overall Study||57
191825|NCT00840996|462164|P2|STARTED|Overall Study||58
191826|NCT00840996|462165|P1|STARTED|Overall Study||58
191827|NCT00840879|462185|P2|NOT COMPLETED|Second Intervention||0
191828|NCT00840879|462186|P1|NOT COMPLETED|Second Intervention||1
191829|NCT00840879|462185|P2|COMPLETED|Second Intervention||14
191830|NCT00840879|462186|P1|COMPLETED|Second Intervention||13
191831|NCT00840879|462185|P2|STARTED|Second Intervention||14
191832|NCT00840879|462186|P1|STARTED|Second Intervention||14
191833|NCT00840879|462185|P2|NOT COMPLETED|Washout: 14 Days||0
191834|NCT00840879|462186|P1|NOT COMPLETED|Washout: 14 Days||0
191835|NCT00840879|462185|P2|COMPLETED|Washout: 14 Days||14
191836|NCT00840879|462186|P1|COMPLETED|Washout: 14 Days||14
191837|NCT00840879|462185|P2|STARTED|Washout: 14 Days||14
191838|NCT00840879|462186|P1|STARTED|Washout: 14 Days||14
191839|NCT00840879|462185|P2|NOT COMPLETED|First Intervention||0
191840|NCT00840879|462186|P1|NOT COMPLETED|First Intervention||0
191841|NCT00840879|462185|P2|COMPLETED|First Intervention||14
191842|NCT00840879|462186|P1|COMPLETED|First Intervention||14
191843|NCT00840879|462185|P2|STARTED|First Intervention||14
191844|NCT00840879|462186|P1|STARTED|First Intervention||14
191845|NCT00840866|462196|P2|NOT COMPLETED|Second Intervention||0
191846|NCT00840866|462197|P1|NOT COMPLETED|Second Intervention||0
191847|NCT00840866|462196|P2|COMPLETED|Second Intervention||19
191848|NCT00840866|462197|P1|COMPLETED|Second Intervention||20
191849|NCT00840866|462196|P2|STARTED|Second Intervention||19
191850|NCT00840866|462197|P1|STARTED|Second Intervention||20
191851|NCT00840866|462196|P2|NOT COMPLETED|Washout of 7 Days||0
191852|NCT00840866|462197|P1|NOT COMPLETED|Washout of 7 Days||0
191853|NCT00840866|462196|P2|COMPLETED|Washout of 7 Days||19
191854|NCT00840866|462197|P1|COMPLETED|Washout of 7 Days||20
191855|NCT00840866|462196|P2|STARTED|Washout of 7 Days||19
191856|NCT00840866|462197|P1|STARTED|Washout of 7 Days||20
191857|NCT00840866|462196|P2|NOT COMPLETED|First Intervention||0
191858|NCT00840866|462197|P1|NOT COMPLETED|First Intervention||0
191859|NCT00840866|462196|P2|COMPLETED|First Intervention||19
191860|NCT00840866|462197|P1|COMPLETED|First Intervention||20
191861|NCT00840866|462196|P2|STARTED|First Intervention||19
191862|NCT00840866|462197|P1|STARTED|First Intervention||20
191863|NCT00840840|462207|P2|NOT COMPLETED|Period 2||0
191864|NCT00840840|462208|P1|NOT COMPLETED|Period 2||0
191865|NCT00840840|462207|P2|COMPLETED|Period 2||24
191866|NCT00840840|462208|P1|COMPLETED|Period 2||23
191867|NCT00840840|462207|P2|STARTED|Period 2||24
191868|NCT00840840|462208|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
191869|NCT00840840|462207|P2|NOT COMPLETED|Period 1||0
191870|NCT00840840|462208|P1|NOT COMPLETED|Period 1||0
191871|NCT00840840|462207|P2|COMPLETED|Period 1||24
191872|NCT00840840|462208|P1|COMPLETED|Period 1||24
191873|NCT00840840|462207|P2|STARTED|Period 1||24
191874|NCT00840840|462208|P1|STARTED|Period 1||24
191875|NCT00840658|462226|P4|NOT COMPLETED|Overall Study||4
191876|NCT00840658|462227|P3|NOT COMPLETED|Overall Study||5
191877|NCT00840658|462228|P2|NOT COMPLETED|Overall Study||3
191878|NCT00840658|462229|P1|NOT COMPLETED|Overall Study||5
191879|NCT00840658|462226|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
191880|NCT00840658|462227|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
191881|NCT00840658|462228|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
191882|NCT00840658|462229|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
191883|NCT00840658|462226|P4|STARTED|Overall Study||146
191884|NCT00840658|462227|P3|STARTED|Overall Study||148
191885|NCT00840658|462228|P2|STARTED|Overall Study||146
191886|NCT00840658|462229|P1|STARTED|Overall Study||144
191887|NCT00840632|462241|P2|NOT COMPLETED|Second Intervention||0
191888|NCT00840632|462242|P1|NOT COMPLETED|Second Intervention||0
191889|NCT00840632|462241|P2|COMPLETED|Second Intervention||18
191890|NCT00840632|462242|P1|COMPLETED|Second Intervention||19
191891|NCT00840632|462241|P2|STARTED|Second Intervention||18
191892|NCT00840632|462242|P1|STARTED|Second Intervention||19
191893|NCT00840632|462241|P2|NOT COMPLETED|Washout||1
191894|NCT00840632|462242|P1|NOT COMPLETED|Washout||1
191895|NCT00840632|462241|P2|COMPLETED|Washout||18
191896|NCT00840632|462242|P1|COMPLETED|Washout||19
191897|NCT00840632|462241|P2|STARTED|Washout||19
191898|NCT00840632|462242|P1|STARTED|Washout||20
191899|NCT00840632|462241|P2|NOT COMPLETED|First Intervention||1
191900|NCT00840632|462242|P1|NOT COMPLETED|First Intervention||0
191901|NCT00840632|462241|P2|COMPLETED|First Intervention||19
191902|NCT00840632|462242|P1|COMPLETED|First Intervention||20
191903|NCT00840632|462241|P2|STARTED|First Intervention||20
191904|NCT00840632|462242|P1|STARTED|First Intervention||20
191905|NCT00840476|462258|P2|NOT COMPLETED|Second Intervention||0
191906|NCT00840476|462259|P1|NOT COMPLETED|Second Intervention||0
191907|NCT00840476|462258|P2|COMPLETED|Second Intervention||14
191908|NCT00840476|462259|P1|COMPLETED|Second Intervention||14
191909|NCT00840476|462258|P2|STARTED|Second Intervention||14
191910|NCT00840476|462259|P1|STARTED|Second Intervention||14
191911|NCT00840476|462258|P2|NOT COMPLETED|Washout: 14 Days||0
191912|NCT00840476|462259|P1|NOT COMPLETED|Washout: 14 Days||0
191913|NCT00840476|462258|P2|COMPLETED|Washout: 14 Days||14
191914|NCT00840476|462259|P1|COMPLETED|Washout: 14 Days||14
191915|NCT00840476|462258|P2|STARTED|Washout: 14 Days||14
191916|NCT00840476|462259|P1|STARTED|Washout: 14 Days||14
191917|NCT00840476|462258|P2|NOT COMPLETED|First Intervention||0
191918|NCT00840476|462259|P1|NOT COMPLETED|First Intervention||0
191919|NCT00840476|462258|P2|COMPLETED|First Intervention||14
191920|NCT00840476|462259|P1|COMPLETED|First Intervention||14
191921|NCT00840476|462258|P2|STARTED|First Intervention||14
191922|NCT00840476|462259|P1|STARTED|First Intervention||14
191923|NCT00840450|462267|P1|NOT COMPLETED|Overall Study||3
191924|NCT00840450|462267|P1|COMPLETED|Overall Study||9
191925|NCT00840450|462267|P1|STARTED|Overall Study||12
191926|NCT00840411|462275|P2|NOT COMPLETED|Second Intervention||0
191927|NCT00840411|462276|P1|NOT COMPLETED|Second Intervention||0
191928|NCT00840411|462275|P2|COMPLETED|Second Intervention||33
191929|NCT00840411|462276|P1|COMPLETED|Second Intervention||31
191930|NCT00840411|462275|P2|STARTED|Second Intervention||33
191931|NCT00840411|462276|P1|STARTED|Second Intervention||31
191932|NCT00840411|462275|P2|NOT COMPLETED|Washout||0
191933|NCT00840411|462276|P1|NOT COMPLETED|Washout||1
191934|NCT00840411|462275|P2|COMPLETED|Washout||33
191935|NCT00840411|462276|P1|COMPLETED|Washout||31
191936|NCT00840411|462275|P2|STARTED|Washout||33
191937|NCT00840411|462276|P1|STARTED|Washout||32
191938|NCT00840411|462275|P2|NOT COMPLETED|First Intervention||0
191939|NCT00840411|462276|P1|NOT COMPLETED|First Intervention||1
191940|NCT00840411|462275|P2|COMPLETED|First Intervention||33
191941|NCT00840411|462276|P1|COMPLETED|First Intervention||32
191942|NCT00840411|462275|P2|STARTED|First Intervention||33
191943|NCT00840411|462276|P1|STARTED|First Intervention||33
191944|NCT00840307|462284|P1|NOT COMPLETED|Overall Study||4
191945|NCT00840307|462284|P1|COMPLETED|Overall Study||16
191946|NCT00840307|462284|P1|STARTED|Overall Study||20
191947|NCT00840294|462290|P2|NOT COMPLETED|Overall Study||5
191948|NCT00840294|462291|P1|NOT COMPLETED|Overall Study||3
191949|NCT00840294|462290|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
191950|NCT00840294|462291|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
191951|NCT00840294|462290|P2|STARTED|Overall Study||43
191952|NCT00840294|462291|P1|STARTED|Overall Study||42
191953|NCT00840281|462301|P2|NOT COMPLETED|Second Intervention||0
191954|NCT00840281|462302|P1|NOT COMPLETED|Second Intervention||0
191955|NCT00840281|462301|P2|COMPLETED|Second Intervention||19
191956|NCT00840281|462302|P1|COMPLETED|Second Intervention||19
191957|NCT00840281|462301|P2|STARTED|Second Intervention||19
191958|NCT00840281|462302|P1|STARTED|Second Intervention||19
191959|NCT00840281|462301|P2|NOT COMPLETED|Washout of 7 Days||0
191960|NCT00840281|462302|P1|NOT COMPLETED|Washout of 7 Days||0
191961|NCT00840281|462301|P2|COMPLETED|Washout of 7 Days||19
191962|NCT00840281|462302|P1|COMPLETED|Washout of 7 Days||19
191963|NCT00840281|462301|P2|STARTED|Washout of 7 Days||19
191964|NCT00840281|462302|P1|STARTED|Washout of 7 Days||19
191965|NCT00840281|462301|P2|NOT COMPLETED|First Intervention||0
191966|NCT00840281|462302|P1|NOT COMPLETED|First Intervention||0
191967|NCT00840281|462301|P2|COMPLETED|First Intervention||19
191968|NCT00840281|462302|P1|COMPLETED|First Intervention||19
191969|NCT00840281|462301|P2|STARTED|First Intervention||19
191970|NCT00840281|462302|P1|STARTED|First Intervention||19
191971|NCT00840216|462312|P2|NOT COMPLETED|Second Intervention||0
191972|NCT00840216|462313|P1|NOT COMPLETED|Second Intervention||0
191973|NCT00840216|462312|P2|COMPLETED|Second Intervention||11
191974|NCT00840216|462313|P1|COMPLETED|Second Intervention||10
191975|NCT00840216|462312|P2|STARTED|Second Intervention||11
191976|NCT00840216|462313|P1|STARTED|Second Intervention||10
191977|NCT00840216|462312|P2|NOT COMPLETED|Washout: 7 Days||0
191978|NCT00840216|462313|P1|NOT COMPLETED|Washout: 7 Days||1
191979|NCT00840216|462312|P2|COMPLETED|Washout: 7 Days||11
191980|NCT00840216|462313|P1|COMPLETED|Washout: 7 Days||10
191981|NCT00840216|462312|P2|STARTED|Washout: 7 Days||11
191982|NCT00840216|462313|P1|STARTED|Washout: 7 Days||11
191983|NCT00840216|462312|P2|NOT COMPLETED|First Intervention||0
191984|NCT00840216|462313|P1|NOT COMPLETED|First Intervention||0
191985|NCT00840216|462312|P2|COMPLETED|First Intervention||11
191986|NCT00840216|462313|P1|COMPLETED|First Intervention||11
191987|NCT00840216|462312|P2|STARTED|First Intervention||11
191988|NCT00840216|462313|P1|STARTED|First Intervention||11
191989|NCT00840203|462323|P2|NOT COMPLETED|Second Intervention||0
191990|NCT00840203|462324|P1|NOT COMPLETED|Second Intervention||0
191991|NCT00840203|462323|P2|COMPLETED|Second Intervention||34
191992|NCT00840203|462324|P1|COMPLETED|Second Intervention||35
191993|NCT00840203|462323|P2|STARTED|Second Intervention||34
191994|NCT00840203|462324|P1|STARTED|Second Intervention||35
191995|NCT00840203|462323|P2|NOT COMPLETED|Washout||0
191996|NCT00840203|462324|P1|NOT COMPLETED|Washout||1
191997|NCT00840203|462323|P2|COMPLETED|Washout||34
191998|NCT00840203|462324|P1|COMPLETED|Washout||35
191999|NCT00840203|462323|P2|STARTED|Washout||34
192000|NCT00840203|462324|P1|STARTED|Washout||36
192001|NCT00840203|462323|P2|NOT COMPLETED|First Intervention||1
192002|NCT00840203|462324|P1|NOT COMPLETED|First Intervention||1
192003|NCT00840203|462323|P2|COMPLETED|First Intervention||34
192004|NCT00840203|462324|P1|COMPLETED|First Intervention||36
192005|NCT00840203|462323|P2|STARTED|First Intervention||35
192006|NCT00840203|462324|P1|STARTED|First Intervention||37
192007|NCT00840099|462340|P2|NOT COMPLETED|Period 2||0
192008|NCT00840099|462341|P1|NOT COMPLETED|Period 2||0
192009|NCT00840099|462340|P2|COMPLETED|Period 2||24
192010|NCT00840099|462341|P1|COMPLETED|Period 2||21
192011|NCT00840099|462340|P2|STARTED|Period 2||24
192012|NCT00840099|462341|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
192013|NCT00840099|462340|P2|NOT COMPLETED|Period 1||0
192014|NCT00840099|462341|P1|NOT COMPLETED|Period 1||0
192015|NCT00840099|462340|P2|COMPLETED|Period 1||24
192016|NCT00840099|462341|P1|COMPLETED|Period 1||24
192017|NCT00840099|462340|P2|STARTED|Period 1||24
192018|NCT00840099|462341|P1|STARTED|Period 1||24
192019|NCT00840086|462355|P1|NOT COMPLETED|Overall Study||4
192020|NCT00840086|462355|P1|COMPLETED|Overall Study||146
192021|NCT00840086|462355|P1|STARTED|Overall Study||150
192022|NCT00840073|462364|P2|NOT COMPLETED|Second Intervention||1
192023|NCT00840073|462365|P1|NOT COMPLETED|Second Intervention||1
192024|NCT00840073|462364|P2|COMPLETED|Second Intervention||24
192025|NCT00840073|462365|P1|COMPLETED|Second Intervention||24
192026|NCT00840073|462364|P2|STARTED|Second Intervention||25
192027|NCT00840073|462365|P1|STARTED|Second Intervention||25
192028|NCT00840073|462364|P2|NOT COMPLETED|First Intervention||0
192029|NCT00840073|462365|P1|NOT COMPLETED|First Intervention||0
192030|NCT00840073|462364|P2|COMPLETED|First Intervention||25
192031|NCT00840073|462365|P1|COMPLETED|First Intervention||25
192032|NCT00840073|462364|P2|STARTED|First Intervention||25
192033|NCT00840073|462365|P1|STARTED|First Intervention||25
192034|NCT00840060|462379|P2|NOT COMPLETED|Overall Study||1
192035|NCT00840060|462380|P1|NOT COMPLETED|Overall Study||1
192036|NCT00840060|462379|P2|COMPLETED|Overall Study||19
192037|NCT00840060|462380|P1|COMPLETED|Overall Study||19
192038|NCT00840060|462379|P2|STARTED|Overall Study||20
192039|NCT00840060|462380|P1|STARTED|Overall Study||20
192040|NCT00840034|462390|P2|NOT COMPLETED|Taper Phase||2
192041|NCT00840034|462391|P1|NOT COMPLETED|Taper Phase||3
192042|NCT00840034|462390|P2|COMPLETED|Taper Phase||80
192043|NCT00840034|462391|P1|COMPLETED|Taper Phase||87
192044|NCT00840034|462390|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
192045|NCT00840034|462391|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
192046|NCT00840034|462390|P2|NOT COMPLETED|Acute Treatment Phase||36
192047|NCT00840034|462391|P1|NOT COMPLETED|Acute Treatment Phase||21
192048|NCT00840034|462390|P2|COMPLETED|Acute Treatment Phase||80
192049|NCT00840034|462391|P1|COMPLETED|Acute Treatment Phase||90
192050|NCT00840034|462390|P2|STARTED|Acute Treatment Phase||116
192051|NCT00840034|462391|P1|STARTED|Acute Treatment Phase||111
192052|NCT00839982|462427|P4|NOT COMPLETED|Overall Study||0
192053|NCT00839982|462428|P3|NOT COMPLETED|Overall Study||0
192054|NCT00839982|462429|P2|NOT COMPLETED|Overall Study||0
192055|NCT00839982|462430|P1|NOT COMPLETED|Overall Study||0
192056|NCT00839982|462427|P4|COMPLETED|Overall Study||3
192057|NCT00839982|462428|P3|COMPLETED|Overall Study||2
192058|NCT00839982|462429|P2|COMPLETED|Overall Study||26
192059|NCT00839982|462430|P1|COMPLETED|Overall Study||4
192060|NCT00839982|462427|P4|STARTED|Overall Study||3
192061|NCT00839982|462428|P3|STARTED|Overall Study||2
192062|NCT00839982|462429|P2|STARTED|Overall Study||26
192063|NCT00839982|462430|P1|STARTED|Overall Study||4
192064|NCT00839956|462444|P1|NOT COMPLETED|Overall Study||12
192065|NCT00839956|462444|P1|COMPLETED|Overall Study||19
192066|NCT00839956|462444|P1|STARTED|Overall Study||31
192067|NCT00839930|462453|P2|NOT COMPLETED|Second Intervention||0
192068|NCT00839930|462454|P1|NOT COMPLETED|Second Intervention||0
192069|NCT00839930|462453|P2|COMPLETED|Second Intervention||15
192070|NCT00839930|462454|P1|COMPLETED|Second Intervention||15
192071|NCT00839930|462453|P2|STARTED|Second Intervention||15
192072|NCT00839930|462454|P1|STARTED|Second Intervention||15
192073|NCT00839930|462453|P2|NOT COMPLETED|Washout: 7 Days||0
192074|NCT00839930|462454|P1|NOT COMPLETED|Washout: 7 Days||0
192075|NCT00839930|462453|P2|COMPLETED|Washout: 7 Days||15
192076|NCT00839930|462454|P1|COMPLETED|Washout: 7 Days||15
192077|NCT00839930|462453|P2|STARTED|Washout: 7 Days||15
192078|NCT00839930|462454|P1|STARTED|Washout: 7 Days||15
192079|NCT00839930|462453|P2|NOT COMPLETED|First Intervention||0
192080|NCT00839930|462454|P1|NOT COMPLETED|First Intervention||0
192081|NCT00839930|462453|P2|COMPLETED|First Intervention||15
192082|NCT00839930|462454|P1|COMPLETED|First Intervention||15
192083|NCT00839930|462453|P2|STARTED|First Intervention||15
192084|NCT00839930|462454|P1|STARTED|First Intervention||15
192085|NCT00839917|462464|P2|NOT COMPLETED|Overall Study||1
192086|NCT00839917|462465|P1|NOT COMPLETED|Overall Study||1
192087|NCT00839917|462464|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
192088|NCT00839917|462465|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
192089|NCT00839917|462464|P2|STARTED|Overall Study||17
192090|NCT00839917|462465|P1|STARTED|Overall Study||13
192091|NCT00839800|462503|P2|NOT COMPLETED|Overall Study||110
192092|NCT00839800|462504|P1|NOT COMPLETED|Overall Study||93
192093|NCT00839800|462503|P2|COMPLETED|Overall Study||932
192094|NCT00839800|462504|P1|COMPLETED|Overall Study||956
192095|NCT00839800|462503|P2|STARTED|Overall Study||1042
192096|NCT00839800|462504|P1|STARTED|Overall Study||1049
192097|NCT00839540|462537|P3|NOT COMPLETED|Overall Study||0
192098|NCT00839540|462538|P2|NOT COMPLETED|Overall Study||0
192099|NCT00839540|462539|P1|NOT COMPLETED|Overall Study||0
192100|NCT00839540|462537|P3|COMPLETED|Overall Study||5
192101|NCT00839540|462538|P2|COMPLETED|Overall Study||8
192102|NCT00839540|462539|P1|COMPLETED|Overall Study||8
192103|NCT00839540|462537|P3|STARTED|Overall Study||5
192104|NCT00839540|462538|P2|STARTED|Overall Study||8
192105|NCT00839540|462539|P1|STARTED|Overall Study||8
192106|NCT00839527|462550|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
192107|NCT00839527|462551|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
192108|NCT00839527|462552|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
192109|NCT00839527|462550|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
192110|NCT00839527|462551|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
192111|NCT00839527|462552|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
192112|NCT00839527|462550|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
192113|NCT00839527|462551|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
192114|NCT00839527|462552|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
192115|NCT00839527|462550|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
192116|NCT00839527|462551|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
192117|NCT00839527|462552|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
192118|NCT00839527|462550|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
192119|NCT00839527|462551|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
192120|NCT00839527|462552|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
192121|NCT00839527|462550|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
192122|NCT00839527|462551|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
192123|NCT00839527|462552|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
192124|NCT00839436|462587|P3|NOT COMPLETED|Overall Study||1
192125|NCT00839436|462588|P2|NOT COMPLETED|Overall Study||1
192126|NCT00839436|462589|P1|NOT COMPLETED|Overall Study||1
192127|NCT00839436|462587|P3|COMPLETED|Overall Study||0
192128|NCT00839436|462588|P2|COMPLETED|Overall Study||4
192129|NCT00839436|462589|P1|COMPLETED|Overall Study||2
192130|NCT00839436|462587|P3|STARTED|Overall Study||1
192131|NCT00839436|462588|P2|STARTED|Overall Study||5
192132|NCT00839436|462589|P1|STARTED|Overall Study||3
192133|NCT00839423|462601|P4|NOT COMPLETED|Overall Study||20
192134|NCT00839423|462602|P3|NOT COMPLETED|Overall Study||18
192135|NCT00839423|462603|P2|NOT COMPLETED|Overall Study||10
192136|NCT00839423|462604|P1|NOT COMPLETED|Overall Study||18
192137|NCT00839423|462601|P4|COMPLETED|Overall Study||93
192138|NCT00839423|462602|P3|COMPLETED|Overall Study||82
192139|NCT00839423|462603|P2|COMPLETED|Overall Study||98
192140|NCT00839423|462604|P1|COMPLETED|Overall Study||87
192141|NCT00839423|462601|P4|STARTED|Overall Study||113
192142|NCT00839423|462602|P3|STARTED|Overall Study||100
192143|NCT00839423|462603|P2|STARTED|Overall Study||108
192144|NCT00839423|462604|P1|STARTED|Overall Study||105
192145|NCT00839332|462645|P3|NOT COMPLETED|Phase 2||39
192146|NCT00839332|462646|P2|NOT COMPLETED|Phase 2||68
192147|NCT00839332|462647|P1|NOT COMPLETED|Phase 2||0
192148|NCT00839332|462645|P3|COMPLETED|Phase 2||0
192149|NCT00839332|462646|P2|COMPLETED|Phase 2||0
192150|NCT00839332|462647|P1|COMPLETED|Phase 2||0
192151|NCT00839332|462645|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
192152|NCT00839332|462646|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
192153|NCT00839332|462647|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
192154|NCT00839332|462645|P3|STARTED|Phase 2||39
192155|NCT00839332|462646|P2|STARTED|Phase 2||68
192156|NCT00839332|462647|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
192157|NCT00839332|462645|P3|NOT COMPLETED|Phase 1||0
192158|NCT00839332|462646|P2|NOT COMPLETED|Phase 1||0
192159|NCT00839332|462647|P1|NOT COMPLETED|Phase 1||50
192160|NCT00839332|462645|P3|COMPLETED|Phase 1||0
192161|NCT00839332|462646|P2|COMPLETED|Phase 1||0
192162|NCT00839332|462647|P1|COMPLETED|Phase 1||0
192163|NCT00839332|462645|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
192164|NCT00839332|462646|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
192165|NCT00839332|462647|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
192166|NCT00839332|462645|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
192167|NCT00839332|462646|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
192168|NCT00839332|462647|P1|STARTED|Phase 1||50
192169|NCT00839319|462675|P5|NOT COMPLETED|Overall Study||0
192170|NCT00839319|462676|P4|NOT COMPLETED|Overall Study||3
192171|NCT00839319|462677|P3|NOT COMPLETED|Overall Study||3
192172|NCT00839319|462678|P2|NOT COMPLETED|Overall Study||1
192173|NCT00839319|462679|P1|NOT COMPLETED|Overall Study||2
192174|NCT00839319|462675|P5|COMPLETED|Overall Study||8
192175|NCT00839319|462676|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
192176|NCT00839319|462677|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
192177|NCT00839319|462678|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
192178|NCT00839319|462679|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
192179|NCT00839319|462675|P5|STARTED|Overall Study||8
192180|NCT00839319|462676|P4|STARTED|Overall Study||8
192181|NCT00839319|462677|P3|STARTED|Overall Study||8
192182|NCT00839319|462678|P2|STARTED|Overall Study||8
192183|NCT00839319|462679|P1|STARTED|Overall Study||8
192184|NCT00839306|462708|P2|NOT COMPLETED|Overall Study||43
192185|NCT00839306|462709|P1|NOT COMPLETED|Overall Study||25
192186|NCT00839306|462708|P2|COMPLETED|Overall Study||134
192187|NCT00839306|462709|P1|COMPLETED|Overall Study||35
192188|NCT00839306|462708|P2|STARTED|Overall Study|Treated|177
192189|NCT00839306|462709|P1|STARTED|Overall Study|Treated|60
192190|NCT00839241|462719|P2|NOT COMPLETED|Overall Study||17
192191|NCT00839241|462720|P1|NOT COMPLETED|Overall Study||5
192192|NCT00839241|462719|P2|COMPLETED|Overall Study||8
192193|NCT00839241|462720|P1|COMPLETED|Overall Study||15
192194|NCT00839241|462719|P2|STARTED|Overall Study||25
192195|NCT00839241|462720|P1|STARTED|Overall Study||20
192196|NCT00839098|462807|P3|NOT COMPLETED|Overall Study||7
192197|NCT00839098|462808|P2|NOT COMPLETED|Overall Study||1
192198|NCT00839098|462809|P1|NOT COMPLETED|Overall Study||2
192199|NCT00839098|462807|P3|COMPLETED|Overall Study||6
192200|NCT00839098|462808|P2|COMPLETED|Overall Study||11
192201|NCT00839098|462809|P1|COMPLETED|Overall Study||1
192202|NCT00839098|462807|P3|STARTED|Overall Study||13
192203|NCT00839098|462808|P2|STARTED|Overall Study||12
192204|NCT00839098|462809|P1|STARTED|Overall Study||3
192205|NCT00839072|462835|P2|NOT COMPLETED|Second Intervention Period||0
192206|NCT00839072|462836|P1|NOT COMPLETED|Second Intervention Period||1
192207|NCT00839072|462835|P2|COMPLETED|Second Intervention Period||11
192208|NCT00839072|462836|P1|COMPLETED|Second Intervention Period||9
192209|NCT00839072|462835|P2|STARTED|Second Intervention Period||11
192210|NCT00839072|462836|P1|STARTED|Second Intervention Period||10
192211|NCT00839072|462835|P2|NOT COMPLETED|Washout Period of 7 Days||0
192212|NCT00839072|462836|P1|NOT COMPLETED|Washout Period of 7 Days||0
192213|NCT00839072|462835|P2|COMPLETED|Washout Period of 7 Days||11
192214|NCT00839072|462836|P1|COMPLETED|Washout Period of 7 Days||10
192215|NCT00839072|462835|P2|STARTED|Washout Period of 7 Days||11
192216|NCT00839072|462836|P1|STARTED|Washout Period of 7 Days||10
192217|NCT00839072|462835|P2|NOT COMPLETED|First Intervention Period||1
192218|NCT00839072|462836|P1|NOT COMPLETED|First Intervention Period||2
192219|NCT00839072|462835|P2|COMPLETED|First Intervention Period||11
192220|NCT00839072|462836|P1|COMPLETED|First Intervention Period||10
192221|NCT00839072|462835|P2|STARTED|First Intervention Period||12
192222|NCT00839072|462836|P1|STARTED|First Intervention Period||12
192223|NCT00838981|462856|P4|NOT COMPLETED|Day 4 to Week 11||7
192224|NCT00838981|462857|P3|NOT COMPLETED|Day 4 to Week 11||11
192225|NCT00838981|462858|P2|NOT COMPLETED|Day 4 to Week 11||8
192226|NCT00838981|462859|P1|NOT COMPLETED|Day 4 to Week 11||7
192227|NCT00838981|462856|P4|COMPLETED|Day 4 to Week 11||12
192228|NCT00838981|462857|P3|COMPLETED|Day 4 to Week 11||16
192229|NCT00838981|462858|P2|COMPLETED|Day 4 to Week 11||11
192230|NCT00838981|462859|P1|COMPLETED|Day 4 to Week 11||19
192231|NCT00838981|462856|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
192232|NCT00838981|462857|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
192233|NCT00838981|462858|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
192234|NCT00838981|462859|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
192235|NCT00838981|462856|P4|STARTED|Day 4 to Week 11||19
192236|NCT00838981|462857|P3|STARTED|Day 4 to Week 11||27
192237|NCT00838981|462858|P2|STARTED|Day 4 to Week 11||19
192238|NCT00838981|462859|P1|STARTED|Day 4 to Week 11||26
192239|NCT00838981|462856|P4|NOT COMPLETED|Week 1 Days 1-3||0
192240|NCT00838981|462857|P3|NOT COMPLETED|Week 1 Days 1-3||0
192241|NCT00838981|462858|P2|NOT COMPLETED|Week 1 Days 1-3||0
192242|NCT00838981|462859|P1|NOT COMPLETED|Week 1 Days 1-3||0
192243|NCT00838981|462856|P4|COMPLETED|Week 1 Days 1-3||19
192244|NCT00838981|462857|P3|COMPLETED|Week 1 Days 1-3||27
192245|NCT00838981|462858|P2|COMPLETED|Week 1 Days 1-3||19
192246|NCT00838981|462859|P1|COMPLETED|Week 1 Days 1-3||26
192247|NCT00838981|462856|P4|STARTED|Week 1 Days 1-3||19
192248|NCT00838981|462857|P3|STARTED|Week 1 Days 1-3||27
192249|NCT00838981|462858|P2|STARTED|Week 1 Days 1-3||19
192250|NCT00838981|462859|P1|STARTED|Week 1 Days 1-3||26
192251|NCT00838929|462880|P3|NOT COMPLETED|Overall Study||1
192252|NCT00838929|462881|P2|NOT COMPLETED|Overall Study||3
192253|NCT00838929|462882|P1|NOT COMPLETED|Overall Study||0
192254|NCT00838929|462880|P3|COMPLETED|Overall Study||5
192255|NCT00838929|462881|P2|COMPLETED|Overall Study||5
192256|NCT00838929|462882|P1|COMPLETED|Overall Study||3
192257|NCT00838929|462880|P3|STARTED|Overall Study||6
192258|NCT00838929|462881|P2|STARTED|Overall Study||8
192259|NCT00838929|462882|P1|STARTED|Overall Study||3
192260|NCT00838916|462890|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
192261|NCT00838916|462891|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
192262|NCT00838916|462890|P2|COMPLETED|Follow-up Period (8 Weeks)||190
192263|NCT00838916|462891|P1|COMPLETED|Follow-up Period (8 Weeks)||408
192264|NCT00838916|462890|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
192265|NCT00838916|462891|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
192266|NCT00838916|462890|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
192267|NCT00838916|462891|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
192268|NCT00838916|462890|P2|COMPLETED|Treatment Period (156 Weeks)||164
192269|NCT00838916|462891|P1|COMPLETED|Treatment Period (156 Weeks)||308
192270|NCT00838916|462890|P2|STARTED|Treatment Period (156 Weeks)||241
192271|NCT00838916|462891|P1|STARTED|Treatment Period (156 Weeks)||504
192272|NCT00838903|462920|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
192273|NCT00838903|462921|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
192274|NCT00838903|462922|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
192275|NCT00838903|462923|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
192276|NCT00838903|462920|P4|COMPLETED|Follow-up Period (8 Weeks)||244
192277|NCT00838903|462921|P3|COMPLETED|Follow-up Period (8 Weeks)||243
192278|NCT00838903|462922|P2|COMPLETED|Follow-up Period (8 Weeks)||237
192279|NCT00838903|462923|P1|COMPLETED|Follow-up Period (8 Weeks)||75
192280|NCT00838903|462920|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
192281|NCT00838903|462921|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
192282|NCT00838903|462922|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
192283|NCT00838903|462923|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
192284|NCT00838903|462920|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
192285|NCT00838903|462921|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
192286|NCT00838903|462922|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
192287|NCT00838903|462923|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
192288|NCT00838903|462920|P4|COMPLETED|Treatment Period (156 Weeks)||192
192289|NCT00838903|462921|P3|COMPLETED|Treatment Period (156 Weeks)||191
192290|NCT00838903|462922|P2|COMPLETED|Treatment Period (156 Weeks)||190
192291|NCT00838903|462923|P1|COMPLETED|Treatment Period (156 Weeks)||55
192292|NCT00838903|462920|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
192293|NCT00838903|462921|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
192294|NCT00838903|462922|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
192295|NCT00838903|462923|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
192296|NCT00838903|462920|P4|STARTED|Treatment Period (156 Weeks)||302
192297|NCT00838903|462921|P3|STARTED|Treatment Period (156 Weeks)||307
192298|NCT00838903|462922|P2|STARTED|Treatment Period (156 Weeks)||302
192299|NCT00838903|462923|P1|STARTED|Treatment Period (156 Weeks)||101
192300|NCT00838682|462967|P2|NOT COMPLETED|Overall Study||19
192301|NCT00838682|462968|P1|NOT COMPLETED|Overall Study||25
192302|NCT00838682|462967|P2|COMPLETED|Overall Study||33
192303|NCT00838682|462968|P1|COMPLETED|Overall Study||29
192304|NCT00838682|462967|P2|STARTED|Overall Study||52
192305|NCT00838682|462968|P1|STARTED|Overall Study||54
192306|NCT00838630|462986|P2|NOT COMPLETED|Second Intervention||0
192307|NCT00838630|462987|P1|NOT COMPLETED|Second Intervention||0
192308|NCT00838630|462986|P2|COMPLETED|Second Intervention||18
192309|NCT00838630|462987|P1|COMPLETED|Second Intervention||16
192310|NCT00838630|462986|P2|STARTED|Second Intervention||18
192311|NCT00838630|462987|P1|STARTED|Second Intervention||16
192312|NCT00838630|462986|P2|NOT COMPLETED|Washout: 7 Days||0
192313|NCT00838630|462987|P1|NOT COMPLETED|Washout: 7 Days||1
192314|NCT00838630|462986|P2|COMPLETED|Washout: 7 Days||18
192315|NCT00838630|462987|P1|COMPLETED|Washout: 7 Days||16
192316|NCT00838630|462986|P2|STARTED|Washout: 7 Days||18
192317|NCT00838630|462987|P1|STARTED|Washout: 7 Days||17
192318|NCT00838630|462986|P2|NOT COMPLETED|First Intervention||0
192319|NCT00838630|462987|P1|NOT COMPLETED|First Intervention||1
192320|NCT00838630|462986|P2|COMPLETED|First Intervention||18
192321|NCT00838630|462987|P1|COMPLETED|First Intervention||17
192322|NCT00838630|462986|P2|STARTED|First Intervention||18
192323|NCT00838630|462987|P1|STARTED|First Intervention||18
192324|NCT00838578|462995|P1|NOT COMPLETED|Overall Study||2
192325|NCT00838578|462995|P1|COMPLETED|Overall Study||63
192326|NCT00838578|462995|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
192327|NCT00838539|463015|P12|NOT COMPLETED|Overall Study||4
192328|NCT00838539|463016|P11|NOT COMPLETED|Overall Study||5
192329|NCT00838539|463017|P10|NOT COMPLETED|Overall Study||8
192330|NCT00838539|463018|P9|NOT COMPLETED|Overall Study||5
192331|NCT00838539|463019|P8|NOT COMPLETED|Overall Study||6
192332|NCT00838539|463020|P7|NOT COMPLETED|Overall Study||5
192333|NCT00838539|463021|P6|NOT COMPLETED|Overall Study||4
192334|NCT00838539|463022|P5|NOT COMPLETED|Overall Study||4
192335|NCT00838539|463023|P4|NOT COMPLETED|Overall Study||4
192336|NCT00838539|463024|P3|NOT COMPLETED|Overall Study||5
192337|NCT00838539|463025|P2|NOT COMPLETED|Overall Study||5
192338|NCT00838539|463026|P1|NOT COMPLETED|Overall Study||3
192339|NCT00838539|463015|P12|COMPLETED|Overall Study||0
192340|NCT00838539|463016|P11|COMPLETED|Overall Study||0
192341|NCT00838539|463017|P10|COMPLETED|Overall Study||0
192342|NCT00838539|463018|P9|COMPLETED|Overall Study||0
192343|NCT00838539|463019|P8|COMPLETED|Overall Study||0
192344|NCT00838539|463020|P7|COMPLETED|Overall Study||2
192345|NCT00838539|463021|P6|COMPLETED|Overall Study||0
192346|NCT00838539|463022|P5|COMPLETED|Overall Study||0
192347|NCT00838539|463023|P4|COMPLETED|Overall Study||0
192348|NCT00838539|463024|P3|COMPLETED|Overall Study||0
192349|NCT00838539|463025|P2|COMPLETED|Overall Study||0
192350|NCT00838539|463026|P1|COMPLETED|Overall Study||0
192351|NCT00838539|463015|P12|STARTED|Overall Study||4
192352|NCT00838539|463016|P11|STARTED|Overall Study||5
192353|NCT00838539|463017|P10|STARTED|Overall Study||8
192354|NCT00838539|463018|P9|STARTED|Overall Study||5
192355|NCT00838539|463019|P8|STARTED|Overall Study||6
192356|NCT00838539|463020|P7|STARTED|Overall Study||7
192357|NCT00838539|463021|P6|STARTED|Overall Study||4
192358|NCT00838539|463022|P5|STARTED|Overall Study||4
192359|NCT00838539|463023|P4|STARTED|Overall Study||4
192360|NCT00838539|463024|P3|STARTED|Overall Study||5
192361|NCT00838539|463025|P2|STARTED|Overall Study||5
192362|NCT00838539|463026|P1|STARTED|Overall Study||3
192363|NCT00838526|463064|P2|NOT COMPLETED|Overall Study||39
192364|NCT00838526|463065|P1|NOT COMPLETED|Overall Study||24
192365|NCT00838526|463064|P2|COMPLETED|Overall Study||137
192366|NCT00838526|463065|P1|COMPLETED|Overall Study||35
192367|NCT00838526|463064|P2|STARTED|Overall Study|Treated|176
192368|NCT00838526|463065|P1|STARTED|Overall Study|Treated|59
192369|NCT00838513|463073|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
192370|NCT00838513|463073|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
192371|NCT00838513|463073|P1|STARTED|Post Treatment Period (Patients Who Disc||5
192372|NCT00838513|463073|P1|NOT COMPLETED|Extension Treatment Period||1
192373|NCT00838513|463073|P1|COMPLETED|Extension Treatment Period||18
192374|NCT00838513|463073|P1|STARTED|Extension Treatment Period||19
192375|NCT00838513|463073|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
192376|NCT00838513|463073|P1|COMPLETED|Treatment Period (26 Weeks)||20
192377|NCT00838513|463073|P1|STARTED|Treatment Period (26 Weeks)||20
192378|NCT00838513|463073|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
192379|NCT00838513|463073|P1|COMPLETED|Observation Period (8 Weeks)||20
192380|NCT00838513|463073|P1|STARTED|Observation Period (8 Weeks)||20
192381|NCT00838513|463073|P1|NOT COMPLETED|Screening Period||3
192382|NCT00838513|463073|P1|COMPLETED|Screening Period||20
192383|NCT00838513|463073|P1|STARTED|Screening Period||23
192384|NCT00838331|463089|P1|NOT COMPLETED|Aged Blood Transfusion||9
192385|NCT00838331|463089|P1|COMPLETED|Aged Blood Transfusion||8
192386|NCT00838331|463089|P1|STARTED|Aged Blood Transfusion||17
192387|NCT00838331|463089|P1|NOT COMPLETED|Fresh Blood Transfusion||0
192388|NCT00838331|463089|P1|COMPLETED|Fresh Blood Transfusion||17
192389|NCT00838331|463089|P1|STARTED|Fresh Blood Transfusion||17
192390|NCT00838279|463095|P2|NOT COMPLETED|Second Intervention||0
192391|NCT00838279|463096|P1|NOT COMPLETED|Second Intervention||0
192392|NCT00838279|463095|P2|COMPLETED|Second Intervention||15
192393|NCT00838279|463096|P1|COMPLETED|Second Intervention||15
192394|NCT00838279|463095|P2|STARTED|Second Intervention||15
192395|NCT00838279|463096|P1|STARTED|Second Intervention||15
192396|NCT00838279|463095|P2|NOT COMPLETED|Washout||1
192397|NCT00838279|463096|P1|NOT COMPLETED|Washout||1
192398|NCT00838279|463095|P2|COMPLETED|Washout||15
192399|NCT00838279|463096|P1|COMPLETED|Washout||15
192400|NCT00838279|463095|P2|STARTED|Washout||16
192401|NCT00838279|463096|P1|STARTED|Washout||16
192402|NCT00838279|463095|P2|NOT COMPLETED|First Intervention||0
192403|NCT00838279|463096|P1|NOT COMPLETED|First Intervention||0
192404|NCT00838279|463095|P2|COMPLETED|First Intervention||16
192405|NCT00838279|463096|P1|COMPLETED|First Intervention||16
192406|NCT00838279|463095|P2|STARTED|First Intervention||16
192407|NCT00838279|463096|P1|STARTED|First Intervention||16
192408|NCT00838201|463106|P2|NOT COMPLETED|Overall Study||53
192409|NCT00838201|463107|P1|NOT COMPLETED|Overall Study||42
192410|NCT00838201|463106|P2|COMPLETED|Overall Study||145
192411|NCT00838201|463107|P1|COMPLETED|Overall Study||144
192412|NCT00838201|463106|P2|STARTED|Overall Study||198
192413|NCT00838201|463107|P1|STARTED|Overall Study||186
192414|NCT00838162|463117|P4|NOT COMPLETED|Overall Study||0
192415|NCT00838162|463118|P3|NOT COMPLETED|Overall Study||0
192416|NCT00838162|463119|P2|NOT COMPLETED|Overall Study||0
192417|NCT00838162|463120|P1|NOT COMPLETED|Overall Study||0
192418|NCT00838162|463117|P4|COMPLETED|Overall Study||8
192419|NCT00838162|463118|P3|COMPLETED|Overall Study||8
192420|NCT00838162|463119|P2|COMPLETED|Overall Study||8
192421|NCT00838162|463120|P1|COMPLETED|Overall Study||9
192422|NCT00838162|463117|P4|STARTED|Overall Study||8
192423|NCT00838162|463118|P3|STARTED|Overall Study||8
192424|NCT00838162|463119|P2|STARTED|Overall Study||8
192425|NCT00838162|463120|P1|STARTED|Overall Study||9
192426|NCT00838136|463164|P2|NOT COMPLETED|Second Intervention||1
192427|NCT00838136|463165|P1|NOT COMPLETED|Second Intervention||0
192428|NCT00838136|463164|P2|COMPLETED|Second Intervention||15
192429|NCT00838136|463165|P1|COMPLETED|Second Intervention||16
192430|NCT00838136|463164|P2|STARTED|Second Intervention||16
192431|NCT00838136|463165|P1|STARTED|Second Intervention||16
192432|NCT00838136|463164|P2|NOT COMPLETED|First Intervention||0
192433|NCT00838136|463165|P1|NOT COMPLETED|First Intervention||0
192434|NCT00838136|463164|P2|COMPLETED|First Intervention||16
192435|NCT00838136|463165|P1|COMPLETED|First Intervention||16
192436|NCT00838136|463164|P2|STARTED|First Intervention||16
192437|NCT00838136|463165|P1|STARTED|First Intervention||16
192438|NCT00838110|463175|P4|NOT COMPLETED|Overall Study||18
192439|NCT00838110|463176|P3|NOT COMPLETED|Overall Study||17
192440|NCT00838110|463177|P2|NOT COMPLETED|Overall Study||22
192441|NCT00838110|463178|P1|NOT COMPLETED|Overall Study||22
192442|NCT00838110|463175|P4|COMPLETED|Overall Study||226
192443|NCT00838110|463176|P3|COMPLETED|Overall Study||226
192444|NCT00838110|463177|P2|COMPLETED|Overall Study||106
192445|NCT00838110|463178|P1|COMPLETED|Overall Study||105
192446|NCT00838110|463175|P4|Treated|Overall Study||244
192447|NCT00838110|463176|P3|Treated|Overall Study||243
192448|NCT00838110|463177|P2|Treated|Overall Study||127
192449|NCT00838110|463178|P1|Treated|Overall Study||127
192450|NCT00838110|463175|P4|STARTED|Overall Study||244
192451|NCT00838110|463176|P3|STARTED|Overall Study||243
192452|NCT00838110|463177|P2|STARTED|Overall Study||128
192453|NCT00838110|463178|P1|STARTED|Overall Study||127
192454|NCT00838097|463198|P1|NOT COMPLETED|Overall Study||176
192455|NCT00838097|463198|P1|COMPLETED|Overall Study||145
192456|NCT00838097|463198|P1|Received Darbepoetin Alfa|Overall Study||319
192457|NCT00838097|463198|P1|STARTED|Overall Study||321
192458|NCT00837967|463206|P2|NOT COMPLETED|Second Intervention||0
192459|NCT00837967|463207|P1|NOT COMPLETED|Second Intervention||0
192460|NCT00837967|463206|P2|COMPLETED|Second Intervention||12
192461|NCT00837967|463207|P1|COMPLETED|Second Intervention||11
192462|NCT00837967|463206|P2|STARTED|Second Intervention||12
192463|NCT00837967|463207|P1|STARTED|Second Intervention||11
192464|NCT00837967|463206|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
192465|NCT00837967|463207|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
192466|NCT00837967|463206|P2|COMPLETED|Washout Period of 7 - 14 Days||12
192467|NCT00837967|463207|P1|COMPLETED|Washout Period of 7 - 14 Days||11
192468|NCT00837967|463206|P2|STARTED|Washout Period of 7 - 14 Days||12
192469|NCT00837967|463207|P1|STARTED|Washout Period of 7 - 14 Days||13
192470|NCT00837967|463206|P2|NOT COMPLETED|First Intervention||0
192471|NCT00837967|463207|P1|NOT COMPLETED|First Intervention||0
192472|NCT00837967|463206|P2|COMPLETED|First Intervention||12
192473|NCT00837967|463207|P1|COMPLETED|First Intervention||13
192474|NCT00837967|463206|P2|STARTED|First Intervention||12
192475|NCT00837967|463207|P1|STARTED|First Intervention||13
192476|NCT00837876|463223|P1|NOT COMPLETED|Overall Study||37
192477|NCT00837876|463223|P1|COMPLETED|Overall Study||0
192478|NCT00837876|463223|P1|STARTED|Overall Study||37
192479|NCT00837824|463232|P2|NOT COMPLETED|Overall Study||0
192480|NCT00837824|463233|P1|NOT COMPLETED|Overall Study||0
192481|NCT00837824|463232|P2|COMPLETED|Overall Study||9
192482|NCT00837824|463233|P1|COMPLETED|Overall Study||11
192483|NCT00837824|463232|P2|STARTED|Overall Study||9
192484|NCT00837824|463233|P1|STARTED|Overall Study||11
192485|NCT00837811|463245|P3|NOT COMPLETED|Overall Study||1
192486|NCT00837811|463246|P2|NOT COMPLETED|Overall Study||34
192487|NCT00837811|463247|P1|NOT COMPLETED|Overall Study||7
192488|NCT00837811|463245|P3|COMPLETED|Overall Study||0
192489|NCT00837811|463246|P2|COMPLETED|Overall Study||87
192490|NCT00837811|463247|P1|COMPLETED|Overall Study||53
192491|NCT00837811|463245|P3|Included in Efficacy Analyses|Overall Study||1
192492|NCT00837811|463246|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
192493|NCT00837811|463247|P1|Included in Efficacy Analyses|Overall Study||59
192494|NCT00837811|463245|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
192495|NCT00837811|463246|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
192496|NCT00837811|463247|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
192497|NCT00837811|463245|P3|Received Any Amount of Study Drug|Overall Study||1
192498|NCT00837811|463246|P2|Received Any Amount of Study Drug|Overall Study||121
192499|NCT00837811|463247|P1|Received Any Amount of Study Drug|Overall Study||60
192500|NCT00837811|463245|P3|STARTED|Overall Study||1
192501|NCT00837811|463246|P2|STARTED|Overall Study||121
192502|NCT00837811|463247|P1|STARTED|Overall Study||60
192503|NCT00837759|463332|P1|NOT COMPLETED|Overall Study||4
192504|NCT00837759|463332|P1|COMPLETED|Overall Study||3
192505|NCT00837759|463332|P1|STARTED|Overall Study||7
192506|NCT00837616|463343|P2|NOT COMPLETED|Overall Study||1
192507|NCT00837616|463344|P1|NOT COMPLETED|Overall Study||0
192508|NCT00837616|463343|P2|COMPLETED|Overall Study||20
192509|NCT00837616|463344|P1|COMPLETED|Overall Study||20
192510|NCT00837616|463343|P2|STARTED|Overall Study||21
192511|NCT00837616|463344|P1|STARTED|Overall Study||20
192512|NCT00837577|463370|P2|NOT COMPLETED|Open-label Period||9
192513|NCT00837577|463371|P1|NOT COMPLETED|Open-label Period||8
192514|NCT00837577|463370|P2|COMPLETED|Open-label Period||54
192515|NCT00837577|463371|P1|COMPLETED|Open-label Period||60
192516|NCT00837577|463370|P2|STARTED|Open-label Period||63
192517|NCT00837577|463371|P1|STARTED|Open-label Period||68
192518|NCT00837577|463370|P2|NOT COMPLETED|Double-blind Period||0
192519|NCT00837577|463371|P1|NOT COMPLETED|Double-blind Period||2
192520|NCT00837577|463370|P2|COMPLETED|Double-blind Period||63
192521|NCT00837577|463371|P1|COMPLETED|Double-blind Period||68
192522|NCT00837577|463370|P2|STARTED|Double-blind Period||63
192523|NCT00837577|463371|P1|STARTED|Double-blind Period||70
192524|NCT00837512|463382|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
192525|NCT00837512|463383|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
192526|NCT00837512|463382|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
192527|NCT00837512|463383|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
192528|NCT00837512|463382|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
192529|NCT00837512|463383|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
192530|NCT00837512|463382|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
192531|NCT00837512|463383|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
192532|NCT00837512|463382|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
192533|NCT00837512|463383|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
192534|NCT00837512|463382|P2|STARTED|Both Arms: Washout (7-28 Days)||8
192535|NCT00837512|463383|P1|STARTED|Both Arms: Washout (7-28 Days)||8
192536|NCT00837512|463382|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
192537|NCT00837512|463383|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
192538|NCT00837512|463382|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
192539|NCT00837512|463383|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
192540|NCT00837512|463382|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
192541|NCT00837512|463383|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
192542|NCT00837486|463391|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
192543|NCT00837486|463392|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
192544|NCT00837486|463391|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
192545|NCT00837486|463392|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
192546|NCT00837486|463391|P2|STARTED|Long-term Follow-up Phase - Open Label||0
192547|NCT00837486|463392|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
192548|NCT00837486|463391|P2|NOT COMPLETED|Blinded-treatment Phase||0
192549|NCT00837486|463392|P1|NOT COMPLETED|Blinded-treatment Phase||1
192550|NCT00837486|463391|P2|COMPLETED|Blinded-treatment Phase||14
192551|NCT00837486|463392|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
192552|NCT00837486|463391|P2|STARTED|Blinded-treatment Phase||14
192553|NCT00837486|463392|P1|STARTED|Blinded-treatment Phase||16
192554|NCT00837473|463404|P1|NOT COMPLETED|Overall Study||3
192555|NCT00837473|463404|P1|COMPLETED|Overall Study||12
192556|NCT00837473|463404|P1|STARTED|Overall Study||15
192557|NCT00837447|463417|P1|NOT COMPLETED|Overall Study||0
192558|NCT00837447|463417|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
192559|NCT00837447|463417|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
192560|NCT00837434|463424|P2|NOT COMPLETED|Overall Study||1
192561|NCT00837434|463425|P1|NOT COMPLETED|Overall Study||9
192562|NCT00837434|463424|P2|COMPLETED|Overall Study||19
192563|NCT00837434|463425|P1|COMPLETED|Overall Study||34
192564|NCT00837434|463424|P2|STARTED|Overall Study||20
192565|NCT00837434|463425|P1|STARTED|Overall Study||43
192566|NCT00837330|463445|P2|NOT COMPLETED|Overall Study||3
192567|NCT00837330|463446|P1|NOT COMPLETED|Overall Study||1
192568|NCT00837330|463445|P2|COMPLETED|Overall Study||7
192569|NCT00837330|463446|P1|COMPLETED|Overall Study||9
192570|NCT00837330|463445|P2|STARTED|Overall Study||10
192571|NCT00837330|463446|P1|STARTED|Overall Study||10
192572|NCT00837252|463452|P1|NOT COMPLETED|Overall Study||0
192573|NCT00837252|463452|P1|COMPLETED|Overall Study||5
192574|NCT00837252|463452|P1|STARTED|Overall Study||5
192575|NCT00837213|463469|P2|NOT COMPLETED|Overall Study||5
192576|NCT00837213|463470|P1|NOT COMPLETED|Overall Study||6
192577|NCT00837213|463469|P2|COMPLETED|Overall Study||12
192578|NCT00837213|463470|P1|COMPLETED|Overall Study||10
192579|NCT00837213|463469|P2|STARTED|Overall Study||17
192580|NCT00837213|463470|P1|STARTED|Overall Study||16
192581|NCT00837200|463490|P1|NOT COMPLETED|Overall Study||0
192582|NCT00837200|463490|P1|COMPLETED|Overall Study||13
192583|NCT00837200|463490|P1|STARTED|Overall Study||13
192584|NCT00837161|463496|P1|NOT COMPLETED|Overall Study||2
192585|NCT00837161|463496|P1|COMPLETED|Overall Study||9
192586|NCT00837161|463496|P1|STARTED|Overall Study||11
192587|NCT00837148|463504|P1|NOT COMPLETED|Overall Study||2
192588|NCT00837148|463504|P1|COMPLETED|Overall Study||35
192589|NCT00837148|463504|P1|STARTED|Overall Study||37
192590|NCT00837031|463508|P1|NOT COMPLETED|Overall Study||0
192591|NCT00837031|463508|P1|COMPLETED|Overall Study||72
192592|NCT00837031|463508|P1|STARTED|Overall Study||72
192593|NCT00836953|463514|P1|NOT COMPLETED|Overall Study||2
192594|NCT00836953|463514|P1|COMPLETED|Overall Study||31
192595|NCT00836953|463514|P1|STARTED|Overall Study||33
192596|NCT00836927|463525|P5|NOT COMPLETED|Overall Study||1
192597|NCT00836927|463526|P4|NOT COMPLETED|Overall Study||1
192598|NCT00836927|463527|P3|NOT COMPLETED|Overall Study||1
192599|NCT00836927|463528|P2|NOT COMPLETED|Overall Study||1
192600|NCT00836927|463529|P1|NOT COMPLETED|Overall Study||3
192601|NCT00836927|463525|P5|COMPLETED|Overall Study||0
192602|NCT00836927|463526|P4|COMPLETED|Overall Study||0
192603|NCT00836927|463527|P3|COMPLETED|Overall Study||0
192604|NCT00836927|463528|P2|COMPLETED|Overall Study||0
192605|NCT00836927|463529|P1|COMPLETED|Overall Study||0
192606|NCT00836927|463525|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
192607|NCT00836927|463526|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
192608|NCT00836927|463527|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continues to receive study drug past the data cut-off date of 03 Apr 2017|1
192609|NCT00836927|463528|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continues to receive study drug past the data cut-off date of 03 Apr 2017|1
192610|NCT00836927|463529|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
192611|NCT00836927|463525|P5|STARTED|Overall Study||1
192612|NCT00836927|463526|P4|STARTED|Overall Study||1
192613|NCT00836927|463527|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
192614|NCT00836927|463528|P2|STARTED|Overall Study||1
192615|NCT00836927|463529|P1|STARTED|Overall Study||3
192616|NCT00836901|463563|P2|NOT COMPLETED|Second Intervention||0
192617|NCT00836901|463564|P1|NOT COMPLETED|Second Intervention||0
192618|NCT00836901|463563|P2|COMPLETED|Second Intervention||28
192619|NCT00836901|463564|P1|COMPLETED|Second Intervention||23
192620|NCT00836901|463563|P2|STARTED|Second Intervention||28
192621|NCT00836901|463564|P1|STARTED|Second Intervention||23
192622|NCT00836901|463563|P2|NOT COMPLETED|First Intervention||0
192623|NCT00836901|463564|P1|NOT COMPLETED|First Intervention||1
192624|NCT00836901|463563|P2|COMPLETED|First Intervention||28
192625|NCT00836901|463564|P1|COMPLETED|First Intervention||23
192626|NCT00836901|463563|P2|STARTED|First Intervention||28
192627|NCT00836901|463564|P1|STARTED|First Intervention||24
192628|NCT00836875|463580|P2|NOT COMPLETED|Overall Study||3
192629|NCT00836875|463581|P1|NOT COMPLETED|Overall Study||3
192630|NCT00836875|463580|P2|COMPLETED|Overall Study||17
192631|NCT00836875|463581|P1|COMPLETED|Overall Study||8
192632|NCT00836875|463580|P2|STARTED|Overall Study||20
192633|NCT00836875|463581|P1|STARTED|Overall Study||11
192634|NCT00836810|463597|P2|NOT COMPLETED|Overall Study||0
192635|NCT00836810|463598|P1|NOT COMPLETED|Overall Study||1
192636|NCT00836810|463597|P2|COMPLETED|Overall Study||6
192637|NCT00836810|463598|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
192638|NCT00836810|463597|P2|STARTED|Overall Study||6
192639|NCT00836810|463598|P1|STARTED|Overall Study||5
192640|NCT00836745|463614|P1|NOT COMPLETED|Overall Study||21
192641|NCT00836745|463614|P1|COMPLETED|Overall Study||15
192642|NCT00836745|463614|P1|STARTED|Overall Study||36
192643|NCT00836719|463621|P1|NOT COMPLETED|Overall Study||0
192644|NCT00836719|463621|P1|COMPLETED|Overall Study||10
192645|NCT00836719|463621|P1|STARTED|Overall Study||10
192646|NCT00836706|463628|P2|NOT COMPLETED|Second Intervention||0
192647|NCT00836706|463629|P1|NOT COMPLETED|Second Intervention||0
192648|NCT00836706|463628|P2|COMPLETED|Second Intervention||11
192649|NCT00836706|463629|P1|COMPLETED|Second Intervention||11
192650|NCT00836706|463628|P2|STARTED|Second Intervention||11
192651|NCT00836706|463629|P1|STARTED|Second Intervention||11
192652|NCT00836706|463628|P2|NOT COMPLETED|Washout: 7 Days||1
192653|NCT00836706|463629|P1|NOT COMPLETED|Washout: 7 Days||0
192654|NCT00836706|463628|P2|COMPLETED|Washout: 7 Days||11
192655|NCT00836706|463629|P1|COMPLETED|Washout: 7 Days||11
192656|NCT00836706|463628|P2|STARTED|Washout: 7 Days||12
192657|NCT00836706|463629|P1|STARTED|Washout: 7 Days||11
192658|NCT00836706|463628|P2|NOT COMPLETED|First Intervention||0
192659|NCT00836706|463629|P1|NOT COMPLETED|First Intervention||0
192660|NCT00836706|463628|P2|COMPLETED|First Intervention||12
192661|NCT00836706|463629|P1|COMPLETED|First Intervention||11
192662|NCT00836706|463628|P2|STARTED|First Intervention||12
192663|NCT00836706|463629|P1|STARTED|First Intervention||11
192664|NCT00836693|463639|P2|NOT COMPLETED|Overall Study||6
192665|NCT00836693|463640|P1|NOT COMPLETED|Overall Study||17
192666|NCT00836693|463639|P2|COMPLETED|Overall Study||64
192667|NCT00836693|463640|P1|COMPLETED|Overall Study||130
192668|NCT00836693|463639|P2|STARTED|Overall Study||70
192669|NCT00836693|463640|P1|STARTED|Overall Study||147
192670|NCT00836641|463682|P2|NOT COMPLETED|Overall Study||0
192671|NCT00836641|463683|P1|NOT COMPLETED|Overall Study||0
192672|NCT00836641|463682|P2|COMPLETED|Overall Study||34
192673|NCT00836641|463683|P1|COMPLETED|Overall Study||36
192674|NCT00836641|463682|P2|STARTED|Overall Study||34
192675|NCT00836641|463683|P1|STARTED|Overall Study||36
192676|NCT00836498|463692|P2|NOT COMPLETED|Overall Study||1
192677|NCT00836498|463693|P1|NOT COMPLETED|Overall Study||4
192678|NCT00836498|463692|P2|COMPLETED|Overall Study||21
192679|NCT00836498|463693|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
192680|NCT00836498|463692|P2|STARTED|Overall Study||22
192681|NCT00836498|463693|P1|STARTED|Overall Study||44
192682|NCT00836472|463725|P2|NOT COMPLETED|Second Intervention||0
192683|NCT00836472|463726|P1|NOT COMPLETED|Second Intervention||0
192684|NCT00836472|463725|P2|COMPLETED|Second Intervention||27
192685|NCT00836472|463726|P1|COMPLETED|Second Intervention||28
192686|NCT00836472|463725|P2|STARTED|Second Intervention||27
192687|NCT00836472|463726|P1|STARTED|Second Intervention||28
192688|NCT00836472|463725|P2|NOT COMPLETED|Washout||3
192689|NCT00836472|463726|P1|NOT COMPLETED|Washout||2
192690|NCT00836472|463725|P2|COMPLETED|Washout||27
192691|NCT00836472|463726|P1|COMPLETED|Washout||28
192692|NCT00836472|463725|P2|STARTED|Washout||30
192693|NCT00836472|463726|P1|STARTED|Washout||30
192694|NCT00836472|463725|P2|NOT COMPLETED|First Intervention||0
192695|NCT00836472|463726|P1|NOT COMPLETED|First Intervention||0
192696|NCT00836472|463725|P2|COMPLETED|First Intervention||30
192697|NCT00836472|463726|P1|COMPLETED|First Intervention||30
192698|NCT00836472|463725|P2|STARTED|First Intervention||30
192699|NCT00836472|463726|P1|STARTED|First Intervention||30
192700|NCT00836433|463742|P2|NOT COMPLETED|Overall Study||7
192701|NCT00836433|463743|P1|NOT COMPLETED|Overall Study||12
192702|NCT00836433|463742|P2|COMPLETED|Overall Study||321
192703|NCT00836433|463743|P1|COMPLETED|Overall Study||349
192704|NCT00836433|463742|P2|STARTED|Overall Study||328
192705|NCT00836433|463743|P1|STARTED|Overall Study||361
192706|NCT00836407|463753|P2|NOT COMPLETED|Overall Study||8
192707|NCT00836407|463754|P1|NOT COMPLETED|Overall Study||11
192708|NCT00836407|463753|P2|COMPLETED|Overall Study||7
192709|NCT00836407|463754|P1|COMPLETED|Overall Study||4
192710|NCT00836407|463753|P2|STARTED|Overall Study||15
192711|NCT00836407|463754|P1|STARTED|Overall Study||15
192712|NCT00836355|463766|P4|NOT COMPLETED|Overall Study||0
192713|NCT00836355|463767|P3|NOT COMPLETED|Overall Study||0
192714|NCT00836355|463768|P2|NOT COMPLETED|Overall Study||0
192715|NCT00836355|463769|P1|NOT COMPLETED|Overall Study||0
192716|NCT00836355|463766|P4|COMPLETED|Overall Study||2
192717|NCT00836355|463767|P3|COMPLETED|Overall Study||0
192718|NCT00836355|463768|P2|COMPLETED|Overall Study||4
192719|NCT00836355|463769|P1|COMPLETED|Overall Study||0
192720|NCT00836355|463766|P4|STARTED|Overall Study||2
192721|NCT00836355|463767|P3|STARTED|Overall Study||0
192722|NCT00836355|463768|P2|STARTED|Overall Study||4
192723|NCT00836355|463769|P1|STARTED|Overall Study||0
192724|NCT00836342|463790|P3|NOT COMPLETED|Overall Study||0
192725|NCT00836342|463791|P2|NOT COMPLETED|Overall Study||0
192726|NCT00836342|463792|P1|NOT COMPLETED|Overall Study||0
192727|NCT00836342|463790|P3|COMPLETED|Overall Study||36
192728|NCT00836342|463791|P2|COMPLETED|Overall Study||23
192729|NCT00836342|463792|P1|COMPLETED|Overall Study||22
192730|NCT00836342|463790|P3|STARTED|Overall Study||36
192731|NCT00836342|463791|P2|STARTED|Overall Study||23
192732|NCT00836342|463792|P1|STARTED|Overall Study||22
192733|NCT00836277|463803|P1|NOT COMPLETED|Overall Study||6
192734|NCT00836277|463803|P1|COMPLETED|Overall Study||18
192735|NCT00836277|463803|P1|STARTED|Overall Study||24
192736|NCT00836095|463813|P2|NOT COMPLETED|Overall Study||3
192737|NCT00836095|463814|P1|NOT COMPLETED|Overall Study||0
192738|NCT00836095|463813|P2|COMPLETED|Overall Study||27
192739|NCT00836095|463814|P1|COMPLETED|Overall Study||22
192740|NCT00836095|463813|P2|STARTED|Overall Study||30
192741|NCT00836095|463814|P1|STARTED|Overall Study||22
192742|NCT00836056|463824|P2|NOT COMPLETED|Second Intervention||0
192743|NCT00836056|463825|P1|NOT COMPLETED|Second Intervention||0
192744|NCT00836056|463824|P2|COMPLETED|Second Intervention||12
192745|NCT00836056|463825|P1|COMPLETED|Second Intervention||11
192746|NCT00836056|463824|P2|STARTED|Second Intervention||12
192747|NCT00836056|463825|P1|STARTED|Second Intervention||11
192748|NCT00836056|463824|P2|NOT COMPLETED|Washout: 7 Days||0
192749|NCT00836056|463825|P1|NOT COMPLETED|Washout: 7 Days||0
192750|NCT00836056|463824|P2|COMPLETED|Washout: 7 Days||12
192751|NCT00836056|463825|P1|COMPLETED|Washout: 7 Days||11
192752|NCT00836056|463824|P2|STARTED|Washout: 7 Days||12
192753|NCT00836056|463825|P1|STARTED|Washout: 7 Days||11
192754|NCT00836056|463824|P2|NOT COMPLETED|First Intervention||0
192755|NCT00836056|463825|P1|NOT COMPLETED|First Intervention||1
192756|NCT00836056|463824|P2|COMPLETED|First Intervention||12
192757|NCT00836056|463825|P1|COMPLETED|First Intervention||11
192758|NCT00836056|463824|P2|STARTED|First Intervention||12
192759|NCT00836056|463825|P1|STARTED|First Intervention||12
192760|NCT00836017|463833|P1|NOT COMPLETED|Overall Study||544
192761|NCT00836017|463833|P1|COMPLETED|Overall Study||502
192762|NCT00836017|463833|P1|STARTED|Overall Study||1046
192763|NCT00836004|463843|P2|NOT COMPLETED|Second Intervention||0
192764|NCT00836004|463844|P1|NOT COMPLETED|Second Intervention||0
192765|NCT00836004|463843|P2|COMPLETED|Second Intervention||12
192766|NCT00836004|463844|P1|COMPLETED|Second Intervention||12
192767|NCT00836004|463843|P2|STARTED|Second Intervention||12
192768|NCT00836004|463844|P1|STARTED|Second Intervention||12
192769|NCT00836004|463843|P2|NOT COMPLETED|Washout: 7 Days||0
192770|NCT00836004|463844|P1|NOT COMPLETED|Washout: 7 Days||0
192771|NCT00836004|463843|P2|COMPLETED|Washout: 7 Days||12
192772|NCT00836004|463844|P1|COMPLETED|Washout: 7 Days||12
192773|NCT00836004|463843|P2|STARTED|Washout: 7 Days||12
192774|NCT00836004|463844|P1|STARTED|Washout: 7 Days||12
192775|NCT00836004|463843|P2|NOT COMPLETED|First Intervention||0
192776|NCT00836004|463844|P1|NOT COMPLETED|First Intervention||0
192777|NCT00836004|463843|P2|COMPLETED|First Intervention||12
192778|NCT00836004|463844|P1|COMPLETED|First Intervention||12
192779|NCT00836004|463843|P2|STARTED|First Intervention||12
192780|NCT00836004|463844|P1|STARTED|First Intervention||12
192781|NCT00835991|463854|P2|NOT COMPLETED|Second Intervention||0
192782|NCT00835991|463855|P1|NOT COMPLETED|Second Intervention||0
192783|NCT00835991|463854|P2|COMPLETED|Second Intervention||26
192784|NCT00835991|463855|P1|COMPLETED|Second Intervention||27
192785|NCT00835991|463854|P2|STARTED|Second Intervention||26
192786|NCT00835991|463855|P1|STARTED|Second Intervention||27
192787|NCT00835991|463854|P2|NOT COMPLETED|Washout||3
192788|NCT00835991|463855|P1|NOT COMPLETED|Washout||3
192789|NCT00835991|463854|P2|COMPLETED|Washout||26
192790|NCT00835991|463855|P1|COMPLETED|Washout||27
192791|NCT00835991|463854|P2|STARTED|Washout||29
192792|NCT00835991|463855|P1|STARTED|Washout||30
192793|NCT00835991|463854|P2|NOT COMPLETED|First Intervention||1
192794|NCT00835991|463855|P1|NOT COMPLETED|First Intervention||0
192795|NCT00835991|463854|P2|COMPLETED|First Intervention||29
192796|NCT00835991|463855|P1|COMPLETED|First Intervention||30
192797|NCT00835991|463854|P2|STARTED|First Intervention||30
192798|NCT00835991|463855|P1|STARTED|First Intervention||30
192799|NCT00835978|463873|P4|NOT COMPLETED|Overall Study||10
192800|NCT00835978|463874|P3|NOT COMPLETED|Overall Study||91
192801|NCT00835978|463875|P2|NOT COMPLETED|Overall Study||56
192802|NCT00835978|463876|P1|NOT COMPLETED|Overall Study||56
192803|NCT00835978|463873|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
192804|NCT00835978|463874|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
192805|NCT00835978|463875|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
192806|NCT00835978|463876|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
192807|NCT00835978|463873|P4|Treated|Overall Study||10
192808|NCT00835978|463874|P3|Treated|Overall Study||91
192809|NCT00835978|463875|P2|Treated|Overall Study||56
192810|NCT00835978|463876|P1|Treated|Overall Study||56
192811|NCT00835978|463873|P4|STARTED|Overall Study||10
192812|NCT00835978|463874|P3|STARTED|Overall Study||91
192813|NCT00835978|463875|P2|STARTED|Overall Study||56
192814|NCT00835978|463876|P1|STARTED|Overall Study||56
192815|NCT00835926|463936|P2|NOT COMPLETED|Overall Study||0
192816|NCT00835926|463937|P1|NOT COMPLETED|Overall Study||0
192817|NCT00835926|463936|P2|COMPLETED|Overall Study||60
192818|NCT00835926|463937|P1|COMPLETED|Overall Study||61
192819|NCT00835926|463936|P2|STARTED|Overall Study||60
192820|NCT00835926|463937|P1|STARTED|Overall Study||61
192821|NCT00835900|463951|P2|NOT COMPLETED|Overall Study||6
192822|NCT00835900|463952|P1|NOT COMPLETED|Overall Study||5
192823|NCT00835900|463951|P2|COMPLETED|Overall Study||22
192824|NCT00835900|463952|P1|COMPLETED|Overall Study||27
192825|NCT00835900|463951|P2|STARTED|Overall Study||28
192826|NCT00835900|463952|P1|STARTED|Overall Study||32
192827|NCT00835861|463962|P2|NOT COMPLETED|Overall Study||2
192828|NCT00835861|463963|P1|NOT COMPLETED|Overall Study||1
192829|NCT00835861|463962|P2|COMPLETED|Overall Study||14
192830|NCT00835861|463963|P1|COMPLETED|Overall Study||14
192831|NCT00835861|463962|P2|STARTED|Overall Study||16
192832|NCT00835861|463963|P1|STARTED|Overall Study||15
192833|NCT00835796|463987|P2|NOT COMPLETED|Second Intervention||0
192834|NCT00835796|463988|P1|NOT COMPLETED|Second Intervention||0
192835|NCT00835796|463987|P2|COMPLETED|Second Intervention||9
192836|NCT00835796|463988|P1|COMPLETED|Second Intervention||10
192837|NCT00835796|463987|P2|STARTED|Second Intervention||9
192838|NCT00835796|463988|P1|STARTED|Second Intervention||10
192839|NCT00835796|463987|P2|NOT COMPLETED|Washout||0
192840|NCT00835796|463988|P1|NOT COMPLETED|Washout||0
192841|NCT00835796|463987|P2|COMPLETED|Washout||9
192842|NCT00835796|463988|P1|COMPLETED|Washout||10
192843|NCT00835796|463987|P2|STARTED|Washout||9
192844|NCT00835796|463988|P1|STARTED|Washout||10
192845|NCT00835796|463987|P2|NOT COMPLETED|First Intervention||1
192846|NCT00835796|463988|P1|NOT COMPLETED|First Intervention||0
192847|NCT00835796|463987|P2|COMPLETED|First Intervention||9
192848|NCT00835796|463988|P1|COMPLETED|First Intervention||10
192849|NCT00835796|463987|P2|STARTED|First Intervention||10
192850|NCT00835796|463988|P1|STARTED|First Intervention||10
192851|NCT00835731|463998|P2|NOT COMPLETED|Overall Study||1
192852|NCT00835731|463999|P1|NOT COMPLETED|Overall Study||2
192853|NCT00835731|463998|P2|COMPLETED|Overall Study||60
192854|NCT00835731|463999|P1|COMPLETED|Overall Study||62
192855|NCT00835731|463998|P2|STARTED|Overall Study||61
192856|NCT00835731|463999|P1|STARTED|Overall Study||64
192857|NCT00835705|464019|P2|NOT COMPLETED|Second Intervention||0
192858|NCT00835705|464020|P1|NOT COMPLETED|Second Intervention||1
192859|NCT00835705|464019|P2|COMPLETED|Second Intervention||28
192860|NCT00835705|464020|P1|COMPLETED|Second Intervention||22
192861|NCT00835705|464019|P2|STARTED|Second Intervention||28
192862|NCT00835705|464020|P1|STARTED|Second Intervention||23
192863|NCT00835705|464019|P2|NOT COMPLETED|First Intervention||0
192864|NCT00835705|464020|P1|NOT COMPLETED|First Intervention||1
192865|NCT00835705|464019|P2|COMPLETED|First Intervention||28
192866|NCT00835705|464020|P1|COMPLETED|First Intervention||23
192867|NCT00835705|464019|P2|STARTED|First Intervention||28
192868|NCT00835705|464020|P1|STARTED|First Intervention||24
192869|NCT00835692|464036|P2|NOT COMPLETED|Second Intervention||0
192870|NCT00835692|464037|P1|NOT COMPLETED|Second Intervention||0
192871|NCT00835692|464036|P2|COMPLETED|Second Intervention||28
192872|NCT00835692|464037|P1|COMPLETED|Second Intervention||27
192873|NCT00835692|464036|P2|STARTED|Second Intervention||28
192874|NCT00835692|464037|P1|STARTED|Second Intervention||27
192875|NCT00835692|464036|P2|NOT COMPLETED|Washout||0
192876|NCT00835692|464037|P1|NOT COMPLETED|Washout||0
192877|NCT00835692|464036|P2|COMPLETED|Washout||28
192878|NCT00835692|464037|P1|COMPLETED|Washout||27
192879|NCT00835692|464036|P2|STARTED|Washout||28
192880|NCT00835692|464037|P1|STARTED|Washout||27
192881|NCT00835692|464036|P2|NOT COMPLETED|First Intervention||0
192882|NCT00835692|464037|P1|NOT COMPLETED|First Intervention||1
192883|NCT00835692|464036|P2|COMPLETED|First Intervention||28
192884|NCT00835692|464037|P1|COMPLETED|First Intervention||27
192885|NCT00835692|464036|P2|STARTED|First Intervention||28
192886|NCT00835692|464037|P1|STARTED|First Intervention||28
192887|NCT00835679|464049|P4|NOT COMPLETED|Overall Study||0
192888|NCT00835679|464050|P3|NOT COMPLETED|Overall Study||0
192889|NCT00835679|464051|P2|NOT COMPLETED|Overall Study||0
192890|NCT00835679|464052|P1|NOT COMPLETED|Overall Study||1
192891|NCT00835679|464049|P4|COMPLETED|Overall Study||0
192892|NCT00835679|464050|P3|COMPLETED|Overall Study||0
192893|NCT00835679|464051|P2|COMPLETED|Overall Study||0
192894|NCT00835679|464052|P1|COMPLETED|Overall Study||8
192895|NCT00835679|464049|P4|STARTED|Overall Study||0
192896|NCT00835679|464050|P3|STARTED|Overall Study||0
192897|NCT00835679|464051|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
192898|NCT00835679|464052|P1|STARTED|Overall Study||9
192899|NCT00835666|464076|P2|NOT COMPLETED|Second Intervention||0
192900|NCT00835666|464077|P1|NOT COMPLETED|Second Intervention||0
192901|NCT00835666|464076|P2|COMPLETED|Second Intervention||16
192902|NCT00835666|464077|P1|COMPLETED|Second Intervention||14
192903|NCT00835666|464076|P2|STARTED|Second Intervention||16
192904|NCT00835666|464077|P1|STARTED|Second Intervention||14
192905|NCT00835666|464076|P2|NOT COMPLETED|Washout||0
192906|NCT00835666|464077|P1|NOT COMPLETED|Washout||2
192907|NCT00835666|464076|P2|COMPLETED|Washout||16
192908|NCT00835666|464077|P1|COMPLETED|Washout||14
192909|NCT00835666|464076|P2|STARTED|Washout||16
192910|NCT00835666|464077|P1|STARTED|Washout||16
192911|NCT00835666|464076|P2|NOT COMPLETED|First Intervention||0
192912|NCT00835666|464077|P1|NOT COMPLETED|First Intervention||0
192913|NCT00835666|464076|P2|COMPLETED|First Intervention||16
192914|NCT00835666|464077|P1|COMPLETED|First Intervention||16
192915|NCT00835666|464076|P2|STARTED|First Intervention||16
192916|NCT00835666|464077|P1|STARTED|First Intervention||16
192917|NCT00835640|464087|P2|NOT COMPLETED|Second Intervention||0
192918|NCT00835640|464088|P1|NOT COMPLETED|Second Intervention||1
192919|NCT00835640|464087|P2|COMPLETED|Second Intervention||12
192920|NCT00835640|464088|P1|COMPLETED|Second Intervention||11
192921|NCT00835640|464087|P2|STARTED|Second Intervention||12
192922|NCT00835640|464088|P1|STARTED|Second Intervention||12
192923|NCT00835640|464087|P2|NOT COMPLETED|Washout of 7 Days||0
192924|NCT00835640|464088|P1|NOT COMPLETED|Washout of 7 Days||0
192925|NCT00835640|464087|P2|COMPLETED|Washout of 7 Days||12
192926|NCT00835640|464088|P1|COMPLETED|Washout of 7 Days||12
192927|NCT00835640|464087|P2|STARTED|Washout of 7 Days||12
192928|NCT00835640|464088|P1|STARTED|Washout of 7 Days||12
192929|NCT00835640|464087|P2|NOT COMPLETED|First Intervention||0
192930|NCT00835640|464088|P1|NOT COMPLETED|First Intervention||0
192931|NCT00835640|464087|P2|COMPLETED|First Intervention||12
192932|NCT00835640|464088|P1|COMPLETED|First Intervention||12
192933|NCT00835640|464087|P2|STARTED|First Intervention||12
192934|NCT00835640|464088|P1|STARTED|First Intervention||12
192935|NCT00835614|464098|P2|NOT COMPLETED|Second Intervention||0
192936|NCT00835614|464099|P1|NOT COMPLETED|Second Intervention||0
192937|NCT00835614|464098|P2|COMPLETED|Second Intervention||13
192938|NCT00835614|464099|P1|COMPLETED|Second Intervention||13
192939|NCT00835614|464098|P2|STARTED|Second Intervention||13
192940|NCT00835614|464099|P1|STARTED|Second Intervention||13
192941|NCT00835614|464098|P2|NOT COMPLETED|Washout of 7 Days||0
192942|NCT00835614|464099|P1|NOT COMPLETED|Washout of 7 Days||0
192943|NCT00835614|464098|P2|COMPLETED|Washout of 7 Days||13
192944|NCT00835614|464099|P1|COMPLETED|Washout of 7 Days||13
192945|NCT00835614|464098|P2|STARTED|Washout of 7 Days||13
192946|NCT00835614|464099|P1|STARTED|Washout of 7 Days||13
192947|NCT00835614|464098|P2|NOT COMPLETED|First Intervention||0
192948|NCT00835614|464099|P1|NOT COMPLETED|First Intervention||0
192949|NCT00835614|464098|P2|COMPLETED|First Intervention||13
192950|NCT00835614|464099|P1|COMPLETED|First Intervention||13
192951|NCT00835614|464098|P2|STARTED|First Intervention||13
192952|NCT00835614|464099|P1|STARTED|First Intervention||13
192953|NCT00835588|464109|P2|NOT COMPLETED|Second Intervention||0
192954|NCT00835588|464110|P1|NOT COMPLETED|Second Intervention||0
192955|NCT00835588|464109|P2|COMPLETED|Second Intervention||50
192956|NCT00835588|464110|P1|COMPLETED|Second Intervention||50
192957|NCT00835588|464109|P2|STARTED|Second Intervention||50
192958|NCT00835588|464110|P1|STARTED|Second Intervention||50
192959|NCT00835588|464109|P2|NOT COMPLETED|Washout: 5 Days||0
192960|NCT00835588|464110|P1|NOT COMPLETED|Washout: 5 Days||0
192961|NCT00835588|464109|P2|COMPLETED|Washout: 5 Days||50
192962|NCT00835588|464110|P1|COMPLETED|Washout: 5 Days||50
192963|NCT00835588|464109|P2|STARTED|Washout: 5 Days||50
192964|NCT00835588|464110|P1|STARTED|Washout: 5 Days||50
192965|NCT00835588|464109|P2|NOT COMPLETED|First Intervention||0
192966|NCT00835588|464110|P1|NOT COMPLETED|First Intervention||0
192967|NCT00835588|464109|P2|COMPLETED|First Intervention||50
192968|NCT00835588|464110|P1|COMPLETED|First Intervention||50
192969|NCT00835588|464109|P2|STARTED|First Intervention||50
192970|NCT00835588|464110|P1|STARTED|First Intervention||50
192971|NCT00835575|464120|P2|NOT COMPLETED|Second Intervention||0
192972|NCT00835575|464121|P1|NOT COMPLETED|Second Intervention||0
192973|NCT00835575|464120|P2|COMPLETED|Second Intervention||16
192974|NCT00835575|464121|P1|COMPLETED|Second Intervention||15
192975|NCT00835575|464120|P2|STARTED|Second Intervention||16
192976|NCT00835575|464121|P1|STARTED|Second Intervention||15
192977|NCT00835575|464120|P2|NOT COMPLETED|Washout of 14 Days||0
192978|NCT00835575|464121|P1|NOT COMPLETED|Washout of 14 Days||1
192979|NCT00835575|464120|P2|COMPLETED|Washout of 14 Days||16
192980|NCT00835575|464121|P1|COMPLETED|Washout of 14 Days||15
192981|NCT00835575|464120|P2|STARTED|Washout of 14 Days||16
192982|NCT00835575|464121|P1|STARTED|Washout of 14 Days||16
192983|NCT00835575|464120|P2|NOT COMPLETED|First Intervention||0
192984|NCT00835575|464121|P1|NOT COMPLETED|First Intervention||0
192985|NCT00835575|464120|P2|COMPLETED|First Intervention||16
192986|NCT00835575|464121|P1|COMPLETED|First Intervention||16
192987|NCT00835575|464120|P2|STARTED|First Intervention||16
192988|NCT00835575|464121|P1|STARTED|First Intervention||16
192989|NCT00835549|464131|P2|NOT COMPLETED|Second Intervention||0
192990|NCT00835549|464132|P1|NOT COMPLETED|Second Intervention||0
192991|NCT00835549|464131|P2|COMPLETED|Second Intervention||16
192992|NCT00835549|464132|P1|COMPLETED|Second Intervention||14
192993|NCT00835549|464131|P2|STARTED|Second Intervention||16
192994|NCT00835549|464132|P1|STARTED|Second Intervention||14
192995|NCT00835549|464131|P2|NOT COMPLETED|Washout of 7 Days||0
192996|NCT00835549|464132|P1|NOT COMPLETED|Washout of 7 Days||2
192997|NCT00835549|464131|P2|COMPLETED|Washout of 7 Days||16
192998|NCT00835549|464132|P1|COMPLETED|Washout of 7 Days||14
192999|NCT00835549|464131|P2|STARTED|Washout of 7 Days||16
193000|NCT00835549|464132|P1|STARTED|Washout of 7 Days||16
193001|NCT00835549|464131|P2|NOT COMPLETED|First Intervention||0
193002|NCT00835549|464132|P1|NOT COMPLETED|First Intervention||0
193003|NCT00835549|464131|P2|COMPLETED|First Intervention||16
193004|NCT00835549|464132|P1|COMPLETED|First Intervention||16
193005|NCT00835549|464131|P2|STARTED|First Intervention||16
193006|NCT00835549|464132|P1|STARTED|First Intervention||16
193007|NCT00835536|464142|P2|NOT COMPLETED|Second Intervention||0
193008|NCT00835536|464143|P1|NOT COMPLETED|Second Intervention||0
193009|NCT00835536|464142|P2|COMPLETED|Second Intervention||14
193010|NCT00835536|464143|P1|COMPLETED|Second Intervention||12
193011|NCT00835536|464142|P2|STARTED|Second Intervention||14
193012|NCT00835536|464143|P1|STARTED|Second Intervention||12
193013|NCT00835536|464142|P2|NOT COMPLETED|Washout of 5 Weeks||0
193014|NCT00835536|464143|P1|NOT COMPLETED|Washout of 5 Weeks||1
193015|NCT00835536|464142|P2|COMPLETED|Washout of 5 Weeks||14
193016|NCT00835536|464143|P1|COMPLETED|Washout of 5 Weeks||12
193017|NCT00835536|464142|P2|STARTED|Washout of 5 Weeks||14
193018|NCT00835536|464143|P1|STARTED|Washout of 5 Weeks||13
193019|NCT00835536|464142|P2|NOT COMPLETED|First Intervention||0
193020|NCT00835536|464143|P1|NOT COMPLETED|First Intervention||0
193021|NCT00835536|464142|P2|COMPLETED|First Intervention||14
193022|NCT00835536|464143|P1|COMPLETED|First Intervention||13
193023|NCT00835536|464142|P2|STARTED|First Intervention||14
193024|NCT00835536|464143|P1|STARTED|First Intervention||13
193025|NCT00835510|464152|P3|NOT COMPLETED|Overall Study||38
193026|NCT00835510|464153|P2|NOT COMPLETED|Overall Study||69
193027|NCT00835510|464154|P1|NOT COMPLETED|Overall Study||76
193028|NCT00835510|464152|P3|COMPLETED|Overall Study||70
193029|NCT00835510|464153|P2|COMPLETED|Overall Study||152
193030|NCT00835510|464154|P1|COMPLETED|Overall Study||143
193031|NCT00835510|464152|P3|Positive Fungal Culture|Overall Study||71
193032|NCT00835510|464153|P2|Positive Fungal Culture|Overall Study||155
193033|NCT00835510|464154|P1|Positive Fungal Culture|Overall Study||149
193034|NCT00835510|464152|P3|STARTED|Overall Study||108
193035|NCT00835510|464153|P2|STARTED|Overall Study||221
193036|NCT00835510|464154|P1|STARTED|Overall Study||219
193037|NCT00835497|464176|P2|NOT COMPLETED|Second Intervention||0
193038|NCT00835497|464177|P1|NOT COMPLETED|Second Intervention||0
193039|NCT00835497|464176|P2|COMPLETED|Second Intervention||20
193040|NCT00835497|464177|P1|COMPLETED|Second Intervention||20
193041|NCT00835497|464176|P2|STARTED|Second Intervention||20
193042|NCT00835497|464177|P1|STARTED|Second Intervention||20
193043|NCT00835497|464176|P2|NOT COMPLETED|Washout: 7 Days||0
193044|NCT00835497|464177|P1|NOT COMPLETED|Washout: 7 Days||0
193045|NCT00835497|464176|P2|COMPLETED|Washout: 7 Days||20
193046|NCT00835497|464177|P1|COMPLETED|Washout: 7 Days||20
193047|NCT00835497|464176|P2|STARTED|Washout: 7 Days||20
193048|NCT00835497|464177|P1|STARTED|Washout: 7 Days||20
193049|NCT00835497|464176|P2|NOT COMPLETED|First Intervention||0
193050|NCT00835497|464177|P1|NOT COMPLETED|First Intervention||0
193051|NCT00835497|464176|P2|COMPLETED|First Intervention||20
193052|NCT00835497|464177|P1|COMPLETED|First Intervention||20
193053|NCT00835497|464176|P2|STARTED|First Intervention||20
193054|NCT00835497|464177|P1|STARTED|First Intervention||20
193055|NCT00835484|464193|P2|NOT COMPLETED|Second Intervention||0
193056|NCT00835484|464194|P1|NOT COMPLETED|Second Intervention||0
193057|NCT00835484|464193|P2|COMPLETED|Second Intervention||16
193058|NCT00835484|464194|P1|COMPLETED|Second Intervention||16
193059|NCT00835484|464193|P2|STARTED|Second Intervention||16
193060|NCT00835484|464194|P1|STARTED|Second Intervention||16
193061|NCT00835484|464193|P2|NOT COMPLETED|Washout of 7 Days||0
193062|NCT00835484|464194|P1|NOT COMPLETED|Washout of 7 Days||0
193063|NCT00835484|464193|P2|COMPLETED|Washout of 7 Days||16
193064|NCT00835484|464194|P1|COMPLETED|Washout of 7 Days||16
193065|NCT00835484|464193|P2|STARTED|Washout of 7 Days||16
193066|NCT00835484|464194|P1|STARTED|Washout of 7 Days||16
193067|NCT00835484|464193|P2|NOT COMPLETED|First Intervention||0
193068|NCT00835484|464194|P1|NOT COMPLETED|First Intervention||0
193069|NCT00835484|464193|P2|COMPLETED|First Intervention||16
193070|NCT00835484|464194|P1|COMPLETED|First Intervention||16
193071|NCT00835484|464193|P2|STARTED|First Intervention||16
193072|NCT00835484|464194|P1|STARTED|First Intervention||16
193073|NCT00835406|464204|P2|NOT COMPLETED|Period: Second Intervention||0
193074|NCT00835406|464205|P1|NOT COMPLETED|Period: Second Intervention||0
193075|NCT00835406|464204|P2|COMPLETED|Period: Second Intervention||67
193076|NCT00835406|464205|P1|COMPLETED|Period: Second Intervention||68
193077|NCT00835406|464204|P2|STARTED|Period: Second Intervention||67
193078|NCT00835406|464205|P1|STARTED|Period: Second Intervention||68
193079|NCT00835406|464204|P2|NOT COMPLETED|Period: Washout of 7 Days||2
193080|NCT00835406|464205|P1|NOT COMPLETED|Period: Washout of 7 Days||0
193081|NCT00835406|464204|P2|COMPLETED|Period: Washout of 7 Days||67
193082|NCT00835406|464205|P1|COMPLETED|Period: Washout of 7 Days||68
193083|NCT00835406|464204|P2|STARTED|Period: Washout of 7 Days||69
193084|NCT00835406|464205|P1|STARTED|Period: Washout of 7 Days||68
193085|NCT00835406|464204|P2|NOT COMPLETED|Period: First Intervention||1
193086|NCT00835406|464205|P1|NOT COMPLETED|Period: First Intervention||2
193087|NCT00835406|464204|P2|COMPLETED|Period: First Intervention||69
193088|NCT00835406|464205|P1|COMPLETED|Period: First Intervention||68
193089|NCT00835406|464204|P2|STARTED|Period: First Intervention||70
193090|NCT00835406|464205|P1|STARTED|Period: First Intervention||70
193091|NCT00835380|464211|P1|NOT COMPLETED|Overall Study||2
193092|NCT00835380|464211|P1|COMPLETED|Overall Study||78
193093|NCT00835380|464211|P1|STARTED|Overall Study||80
193094|NCT00835367|464218|P2|NOT COMPLETED|Second Intervention||1
193095|NCT00835367|464219|P1|NOT COMPLETED|Second Intervention||1
193096|NCT00835367|464218|P2|COMPLETED|Second Intervention||33
193097|NCT00835367|464219|P1|COMPLETED|Second Intervention||30
193098|NCT00835367|464218|P2|STARTED|Second Intervention||34
193099|NCT00835367|464219|P1|STARTED|Second Intervention||31
193100|NCT00835367|464218|P2|NOT COMPLETED|Washout||0
193101|NCT00835367|464219|P1|NOT COMPLETED|Washout||3
193102|NCT00835367|464218|P2|COMPLETED|Washout||34
193103|NCT00835367|464219|P1|COMPLETED|Washout||31
193104|NCT00835367|464218|P2|STARTED|Washout||34
193105|NCT00835367|464219|P1|STARTED|Washout||34
193106|NCT00835367|464218|P2|NOT COMPLETED|First Intervention||0
193107|NCT00835367|464219|P1|NOT COMPLETED|First Intervention||0
193108|NCT00835367|464218|P2|COMPLETED|First Intervention||34
193109|NCT00835367|464219|P1|COMPLETED|First Intervention||34
193110|NCT00835367|464218|P2|STARTED|First Intervention||34
193111|NCT00835367|464219|P1|STARTED|First Intervention||34
193112|NCT00835354|464241|P2|NOT COMPLETED|Second Intervention||0
193113|NCT00835354|464242|P1|NOT COMPLETED|Second Intervention||0
193114|NCT00835354|464241|P2|COMPLETED|Second Intervention||12
193115|NCT00835354|464242|P1|COMPLETED|Second Intervention||13
193116|NCT00835354|464241|P2|STARTED|Second Intervention||12
193117|NCT00835354|464242|P1|STARTED|Second Intervention||13
193118|NCT00835354|464241|P2|NOT COMPLETED|Washout of 7 Days||0
193119|NCT00835354|464242|P1|NOT COMPLETED|Washout of 7 Days||0
193120|NCT00835354|464241|P2|COMPLETED|Washout of 7 Days||12
193121|NCT00835354|464242|P1|COMPLETED|Washout of 7 Days||13
193122|NCT00835354|464241|P2|STARTED|Washout of 7 Days||12
193123|NCT00835354|464242|P1|STARTED|Washout of 7 Days||13
193124|NCT00835354|464241|P2|NOT COMPLETED|First Intervention||1
193125|NCT00835354|464242|P1|NOT COMPLETED|First Intervention||0
193126|NCT00835354|464241|P2|COMPLETED|First Intervention||12
193127|NCT00835354|464242|P1|COMPLETED|First Intervention||13
193128|NCT00835354|464241|P2|STARTED|First Intervention||13
193129|NCT00835354|464242|P1|STARTED|First Intervention||13
193130|NCT00835341|464252|P2|NOT COMPLETED|Overall Study||12
193131|NCT00835341|464253|P1|NOT COMPLETED|Overall Study||3
193132|NCT00835341|464252|P2|COMPLETED|Overall Study||46
193133|NCT00835341|464253|P1|COMPLETED|Overall Study||32
193134|NCT00835341|464252|P2|STARTED|Overall Study||58
193135|NCT00835341|464253|P1|STARTED|Overall Study||35
193136|NCT00835276|464261|P2|NOT COMPLETED|Second Intervention||0
193137|NCT00835276|464262|P1|NOT COMPLETED|Second Intervention||0
193138|NCT00835276|464261|P2|COMPLETED|Second Intervention||24
193139|NCT00835276|464262|P1|COMPLETED|Second Intervention||24
193140|NCT00835276|464261|P2|STARTED|Second Intervention||24
193141|NCT00835276|464262|P1|STARTED|Second Intervention||24
193142|NCT00835276|464261|P2|NOT COMPLETED|Washout of 7 Days||0
193143|NCT00835276|464262|P1|NOT COMPLETED|Washout of 7 Days||0
193144|NCT00835276|464261|P2|COMPLETED|Washout of 7 Days||24
193145|NCT00835276|464262|P1|COMPLETED|Washout of 7 Days||24
193146|NCT00835276|464261|P2|STARTED|Washout of 7 Days||24
193147|NCT00835276|464262|P1|STARTED|Washout of 7 Days||24
193148|NCT00835276|464261|P2|NOT COMPLETED|First Intervention||0
193149|NCT00835276|464262|P1|NOT COMPLETED|First Intervention||0
193150|NCT00835276|464261|P2|COMPLETED|First Intervention||24
193151|NCT00835276|464262|P1|COMPLETED|First Intervention||24
193152|NCT00835276|464261|P2|STARTED|First Intervention||24
193153|NCT00835276|464262|P1|STARTED|First Intervention||24
193154|NCT00835263|464272|P2|NOT COMPLETED|Second Intervention||0
193155|NCT00835263|464273|P1|NOT COMPLETED|Second Intervention||1
193156|NCT00835263|464272|P2|COMPLETED|Second Intervention||16
193157|NCT00835263|464273|P1|COMPLETED|Second Intervention||15
193158|NCT00835263|464272|P2|STARTED|Second Intervention||16
193159|NCT00835263|464273|P1|STARTED|Second Intervention||16
193160|NCT00835263|464272|P2|NOT COMPLETED|First Intervention||0
193161|NCT00835263|464273|P1|NOT COMPLETED|First Intervention||0
193162|NCT00835263|464272|P2|COMPLETED|First Intervention||16
193163|NCT00835263|464273|P1|COMPLETED|First Intervention||16
193164|NCT00835263|464272|P2|STARTED|First Intervention||16
193165|NCT00835263|464273|P1|STARTED|First Intervention||16
193166|NCT00835237|464283|P2|NOT COMPLETED|Overall Study||0
193167|NCT00835237|464284|P1|NOT COMPLETED|Overall Study||6
193168|NCT00835237|464283|P2|COMPLETED|Overall Study||445
193169|NCT00835237|464284|P1|COMPLETED|Overall Study||881
193170|NCT00835237|464283|P2|STARTED|Overall Study||445
193171|NCT00835237|464284|P1|STARTED|Overall Study||887
193172|NCT00835224|464308|P1|NOT COMPLETED|Overall Study||10
193173|NCT00835224|464308|P1|COMPLETED|Overall Study||24
193174|NCT00835224|464308|P1|STARTED|Overall Study||34
193175|NCT00835211|464324|P2|NOT COMPLETED|Second Intervention||0
193176|NCT00835211|464325|P1|NOT COMPLETED|Second Intervention||0
193177|NCT00835211|464324|P2|COMPLETED|Second Intervention||22
193178|NCT00835211|464325|P1|COMPLETED|Second Intervention||21
193179|NCT00835211|464324|P2|STARTED|Second Intervention||22
193180|NCT00835211|464325|P1|STARTED|Second Intervention||21
193181|NCT00835211|464324|P2|NOT COMPLETED|Washout: 7 Days||1
193182|NCT00835211|464325|P1|NOT COMPLETED|Washout: 7 Days||3
193183|NCT00835211|464324|P2|COMPLETED|Washout: 7 Days||22
193184|NCT00835211|464325|P1|COMPLETED|Washout: 7 Days||21
193185|NCT00835211|464324|P2|STARTED|Washout: 7 Days||23
193186|NCT00835211|464325|P1|STARTED|Washout: 7 Days||24
193187|NCT00835211|464324|P2|NOT COMPLETED|First Intervention||1
193188|NCT00835211|464325|P1|NOT COMPLETED|First Intervention||0
193189|NCT00835211|464324|P2|COMPLETED|First Intervention||23
193190|NCT00835211|464325|P1|COMPLETED|First Intervention||24
193191|NCT00835211|464324|P2|STARTED|First Intervention||24
193192|NCT00835211|464325|P1|STARTED|First Intervention||24
193193|NCT00835198|464335|P2|NOT COMPLETED|Overall Study||7
193194|NCT00835198|464336|P1|NOT COMPLETED|Overall Study||8
193195|NCT00835198|464335|P2|COMPLETED|Overall Study||74
193196|NCT00835198|464336|P1|COMPLETED|Overall Study||74
193197|NCT00835198|464335|P2|STARTED|Overall Study||81
193198|NCT00835198|464336|P1|STARTED|Overall Study||82
193199|NCT00835185|464348|P1|NOT COMPLETED|Overall Study||0
193200|NCT00835185|464348|P1|COMPLETED|Overall Study||44
193201|NCT00835185|464348|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
193202|NCT00835185|464348|P1|STARTED|Overall Study||44
193203|NCT00835172|464371|P2|NOT COMPLETED|Second Intervention||0
193204|NCT00835172|464372|P1|NOT COMPLETED|Second Intervention||0
193205|NCT00835172|464371|P2|COMPLETED|Second Intervention||15
193206|NCT00835172|464372|P1|COMPLETED|Second Intervention||16
193207|NCT00835172|464371|P2|STARTED|Second Intervention||15
193208|NCT00835172|464372|P1|STARTED|Second Intervention||16
193209|NCT00835172|464371|P2|NOT COMPLETED|Washout||1
193210|NCT00835172|464372|P1|NOT COMPLETED|Washout||0
193211|NCT00835172|464371|P2|COMPLETED|Washout||15
193212|NCT00835172|464372|P1|COMPLETED|Washout||16
193213|NCT00835172|464371|P2|STARTED|Washout||16
193214|NCT00835172|464372|P1|STARTED|Washout||16
193215|NCT00835172|464371|P2|NOT COMPLETED|First Intervention||0
193216|NCT00835172|464372|P1|NOT COMPLETED|First Intervention||0
193217|NCT00835172|464371|P2|COMPLETED|First Intervention||16
193218|NCT00835172|464372|P1|COMPLETED|First Intervention||16
193219|NCT00835172|464371|P2|STARTED|First Intervention||16
193220|NCT00835172|464372|P1|STARTED|First Intervention||16
193221|NCT00835159|464382|P2|NOT COMPLETED|Overall Study||0
193222|NCT00835159|464383|P1|NOT COMPLETED|Overall Study||0
193223|NCT00835159|464382|P2|COMPLETED|Overall Study||17
193224|NCT00835159|464383|P1|COMPLETED|Overall Study||11
193225|NCT00835159|464382|P2|STARTED|Overall Study||17
193226|NCT00835159|464383|P1|STARTED|Overall Study||11
193227|NCT00835146|464391|P2|NOT COMPLETED|Second Intervention||0
193228|NCT00835146|464392|P1|NOT COMPLETED|Second Intervention||0
193229|NCT00835146|464391|P2|COMPLETED|Second Intervention||14
193230|NCT00835146|464392|P1|COMPLETED|Second Intervention||14
193231|NCT00835146|464391|P2|STARTED|Second Intervention||14
193232|NCT00835146|464392|P1|STARTED|Second Intervention||14
193233|NCT00835146|464391|P2|NOT COMPLETED|Washout of 5 Weeks||0
193234|NCT00835146|464392|P1|NOT COMPLETED|Washout of 5 Weeks||0
193235|NCT00835146|464391|P2|COMPLETED|Washout of 5 Weeks||14
193236|NCT00835146|464392|P1|COMPLETED|Washout of 5 Weeks||14
193237|NCT00835146|464391|P2|STARTED|Washout of 5 Weeks||14
193238|NCT00835146|464392|P1|STARTED|Washout of 5 Weeks||14
193239|NCT00835146|464391|P2|NOT COMPLETED|First Intervention||0
193240|NCT00835146|464392|P1|NOT COMPLETED|First Intervention||0
193241|NCT00835146|464391|P2|COMPLETED|First Intervention||14
193242|NCT00835146|464392|P1|COMPLETED|First Intervention||14
193243|NCT00835146|464391|P2|STARTED|First Intervention||14
193244|NCT00835146|464392|P1|STARTED|First Intervention||14
193245|NCT00835120|464398|P1|NOT COMPLETED|Overall Study||8
193246|NCT00835120|464398|P1|COMPLETED|Overall Study||26
193247|NCT00835120|464398|P1|STARTED|Overall Study||34
193248|NCT00835081|464408|P2|NOT COMPLETED|Second Intervention||0
193249|NCT00835081|464409|P1|NOT COMPLETED|Second Intervention||0
193250|NCT00835081|464408|P2|COMPLETED|Second Intervention||13
193251|NCT00835081|464409|P1|COMPLETED|Second Intervention||12
193252|NCT00835081|464408|P2|STARTED|Second Intervention||13
193253|NCT00835081|464409|P1|STARTED|Second Intervention||12
193254|NCT00835081|464408|P2|NOT COMPLETED|Washout of 7 Days||0
193255|NCT00835081|464409|P1|NOT COMPLETED|Washout of 7 Days||1
193256|NCT00835081|464408|P2|COMPLETED|Washout of 7 Days||13
193257|NCT00835081|464409|P1|COMPLETED|Washout of 7 Days||12
193258|NCT00835081|464408|P2|STARTED|Washout of 7 Days||13
193259|NCT00835081|464409|P1|STARTED|Washout of 7 Days||13
193260|NCT00835081|464408|P2|NOT COMPLETED|First Intervention||0
193261|NCT00835081|464409|P1|NOT COMPLETED|First Intervention||0
193262|NCT00835081|464408|P2|COMPLETED|First Intervention||13
193263|NCT00835081|464409|P1|COMPLETED|First Intervention||13
193264|NCT00835081|464408|P2|STARTED|First Intervention||13
193265|NCT00835081|464409|P1|STARTED|First Intervention||13
193266|NCT00835068|464419|P2|NOT COMPLETED|Overall Study||1
193267|NCT00835068|464420|P1|NOT COMPLETED|Overall Study||10
193268|NCT00835068|464419|P2|COMPLETED|Overall Study||0
193269|NCT00835068|464420|P1|COMPLETED|Overall Study||47
193270|NCT00835068|464419|P2|STARTED|Overall Study||1
193271|NCT00835068|464420|P1|STARTED|Overall Study||57
193272|NCT00835042|464440|P2|NOT COMPLETED|Second Intervention||0
193273|NCT00835042|464441|P1|NOT COMPLETED|Second Intervention||0
193274|NCT00835042|464440|P2|COMPLETED|Second Intervention||24
193275|NCT00835042|464441|P1|COMPLETED|Second Intervention||26
193276|NCT00835042|464440|P2|STARTED|Second Intervention||24
193277|NCT00835042|464441|P1|STARTED|Second Intervention||26
193278|NCT00835042|464440|P2|NOT COMPLETED|Washout of 21 Days||2
193279|NCT00835042|464441|P1|NOT COMPLETED|Washout of 21 Days||0
193280|NCT00835042|464440|P2|COMPLETED|Washout of 21 Days||24
193281|NCT00835042|464441|P1|COMPLETED|Washout of 21 Days||26
193282|NCT00835042|464440|P2|STARTED|Washout of 21 Days||26
193283|NCT00835042|464441|P1|STARTED|Washout of 21 Days||26
193284|NCT00835042|464440|P2|NOT COMPLETED|First Intervention||2
193285|NCT00835042|464441|P1|NOT COMPLETED|First Intervention||4
193286|NCT00835042|464440|P2|COMPLETED|First Intervention||26
193287|NCT00835042|464441|P1|COMPLETED|First Intervention||26
193288|NCT00835042|464440|P2|STARTED|First Intervention||28
193289|NCT00835042|464441|P1|STARTED|First Intervention||30
193290|NCT00835003|464463|P2|NOT COMPLETED|Overall Study||0
193291|NCT00835003|464464|P1|NOT COMPLETED|Overall Study||0
193292|NCT00835003|464463|P2|COMPLETED|Overall Study||638
193293|NCT00835003|464464|P1|COMPLETED|Overall Study||636
193294|NCT00835003|464463|P2|STARTED|Overall Study||638
193295|NCT00835003|464464|P1|STARTED|Overall Study||636
193296|NCT00834990|464472|P2|NOT COMPLETED|Second Intervention||0
193297|NCT00834990|464473|P1|NOT COMPLETED|Second Intervention||0
193298|NCT00834990|464472|P2|COMPLETED|Second Intervention||11
193299|NCT00834990|464473|P1|COMPLETED|Second Intervention||12
193300|NCT00834990|464472|P2|STARTED|Second Intervention||11
193301|NCT00834990|464473|P1|STARTED|Second Intervention||12
193302|NCT00834990|464472|P2|NOT COMPLETED|Washout of 7 Days||0
193303|NCT00834990|464473|P1|NOT COMPLETED|Washout of 7 Days||0
193304|NCT00834990|464472|P2|COMPLETED|Washout of 7 Days||11
193305|NCT00834990|464473|P1|COMPLETED|Washout of 7 Days||12
193306|NCT00834990|464472|P2|STARTED|Washout of 7 Days||11
193307|NCT00834990|464473|P1|STARTED|Washout of 7 Days||12
193308|NCT00834990|464472|P2|NOT COMPLETED|First Intervention||0
193309|NCT00834990|464473|P1|NOT COMPLETED|First Intervention||0
193310|NCT00834990|464472|P2|COMPLETED|First Intervention||11
193311|NCT00834990|464473|P1|COMPLETED|First Intervention||12
193312|NCT00834990|464472|P2|STARTED|First Intervention||11
193313|NCT00834990|464473|P1|STARTED|First Intervention||12
193314|NCT00834977|464483|P2|NOT COMPLETED|Second Intervention||0
193315|NCT00834977|464484|P1|NOT COMPLETED|Second Intervention||0
193316|NCT00834977|464483|P2|COMPLETED|Second Intervention||24
193317|NCT00834977|464484|P1|COMPLETED|Second Intervention||24
193318|NCT00834977|464483|P2|STARTED|Second Intervention||24
193319|NCT00834977|464484|P1|STARTED|Second Intervention||24
193320|NCT00834977|464483|P2|NOT COMPLETED|First Intervention||0
193321|NCT00834977|464484|P1|NOT COMPLETED|First Intervention||0
193322|NCT00834977|464483|P2|COMPLETED|First Intervention||24
193323|NCT00834977|464484|P1|COMPLETED|First Intervention||24
193324|NCT00834977|464483|P2|STARTED|First Intervention||24
193325|NCT00834977|464484|P1|STARTED|First Intervention||24
193326|NCT00834964|464506|P2|NOT COMPLETED|Second Intervention||0
193327|NCT00834964|464507|P1|NOT COMPLETED|Second Intervention||0
193328|NCT00834964|464506|P2|COMPLETED|Second Intervention||15
193329|NCT00834964|464507|P1|COMPLETED|Second Intervention||15
193330|NCT00834964|464506|P2|STARTED|Second Intervention||15
193331|NCT00834964|464507|P1|STARTED|Second Intervention||15
193332|NCT00834964|464506|P2|NOT COMPLETED|Washout: 7 Days||0
193333|NCT00834964|464507|P1|NOT COMPLETED|Washout: 7 Days||0
193334|NCT00834964|464506|P2|COMPLETED|Washout: 7 Days||15
193335|NCT00834964|464507|P1|COMPLETED|Washout: 7 Days||15
193336|NCT00834964|464506|P2|STARTED|Washout: 7 Days||15
193337|NCT00834964|464507|P1|STARTED|Washout: 7 Days||15
193338|NCT00834964|464506|P2|NOT COMPLETED|First Intervention||0
193339|NCT00834964|464507|P1|NOT COMPLETED|First Intervention||0
193340|NCT00834964|464506|P2|COMPLETED|First Intervention||15
193341|NCT00834964|464507|P1|COMPLETED|First Intervention||15
193342|NCT00834964|464506|P2|STARTED|First Intervention||15
193343|NCT00834964|464507|P1|STARTED|First Intervention||15
193344|NCT00834912|464527|P6|NOT COMPLETED|Treatment Period 3||0
193345|NCT00834912|464528|P5|NOT COMPLETED|Treatment Period 3||0
193346|NCT00834912|464529|P4|NOT COMPLETED|Treatment Period 3||0
193347|NCT00834912|464530|P3|NOT COMPLETED|Treatment Period 3||0
193348|NCT00834912|464531|P2|NOT COMPLETED|Treatment Period 3||0
193349|NCT00834912|464532|P1|NOT COMPLETED|Treatment Period 3||0
193350|NCT00834912|464527|P6|COMPLETED|Treatment Period 3||6
193351|NCT00834912|464528|P5|COMPLETED|Treatment Period 3||5
193352|NCT00834912|464529|P4|COMPLETED|Treatment Period 3||5
193353|NCT00834912|464530|P3|COMPLETED|Treatment Period 3||5
193354|NCT00834912|464531|P2|COMPLETED|Treatment Period 3||5
193355|NCT00834912|464532|P1|COMPLETED|Treatment Period 3||6
193356|NCT00834912|464527|P6|STARTED|Treatment Period 3||6
193357|NCT00834912|464528|P5|STARTED|Treatment Period 3||5
193358|NCT00834912|464529|P4|STARTED|Treatment Period 3||5
193359|NCT00834912|464530|P3|STARTED|Treatment Period 3||5
193360|NCT00834912|464531|P2|STARTED|Treatment Period 3||5
193361|NCT00834912|464532|P1|STARTED|Treatment Period 3||6
193362|NCT00834912|464527|P6|NOT COMPLETED|Treatment Period 2||0
193363|NCT00834912|464528|P5|NOT COMPLETED|Treatment Period 2||1
193364|NCT00834912|464529|P4|NOT COMPLETED|Treatment Period 2||0
193365|NCT00834912|464530|P3|NOT COMPLETED|Treatment Period 2||1
193366|NCT00834912|464531|P2|NOT COMPLETED|Treatment Period 2||0
193367|NCT00834912|464532|P1|NOT COMPLETED|Treatment Period 2||0
193368|NCT00834912|464527|P6|COMPLETED|Treatment Period 2||6
193369|NCT00834912|464528|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
193370|NCT00834912|464529|P4|COMPLETED|Treatment Period 2||5
193371|NCT00834912|464530|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
193372|NCT00834912|464531|P2|COMPLETED|Treatment Period 2||5
193373|NCT00834912|464532|P1|COMPLETED|Treatment Period 2||6
193374|NCT00834912|464527|P6|STARTED|Treatment Period 2||6
193375|NCT00834912|464528|P5|STARTED|Treatment Period 2||6
193376|NCT00834912|464529|P4|STARTED|Treatment Period 2||5
193377|NCT00834912|464530|P3|STARTED|Treatment Period 2||6
193378|NCT00834912|464531|P2|STARTED|Treatment Period 2||5
193379|NCT00834912|464532|P1|STARTED|Treatment Period 2||6
193380|NCT00834912|464527|P6|NOT COMPLETED|Treatment Period 1||0
193381|NCT00834912|464528|P5|NOT COMPLETED|Treatment Period 1||0
193382|NCT00834912|464529|P4|NOT COMPLETED|Treatment Period 1||1
193383|NCT00834912|464530|P3|NOT COMPLETED|Treatment Period 1||0
193384|NCT00834912|464531|P2|NOT COMPLETED|Treatment Period 1||1
193385|NCT00834912|464532|P1|NOT COMPLETED|Treatment Period 1||0
193386|NCT00834912|464527|P6|COMPLETED|Treatment Period 1||6
193387|NCT00834912|464528|P5|COMPLETED|Treatment Period 1||6
193388|NCT00834912|464529|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
193389|NCT00834912|464530|P3|COMPLETED|Treatment Period 1||6
193390|NCT00834912|464531|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
193391|NCT00834912|464532|P1|COMPLETED|Treatment Period 1||6
193392|NCT00834912|464527|P6|STARTED|Treatment Period 1||6
193393|NCT00834912|464528|P5|STARTED|Treatment Period 1||6
193394|NCT00834912|464529|P4|STARTED|Treatment Period 1||6
193395|NCT00834912|464530|P3|STARTED|Treatment Period 1||6
193396|NCT00834912|464531|P2|STARTED|Treatment Period 1||6
193397|NCT00834912|464532|P1|STARTED|Treatment Period 1||6
193398|NCT00834899|464554|P2|NOT COMPLETED|Overall Study||1
193399|NCT00834899|464555|P1|NOT COMPLETED|Overall Study||1
193400|NCT00834899|464554|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
193401|NCT00834899|464555|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
193402|NCT00834899|464554|P2|STARTED|Overall Study||4
193403|NCT00834899|464555|P1|STARTED|Overall Study||9
193404|NCT00834886|464571|P4|NOT COMPLETED|Overall Study||0
193405|NCT00834886|464572|P3|NOT COMPLETED|Overall Study||1
193406|NCT00834886|464573|P2|NOT COMPLETED|Overall Study||1
193407|NCT00834886|464574|P1|NOT COMPLETED|Overall Study||0
193408|NCT00834886|464571|P4|COMPLETED|Overall Study||10
193409|NCT00834886|464572|P3|COMPLETED|Overall Study||9
193410|NCT00834886|464573|P2|COMPLETED|Overall Study||9
193411|NCT00834886|464574|P1|COMPLETED|Overall Study||10
193412|NCT00834886|464571|P4|STARTED|Overall Study||10
193413|NCT00834886|464572|P3|STARTED|Overall Study||10
193414|NCT00834886|464573|P2|STARTED|Overall Study||10
193415|NCT00834886|464574|P1|STARTED|Overall Study||10
193416|NCT00834873|464594|P2|NOT COMPLETED|Second Intervention||0
193417|NCT00834873|464595|P1|NOT COMPLETED|Second Intervention||0
193418|NCT00834873|464594|P2|COMPLETED|Second Intervention||11
193419|NCT00834873|464595|P1|COMPLETED|Second Intervention||12
193420|NCT00834873|464594|P2|STARTED|Second Intervention||11
193421|NCT00834873|464595|P1|STARTED|Second Intervention||12
193422|NCT00834873|464594|P2|NOT COMPLETED|Washout: 7 Days||0
193423|NCT00834873|464595|P1|NOT COMPLETED|Washout: 7 Days||0
193424|NCT00834873|464594|P2|COMPLETED|Washout: 7 Days||11
193425|NCT00834873|464595|P1|COMPLETED|Washout: 7 Days||12
193426|NCT00834873|464594|P2|STARTED|Washout: 7 Days||11
193427|NCT00834873|464595|P1|STARTED|Washout: 7 Days||12
193428|NCT00834873|464594|P2|NOT COMPLETED|First Intervention||1
193429|NCT00834873|464595|P1|NOT COMPLETED|First Intervention||0
193430|NCT00834873|464594|P2|COMPLETED|First Intervention||11
193431|NCT00834873|464595|P1|COMPLETED|First Intervention||12
193432|NCT00834873|464594|P2|STARTED|First Intervention||12
193433|NCT00834873|464595|P1|STARTED|First Intervention||12
193434|NCT00834834|464605|P2|NOT COMPLETED|Overall Study||3
193435|NCT00834834|464606|P1|NOT COMPLETED|Overall Study||4
193436|NCT00834834|464605|P2|COMPLETED|Overall Study||39
193437|NCT00834834|464606|P1|COMPLETED|Overall Study||38
193438|NCT00834834|464605|P2|STARTED|Overall Study||42
193439|NCT00834834|464606|P1|STARTED|Overall Study||42
193440|NCT00834808|464617|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
193441|NCT00834808|464618|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
193442|NCT00834808|464619|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
193443|NCT00834808|464617|P3|COMPLETED|Treatment Period 3 (Day 15)||9
193444|NCT00834808|464618|P2|COMPLETED|Treatment Period 3 (Day 15)||9
193445|NCT00834808|464619|P1|COMPLETED|Treatment Period 3 (Day 15)||9
193446|NCT00834808|464617|P3|STARTED|Treatment Period 3 (Day 15)||9
193447|NCT00834808|464618|P2|STARTED|Treatment Period 3 (Day 15)||9
193448|NCT00834808|464619|P1|STARTED|Treatment Period 3 (Day 15)||9
193449|NCT00834808|464617|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
193450|NCT00834808|464618|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
193451|NCT00834808|464619|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
193452|NCT00834808|464617|P3|COMPLETED|Treatment Period 2 (Day 8)||9
193453|NCT00834808|464618|P2|COMPLETED|Treatment Period 2 (Day 8)||9
193454|NCT00834808|464619|P1|COMPLETED|Treatment Period 2 (Day 8)||9
193455|NCT00834808|464617|P3|STARTED|Treatment Period 2 (Day 8)||9
193456|NCT00834808|464618|P2|STARTED|Treatment Period 2 (Day 8)||9
193457|NCT00834808|464619|P1|STARTED|Treatment Period 2 (Day 8)||9
193458|NCT00834808|464617|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
193459|NCT00834808|464618|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
193460|NCT00834808|464619|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
193461|NCT00834808|464617|P3|COMPLETED|Treatment Period 1 (Day 1)||9
193462|NCT00834808|464618|P2|COMPLETED|Treatment Period 1 (Day 1)||9
193463|NCT00834808|464619|P1|COMPLETED|Treatment Period 1 (Day 1)||9
193464|NCT00834808|464617|P3|STARTED|Treatment Period 1 (Day 1)||9
193465|NCT00834808|464618|P2|STARTED|Treatment Period 1 (Day 1)||9
193466|NCT00834808|464619|P1|STARTED|Treatment Period 1 (Day 1)||9
193467|NCT00834795|464641|P2|NOT COMPLETED|Second Intervention||0
193468|NCT00834795|464642|P1|NOT COMPLETED|Second Intervention||1
193469|NCT00834795|464641|P2|COMPLETED|Second Intervention||17
193470|NCT00834795|464642|P1|COMPLETED|Second Intervention||17
193471|NCT00834795|464641|P2|STARTED|Second Intervention||17
193472|NCT00834795|464642|P1|STARTED|Second Intervention||18
193473|NCT00834795|464641|P2|NOT COMPLETED|Washout: 7 Days||1
193474|NCT00834795|464642|P1|NOT COMPLETED|Washout: 7 Days||0
193475|NCT00834795|464641|P2|COMPLETED|Washout: 7 Days||17
193476|NCT00834795|464642|P1|COMPLETED|Washout: 7 Days||18
193477|NCT00834795|464641|P2|STARTED|Washout: 7 Days||18
193478|NCT00834795|464642|P1|STARTED|Washout: 7 Days||18
193479|NCT00834795|464641|P2|NOT COMPLETED|First Intervention||0
193480|NCT00834795|464642|P1|NOT COMPLETED|First Intervention||0
193481|NCT00834795|464641|P2|COMPLETED|First Intervention||18
193482|NCT00834795|464642|P1|COMPLETED|First Intervention||18
193483|NCT00834795|464641|P2|STARTED|First Intervention||18
193484|NCT00834795|464642|P1|STARTED|First Intervention||18
193485|NCT00834756|464652|P2|NOT COMPLETED|Second Intervention||0
193486|NCT00834756|464653|P1|NOT COMPLETED|Second Intervention||0
193487|NCT00834756|464652|P2|COMPLETED|Second Intervention||18
193488|NCT00834756|464653|P1|COMPLETED|Second Intervention||16
193489|NCT00834756|464652|P2|STARTED|Second Intervention||18
193490|NCT00834756|464653|P1|STARTED|Second Intervention||16
193491|NCT00834756|464652|P2|NOT COMPLETED|Washout: 21 Days||0
193492|NCT00834756|464653|P1|NOT COMPLETED|Washout: 21 Days||1
193493|NCT00834756|464652|P2|COMPLETED|Washout: 21 Days||18
193494|NCT00834756|464653|P1|COMPLETED|Washout: 21 Days||16
193495|NCT00834756|464652|P2|STARTED|Washout: 21 Days||18
193496|NCT00834756|464653|P1|STARTED|Washout: 21 Days||17
193497|NCT00834756|464652|P2|NOT COMPLETED|First Intervention||0
193498|NCT00834756|464653|P1|NOT COMPLETED|First Intervention||1
193499|NCT00834756|464652|P2|COMPLETED|First Intervention||18
193500|NCT00834756|464653|P1|COMPLETED|First Intervention||17
193501|NCT00834756|464652|P2|STARTED|First Intervention||18
193502|NCT00834756|464653|P1|STARTED|First Intervention||18
193503|NCT00834743|464663|P2|NOT COMPLETED|Second Intervention||0
193504|NCT00834743|464664|P1|NOT COMPLETED|Second Intervention||1
193505|NCT00834743|464663|P2|COMPLETED|Second Intervention||16
193506|NCT00834743|464664|P1|COMPLETED|Second Intervention||15
193507|NCT00834743|464663|P2|STARTED|Second Intervention||16
193508|NCT00834743|464664|P1|STARTED|Second Intervention||16
193509|NCT00834743|464663|P2|NOT COMPLETED|Washout of 7 Days||0
193510|NCT00834743|464664|P1|NOT COMPLETED|Washout of 7 Days||0
193511|NCT00834743|464663|P2|COMPLETED|Washout of 7 Days||16
193512|NCT00834743|464664|P1|COMPLETED|Washout of 7 Days||16
193513|NCT00834743|464663|P2|STARTED|Washout of 7 Days||16
193514|NCT00834743|464664|P1|STARTED|Washout of 7 Days||16
193515|NCT00834743|464663|P2|NOT COMPLETED|First Intervention||0
193516|NCT00834743|464664|P1|NOT COMPLETED|First Intervention||0
193517|NCT00834743|464663|P2|COMPLETED|First Intervention||16
193518|NCT00834743|464664|P1|COMPLETED|First Intervention||16
193519|NCT00834743|464663|P2|STARTED|First Intervention||16
193520|NCT00834743|464664|P1|STARTED|First Intervention||16
193521|NCT00834717|464674|P2|NOT COMPLETED|Second Intervention||0
193522|NCT00834717|464675|P1|NOT COMPLETED|Second Intervention||0
193523|NCT00834717|464674|P2|COMPLETED|Second Intervention||19
193524|NCT00834717|464675|P1|COMPLETED|Second Intervention||19
193525|NCT00834717|464674|P2|STARTED|Second Intervention||19
193526|NCT00834717|464675|P1|STARTED|Second Intervention||19
193527|NCT00834717|464674|P2|NOT COMPLETED|First Intervention||1
193528|NCT00834717|464675|P1|NOT COMPLETED|First Intervention||1
193529|NCT00834717|464674|P2|COMPLETED|First Intervention||19
193530|NCT00834717|464675|P1|COMPLETED|First Intervention||19
193531|NCT00834717|464674|P2|STARTED|First Intervention||20
193532|NCT00834717|464675|P1|STARTED|First Intervention||20
193533|NCT00834678|464683|P1|NOT COMPLETED|Overall Study||0
193534|NCT00834678|464683|P1|COMPLETED|Overall Study||11
193535|NCT00834678|464683|P1|STARTED|Overall Study||11
193536|NCT00834652|464697|P2|NOT COMPLETED|Overall Study||40
193537|NCT00834652|464698|P1|NOT COMPLETED|Overall Study||38
193538|NCT00834652|464697|P2|COMPLETED|Overall Study||62
193539|NCT00834652|464698|P1|COMPLETED|Overall Study||66
193540|NCT00834652|464697|P2|STARTED|Overall Study||102
193541|NCT00834652|464698|P1|STARTED|Overall Study||104
193542|NCT00834639|464706|P2|NOT COMPLETED|Second Intervention||2
193543|NCT00834639|464707|P1|NOT COMPLETED|Second Intervention||0
193544|NCT00834639|464706|P2|COMPLETED|Second Intervention||10
193545|NCT00834639|464707|P1|COMPLETED|Second Intervention||12
193546|NCT00834639|464706|P2|STARTED|Second Intervention||12
193547|NCT00834639|464707|P1|STARTED|Second Intervention||12
193548|NCT00834639|464706|P2|NOT COMPLETED|Washout of 7 Days||0
193549|NCT00834639|464707|P1|NOT COMPLETED|Washout of 7 Days||0
193550|NCT00834639|464706|P2|COMPLETED|Washout of 7 Days||12
193551|NCT00834639|464707|P1|COMPLETED|Washout of 7 Days||12
193552|NCT00834639|464706|P2|STARTED|Washout of 7 Days||12
193553|NCT00834639|464707|P1|STARTED|Washout of 7 Days||12
193554|NCT00834639|464706|P2|NOT COMPLETED|First Intervention||0
193555|NCT00834639|464707|P1|NOT COMPLETED|First Intervention||0
193556|NCT00834639|464706|P2|COMPLETED|First Intervention||12
193557|NCT00834639|464707|P1|COMPLETED|First Intervention||12
193558|NCT00834639|464706|P2|STARTED|First Intervention||12
193559|NCT00834639|464707|P1|STARTED|First Intervention||12
193560|NCT00834626|464715|P1|NOT COMPLETED|Overall Study||0
193561|NCT00834626|464715|P1|COMPLETED|Overall Study||30
193562|NCT00834626|464715|P1|1 Year Follow-up|Overall Study||30
193563|NCT00834626|464715|P1|STARTED|Overall Study||30
193564|NCT00834613|464724|P2|NOT COMPLETED|Second Intervention||0
193565|NCT00834613|464725|P1|NOT COMPLETED|Second Intervention||0
193566|NCT00834613|464724|P2|COMPLETED|Second Intervention||16
193567|NCT00834613|464725|P1|COMPLETED|Second Intervention||15
193568|NCT00834613|464724|P2|STARTED|Second Intervention||16
193569|NCT00834613|464725|P1|STARTED|Second Intervention||15
193570|NCT00834613|464724|P2|NOT COMPLETED|Washout of 7 Days||0
193571|NCT00834613|464725|P1|NOT COMPLETED|Washout of 7 Days||0
193572|NCT00834613|464724|P2|COMPLETED|Washout of 7 Days||16
193573|NCT00834613|464725|P1|COMPLETED|Washout of 7 Days||15
193574|NCT00834613|464724|P2|STARTED|Washout of 7 Days||16
193575|NCT00834613|464725|P1|STARTED|Washout of 7 Days||15
193576|NCT00834613|464724|P2|NOT COMPLETED|First Intervention||0
193577|NCT00834613|464725|P1|NOT COMPLETED|First Intervention||1
193578|NCT00834613|464724|P2|COMPLETED|First Intervention||16
193579|NCT00834613|464725|P1|COMPLETED|First Intervention||15
193580|NCT00834613|464724|P2|STARTED|First Intervention||16
193581|NCT00834613|464725|P1|STARTED|First Intervention||16
193582|NCT00834587|464735|P2|NOT COMPLETED|Second Intervention||0
193583|NCT00834587|464736|P1|NOT COMPLETED|Second Intervention||0
193584|NCT00834587|464735|P2|COMPLETED|Second Intervention||20
193585|NCT00834587|464736|P1|COMPLETED|Second Intervention||19
193586|NCT00834587|464735|P2|STARTED|Second Intervention||20
193587|NCT00834587|464736|P1|STARTED|Second Intervention||19
193588|NCT00834587|464735|P2|NOT COMPLETED|Washout: 7 Days||0
193589|NCT00834587|464736|P1|NOT COMPLETED|Washout: 7 Days||1
193590|NCT00834587|464735|P2|COMPLETED|Washout: 7 Days||20
193591|NCT00834587|464736|P1|COMPLETED|Washout: 7 Days||19
193592|NCT00834587|464735|P2|STARTED|Washout: 7 Days||20
193593|NCT00834587|464736|P1|STARTED|Washout: 7 Days||20
193594|NCT00834587|464735|P2|NOT COMPLETED|First Intervention||0
193595|NCT00834587|464736|P1|NOT COMPLETED|First Intervention||0
193596|NCT00834587|464735|P2|COMPLETED|First Intervention||20
193597|NCT00834587|464736|P1|COMPLETED|First Intervention||20
193598|NCT00834587|464735|P2|STARTED|First Intervention||20
193599|NCT00834587|464736|P1|STARTED|First Intervention||20
193600|NCT00834574|464752|P2|NOT COMPLETED|Second Intervention||0
193601|NCT00834574|464753|P1|NOT COMPLETED|Second Intervention||0
193602|NCT00834574|464752|P2|COMPLETED|Second Intervention||16
193603|NCT00834574|464753|P1|COMPLETED|Second Intervention||16
193604|NCT00834574|464752|P2|STARTED|Second Intervention||16
193605|NCT00834574|464753|P1|STARTED|Second Intervention||16
193606|NCT00834574|464752|P2|NOT COMPLETED|Washout of 7 Days||0
193607|NCT00834574|464753|P1|NOT COMPLETED|Washout of 7 Days||0
193608|NCT00834574|464752|P2|COMPLETED|Washout of 7 Days||16
193609|NCT00834574|464753|P1|COMPLETED|Washout of 7 Days||16
193610|NCT00834574|464752|P2|STARTED|Washout of 7 Days||16
193611|NCT00834574|464753|P1|STARTED|Washout of 7 Days||16
193612|NCT00834574|464752|P2|NOT COMPLETED|First Intervention||0
193613|NCT00834574|464753|P1|NOT COMPLETED|First Intervention||0
193614|NCT00834574|464752|P2|COMPLETED|First Intervention||16
193615|NCT00834574|464753|P1|COMPLETED|First Intervention||16
193616|NCT00834574|464752|P2|STARTED|First Intervention||16
193617|NCT00834574|464753|P1|STARTED|First Intervention||16
193618|NCT00834561|464763|P2|NOT COMPLETED|Second Intervention||0
193619|NCT00834561|464764|P1|NOT COMPLETED|Second Intervention||0
193620|NCT00834561|464763|P2|COMPLETED|Second Intervention||16
193621|NCT00834561|464764|P1|COMPLETED|Second Intervention||16
193622|NCT00834561|464763|P2|STARTED|Second Intervention||16
193623|NCT00834561|464764|P1|STARTED|Second Intervention||16
193624|NCT00834561|464763|P2|NOT COMPLETED|First Intervention||0
193625|NCT00834561|464764|P1|NOT COMPLETED|First Intervention||0
193626|NCT00834561|464763|P2|COMPLETED|First Intervention||16
193627|NCT00834561|464764|P1|COMPLETED|First Intervention||16
193628|NCT00834561|464763|P2|STARTED|First Intervention||16
193629|NCT00834561|464764|P1|STARTED|First Intervention||16
193630|NCT00834535|464774|P2|NOT COMPLETED|Second Intervention||0
193631|NCT00834535|464775|P1|NOT COMPLETED|Second Intervention||0
193632|NCT00834535|464774|P2|COMPLETED|Second Intervention||16
193633|NCT00834535|464775|P1|COMPLETED|Second Intervention||16
193634|NCT00834535|464774|P2|STARTED|Second Intervention||16
193635|NCT00834535|464775|P1|STARTED|Second Intervention||16
193636|NCT00834535|464774|P2|NOT COMPLETED|Washout of 7 Days||0
193637|NCT00834535|464775|P1|NOT COMPLETED|Washout of 7 Days||0
193638|NCT00834535|464774|P2|COMPLETED|Washout of 7 Days||16
193639|NCT00834535|464775|P1|COMPLETED|Washout of 7 Days||16
193640|NCT00834535|464774|P2|STARTED|Washout of 7 Days||16
193641|NCT00834535|464775|P1|STARTED|Washout of 7 Days||16
193642|NCT00834535|464774|P2|NOT COMPLETED|First Intervention||0
193643|NCT00834535|464775|P1|NOT COMPLETED|First Intervention||0
193644|NCT00834535|464774|P2|COMPLETED|First Intervention||16
193645|NCT00834535|464775|P1|COMPLETED|First Intervention||16
193646|NCT00834535|464774|P2|STARTED|First Intervention||16
193647|NCT00834535|464775|P1|STARTED|First Intervention||16
193648|NCT00834522|464785|P2|NOT COMPLETED|Second Intervention||0
193649|NCT00834522|464786|P1|NOT COMPLETED|Second Intervention||0
193650|NCT00834522|464785|P2|COMPLETED|Second Intervention||39
193651|NCT00834522|464786|P1|COMPLETED|Second Intervention||37
193652|NCT00834522|464785|P2|STARTED|Second Intervention||39
193653|NCT00834522|464786|P1|STARTED|Second Intervention||37
193654|NCT00834522|464785|P2|NOT COMPLETED|Washout||1
193655|NCT00834522|464786|P1|NOT COMPLETED|Washout||3
193656|NCT00834522|464785|P2|COMPLETED|Washout||39
193657|NCT00834522|464786|P1|COMPLETED|Washout||37
193658|NCT00834522|464785|P2|STARTED|Washout||40
193659|NCT00834522|464786|P1|STARTED|Washout||40
193660|NCT00834522|464785|P2|NOT COMPLETED|First Intervention||0
193661|NCT00834522|464786|P1|NOT COMPLETED|First Intervention||0
193662|NCT00834522|464785|P2|COMPLETED|First Intervention||40
193663|NCT00834522|464786|P1|COMPLETED|First Intervention||40
193664|NCT00834522|464785|P2|STARTED|First Intervention||40
193665|NCT00834522|464786|P1|STARTED|First Intervention||40
193666|NCT00834483|464796|P2|NOT COMPLETED|Overall Study||0
193667|NCT00834483|464797|P1|NOT COMPLETED|Overall Study||0
193668|NCT00834483|464796|P2|COMPLETED|Overall Study||29
193669|NCT00834483|464797|P1|COMPLETED|Overall Study||31
193670|NCT00834483|464796|P2|STARTED|Overall Study||29
193671|NCT00834483|464797|P1|STARTED|Overall Study||31
193672|NCT00834444|464809|P2|NOT COMPLETED|Second Intervention||0
193673|NCT00834444|464810|P1|NOT COMPLETED|Second Intervention||1
193674|NCT00834444|464809|P2|COMPLETED|Second Intervention||16
193675|NCT00834444|464810|P1|COMPLETED|Second Intervention||16
193676|NCT00834444|464809|P2|STARTED|Second Intervention||16
193677|NCT00834444|464810|P1|STARTED|Second Intervention||17
193678|NCT00834444|464809|P2|NOT COMPLETED|Washout of 7 Days||1
193679|NCT00834444|464810|P1|NOT COMPLETED|Washout of 7 Days||0
193680|NCT00834444|464809|P2|COMPLETED|Washout of 7 Days||16
193681|NCT00834444|464810|P1|COMPLETED|Washout of 7 Days||17
193682|NCT00834444|464809|P2|STARTED|Washout of 7 Days||17
193683|NCT00834444|464810|P1|STARTED|Washout of 7 Days||17
193684|NCT00834444|464809|P2|NOT COMPLETED|First Intervention||1
193685|NCT00834444|464810|P1|NOT COMPLETED|First Intervention||1
193686|NCT00834444|464809|P2|COMPLETED|First Intervention||17
193687|NCT00834444|464810|P1|COMPLETED|First Intervention||17
193688|NCT00834444|464809|P2|STARTED|First Intervention||18
193689|NCT00834444|464810|P1|STARTED|First Intervention||18
193690|NCT00834431|464820|P2|NOT COMPLETED|Second Intervention||0
193691|NCT00834431|464821|P1|NOT COMPLETED|Second Intervention||0
193692|NCT00834431|464820|P2|COMPLETED|Second Intervention||16
193693|NCT00834431|464821|P1|COMPLETED|Second Intervention||18
193694|NCT00834431|464820|P2|STARTED|Second Intervention||16
193695|NCT00834431|464821|P1|STARTED|Second Intervention||18
193696|NCT00834431|464820|P2|NOT COMPLETED|Washout of 7 Days||1
193697|NCT00834431|464821|P1|NOT COMPLETED|Washout of 7 Days||0
193698|NCT00834431|464820|P2|COMPLETED|Washout of 7 Days||16
193699|NCT00834431|464821|P1|COMPLETED|Washout of 7 Days||18
193700|NCT00834431|464820|P2|STARTED|Washout of 7 Days||17
193701|NCT00834431|464821|P1|STARTED|Washout of 7 Days||18
193702|NCT00834431|464820|P2|NOT COMPLETED|First Intervention||1
193703|NCT00834431|464821|P1|NOT COMPLETED|First Intervention||0
193704|NCT00834431|464820|P2|COMPLETED|First Intervention||17
193705|NCT00834431|464821|P1|COMPLETED|First Intervention||18
193706|NCT00834431|464820|P2|STARTED|First Intervention||18
193707|NCT00834431|464821|P1|STARTED|First Intervention||18
193708|NCT00834418|464831|P2|NOT COMPLETED|Overall Study||2
193709|NCT00834418|464832|P1|NOT COMPLETED|Overall Study||0
193710|NCT00834418|464831|P2|COMPLETED|Overall Study||40
193711|NCT00834418|464832|P1|COMPLETED|Overall Study||42
193712|NCT00834418|464831|P2|STARTED|Overall Study||42
193713|NCT00834418|464832|P1|STARTED|Overall Study||42
193714|NCT00834405|464840|P2|NOT COMPLETED|Overall Study||0
193715|NCT00834405|464841|P1|NOT COMPLETED|Overall Study||0
193716|NCT00834405|464840|P2|COMPLETED|Overall Study||17
193717|NCT00834405|464841|P1|COMPLETED|Overall Study||20
193718|NCT00834405|464840|P2|STARTED|Overall Study||17
193719|NCT00834405|464841|P1|STARTED|Overall Study||20
193720|NCT00834366|464849|P2|NOT COMPLETED|Treatment Period 2||0
193721|NCT00834366|464850|P1|NOT COMPLETED|Treatment Period 2||0
193722|NCT00834366|464849|P2|COMPLETED|Treatment Period 2||12
193723|NCT00834366|464850|P1|COMPLETED|Treatment Period 2||12
193724|NCT00834366|464849|P2|STARTED|Treatment Period 2||12
193725|NCT00834366|464850|P1|STARTED|Treatment Period 2||12
193726|NCT00834366|464849|P2|NOT COMPLETED|Treatment Period 1||1
193727|NCT00834366|464850|P1|NOT COMPLETED|Treatment Period 1||1
193728|NCT00834366|464849|P2|COMPLETED|Treatment Period 1||12
193729|NCT00834366|464850|P1|COMPLETED|Treatment Period 1||12
193730|NCT00834366|464849|P2|STARTED|Treatment Period 1||13
193731|NCT00834366|464850|P1|STARTED|Treatment Period 1||13
193732|NCT00834340|464866|P2|NOT COMPLETED|Second Intervention||0
193733|NCT00834340|464867|P1|NOT COMPLETED|Second Intervention||0
193734|NCT00834340|464866|P2|COMPLETED|Second Intervention||16
193735|NCT00834340|464867|P1|COMPLETED|Second Intervention||14
193736|NCT00834340|464866|P2|STARTED|Second Intervention||16
193737|NCT00834340|464867|P1|STARTED|Second Intervention||14
193738|NCT00834340|464866|P2|NOT COMPLETED|Washout||0
193739|NCT00834340|464867|P1|NOT COMPLETED|Washout||2
193740|NCT00834340|464866|P2|COMPLETED|Washout||16
193741|NCT00834340|464867|P1|COMPLETED|Washout||14
193742|NCT00834340|464866|P2|STARTED|Washout||16
193743|NCT00834340|464867|P1|STARTED|Washout||16
193744|NCT00834340|464866|P2|NOT COMPLETED|First Intervention||0
193745|NCT00834340|464867|P1|NOT COMPLETED|First Intervention||0
193746|NCT00834340|464866|P2|COMPLETED|First Intervention||16
193747|NCT00834340|464867|P1|COMPLETED|First Intervention||16
193748|NCT00834340|464866|P2|STARTED|First Intervention||16
193749|NCT00834340|464867|P1|STARTED|First Intervention||16
193750|NCT00834288|464877|P2|NOT COMPLETED|Treatment Phase II||0
193751|NCT00834288|464878|P1|NOT COMPLETED|Treatment Phase II||0
193752|NCT00834288|464877|P2|COMPLETED|Treatment Phase II||13
193753|NCT00834288|464878|P1|COMPLETED|Treatment Phase II||13
193754|NCT00834288|464877|P2|STARTED|Treatment Phase II||13
193755|NCT00834288|464878|P1|STARTED|Treatment Phase II||13
193756|NCT00834288|464877|P2|NOT COMPLETED|Treatment Phase I||0
193757|NCT00834288|464878|P1|NOT COMPLETED|Treatment Phase I||0
193758|NCT00834288|464877|P2|COMPLETED|Treatment Phase I||13
193759|NCT00834288|464878|P1|COMPLETED|Treatment Phase I||13
193760|NCT00834288|464877|P2|STARTED|Treatment Phase I||13
193761|NCT00834288|464878|P1|STARTED|Treatment Phase I||13
193762|NCT00834275|464900|P2|NOT COMPLETED|Second Intervention||0
193763|NCT00834275|464901|P1|NOT COMPLETED|Second Intervention||0
193764|NCT00834275|464900|P2|COMPLETED|Second Intervention||13
193765|NCT00834275|464901|P1|COMPLETED|Second Intervention||13
193766|NCT00834275|464900|P2|STARTED|Second Intervention||13
193767|NCT00834275|464901|P1|STARTED|Second Intervention||13
193768|NCT00834275|464900|P2|NOT COMPLETED|Washout of 7 Days||0
193769|NCT00834275|464901|P1|NOT COMPLETED|Washout of 7 Days||0
193770|NCT00834275|464900|P2|COMPLETED|Washout of 7 Days||13
193771|NCT00834275|464901|P1|COMPLETED|Washout of 7 Days||13
193772|NCT00834275|464900|P2|STARTED|Washout of 7 Days||13
193773|NCT00834275|464901|P1|STARTED|Washout of 7 Days||13
193774|NCT00834275|464900|P2|NOT COMPLETED|First Intervention||0
193775|NCT00834275|464901|P1|NOT COMPLETED|First Intervention||0
193776|NCT00834275|464900|P2|COMPLETED|First Intervention||13
193777|NCT00834275|464901|P1|COMPLETED|First Intervention||13
193778|NCT00834275|464900|P2|STARTED|First Intervention||13
193779|NCT00834275|464901|P1|STARTED|First Intervention||13
193780|NCT00834249|464911|P2|NOT COMPLETED|Second Intervention||0
193781|NCT00834249|464912|P1|NOT COMPLETED|Second Intervention||1
193782|NCT00834249|464911|P2|COMPLETED|Second Intervention||8
193783|NCT00834249|464912|P1|COMPLETED|Second Intervention||7
193784|NCT00834249|464911|P2|STARTED|Second Intervention||8
193785|NCT00834249|464912|P1|STARTED|Second Intervention||8
193786|NCT00834249|464911|P2|NOT COMPLETED|Washout: 7 Days||1
193787|NCT00834249|464912|P1|NOT COMPLETED|Washout: 7 Days||1
193788|NCT00834249|464911|P2|COMPLETED|Washout: 7 Days||8
193789|NCT00834249|464912|P1|COMPLETED|Washout: 7 Days||8
193790|NCT00834249|464911|P2|STARTED|Washout: 7 Days||9
193791|NCT00834249|464912|P1|STARTED|Washout: 7 Days||9
193792|NCT00834249|464911|P2|NOT COMPLETED|First Intervention||0
193793|NCT00834249|464912|P1|NOT COMPLETED|First Intervention||0
193794|NCT00834249|464911|P2|COMPLETED|First Intervention||9
193795|NCT00834249|464912|P1|COMPLETED|First Intervention||9
193796|NCT00834249|464911|P2|STARTED|First Intervention||9
193797|NCT00834249|464912|P1|STARTED|First Intervention||9
193798|NCT00834236|464928|P2|NOT COMPLETED|Overall Study||0
193799|NCT00834236|464929|P1|NOT COMPLETED|Overall Study||0
193800|NCT00834236|464928|P2|COMPLETED|Overall Study||47
193801|NCT00834236|464929|P1|COMPLETED|Overall Study||29
193802|NCT00834236|464928|P2|STARTED|Overall Study||47
193803|NCT00834236|464929|P1|STARTED|Overall Study||29
193804|NCT00834210|464937|P2|NOT COMPLETED|Overall Study||8
193805|NCT00834210|464938|P1|NOT COMPLETED|Overall Study||3
193806|NCT00834210|464937|P2|COMPLETED|Overall Study||77
193807|NCT00834210|464938|P1|COMPLETED|Overall Study||83
193808|NCT00834210|464937|P2|STARTED|Overall Study||85
193809|NCT00834210|464938|P1|STARTED|Overall Study||86
193810|NCT00834197|464952|P2|NOT COMPLETED|Second Intervention||0
193811|NCT00834197|464953|P1|NOT COMPLETED|Second Intervention||0
193812|NCT00834197|464952|P2|COMPLETED|Second Intervention||16
193813|NCT00834197|464953|P1|COMPLETED|Second Intervention||16
193814|NCT00834197|464952|P2|STARTED|Second Intervention||16
193815|NCT00834197|464953|P1|STARTED|Second Intervention||16
193816|NCT00834197|464952|P2|NOT COMPLETED|Washout of 14 Days||0
193817|NCT00834197|464953|P1|NOT COMPLETED|Washout of 14 Days||0
193818|NCT00834197|464952|P2|COMPLETED|Washout of 14 Days||16
193819|NCT00834197|464953|P1|COMPLETED|Washout of 14 Days||16
193820|NCT00834197|464952|P2|STARTED|Washout of 14 Days||16
193821|NCT00834197|464953|P1|STARTED|Washout of 14 Days||16
193822|NCT00834197|464952|P2|NOT COMPLETED|First Intervention||0
193823|NCT00834197|464953|P1|NOT COMPLETED|First Intervention||0
193824|NCT00834197|464952|P2|COMPLETED|First Intervention||16
193825|NCT00834197|464953|P1|COMPLETED|First Intervention||16
193826|NCT00834197|464952|P2|STARTED|First Intervention||16
193827|NCT00834197|464953|P1|STARTED|First Intervention||16
193828|NCT00834171|464963|P2|NOT COMPLETED|Overall Study||0
193829|NCT00834171|464964|P1|NOT COMPLETED|Overall Study||0
193830|NCT00834171|464963|P2|COMPLETED|Overall Study||7
193831|NCT00834171|464964|P1|COMPLETED|Overall Study||43
193832|NCT00834171|464963|P2|STARTED|Overall Study||7
193833|NCT00834171|464964|P1|STARTED|Overall Study||43
193834|NCT00834132|464972|P2|NOT COMPLETED|Second Intervention||0
193835|NCT00834132|464973|P1|NOT COMPLETED|Second Intervention||0
193836|NCT00834132|464972|P2|COMPLETED|Second Intervention||12
193837|NCT00834132|464973|P1|COMPLETED|Second Intervention||12
193838|NCT00834132|464972|P2|STARTED|Second Intervention||12
193839|NCT00834132|464973|P1|STARTED|Second Intervention||12
193840|NCT00834132|464972|P2|NOT COMPLETED|Washout: 21 Days||0
193841|NCT00834132|464973|P1|NOT COMPLETED|Washout: 21 Days||0
193842|NCT00834132|464972|P2|COMPLETED|Washout: 21 Days||12
193843|NCT00834132|464973|P1|COMPLETED|Washout: 21 Days||12
193844|NCT00834132|464972|P2|STARTED|Washout: 21 Days||12
193845|NCT00834132|464973|P1|STARTED|Washout: 21 Days||12
193846|NCT00834132|464972|P2|NOT COMPLETED|First Intervention||0
193847|NCT00834132|464973|P1|NOT COMPLETED|First Intervention||0
193848|NCT00834132|464972|P2|COMPLETED|First Intervention||12
193849|NCT00834132|464973|P1|COMPLETED|First Intervention||12
193850|NCT00834132|464972|P2|STARTED|First Intervention||12
193851|NCT00834132|464973|P1|STARTED|First Intervention||12
193852|NCT00834106|464983|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
193853|NCT00834106|464984|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
193854|NCT00834106|464983|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
193855|NCT00834106|464984|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
193856|NCT00834106|464983|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
193857|NCT00834106|464984|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
193858|NCT00834106|464983|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
193859|NCT00834106|464984|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
193860|NCT00834106|464983|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
193861|NCT00834106|464984|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
193862|NCT00834106|464983|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
193863|NCT00834106|464984|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
193864|NCT00834106|464983|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
193865|NCT00834106|464984|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
193866|NCT00834106|464983|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
193867|NCT00834106|464984|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
193868|NCT00834080|465008|P1|NOT COMPLETED|Overall Study||23
193869|NCT00834080|465008|P1|COMPLETED|Overall Study||15
193870|NCT00834080|465008|P1|STARTED|Overall Study||38
193871|NCT00834067|465014|P2|NOT COMPLETED|Second Intervention||0
193872|NCT00834067|465015|P1|NOT COMPLETED|Second Intervention||0
193873|NCT00834067|465014|P2|COMPLETED|Second Intervention||29
193874|NCT00834067|465015|P1|COMPLETED|Second Intervention||30
193875|NCT00834067|465014|P2|STARTED|Second Intervention||29
193876|NCT00834067|465015|P1|STARTED|Second Intervention||30
193877|NCT00834067|465014|P2|NOT COMPLETED|Washout of 21 Days||1
193878|NCT00834067|465015|P1|NOT COMPLETED|Washout of 21 Days||0
193879|NCT00834067|465014|P2|COMPLETED|Washout of 21 Days||29
193880|NCT00834067|465015|P1|COMPLETED|Washout of 21 Days||30
193881|NCT00834067|465014|P2|STARTED|Washout of 21 Days||30
193882|NCT00834067|465015|P1|STARTED|Washout of 21 Days||30
193883|NCT00834067|465014|P2|NOT COMPLETED|First Intervention||0
193884|NCT00834067|465015|P1|NOT COMPLETED|First Intervention||0
193885|NCT00834067|465014|P2|COMPLETED|First Intervention||30
193886|NCT00834067|465015|P1|COMPLETED|First Intervention||30
193887|NCT00834067|465014|P2|STARTED|First Intervention||30
193888|NCT00834067|465015|P1|STARTED|First Intervention||30
193889|NCT00834041|465037|P2|NOT COMPLETED|Overall Study||1
193890|NCT00834041|465038|P1|NOT COMPLETED|Overall Study||1
193891|NCT00834041|465037|P2|COMPLETED|Overall Study||19
193892|NCT00834041|465038|P1|COMPLETED|Overall Study||18
193893|NCT00834041|465037|P2|STARTED|Overall Study||20
193894|NCT00834041|465038|P1|STARTED|Overall Study||19
193895|NCT00833989|465056|P4|NOT COMPLETED|Overall Study||2
193896|NCT00833989|465057|P3|NOT COMPLETED|Overall Study||1
193897|NCT00833989|465058|P2|NOT COMPLETED|Overall Study||0
193898|NCT00833989|465059|P1|NOT COMPLETED|Overall Study||3
193899|NCT00833989|465056|P4|COMPLETED|Overall Study||6
193900|NCT00833989|465057|P3|COMPLETED|Overall Study||8
193901|NCT00833989|465058|P2|COMPLETED|Overall Study||8
193902|NCT00833989|465059|P1|COMPLETED|Overall Study||14
193903|NCT00833989|465056|P4|STARTED|Overall Study||8
193904|NCT00833989|465057|P3|STARTED|Overall Study||9
193905|NCT00833989|465058|P2|STARTED|Overall Study||8
193906|NCT00833989|465059|P1|STARTED|Overall Study||17
193907|NCT00833976|465163|P1|NOT COMPLETED|Overall Study||51
193908|NCT00833976|465163|P1|COMPLETED|Overall Study||14
193909|NCT00833976|465163|P1|STARTED|Overall Study||65
193910|NCT00833937|465171|P2|NOT COMPLETED|Second Intervention||0
193911|NCT00833937|465172|P1|NOT COMPLETED|Second Intervention||0
193912|NCT00833937|465171|P2|COMPLETED|Second Intervention||12
193913|NCT00833937|465172|P1|COMPLETED|Second Intervention||11
193914|NCT00833937|465171|P2|STARTED|Second Intervention||12
193915|NCT00833937|465172|P1|STARTED|Second Intervention||11
193916|NCT00833937|465171|P2|NOT COMPLETED|Washout||0
193917|NCT00833937|465172|P1|NOT COMPLETED|Washout||1
193918|NCT00833937|465171|P2|COMPLETED|Washout||12
193919|NCT00833937|465172|P1|COMPLETED|Washout||11
193920|NCT00833937|465171|P2|STARTED|Washout||12
193921|NCT00833937|465172|P1|STARTED|Washout||12
193922|NCT00833937|465171|P2|NOT COMPLETED|First Intervention||0
193923|NCT00833937|465172|P1|NOT COMPLETED|First Intervention||0
193924|NCT00833937|465171|P2|COMPLETED|First Intervention||12
193925|NCT00833937|465172|P1|COMPLETED|First Intervention||12
193926|NCT00833937|465171|P2|STARTED|First Intervention||12
193927|NCT00833937|465172|P1|STARTED|First Intervention||12
193928|NCT00833924|465180|P1|NOT COMPLETED|Overall Study||109
193929|NCT00833924|465180|P1|COMPLETED|Overall Study||11
193930|NCT00833924|465180|P1|12-month|Overall Study||113
193931|NCT00833924|465180|P1|30-day|Overall Study||120
193932|NCT00833924|465180|P1|STARTED|Overall Study||120
193933|NCT00833911|465185|P1|NOT COMPLETED|Maintenance Phase II||10
193934|NCT00833911|465185|P1|COMPLETED|Maintenance Phase II||166
193935|NCT00833911|465185|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
193936|NCT00833911|465185|P1|NOT COMPLETED|Maintenance Phase I||98
193937|NCT00833911|465185|P1|COMPLETED|Maintenance Phase I||273
193938|NCT00833911|465185|P1|STARTED|Maintenance Phase I||371
193939|NCT00833911|465185|P1|NOT COMPLETED|Titration||21
193940|NCT00833911|465185|P1|COMPLETED|Titration||371
193941|NCT00833911|465185|P1|STARTED|Titration||392
193942|NCT00833898|465195|P2|NOT COMPLETED|Overall Study||36
193943|NCT00833898|465196|P1|NOT COMPLETED|Overall Study||40
193944|NCT00833898|465195|P2|COMPLETED|Overall Study||38
193945|NCT00833898|465196|P1|COMPLETED|Overall Study||34
193946|NCT00833898|465195|P2|Month 12 (Post Transplantation)|Overall Study||50
193947|NCT00833898|465196|P1|Month 12 (Post Transplantation)|Overall Study||50
193948|NCT00833898|465195|P2|Month 6 (Post Transplantation)|Overall Study||54
193949|NCT00833898|465196|P1|Month 6 (Post Transplantation)|Overall Study||59
193950|NCT00833898|465195|P2|Month 3 (Post Transplantation)|Overall Study||64
193951|NCT00833898|465196|P1|Month 3 (Post Transplantation)|Overall Study||66
193952|NCT00833898|465195|P2|Month 1 (Post Transplantation)|Overall Study||74
193953|NCT00833898|465196|P1|Month 1 (Post Transplantation)|Overall Study||72
193954|NCT00833898|465195|P2|STARTED|Overall Study||74
193955|NCT00833898|465196|P1|STARTED|Overall Study||74
193956|NCT00833859|465242|P1|NOT COMPLETED|Overall Study||0
193957|NCT00833859|465242|P1|COMPLETED|Overall Study||2
193958|NCT00833859|465242|P1|STARTED|Overall Study||2
193959|NCT00833833|465255|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
193960|NCT00833833|465256|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
193961|NCT00833833|465257|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
193962|NCT00833833|465258|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
193963|NCT00833833|465259|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
193964|NCT00833833|465260|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
193965|NCT00833833|465255|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
193966|NCT00833833|465256|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
193967|NCT00833833|465257|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
193968|NCT00833833|465258|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
193969|NCT00833833|465259|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
193970|NCT00833833|465260|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
193971|NCT00833833|465255|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
193972|NCT00833833|465256|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
193973|NCT00833833|465257|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
193974|NCT00833833|465258|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
193975|NCT00833833|465259|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
193976|NCT00833833|465260|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
193977|NCT00833833|465255|P6|STARTED|Phase 2 (as of 01 April 2011)||108
193978|NCT00833833|465256|P5|STARTED|Phase 2 (as of 01 April 2011)||113
193979|NCT00833833|465257|P4|STARTED|Phase 2 (as of 01 April 2011)||0
193980|NCT00833833|465258|P3|STARTED|Phase 2 (as of 01 April 2011)||0
193981|NCT00833833|465259|P2|STARTED|Phase 2 (as of 01 April 2011)||0
193982|NCT00833833|465260|P1|STARTED|Phase 2 (as of 01 April 2011)||0
193983|NCT00833833|465255|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
193984|NCT00833833|465256|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
193985|NCT00833833|465257|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
193986|NCT00833833|465258|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
193987|NCT00833833|465259|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
193988|NCT00833833|465260|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
193989|NCT00833833|465255|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
193990|NCT00833833|465256|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
193991|NCT00833833|465257|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
193992|NCT00833833|465258|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
193993|NCT00833833|465259|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
193994|NCT00833833|465260|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
193995|NCT00833833|465255|P6|STARTED|Phase 1 (as of 01 April 2011)||0
193996|NCT00833833|465256|P5|STARTED|Phase 1 (as of 01 April 2011)||0
193997|NCT00833833|465257|P4|STARTED|Phase 1 (as of 01 April 2011)||10
193998|NCT00833833|465258|P3|STARTED|Phase 1 (as of 01 April 2011)||14
193999|NCT00833833|465259|P2|STARTED|Phase 1 (as of 01 April 2011)||8
194000|NCT00833833|465260|P1|STARTED|Phase 1 (as of 01 April 2011)||6
194001|NCT00833794|465300|P2|NOT COMPLETED|Double-blind Phase||49
194002|NCT00833794|465301|P1|NOT COMPLETED|Double-blind Phase||106
194003|NCT00833794|465300|P2|COMPLETED|Double-blind Phase||165
194004|NCT00833794|465301|P1|COMPLETED|Double-blind Phase||326
194005|NCT00833794|465300|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
194006|NCT00833794|465301|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
194007|NCT00833794|465300|P2|NOT COMPLETED|Open-label Phase||0
194008|NCT00833794|465301|P1|NOT COMPLETED|Open-label Phase||382
194009|NCT00833794|465300|P2|COMPLETED|Open-label Phase||0
194010|NCT00833794|465301|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
194011|NCT00833794|465300|P2|Received Open-Label Treatment|Open-label Phase||0
194012|NCT00833794|465301|P1|Received Open-Label Treatment|Open-label Phase||1023
194013|NCT00833794|465300|P2|Entered run-in Period|Open-label Phase||0
194014|NCT00833794|465301|P1|Entered run-in Period|Open-label Phase||1027
194015|NCT00833794|465300|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
194016|NCT00833794|465301|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
194017|NCT00833781|465329|P2|NOT COMPLETED|Overall Study||0
194018|NCT00833781|465330|P1|NOT COMPLETED|Overall Study||0
194019|NCT00833781|465329|P2|COMPLETED|Overall Study||5
194020|NCT00833781|465330|P1|COMPLETED|Overall Study||10
194021|NCT00833781|465329|P2|STARTED|Overall Study||5
194022|NCT00833781|465330|P1|STARTED|Overall Study||10
194023|NCT00833755|465345|P4|NOT COMPLETED|Overall Study||6
194024|NCT00833755|465346|P3|NOT COMPLETED|Overall Study||2
194025|NCT00833755|465347|P2|NOT COMPLETED|Overall Study||5
194026|NCT00833755|465348|P1|NOT COMPLETED|Overall Study||4
194027|NCT00833755|465345|P4|COMPLETED|Overall Study||17
194028|NCT00833755|465346|P3|COMPLETED|Overall Study||20
194029|NCT00833755|465347|P2|COMPLETED|Overall Study||13
194030|NCT00833755|465348|P1|COMPLETED|Overall Study||12
194031|NCT00833755|465345|P4|STARTED|Overall Study||23
194032|NCT00833755|465346|P3|STARTED|Overall Study||22
194033|NCT00833755|465347|P2|STARTED|Overall Study||18
194034|NCT00833755|465348|P1|STARTED|Overall Study||16
194035|NCT00833703|465368|P2|NOT COMPLETED|Overall Study||1
194036|NCT00833703|465369|P1|NOT COMPLETED|Overall Study||0
194037|NCT00833703|465368|P2|COMPLETED|Overall Study|Completed follow-up|25
194038|NCT00833703|465369|P1|COMPLETED|Overall Study|Completed follow-up|23
194039|NCT00833703|465368|P2|Completed Treatment|Overall Study||24
194040|NCT00833703|465369|P1|Completed Treatment|Overall Study||22
194041|NCT00833703|465368|P2|Treated|Overall Study||26
194042|NCT00833703|465369|P1|Treated|Overall Study||23
194043|NCT00833703|465368|P2|STARTED|Overall Study|Included|26
194044|NCT00833703|465369|P1|STARTED|Overall Study|Included|23
194045|NCT00833690|465382|P3|NOT COMPLETED|Overall Study||0
194046|NCT00833690|465383|P2|NOT COMPLETED|Overall Study||2
194047|NCT00833690|465384|P1|NOT COMPLETED|Overall Study||4
194048|NCT00833690|465382|P3|COMPLETED|Overall Study||26
194049|NCT00833690|465383|P2|COMPLETED|Overall Study||22
194050|NCT00833690|465384|P1|COMPLETED|Overall Study||21
194051|NCT00833690|465382|P3|STARTED|Overall Study||26
194052|NCT00833690|465383|P2|STARTED|Overall Study||24
194053|NCT00833690|465384|P1|STARTED|Overall Study||25
194054|NCT00833664|465508|P2|NOT COMPLETED|Second Intervention||0
194055|NCT00833664|465509|P1|NOT COMPLETED|Second Intervention||0
194056|NCT00833664|465508|P2|COMPLETED|Second Intervention||11
194057|NCT00833664|465509|P1|COMPLETED|Second Intervention||10
194058|NCT00833664|465508|P2|STARTED|Second Intervention||11
194059|NCT00833664|465509|P1|STARTED|Second Intervention||10
194060|NCT00833664|465508|P2|NOT COMPLETED|Washout: 14 Days||0
194061|NCT00833664|465509|P1|NOT COMPLETED|Washout: 14 Days||1
194062|NCT00833664|465508|P2|COMPLETED|Washout: 14 Days||11
194063|NCT00833664|465509|P1|COMPLETED|Washout: 14 Days||10
194064|NCT00833664|465508|P2|STARTED|Washout: 14 Days||11
194065|NCT00833664|465509|P1|STARTED|Washout: 14 Days||11
194066|NCT00833664|465508|P2|NOT COMPLETED|First Intervention||0
194067|NCT00833664|465509|P1|NOT COMPLETED|First Intervention||0
194068|NCT00833664|465508|P2|COMPLETED|First Intervention||11
194069|NCT00833664|465509|P1|COMPLETED|First Intervention||11
194070|NCT00833664|465508|P2|STARTED|First Intervention||11
194071|NCT00833664|465509|P1|STARTED|First Intervention||11
194072|NCT00833638|465520|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
194073|NCT00833638|465521|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
194074|NCT00833638|465522|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
194075|NCT00833638|465520|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
194076|NCT00833638|465521|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
194077|NCT00833638|465522|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
194078|NCT00833638|465520|P3|STARTED|Phase 3: Open-label Extension Phase||124
194079|NCT00833638|465521|P2|STARTED|Phase 3: Open-label Extension Phase||108
194080|NCT00833638|465522|P1|STARTED|Phase 3: Open-label Extension Phase||111
194081|NCT00833638|465520|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
194082|NCT00833638|465521|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
194083|NCT00833638|465522|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
194084|NCT00833638|465520|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
194085|NCT00833638|465521|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
194086|NCT00833638|465522|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
194087|NCT00833638|465520|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
194088|NCT00833638|465521|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
194089|NCT00833638|465522|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
194090|NCT00833586|465564|P2|NOT COMPLETED|Second Intervention||0
194091|NCT00833586|465565|P1|NOT COMPLETED|Second Intervention||0
194092|NCT00833586|465564|P2|COMPLETED|Second Intervention||14
194093|NCT00833586|465565|P1|COMPLETED|Second Intervention||14
194094|NCT00833586|465564|P2|STARTED|Second Intervention||14
194095|NCT00833586|465565|P1|STARTED|Second Intervention||14
194096|NCT00833586|465564|P2|NOT COMPLETED|Washout: 14 Days||0
194097|NCT00833586|465565|P1|NOT COMPLETED|Washout: 14 Days||0
194098|NCT00833586|465564|P2|COMPLETED|Washout: 14 Days||14
194099|NCT00833586|465565|P1|COMPLETED|Washout: 14 Days||14
194100|NCT00833586|465564|P2|STARTED|Washout: 14 Days||14
194101|NCT00833586|465565|P1|STARTED|Washout: 14 Days||14
194102|NCT00833586|465564|P2|NOT COMPLETED|First Intervention||0
194103|NCT00833586|465565|P1|NOT COMPLETED|First Intervention||0
194104|NCT00833586|465564|P2|COMPLETED|First Intervention||14
194105|NCT00833586|465565|P1|COMPLETED|First Intervention||14
194106|NCT00833586|465564|P2|STARTED|First Intervention||14
194107|NCT00833586|465565|P1|STARTED|First Intervention||14
194108|NCT00833560|465573|P1|NOT COMPLETED|Overall Study||42
194109|NCT00833560|465573|P1|COMPLETED|Overall Study||353
194110|NCT00833560|465573|P1|STARTED|Overall Study||395
194111|NCT00833547|465582|P2|NOT COMPLETED|Overall Study||2
194112|NCT00833547|465583|P1|NOT COMPLETED|Overall Study||2
194113|NCT00833547|465582|P2|COMPLETED|Overall Study||10
194114|NCT00833547|465583|P1|COMPLETED|Overall Study||11
194115|NCT00833547|465582|P2|STARTED|Overall Study||12
194116|NCT00833547|465583|P1|STARTED|Overall Study||13
194117|NCT00833521|465593|P2|NOT COMPLETED|Second Intervention||0
194118|NCT00833521|465594|P1|NOT COMPLETED|Second Intervention||0
194119|NCT00833521|465593|P2|COMPLETED|Second Intervention||19
194120|NCT00833521|465594|P1|COMPLETED|Second Intervention||19
194121|NCT00833521|465593|P2|STARTED|Second Intervention||19
194122|NCT00833521|465594|P1|STARTED|Second Intervention||19
194123|NCT00833521|465593|P2|NOT COMPLETED|First Intervention||0
194124|NCT00833521|465594|P1|NOT COMPLETED|First Intervention||0
194125|NCT00833521|465593|P2|COMPLETED|First Intervention||19
194126|NCT00833521|465594|P1|COMPLETED|First Intervention||19
194127|NCT00833521|465593|P2|STARTED|First Intervention||19
194128|NCT00833521|465594|P1|STARTED|First Intervention||19
194129|NCT00833482|465604|P6|NOT COMPLETED|Days 21-30||0
194130|NCT00833482|465605|P5|NOT COMPLETED|Days 21-30||1
194131|NCT00833482|465606|P4|NOT COMPLETED|Days 21-30||0
194132|NCT00833482|465607|P3|NOT COMPLETED|Days 21-30||1
194133|NCT00833482|465608|P2|NOT COMPLETED|Days 21-30||0
194134|NCT00833482|465609|P1|NOT COMPLETED|Days 21-30||0
194135|NCT00833482|465604|P6|COMPLETED|Days 21-30||0
194136|NCT00833482|465605|P5|COMPLETED|Days 21-30||7
194137|NCT00833482|465606|P4|COMPLETED|Days 21-30||0
194138|NCT00833482|465607|P3|COMPLETED|Days 21-30||20
194139|NCT00833482|465608|P2|COMPLETED|Days 21-30||0
194140|NCT00833482|465609|P1|COMPLETED|Days 21-30||0
194141|NCT00833482|465604|P6|STARTED|Days 21-30||0
194142|NCT00833482|465605|P5|STARTED|Days 21-30||8
194143|NCT00833482|465606|P4|STARTED|Days 21-30||0
194144|NCT00833482|465607|P3|STARTED|Days 21-30||21
194145|NCT00833482|465608|P2|STARTED|Days 21-30||0
194146|NCT00833482|465609|P1|STARTED|Days 21-30||0
194147|NCT00833482|465604|P6|NOT COMPLETED|Days 11-20||0
194148|NCT00833482|465605|P5|NOT COMPLETED|Days 11-20||0
194149|NCT00833482|465606|P4|NOT COMPLETED|Days 11-20||0
194150|NCT00833482|465607|P3|NOT COMPLETED|Days 11-20||0
194151|NCT00833482|465608|P2|NOT COMPLETED|Days 11-20||3
194152|NCT00833482|465609|P1|NOT COMPLETED|Days 11-20||0
194153|NCT00833482|465604|P6|COMPLETED|Days 11-20||8
194154|NCT00833482|465605|P5|COMPLETED|Days 11-20||0
194155|NCT00833482|465606|P4|COMPLETED|Days 11-20||0
194156|NCT00833482|465607|P3|COMPLETED|Days 11-20||0
194157|NCT00833482|465608|P2|COMPLETED|Days 11-20||21
194158|NCT00833482|465609|P1|COMPLETED|Days 11-20||0
194159|NCT00833482|465604|P6|STARTED|Days 11-20|Participants who received treatment.|8
194160|NCT00833482|465605|P5|STARTED|Days 11-20||0
194161|NCT00833482|465606|P4|STARTED|Days 11-20||0
194162|NCT00833482|465607|P3|STARTED|Days 11-20||0
194163|NCT00833482|465608|P2|STARTED|Days 11-20|Participants who received treatment.|24
194164|NCT00833482|465609|P1|STARTED|Days 11-20||0
194165|NCT00833482|465604|P6|NOT COMPLETED|Days 1-3||0
194166|NCT00833482|465605|P5|NOT COMPLETED|Days 1-3||0
194167|NCT00833482|465606|P4|NOT COMPLETED|Days 1-3||0
194168|NCT00833482|465607|P3|NOT COMPLETED|Days 1-3||0
194169|NCT00833482|465608|P2|NOT COMPLETED|Days 1-3||0
194170|NCT00833482|465609|P1|NOT COMPLETED|Days 1-3||0
194171|NCT00833482|465604|P6|COMPLETED|Days 1-3||0
194172|NCT00833482|465605|P5|COMPLETED|Days 1-3||0
194173|NCT00833482|465606|P4|COMPLETED|Days 1-3||8
194174|NCT00833482|465607|P3|COMPLETED|Days 1-3||0
194175|NCT00833482|465608|P2|COMPLETED|Days 1-3||0
194176|NCT00833482|465609|P1|COMPLETED|Days 1-3||24
194177|NCT00833482|465604|P6|STARTED|Days 1-3||0
194178|NCT00833482|465605|P5|STARTED|Days 1-3||0
194179|NCT00833482|465606|P4|STARTED|Days 1-3||8
194180|NCT00833482|465607|P3|STARTED|Days 1-3||0
194181|NCT00833482|465608|P2|STARTED|Days 1-3|Participants who received treatment|0
194182|NCT00833482|465609|P1|STARTED|Days 1-3|Participants who received treatment|24
194183|NCT00833469|465665|P1|NOT COMPLETED|Overall Study||2
194184|NCT00833469|465665|P1|COMPLETED|Overall Study||3
194185|NCT00833469|465665|P1|STARTED|Overall Study||5
194186|NCT00833443|465673|P2|NOT COMPLETED|Overall Study||28
194187|NCT00833443|465674|P1|NOT COMPLETED|Overall Study||20
194188|NCT00833443|465673|P2|COMPLETED|Overall Study||15
194189|NCT00833443|465674|P1|COMPLETED|Overall Study||21
194190|NCT00833443|465673|P2|STARTED|Overall Study||43
194191|NCT00833443|465674|P1|STARTED|Overall Study||41
194192|NCT00833417|465688|P2|NOT COMPLETED|Overall Study||71
194193|NCT00833417|465689|P1|NOT COMPLETED|Overall Study||33
194194|NCT00833417|465688|P2|COMPLETED|Overall Study||0
194195|NCT00833417|465689|P1|COMPLETED|Overall Study||0
194196|NCT00833417|465688|P2|STARTED|Overall Study||71
194197|NCT00833417|465689|P1|STARTED|Overall Study||33
194198|NCT00833365|465704|P2|NOT COMPLETED|Overall Study||0
194199|NCT00833365|465705|P1|NOT COMPLETED|Overall Study||0
194200|NCT00833365|465704|P2|COMPLETED|Overall Study||6
194201|NCT00833365|465705|P1|COMPLETED|Overall Study||9
194202|NCT00833365|465704|P2|STARTED|Overall Study||6
194203|NCT00833365|465705|P1|STARTED|Overall Study||9
194204|NCT00833248|465715|P2|NOT COMPLETED|Overall Study||3
194205|NCT00833248|465716|P1|NOT COMPLETED|Overall Study||4
194206|NCT00833248|465715|P2|COMPLETED|Overall Study||62
194207|NCT00833248|465716|P1|COMPLETED|Overall Study||177
194208|NCT00833248|465715|P2|Safety Analysis Set|Overall Study||64
194209|NCT00833248|465716|P1|Safety Analysis Set|Overall Study||181
194210|NCT00833248|465715|P2|Per Protocol (PP) Analysis Set|Overall Study||57
194211|NCT00833248|465716|P1|Per Protocol (PP) Analysis Set|Overall Study||164
194212|NCT00833248|465715|P2|Full Analysis Set (FAS)|Overall Study||64
194213|NCT00833248|465716|P1|Full Analysis Set (FAS)|Overall Study||180
194214|NCT00833248|465715|P2|STARTED|Overall Study||65
194215|NCT00833248|465716|P1|STARTED|Overall Study||181
194216|NCT00833092|465740|P2|NOT COMPLETED|Overall Study||7
194217|NCT00833092|465741|P1|NOT COMPLETED|Overall Study||4
194218|NCT00833092|465740|P2|COMPLETED|Overall Study||50
194219|NCT00833092|465741|P1|COMPLETED|Overall Study||50
194220|NCT00833092|465740|P2|STARTED|Overall Study||57
194221|NCT00833092|465741|P1|STARTED|Overall Study||54
194222|NCT00833053|465749|P2|NOT COMPLETED|Overall Study||3
194223|NCT00833053|465750|P1|NOT COMPLETED|Overall Study||9
194224|NCT00833053|465749|P2|COMPLETED|Overall Study||17
194225|NCT00833053|465750|P1|COMPLETED|Overall Study||10
194226|NCT00833053|465749|P2|STARTED|Overall Study||20
194227|NCT00833053|465750|P1|STARTED|Overall Study||19
194228|NCT00833040|465768|P6|NOT COMPLETED|Overall Study||1
194229|NCT00833040|465769|P5|NOT COMPLETED|Overall Study||0
194230|NCT00833040|465770|P4|NOT COMPLETED|Overall Study||0
194231|NCT00833040|465771|P3|NOT COMPLETED|Overall Study||0
194232|NCT00833040|465772|P2|NOT COMPLETED|Overall Study||0
194233|NCT00833040|465773|P1|NOT COMPLETED|Overall Study||0
194234|NCT00833040|465768|P6|COMPLETED|Overall Study||4
194235|NCT00833040|465769|P5|COMPLETED|Overall Study||5
194236|NCT00833040|465770|P4|COMPLETED|Overall Study||6
194237|NCT00833040|465771|P3|COMPLETED|Overall Study||6
194238|NCT00833040|465772|P2|COMPLETED|Overall Study||6
194239|NCT00833040|465773|P1|COMPLETED|Overall Study||6
194240|NCT00833040|465768|P6|STARTED|Overall Study||5
194241|NCT00833040|465769|P5|STARTED|Overall Study||5
194242|NCT00833040|465770|P4|STARTED|Overall Study||6
194243|NCT00833040|465771|P3|STARTED|Overall Study||6
194244|NCT00833040|465772|P2|STARTED|Overall Study||6
194245|NCT00833040|465773|P1|STARTED|Overall Study||6
194246|NCT00833027|465778|P1|NOT COMPLETED|Overall Study||211
194247|NCT00833027|465778|P1|COMPLETED|Overall Study||397
194248|NCT00833027|465778|P1|STARTED|Overall Study||608
194249|NCT00832975|465783|P1|NOT COMPLETED|Overall Study||39
194250|NCT00832975|465783|P1|COMPLETED|Overall Study||118
194251|NCT00832975|465783|P1|STARTED|Overall Study||157
194252|NCT00832871|465788|P1|NOT COMPLETED|Overall Study||0
194253|NCT00832871|465788|P1|COMPLETED|Overall Study||4
194254|NCT00832871|465788|P1|STARTED|Overall Study||4
194255|NCT00832819|465797|P3|NOT COMPLETED|Overall Study||1
194256|NCT00832819|465798|P2|NOT COMPLETED|Overall Study||1
194257|NCT00832819|465799|P1|NOT COMPLETED|Overall Study||0
194258|NCT00832819|465797|P3|COMPLETED|Overall Study||15
194259|NCT00832819|465798|P2|COMPLETED|Overall Study||5
194260|NCT00832819|465799|P1|COMPLETED|Overall Study||6
194261|NCT00832819|465797|P3|STARTED|Overall Study||16
194262|NCT00832819|465798|P2|STARTED|Overall Study||6
194263|NCT00832819|465799|P1|STARTED|Overall Study||6
194264|NCT00832780|465805|P1|NOT COMPLETED|Overall Study||25
194265|NCT00832780|465805|P1|COMPLETED|Overall Study||19
194266|NCT00832780|465805|P1|STARTED|Overall Study||44
194267|NCT00832767|465815|P2|NOT COMPLETED|Overall Study||18
194268|NCT00832767|465816|P1|NOT COMPLETED|Overall Study||22
194269|NCT00832767|465815|P2|COMPLETED|Overall Study||63
194270|NCT00832767|465816|P1|COMPLETED|Overall Study||99
194271|NCT00832767|465815|P2|STARTED|Overall Study||81
194272|NCT00832767|465816|P1|STARTED|Overall Study||121
194273|NCT00832650|465847|P3|NOT COMPLETED|Overall Study||1
194274|NCT00832650|465848|P2|NOT COMPLETED|Overall Study||0
194275|NCT00832650|465849|P1|NOT COMPLETED|Overall Study||0
194276|NCT00832650|465847|P3|COMPLETED|Overall Study||22
194277|NCT00832650|465848|P2|COMPLETED|Overall Study||12
194278|NCT00832650|465849|P1|COMPLETED|Overall Study||25
194279|NCT00832650|465847|P3|Treated|Overall Study||22
194280|NCT00832650|465848|P2|Treated|Overall Study||12
194281|NCT00832650|465849|P1|Treated|Overall Study||25
194282|NCT00832650|465847|P3|STARTED|Overall Study||23
194283|NCT00832650|465848|P2|STARTED|Overall Study||12
194284|NCT00832650|465849|P1|STARTED|Overall Study||25
194285|NCT00832637|465881|P1|NOT COMPLETED|Overall Study||0
194286|NCT00832637|465881|P1|COMPLETED|Overall Study||33
194287|NCT00832637|465881|P1|STARTED|Overall Study||33
194288|NCT00832624|465889|P1|NOT COMPLETED|Overall Study||10
194289|NCT00832624|465889|P1|COMPLETED|Overall Study||0
194290|NCT00832624|465889|P1|STARTED|Overall Study||10
194291|NCT00832598|465893|P1|NOT COMPLETED|Overall Study||0
194292|NCT00832598|465893|P1|COMPLETED|Overall Study||13
194293|NCT00832598|465893|P1|STARTED|Overall Study||13
194294|NCT00832585|465899|P1|NOT COMPLETED|Overall Study||2
194295|NCT00832585|465899|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
194296|NCT00832585|465899|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
194297|NCT00832572|465906|P2|NOT COMPLETED|Period 2||0
194298|NCT00832572|465907|P1|NOT COMPLETED|Period 2||0
194299|NCT00832572|465906|P2|COMPLETED|Period 2||2
194300|NCT00832572|465907|P1|COMPLETED|Period 2||3
194301|NCT00832572|465906|P2|STARTED|Period 2||2
194302|NCT00832572|465907|P1|STARTED|Period 2||3
194303|NCT00832572|465906|P2|NOT COMPLETED|Period 1||0
194304|NCT00832572|465907|P1|NOT COMPLETED|Period 1||0
194305|NCT00832572|465906|P2|COMPLETED|Period 1||2
194306|NCT00832572|465907|P1|COMPLETED|Period 1||3
194307|NCT00832572|465906|P2|STARTED|Period 1||2
194308|NCT00832572|465907|P1|STARTED|Period 1||3
194309|NCT00832520|465919|P1|NOT COMPLETED|Overall Study||0
194310|NCT00832520|465919|P1|COMPLETED|Overall Study||13
194311|NCT00832520|465919|P1|STARTED|Overall Study||13
194312|NCT00832455|465924|P1|NOT COMPLETED|Overall Study||72
194313|NCT00832455|465924|P1|COMPLETED|Overall Study||373
194314|NCT00832455|465924|P1|Week 12|Overall Study||373
194315|NCT00832455|465924|P1|Week 8 (Optional)|Overall Study||247
194316|NCT00832455|465924|P1|Week 4|Overall Study||411
194317|NCT00832455|465924|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
194318|NCT00832455|465924|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
194319|NCT00832416|465948|P4|NOT COMPLETED|Overall Study||83
194320|NCT00832416|465949|P3|NOT COMPLETED|Overall Study||61
194321|NCT00832416|465950|P2|NOT COMPLETED|Overall Study||53
194322|NCT00832416|465951|P1|NOT COMPLETED|Overall Study||46
194323|NCT00832416|465948|P4|COMPLETED|Overall Study||144
194324|NCT00832416|465949|P3|COMPLETED|Overall Study||54
194325|NCT00832416|465950|P2|COMPLETED|Overall Study||60
194326|NCT00832416|465951|P1|COMPLETED|Overall Study||64
194327|NCT00832416|465948|P4|STARTED|Overall Study||227
194328|NCT00832416|465949|P3|STARTED|Overall Study||115
194329|NCT00832416|465950|P2|STARTED|Overall Study||113
194330|NCT00832416|465951|P1|STARTED|Overall Study||110
194331|NCT00832390|465992|P3|NOT COMPLETED|Overall Study||0
194332|NCT00832390|465993|P2|NOT COMPLETED|Overall Study||0
194333|NCT00832390|465994|P1|NOT COMPLETED|Overall Study||0
194334|NCT00832390|465992|P3|COMPLETED|Overall Study||1
194335|NCT00832390|465993|P2|COMPLETED|Overall Study||16
194336|NCT00832390|465994|P1|COMPLETED|Overall Study||12
194337|NCT00832390|465992|P3|STARTED|Overall Study||1
194338|NCT00832390|465993|P2|STARTED|Overall Study||16
194339|NCT00832390|465994|P1|STARTED|Overall Study||12
194340|NCT00832377|466002|P1|NOT COMPLETED|Overall Study||1
194341|NCT00832377|466002|P1|COMPLETED|Overall Study||36
194342|NCT00832377|466002|P1|STARTED|Overall Study||37
194343|NCT00832338|466009|P1|NOT COMPLETED|Overall Study||0
194344|NCT00832338|466009|P1|COMPLETED|Overall Study||23
194345|NCT00832338|466009|P1|STARTED|Overall Study||23
194346|NCT00832299|466013|P1|NOT COMPLETED|Overall Study||0
194347|NCT00832299|466013|P1|COMPLETED|Overall Study||2
194348|NCT00832299|466013|P1|STARTED|Overall Study||2
194349|NCT00832260|466018|P1|NOT COMPLETED|Overall Study||0
194350|NCT00832260|466018|P1|COMPLETED|Overall Study||70
194351|NCT00832260|466018|P1|STARTED|Overall Study||70
194352|NCT00832130|466025|P2|NOT COMPLETED|Overall Study||0
194353|NCT00832130|466026|P1|NOT COMPLETED|Overall Study||0
194354|NCT00832130|466025|P2|COMPLETED|Overall Study||70
194355|NCT00832130|466026|P1|COMPLETED|Overall Study||69
194356|NCT00832130|466025|P2|STARTED|Overall Study||70
194357|NCT00832130|466026|P1|STARTED|Overall Study||69
194358|NCT00832117|466048|P1|NOT COMPLETED|Overall Study||12
194359|NCT00832117|466048|P1|COMPLETED|Overall Study||17
194360|NCT00832117|466048|P1|STARTED|Overall Study||29
194361|NCT00832091|466067|P2|NOT COMPLETED|Overall Study||2
194362|NCT00832091|466068|P1|NOT COMPLETED|Overall Study||5
194363|NCT00832091|466067|P2|COMPLETED|Overall Study||53
194364|NCT00832091|466068|P1|COMPLETED|Overall Study||12
194365|NCT00832091|466067|P2|STARTED|Overall Study||55
194366|NCT00832091|466068|P1|STARTED|Overall Study||17
194367|NCT00832078|466076|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
194368|NCT00832078|466077|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
194369|NCT00832078|466076|P2|COMPLETED|Test Day 2 - 2 Period||10
194370|NCT00832078|466077|P1|COMPLETED|Test Day 2 - 2 Period||12
194371|NCT00832078|466076|P2|STARTED|Test Day 2 - 2 Period||10
194372|NCT00832078|466077|P1|STARTED|Test Day 2 - 2 Period||13
194373|NCT00832078|466076|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
194374|NCT00832078|466077|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
194375|NCT00832078|466076|P2|COMPLETED|Test Day 2 - 1 Period||10
194376|NCT00832078|466077|P1|COMPLETED|Test Day 2 - 1 Period||13
194377|NCT00832078|466076|P2|STARTED|Test Day 2 - 1 Period||10
194378|NCT00832078|466077|P1|STARTED|Test Day 2 - 1 Period||13
194379|NCT00832078|466076|P2|NOT COMPLETED|Test Day 1-2 Period||2
194380|NCT00832078|466077|P1|NOT COMPLETED|Test Day 1-2 Period||0
194381|NCT00832078|466076|P2|COMPLETED|Test Day 1-2 Period||10
194382|NCT00832078|466077|P1|COMPLETED|Test Day 1-2 Period||13
194383|NCT00832078|466076|P2|STARTED|Test Day 1-2 Period||12
194384|NCT00832078|466077|P1|STARTED|Test Day 1-2 Period||13
194385|NCT00832078|466076|P2|NOT COMPLETED|Test Day 1- 1 Period||0
194386|NCT00832078|466077|P1|NOT COMPLETED|Test Day 1- 1 Period||0
194387|NCT00832078|466076|P2|COMPLETED|Test Day 1- 1 Period||12
194388|NCT00832078|466077|P1|COMPLETED|Test Day 1- 1 Period||13
194389|NCT00832078|466076|P2|STARTED|Test Day 1- 1 Period||12
194390|NCT00832078|466077|P1|STARTED|Test Day 1- 1 Period||13
194391|NCT00832000|466083|P2|NOT COMPLETED|Overall Study||1
194392|NCT00832000|466084|P1|NOT COMPLETED|Overall Study||6
194393|NCT00832000|466083|P2|COMPLETED|Overall Study||29
194394|NCT00832000|466084|P1|COMPLETED|Overall Study||23
194572|NCT00830791|466598|P3|NOT COMPLETED|Overall Study||0
194395|NCT00832000|466083|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
194396|NCT00832000|466084|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
194397|NCT00832000|466083|P2|STARTED|Overall Study|Placebo|30
194398|NCT00832000|466084|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
194399|NCT00831987|466122|P2|NOT COMPLETED|Overall Study||0
194400|NCT00831987|466123|P1|NOT COMPLETED|Overall Study||0
194401|NCT00831987|466122|P2|COMPLETED|Overall Study||60
194402|NCT00831987|466123|P1|COMPLETED|Overall Study||60
194403|NCT00831987|466122|P2|STARTED|Overall Study||60
194404|NCT00831987|466123|P1|STARTED|Overall Study||60
194405|NCT00831844|466145|P10|NOT COMPLETED|Overall Study||0
194406|NCT00831844|466146|P9|NOT COMPLETED|Overall Study||9
194407|NCT00831844|466147|P8|NOT COMPLETED|Overall Study||10
194408|NCT00831844|466148|P7|NOT COMPLETED|Overall Study||10
194409|NCT00831844|466149|P6|NOT COMPLETED|Overall Study||19
194410|NCT00831844|466150|P5|NOT COMPLETED|Overall Study||14
194411|NCT00831844|466151|P4|NOT COMPLETED|Overall Study||10
194412|NCT00831844|466152|P3|NOT COMPLETED|Overall Study||20
194413|NCT00831844|466153|P2|NOT COMPLETED|Overall Study||12
194414|NCT00831844|466154|P1|NOT COMPLETED|Overall Study||10
194415|NCT00831844|466145|P10|COMPLETED|Overall Study||0
194416|NCT00831844|466146|P9|COMPLETED|Overall Study||0
194417|NCT00831844|466147|P8|COMPLETED|Overall Study||0
194418|NCT00831844|466148|P7|COMPLETED|Overall Study||0
194419|NCT00831844|466149|P6|COMPLETED|Overall Study||1
194420|NCT00831844|466150|P5|COMPLETED|Overall Study||0
194421|NCT00831844|466151|P4|COMPLETED|Overall Study||0
194422|NCT00831844|466152|P3|COMPLETED|Overall Study||1
194423|NCT00831844|466153|P2|COMPLETED|Overall Study||0
194424|NCT00831844|466154|P1|COMPLETED|Overall Study||0
194425|NCT00831844|466145|P10|STARTED|Overall Study||0
194426|NCT00831844|466146|P9|STARTED|Overall Study||9
194427|NCT00831844|466147|P8|STARTED|Overall Study||10
194428|NCT00831844|466148|P7|STARTED|Overall Study||10
194429|NCT00831844|466149|P6|STARTED|Overall Study||20
194430|NCT00831844|466150|P5|STARTED|Overall Study||14
194431|NCT00831844|466151|P4|STARTED|Overall Study||10
194432|NCT00831844|466152|P3|STARTED|Overall Study||21
194433|NCT00831844|466153|P2|STARTED|Overall Study||12
194434|NCT00831844|466154|P1|STARTED|Overall Study||10
194435|NCT00831779|466178|P2|NOT COMPLETED|Overall Study||1
194436|NCT00831779|466179|P1|NOT COMPLETED|Overall Study||1
194437|NCT00831779|466178|P2|COMPLETED|Overall Study||22
194438|NCT00831779|466179|P1|COMPLETED|Overall Study||20
194439|NCT00831779|466178|P2|STARTED|Overall Study||23
194440|NCT00831779|466179|P1|STARTED|Overall Study||21
194441|NCT00831766|466189|P2|NOT COMPLETED|Overall Study||0
194442|NCT00831766|466190|P1|NOT COMPLETED|Overall Study||0
194443|NCT00831766|466189|P2|COMPLETED|Overall Study||28
194444|NCT00831766|466190|P1|COMPLETED|Overall Study||23
194445|NCT00831766|466189|P2|STARTED|Overall Study||28
194446|NCT00831766|466190|P1|STARTED|Overall Study||23
194447|NCT00831753|466198|P2|NOT COMPLETED|Overall Study||0
194448|NCT00831753|466199|P1|NOT COMPLETED|Overall Study||0
194449|NCT00831753|466198|P2|COMPLETED|Overall Study||131
194450|NCT00831753|466199|P1|COMPLETED|Overall Study||132
194451|NCT00831753|466198|P2|STARTED|Overall Study||131
194452|NCT00831753|466199|P1|STARTED|Overall Study||132
194453|NCT00831701|466213|P2|NOT COMPLETED|Overall Study||5
194454|NCT00831701|466214|P1|NOT COMPLETED|Overall Study||5
194455|NCT00831701|466213|P2|COMPLETED|Overall Study||45
194456|NCT00831701|466214|P1|COMPLETED|Overall Study||45
194457|NCT00831701|466213|P2|STARTED|Overall Study||50
194458|NCT00831701|466214|P1|STARTED|Overall Study||50
194459|NCT00831675|466230|P2|NOT COMPLETED|Overall Study||0
194460|NCT00831675|466231|P1|NOT COMPLETED|Overall Study||0
194461|NCT00831675|466230|P2|COMPLETED|Overall Study||18
194462|NCT00831675|466231|P1|COMPLETED|Overall Study||12
194463|NCT00831675|466230|P2|STARTED|Overall Study||18
194464|NCT00831675|466231|P1|STARTED|Overall Study||12
194465|NCT00831493|466243|P1|NOT COMPLETED|Overall Study||1
194466|NCT00831493|466243|P1|COMPLETED|Overall Study||2
194467|NCT00831493|466243|P1|STARTED|Overall Study||3
194468|NCT00831480|466247|P1|NOT COMPLETED|Overall Study||2
194469|NCT00831480|466247|P1|COMPLETED|Overall Study||7
194470|NCT00831480|466247|P1|STARTED|Overall Study||9
194471|NCT00831441|466253|P2|NOT COMPLETED|Follow Up (30 Days)||174
194472|NCT00831441|466254|P1|NOT COMPLETED|Follow Up (30 Days)||133
194473|NCT00831441|466253|P2|COMPLETED|Follow Up (30 Days)||3355
194474|NCT00831441|466254|P1|COMPLETED|Follow Up (30 Days)||3375
194475|NCT00831441|466253|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
194476|NCT00831441|466254|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
194477|NCT00831441|466253|P2|NOT COMPLETED|Randomized||3705
194478|NCT00831441|466254|P1|NOT COMPLETED|Randomized||3687
194479|NCT00831441|466253|P2|COMPLETED|Randomized||0
194480|NCT00831441|466254|P1|COMPLETED|Randomized||0
194481|NCT00831441|466253|P2|Treated|Randomized||3672
194482|NCT00831441|466254|P1|Treated|Randomized||3643
194483|NCT00831441|466253|P2|STARTED|Randomized||3705
194484|NCT00831441|466254|P1|STARTED|Randomized||3687
194485|NCT00831428|466282|P1|NOT COMPLETED|Overall Study||0
194486|NCT00831428|466282|P1|COMPLETED|Overall Study||97
194487|NCT00831428|466282|P1|STARTED|Overall Study||97
194488|NCT00831415|466286|P1|NOT COMPLETED|Overall Study||75
194489|NCT00831415|466286|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
194490|NCT00831415|466286|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
194491|NCT00831415|466286|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
194492|NCT00831415|466286|P1|STARTED|Overall Study||304
194493|NCT00831389|466295|P2|NOT COMPLETED|Overall Study||1
194494|NCT00831389|466296|P1|NOT COMPLETED|Overall Study||0
194495|NCT00831389|466295|P2|COMPLETED|Overall Study||6
194496|NCT00831389|466296|P1|COMPLETED|Overall Study||6
194497|NCT00831389|466295|P2|STARTED|Overall Study||7
194498|NCT00831389|466296|P1|STARTED|Overall Study||6
194499|NCT00831311|466322|P2|NOT COMPLETED|Overall Study||8
194500|NCT00831311|466323|P1|NOT COMPLETED|Overall Study||12
194501|NCT00831311|466322|P2|COMPLETED|Overall Study||304
194502|NCT00831311|466323|P1|COMPLETED|Overall Study||300
194503|NCT00831311|466322|P2|STARTED|Overall Study||312
194504|NCT00831311|466323|P1|STARTED|Overall Study||312
194505|NCT00831272|466345|P4|NOT COMPLETED|Overall Study||10
194506|NCT00831272|466346|P3|NOT COMPLETED|Overall Study||10
194507|NCT00831272|466347|P2|NOT COMPLETED|Overall Study||7
194508|NCT00831272|466348|P1|NOT COMPLETED|Overall Study||8
194509|NCT00831272|466345|P4|COMPLETED|Overall Study||56
194510|NCT00831272|466346|P3|COMPLETED|Overall Study||63
194511|NCT00831272|466347|P2|COMPLETED|Overall Study||37
194512|NCT00831272|466348|P1|COMPLETED|Overall Study||30
194513|NCT00831272|466345|P4|STARTED|Overall Study||66
194514|NCT00831272|466346|P3|STARTED|Overall Study||73
194515|NCT00831272|466347|P2|STARTED|Overall Study||44
194516|NCT00831272|466348|P1|STARTED|Overall Study||38
194517|NCT00831233|466360|P2|NOT COMPLETED|Overall Study||1
194518|NCT00831233|466361|P1|NOT COMPLETED|Overall Study||3
194519|NCT00831233|466360|P2|COMPLETED|Overall Study||12
194520|NCT00831233|466361|P1|COMPLETED|Overall Study||26
194521|NCT00831233|466360|P2|Per Protocol (PP) Analysis Set|Overall Study||11
194522|NCT00831233|466361|P1|Per Protocol (PP) Analysis Set|Overall Study||26
194523|NCT00831233|466360|P2|Full Analysis Set (FAS)|Overall Study||13
194524|NCT00831233|466361|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
194525|NCT00831233|466360|P2|STARTED|Overall Study|ITT population.|13
194526|NCT00831233|466361|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
194527|NCT00831181|466385|P1|NOT COMPLETED|Overall Study||12
194528|NCT00831181|466385|P1|COMPLETED|Overall Study||15
194529|NCT00831181|466385|P1|STARTED|Overall Study||27
194530|NCT00831129|466398|P2|NOT COMPLETED|Overall Study||10
194531|NCT00831129|466399|P1|NOT COMPLETED|Overall Study||0
194532|NCT00831129|466398|P2|COMPLETED|Overall Study||23
194533|NCT00831129|466399|P1|COMPLETED|Overall Study||20
194534|NCT00831129|466398|P2|STARTED|Overall Study||33
194535|NCT00831129|466399|P1|STARTED|Overall Study||20
194536|NCT00830960|466441|P6|NOT COMPLETED|Overall Study||37
194537|NCT00830960|466442|P5|NOT COMPLETED|Overall Study||32
194538|NCT00830960|466443|P4|NOT COMPLETED|Overall Study||32
194539|NCT00830960|466444|P3|NOT COMPLETED|Overall Study||29
194540|NCT00830960|466445|P2|NOT COMPLETED|Overall Study||28
194541|NCT00830960|466446|P1|NOT COMPLETED|Overall Study||33
194542|NCT00830960|466441|P6|COMPLETED|Overall Study||63
194543|NCT00830960|466442|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
194544|NCT00830960|466443|P4|COMPLETED|Overall Study||106
194545|NCT00830960|466444|P3|COMPLETED|Overall Study||108
194546|NCT00830960|466445|P2|COMPLETED|Overall Study||96
194547|NCT00830960|466446|P1|COMPLETED|Overall Study||91
194548|NCT00830960|466441|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
194549|NCT00830960|466442|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
194550|NCT00830960|466443|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
194551|NCT00830960|466444|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
194552|NCT00830960|466445|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
194553|NCT00830960|466446|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
194554|NCT00830960|466441|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
194555|NCT00830960|466442|P5|STARTED|Overall Study||96
194556|NCT00830960|466443|P4|STARTED|Overall Study||138
194557|NCT00830960|466444|P3|STARTED|Overall Study||137
194558|NCT00830960|466445|P2|STARTED|Overall Study||124
194559|NCT00830960|466446|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
194560|NCT00830947|466562|P2|NOT COMPLETED|Overall Study||4
194561|NCT00830947|466563|P1|NOT COMPLETED|Overall Study||4
194562|NCT00830947|466562|P2|COMPLETED|Overall Study||18
194563|NCT00830947|466563|P1|COMPLETED|Overall Study||19
194564|NCT00830947|466562|P2|STARTED|Overall Study||22
194565|NCT00830947|466563|P1|STARTED|Overall Study||23
194566|NCT00830804|466569|P1|NOT COMPLETED|Overall Study||15
194567|NCT00830804|466569|P1|COMPLETED|Overall Study||97
194568|NCT00830804|466569|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
194569|NCT00830791|466595|P6|NOT COMPLETED|Overall Study||0
194570|NCT00830791|466596|P5|NOT COMPLETED|Overall Study||0
194571|NCT00830791|466597|P4|NOT COMPLETED|Overall Study||0
194573|NCT00830791|466599|P2|NOT COMPLETED|Overall Study||0
194574|NCT00830791|466600|P1|NOT COMPLETED|Overall Study||0
194575|NCT00830791|466595|P6|COMPLETED|Overall Study||0
194576|NCT00830791|466596|P5|COMPLETED|Overall Study||0
194577|NCT00830791|466597|P4|COMPLETED|Overall Study||8
194578|NCT00830791|466598|P3|COMPLETED|Overall Study||8
194579|NCT00830791|466599|P2|COMPLETED|Overall Study||8
194580|NCT00830791|466600|P1|COMPLETED|Overall Study||8
194581|NCT00830791|466595|P6|STARTED|Overall Study||0
194582|NCT00830791|466596|P5|STARTED|Overall Study||0
194583|NCT00830791|466597|P4|STARTED|Overall Study||8
194584|NCT00830791|466598|P3|STARTED|Overall Study||8
194585|NCT00830791|466599|P2|STARTED|Overall Study||8
194586|NCT00830791|466600|P1|STARTED|Overall Study||8
194587|NCT00830765|466649|P2|NOT COMPLETED|Overall Study||2
194588|NCT00830765|466650|P1|NOT COMPLETED|Overall Study||3
194589|NCT00830765|466649|P2|COMPLETED|Overall Study||69
194590|NCT00830765|466650|P1|COMPLETED|Overall Study||70
194591|NCT00830765|466649|P2|STARTED|Overall Study||71
194592|NCT00830765|466650|P1|STARTED|Overall Study||73
194593|NCT00830596|466659|P3|NOT COMPLETED|Overall Study||6
194594|NCT00830596|466660|P2|NOT COMPLETED|Overall Study||2
194595|NCT00830596|466661|P1|NOT COMPLETED|Overall Study||2
194596|NCT00830596|466659|P3|COMPLETED|Overall Study||67
194597|NCT00830596|466660|P2|COMPLETED|Overall Study||72
194598|NCT00830596|466661|P1|COMPLETED|Overall Study||72
194599|NCT00830596|466659|P3|STARTED|Overall Study||73
194600|NCT00830596|466660|P2|STARTED|Overall Study||74
194601|NCT00830596|466661|P1|STARTED|Overall Study||74
194602|NCT00830518|466683|P2|NOT COMPLETED|Overall Study||11
194603|NCT00830518|466684|P1|NOT COMPLETED|Overall Study||46
194604|NCT00830518|466683|P2|COMPLETED|Overall Study||0
194605|NCT00830518|466684|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
194606|NCT00830518|466683|P2|STARTED|Overall Study||11
194607|NCT00830518|466684|P1|STARTED|Overall Study||46
194608|NCT00830440|466703|P2|NOT COMPLETED|Overall Study||0
194609|NCT00830440|466704|P1|NOT COMPLETED|Overall Study||8
194610|NCT00830440|466703|P2|COMPLETED|Overall Study||11
194611|NCT00830440|466704|P1|COMPLETED|Overall Study||24
194612|NCT00830440|466703|P2|Completed 24 Week Follow up|Overall Study||0
194613|NCT00830440|466704|P1|Completed 24 Week Follow up|Overall Study||3
194614|NCT00830440|466703|P2|Completed 16 Week Follow up|Overall Study||0
194615|NCT00830440|466704|P1|Completed 16 Week Follow up|Overall Study||4
194616|NCT00830440|466703|P2|Completed 12 Week Follow up|Overall Study||11
194617|NCT00830440|466704|P1|Completed 12 Week Follow up|Overall Study||24
194618|NCT00830440|466703|P2|Received Device|Overall Study||0
194619|NCT00830440|466704|P1|Received Device|Overall Study||26
194620|NCT00830440|466703|P2|STARTED|Overall Study||11
194621|NCT00830440|466704|P1|STARTED|Overall Study||32
194622|NCT00830388|466714|P1|NOT COMPLETED|Overall Study||0
194623|NCT00830388|466714|P1|COMPLETED|Overall Study||11
194624|NCT00830388|466714|P1|STARTED|Overall Study||11
194625|NCT00830375|466719|P1|NOT COMPLETED|Overall Study||1
194626|NCT00830375|466719|P1|COMPLETED|Overall Study||9
194627|NCT00830375|466719|P1|STARTED|Overall Study||10
194628|NCT00830362|466725|P2|NOT COMPLETED|Overall Study||4
194629|NCT00830362|466726|P1|NOT COMPLETED|Overall Study||4
194630|NCT00830362|466725|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
194631|NCT00830362|466726|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
194632|NCT00830362|466725|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
194633|NCT00830362|466726|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
194634|NCT00830362|466725|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
194635|NCT00830362|466726|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
194636|NCT00830336|466734|P2|NOT COMPLETED|Second Intervention||0
194637|NCT00830336|466735|P1|NOT COMPLETED|Second Intervention||0
194638|NCT00830336|466734|P2|COMPLETED|Second Intervention||40
194639|NCT00830336|466735|P1|COMPLETED|Second Intervention||39
194640|NCT00830336|466734|P2|STARTED|Second Intervention||40
194641|NCT00830336|466735|P1|STARTED|Second Intervention||39
194642|NCT00830336|466734|P2|NOT COMPLETED|Washout: 21 Days||0
194643|NCT00830336|466735|P1|NOT COMPLETED|Washout: 21 Days||1
194644|NCT00830336|466734|P2|COMPLETED|Washout: 21 Days||40
194645|NCT00830336|466735|P1|COMPLETED|Washout: 21 Days||39
194646|NCT00830336|466734|P2|STARTED|Washout: 21 Days||40
194647|NCT00830336|466735|P1|STARTED|Washout: 21 Days||40
194648|NCT00830336|466734|P2|NOT COMPLETED|First Intervention||0
194649|NCT00830336|466735|P1|NOT COMPLETED|First Intervention||0
194650|NCT00830336|466734|P2|COMPLETED|First Intervention||40
194651|NCT00830336|466735|P1|COMPLETED|First Intervention||40
194652|NCT00830336|466734|P2|STARTED|First Intervention||40
194653|NCT00830336|466735|P1|STARTED|First Intervention||40
194654|NCT00830310|466743|P1|NOT COMPLETED|Overall Study||13
194655|NCT00830310|466743|P1|COMPLETED|Overall Study||30
194656|NCT00830310|466743|P1|STARTED|Overall Study||43
194657|NCT00830284|466755|P1|NOT COMPLETED|Overall Study||2
194658|NCT00830284|466755|P1|COMPLETED|Overall Study||10
194844|NCT00829829|466996|P3|STARTED|Overall Study||81
194659|NCT00830284|466755|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
194660|NCT00830258|466762|P2|NOT COMPLETED|Second Intervention||0
194661|NCT00830258|466763|P1|NOT COMPLETED|Second Intervention||0
194662|NCT00830258|466762|P2|COMPLETED|Second Intervention||30
194663|NCT00830258|466763|P1|COMPLETED|Second Intervention||28
194664|NCT00830258|466762|P2|STARTED|Second Intervention||30
194665|NCT00830258|466763|P1|STARTED|Second Intervention||28
194666|NCT00830258|466762|P2|NOT COMPLETED|Washout: 7 Days||0
194667|NCT00830258|466763|P1|NOT COMPLETED|Washout: 7 Days||1
194668|NCT00830258|466762|P2|COMPLETED|Washout: 7 Days||30
194669|NCT00830258|466763|P1|COMPLETED|Washout: 7 Days||28
194670|NCT00830258|466762|P2|STARTED|Washout: 7 Days||30
194671|NCT00830258|466763|P1|STARTED|Washout: 7 Days||29
194672|NCT00830258|466762|P2|NOT COMPLETED|First Intervention||0
194673|NCT00830258|466763|P1|NOT COMPLETED|First Intervention||1
194674|NCT00830258|466762|P2|COMPLETED|First Intervention||30
194675|NCT00830258|466763|P1|COMPLETED|First Intervention||29
194676|NCT00830258|466762|P2|STARTED|First Intervention||30
194677|NCT00830258|466763|P1|STARTED|First Intervention||30
194678|NCT00830232|466773|P2|NOT COMPLETED|Overall Study||0
194679|NCT00830232|466774|P1|NOT COMPLETED|Overall Study||0
194680|NCT00830232|466773|P2|COMPLETED|Overall Study||20
194681|NCT00830232|466774|P1|COMPLETED|Overall Study||20
194682|NCT00830232|466773|P2|STARTED|Overall Study||20
194683|NCT00830232|466774|P1|STARTED|Overall Study||20
194684|NCT00830219|466782|P2|NOT COMPLETED|Second Intervention||0
194685|NCT00830219|466783|P1|NOT COMPLETED|Second Intervention||0
194686|NCT00830219|466782|P2|COMPLETED|Second Intervention||22
194687|NCT00830219|466783|P1|COMPLETED|Second Intervention||22
194688|NCT00830219|466782|P2|STARTED|Second Intervention||22
194689|NCT00830219|466783|P1|STARTED|Second Intervention||22
194690|NCT00830219|466782|P2|NOT COMPLETED|Washout of 7 Days||1
194691|NCT00830219|466783|P1|NOT COMPLETED|Washout of 7 Days||1
194692|NCT00830219|466782|P2|COMPLETED|Washout of 7 Days||22
194693|NCT00830219|466783|P1|COMPLETED|Washout of 7 Days||22
194694|NCT00830219|466782|P2|STARTED|Washout of 7 Days||23
194695|NCT00830219|466783|P1|STARTED|Washout of 7 Days||23
194696|NCT00830219|466782|P2|NOT COMPLETED|First Intervention||0
194697|NCT00830219|466783|P1|NOT COMPLETED|First Intervention||0
194698|NCT00830219|466782|P2|COMPLETED|First Intervention||23
194699|NCT00830219|466783|P1|COMPLETED|First Intervention||23
194700|NCT00830219|466782|P2|STARTED|First Intervention||23
194701|NCT00830219|466783|P1|STARTED|First Intervention||23
194702|NCT00830206|466793|P2|NOT COMPLETED|Second Intervention||0
194703|NCT00830206|466794|P1|NOT COMPLETED|Second Intervention||0
194704|NCT00830206|466793|P2|COMPLETED|Second Intervention||39
194705|NCT00830206|466794|P1|COMPLETED|Second Intervention||39
194706|NCT00830206|466793|P2|STARTED|Second Intervention||39
194707|NCT00830206|466794|P1|STARTED|Second Intervention||39
194708|NCT00830206|466793|P2|NOT COMPLETED|Washout: 21 Days||1
194709|NCT00830206|466794|P1|NOT COMPLETED|Washout: 21 Days||1
194710|NCT00830206|466793|P2|COMPLETED|Washout: 21 Days||39
194711|NCT00830206|466794|P1|COMPLETED|Washout: 21 Days||39
194712|NCT00830206|466793|P2|STARTED|Washout: 21 Days||40
194713|NCT00830206|466794|P1|STARTED|Washout: 21 Days||40
194714|NCT00830206|466793|P2|NOT COMPLETED|First Intervention||0
194715|NCT00830206|466794|P1|NOT COMPLETED|First Intervention||0
194716|NCT00830206|466793|P2|COMPLETED|First Intervention||40
194717|NCT00830206|466794|P1|COMPLETED|First Intervention||40
194718|NCT00830206|466793|P2|STARTED|First Intervention||40
194719|NCT00830206|466794|P1|STARTED|First Intervention||40
194720|NCT00830167|466804|P2|NOT COMPLETED|Overall Study||43
194721|NCT00830167|466805|P1|NOT COMPLETED|Overall Study||40
194722|NCT00830167|466804|P2|COMPLETED|Overall Study||207
194723|NCT00830167|466805|P1|COMPLETED|Overall Study||208
194724|NCT00830167|466804|P2|STARTED|Overall Study|Treated|250
194725|NCT00830167|466805|P1|STARTED|Overall Study|Treated|248
194726|NCT00830128|466875|P1|NOT COMPLETED|Overall Study||19
194727|NCT00830128|466875|P1|COMPLETED|Overall Study||87
194728|NCT00830128|466875|P1|STARTED|Overall Study||106
194729|NCT00830115|466890|P1|NOT COMPLETED|Overall Study||3
194730|NCT00830115|466890|P1|COMPLETED|Overall Study||1042
194731|NCT00830115|466890|P1|STARTED|Overall Study||1045
194732|NCT00830076|466906|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
194733|NCT00830076|466906|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
194734|NCT00830076|466906|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
194735|NCT00830076|466906|P1|NOT COMPLETED|7-day Washout||0
194736|NCT00830076|466906|P1|COMPLETED|7-day Washout||18
194737|NCT00830076|466906|P1|STARTED|7-day Washout||18
194738|NCT00830076|466906|P1|NOT COMPLETED|Sitagliptin + Metformin||0
194739|NCT00830076|466906|P1|COMPLETED|Sitagliptin + Metformin||18
194740|NCT00830076|466906|P1|STARTED|Sitagliptin + Metformin||18
194741|NCT00830076|466906|P1|NOT COMPLETED|7-day Washout||0
194742|NCT00830076|466906|P1|COMPLETED|7-day Washout||18
194743|NCT00830076|466906|P1|STARTED|7-day Washout||18
194744|NCT00830076|466906|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
194745|NCT00830076|466906|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
194746|NCT00830076|466906|P1|STARTED|Metformin + Placebo Sitagliptin||18
194747|NCT00830076|466906|P1|NOT COMPLETED|7-day Washout||0
194748|NCT00830076|466906|P1|COMPLETED|7-day Washout||18
194749|NCT00830076|466906|P1|STARTED|7-day Washout||18
194750|NCT00830076|466906|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
194751|NCT00830076|466906|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
194752|NCT00830076|466906|P1|STARTED|Sitagliptin + Placebo Metformin||18
194753|NCT00830037|466917|P2|NOT COMPLETED|Overall Study||19
194754|NCT00830037|466918|P1|NOT COMPLETED|Overall Study||18
194755|NCT00830037|466917|P2|COMPLETED|Overall Study||50
194756|NCT00830037|466918|P1|COMPLETED|Overall Study||49
194757|NCT00830037|466917|P2|STARTED|Overall Study||69
194758|NCT00830037|466918|P1|STARTED|Overall Study||67
194759|NCT00830024|466928|P2|NOT COMPLETED|Second Intervention||0
194760|NCT00830024|466929|P1|NOT COMPLETED|Second Intervention||0
194761|NCT00830024|466928|P2|COMPLETED|Second Intervention||18
194762|NCT00830024|466929|P1|COMPLETED|Second Intervention||17
194763|NCT00830024|466928|P2|STARTED|Second Intervention||18
194764|NCT00830024|466929|P1|STARTED|Second Intervention||17
194765|NCT00830024|466928|P2|NOT COMPLETED|Washout: 7 Days||0
194766|NCT00830024|466929|P1|NOT COMPLETED|Washout: 7 Days||1
194767|NCT00830024|466928|P2|COMPLETED|Washout: 7 Days||18
194768|NCT00830024|466929|P1|COMPLETED|Washout: 7 Days||17
194769|NCT00830024|466928|P2|STARTED|Washout: 7 Days||18
194770|NCT00830024|466929|P1|STARTED|Washout: 7 Days||18
194771|NCT00830024|466928|P2|NOT COMPLETED|First Intervention||0
194772|NCT00830024|466929|P1|NOT COMPLETED|First Intervention||0
194773|NCT00830024|466928|P2|COMPLETED|First Intervention||18
194774|NCT00830024|466929|P1|COMPLETED|First Intervention||18
194775|NCT00830024|466928|P2|STARTED|First Intervention||18
194776|NCT00830024|466929|P1|STARTED|First Intervention||18
194777|NCT00829998|466939|P2|NOT COMPLETED|Second Intervention||0
194778|NCT00829998|466940|P1|NOT COMPLETED|Second Intervention||0
194779|NCT00829998|466939|P2|COMPLETED|Second Intervention||19
194780|NCT00829998|466940|P1|COMPLETED|Second Intervention||21
194781|NCT00829998|466939|P2|STARTED|Second Intervention||19
194782|NCT00829998|466940|P1|STARTED|Second Intervention||21
194783|NCT00829998|466939|P2|NOT COMPLETED|Washout||1
194784|NCT00829998|466940|P1|NOT COMPLETED|Washout||0
194785|NCT00829998|466939|P2|COMPLETED|Washout||19
194786|NCT00829998|466940|P1|COMPLETED|Washout||21
194787|NCT00829998|466939|P2|STARTED|Washout||20
194788|NCT00829998|466940|P1|STARTED|Washout||21
194789|NCT00829998|466939|P2|NOT COMPLETED|First Intervention||0
194790|NCT00829998|466940|P1|NOT COMPLETED|First Intervention||0
194791|NCT00829998|466939|P2|COMPLETED|First Intervention||20
194792|NCT00829998|466940|P1|COMPLETED|First Intervention||21
194793|NCT00829998|466939|P2|STARTED|First Intervention||20
194794|NCT00829998|466940|P1|STARTED|First Intervention||21
194795|NCT00829985|466950|P2|NOT COMPLETED|Overall Study||4
194796|NCT00829985|466951|P1|NOT COMPLETED|Overall Study||9
194797|NCT00829985|466950|P2|COMPLETED|Overall Study||22
194798|NCT00829985|466951|P1|COMPLETED|Overall Study||19
194799|NCT00829985|466950|P2|STARTED|Overall Study||26
194800|NCT00829985|466951|P1|STARTED|Overall Study||28
194801|NCT00829933|466969|P4|NOT COMPLETED|Overall Study||14
194802|NCT00829933|466970|P3|NOT COMPLETED|Overall Study||13
194803|NCT00829933|466971|P2|NOT COMPLETED|Overall Study||13
194804|NCT00829933|466972|P1|NOT COMPLETED|Overall Study||14
194805|NCT00829933|466969|P4|COMPLETED|Overall Study||120
194806|NCT00829933|466970|P3|COMPLETED|Overall Study||119
194807|NCT00829933|466971|P2|COMPLETED|Overall Study||122
194808|NCT00829933|466972|P1|COMPLETED|Overall Study||121
194809|NCT00829933|466969|P4|Baseline Analysis Population|Overall Study||129
194810|NCT00829933|466970|P3|Baseline Analysis Population|Overall Study||131
194811|NCT00829933|466971|P2|Baseline Analysis Population|Overall Study||134
194812|NCT00829933|466972|P1|Baseline Analysis Population|Overall Study||131
194813|NCT00829933|466969|P4|STARTED|Overall Study||134
194814|NCT00829933|466970|P3|STARTED|Overall Study||132
194815|NCT00829933|466971|P2|STARTED|Overall Study||135
194816|NCT00829933|466972|P1|STARTED|Overall Study||135
194817|NCT00829868|466984|P2|NOT COMPLETED|Second Intervention||0
194818|NCT00829868|466985|P1|NOT COMPLETED|Second Intervention||0
194819|NCT00829868|466984|P2|COMPLETED|Second Intervention||21
194820|NCT00829868|466985|P1|COMPLETED|Second Intervention||20
194821|NCT00829868|466984|P2|STARTED|Second Intervention||21
194822|NCT00829868|466985|P1|STARTED|Second Intervention||20
194823|NCT00829868|466984|P2|NOT COMPLETED|Washout||0
194824|NCT00829868|466985|P1|NOT COMPLETED|Washout||1
194825|NCT00829868|466984|P2|COMPLETED|Washout||21
194826|NCT00829868|466985|P1|COMPLETED|Washout||20
194827|NCT00829868|466984|P2|STARTED|Washout||21
194828|NCT00829868|466985|P1|STARTED|Washout||21
194829|NCT00829868|466984|P2|NOT COMPLETED|First Intervention||0
194830|NCT00829868|466985|P1|NOT COMPLETED|First Intervention||0
194831|NCT00829868|466984|P2|COMPLETED|First Intervention||21
194832|NCT00829868|466985|P1|COMPLETED|First Intervention||21
194833|NCT00829868|466984|P2|STARTED|First Intervention||21
194834|NCT00829868|466985|P1|STARTED|First Intervention||21
194835|NCT00829829|466996|P3|NOT COMPLETED|Overall Study||11
194836|NCT00829829|466997|P2|NOT COMPLETED|Overall Study||16
194837|NCT00829829|466998|P1|NOT COMPLETED|Overall Study||22
194838|NCT00829829|466996|P3|COMPLETED|Overall Study||70
194839|NCT00829829|466997|P2|COMPLETED|Overall Study||64
194840|NCT00829829|466998|P1|COMPLETED|Overall Study||58
194841|NCT00829829|466996|P3|Treated|Overall Study||81
194842|NCT00829829|466997|P2|Treated|Overall Study||80
194843|NCT00829829|466998|P1|Treated|Overall Study||79
194845|NCT00829829|466997|P2|STARTED|Overall Study||80
194846|NCT00829829|466998|P1|STARTED|Overall Study||80
194847|NCT00829790|467023|P2|NOT COMPLETED|Second Intervention||0
194848|NCT00829790|467024|P1|NOT COMPLETED|Second Intervention||0
194849|NCT00829790|467023|P2|COMPLETED|Second Intervention||14
194850|NCT00829790|467024|P1|COMPLETED|Second Intervention||15
194851|NCT00829790|467023|P2|STARTED|Second Intervention||14
194852|NCT00829790|467024|P1|STARTED|Second Intervention||15
194853|NCT00829790|467023|P2|NOT COMPLETED|Washout of 14 Days||1
194854|NCT00829790|467024|P1|NOT COMPLETED|Washout of 14 Days||0
194855|NCT00829790|467023|P2|COMPLETED|Washout of 14 Days||14
194856|NCT00829790|467024|P1|COMPLETED|Washout of 14 Days||15
194857|NCT00829790|467023|P2|STARTED|Washout of 14 Days||15
194858|NCT00829790|467024|P1|STARTED|Washout of 14 Days||15
194859|NCT00829790|467023|P2|NOT COMPLETED|First Intervention||0
194860|NCT00829790|467024|P1|NOT COMPLETED|First Intervention||0
194861|NCT00829790|467023|P2|COMPLETED|First Intervention||15
194862|NCT00829790|467024|P1|COMPLETED|First Intervention||15
194863|NCT00829790|467023|P2|STARTED|First Intervention||15
194864|NCT00829790|467024|P1|STARTED|First Intervention||15
194865|NCT00829764|467034|P2|NOT COMPLETED|Second Intervention||0
194866|NCT00829764|467035|P1|NOT COMPLETED|Second Intervention||0
194867|NCT00829764|467034|P2|COMPLETED|Second Intervention||14
194868|NCT00829764|467035|P1|COMPLETED|Second Intervention||13
194869|NCT00829764|467034|P2|STARTED|Second Intervention||14
194870|NCT00829764|467035|P1|STARTED|Second Intervention||13
194871|NCT00829764|467034|P2|NOT COMPLETED|Washout of 14 Days||0
194872|NCT00829764|467035|P1|NOT COMPLETED|Washout of 14 Days||0
194873|NCT00829764|467034|P2|COMPLETED|Washout of 14 Days||14
194874|NCT00829764|467035|P1|COMPLETED|Washout of 14 Days||13
194875|NCT00829764|467034|P2|STARTED|Washout of 14 Days||14
194876|NCT00829764|467035|P1|STARTED|Washout of 14 Days||13
194877|NCT00829764|467034|P2|NOT COMPLETED|First Intervention||1
194878|NCT00829764|467035|P1|NOT COMPLETED|First Intervention||2
194879|NCT00829764|467034|P2|COMPLETED|First Intervention||14
194880|NCT00829764|467035|P1|COMPLETED|First Intervention||13
194881|NCT00829764|467034|P2|STARTED|First Intervention||15
194882|NCT00829764|467035|P1|STARTED|First Intervention||15
194883|NCT00829738|467043|P1|NOT COMPLETED|Overall Study||8
194884|NCT00829738|467043|P1|COMPLETED|Overall Study||4180
194885|NCT00829738|467043|P1|STARTED|Overall Study||4188
194886|NCT00829712|467061|P2|NOT COMPLETED|Second Intervention||0
194887|NCT00829712|467062|P1|NOT COMPLETED|Second Intervention||0
194888|NCT00829712|467061|P2|COMPLETED|Second Intervention||11
194889|NCT00829712|467062|P1|COMPLETED|Second Intervention||12
194890|NCT00829712|467061|P2|STARTED|Second Intervention||11
194891|NCT00829712|467062|P1|STARTED|Second Intervention||12
194892|NCT00829712|467061|P2|NOT COMPLETED|Washout of 7 Days||1
194893|NCT00829712|467062|P1|NOT COMPLETED|Washout of 7 Days||0
194894|NCT00829712|467061|P2|COMPLETED|Washout of 7 Days||11
194895|NCT00829712|467062|P1|COMPLETED|Washout of 7 Days||12
194896|NCT00829712|467061|P2|STARTED|Washout of 7 Days||12
194897|NCT00829712|467062|P1|STARTED|Washout of 7 Days||12
194898|NCT00829712|467061|P2|NOT COMPLETED|First Intervention||0
194899|NCT00829712|467062|P1|NOT COMPLETED|First Intervention||0
194900|NCT00829712|467061|P2|COMPLETED|First Intervention||12
194901|NCT00829712|467062|P1|COMPLETED|First Intervention||12
194902|NCT00829712|467061|P2|STARTED|First Intervention||12
194903|NCT00829712|467062|P1|STARTED|First Intervention||12
194904|NCT00829686|467072|P2|NOT COMPLETED|Overall Study||0
194905|NCT00829686|467073|P1|NOT COMPLETED|Overall Study||0
194906|NCT00829686|467072|P2|COMPLETED|Overall Study||18
194907|NCT00829686|467073|P1|COMPLETED|Overall Study||13
194908|NCT00829686|467072|P2|STARTED|Overall Study||18
194909|NCT00829686|467073|P1|STARTED|Overall Study||13
194910|NCT00829673|467081|P2|NOT COMPLETED|Second Intervention||0
194911|NCT00829673|467082|P1|NOT COMPLETED|Second Intervention||0
194912|NCT00829673|467081|P2|COMPLETED|Second Intervention||12
194913|NCT00829673|467082|P1|COMPLETED|Second Intervention||11
194914|NCT00829673|467081|P2|STARTED|Second Intervention||12
194915|NCT00829673|467082|P1|STARTED|Second Intervention||11
194916|NCT00829673|467081|P2|NOT COMPLETED|Washout of 7 Days||0
194917|NCT00829673|467082|P1|NOT COMPLETED|Washout of 7 Days||1
194918|NCT00829673|467081|P2|COMPLETED|Washout of 7 Days||12
194919|NCT00829673|467082|P1|COMPLETED|Washout of 7 Days||11
194920|NCT00829673|467081|P2|STARTED|Washout of 7 Days||12
194921|NCT00829673|467082|P1|STARTED|Washout of 7 Days||12
194922|NCT00829673|467081|P2|NOT COMPLETED|First Intervention||0
194923|NCT00829673|467082|P1|NOT COMPLETED|First Intervention||0
194924|NCT00829673|467081|P2|COMPLETED|First Intervention||12
194925|NCT00829673|467082|P1|COMPLETED|First Intervention||12
194926|NCT00829673|467081|P2|STARTED|First Intervention||12
194927|NCT00829673|467082|P1|STARTED|First Intervention||12
194928|NCT00829621|467092|P2|NOT COMPLETED|Overall Study||4
194929|NCT00829621|467093|P1|NOT COMPLETED|Overall Study||4
194930|NCT00829621|467092|P2|COMPLETED|Overall Study||8
194931|NCT00829621|467093|P1|COMPLETED|Overall Study||4
194932|NCT00829621|467092|P2|STARTED|Overall Study||12
194933|NCT00829621|467093|P1|STARTED|Overall Study||8
194934|NCT00829530|467101|P2|NOT COMPLETED|Second Intervention||0
194935|NCT00829530|467102|P1|NOT COMPLETED|Second Intervention||1
194936|NCT00829530|467101|P2|COMPLETED|Second Intervention||18
194937|NCT00829530|467102|P1|COMPLETED|Second Intervention||19
194938|NCT00829530|467101|P2|STARTED|Second Intervention||18
194939|NCT00829530|467102|P1|STARTED|Second Intervention||20
194940|NCT00829530|467101|P2|NOT COMPLETED|Washout of 42 Days||0
194941|NCT00829530|467102|P1|NOT COMPLETED|Washout of 42 Days||0
194942|NCT00829530|467101|P2|COMPLETED|Washout of 42 Days||18
194943|NCT00829530|467102|P1|COMPLETED|Washout of 42 Days||20
194944|NCT00829530|467101|P2|STARTED|Washout of 42 Days||18
194945|NCT00829530|467102|P1|STARTED|Washout of 42 Days||20
194946|NCT00829530|467101|P2|NOT COMPLETED|First Intervention||2
194947|NCT00829530|467102|P1|NOT COMPLETED|First Intervention||0
194948|NCT00829530|467101|P2|COMPLETED|First Intervention||18
194949|NCT00829530|467102|P1|COMPLETED|First Intervention||20
194950|NCT00829530|467101|P2|STARTED|First Intervention||20
194951|NCT00829530|467102|P1|STARTED|First Intervention||20
194952|NCT00829504|467116|P2|NOT COMPLETED|Second Intervention||0
194953|NCT00829504|467117|P1|NOT COMPLETED|Second Intervention||1
194954|NCT00829504|467116|P2|COMPLETED|Second Intervention||22
194955|NCT00829504|467117|P1|COMPLETED|Second Intervention||19
194956|NCT00829504|467116|P2|STARTED|Second Intervention||22
194957|NCT00829504|467117|P1|STARTED|Second Intervention||20
194958|NCT00829504|467116|P2|NOT COMPLETED|Washout of 7 Days||0
194959|NCT00829504|467117|P1|NOT COMPLETED|Washout of 7 Days||1
194960|NCT00829504|467116|P2|COMPLETED|Washout of 7 Days||22
194961|NCT00829504|467117|P1|COMPLETED|Washout of 7 Days||20
194962|NCT00829504|467116|P2|STARTED|Washout of 7 Days||22
194963|NCT00829504|467117|P1|STARTED|Washout of 7 Days||21
194964|NCT00829504|467116|P2|NOT COMPLETED|First Intervention||0
194965|NCT00829504|467117|P1|NOT COMPLETED|First Intervention||1
194966|NCT00829504|467116|P2|COMPLETED|First Intervention||22
194967|NCT00829504|467117|P1|COMPLETED|First Intervention||21
194968|NCT00829504|467116|P2|STARTED|First Intervention||22
194969|NCT00829504|467117|P1|STARTED|First Intervention||22
194970|NCT00829452|467127|P2|NOT COMPLETED|Second Intervention||1
194971|NCT00829452|467128|P1|NOT COMPLETED|Second Intervention||0
194972|NCT00829452|467127|P2|COMPLETED|Second Intervention||17
194973|NCT00829452|467128|P1|COMPLETED|Second Intervention||20
194974|NCT00829452|467127|P2|STARTED|Second Intervention||18
194975|NCT00829452|467128|P1|STARTED|Second Intervention||20
194976|NCT00829452|467127|P2|NOT COMPLETED|Washout of 42 Days||1
194977|NCT00829452|467128|P1|NOT COMPLETED|Washout of 42 Days||0
194978|NCT00829452|467127|P2|COMPLETED|Washout of 42 Days||18
194979|NCT00829452|467128|P1|COMPLETED|Washout of 42 Days||20
194980|NCT00829452|467127|P2|STARTED|Washout of 42 Days||19
194981|NCT00829452|467128|P1|STARTED|Washout of 42 Days||20
194982|NCT00829452|467127|P2|NOT COMPLETED|First Intervention||1
194983|NCT00829452|467128|P1|NOT COMPLETED|First Intervention||0
194984|NCT00829452|467127|P2|COMPLETED|First Intervention||19
194985|NCT00829452|467128|P1|COMPLETED|First Intervention||20
194986|NCT00829452|467127|P2|STARTED|First Intervention||20
194987|NCT00829452|467128|P1|STARTED|First Intervention||20
194988|NCT00829439|467140|P4|NOT COMPLETED|Overall Study||0
194989|NCT00829439|467141|P3|NOT COMPLETED|Overall Study||1
194990|NCT00829439|467142|P2|NOT COMPLETED|Overall Study||0
194991|NCT00829439|467143|P1|NOT COMPLETED|Overall Study||0
194992|NCT00829439|467140|P4|COMPLETED|Overall Study||4
194993|NCT00829439|467141|P3|COMPLETED|Overall Study||5
194994|NCT00829439|467142|P2|COMPLETED|Overall Study||3
194995|NCT00829439|467143|P1|COMPLETED|Overall Study||3
194996|NCT00829439|467140|P4|STARTED|Overall Study||4
194997|NCT00829439|467141|P3|STARTED|Overall Study||6
194998|NCT00829439|467142|P2|STARTED|Overall Study||3
194999|NCT00829439|467143|P1|STARTED|Overall Study||3
195000|NCT00829426|467149|P2|NOT COMPLETED|Second Intervention||0
195001|NCT00829426|467150|P1|NOT COMPLETED|Second Intervention||0
195002|NCT00829426|467149|P2|COMPLETED|Second Intervention||16
195003|NCT00829426|467150|P1|COMPLETED|Second Intervention||15
195004|NCT00829426|467149|P2|STARTED|Second Intervention||16
195005|NCT00829426|467150|P1|STARTED|Second Intervention||15
195006|NCT00829426|467149|P2|NOT COMPLETED|Washout: 7 Days||0
195007|NCT00829426|467150|P1|NOT COMPLETED|Washout: 7 Days||1
195008|NCT00829426|467149|P2|COMPLETED|Washout: 7 Days||16
195009|NCT00829426|467150|P1|COMPLETED|Washout: 7 Days||15
195010|NCT00829426|467149|P2|STARTED|Washout: 7 Days||16
195011|NCT00829426|467150|P1|STARTED|Washout: 7 Days||16
195012|NCT00829426|467149|P2|NOT COMPLETED|First Intervention||0
195013|NCT00829426|467150|P1|NOT COMPLETED|First Intervention||0
195014|NCT00829426|467149|P2|COMPLETED|First Intervention||16
195015|NCT00829426|467150|P1|COMPLETED|First Intervention||16
195016|NCT00829426|467149|P2|STARTED|First Intervention||16
195017|NCT00829426|467150|P1|STARTED|First Intervention||16
195018|NCT00829387|467160|P2|NOT COMPLETED|Overall Study||3
195019|NCT00829387|467161|P1|NOT COMPLETED|Overall Study||3
195020|NCT00829387|467160|P2|COMPLETED|Overall Study||21
195021|NCT00829387|467161|P1|COMPLETED|Overall Study||20
195022|NCT00829387|467160|P2|STARTED|Overall Study||24
195023|NCT00829387|467161|P1|STARTED|Overall Study||23
195024|NCT00829309|467179|P2|NOT COMPLETED|Second Intervention||0
195025|NCT00829309|467180|P1|NOT COMPLETED|Second Intervention||0
195026|NCT00829309|467179|P2|COMPLETED|Second Intervention||8
195027|NCT00829309|467180|P1|COMPLETED|Second Intervention||7
195028|NCT00829309|467179|P2|STARTED|Second Intervention||8
195029|NCT00829309|467180|P1|STARTED|Second Intervention||7
195030|NCT00829309|467179|P2|NOT COMPLETED|Washout: 7 Days||0
195031|NCT00829309|467180|P1|NOT COMPLETED|Washout: 7 Days||1
195032|NCT00829309|467179|P2|COMPLETED|Washout: 7 Days||8
195033|NCT00829309|467180|P1|COMPLETED|Washout: 7 Days||7
195034|NCT00829309|467179|P2|STARTED|Washout: 7 Days||8
195035|NCT00829309|467180|P1|STARTED|Washout: 7 Days||8
195036|NCT00829309|467179|P2|NOT COMPLETED|First Intervention||0
195037|NCT00829309|467180|P1|NOT COMPLETED|First Intervention||0
195038|NCT00829309|467179|P2|COMPLETED|First Intervention||8
195039|NCT00829309|467180|P1|COMPLETED|First Intervention||8
195040|NCT00829309|467179|P2|STARTED|First Intervention||8
195041|NCT00829309|467180|P1|STARTED|First Intervention||8
195042|NCT00829296|467190|P2|NOT COMPLETED|Overall Study||4
195043|NCT00829296|467191|P1|NOT COMPLETED|Overall Study||5
195044|NCT00829296|467190|P2|COMPLETED|Overall Study||32
195045|NCT00829296|467191|P1|COMPLETED|Overall Study||29
195046|NCT00829296|467190|P2|STARTED|Overall Study||36
195047|NCT00829296|467191|P1|STARTED|Overall Study||34
195048|NCT00829283|467205|P2|NOT COMPLETED|Overall Study||25
195049|NCT00829283|467206|P1|NOT COMPLETED|Overall Study||7
195050|NCT00829283|467205|P2|COMPLETED|Overall Study||127
195051|NCT00829283|467206|P1|COMPLETED|Overall Study||32
195052|NCT00829283|467205|P2|STARTED|Overall Study||152
195053|NCT00829283|467206|P1|STARTED|Overall Study||39
195054|NCT00829244|467216|P2|NOT COMPLETED|Overall Study||21
195055|NCT00829244|467217|P1|NOT COMPLETED|Overall Study||14
195056|NCT00829244|467216|P2|COMPLETED|Overall Study||83
195057|NCT00829244|467217|P1|COMPLETED|Overall Study||82
195058|NCT00829244|467216|P2|STARTED|Overall Study||104
195059|NCT00829244|467217|P1|STARTED|Overall Study||96
195060|NCT00829179|467247|P1|NOT COMPLETED|Overall Study||1
195061|NCT00829179|467247|P1|COMPLETED|Overall Study||19
195062|NCT00829179|467247|P1|STARTED|Overall Study||20
195063|NCT00829166|467253|P2|NOT COMPLETED|Overall Study||496
195064|NCT00829166|467254|P1|NOT COMPLETED|Overall Study||495
195065|NCT00829166|467253|P2|COMPLETED|Overall Study||0
195066|NCT00829166|467254|P1|COMPLETED|Overall Study||0
195067|NCT00829166|467253|P2|Treated|Overall Study||488
195068|NCT00829166|467254|P1|Treated|Overall Study||490
195069|NCT00829166|467253|P2|STARTED|Overall Study||496
195070|NCT00829166|467254|P1|STARTED|Overall Study||495
195071|NCT00829049|467295|P2|NOT COMPLETED|Overall Study||20
195072|NCT00829049|467296|P1|NOT COMPLETED|Overall Study||17
195073|NCT00829049|467295|P2|COMPLETED|Overall Study||68
195074|NCT00829049|467296|P1|COMPLETED|Overall Study||60
195075|NCT00829049|467295|P2|STARTED|Overall Study||88
195076|NCT00829049|467296|P1|STARTED|Overall Study||77
195077|NCT00829036|467308|P1|NOT COMPLETED|Overall Study||0
195078|NCT00829036|467308|P1|COMPLETED|Overall Study||24
195079|NCT00829036|467308|P1|STARTED|Overall Study||24
195080|NCT00829010|467317|P5|NOT COMPLETED|Overall Study||2
195081|NCT00829010|467318|P4|NOT COMPLETED|Overall Study||8
195082|NCT00829010|467319|P3|NOT COMPLETED|Overall Study||3
195083|NCT00829010|467320|P2|NOT COMPLETED|Overall Study||9
195084|NCT00829010|467321|P1|NOT COMPLETED|Overall Study||10
195085|NCT00829010|467317|P5|COMPLETED|Overall Study||98
195086|NCT00829010|467318|P4|COMPLETED|Overall Study||92
195087|NCT00829010|467319|P3|COMPLETED|Overall Study||97
195088|NCT00829010|467320|P2|COMPLETED|Overall Study||92
195089|NCT00829010|467321|P1|COMPLETED|Overall Study||73
195090|NCT00829010|467317|P5|STARTED|Overall Study||100
195091|NCT00829010|467318|P4|STARTED|Overall Study||100
195092|NCT00829010|467319|P3|STARTED|Overall Study||100
195093|NCT00829010|467320|P2|STARTED|Overall Study||101
195094|NCT00829010|467321|P1|STARTED|Overall Study||83
195095|NCT00828984|467486|P3|NOT COMPLETED|Overall Study||9
195096|NCT00828984|467487|P2|NOT COMPLETED|Overall Study||16
195097|NCT00828984|467488|P1|NOT COMPLETED|Overall Study||14
195098|NCT00828984|467486|P3|COMPLETED|Overall Study||19
195099|NCT00828984|467487|P2|COMPLETED|Overall Study||15
195100|NCT00828984|467488|P1|COMPLETED|Overall Study||14
195101|NCT00828984|467486|P3|Post Intervention Follow-Up|Overall Study||19
195102|NCT00828984|467487|P2|Post Intervention Follow-Up|Overall Study||16
195103|NCT00828984|467488|P1|Post Intervention Follow-Up|Overall Study||15
195104|NCT00828984|467486|P3|Flexible Sigmoidoscopy|Overall Study||19
195105|NCT00828984|467487|P2|Flexible Sigmoidoscopy|Overall Study||19
195106|NCT00828984|467488|P1|Flexible Sigmoidoscopy|Overall Study||20
195107|NCT00828984|467486|P3|Treatment|Overall Study||24
195108|NCT00828984|467487|P2|Treatment|Overall Study||26
195109|NCT00828984|467488|P1|Treatment|Overall Study||24
195110|NCT00828984|467486|P3|Randomization|Overall Study||28
195111|NCT00828984|467487|P2|Randomization|Overall Study||31
195112|NCT00828984|467488|P1|Randomization|Overall Study||28
195113|NCT00828984|467486|P3|STARTED|Overall Study||28
195114|NCT00828984|467487|P2|STARTED|Overall Study||31
195115|NCT00828984|467488|P1|STARTED|Overall Study||28
195116|NCT00828945|467511|P1|NOT COMPLETED|Overall Study||41
195117|NCT00828945|467511|P1|COMPLETED|Overall Study||216
195118|NCT00828945|467511|P1|STARTED|Overall Study||257
195119|NCT00828841|467528|P3|NOT COMPLETED|Overall Study||4
195120|NCT00828841|467529|P2|NOT COMPLETED|Overall Study||4
195121|NCT00828841|467530|P1|NOT COMPLETED|Overall Study||4
195122|NCT00828841|467528|P3|COMPLETED|Overall Study||126
195123|NCT00828841|467529|P2|COMPLETED|Overall Study||232
195124|NCT00828841|467530|P1|COMPLETED|Overall Study||231
195125|NCT00828841|467528|P3|STARTED|Overall Study||130
195126|NCT00828841|467529|P2|STARTED|Overall Study||236
195127|NCT00828841|467530|P1|STARTED|Overall Study||235
195128|NCT00828750|467543|P1|NOT COMPLETED|Overall Study||4
195129|NCT00828750|467543|P1|COMPLETED|Overall Study||15
195130|NCT00828750|467543|P1|STARTED|Overall Study||19
195131|NCT00828711|467557|P3|NOT COMPLETED|Overall Study||0
195132|NCT00828711|467558|P2|NOT COMPLETED|Overall Study||0
195133|NCT00828711|467559|P1|NOT COMPLETED|Overall Study||1
195134|NCT00828711|467557|P3|COMPLETED|Overall Study||131
195135|NCT00828711|467558|P2|COMPLETED|Overall Study||125
195136|NCT00828711|467559|P1|COMPLETED|Overall Study||117
195137|NCT00828711|467557|P3|STARTED|Overall Study||131
195138|NCT00828711|467558|P2|STARTED|Overall Study||125
195139|NCT00828711|467559|P1|STARTED|Overall Study||118
195140|NCT00828568|467591|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
195141|NCT00828568|467592|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
195142|NCT00828568|467593|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
195143|NCT00828568|467591|P3|COMPLETED|Treated - Received at Least One Dose||55
195144|NCT00828568|467592|P2|COMPLETED|Treated - Received at Least One Dose||150
195145|NCT00828568|467593|P1|COMPLETED|Treated - Received at Least One Dose||153
195146|NCT00828568|467591|P3|STARTED|Treated - Received at Least One Dose||60
195147|NCT00828568|467592|P2|STARTED|Treated - Received at Least One Dose||179
195148|NCT00828568|467593|P1|STARTED|Treated - Received at Least One Dose||183
195149|NCT00828568|467591|P3|NOT COMPLETED|Randomized||2
195150|NCT00828568|467592|P2|NOT COMPLETED|Randomized||0
195151|NCT00828568|467593|P1|NOT COMPLETED|Randomized||1
195152|NCT00828568|467591|P3|COMPLETED|Randomized||60
195153|NCT00828568|467592|P2|COMPLETED|Randomized||179
195154|NCT00828568|467593|P1|COMPLETED|Randomized||183
195155|NCT00828568|467591|P3|STARTED|Randomized||62
195156|NCT00828568|467592|P2|STARTED|Randomized||179
195157|NCT00828568|467593|P1|STARTED|Randomized||184
195158|NCT00828542|467608|P2|NOT COMPLETED|Overall Study||3
195159|NCT00828542|467609|P1|NOT COMPLETED|Overall Study||3
195160|NCT00828542|467608|P2|COMPLETED|Overall Study||20
195161|NCT00828542|467609|P1|COMPLETED|Overall Study||20
195162|NCT00828542|467608|P2|STARTED|Overall Study||23
195163|NCT00828542|467609|P1|STARTED|Overall Study||23
195164|NCT00828516|467615|P1|NOT COMPLETED|Clinical Phase: Series 2||0
195165|NCT00828516|467615|P1|COMPLETED|Clinical Phase: Series 2||30
195166|NCT00828516|467615|P1|STARTED|Clinical Phase: Series 2||30
195167|NCT00828516|467615|P1|NOT COMPLETED|Clinical Phase: Series 1||2
195168|NCT00828516|467615|P1|COMPLETED|Clinical Phase: Series 1||33
195169|NCT00828516|467615|P1|STARTED|Clinical Phase: Series 1||35
195170|NCT00828464|467620|P1|NOT COMPLETED|Overall Study||1
195171|NCT00828464|467620|P1|COMPLETED|Overall Study||29
195172|NCT00828464|467620|P1|STARTED|Overall Study||30
195173|NCT00828451|467637|P1|NOT COMPLETED|Overall Study||11
195174|NCT00828451|467637|P1|COMPLETED|Overall Study||18
195175|NCT00828451|467637|P1|STARTED|Overall Study||29
195176|NCT00828412|467645|P2|NOT COMPLETED|Overall Study||2
195177|NCT00828412|467646|P1|NOT COMPLETED|Overall Study||9
195178|NCT00828412|467645|P2|COMPLETED|Overall Study||48
195179|NCT00828412|467646|P1|COMPLETED|Overall Study||41
195180|NCT00828412|467645|P2|STARTED|Overall Study||50
195181|NCT00828412|467646|P1|STARTED|Overall Study||50
195182|NCT00828347|467654|P2|NOT COMPLETED|Overall Study||0
195183|NCT00828347|467655|P1|NOT COMPLETED|Overall Study||0
195184|NCT00828347|467654|P2|COMPLETED|Overall Study||11
195185|NCT00828347|467655|P1|COMPLETED|Overall Study||12
195186|NCT00828347|467654|P2|STARTED|Overall Study||11
195187|NCT00828347|467655|P1|STARTED|Overall Study||12
195188|NCT00828321|467663|P2|NOT COMPLETED|Second Intervention||1
195189|NCT00828321|467664|P1|NOT COMPLETED|Second Intervention||0
195190|NCT00828321|467663|P2|COMPLETED|Second Intervention||19
195191|NCT00828321|467664|P1|COMPLETED|Second Intervention||18
195192|NCT00828321|467663|P2|STARTED|Second Intervention||20
195193|NCT00828321|467664|P1|STARTED|Second Intervention||18
195194|NCT00828321|467663|P2|NOT COMPLETED|Washout of 42 Days||0
195195|NCT00828321|467664|P1|NOT COMPLETED|Washout of 42 Days||2
195196|NCT00828321|467663|P2|COMPLETED|Washout of 42 Days||20
195197|NCT00828321|467664|P1|COMPLETED|Washout of 42 Days||18
195198|NCT00828321|467663|P2|STARTED|Washout of 42 Days||20
195199|NCT00828321|467664|P1|STARTED|Washout of 42 Days||20
195200|NCT00828321|467663|P2|NOT COMPLETED|First Intervention||0
195201|NCT00828321|467664|P1|NOT COMPLETED|First Intervention||0
195202|NCT00828321|467663|P2|COMPLETED|First Intervention||20
195203|NCT00828321|467664|P1|COMPLETED|First Intervention||20
195204|NCT00828321|467663|P2|STARTED|First Intervention||20
195205|NCT00828321|467664|P1|STARTED|First Intervention||20
195206|NCT00828308|467676|P1|NOT COMPLETED|Overall Study||0
195207|NCT00828308|467676|P1|COMPLETED|Overall Study||16
195208|NCT00828308|467676|P1|STARTED|Overall Study||16
195209|NCT00828295|467682|P2|NOT COMPLETED|Overall Study||0
195210|NCT00828295|467683|P1|NOT COMPLETED|Overall Study||0
195211|NCT00828295|467682|P2|COMPLETED|Overall Study||75
195212|NCT00828295|467683|P1|COMPLETED|Overall Study||75
195213|NCT00828295|467682|P2|STARTED|Overall Study||75
195214|NCT00828295|467683|P1|STARTED|Overall Study||75
195215|NCT00828204|467693|P2|NOT COMPLETED|Extension Study||3
195216|NCT00828204|467694|P1|NOT COMPLETED|Extension Study||0
195217|NCT00828204|467693|P2|COMPLETED|Extension Study||61
195218|NCT00828204|467694|P1|COMPLETED|Extension Study||0
195219|NCT00828204|467693|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
195220|NCT00828204|467694|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
195221|NCT00828204|467693|P2|NOT COMPLETED|Main Study: After Study Restart||3
195222|NCT00828204|467694|P1|NOT COMPLETED|Main Study: After Study Restart||0
195223|NCT00828204|467693|P2|COMPLETED|Main Study: After Study Restart||71
195224|NCT00828204|467694|P1|COMPLETED|Main Study: After Study Restart||0
195225|NCT00828204|467693|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
195226|NCT00828204|467694|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
195227|NCT00828204|467693|P2|Completed Manual Injection|Main Study: After Study Restart||74
195228|NCT00828204|467694|P1|Completed Manual Injection|Main Study: After Study Restart||0
195229|NCT00828204|467693|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
195230|NCT00828204|467694|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
195231|NCT00828204|467693|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
195232|NCT00828204|467694|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
195233|NCT00828204|467693|P2|COMPLETED|Main Study: Prior to Study Suspension||0
195234|NCT00828204|467694|P1|COMPLETED|Main Study: Prior to Study Suspension||7
195235|NCT00828204|467693|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
195236|NCT00828204|467694|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
195237|NCT00828204|467693|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
195238|NCT00828204|467694|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
195239|NCT00828204|467693|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
195240|NCT00828204|467694|P1|STARTED|Main Study: Prior to Study Suspension||21
195241|NCT00828191|467713|P2|NOT COMPLETED|Overall Study||10
195242|NCT00828191|467714|P1|NOT COMPLETED|Overall Study||8
195243|NCT00828191|467713|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
195244|NCT00828191|467714|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
195245|NCT00828191|467713|P2|STARTED|Overall Study|Randomized patients|400
195246|NCT00828191|467714|P1|STARTED|Overall Study|Randomized patients|400
195247|NCT00828178|467726|P2|NOT COMPLETED|Overall Study||2
195248|NCT00828178|467727|P1|NOT COMPLETED|Overall Study||0
195249|NCT00828178|467726|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
195250|NCT00828178|467727|P1|COMPLETED|Overall Study||42
195251|NCT00828178|467726|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
195252|NCT00828178|467727|P1|STARTED|Overall Study||42
195253|NCT00828139|467741|P4|NOT COMPLETED|Overall Study||51
195254|NCT00828139|467742|P3|NOT COMPLETED|Overall Study||55
195255|NCT00828139|467743|P2|NOT COMPLETED|Overall Study||41
195256|NCT00828139|467744|P1|NOT COMPLETED|Overall Study||41
195257|NCT00828139|467741|P4|COMPLETED|Overall Study||0
195258|NCT00828139|467742|P3|COMPLETED|Overall Study||0
195259|NCT00828139|467743|P2|COMPLETED|Overall Study||0
195260|NCT00828139|467744|P1|COMPLETED|Overall Study||1
195261|NCT00828139|467741|P4|STARTED|Overall Study||51
195262|NCT00828139|467742|P3|STARTED|Overall Study||55
195263|NCT00828139|467743|P2|STARTED|Overall Study||41
195264|NCT00828139|467744|P1|STARTED|Overall Study||42
195265|NCT00828113|467764|P2|NOT COMPLETED|Overall Study||31
195266|NCT00828113|467765|P1|NOT COMPLETED|Overall Study||30
195267|NCT00828113|467764|P2|COMPLETED|Overall Study||20
195268|NCT00828113|467765|P1|COMPLETED|Overall Study||20
195269|NCT00828113|467764|P2|STARTED|Overall Study||51
195270|NCT00828113|467765|P1|STARTED|Overall Study||50
195271|NCT00828074|467773|P3|NOT COMPLETED|Overall Study||0
195272|NCT00828074|467774|P2|NOT COMPLETED|Overall Study||0
195273|NCT00828074|467775|P1|NOT COMPLETED|Overall Study||0
195274|NCT00828074|467773|P3|COMPLETED|Overall Study||35
195275|NCT00828074|467774|P2|COMPLETED|Overall Study||5
195276|NCT00828074|467775|P1|COMPLETED|Overall Study||6
195277|NCT00828074|467773|P3|STARTED|Overall Study||35
195278|NCT00828074|467774|P2|STARTED|Overall Study||5
195279|NCT00828074|467775|P1|STARTED|Overall Study||6
195280|NCT00828061|467787|P6|NOT COMPLETED|Period 3||0
195281|NCT00828061|467788|P5|NOT COMPLETED|Period 3||0
195282|NCT00828061|467789|P4|NOT COMPLETED|Period 3||0
195283|NCT00828061|467790|P3|NOT COMPLETED|Period 3||0
195284|NCT00828061|467791|P2|NOT COMPLETED|Period 3||0
195285|NCT00828061|467792|P1|NOT COMPLETED|Period 3||0
195286|NCT00828061|467787|P6|COMPLETED|Period 3||3
195287|NCT00828061|467788|P5|COMPLETED|Period 3||3
195288|NCT00828061|467789|P4|COMPLETED|Period 3||3
195289|NCT00828061|467790|P3|COMPLETED|Period 3||3
195290|NCT00828061|467791|P2|COMPLETED|Period 3||3
195291|NCT00828061|467792|P1|COMPLETED|Period 3||4
195292|NCT00828061|467787|P6|STARTED|Period 3||3
195293|NCT00828061|467788|P5|STARTED|Period 3||3
195294|NCT00828061|467789|P4|STARTED|Period 3||3
195295|NCT00828061|467790|P3|STARTED|Period 3||3
195296|NCT00828061|467791|P2|STARTED|Period 3||3
195297|NCT00828061|467792|P1|STARTED|Period 3||4
195298|NCT00828061|467787|P6|NOT COMPLETED|Period 2||0
195299|NCT00828061|467788|P5|NOT COMPLETED|Period 2||0
195300|NCT00828061|467789|P4|NOT COMPLETED|Period 2||0
195301|NCT00828061|467790|P3|NOT COMPLETED|Period 2||0
195302|NCT00828061|467791|P2|NOT COMPLETED|Period 2||0
195303|NCT00828061|467792|P1|NOT COMPLETED|Period 2||0
195304|NCT00828061|467787|P6|COMPLETED|Period 2||3
195305|NCT00828061|467788|P5|COMPLETED|Period 2||3
195306|NCT00828061|467789|P4|COMPLETED|Period 2||3
195307|NCT00828061|467790|P3|COMPLETED|Period 2||3
195308|NCT00828061|467791|P2|COMPLETED|Period 2||3
195309|NCT00828061|467792|P1|COMPLETED|Period 2||4
195310|NCT00828061|467787|P6|STARTED|Period 2||3
195311|NCT00828061|467788|P5|STARTED|Period 2||3
195312|NCT00828061|467789|P4|STARTED|Period 2||3
195313|NCT00828061|467790|P3|STARTED|Period 2||3
195314|NCT00828061|467791|P2|STARTED|Period 2||3
195315|NCT00828061|467792|P1|STARTED|Period 2||4
195316|NCT00828061|467787|P6|NOT COMPLETED|Period 1||0
195317|NCT00828061|467788|P5|NOT COMPLETED|Period 1||0
195318|NCT00828061|467789|P4|NOT COMPLETED|Period 1||0
195319|NCT00828061|467790|P3|NOT COMPLETED|Period 1||0
195320|NCT00828061|467791|P2|NOT COMPLETED|Period 1||0
195321|NCT00828061|467792|P1|NOT COMPLETED|Period 1||0
195322|NCT00828061|467787|P6|COMPLETED|Period 1||3
195323|NCT00828061|467788|P5|COMPLETED|Period 1||3
195324|NCT00828061|467789|P4|COMPLETED|Period 1||3
195325|NCT00828061|467790|P3|COMPLETED|Period 1||3
195326|NCT00828061|467791|P2|COMPLETED|Period 1||3
195327|NCT00828061|467792|P1|COMPLETED|Period 1||4
195328|NCT00828061|467787|P6|STARTED|Period 1||3
195329|NCT00828061|467788|P5|STARTED|Period 1||3
195330|NCT00828061|467789|P4|STARTED|Period 1||3
195331|NCT00828061|467790|P3|STARTED|Period 1||3
195332|NCT00828061|467791|P2|STARTED|Period 1||3
195333|NCT00828061|467792|P1|STARTED|Period 1||4
195334|NCT00827983|467805|P2|NOT COMPLETED|Overall Study||16
195335|NCT00827983|467806|P1|NOT COMPLETED|Overall Study||18
195336|NCT00827983|467805|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
195337|NCT00827983|467806|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
195338|NCT00827983|467805|P2|STARTED|Overall Study|all randomised patients|344
195339|NCT00827983|467806|P1|STARTED|Overall Study|All randomised patients|339
195340|NCT00827944|467818|P2|NOT COMPLETED|Overall Study||59
195341|NCT00827944|467819|P1|NOT COMPLETED|Overall Study||63
195342|NCT00827944|467818|P2|COMPLETED|Overall Study||240
195343|NCT00827944|467819|P1|COMPLETED|Overall Study||241
195344|NCT00827944|467818|P2|STARTED|Overall Study||299
195345|NCT00827944|467819|P1|STARTED|Overall Study||304
195346|NCT00827931|467839|P2|NOT COMPLETED|Overall Study||6
195347|NCT00827931|467840|P1|NOT COMPLETED|Overall Study||6
195348|NCT00827931|467839|P2|COMPLETED|Overall Study||39
195349|NCT00827931|467840|P1|COMPLETED|Overall Study||43
195350|NCT00827931|467839|P2|STARTED|Overall Study||45
195351|NCT00827931|467840|P1|STARTED|Overall Study||49
195352|NCT00827918|467861|P3|NOT COMPLETED|Overall Study||21
195353|NCT00827918|467862|P2|NOT COMPLETED|Overall Study||9
195354|NCT00827918|467863|P1|NOT COMPLETED|Overall Study||28
195355|NCT00827918|467861|P3|COMPLETED|Overall Study||62
195356|NCT00827918|467862|P2|COMPLETED|Overall Study||38
195357|NCT00827918|467863|P1|COMPLETED|Overall Study||58
195358|NCT00827918|467861|P3|STARTED|Overall Study||83
195359|NCT00827918|467862|P2|STARTED|Overall Study||47
195360|NCT00827918|467863|P1|STARTED|Overall Study||86
195361|NCT00827827|467891|P2|NOT COMPLETED|Overall Study||0
195362|NCT00827827|467892|P1|NOT COMPLETED|Overall Study||8
195363|NCT00827827|467891|P2|COMPLETED|Overall Study||16
195364|NCT00827827|467892|P1|COMPLETED|Overall Study||14
195365|NCT00827827|467891|P2|STARTED|Overall Study||16
195366|NCT00827827|467892|P1|STARTED|Overall Study||22
195367|NCT00827632|467936|P2|NOT COMPLETED|Overall Study||23
195368|NCT00827632|467937|P1|NOT COMPLETED|Overall Study||22
195369|NCT00827632|467936|P2|COMPLETED|Overall Study||75
195370|NCT00827632|467937|P1|COMPLETED|Overall Study||106
195371|NCT00827632|467936|P2|STARTED|Overall Study||98
195372|NCT00827632|467937|P1|STARTED|Overall Study||128
195373|NCT00827606|467945|P2|NOT COMPLETED|Overall Study||38
195374|NCT00827606|467946|P1|NOT COMPLETED|Overall Study||27
195375|NCT00827606|467945|P2|COMPLETED|Overall Study||94
195376|NCT00827606|467946|P1|COMPLETED|Overall Study||112
195377|NCT00827606|467945|P2|STARTED|Overall Study||132
195378|NCT00827606|467946|P1|STARTED|Overall Study||139
195379|NCT00827567|468007|P1|NOT COMPLETED|Overall Study||4
195380|NCT00827567|468007|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
195381|NCT00827567|468007|P1|STARTED|Overall Study||4
195382|NCT00827541|468013|P2|NOT COMPLETED|Overall Study||11
195383|NCT00827541|468014|P1|NOT COMPLETED|Overall Study||4
195384|NCT00827541|468013|P2|COMPLETED|Overall Study||85
195385|NCT00827541|468014|P1|COMPLETED|Overall Study||15
195386|NCT00827541|468013|P2|STARTED|Overall Study||96
195387|NCT00827541|468014|P1|STARTED|Overall Study||19
195388|NCT00827502|468026|P1|NOT COMPLETED|Overall Study||21
195389|NCT00827502|468026|P1|COMPLETED|Overall Study||400
195390|NCT00827502|468026|P1|Received Treatment (Number Treated)|Overall Study||410
195391|NCT00827502|468026|P1|STARTED|Overall Study||421
195392|NCT00827372|468032|P1|NOT COMPLETED|Overall Study||8
195393|NCT00827372|468032|P1|COMPLETED|Overall Study||2
195394|NCT00827372|468032|P1|STARTED|Overall Study||10
195395|NCT00827255|468040|P1|NOT COMPLETED|Overall Study||0
195396|NCT00827255|468040|P1|COMPLETED|Overall Study||35
195397|NCT00827255|468040|P1|STARTED|Overall Study||35
195398|NCT00827242|468047|P2|NOT COMPLETED|Overall Study||12
195399|NCT00827242|468048|P1|NOT COMPLETED|Overall Study||13
195400|NCT00827242|468047|P2|COMPLETED|Overall Study||152
195401|NCT00827242|468048|P1|COMPLETED|Overall Study||148
195402|NCT00827242|468047|P2|STARTED|Overall Study||164
195403|NCT00827242|468048|P1|STARTED|Overall Study||161
195404|NCT00827112|468086|P2|NOT COMPLETED|Overall Study||12
195405|NCT00827112|468087|P1|NOT COMPLETED|Overall Study||15
195406|NCT00827112|468086|P2|COMPLETED|Overall Study||52
195407|NCT00827112|468087|P1|COMPLETED|Overall Study||50
195408|NCT00827112|468086|P2|Treated|Overall Study||61
195409|NCT00827112|468087|P1|Treated|Overall Study||60
195410|NCT00827112|468086|P2|STARTED|Overall Study||64
195411|NCT00827112|468087|P1|STARTED|Overall Study||65
195412|NCT00827099|468120|P1|NOT COMPLETED|Overall Study||0
195413|NCT00827099|468120|P1|COMPLETED|Overall Study||5
195414|NCT00827099|468120|P1|STARTED|Overall Study||5
195415|NCT00827073|468131|P2|NOT COMPLETED|Overall Study||0
195416|NCT00827073|468132|P1|NOT COMPLETED|Overall Study||0
195417|NCT00827073|468131|P2|COMPLETED|Overall Study||20
195418|NCT00827073|468132|P1|COMPLETED|Overall Study||20
195419|NCT00827073|468131|P2|STARTED|Overall Study||20
195420|NCT00827073|468132|P1|STARTED|Overall Study||20
195421|NCT00826943|468140|P6|NOT COMPLETED|Overall Study||0
195422|NCT00826943|468141|P5|NOT COMPLETED|Overall Study||1
195423|NCT00826943|468142|P4|NOT COMPLETED|Overall Study||0
195424|NCT00826943|468143|P3|NOT COMPLETED|Overall Study||0
195425|NCT00826943|468144|P2|NOT COMPLETED|Overall Study||0
195426|NCT00826943|468145|P1|NOT COMPLETED|Overall Study||0
195427|NCT00826943|468140|P6|COMPLETED|Overall Study||2
195428|NCT00826943|468141|P5|COMPLETED|Overall Study||6
195429|NCT00826943|468142|P4|COMPLETED|Overall Study||5
195430|NCT00826943|468143|P3|COMPLETED|Overall Study||4
195431|NCT00826943|468144|P2|COMPLETED|Overall Study||6
195432|NCT00826943|468145|P1|COMPLETED|Overall Study||6
195433|NCT00826943|468140|P6|STARTED|Overall Study||2
195434|NCT00826943|468141|P5|STARTED|Overall Study||7
195435|NCT00826943|468142|P4|STARTED|Overall Study||5
195436|NCT00826943|468143|P3|STARTED|Overall Study||4
195437|NCT00826943|468144|P2|STARTED|Overall Study||6
195438|NCT00826943|468145|P1|STARTED|Overall Study||6
195439|NCT00826800|468159|P1|NOT COMPLETED|Overall Study||0
195440|NCT00826800|468159|P1|COMPLETED|Overall Study||2
195441|NCT00826800|468159|P1|STARTED|Overall Study||2
195442|NCT00826748|468166|P3|NOT COMPLETED|Overall Study||4
195443|NCT00826748|468167|P2|NOT COMPLETED|Overall Study||0
195444|NCT00826748|468168|P1|NOT COMPLETED|Overall Study||0
195445|NCT00826748|468166|P3|COMPLETED|Overall Study||8
195446|NCT00826748|468167|P2|COMPLETED|Overall Study||4
195447|NCT00826748|468168|P1|COMPLETED|Overall Study||6
195448|NCT00826748|468166|P3|STARTED|Overall Study||12
195449|NCT00826748|468167|P2|STARTED|Overall Study||4
195450|NCT00826748|468168|P1|STARTED|Overall Study||6
195451|NCT00826618|468176|P1|NOT COMPLETED|Overall Study||1
195452|NCT00826618|468176|P1|COMPLETED|Overall Study||5
195453|NCT00826618|468176|P1|STARTED|Overall Study||6
195454|NCT00826540|468180|P1|NOT COMPLETED|Overall Study||4
195455|NCT00826540|468180|P1|COMPLETED|Overall Study||79
195456|NCT00826540|468180|P1|STARTED|Overall Study||83
195457|NCT00826449|468186|P1|NOT COMPLETED|Overall Study||5
195458|NCT00826449|468186|P1|COMPLETED|Overall Study||42
195459|NCT00826449|468186|P1|Phase II|Overall Study||35
195460|NCT00826449|468186|P1|Phase I|Overall Study||12
195461|NCT00826449|468186|P1|STARTED|Overall Study||47
195462|NCT00826280|468195|P3|NOT COMPLETED|Overall Study||46
195463|NCT00826280|468196|P2|NOT COMPLETED|Overall Study||46
195464|NCT00826280|468197|P1|NOT COMPLETED|Overall Study||48
195465|NCT00826280|468195|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
195466|NCT00826280|468196|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
195467|NCT00826280|468197|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
195468|NCT00826280|468195|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
195469|NCT00826280|468196|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
195470|NCT00826280|468197|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
195471|NCT00826280|468195|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
195472|NCT00826280|468196|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
195473|NCT00826280|468197|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
195474|NCT00826280|468195|P3|STARTED|Overall Study||117
195475|NCT00826280|468196|P2|STARTED|Overall Study||116
195476|NCT00826280|468197|P1|STARTED|Overall Study||114
195477|NCT00826267|468226|P3|NOT COMPLETED|Overall Study||0
195478|NCT00826267|468227|P2|NOT COMPLETED|Overall Study||0
195479|NCT00826267|468228|P1|NOT COMPLETED|Overall Study||1
195480|NCT00826267|468226|P3|COMPLETED|Overall Study||11
195481|NCT00826267|468227|P2|COMPLETED|Overall Study||8
195482|NCT00826267|468228|P1|COMPLETED|Overall Study||9
195483|NCT00826267|468226|P3|STARTED|Overall Study||11
195484|NCT00826267|468227|P2|STARTED|Overall Study||8
195485|NCT00826267|468228|P1|STARTED|Overall Study||10
195486|NCT00826228|468246|P1|NOT COMPLETED|Overall Study||1
195487|NCT00826228|468246|P1|COMPLETED|Overall Study||11
195488|NCT00826228|468246|P1|STARTED|Overall Study||12
195489|NCT00826202|468253|P2|NOT COMPLETED|Overall Study||13
195490|NCT00826202|468254|P1|NOT COMPLETED|Overall Study||10
195491|NCT00826202|468253|P2|COMPLETED|Overall Study||11
195492|NCT00826202|468254|P1|COMPLETED|Overall Study||10
195493|NCT00826202|468253|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
195494|NCT00826202|468254|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
195495|NCT00826202|468253|P2|STARTED|Overall Study||24
195496|NCT00826202|468254|P1|STARTED|Overall Study||20
195497|NCT00826176|468268|P2|NOT COMPLETED|Overall Study||0
195498|NCT00826176|468269|P1|NOT COMPLETED|Overall Study||13
195499|NCT00826176|468268|P2|COMPLETED|Overall Study|treated and completed|36
195500|NCT00826176|468269|P1|COMPLETED|Overall Study|treated and completed|115
195501|NCT00826176|468268|P2|STARTED|Overall Study|enrolled|36
195502|NCT00826176|468269|P1|STARTED|Overall Study|enrolled|128
195503|NCT00826111|468281|P2|NOT COMPLETED|Overall Study||2
195504|NCT00826111|468282|P1|NOT COMPLETED|Overall Study||7
195505|NCT00826111|468281|P2|COMPLETED|Overall Study||3
195506|NCT00826111|468282|P1|COMPLETED|Overall Study||7
195507|NCT00826111|468281|P2|STARTED|Overall Study||5
195508|NCT00826111|468282|P1|STARTED|Overall Study||14
195509|NCT00826007|468306|P2|NOT COMPLETED|Overall Study||0
195510|NCT00826007|468307|P1|NOT COMPLETED|Overall Study||0
195511|NCT00826007|468306|P2|COMPLETED|Overall Study||279
195512|NCT00826007|468307|P1|COMPLETED|Overall Study|Retrospective review|308
195513|NCT00826007|468306|P2|STARTED|Overall Study||279
195514|NCT00826007|468307|P1|STARTED|Overall Study|Retrospective review|308
195515|NCT00825994|468312|P1|NOT COMPLETED|Overall Study||5
195516|NCT00825994|468312|P1|COMPLETED|Overall Study||19
195517|NCT00825994|468312|P1|STARTED|Overall Study||24
195518|NCT00825916|468320|P3|NOT COMPLETED|Overall Study||1
195519|NCT00825916|468321|P2|NOT COMPLETED|Overall Study||2
195520|NCT00825916|468322|P1|NOT COMPLETED|Overall Study||4
195521|NCT00825916|468320|P3|COMPLETED|Overall Study||19
195522|NCT00825916|468321|P2|COMPLETED|Overall Study||18
195523|NCT00825916|468322|P1|COMPLETED|Overall Study||15
195524|NCT00825916|468320|P3|STARTED|Overall Study||20
195525|NCT00825916|468321|P2|STARTED|Overall Study||20
195526|NCT00825916|468322|P1|STARTED|Overall Study||19
195527|NCT00825825|468363|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
195528|NCT00825825|468364|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
195529|NCT00825825|468365|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
195530|NCT00825825|468366|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
195531|NCT00825825|468367|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
195532|NCT00825825|468368|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
195533|NCT00825825|468363|P6|COMPLETED|Third Medication Period (14 Days)||1
195534|NCT00825825|468364|P5|COMPLETED|Third Medication Period (14 Days)||3
195535|NCT00825825|468365|P4|COMPLETED|Third Medication Period (14 Days)||3
195536|NCT00825825|468366|P3|COMPLETED|Third Medication Period (14 Days)||2
195537|NCT00825825|468367|P2|COMPLETED|Third Medication Period (14 Days)||2
195538|NCT00825825|468368|P1|COMPLETED|Third Medication Period (14 Days)||1
195539|NCT00825825|468363|P6|STARTED|Third Medication Period (14 Days)||3
195540|NCT00825825|468364|P5|STARTED|Third Medication Period (14 Days)||3
195541|NCT00825825|468365|P4|STARTED|Third Medication Period (14 Days)||3
195542|NCT00825825|468366|P3|STARTED|Third Medication Period (14 Days)||2
195543|NCT00825825|468367|P2|STARTED|Third Medication Period (14 Days)||4
195544|NCT00825825|468368|P1|STARTED|Third Medication Period (14 Days)||1
195545|NCT00825825|468363|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
195546|NCT00825825|468364|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
195547|NCT00825825|468365|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
195548|NCT00825825|468366|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
195549|NCT00825825|468367|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
195550|NCT00825825|468368|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
195551|NCT00825825|468363|P6|COMPLETED|Second Washout Period (14 Days)||3
195552|NCT00825825|468364|P5|COMPLETED|Second Washout Period (14 Days)||3
195553|NCT00825825|468365|P4|COMPLETED|Second Washout Period (14 Days)||3
195554|NCT00825825|468366|P3|COMPLETED|Second Washout Period (14 Days)||2
195555|NCT00825825|468367|P2|COMPLETED|Second Washout Period (14 Days)||4
195556|NCT00825825|468368|P1|COMPLETED|Second Washout Period (14 Days)||1
195557|NCT00825825|468363|P6|STARTED|Second Washout Period (14 Days)||3
195558|NCT00825825|468364|P5|STARTED|Second Washout Period (14 Days)||3
195559|NCT00825825|468365|P4|STARTED|Second Washout Period (14 Days)||3
195560|NCT00825825|468366|P3|STARTED|Second Washout Period (14 Days)||2
195561|NCT00825825|468367|P2|STARTED|Second Washout Period (14 Days)||4
195562|NCT00825825|468368|P1|STARTED|Second Washout Period (14 Days)||1
195563|NCT00825825|468363|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
195564|NCT00825825|468364|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
195565|NCT00825825|468365|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
195566|NCT00825825|468366|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
195747|NCT00824850|468614|P2|Received Vaccination 13vPnC|Overall Study||36
195567|NCT00825825|468367|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
195568|NCT00825825|468368|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
195569|NCT00825825|468363|P6|COMPLETED|Second Medication Period (14 Days)||3
195570|NCT00825825|468364|P5|COMPLETED|Second Medication Period (14 Days)||3
195571|NCT00825825|468365|P4|COMPLETED|Second Medication Period (14 Days)||3
195572|NCT00825825|468366|P3|COMPLETED|Second Medication Period (14 Days)||2
195573|NCT00825825|468367|P2|COMPLETED|Second Medication Period (14 Days)||4
195574|NCT00825825|468368|P1|COMPLETED|Second Medication Period (14 Days)||1
195575|NCT00825825|468363|P6|STARTED|Second Medication Period (14 Days)||3
195576|NCT00825825|468364|P5|STARTED|Second Medication Period (14 Days)||4
195577|NCT00825825|468365|P4|STARTED|Second Medication Period (14 Days)||5
195578|NCT00825825|468366|P3|STARTED|Second Medication Period (14 Days)||2
195579|NCT00825825|468367|P2|STARTED|Second Medication Period (14 Days)||4
195580|NCT00825825|468368|P1|STARTED|Second Medication Period (14 Days)||3
195581|NCT00825825|468363|P6|NOT COMPLETED|First Washout Period (14 Days)||0
195582|NCT00825825|468364|P5|NOT COMPLETED|First Washout Period (14 Days)||0
195583|NCT00825825|468365|P4|NOT COMPLETED|First Washout Period (14 Days)||0
195584|NCT00825825|468366|P3|NOT COMPLETED|First Washout Period (14 Days)||0
195585|NCT00825825|468367|P2|NOT COMPLETED|First Washout Period (14 Days)||0
195586|NCT00825825|468368|P1|NOT COMPLETED|First Washout Period (14 Days)||0
195587|NCT00825825|468363|P6|COMPLETED|First Washout Period (14 Days)||3
195588|NCT00825825|468364|P5|COMPLETED|First Washout Period (14 Days)||4
195589|NCT00825825|468365|P4|COMPLETED|First Washout Period (14 Days)||5
195590|NCT00825825|468366|P3|COMPLETED|First Washout Period (14 Days)||2
195591|NCT00825825|468367|P2|COMPLETED|First Washout Period (14 Days)||4
195592|NCT00825825|468368|P1|COMPLETED|First Washout Period (14 Days)||3
195593|NCT00825825|468363|P6|STARTED|First Washout Period (14 Days)||3
195594|NCT00825825|468364|P5|STARTED|First Washout Period (14 Days)||4
195595|NCT00825825|468365|P4|STARTED|First Washout Period (14 Days)||5
195596|NCT00825825|468366|P3|STARTED|First Washout Period (14 Days)||2
195597|NCT00825825|468367|P2|STARTED|First Washout Period (14 Days)||4
195598|NCT00825825|468368|P1|STARTED|First Washout Period (14 Days)||3
195599|NCT00825825|468363|P6|NOT COMPLETED|First Medication Period (14 Days)||2
195600|NCT00825825|468364|P5|NOT COMPLETED|First Medication Period (14 Days)||0
195601|NCT00825825|468365|P4|NOT COMPLETED|First Medication Period (14 Days)||0
195602|NCT00825825|468366|P3|NOT COMPLETED|First Medication Period (14 Days)||1
195603|NCT00825825|468367|P2|NOT COMPLETED|First Medication Period (14 Days)||0
195604|NCT00825825|468368|P1|NOT COMPLETED|First Medication Period (14 Days)||3
195605|NCT00825825|468363|P6|COMPLETED|First Medication Period (14 Days)||3
195606|NCT00825825|468364|P5|COMPLETED|First Medication Period (14 Days)||4
195607|NCT00825825|468365|P4|COMPLETED|First Medication Period (14 Days)||5
195608|NCT00825825|468366|P3|COMPLETED|First Medication Period (14 Days)||2
195609|NCT00825825|468367|P2|COMPLETED|First Medication Period (14 Days)||4
195610|NCT00825825|468368|P1|COMPLETED|First Medication Period (14 Days)||3
195611|NCT00825825|468363|P6|STARTED|First Medication Period (14 Days)||5
195612|NCT00825825|468364|P5|STARTED|First Medication Period (14 Days)||4
195613|NCT00825825|468365|P4|STARTED|First Medication Period (14 Days)||5
195614|NCT00825825|468366|P3|STARTED|First Medication Period (14 Days)||3
195615|NCT00825825|468367|P2|STARTED|First Medication Period (14 Days)||4
195616|NCT00825825|468368|P1|STARTED|First Medication Period (14 Days)||6
195617|NCT00825812|468384|P4|NOT COMPLETED|Overall Study||10
195618|NCT00825812|468385|P3|NOT COMPLETED|Overall Study||6
195619|NCT00825812|468386|P2|NOT COMPLETED|Overall Study||1
195620|NCT00825812|468387|P1|NOT COMPLETED|Overall Study||0
195621|NCT00825812|468384|P4|COMPLETED|Overall Study||111
195622|NCT00825812|468385|P3|COMPLETED|Overall Study||120
195623|NCT00825812|468386|P2|COMPLETED|Overall Study||31
195624|NCT00825812|468387|P1|COMPLETED|Overall Study||29
195625|NCT00825812|468384|P4|TREATED|Overall Study||111
195626|NCT00825812|468385|P3|TREATED|Overall Study||120
195627|NCT00825812|468386|P2|TREATED|Overall Study||31
195628|NCT00825812|468387|P1|TREATED|Overall Study||29
195629|NCT00825812|468384|P4|STARTED|Overall Study||121
195630|NCT00825812|468385|P3|STARTED|Overall Study||126
195631|NCT00825812|468386|P2|STARTED|Overall Study||32
195632|NCT00825812|468387|P1|STARTED|Overall Study||29
195633|NCT00825786|468403|P2|NOT COMPLETED|Overall Study||0
195634|NCT00825786|468404|P1|NOT COMPLETED|Overall Study||0
195635|NCT00825786|468403|P2|COMPLETED|Overall Study||51
195636|NCT00825786|468404|P1|COMPLETED|Overall Study||52
195637|NCT00825786|468403|P2|STARTED|Overall Study||51
195638|NCT00825786|468404|P1|STARTED|Overall Study||52
195639|NCT00825734|468422|P3|NOT COMPLETED|Phase II||76
195640|NCT00825734|468423|P2|NOT COMPLETED|Phase II||0
195641|NCT00825734|468424|P1|NOT COMPLETED|Phase II||0
195642|NCT00825734|468422|P3|COMPLETED|Phase II||0
195643|NCT00825734|468423|P2|COMPLETED|Phase II||0
195644|NCT00825734|468424|P1|COMPLETED|Phase II||0
195645|NCT00825734|468422|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
195646|NCT00825734|468423|P2|STARTED|Phase II||0
195647|NCT00825734|468424|P1|STARTED|Phase II||0
195648|NCT00825734|468422|P3|NOT COMPLETED|Phase I||0
195649|NCT00825734|468423|P2|NOT COMPLETED|Phase I||3
195650|NCT00825734|468424|P1|NOT COMPLETED|Phase I||4
195651|NCT00825734|468422|P3|COMPLETED|Phase I||3
195652|NCT00825734|468423|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
195653|NCT00825734|468424|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
195654|NCT00825734|468422|P3|STARTED|Phase I||3
195655|NCT00825734|468423|P2|STARTED|Phase I||3
195656|NCT00825734|468424|P1|STARTED|Phase I||4
195657|NCT00825682|468434|P2|NOT COMPLETED|Overall Study||5
195658|NCT00825682|468435|P1|NOT COMPLETED|Overall Study||13
195659|NCT00825682|468434|P2|COMPLETED|Overall Study||20
195660|NCT00825682|468435|P1|COMPLETED|Overall Study||34
195661|NCT00825682|468434|P2|STARTED|Overall Study||25
195662|NCT00825682|468435|P1|STARTED|Overall Study||47
195663|NCT00825630|468449|P4|NOT COMPLETED|Overall Study||0
195664|NCT00825630|468450|P3|NOT COMPLETED|Overall Study||0
195665|NCT00825630|468451|P2|NOT COMPLETED|Overall Study||0
195666|NCT00825630|468452|P1|NOT COMPLETED|Overall Study||0
195667|NCT00825630|468449|P4|COMPLETED|Overall Study||13
195668|NCT00825630|468450|P3|COMPLETED|Overall Study||19
195669|NCT00825630|468451|P2|COMPLETED|Overall Study||62
195670|NCT00825630|468452|P1|COMPLETED|Overall Study||29
195671|NCT00825630|468449|P4|STARTED|Overall Study||13
195672|NCT00825630|468450|P3|STARTED|Overall Study||19
195673|NCT00825630|468451|P2|STARTED|Overall Study||62
195674|NCT00825630|468452|P1|STARTED|Overall Study||29
195675|NCT00825565|468462|P1|NOT COMPLETED|Overall Study||0
195676|NCT00825565|468462|P1|COMPLETED|Overall Study||8
195677|NCT00825565|468462|P1|STARTED|Overall Study||8
195678|NCT00825500|468475|P3|NOT COMPLETED|Overall Study||0
195679|NCT00825500|468476|P2|NOT COMPLETED|Overall Study||0
195680|NCT00825500|468477|P1|NOT COMPLETED|Overall Study||0
195681|NCT00825500|468475|P3|COMPLETED|Overall Study||120
195682|NCT00825500|468476|P2|COMPLETED|Overall Study||121
195683|NCT00825500|468477|P1|COMPLETED|Overall Study||125
195684|NCT00825500|468475|P3|STARTED|Overall Study||120
195685|NCT00825500|468476|P2|STARTED|Overall Study||121
195686|NCT00825500|468477|P1|STARTED|Overall Study||125
195687|NCT00825370|468490|P2|NOT COMPLETED|Overall Study||0
195688|NCT00825370|468491|P1|NOT COMPLETED|Overall Study||0
195689|NCT00825370|468490|P2|COMPLETED|Overall Study||175
195690|NCT00825370|468491|P1|COMPLETED|Overall Study||175
195691|NCT00825370|468490|P2|STARTED|Overall Study||175
195692|NCT00825370|468491|P1|STARTED|Overall Study||175
195693|NCT00825344|468505|P2|NOT COMPLETED|Overall Study||1
195694|NCT00825344|468506|P1|NOT COMPLETED|Overall Study||1
195695|NCT00825344|468505|P2|COMPLETED|Overall Study||42
195696|NCT00825344|468506|P1|COMPLETED|Overall Study||33
195697|NCT00825344|468505|P2|STARTED|Overall Study||43
195698|NCT00825344|468506|P1|STARTED|Overall Study||34
195699|NCT00825318|468516|P1|NOT COMPLETED|Overall Study||1
195700|NCT00825318|468516|P1|COMPLETED|Overall Study||12
195701|NCT00825318|468516|P1|STARTED|Overall Study||13
195702|NCT00825305|468526|P2|NOT COMPLETED|Overall Study||23
195703|NCT00825305|468527|P1|NOT COMPLETED|Overall Study||17
195704|NCT00825305|468526|P2|COMPLETED|Overall Study||252
195705|NCT00825305|468527|P1|COMPLETED|Overall Study||533
195706|NCT00825305|468526|P2|STARTED|Overall Study||275
195707|NCT00825305|468527|P1|STARTED|Overall Study||550
195708|NCT00825266|468541|P2|NOT COMPLETED|Overall Study||0
195709|NCT00825266|468542|P1|NOT COMPLETED|Overall Study||0
195710|NCT00825266|468541|P2|COMPLETED|Overall Study||1
195711|NCT00825266|468542|P1|COMPLETED|Overall Study||1
195712|NCT00825266|468541|P2|STARTED|Overall Study||1
195713|NCT00825266|468542|P1|STARTED|Overall Study||1
195714|NCT00825227|468554|P2|NOT COMPLETED|Overall Study||0
195715|NCT00825227|468555|P1|NOT COMPLETED|Overall Study||0
195716|NCT00825227|468554|P2|COMPLETED|Overall Study||4
195717|NCT00825227|468555|P1|COMPLETED|Overall Study||6
195718|NCT00825227|468554|P2|STARTED|Overall Study||4
195719|NCT00825227|468555|P1|STARTED|Overall Study||6
195720|NCT00825175|468567|P2|NOT COMPLETED|Overall Study||5
195721|NCT00825175|468568|P1|NOT COMPLETED|Overall Study||0
195722|NCT00825175|468567|P2|COMPLETED|Overall Study||7
195723|NCT00825175|468568|P1|COMPLETED|Overall Study||10
195724|NCT00825175|468567|P2|STARTED|Overall Study||12
195725|NCT00825175|468568|P1|STARTED|Overall Study||10
195726|NCT00825162|468577|P3|NOT COMPLETED|Overall Study||6
195727|NCT00825162|468578|P2|NOT COMPLETED|Overall Study||21
195728|NCT00825162|468579|P1|NOT COMPLETED|Overall Study||28
195729|NCT00825162|468577|P3|COMPLETED|Overall Study||396
195730|NCT00825162|468578|P2|COMPLETED|Overall Study||859
195731|NCT00825162|468579|P1|COMPLETED|Overall Study||682
195732|NCT00825162|468577|P3|STARTED|Overall Study||402
195733|NCT00825162|468578|P2|STARTED|Overall Study||880
195734|NCT00825162|468579|P1|STARTED|Overall Study||710
195735|NCT00824993|468605|P2|NOT COMPLETED|Overall Study||17
195736|NCT00824993|468606|P1|NOT COMPLETED|Overall Study||14
195737|NCT00824993|468605|P2|COMPLETED|Overall Study||22
195738|NCT00824993|468606|P1|COMPLETED|Overall Study||25
195739|NCT00824993|468605|P2|6 Month Follow up|Overall Study||27
195740|NCT00824993|468606|P1|6 Month Follow up|Overall Study||33
195741|NCT00824993|468605|P2|STARTED|Overall Study||39
195742|NCT00824993|468606|P1|STARTED|Overall Study||39
195743|NCT00824850|468614|P2|NOT COMPLETED|Overall Study||1
195744|NCT00824850|468615|P1|NOT COMPLETED|Overall Study||0
195745|NCT00824850|468614|P2|COMPLETED|Overall Study||36
195746|NCT00824850|468615|P1|COMPLETED|Overall Study||38
195748|NCT00824850|468615|P1|Received Vaccination 13vPnC|Overall Study||38
195749|NCT00824850|468614|P2|STARTED|Overall Study||37
195750|NCT00824850|468615|P1|STARTED|Overall Study||38
195751|NCT00824824|468661|P2|NOT COMPLETED|Overall Study||0
195752|NCT00824824|468662|P1|NOT COMPLETED|Overall Study||0
195753|NCT00824824|468661|P2|COMPLETED|Overall Study||3
195754|NCT00824824|468662|P1|COMPLETED|Overall Study||4
195755|NCT00824824|468661|P2|STARTED|Overall Study||3
195756|NCT00824824|468662|P1|STARTED|Overall Study||4
195757|NCT00824772|468668|P1|NOT COMPLETED|Overall Study||8
195758|NCT00824772|468668|P1|COMPLETED|Overall Study||196
195759|NCT00824772|468668|P1|STARTED|Overall Study||204
195760|NCT00824746|468673|P1|NOT COMPLETED|Overall Study||0
195761|NCT00824746|468673|P1|COMPLETED|Overall Study||23
195762|NCT00824746|468673|P1|STARTED|Overall Study||23
195763|NCT00824733|468679|P1|NOT COMPLETED|Overall Study||0
195764|NCT00824733|468679|P1|COMPLETED|Overall Study||6
195765|NCT00824733|468679|P1|STARTED|Overall Study||6
195766|NCT00824720|468688|P3|NOT COMPLETED|Overall Study||1
195767|NCT00824720|468689|P2|NOT COMPLETED|Overall Study||1
195768|NCT00824720|468690|P1|NOT COMPLETED|Overall Study||3
195769|NCT00824720|468688|P3|COMPLETED|Overall Study||19
195770|NCT00824720|468689|P2|COMPLETED|Overall Study||15
195771|NCT00824720|468690|P1|COMPLETED|Overall Study||16
195772|NCT00824720|468688|P3|STARTED|Overall Study||20
195773|NCT00824720|468689|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
195774|NCT00824720|468690|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
195775|NCT00824655|468706|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
195776|NCT00824655|468707|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
195777|NCT00824655|468706|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
195778|NCT00824655|468707|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
195779|NCT00824655|468706|P2|STARTED|Toddler Dose (12 Months of Age)||116
195780|NCT00824655|468707|P1|STARTED|Toddler Dose (12 Months of Age)||118
195781|NCT00824655|468706|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
195782|NCT00824655|468707|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
195783|NCT00824655|468706|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
195784|NCT00824655|468707|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
195785|NCT00824655|468706|P2|STARTED|After Infant Dose (6 Months of Age)||0
195786|NCT00824655|468707|P1|STARTED|After Infant Dose (6 Months of Age)||118
195787|NCT00824655|468706|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
195788|NCT00824655|468707|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
195789|NCT00824655|468706|P2|COMPLETED|Infant Series (5 Months of Age)||0
195790|NCT00824655|468707|P1|COMPLETED|Infant Series (5 Months of Age)||118
195791|NCT00824655|468706|P2|STARTED|Infant Series (5 Months of Age)||0
195792|NCT00824655|468707|P1|STARTED|Infant Series (5 Months of Age)||118
195793|NCT00824616|468727|P2|NOT COMPLETED|Overall Study||7
195794|NCT00824616|468728|P1|NOT COMPLETED|Overall Study||6
195795|NCT00824616|468727|P2|COMPLETED|Overall Study||27
195796|NCT00824616|468728|P1|COMPLETED|Overall Study||28
195797|NCT00824616|468727|P2|STARTED|Overall Study||34
195798|NCT00824616|468728|P1|STARTED|Overall Study||34
195799|NCT00824564|468738|P2|NOT COMPLETED|Overall Study||10
195800|NCT00824564|468739|P1|NOT COMPLETED|Overall Study||8
195801|NCT00824564|468738|P2|COMPLETED|Overall Study||30
195802|NCT00824564|468739|P1|COMPLETED|Overall Study||34
195803|NCT00824564|468738|P2|Treated|Overall Study||40
195804|NCT00824564|468739|P1|Treated|Overall Study||41
195805|NCT00824564|468738|P2|STARTED|Overall Study||40
195806|NCT00824564|468739|P1|STARTED|Overall Study||42
195807|NCT00824538|468757|P1|NOT COMPLETED|Overall Study||2
195808|NCT00824538|468757|P1|COMPLETED|Overall Study||11
195809|NCT00824538|468757|P1|STARTED|Overall Study|13 patients entered the study|13
195810|NCT00824512|468767|P2|NOT COMPLETED|Overall Study||0
195811|NCT00824512|468768|P1|NOT COMPLETED|Overall Study||0
195812|NCT00824512|468767|P2|COMPLETED|Overall Study||11
195813|NCT00824512|468768|P1|COMPLETED|Overall Study||11
195814|NCT00824512|468767|P2|STARTED|Overall Study||11
195815|NCT00824512|468768|P1|STARTED|Overall Study||11
195816|NCT00824473|468818|P2|NOT COMPLETED|Overall Study||13
195817|NCT00824473|468819|P1|NOT COMPLETED|Overall Study||15
195818|NCT00824473|468818|P2|COMPLETED|Overall Study||238
195819|NCT00824473|468819|P1|COMPLETED|Overall Study||240
195820|NCT00824473|468818|P2|STARTED|Overall Study||251
195821|NCT00824473|468819|P1|STARTED|Overall Study|1 subject was randomized in error|255
195822|NCT00824460|468841|P6|NOT COMPLETED|Overall Study||8
195823|NCT00824460|468842|P5|NOT COMPLETED|Overall Study||9
195824|NCT00824460|468843|P4|NOT COMPLETED|Overall Study||12
195825|NCT00824460|468844|P3|NOT COMPLETED|Overall Study||5
195826|NCT00824460|468845|P2|NOT COMPLETED|Overall Study||9
195827|NCT00824460|468846|P1|NOT COMPLETED|Overall Study||8
195828|NCT00824460|468841|P6|COMPLETED|Overall Study||18
195829|NCT00824460|468842|P5|COMPLETED|Overall Study||15
195830|NCT00824460|468843|P4|COMPLETED|Overall Study||15
195831|NCT00824460|468844|P3|COMPLETED|Overall Study||20
195832|NCT00824460|468845|P2|COMPLETED|Overall Study||17
195833|NCT00824460|468846|P1|COMPLETED|Overall Study||18
195834|NCT00824460|468841|P6|STARTED|Overall Study||26
195835|NCT00824460|468842|P5|STARTED|Overall Study||24
195836|NCT00824460|468843|P4|STARTED|Overall Study||27
195837|NCT00824460|468844|P3|STARTED|Overall Study||25
195838|NCT00824460|468845|P2|STARTED|Overall Study||26
195839|NCT00824460|468846|P1|STARTED|Overall Study||26
195840|NCT00824434|468878|P1|NOT COMPLETED|Overall Study||0
195841|NCT00824434|468878|P1|COMPLETED|Overall Study||100
195842|NCT00824434|468878|P1|STARTED|Overall Study||100
195843|NCT00824421|468900|P3|NOT COMPLETED|Overall Study||14
195844|NCT00824421|468901|P2|NOT COMPLETED|Overall Study||22
195845|NCT00824421|468902|P1|NOT COMPLETED|Overall Study||17
195846|NCT00824421|468900|P3|COMPLETED|Overall Study||49
195847|NCT00824421|468901|P2|COMPLETED|Overall Study||44
195848|NCT00824421|468902|P1|COMPLETED|Overall Study||49
195849|NCT00824421|468900|P3|Treated|Overall Study||63
195850|NCT00824421|468901|P2|Treated|Overall Study||65
195851|NCT00824421|468902|P1|Treated|Overall Study||65
195852|NCT00824421|468900|P3|STARTED|Overall Study||63
195853|NCT00824421|468901|P2|STARTED|Overall Study||66
195854|NCT00824421|468902|P1|STARTED|Overall Study||66
195855|NCT00824408|468953|P5|NOT COMPLETED|Randomized Phase||46
195856|NCT00824408|468954|P4|NOT COMPLETED|Randomized Phase||46
195857|NCT00824408|468955|P3|NOT COMPLETED|Randomized Phase||36
195858|NCT00824408|468956|P2|NOT COMPLETED|Randomized Phase||0
195859|NCT00824408|468957|P1|NOT COMPLETED|Randomized Phase||0
195860|NCT00824408|468953|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
195861|NCT00824408|468954|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
195862|NCT00824408|468955|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
195863|NCT00824408|468956|P2|COMPLETED|Randomized Phase||0
195864|NCT00824408|468957|P1|COMPLETED|Randomized Phase||0
195865|NCT00824408|468953|P5|STARTED|Randomized Phase||47
195866|NCT00824408|468954|P4|STARTED|Randomized Phase||47
195867|NCT00824408|468955|P3|STARTED|Randomized Phase||37
195868|NCT00824408|468956|P2|STARTED|Randomized Phase||0
195869|NCT00824408|468957|P1|STARTED|Randomized Phase||0
195870|NCT00824408|468953|P5|NOT COMPLETED|Run-in Phase||0
195871|NCT00824408|468954|P4|NOT COMPLETED|Run-in Phase||0
195872|NCT00824408|468955|P3|NOT COMPLETED|Run-in Phase||0
195873|NCT00824408|468956|P2|NOT COMPLETED|Run-in Phase||6
195874|NCT00824408|468957|P1|NOT COMPLETED|Run-in Phase||6
195875|NCT00824408|468953|P5|COMPLETED|Run-in Phase||0
195876|NCT00824408|468954|P4|COMPLETED|Run-in Phase||0
195877|NCT00824408|468955|P3|COMPLETED|Run-in Phase||0
195878|NCT00824408|468956|P2|COMPLETED|Run-in Phase||0
195879|NCT00824408|468957|P1|COMPLETED|Run-in Phase||0
195880|NCT00824408|468953|P5|STARTED|Run-in Phase||0
195881|NCT00824408|468954|P4|STARTED|Run-in Phase||0
195882|NCT00824408|468955|P3|STARTED|Run-in Phase||0
195883|NCT00824408|468956|P2|STARTED|Run-in Phase||6
195884|NCT00824408|468957|P1|STARTED|Run-in Phase||6
195885|NCT00824382|469009|P4|NOT COMPLETED|Overall Study||5
195886|NCT00824382|469010|P3|NOT COMPLETED|Overall Study||3
195887|NCT00824382|469011|P2|NOT COMPLETED|Overall Study||2
195888|NCT00824382|469012|P1|NOT COMPLETED|Overall Study||5
195889|NCT00824382|469009|P4|COMPLETED|Overall Study||81
195890|NCT00824382|469010|P3|COMPLETED|Overall Study||76
195891|NCT00824382|469011|P2|COMPLETED|Overall Study||82
195892|NCT00824382|469012|P1|COMPLETED|Overall Study||74
195893|NCT00824382|469009|P4|STARTED|Overall Study||86
195894|NCT00824382|469010|P3|STARTED|Overall Study||79
195895|NCT00824382|469011|P2|STARTED|Overall Study||84
195896|NCT00824382|469012|P1|STARTED|Overall Study||79
195897|NCT00824369|469088|P6|NOT COMPLETED|Overall Study||1
195898|NCT00824369|469089|P5|NOT COMPLETED|Overall Study||1
195899|NCT00824369|469090|P4|NOT COMPLETED|Overall Study||2
195900|NCT00824369|469091|P3|NOT COMPLETED|Overall Study||1
195901|NCT00824369|469092|P2|NOT COMPLETED|Overall Study||0
195902|NCT00824369|469093|P1|NOT COMPLETED|Overall Study||1
195903|NCT00824369|469088|P6|COMPLETED|Overall Study||16
195904|NCT00824369|469089|P5|COMPLETED|Overall Study||11
195905|NCT00824369|469090|P4|COMPLETED|Overall Study||9
195906|NCT00824369|469091|P3|COMPLETED|Overall Study||2
195907|NCT00824369|469092|P2|COMPLETED|Overall Study||4
195908|NCT00824369|469093|P1|COMPLETED|Overall Study||4
195909|NCT00824369|469088|P6|STARTED|Overall Study||17
195910|NCT00824369|469089|P5|STARTED|Overall Study||12
195911|NCT00824369|469090|P4|STARTED|Overall Study||11
195912|NCT00824369|469091|P3|STARTED|Overall Study||3
195913|NCT00824369|469092|P2|STARTED|Overall Study||4
195914|NCT00824369|469093|P1|STARTED|Overall Study||5
195915|NCT00824291|469133|P2|NOT COMPLETED|Overall Study||35
195916|NCT00824291|469134|P1|NOT COMPLETED|Overall Study||54
195917|NCT00824291|469133|P2|COMPLETED|Overall Study||107
195918|NCT00824291|469134|P1|COMPLETED|Overall Study||231
195919|NCT00824291|469133|P2|STARTED|Overall Study||142
195920|NCT00824291|469134|P1|STARTED|Overall Study||285
195921|NCT00824265|469156|P2|NOT COMPLETED|Overall Study||80
195922|NCT00824265|469157|P1|NOT COMPLETED|Overall Study||64
195923|NCT00824265|469156|P2|COMPLETED|Overall Study||102
195924|NCT00824265|469157|P1|COMPLETED|Overall Study||119
195925|NCT00824265|469156|P2|STARTED|Overall Study||182
195926|NCT00824265|469157|P1|STARTED|Overall Study||183
195927|NCT00824161|469216|P1|NOT COMPLETED|Overall Study||2
195928|NCT00824161|469216|P1|COMPLETED|Overall Study||26
195929|NCT00824161|469216|P1|STARTED|Overall Study||28
195930|NCT00824070|469225|P3|NOT COMPLETED|Overall Study||0
195931|NCT00824070|469226|P2|NOT COMPLETED|Overall Study||0
195932|NCT00824070|469227|P1|NOT COMPLETED|Overall Study||0
195933|NCT00824070|469225|P3|COMPLETED|Overall Study||36
195934|NCT00824070|469226|P2|COMPLETED|Overall Study||35
195935|NCT00824070|469227|P1|COMPLETED|Overall Study||34
195936|NCT00824070|469225|P3|STARTED|Overall Study||36
195937|NCT00824070|469226|P2|STARTED|Overall Study||35
195938|NCT00824070|469227|P1|STARTED|Overall Study||34
195939|NCT00824044|469237|P2|NOT COMPLETED|Overall Study||6
195940|NCT00824044|469238|P1|NOT COMPLETED|Overall Study||9
195941|NCT00824044|469237|P2|COMPLETED|Overall Study||10
195942|NCT00824044|469238|P1|COMPLETED|Overall Study||14
195943|NCT00824044|469237|P2|STARTED|Overall Study||16
195944|NCT00824044|469238|P1|STARTED|Overall Study||23
195945|NCT00824005|469282|P2|NOT COMPLETED|Overall Study||2
195946|NCT00824005|469283|P1|NOT COMPLETED|Overall Study||0
195947|NCT00824005|469282|P2|COMPLETED|Overall Study||59
195948|NCT00824005|469283|P1|COMPLETED|Overall Study||31
195949|NCT00824005|469282|P2|STARTED|Overall Study||61
195950|NCT00824005|469283|P1|STARTED|Overall Study||31
195951|NCT00823979|469318|P3|NOT COMPLETED|Overall Study||24
195952|NCT00823979|469319|P2|NOT COMPLETED|Overall Study||32
195953|NCT00823979|469320|P1|NOT COMPLETED|Overall Study||29
195954|NCT00823979|469318|P3|COMPLETED|Overall Study||11
195955|NCT00823979|469319|P2|COMPLETED|Overall Study||3
195956|NCT00823979|469320|P1|COMPLETED|Overall Study||6
195957|NCT00823979|469318|P3|Treated|Overall Study||34
195958|NCT00823979|469319|P2|Treated|Overall Study||32
195959|NCT00823979|469320|P1|Treated|Overall Study||31
195960|NCT00823979|469318|P3|STARTED|Overall Study||35
195961|NCT00823979|469319|P2|STARTED|Overall Study||35
195962|NCT00823979|469320|P1|STARTED|Overall Study||35
195963|NCT00823966|469358|P1|NOT COMPLETED|Overall Study||0
195964|NCT00823966|469358|P1|COMPLETED|Overall Study||3
195965|NCT00823966|469358|P1|STARTED|Overall Study||3
195966|NCT00823901|469365|P2|NOT COMPLETED|Overall Study||2
195967|NCT00823901|469366|P1|NOT COMPLETED|Overall Study||4
195968|NCT00823901|469365|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
195969|NCT00823901|469366|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
195970|NCT00823901|469365|P2|STARTED|Overall Study|Randomized to placebo gel|40
195971|NCT00823901|469366|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
195972|NCT00823836|469374|P2|NOT COMPLETED|Long-term Phase||5
195973|NCT00823836|469375|P1|NOT COMPLETED|Long-term Phase||5
195974|NCT00823836|469374|P2|COMPLETED|Long-term Phase||79
195975|NCT00823836|469375|P1|COMPLETED|Long-term Phase||68
195976|NCT00823836|469374|P2|STARTED|Long-term Phase||84
195977|NCT00823836|469375|P1|STARTED|Long-term Phase||73
195978|NCT00823836|469374|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
195979|NCT00823836|469375|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
195980|NCT00823836|469374|P2|COMPLETED|NV and PR/XR Switching Phases||117
195981|NCT00823836|469375|P1|COMPLETED|NV and PR/XR Switching Phases||124
195982|NCT00823836|469374|P2|STARTED|NV and PR/XR Switching Phases||146
195983|NCT00823836|469375|P1|STARTED|NV and PR/XR Switching Phases||156
195984|NCT00823823|469481|P2|NOT COMPLETED|Overall Study||6
195985|NCT00823823|469482|P1|NOT COMPLETED|Overall Study||8
195986|NCT00823823|469481|P2|COMPLETED|Overall Study||101
195987|NCT00823823|469482|P1|COMPLETED|Overall Study||101
195988|NCT00823823|469481|P2|STARTED|Overall Study||107
195989|NCT00823823|469482|P1|STARTED|Overall Study||109
195990|NCT00823797|469492|P2|NOT COMPLETED|Overall Study||0
195991|NCT00823797|469493|P1|NOT COMPLETED|Overall Study||0
195992|NCT00823797|469492|P2|COMPLETED|Overall Study||16
195993|NCT00823797|469493|P1|COMPLETED|Overall Study||29
195994|NCT00823797|469492|P2|STARTED|Overall Study||16
195995|NCT00823797|469493|P1|STARTED|Overall Study||29
195996|NCT00823719|469506|P2|NOT COMPLETED|Overall Study||11
195997|NCT00823719|469507|P1|NOT COMPLETED|Overall Study||6
195998|NCT00823719|469506|P2|COMPLETED|Overall Study||24
195999|NCT00823719|469507|P1|COMPLETED|Overall Study||20
196000|NCT00823719|469506|P2|STARTED|Overall Study||35
196001|NCT00823719|469507|P1|STARTED|Overall Study||26
196002|NCT00823615|469560|P2|NOT COMPLETED|Period 2||2
196003|NCT00823615|469561|P1|NOT COMPLETED|Period 2||3
196004|NCT00823615|469560|P2|COMPLETED|Period 2||17
196005|NCT00823615|469561|P1|COMPLETED|Period 2||16
196006|NCT00823615|469560|P2|STARTED|Period 2||19
196007|NCT00823615|469561|P1|STARTED|Period 2||19
196008|NCT00823615|469560|P2|NOT COMPLETED|Period 1||0
196009|NCT00823615|469561|P1|NOT COMPLETED|Period 1||0
196010|NCT00823615|469560|P2|COMPLETED|Period 1||19
196011|NCT00823615|469561|P1|COMPLETED|Period 1||19
196012|NCT00823615|469560|P2|STARTED|Period 1||19
196013|NCT00823615|469561|P1|STARTED|Period 1||19
196014|NCT00823472|469571|P2|NOT COMPLETED|Overall Study||28
196015|NCT00823472|469572|P1|NOT COMPLETED|Overall Study||24
196016|NCT00823472|469571|P2|COMPLETED|Overall Study||39
196017|NCT00823472|469572|P1|COMPLETED|Overall Study||56
196018|NCT00823472|469571|P2|STARTED|Overall Study||67
196019|NCT00823472|469572|P1|STARTED|Overall Study||80
196020|NCT00823303|469582|P2|NOT COMPLETED|Overall Study||11
196021|NCT00823303|469583|P1|NOT COMPLETED|Overall Study||9
196022|NCT00823303|469582|P2|COMPLETED|Overall Study||45
196023|NCT00823303|469583|P1|COMPLETED|Overall Study||45
196024|NCT00823303|469582|P2|STARTED|Overall Study||56
196025|NCT00823303|469583|P1|STARTED|Overall Study||54
196026|NCT00823264|469591|P2|NOT COMPLETED|Overall Study||0
196027|NCT00823264|469592|P1|NOT COMPLETED|Overall Study||2
196028|NCT00823264|469591|P2|COMPLETED|Overall Study||7
196029|NCT00823264|469592|P1|COMPLETED|Overall Study||8
196030|NCT00823264|469591|P2|STARTED|Overall Study||7
196031|NCT00823264|469592|P1|STARTED|Overall Study||10
196032|NCT00823212|469600|P2|NOT COMPLETED|Overall Study||33
196033|NCT00823212|469601|P1|NOT COMPLETED|Overall Study||35
196034|NCT00823212|469600|P2|COMPLETED|Overall Study|12-month follow-up|735
196035|NCT00823212|469601|P1|COMPLETED|Overall Study|12-month follow-up|727
196036|NCT00823212|469600|P2|STARTED|Overall Study||768
196037|NCT00823212|469601|P1|STARTED|Overall Study||762
196038|NCT00823199|469683|P1|NOT COMPLETED|Overall Study||2
196039|NCT00823199|469683|P1|COMPLETED|Overall Study||8
196040|NCT00823199|469683|P1|STARTED|Overall Study||10
196041|NCT00823095|469689|P1|NOT COMPLETED|Overall Study||0
196042|NCT00823095|469689|P1|COMPLETED|Overall Study||7
196043|NCT00823095|469689|P1|STARTED|Overall Study||7
196044|NCT00823082|469696|P2|NOT COMPLETED|Overall Study||1
196045|NCT00823082|469697|P1|NOT COMPLETED|Overall Study||0
196046|NCT00823082|469696|P2|COMPLETED|Overall Study||99
196047|NCT00823082|469697|P1|COMPLETED|Overall Study||100
196048|NCT00823082|469696|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
196049|NCT00823082|469697|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
196050|NCT00823082|469696|P2|Safety Population|Overall Study||99
196051|NCT00823082|469697|P1|Safety Population|Overall Study||100
196052|NCT00823082|469696|P2|STARTED|Overall Study||100
196053|NCT00823082|469697|P1|STARTED|Overall Study||100
196054|NCT00823069|469731|P1|NOT COMPLETED|Overall Study||0
196055|NCT00823069|469731|P1|COMPLETED|Overall Study||60
196056|NCT00823069|469731|P1|STARTED|Overall Study||60
196057|NCT00823043|469738|P2|NOT COMPLETED|Overall Study||0
196058|NCT00823043|469739|P1|NOT COMPLETED|Overall Study||0
196059|NCT00823043|469738|P2|COMPLETED|Overall Study||39
196060|NCT00823043|469739|P1|COMPLETED|Overall Study||64
196061|NCT00823043|469738|P2|STARTED|Overall Study||39
196062|NCT00823043|469739|P1|STARTED|Overall Study||64
196063|NCT00822926|469752|P2|NOT COMPLETED|Second Injection Visit||1
196064|NCT00822926|469753|P1|NOT COMPLETED|Second Injection Visit||1
196065|NCT00822926|469752|P2|COMPLETED|Second Injection Visit||2
196066|NCT00822926|469753|P1|COMPLETED|Second Injection Visit||1
196067|NCT00822926|469752|P2|STARTED|Second Injection Visit||3
196068|NCT00822926|469753|P1|STARTED|Second Injection Visit||2
196069|NCT00822926|469752|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
196070|NCT00822926|469753|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
196071|NCT00822926|469752|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
196072|NCT00822926|469753|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
196073|NCT00822926|469752|P2|STARTED|Washout (Varies Based on Scheduling)||3
196074|NCT00822926|469753|P1|STARTED|Washout (Varies Based on Scheduling)||2
196075|NCT00822926|469752|P2|NOT COMPLETED|First Injection Visit||0
196076|NCT00822926|469753|P1|NOT COMPLETED|First Injection Visit||0
196077|NCT00822926|469752|P2|COMPLETED|First Injection Visit||3
196078|NCT00822926|469753|P1|COMPLETED|First Injection Visit||2
196079|NCT00822926|469752|P2|STARTED|First Injection Visit||3
196080|NCT00822926|469753|P1|STARTED|First Injection Visit||2
196081|NCT00822900|469767|P2|NOT COMPLETED|Overall Study||93
196082|NCT00822900|469768|P1|NOT COMPLETED|Overall Study||108
196083|NCT00822900|469767|P2|COMPLETED|Overall Study||347
196084|NCT00822900|469768|P1|COMPLETED|Overall Study||334
196085|NCT00822900|469767|P2|STARTED|Overall Study||440
196086|NCT00822900|469768|P1|STARTED|Overall Study||442
196087|NCT00822770|469796|P1|NOT COMPLETED|Overall Study||0
196088|NCT00822770|469796|P1|COMPLETED|Overall Study||47
196089|NCT00822770|469796|P1|STARTED|Overall Study||47
196090|NCT00822757|469802|P2|NOT COMPLETED|Overall Study||0
196091|NCT00822757|469803|P1|NOT COMPLETED|Overall Study||0
196092|NCT00822757|469802|P2|COMPLETED|Overall Study||10
196093|NCT00822757|469803|P1|COMPLETED|Overall Study||41
196094|NCT00822757|469802|P2|STARTED|Overall Study||10
196095|NCT00822757|469803|P1|STARTED|Overall Study||41
196096|NCT00822692|469815|P2|NOT COMPLETED|Overall Study||25
196097|NCT00822692|469816|P1|NOT COMPLETED|Overall Study||17
196098|NCT00822692|469815|P2|COMPLETED|Overall Study|June 1 , 2009|51
196099|NCT00822692|469816|P1|COMPLETED|Overall Study|June 1, 2009|46
196100|NCT00822692|469815|P2|STARTED|Overall Study|July 1, 2008|76
196101|NCT00822692|469816|P1|STARTED|Overall Study|July 1, 2008|63
196102|NCT00822679|469824|P2|NOT COMPLETED|Overall Study||0
196103|NCT00822679|469825|P1|NOT COMPLETED|Overall Study||0
196104|NCT00822679|469824|P2|COMPLETED|Overall Study||0
196105|NCT00822679|469825|P1|COMPLETED|Overall Study||0
196106|NCT00822679|469824|P2|STARTED|Overall Study||0
196107|NCT00822679|469825|P1|STARTED|Overall Study||0
196108|NCT00822588|469833|P2|NOT COMPLETED|Overall Study||4
196109|NCT00822588|469834|P1|NOT COMPLETED|Overall Study||7
196110|NCT00822588|469833|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
196111|NCT00822588|469834|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
196112|NCT00822588|469833|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
196113|NCT00822588|469834|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
196114|NCT00822523|469843|P3|NOT COMPLETED|Overall Study||0
196115|NCT00822523|469844|P2|NOT COMPLETED|Overall Study||0
196116|NCT00822523|469845|P1|NOT COMPLETED|Overall Study||0
196117|NCT00822523|469843|P3|COMPLETED|Overall Study||4
196118|NCT00822523|469844|P2|COMPLETED|Overall Study||4
196119|NCT00822523|469845|P1|COMPLETED|Overall Study||5
196120|NCT00822523|469843|P3|STARTED|Overall Study||4
196121|NCT00822523|469844|P2|STARTED|Overall Study||4
196122|NCT00822523|469845|P1|STARTED|Overall Study||5
196123|NCT00822510|469891|P2|NOT COMPLETED|Overall Study||5
196124|NCT00822510|469892|P1|NOT COMPLETED|Overall Study||3
196125|NCT00822510|469891|P2|COMPLETED|Overall Study||36
196126|NCT00822510|469892|P1|COMPLETED|Overall Study||35
196127|NCT00822510|469891|P2|STARTED|Overall Study||41
196128|NCT00822510|469892|P1|STARTED|Overall Study||38
196129|NCT00822354|469912|P2|NOT COMPLETED|Second Intervention (28 Days)||0
196130|NCT00822354|469913|P1|NOT COMPLETED|Second Intervention (28 Days)||1
196131|NCT00822354|469912|P2|COMPLETED|Second Intervention (28 Days)||5
196132|NCT00822354|469913|P1|COMPLETED|Second Intervention (28 Days)||3
196133|NCT00822354|469912|P2|STARTED|Second Intervention (28 Days)||5
196134|NCT00822354|469913|P1|STARTED|Second Intervention (28 Days)||4
196135|NCT00822354|469912|P2|NOT COMPLETED|Washout (7 Days)||0
196136|NCT00822354|469913|P1|NOT COMPLETED|Washout (7 Days)||0
196137|NCT00822354|469912|P2|COMPLETED|Washout (7 Days)||5
196138|NCT00822354|469913|P1|COMPLETED|Washout (7 Days)||4
196139|NCT00822354|469912|P2|STARTED|Washout (7 Days)||5
196140|NCT00822354|469913|P1|STARTED|Washout (7 Days)||4
196141|NCT00822354|469912|P2|NOT COMPLETED|First Intervention (28 Days)||0
196142|NCT00822354|469913|P1|NOT COMPLETED|First Intervention (28 Days)||1
196143|NCT00822354|469912|P2|COMPLETED|First Intervention (28 Days)||5
196144|NCT00822354|469913|P1|COMPLETED|First Intervention (28 Days)||4
196145|NCT00822354|469912|P2|STARTED|First Intervention (28 Days)||5
196146|NCT00822354|469913|P1|STARTED|First Intervention (28 Days)||5
196147|NCT00822328|469943|P2|NOT COMPLETED|Overall Study||0
196148|NCT00822328|469944|P1|NOT COMPLETED|Overall Study||0
196149|NCT00822328|469943|P2|COMPLETED|Overall Study||12
196150|NCT00822328|469944|P1|COMPLETED|Overall Study||12
196151|NCT00822328|469943|P2|STARTED|Overall Study||12
196152|NCT00822328|469944|P1|STARTED|Overall Study||12
196153|NCT00822237|469954|P2|NOT COMPLETED|Dose 2 Vaccination||11
196154|NCT00822237|469955|P1|NOT COMPLETED|Dose 2 Vaccination||4
196155|NCT00822237|469954|P2|COMPLETED|Dose 2 Vaccination||262
196156|NCT00822237|469955|P1|COMPLETED|Dose 2 Vaccination||270
196157|NCT00822237|469954|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
196158|NCT00822237|469955|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
196159|NCT00822237|469954|P2|NOT COMPLETED|Dose 1 Vaccination||26
196160|NCT00822237|469955|P1|NOT COMPLETED|Dose 1 Vaccination||25
196161|NCT00822237|469954|P2|COMPLETED|Dose 1 Vaccination||273
196162|NCT00822237|469955|P1|COMPLETED|Dose 1 Vaccination||274
196163|NCT00822237|469954|P2|STARTED|Dose 1 Vaccination|Number randomized|299
196164|NCT00822237|469955|P1|STARTED|Dose 1 Vaccination|Number randomized|299
196165|NCT00822185|469965|P5|NOT COMPLETED|Overall Study||0
196166|NCT00822185|469966|P4|NOT COMPLETED|Overall Study||0
196167|NCT00822185|469967|P3|NOT COMPLETED|Overall Study||0
196168|NCT00822185|469968|P2|NOT COMPLETED|Overall Study||0
196169|NCT00822185|469969|P1|NOT COMPLETED|Overall Study||0
196170|NCT00822185|469965|P5|COMPLETED|Overall Study||8
196171|NCT00822185|469966|P4|COMPLETED|Overall Study||6
196172|NCT00822185|469967|P3|COMPLETED|Overall Study||6
196173|NCT00822185|469968|P2|COMPLETED|Overall Study||6
196174|NCT00822185|469969|P1|COMPLETED|Overall Study||6
196175|NCT00822185|469965|P5|STARTED|Overall Study||8
196176|NCT00822185|469966|P4|STARTED|Overall Study||6
196177|NCT00822185|469967|P3|STARTED|Overall Study||6
196178|NCT00822185|469968|P2|STARTED|Overall Study||6
196179|NCT00822185|469969|P1|STARTED|Overall Study||6
196180|NCT00822172|470036|P2|NOT COMPLETED|Overall Study||19
196181|NCT00822172|470037|P1|NOT COMPLETED|Overall Study||15
196182|NCT00822172|470036|P2|COMPLETED|Overall Study||64
196183|NCT00822172|470037|P1|COMPLETED|Overall Study||65
196184|NCT00822172|470036|P2|STARTED|Overall Study||83
196185|NCT00822172|470037|P1|STARTED|Overall Study||80
196186|NCT00822120|470045|P6|NOT COMPLETED|PET-directed Therapy||0
196187|NCT00822120|470046|P5|NOT COMPLETED|PET-directed Therapy||0
196188|NCT00822120|470047|P4|NOT COMPLETED|PET-directed Therapy||10
196189|NCT00822120|470048|P3|NOT COMPLETED|PET-directed Therapy||0
196190|NCT00822120|470049|P2|NOT COMPLETED|PET-directed Therapy||0
196191|NCT00822120|470050|P1|NOT COMPLETED|PET-directed Therapy||0
196192|NCT00822120|470045|P6|COMPLETED|PET-directed Therapy||1
196193|NCT00822120|470046|P5|COMPLETED|PET-directed Therapy||10
196194|NCT00822120|470047|P4|COMPLETED|PET-directed Therapy||45
196195|NCT00822120|470048|P3|COMPLETED|PET-directed Therapy||270
196196|NCT00822120|470049|P2|COMPLETED|PET-directed Therapy||0
196197|NCT00822120|470050|P1|COMPLETED|PET-directed Therapy||0
196198|NCT00822120|470045|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
196199|NCT00822120|470046|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
196200|NCT00822120|470047|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
196201|NCT00822120|470048|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
196202|NCT00822120|470049|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
196203|NCT00822120|470050|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
196204|NCT00822120|470045|P6|STARTED|PET-directed Therapy||1
196205|NCT00822120|470046|P5|STARTED|PET-directed Therapy||10
196206|NCT00822120|470047|P4|STARTED|PET-directed Therapy||55
196207|NCT00822120|470048|P3|STARTED|PET-directed Therapy||270
196208|NCT00822120|470049|P2|STARTED|PET-directed Therapy||0
196209|NCT00822120|470050|P1|STARTED|PET-directed Therapy||0
196210|NCT00822120|470045|P6|NOT COMPLETED|Initial Registration||0
196211|NCT00822120|470046|P5|NOT COMPLETED|Initial Registration||0
196212|NCT00822120|470047|P4|NOT COMPLETED|Initial Registration||0
196213|NCT00822120|470048|P3|NOT COMPLETED|Initial Registration||0
196214|NCT00822120|470049|P2|NOT COMPLETED|Initial Registration||1
196215|NCT00822120|470050|P1|NOT COMPLETED|Initial Registration||26
196216|NCT00822120|470045|P6|COMPLETED|Initial Registration||0
196217|NCT00822120|470046|P5|COMPLETED|Initial Registration||0
196218|NCT00822120|470047|P4|COMPLETED|Initial Registration||0
196219|NCT00822120|470048|P3|COMPLETED|Initial Registration||0
196220|NCT00822120|470049|P2|COMPLETED|Initial Registration||12
196221|NCT00822120|470050|P1|COMPLETED|Initial Registration||332
196222|NCT00822120|470045|P6|Eligible and Evaluable Patients|Initial Registration||0
196223|NCT00822120|470046|P5|Eligible and Evaluable Patients|Initial Registration||0
196224|NCT00822120|470047|P4|Eligible and Evaluable Patients|Initial Registration||0
196225|NCT00822120|470048|P3|Eligible and Evaluable Patients|Initial Registration||0
196226|NCT00822120|470049|P2|Eligible and Evaluable Patients|Initial Registration||12
196227|NCT00822120|470050|P1|Eligible and Evaluable Patients|Initial Registration||336
196228|NCT00822120|470045|P6|STARTED|Initial Registration||0
196229|NCT00822120|470046|P5|STARTED|Initial Registration||0
196230|NCT00822120|470047|P4|STARTED|Initial Registration||0
196231|NCT00822120|470048|P3|STARTED|Initial Registration||0
196232|NCT00822120|470049|P2|STARTED|Initial Registration||13
196233|NCT00822120|470050|P1|STARTED|Initial Registration||358
196234|NCT00822094|470075|P2|NOT COMPLETED|Overall Study||25
196235|NCT00822094|470076|P1|NOT COMPLETED|Overall Study||44
196236|NCT00822094|470075|P2|COMPLETED|Overall Study||20
196237|NCT00822094|470076|P1|COMPLETED|Overall Study||37
196238|NCT00822094|470075|P2|STARTED|Overall Study||45
196239|NCT00822094|470076|P1|STARTED|Overall Study||81
196240|NCT00821964|470092|P1|NOT COMPLETED|Overall Study||6
196241|NCT00821964|470092|P1|COMPLETED|Overall Study||9
196242|NCT00821964|470092|P1|Evaluable for Pathologic Response|Overall Study||7
196243|NCT00821964|470092|P1|Evaluable for Clinical Response|Overall Study||14
196244|NCT00821964|470092|P1|STARTED|Overall Study||15
196245|NCT00821951|470101|P1|NOT COMPLETED|Overall Study||5
196246|NCT00821951|470101|P1|COMPLETED|Overall Study||12
196247|NCT00821951|470101|P1|STARTED|Overall Study||17
196248|NCT00821886|470105|P1|NOT COMPLETED|Overall Study||9
196249|NCT00821886|470105|P1|COMPLETED|Overall Study||49
196250|NCT00821886|470105|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
196251|NCT00821873|470112|P1|NOT COMPLETED|Overall Study||4
196252|NCT00821873|470112|P1|COMPLETED|Overall Study||5
196253|NCT00821873|470112|P1|STARTED|Overall Study||9
196254|NCT00821821|470119|P3|NOT COMPLETED|Overall Study||0
196255|NCT00821821|470120|P2|NOT COMPLETED|Overall Study||0
196256|NCT00821821|470121|P1|NOT COMPLETED|Overall Study||0
196257|NCT00821821|470119|P3|COMPLETED|Overall Study||11
196258|NCT00821821|470120|P2|COMPLETED|Overall Study||13
196259|NCT00821821|470121|P1|COMPLETED|Overall Study||12
196260|NCT00821821|470119|P3|STARTED|Overall Study||11
196261|NCT00821821|470120|P2|STARTED|Overall Study||13
196262|NCT00821821|470121|P1|STARTED|Overall Study||12
196263|NCT00821678|470133|P2|NOT COMPLETED|Overall Study||14
196264|NCT00821678|470134|P1|NOT COMPLETED|Overall Study||21
196265|NCT00821678|470133|P2|COMPLETED|Overall Study||118
196266|NCT00821678|470134|P1|COMPLETED|Overall Study||112
196267|NCT00821678|470133|P2|STARTED|Overall Study||132
196268|NCT00821678|470134|P1|STARTED|Overall Study||133
196269|NCT00821587|470152|P2|NOT COMPLETED|Overall Study||1
196270|NCT00821587|470153|P1|NOT COMPLETED|Overall Study||0
196271|NCT00821587|470152|P2|COMPLETED|Overall Study||18
196272|NCT00821587|470153|P1|COMPLETED|Overall Study||20
196273|NCT00821587|470152|P2|STARTED|Overall Study||19
196274|NCT00821587|470153|P1|STARTED|Overall Study||20
196275|NCT00821509|470162|P3|NOT COMPLETED|Overall Study||34
196276|NCT00821509|470163|P2|NOT COMPLETED|Overall Study||11
196277|NCT00821509|470164|P1|NOT COMPLETED|Overall Study||12
196278|NCT00821509|470162|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
196279|NCT00821509|470163|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
196280|NCT00821509|470164|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
196281|NCT00821509|470162|P3|STARTED|Overall Study||224
196282|NCT00821509|470163|P2|STARTED|Overall Study||202
196283|NCT00821509|470164|P1|STARTED|Overall Study||257
196284|NCT00821431|470177|P2|NOT COMPLETED|Overall Study||5
196285|NCT00821431|470178|P1|NOT COMPLETED|Overall Study||15
196286|NCT00821431|470177|P2|COMPLETED|Overall Study||47
196287|NCT00821431|470178|P1|COMPLETED|Overall Study||23
196288|NCT00821431|470177|P2|STARTED|Overall Study||52
196289|NCT00821431|470178|P1|STARTED|Overall Study||38
196290|NCT00821327|470186|P1|NOT COMPLETED|Overall Study||35
196291|NCT00821327|470186|P1|COMPLETED|Overall Study||1
196292|NCT00821327|470186|P1|STARTED|Overall Study||36
196293|NCT00821236|470195|P1|NOT COMPLETED|Overall Study||3
196294|NCT00821236|470195|P1|COMPLETED|Overall Study||37
196295|NCT00821236|470195|P1|STARTED|Overall Study||40
196296|NCT00821184|470211|P2|NOT COMPLETED|Overall Study||0
196297|NCT00821184|470212|P1|NOT COMPLETED|Overall Study||0
196298|NCT00821184|470211|P2|COMPLETED|Overall Study||6
196299|NCT00821184|470212|P1|COMPLETED|Overall Study||6
196300|NCT00821184|470211|P2|STARTED|Overall Study||6
196301|NCT00821184|470212|P1|STARTED|Overall Study||6
196302|NCT00821119|470222|P2|NOT COMPLETED|Overall Study||0
196303|NCT00821119|470223|P1|NOT COMPLETED|Overall Study||0
196304|NCT00821119|470222|P2|COMPLETED|Overall Study||100
196305|NCT00821119|470223|P1|COMPLETED|Overall Study||100
196306|NCT00821119|470222|P2|STARTED|Overall Study||100
196307|NCT00821119|470223|P1|STARTED|Overall Study||100
196308|NCT00821093|470235|P2|NOT COMPLETED|Overall Study||40
196309|NCT00821093|470236|P1|NOT COMPLETED|Overall Study||49
196310|NCT00821093|470235|P2|COMPLETED|Overall Study||523
196311|NCT00821093|470236|P1|COMPLETED|Overall Study||511
196312|NCT00821093|470235|P2|Exposed to Drug|Overall Study||562
196313|NCT00821093|470236|P1|Exposed to Drug|Overall Study||559
196314|NCT00821093|470235|P2|STARTED|Overall Study||563
196315|NCT00821093|470236|P1|STARTED|Overall Study||560
196316|NCT00821041|470246|P2|NOT COMPLETED|Overall Study||0
196317|NCT00821041|470247|P1|NOT COMPLETED|Overall Study||0
196318|NCT00821041|470246|P2|COMPLETED|Overall Study||59
196319|NCT00821041|470247|P1|COMPLETED|Overall Study||59
196320|NCT00821041|470246|P2|STARTED|Overall Study||59
196321|NCT00821041|470247|P1|STARTED|Overall Study||59
196322|NCT00820898|470255|P1|NOT COMPLETED|Overall Study||1
196323|NCT00820898|470255|P1|COMPLETED|Overall Study||23
196324|NCT00820898|470255|P1|STARTED|Overall Study||24
196325|NCT00820872|470265|P1|NOT COMPLETED|Overall Study||0
196326|NCT00820872|470265|P1|COMPLETED|Overall Study||30
196327|NCT00820872|470265|P1|STARTED|Overall Study||30
196328|NCT00820755|470269|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
196329|NCT00820755|470270|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
196330|NCT00820755|470271|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
196331|NCT00820755|470269|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
196332|NCT00820755|470270|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
196333|NCT00820755|470271|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
196334|NCT00820755|470269|P3|STARTED|Period 2: Maintenance Therapy Phase||154
196335|NCT00820755|470270|P2|STARTED|Period 2: Maintenance Therapy Phase||157
196336|NCT00820755|470271|P1|STARTED|Period 2: Maintenance Therapy Phase||0
196337|NCT00820755|470269|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
196338|NCT00820755|470270|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
196339|NCT00820755|470271|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
196340|NCT00820755|470269|P3|COMPLETED|Period 1: Combination Therapy Phase||0
196341|NCT00820755|470270|P2|COMPLETED|Period 1: Combination Therapy Phase||0
196342|NCT00820755|470271|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
196343|NCT00820755|470269|P3|STARTED|Period 1: Combination Therapy Phase||0
196344|NCT00820755|470270|P2|STARTED|Period 1: Combination Therapy Phase||0
196345|NCT00820755|470271|P1|STARTED|Period 1: Combination Therapy Phase||583
196346|NCT00820664|470295|P3|NOT COMPLETED|Overall Study||0
196347|NCT00820664|470296|P2|NOT COMPLETED|Overall Study||0
196348|NCT00820664|470297|P1|NOT COMPLETED|Overall Study||0
196349|NCT00820664|470295|P3|COMPLETED|Overall Study||9
196350|NCT00820664|470296|P2|COMPLETED|Overall Study||11
196351|NCT00820664|470297|P1|COMPLETED|Overall Study||9
196352|NCT00820664|470295|P3|STARTED|Overall Study||9
196353|NCT00820664|470296|P2|STARTED|Overall Study||11
196354|NCT00820664|470297|P1|STARTED|Overall Study||9
196355|NCT00820612|470307|P2|NOT COMPLETED|Overall Study||0
196356|NCT00820612|470308|P1|NOT COMPLETED|Overall Study||0
196357|NCT00820612|470307|P2|COMPLETED|Overall Study||295
196358|NCT00820612|470308|P1|COMPLETED|Overall Study||307
196359|NCT00820612|470307|P2|STARTED|Overall Study||295
196360|NCT00820612|470308|P1|STARTED|Overall Study||307
196361|NCT00820573|470318|P4|NOT COMPLETED|Overall Study||0
196362|NCT00820573|470319|P3|NOT COMPLETED|Overall Study||0
196363|NCT00820573|470320|P2|NOT COMPLETED|Overall Study||0
196364|NCT00820573|470321|P1|NOT COMPLETED|Overall Study||0
196365|NCT00820573|470318|P4|COMPLETED|Overall Study||4
196366|NCT00820573|470319|P3|COMPLETED|Overall Study||4
196367|NCT00820573|470320|P2|COMPLETED|Overall Study||4
196368|NCT00820573|470321|P1|COMPLETED|Overall Study||4
196369|NCT00820573|470318|P4|STARTED|Overall Study||4
196370|NCT00820573|470319|P3|STARTED|Overall Study||4
196371|NCT00820573|470320|P2|STARTED|Overall Study||4
196372|NCT00820573|470321|P1|STARTED|Overall Study||4
196373|NCT00820534|470345|P2|NOT COMPLETED|Overall Study||0
196374|NCT00820534|470346|P1|NOT COMPLETED|Overall Study||0
196375|NCT00820534|470345|P2|COMPLETED|Overall Study||62
196376|NCT00820534|470346|P1|COMPLETED|Overall Study||64
196377|NCT00820534|470345|P2|STARTED|Overall Study||62
196378|NCT00820534|470346|P1|STARTED|Overall Study||64
196379|NCT00820443|470354|P1|NOT COMPLETED|24 Month||43
196380|NCT00820443|470354|P1|COMPLETED|24 Month||202
196381|NCT00820443|470354|P1|STARTED|24 Month||245
196382|NCT00820443|470354|P1|NOT COMPLETED|12 Month||24
196383|NCT00820443|470354|P1|COMPLETED|12 Month||226
196384|NCT00820443|470354|P1|STARTED|12 Month||250
196385|NCT00820443|470354|P1|NOT COMPLETED|6 Month||20
196386|NCT00820443|470354|P1|COMPLETED|6 Month||233
196387|NCT00820443|470354|P1|STARTED|6 Month||253
196388|NCT00820443|470354|P1|NOT COMPLETED|3 Month||9
196389|NCT00820443|470354|P1|COMPLETED|3 Month||244
196390|NCT00820443|470354|P1|STARTED|3 Month||253
196391|NCT00820443|470354|P1|NOT COMPLETED|Immediately||5
196392|NCT00820443|470354|P1|COMPLETED|Immediately||248
196393|NCT00820443|470354|P1|STARTED|Immediately||253
196394|NCT00820443|470354|P1|NOT COMPLETED|Op||0
196395|NCT00820443|470354|P1|COMPLETED|Op||253
196396|NCT00820443|470354|P1|STARTED|Op||253
196397|NCT00820443|470354|P1|NOT COMPLETED|Pre-Op||0
196398|NCT00820443|470354|P1|COMPLETED|Pre-Op||253
196399|NCT00820443|470354|P1|STARTED|Pre-Op||253
196400|NCT00820248|470364|P2|NOT COMPLETED|Overall Study||1
196401|NCT00820248|470365|P1|NOT COMPLETED|Overall Study||4
196402|NCT00820248|470364|P2|COMPLETED|Overall Study||159
196403|NCT00820248|470365|P1|COMPLETED|Overall Study||156
196404|NCT00820248|470364|P2|Received Protocol Treatment|Overall Study||159
196405|NCT00820248|470365|P1|Received Protocol Treatment|Overall Study||156
196406|NCT00820248|470364|P2|STARTED|Overall Study||160
196407|NCT00820248|470365|P1|STARTED|Overall Study||160
196408|NCT00820222|470375|P2|NOT COMPLETED|Overall Study||211
196409|NCT00820222|470376|P1|NOT COMPLETED|Overall Study||201
196410|NCT00820222|470375|P2|COMPLETED|Overall Study||58
196411|NCT00820222|470376|P1|COMPLETED|Overall Study||70
196412|NCT00820222|470375|P2|Ongoing|Overall Study||191
196413|NCT00820222|470376|P1|Ongoing|Overall Study||185
196414|NCT00820222|470375|P2|STARTED|Overall Study||269
196415|NCT00820222|470376|P1|STARTED|Overall Study||271
196416|NCT00819910|470406|P4|NOT COMPLETED|Overall Study||1
196417|NCT00819910|470407|P3|NOT COMPLETED|Overall Study||3
196418|NCT00819910|470408|P2|NOT COMPLETED|Overall Study||1
196419|NCT00819910|470409|P1|NOT COMPLETED|Overall Study||2
196420|NCT00819910|470406|P4|COMPLETED|Overall Study||10
196421|NCT00819910|470407|P3|COMPLETED|Overall Study||7
196422|NCT00819910|470408|P2|COMPLETED|Overall Study||9
196423|NCT00819910|470409|P1|COMPLETED|Overall Study||8
196424|NCT00819910|470406|P4|STARTED|Overall Study||11
196425|NCT00819910|470407|P3|STARTED|Overall Study||10
196426|NCT00819910|470408|P2|STARTED|Overall Study||10
196427|NCT00819910|470409|P1|STARTED|Overall Study||10
196428|NCT00819832|470441|P6|NOT COMPLETED|Overall Study||0
196429|NCT00819832|470442|P5|NOT COMPLETED|Overall Study||0
196430|NCT00819832|470443|P4|NOT COMPLETED|Overall Study||0
196431|NCT00819832|470444|P3|NOT COMPLETED|Overall Study||0
196432|NCT00819832|470445|P2|NOT COMPLETED|Overall Study||0
196433|NCT00819832|470446|P1|NOT COMPLETED|Overall Study||3
196434|NCT00819832|470441|P6|COMPLETED|Overall Study||0
196435|NCT00819832|470442|P5|COMPLETED|Overall Study||0
196436|NCT00819832|470443|P4|COMPLETED|Overall Study||0
196437|NCT00819832|470444|P3|COMPLETED|Overall Study||0
196438|NCT00819832|470445|P2|COMPLETED|Overall Study||0
196439|NCT00819832|470446|P1|COMPLETED|Overall Study||0
196440|NCT00819832|470441|P6|STARTED|Overall Study||0
196441|NCT00819832|470442|P5|STARTED|Overall Study||0
196442|NCT00819832|470443|P4|STARTED|Overall Study||0
196443|NCT00819832|470444|P3|STARTED|Overall Study||0
196444|NCT00819832|470445|P2|STARTED|Overall Study||0
196445|NCT00819832|470446|P1|STARTED|Overall Study|No patient data analysis.|3
196446|NCT00819780|470462|P2|NOT COMPLETED|Overall Study||21
196447|NCT00819780|470463|P1|NOT COMPLETED|Overall Study||28
196448|NCT00819780|470462|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
196449|NCT00819780|470463|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
196450|NCT00819780|470462|P2|Received Study Treatment|Overall Study||139
196451|NCT00819780|470463|P1|Received Study Treatment|Overall Study||139
196452|NCT00819780|470462|P2|STARTED|Overall Study||143
196453|NCT00819780|470463|P1|STARTED|Overall Study||142
196454|NCT00819767|470497|P2|NOT COMPLETED|Overall Study||2
196455|NCT00819767|470498|P1|NOT COMPLETED|Overall Study||1
196456|NCT00819767|470497|P2|COMPLETED|Overall Study||33
196457|NCT00819767|470498|P1|COMPLETED|Overall Study||32
196458|NCT00819767|470497|P2|STARTED|Overall Study||35
196459|NCT00819767|470498|P1|STARTED|Overall Study||33
196460|NCT00819741|470510|P2|NOT COMPLETED|Overall Study||14
196461|NCT00819741|470511|P1|NOT COMPLETED|Overall Study||22
196462|NCT00819741|470510|P2|COMPLETED|Overall Study||201
196463|NCT00819741|470511|P1|COMPLETED|Overall Study||196
196464|NCT00819741|470510|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
196465|NCT00819741|470511|P1|Exposed to Drug|Overall Study||218
196466|NCT00819741|470510|P2|STARTED|Overall Study||215
196467|NCT00819741|470511|P1|STARTED|Overall Study||218
196468|NCT00819637|470548|P3|NOT COMPLETED|Overall Study||0
196469|NCT00819637|470549|P2|NOT COMPLETED|Overall Study||0
196470|NCT00819637|470550|P1|NOT COMPLETED|Overall Study||0
196471|NCT00819637|470548|P3|COMPLETED|Overall Study||0
196472|NCT00819637|470549|P2|COMPLETED|Overall Study||0
196473|NCT00819637|470550|P1|COMPLETED|Overall Study||2
196474|NCT00819637|470548|P3|STARTED|Overall Study||0
196475|NCT00819637|470549|P2|STARTED|Overall Study||0
196476|NCT00819637|470550|P1|STARTED|Overall Study||2
196477|NCT00819585|470565|P7|NOT COMPLETED|Overall Study||13
196478|NCT00819585|470566|P6|NOT COMPLETED|Overall Study||2
196479|NCT00819585|470567|P5|NOT COMPLETED|Overall Study||3
196480|NCT00819585|470568|P4|NOT COMPLETED|Overall Study||5
196481|NCT00819585|470569|P3|NOT COMPLETED|Overall Study||6
196482|NCT00819585|470570|P2|NOT COMPLETED|Overall Study||6
196483|NCT00819585|470571|P1|NOT COMPLETED|Overall Study||6
196484|NCT00819585|470565|P7|COMPLETED|Overall Study||95
196485|NCT00819585|470566|P6|COMPLETED|Overall Study||52
196486|NCT00819585|470567|P5|COMPLETED|Overall Study||50
196487|NCT00819585|470568|P4|COMPLETED|Overall Study||49
196488|NCT00819585|470569|P3|COMPLETED|Overall Study||48
196489|NCT00819585|470570|P2|COMPLETED|Overall Study||48
196490|NCT00819585|470571|P1|COMPLETED|Overall Study||49
196491|NCT00819585|470565|P7|Safety Population|Overall Study||108
196492|NCT00819585|470566|P6|Safety Population|Overall Study|A pt. who was randomized to repeated dose regimen, found as HIV +ve, didn't take any study drug.|53
196493|NCT00819585|470567|P5|Safety Population|Overall Study||53
196494|NCT00819585|470568|P4|Safety Population|Overall Study||54
196495|NCT00819585|470569|P3|Safety Population|Overall Study||54
196496|NCT00819585|470570|P2|Safety Population|Overall Study||54
196497|NCT00819585|470571|P1|Safety Population|Overall Study||55
196498|NCT00819585|470565|P7|STARTED|Overall Study||108
196499|NCT00819585|470566|P6|STARTED|Overall Study||54
196500|NCT00819585|470567|P5|STARTED|Overall Study||53
196501|NCT00819585|470568|P4|STARTED|Overall Study||54
196502|NCT00819585|470569|P3|STARTED|Overall Study||54
196503|NCT00819585|470570|P2|STARTED|Overall Study||54
196504|NCT00819585|470571|P1|STARTED|Overall Study|"Started indicates randomized as well as full analysis set."|55
196505|NCT00819507|470628|P1|NOT COMPLETED|Overall Study||0
196506|NCT00819507|470628|P1|COMPLETED|Overall Study||25
196507|NCT00819507|470628|P1|STARTED|Overall Study||25
196508|NCT00819403|470635|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
196509|NCT00819403|470636|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
196510|NCT00819403|470635|P2|COMPLETED|Second Intervention (6 Weeks)||8
196511|NCT00819403|470636|P1|COMPLETED|Second Intervention (6 Weeks)||7
196512|NCT00819403|470635|P2|STARTED|Second Intervention (6 Weeks)||8
196513|NCT00819403|470636|P1|STARTED|Second Intervention (6 Weeks)||7
196514|NCT00819403|470635|P2|NOT COMPLETED|Washout (14 Days)||0
196515|NCT00819403|470636|P1|NOT COMPLETED|Washout (14 Days)||0
196516|NCT00819403|470635|P2|COMPLETED|Washout (14 Days)||8
196517|NCT00819403|470636|P1|COMPLETED|Washout (14 Days)||7
196518|NCT00819403|470635|P2|STARTED|Washout (14 Days)||8
196519|NCT00819403|470636|P1|STARTED|Washout (14 Days)||7
196520|NCT00819403|470635|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
196521|NCT00819403|470636|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
196522|NCT00819403|470635|P2|COMPLETED|First Intervention (6 Weeks)||8
196523|NCT00819403|470636|P1|COMPLETED|First Intervention (6 Weeks)||7
196524|NCT00819403|470635|P2|STARTED|First Intervention (6 Weeks)||8
196525|NCT00819403|470636|P1|STARTED|First Intervention (6 Weeks)||7
196526|NCT00819390|470648|P4|NOT COMPLETED|Overall Study||0
196527|NCT00819390|470649|P3|NOT COMPLETED|Overall Study||1
196528|NCT00819390|470650|P2|NOT COMPLETED|Overall Study||1
196529|NCT00819390|470651|P1|NOT COMPLETED|Overall Study||3
196530|NCT00819390|470648|P4|COMPLETED|Overall Study||19
196531|NCT00819390|470649|P3|COMPLETED|Overall Study||17
196532|NCT00819390|470650|P2|COMPLETED|Overall Study||16
196533|NCT00819390|470651|P1|COMPLETED|Overall Study||13
196534|NCT00819390|470648|P4|STARTED|Overall Study||19
196535|NCT00819390|470649|P3|STARTED|Overall Study||18
196536|NCT00819390|470650|P2|STARTED|Overall Study||17
196537|NCT00819390|470651|P1|STARTED|Overall Study||16
196538|NCT00819286|470763|P2|NOT COMPLETED|Overall Study||25
196539|NCT00819286|470764|P1|NOT COMPLETED|Overall Study||14
196540|NCT00819286|470763|P2|COMPLETED|Overall Study||45
196541|NCT00819286|470764|P1|COMPLETED|Overall Study||56
196542|NCT00819286|470763|P2|STARTED|Overall Study||70
196543|NCT00819286|470764|P1|STARTED|Overall Study||70
196544|NCT00819260|470772|P1|NOT COMPLETED|Overall Study||0
196545|NCT00819260|470772|P1|COMPLETED|Overall Study||31
196546|NCT00819260|470772|P1|STARTED|Overall Study||31
196547|NCT00819247|470787|P3|NOT COMPLETED|Overall Study||14
196548|NCT00819247|470788|P2|NOT COMPLETED|Overall Study||16
196549|NCT00819247|470789|P1|NOT COMPLETED|Overall Study||11
196550|NCT00819247|470787|P3|COMPLETED|Overall Study||26
196551|NCT00819247|470788|P2|COMPLETED|Overall Study||30
196552|NCT00819247|470789|P1|COMPLETED|Overall Study||32
196553|NCT00819247|470787|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
196554|NCT00819247|470788|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
196555|NCT00819247|470789|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
196556|NCT00819247|470787|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
196557|NCT00819247|470788|P2|Intent-to-treat Population|Overall Study||46
196558|NCT00819247|470789|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
196559|NCT00819247|470787|P3|Randomized|Overall Study||40
196560|NCT00819247|470788|P2|Randomized|Overall Study||46
196561|NCT00819247|470789|P1|Randomized|Overall Study||43
196562|NCT00819247|470787|P3|STARTED|Overall Study||40
196563|NCT00819247|470788|P2|STARTED|Overall Study||46
196564|NCT00819247|470789|P1|STARTED|Overall Study||43
196565|NCT00819234|470815|P10|NOT COMPLETED|Overall Study||7
196566|NCT00819234|470816|P9|NOT COMPLETED|Overall Study||6
196567|NCT00819234|470817|P8|NOT COMPLETED|Overall Study||9
196568|NCT00819234|470818|P7|NOT COMPLETED|Overall Study||5
196569|NCT00819234|470819|P6|NOT COMPLETED|Overall Study||7
196570|NCT00819234|470820|P5|NOT COMPLETED|Overall Study||1
196571|NCT00819234|470821|P4|NOT COMPLETED|Overall Study||6
196572|NCT00819234|470822|P3|NOT COMPLETED|Overall Study||8
196573|NCT00819234|470823|P2|NOT COMPLETED|Overall Study||15
196574|NCT00819234|470824|P1|NOT COMPLETED|Overall Study||10
196575|NCT00819234|470815|P10|COMPLETED|Overall Study||30
196576|NCT00819234|470816|P9|COMPLETED|Overall Study||31
196577|NCT00819234|470817|P8|COMPLETED|Overall Study||20
196578|NCT00819234|470818|P7|COMPLETED|Overall Study||8
196579|NCT00819234|470819|P6|COMPLETED|Overall Study||7
196580|NCT00819234|470820|P5|COMPLETED|Overall Study||12
196581|NCT00819234|470821|P4|COMPLETED|Overall Study||22
196582|NCT00819234|470822|P3|COMPLETED|Overall Study||28
196583|NCT00819234|470823|P2|COMPLETED|Overall Study||20
196584|NCT00819234|470824|P1|COMPLETED|Overall Study||21
196585|NCT00819234|470815|P10|STARTED|Overall Study||37
196586|NCT00819234|470816|P9|STARTED|Overall Study||37
196587|NCT00819234|470817|P8|STARTED|Overall Study||29
196588|NCT00819234|470818|P7|STARTED|Overall Study||13
196589|NCT00819234|470819|P6|STARTED|Overall Study||14
196590|NCT00819234|470820|P5|STARTED|Overall Study||13
196591|NCT00819234|470821|P4|STARTED|Overall Study||28
196592|NCT00819234|470822|P3|STARTED|Overall Study||36
196593|NCT00819234|470823|P2|STARTED|Overall Study||35
196594|NCT00819234|470824|P1|STARTED|Overall Study||31
196595|NCT00819182|470985|P3|NOT COMPLETED|Overall Study||1
196596|NCT00819182|470986|P2|NOT COMPLETED|Overall Study||8
196597|NCT00819182|470987|P1|NOT COMPLETED|Overall Study||13
196598|NCT00819182|470985|P3|COMPLETED|Overall Study||43
196599|NCT00819182|470986|P2|COMPLETED|Overall Study||78
196600|NCT00819182|470987|P1|COMPLETED|Overall Study||75
196601|NCT00819182|470985|P3|Week 16 Visit|Overall Study||43
196602|NCT00819182|470986|P2|Week 16 Visit|Overall Study||78
196603|NCT00819182|470987|P1|Week 16 Visit|Overall Study||75
196604|NCT00819182|470985|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
196605|NCT00819182|470986|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
196606|NCT00819182|470987|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
196607|NCT00819156|471023|P6|NOT COMPLETED|Overall Study||8
196608|NCT00819156|471024|P5|NOT COMPLETED|Overall Study||6
196609|NCT00819156|471025|P4|NOT COMPLETED|Overall Study||2
196610|NCT00819156|471026|P3|NOT COMPLETED|Overall Study||6
196611|NCT00819156|471027|P2|NOT COMPLETED|Overall Study||10
196612|NCT00819156|471028|P1|NOT COMPLETED|Overall Study||10
196613|NCT00819156|471023|P6|COMPLETED|Overall Study||23
196614|NCT00819156|471024|P5|COMPLETED|Overall Study||27
196615|NCT00819156|471025|P4|COMPLETED|Overall Study||28
196616|NCT00819156|471026|P3|COMPLETED|Overall Study||26
196617|NCT00819156|471027|P2|COMPLETED|Overall Study||23
196618|NCT00819156|471028|P1|COMPLETED|Overall Study||20
196619|NCT00819156|471023|P6|Randomised and Treated (ITT Population)|Overall Study||30
196620|NCT00819156|471024|P5|Randomised and Treated (ITT Population)|Overall Study||33
196621|NCT00819156|471025|P4|Randomised and Treated (ITT Population)|Overall Study||30
196622|NCT00819156|471026|P3|Randomised and Treated (ITT Population)|Overall Study||32
196623|NCT00819156|471027|P2|Randomised and Treated (ITT Population)|Overall Study||32
196624|NCT00819156|471028|P1|Randomised and Treated (ITT Population)|Overall Study||30
196625|NCT00819156|471023|P6|STARTED|Overall Study||31
196626|NCT00819156|471024|P5|STARTED|Overall Study||33
196627|NCT00819156|471025|P4|STARTED|Overall Study||30
196628|NCT00819156|471026|P3|STARTED|Overall Study||32
196629|NCT00819156|471027|P2|STARTED|Overall Study||33
196630|NCT00819156|471028|P1|STARTED|Overall Study||30
196631|NCT00819091|471118|P2|NOT COMPLETED|Overall Study||10
196632|NCT00819091|471119|P1|NOT COMPLETED|Overall Study||7
196633|NCT00819091|471118|P2|COMPLETED|Overall Study||151
196634|NCT00819091|471119|P1|COMPLETED|Overall Study||77
196635|NCT00819091|471118|P2|STARTED|Overall Study||161
196636|NCT00819091|471119|P1|STARTED|Overall Study||84
196637|NCT00819052|471145|P2|NOT COMPLETED|Overall Study||14
196638|NCT00819052|471146|P1|NOT COMPLETED|Overall Study||6
196639|NCT00819052|471145|P2|COMPLETED|Overall Study||281
196640|NCT00819052|471146|P1|COMPLETED|Overall Study||142
196641|NCT00819052|471145|P2|STARTED|Overall Study||295
196642|NCT00819052|471146|P1|STARTED|Overall Study||148
196643|NCT00819039|471261|P3|NOT COMPLETED|Overall Study||1
196644|NCT00819039|471262|P2|NOT COMPLETED|Overall Study||0
196645|NCT00819039|471263|P1|NOT COMPLETED|Overall Study||2
196646|NCT00819039|471261|P3|COMPLETED|Overall Study||24
196647|NCT00819039|471262|P2|COMPLETED|Overall Study||27
196648|NCT00819039|471263|P1|COMPLETED|Overall Study||44
196649|NCT00819039|471261|P3|STARTED|Overall Study||25
196650|NCT00819039|471262|P2|STARTED|Overall Study||27
196651|NCT00819039|471263|P1|STARTED|Overall Study||46
196652|NCT00819013|471293|P4|NOT COMPLETED|Overall Study||4
196653|NCT00819013|471294|P3|NOT COMPLETED|Overall Study||5
196654|NCT00819013|471295|P2|NOT COMPLETED|Overall Study||1
196655|NCT00819013|471296|P1|NOT COMPLETED|Overall Study||3
196656|NCT00819013|471293|P4|COMPLETED|Overall Study||17
196657|NCT00819013|471294|P3|COMPLETED|Overall Study||16
196658|NCT00819013|471295|P2|COMPLETED|Overall Study||22
196659|NCT00819013|471296|P1|COMPLETED|Overall Study||19
196660|NCT00819013|471293|P4|STARTED|Overall Study||21
196661|NCT00819013|471294|P3|STARTED|Overall Study||21
196662|NCT00819013|471295|P2|STARTED|Overall Study||23
196663|NCT00819013|471296|P1|STARTED|Overall Study||22
196664|NCT00818961|471346|P1|NOT COMPLETED|Overall Study||0
196665|NCT00818961|471346|P1|COMPLETED|Overall Study||36
196666|NCT00818961|471346|P1|STARTED|Overall Study||36
196667|NCT00818883|471362|P2|NOT COMPLETED|Overall Study||46
196668|NCT00818883|471363|P1|NOT COMPLETED|Overall Study||51
196669|NCT00818883|471362|P2|COMPLETED|Overall Study||260
196670|NCT00818883|471363|P1|COMPLETED|Overall Study||252
196671|NCT00818883|471362|P2|STARTED|Overall Study||306
196672|NCT00818883|471363|P1|STARTED|Overall Study||303
196673|NCT00818805|471397|P2|NOT COMPLETED|Second Intervention||0
196674|NCT00818805|471398|P1|NOT COMPLETED|Second Intervention||0
196675|NCT00818805|471397|P2|COMPLETED|Second Intervention||25
196676|NCT00818805|471398|P1|COMPLETED|Second Intervention||25
196677|NCT00818805|471397|P2|STARTED|Second Intervention||25
196678|NCT00818805|471398|P1|STARTED|Second Intervention||25
196679|NCT00818805|471397|P2|NOT COMPLETED|First Intervention||0
196680|NCT00818805|471398|P1|NOT COMPLETED|First Intervention||0
196681|NCT00818805|471397|P2|COMPLETED|First Intervention||25
196682|NCT00818805|471398|P1|COMPLETED|First Intervention||25
196683|NCT00818805|471397|P2|STARTED|First Intervention||25
196684|NCT00818805|471398|P1|STARTED|First Intervention||25
196685|NCT00818779|471410|P2|NOT COMPLETED|Overall Study||1
196686|NCT00818779|471411|P1|NOT COMPLETED|Overall Study||6
196687|NCT00818779|471410|P2|COMPLETED|Overall Study||15
196688|NCT00818779|471411|P1|COMPLETED|Overall Study||16
196689|NCT00818779|471410|P2|STARTED|Overall Study||16
196690|NCT00818779|471411|P1|STARTED|Overall Study||22
196691|NCT00818766|471427|P2|NOT COMPLETED|Overall Study||10
196692|NCT00818766|471428|P1|NOT COMPLETED|Overall Study||15
196693|NCT00818766|471427|P2|COMPLETED|Overall Study||116
196694|NCT00818766|471428|P1|COMPLETED|Overall Study||110
196695|NCT00818766|471427|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
196696|NCT00818766|471428|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
196697|NCT00818766|471427|P2|Received Allocated Intervention|Overall Study||126
196698|NCT00818766|471428|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
196699|NCT00818766|471427|P2|STARTED|Overall Study||126
196700|NCT00818766|471428|P1|STARTED|Overall Study||125
196701|NCT00818753|471457|P3|NOT COMPLETED|Overall Study||1
196702|NCT00818753|471458|P2|NOT COMPLETED|Overall Study||0
196703|NCT00818753|471459|P1|NOT COMPLETED|Overall Study||3
196704|NCT00818753|471457|P3|COMPLETED|Overall Study||9
196705|NCT00818753|471458|P2|COMPLETED|Overall Study||21
196706|NCT00818753|471459|P1|COMPLETED|Overall Study||19
196707|NCT00818753|471457|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
196708|NCT00818753|471458|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
196709|NCT00818753|471459|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
196710|NCT00818662|471483|P4|NOT COMPLETED|Overall Study||16
196711|NCT00818662|471484|P3|NOT COMPLETED|Overall Study||9
196712|NCT00818662|471485|P2|NOT COMPLETED|Overall Study||33
196713|NCT00818662|471486|P1|NOT COMPLETED|Overall Study||23
196714|NCT00818662|471483|P4|COMPLETED|Overall Study||47
196715|NCT00818662|471484|P3|COMPLETED|Overall Study||49
196716|NCT00818662|471485|P2|COMPLETED|Overall Study||102
196717|NCT00818662|471486|P1|COMPLETED|Overall Study||104
196718|NCT00818662|471483|P4|STARTED|Overall Study||63
196719|NCT00818662|471484|P3|STARTED|Overall Study||58
196720|NCT00818662|471485|P2|STARTED|Overall Study||135
196721|NCT00818662|471486|P1|STARTED|Overall Study||127
196722|NCT00818649|471572|P1|NOT COMPLETED|Overall Study||4
196723|NCT00818649|471572|P1|COMPLETED|Overall Study||12
196724|NCT00818649|471572|P1|STARTED|Overall Study||16
196725|NCT00818623|471586|P8|NOT COMPLETED|Overall Study||1
196726|NCT00818623|471587|P7|NOT COMPLETED|Overall Study||4
196727|NCT00818623|471588|P6|NOT COMPLETED|Overall Study||3
196728|NCT00818623|471589|P5|NOT COMPLETED|Overall Study||4
196729|NCT00818623|471590|P4|NOT COMPLETED|Overall Study||5
196730|NCT00818623|471591|P3|NOT COMPLETED|Overall Study||4
196731|NCT00818623|471592|P2|NOT COMPLETED|Overall Study||4
196732|NCT00818623|471593|P1|NOT COMPLETED|Overall Study||2
196733|NCT00818623|471586|P8|COMPLETED|Overall Study||26
196734|NCT00818623|471587|P7|COMPLETED|Overall Study||23
196735|NCT00818623|471588|P6|COMPLETED|Overall Study||21
196736|NCT00818623|471589|P5|COMPLETED|Overall Study||23
196737|NCT00818623|471590|P4|COMPLETED|Overall Study||19
196738|NCT00818623|471591|P3|COMPLETED|Overall Study||9
196739|NCT00818623|471592|P2|COMPLETED|Overall Study||8
196740|NCT00818623|471593|P1|COMPLETED|Overall Study||24
196741|NCT00818623|471586|P8|Intent-to-treat (ITT) Population|Overall Study||27
196742|NCT00818623|471587|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
196743|NCT00818623|471588|P6|Intent-to-treat (ITT) Population|Overall Study||24
196744|NCT00818623|471589|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
196745|NCT00818623|471590|P4|Intent-to-treat (ITT) Population|Overall Study||24
196831|NCT00818272|471775|P1|NOT COMPLETED|Overall Study||74
196746|NCT00818623|471591|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
196747|NCT00818623|471592|P2|Intent-to-treat (ITT) Population|Overall Study||12
196748|NCT00818623|471593|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
196749|NCT00818623|471586|P8|STARTED|Overall Study||27
196750|NCT00818623|471587|P7|STARTED|Overall Study||27
196751|NCT00818623|471588|P6|STARTED|Overall Study||24
196752|NCT00818623|471589|P5|STARTED|Overall Study||27
196753|NCT00818623|471590|P4|STARTED|Overall Study||24
196754|NCT00818623|471591|P3|STARTED|Overall Study||13
196755|NCT00818623|471592|P2|STARTED|Overall Study||12
196756|NCT00818623|471593|P1|STARTED|Overall Study||26
196757|NCT00818519|471669|P2|NOT COMPLETED|Overall Study||19
196758|NCT00818519|471670|P1|NOT COMPLETED|Overall Study||14
196759|NCT00818519|471669|P2|COMPLETED|Overall Study||71
196760|NCT00818519|471670|P1|COMPLETED|Overall Study||75
196761|NCT00818519|471669|P2|Participants Received Treatment|Overall Study|= Baseline|86
196762|NCT00818519|471670|P1|Participants Received Treatment|Overall Study|= Baseline|87
196763|NCT00818519|471669|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
196764|NCT00818519|471670|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
196765|NCT00818454|471700|P4|NOT COMPLETED|Treatment Period 3||1
196766|NCT00818454|471701|P3|NOT COMPLETED|Treatment Period 3||0
196767|NCT00818454|471702|P2|NOT COMPLETED|Treatment Period 3||0
196768|NCT00818454|471703|P1|NOT COMPLETED|Treatment Period 3||0
196769|NCT00818454|471700|P4|COMPLETED|Treatment Period 3||138
196770|NCT00818454|471701|P3|COMPLETED|Treatment Period 3||26
196771|NCT00818454|471702|P2|COMPLETED|Treatment Period 3||0
196772|NCT00818454|471703|P1|COMPLETED|Treatment Period 3||0
196773|NCT00818454|471700|P4|STARTED|Treatment Period 3||139
196774|NCT00818454|471701|P3|STARTED|Treatment Period 3||26
196775|NCT00818454|471702|P2|STARTED|Treatment Period 3||0
196776|NCT00818454|471703|P1|STARTED|Treatment Period 3||0
196777|NCT00818454|471700|P4|NOT COMPLETED|Treatment Period 2||0
196778|NCT00818454|471701|P3|NOT COMPLETED|Treatment Period 2||0
196779|NCT00818454|471702|P2|NOT COMPLETED|Treatment Period 2||1
196780|NCT00818454|471703|P1|NOT COMPLETED|Treatment Period 2||2
196781|NCT00818454|471700|P4|COMPLETED|Treatment Period 2||0
196782|NCT00818454|471701|P3|COMPLETED|Treatment Period 2||0
196783|NCT00818454|471702|P2|COMPLETED|Treatment Period 2||106
196784|NCT00818454|471703|P1|COMPLETED|Treatment Period 2||106
196785|NCT00818454|471700|P4|STARTED|Treatment Period 2||0
196786|NCT00818454|471701|P3|STARTED|Treatment Period 2||0
196787|NCT00818454|471702|P2|STARTED|Treatment Period 2||107
196788|NCT00818454|471703|P1|STARTED|Treatment Period 2||108
196789|NCT00818454|471700|P4|NOT COMPLETED|Washout Period of 1 Week||0
196790|NCT00818454|471701|P3|NOT COMPLETED|Washout Period of 1 Week||0
196791|NCT00818454|471702|P2|NOT COMPLETED|Washout Period of 1 Week||3
196792|NCT00818454|471703|P1|NOT COMPLETED|Washout Period of 1 Week||4
196793|NCT00818454|471700|P4|COMPLETED|Washout Period of 1 Week||0
196794|NCT00818454|471701|P3|COMPLETED|Washout Period of 1 Week||0
196795|NCT00818454|471702|P2|COMPLETED|Washout Period of 1 Week||107
196796|NCT00818454|471703|P1|COMPLETED|Washout Period of 1 Week||108
196797|NCT00818454|471700|P4|STARTED|Washout Period of 1 Week||0
196798|NCT00818454|471701|P3|STARTED|Washout Period of 1 Week||0
196799|NCT00818454|471702|P2|STARTED|Washout Period of 1 Week||110
196800|NCT00818454|471703|P1|STARTED|Washout Period of 1 Week||112
196801|NCT00818454|471700|P4|NOT COMPLETED|Treatment Period 1||0
196802|NCT00818454|471701|P3|NOT COMPLETED|Treatment Period 1||0
196803|NCT00818454|471702|P2|NOT COMPLETED|Treatment Period 1||1
196804|NCT00818454|471703|P1|NOT COMPLETED|Treatment Period 1||3
196805|NCT00818454|471700|P4|COMPLETED|Treatment Period 1||0
196806|NCT00818454|471701|P3|COMPLETED|Treatment Period 1||0
196807|NCT00818454|471702|P2|COMPLETED|Treatment Period 1||110
196808|NCT00818454|471703|P1|COMPLETED|Treatment Period 1||112
196809|NCT00818454|471700|P4|STARTED|Treatment Period 1||0
196810|NCT00818454|471701|P3|STARTED|Treatment Period 1||0
196811|NCT00818454|471702|P2|STARTED|Treatment Period 1||111
196812|NCT00818454|471703|P1|STARTED|Treatment Period 1||115
196813|NCT00818441|471731|P2|NOT COMPLETED|Overall Study||30
196814|NCT00818441|471732|P1|NOT COMPLETED|Overall Study||89
196815|NCT00818441|471731|P2|COMPLETED|Overall Study||0
196816|NCT00818441|471732|P1|COMPLETED|Overall Study||0
196817|NCT00818441|471731|P2|STARTED|Overall Study||30
196818|NCT00818441|471732|P1|STARTED|Overall Study||89
196819|NCT00818389|471754|P2|NOT COMPLETED|Overall Study||6
196820|NCT00818389|471755|P1|NOT COMPLETED|Overall Study||4
196821|NCT00818389|471754|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
196822|NCT00818389|471755|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
196823|NCT00818389|471754|P2|STARTED|Overall Study||44
196824|NCT00818389|471755|P1|STARTED|Overall Study||40
196825|NCT00818337|471765|P1|NOT COMPLETED|Overall Study||0
196826|NCT00818337|471765|P1|COMPLETED|Overall Study||36
196827|NCT00818337|471765|P1|STARTED|Overall Study||36
196828|NCT00818324|471770|P1|NOT COMPLETED|Overall Study||27
196829|NCT00818324|471770|P1|COMPLETED|Overall Study||127
196830|NCT00818324|471770|P1|STARTED|Overall Study||154
196832|NCT00818272|471775|P1|COMPLETED|Overall Study||74
196833|NCT00818272|471775|P1|STARTED|Overall Study||148
196834|NCT00818259|471790|P9|NOT COMPLETED|Part V||0
196835|NCT00818259|471791|P8|NOT COMPLETED|Part V||1
196836|NCT00818259|471792|P7|NOT COMPLETED|Part V||0
196837|NCT00818259|471793|P6|NOT COMPLETED|Part V||0
196838|NCT00818259|471794|P5|NOT COMPLETED|Part V||0
196839|NCT00818259|471795|P4|NOT COMPLETED|Part V||0
196840|NCT00818259|471796|P3|NOT COMPLETED|Part V||0
196841|NCT00818259|471797|P2|NOT COMPLETED|Part V||0
196842|NCT00818259|471798|P1|NOT COMPLETED|Part V||0
196843|NCT00818259|471790|P9|COMPLETED|Part V||6
196844|NCT00818259|471791|P8|COMPLETED|Part V||16
196845|NCT00818259|471792|P7|COMPLETED|Part V||0
196846|NCT00818259|471793|P6|COMPLETED|Part V||0
196847|NCT00818259|471794|P5|COMPLETED|Part V||0
196848|NCT00818259|471795|P4|COMPLETED|Part V||0
196849|NCT00818259|471796|P3|COMPLETED|Part V||0
196850|NCT00818259|471797|P2|COMPLETED|Part V||0
196851|NCT00818259|471798|P1|COMPLETED|Part V||0
196852|NCT00818259|471790|P9|STARTED|Part V|Newly enrolled participants|6
196853|NCT00818259|471791|P8|STARTED|Part V|Participants continuing from Part IV|17
196854|NCT00818259|471792|P7|STARTED|Part V||0
196855|NCT00818259|471793|P6|STARTED|Part V||0
196856|NCT00818259|471794|P5|STARTED|Part V||0
196857|NCT00818259|471795|P4|STARTED|Part V||0
196858|NCT00818259|471796|P3|STARTED|Part V||0
196859|NCT00818259|471797|P2|STARTED|Part V||0
196860|NCT00818259|471798|P1|STARTED|Part V||0
196861|NCT00818259|471790|P9|NOT COMPLETED|Part IV||0
196862|NCT00818259|471791|P8|NOT COMPLETED|Part IV||0
196863|NCT00818259|471792|P7|NOT COMPLETED|Part IV||0
196864|NCT00818259|471793|P6|NOT COMPLETED|Part IV||1
196865|NCT00818259|471794|P5|NOT COMPLETED|Part IV||0
196866|NCT00818259|471795|P4|NOT COMPLETED|Part IV||0
196867|NCT00818259|471796|P3|NOT COMPLETED|Part IV||0
196868|NCT00818259|471797|P2|NOT COMPLETED|Part IV||0
196869|NCT00818259|471798|P1|NOT COMPLETED|Part IV||0
196870|NCT00818259|471790|P9|COMPLETED|Part IV||0
196871|NCT00818259|471791|P8|COMPLETED|Part IV||0
196872|NCT00818259|471792|P7|COMPLETED|Part IV||5
196873|NCT00818259|471793|P6|COMPLETED|Part IV||14
196874|NCT00818259|471794|P5|COMPLETED|Part IV||0
196875|NCT00818259|471795|P4|COMPLETED|Part IV||0
196876|NCT00818259|471796|P3|COMPLETED|Part IV||0
196877|NCT00818259|471797|P2|COMPLETED|Part IV||0
196878|NCT00818259|471798|P1|COMPLETED|Part IV||0
196879|NCT00818259|471790|P9|STARTED|Part IV||0
196880|NCT00818259|471791|P8|STARTED|Part IV||0
196881|NCT00818259|471792|P7|STARTED|Part IV|Newly enrolled participants|5
196882|NCT00818259|471793|P6|STARTED|Part IV|Participants continuing from Part III|15
196883|NCT00818259|471794|P5|STARTED|Part IV||0
196884|NCT00818259|471795|P4|STARTED|Part IV||0
196885|NCT00818259|471796|P3|STARTED|Part IV||0
196886|NCT00818259|471797|P2|STARTED|Part IV||0
196887|NCT00818259|471798|P1|STARTED|Part IV||0
196888|NCT00818259|471790|P9|NOT COMPLETED|Part III||0
196889|NCT00818259|471791|P8|NOT COMPLETED|Part III||0
196890|NCT00818259|471792|P7|NOT COMPLETED|Part III||0
196891|NCT00818259|471793|P6|NOT COMPLETED|Part III||0
196892|NCT00818259|471794|P5|NOT COMPLETED|Part III||0
196893|NCT00818259|471795|P4|NOT COMPLETED|Part III||0
196894|NCT00818259|471796|P3|NOT COMPLETED|Part III||0
196895|NCT00818259|471797|P2|NOT COMPLETED|Part III||0
196896|NCT00818259|471798|P1|NOT COMPLETED|Part III||0
196897|NCT00818259|471790|P9|COMPLETED|Part III||0
196898|NCT00818259|471791|P8|COMPLETED|Part III||0
196899|NCT00818259|471792|P7|COMPLETED|Part III||0
196900|NCT00818259|471793|P6|COMPLETED|Part III||0
196901|NCT00818259|471794|P5|COMPLETED|Part III||19
196902|NCT00818259|471795|P4|COMPLETED|Part III||0
196903|NCT00818259|471796|P3|COMPLETED|Part III||0
196904|NCT00818259|471797|P2|COMPLETED|Part III||0
196905|NCT00818259|471798|P1|COMPLETED|Part III||0
196906|NCT00818259|471790|P9|STARTED|Part III||0
196907|NCT00818259|471791|P8|STARTED|Part III||0
196908|NCT00818259|471792|P7|STARTED|Part III||0
196909|NCT00818259|471793|P6|STARTED|Part III||0
196910|NCT00818259|471794|P5|STARTED|Part III|Newly enrolled participants|19
196911|NCT00818259|471795|P4|STARTED|Part III||0
196912|NCT00818259|471796|P3|STARTED|Part III||0
196913|NCT00818259|471797|P2|STARTED|Part III||0
196914|NCT00818259|471798|P1|STARTED|Part III||0
196915|NCT00818259|471790|P9|NOT COMPLETED|Part II||0
196916|NCT00818259|471791|P8|NOT COMPLETED|Part II||0
196917|NCT00818259|471792|P7|NOT COMPLETED|Part II||0
196918|NCT00818259|471793|P6|NOT COMPLETED|Part II||0
196919|NCT00818259|471794|P5|NOT COMPLETED|Part II||0
196920|NCT00818259|471795|P4|NOT COMPLETED|Part II||2
196921|NCT00818259|471796|P3|NOT COMPLETED|Part II||1
196922|NCT00818259|471797|P2|NOT COMPLETED|Part II||0
196923|NCT00818259|471798|P1|NOT COMPLETED|Part II||0
196924|NCT00818259|471790|P9|COMPLETED|Part II||0
196925|NCT00818259|471791|P8|COMPLETED|Part II||0
196926|NCT00818259|471792|P7|COMPLETED|Part II||0
196927|NCT00818259|471793|P6|COMPLETED|Part II||0
196928|NCT00818259|471794|P5|COMPLETED|Part II||0
196929|NCT00818259|471795|P4|COMPLETED|Part II||18
196930|NCT00818259|471796|P3|COMPLETED|Part II||18
196931|NCT00818259|471797|P2|COMPLETED|Part II||0
196932|NCT00818259|471798|P1|COMPLETED|Part II||0
196933|NCT00818259|471790|P9|Treated|Part II||0
196934|NCT00818259|471791|P8|Treated|Part II||0
196935|NCT00818259|471792|P7|Treated|Part II||0
196936|NCT00818259|471793|P6|Treated|Part II||0
196937|NCT00818259|471794|P5|Treated|Part II||0
196938|NCT00818259|471795|P4|Treated|Part II||19
196939|NCT00818259|471796|P3|Treated|Part II||19
196940|NCT00818259|471797|P2|Treated|Part II||0
196941|NCT00818259|471798|P1|Treated|Part II||0
196942|NCT00818259|471790|P9|STARTED|Part II||0
196943|NCT00818259|471791|P8|STARTED|Part II||0
196944|NCT00818259|471792|P7|STARTED|Part II||0
196945|NCT00818259|471793|P6|STARTED|Part II||0
196946|NCT00818259|471794|P5|STARTED|Part II||0
196947|NCT00818259|471795|P4|STARTED|Part II|Newly enrolled participants|20
196948|NCT00818259|471796|P3|STARTED|Part II|Newly enrolled participants|19
196949|NCT00818259|471797|P2|STARTED|Part II||0
196950|NCT00818259|471798|P1|STARTED|Part II||0
196951|NCT00818259|471790|P9|NOT COMPLETED|Part I||0
196952|NCT00818259|471791|P8|NOT COMPLETED|Part I||0
196953|NCT00818259|471792|P7|NOT COMPLETED|Part I||0
196954|NCT00818259|471793|P6|NOT COMPLETED|Part I||0
196955|NCT00818259|471794|P5|NOT COMPLETED|Part I||0
196956|NCT00818259|471795|P4|NOT COMPLETED|Part I||0
196957|NCT00818259|471796|P3|NOT COMPLETED|Part I||0
196958|NCT00818259|471797|P2|NOT COMPLETED|Part I||0
196959|NCT00818259|471798|P1|NOT COMPLETED|Part I||1
196960|NCT00818259|471790|P9|COMPLETED|Part I||0
196961|NCT00818259|471791|P8|COMPLETED|Part I||0
196962|NCT00818259|471792|P7|COMPLETED|Part I||0
196963|NCT00818259|471793|P6|COMPLETED|Part I||0
196964|NCT00818259|471794|P5|COMPLETED|Part I||0
196965|NCT00818259|471795|P4|COMPLETED|Part I||0
196966|NCT00818259|471796|P3|COMPLETED|Part I||0
196967|NCT00818259|471797|P2|COMPLETED|Part I||11
196968|NCT00818259|471798|P1|COMPLETED|Part I||11
196969|NCT00818259|471790|P9|STARTED|Part I||0
196970|NCT00818259|471791|P8|STARTED|Part I||0
196971|NCT00818259|471792|P7|STARTED|Part I||0
196972|NCT00818259|471793|P6|STARTED|Part I||0
196973|NCT00818259|471794|P5|STARTED|Part I||0
196974|NCT00818259|471795|P4|STARTED|Part I||0
196975|NCT00818259|471796|P3|STARTED|Part I||0
196976|NCT00818259|471797|P2|STARTED|Part I|Newly enrolled participants|11
196977|NCT00818259|471798|P1|STARTED|Part I|Newly enrolled participants|12
196978|NCT00818259|471790|P9|NOT COMPLETED|Randomization||0
196979|NCT00818259|471791|P8|NOT COMPLETED|Randomization||0
196980|NCT00818259|471792|P7|NOT COMPLETED|Randomization||0
196981|NCT00818259|471793|P6|NOT COMPLETED|Randomization||0
196982|NCT00818259|471794|P5|NOT COMPLETED|Randomization||0
196983|NCT00818259|471795|P4|NOT COMPLETED|Randomization||0
196984|NCT00818259|471796|P3|NOT COMPLETED|Randomization||0
196985|NCT00818259|471797|P2|NOT COMPLETED|Randomization||0
196986|NCT00818259|471798|P1|NOT COMPLETED|Randomization||0
196987|NCT00818259|471790|P9|COMPLETED|Randomization||6
196988|NCT00818259|471791|P8|COMPLETED|Randomization||0
196989|NCT00818259|471792|P7|COMPLETED|Randomization||5
196990|NCT00818259|471793|P6|COMPLETED|Randomization||0
196991|NCT00818259|471794|P5|COMPLETED|Randomization||19
196992|NCT00818259|471795|P4|COMPLETED|Randomization||20
196993|NCT00818259|471796|P3|COMPLETED|Randomization||19
196994|NCT00818259|471797|P2|COMPLETED|Randomization||11
196995|NCT00818259|471798|P1|COMPLETED|Randomization||12
196996|NCT00818259|471790|P9|STARTED|Randomization||6
196997|NCT00818259|471791|P8|STARTED|Randomization||0
196998|NCT00818259|471792|P7|STARTED|Randomization||5
196999|NCT00818259|471793|P6|STARTED|Randomization||0
197000|NCT00818259|471794|P5|STARTED|Randomization||19
197001|NCT00818259|471795|P4|STARTED|Randomization||20
197002|NCT00818259|471796|P3|STARTED|Randomization||19
197003|NCT00818259|471797|P2|STARTED|Randomization||11
197004|NCT00818259|471798|P1|STARTED|Randomization||12
197005|NCT00818246|471870|P1|NOT COMPLETED|Overall Study||5
197006|NCT00818246|471870|P1|COMPLETED|Overall Study|split-face study|35
197007|NCT00818246|471870|P1|STARTED|Overall Study||40
197008|NCT00818207|471879|P2|NOT COMPLETED|Overall Study||267
197009|NCT00818207|471880|P1|NOT COMPLETED|Overall Study||222
197010|NCT00818207|471879|P2|COMPLETED|Overall Study||417
197011|NCT00818207|471880|P1|COMPLETED|Overall Study||474
197012|NCT00818207|471879|P2|STARTED|Overall Study||684
197013|NCT00818207|471880|P1|STARTED|Overall Study||696
197014|NCT00818168|471894|P1|NOT COMPLETED|Overall Study||70
197015|NCT00818168|471894|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
197016|NCT00818168|471894|P1|STARTED|Overall Study||320
197017|NCT00818116|471902|P1|NOT COMPLETED|Overall Study||0
197018|NCT00818116|471902|P1|COMPLETED|Overall Study||34
197019|NCT00818116|471902|P1|STARTED|Overall Study||34
197020|NCT00817999|471908|P2|NOT COMPLETED|No Grapefruit Juice||0
197021|NCT00817999|471909|P1|NOT COMPLETED|No Grapefruit Juice||0
197022|NCT00817999|471908|P2|COMPLETED|No Grapefruit Juice||17
197023|NCT00817999|471909|P1|COMPLETED|No Grapefruit Juice||15
197024|NCT00817999|471908|P2|STARTED|No Grapefruit Juice||17
197025|NCT00817999|471909|P1|STARTED|No Grapefruit Juice||15
197026|NCT00817999|471908|P2|NOT COMPLETED|Grapefruit Juice||0
197027|NCT00817999|471909|P1|NOT COMPLETED|Grapefruit Juice||0
197028|NCT00817999|471908|P2|COMPLETED|Grapefruit Juice||17
197029|NCT00817999|471909|P1|COMPLETED|Grapefruit Juice||15
197030|NCT00817999|471908|P2|STARTED|Grapefruit Juice||17
197031|NCT00817999|471909|P1|STARTED|Grapefruit Juice||15
197032|NCT00817843|471917|P2|NOT COMPLETED|Second Period (6 Weeks)||1
197033|NCT00817843|471918|P1|NOT COMPLETED|Second Period (6 Weeks)||0
197034|NCT00817843|471917|P2|COMPLETED|Second Period (6 Weeks)||44
197035|NCT00817843|471918|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
197036|NCT00817843|471917|P2|STARTED|Second Period (6 Weeks)||45
197037|NCT00817843|471918|P1|STARTED|Second Period (6 Weeks)||41
197038|NCT00817843|471917|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
197039|NCT00817843|471918|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
197040|NCT00817843|471917|P2|COMPLETED|Washout Period (6 Weeks)||45
197041|NCT00817843|471918|P1|COMPLETED|Washout Period (6 Weeks)||41
197042|NCT00817843|471917|P2|STARTED|Washout Period (6 Weeks)||46
197043|NCT00817843|471918|P1|STARTED|Washout Period (6 Weeks)||42
197044|NCT00817843|471917|P2|NOT COMPLETED|First Period (6 Weeks)||4
197045|NCT00817843|471918|P1|NOT COMPLETED|First Period (6 Weeks)||8
197046|NCT00817843|471917|P2|COMPLETED|First Period (6 Weeks)||46
197047|NCT00817843|471918|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
197048|NCT00817843|471917|P2|STARTED|First Period (6 Weeks)||50
197049|NCT00817843|471918|P1|STARTED|First Period (6 Weeks)||50
197050|NCT00817804|471925|P2|NOT COMPLETED|Overall Study||0
197051|NCT00817804|471926|P1|NOT COMPLETED|Overall Study||0
197052|NCT00817804|471925|P2|COMPLETED|Overall Study||2
197053|NCT00817804|471926|P1|COMPLETED|Overall Study||1
197054|NCT00817804|471925|P2|STARTED|Overall Study||2
197055|NCT00817804|471926|P1|STARTED|Overall Study||1
197056|NCT00817778|471934|P2|NOT COMPLETED|Overall Study||3
197057|NCT00817778|471935|P1|NOT COMPLETED|Overall Study||3
197058|NCT00817778|471934|P2|COMPLETED|Overall Study||5
197059|NCT00817778|471935|P1|COMPLETED|Overall Study||16
197060|NCT00817778|471934|P2|STARTED|Overall Study||8
197061|NCT00817778|471935|P1|STARTED|Overall Study||19
197062|NCT00817596|471960|P1|NOT COMPLETED|Overall Study||48
197063|NCT00817596|471960|P1|COMPLETED|Overall Study||62
197064|NCT00817596|471960|P1|STARTED|Overall Study||110
197065|NCT00817531|471964|P1|NOT COMPLETED|Overall Study||2
197066|NCT00817531|471964|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
197067|NCT00817531|471964|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
197068|NCT00817479|471970|P2|NOT COMPLETED|Overall Study||1
197069|NCT00817479|471971|P1|NOT COMPLETED|Overall Study||1
197070|NCT00817479|471970|P2|COMPLETED|Overall Study||13
197071|NCT00817479|471971|P1|COMPLETED|Overall Study||5
197072|NCT00817479|471970|P2|STARTED|Overall Study||14
197073|NCT00817479|471971|P1|STARTED|Overall Study||6
197074|NCT00817336|471981|P2|NOT COMPLETED|Overall Study||1
197075|NCT00817336|471982|P1|NOT COMPLETED|Overall Study||1
197076|NCT00817336|471981|P2|COMPLETED|Overall Study||7
197077|NCT00817336|471982|P1|COMPLETED|Overall Study||7
197078|NCT00817336|471981|P2|STARTED|Overall Study||8
197079|NCT00817336|471982|P1|STARTED|Overall Study||8
197080|NCT00817219|471993|P1|NOT COMPLETED|Overall Study||0
197081|NCT00817219|471993|P1|COMPLETED|Overall Study||33
197082|NCT00817219|471993|P1|STARTED|Overall Study||33
197083|NCT00817206|472008|P2|NOT COMPLETED|Overall Study||9
197084|NCT00817206|472009|P1|NOT COMPLETED|Overall Study||21
197085|NCT00817206|472008|P2|COMPLETED|Overall Study||154
197086|NCT00817206|472009|P1|COMPLETED|Overall Study||142
197087|NCT00817206|472008|P2|STARTED|Overall Study||163
197088|NCT00817206|472009|P1|STARTED|Overall Study||163
197089|NCT00817063|472017|P2|NOT COMPLETED|Overall Study||170
197090|NCT00817063|472018|P1|NOT COMPLETED|Overall Study||137
197091|NCT00817063|472017|P2|COMPLETED|Overall Study||128
197092|NCT00817063|472018|P1|COMPLETED|Overall Study||161
197093|NCT00817063|472017|P2|STARTED|Overall Study||298
197094|NCT00817063|472018|P1|STARTED|Overall Study||298
197095|NCT00816907|472062|P2|NOT COMPLETED|Overall Study||17
197096|NCT00816907|472063|P1|NOT COMPLETED|Overall Study||13
197097|NCT00816907|472062|P2|COMPLETED|Overall Study||58
197098|NCT00816907|472063|P1|COMPLETED|Overall Study||58
197099|NCT00816907|472062|P2|STARTED|Overall Study||75
197100|NCT00816907|472063|P1|STARTED|Overall Study||71
197101|NCT00816829|472085|P2|NOT COMPLETED|Overall Study||0
197102|NCT00816829|472086|P1|NOT COMPLETED|Overall Study||0
197103|NCT00816829|472085|P2|COMPLETED|Overall Study||18
197104|NCT00816829|472086|P1|COMPLETED|Overall Study||16
197105|NCT00816829|472085|P2|STARTED|Overall Study||18
197106|NCT00816829|472086|P1|STARTED|Overall Study||16
197107|NCT00816777|472112|P2|NOT COMPLETED|Overall Study||0
197108|NCT00816777|472113|P1|NOT COMPLETED|Overall Study||0
197109|NCT00816777|472112|P2|COMPLETED|Overall Study||2
197110|NCT00816777|472113|P1|COMPLETED|Overall Study||2
197111|NCT00816777|472112|P2|STARTED|Overall Study||2
197112|NCT00816777|472113|P1|STARTED|Overall Study||2
197113|NCT00816595|472121|P2|NOT COMPLETED|Overall Study||0
197114|NCT00816595|472122|P1|NOT COMPLETED|Overall Study||2
197115|NCT00816595|472121|P2|COMPLETED|Overall Study||33
197116|NCT00816595|472122|P1|COMPLETED|Overall Study||33
197117|NCT00816595|472121|P2|STARTED|Overall Study||33
197118|NCT00816595|472122|P1|STARTED|Overall Study||35
197119|NCT00816556|472135|P3|NOT COMPLETED|Overall Study||3
197120|NCT00816556|472136|P2|NOT COMPLETED|Overall Study||2
197121|NCT00816556|472137|P1|NOT COMPLETED|Overall Study||2
197122|NCT00816556|472135|P3|COMPLETED|Overall Study||19
197123|NCT00816556|472136|P2|COMPLETED|Overall Study||19
197124|NCT00816556|472137|P1|COMPLETED|Overall Study||18
197125|NCT00816556|472135|P3|STARTED|Overall Study||22
197126|NCT00816556|472136|P2|STARTED|Overall Study||21
197127|NCT00816556|472137|P1|STARTED|Overall Study||20
197128|NCT00816400|472160|P9|NOT COMPLETED|Overall Study||6
197129|NCT00816400|472161|P8|NOT COMPLETED|Overall Study||5
197130|NCT00816400|472162|P7|NOT COMPLETED|Overall Study||2
197131|NCT00816400|472163|P6|NOT COMPLETED|Overall Study||3
197132|NCT00816400|472164|P5|NOT COMPLETED|Overall Study||2
197133|NCT00816400|472165|P4|NOT COMPLETED|Overall Study||3
197134|NCT00816400|472166|P3|NOT COMPLETED|Overall Study||5
197135|NCT00816400|472167|P2|NOT COMPLETED|Overall Study||3
197136|NCT00816400|472168|P1|NOT COMPLETED|Overall Study||2
197137|NCT00816400|472160|P9|COMPLETED|Overall Study||0
197138|NCT00816400|472161|P8|COMPLETED|Overall Study||1
197139|NCT00816400|472162|P7|COMPLETED|Overall Study||1
197140|NCT00816400|472163|P6|COMPLETED|Overall Study||0
197141|NCT00816400|472164|P5|COMPLETED|Overall Study||1
197142|NCT00816400|472165|P4|COMPLETED|Overall Study||0
197143|NCT00816400|472166|P3|COMPLETED|Overall Study||0
197144|NCT00816400|472167|P2|COMPLETED|Overall Study||0
197145|NCT00816400|472168|P1|COMPLETED|Overall Study||1
197146|NCT00816400|472160|P9|STARTED|Overall Study||6
197147|NCT00816400|472161|P8|STARTED|Overall Study||6
197148|NCT00816400|472162|P7|STARTED|Overall Study||3
197149|NCT00816400|472163|P6|STARTED|Overall Study||3
197150|NCT00816400|472164|P5|STARTED|Overall Study||3
197151|NCT00816400|472165|P4|STARTED|Overall Study||3
197152|NCT00816400|472166|P3|STARTED|Overall Study||5
197153|NCT00816400|472167|P2|STARTED|Overall Study||3
197154|NCT00816400|472168|P1|STARTED|Overall Study||3
197155|NCT00816348|472352|P1|NOT COMPLETED|Overall Study||0
197156|NCT00816348|472352|P1|COMPLETED|Overall Study||15
197157|NCT00816348|472352|P1|STARTED|Overall Study||15
197158|NCT00816166|472358|P2|NOT COMPLETED|Overall Study||12
197159|NCT00816166|472359|P1|NOT COMPLETED|Overall Study||10
197160|NCT00816166|472358|P2|COMPLETED|Overall Study||41
197161|NCT00816166|472359|P1|COMPLETED|Overall Study||49
197162|NCT00816166|472358|P2|ITT Population (Met Eligibility)|Overall Study||53
197163|NCT00816166|472359|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
197164|NCT00816166|472358|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
197165|NCT00816166|472359|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
197166|NCT00816101|472368|P3|NOT COMPLETED|Overall Study||0
197167|NCT00816101|472369|P2|NOT COMPLETED|Overall Study||0
197168|NCT00816101|472370|P1|NOT COMPLETED|Overall Study||0
197169|NCT00816101|472368|P3|COMPLETED|Overall Study||5
197170|NCT00816101|472369|P2|COMPLETED|Overall Study||8
197171|NCT00816101|472370|P1|COMPLETED|Overall Study||13
197172|NCT00816101|472368|P3|STARTED|Overall Study||5
197173|NCT00816101|472369|P2|STARTED|Overall Study||8
197174|NCT00816101|472370|P1|STARTED|Overall Study||13
197175|NCT00816062|472384|P1|NOT COMPLETED|Overall Study||127
197176|NCT00816062|472384|P1|COMPLETED|Overall Study||133
197177|NCT00816062|472384|P1|STARTED|Overall Study||260
197178|NCT00816036|472391|P2|NOT COMPLETED|Overall Study||108
197179|NCT00816036|472392|P1|NOT COMPLETED|Overall Study||176
197180|NCT00816036|472391|P2|COMPLETED|Overall Study||287
197181|NCT00816036|472392|P1|COMPLETED|Overall Study||327
197182|NCT00816036|472391|P2|STARTED|Overall Study||395
197183|NCT00816036|472392|P1|STARTED|Overall Study||503
197184|NCT00816023|472406|P4|NOT COMPLETED|Overall Study||12
197185|NCT00816023|472407|P3|NOT COMPLETED|Overall Study||9
197186|NCT00816023|472408|P2|NOT COMPLETED|Overall Study||6
197187|NCT00816023|472409|P1|NOT COMPLETED|Overall Study||9
197188|NCT00816023|472406|P4|COMPLETED|Overall Study||62
197189|NCT00816023|472407|P3|COMPLETED|Overall Study||60
197190|NCT00816023|472408|P2|COMPLETED|Overall Study||56
197191|NCT00816023|472409|P1|COMPLETED|Overall Study||62
197192|NCT00816023|472406|P4|Completed Therapy|Overall Study||63
197193|NCT00816023|472407|P3|Completed Therapy|Overall Study||61
197194|NCT00816023|472408|P2|Completed Therapy|Overall Study||59
197195|NCT00816023|472409|P1|Completed Therapy|Overall Study||65
197196|NCT00816023|472406|P4|STARTED|Overall Study||74
197197|NCT00816023|472407|P3|STARTED|Overall Study||69
197198|NCT00816023|472408|P2|STARTED|Overall Study||62
197199|NCT00816023|472409|P1|STARTED|Overall Study||71
197200|NCT00815919|472423|P1|NOT COMPLETED|Overall Study||4
197201|NCT00815919|472423|P1|COMPLETED|Overall Study||18
197202|NCT00815919|472423|P1|STARTED|Overall Study||22
197203|NCT00815776|472434|P3|NOT COMPLETED|Overall Study||6
197204|NCT00815776|472435|P2|NOT COMPLETED|Overall Study||8
197205|NCT00815776|472436|P1|NOT COMPLETED|Overall Study||8
197206|NCT00815776|472434|P3|COMPLETED|Overall Study||22
197207|NCT00815776|472435|P2|COMPLETED|Overall Study||56
197208|NCT00815776|472436|P1|COMPLETED|Overall Study||52
197209|NCT00815776|472434|P3|STARTED|Overall Study||28
197210|NCT00815776|472435|P2|STARTED|Overall Study||64
197211|NCT00815776|472436|P1|STARTED|Overall Study||60
197212|NCT00815698|472452|P2|NOT COMPLETED|Overall Study||0
197213|NCT00815698|472453|P1|NOT COMPLETED|Overall Study||0
197214|NCT00815698|472452|P2|COMPLETED|Overall Study||171
197215|NCT00815698|472453|P1|COMPLETED|Overall Study||163
197216|NCT00815698|472452|P2|STARTED|Overall Study||171
197217|NCT00815698|472453|P1|STARTED|Overall Study||163
197218|NCT00815685|472461|P1|NOT COMPLETED|Overall Study||22
197219|NCT00815685|472461|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
197220|NCT00815685|472461|P1|STARTED|Overall Study||36
197221|NCT00815659|472466|P1|NOT COMPLETED|Overall Study||23
197222|NCT00815659|472466|P1|COMPLETED|Overall Study||74
197223|NCT00815659|472466|P1|STARTED|Overall Study||97
197224|NCT00815633|472509|P1|NOT COMPLETED|Overall Study||1
197225|NCT00815633|472509|P1|COMPLETED|Overall Study||0
197226|NCT00815633|472509|P1|STARTED|Overall Study||1
197227|NCT00815516|472516|P2|NOT COMPLETED|Overall Study||1
197228|NCT00815516|472517|P1|NOT COMPLETED|Overall Study||4
197229|NCT00815516|472516|P2|COMPLETED|Overall Study||9
197230|NCT00815516|472517|P1|COMPLETED|Overall Study||16
197231|NCT00815516|472516|P2|STARTED|Overall Study||10
197232|NCT00815516|472517|P1|STARTED|Overall Study||20
197233|NCT00815490|472548|P2|NOT COMPLETED|Overall Study||0
197234|NCT00815490|472549|P1|NOT COMPLETED|Overall Study||0
197235|NCT00815490|472548|P2|COMPLETED|Overall Study||9
197236|NCT00815490|472549|P1|COMPLETED|Overall Study||9
197237|NCT00815490|472548|P2|STARTED|Overall Study||9
197238|NCT00815490|472549|P1|STARTED|Overall Study||9
197239|NCT00815360|472557|P2|NOT COMPLETED|Overall Study||0
197240|NCT00815360|472558|P1|NOT COMPLETED|Overall Study||0
197241|NCT00815360|472557|P2|COMPLETED|Overall Study||11
197242|NCT00815360|472558|P1|COMPLETED|Overall Study||11
197243|NCT00815360|472557|P2|STARTED|Overall Study||11
197244|NCT00815360|472558|P1|STARTED|Overall Study||11
197245|NCT00815347|472566|P1|NOT COMPLETED|Overall Study||4
197246|NCT00815347|472566|P1|COMPLETED|Overall Study||7
197247|NCT00815347|472566|P1|STARTED|Overall Study||11
197248|NCT00815308|472582|P1|NOT COMPLETED|Overall Study||10
197249|NCT00815308|472582|P1|COMPLETED|Overall Study||45
197250|NCT00815308|472582|P1|STARTED|Overall Study||55
197251|NCT00815295|472591|P3|NOT COMPLETED|Overall Study||3
197252|NCT00815295|472592|P2|NOT COMPLETED|Overall Study||1
197253|NCT00815295|472593|P1|NOT COMPLETED|Overall Study||0
197254|NCT00815295|472591|P3|COMPLETED|Overall Study||9
197255|NCT00815295|472592|P2|COMPLETED|Overall Study||7
197256|NCT00815295|472593|P1|COMPLETED|Overall Study||8
197257|NCT00815295|472591|P3|STARTED|Overall Study||12
197258|NCT00815295|472592|P2|STARTED|Overall Study||8
197259|NCT00815295|472593|P1|STARTED|Overall Study||8
197260|NCT00815191|472605|P2|NOT COMPLETED|Overall Study||1
197261|NCT00815191|472606|P1|NOT COMPLETED|Overall Study||1
197262|NCT00815191|472605|P2|COMPLETED|Overall Study||34
197263|NCT00815191|472606|P1|COMPLETED|Overall Study||37
197264|NCT00815191|472605|P2|STARTED|Overall Study||35
197265|NCT00815191|472606|P1|STARTED|Overall Study||38
197266|NCT00815087|472614|P2|NOT COMPLETED|Overall Study||0
197267|NCT00815087|472615|P1|NOT COMPLETED|Overall Study||0
197268|NCT00815087|472614|P2|COMPLETED|Overall Study||10
197269|NCT00815087|472615|P1|COMPLETED|Overall Study||10
197270|NCT00815087|472614|P2|STARTED|Overall Study||10
197271|NCT00815087|472615|P1|STARTED|Overall Study||10
197272|NCT00815035|472623|P3|NOT COMPLETED|Open Label Extension Phase||6
197273|NCT00815035|472624|P2|NOT COMPLETED|Open Label Extension Phase||0
197274|NCT00815035|472625|P1|NOT COMPLETED|Open Label Extension Phase||0
197275|NCT00815035|472623|P3|COMPLETED|Open Label Extension Phase||9
197276|NCT00815035|472624|P2|COMPLETED|Open Label Extension Phase||0
197277|NCT00815035|472625|P1|COMPLETED|Open Label Extension Phase||0
197278|NCT00815035|472623|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
197279|NCT00815035|472624|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
197280|NCT00815035|472625|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
197281|NCT00815035|472623|P3|NOT COMPLETED|Blinded Phase||0
197282|NCT00815035|472624|P2|NOT COMPLETED|Blinded Phase||0
197283|NCT00815035|472625|P1|NOT COMPLETED|Blinded Phase||1
197284|NCT00815035|472623|P3|COMPLETED|Blinded Phase||0
197285|NCT00815035|472624|P2|COMPLETED|Blinded Phase||6
197286|NCT00815035|472625|P1|COMPLETED|Blinded Phase||9
197287|NCT00815035|472623|P3|STARTED|Blinded Phase||0
197288|NCT00815035|472624|P2|STARTED|Blinded Phase||6
197289|NCT00815035|472625|P1|STARTED|Blinded Phase||10
197290|NCT00814983|472643|P2|NOT COMPLETED|Overall Study||0
197291|NCT00814983|472644|P1|NOT COMPLETED|Overall Study||3
197292|NCT00814983|472643|P2|COMPLETED|Overall Study||0
197293|NCT00814983|472644|P1|COMPLETED|Overall Study||12
197294|NCT00814983|472643|P2|STARTED|Overall Study||0
197295|NCT00814983|472644|P1|STARTED|Overall Study||15
197296|NCT00814970|472654|P1|NOT COMPLETED|Overall Study||50
197297|NCT00814970|472654|P1|COMPLETED|Overall Study||146
197298|NCT00814970|472654|P1|STARTED|Overall Study||196
197299|NCT00814892|472675|P1|NOT COMPLETED|Overall Study||2
197300|NCT00814892|472675|P1|COMPLETED|Overall Study||0
197301|NCT00814892|472675|P1|STARTED|Overall Study||2
197302|NCT00814879|472687|P2|NOT COMPLETED|By Week 48||3
197303|NCT00814879|472688|P1|NOT COMPLETED|By Week 48||2
197304|NCT00814879|472687|P2|COMPLETED|By Week 48||26
197305|NCT00814879|472688|P1|COMPLETED|By Week 48||25
197306|NCT00814879|472687|P2|STARTED|By Week 48||29
197307|NCT00814879|472688|P1|STARTED|By Week 48||27
197308|NCT00814879|472687|P2|NOT COMPLETED|By Week 24||1
197309|NCT00814879|472688|P1|NOT COMPLETED|By Week 24||1
197310|NCT00814879|472687|P2|COMPLETED|By Week 24||29
197311|NCT00814879|472688|P1|COMPLETED|By Week 24||27
197312|NCT00814879|472687|P2|STARTED|By Week 24||30
197313|NCT00814879|472688|P1|STARTED|By Week 24||28
197314|NCT00814801|472707|P3|NOT COMPLETED|Overall Study||43
197315|NCT00814801|472708|P2|NOT COMPLETED|Overall Study||38
197316|NCT00814801|472709|P1|NOT COMPLETED|Overall Study||34
197317|NCT00814801|472707|P3|COMPLETED|Overall Study||151
197318|NCT00814801|472708|P2|COMPLETED|Overall Study||154
197319|NCT00814801|472709|P1|COMPLETED|Overall Study||160
197320|NCT00814801|472707|P3|STARTED|Overall Study||194
197321|NCT00814801|472708|P2|STARTED|Overall Study||192
197322|NCT00814801|472709|P1|STARTED|Overall Study||194
197323|NCT00814788|472729|P1|NOT COMPLETED|Overall Study||0
197324|NCT00814788|472729|P1|COMPLETED|Overall Study||24
197325|NCT00814788|472729|P1|STARTED|Overall Study||24
197326|NCT00814775|472737|P2|NOT COMPLETED|Overall Study||0
197327|NCT00814775|472738|P1|NOT COMPLETED|Overall Study||0
197328|NCT00814775|472737|P2|COMPLETED|Overall Study||20
197329|NCT00814775|472738|P1|COMPLETED|Overall Study||23
197330|NCT00814775|472737|P2|STARTED|Overall Study||20
197331|NCT00814775|472738|P1|STARTED|Overall Study||23
197332|NCT00814710|472748|P2|NOT COMPLETED|Overall Study||3
197333|NCT00814710|472749|P1|NOT COMPLETED|Overall Study||8
197334|NCT00814710|472748|P2|COMPLETED|Overall Study||117
197335|NCT00814710|472749|P1|COMPLETED|Overall Study||232
197336|NCT00814710|472748|P2|STARTED|Overall Study||120
197337|NCT00814710|472749|P1|STARTED|Overall Study||240
197338|NCT00814697|472787|P1|NOT COMPLETED|Overall Study||0
197339|NCT00814697|472787|P1|COMPLETED|Overall Study||12
197340|NCT00814697|472787|P1|STARTED|Overall Study||12
197341|NCT00814671|472794|P3|NOT COMPLETED|Overall Study||2
197342|NCT00814671|472795|P2|NOT COMPLETED|Overall Study||4
197343|NCT00814671|472796|P1|NOT COMPLETED|Overall Study||7
197344|NCT00814671|472794|P3|COMPLETED|Overall Study||49
197345|NCT00814671|472795|P2|COMPLETED|Overall Study||44
197346|NCT00814671|472796|P1|COMPLETED|Overall Study||47
197347|NCT00814671|472794|P3|STARTED|Overall Study||51
197348|NCT00814671|472795|P2|STARTED|Overall Study||48
197349|NCT00814671|472796|P1|STARTED|Overall Study||54
197350|NCT00814658|472817|P2|NOT COMPLETED|Overall Study||4
197351|NCT00814658|472818|P1|NOT COMPLETED|Overall Study||4
197352|NCT00814658|472817|P2|COMPLETED|Overall Study||8
197353|NCT00814658|472818|P1|COMPLETED|Overall Study||5
197354|NCT00814658|472817|P2|STARTED|Overall Study||12
197355|NCT00814658|472818|P1|STARTED|Overall Study||9
197356|NCT00814632|472884|P1|NOT COMPLETED|Overall Study||2
197357|NCT00814632|472884|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
197358|NCT00814632|472884|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
197359|NCT00814580|472890|P2|NOT COMPLETED|Overall Study||47
197360|NCT00814580|472891|P1|NOT COMPLETED|Overall Study||31
197361|NCT00814580|472890|P2|COMPLETED|Overall Study||141
197362|NCT00814580|472891|P1|COMPLETED|Overall Study||163
197363|NCT00814580|472890|P2|STARTED|Overall Study||188
197364|NCT00814580|472891|P1|STARTED|Overall Study||194
197365|NCT00814502|473021|P2|NOT COMPLETED|Overall Study||2
197366|NCT00814502|473022|P1|NOT COMPLETED|Overall Study||1
197367|NCT00814502|473021|P2|COMPLETED|Overall Study||7
197368|NCT00814502|473022|P1|COMPLETED|Overall Study||7
197369|NCT00814502|473021|P2|STARTED|Overall Study||9
197370|NCT00814502|473022|P1|STARTED|Overall Study||8
197371|NCT00814489|473035|P3|NOT COMPLETED|Overall Study||1
197372|NCT00814489|473036|P2|NOT COMPLETED|Overall Study||0
197373|NCT00814489|473037|P1|NOT COMPLETED|Overall Study||2
197374|NCT00814489|473035|P3|COMPLETED|Overall Study||7
197375|NCT00814489|473036|P2|COMPLETED|Overall Study||17
197376|NCT00814489|473037|P1|COMPLETED|Overall Study||13
197377|NCT00814489|473035|P3|STARTED|Overall Study||8
197378|NCT00814489|473036|P2|STARTED|Overall Study||17
197379|NCT00814489|473037|P1|STARTED|Overall Study||15
197380|NCT00814463|473069|P1|NOT COMPLETED|Overall Study||1
197381|NCT00814463|473069|P1|COMPLETED|Overall Study||0
197382|NCT00814463|473069|P1|STARTED|Overall Study||1
197383|NCT00814346|473075|P2|NOT COMPLETED|Open Phase (17 Months)||0
197384|NCT00814346|473076|P1|NOT COMPLETED|Open Phase (17 Months)||10
197385|NCT00814346|473075|P2|COMPLETED|Open Phase (17 Months)||0
197386|NCT00814346|473076|P1|COMPLETED|Open Phase (17 Months)||31
197387|NCT00814346|473075|P2|AD|Open Phase (17 Months)||0
197388|NCT00814346|473076|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
197389|NCT00814346|473075|P2|MC|Open Phase (17 Months)||0
197390|NCT00814346|473076|P1|MC|Open Phase (17 Months)||20
197391|NCT00814346|473075|P2|CNE|Open Phase (17 Months)||0
197392|NCT00814346|473076|P1|CNE|Open Phase (17 Months)||21
197393|NCT00814346|473075|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
197394|NCT00814346|473076|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
197395|NCT00814346|473075|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
197396|NCT00814346|473076|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
197397|NCT00814346|473075|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
197398|NCT00814346|473076|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
197399|NCT00814346|473075|P2|AD|Double-blind Phase (4 Weeks)||2
197400|NCT00814346|473076|P1|AD|Double-blind Phase (4 Weeks)||3
197401|NCT00814346|473075|P2|MC|Double-blind Phase (4 Weeks)||11
197402|NCT00814346|473076|P1|MC|Double-blind Phase (4 Weeks)||10
197403|NCT00814346|473075|P2|CNE|Double-blind Phase (4 Weeks)||13
197404|NCT00814346|473076|P1|CNE|Double-blind Phase (4 Weeks)||10
197405|NCT00814346|473075|P2|STARTED|Double-blind Phase (4 Weeks)||26
197406|NCT00814346|473076|P1|STARTED|Double-blind Phase (4 Weeks)||23
197407|NCT00814333|473142|P2|NOT COMPLETED|Treatment Period||0
197408|NCT00814333|473143|P1|NOT COMPLETED|Treatment Period||0
197409|NCT00814333|473142|P2|COMPLETED|Treatment Period||0
197410|NCT00814333|473143|P1|COMPLETED|Treatment Period||0
197411|NCT00814333|473142|P2|STARTED|Treatment Period||0
197412|NCT00814333|473143|P1|STARTED|Treatment Period||0
197413|NCT00814333|473142|P2|NOT COMPLETED|Enrollment||0
197414|NCT00814333|473143|P1|NOT COMPLETED|Enrollment||1
197415|NCT00814333|473142|P2|COMPLETED|Enrollment||0
197416|NCT00814333|473143|P1|COMPLETED|Enrollment||0
197417|NCT00814333|473142|P2|STARTED|Enrollment||0
197418|NCT00814333|473143|P1|STARTED|Enrollment||1
197419|NCT00814320|473151|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
197420|NCT00814320|473152|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
197421|NCT00814320|473151|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
197422|NCT00814320|473152|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
197423|NCT00814320|473151|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
197424|NCT00814320|473152|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
197425|NCT00814320|473151|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
197426|NCT00814320|473152|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
197427|NCT00814320|473151|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
197428|NCT00814320|473152|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
197429|NCT00814320|473151|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
197430|NCT00814320|473152|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
197431|NCT00814320|473151|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
197432|NCT00814320|473152|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
197433|NCT00814320|473151|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
197434|NCT00814320|473152|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
197435|NCT00814320|473151|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
197436|NCT00814320|473152|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
197437|NCT00814320|473151|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
197438|NCT00814320|473152|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
197439|NCT00814320|473151|P2|COMPLETED|Epoch 1 (IV Treatment)||71
197440|NCT00814320|473152|P1|COMPLETED|Epoch 1 (IV Treatment)||13
197441|NCT00814320|473151|P2|STARTED|Epoch 1 (IV Treatment)||73
197442|NCT00814320|473152|P1|STARTED|Epoch 1 (IV Treatment)||14
197443|NCT00814307|473284|P4|NOT COMPLETED|Overall Study||10
197444|NCT00814307|473285|P3|NOT COMPLETED|Overall Study||7
197445|NCT00814307|473286|P2|NOT COMPLETED|Overall Study||27
197446|NCT00814307|473287|P1|NOT COMPLETED|Overall Study||12
197447|NCT00814307|473284|P4|COMPLETED|Overall Study||51
197448|NCT00814307|473285|P3|COMPLETED|Overall Study||54
197449|NCT00814307|473286|P2|COMPLETED|Overall Study||218
197450|NCT00814307|473287|P1|COMPLETED|Overall Study||232
197451|NCT00814307|473284|P4|Treated|Overall Study||61
197452|NCT00814307|473285|P3|Treated|Overall Study||61
197453|NCT00814307|473286|P2|Treated|Overall Study||245
197454|NCT00814307|473287|P1|Treated|Overall Study||243
197455|NCT00814307|473284|P4|STARTED|Overall Study||61
197456|NCT00814307|473285|P3|STARTED|Overall Study||61
197457|NCT00814307|473286|P2|STARTED|Overall Study||245
197458|NCT00814307|473287|P1|STARTED|Overall Study||244
197459|NCT00814255|473452|P3|NOT COMPLETED|Overall Study||1
197460|NCT00814255|473453|P2|NOT COMPLETED|Overall Study||0
197461|NCT00814255|473454|P1|NOT COMPLETED|Overall Study||1
197462|NCT00814255|473452|P3|COMPLETED|Overall Study||7
197463|NCT00814255|473453|P2|COMPLETED|Overall Study||7
197464|NCT00814255|473454|P1|COMPLETED|Overall Study||7
197465|NCT00814255|473452|P3|STARTED|Overall Study||8
197466|NCT00814255|473453|P2|STARTED|Overall Study||7
197467|NCT00814255|473454|P1|STARTED|Overall Study||8
197468|NCT00814177|473476|P2|NOT COMPLETED|Overall Study||0
197469|NCT00814177|473477|P1|NOT COMPLETED|Overall Study||0
197470|NCT00814177|473476|P2|COMPLETED|Overall Study||80
197471|NCT00814177|473477|P1|COMPLETED|Overall Study||80
197472|NCT00814177|473476|P2|STARTED|Overall Study||80
197473|NCT00814177|473477|P1|STARTED|Overall Study||80
197474|NCT00814164|473483|P1|NOT COMPLETED|Overall Study||19
197475|NCT00814164|473483|P1|COMPLETED|Overall Study||2
197476|NCT00814164|473483|P1|STARTED|Overall Study||21
197477|NCT00814138|473496|P2|NOT COMPLETED|Overall Study||7
197478|NCT00814138|473497|P1|NOT COMPLETED|Overall Study||1
197479|NCT00814138|473496|P2|COMPLETED|Overall Study||18
197480|NCT00814138|473497|P1|COMPLETED|Overall Study||24
197481|NCT00814138|473496|P2|STARTED|Overall Study||25
197482|NCT00814138|473497|P1|STARTED|Overall Study||25
197483|NCT00813995|473517|P2|NOT COMPLETED|Overall Study||16
197484|NCT00813995|473518|P1|NOT COMPLETED|Overall Study||23
197485|NCT00813995|473517|P2|COMPLETED|Overall Study||182
197486|NCT00813995|473518|P1|COMPLETED|Overall Study||174
197487|NCT00813995|473517|P2|STARTED|Overall Study||198
197488|NCT00813995|473518|P1|STARTED|Overall Study||197
197489|NCT00813982|473532|P1|NOT COMPLETED|Overall Study||0
197490|NCT00813982|473532|P1|COMPLETED|Overall Study||59
197491|NCT00813982|473532|P1|STARTED|Overall Study||59
197492|NCT00813943|473541|P3|NOT COMPLETED|Overall Study||3
197493|NCT00813943|473542|P2|NOT COMPLETED|Overall Study||5
197494|NCT00813943|473543|P1|NOT COMPLETED|Overall Study||5
197495|NCT00813943|473541|P3|COMPLETED|Overall Study||86
197496|NCT00813943|473542|P2|COMPLETED|Overall Study||83
197497|NCT00813943|473543|P1|COMPLETED|Overall Study||83
197498|NCT00813943|473541|P3|STARTED|Overall Study||89
197499|NCT00813943|473542|P2|STARTED|Overall Study||88
197500|NCT00813943|473543|P1|STARTED|Overall Study||88
197501|NCT00813917|473573|P2|NOT COMPLETED|Overall Study||6
197502|NCT00813917|473574|P1|NOT COMPLETED|Overall Study||6
197503|NCT00813917|473573|P2|COMPLETED|Overall Study||32
197504|NCT00813917|473574|P1|COMPLETED|Overall Study||32
197505|NCT00813917|473573|P2|STARTED|Overall Study||38
197506|NCT00813917|473574|P1|STARTED|Overall Study||38
197507|NCT00813904|473580|P1|NOT COMPLETED|Overall Study||1
197508|NCT00813904|473580|P1|COMPLETED|Overall Study||30
197509|NCT00813904|473580|P1|STARTED|Overall Study||31
197510|NCT00813813|473588|P2|NOT COMPLETED|Overall Study||9
197511|NCT00813813|473589|P1|NOT COMPLETED|Overall Study||3
197512|NCT00813813|473588|P2|COMPLETED|Overall Study||16
197513|NCT00813813|473589|P1|COMPLETED|Overall Study||4
197514|NCT00813813|473588|P2|STARTED|Overall Study||25
197515|NCT00813813|473589|P1|STARTED|Overall Study||7
197516|NCT00813800|473605|P1|NOT COMPLETED|Overall Study||6
197517|NCT00813800|473605|P1|COMPLETED|Overall Study||5
197518|NCT00813800|473605|P1|STARTED|Overall Study||11
197519|NCT00813761|473613|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
197520|NCT00813761|473614|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
197521|NCT00813761|473615|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
197522|NCT00813761|473616|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
197523|NCT00813761|473613|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
197524|NCT00813761|473614|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
197525|NCT00813761|473615|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
197526|NCT00813761|473616|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
197527|NCT00813761|473613|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
197528|NCT00813761|473614|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
197529|NCT00813761|473615|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
197530|NCT00813761|473616|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
197531|NCT00813761|473613|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
197532|NCT00813761|473614|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
197533|NCT00813761|473615|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
197534|NCT00813761|473616|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
197535|NCT00813761|473613|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
197536|NCT00813761|473614|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
197537|NCT00813761|473615|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
197538|NCT00813761|473616|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
197539|NCT00813761|473613|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
197540|NCT00813761|473614|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
197541|NCT00813761|473615|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
197542|NCT00813761|473616|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
197543|NCT00813748|473666|P2|NOT COMPLETED|Skin Test Substudy||1
197544|NCT00813748|473667|P1|NOT COMPLETED|Skin Test Substudy||0
197545|NCT00813748|473666|P2|COMPLETED|Skin Test Substudy||7
197546|NCT00813748|473667|P1|COMPLETED|Skin Test Substudy||3
197547|NCT00813748|473666|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
197548|NCT00813748|473667|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
197549|NCT00813748|473666|P2|NOT COMPLETED|Main Observational Study||0
197550|NCT00813748|473667|P1|NOT COMPLETED|Main Observational Study||0
197551|NCT00813748|473666|P2|COMPLETED|Main Observational Study||88
197552|NCT00813748|473667|P1|COMPLETED|Main Observational Study||30
197553|NCT00813748|473666|P2|STARTED|Main Observational Study||88
197554|NCT00813748|473667|P1|STARTED|Main Observational Study||30
197555|NCT00813709|473696|P6|NOT COMPLETED|Open Label Period||11
197556|NCT00813709|473697|P5|NOT COMPLETED|Open Label Period||10
197557|NCT00813709|473698|P4|NOT COMPLETED|Open Label Period||20
197558|NCT00813709|473699|P3|NOT COMPLETED|Open Label Period||0
197559|NCT00813709|473700|P2|NOT COMPLETED|Open Label Period||0
197560|NCT00813709|473701|P1|NOT COMPLETED|Open Label Period||0
197561|NCT00813709|473696|P6|COMPLETED|Open Label Period||35
197562|NCT00813709|473697|P5|COMPLETED|Open Label Period||41
197563|NCT00813709|473698|P4|COMPLETED|Open Label Period||38
197564|NCT00813709|473699|P3|COMPLETED|Open Label Period||0
197565|NCT00813709|473700|P2|COMPLETED|Open Label Period||0
197566|NCT00813709|473701|P1|COMPLETED|Open Label Period||0
197567|NCT00813709|473696|P6|Treated|Open Label Period||45
197568|NCT00813709|473697|P5|Treated|Open Label Period||51
197569|NCT00813709|473698|P4|Treated|Open Label Period||57
197570|NCT00813709|473699|P3|Treated|Open Label Period||0
197571|NCT00813709|473700|P2|Treated|Open Label Period||0
197572|NCT00813709|473701|P1|Treated|Open Label Period||0
197650|NCT00813150|473902|P2|NOT COMPLETED|Treatment Period||32
197573|NCT00813709|473696|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
197574|NCT00813709|473697|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
197575|NCT00813709|473698|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
197576|NCT00813709|473699|P3|STARTED|Open Label Period||0
197577|NCT00813709|473700|P2|STARTED|Open Label Period||0
197578|NCT00813709|473701|P1|STARTED|Open Label Period||0
197579|NCT00813709|473696|P6|NOT COMPLETED|Double Blind Period||0
197580|NCT00813709|473697|P5|NOT COMPLETED|Double Blind Period||0
197581|NCT00813709|473698|P4|NOT COMPLETED|Double Blind Period||0
197582|NCT00813709|473699|P3|NOT COMPLETED|Double Blind Period||31
197583|NCT00813709|473700|P2|NOT COMPLETED|Double Blind Period||41
197584|NCT00813709|473701|P1|NOT COMPLETED|Double Blind Period||31
197585|NCT00813709|473696|P6|COMPLETED|Double Blind Period||0
197586|NCT00813709|473697|P5|COMPLETED|Double Blind Period||0
197587|NCT00813709|473698|P4|COMPLETED|Double Blind Period||0
197588|NCT00813709|473699|P3|COMPLETED|Double Blind Period||68
197589|NCT00813709|473700|P2|COMPLETED|Double Blind Period||76
197590|NCT00813709|473701|P1|COMPLETED|Double Blind Period||53
197591|NCT00813709|473696|P6|Treated|Double Blind Period||0
197592|NCT00813709|473697|P5|Treated|Double Blind Period||0
197593|NCT00813709|473698|P4|Treated|Double Blind Period||0
197594|NCT00813709|473699|P3|Treated|Double Blind Period||98
197595|NCT00813709|473700|P2|Treated|Double Blind Period||114
197596|NCT00813709|473701|P1|Treated|Double Blind Period||83
197597|NCT00813709|473696|P6|STARTED|Double Blind Period||0
197598|NCT00813709|473697|P5|STARTED|Double Blind Period||0
197599|NCT00813709|473698|P4|STARTED|Double Blind Period||0
197600|NCT00813709|473699|P3|STARTED|Double Blind Period||99
197601|NCT00813709|473700|P2|STARTED|Double Blind Period||117
197602|NCT00813709|473701|P1|STARTED|Double Blind Period||84
197603|NCT00813592|473781|P1|NOT COMPLETED|Overall Study||2
197604|NCT00813592|473781|P1|COMPLETED|Overall Study||0
197605|NCT00813592|473781|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
197606|NCT00813592|473781|P1|Treated|Overall Study|Two patients were treated.|2
197607|NCT00813592|473781|P1|STARTED|Overall Study||2
197608|NCT00813488|473790|P2|NOT COMPLETED|Open-label Extension||7
197609|NCT00813488|473791|P1|NOT COMPLETED|Open-label Extension||12
197610|NCT00813488|473790|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
197611|NCT00813488|473791|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
197612|NCT00813488|473790|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
197613|NCT00813488|473791|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
197614|NCT00813488|473790|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
197615|NCT00813488|473791|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
197616|NCT00813488|473790|P2|COMPLETED|Double-blind Treatment Period 2||65
197617|NCT00813488|473791|P1|COMPLETED|Double-blind Treatment Period 2||66
197618|NCT00813488|473790|P2|STARTED|Double-blind Treatment Period 2||66
197619|NCT00813488|473791|P1|STARTED|Double-blind Treatment Period 2||71
197620|NCT00813488|473790|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
197621|NCT00813488|473791|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
197622|NCT00813488|473790|P2|COMPLETED|Double-blind Treatment Period 1||66
197623|NCT00813488|473791|P1|COMPLETED|Double-blind Treatment Period 1||71
197624|NCT00813488|473790|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
197625|NCT00813488|473791|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
197626|NCT00813488|473790|P2|NOT COMPLETED|Titration Period 2||10
197627|NCT00813488|473791|P1|NOT COMPLETED|Titration Period 2||16
197628|NCT00813488|473790|P2|COMPLETED|Titration Period 2||79
197629|NCT00813488|473791|P1|COMPLETED|Titration Period 2||64
197630|NCT00813488|473790|P2|STARTED|Titration Period 2||89
197631|NCT00813488|473791|P1|STARTED|Titration Period 2||80
197632|NCT00813488|473790|P2|NOT COMPLETED|Titration Period 1||17
197633|NCT00813488|473791|P1|NOT COMPLETED|Titration Period 1||27
197634|NCT00813488|473790|P2|COMPLETED|Titration Period 1||89
197635|NCT00813488|473791|P1|COMPLETED|Titration Period 1||80
197636|NCT00813488|473790|P2|STARTED|Titration Period 1||106
197637|NCT00813488|473791|P1|STARTED|Titration Period 1||107
197638|NCT00813319|473889|P2|NOT COMPLETED|Overall Study||0
197639|NCT00813319|473890|P1|NOT COMPLETED|Overall Study||0
197640|NCT00813319|473889|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
197641|NCT00813319|473890|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
197642|NCT00813319|473889|P2|STARTED|Overall Study||108
197643|NCT00813319|473890|P1|STARTED|Overall Study||108
197644|NCT00813150|473902|P2|NOT COMPLETED|Long Term Follow-up||31
197645|NCT00813150|473903|P1|NOT COMPLETED|Long Term Follow-up||24
197646|NCT00813150|473902|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
197647|NCT00813150|473903|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
197648|NCT00813150|473902|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
197649|NCT00813150|473903|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
197651|NCT00813150|473903|P1|NOT COMPLETED|Treatment Period||32
197652|NCT00813150|473902|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
197653|NCT00813150|473903|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
197654|NCT00813150|473902|P2|Intent-to-treat Participants|Treatment Period||47
197655|NCT00813150|473903|P1|Intent-to-treat Participants|Treatment Period||43
197656|NCT00813150|473902|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
197657|NCT00813150|473903|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
197658|NCT00813111|473917|P2|NOT COMPLETED|Overall Study||0
197659|NCT00813111|473918|P1|NOT COMPLETED|Overall Study||2
197660|NCT00813111|473917|P2|COMPLETED|Overall Study||70
197661|NCT00813111|473918|P1|COMPLETED|Overall Study||64
197662|NCT00813111|473917|P2|STARTED|Overall Study||70
197663|NCT00813111|473918|P1|STARTED|Overall Study||66
197664|NCT00813098|473927|P3|NOT COMPLETED|Overall Study||2
197665|NCT00813098|473928|P2|NOT COMPLETED|Overall Study||8
197666|NCT00813098|473929|P1|NOT COMPLETED|Overall Study||3
197667|NCT00813098|473927|P3|COMPLETED|Overall Study||50
197668|NCT00813098|473928|P2|COMPLETED|Overall Study||46
197669|NCT00813098|473929|P1|COMPLETED|Overall Study||46
197670|NCT00813098|473927|P3|STARTED|Overall Study||52
197671|NCT00813098|473928|P2|STARTED|Overall Study||54
197672|NCT00813098|473929|P1|STARTED|Overall Study||49
197673|NCT00812981|473954|P2|NOT COMPLETED|Overall Study||1
197674|NCT00812981|473955|P1|NOT COMPLETED|Overall Study||0
197675|NCT00812981|473954|P2|COMPLETED|Overall Study||159
197676|NCT00812981|473955|P1|COMPLETED|Overall Study||160
197677|NCT00812981|473954|P2|STARTED|Overall Study||160
197678|NCT00812981|473955|P1|STARTED|Overall Study||160
197679|NCT00812968|473993|P1|NOT COMPLETED|Overall Study||11
197680|NCT00812968|473993|P1|COMPLETED|Overall Study||0
197681|NCT00812968|473993|P1|STARTED|Overall Study||11
197682|NCT00812955|474028|P4|NOT COMPLETED|Overall Study||8
197683|NCT00812955|474029|P3|NOT COMPLETED|Overall Study||6
197684|NCT00812955|474030|P2|NOT COMPLETED|Overall Study||7
197685|NCT00812955|474031|P1|NOT COMPLETED|Overall Study||10
197686|NCT00812955|474028|P4|COMPLETED|Overall Study||110
197687|NCT00812955|474029|P3|COMPLETED|Overall Study||113
197688|NCT00812955|474030|P2|COMPLETED|Overall Study||111
197689|NCT00812955|474031|P1|COMPLETED|Overall Study||109
197690|NCT00812955|474028|P4|STARTED|Overall Study||118
197691|NCT00812955|474029|P3|STARTED|Overall Study||119
197692|NCT00812955|474030|P2|STARTED|Overall Study||118
197693|NCT00812955|474031|P1|STARTED|Overall Study||119
197694|NCT00812929|474051|P10|NOT COMPLETED|Treatment Period 5||0
197695|NCT00812929|474052|P9|NOT COMPLETED|Treatment Period 5||0
197696|NCT00812929|474053|P8|NOT COMPLETED|Treatment Period 5||0
197697|NCT00812929|474054|P7|NOT COMPLETED|Treatment Period 5||0
197698|NCT00812929|474055|P6|NOT COMPLETED|Treatment Period 5||0
197699|NCT00812929|474056|P5|NOT COMPLETED|Treatment Period 5||0
197700|NCT00812929|474057|P4|NOT COMPLETED|Treatment Period 5||0
197701|NCT00812929|474058|P3|NOT COMPLETED|Treatment Period 5||0
197702|NCT00812929|474059|P2|NOT COMPLETED|Treatment Period 5||0
197703|NCT00812929|474060|P1|NOT COMPLETED|Treatment Period 5||0
197704|NCT00812929|474051|P10|COMPLETED|Treatment Period 5||4
197705|NCT00812929|474052|P9|COMPLETED|Treatment Period 5||4
197706|NCT00812929|474053|P8|COMPLETED|Treatment Period 5||5
197707|NCT00812929|474054|P7|COMPLETED|Treatment Period 5||5
197708|NCT00812929|474055|P6|COMPLETED|Treatment Period 5||4
197709|NCT00812929|474056|P5|COMPLETED|Treatment Period 5||5
197710|NCT00812929|474057|P4|COMPLETED|Treatment Period 5||4
197711|NCT00812929|474058|P3|COMPLETED|Treatment Period 5||4
197712|NCT00812929|474059|P2|COMPLETED|Treatment Period 5||4
197713|NCT00812929|474060|P1|COMPLETED|Treatment Period 5||5
197714|NCT00812929|474051|P10|STARTED|Treatment Period 5||4
197715|NCT00812929|474052|P9|STARTED|Treatment Period 5||4
197716|NCT00812929|474053|P8|STARTED|Treatment Period 5||5
197717|NCT00812929|474054|P7|STARTED|Treatment Period 5||5
197718|NCT00812929|474055|P6|STARTED|Treatment Period 5||4
197719|NCT00812929|474056|P5|STARTED|Treatment Period 5||5
197720|NCT00812929|474057|P4|STARTED|Treatment Period 5||4
197721|NCT00812929|474058|P3|STARTED|Treatment Period 5||4
197722|NCT00812929|474059|P2|STARTED|Treatment Period 5||4
197723|NCT00812929|474060|P1|STARTED|Treatment Period 5||5
197724|NCT00812929|474051|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
197725|NCT00812929|474052|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
197726|NCT00812929|474053|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
197727|NCT00812929|474054|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
197728|NCT00812929|474055|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
197729|NCT00812929|474056|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
197730|NCT00812929|474057|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
197731|NCT00812929|474058|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
197732|NCT00812929|474059|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
197733|NCT00812929|474060|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
197734|NCT00812929|474051|P10|COMPLETED|Washout Period 4 (7 Days)||4
197735|NCT00812929|474052|P9|COMPLETED|Washout Period 4 (7 Days)||4
197736|NCT00812929|474053|P8|COMPLETED|Washout Period 4 (7 Days)||5
197737|NCT00812929|474054|P7|COMPLETED|Washout Period 4 (7 Days)||5
197738|NCT00812929|474055|P6|COMPLETED|Washout Period 4 (7 Days)||4
197739|NCT00812929|474056|P5|COMPLETED|Washout Period 4 (7 Days)||5
197740|NCT00812929|474057|P4|COMPLETED|Washout Period 4 (7 Days)||4
197741|NCT00812929|474058|P3|COMPLETED|Washout Period 4 (7 Days)||4
197742|NCT00812929|474059|P2|COMPLETED|Washout Period 4 (7 Days)||4
197743|NCT00812929|474060|P1|COMPLETED|Washout Period 4 (7 Days)||5
197744|NCT00812929|474051|P10|STARTED|Washout Period 4 (7 Days)||4
197745|NCT00812929|474052|P9|STARTED|Washout Period 4 (7 Days)||4
197746|NCT00812929|474053|P8|STARTED|Washout Period 4 (7 Days)||5
197747|NCT00812929|474054|P7|STARTED|Washout Period 4 (7 Days)||5
197748|NCT00812929|474055|P6|STARTED|Washout Period 4 (7 Days)||4
197749|NCT00812929|474056|P5|STARTED|Washout Period 4 (7 Days)||5
197750|NCT00812929|474057|P4|STARTED|Washout Period 4 (7 Days)||4
197751|NCT00812929|474058|P3|STARTED|Washout Period 4 (7 Days)||4
197752|NCT00812929|474059|P2|STARTED|Washout Period 4 (7 Days)||4
197753|NCT00812929|474060|P1|STARTED|Washout Period 4 (7 Days)||5
197754|NCT00812929|474051|P10|NOT COMPLETED|Treatment Period 4||0
197755|NCT00812929|474052|P9|NOT COMPLETED|Treatment Period 4||0
197756|NCT00812929|474053|P8|NOT COMPLETED|Treatment Period 4||0
197757|NCT00812929|474054|P7|NOT COMPLETED|Treatment Period 4||0
197758|NCT00812929|474055|P6|NOT COMPLETED|Treatment Period 4||0
197759|NCT00812929|474056|P5|NOT COMPLETED|Treatment Period 4||0
197760|NCT00812929|474057|P4|NOT COMPLETED|Treatment Period 4||0
197761|NCT00812929|474058|P3|NOT COMPLETED|Treatment Period 4||0
197762|NCT00812929|474059|P2|NOT COMPLETED|Treatment Period 4||0
197763|NCT00812929|474060|P1|NOT COMPLETED|Treatment Period 4||0
197764|NCT00812929|474051|P10|COMPLETED|Treatment Period 4||4
197765|NCT00812929|474052|P9|COMPLETED|Treatment Period 4||4
197766|NCT00812929|474053|P8|COMPLETED|Treatment Period 4||5
197767|NCT00812929|474054|P7|COMPLETED|Treatment Period 4||5
197768|NCT00812929|474055|P6|COMPLETED|Treatment Period 4||4
197769|NCT00812929|474056|P5|COMPLETED|Treatment Period 4||5
197770|NCT00812929|474057|P4|COMPLETED|Treatment Period 4||4
197771|NCT00812929|474058|P3|COMPLETED|Treatment Period 4||4
197772|NCT00812929|474059|P2|COMPLETED|Treatment Period 4||4
197773|NCT00812929|474060|P1|COMPLETED|Treatment Period 4||5
197774|NCT00812929|474051|P10|STARTED|Treatment Period 4||4
197775|NCT00812929|474052|P9|STARTED|Treatment Period 4||4
197776|NCT00812929|474053|P8|STARTED|Treatment Period 4||5
197777|NCT00812929|474054|P7|STARTED|Treatment Period 4||5
197778|NCT00812929|474055|P6|STARTED|Treatment Period 4||4
197779|NCT00812929|474056|P5|STARTED|Treatment Period 4||5
197780|NCT00812929|474057|P4|STARTED|Treatment Period 4||4
197781|NCT00812929|474058|P3|STARTED|Treatment Period 4||4
197782|NCT00812929|474059|P2|STARTED|Treatment Period 4||4
197783|NCT00812929|474060|P1|STARTED|Treatment Period 4||5
197784|NCT00812929|474051|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
197785|NCT00812929|474052|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
197786|NCT00812929|474053|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
197787|NCT00812929|474054|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
197788|NCT00812929|474055|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
197789|NCT00812929|474056|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
197790|NCT00812929|474057|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
197791|NCT00812929|474058|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
197792|NCT00812929|474059|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
197793|NCT00812929|474060|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
197794|NCT00812929|474051|P10|COMPLETED|Washout Period 3 (7 Days)||4
197795|NCT00812929|474052|P9|COMPLETED|Washout Period 3 (7 Days)||4
197796|NCT00812929|474053|P8|COMPLETED|Washout Period 3 (7 Days)||5
197797|NCT00812929|474054|P7|COMPLETED|Washout Period 3 (7 Days)||5
197798|NCT00812929|474055|P6|COMPLETED|Washout Period 3 (7 Days)||4
197799|NCT00812929|474056|P5|COMPLETED|Washout Period 3 (7 Days)||5
197800|NCT00812929|474057|P4|COMPLETED|Washout Period 3 (7 Days)||4
197801|NCT00812929|474058|P3|COMPLETED|Washout Period 3 (7 Days)||4
197802|NCT00812929|474059|P2|COMPLETED|Washout Period 3 (7 Days)||4
197803|NCT00812929|474060|P1|COMPLETED|Washout Period 3 (7 Days)||5
197804|NCT00812929|474051|P10|STARTED|Washout Period 3 (7 Days)||4
197805|NCT00812929|474052|P9|STARTED|Washout Period 3 (7 Days)||4
197806|NCT00812929|474053|P8|STARTED|Washout Period 3 (7 Days)||5
197807|NCT00812929|474054|P7|STARTED|Washout Period 3 (7 Days)||5
197808|NCT00812929|474055|P6|STARTED|Washout Period 3 (7 Days)||5
197809|NCT00812929|474056|P5|STARTED|Washout Period 3 (7 Days)||5
197810|NCT00812929|474057|P4|STARTED|Washout Period 3 (7 Days)||4
197811|NCT00812929|474058|P3|STARTED|Washout Period 3 (7 Days)||4
197812|NCT00812929|474059|P2|STARTED|Washout Period 3 (7 Days)||4
197813|NCT00812929|474060|P1|STARTED|Washout Period 3 (7 Days)||5
197814|NCT00812929|474051|P10|NOT COMPLETED|Treatment Period 3||0
197815|NCT00812929|474052|P9|NOT COMPLETED|Treatment Period 3||0
197816|NCT00812929|474053|P8|NOT COMPLETED|Treatment Period 3||0
197817|NCT00812929|474054|P7|NOT COMPLETED|Treatment Period 3||0
197818|NCT00812929|474055|P6|NOT COMPLETED|Treatment Period 3||0
197819|NCT00812929|474056|P5|NOT COMPLETED|Treatment Period 3||0
197820|NCT00812929|474057|P4|NOT COMPLETED|Treatment Period 3||0
197821|NCT00812929|474058|P3|NOT COMPLETED|Treatment Period 3||0
197822|NCT00812929|474059|P2|NOT COMPLETED|Treatment Period 3||0
197823|NCT00812929|474060|P1|NOT COMPLETED|Treatment Period 3||0
197824|NCT00812929|474051|P10|COMPLETED|Treatment Period 3||4
197825|NCT00812929|474052|P9|COMPLETED|Treatment Period 3||4
197826|NCT00812929|474053|P8|COMPLETED|Treatment Period 3||5
197827|NCT00812929|474054|P7|COMPLETED|Treatment Period 3||5
197828|NCT00812929|474055|P6|COMPLETED|Treatment Period 3||5
197829|NCT00812929|474056|P5|COMPLETED|Treatment Period 3||5
197830|NCT00812929|474057|P4|COMPLETED|Treatment Period 3||4
197831|NCT00812929|474058|P3|COMPLETED|Treatment Period 3||4
197832|NCT00812929|474059|P2|COMPLETED|Treatment Period 3||4
197833|NCT00812929|474060|P1|COMPLETED|Treatment Period 3||5
197834|NCT00812929|474051|P10|STARTED|Treatment Period 3||4
197835|NCT00812929|474052|P9|STARTED|Treatment Period 3||4
197836|NCT00812929|474053|P8|STARTED|Treatment Period 3||5
197837|NCT00812929|474054|P7|STARTED|Treatment Period 3||5
197838|NCT00812929|474055|P6|STARTED|Treatment Period 3||5
197839|NCT00812929|474056|P5|STARTED|Treatment Period 3||5
197840|NCT00812929|474057|P4|STARTED|Treatment Period 3||4
197841|NCT00812929|474058|P3|STARTED|Treatment Period 3||4
197842|NCT00812929|474059|P2|STARTED|Treatment Period 3||4
197843|NCT00812929|474060|P1|STARTED|Treatment Period 3||5
197844|NCT00812929|474051|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
197845|NCT00812929|474052|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
197846|NCT00812929|474053|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
197847|NCT00812929|474054|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
197848|NCT00812929|474055|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
197849|NCT00812929|474056|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
197850|NCT00812929|474057|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
197851|NCT00812929|474058|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
197852|NCT00812929|474059|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
197853|NCT00812929|474060|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
197854|NCT00812929|474051|P10|COMPLETED|Washout Period 2 (7 Days)||4
197855|NCT00812929|474052|P9|COMPLETED|Washout Period 2 (7 Days)||4
197856|NCT00812929|474053|P8|COMPLETED|Washout Period 2 (7 Days)||5
197857|NCT00812929|474054|P7|COMPLETED|Washout Period 2 (7 Days)||5
197858|NCT00812929|474055|P6|COMPLETED|Washout Period 2 (7 Days)||5
197859|NCT00812929|474056|P5|COMPLETED|Washout Period 2 (7 Days)||5
197860|NCT00812929|474057|P4|COMPLETED|Washout Period 2 (7 Days)||4
197861|NCT00812929|474058|P3|COMPLETED|Washout Period 2 (7 Days)||4
197862|NCT00812929|474059|P2|COMPLETED|Washout Period 2 (7 Days)||4
197863|NCT00812929|474060|P1|COMPLETED|Washout Period 2 (7 Days)||5
197864|NCT00812929|474051|P10|STARTED|Washout Period 2 (7 Days)||5
197865|NCT00812929|474052|P9|STARTED|Washout Period 2 (7 Days)||4
197866|NCT00812929|474053|P8|STARTED|Washout Period 2 (7 Days)||5
197867|NCT00812929|474054|P7|STARTED|Washout Period 2 (7 Days)||5
197868|NCT00812929|474055|P6|STARTED|Washout Period 2 (7 Days)||5
197869|NCT00812929|474056|P5|STARTED|Washout Period 2 (7 Days)||5
197870|NCT00812929|474057|P4|STARTED|Washout Period 2 (7 Days)||4
197871|NCT00812929|474058|P3|STARTED|Washout Period 2 (7 Days)||4
197872|NCT00812929|474059|P2|STARTED|Washout Period 2 (7 Days)||4
197873|NCT00812929|474060|P1|STARTED|Washout Period 2 (7 Days)||5
197874|NCT00812929|474051|P10|NOT COMPLETED|Treatment Period 2||0
197875|NCT00812929|474052|P9|NOT COMPLETED|Treatment Period 2||0
197876|NCT00812929|474053|P8|NOT COMPLETED|Treatment Period 2||0
197877|NCT00812929|474054|P7|NOT COMPLETED|Treatment Period 2||0
197878|NCT00812929|474055|P6|NOT COMPLETED|Treatment Period 2||0
197879|NCT00812929|474056|P5|NOT COMPLETED|Treatment Period 2||0
197880|NCT00812929|474057|P4|NOT COMPLETED|Treatment Period 2||0
197881|NCT00812929|474058|P3|NOT COMPLETED|Treatment Period 2||0
197882|NCT00812929|474059|P2|NOT COMPLETED|Treatment Period 2||0
197883|NCT00812929|474060|P1|NOT COMPLETED|Treatment Period 2||0
197884|NCT00812929|474051|P10|COMPLETED|Treatment Period 2||5
197885|NCT00812929|474052|P9|COMPLETED|Treatment Period 2||4
197886|NCT00812929|474053|P8|COMPLETED|Treatment Period 2||5
197887|NCT00812929|474054|P7|COMPLETED|Treatment Period 2||5
197888|NCT00812929|474055|P6|COMPLETED|Treatment Period 2||5
197889|NCT00812929|474056|P5|COMPLETED|Treatment Period 2||5
197890|NCT00812929|474057|P4|COMPLETED|Treatment Period 2||4
197891|NCT00812929|474058|P3|COMPLETED|Treatment Period 2||4
197892|NCT00812929|474059|P2|COMPLETED|Treatment Period 2||4
197893|NCT00812929|474060|P1|COMPLETED|Treatment Period 2||5
197894|NCT00812929|474051|P10|STARTED|Treatment Period 2||5
197895|NCT00812929|474052|P9|STARTED|Treatment Period 2||4
197896|NCT00812929|474053|P8|STARTED|Treatment Period 2||5
197897|NCT00812929|474054|P7|STARTED|Treatment Period 2||5
197898|NCT00812929|474055|P6|STARTED|Treatment Period 2||5
197899|NCT00812929|474056|P5|STARTED|Treatment Period 2||5
197900|NCT00812929|474057|P4|STARTED|Treatment Period 2||4
197901|NCT00812929|474058|P3|STARTED|Treatment Period 2||4
197902|NCT00812929|474059|P2|STARTED|Treatment Period 2||4
197903|NCT00812929|474060|P1|STARTED|Treatment Period 2||5
197904|NCT00812929|474051|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
197905|NCT00812929|474052|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
197906|NCT00812929|474053|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
197907|NCT00812929|474054|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
197908|NCT00812929|474055|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
197909|NCT00812929|474056|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
197910|NCT00812929|474057|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
197911|NCT00812929|474058|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
197912|NCT00812929|474059|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
197913|NCT00812929|474060|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
197914|NCT00812929|474051|P10|COMPLETED|Washout Period 1 (7 Days)||5
197915|NCT00812929|474052|P9|COMPLETED|Washout Period 1 (7 Days)||4
197916|NCT00812929|474053|P8|COMPLETED|Washout Period 1 (7 Days)||5
197917|NCT00812929|474054|P7|COMPLETED|Washout Period 1 (7 Days)||5
197918|NCT00812929|474055|P6|COMPLETED|Washout Period 1 (7 Days)||5
197919|NCT00812929|474056|P5|COMPLETED|Washout Period 1 (7 Days)||5
197920|NCT00812929|474057|P4|COMPLETED|Washout Period 1 (7 Days)||4
197921|NCT00812929|474058|P3|COMPLETED|Washout Period 1 (7 Days)||4
197922|NCT00812929|474059|P2|COMPLETED|Washout Period 1 (7 Days)||4
197923|NCT00812929|474060|P1|COMPLETED|Washout Period 1 (7 Days)||5
197924|NCT00812929|474051|P10|STARTED|Washout Period 1 (7 Days)||5
197925|NCT00812929|474052|P9|STARTED|Washout Period 1 (7 Days)||4
197926|NCT00812929|474053|P8|STARTED|Washout Period 1 (7 Days)||5
197927|NCT00812929|474054|P7|STARTED|Washout Period 1 (7 Days)||5
197928|NCT00812929|474055|P6|STARTED|Washout Period 1 (7 Days)||5
197929|NCT00812929|474056|P5|STARTED|Washout Period 1 (7 Days)||5
197930|NCT00812929|474057|P4|STARTED|Washout Period 1 (7 Days)||4
197931|NCT00812929|474058|P3|STARTED|Washout Period 1 (7 Days)||5
197932|NCT00812929|474059|P2|STARTED|Washout Period 1 (7 Days)||4
197933|NCT00812929|474060|P1|STARTED|Washout Period 1 (7 Days)||5
197934|NCT00812929|474051|P10|NOT COMPLETED|Treatment Period 1||0
197935|NCT00812929|474052|P9|NOT COMPLETED|Treatment Period 1||0
197936|NCT00812929|474053|P8|NOT COMPLETED|Treatment Period 1||0
197937|NCT00812929|474054|P7|NOT COMPLETED|Treatment Period 1||0
197938|NCT00812929|474055|P6|NOT COMPLETED|Treatment Period 1||0
197939|NCT00812929|474056|P5|NOT COMPLETED|Treatment Period 1||0
197940|NCT00812929|474057|P4|NOT COMPLETED|Treatment Period 1||0
197941|NCT00812929|474058|P3|NOT COMPLETED|Treatment Period 1||0
197942|NCT00812929|474059|P2|NOT COMPLETED|Treatment Period 1||0
197943|NCT00812929|474060|P1|NOT COMPLETED|Treatment Period 1||0
197944|NCT00812929|474051|P10|COMPLETED|Treatment Period 1||5
197945|NCT00812929|474052|P9|COMPLETED|Treatment Period 1||4
197946|NCT00812929|474053|P8|COMPLETED|Treatment Period 1||5
197947|NCT00812929|474054|P7|COMPLETED|Treatment Period 1||5
197948|NCT00812929|474055|P6|COMPLETED|Treatment Period 1||5
197949|NCT00812929|474056|P5|COMPLETED|Treatment Period 1||5
197950|NCT00812929|474057|P4|COMPLETED|Treatment Period 1||4
197951|NCT00812929|474058|P3|COMPLETED|Treatment Period 1||5
197952|NCT00812929|474059|P2|COMPLETED|Treatment Period 1||4
197953|NCT00812929|474060|P1|COMPLETED|Treatment Period 1||5
197954|NCT00812929|474051|P10|STARTED|Treatment Period 1||5
197955|NCT00812929|474052|P9|STARTED|Treatment Period 1||4
197956|NCT00812929|474053|P8|STARTED|Treatment Period 1||5
197957|NCT00812929|474054|P7|STARTED|Treatment Period 1||5
197958|NCT00812929|474055|P6|STARTED|Treatment Period 1||5
197959|NCT00812929|474056|P5|STARTED|Treatment Period 1||5
197960|NCT00812929|474057|P4|STARTED|Treatment Period 1||4
197961|NCT00812929|474058|P3|STARTED|Treatment Period 1||5
197962|NCT00812929|474059|P2|STARTED|Treatment Period 1||4
197963|NCT00812929|474060|P1|STARTED|Treatment Period 1||5
197964|NCT00812916|474176|P1|NOT COMPLETED|Overall Study||3
197965|NCT00812916|474176|P1|COMPLETED|Overall Study||203
197966|NCT00812916|474176|P1|CFAE - Guided Ablation|Overall Study||203
197967|NCT00812916|474176|P1|Data Available|Overall Study||205
197968|NCT00812916|474176|P1|STARTED|Overall Study|206 enrolled (consented)|206
197969|NCT00812877|474187|P2|NOT COMPLETED|Overall Study||51
197970|NCT00812877|474188|P1|NOT COMPLETED|Overall Study||37
197971|NCT00812877|474187|P2|COMPLETED|Overall Study||130
197972|NCT00812877|474188|P1|COMPLETED|Overall Study||158
197973|NCT00812877|474187|P2|STARTED|Overall Study||181
197974|NCT00812877|474188|P1|STARTED|Overall Study||195
197975|NCT00812812|474198|P2|NOT COMPLETED|Overall Study||4
197976|NCT00812812|474199|P1|NOT COMPLETED|Overall Study||3
197977|NCT00812812|474198|P2|COMPLETED|Overall Study||25
197978|NCT00812812|474199|P1|COMPLETED|Overall Study||24
197979|NCT00812812|474198|P2|STARTED|Overall Study||29
197980|NCT00812812|474199|P1|STARTED|Overall Study||27
197981|NCT00812604|474214|P2|NOT COMPLETED|Overall Study||5
197982|NCT00812604|474215|P1|NOT COMPLETED|Overall Study||5
197983|NCT00812604|474214|P2|COMPLETED|Overall Study||22
197984|NCT00812604|474215|P1|COMPLETED|Overall Study||23
197985|NCT00812604|474214|P2|STARTED|Overall Study||27
197986|NCT00812604|474215|P1|STARTED|Overall Study||28
197987|NCT00812565|474231|P8|NOT COMPLETED|Overall Study||1
197988|NCT00812565|474232|P7|NOT COMPLETED|Overall Study||0
197989|NCT00812565|474233|P6|NOT COMPLETED|Overall Study||1
197990|NCT00812565|474234|P5|NOT COMPLETED|Overall Study||1
197991|NCT00812565|474235|P4|NOT COMPLETED|Overall Study||2
197992|NCT00812565|474236|P3|NOT COMPLETED|Overall Study||0
197993|NCT00812565|474237|P2|NOT COMPLETED|Overall Study||1
197994|NCT00812565|474238|P1|NOT COMPLETED|Overall Study||3
197995|NCT00812565|474231|P8|COMPLETED|Overall Study||6
197996|NCT00812565|474232|P7|COMPLETED|Overall Study||8
197997|NCT00812565|474233|P6|COMPLETED|Overall Study||6
197998|NCT00812565|474234|P5|COMPLETED|Overall Study||6
197999|NCT00812565|474235|P4|COMPLETED|Overall Study||5
198000|NCT00812565|474236|P3|COMPLETED|Overall Study||7
198001|NCT00812565|474237|P2|COMPLETED|Overall Study||6
198002|NCT00812565|474238|P1|COMPLETED|Overall Study||5
198003|NCT00812565|474231|P8|STARTED|Overall Study||7
198004|NCT00812565|474232|P7|STARTED|Overall Study||8
198005|NCT00812565|474233|P6|STARTED|Overall Study||7
198006|NCT00812565|474234|P5|STARTED|Overall Study||7
198007|NCT00812565|474235|P4|STARTED|Overall Study||7
198008|NCT00812565|474236|P3|STARTED|Overall Study||7
198009|NCT00812565|474237|P2|STARTED|Overall Study||7
198010|NCT00812565|474238|P1|STARTED|Overall Study||8
198011|NCT00812487|474362|P2|NOT COMPLETED|Overall Study||3
198012|NCT00812487|474363|P1|NOT COMPLETED|Overall Study||6
198013|NCT00812487|474362|P2|COMPLETED|Overall Study||39
198014|NCT00812487|474363|P1|COMPLETED|Overall Study||26
198015|NCT00812487|474362|P2|STARTED|Overall Study||42
198016|NCT00812487|474363|P1|STARTED|Overall Study||32
198017|NCT00812461|474389|P2|NOT COMPLETED|All Treated Patients||147
198018|NCT00812461|474390|P1|NOT COMPLETED|All Treated Patients||132
198019|NCT00812461|474389|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
198020|NCT00812461|474390|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
198021|NCT00812461|474389|P2|STARTED|All Treated Patients||341
198022|NCT00812461|474390|P1|STARTED|All Treated Patients||337
198023|NCT00812461|474389|P2|NOT COMPLETED|All Randomised Patients||17
198024|NCT00812461|474390|P1|NOT COMPLETED|All Randomised Patients||23
198025|NCT00812461|474389|P2|COMPLETED|All Randomised Patients||341
198026|NCT00812461|474390|P1|COMPLETED|All Randomised Patients||337
198027|NCT00812461|474389|P2|STARTED|All Randomised Patients||358
198028|NCT00812461|474390|P1|STARTED|All Randomised Patients||360
198029|NCT00812331|474413|P5|NOT COMPLETED|Overall Study||0
198030|NCT00812331|474414|P4|NOT COMPLETED|Overall Study||0
198031|NCT00812331|474415|P3|NOT COMPLETED|Overall Study||0
198032|NCT00812331|474416|P2|NOT COMPLETED|Overall Study||0
198033|NCT00812331|474417|P1|NOT COMPLETED|Overall Study||1
198034|NCT00812331|474413|P5|COMPLETED|Overall Study||8
198035|NCT00812331|474414|P4|COMPLETED|Overall Study||7
198036|NCT00812331|474415|P3|COMPLETED|Overall Study||8
198037|NCT00812331|474416|P2|COMPLETED|Overall Study||8
198038|NCT00812331|474417|P1|COMPLETED|Overall Study||5
198039|NCT00812331|474413|P5|STARTED|Overall Study||8
198040|NCT00812331|474414|P4|STARTED|Overall Study||7
198041|NCT00812331|474415|P3|STARTED|Overall Study||8
198042|NCT00812331|474416|P2|STARTED|Overall Study||8
198043|NCT00812331|474417|P1|STARTED|Overall Study||6
198044|NCT00812253|474492|P2|NOT COMPLETED|Overall Study||3
198045|NCT00812253|474493|P1|NOT COMPLETED|Overall Study||6
198046|NCT00812253|474492|P2|COMPLETED|Overall Study||39
198047|NCT00812253|474493|P1|COMPLETED|Overall Study||26
198048|NCT00812253|474492|P2|STARTED|Overall Study||42
198049|NCT00812253|474493|P1|STARTED|Overall Study||32
198050|NCT00812110|474509|P1|NOT COMPLETED|Overall Study||0
198051|NCT00812110|474509|P1|COMPLETED|Overall Study||292
198052|NCT00812110|474509|P1|STARTED|Overall Study||292
198053|NCT00812097|474518|P4|NOT COMPLETED|Overall Study||35
198054|NCT00812097|474519|P3|NOT COMPLETED|Overall Study||57
198055|NCT00812097|474520|P2|NOT COMPLETED|Overall Study||89
198056|NCT00812097|474521|P1|NOT COMPLETED|Overall Study||245
198057|NCT00812097|474518|P4|COMPLETED|Overall Study||34
198058|NCT00812097|474519|P3|COMPLETED|Overall Study||67
198059|NCT00812097|474520|P2|COMPLETED|Overall Study||101
198060|NCT00812097|474521|P1|COMPLETED|Overall Study||327
198061|NCT00812097|474518|P4|STARTED|Overall Study||69
198062|NCT00812097|474519|P3|STARTED|Overall Study||124
198063|NCT00812097|474520|P2|STARTED|Overall Study||190
198064|NCT00812097|474521|P1|STARTED|Overall Study||572
198065|NCT00812006|474550|P3|NOT COMPLETED|Overall Study||6
198066|NCT00812006|474551|P2|NOT COMPLETED|Overall Study||3
198067|NCT00812006|474552|P1|NOT COMPLETED|Overall Study||6
198068|NCT00812006|474550|P3|COMPLETED|Overall Study||30
198069|NCT00812006|474551|P2|COMPLETED|Overall Study||33
198070|NCT00812006|474552|P1|COMPLETED|Overall Study||30
198071|NCT00812006|474550|P3|STARTED|Overall Study||36
198072|NCT00812006|474551|P2|STARTED|Overall Study||36
198073|NCT00812006|474552|P1|STARTED|Overall Study||36
198074|NCT00811954|474569|P3|NOT COMPLETED|Overall Study||101
198075|NCT00811954|474570|P2|NOT COMPLETED|Overall Study||72
198076|NCT00811954|474571|P1|NOT COMPLETED|Overall Study||89
198077|NCT00811954|474569|P3|COMPLETED|Overall Study||500
198078|NCT00811954|474570|P2|COMPLETED|Overall Study||531
198079|NCT00811954|474571|P1|COMPLETED|Overall Study||516
198080|NCT00811954|474569|P3|STARTED|Overall Study||601
198081|NCT00811954|474570|P2|STARTED|Overall Study||603
198082|NCT00811954|474571|P1|STARTED|Overall Study||605
198083|NCT00811941|474635|P2|NOT COMPLETED|All Treated Patients||191
198084|NCT00811941|474636|P1|NOT COMPLETED|All Treated Patients||52
198085|NCT00811941|474635|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
198086|NCT00811941|474636|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
198087|NCT00811941|474635|P2|STARTED|All Treated Patients||501
198088|NCT00811941|474636|P1|STARTED|All Treated Patients||164
198089|NCT00811941|474635|P2|NOT COMPLETED|All Randomised Patients||8
198090|NCT00811941|474636|P1|NOT COMPLETED|All Randomised Patients||2
198091|NCT00811941|474635|P2|COMPLETED|All Randomised Patients||501
198092|NCT00811941|474636|P1|COMPLETED|All Randomised Patients||164
198093|NCT00811941|474635|P2|STARTED|All Randomised Patients||509
198094|NCT00811941|474636|P1|STARTED|All Randomised Patients||166
198095|NCT00811928|474674|P2|NOT COMPLETED|Overall Study||33
198096|NCT00811928|474675|P1|NOT COMPLETED|Overall Study||39
198097|NCT00811928|474674|P2|COMPLETED|Overall Study||90
198098|NCT00811928|474675|P1|COMPLETED|Overall Study||90
198099|NCT00811928|474674|P2|STARTED|Overall Study||123
198100|NCT00811928|474675|P1|STARTED|Overall Study||129
198101|NCT00811850|474693|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
198102|NCT00811850|474693|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
198103|NCT00811850|474693|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
198104|NCT00811850|474693|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
198105|NCT00811850|474693|P1|COMPLETED|Treatment Period 2: Wash Out||15
198106|NCT00811850|474693|P1|STARTED|Treatment Period 2: Wash Out||15
198107|NCT00811850|474693|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
198108|NCT00811850|474693|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
198109|NCT00811850|474693|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
198110|NCT00811798|474713|P1|NOT COMPLETED|Overall Study||0
198111|NCT00811798|474713|P1|COMPLETED|Overall Study||92
198112|NCT00811798|474713|P1|STARTED|Overall Study||92
198113|NCT00811733|474719|P2|NOT COMPLETED|Overall Study||10
198114|NCT00811733|474720|P1|NOT COMPLETED|Overall Study||11
198115|NCT00811733|474719|P2|COMPLETED|Overall Study||12
198116|NCT00811733|474720|P1|COMPLETED|Overall Study||4
198117|NCT00811733|474719|P2|STARTED|Overall Study||22
198118|NCT00811733|474720|P1|STARTED|Overall Study||15
198119|NCT00811720|474768|P2|NOT COMPLETED|All Treated Patients||164
198120|NCT00811720|474769|P1|NOT COMPLETED|All Treated Patients||96
198121|NCT00811720|474768|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
198122|NCT00811720|474769|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
198123|NCT00811720|474768|P2|STARTED|All Treated Patients||302
198124|NCT00811720|474769|P1|STARTED|All Treated Patients||296
198125|NCT00811720|474768|P2|NOT COMPLETED|All Randomised Patients||4
198126|NCT00811720|474769|P1|NOT COMPLETED|All Randomised Patients||2
198127|NCT00811720|474768|P2|COMPLETED|All Randomised Patients||302
198128|NCT00811720|474769|P1|COMPLETED|All Randomised Patients||296
198129|NCT00811720|474768|P2|STARTED|All Randomised Patients||306
198130|NCT00811720|474769|P1|STARTED|All Randomised Patients||298
198131|NCT00811655|474787|P1|NOT COMPLETED|Overall Study||1
198132|NCT00811655|474787|P1|COMPLETED|Overall Study||5
198133|NCT00811655|474787|P1|STARTED|Overall Study||6
198134|NCT00811642|474799|P1|NOT COMPLETED|Overall Study||15
198135|NCT00811642|474799|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
198136|NCT00811642|474799|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
198137|NCT00811590|474809|P1|NOT COMPLETED|Overall Study||0
198138|NCT00811590|474809|P1|COMPLETED|Overall Study||3
198139|NCT00811590|474809|P1|STARTED|Overall Study||3
198140|NCT00811577|474815|P2|NOT COMPLETED|Overall Study||1
198141|NCT00811577|474816|P1|NOT COMPLETED|Overall Study||10
198142|NCT00811577|474815|P2|COMPLETED|Overall Study||23
198143|NCT00811577|474816|P1|COMPLETED|Overall Study||116
198144|NCT00811577|474815|P2|STARTED|Overall Study||24
198145|NCT00811577|474816|P1|STARTED|Overall Study||126
198146|NCT00811564|474867|P2|NOT COMPLETED|Overall Study||2
198147|NCT00811564|474868|P1|NOT COMPLETED|Overall Study||9
198148|NCT00811564|474867|P2|COMPLETED|Overall Study||73
198149|NCT00811564|474868|P1|COMPLETED|Overall Study||64
198150|NCT00811564|474867|P2|STARTED|Overall Study||75
198151|NCT00811564|474868|P1|STARTED|Overall Study||73
198152|NCT00811473|474876|P2|NOT COMPLETED|Overall Study||26
198153|NCT00811473|474877|P1|NOT COMPLETED|Overall Study||23
198154|NCT00811473|474876|P2|COMPLETED|Overall Study||74
198155|NCT00811473|474877|P1|COMPLETED|Overall Study||70
198156|NCT00811473|474876|P2|STARTED|Overall Study||100
198157|NCT00811473|474877|P1|STARTED|Overall Study||93
198158|NCT00811434|474893|P2|NOT COMPLETED|Second Intervention||0
198159|NCT00811434|474894|P1|NOT COMPLETED|Second Intervention||0
198160|NCT00811434|474893|P2|COMPLETED|Second Intervention||5
198161|NCT00811434|474894|P1|COMPLETED|Second Intervention||4
198162|NCT00811434|474893|P2|STARTED|Second Intervention||5
198163|NCT00811434|474894|P1|STARTED|Second Intervention||4
198164|NCT00811434|474893|P2|NOT COMPLETED|Washout (1 Month)||0
198165|NCT00811434|474894|P1|NOT COMPLETED|Washout (1 Month)||0
198166|NCT00811434|474893|P2|COMPLETED|Washout (1 Month)||5
198167|NCT00811434|474894|P1|COMPLETED|Washout (1 Month)||4
198168|NCT00811434|474893|P2|STARTED|Washout (1 Month)||5
198169|NCT00811434|474894|P1|STARTED|Washout (1 Month)||4
198170|NCT00811434|474893|P2|NOT COMPLETED|First Intervention||0
198171|NCT00811434|474894|P1|NOT COMPLETED|First Intervention||3
198172|NCT00811434|474893|P2|COMPLETED|First Intervention||5
198173|NCT00811434|474894|P1|COMPLETED|First Intervention||4
198174|NCT00811434|474893|P2|STARTED|First Intervention||5
198175|NCT00811434|474894|P1|STARTED|First Intervention||7
198176|NCT00811395|474908|P6|NOT COMPLETED|Extension Treatment||2
198177|NCT00811395|474909|P5|NOT COMPLETED|Extension Treatment||0
198178|NCT00811395|474910|P4|NOT COMPLETED|Extension Treatment||3
198179|NCT00811395|474911|P3|NOT COMPLETED|Extension Treatment||3
198180|NCT00811395|474912|P2|NOT COMPLETED|Extension Treatment||6
198181|NCT00811395|474913|P1|NOT COMPLETED|Extension Treatment||2
198182|NCT00811395|474908|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
198183|NCT00811395|474909|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
198184|NCT00811395|474910|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
198185|NCT00811395|474911|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
198186|NCT00811395|474912|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
198187|NCT00811395|474913|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
198188|NCT00811395|474908|P6|STARTED|Extension Treatment|continued initial treatment|29
198189|NCT00811395|474909|P5|STARTED|Extension Treatment|continued initial treatment|30
198190|NCT00811395|474910|P4|STARTED|Extension Treatment|continued initial treatment|37
198191|NCT00811395|474911|P3|STARTED|Extension Treatment|continued initial treatment|27
198192|NCT00811395|474912|P2|STARTED|Extension Treatment|continued initial treatment|28
198193|NCT00811395|474913|P1|STARTED|Extension Treatment|continued initial treatment|31
198194|NCT00811395|474908|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
198195|NCT00811395|474909|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
198196|NCT00811395|474910|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
198197|NCT00811395|474911|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
198198|NCT00811395|474912|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
198199|NCT00811395|474913|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
198200|NCT00811395|474908|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
198201|NCT00811395|474909|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
198202|NCT00811395|474910|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
198203|NCT00811395|474911|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
198204|NCT00811395|474912|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
198205|NCT00811395|474913|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
198206|NCT00811395|474908|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
198207|NCT00811395|474909|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
198208|NCT00811395|474910|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
198209|NCT00811395|474911|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
198210|NCT00811395|474912|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
198211|NCT00811395|474913|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
198212|NCT00811382|474977|P2|NOT COMPLETED|Overall Study||0
198213|NCT00811382|474978|P1|NOT COMPLETED|Overall Study||0
198214|NCT00811382|474977|P2|COMPLETED|Overall Study||75
198215|NCT00811382|474978|P1|COMPLETED|Overall Study||88
198216|NCT00811382|474977|P2|STARTED|Overall Study||75
198217|NCT00811382|474978|P1|STARTED|Overall Study||88
198218|NCT00811317|474990|P1|NOT COMPLETED|Overall Study||0
198219|NCT00811317|474990|P1|COMPLETED|Overall Study||11
198220|NCT00811317|474990|P1|STARTED|Overall Study||11
198221|NCT00811252|475019|P3|NOT COMPLETED|Overall Study||23
198222|NCT00811252|475020|P2|NOT COMPLETED|Overall Study||20
198223|NCT00811252|475021|P1|NOT COMPLETED|Overall Study||17
198224|NCT00811252|475019|P3|COMPLETED|Overall Study||128
198225|NCT00811252|475020|P2|COMPLETED|Overall Study||136
198226|NCT00811252|475021|P1|COMPLETED|Overall Study||128
198227|NCT00811252|475019|P3|STARTED|Overall Study||151
198228|NCT00811252|475020|P2|STARTED|Overall Study||156
198229|NCT00811252|475021|P1|STARTED|Overall Study||145
198230|NCT00811174|475065|P1|NOT COMPLETED|Overall Study||3
198231|NCT00811174|475065|P1|COMPLETED|Overall Study||2
198232|NCT00811174|475065|P1|STARTED|Overall Study||5
198233|NCT00811135|475076|P1|NOT COMPLETED|Overall Study||88
198234|NCT00811135|475076|P1|COMPLETED|Overall Study||0
198235|NCT00811135|475076|P1|STARTED|Overall Study||88
198236|NCT00811070|475094|P6|NOT COMPLETED|Overall Study||1
198237|NCT00811070|475095|P5|NOT COMPLETED|Overall Study||5
198238|NCT00811070|475096|P4|NOT COMPLETED|Overall Study||2
198239|NCT00811070|475097|P3|NOT COMPLETED|Overall Study||0
198240|NCT00811070|475098|P2|NOT COMPLETED|Overall Study||1
198241|NCT00811070|475099|P1|NOT COMPLETED|Overall Study||1
198242|NCT00811070|475094|P6|COMPLETED|Overall Study||10
198243|NCT00811070|475095|P5|COMPLETED|Overall Study||2
198244|NCT00811070|475096|P4|COMPLETED|Overall Study||26
198245|NCT00811070|475097|P3|COMPLETED|Overall Study||3
198246|NCT00811070|475098|P2|COMPLETED|Overall Study||6
198247|NCT00811070|475099|P1|COMPLETED|Overall Study||6
198248|NCT00811070|475094|P6|STARTED|Overall Study||11
198249|NCT00811070|475095|P5|STARTED|Overall Study||7
198250|NCT00811070|475096|P4|STARTED|Overall Study||28
198251|NCT00811070|475097|P3|STARTED|Overall Study||3
198252|NCT00811070|475098|P2|STARTED|Overall Study||7
198253|NCT00811070|475099|P1|STARTED|Overall Study||7
198254|NCT00811057|475159|P3|NOT COMPLETED|Overall Study||10
198255|NCT00811057|475160|P2|NOT COMPLETED|Overall Study||10
198256|NCT00811057|475161|P1|NOT COMPLETED|Overall Study||5
198257|NCT00811057|475159|P3|COMPLETED|Overall Study||87
198258|NCT00811057|475160|P2|COMPLETED|Overall Study||104
198259|NCT00811057|475161|P1|COMPLETED|Overall Study||85
198260|NCT00811057|475159|P3|STARTED|Overall Study||97
198261|NCT00811057|475160|P2|STARTED|Overall Study||114
198262|NCT00811057|475161|P1|STARTED|Overall Study||90
198263|NCT00811018|475172|P1|NOT COMPLETED|Overall Study||968
198264|NCT00811018|475172|P1|COMPLETED|Overall Study||224
198265|NCT00811018|475172|P1|STARTED|Overall Study||1192
198266|NCT00810901|475190|P2|NOT COMPLETED|Overall Study||58
198267|NCT00810901|475191|P1|NOT COMPLETED|Overall Study||88
198268|NCT00810901|475190|P2|COMPLETED|Overall Study||118
198269|NCT00810901|475191|P1|COMPLETED|Overall Study||165
198270|NCT00810901|475190|P2|6-month Follow-up|Overall Study||122
198271|NCT00810901|475191|P1|6-month Follow-up|Overall Study||181
198272|NCT00810901|475190|P2|1-month Follow up|Overall Study||146
198273|NCT00810901|475191|P1|1-month Follow up|Overall Study||242
198274|NCT00810901|475190|P2|STARTED|Overall Study||176
198275|NCT00810901|475191|P1|STARTED|Overall Study||253
198276|NCT00810888|475202|P3|NOT COMPLETED|Overall Study||0
198277|NCT00810888|475203|P2|NOT COMPLETED|Overall Study||0
198278|NCT00810888|475204|P1|NOT COMPLETED|Overall Study||0
198279|NCT00810888|475202|P3|COMPLETED|Overall Study||73
198280|NCT00810888|475203|P2|COMPLETED|Overall Study||9
198281|NCT00810888|475204|P1|COMPLETED|Overall Study||10
198282|NCT00810888|475202|P3|STARTED|Overall Study||73
198283|NCT00810888|475203|P2|STARTED|Overall Study||9
198284|NCT00810888|475204|P1|STARTED|Overall Study||10
198285|NCT00810810|475237|P4|NOT COMPLETED|Overall Study||13
198286|NCT00810810|475238|P3|NOT COMPLETED|Overall Study||11
198287|NCT00810810|475239|P2|NOT COMPLETED|Overall Study||11
198288|NCT00810810|475240|P1|NOT COMPLETED|Overall Study||0
198289|NCT00810810|475237|P4|COMPLETED|Overall Study||38
198290|NCT00810810|475238|P3|COMPLETED|Overall Study||45
198291|NCT00810810|475239|P2|COMPLETED|Overall Study||38
198292|NCT00810810|475240|P1|COMPLETED|Overall Study||124
198293|NCT00810810|475237|P4|STARTED|Overall Study||51
198294|NCT00810810|475238|P3|STARTED|Overall Study||56
198295|NCT00810810|475239|P2|STARTED|Overall Study||49
198296|NCT00810810|475240|P1|STARTED|Overall Study||124
198297|NCT00810771|475257|P3|NOT COMPLETED|Overall Study||0
198298|NCT00810771|475258|P2|NOT COMPLETED|Overall Study||0
198299|NCT00810771|475259|P1|NOT COMPLETED|Overall Study||0
198300|NCT00810771|475257|P3|COMPLETED|Overall Study||84
198301|NCT00810771|475258|P2|COMPLETED|Overall Study||234
198302|NCT00810771|475259|P1|COMPLETED|Overall Study||232
198303|NCT00810771|475257|P3|STARTED|Overall Study||84
198304|NCT00810771|475258|P2|STARTED|Overall Study||234
198305|NCT00810771|475259|P1|STARTED|Overall Study||232
198306|NCT00810719|475279|P1|NOT COMPLETED|Overall Study||0
198307|NCT00810719|475279|P1|COMPLETED|Overall Study||30
198308|NCT00810719|475279|P1|STARTED|Overall Study||30
198309|NCT00810693|475288|P3|NOT COMPLETED|Follow-up Period (FUP)||4
198310|NCT00810693|475289|P2|NOT COMPLETED|Follow-up Period (FUP)||3
198311|NCT00810693|475290|P1|NOT COMPLETED|Follow-up Period (FUP)||8
198312|NCT00810693|475288|P3|COMPLETED|Follow-up Period (FUP)||12
198313|NCT00810693|475289|P2|COMPLETED|Follow-up Period (FUP)||4
198314|NCT00810693|475290|P1|COMPLETED|Follow-up Period (FUP)||15
198315|NCT00810693|475288|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
198316|NCT00810693|475289|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
198317|NCT00810693|475290|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
198318|NCT00810693|475288|P3|NOT COMPLETED|Treatment Period||16
198319|NCT00810693|475289|P2|NOT COMPLETED|Treatment Period||7
198320|NCT00810693|475290|P1|NOT COMPLETED|Treatment Period||17
198321|NCT00810693|475288|P3|COMPLETED|Treatment Period||111
198322|NCT00810693|475289|P2|COMPLETED|Treatment Period||57
198323|NCT00810693|475290|P1|COMPLETED|Treatment Period||237
198324|NCT00810693|475288|P3|Participants Received Treatment|Treatment Period||126
198325|NCT00810693|475289|P2|Participants Received Treatment|Treatment Period||63
198326|NCT00810693|475290|P1|Participants Received Treatment|Treatment Period||254
198327|NCT00810693|475288|P3|STARTED|Treatment Period|1 randomized but not treated|127
198328|NCT00810693|475289|P2|STARTED|Treatment Period|1 randomized but not treated|64
198329|NCT00810693|475290|P1|STARTED|Treatment Period||254
198330|NCT00810641|475322|P3|NOT COMPLETED|Overall Study||2
198331|NCT00810641|475323|P2|NOT COMPLETED|Overall Study||1
198332|NCT00810641|475324|P1|NOT COMPLETED|Overall Study||0
198333|NCT00810641|475322|P3|COMPLETED|Overall Study||49
198334|NCT00810641|475323|P2|COMPLETED|Overall Study||53
198335|NCT00810641|475324|P1|COMPLETED|Overall Study||52
198336|NCT00810641|475322|P3|STARTED|Overall Study||51
198337|NCT00810641|475323|P2|STARTED|Overall Study||54
198338|NCT00810641|475324|P1|STARTED|Overall Study||52
198339|NCT00810602|475332|P2|NOT COMPLETED|Overall Study||3
198340|NCT00810602|475333|P1|NOT COMPLETED|Overall Study||8
198341|NCT00810602|475332|P2|COMPLETED|Overall Study||31
198342|NCT00810602|475333|P1|COMPLETED|Overall Study||19
198343|NCT00810602|475332|P2|STARTED|Overall Study||34
198344|NCT00810602|475333|P1|STARTED|Overall Study||27
198345|NCT00810576|475340|P1|NOT COMPLETED|Overall Study||0
198346|NCT00810576|475340|P1|COMPLETED|Overall Study||1
198347|NCT00810576|475340|P1|STARTED|Overall Study||1
198348|NCT00810511|475346|P2|NOT COMPLETED|Overall Study||4
198349|NCT00810511|475347|P1|NOT COMPLETED|Overall Study||10
198350|NCT00810511|475346|P2|COMPLETED|Overall Study||102
198351|NCT00810511|475347|P1|COMPLETED|Overall Study||97
198352|NCT00810511|475346|P2|STARTED|Overall Study||106
198353|NCT00810511|475347|P1|STARTED|Overall Study||107
198354|NCT00810394|475353|P1|NOT COMPLETED|Overall Study||3
198355|NCT00810394|475353|P1|COMPLETED|Overall Study||47
198356|NCT00810394|475353|P1|Cycle 3 400mg Twice Daily|Overall Study||5
198357|NCT00810394|475353|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
198358|NCT00810394|475353|P1|Cycle 2 400mg Once Daily|Overall Study||22
198359|NCT00810394|475353|P1|Cycle 2 600mg Twice Daily|Overall Study||13
198360|NCT00810394|475353|P1|STARTED|Overall Study||50
198361|NCT00810368|475361|P2|NOT COMPLETED|Overall Study||2
198362|NCT00810368|475362|P1|NOT COMPLETED|Overall Study||6
198363|NCT00810368|475361|P2|COMPLETED|Overall Study||13
198364|NCT00810368|475362|P1|COMPLETED|Overall Study||12
198365|NCT00810368|475361|P2|STARTED|Overall Study||15
198366|NCT00810368|475362|P1|STARTED|Overall Study||18
198367|NCT00810355|475383|P3|NOT COMPLETED|Overall Study||11
198368|NCT00810355|475384|P2|NOT COMPLETED|Overall Study||17
198369|NCT00810355|475385|P1|NOT COMPLETED|Overall Study||14
198370|NCT00810355|475383|P3|COMPLETED|Overall Study||14
198371|NCT00810355|475384|P2|COMPLETED|Overall Study||8
198372|NCT00810355|475385|P1|COMPLETED|Overall Study||11
198373|NCT00810355|475383|P3|STARTED|Overall Study||25
198374|NCT00810355|475384|P2|STARTED|Overall Study||25
198375|NCT00810355|475385|P1|STARTED|Overall Study||25
198376|NCT00810342|475401|P2|NOT COMPLETED|12-month Followup||11
198377|NCT00810342|475402|P1|NOT COMPLETED|12-month Followup||12
198378|NCT00810342|475401|P2|COMPLETED|12-month Followup||136
198379|NCT00810342|475402|P1|COMPLETED|12-month Followup||113
198380|NCT00810342|475401|P2|STARTED|12-month Followup||147
198381|NCT00810342|475402|P1|STARTED|12-month Followup||125
198382|NCT00810342|475401|P2|NOT COMPLETED|6-month Follow-up||8
198383|NCT00810342|475402|P1|NOT COMPLETED|6-month Follow-up||24
198384|NCT00810342|475401|P2|COMPLETED|6-month Follow-up||147
198385|NCT00810342|475402|P1|COMPLETED|6-month Follow-up||125
198386|NCT00810342|475401|P2|STARTED|6-month Follow-up||155
198387|NCT00810342|475402|P1|STARTED|6-month Follow-up||149
198388|NCT00810342|475401|P2|NOT COMPLETED|Month 1 Follow-up||2
198389|NCT00810342|475402|P1|NOT COMPLETED|Month 1 Follow-up||5
198390|NCT00810342|475401|P2|COMPLETED|Month 1 Follow-up||155
198391|NCT00810342|475402|P1|COMPLETED|Month 1 Follow-up||149
198392|NCT00810342|475401|P2|STARTED|Month 1 Follow-up||157
198393|NCT00810342|475402|P1|STARTED|Month 1 Follow-up||154
198394|NCT00810303|475410|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
198395|NCT00810303|475410|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
198396|NCT00810303|475410|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
198397|NCT00810303|475410|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
198398|NCT00810303|475410|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
198399|NCT00810303|475410|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
198400|NCT00810303|475410|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
198401|NCT00810303|475410|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
198402|NCT00810303|475410|P1|STARTED|Ezetimibe Alone - Day 6-15||12
198403|NCT00810303|475410|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
198404|NCT00810303|475410|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
198405|NCT00810303|475410|P1|STARTED|Efavirenz Alone - Day 1-5||12
198406|NCT00810277|475435|P1|NOT COMPLETED|Overall Study||1
198407|NCT00810277|475435|P1|COMPLETED|Overall Study||13
198408|NCT00810277|475435|P1|STARTED|Overall Study||14
198409|NCT00810199|475450|P2|NOT COMPLETED|Overall Study||82
198410|NCT00810199|475451|P1|NOT COMPLETED|Overall Study||59
198411|NCT00810199|475450|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
198412|NCT00810199|475451|P1|COMPLETED|Overall Study||220
198413|NCT00810199|475450|P2|Completed Week 104|Overall Study||201
198414|NCT00810199|475451|P1|Completed Week 104|Overall Study||222
198415|NCT00810199|475450|P2|Completed Week 52|Overall Study||229
198416|NCT00810199|475451|P1|Completed Week 52|Overall Study||243
198417|NCT00810199|475450|P2|Completed Week 24|Overall Study||250
198418|NCT00810199|475451|P1|Completed Week 24|Overall Study||259
198419|NCT00810199|475450|P2|Received Study Drug|Overall Study||276
198420|NCT00810199|475451|P1|Received Study Drug|Overall Study||277
198421|NCT00810199|475450|P2|STARTED|Overall Study||277
198422|NCT00810199|475451|P1|STARTED|Overall Study||279
198423|NCT00810108|475529|P2|NOT COMPLETED|Overall Study||0
198424|NCT00810108|475530|P1|NOT COMPLETED|Overall Study||1
198425|NCT00810108|475529|P2|COMPLETED|Overall Study||7
198426|NCT00810108|475530|P1|COMPLETED|Overall Study||5
198427|NCT00810108|475529|P2|STARTED|Overall Study||7
198428|NCT00810108|475530|P1|STARTED|Overall Study||6
198429|NCT00810095|475535|P1|NOT COMPLETED|Overall Study||0
198430|NCT00810095|475535|P1|COMPLETED|Overall Study||40
198431|NCT00810095|475535|P1|STARTED|Overall Study||40
198432|NCT00810082|475544|P2|NOT COMPLETED|Overall Study||4
198433|NCT00810082|475545|P1|NOT COMPLETED|Overall Study||0
198434|NCT00810082|475544|P2|COMPLETED|Overall Study||27
198435|NCT00810082|475545|P1|COMPLETED|Overall Study||34
198436|NCT00810082|475544|P2|STARTED|Overall Study||31
198437|NCT00810082|475545|P1|STARTED|Overall Study||34
198438|NCT00810069|475553|P3|NOT COMPLETED|Double-Blind Period II||72
198439|NCT00810069|475554|P2|NOT COMPLETED|Double-Blind Period II||56
198440|NCT00810069|475555|P1|NOT COMPLETED|Double-Blind Period II||0
198441|NCT00810069|475553|P3|COMPLETED|Double-Blind Period II||212
198442|NCT00810069|475554|P2|COMPLETED|Double-Blind Period II||226
198443|NCT00810069|475555|P1|COMPLETED|Double-Blind Period II||0
198444|NCT00810069|475553|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
198445|NCT00810069|475554|P2|STARTED|Double-Blind Period II||282
198446|NCT00810069|475555|P1|STARTED|Double-Blind Period II||0
198447|NCT00810069|475553|P3|NOT COMPLETED|Lead-in Period I||0
198448|NCT00810069|475554|P2|NOT COMPLETED|Lead-in Period I||0
198449|NCT00810069|475555|P1|NOT COMPLETED|Lead-in Period I||274
198450|NCT00810069|475553|P3|COMPLETED|Lead-in Period I||0
198451|NCT00810069|475554|P2|COMPLETED|Lead-in Period I||0
198452|NCT00810069|475555|P1|COMPLETED|Lead-in Period I||566
198453|NCT00810069|475553|P3|STARTED|Lead-in Period I||0
198454|NCT00810069|475554|P2|STARTED|Lead-in Period I||0
198455|NCT00810069|475555|P1|STARTED|Lead-in Period I||840
198456|NCT00810043|475600|P3|NOT COMPLETED|Overall Study||8
198457|NCT00810043|475601|P2|NOT COMPLETED|Overall Study||1
198458|NCT00810043|475602|P1|NOT COMPLETED|Overall Study||4
198459|NCT00810043|475600|P3|COMPLETED|Overall Study||0
198460|NCT00810043|475601|P2|COMPLETED|Overall Study||54
198461|NCT00810043|475602|P1|COMPLETED|Overall Study||53
198462|NCT00810043|475600|P3|STARTED|Overall Study||8
198463|NCT00810043|475601|P2|STARTED|Overall Study||55
198464|NCT00810043|475602|P1|STARTED|Overall Study||57
198465|NCT00809965|475624|P3|NOT COMPLETED|Overall Study||844
198466|NCT00809965|475625|P2|NOT COMPLETED|Overall Study||775
198467|NCT00809965|475626|P1|NOT COMPLETED|Overall Study||783
198468|NCT00809965|475624|P3|COMPLETED|Overall Study||4332
198469|NCT00809965|475625|P2|COMPLETED|Overall Study||4399
198470|NCT00809965|475626|P1|COMPLETED|Overall Study||4393
198471|NCT00809965|475624|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
198472|NCT00809965|475625|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
198473|NCT00809965|475626|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
198474|NCT00809965|475624|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
198475|NCT00809965|475625|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
198476|NCT00809965|475626|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
198477|NCT00809965|475624|P3|STARTED|Overall Study||5176
198478|NCT00809965|475625|P2|STARTED|Overall Study||5174
198479|NCT00809965|475626|P1|STARTED|Overall Study||5176
198480|NCT00809926|475648|P2|NOT COMPLETED|Overall Study||23
198481|NCT00809926|475649|P1|NOT COMPLETED|Overall Study||31
198482|NCT00809926|475648|P2|COMPLETED|Overall Study||196
198483|NCT00809926|475649|P1|COMPLETED|Overall Study||201
198484|NCT00809926|475648|P2|STARTED|Overall Study||219
198485|NCT00809926|475649|P1|STARTED|Overall Study||232
198486|NCT00809848|475678|P5|NOT COMPLETED|Overall Study||3
198487|NCT00809848|475679|P4|NOT COMPLETED|Overall Study||1
198488|NCT00809848|475680|P3|NOT COMPLETED|Overall Study||0
198489|NCT00809848|475681|P2|NOT COMPLETED|Overall Study||0
198490|NCT00809848|475682|P1|NOT COMPLETED|Overall Study||0
198491|NCT00809848|475678|P5|COMPLETED|Overall Study||34
198492|NCT00809848|475679|P4|COMPLETED|Overall Study||30
198493|NCT00809848|475680|P3|COMPLETED|Overall Study||34
198494|NCT00809848|475681|P2|COMPLETED|Overall Study||34
198495|NCT00809848|475682|P1|COMPLETED|Overall Study||36
198496|NCT00809848|475678|P5|STARTED|Overall Study||37
198497|NCT00809848|475679|P4|STARTED|Overall Study||31
198498|NCT00809848|475680|P3|STARTED|Overall Study||34
198499|NCT00809848|475681|P2|STARTED|Overall Study||34
198500|NCT00809848|475682|P1|STARTED|Overall Study||36
198501|NCT00809835|475703|P4|NOT COMPLETED|Overall Study||2
198502|NCT00809835|475704|P3|NOT COMPLETED|Overall Study||11
198503|NCT00809835|475705|P2|NOT COMPLETED|Overall Study||7
198504|NCT00809835|475706|P1|NOT COMPLETED|Overall Study||8
198505|NCT00809835|475703|P4|COMPLETED|Overall Study||25
198506|NCT00809835|475704|P3|COMPLETED|Overall Study||27
198507|NCT00809835|475705|P2|COMPLETED|Overall Study||20
198508|NCT00809835|475706|P1|COMPLETED|Overall Study||20
198509|NCT00809835|475703|P4|STARTED|Overall Study||27
198510|NCT00809835|475704|P3|STARTED|Overall Study||38
198511|NCT00809835|475705|P2|STARTED|Overall Study||27
198512|NCT00809835|475706|P1|STARTED|Overall Study||28
198513|NCT00809809|475726|P2|NOT COMPLETED|Overall Study||2
198514|NCT00809809|475727|P1|NOT COMPLETED|Overall Study||3
198515|NCT00809809|475726|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
198516|NCT00809809|475727|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
198517|NCT00809809|475726|P2|STARTED|Overall Study||79
198518|NCT00809809|475727|P1|STARTED|Overall Study||78
198519|NCT00809757|475736|P3|NOT COMPLETED|Overall Study||11
198520|NCT00809757|475737|P2|NOT COMPLETED|Overall Study||5
198521|NCT00809757|475738|P1|NOT COMPLETED|Overall Study||6
198522|NCT00809757|475736|P3|COMPLETED|Overall Study||53
198523|NCT00809757|475737|P2|COMPLETED|Overall Study||60
198524|NCT00809757|475738|P1|COMPLETED|Overall Study||62
198525|NCT00809757|475736|P3|STARTED|Overall Study||64
198526|NCT00809757|475737|P2|STARTED|Overall Study||65
198527|NCT00809757|475738|P1|STARTED|Overall Study||68
198528|NCT00809614|475823|P2|NOT COMPLETED|Overall Study||4
198529|NCT00809614|475824|P1|NOT COMPLETED|Overall Study||3
198530|NCT00809614|475823|P2|COMPLETED|Overall Study||10
198531|NCT00809614|475824|P1|COMPLETED|Overall Study||25
198532|NCT00809614|475823|P2|Pharmacodynamic (PD) Set|Overall Study||13
198533|NCT00809614|475824|P1|Pharmacodynamic (PD) Set|Overall Study||24
198534|NCT00809614|475823|P2|Pharmacokinetic Safety Set|Overall Study||14
198535|NCT00809614|475824|P1|Pharmacokinetic Safety Set|Overall Study||27
198536|NCT00809614|475823|P2|STARTED|Overall Study||14
198537|NCT00809614|475824|P1|STARTED|Overall Study||28
198538|NCT00809523|475854|P2|NOT COMPLETED|Overall Study||4
198539|NCT00809523|475855|P1|NOT COMPLETED|Overall Study||7
198540|NCT00809523|475854|P2|COMPLETED|Overall Study||48
198541|NCT00809523|475855|P1|COMPLETED|Overall Study||47
198542|NCT00809523|475854|P2|STARTED|Overall Study||52
198543|NCT00809523|475855|P1|STARTED|Overall Study||54
198544|NCT00809471|475868|P3|NOT COMPLETED|Overall Study||17
198545|NCT00809471|475869|P2|NOT COMPLETED|Overall Study||20
198546|NCT00809471|475870|P1|NOT COMPLETED|Overall Study||20
198547|NCT00809471|475868|P3|COMPLETED|Overall Study||114
198548|NCT00809471|475869|P2|COMPLETED|Overall Study||109
198549|NCT00809471|475870|P1|COMPLETED|Overall Study||110
198550|NCT00809471|475868|P3|STARTED|Overall Study||131
198551|NCT00809471|475869|P2|STARTED|Overall Study||129
198552|NCT00809471|475870|P1|STARTED|Overall Study||130
198553|NCT00809458|475886|P2|NOT COMPLETED|Overall Study||1
198554|NCT00809458|475887|P1|NOT COMPLETED|Overall Study||1
198555|NCT00809458|475886|P2|COMPLETED|Overall Study||5
198556|NCT00809458|475887|P1|COMPLETED|Overall Study||8
198557|NCT00809458|475886|P2|STARTED|Overall Study||6
198558|NCT00809458|475887|P1|STARTED|Overall Study||9
198559|NCT00809445|475900|P3|NOT COMPLETED|6 Month Follow-up||24
198560|NCT00809445|475901|P2|NOT COMPLETED|6 Month Follow-up||23
198561|NCT00809445|475902|P1|NOT COMPLETED|6 Month Follow-up||24
198562|NCT00809445|475900|P3|COMPLETED|6 Month Follow-up||395
198563|NCT00809445|475901|P2|COMPLETED|6 Month Follow-up||410
198564|NCT00809445|475902|P1|COMPLETED|6 Month Follow-up||405
198565|NCT00809445|475900|P3|STARTED|6 Month Follow-up||419
198566|NCT00809445|475901|P2|STARTED|6 Month Follow-up||433
198567|NCT00809445|475902|P1|STARTED|6 Month Follow-up||429
198568|NCT00809445|475900|P3|NOT COMPLETED|1 Month Follow-up||4
198569|NCT00809445|475901|P2|NOT COMPLETED|1 Month Follow-up||4
198570|NCT00809445|475902|P1|NOT COMPLETED|1 Month Follow-up||2
198571|NCT00809445|475900|P3|COMPLETED|1 Month Follow-up||415
198572|NCT00809445|475901|P2|COMPLETED|1 Month Follow-up||429
198573|NCT00809445|475902|P1|COMPLETED|1 Month Follow-up||427
198574|NCT00809445|475900|P3|STARTED|1 Month Follow-up||419
198575|NCT00809445|475901|P2|STARTED|1 Month Follow-up||433
198576|NCT00809445|475902|P1|STARTED|1 Month Follow-up||429
198577|NCT00809328|475919|P1|NOT COMPLETED|Overall Study||29
198578|NCT00809328|475919|P1|COMPLETED|Overall Study||73
198579|NCT00809328|475919|P1|STARTED|Overall Study||102
198580|NCT00809276|475927|P1|NOT COMPLETED|Overall Study||0
198581|NCT00809276|475927|P1|COMPLETED|Overall Study||92
198582|NCT00809276|475927|P1|STARTED|Overall Study||92
198583|NCT00809185|475931|P1|NOT COMPLETED|Overall Study||0
198584|NCT00809185|475931|P1|COMPLETED|Overall Study||7
198585|NCT00809185|475931|P1|STARTED|Overall Study||7
198586|NCT00809159|475939|P6|NOT COMPLETED|Part 1 and 2||3
198587|NCT00809159|475940|P5|NOT COMPLETED|Part 1 and 2||6
198588|NCT00809159|475941|P4|NOT COMPLETED|Part 1 and 2||5
198589|NCT00809159|475942|P3|NOT COMPLETED|Part 1 and 2||10
198590|NCT00809159|475943|P2|NOT COMPLETED|Part 1 and 2||0
198591|NCT00809159|475944|P1|NOT COMPLETED|Part 1 and 2||0
198592|NCT00809159|475939|P6|COMPLETED|Part 1 and 2||3
198593|NCT00809159|475940|P5|COMPLETED|Part 1 and 2||6
198594|NCT00809159|475941|P4|COMPLETED|Part 1 and 2||7
198595|NCT00809159|475942|P3|COMPLETED|Part 1 and 2||20
198596|NCT00809159|475943|P2|COMPLETED|Part 1 and 2||0
198597|NCT00809159|475944|P1|COMPLETED|Part 1 and 2||0
198598|NCT00809159|475939|P6|PD Analysis Set|Part 1 and 2||6
198599|NCT00809159|475940|P5|PD Analysis Set|Part 1 and 2||12
198600|NCT00809159|475941|P4|PD Analysis Set|Part 1 and 2||12
198601|NCT00809159|475942|P3|PD Analysis Set|Part 1 and 2||28
198602|NCT00809159|475943|P2|PD Analysis Set|Part 1 and 2||0
198603|NCT00809159|475944|P1|PD Analysis Set|Part 1 and 2||0
198604|NCT00809159|475939|P6|PK Analysis Set|Part 1 and 2||6
198605|NCT00809159|475940|P5|PK Analysis Set|Part 1 and 2||12
198606|NCT00809159|475941|P4|PK Analysis Set|Part 1 and 2||12
198607|NCT00809159|475942|P3|PK Analysis Set|Part 1 and 2||30
198608|NCT00809159|475943|P2|PK Analysis Set|Part 1 and 2||0
198609|NCT00809159|475944|P1|PK Analysis Set|Part 1 and 2||0
198610|NCT00809159|475939|P6|STARTED|Part 1 and 2||6
198611|NCT00809159|475940|P5|STARTED|Part 1 and 2||12
198612|NCT00809159|475941|P4|STARTED|Part 1 and 2||12
198613|NCT00809159|475942|P3|STARTED|Part 1 and 2||30
198614|NCT00809159|475943|P2|STARTED|Part 1 and 2||0
198615|NCT00809159|475944|P1|STARTED|Part 1 and 2||0
198616|NCT00809159|475939|P6|NOT COMPLETED|Part 1||0
198617|NCT00809159|475940|P5|NOT COMPLETED|Part 1||0
198618|NCT00809159|475941|P4|NOT COMPLETED|Part 1||0
198619|NCT00809159|475942|P3|NOT COMPLETED|Part 1||0
198620|NCT00809159|475943|P2|NOT COMPLETED|Part 1||3
198621|NCT00809159|475944|P1|NOT COMPLETED|Part 1||8
198622|NCT00809159|475939|P6|COMPLETED|Part 1||0
198623|NCT00809159|475940|P5|COMPLETED|Part 1||0
198624|NCT00809159|475941|P4|COMPLETED|Part 1||0
198625|NCT00809159|475942|P3|COMPLETED|Part 1||0
198626|NCT00809159|475943|P2|COMPLETED|Part 1||3
198627|NCT00809159|475944|P1|COMPLETED|Part 1||16
198628|NCT00809159|475939|P6|PD Analysis Set|Part 1||0
198629|NCT00809159|475940|P5|PD Analysis Set|Part 1||0
198630|NCT00809159|475941|P4|PD Analysis Set|Part 1||0
198631|NCT00809159|475942|P3|PD Analysis Set|Part 1||0
198632|NCT00809159|475943|P2|PD Analysis Set|Part 1||6
198633|NCT00809159|475944|P1|PD Analysis Set|Part 1||23
198634|NCT00809159|475939|P6|PK Analysis Set|Part 1||0
198635|NCT00809159|475940|P5|PK Analysis Set|Part 1||0
198636|NCT00809159|475941|P4|PK Analysis Set|Part 1||0
198637|NCT00809159|475942|P3|PK Analysis Set|Part 1||0
198638|NCT00809159|475943|P2|PK Analysis Set|Part 1||6
198639|NCT00809159|475944|P1|PK Analysis Set|Part 1||24
198640|NCT00809159|475939|P6|STARTED|Part 1||0
198641|NCT00809159|475940|P5|STARTED|Part 1||0
198642|NCT00809159|475941|P4|STARTED|Part 1||0
198643|NCT00809159|475942|P3|STARTED|Part 1||0
198644|NCT00809159|475943|P2|STARTED|Part 1||6
198645|NCT00809159|475944|P1|STARTED|Part 1||24
198646|NCT00809146|476010|P2|NOT COMPLETED|Overall Study||0
198647|NCT00809146|476011|P1|NOT COMPLETED|Overall Study||0
198648|NCT00809146|476010|P2|COMPLETED|Overall Study||445
198649|NCT00809146|476011|P1|COMPLETED|Overall Study||448
198650|NCT00809146|476010|P2|STARTED|Overall Study||445
198651|NCT00809146|476011|P1|STARTED|Overall Study||448
198652|NCT00809133|476049|P14|NOT COMPLETED|Overall Study||7
198653|NCT00809133|476050|P13|NOT COMPLETED|Overall Study||5
198654|NCT00809133|476051|P12|NOT COMPLETED|Overall Study||8
198655|NCT00809133|476052|P11|NOT COMPLETED|Overall Study||6
198656|NCT00809133|476053|P10|NOT COMPLETED|Overall Study||9
198657|NCT00809133|476054|P9|NOT COMPLETED|Overall Study||3
198658|NCT00809133|476055|P8|NOT COMPLETED|Overall Study||8
198659|NCT00809133|476056|P7|NOT COMPLETED|Overall Study||6
198660|NCT00809133|476057|P6|NOT COMPLETED|Overall Study||7
198661|NCT00809133|476058|P5|NOT COMPLETED|Overall Study||5
198662|NCT00809133|476059|P4|NOT COMPLETED|Overall Study||3
198663|NCT00809133|476060|P3|NOT COMPLETED|Overall Study||6
198664|NCT00809133|476061|P2|NOT COMPLETED|Overall Study||7
198665|NCT00809133|476062|P1|NOT COMPLETED|Overall Study||3
198666|NCT00809133|476049|P14|COMPLETED|Overall Study||0
198667|NCT00809133|476050|P13|COMPLETED|Overall Study||0
198668|NCT00809133|476051|P12|COMPLETED|Overall Study||0
198669|NCT00809133|476052|P11|COMPLETED|Overall Study||0
198670|NCT00809133|476053|P10|COMPLETED|Overall Study||0
198671|NCT00809133|476054|P9|COMPLETED|Overall Study||0
198672|NCT00809133|476055|P8|COMPLETED|Overall Study||0
198673|NCT00809133|476056|P7|COMPLETED|Overall Study||0
198674|NCT00809133|476057|P6|COMPLETED|Overall Study||0
198675|NCT00809133|476058|P5|COMPLETED|Overall Study||0
198676|NCT00809133|476059|P4|COMPLETED|Overall Study||0
198677|NCT00809133|476060|P3|COMPLETED|Overall Study||0
198678|NCT00809133|476061|P2|COMPLETED|Overall Study||0
198679|NCT00809133|476062|P1|COMPLETED|Overall Study||0
198680|NCT00809133|476049|P14|STARTED|Overall Study||7
198681|NCT00809133|476050|P13|STARTED|Overall Study||5
198682|NCT00809133|476051|P12|STARTED|Overall Study||8
198683|NCT00809133|476052|P11|STARTED|Overall Study||6
198684|NCT00809133|476053|P10|STARTED|Overall Study||9
198685|NCT00809133|476054|P9|STARTED|Overall Study||3
198686|NCT00809133|476055|P8|STARTED|Overall Study||8
198687|NCT00809133|476056|P7|STARTED|Overall Study||6
198688|NCT00809133|476057|P6|STARTED|Overall Study||7
198689|NCT00809133|476058|P5|STARTED|Overall Study||5
198690|NCT00809133|476059|P4|STARTED|Overall Study||3
198691|NCT00809133|476060|P3|STARTED|Overall Study||6
198692|NCT00809133|476061|P2|STARTED|Overall Study||7
198693|NCT00809133|476062|P1|STARTED|Overall Study||3
198694|NCT00809094|476216|P2|NOT COMPLETED|Overall Study||1
198695|NCT00809094|476217|P1|NOT COMPLETED|Overall Study||0
198696|NCT00809094|476216|P2|COMPLETED|Overall Study||33
198697|NCT00809094|476217|P1|COMPLETED|Overall Study||36
198698|NCT00809094|476216|P2|STARTED|Overall Study||34
198699|NCT00809094|476217|P1|STARTED|Overall Study||36
198700|NCT00809055|476237|P2|NOT COMPLETED|Overall Study||7
198701|NCT00809055|476238|P1|NOT COMPLETED|Overall Study||9
198702|NCT00809055|476237|P2|COMPLETED|Overall Study||30
198703|NCT00809055|476238|P1|COMPLETED|Overall Study||28
198704|NCT00809055|476237|P2|STARTED|Overall Study||37
198705|NCT00809055|476238|P1|STARTED|Overall Study||37
198706|NCT00808899|476262|P1|NOT COMPLETED|Overall Study||4
198707|NCT00808899|476262|P1|COMPLETED|Overall Study||0
198708|NCT00808899|476262|P1|STARTED|Overall Study||4
198709|NCT00808834|476266|P2|NOT COMPLETED|Period 2||0
198710|NCT00808834|476267|P1|NOT COMPLETED|Period 2||0
198711|NCT00808834|476266|P2|COMPLETED|Period 2||99
198712|NCT00808834|476267|P1|COMPLETED|Period 2||97
198713|NCT00808834|476266|P2|STARTED|Period 2||99
198714|NCT00808834|476267|P1|STARTED|Period 2||97
198715|NCT00808834|476266|P2|NOT COMPLETED|Period 1||0
198716|NCT00808834|476267|P1|NOT COMPLETED|Period 1||0
198717|NCT00808834|476266|P2|COMPLETED|Period 1||99
198718|NCT00808834|476267|P1|COMPLETED|Period 1||97
198719|NCT00808834|476266|P2|STARTED|Period 1||99
198720|NCT00808834|476267|P1|STARTED|Period 1||97
198721|NCT00808808|476276|P3|NOT COMPLETED|Overall Study||2557
198722|NCT00808808|476277|P2|NOT COMPLETED|Overall Study||2437
198723|NCT00808808|476278|P1|NOT COMPLETED|Overall Study||2817
198724|NCT00808808|476276|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
198725|NCT00808808|476277|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
198726|NCT00808808|476278|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
198727|NCT00808808|476276|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
198728|NCT00808808|476277|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
198729|NCT00808808|476278|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
198730|NCT00808808|476276|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
198731|NCT00808808|476277|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
198732|NCT00808808|476278|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
198733|NCT00808769|476304|P2|NOT COMPLETED|Second Intervention||0
198734|NCT00808769|476305|P1|NOT COMPLETED|Second Intervention||0
198735|NCT00808769|476304|P2|COMPLETED|Second Intervention||15
198736|NCT00808769|476305|P1|COMPLETED|Second Intervention||15
198737|NCT00808769|476304|P2|STARTED|Second Intervention||15
198738|NCT00808769|476305|P1|STARTED|Second Intervention||15
198739|NCT00808769|476304|P2|NOT COMPLETED|First Intervention||0
198740|NCT00808769|476305|P1|NOT COMPLETED|First Intervention||0
198741|NCT00808769|476304|P2|COMPLETED|First Intervention||15
198742|NCT00808769|476305|P1|COMPLETED|First Intervention||15
198743|NCT00808769|476304|P2|STARTED|First Intervention||15
198744|NCT00808769|476305|P1|STARTED|First Intervention||15
198745|NCT00808665|476313|P2|NOT COMPLETED|Overall Study||3
198746|NCT00808665|476314|P1|NOT COMPLETED|Overall Study||6
198747|NCT00808665|476313|P2|COMPLETED|Overall Study||29
198748|NCT00808665|476314|P1|COMPLETED|Overall Study||25
198749|NCT00808665|476313|P2|Completed Post Operative Doses|Overall Study||29
198750|NCT00808665|476314|P1|Completed Post Operative Doses|Overall Study||25
198751|NCT00808665|476313|P2|Completed Intra-operative Dose|Overall Study||32
198752|NCT00808665|476314|P1|Completed Intra-operative Dose|Overall Study||26
198753|NCT00808665|476313|P2|Medication Started|Overall Study||32
198754|NCT00808665|476314|P1|Medication Started|Overall Study||30
198755|NCT00808665|476313|P2|STARTED|Overall Study||32
198756|NCT00808665|476314|P1|STARTED|Overall Study||31
198757|NCT00808639|476320|P1|NOT COMPLETED|Overall Study||1
198758|NCT00808639|476320|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
198759|NCT00808639|476320|P1|STARTED|Overall Study||39
198760|NCT00808509|476328|P2|NOT COMPLETED|Observation Phase||0
198761|NCT00808509|476329|P1|NOT COMPLETED|Observation Phase||0
198762|NCT00808509|476328|P2|COMPLETED|Observation Phase||15
198763|NCT00808509|476329|P1|COMPLETED|Observation Phase||16
198764|NCT00808509|476328|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
198765|NCT00808509|476329|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
198766|NCT00808509|476328|P2|NOT COMPLETED|Randomized Phase||5
198767|NCT00808509|476329|P1|NOT COMPLETED|Randomized Phase||2
198768|NCT00808509|476328|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
198769|NCT00808509|476329|P1|COMPLETED|Randomized Phase||15
198770|NCT00808509|476328|P2|Received Rescue Therapy|Randomized Phase||9
198771|NCT00808509|476329|P1|Received Rescue Therapy|Randomized Phase||0
198772|NCT00808509|476328|P2|STARTED|Randomized Phase||16
198773|NCT00808509|476329|P1|STARTED|Randomized Phase||17
198774|NCT00808483|476427|P2|NOT COMPLETED|From 5 Months to 12 Months||0
198775|NCT00808483|476428|P1|NOT COMPLETED|From 5 Months to 12 Months||1
198776|NCT00808483|476427|P2|COMPLETED|From 5 Months to 12 Months||32
198777|NCT00808483|476428|P1|COMPLETED|From 5 Months to 12 Months||32
198778|NCT00808483|476427|P2|STARTED|From 5 Months to 12 Months||32
198779|NCT00808483|476428|P1|STARTED|From 5 Months to 12 Months||33
198780|NCT00808483|476427|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
198781|NCT00808483|476428|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
198782|NCT00808483|476427|P2|COMPLETED|From 3 to 5 Months After Surgery||32
198783|NCT00808483|476428|P1|COMPLETED|From 3 to 5 Months After Surgery||33
198784|NCT00808483|476427|P2|STARTED|From 3 to 5 Months After Surgery||33
198785|NCT00808483|476428|P1|STARTED|From 3 to 5 Months After Surgery||35
198786|NCT00808470|476450|P2|NOT COMPLETED|Overall Study||0
198787|NCT00808470|476451|P1|NOT COMPLETED|Overall Study||2
198788|NCT00808470|476450|P2|COMPLETED|Overall Study||35
198789|NCT00808470|476451|P1|COMPLETED|Overall Study||35
198790|NCT00808470|476450|P2|STARTED|Overall Study||35
198791|NCT00808470|476451|P1|STARTED|Overall Study||37
198792|NCT00808444|476465|P2|NOT COMPLETED|Overall Study||1
198793|NCT00808444|476466|P1|NOT COMPLETED|Overall Study||1
198794|NCT00808444|476465|P2|COMPLETED|Overall Study||232
198795|NCT00808444|476466|P1|COMPLETED|Overall Study||232
198796|NCT00808444|476465|P2|STARTED|Overall Study||233
198797|NCT00808444|476466|P1|STARTED|Overall Study||233
198798|NCT00808405|476506|P2|NOT COMPLETED|Overall Study||0
198799|NCT00808405|476507|P1|NOT COMPLETED|Overall Study||0
198800|NCT00808405|476506|P2|COMPLETED|Overall Study||27
198801|NCT00808405|476507|P1|COMPLETED|Overall Study||61
198802|NCT00808405|476506|P2|STARTED|Overall Study||27
198803|NCT00808405|476507|P1|STARTED|Overall Study||61
198804|NCT00808340|476515|P6|NOT COMPLETED|Third Intervention||0
198805|NCT00808340|476516|P5|NOT COMPLETED|Third Intervention||0
198806|NCT00808340|476517|P4|NOT COMPLETED|Third Intervention||0
198807|NCT00808340|476518|P3|NOT COMPLETED|Third Intervention||0
198808|NCT00808340|476519|P2|NOT COMPLETED|Third Intervention||0
198809|NCT00808340|476520|P1|NOT COMPLETED|Third Intervention||0
198810|NCT00808340|476515|P6|COMPLETED|Third Intervention||6
198811|NCT00808340|476516|P5|COMPLETED|Third Intervention||5
198812|NCT00808340|476517|P4|COMPLETED|Third Intervention||3
198813|NCT00808340|476518|P3|COMPLETED|Third Intervention||7
198814|NCT00808340|476519|P2|COMPLETED|Third Intervention||9
198815|NCT00808340|476520|P1|COMPLETED|Third Intervention||4
198816|NCT00808340|476515|P6|STARTED|Third Intervention||6
198817|NCT00808340|476516|P5|STARTED|Third Intervention||5
198818|NCT00808340|476517|P4|STARTED|Third Intervention||3
198819|NCT00808340|476518|P3|STARTED|Third Intervention||7
198820|NCT00808340|476519|P2|STARTED|Third Intervention||9
198821|NCT00808340|476520|P1|STARTED|Third Intervention||4
198822|NCT00808340|476515|P6|NOT COMPLETED|Second Intervention||0
198823|NCT00808340|476516|P5|NOT COMPLETED|Second Intervention||0
198824|NCT00808340|476517|P4|NOT COMPLETED|Second Intervention||0
198825|NCT00808340|476518|P3|NOT COMPLETED|Second Intervention||0
198826|NCT00808340|476519|P2|NOT COMPLETED|Second Intervention||0
198827|NCT00808340|476520|P1|NOT COMPLETED|Second Intervention||0
198828|NCT00808340|476515|P6|COMPLETED|Second Intervention||6
198829|NCT00808340|476516|P5|COMPLETED|Second Intervention||5
198830|NCT00808340|476517|P4|COMPLETED|Second Intervention||3
198831|NCT00808340|476518|P3|COMPLETED|Second Intervention||7
198832|NCT00808340|476519|P2|COMPLETED|Second Intervention||9
198833|NCT00808340|476520|P1|COMPLETED|Second Intervention||4
198834|NCT00808340|476515|P6|STARTED|Second Intervention||6
198835|NCT00808340|476516|P5|STARTED|Second Intervention||5
198836|NCT00808340|476517|P4|STARTED|Second Intervention||3
198837|NCT00808340|476518|P3|STARTED|Second Intervention||7
198838|NCT00808340|476519|P2|STARTED|Second Intervention||9
198839|NCT00808340|476520|P1|STARTED|Second Intervention||4
198840|NCT00808340|476515|P6|NOT COMPLETED|First Intervention||0
198841|NCT00808340|476516|P5|NOT COMPLETED|First Intervention||0
198842|NCT00808340|476517|P4|NOT COMPLETED|First Intervention||0
198843|NCT00808340|476518|P3|NOT COMPLETED|First Intervention||0
198844|NCT00808340|476519|P2|NOT COMPLETED|First Intervention||0
198845|NCT00808340|476520|P1|NOT COMPLETED|First Intervention||0
198846|NCT00808340|476515|P6|COMPLETED|First Intervention||6
198847|NCT00808340|476516|P5|COMPLETED|First Intervention||5
198848|NCT00808340|476517|P4|COMPLETED|First Intervention||3
198849|NCT00808340|476518|P3|COMPLETED|First Intervention||7
198850|NCT00808340|476519|P2|COMPLETED|First Intervention||9
198851|NCT00808340|476520|P1|COMPLETED|First Intervention||4
198852|NCT00808340|476515|P6|STARTED|First Intervention||6
198853|NCT00808340|476516|P5|STARTED|First Intervention||5
198854|NCT00808340|476517|P4|STARTED|First Intervention||3
198855|NCT00808340|476518|P3|STARTED|First Intervention||7
198856|NCT00808340|476519|P2|STARTED|First Intervention||9
198857|NCT00808340|476520|P1|STARTED|First Intervention||4
198858|NCT00808249|476541|P4|NOT COMPLETED|Overall Study||16
198859|NCT00808249|476542|P3|NOT COMPLETED|Overall Study||22
198860|NCT00808249|476543|P2|NOT COMPLETED|Overall Study||15
198861|NCT00808249|476544|P1|NOT COMPLETED|Overall Study||17
198862|NCT00808249|476541|P4|COMPLETED|Overall Study||90
198863|NCT00808249|476542|P3|COMPLETED|Overall Study||83
198864|NCT00808249|476543|P2|COMPLETED|Overall Study||91
198865|NCT00808249|476544|P1|COMPLETED|Overall Study||90
198866|NCT00808249|476541|P4|STARTED|Overall Study||106
198867|NCT00808249|476542|P3|STARTED|Overall Study||105
198868|NCT00808249|476543|P2|STARTED|Overall Study||106
198869|NCT00808249|476544|P1|STARTED|Overall Study||107
198870|NCT00808236|476572|P2|NOT COMPLETED|Overall Study||91
198871|NCT00808236|476573|P1|NOT COMPLETED|Overall Study||82
198872|NCT00808236|476572|P2|COMPLETED|Overall Study||13
198873|NCT00808236|476573|P1|COMPLETED|Overall Study||14
198874|NCT00808236|476572|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
198875|NCT00808236|476573|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
198876|NCT00808236|476572|P2|Achieved ROSC|Overall Study||43
198877|NCT00808236|476573|P1|Achieved ROSC|Overall Study||33
198878|NCT00808236|476572|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
198879|NCT00808236|476573|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
198880|NCT00808236|476572|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
198881|NCT00808236|476573|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
198882|NCT00808236|476572|P2|STARTED|Overall Study||104
198883|NCT00808236|476573|P1|STARTED|Overall Study||96
198884|NCT00808132|476606|P5|NOT COMPLETED|Overall Study||100
198885|NCT00808132|476607|P4|NOT COMPLETED|Overall Study||69
198886|NCT00808132|476608|P3|NOT COMPLETED|Overall Study||54
198887|NCT00808132|476609|P2|NOT COMPLETED|Overall Study||88
198888|NCT00808132|476610|P1|NOT COMPLETED|Overall Study||98
198889|NCT00808132|476606|P5|COMPLETED|Overall Study||383
198890|NCT00808132|476607|P4|COMPLETED|Overall Study||159
198891|NCT00808132|476608|P3|COMPLETED|Overall Study||185
198892|NCT00808132|476609|P2|COMPLETED|Overall Study||393
198893|NCT00808132|476610|P1|COMPLETED|Overall Study||357
198894|NCT00808132|476606|P5|Treated|Overall Study||474
198895|NCT00808132|476607|P4|Treated|Overall Study||220
198896|NCT00808132|476608|P3|Treated|Overall Study||230
198897|NCT00808132|476609|P2|Treated|Overall Study||474
198898|NCT00808132|476610|P1|Treated|Overall Study||445
198899|NCT00808132|476606|P5|STARTED|Overall Study||483
198900|NCT00808132|476607|P4|STARTED|Overall Study||228
198901|NCT00808132|476608|P3|STARTED|Overall Study||239
198902|NCT00808132|476609|P2|STARTED|Overall Study||481
198903|NCT00808132|476610|P1|STARTED|Overall Study||455
198904|NCT00808080|476682|P1|NOT COMPLETED|Overall Study||6
198905|NCT00808080|476682|P1|COMPLETED|Overall Study||0
198906|NCT00808080|476682|P1|STARTED|Overall Study||6
198907|NCT00808067|476688|P2|NOT COMPLETED|Overall Study||518
198908|NCT00808067|476689|P1|NOT COMPLETED|Overall Study||481
198909|NCT00808067|476688|P2|COMPLETED|Overall Study||2438
198910|NCT00808067|476689|P1|COMPLETED|Overall Study||2446
198911|NCT00808067|476688|P2|STARTED|Overall Study|Number of patients which are treated.|2956
198912|NCT00808067|476689|P1|STARTED|Overall Study|Number of patients which are treated.|2927
198913|NCT00808028|476725|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
198914|NCT00808028|476726|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
198915|NCT00808028|476727|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
198916|NCT00808028|476728|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
198917|NCT00808028|476725|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
198918|NCT00808028|476726|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
198919|NCT00808028|476727|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
198920|NCT00808028|476728|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
198921|NCT00808028|476725|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
198922|NCT00808028|476726|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
198923|NCT00808028|476727|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
198924|NCT00808028|476728|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
198925|NCT00808028|476725|P4|NOT COMPLETED|Stage 1 (6 Months)||15
198926|NCT00808028|476726|P3|NOT COMPLETED|Stage 1 (6 Months)||7
198927|NCT00808028|476727|P2|NOT COMPLETED|Stage 1 (6 Months)||1
198928|NCT00808028|476728|P1|NOT COMPLETED|Stage 1 (6 Months)||5
198929|NCT00808028|476725|P4|COMPLETED|Stage 1 (6 Months)||183
198930|NCT00808028|476726|P3|COMPLETED|Stage 1 (6 Months)||191
198931|NCT00808028|476727|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
198932|NCT00808028|476728|P1|COMPLETED|Stage 1 (6 Months)||116
198933|NCT00808028|476725|P4|STARTED|Stage 1 (6 Months)||198
198934|NCT00808028|476726|P3|STARTED|Stage 1 (6 Months)||198
198935|NCT00808028|476727|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
198936|NCT00808028|476728|P1|STARTED|Stage 1 (6 Months)||121
198937|NCT00808015|476764|P1|NOT COMPLETED|Overall Study||344
198938|NCT00808015|476764|P1|COMPLETED|Overall Study||1033
198939|NCT00808015|476764|P1|Treated|Overall Study||1373
198940|NCT00808015|476764|P1|STARTED|Overall Study||1377
198941|NCT00807989|476778|P2|NOT COMPLETED|Overall Study||2
198942|NCT00807989|476779|P1|NOT COMPLETED|Overall Study||3
198943|NCT00807989|476778|P2|COMPLETED|Overall Study||98
198944|NCT00807989|476779|P1|COMPLETED|Overall Study||104
198945|NCT00807989|476778|P2|STARTED|Overall Study||100
198946|NCT00807989|476779|P1|STARTED|Overall Study||107
198947|NCT00807937|476793|P4|NOT COMPLETED|Overall Study||15
198948|NCT00807937|476794|P3|NOT COMPLETED|Overall Study||14
198949|NCT00807937|476795|P2|NOT COMPLETED|Overall Study||25
198950|NCT00807937|476796|P1|NOT COMPLETED|Overall Study||27
198951|NCT00807937|476793|P4|COMPLETED|Overall Study||77
198952|NCT00807937|476794|P3|COMPLETED|Overall Study||78
198953|NCT00807937|476795|P2|COMPLETED|Overall Study||67
198954|NCT00807937|476796|P1|COMPLETED|Overall Study||66
198955|NCT00807937|476793|P4|STARTED|Overall Study||92
198956|NCT00807937|476794|P3|STARTED|Overall Study||92
198957|NCT00807937|476795|P2|STARTED|Overall Study||92
198958|NCT00807937|476796|P1|STARTED|Overall Study||93
198959|NCT00807885|476831|P9|NOT COMPLETED|Overall Study||0
198960|NCT00807885|476832|P8|NOT COMPLETED|Overall Study||0
198961|NCT00807885|476833|P7|NOT COMPLETED|Overall Study||0
198962|NCT00807885|476834|P6|NOT COMPLETED|Overall Study||1
198963|NCT00807885|476835|P5|NOT COMPLETED|Overall Study||0
198964|NCT00807885|476836|P4|NOT COMPLETED|Overall Study||0
198965|NCT00807885|476837|P3|NOT COMPLETED|Overall Study||0
198966|NCT00807885|476838|P2|NOT COMPLETED|Overall Study||0
198967|NCT00807885|476839|P1|NOT COMPLETED|Overall Study||0
198968|NCT00807885|476831|P9|COMPLETED|Overall Study||11
198969|NCT00807885|476832|P8|COMPLETED|Overall Study||11
198970|NCT00807885|476833|P7|COMPLETED|Overall Study||12
198971|NCT00807885|476834|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
198972|NCT00807885|476835|P5|COMPLETED|Overall Study||12
198973|NCT00807885|476836|P4|COMPLETED|Overall Study||10
198974|NCT00807885|476837|P3|COMPLETED|Overall Study||11
198975|NCT00807885|476838|P2|COMPLETED|Overall Study||11
198976|NCT00807885|476839|P1|COMPLETED|Overall Study||10
198977|NCT00807885|476831|P9|STARTED|Overall Study||11
198978|NCT00807885|476832|P8|STARTED|Overall Study||11
198979|NCT00807885|476833|P7|STARTED|Overall Study||12
198980|NCT00807885|476834|P6|STARTED|Overall Study||12
198981|NCT00807885|476835|P5|STARTED|Overall Study||12
198982|NCT00807885|476836|P4|STARTED|Overall Study||10
198983|NCT00807885|476837|P3|STARTED|Overall Study||11
198984|NCT00807885|476838|P2|STARTED|Overall Study||11
198985|NCT00807885|476839|P1|STARTED|Overall Study||10
198986|NCT00807846|476888|P2|NOT COMPLETED|Overall Study||4
198987|NCT00807846|476889|P1|NOT COMPLETED|Overall Study||12
198988|NCT00807846|476888|P2|COMPLETED|Overall Study||94
198989|NCT00807846|476889|P1|COMPLETED|Overall Study||88
198990|NCT00807846|476888|P2|STARTED|Overall Study||98
198991|NCT00807846|476889|P1|STARTED|Overall Study||100
198992|NCT00807768|476923|P2|NOT COMPLETED|Overall Study||0
198993|NCT00807768|476924|P1|NOT COMPLETED|Overall Study||0
198994|NCT00807768|476923|P2|COMPLETED|Overall Study||300
198995|NCT00807768|476924|P1|COMPLETED|Overall Study||301
198996|NCT00807768|476923|P2|STARTED|Overall Study||300
198997|NCT00807768|476924|P1|STARTED|Overall Study||301
198998|NCT00807664|476942|P2|NOT COMPLETED|Overall Study||19
198999|NCT00807664|476943|P1|NOT COMPLETED|Overall Study||11
199000|NCT00807664|476942|P2|COMPLETED|Overall Study||75
199001|NCT00807664|476943|P1|COMPLETED|Overall Study||77
199002|NCT00807664|476942|P2|STARTED|Overall Study||94
199003|NCT00807664|476943|P1|STARTED|Overall Study||88
199004|NCT00807573|476953|P1|NOT COMPLETED|Overall Study||2
199005|NCT00807573|476953|P1|COMPLETED|Overall Study||42
199006|NCT00807573|476953|P1|STARTED|Overall Study||44
199007|NCT00807560|476959|P2|NOT COMPLETED|Overall Study||0
199008|NCT00807560|476960|P1|NOT COMPLETED|Overall Study||0
199009|NCT00807560|476959|P2|COMPLETED|Overall Study||39
199010|NCT00807560|476960|P1|COMPLETED|Overall Study||38
199011|NCT00807560|476959|P2|STARTED|Overall Study||39
199012|NCT00807560|476960|P1|STARTED|Overall Study||38
199013|NCT00807495|476999|P5|NOT COMPLETED|Overall Study||5
199014|NCT00807495|477000|P4|NOT COMPLETED|Overall Study||1
199015|NCT00807495|477001|P3|NOT COMPLETED|Overall Study||4
199016|NCT00807495|477002|P2|NOT COMPLETED|Overall Study||6
199017|NCT00807495|477003|P1|NOT COMPLETED|Overall Study||8
199018|NCT00807495|476999|P5|COMPLETED|Overall Study||2
199019|NCT00807495|477000|P4|COMPLETED|Overall Study||0
199020|NCT00807495|477001|P3|COMPLETED|Overall Study||1
199021|NCT00807495|477002|P2|COMPLETED|Overall Study||7
199022|NCT00807495|477003|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
199023|NCT00807495|476999|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
199024|NCT00807495|477000|P4|STARTED|Overall Study||1
199025|NCT00807495|477001|P3|STARTED|Overall Study||5
199026|NCT00807495|477002|P2|STARTED|Overall Study||13
199027|NCT00807495|477003|P1|STARTED|Overall Study||22
199028|NCT00807456|477045|P1|NOT COMPLETED|Overall Study||0
199029|NCT00807456|477045|P1|COMPLETED|Overall Study||65
199030|NCT00807456|477045|P1|STARTED|Overall Study||65
199031|NCT00807365|477049|P1|NOT COMPLETED|Overall Study||5
199032|NCT00807365|477049|P1|COMPLETED|Overall Study||0
199033|NCT00807365|477049|P1|STARTED|Overall Study||5
199034|NCT00807248|477057|P4|NOT COMPLETED|Overall Study||14
199035|NCT00807248|477058|P3|NOT COMPLETED|Overall Study||18
199036|NCT00807248|477059|P2|NOT COMPLETED|Overall Study||12
199037|NCT00807248|477060|P1|NOT COMPLETED|Overall Study||21
199038|NCT00807248|477057|P4|COMPLETED|Overall Study||126
199039|NCT00807248|477058|P3|COMPLETED|Overall Study||121
199040|NCT00807248|477059|P2|COMPLETED|Overall Study||128
199041|NCT00807248|477060|P1|COMPLETED|Overall Study||50
199042|NCT00807248|477057|P4|STARTED|Overall Study||140
199043|NCT00807248|477058|P3|STARTED|Overall Study||139
199044|NCT00807248|477059|P2|STARTED|Overall Study||140
199045|NCT00807248|477060|P1|STARTED|Overall Study||71
199046|NCT00807235|477104|P2|NOT COMPLETED|Overall Study||0
199047|NCT00807235|477105|P1|NOT COMPLETED|Overall Study||1
199048|NCT00807235|477104|P2|COMPLETED|Overall Study||6
199049|NCT00807235|477105|P1|COMPLETED|Overall Study||10
199050|NCT00807235|477104|P2|STARTED|Overall Study||6
199051|NCT00807235|477105|P1|STARTED|Overall Study||11
199052|NCT00807209|477138|P3|NOT COMPLETED|Overall Study||0
199053|NCT00807209|477139|P2|NOT COMPLETED|Overall Study||0
199054|NCT00807209|477140|P1|NOT COMPLETED|Overall Study||0
199055|NCT00807209|477138|P3|COMPLETED|Overall Study||1
199056|NCT00807209|477139|P2|COMPLETED|Overall Study||1
199057|NCT00807209|477140|P1|COMPLETED|Overall Study||1
199058|NCT00807209|477138|P3|STARTED|Overall Study||1
199059|NCT00807209|477139|P2|STARTED|Overall Study||1
199060|NCT00807209|477140|P1|STARTED|Overall Study||1
199061|NCT00807092|477150|P2|NOT COMPLETED|Overall Study||4
199062|NCT00807092|477151|P1|NOT COMPLETED|Overall Study||1
199063|NCT00807092|477150|P2|COMPLETED|Overall Study||69
199064|NCT00807092|477151|P1|COMPLETED|Overall Study||71
199065|NCT00807092|477150|P2|Exposed to Drug|Overall Study||73
199066|NCT00807092|477151|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
199067|NCT00807092|477150|P2|STARTED|Overall Study||73
199068|NCT00807092|477151|P1|STARTED|Overall Study||72
199069|NCT00807040|477181|P2|NOT COMPLETED|Overall Study||41
199070|NCT00807040|477182|P1|NOT COMPLETED|Overall Study||36
199071|NCT00807040|477181|P2|COMPLETED|Overall Study||84
199072|NCT00807040|477182|P1|COMPLETED|Overall Study||90
199073|NCT00807040|477181|P2|STARTED|Overall Study||125
199074|NCT00807040|477182|P1|STARTED|Overall Study||126
199075|NCT00807014|477192|P2|NOT COMPLETED|Overall Study||27
199076|NCT00807014|477193|P1|NOT COMPLETED|Overall Study||27
199077|NCT00807014|477192|P2|COMPLETED|Overall Study||58
199078|NCT00807014|477193|P1|COMPLETED|Overall Study||56
199079|NCT00807014|477192|P2|STARTED|Overall Study||85
199080|NCT00807014|477193|P1|STARTED|Overall Study||83
199081|NCT00807001|477224|P5|NOT COMPLETED|Overall Study||0
199082|NCT00807001|477225|P4|NOT COMPLETED|Overall Study||0
199083|NCT00807001|477226|P3|NOT COMPLETED|Overall Study||0
199084|NCT00807001|477227|P2|NOT COMPLETED|Overall Study||1
199085|NCT00807001|477228|P1|NOT COMPLETED|Overall Study||0
199086|NCT00807001|477224|P5|COMPLETED|Overall Study||9
199087|NCT00807001|477225|P4|COMPLETED|Overall Study||8
199088|NCT00807001|477226|P3|COMPLETED|Overall Study||8
199089|NCT00807001|477227|P2|COMPLETED|Overall Study||7
199090|NCT00807001|477228|P1|COMPLETED|Overall Study||8
199091|NCT00807001|477224|P5|STARTED|Overall Study||9
199092|NCT00807001|477225|P4|STARTED|Overall Study||8
199093|NCT00807001|477226|P3|STARTED|Overall Study||8
199094|NCT00807001|477227|P2|STARTED|Overall Study||8
199095|NCT00807001|477228|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
199096|NCT00806988|477247|P2|NOT COMPLETED|Overall Study||43
199097|NCT00806988|477248|P1|NOT COMPLETED|Overall Study||27
199098|NCT00806988|477247|P2|COMPLETED|Overall Study||108
199099|NCT00806988|477248|P1|COMPLETED|Overall Study||123
199100|NCT00806988|477247|P2|STARTED|Overall Study||151
199101|NCT00806988|477248|P1|STARTED|Overall Study||150
199102|NCT00806819|477258|P2|NOT COMPLETED|Overall Study||358
199103|NCT00806819|477259|P1|NOT COMPLETED|Overall Study||346
199104|NCT00806819|477258|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
199105|NCT00806819|477259|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
199106|NCT00806819|477258|P2|STARTED|Overall Study|randomised patients|360
199107|NCT00806819|477259|P1|STARTED|Overall Study|randomised patients|353
199108|NCT00806676|477294|P3|NOT COMPLETED|Overall Study||6
199109|NCT00806676|477295|P2|NOT COMPLETED|Overall Study||0
199110|NCT00806676|477296|P1|NOT COMPLETED|Overall Study||4
199111|NCT00806676|477294|P3|COMPLETED|Overall Study||23
199112|NCT00806676|477295|P2|COMPLETED|Overall Study||9
199113|NCT00806676|477296|P1|COMPLETED|Overall Study||25
199114|NCT00806676|477294|P3|STARTED|Overall Study||29
199115|NCT00806676|477295|P2|STARTED|Overall Study||9
199116|NCT00806676|477296|P1|STARTED|Overall Study||29
199117|NCT00806624|477328|P3|NOT COMPLETED|Overall Study||6
199118|NCT00806624|477329|P2|NOT COMPLETED|Overall Study||12
199119|NCT00806624|477330|P1|NOT COMPLETED|Overall Study||9
199120|NCT00806624|477328|P3|COMPLETED|Overall Study||69
199121|NCT00806624|477329|P2|COMPLETED|Overall Study||68
199122|NCT00806624|477330|P1|COMPLETED|Overall Study||70
199123|NCT00806624|477328|P3|STARTED|Overall Study||75
199124|NCT00806624|477329|P2|STARTED|Overall Study||80
199125|NCT00806624|477330|P1|STARTED|Overall Study||79
199126|NCT00806598|477338|P1|NOT COMPLETED|Overall Study||0
199127|NCT00806598|477338|P1|COMPLETED|Overall Study||48
199128|NCT00806598|477338|P1|STARTED|Overall Study||48
199129|NCT00806585|477347|P5|NOT COMPLETED|Overall Study||31
199130|NCT00806585|477348|P4|NOT COMPLETED|Overall Study||15
199131|NCT00806585|477349|P3|NOT COMPLETED|Overall Study||32
199132|NCT00806585|477350|P2|NOT COMPLETED|Overall Study||31
199133|NCT00806585|477351|P1|NOT COMPLETED|Overall Study||32
199134|NCT00806585|477347|P5|COMPLETED|Overall Study||106
199135|NCT00806585|477348|P4|COMPLETED|Overall Study||56
199136|NCT00806585|477349|P3|COMPLETED|Overall Study||109
199137|NCT00806585|477350|P2|COMPLETED|Overall Study||103
199138|NCT00806585|477351|P1|COMPLETED|Overall Study||105
199139|NCT00806585|477347|P5|STARTED|Overall Study||137
199140|NCT00806585|477348|P4|STARTED|Overall Study||71
199141|NCT00806585|477349|P3|STARTED|Overall Study||141
199142|NCT00806585|477350|P2|STARTED|Overall Study||134
199143|NCT00806585|477351|P1|STARTED|Overall Study||137
199144|NCT00806546|477383|P1|NOT COMPLETED|Overall Study||307
199145|NCT00806546|477383|P1|COMPLETED|Overall Study||207
199146|NCT00806546|477383|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
199147|NCT00806494|477387|P1|NOT COMPLETED|Overall Study||80
199148|NCT00806494|477387|P1|COMPLETED|Overall Study||251
199149|NCT00806494|477387|P1|STARTED|Overall Study||331
199150|NCT00806442|477411|P2|NOT COMPLETED|Overall Study||7
199151|NCT00806442|477412|P1|NOT COMPLETED|Overall Study||4
199152|NCT00806442|477411|P2|COMPLETED|Overall Study||14
199153|NCT00806442|477412|P1|COMPLETED|Overall Study||14
199154|NCT00806442|477411|P2|Second Intervention (3 Wks)|Overall Study||14
199155|NCT00806442|477412|P1|Second Intervention (3 Wks)|Overall Study||15
199156|NCT00806442|477411|P2|Washout (3 Wks)|Overall Study||14
199157|NCT00806442|477412|P1|Washout (3 Wks)|Overall Study||15
199158|NCT00806442|477411|P2|First Intervention (3 Wks)|Overall Study||21
199159|NCT00806442|477412|P1|First Intervention (3 Wks)|Overall Study||18
199160|NCT00806442|477411|P2|STARTED|Overall Study||21
199161|NCT00806442|477412|P1|STARTED|Overall Study||18
199162|NCT00806416|477434|P4|NOT COMPLETED|Period 2 - Part II||0
199163|NCT00806416|477435|P3|NOT COMPLETED|Period 2 - Part II||0
199164|NCT00806416|477436|P2|NOT COMPLETED|Period 2 - Part II||0
199165|NCT00806416|477437|P1|NOT COMPLETED|Period 2 - Part II||0
199166|NCT00806416|477434|P4|COMPLETED|Period 2 - Part II||14
199167|NCT00806416|477435|P3|COMPLETED|Period 2 - Part II||14
199168|NCT00806416|477436|P2|COMPLETED|Period 2 - Part II||0
199169|NCT00806416|477437|P1|COMPLETED|Period 2 - Part II||0
199170|NCT00806416|477434|P4|STARTED|Period 2 - Part II||14
199171|NCT00806416|477435|P3|STARTED|Period 2 - Part II||14
199172|NCT00806416|477436|P2|STARTED|Period 2 - Part II||0
199173|NCT00806416|477437|P1|STARTED|Period 2 - Part II||0
199174|NCT00806416|477434|P4|NOT COMPLETED|Period 1 - Part II||2
199175|NCT00806416|477435|P3|NOT COMPLETED|Period 1 - Part II||0
199176|NCT00806416|477436|P2|NOT COMPLETED|Period 1 - Part II||0
199177|NCT00806416|477437|P1|NOT COMPLETED|Period 1 - Part II||0
199178|NCT00806416|477434|P4|COMPLETED|Period 1 - Part II||14
199179|NCT00806416|477435|P3|COMPLETED|Period 1 - Part II||14
199180|NCT00806416|477436|P2|COMPLETED|Period 1 - Part II||0
199181|NCT00806416|477437|P1|COMPLETED|Period 1 - Part II||0
199182|NCT00806416|477434|P4|STARTED|Period 1 - Part II||16
199183|NCT00806416|477435|P3|STARTED|Period 1 - Part II||14
199184|NCT00806416|477436|P2|STARTED|Period 1 - Part II||0
199185|NCT00806416|477437|P1|STARTED|Period 1 - Part II||0
199186|NCT00806416|477434|P4|NOT COMPLETED|Period 2 - Part I||0
199187|NCT00806416|477435|P3|NOT COMPLETED|Period 2 - Part I||0
199188|NCT00806416|477436|P2|NOT COMPLETED|Period 2 - Part I||0
199189|NCT00806416|477437|P1|NOT COMPLETED|Period 2 - Part I||0
199190|NCT00806416|477434|P4|COMPLETED|Period 2 - Part I||0
199191|NCT00806416|477435|P3|COMPLETED|Period 2 - Part I||0
199192|NCT00806416|477436|P2|COMPLETED|Period 2 - Part I||103
199193|NCT00806416|477437|P1|COMPLETED|Period 2 - Part I||104
199194|NCT00806416|477434|P4|STARTED|Period 2 - Part I||0
199195|NCT00806416|477435|P3|STARTED|Period 2 - Part I||0
199196|NCT00806416|477436|P2|STARTED|Period 2 - Part I||103
199197|NCT00806416|477437|P1|STARTED|Period 2 - Part I||104
199198|NCT00806416|477434|P4|NOT COMPLETED|Period 1 - Part I||0
199199|NCT00806416|477435|P3|NOT COMPLETED|Period 1 - Part I||0
199200|NCT00806416|477436|P2|NOT COMPLETED|Period 1 - Part I||4
199201|NCT00806416|477437|P1|NOT COMPLETED|Period 1 - Part I||3
199202|NCT00806416|477434|P4|COMPLETED|Period 1 - Part I||0
199203|NCT00806416|477435|P3|COMPLETED|Period 1 - Part I||0
199204|NCT00806416|477436|P2|COMPLETED|Period 1 - Part I||103
199205|NCT00806416|477437|P1|COMPLETED|Period 1 - Part I||104
199206|NCT00806416|477434|P4|STARTED|Period 1 - Part I||0
199207|NCT00806416|477435|P3|STARTED|Period 1 - Part I||0
199208|NCT00806416|477436|P2|STARTED|Period 1 - Part I||107
199209|NCT00806416|477437|P1|STARTED|Period 1 - Part I||107
199210|NCT00806403|477450|P2|NOT COMPLETED|Overall Study||3
199211|NCT00806403|477451|P1|NOT COMPLETED|Overall Study||4
199212|NCT00806403|477450|P2|COMPLETED|Overall Study||98
199213|NCT00806403|477451|P1|COMPLETED|Overall Study||100
199214|NCT00806403|477450|P2|STARTED|Overall Study||101
199215|NCT00806403|477451|P1|STARTED|Overall Study||104
199216|NCT00806390|477465|P2|NOT COMPLETED|Overall Study||0
199217|NCT00806390|477466|P1|NOT COMPLETED|Overall Study||0
199218|NCT00806390|477465|P2|COMPLETED|Overall Study||8
199219|NCT00806390|477466|P1|COMPLETED|Overall Study||7
199220|NCT00806390|477465|P2|STARTED|Overall Study||8
199221|NCT00806390|477466|P1|STARTED|Overall Study||7
199222|NCT00806351|477474|P2|NOT COMPLETED|Overall Study||4
199223|NCT00806351|477475|P1|NOT COMPLETED|Overall Study||5
199224|NCT00806351|477474|P2|COMPLETED|Overall Study||2
199225|NCT00806351|477475|P1|COMPLETED|Overall Study||10
199226|NCT00806351|477474|P2|STARTED|Overall Study||6
199227|NCT00806351|477475|P1|STARTED|Overall Study||15
199228|NCT00806260|477512|P6|NOT COMPLETED|Period 3||0
199229|NCT00806260|477513|P5|NOT COMPLETED|Period 3||0
199230|NCT00806260|477514|P4|NOT COMPLETED|Period 3||0
199231|NCT00806260|477515|P3|NOT COMPLETED|Period 3||1
199232|NCT00806260|477516|P2|NOT COMPLETED|Period 3||1
199233|NCT00806260|477517|P1|NOT COMPLETED|Period 3||1
199234|NCT00806260|477512|P6|COMPLETED|Period 3||0
199235|NCT00806260|477513|P5|COMPLETED|Period 3||0
199236|NCT00806260|477514|P4|COMPLETED|Period 3||12
199237|NCT00806260|477515|P3|COMPLETED|Period 3||5
199238|NCT00806260|477516|P2|COMPLETED|Period 3||7
199239|NCT00806260|477517|P1|COMPLETED|Period 3||12
199240|NCT00806260|477512|P6|STARTED|Period 3||0
199241|NCT00806260|477513|P5|STARTED|Period 3||0
199242|NCT00806260|477514|P4|STARTED|Period 3||12
199243|NCT00806260|477515|P3|STARTED|Period 3||6
199244|NCT00806260|477516|P2|STARTED|Period 3||8
199245|NCT00806260|477517|P1|STARTED|Period 3||13
199246|NCT00806260|477512|P6|NOT COMPLETED|Period 2||0
199247|NCT00806260|477513|P5|NOT COMPLETED|Period 2||0
199248|NCT00806260|477514|P4|NOT COMPLETED|Period 2||2
199249|NCT00806260|477515|P3|NOT COMPLETED|Period 2||2
199250|NCT00806260|477516|P2|NOT COMPLETED|Period 2||0
199251|NCT00806260|477517|P1|NOT COMPLETED|Period 2||2
199252|NCT00806260|477512|P6|COMPLETED|Period 2||0
199253|NCT00806260|477513|P5|COMPLETED|Period 2||0
199254|NCT00806260|477514|P4|COMPLETED|Period 2||12
199255|NCT00806260|477515|P3|COMPLETED|Period 2||6
199256|NCT00806260|477516|P2|COMPLETED|Period 2||8
199257|NCT00806260|477517|P1|COMPLETED|Period 2||13
199258|NCT00806260|477512|P6|STARTED|Period 2||0
199259|NCT00806260|477513|P5|STARTED|Period 2||0
199260|NCT00806260|477514|P4|STARTED|Period 2||14
199261|NCT00806260|477515|P3|STARTED|Period 2||8
199262|NCT00806260|477516|P2|STARTED|Period 2||8
199263|NCT00806260|477517|P1|STARTED|Period 2||15
199264|NCT00806260|477512|P6|NOT COMPLETED|Period 1 (1 Day)||0
199265|NCT00806260|477513|P5|NOT COMPLETED|Period 1 (1 Day)||3
199266|NCT00806260|477514|P4|NOT COMPLETED|Period 1 (1 Day)||0
199267|NCT00806260|477515|P3|NOT COMPLETED|Period 1 (1 Day)||0
199268|NCT00806260|477516|P2|NOT COMPLETED|Period 1 (1 Day)||0
199269|NCT00806260|477517|P1|NOT COMPLETED|Period 1 (1 Day)||0
199270|NCT00806260|477512|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
199271|NCT00806260|477513|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
199272|NCT00806260|477514|P4|COMPLETED|Period 1 (1 Day)||14
199273|NCT00806260|477515|P3|COMPLETED|Period 1 (1 Day)||8
199274|NCT00806260|477516|P2|COMPLETED|Period 1 (1 Day)||8
199275|NCT00806260|477517|P1|COMPLETED|Period 1 (1 Day)||15
199276|NCT00806260|477512|P6|STARTED|Period 1 (1 Day)||17
199277|NCT00806260|477513|P5|STARTED|Period 1 (1 Day)||18
199278|NCT00806260|477514|P4|STARTED|Period 1 (1 Day)||14
199279|NCT00806260|477515|P3|STARTED|Period 1 (1 Day)||8
199280|NCT00806260|477516|P2|STARTED|Period 1 (1 Day)||8
199281|NCT00806260|477517|P1|STARTED|Period 1 (1 Day)||15
199282|NCT00806234|477532|P3|NOT COMPLETED|Overall Study||12
199283|NCT00806234|477533|P2|NOT COMPLETED|Overall Study||12
199284|NCT00806234|477534|P1|NOT COMPLETED|Overall Study||13
199285|NCT00806234|477532|P3|COMPLETED|Overall Study||37
199286|NCT00806234|477533|P2|COMPLETED|Overall Study||19
199287|NCT00806234|477534|P1|COMPLETED|Overall Study||34
199288|NCT00806234|477532|P3|STARTED|Overall Study||49
199289|NCT00806234|477533|P2|STARTED|Overall Study||31
199290|NCT00806234|477534|P1|STARTED|Overall Study||47
199291|NCT00806221|477551|P1|NOT COMPLETED|Overall Study||2
199292|NCT00806221|477551|P1|COMPLETED|Overall Study||20
199293|NCT00806221|477551|P1|STARTED|Overall Study||22
199294|NCT00806195|477562|P4|NOT COMPLETED|Overall Study||106
199295|NCT00806195|477563|P3|NOT COMPLETED|Overall Study||270
199296|NCT00806195|477564|P2|NOT COMPLETED|Overall Study||162
199297|NCT00806195|477565|P1|NOT COMPLETED|Overall Study||514
199298|NCT00806195|477562|P4|COMPLETED|Overall Study||383
199299|NCT00806195|477563|P3|COMPLETED|Overall Study||1139
199300|NCT00806195|477564|P2|COMPLETED|Overall Study||1321
199301|NCT00806195|477565|P1|COMPLETED|Overall Study||3849
199302|NCT00806195|477562|P4|STARTED|Overall Study||489
199303|NCT00806195|477563|P3|STARTED|Overall Study||1409
199304|NCT00806195|477564|P2|STARTED|Overall Study||1483
199305|NCT00806195|477565|P1|STARTED|Overall Study||4363
199306|NCT00806078|477579|P2|NOT COMPLETED|Second Intervention||0
199307|NCT00806078|477580|P1|NOT COMPLETED|Second Intervention||0
199308|NCT00806078|477579|P2|COMPLETED|Second Intervention||9
199309|NCT00806078|477580|P1|COMPLETED|Second Intervention||9
199310|NCT00806078|477579|P2|STARTED|Second Intervention||9
199311|NCT00806078|477580|P1|STARTED|Second Intervention||9
199312|NCT00806078|477579|P2|NOT COMPLETED|7 Day Washout Period||0
199313|NCT00806078|477580|P1|NOT COMPLETED|7 Day Washout Period||0
199314|NCT00806078|477579|P2|COMPLETED|7 Day Washout Period||9
199315|NCT00806078|477580|P1|COMPLETED|7 Day Washout Period||9
199316|NCT00806078|477579|P2|STARTED|7 Day Washout Period||9
199317|NCT00806078|477580|P1|STARTED|7 Day Washout Period||9
199318|NCT00806078|477579|P2|NOT COMPLETED|First Intervention||0
199319|NCT00806078|477580|P1|NOT COMPLETED|First Intervention||0
199320|NCT00806078|477579|P2|COMPLETED|First Intervention||9
199321|NCT00806078|477580|P1|COMPLETED|First Intervention||9
199322|NCT00806078|477579|P2|STARTED|First Intervention||9
199323|NCT00806078|477580|P1|STARTED|First Intervention||9
199324|NCT00806026|477596|P6|NOT COMPLETED|Overall Study||32
199325|NCT00806026|477597|P5|NOT COMPLETED|Overall Study||30
199326|NCT00806026|477598|P4|NOT COMPLETED|Overall Study||29
199327|NCT00806026|477599|P3|NOT COMPLETED|Overall Study||93
199328|NCT00806026|477600|P2|NOT COMPLETED|Overall Study||101
199329|NCT00806026|477601|P1|NOT COMPLETED|Overall Study||92
199330|NCT00806026|477596|P6|COMPLETED|Overall Study||29
199331|NCT00806026|477597|P5|COMPLETED|Overall Study||29
199332|NCT00806026|477598|P4|COMPLETED|Overall Study||32
199333|NCT00806026|477599|P3|COMPLETED|Overall Study||89
199334|NCT00806026|477600|P2|COMPLETED|Overall Study||82
199335|NCT00806026|477601|P1|COMPLETED|Overall Study||93
199336|NCT00806026|477596|P6|Treated|Overall Study||61
199337|NCT00806026|477597|P5|Treated|Overall Study||59
199338|NCT00806026|477598|P4|Treated|Overall Study||59
199339|NCT00806026|477599|P3|Treated|Overall Study||180
199340|NCT00806026|477600|P2|Treated|Overall Study||178
199341|NCT00806026|477601|P1|Treated|Overall Study||182
199342|NCT00806026|477596|P6|STARTED|Overall Study||61
199343|NCT00806026|477597|P5|STARTED|Overall Study||59
199344|NCT00806026|477598|P4|STARTED|Overall Study||61
199345|NCT00806026|477599|P3|STARTED|Overall Study||182
199346|NCT00806026|477600|P2|STARTED|Overall Study||183
199347|NCT00806026|477601|P1|STARTED|Overall Study||185
199348|NCT00805961|477696|P1|NOT COMPLETED|Maintenance Treatment||34
199349|NCT00805961|477696|P1|COMPLETED|Maintenance Treatment||23
199350|NCT00805961|477696|P1|STARTED|Maintenance Treatment||57
199351|NCT00805961|477696|P1|NOT COMPLETED|Treatment-Free Interval||7
199352|NCT00805961|477696|P1|COMPLETED|Treatment-Free Interval||57
199353|NCT00805961|477696|P1|STARTED|Treatment-Free Interval||64
199354|NCT00805961|477696|P1|NOT COMPLETED|Modality Therapy||4
199355|NCT00805961|477696|P1|COMPLETED|Modality Therapy||64
199356|NCT00805961|477696|P1|STARTED|Modality Therapy||68
199357|NCT00805935|477706|P4|NOT COMPLETED|Overall Study||11
199358|NCT00805935|477707|P3|NOT COMPLETED|Overall Study||15
199359|NCT00805935|477708|P2|NOT COMPLETED|Overall Study||19
199360|NCT00805935|477709|P1|NOT COMPLETED|Overall Study||13
199361|NCT00805935|477706|P4|COMPLETED|Overall Study||19
199362|NCT00805935|477707|P3|COMPLETED|Overall Study||13
199363|NCT00805935|477708|P2|COMPLETED|Overall Study||8
199364|NCT00805935|477709|P1|COMPLETED|Overall Study||12
199365|NCT00805935|477706|P4|STARTED|Overall Study||30
199366|NCT00805935|477707|P3|STARTED|Overall Study||28
199367|NCT00805935|477708|P2|STARTED|Overall Study||27
199368|NCT00805935|477709|P1|STARTED|Overall Study||25
199369|NCT00805870|477763|P2|NOT COMPLETED|Overall Study||0
199370|NCT00805870|477764|P1|NOT COMPLETED|Overall Study||0
199371|NCT00805870|477763|P2|COMPLETED|Overall Study||10
199372|NCT00805870|477764|P1|COMPLETED|Overall Study||10
199373|NCT00805870|477763|P2|STARTED|Overall Study||10
199374|NCT00805870|477764|P1|STARTED|Overall Study||10
199375|NCT00805792|477776|P1|NOT COMPLETED|Overall Study||5
199376|NCT00805792|477776|P1|COMPLETED|Overall Study||28
199377|NCT00805792|477776|P1|STARTED|Overall Study||33
199378|NCT00805766|477784|P1|NOT COMPLETED|Increased Dose Period||13
199379|NCT00805766|477784|P1|COMPLETED|Increased Dose Period||26
199380|NCT00805766|477784|P1|STARTED|Increased Dose Period||39
199381|NCT00805766|477784|P1|NOT COMPLETED|Screening Period||6
199382|NCT00805766|477784|P1|COMPLETED|Screening Period||39
199383|NCT00805766|477784|P1|STARTED|Screening Period||45
199384|NCT00805740|477798|P2|NOT COMPLETED|Overall Study||4
199385|NCT00805740|477799|P1|NOT COMPLETED|Overall Study||11
199386|NCT00805740|477798|P2|COMPLETED|Overall Study||9
199387|NCT00805740|477799|P1|COMPLETED|Overall Study||17
199388|NCT00805740|477798|P2|Treated|Overall Study||13
199389|NCT00805740|477799|P1|Treated|Overall Study||26
199390|NCT00805740|477798|P2|STARTED|Overall Study||13
199391|NCT00805740|477799|P1|STARTED|Overall Study||28
199392|NCT00805675|477824|P3|NOT COMPLETED|Overall Study||1
199393|NCT00805675|477825|P2|NOT COMPLETED|Overall Study||0
199394|NCT00805675|477826|P1|NOT COMPLETED|Overall Study||0
199395|NCT00805675|477824|P3|COMPLETED|Overall Study||15
199396|NCT00805675|477825|P2|COMPLETED|Overall Study||14
199397|NCT00805675|477826|P1|COMPLETED|Overall Study||16
199398|NCT00805675|477824|P3|STARTED|Overall Study||16
199399|NCT00805675|477825|P2|STARTED|Overall Study||14
199400|NCT00805675|477826|P1|STARTED|Overall Study||16
199401|NCT00805545|477860|P2|NOT COMPLETED|Overall Study||3
199402|NCT00805545|477861|P1|NOT COMPLETED|Overall Study||6
199403|NCT00805545|477860|P2|COMPLETED|Overall Study||197
199404|NCT00805545|477861|P1|COMPLETED|Overall Study||194
199405|NCT00805545|477860|P2|STARTED|Overall Study||200
199406|NCT00805545|477861|P1|STARTED|Overall Study||200
199407|NCT00805493|477870|P3|NOT COMPLETED|Overall Study||1
199408|NCT00805493|477871|P2|NOT COMPLETED|Overall Study||0
199409|NCT00805493|477872|P1|NOT COMPLETED|Overall Study||2
199410|NCT00805493|477870|P3|COMPLETED|Overall Study||0
199411|NCT00805493|477871|P2|COMPLETED|Overall Study||2
199412|NCT00805493|477872|P1|COMPLETED|Overall Study||1
199413|NCT00805493|477870|P3|STARTED|Overall Study||1
199414|NCT00805493|477871|P2|STARTED|Overall Study||2
199415|NCT00805493|477872|P1|STARTED|Overall Study||3
199416|NCT00805480|477887|P4|NOT COMPLETED|Overall Study||5
199417|NCT00805480|477888|P3|NOT COMPLETED|Overall Study||12
199418|NCT00805480|477889|P2|NOT COMPLETED|Overall Study||7
199419|NCT00805480|477890|P1|NOT COMPLETED|Overall Study||14
199420|NCT00805480|477887|P4|COMPLETED|Overall Study||5
199421|NCT00805480|477888|P3|COMPLETED|Overall Study||19
199422|NCT00805480|477889|P2|COMPLETED|Overall Study||22
199423|NCT00805480|477890|P1|COMPLETED|Overall Study||16
199424|NCT00805480|477887|P4|Pharmacodynamic Analysis Set|Overall Study||10
199425|NCT00805480|477888|P3|Pharmacodynamic Analysis Set|Overall Study||29
199426|NCT00805480|477889|P2|Pharmacodynamic Analysis Set|Overall Study||25
199427|NCT00805480|477890|P1|Pharmacodynamic Analysis Set|Overall Study||30
199428|NCT00805480|477887|P4|STARTED|Overall Study||10
199429|NCT00805480|477888|P3|STARTED|Overall Study||31
199430|NCT00805480|477889|P2|STARTED|Overall Study||29
199431|NCT00805480|477890|P1|STARTED|Overall Study||30
199432|NCT00805467|477919|P4|NOT COMPLETED|Overall Study||237
199433|NCT00805467|477920|P3|NOT COMPLETED|Overall Study||103
199434|NCT00805467|477921|P2|NOT COMPLETED|Overall Study||34
199435|NCT00805467|477922|P1|NOT COMPLETED|Overall Study||0
199436|NCT00805467|477919|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
199437|NCT00805467|477920|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
199438|NCT00805467|477921|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
199439|NCT00805467|477922|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
199440|NCT00805467|477919|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
199441|NCT00805467|477920|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
199442|NCT00805467|477921|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
199443|NCT00805467|477922|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
199444|NCT00805467|477919|P4|STARTED|Overall Study|Patients who received treatment|381
199445|NCT00805467|477920|P3|STARTED|Overall Study|Patients who received treatment|183
199446|NCT00805467|477921|P2|STARTED|Overall Study|Patients who received treatment|59
199447|NCT00805467|477922|P1|STARTED|Overall Study|Patients who received treatment|1
199448|NCT00805441|477942|P2|NOT COMPLETED|Overall Study||36
199449|NCT00805441|477943|P1|NOT COMPLETED|Overall Study||34
199450|NCT00805441|477942|P2|COMPLETED|Overall Study||60
199451|NCT00805441|477943|P1|COMPLETED|Overall Study||60
199452|NCT00805441|477942|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
199453|NCT00805441|477943|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
199454|NCT00805441|477942|P2|STARTED|Overall Study||96
199455|NCT00805441|477943|P1|STARTED|Overall Study||94
199456|NCT00805389|477978|P5|NOT COMPLETED|Overall Study||13
199457|NCT00805389|477979|P4|NOT COMPLETED|Overall Study||17
199458|NCT00805389|477980|P3|NOT COMPLETED|Overall Study||12
199459|NCT00805389|477981|P2|NOT COMPLETED|Overall Study||5
199460|NCT00805389|477982|P1|NOT COMPLETED|Overall Study||7
199461|NCT00805389|477978|P5|COMPLETED|Overall Study||129
199462|NCT00805389|477979|P4|COMPLETED|Overall Study||128
199463|NCT00805389|477980|P3|COMPLETED|Overall Study||129
199464|NCT00805389|477981|P2|COMPLETED|Overall Study||137
199465|NCT00805389|477982|P1|COMPLETED|Overall Study||136
199466|NCT00805389|477978|P5|STARTED|Overall Study||142
199467|NCT00805389|477979|P4|STARTED|Overall Study||145
199468|NCT00805389|477980|P3|STARTED|Overall Study||141
199469|NCT00805389|477981|P2|STARTED|Overall Study||142
199470|NCT00805389|477982|P1|STARTED|Overall Study||143
199471|NCT00805285|478224|P1|NOT COMPLETED|Overall Study||1
199472|NCT00805285|478224|P1|COMPLETED|Overall Study||0
199473|NCT00805285|478224|P1|STARTED|Overall Study||1
199474|NCT00805194|478234|P2|NOT COMPLETED|Overall Study||654
199475|NCT00805194|478235|P1|NOT COMPLETED|Overall Study||649
199476|NCT00805194|478234|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013).|5
199477|NCT00805194|478235|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013)|6
199478|NCT00805194|478234|P2|STARTED|Overall Study|randomised patients|659
199479|NCT00805194|478235|P1|STARTED|Overall Study|randomised patients|655
199480|NCT00805142|478269|P2|NOT COMPLETED|Maintenance Period||2
199481|NCT00805142|478270|P1|NOT COMPLETED|Maintenance Period||0
199482|NCT00805142|478269|P2|COMPLETED|Maintenance Period||30
199483|NCT00805142|478270|P1|COMPLETED|Maintenance Period||30
199484|NCT00805142|478269|P2|STARTED|Maintenance Period||32
199485|NCT00805142|478270|P1|STARTED|Maintenance Period||30
199486|NCT00805142|478269|P2|NOT COMPLETED|Titration Period||10
199487|NCT00805142|478270|P1|NOT COMPLETED|Titration Period||6
199488|NCT00805142|478269|P2|COMPLETED|Titration Period||32
199489|NCT00805142|478270|P1|COMPLETED|Titration Period||30
199490|NCT00805142|478269|P2|STARTED|Titration Period||42
199491|NCT00805142|478270|P1|STARTED|Titration Period||36
199492|NCT00805038|478296|P2|NOT COMPLETED|Overall Study||0
199493|NCT00805038|478297|P1|NOT COMPLETED|Overall Study||0
199494|NCT00805038|478296|P2|COMPLETED|Overall Study||92
199495|NCT00805038|478297|P1|COMPLETED|Overall Study||75
199496|NCT00805038|478296|P2|STARTED|Overall Study||92
199497|NCT00805038|478297|P1|STARTED|Overall Study||75
199498|NCT00805025|478303|P1|NOT COMPLETED|Overall Study||49
199499|NCT00805025|478303|P1|COMPLETED|Overall Study||82
199500|NCT00805025|478303|P1|Enrolled and Treated|Overall Study||89
199501|NCT00805025|478303|P1|STARTED|Overall Study||131
199502|NCT00804999|478313|P4|NOT COMPLETED|Overall Study||0
199503|NCT00804999|478314|P3|NOT COMPLETED|Overall Study||0
199504|NCT00804999|478315|P2|NOT COMPLETED|Overall Study||0
199505|NCT00804999|478316|P1|NOT COMPLETED|Overall Study||0
199506|NCT00804999|478313|P4|COMPLETED|Overall Study||10
199507|NCT00804999|478314|P3|COMPLETED|Overall Study||14
199508|NCT00804999|478315|P2|COMPLETED|Overall Study||12
199509|NCT00804999|478316|P1|COMPLETED|Overall Study||15
199510|NCT00804999|478313|P4|STARTED|Overall Study||10
199511|NCT00804999|478314|P3|STARTED|Overall Study||14
199512|NCT00804999|478315|P2|STARTED|Overall Study||12
199513|NCT00804999|478316|P1|STARTED|Overall Study||15
199514|NCT00804986|478332|P6|NOT COMPLETED|Overall Study||10
199515|NCT00804986|478333|P5|NOT COMPLETED|Overall Study||9
199516|NCT00804986|478334|P4|NOT COMPLETED|Overall Study||8
199517|NCT00804986|478335|P3|NOT COMPLETED|Overall Study||2
199518|NCT00804986|478336|P2|NOT COMPLETED|Overall Study||8
199519|NCT00804986|478337|P1|NOT COMPLETED|Overall Study||1
199520|NCT00804986|478332|P6|COMPLETED|Overall Study||31
199521|NCT00804986|478333|P5|COMPLETED|Overall Study||34
199522|NCT00804986|478334|P4|COMPLETED|Overall Study||34
199523|NCT00804986|478335|P3|COMPLETED|Overall Study||40
199524|NCT00804986|478336|P2|COMPLETED|Overall Study||35
199525|NCT00804986|478337|P1|COMPLETED|Overall Study||35
199526|NCT00804986|478332|P6|STARTED|Overall Study||41
199527|NCT00804986|478333|P5|STARTED|Overall Study||43
199528|NCT00804986|478334|P4|STARTED|Overall Study||42
199529|NCT00804986|478335|P3|STARTED|Overall Study||42
199530|NCT00804986|478336|P2|STARTED|Overall Study||43
199531|NCT00804986|478337|P1|STARTED|Overall Study||36
199532|NCT00804908|478432|P3|NOT COMPLETED|Overall Study||114
199533|NCT00804908|478433|P2|NOT COMPLETED|Overall Study||116
199534|NCT00804908|478434|P1|NOT COMPLETED|Overall Study||115
199535|NCT00804908|478432|P3|COMPLETED|Overall Study||1
199536|NCT00804908|478433|P2|COMPLETED|Overall Study||0
199537|NCT00804908|478434|P1|COMPLETED|Overall Study||0
199538|NCT00804908|478432|P3|STARTED|Overall Study||115
199539|NCT00804908|478433|P2|STARTED|Overall Study||116
199540|NCT00804908|478434|P1|STARTED|Overall Study||115
199541|NCT00804843|478465|P2|NOT COMPLETED|Overall Study||7
199542|NCT00804843|478466|P1|NOT COMPLETED|Overall Study||10
199543|NCT00804843|478465|P2|COMPLETED|Overall Study||43
199544|NCT00804843|478466|P1|COMPLETED|Overall Study||40
199545|NCT00804843|478465|P2|STARTED|Overall Study||50
199546|NCT00804843|478466|P1|STARTED|Overall Study||50
199547|NCT00804713|478476|P1|NOT COMPLETED|Overall Study||0
199548|NCT00804713|478476|P1|COMPLETED|Overall Study||1978
199549|NCT00804713|478476|P1|STARTED|Overall Study||1978
199550|NCT00804687|478484|P6|NOT COMPLETED|Period 5: Treatment Period||0
199551|NCT00804687|478485|P5|NOT COMPLETED|Period 5: Treatment Period||1
199552|NCT00804687|478486|P4|NOT COMPLETED|Period 5: Treatment Period||0
199553|NCT00804687|478487|P3|NOT COMPLETED|Period 5: Treatment Period||1
199554|NCT00804687|478488|P2|NOT COMPLETED|Period 5: Treatment Period||0
199555|NCT00804687|478489|P1|NOT COMPLETED|Period 5: Treatment Period||1
199556|NCT00804687|478484|P6|COMPLETED|Period 5: Treatment Period||8
199557|NCT00804687|478485|P5|COMPLETED|Period 5: Treatment Period||8
199558|NCT00804687|478486|P4|COMPLETED|Period 5: Treatment Period||8
199559|NCT00804687|478487|P3|COMPLETED|Period 5: Treatment Period||8
199560|NCT00804687|478488|P2|COMPLETED|Period 5: Treatment Period||9
199561|NCT00804687|478489|P1|COMPLETED|Period 5: Treatment Period||8
199562|NCT00804687|478484|P6|STARTED|Period 5: Treatment Period||8
199563|NCT00804687|478485|P5|STARTED|Period 5: Treatment Period||9
199564|NCT00804687|478486|P4|STARTED|Period 5: Treatment Period||8
199565|NCT00804687|478487|P3|STARTED|Period 5: Treatment Period||9
199566|NCT00804687|478488|P2|STARTED|Period 5: Treatment Period||9
199567|NCT00804687|478489|P1|STARTED|Period 5: Treatment Period||9
199568|NCT00804687|478484|P6|NOT COMPLETED|Period 4: Washout Period||0
199569|NCT00804687|478485|P5|NOT COMPLETED|Period 4: Washout Period||0
199570|NCT00804687|478486|P4|NOT COMPLETED|Period 4: Washout Period||0
199571|NCT00804687|478487|P3|NOT COMPLETED|Period 4: Washout Period||0
199572|NCT00804687|478488|P2|NOT COMPLETED|Period 4: Washout Period||0
199573|NCT00804687|478489|P1|NOT COMPLETED|Period 4: Washout Period||0
199574|NCT00804687|478484|P6|COMPLETED|Period 4: Washout Period||8
199575|NCT00804687|478485|P5|COMPLETED|Period 4: Washout Period||9
199576|NCT00804687|478486|P4|COMPLETED|Period 4: Washout Period||8
199577|NCT00804687|478487|P3|COMPLETED|Period 4: Washout Period||9
199578|NCT00804687|478488|P2|COMPLETED|Period 4: Washout Period||9
199579|NCT00804687|478489|P1|COMPLETED|Period 4: Washout Period||9
199580|NCT00804687|478484|P6|STARTED|Period 4: Washout Period||8
199581|NCT00804687|478485|P5|STARTED|Period 4: Washout Period||9
199582|NCT00804687|478486|P4|STARTED|Period 4: Washout Period||8
199583|NCT00804687|478487|P3|STARTED|Period 4: Washout Period||9
199584|NCT00804687|478488|P2|STARTED|Period 4: Washout Period||9
199585|NCT00804687|478489|P1|STARTED|Period 4: Washout Period||9
199586|NCT00804687|478484|P6|NOT COMPLETED|Period 3: Treatment Period||0
199587|NCT00804687|478485|P5|NOT COMPLETED|Period 3: Treatment Period||0
199588|NCT00804687|478486|P4|NOT COMPLETED|Period 3: Treatment Period||1
199589|NCT00804687|478487|P3|NOT COMPLETED|Period 3: Treatment Period||0
199590|NCT00804687|478488|P2|NOT COMPLETED|Period 3: Treatment Period||0
199591|NCT00804687|478489|P1|NOT COMPLETED|Period 3: Treatment Period||0
199592|NCT00804687|478484|P6|COMPLETED|Period 3: Treatment Period||8
199593|NCT00804687|478485|P5|COMPLETED|Period 3: Treatment Period||9
199594|NCT00804687|478486|P4|COMPLETED|Period 3: Treatment Period||8
199595|NCT00804687|478487|P3|COMPLETED|Period 3: Treatment Period||9
199596|NCT00804687|478488|P2|COMPLETED|Period 3: Treatment Period||9
199597|NCT00804687|478489|P1|COMPLETED|Period 3: Treatment Period||9
199598|NCT00804687|478484|P6|STARTED|Period 3: Treatment Period||8
199599|NCT00804687|478485|P5|STARTED|Period 3: Treatment Period||9
199600|NCT00804687|478486|P4|STARTED|Period 3: Treatment Period||9
199601|NCT00804687|478487|P3|STARTED|Period 3: Treatment Period||9
199602|NCT00804687|478488|P2|STARTED|Period 3: Treatment Period||9
199603|NCT00804687|478489|P1|STARTED|Period 3: Treatment Period||9
199604|NCT00804687|478484|P6|NOT COMPLETED|Period 2: Washout Period||0
199605|NCT00804687|478485|P5|NOT COMPLETED|Period 2: Washout Period||0
199606|NCT00804687|478486|P4|NOT COMPLETED|Period 2: Washout Period||0
199607|NCT00804687|478487|P3|NOT COMPLETED|Period 2: Washout Period||0
199608|NCT00804687|478488|P2|NOT COMPLETED|Period 2: Washout Period||0
199609|NCT00804687|478489|P1|NOT COMPLETED|Period 2: Washout Period||0
199610|NCT00804687|478484|P6|COMPLETED|Period 2: Washout Period||8
199611|NCT00804687|478485|P5|COMPLETED|Period 2: Washout Period||9
199612|NCT00804687|478486|P4|COMPLETED|Period 2: Washout Period||9
199613|NCT00804687|478487|P3|COMPLETED|Period 2: Washout Period||9
199614|NCT00804687|478488|P2|COMPLETED|Period 2: Washout Period||9
199615|NCT00804687|478489|P1|COMPLETED|Period 2: Washout Period||9
199616|NCT00804687|478484|P6|STARTED|Period 2: Washout Period||8
199617|NCT00804687|478485|P5|STARTED|Period 2: Washout Period||9
199618|NCT00804687|478486|P4|STARTED|Period 2: Washout Period||9
199619|NCT00804687|478487|P3|STARTED|Period 2: Washout Period||9
199620|NCT00804687|478488|P2|STARTED|Period 2: Washout Period||9
199621|NCT00804687|478489|P1|STARTED|Period 2: Washout Period||9
199622|NCT00804687|478484|P6|NOT COMPLETED|Period 1: Treatment Period||0
199623|NCT00804687|478485|P5|NOT COMPLETED|Period 1: Treatment Period||0
199624|NCT00804687|478486|P4|NOT COMPLETED|Period 1: Treatment Period||0
199625|NCT00804687|478487|P3|NOT COMPLETED|Period 1: Treatment Period||0
199626|NCT00804687|478488|P2|NOT COMPLETED|Period 1: Treatment Period||0
199627|NCT00804687|478489|P1|NOT COMPLETED|Period 1: Treatment Period||0
199628|NCT00804687|478484|P6|COMPLETED|Period 1: Treatment Period||8
199629|NCT00804687|478485|P5|COMPLETED|Period 1: Treatment Period||9
199630|NCT00804687|478486|P4|COMPLETED|Period 1: Treatment Period||9
199631|NCT00804687|478487|P3|COMPLETED|Period 1: Treatment Period||9
199632|NCT00804687|478488|P2|COMPLETED|Period 1: Treatment Period||9
199633|NCT00804687|478489|P1|COMPLETED|Period 1: Treatment Period||9
199634|NCT00804687|478484|P6|STARTED|Period 1: Treatment Period||8
199635|NCT00804687|478485|P5|STARTED|Period 1: Treatment Period||9
199636|NCT00804687|478486|P4|STARTED|Period 1: Treatment Period||9
199637|NCT00804687|478487|P3|STARTED|Period 1: Treatment Period||9
199638|NCT00804687|478488|P2|STARTED|Period 1: Treatment Period||9
199639|NCT00804687|478489|P1|STARTED|Period 1: Treatment Period||9
199640|NCT00804648|478506|P6|NOT COMPLETED|Third Invervention||0
199641|NCT00804648|478507|P5|NOT COMPLETED|Third Invervention||0
199642|NCT00804648|478508|P4|NOT COMPLETED|Third Invervention||0
199643|NCT00804648|478509|P3|NOT COMPLETED|Third Invervention||0
199644|NCT00804648|478510|P2|NOT COMPLETED|Third Invervention||0
199645|NCT00804648|478511|P1|NOT COMPLETED|Third Invervention||0
199646|NCT00804648|478506|P6|COMPLETED|Third Invervention||8
199647|NCT00804648|478507|P5|COMPLETED|Third Invervention||4
199648|NCT00804648|478508|P4|COMPLETED|Third Invervention||4
199649|NCT00804648|478509|P3|COMPLETED|Third Invervention||6
199650|NCT00804648|478510|P2|COMPLETED|Third Invervention||5
199651|NCT00804648|478511|P1|COMPLETED|Third Invervention||3
199652|NCT00804648|478506|P6|STARTED|Third Invervention||8
199653|NCT00804648|478507|P5|STARTED|Third Invervention||4
199654|NCT00804648|478508|P4|STARTED|Third Invervention||4
199655|NCT00804648|478509|P3|STARTED|Third Invervention||6
199656|NCT00804648|478510|P2|STARTED|Third Invervention||5
199657|NCT00804648|478511|P1|STARTED|Third Invervention||3
199658|NCT00804648|478506|P6|NOT COMPLETED|Second Intervention||0
199659|NCT00804648|478507|P5|NOT COMPLETED|Second Intervention||0
199660|NCT00804648|478508|P4|NOT COMPLETED|Second Intervention||0
199661|NCT00804648|478509|P3|NOT COMPLETED|Second Intervention||0
199662|NCT00804648|478510|P2|NOT COMPLETED|Second Intervention||0
199663|NCT00804648|478511|P1|NOT COMPLETED|Second Intervention||0
199664|NCT00804648|478506|P6|COMPLETED|Second Intervention||8
199665|NCT00804648|478507|P5|COMPLETED|Second Intervention||4
199666|NCT00804648|478508|P4|COMPLETED|Second Intervention||4
199667|NCT00804648|478509|P3|COMPLETED|Second Intervention||6
199668|NCT00804648|478510|P2|COMPLETED|Second Intervention||5
199669|NCT00804648|478511|P1|COMPLETED|Second Intervention||3
199670|NCT00804648|478506|P6|STARTED|Second Intervention||8
199671|NCT00804648|478507|P5|STARTED|Second Intervention||4
199672|NCT00804648|478508|P4|STARTED|Second Intervention||4
199673|NCT00804648|478509|P3|STARTED|Second Intervention||6
199674|NCT00804648|478510|P2|STARTED|Second Intervention||5
199675|NCT00804648|478511|P1|STARTED|Second Intervention||3
199676|NCT00804648|478506|P6|NOT COMPLETED|First Intervention||0
199677|NCT00804648|478507|P5|NOT COMPLETED|First Intervention||0
199678|NCT00804648|478508|P4|NOT COMPLETED|First Intervention||0
199679|NCT00804648|478509|P3|NOT COMPLETED|First Intervention||0
199680|NCT00804648|478510|P2|NOT COMPLETED|First Intervention||0
199681|NCT00804648|478511|P1|NOT COMPLETED|First Intervention||0
199682|NCT00804648|478506|P6|COMPLETED|First Intervention||8
199683|NCT00804648|478507|P5|COMPLETED|First Intervention||4
199684|NCT00804648|478508|P4|COMPLETED|First Intervention||4
199685|NCT00804648|478509|P3|COMPLETED|First Intervention||6
199686|NCT00804648|478510|P2|COMPLETED|First Intervention||5
199687|NCT00804648|478511|P1|COMPLETED|First Intervention||3
199688|NCT00804648|478506|P6|STARTED|First Intervention||8
199689|NCT00804648|478507|P5|STARTED|First Intervention||4
199690|NCT00804648|478508|P4|STARTED|First Intervention||4
199691|NCT00804648|478509|P3|STARTED|First Intervention||6
199692|NCT00804648|478510|P2|STARTED|First Intervention||5
199693|NCT00804648|478511|P1|STARTED|First Intervention||3
199694|NCT00804609|478554|P2|NOT COMPLETED|Overall Study||1
199695|NCT00804609|478555|P1|NOT COMPLETED|Overall Study||0
199696|NCT00804609|478554|P2|COMPLETED|Overall Study||14
199697|NCT00804609|478555|P1|COMPLETED|Overall Study||15
199698|NCT00804609|478554|P2|STARTED|Overall Study||15
199699|NCT00804609|478555|P1|STARTED|Overall Study||15
199700|NCT00804596|478561|P1|NOT COMPLETED|Overall Study||0
199701|NCT00804596|478561|P1|COMPLETED|Overall Study||74
199702|NCT00804596|478561|P1|STARTED|Overall Study||74
199703|NCT00804570|478568|P2|NOT COMPLETED|Overall Study||94
199704|NCT00804570|478569|P1|NOT COMPLETED|Overall Study||72
199705|NCT00804570|478568|P2|COMPLETED|Overall Study||94
199706|NCT00804570|478569|P1|COMPLETED|Overall Study||115
199707|NCT00804570|478568|P2|STARTED|Overall Study||188
199708|NCT00804570|478569|P1|STARTED|Overall Study||187
199709|NCT00804193|478628|P3|NOT COMPLETED|Overall Study||32
199710|NCT00804193|478629|P2|NOT COMPLETED|Overall Study||44
199711|NCT00804193|478630|P1|NOT COMPLETED|Overall Study||39
199712|NCT00804193|478628|P3|COMPLETED|Overall Study||77
199713|NCT00804193|478629|P2|COMPLETED|Overall Study||180
199714|NCT00804193|478630|P1|COMPLETED|Overall Study||181
199715|NCT00804193|478628|P3|STARTED|Overall Study||109
199716|NCT00804193|478629|P2|STARTED|Overall Study||224
199717|NCT00804193|478630|P1|STARTED|Overall Study||220
199718|NCT00803959|478646|P2|NOT COMPLETED|Overall Study||51
199719|NCT00803959|478647|P1|NOT COMPLETED|Overall Study||56
199720|NCT00803959|478646|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
199721|NCT00803959|478647|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
199722|NCT00803959|478646|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
199723|NCT00803959|478647|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
199724|NCT00803959|478646|P2|STARTED|Overall Study||315
199725|NCT00803959|478647|P1|STARTED|Overall Study||315
199726|NCT00803790|478679|P4|NOT COMPLETED|Period 2||1
199727|NCT00803790|478680|P3|NOT COMPLETED|Period 2||1
199728|NCT00803790|478681|P2|NOT COMPLETED|Period 2||0
199729|NCT00803790|478682|P1|NOT COMPLETED|Period 2||2
199730|NCT00803790|478679|P4|COMPLETED|Period 2||30
199731|NCT00803790|478680|P3|COMPLETED|Period 2||30
199732|NCT00803790|478681|P2|COMPLETED|Period 2||114
199733|NCT00803790|478682|P1|COMPLETED|Period 2||114
199734|NCT00803790|478679|P4|STARTED|Period 2||31
199735|NCT00803790|478680|P3|STARTED|Period 2||31
199736|NCT00803790|478681|P2|STARTED|Period 2||114
199737|NCT00803790|478682|P1|STARTED|Period 2||116
199738|NCT00803790|478679|P4|NOT COMPLETED|Period 1||4
199739|NCT00803790|478680|P3|NOT COMPLETED|Period 1||1
199740|NCT00803790|478681|P2|NOT COMPLETED|Period 1||12
199741|NCT00803790|478682|P1|NOT COMPLETED|Period 1||9
199742|NCT00803790|478679|P4|COMPLETED|Period 1||31
199743|NCT00803790|478680|P3|COMPLETED|Period 1||31
199744|NCT00803790|478681|P2|COMPLETED|Period 1||114
199745|NCT00803790|478682|P1|COMPLETED|Period 1||116
199746|NCT00803790|478679|P4|STARTED|Period 1||35
199747|NCT00803790|478680|P3|STARTED|Period 1||32
199748|NCT00803790|478681|P2|STARTED|Period 1||126
199749|NCT00803790|478682|P1|STARTED|Period 1||125
199750|NCT00803777|478693|P1|NOT COMPLETED|Overall Study||0
199751|NCT00803777|478693|P1|COMPLETED|Overall Study||147
199752|NCT00803777|478693|P1|STARTED|Overall Study||147
199753|NCT00803751|478703|P2|NOT COMPLETED|Overall Study||0
199754|NCT00803751|478704|P1|NOT COMPLETED|Overall Study||0
199755|NCT00803751|478703|P2|COMPLETED|Overall Study||23
199756|NCT00803751|478704|P1|COMPLETED|Overall Study||26
199757|NCT00803751|478703|P2|STARTED|Overall Study||23
199758|NCT00803751|478704|P1|STARTED|Overall Study||26
199759|NCT00803738|478722|P2|NOT COMPLETED|Overall Study||110
199760|NCT00803738|478723|P1|NOT COMPLETED|Overall Study||94
199761|NCT00803738|478722|P2|COMPLETED|Overall Study||176
199762|NCT00803738|478723|P1|COMPLETED|Overall Study||192
199763|NCT00803738|478722|P2|STARTED|Overall Study||286
199764|NCT00803738|478723|P1|STARTED|Overall Study||286
199765|NCT00803712|478735|P2|NOT COMPLETED|Overall Study||27
199766|NCT00803712|478736|P1|NOT COMPLETED|Overall Study||36
199767|NCT00803712|478735|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
199768|NCT00803712|478736|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
199769|NCT00803712|478735|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
199770|NCT00803712|478736|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
199771|NCT00803712|478735|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
199772|NCT00803712|478736|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
199773|NCT00803712|478735|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
199774|NCT00803712|478736|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
199775|NCT00803686|478804|P4|NOT COMPLETED|Part 2, Period 3||0
199776|NCT00803686|478805|P3|NOT COMPLETED|Part 2, Period 3||0
199777|NCT00803686|478806|P2|NOT COMPLETED|Part 2, Period 3||0
199778|NCT00803686|478807|P1|NOT COMPLETED|Part 2, Period 3||0
199779|NCT00803686|478804|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
199780|NCT00803686|478805|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
199781|NCT00803686|478806|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
199782|NCT00803686|478807|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
199783|NCT00803686|478804|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
199784|NCT00803686|478805|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
199785|NCT00803686|478806|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
199786|NCT00803686|478807|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
199787|NCT00803686|478804|P4|NOT COMPLETED|Part 1, Period 2||0
199788|NCT00803686|478805|P3|NOT COMPLETED|Part 1, Period 2||0
199789|NCT00803686|478806|P2|NOT COMPLETED|Part 1, Period 2||0
199790|NCT00803686|478807|P1|NOT COMPLETED|Part 1, Period 2||0
199791|NCT00803686|478804|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
199792|NCT00803686|478805|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
199793|NCT00803686|478806|P2|COMPLETED|Part 1, Period 2||6
199794|NCT00803686|478807|P1|COMPLETED|Part 1, Period 2||6
199795|NCT00803686|478804|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
199796|NCT00803686|478805|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
199797|NCT00803686|478806|P2|STARTED|Part 1, Period 2||6
199798|NCT00803686|478807|P1|STARTED|Part 1, Period 2||6
199799|NCT00803686|478804|P4|NOT COMPLETED|Part 1, Period 1||0
199800|NCT00803686|478805|P3|NOT COMPLETED|Part 1, Period 1||0
199801|NCT00803686|478806|P2|NOT COMPLETED|Part 1, Period 1||0
199802|NCT00803686|478807|P1|NOT COMPLETED|Part 1, Period 1||0
199803|NCT00803686|478804|P4|COMPLETED|Part 1, Period 1||0
199804|NCT00803686|478805|P3|COMPLETED|Part 1, Period 1||0
199805|NCT00803686|478806|P2|COMPLETED|Part 1, Period 1||6
199806|NCT00803686|478807|P1|COMPLETED|Part 1, Period 1||6
199807|NCT00803686|478804|P4|STARTED|Part 1, Period 1||0
199808|NCT00803686|478805|P3|STARTED|Part 1, Period 1||0
199809|NCT00803686|478806|P2|STARTED|Part 1, Period 1||6
199810|NCT00803686|478807|P1|STARTED|Part 1, Period 1||6
199811|NCT00803647|478825|P1|NOT COMPLETED|Overall Study||0
199812|NCT00803647|478825|P1|COMPLETED|Overall Study||20
199813|NCT00803647|478825|P1|STARTED|Overall Study||20
199814|NCT00803634|478835|P2|NOT COMPLETED|Overall Study||5
199815|NCT00803634|478836|P1|NOT COMPLETED|Overall Study||6
199816|NCT00803634|478835|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
199817|NCT00803634|478836|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
199818|NCT00803634|478835|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
199819|NCT00803634|478836|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
199820|NCT00803634|478835|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
199821|NCT00803634|478836|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
199822|NCT00803595|478865|P3|NOT COMPLETED|Overall Study||16
199823|NCT00803595|478866|P2|NOT COMPLETED|Overall Study||8
199824|NCT00803595|478867|P1|NOT COMPLETED|Overall Study||15
199825|NCT00803595|478865|P3|COMPLETED|Overall Study||322
199826|NCT00803595|478866|P2|COMPLETED|Overall Study||319
199827|NCT00803595|478867|P1|COMPLETED|Overall Study||322
199828|NCT00803595|478865|P3|STARTED|Overall Study||338
199829|NCT00803595|478866|P2|STARTED|Overall Study||327
199830|NCT00803595|478867|P1|STARTED|Overall Study||337
199831|NCT00803543|478880|P2|NOT COMPLETED|Overall Study||12
199832|NCT00803543|478881|P1|NOT COMPLETED|Overall Study||24
199833|NCT00803543|478880|P2|COMPLETED|Overall Study||22
199834|NCT00803543|478881|P1|COMPLETED|Overall Study||45
199835|NCT00803543|478880|P2|STARTED|Overall Study||34
199836|NCT00803543|478881|P1|STARTED|Overall Study||69
199837|NCT00803517|478895|P2|NOT COMPLETED|Overall Study||0
199838|NCT00803517|478896|P1|NOT COMPLETED|Overall Study||0
199839|NCT00803517|478895|P2|COMPLETED|Overall Study||12
199840|NCT00803517|478896|P1|COMPLETED|Overall Study||12
199841|NCT00803517|478895|P2|STARTED|Overall Study||12
199842|NCT00803517|478896|P1|STARTED|Overall Study||12
199843|NCT00803452|478904|P2|NOT COMPLETED|Overall Study||5
199844|NCT00803452|478905|P1|NOT COMPLETED|Overall Study||0
199845|NCT00803452|478904|P2|COMPLETED|Overall Study||17
199846|NCT00803452|478905|P1|COMPLETED|Overall Study||9
199847|NCT00803452|478904|P2|STARTED|Overall Study||22
199848|NCT00803452|478905|P1|STARTED|Overall Study||9
199849|NCT00803413|478915|P4|NOT COMPLETED|Overall Period||0
199850|NCT00803413|478916|P3|NOT COMPLETED|Overall Period||0
199851|NCT00803413|478917|P2|NOT COMPLETED|Overall Period||0
199852|NCT00803413|478918|P1|NOT COMPLETED|Overall Period||0
199853|NCT00803413|478915|P4|COMPLETED|Overall Period||30
199854|NCT00803413|478916|P3|COMPLETED|Overall Period||29
199855|NCT00803413|478917|P2|COMPLETED|Overall Period||32
199856|NCT00803413|478918|P1|COMPLETED|Overall Period||28
199857|NCT00803413|478915|P4|STARTED|Overall Period||30
199858|NCT00803413|478916|P3|STARTED|Overall Period||29
199859|NCT00803413|478917|P2|STARTED|Overall Period||32
199860|NCT00803413|478918|P1|STARTED|Overall Period||28
199861|NCT00803400|478930|P2|NOT COMPLETED|Overall Study||24
199862|NCT00803400|478931|P1|NOT COMPLETED|Overall Study||20
199863|NCT00803400|478930|P2|COMPLETED|Overall Study||51
199864|NCT00803400|478931|P1|COMPLETED|Overall Study||55
199865|NCT00803400|478930|P2|STARTED|Overall Study||75
199866|NCT00803400|478931|P1|STARTED|Overall Study||75
199867|NCT00803361|478943|P2|NOT COMPLETED|Overall Study||28
199868|NCT00803361|478944|P1|NOT COMPLETED|Overall Study||26
199869|NCT00803361|478943|P2|COMPLETED|Overall Study||74
199870|NCT00803361|478944|P1|COMPLETED|Overall Study||82
199871|NCT00803361|478943|P2|STARTED|Overall Study||102
199872|NCT00803361|478944|P1|STARTED|Overall Study||108
199873|NCT00803283|478964|P2|NOT COMPLETED|Overall Study||0
199874|NCT00803283|478965|P1|NOT COMPLETED|Overall Study||0
199875|NCT00803283|478964|P2|COMPLETED|Overall Study||1
199876|NCT00803283|478965|P1|COMPLETED|Overall Study||1
199877|NCT00803283|478964|P2|STARTED|Overall Study||1
199878|NCT00803283|478965|P1|STARTED|Overall Study||1
199879|NCT00803270|478991|P2|NOT COMPLETED|Overall Study||2
199880|NCT00803270|478992|P1|NOT COMPLETED|Overall Study||1
199881|NCT00803270|478991|P2|COMPLETED|Overall Study||12
199882|NCT00803270|478992|P1|COMPLETED|Overall Study||12
199883|NCT00803270|478991|P2|STARTED|Overall Study||14
199884|NCT00803270|478992|P1|STARTED|Overall Study||13
199885|NCT00803244|479002|P2|NOT COMPLETED|Overall Study||15
199886|NCT00803244|479003|P1|NOT COMPLETED|Overall Study||7
199887|NCT00803244|479002|P2|COMPLETED|Overall Study||178
199888|NCT00803244|479003|P1|COMPLETED|Overall Study||181
199889|NCT00803244|479002|P2|STARTED|Overall Study||193
199890|NCT00803244|479003|P1|STARTED|Overall Study||188
199891|NCT00803179|479011|P1|NOT COMPLETED|Overall Study||3
199892|NCT00803179|479011|P1|COMPLETED|Overall Study||2
199893|NCT00803179|479011|P1|STARTED|Overall Study||5
199894|NCT00803114|479017|P2|NOT COMPLETED|Overall Study||0
199895|NCT00803114|479018|P1|NOT COMPLETED|Overall Study||0
199896|NCT00803114|479017|P2|COMPLETED|Overall Study||115
199897|NCT00803114|479018|P1|COMPLETED|Overall Study||113
199898|NCT00803114|479017|P2|STARTED|Overall Study||115
199899|NCT00803114|479018|P1|STARTED|Overall Study||113
199900|NCT00803101|479030|P2|NOT COMPLETED|Overall Study||22
199901|NCT00803101|479031|P1|NOT COMPLETED|Overall Study||18
199902|NCT00803101|479030|P2|COMPLETED|Overall Study||66
199903|NCT00803101|479031|P1|COMPLETED|Overall Study||70
199904|NCT00803101|479030|P2|STARTED|Overall Study||88
199905|NCT00803101|479031|P1|STARTED|Overall Study||88
199906|NCT00803062|479053|P4|NOT COMPLETED|Overall Study||0
199907|NCT00803062|479054|P3|NOT COMPLETED|Overall Study||0
199908|NCT00803062|479055|P2|NOT COMPLETED|Overall Study||0
199909|NCT00803062|479056|P1|NOT COMPLETED|Overall Study||0
199910|NCT00803062|479053|P4|COMPLETED|Overall Study||112
199911|NCT00803062|479054|P3|COMPLETED|Overall Study||111
199912|NCT00803062|479055|P2|COMPLETED|Overall Study||115
199913|NCT00803062|479056|P1|COMPLETED|Overall Study||114
199914|NCT00803062|479053|P4|STARTED|Overall Study||112
199915|NCT00803062|479054|P3|STARTED|Overall Study||111
199916|NCT00803062|479055|P2|STARTED|Overall Study||115
199917|NCT00803062|479056|P1|STARTED|Overall Study||114
199918|NCT00803049|479082|P4|NOT COMPLETED|Overall Study||102
199919|NCT00803049|479083|P3|NOT COMPLETED|Overall Study||44
199920|NCT00803049|479084|P2|NOT COMPLETED|Overall Study||118
199921|NCT00803049|479085|P1|NOT COMPLETED|Overall Study||61
199922|NCT00803049|479082|P4|COMPLETED|Overall Study||151
199923|NCT00803049|479083|P3|COMPLETED|Overall Study||64
199924|NCT00803049|479084|P2|COMPLETED|Overall Study||134
199925|NCT00803049|479085|P1|COMPLETED|Overall Study||68
199926|NCT00803049|479082|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
199927|NCT00803049|479083|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
199928|NCT00803049|479084|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
199929|NCT00803049|479085|P1|Safety Population|Overall Study||129
199930|NCT00803049|479082|P4|Treated|Overall Study||251
199931|NCT00803049|479083|P3|Treated|Overall Study||108
199932|NCT00803049|479084|P2|Treated|Overall Study||252
199933|NCT00803049|479085|P1|Treated|Overall Study||129
199934|NCT00803049|479082|P4|STARTED|Overall Study|Randomized in extension study|253
199935|NCT00803049|479083|P3|STARTED|Overall Study|Randomized in extension study|108
199936|NCT00803049|479084|P2|STARTED|Overall Study|Randomized in extension study|252
199937|NCT00803049|479085|P1|STARTED|Overall Study|Randomized in extension study|129
199938|NCT00803023|479119|P4|NOT COMPLETED|Overall Study||8
199939|NCT00803023|479120|P3|NOT COMPLETED|Overall Study||11
199940|NCT00803023|479121|P2|NOT COMPLETED|Overall Study||8
199941|NCT00803023|479122|P1|NOT COMPLETED|Overall Study||5
199942|NCT00803023|479119|P4|COMPLETED|Overall Study||25
199943|NCT00803023|479120|P3|COMPLETED|Overall Study||20
199944|NCT00803023|479121|P2|COMPLETED|Overall Study||25
199945|NCT00803023|479122|P1|COMPLETED|Overall Study||27
199946|NCT00803023|479119|P4|STARTED|Overall Study||33
199947|NCT00803023|479120|P3|STARTED|Overall Study||31
199948|NCT00803023|479121|P2|STARTED|Overall Study||33
199949|NCT00803023|479122|P1|STARTED|Overall Study||32
199950|NCT00803010|479134|P2|NOT COMPLETED|Overall Study||0
199951|NCT00803010|479135|P1|NOT COMPLETED|Overall Study||0
199952|NCT00803010|479134|P2|COMPLETED|Overall Study||37
199953|NCT00803010|479135|P1|COMPLETED|Overall Study||37
199954|NCT00803010|479134|P2|STARTED|Overall Study||37
199955|NCT00803010|479135|P1|STARTED|Overall Study||37
199956|NCT00802997|479147|P2|NOT COMPLETED|6 Month to 9 Months||0
199957|NCT00802997|479148|P1|NOT COMPLETED|6 Month to 9 Months||2
199958|NCT00802997|479147|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
199959|NCT00802997|479148|P1|COMPLETED|6 Month to 9 Months||25
199960|NCT00802997|479147|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
199961|NCT00802997|479148|P1|STARTED|6 Month to 9 Months||27
199962|NCT00802997|479147|P2|NOT COMPLETED|3 Months to 6 Months||0
199963|NCT00802997|479148|P1|NOT COMPLETED|3 Months to 6 Months||7
199964|NCT00802997|479147|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
199965|NCT00802997|479148|P1|COMPLETED|3 Months to 6 Months||27
199966|NCT00802997|479147|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
199967|NCT00802997|479148|P1|STARTED|3 Months to 6 Months||34
199968|NCT00802997|479147|P2|NOT COMPLETED|Baseline to 3 Months||0
199969|NCT00802997|479148|P1|NOT COMPLETED|Baseline to 3 Months||0
199970|NCT00802997|479147|P2|COMPLETED|Baseline to 3 Months||17
199971|NCT00802997|479148|P1|COMPLETED|Baseline to 3 Months||34
199972|NCT00802997|479147|P2|STARTED|Baseline to 3 Months||17
199973|NCT00802997|479148|P1|STARTED|Baseline to 3 Months||34
199974|NCT00802919|479160|P2|NOT COMPLETED|Overall Study||1
199975|NCT00802919|479161|P1|NOT COMPLETED|Overall Study||3
199976|NCT00802919|479160|P2|COMPLETED|Overall Study||45
199977|NCT00802919|479161|P1|COMPLETED|Overall Study||42
199978|NCT00802919|479160|P2|STARTED|Overall Study||46
199979|NCT00802919|479161|P1|STARTED|Overall Study||45
199980|NCT00802893|479173|P1|NOT COMPLETED|Overall Study||3
199981|NCT00802893|479173|P1|COMPLETED|Overall Study||0
199982|NCT00802893|479173|P1|STARTED|Overall Study||3
199983|NCT00802880|479178|P1|NOT COMPLETED|Overall Study||0
199984|NCT00802880|479178|P1|COMPLETED|Overall Study||80
199985|NCT00802880|479178|P1|STARTED|Overall Study||80
199986|NCT00802867|479197|P1|NOT COMPLETED|Overall Study||13
199987|NCT00802867|479197|P1|COMPLETED|Overall Study||976
199988|NCT00802867|479197|P1|STARTED|Overall Study||989
199989|NCT00802854|479205|P1|NOT COMPLETED|Overall Study||0
199990|NCT00802854|479205|P1|COMPLETED|Overall Study||244
199991|NCT00802854|479205|P1|STARTED|Overall Study||244
199992|NCT00802841|479220|P2|NOT COMPLETED|Overall Study||95
199993|NCT00802841|479221|P1|NOT COMPLETED|Overall Study||96
199994|NCT00802841|479220|P2|COMPLETED|Overall Study||0
199995|NCT00802841|479221|P1|COMPLETED|Overall Study||0
199996|NCT00802841|479220|P2|Cross-over Set|Overall Study||56
199997|NCT00802841|479221|P1|Cross-over Set|Overall Study||13
199998|NCT00802841|479220|P2|Safety Set|Overall Study||93
199999|NCT00802841|479221|P1|Safety Set|Overall Study||96
200000|NCT00802841|479220|P2|Full Analysis Set|Overall Study||95
200001|NCT00802841|479221|P1|Full Analysis Set|Overall Study||96
200002|NCT00802841|479220|P2|STARTED|Overall Study||95
200003|NCT00802841|479221|P1|STARTED|Overall Study||96
200004|NCT00802737|479246|P3|NOT COMPLETED|Overall Study||1
200005|NCT00802737|479247|P2|NOT COMPLETED|Overall Study||11
200006|NCT00802737|479248|P1|NOT COMPLETED|Overall Study||17
200007|NCT00802737|479246|P3|COMPLETED|Overall Study||0
200008|NCT00802737|479247|P2|COMPLETED|Overall Study||0
200009|NCT00802737|479248|P1|COMPLETED|Overall Study||0
200010|NCT00802737|479246|P3|STARTED|Overall Study||1
200011|NCT00802737|479247|P2|STARTED|Overall Study||11
200012|NCT00802737|479248|P1|STARTED|Overall Study||17
200013|NCT00802685|479296|P2|NOT COMPLETED|Overall Study||0
200014|NCT00802685|479297|P1|NOT COMPLETED|Overall Study||0
200015|NCT00802685|479296|P2|COMPLETED|Overall Study||51
200016|NCT00802685|479297|P1|COMPLETED|Overall Study||54
200017|NCT00802685|479296|P2|STARTED|Overall Study||51
200018|NCT00802685|479297|P1|STARTED|Overall Study||54
200019|NCT00802672|479308|P3|NOT COMPLETED|Overall Study||34
200020|NCT00802672|479309|P2|NOT COMPLETED|Overall Study||52
200021|NCT00802672|479310|P1|NOT COMPLETED|Overall Study||68
200022|NCT00802672|479308|P3|COMPLETED|Overall Study||77
200023|NCT00802672|479309|P2|COMPLETED|Overall Study||174
200024|NCT00802672|479310|P1|COMPLETED|Overall Study||156
200025|NCT00802672|479308|P3|STARTED|Overall Study||111
200026|NCT00802672|479309|P2|STARTED|Overall Study||226
200027|NCT00802672|479310|P1|STARTED|Overall Study||224
200028|NCT00802659|479328|P4|NOT COMPLETED|Overall Study||0
200029|NCT00802659|479329|P3|NOT COMPLETED|Overall Study||0
200030|NCT00802659|479330|P2|NOT COMPLETED|Overall Study||1
200031|NCT00802659|479331|P1|NOT COMPLETED|Overall Study||0
200032|NCT00802659|479328|P4|COMPLETED|Overall Study||0
200033|NCT00802659|479329|P3|COMPLETED|Overall Study||0
200034|NCT00802659|479330|P2|COMPLETED|Overall Study||1
200035|NCT00802659|479331|P1|COMPLETED|Overall Study||0
200036|NCT00802659|479328|P4|STARTED|Overall Study||0
200037|NCT00802659|479329|P3|STARTED|Overall Study||0
200038|NCT00802659|479330|P2|STARTED|Overall Study||2
200039|NCT00802659|479331|P1|STARTED|Overall Study||0
200040|NCT00802633|479359|P2|NOT COMPLETED|Overall Study||0
200041|NCT00802633|479360|P1|NOT COMPLETED|Overall Study||0
200042|NCT00802633|479359|P2|COMPLETED|Overall Study||40
200043|NCT00802633|479360|P1|COMPLETED|Overall Study||40
200044|NCT00802633|479359|P2|STARTED|Overall Study||40
200045|NCT00802633|479360|P1|STARTED|Overall Study||40
200046|NCT00802529|479370|P2|NOT COMPLETED|Overall Study||1
200047|NCT00802529|479371|P1|NOT COMPLETED|Overall Study||0
200048|NCT00802529|479370|P2|COMPLETED|Overall Study||29
200049|NCT00802529|479371|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
200050|NCT00802529|479370|P2|STARTED|Overall Study||30
200051|NCT00802529|479371|P1|STARTED|Overall Study||30
200052|NCT00802503|479383|P2|NOT COMPLETED|Overall Study||20
200053|NCT00802503|479384|P1|NOT COMPLETED|Overall Study||10
200054|NCT00802503|479383|P2|COMPLETED|Overall Study||133
200055|NCT00802503|479384|P1|COMPLETED|Overall Study||142
200056|NCT00802503|479383|P2|STARTED|Overall Study||153
200057|NCT00802503|479384|P1|STARTED|Overall Study||152
200058|NCT00802464|479410|P4|NOT COMPLETED|Month 8 - Month 14||0
200059|NCT00802464|479411|P3|NOT COMPLETED|Month 8 - Month 14||1
200060|NCT00802464|479412|P2|NOT COMPLETED|Month 8 - Month 14||2
200061|NCT00802464|479413|P1|NOT COMPLETED|Month 8 - Month 14||1
200062|NCT00802464|479410|P4|COMPLETED|Month 8 - Month 14||126
200063|NCT00802464|479411|P3|COMPLETED|Month 8 - Month 14||129
200064|NCT00802464|479412|P2|COMPLETED|Month 8 - Month 14||63
200065|NCT00802464|479413|P1|COMPLETED|Month 8 - Month 14||33
200066|NCT00802464|479410|P4|STARTED|Month 8 - Month 14||126
200067|NCT00802464|479411|P3|STARTED|Month 8 - Month 14||130
200068|NCT00802464|479412|P2|STARTED|Month 8 - Month 14||65
200069|NCT00802464|479413|P1|STARTED|Month 8 - Month 14||34
200070|NCT00802464|479410|P4|NOT COMPLETED|Month 0 - Month 8||9
200071|NCT00802464|479411|P3|NOT COMPLETED|Month 0 - Month 8||7
200072|NCT00802464|479412|P2|NOT COMPLETED|Month 0 - Month 8||3
200073|NCT00802464|479413|P1|NOT COMPLETED|Month 0 - Month 8||0
200074|NCT00802464|479410|P4|COMPLETED|Month 0 - Month 8||141
200075|NCT00802464|479411|P3|COMPLETED|Month 0 - Month 8||142
200076|NCT00802464|479412|P2|COMPLETED|Month 0 - Month 8||70
200077|NCT00802464|479413|P1|COMPLETED|Month 0 - Month 8||38
200078|NCT00802464|479410|P4|STARTED|Month 0 - Month 8||150
200079|NCT00802464|479411|P3|STARTED|Month 0 - Month 8||149
200080|NCT00802464|479412|P2|STARTED|Month 0 - Month 8||73
200081|NCT00802464|479413|P1|STARTED|Month 0 - Month 8||38
200082|NCT00802438|479499|P1|NOT COMPLETED|Overall Study||28
200083|NCT00802438|479499|P1|COMPLETED|Overall Study||10
200084|NCT00802438|479499|P1|STARTED|Overall Study||38
200085|NCT00802412|479506|P2|NOT COMPLETED|Overall Study||1
200086|NCT00802412|479507|P1|NOT COMPLETED|Overall Study||2
200087|NCT00802412|479506|P2|COMPLETED|Overall Study||66
200088|NCT00802412|479507|P1|COMPLETED|Overall Study||63
200089|NCT00802412|479506|P2|STARTED|Overall Study||67
200090|NCT00802412|479507|P1|STARTED|Overall Study||65
200091|NCT00802360|479519|P4|NOT COMPLETED|Overall Study||22
200092|NCT00802360|479520|P3|NOT COMPLETED|Overall Study||25
200093|NCT00802360|479521|P2|NOT COMPLETED|Overall Study||26
200094|NCT00802360|479522|P1|NOT COMPLETED|Overall Study||24
200095|NCT00802360|479519|P4|COMPLETED|Overall Study||17
200096|NCT00802360|479520|P3|COMPLETED|Overall Study||17
200097|NCT00802360|479521|P2|COMPLETED|Overall Study||16
200098|NCT00802360|479522|P1|COMPLETED|Overall Study||18
200099|NCT00802360|479519|P4|STARTED|Overall Study||39
200100|NCT00802360|479520|P3|STARTED|Overall Study||42
200101|NCT00802360|479521|P2|STARTED|Overall Study||42
200102|NCT00802360|479522|P1|STARTED|Overall Study||42
200103|NCT00802204|479564|P2|NOT COMPLETED|Overall Study||1
200104|NCT00802204|479565|P1|NOT COMPLETED|Overall Study||1
200105|NCT00802204|479564|P2|COMPLETED|Overall Study||18
200106|NCT00802204|479565|P1|COMPLETED|Overall Study||8
200107|NCT00802204|479564|P2|STARTED|Overall Study||19
200108|NCT00802204|479565|P1|STARTED|Overall Study||9
200109|NCT00802178|479589|P1|NOT COMPLETED|Overall Study||113
200110|NCT00802178|479589|P1|COMPLETED|Overall Study||2335
200111|NCT00802178|479589|P1|STARTED|Overall Study||2448
200112|NCT00802100|479599|P3|NOT COMPLETED|Overall Study||4
200113|NCT00802100|479600|P2|NOT COMPLETED|Overall Study||7
200114|NCT00802100|479601|P1|NOT COMPLETED|Overall Study||6
200115|NCT00802100|479599|P3|COMPLETED|Overall Study||2
200116|NCT00802100|479600|P2|COMPLETED|Overall Study||2
200117|NCT00802100|479601|P1|COMPLETED|Overall Study||0
200118|NCT00802100|479599|P3|STARTED|Overall Study||6
200119|NCT00802100|479600|P2|STARTED|Overall Study||9
200120|NCT00802100|479601|P1|STARTED|Overall Study||6
200121|NCT00802074|479616|P6|NOT COMPLETED|Overall Study||0
200122|NCT00802074|479617|P5|NOT COMPLETED|Overall Study||0
200123|NCT00802074|479618|P4|NOT COMPLETED|Overall Study||0
200124|NCT00802074|479619|P3|NOT COMPLETED|Overall Study||1
200125|NCT00802074|479620|P2|NOT COMPLETED|Overall Study||1
200126|NCT00802074|479621|P1|NOT COMPLETED|Overall Study||2
200127|NCT00802074|479616|P6|COMPLETED|Overall Study||7
200128|NCT00802074|479617|P5|COMPLETED|Overall Study||7
200129|NCT00802074|479618|P4|COMPLETED|Overall Study||7
200130|NCT00802074|479619|P3|COMPLETED|Overall Study||6
200131|NCT00802074|479620|P2|COMPLETED|Overall Study||7
200132|NCT00802074|479621|P1|COMPLETED|Overall Study||7
200133|NCT00802074|479616|P6|STARTED|Overall Study||7
200134|NCT00802074|479617|P5|STARTED|Overall Study||7
200135|NCT00802074|479618|P4|STARTED|Overall Study||7
200136|NCT00802074|479619|P3|STARTED|Overall Study||7
200137|NCT00802074|479620|P2|STARTED|Overall Study||8
200138|NCT00802074|479621|P1|STARTED|Overall Study||9
200139|NCT00801983|479655|P2|NOT COMPLETED|Period 2||1
200140|NCT00801983|479656|P1|NOT COMPLETED|Period 2||2
200141|NCT00801983|479655|P2|COMPLETED|Period 2||32
200142|NCT00801983|479656|P1|COMPLETED|Period 2||38
200143|NCT00801983|479655|P2|STARTED|Period 2||33
200144|NCT00801983|479656|P1|STARTED|Period 2||40
200145|NCT00801983|479655|P2|NOT COMPLETED|Period 1||8
200146|NCT00801983|479656|P1|NOT COMPLETED|Period 1||4
200147|NCT00801983|479655|P2|COMPLETED|Period 1||33
200148|NCT00801983|479656|P1|COMPLETED|Period 1||40
200149|NCT00801983|479655|P2|STARTED|Period 1||41
200150|NCT00801983|479656|P1|STARTED|Period 1||44
200151|NCT00801892|479664|P2|NOT COMPLETED|Sham Crossover Period||2
200152|NCT00801892|479665|P1|NOT COMPLETED|Sham Crossover Period||0
200153|NCT00801892|479664|P2|COMPLETED|Sham Crossover Period||5
200154|NCT00801892|479665|P1|COMPLETED|Sham Crossover Period||0
200155|NCT00801892|479664|P2|STARTED|Sham Crossover Period||7
200156|NCT00801892|479665|P1|STARTED|Sham Crossover Period||0
200157|NCT00801892|479664|P2|NOT COMPLETED|Main Study Period||1
200158|NCT00801892|479665|P1|NOT COMPLETED|Main Study Period||0
200159|NCT00801892|479664|P2|COMPLETED|Main Study Period||10
200160|NCT00801892|479665|P1|COMPLETED|Main Study Period||12
200161|NCT00801892|479664|P2|STARTED|Main Study Period||11
200162|NCT00801892|479665|P1|STARTED|Main Study Period||12
200163|NCT00801827|479681|P1|NOT COMPLETED|Overall Study||0
200164|NCT00801827|479681|P1|COMPLETED|Overall Study||5
200165|NCT00801827|479681|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
200166|NCT00801801|479685|P1|NOT COMPLETED|Overall Study||0
200167|NCT00801801|479685|P1|COMPLETED|Overall Study||5
200168|NCT00801801|479685|P1|STARTED|Overall Study||5
200169|NCT00801684|479690|P1|NOT COMPLETED|Overall Study||0
200170|NCT00801684|479690|P1|COMPLETED|Overall Study||24
200171|NCT00801684|479690|P1|STARTED|Overall Study||24
200172|NCT00801632|479712|P1|NOT COMPLETED|Overall Study||1
200173|NCT00801632|479712|P1|COMPLETED|Overall Study||4
200174|NCT00801632|479712|P1|STARTED|Overall Study||5
200175|NCT00801242|479723|P1|NOT COMPLETED|Overall Study||52
200176|NCT00801242|479723|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
200177|NCT00801242|479723|P1|Started Cycle 3|Overall Study||2
200178|NCT00801242|479723|P1|Started Cycle 2|Overall Study||35
200179|NCT00801242|479723|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
200180|NCT00801242|479723|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
200181|NCT00801242|479723|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
200182|NCT00801242|479723|P1|STARTED|Overall Study|Randomized participants.|220
200183|NCT00801229|479736|P2|NOT COMPLETED|Received Study Drug/Placebo||4
200184|NCT00801229|479737|P1|NOT COMPLETED|Received Study Drug/Placebo||4
200185|NCT00801229|479736|P2|COMPLETED|Received Study Drug/Placebo||30
200186|NCT00801229|479737|P1|COMPLETED|Received Study Drug/Placebo||31
200187|NCT00801229|479736|P2|STARTED|Received Study Drug/Placebo||34
200188|NCT00801229|479737|P1|STARTED|Received Study Drug/Placebo||35
200189|NCT00801229|479736|P2|NOT COMPLETED|Signed Consent||3
200190|NCT00801229|479737|P1|NOT COMPLETED|Signed Consent||3
200191|NCT00801229|479736|P2|COMPLETED|Signed Consent||34
200192|NCT00801229|479737|P1|COMPLETED|Signed Consent||35
200193|NCT00801229|479736|P2|STARTED|Signed Consent||37
200194|NCT00801229|479737|P1|STARTED|Signed Consent||38
200195|NCT00801138|479747|P4|NOT COMPLETED|Overall Study||0
200196|NCT00801138|479748|P3|NOT COMPLETED|Overall Study||0
200197|NCT00801138|479749|P2|NOT COMPLETED|Overall Study||0
200198|NCT00801138|479750|P1|NOT COMPLETED|Overall Study||0
200199|NCT00801138|479747|P4|COMPLETED|Overall Study||54
200200|NCT00801138|479748|P3|COMPLETED|Overall Study||54
200201|NCT00801138|479749|P2|COMPLETED|Overall Study||56
200202|NCT00801138|479750|P1|COMPLETED|Overall Study||54
200203|NCT00801138|479747|P4|STARTED|Overall Study||54
200204|NCT00801138|479748|P3|STARTED|Overall Study||54
200205|NCT00801138|479749|P2|STARTED|Overall Study||56
200206|NCT00801138|479750|P1|STARTED|Overall Study||54
200207|NCT00801099|479772|P1|NOT COMPLETED|Overall Study||101
200208|NCT00801099|479772|P1|COMPLETED|Overall Study||175
200209|NCT00801099|479772|P1|STARTED|Overall Study||276
200210|NCT00800982|479778|P2|NOT COMPLETED|Overall Study||3
200211|NCT00800982|479779|P1|NOT COMPLETED|Overall Study||2
200212|NCT00800982|479778|P2|COMPLETED|Overall Study||12
200213|NCT00800982|479779|P1|COMPLETED|Overall Study||13
200214|NCT00800982|479778|P2|STARTED|Overall Study||15
200215|NCT00800982|479779|P1|STARTED|Overall Study||15
200216|NCT00800865|479787|P2|NOT COMPLETED|Overall Study||0
200217|NCT00800865|479788|P1|NOT COMPLETED|Overall Study||0
200218|NCT00800865|479787|P2|COMPLETED|Overall Study||16
200219|NCT00800865|479788|P1|COMPLETED|Overall Study||15
200220|NCT00800865|479787|P2|STARTED|Overall Study||16
200221|NCT00800865|479788|P1|STARTED|Overall Study||15
200222|NCT00800839|479796|P1|NOT COMPLETED|Overall Study||7
200223|NCT00800839|479796|P1|COMPLETED|Overall Study||49
200224|NCT00800839|479796|P1|STARTED|Overall Study||56
200225|NCT00800735|479805|P1|NOT COMPLETED|Overall Study||14
200226|NCT00800735|479805|P1|COMPLETED|Overall Study||16
200227|NCT00800735|479805|P1|STARTED|Overall Study||30
200228|NCT00800683|479811|P2|NOT COMPLETED|Overall Study||19
200229|NCT00800683|479812|P1|NOT COMPLETED|Overall Study||17
200230|NCT00800683|479811|P2|COMPLETED|Overall Study|Number who completed treatment|49
200231|NCT00800683|479812|P1|COMPLETED|Overall Study|Number who completed treatment|48
200232|NCT00800683|479811|P2|STARTED|Overall Study|Number who started treatment|68
200233|NCT00800683|479812|P1|STARTED|Overall Study|Number who started treatment|65
200234|NCT00800540|479858|P2|NOT COMPLETED|Period 2: 6 Weeks||1
200235|NCT00800540|479859|P1|NOT COMPLETED|Period 2: 6 Weeks||0
200236|NCT00800540|479858|P2|COMPLETED|Period 2: 6 Weeks||16
200237|NCT00800540|479859|P1|COMPLETED|Period 2: 6 Weeks||16
200238|NCT00800540|479858|P2|STARTED|Period 2: 6 Weeks||17
200239|NCT00800540|479859|P1|STARTED|Period 2: 6 Weeks||16
200240|NCT00800540|479858|P2|NOT COMPLETED|Washout: 4 Weeks||0
200241|NCT00800540|479859|P1|NOT COMPLETED|Washout: 4 Weeks||0
200242|NCT00800540|479858|P2|COMPLETED|Washout: 4 Weeks||17
200243|NCT00800540|479859|P1|COMPLETED|Washout: 4 Weeks||16
200244|NCT00800540|479858|P2|STARTED|Washout: 4 Weeks||17
200245|NCT00800540|479859|P1|STARTED|Washout: 4 Weeks||16
200246|NCT00800540|479858|P2|NOT COMPLETED|Period One: 6 Weeks||1
200247|NCT00800540|479859|P1|NOT COMPLETED|Period One: 6 Weeks||1
200248|NCT00800540|479858|P2|COMPLETED|Period One: 6 Weeks||17
200249|NCT00800540|479859|P1|COMPLETED|Period One: 6 Weeks||16
200250|NCT00800540|479858|P2|STARTED|Period One: 6 Weeks||18
200251|NCT00800540|479859|P1|STARTED|Period One: 6 Weeks||17
200252|NCT00800436|479894|P7|NOT COMPLETED|Overall Study||0
200253|NCT00800436|479895|P6|NOT COMPLETED|Overall Study||0
200254|NCT00800436|479896|P5|NOT COMPLETED|Overall Study||0
200255|NCT00800436|479897|P4|NOT COMPLETED|Overall Study||1
200256|NCT00800436|479898|P3|NOT COMPLETED|Overall Study||1
200257|NCT00800436|479899|P2|NOT COMPLETED|Overall Study||0
200258|NCT00800436|479900|P1|NOT COMPLETED|Overall Study||0
200259|NCT00800436|479894|P7|COMPLETED|Overall Study||20
200260|NCT00800436|479895|P6|COMPLETED|Overall Study||20
200261|NCT00800436|479896|P5|COMPLETED|Overall Study||6
200262|NCT00800436|479897|P4|COMPLETED|Overall Study||5
200263|NCT00800436|479898|P3|COMPLETED|Overall Study||5
200264|NCT00800436|479899|P2|COMPLETED|Overall Study||6
200265|NCT00800436|479900|P1|COMPLETED|Overall Study||6
200266|NCT00800436|479894|P7|STARTED|Overall Study||20
200267|NCT00800436|479895|P6|STARTED|Overall Study||20
200268|NCT00800436|479896|P5|STARTED|Overall Study||6
200269|NCT00800436|479897|P4|STARTED|Overall Study||6
200270|NCT00800436|479898|P3|STARTED|Overall Study||6
200271|NCT00800436|479899|P2|STARTED|Overall Study||6
200272|NCT00800436|479900|P1|STARTED|Overall Study||6
200273|NCT00800384|479946|P2|NOT COMPLETED|Overall Study||43
200274|NCT00800384|479947|P1|NOT COMPLETED|Overall Study||41
200275|NCT00800384|479946|P2|COMPLETED|Overall Study||1210
200276|NCT00800384|479947|P1|COMPLETED|Overall Study||1206
200277|NCT00800384|479946|P2|STARTED|Overall Study||1253
200278|NCT00800384|479947|P1|STARTED|Overall Study||1247
200279|NCT00800345|479955|P1|NOT COMPLETED|Overall Study||0
200280|NCT00800345|479955|P1|COMPLETED|Overall Study||33
200281|NCT00800345|479955|P1|STARTED|Overall Study||33
200282|NCT00800254|479962|P2|NOT COMPLETED|Overall Study||6
200283|NCT00800254|479963|P1|NOT COMPLETED|Overall Study||5
200284|NCT00800254|479962|P2|COMPLETED|Overall Study||25
200285|NCT00800254|479963|P1|COMPLETED|Overall Study||30
200286|NCT00800254|479962|P2|3.5 Weeks Post-operatively|Overall Study||31
200287|NCT00800254|479963|P1|3.5 Weeks Post-operatively|Overall Study||31
200288|NCT00800254|479962|P2|STARTED|Overall Study||31
200289|NCT00800254|479963|P1|STARTED|Overall Study||35
200290|NCT00800202|479985|P2|NOT COMPLETED|Overall Study||24
200291|NCT00800202|479986|P1|NOT COMPLETED|Overall Study||67
200292|NCT00800202|479985|P2|COMPLETED|Overall Study||0
200293|NCT00800202|479986|P1|COMPLETED|Overall Study||0
200294|NCT00800202|479985|P2|STARTED|Overall Study||24
200295|NCT00800202|479986|P1|STARTED|Overall Study||67
200296|NCT00799903|480006|P2|NOT COMPLETED|Overall Study||278
200297|NCT00799903|480007|P1|NOT COMPLETED|Overall Study||273
200298|NCT00799903|480006|P2|COMPLETED|Overall Study||7646
200299|NCT00799903|480007|P1|COMPLETED|Overall Study||7631
200300|NCT00799903|480006|P2|STARTED|Overall Study||7924
200301|NCT00799903|480007|P1|STARTED|Overall Study||7904
200302|NCT00799825|480027|P1|NOT COMPLETED|Overall Study||48
200303|NCT00799825|480027|P1|COMPLETED|Overall Study||296
200304|NCT00799825|480027|P1|STARTED|Overall Study||344
200305|NCT00799773|480035|P2|NOT COMPLETED|Overall Study||0
200306|NCT00799773|480036|P1|NOT COMPLETED|Overall Study||0
200307|NCT00799773|480035|P2|COMPLETED|Overall Study||1
200308|NCT00799773|480036|P1|COMPLETED|Overall Study||2
200309|NCT00799773|480035|P2|STARTED|Overall Study||1
200310|NCT00799773|480036|P1|STARTED|Overall Study||2
200311|NCT00799708|480067|P3|NOT COMPLETED|Overall Study||0
200312|NCT00799708|480068|P2|NOT COMPLETED|Overall Study||0
200313|NCT00799708|480069|P1|NOT COMPLETED|Overall Study||1
200314|NCT00799708|480067|P3|COMPLETED|Overall Study||11
200315|NCT00799708|480068|P2|COMPLETED|Overall Study||6
200316|NCT00799708|480069|P1|COMPLETED|Overall Study||9
200317|NCT00799708|480067|P3|STARTED|Overall Study||11
200318|NCT00799708|480068|P2|STARTED|Overall Study||6
200319|NCT00799708|480069|P1|STARTED|Overall Study||10
200320|NCT00799643|480081|P2|NOT COMPLETED|Overall Study||27
200321|NCT00799643|480082|P1|NOT COMPLETED|Overall Study||25
200322|NCT00799643|480081|P2|COMPLETED|Overall Study||119
200323|NCT00799643|480082|P1|COMPLETED|Overall Study||115
200324|NCT00799643|480081|P2|STARTED|Overall Study||146
200325|NCT00799643|480082|P1|STARTED|Overall Study||140
200326|NCT00799617|480092|P2|NOT COMPLETED|Anemia Trial||3
200327|NCT00799617|480093|P1|NOT COMPLETED|Anemia Trial||3
200328|NCT00799617|480092|P2|COMPLETED|Anemia Trial||32
200329|NCT00799617|480093|P1|COMPLETED|Anemia Trial||24
200330|NCT00799617|480092|P2|STARTED|Anemia Trial||35
200331|NCT00799617|480093|P1|STARTED|Anemia Trial||27
200332|NCT00799617|480092|P2|NOT COMPLETED|Cognitive Function Trial||1
200333|NCT00799617|480093|P1|NOT COMPLETED|Cognitive Function Trial||0
200334|NCT00799617|480092|P2|COMPLETED|Cognitive Function Trial||245
200335|NCT00799617|480093|P1|COMPLETED|Cognitive Function Trial||247
200336|NCT00799617|480092|P2|STARTED|Cognitive Function Trial||246
200337|NCT00799617|480093|P1|STARTED|Cognitive Function Trial||247
200338|NCT00799617|480092|P2|NOT COMPLETED|Bone Trial||16
200339|NCT00799617|480093|P1|NOT COMPLETED|Bone Trial||6
200340|NCT00799617|480092|P2|COMPLETED|Bone Trial||85
200341|NCT00799617|480093|P1|COMPLETED|Bone Trial||104
200342|NCT00799617|480092|P2|STARTED|Bone Trial||101
200343|NCT00799617|480093|P1|STARTED|Bone Trial||110
200344|NCT00799617|480092|P2|NOT COMPLETED|Cardiovascular Trial||17
200345|NCT00799617|480093|P1|NOT COMPLETED|Cardiovascular Trial||15
200346|NCT00799617|480092|P2|COMPLETED|Cardiovascular Trial||65
200347|NCT00799617|480093|P1|COMPLETED|Cardiovascular Trial||73
200348|NCT00799617|480092|P2|STARTED|Cardiovascular Trial||82
200349|NCT00799617|480093|P1|STARTED|Cardiovascular Trial||88
200350|NCT00799617|480092|P2|NOT COMPLETED|Vitality Trial||22
200351|NCT00799617|480093|P1|NOT COMPLETED|Vitality Trial||7
200352|NCT00799617|480092|P2|COMPLETED|Vitality Trial||216
200353|NCT00799617|480093|P1|COMPLETED|Vitality Trial||229
200354|NCT00799617|480092|P2|STARTED|Vitality Trial||238
200355|NCT00799617|480093|P1|STARTED|Vitality Trial||236
200356|NCT00799617|480092|P2|NOT COMPLETED|Physical Function Trial||11
200357|NCT00799617|480093|P1|NOT COMPLETED|Physical Function Trial||6
200358|NCT00799617|480092|P2|COMPLETED|Physical Function Trial||185
200359|NCT00799617|480093|P1|COMPLETED|Physical Function Trial||185
200360|NCT00799617|480092|P2|STARTED|Physical Function Trial||196
200361|NCT00799617|480093|P1|STARTED|Physical Function Trial||191
200362|NCT00799617|480092|P2|NOT COMPLETED|Sexual Funtion Trial||21
200363|NCT00799617|480093|P1|NOT COMPLETED|Sexual Funtion Trial||16
200364|NCT00799617|480092|P2|COMPLETED|Sexual Funtion Trial||215
200365|NCT00799617|480093|P1|COMPLETED|Sexual Funtion Trial||218
200366|NCT00799617|480092|P2|STARTED|Sexual Funtion Trial||236
200367|NCT00799617|480093|P1|STARTED|Sexual Funtion Trial||234
200368|NCT00799617|480092|P2|NOT COMPLETED|Main Testosterone Trial||21
200369|NCT00799617|480093|P1|NOT COMPLETED|Main Testosterone Trial||19
200370|NCT00799617|480092|P2|COMPLETED|Main Testosterone Trial||374
200371|NCT00799617|480093|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
200372|NCT00799617|480092|P2|STARTED|Main Testosterone Trial||395
200373|NCT00799617|480093|P1|STARTED|Main Testosterone Trial||395
200374|NCT00799604|480174|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
200375|NCT00799604|480175|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
200376|NCT00799604|480176|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
200377|NCT00799604|480174|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
200378|NCT00799604|480175|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
200379|NCT00799604|480176|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
200380|NCT00799604|480174|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
200381|NCT00799604|480175|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
200382|NCT00799604|480176|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
200383|NCT00799604|480174|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
200384|NCT00799604|480175|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
200385|NCT00799604|480176|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
200386|NCT00799604|480174|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
200387|NCT00799604|480175|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
200388|NCT00799604|480176|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
200389|NCT00799604|480174|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
200390|NCT00799604|480175|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
200391|NCT00799604|480176|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
200392|NCT00799591|480200|P1|NOT COMPLETED|Overall Study||66
200393|NCT00799591|480200|P1|COMPLETED|Overall Study||90
200394|NCT00799591|480200|P1|STARTED|Overall Study||156
200395|NCT00799578|480211|P1|NOT COMPLETED|Overall Study||2
200396|NCT00799578|480211|P1|COMPLETED|Overall Study||11
200397|NCT00799578|480211|P1|STARTED|Overall Study||13
200398|NCT00799487|480218|P3|NOT COMPLETED|Double-Blind Assessment Period||2
200399|NCT00799487|480219|P2|NOT COMPLETED|Double-Blind Assessment Period||1
200400|NCT00799487|480220|P1|NOT COMPLETED|Double-Blind Assessment Period||0
200401|NCT00799487|480218|P3|COMPLETED|Double-Blind Assessment Period||32
200402|NCT00799487|480219|P2|COMPLETED|Double-Blind Assessment Period||33
200403|NCT00799487|480220|P1|COMPLETED|Double-Blind Assessment Period||0
200404|NCT00799487|480218|P3|STARTED|Double-Blind Assessment Period||34
200405|NCT00799487|480219|P2|STARTED|Double-Blind Assessment Period||34
200406|NCT00799487|480220|P1|STARTED|Double-Blind Assessment Period||0
200407|NCT00799487|480218|P3|NOT COMPLETED|Dose Adjustment Period||0
200408|NCT00799487|480219|P2|NOT COMPLETED|Dose Adjustment Period||0
200409|NCT00799487|480220|P1|NOT COMPLETED|Dose Adjustment Period||21
200410|NCT00799487|480218|P3|COMPLETED|Dose Adjustment Period||34
200411|NCT00799487|480219|P2|COMPLETED|Dose Adjustment Period||34
200412|NCT00799487|480220|P1|COMPLETED|Dose Adjustment Period||0
200413|NCT00799487|480218|P3|STARTED|Dose Adjustment Period||34
200414|NCT00799487|480219|P2|STARTED|Dose Adjustment Period||34
200415|NCT00799487|480220|P1|STARTED|Dose Adjustment Period||21
200416|NCT00799474|480300|P1|NOT COMPLETED|Overall Study||0
200417|NCT00799474|480300|P1|COMPLETED|Overall Study||609
200418|NCT00799474|480300|P1|STARTED|Overall Study||609
200419|NCT00799435|480308|P2|NOT COMPLETED|Overall Study||0
200420|NCT00799435|480309|P1|NOT COMPLETED|Overall Study||0
200421|NCT00799435|480308|P2|COMPLETED|Overall Study||1
200422|NCT00799435|480309|P1|COMPLETED|Overall Study||1
200423|NCT00799435|480308|P2|STARTED|Overall Study||1
200424|NCT00799435|480309|P1|STARTED|Overall Study||1
200425|NCT00799422|480315|P6|NOT COMPLETED|Third Week of Wear||0
200426|NCT00799422|480316|P5|NOT COMPLETED|Third Week of Wear||0
200427|NCT00799422|480317|P4|NOT COMPLETED|Third Week of Wear||0
200428|NCT00799422|480318|P3|NOT COMPLETED|Third Week of Wear||0
200429|NCT00799422|480319|P2|NOT COMPLETED|Third Week of Wear||0
200430|NCT00799422|480320|P1|NOT COMPLETED|Third Week of Wear||0
200431|NCT00799422|480315|P6|COMPLETED|Third Week of Wear||4
200432|NCT00799422|480316|P5|COMPLETED|Third Week of Wear||4
200433|NCT00799422|480317|P4|COMPLETED|Third Week of Wear||3
200434|NCT00799422|480318|P3|COMPLETED|Third Week of Wear||3
200435|NCT00799422|480319|P2|COMPLETED|Third Week of Wear||4
200436|NCT00799422|480320|P1|COMPLETED|Third Week of Wear||4
200437|NCT00799422|480315|P6|STARTED|Third Week of Wear||4
200438|NCT00799422|480316|P5|STARTED|Third Week of Wear||4
200439|NCT00799422|480317|P4|STARTED|Third Week of Wear||3
200440|NCT00799422|480318|P3|STARTED|Third Week of Wear||3
200441|NCT00799422|480319|P2|STARTED|Third Week of Wear||4
200442|NCT00799422|480320|P1|STARTED|Third Week of Wear||4
200443|NCT00799422|480315|P6|NOT COMPLETED|Second Week of Wear||0
200444|NCT00799422|480316|P5|NOT COMPLETED|Second Week of Wear||0
200445|NCT00799422|480317|P4|NOT COMPLETED|Second Week of Wear||0
200446|NCT00799422|480318|P3|NOT COMPLETED|Second Week of Wear||0
200447|NCT00799422|480319|P2|NOT COMPLETED|Second Week of Wear||0
200448|NCT00799422|480320|P1|NOT COMPLETED|Second Week of Wear||0
200449|NCT00799422|480315|P6|COMPLETED|Second Week of Wear||4
200450|NCT00799422|480316|P5|COMPLETED|Second Week of Wear||4
200451|NCT00799422|480317|P4|COMPLETED|Second Week of Wear||3
200452|NCT00799422|480318|P3|COMPLETED|Second Week of Wear||3
200453|NCT00799422|480319|P2|COMPLETED|Second Week of Wear||4
200454|NCT00799422|480320|P1|COMPLETED|Second Week of Wear||4
200455|NCT00799422|480315|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
200456|NCT00799422|480316|P5|STARTED|Second Week of Wear||4
200457|NCT00799422|480317|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
200458|NCT00799422|480318|P3|STARTED|Second Week of Wear||3
200459|NCT00799422|480319|P2|STARTED|Second Week of Wear||4
200460|NCT00799422|480320|P1|STARTED|Second Week of Wear||4
200461|NCT00799422|480315|P6|NOT COMPLETED|First Week of Wear||0
200462|NCT00799422|480316|P5|NOT COMPLETED|First Week of Wear||0
200463|NCT00799422|480317|P4|NOT COMPLETED|First Week of Wear||1
200464|NCT00799422|480318|P3|NOT COMPLETED|First Week of Wear||1
200465|NCT00799422|480319|P2|NOT COMPLETED|First Week of Wear||0
200466|NCT00799422|480320|P1|NOT COMPLETED|First Week of Wear||0
200467|NCT00799422|480315|P6|COMPLETED|First Week of Wear||5
200468|NCT00799422|480316|P5|COMPLETED|First Week of Wear||4
200469|NCT00799422|480317|P4|COMPLETED|First Week of Wear||4
200470|NCT00799422|480318|P3|COMPLETED|First Week of Wear||3
200471|NCT00799422|480319|P2|COMPLETED|First Week of Wear||4
200472|NCT00799422|480320|P1|COMPLETED|First Week of Wear||4
200473|NCT00799422|480315|P6|STARTED|First Week of Wear||5
200474|NCT00799422|480316|P5|STARTED|First Week of Wear||4
200475|NCT00799422|480317|P4|STARTED|First Week of Wear||5
200476|NCT00799422|480318|P3|STARTED|First Week of Wear||4
200477|NCT00799422|480319|P2|STARTED|First Week of Wear||4
200478|NCT00799422|480320|P1|STARTED|First Week of Wear||4
200479|NCT00799409|480337|P3|NOT COMPLETED|Overall Study||0
200480|NCT00799409|480338|P2|NOT COMPLETED|Overall Study||0
200481|NCT00799409|480339|P1|NOT COMPLETED|Overall Study||7
200482|NCT00799409|480337|P3|COMPLETED|Overall Study||35
200483|NCT00799409|480338|P2|COMPLETED|Overall Study||36
200484|NCT00799409|480339|P1|COMPLETED|Overall Study||0
200485|NCT00799409|480337|P3|STARTED|Overall Study||35
200486|NCT00799409|480338|P2|STARTED|Overall Study||36
200487|NCT00799409|480339|P1|STARTED|Overall Study||7
200488|NCT00799396|480419|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
200489|NCT00799396|480419|P1|COMPLETED|Clopidogrel Plus Aspirin||663
200490|NCT00799396|480419|P1|STARTED|Clopidogrel Plus Aspirin||669
200491|NCT00799396|480419|P1|NOT COMPLETED|Clopidogrel Treatment||13
200492|NCT00799396|480419|P1|COMPLETED|Clopidogrel Treatment||669
200493|NCT00799396|480419|P1|STARTED|Clopidogrel Treatment||682
200494|NCT00799383|480426|P2|NOT COMPLETED|Overall Study||6
200495|NCT00799383|480427|P1|NOT COMPLETED|Overall Study||3
200496|NCT00799383|480426|P2|COMPLETED|Overall Study||18
200497|NCT00799383|480427|P1|COMPLETED|Overall Study||20
200498|NCT00799383|480426|P2|STARTED|Overall Study||24
200499|NCT00799383|480427|P1|STARTED|Overall Study||23
200500|NCT00799292|480449|P2|NOT COMPLETED|Overall Study||0
200501|NCT00799292|480450|P1|NOT COMPLETED|Overall Study||0
200502|NCT00799292|480449|P2|COMPLETED|Overall Study||29
200503|NCT00799292|480450|P1|COMPLETED|Overall Study||29
200504|NCT00799292|480449|P2|STARTED|Overall Study||29
200505|NCT00799292|480450|P1|STARTED|Overall Study||29
200506|NCT00799227|480454|P1|NOT COMPLETED|Overall Study||3
200507|NCT00799227|480454|P1|COMPLETED|Overall Study||53
200508|NCT00799227|480454|P1|STARTED|Overall Study||56
200509|NCT00798967|480463|P2|NOT COMPLETED|Overall Study||4
200510|NCT00798967|480464|P1|NOT COMPLETED|Overall Study||4
200511|NCT00798967|480463|P2|COMPLETED|Overall Study||39
200512|NCT00798967|480464|P1|COMPLETED|Overall Study||39
200513|NCT00798967|480463|P2|Discontinued During Dosing Period|Overall Study||4
200514|NCT00798967|480464|P1|Discontinued During Dosing Period|Overall Study||4
200515|NCT00798967|480463|P2|STARTED|Overall Study||43
200516|NCT00798967|480464|P1|STARTED|Overall Study||43
200517|NCT00798889|480472|P1|NOT COMPLETED|Overall Study||314
200518|NCT00798889|480472|P1|COMPLETED|Overall Study||0
200519|NCT00798889|480472|P1|Treated|Overall Study||311
200520|NCT00798889|480472|P1|STARTED|Overall Study||314
200521|NCT00798759|480478|P2|NOT COMPLETED|Overall Study||13
200522|NCT00798759|480479|P1|NOT COMPLETED|Overall Study||8
200523|NCT00798759|480478|P2|COMPLETED|Overall Study||106
200524|NCT00798759|480479|P1|COMPLETED|Overall Study||109
200525|NCT00798759|480478|P2|STARTED|Overall Study||119
200526|NCT00798759|480479|P1|STARTED|Overall Study||117
200527|NCT00798720|480487|P1|NOT COMPLETED|Overall Study||0
200528|NCT00798720|480487|P1|COMPLETED|Overall Study||18
200529|NCT00798720|480487|P1|STARTED|Overall Study||18
200530|NCT00798707|480497|P3|NOT COMPLETED|Overall Study||22
200531|NCT00798707|480498|P2|NOT COMPLETED|Overall Study||33
200532|NCT00798707|480499|P1|NOT COMPLETED|Overall Study||26
200533|NCT00798707|480497|P3|COMPLETED|Overall Study||215
200534|NCT00798707|480498|P2|COMPLETED|Overall Study||204
200535|NCT00798707|480499|P1|COMPLETED|Overall Study||209
200536|NCT00798707|480497|P3|Treated|Overall Study||236
200537|NCT00798707|480498|P2|Treated|Overall Study||232
200538|NCT00798707|480499|P1|Treated|Overall Study||231
200539|NCT00798707|480497|P3|STARTED|Overall Study||237
200540|NCT00798707|480498|P2|STARTED|Overall Study||237
200541|NCT00798707|480499|P1|STARTED|Overall Study||235
200542|NCT00798655|480549|P1|NOT COMPLETED|Overall Study||2
200543|NCT00798655|480549|P1|COMPLETED|Overall Study||44
200544|NCT00798655|480549|P1|STARTED|Overall Study||46
200545|NCT00798603|480554|P1|NOT COMPLETED|Overall Study||35
200546|NCT00798603|480554|P1|COMPLETED|Overall Study||27
200547|NCT00798603|480554|P1|STARTED|Overall Study||62
200548|NCT00798590|480576|P2|NOT COMPLETED|Overall Study||8
200549|NCT00798590|480577|P1|NOT COMPLETED|Overall Study||11
200550|NCT00798590|480576|P2|COMPLETED|Overall Study||0
200551|NCT00798590|480577|P1|COMPLETED|Overall Study||0
200552|NCT00798590|480576|P2|STARTED|Overall Study||8
200553|NCT00798590|480577|P1|STARTED|Overall Study||11
200554|NCT00798577|480587|P2|NOT COMPLETED|Overall Study||0
200555|NCT00798577|480588|P1|NOT COMPLETED|Overall Study||0
200556|NCT00798577|480587|P2|COMPLETED|Overall Study||7
200557|NCT00798577|480588|P1|COMPLETED|Overall Study||17
200558|NCT00798577|480587|P2|STARTED|Overall Study||7
200559|NCT00798577|480588|P1|STARTED|Overall Study||17
200560|NCT00798486|480602|P1|NOT COMPLETED|Overall Study||0
200561|NCT00798486|480602|P1|COMPLETED|Overall Study||110
200562|NCT00798486|480602|P1|STARTED|Overall Study||110
200563|NCT00798434|480611|P2|NOT COMPLETED|Open-Label||32
200564|NCT00798434|480612|P1|NOT COMPLETED|Open-Label||42
200565|NCT00798434|480611|P2|COMPLETED|Open-Label||282
200566|NCT00798434|480612|P1|COMPLETED|Open-Label||299
200567|NCT00798434|480611|P2|Received Treatment|Open-Label||313
200568|NCT00798434|480612|P1|Received Treatment|Open-Label||341
200569|NCT00798434|480611|P2|STARTED|Open-Label||314
200570|NCT00798434|480612|P1|STARTED|Open-Label||341
200571|NCT00798434|480611|P2|NOT COMPLETED|Double-Blind||84
200572|NCT00798434|480612|P1|NOT COMPLETED|Double-Blind||55
200573|NCT00798434|480611|P2|COMPLETED|Double-Blind||314
200574|NCT00798434|480612|P1|COMPLETED|Double-Blind||341
200575|NCT00798434|480611|P2|Received Treatment|Double-Blind||392
200576|NCT00798434|480612|P1|Received Treatment|Double-Blind||393
200577|NCT00798434|480611|P2|STARTED|Double-Blind||398
200578|NCT00798434|480612|P1|STARTED|Double-Blind||396
200579|NCT00798369|480698|P6|NOT COMPLETED|Overall Study||3
200580|NCT00798369|480699|P5|NOT COMPLETED|Overall Study||1
200581|NCT00798369|480700|P4|NOT COMPLETED|Overall Study||1
200582|NCT00798369|480701|P3|NOT COMPLETED|Overall Study||2
200583|NCT00798369|480702|P2|NOT COMPLETED|Overall Study||1
200584|NCT00798369|480703|P1|NOT COMPLETED|Overall Study||1
200585|NCT00798369|480698|P6|COMPLETED|Overall Study||54
200586|NCT00798369|480699|P5|COMPLETED|Overall Study||27
200587|NCT00798369|480700|P4|COMPLETED|Overall Study||28
200588|NCT00798369|480701|P3|COMPLETED|Overall Study||27
200589|NCT00798369|480702|P2|COMPLETED|Overall Study||28
200590|NCT00798369|480703|P1|COMPLETED|Overall Study||27
200591|NCT00798369|480698|P6|STARTED|Overall Study||57
200592|NCT00798369|480699|P5|STARTED|Overall Study||28
200593|NCT00798369|480700|P4|STARTED|Overall Study||29
200594|NCT00798369|480701|P3|STARTED|Overall Study||29
200595|NCT00798369|480702|P2|STARTED|Overall Study||29
200596|NCT00798369|480703|P1|STARTED|Overall Study||28
200597|NCT00798317|480750|P2|NOT COMPLETED|Overall Study||7
200598|NCT00798317|480751|P1|NOT COMPLETED|Overall Study||10
200599|NCT00798317|480750|P2|COMPLETED|Overall Study||74
200600|NCT00798317|480751|P1|COMPLETED|Overall Study||235
200601|NCT00798317|480750|P2|STARTED|Overall Study||81
200602|NCT00798317|480751|P1|STARTED|Overall Study||245
200603|NCT00798304|480762|P3|NOT COMPLETED|Overall Study||10
200604|NCT00798304|480763|P2|NOT COMPLETED|Overall Study||22
200605|NCT00798304|480764|P1|NOT COMPLETED|Overall Study||14
200606|NCT00798304|480762|P3|COMPLETED|Overall Study||0
200607|NCT00798304|480763|P2|COMPLETED|Overall Study||0
200608|NCT00798304|480764|P1|COMPLETED|Overall Study||0
200609|NCT00798304|480762|P3|STARTED|Overall Study||10
200610|NCT00798304|480763|P2|STARTED|Overall Study||22
200611|NCT00798304|480764|P1|STARTED|Overall Study||14
200612|NCT00798161|480797|P7|NOT COMPLETED|Overall Study||10
200613|NCT00798161|480798|P6|NOT COMPLETED|Overall Study||11
200614|NCT00798161|480799|P5|NOT COMPLETED|Overall Study||16
200615|NCT00798161|480800|P4|NOT COMPLETED|Overall Study||21
200616|NCT00798161|480801|P3|NOT COMPLETED|Overall Study||21
200617|NCT00798161|480802|P2|NOT COMPLETED|Overall Study||17
200618|NCT00798161|480803|P1|NOT COMPLETED|Overall Study||18
200619|NCT00798161|480797|P7|COMPLETED|Overall Study||56
200620|NCT00798161|480798|P6|COMPLETED|Overall Study||132
200621|NCT00798161|480799|P5|COMPLETED|Overall Study||127
200622|NCT00798161|480800|P4|COMPLETED|Overall Study||121
200623|NCT00798161|480801|P3|COMPLETED|Overall Study||126
200624|NCT00798161|480802|P2|COMPLETED|Overall Study||127
200625|NCT00798161|480803|P1|COMPLETED|Overall Study||54
200626|NCT00798161|480797|P7|STARTED|Overall Study||66
200627|NCT00798161|480798|P6|STARTED|Overall Study||143
200628|NCT00798161|480799|P5|STARTED|Overall Study||143
200629|NCT00798161|480800|P4|STARTED|Overall Study||142
200630|NCT00798161|480801|P3|STARTED|Overall Study||147
200631|NCT00798161|480802|P2|STARTED|Overall Study||144
200632|NCT00798161|480803|P1|STARTED|Overall Study||72
200633|NCT00798135|480910|P1|NOT COMPLETED|Overall Study||13
200634|NCT00798135|480910|P1|COMPLETED|Overall Study||0
200635|NCT00798135|480910|P1|STARTED|Overall Study||13
200636|NCT00798096|480916|P1|NOT COMPLETED|Overall Study||2
200637|NCT00798096|480916|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
200638|NCT00798096|480916|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
200639|NCT00798018|480927|P4|NOT COMPLETED|Overall Study||0
200640|NCT00798018|480928|P3|NOT COMPLETED|Overall Study||0
200641|NCT00798018|480929|P2|NOT COMPLETED|Overall Study||0
200642|NCT00798018|480930|P1|NOT COMPLETED|Overall Study||0
200643|NCT00798018|480927|P4|COMPLETED|Overall Study||25
200644|NCT00798018|480928|P3|COMPLETED|Overall Study||25
200645|NCT00798018|480929|P2|COMPLETED|Overall Study||25
200646|NCT00798018|480930|P1|COMPLETED|Overall Study||25
200647|NCT00798018|480927|P4|STARTED|Overall Study||25
200648|NCT00798018|480928|P3|STARTED|Overall Study||25
200649|NCT00798018|480929|P2|STARTED|Overall Study||25
200650|NCT00798018|480930|P1|STARTED|Overall Study||25
200651|NCT00797966|480944|P6|NOT COMPLETED|Phase A+||28
200652|NCT00797966|480945|P5|NOT COMPLETED|Phase A+||0
200653|NCT00797966|480946|P4|NOT COMPLETED|Phase A+||0
200654|NCT00797966|480947|P3|NOT COMPLETED|Phase A+||0
200655|NCT00797966|480948|P2|NOT COMPLETED|Phase A+||0
200656|NCT00797966|480949|P1|NOT COMPLETED|Phase A+||0
200657|NCT00797966|480944|P6|COMPLETED|Phase A+||207
200658|NCT00797966|480945|P5|COMPLETED|Phase A+||0
200659|NCT00797966|480946|P4|COMPLETED|Phase A+||0
200660|NCT00797966|480947|P3|COMPLETED|Phase A+||0
200661|NCT00797966|480948|P2|COMPLETED|Phase A+||0
200662|NCT00797966|480949|P1|COMPLETED|Phase A+||0
200663|NCT00797966|480944|P6|STARTED|Phase A+||235
200664|NCT00797966|480945|P5|STARTED|Phase A+||0
200665|NCT00797966|480946|P4|STARTED|Phase A+||0
200666|NCT00797966|480947|P3|STARTED|Phase A+||0
200667|NCT00797966|480948|P2|STARTED|Phase A+||0
200668|NCT00797966|480949|P1|STARTED|Phase A+||0
200669|NCT00797966|480944|P6|NOT COMPLETED|Phase B||0
200670|NCT00797966|480945|P5|NOT COMPLETED|Phase B||0
200671|NCT00797966|480946|P4|NOT COMPLETED|Phase B||16
200672|NCT00797966|480947|P3|NOT COMPLETED|Phase B||21
200673|NCT00797966|480948|P2|NOT COMPLETED|Phase B||18
200674|NCT00797966|480949|P1|NOT COMPLETED|Phase B||11
200675|NCT00797966|480944|P6|COMPLETED|Phase B||0
200676|NCT00797966|480945|P5|COMPLETED|Phase B||0
200677|NCT00797966|480946|P4|COMPLETED|Phase B||110
200678|NCT00797966|480947|P3|COMPLETED|Phase B||100
200679|NCT00797966|480948|P2|COMPLETED|Phase B||102
200680|NCT00797966|480949|P1|COMPLETED|Phase B||51
200681|NCT00797966|480944|P6|STARTED|Phase B||0
200682|NCT00797966|480945|P5|STARTED|Phase B||0
200683|NCT00797966|480946|P4|STARTED|Phase B|Randomized participants.|126
200684|NCT00797966|480947|P3|STARTED|Phase B|Randomized participants.|121
200685|NCT00797966|480948|P2|STARTED|Phase B|Randomized participants.|120
200686|NCT00797966|480949|P1|STARTED|Phase B|Randomized participants.|62
200687|NCT00797966|480944|P6|NOT COMPLETED|Phase A||0
200688|NCT00797966|480945|P5|NOT COMPLETED|Phase A||185
200689|NCT00797966|480946|P4|NOT COMPLETED|Phase A||0
200690|NCT00797966|480947|P3|NOT COMPLETED|Phase A||0
200691|NCT00797966|480948|P2|NOT COMPLETED|Phase A||0
200692|NCT00797966|480949|P1|NOT COMPLETED|Phase A||0
200693|NCT00797966|480944|P6|COMPLETED|Phase A||0
200694|NCT00797966|480945|P5|COMPLETED|Phase A||664
200695|NCT00797966|480946|P4|COMPLETED|Phase A||0
200696|NCT00797966|480947|P3|COMPLETED|Phase A||0
200697|NCT00797966|480948|P2|COMPLETED|Phase A||0
200698|NCT00797966|480949|P1|COMPLETED|Phase A||0
200699|NCT00797966|480944|P6|STARTED|Phase A||0
200700|NCT00797966|480945|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
200701|NCT00797966|480946|P4|STARTED|Phase A||0
200702|NCT00797966|480947|P3|STARTED|Phase A||0
200703|NCT00797966|480948|P2|STARTED|Phase A||0
200704|NCT00797966|480949|P1|STARTED|Phase A||0
200705|NCT00797862|481014|P3|NOT COMPLETED|Overall Study||86
200706|NCT00797862|481015|P2|NOT COMPLETED|Overall Study||68
200707|NCT00797862|481016|P1|NOT COMPLETED|Overall Study||124
200708|NCT00797862|481014|P3|COMPLETED|Overall Study||230
200709|NCT00797862|481015|P2|COMPLETED|Overall Study||250
200710|NCT00797862|481016|P1|COMPLETED|Overall Study||496
200711|NCT00797862|481014|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
200712|NCT00797862|481015|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
200713|NCT00797862|481016|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
200714|NCT00797862|481014|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
200802|NCT00797212|481164|P1|COMPLETED|Overall Study||50
200715|NCT00797862|481015|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
200716|NCT00797862|481016|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
200717|NCT00797823|481045|P3|NOT COMPLETED|Second Period (Crossover)||0
200718|NCT00797823|481046|P2|NOT COMPLETED|Second Period (Crossover)||0
200719|NCT00797823|481047|P1|NOT COMPLETED|Second Period (Crossover)||0
200720|NCT00797823|481045|P3|COMPLETED|Second Period (Crossover)||0
200721|NCT00797823|481046|P2|COMPLETED|Second Period (Crossover)||4
200722|NCT00797823|481047|P1|COMPLETED|Second Period (Crossover)||3
200723|NCT00797823|481045|P3|STARTED|Second Period (Crossover)||0
200724|NCT00797823|481046|P2|STARTED|Second Period (Crossover)||4
200725|NCT00797823|481047|P1|STARTED|Second Period (Crossover)||3
200726|NCT00797823|481045|P3|NOT COMPLETED|First Period (Initial Randomization)||0
200727|NCT00797823|481046|P2|NOT COMPLETED|First Period (Initial Randomization)||0
200728|NCT00797823|481047|P1|NOT COMPLETED|First Period (Initial Randomization)||1
200729|NCT00797823|481045|P3|COMPLETED|First Period (Initial Randomization)||0
200730|NCT00797823|481046|P2|COMPLETED|First Period (Initial Randomization)||4
200731|NCT00797823|481047|P1|COMPLETED|First Period (Initial Randomization)||3
200732|NCT00797823|481045|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
200733|NCT00797823|481046|P2|STARTED|First Period (Initial Randomization)||4
200734|NCT00797823|481047|P1|STARTED|First Period (Initial Randomization)||4
200735|NCT00797823|481045|P3|NOT COMPLETED|Pilot Studies||0
200736|NCT00797823|481046|P2|NOT COMPLETED|Pilot Studies||0
200737|NCT00797823|481047|P1|NOT COMPLETED|Pilot Studies||0
200738|NCT00797823|481045|P3|COMPLETED|Pilot Studies||6
200739|NCT00797823|481046|P2|COMPLETED|Pilot Studies||0
200740|NCT00797823|481047|P1|COMPLETED|Pilot Studies||0
200741|NCT00797823|481045|P3|STARTED|Pilot Studies||6
200742|NCT00797823|481046|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
200743|NCT00797823|481047|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
200744|NCT00797797|481058|P2|NOT COMPLETED|Overall Study||43
200745|NCT00797797|481059|P1|NOT COMPLETED|Overall Study||55
200746|NCT00797797|481058|P2|COMPLETED|Overall Study||141
200747|NCT00797797|481059|P1|COMPLETED|Overall Study||123
200748|NCT00797797|481058|P2|STARTED|Overall Study||184
200749|NCT00797797|481059|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
200750|NCT00797732|481069|P3|NOT COMPLETED|Overall Study||154
200751|NCT00797732|481070|P2|NOT COMPLETED|Overall Study||3
200752|NCT00797732|481071|P1|NOT COMPLETED|Overall Study||5
200753|NCT00797732|481069|P3|COMPLETED|Overall Study||0
200754|NCT00797732|481070|P2|COMPLETED|Overall Study||18
200755|NCT00797732|481071|P1|COMPLETED|Overall Study||16
200756|NCT00797732|481069|P3|Evaluable at 12 Months|Overall Study||0
200757|NCT00797732|481070|P2|Evaluable at 12 Months|Overall Study||18
200758|NCT00797732|481071|P1|Evaluable at 12 Months|Overall Study||17
200759|NCT00797732|481069|P3|Evaluable at 20 Weeks|Overall Study||0
200760|NCT00797732|481070|P2|Evaluable at 20 Weeks|Overall Study||18
200761|NCT00797732|481071|P1|Evaluable at 20 Weeks|Overall Study||17
200762|NCT00797732|481069|P3|Evaluable at Baseline|Overall Study||0
200763|NCT00797732|481070|P2|Evaluable at Baseline|Overall Study||18
200764|NCT00797732|481071|P1|Evaluable at Baseline|Overall Study||18
200765|NCT00797732|481069|P3|STARTED|Overall Study||154
200766|NCT00797732|481070|P2|STARTED|Overall Study||21
200767|NCT00797732|481071|P1|STARTED|Overall Study||21
200768|NCT00797667|481086|P3|NOT COMPLETED|Overall Study||127
200769|NCT00797667|481087|P2|NOT COMPLETED|Overall Study||259
200770|NCT00797667|481088|P1|NOT COMPLETED|Overall Study||260
200771|NCT00797667|481086|P3|COMPLETED|Overall Study||4
200772|NCT00797667|481087|P2|COMPLETED|Overall Study||5
200773|NCT00797667|481088|P1|COMPLETED|Overall Study||5
200774|NCT00797667|481086|P3|Treated|Overall Study||130
200775|NCT00797667|481087|P2|Treated|Overall Study||263
200776|NCT00797667|481088|P1|Treated|Overall Study||263
200777|NCT00797667|481086|P3|STARTED|Overall Study||131
200778|NCT00797667|481087|P2|STARTED|Overall Study||264
200779|NCT00797667|481088|P1|STARTED|Overall Study||265
200780|NCT00797563|481114|P1|NOT COMPLETED|Overall Study||1
200781|NCT00797563|481114|P1|COMPLETED|Overall Study||101
200782|NCT00797563|481114|P1|STARTED|Overall Study|number of subjects|102
200783|NCT00797511|481120|P1|NOT COMPLETED|Overall Study||1
200784|NCT00797511|481120|P1|COMPLETED|Overall Study||131
200785|NCT00797511|481120|P1|STARTED|Overall Study||132
200786|NCT00797459|481128|P1|NOT COMPLETED|Overall Study||0
200787|NCT00797459|481128|P1|COMPLETED|Overall Study||60
200788|NCT00797459|481128|P1|STARTED|Overall Study||60
200789|NCT00797316|481138|P2|NOT COMPLETED|Overall Study||32
200790|NCT00797316|481139|P1|NOT COMPLETED|Overall Study||23
200791|NCT00797316|481138|P2|COMPLETED|Overall Study||233
200792|NCT00797316|481139|P1|COMPLETED|Overall Study||244
200793|NCT00797316|481138|P2|STARTED|Overall Study||265
200794|NCT00797316|481139|P1|STARTED|Overall Study||267
200795|NCT00797277|481155|P2|NOT COMPLETED|Overall Study||0
200796|NCT00797277|481156|P1|NOT COMPLETED|Overall Study||0
200797|NCT00797277|481155|P2|COMPLETED|Overall Study||30
200798|NCT00797277|481156|P1|COMPLETED|Overall Study||37
200799|NCT00797277|481155|P2|STARTED|Overall Study||30
200800|NCT00797277|481156|P1|STARTED|Overall Study||37
200801|NCT00797212|481164|P1|NOT COMPLETED|Overall Study||0
200803|NCT00797212|481164|P1|STARTED|Overall Study||50
200804|NCT00797108|481173|P3|NOT COMPLETED|Overall Study||6
200805|NCT00797108|481174|P2|NOT COMPLETED|Overall Study||2
200806|NCT00797108|481175|P1|NOT COMPLETED|Overall Study||4
200807|NCT00797108|481173|P3|COMPLETED|Overall Study||6
200808|NCT00797108|481174|P2|COMPLETED|Overall Study||9
200809|NCT00797108|481175|P1|COMPLETED|Overall Study||8
200810|NCT00797108|481173|P3|Treated|Overall Study||12
200811|NCT00797108|481174|P2|Treated|Overall Study||11
200812|NCT00797108|481175|P1|Treated|Overall Study||10
200813|NCT00797108|481173|P3|STARTED|Overall Study||12
200814|NCT00797108|481174|P2|STARTED|Overall Study||11
200815|NCT00797108|481175|P1|STARTED|Overall Study||12
200816|NCT00796991|481210|P3|NOT COMPLETED|Overall Study||14
200817|NCT00796991|481211|P2|NOT COMPLETED|Overall Study||12
200818|NCT00796991|481212|P1|NOT COMPLETED|Overall Study||15
200819|NCT00796991|481210|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
200820|NCT00796991|481211|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
200821|NCT00796991|481212|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
200822|NCT00796991|481210|P3|STARTED|Overall Study||20
200823|NCT00796991|481211|P2|STARTED|Overall Study||19
200824|NCT00796991|481212|P1|STARTED|Overall Study||20
200825|NCT00796926|481312|P2|NOT COMPLETED|Overall Study||0
200826|NCT00796926|481313|P1|NOT COMPLETED|Overall Study||1
200827|NCT00796926|481312|P2|COMPLETED|Overall Study||15
200828|NCT00796926|481313|P1|COMPLETED|Overall Study||14
200829|NCT00796926|481312|P2|STARTED|Overall Study||15
200830|NCT00796926|481313|P1|STARTED|Overall Study||15
200831|NCT00796861|481319|P1|NOT COMPLETED|Overall Study||4
200832|NCT00796861|481319|P1|COMPLETED|Overall Study||0
200833|NCT00796861|481319|P1|STARTED|Overall Study||4
200834|NCT00796822|481325|P2|NOT COMPLETED|Overall Study||0
200835|NCT00796822|481326|P1|NOT COMPLETED|Overall Study||3
200836|NCT00796822|481325|P2|COMPLETED|Overall Study||13
200837|NCT00796822|481326|P1|COMPLETED|Overall Study||10
200838|NCT00796822|481325|P2|STARTED|Overall Study||13
200839|NCT00796822|481326|P1|STARTED|Overall Study||13
200840|NCT00796757|481334|P1|NOT COMPLETED|Overall Study||86
200841|NCT00796757|481334|P1|COMPLETED|Overall Study||60
200842|NCT00796757|481334|P1|STARTED|Overall Study||146
200843|NCT00796744|481349|P3|NOT COMPLETED|Overall Study||1
200844|NCT00796744|481350|P2|NOT COMPLETED|Overall Study||0
200845|NCT00796744|481351|P1|NOT COMPLETED|Overall Study||0
200846|NCT00796744|481349|P3|COMPLETED|Overall Study||27
200847|NCT00796744|481350|P2|COMPLETED|Overall Study||26
200848|NCT00796744|481351|P1|COMPLETED|Overall Study||24
200849|NCT00796744|481349|P3|STARTED|Overall Study||28
200850|NCT00796744|481350|P2|STARTED|Overall Study||26
200851|NCT00796744|481351|P1|STARTED|Overall Study||24
200852|NCT00796718|481368|P1|NOT COMPLETED|Overall Study||9
200853|NCT00796718|481368|P1|COMPLETED|Overall Study||53
200854|NCT00796718|481368|P1|STARTED|Overall Study||62
200855|NCT00796705|481379|P4|NOT COMPLETED|Overall Study||0
200856|NCT00796705|481380|P3|NOT COMPLETED|Overall Study||0
200857|NCT00796705|481381|P2|NOT COMPLETED|Overall Study||0
200858|NCT00796705|481382|P1|NOT COMPLETED|Overall Study||0
200859|NCT00796705|481379|P4|COMPLETED|Overall Study||2
200860|NCT00796705|481380|P3|COMPLETED|Overall Study||4
200861|NCT00796705|481381|P2|COMPLETED|Overall Study||4
200862|NCT00796705|481382|P1|COMPLETED|Overall Study||3
200863|NCT00796705|481379|P4|STARTED|Overall Study||2
200864|NCT00796705|481380|P3|STARTED|Overall Study||4
200865|NCT00796705|481381|P2|STARTED|Overall Study||4
200866|NCT00796705|481382|P1|STARTED|Overall Study||3
200867|NCT00796666|481420|P2|NOT COMPLETED|Overall Study||64
200868|NCT00796666|481421|P1|NOT COMPLETED|Overall Study||67
200869|NCT00796666|481420|P2|COMPLETED|Overall Study||0
200870|NCT00796666|481421|P1|COMPLETED|Overall Study||0
200871|NCT00796666|481420|P2|Randomized and Not Treated|Overall Study||0
200872|NCT00796666|481421|P1|Randomized and Not Treated|Overall Study||1
200873|NCT00796666|481420|P2|Treated|Overall Study||64
200874|NCT00796666|481421|P1|Treated|Overall Study||66
200875|NCT00796666|481420|P2|STARTED|Overall Study||64
200876|NCT00796666|481421|P1|STARTED|Overall Study||67
200877|NCT00796653|481455|P4|NOT COMPLETED|Overall Study||40
200878|NCT00796653|481456|P3|NOT COMPLETED|Overall Study||36
200879|NCT00796653|481457|P2|NOT COMPLETED|Overall Study||37
200880|NCT00796653|481458|P1|NOT COMPLETED|Overall Study||51
200881|NCT00796653|481455|P4|COMPLETED|Overall Study||193
200882|NCT00796653|481456|P3|COMPLETED|Overall Study||198
200883|NCT00796653|481457|P2|COMPLETED|Overall Study||195
200884|NCT00796653|481458|P1|COMPLETED|Overall Study||184
200885|NCT00796653|481455|P4|STARTED|Overall Study||233
200886|NCT00796653|481456|P3|STARTED|Overall Study||234
200887|NCT00796653|481457|P2|STARTED|Overall Study||232
200888|NCT00796653|481458|P1|STARTED|Overall Study||235
200889|NCT00796627|481726|P2|NOT COMPLETED|Overall Study||0
200890|NCT00796627|481727|P1|NOT COMPLETED|Overall Study||0
200891|NCT00796627|481726|P2|COMPLETED|Overall Study||31
200892|NCT00796627|481727|P1|COMPLETED|Overall Study||10
200893|NCT00796627|481726|P2|STARTED|Overall Study||31
200894|NCT00796627|481727|P1|STARTED|Overall Study||10
200895|NCT00796614|481743|P4|NOT COMPLETED|Overall Study||1
200896|NCT00796614|481744|P3|NOT COMPLETED|Overall Study||3
200897|NCT00796614|481745|P2|NOT COMPLETED|Overall Study||4
200898|NCT00796614|481746|P1|NOT COMPLETED|Overall Study||5
200899|NCT00796614|481743|P4|COMPLETED|Overall Study||40
200900|NCT00796614|481744|P3|COMPLETED|Overall Study||36
200901|NCT00796614|481745|P2|COMPLETED|Overall Study||36
200902|NCT00796614|481746|P1|COMPLETED|Overall Study||36
200903|NCT00796614|481743|P4|Not Treated|Overall Study||0
200904|NCT00796614|481744|P3|Not Treated|Overall Study||1
200905|NCT00796614|481745|P2|Not Treated|Overall Study||0
200906|NCT00796614|481746|P1|Not Treated|Overall Study||0
200907|NCT00796614|481743|P4|STARTED|Overall Study||41
200908|NCT00796614|481744|P3|STARTED|Overall Study||39
200909|NCT00796614|481745|P2|STARTED|Overall Study||40
200910|NCT00796614|481746|P1|STARTED|Overall Study||41
200911|NCT00796549|481788|P1|NOT COMPLETED|Overall Study||218
200912|NCT00796549|481788|P1|COMPLETED|Overall Study||0
200913|NCT00796549|481788|P1|Entered|Overall Study|entered and treated|69
200914|NCT00796549|481788|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
200915|NCT00796523|481805|P2|NOT COMPLETED|Overall Study||7
200916|NCT00796523|481806|P1|NOT COMPLETED|Overall Study||9
200917|NCT00796523|481805|P2|COMPLETED|Overall Study||17
200918|NCT00796523|481806|P1|COMPLETED|Overall Study||18
200919|NCT00796523|481805|P2|STARTED|Overall Study||24
200920|NCT00796523|481806|P1|STARTED|Overall Study||27
200921|NCT00796510|481816|P2|NOT COMPLETED|Overall Study||0
200922|NCT00796510|481817|P1|NOT COMPLETED|Overall Study||3
200923|NCT00796510|481816|P2|COMPLETED|Overall Study||0
200924|NCT00796510|481817|P1|COMPLETED|Overall Study||0
200925|NCT00796510|481816|P2|STARTED|Overall Study||0
200926|NCT00796510|481817|P1|STARTED|Overall Study||3
200927|NCT00796419|481829|P2|NOT COMPLETED|Overall Study||1
200928|NCT00796419|481830|P1|NOT COMPLETED|Overall Study||0
200929|NCT00796419|481829|P2|COMPLETED|Overall Study||13
200930|NCT00796419|481830|P1|COMPLETED|Overall Study||13
200931|NCT00796419|481829|P2|STARTED|Overall Study||14
200932|NCT00796419|481830|P1|STARTED|Overall Study||13
200933|NCT00796367|481843|P3|NOT COMPLETED|Overall Study||47
200934|NCT00796367|481844|P2|NOT COMPLETED|Overall Study||25
200935|NCT00796367|481845|P1|NOT COMPLETED|Overall Study||30
200936|NCT00796367|481843|P3|COMPLETED|Overall Study||248
200937|NCT00796367|481844|P2|COMPLETED|Overall Study||129
200938|NCT00796367|481845|P1|COMPLETED|Overall Study||197
200939|NCT00796367|481843|P3|STARTED|Overall Study||295
200940|NCT00796367|481844|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
200941|NCT00796367|481845|P1|STARTED|Overall Study||227
200942|NCT00796328|481856|P1|NOT COMPLETED|Overall Study||6
200943|NCT00796328|481856|P1|COMPLETED|Overall Study||40
200944|NCT00796328|481856|P1|STARTED|Overall Study||46
200945|NCT00796315|481860|P3|NOT COMPLETED|Overall Study||0
200946|NCT00796315|481861|P2|NOT COMPLETED|Overall Study||1
200947|NCT00796315|481862|P1|NOT COMPLETED|Overall Study||0
200948|NCT00796315|481860|P3|COMPLETED|Overall Study||15
200949|NCT00796315|481861|P2|COMPLETED|Overall Study||16
200950|NCT00796315|481862|P1|COMPLETED|Overall Study||9
200951|NCT00796315|481860|P3|STARTED|Overall Study||15
200952|NCT00796315|481861|P2|STARTED|Overall Study||17
200953|NCT00796315|481862|P1|STARTED|Overall Study||9
200954|NCT00796302|481875|P2|NOT COMPLETED|Overall Study||18
200955|NCT00796302|481876|P1|NOT COMPLETED|Overall Study||13
200956|NCT00796302|481875|P2|COMPLETED|Overall Study||66
200957|NCT00796302|481876|P1|COMPLETED|Overall Study||71
200958|NCT00796302|481875|P2|STARTED|Overall Study||84
200959|NCT00796302|481876|P1|STARTED|Overall Study||84
200960|NCT00796224|481890|P2|NOT COMPLETED|Overall Study||1
200961|NCT00796224|481891|P1|NOT COMPLETED|Overall Study||1
200962|NCT00796224|481890|P2|COMPLETED|Overall Study||18
200963|NCT00796224|481891|P1|COMPLETED|Overall Study||18
200964|NCT00796224|481890|P2|STARTED|Overall Study||19
200965|NCT00796224|481891|P1|STARTED|Overall Study||19
200966|NCT00796120|481911|P2|NOT COMPLETED|Overall Study||60
200967|NCT00796120|481912|P1|NOT COMPLETED|Overall Study||61
200968|NCT00796120|481911|P2|COMPLETED|Overall Study||0
200969|NCT00796120|481912|P1|COMPLETED|Overall Study||0
200970|NCT00796120|481911|P2|Treated|Overall Study||57
200971|NCT00796120|481912|P1|Treated|Overall Study||61
200972|NCT00796120|481911|P2|STARTED|Overall Study||60
200973|NCT00796120|481912|P1|STARTED|Overall Study||61
200974|NCT00796003|481928|P2|NOT COMPLETED|Overall Study||29
200975|NCT00796003|481929|P1|NOT COMPLETED|Overall Study||3
200976|NCT00796003|481928|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
200977|NCT00796003|481929|P1|COMPLETED|Overall Study||0
200978|NCT00796003|481928|P2|Treated|Overall Study|Number of participants treated|34
200979|NCT00796003|481929|P1|Treated|Overall Study|Number of participants treated|3
200980|NCT00796003|481928|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
200981|NCT00796003|481929|P1|STARTED|Overall Study|Number of participants enrolled|3
200982|NCT00795951|481950|P1|NOT COMPLETED|Overall Study||2
200983|NCT00795951|481950|P1|COMPLETED|Overall Study||100
200984|NCT00795951|481950|P1|STARTED|Overall Study||102
200985|NCT00795886|481987|P1|NOT COMPLETED|Overall Study||10
200986|NCT00795886|481987|P1|COMPLETED|Overall Study||53
200987|NCT00795886|481987|P1|STARTED|Overall Study||63
200988|NCT00795821|481995|P2|NOT COMPLETED|Taper Phase||0
200989|NCT00795821|481996|P1|NOT COMPLETED|Taper Phase||9
200990|NCT00795821|481995|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
200991|NCT00795821|481996|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
200992|NCT00795821|481995|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
200993|NCT00795821|481996|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
200994|NCT00795821|481995|P2|NOT COMPLETED|Long-term Extension Phase||92
200995|NCT00795821|481996|P1|NOT COMPLETED|Long-term Extension Phase||90
200996|NCT00795821|481995|P2|COMPLETED|Long-term Extension Phase||115
200997|NCT00795821|481996|P1|COMPLETED|Long-term Extension Phase||100
200998|NCT00795821|481995|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
200999|NCT00795821|481996|P1|STARTED|Long-term Extension Phase||190
201000|NCT00795821|481995|P2|NOT COMPLETED|Acute Treatment Phase||31
201001|NCT00795821|481996|P1|NOT COMPLETED|Acute Treatment Phase||56
201002|NCT00795821|481995|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
201003|NCT00795821|481996|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
201004|NCT00795821|481995|P2|STARTED|Acute Treatment Phase||245
201005|NCT00795821|481996|P1|STARTED|Acute Treatment Phase||250
201006|NCT00795769|482065|P1|NOT COMPLETED|Overall Study||0
201007|NCT00795769|482065|P1|COMPLETED|Overall Study||49
201008|NCT00795769|482065|P1|STARTED|Overall Study||49
201009|NCT00795717|482071|P2|NOT COMPLETED|Phase II||1
201010|NCT00795717|482072|P1|NOT COMPLETED|Phase II||0
201011|NCT00795717|482071|P2|COMPLETED|Phase II||18
201012|NCT00795717|482072|P1|COMPLETED|Phase II||18
201013|NCT00795717|482071|P2|STARTED|Phase II||19
201014|NCT00795717|482072|P1|STARTED|Phase II||18
201015|NCT00795717|482071|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
201016|NCT00795717|482072|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
201017|NCT00795717|482071|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
201018|NCT00795717|482072|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
201019|NCT00795717|482071|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
201020|NCT00795717|482072|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
201021|NCT00795704|482084|P2|NOT COMPLETED|Overall Study||3
201022|NCT00795704|482085|P1|NOT COMPLETED|Overall Study||4
201023|NCT00795704|482084|P2|COMPLETED|Overall Study||9
201024|NCT00795704|482085|P1|COMPLETED|Overall Study||8
201025|NCT00795704|482084|P2|STARTED|Overall Study||12
201026|NCT00795704|482085|P1|STARTED|Overall Study||12
201027|NCT00795639|482097|P2|NOT COMPLETED|Overall Study||26
201028|NCT00795639|482098|P1|NOT COMPLETED|Overall Study||21
201029|NCT00795639|482097|P2|COMPLETED|Overall Study||66
201030|NCT00795639|482098|P1|COMPLETED|Overall Study||70
201031|NCT00795639|482097|P2|Randomized and Not Treated|Overall Study||1
201032|NCT00795639|482098|P1|Randomized and Not Treated|Overall Study||0
201033|NCT00795639|482097|P2|STARTED|Overall Study||92
201034|NCT00795639|482098|P1|STARTED|Overall Study||91
201035|NCT00795600|482110|P2|NOT COMPLETED|Overall Study||4
201036|NCT00795600|482111|P1|NOT COMPLETED|Overall Study||4
201037|NCT00795600|482110|P2|COMPLETED|Overall Study||31
201038|NCT00795600|482111|P1|COMPLETED|Overall Study||21
201039|NCT00795600|482110|P2|Exposed to Drug|Overall Study||35
201040|NCT00795600|482111|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
201041|NCT00795600|482110|P2|STARTED|Overall Study||35
201042|NCT00795600|482111|P1|STARTED|Overall Study||25
201043|NCT00795535|482231|P1|NOT COMPLETED|Overall Study||20
201044|NCT00795535|482231|P1|COMPLETED|Overall Study||75
201045|NCT00795535|482231|P1|STARTED|Overall Study||95
201046|NCT00795509|482238|P1|NOT COMPLETED|Overall Study||31
201047|NCT00795509|482238|P1|COMPLETED|Overall Study||343
201048|NCT00795509|482238|P1|STARTED|Overall Study||374
201049|NCT00795366|482245|P2|NOT COMPLETED|Overall Study||0
201050|NCT00795366|482246|P1|NOT COMPLETED|Overall Study||0
201051|NCT00795366|482245|P2|COMPLETED|Overall Study||54
201052|NCT00795366|482246|P1|COMPLETED|Overall Study||42
201053|NCT00795366|482245|P2|STARTED|Overall Study||54
201054|NCT00795366|482246|P1|STARTED|Overall Study||42
201055|NCT00795340|482254|P2|NOT COMPLETED|Overall Study||0
201056|NCT00795340|482255|P1|NOT COMPLETED|Overall Study||7
201057|NCT00795340|482254|P2|COMPLETED|Overall Study||153
201058|NCT00795340|482255|P1|COMPLETED|Overall Study||146
201059|NCT00795340|482254|P2|STARTED|Overall Study||153
201060|NCT00795340|482255|P1|STARTED|Overall Study||153
201061|NCT00795288|482267|P2|NOT COMPLETED|Overall Study||0
201062|NCT00795288|482268|P1|NOT COMPLETED|Overall Study||0
201063|NCT00795288|482267|P2|COMPLETED|Overall Study||21
201064|NCT00795288|482268|P1|COMPLETED|Overall Study||21
201065|NCT00795288|482267|P2|STARTED|Overall Study||21
201066|NCT00795288|482268|P1|STARTED|Overall Study||21
201067|NCT00795210|482281|P3|NOT COMPLETED|Overall Study||2
201068|NCT00795210|482282|P2|NOT COMPLETED|Overall Study||1
201069|NCT00795210|482283|P1|NOT COMPLETED|Overall Study||0
201070|NCT00795210|482281|P3|COMPLETED|Overall Study||3
201071|NCT00795210|482282|P2|COMPLETED|Overall Study||11
201072|NCT00795210|482283|P1|COMPLETED|Overall Study||8
201073|NCT00795210|482281|P3|STARTED|Overall Study||5
201074|NCT00795210|482282|P2|STARTED|Overall Study||12
201075|NCT00795210|482283|P1|STARTED|Overall Study||8
201076|NCT00795184|482294|P2|NOT COMPLETED|Overall Study||13
201077|NCT00795184|482295|P1|NOT COMPLETED|Overall Study||8
201078|NCT00795184|482294|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
201079|NCT00795184|482295|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
201080|NCT00795184|482294|P2|STARTED|Overall Study||57
201081|NCT00795184|482295|P1|STARTED|Overall Study||65
201082|NCT00795145|482306|P7|NOT COMPLETED|Cohort 2||0
201083|NCT00795145|482307|P6|NOT COMPLETED|Cohort 2||0
201084|NCT00795145|482308|P5|NOT COMPLETED|Cohort 2||0
201085|NCT00795145|482309|P4|NOT COMPLETED|Cohort 2||0
201086|NCT00795145|482310|P3|NOT COMPLETED|Cohort 2||0
201087|NCT00795145|482311|P2|NOT COMPLETED|Cohort 2||0
201088|NCT00795145|482312|P1|NOT COMPLETED|Cohort 2||0
201089|NCT00795145|482306|P7|COMPLETED|Cohort 2||10
201090|NCT00795145|482307|P6|COMPLETED|Cohort 2||10
201091|NCT00795145|482308|P5|COMPLETED|Cohort 2||10
201092|NCT00795145|482309|P4|COMPLETED|Cohort 2||10
201093|NCT00795145|482310|P3|COMPLETED|Cohort 2||0
201094|NCT00795145|482311|P2|COMPLETED|Cohort 2||0
201095|NCT00795145|482312|P1|COMPLETED|Cohort 2||0
201096|NCT00795145|482306|P7|STARTED|Cohort 2||10
201097|NCT00795145|482307|P6|STARTED|Cohort 2||10
201098|NCT00795145|482308|P5|STARTED|Cohort 2||10
201099|NCT00795145|482309|P4|STARTED|Cohort 2||10
201100|NCT00795145|482310|P3|STARTED|Cohort 2||0
201101|NCT00795145|482311|P2|STARTED|Cohort 2||0
201102|NCT00795145|482312|P1|STARTED|Cohort 2||0
201103|NCT00795145|482306|P7|NOT COMPLETED|Cohort 1||0
201104|NCT00795145|482307|P6|NOT COMPLETED|Cohort 1||0
201105|NCT00795145|482308|P5|NOT COMPLETED|Cohort 1||0
201106|NCT00795145|482309|P4|NOT COMPLETED|Cohort 1||0
201107|NCT00795145|482310|P3|NOT COMPLETED|Cohort 1||0
201108|NCT00795145|482311|P2|NOT COMPLETED|Cohort 1||0
201109|NCT00795145|482312|P1|NOT COMPLETED|Cohort 1||0
201110|NCT00795145|482306|P7|COMPLETED|Cohort 1||0
201111|NCT00795145|482307|P6|COMPLETED|Cohort 1||0
201112|NCT00795145|482308|P5|COMPLETED|Cohort 1||0
201113|NCT00795145|482309|P4|COMPLETED|Cohort 1||0
201114|NCT00795145|482310|P3|COMPLETED|Cohort 1||3
201115|NCT00795145|482311|P2|COMPLETED|Cohort 1||3
201116|NCT00795145|482312|P1|COMPLETED|Cohort 1||3
201117|NCT00795145|482306|P7|STARTED|Cohort 1||0
201118|NCT00795145|482307|P6|STARTED|Cohort 1||0
201119|NCT00795145|482308|P5|STARTED|Cohort 1||0
201120|NCT00795145|482309|P4|STARTED|Cohort 1||0
201121|NCT00795145|482310|P3|STARTED|Cohort 1||3
201122|NCT00795145|482311|P2|STARTED|Cohort 1||3
201123|NCT00795145|482312|P1|STARTED|Cohort 1||3
201124|NCT00795132|482356|P1|NOT COMPLETED|Overall Study||3
201125|NCT00795132|482356|P1|COMPLETED|Overall Study||44
201126|NCT00795132|482356|P1|STARTED|Overall Study||47
201127|NCT00795002|482370|P2|NOT COMPLETED|Overall Study||2
201128|NCT00795002|482371|P1|NOT COMPLETED|Overall Study||2
201129|NCT00795002|482370|P2|COMPLETED|Overall Study||37
201130|NCT00795002|482371|P1|COMPLETED|Overall Study||37
201131|NCT00795002|482370|P2|STARTED|Overall Study||39
201132|NCT00795002|482371|P1|STARTED|Overall Study||39
201133|NCT00794963|482379|P2|NOT COMPLETED|Overall Study||4
201134|NCT00794963|482380|P1|NOT COMPLETED|Overall Study||1
201135|NCT00794963|482379|P2|COMPLETED|Overall Study||0
201136|NCT00794963|482380|P1|COMPLETED|Overall Study||3
201137|NCT00794963|482379|P2|STARTED|Overall Study||4
201138|NCT00794963|482380|P1|STARTED|Overall Study||4
201139|NCT00794924|482388|P2|NOT COMPLETED|Overall Study||70
201140|NCT00794924|482389|P1|NOT COMPLETED|Overall Study||60
201141|NCT00794924|482388|P2|COMPLETED|Overall Study||101
201142|NCT00794924|482389|P1|COMPLETED|Overall Study||114
201143|NCT00794924|482388|P2|STARTED|Overall Study|14 patients refused to start the study|171
201144|NCT00794924|482389|P1|STARTED|Overall Study|14 patients refused to start the study|174
201145|NCT00794820|482393|P1|NOT COMPLETED|Overall Study||16
201146|NCT00794820|482393|P1|COMPLETED|Overall Study||50
201147|NCT00794820|482393|P1|STARTED|Overall Study||66
201148|NCT00794677|482401|P2|NOT COMPLETED|Second Intervention||0
201149|NCT00794677|482402|P1|NOT COMPLETED|Second Intervention||0
201150|NCT00794677|482401|P2|COMPLETED|Second Intervention||13
201151|NCT00794677|482402|P1|COMPLETED|Second Intervention||11
201152|NCT00794677|482401|P2|STARTED|Second Intervention||13
201153|NCT00794677|482402|P1|STARTED|Second Intervention||11
201154|NCT00794677|482401|P2|NOT COMPLETED|First Intervention||0
201155|NCT00794677|482402|P1|NOT COMPLETED|First Intervention||2
201156|NCT00794677|482401|P2|COMPLETED|First Intervention||13
201157|NCT00794677|482402|P1|COMPLETED|First Intervention||11
201158|NCT00794677|482401|P2|STARTED|First Intervention||13
201159|NCT00794677|482402|P1|STARTED|First Intervention||13
201160|NCT00794664|482424|P2|NOT COMPLETED|Follow-up Period||5
201161|NCT00794664|482425|P1|NOT COMPLETED|Follow-up Period||1
201162|NCT00794664|482424|P2|COMPLETED|Follow-up Period||28
201163|NCT00794664|482425|P1|COMPLETED|Follow-up Period||15
201164|NCT00794664|482424|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
201165|NCT00794664|482425|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
201166|NCT00794664|482424|P2|NOT COMPLETED|Treatment Period||12
201167|NCT00794664|482425|P1|NOT COMPLETED|Treatment Period||1
201168|NCT00794664|482424|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
201169|NCT00794664|482425|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
201170|NCT00794664|482424|P2|STARTED|Treatment Period||39
201171|NCT00794664|482425|P1|STARTED|Treatment Period||19
201172|NCT00794560|482473|P4|NOT COMPLETED|Overall Study||4
201173|NCT00794560|482474|P3|NOT COMPLETED|Overall Study||4
201174|NCT00794560|482475|P2|NOT COMPLETED|Overall Study||4
201175|NCT00794560|482476|P1|NOT COMPLETED|Overall Study||3
201176|NCT00794560|482473|P4|COMPLETED|Overall Study||34
201177|NCT00794560|482474|P3|COMPLETED|Overall Study||40
201178|NCT00794560|482475|P2|COMPLETED|Overall Study||32
201179|NCT00794560|482476|P1|COMPLETED|Overall Study||33
201180|NCT00794560|482473|P4|STARTED|Overall Study||38
201181|NCT00794560|482474|P3|STARTED|Overall Study||44
201182|NCT00794560|482475|P2|STARTED|Overall Study||36
201183|NCT00794560|482476|P1|STARTED|Overall Study||36
201184|NCT00794547|482490|P2|NOT COMPLETED|Overall Study||0
201185|NCT00794547|482491|P1|NOT COMPLETED|Overall Study||0
201186|NCT00794547|482490|P2|COMPLETED|Overall Study||16
201187|NCT00794547|482491|P1|COMPLETED|Overall Study||18
201188|NCT00794547|482490|P2|STARTED|Overall Study||16
201189|NCT00794547|482491|P1|STARTED|Overall Study||18
201190|NCT00794508|482499|P1|NOT COMPLETED|Overall Study||0
201191|NCT00794508|482499|P1|COMPLETED|Overall Study||10
201192|NCT00794508|482499|P1|STARTED|Overall Study||10
201193|NCT00794469|482505|P1|NOT COMPLETED|Overall Study||0
201194|NCT00794469|482505|P1|COMPLETED|Overall Study||21
201195|NCT00794469|482505|P1|STARTED|Overall Study||21
201196|NCT00794365|482510|P1|NOT COMPLETED|Overall Study||79
201197|NCT00794365|482510|P1|COMPLETED|Overall Study||251
201198|NCT00794365|482510|P1|STARTED|Overall Study||330
201199|NCT00794313|482516|P3|NOT COMPLETED|Overall Study||0
201200|NCT00794313|482517|P2|NOT COMPLETED|Overall Study||0
201201|NCT00794313|482518|P1|NOT COMPLETED|Overall Study||0
201202|NCT00794313|482516|P3|COMPLETED|Overall Study||1
201203|NCT00794313|482517|P2|COMPLETED|Overall Study||1
201204|NCT00794313|482518|P1|COMPLETED|Overall Study||1
201205|NCT00794313|482516|P3|STARTED|Overall Study||1
201206|NCT00794313|482517|P2|STARTED|Overall Study||1
201207|NCT00794313|482518|P1|STARTED|Overall Study||1
201208|NCT00794196|482531|P2|NOT COMPLETED|Overall Study||23
201209|NCT00794196|482532|P1|NOT COMPLETED|Overall Study||5
201210|NCT00794196|482531|P2|COMPLETED|Overall Study||64
201211|NCT00794196|482532|P1|COMPLETED|Overall Study||87
201212|NCT00794196|482531|P2|STARTED|Overall Study||87
201213|NCT00794196|482532|P1|STARTED|Overall Study||92
201214|NCT00794170|482542|P2|NOT COMPLETED|Overall Study||3
201215|NCT00794170|482543|P1|NOT COMPLETED|Overall Study||7
201216|NCT00794170|482542|P2|COMPLETED|Overall Study||152
201217|NCT00794170|482543|P1|COMPLETED|Overall Study||150
201218|NCT00794170|482542|P2|STARTED|Overall Study||155
201219|NCT00794170|482543|P1|STARTED|Overall Study||157
201220|NCT00794157|482552|P3|NOT COMPLETED|Overall Study||19
201221|NCT00794157|482553|P2|NOT COMPLETED|Overall Study||10
201222|NCT00794157|482554|P1|NOT COMPLETED|Overall Study||10
201223|NCT00794157|482552|P3|COMPLETED|Overall Study||98
201224|NCT00794157|482553|P2|COMPLETED|Overall Study||106
201225|NCT00794157|482554|P1|COMPLETED|Overall Study||104
201226|NCT00794157|482552|P3|STARTED|Overall Study||117
201227|NCT00794157|482553|P2|STARTED|Overall Study||116
201228|NCT00794157|482554|P1|STARTED|Overall Study||114
201229|NCT00794144|482576|P2|NOT COMPLETED|Overall Study||3
201230|NCT00794144|482577|P1|NOT COMPLETED|Overall Study||3
201231|NCT00794144|482576|P2|COMPLETED|Overall Study||63
201232|NCT00794144|482577|P1|COMPLETED|Overall Study||63
201233|NCT00794144|482576|P2|STARTED|Overall Study||66
201234|NCT00794144|482577|P1|STARTED|Overall Study||66
201235|NCT00794118|482583|P1|NOT COMPLETED|Overall Study||27
201236|NCT00794118|482583|P1|COMPLETED|Overall Study||272
201237|NCT00794118|482583|P1|STARTED|Overall Study||299
201238|NCT00793910|482641|P2|NOT COMPLETED|Overall Study||7
201239|NCT00793910|482642|P1|NOT COMPLETED|Overall Study||5
201240|NCT00793910|482641|P2|COMPLETED|Overall Study||46
201241|NCT00793910|482642|P1|COMPLETED|Overall Study||48
201242|NCT00793910|482641|P2|STARTED|Overall Study||53
201243|NCT00793910|482642|P1|STARTED|Overall Study||53
201244|NCT00793871|482656|P1|NOT COMPLETED|Overall Study||60
201245|NCT00793871|482656|P1|COMPLETED|Overall Study||0
201246|NCT00793871|482656|P1|Received Treatment|Overall Study||59
201247|NCT00793871|482656|P1|STARTED|Overall Study||60
201248|NCT00793819|482670|P2|NOT COMPLETED|Overall Study||9
201249|NCT00793819|482671|P1|NOT COMPLETED|Overall Study||14
201250|NCT00793819|482670|P2|COMPLETED|Overall Study||89
201251|NCT00793819|482671|P1|COMPLETED|Overall Study||97
201252|NCT00793819|482670|P2|STARTED|Overall Study||98
201253|NCT00793819|482671|P1|STARTED|Overall Study||111
201254|NCT00793793|482689|P12|NOT COMPLETED|Overall Study||6
201255|NCT00793793|482690|P11|NOT COMPLETED|Overall Study||3
201256|NCT00793793|482691|P10|NOT COMPLETED|Overall Study||9
201257|NCT00793793|482692|P9|NOT COMPLETED|Overall Study||9
201258|NCT00793793|482693|P8|NOT COMPLETED|Overall Study||0
201259|NCT00793793|482694|P7|NOT COMPLETED|Overall Study||4
201260|NCT00793793|482695|P6|NOT COMPLETED|Overall Study||2
201261|NCT00793793|482696|P5|NOT COMPLETED|Overall Study||2
201262|NCT00793793|482697|P4|NOT COMPLETED|Overall Study||3
201263|NCT00793793|482698|P3|NOT COMPLETED|Overall Study||2
201264|NCT00793793|482699|P2|NOT COMPLETED|Overall Study||1
201265|NCT00793793|482700|P1|NOT COMPLETED|Overall Study||0
201266|NCT00793793|482689|P12|COMPLETED|Overall Study||1
201267|NCT00793793|482690|P11|COMPLETED|Overall Study||3
201268|NCT00793793|482691|P10|COMPLETED|Overall Study||6
201269|NCT00793793|482692|P9|COMPLETED|Overall Study||6
201270|NCT00793793|482693|P8|COMPLETED|Overall Study||6
201271|NCT00793793|482694|P7|COMPLETED|Overall Study||3
201272|NCT00793793|482695|P6|COMPLETED|Overall Study||4
201273|NCT00793793|482696|P5|COMPLETED|Overall Study||4
201274|NCT00793793|482697|P4|COMPLETED|Overall Study||4
201275|NCT00793793|482698|P3|COMPLETED|Overall Study||5
201276|NCT00793793|482699|P2|COMPLETED|Overall Study||5
201277|NCT00793793|482700|P1|COMPLETED|Overall Study||8
201278|NCT00793793|482689|P12|STARTED|Overall Study||7
201279|NCT00793793|482690|P11|STARTED|Overall Study||6
201280|NCT00793793|482691|P10|STARTED|Overall Study||15
201281|NCT00793793|482692|P9|STARTED|Overall Study||15
201282|NCT00793793|482693|P8|STARTED|Overall Study||6
201283|NCT00793793|482694|P7|STARTED|Overall Study||7
201284|NCT00793793|482695|P6|STARTED|Overall Study||6
201285|NCT00793793|482696|P5|STARTED|Overall Study||6
201286|NCT00793793|482697|P4|STARTED|Overall Study||7
201287|NCT00793793|482698|P3|STARTED|Overall Study||7
201288|NCT00793793|482699|P2|STARTED|Overall Study||6
201289|NCT00793793|482700|P1|STARTED|Overall Study||8
201290|NCT00793780|483075|P2|NOT COMPLETED|Overall Study||1
201291|NCT00793780|483076|P1|NOT COMPLETED|Overall Study||2
201292|NCT00793780|483075|P2|COMPLETED|Overall Study||11
201293|NCT00793780|483076|P1|COMPLETED|Overall Study||10
201294|NCT00793780|483075|P2|Collected Baseline Data|Overall Study||12
201295|NCT00793780|483076|P1|Collected Baseline Data|Overall Study||11
201296|NCT00793780|483075|P2|Randomization|Overall Study||12
201297|NCT00793780|483076|P1|Randomization|Overall Study||12
201298|NCT00793780|483075|P2|STARTED|Overall Study||12
201299|NCT00793780|483076|P1|STARTED|Overall Study||12
201300|NCT00793650|483094|P2|NOT COMPLETED|Overall Study||0
201301|NCT00793650|483095|P1|NOT COMPLETED|Overall Study||0
201302|NCT00793650|483094|P2|COMPLETED|Overall Study||20
201303|NCT00793650|483095|P1|COMPLETED|Overall Study||19
201304|NCT00793650|483094|P2|STARTED|Overall Study||20
201305|NCT00793650|483095|P1|STARTED|Overall Study||19
201306|NCT00793624|483107|P4|NOT COMPLETED|Overall Study||43
201307|NCT00793624|483108|P3|NOT COMPLETED|Overall Study||39
201308|NCT00793624|483109|P2|NOT COMPLETED|Overall Study||36
201309|NCT00793624|483110|P1|NOT COMPLETED|Overall Study||57
201310|NCT00793624|483107|P4|COMPLETED|Overall Study||184
201311|NCT00793624|483108|P3|COMPLETED|Overall Study||186
201312|NCT00793624|483109|P2|COMPLETED|Overall Study||191
201313|NCT00793624|483110|P1|COMPLETED|Overall Study||168
201314|NCT00793624|483107|P4|STARTED|Overall Study||227
201315|NCT00793624|483108|P3|STARTED|Overall Study||225
201316|NCT00793624|483109|P2|STARTED|Overall Study||227
201317|NCT00793624|483110|P1|STARTED|Overall Study||225
201318|NCT00793611|483378|P2|NOT COMPLETED|Overall Study||0
201319|NCT00793611|483379|P1|NOT COMPLETED|Overall Study||0
201320|NCT00793611|483378|P2|COMPLETED|Overall Study||10
201321|NCT00793611|483379|P1|COMPLETED|Overall Study||10
201322|NCT00793611|483378|P2|STARTED|Overall Study||10
201323|NCT00793611|483379|P1|STARTED|Overall Study||10
201324|NCT00793585|483391|P2|NOT COMPLETED|Overall Study||3
201325|NCT00793585|483392|P1|NOT COMPLETED|Overall Study||2
201326|NCT00793585|483391|P2|COMPLETED|Overall Study||18
201327|NCT00793585|483392|P1|COMPLETED|Overall Study||17
201328|NCT00793585|483391|P2|STARTED|Overall Study||21
201329|NCT00793585|483392|P1|STARTED|Overall Study||19
201330|NCT00793572|483400|P1|NOT COMPLETED|Overall Study||0
201331|NCT00793572|483400|P1|COMPLETED|Overall Study||32
201332|NCT00793572|483400|P1|STARTED|Overall Study||32
201333|NCT00793546|483411|P2|NOT COMPLETED|Overall Study||28
201334|NCT00793546|483412|P1|NOT COMPLETED|Overall Study||14
201335|NCT00793546|483411|P2|COMPLETED|Overall Study||0
201336|NCT00793546|483412|P1|COMPLETED|Overall Study||0
201337|NCT00793546|483411|P2|STARTED|Overall Study||28
201338|NCT00793546|483412|P1|STARTED|Overall Study||14
201339|NCT00793520|483442|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
201340|NCT00793520|483443|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
201341|NCT00793520|483442|P2|COMPLETED|Placebo Crossover to Milnacipran||0
201342|NCT00793520|483443|P1|COMPLETED|Placebo Crossover to Milnacipran||0
201343|NCT00793520|483442|P2|STARTED|Placebo Crossover to Milnacipran||1
201344|NCT00793520|483443|P1|STARTED|Placebo Crossover to Milnacipran||0
201345|NCT00793520|483442|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
201346|NCT00793520|483443|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
201347|NCT00793520|483442|P2|COMPLETED|Milnacipran Crossover to Placebo||0
201348|NCT00793520|483443|P1|COMPLETED|Milnacipran Crossover to Placebo||0
201349|NCT00793520|483442|P2|STARTED|Milnacipran Crossover to Placebo||0
201350|NCT00793520|483443|P1|STARTED|Milnacipran Crossover to Placebo||1
201351|NCT00793455|483453|P2|NOT COMPLETED|Overall Study||0
201352|NCT00793455|483454|P1|NOT COMPLETED|Overall Study||0
201353|NCT00793455|483453|P2|COMPLETED|Overall Study||314
201354|NCT00793455|483454|P1|COMPLETED|Overall Study||314
201355|NCT00793455|483453|P2|STARTED|Overall Study||314
201356|NCT00793455|483454|P1|STARTED|Overall Study||314
201357|NCT00793403|483462|P1|NOT COMPLETED|Overall Study||73
201358|NCT00793403|483462|P1|COMPLETED|Overall Study||220
201359|NCT00793403|483462|P1|STARTED|Overall Study||293
201360|NCT00793325|483509|P1|NOT COMPLETED|Overall Study||19
201361|NCT00793325|483509|P1|COMPLETED|Overall Study||890
201362|NCT00793325|483509|P1|STARTED|Overall Study||909
201363|NCT00793182|483533|P1|NOT COMPLETED|Overall Study||1
201364|NCT00793182|483533|P1|COMPLETED|Overall Study||5
201365|NCT00793182|483533|P1|STARTED|Overall Study||6
201366|NCT00793169|483537|P1|NOT COMPLETED|Overall Study||0
201367|NCT00793169|483537|P1|COMPLETED|Overall Study||19
201368|NCT00793169|483537|P1|STARTED|Overall Study||19
201369|NCT00793104|483541|P1|NOT COMPLETED|Overall Study||1
201370|NCT00793104|483541|P1|COMPLETED|Overall Study||9
201371|NCT00793104|483541|P1|STARTED|Overall Study||10
201372|NCT00792948|483549|P1|NOT COMPLETED|Overall Study||28
201373|NCT00792948|483549|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
201374|NCT00792948|483549|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
201375|NCT00792935|483560|P2|NOT COMPLETED|Overall Study||3
201376|NCT00792935|483561|P1|NOT COMPLETED|Overall Study||4
201377|NCT00792935|483560|P2|COMPLETED|Overall Study||68
201378|NCT00792935|483561|P1|COMPLETED|Overall Study||68
201379|NCT00792935|483560|P2|STARTED|Overall Study||71
201380|NCT00792935|483561|P1|STARTED|Overall Study||72
201381|NCT00792922|483573|P4|NOT COMPLETED|At 3 Years||0
201382|NCT00792922|483574|P3|NOT COMPLETED|At 3 Years||0
201383|NCT00792922|483575|P2|NOT COMPLETED|At 3 Years||0
201384|NCT00792922|483576|P1|NOT COMPLETED|At 3 Years||0
201385|NCT00792922|483573|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201386|NCT00792922|483574|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201387|NCT00792922|483575|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201388|NCT00792922|483576|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201389|NCT00792922|483573|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201390|NCT00792922|483574|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201391|NCT00792922|483575|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201392|NCT00792922|483576|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201393|NCT00792922|483573|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201394|NCT00792922|483574|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201395|NCT00792922|483575|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201396|NCT00792922|483576|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201397|NCT00792922|483573|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201398|NCT00792922|483574|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201399|NCT00792922|483575|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201400|NCT00792922|483576|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
201401|NCT00792922|483573|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
201402|NCT00792922|483574|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
201403|NCT00792922|483575|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
201404|NCT00792922|483576|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
201405|NCT00792922|483573|P4|NOT COMPLETED|At Baseline||0
201406|NCT00792922|483574|P3|NOT COMPLETED|At Baseline||0
201407|NCT00792922|483575|P2|NOT COMPLETED|At Baseline||0
201408|NCT00792922|483576|P1|NOT COMPLETED|At Baseline||0
201409|NCT00792922|483573|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201410|NCT00792922|483574|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201411|NCT00792922|483575|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201412|NCT00792922|483576|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201413|NCT00792922|483573|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
201414|NCT00792922|483574|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
201415|NCT00792922|483575|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
201416|NCT00792922|483576|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
201417|NCT00792922|483573|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
201418|NCT00792922|483574|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
201419|NCT00792922|483575|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
201420|NCT00792922|483576|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
201421|NCT00792922|483573|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
201422|NCT00792922|483574|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
201423|NCT00792922|483575|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
201424|NCT00792922|483576|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
201425|NCT00792922|483573|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201426|NCT00792922|483574|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201427|NCT00792922|483575|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201428|NCT00792922|483576|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
201429|NCT00792909|483593|P3|NOT COMPLETED|Overall Study||0
201430|NCT00792909|483594|P2|NOT COMPLETED|Overall Study||1
201431|NCT00792909|483595|P1|NOT COMPLETED|Overall Study||0
201432|NCT00792909|483593|P3|COMPLETED|Overall Study||62
201433|NCT00792909|483594|P2|COMPLETED|Overall Study||58
201434|NCT00792909|483595|P1|COMPLETED|Overall Study||51
201435|NCT00792909|483593|P3|STARTED|Overall Study||62
201436|NCT00792909|483594|P2|STARTED|Overall Study||59
201437|NCT00792909|483595|P1|STARTED|Overall Study||51
201438|NCT00792805|483651|P3|NOT COMPLETED|Overall Study||33
201439|NCT00792805|483652|P2|NOT COMPLETED|Overall Study||26
201440|NCT00792805|483653|P1|NOT COMPLETED|Overall Study||22
201441|NCT00792805|483651|P3|COMPLETED|Overall Study||154
201442|NCT00792805|483652|P2|COMPLETED|Overall Study||162
201443|NCT00792805|483653|P1|COMPLETED|Overall Study||166
201444|NCT00792805|483651|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
201445|NCT00792805|483652|P2|Exposed to Study Medication or Placebo|Overall Study||188
201446|NCT00792805|483653|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
201447|NCT00792805|483651|P3|STARTED|Overall Study||187
201448|NCT00792805|483652|P2|STARTED|Overall Study||188
201449|NCT00792805|483653|P1|STARTED|Overall Study||188
201450|NCT00792701|483663|P2|NOT COMPLETED|Overall Study||44
201451|NCT00792701|483664|P1|NOT COMPLETED|Overall Study||19
201452|NCT00792701|483663|P2|COMPLETED|Overall Study||22
201453|NCT00792701|483664|P1|COMPLETED|Overall Study||0
201454|NCT00792701|483663|P2|Eligible and Analyzable|Overall Study||44
201455|NCT00792701|483664|P1|Eligible and Analyzable|Overall Study||17
201456|NCT00792701|483663|P2|Eligible|Overall Study||63
201457|NCT00792701|483664|P1|Eligible|Overall Study||18
201458|NCT00792701|483663|P2|STARTED|Overall Study||66
201459|NCT00792701|483664|P1|STARTED|Overall Study||19
201460|NCT00792688|483678|P3|NOT COMPLETED|Overall Study||0
201461|NCT00792688|483679|P2|NOT COMPLETED|Overall Study||0
201462|NCT00792688|483680|P1|NOT COMPLETED|Overall Study||0
201463|NCT00792688|483678|P3|COMPLETED|Overall Study||9
201464|NCT00792688|483679|P2|COMPLETED|Overall Study||8
201465|NCT00792688|483680|P1|COMPLETED|Overall Study||9
201466|NCT00792688|483678|P3|STARTED|Overall Study||9
201467|NCT00792688|483679|P2|STARTED|Overall Study||8
201468|NCT00792688|483680|P1|STARTED|Overall Study||9
201469|NCT00792636|483694|P3|NOT COMPLETED|Overall Study||81
201470|NCT00792636|483695|P2|NOT COMPLETED|Overall Study||81
201471|NCT00792636|483696|P1|NOT COMPLETED|Overall Study||68
201472|NCT00792636|483694|P3|COMPLETED|Overall Study||55
201473|NCT00792636|483695|P2|COMPLETED|Overall Study||55
201474|NCT00792636|483696|P1|COMPLETED|Overall Study||67
201475|NCT00792636|483694|P3|STARTED|Overall Study||136
201476|NCT00792636|483695|P2|STARTED|Overall Study||136
201477|NCT00792636|483696|P1|STARTED|Overall Study||135
201478|NCT00792623|483733|P1|NOT COMPLETED|Overall Study||7
201479|NCT00792623|483733|P1|COMPLETED|Overall Study||22
201480|NCT00792623|483733|P1|STARTED|Overall Study||29
201481|NCT00792610|483746|P1|NOT COMPLETED|Overall Study||0
201482|NCT00792610|483746|P1|COMPLETED|Overall Study||127
201483|NCT00792610|483746|P1|Youths|Overall Study||127
201484|NCT00792610|483746|P1|STARTED|Overall Study||127
201485|NCT00792428|483752|P2|NOT COMPLETED|Overall Study||0
201486|NCT00792428|483753|P1|NOT COMPLETED|Overall Study||0
201487|NCT00792428|483752|P2|COMPLETED|Overall Study||10
201488|NCT00792428|483753|P1|COMPLETED|Overall Study||10
201489|NCT00792428|483752|P2|STARTED|Overall Study||10
201490|NCT00792428|483753|P1|STARTED|Overall Study||10
201491|NCT00792298|483761|P8|NOT COMPLETED|Treatment Period 2||2
201492|NCT00792298|483762|P7|NOT COMPLETED|Treatment Period 2||1
201493|NCT00792298|483763|P6|NOT COMPLETED|Treatment Period 2||0
201494|NCT00792298|483764|P5|NOT COMPLETED|Treatment Period 2||2
201495|NCT00792298|483765|P4|NOT COMPLETED|Treatment Period 2||2
201496|NCT00792298|483766|P3|NOT COMPLETED|Treatment Period 2||1
201497|NCT00792298|483767|P2|NOT COMPLETED|Treatment Period 2||1
201498|NCT00792298|483768|P1|NOT COMPLETED|Treatment Period 2||1
201499|NCT00792298|483761|P8|COMPLETED|Treatment Period 2||28
201500|NCT00792298|483762|P7|COMPLETED|Treatment Period 2||28
201501|NCT00792298|483763|P6|COMPLETED|Treatment Period 2||27
201502|NCT00792298|483764|P5|COMPLETED|Treatment Period 2||30
201503|NCT00792298|483765|P4|COMPLETED|Treatment Period 2||26
201504|NCT00792298|483766|P3|COMPLETED|Treatment Period 2||30
201505|NCT00792298|483767|P2|COMPLETED|Treatment Period 2||30
201506|NCT00792298|483768|P1|COMPLETED|Treatment Period 2||29
201507|NCT00792298|483761|P8|STARTED|Treatment Period 2||30
201508|NCT00792298|483762|P7|STARTED|Treatment Period 2||29
201509|NCT00792298|483763|P6|STARTED|Treatment Period 2||27
201510|NCT00792298|483764|P5|STARTED|Treatment Period 2||32
201511|NCT00792298|483765|P4|STARTED|Treatment Period 2||28
201512|NCT00792298|483766|P3|STARTED|Treatment Period 2||31
201513|NCT00792298|483767|P2|STARTED|Treatment Period 2||31
201514|NCT00792298|483768|P1|STARTED|Treatment Period 2||30
201515|NCT00792298|483761|P8|NOT COMPLETED|Washout||0
201516|NCT00792298|483762|P7|NOT COMPLETED|Washout||0
201517|NCT00792298|483763|P6|NOT COMPLETED|Washout||2
201518|NCT00792298|483764|P5|NOT COMPLETED|Washout||0
201519|NCT00792298|483765|P4|NOT COMPLETED|Washout||0
201520|NCT00792298|483766|P3|NOT COMPLETED|Washout||1
201521|NCT00792298|483767|P2|NOT COMPLETED|Washout||0
201522|NCT00792298|483768|P1|NOT COMPLETED|Washout||0
201523|NCT00792298|483761|P8|COMPLETED|Washout||30
201524|NCT00792298|483762|P7|COMPLETED|Washout||29
201525|NCT00792298|483763|P6|COMPLETED|Washout||27
201526|NCT00792298|483764|P5|COMPLETED|Washout||32
201527|NCT00792298|483765|P4|COMPLETED|Washout||28
201528|NCT00792298|483766|P3|COMPLETED|Washout||31
201529|NCT00792298|483767|P2|COMPLETED|Washout||31
201530|NCT00792298|483768|P1|COMPLETED|Washout||30
201531|NCT00792298|483761|P8|STARTED|Washout||30
201532|NCT00792298|483762|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
201533|NCT00792298|483763|P6|STARTED|Washout||29
201534|NCT00792298|483764|P5|STARTED|Washout||32
201535|NCT00792298|483765|P4|STARTED|Washout||28
201536|NCT00792298|483766|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
201537|NCT00792298|483767|P2|STARTED|Washout||31
201538|NCT00792298|483768|P1|STARTED|Washout||30
201539|NCT00792298|483761|P8|NOT COMPLETED|Treatment Period 1||1
201540|NCT00792298|483762|P7|NOT COMPLETED|Treatment Period 1||4
201541|NCT00792298|483763|P6|NOT COMPLETED|Treatment Period 1||3
201542|NCT00792298|483764|P5|NOT COMPLETED|Treatment Period 1||0
201543|NCT00792298|483765|P4|NOT COMPLETED|Treatment Period 1||4
201544|NCT00792298|483766|P3|NOT COMPLETED|Treatment Period 1||2
201545|NCT00792298|483767|P2|NOT COMPLETED|Treatment Period 1||1
201546|NCT00792298|483768|P1|NOT COMPLETED|Treatment Period 1||1
201547|NCT00792298|483761|P8|COMPLETED|Treatment Period 1||30
201548|NCT00792298|483762|P7|COMPLETED|Treatment Period 1||27
201549|NCT00792298|483763|P6|COMPLETED|Treatment Period 1||29
201550|NCT00792298|483764|P5|COMPLETED|Treatment Period 1||32
201551|NCT00792298|483765|P4|COMPLETED|Treatment Period 1||28
201552|NCT00792298|483766|P3|COMPLETED|Treatment Period 1||31
201553|NCT00792298|483767|P2|COMPLETED|Treatment Period 1||31
201554|NCT00792298|483768|P1|COMPLETED|Treatment Period 1||30
201555|NCT00792298|483761|P8|STARTED|Treatment Period 1||31
201556|NCT00792298|483762|P7|STARTED|Treatment Period 1||31
201557|NCT00792298|483763|P6|STARTED|Treatment Period 1||32
201558|NCT00792298|483764|P5|STARTED|Treatment Period 1||32
201559|NCT00792298|483765|P4|STARTED|Treatment Period 1||32
201560|NCT00792298|483766|P3|STARTED|Treatment Period 1||33
201561|NCT00792298|483767|P2|STARTED|Treatment Period 1||32
201562|NCT00792298|483768|P1|STARTED|Treatment Period 1||31
201563|NCT00792259|483798|P3|NOT COMPLETED|Overall Study||0
201564|NCT00792259|483799|P2|NOT COMPLETED|Overall Study||0
201565|NCT00792259|483800|P1|NOT COMPLETED|Overall Study||1
201566|NCT00792259|483798|P3|COMPLETED|Overall Study||13
201567|NCT00792259|483799|P2|COMPLETED|Overall Study||20
201568|NCT00792259|483800|P1|COMPLETED|Overall Study||14
201569|NCT00792259|483798|P3|STARTED|Overall Study||13
201570|NCT00792259|483799|P2|STARTED|Overall Study||20
201571|NCT00792259|483800|P1|STARTED|Overall Study||15
201572|NCT00792116|483810|P2|NOT COMPLETED|Overall Study||1
201573|NCT00792116|483811|P1|NOT COMPLETED|Overall Study||1
201574|NCT00792116|483810|P2|COMPLETED|Overall Study||54
201575|NCT00792116|483811|P1|COMPLETED|Overall Study||52
201576|NCT00792116|483810|P2|STARTED|Overall Study||55
201577|NCT00792116|483811|P1|STARTED|Overall Study||53
201578|NCT00792103|483821|P1|NOT COMPLETED|Overall Study||133
201579|NCT00792103|483821|P1|COMPLETED|Overall Study||65
201580|NCT00792103|483821|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
201581|NCT00791999|483833|P4|NOT COMPLETED|Overall Study||52
201582|NCT00791999|483834|P3|NOT COMPLETED|Overall Study||20
201583|NCT00791999|483835|P2|NOT COMPLETED|Overall Study||16
201584|NCT00791999|483836|P1|NOT COMPLETED|Overall Study||21
201585|NCT00791999|483833|P4|COMPLETED|Overall Study||25
201586|NCT00791999|483834|P3|COMPLETED|Overall Study||65
201587|NCT00791999|483835|P2|COMPLETED|Overall Study||66
201588|NCT00791999|483836|P1|COMPLETED|Overall Study||51
201589|NCT00791999|483833|P4|STARTED|Overall Study||77
201590|NCT00791999|483834|P3|STARTED|Overall Study||85
201591|NCT00791999|483835|P2|STARTED|Overall Study||82
201592|NCT00791999|483836|P1|STARTED|Overall Study||72
201593|NCT00791973|483852|P2|NOT COMPLETED|Second Intervention (1 Week)||0
201594|NCT00791973|483853|P1|NOT COMPLETED|Second Intervention (1 Week)||0
201595|NCT00791973|483852|P2|COMPLETED|Second Intervention (1 Week)||7
201596|NCT00791973|483853|P1|COMPLETED|Second Intervention (1 Week)||8
201597|NCT00791973|483852|P2|STARTED|Second Intervention (1 Week)||7
201598|NCT00791973|483853|P1|STARTED|Second Intervention (1 Week)||8
201599|NCT00791973|483852|P2|NOT COMPLETED|Washout (1 Week)||0
201600|NCT00791973|483853|P1|NOT COMPLETED|Washout (1 Week)||0
201601|NCT00791973|483852|P2|COMPLETED|Washout (1 Week)||7
201602|NCT00791973|483853|P1|COMPLETED|Washout (1 Week)||8
201603|NCT00791973|483852|P2|STARTED|Washout (1 Week)||7
201604|NCT00791973|483853|P1|STARTED|Washout (1 Week)||8
201605|NCT00791973|483852|P2|NOT COMPLETED|First Intervention (1 Week)||0
201606|NCT00791973|483853|P1|NOT COMPLETED|First Intervention (1 Week)||0
201607|NCT00791973|483852|P2|COMPLETED|First Intervention (1 Week)||7
201608|NCT00791973|483853|P1|COMPLETED|First Intervention (1 Week)||8
201609|NCT00791973|483852|P2|STARTED|First Intervention (1 Week)||7
201610|NCT00791973|483853|P1|STARTED|First Intervention (1 Week)||8
201611|NCT00791934|483861|P1|NOT COMPLETED|Overall Study||15
201612|NCT00791934|483861|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
201613|NCT00791934|483861|P1|STARTED|Overall Study||63
201614|NCT00791921|483871|P2|NOT COMPLETED|Overall Study||96
201615|NCT00791921|483872|P1|NOT COMPLETED|Overall Study||34
201616|NCT00791921|483871|P2|COMPLETED|Overall Study||18
201617|NCT00791921|483872|P1|COMPLETED|Overall Study||82
201618|NCT00791921|483871|P2|STARTED|Overall Study||114
201619|NCT00791921|483872|P1|STARTED|Overall Study||116
201620|NCT00791908|483880|P1|NOT COMPLETED|Overall Study||0
201621|NCT00791908|483880|P1|COMPLETED|Overall Study||15
201622|NCT00791908|483880|P1|STARTED|Overall Study||15
201623|NCT00791817|483890|P2|NOT COMPLETED|2: Single Dose||0
201624|NCT00791817|483891|P1|NOT COMPLETED|2: Single Dose||0
201625|NCT00791817|483890|P2|COMPLETED|2: Single Dose||5
201626|NCT00791817|483891|P1|COMPLETED|2: Single Dose||5
201627|NCT00791817|483890|P2|STARTED|2: Single Dose||5
201628|NCT00791817|483891|P1|STARTED|2: Single Dose||5
201629|NCT00791817|483890|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
201630|NCT00791817|483891|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
201631|NCT00791817|483890|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
201632|NCT00791817|483891|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
201633|NCT00791817|483890|P2|STARTED|1: Single Dose Followed by Week Washout||5
201634|NCT00791817|483891|P1|STARTED|1: Single Dose Followed by Week Washout||5
201635|NCT00791778|483899|P2|NOT COMPLETED|Follow-up||1
201636|NCT00791778|483900|P1|NOT COMPLETED|Follow-up||5
201637|NCT00791778|483899|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
201638|NCT00791778|483900|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
201639|NCT00791778|483899|P2|STARTED|Follow-up||91
201640|NCT00791778|483900|P1|STARTED|Follow-up||100
201641|NCT00791778|483899|P2|NOT COMPLETED|Double-blind Treatment||48
201642|NCT00791778|483900|P1|NOT COMPLETED|Double-blind Treatment||77
201643|NCT00791778|483899|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
201644|NCT00791778|483900|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
201645|NCT00791778|483899|P2|STARTED|Double-blind Treatment||123
201646|NCT00791778|483900|P1|STARTED|Double-blind Treatment||123
201647|NCT00791765|483954|P2|NOT COMPLETED|Weeks 13 to 24||8
201648|NCT00791765|483955|P1|NOT COMPLETED|Weeks 13 to 24||5
201649|NCT00791765|483954|P2|COMPLETED|Weeks 13 to 24||49
201650|NCT00791765|483955|P1|COMPLETED|Weeks 13 to 24||49
201651|NCT00791765|483954|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
201652|NCT00791765|483955|P1|STARTED|Weeks 13 to 24||54
201653|NCT00791765|483954|P2|NOT COMPLETED|Weeks 1 to 12||4
201654|NCT00791765|483955|P1|NOT COMPLETED|Weeks 1 to 12||8
201655|NCT00791765|483954|P2|COMPLETED|Weeks 1 to 12||58
201656|NCT00791765|483955|P1|COMPLETED|Weeks 1 to 12||54
201657|NCT00791765|483954|P2|Treated|Weeks 1 to 12||59
201658|NCT00791765|483955|P1|Treated|Weeks 1 to 12||62
201659|NCT00791765|483954|P2|STARTED|Weeks 1 to 12||62
201660|NCT00791765|483955|P1|STARTED|Weeks 1 to 12||62
201661|NCT00791700|483970|P4|NOT COMPLETED|Overall Study||18
201662|NCT00791700|483971|P3|NOT COMPLETED|Overall Study||4
201663|NCT00791700|483972|P2|NOT COMPLETED|Overall Study||5
201664|NCT00791700|483973|P1|NOT COMPLETED|Overall Study||4
201665|NCT00791700|483970|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
201666|NCT00791700|483971|P3|COMPLETED|Overall Study||9
201667|NCT00791700|483972|P2|COMPLETED|Overall Study||26
201668|NCT00791700|483973|P1|COMPLETED|Overall Study||12
201669|NCT00791700|483970|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
201670|NCT00791700|483971|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
201671|NCT00791700|483972|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
201672|NCT00791700|483973|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
201673|NCT00791661|484061|P3|NOT COMPLETED|Period 3||0
201674|NCT00791661|484062|P2|NOT COMPLETED|Period 3||0
201675|NCT00791661|484063|P1|NOT COMPLETED|Period 3||0
201676|NCT00791661|484061|P3|COMPLETED|Period 3||6
201677|NCT00791661|484062|P2|COMPLETED|Period 3||8
201678|NCT00791661|484063|P1|COMPLETED|Period 3||8
201679|NCT00791661|484061|P3|Received Matching Placebo to MK-1006|Period 3||1
201680|NCT00791661|484062|P2|Received Matching Placebo to MK-1006|Period 3||2
201681|NCT00791661|484063|P1|Received Matching Placebo to MK-1006|Period 3||2
201682|NCT00791661|484061|P3|Received MK-1006|Period 3||5
201683|NCT00791661|484062|P2|Received MK-1006|Period 3||6
201684|NCT00791661|484063|P1|Received MK-1006|Period 3||6
201685|NCT00791661|484061|P3|STARTED|Period 3||6
201686|NCT00791661|484062|P2|STARTED|Period 3||8
201687|NCT00791661|484063|P1|STARTED|Period 3||8
201688|NCT00791661|484061|P3|NOT COMPLETED|7 Day Wash-out||0
201689|NCT00791661|484062|P2|NOT COMPLETED|7 Day Wash-out||0
201690|NCT00791661|484063|P1|NOT COMPLETED|7 Day Wash-out||0
201691|NCT00791661|484061|P3|COMPLETED|7 Day Wash-out||6
201692|NCT00791661|484062|P2|COMPLETED|7 Day Wash-out||8
201693|NCT00791661|484063|P1|COMPLETED|7 Day Wash-out||8
201694|NCT00791661|484061|P3|STARTED|7 Day Wash-out||6
201695|NCT00791661|484062|P2|STARTED|7 Day Wash-out||8
201696|NCT00791661|484063|P1|STARTED|7 Day Wash-out||8
201697|NCT00791661|484061|P3|NOT COMPLETED|Period 2||0
201698|NCT00791661|484062|P2|NOT COMPLETED|Period 2||0
201699|NCT00791661|484063|P1|NOT COMPLETED|Period 2||0
201700|NCT00791661|484061|P3|COMPLETED|Period 2||6
201701|NCT00791661|484062|P2|COMPLETED|Period 2||8
201702|NCT00791661|484063|P1|COMPLETED|Period 2||8
201703|NCT00791661|484061|P3|Received Matching Placebo to MK-1006|Period 2||2
201704|NCT00791661|484062|P2|Received Matching Placebo to MK-1006|Period 2||2
201705|NCT00791661|484063|P1|Received Matching Placebo to MK-1006|Period 2||2
201706|NCT00791661|484061|P3|Received MK-1006|Period 2||4
201707|NCT00791661|484062|P2|Received MK-1006|Period 2||6
201708|NCT00791661|484063|P1|Received MK-1006|Period 2||6
201709|NCT00791661|484061|P3|STARTED|Period 2||6
201710|NCT00791661|484062|P2|STARTED|Period 2||8
201711|NCT00791661|484063|P1|STARTED|Period 2||8
201712|NCT00791661|484061|P3|NOT COMPLETED|7 Day Wash-out||2
201713|NCT00791661|484062|P2|NOT COMPLETED|7 Day Wash-out||0
201714|NCT00791661|484063|P1|NOT COMPLETED|7 Day Wash-out||0
201715|NCT00791661|484061|P3|COMPLETED|7 Day Wash-out||6
201716|NCT00791661|484062|P2|COMPLETED|7 Day Wash-out||8
201717|NCT00791661|484063|P1|COMPLETED|7 Day Wash-out||8
201718|NCT00791661|484061|P3|STARTED|7 Day Wash-out||8
201719|NCT00791661|484062|P2|STARTED|7 Day Wash-out||8
201720|NCT00791661|484063|P1|STARTED|7 Day Wash-out||8
201721|NCT00791661|484061|P3|NOT COMPLETED|Period 1||0
201722|NCT00791661|484062|P2|NOT COMPLETED|Period 1||0
201723|NCT00791661|484063|P1|NOT COMPLETED|Period 1||0
201724|NCT00791661|484061|P3|COMPLETED|Period 1||8
201725|NCT00791661|484062|P2|COMPLETED|Period 1||8
201726|NCT00791661|484063|P1|COMPLETED|Period 1||8
201727|NCT00791661|484061|P3|Received Matching Placebo to MK-1006|Period 1||2
201728|NCT00791661|484062|P2|Received Matching Placebo to MK-1006|Period 1||2
201729|NCT00791661|484063|P1|Received Matching Placebo to MK-1006|Period 1||2
201730|NCT00791661|484061|P3|Received MK-1006|Period 1||6
201731|NCT00791661|484062|P2|Received MK-1006|Period 1||6
201732|NCT00791661|484063|P1|Received MK-1006|Period 1||6
201733|NCT00791661|484061|P3|STARTED|Period 1||8
201734|NCT00791661|484062|P2|STARTED|Period 1||8
201735|NCT00791661|484063|P1|STARTED|Period 1||8
201736|NCT00791648|484156|P2|NOT COMPLETED|Overall Study||2
201737|NCT00791648|484157|P1|NOT COMPLETED|Overall Study||0
201738|NCT00791648|484156|P2|COMPLETED|Overall Study||307
201739|NCT00791648|484157|P1|COMPLETED|Overall Study||308
201740|NCT00791648|484156|P2|STARTED|Overall Study||309
201741|NCT00791648|484157|P1|STARTED|Overall Study||308
201742|NCT00791557|484173|P1|NOT COMPLETED|Overall Study||1
201743|NCT00791557|484173|P1|COMPLETED|Overall Study||1
201744|NCT00791557|484173|P1|STARTED|Overall Study||2
201745|NCT00791518|484177|P1|NOT COMPLETED|Overall Study||93
201746|NCT00791518|484177|P1|COMPLETED|Overall Study||991
201747|NCT00791518|484177|P1|STARTED|Overall Study||1084
201748|NCT00791492|484205|P2|NOT COMPLETED|Overall Study||3
201749|NCT00791492|484206|P1|NOT COMPLETED|Overall Study||6
201750|NCT00791492|484205|P2|COMPLETED|Overall Study||38
201751|NCT00791492|484206|P1|COMPLETED|Overall Study||39
201752|NCT00791492|484205|P2|TREATED|Overall Study||41
201753|NCT00791492|484206|P1|TREATED|Overall Study||44
201754|NCT00791492|484205|P2|STARTED|Overall Study||41
201755|NCT00791492|484206|P1|STARTED|Overall Study||45
201756|NCT00791479|484254|P6|NOT COMPLETED|Overall Study||3
201757|NCT00791479|484255|P5|NOT COMPLETED|Overall Study||3
201758|NCT00791479|484256|P4|NOT COMPLETED|Overall Study||4
201759|NCT00791479|484257|P3|NOT COMPLETED|Overall Study||0
201760|NCT00791479|484258|P2|NOT COMPLETED|Overall Study||3
201761|NCT00791479|484259|P1|NOT COMPLETED|Overall Study||2
201762|NCT00791479|484254|P6|COMPLETED|Overall Study||29
201763|NCT00791479|484255|P5|COMPLETED|Overall Study||0
201764|NCT00791479|484256|P4|COMPLETED|Overall Study||25
201765|NCT00791479|484257|P3|COMPLETED|Overall Study||34
201766|NCT00791479|484258|P2|COMPLETED|Overall Study||31
201767|NCT00791479|484259|P1|COMPLETED|Overall Study||33
201768|NCT00791479|484254|P6|Received at Least One Dose of Study Drug|Overall Study||32
201769|NCT00791479|484255|P5|Received at Least One Dose of Study Drug|Overall Study||3
201770|NCT00791479|484256|P4|Received at Least One Dose of Study Drug|Overall Study||29
201771|NCT00791479|484257|P3|Received at Least One Dose of Study Drug|Overall Study||34
201772|NCT00791479|484258|P2|Received at Least One Dose of Study Drug|Overall Study||34
201773|NCT00791479|484259|P1|Received at Least One Dose of Study Drug|Overall Study||35
201774|NCT00791479|484254|P6|STARTED|Overall Study||32
201775|NCT00791479|484255|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
201776|NCT00791479|484256|P4|STARTED|Overall Study||29
201777|NCT00791479|484257|P3|STARTED|Overall Study||34
201778|NCT00791479|484258|P2|STARTED|Overall Study||34
201779|NCT00791479|484259|P1|STARTED|Overall Study||35
201780|NCT00791388|484358|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
201781|NCT00791388|484359|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
201782|NCT00791388|484360|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
201783|NCT00791388|484361|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
201784|NCT00791388|484362|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
201785|NCT00791388|484358|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
201786|NCT00791388|484359|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
201787|NCT00791388|484360|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
201788|NCT00791388|484361|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
201789|NCT00791388|484362|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
201790|NCT00791388|484358|P5|STARTED|Period 4 - 400 mg Dose Group||8
201791|NCT00791388|484359|P4|STARTED|Period 4 - 400 mg Dose Group||0
201792|NCT00791388|484360|P3|STARTED|Period 4 - 400 mg Dose Group||0
201793|NCT00791388|484361|P2|STARTED|Period 4 - 400 mg Dose Group||0
201794|NCT00791388|484362|P1|STARTED|Period 4 - 400 mg Dose Group||4
201795|NCT00791388|484358|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
201796|NCT00791388|484359|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
201797|NCT00791388|484360|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
201798|NCT00791388|484361|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
201799|NCT00791388|484362|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
201800|NCT00791388|484358|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
201801|NCT00791388|484359|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
201802|NCT00791388|484360|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
201803|NCT00791388|484361|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
201804|NCT00791388|484362|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
201805|NCT00791388|484358|P5|STARTED|Period 3 - 200 mg Dose Group||0
201806|NCT00791388|484359|P4|STARTED|Period 3 - 200 mg Dose Group||8
201807|NCT00791388|484360|P3|STARTED|Period 3 - 200 mg Dose Group||0
201808|NCT00791388|484361|P2|STARTED|Period 3 - 200 mg Dose Group||0
201809|NCT00791388|484362|P1|STARTED|Period 3 - 200 mg Dose Group||3
201810|NCT00791388|484358|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
201811|NCT00791388|484359|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
201812|NCT00791388|484360|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
201813|NCT00791388|484361|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
201814|NCT00791388|484362|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
201815|NCT00791388|484358|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
201816|NCT00791388|484359|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
201817|NCT00791388|484360|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
201818|NCT00791388|484361|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
201819|NCT00791388|484362|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
201820|NCT00791388|484358|P5|STARTED|Period 2 - 100 mg Dose Group||0
201821|NCT00791388|484359|P4|STARTED|Period 2 - 100 mg Dose Group||0
201822|NCT00791388|484360|P3|STARTED|Period 2 - 100 mg Dose Group||8
201823|NCT00791388|484361|P2|STARTED|Period 2 - 100 mg Dose Group||0
201824|NCT00791388|484362|P1|STARTED|Period 2 - 100 mg Dose Group||3
201825|NCT00791388|484358|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
201826|NCT00791388|484359|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
201827|NCT00791388|484360|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
201828|NCT00791388|484361|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
201829|NCT00791388|484362|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
201830|NCT00791388|484358|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
201831|NCT00791388|484359|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
201832|NCT00791388|484360|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
201833|NCT00791388|484361|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
201834|NCT00791388|484362|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
201835|NCT00791388|484358|P5|STARTED|Period 1 - 50 mg Dose Group||0
201836|NCT00791388|484359|P4|STARTED|Period 1 - 50 mg Dose Group||0
201837|NCT00791388|484360|P3|STARTED|Period 1 - 50 mg Dose Group||0
201838|NCT00791388|484361|P2|STARTED|Period 1 - 50 mg Dose Group||8
201839|NCT00791388|484362|P1|STARTED|Period 1 - 50 mg Dose Group||3
201840|NCT00791336|484389|P1|NOT COMPLETED|Overall Study||0
201841|NCT00791336|484389|P1|COMPLETED|Overall Study||1
201842|NCT00791336|484389|P1|STARTED|Overall Study||1
201843|NCT00791323|484397|P2|NOT COMPLETED|Overall Study||0
201844|NCT00791323|484398|P1|NOT COMPLETED|Overall Study||0
201845|NCT00791323|484397|P2|COMPLETED|Overall Study||3
201846|NCT00791323|484398|P1|COMPLETED|Overall Study||6
201847|NCT00791323|484397|P2|STARTED|Overall Study||3
201848|NCT00791323|484398|P1|STARTED|Overall Study||6
201849|NCT00791258|484404|P1|NOT COMPLETED|Overall Study||263
201850|NCT00791258|484404|P1|COMPLETED|Overall Study||736
201851|NCT00791258|484404|P1|STARTED|Overall Study||999
201852|NCT00791128|484466|P1|NOT COMPLETED|Overall Study||9
201853|NCT00791128|484466|P1|COMPLETED|Overall Study||13
201854|NCT00791128|484466|P1|STARTED|Overall Study||22
201855|NCT00791102|484471|P2|NOT COMPLETED|Period 2||0
201856|NCT00791102|484472|P1|NOT COMPLETED|Period 2||0
201857|NCT00791102|484471|P2|COMPLETED|Period 2||10
201858|NCT00791102|484472|P1|COMPLETED|Period 2||10
201859|NCT00791102|484471|P2|STARTED|Period 2||10
201860|NCT00791102|484472|P1|STARTED|Period 2||10
201861|NCT00791102|484471|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
201862|NCT00791102|484472|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
201863|NCT00791102|484471|P2|COMPLETED|Washout Period of 2 Weeks||10
201864|NCT00791102|484472|P1|COMPLETED|Washout Period of 2 Weeks||10
201865|NCT00791102|484471|P2|STARTED|Washout Period of 2 Weeks||10
201866|NCT00791102|484472|P1|STARTED|Washout Period of 2 Weeks||10
201867|NCT00791102|484471|P2|NOT COMPLETED|Period 1||0
201868|NCT00791102|484472|P1|NOT COMPLETED|Period 1||0
201869|NCT00791102|484471|P2|COMPLETED|Period 1||10
201870|NCT00791102|484472|P1|COMPLETED|Period 1||10
201871|NCT00791102|484471|P2|STARTED|Period 1||10
201872|NCT00791102|484472|P1|STARTED|Period 1||10
201873|NCT00791089|484490|P2|NOT COMPLETED|Overall Study||6
201874|NCT00791089|484491|P1|NOT COMPLETED|Overall Study||6
201875|NCT00791089|484490|P2|COMPLETED|Overall Study||0
201876|NCT00791089|484491|P1|COMPLETED|Overall Study||0
201877|NCT00791089|484490|P2|Six-month Data Collected|Overall Study||5
201878|NCT00791089|484491|P1|Six-month Data Collected|Overall Study||6
201879|NCT00791089|484490|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
201880|NCT00791089|484491|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
201881|NCT00791089|484490|P2|STARTED|Overall Study||6
201882|NCT00791089|484491|P1|STARTED|Overall Study||6
201883|NCT00791076|484497|P1|NOT COMPLETED|Overall Study||8
201884|NCT00791076|484497|P1|COMPLETED|Overall Study||0
201885|NCT00791076|484497|P1|STARTED|Overall Study||8
201886|NCT00791037|484505|P1|NOT COMPLETED|Overall Study||0
201887|NCT00791037|484505|P1|COMPLETED|Overall Study||23
201888|NCT00791037|484505|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
201889|NCT00791037|484505|P1|Primary Outcome|Overall Study||19
201890|NCT00791037|484505|P1|STARTED|Overall Study||23
201891|NCT00790907|484515|P3|NOT COMPLETED|Overall Study||339
201892|NCT00790907|484516|P2|NOT COMPLETED|Overall Study||340
201893|NCT00790907|484517|P1|NOT COMPLETED|Overall Study||455
201894|NCT00790907|484515|P3|COMPLETED|Overall Study||663
201895|NCT00790907|484516|P2|COMPLETED|Overall Study||684
201896|NCT00790907|484517|P1|COMPLETED|Overall Study||754
201897|NCT00790907|484515|P3|STARTED|Overall Study||1002
201898|NCT00790907|484516|P2|STARTED|Overall Study||1024
201899|NCT00790907|484517|P1|STARTED|Overall Study||1209
201900|NCT00790868|484540|P2|NOT COMPLETED|Overall Study||17
201901|NCT00790868|484541|P1|NOT COMPLETED|Overall Study||6
201902|NCT00790868|484540|P2|COMPLETED|Overall Study||75
201903|NCT00790868|484541|P1|COMPLETED|Overall Study||82
201904|NCT00790868|484540|P2|STARTED|Overall Study||92
201905|NCT00790868|484541|P1|STARTED|Overall Study||88
201906|NCT00790855|484555|P1|NOT COMPLETED|Overall Study||0
201907|NCT00790855|484555|P1|COMPLETED|Overall Study||25
201908|NCT00790855|484555|P1|STARTED|Overall Study||25
201909|NCT00790803|484560|P1|NOT COMPLETED|Overall Study||0
201910|NCT00790803|484560|P1|COMPLETED|Overall Study||5
201911|NCT00790803|484560|P1|STARTED|Overall Study||5
201912|NCT00790790|484571|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
201913|NCT00790790|484572|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
201914|NCT00790790|484573|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
201915|NCT00790790|484571|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
201916|NCT00790790|484572|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
201917|NCT00790790|484573|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
201918|NCT00790790|484571|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
201919|NCT00790790|484572|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
201920|NCT00790790|484573|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
201921|NCT00790790|484571|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
201922|NCT00790790|484572|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
201923|NCT00790790|484573|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
201924|NCT00790790|484571|P3|COMPLETED|Study Period 2: Therapy Phase||27
201925|NCT00790790|484572|P2|COMPLETED|Study Period 2: Therapy Phase||32
201926|NCT00790790|484573|P1|COMPLETED|Study Period 2: Therapy Phase||37
201927|NCT00790790|484571|P3|STARTED|Study Period 2: Therapy Phase||48
201928|NCT00790790|484572|P2|STARTED|Study Period 2: Therapy Phase||50
201929|NCT00790790|484573|P1|STARTED|Study Period 2: Therapy Phase||49
201930|NCT00790751|484650|P4|NOT COMPLETED|Overall Study||21
201931|NCT00790751|484651|P3|NOT COMPLETED|Overall Study||20
201932|NCT00790751|484652|P2|NOT COMPLETED|Overall Study||30
201933|NCT00790751|484653|P1|NOT COMPLETED|Overall Study||25
201934|NCT00790751|484650|P4|COMPLETED|Overall Study||141
201935|NCT00790751|484651|P3|COMPLETED|Overall Study||141
201936|NCT00790751|484652|P2|COMPLETED|Overall Study||131
201937|NCT00790751|484653|P1|COMPLETED|Overall Study||137
201938|NCT00790751|484650|P4|STARTED|Overall Study||162
201939|NCT00790751|484651|P3|STARTED|Overall Study||161
201940|NCT00790751|484652|P2|STARTED|Overall Study||161
201941|NCT00790751|484653|P1|STARTED|Overall Study||162
201942|NCT00790738|484673|P2|NOT COMPLETED|Overall Study||3
201943|NCT00790738|484674|P1|NOT COMPLETED|Overall Study||2
201944|NCT00790738|484673|P2|COMPLETED|Overall Study||3
201945|NCT00790738|484674|P1|COMPLETED|Overall Study||3
201946|NCT00790738|484673|P2|STARTED|Overall Study||6
201947|NCT00790738|484674|P1|STARTED|Overall Study||5
201948|NCT00790673|484688|P4|NOT COMPLETED|Overall Study||0
201949|NCT00790673|484689|P3|NOT COMPLETED|Overall Study||0
201950|NCT00790673|484690|P2|NOT COMPLETED|Overall Study||0
201951|NCT00790673|484691|P1|NOT COMPLETED|Overall Study||0
201952|NCT00790673|484688|P4|COMPLETED|Overall Study||8
201953|NCT00790673|484689|P3|COMPLETED|Overall Study||12
201954|NCT00790673|484690|P2|COMPLETED|Overall Study||6
201955|NCT00790673|484691|P1|COMPLETED|Overall Study||6
201956|NCT00790673|484688|P4|STARTED|Overall Study||8
201957|NCT00790673|484689|P3|STARTED|Overall Study||12
201958|NCT00790673|484690|P2|STARTED|Overall Study||6
201959|NCT00790673|484691|P1|STARTED|Overall Study||6
201960|NCT00790647|484701|P1|NOT COMPLETED|Overall Study||1
201961|NCT00790647|484701|P1|COMPLETED|Overall Study||9
201962|NCT00790647|484701|P1|STARTED|Overall Study||10
201963|NCT00790569|484711|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
201964|NCT00790569|484712|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
201965|NCT00790569|484713|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
201966|NCT00790569|484711|P3|COMPLETED|End of Study (12 Month Interview)||83
201967|NCT00790569|484712|P2|COMPLETED|End of Study (12 Month Interview)||26
201968|NCT00790569|484713|P1|COMPLETED|End of Study (12 Month Interview)||71
201969|NCT00790569|484711|P3|STARTED|End of Study (12 Month Interview)||133
201970|NCT00790569|484712|P2|STARTED|End of Study (12 Month Interview)||45
201971|NCT00790569|484713|P1|STARTED|End of Study (12 Month Interview)||137
201972|NCT00790569|484711|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
201973|NCT00790569|484712|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
201974|NCT00790569|484713|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
201975|NCT00790569|484711|P3|COMPLETED|End of Treatment (6 Month Interview)||107
201976|NCT00790569|484712|P2|COMPLETED|End of Treatment (6 Month Interview)||35
201977|NCT00790569|484713|P1|COMPLETED|End of Treatment (6 Month Interview)||115
201978|NCT00790569|484711|P3|STARTED|End of Treatment (6 Month Interview)||133
201979|NCT00790569|484712|P2|STARTED|End of Treatment (6 Month Interview)||45
201980|NCT00790569|484713|P1|STARTED|End of Treatment (6 Month Interview)||137
201981|NCT00790556|484736|P2|NOT COMPLETED|Treatment Period 2||0
201982|NCT00790556|484737|P1|NOT COMPLETED|Treatment Period 2||0
201983|NCT00790556|484736|P2|COMPLETED|Treatment Period 2||6
201984|NCT00790556|484737|P1|COMPLETED|Treatment Period 2||6
201985|NCT00790556|484736|P2|STARTED|Treatment Period 2||6
201986|NCT00790556|484737|P1|STARTED|Treatment Period 2||6
201987|NCT00790556|484736|P2|NOT COMPLETED|Washout After Period 1||0
201988|NCT00790556|484737|P1|NOT COMPLETED|Washout After Period 1||0
201989|NCT00790556|484736|P2|COMPLETED|Washout After Period 1||6
201990|NCT00790556|484737|P1|COMPLETED|Washout After Period 1||6
201991|NCT00790556|484736|P2|STARTED|Washout After Period 1||6
201992|NCT00790556|484737|P1|STARTED|Washout After Period 1||6
201993|NCT00790556|484736|P2|NOT COMPLETED|Treatment Period 1||0
201994|NCT00790556|484737|P1|NOT COMPLETED|Treatment Period 1||2
201995|NCT00790556|484736|P2|COMPLETED|Treatment Period 1||6
201996|NCT00790556|484737|P1|COMPLETED|Treatment Period 1||6
201997|NCT00790556|484736|P2|STARTED|Treatment Period 1||6
201998|NCT00790556|484737|P1|STARTED|Treatment Period 1||8
201999|NCT00790452|484749|P2|NOT COMPLETED|Overall Study||0
202000|NCT00790452|484750|P1|NOT COMPLETED|Overall Study||1
202001|NCT00790452|484749|P2|COMPLETED|Overall Study||0
202002|NCT00790452|484750|P1|COMPLETED|Overall Study||0
202003|NCT00790452|484749|P2|STARTED|Overall Study||0
202004|NCT00790452|484750|P1|STARTED|Overall Study||1
202005|NCT00790400|484758|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
202006|NCT00790400|484759|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
202007|NCT00790400|484758|P2|COMPLETED|Everolimus Period (Core or Extension)||0
202008|NCT00790400|484759|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
202009|NCT00790400|484758|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
202010|NCT00790400|484759|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
202011|NCT00790400|484758|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
202012|NCT00790400|484759|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
202013|NCT00790400|484758|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
202014|NCT00790400|484759|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
202015|NCT00790400|484758|P2|STARTED|Double-blind Period (Core Phase)||39
202016|NCT00790400|484759|P1|STARTED|Double-blind Period (Core Phase)||79
202017|NCT00790335|484788|P2|NOT COMPLETED|Overall Study||112
202018|NCT00790335|484789|P1|NOT COMPLETED|Overall Study||80
202019|NCT00790335|484788|P2|COMPLETED|Overall Study||243
202020|NCT00790335|484789|P1|COMPLETED|Overall Study||257
202021|NCT00790335|484788|P2|STARTED|Overall Study||355
202022|NCT00790335|484789|P1|STARTED|Overall Study||337
202023|NCT00790296|484849|P2|NOT COMPLETED|Overall Study||2
202024|NCT00790296|484850|P1|NOT COMPLETED|Overall Study||1
202025|NCT00790296|484849|P2|COMPLETED|Overall Study||4
202026|NCT00790296|484850|P1|COMPLETED|Overall Study||4
202027|NCT00790296|484849|P2|STARTED|Overall Study||6
202028|NCT00790296|484850|P1|STARTED|Overall Study||5
202029|NCT00790270|484859|P3|NOT COMPLETED|Overall Study||0
202030|NCT00790270|484860|P2|NOT COMPLETED|Overall Study||0
202031|NCT00790270|484861|P1|NOT COMPLETED|Overall Study||0
202032|NCT00790270|484859|P3|COMPLETED|Overall Study||20
202033|NCT00790270|484860|P2|COMPLETED|Overall Study||20
202034|NCT00790270|484861|P1|COMPLETED|Overall Study||21
202035|NCT00790270|484859|P3|STARTED|Overall Study||20
202036|NCT00790270|484860|P2|STARTED|Overall Study||20
202037|NCT00790270|484861|P1|STARTED|Overall Study||21
202038|NCT00790218|484872|P3|NOT COMPLETED|Overall Study||0
202039|NCT00790218|484873|P2|NOT COMPLETED|Overall Study||0
202040|NCT00790218|484874|P1|NOT COMPLETED|Overall Study||1
202041|NCT00790218|484872|P3|COMPLETED|Overall Study||7
202042|NCT00790218|484873|P2|COMPLETED|Overall Study||6
202043|NCT00790218|484874|P1|COMPLETED|Overall Study||5
202044|NCT00790218|484872|P3|STARTED|Overall Study||7
202045|NCT00790218|484873|P2|STARTED|Overall Study||6
202046|NCT00790218|484874|P1|STARTED|Overall Study||6
202047|NCT00790205|484884|P2|NOT COMPLETED|Overall Study||434
202048|NCT00790205|484885|P1|NOT COMPLETED|Overall Study||360
202049|NCT00790205|484884|P2|COMPLETED|Overall Study||6905
202050|NCT00790205|484885|P1|COMPLETED|Overall Study||6972
202051|NCT00790205|484884|P2|Treated|Overall Study||7274
202052|NCT00790205|484885|P1|Treated|Overall Study||7266
202053|NCT00790205|484884|P2|STARTED|Overall Study||7339
202054|NCT00790205|484885|P1|STARTED|Overall Study||7332
202055|NCT00790192|484929|P4|NOT COMPLETED|Overall Study||48
202056|NCT00790192|484930|P3|NOT COMPLETED|Overall Study||23
202057|NCT00790192|484931|P2|NOT COMPLETED|Overall Study||28
202058|NCT00790192|484932|P1|NOT COMPLETED|Overall Study||36
202059|NCT00790192|484929|P4|COMPLETED|Overall Study||74
202060|NCT00790192|484930|P3|COMPLETED|Overall Study||97
202061|NCT00790192|484931|P2|COMPLETED|Overall Study||93
202062|NCT00790192|484932|P1|COMPLETED|Overall Study||89
202063|NCT00790192|484929|P4|STARTED|Overall Study||122
202064|NCT00790192|484930|P3|STARTED|Overall Study||120
202065|NCT00790192|484931|P2|STARTED|Overall Study||121
202066|NCT00790192|484932|P1|STARTED|Overall Study||125
202067|NCT00790062|484949|P3|NOT COMPLETED|Overall Study||0
202068|NCT00790062|484950|P2|NOT COMPLETED|Overall Study||0
202069|NCT00790062|484951|P1|NOT COMPLETED|Overall Study||0
202070|NCT00790062|484949|P3|COMPLETED|Overall Study||658
202071|NCT00790062|484950|P2|COMPLETED|Overall Study||481
202072|NCT00790062|484951|P1|COMPLETED|Overall Study||659
202073|NCT00790062|484949|P3|STARTED|Overall Study||658
202074|NCT00790062|484950|P2|STARTED|Overall Study||481
202075|NCT00790062|484951|P1|STARTED|Overall Study||659
202076|NCT00790036|484982|P2|NOT COMPLETED|Overall Study||121
202077|NCT00790036|484983|P1|NOT COMPLETED|Overall Study||195
202078|NCT00790036|484982|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
202079|NCT00790036|484983|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
202080|NCT00790036|484982|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
202081|NCT00790036|484983|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
202082|NCT00790036|484982|P2|STARTED|Overall Study||370
202083|NCT00790036|484983|P1|STARTED|Overall Study||372
202084|NCT00790023|484997|P3|NOT COMPLETED|Overall Study||21
202085|NCT00790023|484998|P2|NOT COMPLETED|Overall Study||10
202086|NCT00790023|484999|P1|NOT COMPLETED|Overall Study||11
202087|NCT00790023|484997|P3|COMPLETED|Overall Study||214
202088|NCT00790023|484998|P2|COMPLETED|Overall Study||225
202089|NCT00790023|484999|P1|COMPLETED|Overall Study||226
202090|NCT00790023|484997|P3|STARTED|Overall Study||235
202091|NCT00790023|484998|P2|STARTED|Overall Study||235
202092|NCT00790023|484999|P1|STARTED|Overall Study||237
202093|NCT00789997|485089|P2|NOT COMPLETED|Overall Study||2
202094|NCT00789997|485090|P1|NOT COMPLETED|Overall Study||1
202095|NCT00789997|485089|P2|COMPLETED|Overall Study||38
202096|NCT00789997|485090|P1|COMPLETED|Overall Study||40
202097|NCT00789997|485089|P2|STARTED|Overall Study||40
202098|NCT00789997|485090|P1|STARTED|Overall Study||41
202099|NCT00789958|485098|P1|NOT COMPLETED|Overall Study||37
202100|NCT00789958|485098|P1|COMPLETED|Overall Study||68
202101|NCT00789958|485098|P1|Eligible and Analyzable|Overall Study||79
202102|NCT00789958|485098|P1|STARTED|Overall Study||105
202103|NCT00789880|485117|P6|NOT COMPLETED|Overall Study||0
202104|NCT00789880|485118|P5|NOT COMPLETED|Overall Study||3
202105|NCT00789880|485119|P4|NOT COMPLETED|Overall Study||1
202106|NCT00789880|485120|P3|NOT COMPLETED|Overall Study||0
202107|NCT00789880|485121|P2|NOT COMPLETED|Overall Study||1
202108|NCT00789880|485122|P1|NOT COMPLETED|Overall Study||1
202109|NCT00789880|485117|P6|COMPLETED|Overall Study||8
202110|NCT00789880|485118|P5|COMPLETED|Overall Study||15
202111|NCT00789880|485119|P4|COMPLETED|Overall Study||15
202112|NCT00789880|485120|P3|COMPLETED|Overall Study||8
202113|NCT00789880|485121|P2|COMPLETED|Overall Study||15
202114|NCT00789880|485122|P1|COMPLETED|Overall Study||15
202115|NCT00789880|485117|P6|STARTED|Overall Study||8
202116|NCT00789880|485118|P5|STARTED|Overall Study||18
202117|NCT00789880|485119|P4|STARTED|Overall Study||16
202118|NCT00789880|485120|P3|STARTED|Overall Study||8
202119|NCT00789880|485121|P2|STARTED|Overall Study||16
202120|NCT00789880|485122|P1|STARTED|Overall Study||16
202121|NCT00789854|485151|P3|NOT COMPLETED|Overall Study||47
202122|NCT00789854|485152|P2|NOT COMPLETED|Overall Study||35
202123|NCT00789854|485153|P1|NOT COMPLETED|Overall Study||49
202124|NCT00789854|485151|P3|COMPLETED|Overall Study||182
202125|NCT00789854|485152|P2|COMPLETED|Overall Study||196
202126|NCT00789854|485153|P1|COMPLETED|Overall Study||179
202127|NCT00789854|485151|P3|STARTED|Overall Study||229
202128|NCT00789854|485152|P2|STARTED|Overall Study||231
202129|NCT00789854|485153|P1|STARTED|Overall Study||228
202130|NCT00789828|485250|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
202131|NCT00789828|485251|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
202132|NCT00789828|485250|P2|COMPLETED|Open-label Extension Period (4 Years)||0
202133|NCT00789828|485251|P1|COMPLETED|Open-label Extension Period (4 Years)||82
202134|NCT00789828|485250|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
202135|NCT00789828|485251|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
202136|NCT00789828|485250|P2|NOT COMPLETED|Core Period (48 Weeks)||6
202137|NCT00789828|485251|P1|NOT COMPLETED|Core Period (48 Weeks)||0
202138|NCT00789828|485250|P2|COMPLETED|Core Period (48 Weeks)||33
202139|NCT00789828|485251|P1|COMPLETED|Core Period (48 Weeks)||78
202140|NCT00789828|485250|P2|STARTED|Core Period (48 Weeks)||39
202141|NCT00789828|485251|P1|STARTED|Core Period (48 Weeks)||78
202142|NCT00789815|485285|P2|NOT COMPLETED|Overall Study||1
202143|NCT00789815|485286|P1|NOT COMPLETED|Overall Study||7
202144|NCT00789815|485285|P2|COMPLETED|Overall Study||249
202145|NCT00789815|485286|P1|COMPLETED|Overall Study||243
202146|NCT00789815|485285|P2|STARTED|Overall Study||250
202147|NCT00789815|485286|P1|STARTED|Overall Study||250
202148|NCT00789802|485309|P3|NOT COMPLETED|Overall Study||6
202149|NCT00789802|485310|P2|NOT COMPLETED|Overall Study||7
202150|NCT00789802|485311|P1|NOT COMPLETED|Overall Study||10
202151|NCT00789802|485309|P3|COMPLETED|Overall Study||37
202152|NCT00789802|485310|P2|COMPLETED|Overall Study||35
202153|NCT00789802|485311|P1|COMPLETED|Overall Study||34
202154|NCT00789802|485309|P3|STARTED|Overall Study||43
202155|NCT00789802|485310|P2|STARTED|Overall Study||42
202156|NCT00789802|485311|P1|STARTED|Overall Study||44
202157|NCT00789750|485330|P2|NOT COMPLETED|Overall Study||60
202158|NCT00789750|485331|P1|NOT COMPLETED|Overall Study||59
202159|NCT00789750|485330|P2|COMPLETED|Overall Study||222
202160|NCT00789750|485331|P1|COMPLETED|Overall Study||221
202161|NCT00789750|485330|P2|Intent to Treat Set|Overall Study||276
202162|NCT00789750|485331|P1|Intent to Treat Set|Overall Study||271
202163|NCT00789750|485330|P2|Safety Set|Overall Study||277
202164|NCT00789750|485331|P1|Safety Set|Overall Study||274
202165|NCT00789750|485330|P2|Dropped During run-in Period|Overall Study||5
202166|NCT00789750|485331|P1|Dropped During run-in Period|Overall Study||6
202167|NCT00789750|485330|P2|STARTED|Overall Study||282
202168|NCT00789750|485331|P1|STARTED|Overall Study||280
202169|NCT00789737|485375|P2|NOT COMPLETED|Overall Study||55
202170|NCT00789737|485376|P1|NOT COMPLETED|Overall Study||48
202171|NCT00789737|485375|P2|COMPLETED|Overall Study||126
202172|NCT00789737|485376|P1|COMPLETED|Overall Study||128
202173|NCT00789737|485375|P2|STARTED|Overall Study||181
202174|NCT00789737|485376|P1|STARTED|Overall Study||176
202175|NCT00789724|485408|P2|NOT COMPLETED|Overall Study||0
202176|NCT00789724|485409|P1|NOT COMPLETED|Overall Study||0
202177|NCT00789724|485408|P2|COMPLETED|Overall Study||5
202178|NCT00789724|485409|P1|COMPLETED|Overall Study||5
202179|NCT00789724|485408|P2|STARTED|Overall Study||5
202180|NCT00789724|485409|P1|STARTED|Overall Study||5
202181|NCT00789698|485419|P4|NOT COMPLETED|Overall Study||52
202182|NCT00789698|485420|P3|NOT COMPLETED|Overall Study||27
202183|NCT00789698|485421|P2|NOT COMPLETED|Overall Study||33
202184|NCT00789698|485422|P1|NOT COMPLETED|Overall Study||40
202185|NCT00789698|485419|P4|COMPLETED|Overall Study||33
202186|NCT00789698|485420|P3|COMPLETED|Overall Study||29
202187|NCT00789698|485421|P2|COMPLETED|Overall Study||46
202188|NCT00789698|485422|P1|COMPLETED|Overall Study||32
202189|NCT00789698|485419|P4|STARTED|Overall Study||85
202190|NCT00789698|485420|P3|STARTED|Overall Study||56
202191|NCT00789698|485421|P2|STARTED|Overall Study||79
202192|NCT00789698|485422|P1|STARTED|Overall Study||72
202193|NCT00789685|485436|P1|NOT COMPLETED|Overall Study||12
202194|NCT00789685|485436|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
202195|NCT00789685|485436|P1|STARTED|Overall Study||37
202196|NCT00789672|485444|P2|NOT COMPLETED|Overall Study||0
202197|NCT00789672|485445|P1|NOT COMPLETED|Overall Study||0
202198|NCT00789672|485444|P2|COMPLETED|Overall Study||17
202199|NCT00789672|485445|P1|COMPLETED|Overall Study||16
202200|NCT00789672|485444|P2|STARTED|Overall Study||17
202201|NCT00789672|485445|P1|STARTED|Overall Study||16
202202|NCT00789581|485477|P2|NOT COMPLETED|Adjuvant Therapy||57
202203|NCT00789581|485478|P1|NOT COMPLETED|Adjuvant Therapy||40
202204|NCT00789581|485477|P2|COMPLETED|Adjuvant Therapy||234
202205|NCT00789581|485478|P1|COMPLETED|Adjuvant Therapy||255
202206|NCT00789581|485477|P2|STARTED|Adjuvant Therapy||291
202207|NCT00789581|485478|P1|STARTED|Adjuvant Therapy||295
202208|NCT00789581|485477|P2|NOT COMPLETED|AC Therapy||17
202209|NCT00789581|485478|P1|NOT COMPLETED|AC Therapy||11
202210|NCT00789581|485477|P2|COMPLETED|AC Therapy||291
202211|NCT00789581|485478|P1|COMPLETED|AC Therapy||295
202212|NCT00789581|485477|P2|STARTED|AC Therapy||308
202213|NCT00789581|485478|P1|STARTED|AC Therapy||306
202214|NCT00789555|485489|P3|NOT COMPLETED|Overall Study||159
202215|NCT00789555|485490|P2|NOT COMPLETED|Overall Study||139
202216|NCT00789555|485491|P1|NOT COMPLETED|Overall Study||159
202217|NCT00789555|485489|P3|COMPLETED|Overall Study||263
202218|NCT00789555|485490|P2|COMPLETED|Overall Study||278
202219|NCT00789555|485491|P1|COMPLETED|Overall Study||262
202220|NCT00789555|485489|P3|STARTED|Overall Study||422
202221|NCT00789555|485490|P2|STARTED|Overall Study||417
202222|NCT00789555|485491|P1|STARTED|Overall Study||421
202223|NCT00789529|485516|P2|NOT COMPLETED|Overall Study||1
202224|NCT00789529|485517|P1|NOT COMPLETED|Overall Study||1
202225|NCT00789529|485516|P2|COMPLETED|Overall Study||15
202226|NCT00789529|485517|P1|COMPLETED|Overall Study||15
202227|NCT00789529|485516|P2|STARTED|Overall Study||16
202228|NCT00789529|485517|P1|STARTED|Overall Study||16
202229|NCT00789477|485530|P5|NOT COMPLETED|Overall Study||7
202230|NCT00789477|485531|P4|NOT COMPLETED|Overall Study||10
202231|NCT00789477|485532|P3|NOT COMPLETED|Overall Study||11
202232|NCT00789477|485533|P2|NOT COMPLETED|Overall Study||6
202233|NCT00789477|485534|P1|NOT COMPLETED|Overall Study||11
202234|NCT00789477|485530|P5|COMPLETED|Overall Study||38
202235|NCT00789477|485531|P4|COMPLETED|Overall Study||34
202236|NCT00789477|485532|P3|COMPLETED|Overall Study||33
202237|NCT00789477|485533|P2|COMPLETED|Overall Study||38
202238|NCT00789477|485534|P1|COMPLETED|Overall Study||33
202239|NCT00789477|485530|P5|Participants Received Treatment|Overall Study|SAF|45
202240|NCT00789477|485531|P4|Participants Received Treatment|Overall Study|SAF|42
202241|NCT00789477|485532|P3|Participants Received Treatment|Overall Study|SAF|44
202242|NCT00789477|485533|P2|Participants Received Treatment|Overall Study|SAF|44
202243|NCT00789477|485534|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
202244|NCT00789477|485530|P5|STARTED|Overall Study|randomized|45
202245|NCT00789477|485531|P4|STARTED|Overall Study|randomized|44
202246|NCT00789477|485532|P3|STARTED|Overall Study|randomized|44
202247|NCT00789477|485533|P2|STARTED|Overall Study|randomized|44
202248|NCT00789477|485534|P1|STARTED|Overall Study|randomized|44
202249|NCT00789438|485569|P3|NOT COMPLETED|Overall Study||0
202250|NCT00789438|485570|P2|NOT COMPLETED|Overall Study||0
202251|NCT00789438|485571|P1|NOT COMPLETED|Overall Study||0
202252|NCT00789438|485569|P3|COMPLETED|Overall Study||28
202253|NCT00789438|485570|P2|COMPLETED|Overall Study||20
202254|NCT00789438|485571|P1|COMPLETED|Overall Study||21
202255|NCT00789438|485569|P3|STARTED|Overall Study||28
202256|NCT00789438|485570|P2|STARTED|Overall Study||20
202257|NCT00789438|485571|P1|STARTED|Overall Study||21
202258|NCT00789373|485579|P3|NOT COMPLETED|Maintenance||180
202259|NCT00789373|485580|P2|NOT COMPLETED|Maintenance||359
202260|NCT00789373|485581|P1|NOT COMPLETED|Maintenance||0
202261|NCT00789373|485579|P3|COMPLETED|Maintenance||0
202262|NCT00789373|485580|P2|COMPLETED|Maintenance||0
202263|NCT00789373|485581|P1|COMPLETED|Maintenance||0
202264|NCT00789373|485579|P3|STARTED|Maintenance||180
202265|NCT00789373|485580|P2|STARTED|Maintenance||359
202266|NCT00789373|485581|P1|STARTED|Maintenance||0
202267|NCT00789373|485579|P3|NOT COMPLETED|Induction||0
202268|NCT00789373|485580|P2|NOT COMPLETED|Induction||0
202269|NCT00789373|485581|P1|NOT COMPLETED|Induction||399
202270|NCT00789373|485579|P3|COMPLETED|Induction||0
202271|NCT00789373|485580|P2|COMPLETED|Induction||0
202272|NCT00789373|485581|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
202273|NCT00789373|485579|P3|STARTED|Induction||0
202274|NCT00789373|485580|P2|STARTED|Induction||0
202275|NCT00789373|485581|P1|STARTED|Induction||939
202276|NCT00789321|485608|P2|NOT COMPLETED|Overall Study||1
202277|NCT00789321|485609|P1|NOT COMPLETED|Overall Study||0
202278|NCT00789321|485608|P2|COMPLETED|Overall Study||22
202279|NCT00789321|485609|P1|COMPLETED|Overall Study||24
202280|NCT00789321|485608|P2|STARTED|Overall Study||23
202281|NCT00789321|485609|P1|STARTED|Overall Study||24
202282|NCT00789256|485619|P2|NOT COMPLETED|Overall Study||0
202283|NCT00789256|485620|P1|NOT COMPLETED|Overall Study||0
202284|NCT00789256|485619|P2|COMPLETED|Overall Study||12
202285|NCT00789256|485620|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
202286|NCT00789256|485619|P2|STARTED|Overall Study||12
202287|NCT00789256|485620|P1|STARTED|Overall Study||14
202288|NCT00789191|485628|P2|NOT COMPLETED|Overall Study||19
202289|NCT00789191|485629|P1|NOT COMPLETED|Overall Study||14
202290|NCT00789191|485628|P2|COMPLETED|Overall Study||92
202291|NCT00789191|485629|P1|COMPLETED|Overall Study||97
202292|NCT00789191|485628|P2|Exposed|Overall Study|1 non-compliance|110
202293|NCT00789191|485629|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
202294|NCT00789191|485628|P2|STARTED|Overall Study||111
202295|NCT00789191|485629|P1|STARTED|Overall Study||111
202296|NCT00789113|485657|P1|NOT COMPLETED|Overall Study||0
202297|NCT00789113|485657|P1|COMPLETED|Overall Study||12
202298|NCT00789113|485657|P1|STARTED|Overall Study||12
202299|NCT00789074|485664|P2|NOT COMPLETED|Overall Study||13
202300|NCT00789074|485665|P1|NOT COMPLETED|Overall Study||11
202301|NCT00789074|485664|P2|COMPLETED|Overall Study||35
202302|NCT00789074|485665|P1|COMPLETED|Overall Study||42
202303|NCT00789074|485664|P2|STARTED|Overall Study||48
202304|NCT00789074|485665|P1|STARTED|Overall Study||53
202305|NCT00789035|485686|P5|NOT COMPLETED|Overall Study||6
202306|NCT00789035|485687|P4|NOT COMPLETED|Overall Study||1
202307|NCT00789035|485688|P3|NOT COMPLETED|Overall Study||1
202308|NCT00789035|485689|P2|NOT COMPLETED|Overall Study||7
202309|NCT00789035|485690|P1|NOT COMPLETED|Overall Study||6
202310|NCT00789035|485686|P5|COMPLETED|Overall Study||74
202311|NCT00789035|485687|P4|COMPLETED|Overall Study||81
202312|NCT00789035|485688|P3|COMPLETED|Overall Study||80
202313|NCT00789035|485689|P2|COMPLETED|Overall Study||74
202314|NCT00789035|485690|P1|COMPLETED|Overall Study||76
202315|NCT00789035|485686|P5|STARTED|Overall Study||80
202316|NCT00789035|485687|P4|STARTED|Overall Study||82
202317|NCT00789035|485688|P3|STARTED|Overall Study||81
202318|NCT00789035|485689|P2|STARTED|Overall Study||81
202319|NCT00789035|485690|P1|STARTED|Overall Study||82
202320|NCT00788957|485749|P6|NOT COMPLETED|Part 3||11
202321|NCT00788957|485750|P5|NOT COMPLETED|Part 3||9
202322|NCT00788957|485751|P4|NOT COMPLETED|Part 3||0
202323|NCT00788957|485752|P3|NOT COMPLETED|Part 3||0
202324|NCT00788957|485753|P2|NOT COMPLETED|Part 3||0
202325|NCT00788957|485754|P1|NOT COMPLETED|Part 3||0
202326|NCT00788957|485749|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
202327|NCT00788957|485750|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
202328|NCT00788957|485751|P4|COMPLETED|Part 3||0
202329|NCT00788957|485752|P3|COMPLETED|Part 3||0
202330|NCT00788957|485753|P2|COMPLETED|Part 3||0
202331|NCT00788957|485754|P1|COMPLETED|Part 3||0
202332|NCT00788957|485749|P6|STARTED|Part 3||12
202333|NCT00788957|485750|P5|STARTED|Part 3||13
202334|NCT00788957|485751|P4|STARTED|Part 3||0
202335|NCT00788957|485752|P3|STARTED|Part 3||0
202336|NCT00788957|485753|P2|STARTED|Part 3||0
202337|NCT00788957|485754|P1|STARTED|Part 3||0
202338|NCT00788957|485749|P6|NOT COMPLETED|Part 2||0
202339|NCT00788957|485750|P5|NOT COMPLETED|Part 2||0
202340|NCT00788957|485751|P4|NOT COMPLETED|Part 2||41
202341|NCT00788957|485752|P3|NOT COMPLETED|Part 2||44
202342|NCT00788957|485753|P2|NOT COMPLETED|Part 2||42
202343|NCT00788957|485754|P1|NOT COMPLETED|Part 2||0
202344|NCT00788957|485749|P6|COMPLETED|Part 2||0
202345|NCT00788957|485750|P5|COMPLETED|Part 2||0
202346|NCT00788957|485751|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
202347|NCT00788957|485752|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
202348|NCT00788957|485753|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
202349|NCT00788957|485754|P1|COMPLETED|Part 2||0
202350|NCT00788957|485749|P6|STARTED|Part 2||0
202351|NCT00788957|485750|P5|STARTED|Part 2||0
202352|NCT00788957|485751|P4|STARTED|Part 2||46
202353|NCT00788957|485752|P3|STARTED|Part 2||48
202354|NCT00788957|485753|P2|STARTED|Part 2||48
202355|NCT00788957|485754|P1|STARTED|Part 2||0
202356|NCT00788957|485749|P6|NOT COMPLETED|Part 1||0
202357|NCT00788957|485750|P5|NOT COMPLETED|Part 1||0
202358|NCT00788957|485751|P4|NOT COMPLETED|Part 1||0
202359|NCT00788957|485752|P3|NOT COMPLETED|Part 1||0
202360|NCT00788957|485753|P2|NOT COMPLETED|Part 1||0
202361|NCT00788957|485754|P1|NOT COMPLETED|Part 1||9
202362|NCT00788957|485749|P6|COMPLETED|Part 1||0
202363|NCT00788957|485750|P5|COMPLETED|Part 1||0
202364|NCT00788957|485751|P4|COMPLETED|Part 1||0
202365|NCT00788957|485752|P3|COMPLETED|Part 1||0
202366|NCT00788957|485753|P2|COMPLETED|Part 1||0
202367|NCT00788957|485754|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
202368|NCT00788957|485749|P6|STARTED|Part 1||0
202369|NCT00788957|485750|P5|STARTED|Part 1||0
202370|NCT00788957|485751|P4|STARTED|Part 1||0
202371|NCT00788957|485752|P3|STARTED|Part 1||0
202372|NCT00788957|485753|P2|STARTED|Part 1||0
202373|NCT00788957|485754|P1|STARTED|Part 1||11
202374|NCT00788892|485810|P2|NOT COMPLETED|Overall Study||23
202375|NCT00788892|485811|P1|NOT COMPLETED|Overall Study||49
202376|NCT00788892|485810|P2|COMPLETED|Overall Study||18
202377|NCT00788892|485811|P1|COMPLETED|Overall Study||36
202378|NCT00788892|485810|P2|STARTED|Overall Study||41
202379|NCT00788892|485811|P1|STARTED|Overall Study||85
202380|NCT00788775|485829|P2|NOT COMPLETED|Overall Study||8
202381|NCT00788775|485830|P1|NOT COMPLETED|Overall Study||10
202382|NCT00788775|485829|P2|COMPLETED|Overall Study||1
202383|NCT00788775|485830|P1|COMPLETED|Overall Study||1
202384|NCT00788775|485829|P2|Treated|Overall Study||8
202385|NCT00788775|485830|P1|Treated|Overall Study||11
202386|NCT00788775|485829|P2|STARTED|Overall Study||9
202387|NCT00788775|485830|P1|STARTED|Overall Study||11
202388|NCT00788710|485845|P3|NOT COMPLETED|Overall Study||6
202389|NCT00788710|485846|P2|NOT COMPLETED|Overall Study||8
202390|NCT00788710|485847|P1|NOT COMPLETED|Overall Study||5
202391|NCT00788710|485845|P3|COMPLETED|Overall Study||138
202392|NCT00788710|485846|P2|COMPLETED|Overall Study||134
202393|NCT00788710|485847|P1|COMPLETED|Overall Study||139
202394|NCT00788710|485845|P3|STARTED|Overall Study||144
202395|NCT00788710|485846|P2|STARTED|Overall Study||142
202396|NCT00788710|485847|P1|STARTED|Overall Study||144
202397|NCT00788697|485861|P1|NOT COMPLETED|Overall Study||109
202398|NCT00788697|485861|P1|COMPLETED|Overall Study||240
202399|NCT00788697|485861|P1|STARTED|Overall Study||349
202400|NCT00788593|485908|P3|NOT COMPLETED|Second Intervention Period||1
202401|NCT00788593|485909|P2|NOT COMPLETED|Second Intervention Period||1
202402|NCT00788593|485910|P1|NOT COMPLETED|Second Intervention Period||0
202403|NCT00788593|485908|P3|COMPLETED|Second Intervention Period||36
202404|NCT00788593|485909|P2|COMPLETED|Second Intervention Period||37
202405|NCT00788593|485910|P1|COMPLETED|Second Intervention Period||0
202406|NCT00788593|485908|P3|STARTED|Second Intervention Period||37
202407|NCT00788593|485909|P2|STARTED|Second Intervention Period||38
202408|NCT00788593|485910|P1|STARTED|Second Intervention Period||0
202409|NCT00788593|485908|P3|NOT COMPLETED|First Intervention Period||0
202410|NCT00788593|485909|P2|NOT COMPLETED|First Intervention Period||1
202411|NCT00788593|485910|P1|NOT COMPLETED|First Intervention Period||0
202412|NCT00788593|485908|P3|COMPLETED|First Intervention Period||37
202413|NCT00788593|485909|P2|COMPLETED|First Intervention Period||38
202414|NCT00788593|485910|P1|COMPLETED|First Intervention Period||0
202415|NCT00788593|485908|P3|STARTED|First Intervention Period||37
202416|NCT00788593|485909|P2|STARTED|First Intervention Period||39
202417|NCT00788593|485910|P1|STARTED|First Intervention Period||0
202418|NCT00788593|485908|P3|NOT COMPLETED|Placebo Run-in Phase||0
202419|NCT00788593|485909|P2|NOT COMPLETED|Placebo Run-in Phase||0
202420|NCT00788593|485910|P1|NOT COMPLETED|Placebo Run-in Phase||6
202421|NCT00788593|485908|P3|COMPLETED|Placebo Run-in Phase||0
202422|NCT00788593|485909|P2|COMPLETED|Placebo Run-in Phase||0
202423|NCT00788593|485910|P1|COMPLETED|Placebo Run-in Phase||76
202424|NCT00788593|485908|P3|STARTED|Placebo Run-in Phase||0
202425|NCT00788593|485909|P2|STARTED|Placebo Run-in Phase||0
202426|NCT00788593|485910|P1|STARTED|Placebo Run-in Phase||82
202427|NCT00788372|485927|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
202428|NCT00788372|485927|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
202429|NCT00788372|485927|P1|STARTED|Period 2 (Week 4 to Week 52)||111
202430|NCT00788372|485927|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
202431|NCT00788372|485927|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
202432|NCT00788372|485927|P1|STARTED|Period 1 (up to 4 Weeks)||142
202433|NCT00788255|485941|P1|NOT COMPLETED|Overall Study||0
202434|NCT00788255|485941|P1|COMPLETED|Overall Study||25
202435|NCT00788255|485941|P1|Oxytocin: 0 μU/mL|Overall Study||25
202436|NCT00788255|485941|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
202437|NCT00788255|485941|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
202438|NCT00788255|485941|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
202439|NCT00788255|485941|P1|STARTED|Overall Study||25
202440|NCT00788073|485956|P2|NOT COMPLETED|Placebo Then STX209||1
202441|NCT00788073|485957|P1|NOT COMPLETED|Placebo Then STX209||2
202442|NCT00788073|485956|P2|COMPLETED|Placebo Then STX209||29
202443|NCT00788073|485957|P1|COMPLETED|Placebo Then STX209||27
202444|NCT00788073|485956|P2|STARTED|Placebo Then STX209||30
202445|NCT00788073|485957|P1|STARTED|Placebo Then STX209||29
202446|NCT00788073|485956|P2|NOT COMPLETED|STX209 Then Placebo||3
202447|NCT00788073|485957|P1|NOT COMPLETED|STX209 Then Placebo||1
202448|NCT00788073|485956|P2|COMPLETED|STX209 Then Placebo||30
202449|NCT00788073|485957|P1|COMPLETED|STX209 Then Placebo||29
202450|NCT00788073|485956|P2|STARTED|STX209 Then Placebo||33
202451|NCT00788073|485957|P1|STARTED|STX209 Then Placebo||30
202452|NCT00788008|485967|P2|NOT COMPLETED|Overall Study||0
202453|NCT00788008|485968|P1|NOT COMPLETED|Overall Study||0
202454|NCT00788008|485967|P2|COMPLETED|Overall Study||101
202455|NCT00788008|485968|P1|COMPLETED|Overall Study||98
202456|NCT00788008|485967|P2|STARTED|Overall Study||101
202457|NCT00788008|485968|P1|STARTED|Overall Study||98
202458|NCT00787943|485974|P1|NOT COMPLETED|Overall Study||0
202459|NCT00787943|485974|P1|COMPLETED|Overall Study||10
202460|NCT00787943|485974|P1|STARTED|Overall Study||10
202461|NCT00787930|485982|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
202462|NCT00787930|485982|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
202463|NCT00787930|485982|P1|STARTED|Continuation Treatment -- up to 12 Month||19
202464|NCT00787930|485982|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
202465|NCT00787930|485982|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
202466|NCT00787930|485982|P1|STARTED|Acute Treatment -- 3 Weeks||19
202467|NCT00787917|485997|P2|NOT COMPLETED|Open Label||0
202468|NCT00787917|485998|P1|NOT COMPLETED|Open Label||4
202469|NCT00787917|485997|P2|COMPLETED|Open Label||0
202470|NCT00787917|485998|P1|COMPLETED|Open Label||3
202471|NCT00787917|485997|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
202472|NCT00787917|485998|P1|STARTED|Open Label||7
202473|NCT00787917|485997|P2|NOT COMPLETED|Blinded Treatment||2
202474|NCT00787917|485998|P1|NOT COMPLETED|Blinded Treatment||5
202475|NCT00787917|485997|P2|COMPLETED|Blinded Treatment||3
202476|NCT00787917|485998|P1|COMPLETED|Blinded Treatment||4
202477|NCT00787917|485997|P2|STARTED|Blinded Treatment||5
202478|NCT00787917|485998|P1|STARTED|Blinded Treatment||9
202479|NCT00787904|486017|P2|NOT COMPLETED|Overall Study||0
202480|NCT00787904|486018|P1|NOT COMPLETED|Overall Study||0
202481|NCT00787904|486017|P2|COMPLETED|Overall Study||13
202482|NCT00787904|486018|P1|COMPLETED|Overall Study||6
202483|NCT00787904|486017|P2|STARTED|Overall Study||13
202484|NCT00787904|486018|P1|STARTED|Overall Study||6
202485|NCT00787891|486028|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
202486|NCT00787891|486029|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
202487|NCT00787891|486028|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
202488|NCT00787891|486029|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
202489|NCT00787891|486028|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
202490|NCT00787891|486029|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
202491|NCT00787891|486028|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
202492|NCT00787891|486029|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
202493|NCT00787891|486028|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
202494|NCT00787891|486029|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
202495|NCT00787891|486028|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
202496|NCT00787891|486029|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
202497|NCT00787852|486049|P2|NOT COMPLETED|Overall Study||0
202498|NCT00787852|486050|P1|NOT COMPLETED|Overall Study||1
202499|NCT00787852|486049|P2|COMPLETED|Overall Study||5
202500|NCT00787852|486050|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
202501|NCT00787852|486049|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
202502|NCT00787852|486050|P1|STARTED|Overall Study||6
202503|NCT00787839|486056|P1|NOT COMPLETED|Overall Study||404
202504|NCT00787839|486056|P1|COMPLETED|Overall Study||1535
202505|NCT00787839|486056|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
202506|NCT00787839|486056|P1|Completed GCT Screening|Overall Study||1876
202507|NCT00787839|486056|P1|Consented|Overall Study|consented|1939
202508|NCT00787839|486056|P1|STARTED|Overall Study||1939
202509|NCT00787800|486079|P2|NOT COMPLETED|Overall Study||7
202510|NCT00787800|486080|P1|NOT COMPLETED|Overall Study||3
202511|NCT00787800|486079|P2|COMPLETED|Overall Study||43
202512|NCT00787800|486080|P1|COMPLETED|Overall Study||47
202513|NCT00787800|486079|P2|STARTED|Overall Study||50
202514|NCT00787800|486080|P1|STARTED|Overall Study||50
202515|NCT00787787|486096|P1|NOT COMPLETED|Overall Study||7
202516|NCT00787787|486096|P1|COMPLETED|Overall Study||0
202517|NCT00787787|486096|P1|STARTED|Overall Study||7
202518|NCT00787761|486102|P1|NOT COMPLETED|Overall Study||0
202519|NCT00787761|486102|P1|COMPLETED|Overall Study||24
202520|NCT00787761|486102|P1|STARTED|Overall Study||24
202521|NCT00787644|486115|P2|NOT COMPLETED|Overall Study||2
202522|NCT00787644|486116|P1|NOT COMPLETED|Overall Study||2
202523|NCT00787644|486115|P2|COMPLETED|Overall Study||9
202524|NCT00787644|486116|P1|COMPLETED|Overall Study||10
202525|NCT00787644|486115|P2|STARTED|Overall Study||11
202526|NCT00787644|486116|P1|STARTED|Overall Study||12
202527|NCT00787618|486125|P3|NOT COMPLETED|Overall Study||0
202528|NCT00787618|486126|P2|NOT COMPLETED|Overall Study||0
202529|NCT00787618|486127|P1|NOT COMPLETED|Overall Study||0
202530|NCT00787618|486125|P3|COMPLETED|Overall Study||3
202531|NCT00787618|486126|P2|COMPLETED|Overall Study||0
202532|NCT00787618|486127|P1|COMPLETED|Overall Study||3
202533|NCT00787618|486125|P3|STARTED|Overall Study||3
202534|NCT00787618|486126|P2|STARTED|Overall Study||0
202535|NCT00787618|486127|P1|STARTED|Overall Study||3
202536|NCT00787605|486137|P2|NOT COMPLETED|Overall Study||56
202537|NCT00787605|486138|P1|NOT COMPLETED|Overall Study||46
202538|NCT00787605|486137|P2|COMPLETED|Overall Study||376
202539|NCT00787605|486138|P1|COMPLETED|Overall Study||382
202540|NCT00787605|486137|P2|STARTED|Overall Study||432
202541|NCT00787605|486138|P1|STARTED|Overall Study||428
202542|NCT00787566|486157|P3|NOT COMPLETED|Overall Study||0
202543|NCT00787566|486158|P2|NOT COMPLETED|Overall Study||1
202544|NCT00787566|486159|P1|NOT COMPLETED|Overall Study||0
202545|NCT00787566|486157|P3|COMPLETED|Overall Study||22
202546|NCT00787566|486158|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
202547|NCT00787566|486159|P1|COMPLETED|Overall Study||21
202548|NCT00787566|486157|P3|STARTED|Overall Study||22
202549|NCT00787566|486158|P2|STARTED|Overall Study||25
202550|NCT00787566|486159|P1|STARTED|Overall Study||21
202551|NCT00787527|486167|P1|NOT COMPLETED|Overall Study||3
202552|NCT00787527|486167|P1|COMPLETED|Overall Study||11
202553|NCT00787527|486167|P1|STARTED|Overall Study||14
202554|NCT00787332|486177|P2|NOT COMPLETED|Overall Study||0
202555|NCT00787332|486178|P1|NOT COMPLETED|Overall Study||0
202556|NCT00787332|486177|P2|COMPLETED|Overall Study||8
202557|NCT00787332|486178|P1|COMPLETED|Overall Study||8
202558|NCT00787332|486177|P2|STARTED|Overall Study||8
202559|NCT00787332|486178|P1|STARTED|Overall Study||8
202560|NCT00787319|486184|P1|NOT COMPLETED|Overall Study||63
202561|NCT00787319|486184|P1|COMPLETED|Overall Study||45
202562|NCT00787319|486184|P1|STARTED|Overall Study||108
202563|NCT00787267|486196|P1|NOT COMPLETED|Overall Study||12
202564|NCT00787267|486196|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
202565|NCT00787267|486196|P1|STARTED|Overall Study|Signed a consent form|37
202566|NCT00787254|486206|P2|NOT COMPLETED|Overall Study||82
202567|NCT00787254|486207|P1|NOT COMPLETED|Overall Study||76
202568|NCT00787254|486206|P2|COMPLETED|Overall Study||99
202569|NCT00787254|486207|P1|COMPLETED|Overall Study||109
202570|NCT00787254|486206|P2|STARTED|Overall Study||181
202571|NCT00787254|486207|P1|STARTED|Overall Study||185
202572|NCT00787241|486310|P3|NOT COMPLETED|Overall Study||0
202573|NCT00787241|486311|P2|NOT COMPLETED|Overall Study||0
202574|NCT00787241|486312|P1|NOT COMPLETED|Overall Study||0
202575|NCT00787241|486310|P3|COMPLETED|Overall Study||41
202576|NCT00787241|486311|P2|COMPLETED|Overall Study||143
202577|NCT00787241|486312|P1|COMPLETED|Overall Study||261
202578|NCT00787241|486310|P3|STARTED|Overall Study||41
202579|NCT00787241|486311|P2|STARTED|Overall Study||143
202580|NCT00787241|486312|P1|STARTED|Overall Study||261
202581|NCT00787202|486331|P5|NOT COMPLETED|Overall Study||4
202582|NCT00787202|486332|P4|NOT COMPLETED|Overall Study||2
202583|NCT00787202|486333|P3|NOT COMPLETED|Overall Study||7
202584|NCT00787202|486334|P2|NOT COMPLETED|Overall Study||11
202585|NCT00787202|486335|P1|NOT COMPLETED|Overall Study||14
202586|NCT00787202|486331|P5|COMPLETED|Overall Study||45
202587|NCT00787202|486332|P4|COMPLETED|Overall Study||31
202588|NCT00787202|486333|P3|COMPLETED|Overall Study||26
202589|NCT00787202|486334|P2|COMPLETED|Overall Study||20
202590|NCT00787202|486335|P1|COMPLETED|Overall Study||35
202591|NCT00787202|486331|P5|Treated|Overall Study||49
202592|NCT00787202|486332|P4|Treated|Overall Study||33
202593|NCT00787202|486333|P3|Treated|Overall Study||33
202594|NCT00787202|486334|P2|Treated|Overall Study||31
202595|NCT00787202|486335|P1|Treated|Overall Study||48
202596|NCT00787202|486331|P5|STARTED|Overall Study||49
202597|NCT00787202|486332|P4|STARTED|Overall Study||33
202598|NCT00787202|486333|P3|STARTED|Overall Study||33
202599|NCT00787202|486334|P2|STARTED|Overall Study||31
202600|NCT00787202|486335|P1|STARTED|Overall Study||49
202601|NCT00787189|486388|P2|NOT COMPLETED|Overall Study||2
202602|NCT00787189|486389|P1|NOT COMPLETED|Overall Study||2
202603|NCT00787189|486388|P2|COMPLETED|Overall Study|To study end point.|30
202604|NCT00787189|486389|P1|COMPLETED|Overall Study|To study end point.|30
202605|NCT00787189|486388|P2|STARTED|Overall Study||32
202606|NCT00787189|486389|P1|STARTED|Overall Study||32
202607|NCT00787150|486398|P3|NOT COMPLETED|Overall Study||5
202608|NCT00787150|486399|P2|NOT COMPLETED|Overall Study||7
202609|NCT00787150|486400|P1|NOT COMPLETED|Overall Study||9
202610|NCT00787150|486398|P3|COMPLETED|Overall Study||66
202611|NCT00787150|486399|P2|COMPLETED|Overall Study||65
202612|NCT00787150|486400|P1|COMPLETED|Overall Study||66
202613|NCT00787150|486398|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
202614|NCT00787150|486399|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
202615|NCT00787150|486400|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
202616|NCT00787137|486445|P3|NOT COMPLETED|Overall Study||1
202617|NCT00787137|486446|P2|NOT COMPLETED|Overall Study||0
202618|NCT00787137|486447|P1|NOT COMPLETED|Overall Study||0
202619|NCT00787137|486445|P3|COMPLETED|Overall Study||4
202620|NCT00787137|486446|P2|COMPLETED|Overall Study||6
202621|NCT00787137|486447|P1|COMPLETED|Overall Study||6
202622|NCT00787137|486445|P3|STARTED|Overall Study||5
202623|NCT00787137|486446|P2|STARTED|Overall Study||6
202624|NCT00787137|486447|P1|STARTED|Overall Study||6
202625|NCT00787124|486469|P2|NOT COMPLETED|Overall Study||0
202626|NCT00787124|486470|P1|NOT COMPLETED|Overall Study||0
202627|NCT00787124|486469|P2|COMPLETED|Overall Study||4
202628|NCT00787124|486470|P1|COMPLETED|Overall Study||4
202629|NCT00787124|486469|P2|STARTED|Overall Study||4
202630|NCT00787124|486470|P1|STARTED|Overall Study||4
202631|NCT00787020|486480|P2|NOT COMPLETED|Overall Study||0
202632|NCT00787020|486481|P1|NOT COMPLETED|Overall Study||0
202633|NCT00787020|486480|P2|COMPLETED|Overall Study||13
202634|NCT00787020|486481|P1|COMPLETED|Overall Study||24
202635|NCT00787020|486480|P2|STARTED|Overall Study||13
202636|NCT00787020|486481|P1|STARTED|Overall Study||24
202637|NCT00786994|486495|P4|NOT COMPLETED|Overall Study||6
202638|NCT00786994|486496|P3|NOT COMPLETED|Overall Study||2
202639|NCT00786994|486497|P2|NOT COMPLETED|Overall Study||15
202640|NCT00786994|486498|P1|NOT COMPLETED|Overall Study||10
202641|NCT00786994|486495|P4|COMPLETED|Overall Study||22
202642|NCT00786994|486496|P3|COMPLETED|Overall Study||24
202643|NCT00786994|486497|P2|COMPLETED|Overall Study||39
202644|NCT00786994|486498|P1|COMPLETED|Overall Study||47
202645|NCT00786994|486495|P4|ITT|Overall Study||28
202646|NCT00786994|486496|P3|ITT|Overall Study||25
202647|NCT00786994|486497|P2|ITT|Overall Study||51
202648|NCT00786994|486498|P1|ITT|Overall Study||53
202649|NCT00786994|486495|P4|STARTED|Overall Study||28
202650|NCT00786994|486496|P3|STARTED|Overall Study||26
202651|NCT00786994|486497|P2|STARTED|Overall Study||54
202652|NCT00786994|486498|P1|STARTED|Overall Study||57
202653|NCT00786916|486510|P3|NOT COMPLETED|Overall Study||0
202654|NCT00786916|486511|P2|NOT COMPLETED|Overall Study||0
202655|NCT00786916|486512|P1|NOT COMPLETED|Overall Study||0
202656|NCT00786916|486510|P3|COMPLETED|Overall Study||34
202657|NCT00786916|486511|P2|COMPLETED|Overall Study||36
202658|NCT00786916|486512|P1|COMPLETED|Overall Study||39
202659|NCT00786916|486510|P3|STARTED|Overall Study||34
202660|NCT00786916|486511|P2|STARTED|Overall Study||36
202661|NCT00786916|486512|P1|STARTED|Overall Study||39
202662|NCT00786864|486522|P2|NOT COMPLETED|Overall Study||1
202663|NCT00786864|486523|P1|NOT COMPLETED|Overall Study||1
202664|NCT00786864|486522|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
202665|NCT00786864|486523|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
202666|NCT00786864|486522|P2|STARTED|Overall Study||33
202667|NCT00786864|486523|P1|STARTED|Overall Study||39
202668|NCT00786838|486535|P1|NOT COMPLETED|Overall Study||49
202669|NCT00786838|486535|P1|COMPLETED|Overall Study||26
202670|NCT00786838|486535|P1|STARTED|Overall Study||75
202671|NCT00786799|486562|P2|NOT COMPLETED|Overall Study||1
202672|NCT00786799|486563|P1|NOT COMPLETED|Overall Study||1
202673|NCT00786799|486562|P2|COMPLETED|Overall Study||12
202674|NCT00786799|486563|P1|COMPLETED|Overall Study||13
202675|NCT00786799|486562|P2|STARTED|Overall Study||13
202676|NCT00786799|486563|P1|STARTED|Overall Study||14
202677|NCT00786682|486574|P1|NOT COMPLETED|Overall Study||0
202678|NCT00786682|486574|P1|COMPLETED|Overall Study||11
202679|NCT00786682|486574|P1|STARTED|Overall Study||11
202680|NCT00786643|486582|P2|NOT COMPLETED|Overall Study||0
202681|NCT00786643|486583|P1|NOT COMPLETED|Overall Study||0
202682|NCT00786643|486582|P2|COMPLETED|Overall Study||28
202683|NCT00786643|486583|P1|COMPLETED|Overall Study||20
202684|NCT00786643|486582|P2|STARTED|Overall Study||28
202685|NCT00786643|486583|P1|STARTED|Overall Study||20
202686|NCT00786565|486593|P1|NOT COMPLETED|Post Surgery||2
202687|NCT00786565|486593|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
202688|NCT00786565|486593|P1|STARTED|Post Surgery||69
202689|NCT00786565|486593|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
202690|NCT00786565|486593|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
202691|NCT00786565|486593|P1|STARTED|Enrollment Prior to Surgery||75
202692|NCT00786487|486635|P4|NOT COMPLETED|Overall Study||0
202693|NCT00786487|486636|P3|NOT COMPLETED|Overall Study||0
202694|NCT00786487|486637|P2|NOT COMPLETED|Overall Study||0
202695|NCT00786487|486638|P1|NOT COMPLETED|Overall Study||0
202696|NCT00786487|486635|P4|COMPLETED|Overall Study||7
202697|NCT00786487|486636|P3|COMPLETED|Overall Study||9
202698|NCT00786487|486637|P2|COMPLETED|Overall Study||7
202699|NCT00786487|486638|P1|COMPLETED|Overall Study||10
202700|NCT00786487|486635|P4|STARTED|Overall Study||7
202701|NCT00786487|486636|P3|STARTED|Overall Study||9
202702|NCT00786487|486637|P2|STARTED|Overall Study||7
202703|NCT00786487|486638|P1|STARTED|Overall Study||10
202704|NCT00786474|486650|P2|NOT COMPLETED|Overall Study||43
202705|NCT00786474|486651|P1|NOT COMPLETED|Overall Study||37
202706|NCT00786474|486650|P2|COMPLETED|Overall Study||891
202707|NCT00786474|486651|P1|COMPLETED|Overall Study||913
202708|NCT00786474|486650|P2|STARTED|Overall Study||934
202709|NCT00786474|486651|P1|STARTED|Overall Study||950
202710|NCT00786422|486663|P1|NOT COMPLETED|Follow-up Period||3
202711|NCT00786422|486663|P1|COMPLETED|Follow-up Period||17
202712|NCT00786422|486663|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
202713|NCT00786422|486663|P1|NOT COMPLETED|Rivaroxaban Treatment||11
202714|NCT00786422|486663|P1|COMPLETED|Rivaroxaban Treatment||14
202715|NCT00786422|486663|P1|STARTED|Rivaroxaban Treatment||25
202716|NCT00786409|486679|P1|NOT COMPLETED|Overall Study||7
202717|NCT00786409|486679|P1|COMPLETED|Overall Study||20
202718|NCT00786409|486679|P1|STARTED|Overall Study||27
202719|NCT00786188|486696|P2|NOT COMPLETED|Overall Study||1
202720|NCT00786188|486697|P1|NOT COMPLETED|Overall Study||5
202721|NCT00786188|486696|P2|COMPLETED|Overall Study||51
202722|NCT00786188|486697|P1|COMPLETED|Overall Study||45
202723|NCT00786188|486696|P2|STARTED|Overall Study||52
202724|NCT00786188|486697|P1|STARTED|Overall Study||50
202725|NCT00786032|486723|P1|NOT COMPLETED|Overall Study||24
202726|NCT00786032|486723|P1|COMPLETED|Overall Study||3
202727|NCT00786032|486723|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
202728|NCT00786032|486723|P1|STARTED|Overall Study||27
202729|NCT00785980|486733|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
202730|NCT00785980|486733|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
202731|NCT00785980|486733|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
202732|NCT00785980|486733|P1|NOT COMPLETED|Ciprofloxacin Alone||0
202733|NCT00785980|486733|P1|COMPLETED|Ciprofloxacin Alone||21
202734|NCT00785980|486733|P1|STARTED|Ciprofloxacin Alone||21
202735|NCT00785980|486733|P1|NOT COMPLETED|7 Day Washout Period||3
202736|NCT00785980|486733|P1|COMPLETED|7 Day Washout Period||21
202737|NCT00785980|486733|P1|STARTED|7 Day Washout Period||24
202738|NCT00785980|486733|P1|NOT COMPLETED|Quinine Sulfate Alone||0
202739|NCT00785980|486733|P1|COMPLETED|Quinine Sulfate Alone||24
202740|NCT00785980|486733|P1|STARTED|Quinine Sulfate Alone||24
202741|NCT00785798|486744|P1|NOT COMPLETED|Overall Study||1
202742|NCT00785798|486744|P1|COMPLETED|Overall Study||16
202743|NCT00785798|486744|P1|STARTED|Overall Study||17
202744|NCT00785785|486751|P2|NOT COMPLETED|Optional Extension Phase||125
202745|NCT00785785|486752|P1|NOT COMPLETED|Optional Extension Phase||39
202746|NCT00785785|486751|P2|COMPLETED|Optional Extension Phase||0
202747|NCT00785785|486752|P1|COMPLETED|Optional Extension Phase||0
202748|NCT00785785|486751|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
202749|NCT00785785|486752|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
202750|NCT00785785|486751|P2|NOT COMPLETED|Core Phase up to 36 Months||320
202751|NCT00785785|486752|P1|NOT COMPLETED|Core Phase up to 36 Months||324
202752|NCT00785785|486751|P2|COMPLETED|Core Phase up to 36 Months||0
202753|NCT00785785|486752|P1|COMPLETED|Core Phase up to 36 Months||0
202754|NCT00785785|486751|P2|STARTED|Core Phase up to 36 Months||320
202755|NCT00785785|486752|P1|STARTED|Core Phase up to 36 Months||324
202756|NCT00785772|486760|P1|NOT COMPLETED|Overall Study||0
202757|NCT00785772|486760|P1|COMPLETED|Overall Study||1
202758|NCT00785772|486760|P1|STARTED|Overall Study||1
202759|NCT00785707|486766|P1|NOT COMPLETED|Overall Study||7
202760|NCT00785707|486766|P1|COMPLETED|Overall Study||24
202761|NCT00785707|486766|P1|STARTED|Overall Study||31
202762|NCT00785629|486775|P4|NOT COMPLETED|Overall Study||16
202763|NCT00785629|486776|P3|NOT COMPLETED|Overall Study||10
202764|NCT00785629|486777|P2|NOT COMPLETED|Overall Study||5
202765|NCT00785629|486778|P1|NOT COMPLETED|Overall Study||8
202766|NCT00785629|486775|P4|COMPLETED|Overall Study|16 not completed|41
202767|NCT00785629|486776|P3|COMPLETED|Overall Study|10 not completed|18
202768|NCT00785629|486777|P2|COMPLETED|Overall Study|5 not completed|25
202769|NCT00785629|486778|P1|COMPLETED|Overall Study|8 not completed|22
202770|NCT00785629|486775|P4|STARTED|Overall Study||57
202771|NCT00785629|486776|P3|STARTED|Overall Study||28
202772|NCT00785629|486777|P2|STARTED|Overall Study||30
202773|NCT00785629|486778|P1|STARTED|Overall Study||30
202774|NCT00785577|486791|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
202775|NCT00785577|486792|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
202776|NCT00785577|486793|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
202777|NCT00785577|486794|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
202778|NCT00785577|486795|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
202779|NCT00785577|486791|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
202780|NCT00785577|486792|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
202781|NCT00785577|486793|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
202782|NCT00785577|486794|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
202783|NCT00785577|486795|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
202784|NCT00785577|486791|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
202785|NCT00785577|486792|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
202786|NCT00785577|486793|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
202787|NCT00785577|486794|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
202788|NCT00785577|486795|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
202789|NCT00785577|486791|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
202790|NCT00785577|486792|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
202791|NCT00785577|486793|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
202792|NCT00785577|486794|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
202793|NCT00785577|486795|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
202794|NCT00785577|486791|P5|COMPLETED|Study Period 2: Therapy Phase||27
202795|NCT00785577|486792|P4|COMPLETED|Study Period 2: Therapy Phase||36
202796|NCT00785577|486793|P3|COMPLETED|Study Period 2: Therapy Phase||25
202797|NCT00785577|486794|P2|COMPLETED|Study Period 2: Therapy Phase||36
202798|NCT00785577|486795|P1|COMPLETED|Study Period 2: Therapy Phase||78
202799|NCT00785577|486791|P5|STARTED|Study Period 2: Therapy Phase||47
202800|NCT00785577|486792|P4|STARTED|Study Period 2: Therapy Phase||49
202801|NCT00785577|486793|P3|STARTED|Study Period 2: Therapy Phase||43
202802|NCT00785577|486794|P2|STARTED|Study Period 2: Therapy Phase||45
202803|NCT00785577|486795|P1|STARTED|Study Period 2: Therapy Phase||89
202804|NCT00785512|486933|P2|NOT COMPLETED|Overall Study||4
202805|NCT00785512|486934|P1|NOT COMPLETED|Overall Study||3
202806|NCT00785512|486933|P2|COMPLETED|Overall Study||101
202807|NCT00785512|486934|P1|COMPLETED|Overall Study||99
202808|NCT00785512|486933|P2|STARTED|Overall Study||105
202809|NCT00785512|486934|P1|STARTED|Overall Study||102
202810|NCT00785486|486943|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
202811|NCT00785486|486943|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
202812|NCT00785486|486943|P1|STARTED|Midazolam With Qualaquin at Steady State||23
202813|NCT00785486|486943|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
202814|NCT00785486|486943|P1|COMPLETED|Qualaquin Alone at Steady State||23
202815|NCT00785486|486943|P1|STARTED|Qualaquin Alone at Steady State||23
202816|NCT00785486|486943|P1|NOT COMPLETED|3 Day Washout||0
202817|NCT00785486|486943|P1|COMPLETED|3 Day Washout||23
202818|NCT00785486|486943|P1|STARTED|3 Day Washout||23
202819|NCT00785486|486943|P1|NOT COMPLETED|Midazolam Alone||1
202820|NCT00785486|486943|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
202821|NCT00785486|486943|P1|STARTED|Midazolam Alone||24
202822|NCT00785356|486967|P1|NOT COMPLETED|Overall Study||8
202823|NCT00785356|486967|P1|COMPLETED|Overall Study||0
202824|NCT00785356|486967|P1|STARTED|Overall Study||8
202825|NCT00785291|486978|P3|NOT COMPLETED|Overall Study||106
202826|NCT00785291|486979|P2|NOT COMPLETED|Overall Study||149
202827|NCT00785291|486980|P1|NOT COMPLETED|Overall Study||136
202828|NCT00785291|486978|P3|COMPLETED|Overall Study||139
202829|NCT00785291|486979|P2|COMPLETED|Overall Study||122
202830|NCT00785291|486980|P1|COMPLETED|Overall Study||147
202831|NCT00785291|486978|P3|STARTED|Overall Study||245
202832|NCT00785291|486979|P2|STARTED|Overall Study||271
202833|NCT00785291|486980|P1|STARTED|Overall Study||283
202834|NCT00785213|487000|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
202835|NCT00785213|487000|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
202836|NCT00785213|487000|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
202837|NCT00785213|487000|P1|NOT COMPLETED|Quinine Sulfate Alone||4
202838|NCT00785213|487000|P1|COMPLETED|Quinine Sulfate Alone||19
202839|NCT00785213|487000|P1|STARTED|Quinine Sulfate Alone||23
202840|NCT00785213|487000|P1|NOT COMPLETED|2 Day Washout Period||0
202841|NCT00785213|487000|P1|COMPLETED|2 Day Washout Period||23
202842|NCT00785213|487000|P1|STARTED|2 Day Washout Period||23
202843|NCT00785213|487000|P1|NOT COMPLETED|Rosiglitazone Alone||0
202844|NCT00785213|487000|P1|COMPLETED|Rosiglitazone Alone||23
202845|NCT00785213|487000|P1|STARTED|Rosiglitazone Alone||23
202846|NCT00785044|487011|P1|NOT COMPLETED|Overall Study||496
202847|NCT00785044|487011|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
202848|NCT00785044|487011|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
202849|NCT00785044|487011|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
202850|NCT00784979|487016|P1|NOT COMPLETED|Overall Study||6
202851|NCT00784979|487016|P1|COMPLETED|Overall Study||20
202852|NCT00784979|487016|P1|STARTED|Overall Study||26
202853|NCT00784927|487020|P1|NOT COMPLETED|Overall Study||3
202854|NCT00784927|487020|P1|COMPLETED|Overall Study||33
202855|NCT00784927|487020|P1|STARTED|Overall Study||36
202856|NCT00784875|487032|P4|NOT COMPLETED|Period D||1
202857|NCT00784875|487033|P3|NOT COMPLETED|Period D||6
202858|NCT00784875|487034|P2|NOT COMPLETED|Period D||4
202859|NCT00784875|487035|P1|NOT COMPLETED|Period D||5
202860|NCT00784875|487032|P4|COMPLETED|Period D||87
202861|NCT00784875|487033|P3|COMPLETED|Period D||88
202862|NCT00784875|487034|P2|COMPLETED|Period D||85
202863|NCT00784875|487035|P1|COMPLETED|Period D||86
202864|NCT00784875|487032|P4|STARTED|Period D||88
202865|NCT00784875|487033|P3|STARTED|Period D||94
202866|NCT00784875|487034|P2|STARTED|Period D||89
202867|NCT00784875|487035|P1|STARTED|Period D||91
202868|NCT00784875|487032|P4|NOT COMPLETED|Period C||7
202869|NCT00784875|487033|P3|NOT COMPLETED|Period C||13
202870|NCT00784875|487034|P2|NOT COMPLETED|Period C||6
202871|NCT00784875|487035|P1|NOT COMPLETED|Period C||7
202872|NCT00784875|487032|P4|COMPLETED|Period C||91
202873|NCT00784875|487033|P3|COMPLETED|Period C||84
202874|NCT00784875|487034|P2|COMPLETED|Period C||91
202875|NCT00784875|487035|P1|COMPLETED|Period C||96
202876|NCT00784875|487032|P4|STARTED|Period C||98
202877|NCT00784875|487033|P3|STARTED|Period C||97
202878|NCT00784875|487034|P2|STARTED|Period C||97
202879|NCT00784875|487035|P1|STARTED|Period C||103
202880|NCT00784875|487032|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
202881|NCT00784875|487033|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
202882|NCT00784875|487034|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
202883|NCT00784875|487035|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
202884|NCT00784875|487032|P4|COMPLETED|Period B - Efficacy Endpoint||98
202885|NCT00784875|487033|P3|COMPLETED|Period B - Efficacy Endpoint||96
202886|NCT00784875|487034|P2|COMPLETED|Period B - Efficacy Endpoint||101
202887|NCT00784875|487035|P1|COMPLETED|Period B - Efficacy Endpoint||100
202888|NCT00784875|487032|P4|Cohort 2|Period B - Efficacy Endpoint||101
202889|NCT00784875|487033|P3|Cohort 2|Period B - Efficacy Endpoint||102
202890|NCT00784875|487034|P2|Cohort 2|Period B - Efficacy Endpoint||102
202891|NCT00784875|487035|P1|Cohort 2|Period B - Efficacy Endpoint||102
202892|NCT00784875|487032|P4|STARTED|Period B - Efficacy Endpoint||117
202893|NCT00784875|487033|P3|STARTED|Period B - Efficacy Endpoint||117
202894|NCT00784875|487034|P2|STARTED|Period B - Efficacy Endpoint||113
202895|NCT00784875|487035|P1|STARTED|Period B - Efficacy Endpoint||114
202896|NCT00784875|487032|P4|NOT COMPLETED|Period A - Baseline||182
202897|NCT00784875|487033|P3|NOT COMPLETED|Period A - Baseline||0
202898|NCT00784875|487034|P2|NOT COMPLETED|Period A - Baseline||0
202899|NCT00784875|487035|P1|NOT COMPLETED|Period A - Baseline||0
202900|NCT00784875|487032|P4|COMPLETED|Period A - Baseline||461
202901|NCT00784875|487033|P3|COMPLETED|Period A - Baseline||0
202902|NCT00784875|487034|P2|COMPLETED|Period A - Baseline||0
202903|NCT00784875|487035|P1|COMPLETED|Period A - Baseline||0
202904|NCT00784875|487032|P4|STARTED|Period A - Baseline||643
202905|NCT00784875|487033|P3|STARTED|Period A - Baseline||0
202906|NCT00784875|487034|P2|STARTED|Period A - Baseline||0
202907|NCT00784875|487035|P1|STARTED|Period A - Baseline||0
202908|NCT00784849|487149|P1|NOT COMPLETED|Overall Study||0
202909|NCT00784849|487149|P1|COMPLETED|Overall Study||62
202910|NCT00784849|487149|P1|STARTED|Overall Study||62
202911|NCT00784836|487155|P1|NOT COMPLETED|Overall Study||3
202912|NCT00784836|487155|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
202913|NCT00784836|487155|P1|STARTED|Overall Study||3
202914|NCT00784810|487162|P2|NOT COMPLETED|Overall Study||49
202915|NCT00784810|487163|P1|NOT COMPLETED|Overall Study||63
202916|NCT00784810|487162|P2|COMPLETED|Overall Study||74
202917|NCT00784810|487163|P1|COMPLETED|Overall Study||61
202918|NCT00784810|487162|P2|STARTED|Overall Study||123
202919|NCT00784810|487163|P1|STARTED|Overall Study||124
202920|NCT00784784|487173|P2|NOT COMPLETED|Overall Study||2
202921|NCT00784784|487174|P1|NOT COMPLETED|Overall Study||2
202922|NCT00784784|487173|P2|COMPLETED|Overall Study||40
202923|NCT00784784|487174|P1|COMPLETED|Overall Study||20
202924|NCT00784784|487173|P2|STARTED|Overall Study||42
202925|NCT00784784|487174|P1|STARTED|Overall Study||22
202926|NCT00784719|487189|P7|NOT COMPLETED|Overall Study||5
202927|NCT00784719|487190|P6|NOT COMPLETED|Overall Study||3
202928|NCT00784719|487191|P5|NOT COMPLETED|Overall Study||6
202929|NCT00784719|487192|P4|NOT COMPLETED|Overall Study||0
202930|NCT00784719|487193|P3|NOT COMPLETED|Overall Study||1
202931|NCT00784719|487194|P2|NOT COMPLETED|Overall Study||3
202932|NCT00784719|487195|P1|NOT COMPLETED|Overall Study||3
202933|NCT00784719|487189|P7|COMPLETED|Overall Study||42
202934|NCT00784719|487190|P6|COMPLETED|Overall Study||41
202935|NCT00784719|487191|P5|COMPLETED|Overall Study||42
202936|NCT00784719|487192|P4|COMPLETED|Overall Study||48
202937|NCT00784719|487193|P3|COMPLETED|Overall Study||46
202938|NCT00784719|487194|P2|COMPLETED|Overall Study||43
202939|NCT00784719|487195|P1|COMPLETED|Overall Study||44
202940|NCT00784719|487189|P7|STARTED|Overall Study||47
202941|NCT00784719|487190|P6|STARTED|Overall Study||44
202942|NCT00784719|487191|P5|STARTED|Overall Study||48
202943|NCT00784719|487192|P4|STARTED|Overall Study||48
202944|NCT00784719|487193|P3|STARTED|Overall Study||47
202945|NCT00784719|487194|P2|STARTED|Overall Study||46
202946|NCT00784719|487195|P1|STARTED|Overall Study||47
202947|NCT00784654|487365|P3|NOT COMPLETED|Randomized Withdrawal Period||63
202948|NCT00784654|487366|P2|NOT COMPLETED|Randomized Withdrawal Period||18
202949|NCT00784654|487367|P1|NOT COMPLETED|Randomized Withdrawal Period||0
202950|NCT00784654|487365|P3|COMPLETED|Randomized Withdrawal Period||16
202951|NCT00784654|487366|P2|COMPLETED|Randomized Withdrawal Period||60
202952|NCT00784654|487367|P1|COMPLETED|Randomized Withdrawal Period||0
202953|NCT00784654|487365|P3|STARTED|Randomized Withdrawal Period||79
202954|NCT00784654|487366|P2|STARTED|Randomized Withdrawal Period||78
202955|NCT00784654|487367|P1|STARTED|Randomized Withdrawal Period||0
202956|NCT00784654|487365|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
202957|NCT00784654|487366|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
202958|NCT00784654|487367|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
202959|NCT00784654|487365|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
202960|NCT00784654|487366|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
202961|NCT00784654|487367|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
202962|NCT00784654|487365|P3|STARTED|Open-Label Period (Non-Randomized)||0
202963|NCT00784654|487366|P2|STARTED|Open-Label Period (Non-Randomized)||0
202964|NCT00784654|487367|P1|STARTED|Open-Label Period (Non-Randomized)||276
202965|NCT00784563|487402|P3|NOT COMPLETED|Year 3||3
202966|NCT00784563|487403|P2|NOT COMPLETED|Year 3||0
202967|NCT00784563|487404|P1|NOT COMPLETED|Year 3||0
202968|NCT00784563|487402|P3|COMPLETED|Year 3||14
202969|NCT00784563|487403|P2|COMPLETED|Year 3||0
202970|NCT00784563|487404|P1|COMPLETED|Year 3||0
202971|NCT00784563|487402|P3|STARTED|Year 3||17
202972|NCT00784563|487403|P2|STARTED|Year 3||0
202973|NCT00784563|487404|P1|STARTED|Year 3||0
202974|NCT00784563|487402|P3|NOT COMPLETED|Years 1 & 2||0
202975|NCT00784563|487403|P2|NOT COMPLETED|Years 1 & 2||5
202976|NCT00784563|487404|P1|NOT COMPLETED|Years 1 & 2||3
202977|NCT00784563|487402|P3|COMPLETED|Years 1 & 2||0
202978|NCT00784563|487403|P2|COMPLETED|Years 1 & 2||17
202979|NCT00784563|487404|P1|COMPLETED|Years 1 & 2||18
202980|NCT00784563|487402|P3|STARTED|Years 1 & 2||0
202981|NCT00784563|487403|P2|STARTED|Years 1 & 2||22
202982|NCT00784563|487404|P1|STARTED|Years 1 & 2||21
202983|NCT00784550|487422|P2|NOT COMPLETED|Overall Study||42
202984|NCT00784550|487423|P1|NOT COMPLETED|Overall Study||36
202985|NCT00784550|487422|P2|COMPLETED|Overall Study||127
202986|NCT00784550|487423|P1|COMPLETED|Overall Study||137
202987|NCT00784550|487422|P2|STARTED|Overall Study||169
202988|NCT00784550|487423|P1|STARTED|Overall Study||173
202989|NCT00784459|487441|P2|NOT COMPLETED|Overall Study||2
202990|NCT00784459|487442|P1|NOT COMPLETED|Overall Study||0
202991|NCT00784459|487441|P2|COMPLETED|Overall Study||11
202992|NCT00784459|487442|P1|COMPLETED|Overall Study||11
202993|NCT00784459|487441|P2|STARTED|Overall Study||13
202994|NCT00784459|487442|P1|STARTED|Overall Study||11
202995|NCT00784368|487453|P3|NOT COMPLETED|Overall Study||11
202996|NCT00784368|487454|P2|NOT COMPLETED|Overall Study||11
202997|NCT00784368|487455|P1|NOT COMPLETED|Overall Study||8
202998|NCT00784368|487453|P3|COMPLETED|Overall Study||12
202999|NCT00784368|487454|P2|COMPLETED|Overall Study||5
203000|NCT00784368|487455|P1|COMPLETED|Overall Study||8
203001|NCT00784368|487453|P3|STARTED|Overall Study||23
203002|NCT00784368|487454|P2|STARTED|Overall Study||16
203003|NCT00784368|487455|P1|STARTED|Overall Study||16
203004|NCT00784277|487493|P7|NOT COMPLETED|ER Treatment||15
203005|NCT00784277|487494|P6|NOT COMPLETED|ER Treatment||24
203006|NCT00784277|487495|P5|NOT COMPLETED|ER Treatment||9
203007|NCT00784277|487496|P4|NOT COMPLETED|ER Treatment||0
203008|NCT00784277|487497|P3|NOT COMPLETED|ER Treatment||0
203009|NCT00784277|487498|P2|NOT COMPLETED|ER Treatment||0
203010|NCT00784277|487499|P1|NOT COMPLETED|ER Treatment||0
203011|NCT00784277|487493|P7|COMPLETED|ER Treatment||76
203012|NCT00784277|487494|P6|COMPLETED|ER Treatment||226
203013|NCT00784277|487495|P5|COMPLETED|ER Treatment||113
203014|NCT00784277|487496|P4|COMPLETED|ER Treatment||0
203015|NCT00784277|487497|P3|COMPLETED|ER Treatment||0
203016|NCT00784277|487498|P2|COMPLETED|ER Treatment||0
203017|NCT00784277|487499|P1|COMPLETED|ER Treatment||0
203018|NCT00784277|487493|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
203019|NCT00784277|487494|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
203020|NCT00784277|487495|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
203021|NCT00784277|487496|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
203022|NCT00784277|487497|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
203023|NCT00784277|487498|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
203024|NCT00784277|487499|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
203025|NCT00784277|487493|P7|NOT COMPLETED|IR Treatment||0
203026|NCT00784277|487494|P6|NOT COMPLETED|IR Treatment||0
203027|NCT00784277|487495|P5|NOT COMPLETED|IR Treatment||0
203028|NCT00784277|487496|P4|NOT COMPLETED|IR Treatment||43
203029|NCT00784277|487497|P3|NOT COMPLETED|IR Treatment||28
203030|NCT00784277|487498|P2|NOT COMPLETED|IR Treatment||17
203031|NCT00784277|487499|P1|NOT COMPLETED|IR Treatment||16
203032|NCT00784277|487493|P7|COMPLETED|IR Treatment||0
203033|NCT00784277|487494|P6|COMPLETED|IR Treatment||0
203034|NCT00784277|487495|P5|COMPLETED|IR Treatment||0
203035|NCT00784277|487496|P4|COMPLETED|IR Treatment||100
203036|NCT00784277|487497|P3|COMPLETED|IR Treatment||126
203037|NCT00784277|487498|P2|COMPLETED|IR Treatment||134
203038|NCT00784277|487499|P1|COMPLETED|IR Treatment||132
203039|NCT00784277|487493|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
203040|NCT00784277|487494|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
203041|NCT00784277|487495|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
203042|NCT00784277|487496|P4|STARTED|IR Treatment||143
203043|NCT00784277|487497|P3|STARTED|IR Treatment||154
203044|NCT00784277|487498|P2|STARTED|IR Treatment||151
203045|NCT00784277|487499|P1|STARTED|IR Treatment||148
203046|NCT00784238|487516|P1|NOT COMPLETED|Overall Study||119
203047|NCT00784238|487516|P1|COMPLETED|Overall Study||170
203048|NCT00784238|487516|P1|STARTED|Overall Study||289
203049|NCT00784147|487559|P2|NOT COMPLETED|Overall Study||9
203050|NCT00784147|487560|P1|NOT COMPLETED|Overall Study||8
203051|NCT00784147|487559|P2|COMPLETED|Overall Study||45
203052|NCT00784147|487560|P1|COMPLETED|Overall Study||51
203053|NCT00784147|487559|P2|STARTED|Overall Study||54
203054|NCT00784147|487560|P1|STARTED|Overall Study||59
203055|NCT00784134|487580|P2|NOT COMPLETED|Overall Study||6
203056|NCT00784134|487581|P1|NOT COMPLETED|Overall Study||3
203057|NCT00784134|487580|P2|COMPLETED|Overall Study||245
203058|NCT00784134|487581|P1|COMPLETED|Overall Study||246
203059|NCT00784134|487580|P2|STARTED|Overall Study||251
203060|NCT00784134|487581|P1|STARTED|Overall Study||249
203061|NCT00784095|487680|P3|NOT COMPLETED|Overall Study||1
203062|NCT00784095|487681|P2|NOT COMPLETED|Overall Study||1
203063|NCT00784095|487682|P1|NOT COMPLETED|Overall Study||0
203064|NCT00784095|487680|P3|COMPLETED|Overall Study||11
203065|NCT00784095|487681|P2|COMPLETED|Overall Study||11
203066|NCT00784095|487682|P1|COMPLETED|Overall Study||12
203067|NCT00784095|487680|P3|STARTED|Overall Study||12
203068|NCT00784095|487681|P2|STARTED|Overall Study||12
203069|NCT00784095|487682|P1|STARTED|Overall Study||12
203070|NCT00784043|487704|P2|NOT COMPLETED|Overall Study||6
203071|NCT00784043|487705|P1|NOT COMPLETED|Overall Study||31
203072|NCT00784043|487704|P2|COMPLETED|Overall Study||0
203073|NCT00784043|487705|P1|COMPLETED|Overall Study||0
203074|NCT00784043|487704|P2|STARTED|Overall Study||6
203075|NCT00784043|487705|P1|STARTED|Overall Study||31
203076|NCT00784030|487717|P2|NOT COMPLETED|Overall Study||0
203077|NCT00784030|487718|P1|NOT COMPLETED|Overall Study||0
203078|NCT00784030|487717|P2|COMPLETED|Overall Study||10
203079|NCT00784030|487718|P1|COMPLETED|Overall Study||13
203080|NCT00784030|487717|P2|STARTED|Overall Study||10
203081|NCT00784030|487718|P1|STARTED|Overall Study||13
203082|NCT00783965|487726|P2|NOT COMPLETED|Second Intervention (24 Months)||9
203083|NCT00783965|487727|P1|NOT COMPLETED|Second Intervention (24 Months)||0
203084|NCT00783965|487726|P2|COMPLETED|Second Intervention (24 Months)||16
203085|NCT00783965|487727|P1|COMPLETED|Second Intervention (24 Months)||2
203086|NCT00783965|487726|P2|STARTED|Second Intervention (24 Months)||25
203087|NCT00783965|487727|P1|STARTED|Second Intervention (24 Months)||2
203088|NCT00783965|487726|P2|NOT COMPLETED|First Intervention (12 Months)||4
203089|NCT00783965|487727|P1|NOT COMPLETED|First Intervention (12 Months)||3
203090|NCT00783965|487726|P2|COMPLETED|First Intervention (12 Months)||25
203091|NCT00783965|487727|P1|COMPLETED|First Intervention (12 Months)||2
203092|NCT00783965|487726|P2|STARTED|First Intervention (12 Months)||29
203093|NCT00783965|487727|P1|STARTED|First Intervention (12 Months)||5
203094|NCT00783952|487735|P1|NOT COMPLETED|Overall Study||0
203095|NCT00783952|487735|P1|COMPLETED|Overall Study||8
203096|NCT00783952|487735|P1|STARTED|Overall Study||8
203097|NCT00783835|487740|P1|NOT COMPLETED|Overall Study||10
203098|NCT00783835|487740|P1|COMPLETED|Overall Study||50
203099|NCT00783835|487740|P1|STARTED|Overall Study||60
203100|NCT00783796|487752|P1|NOT COMPLETED|Overall Study||6
203101|NCT00783796|487752|P1|COMPLETED|Overall Study||144
203102|NCT00783796|487752|P1|STARTED|Overall Study||150
203103|NCT00783718|487857|P7|NOT COMPLETED|Maintenance Phase||195
203104|NCT00783718|487858|P6|NOT COMPLETED|Maintenance Phase||41
203105|NCT00783718|487859|P5|NOT COMPLETED|Maintenance Phase||45
203106|NCT00783718|487860|P4|NOT COMPLETED|Maintenance Phase||78
203107|NCT00783718|487861|P3|NOT COMPLETED|Maintenance Phase||0
203108|NCT00783718|487862|P2|NOT COMPLETED|Maintenance Phase||0
203109|NCT00783718|487863|P1|NOT COMPLETED|Maintenance Phase||105
203110|NCT00783718|487857|P7|COMPLETED|Maintenance Phase||135
203111|NCT00783718|487858|P6|COMPLETED|Maintenance Phase||84
203112|NCT00783718|487859|P5|COMPLETED|Maintenance Phase||77
203113|NCT00783718|487860|P4|COMPLETED|Maintenance Phase||48
203114|NCT00783718|487861|P3|COMPLETED|Maintenance Phase||0
203115|NCT00783718|487862|P2|COMPLETED|Maintenance Phase||0
203116|NCT00783718|487863|P1|COMPLETED|Maintenance Phase||30
203117|NCT00783718|487857|P7|STARTED|Maintenance Phase||330
203118|NCT00783718|487858|P6|STARTED|Maintenance Phase||125
203119|NCT00783718|487859|P5|STARTED|Maintenance Phase||122
203120|NCT00783718|487860|P4|STARTED|Maintenance Phase||126
203121|NCT00783718|487861|P3|STARTED|Maintenance Phase||0
203122|NCT00783718|487862|P2|STARTED|Maintenance Phase||0
203123|NCT00783718|487863|P1|STARTED|Maintenance Phase||135
203124|NCT00783718|487857|P7|NOT COMPLETED|Induction Phase||0
203125|NCT00783718|487858|P6|NOT COMPLETED|Induction Phase||0
203126|NCT00783718|487859|P5|NOT COMPLETED|Induction Phase||0
203127|NCT00783718|487860|P4|NOT COMPLETED|Induction Phase||0
203128|NCT00783718|487861|P3|NOT COMPLETED|Induction Phase||36
203129|NCT00783718|487862|P2|NOT COMPLETED|Induction Phase||7
203130|NCT00783718|487863|P1|NOT COMPLETED|Induction Phase||14
203131|NCT00783718|487857|P7|COMPLETED|Induction Phase||0
203132|NCT00783718|487858|P6|COMPLETED|Induction Phase||0
203133|NCT00783718|487859|P5|COMPLETED|Induction Phase||0
203134|NCT00783718|487860|P4|COMPLETED|Induction Phase||0
203135|NCT00783718|487861|P3|COMPLETED|Induction Phase||485
203136|NCT00783718|487862|P2|COMPLETED|Induction Phase||218
203137|NCT00783718|487863|P1|COMPLETED|Induction Phase||135
203138|NCT00783718|487857|P7|STARTED|Induction Phase||0
203139|NCT00783718|487858|P6|STARTED|Induction Phase||0
203140|NCT00783718|487859|P5|STARTED|Induction Phase||0
203141|NCT00783718|487860|P4|STARTED|Induction Phase||0
203142|NCT00783718|487861|P3|STARTED|Induction Phase||521
203143|NCT00783718|487862|P2|STARTED|Induction Phase||225
203144|NCT00783718|487863|P1|STARTED|Induction Phase||149
203145|NCT00783705|487891|P2|NOT COMPLETED|Overall Study||5
203146|NCT00783705|487892|P1|NOT COMPLETED|Overall Study||6
203147|NCT00783705|487891|P2|COMPLETED|Overall Study||36
203148|NCT00783705|487892|P1|COMPLETED|Overall Study||38
203149|NCT00783705|487891|P2|STARTED|Overall Study||41
203150|NCT00783705|487892|P1|STARTED|Overall Study||44
203151|NCT00783692|487939|P7|NOT COMPLETED|Maintenance Phase||249
203152|NCT00783692|487940|P6|NOT COMPLETED|Maintenance Phase||72
203153|NCT00783692|487941|P5|NOT COMPLETED|Maintenance Phase||81
203154|NCT00783692|487942|P4|NOT COMPLETED|Maintenance Phase||89
203155|NCT00783692|487943|P3|NOT COMPLETED|Maintenance Phase||0
203156|NCT00783692|487944|P2|NOT COMPLETED|Maintenance Phase||0
203157|NCT00783692|487945|P1|NOT COMPLETED|Maintenance Phase||95
203158|NCT00783692|487939|P7|COMPLETED|Maintenance Phase||163
203159|NCT00783692|487940|P6|COMPLETED|Maintenance Phase||82
203160|NCT00783692|487941|P5|COMPLETED|Maintenance Phase||73
203161|NCT00783692|487942|P4|COMPLETED|Maintenance Phase||64
203162|NCT00783692|487943|P3|COMPLETED|Maintenance Phase||0
203163|NCT00783692|487944|P2|COMPLETED|Maintenance Phase||0
203164|NCT00783692|487945|P1|COMPLETED|Maintenance Phase||42
203165|NCT00783692|487939|P7|STARTED|Maintenance Phase||412
203166|NCT00783692|487940|P6|STARTED|Maintenance Phase||154
203167|NCT00783692|487941|P5|STARTED|Maintenance Phase||154
203168|NCT00783692|487942|P4|STARTED|Maintenance Phase||153
203169|NCT00783692|487943|P3|STARTED|Maintenance Phase||0
203170|NCT00783692|487944|P2|STARTED|Maintenance Phase||0
203171|NCT00783692|487945|P1|STARTED|Maintenance Phase||137
203172|NCT00783692|487939|P7|NOT COMPLETED|Induction Phase||0
203173|NCT00783692|487940|P6|NOT COMPLETED|Induction Phase||0
203174|NCT00783692|487941|P5|NOT COMPLETED|Induction Phase||0
203175|NCT00783692|487942|P4|NOT COMPLETED|Induction Phase||0
203176|NCT00783692|487943|P3|NOT COMPLETED|Induction Phase||74
203177|NCT00783692|487944|P2|NOT COMPLETED|Induction Phase||21
203178|NCT00783692|487945|P1|NOT COMPLETED|Induction Phase||11
203179|NCT00783692|487939|P7|COMPLETED|Induction Phase||0
203180|NCT00783692|487940|P6|COMPLETED|Induction Phase||0
203181|NCT00783692|487941|P5|COMPLETED|Induction Phase||0
203182|NCT00783692|487942|P4|COMPLETED|Induction Phase||0
203183|NCT00783692|487943|P3|COMPLETED|Induction Phase||674
203184|NCT00783692|487944|P2|COMPLETED|Induction Phase||199
203185|NCT00783692|487945|P1|COMPLETED|Induction Phase||137
203186|NCT00783692|487939|P7|Treated|Induction Phase||0
203187|NCT00783692|487940|P6|Treated|Induction Phase||0
203188|NCT00783692|487941|P5|Treated|Induction Phase||0
203189|NCT00783692|487942|P4|Treated|Induction Phase||0
203190|NCT00783692|487943|P3|Treated|Induction Phase||747
203191|NCT00783692|487944|P2|Treated|Induction Phase||220
203192|NCT00783692|487945|P1|Treated|Induction Phase||148
203193|NCT00783692|487939|P7|STARTED|Induction Phase||0
203194|NCT00783692|487940|P6|STARTED|Induction Phase||0
203195|NCT00783692|487941|P5|STARTED|Induction Phase||0
203196|NCT00783692|487942|P4|STARTED|Induction Phase||0
203197|NCT00783692|487943|P3|STARTED|Induction Phase||748
203198|NCT00783692|487944|P2|STARTED|Induction Phase||220
203199|NCT00783692|487945|P1|STARTED|Induction Phase||148
203200|NCT00783614|487972|P4|NOT COMPLETED|Overall Study||0
203201|NCT00783614|487973|P3|NOT COMPLETED|Overall Study||0
203202|NCT00783614|487974|P2|NOT COMPLETED|Overall Study||0
203203|NCT00783614|487975|P1|NOT COMPLETED|Overall Study||0
203204|NCT00783614|487972|P4|COMPLETED|Overall Study||5
203205|NCT00783614|487973|P3|COMPLETED|Overall Study||5
203206|NCT00783614|487974|P2|COMPLETED|Overall Study||6
203207|NCT00783614|487975|P1|COMPLETED|Overall Study||6
203208|NCT00783614|487972|P4|STARTED|Overall Study||5
203209|NCT00783614|487973|P3|STARTED|Overall Study||5
203210|NCT00783614|487974|P2|STARTED|Overall Study||6
203211|NCT00783614|487975|P1|STARTED|Overall Study||6
203212|NCT00783432|487991|P2|NOT COMPLETED|Overall Study||78
203213|NCT00783432|487992|P1|NOT COMPLETED|Overall Study||85
203214|NCT00783432|487991|P2|COMPLETED|Overall Study||354
203215|NCT00783432|487992|P1|COMPLETED|Overall Study||345
203216|NCT00783432|487991|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
203217|NCT00783432|487992|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
203218|NCT00783302|488002|P1|NOT COMPLETED|Overall Study||35
203219|NCT00783302|488002|P1|COMPLETED|Overall Study||850
203220|NCT00783302|488002|P1|STARTED|Overall Study||885
203221|NCT00783263|488024|P4|NOT COMPLETED|Overall Study||3
203222|NCT00783263|488025|P3|NOT COMPLETED|Overall Study||3
203223|NCT00783263|488026|P2|NOT COMPLETED|Overall Study||2
203224|NCT00783263|488027|P1|NOT COMPLETED|Overall Study||4
203225|NCT00783263|488024|P4|COMPLETED|Overall Study||118
203226|NCT00783263|488025|P3|COMPLETED|Overall Study||119
203227|NCT00783263|488026|P2|COMPLETED|Overall Study||96
203228|NCT00783263|488027|P1|COMPLETED|Overall Study||95
203229|NCT00783263|488024|P4|STARTED|Overall Study||121
203230|NCT00783263|488025|P3|STARTED|Overall Study||122
203231|NCT00783263|488026|P2|STARTED|Overall Study||98
203232|NCT00783263|488027|P1|STARTED|Overall Study||99
203233|NCT00783224|488057|P4|NOT COMPLETED|Overall Study||2
203234|NCT00783224|488058|P3|NOT COMPLETED|Overall Study||1
203235|NCT00783224|488059|P2|NOT COMPLETED|Overall Study||0
203236|NCT00783224|488060|P1|NOT COMPLETED|Overall Study||0
203237|NCT00783224|488057|P4|COMPLETED|Overall Study||140
203238|NCT00783224|488058|P3|COMPLETED|Overall Study||142
203239|NCT00783224|488059|P2|COMPLETED|Overall Study||34
203240|NCT00783224|488060|P1|COMPLETED|Overall Study||32
203241|NCT00783224|488057|P4|STARTED|Overall Study||142
203242|NCT00783224|488058|P3|STARTED|Overall Study||143
203243|NCT00783224|488059|P2|STARTED|Overall Study||34
203244|NCT00783224|488060|P1|STARTED|Overall Study||32
203245|NCT00783198|488072|P3|NOT COMPLETED|Overall Study||42
203246|NCT00783198|488073|P2|NOT COMPLETED|Overall Study||43
203247|NCT00783198|488074|P1|NOT COMPLETED|Overall Study||57
203248|NCT00783198|488072|P3|COMPLETED|Overall Study||146
203249|NCT00783198|488073|P2|COMPLETED|Overall Study||144
203250|NCT00783198|488074|P1|COMPLETED|Overall Study||133
203251|NCT00783198|488072|P3|STARTED|Overall Study||188
203252|NCT00783198|488073|P2|STARTED|Overall Study||187
203253|NCT00783198|488074|P1|STARTED|Overall Study||190
203254|NCT00783094|488097|P3|NOT COMPLETED|Open-Label Extension Period||30
203255|NCT00783094|488098|P2|NOT COMPLETED|Open-Label Extension Period||19
203256|NCT00783094|488099|P1|NOT COMPLETED|Open-Label Extension Period||22
203257|NCT00783094|488097|P3|COMPLETED|Open-Label Extension Period||101
203258|NCT00783094|488098|P2|COMPLETED|Open-Label Extension Period||109
203259|NCT00783094|488099|P1|COMPLETED|Open-Label Extension Period||113
203260|NCT00783094|488097|P3|STARTED|Open-Label Extension Period||131
203261|NCT00783094|488098|P2|STARTED|Open-Label Extension Period||128
203262|NCT00783094|488099|P1|STARTED|Open-Label Extension Period||135
203263|NCT00783094|488097|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
203264|NCT00783094|488098|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
203265|NCT00783094|488099|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
203266|NCT00783094|488097|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
203267|NCT00783094|488098|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
203268|NCT00783094|488099|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
203269|NCT00783094|488097|P3|STARTED|Randomized Double-Blind Treatment Period||140
203270|NCT00783094|488098|P2|STARTED|Randomized Double-Blind Treatment Period||140
203271|NCT00783094|488099|P1|STARTED|Randomized Double-Blind Treatment Period||142
203272|NCT00782834|488175|P1|NOT COMPLETED|Treatment Phase||1
203273|NCT00782834|488175|P1|COMPLETED|Treatment Phase||13
203274|NCT00782834|488175|P1|STARTED|Treatment Phase||14
203275|NCT00782834|488175|P1|NOT COMPLETED|Screened Patients||1
203276|NCT00782834|488175|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
203277|NCT00782834|488175|P1|STARTED|Screened Patients||15
203278|NCT00782821|488184|P4|NOT COMPLETED|Overall Study||2
203279|NCT00782821|488185|P3|NOT COMPLETED|Overall Study||1
203280|NCT00782821|488186|P2|NOT COMPLETED|Overall Study||0
203281|NCT00782821|488187|P1|NOT COMPLETED|Overall Study||0
203282|NCT00782821|488184|P4|COMPLETED|Overall Study||8
203283|NCT00782821|488185|P3|COMPLETED|Overall Study||9
203284|NCT00782821|488186|P2|COMPLETED|Overall Study||10
203285|NCT00782821|488187|P1|COMPLETED|Overall Study||10
203286|NCT00782821|488184|P4|STARTED|Overall Study||10
203287|NCT00782821|488185|P3|STARTED|Overall Study||10
203288|NCT00782821|488186|P2|STARTED|Overall Study||10
203289|NCT00782821|488187|P1|STARTED|Overall Study||10
203290|NCT00782795|488215|P2|NOT COMPLETED|Overall Study||2
203291|NCT00782795|488216|P1|NOT COMPLETED|Overall Study||1
203292|NCT00782795|488215|P2|COMPLETED|Overall Study||6
203293|NCT00782795|488216|P1|COMPLETED|Overall Study||16
203294|NCT00782795|488215|P2|24 Week Appointment|Overall Study||7
203295|NCT00782795|488216|P1|24 Week Appointment|Overall Study||16
203296|NCT00782795|488215|P2|6 Weeks (1st Apptment)|Overall Study||7
203297|NCT00782795|488216|P1|6 Weeks (1st Apptment)|Overall Study||16
203298|NCT00782795|488215|P2|STARTED|Overall Study||8
203299|NCT00782795|488216|P1|STARTED|Overall Study||17
203300|NCT00782756|488248|P1|NOT COMPLETED|Overall Study||0
203301|NCT00782756|488248|P1|COMPLETED|Overall Study||40
203302|NCT00782756|488248|P1|STARTED|Overall Study||40
203303|NCT00782717|488256|P2|NOT COMPLETED|Overall Study||28
203304|NCT00782717|488257|P1|NOT COMPLETED|Overall Study||15
203305|NCT00782717|488256|P2|COMPLETED|Overall Study||102
203306|NCT00782717|488257|P1|COMPLETED|Overall Study||118
203307|NCT00782717|488256|P2|STARTED|Overall Study||130
203308|NCT00782717|488257|P1|STARTED|Overall Study||133
203309|NCT00782639|488267|P2|NOT COMPLETED|Overall Study||0
203310|NCT00782639|488268|P1|NOT COMPLETED|Overall Study||0
203311|NCT00782639|488267|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
203312|NCT00782639|488268|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
203313|NCT00782639|488267|P2|STARTED|Overall Study||11
203314|NCT00782639|488268|P1|STARTED|Overall Study||12
203315|NCT00782626|488284|P1|NOT COMPLETED|Overall Study||7
203316|NCT00782626|488284|P1|COMPLETED|Overall Study||16
203317|NCT00782626|488284|P1|STARTED|Overall Study||23
203318|NCT00782509|488291|P3|NOT COMPLETED|Overall Study||36
203319|NCT00782509|488292|P2|NOT COMPLETED|Overall Study||24
203320|NCT00782509|488293|P1|NOT COMPLETED|Overall Study||41
203321|NCT00782509|488291|P3|COMPLETED|Overall Study||181
203322|NCT00782509|488292|P2|COMPLETED|Overall Study||185
203323|NCT00782509|488293|P1|COMPLETED|Overall Study||175
203324|NCT00782509|488291|P3|STARTED|Overall Study||217
203325|NCT00782509|488292|P2|STARTED|Overall Study||209
203326|NCT00782509|488293|P1|STARTED|Overall Study||216
203327|NCT00782496|488486|P2|NOT COMPLETED|Overall Study||15
203328|NCT00782496|488487|P1|NOT COMPLETED|Overall Study||14
203329|NCT00782496|488486|P2|COMPLETED|Overall Study||90
203330|NCT00782496|488487|P1|COMPLETED|Overall Study||92
203331|NCT00782496|488486|P2|STARTED|Overall Study||105
203332|NCT00782496|488487|P1|STARTED|Overall Study||106
203333|NCT00782483|488494|P1|NOT COMPLETED|Overall Study||6
203334|NCT00782483|488494|P1|COMPLETED|Overall Study||0
203335|NCT00782483|488494|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
203336|NCT00782418|488498|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
203337|NCT00782418|488499|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
203338|NCT00782418|488500|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
203339|NCT00782418|488501|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
203340|NCT00782418|488502|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
203341|NCT00782418|488503|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
203342|NCT00782418|488504|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
203343|NCT00782418|488498|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
203344|NCT00782418|488499|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
203345|NCT00782418|488500|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
203346|NCT00782418|488501|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
203347|NCT00782418|488502|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
203348|NCT00782418|488503|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
203349|NCT00782418|488504|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
203350|NCT00782418|488498|P7|STARTED|Period 2 Procedure/Treatment Groups||4
203351|NCT00782418|488499|P6|STARTED|Period 2 Procedure/Treatment Groups||4
203352|NCT00782418|488500|P5|STARTED|Period 2 Procedure/Treatment Groups||3
203353|NCT00782418|488501|P4|STARTED|Period 2 Procedure/Treatment Groups||1
203354|NCT00782418|488502|P3|STARTED|Period 2 Procedure/Treatment Groups||4
203355|NCT00782418|488503|P2|STARTED|Period 2 Procedure/Treatment Groups||4
203356|NCT00782418|488504|P1|STARTED|Period 2 Procedure/Treatment Groups||3
203357|NCT00782418|488498|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
203358|NCT00782418|488499|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
203359|NCT00782418|488500|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
203360|NCT00782418|488501|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
203361|NCT00782418|488502|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
203362|NCT00782418|488503|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
203363|NCT00782418|488504|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
203364|NCT00782418|488498|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
203365|NCT00782418|488499|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
203366|NCT00782418|488500|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
203367|NCT00782418|488501|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
203368|NCT00782418|488502|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
203369|NCT00782418|488503|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
203370|NCT00782418|488504|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
203371|NCT00782418|488498|P7|STARTED|Period 1 Procedure/Treatment Groups||4
203372|NCT00782418|488499|P6|STARTED|Period 1 Procedure/Treatment Groups||5
203373|NCT00782418|488500|P5|STARTED|Period 1 Procedure/Treatment Groups||5
203374|NCT00782418|488501|P4|STARTED|Period 1 Procedure/Treatment Groups||2
203375|NCT00782418|488502|P3|STARTED|Period 1 Procedure/Treatment Groups||4
203376|NCT00782418|488503|P2|STARTED|Period 1 Procedure/Treatment Groups||4
203377|NCT00782418|488504|P1|STARTED|Period 1 Procedure/Treatment Groups||3
203378|NCT00782379|488524|P1|NOT COMPLETED|Overall Study||0
203379|NCT00782379|488524|P1|COMPLETED|Overall Study||20
203380|NCT00782379|488524|P1|STARTED|Overall Study||20
203381|NCT00782340|488541|P3|NOT COMPLETED|Randomized Double Blind||0
203382|NCT00782340|488542|P2|NOT COMPLETED|Randomized Double Blind||0
203383|NCT00782340|488543|P1|NOT COMPLETED|Randomized Double Blind||0
203384|NCT00782340|488541|P3|COMPLETED|Randomized Double Blind||80
203385|NCT00782340|488542|P2|COMPLETED|Randomized Double Blind||82
203386|NCT00782340|488543|P1|COMPLETED|Randomized Double Blind||0
203387|NCT00782340|488541|P3|STARTED|Randomized Double Blind||80
203388|NCT00782340|488542|P2|STARTED|Randomized Double Blind||82
203389|NCT00782340|488543|P1|STARTED|Randomized Double Blind||0
203390|NCT00782340|488541|P3|NOT COMPLETED|Open Label Titration||0
203391|NCT00782340|488542|P2|NOT COMPLETED|Open Label Titration||0
203392|NCT00782340|488543|P1|NOT COMPLETED|Open Label Titration||101
203393|NCT00782340|488541|P3|COMPLETED|Open Label Titration||0
203394|NCT00782340|488542|P2|COMPLETED|Open Label Titration||0
203395|NCT00782340|488543|P1|COMPLETED|Open Label Titration||162
203396|NCT00782340|488541|P3|STARTED|Open Label Titration||0
203397|NCT00782340|488542|P2|STARTED|Open Label Titration||0
203398|NCT00782340|488543|P1|STARTED|Open Label Titration||263
203399|NCT00782288|488569|P3|NOT COMPLETED|Overall Study||0
203400|NCT00782288|488570|P2|NOT COMPLETED|Overall Study||0
203401|NCT00782288|488571|P1|NOT COMPLETED|Overall Study||0
203402|NCT00782288|488569|P3|COMPLETED|Overall Study||8
203403|NCT00782288|488570|P2|COMPLETED|Overall Study||8
203404|NCT00782288|488571|P1|COMPLETED|Overall Study||8
203405|NCT00782288|488569|P3|STARTED|Overall Study||8
203406|NCT00782288|488570|P2|STARTED|Overall Study||8
203407|NCT00782288|488571|P1|STARTED|Overall Study||8
203408|NCT00782275|488613|P1|NOT COMPLETED|Overall Study||41
203409|NCT00782275|488613|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
203410|NCT00782275|488613|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
203411|NCT00782275|488613|P1|Treated|Overall Study||40
203412|NCT00782275|488613|P1|STARTED|Overall Study||41
203413|NCT00782210|488622|P3|NOT COMPLETED|Overall Study||35
203414|NCT00782210|488623|P2|NOT COMPLETED|Overall Study||35
203415|NCT00782210|488624|P1|NOT COMPLETED|Overall Study||50
203416|NCT00782210|488622|P3|COMPLETED|Overall Study||172
203417|NCT00782210|488623|P2|COMPLETED|Overall Study||173
203418|NCT00782210|488624|P1|COMPLETED|Overall Study||159
203419|NCT00782210|488622|P3|STARTED|Overall Study||207
203420|NCT00782210|488623|P2|STARTED|Overall Study||208
203421|NCT00782210|488624|P1|STARTED|Overall Study||209
203422|NCT00782184|488817|P2|NOT COMPLETED|Overall Study||5
203423|NCT00782184|488818|P1|NOT COMPLETED|Overall Study||4
203424|NCT00782184|488817|P2|COMPLETED|Overall Study||125
203425|NCT00782184|488818|P1|COMPLETED|Overall Study||116
203426|NCT00782184|488817|P2|STARTED|Overall Study||130
203427|NCT00782184|488818|P1|STARTED|Overall Study||120
203428|NCT00782171|488855|P2|NOT COMPLETED|Overall Study||19
203429|NCT00782171|488856|P1|NOT COMPLETED|Overall Study||22
203430|NCT00782171|488855|P2|COMPLETED|Overall Study||115
203431|NCT00782171|488856|P1|COMPLETED|Overall Study||124
203432|NCT00782171|488855|P2|Surgery (Baseline)|Overall Study||128
203433|NCT00782171|488856|P1|Surgery (Baseline)|Overall Study||138
203434|NCT00782171|488855|P2|1 Year|Overall Study||120
203435|NCT00782171|488856|P1|1 Year|Overall Study||131
203436|NCT00782171|488855|P2|20-23 Weeks|Overall Study||124
203437|NCT00782171|488856|P1|20-23 Weeks|Overall Study||135
203438|NCT00782171|488855|P2|STARTED|Overall Study||134
203439|NCT00782171|488856|P1|STARTED|Overall Study||146
203440|NCT00782067|488888|P1|NOT COMPLETED|Overall Study||95
203441|NCT00782067|488888|P1|COMPLETED|Overall Study||21
203442|NCT00782067|488888|P1|Primary Efficacy Population (PEP)|Overall Study||89
203443|NCT00782067|488888|P1|Treatment Ongoing|Overall Study||21
203444|NCT00782067|488888|P1|STARTED|Overall Study||116
203445|NCT00781963|488898|P3|NOT COMPLETED|Overall Study||2
203446|NCT00781963|488899|P2|NOT COMPLETED|Overall Study||9
203447|NCT00781963|488900|P1|NOT COMPLETED|Overall Study||8
203448|NCT00781963|488898|P3|COMPLETED|Overall Study||51
203449|NCT00781963|488899|P2|COMPLETED|Overall Study||43
203450|NCT00781963|488900|P1|COMPLETED|Overall Study||46
203451|NCT00781963|488898|P3|6-month Follow-up|Overall Study||52
203452|NCT00781963|488899|P2|6-month Follow-up|Overall Study||44
203453|NCT00781963|488900|P1|6-month Follow-up|Overall Study||48
203454|NCT00781963|488898|P3|Post-treatment|Overall Study||53
203455|NCT00781963|488899|P2|Post-treatment|Overall Study||45
203456|NCT00781963|488900|P1|Post-treatment|Overall Study||52
203457|NCT00781963|488898|P3|STARTED|Overall Study||53
203458|NCT00781963|488899|P2|STARTED|Overall Study||52
203459|NCT00781963|488900|P1|STARTED|Overall Study||54
203460|NCT00781950|488910|P2|NOT COMPLETED|Overall Study||13
203461|NCT00781950|488911|P1|NOT COMPLETED|Overall Study||11
203462|NCT00781950|488910|P2|COMPLETED|Overall Study||45
203463|NCT00781950|488911|P1|COMPLETED|Overall Study||41
203464|NCT00781950|488910|P2|STARTED|Overall Study||58
203465|NCT00781950|488911|P1|STARTED|Overall Study||52
203466|NCT00781937|488921|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
203467|NCT00781937|488922|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
203468|NCT00781937|488921|P2|COMPLETED|Follow up Period (Week 56-68)||141
203469|NCT00781937|488922|P1|COMPLETED|Follow up Period (Week 56-68)||153
203470|NCT00781937|488921|P2|STARTED|Follow up Period (Week 56-68)||146
203471|NCT00781937|488922|P1|STARTED|Follow up Period (Week 56-68)||159
203472|NCT00781937|488921|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
203473|NCT00781937|488922|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
203474|NCT00781937|488921|P2|COMPLETED|Main Trial Period Through Week 56||146
203475|NCT00781937|488922|P1|COMPLETED|Main Trial Period Through Week 56||159
203476|NCT00781937|488921|P2|STARTED|Main Trial Period Through Week 56||210
203477|NCT00781937|488922|P1|STARTED|Main Trial Period Through Week 56||212
203478|NCT00781911|488980|P2|NOT COMPLETED|Overall Study||8
203479|NCT00781911|488981|P1|NOT COMPLETED|Overall Study||6
203480|NCT00781911|488980|P2|COMPLETED|Overall Study||4
203481|NCT00781911|488981|P1|COMPLETED|Overall Study||25
203482|NCT00781911|488980|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
203483|NCT00781911|488981|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
203484|NCT00781911|488980|P2|STARTED|Overall Study||12
203485|NCT00781911|488981|P1|STARTED|Overall Study||31
203486|NCT00781898|489009|P2|NOT COMPLETED|Overall Study||29
203487|NCT00781898|489010|P1|NOT COMPLETED|Overall Study||34
203488|NCT00781898|489009|P2|COMPLETED|Overall Study||126
203489|NCT00781898|489010|P1|COMPLETED|Overall Study||119
203490|NCT00781898|489009|P2|STARTED|Overall Study||155
203491|NCT00781898|489010|P1|STARTED|Overall Study||153
203492|NCT00781859|489018|P2|NOT COMPLETED|Overall Study||9
203493|NCT00781859|489019|P1|NOT COMPLETED|Overall Study||19
203494|NCT00781859|489018|P2|COMPLETED|Overall Study||98
203495|NCT00781859|489019|P1|COMPLETED|Overall Study||200
203496|NCT00781859|489018|P2|STARTED|Overall Study||107
203497|NCT00781859|489019|P1|STARTED|Overall Study||219
203498|NCT00781599|489029|P2|NOT COMPLETED|Overall Study||4
203499|NCT00781599|489030|P1|NOT COMPLETED|Overall Study||7
203500|NCT00781599|489029|P2|COMPLETED|Overall Study||32
203501|NCT00781599|489030|P1|COMPLETED|Overall Study||29
203502|NCT00781599|489029|P2|STARTED|Overall Study||36
203503|NCT00781599|489030|P1|STARTED|Overall Study||36
203504|NCT00781508|489044|P2|NOT COMPLETED|Overall Study||0
203505|NCT00781508|489045|P1|NOT COMPLETED|Overall Study||0
203506|NCT00781508|489044|P2|COMPLETED|Overall Study||5
203507|NCT00781508|489045|P1|COMPLETED|Overall Study||5
203508|NCT00781508|489044|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
203509|NCT00781508|489045|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
203510|NCT00781456|489055|P2|NOT COMPLETED|Overall Study||16
203511|NCT00781456|489056|P1|NOT COMPLETED|Overall Study||21
203512|NCT00781456|489055|P2|COMPLETED|Overall Study||35
203513|NCT00781456|489056|P1|COMPLETED|Overall Study||37
203514|NCT00781456|489055|P2|Received Study Drug|Overall Study||49
203515|NCT00781456|489056|P1|Received Study Drug|Overall Study||57
203516|NCT00781456|489055|P2|STARTED|Overall Study||51
203517|NCT00781456|489056|P1|STARTED|Overall Study||58
203518|NCT00781391|489079|P3|NOT COMPLETED|Overall Study||784
203519|NCT00781391|489080|P2|NOT COMPLETED|Overall Study||807
203520|NCT00781391|489081|P1|NOT COMPLETED|Overall Study||879
203521|NCT00781391|489079|P3|COMPLETED|Overall Study||6250
203522|NCT00781391|489080|P2|COMPLETED|Overall Study||6228
203523|NCT00781391|489081|P1|COMPLETED|Overall Study||6157
203524|NCT00781391|489079|P3|Per Protocol Analysis Set|Overall Study||6982
203525|NCT00781391|489080|P2|Per Protocol Analysis Set|Overall Study||6995
203526|NCT00781391|489081|P1|Per Protocol Analysis Set|Overall Study||6993
203527|NCT00781391|489079|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
203528|NCT00781391|489080|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
203529|NCT00781391|489081|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
203530|NCT00781391|489079|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
203531|NCT00781391|489080|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
203532|NCT00781391|489081|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
203533|NCT00781391|489079|P3|STARTED|Overall Study||7034
203534|NCT00781391|489080|P2|STARTED|Overall Study||7035
203535|NCT00781391|489081|P1|STARTED|Overall Study||7036
203536|NCT00781365|489115|P2|NOT COMPLETED|Overall Study||36
203537|NCT00781365|489116|P1|NOT COMPLETED|Overall Study||34
203538|NCT00781365|489115|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
203539|NCT00781365|489116|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
203540|NCT00781365|489115|P2|STARTED|Overall Study||222
203541|NCT00781365|489116|P1|STARTED|Overall Study||228
203542|NCT00781326|489126|P1|NOT COMPLETED|Phase 2||0
203543|NCT00781326|489126|P1|COMPLETED|Phase 2||0
203544|NCT00781326|489126|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
203545|NCT00781326|489126|P1|NOT COMPLETED|Phase I||4
203546|NCT00781326|489126|P1|COMPLETED|Phase I||2
203547|NCT00781326|489126|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
203548|NCT00781274|489130|P1|NOT COMPLETED|Overall Study||2
203549|NCT00781274|489130|P1|COMPLETED|Overall Study||30
203550|NCT00781274|489130|P1|STARTED|Overall Study||32
203551|NCT00781079|489136|P2|NOT COMPLETED|Overall Study||17
203552|NCT00781079|489137|P1|NOT COMPLETED|Overall Study||27
203553|NCT00781079|489136|P2|COMPLETED|Overall Study||116
203554|NCT00781079|489137|P1|COMPLETED|Overall Study||122
203555|NCT00781079|489136|P2|STARTED|Overall Study||133
203556|NCT00781079|489137|P1|STARTED|Overall Study||149
203557|NCT00780962|489147|P2|NOT COMPLETED|Overall Study||27
203558|NCT00780962|489148|P1|NOT COMPLETED|Overall Study||15
203559|NCT00780962|489147|P2|COMPLETED|Overall Study||172
203560|NCT00780962|489148|P1|COMPLETED|Overall Study||185
203561|NCT00780962|489147|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
203562|NCT00780962|489148|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
203563|NCT00780962|489147|P2|STARTED|Overall Study||199
203564|NCT00780962|489148|P1|STARTED|Overall Study||200
203565|NCT00780910|489154|P1|NOT COMPLETED|Overall Study||2
203566|NCT00780910|489154|P1|COMPLETED|Overall Study||107
203567|NCT00780910|489154|P1|STARTED|Overall Study||109
203568|NCT00780741|489160|P2|NOT COMPLETED|Overall Study||10
203569|NCT00780741|489161|P1|NOT COMPLETED|Overall Study||7
203570|NCT00780741|489160|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
203571|NCT00780741|489161|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
203572|NCT00780741|489160|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
203573|NCT00780741|489161|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
203574|NCT00780741|489160|P2|STARTED|Overall Study|randomized|81
203575|NCT00780741|489161|P1|STARTED|Overall Study|randomized|82
203576|NCT00780715|489177|P4|NOT COMPLETED|Overall Study||0
203577|NCT00780715|489178|P3|NOT COMPLETED|Overall Study||0
203578|NCT00780715|489179|P2|NOT COMPLETED|Overall Study||0
203579|NCT00780715|489180|P1|NOT COMPLETED|Overall Study||0
203580|NCT00780715|489177|P4|COMPLETED|Overall Study||11
203581|NCT00780715|489178|P3|COMPLETED|Overall Study||6
203582|NCT00780715|489179|P2|COMPLETED|Overall Study||6
203583|NCT00780715|489180|P1|COMPLETED|Overall Study||6
203584|NCT00780715|489177|P4|STARTED|Overall Study||11
203585|NCT00780715|489178|P3|STARTED|Overall Study||6
203586|NCT00780715|489179|P2|STARTED|Overall Study||6
203587|NCT00780715|489180|P1|STARTED|Overall Study||6
203588|NCT00780676|489195|P5|NOT COMPLETED|Overall Study||0
203589|NCT00780676|489196|P4|NOT COMPLETED|Overall Study||0
203590|NCT00780676|489197|P3|NOT COMPLETED|Overall Study||0
203591|NCT00780676|489198|P2|NOT COMPLETED|Overall Study||0
203592|NCT00780676|489199|P1|NOT COMPLETED|Overall Study||0
203593|NCT00780676|489195|P5|COMPLETED|Overall Study||0
203594|NCT00780676|489196|P4|COMPLETED|Overall Study||0
203595|NCT00780676|489197|P3|COMPLETED|Overall Study||13
203596|NCT00780676|489198|P2|COMPLETED|Overall Study||8
203597|NCT00780676|489199|P1|COMPLETED|Overall Study||9
203598|NCT00780676|489195|P5|STARTED|Overall Study||0
203599|NCT00780676|489196|P4|STARTED|Overall Study||0
203600|NCT00780676|489197|P3|STARTED|Overall Study||13
203601|NCT00780676|489198|P2|STARTED|Overall Study||8
203602|NCT00780676|489199|P1|STARTED|Overall Study||9
203603|NCT00780572|489207|P2|NOT COMPLETED|Overall Study||0
203604|NCT00780572|489208|P1|NOT COMPLETED|Overall Study||0
203605|NCT00780572|489207|P2|COMPLETED|Overall Study||298
203606|NCT00780572|489208|P1|COMPLETED|Overall Study||297
203607|NCT00780572|489207|P2|STARTED|Overall Study||298
203608|NCT00780572|489208|P1|STARTED|Overall Study||297
203609|NCT00780481|489214|P1|NOT COMPLETED|Overall Study||0
203610|NCT00780481|489214|P1|COMPLETED|Overall Study||13
203611|NCT00780481|489214|P1|STARTED|Overall Study||13
203612|NCT00780455|489223|P2|NOT COMPLETED|Overall Study||0
203613|NCT00780455|489224|P1|NOT COMPLETED|Overall Study||0
203614|NCT00780455|489223|P2|COMPLETED|Overall Study||2
203615|NCT00780455|489224|P1|COMPLETED|Overall Study||2
203616|NCT00780455|489223|P2|STARTED|Overall Study||2
203617|NCT00780455|489224|P1|STARTED|Overall Study||2
203618|NCT00780416|489250|P2|NOT COMPLETED|Overall Study||9
203619|NCT00780416|489251|P1|NOT COMPLETED|Overall Study||12
203620|NCT00780416|489250|P2|COMPLETED|Overall Study||54
203621|NCT00780416|489251|P1|COMPLETED|Overall Study||114
203622|NCT00780416|489250|P2|STARTED|Overall Study||63
203623|NCT00780416|489251|P1|STARTED|Overall Study||126
203624|NCT00780403|489257|P2|NOT COMPLETED|Second Intervention||0
203625|NCT00780403|489258|P1|NOT COMPLETED|Second Intervention||0
203626|NCT00780403|489257|P2|COMPLETED|Second Intervention||111
203627|NCT00780403|489258|P1|COMPLETED|Second Intervention||109
203628|NCT00780403|489257|P2|STARTED|Second Intervention||111
203629|NCT00780403|489258|P1|STARTED|Second Intervention||109
203630|NCT00780403|489257|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
203631|NCT00780403|489258|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
203632|NCT00780403|489257|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
203633|NCT00780403|489258|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
203634|NCT00780403|489257|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
203635|NCT00780403|489258|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
203636|NCT00780403|489257|P2|NOT COMPLETED|First Intervention||0
203637|NCT00780403|489258|P1|NOT COMPLETED|First Intervention||0
203638|NCT00780403|489257|P2|COMPLETED|First Intervention||111
203639|NCT00780403|489258|P1|COMPLETED|First Intervention||109
203640|NCT00780403|489257|P2|STARTED|First Intervention||111
203641|NCT00780403|489258|P1|STARTED|First Intervention||109
203642|NCT00780338|489267|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
203643|NCT00780338|489268|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
203644|NCT00780338|489267|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
203645|NCT00780338|489268|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
203646|NCT00780338|489267|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
203647|NCT00780338|489268|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
203648|NCT00780338|489267|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
203649|NCT00780338|489268|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
203650|NCT00780338|489267|P2|COMPLETED|Baseline to Mid (1 Year)||164
203651|NCT00780338|489268|P1|COMPLETED|Baseline to Mid (1 Year)||169
203652|NCT00780338|489267|P2|STARTED|Baseline to Mid (1 Year)||202
203653|NCT00780338|489268|P1|STARTED|Baseline to Mid (1 Year)||174
203654|NCT00780273|489296|P1|NOT COMPLETED|Overall Study||2
203655|NCT00780273|489296|P1|COMPLETED|Overall Study||17
203656|NCT00780273|489296|P1|STARTED|Overall Study||19
203657|NCT00780026|489307|P2|NOT COMPLETED|Overall Study||0
203658|NCT00780026|489308|P1|NOT COMPLETED|Overall Study||0
203659|NCT00780026|489307|P2|COMPLETED|Overall Study||44
203660|NCT00780026|489308|P1|COMPLETED|Overall Study||42
203661|NCT00780026|489307|P2|STARTED|Overall Study||44
203662|NCT00780026|489308|P1|STARTED|Overall Study||42
203663|NCT00779909|489330|P4|NOT COMPLETED|Overall Study||1
203664|NCT00779909|489331|P3|NOT COMPLETED|Overall Study||0
203665|NCT00779909|489332|P2|NOT COMPLETED|Overall Study||1
203666|NCT00779909|489333|P1|NOT COMPLETED|Overall Study||1
203667|NCT00779909|489330|P4|COMPLETED|Overall Study||7
203668|NCT00779909|489331|P3|COMPLETED|Overall Study||8
203669|NCT00779909|489332|P2|COMPLETED|Overall Study||8
203670|NCT00779909|489333|P1|COMPLETED|Overall Study||9
203671|NCT00779909|489330|P4|STARTED|Overall Study||8
203672|NCT00779909|489331|P3|STARTED|Overall Study||8
203673|NCT00779909|489332|P2|STARTED|Overall Study||9
203674|NCT00779909|489333|P1|STARTED|Overall Study||10
203675|NCT00779857|489375|P1|NOT COMPLETED|Overall Study||6
203676|NCT00779857|489375|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
203677|NCT00779857|489375|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
203678|NCT00779857|489375|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
203679|NCT00779857|489375|P1|STARTED|Overall Study|70 patients treated|70
203680|NCT00779779|489380|P1|NOT COMPLETED|Overall Study||24
203681|NCT00779779|489380|P1|COMPLETED|Overall Study||498
203682|NCT00779779|489380|P1|STARTED|Overall Study||522
203683|NCT00779766|489389|P2|NOT COMPLETED|Overall Study||68
203684|NCT00779766|489390|P1|NOT COMPLETED|Overall Study||85
203685|NCT00779766|489389|P2|COMPLETED|Overall Study|Among those 2814 subjects, 1408 completed the study and 1406 had an unknown completion status.|2957
203686|NCT00779766|489390|P1|COMPLETED|Overall Study|Among those 2831 subjects, 1432 completed the study and 1399 had an unknown completion status.|2941
203687|NCT00779766|489389|P2|STARTED|Overall Study||3025
203688|NCT00779766|489390|P1|STARTED|Overall Study||3026
203689|NCT00779701|489468|P1|NOT COMPLETED|Overall Study||0
203690|NCT00779701|489468|P1|COMPLETED|Overall Study||27
203691|NCT00779701|489468|P1|STARTED|Overall Study||27
203692|NCT00779675|489472|P1|NOT COMPLETED|Extended Treatment Period||46
203693|NCT00779675|489472|P1|COMPLETED|Extended Treatment Period||147
203694|NCT00779675|489472|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
203695|NCT00779675|489472|P1|NOT COMPLETED|Treatment Period||332
203696|NCT00779675|489472|P1|COMPLETED|Treatment Period||328
203697|NCT00779675|489472|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
203698|NCT00779584|489500|P9|NOT COMPLETED|Overall Study||2
203699|NCT00779584|489501|P8|NOT COMPLETED|Overall Study||3
203700|NCT00779584|489502|P7|NOT COMPLETED|Overall Study||8
203701|NCT00779584|489503|P6|NOT COMPLETED|Overall Study||6
203702|NCT00779584|489504|P5|NOT COMPLETED|Overall Study||7
203703|NCT00779584|489505|P4|NOT COMPLETED|Overall Study||6
203704|NCT00779584|489506|P3|NOT COMPLETED|Overall Study||7
203705|NCT00779584|489507|P2|NOT COMPLETED|Overall Study||3
203706|NCT00779584|489508|P1|NOT COMPLETED|Overall Study||3
203707|NCT00779584|489500|P9|COMPLETED|Overall Study||0
203708|NCT00779584|489501|P8|COMPLETED|Overall Study||0
203709|NCT00779584|489502|P7|COMPLETED|Overall Study||0
203710|NCT00779584|489503|P6|COMPLETED|Overall Study||0
203711|NCT00779584|489504|P5|COMPLETED|Overall Study||0
203712|NCT00779584|489505|P4|COMPLETED|Overall Study||0
203713|NCT00779584|489506|P3|COMPLETED|Overall Study||0
203714|NCT00779584|489507|P2|COMPLETED|Overall Study||0
203715|NCT00779584|489508|P1|COMPLETED|Overall Study||0
203716|NCT00779584|489500|P9|Treated|Overall Study||2
203717|NCT00779584|489501|P8|Treated|Overall Study||3
203718|NCT00779584|489502|P7|Treated|Overall Study||8
203719|NCT00779584|489503|P6|Treated|Overall Study||4
203720|NCT00779584|489504|P5|Treated|Overall Study||7
203721|NCT00779584|489505|P4|Treated|Overall Study||6
203722|NCT00779584|489506|P3|Treated|Overall Study||7
203723|NCT00779584|489507|P2|Treated|Overall Study||3
203724|NCT00779584|489508|P1|Treated|Overall Study||3
203725|NCT00779584|489500|P9|STARTED|Overall Study||2
203726|NCT00779584|489501|P8|STARTED|Overall Study||3
203727|NCT00779584|489502|P7|STARTED|Overall Study||8
203728|NCT00779584|489503|P6|STARTED|Overall Study||6
203729|NCT00779584|489504|P5|STARTED|Overall Study||7
203730|NCT00779584|489505|P4|STARTED|Overall Study||6
203731|NCT00779584|489506|P3|STARTED|Overall Study||7
203732|NCT00779584|489507|P2|STARTED|Overall Study||3
203733|NCT00779584|489508|P1|STARTED|Overall Study||3
203734|NCT00779558|489584|P2|NOT COMPLETED|Overall Study||7
203735|NCT00779558|489585|P1|NOT COMPLETED|Overall Study||4
203736|NCT00779558|489584|P2|COMPLETED|Overall Study||37
203737|NCT00779558|489585|P1|COMPLETED|Overall Study||53
203738|NCT00779558|489584|P2|STARTED|Overall Study||44
203739|NCT00779558|489585|P1|STARTED|Overall Study||57
203740|NCT00779506|489599|P1|NOT COMPLETED|Overall Study||29
203741|NCT00779506|489599|P1|COMPLETED|Overall Study||67
203742|NCT00779506|489599|P1|Withdrawal Treatment|Overall Study||27
203743|NCT00779506|489599|P1|Treatment Complete|Overall Study||67
203744|NCT00779506|489599|P1|MITT|Overall Study||89
203745|NCT00779506|489599|P1|Assigned|Overall Study||94
203746|NCT00779506|489599|P1|Screen Failed|Overall Study||2
203747|NCT00779506|489599|P1|Enrolled|Overall Study||96
203748|NCT00779506|489599|P1|STARTED|Overall Study||96
203749|NCT00779467|489613|P4|NOT COMPLETED|Overall Study||19
203750|NCT00779467|489614|P3|NOT COMPLETED|Overall Study||10
203751|NCT00779467|489615|P2|NOT COMPLETED|Overall Study||5
203752|NCT00779467|489616|P1|NOT COMPLETED|Overall Study||15
203753|NCT00779467|489613|P4|COMPLETED|Overall Study||35
203754|NCT00779467|489614|P3|COMPLETED|Overall Study||38
203755|NCT00779467|489615|P2|COMPLETED|Overall Study||40
203756|NCT00779467|489616|P1|COMPLETED|Overall Study||38
203757|NCT00779467|489613|P4|STARTED|Overall Study||54
203758|NCT00779467|489614|P3|STARTED|Overall Study||48
203759|NCT00779467|489615|P2|STARTED|Overall Study||45
203760|NCT00779467|489616|P1|STARTED|Overall Study||53
203761|NCT00779402|489656|P2|NOT COMPLETED|Long-term Follow-up||6
203762|NCT00779402|489657|P1|NOT COMPLETED|Long-term Follow-up||21
203763|NCT00779402|489656|P2|COMPLETED|Long-term Follow-up||7
203764|NCT00779402|489657|P1|COMPLETED|Long-term Follow-up||20
203765|NCT00779402|489656|P2|STARTED|Long-term Follow-up||13
203766|NCT00779402|489657|P1|STARTED|Long-term Follow-up||41
203767|NCT00779402|489656|P2|NOT COMPLETED|Surveillance Phase||31
203768|NCT00779402|489657|P1|NOT COMPLETED|Surveillance Phase||43
203769|NCT00779402|489656|P2|COMPLETED|Surveillance Phase||13
203770|NCT00779402|489657|P1|COMPLETED|Surveillance Phase||41
203771|NCT00779402|489656|P2|STARTED|Surveillance Phase||44
203772|NCT00779402|489657|P1|STARTED|Surveillance Phase||84
203773|NCT00779402|489656|P2|NOT COMPLETED|Treatment Phase 1||15
203774|NCT00779402|489657|P1|NOT COMPLETED|Treatment Phase 1||33
203775|NCT00779402|489656|P2|COMPLETED|Treatment Phase 1||44
203776|NCT00779402|489657|P1|COMPLETED|Treatment Phase 1||84
203777|NCT00779402|489656|P2|Received Booster Infusion|Treatment Phase 1||30
203778|NCT00779402|489657|P1|Received Booster Infusion|Treatment Phase 1||50
203779|NCT00779402|489656|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
203780|NCT00779402|489657|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
203781|NCT00779402|489656|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
203782|NCT00779402|489657|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
203783|NCT00779402|489656|P2|STARTED|Treatment Phase 1||59
203784|NCT00779402|489657|P1|STARTED|Treatment Phase 1||117
203785|NCT00779311|489670|P5|NOT COMPLETED|Overall Study||0
203786|NCT00779311|489671|P4|NOT COMPLETED|Overall Study||0
203787|NCT00779311|489672|P3|NOT COMPLETED|Overall Study||0
203788|NCT00779311|489673|P2|NOT COMPLETED|Overall Study||0
203789|NCT00779311|489674|P1|NOT COMPLETED|Overall Study||0
203790|NCT00779311|489670|P5|COMPLETED|Overall Study||0
203791|NCT00779311|489671|P4|COMPLETED|Overall Study||0
203792|NCT00779311|489672|P3|COMPLETED|Overall Study||0
203793|NCT00779311|489673|P2|COMPLETED|Overall Study||0
203794|NCT00779311|489674|P1|COMPLETED|Overall Study||8
203795|NCT00779311|489670|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
203796|NCT00779311|489671|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
203797|NCT00779311|489672|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
203798|NCT00779311|489673|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
203799|NCT00779311|489674|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
203800|NCT00779311|489670|P5|STARTED|Overall Study||0
203801|NCT00779311|489671|P4|STARTED|Overall Study||0
203802|NCT00779311|489672|P3|STARTED|Overall Study||0
203803|NCT00779311|489673|P2|STARTED|Overall Study||0
203804|NCT00779311|489674|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
203805|NCT00779285|489696|P1|NOT COMPLETED|Overall Study||0
203806|NCT00779285|489696|P1|COMPLETED|Overall Study||1
203807|NCT00779285|489696|P1|STARTED|Overall Study||1
203808|NCT00779259|489700|P1|NOT COMPLETED|Theophylline With Quinine||0
203809|NCT00779259|489700|P1|COMPLETED|Theophylline With Quinine||22
203810|NCT00779259|489700|P1|STARTED|Theophylline With Quinine||22
203811|NCT00779259|489700|P1|NOT COMPLETED|Quinine Alone||2
203812|NCT00779259|489700|P1|COMPLETED|Quinine Alone||22
203813|NCT00779259|489700|P1|STARTED|Quinine Alone||24
203814|NCT00779259|489700|P1|NOT COMPLETED|4 Day Washout Period||0
203815|NCT00779259|489700|P1|COMPLETED|4 Day Washout Period||24
203816|NCT00779259|489700|P1|STARTED|4 Day Washout Period||24
203817|NCT00779259|489700|P1|NOT COMPLETED|Theophylline Alone||0
203818|NCT00779259|489700|P1|COMPLETED|Theophylline Alone||24
203819|NCT00779259|489700|P1|STARTED|Theophylline Alone||24
203820|NCT00779246|489721|P2|NOT COMPLETED|Overall Study||53
203821|NCT00779246|489722|P1|NOT COMPLETED|Overall Study||33
203822|NCT00779246|489721|P2|COMPLETED|Overall Study||715
203823|NCT00779246|489722|P1|COMPLETED|Overall Study||717
203824|NCT00779246|489721|P2|STARTED|Overall Study||768
203825|NCT00779246|489722|P1|STARTED|Overall Study||750
203826|NCT00779155|489734|P2|NOT COMPLETED|Overall Study||0
203827|NCT00779155|489735|P1|NOT COMPLETED|Overall Study||0
203828|NCT00779155|489734|P2|COMPLETED|Overall Study||6
203829|NCT00779155|489735|P1|COMPLETED|Overall Study||6
203830|NCT00779155|489734|P2|STARTED|Overall Study||6
203831|NCT00779155|489735|P1|STARTED|Overall Study||6
203832|NCT00779142|489741|P1|NOT COMPLETED|Overall Study||3
203833|NCT00779142|489741|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
203834|NCT00779142|489741|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
203835|NCT00779116|489747|P2|NOT COMPLETED|Second Intervention||0
203836|NCT00779116|489748|P1|NOT COMPLETED|Second Intervention||0
203837|NCT00779116|489747|P2|COMPLETED|Second Intervention||108
203838|NCT00779116|489748|P1|COMPLETED|Second Intervention||109
203839|NCT00779116|489747|P2|STARTED|Second Intervention||108
203840|NCT00779116|489748|P1|STARTED|Second Intervention||109
203841|NCT00779116|489747|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
203842|NCT00779116|489748|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
203843|NCT00779116|489747|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
203844|NCT00779116|489748|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
203845|NCT00779116|489747|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
203846|NCT00779116|489748|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
203847|NCT00779116|489747|P2|NOT COMPLETED|First Intervention||0
203848|NCT00779116|489748|P1|NOT COMPLETED|First Intervention||0
203849|NCT00779116|489747|P2|COMPLETED|First Intervention||108
203850|NCT00779116|489748|P1|COMPLETED|First Intervention||109
203851|NCT00779116|489747|P2|STARTED|First Intervention||108
203852|NCT00779116|489748|P1|STARTED|First Intervention||109
203853|NCT00779038|489755|P1|NOT COMPLETED|Overall Study||13
203854|NCT00779038|489755|P1|COMPLETED|Overall Study||0
203855|NCT00779038|489755|P1|STARTED|Overall Study||13
203856|NCT00779025|489764|P1|NOT COMPLETED|Overall Study||1
203857|NCT00779025|489764|P1|COMPLETED|Overall Study||81
203858|NCT00779025|489764|P1|STARTED|Overall Study||82
203859|NCT00778999|489775|P2|NOT COMPLETED|Overall Study||34
203860|NCT00778999|489776|P1|NOT COMPLETED|Overall Study||28
203861|NCT00778999|489775|P2|COMPLETED|Overall Study||185
203862|NCT00778999|489776|P1|COMPLETED|Overall Study||195
203863|NCT00778999|489775|P2|STARTED|Overall Study||219
203864|NCT00778999|489776|P1|STARTED|Overall Study||223
203865|NCT00778921|489785|P3|NOT COMPLETED|Overall Study||28
203866|NCT00778921|489786|P2|NOT COMPLETED|Overall Study||19
203867|NCT00778921|489787|P1|NOT COMPLETED|Overall Study||18
203868|NCT00778921|489785|P3|COMPLETED|Overall Study||255
203869|NCT00778921|489786|P2|COMPLETED|Overall Study||266
203870|NCT00778921|489787|P1|COMPLETED|Overall Study||261
203871|NCT00778921|489785|P3|STARTED|Overall Study||283
203872|NCT00778921|489786|P2|STARTED|Overall Study||285
203873|NCT00778921|489787|P1|STARTED|Overall Study||279
203874|NCT00778895|489804|P3|NOT COMPLETED|ESFU Phase||2
203875|NCT00778895|489805|P2|NOT COMPLETED|ESFU Phase||12
203876|NCT00778895|489806|P1|NOT COMPLETED|ESFU Phase||11
203877|NCT00778895|489804|P3|COMPLETED|ESFU Phase||41
203878|NCT00778895|489805|P2|COMPLETED|ESFU Phase||155
203879|NCT00778895|489806|P1|COMPLETED|ESFU Phase||153
203880|NCT00778895|489804|P3|STARTED|ESFU Phase||43
203881|NCT00778895|489805|P2|STARTED|ESFU Phase||167
203882|NCT00778895|489806|P1|STARTED|ESFU Phase||164
203883|NCT00778895|489804|P3|NOT COMPLETED|Active Phase||0
203884|NCT00778895|489805|P2|NOT COMPLETED|Active Phase||6
203885|NCT00778895|489806|P1|NOT COMPLETED|Active Phase||7
203886|NCT00778895|489804|P3|COMPLETED|Active Phase||43
203887|NCT00778895|489805|P2|COMPLETED|Active Phase||161
203888|NCT00778895|489806|P1|COMPLETED|Active Phase||157
203889|NCT00778895|489804|P3|STARTED|Active Phase||43
203890|NCT00778895|489805|P2|STARTED|Active Phase||167
203891|NCT00778895|489806|P1|STARTED|Active Phase||164
203892|NCT00778869|489844|P1|NOT COMPLETED|Overall Study||0
203893|NCT00778869|489844|P1|COMPLETED|Overall Study||10
203894|NCT00778869|489844|P1|STARTED|Overall Study||10
203895|NCT00778830|489850|P2|NOT COMPLETED|Overall Study||1
203896|NCT00778830|489851|P1|NOT COMPLETED|Overall Study||0
203897|NCT00778830|489850|P2|COMPLETED|Overall Study||187
203898|NCT00778830|489851|P1|COMPLETED|Overall Study||101
203899|NCT00778830|489850|P2|STARTED|Overall Study||188
203900|NCT00778830|489851|P1|STARTED|Overall Study||101
203901|NCT00778817|489863|P1|NOT COMPLETED|Overall Study||4
203902|NCT00778817|489863|P1|COMPLETED|Overall Study||16
203903|NCT00778817|489863|P1|STARTED|Overall Study||20
203904|NCT00778648|489880|P2|NOT COMPLETED|Overall Study||5
203905|NCT00778648|489881|P1|NOT COMPLETED|Overall Study||9
203906|NCT00778648|489880|P2|COMPLETED|Overall Study||266
203907|NCT00778648|489881|P1|COMPLETED|Overall Study||263
203908|NCT00778648|489880|P2|STARTED|Overall Study||271
203909|NCT00778648|489881|P1|STARTED|Overall Study||272
203910|NCT00778622|489890|P3|NOT COMPLETED|Overall Study||15
203911|NCT00778622|489891|P2|NOT COMPLETED|Overall Study||15
203912|NCT00778622|489892|P1|NOT COMPLETED|Overall Study||16
203913|NCT00778622|489890|P3|COMPLETED|Overall Study||109
203914|NCT00778622|489891|P2|COMPLETED|Overall Study||107
203915|NCT00778622|489892|P1|COMPLETED|Overall Study||109
203916|NCT00778622|489890|P3|STARTED|Overall Study||124
203917|NCT00778622|489891|P2|STARTED|Overall Study||122
203918|NCT00778622|489892|P1|STARTED|Overall Study||125
203919|NCT00778375|489945|P1|NOT COMPLETED|Overall Study||3
203920|NCT00778375|489945|P1|COMPLETED|Overall Study||119
203921|NCT00778375|489945|P1|STARTED|Overall Study||122
203922|NCT00778336|489959|P4|NOT COMPLETED|3 Month Follow Up||0
203923|NCT00778336|489960|P3|NOT COMPLETED|3 Month Follow Up||5
203924|NCT00778336|489961|P2|NOT COMPLETED|3 Month Follow Up||23
203925|NCT00778336|489962|P1|NOT COMPLETED|3 Month Follow Up||23
203926|NCT00778336|489959|P4|COMPLETED|3 Month Follow Up||12
203927|NCT00778336|489960|P3|COMPLETED|3 Month Follow Up||65
203928|NCT00778336|489961|P2|COMPLETED|3 Month Follow Up||144
203929|NCT00778336|489962|P1|COMPLETED|3 Month Follow Up||169
203930|NCT00778336|489959|P4|STARTED|3 Month Follow Up||12
203931|NCT00778336|489960|P3|STARTED|3 Month Follow Up||70
203932|NCT00778336|489961|P2|STARTED|3 Month Follow Up||167
203933|NCT00778336|489962|P1|STARTED|3 Month Follow Up||192
203934|NCT00778336|489959|P4|NOT COMPLETED|Index Procedure-Discharge||0
203935|NCT00778336|489960|P3|NOT COMPLETED|Index Procedure-Discharge||2
203936|NCT00778336|489961|P2|NOT COMPLETED|Index Procedure-Discharge||3
203937|NCT00778336|489962|P1|NOT COMPLETED|Index Procedure-Discharge||6
203938|NCT00778336|489959|P4|COMPLETED|Index Procedure-Discharge||12
203939|NCT00778336|489960|P3|COMPLETED|Index Procedure-Discharge||70
203940|NCT00778336|489961|P2|COMPLETED|Index Procedure-Discharge||167
203941|NCT00778336|489962|P1|COMPLETED|Index Procedure-Discharge||192
203942|NCT00778336|489959|P4|STARTED|Index Procedure-Discharge||12
203943|NCT00778336|489960|P3|STARTED|Index Procedure-Discharge||72
203944|NCT00778336|489961|P2|STARTED|Index Procedure-Discharge||170
203945|NCT00778336|489962|P1|STARTED|Index Procedure-Discharge||198
203946|NCT00778310|489982|P2|NOT COMPLETED|Overall Study||0
203947|NCT00778310|489983|P1|NOT COMPLETED|Overall Study||0
203948|NCT00778310|489982|P2|COMPLETED|Overall Study||26
203949|NCT00778310|489983|P1|COMPLETED|Overall Study||17
203950|NCT00778310|489982|P2|Usable Data|Overall Study||21
203951|NCT00778310|489983|P1|Usable Data|Overall Study||14
203952|NCT00778310|489982|P2|STARTED|Overall Study||26
203953|NCT00778310|489983|P1|STARTED|Overall Study||17
203954|NCT00778258|490000|P9|NOT COMPLETED|Overall Study||4
203955|NCT00778258|490001|P8|NOT COMPLETED|Overall Study||15
203956|NCT00778258|490002|P7|NOT COMPLETED|Overall Study||15
203957|NCT00778258|490003|P6|NOT COMPLETED|Overall Study||10
203958|NCT00778258|490004|P5|NOT COMPLETED|Overall Study||0
203959|NCT00778258|490005|P4|NOT COMPLETED|Overall Study||3
203960|NCT00778258|490006|P3|NOT COMPLETED|Overall Study||10
203961|NCT00778258|490007|P2|NOT COMPLETED|Overall Study||2
203962|NCT00778258|490008|P1|NOT COMPLETED|Overall Study||7
203963|NCT00778258|490000|P9|COMPLETED|Overall Study||6
203964|NCT00778258|490001|P8|COMPLETED|Overall Study||26
203965|NCT00778258|490002|P7|COMPLETED|Overall Study||19
203966|NCT00778258|490003|P6|COMPLETED|Overall Study||13
203967|NCT00778258|490004|P5|COMPLETED|Overall Study||6
203968|NCT00778258|490005|P4|COMPLETED|Overall Study||12
203969|NCT00778258|490006|P3|COMPLETED|Overall Study||10
203970|NCT00778258|490007|P2|COMPLETED|Overall Study||3
203971|NCT00778258|490008|P1|COMPLETED|Overall Study||9
203972|NCT00778258|490000|P9|STARTED|Overall Study||10
203973|NCT00778258|490001|P8|STARTED|Overall Study||41
203974|NCT00778258|490002|P7|STARTED|Overall Study||34
203975|NCT00778258|490003|P6|STARTED|Overall Study||23
203976|NCT00778258|490004|P5|STARTED|Overall Study||6
203977|NCT00778258|490005|P4|STARTED|Overall Study||15
203978|NCT00778258|490006|P3|STARTED|Overall Study||20
203979|NCT00778258|490007|P2|STARTED|Overall Study||5
203980|NCT00778258|490008|P1|STARTED|Overall Study||16
203981|NCT00778167|490063|P3|NOT COMPLETED|Overall Study||0
203982|NCT00778167|490064|P2|NOT COMPLETED|Overall Study||0
203983|NCT00778167|490065|P1|NOT COMPLETED|Overall Study||0
203984|NCT00778167|490063|P3|COMPLETED|Overall Study||4
203985|NCT00778167|490064|P2|COMPLETED|Overall Study||8
203986|NCT00778167|490065|P1|COMPLETED|Overall Study||6
203987|NCT00778167|490063|P3|STARTED|Overall Study||4
203988|NCT00778167|490064|P2|STARTED|Overall Study||8
203989|NCT00778167|490065|P1|STARTED|Overall Study||6
203990|NCT00778102|490075|P2|NOT COMPLETED|Overall Study||22
203991|NCT00778102|490076|P1|NOT COMPLETED|Overall Study||21
203992|NCT00778102|490075|P2|COMPLETED|Overall Study||19
203993|NCT00778102|490076|P1|COMPLETED|Overall Study||18
203994|NCT00778102|490075|P2|STARTED|Overall Study||41
203995|NCT00778102|490076|P1|STARTED|Overall Study||39
203996|NCT00777946|490111|P3|NOT COMPLETED|Overall Study||16
203997|NCT00777946|490112|P2|NOT COMPLETED|Overall Study||6
203998|NCT00777946|490113|P1|NOT COMPLETED|Overall Study||21
203999|NCT00777946|490111|P3|COMPLETED|Overall Study||244
204000|NCT00777946|490112|P2|COMPLETED|Overall Study||271
204001|NCT00777946|490113|P1|COMPLETED|Overall Study||262
204002|NCT00777946|490111|P3|Safety & Full Analysis Sets|Overall Study||260
204003|NCT00777946|490112|P2|Safety & Full Analysis Sets|Overall Study||276
204004|NCT00777946|490113|P1|Safety & Full Analysis Sets|Overall Study||282
204005|NCT00777946|490111|P3|STARTED|Overall Study||260
204006|NCT00777946|490112|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
204007|NCT00777946|490113|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
204008|NCT00777855|490136|P2|NOT COMPLETED|Second Intervention||0
204009|NCT00777855|490137|P1|NOT COMPLETED|Second Intervention||0
204010|NCT00777855|490136|P2|COMPLETED|Second Intervention||5
204011|NCT00777855|490137|P1|COMPLETED|Second Intervention||5
204012|NCT00777855|490136|P2|STARTED|Second Intervention||5
204013|NCT00777855|490137|P1|STARTED|Second Intervention||5
204014|NCT00777855|490136|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
204015|NCT00777855|490137|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
204016|NCT00777855|490136|P2|COMPLETED|Washout Period (>= 14 Days)||5
204017|NCT00777855|490137|P1|COMPLETED|Washout Period (>= 14 Days)||5
204018|NCT00777855|490136|P2|STARTED|Washout Period (>= 14 Days)||5
204019|NCT00777855|490137|P1|STARTED|Washout Period (>= 14 Days)||5
204020|NCT00777855|490136|P2|NOT COMPLETED|First Intervention||0
204021|NCT00777855|490137|P1|NOT COMPLETED|First Intervention||0
204022|NCT00777855|490136|P2|COMPLETED|First Intervention||5
204023|NCT00777855|490137|P1|COMPLETED|First Intervention||5
204024|NCT00777855|490136|P2|STARTED|First Intervention||5
204025|NCT00777855|490137|P1|STARTED|First Intervention||5
204026|NCT00777803|490148|P2|NOT COMPLETED|Overall Study||7
204027|NCT00777803|490149|P1|NOT COMPLETED|Overall Study||15
204028|NCT00777803|490148|P2|COMPLETED|Overall Study||90
204029|NCT00777803|490149|P1|COMPLETED|Overall Study||269
204030|NCT00777803|490148|P2|STARTED|Overall Study||97
204031|NCT00777803|490149|P1|STARTED|Overall Study||284
204032|NCT00777790|490184|P3|NOT COMPLETED|Overall Study||0
204033|NCT00777790|490185|P2|NOT COMPLETED|Overall Study||0
204034|NCT00777790|490186|P1|NOT COMPLETED|Overall Study||0
204035|NCT00777790|490184|P3|COMPLETED|Overall Study||88
204036|NCT00777790|490185|P2|COMPLETED|Overall Study||77
204037|NCT00777790|490186|P1|COMPLETED|Overall Study||76
204038|NCT00777790|490184|P3|STARTED|Overall Study||88
204039|NCT00777790|490185|P2|STARTED|Overall Study||77
204040|NCT00777790|490186|P1|STARTED|Overall Study||76
204041|NCT00777764|490196|P2|NOT COMPLETED|Overall Study||1
204042|NCT00777764|490197|P1|NOT COMPLETED|Overall Study||0
204043|NCT00777764|490196|P2|COMPLETED|Overall Study||29
204044|NCT00777764|490197|P1|COMPLETED|Overall Study||30
204045|NCT00777764|490196|P2|STARTED|Overall Study||30
204046|NCT00777764|490197|P1|STARTED|Overall Study||30
204047|NCT00777634|490209|P2|NOT COMPLETED|Overall Study||1
204048|NCT00777634|490210|P1|NOT COMPLETED|Overall Study||5
204049|NCT00777634|490209|P2|COMPLETED|Overall Study||133
204050|NCT00777634|490210|P1|COMPLETED|Overall Study||129
204051|NCT00777634|490209|P2|STARTED|Overall Study||134
204052|NCT00777634|490210|P1|STARTED|Overall Study||134
204053|NCT00777608|490228|P2|NOT COMPLETED|Overall Study||6
204054|NCT00777608|490229|P1|NOT COMPLETED|Overall Study||4
204055|NCT00777608|490228|P2|COMPLETED|Overall Study||47
204056|NCT00777608|490229|P1|COMPLETED|Overall Study||49
204057|NCT00777608|490228|P2|STARTED|Overall Study||53
204058|NCT00777608|490229|P1|STARTED|Overall Study||53
204059|NCT00777556|490239|P1|NOT COMPLETED|Overall Study||66
204060|NCT00777556|490239|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
204061|NCT00777556|490239|P1|Used Product|Overall Study||297
204062|NCT00777556|490239|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
204063|NCT00777556|490239|P1|Dispensed Product|Overall Study||307
204064|NCT00777556|490239|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
204065|NCT00777335|490248|P2|NOT COMPLETED|Overall Study||0
204066|NCT00777335|490249|P1|NOT COMPLETED|Overall Study||0
204067|NCT00777335|490248|P2|COMPLETED|Overall Study||2
204068|NCT00777335|490249|P1|COMPLETED|Overall Study||2
204069|NCT00777335|490248|P2|STARTED|Overall Study||2
204070|NCT00777335|490249|P1|STARTED|Overall Study||2
204071|NCT00777257|490260|P3|NOT COMPLETED|Overall Study||9
204072|NCT00777257|490261|P2|NOT COMPLETED|Overall Study||12
204073|NCT00777257|490262|P1|NOT COMPLETED|Overall Study||11
204074|NCT00777257|490260|P3|COMPLETED|Overall Study||442
204075|NCT00777257|490261|P2|COMPLETED|Overall Study||438
204076|NCT00777257|490262|P1|COMPLETED|Overall Study||433
204077|NCT00777257|490260|P3|STARTED|Overall Study||451
204078|NCT00777257|490261|P2|STARTED|Overall Study||450
204079|NCT00777257|490262|P1|STARTED|Overall Study||444
204080|NCT00777205|490281|P2|NOT COMPLETED|Overall Study||71
204081|NCT00777205|490282|P1|NOT COMPLETED|Overall Study||31
204082|NCT00777205|490281|P2|COMPLETED|Overall Study||129
204083|NCT00777205|490282|P1|COMPLETED|Overall Study||212
204084|NCT00777205|490281|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
204085|NCT00777205|490282|P1|Intervention Interruption|Overall Study||0
204086|NCT00777205|490281|P2|STARTED|Overall Study||200
204087|NCT00777205|490282|P1|STARTED|Overall Study||243
204088|NCT00777179|490298|P2|NOT COMPLETED|Overall Study||0
204089|NCT00777179|490299|P1|NOT COMPLETED|Overall Study||0
204090|NCT00777179|490298|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
204091|NCT00777179|490299|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
204092|NCT00777179|490298|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
204093|NCT00777179|490299|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
204094|NCT00777153|490316|P3|NOT COMPLETED|Overall Study||37
204095|NCT00777153|490317|P2|NOT COMPLETED|Overall Study||83
204096|NCT00777153|490318|P1|NOT COMPLETED|Overall Study||90
204097|NCT00777153|490316|P3|COMPLETED|Overall Study||28
204098|NCT00777153|490317|P2|COMPLETED|Overall Study||46
204099|NCT00777153|490318|P1|COMPLETED|Overall Study||41
204100|NCT00777153|490316|P3|STARTED|Overall Study||65
204101|NCT00777153|490317|P2|STARTED|Overall Study||129
204102|NCT00777153|490318|P1|STARTED|Overall Study||131
204103|NCT00777101|490343|P2|NOT COMPLETED|Overall Study||51
204104|NCT00777101|490344|P1|NOT COMPLETED|Overall Study||62
204105|NCT00777101|490343|P2|COMPLETED|Overall Study||65
204106|NCT00777101|490344|P1|COMPLETED|Overall Study||55
204107|NCT00777101|490343|P2|Treated|Overall Study||115
204108|NCT00777101|490344|P1|Treated|Overall Study||116
204109|NCT00777101|490343|P2|STARTED|Overall Study||116
204110|NCT00777101|490344|P1|STARTED|Overall Study||117
204111|NCT00777062|490364|P2|NOT COMPLETED|Overall Study||5
204112|NCT00777062|490365|P1|NOT COMPLETED|Overall Study||3
204113|NCT00777062|490364|P2|COMPLETED|Overall Study||36
204114|NCT00777062|490365|P1|COMPLETED|Overall Study||36
204115|NCT00777062|490364|P2|STARTED|Overall Study||41
204116|NCT00777062|490365|P1|STARTED|Overall Study||39
204117|NCT00777049|490375|P2|NOT COMPLETED|Overall Study||1
204118|NCT00777049|490376|P1|NOT COMPLETED|Overall Study||1
204119|NCT00777049|490375|P2|COMPLETED|Overall Study||20
204120|NCT00777049|490376|P1|COMPLETED|Overall Study||32
204121|NCT00777049|490375|P2|STARTED|Overall Study||21
204122|NCT00777049|490376|P1|STARTED|Overall Study||33
204123|NCT00777036|490385|P3|NOT COMPLETED|Follow-Up||4
204124|NCT00777036|490386|P2|NOT COMPLETED|Follow-Up||8
204125|NCT00777036|490387|P1|NOT COMPLETED|Follow-Up||5
204126|NCT00777036|490385|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
204127|NCT00777036|490386|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
204128|NCT00777036|490387|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
204129|NCT00777036|490385|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
204130|NCT00777036|490386|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
204131|NCT00777036|490387|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
204132|NCT00777036|490385|P3|NOT COMPLETED|On Treatment||23
204133|NCT00777036|490386|P2|NOT COMPLETED|On Treatment||16
204134|NCT00777036|490387|P1|NOT COMPLETED|On Treatment||15
204135|NCT00777036|490385|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
204136|NCT00777036|490386|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
204137|NCT00777036|490387|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
204138|NCT00777036|490385|P3|STARTED|On Treatment||84
204139|NCT00777036|490386|P2|STARTED|On Treatment||17
204140|NCT00777036|490387|P1|STARTED|On Treatment||29
204141|NCT00777023|490483|P3|NOT COMPLETED|Overall Study||37
204142|NCT00777023|490484|P2|NOT COMPLETED|Overall Study||41
204143|NCT00777023|490485|P1|NOT COMPLETED|Overall Study||35
204144|NCT00777023|490483|P3|COMPLETED|Overall Study||146
204145|NCT00777023|490484|P2|COMPLETED|Overall Study||149
204146|NCT00777023|490485|P1|COMPLETED|Overall Study||151
204147|NCT00777023|490483|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
204148|NCT00777023|490484|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
204149|NCT00777023|490485|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
204150|NCT00776997|490502|P1|NOT COMPLETED|Overall Study||2
204151|NCT00776997|490502|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
204152|NCT00776997|490502|P1|STARTED|Overall Study||100
204153|NCT00776984|490511|P2|NOT COMPLETED|Overall Study||21
204154|NCT00776984|490512|P1|NOT COMPLETED|Overall Study||31
204155|NCT00776984|490511|P2|COMPLETED|Overall Study||198
204156|NCT00776984|490512|P1|COMPLETED|Overall Study||203
204157|NCT00776984|490511|P2|STARTED|Overall Study||219
204158|NCT00776984|490512|P1|STARTED|Overall Study||234
204159|NCT00776919|490586|P4|NOT COMPLETED|Overall Study||39
204160|NCT00776919|490587|P3|NOT COMPLETED|Overall Study||32
204161|NCT00776919|490588|P2|NOT COMPLETED|Overall Study||33
204162|NCT00776919|490589|P1|NOT COMPLETED|Overall Study||27
204163|NCT00776919|490586|P4|COMPLETED|Overall Study||293
204164|NCT00776919|490587|P3|COMPLETED|Overall Study||296
204165|NCT00776919|490588|P2|COMPLETED|Overall Study||295
204166|NCT00776919|490589|P1|COMPLETED|Overall Study||300
204167|NCT00776919|490586|P4|STARTED|Overall Study||332
204168|NCT00776919|490587|P3|STARTED|Overall Study||328
204169|NCT00776919|490588|P2|STARTED|Overall Study||328
204170|NCT00776919|490589|P1|STARTED|Overall Study||327
204171|NCT00776789|490653|P2|NOT COMPLETED|Overall Study||3
204172|NCT00776789|490654|P1|NOT COMPLETED|Overall Study||3
204173|NCT00776789|490653|P2|COMPLETED|Overall Study||18
204174|NCT00776789|490654|P1|COMPLETED|Overall Study||17
204175|NCT00776789|490653|P2|STARTED|Overall Study||21
204176|NCT00776789|490654|P1|STARTED|Overall Study||20
204177|NCT00776659|490666|P1|NOT COMPLETED|Overall Study||26
204178|NCT00776659|490666|P1|COMPLETED|Overall Study||13
204179|NCT00776659|490666|P1|STARTED|Overall Study||39
204180|NCT00776594|490678|P2|NOT COMPLETED|Overall Study||2
204181|NCT00776594|490679|P1|NOT COMPLETED|Overall Study||4
204182|NCT00776594|490678|P2|COMPLETED|Overall Study||34
204183|NCT00776594|490679|P1|COMPLETED|Overall Study||62
204184|NCT00776594|490678|P2|STARTED|Overall Study||36
204185|NCT00776594|490679|P1|STARTED|Overall Study||66
204186|NCT00776555|490693|P2|NOT COMPLETED|Overall Study||0
204187|NCT00776555|490694|P1|NOT COMPLETED|Overall Study||3
204188|NCT00776555|490693|P2|COMPLETED|Overall Study||0
204189|NCT00776555|490694|P1|COMPLETED|Overall Study||0
204190|NCT00776555|490693|P2|STARTED|Overall Study||0
204191|NCT00776555|490694|P1|STARTED|Overall Study||3
204192|NCT00776295|490704|P1|NOT COMPLETED|Overall Study||0
204193|NCT00776295|490704|P1|COMPLETED|Overall Study||2
204194|NCT00776295|490704|P1|STARTED|Overall Study||2
204195|NCT00776230|490712|P3|NOT COMPLETED|Overall Study||5
204196|NCT00776230|490713|P2|NOT COMPLETED|Overall Study||3
204197|NCT00776230|490714|P1|NOT COMPLETED|Overall Study||3
204198|NCT00776230|490712|P3|COMPLETED|Overall Study||97
204199|NCT00776230|490713|P2|COMPLETED|Overall Study||100
204200|NCT00776230|490714|P1|COMPLETED|Overall Study||96
204201|NCT00776230|490712|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
204202|NCT00776230|490713|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
204203|NCT00776230|490714|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
204204|NCT00776230|490712|P3|STARTED|Overall Study||102
204205|NCT00776230|490713|P2|STARTED|Overall Study||103
204206|NCT00776230|490714|P1|STARTED|Overall Study||99
204207|NCT00776100|490724|P2|NOT COMPLETED|Overall Study||0
204208|NCT00776100|490725|P1|NOT COMPLETED|Overall Study||1
204209|NCT00776100|490724|P2|COMPLETED|Overall Study||1
204210|NCT00776100|490725|P1|COMPLETED|Overall Study||0
204211|NCT00776100|490724|P2|STARTED|Overall Study||1
204212|NCT00776100|490725|P1|STARTED|Overall Study||1
204213|NCT00776009|490747|P6|NOT COMPLETED|Period 3: Third Intervention||0
204214|NCT00776009|490748|P5|NOT COMPLETED|Period 3: Third Intervention||0
204215|NCT00776009|490749|P4|NOT COMPLETED|Period 3: Third Intervention||0
204216|NCT00776009|490750|P3|NOT COMPLETED|Period 3: Third Intervention||0
204217|NCT00776009|490751|P2|NOT COMPLETED|Period 3: Third Intervention||0
204218|NCT00776009|490752|P1|NOT COMPLETED|Period 3: Third Intervention||1
204219|NCT00776009|490747|P6|COMPLETED|Period 3: Third Intervention||26
204220|NCT00776009|490748|P5|COMPLETED|Period 3: Third Intervention||26
204221|NCT00776009|490749|P4|COMPLETED|Period 3: Third Intervention||27
204222|NCT00776009|490750|P3|COMPLETED|Period 3: Third Intervention||27
204223|NCT00776009|490751|P2|COMPLETED|Period 3: Third Intervention||27
204224|NCT00776009|490752|P1|COMPLETED|Period 3: Third Intervention||24
204225|NCT00776009|490747|P6|STARTED|Period 3: Third Intervention||26
204226|NCT00776009|490748|P5|STARTED|Period 3: Third Intervention||26
204227|NCT00776009|490749|P4|STARTED|Period 3: Third Intervention||27
204228|NCT00776009|490750|P3|STARTED|Period 3: Third Intervention||27
204229|NCT00776009|490751|P2|STARTED|Period 3: Third Intervention||27
204230|NCT00776009|490752|P1|STARTED|Period 3: Third Intervention||25
204231|NCT00776009|490747|P6|NOT COMPLETED|Period 2: Second Intervention||1
204232|NCT00776009|490748|P5|NOT COMPLETED|Period 2: Second Intervention||0
204233|NCT00776009|490749|P4|NOT COMPLETED|Period 2: Second Intervention||0
204234|NCT00776009|490750|P3|NOT COMPLETED|Period 2: Second Intervention||1
204235|NCT00776009|490751|P2|NOT COMPLETED|Period 2: Second Intervention||0
204236|NCT00776009|490752|P1|NOT COMPLETED|Period 2: Second Intervention||1
204237|NCT00776009|490747|P6|COMPLETED|Period 2: Second Intervention||26
204238|NCT00776009|490748|P5|COMPLETED|Period 2: Second Intervention||26
204239|NCT00776009|490749|P4|COMPLETED|Period 2: Second Intervention||27
204240|NCT00776009|490750|P3|COMPLETED|Period 2: Second Intervention||27
204241|NCT00776009|490751|P2|COMPLETED|Period 2: Second Intervention||27
204242|NCT00776009|490752|P1|COMPLETED|Period 2: Second Intervention||25
204243|NCT00776009|490747|P6|STARTED|Period 2: Second Intervention||27
204244|NCT00776009|490748|P5|STARTED|Period 2: Second Intervention||26
204245|NCT00776009|490749|P4|STARTED|Period 2: Second Intervention||27
204246|NCT00776009|490750|P3|STARTED|Period 2: Second Intervention||28
204247|NCT00776009|490751|P2|STARTED|Period 2: Second Intervention||27
204248|NCT00776009|490752|P1|STARTED|Period 2: Second Intervention||26
204249|NCT00776009|490747|P6|NOT COMPLETED|Period 1: First Intervention||0
204250|NCT00776009|490748|P5|NOT COMPLETED|Period 1: First Intervention||2
204251|NCT00776009|490749|P4|NOT COMPLETED|Period 1: First Intervention||0
204252|NCT00776009|490750|P3|NOT COMPLETED|Period 1: First Intervention||1
204253|NCT00776009|490751|P2|NOT COMPLETED|Period 1: First Intervention||1
204254|NCT00776009|490752|P1|NOT COMPLETED|Period 1: First Intervention||0
204255|NCT00776009|490747|P6|COMPLETED|Period 1: First Intervention||27
204256|NCT00776009|490748|P5|COMPLETED|Period 1: First Intervention||26
204257|NCT00776009|490749|P4|COMPLETED|Period 1: First Intervention||27
204258|NCT00776009|490750|P3|COMPLETED|Period 1: First Intervention||28
204259|NCT00776009|490751|P2|COMPLETED|Period 1: First Intervention||27
204260|NCT00776009|490752|P1|COMPLETED|Period 1: First Intervention||26
204261|NCT00776009|490747|P6|STARTED|Period 1: First Intervention||27
204262|NCT00776009|490748|P5|STARTED|Period 1: First Intervention||28
204263|NCT00776009|490749|P4|STARTED|Period 1: First Intervention||27
204264|NCT00776009|490750|P3|STARTED|Period 1: First Intervention||29
204265|NCT00776009|490751|P2|STARTED|Period 1: First Intervention||28
204266|NCT00776009|490752|P1|STARTED|Period 1: First Intervention||26
204267|NCT00775983|490774|P2|NOT COMPLETED|Overall Study||2
204268|NCT00775983|490775|P1|NOT COMPLETED|Overall Study||1
204269|NCT00775983|490774|P2|COMPLETED|Overall Study||34
204270|NCT00775983|490775|P1|COMPLETED|Overall Study||35
204271|NCT00775983|490774|P2|STARTED|Overall Study||36
204272|NCT00775983|490775|P1|STARTED|Overall Study||36
204273|NCT00775944|490787|P4|NOT COMPLETED|Overall Study||16
204274|NCT00775944|490788|P3|NOT COMPLETED|Overall Study||16
204275|NCT00775944|490789|P2|NOT COMPLETED|Overall Study||9
204276|NCT00775944|490790|P1|NOT COMPLETED|Overall Study||15
204277|NCT00775944|490787|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
204278|NCT00775944|490788|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
204279|NCT00775944|490789|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
204280|NCT00775944|490790|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
204281|NCT00775944|490787|P4|STARTED|Overall Study||648
204282|NCT00775944|490788|P3|STARTED|Overall Study||648
204283|NCT00775944|490789|P2|STARTED|Overall Study||647
204284|NCT00775944|490790|P1|STARTED|Overall Study||648
204285|NCT00775684|490819|P3|NOT COMPLETED|Overall Study||3
204286|NCT00775684|490820|P2|NOT COMPLETED|Overall Study||1
204287|NCT00775684|490821|P1|NOT COMPLETED|Overall Study||3
204288|NCT00775684|490819|P3|COMPLETED|Overall Study||14
204289|NCT00775684|490820|P2|COMPLETED|Overall Study||12
204290|NCT00775684|490821|P1|COMPLETED|Overall Study||14
204291|NCT00775684|490819|P3|STARTED|Overall Study||17
204292|NCT00775684|490820|P2|STARTED|Overall Study||13
204293|NCT00775684|490821|P1|STARTED|Overall Study||17
204294|NCT00775671|490843|P2|NOT COMPLETED|Overall Study||0
204295|NCT00775671|490844|P1|NOT COMPLETED|Overall Study||0
204296|NCT00775671|490843|P2|COMPLETED|Overall Study||23
204297|NCT00775671|490844|P1|COMPLETED|Overall Study||23
204298|NCT00775671|490843|P2|STARTED|Overall Study||23
204299|NCT00775671|490844|P1|STARTED|Overall Study||23
204300|NCT00775658|490852|P2|NOT COMPLETED|Second Intervention||0
204301|NCT00775658|490853|P1|NOT COMPLETED|Second Intervention||0
204302|NCT00775658|490852|P2|COMPLETED|Second Intervention||11
204303|NCT00775658|490853|P1|COMPLETED|Second Intervention||10
204304|NCT00775658|490852|P2|STARTED|Second Intervention||11
204305|NCT00775658|490853|P1|STARTED|Second Intervention||10
204306|NCT00775658|490852|P2|NOT COMPLETED|First Intervention||0
204307|NCT00775658|490853|P1|NOT COMPLETED|First Intervention||0
204308|NCT00775658|490852|P2|COMPLETED|First Intervention||11
204309|NCT00775658|490853|P1|COMPLETED|First Intervention||10
204310|NCT00775658|490852|P2|STARTED|First Intervention||11
204311|NCT00775658|490853|P1|STARTED|First Intervention||10
204312|NCT00775645|490863|P2|NOT COMPLETED|Overall Study||20
204313|NCT00775645|490864|P1|NOT COMPLETED|Overall Study||17
204314|NCT00775645|490863|P2|COMPLETED|Overall Study||181
204315|NCT00775645|490864|P1|COMPLETED|Overall Study||191
204316|NCT00775645|490863|P2|STARTED|Overall Study||201
204317|NCT00775645|490864|P1|STARTED|Overall Study||208
204318|NCT00775606|490886|P2|NOT COMPLETED|Overall Study||0
204319|NCT00775606|490887|P1|NOT COMPLETED|Overall Study||3
204320|NCT00775606|490886|P2|COMPLETED|Overall Study||5
204321|NCT00775606|490887|P1|COMPLETED|Overall Study||5
204322|NCT00775606|490886|P2|STARTED|Overall Study||5
204323|NCT00775606|490887|P1|STARTED|Overall Study||8
204324|NCT00775593|490897|P1|NOT COMPLETED|Overall Study||7
204325|NCT00775593|490897|P1|COMPLETED|Overall Study||53
204326|NCT00775593|490897|P1|STARTED|Overall Study||60
204327|NCT00775528|490904|P1|NOT COMPLETED|Overall Study||1
204328|NCT00775528|490904|P1|COMPLETED|Overall Study||18
204329|NCT00775528|490904|P1|STARTED|Overall Study|Started means number of patients who consented|19
204330|NCT00775463|490913|P2|NOT COMPLETED|Overall Study||13
204331|NCT00775463|490914|P1|NOT COMPLETED|Overall Study||11
204332|NCT00775463|490913|P2|COMPLETED|Overall Study||59
204333|NCT00775463|490914|P1|COMPLETED|Overall Study||65
204334|NCT00775463|490913|P2|STARTED|Overall Study||72
204335|NCT00775463|490914|P1|STARTED|Overall Study||76
204336|NCT00775450|490951|P5|NOT COMPLETED|Overall Study||2
204337|NCT00775450|490952|P4|NOT COMPLETED|Overall Study||0
204338|NCT00775450|490953|P3|NOT COMPLETED|Overall Study||0
204339|NCT00775450|490954|P2|NOT COMPLETED|Overall Study||0
204340|NCT00775450|490955|P1|NOT COMPLETED|Overall Study||3
204341|NCT00775450|490951|P5|COMPLETED|Overall Study||199
204342|NCT00775450|490952|P4|COMPLETED|Overall Study||108
204343|NCT00775450|490953|P3|COMPLETED|Overall Study||105
204344|NCT00775450|490954|P2|COMPLETED|Overall Study||98
204345|NCT00775450|490955|P1|COMPLETED|Overall Study||292
204346|NCT00775450|490951|P5|STARTED|Overall Study||201
204347|NCT00775450|490952|P4|STARTED|Overall Study||108
204348|NCT00775450|490953|P3|STARTED|Overall Study||105
204349|NCT00775450|490954|P2|STARTED|Overall Study||98
204350|NCT00775450|490955|P1|STARTED|Overall Study||295
204351|NCT00775437|490982|P1|NOT COMPLETED|Overall Study||6
204352|NCT00775437|490982|P1|COMPLETED|Overall Study||26
204353|NCT00775437|490982|P1|STARTED|Overall Study||32
204354|NCT00775411|491032|P1|NOT COMPLETED|Overall Study||1
204355|NCT00775411|491032|P1|COMPLETED|Overall Study||43
204356|NCT00775411|491032|P1|STARTED|Overall Study||44
204357|NCT00775346|491038|P1|NOT COMPLETED|Overall Study||0
204358|NCT00775346|491038|P1|COMPLETED|Overall Study||92
204359|NCT00775346|491038|P1|STARTED|Overall Study||92
204360|NCT00775229|491044|P2|NOT COMPLETED|Overall Study||2
204361|NCT00775229|491045|P1|NOT COMPLETED|Overall Study||5
204362|NCT00775229|491044|P2|COMPLETED|Overall Study||24
204363|NCT00775229|491045|P1|COMPLETED|Overall Study||20
204364|NCT00775229|491044|P2|STARTED|Overall Study||26
204365|NCT00775229|491045|P1|STARTED|Overall Study||25
204366|NCT00775203|491057|P2|NOT COMPLETED|Overall Study||43
204367|NCT00775203|491058|P1|NOT COMPLETED|Overall Study||62
204368|NCT00775203|491057|P2|COMPLETED|Overall Study||163
204369|NCT00775203|491058|P1|COMPLETED|Overall Study||144
204370|NCT00775203|491057|P2|Received Study Medication|Overall Study||204
204371|NCT00775203|491058|P1|Received Study Medication|Overall Study||202
204372|NCT00775203|491057|P2|STARTED|Overall Study||206
204373|NCT00775203|491058|P1|STARTED|Overall Study||206
204374|NCT00775190|491092|P2|NOT COMPLETED|Overall Study||5
204375|NCT00775190|491093|P1|NOT COMPLETED|Overall Study||4
204376|NCT00775190|491092|P2|COMPLETED|Overall Study||0
204377|NCT00775190|491093|P1|COMPLETED|Overall Study||3
204378|NCT00775190|491092|P2|STARTED|Overall Study||5
204379|NCT00775190|491093|P1|STARTED|Overall Study||7
204380|NCT00775021|491115|P2|NOT COMPLETED|Second Intervention||1
204381|NCT00775021|491116|P1|NOT COMPLETED|Second Intervention||0
204382|NCT00775021|491115|P2|COMPLETED|Second Intervention||59
204383|NCT00775021|491116|P1|COMPLETED|Second Intervention||62
204384|NCT00775021|491115|P2|STARTED|Second Intervention||60
204385|NCT00775021|491116|P1|STARTED|Second Intervention||62
204386|NCT00775021|491115|P2|NOT COMPLETED|First Intervention||0
204387|NCT00775021|491116|P1|NOT COMPLETED|First Intervention||1
204388|NCT00775021|491115|P2|COMPLETED|First Intervention||60
204389|NCT00775021|491116|P1|COMPLETED|First Intervention||62
204390|NCT00775021|491115|P2|STARTED|First Intervention||60
204391|NCT00775021|491116|P1|STARTED|First Intervention||63
204392|NCT00774995|491134|P4|NOT COMPLETED|Overall Study||0
204393|NCT00774995|491135|P3|NOT COMPLETED|Overall Study||1
204394|NCT00774995|491136|P2|NOT COMPLETED|Overall Study||0
204395|NCT00774995|491137|P1|NOT COMPLETED|Overall Study||0
204396|NCT00774995|491134|P4|COMPLETED|Overall Study||16
204397|NCT00774995|491135|P3|COMPLETED|Overall Study||7
204398|NCT00774995|491136|P2|COMPLETED|Overall Study||16
204399|NCT00774995|491137|P1|COMPLETED|Overall Study||9
204400|NCT00774995|491134|P4|STARTED|Overall Study||16
204401|NCT00774995|491135|P3|STARTED|Overall Study||8
204402|NCT00774995|491136|P2|STARTED|Overall Study||16
204403|NCT00774995|491137|P1|STARTED|Overall Study||9
204404|NCT00774930|491177|P2|NOT COMPLETED|LTOLE Phase||17
204405|NCT00774930|491178|P1|NOT COMPLETED|LTOLE Phase||15
204406|NCT00774930|491177|P2|COMPLETED|LTOLE Phase||8
204407|NCT00774930|491178|P1|COMPLETED|LTOLE Phase||17
204408|NCT00774930|491177|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
204409|NCT00774930|491178|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
204410|NCT00774930|491177|P2|NOT COMPLETED|IOL Phase||9
204411|NCT00774930|491178|P1|NOT COMPLETED|IOL Phase||13
204412|NCT00774930|491177|P2|COMPLETED|IOL Phase||37
204413|NCT00774930|491178|P1|COMPLETED|IOL Phase||43
204414|NCT00774930|491177|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
204415|NCT00774930|491178|P1|STARTED|IOL Phase||56
204416|NCT00774930|491177|P2|NOT COMPLETED|DB Phase||22
204417|NCT00774930|491178|P1|NOT COMPLETED|DB Phase||14
204418|NCT00774930|491177|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
204419|NCT00774930|491178|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
204420|NCT00774930|491177|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
204421|NCT00774930|491178|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
204422|NCT00774852|491206|P2|NOT COMPLETED|Overall Study||41
204423|NCT00774852|491207|P1|NOT COMPLETED|Overall Study||45
204424|NCT00774852|491206|P2|COMPLETED|Overall Study||27
204425|NCT00774852|491207|P1|COMPLETED|Overall Study||24
204426|NCT00774852|491206|P2|STARTED|Overall Study||68
204427|NCT00774852|491207|P1|STARTED|Overall Study||69
204428|NCT00774800|491255|P1|NOT COMPLETED|Intervention 4||1
204429|NCT00774800|491255|P1|COMPLETED|Intervention 4||21
204430|NCT00774800|491255|P1|Received at Least One Dose of Study Drug|Intervention 4||21
204431|NCT00774800|491255|P1|STARTED|Intervention 4||22
204432|NCT00774800|491255|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
204433|NCT00774800|491255|P1|COMPLETED|Washout (3 to 10 Days)||22
204434|NCT00774800|491255|P1|STARTED|Washout (3 to 10 Days)||22
204435|NCT00774800|491255|P1|NOT COMPLETED|Intervention 3||0
204436|NCT00774800|491255|P1|COMPLETED|Intervention 3||22
204437|NCT00774800|491255|P1|Received at Least One Dose of Study Drug|Intervention 3||22
204438|NCT00774800|491255|P1|STARTED|Intervention 3||22
204439|NCT00774800|491255|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
204440|NCT00774800|491255|P1|COMPLETED|Washout (3 to 10 Days)||22
204441|NCT00774800|491255|P1|STARTED|Washout (3 to 10 Days)||22
204442|NCT00774800|491255|P1|NOT COMPLETED|Intervention 2||0
204443|NCT00774800|491255|P1|COMPLETED|Intervention 2||22
204444|NCT00774800|491255|P1|Received at Least One Dose of Study Drug|Intervention 2||22
204445|NCT00774800|491255|P1|STARTED|Intervention 2||22
204446|NCT00774800|491255|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
204447|NCT00774800|491255|P1|COMPLETED|Washout (3 to 10 Days)||22
204448|NCT00774800|491255|P1|STARTED|Washout (3 to 10 Days)||22
204449|NCT00774800|491255|P1|NOT COMPLETED|Intervention 1||0
204450|NCT00774800|491255|P1|COMPLETED|Intervention 1||22
204451|NCT00774800|491255|P1|Received at Least One Dose of Study Drug|Intervention 1||22
204452|NCT00774800|491255|P1|STARTED|Intervention 1||22
204453|NCT00774787|491277|P1|NOT COMPLETED|Overall Study||1
204454|NCT00774787|491277|P1|COMPLETED|Overall Study||26
204455|NCT00774787|491277|P1|STARTED|Overall Study||27
204456|NCT00774748|491284|P1|NOT COMPLETED|Overall Study||3
204457|NCT00774748|491284|P1|COMPLETED|Overall Study||18
204458|NCT00774748|491284|P1|STARTED|Overall Study||21
204459|NCT00774397|491299|P7|NOT COMPLETED|Overall Study||30
204460|NCT00774397|491300|P6|NOT COMPLETED|Overall Study||22
204461|NCT00774397|491301|P5|NOT COMPLETED|Overall Study||46
204462|NCT00774397|491302|P4|NOT COMPLETED|Overall Study||17
204463|NCT00774397|491303|P3|NOT COMPLETED|Overall Study||30
204464|NCT00774397|491304|P2|NOT COMPLETED|Overall Study||13
204465|NCT00774397|491305|P1|NOT COMPLETED|Overall Study||14
204466|NCT00774397|491299|P7|COMPLETED|Overall Study||41
204467|NCT00774397|491300|P6|COMPLETED|Overall Study||54
204468|NCT00774397|491301|P5|COMPLETED|Overall Study||97
204469|NCT00774397|491302|P4|COMPLETED|Overall Study||129
204470|NCT00774397|491303|P3|COMPLETED|Overall Study||113
204471|NCT00774397|491304|P2|COMPLETED|Overall Study||56
204472|NCT00774397|491305|P1|COMPLETED|Overall Study||57
204473|NCT00774397|491299|P7|STARTED|Overall Study||71
204474|NCT00774397|491300|P6|STARTED|Overall Study||76
204475|NCT00774397|491301|P5|STARTED|Overall Study||143
204476|NCT00774397|491302|P4|STARTED|Overall Study||146
204477|NCT00774397|491303|P3|STARTED|Overall Study||143
204478|NCT00774397|491304|P2|STARTED|Overall Study||69
204479|NCT00774397|491305|P1|STARTED|Overall Study||71
204480|NCT00774306|491541|P4|NOT COMPLETED|Overall Study||5
204481|NCT00774306|491542|P3|NOT COMPLETED|Overall Study||8
204482|NCT00774306|491543|P2|NOT COMPLETED|Overall Study||2
204483|NCT00774306|491544|P1|NOT COMPLETED|Overall Study||18
204484|NCT00774306|491541|P4|COMPLETED|Overall Study||2
204485|NCT00774306|491542|P3|COMPLETED|Overall Study||8
204486|NCT00774306|491543|P2|COMPLETED|Overall Study||3
204487|NCT00774306|491544|P1|COMPLETED|Overall Study||6
204488|NCT00774306|491541|P4|STARTED|Overall Study||7
204489|NCT00774306|491542|P3|STARTED|Overall Study||16
204490|NCT00774306|491543|P2|STARTED|Overall Study||5
204491|NCT00774306|491544|P1|STARTED|Overall Study||24
204492|NCT00774267|491558|P4|NOT COMPLETED|Overall Study||0
204493|NCT00774267|491559|P3|NOT COMPLETED|Overall Study||0
204494|NCT00774267|491560|P2|NOT COMPLETED|Overall Study||0
204495|NCT00774267|491561|P1|NOT COMPLETED|Overall Study||0
204496|NCT00774267|491558|P4|COMPLETED|Overall Study||135
204497|NCT00774267|491559|P3|COMPLETED|Overall Study||129
204498|NCT00774267|491560|P2|COMPLETED|Overall Study||111
204499|NCT00774267|491561|P1|COMPLETED|Overall Study||132
204500|NCT00774267|491558|P4|STARTED|Overall Study||135
204501|NCT00774267|491559|P3|STARTED|Overall Study||129
204502|NCT00774267|491560|P2|STARTED|Overall Study||111
204503|NCT00774267|491561|P1|STARTED|Overall Study||132
204504|NCT00774163|491573|P2|NOT COMPLETED|Overall Study||0
204505|NCT00774163|491574|P1|NOT COMPLETED|Overall Study||0
204506|NCT00774163|491573|P2|COMPLETED|Overall Study||15
204507|NCT00774163|491574|P1|COMPLETED|Overall Study||30
204508|NCT00774163|491573|P2|STARTED|Overall Study||15
204509|NCT00774163|491574|P1|STARTED|Overall Study||30
204510|NCT00774046|491612|P1|NOT COMPLETED|Autologous Transplant||0
204511|NCT00774046|491612|P1|COMPLETED|Autologous Transplant||4
204512|NCT00774046|491612|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
204513|NCT00774046|491612|P1|NOT COMPLETED|Stem Cell Mobilization||3
204514|NCT00774046|491612|P1|COMPLETED|Stem Cell Mobilization||7
204515|NCT00774046|491612|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
204516|NCT00774046|491612|P1|NOT COMPLETED|Induction Therapy||0
204517|NCT00774046|491612|P1|COMPLETED|Induction Therapy||32
204518|NCT00774046|491612|P1|STARTED|Induction Therapy||32
204519|NCT00774046|491612|P1|NOT COMPLETED|Enrollment||28
204520|NCT00774046|491612|P1|COMPLETED|Enrollment||32
204521|NCT00774046|491612|P1|STARTED|Enrollment||60
204522|NCT00774046|491612|P1|NOT COMPLETED|Screening||56
204523|NCT00774046|491612|P1|COMPLETED|Screening||60
204524|NCT00774046|491612|P1|STARTED|Screening||116
204525|NCT00773968|491622|P1|NOT COMPLETED|Overall Study||45
204526|NCT00773968|491622|P1|COMPLETED|Overall Study||95
204527|NCT00773968|491622|P1|Treated|Overall Study||111
204528|NCT00773968|491622|P1|STARTED|Overall Study||140
204529|NCT00773955|491631|P1|NOT COMPLETED|Overall Study||0
204530|NCT00773955|491631|P1|COMPLETED|Overall Study||15
204531|NCT00773955|491631|P1|STARTED|Overall Study||15
204532|NCT00773786|491638|P2|NOT COMPLETED|Second Intervention (1 Week)||0
204533|NCT00773786|491639|P1|NOT COMPLETED|Second Intervention (1 Week)||0
204534|NCT00773786|491638|P2|COMPLETED|Second Intervention (1 Week)||10
204535|NCT00773786|491639|P1|COMPLETED|Second Intervention (1 Week)||10
204536|NCT00773786|491638|P2|STARTED|Second Intervention (1 Week)||10
204537|NCT00773786|491639|P1|STARTED|Second Intervention (1 Week)||10
204538|NCT00773786|491638|P2|NOT COMPLETED|Washout (1 Week)||0
204539|NCT00773786|491639|P1|NOT COMPLETED|Washout (1 Week)||0
204540|NCT00773786|491638|P2|COMPLETED|Washout (1 Week)||10
204541|NCT00773786|491639|P1|COMPLETED|Washout (1 Week)||10
204542|NCT00773786|491638|P2|STARTED|Washout (1 Week)||10
204543|NCT00773786|491639|P1|STARTED|Washout (1 Week)||10
204544|NCT00773786|491638|P2|NOT COMPLETED|First Intervention (1 Week)||0
204545|NCT00773786|491639|P1|NOT COMPLETED|First Intervention (1 Week)||0
204546|NCT00773786|491638|P2|COMPLETED|First Intervention (1 Week)||10
204547|NCT00773786|491639|P1|COMPLETED|First Intervention (1 Week)||10
204548|NCT00773786|491638|P2|STARTED|First Intervention (1 Week)||10
204549|NCT00773786|491639|P1|STARTED|First Intervention (1 Week)||10
204550|NCT00773734|491653|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
204551|NCT00773734|491654|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
204552|NCT00773734|491655|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
204553|NCT00773734|491656|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
204554|NCT00773734|491657|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
204555|NCT00773734|491658|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
204556|NCT00773734|491653|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
204557|NCT00773734|491654|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
204558|NCT00773734|491655|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
204559|NCT00773734|491656|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
204560|NCT00773734|491657|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
204561|NCT00773734|491658|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
204562|NCT00773734|491653|P6|STARTED|LTE Period: Week 52 to 6 Years||0
204563|NCT00773734|491654|P5|STARTED|LTE Period: Week 52 to 6 Years||0
204564|NCT00773734|491655|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
204565|NCT00773734|491656|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
204566|NCT00773734|491657|P2|STARTED|LTE Period: Week 52 to 6 Years||0
204567|NCT00773734|491658|P1|STARTED|LTE Period: Week 52 to 6 Years||0
204568|NCT00773734|491653|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
204569|NCT00773734|491654|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
204570|NCT00773734|491655|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
204571|NCT00773734|491656|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
204572|NCT00773734|491657|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
204573|NCT00773734|491658|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
204574|NCT00773734|491653|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
204575|NCT00773734|491654|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
204576|NCT00773734|491655|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
204577|NCT00773734|491656|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
204578|NCT00773734|491657|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
204579|NCT00773734|491658|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
204580|NCT00773734|491653|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
204581|NCT00773734|491654|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
204582|NCT00773734|491655|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
204583|NCT00773734|491656|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
204584|NCT00773734|491657|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
204585|NCT00773734|491658|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
204586|NCT00773734|491653|P6|STARTED|Extension: Active Treatment Week 24-52||27
204587|NCT00773734|491654|P5|STARTED|Extension: Active Treatment Week 24-52||27
204588|NCT00773734|491655|P4|STARTED|Extension: Active Treatment Week 24-52||58
204589|NCT00773734|491656|P3|STARTED|Extension: Active Treatment Week 24-52||50
204590|NCT00773734|491657|P2|STARTED|Extension: Active Treatment Week 24-52||47
204591|NCT00773734|491658|P1|STARTED|Extension: Active Treatment Week 24-52||0
204592|NCT00773734|491653|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
204593|NCT00773734|491654|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
204594|NCT00773734|491655|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
204595|NCT00773734|491656|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
204596|NCT00773734|491657|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
204597|NCT00773734|491658|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
204598|NCT00773734|491653|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
204599|NCT00773734|491654|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
204600|NCT00773734|491655|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
204601|NCT00773734|491656|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
204602|NCT00773734|491657|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
204603|NCT00773734|491658|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
204604|NCT00773734|491653|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
204605|NCT00773734|491654|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
204606|NCT00773734|491655|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
204607|NCT00773734|491656|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
204608|NCT00773734|491657|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
204609|NCT00773734|491658|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
204610|NCT00773734|491653|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
204611|NCT00773734|491654|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
204612|NCT00773734|491655|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
204613|NCT00773734|491656|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
204614|NCT00773734|491657|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
204615|NCT00773734|491658|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
204616|NCT00773734|491653|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
204617|NCT00773734|491654|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
204704|NCT00772967|492359|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
204618|NCT00773734|491655|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
204619|NCT00773734|491656|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
204620|NCT00773734|491657|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
204621|NCT00773734|491658|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
204622|NCT00773734|491653|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
204623|NCT00773734|491654|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
204624|NCT00773734|491655|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
204625|NCT00773734|491656|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
204626|NCT00773734|491657|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
204627|NCT00773734|491658|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
204628|NCT00773474|492220|P1|NOT COMPLETED|Overall Study||0
204629|NCT00773474|492220|P1|COMPLETED|Overall Study||29
204630|NCT00773474|492220|P1|STARTED|Overall Study||29
204631|NCT00773461|492229|P2|NOT COMPLETED|Overall Study||4
204632|NCT00773461|492230|P1|NOT COMPLETED|Overall Study||5
204633|NCT00773461|492229|P2|COMPLETED|Overall Study||135
204634|NCT00773461|492230|P1|COMPLETED|Overall Study||65
204635|NCT00773461|492229|P2|STARTED|Overall Study||139
204636|NCT00773461|492230|P1|STARTED|Overall Study||70
204637|NCT00773422|492271|P3|NOT COMPLETED|Overall Study||0
204638|NCT00773422|492272|P2|NOT COMPLETED|Overall Study||0
204639|NCT00773422|492273|P1|NOT COMPLETED|Overall Study||0
204640|NCT00773422|492271|P3|COMPLETED|Overall Study||10
204641|NCT00773422|492272|P2|COMPLETED|Overall Study||9
204642|NCT00773422|492273|P1|COMPLETED|Overall Study||11
204643|NCT00773422|492271|P3|STARTED|Overall Study||10
204644|NCT00773422|492272|P2|STARTED|Overall Study||9
204645|NCT00773422|492273|P1|STARTED|Overall Study||11
204646|NCT00773383|492284|P1|NOT COMPLETED|Overall Study||31
204647|NCT00773383|492284|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
204648|NCT00773383|492284|P1|Received Study Drug|Overall Study||34
204649|NCT00773383|492284|P1|STARTED|Overall Study||35
204650|NCT00773370|492306|P2|NOT COMPLETED|Overall Study||10
204651|NCT00773370|492307|P1|NOT COMPLETED|Overall Study||18
204652|NCT00773370|492306|P2|COMPLETED|Overall Study||23
204653|NCT00773370|492307|P1|COMPLETED|Overall Study||25
204654|NCT00773370|492306|P2|STARTED|Overall Study||33
204655|NCT00773370|492307|P1|STARTED|Overall Study||43
204656|NCT00773279|492319|P2|NOT COMPLETED|Period 2||6
204657|NCT00773279|492320|P1|NOT COMPLETED|Period 2||3
204658|NCT00773279|492319|P2|COMPLETED|Period 2||111
204659|NCT00773279|492320|P1|COMPLETED|Period 2||111
204660|NCT00773279|492319|P2|STARTED|Period 2||117
204661|NCT00773279|492320|P1|STARTED|Period 2||114
204662|NCT00773279|492319|P2|NOT COMPLETED|Period 1||4
204663|NCT00773279|492320|P1|NOT COMPLETED|Period 1||7
204664|NCT00773279|492319|P2|COMPLETED|Period 1||117
204665|NCT00773279|492320|P1|COMPLETED|Period 1||114
204666|NCT00773279|492319|P2|STARTED|Period 1||121
204667|NCT00773279|492320|P1|STARTED|Period 1||121
204668|NCT00773253|492341|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
204669|NCT00773253|492342|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
204670|NCT00773253|492341|P2|COMPLETED|Second Intervention (Week 24-48)||4
204671|NCT00773253|492342|P1|COMPLETED|Second Intervention (Week 24-48)||5
204672|NCT00773253|492341|P2|STARTED|Second Intervention (Week 24-48)||4
204673|NCT00773253|492342|P1|STARTED|Second Intervention (Week 24-48)||5
204674|NCT00773253|492341|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
204675|NCT00773253|492342|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
204676|NCT00773253|492341|P2|COMPLETED|First Intervention (Week 0-24)||4
204677|NCT00773253|492342|P1|COMPLETED|First Intervention (Week 0-24)||5
204678|NCT00773253|492341|P2|STARTED|First Intervention (Week 0-24)||5
204679|NCT00773253|492342|P1|STARTED|First Intervention (Week 0-24)||5
204680|NCT00773136|492348|P1|NOT COMPLETED|Overall Study||2
204681|NCT00773136|492348|P1|COMPLETED|Overall Study||19
204682|NCT00773136|492348|P1|STARTED|Overall Study||21
204683|NCT00773097|492353|P1|NOT COMPLETED|Overall Study||7
204684|NCT00773097|492353|P1|COMPLETED|Overall Study||39
204685|NCT00773097|492353|P1|STARTED|Overall Study||46
204686|NCT00772967|492359|P6|NOT COMPLETED|Crossover Treatment 3||0
204687|NCT00772967|492360|P5|NOT COMPLETED|Crossover Treatment 3||1
204688|NCT00772967|492361|P4|NOT COMPLETED|Crossover Treatment 3||0
204689|NCT00772967|492362|P3|NOT COMPLETED|Crossover Treatment 3||0
204690|NCT00772967|492363|P2|NOT COMPLETED|Crossover Treatment 3||0
204691|NCT00772967|492364|P1|NOT COMPLETED|Crossover Treatment 3||0
204692|NCT00772967|492359|P6|COMPLETED|Crossover Treatment 3||3
204693|NCT00772967|492360|P5|COMPLETED|Crossover Treatment 3||3
204694|NCT00772967|492361|P4|COMPLETED|Crossover Treatment 3||3
204695|NCT00772967|492362|P3|COMPLETED|Crossover Treatment 3||3
204696|NCT00772967|492363|P2|COMPLETED|Crossover Treatment 3||4
204697|NCT00772967|492364|P1|COMPLETED|Crossover Treatment 3||3
204698|NCT00772967|492359|P6|STARTED|Crossover Treatment 3||3
204699|NCT00772967|492360|P5|STARTED|Crossover Treatment 3||4
204700|NCT00772967|492361|P4|STARTED|Crossover Treatment 3||3
204701|NCT00772967|492362|P3|STARTED|Crossover Treatment 3||3
204702|NCT00772967|492363|P2|STARTED|Crossover Treatment 3||4
204703|NCT00772967|492364|P1|STARTED|Crossover Treatment 3||3
204705|NCT00772967|492360|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
204706|NCT00772967|492361|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
204707|NCT00772967|492362|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
204708|NCT00772967|492363|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
204709|NCT00772967|492364|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
204710|NCT00772967|492359|P6|COMPLETED|Break 2 (4-7 Days)||3
204711|NCT00772967|492360|P5|COMPLETED|Break 2 (4-7 Days)||4
204712|NCT00772967|492361|P4|COMPLETED|Break 2 (4-7 Days)||3
204713|NCT00772967|492362|P3|COMPLETED|Break 2 (4-7 Days)||3
204714|NCT00772967|492363|P2|COMPLETED|Break 2 (4-7 Days)||4
204715|NCT00772967|492364|P1|COMPLETED|Break 2 (4-7 Days)||3
204716|NCT00772967|492359|P6|STARTED|Break 2 (4-7 Days)||3
204717|NCT00772967|492360|P5|STARTED|Break 2 (4-7 Days)||4
204718|NCT00772967|492361|P4|STARTED|Break 2 (4-7 Days)||3
204719|NCT00772967|492362|P3|STARTED|Break 2 (4-7 Days)||3
204720|NCT00772967|492363|P2|STARTED|Break 2 (4-7 Days)||4
204721|NCT00772967|492364|P1|STARTED|Break 2 (4-7 Days)||3
204722|NCT00772967|492359|P6|NOT COMPLETED|Crossover Treatment 2||0
204723|NCT00772967|492360|P5|NOT COMPLETED|Crossover Treatment 2||0
204724|NCT00772967|492361|P4|NOT COMPLETED|Crossover Treatment 2||0
204725|NCT00772967|492362|P3|NOT COMPLETED|Crossover Treatment 2||0
204726|NCT00772967|492363|P2|NOT COMPLETED|Crossover Treatment 2||0
204727|NCT00772967|492364|P1|NOT COMPLETED|Crossover Treatment 2||0
204728|NCT00772967|492359|P6|COMPLETED|Crossover Treatment 2||3
204729|NCT00772967|492360|P5|COMPLETED|Crossover Treatment 2||4
204730|NCT00772967|492361|P4|COMPLETED|Crossover Treatment 2||3
204731|NCT00772967|492362|P3|COMPLETED|Crossover Treatment 2||3
204732|NCT00772967|492363|P2|COMPLETED|Crossover Treatment 2||4
204733|NCT00772967|492364|P1|COMPLETED|Crossover Treatment 2||3
204734|NCT00772967|492359|P6|STARTED|Crossover Treatment 2||3
204735|NCT00772967|492360|P5|STARTED|Crossover Treatment 2||4
204736|NCT00772967|492361|P4|STARTED|Crossover Treatment 2||3
204737|NCT00772967|492362|P3|STARTED|Crossover Treatment 2||3
204738|NCT00772967|492363|P2|STARTED|Crossover Treatment 2||4
204739|NCT00772967|492364|P1|STARTED|Crossover Treatment 2||3
204740|NCT00772967|492359|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
204741|NCT00772967|492360|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
204742|NCT00772967|492361|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
204743|NCT00772967|492362|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
204744|NCT00772967|492363|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
204745|NCT00772967|492364|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
204746|NCT00772967|492359|P6|COMPLETED|Break 1 (4-7 Days)||3
204747|NCT00772967|492360|P5|COMPLETED|Break 1 (4-7 Days)||4
204748|NCT00772967|492361|P4|COMPLETED|Break 1 (4-7 Days)||3
204749|NCT00772967|492362|P3|COMPLETED|Break 1 (4-7 Days)||3
204750|NCT00772967|492363|P2|COMPLETED|Break 1 (4-7 Days)||4
204751|NCT00772967|492364|P1|COMPLETED|Break 1 (4-7 Days)||3
204752|NCT00772967|492359|P6|STARTED|Break 1 (4-7 Days)||3
204753|NCT00772967|492360|P5|STARTED|Break 1 (4-7 Days)||4
204754|NCT00772967|492361|P4|STARTED|Break 1 (4-7 Days)||3
204755|NCT00772967|492362|P3|STARTED|Break 1 (4-7 Days)||3
204756|NCT00772967|492363|P2|STARTED|Break 1 (4-7 Days)||5
204757|NCT00772967|492364|P1|STARTED|Break 1 (4-7 Days)||3
204758|NCT00772967|492359|P6|NOT COMPLETED|Crossover Treatment 1||0
204759|NCT00772967|492360|P5|NOT COMPLETED|Crossover Treatment 1||0
204760|NCT00772967|492361|P4|NOT COMPLETED|Crossover Treatment 1||1
204761|NCT00772967|492362|P3|NOT COMPLETED|Crossover Treatment 1||0
204762|NCT00772967|492363|P2|NOT COMPLETED|Crossover Treatment 1||0
204763|NCT00772967|492364|P1|NOT COMPLETED|Crossover Treatment 1||0
204764|NCT00772967|492359|P6|COMPLETED|Crossover Treatment 1||3
204765|NCT00772967|492360|P5|COMPLETED|Crossover Treatment 1||4
204766|NCT00772967|492361|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
204767|NCT00772967|492362|P3|COMPLETED|Crossover Treatment 1||3
204768|NCT00772967|492363|P2|COMPLETED|Crossover Treatment 1||5
204769|NCT00772967|492364|P1|COMPLETED|Crossover Treatment 1||3
204770|NCT00772967|492359|P6|STARTED|Crossover Treatment 1||3
204771|NCT00772967|492360|P5|STARTED|Crossover Treatment 1||4
204772|NCT00772967|492361|P4|STARTED|Crossover Treatment 1||4
204773|NCT00772967|492362|P3|STARTED|Crossover Treatment 1||3
204774|NCT00772967|492363|P2|STARTED|Crossover Treatment 1||5
204775|NCT00772967|492364|P1|STARTED|Crossover Treatment 1||3
204776|NCT00772954|492384|P3|NOT COMPLETED|Overall Study||1
204777|NCT00772954|492385|P2|NOT COMPLETED|Overall Study||0
204778|NCT00772954|492386|P1|NOT COMPLETED|Overall Study||0
204779|NCT00772954|492384|P3|COMPLETED|Overall Study||11
204780|NCT00772954|492385|P2|COMPLETED|Overall Study||12
204781|NCT00772954|492386|P1|COMPLETED|Overall Study||12
204782|NCT00772954|492384|P3|STARTED|Overall Study||12
204783|NCT00772954|492385|P2|STARTED|Overall Study||12
204784|NCT00772954|492386|P1|STARTED|Overall Study||12
204785|NCT00772941|492394|P1|NOT COMPLETED|Overall Study||682
204786|NCT00772941|492394|P1|COMPLETED|Overall Study||3257
204787|NCT00772941|492394|P1|STARTED|Overall Study||3939
204788|NCT00772928|492425|P2|NOT COMPLETED|Overall Study||41
204789|NCT00772928|492426|P1|NOT COMPLETED|Overall Study||44
204790|NCT00772928|492425|P2|COMPLETED|Overall Study||538
204791|NCT00772928|492426|P1|COMPLETED|Overall Study||543
204792|NCT00772928|492425|P2|STARTED|Overall Study||579
204793|NCT00772928|492426|P1|STARTED|Overall Study||587
204794|NCT00772915|492436|P1|NOT COMPLETED|Overall Study||15
204795|NCT00772915|492436|P1|COMPLETED|Overall Study||23
204796|NCT00772915|492436|P1|STARTED|Overall Study||38
204797|NCT00772889|492443|P3|NOT COMPLETED|Overall Study||16
204798|NCT00772889|492444|P2|NOT COMPLETED|Overall Study||18
204799|NCT00772889|492445|P1|NOT COMPLETED|Overall Study||22
204800|NCT00772889|492443|P3|COMPLETED|Overall Study||187
204801|NCT00772889|492444|P2|COMPLETED|Overall Study||375
204802|NCT00772889|492445|P1|COMPLETED|Overall Study||353
204803|NCT00772889|492443|P3|Completed at Day 21|Overall Study||203
204804|NCT00772889|492444|P2|Completed at Day 21|Overall Study||390
204805|NCT00772889|492445|P1|Completed at Day 21|Overall Study||374
204806|NCT00772889|492443|P3|STARTED|Overall Study||203
204807|NCT00772889|492444|P2|STARTED|Overall Study||393
204808|NCT00772889|492445|P1|STARTED|Overall Study||375
204809|NCT00772772|492498|P1|NOT COMPLETED|Overall Study||0
204810|NCT00772772|492498|P1|COMPLETED|Overall Study||12
204811|NCT00772772|492498|P1|STARTED|Overall Study||12
204812|NCT00772707|492503|P1|NOT COMPLETED|Overall Study||3
204813|NCT00772707|492503|P1|COMPLETED|Overall Study||111
204814|NCT00772707|492503|P1|STARTED|Overall Study||114
204815|NCT00772668|492508|P1|NOT COMPLETED|Overall Study||3
204816|NCT00772668|492508|P1|COMPLETED|Overall Study||0
204817|NCT00772668|492508|P1|STARTED|Overall Study||3
204818|NCT00772629|492517|P2|NOT COMPLETED|Overall Study||0
204819|NCT00772629|492518|P1|NOT COMPLETED|Overall Study||1
204820|NCT00772629|492517|P2|COMPLETED|Overall Study||1
204821|NCT00772629|492518|P1|COMPLETED|Overall Study||16
204822|NCT00772629|492517|P2|STARTED|Overall Study||1
204823|NCT00772629|492518|P1|STARTED|Overall Study||17
204824|NCT00772603|492527|P3|NOT COMPLETED|Overall Study||26
204825|NCT00772603|492528|P2|NOT COMPLETED|Overall Study||40
204826|NCT00772603|492529|P1|NOT COMPLETED|Overall Study||52
204827|NCT00772603|492527|P3|COMPLETED|Overall Study||95
204828|NCT00772603|492528|P2|COMPLETED|Overall Study||82
204829|NCT00772603|492529|P1|COMPLETED|Overall Study||71
204830|NCT00772603|492527|P3|STARTED|Overall Study||121
204831|NCT00772603|492528|P2|STARTED|Overall Study||122
204832|NCT00772603|492529|P1|STARTED|Overall Study||123
204833|NCT00772590|492553|P4|NOT COMPLETED|Overall Study||0
204834|NCT00772590|492554|P3|NOT COMPLETED|Overall Study||0
204835|NCT00772590|492555|P2|NOT COMPLETED|Overall Study||0
204836|NCT00772590|492556|P1|NOT COMPLETED|Overall Study||0
204837|NCT00772590|492553|P4|COMPLETED|Overall Study||17
204838|NCT00772590|492554|P3|COMPLETED|Overall Study||18
204839|NCT00772590|492555|P2|COMPLETED|Overall Study||19
204840|NCT00772590|492556|P1|COMPLETED|Overall Study||19
204841|NCT00772590|492553|P4|STARTED|Overall Study||17
204842|NCT00772590|492554|P3|STARTED|Overall Study||18
204843|NCT00772590|492555|P2|STARTED|Overall Study||19
204844|NCT00772590|492556|P1|STARTED|Overall Study||19
204845|NCT00772577|492568|P2|NOT COMPLETED|Overall Study||23
204846|NCT00772577|492569|P1|NOT COMPLETED|Overall Study||23
204847|NCT00772577|492568|P2|COMPLETED|Overall Study||170
204848|NCT00772577|492569|P1|COMPLETED|Overall Study||170
204849|NCT00772577|492568|P2|STARTED|Overall Study||193
204850|NCT00772577|492569|P1|STARTED|Overall Study||193
204851|NCT00772538|492585|P2|NOT COMPLETED|Overall Study||26
204852|NCT00772538|492586|P1|NOT COMPLETED|Overall Study||20
204853|NCT00772538|492585|P2|COMPLETED|Overall Study||211
204854|NCT00772538|492586|P1|COMPLETED|Overall Study||202
204855|NCT00772538|492585|P2|STARTED|Overall Study||237
204856|NCT00772538|492586|P1|STARTED|Overall Study||222
204857|NCT00772447|492658|P2|NOT COMPLETED|Overall Study||24
204858|NCT00772447|492659|P1|NOT COMPLETED|Overall Study||20
204859|NCT00772447|492658|P2|COMPLETED|Overall Study||110
204860|NCT00772447|492659|P1|COMPLETED|Overall Study||111
204861|NCT00772447|492658|P2|STARTED|Overall Study||134
204862|NCT00772447|492659|P1|STARTED|Overall Study||131
204863|NCT00772382|492687|P1|NOT COMPLETED|Overall Study||55
204864|NCT00772382|492687|P1|COMPLETED|Overall Study||61
204865|NCT00772382|492687|P1|STARTED|Overall Study||116
204866|NCT00772369|492692|P1|NOT COMPLETED|Overall Study||1
204867|NCT00772369|492692|P1|COMPLETED|Overall Study||3213
204868|NCT00772369|492692|P1|STARTED|Overall Study||3214
204869|NCT00772304|492697|P1|NOT COMPLETED|Overall Study||0
204870|NCT00772304|492697|P1|COMPLETED|Overall Study||102
204871|NCT00772304|492697|P1|STARTED|Overall Study||102
204872|NCT00772148|492703|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
204873|NCT00772148|492704|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
204874|NCT00772148|492703|P2|COMPLETED|Maintenance Phase (Week 52)||18
204875|NCT00772148|492704|P1|COMPLETED|Maintenance Phase (Week 52)||17
204876|NCT00772148|492703|P2|STARTED|Maintenance Phase (Week 52)||23
204877|NCT00772148|492704|P1|STARTED|Maintenance Phase (Week 52)||21
204878|NCT00772148|492703|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
204879|NCT00772148|492704|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
204880|NCT00772148|492703|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
204881|NCT00772148|492704|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
204882|NCT00772148|492703|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
204883|NCT00772148|492704|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
204884|NCT00772109|492724|P4|NOT COMPLETED|Overall Study||31
204885|NCT00772109|492725|P3|NOT COMPLETED|Overall Study||19
204886|NCT00772109|492726|P2|NOT COMPLETED|Overall Study||19
204887|NCT00772109|492727|P1|NOT COMPLETED|Overall Study||21
204888|NCT00772109|492724|P4|COMPLETED|Overall Study||1397
204889|NCT00772109|492725|P3|COMPLETED|Overall Study||936
204890|NCT00772109|492726|P2|COMPLETED|Overall Study||934
204891|NCT00772109|492727|P1|COMPLETED|Overall Study||935
204892|NCT00772109|492724|P4|STARTED|Overall Study||1428
204893|NCT00772109|492725|P3|STARTED|Overall Study||955
204894|NCT00772109|492726|P2|STARTED|Overall Study||953
204895|NCT00772109|492727|P1|STARTED|Overall Study||956
204896|NCT00772070|492751|P2|NOT COMPLETED|Overall Study||10
204897|NCT00772070|492752|P1|NOT COMPLETED|Overall Study||2
204898|NCT00772070|492751|P2|COMPLETED|Overall Study||61
204899|NCT00772070|492752|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
204900|NCT00772070|492751|P2|STARTED|Overall Study||71
204901|NCT00772070|492752|P1|STARTED|Overall Study||102
204902|NCT00772031|492764|P2|NOT COMPLETED|Overall Study||43
204903|NCT00772031|492765|P1|NOT COMPLETED|Overall Study||32
204904|NCT00772031|492764|P2|COMPLETED|Overall Study||52
204905|NCT00772031|492765|P1|COMPLETED|Overall Study||64
204906|NCT00772031|492764|P2|STARTED|Overall Study||95
204907|NCT00772031|492765|P1|STARTED|Overall Study||96
204908|NCT00772005|492791|P4|NOT COMPLETED|Overall Study||26
204909|NCT00772005|492792|P3|NOT COMPLETED|Overall Study||28
204910|NCT00772005|492793|P2|NOT COMPLETED|Overall Study||30
204911|NCT00772005|492794|P1|NOT COMPLETED|Overall Study||25
204912|NCT00772005|492791|P4|COMPLETED|Overall Study||46
204913|NCT00772005|492792|P3|COMPLETED|Overall Study||44
204914|NCT00772005|492793|P2|COMPLETED|Overall Study||40
204915|NCT00772005|492794|P1|COMPLETED|Overall Study||46
204916|NCT00772005|492791|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
204917|NCT00772005|492792|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
204918|NCT00772005|492793|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
204919|NCT00772005|492794|P1|STARTED|Overall Study||71
204920|NCT00771953|493482|P2|NOT COMPLETED|Overall Study||10
204921|NCT00771953|493483|P1|NOT COMPLETED|Overall Study||10
204922|NCT00771953|493482|P2|COMPLETED|Overall Study||26
204923|NCT00771953|493483|P1|COMPLETED|Overall Study||26
204924|NCT00771953|493482|P2|STARTED|Overall Study||36
204925|NCT00771953|493483|P1|STARTED|Overall Study||36
204926|NCT00771927|493493|P2|NOT COMPLETED|Overall Study||237
204927|NCT00771927|493494|P1|NOT COMPLETED|Overall Study||255
204928|NCT00771927|493493|P2|COMPLETED|Overall Study||256
204929|NCT00771927|493494|P1|COMPLETED|Overall Study||256
204930|NCT00771927|493493|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
204931|NCT00771927|493494|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
204932|NCT00771914|493506|P4|NOT COMPLETED|Overall Study||2
204933|NCT00771914|493507|P3|NOT COMPLETED|Overall Study||0
204934|NCT00771914|493508|P2|NOT COMPLETED|Overall Study||0
204935|NCT00771914|493509|P1|NOT COMPLETED|Overall Study||0
204936|NCT00771914|493506|P4|COMPLETED|Overall Study||6
204937|NCT00771914|493507|P3|COMPLETED|Overall Study||6
204938|NCT00771914|493508|P2|COMPLETED|Overall Study||6
204939|NCT00771914|493509|P1|COMPLETED|Overall Study||7
204940|NCT00771914|493506|P4|STARTED|Overall Study||8
204941|NCT00771914|493507|P3|STARTED|Overall Study||6
204942|NCT00771914|493508|P2|STARTED|Overall Study||6
204943|NCT00771914|493509|P1|STARTED|Overall Study||7
204944|NCT00771901|493522|P3|NOT COMPLETED|Overall Study||4
204945|NCT00771901|493523|P2|NOT COMPLETED|Overall Study||0
204946|NCT00771901|493524|P1|NOT COMPLETED|Overall Study||0
204947|NCT00771901|493522|P3|COMPLETED|Overall Study||6
204948|NCT00771901|493523|P2|COMPLETED|Overall Study||10
204949|NCT00771901|493524|P1|COMPLETED|Overall Study||10
204950|NCT00771901|493522|P3|STARTED|Overall Study||10
204951|NCT00771901|493523|P2|STARTED|Overall Study||10
204952|NCT00771901|493524|P1|STARTED|Overall Study||10
204953|NCT00771875|493541|P3|NOT COMPLETED|Overall Study||0
204954|NCT00771875|493542|P2|NOT COMPLETED|Overall Study||1
204955|NCT00771875|493543|P1|NOT COMPLETED|Overall Study||0
204956|NCT00771875|493541|P3|COMPLETED|Overall Study||10
204957|NCT00771875|493542|P2|COMPLETED|Overall Study||9
204958|NCT00771875|493543|P1|COMPLETED|Overall Study||10
204959|NCT00771875|493541|P3|STARTED|Overall Study||10
204960|NCT00771875|493542|P2|STARTED|Overall Study||10
204961|NCT00771875|493543|P1|STARTED|Overall Study||10
204962|NCT00771849|493571|P2|NOT COMPLETED|Overall Study||4
204963|NCT00771849|493572|P1|NOT COMPLETED|Overall Study||2
204964|NCT00771849|493571|P2|COMPLETED|Overall Study||47
204965|NCT00771849|493572|P1|COMPLETED|Overall Study||50
204966|NCT00771849|493571|P2|STARTED|Overall Study|One subject was not vaccinated|51
204967|NCT00771849|493572|P1|STARTED|Overall Study||52
204968|NCT00771810|493583|P3|NOT COMPLETED|Overall Study||7
204969|NCT00771810|493584|P2|NOT COMPLETED|Overall Study||5
204970|NCT00771810|493585|P1|NOT COMPLETED|Overall Study||5
204971|NCT00771810|493583|P3|COMPLETED|Overall Study||6
204972|NCT00771810|493584|P2|COMPLETED|Overall Study||6
204973|NCT00771810|493585|P1|COMPLETED|Overall Study||5
204974|NCT00771810|493583|P3|STARTED|Overall Study||13
204975|NCT00771810|493584|P2|STARTED|Overall Study||11
204976|NCT00771810|493585|P1|STARTED|Overall Study||10
204977|NCT00771758|493623|P3|NOT COMPLETED|Overall Study||2
204978|NCT00771758|493624|P2|NOT COMPLETED|Overall Study||12
204979|NCT00771758|493625|P1|NOT COMPLETED|Overall Study||8
204980|NCT00771758|493623|P3|COMPLETED|Overall Study||19
204981|NCT00771758|493624|P2|COMPLETED|Overall Study||31
204982|NCT00771758|493625|P1|COMPLETED|Overall Study||36
204983|NCT00771758|493623|P3|STARTED|Overall Study||21
204984|NCT00771758|493624|P2|STARTED|Overall Study||43
204985|NCT00771758|493625|P1|STARTED|Overall Study||44
204986|NCT00771745|493775|P2|NOT COMPLETED|Overall Study||0
204987|NCT00771745|493776|P1|NOT COMPLETED|Overall Study||0
204988|NCT00771745|493775|P2|COMPLETED|Overall Study||5
204989|NCT00771745|493776|P1|COMPLETED|Overall Study||6
204990|NCT00771745|493775|P2|STARTED|Overall Study||5
204991|NCT00771745|493776|P1|STARTED|Overall Study||6
204992|NCT00771667|493786|P10|NOT COMPLETED|Maintenance Phase||17
204993|NCT00771667|493787|P9|NOT COMPLETED|Maintenance Phase||22
204994|NCT00771667|493788|P8|NOT COMPLETED|Maintenance Phase||5
204995|NCT00771667|493789|P7|NOT COMPLETED|Maintenance Phase||10
204996|NCT00771667|493790|P6|NOT COMPLETED|Maintenance Phase||7
204997|NCT00771667|493791|P5|NOT COMPLETED|Maintenance Phase||2
204998|NCT00771667|493792|P4|NOT COMPLETED|Maintenance Phase||0
204999|NCT00771667|493793|P3|NOT COMPLETED|Maintenance Phase||0
205000|NCT00771667|493794|P2|NOT COMPLETED|Maintenance Phase||0
205001|NCT00771667|493795|P1|NOT COMPLETED|Maintenance Phase||0
205002|NCT00771667|493786|P10|COMPLETED|Maintenance Phase||92
205003|NCT00771667|493787|P9|COMPLETED|Maintenance Phase||88
205004|NCT00771667|493788|P8|COMPLETED|Maintenance Phase||67
205005|NCT00771667|493789|P7|COMPLETED|Maintenance Phase||63
205006|NCT00771667|493790|P6|COMPLETED|Maintenance Phase||78
205007|NCT00771667|493791|P5|COMPLETED|Maintenance Phase||26
205008|NCT00771667|493792|P4|COMPLETED|Maintenance Phase||0
205009|NCT00771667|493793|P3|COMPLETED|Maintenance Phase||0
205010|NCT00771667|493794|P2|COMPLETED|Maintenance Phase||0
205011|NCT00771667|493795|P1|COMPLETED|Maintenance Phase||0
205012|NCT00771667|493786|P10|STARTED|Maintenance Phase||109
205013|NCT00771667|493787|P9|STARTED|Maintenance Phase||110
205014|NCT00771667|493788|P8|STARTED|Maintenance Phase||72
205015|NCT00771667|493789|P7|STARTED|Maintenance Phase||73
205016|NCT00771667|493790|P6|STARTED|Maintenance Phase||85
205017|NCT00771667|493791|P5|STARTED|Maintenance Phase||28
205018|NCT00771667|493792|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
205019|NCT00771667|493793|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
205020|NCT00771667|493794|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
205021|NCT00771667|493795|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
205022|NCT00771667|493786|P10|NOT COMPLETED|Induction Phase||0
205023|NCT00771667|493787|P9|NOT COMPLETED|Induction Phase||0
205024|NCT00771667|493788|P8|NOT COMPLETED|Induction Phase||0
205025|NCT00771667|493789|P7|NOT COMPLETED|Induction Phase||0
205026|NCT00771667|493790|P6|NOT COMPLETED|Induction Phase||0
205027|NCT00771667|493791|P5|NOT COMPLETED|Induction Phase||0
205028|NCT00771667|493792|P4|NOT COMPLETED|Induction Phase||8
205029|NCT00771667|493793|P3|NOT COMPLETED|Induction Phase||12
205030|NCT00771667|493794|P2|NOT COMPLETED|Induction Phase||10
205031|NCT00771667|493795|P1|NOT COMPLETED|Induction Phase||19
205032|NCT00771667|493786|P10|COMPLETED|Induction Phase||0
205033|NCT00771667|493787|P9|COMPLETED|Induction Phase||0
205034|NCT00771667|493788|P8|COMPLETED|Induction Phase||0
205035|NCT00771667|493789|P7|COMPLETED|Induction Phase||0
205036|NCT00771667|493790|P6|COMPLETED|Induction Phase||0
205037|NCT00771667|493791|P5|COMPLETED|Induction Phase||0
205038|NCT00771667|493792|P4|COMPLETED|Induction Phase||123
205039|NCT00771667|493793|P3|COMPLETED|Induction Phase||120
205040|NCT00771667|493794|P2|COMPLETED|Induction Phase||121
205041|NCT00771667|493795|P1|COMPLETED|Induction Phase||113
205042|NCT00771667|493786|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
205043|NCT00771667|493787|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
205044|NCT00771667|493788|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
205045|NCT00771667|493789|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
205046|NCT00771667|493790|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
205047|NCT00771667|493791|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
205048|NCT00771667|493792|P4|STARTED|Induction Phase||131
205049|NCT00771667|493793|P3|STARTED|Induction Phase||132
205050|NCT00771667|493794|P2|STARTED|Induction Phase||131
205051|NCT00771667|493795|P1|STARTED|Induction Phase||132
205052|NCT00771615|493840|P9|NOT COMPLETED|Overall Study||0
205053|NCT00771615|493841|P8|NOT COMPLETED|Overall Study||1
205054|NCT00771615|493842|P7|NOT COMPLETED|Overall Study||1
205055|NCT00771615|493843|P6|NOT COMPLETED|Overall Study||1
205056|NCT00771615|493844|P5|NOT COMPLETED|Overall Study||0
205057|NCT00771615|493845|P4|NOT COMPLETED|Overall Study||1
205058|NCT00771615|493846|P3|NOT COMPLETED|Overall Study||1
205059|NCT00771615|493847|P2|NOT COMPLETED|Overall Study||2
205060|NCT00771615|493848|P1|NOT COMPLETED|Overall Study||1
205061|NCT00771615|493840|P9|COMPLETED|Overall Study|Up to Day 364|41
205062|NCT00771615|493841|P8|COMPLETED|Overall Study|Up to Day 364|58
205063|NCT00771615|493842|P7|COMPLETED|Overall Study|Up to Day 364|45
205064|NCT00771615|493843|P6|COMPLETED|Overall Study|Up to Day 364|60
205065|NCT00771615|493844|P5|COMPLETED|Overall Study|Up to Day 364|40
205066|NCT00771615|493845|P4|COMPLETED|Overall Study|Up to Day 364|59
205067|NCT00771615|493846|P3|COMPLETED|Overall Study|Up to Day 364|40
205068|NCT00771615|493847|P2|COMPLETED|Overall Study|Up to Day 364|70
205069|NCT00771615|493848|P1|COMPLETED|Overall Study|Up to Day 364|48
205070|NCT00771615|493840|P9|STARTED|Overall Study||41
205071|NCT00771615|493841|P8|STARTED|Overall Study||59
205072|NCT00771615|493842|P7|STARTED|Overall Study||46
205073|NCT00771615|493843|P6|STARTED|Overall Study||61
205074|NCT00771615|493844|P5|STARTED|Overall Study||40
205075|NCT00771615|493845|P4|STARTED|Overall Study||60
205076|NCT00771615|493846|P3|STARTED|Overall Study||41
205077|NCT00771615|493847|P2|STARTED|Overall Study||72
205078|NCT00771615|493848|P1|STARTED|Overall Study||49
205079|NCT00771602|494042|P3|NOT COMPLETED|Overall Study||0
205080|NCT00771602|494043|P2|NOT COMPLETED|Overall Study||0
205081|NCT00771602|494044|P1|NOT COMPLETED|Overall Study||0
205082|NCT00771602|494042|P3|COMPLETED|Overall Study||0
205083|NCT00771602|494043|P2|COMPLETED|Overall Study||0
205084|NCT00771602|494044|P1|COMPLETED|Overall Study||1
205085|NCT00771602|494042|P3|STARTED|Overall Study||0
205086|NCT00771602|494043|P2|STARTED|Overall Study||0
205087|NCT00771602|494044|P1|STARTED|Overall Study||1
205088|NCT00771537|494068|P16|NOT COMPLETED|Overall Study||0
205089|NCT00771537|494069|P15|NOT COMPLETED|Overall Study||0
205090|NCT00771537|494070|P14|NOT COMPLETED|Overall Study||0
205091|NCT00771537|494071|P13|NOT COMPLETED|Overall Study||0
205092|NCT00771537|494072|P12|NOT COMPLETED|Overall Study||0
205093|NCT00771537|494073|P11|NOT COMPLETED|Overall Study||0
205094|NCT00771537|494074|P10|NOT COMPLETED|Overall Study||0
205095|NCT00771537|494075|P9|NOT COMPLETED|Overall Study||0
205096|NCT00771537|494076|P8|NOT COMPLETED|Overall Study||0
205097|NCT00771537|494077|P7|NOT COMPLETED|Overall Study||0
205098|NCT00771537|494078|P6|NOT COMPLETED|Overall Study||0
205099|NCT00771537|494079|P5|NOT COMPLETED|Overall Study||0
205100|NCT00771537|494080|P4|NOT COMPLETED|Overall Study||0
205101|NCT00771537|494081|P3|NOT COMPLETED|Overall Study||0
205102|NCT00771537|494082|P2|NOT COMPLETED|Overall Study||0
205103|NCT00771537|494083|P1|NOT COMPLETED|Overall Study||0
205104|NCT00771537|494068|P16|COMPLETED|Overall Study||122
205105|NCT00771537|494069|P15|COMPLETED|Overall Study||124
205106|NCT00771537|494070|P14|COMPLETED|Overall Study||124
205107|NCT00771537|494071|P13|COMPLETED|Overall Study||128
205108|NCT00771537|494072|P12|COMPLETED|Overall Study||137
205109|NCT00771537|494073|P11|COMPLETED|Overall Study||133
205110|NCT00771537|494074|P10|COMPLETED|Overall Study||119
205111|NCT00771537|494075|P9|COMPLETED|Overall Study||115
205112|NCT00771537|494076|P8|COMPLETED|Overall Study||132
205113|NCT00771537|494077|P7|COMPLETED|Overall Study||128
205114|NCT00771537|494078|P6|COMPLETED|Overall Study||118
205115|NCT00771537|494079|P5|COMPLETED|Overall Study||127
205116|NCT00771537|494080|P4|COMPLETED|Overall Study||114
205117|NCT00771537|494081|P3|COMPLETED|Overall Study||151
205118|NCT00771537|494082|P2|COMPLETED|Overall Study||124
205119|NCT00771537|494083|P1|COMPLETED|Overall Study||135
205120|NCT00771537|494068|P16|STARTED|Overall Study||122
205121|NCT00771537|494069|P15|STARTED|Overall Study||124
205122|NCT00771537|494070|P14|STARTED|Overall Study||124
205123|NCT00771537|494071|P13|STARTED|Overall Study||128
205124|NCT00771537|494072|P12|STARTED|Overall Study||137
205125|NCT00771537|494073|P11|STARTED|Overall Study||133
205126|NCT00771537|494074|P10|STARTED|Overall Study||119
205127|NCT00771537|494075|P9|STARTED|Overall Study||115
205128|NCT00771537|494076|P8|STARTED|Overall Study||132
205129|NCT00771537|494077|P7|STARTED|Overall Study||128
205130|NCT00771537|494078|P6|STARTED|Overall Study||118
205131|NCT00771537|494079|P5|STARTED|Overall Study||127
205132|NCT00771537|494080|P4|STARTED|Overall Study||114
205133|NCT00771537|494081|P3|STARTED|Overall Study||151
205134|NCT00771537|494082|P2|STARTED|Overall Study||124
205135|NCT00771537|494083|P1|STARTED|Overall Study||135
205136|NCT00771472|494109|P2|NOT COMPLETED|Overall Study||4
205137|NCT00771472|494110|P1|NOT COMPLETED|Overall Study||6
205138|NCT00771472|494109|P2|COMPLETED|Overall Study||0
205139|NCT00771472|494110|P1|COMPLETED|Overall Study||0
205140|NCT00771472|494109|P2|STARTED|Overall Study||4
205141|NCT00771472|494110|P1|STARTED|Overall Study||6
205142|NCT00771407|494121|P2|NOT COMPLETED|Overall Study||25
205143|NCT00771407|494122|P1|NOT COMPLETED|Overall Study||20
205144|NCT00771407|494121|P2|COMPLETED|Overall Study||35
205145|NCT00771407|494122|P1|COMPLETED|Overall Study||40
205146|NCT00771407|494121|P2|STARTED|Overall Study||60
205147|NCT00771407|494122|P1|STARTED|Overall Study||60
205148|NCT00771316|494130|P2|NOT COMPLETED|Overall Study||1
205149|NCT00771316|494131|P1|NOT COMPLETED|Overall Study||2
205150|NCT00771316|494130|P2|COMPLETED|Overall Study||1
205151|NCT00771316|494131|P1|COMPLETED|Overall Study||2
205152|NCT00771316|494130|P2|STARTED|Overall Study||2
205153|NCT00771316|494131|P1|STARTED|Overall Study||4
205154|NCT00771277|494141|P1|NOT COMPLETED|Overall Study||0
205155|NCT00771277|494141|P1|COMPLETED|Overall Study||6
205156|NCT00771277|494141|P1|STARTED|Overall Study||6
205157|NCT00771264|494149|P2|NOT COMPLETED|Overall Study||5
205158|NCT00771264|494150|P1|NOT COMPLETED|Overall Study||7
205159|NCT00771264|494149|P2|COMPLETED|Overall Study||105
205160|NCT00771264|494150|P1|COMPLETED|Overall Study||103
205161|NCT00771264|494149|P2|STARTED|Overall Study||110
205162|NCT00771264|494150|P1|STARTED|Overall Study||110
205163|NCT00771238|494158|P2|NOT COMPLETED|Overall Study||0
205164|NCT00771238|494159|P1|NOT COMPLETED|Overall Study||0
205165|NCT00771238|494158|P2|COMPLETED|Overall Study||21
205166|NCT00771238|494159|P1|COMPLETED|Overall Study||31
205167|NCT00771238|494158|P2|STARTED|Overall Study||21
205168|NCT00771238|494159|P1|STARTED|Overall Study||31
205169|NCT00771173|494169|P2|NOT COMPLETED|Overall Study||17
205170|NCT00771173|494170|P1|NOT COMPLETED|Overall Study||22
205171|NCT00771173|494169|P2|COMPLETED|Overall Study||112
205172|NCT00771173|494170|P1|COMPLETED|Overall Study||107
205173|NCT00771173|494169|P2|STARTED|Overall Study||129
205174|NCT00771173|494170|P1|STARTED|Overall Study||129
205175|NCT00771056|494176|P1|NOT COMPLETED|Overall Study||5
205176|NCT00771056|494176|P1|COMPLETED|Overall Study||18
205177|NCT00771056|494176|P1|STARTED|Overall Study||23
205178|NCT00770991|494183|P2|NOT COMPLETED|Overall Study||5
205179|NCT00770991|494184|P1|NOT COMPLETED|Overall Study||5
205180|NCT00770991|494183|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
205181|NCT00770991|494184|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
205182|NCT00770991|494183|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
205183|NCT00770991|494184|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
205184|NCT00770965|494200|P4|NOT COMPLETED|Excluded Set||13
205185|NCT00770965|494201|P3|NOT COMPLETED|Excluded Set||14
205186|NCT00770965|494202|P2|NOT COMPLETED|Excluded Set||13
205187|NCT00770965|494203|P1|NOT COMPLETED|Excluded Set||15
205188|NCT00770965|494200|P4|COMPLETED|Excluded Set||2
205189|NCT00770965|494201|P3|COMPLETED|Excluded Set||2
205190|NCT00770965|494202|P2|COMPLETED|Excluded Set||3
205191|NCT00770965|494203|P1|COMPLETED|Excluded Set||3
205192|NCT00770965|494200|P4|STARTED|Excluded Set||15
205193|NCT00770965|494201|P3|STARTED|Excluded Set||16
205194|NCT00770965|494202|P2|STARTED|Excluded Set||16
205195|NCT00770965|494203|P1|STARTED|Excluded Set||18
205196|NCT00770965|494200|P4|NOT COMPLETED|Safety Set||1
205197|NCT00770965|494201|P3|NOT COMPLETED|Safety Set||1
205198|NCT00770965|494202|P2|NOT COMPLETED|Safety Set||0
205199|NCT00770965|494203|P1|NOT COMPLETED|Safety Set||0
205200|NCT00770965|494200|P4|COMPLETED|Safety Set||4
205201|NCT00770965|494201|P3|COMPLETED|Safety Set||3
205202|NCT00770965|494202|P2|COMPLETED|Safety Set||4
205203|NCT00770965|494203|P1|COMPLETED|Safety Set||2
205204|NCT00770965|494200|P4|STARTED|Safety Set||5
205205|NCT00770965|494201|P3|STARTED|Safety Set||4
205206|NCT00770965|494202|P2|STARTED|Safety Set||4
205207|NCT00770965|494203|P1|STARTED|Safety Set||2
205208|NCT00770913|494224|P3|NOT COMPLETED|Overall Study||13
205209|NCT00770913|494225|P2|NOT COMPLETED|Overall Study||8
205210|NCT00770913|494226|P1|NOT COMPLETED|Overall Study||11
205211|NCT00770913|494224|P3|COMPLETED|Overall Study||100
205212|NCT00770913|494225|P2|COMPLETED|Overall Study||103
205213|NCT00770913|494226|P1|COMPLETED|Overall Study||102
205214|NCT00770913|494224|P3|STARTED|Overall Study||113
205215|NCT00770913|494225|P2|STARTED|Overall Study||111
205216|NCT00770913|494226|P1|STARTED|Overall Study||113
205217|NCT00770861|494236|P2|NOT COMPLETED|Overall Study||16
205218|NCT00770861|494237|P1|NOT COMPLETED|Overall Study||10
205219|NCT00770861|494236|P2|COMPLETED|Overall Study||120
205220|NCT00770861|494237|P1|COMPLETED|Overall Study||131
205221|NCT00770861|494236|P2|STARTED|Overall Study||136
205222|NCT00770861|494237|P1|STARTED|Overall Study||141
205223|NCT00770809|494248|P3|NOT COMPLETED|Overall Study||23
205224|NCT00770809|494249|P2|NOT COMPLETED|Overall Study||10
205225|NCT00770809|494250|P1|NOT COMPLETED|Overall Study||17
205226|NCT00770809|494248|P3|COMPLETED|Overall Study||44
205227|NCT00770809|494249|P2|COMPLETED|Overall Study||110
205228|NCT00770809|494250|P1|COMPLETED|Overall Study||101
205229|NCT00770809|494248|P3|STARTED|Overall Study||67
205230|NCT00770809|494249|P2|STARTED|Overall Study||120
205231|NCT00770809|494250|P1|STARTED|Overall Study||118
205232|NCT00770770|494260|P2|NOT COMPLETED|Overall Study||1
205233|NCT00770770|494261|P1|NOT COMPLETED|Overall Study||10
205234|NCT00770770|494260|P2|COMPLETED|Overall Study||5
205235|NCT00770770|494261|P1|COMPLETED|Overall Study||4
205236|NCT00770770|494260|P2|STARTED|Overall Study||6
205237|NCT00770770|494261|P1|STARTED|Overall Study||14
205238|NCT00770757|494267|P1|NOT COMPLETED|Overall Study||0
205239|NCT00770757|494267|P1|COMPLETED|Overall Study||13
205240|NCT00770757|494267|P1|STARTED|Overall Study||13
205241|NCT00770692|494279|P4|NOT COMPLETED|Overall Study||11
205242|NCT00770692|494280|P3|NOT COMPLETED|Overall Study||14
205243|NCT00770692|494281|P2|NOT COMPLETED|Overall Study||9
205244|NCT00770692|494282|P1|NOT COMPLETED|Overall Study||12
205245|NCT00770692|494279|P4|COMPLETED|Overall Study||66
205246|NCT00770692|494280|P3|COMPLETED|Overall Study||70
205247|NCT00770692|494281|P2|COMPLETED|Overall Study||74
205248|NCT00770692|494282|P1|COMPLETED|Overall Study||69
205249|NCT00770692|494279|P4|STARTED|Overall Study||77
205250|NCT00770692|494280|P3|STARTED|Overall Study||84
205251|NCT00770692|494281|P2|STARTED|Overall Study||83
205345|NCT00770146|494585|P2|COMPLETED|Follow-up Period||85
205346|NCT00770146|494586|P1|COMPLETED|Follow-up Period||42
205252|NCT00770692|494282|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
205253|NCT00770679|494308|P1|NOT COMPLETED|Overall Study||6
205254|NCT00770679|494308|P1|COMPLETED|Overall Study||10
205255|NCT00770679|494308|P1|STARTED|Overall Study||16
205256|NCT00770653|494316|P2|NOT COMPLETED|Overall Study||29
205257|NCT00770653|494317|P1|NOT COMPLETED|Overall Study||32
205258|NCT00770653|494316|P2|COMPLETED|Overall Study||121
205259|NCT00770653|494317|P1|COMPLETED|Overall Study||123
205260|NCT00770653|494316|P2|STARTED|Overall Study||150
205261|NCT00770653|494317|P1|STARTED|Overall Study||155
205262|NCT00770588|494387|P2|NOT COMPLETED|Overall Study||95
205263|NCT00770588|494388|P1|NOT COMPLETED|Overall Study||81
205264|NCT00770588|494387|P2|COMPLETED|Overall Study||53
205265|NCT00770588|494388|P1|COMPLETED|Overall Study||67
205266|NCT00770588|494387|P2|STARTED|Overall Study||148
205267|NCT00770588|494388|P1|STARTED|Overall Study||148
205268|NCT00770562|494404|P2|NOT COMPLETED|Overall Study||1
205269|NCT00770562|494405|P1|NOT COMPLETED|Overall Study||1
205270|NCT00770562|494404|P2|COMPLETED|Overall Study||49
205271|NCT00770562|494405|P1|COMPLETED|Overall Study||52
205272|NCT00770562|494404|P2|STARTED|Overall Study||50
205273|NCT00770562|494405|P1|STARTED|Overall Study||53
205274|NCT00770510|494416|P1|NOT COMPLETED|Overall Study||5
205275|NCT00770510|494416|P1|COMPLETED|Overall Study||67
205276|NCT00770510|494416|P1|STARTED|Overall Study||72
205277|NCT00770484|494455|P2|NOT COMPLETED|Overall Study||0
205278|NCT00770484|494456|P1|NOT COMPLETED|Overall Study||1
205279|NCT00770484|494455|P2|COMPLETED|Overall Study||4
205280|NCT00770484|494456|P1|COMPLETED|Overall Study||7
205281|NCT00770484|494455|P2|STARTED|Overall Study||4
205282|NCT00770484|494456|P1|STARTED|Overall Study||8
205283|NCT00770432|494464|P2|NOT COMPLETED|Overall Study||7
205284|NCT00770432|494465|P1|NOT COMPLETED|Overall Study||4
205285|NCT00770432|494464|P2|COMPLETED|Overall Study||94
205286|NCT00770432|494465|P1|COMPLETED|Overall Study||98
205287|NCT00770432|494464|P2|STARTED|Overall Study||101
205288|NCT00770432|494465|P1|STARTED|Overall Study||102
205289|NCT00770367|494473|P2|NOT COMPLETED|Second Intervention||0
205290|NCT00770367|494474|P1|NOT COMPLETED|Second Intervention||2
205291|NCT00770367|494473|P2|COMPLETED|Second Intervention||15
205292|NCT00770367|494474|P1|COMPLETED|Second Intervention||16
205293|NCT00770367|494473|P2|STARTED|Second Intervention||15
205294|NCT00770367|494474|P1|STARTED|Second Intervention||18
205295|NCT00770367|494473|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
205296|NCT00770367|494474|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
205297|NCT00770367|494473|P2|COMPLETED|Washout Period of 4 Weeks||15
205298|NCT00770367|494474|P1|COMPLETED|Washout Period of 4 Weeks||18
205299|NCT00770367|494473|P2|STARTED|Washout Period of 4 Weeks||16
205300|NCT00770367|494474|P1|STARTED|Washout Period of 4 Weeks||18
205301|NCT00770367|494473|P2|NOT COMPLETED|First Intervention||2
205302|NCT00770367|494474|P1|NOT COMPLETED|First Intervention||0
205303|NCT00770367|494473|P2|COMPLETED|First Intervention||16
205304|NCT00770367|494474|P1|COMPLETED|First Intervention||18
205305|NCT00770367|494473|P2|STARTED|First Intervention||18
205306|NCT00770367|494474|P1|STARTED|First Intervention||18
205307|NCT00770341|494483|P3|NOT COMPLETED|Overall Study||3
205308|NCT00770341|494484|P2|NOT COMPLETED|Overall Study||5
205309|NCT00770341|494485|P1|NOT COMPLETED|Overall Study||12
205310|NCT00770341|494483|P3|COMPLETED|Overall Study||8
205311|NCT00770341|494484|P2|COMPLETED|Overall Study||17
205312|NCT00770341|494485|P1|COMPLETED|Overall Study||77
205313|NCT00770341|494483|P3|STARTED|Overall Study|Number randomized|11
205314|NCT00770341|494484|P2|STARTED|Overall Study|Number randomized|22
205315|NCT00770341|494485|P1|STARTED|Overall Study|Number randomized|89
205316|NCT00770328|494511|P2|NOT COMPLETED|Overall Study||4
205317|NCT00770328|494512|P1|NOT COMPLETED|Overall Study||13
205318|NCT00770328|494511|P2|COMPLETED|Overall Study||11
205319|NCT00770328|494512|P1|COMPLETED|Overall Study||9
205320|NCT00770328|494511|P2|STARTED|Overall Study||15
205321|NCT00770328|494512|P1|STARTED|Overall Study||22
205322|NCT00770315|494528|P4|NOT COMPLETED|Overall Study||38
205323|NCT00770315|494529|P3|NOT COMPLETED|Overall Study||57
205324|NCT00770315|494530|P2|NOT COMPLETED|Overall Study||43
205325|NCT00770315|494531|P1|NOT COMPLETED|Overall Study||40
205326|NCT00770315|494528|P4|COMPLETED|Overall Study||160
205327|NCT00770315|494529|P3|COMPLETED|Overall Study||137
205328|NCT00770315|494530|P2|COMPLETED|Overall Study||152
205329|NCT00770315|494531|P1|COMPLETED|Overall Study||157
205330|NCT00770315|494528|P4|STARTED|Overall Study||198
205331|NCT00770315|494529|P3|STARTED|Overall Study||194
205332|NCT00770315|494530|P2|STARTED|Overall Study||195
205333|NCT00770315|494531|P1|STARTED|Overall Study||197
205334|NCT00770289|494557|P1|NOT COMPLETED|Overall Study||6
205335|NCT00770289|494557|P1|COMPLETED|Overall Study||845
205336|NCT00770289|494557|P1|STARTED|Overall Study||851
205337|NCT00770211|494568|P2|NOT COMPLETED|Overall Study||2
205338|NCT00770211|494569|P1|NOT COMPLETED|Overall Study||1
205339|NCT00770211|494568|P2|COMPLETED|Overall Study||87
205340|NCT00770211|494569|P1|COMPLETED|Overall Study||181
205341|NCT00770211|494568|P2|STARTED|Overall Study||89
205342|NCT00770211|494569|P1|STARTED|Overall Study||182
205343|NCT00770146|494585|P2|NOT COMPLETED|Follow-up Period||20
205344|NCT00770146|494586|P1|NOT COMPLETED|Follow-up Period||11
205347|NCT00770146|494585|P2|STARTED|Follow-up Period||105
205348|NCT00770146|494586|P1|STARTED|Follow-up Period||53
205349|NCT00770146|494585|P2|NOT COMPLETED|Treatment Period||45
205350|NCT00770146|494586|P1|NOT COMPLETED|Treatment Period||9
205351|NCT00770146|494585|P2|COMPLETED|Treatment Period||60
205352|NCT00770146|494586|P1|COMPLETED|Treatment Period||44
205353|NCT00770146|494585|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
205354|NCT00770146|494586|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
205355|NCT00770146|494585|P2|Treated|Treatment Period||105
205356|NCT00770146|494586|P1|Treated|Treatment Period||52
205357|NCT00770146|494585|P2|STARTED|Treatment Period||105
205358|NCT00770146|494586|P1|STARTED|Treatment Period||53
205359|NCT00770120|494630|P1|NOT COMPLETED|Overall Study||61
205360|NCT00770120|494630|P1|COMPLETED|Overall Study||0
205361|NCT00770120|494630|P1|Not Analyzable|Overall Study||1
205362|NCT00770120|494630|P1|Eligible|Overall Study||60
205363|NCT00770120|494630|P1|STARTED|Overall Study||61
205364|NCT00770029|494639|P2|NOT COMPLETED|Overall Study||3
205365|NCT00770029|494640|P1|NOT COMPLETED|Overall Study||6
205366|NCT00770029|494639|P2|COMPLETED|Overall Study||89
205367|NCT00770029|494640|P1|COMPLETED|Overall Study||178
205368|NCT00770029|494639|P2|STARTED|Overall Study||92
205369|NCT00770029|494640|P1|STARTED|Overall Study||184
205370|NCT00769860|494656|P2|NOT COMPLETED|Overall Study||0
205371|NCT00769860|494657|P1|NOT COMPLETED|Overall Study||2
205372|NCT00769860|494656|P2|COMPLETED|Overall Study||8
205373|NCT00769860|494657|P1|COMPLETED|Overall Study||14
205374|NCT00769860|494656|P2|Month 8|Overall Study||8
205375|NCT00769860|494657|P1|Month 8|Overall Study||14
205376|NCT00769860|494656|P2|Month 4|Overall Study||8
205377|NCT00769860|494657|P1|Month 4|Overall Study||16
205378|NCT00769860|494656|P2|STARTED|Overall Study||8
205379|NCT00769860|494657|P1|STARTED|Overall Study||16
205380|NCT00769704|494685|P2|NOT COMPLETED|Overall Study||199
205381|NCT00769704|494686|P1|NOT COMPLETED|Overall Study||111
205382|NCT00769704|494685|P2|COMPLETED|Overall Study||97
205383|NCT00769704|494686|P1|COMPLETED|Overall Study||30
205384|NCT00769704|494685|P2|Received Treatment|Overall Study||292
205385|NCT00769704|494686|P1|Received Treatment|Overall Study||127
205386|NCT00769704|494685|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
205387|NCT00769704|494686|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
205388|NCT00769704|494685|P2|STARTED|Overall Study||296
205389|NCT00769704|494686|P1|STARTED|Overall Study||141
205390|NCT00769652|494706|P2|NOT COMPLETED|Overall Study||0
205391|NCT00769652|494707|P1|NOT COMPLETED|Overall Study||0
205392|NCT00769652|494706|P2|COMPLETED|Overall Study||1
205393|NCT00769652|494707|P1|COMPLETED|Overall Study||6
205394|NCT00769652|494706|P2|STARTED|Overall Study||1
205395|NCT00769652|494707|P1|STARTED|Overall Study||6
205396|NCT00769561|494719|P2|NOT COMPLETED|Overall Study||5
205397|NCT00769561|494720|P1|NOT COMPLETED|Overall Study||3
205398|NCT00769561|494719|P2|COMPLETED|Overall Study||24
205399|NCT00769561|494720|P1|COMPLETED|Overall Study||26
205400|NCT00769561|494719|P2|STARTED|Overall Study||29
205401|NCT00769561|494720|P1|STARTED|Overall Study||29
205402|NCT00769314|494742|P2|NOT COMPLETED|Overall Study||13
205403|NCT00769314|494743|P1|NOT COMPLETED|Overall Study||17
205404|NCT00769314|494742|P2|COMPLETED|Overall Study||384
205405|NCT00769314|494743|P1|COMPLETED|Overall Study||361
205406|NCT00769314|494742|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
205407|NCT00769314|494743|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
205408|NCT00769184|494769|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
205409|NCT00769184|494770|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
205410|NCT00769184|494769|P2|COMPLETED|No Treatment (6 Weeks)||6
205411|NCT00769184|494770|P1|COMPLETED|No Treatment (6 Weeks)||5
205412|NCT00769184|494769|P2|STARTED|No Treatment (6 Weeks)||7
205413|NCT00769184|494770|P1|STARTED|No Treatment (6 Weeks)||6
205414|NCT00769184|494769|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
205415|NCT00769184|494770|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
205416|NCT00769184|494769|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
205417|NCT00769184|494770|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
205418|NCT00769184|494769|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
205419|NCT00769184|494770|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
205420|NCT00769184|494769|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
205421|NCT00769184|494770|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
205422|NCT00769184|494769|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
205423|NCT00769184|494770|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
205424|NCT00769184|494769|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
205425|NCT00769184|494770|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
205426|NCT00769132|494778|P4|NOT COMPLETED|Period 4||0
205427|NCT00769132|494779|P3|NOT COMPLETED|Period 4||0
205428|NCT00769132|494780|P2|NOT COMPLETED|Period 4||1
205429|NCT00769132|494781|P1|NOT COMPLETED|Period 4||0
205430|NCT00769132|494778|P4|COMPLETED|Period 4||5
205431|NCT00769132|494779|P3|COMPLETED|Period 4||6
205432|NCT00769132|494780|P2|COMPLETED|Period 4||5
205433|NCT00769132|494781|P1|COMPLETED|Period 4||5
205434|NCT00769132|494778|P4|STARTED|Period 4||5
205435|NCT00769132|494779|P3|STARTED|Period 4||6
205436|NCT00769132|494780|P2|STARTED|Period 4||6
205437|NCT00769132|494781|P1|STARTED|Period 4||5
205438|NCT00769132|494778|P4|NOT COMPLETED|Period 3||0
205439|NCT00769132|494779|P3|NOT COMPLETED|Period 3||0
205440|NCT00769132|494780|P2|NOT COMPLETED|Period 3||0
205441|NCT00769132|494781|P1|NOT COMPLETED|Period 3||1
205442|NCT00769132|494778|P4|COMPLETED|Period 3||5
205443|NCT00769132|494779|P3|COMPLETED|Period 3||6
205444|NCT00769132|494780|P2|COMPLETED|Period 3||6
205445|NCT00769132|494781|P1|COMPLETED|Period 3||5
205446|NCT00769132|494778|P4|STARTED|Period 3||5
205447|NCT00769132|494779|P3|STARTED|Period 3||6
205448|NCT00769132|494780|P2|STARTED|Period 3||6
205449|NCT00769132|494781|P1|STARTED|Period 3||6
205450|NCT00769132|494778|P4|NOT COMPLETED|Period 2||1
205451|NCT00769132|494779|P3|NOT COMPLETED|Period 2||0
205452|NCT00769132|494780|P2|NOT COMPLETED|Period 2||0
205453|NCT00769132|494781|P1|NOT COMPLETED|Period 2||0
205454|NCT00769132|494778|P4|COMPLETED|Period 2||5
205455|NCT00769132|494779|P3|COMPLETED|Period 2||6
205456|NCT00769132|494780|P2|COMPLETED|Period 2||6
205457|NCT00769132|494781|P1|COMPLETED|Period 2||6
205458|NCT00769132|494778|P4|STARTED|Period 2||6
205459|NCT00769132|494779|P3|STARTED|Period 2||6
205460|NCT00769132|494780|P2|STARTED|Period 2||6
205461|NCT00769132|494781|P1|STARTED|Period 2||6
205462|NCT00769132|494778|P4|NOT COMPLETED|Period 1||1
205463|NCT00769132|494779|P3|NOT COMPLETED|Period 1||0
205464|NCT00769132|494780|P2|NOT COMPLETED|Period 1||0
205465|NCT00769132|494781|P1|NOT COMPLETED|Period 1||1
205466|NCT00769132|494778|P4|COMPLETED|Period 1||6
205467|NCT00769132|494779|P3|COMPLETED|Period 1||6
205468|NCT00769132|494780|P2|COMPLETED|Period 1||6
205469|NCT00769132|494781|P1|COMPLETED|Period 1||6
205470|NCT00769132|494778|P4|STARTED|Period 1||7
205471|NCT00769132|494779|P3|STARTED|Period 1||6
205472|NCT00769132|494780|P2|STARTED|Period 1||6
205473|NCT00769132|494781|P1|STARTED|Period 1||7
205474|NCT00769119|494797|P2|NOT COMPLETED|Overall Study||3
205475|NCT00769119|494798|P1|NOT COMPLETED|Overall Study||2
205476|NCT00769119|494797|P2|COMPLETED|Overall Study||13
205477|NCT00769119|494798|P1|COMPLETED|Overall Study||20
205478|NCT00769119|494797|P2|STARTED|Overall Study||16
205479|NCT00769119|494798|P1|STARTED|Overall Study||22
205480|NCT00769067|494844|P2|NOT COMPLETED|Overall Study||94
205481|NCT00769067|494845|P1|NOT COMPLETED|Overall Study||94
205482|NCT00769067|494844|P2|COMPLETED|Overall Study||0
205483|NCT00769067|494845|P1|COMPLETED|Overall Study||0
205484|NCT00769067|494844|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
205485|NCT00769067|494845|P1|Treated|Overall Study||94
205486|NCT00769067|494844|P2|STARTED|Overall Study||94
205487|NCT00769067|494845|P1|STARTED|Overall Study||94
205488|NCT00769015|494872|P2|NOT COMPLETED|Overall Study||16
205489|NCT00769015|494873|P1|NOT COMPLETED|Overall Study||9
205490|NCT00769015|494872|P2|COMPLETED|Overall Study||76
205491|NCT00769015|494873|P1|COMPLETED|Overall Study||87
205492|NCT00769015|494872|P2|STARTED|Overall Study||92
205493|NCT00769015|494873|P1|STARTED|Overall Study||96
205494|NCT00768989|494893|P2|NOT COMPLETED|On or After Week 36||27
205495|NCT00768989|494894|P1|NOT COMPLETED|On or After Week 36||51
205496|NCT00768989|494893|P2|COMPLETED|On or After Week 36||0
205497|NCT00768989|494894|P1|COMPLETED|On or After Week 36||0
205498|NCT00768989|494893|P2|STARTED|On or After Week 36||27
205499|NCT00768989|494894|P1|STARTED|On or After Week 36||51
205500|NCT00768989|494893|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
205501|NCT00768989|494894|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
205502|NCT00768989|494893|P2|COMPLETED|Week 24 to Prior to Week 36||27
205503|NCT00768989|494894|P1|COMPLETED|Week 24 to Prior to Week 36||51
205504|NCT00768989|494893|P2|STARTED|Week 24 to Prior to Week 36||27
205505|NCT00768989|494894|P1|STARTED|Week 24 to Prior to Week 36||59
205506|NCT00768989|494893|P2|NOT COMPLETED|Prior to Week 24||3
205507|NCT00768989|494894|P1|NOT COMPLETED|Prior to Week 24||4
205508|NCT00768989|494893|P2|COMPLETED|Prior to Week 24||27
205509|NCT00768989|494894|P1|COMPLETED|Prior to Week 24||59
205510|NCT00768989|494893|P2|STARTED|Prior to Week 24||30
205511|NCT00768989|494894|P1|STARTED|Prior to Week 24||63
205512|NCT00768898|494942|P1|NOT COMPLETED|Overall Study||2
205513|NCT00768898|494942|P1|COMPLETED|Overall Study||28
205514|NCT00768898|494942|P1|STARTED|Overall Study||30
205515|NCT00768755|494966|P4|NOT COMPLETED|Phase 2||57
205516|NCT00768755|494967|P3|NOT COMPLETED|Phase 2||58
205517|NCT00768755|494968|P2|NOT COMPLETED|Phase 2||55
205518|NCT00768755|494969|P1|NOT COMPLETED|Phase 2||0
205519|NCT00768755|494966|P4|COMPLETED|Phase 2||0
205520|NCT00768755|494967|P3|COMPLETED|Phase 2||0
205521|NCT00768755|494968|P2|COMPLETED|Phase 2||0
205522|NCT00768755|494969|P1|COMPLETED|Phase 2||0
205523|NCT00768755|494966|P4|Treated|Phase 2||55
205524|NCT00768755|494967|P3|Treated|Phase 2||58
205525|NCT00768755|494968|P2|Treated|Phase 2||55
205526|NCT00768755|494969|P1|Treated|Phase 2||0
205527|NCT00768755|494966|P4|STARTED|Phase 2||57
205528|NCT00768755|494967|P3|STARTED|Phase 2||58
205529|NCT00768755|494968|P2|STARTED|Phase 2||55
205530|NCT00768755|494969|P1|STARTED|Phase 2||0
205531|NCT00768755|494966|P4|NOT COMPLETED|Phase 1||0
205532|NCT00768755|494967|P3|NOT COMPLETED|Phase 1||0
205533|NCT00768755|494968|P2|NOT COMPLETED|Phase 1||0
205534|NCT00768755|494969|P1|NOT COMPLETED|Phase 1||10
205535|NCT00768755|494966|P4|COMPLETED|Phase 1||0
205536|NCT00768755|494967|P3|COMPLETED|Phase 1||0
205537|NCT00768755|494968|P2|COMPLETED|Phase 1||0
205538|NCT00768755|494969|P1|COMPLETED|Phase 1||0
205539|NCT00768755|494966|P4|STARTED|Phase 1||0
205540|NCT00768755|494967|P3|STARTED|Phase 1||0
205541|NCT00768755|494968|P2|STARTED|Phase 1||0
205542|NCT00768755|494969|P1|STARTED|Phase 1||10
205543|NCT00768651|494993|P1|NOT COMPLETED|Overall Study||1
205544|NCT00768651|494993|P1|COMPLETED|Overall Study||7
205545|NCT00768651|494993|P1|STARTED|Overall Study||8
205546|NCT00768599|495001|P3|NOT COMPLETED|Overall Study||12
205547|NCT00768599|495002|P2|NOT COMPLETED|Overall Study||16
205548|NCT00768599|495003|P1|NOT COMPLETED|Overall Study||11
205549|NCT00768599|495001|P3|COMPLETED|Overall Study||35
205550|NCT00768599|495002|P2|COMPLETED|Overall Study||27
205551|NCT00768599|495003|P1|COMPLETED|Overall Study||34
205552|NCT00768599|495001|P3|STARTED|Overall Study||47
205553|NCT00768599|495002|P2|STARTED|Overall Study||43
205554|NCT00768599|495003|P1|STARTED|Overall Study||45
205555|NCT00768560|495032|P6|NOT COMPLETED|Intervention Set 3||0
205556|NCT00768560|495033|P5|NOT COMPLETED|Intervention Set 3||0
205557|NCT00768560|495034|P4|NOT COMPLETED|Intervention Set 3||0
205558|NCT00768560|495035|P3|NOT COMPLETED|Intervention Set 3||0
205559|NCT00768560|495036|P2|NOT COMPLETED|Intervention Set 3||0
205560|NCT00768560|495037|P1|NOT COMPLETED|Intervention Set 3||0
205561|NCT00768560|495032|P6|COMPLETED|Intervention Set 3||6
205562|NCT00768560|495033|P5|COMPLETED|Intervention Set 3||6
205563|NCT00768560|495034|P4|COMPLETED|Intervention Set 3||6
205564|NCT00768560|495035|P3|COMPLETED|Intervention Set 3||6
205565|NCT00768560|495036|P2|COMPLETED|Intervention Set 3||5
205566|NCT00768560|495037|P1|COMPLETED|Intervention Set 3||5
205567|NCT00768560|495032|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
205568|NCT00768560|495033|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
205569|NCT00768560|495034|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
205570|NCT00768560|495035|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
205571|NCT00768560|495036|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
205572|NCT00768560|495037|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
205573|NCT00768560|495032|P6|NOT COMPLETED|Intervention Set 2||0
205574|NCT00768560|495033|P5|NOT COMPLETED|Intervention Set 2||0
205575|NCT00768560|495034|P4|NOT COMPLETED|Intervention Set 2||0
205576|NCT00768560|495035|P3|NOT COMPLETED|Intervention Set 2||0
205577|NCT00768560|495036|P2|NOT COMPLETED|Intervention Set 2||0
205578|NCT00768560|495037|P1|NOT COMPLETED|Intervention Set 2||0
205579|NCT00768560|495032|P6|COMPLETED|Intervention Set 2||6
205580|NCT00768560|495033|P5|COMPLETED|Intervention Set 2||6
205581|NCT00768560|495034|P4|COMPLETED|Intervention Set 2||6
205582|NCT00768560|495035|P3|COMPLETED|Intervention Set 2||6
205583|NCT00768560|495036|P2|COMPLETED|Intervention Set 2||5
205584|NCT00768560|495037|P1|COMPLETED|Intervention Set 2||5
205585|NCT00768560|495032|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
205586|NCT00768560|495033|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
205587|NCT00768560|495034|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
205588|NCT00768560|495035|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
205589|NCT00768560|495036|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
205590|NCT00768560|495037|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
205591|NCT00768560|495032|P6|NOT COMPLETED|Intervention Set 1||0
205592|NCT00768560|495033|P5|NOT COMPLETED|Intervention Set 1||0
205593|NCT00768560|495034|P4|NOT COMPLETED|Intervention Set 1||0
205594|NCT00768560|495035|P3|NOT COMPLETED|Intervention Set 1||0
205595|NCT00768560|495036|P2|NOT COMPLETED|Intervention Set 1||1
205596|NCT00768560|495037|P1|NOT COMPLETED|Intervention Set 1||0
205597|NCT00768560|495032|P6|COMPLETED|Intervention Set 1||6
205598|NCT00768560|495033|P5|COMPLETED|Intervention Set 1||6
205599|NCT00768560|495034|P4|COMPLETED|Intervention Set 1||6
205600|NCT00768560|495035|P3|COMPLETED|Intervention Set 1||6
205601|NCT00768560|495036|P2|COMPLETED|Intervention Set 1||5
205602|NCT00768560|495037|P1|COMPLETED|Intervention Set 1||5
205603|NCT00768560|495032|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
205604|NCT00768560|495033|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
205605|NCT00768560|495034|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
205606|NCT00768560|495035|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
205607|NCT00768560|495036|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
205608|NCT00768560|495037|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
205609|NCT00768560|495032|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
205610|NCT00768560|495033|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
205611|NCT00768560|495034|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
205612|NCT00768560|495035|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
205613|NCT00768560|495036|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
205614|NCT00768560|495037|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
205615|NCT00768521|495063|P2|NOT COMPLETED|Period 2||0
205616|NCT00768521|495064|P1|NOT COMPLETED|Period 2||0
205617|NCT00768521|495063|P2|COMPLETED|Period 2||11
205618|NCT00768521|495064|P1|COMPLETED|Period 2||9
205619|NCT00768521|495063|P2|STARTED|Period 2||11
205620|NCT00768521|495064|P1|STARTED|Period 2||9
205621|NCT00768521|495063|P2|NOT COMPLETED|Period 1||0
205622|NCT00768521|495064|P1|NOT COMPLETED|Period 1||0
205623|NCT00768521|495063|P2|COMPLETED|Period 1||11
205624|NCT00768521|495064|P1|COMPLETED|Period 1||9
205625|NCT00768521|495063|P2|STARTED|Period 1||11
205626|NCT00768521|495064|P1|STARTED|Period 1||9
205627|NCT00768430|495074|P2|NOT COMPLETED|7 Day Endpoint||3
205628|NCT00768430|495075|P1|NOT COMPLETED|7 Day Endpoint||2
205629|NCT00768430|495074|P2|COMPLETED|7 Day Endpoint||22
205630|NCT00768430|495075|P1|COMPLETED|7 Day Endpoint||45
205631|NCT00768430|495074|P2|STARTED|7 Day Endpoint||25
205632|NCT00768430|495075|P1|STARTED|7 Day Endpoint||47
205633|NCT00768430|495074|P2|NOT COMPLETED|24 Hour Endpoint||0
205634|NCT00768430|495075|P1|NOT COMPLETED|24 Hour Endpoint||1
205635|NCT00768430|495074|P2|COMPLETED|24 Hour Endpoint||25
205636|NCT00768430|495075|P1|COMPLETED|24 Hour Endpoint||47
205637|NCT00768430|495074|P2|STARTED|24 Hour Endpoint||25
205638|NCT00768430|495075|P1|STARTED|24 Hour Endpoint||48
205639|NCT00768300|495083|P2|NOT COMPLETED|Overall Study||163
205640|NCT00768300|495084|P1|NOT COMPLETED|Overall Study||329
205641|NCT00768300|495083|P2|COMPLETED|Overall Study||1
205642|NCT00768300|495084|P1|COMPLETED|Overall Study||1
205643|NCT00768300|495083|P2|Randomized and Treated|Overall Study||163
205644|NCT00768300|495084|P1|Randomized and Treated|Overall Study||329
205645|NCT00768300|495083|P2|STARTED|Overall Study||164
205646|NCT00768300|495084|P1|STARTED|Overall Study||330
205647|NCT00768222|495108|P2|NOT COMPLETED|Overall Study||4
205648|NCT00768222|495109|P1|NOT COMPLETED|Overall Study||4
205649|NCT00768222|495108|P2|COMPLETED|Overall Study||47
205650|NCT00768222|495109|P1|COMPLETED|Overall Study||46
205651|NCT00768222|495108|P2|STARTED|Overall Study||51
205652|NCT00768222|495109|P1|STARTED|Overall Study||50
205653|NCT00768144|495131|P1|NOT COMPLETED|Overall Study||36
205654|NCT00768144|495131|P1|COMPLETED|Overall Study||0
205655|NCT00768144|495131|P1|STARTED|Overall Study||36
205656|NCT00768118|495137|P1|NOT COMPLETED|Overall Study||0
205657|NCT00768118|495137|P1|COMPLETED|Overall Study||11
205658|NCT00768118|495137|P1|STARTED|Overall Study||11
205659|NCT00768066|495144|P3|NOT COMPLETED|Overall Study||0
205660|NCT00768066|495145|P2|NOT COMPLETED|Overall Study||3
205661|NCT00768066|495146|P1|NOT COMPLETED|Overall Study||3
205662|NCT00768066|495144|P3|COMPLETED|Overall Study||21
205663|NCT00768066|495145|P2|COMPLETED|Overall Study||19
205664|NCT00768066|495146|P1|COMPLETED|Overall Study||19
205665|NCT00768066|495144|P3|STARTED|Overall Study||21
205666|NCT00768066|495145|P2|STARTED|Overall Study||22
205667|NCT00768066|495146|P1|STARTED|Overall Study||22
205668|NCT00768053|495178|P1|NOT COMPLETED|Overall Study||11
205669|NCT00768053|495178|P1|COMPLETED|Overall Study||97
205670|NCT00768053|495178|P1|STARTED|Overall Study||108
205671|NCT00768040|495209|P2|NOT COMPLETED|Overall Study||3
205672|NCT00768040|495210|P1|NOT COMPLETED|Overall Study||4
205673|NCT00768040|495209|P2|COMPLETED|Overall Study||16
205674|NCT00768040|495210|P1|COMPLETED|Overall Study||16
205675|NCT00768040|495209|P2|STARTED|Overall Study||19
205676|NCT00768040|495210|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
205677|NCT00767806|495218|P2|NOT COMPLETED|Overall Study||47
205678|NCT00767806|495219|P1|NOT COMPLETED|Overall Study||51
205679|NCT00767806|495218|P2|COMPLETED|Overall Study||156
205680|NCT00767806|495219|P1|COMPLETED|Overall Study||147
205681|NCT00767806|495218|P2|STARTED|Overall Study||203
205682|NCT00767806|495219|P1|STARTED|Overall Study||198
205683|NCT00767767|495280|P5|NOT COMPLETED|Overall Study||0
205684|NCT00767767|495281|P4|NOT COMPLETED|Overall Study||0
205685|NCT00767767|495282|P3|NOT COMPLETED|Overall Study||0
205686|NCT00767767|495283|P2|NOT COMPLETED|Overall Study||0
205687|NCT00767767|495284|P1|NOT COMPLETED|Overall Study||0
205688|NCT00767767|495280|P5|COMPLETED|Overall Study||3
205689|NCT00767767|495281|P4|COMPLETED|Overall Study||3
205690|NCT00767767|495282|P3|COMPLETED|Overall Study||20
205691|NCT00767767|495283|P2|COMPLETED|Overall Study||20
205692|NCT00767767|495284|P1|COMPLETED|Overall Study||21
205693|NCT00767767|495280|P5|STARTED|Overall Study||3
205694|NCT00767767|495281|P4|STARTED|Overall Study||3
205695|NCT00767767|495282|P3|STARTED|Overall Study||20
205696|NCT00767767|495283|P2|STARTED|Overall Study||20
205697|NCT00767767|495284|P1|STARTED|Overall Study||21
205698|NCT00767676|495296|P1|NOT COMPLETED|Overall Study||54
205699|NCT00767676|495296|P1|COMPLETED|Overall Study||205
205700|NCT00767676|495296|P1|STARTED|Overall Study||259
205701|NCT00767624|495302|P2|NOT COMPLETED|Overall Study||17
205702|NCT00767624|495303|P1|NOT COMPLETED|Overall Study||24
205703|NCT00767624|495302|P2|COMPLETED|Overall Study||58
205704|NCT00767624|495303|P1|COMPLETED|Overall Study||51
205705|NCT00767624|495302|P2|STARTED|Overall Study||75
205706|NCT00767624|495303|P1|STARTED|Overall Study||75
205707|NCT00767572|495311|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
205708|NCT00767572|495311|P1|COMPLETED|Second Intervention (12 Weeks)||12
205709|NCT00767572|495311|P1|STARTED|Second Intervention (12 Weeks)||12
205710|NCT00767572|495311|P1|NOT COMPLETED|Washout (4 Weeks)||0
205711|NCT00767572|495311|P1|COMPLETED|Washout (4 Weeks)||12
205712|NCT00767572|495311|P1|STARTED|Washout (4 Weeks)||12
205713|NCT00767572|495311|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
205714|NCT00767572|495311|P1|COMPLETED|First Intervention (12 Weeks)||12
205715|NCT00767572|495311|P1|STARTED|First Intervention (12 Weeks)||12
205716|NCT00767520|495319|P2|NOT COMPLETED|Overall Study||17
205717|NCT00767520|495320|P1|NOT COMPLETED|Overall Study||11
205718|NCT00767520|495319|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
205719|NCT00767520|495320|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
205720|NCT00767520|495319|P2|STARTED|Overall Study||78
205721|NCT00767520|495320|P1|STARTED|Overall Study||79
205722|NCT00767507|495346|P4|NOT COMPLETED|Overall Study||3
205723|NCT00767507|495347|P3|NOT COMPLETED|Overall Study||0
205724|NCT00767507|495348|P2|NOT COMPLETED|Overall Study||0
205725|NCT00767507|495349|P1|NOT COMPLETED|Overall Study||0
205726|NCT00767507|495346|P4|COMPLETED|Overall Study||101
205727|NCT00767507|495347|P3|COMPLETED|Overall Study||106
205728|NCT00767507|495348|P2|COMPLETED|Overall Study||6
205729|NCT00767507|495349|P1|COMPLETED|Overall Study||5
205730|NCT00767507|495346|P4|STARTED|Overall Study||104
205731|NCT00767507|495347|P3|STARTED|Overall Study||106
205732|NCT00767507|495348|P2|STARTED|Overall Study||6
205733|NCT00767507|495349|P1|STARTED|Overall Study||5
205734|NCT00767455|495373|P1|NOT COMPLETED|Overall Study||19
205735|NCT00767455|495373|P1|COMPLETED|Overall Study||40
205736|NCT00767455|495373|P1|STARTED|Overall Study||59
205737|NCT00767364|495381|P2|NOT COMPLETED|Overall Study||0
205738|NCT00767364|495382|P1|NOT COMPLETED|Overall Study||0
205739|NCT00767364|495381|P2|COMPLETED|Overall Study||3
205740|NCT00767364|495382|P1|COMPLETED|Overall Study||5
205741|NCT00767364|495381|P2|STARTED|Overall Study||3
205742|NCT00767364|495382|P1|STARTED|Overall Study||5
205743|NCT00767338|495394|P4|NOT COMPLETED|Overall Study||0
205744|NCT00767338|495395|P3|NOT COMPLETED|Overall Study||0
205745|NCT00767338|495396|P2|NOT COMPLETED|Overall Study||2
205746|NCT00767338|495397|P1|NOT COMPLETED|Overall Study||1
205747|NCT00767338|495394|P4|COMPLETED|Overall Study||0
205748|NCT00767338|495395|P3|COMPLETED|Overall Study||0
205749|NCT00767338|495396|P2|COMPLETED|Overall Study||0
205750|NCT00767338|495397|P1|COMPLETED|Overall Study||0
205751|NCT00767338|495394|P4|STARTED|Overall Study||0
205752|NCT00767338|495395|P3|STARTED|Overall Study||0
205753|NCT00767338|495396|P2|STARTED|Overall Study||2
205754|NCT00767338|495397|P1|STARTED|Overall Study||1
205755|NCT00767325|495407|P1|NOT COMPLETED|Overall Study||15
205756|NCT00767325|495407|P1|COMPLETED|Overall Study||89
205757|NCT00767325|495407|P1|STARTED|Overall Study||104
205758|NCT00767104|495418|P2|NOT COMPLETED|Overall Study||2
205759|NCT00767104|495419|P1|NOT COMPLETED|Overall Study||1
205760|NCT00767104|495418|P2|COMPLETED|Overall Study||18
205761|NCT00767104|495419|P1|COMPLETED|Overall Study||19
205762|NCT00767104|495418|P2|STARTED|Overall Study||20
205763|NCT00767104|495419|P1|STARTED|Overall Study||20
205764|NCT00767039|495429|P2|NOT COMPLETED|Overall Study||2
205765|NCT00767039|495430|P1|NOT COMPLETED|Overall Study||5
205766|NCT00767039|495429|P2|COMPLETED|Overall Study||23
205767|NCT00767039|495430|P1|COMPLETED|Overall Study||22
205768|NCT00767039|495429|P2|STARTED|Overall Study||25
205769|NCT00767039|495430|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
205770|NCT00767000|495461|P5|NOT COMPLETED|Optional 104-week Extension||4
205771|NCT00767000|495462|P4|NOT COMPLETED|Optional 104-week Extension||2
205772|NCT00767000|495463|P3|NOT COMPLETED|Optional 104-week Extension||7
205773|NCT00767000|495464|P2|NOT COMPLETED|Optional 104-week Extension||3
205774|NCT00767000|495465|P1|NOT COMPLETED|Optional 104-week Extension||7
205775|NCT00767000|495461|P5|COMPLETED|Optional 104-week Extension||0
205776|NCT00767000|495462|P4|COMPLETED|Optional 104-week Extension||0
205777|NCT00767000|495463|P3|COMPLETED|Optional 104-week Extension||0
205778|NCT00767000|495464|P2|COMPLETED|Optional 104-week Extension||0
205779|NCT00767000|495465|P1|COMPLETED|Optional 104-week Extension||0
205780|NCT00767000|495461|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
205781|NCT00767000|495462|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
205782|NCT00767000|495463|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
205783|NCT00767000|495464|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
205784|NCT00767000|495465|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
205785|NCT00767000|495461|P5|NOT COMPLETED|54-week Study||224
205786|NCT00767000|495462|P4|NOT COMPLETED|54-week Study||225
205787|NCT00767000|495463|P3|NOT COMPLETED|54-week Study||109
205788|NCT00767000|495464|P2|NOT COMPLETED|54-week Study||113
205789|NCT00767000|495465|P1|NOT COMPLETED|54-week Study||108
205790|NCT00767000|495461|P5|COMPLETED|54-week Study||7
205791|NCT00767000|495462|P4|COMPLETED|54-week Study||4
205792|NCT00767000|495463|P3|COMPLETED|54-week Study||8
205793|NCT00767000|495464|P2|COMPLETED|54-week Study||4
205794|NCT00767000|495465|P1|COMPLETED|54-week Study||11
205880|NCT00766363|495695|P4|STARTED|Overall Study|Number randomized.|12
205795|NCT00767000|495461|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
205796|NCT00767000|495462|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
205797|NCT00767000|495463|P3|STARTED|54-week Study||117
205798|NCT00767000|495464|P2|STARTED|54-week Study||117
205799|NCT00767000|495465|P1|STARTED|54-week Study||119
205800|NCT00766831|495507|P1|NOT COMPLETED|Overall Study||115
205801|NCT00766831|495507|P1|COMPLETED|Overall Study||75
205802|NCT00766831|495507|P1|STARTED|Overall Study||190
205803|NCT00766753|495525|P2|NOT COMPLETED|Overall Study||0
205804|NCT00766753|495526|P1|NOT COMPLETED|Overall Study||0
205805|NCT00766753|495525|P2|COMPLETED|Overall Study||11
205806|NCT00766753|495526|P1|COMPLETED|Overall Study||11
205807|NCT00766753|495525|P2|Completed at Least Four Vaccines|Overall Study||9
205808|NCT00766753|495526|P1|Completed at Least Four Vaccines|Overall Study||10
205809|NCT00766753|495525|P2|Received at Least One Vaccine|Overall Study||11
205810|NCT00766753|495526|P1|Received at Least One Vaccine|Overall Study||11
205811|NCT00766753|495525|P2|STARTED|Overall Study||11
205812|NCT00766753|495526|P1|STARTED|Overall Study||11
205813|NCT00766675|495537|P1|NOT COMPLETED|Overall Study||40
205814|NCT00766675|495537|P1|COMPLETED|Overall Study||40
205815|NCT00766675|495537|P1|STARTED|Overall Study||80
205816|NCT00766649|495550|P1|NOT COMPLETED|Overall Study||10
205817|NCT00766649|495550|P1|COMPLETED|Overall Study||1
205818|NCT00766649|495550|P1|STARTED|Overall Study||11
205819|NCT00766636|495564|P2|NOT COMPLETED|Overall Study||2
205820|NCT00766636|495565|P1|NOT COMPLETED|Overall Study||3
205821|NCT00766636|495564|P2|COMPLETED|Overall Study||0
205822|NCT00766636|495565|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
205823|NCT00766636|495564|P2|STARTED|Overall Study||2
205824|NCT00766636|495565|P1|STARTED|Overall Study||3
205825|NCT00766597|495571|P1|NOT COMPLETED|Overall Study||9
205826|NCT00766597|495571|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
205827|NCT00766597|495571|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
205828|NCT00766597|495571|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
205829|NCT00766597|495571|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
205830|NCT00766597|495571|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
205831|NCT00766597|495571|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
205832|NCT00766532|495583|P1|NOT COMPLETED|Overall Study||2
205833|NCT00766532|495583|P1|COMPLETED|Overall Study||10
205834|NCT00766532|495583|P1|STARTED|Overall Study||12
205835|NCT00766506|495589|P2|NOT COMPLETED|Overall Study||2
205836|NCT00766506|495590|P1|NOT COMPLETED|Overall Study||5
205837|NCT00766506|495589|P2|COMPLETED|Overall Study||48
205838|NCT00766506|495590|P1|COMPLETED|Overall Study||53
205839|NCT00766506|495589|P2|STARTED|Overall Study||50
205840|NCT00766506|495590|P1|STARTED|Overall Study||58
205841|NCT00766493|495614|P1|NOT COMPLETED|30 Days Post-Procedure||12
205842|NCT00766493|495614|P1|COMPLETED|30 Days Post-Procedure||238
205843|NCT00766493|495614|P1|STARTED|30 Days Post-Procedure||250
205844|NCT00766493|495614|P1|NOT COMPLETED|Pre-Discharge||0
205845|NCT00766493|495614|P1|COMPLETED|Pre-Discharge||250
205846|NCT00766493|495614|P1|STARTED|Pre-Discharge||250
205847|NCT00766467|495624|P2|NOT COMPLETED|Overall Study||8
205848|NCT00766467|495625|P1|NOT COMPLETED|Overall Study||11
205849|NCT00766467|495624|P2|COMPLETED|Overall Study||31
205850|NCT00766467|495625|P1|COMPLETED|Overall Study||31
205851|NCT00766467|495624|P2|Initiated Treatment|Overall Study||38
205852|NCT00766467|495625|P1|Initiated Treatment|Overall Study||39
205853|NCT00766467|495624|P2|STARTED|Overall Study||39
205854|NCT00766467|495625|P1|STARTED|Overall Study||42
205855|NCT00766415|495637|P2|NOT COMPLETED|Overall Study||1
205856|NCT00766415|495638|P1|NOT COMPLETED|Overall Study||0
205857|NCT00766415|495637|P2|COMPLETED|Overall Study||26
205858|NCT00766415|495638|P1|COMPLETED|Overall Study||25
205859|NCT00766415|495637|P2|STARTED|Overall Study||27
205860|NCT00766415|495638|P1|STARTED|Overall Study||25
205861|NCT00766376|495686|P1|NOT COMPLETED|Overall Study||27
205862|NCT00766376|495686|P1|COMPLETED|Overall Study||124
205863|NCT00766376|495686|P1|STARTED|Overall Study||151
205864|NCT00766363|495695|P4|NOT COMPLETED|Overall Study||0
205865|NCT00766363|495696|P3|NOT COMPLETED|Overall Study||0
205866|NCT00766363|495697|P2|NOT COMPLETED|Overall Study||1
205867|NCT00766363|495698|P1|NOT COMPLETED|Overall Study||1
205868|NCT00766363|495695|P4|COMPLETED|Overall Study||12
205869|NCT00766363|495696|P3|COMPLETED|Overall Study||12
205870|NCT00766363|495697|P2|COMPLETED|Overall Study||12
205871|NCT00766363|495698|P1|COMPLETED|Overall Study||11
205872|NCT00766363|495695|P4|PK POPULATION|Overall Study||13
205873|NCT00766363|495696|P3|PK POPULATION|Overall Study||10
205874|NCT00766363|495697|P2|PK POPULATION|Overall Study||13
205875|NCT00766363|495698|P1|PK POPULATION|Overall Study||12
205876|NCT00766363|495695|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
205877|NCT00766363|495696|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
205878|NCT00766363|495697|P2|SAFETY POPULATION|Overall Study||13
205879|NCT00766363|495698|P1|SAFETY POPULATION|Overall Study||12
205881|NCT00766363|495696|P3|STARTED|Overall Study|Number randomized.|12
205882|NCT00766363|495697|P2|STARTED|Overall Study||13
205883|NCT00766363|495698|P1|STARTED|Overall Study||12
205884|NCT00766090|495737|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
205885|NCT00766090|495738|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
205886|NCT00766090|495739|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
205887|NCT00766090|495740|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
205888|NCT00766090|495741|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
205889|NCT00766090|495742|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
205890|NCT00766090|495743|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
205891|NCT00766090|495744|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
205892|NCT00766090|495745|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
205893|NCT00766090|495746|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
205894|NCT00766090|495747|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
205895|NCT00766090|495748|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
205896|NCT00766090|495737|P12|COMPLETED|Treatment Period 3 (28 Days)||6
205897|NCT00766090|495738|P11|COMPLETED|Treatment Period 3 (28 Days)||7
205898|NCT00766090|495739|P10|COMPLETED|Treatment Period 3 (28 Days)||8
205899|NCT00766090|495740|P9|COMPLETED|Treatment Period 3 (28 Days)||6
205900|NCT00766090|495741|P8|COMPLETED|Treatment Period 3 (28 Days)||8
205901|NCT00766090|495742|P7|COMPLETED|Treatment Period 3 (28 Days)||6
205902|NCT00766090|495743|P6|COMPLETED|Treatment Period 3 (28 Days)||22
205903|NCT00766090|495744|P5|COMPLETED|Treatment Period 3 (28 Days)||20
205904|NCT00766090|495745|P4|COMPLETED|Treatment Period 3 (28 Days)||24
205905|NCT00766090|495746|P3|COMPLETED|Treatment Period 3 (28 Days)||20
205906|NCT00766090|495747|P2|COMPLETED|Treatment Period 3 (28 Days)||26
205907|NCT00766090|495748|P1|COMPLETED|Treatment Period 3 (28 Days)||22
205908|NCT00766090|495737|P12|STARTED|Treatment Period 3 (28 Days)||7
205909|NCT00766090|495738|P11|STARTED|Treatment Period 3 (28 Days)||7
205910|NCT00766090|495739|P10|STARTED|Treatment Period 3 (28 Days)||8
205911|NCT00766090|495740|P9|STARTED|Treatment Period 3 (28 Days)||6
205912|NCT00766090|495741|P8|STARTED|Treatment Period 3 (28 Days)||8
205913|NCT00766090|495742|P7|STARTED|Treatment Period 3 (28 Days)||6
205914|NCT00766090|495743|P6|STARTED|Treatment Period 3 (28 Days)||23
205915|NCT00766090|495744|P5|STARTED|Treatment Period 3 (28 Days)||21
205916|NCT00766090|495745|P4|STARTED|Treatment Period 3 (28 Days)||25
205917|NCT00766090|495746|P3|STARTED|Treatment Period 3 (28 Days)||20
205918|NCT00766090|495747|P2|STARTED|Treatment Period 3 (28 Days)||27
205919|NCT00766090|495748|P1|STARTED|Treatment Period 3 (28 Days)||22
205920|NCT00766090|495737|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
205921|NCT00766090|495738|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
205922|NCT00766090|495739|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
205923|NCT00766090|495740|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
205924|NCT00766090|495741|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
205925|NCT00766090|495742|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
205926|NCT00766090|495743|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
205927|NCT00766090|495744|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
205928|NCT00766090|495745|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
205929|NCT00766090|495746|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
205930|NCT00766090|495747|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
205931|NCT00766090|495748|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
205932|NCT00766090|495737|P12|COMPLETED|Washout Period 2 (14 Days)||7
205933|NCT00766090|495738|P11|COMPLETED|Washout Period 2 (14 Days)||7
205934|NCT00766090|495739|P10|COMPLETED|Washout Period 2 (14 Days)||8
205935|NCT00766090|495740|P9|COMPLETED|Washout Period 2 (14 Days)||6
205936|NCT00766090|495741|P8|COMPLETED|Washout Period 2 (14 Days)||8
205937|NCT00766090|495742|P7|COMPLETED|Washout Period 2 (14 Days)||6
205938|NCT00766090|495743|P6|COMPLETED|Washout Period 2 (14 Days)||23
205939|NCT00766090|495744|P5|COMPLETED|Washout Period 2 (14 Days)||21
205940|NCT00766090|495745|P4|COMPLETED|Washout Period 2 (14 Days)||25
205941|NCT00766090|495746|P3|COMPLETED|Washout Period 2 (14 Days)||20
205942|NCT00766090|495747|P2|COMPLETED|Washout Period 2 (14 Days)||27
205943|NCT00766090|495748|P1|COMPLETED|Washout Period 2 (14 Days)||22
205944|NCT00766090|495737|P12|STARTED|Washout Period 2 (14 Days)||7
205945|NCT00766090|495738|P11|STARTED|Washout Period 2 (14 Days)||7
205946|NCT00766090|495739|P10|STARTED|Washout Period 2 (14 Days)||8
205947|NCT00766090|495740|P9|STARTED|Washout Period 2 (14 Days)||6
205948|NCT00766090|495741|P8|STARTED|Washout Period 2 (14 Days)||8
205949|NCT00766090|495742|P7|STARTED|Washout Period 2 (14 Days)||6
205950|NCT00766090|495743|P6|STARTED|Washout Period 2 (14 Days)||23
205951|NCT00766090|495744|P5|STARTED|Washout Period 2 (14 Days)||21
205952|NCT00766090|495745|P4|STARTED|Washout Period 2 (14 Days)||25
205953|NCT00766090|495746|P3|STARTED|Washout Period 2 (14 Days)||21
205954|NCT00766090|495747|P2|STARTED|Washout Period 2 (14 Days)||27
205955|NCT00766090|495748|P1|STARTED|Washout Period 2 (14 Days)||22
205956|NCT00766090|495737|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205957|NCT00766090|495738|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205958|NCT00766090|495739|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205959|NCT00766090|495740|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205960|NCT00766090|495741|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205961|NCT00766090|495742|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205962|NCT00766090|495743|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205963|NCT00766090|495744|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
205964|NCT00766090|495745|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205965|NCT00766090|495746|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
205966|NCT00766090|495747|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205967|NCT00766090|495748|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
205968|NCT00766090|495737|P12|COMPLETED|Treatment Period 2 (28 Days)||7
205969|NCT00766090|495738|P11|COMPLETED|Treatment Period 2 (28 Days)||7
205970|NCT00766090|495739|P10|COMPLETED|Treatment Period 2 (28 Days)||8
205971|NCT00766090|495740|P9|COMPLETED|Treatment Period 2 (28 Days)||6
205972|NCT00766090|495741|P8|COMPLETED|Treatment Period 2 (28 Days)||8
205973|NCT00766090|495742|P7|COMPLETED|Treatment Period 2 (28 Days)||6
205974|NCT00766090|495743|P6|COMPLETED|Treatment Period 2 (28 Days)||23
205975|NCT00766090|495744|P5|COMPLETED|Treatment Period 2 (28 Days)||21
205976|NCT00766090|495745|P4|COMPLETED|Treatment Period 2 (28 Days)||25
205977|NCT00766090|495746|P3|COMPLETED|Treatment Period 2 (28 Days)||21
205978|NCT00766090|495747|P2|COMPLETED|Treatment Period 2 (28 Days)||27
205979|NCT00766090|495748|P1|COMPLETED|Treatment Period 2 (28 Days)||22
205980|NCT00766090|495737|P12|STARTED|Treatment Period 2 (28 Days)||7
205981|NCT00766090|495738|P11|STARTED|Treatment Period 2 (28 Days)||7
205982|NCT00766090|495739|P10|STARTED|Treatment Period 2 (28 Days)||8
205983|NCT00766090|495740|P9|STARTED|Treatment Period 2 (28 Days)||6
205984|NCT00766090|495741|P8|STARTED|Treatment Period 2 (28 Days)||8
205985|NCT00766090|495742|P7|STARTED|Treatment Period 2 (28 Days)||6
205986|NCT00766090|495743|P6|STARTED|Treatment Period 2 (28 Days)||23
205987|NCT00766090|495744|P5|STARTED|Treatment Period 2 (28 Days)||23
205988|NCT00766090|495745|P4|STARTED|Treatment Period 2 (28 Days)||25
205989|NCT00766090|495746|P3|STARTED|Treatment Period 2 (28 Days)||22
205990|NCT00766090|495747|P2|STARTED|Treatment Period 2 (28 Days)||27
205991|NCT00766090|495748|P1|STARTED|Treatment Period 2 (28 Days)||22
205992|NCT00766090|495737|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
205993|NCT00766090|495738|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
205994|NCT00766090|495739|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
205995|NCT00766090|495740|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
205996|NCT00766090|495741|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
205997|NCT00766090|495742|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
205998|NCT00766090|495743|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
205999|NCT00766090|495744|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
206000|NCT00766090|495745|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
206001|NCT00766090|495746|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
206002|NCT00766090|495747|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
206003|NCT00766090|495748|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
206004|NCT00766090|495737|P12|COMPLETED|Washout Period 1 (14 Days)||7
206005|NCT00766090|495738|P11|COMPLETED|Washout Period 1 (14 Days)||7
206006|NCT00766090|495739|P10|COMPLETED|Washout Period 1 (14 Days)||8
206007|NCT00766090|495740|P9|COMPLETED|Washout Period 1 (14 Days)||6
206008|NCT00766090|495741|P8|COMPLETED|Washout Period 1 (14 Days)||8
206009|NCT00766090|495742|P7|COMPLETED|Washout Period 1 (14 Days)||6
206010|NCT00766090|495743|P6|COMPLETED|Washout Period 1 (14 Days)||23
206011|NCT00766090|495744|P5|COMPLETED|Washout Period 1 (14 Days)||23
206012|NCT00766090|495745|P4|COMPLETED|Washout Period 1 (14 Days)||25
206013|NCT00766090|495746|P3|COMPLETED|Washout Period 1 (14 Days)||22
206014|NCT00766090|495747|P2|COMPLETED|Washout Period 1 (14 Days)||27
206015|NCT00766090|495748|P1|COMPLETED|Washout Period 1 (14 Days)||22
206016|NCT00766090|495737|P12|STARTED|Washout Period 1 (14 Days)||7
206017|NCT00766090|495738|P11|STARTED|Washout Period 1 (14 Days)||7
206018|NCT00766090|495739|P10|STARTED|Washout Period 1 (14 Days)||8
206019|NCT00766090|495740|P9|STARTED|Washout Period 1 (14 Days)||6
206020|NCT00766090|495741|P8|STARTED|Washout Period 1 (14 Days)||8
206021|NCT00766090|495742|P7|STARTED|Washout Period 1 (14 Days)||6
206022|NCT00766090|495743|P6|STARTED|Washout Period 1 (14 Days)||23
206023|NCT00766090|495744|P5|STARTED|Washout Period 1 (14 Days)||23
206024|NCT00766090|495745|P4|STARTED|Washout Period 1 (14 Days)||25
206025|NCT00766090|495746|P3|STARTED|Washout Period 1 (14 Days)||23
206026|NCT00766090|495747|P2|STARTED|Washout Period 1 (14 Days)||27
206027|NCT00766090|495748|P1|STARTED|Washout Period 1 (14 Days)||22
206028|NCT00766090|495737|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206029|NCT00766090|495738|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206030|NCT00766090|495739|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206031|NCT00766090|495740|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
206032|NCT00766090|495741|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206033|NCT00766090|495742|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206034|NCT00766090|495743|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206035|NCT00766090|495744|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206036|NCT00766090|495745|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
206037|NCT00766090|495746|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206038|NCT00766090|495747|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
206039|NCT00766090|495748|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
206040|NCT00766090|495737|P12|COMPLETED|Treatment Period 1 (28 Days)||7
206041|NCT00766090|495738|P11|COMPLETED|Treatment Period 1 (28 Days)||7
206042|NCT00766090|495739|P10|COMPLETED|Treatment Period 1 (28 Days)||8
206043|NCT00766090|495740|P9|COMPLETED|Treatment Period 1 (28 Days)||6
206044|NCT00766090|495741|P8|COMPLETED|Treatment Period 1 (28 Days)||8
206045|NCT00766090|495742|P7|COMPLETED|Treatment Period 1 (28 Days)||6
206046|NCT00766090|495743|P6|COMPLETED|Treatment Period 1 (28 Days)||23
206047|NCT00766090|495744|P5|COMPLETED|Treatment Period 1 (28 Days)||23
206048|NCT00766090|495745|P4|COMPLETED|Treatment Period 1 (28 Days)||25
206049|NCT00766090|495746|P3|COMPLETED|Treatment Period 1 (28 Days)||23
206050|NCT00766090|495747|P2|COMPLETED|Treatment Period 1 (28 Days)||27
206051|NCT00766090|495748|P1|COMPLETED|Treatment Period 1 (28 Days)||22
206052|NCT00766090|495737|P12|STARTED|Treatment Period 1 (28 Days)||7
206053|NCT00766090|495738|P11|STARTED|Treatment Period 1 (28 Days)||7
206054|NCT00766090|495739|P10|STARTED|Treatment Period 1 (28 Days)||8
206055|NCT00766090|495740|P9|STARTED|Treatment Period 1 (28 Days)||7
206056|NCT00766090|495741|P8|STARTED|Treatment Period 1 (28 Days)||8
206057|NCT00766090|495742|P7|STARTED|Treatment Period 1 (28 Days)||6
206058|NCT00766090|495743|P6|STARTED|Treatment Period 1 (28 Days)||23
206059|NCT00766090|495744|P5|STARTED|Treatment Period 1 (28 Days)||23
206060|NCT00766090|495745|P4|STARTED|Treatment Period 1 (28 Days)||26
206061|NCT00766090|495746|P3|STARTED|Treatment Period 1 (28 Days)||23
206062|NCT00766090|495747|P2|STARTED|Treatment Period 1 (28 Days)||27
206063|NCT00766090|495748|P1|STARTED|Treatment Period 1 (28 Days)||25
206064|NCT00766051|495789|P2|NOT COMPLETED|Overall Study||0
206065|NCT00766051|495790|P1|NOT COMPLETED|Overall Study||2
206066|NCT00766051|495789|P2|COMPLETED|Overall Study||10
206067|NCT00766051|495790|P1|COMPLETED|Overall Study||10
206068|NCT00766051|495789|P2|STARTED|Overall Study||10
206069|NCT00766051|495790|P1|STARTED|Overall Study||12
206070|NCT00765947|495800|P1|NOT COMPLETED|Overall Study||24
206071|NCT00765947|495800|P1|COMPLETED|Overall Study||232
206072|NCT00765947|495800|P1|STARTED|Overall Study||256
206073|NCT00765895|495811|P2|NOT COMPLETED|Overall Study||0
206074|NCT00765895|495812|P1|NOT COMPLETED|Overall Study||0
206075|NCT00765895|495811|P2|COMPLETED|Overall Study||65
206076|NCT00765895|495812|P1|COMPLETED|Overall Study||65
206077|NCT00765895|495811|P2|STARTED|Overall Study||65
206078|NCT00765895|495812|P1|STARTED|Overall Study||65
206079|NCT00765882|495821|P3|NOT COMPLETED|Overall Study||36
206080|NCT00765882|495822|P2|NOT COMPLETED|Overall Study||40
206081|NCT00765882|495823|P1|NOT COMPLETED|Overall Study||24
206082|NCT00765882|495821|P3|COMPLETED|Overall Study||169
206083|NCT00765882|495822|P2|COMPLETED|Overall Study||173
206084|NCT00765882|495823|P1|COMPLETED|Overall Study||191
206085|NCT00765882|495821|P3|STARTED|Overall Study||205
206086|NCT00765882|495822|P2|STARTED|Overall Study||213
206087|NCT00765882|495823|P1|STARTED|Overall Study||215
206088|NCT00765843|495855|P3|NOT COMPLETED|Overall Study||3
206089|NCT00765843|495856|P2|NOT COMPLETED|Overall Study||4
206090|NCT00765843|495857|P1|NOT COMPLETED|Overall Study||1
206091|NCT00765843|495855|P3|COMPLETED|Overall Study||23
206092|NCT00765843|495856|P2|COMPLETED|Overall Study||21
206093|NCT00765843|495857|P1|COMPLETED|Overall Study||25
206094|NCT00765843|495855|P3|STARTED|Overall Study||26
206095|NCT00765843|495856|P2|STARTED|Overall Study||25
206096|NCT00765843|495857|P1|STARTED|Overall Study||26
206097|NCT00765817|495867|P2|NOT COMPLETED|Overall Study||22
206098|NCT00765817|495868|P1|NOT COMPLETED|Overall Study||26
206099|NCT00765817|495867|P2|COMPLETED|Overall Study||101
206100|NCT00765817|495868|P1|COMPLETED|Overall Study||112
206101|NCT00765817|495867|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
206102|NCT00765817|495868|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
206103|NCT00765765|495906|P1|NOT COMPLETED|Overall Study||0
206104|NCT00765765|495906|P1|COMPLETED|Overall Study||6
206105|NCT00765765|495906|P1|STARTED|Overall Study||6
206106|NCT00765726|495916|P1|NOT COMPLETED|Overall Study||9
206107|NCT00765726|495916|P1|COMPLETED|Overall Study||3
206108|NCT00765726|495916|P1|STARTED|Overall Study||12
206109|NCT00765674|495924|P4|NOT COMPLETED|Overall Study||25
206110|NCT00765674|495925|P3|NOT COMPLETED|Overall Study||17
206111|NCT00765674|495926|P2|NOT COMPLETED|Overall Study||22
206112|NCT00765674|495927|P1|NOT COMPLETED|Overall Study||21
206113|NCT00765674|495924|P4|COMPLETED|Overall Study||285
206114|NCT00765674|495925|P3|COMPLETED|Overall Study||279
206115|NCT00765674|495926|P2|COMPLETED|Overall Study||276
206116|NCT00765674|495927|P1|COMPLETED|Overall Study||266
206117|NCT00765674|495924|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
206118|NCT00765674|495925|P3|STARTED|Overall Study||296
206119|NCT00765674|495926|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
206120|NCT00765674|495927|P1|STARTED|Overall Study||287
206121|NCT00765661|495951|P2|NOT COMPLETED|Overall Study||0
206122|NCT00765661|495952|P1|NOT COMPLETED|Overall Study||0
206123|NCT00765661|495951|P2|COMPLETED|Overall Study||31
206124|NCT00765661|495952|P1|COMPLETED|Overall Study||32
206125|NCT00765661|495951|P2|STARTED|Overall Study||31
206126|NCT00765661|495952|P1|STARTED|Overall Study||32
206127|NCT00765648|495966|P2|NOT COMPLETED|Overall Study||2
206128|NCT00765648|495967|P1|NOT COMPLETED|Overall Study||1
206129|NCT00765648|495966|P2|COMPLETED|Overall Study||114
206130|NCT00765648|495967|P1|COMPLETED|Overall Study||109
206131|NCT00765648|495966|P2|STARTED|Overall Study||116
206132|NCT00765648|495967|P1|STARTED|Overall Study||110
206133|NCT00765570|495985|P2|NOT COMPLETED|Overall Study||0
206134|NCT00765570|495986|P1|NOT COMPLETED|Overall Study||2
206135|NCT00765570|495985|P2|COMPLETED|Overall Study||3
206136|NCT00765570|495986|P1|COMPLETED|Overall Study||7
206137|NCT00765570|495985|P2|STARTED|Overall Study||3
206138|NCT00765570|495986|P1|STARTED|Overall Study||9
206139|NCT00765388|495994|P2|NOT COMPLETED|Period 2||0
206140|NCT00765388|495995|P1|NOT COMPLETED|Period 2||0
206141|NCT00765388|495994|P2|COMPLETED|Period 2||6
206142|NCT00765388|495995|P1|COMPLETED|Period 2||15
206143|NCT00765388|495994|P2|STARTED|Period 2||6
206144|NCT00765388|495995|P1|STARTED|Period 2||15
206145|NCT00765388|495994|P2|NOT COMPLETED|Period 1||5
206146|NCT00765388|495995|P1|NOT COMPLETED|Period 1||1
206147|NCT00765388|495994|P2|COMPLETED|Period 1||6
206148|NCT00765388|495995|P1|COMPLETED|Period 1||15
206149|NCT00765388|495994|P2|STARTED|Period 1||11
206150|NCT00765388|495995|P1|STARTED|Period 1|A cross-over study|16
206151|NCT00765375|496023|P1|NOT COMPLETED|Overall Study||0
206152|NCT00765375|496023|P1|COMPLETED|Overall Study||5
206153|NCT00765375|496023|P1|STARTED|Overall Study||5
206154|NCT00765362|496029|P1|NOT COMPLETED|Overall Study||137
206155|NCT00765362|496029|P1|COMPLETED|Overall Study||282
206156|NCT00765362|496029|P1|STARTED|Overall Study||419
206157|NCT00765336|496037|P2|NOT COMPLETED|Overall Study||16
206158|NCT00765336|496038|P1|NOT COMPLETED|Overall Study||19
206159|NCT00765336|496037|P2|COMPLETED|Overall Study||73
206160|NCT00765336|496038|P1|COMPLETED|Overall Study||72
206161|NCT00765336|496037|P2|STARTED|Overall Study||89
206162|NCT00765336|496038|P1|STARTED|Overall Study||91
206163|NCT00765245|496046|P2|NOT COMPLETED|Overall Study||2
206164|NCT00765245|496047|P1|NOT COMPLETED|Overall Study||13
206165|NCT00765245|496046|P2|COMPLETED|Overall Study||20
206166|NCT00765245|496047|P1|COMPLETED|Overall Study||9
206167|NCT00765245|496046|P2|STARTED|Overall Study||22
206168|NCT00765245|496047|P1|STARTED|Overall Study||22
206169|NCT00765232|496059|P2|NOT COMPLETED|Overall Study||0
206170|NCT00765232|496060|P1|NOT COMPLETED|Overall Study||0
206171|NCT00765232|496059|P2|COMPLETED|Overall Study||54
206172|NCT00765232|496060|P1|COMPLETED|Overall Study||57
206173|NCT00765232|496059|P2|STARTED|Overall Study||54
206174|NCT00765232|496060|P1|STARTED|Overall Study||57
206175|NCT00765206|496068|P4|NOT COMPLETED|Second Intervention||0
206176|NCT00765206|496069|P3|NOT COMPLETED|Second Intervention||0
206177|NCT00765206|496070|P2|NOT COMPLETED|Second Intervention||0
206178|NCT00765206|496071|P1|NOT COMPLETED|Second Intervention||0
206179|NCT00765206|496068|P4|COMPLETED|Second Intervention||15
206180|NCT00765206|496069|P3|COMPLETED|Second Intervention||15
206181|NCT00765206|496070|P2|COMPLETED|Second Intervention||15
206182|NCT00765206|496071|P1|COMPLETED|Second Intervention||15
206183|NCT00765206|496068|P4|STARTED|Second Intervention||15
206184|NCT00765206|496069|P3|STARTED|Second Intervention||15
206185|NCT00765206|496070|P2|STARTED|Second Intervention||15
206186|NCT00765206|496071|P1|STARTED|Second Intervention||15
206187|NCT00765206|496068|P4|NOT COMPLETED|Washout Period of 14 Days||0
206188|NCT00765206|496069|P3|NOT COMPLETED|Washout Period of 14 Days||0
206189|NCT00765206|496070|P2|NOT COMPLETED|Washout Period of 14 Days||0
206190|NCT00765206|496071|P1|NOT COMPLETED|Washout Period of 14 Days||0
206191|NCT00765206|496068|P4|COMPLETED|Washout Period of 14 Days||15
206192|NCT00765206|496069|P3|COMPLETED|Washout Period of 14 Days||15
206193|NCT00765206|496070|P2|COMPLETED|Washout Period of 14 Days||15
206194|NCT00765206|496071|P1|COMPLETED|Washout Period of 14 Days||15
206195|NCT00765206|496068|P4|STARTED|Washout Period of 14 Days||15
206196|NCT00765206|496069|P3|STARTED|Washout Period of 14 Days||15
206197|NCT00765206|496070|P2|STARTED|Washout Period of 14 Days||15
206198|NCT00765206|496071|P1|STARTED|Washout Period of 14 Days||15
206199|NCT00765206|496068|P4|NOT COMPLETED|First Intervention||0
206200|NCT00765206|496069|P3|NOT COMPLETED|First Intervention||0
206201|NCT00765206|496070|P2|NOT COMPLETED|First Intervention||0
206202|NCT00765206|496071|P1|NOT COMPLETED|First Intervention||0
206203|NCT00765206|496068|P4|COMPLETED|First Intervention||15
206204|NCT00765206|496069|P3|COMPLETED|First Intervention||15
206205|NCT00765206|496070|P2|COMPLETED|First Intervention||15
206206|NCT00765206|496071|P1|COMPLETED|First Intervention||15
206207|NCT00765206|496068|P4|STARTED|First Intervention||15
206208|NCT00765206|496069|P3|STARTED|First Intervention||15
206209|NCT00765206|496070|P2|STARTED|First Intervention||15
206210|NCT00765206|496071|P1|STARTED|First Intervention||15
206211|NCT00765193|496077|P1|NOT COMPLETED|Full Body Examination||0
206212|NCT00765193|496077|P1|COMPLETED|Full Body Examination||14381
206213|NCT00765193|496077|P1|STARTED|Full Body Examination||14381
206214|NCT00765193|496077|P1|NOT COMPLETED|Problem Area Examination||0
206215|NCT00765193|496077|P1|COMPLETED|Problem Area Examination||14381
206216|NCT00765193|496077|P1|STARTED|Problem Area Examination||14381
206217|NCT00765128|496084|P2|NOT COMPLETED|Overall Study||0
206218|NCT00765128|496085|P1|NOT COMPLETED|Overall Study||0
206219|NCT00765128|496084|P2|COMPLETED|Overall Study||9
206220|NCT00765128|496085|P1|COMPLETED|Overall Study||8
206221|NCT00765128|496084|P2|STARTED|Overall Study||9
206222|NCT00765128|496085|P1|STARTED|Overall Study||8
206223|NCT00765102|496093|P1|NOT COMPLETED|Overall Study||31
206224|NCT00765102|496093|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
206225|NCT00765102|496093|P1|STARTED|Overall Study||32
206226|NCT00765076|496118|P3|NOT COMPLETED|Overall Study||1
206227|NCT00765076|496119|P2|NOT COMPLETED|Overall Study||0
206228|NCT00765076|496120|P1|NOT COMPLETED|Overall Study||1
206229|NCT00765076|496118|P3|COMPLETED|Overall Study||49
206230|NCT00765076|496119|P2|COMPLETED|Overall Study||73
206231|NCT00765076|496120|P1|COMPLETED|Overall Study||68
206232|NCT00765076|496118|P3|STARTED|Overall Study||50
206233|NCT00765076|496119|P2|STARTED|Overall Study||73
206234|NCT00765076|496120|P1|STARTED|Overall Study||69
206235|NCT00765063|496173|P1|NOT COMPLETED|Overall Study||32
206236|NCT00765063|496173|P1|COMPLETED|Overall Study||30
206237|NCT00765063|496173|P1|STARTED|Overall Study||62
206238|NCT00765037|496189|P1|NOT COMPLETED|Overall Study||6
206239|NCT00765037|496189|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
206240|NCT00765037|496189|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
206241|NCT00764946|496196|P3|NOT COMPLETED|Overall Study||4
206242|NCT00764946|496197|P2|NOT COMPLETED|Overall Study||17
206243|NCT00764946|496198|P1|NOT COMPLETED|Overall Study||13
206244|NCT00764946|496196|P3|COMPLETED|Overall Study||18
206245|NCT00764946|496197|P2|COMPLETED|Overall Study||72
206246|NCT00764946|496198|P1|COMPLETED|Overall Study||85
206247|NCT00764946|496196|P3|TREATED|Overall Study||21
206248|NCT00764946|496197|P2|TREATED|Overall Study||88
206249|NCT00764946|496198|P1|TREATED|Overall Study||97
206250|NCT00764946|496196|P3|STARTED|Overall Study||22
206251|NCT00764946|496197|P2|STARTED|Overall Study||89
206252|NCT00764946|496198|P1|STARTED|Overall Study||98
206253|NCT00764881|496226|P2|NOT COMPLETED|Overall Study||10
206254|NCT00764881|496227|P1|NOT COMPLETED|Overall Study||16
206255|NCT00764881|496226|P2|COMPLETED|Overall Study||99
206256|NCT00764881|496227|P1|COMPLETED|Overall Study||92
206257|NCT00764881|496226|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
206258|NCT00764881|496227|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
206259|NCT00764881|496226|P2|STARTED|Overall Study||109
206260|NCT00764881|496227|P1|STARTED|Overall Study||108
206261|NCT00764868|496451|P1|NOT COMPLETED|Overall Study||113
206262|NCT00764868|496451|P1|COMPLETED|Overall Study||156
206263|NCT00764868|496451|P1|STARTED|Overall Study||269
206264|NCT00764790|496460|P3|NOT COMPLETED|Overall Study||30
206265|NCT00764790|496461|P2|NOT COMPLETED|Overall Study||41
206266|NCT00764790|496462|P1|NOT COMPLETED|Overall Study||38
206267|NCT00764790|496460|P3|COMPLETED|Overall Study||1074
206268|NCT00764790|496461|P2|COMPLETED|Overall Study||1065
206269|NCT00764790|496462|P1|COMPLETED|Overall Study||1069
206270|NCT00764790|496460|P3|STARTED|Overall Study||1104
206271|NCT00764790|496461|P2|STARTED|Overall Study||1106
206272|NCT00764790|496462|P1|STARTED|Overall Study||1107
206273|NCT00764699|496494|P1|NOT COMPLETED|Overall Study||3
206274|NCT00764699|496494|P1|COMPLETED|Overall Study||0
206275|NCT00764699|496494|P1|STARTED|Overall Study||3
206276|NCT00764673|496498|P1|NOT COMPLETED|Overall Study||12
206277|NCT00764673|496498|P1|COMPLETED|Overall Study||59
206278|NCT00764673|496498|P1|STARTED|Overall Study||71
206279|NCT00764660|496508|P2|NOT COMPLETED|Overall Study||11
206280|NCT00764660|496509|P1|NOT COMPLETED|Overall Study||22
206281|NCT00764660|496508|P2|COMPLETED|Overall Study||55
206282|NCT00764660|496509|P1|COMPLETED|Overall Study||53
206283|NCT00764660|496508|P2|STARTED|Overall Study||66
206284|NCT00764660|496509|P1|STARTED|Overall Study||75
206285|NCT00764517|496543|P2|NOT COMPLETED|Overall Study||14
206286|NCT00764517|496544|P1|NOT COMPLETED|Overall Study||15
206287|NCT00764517|496543|P2|COMPLETED|Overall Study||4
206288|NCT00764517|496544|P1|COMPLETED|Overall Study||24
206289|NCT00764517|496543|P2|STARTED|Overall Study||18
206290|NCT00764517|496544|P1|STARTED|Overall Study||39
206291|NCT00764504|496565|P3|NOT COMPLETED|Overall Study||103
206292|NCT00764504|496566|P2|NOT COMPLETED|Overall Study||70
206293|NCT00764504|496567|P1|NOT COMPLETED|Overall Study||66
206294|NCT00764504|496565|P3|COMPLETED|Overall Study||131
206295|NCT00764504|496566|P2|COMPLETED|Overall Study||71
206296|NCT00764504|496567|P1|COMPLETED|Overall Study||75
206297|NCT00764504|496565|P3|STARTED|Overall Study||234
206298|NCT00764504|496566|P2|STARTED|Overall Study||141
206299|NCT00764504|496567|P1|STARTED|Overall Study||141
206300|NCT00764478|496596|P3|NOT COMPLETED|Overall Study||8
206301|NCT00764478|496597|P2|NOT COMPLETED|Overall Study||22
206302|NCT00764478|496598|P1|NOT COMPLETED|Overall Study||15
206303|NCT00764478|496596|P3|COMPLETED|Overall Study||118
206304|NCT00764478|496597|P2|COMPLETED|Overall Study||97
206305|NCT00764478|496598|P1|COMPLETED|Overall Study||107
206306|NCT00764478|496596|P3|STARTED|Overall Study||126
206307|NCT00764478|496597|P2|STARTED|Overall Study||119
206308|NCT00764478|496598|P1|STARTED|Overall Study||122
206309|NCT00764465|496678|P6|NOT COMPLETED|Overall Study||1
206310|NCT00764465|496679|P5|NOT COMPLETED|Overall Study||1
206311|NCT00764465|496680|P4|NOT COMPLETED|Overall Study||1
206312|NCT00764465|496681|P3|NOT COMPLETED|Overall Study||1
206313|NCT00764465|496682|P2|NOT COMPLETED|Overall Study||1
206314|NCT00764465|496683|P1|NOT COMPLETED|Overall Study||2
206315|NCT00764465|496678|P6|COMPLETED|Overall Study||7
206316|NCT00764465|496679|P5|COMPLETED|Overall Study||6
206317|NCT00764465|496680|P4|COMPLETED|Overall Study||6
206318|NCT00764465|496681|P3|COMPLETED|Overall Study||6
206319|NCT00764465|496682|P2|COMPLETED|Overall Study||6
206320|NCT00764465|496683|P1|COMPLETED|Overall Study||7
206321|NCT00764465|496678|P6|STARTED|Overall Study||8
206322|NCT00764465|496679|P5|STARTED|Overall Study||7
206323|NCT00764465|496680|P4|STARTED|Overall Study||7
206324|NCT00764465|496681|P3|STARTED|Overall Study||7
206325|NCT00764465|496682|P2|STARTED|Overall Study||7
206326|NCT00764465|496683|P1|STARTED|Overall Study||9
206327|NCT00764361|496711|P2|NOT COMPLETED|Overall Study||4
206328|NCT00764361|496712|P1|NOT COMPLETED|Overall Study||2
206329|NCT00764361|496711|P2|COMPLETED|Overall Study||3
206330|NCT00764361|496712|P1|COMPLETED|Overall Study||6
206331|NCT00764361|496711|P2|STARTED|Overall Study||7
206332|NCT00764361|496712|P1|STARTED|Overall Study||8
206333|NCT00764322|496720|P1|NOT COMPLETED|Overall Study||20
206334|NCT00764322|496720|P1|COMPLETED|Overall Study||480
206335|NCT00764322|496720|P1|STARTED|Overall Study||500
206336|NCT00764309|496737|P1|NOT COMPLETED|Overall Study||0
206337|NCT00764309|496737|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
206338|NCT00764309|496737|P1|STARTED|Overall Study|Number of participants treated.|31
206339|NCT00763971|496747|P3|NOT COMPLETED|Overall Study||69
206340|NCT00763971|496748|P2|NOT COMPLETED|Overall Study||38
206341|NCT00763971|496749|P1|NOT COMPLETED|Overall Study||33
206342|NCT00763971|496747|P3|COMPLETED|Overall Study||42
206343|NCT00763971|496748|P2|COMPLETED|Overall Study||74
206344|NCT00763971|496749|P1|COMPLETED|Overall Study||80
206345|NCT00763971|496747|P3|STARTED|Overall Study||111
206346|NCT00763971|496748|P2|STARTED|Overall Study||112
206347|NCT00763971|496749|P1|STARTED|Overall Study||113
206348|NCT00763958|496780|P2|NOT COMPLETED|Overall Study||11
206349|NCT00763958|496781|P1|NOT COMPLETED|Overall Study||14
206350|NCT00763958|496780|P2|COMPLETED|Overall Study||5
206351|NCT00763958|496781|P1|COMPLETED|Overall Study||14
206352|NCT00763958|496780|P2|STARTED|Overall Study||16
206353|NCT00763958|496781|P1|STARTED|Overall Study||28
206354|NCT00763919|496791|P1|NOT COMPLETED|Overall Study||13
206355|NCT00763919|496791|P1|COMPLETED|Overall Study||30
206356|NCT00763919|496791|P1|STARTED|Overall Study||43
206357|NCT00763867|496819|P2|NOT COMPLETED|Overall Study||12
206358|NCT00763867|496820|P1|NOT COMPLETED|Overall Study||5
206359|NCT00763867|496819|P2|COMPLETED|Overall Study||101
206360|NCT00763867|496820|P1|COMPLETED|Overall Study||98
206361|NCT00763867|496819|P2|STARTED|Overall Study||113
206362|NCT00763867|496820|P1|STARTED|Overall Study||103
206363|NCT00763815|496916|P2|NOT COMPLETED|Overall Study||84
206364|NCT00763815|496917|P1|NOT COMPLETED|Overall Study||52
206365|NCT00763815|496916|P2|COMPLETED|Overall Study||239
206366|NCT00763815|496917|P1|COMPLETED|Overall Study||109
206367|NCT00763815|496916|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
206368|NCT00763815|496917|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
206369|NCT00763815|496916|P2|Treated/Safety Population|Overall Study||323
206370|NCT00763815|496917|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
206371|NCT00763815|496916|P2|STARTED|Overall Study||323
206372|NCT00763815|496917|P1|STARTED|Overall Study|Randomized.|161
206373|NCT00763750|496941|P1|NOT COMPLETED|Overall Study||0
206374|NCT00763750|496941|P1|COMPLETED|Overall Study||25
206375|NCT00763750|496941|P1|STARTED|Overall Study||25
206376|NCT00763698|496945|P1|NOT COMPLETED|Overall Study||10
206377|NCT00763698|496945|P1|COMPLETED|Overall Study||76
206378|NCT00763698|496945|P1|STARTED|Overall Study||86
206379|NCT00763490|496951|P1|NOT COMPLETED|Overall Study||0
206380|NCT00763490|496951|P1|COMPLETED|Overall Study||20
206381|NCT00763490|496951|P1|STARTED|Overall Study||20
206382|NCT00763451|496962|P4|NOT COMPLETED|Overall Study||30
206383|NCT00763451|496963|P3|NOT COMPLETED|Overall Study||40
206384|NCT00763451|496964|P2|NOT COMPLETED|Overall Study||22
206385|NCT00763451|496965|P1|NOT COMPLETED|Overall Study||13
206386|NCT00763451|496962|P4|COMPLETED|Overall Study||131
206387|NCT00763451|496963|P3|COMPLETED|Overall Study||121
206388|NCT00763451|496964|P2|COMPLETED|Overall Study||60
206389|NCT00763451|496965|P1|COMPLETED|Overall Study||67
206390|NCT00763451|496962|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
206391|NCT00763451|496963|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
206392|NCT00763451|496964|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
206393|NCT00763451|496965|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
206394|NCT00763451|496962|P4|Treated/Safety Population|Overall Study||161
206395|NCT00763451|496963|P3|Treated/Safety Population|Overall Study||161
206396|NCT00763451|496964|P2|Treated/Safety Population|Overall Study||81
206397|NCT00763451|496965|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
206398|NCT00763451|496962|P4|STARTED|Overall Study||161
206399|NCT00763451|496963|P3|STARTED|Overall Study||161
206400|NCT00763451|496964|P2|STARTED|Overall Study||82
206401|NCT00763451|496965|P1|STARTED|Overall Study|Randomized.|80
206402|NCT00763412|496999|P2|NOT COMPLETED|Overall Study||4
206403|NCT00763412|497000|P1|NOT COMPLETED|Overall Study||4
206404|NCT00763412|496999|P2|COMPLETED|Overall Study||4
206405|NCT00763412|497000|P1|COMPLETED|Overall Study||4
206406|NCT00763412|496999|P2|STARTED|Overall Study||8
206407|NCT00763412|497000|P1|STARTED|Overall Study||8
206408|NCT00763386|497024|P2|NOT COMPLETED|Overall Study||40
206409|NCT00763386|497025|P1|NOT COMPLETED|Overall Study||48
206410|NCT00763386|497024|P2|COMPLETED|Overall Study||127
206411|NCT00763386|497025|P1|COMPLETED|Overall Study||116
206412|NCT00763386|497024|P2|STARTED|Overall Study||167
206413|NCT00763386|497025|P1|STARTED|Overall Study||164
206414|NCT00763360|497036|P3|NOT COMPLETED|Overall Study||0
206415|NCT00763360|497037|P2|NOT COMPLETED|Overall Study||2
206416|NCT00763360|497038|P1|NOT COMPLETED|Overall Study||0
206417|NCT00763360|497036|P3|COMPLETED|Overall Study||63
206418|NCT00763360|497037|P2|COMPLETED|Overall Study||58
206419|NCT00763360|497038|P1|COMPLETED|Overall Study||61
206420|NCT00763360|497036|P3|STARTED|Overall Study||63
206421|NCT00763360|497037|P2|STARTED|Overall Study||60
206422|NCT00763360|497038|P1|STARTED|Overall Study||61
206423|NCT00763321|497058|P3|NOT COMPLETED|Double-blind Period||29
206424|NCT00763321|497059|P2|NOT COMPLETED|Double-blind Period||21
206425|NCT00763321|497060|P1|NOT COMPLETED|Double-blind Period||0
206426|NCT00763321|497058|P3|COMPLETED|Double-blind Period||84
206427|NCT00763321|497059|P2|COMPLETED|Double-blind Period||88
206428|NCT00763321|497060|P1|COMPLETED|Double-blind Period||0
206429|NCT00763321|497058|P3|STARTED|Double-blind Period||113
206430|NCT00763321|497059|P2|STARTED|Double-blind Period||109
206431|NCT00763321|497060|P1|STARTED|Double-blind Period||0
206432|NCT00763321|497058|P3|NOT COMPLETED|Open-label Period||0
206433|NCT00763321|497059|P2|NOT COMPLETED|Open-label Period||0
206434|NCT00763321|497060|P1|NOT COMPLETED|Open-label Period||63
206435|NCT00763321|497058|P3|COMPLETED|Open-label Period||0
206436|NCT00763321|497059|P2|COMPLETED|Open-label Period||0
206437|NCT00763321|497060|P1|COMPLETED|Open-label Period||222
206438|NCT00763321|497058|P3|STARTED|Open-label Period||0
206439|NCT00763321|497059|P2|STARTED|Open-label Period||0
206440|NCT00763321|497060|P1|STARTED|Open-label Period||285
206441|NCT00763282|497071|P2|NOT COMPLETED|Overall Study||34
206442|NCT00763282|497072|P1|NOT COMPLETED|Overall Study||32
206443|NCT00763282|497071|P2|COMPLETED|Overall Study||38
206444|NCT00763282|497072|P1|COMPLETED|Overall Study||40
206445|NCT00763282|497071|P2|STARTED|Overall Study||72
206446|NCT00763282|497072|P1|STARTED|Overall Study||72
206447|NCT00763269|497088|P2|NOT COMPLETED|Overall Study||13
206448|NCT00763269|497089|P1|NOT COMPLETED|Overall Study||12
206449|NCT00763269|497088|P2|COMPLETED|Overall Study||299
206450|NCT00763269|497089|P1|COMPLETED|Overall Study||302
206451|NCT00763269|497088|P2|STARTED|Overall Study||312
206452|NCT00763269|497089|P1|STARTED|Overall Study||314
206453|NCT00763256|497103|P2|NOT COMPLETED|Overall Study||10
206454|NCT00763256|497104|P1|NOT COMPLETED|Overall Study||7
206455|NCT00763256|497103|P2|COMPLETED|Overall Study||8
206456|NCT00763256|497104|P1|COMPLETED|Overall Study||8
206457|NCT00763256|497103|P2|STARTED|Overall Study||18
206458|NCT00763256|497104|P1|STARTED|Overall Study||15
206459|NCT00763243|497118|P1|NOT COMPLETED|6-Month Follow-Up Period||0
206460|NCT00763243|497118|P1|COMPLETED|6-Month Follow-Up Period||9
206461|NCT00763243|497118|P1|STARTED|6-Month Follow-Up Period||9
206462|NCT00763243|497118|P1|NOT COMPLETED|1-Month Follow-Up Period||0
206463|NCT00763243|497118|P1|COMPLETED|1-Month Follow-Up Period||9
206464|NCT00763243|497118|P1|STARTED|1-Month Follow-Up Period||9
206465|NCT00763243|497118|P1|NOT COMPLETED|Training Period||0
206466|NCT00763243|497118|P1|COMPLETED|Training Period||9
206467|NCT00763243|497118|P1|STARTED|Training Period||9
206468|NCT00763243|497118|P1|NOT COMPLETED|Waiting Period||0
206469|NCT00763243|497118|P1|COMPLETED|Waiting Period||9
206470|NCT00763243|497118|P1|STARTED|Waiting Period||9
206471|NCT00763139|497140|P2|NOT COMPLETED|Overall Study||3
206472|NCT00763139|497141|P1|NOT COMPLETED|Overall Study||5
206473|NCT00763139|497140|P2|COMPLETED|Overall Study||14
206474|NCT00763139|497141|P1|COMPLETED|Overall Study||12
206475|NCT00763139|497140|P2|STARTED|Overall Study||17
206476|NCT00763139|497141|P1|STARTED|Overall Study||17
206477|NCT00763061|497163|P2|NOT COMPLETED|Overall Study||13
206478|NCT00763061|497164|P1|NOT COMPLETED|Overall Study||5
206479|NCT00763061|497163|P2|COMPLETED|Overall Study||44
206480|NCT00763061|497164|P1|COMPLETED|Overall Study||49
206481|NCT00763061|497163|P2|STARTED|Overall Study||57
206482|NCT00763061|497164|P1|STARTED|Overall Study||54
206483|NCT00763048|497178|P2|NOT COMPLETED|Overall Study||0
206484|NCT00763048|497179|P1|NOT COMPLETED|Overall Study||0
206485|NCT00763048|497178|P2|COMPLETED|Overall Study||18
206486|NCT00763048|497179|P1|COMPLETED|Overall Study||21
206487|NCT00763048|497178|P2|STARTED|Overall Study||18
206488|NCT00763048|497179|P1|STARTED|Overall Study||21
206489|NCT00763009|497203|P1|NOT COMPLETED|Overall Study||1
206490|NCT00763009|497203|P1|COMPLETED|Overall Study||7
206491|NCT00763009|497203|P1|STARTED|Overall Study||8
206492|NCT00762996|497208|P4|NOT COMPLETED|Period Two||0
206493|NCT00762996|497209|P3|NOT COMPLETED|Period Two||0
206494|NCT00762996|497210|P2|NOT COMPLETED|Period Two||0
206495|NCT00762996|497211|P1|NOT COMPLETED|Period Two||0
206496|NCT00762996|497208|P4|COMPLETED|Period Two||16
206497|NCT00762996|497209|P3|COMPLETED|Period Two||13
206498|NCT00762996|497210|P2|COMPLETED|Period Two||16
206499|NCT00762996|497211|P1|COMPLETED|Period Two||15
206500|NCT00762996|497208|P4|STARTED|Period Two||16
206501|NCT00762996|497209|P3|STARTED|Period Two||13
206502|NCT00762996|497210|P2|STARTED|Period Two||16
206503|NCT00762996|497211|P1|STARTED|Period Two||15
206504|NCT00762996|497208|P4|NOT COMPLETED|Period One||1
206505|NCT00762996|497209|P3|NOT COMPLETED|Period One||4
206506|NCT00762996|497210|P2|NOT COMPLETED|Period One||0
206507|NCT00762996|497211|P1|NOT COMPLETED|Period One||0
206508|NCT00762996|497208|P4|COMPLETED|Period One||16
206509|NCT00762996|497209|P3|COMPLETED|Period One||13
206510|NCT00762996|497210|P2|COMPLETED|Period One||16
206511|NCT00762996|497211|P1|COMPLETED|Period One||15
206512|NCT00762996|497208|P4|STARTED|Period One||17
206513|NCT00762996|497209|P3|STARTED|Period One||17
206514|NCT00762996|497210|P2|STARTED|Period One||16
206515|NCT00762996|497211|P1|STARTED|Period One||15
206516|NCT00762970|497224|P3|NOT COMPLETED|Overall Study||1
206517|NCT00762970|497225|P2|NOT COMPLETED|Overall Study||9
206518|NCT00762970|497226|P1|NOT COMPLETED|Overall Study||12
206519|NCT00762970|497224|P3|COMPLETED|Overall Study||46
206520|NCT00762970|497225|P2|COMPLETED|Overall Study||35
206521|NCT00762970|497226|P1|COMPLETED|Overall Study||34
206522|NCT00762970|497224|P3|STARTED|Overall Study||47
206523|NCT00762970|497225|P2|STARTED|Overall Study||44
206524|NCT00762970|497226|P1|STARTED|Overall Study||46
206525|NCT00762931|497237|P1|NOT COMPLETED|Overall Study||2
206526|NCT00762931|497237|P1|COMPLETED|Overall Study||23
206527|NCT00762931|497237|P1|STARTED|Overall Study||25
206528|NCT00762892|497244|P2|NOT COMPLETED|Overall Study||6
206529|NCT00762892|497245|P1|NOT COMPLETED|Overall Study||5
206530|NCT00762892|497244|P2|COMPLETED|Overall Study||8
206531|NCT00762892|497245|P1|COMPLETED|Overall Study||9
206532|NCT00762892|497244|P2|STARTED|Overall Study||14
206533|NCT00762892|497245|P1|STARTED|Overall Study||14
206534|NCT00762853|497261|P2|NOT COMPLETED|Second Treatment Period||0
206535|NCT00762853|497262|P1|NOT COMPLETED|Second Treatment Period||0
206536|NCT00762853|497261|P2|COMPLETED|Second Treatment Period||10
206537|NCT00762853|497262|P1|COMPLETED|Second Treatment Period||10
206538|NCT00762853|497261|P2|STARTED|Second Treatment Period||10
206539|NCT00762853|497262|P1|STARTED|Second Treatment Period||10
206540|NCT00762853|497261|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
206541|NCT00762853|497262|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
206542|NCT00762853|497261|P2|COMPLETED|1 Week Washout After Treatment 1||10
206543|NCT00762853|497262|P1|COMPLETED|1 Week Washout After Treatment 1||10
206544|NCT00762853|497261|P2|STARTED|1 Week Washout After Treatment 1||10
206545|NCT00762853|497262|P1|STARTED|1 Week Washout After Treatment 1||10
206546|NCT00762853|497261|P2|NOT COMPLETED|First Treatment Period||0
206547|NCT00762853|497262|P1|NOT COMPLETED|First Treatment Period||0
206548|NCT00762853|497261|P2|COMPLETED|First Treatment Period||10
206549|NCT00762853|497262|P1|COMPLETED|First Treatment Period||10
206550|NCT00762853|497261|P2|STARTED|First Treatment Period||10
206551|NCT00762853|497262|P1|STARTED|First Treatment Period||10
206552|NCT00762788|497274|P6|NOT COMPLETED|Overall Study||21
206553|NCT00762788|497275|P5|NOT COMPLETED|Overall Study||13
206554|NCT00762788|497276|P4|NOT COMPLETED|Overall Study||26
206555|NCT00762788|497277|P3|NOT COMPLETED|Overall Study||21
206556|NCT00762788|497278|P2|NOT COMPLETED|Overall Study||37
206557|NCT00762788|497279|P1|NOT COMPLETED|Overall Study||26
206558|NCT00762788|497274|P6|COMPLETED|Overall Study||31
206559|NCT00762788|497275|P5|COMPLETED|Overall Study||30
206560|NCT00762788|497276|P4|COMPLETED|Overall Study||38
206561|NCT00762788|497277|P3|COMPLETED|Overall Study||21
206562|NCT00762788|497278|P2|COMPLETED|Overall Study||21
206563|NCT00762788|497279|P1|COMPLETED|Overall Study||29
206564|NCT00762788|497274|P6|STARTED|Overall Study||52
206565|NCT00762788|497275|P5|STARTED|Overall Study||43
206566|NCT00762788|497276|P4|STARTED|Overall Study||64
206567|NCT00762788|497277|P3|STARTED|Overall Study||42
206568|NCT00762788|497278|P2|STARTED|Overall Study||58
206569|NCT00762788|497279|P1|STARTED|Overall Study||55
206570|NCT00762762|497301|P2|NOT COMPLETED|Overall Study||10
206571|NCT00762762|497302|P1|NOT COMPLETED|Overall Study||8
206572|NCT00762762|497301|P2|COMPLETED|Overall Study||20
206573|NCT00762762|497302|P1|COMPLETED|Overall Study||22
206574|NCT00762762|497301|P2|STARTED|Overall Study||30
206575|NCT00762762|497302|P1|STARTED|Overall Study||30
206576|NCT00762723|497319|P3|NOT COMPLETED|Overall Study||3
206577|NCT00762723|497320|P2|NOT COMPLETED|Overall Study||5
206578|NCT00762723|497321|P1|NOT COMPLETED|Overall Study||5
206579|NCT00762723|497319|P3|COMPLETED|Overall Study||0
206580|NCT00762723|497320|P2|COMPLETED|Overall Study||6
206581|NCT00762723|497321|P1|COMPLETED|Overall Study||0
206582|NCT00762723|497319|P3|STARTED|Overall Study||3
206583|NCT00762723|497320|P2|STARTED|Overall Study||11
206584|NCT00762723|497321|P1|STARTED|Overall Study||5
206585|NCT00762645|497331|P2|NOT COMPLETED|Overall Study||2
206586|NCT00762645|497332|P1|NOT COMPLETED|Overall Study||4
206587|NCT00762645|497331|P2|COMPLETED|Overall Study||12
206588|NCT00762645|497332|P1|COMPLETED|Overall Study||12
206589|NCT00762645|497331|P2|STARTED|Overall Study||14
206590|NCT00762645|497332|P1|STARTED|Overall Study||16
206591|NCT00762619|497342|P2|NOT COMPLETED|Overall Study||0
206592|NCT00762619|497343|P1|NOT COMPLETED|Overall Study||0
206593|NCT00762619|497342|P2|COMPLETED|Overall Study||50
206594|NCT00762619|497343|P1|COMPLETED|Overall Study||55
206595|NCT00762619|497342|P2|STARTED|Overall Study||50
206596|NCT00762619|497343|P1|STARTED|Overall Study||55
206597|NCT00762606|497485|P2|NOT COMPLETED|Overall Study||13
206598|NCT00762606|497486|P1|NOT COMPLETED|Overall Study||18
206599|NCT00762606|497485|P2|COMPLETED|Overall Study||38
206600|NCT00762606|497486|P1|COMPLETED|Overall Study||37
206601|NCT00762606|497485|P2|STARTED|Overall Study||51
206602|NCT00762606|497486|P1|STARTED|Overall Study||55
206603|NCT00762528|497496|P2|NOT COMPLETED|Overall Study||0
206604|NCT00762528|497497|P1|NOT COMPLETED|Overall Study||0
206605|NCT00762528|497496|P2|COMPLETED|Overall Study||25
206606|NCT00762528|497497|P1|COMPLETED|Overall Study||24
206607|NCT00762528|497496|P2|STARTED|Overall Study||25
206608|NCT00762528|497497|P1|STARTED|Overall Study||24
206609|NCT00762515|497519|P2|NOT COMPLETED|Overall Study||0
206610|NCT00762515|497520|P1|NOT COMPLETED|Overall Study||0
206611|NCT00762515|497519|P2|COMPLETED|Overall Study||22
206612|NCT00762515|497520|P1|COMPLETED|Overall Study||22
206613|NCT00762515|497519|P2|STARTED|Overall Study||22
206614|NCT00762515|497520|P1|STARTED|Overall Study||22
206615|NCT00762502|497531|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
206616|NCT00762502|497532|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
206617|NCT00762502|497533|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
206618|NCT00762502|497531|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
206619|NCT00762502|497532|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
206620|NCT00762502|497533|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
206621|NCT00762502|497531|P3|STARTED|Month 3 to Month 6 (Period 2)||23
206622|NCT00762502|497532|P2|STARTED|Month 3 to Month 6 (Period 2)||5
206623|NCT00762502|497533|P1|STARTED|Month 3 to Month 6 (Period 2)||9
206624|NCT00762502|497531|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
206625|NCT00762502|497532|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
206626|NCT00762502|497533|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
206627|NCT00762502|497531|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
206628|NCT00762502|497532|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
206629|NCT00762502|497533|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
206630|NCT00762502|497531|P3|STARTED|Baseline to Month 3 (Period 1)||51
206631|NCT00762502|497532|P2|STARTED|Baseline to Month 3 (Period 1)||25
206632|NCT00762502|497533|P1|STARTED|Baseline to Month 3 (Period 1)||36
206633|NCT00762476|497547|P2|NOT COMPLETED|Overall Study||36
206634|NCT00762476|497548|P1|NOT COMPLETED|Overall Study||23
206635|NCT00762476|497547|P2|COMPLETED|Overall Study||169
206636|NCT00762476|497548|P1|COMPLETED|Overall Study||183
206637|NCT00762476|497547|P2|STARTED|Overall Study||205
206638|NCT00762476|497548|P1|STARTED|Overall Study||206
206639|NCT00762463|497560|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
206640|NCT00762463|497561|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
206641|NCT00762463|497562|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
206642|NCT00762463|497563|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
206643|NCT00762463|497560|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
206644|NCT00762463|497561|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
206645|NCT00762463|497562|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
206646|NCT00762463|497563|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
206647|NCT00762463|497560|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
206648|NCT00762463|497561|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
206649|NCT00762463|497562|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
206650|NCT00762463|497563|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
206651|NCT00762463|497560|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
206652|NCT00762463|497561|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
206653|NCT00762463|497562|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
206654|NCT00762463|497563|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
206655|NCT00762463|497560|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
206656|NCT00762463|497561|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
206657|NCT00762463|497562|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
206658|NCT00762463|497563|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
206659|NCT00762463|497560|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
206660|NCT00762463|497561|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
206661|NCT00762463|497562|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
206662|NCT00762463|497563|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
206663|NCT00762463|497560|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
206664|NCT00762463|497561|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
206665|NCT00762463|497562|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
206666|NCT00762463|497563|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
206667|NCT00762463|497560|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
206668|NCT00762463|497561|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
206669|NCT00762463|497562|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
206670|NCT00762463|497563|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
206671|NCT00762463|497560|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
206672|NCT00762463|497561|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
206673|NCT00762463|497562|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
206674|NCT00762463|497563|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
206675|NCT00762450|497648|P3|NOT COMPLETED|3rd Treatment Period||0
206676|NCT00762450|497649|P2|NOT COMPLETED|3rd Treatment Period||0
206677|NCT00762450|497650|P1|NOT COMPLETED|3rd Treatment Period||0
206678|NCT00762450|497648|P3|COMPLETED|3rd Treatment Period||2
206679|NCT00762450|497649|P2|COMPLETED|3rd Treatment Period||2
206680|NCT00762450|497650|P1|COMPLETED|3rd Treatment Period||2
206681|NCT00762450|497648|P3|STARTED|3rd Treatment Period||2
206682|NCT00762450|497649|P2|STARTED|3rd Treatment Period||2
206683|NCT00762450|497650|P1|STARTED|3rd Treatment Period||2
206684|NCT00762450|497648|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
206685|NCT00762450|497649|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
206686|NCT00762450|497650|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
206687|NCT00762450|497648|P3|COMPLETED|Washout After 2nd Treatment Period||2
206688|NCT00762450|497649|P2|COMPLETED|Washout After 2nd Treatment Period||2
206689|NCT00762450|497650|P1|COMPLETED|Washout After 2nd Treatment Period||2
206690|NCT00762450|497648|P3|STARTED|Washout After 2nd Treatment Period||2
206691|NCT00762450|497649|P2|STARTED|Washout After 2nd Treatment Period||2
206692|NCT00762450|497650|P1|STARTED|Washout After 2nd Treatment Period||2
206693|NCT00762450|497648|P3|NOT COMPLETED|2nd Treatment Period||0
206694|NCT00762450|497649|P2|NOT COMPLETED|2nd Treatment Period||0
206695|NCT00762450|497650|P1|NOT COMPLETED|2nd Treatment Period||0
206696|NCT00762450|497648|P3|COMPLETED|2nd Treatment Period||2
206697|NCT00762450|497649|P2|COMPLETED|2nd Treatment Period||2
206698|NCT00762450|497650|P1|COMPLETED|2nd Treatment Period||2
206699|NCT00762450|497648|P3|STARTED|2nd Treatment Period||2
206700|NCT00762450|497649|P2|STARTED|2nd Treatment Period||2
206701|NCT00762450|497650|P1|STARTED|2nd Treatment Period||2
206702|NCT00762450|497648|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
206703|NCT00762450|497649|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
206704|NCT00762450|497650|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
206705|NCT00762450|497648|P3|COMPLETED|Washout After 1st Treatment Period||2
206706|NCT00762450|497649|P2|COMPLETED|Washout After 1st Treatment Period||2
206707|NCT00762450|497650|P1|COMPLETED|Washout After 1st Treatment Period||2
206708|NCT00762450|497648|P3|STARTED|Washout After 1st Treatment Period||2
206709|NCT00762450|497649|P2|STARTED|Washout After 1st Treatment Period||2
206710|NCT00762450|497650|P1|STARTED|Washout After 1st Treatment Period||2
206711|NCT00762450|497648|P3|NOT COMPLETED|1st Treatment Period||0
206712|NCT00762450|497649|P2|NOT COMPLETED|1st Treatment Period||0
206713|NCT00762450|497650|P1|NOT COMPLETED|1st Treatment Period||0
206714|NCT00762450|497648|P3|COMPLETED|1st Treatment Period||2
206715|NCT00762450|497649|P2|COMPLETED|1st Treatment Period||2
206716|NCT00762450|497650|P1|COMPLETED|1st Treatment Period||2
206717|NCT00762450|497648|P3|STARTED|1st Treatment Period||2
206718|NCT00762450|497649|P2|STARTED|1st Treatment Period||2
206719|NCT00762450|497650|P1|STARTED|1st Treatment Period||2
206720|NCT00762424|497660|P2|NOT COMPLETED|Overall Study||0
206721|NCT00762424|497661|P1|NOT COMPLETED|Overall Study||0
206722|NCT00762424|497660|P2|COMPLETED|Overall Study||25
206723|NCT00762424|497661|P1|COMPLETED|Overall Study||28
206724|NCT00762424|497660|P2|STARTED|Overall Study||25
206725|NCT00762424|497661|P1|STARTED|Overall Study||28
206726|NCT00762411|497669|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
206727|NCT00762411|497670|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
206728|NCT00762411|497669|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
206729|NCT00762411|497670|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
206730|NCT00762411|497669|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
206731|NCT00762411|497670|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
206732|NCT00762411|497669|P2|NOT COMPLETED|Delayed Start||26
206733|NCT00762411|497670|P1|NOT COMPLETED|Delayed Start||17
206734|NCT00762411|497669|P2|COMPLETED|Delayed Start||8
206735|NCT00762411|497670|P1|COMPLETED|Delayed Start||5
206736|NCT00762411|497669|P2|STARTED|Delayed Start||34
206737|NCT00762411|497670|P1|STARTED|Delayed Start||22
206738|NCT00762411|497669|P2|NOT COMPLETED|Initial Treatment||521
206739|NCT00762411|497670|P1|NOT COMPLETED|Initial Treatment||534
206740|NCT00762411|497669|P2|COMPLETED|Initial Treatment||34
206741|NCT00762411|497670|P1|COMPLETED|Initial Treatment||22
206742|NCT00762411|497669|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
206743|NCT00762411|497670|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
206744|NCT00762411|497669|P2|STARTED|Initial Treatment||555
206745|NCT00762411|497670|P1|STARTED|Initial Treatment||556
206746|NCT00762385|497734|P2|NOT COMPLETED|Second Intervention||3
206747|NCT00762385|497735|P1|NOT COMPLETED|Second Intervention||3
206748|NCT00762385|497734|P2|COMPLETED|Second Intervention||39
206749|NCT00762385|497735|P1|COMPLETED|Second Intervention||46
206750|NCT00762385|497734|P2|STARTED|Second Intervention||42
206751|NCT00762385|497735|P1|STARTED|Second Intervention||49
206752|NCT00762385|497734|P2|NOT COMPLETED|First Intervention||4
206753|NCT00762385|497735|P1|NOT COMPLETED|First Intervention||2
206754|NCT00762385|497734|P2|COMPLETED|First Intervention||42
206755|NCT00762385|497735|P1|COMPLETED|First Intervention||49
206756|NCT00762385|497734|P2|STARTED|First Intervention||46
206757|NCT00762385|497735|P1|STARTED|First Intervention||51
206758|NCT00762359|497747|P2|NOT COMPLETED|Overall Study||57
206759|NCT00762359|497748|P1|NOT COMPLETED|Overall Study||59
206760|NCT00762359|497747|P2|COMPLETED|Overall Study||178
206761|NCT00762359|497748|P1|COMPLETED|Overall Study||167
206762|NCT00762359|497747|P2|STARTED|Overall Study||235
206763|NCT00762359|497748|P1|STARTED|Overall Study||226
206764|NCT00762320|497848|P1|NOT COMPLETED|Overall Study||0
206765|NCT00762320|497848|P1|COMPLETED|Overall Study||8
206766|NCT00762320|497848|P1|STARTED|Overall Study||8
206767|NCT00762268|497865|P2|NOT COMPLETED|Overall Study||2
206768|NCT00762268|497866|P1|NOT COMPLETED|Overall Study||1
206769|NCT00762268|497865|P2|COMPLETED|Overall Study||8
206770|NCT00762268|497866|P1|COMPLETED|Overall Study||9
206771|NCT00762268|497865|P2|STARTED|Overall Study||10
206772|NCT00762268|497866|P1|STARTED|Overall Study||10
206773|NCT00762229|497874|P2|NOT COMPLETED|Overall Study||2
206774|NCT00762229|497875|P1|NOT COMPLETED|Overall Study||1
206775|NCT00762229|497874|P2|COMPLETED|Overall Study||22
206776|NCT00762229|497875|P1|COMPLETED|Overall Study||14
206777|NCT00762229|497874|P2|STARTED|Overall Study||24
206778|NCT00762229|497875|P1|STARTED|Overall Study||15
206779|NCT00762216|497883|P1|NOT COMPLETED|Overall Study||0
206780|NCT00762216|497883|P1|COMPLETED|Overall Study||71
206781|NCT00762216|497883|P1|STARTED|Overall Study||71
206782|NCT00762177|497891|P3|NOT COMPLETED|3rd Treatment Period||0
206783|NCT00762177|497892|P2|NOT COMPLETED|3rd Treatment Period||0
206784|NCT00762177|497893|P1|NOT COMPLETED|3rd Treatment Period||0
206785|NCT00762177|497891|P3|COMPLETED|3rd Treatment Period||8
206786|NCT00762177|497892|P2|COMPLETED|3rd Treatment Period||8
206787|NCT00762177|497893|P1|COMPLETED|3rd Treatment Period||8
206788|NCT00762177|497891|P3|STARTED|3rd Treatment Period||8
206789|NCT00762177|497892|P2|STARTED|3rd Treatment Period||8
206790|NCT00762177|497893|P1|STARTED|3rd Treatment Period||8
206791|NCT00762177|497891|P3|NOT COMPLETED|Washout After 2nd Treatment||0
206792|NCT00762177|497892|P2|NOT COMPLETED|Washout After 2nd Treatment||0
206793|NCT00762177|497893|P1|NOT COMPLETED|Washout After 2nd Treatment||0
206794|NCT00762177|497891|P3|COMPLETED|Washout After 2nd Treatment||8
206795|NCT00762177|497892|P2|COMPLETED|Washout After 2nd Treatment||8
206796|NCT00762177|497893|P1|COMPLETED|Washout After 2nd Treatment||8
206797|NCT00762177|497891|P3|STARTED|Washout After 2nd Treatment||8
206798|NCT00762177|497892|P2|STARTED|Washout After 2nd Treatment||8
206799|NCT00762177|497893|P1|STARTED|Washout After 2nd Treatment||8
206800|NCT00762177|497891|P3|NOT COMPLETED|2nd Treatment Period||0
206801|NCT00762177|497892|P2|NOT COMPLETED|2nd Treatment Period||0
206802|NCT00762177|497893|P1|NOT COMPLETED|2nd Treatment Period||0
206803|NCT00762177|497891|P3|COMPLETED|2nd Treatment Period||8
206804|NCT00762177|497892|P2|COMPLETED|2nd Treatment Period||8
206805|NCT00762177|497893|P1|COMPLETED|2nd Treatment Period||8
206806|NCT00762177|497891|P3|STARTED|2nd Treatment Period||8
206807|NCT00762177|497892|P2|STARTED|2nd Treatment Period||8
206808|NCT00762177|497893|P1|STARTED|2nd Treatment Period||8
206809|NCT00762177|497891|P3|NOT COMPLETED|Washout After 1st Treatment||0
206810|NCT00762177|497892|P2|NOT COMPLETED|Washout After 1st Treatment||0
206811|NCT00762177|497893|P1|NOT COMPLETED|Washout After 1st Treatment||0
206812|NCT00762177|497891|P3|COMPLETED|Washout After 1st Treatment||8
206813|NCT00762177|497892|P2|COMPLETED|Washout After 1st Treatment||8
206814|NCT00762177|497893|P1|COMPLETED|Washout After 1st Treatment||8
206815|NCT00762177|497891|P3|STARTED|Washout After 1st Treatment||8
206816|NCT00762177|497892|P2|STARTED|Washout After 1st Treatment||8
206817|NCT00762177|497893|P1|STARTED|Washout After 1st Treatment||8
206818|NCT00762177|497891|P3|NOT COMPLETED|1st Treatment Period||0
206819|NCT00762177|497892|P2|NOT COMPLETED|1st Treatment Period||0
206820|NCT00762177|497893|P1|NOT COMPLETED|1st Treatment Period||0
206821|NCT00762177|497891|P3|COMPLETED|1st Treatment Period||8
206822|NCT00762177|497892|P2|COMPLETED|1st Treatment Period||8
206823|NCT00762177|497893|P1|COMPLETED|1st Treatment Period||8
206824|NCT00762177|497891|P3|STARTED|1st Treatment Period||8
206825|NCT00762177|497892|P2|STARTED|1st Treatment Period||8
206826|NCT00762177|497893|P1|STARTED|1st Treatment Period||8
206827|NCT00762164|497972|P2|NOT COMPLETED|Overall Study||2
206828|NCT00762164|497973|P1|NOT COMPLETED|Overall Study||3
206829|NCT00762164|497972|P2|COMPLETED|Overall Study||15
206830|NCT00762164|497973|P1|COMPLETED|Overall Study||14
206831|NCT00762164|497972|P2|STARTED|Overall Study||17
206832|NCT00762164|497973|P1|STARTED|Overall Study||17
206833|NCT00762086|497983|P2|NOT COMPLETED|Overall Study||4
206834|NCT00762086|497984|P1|NOT COMPLETED|Overall Study||6
206835|NCT00762086|497983|P2|COMPLETED|Overall Study||24
206836|NCT00762086|497984|P1|COMPLETED|Overall Study||33
206837|NCT00762086|497983|P2|STARTED|Overall Study||28
206838|NCT00762086|497984|P1|STARTED|Overall Study||39
206839|NCT00762073|497994|P4|NOT COMPLETED|Overall Study||3
206840|NCT00762073|497995|P3|NOT COMPLETED|Overall Study||2
206841|NCT00762073|497996|P2|NOT COMPLETED|Overall Study||4
206842|NCT00762073|497997|P1|NOT COMPLETED|Overall Study||4
206843|NCT00762073|497994|P4|COMPLETED|Overall Study||17
206844|NCT00762073|497995|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
206845|NCT00762073|497996|P2|COMPLETED|Overall Study||17
206846|NCT00762073|497997|P1|COMPLETED|Overall Study||17
206847|NCT00762073|497994|P4|STARTED|Overall Study||20
206848|NCT00762073|497995|P3|STARTED|Overall Study||20
206849|NCT00762073|497996|P2|STARTED|Overall Study||21
206850|NCT00762073|497997|P1|STARTED|Overall Study||21
206851|NCT00762034|498061|P2|NOT COMPLETED|Maintenance Period||298
206852|NCT00762034|498062|P1|NOT COMPLETED|Maintenance Period||294
206853|NCT00762034|498061|P2|COMPLETED|Maintenance Period||0
206854|NCT00762034|498062|P1|COMPLETED|Maintenance Period||0
206855|NCT00762034|498061|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
206856|NCT00762034|498062|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
206857|NCT00762034|498061|P2|STARTED|Maintenance Period||298
206858|NCT00762034|498062|P1|STARTED|Maintenance Period||294
206859|NCT00762034|498061|P2|NOT COMPLETED|Induction Period||169
206860|NCT00762034|498062|P1|NOT COMPLETED|Induction Period||178
206861|NCT00762034|498061|P2|COMPLETED|Induction Period||298
206862|NCT00762034|498062|P1|COMPLETED|Induction Period||294
206863|NCT00762034|498061|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
206864|NCT00762034|498062|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
206865|NCT00762034|498061|P2|STARTED|Induction Period||467
206866|NCT00762034|498062|P1|STARTED|Induction Period||472
206867|NCT00762021|498121|P2|NOT COMPLETED|Overall Study||8
206868|NCT00762021|498122|P1|NOT COMPLETED|Overall Study||8
206869|NCT00762021|498121|P2|COMPLETED|Overall Study||44
206870|NCT00762021|498122|P1|COMPLETED|Overall Study||44
206871|NCT00762021|498121|P2|STARTED|Overall Study||52
206872|NCT00762021|498122|P1|STARTED|Overall Study||52
206873|NCT00761969|498134|P2|NOT COMPLETED|Overall Study||140
206874|NCT00761969|498135|P1|NOT COMPLETED|Overall Study||200
206875|NCT00761969|498134|P2|COMPLETED|Overall Study||573
206876|NCT00761969|498135|P1|COMPLETED|Overall Study||542
206877|NCT00761969|498134|P2|STARTED|Overall Study||713
206878|NCT00761969|498135|P1|STARTED|Overall Study||742
206879|NCT00761956|498145|P2|NOT COMPLETED|Overall Study||54
206880|NCT00761956|498146|P1|NOT COMPLETED|Overall Study||35
206881|NCT00761956|498145|P2|COMPLETED|Overall Study||48
206882|NCT00761956|498146|P1|COMPLETED|Overall Study||52
206883|NCT00761956|498145|P2|STARTED|Overall Study||102
206884|NCT00761956|498146|P1|STARTED|Overall Study||87
206885|NCT00761930|498157|P3|NOT COMPLETED|Overall Study||0
206886|NCT00761930|498158|P2|NOT COMPLETED|Overall Study||0
206887|NCT00761930|498159|P1|NOT COMPLETED|Overall Study||0
206888|NCT00761930|498157|P3|COMPLETED|Overall Study||35
206889|NCT00761930|498158|P2|COMPLETED|Overall Study||34
206890|NCT00761930|498159|P1|COMPLETED|Overall Study||34
206891|NCT00761930|498157|P3|STARTED|Overall Study||35
206892|NCT00761930|498158|P2|STARTED|Overall Study||34
206893|NCT00761930|498159|P1|STARTED|Overall Study||34
206894|NCT00761865|498175|P2|NOT COMPLETED|Overall Study||7
206895|NCT00761865|498176|P1|NOT COMPLETED|Overall Study||8
206896|NCT00761865|498175|P2|COMPLETED|Overall Study||11
206897|NCT00761865|498176|P1|COMPLETED|Overall Study||8
206898|NCT00761865|498175|P2|STARTED|Overall Study||18
206899|NCT00761865|498176|P1|STARTED|Overall Study||16
206900|NCT00761813|498186|P2|NOT COMPLETED|Overall Study||14
206901|NCT00761813|498187|P1|NOT COMPLETED|Overall Study||15
206902|NCT00761813|498186|P2|COMPLETED|Overall Study||537
206903|NCT00761813|498187|P1|COMPLETED|Overall Study||542
206904|NCT00761813|498186|P2|STARTED|Overall Study||551
206905|NCT00761813|498187|P1|STARTED|Overall Study||557
206906|NCT00761774|498197|P1|NOT COMPLETED|Overall Study||79
206907|NCT00761774|498197|P1|COMPLETED|Overall Study||29
206908|NCT00761774|498197|P1|STARTED|Overall Study||108
206909|NCT00761761|498208|P2|NOT COMPLETED|Overall Study||1
206910|NCT00761761|498209|P1|NOT COMPLETED|Overall Study||6
206911|NCT00761761|498208|P2|COMPLETED|Overall Study||29
206912|NCT00761761|498209|P1|COMPLETED|Overall Study||24
206913|NCT00761761|498208|P2|STARTED|Overall Study||30
206914|NCT00761761|498209|P1|STARTED|Overall Study||30
206915|NCT00761748|498221|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
206916|NCT00761748|498222|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
206917|NCT00761748|498221|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
206918|NCT00761748|498222|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
206919|NCT00761748|498221|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
206920|NCT00761748|498222|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
206921|NCT00761748|498221|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
206922|NCT00761748|498222|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
206923|NCT00761748|498221|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
206924|NCT00761748|498222|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
206925|NCT00761748|498221|P2|STARTED|First Intervention (21 +/- 3 Days)||10
206926|NCT00761748|498222|P1|STARTED|First Intervention (21 +/- 3 Days)||20
206927|NCT00761735|498228|P1|NOT COMPLETED|Overall Study||14
206928|NCT00761735|498228|P1|COMPLETED|Overall Study||80
206929|NCT00761735|498228|P1|STARTED|Overall Study||94
206930|NCT00761631|498244|P6|NOT COMPLETED|Overall Study||5
206931|NCT00761631|498245|P5|NOT COMPLETED|Overall Study||22
206932|NCT00761631|498246|P4|NOT COMPLETED|Overall Study||3
206933|NCT00761631|498247|P3|NOT COMPLETED|Overall Study||16
206934|NCT00761631|498248|P2|NOT COMPLETED|Overall Study||7
206935|NCT00761631|498249|P1|NOT COMPLETED|Overall Study||15
206936|NCT00761631|498244|P6|COMPLETED|Overall Study||294
206937|NCT00761631|498245|P5|COMPLETED|Overall Study||277
206938|NCT00761631|498246|P4|COMPLETED|Overall Study||116
206939|NCT00761631|498247|P3|COMPLETED|Overall Study||160
206940|NCT00761631|498248|P2|COMPLETED|Overall Study||174
206941|NCT00761631|498249|P1|COMPLETED|Overall Study||111
206942|NCT00761631|498244|P6|Vaccinated Dose 2|Overall Study||0
206943|NCT00761631|498245|P5|Vaccinated Dose 2|Overall Study||0
206944|NCT00761631|498246|P4|Vaccinated Dose 2|Overall Study||0
206945|NCT00761631|498247|P3|Vaccinated Dose 2|Overall Study||165
206946|NCT00761631|498248|P2|Vaccinated Dose 2|Overall Study||0
206947|NCT00761631|498249|P1|Vaccinated Dose 2|Overall Study||112
206948|NCT00761631|498244|P6|Vaccinated Dose 1|Overall Study||298
206949|NCT00761631|498245|P5|Vaccinated Dose 1|Overall Study||294
206950|NCT00761631|498246|P4|Vaccinated Dose 1|Overall Study||118
206951|NCT00761631|498247|P3|Vaccinated Dose 1|Overall Study||175
206952|NCT00761631|498248|P2|Vaccinated Dose 1|Overall Study||179
206953|NCT00761631|498249|P1|Vaccinated Dose 1|Overall Study||124
206954|NCT00761631|498244|P6|STARTED|Overall Study||299
206955|NCT00761631|498245|P5|STARTED|Overall Study||299
206956|NCT00761631|498246|P4|STARTED|Overall Study||119
206957|NCT00761631|498247|P3|STARTED|Overall Study||176
206958|NCT00761631|498248|P2|STARTED|Overall Study||181
206959|NCT00761631|498249|P1|STARTED|Overall Study||126
206960|NCT00761605|498284|P1|NOT COMPLETED|Overall Study||141
206961|NCT00761605|498284|P1|COMPLETED|Overall Study||246
206962|NCT00761605|498284|P1|STARTED|Overall Study||387
206963|NCT00761592|498313|P2|NOT COMPLETED|Overall Study||1
206964|NCT00761592|498314|P1|NOT COMPLETED|Overall Study||1
206965|NCT00761592|498313|P2|COMPLETED|Overall Study||32
206966|NCT00761592|498314|P1|COMPLETED|Overall Study||31
206967|NCT00761592|498313|P2|STARTED|Overall Study||33
206968|NCT00761592|498314|P1|STARTED|Overall Study||32
206969|NCT00761579|498328|P1|NOT COMPLETED|Overall Study||92
206970|NCT00761579|498328|P1|COMPLETED|Overall Study||98
206971|NCT00761579|498328|P1|STARTED|Overall Study||190
206972|NCT00761527|498361|P1|NOT COMPLETED|Overall Study||22
206973|NCT00761527|498361|P1|COMPLETED|Overall Study||2958
206974|NCT00761527|498361|P1|Received One Dose of Study Medication|Overall Study||2978
206975|NCT00761527|498361|P1|STARTED|Overall Study||2980
206976|NCT00761514|498368|P1|NOT COMPLETED|Overall Study||7
206977|NCT00761514|498368|P1|COMPLETED|Overall Study||7
206978|NCT00761514|498368|P1|STARTED|Overall Study||14
206979|NCT00761462|498375|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
206980|NCT00761462|498376|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
206981|NCT00761462|498375|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
206982|NCT00761462|498376|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
206983|NCT00761462|498375|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
206984|NCT00761462|498376|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
206985|NCT00761462|498375|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
206986|NCT00761462|498376|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
206987|NCT00761462|498375|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
206988|NCT00761462|498376|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
206989|NCT00761462|498375|P2|NOT COMPLETED|Treatment||12
206990|NCT00761462|498376|P1|NOT COMPLETED|Treatment||23
206991|NCT00761462|498375|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
206992|NCT00761462|498376|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
206993|NCT00761462|498375|P2|STARTED|Treatment|Patients enrolled in study group|519
206994|NCT00761462|498376|P1|STARTED|Treatment|Patients enrolled in study group|510
206995|NCT00761345|498384|P1|NOT COMPLETED|Overall Study||3
206996|NCT00761345|498384|P1|COMPLETED|Overall Study||24
206997|NCT00761345|498384|P1|STARTED|Overall Study||27
206998|NCT00761319|498390|P2|NOT COMPLETED|Overall Study||34
206999|NCT00761319|498391|P1|NOT COMPLETED|Overall Study||48
207000|NCT00761319|498390|P2|COMPLETED|Overall Study||318
207001|NCT00761319|498391|P1|COMPLETED|Overall Study||305
207002|NCT00761319|498390|P2|STARTED|Overall Study||352
207003|NCT00761319|498391|P1|STARTED|Overall Study||353
207004|NCT00761306|498399|P1|NOT COMPLETED|Overall Study||20
207005|NCT00761306|498399|P1|COMPLETED|Overall Study||54
207006|NCT00761306|498399|P1|STARTED|Overall Study||74
207007|NCT00761280|498410|P2|NOT COMPLETED|First Dose to End of Study||11
207008|NCT00761280|498411|P1|NOT COMPLETED|First Dose to End of Study||12
207009|NCT00761280|498410|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
207010|NCT00761280|498411|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
207011|NCT00761280|498410|P2|STARTED|First Dose to End of Study||11
207012|NCT00761280|498411|P1|STARTED|First Dose to End of Study||12
207013|NCT00761280|498410|P2|NOT COMPLETED|Randomization to First Dose||2
207014|NCT00761280|498411|P1|NOT COMPLETED|Randomization to First Dose||2
207015|NCT00761280|498410|P2|COMPLETED|Randomization to First Dose||11
207016|NCT00761280|498411|P1|COMPLETED|Randomization to First Dose||12
207017|NCT00761280|498410|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
207018|NCT00761280|498411|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
207019|NCT00761280|498410|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
207020|NCT00761280|498411|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
207021|NCT00761280|498410|P2|STARTED|Randomization to First Dose||13
207022|NCT00761280|498411|P1|STARTED|Randomization to First Dose||14
207023|NCT00761215|498442|P3|NOT COMPLETED|Overall Study||8
207024|NCT00761215|498443|P2|NOT COMPLETED|Overall Study||4
207025|NCT00761215|498444|P1|NOT COMPLETED|Overall Study||9
207026|NCT00761215|498442|P3|COMPLETED|Overall Study||56
207027|NCT00761215|498443|P2|COMPLETED|Overall Study||60
207028|NCT00761215|498444|P1|COMPLETED|Overall Study||55
207029|NCT00761215|498442|P3|STARTED|Overall Study||64
207030|NCT00761215|498443|P2|STARTED|Overall Study||64
207031|NCT00761215|498444|P1|STARTED|Overall Study||64
207032|NCT00761202|498469|P2|NOT COMPLETED|Overall Study||2
207033|NCT00761202|498470|P1|NOT COMPLETED|Overall Study||1
207034|NCT00761202|498469|P2|COMPLETED|Overall Study||26
207035|NCT00761202|498470|P1|COMPLETED|Overall Study||21
207036|NCT00761202|498469|P2|STARTED|Overall Study||28
207037|NCT00761202|498470|P1|STARTED|Overall Study||22
207038|NCT00761189|498486|P1|NOT COMPLETED|Overall Study||185
207039|NCT00761189|498486|P1|COMPLETED|Overall Study||306
207040|NCT00761189|498486|P1|STARTED|Overall Study||491
207041|NCT00761176|498503|P2|NOT COMPLETED|Overall Study||1
207042|NCT00761176|498504|P1|NOT COMPLETED|Overall Study||2
207043|NCT00761176|498503|P2|COMPLETED|Overall Study||3
207044|NCT00761176|498504|P1|COMPLETED|Overall Study||2
207045|NCT00761176|498503|P2|STARTED|Overall Study||4
207046|NCT00761176|498504|P1|STARTED|Overall Study||4
207047|NCT00761150|498513|P3|NOT COMPLETED|Double-blind Period||29
207048|NCT00761150|498514|P2|NOT COMPLETED|Double-blind Period||14
207049|NCT00761150|498515|P1|NOT COMPLETED|Double-blind Period||0
207050|NCT00761150|498513|P3|COMPLETED|Double-blind Period||89
207051|NCT00761150|498514|P2|COMPLETED|Double-blind Period||106
207052|NCT00761150|498515|P1|COMPLETED|Double-blind Period||0
207053|NCT00761150|498513|P3|STARTED|Double-blind Period||118
207054|NCT00761150|498514|P2|STARTED|Double-blind Period||120
207055|NCT00761150|498515|P1|STARTED|Double-blind Period||0
207056|NCT00761150|498513|P3|NOT COMPLETED|Open-label Period||0
207057|NCT00761150|498514|P2|NOT COMPLETED|Open-label Period||0
207058|NCT00761150|498515|P1|NOT COMPLETED|Open-label Period||70
207059|NCT00761150|498513|P3|COMPLETED|Open-label Period||0
207060|NCT00761150|498514|P2|COMPLETED|Open-label Period||0
207061|NCT00761150|498515|P1|COMPLETED|Open-label Period||238
207062|NCT00761150|498513|P3|STARTED|Open-label Period||0
207063|NCT00761150|498514|P2|STARTED|Open-label Period||0
207064|NCT00761150|498515|P1|STARTED|Open-label Period||308
207065|NCT00761137|498524|P1|NOT COMPLETED|Overall Study||0
207066|NCT00761137|498524|P1|COMPLETED|Overall Study||19
207067|NCT00761137|498524|P1|3 mg Tropicamide|Overall Study||19
207068|NCT00761137|498524|P1|1 mg Tropicamide|Overall Study||19
207069|NCT00761137|498524|P1|0.3 mg Tropicamide|Overall Study||19
207070|NCT00761137|498524|P1|Placebo|Overall Study||19
207071|NCT00761137|498524|P1|STARTED|Overall Study||19
207072|NCT00761007|498539|P4|NOT COMPLETED|Overall Study||7
207073|NCT00761007|498540|P3|NOT COMPLETED|Overall Study||18
207074|NCT00761007|498541|P2|NOT COMPLETED|Overall Study||11
207075|NCT00761007|498542|P1|NOT COMPLETED|Overall Study||13
207076|NCT00761007|498539|P4|COMPLETED|Overall Study||131
207077|NCT00761007|498540|P3|COMPLETED|Overall Study||121
207078|NCT00761007|498541|P2|COMPLETED|Overall Study||124
207079|NCT00761007|498542|P1|COMPLETED|Overall Study||129
207080|NCT00761007|498539|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
207081|NCT00761007|498540|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
207082|NCT00761007|498541|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
207083|NCT00761007|498542|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
207084|NCT00761007|498539|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
207085|NCT00761007|498540|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
207086|NCT00761007|498541|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
207087|NCT00761007|498542|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
207088|NCT00761007|498539|P4|STARTED|Overall Study||138
207089|NCT00761007|498540|P3|STARTED|Overall Study||139
207090|NCT00761007|498541|P2|STARTED|Overall Study||135
207091|NCT00761007|498542|P1|STARTED|Overall Study||142
207092|NCT00760877|498566|P2|NOT COMPLETED|Overall Study||26
207093|NCT00760877|498567|P1|NOT COMPLETED|Overall Study||45
207094|NCT00760877|498566|P2|COMPLETED|Overall Study||77
207095|NCT00760877|498567|P1|COMPLETED|Overall Study||59
207096|NCT00760877|498566|P2|Safety Set|Overall Study||103
207097|NCT00760877|498567|P1|Safety Set|Overall Study||101
207098|NCT00760877|498566|P2|Cross-over to Nilotinib|Overall Study||46
207099|NCT00760877|498567|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
207100|NCT00760877|498566|P2|STARTED|Overall Study||103
207101|NCT00760877|498567|P1|STARTED|Overall Study||104
207102|NCT00760838|498585|P2|NOT COMPLETED|Overall Study||2
207103|NCT00760838|498586|P1|NOT COMPLETED|Overall Study||5
207104|NCT00760838|498585|P2|COMPLETED|Overall Study||53
207105|NCT00760838|498586|P1|COMPLETED|Overall Study||49
207106|NCT00760838|498585|P2|STARTED|Overall Study||55
207107|NCT00760838|498586|P1|STARTED|Overall Study||54
207108|NCT00760747|498604|P2|NOT COMPLETED|Study Period III||3
207109|NCT00760747|498605|P1|NOT COMPLETED|Study Period III||3
207110|NCT00760747|498604|P2|COMPLETED|Study Period III||38
207111|NCT00760747|498605|P1|COMPLETED|Study Period III||41
207112|NCT00760747|498604|P2|STARTED|Study Period III||41
207113|NCT00760747|498605|P1|STARTED|Study Period III||44
207114|NCT00760747|498604|P2|NOT COMPLETED|Study Period II||14
207115|NCT00760747|498605|P1|NOT COMPLETED|Study Period II||13
207116|NCT00760747|498604|P2|COMPLETED|Study Period II||41
207117|NCT00760747|498605|P1|COMPLETED|Study Period II||44
207118|NCT00760747|498604|P2|Received at Least One Dose of Study Drug|Study Period II||54
207119|NCT00760747|498605|P1|Received at Least One Dose of Study Drug|Study Period II||57
207120|NCT00760747|498604|P2|STARTED|Study Period II||55
207121|NCT00760747|498605|P1|STARTED|Study Period II||57
207122|NCT00760669|498633|P1|NOT COMPLETED|Overall Study||30
207123|NCT00760669|498633|P1|COMPLETED|Overall Study||1031
207124|NCT00760669|498633|P1|STARTED|Overall Study||1061
207125|NCT00760617|498650|P3|NOT COMPLETED|Overall Study||5
207126|NCT00760617|498651|P2|NOT COMPLETED|Overall Study||2
207127|NCT00760617|498652|P1|NOT COMPLETED|Overall Study||5
207128|NCT00760617|498650|P3|COMPLETED|Overall Study||111
207129|NCT00760617|498651|P2|COMPLETED|Overall Study||142
207130|NCT00760617|498652|P1|COMPLETED|Overall Study||261
207131|NCT00760617|498650|P3|STARTED|Overall Study||116
207132|NCT00760617|498651|P2|STARTED|Overall Study||144
207133|NCT00760617|498652|P1|STARTED|Overall Study||266
207134|NCT00760578|498727|P4|NOT COMPLETED|Overall Study||4
207135|NCT00760578|498728|P3|NOT COMPLETED|Overall Study||5
207136|NCT00760578|498729|P2|NOT COMPLETED|Overall Study||2
207137|NCT00760578|498730|P1|NOT COMPLETED|Overall Study||3
207138|NCT00760578|498727|P4|COMPLETED|Overall Study||18
207139|NCT00760578|498728|P3|COMPLETED|Overall Study||16
207140|NCT00760578|498729|P2|COMPLETED|Overall Study||19
207141|NCT00760578|498730|P1|COMPLETED|Overall Study||19
207142|NCT00760578|498727|P4|Entered Drug Treatment Period|Overall Study||22
207143|NCT00760578|498728|P3|Entered Drug Treatment Period|Overall Study||19
207144|NCT00760578|498729|P2|Entered Drug Treatment Period|Overall Study||20
207145|NCT00760578|498730|P1|Entered Drug Treatment Period|Overall Study||21
207146|NCT00760578|498727|P4|STARTED|Overall Study||22
207147|NCT00760578|498728|P3|STARTED|Overall Study||21
207148|NCT00760578|498729|P2|STARTED|Overall Study||21
207149|NCT00760578|498730|P1|STARTED|Overall Study||22
207150|NCT00760552|498766|P2|NOT COMPLETED|Overall Study||10
207151|NCT00760552|498767|P1|NOT COMPLETED|Overall Study||13
207152|NCT00760552|498766|P2|COMPLETED|Overall Study||52
207153|NCT00760552|498767|P1|COMPLETED|Overall Study||48
207154|NCT00760552|498766|P2|STARTED|Overall Study||62
207155|NCT00760552|498767|P1|STARTED|Overall Study||61
207156|NCT00760526|498775|P2|NOT COMPLETED|Overall Study||4
207157|NCT00760526|498776|P1|NOT COMPLETED|Overall Study||5
207158|NCT00760526|498775|P2|COMPLETED|Overall Study||68
207159|NCT00760526|498776|P1|COMPLETED|Overall Study||69
207160|NCT00760526|498775|P2|STARTED|Overall Study||72
207161|NCT00760526|498776|P1|STARTED|Overall Study||74
207162|NCT00760487|498801|P1|NOT COMPLETED|Overall Study||3
207163|NCT00760487|498801|P1|COMPLETED|Overall Study||117
207164|NCT00760487|498801|P1|STARTED|Overall Study||120
207165|NCT00760474|498807|P2|NOT COMPLETED|Period 2 (P2)||1
207166|NCT00760474|498808|P1|NOT COMPLETED|Period 2 (P2)||1
207167|NCT00760474|498807|P2|COMPLETED|Period 2 (P2)||11
207168|NCT00760474|498808|P1|COMPLETED|Period 2 (P2)||11
207169|NCT00760474|498807|P2|STARTED|Period 2 (P2)||12
207170|NCT00760474|498808|P1|STARTED|Period 2 (P2)||12
207171|NCT00760474|498807|P2|NOT COMPLETED|Placebo Washout Period||1
207172|NCT00760474|498808|P1|NOT COMPLETED|Placebo Washout Period||0
207173|NCT00760474|498807|P2|COMPLETED|Placebo Washout Period||12
207174|NCT00760474|498808|P1|COMPLETED|Placebo Washout Period||12
207175|NCT00760474|498807|P2|STARTED|Placebo Washout Period||13
207176|NCT00760474|498808|P1|STARTED|Placebo Washout Period||12
207177|NCT00760474|498807|P2|NOT COMPLETED|Period 1 (P1)||1
207178|NCT00760474|498808|P1|NOT COMPLETED|Period 1 (P1)||1
207179|NCT00760474|498807|P2|COMPLETED|Period 1 (P1)||13
207180|NCT00760474|498808|P1|COMPLETED|Period 1 (P1)||12
207181|NCT00760474|498807|P2|Overall Number of Unique Participants|Period 1 (P1)||13
207182|NCT00760474|498808|P1|Overall Number of Unique Participants|Period 1 (P1)||12
207183|NCT00760474|498807|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
207184|NCT00760474|498808|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
207185|NCT00760474|498807|P2|STARTED|Period 1 (P1)||14
207186|NCT00760474|498808|P1|STARTED|Period 1 (P1)||13
207187|NCT00760461|498844|P1|NOT COMPLETED|Overall Study||44
207188|NCT00760461|498844|P1|COMPLETED|Overall Study||0
207189|NCT00760461|498844|P1|STARTED|Overall Study||44
207190|NCT00760435|498850|P2|NOT COMPLETED|Overall Study||5
207191|NCT00760435|498851|P1|NOT COMPLETED|Overall Study||4
207192|NCT00760435|498850|P2|COMPLETED|Overall Study||93
207193|NCT00760435|498851|P1|COMPLETED|Overall Study||94
207194|NCT00760435|498850|P2|STARTED|Overall Study||98
207195|NCT00760435|498851|P1|STARTED|Overall Study||98
207196|NCT00760383|498865|P2|NOT COMPLETED|Overall Study||7
207197|NCT00760383|498866|P1|NOT COMPLETED|Overall Study||5
207198|NCT00760383|498865|P2|COMPLETED|Overall Study||12
207199|NCT00760383|498866|P1|COMPLETED|Overall Study||16
207200|NCT00760383|498865|P2|STARTED|Overall Study||19
207201|NCT00760383|498866|P1|STARTED|Overall Study||21
207202|NCT00760266|498878|P2|NOT COMPLETED|Overall Study||18
207203|NCT00760266|498879|P1|NOT COMPLETED|Overall Study||24
207204|NCT00760266|498878|P2|COMPLETED|Overall Study||205
207205|NCT00760266|498879|P1|COMPLETED|Overall Study||204
207206|NCT00760266|498878|P2|STARTED|Overall Study||223
207207|NCT00760266|498879|P1|STARTED|Overall Study||228
207208|NCT00760214|498896|P3|NOT COMPLETED|Overall Study||41
207209|NCT00760214|498897|P2|NOT COMPLETED|Overall Study||30
207210|NCT00760214|498898|P1|NOT COMPLETED|Overall Study||30
207211|NCT00760214|498896|P3|COMPLETED|Overall Study||255
207212|NCT00760214|498897|P2|COMPLETED|Overall Study||264
207213|NCT00760214|498898|P1|COMPLETED|Overall Study||265
207214|NCT00760214|498896|P3|STARTED|Overall Study||296
207215|NCT00760214|498897|P2|STARTED|Overall Study||294
207216|NCT00760214|498898|P1|STARTED|Overall Study||295
207217|NCT00760084|498939|P1|NOT COMPLETED|Overall Study||10
207218|NCT00760084|498939|P1|COMPLETED|Overall Study||0
207219|NCT00760084|498939|P1|STARTED|Overall Study||10
207220|NCT00760019|498945|P4|NOT COMPLETED|Overall Study||0
207221|NCT00760019|498946|P3|NOT COMPLETED|Overall Study||0
207222|NCT00760019|498947|P2|NOT COMPLETED|Overall Study||0
207223|NCT00760019|498948|P1|NOT COMPLETED|Overall Study||0
207224|NCT00760019|498945|P4|COMPLETED|Overall Study||14
207225|NCT00760019|498946|P3|COMPLETED|Overall Study||14
207226|NCT00760019|498947|P2|COMPLETED|Overall Study||15
207227|NCT00760019|498948|P1|COMPLETED|Overall Study||15
207228|NCT00760019|498945|P4|STARTED|Overall Study||14
207229|NCT00760019|498946|P3|STARTED|Overall Study||14
207230|NCT00760019|498947|P2|STARTED|Overall Study||15
207231|NCT00760019|498948|P1|STARTED|Overall Study||15
207232|NCT00760006|498956|P2|NOT COMPLETED|Overall Study||0
207233|NCT00760006|498957|P1|NOT COMPLETED|Overall Study||0
207234|NCT00760006|498956|P2|COMPLETED|Overall Study||138
207235|NCT00760006|498957|P1|COMPLETED|Overall Study||86
207236|NCT00760006|498956|P2|STARTED|Overall Study||138
207237|NCT00760006|498957|P1|STARTED|Overall Study||86
207238|NCT00759967|498963|P2|NOT COMPLETED|Second Intervention||0
207239|NCT00759967|498964|P1|NOT COMPLETED|Second Intervention||2
207240|NCT00759967|498963|P2|COMPLETED|Second Intervention||9
207241|NCT00759967|498964|P1|COMPLETED|Second Intervention||8
207242|NCT00759967|498963|P2|STARTED|Second Intervention||9
207243|NCT00759967|498964|P1|STARTED|Second Intervention||10
207244|NCT00759967|498963|P2|NOT COMPLETED|First Intervention||0
207245|NCT00759967|498964|P1|NOT COMPLETED|First Intervention||0
207246|NCT00759967|498963|P2|COMPLETED|First Intervention||9
207247|NCT00759967|498964|P1|COMPLETED|First Intervention||10
207248|NCT00759967|498963|P2|STARTED|First Intervention||9
207249|NCT00759967|498964|P1|STARTED|First Intervention||10
207250|NCT00759954|498982|P2|NOT COMPLETED|Overall Study||2
207251|NCT00759954|498983|P1|NOT COMPLETED|Overall Study||2
207252|NCT00759954|498982|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
207253|NCT00759954|498983|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
207254|NCT00759954|498982|P2|STARTED|Overall Study|All assigned participants entered trial|18
207255|NCT00759954|498983|P1|STARTED|Overall Study|All assigned participants entered trial|18
207256|NCT00759941|498997|P2|NOT COMPLETED|Overall Study||1
207257|NCT00759941|498998|P1|NOT COMPLETED|Overall Study||3
207258|NCT00759941|498997|P2|COMPLETED|Overall Study||43
207259|NCT00759941|498998|P1|COMPLETED|Overall Study||39
207260|NCT00759941|498997|P2|STARTED|Overall Study||44
207261|NCT00759941|498998|P1|STARTED|Overall Study||42
207262|NCT00759915|499012|P2|NOT COMPLETED|Overall Study||1
207263|NCT00759915|499013|P1|NOT COMPLETED|Overall Study||1
207264|NCT00759915|499012|P2|COMPLETED|Overall Study||17
207265|NCT00759915|499013|P1|COMPLETED|Overall Study||17
207266|NCT00759915|499012|P2|STARTED|Overall Study||18
207267|NCT00759915|499013|P1|STARTED|Overall Study||18
207268|NCT00759902|499027|P2|NOT COMPLETED|Overall Study||1
207269|NCT00759902|499028|P1|NOT COMPLETED|Overall Study||0
207270|NCT00759902|499027|P2|COMPLETED|Overall Study||17
207271|NCT00759902|499028|P1|COMPLETED|Overall Study||18
207272|NCT00759902|499027|P2|STARTED|Overall Study||18
207273|NCT00759902|499028|P1|STARTED|Overall Study||18
207274|NCT00759863|499042|P2|NOT COMPLETED|Overall Study||18
207275|NCT00759863|499043|P1|NOT COMPLETED|Overall Study||20
207276|NCT00759863|499042|P2|COMPLETED|Overall Study||80
207277|NCT00759863|499043|P1|COMPLETED|Overall Study||124
207278|NCT00759863|499042|P2|STARTED|Overall Study||98
207279|NCT00759863|499043|P1|STARTED|Overall Study||144
207280|NCT00759811|499055|P2|NOT COMPLETED|Overall Study||1
207281|NCT00759811|499056|P1|NOT COMPLETED|Overall Study||2
207282|NCT00759811|499055|P2|COMPLETED|Overall Study||24
207283|NCT00759811|499056|P1|COMPLETED|Overall Study||23
207284|NCT00759811|499055|P2|STARTED|Overall Study||25
207285|NCT00759811|499056|P1|STARTED|Overall Study||25
207286|NCT00759785|499064|P2|NOT COMPLETED|Overall Study||5
207287|NCT00759785|499065|P1|NOT COMPLETED|Overall Study||12
207288|NCT00759785|499064|P2|COMPLETED|Overall Study||17
207289|NCT00759785|499065|P1|COMPLETED|Overall Study||14
207290|NCT00759785|499064|P2|Treated|Overall Study||20
207291|NCT00759785|499065|P1|Treated|Overall Study||25
207292|NCT00759785|499064|P2|STARTED|Overall Study||22
207293|NCT00759785|499065|P1|STARTED|Overall Study||26
207294|NCT00759772|499079|P2|NOT COMPLETED|Overall Study||0
207295|NCT00759772|499080|P1|NOT COMPLETED|Overall Study||0
207296|NCT00759772|499079|P2|COMPLETED|Overall Study||11
207297|NCT00759772|499080|P1|COMPLETED|Overall Study||12
207298|NCT00759772|499079|P2|STARTED|Overall Study||11
207299|NCT00759772|499080|P1|STARTED|Overall Study||12
207300|NCT00759759|499088|P2|NOT COMPLETED|Overall Study||1
207301|NCT00759759|499089|P1|NOT COMPLETED|Overall Study||4
207302|NCT00759759|499088|P2|COMPLETED|Overall Study||17
207303|NCT00759759|499089|P1|COMPLETED|Overall Study||14
207304|NCT00759759|499088|P2|STARTED|Overall Study||18
207305|NCT00759759|499089|P1|STARTED|Overall Study||18
207306|NCT00759707|499101|P1|NOT COMPLETED|Overall Study||0
207307|NCT00759707|499101|P1|COMPLETED|Overall Study||19
207308|NCT00759707|499101|P1|STARTED|Overall Study||19
207309|NCT00759681|499107|P2|NOT COMPLETED|Overall Study||10
207310|NCT00759681|499108|P1|NOT COMPLETED|Overall Study||10
207311|NCT00759681|499107|P2|COMPLETED|Overall Study||100
207312|NCT00759681|499108|P1|COMPLETED|Overall Study||97
207313|NCT00759681|499107|P2|STARTED|Overall Study||110
207314|NCT00759681|499108|P1|STARTED|Overall Study||107
207315|NCT00759668|499118|P2|NOT COMPLETED|Overall Study||3
207316|NCT00759668|499119|P1|NOT COMPLETED|Overall Study||1
207317|NCT00759668|499118|P2|COMPLETED|Overall Study||15
207318|NCT00759668|499119|P1|COMPLETED|Overall Study||16
207319|NCT00759668|499118|P2|STARTED|Overall Study||18
207320|NCT00759668|499119|P1|STARTED|Overall Study||17
207321|NCT00759655|499135|P1|NOT COMPLETED|Overall Study||1
207322|NCT00759655|499135|P1|COMPLETED|Overall Study||0
207323|NCT00759655|499135|P1|STARTED|Overall Study||1
207324|NCT00759642|499146|P1|NOT COMPLETED|Overall Study||0
207325|NCT00759642|499146|P1|COMPLETED|Overall Study||33
207326|NCT00759642|499146|P1|STARTED|Overall Study||33
207327|NCT00759603|499150|P1|NOT COMPLETED|Overall Study||0
207328|NCT00759603|499150|P1|COMPLETED|Overall Study||59
207329|NCT00759603|499150|P1|STARTED|Overall Study||59
207330|NCT00759577|499154|P1|NOT COMPLETED|Overall Study||0
207331|NCT00759577|499154|P1|COMPLETED|Overall Study||36
207332|NCT00759577|499154|P1|STARTED|Overall Study||36
207333|NCT00759564|499163|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
207334|NCT00759564|499164|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
207335|NCT00759564|499165|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
207336|NCT00759564|499166|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
207337|NCT00759564|499167|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
207338|NCT00759564|499163|P5|COMPLETED|Second Intervention Period (4 Days)||3
207339|NCT00759564|499164|P4|COMPLETED|Second Intervention Period (4 Days)||1
207340|NCT00759564|499165|P3|COMPLETED|Second Intervention Period (4 Days)||8
207341|NCT00759564|499166|P2|COMPLETED|Second Intervention Period (4 Days)||8
207342|NCT00759564|499167|P1|COMPLETED|Second Intervention Period (4 Days)||8
207343|NCT00759564|499163|P5|STARTED|Second Intervention Period (4 Days)||3
207344|NCT00759564|499164|P4|STARTED|Second Intervention Period (4 Days)||1
207345|NCT00759564|499165|P3|STARTED|Second Intervention Period (4 Days)||8
207346|NCT00759564|499166|P2|STARTED|Second Intervention Period (4 Days)||8
207347|NCT00759564|499167|P1|STARTED|Second Intervention Period (4 Days)||8
207348|NCT00759564|499163|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
207349|NCT00759564|499164|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
207350|NCT00759564|499165|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
207351|NCT00759564|499166|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
207352|NCT00759564|499167|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
207353|NCT00759564|499163|P5|COMPLETED|Washout Period (at Least 14 Days)||3
207354|NCT00759564|499164|P4|COMPLETED|Washout Period (at Least 14 Days)||1
207355|NCT00759564|499165|P3|COMPLETED|Washout Period (at Least 14 Days)||8
207356|NCT00759564|499166|P2|COMPLETED|Washout Period (at Least 14 Days)||8
207357|NCT00759564|499167|P1|COMPLETED|Washout Period (at Least 14 Days)||8
207358|NCT00759564|499163|P5|STARTED|Washout Period (at Least 14 Days)||4
207359|NCT00759564|499164|P4|STARTED|Washout Period (at Least 14 Days)||1
207360|NCT00759564|499165|P3|STARTED|Washout Period (at Least 14 Days)||8
207361|NCT00759564|499166|P2|STARTED|Washout Period (at Least 14 Days)||8
207362|NCT00759564|499167|P1|STARTED|Washout Period (at Least 14 Days)||8
207363|NCT00759564|499163|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
207364|NCT00759564|499164|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
207365|NCT00759564|499165|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
207366|NCT00759564|499166|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
207367|NCT00759564|499167|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
207368|NCT00759564|499163|P5|COMPLETED|First Intervention Period (4 Days)||4
207369|NCT00759564|499164|P4|COMPLETED|First Intervention Period (4 Days)||1
207370|NCT00759564|499165|P3|COMPLETED|First Intervention Period (4 Days)||8
207371|NCT00759564|499166|P2|COMPLETED|First Intervention Period (4 Days)||8
207372|NCT00759564|499167|P1|COMPLETED|First Intervention Period (4 Days)||8
207373|NCT00759564|499163|P5|STARTED|First Intervention Period (4 Days)||4
207374|NCT00759564|499164|P4|STARTED|First Intervention Period (4 Days)||1
207375|NCT00759564|499165|P3|STARTED|First Intervention Period (4 Days)||8
207376|NCT00759564|499166|P2|STARTED|First Intervention Period (4 Days)||8
207377|NCT00759564|499167|P1|STARTED|First Intervention Period (4 Days)||8
207378|NCT00759525|499307|P2|NOT COMPLETED|Second Intervention (14 Days)||0
207379|NCT00759525|499308|P1|NOT COMPLETED|Second Intervention (14 Days)||0
207380|NCT00759525|499307|P2|COMPLETED|Second Intervention (14 Days)||8
207381|NCT00759525|499308|P1|COMPLETED|Second Intervention (14 Days)||7
207382|NCT00759525|499307|P2|STARTED|Second Intervention (14 Days)||8
207383|NCT00759525|499308|P1|STARTED|Second Intervention (14 Days)||7
207384|NCT00759525|499307|P2|NOT COMPLETED|Washout (14 Days)||0
207385|NCT00759525|499308|P1|NOT COMPLETED|Washout (14 Days)||0
207386|NCT00759525|499307|P2|COMPLETED|Washout (14 Days)||8
207387|NCT00759525|499308|P1|COMPLETED|Washout (14 Days)||7
207388|NCT00759525|499307|P2|STARTED|Washout (14 Days)||8
207389|NCT00759525|499308|P1|STARTED|Washout (14 Days)||7
207390|NCT00759525|499307|P2|NOT COMPLETED|First Intervention (14 Days)||0
207391|NCT00759525|499308|P1|NOT COMPLETED|First Intervention (14 Days)||0
207392|NCT00759525|499307|P2|COMPLETED|First Intervention (14 Days)||8
207393|NCT00759525|499308|P1|COMPLETED|First Intervention (14 Days)||7
207394|NCT00759525|499307|P2|STARTED|First Intervention (14 Days)||8
207395|NCT00759525|499308|P1|STARTED|First Intervention (14 Days)||7
207396|NCT00759473|499319|P5|NOT COMPLETED|Overall Study||0
207397|NCT00759473|499320|P4|NOT COMPLETED|Overall Study||0
207398|NCT00759473|499321|P3|NOT COMPLETED|Overall Study||0
207399|NCT00759473|499322|P2|NOT COMPLETED|Overall Study||0
207400|NCT00759473|499323|P1|NOT COMPLETED|Overall Study||0
207401|NCT00759473|499319|P5|COMPLETED|Overall Study||24
207402|NCT00759473|499320|P4|COMPLETED|Overall Study||23
207403|NCT00759473|499321|P3|COMPLETED|Overall Study||12
207404|NCT00759473|499322|P2|COMPLETED|Overall Study||10
207405|NCT00759473|499323|P1|COMPLETED|Overall Study||10
207406|NCT00759473|499319|P5|STARTED|Overall Study||24
207407|NCT00759473|499320|P4|STARTED|Overall Study||23
207408|NCT00759473|499321|P3|STARTED|Overall Study||12
207409|NCT00759473|499322|P2|STARTED|Overall Study||10
207410|NCT00759473|499323|P1|STARTED|Overall Study||10
207411|NCT00759395|499337|P2|NOT COMPLETED|Overall Study||2
207412|NCT00759395|499338|P1|NOT COMPLETED|Overall Study||2
207413|NCT00759395|499337|P2|COMPLETED|Overall Study||7
207414|NCT00759395|499338|P1|COMPLETED|Overall Study||11
207415|NCT00759395|499337|P2|STARTED|Overall Study||9
207416|NCT00759395|499338|P1|STARTED|Overall Study||13
207417|NCT00759356|499354|P2|NOT COMPLETED|Overall Study||3
207418|NCT00759356|499355|P1|NOT COMPLETED|Overall Study||1
207419|NCT00759356|499354|P2|COMPLETED|Overall Study||15
207420|NCT00759356|499355|P1|COMPLETED|Overall Study||17
207421|NCT00759356|499354|P2|STARTED|Overall Study||18
207422|NCT00759356|499355|P1|STARTED|Overall Study||18
207423|NCT00759330|499371|P4|NOT COMPLETED|Overall Study||2
207424|NCT00759330|499372|P3|NOT COMPLETED|Overall Study||0
207425|NCT00759330|499373|P2|NOT COMPLETED|Overall Study||1
207426|NCT00759330|499374|P1|NOT COMPLETED|Overall Study||1
207427|NCT00759330|499371|P4|COMPLETED|Overall Study||41
207428|NCT00759330|499372|P3|COMPLETED|Overall Study||22
207429|NCT00759330|499373|P2|COMPLETED|Overall Study||41
207430|NCT00759330|499374|P1|COMPLETED|Overall Study||19
207431|NCT00759330|499371|P4|STARTED|Overall Study||43
207432|NCT00759330|499372|P3|STARTED|Overall Study||22
207433|NCT00759330|499373|P2|STARTED|Overall Study||42
207434|NCT00759330|499374|P1|STARTED|Overall Study||20
207435|NCT00759187|499423|P3|NOT COMPLETED|Overall Study||0
207436|NCT00759187|499424|P2|NOT COMPLETED|Overall Study||0
207437|NCT00759187|499425|P1|NOT COMPLETED|Overall Study||0
207438|NCT00759187|499423|P3|COMPLETED|Overall Study||9
207439|NCT00759187|499424|P2|COMPLETED|Overall Study||8
207440|NCT00759187|499425|P1|COMPLETED|Overall Study||8
207441|NCT00759187|499423|P3|STARTED|Overall Study||9
207442|NCT00759187|499424|P2|STARTED|Overall Study||8
207443|NCT00759187|499425|P1|STARTED|Overall Study||8
207444|NCT00759174|499435|P2|NOT COMPLETED|Overall Study||2
207445|NCT00759174|499436|P1|NOT COMPLETED|Overall Study||0
207446|NCT00759174|499435|P2|COMPLETED|Overall Study||595
207447|NCT00759174|499436|P1|COMPLETED|Overall Study||76
207448|NCT00759174|499435|P2|STARTED|Overall Study||597
207449|NCT00759174|499436|P1|STARTED|Overall Study||76
207450|NCT00759161|499445|P1|NOT COMPLETED|Overall Study||0
207451|NCT00759161|499445|P1|COMPLETED|Overall Study||35
207452|NCT00759161|499445|P1|STARTED|Overall Study||35
207453|NCT00759148|499460|P2|NOT COMPLETED|Overall Study||32
207454|NCT00759148|499461|P1|NOT COMPLETED|Overall Study||14
207455|NCT00759148|499460|P2|COMPLETED|Overall Study||554
207456|NCT00759148|499461|P1|COMPLETED|Overall Study||579
207457|NCT00759148|499460|P2|STARTED|Overall Study||586
207458|NCT00759148|499461|P1|STARTED|Overall Study||593
207459|NCT00759109|499471|P2|NOT COMPLETED|Overall Study||35
207460|NCT00759109|499472|P1|NOT COMPLETED|Overall Study||39
207461|NCT00759109|499471|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
207462|NCT00759109|499472|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
207463|NCT00759109|499471|P2|STARTED|Overall Study||76
207464|NCT00759109|499472|P1|STARTED|Overall Study||74
207465|NCT00759096|499488|P1|NOT COMPLETED|Overall Study||0
207466|NCT00759096|499488|P1|COMPLETED|Overall Study||30
207467|NCT00759096|499488|P1|STARTED|Overall Study||30
207468|NCT00759031|499494|P2|NOT COMPLETED|Second Intervention (1 Day)||0
207469|NCT00759031|499495|P1|NOT COMPLETED|Second Intervention (1 Day)||0
207470|NCT00759031|499494|P2|COMPLETED|Second Intervention (1 Day)||8
207471|NCT00759031|499495|P1|COMPLETED|Second Intervention (1 Day)||8
207472|NCT00759031|499494|P2|STARTED|Second Intervention (1 Day)||8
207473|NCT00759031|499495|P1|STARTED|Second Intervention (1 Day)||8
207474|NCT00759031|499494|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
207475|NCT00759031|499495|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
207476|NCT00759031|499494|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
207477|NCT00759031|499495|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
207478|NCT00759031|499494|P2|STARTED|Washout After 1st Intervention (1 Week)||8
207479|NCT00759031|499495|P1|STARTED|Washout After 1st Intervention (1 Week)||8
207480|NCT00759031|499494|P2|NOT COMPLETED|First Intervention (1 Day)||1
207481|NCT00759031|499495|P1|NOT COMPLETED|First Intervention (1 Day)||2
207482|NCT00759031|499494|P2|COMPLETED|First Intervention (1 Day)||8
207483|NCT00759031|499495|P1|COMPLETED|First Intervention (1 Day)||8
207484|NCT00759031|499494|P2|STARTED|First Intervention (1 Day)||9
207485|NCT00759031|499495|P1|STARTED|First Intervention (1 Day)||10
207486|NCT00758836|499505|P4|NOT COMPLETED|Overall Study||32
207487|NCT00758836|499506|P3|NOT COMPLETED|Overall Study||38
207488|NCT00758836|499507|P2|NOT COMPLETED|Overall Study||26
207489|NCT00758836|499508|P1|NOT COMPLETED|Overall Study||24
207490|NCT00758836|499505|P4|COMPLETED|Overall Study||138
207491|NCT00758836|499506|P3|COMPLETED|Overall Study||133
207492|NCT00758836|499507|P2|COMPLETED|Overall Study||145
207493|NCT00758836|499508|P1|COMPLETED|Overall Study||147
207494|NCT00758836|499505|P4|Treated|Overall Study||138
207495|NCT00758836|499506|P3|Treated|Overall Study||133
207496|NCT00758836|499507|P2|Treated|Overall Study||145
207497|NCT00758836|499508|P1|Treated|Overall Study||147
207498|NCT00758836|499505|P4|STARTED|Overall Study||170
207499|NCT00758836|499506|P3|STARTED|Overall Study||171
207500|NCT00758836|499507|P2|STARTED|Overall Study||171
207501|NCT00758836|499508|P1|STARTED|Overall Study||171
207502|NCT00758771|499532|P2|NOT COMPLETED|Overall Study||5
207503|NCT00758771|499533|P1|NOT COMPLETED|Overall Study||3
207504|NCT00758771|499532|P2|COMPLETED|Overall Study||15
207505|NCT00758771|499533|P1|COMPLETED|Overall Study||15
207506|NCT00758771|499532|P2|STARTED|Overall Study||20
207507|NCT00758771|499533|P1|STARTED|Overall Study||18
207508|NCT00758758|499547|P8|NOT COMPLETED|Overall Study||0
207509|NCT00758758|499548|P7|NOT COMPLETED|Overall Study||14
207510|NCT00758758|499549|P6|NOT COMPLETED|Overall Study||14
207511|NCT00758758|499550|P5|NOT COMPLETED|Overall Study||2
207512|NCT00758758|499551|P4|NOT COMPLETED|Overall Study||2
207513|NCT00758758|499552|P3|NOT COMPLETED|Overall Study||18
207514|NCT00758758|499553|P2|NOT COMPLETED|Overall Study||25
207515|NCT00758758|499554|P1|NOT COMPLETED|Overall Study||3
207516|NCT00758758|499547|P8|COMPLETED|Overall Study||0
207517|NCT00758758|499548|P7|COMPLETED|Overall Study||17
207518|NCT00758758|499549|P6|COMPLETED|Overall Study||36
207519|NCT00758758|499550|P5|COMPLETED|Overall Study||1
207520|NCT00758758|499551|P4|COMPLETED|Overall Study||4
207521|NCT00758758|499552|P3|COMPLETED|Overall Study||35
207522|NCT00758758|499553|P2|COMPLETED|Overall Study||49
207523|NCT00758758|499554|P1|COMPLETED|Overall Study||11
207524|NCT00758758|499547|P8|STARTED|Overall Study||0
207525|NCT00758758|499548|P7|STARTED|Overall Study||31
207526|NCT00758758|499549|P6|STARTED|Overall Study||50
207527|NCT00758758|499550|P5|STARTED|Overall Study||3
207528|NCT00758758|499551|P4|STARTED|Overall Study||6
207529|NCT00758758|499552|P3|STARTED|Overall Study||53
207530|NCT00758758|499553|P2|STARTED|Overall Study||74
207531|NCT00758758|499554|P1|STARTED|Overall Study||14
207532|NCT00758745|499582|P2|NOT COMPLETED|Overall Study||21
207533|NCT00758745|499583|P1|NOT COMPLETED|Overall Study||21
207534|NCT00758745|499582|P2|COMPLETED|Overall Study||60
207535|NCT00758745|499583|P1|COMPLETED|Overall Study||60
207536|NCT00758745|499582|P2|STARTED|Overall Study||81
207537|NCT00758745|499583|P1|STARTED|Overall Study||81
207538|NCT00758706|499591|P2|NOT COMPLETED|Overall Study||4
207539|NCT00758706|499592|P1|NOT COMPLETED|Overall Study||4
207540|NCT00758706|499591|P2|COMPLETED|Overall Study||25
207541|NCT00758706|499592|P1|COMPLETED|Overall Study||22
207542|NCT00758706|499591|P2|STARTED|Overall Study||29
207543|NCT00758706|499592|P1|STARTED|Overall Study||26
207544|NCT00758680|499628|P10|NOT COMPLETED|Overall Study||1
207545|NCT00758680|499629|P9|NOT COMPLETED|Overall Study||2
207546|NCT00758680|499630|P8|NOT COMPLETED|Overall Study||1
207547|NCT00758680|499631|P7|NOT COMPLETED|Overall Study||1
207548|NCT00758680|499632|P6|NOT COMPLETED|Overall Study||0
207549|NCT00758680|499633|P5|NOT COMPLETED|Overall Study||0
207550|NCT00758680|499634|P4|NOT COMPLETED|Overall Study||0
207551|NCT00758680|499635|P3|NOT COMPLETED|Overall Study||0
207552|NCT00758680|499636|P2|NOT COMPLETED|Overall Study||0
207553|NCT00758680|499637|P1|NOT COMPLETED|Overall Study||0
207554|NCT00758680|499628|P10|COMPLETED|Overall Study||28
207555|NCT00758680|499629|P9|COMPLETED|Overall Study||18
207556|NCT00758680|499630|P8|COMPLETED|Overall Study||19
207557|NCT00758680|499631|P7|COMPLETED|Overall Study||6
207558|NCT00758680|499632|P6|COMPLETED|Overall Study||6
207559|NCT00758680|499633|P5|COMPLETED|Overall Study||6
207560|NCT00758680|499634|P4|COMPLETED|Overall Study||6
207561|NCT00758680|499635|P3|COMPLETED|Overall Study||6
207562|NCT00758680|499636|P2|COMPLETED|Overall Study||6
207563|NCT00758680|499637|P1|COMPLETED|Overall Study||6
207564|NCT00758680|499628|P10|STARTED|Overall Study||29
207565|NCT00758680|499629|P9|STARTED|Overall Study||20
207566|NCT00758680|499630|P8|STARTED|Overall Study||20
207567|NCT00758680|499631|P7|STARTED|Overall Study||7
207568|NCT00758680|499632|P6|STARTED|Overall Study||6
207569|NCT00758680|499633|P5|STARTED|Overall Study||6
207570|NCT00758680|499634|P4|STARTED|Overall Study||6
207571|NCT00758680|499635|P3|STARTED|Overall Study||6
207572|NCT00758680|499636|P2|STARTED|Overall Study||6
207573|NCT00758680|499637|P1|STARTED|Overall Study||6
207574|NCT00758667|499679|P2|NOT COMPLETED|Overall Study||0
207575|NCT00758667|499680|P1|NOT COMPLETED|Overall Study||0
207576|NCT00758667|499679|P2|COMPLETED|Overall Study||11
207577|NCT00758667|499680|P1|COMPLETED|Overall Study||9
207578|NCT00758667|499679|P2|STARTED|Overall Study||11
207579|NCT00758667|499680|P1|STARTED|Overall Study||9
207580|NCT00758602|499690|P2|NOT COMPLETED|Overall Study||22
207581|NCT00758602|499691|P1|NOT COMPLETED|Overall Study||19
207582|NCT00758602|499690|P2|COMPLETED|Overall Study||84
207583|NCT00758602|499691|P1|COMPLETED|Overall Study||85
207584|NCT00758602|499690|P2|STARTED|Overall Study||106
207585|NCT00758602|499691|P1|STARTED|Overall Study||104
207586|NCT00758589|499717|P4|NOT COMPLETED|Overall Study||6
207587|NCT00758589|499718|P3|NOT COMPLETED|Overall Study||6
207588|NCT00758589|499719|P2|NOT COMPLETED|Overall Study||3
207589|NCT00758589|499720|P1|NOT COMPLETED|Overall Study||3
207590|NCT00758589|499717|P4|COMPLETED|Overall Study||85
207591|NCT00758589|499718|P3|COMPLETED|Overall Study||86
207592|NCT00758589|499719|P2|COMPLETED|Overall Study||87
207593|NCT00758589|499720|P1|COMPLETED|Overall Study||92
207594|NCT00758589|499717|P4|STARTED|Overall Study||91
207595|NCT00758589|499718|P3|STARTED|Overall Study||92
207596|NCT00758589|499719|P2|STARTED|Overall Study||90
207597|NCT00758589|499720|P1|STARTED|Overall Study||95
207598|NCT00758576|499786|P1|NOT COMPLETED|Overall Study||1
207599|NCT00758576|499786|P1|COMPLETED|Overall Study||63
207600|NCT00758576|499786|P1|STARTED|Overall Study||64
207601|NCT00758563|499794|P2|NOT COMPLETED|Overall Study||0
207602|NCT00758563|499795|P1|NOT COMPLETED|Overall Study||0
207603|NCT00758563|499794|P2|COMPLETED|Overall Study||8
207604|NCT00758563|499795|P1|COMPLETED|Overall Study||7
207605|NCT00758563|499794|P2|STARTED|Overall Study||8
207606|NCT00758563|499795|P1|STARTED|Overall Study||7
207607|NCT00758550|499801|P2|NOT COMPLETED|Overall Study||0
207608|NCT00758550|499802|P1|NOT COMPLETED|Overall Study||0
207609|NCT00758550|499801|P2|COMPLETED|Overall Study||30
207610|NCT00758550|499802|P1|COMPLETED|Overall Study||30
207611|NCT00758550|499801|P2|STARTED|Overall Study||30
207612|NCT00758550|499802|P1|STARTED|Overall Study||30
207613|NCT00758498|499813|P3|NOT COMPLETED|Overall Study||5
207614|NCT00758498|499814|P2|NOT COMPLETED|Overall Study||2
207615|NCT00758498|499815|P1|NOT COMPLETED|Overall Study||3
207616|NCT00758498|499813|P3|COMPLETED|Overall Study||137
207617|NCT00758498|499814|P2|COMPLETED|Overall Study||141
207618|NCT00758498|499815|P1|COMPLETED|Overall Study||139
207619|NCT00758498|499813|P3|STARTED|Overall Study||142
207620|NCT00758498|499814|P2|STARTED|Overall Study||143
207621|NCT00758498|499815|P1|STARTED|Overall Study||142
207622|NCT00758485|499900|P2|NOT COMPLETED|Overall Study||3
207623|NCT00758485|499901|P1|NOT COMPLETED|Overall Study||1
207624|NCT00758485|499900|P2|COMPLETED|Overall Study||67
207625|NCT00758485|499901|P1|COMPLETED|Overall Study||69
207626|NCT00758485|499900|P2|TREATED|Overall Study||68
207627|NCT00758485|499901|P1|TREATED|Overall Study||69
207628|NCT00758485|499900|P2|STARTED|Overall Study||70
207629|NCT00758485|499901|P1|STARTED|Overall Study||70
207630|NCT00758459|499913|P2|NOT COMPLETED|Overall Study||4
207631|NCT00758459|499914|P1|NOT COMPLETED|Overall Study||3
207632|NCT00758459|499913|P2|COMPLETED|Overall Study||35
207633|NCT00758459|499914|P1|COMPLETED|Overall Study||32
207634|NCT00758459|499913|P2|STARTED|Overall Study||39
207635|NCT00758459|499914|P1|STARTED|Overall Study||35
207636|NCT00758420|499948|P2|NOT COMPLETED|Overall Study||0
207637|NCT00758420|499949|P1|NOT COMPLETED|Overall Study||0
207638|NCT00758420|499948|P2|COMPLETED|Overall Study||38
207639|NCT00758420|499949|P1|COMPLETED|Overall Study||39
207640|NCT00758420|499948|P2|STARTED|Overall Study||38
207641|NCT00758420|499949|P1|STARTED|Overall Study||39
207642|NCT00758394|499959|P4|NOT COMPLETED|4th Intervention||0
207643|NCT00758394|499960|P3|NOT COMPLETED|4th Intervention||0
207644|NCT00758394|499961|P2|NOT COMPLETED|4th Intervention||0
207645|NCT00758394|499962|P1|NOT COMPLETED|4th Intervention||0
207646|NCT00758394|499959|P4|COMPLETED|4th Intervention||7
207647|NCT00758394|499960|P3|COMPLETED|4th Intervention||6
207648|NCT00758394|499961|P2|COMPLETED|4th Intervention||6
207649|NCT00758394|499962|P1|COMPLETED|4th Intervention||7
207650|NCT00758394|499959|P4|STARTED|4th Intervention||7
207651|NCT00758394|499960|P3|STARTED|4th Intervention||6
207652|NCT00758394|499961|P2|STARTED|4th Intervention||6
207653|NCT00758394|499962|P1|STARTED|4th Intervention||7
207654|NCT00758394|499959|P4|NOT COMPLETED|Washout After 3rd Intervention||0
207655|NCT00758394|499960|P3|NOT COMPLETED|Washout After 3rd Intervention||0
207656|NCT00758394|499961|P2|NOT COMPLETED|Washout After 3rd Intervention||0
207657|NCT00758394|499962|P1|NOT COMPLETED|Washout After 3rd Intervention||0
207658|NCT00758394|499959|P4|COMPLETED|Washout After 3rd Intervention||7
207659|NCT00758394|499960|P3|COMPLETED|Washout After 3rd Intervention||6
207660|NCT00758394|499961|P2|COMPLETED|Washout After 3rd Intervention||6
207661|NCT00758394|499962|P1|COMPLETED|Washout After 3rd Intervention||7
207662|NCT00758394|499959|P4|STARTED|Washout After 3rd Intervention||7
207663|NCT00758394|499960|P3|STARTED|Washout After 3rd Intervention||6
207664|NCT00758394|499961|P2|STARTED|Washout After 3rd Intervention||6
207665|NCT00758394|499962|P1|STARTED|Washout After 3rd Intervention||7
207666|NCT00758394|499959|P4|NOT COMPLETED|3rd Intervention||1
207667|NCT00758394|499960|P3|NOT COMPLETED|3rd Intervention||0
207668|NCT00758394|499961|P2|NOT COMPLETED|3rd Intervention||0
207669|NCT00758394|499962|P1|NOT COMPLETED|3rd Intervention||1
207670|NCT00758394|499959|P4|COMPLETED|3rd Intervention||7
207671|NCT00758394|499960|P3|COMPLETED|3rd Intervention||6
207672|NCT00758394|499961|P2|COMPLETED|3rd Intervention||6
207673|NCT00758394|499962|P1|COMPLETED|3rd Intervention||7
207674|NCT00758394|499959|P4|STARTED|3rd Intervention||8
207675|NCT00758394|499960|P3|STARTED|3rd Intervention||6
207676|NCT00758394|499961|P2|STARTED|3rd Intervention||6
207677|NCT00758394|499962|P1|STARTED|3rd Intervention||8
207678|NCT00758394|499959|P4|NOT COMPLETED|Washout After 2nd Intervention||0
207679|NCT00758394|499960|P3|NOT COMPLETED|Washout After 2nd Intervention||0
207680|NCT00758394|499961|P2|NOT COMPLETED|Washout After 2nd Intervention||0
207681|NCT00758394|499962|P1|NOT COMPLETED|Washout After 2nd Intervention||0
207682|NCT00758394|499959|P4|COMPLETED|Washout After 2nd Intervention||8
207683|NCT00758394|499960|P3|COMPLETED|Washout After 2nd Intervention||6
207684|NCT00758394|499961|P2|COMPLETED|Washout After 2nd Intervention||6
207685|NCT00758394|499962|P1|COMPLETED|Washout After 2nd Intervention||8
207686|NCT00758394|499959|P4|STARTED|Washout After 2nd Intervention||8
207687|NCT00758394|499960|P3|STARTED|Washout After 2nd Intervention||6
207688|NCT00758394|499961|P2|STARTED|Washout After 2nd Intervention||6
207689|NCT00758394|499962|P1|STARTED|Washout After 2nd Intervention||8
207690|NCT00758394|499959|P4|NOT COMPLETED|2nd Intervention Order||0
207691|NCT00758394|499960|P3|NOT COMPLETED|2nd Intervention Order||0
207692|NCT00758394|499961|P2|NOT COMPLETED|2nd Intervention Order||1
207693|NCT00758394|499962|P1|NOT COMPLETED|2nd Intervention Order||0
207694|NCT00758394|499959|P4|COMPLETED|2nd Intervention Order||8
207695|NCT00758394|499960|P3|COMPLETED|2nd Intervention Order||6
207696|NCT00758394|499961|P2|COMPLETED|2nd Intervention Order||6
207697|NCT00758394|499962|P1|COMPLETED|2nd Intervention Order||8
207698|NCT00758394|499959|P4|STARTED|2nd Intervention Order||8
207699|NCT00758394|499960|P3|STARTED|2nd Intervention Order||6
207700|NCT00758394|499961|P2|STARTED|2nd Intervention Order||7
207701|NCT00758394|499962|P1|STARTED|2nd Intervention Order||8
207702|NCT00758394|499959|P4|NOT COMPLETED|Washout After 1st Intervention||0
207703|NCT00758394|499960|P3|NOT COMPLETED|Washout After 1st Intervention||0
207704|NCT00758394|499961|P2|NOT COMPLETED|Washout After 1st Intervention||0
207705|NCT00758394|499962|P1|NOT COMPLETED|Washout After 1st Intervention||0
207706|NCT00758394|499959|P4|COMPLETED|Washout After 1st Intervention||8
207707|NCT00758394|499960|P3|COMPLETED|Washout After 1st Intervention||6
207708|NCT00758394|499961|P2|COMPLETED|Washout After 1st Intervention||7
207709|NCT00758394|499962|P1|COMPLETED|Washout After 1st Intervention||8
207710|NCT00758394|499959|P4|STARTED|Washout After 1st Intervention||8
207711|NCT00758394|499960|P3|STARTED|Washout After 1st Intervention||6
207712|NCT00758394|499961|P2|STARTED|Washout After 1st Intervention||7
207713|NCT00758394|499962|P1|STARTED|Washout After 1st Intervention||8
207714|NCT00758394|499959|P4|NOT COMPLETED|1st Intervention||0
207715|NCT00758394|499960|P3|NOT COMPLETED|1st Intervention||0
207716|NCT00758394|499961|P2|NOT COMPLETED|1st Intervention||0
207717|NCT00758394|499962|P1|NOT COMPLETED|1st Intervention||0
207718|NCT00758394|499959|P4|COMPLETED|1st Intervention||8
207719|NCT00758394|499960|P3|COMPLETED|1st Intervention||6
207720|NCT00758394|499961|P2|COMPLETED|1st Intervention||7
207721|NCT00758394|499962|P1|COMPLETED|1st Intervention||8
207722|NCT00758394|499959|P4|STARTED|1st Intervention||8
207723|NCT00758394|499960|P3|STARTED|1st Intervention||6
207724|NCT00758394|499961|P2|STARTED|1st Intervention||7
207725|NCT00758394|499962|P1|STARTED|1st Intervention||8
207726|NCT00758342|499974|P2|NOT COMPLETED|Overall Study||1
207727|NCT00758342|499975|P1|NOT COMPLETED|Overall Study||4
207728|NCT00758342|499974|P2|COMPLETED|Overall Study||17
207729|NCT00758342|499975|P1|COMPLETED|Overall Study||15
207730|NCT00758342|499974|P2|STARTED|Overall Study||18
207731|NCT00758342|499975|P1|STARTED|Overall Study||19
207732|NCT00758290|499983|P2|NOT COMPLETED|Overall Study||0
207733|NCT00758290|499984|P1|NOT COMPLETED|Overall Study||0
207734|NCT00758290|499983|P2|COMPLETED|Overall Study||12
207735|NCT00758290|499984|P1|COMPLETED|Overall Study||11
207736|NCT00758290|499983|P2|STARTED|Overall Study||12
207737|NCT00758290|499984|P1|STARTED|Overall Study||11
207738|NCT00758264|499991|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
207739|NCT00758264|499992|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
207740|NCT00758264|499993|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
207741|NCT00758264|499991|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
207742|NCT00758264|499992|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
207743|NCT00758264|499993|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
207744|NCT00758264|499991|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
207745|NCT00758264|499992|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
207746|NCT00758264|499993|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
207747|NCT00758264|499991|P3|NOT COMPLETED|Active Phase||5
207748|NCT00758264|499992|P2|NOT COMPLETED|Active Phase||0
207749|NCT00758264|499993|P1|NOT COMPLETED|Active Phase||1
207750|NCT00758264|499991|P3|COMPLETED|Active Phase||85
207751|NCT00758264|499992|P2|COMPLETED|Active Phase||91
207752|NCT00758264|499993|P1|COMPLETED|Active Phase||181
207753|NCT00758264|499991|P3|STARTED|Active Phase||90
207754|NCT00758264|499992|P2|STARTED|Active Phase||91
207755|NCT00758264|499993|P1|STARTED|Active Phase||182
207756|NCT00758160|500052|P1|NOT COMPLETED|Overall Study||66
207757|NCT00758160|500052|P1|COMPLETED|Overall Study||230
207758|NCT00758160|500052|P1|STARTED|Overall Study||296
207759|NCT00758069|500073|P3|NOT COMPLETED|Overall Study||1
207760|NCT00758069|500074|P2|NOT COMPLETED|Overall Study||0
207761|NCT00758069|500075|P1|NOT COMPLETED|Overall Study||1
207762|NCT00758069|500073|P3|COMPLETED|Overall Study||27
207763|NCT00758069|500074|P2|COMPLETED|Overall Study||25
207764|NCT00758069|500075|P1|COMPLETED|Overall Study||26
207765|NCT00758069|500073|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
207766|NCT00758069|500074|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
207767|NCT00758069|500075|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
207768|NCT00758043|500090|P4|NOT COMPLETED|Overall Study||100
207769|NCT00758043|500091|P3|NOT COMPLETED|Overall Study||39
207770|NCT00758043|500092|P2|NOT COMPLETED|Overall Study||41
207771|NCT00758043|500093|P1|NOT COMPLETED|Overall Study||1
207772|NCT00758043|500090|P4|COMPLETED|Overall Study||0
207773|NCT00758043|500091|P3|COMPLETED|Overall Study||79
207774|NCT00758043|500092|P2|COMPLETED|Overall Study||119
207775|NCT00758043|500093|P1|COMPLETED|Overall Study||161
207776|NCT00758043|500090|P4|STARTED|Overall Study||100
207777|NCT00758043|500091|P3|STARTED|Overall Study||118
207778|NCT00758043|500092|P2|STARTED|Overall Study||160
207779|NCT00758043|500093|P1|STARTED|Overall Study||162
207780|NCT00757848|500121|P2|NOT COMPLETED|Overall Study||2
207781|NCT00757848|500122|P1|NOT COMPLETED|Overall Study||3
207782|NCT00757848|500121|P2|COMPLETED|Overall Study||27
207783|NCT00757848|500122|P1|COMPLETED|Overall Study||24
207784|NCT00757848|500121|P2|STARTED|Overall Study||29
207785|NCT00757848|500122|P1|STARTED|Overall Study||27
207786|NCT00757822|500168|P2|NOT COMPLETED|Overall Study||31
207787|NCT00757822|500169|P1|NOT COMPLETED|Overall Study||28
207788|NCT00757822|500168|P2|COMPLETED|Overall Study||57
207789|NCT00757822|500169|P1|COMPLETED|Overall Study||64
207790|NCT00757822|500168|P2|Data Lock, Unblinding Analysis|Overall Study||57
207791|NCT00757822|500169|P1|Data Lock, Unblinding Analysis|Overall Study||64
207792|NCT00757822|500168|P2|Withdrawn-protocol Deviation|Overall Study||8
207793|NCT00757822|500169|P1|Withdrawn-protocol Deviation|Overall Study||9
207794|NCT00757822|500168|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
207795|NCT00757822|500169|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
207796|NCT00757822|500168|P2|Data Entry, QC Assessment|Overall Study||74
207797|NCT00757822|500169|P1|Data Entry, QC Assessment|Overall Study||85
207798|NCT00757822|500168|P2|2-6 wk Post-op Assessment|Overall Study||74
207799|NCT00757822|500169|P1|2-6 wk Post-op Assessment|Overall Study||85
207800|NCT00757822|500168|P2|24-48 hr Telephone Assessment|Overall Study||74
207801|NCT00757822|500169|P1|24-48 hr Telephone Assessment|Overall Study||85
207802|NCT00757822|500168|P2|DOS: Post-operative Assessments|Overall Study||74
207803|NCT00757822|500169|P1|DOS: Post-operative Assessments|Overall Study||85
207804|NCT00757822|500168|P2|Received Study Intervention|Overall Study||74
207805|NCT00757822|500169|P1|Received Study Intervention|Overall Study||85
207806|NCT00757822|500168|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
207807|NCT00757822|500169|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
207808|NCT00757822|500168|P2|Withdrawal by Subject-no Intervention|Overall Study||3
207809|NCT00757822|500169|P1|Withdrawal by Subject-no Intervention|Overall Study||1
207810|NCT00757822|500168|P2|Day of Surgery (DOS) Assessment|Overall Study||88
207811|NCT00757822|500169|P1|Day of Surgery (DOS) Assessment|Overall Study||92
207812|NCT00757822|500168|P2|STARTED|Overall Study||88
207813|NCT00757822|500169|P1|STARTED|Overall Study||92
207814|NCT00757783|500191|P2|NOT COMPLETED|Overall Study||6
207815|NCT00757783|500192|P1|NOT COMPLETED|Overall Study||5
207816|NCT00757783|500191|P2|COMPLETED|Overall Study||25
207817|NCT00757783|500192|P1|COMPLETED|Overall Study||29
207818|NCT00757783|500191|P2|STARTED|Overall Study||31
207819|NCT00757783|500192|P1|STARTED|Overall Study||34
207820|NCT00757705|500228|P1|NOT COMPLETED|Overall Study||121
207821|NCT00757705|500228|P1|COMPLETED|Overall Study||178
207822|NCT00757705|500228|P1|STARTED|Overall Study||299
207823|NCT00757666|500242|P2|NOT COMPLETED|Overall Study||23
207824|NCT00757666|500243|P1|NOT COMPLETED|Overall Study||22
207825|NCT00757666|500242|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
207826|NCT00757666|500243|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
207827|NCT00757666|500242|P2|STARTED|Overall Study||34
207828|NCT00757666|500243|P1|STARTED|Overall Study||34
207829|NCT00757627|500257|P1|NOT COMPLETED|Overall Study||81
207830|NCT00757627|500257|P1|COMPLETED|Overall Study||419
207831|NCT00757627|500257|P1|STARTED|Overall Study||500
207832|NCT00757601|500270|P12|NOT COMPLETED|Period 5||0
207833|NCT00757601|500271|P11|NOT COMPLETED|Period 5||0
207834|NCT00757601|500272|P10|NOT COMPLETED|Period 5||0
207835|NCT00757601|500273|P9|NOT COMPLETED|Period 5||0
207836|NCT00757601|500274|P8|NOT COMPLETED|Period 5||0
207837|NCT00757601|500275|P7|NOT COMPLETED|Period 5||0
207838|NCT00757601|500276|P6|NOT COMPLETED|Period 5||0
207839|NCT00757601|500277|P5|NOT COMPLETED|Period 5||0
207840|NCT00757601|500278|P4|NOT COMPLETED|Period 5||0
207841|NCT00757601|500279|P3|NOT COMPLETED|Period 5||0
207842|NCT00757601|500280|P2|NOT COMPLETED|Period 5||0
207843|NCT00757601|500281|P1|NOT COMPLETED|Period 5||0
207844|NCT00757601|500270|P12|COMPLETED|Period 5||1
207845|NCT00757601|500271|P11|COMPLETED|Period 5||2
207846|NCT00757601|500272|P10|COMPLETED|Period 5||1
207847|NCT00757601|500273|P9|COMPLETED|Period 5||2
207848|NCT00757601|500274|P8|COMPLETED|Period 5||2
207849|NCT00757601|500275|P7|COMPLETED|Period 5||2
207850|NCT00757601|500276|P6|COMPLETED|Period 5||2
207851|NCT00757601|500277|P5|COMPLETED|Period 5||2
207852|NCT00757601|500278|P4|COMPLETED|Period 5||2
207853|NCT00757601|500279|P3|COMPLETED|Period 5||2
207854|NCT00757601|500280|P2|COMPLETED|Period 5||2
207855|NCT00757601|500281|P1|COMPLETED|Period 5||2
207856|NCT00757601|500270|P12|STARTED|Period 5||1
207857|NCT00757601|500271|P11|STARTED|Period 5||2
207858|NCT00757601|500272|P10|STARTED|Period 5||1
207859|NCT00757601|500273|P9|STARTED|Period 5||2
207860|NCT00757601|500274|P8|STARTED|Period 5||2
207861|NCT00757601|500275|P7|STARTED|Period 5||2
207862|NCT00757601|500276|P6|STARTED|Period 5||2
207863|NCT00757601|500277|P5|STARTED|Period 5||2
207864|NCT00757601|500278|P4|STARTED|Period 5||2
207865|NCT00757601|500279|P3|STARTED|Period 5||2
207866|NCT00757601|500280|P2|STARTED|Period 5||2
207867|NCT00757601|500281|P1|STARTED|Period 5||2
207868|NCT00757601|500270|P12|NOT COMPLETED|Period 4||1
207869|NCT00757601|500271|P11|NOT COMPLETED|Period 4||0
207870|NCT00757601|500272|P10|NOT COMPLETED|Period 4||1
207871|NCT00757601|500273|P9|NOT COMPLETED|Period 4||0
207872|NCT00757601|500274|P8|NOT COMPLETED|Period 4||0
207873|NCT00757601|500275|P7|NOT COMPLETED|Period 4||0
207874|NCT00757601|500276|P6|NOT COMPLETED|Period 4||0
207875|NCT00757601|500277|P5|NOT COMPLETED|Period 4||0
207876|NCT00757601|500278|P4|NOT COMPLETED|Period 4||0
207877|NCT00757601|500279|P3|NOT COMPLETED|Period 4||0
207878|NCT00757601|500280|P2|NOT COMPLETED|Period 4||0
207879|NCT00757601|500281|P1|NOT COMPLETED|Period 4||0
207880|NCT00757601|500270|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
207881|NCT00757601|500271|P11|COMPLETED|Period 4||2
207882|NCT00757601|500272|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
207883|NCT00757601|500273|P9|COMPLETED|Period 4||2
207884|NCT00757601|500274|P8|COMPLETED|Period 4||2
207885|NCT00757601|500275|P7|COMPLETED|Period 4||2
207886|NCT00757601|500276|P6|COMPLETED|Period 4||2
207887|NCT00757601|500277|P5|COMPLETED|Period 4||2
207888|NCT00757601|500278|P4|COMPLETED|Period 4||2
207889|NCT00757601|500279|P3|COMPLETED|Period 4||2
207890|NCT00757601|500280|P2|COMPLETED|Period 4||2
207891|NCT00757601|500281|P1|COMPLETED|Period 4||2
207892|NCT00757601|500270|P12|STARTED|Period 4||2
207893|NCT00757601|500271|P11|STARTED|Period 4||2
207894|NCT00757601|500272|P10|STARTED|Period 4||2
207895|NCT00757601|500273|P9|STARTED|Period 4||2
207896|NCT00757601|500274|P8|STARTED|Period 4||2
207897|NCT00757601|500275|P7|STARTED|Period 4||2
207898|NCT00757601|500276|P6|STARTED|Period 4||2
207899|NCT00757601|500277|P5|STARTED|Period 4||2
207900|NCT00757601|500278|P4|STARTED|Period 4||2
207901|NCT00757601|500279|P3|STARTED|Period 4||2
207902|NCT00757601|500280|P2|STARTED|Period 4||2
207903|NCT00757601|500281|P1|STARTED|Period 4||2
207904|NCT00757601|500270|P12|NOT COMPLETED|Period 3||0
207905|NCT00757601|500271|P11|NOT COMPLETED|Period 3||0
207906|NCT00757601|500272|P10|NOT COMPLETED|Period 3||0
207907|NCT00757601|500273|P9|NOT COMPLETED|Period 3||0
207908|NCT00757601|500274|P8|NOT COMPLETED|Period 3||0
207909|NCT00757601|500275|P7|NOT COMPLETED|Period 3||0
207910|NCT00757601|500276|P6|NOT COMPLETED|Period 3||0
207911|NCT00757601|500277|P5|NOT COMPLETED|Period 3||0
207912|NCT00757601|500278|P4|NOT COMPLETED|Period 3||0
207913|NCT00757601|500279|P3|NOT COMPLETED|Period 3||0
207914|NCT00757601|500280|P2|NOT COMPLETED|Period 3||0
207915|NCT00757601|500281|P1|NOT COMPLETED|Period 3||0
207916|NCT00757601|500270|P12|COMPLETED|Period 3||2
207917|NCT00757601|500271|P11|COMPLETED|Period 3||2
207918|NCT00757601|500272|P10|COMPLETED|Period 3||2
207919|NCT00757601|500273|P9|COMPLETED|Period 3||2
207920|NCT00757601|500274|P8|COMPLETED|Period 3||2
207921|NCT00757601|500275|P7|COMPLETED|Period 3||2
207922|NCT00757601|500276|P6|COMPLETED|Period 3||2
207923|NCT00757601|500277|P5|COMPLETED|Period 3||2
207924|NCT00757601|500278|P4|COMPLETED|Period 3||2
207925|NCT00757601|500279|P3|COMPLETED|Period 3||2
207926|NCT00757601|500280|P2|COMPLETED|Period 3||2
207927|NCT00757601|500281|P1|COMPLETED|Period 3||2
207928|NCT00757601|500270|P12|STARTED|Period 3||2
207929|NCT00757601|500271|P11|STARTED|Period 3||2
207930|NCT00757601|500272|P10|STARTED|Period 3||2
207931|NCT00757601|500273|P9|STARTED|Period 3||2
207932|NCT00757601|500274|P8|STARTED|Period 3||2
207933|NCT00757601|500275|P7|STARTED|Period 3||2
207934|NCT00757601|500276|P6|STARTED|Period 3||2
207935|NCT00757601|500277|P5|STARTED|Period 3||2
207936|NCT00757601|500278|P4|STARTED|Period 3||2
207937|NCT00757601|500279|P3|STARTED|Period 3||2
207938|NCT00757601|500280|P2|STARTED|Period 3||2
207939|NCT00757601|500281|P1|STARTED|Period 3||2
207940|NCT00757601|500270|P12|NOT COMPLETED|Period 2||1
207941|NCT00757601|500271|P11|NOT COMPLETED|Period 2||0
207942|NCT00757601|500272|P10|NOT COMPLETED|Period 2||0
207943|NCT00757601|500273|P9|NOT COMPLETED|Period 2||0
207944|NCT00757601|500274|P8|NOT COMPLETED|Period 2||0
207945|NCT00757601|500275|P7|NOT COMPLETED|Period 2||0
207946|NCT00757601|500276|P6|NOT COMPLETED|Period 2||0
207947|NCT00757601|500277|P5|NOT COMPLETED|Period 2||0
207948|NCT00757601|500278|P4|NOT COMPLETED|Period 2||0
207949|NCT00757601|500279|P3|NOT COMPLETED|Period 2||0
207950|NCT00757601|500280|P2|NOT COMPLETED|Period 2||0
207951|NCT00757601|500281|P1|NOT COMPLETED|Period 2||0
207952|NCT00757601|500270|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
207953|NCT00757601|500271|P11|COMPLETED|Period 2||2
207954|NCT00757601|500272|P10|COMPLETED|Period 2||2
207955|NCT00757601|500273|P9|COMPLETED|Period 2||2
207956|NCT00757601|500274|P8|COMPLETED|Period 2||2
207957|NCT00757601|500275|P7|COMPLETED|Period 2||2
207958|NCT00757601|500276|P6|COMPLETED|Period 2||2
207959|NCT00757601|500277|P5|COMPLETED|Period 2||2
207960|NCT00757601|500278|P4|COMPLETED|Period 2||2
207961|NCT00757601|500279|P3|COMPLETED|Period 2||2
207962|NCT00757601|500280|P2|COMPLETED|Period 2||2
207963|NCT00757601|500281|P1|COMPLETED|Period 2||2
207964|NCT00757601|500270|P12|STARTED|Period 2||3
207965|NCT00757601|500271|P11|STARTED|Period 2||2
207966|NCT00757601|500272|P10|STARTED|Period 2||2
207967|NCT00757601|500273|P9|STARTED|Period 2||2
207968|NCT00757601|500274|P8|STARTED|Period 2||2
207969|NCT00757601|500275|P7|STARTED|Period 2||2
207970|NCT00757601|500276|P6|STARTED|Period 2||2
207971|NCT00757601|500277|P5|STARTED|Period 2||2
207972|NCT00757601|500278|P4|STARTED|Period 2||2
207973|NCT00757601|500279|P3|STARTED|Period 2||2
207974|NCT00757601|500280|P2|STARTED|Period 2||2
207975|NCT00757601|500281|P1|STARTED|Period 2||2
207976|NCT00757601|500270|P12|NOT COMPLETED|Period 1||0
207977|NCT00757601|500271|P11|NOT COMPLETED|Period 1||0
207978|NCT00757601|500272|P10|NOT COMPLETED|Period 1||0
207979|NCT00757601|500273|P9|NOT COMPLETED|Period 1||0
207980|NCT00757601|500274|P8|NOT COMPLETED|Period 1||0
207981|NCT00757601|500275|P7|NOT COMPLETED|Period 1||0
207982|NCT00757601|500276|P6|NOT COMPLETED|Period 1||0
207983|NCT00757601|500277|P5|NOT COMPLETED|Period 1||0
207984|NCT00757601|500278|P4|NOT COMPLETED|Period 1||0
207985|NCT00757601|500279|P3|NOT COMPLETED|Period 1||0
207986|NCT00757601|500280|P2|NOT COMPLETED|Period 1||0
207987|NCT00757601|500281|P1|NOT COMPLETED|Period 1||0
207988|NCT00757601|500270|P12|COMPLETED|Period 1||3
207989|NCT00757601|500271|P11|COMPLETED|Period 1||2
207990|NCT00757601|500272|P10|COMPLETED|Period 1||2
207991|NCT00757601|500273|P9|COMPLETED|Period 1||2
207992|NCT00757601|500274|P8|COMPLETED|Period 1||2
207993|NCT00757601|500275|P7|COMPLETED|Period 1||2
207994|NCT00757601|500276|P6|COMPLETED|Period 1||2
207995|NCT00757601|500277|P5|COMPLETED|Period 1||2
207996|NCT00757601|500278|P4|COMPLETED|Period 1||2
207997|NCT00757601|500279|P3|COMPLETED|Period 1||2
207998|NCT00757601|500280|P2|COMPLETED|Period 1||2
207999|NCT00757601|500281|P1|COMPLETED|Period 1||2
208000|NCT00757601|500270|P12|STARTED|Period 1||3
208001|NCT00757601|500271|P11|STARTED|Period 1||2
208002|NCT00757601|500272|P10|STARTED|Period 1||2
208003|NCT00757601|500273|P9|STARTED|Period 1||2
208004|NCT00757601|500274|P8|STARTED|Period 1||2
208005|NCT00757601|500275|P7|STARTED|Period 1||2
208006|NCT00757601|500276|P6|STARTED|Period 1||2
208007|NCT00757601|500277|P5|STARTED|Period 1||2
208008|NCT00757601|500278|P4|STARTED|Period 1||2
208009|NCT00757601|500279|P3|STARTED|Period 1||2
208010|NCT00757601|500280|P2|STARTED|Period 1||2
208011|NCT00757601|500281|P1|STARTED|Period 1||2
208012|NCT00757588|500392|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
208013|NCT00757588|500393|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
208014|NCT00757588|500392|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
208015|NCT00757588|500393|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
208016|NCT00757588|500392|P2|STARTED|Period 2: Long-term (52-week) Phase||134
208017|NCT00757588|500393|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
208018|NCT00757588|500392|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
208019|NCT00757588|500393|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
208020|NCT00757588|500392|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
208021|NCT00757588|500393|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
208022|NCT00757588|500392|P2|STARTED|Period 1: Short-term (24-week) Phase||151
208023|NCT00757588|500393|P1|STARTED|Period 1: Short-term (24-week) Phase||304
208024|NCT00757484|500425|P1|NOT COMPLETED|Overall Study||0
208025|NCT00757484|500425|P1|COMPLETED|Overall Study||491
208026|NCT00757484|500425|P1|STARTED|Overall Study||491
208027|NCT00757237|500434|P2|NOT COMPLETED|Overall Study||25
208028|NCT00757237|500435|P1|NOT COMPLETED|Overall Study||13
208029|NCT00757237|500434|P2|COMPLETED|Overall Study||111
208030|NCT00757237|500435|P1|COMPLETED|Overall Study||124
208031|NCT00757237|500434|P2|Treated|Overall Study||132
208032|NCT00757237|500435|P1|Treated|Overall Study||136
208033|NCT00757237|500434|P2|STARTED|Overall Study||136
208034|NCT00757237|500435|P1|STARTED|Overall Study||137
208035|NCT00757172|500463|P1|NOT COMPLETED|Overall Study||11
208036|NCT00757172|500463|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
208037|NCT00757172|500463|P1|STARTED|Overall Study||65
208038|NCT00757003|500471|P1|NOT COMPLETED|Overall Study||49
208039|NCT00757003|500471|P1|COMPLETED|Overall Study||51
208040|NCT00757003|500471|P1|STARTED|Overall Study||100
208041|NCT00756977|500479|P2|NOT COMPLETED|Overall Study||11
208042|NCT00756977|500480|P1|NOT COMPLETED|Overall Study||21
208043|NCT00756977|500479|P2|COMPLETED|Overall Study||187
208044|NCT00756977|500480|P1|COMPLETED|Overall Study||175
208045|NCT00756977|500479|P2|STARTED|Overall Study||198
208046|NCT00756977|500480|P1|STARTED|Overall Study||196
208047|NCT00756964|500508|P2|NOT COMPLETED|Overall Study||0
208048|NCT00756964|500509|P1|NOT COMPLETED|Overall Study||0
208049|NCT00756964|500508|P2|COMPLETED|Overall Study||13
208050|NCT00756964|500509|P1|COMPLETED|Overall Study||13
208051|NCT00756964|500508|P2|STARTED|Overall Study||13
208052|NCT00756964|500509|P1|STARTED|Overall Study||13
208053|NCT00756938|500518|P4|NOT COMPLETED|Optional Extension||37
208054|NCT00756938|500519|P3|NOT COMPLETED|Optional Extension||0
208055|NCT00756938|500520|P2|NOT COMPLETED|Optional Extension||0
208056|NCT00756938|500521|P1|NOT COMPLETED|Optional Extension||0
208057|NCT00756938|500518|P4|COMPLETED|Optional Extension||53
208058|NCT00756938|500519|P3|COMPLETED|Optional Extension||0
208059|NCT00756938|500520|P2|COMPLETED|Optional Extension||0
208060|NCT00756938|500521|P1|COMPLETED|Optional Extension||0
208061|NCT00756938|500518|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
208062|NCT00756938|500519|P3|STARTED|Optional Extension||0
208063|NCT00756938|500520|P2|STARTED|Optional Extension||0
208064|NCT00756938|500521|P1|STARTED|Optional Extension||0
208065|NCT00756938|500518|P4|NOT COMPLETED|12-week Base Study||0
208066|NCT00756938|500519|P3|NOT COMPLETED|12-week Base Study||2
208067|NCT00756938|500520|P2|NOT COMPLETED|12-week Base Study||0
208068|NCT00756938|500521|P1|NOT COMPLETED|12-week Base Study||2
208069|NCT00756938|500518|P4|COMPLETED|12-week Base Study||0
208070|NCT00756938|500519|P3|COMPLETED|12-week Base Study||32
208071|NCT00756938|500520|P2|COMPLETED|12-week Base Study||34
208072|NCT00756938|500521|P1|COMPLETED|12-week Base Study||31
208073|NCT00756938|500518|P4|STARTED|12-week Base Study||0
208074|NCT00756938|500519|P3|STARTED|12-week Base Study||34
208075|NCT00756938|500520|P2|STARTED|12-week Base Study||34
208076|NCT00756938|500521|P1|STARTED|12-week Base Study||33
208077|NCT00756886|500549|P2|NOT COMPLETED|Overall Study||7
208078|NCT00756886|500550|P1|NOT COMPLETED|Overall Study||11
208079|NCT00756886|500549|P2|COMPLETED|Overall Study||25
208080|NCT00756886|500550|P1|COMPLETED|Overall Study||30
208081|NCT00756886|500549|P2|STARTED|Overall Study||32
208082|NCT00756886|500550|P1|STARTED|Overall Study||41
208083|NCT00756730|500558|P2|NOT COMPLETED|Overall Study||2
208084|NCT00756730|500559|P1|NOT COMPLETED|Overall Study||0
208085|NCT00756730|500558|P2|COMPLETED|Overall Study||22
208086|NCT00756730|500559|P1|COMPLETED|Overall Study||25
208087|NCT00756730|500558|P2|STARTED|Overall Study||24
208088|NCT00756730|500559|P1|STARTED|Overall Study||25
208089|NCT00756678|500579|P1|NOT COMPLETED|Overall Study||1
208090|NCT00756678|500579|P1|COMPLETED|Overall Study||50
208091|NCT00756678|500579|P1|STARTED|Overall Study||51
208092|NCT00756574|500592|P2|NOT COMPLETED|Overall Study||11
208093|NCT00756574|500593|P1|NOT COMPLETED|Overall Study||13
208094|NCT00756574|500592|P2|COMPLETED|Overall Study||210
208095|NCT00756574|500593|P1|COMPLETED|Overall Study||212
208096|NCT00756574|500592|P2|STARTED|Overall Study||221
208097|NCT00756574|500593|P1|STARTED|Overall Study||225
208098|NCT00756561|500603|P1|NOT COMPLETED|Overall Study||0
208099|NCT00756561|500603|P1|COMPLETED|Overall Study||10
208100|NCT00756561|500603|P1|STARTED|Overall Study||10
208101|NCT00756548|500610|P2|NOT COMPLETED|Overall Study||0
208102|NCT00756548|500611|P1|NOT COMPLETED|Overall Study||2
208103|NCT00756548|500610|P2|COMPLETED|Overall Study||185
208104|NCT00756548|500611|P1|COMPLETED|Overall Study||184
208105|NCT00756548|500610|P2|STARTED|Overall Study||185
208106|NCT00756548|500611|P1|STARTED|Overall Study||186
208107|NCT00756470|500637|P1|NOT COMPLETED|Overall Study||5
208108|NCT00756470|500637|P1|COMPLETED|Overall Study||10
208109|NCT00756470|500637|P1|STARTED|Overall Study||15
208110|NCT00756457|500644|P2|NOT COMPLETED|Overall Study||2
208111|NCT00756457|500645|P1|NOT COMPLETED|Overall Study||1
208112|NCT00756457|500644|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
208113|NCT00756457|500645|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
208114|NCT00756457|500644|P2|STARTED|Overall Study||19
208115|NCT00756457|500645|P1|STARTED|Overall Study||20
208116|NCT00756444|500675|P2|NOT COMPLETED|Overall Study||21
208117|NCT00756444|500676|P1|NOT COMPLETED|Overall Study||15
208118|NCT00756444|500675|P2|COMPLETED|Overall Study||13
208119|NCT00756444|500676|P1|COMPLETED|Overall Study||18
208120|NCT00756444|500675|P2|STARTED|Overall Study||34
208121|NCT00756444|500676|P1|STARTED|Overall Study||33
208122|NCT00756314|500687|P2|NOT COMPLETED|Overall Study||59
208123|NCT00756314|500688|P1|NOT COMPLETED|Overall Study||2
208212|NCT00755937|500852|P1|NOT COMPLETED|Recruitment||164
208124|NCT00756314|500687|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
208125|NCT00756314|500688|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
208126|NCT00756314|500687|P2|STARTED|Overall Study||123
208127|NCT00756314|500688|P1|STARTED|Overall Study||123
208128|NCT00756275|500704|P2|NOT COMPLETED|Overall Study||28
208129|NCT00756275|500705|P1|NOT COMPLETED|Overall Study||29
208130|NCT00756275|500704|P2|COMPLETED|Overall Study||49
208131|NCT00756275|500705|P1|COMPLETED|Overall Study||31
208132|NCT00756275|500704|P2|STARTED|Overall Study||77
208133|NCT00756275|500705|P1|STARTED|Overall Study||60
208134|NCT00756236|500732|P3|NOT COMPLETED|Overall Study||0
208135|NCT00756236|500733|P2|NOT COMPLETED|Overall Study||0
208136|NCT00756236|500734|P1|NOT COMPLETED|Overall Study||0
208137|NCT00756236|500732|P3|COMPLETED|Overall Study||20
208138|NCT00756236|500733|P2|COMPLETED|Overall Study||20
208139|NCT00756236|500734|P1|COMPLETED|Overall Study||20
208140|NCT00756236|500732|P3|STARTED|Overall Study||20
208141|NCT00756236|500733|P2|STARTED|Overall Study||20
208142|NCT00756236|500734|P1|STARTED|Overall Study||20
208143|NCT00756093|500742|P4|NOT COMPLETED|Fourth Intervention||0
208144|NCT00756093|500743|P3|NOT COMPLETED|Fourth Intervention||0
208145|NCT00756093|500744|P2|NOT COMPLETED|Fourth Intervention||0
208146|NCT00756093|500745|P1|NOT COMPLETED|Fourth Intervention||0
208147|NCT00756093|500742|P4|COMPLETED|Fourth Intervention||5
208148|NCT00756093|500743|P3|COMPLETED|Fourth Intervention||5
208149|NCT00756093|500744|P2|COMPLETED|Fourth Intervention||5
208150|NCT00756093|500745|P1|COMPLETED|Fourth Intervention||5
208151|NCT00756093|500742|P4|STARTED|Fourth Intervention||5
208152|NCT00756093|500743|P3|STARTED|Fourth Intervention||5
208153|NCT00756093|500744|P2|STARTED|Fourth Intervention||5
208154|NCT00756093|500745|P1|STARTED|Fourth Intervention||5
208155|NCT00756093|500742|P4|NOT COMPLETED|Third Intervention||0
208156|NCT00756093|500743|P3|NOT COMPLETED|Third Intervention||0
208157|NCT00756093|500744|P2|NOT COMPLETED|Third Intervention||0
208158|NCT00756093|500745|P1|NOT COMPLETED|Third Intervention||0
208159|NCT00756093|500742|P4|COMPLETED|Third Intervention||5
208160|NCT00756093|500743|P3|COMPLETED|Third Intervention||5
208161|NCT00756093|500744|P2|COMPLETED|Third Intervention||5
208162|NCT00756093|500745|P1|COMPLETED|Third Intervention||5
208163|NCT00756093|500742|P4|STARTED|Third Intervention||5
208164|NCT00756093|500743|P3|STARTED|Third Intervention||5
208165|NCT00756093|500744|P2|STARTED|Third Intervention||5
208166|NCT00756093|500745|P1|STARTED|Third Intervention||5
208167|NCT00756093|500742|P4|NOT COMPLETED|Second Intervention||0
208168|NCT00756093|500743|P3|NOT COMPLETED|Second Intervention||0
208169|NCT00756093|500744|P2|NOT COMPLETED|Second Intervention||0
208170|NCT00756093|500745|P1|NOT COMPLETED|Second Intervention||0
208171|NCT00756093|500742|P4|COMPLETED|Second Intervention||5
208172|NCT00756093|500743|P3|COMPLETED|Second Intervention||5
208173|NCT00756093|500744|P2|COMPLETED|Second Intervention||5
208174|NCT00756093|500745|P1|COMPLETED|Second Intervention||5
208175|NCT00756093|500742|P4|STARTED|Second Intervention||5
208176|NCT00756093|500743|P3|STARTED|Second Intervention||5
208177|NCT00756093|500744|P2|STARTED|Second Intervention||5
208178|NCT00756093|500745|P1|STARTED|Second Intervention||5
208179|NCT00756093|500742|P4|NOT COMPLETED|First Intervention||0
208180|NCT00756093|500743|P3|NOT COMPLETED|First Intervention||0
208181|NCT00756093|500744|P2|NOT COMPLETED|First Intervention||0
208182|NCT00756093|500745|P1|NOT COMPLETED|First Intervention||0
208183|NCT00756093|500742|P4|COMPLETED|First Intervention||5
208184|NCT00756093|500743|P3|COMPLETED|First Intervention||5
208185|NCT00756093|500744|P2|COMPLETED|First Intervention||5
208186|NCT00756093|500745|P1|COMPLETED|First Intervention||5
208187|NCT00756093|500742|P4|STARTED|First Intervention||5
208188|NCT00756093|500743|P3|STARTED|First Intervention||5
208189|NCT00756093|500744|P2|STARTED|First Intervention||5
208190|NCT00756093|500745|P1|STARTED|First Intervention||5
208191|NCT00756002|500757|P2|NOT COMPLETED|Placebo Run-out||0
208192|NCT00756002|500758|P1|NOT COMPLETED|Placebo Run-out||0
208193|NCT00756002|500757|P2|COMPLETED|Placebo Run-out||0
208194|NCT00756002|500758|P1|COMPLETED|Placebo Run-out||114
208195|NCT00756002|500757|P2|STARTED|Placebo Run-out||0
208196|NCT00756002|500758|P1|STARTED|Placebo Run-out||114
208197|NCT00756002|500757|P2|NOT COMPLETED|Double-Blind Treatment Period||15
208198|NCT00756002|500758|P1|NOT COMPLETED|Double-Blind Treatment Period||15
208199|NCT00756002|500757|P2|COMPLETED|Double-Blind Treatment Period||115
208200|NCT00756002|500758|P1|COMPLETED|Double-Blind Treatment Period||114
208201|NCT00756002|500757|P2|STARTED|Double-Blind Treatment Period||130
208202|NCT00756002|500758|P1|STARTED|Double-Blind Treatment Period||129
208203|NCT00756002|500757|P2|NOT COMPLETED|Placebo Run-in||0
208204|NCT00756002|500758|P1|NOT COMPLETED|Placebo Run-in||229
208205|NCT00756002|500757|P2|COMPLETED|Placebo Run-in||0
208206|NCT00756002|500758|P1|COMPLETED|Placebo Run-in||259
208207|NCT00756002|500757|P2|STARTED|Placebo Run-in||0
208208|NCT00756002|500758|P1|STARTED|Placebo Run-in||488
208209|NCT00755937|500852|P1|NOT COMPLETED|Observational Follow-up||148
208210|NCT00755937|500852|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
208211|NCT00755937|500852|P1|STARTED|Observational Follow-up||392
208213|NCT00755937|500852|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
208214|NCT00755937|500852|P1|STARTED|Recruitment|Subjects registered in the program|556
208215|NCT00755911|500864|P2|NOT COMPLETED|Overall Study||0
208216|NCT00755911|500865|P1|NOT COMPLETED|Overall Study||0
208217|NCT00755911|500864|P2|COMPLETED|Overall Study||12
208218|NCT00755911|500865|P1|COMPLETED|Overall Study||12
208219|NCT00755911|500864|P2|STARTED|Overall Study||12
208220|NCT00755911|500865|P1|STARTED|Overall Study||12
208221|NCT00755846|500879|P6|NOT COMPLETED|Overall Study||14
208222|NCT00755846|500880|P5|NOT COMPLETED|Overall Study||17
208223|NCT00755846|500881|P4|NOT COMPLETED|Overall Study||13
208224|NCT00755846|500882|P3|NOT COMPLETED|Overall Study||12
208225|NCT00755846|500883|P2|NOT COMPLETED|Overall Study||17
208226|NCT00755846|500884|P1|NOT COMPLETED|Overall Study||25
208227|NCT00755846|500879|P6|COMPLETED|Overall Study||31
208228|NCT00755846|500880|P5|COMPLETED|Overall Study||27
208229|NCT00755846|500881|P4|COMPLETED|Overall Study||32
208230|NCT00755846|500882|P3|COMPLETED|Overall Study||32
208231|NCT00755846|500883|P2|COMPLETED|Overall Study||27
208232|NCT00755846|500884|P1|COMPLETED|Overall Study||18
208233|NCT00755846|500879|P6|STARTED|Overall Study||45
208234|NCT00755846|500880|P5|STARTED|Overall Study||44
208235|NCT00755846|500881|P4|STARTED|Overall Study||45
208236|NCT00755846|500882|P3|STARTED|Overall Study||44
208237|NCT00755846|500883|P2|STARTED|Overall Study||44
208238|NCT00755846|500884|P1|STARTED|Overall Study||43
208239|NCT00755807|500984|P2|NOT COMPLETED|Open-label Extension Phase||16
208240|NCT00755807|500985|P1|NOT COMPLETED|Open-label Extension Phase||18
208241|NCT00755807|500984|P2|COMPLETED|Open-label Extension Phase||93
208242|NCT00755807|500985|P1|COMPLETED|Open-label Extension Phase||82
208243|NCT00755807|500984|P2|STARTED|Open-label Extension Phase||109
208244|NCT00755807|500985|P1|STARTED|Open-label Extension Phase||100
208245|NCT00755807|500984|P2|NOT COMPLETED|Acute Phase||12
208246|NCT00755807|500985|P1|NOT COMPLETED|Acute Phase||18
208247|NCT00755807|500984|P2|COMPLETED|Acute Phase||109
208248|NCT00755807|500985|P1|COMPLETED|Acute Phase||100
208249|NCT00755807|500984|P2|STARTED|Acute Phase||121
208250|NCT00755807|500985|P1|STARTED|Acute Phase||118
208251|NCT00755755|501049|P3|NOT COMPLETED|Overall Study||3
208252|NCT00755755|501050|P2|NOT COMPLETED|Overall Study||8
208253|NCT00755755|501051|P1|NOT COMPLETED|Overall Study||6
208254|NCT00755755|501049|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
208255|NCT00755755|501050|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
208256|NCT00755755|501051|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
208257|NCT00755755|501049|P3|STARTED|Overall Study|Safety population|48
208258|NCT00755755|501050|P2|STARTED|Overall Study|Safety population|98
208259|NCT00755755|501051|P1|STARTED|Overall Study|Safety population|95
208260|NCT00755716|501065|P3|NOT COMPLETED|Overall Study||3
208261|NCT00755716|501066|P2|NOT COMPLETED|Overall Study||8
208262|NCT00755716|501067|P1|NOT COMPLETED|Overall Study||8
208263|NCT00755716|501065|P3|COMPLETED|Overall Study||16
208264|NCT00755716|501066|P2|COMPLETED|Overall Study||11
208265|NCT00755716|501067|P1|COMPLETED|Overall Study||11
208266|NCT00755716|501065|P3|STARTED|Overall Study||19
208267|NCT00755716|501066|P2|STARTED|Overall Study||19
208268|NCT00755716|501067|P1|STARTED|Overall Study||19
208269|NCT00755417|501081|P3|NOT COMPLETED|Overall Study||42
208270|NCT00755417|501082|P2|NOT COMPLETED|Overall Study||55
208271|NCT00755417|501083|P1|NOT COMPLETED|Overall Study||62
208272|NCT00755417|501081|P3|COMPLETED|Overall Study||135
208273|NCT00755417|501082|P2|COMPLETED|Overall Study||126
208274|NCT00755417|501083|P1|COMPLETED|Overall Study||112
208275|NCT00755417|501081|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
208276|NCT00755417|501082|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
208277|NCT00755417|501083|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
208278|NCT00755274|501102|P2|NOT COMPLETED|Overall Study||0
208279|NCT00755274|501103|P1|NOT COMPLETED|Overall Study||0
208280|NCT00755274|501102|P2|COMPLETED|Overall Study||8
208281|NCT00755274|501103|P1|COMPLETED|Overall Study||24
208282|NCT00755274|501102|P2|STARTED|Overall Study||8
208283|NCT00755274|501103|P1|STARTED|Overall Study||24
208284|NCT00755261|501123|P1|NOT COMPLETED|Overall Study||2
208285|NCT00755261|501123|P1|COMPLETED|Overall Study||4
208286|NCT00755261|501123|P1|STARTED|Overall Study||6
208287|NCT00755235|501129|P2|NOT COMPLETED|Overall Study||9
208288|NCT00755235|501130|P1|NOT COMPLETED|Overall Study||2
208289|NCT00755235|501129|P2|COMPLETED|Overall Study||93
208290|NCT00755235|501130|P1|COMPLETED|Overall Study||104
208291|NCT00755235|501129|P2|STARTED|Overall Study||102
208292|NCT00755235|501130|P1|STARTED|Overall Study||106
208293|NCT00755222|501140|P2|NOT COMPLETED|Overall Study||2
208294|NCT00755222|501141|P1|NOT COMPLETED|Overall Study||8
208295|NCT00755222|501140|P2|COMPLETED|Overall Study||34
208296|NCT00755222|501141|P1|COMPLETED|Overall Study||103
208297|NCT00755222|501140|P2|STARTED|Overall Study||36
208298|NCT00755222|501141|P1|STARTED|Overall Study||111
208299|NCT00755196|501155|P1|NOT COMPLETED|Overall Study||2
208300|NCT00755196|501155|P1|COMPLETED|Overall Study||28
208301|NCT00755196|501155|P1|STARTED|Overall Study||30
208302|NCT00755131|501162|P2|NOT COMPLETED|Overall Study||0
208303|NCT00755131|501163|P1|NOT COMPLETED|Overall Study||0
208304|NCT00755131|501162|P2|COMPLETED|Overall Study||38
208305|NCT00755131|501163|P1|COMPLETED|Overall Study||37
208306|NCT00755131|501162|P2|STARTED|Overall Study||38
208307|NCT00755131|501163|P1|STARTED|Overall Study||37
208308|NCT00755105|501176|P3|NOT COMPLETED|Overall Study||4
208309|NCT00755105|501177|P2|NOT COMPLETED|Overall Study||11
208310|NCT00755105|501178|P1|NOT COMPLETED|Overall Study||9
208311|NCT00755105|501176|P3|COMPLETED|Overall Study||5
208312|NCT00755105|501177|P2|COMPLETED|Overall Study||19
208313|NCT00755105|501178|P1|COMPLETED|Overall Study||29
208314|NCT00755105|501176|P3|STARTED|Overall Study||9
208315|NCT00755105|501177|P2|STARTED|Overall Study||30
208316|NCT00755105|501178|P1|STARTED|Overall Study||38
208317|NCT00755079|501188|P2|NOT COMPLETED|Overall Study||6
208318|NCT00755079|501189|P1|NOT COMPLETED|Overall Study||1
208319|NCT00755079|501188|P2|COMPLETED|Overall Study||16
208320|NCT00755079|501189|P1|COMPLETED|Overall Study||17
208321|NCT00755079|501188|P2|STARTED|Overall Study||22
208322|NCT00755079|501189|P1|STARTED|Overall Study||18
208323|NCT00755040|501199|P2|NOT COMPLETED|Overall Study||34
208324|NCT00755040|501200|P1|NOT COMPLETED|Overall Study||43
208325|NCT00755040|501199|P2|COMPLETED|Overall Study||47
208326|NCT00755040|501200|P1|COMPLETED|Overall Study||40
208327|NCT00755040|501199|P2|STARTED|Overall Study||81
208328|NCT00755040|501200|P1|STARTED|Overall Study||83
208329|NCT00754923|501208|P1|NOT COMPLETED|Overall Study||0
208330|NCT00754923|501208|P1|COMPLETED|Overall Study||11
208331|NCT00754923|501208|P1|STARTED|Overall Study||11
208332|NCT00754832|501213|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
208333|NCT00754832|501214|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
208334|NCT00754832|501213|P2|COMPLETED|Second 6 Weeks Intervention||24
208335|NCT00754832|501214|P1|COMPLETED|Second 6 Weeks Intervention||17
208336|NCT00754832|501213|P2|STARTED|Second 6 Weeks Intervention||26
208337|NCT00754832|501214|P1|STARTED|Second 6 Weeks Intervention||17
208338|NCT00754832|501213|P2|NOT COMPLETED|2 Weeks Washout||2
208339|NCT00754832|501214|P1|NOT COMPLETED|2 Weeks Washout||1
208340|NCT00754832|501213|P2|COMPLETED|2 Weeks Washout||26
208341|NCT00754832|501214|P1|COMPLETED|2 Weeks Washout||17
208342|NCT00754832|501213|P2|STARTED|2 Weeks Washout||28
208343|NCT00754832|501214|P1|STARTED|2 Weeks Washout||18
208344|NCT00754832|501213|P2|NOT COMPLETED|First 6 Weeks Intervention||2
208345|NCT00754832|501214|P1|NOT COMPLETED|First 6 Weeks Intervention||8
208346|NCT00754832|501213|P2|COMPLETED|First 6 Weeks Intervention||28
208347|NCT00754832|501214|P1|COMPLETED|First 6 Weeks Intervention||18
208348|NCT00754832|501213|P2|STARTED|First 6 Weeks Intervention||30
208349|NCT00754832|501214|P1|STARTED|First 6 Weeks Intervention||26
208350|NCT00754793|501226|P2|NOT COMPLETED|Overall Study||1
208351|NCT00754793|501227|P1|NOT COMPLETED|Overall Study||0
208352|NCT00754793|501226|P2|COMPLETED|Overall Study||1
208353|NCT00754793|501227|P1|COMPLETED|Overall Study||1
208354|NCT00754793|501226|P2|STARTED|Overall Study||2
208355|NCT00754793|501227|P1|STARTED|Overall Study||1
208356|NCT00754767|501235|P2|NOT COMPLETED|Overall Study||0
208357|NCT00754767|501236|P1|NOT COMPLETED|Overall Study||0
208358|NCT00754767|501235|P2|COMPLETED|Overall Study||0
208359|NCT00754767|501236|P1|COMPLETED|Overall Study||2
208360|NCT00754767|501235|P2|STARTED|Overall Study||0
208361|NCT00754767|501236|P1|STARTED|Overall Study||2
208362|NCT00754741|501245|P3|NOT COMPLETED|Overall Study||54
208363|NCT00754741|501246|P2|NOT COMPLETED|Overall Study||69
208364|NCT00754741|501247|P1|NOT COMPLETED|Overall Study||57
208365|NCT00754741|501245|P3|COMPLETED|Overall Study||502
208366|NCT00754741|501246|P2|COMPLETED|Overall Study||500
208367|NCT00754741|501247|P1|COMPLETED|Overall Study||510
208368|NCT00754741|501245|P3|STARTED|Overall Study||556
208369|NCT00754741|501246|P2|STARTED|Overall Study||569
208370|NCT00754741|501247|P1|STARTED|Overall Study||567
208371|NCT00754650|501294|P1|NOT COMPLETED|Overall Study||2
208372|NCT00754650|501294|P1|COMPLETED|Overall Study||0
208373|NCT00754650|501294|P1|STARTED|Overall Study||2
208374|NCT00754624|501299|P1|NOT COMPLETED|Overall Study||69
208375|NCT00754624|501299|P1|COMPLETED|Overall Study||160
208376|NCT00754624|501299|P1|STARTED|Overall Study||229
208377|NCT00754572|501309|P1|NOT COMPLETED|Overall Study||71
208378|NCT00754572|501309|P1|COMPLETED|Overall Study||347
208379|NCT00754572|501309|P1|STARTED|Overall Study||418
208380|NCT00754559|501336|P1|NOT COMPLETED|Overall Study||47
208381|NCT00754559|501336|P1|COMPLETED|Overall Study||239
208382|NCT00754559|501336|P1|STARTED|Overall Study||286
208383|NCT00754546|501360|P1|NOT COMPLETED|Overall Study||0
208384|NCT00754546|501360|P1|COMPLETED|Overall Study||20
208385|NCT00754546|501360|P1|STARTED|Overall Study||20
208386|NCT00754494|501377|P3|NOT COMPLETED|Overall Study||1
208387|NCT00754494|501378|P2|NOT COMPLETED|Overall Study||0
208388|NCT00754494|501379|P1|NOT COMPLETED|Overall Study||2
208389|NCT00754494|501377|P3|COMPLETED|Overall Study||14
208390|NCT00754494|501378|P2|COMPLETED|Overall Study||15
208391|NCT00754494|501379|P1|COMPLETED|Overall Study||13
208392|NCT00754494|501377|P3|STARTED|Overall Study||15
208393|NCT00754494|501378|P2|STARTED|Overall Study||15
208394|NCT00754494|501379|P1|STARTED|Overall Study||15
208395|NCT00754468|501425|P2|NOT COMPLETED|Overall Study||0
208396|NCT00754468|501426|P1|NOT COMPLETED|Overall Study||0
208397|NCT00754468|501425|P2|COMPLETED|Overall Study||3
208398|NCT00754468|501426|P1|COMPLETED|Overall Study||4
208399|NCT00754468|501425|P2|STARTED|Overall Study||3
208400|NCT00754468|501426|P1|STARTED|Overall Study||4
208401|NCT00754442|501436|P2|NOT COMPLETED|Overall Study||3
208402|NCT00754442|501437|P1|NOT COMPLETED|Overall Study||5
208403|NCT00754442|501436|P2|COMPLETED|Overall Study||6
208404|NCT00754442|501437|P1|COMPLETED|Overall Study||6
208405|NCT00754442|501436|P2|STARTED|Overall Study|patients 9|9
208406|NCT00754442|501437|P1|STARTED|Overall Study|controls 11|11
208407|NCT00754390|501444|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
208408|NCT00754390|501444|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
208409|NCT00754390|501444|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
208410|NCT00754390|501444|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
208411|NCT00754390|501444|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
208412|NCT00754390|501444|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
208413|NCT00754390|501444|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
208414|NCT00754390|501444|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
208415|NCT00754390|501444|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
208416|NCT00754390|501444|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
208417|NCT00754390|501444|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
208418|NCT00754390|501444|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
208419|NCT00754377|501453|P2|NOT COMPLETED|Overall Study||0
208420|NCT00754377|501454|P1|NOT COMPLETED|Overall Study||0
208421|NCT00754377|501453|P2|COMPLETED|Overall Study||42
208422|NCT00754377|501454|P1|COMPLETED|Overall Study||50
208423|NCT00754377|501453|P2|STARTED|Overall Study||42
208424|NCT00754377|501454|P1|STARTED|Overall Study||50
208425|NCT00754338|501466|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
208426|NCT00754338|501467|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
208427|NCT00754338|501468|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
208428|NCT00754338|501469|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
208429|NCT00754338|501466|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
208430|NCT00754338|501467|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
208431|NCT00754338|501468|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
208432|NCT00754338|501469|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
208433|NCT00754338|501466|P4|STARTED|Second Intervention for Phase1&Phase2||19
208434|NCT00754338|501467|P3|STARTED|Second Intervention for Phase1&Phase2||16
208435|NCT00754338|501468|P2|STARTED|Second Intervention for Phase1&Phase2||18
208436|NCT00754338|501469|P1|STARTED|Second Intervention for Phase1&Phase2||17
208437|NCT00754338|501466|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
208438|NCT00754338|501467|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
208439|NCT00754338|501468|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
208440|NCT00754338|501469|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
208441|NCT00754338|501466|P4|COMPLETED|First Intervention for Phase1&Phase2||19
208442|NCT00754338|501467|P3|COMPLETED|First Intervention for Phase1&Phase2||16
208443|NCT00754338|501468|P2|COMPLETED|First Intervention for Phase1&Phase2||18
208444|NCT00754338|501469|P1|COMPLETED|First Intervention for Phase1&Phase2||17
208445|NCT00754338|501466|P4|STARTED|First Intervention for Phase1&Phase2||19
208446|NCT00754338|501467|P3|STARTED|First Intervention for Phase1&Phase2||19
208447|NCT00754338|501468|P2|STARTED|First Intervention for Phase1&Phase2||21
208448|NCT00754338|501469|P1|STARTED|First Intervention for Phase1&Phase2||17
208449|NCT00754325|501501|P2|NOT COMPLETED|Progression and Cross-over||21
208450|NCT00754325|501502|P1|NOT COMPLETED|Progression and Cross-over||0
208451|NCT00754325|501501|P2|COMPLETED|Progression and Cross-over||0
208452|NCT00754325|501502|P1|COMPLETED|Progression and Cross-over||0
208453|NCT00754325|501501|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
208454|NCT00754325|501502|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
208455|NCT00754325|501501|P2|NOT COMPLETED|Initial Treatment||49
208456|NCT00754325|501502|P1|NOT COMPLETED|Initial Treatment||50
208457|NCT00754325|501501|P2|COMPLETED|Initial Treatment||0
208458|NCT00754325|501502|P1|COMPLETED|Initial Treatment||0
208459|NCT00754325|501501|P2|STARTED|Initial Treatment||49
208460|NCT00754325|501502|P1|STARTED|Initial Treatment||50
208461|NCT00754234|501521|P1|NOT COMPLETED|Overall Study||3
208462|NCT00754234|501521|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
208463|NCT00754234|501521|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
208464|NCT00754208|501525|P1|NOT COMPLETED|Overall Study||0
208465|NCT00754208|501525|P1|COMPLETED|Overall Study||7
208466|NCT00754208|501525|P1|STARTED|Overall Study||7
208467|NCT00754156|501534|P2|NOT COMPLETED|Overall Study||0
208468|NCT00754156|501535|P1|NOT COMPLETED|Overall Study||0
208469|NCT00754156|501534|P2|COMPLETED|Overall Study||6
208470|NCT00754156|501535|P1|COMPLETED|Overall Study||8
208471|NCT00754156|501534|P2|STARTED|Overall Study||6
208472|NCT00754156|501535|P1|STARTED|Overall Study||8
208473|NCT00754130|501559|P6|NOT COMPLETED|Period 2 (5 Days)||0
208474|NCT00754130|501560|P5|NOT COMPLETED|Period 2 (5 Days)||0
208475|NCT00754130|501561|P4|NOT COMPLETED|Period 2 (5 Days)||0
208476|NCT00754130|501562|P3|NOT COMPLETED|Period 2 (5 Days)||0
208477|NCT00754130|501563|P2|NOT COMPLETED|Period 2 (5 Days)||0
208478|NCT00754130|501564|P1|NOT COMPLETED|Period 2 (5 Days)||0
208479|NCT00754130|501559|P6|COMPLETED|Period 2 (5 Days)||4
208480|NCT00754130|501560|P5|COMPLETED|Period 2 (5 Days)||2
208481|NCT00754130|501561|P4|COMPLETED|Period 2 (5 Days)||2
208482|NCT00754130|501562|P3|COMPLETED|Period 2 (5 Days)||4
208483|NCT00754130|501563|P2|COMPLETED|Period 2 (5 Days)||2
208484|NCT00754130|501564|P1|COMPLETED|Period 2 (5 Days)||2
208485|NCT00754130|501559|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
208486|NCT00754130|501560|P5|STARTED|Period 2 (5 Days)||2
208487|NCT00754130|501561|P4|STARTED|Period 2 (5 Days)||2
208488|NCT00754130|501562|P3|STARTED|Period 2 (5 Days)||4
208489|NCT00754130|501563|P2|STARTED|Period 2 (5 Days)||2
208490|NCT00754130|501564|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
208491|NCT00754130|501559|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
208492|NCT00754130|501560|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
208493|NCT00754130|501561|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
208494|NCT00754130|501562|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
208495|NCT00754130|501563|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
208496|NCT00754130|501564|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
208497|NCT00754130|501559|P6|COMPLETED|Washout Period (>=8 Days)||4
208498|NCT00754130|501560|P5|COMPLETED|Washout Period (>=8 Days)||2
208499|NCT00754130|501561|P4|COMPLETED|Washout Period (>=8 Days)||2
208500|NCT00754130|501562|P3|COMPLETED|Washout Period (>=8 Days)||4
208501|NCT00754130|501563|P2|COMPLETED|Washout Period (>=8 Days)||2
208502|NCT00754130|501564|P1|COMPLETED|Washout Period (>=8 Days)||2
208503|NCT00754130|501559|P6|STARTED|Washout Period (>=8 Days)||4
208504|NCT00754130|501560|P5|STARTED|Washout Period (>=8 Days)||2
208505|NCT00754130|501561|P4|STARTED|Washout Period (>=8 Days)||2
208506|NCT00754130|501562|P3|STARTED|Washout Period (>=8 Days)||4
208507|NCT00754130|501563|P2|STARTED|Washout Period (>=8 Days)||2
208508|NCT00754130|501564|P1|STARTED|Washout Period (>=8 Days)||2
208509|NCT00754130|501559|P6|NOT COMPLETED|Period 1 (5 Days)||0
208510|NCT00754130|501560|P5|NOT COMPLETED|Period 1 (5 Days)||0
208511|NCT00754130|501561|P4|NOT COMPLETED|Period 1 (5 Days)||0
208512|NCT00754130|501562|P3|NOT COMPLETED|Period 1 (5 Days)||0
208513|NCT00754130|501563|P2|NOT COMPLETED|Period 1 (5 Days)||0
208514|NCT00754130|501564|P1|NOT COMPLETED|Period 1 (5 Days)||0
208515|NCT00754130|501559|P6|COMPLETED|Period 1 (5 Days)||4
208516|NCT00754130|501560|P5|COMPLETED|Period 1 (5 Days)||2
208517|NCT00754130|501561|P4|COMPLETED|Period 1 (5 Days)||2
208518|NCT00754130|501562|P3|COMPLETED|Period 1 (5 Days)||4
208519|NCT00754130|501563|P2|COMPLETED|Period 1 (5 Days)||2
208520|NCT00754130|501564|P1|COMPLETED|Period 1 (5 Days)||2
208521|NCT00754130|501559|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
208522|NCT00754130|501560|P5|STARTED|Period 1 (5 Days)||2
208523|NCT00754130|501561|P4|STARTED|Period 1 (5 Days)||2
208524|NCT00754130|501562|P3|STARTED|Period 1 (5 Days)||4
208525|NCT00754130|501563|P2|STARTED|Period 1 (5 Days)||2
208526|NCT00754130|501564|P1|STARTED|Period 1 (5 Days)||2
208527|NCT00754065|501607|P2|NOT COMPLETED|Overall Study||80
208528|NCT00754065|501608|P1|NOT COMPLETED|Overall Study||81
208529|NCT00754065|501607|P2|COMPLETED|Overall Study||126
208530|NCT00754065|501608|P1|COMPLETED|Overall Study||122
208531|NCT00754065|501607|P2|Cycle 6|Overall Study||153
208532|NCT00754065|501608|P1|Cycle 6|Overall Study||141
208533|NCT00754065|501607|P2|Participants Received Treatment|Overall Study||204
208534|NCT00754065|501608|P1|Participants Received Treatment|Overall Study||191
208535|NCT00754065|501607|P2|STARTED|Overall Study||206
208536|NCT00754065|501608|P1|STARTED|Overall Study||203
208537|NCT00754052|501848|P2|NOT COMPLETED|Overall Study||3
208538|NCT00754052|501849|P1|NOT COMPLETED|Overall Study||5
208539|NCT00754052|501848|P2|COMPLETED|Overall Study||0
208540|NCT00754052|501849|P1|COMPLETED|Overall Study||0
208541|NCT00754052|501848|P2|STARTED|Overall Study||3
208542|NCT00754052|501849|P1|STARTED|Overall Study||5
208543|NCT00754013|501863|P2|NOT COMPLETED|Overall Study||5
208544|NCT00754013|501864|P1|NOT COMPLETED|Overall Study||4
208545|NCT00754013|501863|P2|COMPLETED|Overall Study||0
208546|NCT00754013|501864|P1|COMPLETED|Overall Study||0
208547|NCT00754013|501863|P2|STARTED|Overall Study||5
208548|NCT00754013|501864|P1|STARTED|Overall Study||4
208549|NCT00753948|501875|P3|NOT COMPLETED|Overall Study||0
208550|NCT00753948|501876|P2|NOT COMPLETED|Overall Study||0
208551|NCT00753948|501877|P1|NOT COMPLETED|Overall Study||0
208552|NCT00753948|501875|P3|COMPLETED|Overall Study||7
208553|NCT00753948|501876|P2|COMPLETED|Overall Study||7
208554|NCT00753948|501877|P1|COMPLETED|Overall Study||9
208555|NCT00753948|501875|P3|STARTED|Overall Study||7
208556|NCT00753948|501876|P2|STARTED|Overall Study||7
208557|NCT00753948|501877|P1|STARTED|Overall Study||9
208558|NCT00753935|501887|P2|NOT COMPLETED|Overall Study||0
208559|NCT00753935|501888|P1|NOT COMPLETED|Overall Study||0
208560|NCT00753935|501887|P2|COMPLETED|Overall Study||47
208561|NCT00753935|501888|P1|COMPLETED|Overall Study||45
208562|NCT00753935|501887|P2|STARTED|Overall Study||47
208563|NCT00753935|501888|P1|STARTED|Overall Study||45
208564|NCT00753922|501898|P4|NOT COMPLETED|Overall Study||23
208565|NCT00753922|501899|P3|NOT COMPLETED|Overall Study||63
208566|NCT00753922|501900|P2|NOT COMPLETED|Overall Study||94
208567|NCT00753922|501901|P1|NOT COMPLETED|Overall Study||246
208568|NCT00753922|501898|P4|COMPLETED|Overall Study||37
208569|NCT00753922|501899|P3|COMPLETED|Overall Study||82
208570|NCT00753922|501900|P2|COMPLETED|Overall Study||157
208571|NCT00753922|501901|P1|COMPLETED|Overall Study||306
208572|NCT00753922|501898|P4|STARTED|Overall Study||60
208573|NCT00753922|501899|P3|STARTED|Overall Study||145
208574|NCT00753922|501900|P2|STARTED|Overall Study||251
208575|NCT00753922|501901|P1|STARTED|Overall Study||552
208576|NCT00753896|501931|P1|NOT COMPLETED|Overall Study||16
208577|NCT00753896|501931|P1|COMPLETED|Overall Study||118
208578|NCT00753896|501931|P1|STARTED|Overall Study||134
208579|NCT00753766|501947|P2|NOT COMPLETED|Overall Study||0
208580|NCT00753766|501948|P1|NOT COMPLETED|Overall Study||1
208581|NCT00753766|501947|P2|COMPLETED|Overall Study||0
208582|NCT00753766|501948|P1|COMPLETED|Overall Study||0
208583|NCT00753766|501947|P2|STARTED|Overall Study||0
208584|NCT00753766|501948|P1|STARTED|Overall Study||1
208585|NCT00753714|501958|P2|NOT COMPLETED|Overall Study||62
208586|NCT00753714|501959|P1|NOT COMPLETED|Overall Study||60
208587|NCT00753714|501958|P2|COMPLETED|Overall Study||1
208588|NCT00753714|501959|P1|COMPLETED|Overall Study||1
208589|NCT00753714|501958|P2|STARTED|Overall Study||63
208590|NCT00753714|501959|P1|STARTED|Overall Study||61
208591|NCT00753688|501975|P2|NOT COMPLETED|Overall Study||246
208592|NCT00753688|501976|P1|NOT COMPLETED|Overall Study||123
208593|NCT00753688|501975|P2|COMPLETED|Overall Study||0
208594|NCT00753688|501976|P1|COMPLETED|Overall Study||0
208595|NCT00753688|501975|P2|Ongoing - in Follow-up|Overall Study||31
208596|NCT00753688|501976|P1|Ongoing - in Follow-up|Overall Study||15
208597|NCT00753688|501975|P2|STARTED|Overall Study||246
208598|NCT00753688|501976|P1|STARTED|Overall Study||123
208599|NCT00753675|502005|P3|NOT COMPLETED|Overall Study||56
208600|NCT00753675|502006|P2|NOT COMPLETED|Overall Study||59
208601|NCT00753675|502007|P1|NOT COMPLETED|Overall Study||59
208602|NCT00753675|502005|P3|COMPLETED|Overall Study||0
208603|NCT00753675|502006|P2|COMPLETED|Overall Study||0
208604|NCT00753675|502007|P1|COMPLETED|Overall Study||0
208605|NCT00753675|502005|P3|STARTED|Overall Study||56
208606|NCT00753675|502006|P2|STARTED|Overall Study||59
208607|NCT00753675|502007|P1|STARTED|Overall Study||59
208608|NCT00753649|502029|P2|NOT COMPLETED|Overall Study||0
208609|NCT00753649|502030|P1|NOT COMPLETED|Overall Study||7
208610|NCT00753649|502029|P2|COMPLETED|Overall Study||112
208611|NCT00753649|502030|P1|COMPLETED|Overall Study||105
208612|NCT00753649|502029|P2|STARTED|Overall Study||112
208613|NCT00753649|502030|P1|STARTED|Overall Study||112
208614|NCT00753636|502050|P1|NOT COMPLETED|Overall Study||6
208615|NCT00753636|502050|P1|COMPLETED|Overall Study||25
208616|NCT00753636|502050|P1|STARTED|Overall Study||31
208617|NCT00753623|502062|P2|NOT COMPLETED|Phase II (14 Days)||1
208618|NCT00753623|502063|P1|NOT COMPLETED|Phase II (14 Days)||0
208619|NCT00753623|502062|P2|COMPLETED|Phase II (14 Days)||7
208620|NCT00753623|502063|P1|COMPLETED|Phase II (14 Days)||8
208621|NCT00753623|502062|P2|STARTED|Phase II (14 Days)||8
208622|NCT00753623|502063|P1|STARTED|Phase II (14 Days)||8
208623|NCT00753623|502062|P2|NOT COMPLETED|Washout (7 Days)||0
208624|NCT00753623|502063|P1|NOT COMPLETED|Washout (7 Days)||1
208625|NCT00753623|502062|P2|COMPLETED|Washout (7 Days)||8
208626|NCT00753623|502063|P1|COMPLETED|Washout (7 Days)||8
208627|NCT00753623|502062|P2|STARTED|Washout (7 Days)||8
208628|NCT00753623|502063|P1|STARTED|Washout (7 Days)||9
208629|NCT00753623|502062|P2|NOT COMPLETED|Phase I (14 Days)||4
208630|NCT00753623|502063|P1|NOT COMPLETED|Phase I (14 Days)||2
208631|NCT00753623|502062|P2|COMPLETED|Phase I (14 Days)||8
208632|NCT00753623|502063|P1|COMPLETED|Phase I (14 Days)||9
208633|NCT00753623|502062|P2|STARTED|Phase I (14 Days)||12
208634|NCT00753623|502063|P1|STARTED|Phase I (14 Days)||11
208635|NCT00753545|502071|P2|NOT COMPLETED|Overall Study||118
208636|NCT00753545|502072|P1|NOT COMPLETED|Overall Study||108
208637|NCT00753545|502071|P2|COMPLETED|Overall Study|Patients completing the Study|11
208638|NCT00753545|502072|P1|COMPLETED|Overall Study|Patients completing the Study|28
208639|NCT00753545|502071|P2|STARTED|Overall Study|Patients randomized|129
208640|NCT00753545|502072|P1|STARTED|Overall Study|Patients randomized|136
208641|NCT00753519|502110|P2|NOT COMPLETED|Overall Study||2
208642|NCT00753519|502111|P1|NOT COMPLETED|Overall Study||0
208643|NCT00753519|502110|P2|COMPLETED|Overall Study||13
208644|NCT00753519|502111|P1|COMPLETED|Overall Study||13
208645|NCT00753519|502110|P2|STARTED|Overall Study||15
208646|NCT00753519|502111|P1|STARTED|Overall Study||13
208647|NCT00753506|502133|P2|NOT COMPLETED|Overall Study||2
208648|NCT00753506|502134|P1|NOT COMPLETED|Overall Study||7
208649|NCT00753506|502133|P2|COMPLETED|Overall Study||31
208650|NCT00753506|502134|P1|COMPLETED|Overall Study||26
208651|NCT00753506|502133|P2|STARTED|Overall Study||33
208652|NCT00753506|502134|P1|STARTED|Overall Study||33
208653|NCT00753454|502140|P1|NOT COMPLETED|Overall Study||14
208654|NCT00753454|502140|P1|COMPLETED|Overall Study||154
208655|NCT00753454|502140|P1|STARTED|Overall Study||168
208656|NCT00753415|502174|P10|NOT COMPLETED|Part B||1
208657|NCT00753415|502175|P9|NOT COMPLETED|Part B||3
208658|NCT00753415|502176|P8|NOT COMPLETED|Part B||1
208659|NCT00753415|502177|P7|NOT COMPLETED|Part B||0
208660|NCT00753415|502178|P6|NOT COMPLETED|Part B||0
208661|NCT00753415|502179|P5|NOT COMPLETED|Part B||0
208662|NCT00753415|502180|P4|NOT COMPLETED|Part B||0
208663|NCT00753415|502181|P3|NOT COMPLETED|Part B||0
208664|NCT00753415|502182|P2|NOT COMPLETED|Part B||0
208665|NCT00753415|502183|P1|NOT COMPLETED|Part B||0
208666|NCT00753415|502174|P10|COMPLETED|Part B||8
208667|NCT00753415|502175|P9|COMPLETED|Part B||6
208668|NCT00753415|502176|P8|COMPLETED|Part B||6
208669|NCT00753415|502177|P7|COMPLETED|Part B||2
208670|NCT00753415|502178|P6|COMPLETED|Part B||1
208671|NCT00753415|502179|P5|COMPLETED|Part B||0
208672|NCT00753415|502180|P4|COMPLETED|Part B||0
208673|NCT00753415|502181|P3|COMPLETED|Part B||0
208674|NCT00753415|502182|P2|COMPLETED|Part B||0
208675|NCT00753415|502183|P1|COMPLETED|Part B||0
208676|NCT00753415|502174|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
208677|NCT00753415|502175|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
208678|NCT00753415|502176|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
208679|NCT00753415|502177|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
208680|NCT00753415|502178|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
208681|NCT00753415|502179|P5|STARTED|Part B||0
208682|NCT00753415|502180|P4|STARTED|Part B||0
208683|NCT00753415|502181|P3|STARTED|Part B||0
208684|NCT00753415|502182|P2|STARTED|Part B||0
208685|NCT00753415|502183|P1|STARTED|Part B||0
208686|NCT00753415|502174|P10|NOT COMPLETED|Part A||0
208687|NCT00753415|502175|P9|NOT COMPLETED|Part A||0
208688|NCT00753415|502176|P8|NOT COMPLETED|Part A||0
208689|NCT00753415|502177|P7|NOT COMPLETED|Part A||0
208690|NCT00753415|502178|P6|NOT COMPLETED|Part A||0
208691|NCT00753415|502179|P5|NOT COMPLETED|Part A||0
208692|NCT00753415|502180|P4|NOT COMPLETED|Part A||2
208693|NCT00753415|502181|P3|NOT COMPLETED|Part A||2
208694|NCT00753415|502182|P2|NOT COMPLETED|Part A||0
208695|NCT00753415|502183|P1|NOT COMPLETED|Part A||1
208696|NCT00753415|502174|P10|COMPLETED|Part A||0
208697|NCT00753415|502175|P9|COMPLETED|Part A||0
208698|NCT00753415|502176|P8|COMPLETED|Part A||0
208699|NCT00753415|502177|P7|COMPLETED|Part A||0
208700|NCT00753415|502178|P6|COMPLETED|Part A||0
208701|NCT00753415|502179|P5|COMPLETED|Part A||10
208702|NCT00753415|502180|P4|COMPLETED|Part A||9
208703|NCT00753415|502181|P3|COMPLETED|Part A||8
208704|NCT00753415|502182|P2|COMPLETED|Part A||3
208705|NCT00753415|502183|P1|COMPLETED|Part A||2
208706|NCT00753415|502174|P10|STARTED|Part A||0
208707|NCT00753415|502175|P9|STARTED|Part A||0
208708|NCT00753415|502176|P8|STARTED|Part A||0
208709|NCT00753415|502177|P7|STARTED|Part A||0
208710|NCT00753415|502178|P6|STARTED|Part A||0
208711|NCT00753415|502179|P5|STARTED|Part A||10
208712|NCT00753415|502180|P4|STARTED|Part A||11
208713|NCT00753415|502181|P3|STARTED|Part A||10
208714|NCT00753415|502182|P2|STARTED|Part A||3
208715|NCT00753415|502183|P1|STARTED|Part A||3
208716|NCT00753363|502227|P2|NOT COMPLETED|Overall Study||39
208717|NCT00753363|502228|P1|NOT COMPLETED|Overall Study||40
208718|NCT00753363|502227|P2|COMPLETED|Overall Study||21
208719|NCT00753363|502228|P1|COMPLETED|Overall Study||19
208720|NCT00753363|502227|P2|STARTED|Overall Study||60
208721|NCT00753363|502228|P1|STARTED|Overall Study||59
208722|NCT00753337|502238|P1|NOT COMPLETED|Overall Study||0
208723|NCT00753337|502238|P1|COMPLETED|Overall Study||123
208724|NCT00753337|502238|P1|STARTED|Overall Study||123
208725|NCT00753298|502254|P2|NOT COMPLETED|Overall Study||4
208726|NCT00753298|502255|P1|NOT COMPLETED|Overall Study||8
208727|NCT00753298|502254|P2|COMPLETED|Overall Study||94
208728|NCT00753298|502255|P1|COMPLETED|Overall Study||89
208729|NCT00753298|502254|P2|STARTED|Overall Study||98
208730|NCT00753298|502255|P1|STARTED|Overall Study||97
208731|NCT00753272|502273|P2|NOT COMPLETED|Overall Study||4907
208732|NCT00753272|502274|P1|NOT COMPLETED|Overall Study||4982
208733|NCT00753272|502273|P2|COMPLETED|Overall Study||16895
208734|NCT00753272|502274|P1|COMPLETED|Overall Study||16911
208735|NCT00753272|502273|P2|STARTED|Overall Study||21802
208736|NCT00753272|502274|P1|STARTED|Overall Study||21893
208737|NCT00753220|502340|P1|NOT COMPLETED|Overall Study||5
208738|NCT00753220|502340|P1|COMPLETED|Overall Study||2
208739|NCT00753220|502340|P1|STARTED|Overall Study||7
208740|NCT00753142|502347|P3|NOT COMPLETED|Overall Study||0
208741|NCT00753142|502348|P2|NOT COMPLETED|Overall Study||0
208742|NCT00753142|502349|P1|NOT COMPLETED|Overall Study||0
208743|NCT00753142|502347|P3|COMPLETED|Overall Study||13
208744|NCT00753142|502348|P2|COMPLETED|Overall Study||7
208745|NCT00753142|502349|P1|COMPLETED|Overall Study||8
208746|NCT00753142|502347|P3|STARTED|Overall Study||13
208747|NCT00753142|502348|P2|STARTED|Overall Study||7
208748|NCT00753142|502349|P1|STARTED|Overall Study||8
208749|NCT00753012|502359|P2|NOT COMPLETED|Overall Study||1
208750|NCT00753012|502360|P1|NOT COMPLETED|Overall Study||8
208751|NCT00753012|502359|P2|COMPLETED|Overall Study||8
208752|NCT00753012|502360|P1|COMPLETED|Overall Study||7
208753|NCT00753012|502359|P2|STARTED|Overall Study||9
208754|NCT00753012|502360|P1|STARTED|Overall Study||15
208755|NCT00752986|502373|P3|NOT COMPLETED|Overall Study||2
208756|NCT00752986|502374|P2|NOT COMPLETED|Overall Study||1
208757|NCT00752986|502375|P1|NOT COMPLETED|Overall Study||5
208758|NCT00752986|502373|P3|COMPLETED|Overall Study||9
208759|NCT00752986|502374|P2|COMPLETED|Overall Study||11
208760|NCT00752986|502375|P1|COMPLETED|Overall Study||11
208761|NCT00752986|502373|P3|STARTED|Overall Study||11
208762|NCT00752986|502374|P2|STARTED|Overall Study||12
208763|NCT00752986|502375|P1|STARTED|Overall Study||16
208764|NCT00752973|502392|P1|NOT COMPLETED|Overall Study||0
208765|NCT00752973|502392|P1|COMPLETED|Overall Study||12
208766|NCT00752973|502392|P1|STARTED|Overall Study||12
208767|NCT00752895|502404|P2|NOT COMPLETED|Overall Study||3
208768|NCT00752895|502405|P1|NOT COMPLETED|Overall Study||8
208769|NCT00752895|502404|P2|COMPLETED|Overall Study||143
208770|NCT00752895|502405|P1|COMPLETED|Overall Study||139
208771|NCT00752895|502404|P2|STARTED|Overall Study||146
208772|NCT00752895|502405|P1|STARTED|Overall Study||147
208773|NCT00752791|502413|P1|NOT COMPLETED|Overall Study||16
208774|NCT00752791|502413|P1|COMPLETED|Overall Study||43
208775|NCT00752791|502413|P1|STARTED|Overall Study||59
208776|NCT00752726|502425|P2|NOT COMPLETED|Overall Study||13
208777|NCT00752726|502426|P1|NOT COMPLETED|Overall Study||11
208778|NCT00752726|502425|P2|COMPLETED|Overall Study||53
208779|NCT00752726|502426|P1|COMPLETED|Overall Study||54
208780|NCT00752726|502425|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
208781|NCT00752726|502426|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
208782|NCT00752726|502425|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
208783|NCT00752726|502426|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
208784|NCT00752726|502425|P2|STARTED|Overall Study||66
208785|NCT00752726|502426|P1|STARTED|Overall Study||65
208786|NCT00752622|502451|P1|NOT COMPLETED|Interventional Phase||8
208787|NCT00752622|502451|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
208788|NCT00752622|502451|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
208789|NCT00752622|502451|P1|NOT COMPLETED|Observational Phase||43
208790|NCT00752622|502451|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
208791|NCT00752622|502451|P1|STARTED|Observational Phase||65
208792|NCT00752622|502451|P1|NOT COMPLETED|Induction Phase||35
208793|NCT00752622|502451|P1|COMPLETED|Induction Phase||65
208794|NCT00752622|502451|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
208795|NCT00752609|502464|P2|NOT COMPLETED|Overall Study||2
208796|NCT00752609|502465|P1|NOT COMPLETED|Overall Study||9
208797|NCT00752609|502464|P2|COMPLETED|Overall Study||47
208798|NCT00752609|502465|P1|COMPLETED|Overall Study||44
208799|NCT00752609|502464|P2|Full Analysis Set|Overall Study||49
208800|NCT00752609|502465|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
208801|NCT00752609|502464|P2|STARTED|Overall Study||49
208802|NCT00752609|502465|P1|STARTED|Overall Study||53
208803|NCT00752232|502491|P7|NOT COMPLETED|Overall Study||0
208804|NCT00752232|502492|P6|NOT COMPLETED|Overall Study||1
208805|NCT00752232|502493|P5|NOT COMPLETED|Overall Study||3
208806|NCT00752232|502494|P4|NOT COMPLETED|Overall Study||1
208807|NCT00752232|502495|P3|NOT COMPLETED|Overall Study||1
208808|NCT00752232|502496|P2|NOT COMPLETED|Overall Study||0
208809|NCT00752232|502497|P1|NOT COMPLETED|Overall Study||2
208810|NCT00752232|502491|P7|COMPLETED|Overall Study||4
208811|NCT00752232|502492|P6|COMPLETED|Overall Study||5
208812|NCT00752232|502493|P5|COMPLETED|Overall Study||3
208813|NCT00752232|502494|P4|COMPLETED|Overall Study||5
208814|NCT00752232|502495|P3|COMPLETED|Overall Study||5
208815|NCT00752232|502496|P2|COMPLETED|Overall Study||6
208816|NCT00752232|502497|P1|COMPLETED|Overall Study||4
208817|NCT00752232|502491|P7|STARTED|Overall Study||4
208818|NCT00752232|502492|P6|STARTED|Overall Study||6
208819|NCT00752232|502493|P5|STARTED|Overall Study||6
208820|NCT00752232|502494|P4|STARTED|Overall Study||6
208821|NCT00752232|502495|P3|STARTED|Overall Study||6
208822|NCT00752232|502496|P2|STARTED|Overall Study||6
208823|NCT00752232|502497|P1|STARTED|Overall Study||6
208824|NCT00752128|502569|P1|NOT COMPLETED|Overall Study||4
208825|NCT00752128|502569|P1|COMPLETED|Overall Study||2345
208826|NCT00752128|502569|P1|STARTED|Overall Study||2349
208827|NCT00752102|502576|P2|NOT COMPLETED|Overall Study||1
208828|NCT00752102|502577|P1|NOT COMPLETED|Overall Study||3
208829|NCT00752102|502576|P2|COMPLETED|Overall Study||21
208830|NCT00752102|502577|P1|COMPLETED|Overall Study||19
208831|NCT00752102|502576|P2|STARTED|Overall Study||22
208832|NCT00752102|502577|P1|STARTED|Overall Study||22
208833|NCT00752089|502583|P1|NOT COMPLETED|Overall Study||6
208834|NCT00752089|502583|P1|COMPLETED|Overall Study||14
208835|NCT00752089|502583|P1|Received Placebo|Overall Study||18
208836|NCT00752089|502583|P1|Received NaF|Overall Study||18
208837|NCT00752089|502583|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
208838|NCT00752089|502583|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
208839|NCT00752089|502583|P1|STARTED|Overall Study||20
208840|NCT00751998|502597|P1|NOT COMPLETED|Overall Study||20
208841|NCT00751998|502597|P1|COMPLETED|Overall Study||277
208842|NCT00751998|502597|P1|STARTED|Overall Study||297
208843|NCT00751972|502603|P2|NOT COMPLETED|Overall Study||0
208844|NCT00751972|502604|P1|NOT COMPLETED|Overall Study||0
208845|NCT00751972|502603|P2|COMPLETED|Overall Study||499
208846|NCT00751972|502604|P1|COMPLETED|Overall Study||140
208847|NCT00751972|502603|P2|STARTED|Overall Study||499
208848|NCT00751972|502604|P1|STARTED|Overall Study||140
208849|NCT00751933|502616|P4|NOT COMPLETED|Overall Study||1
208850|NCT00751933|502617|P3|NOT COMPLETED|Overall Study||1
208851|NCT00751933|502618|P2|NOT COMPLETED|Overall Study||1
208852|NCT00751933|502619|P1|NOT COMPLETED|Overall Study||0
208853|NCT00751933|502616|P4|COMPLETED|Overall Study||0
208854|NCT00751933|502617|P3|COMPLETED|Overall Study||0
208855|NCT00751933|502618|P2|COMPLETED|Overall Study||0
208856|NCT00751933|502619|P1|COMPLETED|Overall Study||0
208857|NCT00751933|502616|P4|STARTED|Overall Study||1
208858|NCT00751933|502617|P3|STARTED|Overall Study||1
208859|NCT00751933|502618|P2|STARTED|Overall Study||1
208860|NCT00751933|502619|P1|STARTED|Overall Study||0
208861|NCT00751881|502627|P3|NOT COMPLETED|Extension Study Period||66
208862|NCT00751881|502628|P2|NOT COMPLETED|Extension Study Period||71
208863|NCT00751881|502629|P1|NOT COMPLETED|Extension Study Period||65
208864|NCT00751881|502627|P3|COMPLETED|Extension Study Period||167
208865|NCT00751881|502628|P2|COMPLETED|Extension Study Period||194
208866|NCT00751881|502629|P1|COMPLETED|Extension Study Period||188
208867|NCT00751881|502627|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
208868|NCT00751881|502628|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
208869|NCT00751881|502629|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
208870|NCT00751881|502627|P3|NOT COMPLETED|Core Treatment Period||128
208871|NCT00751881|502628|P2|NOT COMPLETED|Core Treatment Period||135
208872|NCT00751881|502629|P1|NOT COMPLETED|Core Treatment Period||126
208873|NCT00751881|502627|P3|COMPLETED|Core Treatment Period||244
208874|NCT00751881|502628|P2|COMPLETED|Core Treatment Period||273
208875|NCT00751881|502629|P1|COMPLETED|Core Treatment Period||263
208876|NCT00751881|502627|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
208877|NCT00751881|502628|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
208878|NCT00751881|502629|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
208879|NCT00751881|502627|P3|STARTED|Core Treatment Period|Randomized|372
208880|NCT00751881|502628|P2|STARTED|Core Treatment Period|Randomized|408
208881|NCT00751881|502629|P1|STARTED|Core Treatment Period|Randomized|389
208882|NCT00751790|502676|P1|NOT COMPLETED|Overall Study||5
208883|NCT00751790|502676|P1|COMPLETED|Overall Study||115
208884|NCT00751790|502676|P1|STARTED|Overall Study||120
208885|NCT00751777|502682|P2|NOT COMPLETED|Overall Study||3
208886|NCT00751777|502683|P1|NOT COMPLETED|Overall Study||11
208887|NCT00751777|502682|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
208888|NCT00751777|502683|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
208889|NCT00751777|502682|P2|STARTED|Overall Study||39
208890|NCT00751777|502683|P1|STARTED|Overall Study||81
208891|NCT00751634|502693|P1|NOT COMPLETED|Overall Study||0
208892|NCT00751634|502693|P1|COMPLETED|Overall Study||20
208893|NCT00751634|502693|P1|STARTED|Overall Study||20
208894|NCT00751621|502701|P1|NOT COMPLETED|Overall Study||4
208895|NCT00751621|502701|P1|COMPLETED|Overall Study||36
208896|NCT00751621|502701|P1|STARTED|Overall Study||40
208897|NCT00751530|502720|P2|NOT COMPLETED|Overall Study||0
208898|NCT00751530|502721|P1|NOT COMPLETED|Overall Study||0
208899|NCT00751530|502720|P2|COMPLETED|Overall Study||110
208900|NCT00751530|502721|P1|COMPLETED|Overall Study||332
208901|NCT00751530|502720|P2|STARTED|Overall Study||110
208902|NCT00751530|502721|P1|STARTED|Overall Study||332
208903|NCT00751400|502735|P1|NOT COMPLETED|Overall Study||10
208904|NCT00751400|502735|P1|COMPLETED|Overall Study||487
208905|NCT00751400|502735|P1|Subjects Provided Detailed Use Data|Overall Study||467
208906|NCT00751400|502735|P1|Subjects Consumed Drug|Overall Study||485
208907|NCT00751400|502735|P1|Subjects Provided Drug|Overall Study||497
208908|NCT00751400|502735|P1|STARTED|Overall Study||497
208909|NCT00751348|502750|P2|NOT COMPLETED|Overall Study||2
208910|NCT00751348|502751|P1|NOT COMPLETED|Overall Study||6
208911|NCT00751348|502750|P2|COMPLETED|Overall Study||159
208912|NCT00751348|502751|P1|COMPLETED|Overall Study||307
208913|NCT00751348|502750|P2|STARTED|Overall Study||161
208914|NCT00751348|502751|P1|STARTED|Overall Study||313
208915|NCT00751296|502773|P1|NOT COMPLETED|Overall Study||2
208916|NCT00751296|502773|P1|COMPLETED|Overall Study||25
208917|NCT00751296|502773|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
208918|NCT00751179|502780|P2|NOT COMPLETED|Overall Study||15
208919|NCT00751179|502781|P1|NOT COMPLETED|Overall Study||14
208920|NCT00751179|502780|P2|COMPLETED|Overall Study||70
208921|NCT00751179|502781|P1|COMPLETED|Overall Study||62
208922|NCT00751179|502780|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
208923|NCT00751179|502781|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
208924|NCT00751140|502801|P1|NOT COMPLETED|Overall Study||1
208925|NCT00751140|502801|P1|COMPLETED|Overall Study||19
208926|NCT00751140|502801|P1|STARTED|Overall Study||20
208927|NCT00751114|502811|P2|NOT COMPLETED|Overall Study||32
208928|NCT00751114|502812|P1|NOT COMPLETED|Overall Study||38
208929|NCT00751114|502811|P2|COMPLETED|Overall Study||233
208930|NCT00751114|502812|P1|COMPLETED|Overall Study||212
208931|NCT00751114|502811|P2|mITT Population|Overall Study||253
208932|NCT00751114|502812|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
208933|NCT00751114|502811|P2|TREATED = Safety Population|Overall Study||264
208934|NCT00751114|502812|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
208935|NCT00751114|502811|P2|STARTED|Overall Study||265
208936|NCT00751114|502812|P1|STARTED|Overall Study|randomized|250
208937|NCT00751036|502837|P2|NOT COMPLETED|Overall Study||46
208938|NCT00751036|502838|P1|NOT COMPLETED|Overall Study||48
208939|NCT00751036|502837|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
208940|NCT00751036|502838|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
208941|NCT00751036|502837|P2|STARTED|Overall Study|Started = Treated|46
208942|NCT00751036|502838|P1|STARTED|Overall Study|Started = Treated|48
208943|NCT00750919|502850|P1|NOT COMPLETED|Overall Study||58
208944|NCT00750919|502850|P1|COMPLETED|Overall Study||126
208945|NCT00750919|502850|P1|STARTED|Overall Study||184
208946|NCT00750893|502858|P1|NOT COMPLETED|Overall Study||542
208947|NCT00750893|502858|P1|COMPLETED|Overall Study||2569
208948|NCT00750893|502858|P1|STARTED|Overall Study||3111
208949|NCT00750880|502873|P1|NOT COMPLETED|Overall Study||215
208950|NCT00750880|502873|P1|COMPLETED|Overall Study||1466
208951|NCT00750880|502873|P1|STARTED|Overall Study||1681
208952|NCT00750867|502896|P1|NOT COMPLETED|Overall Study||2
208953|NCT00750867|502896|P1|COMPLETED|Overall Study||7
208954|NCT00750867|502896|P1|STARTED|Overall Study||9
208955|NCT00750815|502903|P2|NOT COMPLETED|Overall Study||0
208956|NCT00750815|502904|P1|NOT COMPLETED|Overall Study||0
208957|NCT00750815|502903|P2|COMPLETED|Overall Study||46
208958|NCT00750815|502904|P1|COMPLETED|Overall Study||12
208959|NCT00750815|502903|P2|STARTED|Overall Study||46
208960|NCT00750815|502904|P1|STARTED|Overall Study||12
208961|NCT00750737|502917|P2|NOT COMPLETED|Overall Study||3
208962|NCT00750737|502918|P1|NOT COMPLETED|Overall Study||3
208963|NCT00750737|502917|P2|COMPLETED|Overall Study||19
208964|NCT00750737|502918|P1|COMPLETED|Overall Study||21
208965|NCT00750737|502917|P2|STARTED|Overall Study||22
208966|NCT00750737|502918|P1|STARTED|Overall Study||24
208967|NCT00750373|502928|P2|NOT COMPLETED|Overall Study||0
208968|NCT00750373|502929|P1|NOT COMPLETED|Overall Study||0
208969|NCT00750373|502928|P2|COMPLETED|Overall Study||37
208970|NCT00750373|502929|P1|COMPLETED|Overall Study||39
208971|NCT00750373|502928|P2|STARTED|Overall Study||37
208972|NCT00750373|502929|P1|STARTED|Overall Study||39
208973|NCT00750360|502941|P6|NOT COMPLETED|Overall Study||0
208974|NCT00750360|502942|P5|NOT COMPLETED|Overall Study||0
208975|NCT00750360|502943|P4|NOT COMPLETED|Overall Study||0
208976|NCT00750360|502944|P3|NOT COMPLETED|Overall Study||0
208977|NCT00750360|502945|P2|NOT COMPLETED|Overall Study||0
208978|NCT00750360|502946|P1|NOT COMPLETED|Overall Study||0
208979|NCT00750360|502941|P6|COMPLETED|Overall Study||71
208980|NCT00750360|502942|P5|COMPLETED|Overall Study||46
208981|NCT00750360|502943|P4|COMPLETED|Overall Study||79
208982|NCT00750360|502944|P3|COMPLETED|Overall Study||384
208983|NCT00750360|502945|P2|COMPLETED|Overall Study||1
208984|NCT00750360|502946|P1|COMPLETED|Overall Study||294
208985|NCT00750360|502941|P6|STARTED|Overall Study||71
208986|NCT00750360|502942|P5|STARTED|Overall Study||46
208987|NCT00750360|502943|P4|STARTED|Overall Study||79
208988|NCT00750360|502944|P3|STARTED|Overall Study||384
208989|NCT00750360|502945|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
208990|NCT00750360|502946|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
208991|NCT00750308|502978|P12|NOT COMPLETED|Fourth Treatment||0
208992|NCT00750308|502979|P11|NOT COMPLETED|Fourth Treatment||0
208993|NCT00750308|502980|P10|NOT COMPLETED|Fourth Treatment||0
208994|NCT00750308|502981|P9|NOT COMPLETED|Fourth Treatment||0
208995|NCT00750308|502982|P8|NOT COMPLETED|Fourth Treatment||0
208996|NCT00750308|502983|P7|NOT COMPLETED|Fourth Treatment||0
208997|NCT00750308|502984|P6|NOT COMPLETED|Fourth Treatment||0
208998|NCT00750308|502985|P5|NOT COMPLETED|Fourth Treatment||0
208999|NCT00750308|502986|P4|NOT COMPLETED|Fourth Treatment||0
209000|NCT00750308|502987|P3|NOT COMPLETED|Fourth Treatment||0
209001|NCT00750308|502988|P2|NOT COMPLETED|Fourth Treatment||0
209002|NCT00750308|502989|P1|NOT COMPLETED|Fourth Treatment||0
209003|NCT00750308|502978|P12|COMPLETED|Fourth Treatment||1
209004|NCT00750308|502979|P11|COMPLETED|Fourth Treatment||1
209005|NCT00750308|502980|P10|COMPLETED|Fourth Treatment||2
209006|NCT00750308|502981|P9|COMPLETED|Fourth Treatment||1
209007|NCT00750308|502982|P8|COMPLETED|Fourth Treatment||2
209008|NCT00750308|502983|P7|COMPLETED|Fourth Treatment||2
209009|NCT00750308|502984|P6|COMPLETED|Fourth Treatment||2
209010|NCT00750308|502985|P5|COMPLETED|Fourth Treatment||1
209011|NCT00750308|502986|P4|COMPLETED|Fourth Treatment||1
209012|NCT00750308|502987|P3|COMPLETED|Fourth Treatment||2
209013|NCT00750308|502988|P2|COMPLETED|Fourth Treatment||1
209014|NCT00750308|502989|P1|COMPLETED|Fourth Treatment||2
209015|NCT00750308|502978|P12|STARTED|Fourth Treatment||1
209016|NCT00750308|502979|P11|STARTED|Fourth Treatment||1
209017|NCT00750308|502980|P10|STARTED|Fourth Treatment||2
209018|NCT00750308|502981|P9|STARTED|Fourth Treatment||1
209019|NCT00750308|502982|P8|STARTED|Fourth Treatment||2
209020|NCT00750308|502983|P7|STARTED|Fourth Treatment||2
209021|NCT00750308|502984|P6|STARTED|Fourth Treatment||2
209022|NCT00750308|502985|P5|STARTED|Fourth Treatment||1
209023|NCT00750308|502986|P4|STARTED|Fourth Treatment||1
209024|NCT00750308|502987|P3|STARTED|Fourth Treatment||2
209025|NCT00750308|502988|P2|STARTED|Fourth Treatment||1
209026|NCT00750308|502989|P1|STARTED|Fourth Treatment||2
209027|NCT00750308|502978|P12|NOT COMPLETED|Washout||0
209028|NCT00750308|502979|P11|NOT COMPLETED|Washout||0
209029|NCT00750308|502980|P10|NOT COMPLETED|Washout||0
209030|NCT00750308|502981|P9|NOT COMPLETED|Washout||0
209031|NCT00750308|502982|P8|NOT COMPLETED|Washout||0
209032|NCT00750308|502983|P7|NOT COMPLETED|Washout||0
209033|NCT00750308|502984|P6|NOT COMPLETED|Washout||0
209034|NCT00750308|502985|P5|NOT COMPLETED|Washout||0
209035|NCT00750308|502986|P4|NOT COMPLETED|Washout||0
209036|NCT00750308|502987|P3|NOT COMPLETED|Washout||0
209037|NCT00750308|502988|P2|NOT COMPLETED|Washout||0
209038|NCT00750308|502989|P1|NOT COMPLETED|Washout||0
209039|NCT00750308|502978|P12|COMPLETED|Washout||1
209040|NCT00750308|502979|P11|COMPLETED|Washout||1
209041|NCT00750308|502980|P10|COMPLETED|Washout||2
209042|NCT00750308|502981|P9|COMPLETED|Washout||1
209043|NCT00750308|502982|P8|COMPLETED|Washout||2
209044|NCT00750308|502983|P7|COMPLETED|Washout||2
209045|NCT00750308|502984|P6|COMPLETED|Washout||2
209046|NCT00750308|502985|P5|COMPLETED|Washout||1
209047|NCT00750308|502986|P4|COMPLETED|Washout||1
209048|NCT00750308|502987|P3|COMPLETED|Washout||2
209049|NCT00750308|502988|P2|COMPLETED|Washout||1
209050|NCT00750308|502989|P1|COMPLETED|Washout||2
209051|NCT00750308|502978|P12|STARTED|Washout||1
209052|NCT00750308|502979|P11|STARTED|Washout||1
209053|NCT00750308|502980|P10|STARTED|Washout||2
209054|NCT00750308|502981|P9|STARTED|Washout||1
209055|NCT00750308|502982|P8|STARTED|Washout||2
209056|NCT00750308|502983|P7|STARTED|Washout||2
209057|NCT00750308|502984|P6|STARTED|Washout||2
209058|NCT00750308|502985|P5|STARTED|Washout||1
209059|NCT00750308|502986|P4|STARTED|Washout||1
209060|NCT00750308|502987|P3|STARTED|Washout||2
209061|NCT00750308|502988|P2|STARTED|Washout||1
209062|NCT00750308|502989|P1|STARTED|Washout||2
209063|NCT00750308|502978|P12|NOT COMPLETED|Third Treatment||0
209064|NCT00750308|502979|P11|NOT COMPLETED|Third Treatment||0
209065|NCT00750308|502980|P10|NOT COMPLETED|Third Treatment||0
209066|NCT00750308|502981|P9|NOT COMPLETED|Third Treatment||0
209067|NCT00750308|502982|P8|NOT COMPLETED|Third Treatment||0
209068|NCT00750308|502983|P7|NOT COMPLETED|Third Treatment||0
209069|NCT00750308|502984|P6|NOT COMPLETED|Third Treatment||0
209070|NCT00750308|502985|P5|NOT COMPLETED|Third Treatment||0
209071|NCT00750308|502986|P4|NOT COMPLETED|Third Treatment||0
209072|NCT00750308|502987|P3|NOT COMPLETED|Third Treatment||0
209073|NCT00750308|502988|P2|NOT COMPLETED|Third Treatment||1
209074|NCT00750308|502989|P1|NOT COMPLETED|Third Treatment||0
209075|NCT00750308|502978|P12|COMPLETED|Third Treatment||1
209076|NCT00750308|502979|P11|COMPLETED|Third Treatment||1
209077|NCT00750308|502980|P10|COMPLETED|Third Treatment||2
209078|NCT00750308|502981|P9|COMPLETED|Third Treatment||1
209079|NCT00750308|502982|P8|COMPLETED|Third Treatment||2
209080|NCT00750308|502983|P7|COMPLETED|Third Treatment||2
209081|NCT00750308|502984|P6|COMPLETED|Third Treatment||2
209082|NCT00750308|502985|P5|COMPLETED|Third Treatment||1
209083|NCT00750308|502986|P4|COMPLETED|Third Treatment||1
209084|NCT00750308|502987|P3|COMPLETED|Third Treatment||2
209085|NCT00750308|502988|P2|COMPLETED|Third Treatment||1
209086|NCT00750308|502989|P1|COMPLETED|Third Treatment||2
209087|NCT00750308|502978|P12|STARTED|Third Treatment||1
209088|NCT00750308|502979|P11|STARTED|Third Treatment||1
209089|NCT00750308|502980|P10|STARTED|Third Treatment||2
209090|NCT00750308|502981|P9|STARTED|Third Treatment||1
209091|NCT00750308|502982|P8|STARTED|Third Treatment||2
209092|NCT00750308|502983|P7|STARTED|Third Treatment||2
209093|NCT00750308|502984|P6|STARTED|Third Treatment||2
209094|NCT00750308|502985|P5|STARTED|Third Treatment||1
209095|NCT00750308|502986|P4|STARTED|Third Treatment||1
209096|NCT00750308|502987|P3|STARTED|Third Treatment||2
209097|NCT00750308|502988|P2|STARTED|Third Treatment||2
209098|NCT00750308|502989|P1|STARTED|Third Treatment||2
209099|NCT00750308|502978|P12|NOT COMPLETED|Washout||0
209100|NCT00750308|502979|P11|NOT COMPLETED|Washout||0
209101|NCT00750308|502980|P10|NOT COMPLETED|Washout||0
209102|NCT00750308|502981|P9|NOT COMPLETED|Washout||0
209103|NCT00750308|502982|P8|NOT COMPLETED|Washout||0
209104|NCT00750308|502983|P7|NOT COMPLETED|Washout||0
209105|NCT00750308|502984|P6|NOT COMPLETED|Washout||0
209106|NCT00750308|502985|P5|NOT COMPLETED|Washout||0
209107|NCT00750308|502986|P4|NOT COMPLETED|Washout||0
209108|NCT00750308|502987|P3|NOT COMPLETED|Washout||0
209109|NCT00750308|502988|P2|NOT COMPLETED|Washout||0
209110|NCT00750308|502989|P1|NOT COMPLETED|Washout||0
209111|NCT00750308|502978|P12|COMPLETED|Washout||1
209112|NCT00750308|502979|P11|COMPLETED|Washout||1
209113|NCT00750308|502980|P10|COMPLETED|Washout||2
209114|NCT00750308|502981|P9|COMPLETED|Washout||1
209115|NCT00750308|502982|P8|COMPLETED|Washout||2
209116|NCT00750308|502983|P7|COMPLETED|Washout||2
209117|NCT00750308|502984|P6|COMPLETED|Washout||2
209118|NCT00750308|502985|P5|COMPLETED|Washout||1
209119|NCT00750308|502986|P4|COMPLETED|Washout||1
209120|NCT00750308|502987|P3|COMPLETED|Washout||2
209121|NCT00750308|502988|P2|COMPLETED|Washout||2
209122|NCT00750308|502989|P1|COMPLETED|Washout||2
209123|NCT00750308|502978|P12|STARTED|Washout||1
209124|NCT00750308|502979|P11|STARTED|Washout||1
209125|NCT00750308|502980|P10|STARTED|Washout||2
209126|NCT00750308|502981|P9|STARTED|Washout||1
209127|NCT00750308|502982|P8|STARTED|Washout||2
209128|NCT00750308|502983|P7|STARTED|Washout||2
209129|NCT00750308|502984|P6|STARTED|Washout||2
209130|NCT00750308|502985|P5|STARTED|Washout||1
209131|NCT00750308|502986|P4|STARTED|Washout||1
209132|NCT00750308|502987|P3|STARTED|Washout||2
209133|NCT00750308|502988|P2|STARTED|Washout||2
209134|NCT00750308|502989|P1|STARTED|Washout||2
209135|NCT00750308|502978|P12|NOT COMPLETED|Second Treatment||0
209136|NCT00750308|502979|P11|NOT COMPLETED|Second Treatment||0
209137|NCT00750308|502980|P10|NOT COMPLETED|Second Treatment||0
209138|NCT00750308|502981|P9|NOT COMPLETED|Second Treatment||1
209139|NCT00750308|502982|P8|NOT COMPLETED|Second Treatment||0
209140|NCT00750308|502983|P7|NOT COMPLETED|Second Treatment||0
209141|NCT00750308|502984|P6|NOT COMPLETED|Second Treatment||1
209142|NCT00750308|502985|P5|NOT COMPLETED|Second Treatment||1
209143|NCT00750308|502986|P4|NOT COMPLETED|Second Treatment||0
209144|NCT00750308|502987|P3|NOT COMPLETED|Second Treatment||0
209145|NCT00750308|502988|P2|NOT COMPLETED|Second Treatment||0
209146|NCT00750308|502989|P1|NOT COMPLETED|Second Treatment||0
209147|NCT00750308|502978|P12|COMPLETED|Second Treatment||1
209148|NCT00750308|502979|P11|COMPLETED|Second Treatment||1
209149|NCT00750308|502980|P10|COMPLETED|Second Treatment||2
209150|NCT00750308|502981|P9|COMPLETED|Second Treatment||1
209151|NCT00750308|502982|P8|COMPLETED|Second Treatment||2
209152|NCT00750308|502983|P7|COMPLETED|Second Treatment||2
209153|NCT00750308|502984|P6|COMPLETED|Second Treatment||2
209154|NCT00750308|502985|P5|COMPLETED|Second Treatment||1
209155|NCT00750308|502986|P4|COMPLETED|Second Treatment||1
209156|NCT00750308|502987|P3|COMPLETED|Second Treatment||2
209157|NCT00750308|502988|P2|COMPLETED|Second Treatment||2
209158|NCT00750308|502989|P1|COMPLETED|Second Treatment||2
209159|NCT00750308|502978|P12|STARTED|Second Treatment||1
209160|NCT00750308|502979|P11|STARTED|Second Treatment||1
209161|NCT00750308|502980|P10|STARTED|Second Treatment||2
209162|NCT00750308|502981|P9|STARTED|Second Treatment||2
209163|NCT00750308|502982|P8|STARTED|Second Treatment||2
209164|NCT00750308|502983|P7|STARTED|Second Treatment||2
209165|NCT00750308|502984|P6|STARTED|Second Treatment||3
209166|NCT00750308|502985|P5|STARTED|Second Treatment||2
209167|NCT00750308|502986|P4|STARTED|Second Treatment||1
209168|NCT00750308|502987|P3|STARTED|Second Treatment||2
209169|NCT00750308|502988|P2|STARTED|Second Treatment||2
209170|NCT00750308|502989|P1|STARTED|Second Treatment||2
209171|NCT00750308|502978|P12|NOT COMPLETED|Washout||0
209172|NCT00750308|502979|P11|NOT COMPLETED|Washout||0
209173|NCT00750308|502980|P10|NOT COMPLETED|Washout||0
209174|NCT00750308|502981|P9|NOT COMPLETED|Washout||0
209175|NCT00750308|502982|P8|NOT COMPLETED|Washout||0
209176|NCT00750308|502983|P7|NOT COMPLETED|Washout||0
209177|NCT00750308|502984|P6|NOT COMPLETED|Washout||0
209178|NCT00750308|502985|P5|NOT COMPLETED|Washout||0
209179|NCT00750308|502986|P4|NOT COMPLETED|Washout||0
209180|NCT00750308|502987|P3|NOT COMPLETED|Washout||0
209181|NCT00750308|502988|P2|NOT COMPLETED|Washout||0
209182|NCT00750308|502989|P1|NOT COMPLETED|Washout||0
209183|NCT00750308|502978|P12|COMPLETED|Washout||1
209184|NCT00750308|502979|P11|COMPLETED|Washout||1
209185|NCT00750308|502980|P10|COMPLETED|Washout||2
209186|NCT00750308|502981|P9|COMPLETED|Washout||2
209187|NCT00750308|502982|P8|COMPLETED|Washout||2
209188|NCT00750308|502983|P7|COMPLETED|Washout||2
209189|NCT00750308|502984|P6|COMPLETED|Washout||3
209190|NCT00750308|502985|P5|COMPLETED|Washout||2
209191|NCT00750308|502986|P4|COMPLETED|Washout||1
209192|NCT00750308|502987|P3|COMPLETED|Washout||2
209193|NCT00750308|502988|P2|COMPLETED|Washout||2
209194|NCT00750308|502989|P1|COMPLETED|Washout||2
209195|NCT00750308|502978|P12|STARTED|Washout||1
209196|NCT00750308|502979|P11|STARTED|Washout||1
209197|NCT00750308|502980|P10|STARTED|Washout||2
209198|NCT00750308|502981|P9|STARTED|Washout||2
209199|NCT00750308|502982|P8|STARTED|Washout||2
209200|NCT00750308|502983|P7|STARTED|Washout||2
209201|NCT00750308|502984|P6|STARTED|Washout||3
209202|NCT00750308|502985|P5|STARTED|Washout||2
209203|NCT00750308|502986|P4|STARTED|Washout||1
209204|NCT00750308|502987|P3|STARTED|Washout||2
209205|NCT00750308|502988|P2|STARTED|Washout||2
209206|NCT00750308|502989|P1|STARTED|Washout||2
209207|NCT00750308|502978|P12|NOT COMPLETED|First Treatment||1
209208|NCT00750308|502979|P11|NOT COMPLETED|First Treatment||1
209209|NCT00750308|502980|P10|NOT COMPLETED|First Treatment||0
209210|NCT00750308|502981|P9|NOT COMPLETED|First Treatment||0
209211|NCT00750308|502982|P8|NOT COMPLETED|First Treatment||1
209212|NCT00750308|502983|P7|NOT COMPLETED|First Treatment||0
209213|NCT00750308|502984|P6|NOT COMPLETED|First Treatment||0
209214|NCT00750308|502985|P5|NOT COMPLETED|First Treatment||0
209215|NCT00750308|502986|P4|NOT COMPLETED|First Treatment||1
209216|NCT00750308|502987|P3|NOT COMPLETED|First Treatment||0
209217|NCT00750308|502988|P2|NOT COMPLETED|First Treatment||1
209218|NCT00750308|502989|P1|NOT COMPLETED|First Treatment||0
209219|NCT00750308|502978|P12|COMPLETED|First Treatment||1
209220|NCT00750308|502979|P11|COMPLETED|First Treatment||1
209221|NCT00750308|502980|P10|COMPLETED|First Treatment||2
209222|NCT00750308|502981|P9|COMPLETED|First Treatment||2
209223|NCT00750308|502982|P8|COMPLETED|First Treatment||2
209224|NCT00750308|502983|P7|COMPLETED|First Treatment||2
209225|NCT00750308|502984|P6|COMPLETED|First Treatment||3
209226|NCT00750308|502985|P5|COMPLETED|First Treatment||2
209227|NCT00750308|502986|P4|COMPLETED|First Treatment||1
209228|NCT00750308|502987|P3|COMPLETED|First Treatment||2
209229|NCT00750308|502988|P2|COMPLETED|First Treatment||2
209230|NCT00750308|502989|P1|COMPLETED|First Treatment||2
209231|NCT00750308|502978|P12|STARTED|First Treatment||2
209232|NCT00750308|502979|P11|STARTED|First Treatment||2
209233|NCT00750308|502980|P10|STARTED|First Treatment||2
209234|NCT00750308|502981|P9|STARTED|First Treatment||2
209235|NCT00750308|502982|P8|STARTED|First Treatment||3
209236|NCT00750308|502983|P7|STARTED|First Treatment||2
209237|NCT00750308|502984|P6|STARTED|First Treatment||3
209238|NCT00750308|502985|P5|STARTED|First Treatment||2
209239|NCT00750308|502986|P4|STARTED|First Treatment||2
209240|NCT00750308|502987|P3|STARTED|First Treatment||2
209241|NCT00750308|502988|P2|STARTED|First Treatment||3
209242|NCT00750308|502989|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
209243|NCT00750282|503007|P4|NOT COMPLETED|Overall Study||1
209244|NCT00750282|503008|P3|NOT COMPLETED|Overall Study||1
209245|NCT00750282|503009|P2|NOT COMPLETED|Overall Study||1
209246|NCT00750282|503010|P1|NOT COMPLETED|Overall Study||0
209247|NCT00750282|503007|P4|COMPLETED|Overall Study||147
209248|NCT00750282|503008|P3|COMPLETED|Overall Study||125
209249|NCT00750282|503009|P2|COMPLETED|Overall Study||81
209250|NCT00750282|503010|P1|COMPLETED|Overall Study||69
209251|NCT00750282|503007|P4|STARTED|Overall Study||148
209252|NCT00750282|503008|P3|STARTED|Overall Study||126
209253|NCT00750282|503009|P2|STARTED|Overall Study||82
209254|NCT00750282|503010|P1|STARTED|Overall Study||69
209255|NCT00750269|503039|P5|NOT COMPLETED|Overall Study||10
209256|NCT00750269|503040|P4|NOT COMPLETED|Overall Study||5
209257|NCT00750269|503041|P3|NOT COMPLETED|Overall Study||4
209258|NCT00750269|503042|P2|NOT COMPLETED|Overall Study||1
209259|NCT00750269|503043|P1|NOT COMPLETED|Overall Study||0
209260|NCT00750269|503039|P5|COMPLETED|Overall Study||33
209261|NCT00750269|503040|P4|COMPLETED|Overall Study||38
209262|NCT00750269|503041|P3|COMPLETED|Overall Study||14
209263|NCT00750269|503042|P2|COMPLETED|Overall Study||7
209264|NCT00750269|503043|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
209265|NCT00750269|503039|P5|STARTED|Overall Study||43
209266|NCT00750269|503040|P4|STARTED|Overall Study||43
209267|NCT00750269|503041|P3|STARTED|Overall Study||18
209268|NCT00750269|503042|P2|STARTED|Overall Study||8
209269|NCT00750269|503043|P1|STARTED|Overall Study||8
209270|NCT00750204|503090|P2|NOT COMPLETED|Overall Study||1
209271|NCT00750204|503091|P1|NOT COMPLETED|Overall Study||1
209272|NCT00750204|503090|P2|COMPLETED|Overall Study||0
209273|NCT00750204|503091|P1|COMPLETED|Overall Study||0
209274|NCT00750204|503090|P2|STARTED|Overall Study||1
209275|NCT00750204|503091|P1|STARTED|Overall Study||1
209276|NCT00750191|503099|P2|NOT COMPLETED|Overall Study||10
209277|NCT00750191|503100|P1|NOT COMPLETED|Overall Study||5
209278|NCT00750191|503099|P2|COMPLETED|Overall Study||20
209279|NCT00750191|503100|P1|COMPLETED|Overall Study||22
209280|NCT00750191|503099|P2|STARTED|Overall Study||30
209281|NCT00750191|503100|P1|STARTED|Overall Study||27
209282|NCT00750152|503114|P2|NOT COMPLETED|Overall Study||27
209283|NCT00750152|503115|P1|NOT COMPLETED|Overall Study||22
209284|NCT00750152|503114|P2|COMPLETED|Overall Study||141
209285|NCT00750152|503115|P1|COMPLETED|Overall Study||144
209286|NCT00750152|503114|P2|STARTED|Overall Study||168
209287|NCT00750152|503115|P1|STARTED|Overall Study||166
209288|NCT00750139|503127|P4|NOT COMPLETED|Overall Study||46
209289|NCT00750139|503128|P3|NOT COMPLETED|Overall Study||101
209290|NCT00750139|503129|P2|NOT COMPLETED|Overall Study||59
209291|NCT00750139|503130|P1|NOT COMPLETED|Overall Study||89
209292|NCT00750139|503127|P4|COMPLETED|Overall Study||73
209293|NCT00750139|503128|P3|COMPLETED|Overall Study||135
209294|NCT00750139|503129|P2|COMPLETED|Overall Study||59
209295|NCT00750139|503130|P1|COMPLETED|Overall Study||145
209296|NCT00750139|503127|P4|STARTED|Overall Study||119
209297|NCT00750139|503128|P3|STARTED|Overall Study||236
209298|NCT00750139|503129|P2|STARTED|Overall Study||118
209299|NCT00750139|503130|P1|STARTED|Overall Study||234
209300|NCT00750061|503146|P2|NOT COMPLETED|Overall Study||2
209301|NCT00750061|503147|P1|NOT COMPLETED|Overall Study||2
209302|NCT00750061|503146|P2|COMPLETED|Overall Study||18
209303|NCT00750061|503147|P1|COMPLETED|Overall Study||18
209304|NCT00750061|503146|P2|STARTED|Overall Study||20
209305|NCT00750061|503147|P1|STARTED|Overall Study||20
209306|NCT00749996|503157|P2|NOT COMPLETED|Overall Study||13
209307|NCT00749996|503158|P1|NOT COMPLETED|Overall Study||18
209308|NCT00749996|503157|P2|COMPLETED|Overall Study||58
209309|NCT00749996|503158|P1|COMPLETED|Overall Study||57
209310|NCT00749996|503157|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
209311|NCT00749996|503158|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
209312|NCT00749996|503157|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
209313|NCT00749996|503158|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
209314|NCT00749996|503157|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
209315|NCT00749996|503158|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
209316|NCT00749996|503157|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
209317|NCT00749996|503158|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
209318|NCT00749996|503157|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
209319|NCT00749996|503158|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
209320|NCT00749996|503157|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
209321|NCT00749996|503158|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
209322|NCT00749957|503168|P2|NOT COMPLETED|Overall Study||0
209323|NCT00749957|503169|P1|NOT COMPLETED|Overall Study||0
209324|NCT00749957|503168|P2|COMPLETED|Overall Study||6
209325|NCT00749957|503169|P1|COMPLETED|Overall Study||6
209326|NCT00749957|503168|P2|STARTED|Overall Study||6
209327|NCT00749957|503169|P1|STARTED|Overall Study||6
209328|NCT00749944|503181|P2|NOT COMPLETED|Overall Study||1
209329|NCT00749944|503182|P1|NOT COMPLETED|Overall Study||5
209330|NCT00749944|503181|P2|COMPLETED|Overall Study||54
209331|NCT00749944|503182|P1|COMPLETED|Overall Study||50
209332|NCT00749944|503181|P2|STARTED|Overall Study||55
209333|NCT00749944|503182|P1|STARTED|Overall Study||55
209334|NCT00749931|503250|P3|NOT COMPLETED|Overall Study||0
209335|NCT00749931|503251|P2|NOT COMPLETED|Overall Study||0
209336|NCT00749931|503252|P1|NOT COMPLETED|Overall Study||0
209337|NCT00749931|503250|P3|COMPLETED|Overall Study||68
209338|NCT00749931|503251|P2|COMPLETED|Overall Study||298
209339|NCT00749931|503252|P1|COMPLETED|Overall Study||298
209340|NCT00749931|503250|P3|STARTED|Overall Study||68
209341|NCT00749931|503251|P2|STARTED|Overall Study||298
209342|NCT00749931|503252|P1|STARTED|Overall Study||298
209343|NCT00749775|503261|P1|NOT COMPLETED|Overall Study||107
209344|NCT00749775|503261|P1|COMPLETED|Overall Study||3210
209345|NCT00749775|503261|P1|STARTED|Overall Study||3317
209346|NCT00749684|503277|P1|NOT COMPLETED|Overall Study||82
209347|NCT00749684|503277|P1|COMPLETED|Overall Study||56
209348|NCT00749684|503277|P1|STARTED|Overall Study||138
209349|NCT00749671|503284|P2|NOT COMPLETED|Overall Study||0
209350|NCT00749671|503285|P1|NOT COMPLETED|Overall Study||0
209351|NCT00749671|503284|P2|COMPLETED|Overall Study||9
209352|NCT00749671|503285|P1|COMPLETED|Overall Study||11
209353|NCT00749671|503284|P2|STARTED|Overall Study||9
209354|NCT00749671|503285|P1|STARTED|Overall Study||11
209355|NCT00749606|503295|P2|NOT COMPLETED|Year 3 (Observation)||3
209356|NCT00749606|503296|P1|NOT COMPLETED|Year 3 (Observation)||0
209357|NCT00749606|503295|P2|COMPLETED|Year 3 (Observation)||69
209358|NCT00749606|503296|P1|COMPLETED|Year 3 (Observation)||63
209359|NCT00749606|503295|P2|STARTED|Year 3 (Observation)||72
209360|NCT00749606|503296|P1|STARTED|Year 3 (Observation)||63
209361|NCT00749606|503295|P2|NOT COMPLETED|Year 2||8
209362|NCT00749606|503296|P1|NOT COMPLETED|Year 2||11
209363|NCT00749606|503295|P2|COMPLETED|Year 2||72
209364|NCT00749606|503296|P1|COMPLETED|Year 2||63
209365|NCT00749606|503295|P2|STARTED|Year 2||80
209366|NCT00749606|503296|P1|STARTED|Year 2||74
209367|NCT00749606|503295|P2|NOT COMPLETED|Year 1||48
209368|NCT00749606|503296|P1|NOT COMPLETED|Year 1||55
209369|NCT00749606|503295|P2|COMPLETED|Year 1||80
209370|NCT00749606|503296|P1|COMPLETED|Year 1||74
209371|NCT00749606|503295|P2|STARTED|Year 1||128
209372|NCT00749606|503296|P1|STARTED|Year 1||129
209373|NCT00749580|503316|P2|NOT COMPLETED|Overall Study||9
209374|NCT00749580|503317|P1|NOT COMPLETED|Overall Study||4
209375|NCT00749580|503316|P2|COMPLETED|Overall Study||16
209376|NCT00749580|503317|P1|COMPLETED|Overall Study|December 2010|17
209377|NCT00749580|503316|P2|STARTED|Overall Study||25
209378|NCT00749580|503317|P1|STARTED|Overall Study|September 2008|21
209379|NCT00749476|503325|P1|NOT COMPLETED|Overall Study||0
209380|NCT00749476|503325|P1|COMPLETED|Overall Study||1
209381|NCT00749476|503325|P1|STARTED|Overall Study||1
209382|NCT00749463|503332|P3|NOT COMPLETED|Overall Study||1
209383|NCT00749463|503333|P2|NOT COMPLETED|Overall Study||4
209384|NCT00749463|503334|P1|NOT COMPLETED|Overall Study||1
209385|NCT00749463|503332|P3|COMPLETED|Overall Study||149
209386|NCT00749463|503333|P2|COMPLETED|Overall Study||60
209387|NCT00749463|503334|P1|COMPLETED|Overall Study||85
209388|NCT00749463|503332|P3|STARTED|Overall Study||150
209389|NCT00749463|503333|P2|STARTED|Overall Study||64
209390|NCT00749463|503334|P1|STARTED|Overall Study||86
209391|NCT00749398|503360|P1|NOT COMPLETED|Overall Study||53
209392|NCT00749398|503360|P1|COMPLETED|Overall Study||71
209393|NCT00749398|503360|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
209394|NCT00749268|503378|P2|NOT COMPLETED|Overall Study||36
209395|NCT00749268|503379|P1|NOT COMPLETED|Overall Study||34
209396|NCT00749268|503378|P2|COMPLETED|Overall Study||74
209397|NCT00749268|503379|P1|COMPLETED|Overall Study||72
209398|NCT00749268|503378|P2|STARTED|Overall Study||110
209399|NCT00749268|503379|P1|STARTED|Overall Study||106
209400|NCT00749203|503403|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
209401|NCT00749203|503404|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
209402|NCT00749203|503403|P2|COMPLETED|Second Infusion at 2 Weeks||13
209403|NCT00749203|503404|P1|COMPLETED|Second Infusion at 2 Weeks||16
209404|NCT00749203|503403|P2|STARTED|Second Infusion at 2 Weeks||15
209405|NCT00749203|503404|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
209406|NCT00749203|503403|P2|NOT COMPLETED|no Infusion at Week 1||4
209407|NCT00749203|503404|P1|NOT COMPLETED|no Infusion at Week 1||0
209408|NCT00749203|503403|P2|COMPLETED|no Infusion at Week 1||15
209409|NCT00749203|503404|P1|COMPLETED|no Infusion at Week 1||22
209410|NCT00749203|503403|P2|STARTED|no Infusion at Week 1||19
209411|NCT00749203|503404|P1|STARTED|no Infusion at Week 1||22
209412|NCT00749203|503403|P2|NOT COMPLETED|First Infusion Day 1||0
209413|NCT00749203|503404|P1|NOT COMPLETED|First Infusion Day 1||0
209414|NCT00749203|503403|P2|COMPLETED|First Infusion Day 1||19
209415|NCT00749203|503404|P1|COMPLETED|First Infusion Day 1||22
209416|NCT00749203|503403|P2|STARTED|First Infusion Day 1||19
209417|NCT00749203|503404|P1|STARTED|First Infusion Day 1||22
209418|NCT00749190|503425|P7|NOT COMPLETED|Overall Study||1
209419|NCT00749190|503426|P6|NOT COMPLETED|Overall Study||5
209420|NCT00749190|503427|P5|NOT COMPLETED|Overall Study||0
209421|NCT00749190|503428|P4|NOT COMPLETED|Overall Study||5
209422|NCT00749190|503429|P3|NOT COMPLETED|Overall Study||1
209423|NCT00749190|503430|P2|NOT COMPLETED|Overall Study||5
209424|NCT00749190|503431|P1|NOT COMPLETED|Overall Study||5
209425|NCT00749190|503425|P7|COMPLETED|Overall Study||70
209426|NCT00749190|503426|P6|COMPLETED|Overall Study||65
209427|NCT00749190|503427|P5|COMPLETED|Overall Study||70
209428|NCT00749190|503428|P4|COMPLETED|Overall Study||66
209429|NCT00749190|503429|P3|COMPLETED|Overall Study||70
209430|NCT00749190|503430|P2|COMPLETED|Overall Study||66
209431|NCT00749190|503431|P1|COMPLETED|Overall Study||66
209432|NCT00749190|503425|P7|STARTED|Overall Study||71
209433|NCT00749190|503426|P6|STARTED|Overall Study||70
209434|NCT00749190|503427|P5|STARTED|Overall Study||70
209435|NCT00749190|503428|P4|STARTED|Overall Study||71
209436|NCT00749190|503429|P3|STARTED|Overall Study||71
209437|NCT00749190|503430|P2|STARTED|Overall Study||71
209438|NCT00749190|503431|P1|STARTED|Overall Study||71
209439|NCT00749073|503508|P1|NOT COMPLETED|Overall Study||0
209440|NCT00749073|503508|P1|COMPLETED|Overall Study||10
209441|NCT00749073|503508|P1|STARTED|Overall Study||10
209442|NCT00748982|503516|P2|NOT COMPLETED|Overall Study||0
209443|NCT00748982|503517|P1|NOT COMPLETED|Overall Study||0
209444|NCT00748982|503516|P2|COMPLETED|Overall Study||4
209445|NCT00748982|503517|P1|COMPLETED|Overall Study||12
209446|NCT00748982|503516|P2|STARTED|Overall Study||4
209447|NCT00748982|503517|P1|STARTED|Overall Study||12
209448|NCT00748969|503531|P2|NOT COMPLETED|Overall Study||1
209449|NCT00748969|503532|P1|NOT COMPLETED|Overall Study||1
209450|NCT00748969|503531|P2|COMPLETED|Overall Study||0
209451|NCT00748969|503532|P1|COMPLETED|Overall Study||0
209452|NCT00748969|503531|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
209453|NCT00748969|503532|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
209454|NCT00748956|503541|P3|NOT COMPLETED|Overall Study||0
209455|NCT00748956|503542|P2|NOT COMPLETED|Overall Study||0
209456|NCT00748956|503543|P1|NOT COMPLETED|Overall Study||0
209457|NCT00748956|503541|P3|COMPLETED|Overall Study||5
209458|NCT00748956|503542|P2|COMPLETED|Overall Study||5
209459|NCT00748956|503543|P1|COMPLETED|Overall Study||0
209460|NCT00748956|503541|P3|STARTED|Overall Study||5
209461|NCT00748956|503542|P2|STARTED|Overall Study||5
209462|NCT00748956|503543|P1|STARTED|Overall Study||0
209463|NCT00748865|503566|P2|NOT COMPLETED|Overall Study||0
209464|NCT00748865|503567|P1|NOT COMPLETED|Overall Study||0
209465|NCT00748865|503566|P2|COMPLETED|Overall Study||10
209466|NCT00748865|503567|P1|COMPLETED|Overall Study||10
209467|NCT00748865|503566|P2|STARTED|Overall Study||10
209468|NCT00748865|503567|P1|STARTED|Overall Study||10
209469|NCT00748826|503573|P1|NOT COMPLETED|Overall Study||301
209470|NCT00748826|503573|P1|COMPLETED|Overall Study||207
209471|NCT00748826|503573|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
209472|NCT00748709|503580|P1|NOT COMPLETED|Overall Study||20
209473|NCT00748709|503580|P1|COMPLETED|Overall Study||0
209474|NCT00748709|503580|P1|STARTED|Overall Study|Treated|20
209475|NCT00748657|503592|P1|NOT COMPLETED|Overall Study||0
209476|NCT00748657|503592|P1|COMPLETED|Overall Study||36
209477|NCT00748657|503592|P1|STARTED|Overall Study||36
209478|NCT00748579|503600|P2|NOT COMPLETED|Overall Study||0
209479|NCT00748579|503601|P1|NOT COMPLETED|Overall Study||0
209480|NCT00748579|503600|P2|COMPLETED|Overall Study||0
209481|NCT00748579|503601|P1|COMPLETED|Overall Study||2
209482|NCT00748579|503600|P2|STARTED|Overall Study||0
209483|NCT00748579|503601|P1|STARTED|Overall Study||2
209484|NCT00748566|503607|P1|NOT COMPLETED|Overall Study||112
209485|NCT00748566|503607|P1|COMPLETED|Overall Study||60
209486|NCT00748566|503607|P1|STARTED|Overall Study||172
209487|NCT00748553|503637|P2|NOT COMPLETED|Overall Study||1
209488|NCT00748553|503638|P1|NOT COMPLETED|Overall Study||3
209489|NCT00748553|503637|P2|COMPLETED|Overall Study||13
209490|NCT00748553|503638|P1|COMPLETED|Overall Study||13
209491|NCT00748553|503637|P2|STARTED|Overall Study||14
209492|NCT00748553|503638|P1|STARTED|Overall Study||16
209493|NCT00748410|503647|P2|NOT COMPLETED|Overall Study||0
209494|NCT00748410|503648|P1|NOT COMPLETED|Overall Study||0
209495|NCT00748410|503647|P2|COMPLETED|Overall Study||2
209496|NCT00748410|503648|P1|COMPLETED|Overall Study||1
209497|NCT00748410|503647|P2|STARTED|Overall Study||2
209498|NCT00748410|503648|P1|STARTED|Overall Study||1
209499|NCT00748241|503664|P1|NOT COMPLETED|Overall Study||8
209500|NCT00748241|503664|P1|COMPLETED|Overall Study||11
209501|NCT00748241|503664|P1|STARTED|Overall Study||19
209502|NCT00748189|503674|P2|NOT COMPLETED|Overall Study||221
209503|NCT00748189|503675|P1|NOT COMPLETED|Overall Study||225
209504|NCT00748189|503674|P2|COMPLETED|Overall Study||0
209505|NCT00748189|503675|P1|COMPLETED|Overall Study|This participant was entered incorrectly by the site and has not completed the 5 year follow-up.|1
209506|NCT00748189|503674|P2|Ongoing|Overall Study|One par. was incorrectly recorded as withdrawn due to “Study Terminated by Sponsor” and is ongoing.|162
209507|NCT00748189|503675|P1|Ongoing|Overall Study||155
209508|NCT00748189|503674|P2|STARTED|Overall Study||221
209509|NCT00748189|503675|P1|STARTED|Overall Study||226
209510|NCT00748098|503729|P2|NOT COMPLETED|Second Taper Period||0
209511|NCT00748098|503730|P1|NOT COMPLETED|Second Taper Period||0
209512|NCT00748098|503729|P2|COMPLETED|Second Taper Period||61
209513|NCT00748098|503730|P1|COMPLETED|Second Taper Period||53
209514|NCT00748098|503729|P2|STARTED|Second Taper Period||61
209515|NCT00748098|503730|P1|STARTED|Second Taper Period||53
209516|NCT00748098|503729|P2|NOT COMPLETED|Second Treatment Intervention Period||3
209517|NCT00748098|503730|P1|NOT COMPLETED|Second Treatment Intervention Period||6
209518|NCT00748098|503729|P2|COMPLETED|Second Treatment Intervention Period||61
209519|NCT00748098|503730|P1|COMPLETED|Second Treatment Intervention Period||53
209520|NCT00748098|503729|P2|STARTED|Second Treatment Intervention Period||64
209521|NCT00748098|503730|P1|STARTED|Second Treatment Intervention Period||59
209522|NCT00748098|503729|P2|NOT COMPLETED|1-Week Washout Period||1
209523|NCT00748098|503730|P1|NOT COMPLETED|1-Week Washout Period||2
209524|NCT00748098|503729|P2|COMPLETED|1-Week Washout Period||64
209525|NCT00748098|503730|P1|COMPLETED|1-Week Washout Period||59
209526|NCT00748098|503729|P2|STARTED|1-Week Washout Period||65
209527|NCT00748098|503730|P1|STARTED|1-Week Washout Period||61
209528|NCT00748098|503729|P2|NOT COMPLETED|First Taper Period||1
209529|NCT00748098|503730|P1|NOT COMPLETED|First Taper Period||3
209530|NCT00748098|503729|P2|COMPLETED|First Taper Period||65
209531|NCT00748098|503730|P1|COMPLETED|First Taper Period||61
209532|NCT00748098|503729|P2|STARTED|First Taper Period||66
209533|NCT00748098|503730|P1|STARTED|First Taper Period||64
209534|NCT00748098|503729|P2|NOT COMPLETED|First Treatment Intervention Period||1
209535|NCT00748098|503730|P1|NOT COMPLETED|First Treatment Intervention Period||5
209536|NCT00748098|503729|P2|COMPLETED|First Treatment Intervention Period||66
209537|NCT00748098|503730|P1|COMPLETED|First Treatment Intervention Period||64
209538|NCT00748098|503729|P2|STARTED|First Treatment Intervention Period||67
209539|NCT00748098|503730|P1|STARTED|First Treatment Intervention Period||69
209540|NCT00748085|503790|P1|NOT COMPLETED|Overall Study||0
209541|NCT00748085|503790|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
209542|NCT00748085|503790|P1|STARTED|Overall Study||5
209543|NCT00748072|503797|P2|NOT COMPLETED|Overall Study||0
209544|NCT00748072|503798|P1|NOT COMPLETED|Overall Study||0
209545|NCT00748072|503797|P2|COMPLETED|Overall Study||80
209546|NCT00748072|503798|P1|COMPLETED|Overall Study||82
209547|NCT00748072|503797|P2|STARTED|Overall Study||80
209548|NCT00748072|503798|P1|STARTED|Overall Study||82
209549|NCT00747916|503804|P1|NOT COMPLETED|Overall Study||0
209550|NCT00747916|503804|P1|COMPLETED|Overall Study||3
209551|NCT00747916|503804|P1|STARTED|Overall Study||3
209552|NCT00747812|503811|P2|NOT COMPLETED|Overall Study||3
209553|NCT00747812|503812|P1|NOT COMPLETED|Overall Study||5
209554|NCT00747812|503811|P2|COMPLETED|Overall Study||0
209555|NCT00747812|503812|P1|COMPLETED|Overall Study||0
209556|NCT00747812|503811|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
209557|NCT00747812|503812|P1|STARTED|Overall Study||5
209558|NCT00747747|503823|P3|NOT COMPLETED|Overall Study||0
209559|NCT00747747|503824|P2|NOT COMPLETED|Overall Study||0
209560|NCT00747747|503825|P1|NOT COMPLETED|Overall Study||0
209561|NCT00747747|503823|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
209562|NCT00747747|503824|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
209563|NCT00747747|503825|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
209564|NCT00747747|503823|P3|STARTED|Overall Study||21
209565|NCT00747747|503824|P2|STARTED|Overall Study||14
209566|NCT00747747|503825|P1|STARTED|Overall Study||14
209567|NCT00747643|503850|P2|NOT COMPLETED|Overall Study||27
209568|NCT00747643|503851|P1|NOT COMPLETED|Overall Study||36
209569|NCT00747643|503850|P2|COMPLETED|Overall Study||54
209570|NCT00747643|503851|P1|COMPLETED|Overall Study||46
209571|NCT00747643|503850|P2|STARTED|Overall Study||81
209572|NCT00747643|503851|P1|STARTED|Overall Study||82
209573|NCT00747617|503865|P2|NOT COMPLETED|Overall Study||1
209574|NCT00747617|503866|P1|NOT COMPLETED|Overall Study||3
209575|NCT00747617|503865|P2|COMPLETED|Overall Study||11
209576|NCT00747617|503866|P1|COMPLETED|Overall Study||10
209577|NCT00747617|503865|P2|STARTED|Overall Study||12
209578|NCT00747617|503866|P1|STARTED|Overall Study||13
209579|NCT00747565|503874|P2|NOT COMPLETED|Overall Study||7
209580|NCT00747565|503875|P1|NOT COMPLETED|Overall Study||14
209581|NCT00747565|503874|P2|COMPLETED|Overall Study||116
209582|NCT00747565|503875|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
209583|NCT00747565|503874|P2|STARTED|Overall Study||123
209584|NCT00747565|503875|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
209585|NCT00747552|503883|P1|NOT COMPLETED|Overall Study||0
209586|NCT00747552|503883|P1|COMPLETED|Overall Study||30
209587|NCT00747552|503883|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
209588|NCT00747474|503888|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209589|NCT00747474|503889|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209590|NCT00747474|503890|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209591|NCT00747474|503891|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209592|NCT00747474|503892|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209593|NCT00747474|503893|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209594|NCT00747474|503894|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209595|NCT00747474|503895|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209596|NCT00747474|503896|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209597|NCT00747474|503897|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209598|NCT00747474|503898|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209599|NCT00747474|503899|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209600|NCT00747474|503888|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
209601|NCT00747474|503889|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209602|NCT00747474|503890|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209603|NCT00747474|503891|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209604|NCT00747474|503892|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209605|NCT00747474|503893|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209606|NCT00747474|503894|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209607|NCT00747474|503895|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209608|NCT00747474|503896|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209609|NCT00747474|503897|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209610|NCT00747474|503898|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209611|NCT00747474|503899|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
209612|NCT00747474|503888|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
209613|NCT00747474|503889|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
209614|NCT00747474|503890|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
209615|NCT00747474|503891|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
209616|NCT00747474|503892|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
209617|NCT00747474|503893|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
209618|NCT00747474|503894|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
209619|NCT00747474|503895|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
209620|NCT00747474|503896|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
209621|NCT00747474|503897|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
209622|NCT00747474|503898|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
209623|NCT00747474|503899|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
209624|NCT00747474|503888|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209625|NCT00747474|503889|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209626|NCT00747474|503890|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209627|NCT00747474|503891|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209628|NCT00747474|503892|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209629|NCT00747474|503893|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209630|NCT00747474|503894|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209631|NCT00747474|503895|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209632|NCT00747474|503896|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209633|NCT00747474|503897|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209634|NCT00747474|503898|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209635|NCT00747474|503899|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209636|NCT00747474|503888|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209637|NCT00747474|503889|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
209638|NCT00747474|503890|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209639|NCT00747474|503891|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209640|NCT00747474|503892|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209641|NCT00747474|503893|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209642|NCT00747474|503894|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209643|NCT00747474|503895|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209644|NCT00747474|503896|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209645|NCT00747474|503897|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209646|NCT00747474|503898|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209647|NCT00747474|503899|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
209648|NCT00747474|503888|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
209649|NCT00747474|503889|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
209650|NCT00747474|503890|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
209651|NCT00747474|503891|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
209652|NCT00747474|503892|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
209653|NCT00747474|503893|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
209654|NCT00747474|503894|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
209655|NCT00747474|503895|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
209656|NCT00747474|503896|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
209657|NCT00747474|503897|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
209658|NCT00747474|503898|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
209659|NCT00747474|503899|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
209660|NCT00747474|503888|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209661|NCT00747474|503889|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209662|NCT00747474|503890|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209663|NCT00747474|503891|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209664|NCT00747474|503892|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209665|NCT00747474|503893|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209666|NCT00747474|503894|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209667|NCT00747474|503895|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209668|NCT00747474|503896|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209669|NCT00747474|503897|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209670|NCT00747474|503898|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209671|NCT00747474|503899|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209672|NCT00747474|503888|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209673|NCT00747474|503889|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209674|NCT00747474|503890|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
209675|NCT00747474|503891|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209676|NCT00747474|503892|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209677|NCT00747474|503893|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209678|NCT00747474|503894|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209679|NCT00747474|503895|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209680|NCT00747474|503896|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209681|NCT00747474|503897|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209682|NCT00747474|503898|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209683|NCT00747474|503899|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
209684|NCT00747474|503888|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
209685|NCT00747474|503889|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
209686|NCT00747474|503890|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
209687|NCT00747474|503891|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
209688|NCT00747474|503892|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
209689|NCT00747474|503893|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
209690|NCT00747474|503894|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
209691|NCT00747474|503895|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
209692|NCT00747474|503896|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
209693|NCT00747474|503897|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
209694|NCT00747474|503898|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
209695|NCT00747474|503899|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
209696|NCT00747474|503888|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209697|NCT00747474|503889|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209698|NCT00747474|503890|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209699|NCT00747474|503891|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209700|NCT00747474|503892|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209701|NCT00747474|503893|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209702|NCT00747474|503894|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209703|NCT00747474|503895|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209704|NCT00747474|503896|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209705|NCT00747474|503897|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209706|NCT00747474|503898|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209707|NCT00747474|503899|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209708|NCT00747474|503888|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209709|NCT00747474|503889|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209710|NCT00747474|503890|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209711|NCT00747474|503891|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
209712|NCT00747474|503892|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209713|NCT00747474|503893|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209714|NCT00747474|503894|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209715|NCT00747474|503895|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209716|NCT00747474|503896|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209717|NCT00747474|503897|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209718|NCT00747474|503898|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209719|NCT00747474|503899|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
209720|NCT00747474|503888|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
209721|NCT00747474|503889|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
209722|NCT00747474|503890|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
209723|NCT00747474|503891|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
209724|NCT00747474|503892|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
209725|NCT00747474|503893|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
209726|NCT00747474|503894|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
209727|NCT00747474|503895|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
209728|NCT00747474|503896|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
209729|NCT00747474|503897|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
209730|NCT00747474|503898|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
209731|NCT00747474|503899|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
209732|NCT00747474|503888|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209733|NCT00747474|503889|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209734|NCT00747474|503890|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209735|NCT00747474|503891|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209736|NCT00747474|503892|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
209737|NCT00747474|503893|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209738|NCT00747474|503894|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209739|NCT00747474|503895|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209740|NCT00747474|503896|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209741|NCT00747474|503897|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209742|NCT00747474|503898|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209743|NCT00747474|503899|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209744|NCT00747474|503888|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209745|NCT00747474|503889|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209746|NCT00747474|503890|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209747|NCT00747474|503891|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209748|NCT00747474|503892|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
209749|NCT00747474|503893|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209750|NCT00747474|503894|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209751|NCT00747474|503895|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209752|NCT00747474|503896|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209753|NCT00747474|503897|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209754|NCT00747474|503898|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209755|NCT00747474|503899|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
209756|NCT00747474|503888|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
209757|NCT00747474|503889|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
209758|NCT00747474|503890|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
209759|NCT00747474|503891|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
209760|NCT00747474|503892|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
209761|NCT00747474|503893|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
209762|NCT00747474|503894|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
209763|NCT00747474|503895|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
209764|NCT00747474|503896|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
209765|NCT00747474|503897|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
209766|NCT00747474|503898|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
209767|NCT00747474|503899|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
209768|NCT00747474|503888|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209769|NCT00747474|503889|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209770|NCT00747474|503890|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209771|NCT00747474|503891|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209772|NCT00747474|503892|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209773|NCT00747474|503893|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209774|NCT00747474|503894|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209775|NCT00747474|503895|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209776|NCT00747474|503896|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209777|NCT00747474|503897|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209778|NCT00747474|503898|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209779|NCT00747474|503899|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209780|NCT00747474|503888|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209781|NCT00747474|503889|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209782|NCT00747474|503890|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209783|NCT00747474|503891|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209784|NCT00747474|503892|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209785|NCT00747474|503893|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
209786|NCT00747474|503894|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209787|NCT00747474|503895|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209788|NCT00747474|503896|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209789|NCT00747474|503897|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209790|NCT00747474|503898|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209791|NCT00747474|503899|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
209792|NCT00747474|503888|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
209793|NCT00747474|503889|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
209794|NCT00747474|503890|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
209795|NCT00747474|503891|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
209796|NCT00747474|503892|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
209797|NCT00747474|503893|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
209798|NCT00747474|503894|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
209799|NCT00747474|503895|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
209800|NCT00747474|503896|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
209801|NCT00747474|503897|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
209802|NCT00747474|503898|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
209803|NCT00747474|503899|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
209804|NCT00747474|503888|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209805|NCT00747474|503889|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209806|NCT00747474|503890|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209807|NCT00747474|503891|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209808|NCT00747474|503892|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209809|NCT00747474|503893|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209810|NCT00747474|503894|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209811|NCT00747474|503895|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209812|NCT00747474|503896|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209813|NCT00747474|503897|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209814|NCT00747474|503898|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209815|NCT00747474|503899|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209816|NCT00747474|503888|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209817|NCT00747474|503889|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209818|NCT00747474|503890|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209819|NCT00747474|503891|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209820|NCT00747474|503892|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209821|NCT00747474|503893|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209822|NCT00747474|503894|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
209823|NCT00747474|503895|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209824|NCT00747474|503896|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209825|NCT00747474|503897|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209826|NCT00747474|503898|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209827|NCT00747474|503899|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
209828|NCT00747474|503888|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
209829|NCT00747474|503889|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
209830|NCT00747474|503890|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
209831|NCT00747474|503891|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
209832|NCT00747474|503892|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
209833|NCT00747474|503893|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
209834|NCT00747474|503894|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
209835|NCT00747474|503895|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
209836|NCT00747474|503896|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
209837|NCT00747474|503897|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
209838|NCT00747474|503898|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
209839|NCT00747474|503899|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
209840|NCT00747474|503888|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209841|NCT00747474|503889|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209842|NCT00747474|503890|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209843|NCT00747474|503891|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209844|NCT00747474|503892|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209845|NCT00747474|503893|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209846|NCT00747474|503894|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209847|NCT00747474|503895|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209848|NCT00747474|503896|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209849|NCT00747474|503897|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209850|NCT00747474|503898|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209851|NCT00747474|503899|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209852|NCT00747474|503888|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209853|NCT00747474|503889|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209854|NCT00747474|503890|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209855|NCT00747474|503891|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209856|NCT00747474|503892|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209857|NCT00747474|503893|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209858|NCT00747474|503894|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209859|NCT00747474|503895|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
209860|NCT00747474|503896|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209861|NCT00747474|503897|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209862|NCT00747474|503898|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209863|NCT00747474|503899|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
209864|NCT00747474|503888|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209865|NCT00747474|503889|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209866|NCT00747474|503890|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209867|NCT00747474|503891|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209868|NCT00747474|503892|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209869|NCT00747474|503893|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209870|NCT00747474|503894|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209871|NCT00747474|503895|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
209872|NCT00747474|503896|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209873|NCT00747474|503897|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209874|NCT00747474|503898|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209875|NCT00747474|503899|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
209876|NCT00747474|503888|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209877|NCT00747474|503889|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209878|NCT00747474|503890|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209879|NCT00747474|503891|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209880|NCT00747474|503892|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209881|NCT00747474|503893|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209882|NCT00747474|503894|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209883|NCT00747474|503895|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209884|NCT00747474|503896|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209885|NCT00747474|503897|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209886|NCT00747474|503898|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209887|NCT00747474|503899|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209888|NCT00747474|503888|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209889|NCT00747474|503889|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209890|NCT00747474|503890|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209891|NCT00747474|503891|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209892|NCT00747474|503892|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209893|NCT00747474|503893|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209894|NCT00747474|503894|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209895|NCT00747474|503895|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209896|NCT00747474|503896|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
209897|NCT00747474|503897|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209898|NCT00747474|503898|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209899|NCT00747474|503899|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
209900|NCT00747474|503888|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
209901|NCT00747474|503889|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
209902|NCT00747474|503890|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
209903|NCT00747474|503891|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
209904|NCT00747474|503892|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
209905|NCT00747474|503893|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
209906|NCT00747474|503894|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
209907|NCT00747474|503895|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
209908|NCT00747474|503896|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
209909|NCT00747474|503897|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
209910|NCT00747474|503898|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
209911|NCT00747474|503899|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
209912|NCT00747474|503888|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209913|NCT00747474|503889|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209914|NCT00747474|503890|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209915|NCT00747474|503891|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209916|NCT00747474|503892|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209917|NCT00747474|503893|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209918|NCT00747474|503894|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209919|NCT00747474|503895|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209920|NCT00747474|503896|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209921|NCT00747474|503897|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209922|NCT00747474|503898|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209923|NCT00747474|503899|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209924|NCT00747474|503888|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209925|NCT00747474|503889|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209926|NCT00747474|503890|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209927|NCT00747474|503891|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209928|NCT00747474|503892|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209929|NCT00747474|503893|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209930|NCT00747474|503894|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209931|NCT00747474|503895|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209932|NCT00747474|503896|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209933|NCT00747474|503897|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
209934|NCT00747474|503898|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209935|NCT00747474|503899|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
209936|NCT00747474|503888|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
209937|NCT00747474|503889|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
209938|NCT00747474|503890|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
209939|NCT00747474|503891|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
209940|NCT00747474|503892|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
209941|NCT00747474|503893|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
209942|NCT00747474|503894|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
209943|NCT00747474|503895|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
209944|NCT00747474|503896|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
209945|NCT00747474|503897|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
209946|NCT00747474|503898|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
209947|NCT00747474|503899|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
209948|NCT00747474|503888|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209949|NCT00747474|503889|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209950|NCT00747474|503890|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209951|NCT00747474|503891|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209952|NCT00747474|503892|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209953|NCT00747474|503893|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209954|NCT00747474|503894|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209955|NCT00747474|503895|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209956|NCT00747474|503896|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209957|NCT00747474|503897|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209958|NCT00747474|503898|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209959|NCT00747474|503899|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209960|NCT00747474|503888|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209961|NCT00747474|503889|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209962|NCT00747474|503890|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209963|NCT00747474|503891|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209964|NCT00747474|503892|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209965|NCT00747474|503893|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209966|NCT00747474|503894|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209967|NCT00747474|503895|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209968|NCT00747474|503896|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209969|NCT00747474|503897|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209970|NCT00747474|503898|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
209971|NCT00747474|503899|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
209972|NCT00747474|503888|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
209973|NCT00747474|503889|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
209974|NCT00747474|503890|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
209975|NCT00747474|503891|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
209976|NCT00747474|503892|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
209977|NCT00747474|503893|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
209978|NCT00747474|503894|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
209979|NCT00747474|503895|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
209980|NCT00747474|503896|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
209981|NCT00747474|503897|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
209982|NCT00747474|503898|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
209983|NCT00747474|503899|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
209984|NCT00747474|503888|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209985|NCT00747474|503889|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209986|NCT00747474|503890|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209987|NCT00747474|503891|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209988|NCT00747474|503892|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209989|NCT00747474|503893|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209990|NCT00747474|503894|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209991|NCT00747474|503895|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209992|NCT00747474|503896|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209993|NCT00747474|503897|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209994|NCT00747474|503898|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209995|NCT00747474|503899|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209996|NCT00747474|503888|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209997|NCT00747474|503889|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209998|NCT00747474|503890|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
209999|NCT00747474|503891|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210000|NCT00747474|503892|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210001|NCT00747474|503893|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210002|NCT00747474|503894|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210003|NCT00747474|503895|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210004|NCT00747474|503896|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210005|NCT00747474|503897|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210006|NCT00747474|503898|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
210007|NCT00747474|503899|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
210008|NCT00747474|503888|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210009|NCT00747474|503889|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210010|NCT00747474|503890|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210011|NCT00747474|503891|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210012|NCT00747474|503892|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210013|NCT00747474|503893|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210014|NCT00747474|503894|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210015|NCT00747474|503895|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210016|NCT00747474|503896|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210017|NCT00747474|503897|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210018|NCT00747474|503898|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
210019|NCT00747474|503899|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
210020|NCT00747461|503925|P1|NOT COMPLETED|Overall Study||5
210021|NCT00747461|503925|P1|COMPLETED|Overall Study||0
210022|NCT00747461|503925|P1|STARTED|Overall Study||5
210023|NCT00747435|503930|P1|NOT COMPLETED|Overall Study||6
210024|NCT00747435|503930|P1|COMPLETED|Overall Study||67
210025|NCT00747435|503930|P1|STARTED|Overall Study||73
210026|NCT00747344|503940|P4|NOT COMPLETED|After Controlled Period||1
210027|NCT00747344|503941|P3|NOT COMPLETED|After Controlled Period||0
210028|NCT00747344|503942|P2|NOT COMPLETED|After Controlled Period||0
210029|NCT00747344|503943|P1|NOT COMPLETED|After Controlled Period||0
210030|NCT00747344|503940|P4|COMPLETED|After Controlled Period||56
210031|NCT00747344|503941|P3|COMPLETED|After Controlled Period||55
210032|NCT00747344|503942|P2|COMPLETED|After Controlled Period||0
210033|NCT00747344|503943|P1|COMPLETED|After Controlled Period||0
210034|NCT00747344|503940|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
210035|NCT00747344|503941|P3|STARTED|After Controlled Period||55
210036|NCT00747344|503942|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
210037|NCT00747344|503943|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
210038|NCT00747344|503940|P4|NOT COMPLETED|Controlled Period||0
210039|NCT00747344|503941|P3|NOT COMPLETED|Controlled Period||0
210040|NCT00747344|503942|P2|NOT COMPLETED|Controlled Period||4
210041|NCT00747344|503943|P1|NOT COMPLETED|Controlled Period||5
210042|NCT00747344|503940|P4|COMPLETED|Controlled Period||0
210043|NCT00747344|503941|P3|COMPLETED|Controlled Period||0
210044|NCT00747344|503942|P2|COMPLETED|Controlled Period||57
210045|NCT00747344|503943|P1|COMPLETED|Controlled Period||55
210046|NCT00747344|503940|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
210047|NCT00747344|503941|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
210048|NCT00747344|503942|P2|STARTED|Controlled Period||61
210049|NCT00747344|503943|P1|STARTED|Controlled Period||60
210050|NCT00747227|503957|P2|NOT COMPLETED|Overall Study||4
210051|NCT00747227|503958|P1|NOT COMPLETED|Overall Study||6
210052|NCT00747227|503957|P2|COMPLETED|Overall Study||120
210053|NCT00747227|503958|P1|COMPLETED|Overall Study||120
210054|NCT00747227|503957|P2|STARTED|Overall Study||124
210055|NCT00747227|503958|P1|STARTED|Overall Study||126
210056|NCT00747214|503972|P2|NOT COMPLETED|Overall Study||3
210057|NCT00747214|503973|P1|NOT COMPLETED|Overall Study||8
210058|NCT00747214|503972|P2|COMPLETED|Overall Study||29
210059|NCT00747214|503973|P1|COMPLETED|Overall Study||19
210060|NCT00747214|503972|P2|STARTED|Overall Study||32
210061|NCT00747214|503973|P1|STARTED|Overall Study||27
210062|NCT00747149|503987|P2|NOT COMPLETED|Overall Study||43
210063|NCT00747149|503988|P1|NOT COMPLETED|Overall Study||1
210064|NCT00747149|503987|P2|COMPLETED|Overall Study||401
210065|NCT00747149|503988|P1|COMPLETED|Overall Study||153
210066|NCT00747149|503987|P2|STARTED|Overall Study||444
210067|NCT00747149|503988|P1|STARTED|Overall Study||154
210068|NCT00747006|504003|P3|NOT COMPLETED|Overall Study||1
210069|NCT00747006|504004|P2|NOT COMPLETED|Overall Study||1
210070|NCT00747006|504005|P1|NOT COMPLETED|Overall Study||3
210071|NCT00747006|504003|P3|COMPLETED|Overall Study||2
210072|NCT00747006|504004|P2|COMPLETED|Overall Study||7
210073|NCT00747006|504005|P1|COMPLETED|Overall Study||4
210074|NCT00747006|504003|P3|STARTED|Overall Study||3
210075|NCT00747006|504004|P2|STARTED|Overall Study||8
210076|NCT00747006|504005|P1|STARTED|Overall Study||7
210077|NCT00746954|504071|P3|NOT COMPLETED|Overall Study||0
210078|NCT00746954|504072|P2|NOT COMPLETED|Overall Study||0
210079|NCT00746954|504073|P1|NOT COMPLETED|Overall Study||0
210080|NCT00746954|504071|P3|COMPLETED|Overall Study||2
210081|NCT00746954|504072|P2|COMPLETED|Overall Study||3
210082|NCT00746954|504073|P1|COMPLETED|Overall Study||3
210083|NCT00746954|504071|P3|STARTED|Overall Study||2
210084|NCT00746954|504072|P2|STARTED|Overall Study||3
210085|NCT00746954|504073|P1|STARTED|Overall Study||3
210086|NCT00746941|504083|P4|NOT COMPLETED|Overall Study||13
210087|NCT00746941|504084|P3|NOT COMPLETED|Overall Study||2
210088|NCT00746941|504085|P2|NOT COMPLETED|Overall Study||4
210089|NCT00746941|504086|P1|NOT COMPLETED|Overall Study||7
210090|NCT00746941|504083|P4|COMPLETED|Overall Study||7
210091|NCT00746941|504084|P3|COMPLETED|Overall Study||3
210092|NCT00746941|504085|P2|COMPLETED|Overall Study||1
210093|NCT00746941|504086|P1|COMPLETED|Overall Study||0
210094|NCT00746941|504083|P4|STARTED|Overall Study||20
210095|NCT00746941|504084|P3|STARTED|Overall Study||5
210096|NCT00746941|504085|P2|STARTED|Overall Study||5
210097|NCT00746941|504086|P1|STARTED|Overall Study||7
210098|NCT00746889|504114|P2|NOT COMPLETED|Overall Study||4
210099|NCT00746889|504115|P1|NOT COMPLETED|Overall Study||4
210100|NCT00746889|504114|P2|COMPLETED|Overall Study||35
210101|NCT00746889|504115|P1|COMPLETED|Overall Study||36
210102|NCT00746889|504114|P2|STARTED|Overall Study||39
210103|NCT00746889|504115|P1|STARTED|Overall Study||40
210104|NCT00746863|504125|P2|NOT COMPLETED|Overall Study||0
210105|NCT00746863|504126|P1|NOT COMPLETED|Overall Study||0
210106|NCT00746863|504125|P2|COMPLETED|Overall Study||21
210107|NCT00746863|504126|P1|COMPLETED|Overall Study||21
210108|NCT00746863|504125|P2|STARTED|Overall Study||21
210109|NCT00746863|504126|P1|STARTED|Overall Study||21
210110|NCT00746798|504144|P4|NOT COMPLETED|Overall Study||0
210111|NCT00746798|504145|P3|NOT COMPLETED|Overall Study||3
210112|NCT00746798|504146|P2|NOT COMPLETED|Overall Study||2
210113|NCT00746798|504147|P1|NOT COMPLETED|Overall Study||1
210114|NCT00746798|504144|P4|COMPLETED|Overall Study||120
210115|NCT00746798|504145|P3|COMPLETED|Overall Study||110
210116|NCT00746798|504146|P2|COMPLETED|Overall Study||122
210117|NCT00746798|504147|P1|COMPLETED|Overall Study||121
210118|NCT00746798|504144|P4|STARTED|Overall Study||120
210119|NCT00746798|504145|P3|STARTED|Overall Study||113
210120|NCT00746798|504146|P2|STARTED|Overall Study||124
210121|NCT00746798|504147|P1|STARTED|Overall Study||122
210122|NCT00746785|504172|P3|NOT COMPLETED|Overall Study||27
210123|NCT00746785|504173|P2|NOT COMPLETED|Overall Study||25
210124|NCT00746785|504174|P1|NOT COMPLETED|Overall Study||29
210125|NCT00746785|504172|P3|COMPLETED|Overall Study||13
210126|NCT00746785|504173|P2|COMPLETED|Overall Study||21
210127|NCT00746785|504174|P1|COMPLETED|Overall Study||14
210128|NCT00746785|504172|P3|STARTED|Overall Study||40
210129|NCT00746785|504173|P2|STARTED|Overall Study||46
210130|NCT00746785|504174|P1|STARTED|Overall Study||43
210131|NCT00746733|504182|P2|NOT COMPLETED|Fourth Intervention||0
210132|NCT00746733|504183|P1|NOT COMPLETED|Fourth Intervention||0
210133|NCT00746733|504182|P2|COMPLETED|Fourth Intervention||11
210134|NCT00746733|504183|P1|COMPLETED|Fourth Intervention||10
210135|NCT00746733|504182|P2|STARTED|Fourth Intervention||11
210136|NCT00746733|504183|P1|STARTED|Fourth Intervention||10
210137|NCT00746733|504182|P2|NOT COMPLETED|Third Intervention||1
210138|NCT00746733|504183|P1|NOT COMPLETED|Third Intervention||1
210139|NCT00746733|504182|P2|COMPLETED|Third Intervention||11
210140|NCT00746733|504183|P1|COMPLETED|Third Intervention||10
210141|NCT00746733|504182|P2|STARTED|Third Intervention||12
210142|NCT00746733|504183|P1|STARTED|Third Intervention||11
210143|NCT00746733|504182|P2|NOT COMPLETED|Second Intervention||0
210144|NCT00746733|504183|P1|NOT COMPLETED|Second Intervention||1
210145|NCT00746733|504182|P2|COMPLETED|Second Intervention||12
210146|NCT00746733|504183|P1|COMPLETED|Second Intervention||11
210147|NCT00746733|504182|P2|STARTED|Second Intervention||12
210148|NCT00746733|504183|P1|STARTED|Second Intervention||12
210149|NCT00746733|504182|P2|NOT COMPLETED|First Intervention||0
210150|NCT00746733|504183|P1|NOT COMPLETED|First Intervention||0
210151|NCT00746733|504182|P2|COMPLETED|First Intervention||12
210152|NCT00746733|504183|P1|COMPLETED|First Intervention||12
210153|NCT00746733|504182|P2|STARTED|First Intervention||12
210154|NCT00746733|504183|P1|STARTED|First Intervention||12
210155|NCT00746694|504243|P1|NOT COMPLETED|Overall Study||0
210156|NCT00746694|504243|P1|COMPLETED|Overall Study||154
210157|NCT00746694|504243|P1|STARTED|Overall Study||154
210158|NCT00746668|504248|P7|NOT COMPLETED|Overall Study||0
210159|NCT00746668|504249|P6|NOT COMPLETED|Overall Study||0
210160|NCT00746668|504250|P5|NOT COMPLETED|Overall Study||0
210161|NCT00746668|504251|P4|NOT COMPLETED|Overall Study||0
210162|NCT00746668|504252|P3|NOT COMPLETED|Overall Study||0
210163|NCT00746668|504253|P2|NOT COMPLETED|Overall Study||0
210164|NCT00746668|504254|P1|NOT COMPLETED|Overall Study||0
210165|NCT00746668|504248|P7|COMPLETED|Overall Study||5
210166|NCT00746668|504249|P6|COMPLETED|Overall Study||5
210167|NCT00746668|504250|P5|COMPLETED|Overall Study||5
210168|NCT00746668|504251|P4|COMPLETED|Overall Study||5
210169|NCT00746668|504252|P3|COMPLETED|Overall Study||5
210170|NCT00746668|504253|P2|COMPLETED|Overall Study||5
210171|NCT00746668|504254|P1|COMPLETED|Overall Study||6
210172|NCT00746668|504248|P7|STARTED|Overall Study||5
210173|NCT00746668|504249|P6|STARTED|Overall Study||5
210174|NCT00746668|504250|P5|STARTED|Overall Study||5
210175|NCT00746668|504251|P4|STARTED|Overall Study||5
210176|NCT00746668|504252|P3|STARTED|Overall Study||5
210177|NCT00746668|504253|P2|STARTED|Overall Study||5
210178|NCT00746668|504254|P1|STARTED|Overall Study||6
210179|NCT00746590|504267|P1|NOT COMPLETED|Overall Study||1
210180|NCT00746590|504267|P1|COMPLETED|Overall Study||0
210181|NCT00746590|504267|P1|STARTED|Overall Study||1
210182|NCT00746564|504271|P1|NOT COMPLETED|Overall Study||2
210183|NCT00746564|504271|P1|COMPLETED|Overall Study||73
210184|NCT00746564|504271|P1|STARTED|Overall Study||75
210185|NCT00746551|504286|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
210186|NCT00746551|504287|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
210187|NCT00746551|504286|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
210188|NCT00746551|504287|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
210189|NCT00746551|504286|P2|STARTED|At Delivery (GA of 39 Weeks)||40
210190|NCT00746551|504287|P1|STARTED|At Delivery (GA of 39 Weeks)||40
210191|NCT00746551|504286|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
210192|NCT00746551|504287|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
210193|NCT00746551|504286|P2|COMPLETED|At Gestational Age of 36 Weeks||36
210194|NCT00746551|504287|P1|COMPLETED|At Gestational Age of 36 Weeks||38
210195|NCT00746551|504286|P2|STARTED|At Gestational Age of 36 Weeks||40
210196|NCT00746551|504287|P1|STARTED|At Gestational Age of 36 Weeks||40
210197|NCT00746512|504299|P4|NOT COMPLETED|Overall Study||0
210198|NCT00746512|504300|P3|NOT COMPLETED|Overall Study||0
210199|NCT00746512|504301|P2|NOT COMPLETED|Overall Study||0
210200|NCT00746512|504302|P1|NOT COMPLETED|Overall Study||0
210201|NCT00746512|504299|P4|COMPLETED|Overall Study||9
210202|NCT00746512|504300|P3|COMPLETED|Overall Study||18
210203|NCT00746512|504301|P2|COMPLETED|Overall Study||10
210204|NCT00746512|504302|P1|COMPLETED|Overall Study||8
210205|NCT00746512|504299|P4|STARTED|Overall Study||9
210206|NCT00746512|504300|P3|STARTED|Overall Study||18
210207|NCT00746512|504301|P2|STARTED|Overall Study||10
210208|NCT00746512|504302|P1|STARTED|Overall Study||8
210209|NCT00746421|504318|P2|NOT COMPLETED|Overall Study||2
210210|NCT00746421|504319|P1|NOT COMPLETED|Overall Study||7
210211|NCT00746421|504318|P2|COMPLETED|Overall Study||9
210212|NCT00746421|504319|P1|COMPLETED|Overall Study||5
210213|NCT00746421|504318|P2|STARTED|Overall Study||11
210214|NCT00746421|504319|P1|STARTED|Overall Study||12
210215|NCT00746395|504329|P2|NOT COMPLETED|Overall Study||0
210216|NCT00746395|504330|P1|NOT COMPLETED|Overall Study||0
210217|NCT00746395|504329|P2|COMPLETED|Overall Study||20
210218|NCT00746395|504330|P1|COMPLETED|Overall Study||20
210219|NCT00746395|504329|P2|STARTED|Overall Study||20
210220|NCT00746395|504330|P1|STARTED|Overall Study||20
210221|NCT00746356|504338|P2|NOT COMPLETED|Overall Study||7
210222|NCT00746356|504339|P1|NOT COMPLETED|Overall Study||11
210223|NCT00746356|504338|P2|COMPLETED|Overall Study||40
210224|NCT00746356|504339|P1|COMPLETED|Overall Study||70
210225|NCT00746356|504338|P2|STARTED|Overall Study||47
210226|NCT00746356|504339|P1|STARTED|Overall Study||81
210227|NCT00746330|504351|P4|NOT COMPLETED|Period 4||0
210228|NCT00746330|504352|P3|NOT COMPLETED|Period 4||0
210229|NCT00746330|504353|P2|NOT COMPLETED|Period 4||0
210230|NCT00746330|504354|P1|NOT COMPLETED|Period 4||0
210231|NCT00746330|504351|P4|COMPLETED|Period 4||7
210232|NCT00746330|504352|P3|COMPLETED|Period 4||8
210233|NCT00746330|504353|P2|COMPLETED|Period 4||9
210234|NCT00746330|504354|P1|COMPLETED|Period 4||7
210235|NCT00746330|504351|P4|STARTED|Period 4||7
210236|NCT00746330|504352|P3|STARTED|Period 4||8
210237|NCT00746330|504353|P2|STARTED|Period 4||9
210238|NCT00746330|504354|P1|STARTED|Period 4||7
210239|NCT00746330|504351|P4|NOT COMPLETED|Period 3||0
210240|NCT00746330|504352|P3|NOT COMPLETED|Period 3||0
210241|NCT00746330|504353|P2|NOT COMPLETED|Period 3||0
210242|NCT00746330|504354|P1|NOT COMPLETED|Period 3||0
210243|NCT00746330|504351|P4|COMPLETED|Period 3||7
210244|NCT00746330|504352|P3|COMPLETED|Period 3||8
210245|NCT00746330|504353|P2|COMPLETED|Period 3||9
210246|NCT00746330|504354|P1|COMPLETED|Period 3||7
210247|NCT00746330|504351|P4|STARTED|Period 3||7
210248|NCT00746330|504352|P3|STARTED|Period 3||8
210249|NCT00746330|504353|P2|STARTED|Period 3||9
210250|NCT00746330|504354|P1|STARTED|Period 3||7
210251|NCT00746330|504351|P4|NOT COMPLETED|Period 2||0
210252|NCT00746330|504352|P3|NOT COMPLETED|Period 2||0
210253|NCT00746330|504353|P2|NOT COMPLETED|Period 2||0
210254|NCT00746330|504354|P1|NOT COMPLETED|Period 2||0
210255|NCT00746330|504351|P4|COMPLETED|Period 2||7
210256|NCT00746330|504352|P3|COMPLETED|Period 2||8
210257|NCT00746330|504353|P2|COMPLETED|Period 2||9
210258|NCT00746330|504354|P1|COMPLETED|Period 2||7
210259|NCT00746330|504351|P4|STARTED|Period 2||7
210260|NCT00746330|504352|P3|STARTED|Period 2||8
210261|NCT00746330|504353|P2|STARTED|Period 2||9
210262|NCT00746330|504354|P1|STARTED|Period 2||7
210263|NCT00746330|504351|P4|NOT COMPLETED|Period 1||0
210264|NCT00746330|504352|P3|NOT COMPLETED|Period 1||1
210265|NCT00746330|504353|P2|NOT COMPLETED|Period 1||0
210266|NCT00746330|504354|P1|NOT COMPLETED|Period 1||0
210267|NCT00746330|504351|P4|COMPLETED|Period 1||7
210268|NCT00746330|504352|P3|COMPLETED|Period 1||8
210269|NCT00746330|504353|P2|COMPLETED|Period 1||9
210270|NCT00746330|504354|P1|COMPLETED|Period 1||7
210271|NCT00746330|504351|P4|STARTED|Period 1||7
210272|NCT00746330|504352|P3|STARTED|Period 1||9
210273|NCT00746330|504353|P2|STARTED|Period 1||9
210274|NCT00746330|504354|P1|STARTED|Period 1||7
210275|NCT00746252|504384|P2|NOT COMPLETED|Overall Study||2
210276|NCT00746252|504385|P1|NOT COMPLETED|Overall Study||1
210277|NCT00746252|504384|P2|COMPLETED|Overall Study||0
210278|NCT00746252|504385|P1|COMPLETED|Overall Study||0
210279|NCT00746252|504384|P2|STARTED|Overall Study||2
210280|NCT00746252|504385|P1|STARTED|Overall Study||1
210281|NCT00746239|504391|P1|NOT COMPLETED|Overall Study||6
210282|NCT00746239|504391|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
210283|NCT00746239|504391|P1|STARTED|Overall Study||11
210284|NCT00746187|504398|P2|NOT COMPLETED|Overall Study||2
210285|NCT00746187|504399|P1|NOT COMPLETED|Overall Study||3
210286|NCT00746187|504398|P2|COMPLETED|Overall Study||16
210287|NCT00746187|504399|P1|COMPLETED|Overall Study||15
210288|NCT00746187|504398|P2|STARTED|Overall Study||18
210289|NCT00746187|504399|P1|STARTED|Overall Study||18
210290|NCT00746096|504407|P2|NOT COMPLETED|Overall Study||3
210291|NCT00746096|504408|P1|NOT COMPLETED|Overall Study||10
210292|NCT00746096|504407|P2|COMPLETED|Overall Study||54
210293|NCT00746096|504408|P1|COMPLETED|Overall Study||48
210294|NCT00746096|504407|P2|STARTED|Overall Study||57
210295|NCT00746096|504408|P1|STARTED|Overall Study||58
210296|NCT00746018|504416|P1|NOT COMPLETED|Overall Study||0
210297|NCT00746018|504416|P1|COMPLETED|Overall Study||39
210298|NCT00746018|504416|P1|STARTED|Overall Study||39
210299|NCT00745940|504422|P2|NOT COMPLETED|Overall Study||10
210300|NCT00745940|504423|P1|NOT COMPLETED|Overall Study||19
210301|NCT00745940|504422|P2|COMPLETED|Overall Study||38
210302|NCT00745940|504423|P1|COMPLETED|Overall Study||38
210303|NCT00745940|504422|P2|STARTED|Overall Study||48
210304|NCT00745940|504423|P1|STARTED|Overall Study||57
210305|NCT00745901|504439|P2|NOT COMPLETED|Overall Study||21
210306|NCT00745901|504440|P1|NOT COMPLETED|Overall Study||24
210307|NCT00745901|504439|P2|COMPLETED|Overall Study||156
210308|NCT00745901|504440|P1|COMPLETED|Overall Study||154
210309|NCT00745901|504439|P2|STARTED|Overall Study|Number of Patients Randomized|177
210310|NCT00745901|504440|P1|STARTED|Overall Study|Number of Patients Randomized|178
210311|NCT00745875|504486|P2|NOT COMPLETED|Overall Study||4
210312|NCT00745875|504487|P1|NOT COMPLETED|Overall Study||4
210313|NCT00745875|504486|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
210314|NCT00745875|504487|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
210315|NCT00745875|504486|P2|STARTED|Overall Study|Started – Number of patients randomised|30
210316|NCT00745875|504487|P1|STARTED|Overall Study|Started – Number of patients randomised|36
210317|NCT00745823|504497|P2|NOT COMPLETED|Overall Study||386
210318|NCT00745823|504498|P1|NOT COMPLETED|Overall Study||385
210319|NCT00745823|504497|P2|COMPLETED|Overall Study||3
210320|NCT00745823|504498|P1|COMPLETED|Overall Study||1
210321|NCT00745823|504497|P2|TREATED Week 0 - 96|Overall Study||388
210322|NCT00745823|504498|P1|TREATED Week 0 - 96|Overall Study||382
210323|NCT00745823|504497|P2|STARTED|Overall Study||389
210324|NCT00745823|504498|P1|STARTED|Overall Study||386
210325|NCT00745498|504525|P3|NOT COMPLETED|Overall Study||8
210326|NCT00745498|504526|P2|NOT COMPLETED|Overall Study||6
210327|NCT00745498|504527|P1|NOT COMPLETED|Overall Study||5
210328|NCT00745498|504525|P3|COMPLETED|Overall Study||34
210329|NCT00745498|504526|P2|COMPLETED|Overall Study||37
210330|NCT00745498|504527|P1|COMPLETED|Overall Study||36
210331|NCT00745498|504525|P3|STARTED|Overall Study||42
210332|NCT00745498|504526|P2|STARTED|Overall Study||43
210333|NCT00745498|504527|P1|STARTED|Overall Study||41
210334|NCT00745420|504541|P1|NOT COMPLETED|Overall Study||1
210335|NCT00745420|504541|P1|COMPLETED|Overall Study||29
210336|NCT00745420|504541|P1|STARTED|Overall Study||30
210337|NCT00745368|504558|P1|NOT COMPLETED|Overall Study||3
210338|NCT00745368|504558|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
210339|NCT00745368|504558|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
210340|NCT00745290|504571|P2|NOT COMPLETED|Overall Study||0
210341|NCT00745290|504572|P1|NOT COMPLETED|Overall Study||0
210342|NCT00745290|504571|P2|COMPLETED|Overall Study||122
210343|NCT00745290|504572|P1|COMPLETED|Overall Study||123
210344|NCT00745290|504571|P2|STARTED|Overall Study||122
210345|NCT00745290|504572|P1|STARTED|Overall Study||123
210346|NCT00745251|504580|P2|NOT COMPLETED|Overall Study||3
210347|NCT00745251|504581|P1|NOT COMPLETED|Overall Study||2
210348|NCT00745251|504580|P2|COMPLETED|Overall Study||19
210349|NCT00745251|504581|P1|COMPLETED|Overall Study||21
210350|NCT00745251|504580|P2|STARTED|Overall Study||22
210351|NCT00745251|504581|P1|STARTED|Overall Study||23
210352|NCT00745095|504595|P6|NOT COMPLETED|Overall Study||123
210353|NCT00745095|504596|P5|NOT COMPLETED|Overall Study||122
210354|NCT00745095|504597|P4|NOT COMPLETED|Overall Study||3
210355|NCT00745095|504598|P3|NOT COMPLETED|Overall Study||3
210356|NCT00745095|504599|P2|NOT COMPLETED|Overall Study||2
210357|NCT00745095|504600|P1|NOT COMPLETED|Overall Study||1
210358|NCT00745095|504595|P6|COMPLETED|Overall Study||27
210359|NCT00745095|504596|P5|COMPLETED|Overall Study||28
210360|NCT00745095|504597|P4|COMPLETED|Overall Study||12
210361|NCT00745095|504598|P3|COMPLETED|Overall Study||12
210362|NCT00745095|504599|P2|COMPLETED|Overall Study||13
210363|NCT00745095|504600|P1|COMPLETED|Overall Study||14
210364|NCT00745095|504595|P6|STARTED|Overall Study||150
210365|NCT00745095|504596|P5|STARTED|Overall Study||150
210366|NCT00745095|504597|P4|STARTED|Overall Study||15
210367|NCT00745095|504598|P3|STARTED|Overall Study||15
210368|NCT00745095|504599|P2|STARTED|Overall Study||15
210369|NCT00745095|504600|P1|STARTED|Overall Study||15
210370|NCT00745030|504622|P2|NOT COMPLETED|Overall Study||0
210371|NCT00745030|504623|P1|NOT COMPLETED|Overall Study||0
210372|NCT00745030|504622|P2|COMPLETED|Overall Study||2
210373|NCT00745030|504623|P1|COMPLETED|Overall Study||1
210374|NCT00745030|504622|P2|STARTED|Overall Study||2
210375|NCT00745030|504623|P1|STARTED|Overall Study||1
210376|NCT00744978|504631|P2|NOT COMPLETED|Period 2||1
210377|NCT00744978|504632|P1|NOT COMPLETED|Period 2||0
210378|NCT00744978|504631|P2|COMPLETED|Period 2||28
210379|NCT00744978|504632|P1|COMPLETED|Period 2||26
210380|NCT00744978|504631|P2|STARTED|Period 2||29
210381|NCT00744978|504632|P1|STARTED|Period 2||26
210382|NCT00744978|504631|P2|NOT COMPLETED|Placebo Washout||0
210383|NCT00744978|504632|P1|NOT COMPLETED|Placebo Washout||0
210384|NCT00744978|504631|P2|COMPLETED|Placebo Washout||29
210385|NCT00744978|504632|P1|COMPLETED|Placebo Washout||26
210386|NCT00744978|504631|P2|STARTED|Placebo Washout||29
210387|NCT00744978|504632|P1|STARTED|Placebo Washout||26
210388|NCT00744978|504631|P2|NOT COMPLETED|Period 1||5
210389|NCT00744978|504632|P1|NOT COMPLETED|Period 1||6
210390|NCT00744978|504631|P2|COMPLETED|Period 1||29
210391|NCT00744978|504632|P1|COMPLETED|Period 1||26
210392|NCT00744978|504631|P2|Treated|Period 1||33
210393|NCT00744978|504632|P1|Treated|Period 1||31
210394|NCT00744978|504631|P2|STARTED|Period 1||34
210395|NCT00744978|504632|P1|STARTED|Period 1||32
210396|NCT00744939|504684|P1|NOT COMPLETED|Overall Study||91
210397|NCT00744939|504684|P1|COMPLETED|Overall Study||77
210398|NCT00744939|504684|P1|Treatment Received|Overall Study||141
210399|NCT00744939|504684|P1|STARTED|Overall Study||168
210400|NCT00744874|504720|P1|NOT COMPLETED|Overall Study||4
210401|NCT00744874|504720|P1|COMPLETED|Overall Study||51
210402|NCT00744874|504720|P1|STARTED|Overall Study||55
210403|NCT00744848|504738|P2|NOT COMPLETED|Overall Study||0
210404|NCT00744848|504739|P1|NOT COMPLETED|Overall Study||0
210405|NCT00744848|504738|P2|COMPLETED|Overall Study||101
210406|NCT00744848|504739|P1|COMPLETED|Overall Study||103
210407|NCT00744848|504738|P2|STARTED|Overall Study||101
210408|NCT00744848|504739|P1|STARTED|Overall Study||103
210409|NCT00744757|504745|P1|NOT COMPLETED|Overall Study||21
210410|NCT00744757|504745|P1|COMPLETED|Overall Study||16
210411|NCT00744757|504745|P1|STARTED|Overall Study||37
210412|NCT00744692|504758|P1|NOT COMPLETED|Overall Study||0
210413|NCT00744692|504758|P1|COMPLETED|Overall Study||22
210414|NCT00744692|504758|P1|STARTED|Overall Study||22
210415|NCT00744653|504770|P1|NOT COMPLETED|Overall Study||16
210416|NCT00744653|504770|P1|COMPLETED|Overall Study||1
210417|NCT00744653|504770|P1|STARTED|Overall Study||17
210418|NCT00744627|504778|P2|NOT COMPLETED|Overall Study||22
210419|NCT00744627|504779|P1|NOT COMPLETED|Overall Study||25
210420|NCT00744627|504778|P2|COMPLETED|Overall Study||128
210421|NCT00744627|504779|P1|COMPLETED|Overall Study||126
210422|NCT00744627|504778|P2|Treated|Overall Study||150
210423|NCT00744627|504779|P1|Treated|Overall Study||150
210424|NCT00744627|504778|P2|STARTED|Overall Study||150
210425|NCT00744627|504779|P1|STARTED|Overall Study||151
210426|NCT00744523|504835|P2|NOT COMPLETED|30 Days After the Procedure||5
210427|NCT00744523|504836|P1|NOT COMPLETED|30 Days After the Procedure||0
210428|NCT00744523|504835|P2|COMPLETED|30 Days After the Procedure||220
210429|NCT00744523|504836|P1|COMPLETED|30 Days After the Procedure||37
210430|NCT00744523|504835|P2|STARTED|30 Days After the Procedure||225
210431|NCT00744523|504836|P1|STARTED|30 Days After the Procedure||37
210432|NCT00744523|504835|P2|NOT COMPLETED|Procedure||0
210433|NCT00744523|504836|P1|NOT COMPLETED|Procedure||0
210434|NCT00744523|504835|P2|COMPLETED|Procedure||225
210435|NCT00744523|504836|P1|COMPLETED|Procedure||37
210436|NCT00744523|504835|P2|STARTED|Procedure||225
210437|NCT00744523|504836|P1|STARTED|Procedure||37
210438|NCT00744497|504856|P2|NOT COMPLETED|Overall Study||762
210439|NCT00744497|504857|P1|NOT COMPLETED|Overall Study||760
210440|NCT00744497|504856|P2|COMPLETED|Overall Study||0
210441|NCT00744497|504857|P1|COMPLETED|Overall Study||0
210442|NCT00744497|504856|P2|Received Treatment|Overall Study||761
210443|NCT00744497|504857|P1|Received Treatment|Overall Study||757
210444|NCT00744497|504856|P2|STARTED|Overall Study|Randomized|762
210445|NCT00744497|504857|P1|STARTED|Overall Study|Randomized|760
210446|NCT00744380|504893|P2|NOT COMPLETED|Overall Study||0
210447|NCT00744380|504894|P1|NOT COMPLETED|Overall Study||0
210448|NCT00744380|504893|P2|COMPLETED|Overall Study||11
210449|NCT00744380|504894|P1|COMPLETED|Overall Study||12
210450|NCT00744380|504893|P2|STARTED|Overall Study||11
210451|NCT00744380|504894|P1|STARTED|Overall Study||12
210452|NCT00744328|504917|P3|NOT COMPLETED|Overall Study||8
210453|NCT00744328|504918|P2|NOT COMPLETED|Overall Study||8
210454|NCT00744328|504919|P1|NOT COMPLETED|Overall Study||7
210455|NCT00744328|504917|P3|COMPLETED|Overall Study||21
210456|NCT00744328|504918|P2|COMPLETED|Overall Study||22
210457|NCT00744328|504919|P1|COMPLETED|Overall Study||19
210458|NCT00744328|504917|P3|STARTED|Overall Study||29
210459|NCT00744328|504918|P2|STARTED|Overall Study||30
210460|NCT00744328|504919|P1|STARTED|Overall Study||26
210461|NCT00744263|504929|P2|NOT COMPLETED|Overall Study||5320
210462|NCT00744263|504930|P1|NOT COMPLETED|Overall Study||5236
210463|NCT00744263|504929|P2|COMPLETED|Overall Study||36936
210464|NCT00744263|504930|P1|COMPLETED|Overall Study||37004
210465|NCT00744263|504929|P2|STARTED|Overall Study||42256
210466|NCT00744263|504930|P1|STARTED|Overall Study||42240
210467|NCT00744237|504953|P3|NOT COMPLETED|Overall Study||15
210468|NCT00744237|504954|P2|NOT COMPLETED|Overall Study||27
210469|NCT00744237|504955|P1|NOT COMPLETED|Overall Study||27
210470|NCT00744237|504953|P3|COMPLETED|Overall Study||59
210471|NCT00744237|504954|P2|COMPLETED|Overall Study||46
210472|NCT00744237|504955|P1|COMPLETED|Overall Study||56
210473|NCT00744237|504953|P3|STARTED|Overall Study||74
210474|NCT00744237|504954|P2|STARTED|Overall Study||73
210475|NCT00744237|504955|P1|STARTED|Overall Study||83
210476|NCT00744211|504969|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
210477|NCT00744211|504970|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
210478|NCT00744211|504971|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
210479|NCT00744211|504969|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
210480|NCT00744211|504970|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
210481|NCT00744211|504971|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
210482|NCT00744211|504969|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
210483|NCT00744211|504970|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
210484|NCT00744211|504971|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
210485|NCT00744211|504969|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
210486|NCT00744211|504970|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
210487|NCT00744211|504971|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
210488|NCT00744211|504969|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
210489|NCT00744211|504970|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
210490|NCT00744211|504971|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
210491|NCT00744211|504969|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
210492|NCT00744211|504970|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
210493|NCT00744211|504971|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
210494|NCT00744211|504969|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
210495|NCT00744211|504970|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
210496|NCT00744211|504971|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
210497|NCT00744211|504969|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
210498|NCT00744211|504970|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
210499|NCT00744211|504971|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
210500|NCT00744211|504969|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
210501|NCT00744211|504970|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
210502|NCT00744211|504971|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
210503|NCT00744211|504969|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
210504|NCT00744211|504970|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
210505|NCT00744211|504971|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
210506|NCT00744211|504969|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
210507|NCT00744211|504970|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
210508|NCT00744211|504971|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
210509|NCT00744211|504969|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
210510|NCT00744211|504970|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
210511|NCT00744211|504971|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
210512|NCT00744211|504969|P3|NOT COMPLETED|Baseline||0
210513|NCT00744211|504970|P2|NOT COMPLETED|Baseline||0
210514|NCT00744211|504971|P1|NOT COMPLETED|Baseline||0
210515|NCT00744211|504969|P3|COMPLETED|Baseline||10
210516|NCT00744211|504970|P2|COMPLETED|Baseline||9
210517|NCT00744211|504971|P1|COMPLETED|Baseline||10
210518|NCT00744211|504969|P3|STARTED|Baseline||10
210519|NCT00744211|504970|P2|STARTED|Baseline||9
210520|NCT00744211|504971|P1|STARTED|Baseline||10
210521|NCT00744055|504989|P2|NOT COMPLETED|Overall Study||14
210522|NCT00744055|504990|P1|NOT COMPLETED|Overall Study||7
210523|NCT00744055|504989|P2|COMPLETED|Overall Study||32
210524|NCT00744055|504990|P1|COMPLETED|Overall Study||43
210525|NCT00744055|504989|P2|STARTED|Overall Study||46
210526|NCT00744055|504990|P1|STARTED|Overall Study||50
210527|NCT00744042|504998|P1|NOT COMPLETED|Overall Study||1
210528|NCT00744042|504998|P1|COMPLETED|Overall Study||10
210529|NCT00744042|504998|P1|STARTED|Overall Study||11
210530|NCT00743730|505014|P3|NOT COMPLETED|Overall Study||5
210531|NCT00743730|505015|P2|NOT COMPLETED|Overall Study||4
210532|NCT00743730|505016|P1|NOT COMPLETED|Overall Study||5
210533|NCT00743730|505014|P3|COMPLETED|Overall Study||28
210534|NCT00743730|505015|P2|COMPLETED|Overall Study||30
210535|NCT00743730|505016|P1|COMPLETED|Overall Study||22
210536|NCT00743730|505014|P3|STARTED|Overall Study||33
210537|NCT00743730|505015|P2|STARTED|Overall Study||34
210538|NCT00743730|505016|P1|STARTED|Overall Study||27
210539|NCT00743717|505029|P2|NOT COMPLETED|Overall Study||0
210540|NCT00743717|505030|P1|NOT COMPLETED|Overall Study||0
210541|NCT00743717|505029|P2|COMPLETED|Overall Study||2
210542|NCT00743717|505030|P1|COMPLETED|Overall Study||2
210543|NCT00743717|505029|P2|STARTED|Overall Study||2
210544|NCT00743717|505030|P1|STARTED|Overall Study||2
210545|NCT00743652|505041|P5|NOT COMPLETED|Overall Study||0
210546|NCT00743652|505042|P4|NOT COMPLETED|Overall Study||4
210547|NCT00743652|505043|P3|NOT COMPLETED|Overall Study||2
210548|NCT00743652|505044|P2|NOT COMPLETED|Overall Study||3
210549|NCT00743652|505045|P1|NOT COMPLETED|Overall Study||10
210550|NCT00743652|505041|P5|COMPLETED|Overall Study||79
210551|NCT00743652|505042|P4|COMPLETED|Overall Study||63
210552|NCT00743652|505043|P3|COMPLETED|Overall Study||23
210553|NCT00743652|505044|P2|COMPLETED|Overall Study||48
210554|NCT00743652|505045|P1|COMPLETED|Overall Study||141
210555|NCT00743652|505041|P5|Toddler Dose|Overall Study||0
210556|NCT00743652|505042|P4|Toddler Dose|Overall Study||0
210557|NCT00743652|505043|P3|Toddler Dose|Overall Study||16
210558|NCT00743652|505044|P2|Toddler Dose|Overall Study||23
210559|NCT00743652|505045|P1|Toddler Dose|Overall Study||15
210560|NCT00743652|505041|P5|Vaccinated Dose 3|Overall Study||0
210561|NCT00743652|505042|P4|Vaccinated Dose 3|Overall Study||0
210562|NCT00743652|505043|P3|Vaccinated Dose 3|Overall Study||0
210563|NCT00743652|505044|P2|Vaccinated Dose 3|Overall Study||0
210564|NCT00743652|505045|P1|Vaccinated Dose 3|Overall Study||74
210565|NCT00743652|505041|P5|Vaccinated Dose 2|Overall Study||0
210566|NCT00743652|505042|P4|Vaccinated Dose 2|Overall Study||49
210567|NCT00743652|505043|P3|Vaccinated Dose 2|Overall Study||0
210568|NCT00743652|505044|P2|Vaccinated Dose 2|Overall Study||41
210569|NCT00743652|505045|P1|Vaccinated Dose 2|Overall Study||112
210570|NCT00743652|505041|P5|Vaccinated Dose 1|Overall Study||79
210571|NCT00743652|505042|P4|Vaccinated Dose 1|Overall Study||66
210572|NCT00743652|505043|P3|Vaccinated Dose 1|Overall Study||25
210573|NCT00743652|505044|P2|Vaccinated Dose 1|Overall Study||51
210574|NCT00743652|505045|P1|Vaccinated Dose 1|Overall Study||151
210575|NCT00743652|505041|P5|STARTED|Overall Study||79
210576|NCT00743652|505042|P4|STARTED|Overall Study||67
210577|NCT00743652|505043|P3|STARTED|Overall Study||25
210578|NCT00743652|505044|P2|STARTED|Overall Study||51
210579|NCT00743652|505045|P1|STARTED|Overall Study||151
210580|NCT00743574|505120|P1|NOT COMPLETED|Overall Study||24
210581|NCT00743574|505120|P1|COMPLETED|Overall Study||12
210582|NCT00743574|505120|P1|Dropped Out After Initiating Trial|Overall Study||3
210583|NCT00743574|505120|P1|Further Exclusions|Overall Study||8
210584|NCT00743574|505120|P1|Dropped Out Before Eligibility Testing|Overall Study||13
210585|NCT00743574|505120|P1|STARTED|Overall Study||36
210586|NCT00743509|505129|P1|NOT COMPLETED|Overall Study||2
210587|NCT00743509|505129|P1|COMPLETED|Overall Study||47
210588|NCT00743509|505129|P1|STARTED|Overall Study||49
210589|NCT00743483|505134|P1|NOT COMPLETED|Treatment Period||1
210590|NCT00743483|505134|P1|COMPLETED|Treatment Period||13
210591|NCT00743483|505134|P1|STARTED|Treatment Period||14
210592|NCT00743483|505134|P1|NOT COMPLETED|Baseline Period||1
210593|NCT00743483|505134|P1|COMPLETED|Baseline Period||14
210594|NCT00743483|505134|P1|STARTED|Baseline Period||15
210595|NCT00743444|505138|P2|NOT COMPLETED|Second Intervention||0
210596|NCT00743444|505139|P1|NOT COMPLETED|Second Intervention||0
210597|NCT00743444|505138|P2|COMPLETED|Second Intervention||11
210598|NCT00743444|505139|P1|COMPLETED|Second Intervention||14
210599|NCT00743444|505138|P2|STARTED|Second Intervention||11
210600|NCT00743444|505139|P1|STARTED|Second Intervention||14
210601|NCT00743444|505138|P2|NOT COMPLETED|Washout Period||1
210602|NCT00743444|505139|P1|NOT COMPLETED|Washout Period||0
210603|NCT00743444|505138|P2|COMPLETED|Washout Period||11
210604|NCT00743444|505139|P1|COMPLETED|Washout Period||14
210605|NCT00743444|505138|P2|STARTED|Washout Period||12
210606|NCT00743444|505139|P1|STARTED|Washout Period||14
210607|NCT00743444|505138|P2|NOT COMPLETED|First Intervention||1
210608|NCT00743444|505139|P1|NOT COMPLETED|First Intervention||0
210609|NCT00743444|505138|P2|COMPLETED|First Intervention||12
210610|NCT00743444|505139|P1|COMPLETED|First Intervention||14
210611|NCT00743444|505138|P2|STARTED|First Intervention||13
210612|NCT00743444|505139|P1|STARTED|First Intervention||14
210613|NCT00743431|505148|P1|NOT COMPLETED|Overall Study||126
210614|NCT00743431|505148|P1|COMPLETED|Overall Study||98
210615|NCT00743431|505148|P1|STARTED|Overall Study||224
210616|NCT00743366|505152|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
210617|NCT00743366|505153|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
210618|NCT00743366|505152|P2|COMPLETED|Intervention 2 (8 Days)||7
210619|NCT00743366|505153|P1|COMPLETED|Intervention 2 (8 Days)||7
210620|NCT00743366|505152|P2|STARTED|Intervention 2 (8 Days)||7
210621|NCT00743366|505153|P1|STARTED|Intervention 2 (8 Days)||7
210622|NCT00743366|505152|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
210623|NCT00743366|505153|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
210624|NCT00743366|505152|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
210716|NCT00742872|505328|P2|NOT COMPLETED|Overall Study||8
210625|NCT00743366|505153|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
210626|NCT00743366|505152|P2|STARTED|Intervention 1 (8 Days)||10
210627|NCT00743366|505153|P1|STARTED|Intervention 1 (8 Days)||10
210628|NCT00743340|505159|P1|NOT COMPLETED|Overall Study||41
210629|NCT00743340|505159|P1|COMPLETED|Overall Study||9
210630|NCT00743340|505159|P1|STARTED|Overall Study||50
210631|NCT00743288|505163|P7|NOT COMPLETED|Overall Study||9
210632|NCT00743288|505164|P6|NOT COMPLETED|Overall Study||5
210633|NCT00743288|505165|P5|NOT COMPLETED|Overall Study||6
210634|NCT00743288|505166|P4|NOT COMPLETED|Overall Study||7
210635|NCT00743288|505167|P3|NOT COMPLETED|Overall Study||5
210636|NCT00743288|505168|P2|NOT COMPLETED|Overall Study||3
210637|NCT00743288|505169|P1|NOT COMPLETED|Overall Study||3
210638|NCT00743288|505163|P7|COMPLETED|Overall Study||0
210639|NCT00743288|505164|P6|COMPLETED|Overall Study||1
210640|NCT00743288|505165|P5|COMPLETED|Overall Study||0
210641|NCT00743288|505166|P4|COMPLETED|Overall Study||0
210642|NCT00743288|505167|P3|COMPLETED|Overall Study||1
210643|NCT00743288|505168|P2|COMPLETED|Overall Study||0
210644|NCT00743288|505169|P1|COMPLETED|Overall Study||0
210645|NCT00743288|505163|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
210646|NCT00743288|505164|P6|STARTED|Overall Study||6
210647|NCT00743288|505165|P5|STARTED|Overall Study||6
210648|NCT00743288|505166|P4|STARTED|Overall Study||7
210649|NCT00743288|505167|P3|STARTED|Overall Study||6
210650|NCT00743288|505168|P2|STARTED|Overall Study||3
210651|NCT00743288|505169|P1|STARTED|Overall Study||3
210652|NCT00743275|505183|P2|NOT COMPLETED|Overall Study||1
210653|NCT00743275|505184|P1|NOT COMPLETED|Overall Study||0
210654|NCT00743275|505183|P2|COMPLETED|Overall Study||60
210655|NCT00743275|505184|P1|COMPLETED|Overall Study||59
210656|NCT00743275|505183|P2|STARTED|Overall Study||61
210657|NCT00743275|505184|P1|STARTED|Overall Study||59
210658|NCT00743262|505196|P1|NOT COMPLETED|Overall Study||0
210659|NCT00743262|505196|P1|COMPLETED|Overall Study||15
210660|NCT00743262|505196|P1|STARTED|Overall Study||15
210661|NCT00743249|505204|P2|NOT COMPLETED|Overall Study||6
210662|NCT00743249|505205|P1|NOT COMPLETED|Overall Study||2
210663|NCT00743249|505204|P2|COMPLETED|Overall Study||24
210664|NCT00743249|505205|P1|COMPLETED|Overall Study||28
210665|NCT00743249|505204|P2|STARTED|Overall Study||30
210666|NCT00743249|505205|P1|STARTED|Overall Study||30
210667|NCT00743197|505215|P2|NOT COMPLETED|Overall Study||2
210668|NCT00743197|505216|P1|NOT COMPLETED|Overall Study||1
210669|NCT00743197|505215|P2|COMPLETED|Overall Study||0
210670|NCT00743197|505216|P1|COMPLETED|Overall Study||0
210671|NCT00743197|505215|P2|STARTED|Overall Study||2
210672|NCT00743197|505216|P1|STARTED|Overall Study||1
210673|NCT00743119|505222|P1|NOT COMPLETED|Overall Study||4
210674|NCT00743119|505222|P1|COMPLETED|Overall Study||30
210675|NCT00743119|505222|P1|STARTED|Overall Study||34
210676|NCT00743106|505236|P2|NOT COMPLETED|Overall Study||5
210677|NCT00743106|505237|P1|NOT COMPLETED|Overall Study||8
210678|NCT00743106|505236|P2|COMPLETED|Overall Study||43
210679|NCT00743106|505237|P1|COMPLETED|Overall Study||34
210680|NCT00743106|505236|P2|STARTED|Overall Study||48
210681|NCT00743106|505237|P1|STARTED|Overall Study||42
210682|NCT00743093|505247|P2|NOT COMPLETED|Extended Dosing Period||0
210683|NCT00743093|505248|P1|NOT COMPLETED|Extended Dosing Period||3
210684|NCT00743093|505247|P2|COMPLETED|Extended Dosing Period||1
210685|NCT00743093|505248|P1|COMPLETED|Extended Dosing Period||48
210686|NCT00743093|505247|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
210687|NCT00743093|505248|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
210688|NCT00743093|505247|P2|NOT COMPLETED|Base Study Period||5
210689|NCT00743093|505248|P1|NOT COMPLETED|Base Study Period||19
210690|NCT00743093|505247|P2|COMPLETED|Base Study Period||47
210691|NCT00743093|505248|P1|COMPLETED|Base Study Period||205
210692|NCT00743093|505247|P2|STARTED|Base Study Period||52
210693|NCT00743093|505248|P1|STARTED|Base Study Period||224
210694|NCT00742963|505256|P1|NOT COMPLETED|Overall Study||33
210695|NCT00742963|505256|P1|COMPLETED|Overall Study||68
210696|NCT00742963|505256|P1|Completed All Treatment Cycles|Overall Study||68
210697|NCT00742963|505256|P1|STARTED|Overall Study||101
210698|NCT00742924|505264|P4|NOT COMPLETED|Overall Study||6
210699|NCT00742924|505265|P3|NOT COMPLETED|Overall Study||4
210700|NCT00742924|505266|P2|NOT COMPLETED|Overall Study||2
210701|NCT00742924|505267|P1|NOT COMPLETED|Overall Study||5
210702|NCT00742924|505264|P4|COMPLETED|Overall Study||0
210703|NCT00742924|505265|P3|COMPLETED|Overall Study||2
210704|NCT00742924|505266|P2|COMPLETED|Overall Study||4
210705|NCT00742924|505267|P1|COMPLETED|Overall Study||1
210706|NCT00742924|505264|P4|STARTED|Overall Study||6
210707|NCT00742924|505265|P3|STARTED|Overall Study||6
210708|NCT00742924|505266|P2|STARTED|Overall Study||6
210709|NCT00742924|505267|P1|STARTED|Overall Study||6
210710|NCT00742885|505279|P2|NOT COMPLETED|Overall Study||0
210711|NCT00742885|505280|P1|NOT COMPLETED|Overall Study||1
210712|NCT00742885|505279|P2|COMPLETED|Overall Study|to Day 182|50
210713|NCT00742885|505280|P1|COMPLETED|Overall Study|to Day 182|49
210714|NCT00742885|505279|P2|STARTED|Overall Study||50
210715|NCT00742885|505280|P1|STARTED|Overall Study||50
210717|NCT00742872|505329|P1|NOT COMPLETED|Overall Study||12
210718|NCT00742872|505328|P2|COMPLETED|Overall Study||12
210719|NCT00742872|505329|P1|COMPLETED|Overall Study||9
210720|NCT00742872|505328|P2|STARTED|Overall Study||20
210721|NCT00742872|505329|P1|STARTED|Overall Study||21
210722|NCT00742859|505339|P4|NOT COMPLETED|Overall Study||8
210723|NCT00742859|505340|P3|NOT COMPLETED|Overall Study||11
210724|NCT00742859|505341|P2|NOT COMPLETED|Overall Study||12
210725|NCT00742859|505342|P1|NOT COMPLETED|Overall Study||11
210726|NCT00742859|505339|P4|COMPLETED|Overall Study||119
210727|NCT00742859|505340|P3|COMPLETED|Overall Study||116
210728|NCT00742859|505341|P2|COMPLETED|Overall Study||115
210729|NCT00742859|505342|P1|COMPLETED|Overall Study||116
210730|NCT00742859|505339|P4|STARTED|Overall Study||127
210731|NCT00742859|505340|P3|STARTED|Overall Study||127
210732|NCT00742859|505341|P2|STARTED|Overall Study||127
210733|NCT00742859|505342|P1|STARTED|Overall Study||127
210734|NCT00742781|505356|P1|NOT COMPLETED|Overall Study||3
210735|NCT00742781|505356|P1|COMPLETED|Overall Study||18
210736|NCT00742781|505356|P1|STARTED|Overall Study||21
210737|NCT00742625|505365|P1|NOT COMPLETED|Consolidation||21
210738|NCT00742625|505365|P1|COMPLETED|Consolidation||20
210739|NCT00742625|505365|P1|STARTED|Consolidation||41
210740|NCT00742625|505365|P1|NOT COMPLETED|Remission Induction||54
210741|NCT00742625|505365|P1|COMPLETED|Remission Induction||41
210742|NCT00742625|505365|P1|STARTED|Remission Induction||95
210743|NCT00742560|505379|P5|NOT COMPLETED|Overall Study||37
210744|NCT00742560|505380|P4|NOT COMPLETED|Overall Study||36
210745|NCT00742560|505381|P3|NOT COMPLETED|Overall Study||22
210746|NCT00742560|505382|P2|NOT COMPLETED|Overall Study||3
210747|NCT00742560|505383|P1|NOT COMPLETED|Overall Study||3
210748|NCT00742560|505379|P5|COMPLETED|Overall Study||0
210749|NCT00742560|505380|P4|COMPLETED|Overall Study||0
210750|NCT00742560|505381|P3|COMPLETED|Overall Study||0
210751|NCT00742560|505382|P2|COMPLETED|Overall Study||0
210752|NCT00742560|505383|P1|COMPLETED|Overall Study||0
210753|NCT00742560|505379|P5|STARTED|Overall Study||37
210754|NCT00742560|505380|P4|STARTED|Overall Study||36
210755|NCT00742560|505381|P3|STARTED|Overall Study||22
210756|NCT00742560|505382|P2|STARTED|Overall Study||3
210757|NCT00742560|505383|P1|STARTED|Overall Study||3
210758|NCT00742508|505457|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
210759|NCT00742508|505458|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
210760|NCT00742508|505457|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
210761|NCT00742508|505458|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
210762|NCT00742508|505457|P2|STARTED|4-Week Exploratory Evaluation Period||8
210763|NCT00742508|505458|P1|STARTED|4-Week Exploratory Evaluation Period||0
210764|NCT00742508|505457|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
210765|NCT00742508|505458|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
210766|NCT00742508|505457|P2|COMPLETED|8-Week Primary Evaluation Period||8
210767|NCT00742508|505458|P1|COMPLETED|8-Week Primary Evaluation Period||11
210768|NCT00742508|505457|P2|STARTED|8-Week Primary Evaluation Period||19
210769|NCT00742508|505458|P1|STARTED|8-Week Primary Evaluation Period||22
210770|NCT00742417|505522|P2|NOT COMPLETED|Maintenance II||0
210771|NCT00742417|505523|P1|NOT COMPLETED|Maintenance II||0
210772|NCT00742417|505522|P2|COMPLETED|Maintenance II||19
210773|NCT00742417|505523|P1|COMPLETED|Maintenance II||16
210774|NCT00742417|505522|P2|STARTED|Maintenance II||19
210775|NCT00742417|505523|P1|STARTED|Maintenance II||16
210776|NCT00742417|505522|P2|NOT COMPLETED|Maintenance I||0
210777|NCT00742417|505523|P1|NOT COMPLETED|Maintenance I||0
210778|NCT00742417|505522|P2|COMPLETED|Maintenance I||19
210779|NCT00742417|505523|P1|COMPLETED|Maintenance I||16
210780|NCT00742417|505522|P2|STARTED|Maintenance I||19
210781|NCT00742417|505523|P1|STARTED|Maintenance I||16
210782|NCT00742417|505522|P2|NOT COMPLETED|Intensive Period||1
210783|NCT00742417|505523|P1|NOT COMPLETED|Intensive Period||3
210784|NCT00742417|505522|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
210785|NCT00742417|505523|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
210786|NCT00742417|505522|P2|STARTED|Intensive Period||20
210787|NCT00742417|505523|P1|STARTED|Intensive Period||19
210788|NCT00742417|505522|P2|NOT COMPLETED|Randomized||1
210789|NCT00742417|505523|P1|NOT COMPLETED|Randomized||2
210790|NCT00742417|505522|P2|COMPLETED|Randomized||20
210791|NCT00742417|505523|P1|COMPLETED|Randomized||19
210792|NCT00742417|505522|P2|STARTED|Randomized||21
210793|NCT00742417|505523|P1|STARTED|Randomized||21
210794|NCT00742391|505547|P2|NOT COMPLETED|Overall Study||1
210795|NCT00742391|505548|P1|NOT COMPLETED|Overall Study||4
210796|NCT00742391|505547|P2|COMPLETED|Overall Study||128
210797|NCT00742391|505548|P1|COMPLETED|Overall Study||122
210798|NCT00742391|505547|P2|STARTED|Overall Study||129
210799|NCT00742391|505548|P1|STARTED|Overall Study||126
210800|NCT00742326|505558|P2|NOT COMPLETED|Overall Study||1
210801|NCT00742326|505559|P1|NOT COMPLETED|Overall Study||0
210802|NCT00742326|505558|P2|COMPLETED|Overall Study||6
210803|NCT00742326|505559|P1|COMPLETED|Overall Study||6
210804|NCT00742326|505558|P2|STARTED|Overall Study||7
210805|NCT00742326|505559|P1|STARTED|Overall Study||6
210806|NCT00742313|505569|P2|NOT COMPLETED|Overall Study||0
210807|NCT00742313|505570|P1|NOT COMPLETED|Overall Study||1
210808|NCT00742313|505569|P2|COMPLETED|Overall Study||19
210809|NCT00742313|505570|P1|COMPLETED|Overall Study||24
210810|NCT00742313|505569|P2|STARTED|Overall Study||19
210811|NCT00742313|505570|P1|STARTED|Overall Study||25
210812|NCT00742274|505578|P2|NOT COMPLETED|Overall Study||3
210813|NCT00742274|505579|P1|NOT COMPLETED|Overall Study||3
210814|NCT00742274|505578|P2|COMPLETED|Overall Study||28
210815|NCT00742274|505579|P1|COMPLETED|Overall Study||27
210816|NCT00742274|505578|P2|STARTED|Overall Study||31
210817|NCT00742274|505579|P1|STARTED|Overall Study||30
210818|NCT00742235|505587|P2|NOT COMPLETED|Overall Study||31
210819|NCT00742235|505588|P1|NOT COMPLETED|Overall Study||0
210820|NCT00742235|505587|P2|COMPLETED|Overall Study||36
210821|NCT00742235|505588|P1|COMPLETED|Overall Study||32
210822|NCT00742235|505587|P2|STARTED|Overall Study||67
210823|NCT00742235|505588|P1|STARTED|Overall Study||32
210824|NCT00742209|505601|P5|NOT COMPLETED|Overall Study||25
210825|NCT00742209|505602|P4|NOT COMPLETED|Overall Study||37
210826|NCT00742209|505603|P3|NOT COMPLETED|Overall Study||46
210827|NCT00742209|505604|P2|NOT COMPLETED|Overall Study||18
210828|NCT00742209|505605|P1|NOT COMPLETED|Overall Study||34
210829|NCT00742209|505601|P5|COMPLETED|Overall Study||37
210830|NCT00742209|505602|P4|COMPLETED|Overall Study||97
210831|NCT00742209|505603|P3|COMPLETED|Overall Study||88
210832|NCT00742209|505604|P2|COMPLETED|Overall Study||49
210833|NCT00742209|505605|P1|COMPLETED|Overall Study||95
210834|NCT00742209|505601|P5|STARTED|Overall Study||62
210835|NCT00742209|505602|P4|STARTED|Overall Study||134
210836|NCT00742209|505603|P3|STARTED|Overall Study||134
210837|NCT00742209|505604|P2|STARTED|Overall Study||67
210838|NCT00742209|505605|P1|STARTED|Overall Study||129
210839|NCT00742183|505708|P2|NOT COMPLETED|Overall Study||12
210840|NCT00742183|505709|P1|NOT COMPLETED|Overall Study||9
210841|NCT00742183|505708|P2|COMPLETED|Overall Study||39
210842|NCT00742183|505709|P1|COMPLETED|Overall Study||40
210843|NCT00742183|505708|P2|STARTED|Overall Study||51
210844|NCT00742183|505709|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
210845|NCT00742170|505717|P2|NOT COMPLETED|Overall Study||5
210846|NCT00742170|505718|P1|NOT COMPLETED|Overall Study||2
210847|NCT00742170|505717|P2|COMPLETED|Overall Study||24
210848|NCT00742170|505718|P1|COMPLETED|Overall Study||24
210849|NCT00742170|505717|P2|STARTED|Overall Study||29
210850|NCT00742170|505718|P1|STARTED|Overall Study||26
210851|NCT00742079|505728|P2|NOT COMPLETED|Overall Study||1
210852|NCT00742079|505729|P1|NOT COMPLETED|Overall Study||0
210853|NCT00742079|505728|P2|COMPLETED|Overall Study||9
210854|NCT00742079|505729|P1|COMPLETED|Overall Study||11
210855|NCT00742079|505728|P2|Week 2 (Received Dose 2)|Overall Study||9
210856|NCT00742079|505729|P1|Week 2 (Received Dose 2)|Overall Study||11
210857|NCT00742079|505728|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
210858|NCT00742079|505729|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
210859|NCT00742079|505728|P2|STARTED|Overall Study||10
210860|NCT00742079|505729|P1|STARTED|Overall Study||11
210861|NCT00742053|505743|P1|NOT COMPLETED|Overall Study||0
210862|NCT00742053|505743|P1|COMPLETED|Overall Study||7
210863|NCT00742053|505743|P1|STARTED|Overall Study||7
210864|NCT00741988|505749|P2|NOT COMPLETED|Overall Study||4
210865|NCT00741988|505750|P1|NOT COMPLETED|Overall Study||4
210866|NCT00741988|505749|P2|COMPLETED|Overall Study||36
210867|NCT00741988|505750|P1|COMPLETED|Overall Study||38
210868|NCT00741988|505749|P2|STARTED|Overall Study||40
210869|NCT00741988|505750|P1|STARTED|Overall Study||42
210870|NCT00741936|505762|P2|NOT COMPLETED|Overall Study||8
210871|NCT00741936|505763|P1|NOT COMPLETED|Overall Study||9
210872|NCT00741936|505762|P2|COMPLETED|Overall Study||52
210873|NCT00741936|505763|P1|COMPLETED|Overall Study||51
210874|NCT00741936|505762|P2|STARTED|Overall Study||60
210875|NCT00741936|505763|P1|STARTED|Overall Study||60
210876|NCT00741858|505791|P2|NOT COMPLETED|Overall Study||0
210877|NCT00741858|505792|P1|NOT COMPLETED|Overall Study||0
210878|NCT00741858|505791|P2|COMPLETED|Overall Study||18
210879|NCT00741858|505792|P1|COMPLETED|Overall Study||16
210880|NCT00741858|505791|P2|STARTED|Overall Study||18
210881|NCT00741858|505792|P1|STARTED|Overall Study||16
210882|NCT00741819|505798|P1|NOT COMPLETED|Overall Study||8
210883|NCT00741819|505798|P1|COMPLETED|Overall Study||65
210884|NCT00741819|505798|P1|STARTED|Overall Study||73
210885|NCT00741611|505812|P3|NOT COMPLETED|Overall Study||3
210886|NCT00741611|505813|P2|NOT COMPLETED|Overall Study||2
210887|NCT00741611|505814|P1|NOT COMPLETED|Overall Study||0
210888|NCT00741611|505812|P3|COMPLETED|Overall Study||26
210889|NCT00741611|505813|P2|COMPLETED|Overall Study||1
210890|NCT00741611|505814|P1|COMPLETED|Overall Study||4
210891|NCT00741611|505812|P3|STARTED|Overall Study||29
210892|NCT00741611|505813|P2|STARTED|Overall Study||3
210893|NCT00741611|505814|P1|STARTED|Overall Study||4
210894|NCT00741598|505833|P2|NOT COMPLETED|Overall Study||9
210895|NCT00741598|505834|P1|NOT COMPLETED|Overall Study||9
210896|NCT00741598|505833|P2|COMPLETED|Overall Study||30
210897|NCT00741598|505834|P1|COMPLETED|Overall Study||24
210898|NCT00741598|505833|P2|STARTED|Overall Study||39
210899|NCT00741598|505834|P1|STARTED|Overall Study||33
210900|NCT00741468|505848|P1|NOT COMPLETED|Overall Study||0
210901|NCT00741468|505848|P1|COMPLETED|Overall Study||18
210902|NCT00741468|505848|P1|STARTED|Overall Study||18
210903|NCT00741390|505856|P4|NOT COMPLETED|Visit 2||1
210904|NCT00741390|505857|P3|NOT COMPLETED|Visit 2||1
210905|NCT00741390|505858|P2|NOT COMPLETED|Visit 2||0
210906|NCT00741390|505859|P1|NOT COMPLETED|Visit 2||0
210907|NCT00741390|505856|P4|COMPLETED|Visit 2||60
210908|NCT00741390|505857|P3|COMPLETED|Visit 2||54
210909|NCT00741390|505858|P2|COMPLETED|Visit 2||61
210910|NCT00741390|505859|P1|COMPLETED|Visit 2||59
210911|NCT00741390|505856|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
210912|NCT00741390|505857|P3|STARTED|Visit 2||55
210913|NCT00741390|505858|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
210914|NCT00741390|505859|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
210915|NCT00741390|505856|P4|NOT COMPLETED|Visit 1||1
210916|NCT00741390|505857|P3|NOT COMPLETED|Visit 1||7
210917|NCT00741390|505858|P2|NOT COMPLETED|Visit 1||0
210918|NCT00741390|505859|P1|NOT COMPLETED|Visit 1||2
210919|NCT00741390|505856|P4|COMPLETED|Visit 1||62
210920|NCT00741390|505857|P3|COMPLETED|Visit 1||55
210921|NCT00741390|505858|P2|COMPLETED|Visit 1||63
210922|NCT00741390|505859|P1|COMPLETED|Visit 1||60
210923|NCT00741390|505856|P4|STARTED|Visit 1||63
210924|NCT00741390|505857|P3|STARTED|Visit 1||62
210925|NCT00741390|505858|P2|STARTED|Visit 1||63
210926|NCT00741390|505859|P1|STARTED|Visit 1||62
210927|NCT00741338|505880|P2|NOT COMPLETED|Overall Study||1
210928|NCT00741338|505881|P1|NOT COMPLETED|Overall Study||0
210929|NCT00741338|505880|P2|COMPLETED|Overall Study||2
210930|NCT00741338|505881|P1|COMPLETED|Overall Study||3
210931|NCT00741338|505880|P2|STARTED|Overall Study||3
210932|NCT00741338|505881|P1|STARTED|Overall Study||3
210933|NCT00741286|505891|P2|NOT COMPLETED|Overall Study||19
210934|NCT00741286|505892|P1|NOT COMPLETED|Overall Study||20
210935|NCT00741286|505891|P2|COMPLETED|Overall Study||81
210936|NCT00741286|505892|P1|COMPLETED|Overall Study||83
210937|NCT00741286|505891|P2|STARTED|Overall Study||100
210938|NCT00741286|505892|P1|STARTED|Overall Study||103
210939|NCT00741273|505902|P2|NOT COMPLETED|Overall Study||0
210940|NCT00741273|505903|P1|NOT COMPLETED|Overall Study||0
210941|NCT00741273|505902|P2|COMPLETED|Overall Study||8
210942|NCT00741273|505903|P1|COMPLETED|Overall Study||8
210943|NCT00741273|505902|P2|STARTED|Overall Study||8
210944|NCT00741273|505903|P1|STARTED|Overall Study||8
210945|NCT00741260|505926|P7|NOT COMPLETED|Overall Study||7
210946|NCT00741260|505927|P6|NOT COMPLETED|Overall Study||45
210947|NCT00741260|505928|P5|NOT COMPLETED|Overall Study||9
210948|NCT00741260|505929|P4|NOT COMPLETED|Overall Study||6
210949|NCT00741260|505930|P3|NOT COMPLETED|Overall Study||4
210950|NCT00741260|505931|P2|NOT COMPLETED|Overall Study||8
210951|NCT00741260|505932|P1|NOT COMPLETED|Overall Study||6
210952|NCT00741260|505926|P7|COMPLETED|Overall Study||0
210953|NCT00741260|505927|P6|COMPLETED|Overall Study||20
210954|NCT00741260|505928|P5|COMPLETED|Overall Study||0
210955|NCT00741260|505929|P4|COMPLETED|Overall Study||0
210956|NCT00741260|505930|P3|COMPLETED|Overall Study||0
210957|NCT00741260|505931|P2|COMPLETED|Overall Study||0
210958|NCT00741260|505932|P1|COMPLETED|Overall Study||0
210959|NCT00741260|505926|P7|STARTED|Overall Study||7
210960|NCT00741260|505927|P6|STARTED|Overall Study||65
210961|NCT00741260|505928|P5|STARTED|Overall Study||9
210962|NCT00741260|505929|P4|STARTED|Overall Study||6
210963|NCT00741260|505930|P3|STARTED|Overall Study||4
210964|NCT00741260|505931|P2|STARTED|Overall Study||8
210965|NCT00741260|505932|P1|STARTED|Overall Study||6
210966|NCT00741156|505957|P1|NOT COMPLETED|Overall Study||0
210967|NCT00741156|505957|P1|COMPLETED|Overall Study||12
210968|NCT00741156|505957|P1|STARTED|Overall Study||12
210969|NCT00741104|505972|P1|NOT COMPLETED|Overall Study||0
210970|NCT00741104|505972|P1|COMPLETED|Overall Study||363
210971|NCT00741104|505972|P1|STARTED|Overall Study||363
210972|NCT00741091|505979|P1|NOT COMPLETED|Overall Study||57
210973|NCT00741091|505979|P1|COMPLETED|Overall Study||1040
210974|NCT00741091|505979|P1|STARTED|Overall Study||1097
210975|NCT00741039|505989|P2|NOT COMPLETED|Overall Study||0
210976|NCT00741039|505990|P1|NOT COMPLETED|Overall Study||2
210977|NCT00741039|505989|P2|COMPLETED|Overall Study||25
210978|NCT00741039|505990|P1|COMPLETED|Overall Study||100
210979|NCT00741039|505989|P2|STARTED|Overall Study||25
210980|NCT00741039|505990|P1|STARTED|Overall Study||102
210981|NCT00741026|505996|P1|NOT COMPLETED|Overall Study||0
210982|NCT00741026|505996|P1|COMPLETED|Overall Study||15
210983|NCT00741026|505996|P1|STARTED|Overall Study||15
210984|NCT00741013|506027|P3|NOT COMPLETED|Overall Study||1
210985|NCT00741013|506028|P2|NOT COMPLETED|Overall Study||2
210986|NCT00741013|506029|P1|NOT COMPLETED|Overall Study||1
210987|NCT00741013|506027|P3|COMPLETED|Overall Study||6
210988|NCT00741013|506028|P2|COMPLETED|Overall Study||6
210989|NCT00741013|506029|P1|COMPLETED|Overall Study||6
210990|NCT00741013|506027|P3|STARTED|Overall Study||7
210991|NCT00741013|506028|P2|STARTED|Overall Study||8
210992|NCT00741013|506029|P1|STARTED|Overall Study||7
210993|NCT00740870|506040|P1|NOT COMPLETED|Overall Study||21
210994|NCT00740870|506040|P1|COMPLETED|Overall Study||150
210995|NCT00740870|506040|P1|STARTED|Overall Study||171
210996|NCT00740857|506055|P3|NOT COMPLETED|Overall Study||0
210997|NCT00740857|506056|P2|NOT COMPLETED|Overall Study||0
210998|NCT00740857|506057|P1|NOT COMPLETED|Overall Study||1
210999|NCT00740857|506055|P3|COMPLETED|Overall Study||90
211000|NCT00740857|506056|P2|COMPLETED|Overall Study||88
211001|NCT00740857|506057|P1|COMPLETED|Overall Study||32
211002|NCT00740857|506055|P3|STARTED|Overall Study||90
211003|NCT00740857|506056|P2|STARTED|Overall Study||88
211004|NCT00740857|506057|P1|STARTED|Overall Study||33
211005|NCT00740831|506089|P3|NOT COMPLETED|Overall Study||6
211006|NCT00740831|506090|P2|NOT COMPLETED|Overall Study||3
211007|NCT00740831|506091|P1|NOT COMPLETED|Overall Study||4
211008|NCT00740831|506089|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
211009|NCT00740831|506090|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
211010|NCT00740831|506091|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
211011|NCT00740831|506089|P3|STARTED|Overall Study|Safety population|101
211012|NCT00740831|506090|P2|STARTED|Overall Study|Safety population|103
211013|NCT00740831|506091|P1|STARTED|Overall Study|Safety population|97
211014|NCT00740792|506112|P4|NOT COMPLETED|Overall Study||10
211015|NCT00740792|506113|P3|NOT COMPLETED|Overall Study||9
211016|NCT00740792|506114|P2|NOT COMPLETED|Overall Study||8
211017|NCT00740792|506115|P1|NOT COMPLETED|Overall Study||10
211018|NCT00740792|506112|P4|COMPLETED|Overall Study||190
211019|NCT00740792|506113|P3|COMPLETED|Overall Study||180
211020|NCT00740792|506114|P2|COMPLETED|Overall Study||186
211021|NCT00740792|506115|P1|COMPLETED|Overall Study||183
211022|NCT00740792|506112|P4|STARTED|Overall Study||200
211023|NCT00740792|506113|P3|STARTED|Overall Study||189
211024|NCT00740792|506114|P2|STARTED|Overall Study||194
211025|NCT00740792|506115|P1|STARTED|Overall Study||193
211026|NCT00740779|506136|P3|NOT COMPLETED|Overall Study||13
211027|NCT00740779|506137|P2|NOT COMPLETED|Overall Study||14
211028|NCT00740779|506138|P1|NOT COMPLETED|Overall Study||9
211029|NCT00740779|506136|P3|COMPLETED|Overall Study||41
211030|NCT00740779|506137|P2|COMPLETED|Overall Study||31
211031|NCT00740779|506138|P1|COMPLETED|Overall Study||43
211032|NCT00740779|506136|P3|STARTED|Overall Study||54
211033|NCT00740779|506137|P2|STARTED|Overall Study||45
211034|NCT00740779|506138|P1|STARTED|Overall Study||52
211035|NCT00740727|506146|P1|NOT COMPLETED|Overall Study||0
211036|NCT00740727|506146|P1|COMPLETED|Overall Study||18
211037|NCT00740727|506146|P1|STARTED|Overall Study||18
211038|NCT00740714|506155|P3|NOT COMPLETED|Overall Study||29
211039|NCT00740714|506156|P2|NOT COMPLETED|Overall Study||19
211040|NCT00740714|506157|P1|NOT COMPLETED|Overall Study||17
211041|NCT00740714|506155|P3|COMPLETED|Overall Study||174
211042|NCT00740714|506156|P2|COMPLETED|Overall Study||182
211043|NCT00740714|506157|P1|COMPLETED|Overall Study||179
211044|NCT00740714|506155|P3|Active Patients at Study Termination|Overall Study||33
211045|NCT00740714|506156|P2|Active Patients at Study Termination|Overall Study||12
211046|NCT00740714|506157|P1|Active Patients at Study Termination|Overall Study||24
211047|NCT00740714|506155|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
211048|NCT00740714|506156|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
211049|NCT00740714|506157|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
211050|NCT00740714|506155|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
211051|NCT00740714|506156|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
211052|NCT00740714|506157|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
211053|NCT00740636|506233|P2|NOT COMPLETED|Overall Study||4
211054|NCT00740636|506234|P1|NOT COMPLETED|Overall Study||2
211055|NCT00740636|506233|P2|COMPLETED|Overall Study||63
211056|NCT00740636|506234|P1|COMPLETED|Overall Study||23
211057|NCT00740636|506233|P2|STARTED|Overall Study||67
211058|NCT00740636|506234|P1|STARTED|Overall Study||25
211059|NCT00740597|506240|P1|NOT COMPLETED|Overall Study||1
211060|NCT00740597|506240|P1|COMPLETED|Overall Study||0
211061|NCT00740597|506240|P1|STARTED|Overall Study||1
211062|NCT00740584|506244|P1|NOT COMPLETED|Overall Study||1
211063|NCT00740584|506244|P1|COMPLETED|Overall Study||11
211064|NCT00740584|506244|P1|STARTED|Overall Study||12
211065|NCT00740480|506248|P1|NOT COMPLETED|Overall Study||2
211066|NCT00740480|506248|P1|COMPLETED|Overall Study||23
211067|NCT00740480|506248|P1|STARTED|Overall Study||25
211068|NCT00740220|506252|P1|NOT COMPLETED|Overall Study||9
211069|NCT00740220|506252|P1|COMPLETED|Overall Study||88
211070|NCT00740220|506252|P1|STARTED|Overall Study||97
211071|NCT00740207|506258|P2|NOT COMPLETED|Overall Study||0
211072|NCT00740207|506259|P1|NOT COMPLETED|Overall Study||0
211073|NCT00740207|506258|P2|COMPLETED|Overall Study||16
211074|NCT00740207|506259|P1|COMPLETED|Overall Study||17
211075|NCT00740207|506258|P2|STARTED|Overall Study||16
211076|NCT00740207|506259|P1|STARTED|Overall Study||17
211077|NCT00740181|506271|P1|NOT COMPLETED|Overall Study||0
211078|NCT00740181|506271|P1|COMPLETED|Overall Study||9
211079|NCT00740181|506271|P1|STARTED|Overall Study||9
211080|NCT00740051|506277|P2|NOT COMPLETED|Overall Study||32
211081|NCT00740051|506278|P1|NOT COMPLETED|Overall Study||18
211082|NCT00740051|506277|P2|COMPLETED|Overall Study||119
211083|NCT00740051|506278|P1|COMPLETED|Overall Study||58
211084|NCT00740051|506277|P2|STARTED|Overall Study||151
211085|NCT00740051|506278|P1|STARTED|Overall Study||76
211086|NCT00739999|506300|P2|NOT COMPLETED|Overall Study||0
211087|NCT00739999|506301|P1|NOT COMPLETED|Overall Study||0
211088|NCT00739999|506300|P2|COMPLETED|Overall Study||24
211089|NCT00739999|506301|P1|COMPLETED|Overall Study||15
211090|NCT00739999|506300|P2|STARTED|Overall Study||24
211091|NCT00739999|506301|P1|STARTED|Overall Study||15
211092|NCT00739973|506381|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
211093|NCT00739973|506382|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
211094|NCT00739973|506383|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
211095|NCT00739973|506384|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
211096|NCT00739973|506385|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
211097|NCT00739973|506386|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
211098|NCT00739973|506387|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
211099|NCT00739973|506388|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
211100|NCT00739973|506389|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
211101|NCT00739973|506381|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
211102|NCT00739973|506382|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
211103|NCT00739973|506383|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
211104|NCT00739973|506384|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
211105|NCT00739973|506385|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
211106|NCT00739973|506386|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
211107|NCT00739973|506387|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
211108|NCT00739973|506388|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
211109|NCT00739973|506389|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
211110|NCT00739973|506381|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
211111|NCT00739973|506382|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
211112|NCT00739973|506383|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
211113|NCT00739973|506384|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
211114|NCT00739973|506385|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
211115|NCT00739973|506386|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
211116|NCT00739973|506387|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
211117|NCT00739973|506388|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
211118|NCT00739973|506389|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
211119|NCT00739973|506381|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211120|NCT00739973|506382|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211121|NCT00739973|506383|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211122|NCT00739973|506384|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211123|NCT00739973|506385|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211124|NCT00739973|506386|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211125|NCT00739973|506387|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211126|NCT00739973|506388|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211127|NCT00739973|506389|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
211128|NCT00739973|506381|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211129|NCT00739973|506382|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211130|NCT00739973|506383|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211131|NCT00739973|506384|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211132|NCT00739973|506385|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211133|NCT00739973|506386|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211134|NCT00739973|506387|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211135|NCT00739973|506388|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
211136|NCT00739973|506389|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
211137|NCT00739973|506381|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
211138|NCT00739973|506382|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
211139|NCT00739973|506383|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
211140|NCT00739973|506384|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
211141|NCT00739973|506385|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
211142|NCT00739973|506386|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
211143|NCT00739973|506387|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
211144|NCT00739973|506388|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
211145|NCT00739973|506389|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
211146|NCT00739934|506475|P1|NOT COMPLETED|Voriconazole Oral||3
211147|NCT00739934|506475|P1|COMPLETED|Voriconazole Oral||31
211148|NCT00739934|506475|P1|STARTED|Voriconazole Oral||34
211149|NCT00739934|506475|P1|NOT COMPLETED|Voriconazole IV||6
211150|NCT00739934|506475|P1|COMPLETED|Voriconazole IV||34
211151|NCT00739934|506475|P1|STARTED|Voriconazole IV||40
211152|NCT00739908|506497|P2|NOT COMPLETED|Overall Study||25
211153|NCT00739908|506498|P1|NOT COMPLETED|Overall Study||25
211154|NCT00739908|506497|P2|COMPLETED|Overall Study||118
211155|NCT00739908|506498|P1|COMPLETED|Overall Study||117
211156|NCT00739908|506497|P2|STARTED|Overall Study||143
211157|NCT00739908|506498|P1|STARTED|Overall Study||142
211158|NCT00739882|506518|P2|NOT COMPLETED|Open-label Period||5
211159|NCT00739882|506519|P1|NOT COMPLETED|Open-label Period||10
211160|NCT00739882|506518|P2|COMPLETED|Open-label Period||9
211161|NCT00739882|506519|P1|COMPLETED|Open-label Period||7
211162|NCT00739882|506518|P2|STARTED|Open-label Period||14
211163|NCT00739882|506519|P1|STARTED|Open-label Period||17
211164|NCT00739882|506518|P2|NOT COMPLETED|Double-blind Period||11
211165|NCT00739882|506519|P1|NOT COMPLETED|Double-blind Period||19
211166|NCT00739882|506518|P2|COMPLETED|Double-blind Period||14
211167|NCT00739882|506519|P1|COMPLETED|Double-blind Period||32
211168|NCT00739882|506518|P2|STARTED|Double-blind Period||25
211169|NCT00739882|506519|P1|STARTED|Double-blind Period||51
211170|NCT00739765|506540|P3|NOT COMPLETED|Overall Study||11
211171|NCT00739765|506541|P2|NOT COMPLETED|Overall Study||11
211172|NCT00739765|506542|P1|NOT COMPLETED|Overall Study||6
211173|NCT00739765|506540|P3|COMPLETED|Overall Study||21
211174|NCT00739765|506541|P2|COMPLETED|Overall Study||27
211175|NCT00739765|506542|P1|COMPLETED|Overall Study||34
211176|NCT00739765|506540|P3|STARTED|Overall Study||32
211177|NCT00739765|506541|P2|STARTED|Overall Study||38
211178|NCT00739765|506542|P1|STARTED|Overall Study||40
211179|NCT00739752|506559|P6|NOT COMPLETED|Overall Study||0
211180|NCT00739752|506560|P5|NOT COMPLETED|Overall Study||0
211181|NCT00739752|506561|P4|NOT COMPLETED|Overall Study||0
211182|NCT00739752|506562|P3|NOT COMPLETED|Overall Study||0
211183|NCT00739752|506563|P2|NOT COMPLETED|Overall Study||0
211184|NCT00739752|506564|P1|NOT COMPLETED|Overall Study||0
211185|NCT00739752|506559|P6|COMPLETED|Overall Study||293
211186|NCT00739752|506560|P5|COMPLETED|Overall Study||291
211187|NCT00739752|506561|P4|COMPLETED|Overall Study||288
211188|NCT00739752|506562|P3|COMPLETED|Overall Study||292
211189|NCT00739752|506563|P2|COMPLETED|Overall Study||284
211190|NCT00739752|506564|P1|COMPLETED|Overall Study||299
211191|NCT00739752|506559|P6|STARTED|Overall Study||293
211192|NCT00739752|506560|P5|STARTED|Overall Study||291
211193|NCT00739752|506561|P4|STARTED|Overall Study||288
211194|NCT00739752|506562|P3|STARTED|Overall Study||292
211195|NCT00739752|506563|P2|STARTED|Overall Study||284
211196|NCT00739752|506564|P1|STARTED|Overall Study||299
211197|NCT00739674|506580|P2|NOT COMPLETED|Overall Study||122
211198|NCT00739674|506581|P1|NOT COMPLETED|Overall Study||181
211199|NCT00739674|506580|P2|COMPLETED|Overall Study||335
211200|NCT00739674|506581|P1|COMPLETED|Overall Study||354
211201|NCT00739674|506580|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
211202|NCT00739674|506581|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
211203|NCT00739674|506580|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
211204|NCT00739674|506581|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
211205|NCT00739674|506580|P2|No Follow-up Data|Overall Study||18
211206|NCT00739674|506581|P1|No Follow-up Data|Overall Study||33
211207|NCT00739674|506580|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
211208|NCT00739674|506581|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
211209|NCT00739674|506580|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
211210|NCT00739674|506581|P1|Screening Failures|Overall Study||19
211211|NCT00739674|506580|P2|STARTED|Overall Study||457
211212|NCT00739674|506581|P1|STARTED|Overall Study||535
211213|NCT00739661|506609|P2|NOT COMPLETED|Overall Study||42
211214|NCT00739661|506610|P1|NOT COMPLETED|Overall Study||46
211215|NCT00739661|506609|P2|COMPLETED|Overall Study||10
211216|NCT00739661|506610|P1|COMPLETED|Overall Study||6
211217|NCT00739661|506609|P2|STARTED|Overall Study||52
211218|NCT00739661|506610|P1|STARTED|Overall Study||52
211219|NCT00739648|506622|P2|NOT COMPLETED|Overall Study||53
211220|NCT00739648|506623|P1|NOT COMPLETED|Overall Study||26
211221|NCT00739648|506622|P2|COMPLETED|Overall Study||161
211222|NCT00739648|506623|P1|COMPLETED|Overall Study||82
211223|NCT00739648|506622|P2|STARTED|Overall Study||214
211224|NCT00739648|506623|P1|STARTED|Overall Study||108
211225|NCT00739596|506637|P2|NOT COMPLETED|Overall Study||17
211226|NCT00739596|506638|P1|NOT COMPLETED|Overall Study||25
211227|NCT00739596|506637|P2|COMPLETED|Overall Study||149
211228|NCT00739596|506638|P1|COMPLETED|Overall Study||141
211229|NCT00739596|506637|P2|STARTED|Overall Study||166
211230|NCT00739596|506638|P1|STARTED|Overall Study||166
211231|NCT00739583|506654|P2|NOT COMPLETED|Overall Study||0
211232|NCT00739583|506655|P1|NOT COMPLETED|Overall Study||0
211233|NCT00739583|506654|P2|COMPLETED|Overall Study||10
211234|NCT00739583|506655|P1|COMPLETED|Overall Study||10
211235|NCT00739583|506654|P2|STARTED|Overall Study||10
211236|NCT00739583|506655|P1|STARTED|Overall Study||10
211237|NCT00739336|506667|P2|NOT COMPLETED|Overall Study||0
211238|NCT00739336|506668|P1|NOT COMPLETED|Overall Study||4
211239|NCT00739336|506667|P2|COMPLETED|Overall Study||24
211240|NCT00739336|506668|P1|COMPLETED|Overall Study||17
211241|NCT00739336|506667|P2|STARTED|Overall Study||24
211242|NCT00739336|506668|P1|STARTED|Overall Study||21
211243|NCT00739310|506680|P1|NOT COMPLETED|Overall Study||7
211244|NCT00739310|506680|P1|COMPLETED|Overall Study||22
211245|NCT00739310|506680|P1|STARTED|Overall Study||29
211246|NCT00739297|506685|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
211247|NCT00739297|506686|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
211248|NCT00739297|506687|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
211249|NCT00739297|506688|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
211250|NCT00739297|506689|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
211251|NCT00739297|506690|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
211252|NCT00739297|506691|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
211253|NCT00739297|506685|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
211254|NCT00739297|506686|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
211255|NCT00739297|506687|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
211256|NCT00739297|506688|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
211257|NCT00739297|506689|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
211258|NCT00739297|506690|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
211259|NCT00739297|506691|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
211260|NCT00739297|506685|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
211261|NCT00739297|506686|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
211262|NCT00739297|506687|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
211263|NCT00739297|506688|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
211264|NCT00739297|506689|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
211265|NCT00739297|506690|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
211266|NCT00739297|506691|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
211267|NCT00739297|506685|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
211268|NCT00739297|506686|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
211269|NCT00739297|506687|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
211270|NCT00739297|506688|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
211271|NCT00739297|506689|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
211272|NCT00739297|506690|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
211273|NCT00739297|506691|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
211274|NCT00739297|506685|P7|COMPLETED|Third Washout Period of 4-7 Days||66
211275|NCT00739297|506686|P6|COMPLETED|Third Washout Period of 4-7 Days||8
211276|NCT00739297|506687|P5|COMPLETED|Third Washout Period of 4-7 Days||6
211277|NCT00739297|506688|P4|COMPLETED|Third Washout Period of 4-7 Days||18
211278|NCT00739297|506689|P3|COMPLETED|Third Washout Period of 4-7 Days||6
211279|NCT00739297|506690|P2|COMPLETED|Third Washout Period of 4-7 Days||12
211280|NCT00739297|506691|P1|COMPLETED|Third Washout Period of 4-7 Days||16
211281|NCT00739297|506685|P7|STARTED|Third Washout Period of 4-7 Days||66
211282|NCT00739297|506686|P6|STARTED|Third Washout Period of 4-7 Days||8
211283|NCT00739297|506687|P5|STARTED|Third Washout Period of 4-7 Days||6
211284|NCT00739297|506688|P4|STARTED|Third Washout Period of 4-7 Days||18
211285|NCT00739297|506689|P3|STARTED|Third Washout Period of 4-7 Days||6
211286|NCT00739297|506690|P2|STARTED|Third Washout Period of 4-7 Days||12
211287|NCT00739297|506691|P1|STARTED|Third Washout Period of 4-7 Days||16
211288|NCT00739297|506685|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
211289|NCT00739297|506686|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
211290|NCT00739297|506687|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
211291|NCT00739297|506688|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
211292|NCT00739297|506689|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
211293|NCT00739297|506690|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
211294|NCT00739297|506691|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
211295|NCT00739297|506685|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
211296|NCT00739297|506686|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
211297|NCT00739297|506687|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
211298|NCT00739297|506688|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
211299|NCT00739297|506689|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
211300|NCT00739297|506690|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
211301|NCT00739297|506691|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
211302|NCT00739297|506685|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
211303|NCT00739297|506686|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
211304|NCT00739297|506687|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
211305|NCT00739297|506688|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
211306|NCT00739297|506689|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
211307|NCT00739297|506690|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
211308|NCT00739297|506691|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
211309|NCT00739297|506685|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
211310|NCT00739297|506686|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
211311|NCT00739297|506687|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
211312|NCT00739297|506688|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
211313|NCT00739297|506689|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
211314|NCT00739297|506690|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
211315|NCT00739297|506691|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
211316|NCT00739297|506685|P7|COMPLETED|Second Washout Period of 4-7 Days||66
211317|NCT00739297|506686|P6|COMPLETED|Second Washout Period of 4-7 Days||10
211318|NCT00739297|506687|P5|COMPLETED|Second Washout Period of 4-7 Days||6
211319|NCT00739297|506688|P4|COMPLETED|Second Washout Period of 4-7 Days||14
211320|NCT00739297|506689|P3|COMPLETED|Second Washout Period of 4-7 Days||10
211321|NCT00739297|506690|P2|COMPLETED|Second Washout Period of 4-7 Days||8
211322|NCT00739297|506691|P1|COMPLETED|Second Washout Period of 4-7 Days||18
211323|NCT00739297|506685|P7|STARTED|Second Washout Period of 4-7 Days||66
211324|NCT00739297|506686|P6|STARTED|Second Washout Period of 4-7 Days||10
211325|NCT00739297|506687|P5|STARTED|Second Washout Period of 4-7 Days||6
211326|NCT00739297|506688|P4|STARTED|Second Washout Period of 4-7 Days||14
211327|NCT00739297|506689|P3|STARTED|Second Washout Period of 4-7 Days||10
211328|NCT00739297|506690|P2|STARTED|Second Washout Period of 4-7 Days||8
211329|NCT00739297|506691|P1|STARTED|Second Washout Period of 4-7 Days||18
211330|NCT00739297|506685|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
211331|NCT00739297|506686|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
211332|NCT00739297|506687|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
211333|NCT00739297|506688|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
211334|NCT00739297|506689|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
211335|NCT00739297|506690|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
211336|NCT00739297|506691|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
211337|NCT00739297|506685|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
211338|NCT00739297|506686|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
211339|NCT00739297|506687|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
211340|NCT00739297|506688|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
211341|NCT00739297|506689|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
211342|NCT00739297|506690|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
211343|NCT00739297|506691|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
211344|NCT00739297|506685|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
211345|NCT00739297|506686|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
211346|NCT00739297|506687|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
211347|NCT00739297|506688|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
211348|NCT00739297|506689|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
211349|NCT00739297|506690|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
211350|NCT00739297|506691|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
211351|NCT00739297|506685|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
211352|NCT00739297|506686|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
211353|NCT00739297|506687|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
211354|NCT00739297|506688|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
211355|NCT00739297|506689|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
211356|NCT00739297|506690|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
211357|NCT00739297|506691|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
211358|NCT00739297|506685|P7|COMPLETED|First Washout Period of 4-7 Days||66
211359|NCT00739297|506686|P6|COMPLETED|First Washout Period of 4-7 Days||9
211360|NCT00739297|506687|P5|COMPLETED|First Washout Period of 4-7 Days||6
211361|NCT00739297|506688|P4|COMPLETED|First Washout Period of 4-7 Days||17
211362|NCT00739297|506689|P3|COMPLETED|First Washout Period of 4-7 Days||6
211363|NCT00739297|506690|P2|COMPLETED|First Washout Period of 4-7 Days||11
211364|NCT00739297|506691|P1|COMPLETED|First Washout Period of 4-7 Days||17
211365|NCT00739297|506685|P7|STARTED|First Washout Period of 4-7 Days||68
211366|NCT00739297|506686|P6|STARTED|First Washout Period of 4-7 Days||9
211367|NCT00739297|506687|P5|STARTED|First Washout Period of 4-7 Days||6
211368|NCT00739297|506688|P4|STARTED|First Washout Period of 4-7 Days||19
211369|NCT00739297|506689|P3|STARTED|First Washout Period of 4-7 Days||6
211370|NCT00739297|506690|P2|STARTED|First Washout Period of 4-7 Days||11
211371|NCT00739297|506691|P1|STARTED|First Washout Period of 4-7 Days||17
211372|NCT00739297|506685|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
211373|NCT00739297|506686|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
211374|NCT00739297|506687|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
211375|NCT00739297|506688|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
211376|NCT00739297|506689|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
211377|NCT00739297|506690|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
211378|NCT00739297|506691|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
211379|NCT00739297|506685|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
211380|NCT00739297|506686|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
211381|NCT00739297|506687|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
211382|NCT00739297|506688|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
211383|NCT00739297|506689|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
211384|NCT00739297|506690|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
211385|NCT00739297|506691|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
211386|NCT00739297|506685|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
211387|NCT00739297|506686|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
211388|NCT00739297|506687|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
211389|NCT00739297|506688|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
211390|NCT00739297|506689|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
211391|NCT00739297|506690|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
211392|NCT00739297|506691|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
211393|NCT00739102|506719|P1|NOT COMPLETED|Overall Study||15
211394|NCT00739102|506719|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
211395|NCT00739102|506719|P1|STARTED|Overall Study||250
211396|NCT00739063|506735|P1|NOT COMPLETED|Overall Study||8
211397|NCT00739063|506735|P1|COMPLETED|Overall Study||3
211398|NCT00739063|506735|P1|STARTED|Overall Study||11
211399|NCT00739050|506739|P2|NOT COMPLETED|Overall Study||0
211400|NCT00739050|506740|P1|NOT COMPLETED|Overall Study||1
211401|NCT00739050|506739|P2|COMPLETED|Overall Study||0
211402|NCT00739050|506740|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
211403|NCT00739050|506739|P2|STARTED|Overall Study||0
211404|NCT00739050|506740|P1|STARTED|Overall Study||4
211405|NCT00739024|506754|P2|NOT COMPLETED|Overall Study||0
211406|NCT00739024|506755|P1|NOT COMPLETED|Overall Study||0
211407|NCT00739024|506754|P2|COMPLETED|Overall Study||6
211408|NCT00739024|506755|P1|COMPLETED|Overall Study||7
211409|NCT00739024|506754|P2|STARTED|Overall Study||6
211410|NCT00739024|506755|P1|STARTED|Overall Study||7
211411|NCT00738972|506765|P4|NOT COMPLETED|Overall Study||1
211412|NCT00738972|506766|P3|NOT COMPLETED|Overall Study||0
211413|NCT00738972|506767|P2|NOT COMPLETED|Overall Study||0
211414|NCT00738972|506768|P1|NOT COMPLETED|Overall Study||0
211415|NCT00738972|506765|P4|COMPLETED|Overall Study||2
211416|NCT00738972|506766|P3|COMPLETED|Overall Study||3
211417|NCT00738972|506767|P2|COMPLETED|Overall Study||3
211418|NCT00738972|506768|P1|COMPLETED|Overall Study||3
211419|NCT00738972|506765|P4|STARTED|Overall Study||3
211420|NCT00738972|506766|P3|STARTED|Overall Study||3
211421|NCT00738972|506767|P2|STARTED|Overall Study||3
211422|NCT00738972|506768|P1|STARTED|Overall Study||3
211423|NCT00738881|506780|P2|NOT COMPLETED|Overall Study||2
211424|NCT00738881|506781|P1|NOT COMPLETED|Overall Study||0
211425|NCT00738881|506780|P2|COMPLETED|Overall Study||10
211426|NCT00738881|506781|P1|COMPLETED|Overall Study||11
211427|NCT00738881|506780|P2|STARTED|Overall Study||12
211428|NCT00738881|506781|P1|STARTED|Overall Study||11
211429|NCT00738699|506795|P2|NOT COMPLETED|Overall Study||140
211430|NCT00738699|506796|P1|NOT COMPLETED|Overall Study||275
211431|NCT00738699|506795|P2|COMPLETED|Overall Study||0
211432|NCT00738699|506796|P1|COMPLETED|Overall Study||0
211433|NCT00738699|506795|P2|Participants Treated|Overall Study||139
211434|NCT00738699|506796|P1|Participants Treated|Overall Study||273
211435|NCT00738699|506795|P2|Participants Not Treated|Overall Study||1
211436|NCT00738699|506796|P1|Participants Not Treated|Overall Study||2
211437|NCT00738699|506795|P2|STARTED|Overall Study||140
211438|NCT00738699|506796|P1|STARTED|Overall Study||275
211439|NCT00738673|506814|P2|NOT COMPLETED|Overall Study||11
211440|NCT00738673|506815|P1|NOT COMPLETED|Overall Study||24
211441|NCT00738673|506814|P2|COMPLETED|Overall Study||1
211442|NCT00738673|506815|P1|COMPLETED|Overall Study||1
211443|NCT00738673|506814|P2|Intent to Treat Population|Overall Study||12
211444|NCT00738673|506815|P1|Intent to Treat Population|Overall Study||24
211445|NCT00738673|506814|P2|STARTED|Overall Study||12
211446|NCT00738673|506815|P1|STARTED|Overall Study||25
211447|NCT00738543|506843|P1|NOT COMPLETED|Control||0
211448|NCT00738543|506843|P1|COMPLETED|Control||48
211449|NCT00738543|506843|P1|STARTED|Control||48
211450|NCT00738543|506843|P1|NOT COMPLETED|Sodium Hypochlorite||0
211451|NCT00738543|506843|P1|COMPLETED|Sodium Hypochlorite||48
211452|NCT00738543|506843|P1|STARTED|Sodium Hypochlorite||48
211453|NCT00738543|506843|P1|NOT COMPLETED|Povidone Iodine||0
211454|NCT00738543|506843|P1|COMPLETED|Povidone Iodine||48
211455|NCT00738543|506843|P1|STARTED|Povidone Iodine||48
211456|NCT00738530|506853|P2|NOT COMPLETED|Overall Study||238
211457|NCT00738530|506854|P1|NOT COMPLETED|Overall Study||234
211458|NCT00738530|506853|P2|COMPLETED|Overall Study||84
211459|NCT00738530|506854|P1|COMPLETED|Overall Study||93
211460|NCT00738530|506853|P2|Treated|Overall Study||316
211461|NCT00738530|506854|P1|Treated|Overall Study||325
211462|NCT00738530|506853|P2|STARTED|Overall Study||322
211463|NCT00738530|506854|P1|STARTED|Overall Study||327
211464|NCT00738426|506880|P2|NOT COMPLETED|Overall Study||3
211465|NCT00738426|506881|P1|NOT COMPLETED|Overall Study||2
211466|NCT00738426|506880|P2|COMPLETED|Overall Study||32
211467|NCT00738426|506881|P1|COMPLETED|Overall Study||35
211468|NCT00738426|506880|P2|STARTED|Overall Study||35
211469|NCT00738426|506881|P1|STARTED|Overall Study||37
211470|NCT00738400|506889|P2|NOT COMPLETED|Overall Study||7
211471|NCT00738400|506890|P1|NOT COMPLETED|Overall Study||4
211472|NCT00738400|506889|P2|COMPLETED|Overall Study||67
211473|NCT00738400|506890|P1|COMPLETED|Overall Study||72
211474|NCT00738400|506889|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
211475|NCT00738400|506890|P1|ITT (Intent To Treatment) Population|Overall Study||75
211476|NCT00738400|506889|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
211477|NCT00738400|506890|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
211478|NCT00738400|506889|P2|STARTED|Overall Study||74
211479|NCT00738400|506890|P1|STARTED|Overall Study||76
211480|NCT00738374|506911|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
211481|NCT00738374|506912|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
211482|NCT00738374|506913|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
211483|NCT00738374|506914|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
211484|NCT00738374|506911|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
211485|NCT00738374|506912|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
211486|NCT00738374|506913|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
211487|NCT00738374|506914|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
211488|NCT00738374|506911|P4|STARTED|Maintenance Treatment/Observation Phase||32
211489|NCT00738374|506912|P3|STARTED|Maintenance Treatment/Observation Phase||34
211490|NCT00738374|506913|P2|STARTED|Maintenance Treatment/Observation Phase||7
211491|NCT00738374|506914|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
211492|NCT00738374|506911|P4|NOT COMPLETED|Induction Treatment Phase||0
211493|NCT00738374|506912|P3|NOT COMPLETED|Induction Treatment Phase||0
211494|NCT00738374|506913|P2|NOT COMPLETED|Induction Treatment Phase||0
211495|NCT00738374|506914|P1|NOT COMPLETED|Induction Treatment Phase||24
211496|NCT00738374|506911|P4|COMPLETED|Induction Treatment Phase||0
211497|NCT00738374|506912|P3|COMPLETED|Induction Treatment Phase||0
211498|NCT00738374|506913|P2|COMPLETED|Induction Treatment Phase||0
211499|NCT00738374|506914|P1|COMPLETED|Induction Treatment Phase||73
211500|NCT00738374|506911|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
211501|NCT00738374|506912|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
211502|NCT00738374|506913|P2|STARTED|Induction Treatment Phase||0
211503|NCT00738374|506914|P1|STARTED|Induction Treatment Phase||97
211504|NCT00738361|506946|P1|NOT COMPLETED|Overall Study||0
211505|NCT00738361|506946|P1|COMPLETED|Overall Study||4
211506|NCT00738361|506946|P1|STARTED|Overall Study||4
211507|NCT00738283|506952|P1|NOT COMPLETED|Overall Study||4
211508|NCT00738283|506952|P1|COMPLETED|Overall Study||13
211509|NCT00738283|506952|P1|STARTED|Overall Study||17
211510|NCT00738062|506959|P3|NOT COMPLETED|Open-Label Extension||0
211511|NCT00738062|506960|P2|NOT COMPLETED|Open-Label Extension||0
211512|NCT00738062|506961|P1|NOT COMPLETED|Open-Label Extension||17
211513|NCT00738062|506959|P3|COMPLETED|Open-Label Extension||0
211514|NCT00738062|506960|P2|COMPLETED|Open-Label Extension||0
211515|NCT00738062|506961|P1|COMPLETED|Open-Label Extension||57
211516|NCT00738062|506959|P3|STARTED|Open-Label Extension||0
211517|NCT00738062|506960|P2|STARTED|Open-Label Extension||0
211518|NCT00738062|506961|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
211519|NCT00738062|506959|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
211520|NCT00738062|506960|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
211521|NCT00738062|506961|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
211522|NCT00738062|506959|P3|COMPLETED|2 Week Randomized Withdrawal||37
211523|NCT00738062|506960|P2|COMPLETED|2 Week Randomized Withdrawal||38
211524|NCT00738062|506961|P1|COMPLETED|2 Week Randomized Withdrawal||0
211525|NCT00738062|506959|P3|STARTED|2 Week Randomized Withdrawal||37
211526|NCT00738062|506960|P2|STARTED|2 Week Randomized Withdrawal||38
211527|NCT00738062|506961|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
211528|NCT00738062|506959|P3|NOT COMPLETED|Open Label Treatment||0
211529|NCT00738062|506960|P2|NOT COMPLETED|Open Label Treatment||0
211530|NCT00738062|506961|P1|NOT COMPLETED|Open Label Treatment||28
211531|NCT00738062|506959|P3|COMPLETED|Open Label Treatment||0
211532|NCT00738062|506960|P2|COMPLETED|Open Label Treatment||0
211533|NCT00738062|506961|P1|COMPLETED|Open Label Treatment||75
211534|NCT00738062|506959|P3|STARTED|Open Label Treatment||0
211535|NCT00738062|506960|P2|STARTED|Open Label Treatment||0
211536|NCT00738062|506961|P1|STARTED|Open Label Treatment||103
211537|NCT00738049|506988|P2|NOT COMPLETED|Washout||0
211538|NCT00738049|506989|P1|NOT COMPLETED|Washout||0
211539|NCT00738049|506988|P2|COMPLETED|Washout||7
211540|NCT00738049|506989|P1|COMPLETED|Washout||13
211541|NCT00738049|506988|P2|STARTED|Washout||7
211542|NCT00738049|506989|P1|STARTED|Washout||13
211543|NCT00738049|506988|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
211544|NCT00738049|506989|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
211545|NCT00738049|506988|P2|COMPLETED|2nd Intervention(14 Days)||7
211546|NCT00738049|506989|P1|COMPLETED|2nd Intervention(14 Days)||13
211547|NCT00738049|506988|P2|STARTED|2nd Intervention(14 Days)||7
211548|NCT00738049|506989|P1|STARTED|2nd Intervention(14 Days)||13
211549|NCT00738049|506988|P2|NOT COMPLETED|1st Intervention(14 Days)||0
211550|NCT00738049|506989|P1|NOT COMPLETED|1st Intervention(14 Days)||0
211551|NCT00738049|506988|P2|COMPLETED|1st Intervention(14 Days)||7
211552|NCT00738049|506989|P1|COMPLETED|1st Intervention(14 Days)||13
211553|NCT00738049|506988|P2|STARTED|1st Intervention(14 Days)||7
211554|NCT00738049|506989|P1|STARTED|1st Intervention(14 Days)||13
211555|NCT00738023|507003|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
211556|NCT00738023|507004|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
211557|NCT00738023|507003|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
211558|NCT00738023|507004|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
211559|NCT00738023|507003|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
211560|NCT00738023|507004|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
211561|NCT00738023|507003|P2|NOT COMPLETED|Saline Infusion||0
211562|NCT00738023|507004|P1|NOT COMPLETED|Saline Infusion||0
211563|NCT00738023|507003|P2|COMPLETED|Saline Infusion||0
211564|NCT00738023|507004|P1|COMPLETED|Saline Infusion||19
211565|NCT00738023|507003|P2|STARTED|Saline Infusion||0
211566|NCT00738023|507004|P1|STARTED|Saline Infusion||19
211567|NCT00738023|507003|P2|NOT COMPLETED|Intralipid Infusion||0
211568|NCT00738023|507004|P1|NOT COMPLETED|Intralipid Infusion||0
211569|NCT00738023|507003|P2|COMPLETED|Intralipid Infusion||13
211570|NCT00738023|507004|P1|COMPLETED|Intralipid Infusion||19
211571|NCT00738023|507003|P2|STARTED|Intralipid Infusion||13
211572|NCT00738023|507004|P1|STARTED|Intralipid Infusion||19
211573|NCT00737737|507014|P2|NOT COMPLETED|Overall Study||0
211574|NCT00737737|507015|P1|NOT COMPLETED|Overall Study||0
211575|NCT00737737|507014|P2|COMPLETED|Overall Study||2
211576|NCT00737737|507015|P1|COMPLETED|Overall Study||2
211577|NCT00737737|507014|P2|STARTED|Overall Study||2
211578|NCT00737737|507015|P1|STARTED|Overall Study||2
211579|NCT00737711|507023|P1|NOT COMPLETED|Overall Study||31
211580|NCT00737711|507023|P1|COMPLETED|Overall Study||158
211581|NCT00737711|507023|P1|STARTED|Overall Study||189
211582|NCT00737672|507056|P2|NOT COMPLETED|Overall Study||83
211583|NCT00737672|507057|P1|NOT COMPLETED|Overall Study||80
211584|NCT00737672|507056|P2|COMPLETED|Overall Study||65
211585|NCT00737672|507057|P1|COMPLETED|Overall Study||65
211586|NCT00737672|507056|P2|Per Protocol Population|Overall Study||138
211587|NCT00737672|507057|P1|Per Protocol Population|Overall Study||131
211588|NCT00737672|507056|P2|Exclusions Due to Protocol Deviations|Overall Study||10
211589|NCT00737672|507057|P1|Exclusions Due to Protocol Deviations|Overall Study||14
211590|NCT00737672|507056|P2|STARTED|Overall Study||148
211591|NCT00737672|507057|P1|STARTED|Overall Study||145
211592|NCT00737633|507095|P2|NOT COMPLETED|Overall Study||57
211593|NCT00737633|507096|P1|NOT COMPLETED|Overall Study||44
211594|NCT00737633|507095|P2|COMPLETED|Overall Study||0
211595|NCT00737633|507096|P1|COMPLETED|Overall Study||0
211596|NCT00737633|507095|P2|STARTED|Overall Study||57
211597|NCT00737633|507096|P1|STARTED|Overall Study||44
211598|NCT00737594|507107|P3|NOT COMPLETED|Overall Study||0
211599|NCT00737594|507108|P2|NOT COMPLETED|Overall Study||0
211600|NCT00737594|507109|P1|NOT COMPLETED|Overall Study||0
211601|NCT00737594|507107|P3|COMPLETED|Overall Study||0
211602|NCT00737594|507108|P2|COMPLETED|Overall Study||0
211603|NCT00737594|507109|P1|COMPLETED|Overall Study||0
211604|NCT00737594|507107|P3|STARTED|Overall Study||0
211605|NCT00737594|507108|P2|STARTED|Overall Study||0
211606|NCT00737594|507109|P1|STARTED|Overall Study||0
211607|NCT00737568|507119|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
211608|NCT00737568|507120|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
211609|NCT00737568|507119|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
211610|NCT00737568|507120|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
211611|NCT00737568|507119|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
211612|NCT00737568|507120|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
211613|NCT00737568|507119|P2|NOT COMPLETED|Treatment Period Through Week 240||21
211614|NCT00737568|507120|P1|NOT COMPLETED|Treatment Period Through Week 240||20
211615|NCT00737568|507119|P2|COMPLETED|Treatment Period Through Week 240||118
211616|NCT00737568|507120|P1|COMPLETED|Treatment Period Through Week 240||121
211617|NCT00737568|507119|P2|STARTED|Treatment Period Through Week 240||139
211618|NCT00737568|507120|P1|STARTED|Treatment Period Through Week 240||141
211619|NCT00737529|507150|P1|NOT COMPLETED|Overall Study||112
211620|NCT00737529|507150|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 02 July 2012|22
211621|NCT00737529|507150|P1|STARTED|Overall Study||134
211622|NCT00737477|507164|P1|NOT COMPLETED|Overall Study||34
211623|NCT00737477|507164|P1|COMPLETED|Overall Study||62
211624|NCT00737477|507164|P1|STARTED|Overall Study||96
211625|NCT00737464|507180|P1|NOT COMPLETED|Overall Study||18
211626|NCT00737464|507180|P1|COMPLETED|Overall Study||114
211627|NCT00737464|507180|P1|STARTED|Overall Study||132
211628|NCT00737438|507201|P1|NOT COMPLETED|Overall Study||3
211629|NCT00737438|507201|P1|COMPLETED|Overall Study||20
211630|NCT00737438|507201|P1|STARTED|Overall Study||23
211631|NCT00737360|507205|P1|NOT COMPLETED|Overall Study||0
211632|NCT00737360|507205|P1|COMPLETED|Overall Study||27
211633|NCT00737360|507205|P1|STARTED|Overall Study||27
211634|NCT00737282|507214|P1|NOT COMPLETED|Overall Study||175
211635|NCT00737282|507214|P1|COMPLETED|Overall Study||0
211636|NCT00737282|507214|P1|STARTED|Overall Study||175
211637|NCT00737243|507220|P1|NOT COMPLETED|Overall Study||95
211638|NCT00737243|507220|P1|COMPLETED|Overall Study||194
211639|NCT00737243|507220|P1|Empiric CUP Therapy|Overall Study||29
211640|NCT00737243|507220|P1|Site Specific Therapy Less Responsive|Overall Study||79
211641|NCT00737243|507220|P1|Site Specific Therapy More Responsive|Overall Study||115
211642|NCT00737243|507220|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
211643|NCT00737243|507220|P1|Treated|Overall Study||223
211644|NCT00737243|507220|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
211645|NCT00737243|507220|P1|Successful Assay Performed|Overall Study||252
211646|NCT00737243|507220|P1|STARTED|Overall Study||289
211647|NCT00737204|507228|P2|NOT COMPLETED|Overall Study||6
211648|NCT00737204|507229|P1|NOT COMPLETED|Overall Study||0
211649|NCT00737204|507228|P2|COMPLETED|Overall Study||28
211650|NCT00737204|507229|P1|COMPLETED|Overall Study||36
211651|NCT00737204|507228|P2|STARTED|Overall Study||34
211652|NCT00737204|507229|P1|STARTED|Overall Study||36
211653|NCT00737178|507243|P2|NOT COMPLETED|Overall Study||9
211654|NCT00737178|507244|P1|NOT COMPLETED|Overall Study||5
211655|NCT00737178|507243|P2|COMPLETED|Overall Study||76
211656|NCT00737178|507244|P1|COMPLETED|Overall Study||66
211657|NCT00737178|507243|P2|STARTED|Overall Study||85
211658|NCT00737178|507244|P1|STARTED|Overall Study||71
211659|NCT00737100|507257|P3|NOT COMPLETED|Overall Study||7
211660|NCT00737100|507258|P2|NOT COMPLETED|Overall Study||7
211661|NCT00737100|507259|P1|NOT COMPLETED|Overall Study||7
211662|NCT00737100|507257|P3|COMPLETED|Overall Study||169
211663|NCT00737100|507258|P2|COMPLETED|Overall Study||159
211664|NCT00737100|507259|P1|COMPLETED|Overall Study||161
211665|NCT00737100|507257|P3|STARTED|Overall Study||176
211666|NCT00737100|507258|P2|STARTED|Overall Study||166
211667|NCT00737100|507259|P1|STARTED|Overall Study||168
211668|NCT00737061|507303|P1|NOT COMPLETED|1 Year Wearing Period||17
211669|NCT00737061|507303|P1|COMPLETED|1 Year Wearing Period||553
211670|NCT00737061|507303|P1|STARTED|1 Year Wearing Period||570
211671|NCT00737061|507303|P1|NOT COMPLETED|Waiting Period||75
211672|NCT00737061|507303|P1|COMPLETED|Waiting Period||570
211673|NCT00737061|507303|P1|STARTED|Waiting Period||645
211674|NCT00737048|507320|P3|NOT COMPLETED|Overall Study||4
211675|NCT00737048|507321|P2|NOT COMPLETED|Overall Study||6
211676|NCT00737048|507322|P1|NOT COMPLETED|Overall Study||3
211677|NCT00737048|507320|P3|COMPLETED|Overall Study||126
211678|NCT00737048|507321|P2|COMPLETED|Overall Study||60
211679|NCT00737048|507322|P1|COMPLETED|Overall Study||129
211680|NCT00737048|507320|P3|STARTED|Overall Study||130
211681|NCT00737048|507321|P2|STARTED|Overall Study||66
211682|NCT00737048|507322|P1|STARTED|Overall Study||132
211683|NCT00736996|507366|P3|NOT COMPLETED|Overall Study||2
211684|NCT00736996|507367|P2|NOT COMPLETED|Overall Study||9
211685|NCT00736996|507368|P1|NOT COMPLETED|Overall Study||1
211686|NCT00736996|507366|P3|COMPLETED|Overall Study||25
211687|NCT00736996|507367|P2|COMPLETED|Overall Study||17
211688|NCT00736996|507368|P1|COMPLETED|Overall Study||24
211689|NCT00736996|507366|P3|STARTED|Overall Study||27
211690|NCT00736996|507367|P2|STARTED|Overall Study||26
211691|NCT00736996|507368|P1|STARTED|Overall Study||25
211692|NCT00736957|507382|P1|NOT COMPLETED|Overall Study||122
211693|NCT00736957|507382|P1|COMPLETED|Overall Study||97
211694|NCT00736957|507382|P1|Treated|Overall Study||190
211695|NCT00736957|507382|P1|STARTED|Overall Study||219
211696|NCT00736944|507392|P1|NOT COMPLETED|Definitive Treatment||1
211697|NCT00736944|507392|P1|COMPLETED|Definitive Treatment||28
211698|NCT00736944|507392|P1|STARTED|Definitive Treatment||29
211699|NCT00736944|507392|P1|NOT COMPLETED|Induction||1
211700|NCT00736944|507392|P1|COMPLETED|Induction||29
211701|NCT00736944|507392|P1|STARTED|Induction||30
211702|NCT00736879|507423|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
211703|NCT00736879|507424|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
211704|NCT00736879|507425|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
211705|NCT00736879|507426|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
211706|NCT00736879|507423|P4|COMPLETED|Follow up Period - No Drug Treatment||62
211707|NCT00736879|507424|P3|COMPLETED|Follow up Period - No Drug Treatment||66
211708|NCT00736879|507425|P2|COMPLETED|Follow up Period - No Drug Treatment||67
211709|NCT00736879|507426|P1|COMPLETED|Follow up Period - No Drug Treatment||65
211710|NCT00736879|507423|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
211711|NCT00736879|507424|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
211712|NCT00736879|507425|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
211713|NCT00736879|507426|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
211714|NCT00736879|507423|P4|NOT COMPLETED|Double Blind Treatment Period||5
211715|NCT00736879|507424|P3|NOT COMPLETED|Double Blind Treatment Period||7
211716|NCT00736879|507425|P2|NOT COMPLETED|Double Blind Treatment Period||4
211717|NCT00736879|507426|P1|NOT COMPLETED|Double Blind Treatment Period||3
211718|NCT00736879|507423|P4|COMPLETED|Double Blind Treatment Period||63
211719|NCT00736879|507424|P3|COMPLETED|Double Blind Treatment Period||67
211720|NCT00736879|507425|P2|COMPLETED|Double Blind Treatment Period||68
211721|NCT00736879|507426|P1|COMPLETED|Double Blind Treatment Period||65
211722|NCT00736879|507423|P4|STARTED|Double Blind Treatment Period||68
211723|NCT00736879|507424|P3|STARTED|Double Blind Treatment Period||74
211724|NCT00736879|507425|P2|STARTED|Double Blind Treatment Period||72
211725|NCT00736879|507426|P1|STARTED|Double Blind Treatment Period||68
211726|NCT00736853|507480|P3|NOT COMPLETED|Double-Blind Period||48
211727|NCT00736853|507481|P2|NOT COMPLETED|Double-Blind Period||24
211728|NCT00736853|507482|P1|NOT COMPLETED|Double-Blind Period||0
211729|NCT00736853|507480|P3|COMPLETED|Double-Blind Period||45
211730|NCT00736853|507481|P2|COMPLETED|Double-Blind Period||70
211731|NCT00736853|507482|P1|COMPLETED|Double-Blind Period||0
211732|NCT00736853|507480|P3|STARTED|Double-Blind Period||93
211733|NCT00736853|507481|P2|STARTED|Double-Blind Period||94
211734|NCT00736853|507482|P1|STARTED|Double-Blind Period||0
211735|NCT00736853|507480|P3|NOT COMPLETED|Open-Label Period||0
211736|NCT00736853|507481|P2|NOT COMPLETED|Open-Label Period||0
211737|NCT00736853|507482|P1|NOT COMPLETED|Open-Label Period||132
211738|NCT00736853|507480|P3|COMPLETED|Open-Label Period||0
211739|NCT00736853|507481|P2|COMPLETED|Open-Label Period||0
211740|NCT00736853|507482|P1|COMPLETED|Open-Label Period||187
211741|NCT00736853|507480|P3|Treated|Open-Label Period||0
211742|NCT00736853|507481|P2|Treated|Open-Label Period||0
211743|NCT00736853|507482|P1|Treated|Open-Label Period||277
211744|NCT00736853|507480|P3|STARTED|Open-Label Period||0
211745|NCT00736853|507481|P2|STARTED|Open-Label Period||0
211746|NCT00736853|507482|P1|STARTED|Open-Label Period||319
211747|NCT00736840|507522|P1|NOT COMPLETED|Overall Study||13
211848|NCT00736489|507577|P1|STARTED|Period 3||5
211748|NCT00736840|507522|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
211749|NCT00736840|507522|P1|STARTED|Overall Study||414
211750|NCT00736723|507529|P2|NOT COMPLETED|Overall Study||3
211751|NCT00736723|507530|P1|NOT COMPLETED|Overall Study||4
211752|NCT00736723|507529|P2|COMPLETED|Overall Study||18
211753|NCT00736723|507530|P1|COMPLETED|Overall Study||26
211754|NCT00736723|507529|P2|STARTED|Overall Study||21
211755|NCT00736723|507530|P1|STARTED|Overall Study||30
211756|NCT00736645|507540|P4|NOT COMPLETED|Overall Study||0
211757|NCT00736645|507541|P3|NOT COMPLETED|Overall Study||0
211758|NCT00736645|507542|P2|NOT COMPLETED|Overall Study||2
211759|NCT00736645|507543|P1|NOT COMPLETED|Overall Study||0
211760|NCT00736645|507540|P4|COMPLETED|Overall Study||13
211761|NCT00736645|507541|P3|COMPLETED|Overall Study||14
211762|NCT00736645|507542|P2|COMPLETED|Overall Study||13
211763|NCT00736645|507543|P1|COMPLETED|Overall Study||13
211764|NCT00736645|507540|P4|STARTED|Overall Study||13
211765|NCT00736645|507541|P3|STARTED|Overall Study||14
211766|NCT00736645|507542|P2|STARTED|Overall Study||15
211767|NCT00736645|507543|P1|STARTED|Overall Study||13
211768|NCT00736580|507559|P2|NOT COMPLETED|Overall Study||0
211769|NCT00736580|507560|P1|NOT COMPLETED|Overall Study||0
211770|NCT00736580|507559|P2|COMPLETED|Overall Study||123
211771|NCT00736580|507560|P1|COMPLETED|Overall Study||117
211772|NCT00736580|507559|P2|STARTED|Overall Study||123
211773|NCT00736580|507560|P1|STARTED|Overall Study||117
211774|NCT00736502|507566|P1|NOT COMPLETED|Overall Study||65
211775|NCT00736502|507566|P1|COMPLETED|Overall Study||213
211776|NCT00736502|507566|P1|STARTED|Overall Study|Entered and treated.|278
211777|NCT00736489|507572|P6|NOT COMPLETED|Period 6||0
211778|NCT00736489|507573|P5|NOT COMPLETED|Period 6||0
211779|NCT00736489|507574|P4|NOT COMPLETED|Period 6||0
211780|NCT00736489|507575|P3|NOT COMPLETED|Period 6||0
211781|NCT00736489|507576|P2|NOT COMPLETED|Period 6||0
211782|NCT00736489|507577|P1|NOT COMPLETED|Period 6||0
211783|NCT00736489|507572|P6|COMPLETED|Period 6||5
211784|NCT00736489|507573|P5|COMPLETED|Period 6||7
211785|NCT00736489|507574|P4|COMPLETED|Period 6||7
211786|NCT00736489|507575|P3|COMPLETED|Period 6||6
211787|NCT00736489|507576|P2|COMPLETED|Period 6||5
211788|NCT00736489|507577|P1|COMPLETED|Period 6||5
211789|NCT00736489|507572|P6|STARTED|Period 6||5
211790|NCT00736489|507573|P5|STARTED|Period 6||7
211791|NCT00736489|507574|P4|STARTED|Period 6||7
211792|NCT00736489|507575|P3|STARTED|Period 6||6
211793|NCT00736489|507576|P2|STARTED|Period 6||5
211794|NCT00736489|507577|P1|STARTED|Period 6||5
211795|NCT00736489|507572|P6|NOT COMPLETED|Period 5||0
211796|NCT00736489|507573|P5|NOT COMPLETED|Period 5||0
211797|NCT00736489|507574|P4|NOT COMPLETED|Period 5||0
211798|NCT00736489|507575|P3|NOT COMPLETED|Period 5||0
211799|NCT00736489|507576|P2|NOT COMPLETED|Period 5||0
211800|NCT00736489|507577|P1|NOT COMPLETED|Period 5||0
211801|NCT00736489|507572|P6|COMPLETED|Period 5||5
211802|NCT00736489|507573|P5|COMPLETED|Period 5||7
211803|NCT00736489|507574|P4|COMPLETED|Period 5||7
211804|NCT00736489|507575|P3|COMPLETED|Period 5||6
211805|NCT00736489|507576|P2|COMPLETED|Period 5||5
211806|NCT00736489|507577|P1|COMPLETED|Period 5||5
211807|NCT00736489|507572|P6|STARTED|Period 5||5
211808|NCT00736489|507573|P5|STARTED|Period 5||7
211809|NCT00736489|507574|P4|STARTED|Period 5||7
211810|NCT00736489|507575|P3|STARTED|Period 5||6
211811|NCT00736489|507576|P2|STARTED|Period 5||5
211812|NCT00736489|507577|P1|STARTED|Period 5||5
211813|NCT00736489|507572|P6|NOT COMPLETED|Period 4||0
211814|NCT00736489|507573|P5|NOT COMPLETED|Period 4||0
211815|NCT00736489|507574|P4|NOT COMPLETED|Period 4||0
211816|NCT00736489|507575|P3|NOT COMPLETED|Period 4||0
211817|NCT00736489|507576|P2|NOT COMPLETED|Period 4||0
211818|NCT00736489|507577|P1|NOT COMPLETED|Period 4||0
211819|NCT00736489|507572|P6|COMPLETED|Period 4||5
211820|NCT00736489|507573|P5|COMPLETED|Period 4||7
211821|NCT00736489|507574|P4|COMPLETED|Period 4||7
211822|NCT00736489|507575|P3|COMPLETED|Period 4||6
211823|NCT00736489|507576|P2|COMPLETED|Period 4||5
211824|NCT00736489|507577|P1|COMPLETED|Period 4||5
211825|NCT00736489|507572|P6|STARTED|Period 4||5
211826|NCT00736489|507573|P5|STARTED|Period 4||7
211827|NCT00736489|507574|P4|STARTED|Period 4||7
211828|NCT00736489|507575|P3|STARTED|Period 4||6
211829|NCT00736489|507576|P2|STARTED|Period 4||5
211830|NCT00736489|507577|P1|STARTED|Period 4||5
211831|NCT00736489|507572|P6|NOT COMPLETED|Period 3||0
211832|NCT00736489|507573|P5|NOT COMPLETED|Period 3||0
211833|NCT00736489|507574|P4|NOT COMPLETED|Period 3||0
211834|NCT00736489|507575|P3|NOT COMPLETED|Period 3||0
211835|NCT00736489|507576|P2|NOT COMPLETED|Period 3||0
211836|NCT00736489|507577|P1|NOT COMPLETED|Period 3||0
211837|NCT00736489|507572|P6|COMPLETED|Period 3||5
211838|NCT00736489|507573|P5|COMPLETED|Period 3||7
211839|NCT00736489|507574|P4|COMPLETED|Period 3||7
211840|NCT00736489|507575|P3|COMPLETED|Period 3||6
211841|NCT00736489|507576|P2|COMPLETED|Period 3||5
211842|NCT00736489|507577|P1|COMPLETED|Period 3||5
211843|NCT00736489|507572|P6|STARTED|Period 3||5
211844|NCT00736489|507573|P5|STARTED|Period 3||7
211845|NCT00736489|507574|P4|STARTED|Period 3||7
211846|NCT00736489|507575|P3|STARTED|Period 3||6
211847|NCT00736489|507576|P2|STARTED|Period 3||5
211849|NCT00736489|507572|P6|NOT COMPLETED|Period 2||0
211850|NCT00736489|507573|P5|NOT COMPLETED|Period 2||0
211851|NCT00736489|507574|P4|NOT COMPLETED|Period 2||0
211852|NCT00736489|507575|P3|NOT COMPLETED|Period 2||0
211853|NCT00736489|507576|P2|NOT COMPLETED|Period 2||0
211854|NCT00736489|507577|P1|NOT COMPLETED|Period 2||0
211855|NCT00736489|507572|P6|COMPLETED|Period 2||5
211856|NCT00736489|507573|P5|COMPLETED|Period 2||7
211857|NCT00736489|507574|P4|COMPLETED|Period 2||7
211858|NCT00736489|507575|P3|COMPLETED|Period 2||6
211859|NCT00736489|507576|P2|COMPLETED|Period 2||5
211860|NCT00736489|507577|P1|COMPLETED|Period 2||5
211861|NCT00736489|507572|P6|STARTED|Period 2||5
211862|NCT00736489|507573|P5|STARTED|Period 2||7
211863|NCT00736489|507574|P4|STARTED|Period 2||7
211864|NCT00736489|507575|P3|STARTED|Period 2||6
211865|NCT00736489|507576|P2|STARTED|Period 2||5
211866|NCT00736489|507577|P1|STARTED|Period 2||5
211867|NCT00736489|507572|P6|NOT COMPLETED|Period 1||1
211868|NCT00736489|507573|P5|NOT COMPLETED|Period 1||0
211869|NCT00736489|507574|P4|NOT COMPLETED|Period 1||0
211870|NCT00736489|507575|P3|NOT COMPLETED|Period 1||0
211871|NCT00736489|507576|P2|NOT COMPLETED|Period 1||0
211872|NCT00736489|507577|P1|NOT COMPLETED|Period 1||1
211873|NCT00736489|507572|P6|COMPLETED|Period 1||5
211874|NCT00736489|507573|P5|COMPLETED|Period 1||7
211875|NCT00736489|507574|P4|COMPLETED|Period 1||7
211876|NCT00736489|507575|P3|COMPLETED|Period 1||6
211877|NCT00736489|507576|P2|COMPLETED|Period 1||5
211878|NCT00736489|507577|P1|COMPLETED|Period 1||5
211879|NCT00736489|507572|P6|STARTED|Period 1||6
211880|NCT00736489|507573|P5|STARTED|Period 1||7
211881|NCT00736489|507574|P4|STARTED|Period 1||7
211882|NCT00736489|507575|P3|STARTED|Period 1||6
211883|NCT00736489|507576|P2|STARTED|Period 1||5
211884|NCT00736489|507577|P1|STARTED|Period 1|Cross-over study|6
211885|NCT00736476|507731|P2|NOT COMPLETED|Overall Study||0
211886|NCT00736476|507732|P1|NOT COMPLETED|Overall Study||1
211887|NCT00736476|507731|P2|COMPLETED|Overall Study||27
211888|NCT00736476|507732|P1|COMPLETED|Overall Study||35
211889|NCT00736476|507731|P2|STARTED|Overall Study||27
211890|NCT00736476|507732|P1|STARTED|Overall Study||36
211891|NCT00736385|507754|P2|NOT COMPLETED|Overall Study||3
211892|NCT00736385|507755|P1|NOT COMPLETED|Overall Study||2
211893|NCT00736385|507754|P2|COMPLETED|Overall Study||2
211894|NCT00736385|507755|P1|COMPLETED|Overall Study||2
211895|NCT00736385|507754|P2|STARTED|Overall Study||5
211896|NCT00736385|507755|P1|STARTED|Overall Study||4
211897|NCT00736333|507767|P1|NOT COMPLETED|Overall Study||111
211898|NCT00736333|507767|P1|COMPLETED|Overall Study||56
211899|NCT00736333|507767|P1|STARTED|Overall Study||167
211900|NCT00736255|507778|P2|NOT COMPLETED|Overall Study||1
211901|NCT00736255|507779|P1|NOT COMPLETED|Overall Study||3
211902|NCT00736255|507778|P2|COMPLETED|Overall Study||14
211903|NCT00736255|507779|P1|COMPLETED|Overall Study||14
211904|NCT00736255|507778|P2|STARTED|Overall Study||15
211905|NCT00736255|507779|P1|STARTED|Overall Study||17
211906|NCT00736242|507789|P1|NOT COMPLETED|Overall Study||125
211907|NCT00736242|507789|P1|COMPLETED|Overall Study||107
211908|NCT00736242|507789|P1|Participants in Safety Analysis Set|Overall Study||229
211909|NCT00736242|507789|P1|STARTED|Overall Study||232
211910|NCT00736229|507803|P3|NOT COMPLETED|Overall Study||0
211911|NCT00736229|507804|P2|NOT COMPLETED|Overall Study||0
211912|NCT00736229|507805|P1|NOT COMPLETED|Overall Study||0
211913|NCT00736229|507803|P3|COMPLETED|Overall Study||84
211914|NCT00736229|507804|P2|COMPLETED|Overall Study||71
211915|NCT00736229|507805|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
211916|NCT00736229|507803|P3|STARTED|Overall Study|Historic Control|84
211917|NCT00736229|507804|P2|STARTED|Overall Study|Historic control|71
211918|NCT00736229|507805|P1|STARTED|Overall Study|Actively Enrolled|40
211919|NCT00736190|507818|P1|NOT COMPLETED|Overall Study||3
211920|NCT00736190|507818|P1|COMPLETED|Overall Study||87
211921|NCT00736190|507818|P1|STARTED|Overall Study||90
211922|NCT00736125|507833|P2|NOT COMPLETED|Overall Study||2
211923|NCT00736125|507834|P1|NOT COMPLETED|Overall Study||1
211924|NCT00736125|507833|P2|COMPLETED|Overall Study||8
211925|NCT00736125|507834|P1|COMPLETED|Overall Study||9
211926|NCT00736125|507833|P2|STARTED|Overall Study||10
211927|NCT00736125|507834|P1|STARTED|Overall Study||10
211928|NCT00736099|507844|P2|NOT COMPLETED|Overall Study||58
211929|NCT00736099|507845|P1|NOT COMPLETED|Overall Study||183
211930|NCT00736099|507844|P2|COMPLETED|Overall Study|Number who completed treatment.|531
211931|NCT00736099|507845|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
211932|NCT00736099|507844|P2|STARTED|Overall Study|Number who started treatment.|589
211933|NCT00736099|507845|P1|STARTED|Overall Study|Number who started treatment.|1532
211934|NCT00736073|507943|P2|NOT COMPLETED|Overall Study||0
211935|NCT00736073|507944|P1|NOT COMPLETED|Overall Study||0
211936|NCT00736073|507943|P2|COMPLETED|Overall Study||39
211937|NCT00736073|507944|P1|COMPLETED|Overall Study||34
211938|NCT00736073|507943|P2|STARTED|Overall Study||39
211939|NCT00736073|507944|P1|STARTED|Overall Study||34
211940|NCT00736034|507954|P1|NOT COMPLETED|Overall Study||2
211941|NCT00736034|507954|P1|COMPLETED|Overall Study||16
211942|NCT00736034|507954|P1|STARTED|Overall Study||18
211943|NCT00735969|507958|P1|NOT COMPLETED|Overall Study||0
211944|NCT00735969|507958|P1|COMPLETED|Overall Study||21
211945|NCT00735969|507958|P1|STARTED|Overall Study||21
211946|NCT00735943|507962|P1|NOT COMPLETED|Overall Study||2
211947|NCT00735943|507962|P1|COMPLETED|Overall Study||20
211948|NCT00735943|507962|P1|STARTED|Overall Study||22
211949|NCT00735917|507979|P1|NOT COMPLETED|Overall Study||0
211950|NCT00735917|507979|P1|COMPLETED|Overall Study||19
211951|NCT00735917|507979|P1|STARTED|Overall Study||19
211952|NCT00735904|507987|P1|NOT COMPLETED|Overall Study||38
211953|NCT00735904|507987|P1|COMPLETED|Overall Study||0
211954|NCT00735904|507987|P1|STARTED|Overall Study||38
211955|NCT00735839|507996|P2|NOT COMPLETED|Overall Study||0
211956|NCT00735839|507997|P1|NOT COMPLETED|Overall Study||0
211957|NCT00735839|507996|P2|COMPLETED|Overall Study||10
211958|NCT00735839|507997|P1|COMPLETED|Overall Study||30
211959|NCT00735839|507996|P2|STARTED|Overall Study||10
211960|NCT00735839|507997|P1|STARTED|Overall Study||30
211961|NCT00735787|508007|P2|NOT COMPLETED|Period 2||1
211962|NCT00735787|508008|P1|NOT COMPLETED|Period 2||5
211963|NCT00735787|508007|P2|COMPLETED|Period 2||40
211964|NCT00735787|508008|P1|COMPLETED|Period 2||13
211965|NCT00735787|508007|P2|STARTED|Period 2||41
211966|NCT00735787|508008|P1|STARTED|Period 2||18
211967|NCT00735787|508007|P2|NOT COMPLETED|Period 1||8
211968|NCT00735787|508008|P1|NOT COMPLETED|Period 1||6
211969|NCT00735787|508007|P2|COMPLETED|Period 1||41
211970|NCT00735787|508008|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
211971|NCT00735787|508007|P2|STARTED|Period 1||49
211972|NCT00735787|508008|P1|STARTED|Period 1||23
211973|NCT00735709|508056|P4|NOT COMPLETED|Overall Study||18
211974|NCT00735709|508057|P3|NOT COMPLETED|Overall Study||11
211975|NCT00735709|508058|P2|NOT COMPLETED|Overall Study||13
211976|NCT00735709|508059|P1|NOT COMPLETED|Overall Study||13
211977|NCT00735709|508056|P4|COMPLETED|Overall Study||122
211978|NCT00735709|508057|P3|COMPLETED|Overall Study||129
211979|NCT00735709|508058|P2|COMPLETED|Overall Study||127
211980|NCT00735709|508059|P1|COMPLETED|Overall Study||127
211981|NCT00735709|508056|P4|Treated|Overall Study||139
211982|NCT00735709|508057|P3|Treated|Overall Study||140
211983|NCT00735709|508058|P2|Treated|Overall Study||140
211984|NCT00735709|508059|P1|Treated|Overall Study||140
211985|NCT00735709|508056|P4|STARTED|Overall Study||140
211986|NCT00735709|508057|P3|STARTED|Overall Study||140
211987|NCT00735709|508058|P2|STARTED|Overall Study||140
211988|NCT00735709|508059|P1|STARTED|Overall Study||140
211989|NCT00735696|508169|P1|NOT COMPLETED|Overall Study||2
211990|NCT00735696|508169|P1|COMPLETED|Overall Study||39
211991|NCT00735696|508169|P1|Received Any Quantity of Study Drug|Overall Study||40
211992|NCT00735696|508169|P1|STARTED|Overall Study||41
211993|NCT00735670|508183|P2|NOT COMPLETED|Overall Study||5
211994|NCT00735670|508184|P1|NOT COMPLETED|Overall Study||4
211995|NCT00735670|508183|P2|COMPLETED|Overall Study||6
211996|NCT00735670|508184|P1|COMPLETED|Overall Study||6
211997|NCT00735670|508183|P2|STARTED|Overall Study||11
211998|NCT00735670|508184|P1|STARTED|Overall Study||10
211999|NCT00735644|508197|P5|NOT COMPLETED|Overall Study||0
212000|NCT00735644|508198|P4|NOT COMPLETED|Overall Study||1
212001|NCT00735644|508199|P3|NOT COMPLETED|Overall Study||1
212002|NCT00735644|508200|P2|NOT COMPLETED|Overall Study||2
212003|NCT00735644|508201|P1|NOT COMPLETED|Overall Study||0
212004|NCT00735644|508197|P5|COMPLETED|Overall Study||102
212005|NCT00735644|508198|P4|COMPLETED|Overall Study||198
212006|NCT00735644|508199|P3|COMPLETED|Overall Study||295
212007|NCT00735644|508200|P2|COMPLETED|Overall Study||298
212008|NCT00735644|508201|P1|COMPLETED|Overall Study||303
212009|NCT00735644|508197|P5|STARTED|Overall Study||102
212010|NCT00735644|508198|P4|STARTED|Overall Study||199
212011|NCT00735644|508199|P3|STARTED|Overall Study||296
212012|NCT00735644|508200|P2|STARTED|Overall Study||300
212013|NCT00735644|508201|P1|STARTED|Overall Study||303
212014|NCT00735618|508238|P1|NOT COMPLETED|Overall Study||0
212015|NCT00735618|508238|P1|COMPLETED|Overall Study||19
212016|NCT00735618|508238|P1|STARTED|Overall Study||19
212017|NCT00735553|508245|P1|NOT COMPLETED|Overall Study||77
212018|NCT00735553|508245|P1|COMPLETED|Overall Study||0
212019|NCT00735553|508245|P1|STARTED|Overall Study||77
212020|NCT00735475|508255|P2|NOT COMPLETED|Overall Study||11
212021|NCT00735475|508256|P1|NOT COMPLETED|Overall Study||8
212022|NCT00735475|508255|P2|COMPLETED|Overall Study||626
212023|NCT00735475|508256|P1|COMPLETED|Overall Study||623
212024|NCT00735475|508255|P2|STARTED|Overall Study||637
212025|NCT00735475|508256|P1|STARTED|Overall Study||631
212026|NCT00735462|508277|P3|NOT COMPLETED|Overall Study||28
212027|NCT00735462|508278|P2|NOT COMPLETED|Overall Study||55
212028|NCT00735462|508279|P1|NOT COMPLETED|Overall Study||63
212029|NCT00735462|508277|P3|COMPLETED|Overall Study||77
212030|NCT00735462|508278|P2|COMPLETED|Overall Study||149
212031|NCT00735462|508279|P1|COMPLETED|Overall Study||139
212032|NCT00735462|508277|P3|STARTED|Overall Study||105
212033|NCT00735462|508278|P2|STARTED|Overall Study||204
212034|NCT00735462|508279|P1|STARTED|Overall Study||202
212035|NCT00735449|508292|P2|NOT COMPLETED|Overall Study||6
212036|NCT00735449|508293|P1|NOT COMPLETED|Overall Study||7
212037|NCT00735449|508292|P2|COMPLETED|Overall Study||96
212038|NCT00735449|508293|P1|COMPLETED|Overall Study||95
212039|NCT00735449|508292|P2|STARTED|Overall Study||102
212040|NCT00735449|508293|P1|STARTED|Overall Study||102
212041|NCT00735436|508307|P1|NOT COMPLETED|Overall Study||0
212042|NCT00735436|508307|P1|COMPLETED|Overall Study||18
212043|NCT00735436|508307|P1|STARTED|Overall Study||18
212044|NCT00735397|508316|P1|NOT COMPLETED|Overall Study||1183
212045|NCT00735397|508316|P1|COMPLETED|Overall Study||35
212046|NCT00735397|508316|P1|STARTED|Overall Study||1218
212047|NCT00735371|508330|P4|NOT COMPLETED|Overall Study||10
212048|NCT00735371|508331|P3|NOT COMPLETED|Overall Study||11
212049|NCT00735371|508332|P2|NOT COMPLETED|Overall Study||13
212050|NCT00735371|508333|P1|NOT COMPLETED|Overall Study||15
212051|NCT00735371|508330|P4|COMPLETED|Overall Study||69
212052|NCT00735371|508331|P3|COMPLETED|Overall Study||67
212053|NCT00735371|508332|P2|COMPLETED|Overall Study||66
212054|NCT00735371|508333|P1|COMPLETED|Overall Study||63
212055|NCT00735371|508330|P4|STARTED|Overall Study||79
212056|NCT00735371|508331|P3|STARTED|Overall Study||78
212057|NCT00735371|508332|P2|STARTED|Overall Study||79
212058|NCT00735371|508333|P1|STARTED|Overall Study||78
212059|NCT00735306|508351|P1|NOT COMPLETED|Overall Study||0
212060|NCT00735306|508351|P1|COMPLETED|Overall Study||12
212061|NCT00735306|508351|P1|STARTED|Overall Study||12
212062|NCT00735254|508361|P4|NOT COMPLETED|Overall Study||0
212063|NCT00735254|508362|P3|NOT COMPLETED|Overall Study||1
212064|NCT00735254|508363|P2|NOT COMPLETED|Overall Study||1
212065|NCT00735254|508364|P1|NOT COMPLETED|Overall Study||1
212066|NCT00735254|508361|P4|COMPLETED|Overall Study||0
212067|NCT00735254|508362|P3|COMPLETED|Overall Study||0
212068|NCT00735254|508363|P2|COMPLETED|Overall Study||0
212069|NCT00735254|508364|P1|COMPLETED|Overall Study||0
212070|NCT00735254|508361|P4|STARTED|Overall Study||0
212071|NCT00735254|508362|P3|STARTED|Overall Study||1
212072|NCT00735254|508363|P2|STARTED|Overall Study||1
212073|NCT00735254|508364|P1|STARTED|Overall Study||1
212074|NCT00735072|508376|P2|NOT COMPLETED|Overall Study||1
212075|NCT00735072|508377|P1|NOT COMPLETED|Overall Study||1
212076|NCT00735072|508376|P2|COMPLETED|Overall Study||21
212077|NCT00735072|508377|P1|COMPLETED|Overall Study||22
212078|NCT00735072|508376|P2|STARTED|Overall Study||22
212079|NCT00735072|508377|P1|STARTED|Overall Study||23
212080|NCT00735007|508383|P1|NOT COMPLETED|Overall Study||5
212081|NCT00735007|508383|P1|COMPLETED|Overall Study||101
212082|NCT00735007|508383|P1|STARTED|Overall Study||106
212083|NCT00734994|508408|P1|NOT COMPLETED|Overall Study||1
212084|NCT00734994|508408|P1|COMPLETED|Overall Study||14
212085|NCT00734994|508408|P1|STARTED|Overall Study||15
212086|NCT00734968|508415|P2|NOT COMPLETED|Overall Study||1
212087|NCT00734968|508416|P1|NOT COMPLETED|Overall Study||1
212088|NCT00734968|508415|P2|COMPLETED|Overall Study||75
212089|NCT00734968|508416|P1|COMPLETED|Overall Study||76
212090|NCT00734968|508415|P2|STARTED|Overall Study||76
212091|NCT00734968|508416|P1|STARTED|Overall Study||77
212092|NCT00734929|508428|P2|NOT COMPLETED|Overall Study||5
212093|NCT00734929|508429|P1|NOT COMPLETED|Overall Study||6
212094|NCT00734929|508428|P2|COMPLETED|Overall Study||53
212095|NCT00734929|508429|P1|COMPLETED|Overall Study||51
212096|NCT00734929|508428|P2|STARTED|Overall Study||58
212097|NCT00734929|508429|P1|STARTED|Overall Study||57
212098|NCT00734851|508457|P1|NOT COMPLETED|Overall Study||21
212099|NCT00734851|508457|P1|COMPLETED|Overall Study||13
212100|NCT00734851|508457|P1|STARTED|Overall Study||34
212101|NCT00734799|508469|P2|NOT COMPLETED|Overall Study||4
212102|NCT00734799|508470|P1|NOT COMPLETED|Overall Study||0
212103|NCT00734799|508469|P2|COMPLETED|Overall Study||9
212104|NCT00734799|508470|P1|COMPLETED|Overall Study||9
212105|NCT00734799|508469|P2|STARTED|Overall Study||13
212106|NCT00734799|508470|P1|STARTED|Overall Study||9
212107|NCT00734747|508478|P1|NOT COMPLETED|6 Month Follow-up||3
212108|NCT00734747|508478|P1|COMPLETED|6 Month Follow-up||66
212109|NCT00734747|508478|P1|STARTED|6 Month Follow-up||69
212110|NCT00734747|508478|P1|NOT COMPLETED|SRS Procedure||3
212111|NCT00734747|508478|P1|COMPLETED|SRS Procedure||69
212112|NCT00734747|508478|P1|STARTED|SRS Procedure||72
212113|NCT00734734|508485|P1|NOT COMPLETED|Overall Study||0
212114|NCT00734734|508485|P1|COMPLETED|Overall Study||64
212115|NCT00734734|508485|P1|STARTED|Overall Study||64
212116|NCT00734656|508492|P4|NOT COMPLETED|Lab Session 4||1
212117|NCT00734656|508493|P3|NOT COMPLETED|Lab Session 4||0
212118|NCT00734656|508494|P2|NOT COMPLETED|Lab Session 4||0
212119|NCT00734656|508495|P1|NOT COMPLETED|Lab Session 4||0
212120|NCT00734656|508492|P4|COMPLETED|Lab Session 4||19
212121|NCT00734656|508493|P3|COMPLETED|Lab Session 4||16
212122|NCT00734656|508494|P2|COMPLETED|Lab Session 4||18
212123|NCT00734656|508495|P1|COMPLETED|Lab Session 4||20
212124|NCT00734656|508492|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
212125|NCT00734656|508493|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
212126|NCT00734656|508494|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
212127|NCT00734656|508495|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
212128|NCT00734656|508492|P4|NOT COMPLETED|Washout 3||1
212129|NCT00734656|508493|P3|NOT COMPLETED|Washout 3||0
212130|NCT00734656|508494|P2|NOT COMPLETED|Washout 3||0
212131|NCT00734656|508495|P1|NOT COMPLETED|Washout 3||1
212132|NCT00734656|508492|P4|COMPLETED|Washout 3||18
212133|NCT00734656|508493|P3|COMPLETED|Washout 3||20
212134|NCT00734656|508494|P2|COMPLETED|Washout 3||19
212135|NCT00734656|508495|P1|COMPLETED|Washout 3||17
212136|NCT00734656|508492|P4|STARTED|Washout 3||19
212137|NCT00734656|508493|P3|STARTED|Washout 3||20
212138|NCT00734656|508494|P2|STARTED|Washout 3||19
212139|NCT00734656|508495|P1|STARTED|Washout 3||18
212140|NCT00734656|508492|P4|NOT COMPLETED|Lab Session 3||0
212141|NCT00734656|508493|P3|NOT COMPLETED|Lab Session 3||0
212142|NCT00734656|508494|P2|NOT COMPLETED|Lab Session 3||0
212143|NCT00734656|508495|P1|NOT COMPLETED|Lab Session 3||0
212144|NCT00734656|508492|P4|COMPLETED|Lab Session 3||19
212145|NCT00734656|508493|P3|COMPLETED|Lab Session 3||20
212146|NCT00734656|508494|P2|COMPLETED|Lab Session 3||19
212147|NCT00734656|508495|P1|COMPLETED|Lab Session 3||18
212148|NCT00734656|508492|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
212149|NCT00734656|508493|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
212150|NCT00734656|508494|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
212151|NCT00734656|508495|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
212152|NCT00734656|508492|P4|NOT COMPLETED|Washout 2||0
212153|NCT00734656|508493|P3|NOT COMPLETED|Washout 2||1
212154|NCT00734656|508494|P2|NOT COMPLETED|Washout 2||1
212155|NCT00734656|508495|P1|NOT COMPLETED|Washout 2||1
212156|NCT00734656|508492|P4|COMPLETED|Washout 2||19
212157|NCT00734656|508493|P3|COMPLETED|Washout 2||20
212158|NCT00734656|508494|P2|COMPLETED|Washout 2||20
212159|NCT00734656|508495|P1|COMPLETED|Washout 2||17
212160|NCT00734656|508492|P4|STARTED|Washout 2||19
212161|NCT00734656|508493|P3|STARTED|Washout 2||21
212162|NCT00734656|508494|P2|STARTED|Washout 2||21
212163|NCT00734656|508495|P1|STARTED|Washout 2||18
212164|NCT00734656|508492|P4|NOT COMPLETED|Lab Session 2||1
212165|NCT00734656|508493|P3|NOT COMPLETED|Lab Session 2||0
212166|NCT00734656|508494|P2|NOT COMPLETED|Lab Session 2||0
212167|NCT00734656|508495|P1|NOT COMPLETED|Lab Session 2||1
212168|NCT00734656|508492|P4|COMPLETED|Lab Session 2||19
212169|NCT00734656|508493|P3|COMPLETED|Lab Session 2||21
212170|NCT00734656|508494|P2|COMPLETED|Lab Session 2||21
212171|NCT00734656|508495|P1|COMPLETED|Lab Session 2||18
212172|NCT00734656|508492|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
212173|NCT00734656|508493|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
212174|NCT00734656|508494|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
212175|NCT00734656|508495|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
212176|NCT00734656|508492|P4|NOT COMPLETED|Washout 1||3
212177|NCT00734656|508493|P3|NOT COMPLETED|Washout 1||2
212178|NCT00734656|508494|P2|NOT COMPLETED|Washout 1||5
212179|NCT00734656|508495|P1|NOT COMPLETED|Washout 1||1
212180|NCT00734656|508492|P4|COMPLETED|Washout 1||18
212181|NCT00734656|508493|P3|COMPLETED|Washout 1||24
212182|NCT00734656|508494|P2|COMPLETED|Washout 1||18
212183|NCT00734656|508495|P1|COMPLETED|Washout 1||21
212184|NCT00734656|508492|P4|STARTED|Washout 1||21
212185|NCT00734656|508493|P3|STARTED|Washout 1||26
212186|NCT00734656|508494|P2|STARTED|Washout 1||23
212187|NCT00734656|508495|P1|STARTED|Washout 1||22
212188|NCT00734656|508492|P4|NOT COMPLETED|Lab Session 1||0
212189|NCT00734656|508493|P3|NOT COMPLETED|Lab Session 1||0
212190|NCT00734656|508494|P2|NOT COMPLETED|Lab Session 1||0
212191|NCT00734656|508495|P1|NOT COMPLETED|Lab Session 1||2
212192|NCT00734656|508492|P4|COMPLETED|Lab Session 1||21
212193|NCT00734656|508493|P3|COMPLETED|Lab Session 1||26
212194|NCT00734656|508494|P2|COMPLETED|Lab Session 1||23
212195|NCT00734656|508495|P1|COMPLETED|Lab Session 1||22
212196|NCT00734656|508492|P4|STARTED|Lab Session 1||21
212197|NCT00734656|508493|P3|STARTED|Lab Session 1||26
212198|NCT00734656|508494|P2|STARTED|Lab Session 1||23
212199|NCT00734656|508495|P1|STARTED|Lab Session 1||24
212200|NCT00734630|508519|P2|NOT COMPLETED|Overall Study||33
212201|NCT00734630|508520|P1|NOT COMPLETED|Overall Study||29
212202|NCT00734630|508519|P2|COMPLETED|Overall Study||200
212203|NCT00734630|508520|P1|COMPLETED|Overall Study||229
212204|NCT00734630|508519|P2|STARTED|Overall Study||233
212205|NCT00734630|508520|P1|STARTED|Overall Study||258
212206|NCT00734617|508530|P2|NOT COMPLETED|Overall Study||102
212207|NCT00734617|508531|P1|NOT COMPLETED|Overall Study||107
212208|NCT00734617|508530|P2|COMPLETED|Overall Study||128
212209|NCT00734617|508531|P1|COMPLETED|Overall Study||142
212210|NCT00734617|508530|P2|STARTED|Overall Study||230
212211|NCT00734617|508531|P1|STARTED|Overall Study||249
212212|NCT00734604|508543|P6|NOT COMPLETED|Overall Study||6
212213|NCT00734604|508544|P5|NOT COMPLETED|Overall Study||8
212214|NCT00734604|508545|P4|NOT COMPLETED|Overall Study||9
212215|NCT00734604|508546|P3|NOT COMPLETED|Overall Study||6
212216|NCT00734604|508547|P2|NOT COMPLETED|Overall Study||12
212217|NCT00734604|508548|P1|NOT COMPLETED|Overall Study||3
212218|NCT00734604|508543|P6|COMPLETED|Overall Study||58
212219|NCT00734604|508544|P5|COMPLETED|Overall Study||55
212220|NCT00734604|508545|P4|COMPLETED|Overall Study||54
212221|NCT00734604|508546|P3|COMPLETED|Overall Study||57
212222|NCT00734604|508547|P2|COMPLETED|Overall Study||51
212223|NCT00734604|508548|P1|COMPLETED|Overall Study||59
212224|NCT00734604|508543|P6|STARTED|Overall Study||64
212225|NCT00734604|508544|P5|STARTED|Overall Study||63
212226|NCT00734604|508545|P4|STARTED|Overall Study||63
212227|NCT00734604|508546|P3|STARTED|Overall Study||63
212228|NCT00734604|508547|P2|STARTED|Overall Study||63
212229|NCT00734604|508548|P1|STARTED|Overall Study||62
212230|NCT00734591|508598|P2|NOT COMPLETED|Prospective Period||44
212231|NCT00734591|508599|P1|NOT COMPLETED|Prospective Period||51
212232|NCT00734591|508598|P2|COMPLETED|Prospective Period||1229
212233|NCT00734591|508599|P1|COMPLETED|Prospective Period||1307
212234|NCT00734591|508598|P2|STARTED|Prospective Period||1273
212235|NCT00734591|508599|P1|STARTED|Prospective Period||1358
212236|NCT00734591|508598|P2|NOT COMPLETED|Screening for Prospective Period||2291
212237|NCT00734591|508599|P1|NOT COMPLETED|Screening for Prospective Period||2517
212238|NCT00734591|508598|P2|COMPLETED|Screening for Prospective Period||1273
212239|NCT00734591|508599|P1|COMPLETED|Screening for Prospective Period||1358
212240|NCT00734591|508598|P2|STARTED|Screening for Prospective Period||3564
212241|NCT00734591|508599|P1|STARTED|Screening for Prospective Period||3875
212242|NCT00734591|508598|P2|NOT COMPLETED|Retrospective Period||0
212243|NCT00734591|508599|P1|NOT COMPLETED|Retrospective Period||0
212244|NCT00734591|508598|P2|COMPLETED|Retrospective Period||3564
212245|NCT00734591|508599|P1|COMPLETED|Retrospective Period||3875
212246|NCT00734591|508598|P2|STARTED|Retrospective Period||3564
212247|NCT00734591|508599|P1|STARTED|Retrospective Period||3875
212248|NCT00734578|508614|P3|NOT COMPLETED|Overall Study||25
212249|NCT00734578|508615|P2|NOT COMPLETED|Overall Study||25
212250|NCT00734578|508616|P1|NOT COMPLETED|Overall Study||33
212251|NCT00734578|508614|P3|COMPLETED|Overall Study||129
212252|NCT00734578|508615|P2|COMPLETED|Overall Study||128
212253|NCT00734578|508616|P1|COMPLETED|Overall Study||121
212254|NCT00734578|508614|P3|STARTED|Overall Study||154
212255|NCT00734578|508615|P2|STARTED|Overall Study||153
212256|NCT00734578|508616|P1|STARTED|Overall Study||154
212257|NCT00734539|508650|P2|NOT COMPLETED|Long Term Follow up||31
212258|NCT00734539|508651|P1|NOT COMPLETED|Long Term Follow up||34
212259|NCT00734539|508650|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
212260|NCT00734539|508651|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
212261|NCT00734539|508650|P2|STARTED|Long Term Follow up||138
212262|NCT00734539|508651|P1|STARTED|Long Term Follow up||152
212263|NCT00734539|508650|P2|NOT COMPLETED|Main Study||35
212264|NCT00734539|508651|P1|NOT COMPLETED|Main Study||37
212265|NCT00734539|508650|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
212266|NCT00734539|508651|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
212267|NCT00734539|508650|P2|STARTED|Main Study||173
212268|NCT00734539|508651|P1|STARTED|Main Study||189
212269|NCT00734500|508679|P1|NOT COMPLETED|Overall Study||1
212270|NCT00734500|508679|P1|COMPLETED|Overall Study||14
212271|NCT00734500|508679|P1|STARTED|Overall Study||15
212272|NCT00734474|508693|P9|NOT COMPLETED|Overall Study||82
212273|NCT00734474|508694|P8|NOT COMPLETED|Overall Study||129
212274|NCT00734474|508695|P7|NOT COMPLETED|Overall Study||24
212275|NCT00734474|508696|P6|NOT COMPLETED|Overall Study||25
212276|NCT00734474|508697|P5|NOT COMPLETED|Overall Study||118
212277|NCT00734474|508698|P4|NOT COMPLETED|Overall Study||10
212278|NCT00734474|508699|P3|NOT COMPLETED|Overall Study||112
212279|NCT00734474|508700|P2|NOT COMPLETED|Overall Study||30
212280|NCT00734474|508701|P1|NOT COMPLETED|Overall Study||15
212281|NCT00734474|508693|P9|COMPLETED|Overall Study||95
212282|NCT00734474|508694|P8|COMPLETED|Overall Study||186
212283|NCT00734474|508695|P7|COMPLETED|Overall Study||0
212284|NCT00734474|508696|P6|COMPLETED|Overall Study||0
212285|NCT00734474|508697|P5|COMPLETED|Overall Study||184
212286|NCT00734474|508698|P4|COMPLETED|Overall Study||0
212287|NCT00734474|508699|P3|COMPLETED|Overall Study||192
212288|NCT00734474|508700|P2|COMPLETED|Overall Study||0
212289|NCT00734474|508701|P1|COMPLETED|Overall Study||0
212290|NCT00734474|508693|P9|Completed 52-Week Visit|Overall Study||112
212291|NCT00734474|508694|P8|Completed 52-Week Visit|Overall Study||238
212292|NCT00734474|508695|P7|Completed 52-Week Visit|Overall Study||0
212293|NCT00734474|508696|P6|Completed 52-Week Visit|Overall Study||0
212294|NCT00734474|508697|P5|Completed 52-Week Visit|Overall Study||243
212295|NCT00734474|508698|P4|Completed 52-Week Visit|Overall Study||0
212296|NCT00734474|508699|P3|Completed 52-Week Visit|Overall Study||238
212297|NCT00734474|508700|P2|Completed 52-Week Visit|Overall Study||0
212298|NCT00734474|508701|P1|Completed 52-Week Visit|Overall Study||0
212299|NCT00734474|508693|P9|Completed 26-Week Visit|Overall Study||124
212300|NCT00734474|508694|P8|Completed 26-Week Visit|Overall Study||270
212301|NCT00734474|508695|P7|Completed 26-Week Visit|Overall Study||2
212302|NCT00734474|508696|P6|Completed 26-Week Visit|Overall Study||2
212303|NCT00734474|508697|P5|Completed 26-Week Visit|Overall Study||268
212304|NCT00734474|508698|P4|Completed 26-Week Visit|Overall Study||2
212305|NCT00734474|508699|P3|Completed 26-Week Visit|Overall Study||258
212306|NCT00734474|508700|P2|Completed 26-Week Visit|Overall Study||0
212307|NCT00734474|508701|P1|Completed 26-Week Visit|Overall Study||0
212308|NCT00734474|508693|P9|Entered Study After Dose Decision Point|Overall Study||139
212309|NCT00734474|508694|P8|Entered Study After Dose Decision Point|Overall Study||273
212310|NCT00734474|508695|P7|Entered Study After Dose Decision Point|Overall Study||0
212311|NCT00734474|508696|P6|Entered Study After Dose Decision Point|Overall Study||0
212312|NCT00734474|508697|P5|Entered Study After Dose Decision Point|Overall Study||281
212313|NCT00734474|508698|P4|Entered Study After Dose Decision Point|Overall Study||0
212314|NCT00734474|508699|P3|Entered Study After Dose Decision Point|Overall Study||279
212315|NCT00734474|508700|P2|Entered Study After Dose Decision Point|Overall Study||0
212316|NCT00734474|508701|P1|Entered Study After Dose Decision Point|Overall Study||0
212317|NCT00734474|508693|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
212318|NCT00734474|508694|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
212319|NCT00734474|508695|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
212320|NCT00734474|508696|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
212321|NCT00734474|508697|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
212322|NCT00734474|508698|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
212323|NCT00734474|508699|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
212324|NCT00734474|508700|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
212325|NCT00734474|508701|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
212326|NCT00734474|508693|P9|Entered Study Before Dose Decision Point|Overall Study||38
212327|NCT00734474|508694|P8|Entered Study Before Dose Decision Point|Overall Study||42
212328|NCT00734474|508695|P7|Entered Study Before Dose Decision Point|Overall Study||24
212329|NCT00734474|508696|P6|Entered Study Before Dose Decision Point|Overall Study||25
212330|NCT00734474|508697|P5|Entered Study Before Dose Decision Point|Overall Study||21
212331|NCT00734474|508698|P4|Entered Study Before Dose Decision Point|Overall Study||10
212332|NCT00734474|508699|P3|Entered Study Before Dose Decision Point|Overall Study||25
212333|NCT00734474|508700|P2|Entered Study Before Dose Decision Point|Overall Study||30
212334|NCT00734474|508701|P1|Entered Study Before Dose Decision Point|Overall Study||15
212335|NCT00734474|508693|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
212336|NCT00734474|508694|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
212337|NCT00734474|508695|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
212338|NCT00734474|508696|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
212339|NCT00734474|508697|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
212340|NCT00734474|508698|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
212341|NCT00734474|508699|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
212342|NCT00734474|508700|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
212343|NCT00734474|508701|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
212344|NCT00734474|508693|P9|STARTED|Overall Study||177
212345|NCT00734474|508694|P8|STARTED|Overall Study||315
212346|NCT00734474|508695|P7|STARTED|Overall Study||24
212347|NCT00734474|508696|P6|STARTED|Overall Study||25
212348|NCT00734474|508697|P5|STARTED|Overall Study||302
212349|NCT00734474|508698|P4|STARTED|Overall Study||10
212350|NCT00734474|508699|P3|STARTED|Overall Study||304
212351|NCT00734474|508700|P2|STARTED|Overall Study||30
212352|NCT00734474|508701|P1|STARTED|Overall Study||15
212353|NCT00734409|508870|P2|NOT COMPLETED|Overall Study||0
212354|NCT00734409|508871|P1|NOT COMPLETED|Overall Study||0
212355|NCT00734409|508870|P2|COMPLETED|Overall Study||145
212356|NCT00734409|508871|P1|COMPLETED|Overall Study||155
212357|NCT00734409|508870|P2|STARTED|Overall Study||145
212358|NCT00734409|508871|P1|STARTED|Overall Study||155
212359|NCT00734344|508883|P2|NOT COMPLETED|Overall Study||0
212360|NCT00734344|508884|P1|NOT COMPLETED|Overall Study||0
212361|NCT00734344|508883|P2|COMPLETED|Overall Study||9
212362|NCT00734344|508884|P1|COMPLETED|Overall Study||9
212363|NCT00734344|508883|P2|STARTED|Overall Study||9
212364|NCT00734344|508884|P1|STARTED|Overall Study||9
212365|NCT00734305|508954|P7|NOT COMPLETED|Overall Study||0
212366|NCT00734305|508955|P6|NOT COMPLETED|Overall Study||0
212367|NCT00734305|508956|P5|NOT COMPLETED|Overall Study||0
212368|NCT00734305|508957|P4|NOT COMPLETED|Overall Study||0
212369|NCT00734305|508958|P3|NOT COMPLETED|Overall Study||0
212370|NCT00734305|508959|P2|NOT COMPLETED|Overall Study||0
212371|NCT00734305|508960|P1|NOT COMPLETED|Overall Study||1
212372|NCT00734305|508954|P7|COMPLETED|Overall Study||18
212373|NCT00734305|508955|P6|COMPLETED|Overall Study||4
212374|NCT00734305|508956|P5|COMPLETED|Overall Study||5
212375|NCT00734305|508957|P4|COMPLETED|Overall Study||3
212376|NCT00734305|508958|P3|COMPLETED|Overall Study||4
212377|NCT00734305|508959|P2|COMPLETED|Overall Study||3
212378|NCT00734305|508960|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
212379|NCT00734305|508954|P7|STARTED|Overall Study||18
212380|NCT00734305|508955|P6|STARTED|Overall Study||4
212381|NCT00734305|508956|P5|STARTED|Overall Study||5
212382|NCT00734305|508957|P4|STARTED|Overall Study||3
212383|NCT00734305|508958|P3|STARTED|Overall Study||4
212384|NCT00734305|508959|P2|STARTED|Overall Study||3
212385|NCT00734305|508960|P1|STARTED|Overall Study||7
212386|NCT00734214|508991|P2|NOT COMPLETED|Overall Study||4
212387|NCT00734214|508992|P1|NOT COMPLETED|Overall Study||4
212388|NCT00734214|508991|P2|COMPLETED|Overall Study||126
212389|NCT00734214|508992|P1|COMPLETED|Overall Study||124
212390|NCT00734214|508991|P2|STARTED|Overall Study||130
212391|NCT00734214|508992|P1|STARTED|Overall Study||128
212392|NCT00734162|509002|P4|NOT COMPLETED|Open-Label Phase||3
212393|NCT00734162|509003|P3|NOT COMPLETED|Open-Label Phase||1
212394|NCT00734162|509004|P2|NOT COMPLETED|Open-Label Phase||2
212395|NCT00734162|509005|P1|NOT COMPLETED|Open-Label Phase||3
212396|NCT00734162|509002|P4|COMPLETED|Open-Label Phase||36
212397|NCT00734162|509003|P3|COMPLETED|Open-Label Phase||12
212398|NCT00734162|509004|P2|COMPLETED|Open-Label Phase||39
212399|NCT00734162|509005|P1|COMPLETED|Open-Label Phase||7
212400|NCT00734162|509002|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
212401|NCT00734162|509003|P3|STARTED|Open-Label Phase||13
212402|NCT00734162|509004|P2|STARTED|Open-Label Phase||41
212403|NCT00734162|509005|P1|STARTED|Open-Label Phase||10
212404|NCT00734162|509002|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
212405|NCT00734162|509003|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
212406|NCT00734162|509004|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
212407|NCT00734162|509005|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
212408|NCT00734162|509002|P4|COMPLETED|Randomized Phase (Through Week 72)||37
212409|NCT00734162|509003|P3|COMPLETED|Randomized Phase (Through Week 72)||13
212410|NCT00734162|509004|P2|COMPLETED|Randomized Phase (Through Week 72)||41
212411|NCT00734162|509005|P1|COMPLETED|Randomized Phase (Through Week 72)||10
212412|NCT00734162|509002|P4|STARTED|Randomized Phase (Through Week 72)||41
212413|NCT00734162|509003|P3|STARTED|Randomized Phase (Through Week 72)||13
212414|NCT00734162|509004|P2|STARTED|Randomized Phase (Through Week 72)||42
212415|NCT00734162|509005|P1|STARTED|Randomized Phase (Through Week 72)||10
212416|NCT00734149|509229|P1|NOT COMPLETED|Overall Study||1
212417|NCT00734149|509229|P1|COMPLETED|Overall Study||44
212418|NCT00734149|509229|P1|STARTED|Overall Study||45
212419|NCT00734097|509236|P1|NOT COMPLETED|Open Label||16
212420|NCT00734097|509236|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
212421|NCT00734097|509236|P1|Per Protocol|Open Label||301
212422|NCT00734097|509236|P1|Full Analysis|Open Label||311
212423|NCT00734097|509236|P1|Safety Analysis|Open Label||317
212424|NCT00734097|509236|P1|STARTED|Open Label|Full analysis performed in 311|317
212425|NCT00734097|509236|P1|NOT COMPLETED|Screening||20
212426|NCT00734097|509236|P1|COMPLETED|Screening|20 participants were screening failure.|317
212427|NCT00734097|509236|P1|STARTED|Screening||337
212428|NCT00734071|509253|P2|NOT COMPLETED|Overall Study||27
212429|NCT00734071|509254|P1|NOT COMPLETED|Overall Study||38
212430|NCT00734071|509253|P2|COMPLETED|Overall Study||125
212431|NCT00734071|509254|P1|COMPLETED|Overall Study||114
212432|NCT00734071|509253|P2|Treated|Overall Study||148
212433|NCT00734071|509254|P1|Treated|Overall Study||151
212434|NCT00734071|509253|P2|STARTED|Overall Study||152
212435|NCT00734071|509254|P1|STARTED|Overall Study||152
212436|NCT00734032|509312|P4|NOT COMPLETED|Overall Study||0
212437|NCT00734032|509313|P3|NOT COMPLETED|Overall Study||0
212438|NCT00734032|509314|P2|NOT COMPLETED|Overall Study||1
212439|NCT00734032|509315|P1|NOT COMPLETED|Overall Study||0
212440|NCT00734032|509312|P4|COMPLETED|Overall Study||26
212441|NCT00734032|509313|P3|COMPLETED|Overall Study||28
212442|NCT00734032|509314|P2|COMPLETED|Overall Study||27
212443|NCT00734032|509315|P1|COMPLETED|Overall Study||25
212444|NCT00734032|509312|P4|STARTED|Overall Study||26
212445|NCT00734032|509313|P3|STARTED|Overall Study||28
212446|NCT00734032|509314|P2|STARTED|Overall Study||28
212447|NCT00734032|509315|P1|STARTED|Overall Study||25
212448|NCT00733993|509335|P2|NOT COMPLETED|Overall Study||0
212449|NCT00733993|509336|P1|NOT COMPLETED|Overall Study||0
212450|NCT00733993|509335|P2|COMPLETED|Overall Study||10
212451|NCT00733993|509336|P1|COMPLETED|Overall Study||13
212452|NCT00733993|509335|P2|STARTED|Overall Study||10
212453|NCT00733993|509336|P1|STARTED|Overall Study||13
212454|NCT00733980|509371|P2|NOT COMPLETED|Overall Study||21
212455|NCT00733980|509372|P1|NOT COMPLETED|Overall Study||22
212456|NCT00733980|509371|P2|COMPLETED|Overall Study||55
212457|NCT00733980|509372|P1|COMPLETED|Overall Study||52
212458|NCT00733980|509371|P2|STARTED|Overall Study||76
212459|NCT00733980|509372|P1|STARTED|Overall Study||74
212460|NCT00733954|509416|P2|NOT COMPLETED|Overall Study||2
212461|NCT00733954|509417|P1|NOT COMPLETED|Overall Study||8
212462|NCT00733954|509416|P2|COMPLETED|Overall Study||123
212463|NCT00733954|509417|P1|COMPLETED|Overall Study||116
212464|NCT00733954|509416|P2|STARTED|Overall Study||125
212465|NCT00733954|509417|P1|STARTED|Overall Study||124
212466|NCT00733824|509464|P5|NOT COMPLETED|Phase II||0
212467|NCT00733824|509465|P4|NOT COMPLETED|Phase II||0
212468|NCT00733824|509466|P3|NOT COMPLETED|Phase II||0
212469|NCT00733824|509467|P2|NOT COMPLETED|Phase II||0
212470|NCT00733824|509468|P1|NOT COMPLETED|Phase II||0
212471|NCT00733824|509464|P5|COMPLETED|Phase II||36
212472|NCT00733824|509465|P4|COMPLETED|Phase II||0
212473|NCT00733824|509466|P3|COMPLETED|Phase II||0
212474|NCT00733824|509467|P2|COMPLETED|Phase II||0
212475|NCT00733824|509468|P1|COMPLETED|Phase II||0
212476|NCT00733824|509464|P5|STARTED|Phase II||36
212477|NCT00733824|509465|P4|STARTED|Phase II||0
212478|NCT00733824|509466|P3|STARTED|Phase II||0
212479|NCT00733824|509467|P2|STARTED|Phase II||0
212480|NCT00733824|509468|P1|STARTED|Phase II||0
212481|NCT00733824|509464|P5|NOT COMPLETED|Phase I||0
212482|NCT00733824|509465|P4|NOT COMPLETED|Phase I||0
212483|NCT00733824|509466|P3|NOT COMPLETED|Phase I||0
212484|NCT00733824|509467|P2|NOT COMPLETED|Phase I||0
212485|NCT00733824|509468|P1|NOT COMPLETED|Phase I||1
212486|NCT00733824|509464|P5|COMPLETED|Phase I||0
212487|NCT00733824|509465|P4|COMPLETED|Phase I||6
212488|NCT00733824|509466|P3|COMPLETED|Phase I||6
212489|NCT00733824|509467|P2|COMPLETED|Phase I||3
212490|NCT00733824|509468|P1|COMPLETED|Phase I||9
212491|NCT00733824|509464|P5|STARTED|Phase I||0
212492|NCT00733824|509465|P4|STARTED|Phase I||6
212493|NCT00733824|509466|P3|STARTED|Phase I||6
212494|NCT00733824|509467|P2|STARTED|Phase I||3
212495|NCT00733824|509468|P1|STARTED|Phase I||10
212496|NCT00733746|509487|P1|NOT COMPLETED|Overall Study||5
212497|NCT00733746|509487|P1|COMPLETED|Overall Study||114
212498|NCT00733746|509487|P1|STARTED|Overall Study||119
212499|NCT00733512|509495|P1|NOT COMPLETED|Overall Study||0
212500|NCT00733512|509495|P1|COMPLETED|Overall Study||146
212501|NCT00733512|509495|P1|STARTED|Overall Study||146
212502|NCT00733499|509502|P2|NOT COMPLETED|24 Months Follow-up||1
212503|NCT00733499|509503|P1|NOT COMPLETED|24 Months Follow-up||0
212504|NCT00733499|509502|P2|COMPLETED|24 Months Follow-up||95
212505|NCT00733499|509503|P1|COMPLETED|24 Months Follow-up||99
212506|NCT00733499|509502|P2|STARTED|24 Months Follow-up||96
212507|NCT00733499|509503|P1|STARTED|24 Months Follow-up||99
212508|NCT00733499|509502|P2|NOT COMPLETED|12 Months Follow-up||1
212509|NCT00733499|509503|P1|NOT COMPLETED|12 Months Follow-up||2
212510|NCT00733499|509502|P2|COMPLETED|12 Months Follow-up||96
212511|NCT00733499|509503|P1|COMPLETED|12 Months Follow-up||99
212512|NCT00733499|509502|P2|STARTED|12 Months Follow-up||97
212513|NCT00733499|509503|P1|STARTED|12 Months Follow-up||101
212514|NCT00733499|509502|P2|NOT COMPLETED|6 Months Follow-up||3
212515|NCT00733499|509503|P1|NOT COMPLETED|6 Months Follow-up||0
212516|NCT00733499|509502|P2|COMPLETED|6 Months Follow-up||97
212517|NCT00733499|509503|P1|COMPLETED|6 Months Follow-up||101
212518|NCT00733499|509502|P2|STARTED|6 Months Follow-up||100
212519|NCT00733499|509503|P1|STARTED|6 Months Follow-up||101
212520|NCT00733499|509502|P2|NOT COMPLETED|3 Months Follow-up||2
212521|NCT00733499|509503|P1|NOT COMPLETED|3 Months Follow-up||1
212522|NCT00733499|509502|P2|COMPLETED|3 Months Follow-up||100
212523|NCT00733499|509503|P1|COMPLETED|3 Months Follow-up||101
212524|NCT00733499|509502|P2|STARTED|3 Months Follow-up||102
212525|NCT00733499|509503|P1|STARTED|3 Months Follow-up||102
212526|NCT00733499|509502|P2|NOT COMPLETED|Pre-operative||1
212527|NCT00733499|509503|P1|NOT COMPLETED|Pre-operative||0
212528|NCT00733499|509502|P2|COMPLETED|Pre-operative||102
212529|NCT00733499|509503|P1|COMPLETED|Pre-operative||102
212530|NCT00733499|509502|P2|STARTED|Pre-operative||103
212531|NCT00733499|509503|P1|STARTED|Pre-operative||102
212532|NCT00733421|509511|P2|NOT COMPLETED|Overall Study||1
212533|NCT00733421|509512|P1|NOT COMPLETED|Overall Study||1
212534|NCT00733421|509511|P2|COMPLETED|Overall Study|All but one randomised patient|49
212535|NCT00733421|509512|P1|COMPLETED|Overall Study|All but one randomsied patient|49
212536|NCT00733421|509511|P2|STARTED|Overall Study|November 2008|50
212537|NCT00733421|509512|P1|STARTED|Overall Study|November 2008|50
212538|NCT00733369|509536|P2|NOT COMPLETED|Overall Study||9
212539|NCT00733369|509537|P1|NOT COMPLETED|Overall Study||10
212540|NCT00733369|509536|P2|COMPLETED|Overall Study||47
212541|NCT00733369|509537|P1|COMPLETED|Overall Study||40
212542|NCT00733369|509536|P2|STARTED|Overall Study||56
212543|NCT00733369|509537|P1|STARTED|Overall Study||50
212544|NCT00733356|509653|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
212545|NCT00733356|509653|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
212546|NCT00733356|509653|P1|STARTED|Modified Lab School, Reading Evaluation||26
212547|NCT00733356|509653|P1|NOT COMPLETED|Vyvanse Dose Titration||2
212548|NCT00733356|509653|P1|COMPLETED|Vyvanse Dose Titration||26
212549|NCT00733356|509653|P1|STARTED|Vyvanse Dose Titration||28
212550|NCT00733330|509659|P2|NOT COMPLETED|Overall Study||4
212551|NCT00733330|509660|P1|NOT COMPLETED|Overall Study||2
212552|NCT00733330|509659|P2|COMPLETED|Overall Study||48
212553|NCT00733330|509660|P1|COMPLETED|Overall Study||30
212554|NCT00733330|509659|P2|STARTED|Overall Study||52
212555|NCT00733330|509660|P1|STARTED|Overall Study||32
212556|NCT00733304|509745|P3|NOT COMPLETED|Overall Study||5
212557|NCT00733304|509746|P2|NOT COMPLETED|Overall Study||3
212558|NCT00733304|509747|P1|NOT COMPLETED|Overall Study||7
212559|NCT00733304|509745|P3|COMPLETED|Overall Study||3
212560|NCT00733304|509746|P2|COMPLETED|Overall Study||12
212561|NCT00733304|509747|P1|COMPLETED|Overall Study||12
212562|NCT00733304|509745|P3|STARTED|Overall Study||8
212563|NCT00733304|509746|P2|STARTED|Overall Study||15
212564|NCT00733304|509747|P1|STARTED|Overall Study||19
212565|NCT00733291|509829|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
212566|NCT00733291|509830|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
212567|NCT00733291|509831|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
212568|NCT00733291|509832|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
212656|NCT00732680|510045|P1|COMPLETED|Overall Study||9
212569|NCT00733291|509829|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
212570|NCT00733291|509830|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
212571|NCT00733291|509831|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
212572|NCT00733291|509832|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
212573|NCT00733291|509829|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
212574|NCT00733291|509830|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
212575|NCT00733291|509831|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
212576|NCT00733291|509832|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
212577|NCT00733291|509829|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
212578|NCT00733291|509830|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
212579|NCT00733291|509831|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
212580|NCT00733291|509832|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
212581|NCT00733291|509829|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
212582|NCT00733291|509830|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
212583|NCT00733291|509831|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
212584|NCT00733291|509832|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
212585|NCT00733291|509829|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
212586|NCT00733291|509830|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
212587|NCT00733291|509831|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
212588|NCT00733291|509832|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
212589|NCT00733291|509829|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
212590|NCT00733291|509830|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
212591|NCT00733291|509831|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
212592|NCT00733291|509832|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
212593|NCT00733291|509829|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
212594|NCT00733291|509830|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
212595|NCT00733291|509831|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
212596|NCT00733291|509832|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
212597|NCT00733291|509829|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
212598|NCT00733291|509830|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
212599|NCT00733291|509831|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
212600|NCT00733291|509832|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
212601|NCT00733278|509854|P1|NOT COMPLETED|Overall Study||0
212602|NCT00733278|509854|P1|COMPLETED|Overall Study||7
212603|NCT00733278|509854|P1|STARTED|Overall Study||7
212604|NCT00733226|509861|P2|NOT COMPLETED|Overall Study||0
212605|NCT00733226|509862|P1|NOT COMPLETED|Overall Study||5
212606|NCT00733226|509861|P2|COMPLETED|Overall Study||40
212607|NCT00733226|509862|P1|COMPLETED|Overall Study||35
212608|NCT00733226|509861|P2|STARTED|Overall Study||40
212609|NCT00733226|509862|P1|STARTED|Overall Study||40
212610|NCT00733135|509878|P1|NOT COMPLETED|Overall Study||2
212611|NCT00733135|509878|P1|COMPLETED|Overall Study||131
212612|NCT00733135|509878|P1|STARTED|Overall Study||133
212613|NCT00733096|509890|P3|NOT COMPLETED|Overall Study||0
212614|NCT00733096|509891|P2|NOT COMPLETED|Overall Study||0
212615|NCT00733096|509892|P1|NOT COMPLETED|Overall Study||0
212616|NCT00733096|509890|P3|COMPLETED|Overall Study||30
212617|NCT00733096|509891|P2|COMPLETED|Overall Study||26
212618|NCT00733096|509892|P1|COMPLETED|Overall Study||28
212619|NCT00733096|509890|P3|STARTED|Overall Study||30
212620|NCT00733096|509891|P2|STARTED|Overall Study||26
212621|NCT00733096|509892|P1|STARTED|Overall Study||28
212622|NCT00733005|509911|P2|NOT COMPLETED|Overall Study||3
212623|NCT00733005|509912|P1|NOT COMPLETED|Overall Study||2
212624|NCT00733005|509911|P2|COMPLETED|Overall Study||159
212625|NCT00733005|509912|P1|COMPLETED|Overall Study||160
212626|NCT00733005|509911|P2|STARTED|Overall Study||162
212627|NCT00733005|509912|P1|STARTED|Overall Study||162
212628|NCT00732992|509922|P2|NOT COMPLETED|Overall Study||6
212629|NCT00732992|509923|P1|NOT COMPLETED|Overall Study||6
212630|NCT00732992|509922|P2|COMPLETED|Overall Study||0
212631|NCT00732992|509923|P1|COMPLETED|Overall Study||0
212632|NCT00732992|509922|P2|STARTED|Overall Study||6
212633|NCT00732992|509923|P1|STARTED|Overall Study||6
212634|NCT00732940|509942|P2|NOT COMPLETED|Overall Study||3
212635|NCT00732940|509943|P1|NOT COMPLETED|Overall Study||2
212636|NCT00732940|509942|P2|COMPLETED|Overall Study||25
212637|NCT00732940|509943|P1|COMPLETED|Overall Study||26
212638|NCT00732940|509942|P2|STARTED|Overall Study||28
212639|NCT00732940|509943|P1|STARTED|Overall Study||28
212640|NCT00732901|510013|P2|NOT COMPLETED|Overall Study||0
212641|NCT00732901|510014|P1|NOT COMPLETED|Overall Study||0
212642|NCT00732901|510013|P2|COMPLETED|Overall Study||12
212643|NCT00732901|510014|P1|COMPLETED|Overall Study||11
212644|NCT00732901|510013|P2|STARTED|Overall Study||12
212645|NCT00732901|510014|P1|STARTED|Overall Study||11
212646|NCT00732875|510024|P1|NOT COMPLETED|Overall Study||35
212647|NCT00732875|510024|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
212648|NCT00732875|510024|P1|STARTED|Overall Study||92
212649|NCT00732758|510032|P2|NOT COMPLETED|Overall Study||16
212650|NCT00732758|510033|P1|NOT COMPLETED|Overall Study||8
212651|NCT00732758|510032|P2|COMPLETED|Overall Study||63
212652|NCT00732758|510033|P1|COMPLETED|Overall Study||70
212653|NCT00732758|510032|P2|STARTED|Overall Study||79
212654|NCT00732758|510033|P1|STARTED|Overall Study||78
212655|NCT00732680|510045|P1|NOT COMPLETED|Overall Study||0
212657|NCT00732680|510045|P1|STARTED|Overall Study||9
212658|NCT00732654|510052|P3|NOT COMPLETED|Overall Study||0
212659|NCT00732654|510053|P2|NOT COMPLETED|Overall Study||1
212660|NCT00732654|510054|P1|NOT COMPLETED|Overall Study||0
212661|NCT00732654|510052|P3|COMPLETED|Overall Study||10
212662|NCT00732654|510053|P2|COMPLETED|Overall Study||9
212663|NCT00732654|510054|P1|COMPLETED|Overall Study||10
212664|NCT00732654|510052|P3|STARTED|Overall Study||10
212665|NCT00732654|510053|P2|STARTED|Overall Study||10
212666|NCT00732654|510054|P1|STARTED|Overall Study||10
212667|NCT00732641|510073|P2|NOT COMPLETED|Overall Study||112
212668|NCT00732641|510074|P1|NOT COMPLETED|Overall Study||106
212669|NCT00732641|510073|P2|COMPLETED|Overall Study||9
212670|NCT00732641|510074|P1|COMPLETED|Overall Study||17
212671|NCT00732641|510073|P2|STARTED|Overall Study||121
212672|NCT00732641|510074|P1|STARTED|Overall Study||123
212673|NCT00732615|510094|P2|NOT COMPLETED|Overall Study||5
212674|NCT00732615|510095|P1|NOT COMPLETED|Overall Study||7
212675|NCT00732615|510094|P2|COMPLETED|Overall Study||79
212676|NCT00732615|510095|P1|COMPLETED|Overall Study||33
212677|NCT00732615|510094|P2|STARTED|Overall Study||84
212678|NCT00732615|510095|P1|STARTED|Overall Study||40
212679|NCT00732472|510111|P4|NOT COMPLETED|Overall Study||3
212680|NCT00732472|510112|P3|NOT COMPLETED|Overall Study||1
212681|NCT00732472|510113|P2|NOT COMPLETED|Overall Study||3
212682|NCT00732472|510114|P1|NOT COMPLETED|Overall Study||0
212683|NCT00732472|510111|P4|COMPLETED|Overall Study||6
212684|NCT00732472|510112|P3|COMPLETED|Overall Study||9
212685|NCT00732472|510113|P2|COMPLETED|Overall Study||7
212686|NCT00732472|510114|P1|COMPLETED|Overall Study||9
212687|NCT00732472|510111|P4|STARTED|Overall Study||9
212688|NCT00732472|510112|P3|STARTED|Overall Study||10
212689|NCT00732472|510113|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
212690|NCT00732472|510114|P1|STARTED|Overall Study||9
212691|NCT00732381|510214|P2|NOT COMPLETED|Overall Study||1
212692|NCT00732381|510215|P1|NOT COMPLETED|Overall Study||2
212693|NCT00732381|510214|P2|COMPLETED|Overall Study||174
212694|NCT00732381|510215|P1|COMPLETED|Overall Study||174
212695|NCT00732381|510214|P2|STARTED|Overall Study||175
212696|NCT00732381|510215|P1|STARTED|Overall Study||176
212697|NCT00732303|510223|P1|NOT COMPLETED|Overall Study||2
212698|NCT00732303|510223|P1|COMPLETED|Overall Study||6
212699|NCT00732303|510223|P1|STARTED|Overall Study||8
212700|NCT00732251|510229|P1|NOT COMPLETED|Overall Study||7
212701|NCT00732251|510229|P1|COMPLETED|Overall Study||1
212702|NCT00732251|510229|P1|STARTED|Overall Study||8
212703|NCT00732238|510235|P2|NOT COMPLETED|Overall Study||1
212704|NCT00732238|510236|P1|NOT COMPLETED|Overall Study||5
212705|NCT00732238|510235|P2|COMPLETED|Overall Study||27
212706|NCT00732238|510236|P1|COMPLETED|Overall Study||28
212707|NCT00732238|510235|P2|STARTED|Overall Study||28
212708|NCT00732238|510236|P1|STARTED|Overall Study||33
212709|NCT00732225|510249|P5|NOT COMPLETED|Overall Study||6
212710|NCT00732225|510250|P4|NOT COMPLETED|Overall Study||4
212711|NCT00732225|510251|P3|NOT COMPLETED|Overall Study||3
212712|NCT00732225|510252|P2|NOT COMPLETED|Overall Study||8
212713|NCT00732225|510253|P1|NOT COMPLETED|Overall Study||11
212714|NCT00732225|510249|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
212715|NCT00732225|510250|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
212716|NCT00732225|510251|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
212717|NCT00732225|510252|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
212718|NCT00732225|510253|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
212719|NCT00732225|510249|P5|STARTED|Overall Study|55 eyes of 54 patients|54
212720|NCT00732225|510250|P4|STARTED|Overall Study|33 eyes of 33 patients|33
212721|NCT00732225|510251|P3|STARTED|Overall Study|26 eyes of 26 patients|26
212722|NCT00732225|510252|P2|STARTED|Overall Study|41 eyes of 40 patients|40
212723|NCT00732225|510253|P1|STARTED|Overall Study|76 eyes of 71 patients|71
212724|NCT00732212|510304|P2|NOT COMPLETED|Overall Study||0
212725|NCT00732212|510305|P1|NOT COMPLETED|Overall Study||0
212726|NCT00732212|510304|P2|COMPLETED|Overall Study||123
212727|NCT00732212|510305|P1|COMPLETED|Overall Study||112
212728|NCT00732212|510304|P2|Temporarily Suspended|Overall Study||50
212729|NCT00732212|510305|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
212730|NCT00732212|510304|P2|STARTED|Overall Study||123
212731|NCT00732212|510305|P1|STARTED|Overall Study||112
212732|NCT00732199|510337|P2|NOT COMPLETED|Overall Study||26
212733|NCT00732199|510338|P1|NOT COMPLETED|Overall Study||34
212734|NCT00732199|510337|P2|COMPLETED|Overall Study||16
212735|NCT00732199|510338|P1|COMPLETED|Overall Study||16
212736|NCT00732199|510337|P2|STARTED|Overall Study||42
212737|NCT00732199|510338|P1|STARTED|Overall Study||50
212738|NCT00732160|510353|P4|NOT COMPLETED|Overall Study||2
212739|NCT00732160|510354|P3|NOT COMPLETED|Overall Study||3
212740|NCT00732160|510355|P2|NOT COMPLETED|Overall Study||4
212741|NCT00732160|510356|P1|NOT COMPLETED|Overall Study||5
212742|NCT00732160|510353|P4|COMPLETED|Overall Study||3
212743|NCT00732160|510354|P3|COMPLETED|Overall Study||3
212744|NCT00732160|510355|P2|COMPLETED|Overall Study||1
212745|NCT00732160|510356|P1|COMPLETED|Overall Study||2
212746|NCT00732160|510353|P4|LS Aldosterone|Overall Study||5
212747|NCT00732160|510354|P3|LS Aldosterone|Overall Study||6
212748|NCT00732160|510355|P2|LS Aldosterone|Overall Study||1
212749|NCT00732160|510356|P1|LS Aldosterone|Overall Study||2
212750|NCT00732160|510353|P4|LS Vehicle|Overall Study||5
212751|NCT00732160|510354|P3|LS Vehicle|Overall Study||6
212752|NCT00732160|510355|P2|LS Vehicle|Overall Study||1
212753|NCT00732160|510356|P1|LS Vehicle|Overall Study||2
212754|NCT00732160|510353|P4|HS Aldosterone|Overall Study||3
212755|NCT00732160|510354|P3|HS Aldosterone|Overall Study||3
212756|NCT00732160|510355|P2|HS Aldosterone|Overall Study||5
212757|NCT00732160|510356|P1|HS Aldosterone|Overall Study||7
212758|NCT00732160|510353|P4|HS Vehicle|Overall Study||3
212759|NCT00732160|510354|P3|HS Vehicle|Overall Study||3
212760|NCT00732160|510355|P2|HS Vehicle|Overall Study||5
212761|NCT00732160|510356|P1|HS Vehicle|Overall Study||7
212762|NCT00732160|510353|P4|STARTED|Overall Study||5
212763|NCT00732160|510354|P3|STARTED|Overall Study||6
212764|NCT00732160|510355|P2|STARTED|Overall Study||5
212765|NCT00732160|510356|P1|STARTED|Overall Study||7
212766|NCT00732069|510370|P6|NOT COMPLETED|Third Study Drug||0
212767|NCT00732069|510371|P5|NOT COMPLETED|Third Study Drug||0
212768|NCT00732069|510372|P4|NOT COMPLETED|Third Study Drug||0
212769|NCT00732069|510373|P3|NOT COMPLETED|Third Study Drug||0
212770|NCT00732069|510374|P2|NOT COMPLETED|Third Study Drug||0
212771|NCT00732069|510375|P1|NOT COMPLETED|Third Study Drug||0
212772|NCT00732069|510370|P6|COMPLETED|Third Study Drug||2
212773|NCT00732069|510371|P5|COMPLETED|Third Study Drug||3
212774|NCT00732069|510372|P4|COMPLETED|Third Study Drug||2
212775|NCT00732069|510373|P3|COMPLETED|Third Study Drug||3
212776|NCT00732069|510374|P2|COMPLETED|Third Study Drug||3
212777|NCT00732069|510375|P1|COMPLETED|Third Study Drug||2
212778|NCT00732069|510370|P6|STARTED|Third Study Drug||2
212779|NCT00732069|510371|P5|STARTED|Third Study Drug||3
212780|NCT00732069|510372|P4|STARTED|Third Study Drug||2
212781|NCT00732069|510373|P3|STARTED|Third Study Drug||3
212782|NCT00732069|510374|P2|STARTED|Third Study Drug||3
212783|NCT00732069|510375|P1|STARTED|Third Study Drug||2
212784|NCT00732069|510370|P6|NOT COMPLETED|Washout After Second Study Drug||0
212785|NCT00732069|510371|P5|NOT COMPLETED|Washout After Second Study Drug||0
212786|NCT00732069|510372|P4|NOT COMPLETED|Washout After Second Study Drug||0
212787|NCT00732069|510373|P3|NOT COMPLETED|Washout After Second Study Drug||0
212788|NCT00732069|510374|P2|NOT COMPLETED|Washout After Second Study Drug||0
212789|NCT00732069|510375|P1|NOT COMPLETED|Washout After Second Study Drug||0
212790|NCT00732069|510370|P6|COMPLETED|Washout After Second Study Drug||2
212791|NCT00732069|510371|P5|COMPLETED|Washout After Second Study Drug||3
212792|NCT00732069|510372|P4|COMPLETED|Washout After Second Study Drug||2
212793|NCT00732069|510373|P3|COMPLETED|Washout After Second Study Drug||3
212794|NCT00732069|510374|P2|COMPLETED|Washout After Second Study Drug||3
212795|NCT00732069|510375|P1|COMPLETED|Washout After Second Study Drug||2
212796|NCT00732069|510370|P6|STARTED|Washout After Second Study Drug||2
212797|NCT00732069|510371|P5|STARTED|Washout After Second Study Drug||3
212798|NCT00732069|510372|P4|STARTED|Washout After Second Study Drug||2
212799|NCT00732069|510373|P3|STARTED|Washout After Second Study Drug||3
212800|NCT00732069|510374|P2|STARTED|Washout After Second Study Drug||3
212801|NCT00732069|510375|P1|STARTED|Washout After Second Study Drug||2
212802|NCT00732069|510370|P6|NOT COMPLETED|Second Study Drug||0
212803|NCT00732069|510371|P5|NOT COMPLETED|Second Study Drug||0
212804|NCT00732069|510372|P4|NOT COMPLETED|Second Study Drug||0
212805|NCT00732069|510373|P3|NOT COMPLETED|Second Study Drug||0
212806|NCT00732069|510374|P2|NOT COMPLETED|Second Study Drug||0
212807|NCT00732069|510375|P1|NOT COMPLETED|Second Study Drug||0
212808|NCT00732069|510370|P6|COMPLETED|Second Study Drug||2
212809|NCT00732069|510371|P5|COMPLETED|Second Study Drug||3
212810|NCT00732069|510372|P4|COMPLETED|Second Study Drug||2
212811|NCT00732069|510373|P3|COMPLETED|Second Study Drug||3
212812|NCT00732069|510374|P2|COMPLETED|Second Study Drug||3
212813|NCT00732069|510375|P1|COMPLETED|Second Study Drug||2
212814|NCT00732069|510370|P6|STARTED|Second Study Drug||2
212815|NCT00732069|510371|P5|STARTED|Second Study Drug||3
212816|NCT00732069|510372|P4|STARTED|Second Study Drug||2
212817|NCT00732069|510373|P3|STARTED|Second Study Drug||3
212818|NCT00732069|510374|P2|STARTED|Second Study Drug||3
212819|NCT00732069|510375|P1|STARTED|Second Study Drug||2
212820|NCT00732069|510370|P6|NOT COMPLETED|Washout After First Study Drug||0
212821|NCT00732069|510371|P5|NOT COMPLETED|Washout After First Study Drug||0
212822|NCT00732069|510372|P4|NOT COMPLETED|Washout After First Study Drug||0
212823|NCT00732069|510373|P3|NOT COMPLETED|Washout After First Study Drug||0
212824|NCT00732069|510374|P2|NOT COMPLETED|Washout After First Study Drug||0
212825|NCT00732069|510375|P1|NOT COMPLETED|Washout After First Study Drug||1
212826|NCT00732069|510370|P6|COMPLETED|Washout After First Study Drug||2
212827|NCT00732069|510371|P5|COMPLETED|Washout After First Study Drug||3
212828|NCT00732069|510372|P4|COMPLETED|Washout After First Study Drug||2
212829|NCT00732069|510373|P3|COMPLETED|Washout After First Study Drug||3
212830|NCT00732069|510374|P2|COMPLETED|Washout After First Study Drug||3
212831|NCT00732069|510375|P1|COMPLETED|Washout After First Study Drug||2
212832|NCT00732069|510370|P6|STARTED|Washout After First Study Drug||2
212833|NCT00732069|510371|P5|STARTED|Washout After First Study Drug||3
212834|NCT00732069|510372|P4|STARTED|Washout After First Study Drug||2
212835|NCT00732069|510373|P3|STARTED|Washout After First Study Drug||3
212836|NCT00732069|510374|P2|STARTED|Washout After First Study Drug||3
212837|NCT00732069|510375|P1|STARTED|Washout After First Study Drug||3
212838|NCT00732069|510370|P6|NOT COMPLETED|First Study Drug||0
212839|NCT00732069|510371|P5|NOT COMPLETED|First Study Drug||0
212840|NCT00732069|510372|P4|NOT COMPLETED|First Study Drug||0
212841|NCT00732069|510373|P3|NOT COMPLETED|First Study Drug||0
212842|NCT00732069|510374|P2|NOT COMPLETED|First Study Drug||0
212843|NCT00732069|510375|P1|NOT COMPLETED|First Study Drug||0
212844|NCT00732069|510370|P6|COMPLETED|First Study Drug||2
212845|NCT00732069|510371|P5|COMPLETED|First Study Drug||3
212846|NCT00732069|510372|P4|COMPLETED|First Study Drug||2
212847|NCT00732069|510373|P3|COMPLETED|First Study Drug||3
212848|NCT00732069|510374|P2|COMPLETED|First Study Drug||3
212849|NCT00732069|510375|P1|COMPLETED|First Study Drug||3
212850|NCT00732069|510370|P6|STARTED|First Study Drug||2
212851|NCT00732069|510371|P5|STARTED|First Study Drug||3
212852|NCT00732069|510372|P4|STARTED|First Study Drug||2
212853|NCT00732069|510373|P3|STARTED|First Study Drug||3
212854|NCT00732069|510374|P2|STARTED|First Study Drug||3
212855|NCT00732069|510375|P1|STARTED|First Study Drug||3
212856|NCT00732030|510386|P1|NOT COMPLETED|Overall Study||2
212857|NCT00732030|510386|P1|COMPLETED|Overall Study||24
212858|NCT00732030|510386|P1|STARTED|Overall Study||26
212859|NCT00731939|510393|P1|NOT COMPLETED|Overall Study||34
212860|NCT00731939|510393|P1|COMPLETED|Overall Study||90
212861|NCT00731939|510393|P1|STARTED|Overall Study||124
212862|NCT00731874|510443|P2|NOT COMPLETED|Overall Study||0
212863|NCT00731874|510444|P1|NOT COMPLETED|Overall Study||0
212864|NCT00731874|510443|P2|COMPLETED|Overall Study||13
212865|NCT00731874|510444|P1|COMPLETED|Overall Study||10
212866|NCT00731874|510443|P2|STARTED|Overall Study||13
212867|NCT00731874|510444|P1|STARTED|Overall Study||10
212868|NCT00731822|510454|P2|NOT COMPLETED|Overall Study||1
212869|NCT00731822|510455|P1|NOT COMPLETED|Overall Study||4
212870|NCT00731822|510454|P2|COMPLETED|Overall Study||39
212871|NCT00731822|510455|P1|COMPLETED|Overall Study||16
212872|NCT00731822|510454|P2|STARTED|Overall Study||40
212873|NCT00731822|510455|P1|STARTED|Overall Study||20
212874|NCT00731783|510469|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
212875|NCT00731783|510470|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
212876|NCT00731783|510469|P2|COMPLETED|12 Month Follow-Up Visit||58
212877|NCT00731783|510470|P1|COMPLETED|12 Month Follow-Up Visit||68
212878|NCT00731783|510469|P2|STARTED|12 Month Follow-Up Visit||65
212879|NCT00731783|510470|P1|STARTED|12 Month Follow-Up Visit||74
212880|NCT00731783|510469|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
212881|NCT00731783|510470|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
212882|NCT00731783|510469|P2|COMPLETED|Six Month Follow-Up Visit||64
212883|NCT00731783|510470|P1|COMPLETED|Six Month Follow-Up Visit||71
212884|NCT00731783|510469|P2|STARTED|Six Month Follow-Up Visit||67
212885|NCT00731783|510470|P1|STARTED|Six Month Follow-Up Visit||77
212886|NCT00731783|510469|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
212887|NCT00731783|510470|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
212888|NCT00731783|510469|P2|COMPLETED|Three Month Follow-Up Visit||57
212889|NCT00731783|510470|P1|COMPLETED|Three Month Follow-Up Visit||72
212890|NCT00731783|510469|P2|STARTED|Three Month Follow-Up Visit||73
212891|NCT00731783|510470|P1|STARTED|Three Month Follow-Up Visit||79
212892|NCT00731783|510469|P2|NOT COMPLETED|One Month Follow-Up Visit||22
212893|NCT00731783|510470|P1|NOT COMPLETED|One Month Follow-Up Visit||14
212894|NCT00731783|510469|P2|COMPLETED|One Month Follow-Up Visit||69
212895|NCT00731783|510470|P1|COMPLETED|One Month Follow-Up Visit||78
212896|NCT00731783|510469|P2|STARTED|One Month Follow-Up Visit||91
212897|NCT00731783|510470|P1|STARTED|One Month Follow-Up Visit||92
212898|NCT00731731|510493|P3|NOT COMPLETED|Overall Study||3
212899|NCT00731731|510494|P2|NOT COMPLETED|Overall Study||0
212900|NCT00731731|510495|P1|NOT COMPLETED|Overall Study||0
212901|NCT00731731|510493|P3|COMPLETED|Overall Study||107
212902|NCT00731731|510494|P2|COMPLETED|Overall Study||3
212903|NCT00731731|510495|P1|COMPLETED|Overall Study||12
212904|NCT00731731|510493|P3|STARTED|Overall Study||110
212905|NCT00731731|510494|P2|STARTED|Overall Study||3
212906|NCT00731731|510495|P1|STARTED|Overall Study||12
212907|NCT00731692|510513|P3|NOT COMPLETED|Extension Phase||301
212908|NCT00731692|510514|P2|NOT COMPLETED|Extension Phase||196
212909|NCT00731692|510515|P1|NOT COMPLETED|Extension Phase||74
212910|NCT00731692|510513|P3|COMPLETED|Extension Phase||0
212911|NCT00731692|510514|P2|COMPLETED|Extension Phase||0
212912|NCT00731692|510515|P1|COMPLETED|Extension Phase||0
212913|NCT00731692|510513|P3|STARTED|Extension Phase||301
212914|NCT00731692|510514|P2|STARTED|Extension Phase||196
212915|NCT00731692|510515|P1|STARTED|Extension Phase||74
212916|NCT00731692|510513|P3|NOT COMPLETED|Core Study (36 Months)||170
212917|NCT00731692|510514|P2|NOT COMPLETED|Core Study (36 Months)||116
212918|NCT00731692|510515|P1|NOT COMPLETED|Core Study (36 Months)||68
212919|NCT00731692|510513|P3|COMPLETED|Core Study (36 Months)||317
212920|NCT00731692|510514|P2|COMPLETED|Core Study (36 Months)||220
212921|NCT00731692|510515|P1|COMPLETED|Core Study (36 Months)||79
212922|NCT00731692|510513|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
212923|NCT00731692|510514|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
212924|NCT00731692|510515|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
212925|NCT00731692|510513|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
212926|NCT00731692|510514|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
212927|NCT00731692|510515|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
212928|NCT00731692|510513|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
212929|NCT00731692|510514|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
212930|NCT00731692|510515|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
212931|NCT00731692|510513|P3|Safety Set (SAF)|Core Study (36 Months)||487
212932|NCT00731692|510514|P2|Safety Set (SAF)|Core Study (36 Months)||336
212933|NCT00731692|510515|P1|Safety Set (SAF)|Core Study (36 Months)||0
212934|NCT00731692|510513|P3|STARTED|Core Study (36 Months)||487
212935|NCT00731692|510514|P2|STARTED|Core Study (36 Months)||336
212936|NCT00731692|510515|P1|STARTED|Core Study (36 Months)||147
212937|NCT00731679|510561|P2|NOT COMPLETED|Overall Study||26
212938|NCT00731679|510562|P1|NOT COMPLETED|Overall Study||22
212939|NCT00731679|510561|P2|COMPLETED|Overall Study||283
212940|NCT00731679|510562|P1|COMPLETED|Overall Study||292
212941|NCT00731679|510561|P2|STARTED|Overall Study||309
212942|NCT00731679|510562|P1|STARTED|Overall Study||314
212943|NCT00731666|510570|P1|NOT COMPLETED|Overall Study||12
212944|NCT00731666|510570|P1|COMPLETED|Overall Study||28
212945|NCT00731666|510570|P1|STARTED|Overall Study||40
212946|NCT00731653|510576|P1|NOT COMPLETED|Overall Study||9
212947|NCT00731653|510576|P1|COMPLETED|Overall Study||72
212948|NCT00731653|510576|P1|STARTED|Overall Study||81
212949|NCT00731640|510582|P2|NOT COMPLETED|Overall Study||0
212950|NCT00731640|510583|P1|NOT COMPLETED|Overall Study||0
212951|NCT00731640|510582|P2|COMPLETED|Overall Study||32
212952|NCT00731640|510583|P1|COMPLETED|Overall Study||20
212953|NCT00731640|510582|P2|STARTED|Overall Study||32
212954|NCT00731640|510583|P1|STARTED|Overall Study||20
212955|NCT00731614|510597|P2|NOT COMPLETED|Overall Study||13
212956|NCT00731614|510598|P1|NOT COMPLETED|Overall Study||7
212957|NCT00731614|510597|P2|COMPLETED|Overall Study||18
212958|NCT00731614|510598|P1|COMPLETED|Overall Study||16
212959|NCT00731614|510597|P2|12 Weeks Posttreatment|Overall Study||23
212960|NCT00731614|510598|P1|12 Weeks Posttreatment|Overall Study||18
212961|NCT00731614|510597|P2|End of Treatment|Overall Study||24
212962|NCT00731614|510598|P1|End of Treatment|Overall Study||16
212963|NCT00731614|510597|P2|STARTED|Overall Study||31
212964|NCT00731614|510598|P1|STARTED|Overall Study||23
212965|NCT00731549|510604|P1|NOT COMPLETED|Overall Study||223
212966|NCT00731549|510604|P1|COMPLETED|Overall Study||858
212967|NCT00731549|510604|P1|STARTED|Overall Study||1081
212968|NCT00731484|510617|P1|NOT COMPLETED|Overall Study||0
212969|NCT00731484|510617|P1|COMPLETED|Overall Study||233
212970|NCT00731484|510617|P1|STARTED|Overall Study||233
212971|NCT00731341|510621|P1|NOT COMPLETED|Overall Study||0
212972|NCT00731341|510621|P1|COMPLETED|Overall Study||3
212973|NCT00731341|510621|P1|STARTED|Overall Study||3
212974|NCT00731211|510630|P1|NOT COMPLETED|Overall Study||0
212975|NCT00731211|510630|P1|COMPLETED|Overall Study||55
212976|NCT00731211|510630|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
212977|NCT00731198|510637|P2|NOT COMPLETED|Overall Study||6
212978|NCT00731198|510638|P1|NOT COMPLETED|Overall Study||6
212979|NCT00731198|510637|P2|COMPLETED|Overall Study||319
212980|NCT00731198|510638|P1|COMPLETED|Overall Study||319
212981|NCT00731198|510637|P2|STARTED|Overall Study||325
212982|NCT00731198|510638|P1|STARTED|Overall Study||325
212983|NCT00731133|510644|P1|NOT COMPLETED|Overall Study||10
212984|NCT00731133|510644|P1|COMPLETED|Overall Study||5
212985|NCT00731133|510644|P1|STARTED|Overall Study||15
212986|NCT00731120|510652|P3|NOT COMPLETED|Overall Study||36
212987|NCT00731120|510653|P2|NOT COMPLETED|Overall Study||43
212988|NCT00731120|510654|P1|NOT COMPLETED|Overall Study||42
212989|NCT00731120|510652|P3|COMPLETED|Overall Study||116
212990|NCT00731120|510653|P2|COMPLETED|Overall Study||109
212991|NCT00731120|510654|P1|COMPLETED|Overall Study||111
212992|NCT00731120|510652|P3|Treated|Overall Study||152
212993|NCT00731120|510653|P2|Treated|Overall Study||151
212994|NCT00731120|510654|P1|Treated|Overall Study||153
212995|NCT00731120|510652|P3|STARTED|Overall Study||152
212996|NCT00731120|510653|P2|STARTED|Overall Study||152
212997|NCT00731120|510654|P1|STARTED|Overall Study||153
212998|NCT00731094|510691|P2|NOT COMPLETED|Overall Study||11
212999|NCT00731094|510692|P1|NOT COMPLETED|Overall Study||18
213000|NCT00731094|510691|P2|COMPLETED|Overall Study||105
213001|NCT00731094|510692|P1|COMPLETED|Overall Study||98
213002|NCT00731094|510691|P2|Month 6|Overall Study||107
213003|NCT00731094|510692|P1|Month 6|Overall Study||101
213004|NCT00731094|510691|P2|STARTED|Overall Study||116
213005|NCT00731094|510692|P1|STARTED|Overall Study||116
213006|NCT00731055|510762|P1|NOT COMPLETED|Overall Study||0
213007|NCT00731055|510762|P1|COMPLETED|Overall Study||16
213008|NCT00731055|510762|P1|Received Varenicline 2.0 mg|Overall Study||16
213009|NCT00731055|510762|P1|Received Varenicline 1.0 mg|Overall Study||16
213010|NCT00731055|510762|P1|Received Varenicline 0.5 mg|Overall Study||16
213011|NCT00731055|510762|P1|Received Placebo|Overall Study||16
213012|NCT00731055|510762|P1|STARTED|Overall Study|This is a within-subjects study design.|16
213013|NCT00731042|510771|P2|NOT COMPLETED|Second Intervention||2
213014|NCT00731042|510772|P1|NOT COMPLETED|Second Intervention||0
213106|NCT00730405|511030|P2|STARTED|Overall Study-follow-up Phase||117
213015|NCT00731042|510771|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
213016|NCT00731042|510772|P1|COMPLETED|Second Intervention||16
213017|NCT00731042|510771|P2|STARTED|Second Intervention||17
213018|NCT00731042|510772|P1|STARTED|Second Intervention||16
213019|NCT00731042|510771|P2|NOT COMPLETED|Wash-out||0
213020|NCT00731042|510772|P1|NOT COMPLETED|Wash-out||0
213021|NCT00731042|510771|P2|COMPLETED|Wash-out||17
213022|NCT00731042|510772|P1|COMPLETED|Wash-out||16
213023|NCT00731042|510771|P2|STARTED|Wash-out||17
213024|NCT00731042|510772|P1|STARTED|Wash-out||16
213025|NCT00731042|510771|P2|NOT COMPLETED|First Intervention||0
213026|NCT00731042|510772|P1|NOT COMPLETED|First Intervention||0
213027|NCT00731042|510771|P2|COMPLETED|First Intervention||17
213028|NCT00731042|510772|P1|COMPLETED|First Intervention||16
213029|NCT00731042|510771|P2|STARTED|First Intervention||17
213030|NCT00731042|510772|P1|STARTED|First Intervention||16
213031|NCT00730964|510778|P1|NOT COMPLETED|Overall Study||0
213032|NCT00730964|510778|P1|COMPLETED|Overall Study||1039
213033|NCT00730964|510778|P1|STARTED|Overall Study||1039
213034|NCT00730925|510783|P1|NOT COMPLETED|Overall Study||41
213035|NCT00730925|510783|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
213036|NCT00730925|510783|P1|STARTED|Overall Study||41
213037|NCT00730912|510793|P3|NOT COMPLETED|Overall Study||1
213038|NCT00730912|510794|P2|NOT COMPLETED|Overall Study||0
213039|NCT00730912|510795|P1|NOT COMPLETED|Overall Study||0
213040|NCT00730912|510793|P3|COMPLETED|Overall Study||103
213041|NCT00730912|510794|P2|COMPLETED|Overall Study||104
213042|NCT00730912|510795|P1|COMPLETED|Overall Study||53
213043|NCT00730912|510793|P3|STARTED|Overall Study||104
213044|NCT00730912|510794|P2|STARTED|Overall Study||104
213045|NCT00730912|510795|P1|STARTED|Overall Study||53
213046|NCT00730847|510806|P1|NOT COMPLETED|Overall Study||131
213047|NCT00730847|510806|P1|COMPLETED|Overall Study||465
213048|NCT00730847|510806|P1|STARTED|Overall Study||596
213049|NCT00730756|510815|P2|NOT COMPLETED|Overall Study||5
213050|NCT00730756|510816|P1|NOT COMPLETED|Overall Study||4
213051|NCT00730756|510815|P2|COMPLETED|Overall Study||48
213052|NCT00730756|510816|P1|COMPLETED|Overall Study||45
213053|NCT00730756|510815|P2|STARTED|Overall Study||53
213054|NCT00730756|510816|P1|STARTED|Overall Study||49
213055|NCT00730730|510838|P1|NOT COMPLETED|Overall Study||0
213056|NCT00730730|510838|P1|COMPLETED|Overall Study||50
213057|NCT00730730|510838|P1|STARTED|Overall Study||50
213058|NCT00730691|510850|P5|NOT COMPLETED|Overall Study||50
213059|NCT00730691|510851|P4|NOT COMPLETED|Overall Study||45
213060|NCT00730691|510852|P3|NOT COMPLETED|Overall Study||39
213061|NCT00730691|510853|P2|NOT COMPLETED|Overall Study||36
213062|NCT00730691|510854|P1|NOT COMPLETED|Overall Study||36
213063|NCT00730691|510850|P5|COMPLETED|Overall Study||106
213064|NCT00730691|510851|P4|COMPLETED|Overall Study||111
213065|NCT00730691|510852|P3|COMPLETED|Overall Study||117
213066|NCT00730691|510853|P2|COMPLETED|Overall Study||120
213067|NCT00730691|510854|P1|COMPLETED|Overall Study||121
213068|NCT00730691|510850|P5|STARTED|Overall Study||156
213069|NCT00730691|510851|P4|STARTED|Overall Study||156
213070|NCT00730691|510852|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
213071|NCT00730691|510853|P2|STARTED|Overall Study||156
213072|NCT00730691|510854|P1|STARTED|Overall Study||157
213073|NCT00730639|510946|P5|NOT COMPLETED|Overall Study||131
213074|NCT00730639|510947|P4|NOT COMPLETED|Overall Study||54
213075|NCT00730639|510948|P3|NOT COMPLETED|Overall Study||86
213076|NCT00730639|510949|P2|NOT COMPLETED|Overall Study||18
213077|NCT00730639|510950|P1|NOT COMPLETED|Overall Study||17
213078|NCT00730639|510946|P5|COMPLETED|Overall Study||0
213079|NCT00730639|510947|P4|COMPLETED|Overall Study||0
213080|NCT00730639|510948|P3|COMPLETED|Overall Study||0
213081|NCT00730639|510949|P2|COMPLETED|Overall Study||0
213082|NCT00730639|510950|P1|COMPLETED|Overall Study||0
213083|NCT00730639|510946|P5|STARTED|Overall Study||131
213084|NCT00730639|510947|P4|STARTED|Overall Study||54
213085|NCT00730639|510948|P3|STARTED|Overall Study||86
213086|NCT00730639|510949|P2|STARTED|Overall Study||18
213087|NCT00730639|510950|P1|STARTED|Overall Study||17
213088|NCT00730483|511014|P1|NOT COMPLETED|Overall Study||7
213089|NCT00730483|511014|P1|COMPLETED|Overall Study||6
213090|NCT00730483|511014|P1|6 Months After First DEB-TACE|Overall Study||10
213091|NCT00730483|511014|P1|1 Month After First DEB-TACE|Overall Study||13
213092|NCT00730483|511014|P1|STARTED|Overall Study||13
213093|NCT00730405|511027|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
213094|NCT00730405|511028|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
213095|NCT00730405|511029|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
213096|NCT00730405|511030|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
213097|NCT00730405|511031|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
213098|NCT00730405|511027|P5|COMPLETED|Overall Study-follow-up Phase||93
213099|NCT00730405|511028|P4|COMPLETED|Overall Study-follow-up Phase||100
213100|NCT00730405|511029|P3|COMPLETED|Overall Study-follow-up Phase||94
213101|NCT00730405|511030|P2|COMPLETED|Overall Study-follow-up Phase||96
213102|NCT00730405|511031|P1|COMPLETED|Overall Study-follow-up Phase||95
213103|NCT00730405|511027|P5|STARTED|Overall Study-follow-up Phase||115
213104|NCT00730405|511028|P4|STARTED|Overall Study-follow-up Phase||117
213105|NCT00730405|511029|P3|STARTED|Overall Study-follow-up Phase||117
213107|NCT00730405|511031|P1|STARTED|Overall Study-follow-up Phase||116
213108|NCT00730405|511027|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
213109|NCT00730405|511028|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
213110|NCT00730405|511029|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
213111|NCT00730405|511030|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
213112|NCT00730405|511031|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
213113|NCT00730405|511027|P5|COMPLETED|Overall Study-Treatment Phase||95
213114|NCT00730405|511028|P4|COMPLETED|Overall Study-Treatment Phase||98
213115|NCT00730405|511029|P3|COMPLETED|Overall Study-Treatment Phase||96
213116|NCT00730405|511030|P2|COMPLETED|Overall Study-Treatment Phase||96
213117|NCT00730405|511031|P1|COMPLETED|Overall Study-Treatment Phase||97
213118|NCT00730405|511027|P5|STARTED|Overall Study-Treatment Phase||115
213119|NCT00730405|511028|P4|STARTED|Overall Study-Treatment Phase||117
213120|NCT00730405|511029|P3|STARTED|Overall Study-Treatment Phase||117
213121|NCT00730405|511030|P2|STARTED|Overall Study-Treatment Phase||117
213122|NCT00730405|511031|P1|STARTED|Overall Study-Treatment Phase||116
213123|NCT00730353|511068|P1|NOT COMPLETED|Overall Study||0
213124|NCT00730353|511068|P1|COMPLETED|Overall Study||28
213125|NCT00730353|511068|P1|STARTED|Overall Study||28
213126|NCT00730327|511078|P2|NOT COMPLETED|Overall Study||37
213127|NCT00730327|511079|P1|NOT COMPLETED|Overall Study||27
213128|NCT00730327|511078|P2|COMPLETED|Overall Study||93
213129|NCT00730327|511079|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
213130|NCT00730327|511078|P2|Completed Week 26|Overall Study||99
213131|NCT00730327|511079|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
213132|NCT00730327|511078|P2|STARTED|Overall Study||130
213133|NCT00730327|511079|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
213134|NCT00730275|511104|P4|NOT COMPLETED|Overall Study||1
213135|NCT00730275|511105|P3|NOT COMPLETED|Overall Study||0
213136|NCT00730275|511106|P2|NOT COMPLETED|Overall Study||0
213137|NCT00730275|511107|P1|NOT COMPLETED|Overall Study||0
213138|NCT00730275|511104|P4|COMPLETED|Overall Study||8
213139|NCT00730275|511105|P3|COMPLETED|Overall Study||8
213140|NCT00730275|511106|P2|COMPLETED|Overall Study||9
213141|NCT00730275|511107|P1|COMPLETED|Overall Study||9
213142|NCT00730275|511104|P4|STARTED|Overall Study||9
213143|NCT00730275|511105|P3|STARTED|Overall Study||8
213144|NCT00730275|511106|P2|STARTED|Overall Study||9
213145|NCT00730275|511107|P1|STARTED|Overall Study||9
213146|NCT00730236|511133|P1|NOT COMPLETED|Overall Study||6
213147|NCT00730236|511133|P1|COMPLETED|Overall Study||23
213148|NCT00730236|511133|P1|STARTED|Overall Study||29
213149|NCT00730171|511148|P1|NOT COMPLETED|Overall Study||771
213150|NCT00730171|511148|P1|COMPLETED|Overall Study||954
213151|NCT00730171|511148|P1|IBS-C Safety Population|Overall Study||1119
213152|NCT00730171|511148|P1|CC Safety Population|Overall Study||607
213153|NCT00730171|511148|P1|STARTED|Overall Study||1725
213154|NCT00730132|511156|P1|NOT COMPLETED|Overall Study||155
213155|NCT00730132|511156|P1|COMPLETED|Overall Study||557
213156|NCT00730132|511156|P1|STARTED|Overall Study||712
213157|NCT00730041|511174|P2|NOT COMPLETED|Overall Study||2
213158|NCT00730041|511175|P1|NOT COMPLETED|Overall Study||0
213159|NCT00730041|511174|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
213160|NCT00730041|511175|P1|COMPLETED|Overall Study||26
213161|NCT00730041|511174|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
213162|NCT00730041|511175|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
213163|NCT00730028|511198|P5|NOT COMPLETED|Overall Study||82
213164|NCT00730028|511199|P4|NOT COMPLETED|Overall Study||56
213165|NCT00730028|511200|P3|NOT COMPLETED|Overall Study||45
213166|NCT00730028|511201|P2|NOT COMPLETED|Overall Study||66
213167|NCT00730028|511202|P1|NOT COMPLETED|Overall Study||60
213168|NCT00730028|511198|P5|COMPLETED|Overall Study||175
213169|NCT00730028|511199|P4|COMPLETED|Overall Study||207
213170|NCT00730028|511200|P3|COMPLETED|Overall Study||221
213171|NCT00730028|511201|P2|COMPLETED|Overall Study||194
213172|NCT00730028|511202|P1|COMPLETED|Overall Study||204
213173|NCT00730028|511198|P5|STARTED|Overall Study||257
213174|NCT00730028|511199|P4|STARTED|Overall Study||263
213175|NCT00730028|511200|P3|STARTED|Overall Study||266
213176|NCT00730028|511201|P2|STARTED|Overall Study||260
213177|NCT00730028|511202|P1|STARTED|Overall Study||264
213178|NCT00730015|511252|P3|NOT COMPLETED|Overall Study||32
213179|NCT00730015|511253|P2|NOT COMPLETED|Overall Study||40
213180|NCT00730015|511254|P1|NOT COMPLETED|Overall Study||31
213181|NCT00730015|511252|P3|COMPLETED|Overall Study||177
213182|NCT00730015|511253|P2|COMPLETED|Overall Study||177
213183|NCT00730015|511254|P1|COMPLETED|Overall Study||186
213184|NCT00730015|511252|P3|STARTED|Overall Study||209
213185|NCT00730015|511253|P2|STARTED|Overall Study||217
213186|NCT00730015|511254|P1|STARTED|Overall Study||217
213187|NCT00729937|511294|P6|NOT COMPLETED|Overall Study||37
213188|NCT00729937|511295|P5|NOT COMPLETED|Overall Study||28
213189|NCT00729937|511296|P4|NOT COMPLETED|Overall Study||34
213190|NCT00729937|511297|P3|NOT COMPLETED|Overall Study||29
213191|NCT00729937|511298|P2|NOT COMPLETED|Overall Study||88
213192|NCT00729937|511299|P1|NOT COMPLETED|Overall Study||74
213193|NCT00729937|511294|P6|COMPLETED|Overall Study||214
213194|NCT00729937|511295|P5|COMPLETED|Overall Study||221
213195|NCT00729937|511296|P4|COMPLETED|Overall Study||215
213196|NCT00729937|511297|P3|COMPLETED|Overall Study||222
213197|NCT00729937|511298|P2|COMPLETED|Overall Study||548
213198|NCT00729937|511299|P1|COMPLETED|Overall Study||555
213199|NCT00729937|511294|P6|STARTED|Overall Study||251
213200|NCT00729937|511295|P5|STARTED|Overall Study||249
213201|NCT00729937|511296|P4|STARTED|Overall Study||249
213202|NCT00729937|511297|P3|STARTED|Overall Study||251
213203|NCT00729937|511298|P2|STARTED|Overall Study||636
213204|NCT00729937|511299|P1|STARTED|Overall Study||629
213205|NCT00729924|511493|P1|NOT COMPLETED|Overall Study||0
213206|NCT00729924|511493|P1|COMPLETED|Overall Study||40
213207|NCT00729924|511493|P1|STARTED|Overall Study||40
213208|NCT00729859|511503|P3|NOT COMPLETED|Overall Study||0
213209|NCT00729859|511504|P2|NOT COMPLETED|Overall Study||2
213210|NCT00729859|511505|P1|NOT COMPLETED|Overall Study||0
213211|NCT00729859|511503|P3|COMPLETED|Overall Study||8
213212|NCT00729859|511504|P2|COMPLETED|Overall Study||6
213213|NCT00729859|511505|P1|COMPLETED|Overall Study||8
213214|NCT00729859|511503|P3|STARTED|Overall Study||8
213215|NCT00729859|511504|P2|STARTED|Overall Study||8
213216|NCT00729859|511505|P1|STARTED|Overall Study||8
213217|NCT00729846|511542|P2|NOT COMPLETED|Overall Study||0
213218|NCT00729846|511543|P1|NOT COMPLETED|Overall Study||0
213219|NCT00729846|511542|P2|COMPLETED|Overall Study||11
213220|NCT00729846|511543|P1|COMPLETED|Overall Study||11
213221|NCT00729846|511542|P2|STARTED|Overall Study||11
213222|NCT00729846|511543|P1|STARTED|Overall Study||11
213223|NCT00729833|511549|P4|NOT COMPLETED|Overall Study||6
213224|NCT00729833|511550|P3|NOT COMPLETED|Overall Study||12
213225|NCT00729833|511551|P2|NOT COMPLETED|Overall Study||7
213226|NCT00729833|511552|P1|NOT COMPLETED|Overall Study||20
213227|NCT00729833|511549|P4|COMPLETED|Overall Study||0
213228|NCT00729833|511550|P3|COMPLETED|Overall Study||0
213229|NCT00729833|511551|P2|COMPLETED|Overall Study||0
213230|NCT00729833|511552|P1|COMPLETED|Overall Study||0
213231|NCT00729833|511549|P4|STARTED|Overall Study||6
213232|NCT00729833|511550|P3|STARTED|Overall Study||12
213233|NCT00729833|511551|P2|STARTED|Overall Study||7
213234|NCT00729833|511552|P1|STARTED|Overall Study||20
213235|NCT00729807|511591|P1|NOT COMPLETED|Overall Study||0
213236|NCT00729807|511591|P1|COMPLETED|Overall Study||6
213237|NCT00729807|511591|P1|STARTED|Overall Study||6
213238|NCT00729781|511595|P1|NOT COMPLETED|Long-term Follow-up Study||0
213239|NCT00729781|511595|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
213240|NCT00729781|511595|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
213241|NCT00729781|511595|P1|NOT COMPLETED|Original Study||0
213242|NCT00729781|511595|P1|COMPLETED|Original Study||45
213243|NCT00729781|511595|P1|STARTED|Original Study||45
213244|NCT00729690|511604|P3|NOT COMPLETED|Overall Study||2
213245|NCT00729690|511605|P2|NOT COMPLETED|Overall Study||2
213246|NCT00729690|511606|P1|NOT COMPLETED|Overall Study||0
213247|NCT00729690|511604|P3|COMPLETED|Overall Study||14
213248|NCT00729690|511605|P2|COMPLETED|Overall Study||14
213249|NCT00729690|511606|P1|COMPLETED|Overall Study||16
213250|NCT00729690|511604|P3|STARTED|Overall Study||16
213251|NCT00729690|511605|P2|STARTED|Overall Study||16
213252|NCT00729690|511606|P1|STARTED|Overall Study||16
213253|NCT00729677|511623|P1|NOT COMPLETED|Overall Study||0
213254|NCT00729677|511623|P1|COMPLETED|Overall Study||64
213255|NCT00729677|511623|P1|STARTED|Overall Study||64
213256|NCT00729651|511636|P2|NOT COMPLETED|Overall Study||18
213257|NCT00729651|511637|P1|NOT COMPLETED|Overall Study||19
213258|NCT00729651|511636|P2|COMPLETED|Overall Study||152
213259|NCT00729651|511637|P1|COMPLETED|Overall Study||154
213260|NCT00729651|511636|P2|STARTED|Overall Study||170
213261|NCT00729651|511637|P1|STARTED|Overall Study||173
213262|NCT00729612|511649|P1|NOT COMPLETED|Overall Study||10
213263|NCT00729612|511649|P1|COMPLETED|Overall Study||53
213264|NCT00729612|511649|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
213265|NCT00729612|511649|P1|Received Cycle 2|Overall Study||54
213266|NCT00729612|511649|P1|Did Not Receive Cycle 2|Overall Study||7
213267|NCT00729612|511649|P1|Received Cycle 1|Overall Study||62
213268|NCT00729612|511649|P1|Died Before Cycle 1|Overall Study||1
213269|NCT00729612|511649|P1|STARTED|Overall Study||63
213270|NCT00729560|511656|P1|NOT COMPLETED|Overall Study||3
213271|NCT00729560|511656|P1|COMPLETED|Overall Study||5
213272|NCT00729560|511656|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
213273|NCT00729521|511663|P3|NOT COMPLETED|Overall Study||0
213274|NCT00729521|511664|P2|NOT COMPLETED|Overall Study||0
213275|NCT00729521|511665|P1|NOT COMPLETED|Overall Study||0
213276|NCT00729521|511663|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
213277|NCT00729521|511664|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
213278|NCT00729521|511665|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
213279|NCT00729521|511663|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
213280|NCT00729521|511664|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
213281|NCT00729521|511665|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
213282|NCT00729482|511673|P1|NOT COMPLETED|Overall Study||0
213283|NCT00729482|511673|P1|COMPLETED|Overall Study||54
213284|NCT00729482|511673|P1|STARTED|Overall Study||54
213285|NCT00729469|511682|P2|NOT COMPLETED|Overall Study||47
213286|NCT00729469|511683|P1|NOT COMPLETED|Overall Study||53
213287|NCT00729469|511682|P2|COMPLETED|Overall Study||416
213288|NCT00729469|511683|P1|COMPLETED|Overall Study||403
213289|NCT00729469|511682|P2|STARTED|Overall Study||463
213290|NCT00729469|511683|P1|STARTED|Overall Study||456
213291|NCT00729430|511721|P2|NOT COMPLETED|Overall Study||50
213292|NCT00729430|511722|P1|NOT COMPLETED|Overall Study||47
213293|NCT00729430|511721|P2|COMPLETED|Overall Study||128
213294|NCT00729430|511722|P1|COMPLETED|Overall Study||133
213295|NCT00729430|511721|P2|STARTED|Overall Study||178
213296|NCT00729430|511722|P1|STARTED|Overall Study||180
213297|NCT00729378|511736|P2|NOT COMPLETED|36-months||6
213298|NCT00729378|511737|P1|NOT COMPLETED|36-months||15
213299|NCT00729378|511736|P2|COMPLETED|36-months||95
213300|NCT00729378|511737|P1|COMPLETED|36-months||105
213301|NCT00729378|511736|P2|STARTED|36-months||101
213302|NCT00729378|511737|P1|STARTED|36-months||120
213303|NCT00729378|511736|P2|NOT COMPLETED|24-months||51
213304|NCT00729378|511737|P1|NOT COMPLETED|24-months||72
213305|NCT00729378|511736|P2|COMPLETED|24-months||101
213306|NCT00729378|511737|P1|COMPLETED|24-months||120
213307|NCT00729378|511736|P2|STARTED|24-months||152
213308|NCT00729378|511737|P1|STARTED|24-months||192
213309|NCT00729378|511736|P2|NOT COMPLETED|12-months||65
213310|NCT00729378|511737|P1|NOT COMPLETED|12-months||100
213311|NCT00729378|511736|P2|COMPLETED|12-months||152
213312|NCT00729378|511737|P1|COMPLETED|12-months||192
213313|NCT00729378|511736|P2|STARTED|12-months||217
213314|NCT00729378|511737|P1|STARTED|12-months||292
213315|NCT00729378|511736|P2|NOT COMPLETED|Baseline||92
213316|NCT00729378|511737|P1|NOT COMPLETED|Baseline||138
213317|NCT00729378|511736|P2|COMPLETED|Baseline||217
213318|NCT00729378|511737|P1|COMPLETED|Baseline||292
213319|NCT00729378|511736|P2|STARTED|Baseline||309
213320|NCT00729378|511737|P1|STARTED|Baseline||430
213321|NCT00729365|511936|P3|NOT COMPLETED|Overall Study||7
213322|NCT00729365|511937|P2|NOT COMPLETED|Overall Study||6
213323|NCT00729365|511938|P1|NOT COMPLETED|Overall Study||33
213324|NCT00729365|511936|P3|COMPLETED|Overall Study|Study terminated|0
213325|NCT00729365|511937|P2|COMPLETED|Overall Study|Study Terminated|0
213326|NCT00729365|511938|P1|COMPLETED|Overall Study|Study terminated|0
213327|NCT00729365|511936|P3|STARTED|Overall Study||7
213328|NCT00729365|511937|P2|STARTED|Overall Study||6
213329|NCT00729365|511938|P1|STARTED|Overall Study||33
213330|NCT00729326|511951|P2|NOT COMPLETED|Overall Study||9
213331|NCT00729326|511952|P1|NOT COMPLETED|Overall Study||10
213332|NCT00729326|511951|P2|COMPLETED|Overall Study||33
213333|NCT00729326|511952|P1|COMPLETED|Overall Study||31
213334|NCT00729326|511951|P2|STARTED|Overall Study||42
213335|NCT00729326|511952|P1|STARTED|Overall Study||41
213336|NCT00729248|511994|P1|NOT COMPLETED|Overall Study||2
213337|NCT00729248|511994|P1|COMPLETED|Overall Study||10
213338|NCT00729248|511994|P1|STARTED|Overall Study||12
213339|NCT00729183|512001|P2|NOT COMPLETED|Overall Study||15
213340|NCT00729183|512002|P1|NOT COMPLETED|Overall Study||25
213341|NCT00729183|512001|P2|COMPLETED|Overall Study|Completed 24 month visit|90
213342|NCT00729183|512002|P1|COMPLETED|Overall Study|Completed 24 month visit|84
213343|NCT00729183|512001|P2|STARTED|Overall Study||105
213344|NCT00729183|512002|P1|STARTED|Overall Study||109
213345|NCT00729157|512034|P1|NOT COMPLETED|Overall Study||1
213346|NCT00729157|512034|P1|COMPLETED|Overall Study||40
213347|NCT00729157|512034|P1|STARTED|Overall Study||41
213348|NCT00728988|512044|P2|NOT COMPLETED|Overall Study||88
213349|NCT00728988|512045|P1|NOT COMPLETED|Overall Study||93
213350|NCT00728988|512044|P2|COMPLETED|Overall Study||164
213351|NCT00728988|512045|P1|COMPLETED|Overall Study||154
213352|NCT00728988|512044|P2|Full Analysis Set|Overall Study||172
213353|NCT00728988|512045|P1|Full Analysis Set|Overall Study||163
213354|NCT00728988|512044|P2|Treated|Overall Study||250
213355|NCT00728988|512045|P1|Treated|Overall Study||245
213356|NCT00728988|512044|P2|STARTED|Overall Study||252
213357|NCT00728988|512045|P1|STARTED|Overall Study||247
213358|NCT00728962|512063|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
213359|NCT00728962|512063|P1|COMPLETED|Two Year Post Placement Follow-up||59
213360|NCT00728962|512063|P1|STARTED|Two Year Post Placement Follow-up||62
213361|NCT00728962|512063|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
213362|NCT00728962|512063|P1|COMPLETED|One Year Post Placement Follow-up||62
213363|NCT00728962|512063|P1|STARTED|One Year Post Placement Follow-up||62
213364|NCT00728962|512063|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
213365|NCT00728962|512063|P1|COMPLETED|Permanent Prosthesis Placement||62
213366|NCT00728962|512063|P1|STARTED|Permanent Prosthesis Placement||65
213367|NCT00728962|512063|P1|NOT COMPLETED|Implant Placement Surgery||10
213368|NCT00728962|512063|P1|COMPLETED|Implant Placement Surgery||65
213369|NCT00728962|512063|P1|STARTED|Implant Placement Surgery||75
213370|NCT00728923|512067|P1|NOT COMPLETED|Overall Study||0
213371|NCT00728923|512067|P1|COMPLETED|Overall Study||9
213372|NCT00728923|512067|P1|STARTED|Overall Study||9
213373|NCT00728910|512072|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
213374|NCT00728910|512072|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
213375|NCT00728910|512072|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
213376|NCT00728910|512072|P1|NOT COMPLETED|Atorvastatin+ABT335||0
213377|NCT00728910|512072|P1|COMPLETED|Atorvastatin+ABT335||22
213378|NCT00728910|512072|P1|STARTED|Atorvastatin+ABT335||22
213379|NCT00728910|512072|P1|NOT COMPLETED|Atorvastatin||3
213380|NCT00728910|512072|P1|COMPLETED|Atorvastatin||22
213381|NCT00728910|512072|P1|STARTED|Atorvastatin||25
213382|NCT00728884|512084|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
213383|NCT00728884|512084|P1|COMPLETED|Two Year Post Placement Follow-up||145
213384|NCT00728884|512084|P1|STARTED|Two Year Post Placement Follow-up||145
213385|NCT00728884|512084|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
213386|NCT00728884|512084|P1|COMPLETED|One Year Post Placement Follow-up||145
213387|NCT00728884|512084|P1|STARTED|One Year Post Placement Follow-up||149
213388|NCT00728884|512084|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
213389|NCT00728884|512084|P1|COMPLETED|Permanent Prosthesis Placement||149
213390|NCT00728884|512084|P1|STARTED|Permanent Prosthesis Placement||162
213391|NCT00728884|512084|P1|NOT COMPLETED|Implant Placement Surgery||0
213392|NCT00728884|512084|P1|COMPLETED|Implant Placement Surgery||162
213393|NCT00728884|512084|P1|STARTED|Implant Placement Surgery||162
213394|NCT00728845|512090|P2|NOT COMPLETED|Overall Study||0
213395|NCT00728845|512091|P1|NOT COMPLETED|Overall Study||0
213396|NCT00728845|512090|P2|COMPLETED|Overall Study||0
213397|NCT00728845|512091|P1|COMPLETED|Overall Study||8
213398|NCT00728845|512090|P2|STARTED|Overall Study||0
213399|NCT00728845|512091|P1|STARTED|Overall Study||8
213400|NCT00728819|512107|P2|NOT COMPLETED|Overall Study||29
213401|NCT00728819|512108|P1|NOT COMPLETED|Overall Study||36
213402|NCT00728819|512107|P2|COMPLETED|Overall Study||139
213403|NCT00728819|512108|P1|COMPLETED|Overall Study||135
213404|NCT00728819|512107|P2|STARTED|Overall Study||168
213405|NCT00728819|512108|P1|STARTED|Overall Study||171
213406|NCT00728754|512120|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
213407|NCT00728754|512121|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
213408|NCT00728754|512120|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
213409|NCT00728754|512121|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
213410|NCT00728754|512120|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
213411|NCT00728754|512121|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
213412|NCT00728754|512120|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
213413|NCT00728754|512121|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
213414|NCT00728754|512120|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
213415|NCT00728754|512121|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
213416|NCT00728754|512120|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
213417|NCT00728754|512121|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
213418|NCT00728754|512120|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
213419|NCT00728754|512121|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
213420|NCT00728754|512120|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
213421|NCT00728754|512121|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
213422|NCT00728754|512120|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
213423|NCT00728754|512121|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
213424|NCT00728754|512120|P2|NOT COMPLETED|Implant Placement Surgery||0
213425|NCT00728754|512121|P1|NOT COMPLETED|Implant Placement Surgery||0
213426|NCT00728754|512120|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
213427|NCT00728754|512121|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
213428|NCT00728754|512120|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
213429|NCT00728754|512121|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
213430|NCT00728728|512129|P2|NOT COMPLETED|Overall Study||12
213431|NCT00728728|512130|P1|NOT COMPLETED|Overall Study||4
213432|NCT00728728|512129|P2|COMPLETED|Overall Study||34
213433|NCT00728728|512130|P1|COMPLETED|Overall Study||38
213434|NCT00728728|512129|P2|STARTED|Overall Study||46
213435|NCT00728728|512130|P1|STARTED|Overall Study||42
213436|NCT00728689|512150|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
213437|NCT00728689|512151|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
213438|NCT00728689|512150|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
213439|NCT00728689|512151|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
213440|NCT00728689|512150|P2|STARTED|Second Intervention (Days 11 - 13)||6
213441|NCT00728689|512151|P1|STARTED|Second Intervention (Days 11 - 13)||5
213442|NCT00728689|512150|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
213443|NCT00728689|512151|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
213444|NCT00728689|512150|P2|COMPLETED|Washout Period (Days 4 - 10)||6
213445|NCT00728689|512151|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
213446|NCT00728689|512150|P2|STARTED|Washout Period (Days 4 - 10)||6
213447|NCT00728689|512151|P1|STARTED|Washout Period (Days 4 - 10)||6
213448|NCT00728689|512150|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
213449|NCT00728689|512151|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
213450|NCT00728689|512150|P2|COMPLETED|First Intervention (Days 1 - 3)||6
213451|NCT00728689|512151|P1|COMPLETED|First Intervention (Days 1 - 3)||6
213452|NCT00728689|512150|P2|STARTED|First Intervention (Days 1 - 3)||6
213453|NCT00728689|512151|P1|STARTED|First Intervention (Days 1 - 3)||6
213454|NCT00728507|512169|P2|NOT COMPLETED|Overall Study||8
213455|NCT00728507|512170|P1|NOT COMPLETED|Overall Study||2
213456|NCT00728507|512169|P2|COMPLETED|Overall Study||51
213457|NCT00728507|512170|P1|COMPLETED|Overall Study||60
213458|NCT00728507|512169|P2|STARTED|Overall Study||59
213459|NCT00728507|512170|P1|STARTED|Overall Study||62
213460|NCT00728494|512180|P2|NOT COMPLETED|Overall Study||7
213461|NCT00728494|512181|P1|NOT COMPLETED|Overall Study||9
213462|NCT00728494|512180|P2|COMPLETED|Overall Study||32
213463|NCT00728494|512181|P1|COMPLETED|Overall Study||51
213464|NCT00728494|512180|P2|STARTED|Overall Study||39
213465|NCT00728494|512181|P1|STARTED|Overall Study||60
213466|NCT00728481|512199|P2|NOT COMPLETED|Overall Study||4
213467|NCT00728481|512200|P1|NOT COMPLETED|Overall Study||1
213468|NCT00728481|512199|P2|COMPLETED|Overall Study||28
213469|NCT00728481|512200|P1|COMPLETED|Overall Study||18
213470|NCT00728481|512199|P2|STARTED|Overall Study||32
213471|NCT00728481|512200|P1|STARTED|Overall Study||19
213472|NCT00728468|512216|P1|NOT COMPLETED|Overall Study||16
213473|NCT00728468|512216|P1|COMPLETED|Overall Study||0
213474|NCT00728468|512216|P1|Treated|Overall Study||15
213475|NCT00728468|512216|P1|STARTED|Overall Study||16
213476|NCT00728416|512240|P2|NOT COMPLETED|Overall Study||2
213477|NCT00728416|512241|P1|NOT COMPLETED|Overall Study||2
213478|NCT00728416|512240|P2|COMPLETED|Overall Study||163
213479|NCT00728416|512241|P1|COMPLETED|Overall Study||166
213480|NCT00728416|512240|P2|STARTED|Overall Study||165
213481|NCT00728416|512241|P1|STARTED|Overall Study||168
213482|NCT00728260|512249|P1|NOT COMPLETED|Overall Study||0
213483|NCT00728260|512249|P1|COMPLETED|Overall Study||1421
213484|NCT00728260|512249|P1|STARTED|Overall Study||1421
213485|NCT00728182|512257|P2|NOT COMPLETED|Overall Study||3
213486|NCT00728182|512258|P1|NOT COMPLETED|Overall Study||3
213487|NCT00728182|512257|P2|COMPLETED|Overall Study||90
213488|NCT00728182|512258|P1|COMPLETED|Overall Study||89
213489|NCT00728182|512257|P2|STARTED|Overall Study||93
213490|NCT00728182|512258|P1|STARTED|Overall Study||92
213491|NCT00728130|512286|P1|NOT COMPLETED|Overall Study||3
213492|NCT00728130|512286|P1|COMPLETED|Overall Study||19
213493|NCT00728130|512286|P1|STARTED|Overall Study||22
213494|NCT00727961|512291|P1|NOT COMPLETED|Overall Study||37
213495|NCT00727961|512291|P1|COMPLETED|Overall Study||21
213496|NCT00727961|512291|P1|STARTED|Overall Study||58
213497|NCT00727909|512301|P4|NOT COMPLETED|Overall Study||5
213498|NCT00727909|512302|P3|NOT COMPLETED|Overall Study||9
213499|NCT00727909|512303|P2|NOT COMPLETED|Overall Study||11
213500|NCT00727909|512304|P1|NOT COMPLETED|Overall Study||5
213501|NCT00727909|512301|P4|COMPLETED|Overall Study||70
213502|NCT00727909|512302|P3|COMPLETED|Overall Study||58
213503|NCT00727909|512303|P2|COMPLETED|Overall Study||61
213504|NCT00727909|512304|P1|COMPLETED|Overall Study||60
213505|NCT00727909|512301|P4|STARTED|Overall Study||75
213506|NCT00727909|512302|P3|STARTED|Overall Study||67
213507|NCT00727909|512303|P2|STARTED|Overall Study||72
213508|NCT00727909|512304|P1|STARTED|Overall Study||65
213509|NCT00727857|512311|P3|NOT COMPLETED|Overall Study||68
213510|NCT00727857|512312|P2|NOT COMPLETED|Overall Study||64
213511|NCT00727857|512313|P1|NOT COMPLETED|Overall Study||44
213512|NCT00727857|512311|P3|COMPLETED|Overall Study||142
213513|NCT00727857|512312|P2|COMPLETED|Overall Study||125
213514|NCT00727857|512313|P1|COMPLETED|Overall Study||157
213515|NCT00727857|512311|P3|STARTED|Overall Study||210
213516|NCT00727857|512312|P2|STARTED|Overall Study||189
213517|NCT00727857|512313|P1|STARTED|Overall Study||201
213518|NCT00727844|512401|P4|NOT COMPLETED|Second Randomization||0
213519|NCT00727844|512402|P3|NOT COMPLETED|Second Randomization||0
213520|NCT00727844|512403|P2|NOT COMPLETED|Second Randomization||0
213521|NCT00727844|512404|P1|NOT COMPLETED|Second Randomization||0
213522|NCT00727844|512401|P4|COMPLETED|Second Randomization||16
213523|NCT00727844|512402|P3|COMPLETED|Second Randomization||17
213524|NCT00727844|512403|P2|COMPLETED|Second Randomization||0
213525|NCT00727844|512404|P1|COMPLETED|Second Randomization||0
213526|NCT00727844|512401|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
213527|NCT00727844|512402|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
213528|NCT00727844|512403|P2|STARTED|Second Randomization||0
213529|NCT00727844|512404|P1|STARTED|Second Randomization||0
213530|NCT00727844|512401|P4|NOT COMPLETED|Initial Randomization||0
213531|NCT00727844|512402|P3|NOT COMPLETED|Initial Randomization||0
213532|NCT00727844|512403|P2|NOT COMPLETED|Initial Randomization||0
213533|NCT00727844|512404|P1|NOT COMPLETED|Initial Randomization||2
213534|NCT00727844|512401|P4|COMPLETED|Initial Randomization||0
213535|NCT00727844|512402|P3|COMPLETED|Initial Randomization||0
213536|NCT00727844|512403|P2|COMPLETED|Initial Randomization||20
213537|NCT00727844|512404|P1|COMPLETED|Initial Randomization||19
213538|NCT00727844|512401|P4|Included in MITT Analysis|Initial Randomization||0
213539|NCT00727844|512402|P3|Included in MITT Analysis|Initial Randomization||0
213540|NCT00727844|512403|P2|Included in MITT Analysis|Initial Randomization||20
213541|NCT00727844|512404|P1|Included in MITT Analysis|Initial Randomization||19
213542|NCT00727844|512401|P4|STARTED|Initial Randomization||0
213543|NCT00727844|512402|P3|STARTED|Initial Randomization||0
213544|NCT00727844|512403|P2|STARTED|Initial Randomization||20
213545|NCT00727844|512404|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
213546|NCT00727740|512411|P2|NOT COMPLETED|Overall Study||0
213547|NCT00727740|512412|P1|NOT COMPLETED|Overall Study||0
213548|NCT00727740|512411|P2|COMPLETED|Overall Study||61
213549|NCT00727740|512412|P1|COMPLETED|Overall Study||56
213550|NCT00727740|512411|P2|STARTED|Overall Study||61
213551|NCT00727740|512412|P1|STARTED|Overall Study||56
213552|NCT00727714|512418|P1|NOT COMPLETED|Overall Study||2
213553|NCT00727714|512418|P1|COMPLETED|Overall Study||93
213554|NCT00727714|512418|P1|STARTED|Overall Study||95
213555|NCT00727649|512428|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
213556|NCT00727649|512429|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
213557|NCT00727649|512428|P2|COMPLETED|Second Intervention (4-weeks)||34
213558|NCT00727649|512429|P1|COMPLETED|Second Intervention (4-weeks)||29
213559|NCT00727649|512428|P2|STARTED|Second Intervention (4-weeks)||37
213560|NCT00727649|512429|P1|STARTED|Second Intervention (4-weeks)||30
213561|NCT00727649|512428|P2|NOT COMPLETED|Wash-out (2-weeks)||3
213562|NCT00727649|512429|P1|NOT COMPLETED|Wash-out (2-weeks)||4
213563|NCT00727649|512428|P2|COMPLETED|Wash-out (2-weeks)||37
213564|NCT00727649|512429|P1|COMPLETED|Wash-out (2-weeks)||30
213565|NCT00727649|512428|P2|STARTED|Wash-out (2-weeks)||40
213566|NCT00727649|512429|P1|STARTED|Wash-out (2-weeks)||34
213567|NCT00727649|512428|P2|NOT COMPLETED|First Intervention (4-weeks)||3
213568|NCT00727649|512429|P1|NOT COMPLETED|First Intervention (4-weeks)||3
213569|NCT00727649|512428|P2|COMPLETED|First Intervention (4-weeks)||40
213570|NCT00727649|512429|P1|COMPLETED|First Intervention (4-weeks)||34
213571|NCT00727649|512428|P2|STARTED|First Intervention (4-weeks)||43
213572|NCT00727649|512429|P1|STARTED|First Intervention (4-weeks)||37
213573|NCT00727636|512443|P2|NOT COMPLETED|Overall Study||0
213574|NCT00727636|512444|P1|NOT COMPLETED|Overall Study||4
213575|NCT00727636|512443|P2|COMPLETED|Overall Study||15
213576|NCT00727636|512444|P1|COMPLETED|Overall Study||33
213577|NCT00727636|512443|P2|STARTED|Overall Study||15
213578|NCT00727636|512444|P1|STARTED|Overall Study||37
213579|NCT00727597|512458|P2|NOT COMPLETED|Overall Study||0
213580|NCT00727597|512459|P1|NOT COMPLETED|Overall Study||0
213581|NCT00727597|512458|P2|COMPLETED|Overall Study||50
213582|NCT00727597|512459|P1|COMPLETED|Overall Study||51
213583|NCT00727597|512458|P2|STARTED|Overall Study||50
213584|NCT00727597|512459|P1|STARTED|Overall Study||51
213585|NCT00727571|512471|P4|NOT COMPLETED|Overall Study||6
213586|NCT00727571|512472|P3|NOT COMPLETED|Overall Study||30
213587|NCT00727571|512473|P2|NOT COMPLETED|Overall Study||55
213588|NCT00727571|512474|P1|NOT COMPLETED|Overall Study||1
213589|NCT00727571|512471|P4|COMPLETED|Overall Study||163
213590|NCT00727571|512472|P3|COMPLETED|Overall Study||135
213591|NCT00727571|512473|P2|COMPLETED|Overall Study||173
213592|NCT00727571|512474|P1|COMPLETED|Overall Study||231
213593|NCT00727571|512471|P4|STARTED|Overall Study||169
213594|NCT00727571|512472|P3|STARTED|Overall Study||165
213595|NCT00727571|512473|P2|STARTED|Overall Study||228
213596|NCT00727571|512474|P1|STARTED|Overall Study||232
213597|NCT00727558|512501|P2|NOT COMPLETED|Overall Study||3
213598|NCT00727558|512502|P1|NOT COMPLETED|Overall Study||2
213599|NCT00727558|512501|P2|COMPLETED|Overall Study||118
213600|NCT00727558|512502|P1|COMPLETED|Overall Study||125
213601|NCT00727558|512501|P2|STARTED|Overall Study||121
213602|NCT00727558|512502|P1|STARTED|Overall Study||127
213603|NCT00727506|512526|P6|NOT COMPLETED|Overall Study||39
213604|NCT00727506|512527|P5|NOT COMPLETED|Overall Study||41
213605|NCT00727506|512528|P4|NOT COMPLETED|Overall Study||39
213606|NCT00727506|512529|P3|NOT COMPLETED|Overall Study||18
213607|NCT00727506|512530|P2|NOT COMPLETED|Overall Study||8
213608|NCT00727506|512531|P1|NOT COMPLETED|Overall Study||6
213609|NCT00727506|512526|P6|COMPLETED|Overall Study||0
213610|NCT00727506|512527|P5|COMPLETED|Overall Study||0
213611|NCT00727506|512528|P4|COMPLETED|Overall Study||0
213612|NCT00727506|512529|P3|COMPLETED|Overall Study||0
213613|NCT00727506|512530|P2|COMPLETED|Overall Study||0
213614|NCT00727506|512531|P1|COMPLETED|Overall Study||0
213615|NCT00727506|512526|P6|STARTED|Overall Study|Randomized|39
213616|NCT00727506|512527|P5|STARTED|Overall Study|Randomized|41
213617|NCT00727506|512528|P4|STARTED|Overall Study|Randomized|39
213618|NCT00727506|512529|P3|STARTED|Overall Study|Entered|18
213619|NCT00727506|512530|P2|STARTED|Overall Study|Entered|8
213620|NCT00727506|512531|P1|STARTED|Overall Study|Entered|6
213621|NCT00727402|512624|P1|NOT COMPLETED|Overall Study||116
213622|NCT00727402|512624|P1|COMPLETED|Overall Study||89
213623|NCT00727402|512624|P1|STARTED|Overall Study||205
213624|NCT00727337|512632|P4|NOT COMPLETED|Overall Study||7
213625|NCT00727337|512633|P3|NOT COMPLETED|Overall Study||9
213626|NCT00727337|512634|P2|NOT COMPLETED|Overall Study||10
213627|NCT00727337|512635|P1|NOT COMPLETED|Overall Study||10
213628|NCT00727337|512632|P4|COMPLETED|Overall Study||61
213629|NCT00727337|512633|P3|COMPLETED|Overall Study||64
213630|NCT00727337|512634|P2|COMPLETED|Overall Study||63
213631|NCT00727337|512635|P1|COMPLETED|Overall Study||55
213632|NCT00727337|512632|P4|STARTED|Overall Study||68
213633|NCT00727337|512633|P3|STARTED|Overall Study||73
213634|NCT00727337|512634|P2|STARTED|Overall Study||73
213635|NCT00727337|512635|P1|STARTED|Overall Study||65
213636|NCT00727311|512645|P1|NOT COMPLETED|Overall Study||1107
213637|NCT00727311|512645|P1|COMPLETED|Overall Study||1195
213638|NCT00727311|512645|P1|STARTED|Overall Study||2302
213639|NCT00727298|512652|P1|NOT COMPLETED|Overall Study||1257
213640|NCT00727298|512652|P1|COMPLETED|Overall Study||3228
213641|NCT00727298|512652|P1|STARTED|Overall Study||4485
213642|NCT00727272|512658|P3|NOT COMPLETED|Period III||0
213643|NCT00727272|512659|P2|NOT COMPLETED|Period III||0
213644|NCT00727272|512660|P1|NOT COMPLETED|Period III||0
213645|NCT00727272|512658|P3|COMPLETED|Period III||7
213646|NCT00727272|512659|P2|COMPLETED|Period III||9
213647|NCT00727272|512660|P1|COMPLETED|Period III||9
213648|NCT00727272|512658|P3|STARTED|Period III||7
213649|NCT00727272|512659|P2|STARTED|Period III||9
213650|NCT00727272|512660|P1|STARTED|Period III||9
213651|NCT00727272|512658|P3|NOT COMPLETED|Washout Period B||1
213652|NCT00727272|512659|P2|NOT COMPLETED|Washout Period B||0
213653|NCT00727272|512660|P1|NOT COMPLETED|Washout Period B||0
213654|NCT00727272|512658|P3|COMPLETED|Washout Period B|personal reasons|7
213655|NCT00727272|512659|P2|COMPLETED|Washout Period B||9
213656|NCT00727272|512660|P1|COMPLETED|Washout Period B||9
213657|NCT00727272|512658|P3|STARTED|Washout Period B||8
213658|NCT00727272|512659|P2|STARTED|Washout Period B||9
213659|NCT00727272|512660|P1|STARTED|Washout Period B||9
213660|NCT00727272|512658|P3|NOT COMPLETED|Period II||0
213661|NCT00727272|512659|P2|NOT COMPLETED|Period II||0
213662|NCT00727272|512660|P1|NOT COMPLETED|Period II||0
213663|NCT00727272|512658|P3|COMPLETED|Period II||8
213664|NCT00727272|512659|P2|COMPLETED|Period II||9
213665|NCT00727272|512660|P1|COMPLETED|Period II||9
213666|NCT00727272|512658|P3|STARTED|Period II||8
213667|NCT00727272|512659|P2|STARTED|Period II||9
213668|NCT00727272|512660|P1|STARTED|Period II||9
213669|NCT00727272|512658|P3|NOT COMPLETED|Washout Period A||1
213670|NCT00727272|512659|P2|NOT COMPLETED|Washout Period A||0
213671|NCT00727272|512660|P1|NOT COMPLETED|Washout Period A||0
213672|NCT00727272|512658|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
213673|NCT00727272|512659|P2|COMPLETED|Washout Period A||9
213674|NCT00727272|512660|P1|COMPLETED|Washout Period A||9
213675|NCT00727272|512658|P3|STARTED|Washout Period A||9
213676|NCT00727272|512659|P2|STARTED|Washout Period A||9
213677|NCT00727272|512660|P1|STARTED|Washout Period A||9
213678|NCT00727272|512658|P3|NOT COMPLETED|Period I||0
213679|NCT00727272|512659|P2|NOT COMPLETED|Period I||0
213680|NCT00727272|512660|P1|NOT COMPLETED|Period I||0
213681|NCT00727272|512658|P3|COMPLETED|Period I||9
213682|NCT00727272|512659|P2|COMPLETED|Period I||9
213683|NCT00727272|512660|P1|COMPLETED|Period I||9
213684|NCT00727272|512658|P3|STARTED|Period I||9
213685|NCT00727272|512659|P2|STARTED|Period I||9
213686|NCT00727272|512660|P1|STARTED|Period I||9
213687|NCT00727259|512677|P1|NOT COMPLETED|Overall Study||1055
213688|NCT00727259|512677|P1|COMPLETED|Overall Study||940
213689|NCT00727259|512677|P1|STARTED|Overall Study||1995
213690|NCT00727246|512686|P4|NOT COMPLETED|Overall Study||2
213691|NCT00727246|512687|P3|NOT COMPLETED|Overall Study||1
213692|NCT00727246|512688|P2|NOT COMPLETED|Overall Study||1
213693|NCT00727246|512689|P1|NOT COMPLETED|Overall Study||0
213694|NCT00727246|512686|P4|COMPLETED|Overall Study||3
213695|NCT00727246|512687|P3|COMPLETED|Overall Study||7
213696|NCT00727246|512688|P2|COMPLETED|Overall Study||2
213697|NCT00727246|512689|P1|COMPLETED|Overall Study||3
213698|NCT00727246|512686|P4|STARTED|Overall Study||5
213699|NCT00727246|512687|P3|STARTED|Overall Study||8
213700|NCT00727246|512688|P2|STARTED|Overall Study||3
213701|NCT00727246|512689|P1|STARTED|Overall Study||3
213702|NCT00727220|512705|P2|NOT COMPLETED|Overall Study||4
213703|NCT00727220|512706|P1|NOT COMPLETED|Overall Study||1
213704|NCT00727220|512705|P2|COMPLETED|Overall Study||17
213705|NCT00727220|512706|P1|COMPLETED|Overall Study||20
213706|NCT00727220|512705|P2|STARTED|Overall Study||21
213707|NCT00727220|512706|P1|STARTED|Overall Study||21
213708|NCT00727194|512712|P3|NOT COMPLETED|Treatment Period 2||0
213709|NCT00727194|512713|P2|NOT COMPLETED|Treatment Period 2||1
213710|NCT00727194|512714|P1|NOT COMPLETED|Treatment Period 2||0
213711|NCT00727194|512712|P3|COMPLETED|Treatment Period 2||0
213712|NCT00727194|512713|P2|COMPLETED|Treatment Period 2||5
213713|NCT00727194|512714|P1|COMPLETED|Treatment Period 2||6
213714|NCT00727194|512712|P3|STARTED|Treatment Period 2||0
213715|NCT00727194|512713|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
213716|NCT00727194|512714|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
213717|NCT00727194|512712|P3|NOT COMPLETED|Washout Period||0
213718|NCT00727194|512713|P2|NOT COMPLETED|Washout Period||0
213719|NCT00727194|512714|P1|NOT COMPLETED|Washout Period||0
213720|NCT00727194|512712|P3|COMPLETED|Washout Period||0
213721|NCT00727194|512713|P2|COMPLETED|Washout Period||7
213722|NCT00727194|512714|P1|COMPLETED|Washout Period||7
213723|NCT00727194|512712|P3|STARTED|Washout Period||0
213724|NCT00727194|512713|P2|STARTED|Washout Period||7
213725|NCT00727194|512714|P1|STARTED|Washout Period||7
213726|NCT00727194|512712|P3|NOT COMPLETED|Treatment Period 1||0
213727|NCT00727194|512713|P2|NOT COMPLETED|Treatment Period 1||0
213728|NCT00727194|512714|P1|NOT COMPLETED|Treatment Period 1||0
213729|NCT00727194|512712|P3|COMPLETED|Treatment Period 1||0
213730|NCT00727194|512713|P2|COMPLETED|Treatment Period 1||7
213731|NCT00727194|512714|P1|COMPLETED|Treatment Period 1||7
213732|NCT00727194|512712|P3|STARTED|Treatment Period 1||0
213733|NCT00727194|512713|P2|STARTED|Treatment Period 1||7
213734|NCT00727194|512714|P1|STARTED|Treatment Period 1||7
213735|NCT00727194|512712|P3|NOT COMPLETED|Screening Period||16
213736|NCT00727194|512713|P2|NOT COMPLETED|Screening Period||0
213737|NCT00727194|512714|P1|NOT COMPLETED|Screening Period||0
213738|NCT00727194|512712|P3|COMPLETED|Screening Period||0
213739|NCT00727194|512713|P2|COMPLETED|Screening Period||7
213740|NCT00727194|512714|P1|COMPLETED|Screening Period||7
213741|NCT00727194|512712|P3|STARTED|Screening Period||16
213742|NCT00727194|512713|P2|STARTED|Screening Period||7
213743|NCT00727194|512714|P1|STARTED|Screening Period||7
213744|NCT00727090|512750|P2|NOT COMPLETED|Overall Study||0
213745|NCT00727090|512751|P1|NOT COMPLETED|Overall Study||0
213746|NCT00727090|512750|P2|COMPLETED|Overall Study||3
213747|NCT00727090|512751|P1|COMPLETED|Overall Study||3
213748|NCT00727090|512750|P2|STARTED|Overall Study||3
213749|NCT00727090|512751|P1|STARTED|Overall Study||3
213750|NCT00727064|512769|P2|NOT COMPLETED|Overall Study||0
213751|NCT00727064|512770|P1|NOT COMPLETED|Overall Study||0
213752|NCT00727064|512769|P2|COMPLETED|Overall Study||7
213753|NCT00727064|512770|P1|COMPLETED|Overall Study||7
213754|NCT00727064|512769|P2|STARTED|Overall Study||7
213755|NCT00727064|512770|P1|STARTED|Overall Study||7
213756|NCT00727025|512786|P1|NOT COMPLETED|Overall Study||23
213757|NCT00727025|512786|P1|COMPLETED|Overall Study||51
213758|NCT00727025|512786|P1|STARTED|Overall Study||74
213759|NCT00726999|512798|P2|NOT COMPLETED|Overall Study||1
213760|NCT00726999|512799|P1|NOT COMPLETED|Overall Study||3
213761|NCT00726999|512798|P2|COMPLETED|Overall Study||30
213762|NCT00726999|512799|P1|COMPLETED|Overall Study||29
213763|NCT00726999|512798|P2|STARTED|Overall Study||31
213764|NCT00726999|512799|P1|STARTED|Overall Study||32
213765|NCT00726986|512809|P1|NOT COMPLETED|Maintenance Phase||3
213766|NCT00726986|512809|P1|COMPLETED|Maintenance Phase||0
213767|NCT00726986|512809|P1|STARTED|Maintenance Phase||3
213768|NCT00726986|512809|P1|NOT COMPLETED|Induction Phase||15
213769|NCT00726986|512809|P1|COMPLETED|Induction Phase||3
213770|NCT00726986|512809|P1|Maintance|Induction Phase||3
213771|NCT00726986|512809|P1|STARTED|Induction Phase||18
213772|NCT00726895|512816|P2|NOT COMPLETED|Second Intervention||0
213773|NCT00726895|512817|P1|NOT COMPLETED|Second Intervention||0
213774|NCT00726895|512816|P2|COMPLETED|Second Intervention||11
213775|NCT00726895|512817|P1|COMPLETED|Second Intervention||12
213776|NCT00726895|512816|P2|STARTED|Second Intervention||11
213777|NCT00726895|512817|P1|STARTED|Second Intervention||12
213778|NCT00726895|512816|P2|NOT COMPLETED|Washout Period of 7 Days||1
213779|NCT00726895|512817|P1|NOT COMPLETED|Washout Period of 7 Days||0
213780|NCT00726895|512816|P2|COMPLETED|Washout Period of 7 Days||11
213781|NCT00726895|512817|P1|COMPLETED|Washout Period of 7 Days||12
213782|NCT00726895|512816|P2|STARTED|Washout Period of 7 Days||12
213783|NCT00726895|512817|P1|STARTED|Washout Period of 7 Days||12
213784|NCT00726895|512816|P2|NOT COMPLETED|First Intervention||0
213785|NCT00726895|512817|P1|NOT COMPLETED|First Intervention||0
213786|NCT00726895|512816|P2|COMPLETED|First Intervention||12
213787|NCT00726895|512817|P1|COMPLETED|First Intervention||12
213788|NCT00726895|512816|P2|STARTED|First Intervention||12
213789|NCT00726895|512817|P1|STARTED|First Intervention||12
213790|NCT00726882|512830|P1|NOT COMPLETED|Overall Study||22
213791|NCT00726882|512830|P1|COMPLETED|Overall Study||13
213792|NCT00726882|512830|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
213793|NCT00726882|512830|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
213794|NCT00726882|512830|P1|STARTED|Overall Study||35
213795|NCT00726830|512838|P2|NOT COMPLETED|Overall Study||0
213796|NCT00726830|512839|P1|NOT COMPLETED|Overall Study||0
213797|NCT00726830|512838|P2|COMPLETED|Overall Study||0
213798|NCT00726830|512839|P1|COMPLETED|Overall Study||1
213799|NCT00726830|512838|P2|STARTED|Overall Study||0
213800|NCT00726830|512839|P1|STARTED|Overall Study||1
213801|NCT00726752|512845|P1|NOT COMPLETED|Overall Study||6
213802|NCT00726752|512845|P1|COMPLETED|Overall Study||0
213803|NCT00726752|512845|P1|STARTED|Overall Study||6
213804|NCT00726739|512861|P2|NOT COMPLETED|Overall Study||0
213805|NCT00726739|512862|P1|NOT COMPLETED|Overall Study||1
213806|NCT00726739|512861|P2|COMPLETED|Overall Study||10
213807|NCT00726739|512862|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
213808|NCT00726739|512861|P2|STARTED|Overall Study||10
213809|NCT00726739|512862|P1|STARTED|Overall Study||11
213810|NCT00726713|512878|P2|NOT COMPLETED|Overall Study||7
213811|NCT00726713|512879|P1|NOT COMPLETED|Overall Study||7
213812|NCT00726713|512878|P2|COMPLETED|Overall Study||101
213813|NCT00726713|512879|P1|COMPLETED|Overall Study||99
213814|NCT00726713|512878|P2|STARTED|Overall Study||108
213815|NCT00726713|512879|P1|STARTED|Overall Study||106
213816|NCT00726661|512907|P2|NOT COMPLETED|Overall Study||418
213817|NCT00726661|512908|P1|NOT COMPLETED|Overall Study||814
213818|NCT00726661|512907|P2|COMPLETED|Overall Study||17
213819|NCT00726661|512908|P1|COMPLETED|Overall Study||18
213820|NCT00726661|512907|P2|STARTED|Overall Study||435
213821|NCT00726661|512908|P1|STARTED|Overall Study||832
213822|NCT00726622|512925|P2|NOT COMPLETED|Overall Study||3
213823|NCT00726622|512926|P1|NOT COMPLETED|Overall Study||18
213824|NCT00726622|512925|P2|COMPLETED|Overall Study||240
213825|NCT00726622|512926|P1|COMPLETED|Overall Study||225
213826|NCT00726622|512925|P2|STARTED|Overall Study||243
213827|NCT00726622|512926|P1|STARTED|Overall Study||243
213828|NCT00726609|512944|P1|NOT COMPLETED|Overall Study||98
213829|NCT00726609|512944|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
213830|NCT00726609|512944|P1|STARTED|Overall Study||214
213831|NCT00726557|512948|P1|NOT COMPLETED|Overall Study||128
213832|NCT00726557|512948|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
213833|NCT00726557|512948|P1|STARTED|Overall Study||246
213834|NCT00726453|512955|P2|NOT COMPLETED|38 mm Length Group||3
213835|NCT00726453|512956|P1|NOT COMPLETED|38 mm Length Group||0
213836|NCT00726453|512955|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
213837|NCT00726453|512956|P1|COMPLETED|38 mm Length Group||0
213838|NCT00726453|512955|P2|STARTED|38 mm Length Group||114
213839|NCT00726453|512956|P1|STARTED|38 mm Length Group||0
213840|NCT00726453|512955|P2|NOT COMPLETED|Primary Enrollment Group||0
213841|NCT00726453|512956|P1|NOT COMPLETED|Primary Enrollment Group||31
213842|NCT00726453|512955|P2|COMPLETED|Primary Enrollment Group||0
213843|NCT00726453|512956|P1|COMPLETED|Primary Enrollment Group||1371
213844|NCT00726453|512955|P2|STARTED|Primary Enrollment Group||0
213845|NCT00726453|512956|P1|STARTED|Primary Enrollment Group||1402
213846|NCT00726414|512966|P2|NOT COMPLETED|Second Intervention||0
213847|NCT00726414|512967|P1|NOT COMPLETED|Second Intervention||0
213848|NCT00726414|512966|P2|COMPLETED|Second Intervention||11
213849|NCT00726414|512967|P1|COMPLETED|Second Intervention||11
213850|NCT00726414|512966|P2|STARTED|Second Intervention||11
213851|NCT00726414|512967|P1|STARTED|Second Intervention||11
213852|NCT00726414|512966|P2|NOT COMPLETED|Washout Period of 7 Days||0
213853|NCT00726414|512967|P1|NOT COMPLETED|Washout Period of 7 Days||0
213854|NCT00726414|512966|P2|COMPLETED|Washout Period of 7 Days||11
213855|NCT00726414|512967|P1|COMPLETED|Washout Period of 7 Days||11
213856|NCT00726414|512966|P2|STARTED|Washout Period of 7 Days||11
213857|NCT00726414|512967|P1|STARTED|Washout Period of 7 Days||11
213858|NCT00726414|512966|P2|NOT COMPLETED|First Intervention||0
213859|NCT00726414|512967|P1|NOT COMPLETED|First Intervention||0
213860|NCT00726414|512966|P2|COMPLETED|First Intervention||11
213861|NCT00726414|512967|P1|COMPLETED|First Intervention||11
213862|NCT00726414|512966|P2|STARTED|First Intervention||11
213863|NCT00726414|512967|P1|STARTED|First Intervention||11
213864|NCT00726375|512977|P1|NOT COMPLETED|Overall Study||0
213865|NCT00726375|512977|P1|COMPLETED|Overall Study||34
213866|NCT00726375|512977|P1|STARTED|Overall Study||34
213867|NCT00726323|512984|P2|NOT COMPLETED|Overall Study||31
213868|NCT00726323|512985|P1|NOT COMPLETED|Overall Study||37
213869|NCT00726323|512984|P2|COMPLETED|Overall Study||6
213870|NCT00726323|512985|P1|COMPLETED|Overall Study||0
213871|NCT00726323|512984|P2|STARTED|Overall Study||37
213872|NCT00726323|512985|P1|STARTED|Overall Study||37
213873|NCT00726232|513015|P6|NOT COMPLETED|Overall Study||4
213874|NCT00726232|513016|P5|NOT COMPLETED|Overall Study||5
213875|NCT00726232|513017|P4|NOT COMPLETED|Overall Study||1
213876|NCT00726232|513018|P3|NOT COMPLETED|Overall Study||0
213877|NCT00726232|513019|P2|NOT COMPLETED|Overall Study||1
213878|NCT00726232|513020|P1|NOT COMPLETED|Overall Study||5
213879|NCT00726232|513015|P6|COMPLETED|Overall Study||5
213880|NCT00726232|513016|P5|COMPLETED|Overall Study||17
213881|NCT00726232|513017|P4|COMPLETED|Overall Study||7
213882|NCT00726232|513018|P3|COMPLETED|Overall Study||7
213883|NCT00726232|513019|P2|COMPLETED|Overall Study||7
213884|NCT00726232|513020|P1|COMPLETED|Overall Study|Represents patients ongoing in the study as of the data cut-off date of 18 June 2010.|14
213885|NCT00726232|513015|P6|STARTED|Overall Study||9
213886|NCT00726232|513016|P5|STARTED|Overall Study|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
213887|NCT00726232|513017|P4|STARTED|Overall Study||8
213888|NCT00726232|513018|P3|STARTED|Overall Study||7
213889|NCT00726232|513019|P2|STARTED|Overall Study||8
213890|NCT00726232|513020|P1|STARTED|Overall Study|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
213891|NCT00726180|513064|P1|NOT COMPLETED|Overall Study||0
213892|NCT00726180|513064|P1|COMPLETED|Overall Study||1
213893|NCT00726180|513064|P1|STARTED|Overall Study||1
213894|NCT00726063|513070|P2|NOT COMPLETED|Overall Study||7
213895|NCT00726063|513071|P1|NOT COMPLETED|Overall Study||9
213896|NCT00726063|513070|P2|COMPLETED|Overall Study|Number of implants = 239|112
213897|NCT00726063|513071|P1|COMPLETED|Overall Study|Number of implants =230|113
213898|NCT00726063|513070|P2|STARTED|Overall Study|Number of implants= 246|119
213899|NCT00726063|513071|P1|STARTED|Overall Study|Number of implants= 239|122
213900|NCT00726037|513077|P1|NOT COMPLETED|Overall Study||0
213901|NCT00726037|513077|P1|COMPLETED|Overall Study||7
213902|NCT00726037|513077|P1|STARTED|Overall Study||7
213903|NCT00725985|513085|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
213904|NCT00725985|513086|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
213905|NCT00725985|513087|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
213906|NCT00725985|513088|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213907|NCT00725985|513089|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213908|NCT00725985|513090|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213909|NCT00725985|513091|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213910|NCT00725985|513092|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213911|NCT00725985|513093|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213912|NCT00725985|513094|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213913|NCT00725985|513095|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213914|NCT00725985|513096|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
213915|NCT00725985|513085|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
213916|NCT00725985|513086|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
213917|NCT00725985|513087|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
213918|NCT00725985|513088|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
213919|NCT00725985|513089|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
213920|NCT00725985|513090|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
213921|NCT00725985|513091|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
213922|NCT00725985|513092|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
213923|NCT00725985|513093|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
213924|NCT00725985|513094|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
213925|NCT00725985|513095|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
213926|NCT00725985|513096|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
213927|NCT00725985|513085|P12|STARTED|LTFU (No Cladribine Treatment)||14
213928|NCT00725985|513086|P11|STARTED|LTFU (No Cladribine Treatment)||36
213929|NCT00725985|513087|P10|STARTED|LTFU (No Cladribine Treatment)||34
213930|NCT00725985|513088|P9|STARTED|LTFU (No Cladribine Treatment)||0
213931|NCT00725985|513089|P8|STARTED|LTFU (No Cladribine Treatment)||0
213932|NCT00725985|513090|P7|STARTED|LTFU (No Cladribine Treatment)||0
213933|NCT00725985|513091|P6|STARTED|LTFU (No Cladribine Treatment)||0
213934|NCT00725985|513092|P5|STARTED|LTFU (No Cladribine Treatment)||0
213935|NCT00725985|513093|P4|STARTED|LTFU (No Cladribine Treatment)||0
213936|NCT00725985|513094|P3|STARTED|LTFU (No Cladribine Treatment)||0
213937|NCT00725985|513095|P2|STARTED|LTFU (No Cladribine Treatment)||0
213938|NCT00725985|513096|P1|STARTED|LTFU (No Cladribine Treatment)||0
213939|NCT00725985|513085|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213940|NCT00725985|513086|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213941|NCT00725985|513087|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213942|NCT00725985|513088|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
213943|NCT00725985|513089|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
213944|NCT00725985|513090|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
213945|NCT00725985|513091|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213946|NCT00725985|513092|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213947|NCT00725985|513093|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213948|NCT00725985|513094|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213949|NCT00725985|513095|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213950|NCT00725985|513096|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
213951|NCT00725985|513085|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
213952|NCT00725985|513086|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
213953|NCT00725985|513087|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
213954|NCT00725985|513088|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
213955|NCT00725985|513089|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
213956|NCT00725985|513090|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
213957|NCT00725985|513091|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
213958|NCT00725985|513092|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
213959|NCT00725985|513093|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
213960|NCT00725985|513094|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
213961|NCT00725985|513095|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
213962|NCT00725985|513096|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
213963|NCT00725985|513085|P12|STARTED|LTFU (With Cladribine Treatment)||0
213964|NCT00725985|513086|P11|STARTED|LTFU (With Cladribine Treatment)||0
213965|NCT00725985|513087|P10|STARTED|LTFU (With Cladribine Treatment)||0
213966|NCT00725985|513088|P9|STARTED|LTFU (With Cladribine Treatment)||17
213967|NCT00725985|513089|P8|STARTED|LTFU (With Cladribine Treatment)||9
213968|NCT00725985|513090|P7|STARTED|LTFU (With Cladribine Treatment)||9
213969|NCT00725985|513091|P6|STARTED|LTFU (With Cladribine Treatment)||0
213970|NCT00725985|513092|P5|STARTED|LTFU (With Cladribine Treatment)||0
213971|NCT00725985|513093|P4|STARTED|LTFU (With Cladribine Treatment)||0
213972|NCT00725985|513094|P3|STARTED|LTFU (With Cladribine Treatment)||0
213973|NCT00725985|513095|P2|STARTED|LTFU (With Cladribine Treatment)||0
213974|NCT00725985|513096|P1|STARTED|LTFU (With Cladribine Treatment)||0
213975|NCT00725985|513085|P12|NOT COMPLETED|OLMP||0
213976|NCT00725985|513086|P11|NOT COMPLETED|OLMP||0
213977|NCT00725985|513087|P10|NOT COMPLETED|OLMP||0
213978|NCT00725985|513088|P9|NOT COMPLETED|OLMP||0
213979|NCT00725985|513089|P8|NOT COMPLETED|OLMP||0
213980|NCT00725985|513090|P7|NOT COMPLETED|OLMP||0
213981|NCT00725985|513091|P6|NOT COMPLETED|OLMP||53
213982|NCT00725985|513092|P5|NOT COMPLETED|OLMP||23
213983|NCT00725985|513093|P4|NOT COMPLETED|OLMP||18
213984|NCT00725985|513094|P3|NOT COMPLETED|OLMP||0
213985|NCT00725985|513095|P2|NOT COMPLETED|OLMP||0
213986|NCT00725985|513096|P1|NOT COMPLETED|OLMP||0
213987|NCT00725985|513085|P12|COMPLETED|OLMP||0
213988|NCT00725985|513086|P11|COMPLETED|OLMP||0
213989|NCT00725985|513087|P10|COMPLETED|OLMP||0
213990|NCT00725985|513088|P9|COMPLETED|OLMP||0
213991|NCT00725985|513089|P8|COMPLETED|OLMP||0
213992|NCT00725985|513090|P7|COMPLETED|OLMP||0
213993|NCT00725985|513091|P6|COMPLETED|OLMP||7
213994|NCT00725985|513092|P5|COMPLETED|OLMP||2
213995|NCT00725985|513093|P4|COMPLETED|OLMP||6
213996|NCT00725985|513094|P3|COMPLETED|OLMP||0
213997|NCT00725985|513095|P2|COMPLETED|OLMP||0
213998|NCT00725985|513096|P1|COMPLETED|OLMP||0
213999|NCT00725985|513085|P12|STARTED|OLMP||0
214000|NCT00725985|513086|P11|STARTED|OLMP||0
214001|NCT00725985|513087|P10|STARTED|OLMP||0
214002|NCT00725985|513088|P9|STARTED|OLMP||0
214003|NCT00725985|513089|P8|STARTED|OLMP||0
214004|NCT00725985|513090|P7|STARTED|OLMP||0
214005|NCT00725985|513091|P6|STARTED|OLMP||60
214006|NCT00725985|513092|P5|STARTED|OLMP||25
214007|NCT00725985|513093|P4|STARTED|OLMP||24
214008|NCT00725985|513094|P3|STARTED|OLMP||0
214009|NCT00725985|513095|P2|STARTED|OLMP||0
214010|NCT00725985|513096|P1|STARTED|OLMP||0
214011|NCT00725985|513085|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214012|NCT00725985|513086|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214013|NCT00725985|513087|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214014|NCT00725985|513088|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214015|NCT00725985|513089|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214016|NCT00725985|513090|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214017|NCT00725985|513091|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214018|NCT00725985|513092|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214019|NCT00725985|513093|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
214020|NCT00725985|513094|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
214021|NCT00725985|513095|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
214022|NCT00725985|513096|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
214023|NCT00725985|513085|P12|COMPLETED|ITP (Up to 96 Weeks)||0
214024|NCT00725985|513086|P11|COMPLETED|ITP (Up to 96 Weeks)||0
214025|NCT00725985|513087|P10|COMPLETED|ITP (Up to 96 Weeks)||0
214026|NCT00725985|513088|P9|COMPLETED|ITP (Up to 96 Weeks)||0
214027|NCT00725985|513089|P8|COMPLETED|ITP (Up to 96 Weeks)||0
214028|NCT00725985|513090|P7|COMPLETED|ITP (Up to 96 Weeks)||0
214029|NCT00725985|513091|P6|COMPLETED|ITP (Up to 96 Weeks)||0
214030|NCT00725985|513092|P5|COMPLETED|ITP (Up to 96 Weeks)||0
214031|NCT00725985|513093|P4|COMPLETED|ITP (Up to 96 Weeks)||0
214032|NCT00725985|513094|P3|COMPLETED|ITP (Up to 96 Weeks)||104
214033|NCT00725985|513095|P2|COMPLETED|ITP (Up to 96 Weeks)||131
214034|NCT00725985|513096|P1|COMPLETED|ITP (Up to 96 Weeks)||104
214035|NCT00725985|513085|P12|Treated|ITP (Up to 96 Weeks)||0
214036|NCT00725985|513086|P11|Treated|ITP (Up to 96 Weeks)||0
214037|NCT00725985|513087|P10|Treated|ITP (Up to 96 Weeks)||0
214038|NCT00725985|513088|P9|Treated|ITP (Up to 96 Weeks)||0
214039|NCT00725985|513089|P8|Treated|ITP (Up to 96 Weeks)||0
214040|NCT00725985|513090|P7|Treated|ITP (Up to 96 Weeks)||0
214041|NCT00725985|513091|P6|Treated|ITP (Up to 96 Weeks)||0
214042|NCT00725985|513092|P5|Treated|ITP (Up to 96 Weeks)||0
214043|NCT00725985|513093|P4|Treated|ITP (Up to 96 Weeks)||0
214044|NCT00725985|513094|P3|Treated|ITP (Up to 96 Weeks)||206
214045|NCT00725985|513095|P2|Treated|ITP (Up to 96 Weeks)||206
214046|NCT00725985|513096|P1|Treated|ITP (Up to 96 Weeks)||204
214047|NCT00725985|513085|P12|STARTED|ITP (Up to 96 Weeks)||0
214048|NCT00725985|513086|P11|STARTED|ITP (Up to 96 Weeks)||0
214049|NCT00725985|513087|P10|STARTED|ITP (Up to 96 Weeks)||0
214050|NCT00725985|513088|P9|STARTED|ITP (Up to 96 Weeks)||0
214051|NCT00725985|513089|P8|STARTED|ITP (Up to 96 Weeks)||0
214052|NCT00725985|513090|P7|STARTED|ITP (Up to 96 Weeks)||0
214053|NCT00725985|513091|P6|STARTED|ITP (Up to 96 Weeks)||0
214054|NCT00725985|513092|P5|STARTED|ITP (Up to 96 Weeks)||0
214055|NCT00725985|513093|P4|STARTED|ITP (Up to 96 Weeks)||0
214056|NCT00725985|513094|P3|STARTED|ITP (Up to 96 Weeks)||206
214057|NCT00725985|513095|P2|STARTED|ITP (Up to 96 Weeks)||206
214058|NCT00725985|513096|P1|STARTED|ITP (Up to 96 Weeks)||205
214059|NCT00725959|513124|P2|NOT COMPLETED|Overall Study||197
214060|NCT00725959|513125|P1|NOT COMPLETED|Overall Study||289
214061|NCT00725959|513124|P2|COMPLETED|Overall Study||439
214062|NCT00725959|513125|P1|COMPLETED|Overall Study||653
214063|NCT00725959|513124|P2|STARTED|Overall Study||636
214064|NCT00725959|513125|P1|STARTED|Overall Study||942
214065|NCT00725920|513133|P2|NOT COMPLETED|Overall Study||6
214066|NCT00725920|513134|P1|NOT COMPLETED|Overall Study||3
214067|NCT00725920|513133|P2|COMPLETED|Overall Study||12
214068|NCT00725920|513134|P1|COMPLETED|Overall Study||14
214069|NCT00725920|513133|P2|STARTED|Overall Study||18
214070|NCT00725920|513134|P1|STARTED|Overall Study||17
214071|NCT00725842|513140|P1|NOT COMPLETED|Overall Study||40
214072|NCT00725842|513140|P1|COMPLETED|Overall Study||57
214073|NCT00725842|513140|P1|Participants Eligible for Analysis|Overall Study||90
214074|NCT00725842|513140|P1|STARTED|Overall Study||97
214075|NCT00725764|513147|P1|NOT COMPLETED|Overall Study||14
214076|NCT00725764|513147|P1|COMPLETED|Overall Study||0
214077|NCT00725764|513147|P1|STARTED|Overall Study||14
214078|NCT00725751|513167|P2|NOT COMPLETED|Overall Study||108
214079|NCT00725751|513168|P1|NOT COMPLETED|Overall Study||34
214080|NCT00725751|513167|P2|COMPLETED|Overall Study||150
214081|NCT00725751|513168|P1|COMPLETED|Overall Study||56
214082|NCT00725751|513167|P2|STARTED|Overall Study||258
214083|NCT00725751|513168|P1|STARTED|Overall Study||90
214084|NCT00725725|513180|P3|NOT COMPLETED|Overall Study||5
214085|NCT00725725|513181|P2|NOT COMPLETED|Overall Study||4
214086|NCT00725725|513182|P1|NOT COMPLETED|Overall Study||4
214087|NCT00725725|513180|P3|COMPLETED|Overall Study||12
214088|NCT00725725|513181|P2|COMPLETED|Overall Study||11
214089|NCT00725725|513182|P1|COMPLETED|Overall Study||10
214090|NCT00725725|513180|P3|Treated|Overall Study||14
214091|NCT00725725|513181|P2|Treated|Overall Study||15
214092|NCT00725725|513182|P1|Treated|Overall Study||11
214093|NCT00725725|513180|P3|STARTED|Overall Study||17
214094|NCT00725725|513181|P2|STARTED|Overall Study||15
214095|NCT00725725|513182|P1|STARTED|Overall Study||14
214096|NCT00725712|513225|P2|NOT COMPLETED|Overall Study||26
214097|NCT00725712|513226|P1|NOT COMPLETED|Overall Study||48
214098|NCT00725712|513225|P2|COMPLETED|Overall Study||0
214099|NCT00725712|513226|P1|COMPLETED|Overall Study||0
214100|NCT00725712|513225|P2|STARTED|Overall Study||26
214101|NCT00725712|513226|P1|STARTED|Overall Study||48
214102|NCT00725621|513262|P1|NOT COMPLETED|Overall Study||271
214103|NCT00725621|513262|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
214104|NCT00725621|513262|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
214105|NCT00725608|513285|P1|NOT COMPLETED|Overall Study||167
214106|NCT00725608|513285|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
214107|NCT00725608|513285|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
214108|NCT00725543|513291|P1|NOT COMPLETED|Overall Study||153
214109|NCT00725543|513291|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
214110|NCT00725543|513291|P1|STARTED|Overall Study||358
214111|NCT00725530|513300|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
214112|NCT00725530|513301|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
214113|NCT00725530|513300|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
214114|NCT00725530|513301|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
214115|NCT00725530|513300|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
214116|NCT00725530|513301|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
214117|NCT00725530|513300|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
214118|NCT00725530|513301|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
214119|NCT00725530|513300|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
214120|NCT00725530|513301|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
214121|NCT00725530|513300|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
214122|NCT00725530|513301|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
214123|NCT00725504|513307|P1|NOT COMPLETED|Overall Study||0
214124|NCT00725504|513307|P1|COMPLETED|Overall Study||71
214125|NCT00725504|513307|P1|STARTED|Overall Study||71
214126|NCT00725491|513316|P2|NOT COMPLETED|Overall Study||18
214127|NCT00725491|513317|P1|NOT COMPLETED|Overall Study||9
214128|NCT00725491|513316|P2|COMPLETED|Overall Study||102
214129|NCT00725491|513317|P1|COMPLETED|Overall Study||104
214130|NCT00725491|513316|P2|STARTED|Overall Study|Intent-to-Treat Group|120
214131|NCT00725491|513317|P1|STARTED|Overall Study|Intent-to-Treat Group|113
214132|NCT00725452|513323|P1|NOT COMPLETED|Overall Study||11
214133|NCT00725452|513323|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
214134|NCT00725452|513323|P1|STARTED|Overall Study||26
214135|NCT00725361|513332|P1|NOT COMPLETED|Overall Study||4
214136|NCT00725361|513332|P1|COMPLETED|Overall Study||16
214137|NCT00725361|513332|P1|STARTED|Overall Study||20
214138|NCT00725322|513342|P2|NOT COMPLETED|Second Injection Visit||0
214139|NCT00725322|513343|P1|NOT COMPLETED|Second Injection Visit||0
214140|NCT00725322|513342|P2|COMPLETED|Second Injection Visit||14
214141|NCT00725322|513343|P1|COMPLETED|Second Injection Visit||13
214142|NCT00725322|513342|P2|STARTED|Second Injection Visit||14
214143|NCT00725322|513343|P1|STARTED|Second Injection Visit||13
214144|NCT00725322|513342|P2|NOT COMPLETED|Washout (28 Days)||1
214145|NCT00725322|513343|P1|NOT COMPLETED|Washout (28 Days)||2
214146|NCT00725322|513342|P2|COMPLETED|Washout (28 Days)||14
214147|NCT00725322|513343|P1|COMPLETED|Washout (28 Days)||13
214148|NCT00725322|513342|P2|STARTED|Washout (28 Days)||15
214149|NCT00725322|513343|P1|STARTED|Washout (28 Days)||15
214150|NCT00725322|513342|P2|NOT COMPLETED|First Injection Visit||0
214151|NCT00725322|513343|P1|NOT COMPLETED|First Injection Visit||0
214152|NCT00725322|513342|P2|COMPLETED|First Injection Visit||15
214153|NCT00725322|513343|P1|COMPLETED|First Injection Visit||15
214154|NCT00725322|513342|P2|STARTED|First Injection Visit||15
214155|NCT00725322|513343|P1|STARTED|First Injection Visit||15
214156|NCT00725296|513351|P1|NOT COMPLETED|Overall Study||62
214157|NCT00725296|513351|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
214158|NCT00725296|513351|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
214159|NCT00725270|513362|P2|NOT COMPLETED|Overall Study||0
214160|NCT00725270|513363|P1|NOT COMPLETED|Overall Study||0
214161|NCT00725270|513362|P2|COMPLETED|Overall Study||7
214162|NCT00725270|513363|P1|COMPLETED|Overall Study||5
214163|NCT00725270|513362|P2|STARTED|Overall Study||7
214164|NCT00725270|513363|P1|STARTED|Overall Study||5
214165|NCT00725205|513371|P1|NOT COMPLETED|Overall Study||87
214166|NCT00725205|513371|P1|COMPLETED|Overall Study||207
214167|NCT00725205|513371|P1|STARTED|Overall Study||294
214168|NCT00725153|513377|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
214169|NCT00725153|513378|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
214170|NCT00725153|513377|P2|COMPLETED|Period Two, 10 Hours of Wear||28
214171|NCT00725153|513378|P1|COMPLETED|Period Two, 10 Hours of Wear||27
214172|NCT00725153|513377|P2|STARTED|Period Two, 10 Hours of Wear||28
214173|NCT00725153|513378|P1|STARTED|Period Two, 10 Hours of Wear||27
214174|NCT00725153|513377|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
214175|NCT00725153|513378|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
214176|NCT00725153|513377|P2|COMPLETED|Period One, 10 Hours of Wear||28
214177|NCT00725153|513378|P1|COMPLETED|Period One, 10 Hours of Wear||27
214178|NCT00725153|513377|P2|STARTED|Period One, 10 Hours of Wear||28
214179|NCT00725153|513378|P1|STARTED|Period One, 10 Hours of Wear||27
214180|NCT00725101|513384|P1|NOT COMPLETED|Overall Study||495
214181|NCT00725101|513384|P1|COMPLETED|Overall Study||1205
214182|NCT00725101|513384|P1|STARTED|Overall Study||1700
214183|NCT00725075|513407|P3|NOT COMPLETED|Overall Study||9
214184|NCT00725075|513408|P2|NOT COMPLETED|Overall Study||8
214185|NCT00725075|513409|P1|NOT COMPLETED|Overall Study||11
214186|NCT00725075|513407|P3|COMPLETED|Overall Study||61
214187|NCT00725075|513408|P2|COMPLETED|Overall Study||65
214188|NCT00725075|513409|P1|COMPLETED|Overall Study||61
214189|NCT00725075|513407|P3|Treated|Overall Study||70
214190|NCT00725075|513408|P2|Treated|Overall Study||73
214191|NCT00725075|513409|P1|Treated|Overall Study||71
214192|NCT00725075|513407|P3|STARTED|Overall Study||70
214193|NCT00725075|513408|P2|STARTED|Overall Study||73
214194|NCT00725075|513409|P1|STARTED|Overall Study||72
214195|NCT00725049|513455|P2|NOT COMPLETED|Overall Study||0
214196|NCT00725049|513456|P1|NOT COMPLETED|Overall Study||0
214197|NCT00725049|513455|P2|COMPLETED|Overall Study||20
214198|NCT00725049|513456|P1|COMPLETED|Overall Study||17
214199|NCT00725049|513455|P2|STARTED|Overall Study||20
214200|NCT00725049|513456|P1|STARTED|Overall Study||17
214201|NCT00725010|513462|P1|NOT COMPLETED|Overall Study||25
214202|NCT00725010|513462|P1|COMPLETED|Overall Study||25
214203|NCT00725010|513462|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
214204|NCT00724984|513476|P6|NOT COMPLETED|Overall Study||5
214205|NCT00724984|513477|P5|NOT COMPLETED|Overall Study||4
214206|NCT00724984|513478|P4|NOT COMPLETED|Overall Study||2
214207|NCT00724984|513479|P3|NOT COMPLETED|Overall Study||0
214208|NCT00724984|513480|P2|NOT COMPLETED|Overall Study||1
214209|NCT00724984|513481|P1|NOT COMPLETED|Overall Study||1
214210|NCT00724984|513476|P6|COMPLETED|Overall Study||9
214211|NCT00724984|513477|P5|COMPLETED|Overall Study||12
214212|NCT00724984|513478|P4|COMPLETED|Overall Study||7
214213|NCT00724984|513479|P3|COMPLETED|Overall Study||3
214214|NCT00724984|513480|P2|COMPLETED|Overall Study||7
214215|NCT00724984|513481|P1|COMPLETED|Overall Study||4
214216|NCT00724984|513476|P6|STARTED|Overall Study||14
214217|NCT00724984|513477|P5|STARTED|Overall Study||16
214218|NCT00724984|513478|P4|STARTED|Overall Study||9
214219|NCT00724984|513479|P3|STARTED|Overall Study||3
214220|NCT00724984|513480|P2|STARTED|Overall Study||8
214221|NCT00724984|513481|P1|STARTED|Overall Study||5
214222|NCT00724958|513495|P1|NOT COMPLETED|Overall Study||182
214223|NCT00724958|513495|P1|COMPLETED|Overall Study||166
214224|NCT00724958|513495|P1|STARTED|Overall Study||348
214225|NCT00724945|513504|P2|NOT COMPLETED|Period 2||0
214226|NCT00724945|513505|P1|NOT COMPLETED|Period 2||4
214227|NCT00724945|513504|P2|COMPLETED|Period 2||54
214228|NCT00724945|513505|P1|COMPLETED|Period 2||51
214229|NCT00724945|513504|P2|STARTED|Period 2||54
214230|NCT00724945|513505|P1|STARTED|Period 2||55
214231|NCT00724945|513504|P2|NOT COMPLETED|Period 1||1
214232|NCT00724945|513505|P1|NOT COMPLETED|Period 1||3
214233|NCT00724945|513504|P2|COMPLETED|Period 1||54
214234|NCT00724945|513505|P1|COMPLETED|Period 1||55
214235|NCT00724945|513504|P2|STARTED|Period 1||55
214236|NCT00724945|513505|P1|STARTED|Period 1||58
214237|NCT00724932|513517|P2|NOT COMPLETED|Overall Study||3
214238|NCT00724932|513518|P1|NOT COMPLETED|Overall Study||5
214239|NCT00724932|513517|P2|COMPLETED|Overall Study||67
214240|NCT00724932|513518|P1|COMPLETED|Overall Study||65
214241|NCT00724932|513517|P2|STARTED|Overall Study||70
214242|NCT00724932|513518|P1|STARTED|Overall Study||70
214243|NCT00724893|513589|P2|NOT COMPLETED|Overall Study||458
214244|NCT00724893|513590|P1|NOT COMPLETED|Overall Study||364
214245|NCT00724893|513589|P2|COMPLETED|Overall Study||670
214246|NCT00724893|513590|P1|COMPLETED|Overall Study||938
214247|NCT00724893|513589|P2|STARTED|Overall Study||1128
214248|NCT00724893|513590|P1|STARTED|Overall Study||1302
214249|NCT00724867|513658|P1|NOT COMPLETED|Overall Study||128
214250|NCT00724867|513658|P1|COMPLETED|Overall Study||140
214251|NCT00724867|513658|P1|STARTED|Overall Study||268
214252|NCT00724854|513698|P2|NOT COMPLETED|Overall Study||31
214253|NCT00724854|513699|P1|NOT COMPLETED|Overall Study||403
214254|NCT00724854|513698|P2|COMPLETED|Overall Study||41
214255|NCT00724854|513699|P1|COMPLETED|Overall Study||607
214256|NCT00724854|513698|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
214257|NCT00724854|513699|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
214258|NCT00724815|513716|P2|NOT COMPLETED|Overall Study||39
214259|NCT00724815|513717|P1|NOT COMPLETED|Overall Study||43
214260|NCT00724815|513716|P2|COMPLETED|Overall Study||226
214261|NCT00724815|513717|P1|COMPLETED|Overall Study||222
214262|NCT00724815|513716|P2|STARTED|Overall Study|subjects randomized|265
214263|NCT00724815|513717|P1|STARTED|Overall Study|subjects randomized|265
214264|NCT00724750|513731|P2|NOT COMPLETED|Overall Study||0
214265|NCT00724750|513732|P1|NOT COMPLETED|Overall Study||0
214266|NCT00724750|513731|P2|COMPLETED|Overall Study||42
214267|NCT00724750|513732|P1|COMPLETED|Overall Study||45
214268|NCT00724750|513731|P2|STARTED|Overall Study||42
214269|NCT00724750|513732|P1|STARTED|Overall Study||45
214270|NCT00724711|513750|P2|NOT COMPLETED|Overall Study||17
214271|NCT00724711|513751|P1|NOT COMPLETED|Overall Study||17
214272|NCT00724711|513750|P2|COMPLETED|Overall Study||139
214273|NCT00724711|513751|P1|COMPLETED|Overall Study||138
214274|NCT00724711|513750|P2|STARTED|Overall Study||156
214275|NCT00724711|513751|P1|STARTED|Overall Study||155
214276|NCT00724698|513783|P1|NOT COMPLETED|Overall Study||90
214277|NCT00724698|513783|P1|COMPLETED|Overall Study||2921
214278|NCT00724698|513783|P1|STARTED|Overall Study||3011
214279|NCT00724594|513790|P4|NOT COMPLETED|Overall Study||1
214280|NCT00724594|513791|P3|NOT COMPLETED|Overall Study||0
214281|NCT00724594|513792|P2|NOT COMPLETED|Overall Study||0
214282|NCT00724594|513793|P1|NOT COMPLETED|Overall Study||0
214283|NCT00724594|513790|P4|COMPLETED|Overall Study||10
214284|NCT00724594|513791|P3|COMPLETED|Overall Study||11
214285|NCT00724594|513792|P2|COMPLETED|Overall Study||12
214286|NCT00724594|513793|P1|COMPLETED|Overall Study||12
214287|NCT00724594|513790|P4|STARTED|Overall Study||11
214288|NCT00724594|513791|P3|STARTED|Overall Study||11
214289|NCT00724594|513792|P2|STARTED|Overall Study||12
214290|NCT00724594|513793|P1|STARTED|Overall Study||12
214291|NCT00724568|513816|P2|NOT COMPLETED|Overall Study||0
214292|NCT00724568|513817|P1|NOT COMPLETED|Overall Study||0
214293|NCT00724568|513816|P2|COMPLETED|Overall Study||32
214294|NCT00724568|513817|P1|COMPLETED|Overall Study||42
214295|NCT00724568|513816|P2|STARTED|Overall Study||32
214296|NCT00724568|513817|P1|STARTED|Overall Study||42
214297|NCT00724477|513822|P1|NOT COMPLETED|Overall Study||0
214298|NCT00724477|513822|P1|COMPLETED|Overall Study||1663
214299|NCT00724477|513822|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
214300|NCT00724464|513826|P1|NOT COMPLETED|Overall Study||23
214301|NCT00724464|513826|P1|COMPLETED|Overall Study||309
214302|NCT00724464|513826|P1|STARTED|Overall Study||332
214303|NCT00724451|513838|P1|NOT COMPLETED|Overall Study||802
214304|NCT00724451|513838|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
214305|NCT00724451|513838|P1|Received Antiviral Treatment|Overall Study||500
214306|NCT00724451|513838|P1|STARTED|Overall Study||1128
214307|NCT00724373|513844|P1|NOT COMPLETED|Overall Study||171
214308|NCT00724373|513844|P1|COMPLETED|Overall Study||271
214309|NCT00724373|513844|P1|STARTED|Overall Study||442
214310|NCT00724347|513848|P1|NOT COMPLETED|Overall Study||2
214311|NCT00724347|513848|P1|COMPLETED|Overall Study||16
214312|NCT00724347|513848|P1|Baseline Testing|Overall Study||18
214313|NCT00724347|513848|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
214314|NCT00724308|513854|P2|NOT COMPLETED|Overall Study||97
214315|NCT00724308|513855|P1|NOT COMPLETED|Overall Study||80
214316|NCT00724308|513854|P2|COMPLETED|Overall Study||210
214317|NCT00724308|513855|P1|COMPLETED|Overall Study||190
214318|NCT00724308|513854|P2|STARTED|Overall Study||307
214319|NCT00724308|513855|P1|STARTED|Overall Study||270
214320|NCT00724282|513861|P1|NOT COMPLETED|Overall Study||4
214321|NCT00724282|513861|P1|COMPLETED|Overall Study||16
214322|NCT00724282|513861|P1|STARTED|Overall Study||20
214323|NCT00724243|513865|P1|NOT COMPLETED|Overall Study||15
214324|NCT00724243|513865|P1|COMPLETED|Overall Study||18
214325|NCT00724243|513865|P1|STARTED|Overall Study||33
214326|NCT00724152|513875|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
214327|NCT00724152|513876|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
214328|NCT00724152|513877|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
214329|NCT00724152|513875|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
214330|NCT00724152|513876|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
214331|NCT00724152|513877|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
214332|NCT00724152|513875|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
214333|NCT00724152|513876|P2|STARTED|Three-arm Study Period (+Standard Care)||2
214334|NCT00724152|513877|P1|STARTED|Three-arm Study Period (+Standard Care)||4
214335|NCT00724152|513875|P3|NOT COMPLETED|Two-arm Study Period||0
214336|NCT00724152|513876|P2|NOT COMPLETED|Two-arm Study Period||2
214337|NCT00724152|513877|P1|NOT COMPLETED|Two-arm Study Period||3
214338|NCT00724152|513875|P3|COMPLETED|Two-arm Study Period||0
214339|NCT00724152|513876|P2|COMPLETED|Two-arm Study Period||9
214340|NCT00724152|513877|P1|COMPLETED|Two-arm Study Period||11
214341|NCT00724152|513875|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
214342|NCT00724152|513876|P2|STARTED|Two-arm Study Period||11
214343|NCT00724152|513877|P1|STARTED|Two-arm Study Period||14
214344|NCT00724126|513894|P2|NOT COMPLETED|Overall Study||15
214345|NCT00724126|513895|P1|NOT COMPLETED|Overall Study||19
214346|NCT00724126|513894|P2|COMPLETED|Overall Study||301
214347|NCT00724126|513895|P1|COMPLETED|Overall Study||302
214348|NCT00724126|513894|P2|STARTED|Overall Study||316
214349|NCT00724126|513895|P1|STARTED|Overall Study||321
214350|NCT00724061|513903|P1|NOT COMPLETED|Maintenance Therapy||0
214351|NCT00724061|513903|P1|COMPLETED|Maintenance Therapy||2
214352|NCT00724061|513903|P1|STARTED|Maintenance Therapy||2
214353|NCT00724061|513903|P1|NOT COMPLETED|Dose Escalation Phase||5
214354|NCT00724061|513903|P1|COMPLETED|Dose Escalation Phase||2
214355|NCT00724061|513903|P1|STARTED|Dose Escalation Phase||7
214356|NCT00724009|513907|P1|NOT COMPLETED|Overall Study||0
214357|NCT00724009|513907|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
214358|NCT00724009|513907|P1|STARTED|Overall Study||29
214359|NCT00723957|513920|P2|NOT COMPLETED|Overall Study||53
214360|NCT00723957|513921|P1|NOT COMPLETED|Overall Study||51
214361|NCT00723957|513920|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
214362|NCT00723957|513921|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
214363|NCT00723957|513920|P2|STARTED|Overall Study|Randomized|99
214364|NCT00723957|513921|P1|STARTED|Overall Study|Randomized|98
214365|NCT00723944|513945|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
214366|NCT00723944|513946|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
214367|NCT00723944|513945|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
214368|NCT00723944|513946|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
214369|NCT00723944|513945|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
214370|NCT00723944|513946|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
214371|NCT00723944|513945|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
214372|NCT00723944|513946|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
214373|NCT00723944|513945|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
214374|NCT00723944|513946|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
214375|NCT00723944|513945|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
214376|NCT00723944|513946|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
214377|NCT00723944|513945|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
214378|NCT00723944|513946|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
214379|NCT00723944|513945|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
214380|NCT00723944|513946|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
214381|NCT00723944|513945|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
214382|NCT00723944|513946|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
214383|NCT00723944|513945|P2|NOT COMPLETED|Implant Placement Surgery||0
214384|NCT00723944|513946|P1|NOT COMPLETED|Implant Placement Surgery||0
214385|NCT00723944|513945|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
214386|NCT00723944|513946|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
214387|NCT00723944|513945|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
214388|NCT00723944|513946|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
214389|NCT00723931|513952|P1|NOT COMPLETED|Overall Study||0
214390|NCT00723931|513952|P1|COMPLETED|Overall Study||1267
214391|NCT00723931|513952|P1|STARTED|Overall Study||1267
214392|NCT00723892|513959|P2|NOT COMPLETED|Overall Study||87
214393|NCT00723892|513960|P1|NOT COMPLETED|Overall Study||107
214394|NCT00723892|513959|P2|COMPLETED|Overall Study||168
214395|NCT00723892|513960|P1|COMPLETED|Overall Study||206
214396|NCT00723892|513959|P2|STARTED|Overall Study||255
214397|NCT00723892|513960|P1|STARTED|Overall Study||313
214398|NCT00723840|513967|P1|NOT COMPLETED|Overall Study||82
214399|NCT00723840|513967|P1|COMPLETED|Overall Study||163
214400|NCT00723840|513967|P1|STARTED|Overall Study||245
214401|NCT00723827|513978|P1|NOT COMPLETED|Overall Study||0
214402|NCT00723827|513978|P1|COMPLETED|Overall Study||682
214403|NCT00723827|513978|P1|STARTED|Overall Study||682
214404|NCT00723801|513988|P2|NOT COMPLETED|Overall Study||3
214405|NCT00723801|513989|P1|NOT COMPLETED|Overall Study||3
214406|NCT00723801|513988|P2|COMPLETED|Overall Study||17
214407|NCT00723801|513989|P1|COMPLETED|Overall Study||17
214408|NCT00723801|513988|P2|STARTED|Overall Study||20
214409|NCT00723801|513989|P1|STARTED|Overall Study||20
214410|NCT00723788|513997|P1|NOT COMPLETED|Overall Study||0
214411|NCT00723788|513997|P1|COMPLETED|Overall Study||21
214412|NCT00723788|513997|P1|STARTED|Overall Study||21
214413|NCT00723749|514003|P1|NOT COMPLETED|Overall Study||163
214414|NCT00723749|514003|P1|COMPLETED|Overall Study||182
214415|NCT00723749|514003|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
214416|NCT00723736|514010|P1|NOT COMPLETED|Overall Study||1
214417|NCT00723736|514010|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
214418|NCT00723736|514010|P1|STARTED|Overall Study||100
214419|NCT00723710|514014|P1|NOT COMPLETED|Overall Study||174
214420|NCT00723710|514014|P1|COMPLETED|Overall Study||120
214421|NCT00723710|514014|P1|STARTED|Overall Study||294
214422|NCT00723697|514018|P1|NOT COMPLETED|Overall Study||18
214423|NCT00723697|514018|P1|COMPLETED|Overall Study||1289
214424|NCT00723697|514018|P1|STARTED|Overall Study||1307
214425|NCT00723645|514026|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
214426|NCT00723645|514026|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
214427|NCT00723645|514026|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
214428|NCT00723645|514026|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
214429|NCT00723645|514026|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
214430|NCT00723645|514026|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
214431|NCT00723645|514026|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
214432|NCT00723645|514026|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
214433|NCT00723645|514026|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
214434|NCT00723632|514031|P1|NOT COMPLETED|Overall Study||203
214435|NCT00723632|514031|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
214436|NCT00723632|514031|P1|STARTED|Overall Study||901
214437|NCT00723606|514039|P2|NOT COMPLETED|Overall Study||7
214438|NCT00723606|514040|P1|NOT COMPLETED|Overall Study||4
214439|NCT00723606|514039|P2|COMPLETED|Overall Study||180
214440|NCT00723606|514040|P1|COMPLETED|Overall Study||185
214441|NCT00723606|514039|P2|STARTED|Overall Study||187
214442|NCT00723606|514040|P1|STARTED|Overall Study||189
214443|NCT00723580|514056|P1|NOT COMPLETED|Overall Study||0
214444|NCT00723580|514056|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
214445|NCT00723580|514056|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
214446|NCT00723580|514056|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
214447|NCT00723554|514060|P1|NOT COMPLETED|Overall Study||29
214448|NCT00723554|514060|P1|COMPLETED|Overall Study||34
214449|NCT00723554|514060|P1|STARTED|Overall Study||63
214450|NCT00723528|514110|P7|NOT COMPLETED|Period 2: After Controlled Period||4
214451|NCT00723528|514111|P6|NOT COMPLETED|Period 2: After Controlled Period||6
214452|NCT00723528|514112|P5|NOT COMPLETED|Period 2: After Controlled Period||2
214453|NCT00723528|514113|P4|NOT COMPLETED|Period 2: After Controlled Period||1
214454|NCT00723528|514114|P3|NOT COMPLETED|Period 2: After Controlled Period||0
214455|NCT00723528|514115|P2|NOT COMPLETED|Period 2: After Controlled Period||0
214456|NCT00723528|514116|P1|NOT COMPLETED|Period 2: After Controlled Period||0
214457|NCT00723528|514110|P7|COMPLETED|Period 2: After Controlled Period||54
214458|NCT00723528|514111|P6|COMPLETED|Period 2: After Controlled Period||58
214459|NCT00723528|514112|P5|COMPLETED|Period 2: After Controlled Period||11
214460|NCT00723528|514113|P4|COMPLETED|Period 2: After Controlled Period||14
214461|NCT00723528|514114|P3|COMPLETED|Period 2: After Controlled Period||0
214462|NCT00723528|514115|P2|COMPLETED|Period 2: After Controlled Period||0
214463|NCT00723528|514116|P1|COMPLETED|Period 2: After Controlled Period||0
214464|NCT00723528|514110|P7|STARTED|Period 2: After Controlled Period||58
214465|NCT00723528|514111|P6|STARTED|Period 2: After Controlled Period||64
214466|NCT00723528|514112|P5|STARTED|Period 2: After Controlled Period||13
214467|NCT00723528|514113|P4|STARTED|Period 2: After Controlled Period||15
214468|NCT00723528|514114|P3|STARTED|Period 2: After Controlled Period||0
214469|NCT00723528|514115|P2|STARTED|Period 2: After Controlled Period||0
214470|NCT00723528|514116|P1|STARTED|Period 2: After Controlled Period||0
214471|NCT00723528|514110|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
214472|NCT00723528|514111|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
214473|NCT00723528|514112|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
214474|NCT00723528|514113|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
214475|NCT00723528|514114|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
214476|NCT00723528|514115|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
214477|NCT00723528|514116|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
214478|NCT00723528|514110|P7|COMPLETED|Period 1: Controlled Period (CP)||0
214479|NCT00723528|514111|P6|COMPLETED|Period 1: Controlled Period (CP)||0
214480|NCT00723528|514112|P5|COMPLETED|Period 1: Controlled Period (CP)||0
214481|NCT00723528|514113|P4|COMPLETED|Period 1: Controlled Period (CP)||0
214482|NCT00723528|514114|P3|COMPLETED|Period 1: Controlled Period (CP)||58
214483|NCT00723528|514115|P2|COMPLETED|Period 1: Controlled Period (CP)||64
214484|NCT00723528|514116|P1|COMPLETED|Period 1: Controlled Period (CP)||28
214485|NCT00723528|514110|P7|STARTED|Period 1: Controlled Period (CP)||0
214486|NCT00723528|514111|P6|STARTED|Period 1: Controlled Period (CP)||0
214487|NCT00723528|514112|P5|STARTED|Period 1: Controlled Period (CP)||0
214488|NCT00723528|514113|P4|STARTED|Period 1: Controlled Period (CP)||0
214489|NCT00723528|514114|P3|STARTED|Period 1: Controlled Period (CP)||62
214490|NCT00723528|514115|P2|STARTED|Period 1: Controlled Period (CP)||64
214491|NCT00723528|514116|P1|STARTED|Period 1: Controlled Period (CP)||32
214492|NCT00723489|514178|P4|NOT COMPLETED|Overall Study||3
214493|NCT00723489|514179|P3|NOT COMPLETED|Overall Study||0
214494|NCT00723489|514180|P2|NOT COMPLETED|Overall Study||4
214495|NCT00723489|514181|P1|NOT COMPLETED|Overall Study||1
214496|NCT00723489|514178|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
214497|NCT00723489|514179|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
214498|NCT00723489|514180|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
214499|NCT00723489|514181|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
214500|NCT00723489|514178|P4|STARTED|Overall Study||23
214501|NCT00723489|514179|P3|STARTED|Overall Study||19
214502|NCT00723489|514180|P2|STARTED|Overall Study||19
214503|NCT00723489|514181|P1|STARTED|Overall Study||21
214504|NCT00723450|514209|P3|NOT COMPLETED|Randomized Phase||67
214505|NCT00723450|514210|P2|NOT COMPLETED|Randomized Phase||65
214506|NCT00723450|514211|P1|NOT COMPLETED|Randomized Phase||0
214507|NCT00723450|514209|P3|COMPLETED|Randomized Phase||20
214508|NCT00723450|514210|P2|COMPLETED|Randomized Phase||21
214509|NCT00723450|514211|P1|COMPLETED|Randomized Phase||0
214510|NCT00723450|514209|P3|STARTED|Randomized Phase||87
214511|NCT00723450|514210|P2|STARTED|Randomized Phase||86
214512|NCT00723450|514211|P1|STARTED|Randomized Phase||0
214513|NCT00723450|514209|P3|NOT COMPLETED|Open-Label Phase||0
214514|NCT00723450|514210|P2|NOT COMPLETED|Open-Label Phase||0
214515|NCT00723450|514211|P1|NOT COMPLETED|Open-Label Phase||125
214516|NCT00723450|514209|P3|COMPLETED|Open-Label Phase||0
214517|NCT00723450|514210|P2|COMPLETED|Open-Label Phase||0
214518|NCT00723450|514211|P1|COMPLETED|Open-Label Phase||173
214519|NCT00723450|514209|P3|STARTED|Open-Label Phase||0
214520|NCT00723450|514210|P2|STARTED|Open-Label Phase||0
214521|NCT00723450|514211|P1|STARTED|Open-Label Phase||298
214522|NCT00723294|514252|P1|NOT COMPLETED|Overall Study||13
214523|NCT00723294|514252|P1|COMPLETED|Overall Study||86
214524|NCT00723294|514252|P1|STARTED|Overall Study||99
214525|NCT00723255|514257|P1|NOT COMPLETED|Overall Study||4
214526|NCT00723255|514257|P1|COMPLETED|Overall Study|Eligible and treated patients|49
214527|NCT00723255|514257|P1|STARTED|Overall Study||53
214528|NCT00723229|514284|P2|NOT COMPLETED|Second Intervention||0
214529|NCT00723229|514285|P1|NOT COMPLETED|Second Intervention||0
214530|NCT00723229|514284|P2|COMPLETED|Second Intervention||20
214531|NCT00723229|514285|P1|COMPLETED|Second Intervention||18
214532|NCT00723229|514284|P2|STARTED|Second Intervention||20
214533|NCT00723229|514285|P1|STARTED|Second Intervention||18
214534|NCT00723229|514284|P2|NOT COMPLETED|First Intervention||3
214535|NCT00723229|514285|P1|NOT COMPLETED|First Intervention||7
214536|NCT00723229|514284|P2|COMPLETED|First Intervention||20
214537|NCT00723229|514285|P1|COMPLETED|First Intervention||18
214538|NCT00723229|514284|P2|STARTED|First Intervention||23
214539|NCT00723229|514285|P1|STARTED|First Intervention||25
214540|NCT00723203|514297|P1|NOT COMPLETED|Overall Study||3
214541|NCT00723203|514297|P1|COMPLETED|Overall Study||13
214542|NCT00723203|514297|P1|STARTED|Overall Study||16
214543|NCT00723190|514301|P1|NOT COMPLETED|Overall Study||142
214544|NCT00723190|514301|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
214545|NCT00723190|514301|P1|SAFETY POPULATION|Overall Study||301
214546|NCT00723190|514301|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
214547|NCT00723177|514319|P3|NOT COMPLETED|Overall Study||5
214548|NCT00723177|514320|P2|NOT COMPLETED|Overall Study||4
214549|NCT00723177|514321|P1|NOT COMPLETED|Overall Study||5
214550|NCT00723177|514319|P3|COMPLETED|Overall Study||10
214551|NCT00723177|514320|P2|COMPLETED|Overall Study||10
214552|NCT00723177|514321|P1|COMPLETED|Overall Study||10
214553|NCT00723177|514319|P3|STARTED|Overall Study||15
214554|NCT00723177|514320|P2|STARTED|Overall Study||14
214555|NCT00723177|514321|P1|STARTED|Overall Study||15
214556|NCT00723125|514334|P2|NOT COMPLETED|Overall Study||6
214557|NCT00723125|514335|P1|NOT COMPLETED|Overall Study||18
214558|NCT00723125|514334|P2|COMPLETED|Overall Study||21
214559|NCT00723125|514335|P1|COMPLETED|Overall Study||15
214560|NCT00723125|514334|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
214561|NCT00723125|514335|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
214562|NCT00723073|514347|P2|NOT COMPLETED|Overall Study||0
214563|NCT00723073|514348|P1|NOT COMPLETED|Overall Study||0
214564|NCT00723073|514347|P2|COMPLETED|Overall Study||174
214565|NCT00723073|514348|P1|COMPLETED|Overall Study||149
214566|NCT00723073|514347|P2|STARTED|Overall Study||174
214567|NCT00723073|514348|P1|STARTED|Overall Study||149
214568|NCT00723021|514372|P5|NOT COMPLETED|Intervention Period 5||0
214569|NCT00723021|514373|P4|NOT COMPLETED|Intervention Period 5||0
214570|NCT00723021|514374|P3|NOT COMPLETED|Intervention Period 5||0
214571|NCT00723021|514375|P2|NOT COMPLETED|Intervention Period 5||0
214572|NCT00723021|514376|P1|NOT COMPLETED|Intervention Period 5||0
214573|NCT00723021|514372|P5|COMPLETED|Intervention Period 5||2
214574|NCT00723021|514373|P4|COMPLETED|Intervention Period 5||3
214575|NCT00723021|514374|P3|COMPLETED|Intervention Period 5||3
214576|NCT00723021|514375|P2|COMPLETED|Intervention Period 5||3
214577|NCT00723021|514376|P1|COMPLETED|Intervention Period 5||3
214578|NCT00723021|514372|P5|STARTED|Intervention Period 5||2
214579|NCT00723021|514373|P4|STARTED|Intervention Period 5||3
214580|NCT00723021|514374|P3|STARTED|Intervention Period 5||3
214581|NCT00723021|514375|P2|STARTED|Intervention Period 5||3
214582|NCT00723021|514376|P1|STARTED|Intervention Period 5||3
214583|NCT00723021|514372|P5|NOT COMPLETED|Intervention Period 4||1
214584|NCT00723021|514373|P4|NOT COMPLETED|Intervention Period 4||0
214585|NCT00723021|514374|P3|NOT COMPLETED|Intervention Period 4||0
214586|NCT00723021|514375|P2|NOT COMPLETED|Intervention Period 4||0
214587|NCT00723021|514376|P1|NOT COMPLETED|Intervention Period 4||0
214588|NCT00723021|514372|P5|COMPLETED|Intervention Period 4||2
214589|NCT00723021|514373|P4|COMPLETED|Intervention Period 4||3
214590|NCT00723021|514374|P3|COMPLETED|Intervention Period 4||3
214591|NCT00723021|514375|P2|COMPLETED|Intervention Period 4||3
214592|NCT00723021|514376|P1|COMPLETED|Intervention Period 4||3
214593|NCT00723021|514372|P5|STARTED|Intervention Period 4||3
214594|NCT00723021|514373|P4|STARTED|Intervention Period 4||3
214595|NCT00723021|514374|P3|STARTED|Intervention Period 4||3
214596|NCT00723021|514375|P2|STARTED|Intervention Period 4||3
214597|NCT00723021|514376|P1|STARTED|Intervention Period 4||3
214598|NCT00723021|514372|P5|NOT COMPLETED|Intervention Period 3||0
214599|NCT00723021|514373|P4|NOT COMPLETED|Intervention Period 3||0
214600|NCT00723021|514374|P3|NOT COMPLETED|Intervention Period 3||0
214601|NCT00723021|514375|P2|NOT COMPLETED|Intervention Period 3||0
214602|NCT00723021|514376|P1|NOT COMPLETED|Intervention Period 3||0
214603|NCT00723021|514372|P5|COMPLETED|Intervention Period 3||3
214604|NCT00723021|514373|P4|COMPLETED|Intervention Period 3||3
214605|NCT00723021|514374|P3|COMPLETED|Intervention Period 3||3
214606|NCT00723021|514375|P2|COMPLETED|Intervention Period 3||3
214607|NCT00723021|514376|P1|COMPLETED|Intervention Period 3||3
214608|NCT00723021|514372|P5|STARTED|Intervention Period 3||3
214609|NCT00723021|514373|P4|STARTED|Intervention Period 3||3
214610|NCT00723021|514374|P3|STARTED|Intervention Period 3||3
214611|NCT00723021|514375|P2|STARTED|Intervention Period 3||3
214612|NCT00723021|514376|P1|STARTED|Intervention Period 3||3
214613|NCT00723021|514372|P5|NOT COMPLETED|Intervention Period 2||0
214614|NCT00723021|514373|P4|NOT COMPLETED|Intervention Period 2||0
214615|NCT00723021|514374|P3|NOT COMPLETED|Intervention Period 2||0
214616|NCT00723021|514375|P2|NOT COMPLETED|Intervention Period 2||0
214617|NCT00723021|514376|P1|NOT COMPLETED|Intervention Period 2||0
214618|NCT00723021|514372|P5|COMPLETED|Intervention Period 2||3
214619|NCT00723021|514373|P4|COMPLETED|Intervention Period 2||3
214620|NCT00723021|514374|P3|COMPLETED|Intervention Period 2||3
214621|NCT00723021|514375|P2|COMPLETED|Intervention Period 2||3
214622|NCT00723021|514376|P1|COMPLETED|Intervention Period 2||3
214623|NCT00723021|514372|P5|STARTED|Intervention Period 2||3
214624|NCT00723021|514373|P4|STARTED|Intervention Period 2||3
214625|NCT00723021|514374|P3|STARTED|Intervention Period 2||3
214626|NCT00723021|514375|P2|STARTED|Intervention Period 2||3
214627|NCT00723021|514376|P1|STARTED|Intervention Period 2||3
214628|NCT00723021|514372|P5|NOT COMPLETED|Intervention Period 1||0
214629|NCT00723021|514373|P4|NOT COMPLETED|Intervention Period 1||0
214630|NCT00723021|514374|P3|NOT COMPLETED|Intervention Period 1||0
214631|NCT00723021|514375|P2|NOT COMPLETED|Intervention Period 1||0
214632|NCT00723021|514376|P1|NOT COMPLETED|Intervention Period 1||0
214633|NCT00723021|514372|P5|COMPLETED|Intervention Period 1||3
214634|NCT00723021|514373|P4|COMPLETED|Intervention Period 1||3
214635|NCT00723021|514374|P3|COMPLETED|Intervention Period 1||3
214636|NCT00723021|514375|P2|COMPLETED|Intervention Period 1||3
214637|NCT00723021|514376|P1|COMPLETED|Intervention Period 1||3
214638|NCT00723021|514372|P5|STARTED|Intervention Period 1||3
214639|NCT00723021|514373|P4|STARTED|Intervention Period 1||3
214640|NCT00723021|514374|P3|STARTED|Intervention Period 1||3
214641|NCT00723021|514375|P2|STARTED|Intervention Period 1||3
214642|NCT00723021|514376|P1|STARTED|Intervention Period 1||3
214643|NCT00723008|514430|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
214644|NCT00723008|514431|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
214645|NCT00723008|514430|P2|COMPLETED|4-Week Unblinded Treatment||3
214646|NCT00723008|514431|P1|COMPLETED|4-Week Unblinded Treatment||4
214647|NCT00723008|514430|P2|STARTED|4-Week Unblinded Treatment||4
214648|NCT00723008|514431|P1|STARTED|4-Week Unblinded Treatment||5
214649|NCT00723008|514430|P2|NOT COMPLETED|4-Week Double Blinded||5
214650|NCT00723008|514431|P1|NOT COMPLETED|4-Week Double Blinded||5
214651|NCT00723008|514430|P2|COMPLETED|4-Week Double Blinded||4
214652|NCT00723008|514431|P1|COMPLETED|4-Week Double Blinded||5
214653|NCT00723008|514430|P2|STARTED|4-Week Double Blinded||9
214654|NCT00723008|514431|P1|STARTED|4-Week Double Blinded||10
214655|NCT00723008|514430|P2|NOT COMPLETED|Enrollment||0
214656|NCT00723008|514431|P1|NOT COMPLETED|Enrollment||1
214657|NCT00723008|514430|P2|COMPLETED|Enrollment||9
214658|NCT00723008|514431|P1|COMPLETED|Enrollment||10
214659|NCT00723008|514430|P2|STARTED|Enrollment||9
214660|NCT00723008|514431|P1|STARTED|Enrollment||11
214661|NCT00722865|514453|P1|NOT COMPLETED|Overall Study||2
214662|NCT00722865|514453|P1|COMPLETED|Overall Study||23
214663|NCT00722865|514453|P1|STARTED|Overall Study||25
214664|NCT00722800|514463|P2|NOT COMPLETED|Overall Study||0
214665|NCT00722800|514464|P1|NOT COMPLETED|Overall Study||2
214666|NCT00722800|514463|P2|COMPLETED|Overall Study||2
214667|NCT00722800|514464|P1|COMPLETED|Overall Study||0
214668|NCT00722800|514463|P2|STARTED|Overall Study||2
214669|NCT00722800|514464|P1|STARTED|Overall Study||2
214670|NCT00722761|514476|P2|NOT COMPLETED|Overall Study||6
214671|NCT00722761|514477|P1|NOT COMPLETED|Overall Study||6
214672|NCT00722761|514476|P2|COMPLETED|Overall Study||8
214673|NCT00722761|514477|P1|COMPLETED|Overall Study||10
214674|NCT00722761|514476|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
214675|NCT00722761|514477|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
214676|NCT00722761|514476|P2|STARTED|Overall Study||14
214677|NCT00722761|514477|P1|STARTED|Overall Study||16
214678|NCT00722722|514488|P3|NOT COMPLETED|Overall Study||0
214679|NCT00722722|514489|P2|NOT COMPLETED|Overall Study||0
214680|NCT00722722|514490|P1|NOT COMPLETED|Overall Study||0
214681|NCT00722722|514488|P3|COMPLETED|Overall Study||10
214682|NCT00722722|514489|P2|COMPLETED|Overall Study||5
214683|NCT00722722|514490|P1|COMPLETED|Overall Study||3
214684|NCT00722722|514488|P3|STARTED|Overall Study||10
214685|NCT00722722|514489|P2|STARTED|Overall Study||5
214686|NCT00722722|514490|P1|STARTED|Overall Study||3
214687|NCT00722566|514500|P2|NOT COMPLETED|Overall Study||35
214688|NCT00722566|514501|P1|NOT COMPLETED|Overall Study||67
214689|NCT00722566|514500|P2|COMPLETED|Overall Study|Completed 8 cycles|39
214690|NCT00722566|514501|P1|COMPLETED|Overall Study|Completed 8 cycles|81
214691|NCT00722566|514500|P2|STARTED|Overall Study||74
214692|NCT00722566|514501|P1|STARTED|Overall Study|One patient randomized and not dosed|148
214693|NCT00722553|514509|P1|NOT COMPLETED|Overall Study||0
214694|NCT00722553|514509|P1|COMPLETED|Overall Study||30
214695|NCT00722553|514509|P1|STARTED|Overall Study||30
214696|NCT00722436|514519|P2|NOT COMPLETED|Overall Study||0
214697|NCT00722436|514520|P1|NOT COMPLETED|Overall Study||0
214698|NCT00722436|514519|P2|COMPLETED|Overall Study||11
214699|NCT00722436|514520|P1|COMPLETED|Overall Study||9
214700|NCT00722436|514519|P2|STARTED|Overall Study||11
214701|NCT00722436|514520|P1|STARTED|Overall Study||9
214702|NCT00722423|514534|P2|NOT COMPLETED|Overall Study||1
214703|NCT00722423|514535|P1|NOT COMPLETED|Overall Study||0
214704|NCT00722423|514534|P2|COMPLETED|Overall Study||181
214705|NCT00722423|514535|P1|COMPLETED|Overall Study||182
214706|NCT00722423|514534|P2|STARTED|Overall Study||182
214707|NCT00722423|514535|P1|STARTED|Overall Study||182
214708|NCT00722371|514550|P7|NOT COMPLETED|Overall Study||51
214709|NCT00722371|514551|P6|NOT COMPLETED|Overall Study||53
214710|NCT00722371|514552|P5|NOT COMPLETED|Overall Study||48
214711|NCT00722371|514553|P4|NOT COMPLETED|Overall Study||63
214712|NCT00722371|514554|P3|NOT COMPLETED|Overall Study||65
214713|NCT00722371|514555|P2|NOT COMPLETED|Overall Study||72
214714|NCT00722371|514556|P1|NOT COMPLETED|Overall Study||56
214715|NCT00722371|514550|P7|COMPLETED|Overall Study||179
214716|NCT00722371|514551|P6|COMPLETED|Overall Study||178
214717|NCT00722371|514552|P5|COMPLETED|Overall Study||182
214718|NCT00722371|514553|P4|COMPLETED|Overall Study||167
214719|NCT00722371|514554|P3|COMPLETED|Overall Study||168
214720|NCT00722371|514555|P2|COMPLETED|Overall Study||158
214721|NCT00722371|514556|P1|COMPLETED|Overall Study||175
214722|NCT00722371|514550|P7|STARTED|Overall Study||230
214723|NCT00722371|514551|P6|STARTED|Overall Study||231
214724|NCT00722371|514552|P5|STARTED|Overall Study||230
214725|NCT00722371|514553|P4|STARTED|Overall Study||230
214726|NCT00722371|514554|P3|STARTED|Overall Study||233
214727|NCT00722371|514555|P2|STARTED|Overall Study||230
214728|NCT00722371|514556|P1|STARTED|Overall Study||231
214729|NCT00722137|514609|P2|NOT COMPLETED|Overall Study||45
214730|NCT00722137|514610|P1|NOT COMPLETED|Overall Study||48
214731|NCT00722137|514609|P2|COMPLETED|Overall Study||199
214732|NCT00722137|514610|P1|COMPLETED|Overall Study||195
214733|NCT00722137|514609|P2|STARTED|Overall Study||244
214734|NCT00722137|514610|P1|STARTED|Overall Study||243
214735|NCT00722124|514637|P3|NOT COMPLETED|Overall Study||20
214736|NCT00722124|514638|P2|NOT COMPLETED|Overall Study||14
214737|NCT00722124|514639|P1|NOT COMPLETED|Overall Study||17
214738|NCT00722124|514637|P3|COMPLETED|Overall Study||20
214739|NCT00722124|514638|P2|COMPLETED|Overall Study||26
214740|NCT00722124|514639|P1|COMPLETED|Overall Study||23
214741|NCT00722124|514637|P3|STARTED|Overall Study||40
214742|NCT00722124|514638|P2|STARTED|Overall Study||40
214743|NCT00722124|514639|P1|STARTED|Overall Study||40
214744|NCT00722111|514649|P2|NOT COMPLETED|Overall Study||0
214745|NCT00722111|514650|P1|NOT COMPLETED|Overall Study||0
214746|NCT00722111|514649|P2|COMPLETED|Overall Study||72
214747|NCT00722111|514650|P1|COMPLETED|Overall Study||11
214748|NCT00722111|514649|P2|STARTED|Overall Study||72
214749|NCT00722111|514650|P1|STARTED|Overall Study||11
214750|NCT00722072|514657|P1|NOT COMPLETED|Overall Study||3
214751|NCT00722072|514657|P1|COMPLETED|Overall Study||9
214752|NCT00722072|514657|P1|STARTED|Overall Study||12
214753|NCT00722020|514667|P2|NOT COMPLETED|Overall Study||0
214754|NCT00722020|514668|P1|NOT COMPLETED|Overall Study||0
214755|NCT00722020|514667|P2|COMPLETED|Overall Study||24
214756|NCT00722020|514668|P1|COMPLETED|Overall Study||19
214757|NCT00722020|514667|P2|STARTED|Overall Study||24
214758|NCT00722020|514668|P1|STARTED|Overall Study||19
214759|NCT00721968|514678|P2|NOT COMPLETED|Overall Study||0
214760|NCT00721968|514679|P1|NOT COMPLETED|Overall Study||2
214761|NCT00721968|514678|P2|COMPLETED|Overall Study||17
214762|NCT00721968|514679|P1|COMPLETED|Overall Study||25
214763|NCT00721968|514678|P2|STARTED|Overall Study||17
214764|NCT00721968|514679|P1|STARTED|Overall Study||27
214765|NCT00721955|514690|P3|NOT COMPLETED|Overall Study||2
214766|NCT00721955|514691|P2|NOT COMPLETED|Overall Study||0
214767|NCT00721955|514692|P1|NOT COMPLETED|Overall Study||0
214768|NCT00721955|514690|P3|COMPLETED|Overall Study||103
214769|NCT00721955|514691|P2|COMPLETED|Overall Study||104
214770|NCT00721955|514692|P1|COMPLETED|Overall Study||105
214771|NCT00721955|514690|P3|STARTED|Overall Study||105
214772|NCT00721955|514691|P2|STARTED|Overall Study||104
214773|NCT00721955|514692|P1|STARTED|Overall Study||105
214774|NCT00721799|514706|P1|NOT COMPLETED|Overall Study||8
214775|NCT00721799|514706|P1|COMPLETED|Overall Study||25
214776|NCT00721799|514706|P1|Received FLT PET Scan #2|Overall Study||25
214777|NCT00721799|514706|P1|Recieved FLT PET Scan 1|Overall Study||26
214778|NCT00721799|514706|P1|STARTED|Overall Study||33
214779|NCT00721734|514746|P5|NOT COMPLETED|Overall Study||6
214780|NCT00721734|514747|P4|NOT COMPLETED|Overall Study||6
214781|NCT00721734|514748|P3|NOT COMPLETED|Overall Study||8
214782|NCT00721734|514749|P2|NOT COMPLETED|Overall Study||12
214783|NCT00721734|514750|P1|NOT COMPLETED|Overall Study||8
214784|NCT00721734|514746|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
214785|NCT00721734|514747|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
214786|NCT00721734|514748|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
214787|NCT00721734|514749|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
214788|NCT00721734|514750|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
214789|NCT00721734|514746|P5|STARTED|Overall Study||8
214790|NCT00721734|514747|P4|STARTED|Overall Study||8
214791|NCT00721734|514748|P3|STARTED|Overall Study||10
214792|NCT00721734|514749|P2|STARTED|Overall Study||12
214793|NCT00721734|514750|P1|STARTED|Overall Study||12
214794|NCT00721630|514862|P1|NOT COMPLETED|Overall Study||1
214795|NCT00721630|514862|P1|COMPLETED|Overall Study||23
214796|NCT00721630|514862|P1|STARTED|Overall Study||24
214797|NCT00721617|514867|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
214798|NCT00721617|514867|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
214799|NCT00721617|514867|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
214800|NCT00721617|514867|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
214801|NCT00721617|514867|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
214802|NCT00721617|514867|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
214803|NCT00721617|514867|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
214804|NCT00721617|514867|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
214805|NCT00721617|514867|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
214806|NCT00721617|514867|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
214807|NCT00721617|514867|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
214808|NCT00721617|514867|P1|STARTED|8 Hours Into Dextrose Infusion||12
214809|NCT00721617|514867|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
214810|NCT00721617|514867|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
214811|NCT00721617|514867|P1|STARTED|4 Hours Into Dextrose Infusion||12
214812|NCT00721617|514867|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
214813|NCT00721617|514867|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
214814|NCT00721617|514867|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
214815|NCT00721617|514867|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
214816|NCT00721617|514867|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
214817|NCT00721617|514867|P1|STARTED|8 Hours Into Intralipid Infusion||12
214818|NCT00721617|514867|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
214819|NCT00721617|514867|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
214820|NCT00721617|514867|P1|STARTED|4 Hours Into Intralipid Infusion||12
214821|NCT00721617|514867|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
214822|NCT00721617|514867|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
214823|NCT00721617|514867|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
214824|NCT00721617|514867|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
214825|NCT00721617|514867|P1|COMPLETED|8 Hours Into Saline Infusion||12
214826|NCT00721617|514867|P1|STARTED|8 Hours Into Saline Infusion||12
214827|NCT00721617|514867|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
214828|NCT00721617|514867|P1|COMPLETED|4 Hours Into Saline Infusion||12
214829|NCT00721617|514867|P1|STARTED|4 Hours Into Saline Infusion||12
214830|NCT00721617|514867|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
214831|NCT00721617|514867|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
214832|NCT00721617|514867|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
214833|NCT00721578|514891|P2|NOT COMPLETED|Overall Study||2
214834|NCT00721578|514892|P1|NOT COMPLETED|Overall Study||2
214835|NCT00721578|514891|P2|COMPLETED|Overall Study||9
214836|NCT00721578|514892|P1|COMPLETED|Overall Study||10
214837|NCT00721578|514891|P2|STARTED|Overall Study||11
214838|NCT00721578|514892|P1|STARTED|Overall Study||12
214839|NCT00721539|514904|P1|NOT COMPLETED|Overall Study||0
214840|NCT00721539|514904|P1|COMPLETED|Overall Study||9
214841|NCT00721539|514904|P1|STARTED|Overall Study||9
214842|NCT00721500|514911|P4|NOT COMPLETED|Period Three||0
214843|NCT00721500|514912|P3|NOT COMPLETED|Period Three||0
214844|NCT00721500|514913|P2|NOT COMPLETED|Period Three||0
214845|NCT00721500|514914|P1|NOT COMPLETED|Period Three||0
214846|NCT00721500|514911|P4|COMPLETED|Period Three||6
214847|NCT00721500|514912|P3|COMPLETED|Period Three||6
214848|NCT00721500|514913|P2|COMPLETED|Period Three||7
214849|NCT00721500|514914|P1|COMPLETED|Period Three||6
214850|NCT00721500|514911|P4|STARTED|Period Three||6
214851|NCT00721500|514912|P3|STARTED|Period Three||6
214852|NCT00721500|514913|P2|STARTED|Period Three||7
214853|NCT00721500|514914|P1|STARTED|Period Three||6
214854|NCT00721500|514911|P4|NOT COMPLETED|Period Two||0
214855|NCT00721500|514912|P3|NOT COMPLETED|Period Two||0
214856|NCT00721500|514913|P2|NOT COMPLETED|Period Two||0
214857|NCT00721500|514914|P1|NOT COMPLETED|Period Two||0
214858|NCT00721500|514911|P4|COMPLETED|Period Two||6
214859|NCT00721500|514912|P3|COMPLETED|Period Two||6
214860|NCT00721500|514913|P2|COMPLETED|Period Two||7
214861|NCT00721500|514914|P1|COMPLETED|Period Two||6
214862|NCT00721500|514911|P4|STARTED|Period Two||6
214863|NCT00721500|514912|P3|STARTED|Period Two||6
214864|NCT00721500|514913|P2|STARTED|Period Two||7
214865|NCT00721500|514914|P1|STARTED|Period Two||6
214866|NCT00721500|514911|P4|NOT COMPLETED|Period One||0
214867|NCT00721500|514912|P3|NOT COMPLETED|Period One||0
214868|NCT00721500|514913|P2|NOT COMPLETED|Period One||0
214869|NCT00721500|514914|P1|NOT COMPLETED|Period One||0
214870|NCT00721500|514911|P4|COMPLETED|Period One||6
214871|NCT00721500|514912|P3|COMPLETED|Period One||6
214872|NCT00721500|514913|P2|COMPLETED|Period One||7
214873|NCT00721500|514914|P1|COMPLETED|Period One||6
214874|NCT00721500|514911|P4|STARTED|Period One||6
214875|NCT00721500|514912|P3|STARTED|Period One||6
214876|NCT00721500|514913|P2|STARTED|Period One||7
214877|NCT00721500|514914|P1|STARTED|Period One||6
214878|NCT00721409|514935|P3|NOT COMPLETED|Overall Study||81
214879|NCT00721409|514936|P2|NOT COMPLETED|Overall Study||84
214880|NCT00721409|514937|P1|NOT COMPLETED|Overall Study||12
214881|NCT00721409|514935|P3|COMPLETED|Overall Study||0
214882|NCT00721409|514936|P2|COMPLETED|Overall Study||0
214883|NCT00721409|514937|P1|COMPLETED|Overall Study||0
214884|NCT00721409|514935|P3|Treated|Overall Study||77
214885|NCT00721409|514936|P2|Treated|Overall Study||83
214886|NCT00721409|514937|P1|Treated|Overall Study||12
214887|NCT00721409|514935|P3|STARTED|Overall Study||81
214888|NCT00721409|514936|P2|STARTED|Overall Study||84
214889|NCT00721409|514937|P1|STARTED|Overall Study||12
214890|NCT00721396|515064|P4|NOT COMPLETED|Overall Study||10
214891|NCT00721396|515065|P3|NOT COMPLETED|Overall Study||10
214892|NCT00721396|515066|P2|NOT COMPLETED|Overall Study||36
214893|NCT00721396|515067|P1|NOT COMPLETED|Overall Study||30
214894|NCT00721396|515064|P4|COMPLETED|Overall Study||302
214895|NCT00721396|515065|P3|COMPLETED|Overall Study||308
214896|NCT00721396|515066|P2|COMPLETED|Overall Study||592
214897|NCT00721396|515067|P1|COMPLETED|Overall Study||597
214898|NCT00721396|515064|P4|STARTED|Overall Study||312
214899|NCT00721396|515065|P3|STARTED|Overall Study||318
214900|NCT00721396|515066|P2|STARTED|Overall Study||628
214901|NCT00721396|515067|P1|STARTED|Overall Study||627
214902|NCT00721357|515105|P2|NOT COMPLETED|Overall Study||0
214903|NCT00721357|515106|P1|NOT COMPLETED|Overall Study||0
214904|NCT00721357|515105|P2|COMPLETED|Overall Study||15
214905|NCT00721357|515106|P1|COMPLETED|Overall Study||15
214906|NCT00721357|515105|P2|STARTED|Overall Study||15
214907|NCT00721357|515106|P1|STARTED|Overall Study||15
214908|NCT00721279|515114|P2|NOT COMPLETED|Overall Study||24
214909|NCT00721279|515115|P1|NOT COMPLETED|Overall Study||36
214910|NCT00721279|515114|P2|COMPLETED|Overall Study||73
214911|NCT00721279|515115|P1|COMPLETED|Overall Study||416
214912|NCT00721279|515114|P2|STARTED|Overall Study||97
214913|NCT00721279|515115|P1|STARTED|Overall Study||452
214914|NCT00721253|515129|P3|NOT COMPLETED|Overall Study||0
214915|NCT00721253|515130|P2|NOT COMPLETED|Overall Study||0
214916|NCT00721253|515131|P1|NOT COMPLETED|Overall Study||0
214917|NCT00721253|515129|P3|COMPLETED|Overall Study||0
214918|NCT00721253|515130|P2|COMPLETED|Overall Study||22
214919|NCT00721253|515131|P1|COMPLETED|Overall Study||20
214920|NCT00721253|515129|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
214921|NCT00721253|515130|P2|STARTED|Overall Study||22
214922|NCT00721253|515131|P1|STARTED|Overall Study||20
214923|NCT00721227|515143|P2|NOT COMPLETED|Overall Study||0
214924|NCT00721227|515144|P1|NOT COMPLETED|Overall Study||4
214925|NCT00721227|515143|P2|COMPLETED|Overall Study||6
214926|NCT00721227|515144|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
214927|NCT00721227|515143|P2|STARTED|Overall Study||6
214928|NCT00721227|515144|P1|STARTED|Overall Study||9
214929|NCT00721214|515154|P1|NOT COMPLETED|Overall Study||4
214930|NCT00721214|515154|P1|COMPLETED|Overall Study||12
214931|NCT00721214|515154|P1|STARTED|Overall Study||16
214932|NCT00721188|515165|P1|NOT COMPLETED|Overall Study||0
214933|NCT00721188|515165|P1|COMPLETED|Overall Study||11
214934|NCT00721188|515165|P1|STARTED|Overall Study||11
214935|NCT00721175|515182|P2|NOT COMPLETED|Overall Study||0
214936|NCT00721175|515183|P1|NOT COMPLETED|Overall Study||0
214937|NCT00721175|515182|P2|COMPLETED|Overall Study||54
214938|NCT00721175|515183|P1|COMPLETED|Overall Study||54
214939|NCT00721175|515182|P2|STARTED|Overall Study||54
214940|NCT00721175|515183|P1|STARTED|Overall Study||54
214941|NCT00721162|515195|P1|NOT COMPLETED|Overall Study||0
214942|NCT00721162|515195|P1|COMPLETED|Overall Study||60
214943|NCT00721162|515195|P1|Received Any Amount of Study Drug|Overall Study||60
214944|NCT00721162|515195|P1|STARTED|Overall Study||60
214945|NCT00721149|515204|P1|NOT COMPLETED|Overall Study||1
214946|NCT00721149|515204|P1|COMPLETED|Overall Study||9
214947|NCT00721149|515204|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
214948|NCT00721136|515217|P4|NOT COMPLETED|Overall Study||0
214949|NCT00721136|515218|P3|NOT COMPLETED|Overall Study||0
214950|NCT00721136|515219|P2|NOT COMPLETED|Overall Study||0
214951|NCT00721136|515220|P1|NOT COMPLETED|Overall Study||0
214952|NCT00721136|515217|P4|COMPLETED|Overall Study||8
214953|NCT00721136|515218|P3|COMPLETED|Overall Study||8
214954|NCT00721136|515219|P2|COMPLETED|Overall Study||42
214955|NCT00721136|515220|P1|COMPLETED|Overall Study||42
214956|NCT00721136|515217|P4|STARTED|Overall Study||8
214957|NCT00721136|515218|P3|STARTED|Overall Study||8
214958|NCT00721136|515219|P2|STARTED|Overall Study||42
214959|NCT00721136|515220|P1|STARTED|Overall Study||42
214960|NCT00721123|515238|P1|NOT COMPLETED|Overall Study||183
214961|NCT00721123|515238|P1|COMPLETED|Overall Study||355
214962|NCT00721123|515238|P1|STARTED|Overall Study||538
214963|NCT00721110|515316|P4|NOT COMPLETED|Overall Study||0
214964|NCT00721110|515317|P3|NOT COMPLETED|Overall Study||1
214965|NCT00721110|515318|P2|NOT COMPLETED|Overall Study||0
214966|NCT00721110|515319|P1|NOT COMPLETED|Overall Study||1
214967|NCT00721110|515316|P4|COMPLETED|Overall Study||16
214968|NCT00721110|515317|P3|COMPLETED|Overall Study||15
214969|NCT00721110|515318|P2|COMPLETED|Overall Study||16
214970|NCT00721110|515319|P1|COMPLETED|Overall Study||15
214971|NCT00721110|515316|P4|STARTED|Overall Study||16
214972|NCT00721110|515317|P3|STARTED|Overall Study||16
214973|NCT00721110|515318|P2|STARTED|Overall Study||16
214974|NCT00721110|515319|P1|STARTED|Overall Study||16
214975|NCT00720941|515347|P2|NOT COMPLETED|Overall Study||415
214976|NCT00720941|515348|P1|NOT COMPLETED|Overall Study||413
214977|NCT00720941|515347|P2|COMPLETED|Overall Study||138
214978|NCT00720941|515348|P1|COMPLETED|Overall Study||144
214979|NCT00720941|515347|P2|Ongoing|Overall Study||23
214980|NCT00720941|515348|P1|Ongoing|Overall Study||34
214981|NCT00720941|515347|P2|STARTED|Overall Study||553
214982|NCT00720941|515348|P1|STARTED|Overall Study||557
214983|NCT00720798|515388|P1|NOT COMPLETED|Overall Study||756
214984|NCT00720798|515388|P1|COMPLETED|Overall Study||1311
214985|NCT00720798|515388|P1|STARTED|Overall Study||2067
214986|NCT00720759|515411|P4|NOT COMPLETED|Overall Study||0
214987|NCT00720759|515412|P3|NOT COMPLETED|Overall Study||1
214988|NCT00720759|515413|P2|NOT COMPLETED|Overall Study||1
214989|NCT00720759|515414|P1|NOT COMPLETED|Overall Study||0
214990|NCT00720759|515411|P4|COMPLETED|Overall Study||6
214991|NCT00720759|515412|P3|COMPLETED|Overall Study||5
214992|NCT00720759|515413|P2|COMPLETED|Overall Study||5
214993|NCT00720759|515414|P1|COMPLETED|Overall Study||6
214994|NCT00720759|515411|P4|STARTED|Overall Study||6
214995|NCT00720759|515412|P3|STARTED|Overall Study||6
214996|NCT00720759|515413|P2|STARTED|Overall Study||6
214997|NCT00720759|515414|P1|STARTED|Overall Study||6
214998|NCT00720629|515424|P1|NOT COMPLETED|Overall Study||0
214999|NCT00720629|515424|P1|COMPLETED|Overall Study||8
215000|NCT00720629|515424|P1|STARTED|Overall Study||8
215001|NCT00720499|515434|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
215002|NCT00720499|515435|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
215003|NCT00720499|515434|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
215004|NCT00720499|515435|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
215005|NCT00720499|515434|P2|STARTED|Treatment Period 2 (4 Weeks)||70
215006|NCT00720499|515435|P1|STARTED|Treatment Period 2 (4 Weeks)||66
215007|NCT00720499|515434|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
215008|NCT00720499|515435|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
215009|NCT00720499|515434|P2|COMPLETED|Washout Period (2 Weeks)||70
215010|NCT00720499|515435|P1|COMPLETED|Washout Period (2 Weeks)||66
215011|NCT00720499|515434|P2|STARTED|Washout Period (2 Weeks)||70
215012|NCT00720499|515435|P1|STARTED|Washout Period (2 Weeks)||66
215013|NCT00720499|515434|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
215014|NCT00720499|515435|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
215015|NCT00720499|515434|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
215016|NCT00720499|515435|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
215017|NCT00720499|515434|P2|STARTED|Treatment Period 1 (4 Weeks)||72
215018|NCT00720499|515435|P1|STARTED|Treatment Period 1 (4 Weeks)||69
215019|NCT00720473|515499|P2|NOT COMPLETED|Overall Study||8
215020|NCT00720473|515500|P1|NOT COMPLETED|Overall Study||30
215021|NCT00720473|515499|P2|COMPLETED|Overall Study||16
215022|NCT00720473|515500|P1|COMPLETED|Overall Study||15
215023|NCT00720473|515499|P2|STARTED|Overall Study||24
215024|NCT00720473|515500|P1|STARTED|Overall Study||45
215025|NCT00720434|515528|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
215026|NCT00720434|515529|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
215027|NCT00720434|515530|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
215028|NCT00720434|515531|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
215029|NCT00720434|515528|P4|COMPLETED|Open-Label Period (Week 5-72)||4
215030|NCT00720434|515529|P3|COMPLETED|Open-Label Period (Week 5-72)||4
215031|NCT00720434|515530|P2|COMPLETED|Open-Label Period (Week 5-72)||5
215032|NCT00720434|515531|P1|COMPLETED|Open-Label Period (Week 5-72)||4
215033|NCT00720434|515528|P4|STARTED|Open-Label Period (Week 5-72)||8
215034|NCT00720434|515529|P3|STARTED|Open-Label Period (Week 5-72)||8
215035|NCT00720434|515530|P2|STARTED|Open-Label Period (Week 5-72)||8
215036|NCT00720434|515531|P1|STARTED|Open-Label Period (Week 5-72)||10
215037|NCT00720434|515528|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
215038|NCT00720434|515529|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
215039|NCT00720434|515530|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
215040|NCT00720434|515531|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
215041|NCT00720434|515528|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
215042|NCT00720434|515529|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
215043|NCT00720434|515530|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
215044|NCT00720434|515531|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
215045|NCT00720434|515528|P4|STARTED|Double-Blind Period (Week 1-4)||8
215046|NCT00720434|515529|P3|STARTED|Double-Blind Period (Week 1-4)||8
215047|NCT00720434|515530|P2|STARTED|Double-Blind Period (Week 1-4)||9
215048|NCT00720434|515531|P1|STARTED|Double-Blind Period (Week 1-4)||10
215049|NCT00720382|515555|P2|NOT COMPLETED|Overall Study||59
215050|NCT00720382|515556|P1|NOT COMPLETED|Overall Study||176
215051|NCT00720382|515555|P2|COMPLETED|Overall Study||178
215052|NCT00720382|515556|P1|COMPLETED|Overall Study||290
215053|NCT00720382|515555|P2|STARTED|Overall Study||237
215054|NCT00720382|515556|P1|STARTED|Overall Study||466
215055|NCT00720369|515566|P2|NOT COMPLETED|Overall Study||0
215056|NCT00720369|515567|P1|NOT COMPLETED|Overall Study||1
215057|NCT00720369|515566|P2|COMPLETED|Overall Study||8
215058|NCT00720369|515567|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
215059|NCT00720369|515566|P2|STARTED|Overall Study||8
215060|NCT00720369|515567|P1|STARTED|Overall Study||11
215061|NCT00720343|515575|P1|NOT COMPLETED|Overall Study||6
215062|NCT00720343|515575|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
215063|NCT00720343|515575|P1|STARTED|Overall Study||54
215064|NCT00720330|515584|P3|NOT COMPLETED|Overall Study||0
215065|NCT00720330|515585|P2|NOT COMPLETED|Overall Study||0
215066|NCT00720330|515586|P1|NOT COMPLETED|Overall Study||0
215067|NCT00720330|515584|P3|COMPLETED|Overall Study||3
215068|NCT00720330|515585|P2|COMPLETED|Overall Study||4
215069|NCT00720330|515586|P1|COMPLETED|Overall Study||5
215070|NCT00720330|515584|P3|STARTED|Overall Study||3
215071|NCT00720330|515585|P2|STARTED|Overall Study||4
215072|NCT00720330|515586|P1|STARTED|Overall Study||5
215073|NCT00720278|515609|P3|NOT COMPLETED|Overall Study||6
215074|NCT00720278|515610|P2|NOT COMPLETED|Overall Study||4
215075|NCT00720278|515611|P1|NOT COMPLETED|Overall Study||7
215076|NCT00720278|515609|P3|COMPLETED|Overall Study||172
215077|NCT00720278|515610|P2|COMPLETED|Overall Study||166
215078|NCT00720278|515611|P1|COMPLETED|Overall Study||171
215079|NCT00720278|515609|P3|STARTED|Overall Study|1 subject was randomized in error|178
215080|NCT00720278|515610|P2|STARTED|Overall Study|1 subject was randomized in error|170
215081|NCT00720278|515611|P1|STARTED|Overall Study|1 subject was randomized in error|178
215082|NCT00720226|515633|P2|NOT COMPLETED|Overall Study||4
215083|NCT00720226|515634|P1|NOT COMPLETED|Overall Study||7
215084|NCT00720226|515633|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
215085|NCT00720226|515634|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
215086|NCT00720226|515633|P2|STARTED|Overall Study||52
215087|NCT00720226|515634|P1|STARTED|Overall Study||54
215088|NCT00720122|515642|P1|NOT COMPLETED|Overall Study||9
215089|NCT00720122|515642|P1|COMPLETED|Overall Study||19
215090|NCT00720122|515642|P1|STARTED|Overall Study||28
215091|NCT00720109|515646|P3|NOT COMPLETED|Risk Stratification Period||8
215092|NCT00720109|515647|P2|NOT COMPLETED|Risk Stratification Period||15
215093|NCT00720109|515648|P1|NOT COMPLETED|Risk Stratification Period||0
215094|NCT00720109|515646|P3|COMPLETED|Risk Stratification Period||1
215095|NCT00720109|515647|P2|COMPLETED|Risk Stratification Period||33
215096|NCT00720109|515648|P1|COMPLETED|Risk Stratification Period||0
215097|NCT00720109|515646|P3|STARTED|Risk Stratification Period||9
215098|NCT00720109|515647|P2|STARTED|Risk Stratification Period||48
215099|NCT00720109|515648|P1|STARTED|Risk Stratification Period||0
215100|NCT00720109|515646|P3|NOT COMPLETED|Induction Period||0
215101|NCT00720109|515647|P2|NOT COMPLETED|Induction Period||0
215102|NCT00720109|515648|P1|NOT COMPLETED|Induction Period||6
215103|NCT00720109|515646|P3|COMPLETED|Induction Period||0
215104|NCT00720109|515647|P2|COMPLETED|Induction Period||0
215105|NCT00720109|515648|P1|COMPLETED|Induction Period||57
215106|NCT00720109|515646|P3|STARTED|Induction Period||0
215107|NCT00720109|515647|P2|STARTED|Induction Period||0
215108|NCT00720109|515648|P1|STARTED|Induction Period||63
215109|NCT00720096|515668|P2|NOT COMPLETED|Overall Study||2
215110|NCT00720096|515669|P1|NOT COMPLETED|Overall Study||0
215111|NCT00720096|515668|P2|COMPLETED|Overall Study||0
215112|NCT00720096|515669|P1|COMPLETED|Overall Study||2
215113|NCT00720096|515668|P2|STARTED|Overall Study||2
215114|NCT00720096|515669|P1|STARTED|Overall Study||2
215115|NCT00720083|515681|P2|NOT COMPLETED|Overall Study||2
215116|NCT00720083|515682|P1|NOT COMPLETED|Overall Study||1
215117|NCT00720083|515681|P2|COMPLETED|Overall Study||13
215118|NCT00720083|515682|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
215119|NCT00720083|515681|P2|STARTED|Overall Study||15
215120|NCT00720083|515682|P1|STARTED|Overall Study||17
215121|NCT00720057|515690|P2|NOT COMPLETED|Overall Study||3
215122|NCT00720057|515691|P1|NOT COMPLETED|Overall Study||1
215123|NCT00720057|515690|P2|COMPLETED|Overall Study||156
215124|NCT00720057|515691|P1|COMPLETED|Overall Study||152
215125|NCT00720057|515690|P2|STARTED|Overall Study||159
215126|NCT00720057|515691|P1|STARTED|Overall Study||153
215127|NCT00719953|515707|P1|NOT COMPLETED|Overall Study||4
215128|NCT00719953|515707|P1|COMPLETED|Overall Study||26
215129|NCT00719953|515707|P1|STARTED|Overall Study||30
215130|NCT00719914|515713|P2|NOT COMPLETED|Overall Study||0
215131|NCT00719914|515714|P1|NOT COMPLETED|Overall Study||0
215132|NCT00719914|515713|P2|COMPLETED|Overall Study||7
215133|NCT00719914|515714|P1|COMPLETED|Overall Study||10
215134|NCT00719914|515713|P2|STARTED|Overall Study||7
215135|NCT00719914|515714|P1|STARTED|Overall Study||10
215136|NCT00719901|515720|P1|NOT COMPLETED|Overall Study||11
215137|NCT00719901|515720|P1|COMPLETED|Overall Study||0
215138|NCT00719901|515720|P1|STARTED|Overall Study||11
215139|NCT00719862|515732|P2|NOT COMPLETED|Overall Study||6
215140|NCT00719862|515733|P1|NOT COMPLETED|Overall Study||8
215141|NCT00719862|515732|P2|COMPLETED|Overall Study||233
215142|NCT00719862|515733|P1|COMPLETED|Overall Study||234
215143|NCT00719862|515732|P2|STARTED|Overall Study|1 subject was randomized in error|239
215144|NCT00719862|515733|P1|STARTED|Overall Study||242
215145|NCT00719849|515751|P2|NOT COMPLETED|Overall Study||1
215146|NCT00719849|515752|P1|NOT COMPLETED|Overall Study||0
215147|NCT00719849|515751|P2|COMPLETED|Overall Study||8
215148|NCT00719849|515752|P1|COMPLETED|Overall Study||4
215149|NCT00719849|515751|P2|STARTED|Overall Study||9
215150|NCT00719849|515752|P1|STARTED|Overall Study||4
215151|NCT00719810|515791|P3|NOT COMPLETED|Overall Study||8
215152|NCT00719810|515792|P2|NOT COMPLETED|Overall Study||4
215153|NCT00719810|515793|P1|NOT COMPLETED|Overall Study||3
215154|NCT00719810|515791|P3|COMPLETED|Overall Study||42
215155|NCT00719810|515792|P2|COMPLETED|Overall Study||47
215156|NCT00719810|515793|P1|COMPLETED|Overall Study||46
215157|NCT00719810|515791|P3|STARTED|Overall Study||50
215158|NCT00719810|515792|P2|STARTED|Overall Study||51
215159|NCT00719810|515793|P1|STARTED|Overall Study||49
215160|NCT00719732|515804|P1|NOT COMPLETED|Overall Study||22
215161|NCT00719732|515804|P1|COMPLETED|Overall Study||196
215162|NCT00719732|515804|P1|STARTED|Overall Study||218
215163|NCT00719706|515810|P2|NOT COMPLETED|Overall Study||6
215164|NCT00719706|515811|P1|NOT COMPLETED|Overall Study||9
215165|NCT00719706|515810|P2|COMPLETED|Overall Study||14
215166|NCT00719706|515811|P1|COMPLETED|Overall Study||11
215167|NCT00719706|515810|P2|STARTED|Overall Study||20
215168|NCT00719706|515811|P1|STARTED|Overall Study||20
215169|NCT00719680|515825|P1|NOT COMPLETED|Overall Study||5
215170|NCT00719680|515825|P1|COMPLETED|Overall Study||16
215171|NCT00719680|515825|P1|STARTED|Overall Study||21
215172|NCT00719615|515848|P3|NOT COMPLETED|Overall Study||0
215173|NCT00719615|515849|P2|NOT COMPLETED|Overall Study||0
215174|NCT00719615|515850|P1|NOT COMPLETED|Overall Study||0
215175|NCT00719615|515848|P3|COMPLETED|Overall Study||24
215176|NCT00719615|515849|P2|COMPLETED|Overall Study||45
215177|NCT00719615|515850|P1|COMPLETED|Overall Study||42
215178|NCT00719615|515848|P3|STARTED|Overall Study||24
215179|NCT00719615|515849|P2|STARTED|Overall Study||45
215180|NCT00719615|515850|P1|STARTED|Overall Study||42
215181|NCT00719576|515860|P2|NOT COMPLETED|Overall Study||5
215182|NCT00719576|515861|P1|NOT COMPLETED|Overall Study||2
215183|NCT00719576|515860|P2|COMPLETED|Overall Study||67
215184|NCT00719576|515861|P1|COMPLETED|Overall Study||70
215185|NCT00719576|515860|P2|STARTED|Overall Study||72
215186|NCT00719576|515861|P1|STARTED|Overall Study||72
215187|NCT00719563|515881|P2|NOT COMPLETED|Overall Study||42
215188|NCT00719563|515882|P1|NOT COMPLETED|Overall Study||38
215189|NCT00719563|515881|P2|COMPLETED|Overall Study||128
215190|NCT00719563|515882|P1|COMPLETED|Overall Study||133
215191|NCT00719563|515881|P2|STARTED|Overall Study||170
215192|NCT00719563|515882|P1|STARTED|Overall Study||171
215193|NCT00719537|515914|P2|NOT COMPLETED|Overall Study||1
215194|NCT00719537|515915|P1|NOT COMPLETED|Overall Study||1
215195|NCT00719537|515914|P2|COMPLETED|Overall Study||0
215196|NCT00719537|515915|P1|COMPLETED|Overall Study||1
215197|NCT00719537|515914|P2|STARTED|Overall Study||1
215198|NCT00719537|515915|P1|STARTED|Overall Study||2
215199|NCT00719472|515921|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
215200|NCT00719472|515921|P1|COMPLETED|Received Cycle 2 Treatment||304
215201|NCT00719472|515921|P1|STARTED|Received Cycle 2 Treatment||372
215202|NCT00719472|515921|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
215203|NCT00719472|515921|P1|COMPLETED|Received Cycle 1 Treatment||372
215204|NCT00719472|515921|P1|STARTED|Received Cycle 1 Treatment||425
215205|NCT00719472|515921|P1|NOT COMPLETED|Enrolled in Study||26
215206|NCT00719472|515921|P1|COMPLETED|Enrolled in Study||425
215207|NCT00719472|515921|P1|STARTED|Enrolled in Study||451
215208|NCT00719355|515932|P2|NOT COMPLETED|Overall Study||13
215209|NCT00719355|515933|P1|NOT COMPLETED|Overall Study||18
215210|NCT00719355|515932|P2|COMPLETED|Overall Study||39
215211|NCT00719355|515933|P1|COMPLETED|Overall Study||33
215212|NCT00719355|515932|P2|Completed 32 Weeks|Overall Study||39
215213|NCT00719355|515933|P1|Completed 32 Weeks|Overall Study||33
215214|NCT00719355|515932|P2|Completed 24 Weeks|Overall Study||43
215215|NCT00719355|515933|P1|Completed 24 Weeks|Overall Study||34
215216|NCT00719355|515932|P2|Completed 12 Weeks|Overall Study||46
215217|NCT00719355|515933|P1|Completed 12 Weeks|Overall Study||43
215218|NCT00719355|515932|P2|Completed 6 Weeks|Overall Study||48
215219|NCT00719355|515933|P1|Completed 6 Weeks|Overall Study||49
215220|NCT00719355|515932|P2|STARTED|Overall Study||52
215221|NCT00719355|515933|P1|STARTED|Overall Study||51
215222|NCT00719329|515944|P3|NOT COMPLETED|Overall Study||1
215223|NCT00719329|515945|P2|NOT COMPLETED|Overall Study||2
215224|NCT00719329|515946|P1|NOT COMPLETED|Overall Study||0
215225|NCT00719329|515944|P3|COMPLETED|Overall Study||646
215226|NCT00719329|515945|P2|COMPLETED|Overall Study||569
215227|NCT00719329|515946|P1|COMPLETED|Overall Study||705
215228|NCT00719329|515944|P3|Day 7 Swab|Overall Study||561
215229|NCT00719329|515945|P2|Day 7 Swab|Overall Study||467
215230|NCT00719329|515946|P1|Day 7 Swab|Overall Study||593
215231|NCT00719329|515944|P3|Day 3 Swab|Overall Study||578
215232|NCT00719329|515945|P2|Day 3 Swab|Overall Study||501
215233|NCT00719329|515946|P1|Day 3 Swab|Overall Study||614
215234|NCT00719329|515944|P3|Day 1 Swab|Overall Study||646
215235|NCT00719329|515945|P2|Day 1 Swab|Overall Study||569
215236|NCT00719329|515946|P1|Day 1 Swab|Overall Study||705
215237|NCT00719329|515944|P3|STARTED|Overall Study||647
215238|NCT00719329|515945|P2|STARTED|Overall Study||571
215239|NCT00719329|515946|P1|STARTED|Overall Study||705
215240|NCT00719264|515962|P2|NOT COMPLETED|Overall Study||183
215241|NCT00719264|515963|P1|NOT COMPLETED|Overall Study||182
215242|NCT00719264|515962|P2|COMPLETED|Overall Study||0
215243|NCT00719264|515963|P1|COMPLETED|Overall Study||0
215244|NCT00719264|515962|P2|Safety Set|Overall Study||181
215245|NCT00719264|515963|P1|Safety Set|Overall Study||180
215246|NCT00719264|515962|P2|Full Analysis Set|Overall Study||183
215247|NCT00719264|515963|P1|Full Analysis Set|Overall Study||182
215248|NCT00719264|515962|P2|STARTED|Overall Study||183
215249|NCT00719264|515963|P1|STARTED|Overall Study||182
215250|NCT00719212|515982|P1|NOT COMPLETED|Overall Study||44
215251|NCT00719212|515982|P1|COMPLETED|Overall Study||17
215252|NCT00719212|515982|P1|STARTED|Overall Study||61
215253|NCT00719186|515994|P2|NOT COMPLETED|Overall Study||0
215254|NCT00719186|515995|P1|NOT COMPLETED|Overall Study||0
215255|NCT00719186|515994|P2|COMPLETED|Overall Study||374
215256|NCT00719186|515995|P1|COMPLETED|Overall Study||376
215257|NCT00719186|515994|P2|STARTED|Overall Study||374
215258|NCT00719186|515995|P1|STARTED|Overall Study||376
215259|NCT00719160|516009|P2|NOT COMPLETED|Overall Study||0
215260|NCT00719160|516010|P1|NOT COMPLETED|Overall Study||0
215261|NCT00719160|516009|P2|COMPLETED|Overall Study||6
215262|NCT00719160|516010|P1|COMPLETED|Overall Study||6
215263|NCT00719160|516009|P2|STARTED|Overall Study||6
215264|NCT00719160|516010|P1|STARTED|Overall Study||6
215265|NCT00719134|516017|P1|NOT COMPLETED|Overall Study||10
215266|NCT00719134|516017|P1|COMPLETED|Overall Study||66
215267|NCT00719134|516017|P1|STARTED|Overall Study||76
215268|NCT00719043|516030|P7|NOT COMPLETED|Overall Study||28
215269|NCT00719043|516031|P6|NOT COMPLETED|Overall Study||34
215270|NCT00719043|516032|P5|NOT COMPLETED|Overall Study||27
215271|NCT00719043|516033|P4|NOT COMPLETED|Overall Study||23
215272|NCT00719043|516034|P3|NOT COMPLETED|Overall Study||20
215273|NCT00719043|516035|P2|NOT COMPLETED|Overall Study||25
215274|NCT00719043|516036|P1|NOT COMPLETED|Overall Study||32
215275|NCT00719043|516030|P7|COMPLETED|Overall Study|Up to Day 909|92
215276|NCT00719043|516031|P6|COMPLETED|Overall Study|Up to Day 909|86
215277|NCT00719043|516032|P5|COMPLETED|Overall Study|Up to Day 909|95
215278|NCT00719043|516033|P4|COMPLETED|Overall Study|Up to Day 909|96
215279|NCT00719043|516034|P3|COMPLETED|Overall Study|Up to Day 909|99
215280|NCT00719043|516035|P2|COMPLETED|Overall Study|Up to Day 909|96
215281|NCT00719043|516036|P1|COMPLETED|Overall Study|Up to Day 909|88
215282|NCT00719043|516030|P7|STARTED|Overall Study||120
215283|NCT00719043|516031|P6|STARTED|Overall Study||120
215284|NCT00719043|516032|P5|STARTED|Overall Study||122
215285|NCT00719043|516033|P4|STARTED|Overall Study||119
215286|NCT00719043|516034|P3|STARTED|Overall Study||119
215287|NCT00719043|516035|P2|STARTED|Overall Study||121
215288|NCT00719043|516036|P1|STARTED|Overall Study||120
215289|NCT00718887|516160|P2|NOT COMPLETED|Overall Study||9
215290|NCT00718887|516161|P1|NOT COMPLETED|Overall Study||5
215291|NCT00718887|516160|P2|COMPLETED|Overall Study||68
215292|NCT00718887|516161|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
215293|NCT00718887|516160|P2|STARTED|Overall Study|Participants who received treatment.|77
215294|NCT00718887|516161|P1|STARTED|Overall Study|Participants who received treatment.|89
215295|NCT00718861|516185|P2|NOT COMPLETED|Overall Study||18
215296|NCT00718861|516186|P1|NOT COMPLETED|Overall Study||21
215297|NCT00718861|516185|P2|COMPLETED|Overall Study||77
215298|NCT00718861|516186|P1|COMPLETED|Overall Study||74
215299|NCT00718861|516185|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
215300|NCT00718861|516186|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
215301|NCT00718861|516185|P2|Safety Set|Overall Study||95
215302|NCT00718861|516186|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
215303|NCT00718861|516185|P2|STARTED|Overall Study||95
215304|NCT00718861|516186|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
215305|NCT00718809|516214|P2|NOT COMPLETED|Overall Study||9
215306|NCT00718809|516215|P1|NOT COMPLETED|Overall Study||12
215307|NCT00718809|516214|P2|COMPLETED|Overall Study||0
215308|NCT00718809|516215|P1|COMPLETED|Overall Study||0
215309|NCT00718809|516214|P2|STARTED|Overall Study||9
215310|NCT00718809|516215|P1|STARTED|Overall Study||12
215311|NCT00718770|516229|P1|NOT COMPLETED|Overall Study||8
215312|NCT00718770|516229|P1|COMPLETED|Overall Study||2
215313|NCT00718770|516229|P1|STARTED|Overall Study||10
215314|NCT00718718|516240|P10|NOT COMPLETED|Week 12 to End of Study||0
215315|NCT00718718|516241|P9|NOT COMPLETED|Week 12 to End of Study||1
215316|NCT00718718|516242|P8|NOT COMPLETED|Week 12 to End of Study||1
215317|NCT00718718|516243|P7|NOT COMPLETED|Week 12 to End of Study||2
215318|NCT00718718|516244|P6|NOT COMPLETED|Week 12 to End of Study||3
215319|NCT00718718|516245|P5|NOT COMPLETED|Week 12 to End of Study||0
215320|NCT00718718|516246|P4|NOT COMPLETED|Week 12 to End of Study||1
215321|NCT00718718|516247|P3|NOT COMPLETED|Week 12 to End of Study||0
215322|NCT00718718|516248|P2|NOT COMPLETED|Week 12 to End of Study||1
215323|NCT00718718|516249|P1|NOT COMPLETED|Week 12 to End of Study||0
215324|NCT00718718|516240|P10|COMPLETED|Week 12 to End of Study||31
215325|NCT00718718|516241|P9|COMPLETED|Week 12 to End of Study||27
215326|NCT00718718|516242|P8|COMPLETED|Week 12 to End of Study||27
215327|NCT00718718|516243|P7|COMPLETED|Week 12 to End of Study||27
215328|NCT00718718|516244|P6|COMPLETED|Week 12 to End of Study||24
215329|NCT00718718|516245|P5|COMPLETED|Week 12 to End of Study||0
215330|NCT00718718|516246|P4|COMPLETED|Week 12 to End of Study||15
215331|NCT00718718|516247|P3|COMPLETED|Week 12 to End of Study||0
215332|NCT00718718|516248|P2|COMPLETED|Week 12 to End of Study||17
215333|NCT00718718|516249|P1|COMPLETED|Week 12 to End of Study||0
215334|NCT00718718|516240|P10|Treated|Week 12 to End of Study||31
215335|NCT00718718|516241|P9|Treated|Week 12 to End of Study||28
215336|NCT00718718|516242|P8|Treated|Week 12 to End of Study||28
215337|NCT00718718|516243|P7|Treated|Week 12 to End of Study||29
215338|NCT00718718|516244|P6|Treated|Week 12 to End of Study||26
215339|NCT00718718|516245|P5|Treated|Week 12 to End of Study||0
215340|NCT00718718|516246|P4|Treated|Week 12 to End of Study||16
215341|NCT00718718|516247|P3|Treated|Week 12 to End of Study||0
215342|NCT00718718|516248|P2|Treated|Week 12 to End of Study||18
215343|NCT00718718|516249|P1|Treated|Week 12 to End of Study||0
215344|NCT00718718|516240|P10|STARTED|Week 12 to End of Study||31
215345|NCT00718718|516241|P9|STARTED|Week 12 to End of Study||28
215346|NCT00718718|516242|P8|STARTED|Week 12 to End of Study||28
215347|NCT00718718|516243|P7|STARTED|Week 12 to End of Study||29
215348|NCT00718718|516244|P6|STARTED|Week 12 to End of Study||27
215349|NCT00718718|516245|P5|STARTED|Week 12 to End of Study||0
215350|NCT00718718|516246|P4|STARTED|Week 12 to End of Study||16
215351|NCT00718718|516247|P3|STARTED|Week 12 to End of Study||0
215352|NCT00718718|516248|P2|STARTED|Week 12 to End of Study||18
215353|NCT00718718|516249|P1|STARTED|Week 12 to End of Study||0
215354|NCT00718718|516240|P10|NOT COMPLETED|Prior to Week 12||0
215355|NCT00718718|516241|P9|NOT COMPLETED|Prior to Week 12||2
215356|NCT00718718|516242|P8|NOT COMPLETED|Prior to Week 12||2
215357|NCT00718718|516243|P7|NOT COMPLETED|Prior to Week 12||1
215358|NCT00718718|516244|P6|NOT COMPLETED|Prior to Week 12||0
215359|NCT00718718|516245|P5|NOT COMPLETED|Prior to Week 12||3
215360|NCT00718718|516246|P4|NOT COMPLETED|Prior to Week 12||0
215361|NCT00718718|516247|P3|NOT COMPLETED|Prior to Week 12||1
215362|NCT00718718|516248|P2|NOT COMPLETED|Prior to Week 12||0
215363|NCT00718718|516249|P1|NOT COMPLETED|Prior to Week 12||1
215364|NCT00718718|516240|P10|COMPLETED|Prior to Week 12||31
215365|NCT00718718|516241|P9|COMPLETED|Prior to Week 12||28
215366|NCT00718718|516242|P8|COMPLETED|Prior to Week 12||28
215367|NCT00718718|516243|P7|COMPLETED|Prior to Week 12||29
215368|NCT00718718|516244|P6|COMPLETED|Prior to Week 12||0
215369|NCT00718718|516245|P5|COMPLETED|Prior to Week 12||27
215370|NCT00718718|516246|P4|COMPLETED|Prior to Week 12||0
215371|NCT00718718|516247|P3|COMPLETED|Prior to Week 12||16
215372|NCT00718718|516248|P2|COMPLETED|Prior to Week 12||0
215373|NCT00718718|516249|P1|COMPLETED|Prior to Week 12||18
215374|NCT00718718|516240|P10|STARTED|Prior to Week 12||31
215375|NCT00718718|516241|P9|STARTED|Prior to Week 12||30
215376|NCT00718718|516242|P8|STARTED|Prior to Week 12||30
215377|NCT00718718|516243|P7|STARTED|Prior to Week 12||30
215378|NCT00718718|516244|P6|STARTED|Prior to Week 12||0
215379|NCT00718718|516245|P5|STARTED|Prior to Week 12||30
215380|NCT00718718|516246|P4|STARTED|Prior to Week 12||0
215381|NCT00718718|516247|P3|STARTED|Prior to Week 12||17
215382|NCT00718718|516248|P2|STARTED|Prior to Week 12||0
215383|NCT00718718|516249|P1|STARTED|Prior to Week 12||19
215384|NCT00718640|516289|P1|NOT COMPLETED|Overall Study||7
215385|NCT00718640|516289|P1|COMPLETED|Overall Study||3
215386|NCT00718640|516289|P1|STARTED|Overall Study||10
215387|NCT00718523|516303|P2|NOT COMPLETED|Overall Study||24
215388|NCT00718523|516304|P1|NOT COMPLETED|Overall Study||18
215389|NCT00718523|516303|P2|COMPLETED|Overall Study||62
215390|NCT00718523|516304|P1|COMPLETED|Overall Study||66
215391|NCT00718523|516303|P2|STARTED|Overall Study||86
215392|NCT00718523|516304|P1|STARTED|Overall Study||84
215393|NCT00718510|516316|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
215394|NCT00718510|516317|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
215395|NCT00718510|516316|P2|COMPLETED|Second Intervention (3 Weeks)||7
215396|NCT00718510|516317|P1|COMPLETED|Second Intervention (3 Weeks)||6
215397|NCT00718510|516316|P2|STARTED|Second Intervention (3 Weeks)||7
215398|NCT00718510|516317|P1|STARTED|Second Intervention (3 Weeks)||7
215399|NCT00718510|516316|P2|NOT COMPLETED|Washout (5 Days)||0
215400|NCT00718510|516317|P1|NOT COMPLETED|Washout (5 Days)||0
215401|NCT00718510|516316|P2|COMPLETED|Washout (5 Days)||7
215402|NCT00718510|516317|P1|COMPLETED|Washout (5 Days)||7
215403|NCT00718510|516316|P2|STARTED|Washout (5 Days)||7
215404|NCT00718510|516317|P1|STARTED|Washout (5 Days)||7
215405|NCT00718510|516316|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
215406|NCT00718510|516317|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
215407|NCT00718510|516316|P2|COMPLETED|First Intervention (3 Weeks)||7
215408|NCT00718510|516317|P1|COMPLETED|First Intervention (3 Weeks)||7
215409|NCT00718510|516316|P2|Received Intervention|First Intervention (3 Weeks)||7
215410|NCT00718510|516317|P1|Received Intervention|First Intervention (3 Weeks)||7
215411|NCT00718510|516316|P2|STARTED|First Intervention (3 Weeks)||8
215412|NCT00718510|516317|P1|STARTED|First Intervention (3 Weeks)||7
215413|NCT00718328|516329|P2|NOT COMPLETED|Overall Study||0
215414|NCT00718328|516330|P1|NOT COMPLETED|Overall Study||1
215415|NCT00718328|516329|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
215416|NCT00718328|516330|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
215417|NCT00718328|516329|P2|STARTED|Overall Study||0
215418|NCT00718328|516330|P1|STARTED|Overall Study||1
215419|NCT00718315|516339|P3|NOT COMPLETED|Overall Study||21
215420|NCT00718315|516340|P2|NOT COMPLETED|Overall Study||22
215421|NCT00718315|516341|P1|NOT COMPLETED|Overall Study||19
215422|NCT00718315|516339|P3|COMPLETED|Overall Study||46
215423|NCT00718315|516340|P2|COMPLETED|Overall Study||45
215424|NCT00718315|516341|P1|COMPLETED|Overall Study||48
215425|NCT00718315|516339|P3|STARTED|Overall Study||67
215426|NCT00718315|516340|P2|STARTED|Overall Study||67
215427|NCT00718315|516341|P1|STARTED|Overall Study||67
215428|NCT00718302|516375|P2|NOT COMPLETED|Overall Study||0
215429|NCT00718302|516376|P1|NOT COMPLETED|Overall Study||0
215430|NCT00718302|516375|P2|COMPLETED|Overall Study||114
215431|NCT00718302|516376|P1|COMPLETED|Overall Study||119
215432|NCT00718302|516375|P2|STARTED|Overall Study||114
215433|NCT00718302|516376|P1|STARTED|Overall Study||119
215434|NCT00718237|516392|P2|NOT COMPLETED|Overall Study||15
215435|NCT00718237|516393|P1|NOT COMPLETED|Overall Study||13
215436|NCT00718237|516392|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
215437|NCT00718237|516393|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
215438|NCT00718237|516392|P2|Vaccinated at Visit 3|Overall Study||369
215439|NCT00718237|516393|P1|Vaccinated at Visit 3|Overall Study||371
215440|NCT00718237|516392|P2|Vaccinated at Visit 2|Overall Study||374
215441|NCT00718237|516393|P1|Vaccinated at Visit 2|Overall Study||373
215442|NCT00718237|516392|P2|Vaccinated at Visit 1|Overall Study||381
215443|NCT00718237|516393|P1|Vaccinated at Visit 1|Overall Study||380
215444|NCT00718237|516392|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
215445|NCT00718237|516393|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
215446|NCT00718120|516405|P2|NOT COMPLETED|Overall Study||0
215447|NCT00718120|516406|P1|NOT COMPLETED|Overall Study||0
215448|NCT00718120|516405|P2|COMPLETED|Overall Study||55
215449|NCT00718120|516406|P1|COMPLETED|Overall Study||55
215450|NCT00718120|516405|P2|STARTED|Overall Study||55
215451|NCT00718120|516406|P1|STARTED|Overall Study||55
215452|NCT00718094|516426|P2|NOT COMPLETED|Overall Study||0
215453|NCT00718094|516427|P1|NOT COMPLETED|Overall Study||0
215454|NCT00718094|516426|P2|COMPLETED|Overall Study||5
215455|NCT00718094|516427|P1|COMPLETED|Overall Study||15
215456|NCT00718094|516426|P2|STARTED|Overall Study||5
215457|NCT00718094|516427|P1|STARTED|Overall Study||15
215458|NCT00718081|516436|P3|NOT COMPLETED|Overall Study||21
215459|NCT00718081|516437|P2|NOT COMPLETED|Overall Study||4
215460|NCT00718081|516438|P1|NOT COMPLETED|Overall Study||7
215461|NCT00718081|516436|P3|COMPLETED|Overall Study||9
215462|NCT00718081|516437|P2|COMPLETED|Overall Study||25
215463|NCT00718081|516438|P1|COMPLETED|Overall Study||22
215464|NCT00718081|516436|P3|STARTED|Overall Study||30
215465|NCT00718081|516437|P2|STARTED|Overall Study||29
215466|NCT00718081|516438|P1|STARTED|Overall Study||29
215467|NCT00718042|516455|P6|NOT COMPLETED|Donor Follow-up||0
215468|NCT00718042|516456|P5|NOT COMPLETED|Donor Follow-up||19
215469|NCT00718042|516457|P4|NOT COMPLETED|Donor Follow-up||0
215470|NCT00718042|516458|P3|NOT COMPLETED|Donor Follow-up||0
215471|NCT00718042|516459|P2|NOT COMPLETED|Donor Follow-up||0
215472|NCT00718042|516460|P1|NOT COMPLETED|Donor Follow-up||13
215473|NCT00718042|516455|P6|COMPLETED|Donor Follow-up||0
215474|NCT00718042|516456|P5|COMPLETED|Donor Follow-up||24
215475|NCT00718042|516457|P4|COMPLETED|Donor Follow-up||0
215476|NCT00718042|516458|P3|COMPLETED|Donor Follow-up||0
215477|NCT00718042|516459|P2|COMPLETED|Donor Follow-up||0
215478|NCT00718042|516460|P1|COMPLETED|Donor Follow-up||23
215479|NCT00718042|516455|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
215480|NCT00718042|516456|P5|STARTED|Donor Follow-up||43
215481|NCT00718042|516457|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
215482|NCT00718042|516458|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
215483|NCT00718042|516459|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
215484|NCT00718042|516460|P1|STARTED|Donor Follow-up||36
215485|NCT00718042|516455|P6|NOT COMPLETED|ESA Chagas Testing||0
215486|NCT00718042|516456|P5|NOT COMPLETED|ESA Chagas Testing||0
215487|NCT00718042|516457|P4|NOT COMPLETED|ESA Chagas Testing||0
215488|NCT00718042|516458|P3|NOT COMPLETED|ESA Chagas Testing||0
215489|NCT00718042|516459|P2|NOT COMPLETED|ESA Chagas Testing||0
215490|NCT00718042|516460|P1|NOT COMPLETED|ESA Chagas Testing||0
215491|NCT00718042|516455|P6|COMPLETED|ESA Chagas Testing||330
215492|NCT00718042|516456|P5|COMPLETED|ESA Chagas Testing||43
215493|NCT00718042|516457|P4|COMPLETED|ESA Chagas Testing||110
215494|NCT00718042|516458|P3|COMPLETED|ESA Chagas Testing||524
215495|NCT00718042|516459|P2|COMPLETED|ESA Chagas Testing||287
215496|NCT00718042|516460|P1|COMPLETED|ESA Chagas Testing||36
215497|NCT00718042|516455|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
215498|NCT00718042|516456|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
215499|NCT00718042|516457|P4|STARTED|ESA Chagas Testing||110
215500|NCT00718042|516458|P3|STARTED|ESA Chagas Testing||524
215501|NCT00718042|516459|P2|STARTED|ESA Chagas Testing||287
215502|NCT00718042|516460|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
215503|NCT00718042|516455|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
215504|NCT00718042|516456|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
215505|NCT00718042|516457|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
215506|NCT00718042|516458|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
215507|NCT00718042|516459|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
215508|NCT00718042|516460|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
215509|NCT00718042|516455|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
215510|NCT00718042|516456|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
215511|NCT00718042|516457|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
215512|NCT00718042|516458|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
215513|NCT00718042|516459|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
215514|NCT00718042|516460|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
215515|NCT00718042|516455|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
215516|NCT00718042|516456|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
215517|NCT00718042|516457|P4|STARTED|ABBOTT PRISM Chagas Testing||110
215518|NCT00718042|516458|P3|STARTED|ABBOTT PRISM Chagas Testing||525
215519|NCT00718042|516459|P2|STARTED|ABBOTT PRISM Chagas Testing||289
215520|NCT00718042|516460|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
215521|NCT00717977|516472|P1|NOT COMPLETED|Overall Study||0
215522|NCT00717977|516472|P1|COMPLETED|Overall Study||74
215523|NCT00717977|516472|P1|STARTED|Overall Study||74
215524|NCT00717912|516500|P6|NOT COMPLETED|Overall Study||0
215525|NCT00717912|516501|P5|NOT COMPLETED|Overall Study||0
215526|NCT00717912|516502|P4|NOT COMPLETED|Overall Study||0
215527|NCT00717912|516503|P3|NOT COMPLETED|Overall Study||0
215528|NCT00717912|516504|P2|NOT COMPLETED|Overall Study||0
215529|NCT00717912|516505|P1|NOT COMPLETED|Overall Study||0
215530|NCT00717912|516500|P6|COMPLETED|Overall Study||1
215531|NCT00717912|516501|P5|COMPLETED|Overall Study||1
215532|NCT00717912|516502|P4|COMPLETED|Overall Study||1
215533|NCT00717912|516503|P3|COMPLETED|Overall Study||1
215534|NCT00717912|516504|P2|COMPLETED|Overall Study||1
215535|NCT00717912|516505|P1|COMPLETED|Overall Study||1
215536|NCT00717912|516500|P6|STARTED|Overall Study||1
215537|NCT00717912|516501|P5|STARTED|Overall Study||1
215538|NCT00717912|516502|P4|STARTED|Overall Study||1
215539|NCT00717912|516503|P3|STARTED|Overall Study||1
215540|NCT00717912|516504|P2|STARTED|Overall Study||1
215541|NCT00717912|516505|P1|STARTED|Overall Study||1
215542|NCT00717886|516516|P1|NOT COMPLETED|Overall Study||4
215543|NCT00717886|516516|P1|COMPLETED|Overall Study||9
215544|NCT00717886|516516|P1|STARTED|Overall Study||13
215545|NCT00717873|516522|P2|NOT COMPLETED|Overall Study||0
215546|NCT00717873|516523|P1|NOT COMPLETED|Overall Study||0
215547|NCT00717873|516522|P2|COMPLETED|Overall Study||59
215548|NCT00717873|516523|P1|COMPLETED|Overall Study||46
215549|NCT00717873|516522|P2|STARTED|Overall Study||59
215550|NCT00717873|516523|P1|STARTED|Overall Study||46
215551|NCT00717860|516531|P2|NOT COMPLETED|Overall Study||28
215552|NCT00717860|516532|P1|NOT COMPLETED|Overall Study||27
215553|NCT00717860|516531|P2|COMPLETED|Overall Study||32
215554|NCT00717860|516532|P1|COMPLETED|Overall Study||34
215555|NCT00717860|516531|P2|STARTED|Overall Study||60
215556|NCT00717860|516532|P1|STARTED|Overall Study||61
215557|NCT00717756|516542|P1|NOT COMPLETED|Overall Study||1
215558|NCT00717756|516542|P1|COMPLETED|Overall Study||40
215559|NCT00717756|516542|P1|STARTED|Overall Study||41
215560|NCT00717574|516548|P2|NOT COMPLETED|Overall Study||2
215561|NCT00717574|516549|P1|NOT COMPLETED|Overall Study||2
215562|NCT00717574|516548|P2|COMPLETED|Overall Study||14
215563|NCT00717574|516549|P1|COMPLETED|Overall Study||14
215564|NCT00717574|516548|P2|STARTED|Overall Study||16
215565|NCT00717574|516549|P1|STARTED|Overall Study||16
215566|NCT00717522|516555|P1|NOT COMPLETED|Overall Study||7
215567|NCT00717522|516555|P1|COMPLETED|Overall Study||0
215568|NCT00717522|516555|P1|STARTED|Overall Study||7
215569|NCT00717418|516564|P4|NOT COMPLETED|1-Year Follow-Up||4
215570|NCT00717418|516565|P3|NOT COMPLETED|1-Year Follow-Up||434
215571|NCT00717418|516566|P2|NOT COMPLETED|1-Year Follow-Up||51
215572|NCT00717418|516567|P1|NOT COMPLETED|1-Year Follow-Up||147
215573|NCT00717418|516564|P4|COMPLETED|1-Year Follow-Up||0
215574|NCT00717418|516565|P3|COMPLETED|1-Year Follow-Up||74
215575|NCT00717418|516566|P2|COMPLETED|1-Year Follow-Up||23
215576|NCT00717418|516567|P1|COMPLETED|1-Year Follow-Up||33
215577|NCT00717418|516564|P4|STARTED|1-Year Follow-Up||4
215578|NCT00717418|516565|P3|STARTED|1-Year Follow-Up||508
215579|NCT00717418|516566|P2|STARTED|1-Year Follow-Up||74
215580|NCT00717418|516567|P1|STARTED|1-Year Follow-Up||180
215581|NCT00717418|516564|P4|NOT COMPLETED|Baseline||15
215582|NCT00717418|516565|P3|NOT COMPLETED|Baseline||0
215583|NCT00717418|516566|P2|NOT COMPLETED|Baseline||0
215584|NCT00717418|516567|P1|NOT COMPLETED|Baseline||0
215585|NCT00717418|516564|P4|COMPLETED|Baseline||4
215586|NCT00717418|516565|P3|COMPLETED|Baseline||508
215587|NCT00717418|516566|P2|COMPLETED|Baseline||74
215588|NCT00717418|516567|P1|COMPLETED|Baseline||180
215589|NCT00717418|516564|P4|STARTED|Baseline||19
215590|NCT00717418|516565|P3|STARTED|Baseline||508
215591|NCT00717418|516566|P2|STARTED|Baseline||74
215592|NCT00717418|516567|P1|STARTED|Baseline||180
215593|NCT00717405|516572|P1|NOT COMPLETED|Overall Study||0
215594|NCT00717405|516572|P1|COMPLETED|Overall Study||52
215595|NCT00717405|516572|P1|STARTED|Overall Study||52
215596|NCT00717366|516591|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
215597|NCT00717366|516592|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
215598|NCT00717366|516591|P2|COMPLETED|Extension Period (52 Weeks)||12
215599|NCT00717366|516592|P1|COMPLETED|Extension Period (52 Weeks)||5
215600|NCT00717366|516591|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
215601|NCT00717366|516592|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
215602|NCT00717366|516591|P2|STARTED|Extension Period (52 Weeks)||28
215603|NCT00717366|516592|P1|STARTED|Extension Period (52 Weeks)||9
215604|NCT00717366|516591|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
215605|NCT00717366|516592|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
215606|NCT00717366|516591|P2|COMPLETED|Core Study Period (20 Weeks)||35
215607|NCT00717366|516592|P1|COMPLETED|Core Study Period (20 Weeks)||12
215608|NCT00717366|516591|P2|STARTED|Core Study Period (20 Weeks)||48
215609|NCT00717366|516592|P1|STARTED|Core Study Period (20 Weeks)||16
215610|NCT00717314|516616|P2|NOT COMPLETED|Overall Study||10
215611|NCT00717314|516617|P1|NOT COMPLETED|Overall Study||6
215612|NCT00717314|516616|P2|COMPLETED|Overall Study||34
215613|NCT00717314|516617|P1|COMPLETED|Overall Study||37
215614|NCT00717314|516616|P2|STARTED|Overall Study||44
215615|NCT00717314|516617|P1|STARTED|Overall Study||43
215616|NCT00717288|516638|P3|NOT COMPLETED|Overall Study||0
215617|NCT00717288|516639|P2|NOT COMPLETED|Overall Study||0
215618|NCT00717288|516640|P1|NOT COMPLETED|Overall Study||0
215619|NCT00717288|516638|P3|COMPLETED|Overall Study||25
215620|NCT00717288|516639|P2|COMPLETED|Overall Study||29
215621|NCT00717288|516640|P1|COMPLETED|Overall Study||28
215622|NCT00717288|516638|P3|STARTED|Overall Study||25
215623|NCT00717288|516639|P2|STARTED|Overall Study||29
215624|NCT00717288|516640|P1|STARTED|Overall Study||28
215625|NCT00717275|516654|P1|NOT COMPLETED|Overall Study||3
215626|NCT00717275|516654|P1|COMPLETED|Overall Study||0
215627|NCT00717275|516654|P1|STARTED|Overall Study||3
215628|NCT00717249|516660|P2|NOT COMPLETED|Overall Study||15
215629|NCT00717249|516661|P1|NOT COMPLETED|Overall Study||22
215630|NCT00717249|516660|P2|COMPLETED|Overall Study||150
215631|NCT00717249|516661|P1|COMPLETED|Overall Study||304
215632|NCT00717249|516660|P2|STARTED|Overall Study||165
215633|NCT00717249|516661|P1|STARTED|Overall Study||326
215634|NCT00717236|516675|P2|NOT COMPLETED|Open-Label Period||21
215635|NCT00717236|516676|P1|NOT COMPLETED|Open-Label Period||125
215636|NCT00717236|516675|P2|COMPLETED|Open-Label Period||163
215637|NCT00717236|516676|P1|COMPLETED|Open-Label Period||646
215638|NCT00717236|516675|P2|STARTED|Open-Label Period||184
215639|NCT00717236|516676|P1|STARTED|Open-Label Period||771
215640|NCT00717236|516675|P2|NOT COMPLETED|Double-Blind Period||28
215641|NCT00717236|516676|P1|NOT COMPLETED|Double-Blind Period||80
215642|NCT00717236|516675|P2|COMPLETED|Double-Blind Period||184
215643|NCT00717236|516676|P1|COMPLETED|Double-Blind Period||771
215644|NCT00717236|516675|P2|STARTED|Double-Blind Period||212
215645|NCT00717236|516676|P1|STARTED|Double-Blind Period||851
215646|NCT00717197|516745|P1|NOT COMPLETED|Overall Study||7
215647|NCT00717197|516745|P1|COMPLETED|Overall Study||23
215648|NCT00717197|516745|P1|STARTED|Overall Study||30
215649|NCT00717093|516751|P2|NOT COMPLETED|Overall Study||48
215650|NCT00717093|516752|P1|NOT COMPLETED|Overall Study||44
215651|NCT00717093|516751|P2|COMPLETED|Overall Study||170
215652|NCT00717093|516752|P1|COMPLETED|Overall Study||170
215653|NCT00717093|516751|P2|Received Treatment|Overall Study||218
215654|NCT00717093|516752|P1|Received Treatment|Overall Study||213
215655|NCT00717093|516751|P2|STARTED|Overall Study||218
215656|NCT00717093|516752|P1|STARTED|Overall Study||214
215657|NCT00717067|516769|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
215658|NCT00717067|516770|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
215659|NCT00717067|516771|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
215660|NCT00717067|516772|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
215661|NCT00717067|516773|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
215662|NCT00717067|516769|P5|COMPLETED|Part 2: End Stage Renal Disease||6
215663|NCT00717067|516770|P4|COMPLETED|Part 2: End Stage Renal Disease||0
215664|NCT00717067|516771|P3|COMPLETED|Part 2: End Stage Renal Disease||0
215665|NCT00717067|516772|P2|COMPLETED|Part 2: End Stage Renal Disease||0
215666|NCT00717067|516773|P1|COMPLETED|Part 2: End Stage Renal Disease||0
215667|NCT00717067|516769|P5|STARTED|Part 2: End Stage Renal Disease||6
215668|NCT00717067|516770|P4|STARTED|Part 2: End Stage Renal Disease||0
215669|NCT00717067|516771|P3|STARTED|Part 2: End Stage Renal Disease||0
215670|NCT00717067|516772|P2|STARTED|Part 2: End Stage Renal Disease||0
215671|NCT00717067|516773|P1|STARTED|Part 2: End Stage Renal Disease||0
215672|NCT00717067|516769|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
215673|NCT00717067|516770|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
215674|NCT00717067|516771|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
215675|NCT00717067|516772|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
215676|NCT00717067|516773|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
215677|NCT00717067|516769|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
215678|NCT00717067|516770|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
215679|NCT00717067|516771|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
215680|NCT00717067|516772|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
215681|NCT00717067|516773|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
215682|NCT00717067|516769|P5|STARTED|Part 1b: Severe Renal Impairment||0
215683|NCT00717067|516770|P4|STARTED|Part 1b: Severe Renal Impairment||6
215684|NCT00717067|516771|P3|STARTED|Part 1b: Severe Renal Impairment||0
215685|NCT00717067|516772|P2|STARTED|Part 1b: Severe Renal Impairment||0
215686|NCT00717067|516773|P1|STARTED|Part 1b: Severe Renal Impairment||0
215687|NCT00717067|516769|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
215688|NCT00717067|516770|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
215689|NCT00717067|516771|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
215690|NCT00717067|516772|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
215691|NCT00717067|516773|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
215692|NCT00717067|516769|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
215693|NCT00717067|516770|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
215694|NCT00717067|516771|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
215695|NCT00717067|516772|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
215696|NCT00717067|516773|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
215697|NCT00717067|516769|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
215698|NCT00717067|516770|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
215699|NCT00717067|516771|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
215700|NCT00717067|516772|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
215701|NCT00717067|516773|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
215702|NCT00717054|516857|P2|NOT COMPLETED|Overall Study||0
215703|NCT00717054|516858|P1|NOT COMPLETED|Overall Study||0
215704|NCT00717054|516857|P2|COMPLETED|Overall Study||57
215705|NCT00717054|516858|P1|COMPLETED|Overall Study||58
215706|NCT00717054|516857|P2|STARTED|Overall Study||57
215707|NCT00717054|516858|P1|STARTED|Overall Study||58
215708|NCT00717041|516870|P1|NOT COMPLETED|Overall Study||0
215709|NCT00717041|516870|P1|COMPLETED|Overall Study||1206
215710|NCT00717041|516870|P1|STARTED|Overall Study||1206
215711|NCT00716976|516880|P2|NOT COMPLETED|Overall Study||9
215712|NCT00716976|516881|P1|NOT COMPLETED|Overall Study||20
215713|NCT00716976|516880|P2|COMPLETED|Overall Study||57
215714|NCT00716976|516881|P1|COMPLETED|Overall Study||45
215715|NCT00716976|516880|P2|STARTED|Overall Study||66
215716|NCT00716976|516881|P1|STARTED|Overall Study||65
215717|NCT00716963|516901|P6|NOT COMPLETED|Overall Study||0
215718|NCT00716963|516902|P5|NOT COMPLETED|Overall Study||0
215719|NCT00716963|516903|P4|NOT COMPLETED|Overall Study||0
215720|NCT00716963|516904|P3|NOT COMPLETED|Overall Study||0
215721|NCT00716963|516905|P2|NOT COMPLETED|Overall Study||0
215722|NCT00716963|516906|P1|NOT COMPLETED|Overall Study||1
215723|NCT00716963|516901|P6|COMPLETED|Overall Study||1
215724|NCT00716963|516902|P5|COMPLETED|Overall Study||1
215725|NCT00716963|516903|P4|COMPLETED|Overall Study||1
215726|NCT00716963|516904|P3|COMPLETED|Overall Study||1
215727|NCT00716963|516905|P2|COMPLETED|Overall Study||1
215728|NCT00716963|516906|P1|COMPLETED|Overall Study||1
215729|NCT00716963|516901|P6|STARTED|Overall Study||1
215730|NCT00716963|516902|P5|STARTED|Overall Study||1
215731|NCT00716963|516903|P4|STARTED|Overall Study||1
215732|NCT00716963|516904|P3|STARTED|Overall Study||1
215733|NCT00716963|516905|P2|STARTED|Overall Study||1
215734|NCT00716963|516906|P1|STARTED|Overall Study||2
215735|NCT00716859|516919|P2|NOT COMPLETED|Overall Study||5
215736|NCT00716859|516920|P1|NOT COMPLETED|Overall Study||9
215737|NCT00716859|516919|P2|COMPLETED|Overall Study||64
215738|NCT00716859|516920|P1|COMPLETED|Overall Study||61
215739|NCT00716859|516919|P2|Received Treatment|Overall Study||68
215740|NCT00716859|516920|P1|Received Treatment|Overall Study||69
215741|NCT00716859|516919|P2|STARTED|Overall Study||69
215742|NCT00716859|516920|P1|STARTED|Overall Study||70
215743|NCT00716820|516944|P1|NOT COMPLETED|Overall Study||0
215744|NCT00716820|516944|P1|COMPLETED|Overall Study||472
215745|NCT00716820|516944|P1|STARTED|Overall Study||472
215746|NCT00716807|516979|P4|NOT COMPLETED|Overall Study||0
215747|NCT00716807|516980|P3|NOT COMPLETED|Overall Study||0
215748|NCT00716807|516981|P2|NOT COMPLETED|Overall Study||0
215749|NCT00716807|516982|P1|NOT COMPLETED|Overall Study||0
215750|NCT00716807|516979|P4|COMPLETED|Overall Study||15
215751|NCT00716807|516980|P3|COMPLETED|Overall Study||18
215752|NCT00716807|516981|P2|COMPLETED|Overall Study||5
215753|NCT00716807|516982|P1|COMPLETED|Overall Study||8
215754|NCT00716807|516979|P4|STARTED|Overall Study||15
215755|NCT00716807|516980|P3|STARTED|Overall Study||18
215756|NCT00716807|516981|P2|STARTED|Overall Study||5
215757|NCT00716807|516982|P1|STARTED|Overall Study||8
215758|NCT00716742|516995|P3|NOT COMPLETED|3 Year Follow-up||21
215759|NCT00716742|516996|P2|NOT COMPLETED|3 Year Follow-up||32
215760|NCT00716742|516997|P1|NOT COMPLETED|3 Year Follow-up||30
215761|NCT00716742|516995|P3|COMPLETED|3 Year Follow-up||29
215762|NCT00716742|516996|P2|COMPLETED|3 Year Follow-up||35
215763|NCT00716742|516997|P1|COMPLETED|3 Year Follow-up||26
215764|NCT00716742|516995|P3|STARTED|3 Year Follow-up||50
215765|NCT00716742|516996|P2|STARTED|3 Year Follow-up||67
215766|NCT00716742|516997|P1|STARTED|3 Year Follow-up||56
215767|NCT00716742|516995|P3|NOT COMPLETED|2 Year Follow-up||102
215768|NCT00716742|516996|P2|NOT COMPLETED|2 Year Follow-up||96
215769|NCT00716742|516997|P1|NOT COMPLETED|2 Year Follow-up||104
215770|NCT00716742|516995|P3|COMPLETED|2 Year Follow-up||50
215771|NCT00716742|516996|P2|COMPLETED|2 Year Follow-up||67
215772|NCT00716742|516997|P1|COMPLETED|2 Year Follow-up||56
215773|NCT00716742|516995|P3|STARTED|2 Year Follow-up||152
215774|NCT00716742|516996|P2|STARTED|2 Year Follow-up||163
215775|NCT00716742|516997|P1|STARTED|2 Year Follow-up||160
215776|NCT00716742|516995|P3|NOT COMPLETED|1 Year Follow-up||200
215777|NCT00716742|516996|P2|NOT COMPLETED|1 Year Follow-up||193
215778|NCT00716742|516997|P1|NOT COMPLETED|1 Year Follow-up||187
215779|NCT00716742|516995|P3|COMPLETED|1 Year Follow-up||152
215780|NCT00716742|516996|P2|COMPLETED|1 Year Follow-up||163
215781|NCT00716742|516997|P1|COMPLETED|1 Year Follow-up||160
215782|NCT00716742|516995|P3|STARTED|1 Year Follow-up||352
215783|NCT00716742|516996|P2|STARTED|1 Year Follow-up||356
215784|NCT00716742|516997|P1|STARTED|1 Year Follow-up||347
215785|NCT00716742|516995|P3|NOT COMPLETED|Baseline||13
215786|NCT00716742|516996|P2|NOT COMPLETED|Baseline||14
215787|NCT00716742|516997|P1|NOT COMPLETED|Baseline||17
215788|NCT00716742|516995|P3|COMPLETED|Baseline||352
215789|NCT00716742|516996|P2|COMPLETED|Baseline||356
215790|NCT00716742|516997|P1|COMPLETED|Baseline||347
215791|NCT00716742|516995|P3|STARTED|Baseline||365
215792|NCT00716742|516996|P2|STARTED|Baseline||370
215793|NCT00716742|516997|P1|STARTED|Baseline||364
215794|NCT00716625|517005|P1|NOT COMPLETED|Overall Study||1
215795|NCT00716625|517005|P1|COMPLETED|Overall Study||1673
215796|NCT00716625|517005|P1|STARTED|Overall Study||1674
215797|NCT00716482|517030|P1|NOT COMPLETED|Overall Study||119
215798|NCT00716482|517030|P1|COMPLETED|Overall Study||1562
215799|NCT00716482|517030|P1|STARTED|Overall Study||1681
215800|NCT00716456|517043|P3|NOT COMPLETED|Overall Study||0
215801|NCT00716456|517044|P2|NOT COMPLETED|Overall Study||2
215802|NCT00716456|517045|P1|NOT COMPLETED|Overall Study||0
215803|NCT00716456|517043|P3|COMPLETED|Overall Study||13
215804|NCT00716456|517044|P2|COMPLETED|Overall Study||3
215805|NCT00716456|517045|P1|COMPLETED|Overall Study||3
215806|NCT00716456|517043|P3|STARTED|Overall Study||13
215807|NCT00716456|517044|P2|STARTED|Overall Study||5
215808|NCT00716456|517045|P1|STARTED|Overall Study||3
215809|NCT00716443|517053|P1|NOT COMPLETED|Overall Study||0
215810|NCT00716443|517053|P1|COMPLETED|Overall Study||51
215811|NCT00716443|517053|P1|STARTED|Overall Study||51
215812|NCT00716417|517096|P10|NOT COMPLETED|Overall Study||3
215813|NCT00716417|517097|P9|NOT COMPLETED|Overall Study||5
215814|NCT00716417|517098|P8|NOT COMPLETED|Overall Study||3
215815|NCT00716417|517099|P7|NOT COMPLETED|Overall Study||7
215816|NCT00716417|517100|P6|NOT COMPLETED|Overall Study||3
215817|NCT00716417|517101|P5|NOT COMPLETED|Overall Study||1
215818|NCT00716417|517102|P4|NOT COMPLETED|Overall Study||11
215819|NCT00716417|517103|P3|NOT COMPLETED|Overall Study||5
215820|NCT00716417|517104|P2|NOT COMPLETED|Overall Study||6
215821|NCT00716417|517105|P1|NOT COMPLETED|Overall Study||3
215822|NCT00716417|517096|P10|COMPLETED|Overall Study||0
215823|NCT00716417|517097|P9|COMPLETED|Overall Study||0
215824|NCT00716417|517098|P8|COMPLETED|Overall Study||0
215825|NCT00716417|517099|P7|COMPLETED|Overall Study||0
215826|NCT00716417|517100|P6|COMPLETED|Overall Study||0
215827|NCT00716417|517101|P5|COMPLETED|Overall Study||0
215828|NCT00716417|517102|P4|COMPLETED|Overall Study||0
215829|NCT00716417|517103|P3|COMPLETED|Overall Study||0
215830|NCT00716417|517104|P2|COMPLETED|Overall Study||0
215831|NCT00716417|517105|P1|COMPLETED|Overall Study||0
215832|NCT00716417|517096|P10|STARTED|Overall Study||3
215833|NCT00716417|517097|P9|STARTED|Overall Study||5
215834|NCT00716417|517098|P8|STARTED|Overall Study||3
215835|NCT00716417|517099|P7|STARTED|Overall Study||7
215836|NCT00716417|517100|P6|STARTED|Overall Study||3
215837|NCT00716417|517101|P5|STARTED|Overall Study||1
215838|NCT00716417|517102|P4|STARTED|Overall Study||11
215839|NCT00716417|517103|P3|STARTED|Overall Study||5
215840|NCT00716417|517104|P2|STARTED|Overall Study||6
215841|NCT00716417|517105|P1|STARTED|Overall Study||3
215842|NCT00716274|517152|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
215843|NCT00716274|517153|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
215844|NCT00716274|517154|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
215845|NCT00716274|517155|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
215846|NCT00716274|517156|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
215847|NCT00716274|517157|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
215848|NCT00716274|517152|P6|COMPLETED|Study Period III (16-Weeks)||19
215849|NCT00716274|517153|P5|COMPLETED|Study Period III (16-Weeks)||32
215850|NCT00716274|517154|P4|COMPLETED|Study Period III (16-Weeks)||17
215851|NCT00716274|517155|P3|COMPLETED|Study Period III (16-Weeks)||16
215852|NCT00716274|517156|P2|COMPLETED|Study Period III (16-Weeks)||0
215853|NCT00716274|517157|P1|COMPLETED|Study Period III (16-Weeks)||0
215854|NCT00716274|517152|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
215855|NCT00716274|517153|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
215856|NCT00716274|517154|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
215857|NCT00716274|517155|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
215858|NCT00716274|517156|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
215859|NCT00716274|517157|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
215860|NCT00716274|517152|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
215861|NCT00716274|517153|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
215862|NCT00716274|517154|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
215863|NCT00716274|517155|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
215864|NCT00716274|517156|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
215865|NCT00716274|517157|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
215866|NCT00716274|517152|P6|COMPLETED|Study Period II (16-Weeks)||19
215867|NCT00716274|517153|P5|COMPLETED|Study Period II (16-Weeks)||0
215868|NCT00716274|517154|P4|COMPLETED|Study Period II (16-Weeks)||0
215869|NCT00716274|517155|P3|COMPLETED|Study Period II (16-Weeks)||0
215870|NCT00716274|517156|P2|COMPLETED|Study Period II (16-Weeks)||35
215871|NCT00716274|517157|P1|COMPLETED|Study Period II (16-Weeks)||36
215872|NCT00716274|517152|P6|STARTED|Study Period II (16-Weeks)||21
215873|NCT00716274|517153|P5|STARTED|Study Period II (16-Weeks)||0
215874|NCT00716274|517154|P4|STARTED|Study Period II (16-Weeks)||0
215875|NCT00716274|517155|P3|STARTED|Study Period II (16-Weeks)||0
215876|NCT00716274|517156|P2|STARTED|Study Period II (16-Weeks)||44
215877|NCT00716274|517157|P1|STARTED|Study Period II (16-Weeks)||45
215878|NCT00716144|517291|P4|NOT COMPLETED|Overall Study||12
215879|NCT00716144|517292|P3|NOT COMPLETED|Overall Study||12
215880|NCT00716144|517293|P2|NOT COMPLETED|Overall Study||7
215881|NCT00716144|517294|P1|NOT COMPLETED|Overall Study||9
215882|NCT00716144|517291|P4|COMPLETED|Overall Study||33
215883|NCT00716144|517292|P3|COMPLETED|Overall Study||33
215884|NCT00716144|517293|P2|COMPLETED|Overall Study||38
215885|NCT00716144|517294|P1|COMPLETED|Overall Study||32
215886|NCT00716144|517291|P4|STARTED|Overall Study||45
215887|NCT00716144|517292|P3|STARTED|Overall Study||45
215888|NCT00716144|517293|P2|STARTED|Overall Study||45
215889|NCT00716144|517294|P1|STARTED|Overall Study||41
215890|NCT00716092|517319|P3|NOT COMPLETED|Overall Study||0
215891|NCT00716092|517320|P2|NOT COMPLETED|Overall Study||1
215892|NCT00716092|517321|P1|NOT COMPLETED|Overall Study||2
215893|NCT00716092|517319|P3|COMPLETED|Overall Study||41
215894|NCT00716092|517320|P2|COMPLETED|Overall Study||39
215895|NCT00716092|517321|P1|COMPLETED|Overall Study||38
215896|NCT00716092|517319|P3|STARTED|Overall Study||41
215897|NCT00716092|517320|P2|STARTED|Overall Study||40
215898|NCT00716092|517321|P1|STARTED|Overall Study||40
215899|NCT00716079|517352|P2|NOT COMPLETED|Overall Study||15
215900|NCT00716079|517353|P1|NOT COMPLETED|Overall Study||9
215901|NCT00716079|517352|P2|COMPLETED|Overall Study||1421
215902|NCT00716079|517353|P1|COMPLETED|Overall Study||1394
215903|NCT00716079|517352|P2|STARTED|Overall Study||1436
215904|NCT00716079|517353|P1|STARTED|Overall Study||1403
215905|NCT00715962|517363|P2|NOT COMPLETED|Overall Study||2
215906|NCT00715962|517364|P1|NOT COMPLETED|Overall Study||6
215907|NCT00715962|517363|P2|COMPLETED|Overall Study||48
215908|NCT00715962|517364|P1|COMPLETED|Overall Study||44
215909|NCT00715962|517363|P2|STARTED|Overall Study||50
215910|NCT00715962|517364|P1|STARTED|Overall Study||50
215911|NCT00715949|517374|P1|NOT COMPLETED|Overall Study||4
215912|NCT00715949|517374|P1|COMPLETED|Overall Study|116 patients completed first test|116
215913|NCT00715949|517374|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
215914|NCT00715910|517382|P6|NOT COMPLETED|Booster and ESFU Phase||13
215915|NCT00715910|517383|P5|NOT COMPLETED|Booster and ESFU Phase||2
215916|NCT00715910|517384|P4|NOT COMPLETED|Booster and ESFU Phase||11
215917|NCT00715910|517385|P3|NOT COMPLETED|Booster and ESFU Phase||0
215918|NCT00715910|517386|P2|NOT COMPLETED|Booster and ESFU Phase||0
215919|NCT00715910|517387|P1|NOT COMPLETED|Booster and ESFU Phase||0
215920|NCT00715910|517382|P6|COMPLETED|Booster and ESFU Phase||88
215921|NCT00715910|517383|P5|COMPLETED|Booster and ESFU Phase||36
215922|NCT00715910|517384|P4|COMPLETED|Booster and ESFU Phase||172
215923|NCT00715910|517385|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
215924|NCT00715910|517386|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
215925|NCT00715910|517387|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
215926|NCT00715910|517382|P6|STARTED|Booster and ESFU Phase||101
215927|NCT00715910|517383|P5|STARTED|Booster and ESFU Phase||38
215928|NCT00715910|517384|P4|STARTED|Booster and ESFU Phase||183
215929|NCT00715910|517385|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
215930|NCT00715910|517386|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
215931|NCT00715910|517387|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
215932|NCT00715910|517382|P6|NOT COMPLETED|Year 5||0
215933|NCT00715910|517383|P5|NOT COMPLETED|Year 5||0
215934|NCT00715910|517384|P4|NOT COMPLETED|Year 5||0
215935|NCT00715910|517385|P3|NOT COMPLETED|Year 5||0
215936|NCT00715910|517386|P2|NOT COMPLETED|Year 5||0
215937|NCT00715910|517387|P1|NOT COMPLETED|Year 5||0
215938|NCT00715910|517382|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
215939|NCT00715910|517383|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
215940|NCT00715910|517384|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
215941|NCT00715910|517385|P3|COMPLETED|Year 5||38
215942|NCT00715910|517386|P2|COMPLETED|Year 5||56
215943|NCT00715910|517387|P1|COMPLETED|Year 5||218
215944|NCT00715910|517382|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
215945|NCT00715910|517383|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
215946|NCT00715910|517384|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
215947|NCT00715910|517385|P3|STARTED|Year 5||38
215948|NCT00715910|517386|P2|STARTED|Year 5||56
215949|NCT00715910|517387|P1|STARTED|Year 5||218
215950|NCT00715910|517382|P6|NOT COMPLETED|Year 3||0
215951|NCT00715910|517383|P5|NOT COMPLETED|Year 3||0
215952|NCT00715910|517384|P4|NOT COMPLETED|Year 3||0
215953|NCT00715910|517385|P3|NOT COMPLETED|Year 3||0
215954|NCT00715910|517386|P2|NOT COMPLETED|Year 3||0
215955|NCT00715910|517387|P1|NOT COMPLETED|Year 3||0
215956|NCT00715910|517382|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
215957|NCT00715910|517383|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
215958|NCT00715910|517384|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
215959|NCT00715910|517385|P3|COMPLETED|Year 3||56
215960|NCT00715910|517386|P2|COMPLETED|Year 3||86
215961|NCT00715910|517387|P1|COMPLETED|Year 3||345
215962|NCT00715910|517382|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
215963|NCT00715910|517383|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
215964|NCT00715910|517384|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
215965|NCT00715910|517385|P3|STARTED|Year 3||56
215966|NCT00715910|517386|P2|STARTED|Year 3||86
215967|NCT00715910|517387|P1|STARTED|Year 3||345
215968|NCT00715910|517382|P6|NOT COMPLETED|Year 1||0
215969|NCT00715910|517383|P5|NOT COMPLETED|Year 1||0
215970|NCT00715910|517384|P4|NOT COMPLETED|Year 1||0
215971|NCT00715910|517385|P3|NOT COMPLETED|Year 1||0
215972|NCT00715910|517386|P2|NOT COMPLETED|Year 1||0
215973|NCT00715910|517387|P1|NOT COMPLETED|Year 1||0
215974|NCT00715910|517382|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
215975|NCT00715910|517383|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
215976|NCT00715910|517384|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
215977|NCT00715910|517385|P3|COMPLETED|Year 1||68
215978|NCT00715910|517386|P2|COMPLETED|Year 1||147
215979|NCT00715910|517387|P1|COMPLETED|Year 1||433
215980|NCT00715910|517382|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
215981|NCT00715910|517383|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
215982|NCT00715910|517384|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
215983|NCT00715910|517385|P3|STARTED|Year 1||68
215984|NCT00715910|517386|P2|STARTED|Year 1||147
215985|NCT00715910|517387|P1|STARTED|Year 1||433
215986|NCT00715884|517463|P2|NOT COMPLETED|Overall Study||1
215987|NCT00715884|517464|P1|NOT COMPLETED|Overall Study||8
215988|NCT00715884|517463|P2|COMPLETED|Overall Study||225
215989|NCT00715884|517464|P1|COMPLETED|Overall Study||444
215990|NCT00715884|517463|P2|STARTED|Overall Study||226
215991|NCT00715884|517464|P1|STARTED|Overall Study||452
215992|NCT00715793|517506|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
215993|NCT00715793|517507|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
215994|NCT00715793|517506|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
215995|NCT00715793|517507|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
215996|NCT00715793|517506|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
215997|NCT00715793|517507|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
215998|NCT00715793|517506|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
215999|NCT00715793|517507|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
216000|NCT00715793|517506|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
216001|NCT00715793|517507|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
216002|NCT00715793|517506|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
216003|NCT00715793|517507|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
216004|NCT00715754|517519|P1|NOT COMPLETED|Overall Study||0
216005|NCT00715754|517519|P1|COMPLETED|Overall Study||47
216006|NCT00715754|517519|P1|STARTED|Overall Study||47
216007|NCT00715741|517529|P4|NOT COMPLETED|Overall Study||0
216008|NCT00715741|517530|P3|NOT COMPLETED|Overall Study||0
216009|NCT00715741|517531|P2|NOT COMPLETED|Overall Study||0
216010|NCT00715741|517532|P1|NOT COMPLETED|Overall Study||0
216011|NCT00715741|517529|P4|COMPLETED|Overall Study||25
216012|NCT00715741|517530|P3|COMPLETED|Overall Study||25
216013|NCT00715741|517531|P2|COMPLETED|Overall Study||25
216014|NCT00715741|517532|P1|COMPLETED|Overall Study||25
216015|NCT00715741|517529|P4|STARTED|Overall Study||25
216016|NCT00715741|517530|P3|STARTED|Overall Study||25
216017|NCT00715741|517531|P2|STARTED|Overall Study||25
216018|NCT00715741|517532|P1|STARTED|Overall Study||25
216019|NCT00715676|517557|P3|NOT COMPLETED|Overall Study||32
216020|NCT00715676|517558|P2|NOT COMPLETED|Overall Study||11
216021|NCT00715676|517559|P1|NOT COMPLETED|Overall Study||6
216022|NCT00715676|517557|P3|COMPLETED|Overall Study||21
216023|NCT00715676|517558|P2|COMPLETED|Overall Study||43
216024|NCT00715676|517559|P1|COMPLETED|Overall Study||43
216025|NCT00715676|517557|P3|STARTED|Overall Study||53
216026|NCT00715676|517558|P2|STARTED|Overall Study||54
216027|NCT00715676|517559|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
216028|NCT00715650|517587|P2|NOT COMPLETED|Follow-up||5
216029|NCT00715650|517588|P1|NOT COMPLETED|Follow-up||13
216030|NCT00715650|517587|P2|COMPLETED|Follow-up||37
216031|NCT00715650|517588|P1|COMPLETED|Follow-up||29
216032|NCT00715650|517587|P2|Completed Month 6 Follow-up|Follow-up||37
216033|NCT00715650|517588|P1|Completed Month 6 Follow-up|Follow-up||29
216034|NCT00715650|517587|P2|Completed Month 3 Follow-up|Follow-up||40
216035|NCT00715650|517588|P1|Completed Month 3 Follow-up|Follow-up||35
216036|NCT00715650|517587|P2|Completed Month 1 Follow-up|Follow-up||38
216037|NCT00715650|517588|P1|Completed Month 1 Follow-up|Follow-up||40
216038|NCT00715650|517587|P2|STARTED|Follow-up||42
216039|NCT00715650|517588|P1|STARTED|Follow-up||42
216040|NCT00715650|517587|P2|NOT COMPLETED|Intervention||3
216041|NCT00715650|517588|P1|NOT COMPLETED|Intervention||5
216042|NCT00715650|517587|P2|COMPLETED|Intervention||42
216043|NCT00715650|517588|P1|COMPLETED|Intervention||42
216044|NCT00715650|517587|P2|Attended ≥ 3 Sessions|Intervention||17
216045|NCT00715650|517588|P1|Attended ≥ 3 Sessions|Intervention||23
216046|NCT00715650|517587|P2|Attended ≥ 2 Sessions|Intervention||33
216047|NCT00715650|517588|P1|Attended ≥ 2 Sessions|Intervention||36
216048|NCT00715650|517587|P2|Received Any Session|Intervention||38
216049|NCT00715650|517588|P1|Received Any Session|Intervention||39
216050|NCT00715650|517587|P2|STARTED|Intervention||45
216051|NCT00715650|517588|P1|STARTED|Intervention||47
216052|NCT00715624|517602|P2|NOT COMPLETED|Overall Study||116
216053|NCT00715624|517603|P1|NOT COMPLETED|Overall Study||52
216054|NCT00715624|517602|P2|COMPLETED|Overall Study||213
216055|NCT00715624|517603|P1|COMPLETED|Overall Study||115
216056|NCT00715624|517602|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
216057|NCT00715624|517603|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
216058|NCT00715624|517602|P2|Treated/Safety Population|Overall Study||328
216059|NCT00715624|517603|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
216060|NCT00715624|517602|P2|STARTED|Overall Study||329
216061|NCT00715624|517603|P1|STARTED|Overall Study|Randomized|167
216062|NCT00715559|517631|P1|NOT COMPLETED|Overall Study||1
216063|NCT00715559|517631|P1|COMPLETED|Overall Study||2
216064|NCT00715559|517631|P1|STARTED|Overall Study||3
216065|NCT00715520|517641|P3|NOT COMPLETED|Overall Study||2
216066|NCT00715520|517642|P2|NOT COMPLETED|Overall Study||1
216067|NCT00715520|517643|P1|NOT COMPLETED|Overall Study||10
216068|NCT00715520|517641|P3|COMPLETED|Overall Study||1
216069|NCT00715520|517642|P2|COMPLETED|Overall Study||9
216070|NCT00715520|517643|P1|COMPLETED|Overall Study||10
216071|NCT00715520|517641|P3|STARTED|Overall Study||3
216072|NCT00715520|517642|P2|STARTED|Overall Study||10
216073|NCT00715520|517643|P1|STARTED|Overall Study||20
216074|NCT00715403|517663|P7|NOT COMPLETED|Overall Study||1
216075|NCT00715403|517664|P6|NOT COMPLETED|Overall Study||19
216076|NCT00715403|517665|P5|NOT COMPLETED|Overall Study||6
216077|NCT00715403|517666|P4|NOT COMPLETED|Overall Study||9
216078|NCT00715403|517667|P3|NOT COMPLETED|Overall Study||4
216079|NCT00715403|517668|P2|NOT COMPLETED|Overall Study||1
216080|NCT00715403|517669|P1|NOT COMPLETED|Overall Study||1
216081|NCT00715403|517663|P7|COMPLETED|Overall Study||0
216082|NCT00715403|517664|P6|COMPLETED|Overall Study||0
216083|NCT00715403|517665|P5|COMPLETED|Overall Study||0
216084|NCT00715403|517666|P4|COMPLETED|Overall Study||0
216085|NCT00715403|517667|P3|COMPLETED|Overall Study||0
216086|NCT00715403|517668|P2|COMPLETED|Overall Study||0
216087|NCT00715403|517669|P1|COMPLETED|Overall Study||0
216088|NCT00715403|517663|P7|STARTED|Overall Study||1
216089|NCT00715403|517664|P6|STARTED|Overall Study||19
216090|NCT00715403|517665|P5|STARTED|Overall Study||6
216091|NCT00715403|517666|P4|STARTED|Overall Study||9
216092|NCT00715403|517667|P3|STARTED|Overall Study||4
216093|NCT00715403|517668|P2|STARTED|Overall Study||1
216094|NCT00715403|517669|P1|STARTED|Overall Study||1
216095|NCT00715390|517804|P1|NOT COMPLETED|Overall Study||0
216096|NCT00715390|517804|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
216097|NCT00715390|517804|P1|Eligible|Overall Study||234
216098|NCT00715390|517804|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
216099|NCT00715299|517808|P1|NOT COMPLETED|Overall Study||6
216100|NCT00715299|517808|P1|COMPLETED|Overall Study||30
216101|NCT00715299|517808|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
216102|NCT00715208|517814|P2|NOT COMPLETED|Overall Study||9
216103|NCT00715208|517815|P1|NOT COMPLETED|Overall Study||1
216104|NCT00715208|517814|P2|COMPLETED|Overall Study||39
216105|NCT00715208|517815|P1|COMPLETED|Overall Study||6
216106|NCT00715208|517814|P2|STARTED|Overall Study||48
216107|NCT00715208|517815|P1|STARTED|Overall Study||7
216108|NCT00715117|517831|P2|NOT COMPLETED|Overall Study||1
216109|NCT00715117|517832|P1|NOT COMPLETED|Overall Study||0
216110|NCT00715117|517831|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
216111|NCT00715117|517832|P1|COMPLETED|Overall Study||6
216112|NCT00715117|517831|P2|Completion fo 8 Week Study|Overall Study||6
216113|NCT00715117|517832|P1|Completion fo 8 Week Study|Overall Study||6
216114|NCT00715117|517831|P2|STARTED|Overall Study||6
216115|NCT00715117|517832|P1|STARTED|Overall Study||6
216116|NCT00715104|517846|P3|NOT COMPLETED|Overall Study||0
216117|NCT00715104|517847|P2|NOT COMPLETED|Overall Study||0
216118|NCT00715104|517848|P1|NOT COMPLETED|Overall Study||0
216119|NCT00715104|517846|P3|COMPLETED|Overall Study||8
216120|NCT00715104|517847|P2|COMPLETED|Overall Study||16
216121|NCT00715104|517848|P1|COMPLETED|Overall Study||18
216122|NCT00715104|517846|P3|STARTED|Overall Study||8
216123|NCT00715104|517847|P2|STARTED|Overall Study||16
216124|NCT00715104|517848|P1|STARTED|Overall Study||18
216125|NCT00715078|517900|P3|NOT COMPLETED|Overall Study||38
216126|NCT00715078|517901|P2|NOT COMPLETED|Overall Study||36
216127|NCT00715078|517902|P1|NOT COMPLETED|Overall Study||30
216128|NCT00715078|517900|P3|COMPLETED|Overall Study||3
216129|NCT00715078|517901|P2|COMPLETED|Overall Study||4
216130|NCT00715078|517902|P1|COMPLETED|Overall Study||11
216131|NCT00715078|517900|P3|Received ≥ 1 Leukapheresis|Overall Study||40
216132|NCT00715078|517901|P2|Received ≥ 1 Leukapheresis|Overall Study||40
216133|NCT00715078|517902|P1|Received ≥ 1 Leukapheresis|Overall Study||40
216134|NCT00715078|517900|P3|Received ≥ 1 Study Infusion|Overall Study||39
216135|NCT00715078|517901|P2|Received ≥ 1 Study Infusion|Overall Study||40
216136|NCT00715078|517902|P1|Received ≥ 1 Study Infusion|Overall Study||40
216137|NCT00715078|517900|P3|STARTED|Overall Study||41
216138|NCT00715078|517901|P2|STARTED|Overall Study||40
216139|NCT00715078|517902|P1|STARTED|Overall Study||41
216140|NCT00715026|517910|P1|NOT COMPLETED|Overall Study||10
216141|NCT00715026|517910|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
216142|NCT00715026|517910|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
216143|NCT00715026|517910|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
216144|NCT00714948|517915|P1|NOT COMPLETED|Overall Study||2
216145|NCT00714948|517915|P1|COMPLETED|Overall Study||0
216146|NCT00714948|517915|P1|STARTED|Overall Study||2
216147|NCT00714870|517921|P2|NOT COMPLETED|Overall Study||5
216148|NCT00714870|517922|P1|NOT COMPLETED|Overall Study||27
216149|NCT00714870|517921|P2|COMPLETED|Overall Study||22
216150|NCT00714870|517922|P1|COMPLETED|Overall Study||22
216151|NCT00714870|517921|P2|STARTED|Overall Study||27
216152|NCT00714870|517922|P1|STARTED|Overall Study||49
216153|NCT00714792|517930|P2|NOT COMPLETED|Overall Study||0
216154|NCT00714792|517931|P1|NOT COMPLETED|Overall Study||0
216155|NCT00714792|517930|P2|COMPLETED|Overall Study||8
216156|NCT00714792|517931|P1|COMPLETED|Overall Study||10
216157|NCT00714792|517930|P2|STARTED|Overall Study||8
216158|NCT00714792|517931|P1|STARTED|Overall Study||10
216159|NCT00714714|517937|P1|NOT COMPLETED|Overall Study||1
216160|NCT00714714|517937|P1|COMPLETED|Overall Study||24
216161|NCT00714714|517937|P1|STARTED|Overall Study||25
216162|NCT00714688|517946|P3|NOT COMPLETED|Overall Study||37
216163|NCT00714688|517947|P2|NOT COMPLETED|Overall Study||35
216164|NCT00714688|517948|P1|NOT COMPLETED|Overall Study||29
216165|NCT00714688|517946|P3|COMPLETED|Overall Study||55
216166|NCT00714688|517947|P2|COMPLETED|Overall Study||55
216167|NCT00714688|517948|P1|COMPLETED|Overall Study||68
216168|NCT00714688|517946|P3|STARTED|Overall Study||92
216169|NCT00714688|517947|P2|STARTED|Overall Study||90
216170|NCT00714688|517948|P1|STARTED|Overall Study||97
216171|NCT00714571|517971|P6|NOT COMPLETED|Stage 2||0
216172|NCT00714571|517972|P5|NOT COMPLETED|Stage 2||0
216173|NCT00714571|517973|P4|NOT COMPLETED|Stage 2||0
216174|NCT00714571|517974|P3|NOT COMPLETED|Stage 2||0
216175|NCT00714571|517975|P2|NOT COMPLETED|Stage 2||0
216176|NCT00714571|517976|P1|NOT COMPLETED|Stage 2||0
216177|NCT00714571|517971|P6|COMPLETED|Stage 2||15
216178|NCT00714571|517972|P5|COMPLETED|Stage 2||15
216179|NCT00714571|517973|P4|COMPLETED|Stage 2||0
216180|NCT00714571|517974|P3|COMPLETED|Stage 2||0
216181|NCT00714571|517975|P2|COMPLETED|Stage 2||0
216182|NCT00714571|517976|P1|COMPLETED|Stage 2||0
216183|NCT00714571|517971|P6|STARTED|Stage 2||15
216184|NCT00714571|517972|P5|STARTED|Stage 2||15
216185|NCT00714571|517973|P4|STARTED|Stage 2||0
216186|NCT00714571|517974|P3|STARTED|Stage 2||0
216187|NCT00714571|517975|P2|STARTED|Stage 2||0
216188|NCT00714571|517976|P1|STARTED|Stage 2||0
216189|NCT00714571|517971|P6|NOT COMPLETED|Stage 1||0
216190|NCT00714571|517972|P5|NOT COMPLETED|Stage 1||0
216191|NCT00714571|517973|P4|NOT COMPLETED|Stage 1||0
216192|NCT00714571|517974|P3|NOT COMPLETED|Stage 1||1
216193|NCT00714571|517975|P2|NOT COMPLETED|Stage 1||0
216194|NCT00714571|517976|P1|NOT COMPLETED|Stage 1||0
216195|NCT00714571|517971|P6|COMPLETED|Stage 1||0
216196|NCT00714571|517972|P5|COMPLETED|Stage 1||0
216197|NCT00714571|517973|P4|COMPLETED|Stage 1||14
216198|NCT00714571|517974|P3|COMPLETED|Stage 1||10
216199|NCT00714571|517975|P2|COMPLETED|Stage 1||15
216200|NCT00714571|517976|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
216201|NCT00714571|517971|P6|STARTED|Stage 1||0
216202|NCT00714571|517972|P5|STARTED|Stage 1||0
216203|NCT00714571|517973|P4|STARTED|Stage 1||14
216204|NCT00714571|517974|P3|STARTED|Stage 1||11
216205|NCT00714571|517975|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
216206|NCT00714571|517976|P1|STARTED|Stage 1||12
216207|NCT00714493|517990|P1|NOT COMPLETED|Overall Study||49
216208|NCT00714493|517990|P1|COMPLETED|Overall Study||154
216209|NCT00714493|517990|P1|STARTED|Overall Study||203
216210|NCT00714389|518000|P1|NOT COMPLETED|Overall Study||0
216211|NCT00714389|518000|P1|COMPLETED|Overall Study||12
216212|NCT00714389|518000|P1|STARTED|Overall Study||12
216213|NCT00714311|518007|P2|NOT COMPLETED|Overall Study||22
216214|NCT00714311|518008|P1|NOT COMPLETED|Overall Study||13
216215|NCT00714311|518007|P2|COMPLETED|Overall Study||30
216216|NCT00714311|518008|P1|COMPLETED|Overall Study||39
216217|NCT00714311|518007|P2|STARTED|Overall Study||52
216218|NCT00714311|518008|P1|STARTED|Overall Study||52
216219|NCT00714285|518018|P4|NOT COMPLETED|Overall Study||1
216220|NCT00714285|518019|P3|NOT COMPLETED|Overall Study||0
216221|NCT00714285|518020|P2|NOT COMPLETED|Overall Study||3
216222|NCT00714285|518021|P1|NOT COMPLETED|Overall Study||0
216223|NCT00714285|518018|P4|COMPLETED|Overall Study|Completed upto Day 180|104
216224|NCT00714285|518019|P3|COMPLETED|Overall Study|Completed upto Day 180|105
216225|NCT00714285|518020|P2|COMPLETED|Overall Study|Completed upto Day 180|102
216226|NCT00714285|518021|P1|COMPLETED|Overall Study|Completed upto Day 180|105
216227|NCT00714285|518018|P4|STARTED|Overall Study||105
216228|NCT00714285|518019|P3|STARTED|Overall Study||105
216229|NCT00714285|518020|P2|STARTED|Overall Study||105
216230|NCT00714285|518021|P1|STARTED|Overall Study||105
216231|NCT00714259|518071|P1|NOT COMPLETED|Overall Study||2
216232|NCT00714259|518071|P1|COMPLETED|Overall Study||3
216233|NCT00714259|518071|P1|STARTED|Overall Study||5
216234|NCT00714233|518085|P4|NOT COMPLETED|Overall Study||4
216235|NCT00714233|518086|P3|NOT COMPLETED|Overall Study||1
216236|NCT00714233|518087|P2|NOT COMPLETED|Overall Study||1
216237|NCT00714233|518088|P1|NOT COMPLETED|Overall Study||4
216238|NCT00714233|518085|P4|COMPLETED|Overall Study||6
216239|NCT00714233|518086|P3|COMPLETED|Overall Study||10
216240|NCT00714233|518087|P2|COMPLETED|Overall Study||10
216241|NCT00714233|518088|P1|COMPLETED|Overall Study||6
216242|NCT00714233|518085|P4|STARTED|Overall Study||10
216243|NCT00714233|518086|P3|STARTED|Overall Study||11
216244|NCT00714233|518087|P2|STARTED|Overall Study||11
216245|NCT00714233|518088|P1|STARTED|Overall Study||10
216246|NCT00714168|518117|P2|NOT COMPLETED|Overall Study||59
216247|NCT00714168|518118|P1|NOT COMPLETED|Overall Study||44
216248|NCT00714168|518117|P2|COMPLETED|Overall Study||139
216249|NCT00714168|518118|P1|COMPLETED|Overall Study||121
216250|NCT00714168|518117|P2|STARTED|Overall Study||198
216251|NCT00714168|518118|P1|STARTED|Overall Study||165
216252|NCT00714051|518134|P2|NOT COMPLETED|Overall Study||1
216253|NCT00714051|518135|P1|NOT COMPLETED|Overall Study||1
216254|NCT00714051|518134|P2|COMPLETED|Overall Study||27
216255|NCT00714051|518135|P1|COMPLETED|Overall Study||26
216256|NCT00714051|518134|P2|STARTED|Overall Study||28
216257|NCT00714051|518135|P1|STARTED|Overall Study||27
216258|NCT00713830|518143|P2|NOT COMPLETED|Overall Study||177
216259|NCT00713830|518144|P1|NOT COMPLETED|Overall Study||82
216260|NCT00713830|518143|P2|COMPLETED|Overall Study||396
216261|NCT00713830|518144|P1|COMPLETED|Overall Study||204
216262|NCT00713830|518143|P2|Subgroup for Standardized Meal Test|Overall Study||313
216263|NCT00713830|518144|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
216264|NCT00713830|518143|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
216265|NCT00713830|518144|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
216266|NCT00713830|518143|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
216267|NCT00713830|518144|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
216268|NCT00713830|518143|P2|STARTED|Overall Study||573
216269|NCT00713830|518144|P1|STARTED|Overall Study|Randomized.|286
216270|NCT00713817|518182|P2|NOT COMPLETED|Overall Study||0
216271|NCT00713817|518183|P1|NOT COMPLETED|Overall Study||0
216272|NCT00713817|518182|P2|COMPLETED|Overall Study||9
216273|NCT00713817|518183|P1|COMPLETED|Overall Study||10
216274|NCT00713817|518182|P2|STARTED|Overall Study||9
216275|NCT00713817|518183|P1|STARTED|Overall Study||10
216276|NCT00713700|518201|P1|NOT COMPLETED|Overall Study||4
216277|NCT00713700|518201|P1|COMPLETED|Overall Study||188
216278|NCT00713700|518201|P1|STARTED|Overall Study||192
216279|NCT00713661|518210|P4|NOT COMPLETED|Overall Study||0
216280|NCT00713661|518211|P3|NOT COMPLETED|Overall Study||0
216281|NCT00713661|518212|P2|NOT COMPLETED|Overall Study||0
216282|NCT00713661|518213|P1|NOT COMPLETED|Overall Study||0
216283|NCT00713661|518210|P4|COMPLETED|Overall Study||5
216284|NCT00713661|518211|P3|COMPLETED|Overall Study||4
216285|NCT00713661|518212|P2|COMPLETED|Overall Study||9
216286|NCT00713661|518213|P1|COMPLETED|Overall Study||7
216287|NCT00713661|518210|P4|STARTED|Overall Study||5
216288|NCT00713661|518211|P3|STARTED|Overall Study||4
216289|NCT00713661|518212|P2|STARTED|Overall Study||9
216290|NCT00713661|518213|P1|STARTED|Overall Study||7
216291|NCT00713648|518227|P1|NOT COMPLETED|Overall Study||8
216292|NCT00713648|518227|P1|COMPLETED|Overall Study||33
216293|NCT00713648|518227|P1|STARTED|Overall Study||41
216294|NCT00713609|518240|P6|NOT COMPLETED|Overall Study||8
216295|NCT00713609|518241|P5|NOT COMPLETED|Overall Study||19
216296|NCT00713609|518242|P4|NOT COMPLETED|Overall Study||9
216297|NCT00713609|518243|P3|NOT COMPLETED|Overall Study||15
216298|NCT00713609|518244|P2|NOT COMPLETED|Overall Study||15
216299|NCT00713609|518245|P1|NOT COMPLETED|Overall Study||21
216300|NCT00713609|518240|P6|COMPLETED|Overall Study||47
216301|NCT00713609|518241|P5|COMPLETED|Overall Study||87
216302|NCT00713609|518242|P4|COMPLETED|Overall Study||99
216303|NCT00713609|518243|P3|COMPLETED|Overall Study||92
216304|NCT00713609|518244|P2|COMPLETED|Overall Study||90
216305|NCT00713609|518245|P1|COMPLETED|Overall Study||85
216306|NCT00713609|518240|P6|STARTED|Overall Study||55
216307|NCT00713609|518241|P5|STARTED|Overall Study||106
216308|NCT00713609|518242|P4|STARTED|Overall Study||108
216309|NCT00713609|518243|P3|STARTED|Overall Study||107
216310|NCT00713609|518244|P2|STARTED|Overall Study||105
216311|NCT00713609|518245|P1|STARTED|Overall Study||106
216312|NCT00713596|518280|P3|NOT COMPLETED|Overall Study||2
216313|NCT00713596|518281|P2|NOT COMPLETED|Overall Study||3
216314|NCT00713596|518282|P1|NOT COMPLETED|Overall Study||2
216315|NCT00713596|518280|P3|COMPLETED|Overall Study||6
216316|NCT00713596|518281|P2|COMPLETED|Overall Study||5
216317|NCT00713596|518282|P1|COMPLETED|Overall Study||7
216318|NCT00713596|518280|P3|STARTED|Overall Study||8
216319|NCT00713596|518281|P2|STARTED|Overall Study||8
216320|NCT00713596|518282|P1|STARTED|Overall Study||9
216321|NCT00713583|518295|P2|NOT COMPLETED|Overall Study||0
216322|NCT00713583|518296|P1|NOT COMPLETED|Overall Study||0
216323|NCT00713583|518295|P2|COMPLETED|Overall Study||40
216324|NCT00713583|518296|P1|COMPLETED|Overall Study||45
216325|NCT00713583|518295|P2|STARTED|Overall Study||40
216326|NCT00713583|518296|P1|STARTED|Overall Study||45
216327|NCT00713544|518308|P6|NOT COMPLETED|Overall Study||9
216328|NCT00713544|518309|P5|NOT COMPLETED|Overall Study||8
216329|NCT00713544|518310|P4|NOT COMPLETED|Overall Study||10
216330|NCT00713544|518311|P3|NOT COMPLETED|Overall Study||11
216331|NCT00713544|518312|P2|NOT COMPLETED|Overall Study||6
216332|NCT00713544|518313|P1|NOT COMPLETED|Overall Study||7
216333|NCT00713544|518308|P6|COMPLETED|Overall Study||67
216334|NCT00713544|518309|P5|COMPLETED|Overall Study||57
216335|NCT00713544|518310|P4|COMPLETED|Overall Study||66
216336|NCT00713544|518311|P3|COMPLETED|Overall Study||41
216337|NCT00713544|518312|P2|COMPLETED|Overall Study||46
216338|NCT00713544|518313|P1|COMPLETED|Overall Study||45
216339|NCT00713544|518308|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
216340|NCT00713544|518309|P5|STARTED|Overall Study||65
216341|NCT00713544|518310|P4|STARTED|Overall Study||76
216342|NCT00713544|518311|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
216343|NCT00713544|518312|P2|STARTED|Overall Study||52
216344|NCT00713544|518313|P1|STARTED|Overall Study||52
216345|NCT00713479|518351|P2|NOT COMPLETED|Next Medication Condition||0
216346|NCT00713479|518352|P1|NOT COMPLETED|Next Medication Condition||0
216347|NCT00713479|518351|P2|COMPLETED|Next Medication Condition||6
216348|NCT00713479|518352|P1|COMPLETED|Next Medication Condition||2
216349|NCT00713479|518351|P2|STARTED|Next Medication Condition||6
216350|NCT00713479|518352|P1|STARTED|Next Medication Condition||2
216351|NCT00713479|518351|P2|NOT COMPLETED|Washout||0
216352|NCT00713479|518352|P1|NOT COMPLETED|Washout||0
216353|NCT00713479|518351|P2|COMPLETED|Washout||6
216354|NCT00713479|518352|P1|COMPLETED|Washout||2
216355|NCT00713479|518351|P2|STARTED|Washout||6
216356|NCT00713479|518352|P1|STARTED|Washout||2
216357|NCT00713479|518351|P2|NOT COMPLETED|First Medication Condition||0
216358|NCT00713479|518352|P1|NOT COMPLETED|First Medication Condition||4
216359|NCT00713479|518351|P2|COMPLETED|First Medication Condition||6
216360|NCT00713479|518352|P1|COMPLETED|First Medication Condition||2
216361|NCT00713479|518351|P2|STARTED|First Medication Condition||6
216362|NCT00713479|518352|P1|STARTED|First Medication Condition||6
216363|NCT00713349|518364|P1|NOT COMPLETED|Overall Study||1
216364|NCT00713349|518364|P1|COMPLETED|Overall Study||24
216365|NCT00713349|518364|P1|STARTED|Overall Study||25
216366|NCT00713323|518370|P1|NOT COMPLETED|Overall Study||146
216367|NCT00713323|518370|P1|COMPLETED|Overall Study||234
216368|NCT00713323|518370|P1|STARTED|Overall Study||380
216369|NCT00713310|518383|P2|NOT COMPLETED|Overall Study||6
216370|NCT00713310|518384|P1|NOT COMPLETED|Overall Study||5
216371|NCT00713310|518383|P2|COMPLETED|Overall Study||36
216372|NCT00713310|518384|P1|COMPLETED|Overall Study||36
216373|NCT00713310|518383|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
216374|NCT00713310|518384|P1|mITT Population|Overall Study||41
216375|NCT00713310|518383|P2|STARTED|Overall Study||42
216376|NCT00713310|518384|P1|STARTED|Overall Study||41
216377|NCT00713258|518394|P2|NOT COMPLETED|Overall Study||6
216378|NCT00713258|518395|P1|NOT COMPLETED|Overall Study||5
216379|NCT00713258|518394|P2|COMPLETED|Overall Study||28
216380|NCT00713258|518395|P1|COMPLETED|Overall Study||36
216381|NCT00713258|518394|P2|STARTED|Overall Study||34
216382|NCT00713258|518395|P1|STARTED|Overall Study||41
216383|NCT00713219|518403|P1|NOT COMPLETED|Overall Study||2
216384|NCT00713219|518403|P1|COMPLETED|Overall Study||12
216385|NCT00713219|518403|P1|STARTED|Overall Study||14
216386|NCT00713206|518409|P2|NOT COMPLETED|Overall Study||3
216387|NCT00713206|518410|P1|NOT COMPLETED|Overall Study||7
216388|NCT00713206|518409|P2|COMPLETED|Overall Study||27
216389|NCT00713206|518410|P1|COMPLETED|Overall Study||55
216390|NCT00713206|518409|P2|STARTED|Overall Study||30
216391|NCT00713206|518410|P1|STARTED|Overall Study||62
216392|NCT00712985|518416|P1|NOT COMPLETED|Overall Study||5
216393|NCT00712985|518416|P1|COMPLETED|Overall Study||13
216394|NCT00712985|518416|P1|STARTED|Overall Study||18
216395|NCT00712959|518422|P2|NOT COMPLETED|Overall Study||3
216396|NCT00712959|518423|P1|NOT COMPLETED|Overall Study||19
216397|NCT00712959|518422|P2|COMPLETED|Overall Study||404
216398|NCT00712959|518423|P1|COMPLETED|Overall Study||342
216399|NCT00712959|518422|P2|STARTED|Overall Study||407
216400|NCT00712959|518423|P1|STARTED|Overall Study||361
216401|NCT00712933|518441|P1|NOT COMPLETED|Overall Study||367
216402|NCT00712933|518441|P1|COMPLETED|Overall Study||368
216403|NCT00712933|518441|P1|STARTED|Overall Study||735
216404|NCT00712920|518471|P3|NOT COMPLETED|Overall Study||12
216405|NCT00712920|518472|P2|NOT COMPLETED|Overall Study||17
216406|NCT00712920|518473|P1|NOT COMPLETED|Overall Study||17
216407|NCT00712920|518471|P3|COMPLETED|Overall Study||180
216408|NCT00712920|518472|P2|COMPLETED|Overall Study||180
216409|NCT00712920|518473|P1|COMPLETED|Overall Study||175
216410|NCT00712920|518471|P3|STARTED|Overall Study||192
216411|NCT00712920|518472|P2|STARTED|Overall Study|3 subjects were randomized in error|197
216412|NCT00712920|518473|P1|STARTED|Overall Study||192
216413|NCT00712725|518501|P8|NOT COMPLETED|Overall Study||11
216414|NCT00712725|518502|P7|NOT COMPLETED|Overall Study||22
216415|NCT00712725|518503|P6|NOT COMPLETED|Overall Study||16
216416|NCT00712725|518504|P5|NOT COMPLETED|Overall Study||19
216417|NCT00712725|518505|P4|NOT COMPLETED|Overall Study||17
216418|NCT00712725|518506|P3|NOT COMPLETED|Overall Study||10
216419|NCT00712725|518507|P2|NOT COMPLETED|Overall Study||6
216420|NCT00712725|518508|P1|NOT COMPLETED|Overall Study||29
216421|NCT00712725|518501|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
216422|NCT00712725|518502|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
216423|NCT00712725|518503|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
216424|NCT00712725|518504|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
216425|NCT00712725|518505|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
216426|NCT00712725|518506|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
216427|NCT00712725|518507|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
216428|NCT00712725|518508|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
216429|NCT00712725|518501|P8|STARTED|Overall Study||74
216430|NCT00712725|518502|P7|STARTED|Overall Study||83
216431|NCT00712725|518503|P6|STARTED|Overall Study||84
216432|NCT00712725|518504|P5|STARTED|Overall Study||86
216433|NCT00712725|518505|P4|STARTED|Overall Study||84
216434|NCT00712725|518506|P3|STARTED|Overall Study||57
216435|NCT00712725|518507|P2|STARTED|Overall Study||39
216436|NCT00712725|518508|P1|STARTED|Overall Study||169
216437|NCT00712673|518569|P4|NOT COMPLETED|Overall Study||70
216438|NCT00712673|518570|P3|NOT COMPLETED|Overall Study||57
216439|NCT00712673|518571|P2|NOT COMPLETED|Overall Study||21
216440|NCT00712673|518572|P1|NOT COMPLETED|Overall Study||21
216441|NCT00712673|518569|P4|COMPLETED|Overall Study||185
216442|NCT00712673|518570|P3|COMPLETED|Overall Study||198
216443|NCT00712673|518571|P2|COMPLETED|Overall Study||64
216444|NCT00712673|518572|P1|COMPLETED|Overall Study||64
216445|NCT00712673|518569|P4|Subgroup for Standardized Meal Test|Overall Study||0
216446|NCT00712673|518570|P3|Subgroup for Standardized Meal Test|Overall Study||255
216447|NCT00712673|518571|P2|Subgroup for Standardized Meal Test|Overall Study||0
216448|NCT00712673|518572|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
216449|NCT00712673|518569|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
216450|NCT00712673|518570|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
216451|NCT00712673|518571|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
216452|NCT00712673|518572|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
216453|NCT00712673|518569|P4|Safety Population|Overall Study||255
216454|NCT00712673|518570|P3|Safety Population|Overall Study||255
216455|NCT00712673|518571|P2|Safety Population|Overall Study||85
216456|NCT00712673|518572|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
216457|NCT00712673|518569|P4|STARTED|Overall Study||255
216458|NCT00712673|518570|P3|STARTED|Overall Study||255
216459|NCT00712673|518571|P2|STARTED|Overall Study||85
216460|NCT00712673|518572|P1|STARTED|Overall Study|Randomized.|85
216461|NCT00712543|518636|P2|NOT COMPLETED|Day 8-14||2
216462|NCT00712543|518637|P1|NOT COMPLETED|Day 8-14||0
216463|NCT00712543|518636|P2|COMPLETED|Day 8-14||25
216464|NCT00712543|518637|P1|COMPLETED|Day 8-14||23
216465|NCT00712543|518636|P2|STARTED|Day 8-14||27
216466|NCT00712543|518637|P1|STARTED|Day 8-14||23
216467|NCT00712543|518636|P2|NOT COMPLETED|Day 1-7||0
216468|NCT00712543|518637|P1|NOT COMPLETED|Day 1-7||0
216469|NCT00712543|518636|P2|COMPLETED|Day 1-7||27
216470|NCT00712543|518637|P1|COMPLETED|Day 1-7||23
216471|NCT00712543|518636|P2|STARTED|Day 1-7||27
216472|NCT00712543|518637|P1|STARTED|Day 1-7||23
216473|NCT00712530|518646|P3|NOT COMPLETED|Overall Study||0
216474|NCT00712530|518647|P2|NOT COMPLETED|Overall Study||0
216475|NCT00712530|518648|P1|NOT COMPLETED|Overall Study||0
216476|NCT00712530|518646|P3|COMPLETED|Overall Study||3
216477|NCT00712530|518647|P2|COMPLETED|Overall Study||3
216478|NCT00712530|518648|P1|COMPLETED|Overall Study||3
216479|NCT00712530|518646|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
216480|NCT00712530|518647|P2|STARTED|Overall Study||3
216481|NCT00712530|518648|P1|STARTED|Overall Study||3
216482|NCT00712348|518671|P1|NOT COMPLETED|Overall Study||1
216483|NCT00712348|518671|P1|COMPLETED|Overall Study||30
216484|NCT00712348|518671|P1|STARTED|Overall Study||31
216485|NCT00712335|518683|P5|NOT COMPLETED|Overall Study||0
216486|NCT00712335|518684|P4|NOT COMPLETED|Overall Study||5
216487|NCT00712335|518685|P3|NOT COMPLETED|Overall Study||5
216488|NCT00712335|518686|P2|NOT COMPLETED|Overall Study||17
216489|NCT00712335|518687|P1|NOT COMPLETED|Overall Study||3
216490|NCT00712335|518683|P5|COMPLETED|Overall Study||30
216491|NCT00712335|518684|P4|COMPLETED|Overall Study||19
216492|NCT00712335|518685|P3|COMPLETED|Overall Study||6
216493|NCT00712335|518686|P2|COMPLETED|Overall Study||15
216494|NCT00712335|518687|P1|COMPLETED|Overall Study||5
216495|NCT00712335|518683|P5|STARTED|Overall Study||30
216496|NCT00712335|518684|P4|STARTED|Overall Study||24
216497|NCT00712335|518685|P3|STARTED|Overall Study||11
216498|NCT00712335|518686|P2|STARTED|Overall Study||32
216499|NCT00712335|518687|P1|STARTED|Overall Study||8
216500|NCT00712244|518733|P4|NOT COMPLETED|Overall Study||1
216501|NCT00712244|518734|P3|NOT COMPLETED|Overall Study||2
216502|NCT00712244|518735|P2|NOT COMPLETED|Overall Study||1
216503|NCT00712244|518736|P1|NOT COMPLETED|Overall Study||4
216504|NCT00712244|518733|P4|COMPLETED|Overall Study||26
216505|NCT00712244|518734|P3|COMPLETED|Overall Study||25
216506|NCT00712244|518735|P2|COMPLETED|Overall Study||28
216507|NCT00712244|518736|P1|COMPLETED|Overall Study||25
216508|NCT00712244|518733|P4|STARTED|Overall Study||27
216509|NCT00712244|518734|P3|STARTED|Overall Study||27
216510|NCT00712244|518735|P2|STARTED|Overall Study||29
216511|NCT00712244|518736|P1|STARTED|Overall Study||29
216512|NCT00712179|518778|P1|NOT COMPLETED|Overall Study||12
216513|NCT00712179|518778|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
216514|NCT00712179|518778|P1|STARTED|Overall Study||49
216515|NCT00712166|518784|P2|NOT COMPLETED|Overall Study||1
216516|NCT00712166|518785|P1|NOT COMPLETED|Overall Study||0
216517|NCT00712166|518784|P2|COMPLETED|Overall Study||75
216518|NCT00712166|518785|P1|COMPLETED|Overall Study||81
216519|NCT00712166|518784|P2|STARTED|Overall Study||76
216520|NCT00712166|518785|P1|STARTED|Overall Study||81
216521|NCT00712075|518812|P3|NOT COMPLETED|Overall Study||11
216522|NCT00712075|518813|P2|NOT COMPLETED|Overall Study||4
216523|NCT00712075|518814|P1|NOT COMPLETED|Overall Study||5
216524|NCT00712075|518812|P3|COMPLETED|Overall Study||14
216525|NCT00712075|518813|P2|COMPLETED|Overall Study||26
216526|NCT00712075|518814|P1|COMPLETED|Overall Study||17
216527|NCT00712075|518812|P3|STARTED|Overall Study||25
216528|NCT00712075|518813|P2|STARTED|Overall Study||30
216529|NCT00712075|518814|P1|STARTED|Overall Study||22
216530|NCT00712010|518828|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
216531|NCT00712010|518828|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
216532|NCT00712010|518828|P1|STARTED|7th and Last Protein Testing (1 Day)||23
216533|NCT00712010|518828|P1|NOT COMPLETED|Washout (7 Days)||0
216534|NCT00712010|518828|P1|COMPLETED|Washout (7 Days)||23
216535|NCT00712010|518828|P1|STARTED|Washout (7 Days)||23
216536|NCT00712010|518828|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
216537|NCT00712010|518828|P1|COMPLETED|6th Protein Testing (1 Day)||23
216538|NCT00712010|518828|P1|STARTED|6th Protein Testing (1 Day)||23
216539|NCT00712010|518828|P1|NOT COMPLETED|Washout (7 Days)||0
216540|NCT00712010|518828|P1|COMPLETED|Washout (7 Days)||23
216541|NCT00712010|518828|P1|STARTED|Washout (7 Days)||23
216542|NCT00712010|518828|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
216543|NCT00712010|518828|P1|COMPLETED|5th Protein Testing (1 Day)||23
216544|NCT00712010|518828|P1|STARTED|5th Protein Testing (1 Day)||23
216545|NCT00712010|518828|P1|NOT COMPLETED|Washout (7 Days)||1
216546|NCT00712010|518828|P1|COMPLETED|Washout (7 Days)||23
216547|NCT00712010|518828|P1|STARTED|Washout (7 Days)||24
216548|NCT00712010|518828|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
216549|NCT00712010|518828|P1|COMPLETED|4th Protein Testing (1 Day)||24
216550|NCT00712010|518828|P1|STARTED|4th Protein Testing (1 Day)||24
216551|NCT00712010|518828|P1|NOT COMPLETED|Washout (7 Days)||0
216552|NCT00712010|518828|P1|COMPLETED|Washout (7 Days)||24
216553|NCT00712010|518828|P1|STARTED|Washout (7 Days)||24
216554|NCT00712010|518828|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
216555|NCT00712010|518828|P1|COMPLETED|3rd Protein Testing (1 Day)||24
216556|NCT00712010|518828|P1|STARTED|3rd Protein Testing (1 Day)||24
216557|NCT00712010|518828|P1|NOT COMPLETED|Washout (7 Days)||0
216558|NCT00712010|518828|P1|COMPLETED|Washout (7 Days)||24
216559|NCT00712010|518828|P1|STARTED|Washout (7 Days)||24
216560|NCT00712010|518828|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
216561|NCT00712010|518828|P1|COMPLETED|2nd Protein Testing (1 Day)||24
216562|NCT00712010|518828|P1|STARTED|2nd Protein Testing (1 Day)||24
216563|NCT00712010|518828|P1|NOT COMPLETED|Washout (7 Days)||0
216564|NCT00712010|518828|P1|COMPLETED|Washout (7 Days)||24
216565|NCT00712010|518828|P1|STARTED|Washout (7 Days)||24
216566|NCT00712010|518828|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
216567|NCT00712010|518828|P1|COMPLETED|1st Protein Testing (1 Day)||24
216568|NCT00712010|518828|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
216569|NCT00711997|518853|P2|NOT COMPLETED|Overall Study||0
216570|NCT00711997|518854|P1|NOT COMPLETED|Overall Study||0
216571|NCT00711997|518853|P2|COMPLETED|Overall Study||6
216572|NCT00711997|518854|P1|COMPLETED|Overall Study||3
216573|NCT00711997|518853|P2|STARTED|Overall Study||6
216574|NCT00711997|518854|P1|STARTED|Overall Study||3
216575|NCT00711971|518867|P3|NOT COMPLETED|Overall Study||1
216576|NCT00711971|518868|P2|NOT COMPLETED|Overall Study||4
216577|NCT00711971|518869|P1|NOT COMPLETED|Overall Study||3
216578|NCT00711971|518867|P3|COMPLETED|Overall Study||41
216579|NCT00711971|518868|P2|COMPLETED|Overall Study||38
216580|NCT00711971|518869|P1|COMPLETED|Overall Study||39
216581|NCT00711971|518867|P3|STARTED|Overall Study||42
216582|NCT00711971|518868|P2|STARTED|Overall Study||42
216583|NCT00711971|518869|P1|STARTED|Overall Study||42
216584|NCT00711958|518903|P2|NOT COMPLETED|Overall Study||23
216585|NCT00711958|518904|P1|NOT COMPLETED|Overall Study||33
216586|NCT00711958|518903|P2|COMPLETED|Overall Study||17
216587|NCT00711958|518904|P1|COMPLETED|Overall Study||41
216588|NCT00711958|518903|P2|STARTED|Overall Study||40
216589|NCT00711958|518904|P1|STARTED|Overall Study||74
216590|NCT00711880|518912|P2|NOT COMPLETED|Overall Study||7
216591|NCT00711880|518913|P1|NOT COMPLETED|Overall Study||13
216592|NCT00711880|518912|P2|COMPLETED|Overall Study||55
216593|NCT00711880|518913|P1|COMPLETED|Overall Study||50
216594|NCT00711880|518912|P2|STARTED|Overall Study||62
216595|NCT00711880|518913|P1|STARTED|Overall Study||63
216596|NCT00711867|518951|P2|NOT COMPLETED|Overall Study||4
216597|NCT00711867|518952|P1|NOT COMPLETED|Overall Study||5
216598|NCT00711867|518951|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
216599|NCT00711867|518952|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
216600|NCT00711867|518951|P2|STARTED|Overall Study||25
216601|NCT00711867|518952|P1|STARTED|Overall Study||30
216602|NCT00711828|518958|P1|NOT COMPLETED|Overall Study||0
216603|NCT00711828|518958|P1|COMPLETED|Overall Study||21
216604|NCT00711828|518958|P1|STARTED|Overall Study||21
216605|NCT00711802|518975|P8|NOT COMPLETED|Overall Study||2
216606|NCT00711802|518976|P7|NOT COMPLETED|Overall Study||5
216607|NCT00711802|518977|P6|NOT COMPLETED|Overall Study||8
216608|NCT00711802|518978|P5|NOT COMPLETED|Overall Study||14
216609|NCT00711802|518979|P4|NOT COMPLETED|Overall Study||3
216610|NCT00711802|518980|P3|NOT COMPLETED|Overall Study||6
216611|NCT00711802|518981|P2|NOT COMPLETED|Overall Study||6
216612|NCT00711802|518982|P1|NOT COMPLETED|Overall Study||2
216613|NCT00711802|518975|P8|COMPLETED|Overall Study||13
216614|NCT00711802|518976|P7|COMPLETED|Overall Study||25
216615|NCT00711802|518977|P6|COMPLETED|Overall Study||34
216616|NCT00711802|518978|P5|COMPLETED|Overall Study||69
216617|NCT00711802|518979|P4|COMPLETED|Overall Study||35
216618|NCT00711802|518980|P3|COMPLETED|Overall Study||69
216619|NCT00711802|518981|P2|COMPLETED|Overall Study||32
216620|NCT00711802|518982|P1|COMPLETED|Overall Study||73
216621|NCT00711802|518975|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
216622|NCT00711802|518976|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
216623|NCT00711802|518977|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
216624|NCT00711802|518978|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
216625|NCT00711802|518979|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
216626|NCT00711802|518980|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
216627|NCT00711802|518981|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
216628|NCT00711802|518982|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
216629|NCT00711802|518975|P8|STARTED|Overall Study||15
216630|NCT00711802|518976|P7|STARTED|Overall Study||30
216631|NCT00711802|518977|P6|STARTED|Overall Study||42
216632|NCT00711802|518978|P5|STARTED|Overall Study||83
216633|NCT00711802|518979|P4|STARTED|Overall Study||38
216634|NCT00711802|518980|P3|STARTED|Overall Study||75
216635|NCT00711802|518981|P2|STARTED|Overall Study||38
216636|NCT00711802|518982|P1|STARTED|Overall Study||75
216637|NCT00711646|519014|P2|NOT COMPLETED|Overall Study||3
216638|NCT00711646|519015|P1|NOT COMPLETED|Overall Study||12
216639|NCT00711646|519014|P2|COMPLETED|Overall Study||62
216640|NCT00711646|519015|P1|COMPLETED|Overall Study||112
216641|NCT00711646|519014|P2|STARTED|Overall Study||65
216642|NCT00711646|519015|P1|STARTED|Overall Study||124
216643|NCT00711594|519037|P4|NOT COMPLETED|Overall Study||62
216644|NCT00711594|519038|P3|NOT COMPLETED|Overall Study||6
216645|NCT00711594|519039|P2|NOT COMPLETED|Overall Study||3
216646|NCT00711594|519040|P1|NOT COMPLETED|Overall Study||3
216647|NCT00711594|519037|P4|COMPLETED|Overall Study||0
216648|NCT00711594|519038|P3|COMPLETED|Overall Study||0
216649|NCT00711594|519039|P2|COMPLETED|Overall Study||0
216650|NCT00711594|519040|P1|COMPLETED|Overall Study||0
216651|NCT00711594|519037|P4|STARTED|Overall Study||62
216652|NCT00711594|519038|P3|STARTED|Overall Study||6
216653|NCT00711594|519039|P2|STARTED|Overall Study||3
216654|NCT00711594|519040|P1|STARTED|Overall Study||3
216655|NCT00711555|519077|P1|NOT COMPLETED|Overall Study||3
216656|NCT00711555|519077|P1|COMPLETED|Overall Study||19
216657|NCT00711555|519077|P1|STARTED|Overall Study||22
216658|NCT00711529|519086|P2|NOT COMPLETED|Overall Study||6
216659|NCT00711529|519087|P1|NOT COMPLETED|Overall Study||4
216660|NCT00711529|519086|P2|COMPLETED|Overall Study||8
216661|NCT00711529|519087|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
216662|NCT00711529|519086|P2|STARTED|Overall Study||14
216663|NCT00711529|519087|P1|STARTED|Overall Study||13
216664|NCT00711516|519111|P2|NOT COMPLETED|Overall Study||3
216665|NCT00711516|519112|P1|NOT COMPLETED|Overall Study||1
216666|NCT00711516|519111|P2|COMPLETED|Overall Study||16
216667|NCT00711516|519112|P1|COMPLETED|Overall Study||20
216668|NCT00711516|519111|P2|STARTED|Overall Study||19
216669|NCT00711516|519112|P1|STARTED|Overall Study||21
216670|NCT00711490|519206|P1|NOT COMPLETED|Overall Study||0
216671|NCT00711490|519206|P1|COMPLETED|Overall Study||5
216672|NCT00711490|519206|P1|STARTED|Overall Study||5
216673|NCT00711477|519219|P2|NOT COMPLETED|Overall Study||3
216674|NCT00711477|519220|P1|NOT COMPLETED|Overall Study||3
216675|NCT00711477|519219|P2|COMPLETED|Overall Study||20
216676|NCT00711477|519220|P1|COMPLETED|Overall Study||20
216677|NCT00711477|519219|P2|STARTED|Overall Study||23
216678|NCT00711477|519220|P1|STARTED|Overall Study||23
216679|NCT00711464|519248|P1|NOT COMPLETED|Overall Study||0
216680|NCT00711464|519248|P1|COMPLETED|Overall Study||29
216681|NCT00711464|519248|P1|STARTED|Overall Study||29
216682|NCT00711425|519266|P1|NOT COMPLETED|Overall Study||4
216683|NCT00711425|519266|P1|COMPLETED|Overall Study||41
216684|NCT00711425|519266|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
216685|NCT00711347|519274|P2|NOT COMPLETED|Overall Study||0
216686|NCT00711347|519275|P1|NOT COMPLETED|Overall Study||0
216687|NCT00711347|519274|P2|COMPLETED|Overall Study||14
216688|NCT00711347|519275|P1|COMPLETED|Overall Study||14
216689|NCT00711347|519274|P2|STARTED|Overall Study||14
216690|NCT00711347|519275|P1|STARTED|Overall Study||14
216691|NCT00711191|519294|P3|NOT COMPLETED|Overall Study||12
216692|NCT00711191|519295|P2|NOT COMPLETED|Overall Study||5
216693|NCT00711191|519296|P1|NOT COMPLETED|Overall Study||3
216694|NCT00711191|519294|P3|COMPLETED|Overall Study||1
216695|NCT00711191|519295|P2|COMPLETED|Overall Study||1
216696|NCT00711191|519296|P1|COMPLETED|Overall Study||0
216697|NCT00711191|519294|P3|STARTED|Overall Study||13
216698|NCT00711191|519295|P2|STARTED|Overall Study||6
216699|NCT00711191|519296|P1|STARTED|Overall Study||3
216700|NCT00711113|519333|P1|NOT COMPLETED|Overall Study||11
216701|NCT00711113|519333|P1|COMPLETED|Overall Study||36
216702|NCT00711113|519333|P1|STARTED|Overall Study||47
216703|NCT00711100|519339|P1|NOT COMPLETED|Overall Study||13
216704|NCT00711100|519339|P1|COMPLETED|Overall Study||91
216705|NCT00711100|519339|P1|STARTED|Overall Study||104
216706|NCT00711087|519357|P2|NOT COMPLETED|Overall Study||0
216707|NCT00711087|519358|P1|NOT COMPLETED|Overall Study||1
216708|NCT00711087|519357|P2|COMPLETED|Overall Study||0
216709|NCT00711087|519358|P1|COMPLETED|Overall Study||0
216710|NCT00711087|519357|P2|STARTED|Overall Study||0
216711|NCT00711087|519358|P1|STARTED|Overall Study||1
216712|NCT00711022|519364|P1|NOT COMPLETED|Overall Study||11
216713|NCT00711022|519364|P1|COMPLETED|Overall Study||40
216714|NCT00711022|519364|P1|STARTED|Overall Study||51
216715|NCT00711009|519370|P2|NOT COMPLETED|Overall Study||19
216716|NCT00711009|519371|P1|NOT COMPLETED|Overall Study||15
216717|NCT00711009|519370|P2|COMPLETED|Overall Study||82
216718|NCT00711009|519371|P1|COMPLETED|Overall Study||90
216719|NCT00711009|519370|P2|STARTED|Overall Study||101
216720|NCT00711009|519371|P1|STARTED|Overall Study||105
216721|NCT00710996|519542|P3|NOT COMPLETED|Overall Study||0
216722|NCT00710996|519543|P2|NOT COMPLETED|Overall Study||4
216723|NCT00710996|519544|P1|NOT COMPLETED|Overall Study||1
216724|NCT00710996|519542|P3|COMPLETED|Overall Study||21
216725|NCT00710996|519543|P2|COMPLETED|Overall Study||16
216726|NCT00710996|519544|P1|COMPLETED|Overall Study||16
216727|NCT00710996|519542|P3|STARTED|Overall Study||21
216728|NCT00710996|519543|P2|STARTED|Overall Study||20
216729|NCT00710996|519544|P1|STARTED|Overall Study||17
216730|NCT00710970|519552|P1|NOT COMPLETED|Overall Study||10
216731|NCT00710970|519552|P1|COMPLETED|Overall Study||18
216732|NCT00710970|519552|P1|STARTED|Overall Study||28
216733|NCT00710944|519559|P3|NOT COMPLETED|Overall Study||2
216734|NCT00710944|519560|P2|NOT COMPLETED|Overall Study||9
216735|NCT00710944|519561|P1|NOT COMPLETED|Overall Study||10
216736|NCT00710944|519559|P3|COMPLETED|Overall Study||17
216737|NCT00710944|519560|P2|COMPLETED|Overall Study||49
216738|NCT00710944|519561|P1|COMPLETED|Overall Study||45
216739|NCT00710944|519559|P3|STARTED|Overall Study||19
216740|NCT00710944|519560|P2|STARTED|Overall Study||58
216741|NCT00710944|519561|P1|STARTED|Overall Study||55
216742|NCT00710931|519569|P1|NOT COMPLETED|Overall Study||5
216743|NCT00710931|519569|P1|COMPLETED|Overall Study||29
216744|NCT00710931|519569|P1|STARTED|Overall Study||34
216745|NCT00710905|519573|P1|NOT COMPLETED|Overall Study||16
216746|NCT00710905|519573|P1|COMPLETED|Overall Study||34
216747|NCT00710905|519573|P1|STARTED|Overall Study||50
216748|NCT00710879|519579|P2|NOT COMPLETED|Overall Study||4
216749|NCT00710879|519580|P1|NOT COMPLETED|Overall Study||2
216750|NCT00710879|519579|P2|COMPLETED|Overall Study||113
216751|NCT00710879|519580|P1|COMPLETED|Overall Study||58
216752|NCT00710879|519579|P2|STARTED|Overall Study||117
216753|NCT00710879|519580|P1|STARTED|Overall Study||60
216754|NCT00710866|519592|P2|NOT COMPLETED|Overall Study||6
216755|NCT00710866|519593|P1|NOT COMPLETED|Overall Study||9
216756|NCT00710866|519592|P2|COMPLETED|Overall Study||128
216757|NCT00710866|519593|P1|COMPLETED|Overall Study||124
216758|NCT00710866|519592|P2|STARTED|Overall Study||134
216759|NCT00710866|519593|P1|STARTED|Overall Study||133
216760|NCT00710840|519615|P2|NOT COMPLETED|Overall Study||3
216761|NCT00710840|519616|P1|NOT COMPLETED|Overall Study||0
216762|NCT00710840|519615|P2|COMPLETED|Overall Study||19
216763|NCT00710840|519616|P1|COMPLETED|Overall Study||22
216764|NCT00710840|519615|P2|STARTED|Overall Study||22
216765|NCT00710840|519616|P1|STARTED|Overall Study||22
216766|NCT00710814|519630|P2|NOT COMPLETED|Overall Study||3
216767|NCT00710814|519631|P1|NOT COMPLETED|Overall Study||1
216768|NCT00710814|519630|P2|COMPLETED|Overall Study||13
216769|NCT00710814|519631|P1|COMPLETED|Overall Study||14
216770|NCT00710814|519630|P2|STARTED|Overall Study||16
216771|NCT00710814|519631|P1|STARTED|Overall Study||15
216772|NCT00710762|519639|P2|NOT COMPLETED|Overall Study||40
216773|NCT00710762|519640|P1|NOT COMPLETED|Overall Study||39
216774|NCT00710762|519639|P2|COMPLETED|Overall Study||0
216775|NCT00710762|519640|P1|COMPLETED|Overall Study||5
216776|NCT00710762|519639|P2|STARTED|Overall Study||40
216777|NCT00710762|519640|P1|STARTED|Overall Study||44
216778|NCT00710749|519656|P2|NOT COMPLETED|Second Intervention||0
216779|NCT00710749|519657|P1|NOT COMPLETED|Second Intervention||0
216780|NCT00710749|519656|P2|COMPLETED|Second Intervention||30
216781|NCT00710749|519657|P1|COMPLETED|Second Intervention||29
216782|NCT00710749|519656|P2|STARTED|Second Intervention||30
216783|NCT00710749|519657|P1|STARTED|Second Intervention||29
216784|NCT00710749|519656|P2|NOT COMPLETED|First Intervention||0
216785|NCT00710749|519657|P1|NOT COMPLETED|First Intervention||1
216786|NCT00710749|519656|P2|COMPLETED|First Intervention||30
216787|NCT00710749|519657|P1|COMPLETED|First Intervention||29
216788|NCT00710749|519656|P2|STARTED|First Intervention||30
216789|NCT00710749|519657|P1|STARTED|First Intervention||30
216790|NCT00710749|519656|P2|NOT COMPLETED|Clinic Baseline Recording||0
216791|NCT00710749|519657|P1|NOT COMPLETED|Clinic Baseline Recording||0
216792|NCT00710749|519656|P2|COMPLETED|Clinic Baseline Recording||30
216793|NCT00710749|519657|P1|COMPLETED|Clinic Baseline Recording||30
216794|NCT00710749|519656|P2|STARTED|Clinic Baseline Recording||30
216795|NCT00710749|519657|P1|STARTED|Clinic Baseline Recording||30
216796|NCT00710684|519668|P3|NOT COMPLETED|Overall Study||64
216797|NCT00710684|519669|P2|NOT COMPLETED|Overall Study||74
216798|NCT00710684|519670|P1|NOT COMPLETED|Overall Study||74
216799|NCT00710684|519668|P3|COMPLETED|Overall Study||172
216800|NCT00710684|519669|P2|COMPLETED|Overall Study||147
216801|NCT00710684|519670|P1|COMPLETED|Overall Study||151
216802|NCT00710684|519668|P3|STARTED|Overall Study||236
216803|NCT00710684|519669|P2|STARTED|Overall Study||221
216804|NCT00710684|519670|P1|STARTED|Overall Study||225
216805|NCT00710606|519727|P2|NOT COMPLETED|Overall Study||2
216806|NCT00710606|519728|P1|NOT COMPLETED|Overall Study||0
216807|NCT00710606|519727|P2|COMPLETED|Overall Study||18
216808|NCT00710606|519728|P1|COMPLETED|Overall Study||20
216809|NCT00710606|519727|P2|STARTED|Overall Study||20
216810|NCT00710606|519728|P1|STARTED|Overall Study||20
216811|NCT00710593|519740|P2|NOT COMPLETED|Overall Study||5
216812|NCT00710593|519741|P1|NOT COMPLETED|Overall Study||15
216813|NCT00710593|519740|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
216814|NCT00710593|519741|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
216815|NCT00710593|519740|P2|STARTED|Overall Study||30
216816|NCT00710593|519741|P1|STARTED|Overall Study||69
216817|NCT00710554|519784|P2|NOT COMPLETED|Overall Study||24
216818|NCT00710554|519785|P1|NOT COMPLETED|Overall Study||49
216819|NCT00710554|519784|P2|COMPLETED|Overall Study||94
216820|NCT00710554|519785|P1|COMPLETED|Overall Study||79
216821|NCT00710554|519784|P2|STARTED|Overall Study||118
216822|NCT00710554|519785|P1|STARTED|Overall Study||128
216823|NCT00710424|519813|P2|NOT COMPLETED|Overall Study||23
216824|NCT00710424|519814|P1|NOT COMPLETED|Overall Study||44
216825|NCT00710424|519813|P2|COMPLETED|Overall Study||125
216826|NCT00710424|519814|P1|COMPLETED|Overall Study||105
216827|NCT00710424|519813|P2|STARTED|Overall Study||148
216828|NCT00710424|519814|P1|STARTED|Overall Study||149
216829|NCT00710385|519838|P1|NOT COMPLETED|Overall Study||5
216830|NCT00710385|519838|P1|COMPLETED|Overall Study||12
216831|NCT00710385|519838|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
216832|NCT00710203|519855|P1|NOT COMPLETED|Overall Study||0
216833|NCT00710203|519855|P1|COMPLETED|Overall Study||10
216834|NCT00710203|519855|P1|STARTED|Overall Study||10
216835|NCT00710034|519883|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
216836|NCT00710034|519884|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
216837|NCT00710034|519883|P2|COMPLETED|Completed 12 Weeks of Treatment||138
216838|NCT00710034|519884|P1|COMPLETED|Completed 12 Weeks of Treatment||141
216839|NCT00710034|519883|P2|STARTED|Completed 12 Weeks of Treatment||149
216840|NCT00710034|519884|P1|STARTED|Completed 12 Weeks of Treatment||154
216841|NCT00710034|519883|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
216842|NCT00710034|519884|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
216843|NCT00710034|519883|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
216844|NCT00710034|519884|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
216845|NCT00710034|519883|P2|STARTED|Completed 6 Weeks of Treatment||196
216846|NCT00710034|519884|P1|STARTED|Completed 6 Weeks of Treatment||195
216847|NCT00710021|519901|P3|NOT COMPLETED|Overall Study||1
216848|NCT00710021|519902|P2|NOT COMPLETED|Overall Study||3
216849|NCT00710021|519903|P1|NOT COMPLETED|Overall Study||1
216850|NCT00710021|519901|P3|COMPLETED|Overall Study||18
216851|NCT00710021|519902|P2|COMPLETED|Overall Study||16
216852|NCT00710021|519903|P1|COMPLETED|Overall Study||18
216853|NCT00710021|519901|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
216854|NCT00710021|519902|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
216855|NCT00710021|519903|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
216856|NCT00710021|519901|P3|STARTED|Overall Study||19
216857|NCT00710021|519902|P2|STARTED|Overall Study||19
216858|NCT00710021|519903|P1|STARTED|Overall Study||19
216859|NCT00709956|520018|P2|NOT COMPLETED|Overall Study||4
216860|NCT00709956|520019|P1|NOT COMPLETED|Overall Study||3
216861|NCT00709956|520018|P2|COMPLETED|Overall Study||33
216862|NCT00709956|520019|P1|COMPLETED|Overall Study||30
216863|NCT00709956|520018|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
216864|NCT00709956|520019|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
216865|NCT00709956|520018|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
216866|NCT00709956|520019|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
216867|NCT00709891|520027|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
216868|NCT00709891|520027|P1|COMPLETED|Longitudinal Follow-up Phase||5020
216869|NCT00709891|520027|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
216870|NCT00709891|520027|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
216871|NCT00709891|520027|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
216872|NCT00709891|520027|P1|STARTED|Baseline, Cross-sectional Phase||47208
216873|NCT00709878|520036|P4|NOT COMPLETED|Overall Study||0
216874|NCT00709878|520037|P3|NOT COMPLETED|Overall Study||0
216875|NCT00709878|520038|P2|NOT COMPLETED|Overall Study||0
216876|NCT00709878|520039|P1|NOT COMPLETED|Overall Study||0
216877|NCT00709878|520036|P4|COMPLETED|Overall Study||8
216878|NCT00709878|520037|P3|COMPLETED|Overall Study||8
216879|NCT00709878|520038|P2|COMPLETED|Overall Study||8
216880|NCT00709878|520039|P1|COMPLETED|Overall Study||8
216881|NCT00709878|520036|P4|STARTED|Overall Study||8
216882|NCT00709878|520037|P3|STARTED|Overall Study||8
216883|NCT00709878|520038|P2|STARTED|Overall Study||8
216884|NCT00709878|520039|P1|STARTED|Overall Study||8
216885|NCT00709852|520049|P2|NOT COMPLETED|Period 2||2
216886|NCT00709852|520050|P1|NOT COMPLETED|Period 2||9
216887|NCT00709852|520049|P2|COMPLETED|Period 2||169
216888|NCT00709852|520050|P1|COMPLETED|Period 2||211
216889|NCT00709852|520049|P2|STARTED|Period 2||171
216890|NCT00709852|520050|P1|STARTED|Period 2||220
216891|NCT00709852|520049|P2|NOT COMPLETED|Period 1||3
216892|NCT00709852|520050|P1|NOT COMPLETED|Period 1||8
216893|NCT00709852|520049|P2|COMPLETED|Period 1||171
216894|NCT00709852|520050|P1|COMPLETED|Period 1||220
216895|NCT00709852|520049|P2|STARTED|Period 1||174
216896|NCT00709852|520050|P1|STARTED|Period 1||228
216897|NCT00709826|520205|P2|NOT COMPLETED|Overall Study||1
216898|NCT00709826|520206|P1|NOT COMPLETED|Overall Study||2
216899|NCT00709826|520205|P2|COMPLETED|Overall Study||38
216900|NCT00709826|520206|P1|COMPLETED|Overall Study||68
216901|NCT00709826|520205|P2|STARTED|Overall Study||39
216902|NCT00709826|520206|P1|STARTED|Overall Study||70
216903|NCT00709761|520214|P1|NOT COMPLETED|Overall Study||47
216904|NCT00709761|520214|P1|COMPLETED|Overall Study||13
216905|NCT00709761|520214|P1|Ongoing|Overall Study|At time of clinical data cut off, 11 participants were on study treatment; 29 were in follow up.|40
216906|NCT00709761|520214|P1|STARTED|Overall Study||60
216907|NCT00709735|520225|P2|NOT COMPLETED|Overall Study||2
216908|NCT00709735|520226|P1|NOT COMPLETED|Overall Study||3
216909|NCT00709735|520225|P2|COMPLETED|Overall Study||10
216910|NCT00709735|520226|P1|COMPLETED|Overall Study||8
216911|NCT00709735|520225|P2|STARTED|Overall Study||12
216912|NCT00709735|520226|P1|STARTED|Overall Study||11
216913|NCT00709722|520234|P1|NOT COMPLETED|Overall Study||1
216914|NCT00709722|520234|P1|COMPLETED|Overall Study||20
216915|NCT00709722|520234|P1|STARTED|Overall Study||21
216916|NCT00709696|520242|P2|NOT COMPLETED|Overall Study||0
216917|NCT00709696|520243|P1|NOT COMPLETED|Overall Study||0
216918|NCT00709696|520242|P2|COMPLETED|Overall Study||3
216919|NCT00709696|520243|P1|COMPLETED|Overall Study||4
216920|NCT00709696|520242|P2|STARTED|Overall Study||3
216921|NCT00709696|520243|P1|STARTED|Overall Study||4
216922|NCT00709618|520249|P1|NOT COMPLETED|Overall Study||30
216923|NCT00709618|520249|P1|COMPLETED|Overall Study||14
216924|NCT00709618|520249|P1|STARTED|Overall Study||44
216925|NCT00709592|520261|P2|NOT COMPLETED|Overall Study||1
216926|NCT00709592|520262|P1|NOT COMPLETED|Overall Study||0
216927|NCT00709592|520261|P2|COMPLETED|Overall Study||22
216928|NCT00709592|520262|P1|COMPLETED|Overall Study||19
216929|NCT00709592|520261|P2|STARTED|Overall Study||23
216930|NCT00709592|520262|P1|STARTED|Overall Study||19
216931|NCT00709319|520282|P1|NOT COMPLETED|Overall Study||6
216932|NCT00709319|520282|P1|COMPLETED|Overall Study||81
216933|NCT00709319|520282|P1|STARTED|Overall Study||87
216934|NCT00709306|520294|P4|NOT COMPLETED|Overall Study||10
216935|NCT00709306|520295|P3|NOT COMPLETED|Overall Study||10
216936|NCT00709306|520296|P2|NOT COMPLETED|Overall Study||14
216937|NCT00709306|520297|P1|NOT COMPLETED|Overall Study||9
216938|NCT00709306|520294|P4|COMPLETED|Overall Study||37
216939|NCT00709306|520295|P3|COMPLETED|Overall Study||48
216940|NCT00709306|520296|P2|COMPLETED|Overall Study||30
216941|NCT00709306|520297|P1|COMPLETED|Overall Study||39
216942|NCT00709306|520294|P4|STARTED|Overall Study||47
216943|NCT00709306|520295|P3|STARTED|Overall Study||58
216944|NCT00709306|520296|P2|STARTED|Overall Study||44
216945|NCT00709306|520297|P1|STARTED|Overall Study||48
216946|NCT00709228|520311|P1|NOT COMPLETED|Overall Study||332
216947|NCT00709228|520311|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
216948|NCT00709228|520311|P1|STARTED|Overall Study||496
216949|NCT00709124|520317|P2|NOT COMPLETED|Overall Study||1
216950|NCT00709124|520318|P1|NOT COMPLETED|Overall Study||4
216951|NCT00709124|520317|P2|COMPLETED|Overall Study||17
216952|NCT00709124|520318|P1|COMPLETED|Overall Study||12
216953|NCT00709124|520317|P2|STARTED|Overall Study||18
216954|NCT00709124|520318|P1|STARTED|Overall Study||16
216955|NCT00709111|520352|P1|NOT COMPLETED|Overall Study||2
216956|NCT00709111|520352|P1|COMPLETED|Overall Study||32
216957|NCT00709111|520352|P1|Week 22/24|Overall Study||33
216958|NCT00709111|520352|P1|STARTED|Overall Study||34
216959|NCT00709098|520393|P3|NOT COMPLETED|Open-label Period||14
216960|NCT00709098|520394|P2|NOT COMPLETED|Open-label Period||0
216961|NCT00709098|520395|P1|NOT COMPLETED|Open-label Period||0
216962|NCT00709098|520393|P3|COMPLETED|Open-label Period||18
216963|NCT00709098|520394|P2|COMPLETED|Open-label Period||0
216964|NCT00709098|520395|P1|COMPLETED|Open-label Period||0
216965|NCT00709098|520393|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
216966|NCT00709098|520394|P2|STARTED|Open-label Period||0
216967|NCT00709098|520395|P1|STARTED|Open-label Period||0
216968|NCT00709098|520393|P3|NOT COMPLETED|Double-blind Period||0
216969|NCT00709098|520394|P2|NOT COMPLETED|Double-blind Period||8
216970|NCT00709098|520395|P1|NOT COMPLETED|Double-blind Period||6
216971|NCT00709098|520393|P3|COMPLETED|Double-blind Period||0
216972|NCT00709098|520394|P2|COMPLETED|Double-blind Period||16
216973|NCT00709098|520395|P1|COMPLETED|Double-blind Period||19
216974|NCT00709098|520393|P3|STARTED|Double-blind Period||0
216975|NCT00709098|520394|P2|STARTED|Double-blind Period||24
216976|NCT00709098|520395|P1|STARTED|Double-blind Period||25
216977|NCT00709059|520414|P1|NOT COMPLETED|Overall Study||94
216978|NCT00709059|520414|P1|COMPLETED|Overall Study||444
216979|NCT00709059|520414|P1|STARTED|Overall Study||538
216980|NCT00708942|520423|P5|NOT COMPLETED|Overall Study||1
216981|NCT00708942|520424|P4|NOT COMPLETED|Overall Study||0
216982|NCT00708942|520425|P3|NOT COMPLETED|Overall Study||2
216983|NCT00708942|520426|P2|NOT COMPLETED|Overall Study||1
216984|NCT00708942|520427|P1|NOT COMPLETED|Overall Study||7
216985|NCT00708942|520423|P5|COMPLETED|Overall Study||2
216986|NCT00708942|520424|P4|COMPLETED|Overall Study||10
216987|NCT00708942|520425|P3|COMPLETED|Overall Study||9
216988|NCT00708942|520426|P2|COMPLETED|Overall Study||11
216989|NCT00708942|520427|P1|COMPLETED|Overall Study||40
216990|NCT00708942|520423|P5|STARTED|Overall Study||3
216991|NCT00708942|520424|P4|STARTED|Overall Study||10
216992|NCT00708942|520425|P3|STARTED|Overall Study||11
216993|NCT00708942|520426|P2|STARTED|Overall Study||12
216994|NCT00708942|520427|P1|STARTED|Overall Study||47
216995|NCT00708877|520449|P1|NOT COMPLETED|Overall Study||0
216996|NCT00708877|520449|P1|COMPLETED|Overall Study||5
216997|NCT00708877|520449|P1|STARTED|Overall Study||5
216998|NCT00708851|520453|P1|NOT COMPLETED|Overall Study||0
216999|NCT00708851|520453|P1|COMPLETED|Overall Study||12
217000|NCT00708851|520453|P1|STARTED|Overall Study||12
217001|NCT00708734|520461|P1|NOT COMPLETED|Overall Study||7
217002|NCT00708734|520461|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
217003|NCT00708734|520461|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
217004|NCT00708721|520465|P4|NOT COMPLETED|Overall Study||0
217005|NCT00708721|520466|P3|NOT COMPLETED|Overall Study||0
217006|NCT00708721|520467|P2|NOT COMPLETED|Overall Study||0
217007|NCT00708721|520468|P1|NOT COMPLETED|Overall Study||0
217008|NCT00708721|520465|P4|COMPLETED|Overall Study||2
217009|NCT00708721|520466|P3|COMPLETED|Overall Study||3
217010|NCT00708721|520467|P2|COMPLETED|Overall Study||4
217011|NCT00708721|520468|P1|COMPLETED|Overall Study||2
217012|NCT00708721|520465|P4|STARTED|Overall Study||2
217013|NCT00708721|520466|P3|STARTED|Overall Study||3
217014|NCT00708721|520467|P2|STARTED|Overall Study||4
217015|NCT00708721|520468|P1|STARTED|Overall Study||2
217016|NCT00708708|520481|P1|NOT COMPLETED|Overall Study||742
217017|NCT00708708|520481|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
217018|NCT00708708|520481|P1|STARTED|Overall Study||955
217019|NCT00708682|520529|P1|NOT COMPLETED|Toddler Dose||8
217020|NCT00708682|520529|P1|COMPLETED|Toddler Dose||183
217021|NCT00708682|520529|P1|STARTED|Toddler Dose||191
217022|NCT00708682|520529|P1|NOT COMPLETED|After Infant Series||1
217023|NCT00708682|520529|P1|COMPLETED|After Infant Series||191
217024|NCT00708682|520529|P1|STARTED|After Infant Series||192
217025|NCT00708682|520529|P1|NOT COMPLETED|Infant Series||33
217026|NCT00708682|520529|P1|COMPLETED|Infant Series||192
217027|NCT00708682|520529|P1|Vaccinated Dose 3|Infant Series||194
217028|NCT00708682|520529|P1|Vaccinated Dose 2|Infant Series||214
217029|NCT00708682|520529|P1|Vaccinated Dose 1|Infant Series||223
217030|NCT00708682|520529|P1|STARTED|Infant Series||225
217031|NCT00708643|520550|P2|NOT COMPLETED|Overall Study||1
217032|NCT00708643|520551|P1|NOT COMPLETED|Overall Study||0
217033|NCT00708643|520550|P2|COMPLETED|Overall Study||39
217034|NCT00708643|520551|P1|COMPLETED|Overall Study||40
217035|NCT00708643|520550|P2|STARTED|Overall Study||40
217036|NCT00708643|520551|P1|STARTED|Overall Study||40
217037|NCT00708552|520571|P4|NOT COMPLETED|Overall Study||21
217038|NCT00708552|520572|P3|NOT COMPLETED|Overall Study||15
217039|NCT00708552|520573|P2|NOT COMPLETED|Overall Study||18
217040|NCT00708552|520574|P1|NOT COMPLETED|Overall Study||27
217041|NCT00708552|520571|P4|COMPLETED|Overall Study||130
217042|NCT00708552|520572|P3|COMPLETED|Overall Study||118
217043|NCT00708552|520573|P2|COMPLETED|Overall Study||127
217044|NCT00708552|520574|P1|COMPLETED|Overall Study||118
217045|NCT00708552|520571|P4|STARTED|Overall Study||151
217046|NCT00708552|520572|P3|STARTED|Overall Study||133
217047|NCT00708552|520573|P2|STARTED|Overall Study||145
217048|NCT00708552|520574|P1|STARTED|Overall Study||145
217049|NCT00708526|520724|P2|NOT COMPLETED|Return of Cognitive Function||0
217050|NCT00708526|520725|P1|NOT COMPLETED|Return of Cognitive Function||0
217051|NCT00708526|520724|P2|COMPLETED|Return of Cognitive Function||11
217052|NCT00708526|520725|P1|COMPLETED|Return of Cognitive Function||11
217053|NCT00708526|520724|P2|STARTED|Return of Cognitive Function||11
217054|NCT00708526|520725|P1|STARTED|Return of Cognitive Function||11
217055|NCT00708526|520724|P2|NOT COMPLETED|Wake up After Anesthesia||0
217056|NCT00708526|520725|P1|NOT COMPLETED|Wake up After Anesthesia||0
217057|NCT00708526|520724|P2|COMPLETED|Wake up After Anesthesia||11
217058|NCT00708526|520725|P1|COMPLETED|Wake up After Anesthesia||11
217059|NCT00708526|520724|P2|STARTED|Wake up After Anesthesia||11
217060|NCT00708526|520725|P1|STARTED|Wake up After Anesthesia||11
217061|NCT00708500|520736|P3|NOT COMPLETED|FOLLOWUP||15
217062|NCT00708500|520737|P2|NOT COMPLETED|FOLLOWUP||15
217063|NCT00708500|520738|P1|NOT COMPLETED|FOLLOWUP||40
217064|NCT00708500|520736|P3|COMPLETED|FOLLOWUP||143
217065|NCT00708500|520737|P2|COMPLETED|FOLLOWUP||136
217066|NCT00708500|520738|P1|COMPLETED|FOLLOWUP||37
217067|NCT00708500|520736|P3|STARTED|FOLLOWUP||158
217068|NCT00708500|520737|P2|STARTED|FOLLOWUP||151
217069|NCT00708500|520738|P1|STARTED|FOLLOWUP||77
217070|NCT00708500|520736|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
217071|NCT00708500|520737|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
217072|NCT00708500|520738|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
217073|NCT00708500|520736|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
217074|NCT00708500|520737|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
217075|NCT00708500|520738|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
217076|NCT00708500|520736|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
217077|NCT00708500|520737|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
217078|NCT00708500|520738|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
217079|NCT00708500|520736|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
217080|NCT00708500|520737|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
217081|NCT00708500|520738|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
217082|NCT00708500|520736|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
217083|NCT00708500|520737|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
217084|NCT00708500|520738|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
217085|NCT00708500|520736|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
217086|NCT00708500|520737|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
217087|NCT00708500|520738|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
217088|NCT00708500|520736|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
217089|NCT00708500|520737|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
217090|NCT00708500|520738|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
217091|NCT00708461|520757|P2|NOT COMPLETED|Overall Study||200
217092|NCT00708461|520758|P1|NOT COMPLETED|Overall Study||141
217093|NCT00708461|520757|P2|COMPLETED|Overall Study||795
217094|NCT00708461|520758|P1|COMPLETED|Overall Study||611
217095|NCT00708461|520757|P2|STARTED|Overall Study||995
217096|NCT00708461|520758|P1|STARTED|Overall Study||752
217097|NCT00708435|520766|P2|NOT COMPLETED|Overall Study||17
217098|NCT00708435|520767|P1|NOT COMPLETED|Overall Study||25
217099|NCT00708435|520766|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
217100|NCT00708435|520767|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
217101|NCT00708435|520766|P2|STARTED|Overall Study||109
217102|NCT00708435|520767|P1|STARTED|Overall Study||107
217103|NCT00708422|520794|P2|NOT COMPLETED|Overall Study||1
217104|NCT00708422|520795|P1|NOT COMPLETED|Overall Study||4
217105|NCT00708422|520794|P2|COMPLETED|Overall Study||114
217106|NCT00708422|520795|P1|COMPLETED|Overall Study||112
217107|NCT00708422|520794|P2|STARTED|Overall Study||115
217108|NCT00708422|520795|P1|STARTED|Overall Study||116
217109|NCT00708305|520803|P4|NOT COMPLETED|Period 4||0
217110|NCT00708305|520804|P3|NOT COMPLETED|Period 4||0
217111|NCT00708305|520805|P2|NOT COMPLETED|Period 4||0
217112|NCT00708305|520806|P1|NOT COMPLETED|Period 4||0
217113|NCT00708305|520803|P4|COMPLETED|Period 4||14
217114|NCT00708305|520804|P3|COMPLETED|Period 4||14
217115|NCT00708305|520805|P2|COMPLETED|Period 4||14
217116|NCT00708305|520806|P1|COMPLETED|Period 4||12
217117|NCT00708305|520803|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
217118|NCT00708305|520804|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
217119|NCT00708305|520805|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
217120|NCT00708305|520806|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
217121|NCT00708305|520803|P4|NOT COMPLETED|Period 3||0
217122|NCT00708305|520804|P3|NOT COMPLETED|Period 3||0
217123|NCT00708305|520805|P2|NOT COMPLETED|Period 3||2
217124|NCT00708305|520806|P1|NOT COMPLETED|Period 3||1
217125|NCT00708305|520803|P4|COMPLETED|Period 3||14
217126|NCT00708305|520804|P3|COMPLETED|Period 3||14
217127|NCT00708305|520805|P2|COMPLETED|Period 3||12
217128|NCT00708305|520806|P1|COMPLETED|Period 3||14
217129|NCT00708305|520803|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
217130|NCT00708305|520804|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
217131|NCT00708305|520805|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
217132|NCT00708305|520806|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
217133|NCT00708305|520803|P4|NOT COMPLETED|Period 2||1
217134|NCT00708305|520804|P3|NOT COMPLETED|Period 2||0
217135|NCT00708305|520805|P2|NOT COMPLETED|Period 2||2
217136|NCT00708305|520806|P1|NOT COMPLETED|Period 2||1
217137|NCT00708305|520803|P4|COMPLETED|Period 2||14
217138|NCT00708305|520804|P3|COMPLETED|Period 2||16
217139|NCT00708305|520805|P2|COMPLETED|Period 2||13
217140|NCT00708305|520806|P1|COMPLETED|Period 2||14
217141|NCT00708305|520803|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
217142|NCT00708305|520804|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
217143|NCT00708305|520805|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
217144|NCT00708305|520806|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
217145|NCT00708305|520803|P4|NOT COMPLETED|Period 1||2
217146|NCT00708305|520804|P3|NOT COMPLETED|Period 1||1
217147|NCT00708305|520805|P2|NOT COMPLETED|Period 1||0
217148|NCT00708305|520806|P1|NOT COMPLETED|Period 1||1
217149|NCT00708305|520803|P4|COMPLETED|Period 1||14
217150|NCT00708305|520804|P3|COMPLETED|Period 1||16
217151|NCT00708305|520805|P2|COMPLETED|Period 1||16
217152|NCT00708305|520806|P1|COMPLETED|Period 1||15
217153|NCT00708305|520803|P4|STARTED|Period 1||16
217154|NCT00708305|520804|P3|STARTED|Period 1||17
217155|NCT00708305|520805|P2|STARTED|Period 1||16
217156|NCT00708305|520806|P1|STARTED|Period 1||16
217157|NCT00708227|520842|P4|NOT COMPLETED|Overall Study||3
217158|NCT00708227|520843|P3|NOT COMPLETED|Overall Study||1
217159|NCT00708227|520844|P2|NOT COMPLETED|Overall Study||5
217160|NCT00708227|520845|P1|NOT COMPLETED|Overall Study||1
217161|NCT00708227|520842|P4|COMPLETED|Overall Study||22
217162|NCT00708227|520843|P3|COMPLETED|Overall Study||17
217163|NCT00708227|520844|P2|COMPLETED|Overall Study||21
217164|NCT00708227|520845|P1|COMPLETED|Overall Study||18
217165|NCT00708227|520842|P4|STARTED|Overall Study||25
217166|NCT00708227|520843|P3|STARTED|Overall Study||18
217167|NCT00708227|520844|P2|STARTED|Overall Study||26
217168|NCT00708227|520845|P1|STARTED|Overall Study||19
217169|NCT00708214|520878|P3|NOT COMPLETED|Overall Study||8
217170|NCT00708214|520879|P2|NOT COMPLETED|Overall Study||13
217171|NCT00708214|520880|P1|NOT COMPLETED|Overall Study||7
217172|NCT00708214|520878|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
217173|NCT00708214|520879|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
217174|NCT00708214|520880|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
217175|NCT00708214|520878|P3|STARTED|Overall Study||8
217176|NCT00708214|520879|P2|STARTED|Overall Study||13
217177|NCT00708214|520880|P1|STARTED|Overall Study||7
217178|NCT00708201|520923|P2|NOT COMPLETED|Overall Study||6
217179|NCT00708201|520924|P1|NOT COMPLETED|Overall Study||7
217180|NCT00708201|520923|P2|COMPLETED|Overall Study||137
217181|NCT00708201|520924|P1|COMPLETED|Overall Study||130
217182|NCT00708201|520923|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
217183|NCT00708201|520924|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
217184|NCT00708201|520923|P2|STARTED|Overall Study||143
217185|NCT00708201|520924|P1|STARTED|Overall Study||137
217186|NCT00708175|520948|P2|NOT COMPLETED|Overall Study||21
217187|NCT00708175|520949|P1|NOT COMPLETED|Overall Study||18
217188|NCT00708175|520948|P2|COMPLETED|Overall Study||57
217189|NCT00708175|520949|P1|COMPLETED|Overall Study||60
217190|NCT00708175|520948|P2|STARTED|Overall Study||78
217191|NCT00708175|520949|P1|STARTED|Overall Study||78
217192|NCT00708162|520965|P2|NOT COMPLETED|Open-Label Phase||30
217193|NCT00708162|520966|P1|NOT COMPLETED|Open-Label Phase||44
217194|NCT00708162|520965|P2|COMPLETED|Open-Label Phase||121
217195|NCT00708162|520966|P1|COMPLETED|Open-Label Phase||152
217196|NCT00708162|520965|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
217197|NCT00708162|520966|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
217198|NCT00708162|520965|P2|NOT COMPLETED|Randomized Phase||154
217199|NCT00708162|520966|P1|NOT COMPLETED|Randomized Phase||156
217200|NCT00708162|520965|P2|COMPLETED|Randomized Phase||209
217201|NCT00708162|520966|P1|COMPLETED|Randomized Phase||205
217202|NCT00708162|520965|P2|Randomized and Treated|Randomized Phase||358
217203|NCT00708162|520966|P1|Randomized and Treated|Randomized Phase||354
217204|NCT00708162|520965|P2|STARTED|Randomized Phase||363
217205|NCT00708162|520966|P1|STARTED|Randomized Phase||361
217206|NCT00708123|521007|P5|NOT COMPLETED|Period 5||0
217207|NCT00708123|521008|P4|NOT COMPLETED|Period 5||0
217208|NCT00708123|521009|P3|NOT COMPLETED|Period 5||0
217209|NCT00708123|521010|P2|NOT COMPLETED|Period 5||0
217210|NCT00708123|521011|P1|NOT COMPLETED|Period 5||0
217211|NCT00708123|521007|P5|COMPLETED|Period 5||10
217212|NCT00708123|521008|P4|COMPLETED|Period 5||11
217213|NCT00708123|521009|P3|COMPLETED|Period 5||11
217214|NCT00708123|521010|P2|COMPLETED|Period 5||10
217215|NCT00708123|521011|P1|COMPLETED|Period 5||10
217216|NCT00708123|521007|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
217217|NCT00708123|521008|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
217218|NCT00708123|521009|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
217219|NCT00708123|521010|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
217220|NCT00708123|521011|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
217221|NCT00708123|521007|P5|NOT COMPLETED|Period 4||0
217222|NCT00708123|521008|P4|NOT COMPLETED|Period 4||0
217223|NCT00708123|521009|P3|NOT COMPLETED|Period 4||0
217224|NCT00708123|521010|P2|NOT COMPLETED|Period 4||1
217225|NCT00708123|521011|P1|NOT COMPLETED|Period 4||0
217226|NCT00708123|521007|P5|COMPLETED|Period 4||11
217227|NCT00708123|521008|P4|COMPLETED|Period 4||10
217228|NCT00708123|521009|P3|COMPLETED|Period 4||10
217229|NCT00708123|521010|P2|COMPLETED|Period 4||11
217230|NCT00708123|521011|P1|COMPLETED|Period 4||10
217231|NCT00708123|521007|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
217232|NCT00708123|521008|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
217233|NCT00708123|521009|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
217234|NCT00708123|521010|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
217235|NCT00708123|521011|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
217236|NCT00708123|521007|P5|NOT COMPLETED|Period 3||0
217237|NCT00708123|521008|P4|NOT COMPLETED|Period 3||1
217238|NCT00708123|521009|P3|NOT COMPLETED|Period 3||1
217239|NCT00708123|521010|P2|NOT COMPLETED|Period 3||0
217240|NCT00708123|521011|P1|NOT COMPLETED|Period 3||0
217241|NCT00708123|521007|P5|COMPLETED|Period 3||10
217242|NCT00708123|521008|P4|COMPLETED|Period 3||11
217243|NCT00708123|521009|P3|COMPLETED|Period 3||10
217244|NCT00708123|521010|P2|COMPLETED|Period 3||10
217245|NCT00708123|521011|P1|COMPLETED|Period 3||12
217246|NCT00708123|521007|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
217247|NCT00708123|521008|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
217248|NCT00708123|521009|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
217249|NCT00708123|521010|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
217250|NCT00708123|521011|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
217251|NCT00708123|521007|P5|NOT COMPLETED|Period 2||0
217252|NCT00708123|521008|P4|NOT COMPLETED|Period 2||1
217253|NCT00708123|521009|P3|NOT COMPLETED|Period 2||0
217254|NCT00708123|521010|P2|NOT COMPLETED|Period 2||0
217255|NCT00708123|521011|P1|NOT COMPLETED|Period 2||1
217256|NCT00708123|521007|P5|COMPLETED|Period 2||11
217257|NCT00708123|521008|P4|COMPLETED|Period 2||10
217258|NCT00708123|521009|P3|COMPLETED|Period 2||12
217259|NCT00708123|521010|P2|COMPLETED|Period 2||12
217260|NCT00708123|521011|P1|COMPLETED|Period 2||10
217261|NCT00708123|521007|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
217262|NCT00708123|521008|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
217263|NCT00708123|521009|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
217264|NCT00708123|521010|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
217265|NCT00708123|521011|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
217266|NCT00708123|521007|P5|NOT COMPLETED|Period 1||0
217267|NCT00708123|521008|P4|NOT COMPLETED|Period 1||1
217268|NCT00708123|521009|P3|NOT COMPLETED|Period 1||1
217269|NCT00708123|521010|P2|NOT COMPLETED|Period 1||1
217270|NCT00708123|521011|P1|NOT COMPLETED|Period 1||0
217271|NCT00708123|521007|P5|COMPLETED|Period 1||12
217272|NCT00708123|521008|P4|COMPLETED|Period 1||11
217273|NCT00708123|521009|P3|COMPLETED|Period 1||11
217274|NCT00708123|521010|P2|COMPLETED|Period 1||11
217275|NCT00708123|521011|P1|COMPLETED|Period 1||12
217276|NCT00708123|521007|P5|STARTED|Period 1||12
217277|NCT00708123|521008|P4|STARTED|Period 1||12
217278|NCT00708123|521009|P3|STARTED|Period 1||12
217279|NCT00708123|521010|P2|STARTED|Period 1||12
217280|NCT00708123|521011|P1|STARTED|Period 1||12
217281|NCT00708110|521035|P4|NOT COMPLETED|Overall Study||0
217282|NCT00708110|521036|P3|NOT COMPLETED|Overall Study||0
217283|NCT00708110|521037|P2|NOT COMPLETED|Overall Study||0
217284|NCT00708110|521038|P1|NOT COMPLETED|Overall Study||0
217285|NCT00708110|521035|P4|COMPLETED|Overall Study||10
217286|NCT00708110|521036|P3|COMPLETED|Overall Study||9
217287|NCT00708110|521037|P2|COMPLETED|Overall Study||9
217288|NCT00708110|521038|P1|COMPLETED|Overall Study||7
217289|NCT00708110|521035|P4|STARTED|Overall Study||10
217290|NCT00708110|521036|P3|STARTED|Overall Study||9
217291|NCT00708110|521037|P2|STARTED|Overall Study||9
217292|NCT00708110|521038|P1|STARTED|Overall Study||7
217293|NCT00708097|521144|P5|NOT COMPLETED|Period 5||0
217294|NCT00708097|521145|P4|NOT COMPLETED|Period 5||0
217295|NCT00708097|521146|P3|NOT COMPLETED|Period 5||0
217296|NCT00708097|521147|P2|NOT COMPLETED|Period 5||0
217297|NCT00708097|521148|P1|NOT COMPLETED|Period 5||0
217298|NCT00708097|521144|P5|COMPLETED|Period 5||12
217299|NCT00708097|521145|P4|COMPLETED|Period 5||10
217300|NCT00708097|521146|P3|COMPLETED|Period 5||11
217301|NCT00708097|521147|P2|COMPLETED|Period 5||9
217302|NCT00708097|521148|P1|COMPLETED|Period 5||8
217303|NCT00708097|521144|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
217304|NCT00708097|521145|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
217305|NCT00708097|521146|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
217306|NCT00708097|521147|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
217307|NCT00708097|521148|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
217308|NCT00708097|521144|P5|NOT COMPLETED|Period 4||0
217309|NCT00708097|521145|P4|NOT COMPLETED|Period 4||0
217310|NCT00708097|521146|P3|NOT COMPLETED|Period 4||0
217311|NCT00708097|521147|P2|NOT COMPLETED|Period 4||0
217312|NCT00708097|521148|P1|NOT COMPLETED|Period 4||0
217313|NCT00708097|521144|P5|COMPLETED|Period 4||8
217314|NCT00708097|521145|P4|COMPLETED|Period 4||11
217315|NCT00708097|521146|P3|COMPLETED|Period 4||10
217316|NCT00708097|521147|P2|COMPLETED|Period 4||9
217317|NCT00708097|521148|P1|COMPLETED|Period 4||12
217318|NCT00708097|521144|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
217319|NCT00708097|521145|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
217320|NCT00708097|521146|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
217321|NCT00708097|521147|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
217322|NCT00708097|521148|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
217323|NCT00708097|521144|P5|NOT COMPLETED|Period 3||0
217324|NCT00708097|521145|P4|NOT COMPLETED|Period 3||0
217325|NCT00708097|521146|P3|NOT COMPLETED|Period 3||0
217326|NCT00708097|521147|P2|NOT COMPLETED|Period 3||0
217327|NCT00708097|521148|P1|NOT COMPLETED|Period 3||0
217328|NCT00708097|521144|P5|COMPLETED|Period 3||10
217329|NCT00708097|521145|P4|COMPLETED|Period 3||10
217330|NCT00708097|521146|P3|COMPLETED|Period 3||10
217331|NCT00708097|521147|P2|COMPLETED|Period 3||11
217332|NCT00708097|521148|P1|COMPLETED|Period 3||9
217333|NCT00708097|521144|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
217334|NCT00708097|521145|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
217335|NCT00708097|521146|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
217336|NCT00708097|521147|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
217337|NCT00708097|521148|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
217338|NCT00708097|521144|P5|NOT COMPLETED|Period 2||0
217339|NCT00708097|521145|P4|NOT COMPLETED|Period 2||1
217340|NCT00708097|521146|P3|NOT COMPLETED|Period 2||1
217341|NCT00708097|521147|P2|NOT COMPLETED|Period 2||1
217342|NCT00708097|521148|P1|NOT COMPLETED|Period 2||0
217343|NCT00708097|521144|P5|COMPLETED|Period 2||10
217344|NCT00708097|521145|P4|COMPLETED|Period 2||10
217345|NCT00708097|521146|P3|COMPLETED|Period 2||9
217346|NCT00708097|521147|P2|COMPLETED|Period 2||11
217347|NCT00708097|521148|P1|COMPLETED|Period 2||10
217348|NCT00708097|521144|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
217441|NCT00707746|521458|P2|COMPLETED|Treatment Period||17
217349|NCT00708097|521145|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
217350|NCT00708097|521146|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
217351|NCT00708097|521147|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
217352|NCT00708097|521148|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
217353|NCT00708097|521144|P5|NOT COMPLETED|Period 1||1
217354|NCT00708097|521145|P4|NOT COMPLETED|Period 1||2
217355|NCT00708097|521146|P3|NOT COMPLETED|Period 1||0
217356|NCT00708097|521147|P2|NOT COMPLETED|Period 1||1
217357|NCT00708097|521148|P1|NOT COMPLETED|Period 1||0
217358|NCT00708097|521144|P5|COMPLETED|Period 1||10
217359|NCT00708097|521145|P4|COMPLETED|Period 1||9
217360|NCT00708097|521146|P3|COMPLETED|Period 1||12
217361|NCT00708097|521147|P2|COMPLETED|Period 1||11
217362|NCT00708097|521148|P1|COMPLETED|Period 1||11
217363|NCT00708097|521144|P5|STARTED|Period 1||11
217364|NCT00708097|521145|P4|STARTED|Period 1||11
217365|NCT00708097|521146|P3|STARTED|Period 1||12
217366|NCT00708097|521147|P2|STARTED|Period 1||12
217367|NCT00708097|521148|P1|STARTED|Period 1||11
217368|NCT00708071|521178|P1|NOT COMPLETED|Overall Study||0
217369|NCT00708071|521178|P1|COMPLETED|Overall Study||45
217370|NCT00708071|521178|P1|STARTED|Overall Study|Randomized and treated|45
217371|NCT00708032|521258|P2|NOT COMPLETED|Overall Study||16
217372|NCT00708032|521259|P1|NOT COMPLETED|Overall Study||10
217373|NCT00708032|521258|P2|COMPLETED|Overall Study||22
217374|NCT00708032|521259|P1|COMPLETED|Overall Study||26
217375|NCT00708032|521258|P2|STARTED|Overall Study||38
217376|NCT00708032|521259|P1|STARTED|Overall Study||36
217377|NCT00708019|521275|P2|NOT COMPLETED|Overall Study||15
217378|NCT00708019|521276|P1|NOT COMPLETED|Overall Study||15
217379|NCT00708019|521275|P2|COMPLETED|Overall Study||78
217380|NCT00708019|521276|P1|COMPLETED|Overall Study||77
217381|NCT00708019|521275|P2|STARTED|Overall Study||93
217382|NCT00708019|521276|P1|STARTED|Overall Study||92
217383|NCT00707993|521286|P2|NOT COMPLETED|Overall Study||94
217384|NCT00707993|521287|P1|NOT COMPLETED|Overall Study||89
217385|NCT00707993|521286|P2|COMPLETED|Overall Study||125
217386|NCT00707993|521287|P1|COMPLETED|Overall Study||133
217387|NCT00707993|521286|P2|STARTED|Overall Study||219
217388|NCT00707993|521287|P1|STARTED|Overall Study||222
217389|NCT00707980|521329|P1|NOT COMPLETED|Overall Study||310
217390|NCT00707980|521329|P1|COMPLETED|Overall Study||526
217391|NCT00707980|521329|P1|Received Treatment|Overall Study||834
217392|NCT00707980|521329|P1|STARTED|Overall Study||836
217393|NCT00707967|521347|P3|NOT COMPLETED|Overall Study||0
217394|NCT00707967|521348|P2|NOT COMPLETED|Overall Study||0
217395|NCT00707967|521349|P1|NOT COMPLETED|Overall Study||0
217396|NCT00707967|521347|P3|COMPLETED|Overall Study||7
217397|NCT00707967|521348|P2|COMPLETED|Overall Study||8
217398|NCT00707967|521349|P1|COMPLETED|Overall Study||22
217399|NCT00707967|521347|P3|STARTED|Overall Study||7
217400|NCT00707967|521348|P2|STARTED|Overall Study||8
217401|NCT00707967|521349|P1|STARTED|Overall Study||22
217402|NCT00707954|521413|P5|NOT COMPLETED|Overall Study||1
217403|NCT00707954|521414|P4|NOT COMPLETED|Overall Study||0
217404|NCT00707954|521415|P3|NOT COMPLETED|Overall Study||0
217405|NCT00707954|521416|P2|NOT COMPLETED|Overall Study||0
217406|NCT00707954|521417|P1|NOT COMPLETED|Overall Study||0
217407|NCT00707954|521413|P5|COMPLETED|Overall Study||9
217408|NCT00707954|521414|P4|COMPLETED|Overall Study||13
217409|NCT00707954|521415|P3|COMPLETED|Overall Study||14
217410|NCT00707954|521416|P2|COMPLETED|Overall Study||12
217411|NCT00707954|521417|P1|COMPLETED|Overall Study||12
217412|NCT00707954|521413|P5|STARTED|Overall Study||10
217413|NCT00707954|521414|P4|STARTED|Overall Study||13
217414|NCT00707954|521415|P3|STARTED|Overall Study||14
217415|NCT00707954|521416|P2|STARTED|Overall Study||12
217416|NCT00707954|521417|P1|STARTED|Overall Study||12
217417|NCT00707915|521429|P1|NOT COMPLETED|Overall Study||0
217418|NCT00707915|521429|P1|COMPLETED|Overall Study||30
217419|NCT00707915|521429|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
217420|NCT00707915|521429|P1|STARTED|Overall Study||30
217421|NCT00707863|521440|P2|NOT COMPLETED|Overall Study||3
217422|NCT00707863|521441|P1|NOT COMPLETED|Overall Study||0
217423|NCT00707863|521440|P2|COMPLETED|Overall Study||8
217424|NCT00707863|521441|P1|COMPLETED|Overall Study||6
217425|NCT00707863|521440|P2|STARTED|Overall Study||11
217426|NCT00707863|521441|P1|STARTED|Overall Study||6
217427|NCT00707759|521449|P2|NOT COMPLETED|Overall Study||2
217428|NCT00707759|521450|P1|NOT COMPLETED|Overall Study||2
217429|NCT00707759|521449|P2|COMPLETED|Overall Study||12
217430|NCT00707759|521450|P1|COMPLETED|Overall Study||12
217431|NCT00707759|521449|P2|STARTED|Overall Study||14
217432|NCT00707759|521450|P1|STARTED|Overall Study||14
217433|NCT00707746|521458|P2|NOT COMPLETED|Follow-up Period||0
217434|NCT00707746|521459|P1|NOT COMPLETED|Follow-up Period||0
217435|NCT00707746|521458|P2|COMPLETED|Follow-up Period||21
217436|NCT00707746|521459|P1|COMPLETED|Follow-up Period||12
217437|NCT00707746|521458|P2|STARTED|Follow-up Period||21
217438|NCT00707746|521459|P1|STARTED|Follow-up Period||12
217439|NCT00707746|521458|P2|NOT COMPLETED|Treatment Period||5
217440|NCT00707746|521459|P1|NOT COMPLETED|Treatment Period||2
217442|NCT00707746|521459|P1|COMPLETED|Treatment Period||10
217443|NCT00707746|521458|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
217444|NCT00707746|521459|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
217445|NCT00707746|521458|P2|STARTED|Treatment Period||22
217446|NCT00707746|521459|P1|STARTED|Treatment Period||12
217447|NCT00707655|521507|P2|NOT COMPLETED|Overall Study||2
217448|NCT00707655|521508|P1|NOT COMPLETED|Overall Study||0
217449|NCT00707655|521507|P2|COMPLETED|Overall Study||3
217450|NCT00707655|521508|P1|COMPLETED|Overall Study||3
217451|NCT00707655|521507|P2|STARTED|Overall Study||5
217452|NCT00707655|521508|P1|STARTED|Overall Study||3
217453|NCT00707577|521520|P2|NOT COMPLETED|Overall Study||38
217454|NCT00707577|521521|P1|NOT COMPLETED|Overall Study||54
217455|NCT00707577|521520|P2|COMPLETED|Overall Study||118
217456|NCT00707577|521521|P1|COMPLETED|Overall Study||120
217457|NCT00707577|521520|P2|STARTED|Overall Study||156
217458|NCT00707577|521521|P1|STARTED|Overall Study||174
217459|NCT00707486|521527|P1|NOT COMPLETED|Overall Study||1
217460|NCT00707486|521527|P1|COMPLETED|Overall Study||71
217461|NCT00707486|521527|P1|STARTED|Overall Study||72
217462|NCT00707447|521538|P2|NOT COMPLETED|Overall Study||8
217463|NCT00707447|521539|P1|NOT COMPLETED|Overall Study||8
217464|NCT00707447|521538|P2|COMPLETED|Overall Study||85
217465|NCT00707447|521539|P1|COMPLETED|Overall Study||81
217466|NCT00707447|521538|P2|STARTED|Overall Study||93
217467|NCT00707447|521539|P1|STARTED|Overall Study||89
217468|NCT00707343|521563|P1|NOT COMPLETED|Overall Study||0
217469|NCT00707343|521563|P1|COMPLETED|Overall Study||15
217470|NCT00707343|521563|P1|STARTED|Overall Study||15
217471|NCT00707239|521570|P3|NOT COMPLETED|Overall Study||14
217472|NCT00707239|521571|P2|NOT COMPLETED|Overall Study||11
217473|NCT00707239|521572|P1|NOT COMPLETED|Overall Study||19
217474|NCT00707239|521570|P3|COMPLETED|Overall Study||21
217475|NCT00707239|521571|P2|COMPLETED|Overall Study||25
217476|NCT00707239|521572|P1|COMPLETED|Overall Study||18
217477|NCT00707239|521570|P3|Treated|Overall Study||34
217478|NCT00707239|521571|P2|Treated|Overall Study||35
217479|NCT00707239|521572|P1|Treated|Overall Study||36
217480|NCT00707239|521570|P3|STARTED|Overall Study||35
217481|NCT00707239|521571|P2|STARTED|Overall Study||36
217482|NCT00707239|521572|P1|STARTED|Overall Study||37
217483|NCT00707174|521620|P2|NOT COMPLETED|Overall Study||7
217484|NCT00707174|521621|P1|NOT COMPLETED|Overall Study||5
217485|NCT00707174|521620|P2|COMPLETED|Overall Study||37
217486|NCT00707174|521621|P1|COMPLETED|Overall Study||41
217487|NCT00707174|521620|P2|STARTED|Overall Study||44
217488|NCT00707174|521621|P1|STARTED|Overall Study||46
217489|NCT00707161|521627|P1|NOT COMPLETED|Overall Study||6
217490|NCT00707161|521627|P1|COMPLETED|Overall Study||0
217491|NCT00707161|521627|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
217492|NCT00707057|521633|P2|NOT COMPLETED|Overall Study||4
217493|NCT00707057|521634|P1|NOT COMPLETED|Overall Study||8
217494|NCT00707057|521633|P2|COMPLETED|Overall Study||83
217495|NCT00707057|521634|P1|COMPLETED|Overall Study||161
217496|NCT00707057|521633|P2|STARTED|Overall Study||87
217497|NCT00707057|521634|P1|STARTED|Overall Study||169
217498|NCT00707031|521668|P2|NOT COMPLETED|Overall Study||99
217499|NCT00707031|521669|P1|NOT COMPLETED|Overall Study||104
217500|NCT00707031|521668|P2|COMPLETED|Overall Study||220
217501|NCT00707031|521669|P1|COMPLETED|Overall Study||216
217502|NCT00707031|521668|P2|Modified Intent-to-Treat Population|Overall Study||315
217503|NCT00707031|521669|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
217504|NCT00707031|521668|P2|Treated/Safety Population|Overall Study||316
217505|NCT00707031|521669|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
217506|NCT00707031|521668|P2|STARTED|Overall Study||319
217507|NCT00707031|521669|P1|STARTED|Overall Study|Randomized|320
217508|NCT00706992|521698|P7|NOT COMPLETED|Overall Study||3
217509|NCT00706992|521699|P6|NOT COMPLETED|Overall Study||2
217510|NCT00706992|521700|P5|NOT COMPLETED|Overall Study||4
217511|NCT00706992|521701|P4|NOT COMPLETED|Overall Study||2
217512|NCT00706992|521702|P3|NOT COMPLETED|Overall Study||6
217513|NCT00706992|521703|P2|NOT COMPLETED|Overall Study||5
217514|NCT00706992|521704|P1|NOT COMPLETED|Overall Study||5
217515|NCT00706992|521698|P7|COMPLETED|Overall Study||3
217516|NCT00706992|521699|P6|COMPLETED|Overall Study||3
217517|NCT00706992|521700|P5|COMPLETED|Overall Study||2
217518|NCT00706992|521701|P4|COMPLETED|Overall Study||6
217519|NCT00706992|521702|P3|COMPLETED|Overall Study||3
217520|NCT00706992|521703|P2|COMPLETED|Overall Study||3
217521|NCT00706992|521704|P1|COMPLETED|Overall Study||3
217522|NCT00706992|521698|P7|STARTED|Overall Study||6
217523|NCT00706992|521699|P6|STARTED|Overall Study||5
217524|NCT00706992|521700|P5|STARTED|Overall Study||6
217525|NCT00706992|521701|P4|STARTED|Overall Study||8
217526|NCT00706992|521702|P3|STARTED|Overall Study||9
217527|NCT00706992|521703|P2|STARTED|Overall Study||8
217528|NCT00706992|521704|P1|STARTED|Overall Study||8
217529|NCT00706979|521723|P2|NOT COMPLETED|Overall Study||0
217530|NCT00706979|521724|P1|NOT COMPLETED|Overall Study||0
217531|NCT00706979|521723|P2|COMPLETED|Overall Study||423
217532|NCT00706979|521724|P1|COMPLETED|Overall Study||426
217533|NCT00706979|521723|P2|STARTED|Overall Study||423
217534|NCT00706979|521724|P1|STARTED|Overall Study||426
217535|NCT00706966|521736|P1|NOT COMPLETED|Overall Study||1
217536|NCT00706966|521736|P1|COMPLETED|Overall Study||9
217537|NCT00706966|521736|P1|STARTED|Overall Study||10
217538|NCT00706914|521772|P3|NOT COMPLETED|Overall Study||1
217539|NCT00706914|521773|P2|NOT COMPLETED|Overall Study||4
217540|NCT00706914|521774|P1|NOT COMPLETED|Overall Study||6
217541|NCT00706914|521772|P3|COMPLETED|Overall Study||30
217542|NCT00706914|521773|P2|COMPLETED|Overall Study||58
217543|NCT00706914|521774|P1|COMPLETED|Overall Study||57
217544|NCT00706914|521772|P3|STARTED|Overall Study||31
217545|NCT00706914|521773|P2|STARTED|Overall Study||62
217546|NCT00706914|521774|P1|STARTED|Overall Study||63
217547|NCT00706901|521797|P3|NOT COMPLETED|Overall Study||8
217548|NCT00706901|521798|P2|NOT COMPLETED|Overall Study||5
217549|NCT00706901|521799|P1|NOT COMPLETED|Overall Study||8
217550|NCT00706901|521797|P3|COMPLETED|Overall Study||51
217551|NCT00706901|521798|P2|COMPLETED|Overall Study||57
217552|NCT00706901|521799|P1|COMPLETED|Overall Study||51
217553|NCT00706901|521797|P3|STARTED|Overall Study||59
217554|NCT00706901|521798|P2|STARTED|Overall Study||62
217555|NCT00706901|521799|P1|STARTED|Overall Study||59
217556|NCT00706849|521824|P2|NOT COMPLETED|Follow-up Period||3
217557|NCT00706849|521825|P1|NOT COMPLETED|Follow-up Period||0
217558|NCT00706849|521824|P2|COMPLETED|Follow-up Period||25
217559|NCT00706849|521825|P1|COMPLETED|Follow-up Period||3
217560|NCT00706849|521824|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
217561|NCT00706849|521825|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
217562|NCT00706849|521824|P2|NOT COMPLETED|Treatment Period||10
217563|NCT00706849|521825|P1|NOT COMPLETED|Treatment Period||0
217564|NCT00706849|521824|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
217565|NCT00706849|521825|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
217566|NCT00706849|521824|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
217567|NCT00706849|521825|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
217568|NCT00706849|521824|P2|STARTED|Treatment Period||83
217569|NCT00706849|521825|P1|STARTED|Treatment Period||41
217570|NCT00706836|521869|P1|NOT COMPLETED|Overall Study||0
217571|NCT00706836|521869|P1|COMPLETED|Overall Study||16
217572|NCT00706836|521869|P1|STARTED|Overall Study||16
217573|NCT00706823|521879|P2|NOT COMPLETED|Overall Study||0
217574|NCT00706823|521880|P1|NOT COMPLETED|Overall Study||0
217575|NCT00706823|521879|P2|COMPLETED|Overall Study||25
217576|NCT00706823|521880|P1|COMPLETED|Overall Study||25
217577|NCT00706823|521879|P2|STARTED|Overall Study||25
217578|NCT00706823|521880|P1|STARTED|Overall Study||25
217579|NCT00706810|521896|P1|NOT COMPLETED|Overall Study||1
217580|NCT00706810|521896|P1|COMPLETED|Overall Study||7
217581|NCT00706810|521896|P1|STARTED|Overall Study||8
217582|NCT00706797|521903|P2|NOT COMPLETED|Overall Study||71
217583|NCT00706797|521904|P1|NOT COMPLETED|Overall Study||69
217584|NCT00706797|521903|P2|COMPLETED|Overall Study||0
217585|NCT00706797|521904|P1|COMPLETED|Overall Study||1
217586|NCT00706797|521903|P2|Safety Population|Overall Study||71
217587|NCT00706797|521904|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
217588|NCT00706797|521903|P2|STARTED|Overall Study||71
217589|NCT00706797|521904|P1|STARTED|Overall Study||70
217590|NCT00706784|521946|P2|NOT COMPLETED|Overall Study||0
217591|NCT00706784|521947|P1|NOT COMPLETED|Overall Study||0
217592|NCT00706784|521946|P2|COMPLETED|Overall Study||3
217593|NCT00706784|521947|P1|COMPLETED|Overall Study||3
217594|NCT00706784|521946|P2|STARTED|Overall Study||3
217595|NCT00706784|521947|P1|STARTED|Overall Study||3
217596|NCT00706719|521956|P3|NOT COMPLETED|Overall Study||4
217597|NCT00706719|521957|P2|NOT COMPLETED|Overall Study||1
217598|NCT00706719|521958|P1|NOT COMPLETED|Overall Study||0
217599|NCT00706719|521956|P3|COMPLETED|Overall Study||1
217600|NCT00706719|521957|P2|COMPLETED|Overall Study||6
217601|NCT00706719|521958|P1|COMPLETED|Overall Study||5
217602|NCT00706719|521956|P3|STARTED|Overall Study||5
217603|NCT00706719|521957|P2|STARTED|Overall Study||7
217604|NCT00706719|521958|P1|STARTED|Overall Study||5
217605|NCT00706706|521973|P1|NOT COMPLETED|Overall Study||105
217606|NCT00706706|521973|P1|COMPLETED|Overall Study||0
217607|NCT00706706|521973|P1|STARTED|Overall Study||105
217608|NCT00706654|521983|P4|NOT COMPLETED|Depot Maintenance Phase||70
217609|NCT00706654|521984|P3|NOT COMPLETED|Depot Maintenance Phase||88
217610|NCT00706654|521985|P2|NOT COMPLETED|Depot Maintenance Phase||69
217611|NCT00706654|521986|P1|NOT COMPLETED|Depot Maintenance Phase||0
217612|NCT00706654|521983|P4|COMPLETED|Depot Maintenance Phase||61
217613|NCT00706654|521984|P3|COMPLETED|Depot Maintenance Phase||178
217614|NCT00706654|521985|P2|COMPLETED|Depot Maintenance Phase||196
217615|NCT00706654|521986|P1|COMPLETED|Depot Maintenance Phase||0
217616|NCT00706654|521983|P4|STARTED|Depot Maintenance Phase||131
217617|NCT00706654|521984|P3|STARTED|Depot Maintenance Phase||266
217618|NCT00706654|521985|P2|STARTED|Depot Maintenance Phase||265
217619|NCT00706654|521986|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
217620|NCT00706654|521983|P4|NOT COMPLETED|Oral Stabilization Phase||0
217621|NCT00706654|521984|P3|NOT COMPLETED|Oral Stabilization Phase||0
217622|NCT00706654|521985|P2|NOT COMPLETED|Oral Stabilization Phase||0
217623|NCT00706654|521986|P1|NOT COMPLETED|Oral Stabilization Phase||180
217624|NCT00706654|521983|P4|COMPLETED|Oral Stabilization Phase||0
217625|NCT00706654|521984|P3|COMPLETED|Oral Stabilization Phase||0
217626|NCT00706654|521985|P2|COMPLETED|Oral Stabilization Phase||0
217627|NCT00706654|521986|P1|COMPLETED|Oral Stabilization Phase||662
217628|NCT00706654|521983|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
217629|NCT00706654|521984|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
217630|NCT00706654|521985|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
217631|NCT00706654|521986|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
217632|NCT00706654|521983|P4|NOT COMPLETED|Conversion Phase||0
217633|NCT00706654|521984|P3|NOT COMPLETED|Conversion Phase||0
217634|NCT00706654|521985|P2|NOT COMPLETED|Conversion Phase||0
217635|NCT00706654|521986|P1|NOT COMPLETED|Conversion Phase||95
217636|NCT00706654|521983|P4|COMPLETED|Conversion Phase||0
217637|NCT00706654|521984|P3|COMPLETED|Conversion Phase||0
217638|NCT00706654|521985|P2|COMPLETED|Conversion Phase||0
217639|NCT00706654|521986|P1|COMPLETED|Conversion Phase||614
217640|NCT00706654|521983|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
217641|NCT00706654|521984|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
217642|NCT00706654|521985|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
217643|NCT00706654|521986|P1|STARTED|Conversion Phase||709
217644|NCT00706641|522005|P1|NOT COMPLETED|Radical Cystectomy||1
217645|NCT00706641|522005|P1|COMPLETED|Radical Cystectomy||22
217646|NCT00706641|522005|P1|STARTED|Radical Cystectomy||23
217647|NCT00706641|522005|P1|NOT COMPLETED|Dasatinib Administration||2
217648|NCT00706641|522005|P1|COMPLETED|Dasatinib Administration||23
217649|NCT00706641|522005|P1|Toxicity Evaluation|Dasatinib Administration||24
217650|NCT00706641|522005|P1|STARTED|Dasatinib Administration||25
217651|NCT00706628|522019|P4|NOT COMPLETED|Overall Study||3
217652|NCT00706628|522020|P3|NOT COMPLETED|Overall Study||16
217653|NCT00706628|522021|P2|NOT COMPLETED|Overall Study||21
217654|NCT00706628|522022|P1|NOT COMPLETED|Overall Study||47
217655|NCT00706628|522019|P4|COMPLETED|Overall Study||0
217656|NCT00706628|522020|P3|COMPLETED|Overall Study||0
217657|NCT00706628|522021|P2|COMPLETED|Overall Study||0
217658|NCT00706628|522022|P1|COMPLETED|Overall Study||0
217659|NCT00706628|522019|P4|STARTED|Overall Study||3
217660|NCT00706628|522020|P3|STARTED|Overall Study||16
217661|NCT00706628|522021|P2|STARTED|Overall Study||21
217662|NCT00706628|522022|P1|STARTED|Overall Study||47
217663|NCT00706589|522072|P2|NOT COMPLETED|Overall Study||4
217664|NCT00706589|522073|P1|NOT COMPLETED|Overall Study||3
217665|NCT00706589|522072|P2|COMPLETED|Overall Study||25
217666|NCT00706589|522073|P1|COMPLETED|Overall Study||29
217667|NCT00706589|522072|P2|STARTED|Overall Study||29
217668|NCT00706589|522073|P1|STARTED|Overall Study||32
217669|NCT00706563|522081|P2|NOT COMPLETED|Overall Study||0
217670|NCT00706563|522082|P1|NOT COMPLETED|Overall Study||0
217671|NCT00706563|522081|P2|COMPLETED|Overall Study||59
217672|NCT00706563|522082|P1|COMPLETED|Overall Study||61
217673|NCT00706563|522081|P2|STARTED|Overall Study||59
217674|NCT00706563|522082|P1|STARTED|Overall Study||61
217675|NCT00706550|522106|P2|NOT COMPLETED|Overall Study||28
217676|NCT00706550|522107|P1|NOT COMPLETED|Overall Study||7
217677|NCT00706550|522106|P2|COMPLETED|Overall Study||36
217678|NCT00706550|522107|P1|COMPLETED|Overall Study||36
217679|NCT00706550|522106|P2|STARTED|Overall Study||64
217680|NCT00706550|522107|P1|STARTED|Overall Study||43
217681|NCT00706485|522123|P1|NOT COMPLETED|Overall Study||0
217682|NCT00706485|522123|P1|COMPLETED|Overall Study||5
217683|NCT00706485|522123|P1|STARTED|Overall Study||5
217684|NCT00706446|522135|P6|NOT COMPLETED|Overall Study||38
217685|NCT00706446|522136|P5|NOT COMPLETED|Overall Study||44
217686|NCT00706446|522137|P4|NOT COMPLETED|Overall Study||22
217687|NCT00706446|522138|P3|NOT COMPLETED|Overall Study||37
217688|NCT00706446|522139|P2|NOT COMPLETED|Overall Study||49
217689|NCT00706446|522140|P1|NOT COMPLETED|Overall Study||26
217690|NCT00706446|522135|P6|COMPLETED|Overall Study||7
217691|NCT00706446|522136|P5|COMPLETED|Overall Study||10
217692|NCT00706446|522137|P4|COMPLETED|Overall Study||4
217693|NCT00706446|522138|P3|COMPLETED|Overall Study||7
217694|NCT00706446|522139|P2|COMPLETED|Overall Study||8
217695|NCT00706446|522140|P1|COMPLETED|Overall Study||3
217696|NCT00706446|522135|P6|STARTED|Overall Study||45
217697|NCT00706446|522136|P5|STARTED|Overall Study||54
217698|NCT00706446|522137|P4|STARTED|Overall Study||26
217699|NCT00706446|522138|P3|STARTED|Overall Study||44
217700|NCT00706446|522139|P2|STARTED|Overall Study||57
217701|NCT00706446|522140|P1|STARTED|Overall Study||29
217702|NCT00706433|522182|P4|NOT COMPLETED|Overall Study||2
217703|NCT00706433|522183|P3|NOT COMPLETED|Overall Study||10
217704|NCT00706433|522184|P2|NOT COMPLETED|Overall Study||3
217705|NCT00706433|522185|P1|NOT COMPLETED|Overall Study||5
217706|NCT00706433|522182|P4|COMPLETED|Overall Study||64
217707|NCT00706433|522183|P3|COMPLETED|Overall Study||57
217708|NCT00706433|522184|P2|COMPLETED|Overall Study||62
217709|NCT00706433|522185|P1|COMPLETED|Overall Study||63
217710|NCT00706433|522182|P4|STARTED|Overall Study||66
217711|NCT00706433|522183|P3|STARTED|Overall Study||67
217712|NCT00706433|522184|P2|STARTED|Overall Study||65
217713|NCT00706433|522185|P1|STARTED|Overall Study||68
217714|NCT00706407|522501|P1|NOT COMPLETED|Overall Study||9
217715|NCT00706407|522501|P1|COMPLETED|Overall Study||33
217716|NCT00706407|522501|P1|STARTED|Overall Study||42
217717|NCT00706355|522512|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
217718|NCT00706355|522513|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
217719|NCT00706355|522514|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
217720|NCT00706355|522515|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
217721|NCT00706355|522512|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
217722|NCT00706355|522513|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
217723|NCT00706355|522514|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
217724|NCT00706355|522515|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
217725|NCT00706355|522512|P4|STARTED|Period 4: PF-04217903 150 mg||4
217726|NCT00706355|522513|P3|STARTED|Period 4: PF-04217903 150 mg||0
217727|NCT00706355|522514|P2|STARTED|Period 4: PF-04217903 150 mg||0
217728|NCT00706355|522515|P1|STARTED|Period 4: PF-04217903 150 mg||0
217729|NCT00706355|522512|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
217730|NCT00706355|522513|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
217731|NCT00706355|522514|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
217732|NCT00706355|522515|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
217733|NCT00706355|522512|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
217734|NCT00706355|522513|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
217735|NCT00706355|522514|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
217736|NCT00706355|522515|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
217737|NCT00706355|522512|P4|STARTED|Period 3: PF-04217903 200 mg||0
217738|NCT00706355|522513|P3|STARTED|Period 3: PF-04217903 200 mg||2
217739|NCT00706355|522514|P2|STARTED|Period 3: PF-04217903 200 mg||0
217740|NCT00706355|522515|P1|STARTED|Period 3: PF-04217903 200 mg||0
217741|NCT00706355|522512|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
217742|NCT00706355|522513|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
217743|NCT00706355|522514|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
217744|NCT00706355|522515|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
217745|NCT00706355|522512|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
217746|NCT00706355|522513|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
217747|NCT00706355|522514|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
217748|NCT00706355|522515|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
217749|NCT00706355|522512|P4|STARTED|Period 2: PF-04217903 100 mg||0
217750|NCT00706355|522513|P3|STARTED|Period 2: PF-04217903 100 mg||0
217751|NCT00706355|522514|P2|STARTED|Period 2: PF-04217903 100 mg||7
217752|NCT00706355|522515|P1|STARTED|Period 2: PF-04217903 100 mg||0
217753|NCT00706355|522512|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
217754|NCT00706355|522513|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
217755|NCT00706355|522514|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
217756|NCT00706355|522515|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
217757|NCT00706355|522512|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
217758|NCT00706355|522513|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
217759|NCT00706355|522514|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
217760|NCT00706355|522515|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
217761|NCT00706355|522512|P4|STARTED|Period 1: PF-04217903 50 mg||0
217762|NCT00706355|522513|P3|STARTED|Period 1: PF-04217903 50 mg||0
217763|NCT00706355|522514|P2|STARTED|Period 1: PF-04217903 50 mg||0
217764|NCT00706355|522515|P1|STARTED|Period 1: PF-04217903 50 mg||3
217765|NCT00706342|522567|P1|NOT COMPLETED|Overall Study||18
217766|NCT00706342|522567|P1|COMPLETED|Overall Study||0
217767|NCT00706342|522567|P1|STARTED|Overall Study||18
217768|NCT00706329|522576|P1|NOT COMPLETED|Overall Study||0
217769|NCT00706329|522576|P1|COMPLETED|Overall Study||25
217770|NCT00706329|522576|P1|STARTED|Overall Study||25
217771|NCT00706134|522584|P4|NOT COMPLETED|Overall Study||11
217772|NCT00706134|522585|P3|NOT COMPLETED|Overall Study||6
217773|NCT00706134|522586|P2|NOT COMPLETED|Overall Study||19
217774|NCT00706134|522587|P1|NOT COMPLETED|Overall Study||20
217775|NCT00706134|522584|P4|COMPLETED|Overall Study||175
217776|NCT00706134|522585|P3|COMPLETED|Overall Study||183
217777|NCT00706134|522586|P2|COMPLETED|Overall Study||173
217778|NCT00706134|522587|P1|COMPLETED|Overall Study||169
217779|NCT00706134|522584|P4|Entered Double-blind Period|Overall Study||186
217780|NCT00706134|522585|P3|Entered Double-blind Period|Overall Study||189
217781|NCT00706134|522586|P2|Entered Double-blind Period|Overall Study||192
217782|NCT00706134|522587|P1|Entered Double-blind Period|Overall Study||187
217783|NCT00706134|522584|P4|STARTED|Overall Study||186
217784|NCT00706134|522585|P3|STARTED|Overall Study||189
217785|NCT00706134|522586|P2|STARTED|Overall Study||192
217786|NCT00706134|522587|P1|STARTED|Overall Study||189
217787|NCT00706121|522621|P4|NOT COMPLETED|Overall Study||352
217788|NCT00706121|522622|P3|NOT COMPLETED|Overall Study||404
217789|NCT00706121|522623|P2|NOT COMPLETED|Overall Study||396
217790|NCT00706121|522624|P1|NOT COMPLETED|Overall Study||396
217791|NCT00706121|522621|P4|COMPLETED|Overall Study||1577
217792|NCT00706121|522622|P3|COMPLETED|Overall Study||1626
217793|NCT00706121|522623|P2|COMPLETED|Overall Study||1700
217794|NCT00706121|522624|P1|COMPLETED|Overall Study||1643
217795|NCT00706121|522621|P4|STARTED|Overall Study||1929
217796|NCT00706121|522622|P3|STARTED|Overall Study||2030
217797|NCT00706121|522623|P2|STARTED|Overall Study||2096
217798|NCT00706121|522624|P1|STARTED|Overall Study||2039
217799|NCT00706095|522653|P3|NOT COMPLETED|Overall Study||5
217800|NCT00706095|522654|P2|NOT COMPLETED|Overall Study||7
217801|NCT00706095|522655|P1|NOT COMPLETED|Overall Study||6
217802|NCT00706095|522653|P3|COMPLETED|Overall Study||0
217803|NCT00706095|522654|P2|COMPLETED|Overall Study||0
217804|NCT00706095|522655|P1|COMPLETED|Overall Study||0
217805|NCT00706095|522653|P3|STARTED|Overall Study||5
217806|NCT00706095|522654|P2|STARTED|Overall Study||7
217807|NCT00706095|522655|P1|STARTED|Overall Study||6
217808|NCT00706030|522673|P4|NOT COMPLETED|Overall Study||16
217809|NCT00706030|522674|P3|NOT COMPLETED|Overall Study||60
217810|NCT00706030|522675|P2|NOT COMPLETED|Overall Study||6
217811|NCT00706030|522676|P1|NOT COMPLETED|Overall Study||6
217812|NCT00706030|522673|P4|COMPLETED|Overall Study||0
217813|NCT00706030|522674|P3|COMPLETED|Overall Study||4
217814|NCT00706030|522675|P2|COMPLETED|Overall Study||0
217815|NCT00706030|522676|P1|COMPLETED|Overall Study||0
217816|NCT00706030|522673|P4|Treated|Overall Study||15
217817|NCT00706030|522674|P3|Treated|Overall Study||64
217818|NCT00706030|522675|P2|Treated|Overall Study||6
217819|NCT00706030|522676|P1|Treated|Overall Study||6
217820|NCT00706030|522673|P4|STARTED|Overall Study||16
217821|NCT00706030|522674|P3|STARTED|Overall Study||64
217822|NCT00706030|522675|P2|STARTED|Overall Study||6
217823|NCT00706030|522676|P1|STARTED|Overall Study||6
217824|NCT00706004|522691|P1|NOT COMPLETED|Overall Study||2
217825|NCT00706004|522691|P1|COMPLETED|Overall Study||7
217826|NCT00706004|522691|P1|STARTED|Overall Study||9
217827|NCT00705939|522719|P3|NOT COMPLETED|Overall Study||4
217828|NCT00705939|522720|P2|NOT COMPLETED|Overall Study||2
217829|NCT00705939|522721|P1|NOT COMPLETED|Overall Study||0
217830|NCT00705939|522719|P3|COMPLETED|Overall Study||14
217831|NCT00705939|522720|P2|COMPLETED|Overall Study||12
217832|NCT00705939|522721|P1|COMPLETED|Overall Study||12
217833|NCT00705939|522719|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
217834|NCT00705939|522720|P2|STARTED|Overall Study||14
217835|NCT00705939|522721|P1|STARTED|Overall Study||12
217836|NCT00705874|522751|P7|NOT COMPLETED|Overall Study||0
217837|NCT00705874|522752|P6|NOT COMPLETED|Overall Study||4
217838|NCT00705874|522753|P5|NOT COMPLETED|Overall Study||12
217839|NCT00705874|522754|P4|NOT COMPLETED|Overall Study||1
217840|NCT00705874|522755|P3|NOT COMPLETED|Overall Study||2
217841|NCT00705874|522756|P2|NOT COMPLETED|Overall Study||1
217842|NCT00705874|522757|P1|NOT COMPLETED|Overall Study||2
217843|NCT00705874|522751|P7|COMPLETED|Overall Study||3
217844|NCT00705874|522752|P6|COMPLETED|Overall Study||28
217845|NCT00705874|522753|P5|COMPLETED|Overall Study||36
217846|NCT00705874|522754|P4|COMPLETED|Overall Study||33
217847|NCT00705874|522755|P3|COMPLETED|Overall Study||32
217848|NCT00705874|522756|P2|COMPLETED|Overall Study||8
217849|NCT00705874|522757|P1|COMPLETED|Overall Study||10
217850|NCT00705874|522751|P7|STARTED|Overall Study||3
217851|NCT00705874|522752|P6|STARTED|Overall Study||32
217852|NCT00705874|522753|P5|STARTED|Overall Study||48
217853|NCT00705874|522754|P4|STARTED|Overall Study||34
217854|NCT00705874|522755|P3|STARTED|Overall Study||34
217855|NCT00705874|522756|P2|STARTED|Overall Study||9
217856|NCT00705874|522757|P1|STARTED|Overall Study||12
217857|NCT00705783|522775|P3|NOT COMPLETED|Depot Maintenance Phase||131
217858|NCT00705783|522776|P2|NOT COMPLETED|Depot Maintenance Phase||246
217859|NCT00705783|522777|P1|NOT COMPLETED|Depot Maintenance Phase||0
217860|NCT00705783|522775|P3|COMPLETED|Depot Maintenance Phase||3
217861|NCT00705783|522776|P2|COMPLETED|Depot Maintenance Phase||23
217862|NCT00705783|522777|P1|COMPLETED|Depot Maintenance Phase||0
217863|NCT00705783|522775|P3|STARTED|Depot Maintenance Phase||134
217864|NCT00705783|522776|P2|STARTED|Depot Maintenance Phase||269
217865|NCT00705783|522777|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
217866|NCT00705783|522775|P3|NOT COMPLETED|Depot Stabilization Phase||0
217867|NCT00705783|522776|P2|NOT COMPLETED|Depot Stabilization Phase||0
217868|NCT00705783|522777|P1|NOT COMPLETED|Depot Stabilization Phase||173
217869|NCT00705783|522775|P3|COMPLETED|Depot Stabilization Phase||0
217870|NCT00705783|522776|P2|COMPLETED|Depot Stabilization Phase||0
217871|NCT00705783|522777|P1|COMPLETED|Depot Stabilization Phase||403
217872|NCT00705783|522775|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
217873|NCT00705783|522776|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
217874|NCT00705783|522777|P1|STARTED|Depot Stabilization Phase||576
217875|NCT00705783|522775|P3|NOT COMPLETED|Oral Stabilization Phase||0
217876|NCT00705783|522776|P2|NOT COMPLETED|Oral Stabilization Phase||0
217877|NCT00705783|522777|P1|NOT COMPLETED|Oral Stabilization Phase||134
217878|NCT00705783|522775|P3|COMPLETED|Oral Stabilization Phase||0
217879|NCT00705783|522776|P2|COMPLETED|Oral Stabilization Phase||0
217880|NCT00705783|522777|P1|COMPLETED|Oral Stabilization Phase||576
217881|NCT00705783|522775|P3|Received Study Medication|Oral Stabilization Phase||0
217882|NCT00705783|522776|P2|Received Study Medication|Oral Stabilization Phase||0
217883|NCT00705783|522777|P1|Received Study Medication|Oral Stabilization Phase||709
217884|NCT00705783|522775|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
217885|NCT00705783|522776|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
217886|NCT00705783|522777|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
217887|NCT00705783|522775|P3|NOT COMPLETED|Conversion Phase||0
217888|NCT00705783|522776|P2|NOT COMPLETED|Conversion Phase||0
217889|NCT00705783|522777|P1|NOT COMPLETED|Conversion Phase||133
217890|NCT00705783|522775|P3|COMPLETED|Conversion Phase||0
217891|NCT00705783|522776|P2|COMPLETED|Conversion Phase||0
217892|NCT00705783|522777|P1|COMPLETED|Conversion Phase||500
217893|NCT00705783|522775|P3|Received Study Medication|Conversion Phase||0
217894|NCT00705783|522776|P2|Received Study Medication|Conversion Phase||0
217895|NCT00705783|522777|P1|Received Study Medication|Conversion Phase||632
217896|NCT00705783|522775|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
217897|NCT00705783|522776|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
217898|NCT00705783|522777|P1|STARTED|Conversion Phase||633
217899|NCT00705757|522807|P3|NOT COMPLETED|Overall Study||11
217900|NCT00705757|522808|P2|NOT COMPLETED|Overall Study||8
217901|NCT00705757|522809|P1|NOT COMPLETED|Overall Study||13
217902|NCT00705757|522807|P3|COMPLETED|Overall Study||17
217903|NCT00705757|522808|P2|COMPLETED|Overall Study||21
217904|NCT00705757|522809|P1|COMPLETED|Overall Study||19
217905|NCT00705757|522807|P3|STARTED|Overall Study||28
217906|NCT00705757|522808|P2|STARTED|Overall Study||29
217907|NCT00705757|522809|P1|STARTED|Overall Study||32
217908|NCT00705718|522819|P2|NOT COMPLETED|Overall Study||22
217909|NCT00705718|522820|P1|NOT COMPLETED|Overall Study||7
217910|NCT00705718|522819|P2|COMPLETED|Overall Study||128
217911|NCT00705718|522820|P1|COMPLETED|Overall Study||37
217912|NCT00705718|522819|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
217913|NCT00705718|522820|P1|12 Month Follow up|Overall Study|2 Deaths|37
217914|NCT00705718|522819|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
217915|NCT00705718|522820|P1|6 Month Follow up|Overall Study|3 Deaths|40
217916|NCT00705718|522819|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
217917|NCT00705718|522820|P1|1 Month Follow up|Overall Study|1 Death|43
217918|NCT00705718|522819|P2|STARTED|Overall Study||150
217919|NCT00705718|522820|P1|STARTED|Overall Study||44
217920|NCT00705679|522841|P5|NOT COMPLETED|Overall Study||69
217921|NCT00705679|522842|P4|NOT COMPLETED|Overall Study||80
217922|NCT00705679|522843|P3|NOT COMPLETED|Overall Study||115
217923|NCT00705679|522844|P2|NOT COMPLETED|Overall Study||139
217924|NCT00705679|522845|P1|NOT COMPLETED|Overall Study||65
217925|NCT00705679|522841|P5|COMPLETED|Overall Study||934
217926|NCT00705679|522842|P4|COMPLETED|Overall Study||927
217927|NCT00705679|522843|P3|COMPLETED|Overall Study||894
217928|NCT00705679|522844|P2|COMPLETED|Overall Study||864
217929|NCT00705679|522845|P1|COMPLETED|Overall Study||942
217930|NCT00705679|522841|P5|STARTED|Overall Study||1003
217931|NCT00705679|522842|P4|STARTED|Overall Study||1007
217932|NCT00705679|522843|P3|STARTED|Overall Study||1009
217933|NCT00705679|522844|P2|STARTED|Overall Study||1003
217934|NCT00705679|522845|P1|STARTED|Overall Study||1007
217935|NCT00705666|522880|P1|NOT COMPLETED|Overall Study||339
217936|NCT00705666|522880|P1|COMPLETED|Overall Study||450
217937|NCT00705666|522880|P1|STARTED|Overall Study||789
217938|NCT00705653|522884|P1|NOT COMPLETED|Overall Study||0
217939|NCT00705653|522884|P1|COMPLETED|Overall Study||46
217940|NCT00705653|522884|P1|STARTED|Overall Study||46
217941|NCT00705614|522891|P2|NOT COMPLETED|Switch to Remicade||49
217942|NCT00705614|522892|P1|NOT COMPLETED|Switch to Remicade||0
217943|NCT00705614|522891|P2|COMPLETED|Switch to Remicade||249
217944|NCT00705614|522892|P1|COMPLETED|Switch to Remicade||0
217945|NCT00705614|522891|P2|STARTED|Switch to Remicade||298
217946|NCT00705614|522892|P1|STARTED|Switch to Remicade||0
217947|NCT00705614|522891|P2|NOT COMPLETED|Initial Intervention||321
217948|NCT00705614|522892|P1|NOT COMPLETED|Initial Intervention||518
217949|NCT00705614|522891|P2|COMPLETED|Initial Intervention||800
217950|NCT00705614|522892|P1|COMPLETED|Initial Intervention||1023
217951|NCT00705614|522891|P2|STARTED|Initial Intervention||1121
217952|NCT00705614|522892|P1|STARTED|Initial Intervention||1541
217953|NCT00705575|522941|P2|NOT COMPLETED|Overall Study||46
217954|NCT00705575|522942|P1|NOT COMPLETED|Overall Study||23
217955|NCT00705575|522941|P2|COMPLETED|Overall Study||293
217956|NCT00705575|522942|P1|COMPLETED|Overall Study||326
217957|NCT00705575|522941|P2|STARTED|Overall Study||339
217958|NCT00705575|522942|P1|STARTED|Overall Study||349
217959|NCT00705536|522956|P4|NOT COMPLETED|Completed Study||0
217960|NCT00705536|522957|P3|NOT COMPLETED|Completed Study||0
217961|NCT00705536|522958|P2|NOT COMPLETED|Completed Study||0
217962|NCT00705536|522959|P1|NOT COMPLETED|Completed Study||0
217963|NCT00705536|522956|P4|COMPLETED|Completed Study||6
217964|NCT00705536|522957|P3|COMPLETED|Completed Study||7
217965|NCT00705536|522958|P2|COMPLETED|Completed Study||6
217966|NCT00705536|522959|P1|COMPLETED|Completed Study||6
217967|NCT00705536|522956|P4|STARTED|Completed Study||6
217968|NCT00705536|522957|P3|STARTED|Completed Study||7
217969|NCT00705536|522958|P2|STARTED|Completed Study||6
217970|NCT00705536|522959|P1|STARTED|Completed Study||6
217971|NCT00705536|522956|P4|NOT COMPLETED|Start Period 2||0
217972|NCT00705536|522957|P3|NOT COMPLETED|Start Period 2||0
217973|NCT00705536|522958|P2|NOT COMPLETED|Start Period 2||0
217974|NCT00705536|522959|P1|NOT COMPLETED|Start Period 2||0
217975|NCT00705536|522956|P4|COMPLETED|Start Period 2||6
217976|NCT00705536|522957|P3|COMPLETED|Start Period 2||7
217977|NCT00705536|522958|P2|COMPLETED|Start Period 2||6
217978|NCT00705536|522959|P1|COMPLETED|Start Period 2||6
217979|NCT00705536|522956|P4|STARTED|Start Period 2||6
217980|NCT00705536|522957|P3|STARTED|Start Period 2||7
217981|NCT00705536|522958|P2|STARTED|Start Period 2||6
217982|NCT00705536|522959|P1|STARTED|Start Period 2||6
217983|NCT00705536|522956|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
217984|NCT00705536|522957|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
217985|NCT00705536|522958|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
217986|NCT00705536|522959|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
217987|NCT00705536|522956|P4|COMPLETED|Washout Period of at Least 6 Days||6
217988|NCT00705536|522957|P3|COMPLETED|Washout Period of at Least 6 Days||7
217989|NCT00705536|522958|P2|COMPLETED|Washout Period of at Least 6 Days||6
217990|NCT00705536|522959|P1|COMPLETED|Washout Period of at Least 6 Days||6
217991|NCT00705536|522956|P4|STARTED|Washout Period of at Least 6 Days||6
217992|NCT00705536|522957|P3|STARTED|Washout Period of at Least 6 Days||7
217993|NCT00705536|522958|P2|STARTED|Washout Period of at Least 6 Days||6
217994|NCT00705536|522959|P1|STARTED|Washout Period of at Least 6 Days||6
217995|NCT00705536|522956|P4|NOT COMPLETED|Start Period 1||1
217996|NCT00705536|522957|P3|NOT COMPLETED|Start Period 1||0
217997|NCT00705536|522958|P2|NOT COMPLETED|Start Period 1||0
217998|NCT00705536|522959|P1|NOT COMPLETED|Start Period 1||0
217999|NCT00705536|522956|P4|COMPLETED|Start Period 1||6
218000|NCT00705536|522957|P3|COMPLETED|Start Period 1||7
218001|NCT00705536|522958|P2|COMPLETED|Start Period 1||6
218002|NCT00705536|522959|P1|COMPLETED|Start Period 1||6
218003|NCT00705536|522956|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
218004|NCT00705536|522957|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
218005|NCT00705536|522958|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
218006|NCT00705536|522959|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
218007|NCT00705536|522956|P4|STARTED|Start Period 1||7
218008|NCT00705536|522957|P3|STARTED|Start Period 1||7
218009|NCT00705536|522958|P2|STARTED|Start Period 1||6
218010|NCT00705536|522959|P1|STARTED|Start Period 1||6
218011|NCT00705523|523020|P2|NOT COMPLETED|Overall Study||3
218012|NCT00705523|523021|P1|NOT COMPLETED|Overall Study||2
218013|NCT00705523|523020|P2|COMPLETED|Overall Study||18
218014|NCT00705523|523021|P1|COMPLETED|Overall Study||17
218015|NCT00705523|523020|P2|STARTED|Overall Study||21
218016|NCT00705523|523021|P1|STARTED|Overall Study||19
218017|NCT00705432|523035|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
218018|NCT00705432|523036|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
218019|NCT00705432|523037|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
218020|NCT00705432|523038|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
218021|NCT00705432|523039|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
218022|NCT00705432|523040|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
218023|NCT00705432|523035|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
218024|NCT00705432|523036|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
218025|NCT00705432|523037|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
218026|NCT00705432|523038|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
218027|NCT00705432|523039|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
218028|NCT00705432|523040|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
218029|NCT00705432|523035|P6|STARTED|Follow-up Period (Upto Week 72)||53
218030|NCT00705432|523036|P5|STARTED|Follow-up Period (Upto Week 72)||44
218031|NCT00705432|523037|P4|STARTED|Follow-up Period (Upto Week 72)||42
218032|NCT00705432|523038|P3|STARTED|Follow-up Period (Upto Week 72)||291
218033|NCT00705432|523039|P2|STARTED|Follow-up Period (Upto Week 72)||295
218034|NCT00705432|523040|P1|STARTED|Follow-up Period (Upto Week 72)||278
218035|NCT00705432|523035|P6|NOT COMPLETED|Treatment Period||30
218036|NCT00705432|523036|P5|NOT COMPLETED|Treatment Period||28
218037|NCT00705432|523037|P4|NOT COMPLETED|Treatment Period||41
218038|NCT00705432|523038|P3|NOT COMPLETED|Treatment Period||121
218039|NCT00705432|523039|P2|NOT COMPLETED|Treatment Period||111
218040|NCT00705432|523040|P1|NOT COMPLETED|Treatment Period||163
218041|NCT00705432|523035|P6|COMPLETED|Treatment Period||25
218042|NCT00705432|523036|P5|COMPLETED|Treatment Period||24
218043|NCT00705432|523037|P4|COMPLETED|Treatment Period||11
218044|NCT00705432|523038|P3|COMPLETED|Treatment Period||190
218045|NCT00705432|523039|P2|COMPLETED|Treatment Period||205
218046|NCT00705432|523040|P1|COMPLETED|Treatment Period||148
218047|NCT00705432|523035|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
218048|NCT00705432|523036|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
218049|NCT00705432|523037|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
218050|NCT00705432|523038|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
218051|NCT00705432|523039|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
218052|NCT00705432|523040|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
218053|NCT00705432|523035|P6|STARTED|Treatment Period||55
218054|NCT00705432|523036|P5|STARTED|Treatment Period||52
218055|NCT00705432|523037|P4|STARTED|Treatment Period||52
218056|NCT00705432|523038|P3|STARTED|Treatment Period||311
218057|NCT00705432|523039|P2|STARTED|Treatment Period||316
218058|NCT00705432|523040|P1|STARTED|Treatment Period||311
218059|NCT00705406|523077|P2|NOT COMPLETED|Overall Study||5
218060|NCT00705406|523078|P1|NOT COMPLETED|Overall Study||4
218061|NCT00705406|523077|P2|COMPLETED|Overall Study||197
218062|NCT00705406|523078|P1|COMPLETED|Overall Study||199
218063|NCT00705406|523077|P2|STARTED|Overall Study||202
218064|NCT00705406|523078|P1|STARTED|Overall Study||203
218065|NCT00705367|523102|P2|NOT COMPLETED|Long-term Extension Period||0
218066|NCT00705367|523103|P1|NOT COMPLETED|Long-term Extension Period||9
218067|NCT00705367|523102|P2|COMPLETED|Long-term Extension Period||0
218068|NCT00705367|523103|P1|COMPLETED|Long-term Extension Period||0
218069|NCT00705367|523102|P2|STARTED|Long-term Extension Period||0
218070|NCT00705367|523103|P1|STARTED|Long-term Extension Period||9
218071|NCT00705367|523102|P2|NOT COMPLETED|Short-term Period||0
218072|NCT00705367|523103|P1|NOT COMPLETED|Short-term Period||0
218073|NCT00705367|523102|P2|COMPLETED|Short-term Period||3
218074|NCT00705367|523103|P1|COMPLETED|Short-term Period||6
218075|NCT00705367|523102|P2|STARTED|Short-term Period||3
218076|NCT00705367|523103|P1|STARTED|Short-term Period||6
218077|NCT00705341|523130|P4|NOT COMPLETED|Phase 2: Trial||4
218078|NCT00705341|523131|P3|NOT COMPLETED|Phase 2: Trial||7
218079|NCT00705341|523132|P2|NOT COMPLETED|Phase 2: Trial||0
218080|NCT00705341|523133|P1|NOT COMPLETED|Phase 2: Trial||0
218081|NCT00705341|523130|P4|COMPLETED|Phase 2: Trial||28
218082|NCT00705341|523131|P3|COMPLETED|Phase 2: Trial||23
218083|NCT00705341|523132|P2|COMPLETED|Phase 2: Trial||0
218084|NCT00705341|523133|P1|COMPLETED|Phase 2: Trial||0
218085|NCT00705341|523130|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
218086|NCT00705341|523131|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
218087|NCT00705341|523132|P2|STARTED|Phase 2: Trial||0
218088|NCT00705341|523133|P1|STARTED|Phase 2: Trial||0
218089|NCT00705341|523130|P4|NOT COMPLETED|Phase 1:Control Challenge||0
218090|NCT00705341|523131|P3|NOT COMPLETED|Phase 1:Control Challenge||0
218091|NCT00705341|523132|P2|NOT COMPLETED|Phase 1:Control Challenge||0
218092|NCT00705341|523133|P1|NOT COMPLETED|Phase 1:Control Challenge||0
218093|NCT00705341|523130|P4|COMPLETED|Phase 1:Control Challenge||0
218094|NCT00705341|523131|P3|COMPLETED|Phase 1:Control Challenge||0
218095|NCT00705341|523132|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
218096|NCT00705341|523133|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
218097|NCT00705341|523130|P4|STARTED|Phase 1:Control Challenge||0
218098|NCT00705341|523131|P3|STARTED|Phase 1:Control Challenge||0
218099|NCT00705341|523132|P2|STARTED|Phase 1:Control Challenge||93
218100|NCT00705341|523133|P1|STARTED|Phase 1:Control Challenge||126
218101|NCT00705289|523141|P1|NOT COMPLETED|Overall Study||131
218102|NCT00705289|523141|P1|COMPLETED|Overall Study||597
218103|NCT00705289|523141|P1|STARTED|Overall Study||728
218104|NCT00705263|523165|P1|NOT COMPLETED|Overall Study||2
218105|NCT00705263|523165|P1|COMPLETED|Overall Study||108
218106|NCT00705263|523165|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
218107|NCT00705250|523169|P1|NOT COMPLETED|Overall Study||2
218108|NCT00705250|523169|P1|COMPLETED|Overall Study||34
218109|NCT00705250|523169|P1|STARTED|Overall Study||36
218110|NCT00705224|523173|P1|NOT COMPLETED|Overall Study||11
218111|NCT00705224|523173|P1|COMPLETED|Overall Study||239
218112|NCT00705224|523173|P1|STARTED|Overall Study||250
218113|NCT00705159|523189|P4|NOT COMPLETED|Overall Study||4
218114|NCT00705159|523190|P3|NOT COMPLETED|Overall Study||5
218115|NCT00705159|523191|P2|NOT COMPLETED|Overall Study||2
218116|NCT00705159|523192|P1|NOT COMPLETED|Overall Study||0
218117|NCT00705159|523189|P4|COMPLETED|Overall Study||30
218118|NCT00705159|523190|P3|COMPLETED|Overall Study||29
218119|NCT00705159|523191|P2|COMPLETED|Overall Study||33
218120|NCT00705159|523192|P1|COMPLETED|Overall Study||34
218121|NCT00705159|523189|P4|STARTED|Overall Study||34
218122|NCT00705159|523190|P3|STARTED|Overall Study||34
218123|NCT00705159|523191|P2|STARTED|Overall Study||35
218124|NCT00705159|523192|P1|STARTED|Overall Study||34
218125|NCT00705146|523212|P2|NOT COMPLETED|Overall Study||1
218126|NCT00705146|523213|P1|NOT COMPLETED|Overall Study||1
218127|NCT00705146|523212|P2|COMPLETED|Overall Study||23
218128|NCT00705146|523213|P1|COMPLETED|Overall Study||31
218129|NCT00705146|523212|P2|STARTED|Overall Study||24
218130|NCT00705146|523213|P1|STARTED|Overall Study||32
218131|NCT00705107|523221|P1|NOT COMPLETED|Overall Study||49
218132|NCT00705107|523221|P1|COMPLETED|Overall Study||218
218133|NCT00705107|523221|P1|STARTED|Overall Study||267
218134|NCT00705081|523228|P2|NOT COMPLETED|Overall Study||0
218135|NCT00705081|523229|P1|NOT COMPLETED|Overall Study||0
218136|NCT00705081|523228|P2|COMPLETED|Overall Study||198
218137|NCT00705081|523229|P1|COMPLETED|Overall Study||255
218138|NCT00705081|523228|P2|STARTED|Overall Study||198
218139|NCT00705081|523229|P1|STARTED|Overall Study||255
218140|NCT00705016|523242|P3|NOT COMPLETED|Overall Study||58
218141|NCT00705016|523243|P2|NOT COMPLETED|Overall Study||58
218142|NCT00705016|523244|P1|NOT COMPLETED|Overall Study||60
218143|NCT00705016|523242|P3|COMPLETED|Overall Study||4
218144|NCT00705016|523243|P2|COMPLETED|Overall Study||2
218145|NCT00705016|523244|P1|COMPLETED|Overall Study||2
218146|NCT00705016|523242|P3|STARTED|Overall Study||62
218147|NCT00705016|523243|P2|STARTED|Overall Study||60
218148|NCT00705016|523244|P1|STARTED|Overall Study||62
218149|NCT00705003|523273|P3|NOT COMPLETED|Treated||3
218150|NCT00705003|523274|P2|NOT COMPLETED|Treated||6
218151|NCT00705003|523275|P1|NOT COMPLETED|Treated||13
218152|NCT00705003|523273|P3|COMPLETED|Treated||30
218153|NCT00705003|523274|P2|COMPLETED|Treated||28
218154|NCT00705003|523275|P1|COMPLETED|Treated||54
218155|NCT00705003|523273|P3|STARTED|Treated||33
218156|NCT00705003|523274|P2|STARTED|Treated||34
218157|NCT00705003|523275|P1|STARTED|Treated||67
218158|NCT00705003|523273|P3|NOT COMPLETED|Enrolled||1
218159|NCT00705003|523274|P2|NOT COMPLETED|Enrolled||3
218160|NCT00705003|523275|P1|NOT COMPLETED|Enrolled||4
218161|NCT00705003|523273|P3|COMPLETED|Enrolled||33
218162|NCT00705003|523274|P2|COMPLETED|Enrolled||34
218163|NCT00705003|523275|P1|COMPLETED|Enrolled||67
218164|NCT00705003|523273|P3|STARTED|Enrolled||34
218165|NCT00705003|523274|P2|STARTED|Enrolled||37
218166|NCT00705003|523275|P1|STARTED|Enrolled||71
218167|NCT00704964|523295|P1|NOT COMPLETED|Overall Study||328
218168|NCT00704964|523295|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
218169|NCT00704964|523295|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
218170|NCT00704938|523302|P2|NOT COMPLETED|Overall Study||0
218171|NCT00704938|523303|P1|NOT COMPLETED|Overall Study||0
218172|NCT00704938|523302|P2|COMPLETED|Overall Study||1
218173|NCT00704938|523303|P1|COMPLETED|Overall Study||2
218174|NCT00704938|523302|P2|STARTED|Overall Study||1
218175|NCT00704938|523303|P1|STARTED|Overall Study||2
218176|NCT00704912|523314|P3|NOT COMPLETED|Overall Study||7
218177|NCT00704912|523315|P2|NOT COMPLETED|Overall Study||4
218178|NCT00704912|523316|P1|NOT COMPLETED|Overall Study||6
218179|NCT00704912|523314|P3|COMPLETED|Overall Study||43
218180|NCT00704912|523315|P2|COMPLETED|Overall Study||45
218181|NCT00704912|523316|P1|COMPLETED|Overall Study||44
218182|NCT00704912|523314|P3|STARTED|Overall Study||50
218183|NCT00704912|523315|P2|STARTED|Overall Study||49
218184|NCT00704912|523316|P1|STARTED|Overall Study||50
218185|NCT00704847|523335|P2|NOT COMPLETED|Overall Study||170
218186|NCT00704847|523336|P1|NOT COMPLETED|Overall Study||221
218187|NCT00704847|523335|P2|COMPLETED|Overall Study||339
218188|NCT00704847|523336|P1|COMPLETED|Overall Study||300
218189|NCT00704847|523335|P2|STARTED|Overall Study||509
218190|NCT00704847|523336|P1|STARTED|Overall Study||521
218191|NCT00704808|523344|P1|NOT COMPLETED|Overall Study||131
218192|NCT00704808|523344|P1|COMPLETED|Overall Study||49
218193|NCT00704808|523344|P1|STARTED|Overall Study||180
218194|NCT00704769|523348|P1|NOT COMPLETED|Overall Study||0
218195|NCT00704769|523348|P1|COMPLETED|Overall Study||591
218196|NCT00704769|523348|P1|STARTED|Overall Study||591
218197|NCT00704730|523355|P2|NOT COMPLETED|Overall Study||96
218198|NCT00704730|523356|P1|NOT COMPLETED|Overall Study||121
218199|NCT00704730|523355|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
218200|NCT00704730|523356|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
218201|NCT00704730|523355|P2|STARTED|Overall Study|Randomized|111
218202|NCT00704730|523356|P1|STARTED|Overall Study|Randomized|219
218203|NCT00704717|523372|P1|NOT COMPLETED|Overall Study||0
218204|NCT00704717|523372|P1|COMPLETED|Overall Study||185
218205|NCT00704717|523372|P1|STARTED|Overall Study||185
218206|NCT00704535|523376|P1|NOT COMPLETED|Overall Study||146
218207|NCT00704535|523376|P1|COMPLETED|Overall Study||3959
218208|NCT00704535|523376|P1|STARTED|Overall Study||4105
218209|NCT00704522|523389|P2|NOT COMPLETED|Overall Study||45
218210|NCT00704522|523390|P1|NOT COMPLETED|Overall Study||183
218211|NCT00704522|523389|P2|COMPLETED|Overall Study||75
218212|NCT00704522|523390|P1|COMPLETED|Overall Study||298
218213|NCT00704522|523389|P2|STARTED|Overall Study||120
218214|NCT00704522|523390|P1|STARTED|Overall Study||481
218215|NCT00704496|523399|P2|NOT COMPLETED|Overall Study||0
218216|NCT00704496|523400|P1|NOT COMPLETED|Overall Study||0
218217|NCT00704496|523399|P2|COMPLETED|Overall Study||0
218218|NCT00704496|523400|P1|COMPLETED|Overall Study||0
218219|NCT00704496|523399|P2|STARTED|Overall Study||0
218220|NCT00704496|523400|P1|STARTED|Overall Study||0
218221|NCT00704418|523410|P2|NOT COMPLETED|Overall Study||6
218222|NCT00704418|523411|P1|NOT COMPLETED|Overall Study||5
218223|NCT00704418|523410|P2|COMPLETED|Overall Study||72
218224|NCT00704418|523411|P1|COMPLETED|Overall Study||73
218225|NCT00704418|523410|P2|STARTED|Overall Study||78
218226|NCT00704418|523411|P1|STARTED|Overall Study||78
218227|NCT00704405|523424|P5|NOT COMPLETED|Overall Study (C Population)||0
218228|NCT00704405|523425|P4|NOT COMPLETED|Overall Study (C Population)||1
218229|NCT00704405|523426|P3|NOT COMPLETED|Overall Study (C Population)||1
218230|NCT00704405|523427|P2|NOT COMPLETED|Overall Study (C Population)||3
218231|NCT00704405|523428|P1|NOT COMPLETED|Overall Study (C Population)||1
218232|NCT00704405|523424|P5|COMPLETED|Overall Study (C Population)||14
218233|NCT00704405|523425|P4|COMPLETED|Overall Study (C Population)||14
218234|NCT00704405|523426|P3|COMPLETED|Overall Study (C Population)||14
218235|NCT00704405|523427|P2|COMPLETED|Overall Study (C Population)||11
218236|NCT00704405|523428|P1|COMPLETED|Overall Study (C Population)||15
218237|NCT00704405|523424|P5|STARTED|Overall Study (C Population)||14
218238|NCT00704405|523425|P4|STARTED|Overall Study (C Population)||15
218239|NCT00704405|523426|P3|STARTED|Overall Study (C Population)||15
218240|NCT00704405|523427|P2|STARTED|Overall Study (C Population)||14
218241|NCT00704405|523428|P1|STARTED|Overall Study (C Population)||16
218242|NCT00704405|523424|P5|NOT COMPLETED|Overall Study (NC Population)||5
218243|NCT00704405|523425|P4|NOT COMPLETED|Overall Study (NC Population)||4
218244|NCT00704405|523426|P3|NOT COMPLETED|Overall Study (NC Population)||3
218245|NCT00704405|523427|P2|NOT COMPLETED|Overall Study (NC Population)||4
218246|NCT00704405|523428|P1|NOT COMPLETED|Overall Study (NC Population)||5
218247|NCT00704405|523424|P5|COMPLETED|Overall Study (NC Population)||37
218248|NCT00704405|523425|P4|COMPLETED|Overall Study (NC Population)||38
218249|NCT00704405|523426|P3|COMPLETED|Overall Study (NC Population)||38
218250|NCT00704405|523427|P2|COMPLETED|Overall Study (NC Population)||40
218251|NCT00704405|523428|P1|COMPLETED|Overall Study (NC Population)||37
218252|NCT00704405|523424|P5|STARTED|Overall Study (NC Population)||42
218253|NCT00704405|523425|P4|STARTED|Overall Study (NC Population)||42
218254|NCT00704405|523426|P3|STARTED|Overall Study (NC Population)||41
218255|NCT00704405|523427|P2|STARTED|Overall Study (NC Population)||44
218256|NCT00704405|523428|P1|STARTED|Overall Study (NC Population)||42
218257|NCT00704379|523458|P2|NOT COMPLETED|Overall Study||7
218258|NCT00704379|523459|P1|NOT COMPLETED|Overall Study||7
218259|NCT00704379|523458|P2|COMPLETED|Overall Study||41
218260|NCT00704379|523459|P1|COMPLETED|Overall Study||39
218261|NCT00704379|523458|P2|STARTED|Overall Study||48
218262|NCT00704379|523459|P1|STARTED|Overall Study||46
218263|NCT00704353|523477|P2|NOT COMPLETED|Overall Study||114
218264|NCT00704353|523478|P1|NOT COMPLETED|Overall Study||98
218265|NCT00704353|523477|P2|COMPLETED|Overall Study||255
218266|NCT00704353|523478|P1|COMPLETED|Overall Study||268
218267|NCT00704353|523477|P2|STARTED|Overall Study||369
218268|NCT00704353|523478|P1|STARTED|Overall Study||366
218269|NCT00704340|523486|P2|NOT COMPLETED|Overall Study||2
218270|NCT00704340|523487|P1|NOT COMPLETED|Overall Study||2
218271|NCT00704340|523486|P2|COMPLETED|Overall Study||115
218272|NCT00704340|523487|P1|COMPLETED|Overall Study||118
218273|NCT00704340|523486|P2|STARTED|Overall Study||117
218274|NCT00704340|523487|P1|STARTED|Overall Study||120
218275|NCT00704184|523502|P5|NOT COMPLETED|Open-Label Treatment||3
218276|NCT00704184|523503|P4|NOT COMPLETED|Open-Label Treatment||5
218277|NCT00704184|523504|P3|NOT COMPLETED|Open-Label Treatment||4
218278|NCT00704184|523505|P2|NOT COMPLETED|Open-Label Treatment||2
218279|NCT00704184|523506|P1|NOT COMPLETED|Open-Label Treatment||1
218280|NCT00704184|523502|P5|COMPLETED|Open-Label Treatment||16
218281|NCT00704184|523503|P4|COMPLETED|Open-Label Treatment||13
218282|NCT00704184|523504|P3|COMPLETED|Open-Label Treatment||16
218283|NCT00704184|523505|P2|COMPLETED|Open-Label Treatment||16
218284|NCT00704184|523506|P1|COMPLETED|Open-Label Treatment||18
218285|NCT00704184|523502|P5|STARTED|Open-Label Treatment||19
218286|NCT00704184|523503|P4|STARTED|Open-Label Treatment||18
218287|NCT00704184|523504|P3|STARTED|Open-Label Treatment||20
218288|NCT00704184|523505|P2|STARTED|Open-Label Treatment||18
218289|NCT00704184|523506|P1|STARTED|Open-Label Treatment||19
218290|NCT00704184|523502|P5|NOT COMPLETED|Double-Blind Treatment||0
218291|NCT00704184|523503|P4|NOT COMPLETED|Double-Blind Treatment||0
218292|NCT00704184|523504|P3|NOT COMPLETED|Double-Blind Treatment||0
218293|NCT00704184|523505|P2|NOT COMPLETED|Double-Blind Treatment||0
218294|NCT00704184|523506|P1|NOT COMPLETED|Double-Blind Treatment||1
218295|NCT00704184|523502|P5|COMPLETED|Double-Blind Treatment||19
218296|NCT00704184|523503|P4|COMPLETED|Double-Blind Treatment||18
218297|NCT00704184|523504|P3|COMPLETED|Double-Blind Treatment||20
218298|NCT00704184|523505|P2|COMPLETED|Double-Blind Treatment||18
218299|NCT00704184|523506|P1|COMPLETED|Double-Blind Treatment||19
218300|NCT00704184|523502|P5|Treated|Double-Blind Treatment||19
218301|NCT00704184|523503|P4|Treated|Double-Blind Treatment||18
218302|NCT00704184|523504|P3|Treated|Double-Blind Treatment||20
218303|NCT00704184|523505|P2|Treated|Double-Blind Treatment||18
218304|NCT00704184|523506|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
218305|NCT00704184|523502|P5|STARTED|Double-Blind Treatment||19
218306|NCT00704184|523503|P4|STARTED|Double-Blind Treatment||18
218307|NCT00704184|523504|P3|STARTED|Double-Blind Treatment||20
218308|NCT00704184|523505|P2|STARTED|Double-Blind Treatment||18
218309|NCT00704184|523506|P1|STARTED|Double-Blind Treatment||20
218310|NCT00704171|523545|P2|NOT COMPLETED|Overall Study||0
218311|NCT00704171|523546|P1|NOT COMPLETED|Overall Study||1
218312|NCT00704171|523545|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
218313|NCT00704171|523546|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
218314|NCT00704171|523545|P2|STARTED|Overall Study||59
218315|NCT00704171|523546|P1|STARTED|Overall Study||62
218316|NCT00704132|523564|P2|NOT COMPLETED|Overall Study||2
218317|NCT00704132|523565|P1|NOT COMPLETED|Overall Study||1
218318|NCT00704132|523564|P2|COMPLETED|Overall Study||22
218319|NCT00704132|523565|P1|COMPLETED|Overall Study||25
218320|NCT00704132|523564|P2|STARTED|Overall Study||24
218321|NCT00704132|523565|P1|STARTED|Overall Study||26
218322|NCT00704028|523573|P2|NOT COMPLETED|Overall Study||21
218323|NCT00704028|523574|P1|NOT COMPLETED|Overall Study||12
218324|NCT00704028|523573|P2|COMPLETED|Overall Study||57
218325|NCT00704028|523574|P1|COMPLETED|Overall Study||70
218326|NCT00704028|523573|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
218327|NCT00704028|523574|P1|STARTED|Overall Study||82
218328|NCT00703976|523582|P2|NOT COMPLETED|Overall Study||0
218329|NCT00703976|523583|P1|NOT COMPLETED|Overall Study||0
218330|NCT00703976|523582|P2|COMPLETED|Overall Study||41
218331|NCT00703976|523583|P1|COMPLETED|Overall Study||37
218332|NCT00703976|523582|P2|STARTED|Overall Study||41
218333|NCT00703976|523583|P1|STARTED|Overall Study||37
218334|NCT00703963|523593|P2|NOT COMPLETED|Overall Study||14
218335|NCT00703963|523594|P1|NOT COMPLETED|Overall Study||7
218336|NCT00703963|523593|P2|COMPLETED|Overall Study||86
218337|NCT00703963|523594|P1|COMPLETED|Overall Study||93
218338|NCT00703963|523593|P2|STARTED|Overall Study||100
218339|NCT00703963|523594|P1|STARTED|Overall Study||100
218340|NCT00703937|523606|P2|NOT COMPLETED|Overall Study||93
218341|NCT00703937|523607|P1|NOT COMPLETED|Overall Study||65
218342|NCT00703937|523606|P2|COMPLETED|Overall Study||267
218343|NCT00703937|523607|P1|COMPLETED|Overall Study||278
218344|NCT00703937|523606|P2|STARTED|Overall Study||360
218345|NCT00703937|523607|P1|STARTED|Overall Study||343
218346|NCT00703924|523615|P2|NOT COMPLETED|Overall Study||1
218347|NCT00703924|523616|P1|NOT COMPLETED|Overall Study||1
218348|NCT00703924|523615|P2|COMPLETED|Overall Study||41
218349|NCT00703924|523616|P1|COMPLETED|Overall Study||49
218350|NCT00703924|523615|P2|STARTED|Overall Study||42
218351|NCT00703924|523616|P1|STARTED|Overall Study||50
218352|NCT00703911|523632|P1|NOT COMPLETED|Overall Study||10
218353|NCT00703911|523632|P1|COMPLETED|Overall Study||92
218354|NCT00703911|523632|P1|STARTED|Overall Study||102
218355|NCT00703885|523660|P1|NOT COMPLETED|Overall Study||0
218356|NCT00703885|523660|P1|COMPLETED|Overall Study||16
218357|NCT00703885|523660|P1|STARTED|Overall Study||16
218358|NCT00703846|523665|P1|NOT COMPLETED|Overall Study||137
218359|NCT00703846|523665|P1|COMPLETED|Overall Study||363
218360|NCT00703846|523665|P1|STARTED|Overall Study||500
218361|NCT00703820|523681|P2|NOT COMPLETED|Overall Study||34
218362|NCT00703820|523682|P1|NOT COMPLETED|Overall Study||35
218363|NCT00703820|523681|P2|COMPLETED|Overall Study||95
218364|NCT00703820|523682|P1|COMPLETED|Overall Study||98
218365|NCT00703820|523681|P2|STARTED|Overall Study||129
218366|NCT00703820|523682|P1|STARTED|Overall Study||133
218367|NCT00703781|523691|P2|NOT COMPLETED|Overall Study||2
218368|NCT00703781|523692|P1|NOT COMPLETED|Overall Study||2
218369|NCT00703781|523691|P2|COMPLETED|Overall Study||61
218370|NCT00703781|523692|P1|COMPLETED|Overall Study||61
218371|NCT00703781|523691|P2|STARTED|Overall Study||63
218372|NCT00703781|523692|P1|STARTED|Overall Study||63
218373|NCT00703729|523702|P2|NOT COMPLETED|Overall Study||3
218374|NCT00703729|523703|P1|NOT COMPLETED|Overall Study||0
218375|NCT00703729|523702|P2|COMPLETED|Overall Study||21
218376|NCT00703729|523703|P1|COMPLETED|Overall Study||25
218377|NCT00703729|523702|P2|STARTED|Overall Study||24
218378|NCT00703729|523703|P1|STARTED|Overall Study||25
218379|NCT00703677|523737|P1|NOT COMPLETED|Overall Study||3
218380|NCT00703677|523737|P1|COMPLETED|Overall Study||14
218381|NCT00703677|523737|P1|STARTED|Overall Study||17
218382|NCT00703534|523752|P2|NOT COMPLETED|Overall Study||25
218383|NCT00703534|523753|P1|NOT COMPLETED|Overall Study||30
218384|NCT00703534|523752|P2|COMPLETED|Overall Study||218
218385|NCT00703534|523753|P1|COMPLETED|Overall Study||205
218386|NCT00703534|523752|P2|STARTED|Overall Study||243
218387|NCT00703534|523753|P1|STARTED|Overall Study||235
218388|NCT00703508|523759|P1|NOT COMPLETED|Overall Study||0
218389|NCT00703508|523759|P1|COMPLETED|Overall Study||26
218390|NCT00703508|523759|P1|STARTED|Overall Study||26
218391|NCT00703391|523773|P2|NOT COMPLETED|Overall Study||0
218392|NCT00703391|523774|P1|NOT COMPLETED|Overall Study||0
218393|NCT00703391|523773|P2|COMPLETED|Overall Study||6
218394|NCT00703391|523774|P1|COMPLETED|Overall Study||12
218395|NCT00703391|523773|P2|STARTED|Overall Study||6
218396|NCT00703391|523774|P1|STARTED|Overall Study||12
218397|NCT00703339|523818|P1|NOT COMPLETED|Overall Study||0
218398|NCT00703339|523818|P1|COMPLETED|Overall Study||1
218399|NCT00703339|523818|P1|STARTED|Overall Study||1
218400|NCT00703326|523825|P2|NOT COMPLETED|Overall Study||225
218401|NCT00703326|523826|P1|NOT COMPLETED|Overall Study||447
218402|NCT00703326|523825|P2|COMPLETED|Overall Study||160
218403|NCT00703326|523826|P1|COMPLETED|Overall Study||312
218404|NCT00703326|523825|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
218405|NCT00703326|523826|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
218406|NCT00703326|523825|P2|STARTED|Overall Study||385
218407|NCT00703326|523826|P1|STARTED|Overall Study||759
218408|NCT00703261|523848|P2|NOT COMPLETED|Overall Study||6
218409|NCT00703261|523849|P1|NOT COMPLETED|Overall Study||6
218410|NCT00703261|523848|P2|COMPLETED|Overall Study||35
218411|NCT00703261|523849|P1|COMPLETED|Overall Study||36
218412|NCT00703261|523848|P2|STARTED|Overall Study||41
218413|NCT00703261|523849|P1|STARTED|Overall Study||42
218414|NCT00703157|523858|P2|NOT COMPLETED|Overall Study||2
218415|NCT00703157|523859|P1|NOT COMPLETED|Overall Study||4
218416|NCT00703157|523858|P2|COMPLETED|Overall Study||24
218417|NCT00703157|523859|P1|COMPLETED|Overall Study||22
218418|NCT00703157|523858|P2|24 Months FU|Overall Study||24
218419|NCT00703157|523859|P1|24 Months FU|Overall Study||22
218420|NCT00703157|523858|P2|6 Months FU|Overall Study||25
218421|NCT00703157|523859|P1|6 Months FU|Overall Study||25
218422|NCT00703157|523858|P2|STARTED|Overall Study||26
218423|NCT00703157|523859|P1|STARTED|Overall Study||26
218424|NCT00703118|523893|P3|NOT COMPLETED|Overall Study||22
218425|NCT00703118|523894|P2|NOT COMPLETED|Overall Study||16
218426|NCT00703118|523895|P1|NOT COMPLETED|Overall Study||21
218427|NCT00703118|523893|P3|COMPLETED|Overall Study||110
218428|NCT00703118|523894|P2|COMPLETED|Overall Study||248
218429|NCT00703118|523895|P1|COMPLETED|Overall Study||245
218430|NCT00703118|523893|P3|STARTED|Overall Study||132
218431|NCT00703118|523894|P2|STARTED|Overall Study||264
218432|NCT00703118|523895|P1|STARTED|Overall Study||266
218433|NCT00703092|523926|P1|NOT COMPLETED|Overall Study||2
218434|NCT00703092|523926|P1|COMPLETED|Overall Study||0
218435|NCT00703092|523926|P1|STARTED|Overall Study||2
218436|NCT00703053|523940|P9|NOT COMPLETED|Overall Study||1
218437|NCT00703053|523941|P8|NOT COMPLETED|Overall Study||6
218438|NCT00703053|523942|P7|NOT COMPLETED|Overall Study||7
218439|NCT00703053|523943|P6|NOT COMPLETED|Overall Study||6
218440|NCT00703053|523944|P5|NOT COMPLETED|Overall Study||1
218441|NCT00703053|523945|P4|NOT COMPLETED|Overall Study||3
218442|NCT00703053|523946|P3|NOT COMPLETED|Overall Study||3
218443|NCT00703053|523947|P2|NOT COMPLETED|Overall Study||2
218444|NCT00703053|523948|P1|NOT COMPLETED|Overall Study||1
218445|NCT00703053|523940|P9|COMPLETED|Overall Study||102
218446|NCT00703053|523941|P8|COMPLETED|Overall Study||91
218447|NCT00703053|523942|P7|COMPLETED|Overall Study||45
218448|NCT00703053|523943|P6|COMPLETED|Overall Study||43
218449|NCT00703053|523944|P5|COMPLETED|Overall Study||50
218450|NCT00703053|523945|P4|COMPLETED|Overall Study||46
218451|NCT00703053|523946|P3|COMPLETED|Overall Study||48
218452|NCT00703053|523947|P2|COMPLETED|Overall Study||24
218453|NCT00703053|523948|P1|COMPLETED|Overall Study||26
218454|NCT00703053|523940|P9|STARTED|Overall Study||103
218455|NCT00703053|523941|P8|STARTED|Overall Study||97
218456|NCT00703053|523942|P7|STARTED|Overall Study||52
218457|NCT00703053|523943|P6|STARTED|Overall Study||49
218458|NCT00703053|523944|P5|STARTED|Overall Study||51
218459|NCT00703053|523945|P4|STARTED|Overall Study||49
218460|NCT00703053|523946|P3|STARTED|Overall Study||51
218461|NCT00703053|523947|P2|STARTED|Overall Study||26
218462|NCT00703053|523948|P1|STARTED|Overall Study||27
218463|NCT00703014|524134|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
218464|NCT00703014|524135|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
218465|NCT00703014|524136|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
218466|NCT00703014|524137|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
218467|NCT00703014|524134|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
218468|NCT00703014|524135|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
218469|NCT00703014|524136|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
218470|NCT00703014|524137|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
218471|NCT00703014|524134|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
218472|NCT00703014|524135|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
218473|NCT00703014|524136|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
218474|NCT00703014|524137|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
218475|NCT00703014|524134|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
218476|NCT00703014|524135|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
218477|NCT00703014|524136|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
218478|NCT00703014|524137|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
218479|NCT00703014|524134|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
218480|NCT00703014|524135|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
218481|NCT00703014|524136|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
218482|NCT00703014|524137|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
218483|NCT00703014|524134|P4|COMPLETED|Mothers Follow Up Trial P05712||0
218484|NCT00703014|524135|P3|COMPLETED|Mothers Follow Up Trial P05712||0
218485|NCT00703014|524136|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
218486|NCT00703014|524137|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
218487|NCT00703014|524134|P4|STARTED|Mothers Follow Up Trial P05712||0
218488|NCT00703014|524135|P3|STARTED|Mothers Follow Up Trial P05712||0
218489|NCT00703014|524136|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
218490|NCT00703014|524137|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
218491|NCT00703014|524134|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
218492|NCT00703014|524135|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
218493|NCT00703014|524136|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
218494|NCT00703014|524137|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
218495|NCT00703014|524134|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
218496|NCT00703014|524135|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
218497|NCT00703014|524136|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
218498|NCT00703014|524137|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
218499|NCT00703014|524134|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
218500|NCT00703014|524135|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
218501|NCT00703014|524136|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
218502|NCT00703014|524137|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
218503|NCT00703014|524134|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
218504|NCT00703014|524135|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
218505|NCT00703014|524136|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
218506|NCT00703014|524137|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
218507|NCT00703014|524134|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
218508|NCT00703014|524135|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
218509|NCT00703014|524136|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
218510|NCT00703014|524137|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
218511|NCT00702949|524158|P3|NOT COMPLETED|Overall Study||8
218512|NCT00702949|524159|P2|NOT COMPLETED|Overall Study||9
218513|NCT00702949|524160|P1|NOT COMPLETED|Overall Study||5
218514|NCT00702949|524158|P3|COMPLETED|Overall Study||54
218515|NCT00702949|524159|P2|COMPLETED|Overall Study||57
218516|NCT00702949|524160|P1|COMPLETED|Overall Study||58
218517|NCT00702949|524158|P3|Evaluable for Primary Endpoint|Overall Study||51
218518|NCT00702949|524159|P2|Evaluable for Primary Endpoint|Overall Study||56
218519|NCT00702949|524160|P1|Evaluable for Primary Endpoint|Overall Study||56
218520|NCT00702949|524158|P3|STARTED|Overall Study||62
218521|NCT00702949|524159|P2|STARTED|Overall Study||66
218522|NCT00702949|524160|P1|STARTED|Overall Study||63
218523|NCT00702923|524185|P1|NOT COMPLETED|Overall Study||1
218524|NCT00702923|524185|P1|COMPLETED|Overall Study||11
218525|NCT00702923|524185|P1|STARTED|Overall Study||12
218526|NCT00702884|524194|P1|NOT COMPLETED|Overall Study||0
218527|NCT00702884|524194|P1|COMPLETED|Overall Study||25
218528|NCT00702884|524194|P1|STARTED|Overall Study||25
218529|NCT00702845|524208|P2|NOT COMPLETED|Overall Study||8
218530|NCT00702845|524209|P1|NOT COMPLETED|Overall Study||22
218531|NCT00702845|524208|P2|COMPLETED|Overall Study||121
218532|NCT00702845|524209|P1|COMPLETED|Overall Study||246
218533|NCT00702845|524208|P2|Randomized|Overall Study||128
218534|NCT00702845|524209|P1|Randomized|Overall Study||268
218535|NCT00702845|524208|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
218536|NCT00702845|524209|P1|STARTED|Overall Study||268
218537|NCT00702780|524249|P2|NOT COMPLETED|Overall Study||8
218538|NCT00702780|524250|P1|NOT COMPLETED|Overall Study||9
218539|NCT00702780|524249|P2|COMPLETED|Overall Study||29
218540|NCT00702780|524250|P1|COMPLETED|Overall Study||28
218541|NCT00702780|524249|P2|STARTED|Overall Study||37
218542|NCT00702780|524250|P1|STARTED|Overall Study||37
218543|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
218544|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
218545|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
218546|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
218547|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
218548|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
218549|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
218550|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
218551|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
218552|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
218553|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
218554|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
218555|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
218556|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
218557|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
218558|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
218559|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
218560|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
218561|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
218562|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
218563|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
218564|NCT00702754|524258|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
218565|NCT00702754|524258|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
218566|NCT00702754|524258|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
218567|NCT00702715|524271|P2|NOT COMPLETED|Overall Study||0
218568|NCT00702715|524272|P1|NOT COMPLETED|Overall Study||1
218569|NCT00702715|524271|P2|COMPLETED|Overall Study||33
218570|NCT00702715|524272|P1|COMPLETED|Overall Study||34
218571|NCT00702715|524271|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
218572|NCT00702715|524272|P1|STARTED|Overall Study||35
218573|NCT00702702|524285|P1|NOT COMPLETED|Overall Study||56
218574|NCT00702702|524285|P1|COMPLETED|Overall Study||0
218575|NCT00702702|524285|P1|STARTED|Overall Study||56
218576|NCT00702689|524293|P1|NOT COMPLETED|Overall Study||6
218577|NCT00702689|524293|P1|COMPLETED|Overall Study||14
218578|NCT00702689|524293|P1|STARTED|Overall Study||20
218579|NCT00702650|524304|P1|NOT COMPLETED|Overall Study||20
218580|NCT00702650|524304|P1|COMPLETED|Overall Study||135
218581|NCT00702650|524304|P1|STARTED|Overall Study||155
218582|NCT00702624|524324|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
218583|NCT00702624|524325|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
218584|NCT00702624|524326|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
218585|NCT00702624|524327|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
218586|NCT00702624|524324|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
218587|NCT00702624|524325|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
218588|NCT00702624|524326|P2|COMPLETED|Fetuses/Infant Follow-up||0
218589|NCT00702624|524327|P1|COMPLETED|Fetuses/Infant Follow-up||0
218590|NCT00702624|524324|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
218591|NCT00702624|524325|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
218592|NCT00702624|524326|P2|Live Born Infants|Fetuses/Infant Follow-up||0
218593|NCT00702624|524327|P1|Live Born Infants|Fetuses/Infant Follow-up||0
218594|NCT00702624|524324|P4|STARTED|Fetuses/Infant Follow-up||55
218595|NCT00702624|524325|P3|STARTED|Fetuses/Infant Follow-up||88
218596|NCT00702624|524326|P2|STARTED|Fetuses/Infant Follow-up||0
218597|NCT00702624|524327|P1|STARTED|Fetuses/Infant Follow-up||0
218598|NCT00702624|524324|P4|NOT COMPLETED|Expectant Mother Follow-up||0
218599|NCT00702624|524325|P3|NOT COMPLETED|Expectant Mother Follow-up||0
218600|NCT00702624|524326|P2|NOT COMPLETED|Expectant Mother Follow-up||0
218601|NCT00702624|524327|P1|NOT COMPLETED|Expectant Mother Follow-up||7
218602|NCT00702624|524324|P4|COMPLETED|Expectant Mother Follow-up||0
218603|NCT00702624|524325|P3|COMPLETED|Expectant Mother Follow-up||0
218604|NCT00702624|524326|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
218605|NCT00702624|524327|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
218606|NCT00702624|524324|P4|STARTED|Expectant Mother Follow-up||0
218607|NCT00702624|524325|P3|STARTED|Expectant Mother Follow-up||0
218608|NCT00702624|524326|P2|STARTED|Expectant Mother Follow-up||45
218609|NCT00702624|524327|P1|STARTED|Expectant Mother Follow-up||68
218610|NCT00702624|524324|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
218611|NCT00702624|524325|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
218612|NCT00702624|524326|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
218613|NCT00702624|524327|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
218614|NCT00702624|524324|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
218615|NCT00702624|524325|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
218616|NCT00702624|524326|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
218617|NCT00702624|524327|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
218618|NCT00702624|524324|P4|STARTED|Base Study P05690 (NCT00702845)||0
218619|NCT00702624|524325|P3|STARTED|Base Study P05690 (NCT00702845)||0
218620|NCT00702624|524326|P2|STARTED|Base Study P05690 (NCT00702845)||128
218621|NCT00702624|524327|P1|STARTED|Base Study P05690 (NCT00702845)||268
218622|NCT00702546|524345|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
218623|NCT00702546|524346|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
218624|NCT00702546|524345|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
218625|NCT00702546|524346|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
218626|NCT00702546|524345|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
218627|NCT00702546|524346|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
218628|NCT00702546|524345|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
218629|NCT00702546|524346|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
218630|NCT00702546|524345|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
218631|NCT00702546|524346|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
218632|NCT00702546|524345|P2|STARTED|Base Study P05690 (NCT00702845)||128
218633|NCT00702546|524346|P1|STARTED|Base Study P05690 (NCT00702845)||268
218634|NCT00702520|524366|P4|NOT COMPLETED|Follow-up Study P05783||0
218635|NCT00702520|524367|P3|NOT COMPLETED|Follow-up Study P05783||0
218636|NCT00702520|524368|P2|NOT COMPLETED|Follow-up Study P05783||0
218637|NCT00702520|524369|P1|NOT COMPLETED|Follow-up Study P05783||0
218638|NCT00702520|524366|P4|COMPLETED|Follow-up Study P05783||11
218639|NCT00702520|524367|P3|COMPLETED|Follow-up Study P05783||8
218640|NCT00702520|524368|P2|COMPLETED|Follow-up Study P05783||8
218641|NCT00702520|524369|P1|COMPLETED|Follow-up Study P05783||7
218642|NCT00702520|524366|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
218643|NCT00702520|524367|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
218644|NCT00702520|524368|P2|STARTED|Follow-up Study P05783||8
218645|NCT00702520|524369|P1|STARTED|Follow-up Study P05783||7
218646|NCT00702520|524366|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
218647|NCT00702520|524367|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
218648|NCT00702520|524368|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
218649|NCT00702520|524369|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
218650|NCT00702520|524366|P4|COMPLETED|Base Study P05788 - Follow-Up||0
218651|NCT00702520|524367|P3|COMPLETED|Base Study P05788 - Follow-Up||0
218652|NCT00702520|524368|P2|COMPLETED|Base Study P05788 - Follow-Up||8
218653|NCT00702520|524369|P1|COMPLETED|Base Study P05788 - Follow-Up||7
218654|NCT00702520|524366|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
218655|NCT00702520|524367|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
218656|NCT00702520|524368|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
218657|NCT00702520|524369|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
218658|NCT00702520|524366|P4|STARTED|Base Study P05788 - Follow-Up||0
218659|NCT00702520|524367|P3|STARTED|Base Study P05788 - Follow-Up||0
218660|NCT00702520|524368|P2|STARTED|Base Study P05788 - Follow-Up||18
218661|NCT00702520|524369|P1|STARTED|Base Study P05788 - Follow-Up||22
218662|NCT00702520|524366|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
218663|NCT00702520|524367|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
218664|NCT00702520|524368|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
218665|NCT00702520|524369|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
218666|NCT00702520|524366|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
218667|NCT00702520|524367|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
218668|NCT00702520|524368|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
218669|NCT00702520|524369|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
218670|NCT00702520|524366|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
218671|NCT00702520|524367|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
218672|NCT00702520|524368|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
218673|NCT00702520|524369|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
218674|NCT00702520|524366|P4|STARTED|Base Study P05788 - Embryo Transfer||0
218675|NCT00702520|524367|P3|STARTED|Base Study P05788 - Embryo Transfer||0
218676|NCT00702520|524368|P2|STARTED|Base Study P05788 - Embryo Transfer||24
218677|NCT00702520|524369|P1|STARTED|Base Study P05788 - Embryo Transfer||25
218678|NCT00702520|524366|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
218679|NCT00702520|524367|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
218680|NCT00702520|524368|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
218681|NCT00702520|524369|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
218682|NCT00702520|524366|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
218683|NCT00702520|524367|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
218684|NCT00702520|524368|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
218685|NCT00702520|524369|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
218686|NCT00702520|524366|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
218687|NCT00702520|524367|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
218688|NCT00702520|524368|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
218689|NCT00702520|524369|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
218690|NCT00702520|524366|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
218691|NCT00702520|524367|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
218692|NCT00702520|524368|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
218693|NCT00702520|524369|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
218694|NCT00702520|524366|P4|STARTED|Base Study P05788 - Assigned Treatment||0
218695|NCT00702520|524367|P3|STARTED|Base Study P05788 - Assigned Treatment||0
218696|NCT00702520|524368|P2|STARTED|Base Study P05788 - Assigned Treatment||25
218697|NCT00702520|524369|P1|STARTED|Base Study P05788 - Assigned Treatment||25
218698|NCT00702507|524385|P1|NOT COMPLETED|Follow-up Phase||27
218699|NCT00702507|524385|P1|COMPLETED|Follow-up Phase||132
218700|NCT00702507|524385|P1|STARTED|Follow-up Phase||159
218701|NCT00702507|524385|P1|NOT COMPLETED|Initial Treatment Phase||41
218702|NCT00702507|524385|P1|COMPLETED|Initial Treatment Phase||159
218703|NCT00702507|524385|P1|STARTED|Initial Treatment Phase||200
218704|NCT00702468|524399|P2|NOT COMPLETED|Overall Study||16
218705|NCT00702468|524400|P1|NOT COMPLETED|Overall Study||3
218706|NCT00702468|524399|P2|COMPLETED|Overall Study||2
218707|NCT00702468|524400|P1|COMPLETED|Overall Study||15
218708|NCT00702468|524399|P2|STARTED|Overall Study||18
218709|NCT00702468|524400|P1|STARTED|Overall Study||18
218710|NCT00702403|524422|P1|NOT COMPLETED|From Engraftment to Study Completion||27
218711|NCT00702403|524422|P1|COMPLETED|From Engraftment to Study Completion||13
218712|NCT00702403|524422|P1|Patient Drop-outs|From Engraftment to Study Completion||27
218713|NCT00702403|524422|P1|STARTED|From Engraftment to Study Completion||40
218714|NCT00702403|524422|P1|NOT COMPLETED|From Consent to Engraftment||17
218715|NCT00702403|524422|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
218716|NCT00702403|524422|P1|Ineligible for Study Drug|From Consent to Engraftment||17
218717|NCT00702403|524422|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
218718|NCT00702377|524432|P2|NOT COMPLETED|Overall Study||3
218719|NCT00702377|524433|P1|NOT COMPLETED|Overall Study||1
218720|NCT00702377|524432|P2|COMPLETED|Overall Study||53
218721|NCT00702377|524433|P1|COMPLETED|Overall Study||52
218722|NCT00702377|524432|P2|STARTED|Overall Study||56
218723|NCT00702377|524433|P1|STARTED|Overall Study||53
218724|NCT00702364|524445|P2|NOT COMPLETED|Overall Study||4
218725|NCT00702364|524446|P1|NOT COMPLETED|Overall Study||2
218726|NCT00702364|524445|P2|COMPLETED|Overall Study||25
218727|NCT00702364|524446|P1|COMPLETED|Overall Study||24
218728|NCT00702364|524445|P2|STARTED|Overall Study||29
218729|NCT00702364|524446|P1|STARTED|Overall Study||26
218730|NCT00702338|524458|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
218731|NCT00702338|524459|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
218732|NCT00702338|524460|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
218733|NCT00702338|524458|P3|COMPLETED|Follow-up Study: Infant FU||0
218734|NCT00702338|524459|P2|COMPLETED|Follow-up Study: Infant FU||0
218735|NCT00702338|524460|P1|COMPLETED|Follow-up Study: Infant FU||0
218736|NCT00702338|524458|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
218737|NCT00702338|524459|P2|STARTED|Follow-up Study: Infant FU||0
218738|NCT00702338|524460|P1|STARTED|Follow-up Study: Infant FU||0
218739|NCT00702338|524458|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
218740|NCT00702338|524459|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
218741|NCT00702338|524460|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
218742|NCT00702338|524458|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
218743|NCT00702338|524459|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
218744|NCT00702338|524460|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
218745|NCT00702338|524458|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
218746|NCT00702338|524459|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
218747|NCT00702338|524460|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
218748|NCT00702338|524458|P3|NOT COMPLETED|Base Study (NCT00697255)||0
218749|NCT00702338|524459|P2|NOT COMPLETED|Base Study (NCT00697255)||2
218750|NCT00702338|524460|P1|NOT COMPLETED|Base Study (NCT00697255)||3
218751|NCT00702338|524458|P3|COMPLETED|Base Study (NCT00697255)||0
218752|NCT00702338|524459|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
218753|NCT00702338|524460|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
218754|NCT00702338|524458|P3|STARTED|Base Study (NCT00697255)||0
218755|NCT00702338|524459|P2|STARTED|Base Study (NCT00697255)||3
218756|NCT00702338|524460|P1|STARTED|Base Study (NCT00697255)||5
218757|NCT00702325|524476|P2|NOT COMPLETED|Overall Study||53
218758|NCT00702325|524477|P1|NOT COMPLETED|Overall Study||38
218759|NCT00702325|524476|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
218760|NCT00702325|524477|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
218761|NCT00702325|524476|P2|STARTED|Overall Study|Randomized|155
218762|NCT00702325|524477|P1|STARTED|Overall Study|Randomized|156
218763|NCT00702299|524529|P1|NOT COMPLETED|Overall Study||0
218764|NCT00702299|524529|P1|COMPLETED|Overall Study||15
218765|NCT00702299|524529|P1|STARTED|Overall Study||15
218766|NCT00702273|524542|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
218767|NCT00702273|524543|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
218768|NCT00702273|524542|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
218769|NCT00702273|524543|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
218770|NCT00702273|524542|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
218771|NCT00702273|524543|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
218772|NCT00702273|524542|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
218773|NCT00702273|524543|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
218774|NCT00702273|524542|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
218775|NCT00702273|524543|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
218776|NCT00702273|524542|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
218777|NCT00702273|524543|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
218778|NCT00702273|524542|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
218779|NCT00702273|524543|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
218780|NCT00702234|524561|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
218781|NCT00702234|524562|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
218782|NCT00702234|524561|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
218783|NCT00702234|524562|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
218784|NCT00702234|524561|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
218785|NCT00702234|524562|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
218786|NCT00702234|524561|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
218787|NCT00702234|524562|P1|STARTED|Follow-up Study: Fetuses/Infants||0
218788|NCT00702234|524561|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
218789|NCT00702234|524562|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
218790|NCT00702234|524561|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
218791|NCT00702234|524562|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
218792|NCT00702234|524561|P2|STARTED|Follow-up Study: Expectant Mothers||0
218793|NCT00702234|524562|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
218794|NCT00702234|524561|P2|NOT COMPLETED|Base Study (NCT00696878)||0
218795|NCT00702234|524562|P1|NOT COMPLETED|Base Study (NCT00696878)||504
218796|NCT00702234|524561|P2|COMPLETED|Base Study (NCT00696878)||0
218797|NCT00702234|524562|P1|COMPLETED|Base Study (NCT00696878)||178
218798|NCT00702234|524561|P2|STARTED|Base Study (NCT00696878)||0
218799|NCT00702234|524562|P1|STARTED|Base Study (NCT00696878)||682
218800|NCT00702221|524573|P2|NOT COMPLETED|Overall Study||3
218801|NCT00702221|524574|P1|NOT COMPLETED|Overall Study||4
218802|NCT00702221|524573|P2|COMPLETED|Overall Study||7
218803|NCT00702221|524574|P1|COMPLETED|Overall Study||6
218804|NCT00702221|524573|P2|STARTED|Overall Study||10
218805|NCT00702221|524574|P1|STARTED|Overall Study||10
218806|NCT00702208|524580|P1|NOT COMPLETED|Overall Study||31
218807|NCT00702208|524580|P1|COMPLETED|Overall Study||167
218808|NCT00702208|524580|P1|STARTED|Overall Study||198
218809|NCT00702143|524589|P3|NOT COMPLETED|Overall Study||1
218810|NCT00702143|524590|P2|NOT COMPLETED|Overall Study||0
218811|NCT00702143|524591|P1|NOT COMPLETED|Overall Study||0
218812|NCT00702143|524589|P3|COMPLETED|Overall Study||78
218813|NCT00702143|524590|P2|COMPLETED|Overall Study||60
218814|NCT00702143|524591|P1|COMPLETED|Overall Study||45
218815|NCT00702143|524589|P3|STARTED|Overall Study||79
218816|NCT00702143|524590|P2|STARTED|Overall Study||60
218817|NCT00702143|524591|P1|STARTED|Overall Study||45
218818|NCT00701935|524605|P2|NOT COMPLETED|Overall Study||11
218819|NCT00701935|524606|P1|NOT COMPLETED|Overall Study||16
218820|NCT00701935|524605|P2|COMPLETED|Overall Study||26
218821|NCT00701935|524606|P1|COMPLETED|Overall Study||27
218822|NCT00701935|524605|P2|STARTED|Overall Study||37
218823|NCT00701935|524606|P1|STARTED|Overall Study||43
218824|NCT00701805|524640|P4|NOT COMPLETED|Overall Study||4
218825|NCT00701805|524641|P3|NOT COMPLETED|Overall Study||7
218826|NCT00701805|524642|P2|NOT COMPLETED|Overall Study||4
218827|NCT00701805|524643|P1|NOT COMPLETED|Overall Study||3
218828|NCT00701805|524640|P4|COMPLETED|Overall Study||22
218829|NCT00701805|524641|P3|COMPLETED|Overall Study||16
218830|NCT00701805|524642|P2|COMPLETED|Overall Study||25
218831|NCT00701805|524643|P1|COMPLETED|Overall Study||23
218832|NCT00701805|524640|P4|STARTED|Overall Study||26
218833|NCT00701805|524641|P3|STARTED|Overall Study||23
218834|NCT00701805|524642|P2|STARTED|Overall Study||29
218835|NCT00701805|524643|P1|STARTED|Overall Study||26
218836|NCT00701779|524693|P1|NOT COMPLETED|Overall Study||9
218837|NCT00701779|524693|P1|COMPLETED|Overall Study||54
218838|NCT00701779|524693|P1|12 Month|Overall Study||54
218839|NCT00701779|524693|P1|9 Month|Overall Study||56
218840|NCT00701779|524693|P1|6 Month|Overall Study||58
218841|NCT00701779|524693|P1|3 Month|Overall Study||60
218842|NCT00701779|524693|P1|STARTED|Overall Study||63
218843|NCT00701727|524702|P2|NOT COMPLETED|Second Treatment Period||0
218844|NCT00701727|524703|P1|NOT COMPLETED|Second Treatment Period||2
218845|NCT00701727|524702|P2|COMPLETED|Second Treatment Period||13
218846|NCT00701727|524703|P1|COMPLETED|Second Treatment Period||13
218847|NCT00701727|524702|P2|STARTED|Second Treatment Period||13
218848|NCT00701727|524703|P1|STARTED|Second Treatment Period||15
218849|NCT00701727|524702|P2|NOT COMPLETED|First Treatment Period||2
218850|NCT00701727|524703|P1|NOT COMPLETED|First Treatment Period||1
218851|NCT00701727|524702|P2|COMPLETED|First Treatment Period||13
218852|NCT00701727|524703|P1|COMPLETED|First Treatment Period||15
218853|NCT00701727|524702|P2|STARTED|First Treatment Period||15
218854|NCT00701727|524703|P1|STARTED|First Treatment Period||16
218855|NCT00701714|524723|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
218856|NCT00701714|524724|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
218857|NCT00701714|524723|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
218858|NCT00701714|524724|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
218859|NCT00701714|524723|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
218860|NCT00701714|524724|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
218861|NCT00701714|524723|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
218862|NCT00701714|524724|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
218863|NCT00701714|524723|P2|COMPLETED|Treatment Period (up to 1 Year)||29
218864|NCT00701714|524724|P1|COMPLETED|Treatment Period (up to 1 Year)||37
218865|NCT00701714|524723|P2|STARTED|Treatment Period (up to 1 Year)||163
218866|NCT00701714|524724|P1|STARTED|Treatment Period (up to 1 Year)||174
218867|NCT00701675|524739|P3|NOT COMPLETED|Overall Study||7
218868|NCT00701675|524740|P2|NOT COMPLETED|Overall Study||8
218869|NCT00701675|524741|P1|NOT COMPLETED|Overall Study||4
218870|NCT00701675|524739|P3|COMPLETED|Overall Study||7
218871|NCT00701675|524740|P2|COMPLETED|Overall Study||6
218872|NCT00701675|524741|P1|COMPLETED|Overall Study||10
218873|NCT00701675|524739|P3|STARTED|Overall Study||14
218874|NCT00701675|524740|P2|STARTED|Overall Study||14
218875|NCT00701675|524741|P1|STARTED|Overall Study||14
218876|NCT00701662|524749|P1|NOT COMPLETED|Overall Study||1
218877|NCT00701662|524749|P1|COMPLETED|Overall Study||7
218878|NCT00701662|524749|P1|STARTED|Overall Study||8
218879|NCT00701636|524768|P2|NOT COMPLETED|Overall Study||0
218880|NCT00701636|524769|P1|NOT COMPLETED|Overall Study||0
218881|NCT00701636|524768|P2|COMPLETED|Overall Study||15
218882|NCT00701636|524769|P1|COMPLETED|Overall Study||15
218883|NCT00701636|524768|P2|STARTED|Overall Study||15
218884|NCT00701636|524769|P1|STARTED|Overall Study||15
218885|NCT00701558|524774|P1|NOT COMPLETED|Overall Study||15
218886|NCT00701558|524774|P1|COMPLETED|Overall Study||4
218887|NCT00701558|524774|P1|STARTED|Overall Study||19
218888|NCT00701441|524782|P2|NOT COMPLETED|Overall Study||4
218889|NCT00701441|524783|P1|NOT COMPLETED|Overall Study||0
218890|NCT00701441|524782|P2|COMPLETED|Overall Study||12
218891|NCT00701441|524783|P1|COMPLETED|Overall Study||9
218892|NCT00701441|524782|P2|STARTED|Overall Study||16
218893|NCT00701441|524783|P1|STARTED|Overall Study||9
218894|NCT00701415|524795|P2|NOT COMPLETED|Overall Study||1
218895|NCT00701415|524796|P1|NOT COMPLETED|Overall Study||1
218896|NCT00701415|524795|P2|COMPLETED|Overall Study||14
218897|NCT00701415|524796|P1|COMPLETED|Overall Study||15
218898|NCT00701415|524795|P2|STARTED|Overall Study||15
218899|NCT00701415|524796|P1|STARTED|Overall Study||16
218900|NCT00701389|524806|P4|NOT COMPLETED|Period 4||0
218901|NCT00701389|524807|P3|NOT COMPLETED|Period 4||0
218902|NCT00701389|524808|P2|NOT COMPLETED|Period 4||0
218903|NCT00701389|524809|P1|NOT COMPLETED|Period 4||0
218904|NCT00701389|524806|P4|COMPLETED|Period 4||6
218905|NCT00701389|524807|P3|COMPLETED|Period 4||6
218906|NCT00701389|524808|P2|COMPLETED|Period 4||6
218907|NCT00701389|524809|P1|COMPLETED|Period 4||6
218908|NCT00701389|524806|P4|STARTED|Period 4||6
218909|NCT00701389|524807|P3|STARTED|Period 4||6
218910|NCT00701389|524808|P2|STARTED|Period 4||6
218911|NCT00701389|524809|P1|STARTED|Period 4||6
218912|NCT00701389|524806|P4|NOT COMPLETED|Period 3||0
218913|NCT00701389|524807|P3|NOT COMPLETED|Period 3||0
218914|NCT00701389|524808|P2|NOT COMPLETED|Period 3||0
218915|NCT00701389|524809|P1|NOT COMPLETED|Period 3||0
218916|NCT00701389|524806|P4|COMPLETED|Period 3||6
218917|NCT00701389|524807|P3|COMPLETED|Period 3||6
218918|NCT00701389|524808|P2|COMPLETED|Period 3||6
218919|NCT00701389|524809|P1|COMPLETED|Period 3||6
218920|NCT00701389|524806|P4|STARTED|Period 3||6
218921|NCT00701389|524807|P3|STARTED|Period 3||6
218922|NCT00701389|524808|P2|STARTED|Period 3||6
218923|NCT00701389|524809|P1|STARTED|Period 3||6
218924|NCT00701389|524806|P4|NOT COMPLETED|Period 2||0
218925|NCT00701389|524807|P3|NOT COMPLETED|Period 2||0
218926|NCT00701389|524808|P2|NOT COMPLETED|Period 2||0
218927|NCT00701389|524809|P1|NOT COMPLETED|Period 2||0
218928|NCT00701389|524806|P4|COMPLETED|Period 2||6
218929|NCT00701389|524807|P3|COMPLETED|Period 2||6
218930|NCT00701389|524808|P2|COMPLETED|Period 2||6
218931|NCT00701389|524809|P1|COMPLETED|Period 2||6
218932|NCT00701389|524806|P4|STARTED|Period 2||6
218933|NCT00701389|524807|P3|STARTED|Period 2||6
218934|NCT00701389|524808|P2|STARTED|Period 2||6
218935|NCT00701389|524809|P1|STARTED|Period 2||6
218936|NCT00701389|524806|P4|NOT COMPLETED|Period 1||0
218937|NCT00701389|524807|P3|NOT COMPLETED|Period 1||0
218938|NCT00701389|524808|P2|NOT COMPLETED|Period 1||0
218939|NCT00701389|524809|P1|NOT COMPLETED|Period 1||0
218940|NCT00701389|524806|P4|COMPLETED|Period 1||6
218941|NCT00701389|524807|P3|COMPLETED|Period 1||6
218942|NCT00701389|524808|P2|COMPLETED|Period 1||6
218943|NCT00701389|524809|P1|COMPLETED|Period 1||6
218944|NCT00701389|524806|P4|STARTED|Period 1||6
218945|NCT00701389|524807|P3|STARTED|Period 1||6
218946|NCT00701389|524808|P2|STARTED|Period 1||6
218947|NCT00701389|524809|P1|STARTED|Period 1||6
218948|NCT00701363|524831|P4|NOT COMPLETED|Treatment Phase 2||0
218949|NCT00701363|524832|P3|NOT COMPLETED|Treatment Phase 2||2
218950|NCT00701363|524833|P2|NOT COMPLETED|Treatment Phase 2||0
218951|NCT00701363|524834|P1|NOT COMPLETED|Treatment Phase 2||0
218952|NCT00701363|524831|P4|COMPLETED|Treatment Phase 2||26
218953|NCT00701363|524832|P3|COMPLETED|Treatment Phase 2||68
218954|NCT00701363|524833|P2|COMPLETED|Treatment Phase 2||13
218955|NCT00701363|524834|P1|COMPLETED|Treatment Phase 2||0
218956|NCT00701363|524831|P4|STARTED|Treatment Phase 2||26
218957|NCT00701363|524832|P3|STARTED|Treatment Phase 2||70
218958|NCT00701363|524833|P2|STARTED|Treatment Phase 2||13
218959|NCT00701363|524834|P1|STARTED|Treatment Phase 2||0
218960|NCT00701363|524831|P4|NOT COMPLETED|Treatment Phase 1||0
218961|NCT00701363|524832|P3|NOT COMPLETED|Treatment Phase 1||0
218962|NCT00701363|524833|P2|NOT COMPLETED|Treatment Phase 1||0
218963|NCT00701363|524834|P1|NOT COMPLETED|Treatment Phase 1||15
218964|NCT00701363|524831|P4|COMPLETED|Treatment Phase 1||0
218965|NCT00701363|524832|P3|COMPLETED|Treatment Phase 1||0
218966|NCT00701363|524833|P2|COMPLETED|Treatment Phase 1||0
218967|NCT00701363|524834|P1|COMPLETED|Treatment Phase 1||109
218968|NCT00701363|524831|P4|STARTED|Treatment Phase 1||0
218969|NCT00701363|524832|P3|STARTED|Treatment Phase 1||0
218970|NCT00701363|524833|P2|STARTED|Treatment Phase 1||0
218971|NCT00701363|524834|P1|STARTED|Treatment Phase 1||124
218972|NCT00701363|524831|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
218973|NCT00701363|524832|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
218974|NCT00701363|524833|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
218975|NCT00701363|524834|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
218976|NCT00701363|524831|P4|COMPLETED|Screening (Pre-assignment) Phase||0
218977|NCT00701363|524832|P3|COMPLETED|Screening (Pre-assignment) Phase||0
218978|NCT00701363|524833|P2|COMPLETED|Screening (Pre-assignment) Phase||0
218979|NCT00701363|524834|P1|COMPLETED|Screening (Pre-assignment) Phase||124
218980|NCT00701363|524831|P4|STARTED|Screening (Pre-assignment) Phase||0
218981|NCT00701363|524832|P3|STARTED|Screening (Pre-assignment) Phase||0
218982|NCT00701363|524833|P2|STARTED|Screening (Pre-assignment) Phase||0
218983|NCT00701363|524834|P1|STARTED|Screening (Pre-assignment) Phase||128
218984|NCT00701311|524874|P1|NOT COMPLETED|Overall Study||8
218985|NCT00701311|524874|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
218986|NCT00701311|524874|P1|STARTED|Overall Study||17
218987|NCT00701129|524878|P1|NOT COMPLETED|Overall Study||2
218988|NCT00701129|524878|P1|COMPLETED|Overall Study||2
218989|NCT00701129|524878|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
218990|NCT00701129|524878|P1|STARTED|Overall Study||4
218991|NCT00701103|524900|P11|NOT COMPLETED|Overall Study||11
218992|NCT00701103|524901|P10|NOT COMPLETED|Overall Study||11
218993|NCT00701103|524902|P9|NOT COMPLETED|Overall Study||9
218994|NCT00701103|524903|P8|NOT COMPLETED|Overall Study||7
218995|NCT00701103|524904|P7|NOT COMPLETED|Overall Study||8
218996|NCT00701103|524905|P6|NOT COMPLETED|Overall Study||6
218997|NCT00701103|524906|P5|NOT COMPLETED|Overall Study||6
218998|NCT00701103|524907|P4|NOT COMPLETED|Overall Study||6
218999|NCT00701103|524908|P3|NOT COMPLETED|Overall Study||8
219000|NCT00701103|524909|P2|NOT COMPLETED|Overall Study||3
219001|NCT00701103|524910|P1|NOT COMPLETED|Overall Study||5
219002|NCT00701103|524900|P11|COMPLETED|Overall Study||0
219003|NCT00701103|524901|P10|COMPLETED|Overall Study||0
219004|NCT00701103|524902|P9|COMPLETED|Overall Study||0
219005|NCT00701103|524903|P8|COMPLETED|Overall Study||0
219006|NCT00701103|524904|P7|COMPLETED|Overall Study||0
219007|NCT00701103|524905|P6|COMPLETED|Overall Study||0
219008|NCT00701103|524906|P5|COMPLETED|Overall Study||0
219009|NCT00701103|524907|P4|COMPLETED|Overall Study||0
219010|NCT00701103|524908|P3|COMPLETED|Overall Study||0
219011|NCT00701103|524909|P2|COMPLETED|Overall Study||0
219012|NCT00701103|524910|P1|COMPLETED|Overall Study||0
219013|NCT00701103|524900|P11|STARTED|Overall Study||11
219014|NCT00701103|524901|P10|STARTED|Overall Study||11
219015|NCT00701103|524902|P9|STARTED|Overall Study||9
219016|NCT00701103|524903|P8|STARTED|Overall Study||7
219017|NCT00701103|524904|P7|STARTED|Overall Study||8
219018|NCT00701103|524905|P6|STARTED|Overall Study||6
219019|NCT00701103|524906|P5|STARTED|Overall Study||6
219020|NCT00701103|524907|P4|STARTED|Overall Study||6
219021|NCT00701103|524908|P3|STARTED|Overall Study||8
219022|NCT00701103|524909|P2|STARTED|Overall Study||3
219023|NCT00701103|524910|P1|STARTED|Overall Study||5
219024|NCT00701090|525016|P2|NOT COMPLETED|Overall Study||51
219025|NCT00701090|525017|P1|NOT COMPLETED|Overall Study||48
219026|NCT00701090|525016|P2|COMPLETED|Overall Study||468
219027|NCT00701090|525017|P1|COMPLETED|Overall Study||468
219028|NCT00701090|525016|P2|STARTED|Overall Study||519
219029|NCT00701090|525017|P1|STARTED|Overall Study||516
219030|NCT00701064|525035|P2|NOT COMPLETED|Overall Study||4
219031|NCT00701064|525036|P1|NOT COMPLETED|Overall Study||4
219032|NCT00701064|525035|P2|COMPLETED|Overall Study||32
219033|NCT00701064|525036|P1|COMPLETED|Overall Study||31
219034|NCT00701064|525035|P2|STARTED|Overall Study||36
219035|NCT00701064|525036|P1|STARTED|Overall Study||35
219036|NCT00701051|525044|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
219037|NCT00701051|525045|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
219038|NCT00701051|525046|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
219039|NCT00701051|525044|P3|COMPLETED|Detraining Intervention (Optional)||6
219040|NCT00701051|525045|P2|COMPLETED|Detraining Intervention (Optional)||6
219041|NCT00701051|525046|P1|COMPLETED|Detraining Intervention (Optional)||0
219042|NCT00701051|525044|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
219043|NCT00701051|525045|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
219044|NCT00701051|525046|P1|STARTED|Detraining Intervention (Optional)||0
219045|NCT00701051|525044|P3|NOT COMPLETED|Exercise Intervention||3
219046|NCT00701051|525045|P2|NOT COMPLETED|Exercise Intervention||5
219047|NCT00701051|525046|P1|NOT COMPLETED|Exercise Intervention||0
219048|NCT00701051|525044|P3|COMPLETED|Exercise Intervention||9
219049|NCT00701051|525045|P2|COMPLETED|Exercise Intervention||14
219050|NCT00701051|525046|P1|COMPLETED|Exercise Intervention||0
219051|NCT00701051|525044|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
219052|NCT00701051|525045|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
219053|NCT00701051|525046|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
219054|NCT00701051|525044|P3|NOT COMPLETED|Screening||0
219055|NCT00701051|525045|P2|NOT COMPLETED|Screening||0
219056|NCT00701051|525046|P1|NOT COMPLETED|Screening||59
219057|NCT00701051|525044|P3|COMPLETED|Screening||0
219058|NCT00701051|525045|P2|COMPLETED|Screening||0
219059|NCT00701051|525046|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
219060|NCT00701051|525044|P3|STARTED|Screening||0
219061|NCT00701051|525045|P2|STARTED|Screening||0
219062|NCT00701051|525046|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
219063|NCT00701038|525064|P2|NOT COMPLETED|Overall Study||4
219064|NCT00701038|525065|P1|NOT COMPLETED|Overall Study||4
219065|NCT00701038|525064|P2|COMPLETED|Overall Study||23
219066|NCT00701038|525065|P1|COMPLETED|Overall Study||23
219067|NCT00701038|525064|P2|STARTED|Overall Study||27
219068|NCT00701038|525065|P1|STARTED|Overall Study||27
219069|NCT00700999|525073|P2|NOT COMPLETED|Overall Study||9
219070|NCT00700999|525074|P1|NOT COMPLETED|Overall Study||15
219071|NCT00700999|525073|P2|COMPLETED|Overall Study||20
219072|NCT00700999|525074|P1|COMPLETED|Overall Study||21
219073|NCT00700999|525073|P2|Second MRI Scan|Overall Study||18
219074|NCT00700999|525074|P1|Second MRI Scan|Overall Study||19
219075|NCT00700999|525073|P2|First MRI Scan|Overall Study||22
219076|NCT00700999|525074|P1|First MRI Scan|Overall Study||29
219077|NCT00700999|525073|P2|STARTED|Overall Study||29
219078|NCT00700999|525074|P1|STARTED|Overall Study||36
219079|NCT00700973|525082|P2|NOT COMPLETED|Overall Study||7
219080|NCT00700973|525083|P1|NOT COMPLETED|Overall Study||8
219081|NCT00700973|525082|P2|COMPLETED|Overall Study||63
219082|NCT00700973|525083|P1|COMPLETED|Overall Study||63
219083|NCT00700973|525082|P2|STARTED|Overall Study||70
219084|NCT00700973|525083|P1|STARTED|Overall Study||71
219085|NCT00700817|525094|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
219086|NCT00700817|525095|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
219087|NCT00700817|525096|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
219088|NCT00700817|525097|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
219089|NCT00700817|525098|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
219090|NCT00700817|525094|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
219091|NCT00700817|525095|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
219092|NCT00700817|525096|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
219093|NCT00700817|525097|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
219094|NCT00700817|525098|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
219095|NCT00700817|525094|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
219096|NCT00700817|525095|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
219097|NCT00700817|525096|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
219098|NCT00700817|525097|P2|STARTED|Week 52-78 (Extension Period 2)||150
219099|NCT00700817|525098|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
219100|NCT00700817|525094|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
219101|NCT00700817|525095|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
219102|NCT00700817|525096|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
219103|NCT00700817|525097|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
219104|NCT00700817|525098|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
219105|NCT00700817|525094|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
219106|NCT00700817|525095|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
219107|NCT00700817|525096|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
219108|NCT00700817|525097|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
219109|NCT00700817|525098|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
219110|NCT00700817|525094|P5|STARTED|Week 26-52 (Extension Period 1)||0
219111|NCT00700817|525095|P4|STARTED|Week 26-52 (Extension Period 1)||0
219112|NCT00700817|525096|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
219113|NCT00700817|525097|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
219114|NCT00700817|525098|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
219115|NCT00700817|525094|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
219116|NCT00700817|525095|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
219117|NCT00700817|525096|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
219118|NCT00700817|525097|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
219119|NCT00700817|525098|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
219120|NCT00700817|525094|P5|COMPLETED|Week 0-26 (Main Period)||0
219121|NCT00700817|525095|P4|COMPLETED|Week 0-26 (Main Period)||0
219122|NCT00700817|525096|P3|COMPLETED|Week 0-26 (Main Period)||194
219123|NCT00700817|525097|P2|COMPLETED|Week 0-26 (Main Period)||191
219124|NCT00700817|525098|P1|COMPLETED|Week 0-26 (Main Period)||169
219125|NCT00700817|525094|P5|Exposed|Week 0-26 (Main Period)||0
219126|NCT00700817|525095|P4|Exposed|Week 0-26 (Main Period)||0
219127|NCT00700817|525096|P3|Exposed|Week 0-26 (Main Period)||219
219128|NCT00700817|525097|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
219129|NCT00700817|525098|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
219130|NCT00700817|525094|P5|STARTED|Week 0-26 (Main Period)||0
219131|NCT00700817|525095|P4|STARTED|Week 0-26 (Main Period)||0
219132|NCT00700817|525096|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
219133|NCT00700817|525097|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
219134|NCT00700817|525098|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
219135|NCT00700804|525480|P2|NOT COMPLETED|Overall Study||4
219136|NCT00700804|525481|P1|NOT COMPLETED|Overall Study||3
219137|NCT00700804|525480|P2|COMPLETED|Overall Study||13
219138|NCT00700804|525481|P1|COMPLETED|Overall Study||14
219139|NCT00700804|525480|P2|STARTED|Overall Study||17
219140|NCT00700804|525481|P1|STARTED|Overall Study||17
219141|NCT00700752|525489|P2|NOT COMPLETED|Second Intervention||0
219142|NCT00700752|525490|P1|NOT COMPLETED|Second Intervention||0
219143|NCT00700752|525489|P2|COMPLETED|Second Intervention||18
219144|NCT00700752|525490|P1|COMPLETED|Second Intervention||20
219145|NCT00700752|525489|P2|STARTED|Second Intervention||18
219146|NCT00700752|525490|P1|STARTED|Second Intervention||20
219147|NCT00700752|525489|P2|NOT COMPLETED|First Intervention||2
219148|NCT00700752|525490|P1|NOT COMPLETED|First Intervention||0
219149|NCT00700752|525489|P2|COMPLETED|First Intervention||18
219150|NCT00700752|525490|P1|COMPLETED|First Intervention||20
219151|NCT00700752|525489|P2|STARTED|First Intervention||20
219152|NCT00700752|525490|P1|STARTED|First Intervention||20
219153|NCT00700739|525498|P2|NOT COMPLETED|Overall Study||4
219154|NCT00700739|525499|P1|NOT COMPLETED|Overall Study||4
219155|NCT00700739|525498|P2|COMPLETED|Overall Study||12
219156|NCT00700739|525499|P1|COMPLETED|Overall Study||18
219157|NCT00700739|525498|P2|STARTED|Overall Study||16
219158|NCT00700739|525499|P1|STARTED|Overall Study||22
219159|NCT00700713|525538|P3|NOT COMPLETED|Overall Study||2
219160|NCT00700713|525539|P2|NOT COMPLETED|Overall Study||0
219161|NCT00700713|525540|P1|NOT COMPLETED|Overall Study||1
219162|NCT00700713|525538|P3|COMPLETED|Overall Study||65
219163|NCT00700713|525539|P2|COMPLETED|Overall Study||66
219164|NCT00700713|525540|P1|COMPLETED|Overall Study||47
219165|NCT00700713|525538|P3|STARTED|Overall Study||67
219166|NCT00700713|525539|P2|STARTED|Overall Study||66
219167|NCT00700713|525540|P1|STARTED|Overall Study||48
219168|NCT00700635|525557|P3|NOT COMPLETED|Overall Study||1
219169|NCT00700635|525558|P2|NOT COMPLETED|Overall Study||8
219170|NCT00700635|525559|P1|NOT COMPLETED|Overall Study||11
219171|NCT00700635|525557|P3|COMPLETED|Overall Study||110
219172|NCT00700635|525558|P2|COMPLETED|Overall Study||103
219173|NCT00700635|525559|P1|COMPLETED|Overall Study||100
219174|NCT00700635|525557|P3|STARTED|Overall Study||111
219175|NCT00700635|525558|P2|STARTED|Overall Study||111
219176|NCT00700635|525559|P1|STARTED|Overall Study||111
219177|NCT00700622|525581|P2|NOT COMPLETED|Overall Study||5
219178|NCT00700622|525582|P1|NOT COMPLETED|Overall Study||13
219179|NCT00700622|525581|P2|COMPLETED|Overall Study||60
219180|NCT00700622|525582|P1|COMPLETED|Overall Study||52
219181|NCT00700622|525581|P2|STARTED|Overall Study||65
219182|NCT00700622|525582|P1|STARTED|Overall Study||65
219183|NCT00700570|525590|P2|NOT COMPLETED|Overall Study||26
219184|NCT00700570|525591|P1|NOT COMPLETED|Overall Study||11
219185|NCT00700570|525590|P2|COMPLETED|Overall Study||0
219186|NCT00700570|525591|P1|COMPLETED|Overall Study||8
219187|NCT00700570|525590|P2|STARTED|Overall Study||26
219188|NCT00700570|525591|P1|STARTED|Overall Study||19
219189|NCT00700440|525603|P1|NOT COMPLETED|Overall Study||0
219190|NCT00700440|525603|P1|COMPLETED|Overall Study||100
219191|NCT00700440|525603|P1|STARTED|Overall Study||100
219192|NCT00700427|525607|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
219193|NCT00700427|525608|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
219194|NCT00700427|525609|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
219195|NCT00700427|525610|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
219196|NCT00700427|525611|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
219197|NCT00700427|525607|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
219198|NCT00700427|525608|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
219199|NCT00700427|525609|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
219200|NCT00700427|525610|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
219201|NCT00700427|525611|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
219202|NCT00700427|525607|P5|STARTED|Study Period 4 (Open-Label Extension)||180
219203|NCT00700427|525608|P4|STARTED|Study Period 4 (Open-Label Extension)||0
219204|NCT00700427|525609|P3|STARTED|Study Period 4 (Open-Label Extension)||0
219205|NCT00700427|525610|P2|STARTED|Study Period 4 (Open-Label Extension)||0
219206|NCT00700427|525611|P1|STARTED|Study Period 4 (Open-Label Extension)||0
219207|NCT00700427|525607|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
219208|NCT00700427|525608|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
219209|NCT00700427|525609|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
219210|NCT00700427|525610|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
219211|NCT00700427|525611|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
219212|NCT00700427|525607|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
219213|NCT00700427|525608|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
219214|NCT00700427|525609|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
219215|NCT00700427|525610|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
219216|NCT00700427|525611|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
219217|NCT00700427|525607|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
219218|NCT00700427|525608|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
219219|NCT00700427|525609|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
219220|NCT00700427|525610|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
219221|NCT00700427|525611|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
219222|NCT00700427|525607|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
219223|NCT00700427|525608|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
219224|NCT00700427|525609|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
219225|NCT00700427|525610|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
219226|NCT00700427|525611|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
219227|NCT00700427|525607|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
219228|NCT00700427|525608|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
219229|NCT00700427|525609|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
219230|NCT00700427|525610|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
219231|NCT00700427|525611|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
219232|NCT00700427|525607|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
219233|NCT00700427|525608|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
219234|NCT00700427|525609|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
219235|NCT00700427|525610|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
219236|NCT00700427|525611|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
219237|NCT00700427|525607|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219238|NCT00700427|525608|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219239|NCT00700427|525609|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219240|NCT00700427|525610|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219241|NCT00700427|525611|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
219242|NCT00700427|525607|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219243|NCT00700427|525608|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219244|NCT00700427|525609|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219245|NCT00700427|525610|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
219246|NCT00700427|525611|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
219247|NCT00700427|525607|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
219248|NCT00700427|525608|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
219249|NCT00700427|525609|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
219250|NCT00700427|525610|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
219251|NCT00700427|525611|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
219252|NCT00700427|525607|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
219253|NCT00700427|525608|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
219254|NCT00700427|525609|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
219255|NCT00700427|525610|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
219256|NCT00700427|525611|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
219257|NCT00700401|525633|P1|NOT COMPLETED|Overall Study||94
219258|NCT00700401|525633|P1|COMPLETED|Overall Study||168
219259|NCT00700401|525633|P1|STARTED|Overall Study||262
219260|NCT00700375|525646|P2|NOT COMPLETED|Overall Study||0
219261|NCT00700375|525647|P1|NOT COMPLETED|Overall Study||0
219262|NCT00700375|525646|P2|COMPLETED|Overall Study||29
219263|NCT00700375|525647|P1|COMPLETED|Overall Study||30
219264|NCT00700375|525646|P2|2 Days After Creatinine Mesurement|Overall Study||29
219265|NCT00700375|525647|P1|2 Days After Creatinine Mesurement|Overall Study||30
219266|NCT00700375|525646|P2|STARTED|Overall Study||29
219267|NCT00700375|525647|P1|STARTED|Overall Study||30
219268|NCT00700310|525657|P4|NOT COMPLETED|Overall Study||26
219269|NCT00700310|525658|P3|NOT COMPLETED|Overall Study||16
219270|NCT00700310|525659|P2|NOT COMPLETED|Overall Study||26
219271|NCT00700310|525660|P1|NOT COMPLETED|Overall Study||21
219272|NCT00700310|525657|P4|COMPLETED|Overall Study||145
219273|NCT00700310|525658|P3|COMPLETED|Overall Study||158
219274|NCT00700310|525659|P2|COMPLETED|Overall Study||154
219275|NCT00700310|525660|P1|COMPLETED|Overall Study||166
219276|NCT00700310|525657|P4|STARTED|Overall Study||171
219277|NCT00700310|525658|P3|STARTED|Overall Study||174
219278|NCT00700310|525659|P2|STARTED|Overall Study||180
219279|NCT00700310|525660|P1|STARTED|Overall Study||187
219280|NCT00700271|525680|P2|NOT COMPLETED|Overall Study||12
219281|NCT00700271|525681|P1|NOT COMPLETED|Overall Study||14
219282|NCT00700271|525680|P2|COMPLETED|Overall Study||256
219283|NCT00700271|525681|P1|COMPLETED|Overall Study||264
219284|NCT00700271|525680|P2|STARTED|Overall Study||268
219285|NCT00700271|525681|P1|STARTED|Overall Study||278
219286|NCT00700180|525709|P2|NOT COMPLETED|Overall Study||149
219287|NCT00700180|525710|P1|NOT COMPLETED|Overall Study||154
219288|NCT00700180|525709|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
219289|NCT00700180|525710|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
219290|NCT00700180|525709|P2|STARTED|Overall Study||149
219291|NCT00700180|525710|P1|STARTED|Overall Study||154
219292|NCT00700141|525732|P1|NOT COMPLETED|Overall Study||0
219293|NCT00700141|525732|P1|COMPLETED|Overall Study||482
219294|NCT00700141|525732|P1|STARTED|Overall Study||482
219295|NCT00700115|525739|P2|NOT COMPLETED|Overall Study||1
219296|NCT00700115|525740|P1|NOT COMPLETED|Overall Study||1
219297|NCT00700115|525739|P2|COMPLETED|Overall Study||19
219298|NCT00700115|525740|P1|COMPLETED|Overall Study||39
219299|NCT00700115|525739|P2|STARTED|Overall Study||20
219300|NCT00700115|525740|P1|STARTED|Overall Study||40
219301|NCT00700102|525750|P2|NOT COMPLETED|Overall Study||395
219302|NCT00700102|525751|P1|NOT COMPLETED|Overall Study||402
219303|NCT00700102|525750|P2|COMPLETED|Overall Study||14
219304|NCT00700102|525751|P1|COMPLETED|Overall Study||9
219305|NCT00700102|525750|P2|Received at Least One Dose|Overall Study||403
219306|NCT00700102|525751|P1|Received at Least One Dose|Overall Study||407
219307|NCT00700102|525750|P2|Intention to Treat|Overall Study||409
219308|NCT00700102|525751|P1|Intention to Treat|Overall Study||410
219309|NCT00700102|525750|P2|STARTED|Overall Study||409
219310|NCT00700102|525751|P1|STARTED|Overall Study||411
219311|NCT00700063|525775|P8|NOT COMPLETED|Overall Study||0
219312|NCT00700063|525776|P7|NOT COMPLETED|Overall Study||0
219313|NCT00700063|525777|P6|NOT COMPLETED|Overall Study||0
219314|NCT00700063|525778|P5|NOT COMPLETED|Overall Study||2
219315|NCT00700063|525779|P4|NOT COMPLETED|Overall Study||2
219316|NCT00700063|525780|P3|NOT COMPLETED|Overall Study||0
219317|NCT00700063|525781|P2|NOT COMPLETED|Overall Study||0
219318|NCT00700063|525782|P1|NOT COMPLETED|Overall Study||1
219319|NCT00700063|525775|P8|COMPLETED|Overall Study||33
219320|NCT00700063|525776|P7|COMPLETED|Overall Study||32
219321|NCT00700063|525777|P6|COMPLETED|Overall Study||34
219322|NCT00700063|525778|P5|COMPLETED|Overall Study||31
219323|NCT00700063|525779|P4|COMPLETED|Overall Study||31
219324|NCT00700063|525780|P3|COMPLETED|Overall Study||33
219325|NCT00700063|525781|P2|COMPLETED|Overall Study||34
219326|NCT00700063|525782|P1|COMPLETED|Overall Study||32
219327|NCT00700063|525775|P8|STARTED|Overall Study||33
219328|NCT00700063|525776|P7|STARTED|Overall Study||32
219329|NCT00700063|525777|P6|STARTED|Overall Study||34
219330|NCT00700063|525778|P5|STARTED|Overall Study||33
219331|NCT00700063|525779|P4|STARTED|Overall Study||33
219332|NCT00700063|525780|P3|STARTED|Overall Study||33
219333|NCT00700063|525781|P2|STARTED|Overall Study||34
219334|NCT00700063|525782|P1|STARTED|Overall Study||33
219335|NCT00700011|525890|P2|NOT COMPLETED|Overall Study||1
219336|NCT00700011|525891|P1|NOT COMPLETED|Overall Study||0
219337|NCT00700011|525890|P2|COMPLETED|Overall Study||1
219338|NCT00700011|525891|P1|COMPLETED|Overall Study||8
219339|NCT00700011|525890|P2|STARTED|Overall Study||2
219340|NCT00700011|525891|P1|STARTED|Overall Study||8
219341|NCT00699998|525907|P4|NOT COMPLETED|Overall Study||82
219342|NCT00699998|525908|P3|NOT COMPLETED|Overall Study||206
219343|NCT00699998|525909|P2|NOT COMPLETED|Overall Study||86
219344|NCT00699998|525910|P1|NOT COMPLETED|Overall Study||199
219345|NCT00699998|525907|P4|COMPLETED|Overall Study||958
219346|NCT00699998|525908|P3|COMPLETED|Overall Study||3417
219347|NCT00699998|525909|P2|COMPLETED|Overall Study||957
219348|NCT00699998|525910|P1|COMPLETED|Overall Study||3421
219349|NCT00699998|525907|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
219350|NCT00699998|525908|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
219351|NCT00699998|525909|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
219352|NCT00699998|525910|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
219353|NCT00699998|525907|P4|STARTED|Overall Study||1040
219354|NCT00699998|525908|P3|STARTED|Overall Study||3623
219355|NCT00699998|525909|P2|STARTED|Overall Study||1043
219356|NCT00699998|525910|P1|STARTED|Overall Study||3620
219357|NCT00699972|525955|P3|NOT COMPLETED|Overall Study||35
219358|NCT00699972|525956|P2|NOT COMPLETED|Overall Study||19
219359|NCT00699972|525957|P1|NOT COMPLETED|Overall Study||16
219360|NCT00699972|525955|P3|COMPLETED|Overall Study||100
219361|NCT00699972|525956|P2|COMPLETED|Overall Study||114
219362|NCT00699972|525957|P1|COMPLETED|Overall Study||106
219363|NCT00699972|525955|P3|STARTED|Overall Study||135
219364|NCT00699972|525956|P2|STARTED|Overall Study||133
219365|NCT00699972|525957|P1|STARTED|Overall Study||122
219366|NCT00699907|525974|P3|NOT COMPLETED|Overall Study||8
219367|NCT00699907|525975|P2|NOT COMPLETED|Overall Study||10
219368|NCT00699907|525976|P1|NOT COMPLETED|Overall Study||2
219369|NCT00699907|525974|P3|COMPLETED|Overall Study||48
219370|NCT00699907|525975|P2|COMPLETED|Overall Study||47
219371|NCT00699907|525976|P1|COMPLETED|Overall Study||12
219372|NCT00699907|525974|P3|STARTED|Overall Study||56
219373|NCT00699907|525975|P2|STARTED|Overall Study||57
219374|NCT00699907|525976|P1|STARTED|Overall Study||14
219375|NCT00699842|526011|P3|NOT COMPLETED|Overall Study||0
219376|NCT00699842|526012|P2|NOT COMPLETED|Overall Study||1
219377|NCT00699842|526013|P1|NOT COMPLETED|Overall Study||0
219378|NCT00699842|526011|P3|COMPLETED|Overall Study||0
219379|NCT00699842|526012|P2|COMPLETED|Overall Study||4
219380|NCT00699842|526013|P1|COMPLETED|Overall Study||3
219381|NCT00699842|526011|P3|STARTED|Overall Study||0
219382|NCT00699842|526012|P2|STARTED|Overall Study||5
219383|NCT00699842|526013|P1|STARTED|Overall Study||3
219384|NCT00699816|526026|P2|NOT COMPLETED|Overall Study||3
219385|NCT00699816|526027|P1|NOT COMPLETED|Overall Study||1
219386|NCT00699816|526026|P2|COMPLETED|Overall Study||112
219387|NCT00699816|526027|P1|COMPLETED|Overall Study||114
219388|NCT00699816|526026|P2|STARTED|Overall Study||115
219389|NCT00699816|526027|P1|STARTED|Overall Study||115
219390|NCT00699751|526045|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
219391|NCT00699751|526046|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
219392|NCT00699751|526045|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
219393|NCT00699751|526046|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
219394|NCT00699751|526045|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
219395|NCT00699751|526046|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
219396|NCT00699751|526045|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
219397|NCT00699751|526046|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
219398|NCT00699751|526045|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
219399|NCT00699751|526046|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
219400|NCT00699751|526045|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
219401|NCT00699751|526046|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
219402|NCT00699751|526045|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
219403|NCT00699751|526046|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
219404|NCT00699751|526045|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
219405|NCT00699751|526046|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
219406|NCT00699751|526045|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
219407|NCT00699751|526046|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
219408|NCT00699751|526045|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
219409|NCT00699751|526046|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
219410|NCT00699751|526045|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
219411|NCT00699751|526046|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
219412|NCT00699751|526045|P2|STARTED|Period 1: Without/Before Drug Switch||307
219413|NCT00699751|526046|P1|STARTED|Period 1: Without/Before Drug Switch||614
219414|NCT00699699|526131|P1|NOT COMPLETED|Overall Study||57
219415|NCT00699699|526131|P1|COMPLETED|Overall Study||1223
219416|NCT00699699|526131|P1|STARTED|Overall Study||1280
219417|NCT00699660|526140|P2|NOT COMPLETED|Overall Study||8
219418|NCT00699660|526141|P1|NOT COMPLETED|Overall Study||14
219419|NCT00699660|526140|P2|COMPLETED|Overall Study||208
219420|NCT00699660|526141|P1|COMPLETED|Overall Study||176
219421|NCT00699660|526140|P2|STARTED|Overall Study||216
219422|NCT00699660|526141|P1|STARTED|Overall Study||190
219423|NCT00699608|526153|P6|NOT COMPLETED|Third Intervention||0
219424|NCT00699608|526154|P5|NOT COMPLETED|Third Intervention||0
219425|NCT00699608|526155|P4|NOT COMPLETED|Third Intervention||0
219426|NCT00699608|526156|P3|NOT COMPLETED|Third Intervention||0
219427|NCT00699608|526157|P2|NOT COMPLETED|Third Intervention||0
219428|NCT00699608|526158|P1|NOT COMPLETED|Third Intervention||0
219429|NCT00699608|526153|P6|COMPLETED|Third Intervention||15
219430|NCT00699608|526154|P5|COMPLETED|Third Intervention||14
219431|NCT00699608|526155|P4|COMPLETED|Third Intervention||14
219432|NCT00699608|526156|P3|COMPLETED|Third Intervention||13
219433|NCT00699608|526157|P2|COMPLETED|Third Intervention||15
219434|NCT00699608|526158|P1|COMPLETED|Third Intervention||16
219435|NCT00699608|526153|P6|STARTED|Third Intervention||15
219436|NCT00699608|526154|P5|STARTED|Third Intervention||14
219437|NCT00699608|526155|P4|STARTED|Third Intervention||14
219438|NCT00699608|526156|P3|STARTED|Third Intervention||13
219439|NCT00699608|526157|P2|STARTED|Third Intervention||15
219440|NCT00699608|526158|P1|STARTED|Third Intervention||16
219441|NCT00699608|526153|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
219442|NCT00699608|526154|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
219443|NCT00699608|526155|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
219444|NCT00699608|526156|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
219445|NCT00699608|526157|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
219446|NCT00699608|526158|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
219447|NCT00699608|526153|P6|COMPLETED|Second 4-14 Day Washout Period||15
219448|NCT00699608|526154|P5|COMPLETED|Second 4-14 Day Washout Period||14
219449|NCT00699608|526155|P4|COMPLETED|Second 4-14 Day Washout Period||14
219450|NCT00699608|526156|P3|COMPLETED|Second 4-14 Day Washout Period||13
219451|NCT00699608|526157|P2|COMPLETED|Second 4-14 Day Washout Period||15
219452|NCT00699608|526158|P1|COMPLETED|Second 4-14 Day Washout Period||16
219453|NCT00699608|526153|P6|STARTED|Second 4-14 Day Washout Period||15
219454|NCT00699608|526154|P5|STARTED|Second 4-14 Day Washout Period||14
219455|NCT00699608|526155|P4|STARTED|Second 4-14 Day Washout Period||14
219456|NCT00699608|526156|P3|STARTED|Second 4-14 Day Washout Period||13
219457|NCT00699608|526157|P2|STARTED|Second 4-14 Day Washout Period||15
219458|NCT00699608|526158|P1|STARTED|Second 4-14 Day Washout Period||16
219459|NCT00699608|526153|P6|NOT COMPLETED|Second Intervention||0
219460|NCT00699608|526154|P5|NOT COMPLETED|Second Intervention||0
219461|NCT00699608|526155|P4|NOT COMPLETED|Second Intervention||1
219462|NCT00699608|526156|P3|NOT COMPLETED|Second Intervention||1
219463|NCT00699608|526157|P2|NOT COMPLETED|Second Intervention||0
219464|NCT00699608|526158|P1|NOT COMPLETED|Second Intervention||0
219465|NCT00699608|526153|P6|COMPLETED|Second Intervention||15
219466|NCT00699608|526154|P5|COMPLETED|Second Intervention||14
219467|NCT00699608|526155|P4|COMPLETED|Second Intervention||14
219468|NCT00699608|526156|P3|COMPLETED|Second Intervention||13
219469|NCT00699608|526157|P2|COMPLETED|Second Intervention||15
219470|NCT00699608|526158|P1|COMPLETED|Second Intervention||16
219471|NCT00699608|526153|P6|STARTED|Second Intervention||15
219472|NCT00699608|526154|P5|STARTED|Second Intervention||14
219473|NCT00699608|526155|P4|STARTED|Second Intervention||15
219474|NCT00699608|526156|P3|STARTED|Second Intervention||14
219475|NCT00699608|526157|P2|STARTED|Second Intervention||15
219476|NCT00699608|526158|P1|STARTED|Second Intervention||16
219477|NCT00699608|526153|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
219478|NCT00699608|526154|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
219479|NCT00699608|526155|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
219480|NCT00699608|526156|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
219481|NCT00699608|526157|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
219482|NCT00699608|526158|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
219483|NCT00699608|526153|P6|COMPLETED|First 4-14 Day Washout Period||15
219484|NCT00699608|526154|P5|COMPLETED|First 4-14 Day Washout Period||14
219485|NCT00699608|526155|P4|COMPLETED|First 4-14 Day Washout Period||15
219486|NCT00699608|526156|P3|COMPLETED|First 4-14 Day Washout Period||14
219487|NCT00699608|526157|P2|COMPLETED|First 4-14 Day Washout Period||15
219488|NCT00699608|526158|P1|COMPLETED|First 4-14 Day Washout Period||16
219489|NCT00699608|526153|P6|STARTED|First 4-14 Day Washout Period||15
219490|NCT00699608|526154|P5|STARTED|First 4-14 Day Washout Period||14
219491|NCT00699608|526155|P4|STARTED|First 4-14 Day Washout Period||15
219492|NCT00699608|526156|P3|STARTED|First 4-14 Day Washout Period||14
219493|NCT00699608|526157|P2|STARTED|First 4-14 Day Washout Period||15
219494|NCT00699608|526158|P1|STARTED|First 4-14 Day Washout Period||16
219495|NCT00699608|526153|P6|NOT COMPLETED|First Intervention||0
219496|NCT00699608|526154|P5|NOT COMPLETED|First Intervention||1
219497|NCT00699608|526155|P4|NOT COMPLETED|First Intervention||0
219498|NCT00699608|526156|P3|NOT COMPLETED|First Intervention||1
219499|NCT00699608|526157|P2|NOT COMPLETED|First Intervention||0
219500|NCT00699608|526158|P1|NOT COMPLETED|First Intervention||0
219501|NCT00699608|526153|P6|COMPLETED|First Intervention||15
219502|NCT00699608|526154|P5|COMPLETED|First Intervention||14
219503|NCT00699608|526155|P4|COMPLETED|First Intervention||15
219504|NCT00699608|526156|P3|COMPLETED|First Intervention||14
219505|NCT00699608|526157|P2|COMPLETED|First Intervention||15
219506|NCT00699608|526158|P1|COMPLETED|First Intervention||16
219507|NCT00699608|526153|P6|STARTED|First Intervention||15
219508|NCT00699608|526154|P5|STARTED|First Intervention||15
219509|NCT00699608|526155|P4|STARTED|First Intervention||15
219510|NCT00699608|526156|P3|STARTED|First Intervention||15
219511|NCT00699608|526157|P2|STARTED|First Intervention||15
219512|NCT00699608|526158|P1|STARTED|First Intervention||16
219513|NCT00699582|526211|P3|NOT COMPLETED|Overall Study||28
219514|NCT00699582|526212|P2|NOT COMPLETED|Overall Study||22
219515|NCT00699582|526213|P1|NOT COMPLETED|Overall Study||18
219516|NCT00699582|526211|P3|COMPLETED|Overall Study||93
219517|NCT00699582|526212|P2|COMPLETED|Overall Study||108
219518|NCT00699582|526213|P1|COMPLETED|Overall Study||120
219519|NCT00699582|526211|P3|STARTED|Overall Study||121
219520|NCT00699582|526212|P2|STARTED|Overall Study||130
219521|NCT00699582|526213|P1|STARTED|Overall Study||138
219522|NCT00699556|526227|P2|NOT COMPLETED|Second Intervention (1 Day)||0
219523|NCT00699556|526228|P1|NOT COMPLETED|Second Intervention (1 Day)||0
219524|NCT00699556|526227|P2|COMPLETED|Second Intervention (1 Day)||11
219525|NCT00699556|526228|P1|COMPLETED|Second Intervention (1 Day)||11
219526|NCT00699556|526227|P2|STARTED|Second Intervention (1 Day)||11
219527|NCT00699556|526228|P1|STARTED|Second Intervention (1 Day)||11
219528|NCT00699556|526227|P2|NOT COMPLETED|First Intervention (1 Day)||0
219529|NCT00699556|526228|P1|NOT COMPLETED|First Intervention (1 Day)||0
219530|NCT00699556|526227|P2|COMPLETED|First Intervention (1 Day)||11
219531|NCT00699556|526228|P1|COMPLETED|First Intervention (1 Day)||11
219532|NCT00699556|526227|P2|STARTED|First Intervention (1 Day)||11
219533|NCT00699556|526228|P1|STARTED|First Intervention (1 Day)||11
219534|NCT00699491|526242|P6|NOT COMPLETED|Overall Study||0
219535|NCT00699491|526243|P5|NOT COMPLETED|Overall Study||0
219536|NCT00699491|526244|P4|NOT COMPLETED|Overall Study||0
219537|NCT00699491|526245|P3|NOT COMPLETED|Overall Study||0
219538|NCT00699491|526246|P2|NOT COMPLETED|Overall Study||0
219539|NCT00699491|526247|P1|NOT COMPLETED|Overall Study||0
219540|NCT00699491|526242|P6|COMPLETED|Overall Study||22
219541|NCT00699491|526243|P5|COMPLETED|Overall Study||8
219542|NCT00699491|526244|P4|COMPLETED|Overall Study||6
219543|NCT00699491|526245|P3|COMPLETED|Overall Study||7
219544|NCT00699491|526246|P2|COMPLETED|Overall Study||2
219545|NCT00699491|526247|P1|COMPLETED|Overall Study||3
219546|NCT00699491|526242|P6|STARTED|Overall Study||22
219547|NCT00699491|526243|P5|STARTED|Overall Study||8
219548|NCT00699491|526244|P4|STARTED|Overall Study||6
219549|NCT00699491|526245|P3|STARTED|Overall Study||7
219550|NCT00699491|526246|P2|STARTED|Overall Study||2
219551|NCT00699491|526247|P1|STARTED|Overall Study||3
219552|NCT00699413|526268|P2|NOT COMPLETED|Overall Study||2
219553|NCT00699413|526269|P1|NOT COMPLETED|Overall Study||0
219554|NCT00699413|526268|P2|COMPLETED|Overall Study||2
219555|NCT00699413|526269|P1|COMPLETED|Overall Study||4
219556|NCT00699413|526268|P2|STARTED|Overall Study||4
219557|NCT00699413|526269|P1|STARTED|Overall Study||4
219558|NCT00699400|526278|P6|NOT COMPLETED|Overall Study||11
219559|NCT00699400|526279|P5|NOT COMPLETED|Overall Study||0
219560|NCT00699400|526280|P4|NOT COMPLETED|Overall Study||0
219561|NCT00699400|526281|P3|NOT COMPLETED|Overall Study||0
219562|NCT00699400|526282|P2|NOT COMPLETED|Overall Study||0
219563|NCT00699400|526283|P1|NOT COMPLETED|Overall Study||0
219564|NCT00699400|526278|P6|COMPLETED|Overall Study||0
219565|NCT00699400|526279|P5|COMPLETED|Overall Study||4
219566|NCT00699400|526280|P4|COMPLETED|Overall Study||6
219567|NCT00699400|526281|P3|COMPLETED|Overall Study||138
219568|NCT00699400|526282|P2|COMPLETED|Overall Study||3
219569|NCT00699400|526283|P1|COMPLETED|Overall Study||42
219570|NCT00699400|526278|P6|STARTED|Overall Study||11
219571|NCT00699400|526279|P5|STARTED|Overall Study||4
219572|NCT00699400|526280|P4|STARTED|Overall Study||6
219573|NCT00699400|526281|P3|STARTED|Overall Study||138
219574|NCT00699400|526282|P2|STARTED|Overall Study||3
219575|NCT00699400|526283|P1|STARTED|Overall Study||42
219576|NCT00699374|526317|P2|NOT COMPLETED|Overall Study||544
219577|NCT00699374|526318|P1|NOT COMPLETED|Overall Study||530
219578|NCT00699374|526317|P2|COMPLETED|Overall Study||0
219579|NCT00699374|526318|P1|COMPLETED|Overall Study||0
219580|NCT00699374|526317|P2|Treated|Overall Study||542
219581|NCT00699374|526318|P1|Treated|Overall Study||526
219582|NCT00699374|526317|P2|STARTED|Overall Study||544
219583|NCT00699374|526318|P1|STARTED|Overall Study||530
219584|NCT00699348|526330|P1|NOT COMPLETED|Overall Study||90
219585|NCT00699348|526330|P1|COMPLETED|Overall Study||261
219586|NCT00699348|526330|P1|STARTED|Overall Study||351
219587|NCT00699335|526339|P1|NOT COMPLETED|Overall Study||228
219588|NCT00699335|526339|P1|COMPLETED|Overall Study||5080
219589|NCT00699335|526339|P1|STARTED|Overall Study||5308
219590|NCT00699283|526372|P2|NOT COMPLETED|Overall Study||8
219591|NCT00699283|526373|P1|NOT COMPLETED|Overall Study||33
219592|NCT00699283|526372|P2|COMPLETED|Overall Study||7
219593|NCT00699283|526373|P1|COMPLETED|Overall Study||14
219594|NCT00699283|526372|P2|STARTED|Overall Study||15
219595|NCT00699283|526373|P1|STARTED|Overall Study||47
219596|NCT00699192|526381|P3|NOT COMPLETED|Overall Study||11
219597|NCT00699192|526382|P2|NOT COMPLETED|Overall Study||12
219598|NCT00699192|526383|P1|NOT COMPLETED|Overall Study||16
219599|NCT00699192|526381|P3|COMPLETED|Overall Study||261
219600|NCT00699192|526382|P2|COMPLETED|Overall Study||260
219601|NCT00699192|526383|P1|COMPLETED|Overall Study||259
219602|NCT00699192|526381|P3|STARTED|Overall Study||272
219603|NCT00699192|526382|P2|STARTED|Overall Study||272
219604|NCT00699192|526383|P1|STARTED|Overall Study||275
219605|NCT00699153|526405|P2|NOT COMPLETED|Overall Study||2
219606|NCT00699153|526406|P1|NOT COMPLETED|Overall Study||3
219607|NCT00699153|526405|P2|COMPLETED|Overall Study||200
219608|NCT00699153|526406|P1|COMPLETED|Overall Study||200
219609|NCT00699153|526405|P2|STARTED|Overall Study|Intent to treat population|202
219610|NCT00699153|526406|P1|STARTED|Overall Study|Intent to treat population|203
219611|NCT00699140|526418|P1|NOT COMPLETED|Overall Study||0
219612|NCT00699140|526418|P1|COMPLETED|Overall Study||18
219613|NCT00699140|526418|P1|STARTED|Overall Study||18
219614|NCT00698932|526432|P2|NOT COMPLETED|Overall Study||36
219615|NCT00698932|526433|P1|NOT COMPLETED|Overall Study||22
219616|NCT00698932|526432|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
219617|NCT00698932|526433|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
219618|NCT00698932|526432|P2|STARTED|Overall Study|Randomized and treated|284
219619|NCT00698932|526433|P1|STARTED|Overall Study|Randomized and treated|284
219620|NCT00698867|526449|P1|NOT COMPLETED|Overall Study||91
219621|NCT00698867|526449|P1|COMPLETED|Overall Study||27
219622|NCT00698867|526449|P1|Subjects With 4 Year Data|Overall Study||34
219623|NCT00698867|526449|P1|Subjects With 3 Year Data|Overall Study||35
219624|NCT00698867|526449|P1|Subjects With 2 Year Data|Overall Study||55
219625|NCT00698867|526449|P1|Subjects With 1 Year Data|Overall Study||68
219626|NCT00698867|526449|P1|STARTED|Overall Study||118
219627|NCT00698841|526459|P1|NOT COMPLETED|Overall Study||18
219628|NCT00698841|526459|P1|COMPLETED|Overall Study||33
219629|NCT00698841|526459|P1|STARTED|Overall Study||51
219630|NCT00698815|526473|P3|NOT COMPLETED|Overall Study||10
219631|NCT00698815|526474|P2|NOT COMPLETED|Overall Study||14
219632|NCT00698815|526475|P1|NOT COMPLETED|Overall Study||10
219633|NCT00698815|526473|P3|COMPLETED|Overall Study||31
219634|NCT00698815|526474|P2|COMPLETED|Overall Study||33
219635|NCT00698815|526475|P1|COMPLETED|Overall Study||32
219636|NCT00698815|526473|P3|STARTED|Overall Study||41
219637|NCT00698815|526474|P2|STARTED|Overall Study||47
219638|NCT00698815|526475|P1|STARTED|Overall Study||42
219639|NCT00698685|526492|P1|NOT COMPLETED|Overall Study||2
219640|NCT00698685|526492|P1|COMPLETED|Overall Study||12
219641|NCT00698685|526492|P1|STARTED|Overall Study||14
219642|NCT00698646|526500|P3|NOT COMPLETED|Overall Study||29
219643|NCT00698646|526501|P2|NOT COMPLETED|Overall Study||31
219644|NCT00698646|526502|P1|NOT COMPLETED|Overall Study||36
219645|NCT00698646|526500|P3|COMPLETED|Overall Study||99
219646|NCT00698646|526501|P2|COMPLETED|Overall Study||97
219647|NCT00698646|526502|P1|COMPLETED|Overall Study||92
219648|NCT00698646|526500|P3|STARTED|Overall Study||128
219649|NCT00698646|526501|P2|STARTED|Overall Study||128
219650|NCT00698646|526502|P1|STARTED|Overall Study||128
219651|NCT00698581|526527|P2|NOT COMPLETED|Overall Study||12
219652|NCT00698581|526528|P1|NOT COMPLETED|Overall Study||45
219653|NCT00698581|526527|P2|COMPLETED|Overall Study||8
219654|NCT00698581|526528|P1|COMPLETED|Overall Study||23
219655|NCT00698581|526527|P2|STARTED|Overall Study||20
219656|NCT00698581|526528|P1|STARTED|Overall Study||68
219657|NCT00698516|526539|P1|NOT COMPLETED|Overall Study||5
219658|NCT00698516|526539|P1|COMPLETED|Overall Study||45
219659|NCT00698516|526539|P1|STARTED|Overall Study||50
219660|NCT00698451|526557|P1|NOT COMPLETED|Overall Study||39
219661|NCT00698451|526557|P1|COMPLETED|Overall Study||15
219662|NCT00698451|526557|P1|STARTED|Overall Study||54
219663|NCT00698204|526564|P2|NOT COMPLETED|Overall Study||0
219664|NCT00698204|526565|P1|NOT COMPLETED|Overall Study||1
219665|NCT00698204|526564|P2|COMPLETED|Overall Study||20
219666|NCT00698204|526565|P1|COMPLETED|Overall Study||19
219667|NCT00698204|526564|P2|STARTED|Overall Study||20
219668|NCT00698204|526565|P1|STARTED|Overall Study||20
219669|NCT00698139|526576|P3|NOT COMPLETED|Overall Study||0
219670|NCT00698139|526577|P2|NOT COMPLETED|Overall Study||0
219671|NCT00698139|526578|P1|NOT COMPLETED|Overall Study||0
219672|NCT00698139|526576|P3|COMPLETED|Overall Study||1
219673|NCT00698139|526577|P2|COMPLETED|Overall Study||1
219674|NCT00698139|526578|P1|COMPLETED|Overall Study||1
219675|NCT00698139|526576|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
219676|NCT00698139|526577|P2|2nd Visit|Overall Study||1
219677|NCT00698139|526578|P1|2nd Visit|Overall Study||1
219678|NCT00698139|526576|P3|STARTED|Overall Study||1
219679|NCT00698139|526577|P2|STARTED|Overall Study||1
219680|NCT00698139|526578|P1|STARTED|Overall Study||1
219681|NCT00698035|526594|P2|NOT COMPLETED|Overall Study||2
219682|NCT00698035|526595|P1|NOT COMPLETED|Overall Study||4
219683|NCT00698035|526594|P2|COMPLETED|Overall Study||34
219684|NCT00698035|526595|P1|COMPLETED|Overall Study||35
219685|NCT00698035|526594|P2|STARTED|Overall Study||36
219686|NCT00698035|526595|P1|STARTED|Overall Study||39
219687|NCT00698022|526615|P3|NOT COMPLETED|Overall Study||2
219688|NCT00698022|526616|P2|NOT COMPLETED|Overall Study||10
219689|NCT00698022|526617|P1|NOT COMPLETED|Overall Study||16
219690|NCT00698022|526615|P3|COMPLETED|Overall Study||14
219691|NCT00698022|526616|P2|COMPLETED|Overall Study||20
219692|NCT00698022|526617|P1|COMPLETED|Overall Study||14
219693|NCT00698022|526615|P3|STARTED|Overall Study||16
219694|NCT00698022|526616|P2|STARTED|Overall Study||30
219695|NCT00698022|526617|P1|STARTED|Overall Study||30
219696|NCT00698009|526625|P1|NOT COMPLETED|Overall Study||1
219697|NCT00698009|526625|P1|COMPLETED|Overall Study||0
219698|NCT00698009|526625|P1|STARTED|Overall Study||1
219699|NCT00697827|526631|P2|NOT COMPLETED|Overall Study||1
219700|NCT00697827|526632|P1|NOT COMPLETED|Overall Study||2
219701|NCT00697827|526631|P2|COMPLETED|Overall Study||15
219702|NCT00697827|526632|P1|COMPLETED|Overall Study||26
219703|NCT00697827|526631|P2|STARTED|Overall Study||16
219704|NCT00697827|526632|P1|STARTED|Overall Study||28
219705|NCT00697801|526643|P3|NOT COMPLETED|Overall Study||24
219706|NCT00697801|526644|P2|NOT COMPLETED|Overall Study||12
219707|NCT00697801|526645|P1|NOT COMPLETED|Overall Study||12
219708|NCT00697801|526643|P3|COMPLETED|Overall Study||45
219709|NCT00697801|526644|P2|COMPLETED|Overall Study||58
219710|NCT00697801|526645|P1|COMPLETED|Overall Study||57
219711|NCT00697801|526643|P3|STARTED|Overall Study||69
219712|NCT00697801|526644|P2|STARTED|Overall Study||70
219713|NCT00697801|526645|P1|STARTED|Overall Study||69
219714|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219715|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219716|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219717|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219718|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219719|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219720|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219721|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219722|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
219723|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219724|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219725|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219726|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219727|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219728|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219729|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219730|NCT00697788|526659|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
219731|NCT00697788|526660|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219732|NCT00697788|526661|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219733|NCT00697788|526662|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219734|NCT00697788|526663|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219735|NCT00697788|526664|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219736|NCT00697788|526665|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219737|NCT00697788|526666|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
219738|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219739|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219740|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219741|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219742|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219743|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219744|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219745|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219746|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219747|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
219748|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219749|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219750|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219751|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219752|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219753|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219754|NCT00697788|526659|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219755|NCT00697788|526660|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
219756|NCT00697788|526661|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219757|NCT00697788|526662|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219758|NCT00697788|526663|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219759|NCT00697788|526664|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219760|NCT00697788|526665|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219761|NCT00697788|526666|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
219762|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219763|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219764|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219765|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219766|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219767|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219768|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219769|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219770|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219771|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219772|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
219773|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219774|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219775|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219776|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219777|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219778|NCT00697788|526659|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219779|NCT00697788|526660|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219780|NCT00697788|526661|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
219781|NCT00697788|526662|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219782|NCT00697788|526663|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219783|NCT00697788|526664|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219784|NCT00697788|526665|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219785|NCT00697788|526666|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
219786|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219787|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219788|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219789|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
219790|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219791|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219792|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219793|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219794|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219795|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219796|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219797|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
219798|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219799|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219800|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219801|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219802|NCT00697788|526659|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219803|NCT00697788|526660|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219804|NCT00697788|526661|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219805|NCT00697788|526662|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
219806|NCT00697788|526663|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219807|NCT00697788|526664|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219808|NCT00697788|526665|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219809|NCT00697788|526666|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
219810|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219811|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219812|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219813|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219814|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219815|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219816|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219817|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219818|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219819|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219820|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219821|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219822|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
219823|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219824|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219825|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219826|NCT00697788|526659|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219827|NCT00697788|526660|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219828|NCT00697788|526661|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219829|NCT00697788|526662|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219830|NCT00697788|526663|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
219831|NCT00697788|526664|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219832|NCT00697788|526665|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219833|NCT00697788|526666|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
219834|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219835|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219836|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219837|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219838|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219839|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219840|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219841|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219842|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219843|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219844|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219845|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219846|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219847|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
219848|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219849|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219850|NCT00697788|526659|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219851|NCT00697788|526660|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219852|NCT00697788|526661|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219853|NCT00697788|526662|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219854|NCT00697788|526663|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219855|NCT00697788|526664|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
219856|NCT00697788|526665|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219857|NCT00697788|526666|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
219858|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219859|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219860|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219861|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219862|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219863|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219864|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
219865|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219866|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219867|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219868|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219869|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219870|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219871|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219872|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
219873|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219874|NCT00697788|526659|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219875|NCT00697788|526660|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219876|NCT00697788|526661|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219877|NCT00697788|526662|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219878|NCT00697788|526663|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219879|NCT00697788|526664|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219880|NCT00697788|526665|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
219881|NCT00697788|526666|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
219882|NCT00697788|526659|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219883|NCT00697788|526660|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219884|NCT00697788|526661|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219885|NCT00697788|526662|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219886|NCT00697788|526663|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219887|NCT00697788|526664|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219888|NCT00697788|526665|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219889|NCT00697788|526666|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219890|NCT00697788|526659|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219891|NCT00697788|526660|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219892|NCT00697788|526661|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219893|NCT00697788|526662|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219894|NCT00697788|526663|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219895|NCT00697788|526664|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219896|NCT00697788|526665|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
219897|NCT00697788|526666|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
219898|NCT00697788|526659|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
219899|NCT00697788|526660|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
219900|NCT00697788|526661|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
219901|NCT00697788|526662|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
219902|NCT00697788|526663|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
219903|NCT00697788|526664|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
219904|NCT00697788|526665|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
219905|NCT00697788|526666|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
219906|NCT00697697|526710|P2|NOT COMPLETED|Overall Study||54
219907|NCT00697697|526711|P1|NOT COMPLETED|Overall Study||49
219908|NCT00697697|526710|P2|COMPLETED|Overall Study||44
219909|NCT00697697|526711|P1|COMPLETED|Overall Study||45
219910|NCT00697697|526710|P2|STARTED|Overall Study||98
219911|NCT00697697|526711|P1|STARTED|Overall Study||94
219912|NCT00697619|526721|P2|NOT COMPLETED|Overall Study||8
219913|NCT00697619|526722|P1|NOT COMPLETED|Overall Study||6
219914|NCT00697619|526721|P2|COMPLETED|Overall Study||22
219915|NCT00697619|526722|P1|COMPLETED|Overall Study||24
219916|NCT00697619|526721|P2|STARTED|Overall Study||30
219917|NCT00697619|526722|P1|STARTED|Overall Study||30
219918|NCT00697593|526728|P1|NOT COMPLETED|Overall Study||19
219919|NCT00697593|526728|P1|COMPLETED|Overall Study||51
219920|NCT00697593|526728|P1|STARTED|Overall Study||70
219921|NCT00697541|526761|P2|NOT COMPLETED|Overall Study||1
219922|NCT00697541|526762|P1|NOT COMPLETED|Overall Study||2
219923|NCT00697541|526761|P2|COMPLETED|Overall Study||9
219924|NCT00697541|526762|P1|COMPLETED|Overall Study||8
219925|NCT00697541|526761|P2|STARTED|Overall Study||10
219926|NCT00697541|526762|P1|STARTED|Overall Study||10
219927|NCT00697515|526772|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
219928|NCT00697515|526773|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
219929|NCT00697515|526772|P2|COMPLETED|Second Intervention (Crossover Period)||51
219930|NCT00697515|526773|P1|COMPLETED|Second Intervention (Crossover Period)||52
219931|NCT00697515|526772|P2|STARTED|Second Intervention (Crossover Period)||52
219932|NCT00697515|526773|P1|STARTED|Second Intervention (Crossover Period)||53
219933|NCT00697515|526772|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
219934|NCT00697515|526773|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
219935|NCT00697515|526772|P2|COMPLETED|First Intervention (Crossover Period)||52
219936|NCT00697515|526773|P1|COMPLETED|First Intervention (Crossover Period)||53
219937|NCT00697515|526772|P2|STARTED|First Intervention (Crossover Period)||64
219938|NCT00697515|526773|P1|STARTED|First Intervention (Crossover Period)||63
219939|NCT00697515|526772|P2|NOT COMPLETED|Dose Optimization Period||0
219940|NCT00697515|526773|P1|NOT COMPLETED|Dose Optimization Period||15
219941|NCT00697515|526772|P2|COMPLETED|Dose Optimization Period||0
219942|NCT00697515|526773|P1|COMPLETED|Dose Optimization Period||127
219943|NCT00697515|526772|P2|STARTED|Dose Optimization Period||0
219944|NCT00697515|526773|P1|STARTED|Dose Optimization Period||142
219945|NCT00697255|526803|P2|NOT COMPLETED|Stage 1b||2
219946|NCT00697255|526804|P1|NOT COMPLETED|Stage 1b||0
219947|NCT00697255|526803|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
219948|NCT00697255|526804|P1|COMPLETED|Stage 1b||0
219949|NCT00697255|526803|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
219950|NCT00697255|526804|P1|STARTED|Stage 1b||0
219951|NCT00697255|526803|P2|NOT COMPLETED|Stage 1a||0
219952|NCT00697255|526804|P1|NOT COMPLETED|Stage 1a||3
219953|NCT00697255|526803|P2|COMPLETED|Stage 1a||0
219954|NCT00697255|526804|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
219955|NCT00697255|526803|P2|STARTED|Stage 1a||0
219956|NCT00697255|526804|P1|STARTED|Stage 1a||5
219957|NCT00697190|526820|P2|NOT COMPLETED|Second Intervention||0
219958|NCT00697190|526821|P1|NOT COMPLETED|Second Intervention||0
219959|NCT00697190|526820|P2|COMPLETED|Second Intervention||20
219960|NCT00697190|526821|P1|COMPLETED|Second Intervention||18
219961|NCT00697190|526820|P2|STARTED|Second Intervention||20
219962|NCT00697190|526821|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
219963|NCT00697190|526820|P2|NOT COMPLETED|First Intervention||0
219964|NCT00697190|526821|P1|NOT COMPLETED|First Intervention||0
219965|NCT00697190|526820|P2|COMPLETED|First Intervention||20
219966|NCT00697190|526821|P1|COMPLETED|First Intervention||19
219967|NCT00697190|526820|P2|STARTED|First Intervention||20
219968|NCT00697190|526821|P1|STARTED|First Intervention||19
219969|NCT00697112|526855|P1|NOT COMPLETED|Overall Study||10
219970|NCT00697112|526855|P1|COMPLETED|Overall Study||43
219971|NCT00697112|526855|P1|Met the Inclusion Criteria|Overall Study||52
219972|NCT00697112|526855|P1|STARTED|Overall Study||53
219973|NCT00697073|526879|P1|NOT COMPLETED|Overall Study||9
219974|NCT00697073|526879|P1|COMPLETED|Overall Study||59
219975|NCT00697073|526879|P1|STARTED|Overall Study||68
219976|NCT00696878|526883|P1|NOT COMPLETED|Overall Study||504
219977|NCT00696878|526883|P1|COMPLETED|Overall Study||178
219978|NCT00696878|526883|P1|STARTED|Overall Study||682
219979|NCT00696800|526957|P2|NOT COMPLETED|Overall Study||48
219980|NCT00696800|526958|P1|NOT COMPLETED|Overall Study||85
219981|NCT00696800|526957|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
219982|NCT00696800|526958|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
219983|NCT00696800|526957|P2|Treated (ITT)|Overall Study|The ITT group|750
219984|NCT00696800|526958|P1|Treated (ITT)|Overall Study|The ITT group|756
219985|NCT00696800|526957|P2|STARTED|Overall Study||752
219986|NCT00696800|526958|P1|STARTED|Overall Study||757
219987|NCT00696787|527011|P3|NOT COMPLETED|Overall Study||26
219988|NCT00696787|527012|P2|NOT COMPLETED|Overall Study||20
219989|NCT00696787|527013|P1|NOT COMPLETED|Overall Study||15
219990|NCT00696787|527011|P3|COMPLETED|Overall Study||17
219991|NCT00696787|527012|P2|COMPLETED|Overall Study||22
219992|NCT00696787|527013|P1|COMPLETED|Overall Study||25
219993|NCT00696787|527011|P3|STARTED|Overall Study||43
219994|NCT00696787|527012|P2|STARTED|Overall Study||42
219995|NCT00696787|527013|P1|STARTED|Overall Study||40
219996|NCT00696774|527027|P3|NOT COMPLETED|Period III||0
219997|NCT00696774|527028|P2|NOT COMPLETED|Period III||7
219998|NCT00696774|527029|P1|NOT COMPLETED|Period III||7
219999|NCT00696774|527027|P3|COMPLETED|Period III||0
220000|NCT00696774|527028|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
220001|NCT00696774|527029|P1|COMPLETED|Period III||106
220002|NCT00696774|527027|P3|STARTED|Period III||0
220003|NCT00696774|527028|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
220004|NCT00696774|527029|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
220005|NCT00696774|527027|P3|NOT COMPLETED|Period II||36
220006|NCT00696774|527028|P2|NOT COMPLETED|Period II||0
220007|NCT00696774|527029|P1|NOT COMPLETED|Period II||0
220008|NCT00696774|527027|P3|COMPLETED|Period II||0
220009|NCT00696774|527028|P2|COMPLETED|Period II||91
220010|NCT00696774|527029|P1|COMPLETED|Period II||115
220011|NCT00696774|527027|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
220012|NCT00696774|527028|P2|STARTED|Period II||91
220013|NCT00696774|527029|P1|STARTED|Period II||115
220014|NCT00696761|527067|P4|NOT COMPLETED|Overall Study||10
220015|NCT00696761|527068|P3|NOT COMPLETED|Overall Study||11
220016|NCT00696761|527069|P2|NOT COMPLETED|Overall Study||26
220017|NCT00696761|527070|P1|NOT COMPLETED|Overall Study||20
220018|NCT00696761|527067|P4|COMPLETED|Overall Study||44
220019|NCT00696761|527068|P3|COMPLETED|Overall Study||30
220020|NCT00696761|527069|P2|COMPLETED|Overall Study||50
220021|NCT00696761|527070|P1|COMPLETED|Overall Study||41
220022|NCT00696761|527067|P4|STARTED|Overall Study||54
220023|NCT00696761|527068|P3|STARTED|Overall Study||41
220024|NCT00696761|527069|P2|STARTED|Overall Study||76
220025|NCT00696761|527070|P1|STARTED|Overall Study||61
220026|NCT00696696|527084|P1|NOT COMPLETED|Overall Study||18
220027|NCT00696696|527084|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
220028|NCT00696696|527084|P1|STARTED|Overall Study||44
220029|NCT00696618|527093|P3|NOT COMPLETED|Overall Study||0
220030|NCT00696618|527094|P2|NOT COMPLETED|Overall Study||0
220031|NCT00696618|527095|P1|NOT COMPLETED|Overall Study||0
220032|NCT00696618|527093|P3|COMPLETED|Overall Study||3
220033|NCT00696618|527094|P2|COMPLETED|Overall Study||3
220034|NCT00696618|527095|P1|COMPLETED|Overall Study||3
220035|NCT00696618|527093|P3|STARTED|Overall Study||3
220036|NCT00696618|527094|P2|STARTED|Overall Study||3
220037|NCT00696618|527095|P1|STARTED|Overall Study||3
220038|NCT00696488|527109|P1|NOT COMPLETED|Overall Study||0
220039|NCT00696488|527109|P1|COMPLETED|Overall Study||20
220040|NCT00696488|527109|P1|STARTED|Overall Study||20
220041|NCT00696449|527117|P4|NOT COMPLETED|Overall Study||3
220042|NCT00696449|527118|P3|NOT COMPLETED|Overall Study||1
220043|NCT00696449|527119|P2|NOT COMPLETED|Overall Study||6
220044|NCT00696449|527120|P1|NOT COMPLETED|Overall Study||3
220045|NCT00696449|527117|P4|COMPLETED|Overall Study||13
220046|NCT00696449|527118|P3|COMPLETED|Overall Study||14
220047|NCT00696449|527119|P2|COMPLETED|Overall Study||9
220048|NCT00696449|527120|P1|COMPLETED|Overall Study||12
220049|NCT00696449|527117|P4|STARTED|Overall Study||16
220050|NCT00696449|527118|P3|STARTED|Overall Study||15
220051|NCT00696449|527119|P2|STARTED|Overall Study||15
220052|NCT00696449|527120|P1|STARTED|Overall Study||15
220053|NCT00696436|527135|P5|NOT COMPLETED|Overall Study||13
220054|NCT00696436|527136|P4|NOT COMPLETED|Overall Study||22
220055|NCT00696436|527137|P3|NOT COMPLETED|Overall Study||28
220056|NCT00696436|527138|P2|NOT COMPLETED|Overall Study||30
220057|NCT00696436|527139|P1|NOT COMPLETED|Overall Study||23
220058|NCT00696436|527135|P5|COMPLETED|Overall Study||141
220059|NCT00696436|527136|P4|COMPLETED|Overall Study||268
220060|NCT00696436|527137|P3|COMPLETED|Overall Study||254
220061|NCT00696436|527138|P2|COMPLETED|Overall Study||255
220062|NCT00696436|527139|P1|COMPLETED|Overall Study||257
220063|NCT00696436|527135|P5|STARTED|Overall Study|Randomized participants only.|154
220064|NCT00696436|527136|P4|STARTED|Overall Study|Randomized participants only.|290
220065|NCT00696436|527137|P3|STARTED|Overall Study|Randomized participants only.|282
220066|NCT00696436|527138|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
220067|NCT00696436|527139|P1|STARTED|Overall Study|Randomized participants only.|280
220068|NCT00696423|527223|P2|NOT COMPLETED|Overall Study||5
220069|NCT00696423|527224|P1|NOT COMPLETED|Overall Study||0
220070|NCT00696423|527223|P2|COMPLETED|Overall Study||218
220071|NCT00696423|527224|P1|COMPLETED|Overall Study||244
220072|NCT00696423|527223|P2|STARTED|Overall Study||223
220073|NCT00696423|527224|P1|STARTED|Overall Study||244
220074|NCT00696410|527256|P2|NOT COMPLETED|Overall Study||0
220075|NCT00696410|527257|P1|NOT COMPLETED|Overall Study||13
220076|NCT00696410|527256|P2|COMPLETED|Overall Study||10
220077|NCT00696410|527257|P1|COMPLETED|Overall Study||25
220078|NCT00696410|527256|P2|STARTED|Overall Study||10
220079|NCT00696410|527257|P1|STARTED|Overall Study||38
220080|NCT00696384|527271|P3|NOT COMPLETED|Double Blind Phase||6
220081|NCT00696384|527272|P2|NOT COMPLETED|Double Blind Phase||11
220082|NCT00696384|527273|P1|NOT COMPLETED|Double Blind Phase||0
220083|NCT00696384|527271|P3|COMPLETED|Double Blind Phase||145
220084|NCT00696384|527272|P2|COMPLETED|Double Blind Phase||137
220085|NCT00696384|527273|P1|COMPLETED|Double Blind Phase||0
220086|NCT00696384|527271|P3|STARTED|Double Blind Phase||151
220087|NCT00696384|527272|P2|STARTED|Double Blind Phase||148
220088|NCT00696384|527273|P1|STARTED|Double Blind Phase||0
220089|NCT00696384|527271|P3|NOT COMPLETED|Open Label Phase||0
220090|NCT00696384|527272|P2|NOT COMPLETED|Open Label Phase||0
220091|NCT00696384|527273|P1|NOT COMPLETED|Open Label Phase||119
220092|NCT00696384|527271|P3|COMPLETED|Open Label Phase||0
220093|NCT00696384|527272|P2|COMPLETED|Open Label Phase||0
220094|NCT00696384|527273|P1|COMPLETED|Open Label Phase||299
220095|NCT00696384|527271|P3|STARTED|Open Label Phase||0
220096|NCT00696384|527272|P2|STARTED|Open Label Phase||0
220097|NCT00696384|527273|P1|STARTED|Open Label Phase||418
220098|NCT00696293|527287|P1|NOT COMPLETED|Overall Study||2
220099|NCT00696293|527287|P1|COMPLETED|Overall Study||28
220100|NCT00696293|527287|P1|STARTED|Overall Study||30
220101|NCT00696241|527297|P5|NOT COMPLETED|Overall Study||12
220102|NCT00696241|527298|P4|NOT COMPLETED|Overall Study||14
220103|NCT00696241|527299|P3|NOT COMPLETED|Overall Study||24
220104|NCT00696241|527300|P2|NOT COMPLETED|Overall Study||22
220105|NCT00696241|527301|P1|NOT COMPLETED|Overall Study||24
220106|NCT00696241|527297|P5|COMPLETED|Overall Study||130
220107|NCT00696241|527298|P4|COMPLETED|Overall Study||268
220108|NCT00696241|527299|P3|COMPLETED|Overall Study||261
220109|NCT00696241|527300|P2|COMPLETED|Overall Study||261
220110|NCT00696241|527301|P1|COMPLETED|Overall Study||259
220111|NCT00696241|527297|P5|STARTED|Overall Study||142
220112|NCT00696241|527298|P4|STARTED|Overall Study||282
220113|NCT00696241|527299|P3|STARTED|Overall Study||285
220114|NCT00696241|527300|P2|STARTED|Overall Study||283
220115|NCT00696241|527301|P1|STARTED|Overall Study||283
220116|NCT00696072|527385|P2|NOT COMPLETED|Overall Study||63
220117|NCT00696072|527386|P1|NOT COMPLETED|Overall Study||57
220118|NCT00696072|527385|P2|COMPLETED|Overall Study||0
220119|NCT00696072|527386|P1|COMPLETED|Overall Study||0
220120|NCT00696072|527385|P2|STARTED|Overall Study||63
220121|NCT00696072|527386|P1|STARTED|Overall Study||57
220122|NCT00696020|527407|P4|NOT COMPLETED|Overall Study||4
220123|NCT00696020|527408|P3|NOT COMPLETED|Overall Study||3
220124|NCT00696020|527409|P2|NOT COMPLETED|Overall Study||2
220125|NCT00696020|527410|P1|NOT COMPLETED|Overall Study||4
220126|NCT00696020|527407|P4|COMPLETED|Overall Study||84
220127|NCT00696020|527408|P3|COMPLETED|Overall Study||90
220128|NCT00696020|527409|P2|COMPLETED|Overall Study||87
220129|NCT00696020|527410|P1|COMPLETED|Overall Study||86
220130|NCT00696020|527407|P4|STARTED|Overall Study||88
220131|NCT00696020|527408|P3|STARTED|Overall Study||93
220132|NCT00696020|527409|P2|STARTED|Overall Study||89
220133|NCT00696020|527410|P1|STARTED|Overall Study||90
220134|NCT00695955|527518|P1|NOT COMPLETED|Cohort 2||104
220135|NCT00695955|527518|P1|COMPLETED|Cohort 2||203
220136|NCT00695955|527518|P1|STARTED|Cohort 2||307
220137|NCT00695955|527518|P1|NOT COMPLETED|Cohort 1||102
220138|NCT00695955|527518|P1|COMPLETED|Cohort 1||260
220139|NCT00695955|527518|P1|STARTED|Cohort 1||362
220140|NCT00695903|527530|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
220141|NCT00695903|527531|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
220142|NCT00695903|527530|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
220143|NCT00695903|527531|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
220144|NCT00695903|527530|P2|STARTED|Had Test of Cure (TOC) Assessment||4
220145|NCT00695903|527531|P1|STARTED|Had Test of Cure (TOC) Assessment||7
220146|NCT00695903|527530|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
220147|NCT00695903|527531|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
220148|NCT00695903|527530|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
220149|NCT00695903|527531|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
220150|NCT00695903|527530|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
220151|NCT00695903|527531|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
220152|NCT00695903|527530|P2|STARTED|Had End of Therapy (EOT) Assessment||19
220153|NCT00695903|527531|P1|STARTED|Had End of Therapy (EOT) Assessment||19
220154|NCT00695864|527543|P1|NOT COMPLETED|Ondansetron||5
220155|NCT00695864|527543|P1|COMPLETED|Ondansetron||9
220156|NCT00695864|527543|P1|STARTED|Ondansetron||14
220157|NCT00695864|527543|P1|NOT COMPLETED|Placebo||5
220158|NCT00695864|527543|P1|COMPLETED|Placebo||9
220159|NCT00695864|527543|P1|STARTED|Placebo||14
220160|NCT00695669|527553|P4|NOT COMPLETED|Overall Study||4
220161|NCT00695669|527554|P3|NOT COMPLETED|Overall Study||3
220162|NCT00695669|527555|P2|NOT COMPLETED|Overall Study||4
220163|NCT00695669|527556|P1|NOT COMPLETED|Overall Study||4
220164|NCT00695669|527553|P4|COMPLETED|Overall Study||74
220165|NCT00695669|527554|P3|COMPLETED|Overall Study||75
220166|NCT00695669|527555|P2|COMPLETED|Overall Study||74
220167|NCT00695669|527556|P1|COMPLETED|Overall Study||74
220168|NCT00695669|527553|P4|STARTED|Overall Study||78
220169|NCT00695669|527554|P3|STARTED|Overall Study||78
220170|NCT00695669|527555|P2|STARTED|Overall Study||78
220171|NCT00695669|527556|P1|STARTED|Overall Study||78
220172|NCT00695565|527632|P2|NOT COMPLETED|Overall Study||9
220173|NCT00695565|527633|P1|NOT COMPLETED|Overall Study||13
220174|NCT00695565|527632|P2|COMPLETED|Overall Study||81
220175|NCT00695565|527633|P1|COMPLETED|Overall Study||77
220176|NCT00695565|527632|P2|STARTED|Overall Study||90
220177|NCT00695565|527633|P1|STARTED|Overall Study||90
220178|NCT00695500|527667|P2|NOT COMPLETED|Overall Study||5
220179|NCT00695500|527668|P1|NOT COMPLETED|Overall Study||3
220180|NCT00695500|527667|P2|COMPLETED|Overall Study||17
220181|NCT00695500|527668|P1|COMPLETED|Overall Study||21
220182|NCT00695500|527667|P2|STARTED|Overall Study||22
220183|NCT00695500|527668|P1|STARTED|Overall Study||24
220184|NCT00695435|527678|P3|NOT COMPLETED|Overall Study||0
220185|NCT00695435|527679|P2|NOT COMPLETED|Overall Study||0
220186|NCT00695435|527680|P1|NOT COMPLETED|Overall Study||0
220187|NCT00695435|527678|P3|COMPLETED|Overall Study||7
220188|NCT00695435|527679|P2|COMPLETED|Overall Study||7
220189|NCT00695435|527680|P1|COMPLETED|Overall Study||7
220190|NCT00695435|527678|P3|STARTED|Overall Study||7
220191|NCT00695435|527679|P2|STARTED|Overall Study||7
220192|NCT00695435|527680|P1|STARTED|Overall Study||7
220193|NCT00695396|527694|P3|NOT COMPLETED|Overall Study||8
220194|NCT00695396|527695|P2|NOT COMPLETED|Overall Study||8
220195|NCT00695396|527696|P1|NOT COMPLETED|Overall Study||7
220196|NCT00695396|527694|P3|COMPLETED|Overall Study||1
220197|NCT00695396|527695|P2|COMPLETED|Overall Study||0
220198|NCT00695396|527696|P1|COMPLETED|Overall Study||1
220199|NCT00695396|527694|P3|STARTED|Overall Study||9
220200|NCT00695396|527695|P2|STARTED|Overall Study||8
220201|NCT00695396|527696|P1|STARTED|Overall Study||8
220202|NCT00695318|527712|P2|NOT COMPLETED|Overall Study||1
220203|NCT00695318|527713|P1|NOT COMPLETED|Overall Study||5
220204|NCT00695318|527712|P2|COMPLETED|Overall Study||6
220205|NCT00695318|527713|P1|COMPLETED|Overall Study||5
220206|NCT00695318|527712|P2|STARTED|Overall Study||7
220207|NCT00695318|527713|P1|STARTED|Overall Study||10
220208|NCT00695292|527724|P1|NOT COMPLETED|Overall Study||0
220209|NCT00695292|527724|P1|COMPLETED|Overall Study||37
220210|NCT00695292|527724|P1|STARTED|Overall Study||37
220211|NCT00695188|527731|P2|NOT COMPLETED|Overall Study||0
220212|NCT00695188|527732|P1|NOT COMPLETED|Overall Study||0
220213|NCT00695188|527731|P2|COMPLETED|Overall Study||9
220214|NCT00695188|527732|P1|COMPLETED|Overall Study||10
220215|NCT00695188|527731|P2|STARTED|Overall Study||9
220216|NCT00695188|527732|P1|STARTED|Overall Study||10
220217|NCT00695136|527738|P1|NOT COMPLETED|Overall Study||2
220218|NCT00695136|527738|P1|COMPLETED|Overall Study||5
220219|NCT00695136|527738|P1|STARTED|Overall Study|7|7
220220|NCT00695097|527744|P2|NOT COMPLETED|Overall Study||0
220221|NCT00695097|527745|P1|NOT COMPLETED|Overall Study||1
220222|NCT00695097|527744|P2|COMPLETED|Overall Study||5
220223|NCT00695097|527745|P1|COMPLETED|Overall Study||9
220224|NCT00695097|527744|P2|STARTED|Overall Study||5
220225|NCT00695097|527745|P1|STARTED|Overall Study||10
220226|NCT00695019|527754|P3|NOT COMPLETED|Overall Study||10
220227|NCT00695019|527755|P2|NOT COMPLETED|Overall Study||14
220228|NCT00695019|527756|P1|NOT COMPLETED|Overall Study||13
220229|NCT00695019|527754|P3|COMPLETED|Overall Study||47
220230|NCT00695019|527755|P2|COMPLETED|Overall Study||39
220231|NCT00695019|527756|P1|COMPLETED|Overall Study||46
220232|NCT00695019|527754|P3|STARTED|Overall Study||57
220233|NCT00695019|527755|P2|STARTED|Overall Study||53
220234|NCT00695019|527756|P1|STARTED|Overall Study||59
220235|NCT00694603|527785|P1|NOT COMPLETED|Overall Study||0
220236|NCT00694603|527785|P1|COMPLETED|Overall Study||18
220237|NCT00694603|527785|P1|STARTED|Overall Study||18
220238|NCT00694564|527790|P1|NOT COMPLETED|Overall Study||2
220239|NCT00694564|527790|P1|COMPLETED|Overall Study||6
220240|NCT00694564|527790|P1|STARTED|Overall Study||8
220241|NCT00694551|527797|P3|NOT COMPLETED|Overall Study||1
220242|NCT00694551|527798|P2|NOT COMPLETED|Overall Study||0
220243|NCT00694551|527799|P1|NOT COMPLETED|Overall Study||1
220244|NCT00694551|527797|P3|COMPLETED|Overall Study||8
220245|NCT00694551|527798|P2|COMPLETED|Overall Study||10
220246|NCT00694551|527799|P1|COMPLETED|Overall Study||9
220247|NCT00694551|527797|P3|STARTED|Overall Study||9
220248|NCT00694551|527798|P2|STARTED|Overall Study||10
220249|NCT00694551|527799|P1|STARTED|Overall Study||10
220250|NCT00694473|527813|P1|NOT COMPLETED|Overall Study||7
220251|NCT00694473|527813|P1|COMPLETED|Overall Study|Dec 2010|69
220252|NCT00694473|527813|P1|STARTED|Overall Study|Aug 2008|76
220253|NCT00694369|527828|P5|NOT COMPLETED|Overall Study||6
220254|NCT00694369|527829|P4|NOT COMPLETED|Overall Study||3
220255|NCT00694369|527830|P3|NOT COMPLETED|Overall Study||2
220256|NCT00694369|527831|P2|NOT COMPLETED|Overall Study||3
220257|NCT00694369|527832|P1|NOT COMPLETED|Overall Study||1
220258|NCT00694369|527828|P5|COMPLETED|Overall Study||56
220259|NCT00694369|527829|P4|COMPLETED|Overall Study||189
220260|NCT00694369|527830|P3|COMPLETED|Overall Study||95
220261|NCT00694369|527831|P2|COMPLETED|Overall Study||188
220262|NCT00694369|527832|P1|COMPLETED|Overall Study||45
220263|NCT00694369|527828|P5|STARTED|Overall Study||62
220264|NCT00694369|527829|P4|STARTED|Overall Study||192
220265|NCT00694369|527830|P3|STARTED|Overall Study||97
220266|NCT00694369|527831|P2|STARTED|Overall Study||191
220267|NCT00694369|527832|P1|STARTED|Overall Study||46
220268|NCT00694356|527852|P3|NOT COMPLETED|Overall Study||6
220269|NCT00694356|527853|P2|NOT COMPLETED|Overall Study||6
220270|NCT00694356|527854|P1|NOT COMPLETED|Overall Study||3
220271|NCT00694356|527852|P3|COMPLETED|Overall Study||0
220272|NCT00694356|527853|P2|COMPLETED|Overall Study||0
220273|NCT00694356|527854|P1|COMPLETED|Overall Study||0
220274|NCT00694356|527852|P3|STARTED|Overall Study||6
220275|NCT00694356|527853|P2|STARTED|Overall Study||6
220276|NCT00694356|527854|P1|STARTED|Overall Study||3
220277|NCT00694304|527889|P1|NOT COMPLETED|Overall Study||207
220278|NCT00694304|527889|P1|COMPLETED|Overall Study||328
220279|NCT00694304|527889|P1|STARTED|Overall Study||535
220280|NCT00694161|527902|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
220281|NCT00694161|527902|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
220282|NCT00694161|527902|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
220283|NCT00694161|527902|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
220284|NCT00694161|527902|P1|COMPLETED|Part 1 (up to Week 6)||35
220285|NCT00694161|527902|P1|STARTED|Part 1 (up to Week 6)||35
220286|NCT00694122|527941|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
220287|NCT00694122|527942|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
220288|NCT00694122|527941|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
220289|NCT00694122|527942|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
220290|NCT00694122|527941|P2|STARTED|Second Intervention (3-4 Weeks)||5
220291|NCT00694122|527942|P1|STARTED|Second Intervention (3-4 Weeks)||10
220292|NCT00694122|527941|P2|NOT COMPLETED|Washout (1 Day)||0
220293|NCT00694122|527942|P1|NOT COMPLETED|Washout (1 Day)||0
220294|NCT00694122|527941|P2|COMPLETED|Washout (1 Day)||5
220295|NCT00694122|527942|P1|COMPLETED|Washout (1 Day)||10
220296|NCT00694122|527941|P2|STARTED|Washout (1 Day)||5
220297|NCT00694122|527942|P1|STARTED|Washout (1 Day)||10
220298|NCT00694122|527941|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
220299|NCT00694122|527942|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
220300|NCT00694122|527941|P2|COMPLETED|First Intervention (3-4 Weeks)||5
220301|NCT00694122|527942|P1|COMPLETED|First Intervention (3-4 Weeks)||10
220302|NCT00694122|527941|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
220303|NCT00694122|527942|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
220304|NCT00694109|527958|P1|NOT COMPLETED|Overall Study||117
220305|NCT00694109|527958|P1|COMPLETED|Overall Study||25
220306|NCT00694109|527958|P1|Completed Consented Length of Treatment|Overall Study||60
220307|NCT00694109|527958|P1|Consented 2 Years Additional Treatment|Overall Study||42
220308|NCT00694109|527958|P1|Treated|Overall Study||141
220309|NCT00694109|527958|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
220310|NCT00694096|527982|P1|NOT COMPLETED|Overall Study||5
220311|NCT00694096|527982|P1|COMPLETED|Overall Study||20
220312|NCT00694096|527982|P1|STARTED|Overall Study||25
220313|NCT00694070|527988|P1|NOT COMPLETED|Overall Study||0
220314|NCT00694070|527988|P1|COMPLETED|Overall Study||51
220315|NCT00694070|527988|P1|STARTED|Overall Study||51
220316|NCT00694018|527996|P2|NOT COMPLETED|Overall Study||9
220317|NCT00694018|527997|P1|NOT COMPLETED|Overall Study||13
220318|NCT00694018|527996|P2|COMPLETED|Overall Study||102
220319|NCT00694018|527997|P1|COMPLETED|Overall Study||105
220320|NCT00694018|527996|P2|6 Months|Overall Study||101
220321|NCT00694018|527997|P1|6 Months|Overall Study||106
220322|NCT00694018|527996|P2|STARTED|Overall Study||111
220323|NCT00694018|527997|P1|STARTED|Overall Study||118
220324|NCT00693992|528005|P2|NOT COMPLETED|Overall Study||0
220325|NCT00693992|528006|P1|NOT COMPLETED|Overall Study||0
220326|NCT00693992|528005|P2|COMPLETED|Overall Study||104
220327|NCT00693992|528006|P1|COMPLETED|Overall Study||106
220328|NCT00693992|528005|P2|STARTED|Overall Study||104
220329|NCT00693992|528006|P1|STARTED|Overall Study||106
220330|NCT00693784|528022|P1|NOT COMPLETED|Overall Study||4
220331|NCT00693784|528022|P1|COMPLETED|Overall Study||11
220332|NCT00693784|528022|P1|104-week Extended Follow-up|Overall Study||11
220333|NCT00693784|528022|P1|52-week Extended Follow-up|Overall Study||13
220334|NCT00693784|528022|P1|26-Week Primary Endpoint|Overall Study||15
220335|NCT00693784|528022|P1|STARTED|Overall Study||15
220336|NCT00693719|528028|P1|NOT COMPLETED|Overall Study||0
220337|NCT00693719|528028|P1|COMPLETED|Overall Study||31
220338|NCT00693719|528028|P1|STARTED|Overall Study||31
220339|NCT00693706|528035|P2|NOT COMPLETED|Overall Study||1
220340|NCT00693706|528036|P1|NOT COMPLETED|Overall Study||0
220341|NCT00693706|528035|P2|COMPLETED|Overall Study||98
220342|NCT00693706|528036|P1|COMPLETED|Overall Study||101
220343|NCT00693706|528035|P2|STARTED|Overall Study||99
220344|NCT00693706|528036|P1|STARTED|Overall Study||101
220345|NCT00693693|528063|P3|NOT COMPLETED|Overall Study||2
220346|NCT00693693|528064|P2|NOT COMPLETED|Overall Study||1
220347|NCT00693693|528065|P1|NOT COMPLETED|Overall Study||1
220348|NCT00693693|528063|P3|COMPLETED|Overall Study||7
220349|NCT00693693|528064|P2|COMPLETED|Overall Study||8
220350|NCT00693693|528065|P1|COMPLETED|Overall Study||6
220351|NCT00693693|528063|P3|STARTED|Overall Study||9
220352|NCT00693693|528064|P2|STARTED|Overall Study||9
220353|NCT00693693|528065|P1|STARTED|Overall Study||7
220354|NCT00693654|528075|P2|NOT COMPLETED|Overall Study||0
220355|NCT00693654|528076|P1|NOT COMPLETED|Overall Study||0
220356|NCT00693654|528075|P2|COMPLETED|Overall Study||14
220357|NCT00693654|528076|P1|COMPLETED|Overall Study||14
220358|NCT00693654|528075|P2|STARTED|Overall Study||14
220359|NCT00693654|528076|P1|STARTED|Overall Study||14
220360|NCT00693628|528086|P2|NOT COMPLETED|Overall Study||0
220361|NCT00693628|528087|P1|NOT COMPLETED|Overall Study||0
220362|NCT00693628|528086|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
220363|NCT00693628|528087|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
220364|NCT00693628|528086|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
220365|NCT00693628|528087|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
220366|NCT00693498|528095|P2|NOT COMPLETED|Overall Study||0
220367|NCT00693498|528096|P1|NOT COMPLETED|Overall Study||0
220368|NCT00693498|528095|P2|COMPLETED|Overall Study||81
220369|NCT00693498|528096|P1|COMPLETED|Overall Study||81
220370|NCT00693498|528095|P2|STARTED|Overall Study||81
220371|NCT00693498|528096|P1|STARTED|Overall Study||81
220372|NCT00693485|528107|P3|NOT COMPLETED|Overall Study||0
220373|NCT00693485|528108|P2|NOT COMPLETED|Overall Study||2
220374|NCT00693485|528109|P1|NOT COMPLETED|Overall Study||0
220375|NCT00693485|528107|P3|COMPLETED|Overall Study||24
220376|NCT00693485|528108|P2|COMPLETED|Overall Study||19
220377|NCT00693485|528109|P1|COMPLETED|Overall Study||25
220378|NCT00693485|528107|P3|STARTED|Overall Study||24
220379|NCT00693485|528108|P2|STARTED|Overall Study||21
220380|NCT00693485|528109|P1|STARTED|Overall Study||25
220381|NCT00693472|528124|P4|NOT COMPLETED|Part 2||2
220382|NCT00693472|528125|P3|NOT COMPLETED|Part 2||2
220383|NCT00693472|528126|P2|NOT COMPLETED|Part 2||0
220384|NCT00693472|528127|P1|NOT COMPLETED|Part 2||0
220385|NCT00693472|528124|P4|COMPLETED|Part 2||4
220386|NCT00693472|528125|P3|COMPLETED|Part 2||6
220387|NCT00693472|528126|P2|COMPLETED|Part 2||0
220388|NCT00693472|528127|P1|COMPLETED|Part 2||0
220389|NCT00693472|528124|P4|STARTED|Part 2||6
220390|NCT00693472|528125|P3|STARTED|Part 2||8
220391|NCT00693472|528126|P2|STARTED|Part 2||0
220392|NCT00693472|528127|P1|STARTED|Part 2||0
220393|NCT00693472|528124|P4|NOT COMPLETED|Part 1||0
220394|NCT00693472|528125|P3|NOT COMPLETED|Part 1||0
220395|NCT00693472|528126|P2|NOT COMPLETED|Part 1||4
220396|NCT00693472|528127|P1|NOT COMPLETED|Part 1||6
220397|NCT00693472|528124|P4|COMPLETED|Part 1||0
220398|NCT00693472|528125|P3|COMPLETED|Part 1||0
220399|NCT00693472|528126|P2|COMPLETED|Part 1||9
220400|NCT00693472|528127|P1|COMPLETED|Part 1||13
220401|NCT00693472|528124|P4|STARTED|Part 1||0
220402|NCT00693472|528125|P3|STARTED|Part 1||0
220403|NCT00693472|528126|P2|STARTED|Part 1||13
220404|NCT00693472|528127|P1|STARTED|Part 1||19
220405|NCT00693420|528147|P2|NOT COMPLETED|Overall Study||15
220406|NCT00693420|528148|P1|NOT COMPLETED|Overall Study||6
220407|NCT00693420|528147|P2|COMPLETED|Overall Study||126
220408|NCT00693420|528148|P1|COMPLETED|Overall Study||131
220409|NCT00693420|528147|P2|STARTED|Overall Study||141
220410|NCT00693420|528148|P1|STARTED|Overall Study||137
220411|NCT00693303|528172|P1|NOT COMPLETED|Overall Study||0
220412|NCT00693303|528172|P1|COMPLETED|Overall Study||21
220413|NCT00693303|528172|P1|STARTED|Overall Study||21
220414|NCT00693238|528178|P2|NOT COMPLETED|Overall Study||0
220415|NCT00693238|528179|P1|NOT COMPLETED|Overall Study||0
220416|NCT00693238|528178|P2|COMPLETED|Overall Study||106
220417|NCT00693238|528179|P1|COMPLETED|Overall Study||122
220418|NCT00693238|528178|P2|STARTED|Overall Study||106
220419|NCT00693238|528179|P1|STARTED|Overall Study||122
220420|NCT00693225|528187|P2|NOT COMPLETED|Overall Study||5
220421|NCT00693225|528188|P1|NOT COMPLETED|Overall Study||2
220422|NCT00693225|528187|P2|COMPLETED|Overall Study||43
220423|NCT00693225|528188|P1|COMPLETED|Overall Study||41
220424|NCT00693225|528187|P2|STARTED|Overall Study||48
220425|NCT00693225|528188|P1|STARTED|Overall Study||43
220426|NCT00693160|528200|P2|NOT COMPLETED|Overall Study||0
220427|NCT00693160|528201|P1|NOT COMPLETED|Overall Study||0
220428|NCT00693160|528200|P2|COMPLETED|Overall Study||16
220429|NCT00693160|528201|P1|COMPLETED|Overall Study||14
220430|NCT00693160|528200|P2|STARTED|Overall Study||16
220431|NCT00693160|528201|P1|STARTED|Overall Study||14
220432|NCT00693017|528211|P2|NOT COMPLETED|Overall Study||2
220433|NCT00693017|528212|P1|NOT COMPLETED|Overall Study||2
220434|NCT00693017|528211|P2|COMPLETED|Overall Study||0
220435|NCT00693017|528212|P1|COMPLETED|Overall Study||0
220436|NCT00693017|528211|P2|STARTED|Overall Study||2
220437|NCT00693017|528212|P1|STARTED|Overall Study||2
220438|NCT00692913|528222|P2|NOT COMPLETED|Overall Study||30
220439|NCT00692913|528223|P1|NOT COMPLETED|Overall Study||29
220440|NCT00692913|528222|P2|COMPLETED|Overall Study||228
220441|NCT00692913|528223|P1|COMPLETED|Overall Study||228
220442|NCT00692913|528222|P2|STARTED|Overall Study||258
220443|NCT00692913|528223|P1|STARTED|Overall Study||257
220444|NCT00692770|528245|P2|NOT COMPLETED|Overall Study||558
220445|NCT00692770|528246|P1|NOT COMPLETED|Overall Study||556
220446|NCT00692770|528245|P2|COMPLETED|Overall Study||0
220447|NCT00692770|528246|P1|COMPLETED|Overall Study||0
220448|NCT00692770|528245|P2|Participants Received Treatment|Overall Study||554
220449|NCT00692770|528246|P1|Participants Received Treatment|Overall Study||553
220450|NCT00692770|528245|P2|STARTED|Overall Study||558
220451|NCT00692770|528246|P1|STARTED|Overall Study||556
220452|NCT00692692|528270|P2|NOT COMPLETED|Overall Study||0
220453|NCT00692692|528271|P1|NOT COMPLETED|Overall Study||0
220454|NCT00692692|528270|P2|COMPLETED|Overall Study||16
220455|NCT00692692|528271|P1|COMPLETED|Overall Study||20
220456|NCT00692692|528270|P2|STARTED|Overall Study||16
220457|NCT00692692|528271|P1|STARTED|Overall Study||20
220458|NCT00692419|528281|P2|NOT COMPLETED|Overall Study||18
220459|NCT00692419|528282|P1|NOT COMPLETED|Overall Study||16
220460|NCT00692419|528281|P2|COMPLETED|Overall Study||102
220461|NCT00692419|528282|P1|COMPLETED|Overall Study||84
220462|NCT00692419|528281|P2|STARTED|Overall Study||120
220463|NCT00692419|528282|P1|STARTED|Overall Study||100
220464|NCT00692406|528292|P1|NOT COMPLETED|Overall Study||57
220465|NCT00692406|528292|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
220466|NCT00692406|528292|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
220467|NCT00692341|528306|P3|NOT COMPLETED|Overall Study||0
220468|NCT00692341|528307|P2|NOT COMPLETED|Overall Study||0
220469|NCT00692341|528308|P1|NOT COMPLETED|Overall Study||0
220470|NCT00692341|528306|P3|COMPLETED|Overall Study||8
220471|NCT00692341|528307|P2|COMPLETED|Overall Study||8
220472|NCT00692341|528308|P1|COMPLETED|Overall Study||8
220473|NCT00692341|528306|P3|STARTED|Overall Study||8
220474|NCT00692341|528307|P2|STARTED|Overall Study||8
220475|NCT00692341|528308|P1|STARTED|Overall Study||8
220476|NCT00692237|528354|P2|NOT COMPLETED|Overall Study||4
220477|NCT00692237|528355|P1|NOT COMPLETED|Overall Study||1
220478|NCT00692237|528354|P2|COMPLETED|Overall Study||25
220479|NCT00692237|528355|P1|COMPLETED|Overall Study||29
220480|NCT00692237|528354|P2|STARTED|Overall Study||29
220481|NCT00692237|528355|P1|STARTED|Overall Study||30
220482|NCT00692211|528365|P2|NOT COMPLETED|Overall Study||0
220483|NCT00692211|528366|P1|NOT COMPLETED|Overall Study||0
220484|NCT00692211|528365|P2|COMPLETED|Overall Study||202
220485|NCT00692211|528366|P1|COMPLETED|Overall Study||202
220486|NCT00692211|528365|P2|STARTED|Overall Study||202
220487|NCT00692211|528366|P1|STARTED|Overall Study||202
220488|NCT00692198|528374|P2|NOT COMPLETED|Overall Study||0
220489|NCT00692198|528375|P1|NOT COMPLETED|Overall Study||0
220490|NCT00692198|528374|P2|COMPLETED|Overall Study||370
220491|NCT00692198|528375|P1|COMPLETED|Overall Study||368
220492|NCT00692198|528374|P2|STARTED|Overall Study||370
220493|NCT00692198|528375|P1|STARTED|Overall Study||368
220494|NCT00692185|528410|P2|NOT COMPLETED|Overall Study||3
220495|NCT00692185|528411|P1|NOT COMPLETED|Overall Study||3
220496|NCT00692185|528410|P2|COMPLETED|Overall Study||9
220497|NCT00692185|528411|P1|COMPLETED|Overall Study||8
220498|NCT00692185|528410|P2|STARTED|Overall Study||12
220499|NCT00692185|528411|P1|STARTED|Overall Study||11
220500|NCT00692003|528419|P2|NOT COMPLETED|Overall Study||1
220501|NCT00692003|528420|P1|NOT COMPLETED|Overall Study||5
220502|NCT00692003|528419|P2|COMPLETED|Overall Study||0
220503|NCT00692003|528420|P1|COMPLETED|Overall Study||0
220504|NCT00692003|528419|P2|STARTED|Overall Study||1
220505|NCT00692003|528420|P1|STARTED|Overall Study||5
220506|NCT00691938|528435|P7|NOT COMPLETED|Overall Study||0
220507|NCT00691938|528436|P6|NOT COMPLETED|Overall Study||0
220508|NCT00691938|528437|P5|NOT COMPLETED|Overall Study||0
220509|NCT00691938|528438|P4|NOT COMPLETED|Overall Study||0
220510|NCT00691938|528439|P3|NOT COMPLETED|Overall Study||0
220511|NCT00691938|528440|P2|NOT COMPLETED|Overall Study||0
220512|NCT00691938|528441|P1|NOT COMPLETED|Overall Study||1
220513|NCT00691938|528435|P7|COMPLETED|Overall Study||14
220514|NCT00691938|528436|P6|COMPLETED|Overall Study||6
220515|NCT00691938|528437|P5|COMPLETED|Overall Study||10
220516|NCT00691938|528438|P4|COMPLETED|Overall Study||8
220517|NCT00691938|528439|P3|COMPLETED|Overall Study||6
220518|NCT00691938|528440|P2|COMPLETED|Overall Study||3
220519|NCT00691938|528441|P1|COMPLETED|Overall Study||4
220520|NCT00691938|528435|P7|STARTED|Overall Study||14
220521|NCT00691938|528436|P6|STARTED|Overall Study||6
220522|NCT00691938|528437|P5|STARTED|Overall Study||10
220523|NCT00691938|528438|P4|STARTED|Overall Study||8
220524|NCT00691938|528439|P3|STARTED|Overall Study||6
220525|NCT00691938|528440|P2|STARTED|Overall Study||3
220526|NCT00691938|528441|P1|STARTED|Overall Study||5
220527|NCT00691808|528465|P3|NOT COMPLETED|Overall Study||0
220528|NCT00691808|528466|P2|NOT COMPLETED|Overall Study||1
220529|NCT00691808|528467|P1|NOT COMPLETED|Overall Study||0
220530|NCT00691808|528465|P3|COMPLETED|Overall Study||32
220531|NCT00691808|528466|P2|COMPLETED|Overall Study||35
220532|NCT00691808|528467|P1|COMPLETED|Overall Study||35
220533|NCT00691808|528465|P3|STARTED|Overall Study||32
220534|NCT00691808|528466|P2|STARTED|Overall Study||36
220535|NCT00691808|528467|P1|STARTED|Overall Study||35
220536|NCT00691704|528508|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
220537|NCT00691704|528508|P1|COMPLETED|Two Years of Maintenance Therapy||3
220538|NCT00691704|528508|P1|STARTED|Two Years of Maintenance Therapy||16
220539|NCT00691704|528508|P1|NOT COMPLETED|Induction Therapy||2
220540|NCT00691704|528508|P1|COMPLETED|Induction Therapy||16
220541|NCT00691704|528508|P1|STARTED|Induction Therapy||18
220542|NCT00691665|528518|P2|NOT COMPLETED|Overall Study||0
220543|NCT00691665|528519|P1|NOT COMPLETED|Overall Study||0
220544|NCT00691665|528518|P2|COMPLETED|Overall Study||65
220545|NCT00691665|528519|P1|COMPLETED|Overall Study||65
220546|NCT00691665|528518|P2|STARTED|Overall Study||65
220547|NCT00691665|528519|P1|STARTED|Overall Study||65
220548|NCT00691652|528531|P1|NOT COMPLETED|Overall Study||1
220549|NCT00691652|528531|P1|COMPLETED|Overall Study||1
220550|NCT00691652|528531|P1|STARTED|Overall Study||2
220551|NCT00691483|528537|P2|NOT COMPLETED|Overall Study||25
220552|NCT00691483|528538|P1|NOT COMPLETED|Overall Study||68
220553|NCT00691483|528537|P2|COMPLETED|Overall Study||141
220554|NCT00691483|528538|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
220555|NCT00691483|528537|P2|Received Treatment|Overall Study||165
220556|NCT00691483|528538|P1|Received Treatment|Overall Study||486
220557|NCT00691483|528537|P2|STARTED|Overall Study||166
220558|NCT00691483|528538|P1|STARTED|Overall Study||493
220559|NCT00691327|528556|P2|NOT COMPLETED|Overall Study||2508
220560|NCT00691327|528557|P1|NOT COMPLETED|Overall Study||2841
220561|NCT00691327|528556|P2|COMPLETED|Overall Study||36766
220562|NCT00691327|528557|P1|COMPLETED|Overall Study||42214
220563|NCT00691327|528556|P2|STARTED|Overall Study||39274
220564|NCT00691327|528557|P1|STARTED|Overall Study||45055
220565|NCT00691301|528565|P1|NOT COMPLETED|Overall Study||54
220566|NCT00691301|528565|P1|COMPLETED|Overall Study||1
220567|NCT00691301|528565|P1|STARTED|Overall Study||55
220568|NCT00691210|528585|P8|NOT COMPLETED|Overall Study||0
220569|NCT00691210|528586|P7|NOT COMPLETED|Overall Study||0
220570|NCT00691210|528587|P6|NOT COMPLETED|Overall Study||1
220571|NCT00691210|528588|P5|NOT COMPLETED|Overall Study||0
220572|NCT00691210|528589|P4|NOT COMPLETED|Overall Study||3
220573|NCT00691210|528590|P3|NOT COMPLETED|Overall Study||0
220574|NCT00691210|528591|P2|NOT COMPLETED|Overall Study||0
220575|NCT00691210|528592|P1|NOT COMPLETED|Overall Study||0
220576|NCT00691210|528585|P8|COMPLETED|Overall Study||0
220577|NCT00691210|528586|P7|COMPLETED|Overall Study||6
220578|NCT00691210|528587|P6|COMPLETED|Overall Study||6
220579|NCT00691210|528588|P5|COMPLETED|Overall Study||5
220580|NCT00691210|528589|P4|COMPLETED|Overall Study||6
220581|NCT00691210|528590|P3|COMPLETED|Overall Study||3
220582|NCT00691210|528591|P2|COMPLETED|Overall Study||5
220583|NCT00691210|528592|P1|COMPLETED|Overall Study||3
220584|NCT00691210|528585|P8|STARTED|Overall Study||0
220585|NCT00691210|528586|P7|STARTED|Overall Study||6
220586|NCT00691210|528587|P6|STARTED|Overall Study||7
220587|NCT00691210|528588|P5|STARTED|Overall Study||5
220588|NCT00691210|528589|P4|STARTED|Overall Study||9
220589|NCT00691210|528590|P3|STARTED|Overall Study||3
220590|NCT00691210|528591|P2|STARTED|Overall Study||5
220591|NCT00691210|528592|P1|STARTED|Overall Study||3
220592|NCT00691197|528612|P2|NOT COMPLETED|Overall Study||5
220593|NCT00691197|528613|P1|NOT COMPLETED|Overall Study||11
220594|NCT00691197|528612|P2|COMPLETED|Overall Study||75
220595|NCT00691197|528613|P1|COMPLETED|Overall Study||155
220596|NCT00691197|528612|P2|STARTED|Overall Study||80
220597|NCT00691197|528613|P1|STARTED|Overall Study||166
220598|NCT00691132|528627|P2|NOT COMPLETED|Overall Study||13
220599|NCT00691132|528628|P1|NOT COMPLETED|Overall Study||12
220600|NCT00691132|528627|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
220601|NCT00691132|528628|P1|COMPLETED|Overall Study||41
220602|NCT00691132|528627|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
220603|NCT00691132|528628|P1|STARTED|Overall Study||53
220604|NCT00691093|528647|P1|NOT COMPLETED|Overall Study||7
220605|NCT00691093|528647|P1|COMPLETED|Overall Study||816
220606|NCT00691093|528647|P1|STARTED|Overall Study||823
220607|NCT00691054|528681|P1|NOT COMPLETED|Overall Study||1
220608|NCT00691054|528681|P1|COMPLETED|Overall Study||19
220609|NCT00691054|528681|P1|STARTED|Overall Study||20
220610|NCT00691028|528693|P4|NOT COMPLETED|Double-blind Period||0
220611|NCT00691028|528694|P3|NOT COMPLETED|Double-blind Period||9
220612|NCT00691028|528695|P2|NOT COMPLETED|Double-blind Period||13
220613|NCT00691028|528696|P1|NOT COMPLETED|Double-blind Period||13
220614|NCT00691028|528693|P4|COMPLETED|Double-blind Period||0
220615|NCT00691028|528694|P3|COMPLETED|Double-blind Period||95
220616|NCT00691028|528695|P2|COMPLETED|Double-blind Period||91
220617|NCT00691028|528696|P1|COMPLETED|Double-blind Period||86
220618|NCT00691028|528693|P4|STARTED|Double-blind Period||0
220619|NCT00691028|528694|P3|STARTED|Double-blind Period||104
220620|NCT00691028|528695|P2|STARTED|Double-blind Period||104
220621|NCT00691028|528696|P1|STARTED|Double-blind Period||99
220622|NCT00691028|528693|P4|NOT COMPLETED|Open-label Period||20
220623|NCT00691028|528694|P3|NOT COMPLETED|Open-label Period||0
220624|NCT00691028|528695|P2|NOT COMPLETED|Open-label Period||0
220625|NCT00691028|528696|P1|NOT COMPLETED|Open-label Period||0
220626|NCT00691028|528693|P4|COMPLETED|Open-label Period||307
220627|NCT00691028|528694|P3|COMPLETED|Open-label Period||0
220628|NCT00691028|528695|P2|COMPLETED|Open-label Period||0
220629|NCT00691028|528696|P1|COMPLETED|Open-label Period||0
220630|NCT00691028|528693|P4|STARTED|Open-label Period||327
220631|NCT00691028|528694|P3|STARTED|Open-label Period||0
220632|NCT00691028|528695|P2|STARTED|Open-label Period||0
220633|NCT00691028|528696|P1|STARTED|Open-label Period||0
220634|NCT00691015|528729|P1|NOT COMPLETED|Overall Study||1
220635|NCT00691015|528729|P1|COMPLETED|Overall Study||47
220636|NCT00691015|528729|P1|STARTED|Overall Study||48
220637|NCT00690924|528740|P1|NOT COMPLETED|Overall Study||0
220638|NCT00690924|528740|P1|COMPLETED|Overall Study||16
220639|NCT00690924|528740|P1|STARTED|Overall Study||16
220640|NCT00690898|528744|P1|NOT COMPLETED|TREATMENT||26
220641|NCT00690898|528744|P1|COMPLETED|TREATMENT||64
220642|NCT00690898|528744|P1|STARTED|TREATMENT|Total number of patients treated.|90
220643|NCT00690898|528744|P1|NOT COMPLETED|SCREENING||18
220644|NCT00690898|528744|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
220645|NCT00690898|528744|P1|STARTED|SCREENING|Total of patients screened for the study.|108
220646|NCT00690833|528758|P1|NOT COMPLETED|Overall Study||2
220647|NCT00690833|528758|P1|COMPLETED|Overall Study||39
220648|NCT00690833|528758|P1|STARTED|Overall Study||41
220649|NCT00690820|528764|P2|NOT COMPLETED|Period 2||0
220650|NCT00690820|528765|P1|NOT COMPLETED|Period 2||0
220651|NCT00690820|528764|P2|COMPLETED|Period 2||8
220652|NCT00690820|528765|P1|COMPLETED|Period 2||8
220653|NCT00690820|528764|P2|STARTED|Period 2||8
220654|NCT00690820|528765|P1|STARTED|Period 2||8
220655|NCT00690820|528764|P2|NOT COMPLETED|Period 1||1
220656|NCT00690820|528765|P1|NOT COMPLETED|Period 1||0
220657|NCT00690820|528764|P2|COMPLETED|Period 1||8
220658|NCT00690820|528765|P1|COMPLETED|Period 1||8
220659|NCT00690820|528764|P2|STARTED|Period 1||9
220660|NCT00690820|528765|P1|STARTED|Period 1||8
220661|NCT00690794|528787|P2|NOT COMPLETED|Overall Study||35
220662|NCT00690794|528788|P1|NOT COMPLETED|Overall Study||21
220663|NCT00690794|528787|P2|COMPLETED|Overall Study||328
220664|NCT00690794|528788|P1|COMPLETED|Overall Study||342
220665|NCT00690794|528787|P2|STARTED|Overall Study||363
220666|NCT00690794|528788|P1|STARTED|Overall Study||363
220667|NCT00690755|528803|P7|NOT COMPLETED|Overall Study||0
220668|NCT00690755|528804|P6|NOT COMPLETED|Overall Study||4
220669|NCT00690755|528805|P5|NOT COMPLETED|Overall Study||0
220670|NCT00690755|528806|P4|NOT COMPLETED|Overall Study||5
220671|NCT00690755|528807|P3|NOT COMPLETED|Overall Study||46
220672|NCT00690755|528808|P2|NOT COMPLETED|Overall Study||0
220673|NCT00690755|528809|P1|NOT COMPLETED|Overall Study||2
220674|NCT00690755|528803|P7|COMPLETED|Overall Study||0
220675|NCT00690755|528804|P6|COMPLETED|Overall Study||6
220676|NCT00690755|528805|P5|COMPLETED|Overall Study||0
220677|NCT00690755|528806|P4|COMPLETED|Overall Study||15
220678|NCT00690755|528807|P3|COMPLETED|Overall Study||51
220679|NCT00690755|528808|P2|COMPLETED|Overall Study||0
220680|NCT00690755|528809|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
220681|NCT00690755|528803|P7|STARTED|Overall Study||0
220682|NCT00690755|528804|P6|STARTED|Overall Study||10
220683|NCT00690755|528805|P5|STARTED|Overall Study||0
220684|NCT00690755|528806|P4|STARTED|Overall Study||20
220685|NCT00690755|528807|P3|STARTED|Overall Study||97
220686|NCT00690755|528808|P2|STARTED|Overall Study||0
220687|NCT00690755|528809|P1|STARTED|Overall Study||30
220688|NCT00690612|528825|P1|NOT COMPLETED|Overall Study||3
220689|NCT00690612|528825|P1|COMPLETED|Overall Study||32
220690|NCT00690612|528825|P1|STARTED|Overall Study||35
220691|NCT00690573|528830|P1|NOT COMPLETED|Overall Study||9
220692|NCT00690573|528830|P1|COMPLETED|Overall Study||16
220693|NCT00690573|528830|P1|STARTED|Overall Study||25
220694|NCT00690495|528840|P2|NOT COMPLETED|Overall Study||0
220695|NCT00690495|528841|P1|NOT COMPLETED|Overall Study||0
220696|NCT00690495|528840|P2|COMPLETED|Overall Study||50
220697|NCT00690495|528841|P1|COMPLETED|Overall Study||50
220698|NCT00690495|528840|P2|Primary Endpoint|Overall Study||50
220699|NCT00690495|528841|P1|Primary Endpoint|Overall Study||50
220700|NCT00690495|528840|P2|STARTED|Overall Study||50
220701|NCT00690495|528841|P1|STARTED|Overall Study||50
220702|NCT00690482|528849|P2|NOT COMPLETED|Overall Study||3
220703|NCT00690482|528850|P1|NOT COMPLETED|Overall Study||4
220704|NCT00690482|528849|P2|COMPLETED|Overall Study||54
220705|NCT00690482|528850|P1|COMPLETED|Overall Study||57
220706|NCT00690482|528849|P2|STARTED|Overall Study||57
220707|NCT00690482|528850|P1|STARTED|Overall Study||61
220708|NCT00690443|528884|P2|NOT COMPLETED|Overall Study||2
220709|NCT00690443|528885|P1|NOT COMPLETED|Overall Study||1
220710|NCT00690443|528884|P2|COMPLETED|Overall Study||19
220711|NCT00690443|528885|P1|COMPLETED|Overall Study||22
220712|NCT00690443|528884|P2|STARTED|Overall Study||21
220713|NCT00690443|528885|P1|STARTED|Overall Study||23
220714|NCT00690430|528895|P3|NOT COMPLETED|Extension Phase||13
220715|NCT00690430|528896|P2|NOT COMPLETED|Extension Phase||5
220716|NCT00690430|528897|P1|NOT COMPLETED|Extension Phase||18
220717|NCT00690430|528895|P3|COMPLETED|Extension Phase||2
220718|NCT00690430|528896|P2|COMPLETED|Extension Phase||1
220719|NCT00690430|528897|P1|COMPLETED|Extension Phase||2
220720|NCT00690430|528895|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
220721|NCT00690430|528896|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
220722|NCT00690430|528897|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
220723|NCT00690430|528895|P3|NOT COMPLETED|Core Phase||0
220724|NCT00690430|528896|P2|NOT COMPLETED|Core Phase||23
220725|NCT00690430|528897|P1|NOT COMPLETED|Core Phase||18
220726|NCT00690430|528895|P3|COMPLETED|Core Phase||0
220727|NCT00690430|528896|P2|COMPLETED|Core Phase||34
220728|NCT00690430|528897|P1|COMPLETED|Core Phase||35
220729|NCT00690430|528895|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
220730|NCT00690430|528896|P2|STARTED|Core Phase||57
220731|NCT00690430|528897|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
220732|NCT00690378|528926|P2|NOT COMPLETED|Overall Study||14
220733|NCT00690378|528927|P1|NOT COMPLETED|Overall Study||20
220734|NCT00690378|528926|P2|COMPLETED|Overall Study|Up to LFU visit|54
220735|NCT00690378|528927|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
220736|NCT00690378|528926|P2|Treated|Overall Study||67
220737|NCT00690378|528927|P1|Treated|Overall Study||68
220738|NCT00690378|528926|P2|STARTED|Overall Study|Randomized|68
220739|NCT00690378|528927|P1|STARTED|Overall Study|Randomized|69
220740|NCT00690339|528975|P4|NOT COMPLETED|Overall Study||25
220741|NCT00690339|528976|P3|NOT COMPLETED|Overall Study||57
220742|NCT00690339|528977|P2|NOT COMPLETED|Overall Study||81
220743|NCT00690339|528978|P1|NOT COMPLETED|Overall Study||117
220744|NCT00690339|528975|P4|COMPLETED|Overall Study||43
220745|NCT00690339|528976|P3|COMPLETED|Overall Study||99
220746|NCT00690339|528977|P2|COMPLETED|Overall Study||144
220747|NCT00690339|528978|P1|COMPLETED|Overall Study||375
220748|NCT00690339|528975|P4|STARTED|Overall Study||68
220749|NCT00690339|528976|P3|STARTED|Overall Study||156
220750|NCT00690339|528977|P2|STARTED|Overall Study||225
220751|NCT00690339|528978|P1|STARTED|Overall Study||492
220752|NCT00690040|528994|P2|NOT COMPLETED|Overall Study||0
220753|NCT00690040|528995|P1|NOT COMPLETED|Overall Study||0
220754|NCT00690040|528994|P2|COMPLETED|Overall Study||148
220755|NCT00690040|528995|P1|COMPLETED|Overall Study||145
220756|NCT00690040|528994|P2|STARTED|Overall Study||148
220757|NCT00690040|528995|P1|STARTED|Overall Study||145
220758|NCT00689936|529004|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
220759|NCT00689936|529005|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
220760|NCT00689936|529006|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
220761|NCT00689936|529004|P3|COMPLETED|Long-Term Follow Up Phase||315
220762|NCT00689936|529005|P2|COMPLETED|Long-Term Follow Up Phase||275
220763|NCT00689936|529006|P1|COMPLETED|Long-Term Follow Up Phase||255
220764|NCT00689936|529004|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
220765|NCT00689936|529005|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
220766|NCT00689936|529006|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
220767|NCT00689936|529004|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
220768|NCT00689936|529005|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
220769|NCT00689936|529006|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
220770|NCT00689936|529004|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
220771|NCT00689936|529005|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
220772|NCT00689936|529006|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
220773|NCT00689936|529004|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
220774|NCT00689936|529005|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
220775|NCT00689936|529006|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
220776|NCT00689936|529004|P3|NOT COMPLETED|Active Treatment Phase||547
220777|NCT00689936|529005|P2|NOT COMPLETED|Active Treatment Phase||541
220778|NCT00689936|529006|P1|NOT COMPLETED|Active Treatment Phase||535
220779|NCT00689936|529004|P3|COMPLETED|Active Treatment Phase||0
220780|NCT00689936|529005|P2|COMPLETED|Active Treatment Phase||0
220781|NCT00689936|529006|P1|COMPLETED|Active Treatment Phase||0
220782|NCT00689936|529004|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
220783|NCT00689936|529005|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
220784|NCT00689936|529006|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
220785|NCT00689936|529004|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
220786|NCT00689936|529005|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
220787|NCT00689936|529006|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
220788|NCT00689936|529004|P3|STARTED|Active Treatment Phase||547
220789|NCT00689936|529005|P2|STARTED|Active Treatment Phase||541
220790|NCT00689936|529006|P1|STARTED|Active Treatment Phase||535
220791|NCT00689884|529146|P1|NOT COMPLETED|Overall Study||0
220792|NCT00689884|529146|P1|COMPLETED|Overall Study||7
220793|NCT00689884|529146|P1|STARTED|Overall Study||7
220794|NCT00689871|529155|P4|NOT COMPLETED|Overall Study||7
220795|NCT00689871|529156|P3|NOT COMPLETED|Overall Study||73
220796|NCT00689871|529157|P2|NOT COMPLETED|Overall Study||52
220797|NCT00689871|529158|P1|NOT COMPLETED|Overall Study||175
220798|NCT00689871|529155|P4|COMPLETED|Overall Study|4 Patients discontinued|8
220799|NCT00689871|529156|P3|COMPLETED|Overall Study|28 Patients discontinued|74
220800|NCT00689871|529157|P2|COMPLETED|Overall Study|35 Patients discontinued|46
220801|NCT00689871|529158|P1|COMPLETED|Overall Study|35 Patients discontinued|280
220802|NCT00689871|529155|P4|STARTED|Overall Study|25 Implants|15
220803|NCT00689871|529156|P3|STARTED|Overall Study|288 Implants|147
220804|NCT00689871|529157|P2|STARTED|Overall Study|127 Implants|98
220805|NCT00689871|529158|P1|STARTED|Overall Study|908 Implants|455
220806|NCT00689819|529174|P2|NOT COMPLETED|Overall Study||15
220807|NCT00689819|529175|P1|NOT COMPLETED|Overall Study||20
220808|NCT00689819|529174|P2|COMPLETED|Overall Study||43
220809|NCT00689819|529175|P1|COMPLETED|Overall Study||45
220810|NCT00689819|529174|P2|STARTED|Overall Study||58
220811|NCT00689819|529175|P1|STARTED|Overall Study||65
220812|NCT00689793|529185|P2|NOT COMPLETED|Overall Study||5
220813|NCT00689793|529186|P1|NOT COMPLETED|Overall Study||4
220814|NCT00689793|529185|P2|COMPLETED|Overall Study||71
220815|NCT00689793|529186|P1|COMPLETED|Overall Study||74
220816|NCT00689793|529185|P2|STARTED|Overall Study||76
220817|NCT00689793|529186|P1|STARTED|Overall Study||78
220818|NCT00689611|529204|P2|NOT COMPLETED|Overall Study||46
220819|NCT00689611|529205|P1|NOT COMPLETED|Overall Study||41
220820|NCT00689611|529204|P2|COMPLETED|Overall Study||146
220821|NCT00689611|529205|P1|COMPLETED|Overall Study||159
220822|NCT00689611|529204|P2|STARTED|Overall Study||192
220823|NCT00689611|529205|P1|STARTED|Overall Study||200
220824|NCT00689481|529215|P2|NOT COMPLETED|Overall Study||14
220825|NCT00689481|529216|P1|NOT COMPLETED|Overall Study||24
220826|NCT00689481|529215|P2|COMPLETED|Overall Study||95
220827|NCT00689481|529216|P1|COMPLETED|Overall Study||190
220828|NCT00689481|529215|P2|STARTED|Overall Study||109
220829|NCT00689481|529216|P1|STARTED|Overall Study||214
220830|NCT00689390|529234|P2|NOT COMPLETED|Overall Study||10
220831|NCT00689390|529235|P1|NOT COMPLETED|Overall Study||426
220832|NCT00689390|529234|P2|COMPLETED|Overall Study||37
220833|NCT00689390|529235|P1|COMPLETED|Overall Study||1481
220834|NCT00689390|529234|P2|STARTED|Overall Study||47
220835|NCT00689390|529235|P1|STARTED|Overall Study||1907
220836|NCT00689351|529253|P2|NOT COMPLETED|Toddler Dose||0
220837|NCT00689351|529254|P1|NOT COMPLETED|Toddler Dose||0
220838|NCT00689351|529253|P2|COMPLETED|Toddler Dose||88
220839|NCT00689351|529254|P1|COMPLETED|Toddler Dose||84
220840|NCT00689351|529253|P2|STARTED|Toddler Dose||88
220841|NCT00689351|529254|P1|STARTED|Toddler Dose||84
220842|NCT00689351|529253|P2|NOT COMPLETED|After Infant Series||0
220843|NCT00689351|529254|P1|NOT COMPLETED|After Infant Series||1
220844|NCT00689351|529253|P2|COMPLETED|After Infant Series||88
220845|NCT00689351|529254|P1|COMPLETED|After Infant Series||84
220846|NCT00689351|529253|P2|STARTED|After Infant Series||88
220847|NCT00689351|529254|P1|STARTED|After Infant Series||85
220848|NCT00689351|529253|P2|NOT COMPLETED|Infant Series of Dosing||1
220849|NCT00689351|529254|P1|NOT COMPLETED|Infant Series of Dosing||6
220850|NCT00689351|529253|P2|COMPLETED|Infant Series of Dosing||88
220851|NCT00689351|529254|P1|COMPLETED|Infant Series of Dosing||85
220852|NCT00689351|529253|P2|Vaccinated Dose 3|Infant Series of Dosing||88
220853|NCT00689351|529254|P1|Vaccinated Dose 3|Infant Series of Dosing||85
220854|NCT00689351|529253|P2|Vaccinated Dose 2|Infant Series of Dosing||88
220855|NCT00689351|529254|P1|Vaccinated Dose 2|Infant Series of Dosing||86
220856|NCT00689351|529253|P2|Vaccinated Dose 1|Infant Series of Dosing||89
220857|NCT00689351|529254|P1|Vaccinated Dose 1|Infant Series of Dosing||88
220858|NCT00689351|529253|P2|STARTED|Infant Series of Dosing||89
220859|NCT00689351|529254|P1|STARTED|Infant Series of Dosing||91
220860|NCT00689338|529286|P1|NOT COMPLETED|Overall Study||143
220861|NCT00689338|529286|P1|COMPLETED|Overall Study||73
220862|NCT00689338|529286|P1|STARTED|Overall Study||216
220863|NCT00689299|529299|P3|NOT COMPLETED|Overall Study||5
220864|NCT00689299|529300|P2|NOT COMPLETED|Overall Study||3
220865|NCT00689299|529301|P1|NOT COMPLETED|Overall Study||7
220866|NCT00689299|529299|P3|COMPLETED|Overall Study||49
220867|NCT00689299|529300|P2|COMPLETED|Overall Study||54
220868|NCT00689299|529301|P1|COMPLETED|Overall Study||51
220869|NCT00689299|529299|P3|STARTED|Overall Study||54
220870|NCT00689299|529300|P2|STARTED|Overall Study||57
220871|NCT00689299|529301|P1|STARTED|Overall Study||58
220872|NCT00689260|529311|P2|NOT COMPLETED|Overall Study||0
220873|NCT00689260|529312|P1|NOT COMPLETED|Overall Study||2
220874|NCT00689260|529311|P2|COMPLETED|Overall Study||21
220875|NCT00689260|529312|P1|COMPLETED|Overall Study||19
220876|NCT00689260|529311|P2|STARTED|Overall Study||21
220877|NCT00689260|529312|P1|STARTED|Overall Study||21
220878|NCT00689221|529330|P2|NOT COMPLETED|Overall Study||36
220879|NCT00689221|529331|P1|NOT COMPLETED|Overall Study||39
220880|NCT00689221|529330|P2|COMPLETED|Overall Study||237
220881|NCT00689221|529331|P1|COMPLETED|Overall Study||233
220882|NCT00689221|529330|P2|STARTED|Overall Study||273
220883|NCT00689221|529331|P1|STARTED|Overall Study||272
220884|NCT00689117|529360|P4|NOT COMPLETED|Overall Study||31
220885|NCT00689117|529361|P3|NOT COMPLETED|Overall Study||59
220886|NCT00689117|529362|P2|NOT COMPLETED|Overall Study||51
220887|NCT00689117|529363|P1|NOT COMPLETED|Overall Study||62
220888|NCT00689117|529360|P4|COMPLETED|Overall Study||211
220889|NCT00689117|529361|P3|COMPLETED|Overall Study||405
220890|NCT00689117|529362|P2|COMPLETED|Overall Study||416
220891|NCT00689117|529363|P1|COMPLETED|Overall Study||414
220892|NCT00689117|529360|P4|STARTED|Overall Study||242
220893|NCT00689117|529361|P3|STARTED|Overall Study||464
220894|NCT00689117|529362|P2|STARTED|Overall Study||467
220895|NCT00689117|529363|P1|STARTED|Overall Study||476
220896|NCT00689104|529393|P4|NOT COMPLETED|Overall Study||50
220897|NCT00689104|529394|P3|NOT COMPLETED|Overall Study||45
220898|NCT00689104|529395|P2|NOT COMPLETED|Overall Study||57
220899|NCT00689104|529396|P1|NOT COMPLETED|Overall Study||44
220900|NCT00689104|529393|P4|COMPLETED|Overall Study||445
220901|NCT00689104|529394|P3|COMPLETED|Overall Study||453
220902|NCT00689104|529395|P2|COMPLETED|Overall Study||440
220903|NCT00689104|529396|P1|COMPLETED|Overall Study||453
220904|NCT00689104|529393|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
220905|NCT00689104|529394|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
220906|NCT00689104|529395|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
220907|NCT00689104|529396|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
220908|NCT00689104|529393|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
220909|NCT00689104|529394|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
220910|NCT00689104|529395|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
220911|NCT00689104|529396|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
220912|NCT00689104|529393|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
220913|NCT00689104|529394|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
220914|NCT00689104|529395|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
220915|NCT00689104|529396|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
220916|NCT00689104|529393|P4|STARTED|Overall Study||495
220917|NCT00689104|529394|P3|STARTED|Overall Study||498
220918|NCT00689104|529395|P2|STARTED|Overall Study||497
220919|NCT00689104|529396|P1|STARTED|Overall Study||497
220920|NCT00689091|529528|P2|NOT COMPLETED|Overall Study||1394
220921|NCT00689091|529529|P1|NOT COMPLETED|Overall Study||1371
220922|NCT00689091|529528|P2|COMPLETED|Overall Study||9376
220923|NCT00689091|529529|P1|COMPLETED|Overall Study||9460
220924|NCT00689091|529528|P2|STARTED|Overall Study||10770
220925|NCT00689091|529529|P1|STARTED|Overall Study||10831
220926|NCT00689052|529549|P2|NOT COMPLETED|Overall Study||30
220927|NCT00689052|529550|P1|NOT COMPLETED|Overall Study||31
220928|NCT00689052|529549|P2|COMPLETED|Overall Study||0
220929|NCT00689052|529550|P1|COMPLETED|Overall Study||0
220930|NCT00689052|529549|P2|STARTED|Overall Study||30
220931|NCT00689052|529550|P1|STARTED|Overall Study||31
220932|NCT00689026|529582|P2|NOT COMPLETED|Overall Study||6
220933|NCT00689026|529583|P1|NOT COMPLETED|Overall Study||13
220934|NCT00689026|529582|P2|COMPLETED|Overall Study||24
220935|NCT00689026|529583|P1|COMPLETED|Overall Study||17
220936|NCT00689026|529582|P2|STARTED|Overall Study||30
220937|NCT00689026|529583|P1|STARTED|Overall Study||30
220938|NCT00688870|529591|P2|NOT COMPLETED|Toddler Dose||0
220939|NCT00688870|529592|P1|NOT COMPLETED|Toddler Dose||0
220940|NCT00688870|529591|P2|COMPLETED|Toddler Dose||84
220941|NCT00688870|529592|P1|COMPLETED|Toddler Dose||80
220942|NCT00688870|529591|P2|STARTED|Toddler Dose||84
220943|NCT00688870|529592|P1|STARTED|Toddler Dose||80
220944|NCT00688870|529591|P2|NOT COMPLETED|After Infant Series||0
220945|NCT00688870|529592|P1|NOT COMPLETED|After Infant Series||0
220946|NCT00688870|529591|P2|COMPLETED|After Infant Series||84
220947|NCT00688870|529592|P1|COMPLETED|After Infant Series||80
220948|NCT00688870|529591|P2|STARTED|After Infant Series||84
220949|NCT00688870|529592|P1|STARTED|After Infant Series||80
220950|NCT00688870|529591|P2|NOT COMPLETED|Infant Series||0
220951|NCT00688870|529592|P1|NOT COMPLETED|Infant Series||4
220952|NCT00688870|529591|P2|COMPLETED|Infant Series||84
220953|NCT00688870|529592|P1|COMPLETED|Infant Series||80
220954|NCT00688870|529591|P2|Vaccinated Dose 3|Infant Series||84
220955|NCT00688870|529592|P1|Vaccinated Dose 3|Infant Series||80
220956|NCT00688870|529591|P2|Vaccinated Dose 2|Infant Series||84
220957|NCT00688870|529592|P1|Vaccinated Dose 2|Infant Series||80
220958|NCT00688870|529591|P2|Vaccinated Dose 1|Infant Series||84
220959|NCT00688870|529592|P1|Vaccinated Dose 1|Infant Series||83
220960|NCT00688870|529591|P2|STARTED|Infant Series||84
220961|NCT00688870|529592|P1|STARTED|Infant Series||84
220962|NCT00688844|529624|P1|NOT COMPLETED|Overall Study||10
220963|NCT00688844|529624|P1|COMPLETED|Overall Study||48
220964|NCT00688844|529624|P1|STARTED|Overall Study||58
220965|NCT00688753|529634|P1|NOT COMPLETED|Overall Study||92
220966|NCT00688753|529634|P1|COMPLETED|Overall Study||0
220967|NCT00688753|529634|P1|STARTED|Overall Study||92
220968|NCT00688740|529645|P2|NOT COMPLETED|Overall Study||35
220969|NCT00688740|529646|P1|NOT COMPLETED|Overall Study||66
220970|NCT00688740|529645|P2|COMPLETED|Overall Study||711
220971|NCT00688740|529646|P1|COMPLETED|Overall Study||679
220972|NCT00688740|529645|P2|STARTED|Overall Study||746
220973|NCT00688740|529646|P1|STARTED|Overall Study||745
220974|NCT00688701|529659|P4|NOT COMPLETED|Overall Study||11
220975|NCT00688701|529660|P3|NOT COMPLETED|Overall Study||10
220976|NCT00688701|529661|P2|NOT COMPLETED|Overall Study||5
220977|NCT00688701|529662|P1|NOT COMPLETED|Overall Study||4
220978|NCT00688701|529659|P4|COMPLETED|Overall Study||108
220979|NCT00688701|529660|P3|COMPLETED|Overall Study||110
220980|NCT00688701|529661|P2|COMPLETED|Overall Study||56
220981|NCT00688701|529662|P1|COMPLETED|Overall Study||57
220982|NCT00688701|529659|P4|Subgroup for Standardized Meal Test|Overall Study||65
220983|NCT00688701|529660|P3|Subgroup for Standardized Meal Test|Overall Study||60
220984|NCT00688701|529661|P2|Subgroup for Standardized Meal Test|Overall Study||35
220985|NCT00688701|529662|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
220986|NCT00688701|529659|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
220987|NCT00688701|529660|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
220988|NCT00688701|529661|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
220989|NCT00688701|529662|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
220990|NCT00688701|529659|P4|Treated/Safety Population|Overall Study||119
220991|NCT00688701|529660|P3|Treated/Safety Population|Overall Study||120
220992|NCT00688701|529661|P2|Treated/Safety Population|Overall Study||61
220993|NCT00688701|529662|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
220994|NCT00688701|529659|P4|STARTED|Overall Study||119
220995|NCT00688701|529660|P3|STARTED|Overall Study||120
220996|NCT00688701|529661|P2|STARTED|Overall Study||61
220997|NCT00688701|529662|P1|STARTED|Overall Study|Randomized|61
220998|NCT00688688|529703|P3|NOT COMPLETED|Overall Study||192
220999|NCT00688688|529704|P2|NOT COMPLETED|Overall Study||179
221000|NCT00688688|529705|P1|NOT COMPLETED|Overall Study||186
221001|NCT00688688|529703|P3|COMPLETED|Overall Study||621
221002|NCT00688688|529704|P2|COMPLETED|Overall Study||645
221003|NCT00688688|529705|P1|COMPLETED|Overall Study||629
221004|NCT00688688|529703|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
221005|NCT00688688|529704|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
221006|NCT00688688|529705|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
221007|NCT00688688|529703|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
221008|NCT00688688|529704|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
221009|NCT00688688|529705|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
221010|NCT00688688|529703|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
221011|NCT00688688|529704|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
221012|NCT00688688|529705|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
221013|NCT00688688|529703|P3|STARTED|Overall Study||813
221014|NCT00688688|529704|P2|STARTED|Overall Study||824
221015|NCT00688688|529705|P1|STARTED|Overall Study||815
221016|NCT00688662|529796|P2|NOT COMPLETED|Overall Study||18
221017|NCT00688662|529797|P1|NOT COMPLETED|Overall Study||23
221018|NCT00688662|529796|P2|COMPLETED|Overall Study||55
221019|NCT00688662|529797|P1|COMPLETED|Overall Study||118
221020|NCT00688662|529796|P2|STARTED|Overall Study||73
221021|NCT00688662|529797|P1|STARTED|Overall Study||141
221022|NCT00688636|529807|P2|NOT COMPLETED|Overall Study||1
221023|NCT00688636|529808|P1|NOT COMPLETED|Overall Study||2
221024|NCT00688636|529807|P2|COMPLETED|Overall Study||12
221025|NCT00688636|529808|P1|COMPLETED|Overall Study||9
221026|NCT00688636|529807|P2|STARTED|Overall Study||13
221027|NCT00688636|529808|P1|STARTED|Overall Study||11
221028|NCT00688545|529824|P2|NOT COMPLETED|Overall Study||15
221029|NCT00688545|529825|P1|NOT COMPLETED|Overall Study||5
221030|NCT00688545|529824|P2|COMPLETED|Overall Study||204
221031|NCT00688545|529825|P1|COMPLETED|Overall Study||50
221032|NCT00688545|529824|P2|Switched Treatment at Least Once|Overall Study||13
221033|NCT00688545|529825|P1|Switched Treatment at Least Once|Overall Study||6
221034|NCT00688545|529824|P2|STARTED|Overall Study||219
221035|NCT00688545|529825|P1|STARTED|Overall Study||55
221036|NCT00688519|529835|P2|NOT COMPLETED|Overall Study||15
221037|NCT00688519|529836|P1|NOT COMPLETED|Overall Study||19
221038|NCT00688519|529835|P2|COMPLETED|Overall Study||98
221039|NCT00688519|529836|P1|COMPLETED|Overall Study||204
221040|NCT00688519|529835|P2|STARTED|Overall Study||113
221041|NCT00688519|529836|P1|STARTED|Overall Study||223
221042|NCT00688467|529854|P2|NOT COMPLETED|Treatment Period 2||2
221043|NCT00688467|529855|P1|NOT COMPLETED|Treatment Period 2||0
221044|NCT00688467|529854|P2|COMPLETED|Treatment Period 2||6
221045|NCT00688467|529855|P1|COMPLETED|Treatment Period 2||7
221046|NCT00688467|529854|P2|STARTED|Treatment Period 2||8
221047|NCT00688467|529855|P1|STARTED|Treatment Period 2||7
221048|NCT00688467|529854|P2|NOT COMPLETED|Treatment Period 1||2
221049|NCT00688467|529855|P1|NOT COMPLETED|Treatment Period 1||2
221050|NCT00688467|529854|P2|COMPLETED|Treatment Period 1||8
221051|NCT00688467|529855|P1|COMPLETED|Treatment Period 1||7
221052|NCT00688467|529854|P2|STARTED|Treatment Period 1||10
221053|NCT00688467|529855|P1|STARTED|Treatment Period 1||9
221054|NCT00688324|529885|P1|NOT COMPLETED|Overall Study||8
221055|NCT00688324|529885|P1|COMPLETED|Overall Study||28
221056|NCT00688324|529885|P1|STARTED|Overall Study||36
221057|NCT00688259|529930|P2|NOT COMPLETED|Overall Study||8
221058|NCT00688259|529931|P1|NOT COMPLETED|Overall Study||7
221059|NCT00688259|529930|P2|COMPLETED|Overall Study||36
221060|NCT00688259|529931|P1|COMPLETED|Overall Study||37
221061|NCT00688259|529930|P2|End to Active Treatment,|Overall Study||37
221062|NCT00688259|529931|P1|End to Active Treatment,|Overall Study||37
221063|NCT00688259|529930|P2|STARTED|Overall Study||44
221064|NCT00688259|529931|P1|STARTED|Overall Study||44
221065|NCT00688155|529951|P4|NOT COMPLETED|Overall Study||1
221066|NCT00688155|529952|P3|NOT COMPLETED|Overall Study||1
221067|NCT00688155|529953|P2|NOT COMPLETED|Overall Study||2
221068|NCT00688155|529954|P1|NOT COMPLETED|Overall Study||2
221069|NCT00688155|529951|P4|COMPLETED|Overall Study||17
221070|NCT00688155|529952|P3|COMPLETED|Overall Study||18
221071|NCT00688155|529953|P2|COMPLETED|Overall Study||16
221072|NCT00688155|529954|P1|COMPLETED|Overall Study||16
221073|NCT00688155|529951|P4|STARTED|Overall Study||18
221074|NCT00688155|529952|P3|STARTED|Overall Study||19
221075|NCT00688155|529953|P2|STARTED|Overall Study||18
221076|NCT00688155|529954|P1|STARTED|Overall Study||18
221077|NCT00688103|529974|P2|NOT COMPLETED|Overall Study||13
221078|NCT00688103|529975|P1|NOT COMPLETED|Overall Study||30
221079|NCT00688103|529974|P2|COMPLETED|Overall Study||64
221080|NCT00688103|529975|P1|COMPLETED|Overall Study||44
221081|NCT00688103|529974|P2|Actually Treated|Overall Study||76
221082|NCT00688103|529975|P1|Actually Treated|Overall Study||71
221083|NCT00688103|529974|P2|STARTED|Overall Study||77
221084|NCT00688103|529975|P1|STARTED|Overall Study||74
221085|NCT00688064|529987|P2|NOT COMPLETED|Overall Study||26
221086|NCT00688064|529988|P1|NOT COMPLETED|Overall Study||21
221087|NCT00688064|529987|P2|COMPLETED|Overall Study||201
221088|NCT00688064|529988|P1|COMPLETED|Overall Study||211
221089|NCT00688064|529987|P2|STARTED|Overall Study||227
221090|NCT00688064|529988|P1|STARTED|Overall Study||232
221091|NCT00687973|530004|P2|NOT COMPLETED|Overall Study||38
221092|NCT00687973|530005|P1|NOT COMPLETED|Overall Study||24
221093|NCT00687973|530004|P2|COMPLETED|Overall Study||162
221094|NCT00687973|530005|P1|COMPLETED|Overall Study||169
221095|NCT00687973|530004|P2|STARTED|Overall Study||200
221096|NCT00687973|530005|P1|STARTED|Overall Study||193
221097|NCT00687908|530034|P2|NOT COMPLETED|Overall Study||42
221098|NCT00687908|530035|P1|NOT COMPLETED|Overall Study||18
221099|NCT00687908|530034|P2|COMPLETED|Overall Study||78
221100|NCT00687908|530035|P1|COMPLETED|Overall Study||105
221101|NCT00687908|530034|P2|STARTED|Overall Study||120
221102|NCT00687908|530035|P1|STARTED|Overall Study||123
221103|NCT00687856|530049|P1|NOT COMPLETED|Overall Study||0
221104|NCT00687856|530049|P1|COMPLETED|Overall Study||211
221105|NCT00687856|530049|P1|STARTED|Overall Study||211
221106|NCT00687830|530055|P2|NOT COMPLETED|Overall Study||0
221107|NCT00687830|530056|P1|NOT COMPLETED|Overall Study||0
221108|NCT00687830|530055|P2|COMPLETED|Overall Study||68
221109|NCT00687830|530056|P1|COMPLETED|Overall Study||68
221110|NCT00687830|530055|P2|STARTED|Overall Study||68
221111|NCT00687830|530056|P1|STARTED|Overall Study||68
221112|NCT00687804|530067|P3|NOT COMPLETED|Open-Label Extension Study||11
221113|NCT00687804|530068|P2|NOT COMPLETED|Open-Label Extension Study||11
221114|NCT00687804|530069|P1|NOT COMPLETED|Open-Label Extension Study||10
221115|NCT00687804|530067|P3|COMPLETED|Open-Label Extension Study||63
221116|NCT00687804|530068|P2|COMPLETED|Open-Label Extension Study||72
221117|NCT00687804|530069|P1|COMPLETED|Open-Label Extension Study||73
221118|NCT00687804|530067|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
221119|NCT00687804|530068|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
221120|NCT00687804|530069|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
221121|NCT00687804|530067|P3|STARTED|Open-Label Extension Study||74
221122|NCT00687804|530068|P2|STARTED|Open-Label Extension Study||83
221123|NCT00687804|530069|P1|STARTED|Open-Label Extension Study||83
221124|NCT00687804|530067|P3|NOT COMPLETED|Core Study||13
221125|NCT00687804|530068|P2|NOT COMPLETED|Core Study||15
221126|NCT00687804|530069|P1|NOT COMPLETED|Core Study||14
221127|NCT00687804|530067|P3|COMPLETED|Core Study||98
221128|NCT00687804|530068|P2|COMPLETED|Core Study||103
221129|NCT00687804|530069|P1|COMPLETED|Core Study||102
221130|NCT00687804|530067|P3|STARTED|Core Study||111
221131|NCT00687804|530068|P2|STARTED|Core Study||118
221132|NCT00687804|530069|P1|STARTED|Core Study||116
221133|NCT00687713|530114|P2|NOT COMPLETED|Overall Study||40
221134|NCT00687713|530115|P1|NOT COMPLETED|Overall Study||32
221135|NCT00687713|530114|P2|COMPLETED|Overall Study||64
221136|NCT00687713|530115|P1|COMPLETED|Overall Study||68
221137|NCT00687713|530114|P2|STARTED|Overall Study||104
221138|NCT00687713|530115|P1|STARTED|Overall Study||100
221139|NCT00687674|530123|P1|NOT COMPLETED|Overall Study||2
221140|NCT00687674|530123|P1|COMPLETED|Overall Study||11
221141|NCT00687674|530123|P1|STARTED|Overall Study||13
221142|NCT00687609|530130|P1|NOT COMPLETED|Overall Study||3
221143|NCT00687609|530130|P1|COMPLETED|Overall Study||4
221144|NCT00687609|530130|P1|STARTED|Overall Study||7
221145|NCT00687544|530144|P1|NOT COMPLETED|Overall Study||11
221146|NCT00687544|530144|P1|COMPLETED|Overall Study||0
221147|NCT00687544|530144|P1|STARTED|Overall Study||11
221148|NCT00687531|530153|P1|NOT COMPLETED|Overall Study||135
221149|NCT00687531|530153|P1|COMPLETED|Overall Study||250
221150|NCT00687531|530153|P1|RECEIVED TREATMENT|Overall Study||281
221151|NCT00687531|530153|P1|STARTED|Overall Study|Completed screening procedures|385
221152|NCT00687453|530169|P2|NOT COMPLETED|Overall Study||6
221153|NCT00687453|530170|P1|NOT COMPLETED|Overall Study||3
221154|NCT00687453|530169|P2|COMPLETED|Overall Study||7
221155|NCT00687453|530170|P1|COMPLETED|Overall Study||8
221156|NCT00687453|530169|P2|STARTED|Overall Study||13
221157|NCT00687453|530170|P1|STARTED|Overall Study||11
221158|NCT00687440|530176|P1|NOT COMPLETED|Overall Study||12
221159|NCT00687440|530176|P1|COMPLETED|Overall Study||15
221160|NCT00687440|530176|P1|STARTED|Overall Study|Number of screened participants|27
221161|NCT00687401|530180|P1|NOT COMPLETED|Overall Study||30
221162|NCT00687401|530180|P1|COMPLETED|Overall Study||129
221163|NCT00687401|530180|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
221164|NCT00687362|530185|P1|NOT COMPLETED|Overall Study||3
221165|NCT00687362|530185|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
221166|NCT00687362|530185|P1|STARTED|Overall Study||22
221167|NCT00687323|530189|P1|NOT COMPLETED|Overall Study||180
221168|NCT00687323|530189|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
221169|NCT00687323|530189|P1|Received Treatment|Overall Study||47
221170|NCT00687323|530189|P1|STARTED|Overall Study|Number of screened participants|195
221171|NCT00687297|530205|P2|NOT COMPLETED|Maintenance||1
221172|NCT00687297|530206|P1|NOT COMPLETED|Maintenance||3
221173|NCT00687297|530205|P2|COMPLETED|Maintenance||25
221174|NCT00687297|530206|P1|COMPLETED|Maintenance||29
221175|NCT00687297|530205|P2|STARTED|Maintenance||26
221176|NCT00687297|530206|P1|STARTED|Maintenance||32
221177|NCT00687297|530205|P2|NOT COMPLETED|Induction||55
221178|NCT00687297|530206|P1|NOT COMPLETED|Induction||45
221179|NCT00687297|530205|P2|COMPLETED|Induction||26
221180|NCT00687297|530206|P1|COMPLETED|Induction||32
221181|NCT00687297|530205|P2|STARTED|Induction||81
221182|NCT00687297|530206|P1|STARTED|Induction||77
221183|NCT00687297|530205|P2|NOT COMPLETED|Randomization||1
221184|NCT00687297|530206|P1|NOT COMPLETED|Randomization||3
221185|NCT00687297|530205|P2|COMPLETED|Randomization||81
221186|NCT00687297|530206|P1|COMPLETED|Randomization||77
221187|NCT00687297|530205|P2|STARTED|Randomization||82
221188|NCT00687297|530206|P1|STARTED|Randomization||80
221189|NCT00687219|530216|P1|NOT COMPLETED|Overall Study||51
221190|NCT00687219|530216|P1|COMPLETED|Overall Study||51
221191|NCT00687219|530216|P1|STARTED|Overall Study||102
221192|NCT00687193|530228|P6|NOT COMPLETED|Overall Study||4
221193|NCT00687193|530229|P5|NOT COMPLETED|Overall Study||2
221194|NCT00687193|530230|P4|NOT COMPLETED|Overall Study||4
221195|NCT00687193|530231|P3|NOT COMPLETED|Overall Study||2
221196|NCT00687193|530232|P2|NOT COMPLETED|Overall Study||4
221197|NCT00687193|530233|P1|NOT COMPLETED|Overall Study||2
221198|NCT00687193|530228|P6|COMPLETED|Overall Study||48
221199|NCT00687193|530229|P5|COMPLETED|Overall Study||52
221200|NCT00687193|530230|P4|COMPLETED|Overall Study||49
221201|NCT00687193|530231|P3|COMPLETED|Overall Study||50
221202|NCT00687193|530232|P2|COMPLETED|Overall Study||49
221203|NCT00687193|530233|P1|COMPLETED|Overall Study||51
221204|NCT00687193|530228|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
221205|NCT00687193|530229|P5|STARTED|Overall Study||54
221206|NCT00687193|530230|P4|STARTED|Overall Study||53
221207|NCT00687193|530231|P3|STARTED|Overall Study||52
221208|NCT00687193|530232|P2|STARTED|Overall Study||53
221209|NCT00687193|530233|P1|STARTED|Overall Study||53
221210|NCT00687167|530397|P2|NOT COMPLETED|Second Intervention||0
221211|NCT00687167|530398|P1|NOT COMPLETED|Second Intervention||0
221212|NCT00687167|530397|P2|COMPLETED|Second Intervention||17
221213|NCT00687167|530398|P1|COMPLETED|Second Intervention||17
221214|NCT00687167|530397|P2|STARTED|Second Intervention||17
221215|NCT00687167|530398|P1|STARTED|Second Intervention||17
221216|NCT00687167|530397|P2|NOT COMPLETED|Washout Period of 28 Days||0
221217|NCT00687167|530398|P1|NOT COMPLETED|Washout Period of 28 Days||0
221218|NCT00687167|530397|P2|COMPLETED|Washout Period of 28 Days||17
221219|NCT00687167|530398|P1|COMPLETED|Washout Period of 28 Days||17
221220|NCT00687167|530397|P2|STARTED|Washout Period of 28 Days||17
221221|NCT00687167|530398|P1|STARTED|Washout Period of 28 Days||17
221222|NCT00687167|530397|P2|NOT COMPLETED|First Intervention||0
221223|NCT00687167|530398|P1|NOT COMPLETED|First Intervention||0
221224|NCT00687167|530397|P2|COMPLETED|First Intervention||17
221225|NCT00687167|530398|P1|COMPLETED|First Intervention||17
221226|NCT00687167|530397|P2|STARTED|First Intervention||17
221227|NCT00687167|530398|P1|STARTED|First Intervention||17
221228|NCT00687102|530408|P2|NOT COMPLETED|Overall Study||0
221229|NCT00687102|530409|P1|NOT COMPLETED|Overall Study||0
221230|NCT00687102|530408|P2|COMPLETED|Overall Study||765
221231|NCT00687102|530409|P1|COMPLETED|Overall Study||733
221232|NCT00687102|530408|P2|STARTED|Overall Study||765
221233|NCT00687102|530409|P1|STARTED|Overall Study||733
221234|NCT00687076|530431|P2|NOT COMPLETED|Overall Study||30
221235|NCT00687076|530432|P1|NOT COMPLETED|Overall Study||32
221236|NCT00687076|530431|P2|COMPLETED|Overall Study||21
221237|NCT00687076|530432|P1|COMPLETED|Overall Study||19
221238|NCT00687076|530431|P2|STARTED|Overall Study||51
221239|NCT00687076|530432|P1|STARTED|Overall Study||51
221240|NCT00686998|530443|P3|NOT COMPLETED|Overall Study||4
221241|NCT00686998|530444|P2|NOT COMPLETED|Overall Study||8
221242|NCT00686998|530445|P1|NOT COMPLETED|Overall Study||13
221243|NCT00686998|530443|P3|COMPLETED|Overall Study||18
221244|NCT00686998|530444|P2|COMPLETED|Overall Study||33
221245|NCT00686998|530445|P1|COMPLETED|Overall Study||30
221246|NCT00686998|530443|P3|Completed Scheduled Treatment|Overall Study||18
221247|NCT00686998|530444|P2|Completed Scheduled Treatment|Overall Study||33
221248|NCT00686998|530445|P1|Completed Scheduled Treatment|Overall Study||30
221249|NCT00686998|530443|P3|Eligible for Efficacy Analysis|Overall Study||21
221250|NCT00686998|530444|P2|Eligible for Efficacy Analysis|Overall Study||39
221251|NCT00686998|530445|P1|Eligible for Efficacy Analysis|Overall Study||42
221252|NCT00686998|530443|P3|Received Treatment|Overall Study||22
221253|NCT00686998|530444|P2|Received Treatment|Overall Study||41
221254|NCT00686998|530445|P1|Received Treatment|Overall Study||43
221255|NCT00686998|530443|P3|Randomized|Overall Study||22
221256|NCT00686998|530444|P2|Randomized|Overall Study||41
221257|NCT00686998|530445|P1|Randomized|Overall Study||43
221258|NCT00686998|530443|P3|STARTED|Overall Study|Randomized & received study medication|22
221259|NCT00686998|530444|P2|STARTED|Overall Study|Randomized & received study medication|41
221260|NCT00686998|530445|P1|STARTED|Overall Study|Randomized & received study medication|43
221261|NCT00686972|530453|P1|NOT COMPLETED|Overall Study||51
221262|NCT00686972|530453|P1|COMPLETED|Overall Study||0
221263|NCT00686972|530453|P1|STARTED|Overall Study||51
221264|NCT00686959|530459|P2|NOT COMPLETED|Overall Study||117
221265|NCT00686959|530460|P1|NOT COMPLETED|Overall Study||124
221266|NCT00686959|530459|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
221267|NCT00686959|530460|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
221268|NCT00686959|530459|P2|Entered Consolidation Phase|Overall Study||202
221269|NCT00686959|530460|P1|Entered Consolidation Phase|Overall Study||229
221270|NCT00686959|530459|P2|Received at Least One Dose of Study Drug|Overall Study||272
221271|NCT00686959|530460|P1|Received at Least One Dose of Study Drug|Overall Study||283
221272|NCT00686959|530459|P2|STARTED|Overall Study||297
221273|NCT00686959|530460|P1|STARTED|Overall Study||301
221274|NCT00686894|530478|P1|NOT COMPLETED|Overall Study||6
221275|NCT00686894|530478|P1|COMPLETED|Overall Study||1
221276|NCT00686894|530478|P1|STARTED|Overall Study||7
221277|NCT00686881|530484|P2|NOT COMPLETED|Overall Study||81
221278|NCT00686881|530485|P1|NOT COMPLETED|Overall Study||82
221279|NCT00686881|530484|P2|COMPLETED|Overall Study||53
221280|NCT00686881|530485|P1|COMPLETED|Overall Study||45
221281|NCT00686881|530484|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
221282|NCT00686881|530485|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
221283|NCT00686855|530497|P2|NOT COMPLETED|Overall Study||1
221284|NCT00686855|530498|P1|NOT COMPLETED|Overall Study||1
221285|NCT00686855|530497|P2|COMPLETED|Overall Study||17
221286|NCT00686855|530498|P1|COMPLETED|Overall Study||27
221287|NCT00686855|530497|P2|STARTED|Overall Study||18
221288|NCT00686855|530498|P1|STARTED|Overall Study||28
221289|NCT00686842|530504|P1|NOT COMPLETED|Overall Study||0
221290|NCT00686842|530504|P1|COMPLETED|Overall Study||17
221291|NCT00686842|530504|P1|STARTED|Overall Study||17
221292|NCT00686803|530511|P3|NOT COMPLETED|Overall Study||0
221293|NCT00686803|530512|P2|NOT COMPLETED|Overall Study||0
221294|NCT00686803|530513|P1|NOT COMPLETED|Overall Study||0
221295|NCT00686803|530511|P3|COMPLETED|Overall Study||3
221296|NCT00686803|530512|P2|COMPLETED|Overall Study||12
221297|NCT00686803|530513|P1|COMPLETED|Overall Study||6
221298|NCT00686803|530511|P3|STARTED|Overall Study||3
221299|NCT00686803|530512|P2|STARTED|Overall Study||12
221300|NCT00686803|530513|P1|STARTED|Overall Study||6
221301|NCT00686790|530524|P1|NOT COMPLETED|Overall Study||16
221302|NCT00686790|530524|P1|COMPLETED|Overall Study||32
221303|NCT00686790|530524|P1|STARTED|Overall Study||48
221304|NCT00686777|530532|P1|NOT COMPLETED|Overall Study||10
221305|NCT00686777|530532|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
221306|NCT00686777|530532|P1|Completed 24 Weeks of Follow-up|Overall Study||70
221307|NCT00686777|530532|P1|Included in Follow-up (All Treated)|Overall Study||75
221308|NCT00686777|530532|P1|Completed 48 Weeks of Treatment|Overall Study||65
221309|NCT00686777|530532|P1|Completed 24 Weeks of Treatment|Overall Study||69
221310|NCT00686777|530532|P1|STARTED|Overall Study||75
221311|NCT00686725|530540|P2|NOT COMPLETED|Overall Study||42
221312|NCT00686725|530541|P1|NOT COMPLETED|Overall Study||46
221313|NCT00686725|530540|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
221314|NCT00686725|530541|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
221315|NCT00686725|530540|P2|STARTED|Overall Study||52
221316|NCT00686725|530541|P1|STARTED|Overall Study||47
221317|NCT00686712|530566|P3|NOT COMPLETED|Overall Study||13
221318|NCT00686712|530567|P2|NOT COMPLETED|Overall Study||11
221319|NCT00686712|530568|P1|NOT COMPLETED|Overall Study||10
221320|NCT00686712|530566|P3|COMPLETED|Overall Study||17
221321|NCT00686712|530567|P2|COMPLETED|Overall Study||14
221322|NCT00686712|530568|P1|COMPLETED|Overall Study||20
221323|NCT00686712|530566|P3|STARTED|Overall Study||30
221324|NCT00686712|530567|P2|STARTED|Overall Study||25
221325|NCT00686712|530568|P1|STARTED|Overall Study||30
221326|NCT00686699|530596|P2|NOT COMPLETED|Treatment Period 2||0
221327|NCT00686699|530597|P1|NOT COMPLETED|Treatment Period 2||0
221328|NCT00686699|530596|P2|COMPLETED|Treatment Period 2||5
221329|NCT00686699|530597|P1|COMPLETED|Treatment Period 2||4
221330|NCT00686699|530596|P2|STARTED|Treatment Period 2||5
221331|NCT00686699|530597|P1|STARTED|Treatment Period 2||4
221332|NCT00686699|530596|P2|NOT COMPLETED|Treatment Period 1||2
221333|NCT00686699|530597|P1|NOT COMPLETED|Treatment Period 1||0
221334|NCT00686699|530596|P2|COMPLETED|Treatment Period 1||5
221335|NCT00686699|530597|P1|COMPLETED|Treatment Period 1||4
221336|NCT00686699|530596|P2|STARTED|Treatment Period 1||7
221337|NCT00686699|530597|P1|STARTED|Treatment Period 1||4
221338|NCT00686686|530621|P1|NOT COMPLETED|Overall Study||6
221339|NCT00686686|530621|P1|COMPLETED|Overall Study||17
221340|NCT00686686|530621|P1|STARTED|Overall Study||23
221341|NCT00686647|530629|P1|NOT COMPLETED|Overall Study||2
221342|NCT00686647|530629|P1|COMPLETED|Overall Study||91
221343|NCT00686647|530629|P1|STARTED|Overall Study||93
221344|NCT00686634|530635|P1|NOT COMPLETED|Overall Study||6
221345|NCT00686634|530635|P1|COMPLETED|Overall Study||102
221346|NCT00686634|530635|P1|STARTED|Overall Study||108
221347|NCT00686595|530642|P1|NOT COMPLETED|Overall Study||7
221348|NCT00686595|530642|P1|COMPLETED|Overall Study||31
221349|NCT00686595|530642|P1|STARTED|Overall Study||38
221350|NCT00686543|530671|P4|NOT COMPLETED|Overall Study||3
221351|NCT00686543|530672|P3|NOT COMPLETED|Overall Study||5
221352|NCT00686543|530673|P2|NOT COMPLETED|Overall Study||1
221353|NCT00686543|530674|P1|NOT COMPLETED|Overall Study||14
221354|NCT00686543|530671|P4|COMPLETED|Overall Study||17
221355|NCT00686543|530672|P3|COMPLETED|Overall Study||15
221356|NCT00686543|530673|P2|COMPLETED|Overall Study||20
221357|NCT00686543|530674|P1|COMPLETED|Overall Study||0
221358|NCT00686543|530671|P4|STARTED|Overall Study||20
221359|NCT00686543|530672|P3|STARTED|Overall Study||20
221360|NCT00686543|530673|P2|STARTED|Overall Study||21
221361|NCT00686543|530674|P1|STARTED|Overall Study||14
221362|NCT00686517|530695|P3|NOT COMPLETED|Follow-up||10
221363|NCT00686517|530696|P2|NOT COMPLETED|Follow-up||10
221364|NCT00686517|530697|P1|NOT COMPLETED|Follow-up||8
221365|NCT00686517|530695|P3|COMPLETED|Follow-up||29
221366|NCT00686517|530696|P2|COMPLETED|Follow-up||28
221367|NCT00686517|530697|P1|COMPLETED|Follow-up||29
221368|NCT00686517|530695|P3|STARTED|Follow-up||39
221369|NCT00686517|530696|P2|STARTED|Follow-up||38
221370|NCT00686517|530697|P1|STARTED|Follow-up||37
221371|NCT00686517|530695|P3|NOT COMPLETED|Treatment||1
221372|NCT00686517|530696|P2|NOT COMPLETED|Treatment||3
221373|NCT00686517|530697|P1|NOT COMPLETED|Treatment||6
221374|NCT00686517|530695|P3|COMPLETED|Treatment||42
221375|NCT00686517|530696|P2|COMPLETED|Treatment||40
221376|NCT00686517|530697|P1|COMPLETED|Treatment||38
221377|NCT00686517|530695|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
221378|NCT00686517|530696|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
221379|NCT00686517|530697|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
221380|NCT00686517|530695|P3|STARTED|Treatment||43
221381|NCT00686517|530696|P2|STARTED|Treatment||43
221382|NCT00686517|530697|P1|STARTED|Treatment||44
221383|NCT00686374|530720|P1|NOT COMPLETED|Overall Study||61
221384|NCT00686374|530720|P1|COMPLETED|Overall Study||39
221385|NCT00686374|530720|P1|STARTED|Overall Study||100
221386|NCT00686335|530731|P1|NOT COMPLETED|Treatment Period||0
221387|NCT00686335|530731|P1|COMPLETED|Treatment Period||7
221388|NCT00686335|530731|P1|STARTED|Treatment Period||7
221389|NCT00686335|530731|P1|NOT COMPLETED|Run-in Period||5
221390|NCT00686335|530731|P1|COMPLETED|Run-in Period||7
221391|NCT00686335|530731|P1|STARTED|Run-in Period||12
221392|NCT00686257|530739|P2|NOT COMPLETED|Overall Study||0
221393|NCT00686257|530740|P1|NOT COMPLETED|Overall Study||0
221394|NCT00686257|530739|P2|COMPLETED|Overall Study||31
221395|NCT00686257|530740|P1|COMPLETED|Overall Study||29
221396|NCT00686257|530739|P2|STARTED|Overall Study||31
221397|NCT00686257|530740|P1|STARTED|Overall Study||29
221398|NCT00686231|530749|P3|NOT COMPLETED|Overall Study||0
221399|NCT00686231|530750|P2|NOT COMPLETED|Overall Study||0
221400|NCT00686231|530751|P1|NOT COMPLETED|Overall Study||0
221401|NCT00686231|530749|P3|COMPLETED|Overall Study||20
221402|NCT00686231|530750|P2|COMPLETED|Overall Study||20
221403|NCT00686231|530751|P1|COMPLETED|Overall Study||20
221404|NCT00686231|530749|P3|STARTED|Overall Study||20
221405|NCT00686231|530750|P2|STARTED|Overall Study||20
221406|NCT00686231|530751|P1|STARTED|Overall Study||20
221407|NCT00686205|530761|P2|NOT COMPLETED|Overall Study||981
221408|NCT00686205|530762|P1|NOT COMPLETED|Overall Study||6007
221409|NCT00686205|530761|P2|COMPLETED|Overall Study||1524
221410|NCT00686205|530762|P1|COMPLETED|Overall Study||15599
221411|NCT00686205|530761|P2|STARTED|Overall Study||2505
221412|NCT00686205|530762|P1|STARTED|Overall Study||21606
221413|NCT00686166|530768|P1|NOT COMPLETED|Overall Study||20
221414|NCT00686166|530768|P1|COMPLETED|Overall Study||63
221415|NCT00686166|530768|P1|Eligible and Began Protocol Therapy|Overall Study||74
221416|NCT00686166|530768|P1|Eligible|Overall Study||78
221417|NCT00686166|530768|P1|STARTED|Overall Study||83
221418|NCT00686127|530780|P2|NOT COMPLETED|Overall Study||6
221419|NCT00686127|530781|P1|NOT COMPLETED|Overall Study||14
221420|NCT00686127|530780|P2|COMPLETED|Overall Study||1
221421|NCT00686127|530781|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
221422|NCT00686127|530780|P2|STARTED|Overall Study||7
221423|NCT00686127|530781|P1|STARTED|Overall Study||14
221424|NCT00686075|530797|P10|NOT COMPLETED|Overall Study||10
221425|NCT00686075|530798|P9|NOT COMPLETED|Overall Study||6
221426|NCT00686075|530799|P8|NOT COMPLETED|Overall Study||2
221427|NCT00686075|530800|P7|NOT COMPLETED|Overall Study||0
221428|NCT00686075|530801|P6|NOT COMPLETED|Overall Study||3
221429|NCT00686075|530802|P5|NOT COMPLETED|Overall Study||4
221430|NCT00686075|530803|P4|NOT COMPLETED|Overall Study||9
221431|NCT00686075|530804|P3|NOT COMPLETED|Overall Study||6
221432|NCT00686075|530805|P2|NOT COMPLETED|Overall Study||10
221433|NCT00686075|530806|P1|NOT COMPLETED|Overall Study||8
221434|NCT00686075|530797|P10|COMPLETED|Overall Study||69
221435|NCT00686075|530798|P9|COMPLETED|Overall Study||75
221436|NCT00686075|530799|P8|COMPLETED|Overall Study||76
221437|NCT00686075|530800|P7|COMPLETED|Overall Study||82
221438|NCT00686075|530801|P6|COMPLETED|Overall Study||37
221439|NCT00686075|530802|P5|COMPLETED|Overall Study||36
221440|NCT00686075|530803|P4|COMPLETED|Overall Study||71
221441|NCT00686075|530804|P3|COMPLETED|Overall Study||74
221442|NCT00686075|530805|P2|COMPLETED|Overall Study||71
221443|NCT00686075|530806|P1|COMPLETED|Overall Study||71
221444|NCT00686075|530797|P10|Treated|Overall Study||78
221445|NCT00686075|530798|P9|Treated|Overall Study||80
221446|NCT00686075|530799|P8|Treated|Overall Study||77
221447|NCT00686075|530800|P7|Treated|Overall Study||82
221448|NCT00686075|530801|P6|Treated|Overall Study||40
221449|NCT00686075|530802|P5|Treated|Overall Study||40
221450|NCT00686075|530803|P4|Treated|Overall Study||80
221451|NCT00686075|530804|P3|Treated|Overall Study||80
221452|NCT00686075|530805|P2|Treated|Overall Study||79
221453|NCT00686075|530806|P1|Treated|Overall Study||78
221454|NCT00686075|530797|P10|STARTED|Overall Study||79
221455|NCT00686075|530798|P9|STARTED|Overall Study||81
221456|NCT00686075|530799|P8|STARTED|Overall Study||78
221457|NCT00686075|530800|P7|STARTED|Overall Study||82
221458|NCT00686075|530801|P6|STARTED|Overall Study||40
221459|NCT00686075|530802|P5|STARTED|Overall Study||40
221460|NCT00686075|530803|P4|STARTED|Overall Study||80
221461|NCT00686075|530804|P3|STARTED|Overall Study||80
221462|NCT00686075|530805|P2|STARTED|Overall Study||81
221463|NCT00686075|530806|P1|STARTED|Overall Study||79
221464|NCT00686036|531000|P2|NOT COMPLETED|Overall Study||6
221465|NCT00686036|531001|P1|NOT COMPLETED|Overall Study||9
221466|NCT00686036|531000|P2|COMPLETED|Overall Study||2
221467|NCT00686036|531001|P1|COMPLETED|Overall Study||0
221468|NCT00686036|531000|P2|STARTED|Overall Study||8
221469|NCT00686036|531001|P1|STARTED|Overall Study||9
221470|NCT00685945|531013|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
221471|NCT00685945|531013|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
221472|NCT00685945|531013|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
221473|NCT00685945|531013|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
221474|NCT00685945|531013|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
221475|NCT00685945|531013|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
221476|NCT00685945|531013|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
221477|NCT00685945|531013|P1|COMPLETED|L-NMMA + Bradykinin||23
221478|NCT00685945|531013|P1|STARTED|L-NMMA + Bradykinin||24
221479|NCT00685945|531013|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
221480|NCT00685945|531013|P1|COMPLETED|Control (Bradykinin Infusion)||24
221481|NCT00685945|531013|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
221482|NCT00685932|531030|P2|NOT COMPLETED|Overall Study||20
221483|NCT00685932|531031|P1|NOT COMPLETED|Overall Study||21
221484|NCT00685932|531030|P2|COMPLETED|Overall Study||58
221485|NCT00685932|531031|P1|COMPLETED|Overall Study||55
221486|NCT00685932|531030|P2|STARTED|Overall Study||78
221487|NCT00685932|531031|P1|STARTED|Overall Study||76
221488|NCT00685880|531041|P2|NOT COMPLETED|Overall Study||0
221489|NCT00685880|531042|P1|NOT COMPLETED|Overall Study||0
221490|NCT00685880|531041|P2|COMPLETED|Overall Study||2
221491|NCT00685880|531042|P1|COMPLETED|Overall Study||0
221492|NCT00685880|531041|P2|STARTED|Overall Study||2
221493|NCT00685880|531042|P1|STARTED|Overall Study||0
221494|NCT00685802|531048|P2|NOT COMPLETED|Second Intervention||0
221495|NCT00685802|531049|P1|NOT COMPLETED|Second Intervention||0
221496|NCT00685802|531048|P2|COMPLETED|Second Intervention||15
221497|NCT00685802|531049|P1|COMPLETED|Second Intervention||14
221498|NCT00685802|531048|P2|STARTED|Second Intervention||15
221499|NCT00685802|531049|P1|STARTED|Second Intervention||14
221500|NCT00685802|531048|P2|NOT COMPLETED|Washout Period of 7 Days||1
221501|NCT00685802|531049|P1|NOT COMPLETED|Washout Period of 7 Days||2
221502|NCT00685802|531048|P2|COMPLETED|Washout Period of 7 Days||15
221503|NCT00685802|531049|P1|COMPLETED|Washout Period of 7 Days||14
221504|NCT00685802|531048|P2|STARTED|Washout Period of 7 Days||16
221505|NCT00685802|531049|P1|STARTED|Washout Period of 7 Days||16
221506|NCT00685802|531048|P2|NOT COMPLETED|First Intervention||0
221507|NCT00685802|531049|P1|NOT COMPLETED|First Intervention||0
221508|NCT00685802|531048|P2|COMPLETED|First Intervention||16
221509|NCT00685802|531049|P1|COMPLETED|First Intervention||16
221510|NCT00685802|531048|P2|STARTED|First Intervention||16
221511|NCT00685802|531049|P1|STARTED|First Intervention||16
221512|NCT00685763|531059|P1|NOT COMPLETED|Overall Study||2
221513|NCT00685763|531059|P1|COMPLETED|Overall Study||11
221514|NCT00685763|531059|P1|STARTED|Overall Study||13
221515|NCT00685698|531063|P1|NOT COMPLETED|Overall Study||13
221516|NCT00685698|531063|P1|COMPLETED|Overall Study||25
221517|NCT00685698|531063|P1|STARTED|Overall Study||38
221518|NCT00685685|531098|P2|NOT COMPLETED|Second Intervention||0
221519|NCT00685685|531099|P1|NOT COMPLETED|Second Intervention||0
221520|NCT00685685|531098|P2|COMPLETED|Second Intervention||26
221521|NCT00685685|531099|P1|COMPLETED|Second Intervention||25
221522|NCT00685685|531098|P2|STARTED|Second Intervention||26
221523|NCT00685685|531099|P1|STARTED|Second Intervention||25
221524|NCT00685685|531098|P2|NOT COMPLETED|Washout Period of 7 Days||1
221525|NCT00685685|531099|P1|NOT COMPLETED|Washout Period of 7 Days||2
221526|NCT00685685|531098|P2|COMPLETED|Washout Period of 7 Days||26
221527|NCT00685685|531099|P1|COMPLETED|Washout Period of 7 Days||25
221528|NCT00685685|531098|P2|STARTED|Washout Period of 7 Days||27
221529|NCT00685685|531099|P1|STARTED|Washout Period of 7 Days||27
221530|NCT00685685|531098|P2|NOT COMPLETED|First Intervention||0
221531|NCT00685685|531099|P1|NOT COMPLETED|First Intervention||0
221532|NCT00685685|531098|P2|COMPLETED|First Intervention||27
221533|NCT00685685|531099|P1|COMPLETED|First Intervention||27
221534|NCT00685685|531098|P2|STARTED|First Intervention||27
221535|NCT00685685|531099|P1|STARTED|First Intervention||27
221536|NCT00685659|531112|P3|NOT COMPLETED|Overall Study||15
221537|NCT00685659|531113|P2|NOT COMPLETED|Overall Study||25
221538|NCT00685659|531114|P1|NOT COMPLETED|Overall Study||31
221539|NCT00685659|531112|P3|COMPLETED|Overall Study||92
221540|NCT00685659|531113|P2|COMPLETED|Overall Study||81
221541|NCT00685659|531114|P1|COMPLETED|Overall Study||77
221542|NCT00685659|531112|P3|STARTED|Overall Study||107
221543|NCT00685659|531113|P2|STARTED|Overall Study||106
221544|NCT00685659|531114|P1|STARTED|Overall Study||108
221545|NCT00685516|531212|P3|NOT COMPLETED|Overall Study||7
221546|NCT00685516|531213|P2|NOT COMPLETED|Overall Study||5
221547|NCT00685516|531214|P1|NOT COMPLETED|Overall Study||8
221548|NCT00685516|531212|P3|COMPLETED|Overall Study||26
221549|NCT00685516|531213|P2|COMPLETED|Overall Study||33
221550|NCT00685516|531214|P1|COMPLETED|Overall Study||34
221551|NCT00685516|531212|P3|STARTED|Overall Study||33
221552|NCT00685516|531213|P2|STARTED|Overall Study||38
221553|NCT00685516|531214|P1|STARTED|Overall Study||42
221554|NCT00685477|531231|P6|NOT COMPLETED|Overall Study||0
221555|NCT00685477|531232|P5|NOT COMPLETED|Overall Study||0
221556|NCT00685477|531233|P4|NOT COMPLETED|Overall Study||0
221557|NCT00685477|531234|P3|NOT COMPLETED|Overall Study||0
221558|NCT00685477|531235|P2|NOT COMPLETED|Overall Study||0
221559|NCT00685477|531236|P1|NOT COMPLETED|Overall Study||0
221560|NCT00685477|531231|P6|COMPLETED|Overall Study||10
221561|NCT00685477|531232|P5|COMPLETED|Overall Study||10
221562|NCT00685477|531233|P4|COMPLETED|Overall Study||10
221563|NCT00685477|531234|P3|COMPLETED|Overall Study||10
221564|NCT00685477|531235|P2|COMPLETED|Overall Study||10
221565|NCT00685477|531236|P1|COMPLETED|Overall Study||10
221566|NCT00685477|531231|P6|STARTED|Overall Study||10
221567|NCT00685477|531232|P5|STARTED|Overall Study||10
221568|NCT00685477|531233|P4|STARTED|Overall Study||10
221569|NCT00685477|531234|P3|STARTED|Overall Study||10
221570|NCT00685477|531235|P2|STARTED|Overall Study||10
221571|NCT00685477|531236|P1|STARTED|Overall Study||10
221572|NCT00685399|531252|P8|NOT COMPLETED|Extension||0
221573|NCT00685399|531253|P7|NOT COMPLETED|Extension||0
221574|NCT00685399|531254|P6|NOT COMPLETED|Extension||0
221575|NCT00685399|531255|P5|NOT COMPLETED|Extension||0
221576|NCT00685399|531256|P4|NOT COMPLETED|Extension||7
221577|NCT00685399|531257|P3|NOT COMPLETED|Extension||0
221578|NCT00685399|531258|P2|NOT COMPLETED|Extension||0
221579|NCT00685399|531259|P1|NOT COMPLETED|Extension||0
221580|NCT00685399|531252|P8|COMPLETED|Extension||0
221581|NCT00685399|531253|P7|COMPLETED|Extension||0
221582|NCT00685399|531254|P6|COMPLETED|Extension||0
221583|NCT00685399|531255|P5|COMPLETED|Extension||0
221584|NCT00685399|531256|P4|COMPLETED|Extension||21
221585|NCT00685399|531257|P3|COMPLETED|Extension||0
221586|NCT00685399|531258|P2|COMPLETED|Extension||0
221587|NCT00685399|531259|P1|COMPLETED|Extension||0
221588|NCT00685399|531252|P8|STARTED|Extension||0
221589|NCT00685399|531253|P7|STARTED|Extension||0
221590|NCT00685399|531254|P6|STARTED|Extension||0
221591|NCT00685399|531255|P5|STARTED|Extension||0
221592|NCT00685399|531256|P4|STARTED|Extension||28
221593|NCT00685399|531257|P3|STARTED|Extension||0
221594|NCT00685399|531258|P2|STARTED|Extension||0
221595|NCT00685399|531259|P1|STARTED|Extension||0
221596|NCT00685399|531252|P8|NOT COMPLETED|Treatment Period 2||2
221597|NCT00685399|531253|P7|NOT COMPLETED|Treatment Period 2||0
221598|NCT00685399|531254|P6|NOT COMPLETED|Treatment Period 2||2
221599|NCT00685399|531255|P5|NOT COMPLETED|Treatment Period 2||0
221600|NCT00685399|531256|P4|NOT COMPLETED|Treatment Period 2||0
221601|NCT00685399|531257|P3|NOT COMPLETED|Treatment Period 2||3
221602|NCT00685399|531258|P2|NOT COMPLETED|Treatment Period 2||12
221603|NCT00685399|531259|P1|NOT COMPLETED|Treatment Period 2||0
221604|NCT00685399|531252|P8|COMPLETED|Treatment Period 2||10
221605|NCT00685399|531253|P7|COMPLETED|Treatment Period 2||13
221606|NCT00685399|531254|P6|COMPLETED|Treatment Period 2||10
221607|NCT00685399|531255|P5|COMPLETED|Treatment Period 2||4
221608|NCT00685399|531256|P4|COMPLETED|Treatment Period 2|in extension period only|0
221609|NCT00685399|531257|P3|COMPLETED|Treatment Period 2||2
221610|NCT00685399|531258|P2|COMPLETED|Treatment Period 2||2
221611|NCT00685399|531259|P1|COMPLETED|Treatment Period 2||0
221612|NCT00685399|531252|P8|STARTED|Treatment Period 2||12
221613|NCT00685399|531253|P7|STARTED|Treatment Period 2||13
221614|NCT00685399|531254|P6|STARTED|Treatment Period 2||12
221615|NCT00685399|531255|P5|STARTED|Treatment Period 2||4
221616|NCT00685399|531256|P4|STARTED|Treatment Period 2|in extension period only|0
221617|NCT00685399|531257|P3|STARTED|Treatment Period 2||5
221618|NCT00685399|531258|P2|STARTED|Treatment Period 2||14
221619|NCT00685399|531259|P1|STARTED|Treatment Period 2||0
221620|NCT00685399|531252|P8|NOT COMPLETED|Treatment Period 1||0
221621|NCT00685399|531253|P7|NOT COMPLETED|Treatment Period 1||0
221622|NCT00685399|531254|P6|NOT COMPLETED|Treatment Period 1||0
221623|NCT00685399|531255|P5|NOT COMPLETED|Treatment Period 1||0
221624|NCT00685399|531256|P4|NOT COMPLETED|Treatment Period 1||0
221625|NCT00685399|531257|P3|NOT COMPLETED|Treatment Period 1||0
221626|NCT00685399|531258|P2|NOT COMPLETED|Treatment Period 1||0
221627|NCT00685399|531259|P1|NOT COMPLETED|Treatment Period 1||6
221628|NCT00685399|531252|P8|COMPLETED|Treatment Period 1||0
221629|NCT00685399|531253|P7|COMPLETED|Treatment Period 1||0
221630|NCT00685399|531254|P6|COMPLETED|Treatment Period 1||0
221631|NCT00685399|531255|P5|COMPLETED|Treatment Period 1||0
221632|NCT00685399|531256|P4|COMPLETED|Treatment Period 1||0
221633|NCT00685399|531257|P3|COMPLETED|Treatment Period 1||0
221634|NCT00685399|531258|P2|COMPLETED|Treatment Period 1||0
221635|NCT00685399|531259|P1|COMPLETED|Treatment Period 1||10
221636|NCT00685399|531252|P8|STARTED|Treatment Period 1||0
221637|NCT00685399|531253|P7|STARTED|Treatment Period 1||0
221638|NCT00685399|531254|P6|STARTED|Treatment Period 1||0
221639|NCT00685399|531255|P5|STARTED|Treatment Period 1||0
221640|NCT00685399|531256|P4|STARTED|Treatment Period 1||0
221641|NCT00685399|531257|P3|STARTED|Treatment Period 1||0
221642|NCT00685399|531258|P2|STARTED|Treatment Period 1||0
221643|NCT00685399|531259|P1|STARTED|Treatment Period 1||16
221644|NCT00685373|531292|P1|NOT COMPLETED|Overall Study||15
221645|NCT00685373|531292|P1|COMPLETED|Overall Study||151
221646|NCT00685373|531292|P1|STARTED|Overall Study||166
221647|NCT00685334|531301|P2|NOT COMPLETED|Overall Study||7
221648|NCT00685334|531302|P1|NOT COMPLETED|Overall Study||10
221649|NCT00685334|531301|P2|COMPLETED|Overall Study||3
221650|NCT00685334|531302|P1|COMPLETED|Overall Study||2
221651|NCT00685334|531301|P2|STARTED|Overall Study||10
221652|NCT00685334|531302|P1|STARTED|Overall Study||12
221653|NCT00685295|531312|P2|NOT COMPLETED|Overall Study||0
221654|NCT00685295|531313|P1|NOT COMPLETED|Overall Study||0
221655|NCT00685295|531312|P2|COMPLETED|Overall Study||30
221656|NCT00685295|531313|P1|COMPLETED|Overall Study||30
221657|NCT00685295|531312|P2|STARTED|Overall Study||30
221658|NCT00685295|531313|P1|STARTED|Overall Study||30
221659|NCT00685178|531327|P4|NOT COMPLETED|Overall Study||14
221660|NCT00685178|531328|P3|NOT COMPLETED|Overall Study||12
221661|NCT00685178|531329|P2|NOT COMPLETED|Overall Study||19
221662|NCT00685178|531330|P1|NOT COMPLETED|Overall Study||13
221663|NCT00685178|531327|P4|COMPLETED|Overall Study||33
221664|NCT00685178|531328|P3|COMPLETED|Overall Study||27
221665|NCT00685178|531329|P2|COMPLETED|Overall Study||26
221666|NCT00685178|531330|P1|COMPLETED|Overall Study||27
221667|NCT00685178|531327|P4|STARTED|Overall Study||47
221668|NCT00685178|531328|P3|STARTED|Overall Study||39
221669|NCT00685178|531329|P2|STARTED|Overall Study||45
221670|NCT00685178|531330|P1|STARTED|Overall Study||40
221671|NCT00685165|531344|P2|NOT COMPLETED|Second Intervention||0
221672|NCT00685165|531345|P1|NOT COMPLETED|Second Intervention||0
221673|NCT00685165|531344|P2|COMPLETED|Second Intervention||11
221674|NCT00685165|531345|P1|COMPLETED|Second Intervention||10
221675|NCT00685165|531344|P2|STARTED|Second Intervention||11
221676|NCT00685165|531345|P1|STARTED|Second Intervention||10
221677|NCT00685165|531344|P2|NOT COMPLETED|Washout Period of 14 Days||0
221678|NCT00685165|531345|P1|NOT COMPLETED|Washout Period of 14 Days||1
221679|NCT00685165|531344|P2|COMPLETED|Washout Period of 14 Days||11
221680|NCT00685165|531345|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
221681|NCT00685165|531344|P2|STARTED|Washout Period of 14 Days||11
221682|NCT00685165|531345|P1|STARTED|Washout Period of 14 Days||11
221683|NCT00685165|531344|P2|NOT COMPLETED|First Intervention||0
221684|NCT00685165|531345|P1|NOT COMPLETED|First Intervention||0
221685|NCT00685165|531344|P2|COMPLETED|First Intervention||11
221686|NCT00685165|531345|P1|COMPLETED|First Intervention||11
221687|NCT00685165|531344|P2|STARTED|First Intervention||11
221688|NCT00685165|531345|P1|STARTED|First Intervention||11
221689|NCT00685139|531355|P2|NOT COMPLETED|Second Intervention||0
221690|NCT00685139|531356|P1|NOT COMPLETED|Second Intervention||0
221691|NCT00685139|531355|P2|COMPLETED|Second Intervention||17
221692|NCT00685139|531356|P1|COMPLETED|Second Intervention||17
221693|NCT00685139|531355|P2|STARTED|Second Intervention||17
221694|NCT00685139|531356|P1|STARTED|Second Intervention||17
221695|NCT00685139|531355|P2|NOT COMPLETED|Washout Period of 28 Days||0
221696|NCT00685139|531356|P1|NOT COMPLETED|Washout Period of 28 Days||0
221697|NCT00685139|531355|P2|COMPLETED|Washout Period of 28 Days||17
221698|NCT00685139|531356|P1|COMPLETED|Washout Period of 28 Days||17
221699|NCT00685139|531355|P2|STARTED|Washout Period of 28 Days||17
221700|NCT00685139|531356|P1|STARTED|Washout Period of 28 Days||17
221701|NCT00685139|531355|P2|NOT COMPLETED|First Intervention||0
221702|NCT00685139|531356|P1|NOT COMPLETED|First Intervention||0
221703|NCT00685139|531355|P2|COMPLETED|First Intervention||17
221704|NCT00685139|531356|P1|COMPLETED|First Intervention||17
221705|NCT00685139|531355|P2|STARTED|First Intervention||17
221706|NCT00685139|531356|P1|STARTED|First Intervention||17
221707|NCT00685035|531364|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
221708|NCT00685035|531365|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
221709|NCT00685035|531364|P2|COMPLETED|Period 3: 2nd Intervention||8
221710|NCT00685035|531365|P1|COMPLETED|Period 3: 2nd Intervention||8
221711|NCT00685035|531364|P2|STARTED|Period 3: 2nd Intervention||8
221712|NCT00685035|531365|P1|STARTED|Period 3: 2nd Intervention||8
221713|NCT00685035|531364|P2|NOT COMPLETED|Period 2: 2-day Washout||0
221714|NCT00685035|531365|P1|NOT COMPLETED|Period 2: 2-day Washout||0
221715|NCT00685035|531364|P2|COMPLETED|Period 2: 2-day Washout||8
221716|NCT00685035|531365|P1|COMPLETED|Period 2: 2-day Washout||8
221717|NCT00685035|531364|P2|STARTED|Period 2: 2-day Washout||8
221718|NCT00685035|531365|P1|STARTED|Period 2: 2-day Washout||8
221719|NCT00685035|531364|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
221720|NCT00685035|531365|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
221721|NCT00685035|531364|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
221722|NCT00685035|531365|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
221723|NCT00685035|531364|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
221724|NCT00685035|531365|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
221725|NCT00684996|531389|P1|NOT COMPLETED|Overall Study||5
221726|NCT00684996|531389|P1|COMPLETED|Overall Study||0
221727|NCT00684996|531389|P1|Eligible|Overall Study||5
221728|NCT00684996|531389|P1|STARTED|Overall Study||5
221729|NCT00684983|531404|P2|NOT COMPLETED|Overall Study||0
221730|NCT00684983|531405|P1|NOT COMPLETED|Overall Study||0
221731|NCT00684983|531404|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
221732|NCT00684983|531405|P1|COMPLETED|Overall Study||19
221733|NCT00684983|531404|P2|STARTED|Overall Study||45
221734|NCT00684983|531405|P1|STARTED|Overall Study||19
221735|NCT00684814|531421|P2|NOT COMPLETED|Second Intervention||0
221736|NCT00684814|531422|P1|NOT COMPLETED|Second Intervention||1
221737|NCT00684814|531421|P2|COMPLETED|Second Intervention||15
221738|NCT00684814|531422|P1|COMPLETED|Second Intervention||16
221739|NCT00684814|531421|P2|STARTED|Second Intervention||15
221740|NCT00684814|531422|P1|STARTED|Second Intervention||17
221741|NCT00684814|531421|P2|NOT COMPLETED|Washout Period of 7 Days||4
221742|NCT00684814|531422|P1|NOT COMPLETED|Washout Period of 7 Days||2
221743|NCT00684814|531421|P2|COMPLETED|Washout Period of 7 Days||15
221744|NCT00684814|531422|P1|COMPLETED|Washout Period of 7 Days||17
221745|NCT00684814|531421|P2|STARTED|Washout Period of 7 Days||19
221746|NCT00684814|531422|P1|STARTED|Washout Period of 7 Days||19
221747|NCT00684814|531421|P2|NOT COMPLETED|First Intervention||0
221748|NCT00684814|531422|P1|NOT COMPLETED|First Intervention||0
221749|NCT00684814|531421|P2|COMPLETED|First Intervention||19
221750|NCT00684814|531422|P1|COMPLETED|First Intervention||19
221751|NCT00684814|531421|P2|STARTED|First Intervention||19
221752|NCT00684814|531422|P1|STARTED|First Intervention||19
221753|NCT00684788|531434|P2|NOT COMPLETED|Overall Study||0
221754|NCT00684788|531435|P1|NOT COMPLETED|Overall Study||0
221755|NCT00684788|531434|P2|COMPLETED|Overall Study||18
221756|NCT00684788|531435|P1|COMPLETED|Overall Study||17
221757|NCT00684788|531434|P2|STARTED|Overall Study||18
221758|NCT00684788|531435|P1|STARTED|Overall Study||17
221759|NCT00684775|531455|P2|NOT COMPLETED|Overall Study||0
221760|NCT00684775|531456|P1|NOT COMPLETED|Overall Study||0
221761|NCT00684775|531455|P2|COMPLETED|Overall Study||19
221762|NCT00684775|531456|P1|COMPLETED|Overall Study||19
221763|NCT00684775|531455|P2|STARTED|Overall Study||19
221764|NCT00684775|531456|P1|STARTED|Overall Study||19
221765|NCT00684762|531474|P2|NOT COMPLETED|Second Intervention||0
221766|NCT00684762|531475|P1|NOT COMPLETED|Second Intervention||0
221767|NCT00684762|531474|P2|COMPLETED|Second Intervention||14
221768|NCT00684762|531475|P1|COMPLETED|Second Intervention||14
221769|NCT00684762|531474|P2|STARTED|Second Intervention||14
221770|NCT00684762|531475|P1|STARTED|Second Intervention||14
221771|NCT00684762|531474|P2|NOT COMPLETED|Washout Period of 7 Days||2
221772|NCT00684762|531475|P1|NOT COMPLETED|Washout Period of 7 Days||2
221773|NCT00684762|531474|P2|COMPLETED|Washout Period of 7 Days||14
221774|NCT00684762|531475|P1|COMPLETED|Washout Period of 7 Days||14
221775|NCT00684762|531474|P2|STARTED|Washout Period of 7 Days||16
221776|NCT00684762|531475|P1|STARTED|Washout Period of 7 Days||16
221777|NCT00684762|531474|P2|NOT COMPLETED|First Intervention||0
221778|NCT00684762|531475|P1|NOT COMPLETED|First Intervention||0
221779|NCT00684762|531474|P2|COMPLETED|First Intervention||16
221780|NCT00684762|531475|P1|COMPLETED|First Intervention||16
221781|NCT00684762|531474|P2|STARTED|First Intervention||16
221782|NCT00684762|531475|P1|STARTED|First Intervention||16
221783|NCT00684749|531485|P1|NOT COMPLETED|Overall Study||0
221784|NCT00684749|531485|P1|COMPLETED|Overall Study||142
221785|NCT00684749|531485|P1|STARTED|Overall Study||142
221786|NCT00684723|531489|P2|NOT COMPLETED|Second Intervention||0
221787|NCT00684723|531490|P1|NOT COMPLETED|Second Intervention||0
221788|NCT00684723|531489|P2|COMPLETED|Second Intervention||27
221789|NCT00684723|531490|P1|COMPLETED|Second Intervention||27
221790|NCT00684723|531489|P2|STARTED|Second Intervention||27
221791|NCT00684723|531490|P1|STARTED|Second Intervention||27
221792|NCT00684723|531489|P2|NOT COMPLETED|Washout Period of 7 Days||0
221793|NCT00684723|531490|P1|NOT COMPLETED|Washout Period of 7 Days||0
221794|NCT00684723|531489|P2|COMPLETED|Washout Period of 7 Days||27
221795|NCT00684723|531490|P1|COMPLETED|Washout Period of 7 Days||27
221796|NCT00684723|531489|P2|STARTED|Washout Period of 7 Days||27
221797|NCT00684723|531490|P1|STARTED|Washout Period of 7 Days||27
221798|NCT00684723|531489|P2|NOT COMPLETED|First Intervention||0
221799|NCT00684723|531490|P1|NOT COMPLETED|First Intervention||0
221800|NCT00684723|531489|P2|COMPLETED|First Intervention||27
221801|NCT00684723|531490|P1|COMPLETED|First Intervention||27
221802|NCT00684723|531489|P2|STARTED|First Intervention||27
221803|NCT00684723|531490|P1|STARTED|First Intervention||27
221804|NCT00684671|531503|P3|NOT COMPLETED|Overall Study||0
221805|NCT00684671|531504|P2|NOT COMPLETED|Overall Study||0
221806|NCT00684671|531505|P1|NOT COMPLETED|Overall Study||3
221807|NCT00684671|531503|P3|COMPLETED|Overall Study||164
221808|NCT00684671|531504|P2|COMPLETED|Overall Study||170
221809|NCT00684671|531505|P1|COMPLETED|Overall Study||169
221810|NCT00684671|531503|P3|STARTED|Overall Study||164
221811|NCT00684671|531504|P2|STARTED|Overall Study||170
221812|NCT00684671|531505|P1|STARTED|Overall Study||172
221813|NCT00684645|531534|P1|NOT COMPLETED|Overall Study||114
221814|NCT00684645|531534|P1|COMPLETED|Overall Study||72
221815|NCT00684645|531534|P1|STARTED|Overall Study||186
221816|NCT00684593|531554|P2|NOT COMPLETED|Overall Study||2
221817|NCT00684593|531555|P1|NOT COMPLETED|Overall Study||0
221818|NCT00684593|531554|P2|COMPLETED|Overall Study||8
221819|NCT00684593|531555|P1|COMPLETED|Overall Study||21
221820|NCT00684593|531554|P2|STARTED|Overall Study||10
221821|NCT00684593|531555|P1|STARTED|Overall Study||21
221822|NCT00684567|531567|P1|NOT COMPLETED|Monotherapy Period||14
221823|NCT00684567|531567|P1|COMPLETED|Monotherapy Period||9
221824|NCT00684567|531567|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
221825|NCT00684567|531567|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
221826|NCT00684567|531567|P1|COMPLETED|Concomitant Radiotherapy Period||28
221827|NCT00684567|531567|P1|STARTED|Concomitant Radiotherapy Period||30
221828|NCT00684554|531577|P2|NOT COMPLETED|Overall Study||0
221829|NCT00684554|531578|P1|NOT COMPLETED|Overall Study||0
221830|NCT00684554|531577|P2|COMPLETED|Overall Study||10
221831|NCT00684554|531578|P1|COMPLETED|Overall Study||10
221832|NCT00684554|531577|P2|STARTED|Overall Study||10
221833|NCT00684554|531578|P1|STARTED|Overall Study||10
221834|NCT00684541|531588|P2|NOT COMPLETED|Overall Study||3
221835|NCT00684541|531589|P1|NOT COMPLETED|Overall Study||3
221836|NCT00684541|531588|P2|COMPLETED|Overall Study||23
221837|NCT00684541|531589|P1|COMPLETED|Overall Study||20
221838|NCT00684541|531588|P2|STARTED|Overall Study||26
221839|NCT00684541|531589|P1|STARTED|Overall Study||23
221840|NCT00684515|531600|P3|NOT COMPLETED|Overall Study||1
221841|NCT00684515|531601|P2|NOT COMPLETED|Overall Study||3
221842|NCT00684515|531602|P1|NOT COMPLETED|Overall Study||4
221843|NCT00684515|531600|P3|COMPLETED|Overall Study||27
221844|NCT00684515|531601|P2|COMPLETED|Overall Study||26
221845|NCT00684515|531602|P1|COMPLETED|Overall Study||29
221846|NCT00684515|531600|P3|STARTED|Overall Study||28
221847|NCT00684515|531601|P2|STARTED|Overall Study||29
221848|NCT00684515|531602|P1|STARTED|Overall Study||33
221849|NCT00684424|531625|P1|NOT COMPLETED|Overall Study||5
221850|NCT00684424|531625|P1|COMPLETED|Overall Study||194
221851|NCT00684424|531625|P1|STARTED|Overall Study||199
221852|NCT00684411|531640|P1|NOT COMPLETED|Overall Study||12
221853|NCT00684411|531640|P1|COMPLETED|Overall Study||0
221854|NCT00684411|531640|P1|Disease Evaluable|Overall Study||11
221855|NCT00684411|531640|P1|STARTED|Overall Study||12
221856|NCT00684320|531648|P2|NOT COMPLETED|Overall Study||0
221857|NCT00684320|531649|P1|NOT COMPLETED|Overall Study||4
221858|NCT00684320|531648|P2|COMPLETED|Overall Study||22
221859|NCT00684320|531649|P1|COMPLETED|Overall Study||22
221860|NCT00684320|531648|P2|STARTED|Overall Study||22
221861|NCT00684320|531649|P1|STARTED|Overall Study||26
221862|NCT00684307|531662|P5|NOT COMPLETED|Overall Study||25
221863|NCT00684307|531663|P4|NOT COMPLETED|Overall Study||32
221864|NCT00684307|531664|P3|NOT COMPLETED|Overall Study||28
221865|NCT00684307|531665|P2|NOT COMPLETED|Overall Study||22
221866|NCT00684307|531666|P1|NOT COMPLETED|Overall Study||24
221867|NCT00684307|531662|P5|COMPLETED|Overall Study||293
221868|NCT00684307|531663|P4|COMPLETED|Overall Study||128
221869|NCT00684307|531664|P3|COMPLETED|Overall Study||128
221870|NCT00684307|531665|P2|COMPLETED|Overall Study||129
221871|NCT00684307|531666|P1|COMPLETED|Overall Study||140
221872|NCT00684307|531662|P5|On Treatment Period Completed|Overall Study||293
221873|NCT00684307|531663|P4|On Treatment Period Completed|Overall Study||128
221874|NCT00684307|531664|P3|On Treatment Period Completed|Overall Study||128
221875|NCT00684307|531665|P2|On Treatment Period Completed|Overall Study||129
221876|NCT00684307|531666|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
221877|NCT00684307|531662|P5|On Treatment Period Started|Overall Study||318
221878|NCT00684307|531663|P4|On Treatment Period Started|Overall Study||160
221879|NCT00684307|531664|P3|On Treatment Period Started|Overall Study||156
221880|NCT00684307|531665|P2|On Treatment Period Started|Overall Study||151
221881|NCT00684307|531666|P1|On Treatment Period Started|Overall Study||164
221882|NCT00684307|531662|P5|STARTED|Overall Study||318
221883|NCT00684307|531663|P4|STARTED|Overall Study||160
221884|NCT00684307|531664|P3|STARTED|Overall Study||156
221885|NCT00684307|531665|P2|STARTED|Overall Study||151
221886|NCT00684307|531666|P1|STARTED|Overall Study|Patients who received treatment|164
221887|NCT00684255|531733|P1|NOT COMPLETED|Overall Study||0
221888|NCT00684255|531733|P1|COMPLETED|Overall Study||1
221889|NCT00684255|531733|P1|STARTED|Overall Study||1
221890|NCT00684242|531738|P1|NOT COMPLETED|Overall Study||0
221891|NCT00684242|531738|P1|COMPLETED|Overall Study||3
221892|NCT00684242|531738|P1|STARTED|Overall Study||3
221893|NCT00684203|531748|P6|NOT COMPLETED|Overall Study||0
221894|NCT00684203|531749|P5|NOT COMPLETED|Overall Study||0
221895|NCT00684203|531750|P4|NOT COMPLETED|Overall Study||0
221896|NCT00684203|531751|P3|NOT COMPLETED|Overall Study||9
221897|NCT00684203|531752|P2|NOT COMPLETED|Overall Study||8
221898|NCT00684203|531753|P1|NOT COMPLETED|Overall Study||9
221899|NCT00684203|531748|P6|COMPLETED|Overall Study||2
221900|NCT00684203|531749|P5|COMPLETED|Overall Study||17
221901|NCT00684203|531750|P4|COMPLETED|Overall Study||6
221902|NCT00684203|531751|P3|COMPLETED|Overall Study||12
221903|NCT00684203|531752|P2|COMPLETED|Overall Study||23
221904|NCT00684203|531753|P1|COMPLETED|Overall Study||31
221905|NCT00684203|531748|P6|STARTED|Overall Study||2
221906|NCT00684203|531749|P5|STARTED|Overall Study||17
221907|NCT00684203|531750|P4|STARTED|Overall Study||6
221908|NCT00684203|531751|P3|STARTED|Overall Study||21
221909|NCT00684203|531752|P2|STARTED|Overall Study||31
221910|NCT00684203|531753|P1|STARTED|Overall Study||40
221911|NCT00684177|531814|P2|NOT COMPLETED|Overall Study||23
221912|NCT00684177|531815|P1|NOT COMPLETED|Overall Study||21
221913|NCT00684177|531814|P2|COMPLETED|Overall Study||141
221914|NCT00684177|531815|P1|COMPLETED|Overall Study||322
221915|NCT00684177|531814|P2|STARTED|Overall Study||164
221916|NCT00684177|531815|P1|STARTED|Overall Study||343
221917|NCT00684138|531833|P2|NOT COMPLETED|Overall Study||8
221918|NCT00684138|531834|P1|NOT COMPLETED|Overall Study||3
221919|NCT00684138|531833|P2|COMPLETED|Overall Study||131
221920|NCT00684138|531834|P1|COMPLETED|Overall Study||138
221921|NCT00684138|531833|P2|STARTED|Overall Study||139
221922|NCT00684138|531834|P1|STARTED|Overall Study||141
221923|NCT00684073|531850|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
221924|NCT00684073|531850|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
221925|NCT00684073|531850|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
221926|NCT00684073|531850|P1|NOT COMPLETED|Selection||7
221927|NCT00684073|531850|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
221928|NCT00684073|531850|P1|STARTED|Selection||60
221929|NCT00684060|531860|P2|NOT COMPLETED|Overall Study||3
221930|NCT00684060|531861|P1|NOT COMPLETED|Overall Study||3
221931|NCT00684060|531860|P2|COMPLETED|Overall Study||26
221932|NCT00684060|531861|P1|COMPLETED|Overall Study||55
221933|NCT00684060|531860|P2|STARTED|Overall Study||29
221934|NCT00684060|531861|P1|STARTED|Overall Study||58
221935|NCT00684047|531884|P3|NOT COMPLETED|Overall Study||5
221936|NCT00684047|531885|P2|NOT COMPLETED|Overall Study||16
221937|NCT00684047|531886|P1|NOT COMPLETED|Overall Study||13
221938|NCT00684047|531884|P3|COMPLETED|Overall Study||52
221939|NCT00684047|531885|P2|COMPLETED|Overall Study||94
221940|NCT00684047|531886|P1|COMPLETED|Overall Study||59
221941|NCT00684047|531884|P3|STARTED|Overall Study||57
221942|NCT00684047|531885|P2|STARTED|Overall Study||110
221943|NCT00684047|531886|P1|STARTED|Overall Study||72
221944|NCT00684021|531900|P4|NOT COMPLETED|Overall Study||2
221945|NCT00684021|531901|P3|NOT COMPLETED|Overall Study||2
221946|NCT00684021|531902|P2|NOT COMPLETED|Overall Study||2
221947|NCT00684021|531903|P1|NOT COMPLETED|Overall Study||2
221948|NCT00684021|531900|P4|COMPLETED|Overall Study||15
221949|NCT00684021|531901|P3|COMPLETED|Overall Study||34
221950|NCT00684021|531902|P2|COMPLETED|Overall Study||22
221951|NCT00684021|531903|P1|COMPLETED|Overall Study||41
221952|NCT00684021|531900|P4|STARTED|Overall Study||17
221953|NCT00684021|531901|P3|STARTED|Overall Study||36
221954|NCT00684021|531902|P2|STARTED|Overall Study||24
221955|NCT00684021|531903|P1|STARTED|Overall Study||43
221956|NCT00683930|531944|P3|NOT COMPLETED|Overall Study||9
221957|NCT00683930|531945|P2|NOT COMPLETED|Overall Study||3
221958|NCT00683930|531946|P1|NOT COMPLETED|Overall Study||7
221959|NCT00683930|531944|P3|COMPLETED|Overall Study||28
221960|NCT00683930|531945|P2|COMPLETED|Overall Study||18
221961|NCT00683930|531946|P1|COMPLETED|Overall Study||29
221962|NCT00683930|531944|P3|STARTED|Overall Study||37
221963|NCT00683930|531945|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
221964|NCT00683930|531946|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
221965|NCT00683917|531964|P1|NOT COMPLETED|Overall Study||10
221966|NCT00683917|531964|P1|COMPLETED|Overall Study||0
221967|NCT00683917|531964|P1|STARTED|Overall Study||10
221968|NCT00683904|531974|P2|NOT COMPLETED|Dose Level 2||2
221969|NCT00683904|531975|P1|NOT COMPLETED|Dose Level 2||0
221970|NCT00683904|531974|P2|COMPLETED|Dose Level 2||4
221971|NCT00683904|531975|P1|COMPLETED|Dose Level 2||0
221972|NCT00683904|531974|P2|STARTED|Dose Level 2||6
221973|NCT00683904|531975|P1|STARTED|Dose Level 2||0
221974|NCT00683904|531974|P2|NOT COMPLETED|Dose Level 1||0
221975|NCT00683904|531975|P1|NOT COMPLETED|Dose Level 1||3
221976|NCT00683904|531974|P2|COMPLETED|Dose Level 1||0
221977|NCT00683904|531975|P1|COMPLETED|Dose Level 1||3
221978|NCT00683904|531974|P2|STARTED|Dose Level 1||0
221979|NCT00683904|531975|P1|STARTED|Dose Level 1||6
221980|NCT00683878|532011|P3|NOT COMPLETED|Overall Study||14
221981|NCT00683878|532012|P2|NOT COMPLETED|Overall Study||16
221982|NCT00683878|532013|P1|NOT COMPLETED|Overall Study||23
221983|NCT00683878|532011|P3|COMPLETED|Overall Study||126
221984|NCT00683878|532012|P2|COMPLETED|Overall Study||125
221985|NCT00683878|532013|P1|COMPLETED|Overall Study||116
221986|NCT00683878|532011|P3|STARTED|Overall Study||140
221987|NCT00683878|532012|P2|STARTED|Overall Study||141
221988|NCT00683878|532013|P1|STARTED|Overall Study||139
221989|NCT00683852|532041|P3|NOT COMPLETED|30-Day Phase 2 Period||9
221990|NCT00683852|532042|P2|NOT COMPLETED|30-Day Phase 2 Period||5
221991|NCT00683852|532043|P1|NOT COMPLETED|30-Day Phase 2 Period||6
221992|NCT00683852|532041|P3|COMPLETED|30-Day Phase 2 Period||75
221993|NCT00683852|532042|P2|COMPLETED|30-Day Phase 2 Period||78
221994|NCT00683852|532043|P1|COMPLETED|30-Day Phase 2 Period||48
221995|NCT00683852|532041|P3|STARTED|30-Day Phase 2 Period||84
221996|NCT00683852|532042|P2|STARTED|30-Day Phase 2 Period||83
221997|NCT00683852|532043|P1|STARTED|30-Day Phase 2 Period||54
221998|NCT00683852|532041|P3|NOT COMPLETED|30-Day Phase 1 Period||1
221999|NCT00683852|532042|P2|NOT COMPLETED|30-Day Phase 1 Period||1
222000|NCT00683852|532043|P1|NOT COMPLETED|30-Day Phase 1 Period||2
222001|NCT00683852|532041|P3|COMPLETED|30-Day Phase 1 Period||84
222002|NCT00683852|532042|P2|COMPLETED|30-Day Phase 1 Period||83
222003|NCT00683852|532043|P1|COMPLETED|30-Day Phase 1 Period||54
222004|NCT00683852|532041|P3|STARTED|30-Day Phase 1 Period||85
222005|NCT00683852|532042|P2|STARTED|30-Day Phase 1 Period||84
222006|NCT00683852|532043|P1|STARTED|30-Day Phase 1 Period||56
222007|NCT00683826|532077|P1|NOT COMPLETED|Overall Study||1
222008|NCT00683826|532077|P1|COMPLETED|Overall Study||7
222009|NCT00683826|532077|P1|4g Leucine|Overall Study||7
222010|NCT00683826|532077|P1|8g Leucine|Overall Study||8
222011|NCT00683826|532077|P1|0g Leucine|Overall Study||8
222012|NCT00683826|532077|P1|STARTED|Overall Study||8
222013|NCT00683800|532087|P2|NOT COMPLETED|Overall Study||366
222014|NCT00683800|532088|P1|NOT COMPLETED|Overall Study||432
222015|NCT00683800|532087|P2|COMPLETED|Overall Study||719
222016|NCT00683800|532088|P1|COMPLETED|Overall Study||669
222017|NCT00683800|532087|P2|Treated|Overall Study||1052
222018|NCT00683800|532088|P1|Treated|Overall Study||1066
222019|NCT00683800|532087|P2|STARTED|Overall Study||1085
222020|NCT00683800|532088|P1|STARTED|Overall Study||1101
222021|NCT00683787|532155|P3|NOT COMPLETED|Overall Study||2
222022|NCT00683787|532156|P2|NOT COMPLETED|Overall Study||3
222023|NCT00683787|532157|P1|NOT COMPLETED|Overall Study||3
222024|NCT00683787|532155|P3|COMPLETED|Overall Study||0
222025|NCT00683787|532156|P2|COMPLETED|Overall Study||0
222026|NCT00683787|532157|P1|COMPLETED|Overall Study||0
222027|NCT00683787|532155|P3|STARTED|Overall Study||2
222028|NCT00683787|532156|P2|STARTED|Overall Study||3
222029|NCT00683787|532157|P1|STARTED|Overall Study||3
222030|NCT00683774|532176|P2|NOT COMPLETED|Overall Study||1
222031|NCT00683774|532177|P1|NOT COMPLETED|Overall Study||3
222032|NCT00683774|532176|P2|COMPLETED|Overall Study||9
222033|NCT00683774|532177|P1|COMPLETED|Overall Study||8
222034|NCT00683774|532176|P2|STARTED|Overall Study||10
222035|NCT00683774|532177|P1|STARTED|Overall Study||11
222036|NCT00683696|532187|P2|NOT COMPLETED|Overall Study||405
222037|NCT00683696|532188|P1|NOT COMPLETED|Overall Study||404
222038|NCT00683696|532187|P2|COMPLETED|Overall Study||0
222039|NCT00683696|532188|P1|COMPLETED|Overall Study||0
222040|NCT00683696|532187|P2|STARTED|Overall Study||405
222041|NCT00683696|532188|P1|STARTED|Overall Study||404
222042|NCT00683657|532207|P2|NOT COMPLETED|Overall Study||1
222043|NCT00683657|532208|P1|NOT COMPLETED|Overall Study||1
222044|NCT00683657|532207|P2|COMPLETED|Overall Study||46
222045|NCT00683657|532208|P1|COMPLETED|Overall Study||45
222046|NCT00683657|532207|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
222047|NCT00683657|532208|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
222048|NCT00683657|532207|P2|STARTED|Overall Study||47
222049|NCT00683657|532208|P1|STARTED|Overall Study||46
222050|NCT00683644|532224|P2|NOT COMPLETED|Overall Study||14
222051|NCT00683644|532225|P1|NOT COMPLETED|Overall Study||13
222052|NCT00683644|532224|P2|COMPLETED|Overall Study||44
222053|NCT00683644|532225|P1|COMPLETED|Overall Study||45
222054|NCT00683644|532224|P2|STARTED|Overall Study||58
222055|NCT00683644|532225|P1|STARTED|Overall Study||58
222056|NCT00683618|532238|P3|NOT COMPLETED|Extension Treatment Period||0
222057|NCT00683618|532239|P2|NOT COMPLETED|Extension Treatment Period||0
222058|NCT00683618|532240|P1|NOT COMPLETED|Extension Treatment Period||3
222059|NCT00683618|532238|P3|COMPLETED|Extension Treatment Period||0
222060|NCT00683618|532239|P2|COMPLETED|Extension Treatment Period||23
222061|NCT00683618|532240|P1|COMPLETED|Extension Treatment Period||33
222062|NCT00683618|532238|P3|STARTED|Extension Treatment Period||0
222063|NCT00683618|532239|P2|STARTED|Extension Treatment Period||23
222064|NCT00683618|532240|P1|STARTED|Extension Treatment Period||36
222065|NCT00683618|532238|P3|NOT COMPLETED|Randomised Treatment Period||6
222066|NCT00683618|532239|P2|NOT COMPLETED|Randomised Treatment Period||2
222067|NCT00683618|532240|P1|NOT COMPLETED|Randomised Treatment Period||6
222068|NCT00683618|532238|P3|COMPLETED|Randomised Treatment Period||140
222069|NCT00683618|532239|P2|COMPLETED|Randomised Treatment Period||143
222070|NCT00683618|532240|P1|COMPLETED|Randomised Treatment Period||139
222071|NCT00683618|532238|P3|STARTED|Randomised Treatment Period||146
222072|NCT00683618|532239|P2|STARTED|Randomised Treatment Period||145
222073|NCT00683618|532240|P1|STARTED|Randomised Treatment Period||145
222074|NCT00683592|532290|P2|NOT COMPLETED|Overall Study||46
222075|NCT00683592|532291|P1|NOT COMPLETED|Overall Study||47
222076|NCT00683592|532290|P2|COMPLETED|Overall Study||195
222077|NCT00683592|532291|P1|COMPLETED|Overall Study||193
222078|NCT00683592|532290|P2|Safety Population|Overall Study||233
222079|NCT00683592|532291|P1|Safety Population|Overall Study||235
222080|NCT00683592|532290|P2|Intent to Treat Population|Overall Study||232
222081|NCT00683592|532291|P1|Intent to Treat Population|Overall Study||231
222082|NCT00683592|532290|P2|STARTED|Overall Study||241
222083|NCT00683592|532291|P1|STARTED|Overall Study||240
222084|NCT00683475|532309|P2|NOT COMPLETED|Overall Study||3
222085|NCT00683475|532310|P1|NOT COMPLETED|Overall Study||4
222086|NCT00683475|532309|P2|COMPLETED|Overall Study||66
222087|NCT00683475|532310|P1|COMPLETED|Overall Study||65
222088|NCT00683475|532309|P2|Received Any Quantity of Study Drug|Overall Study||66
222089|NCT00683475|532310|P1|Received Any Quantity of Study Drug|Overall Study||66
222090|NCT00683475|532309|P2|STARTED|Overall Study||69
222091|NCT00683475|532310|P1|STARTED|Overall Study||69
222092|NCT00683449|532345|P5|NOT COMPLETED|Overall Study||0
222093|NCT00683449|532346|P4|NOT COMPLETED|Overall Study||0
222094|NCT00683449|532347|P3|NOT COMPLETED|Overall Study||0
222095|NCT00683449|532348|P2|NOT COMPLETED|Overall Study||1
222096|NCT00683449|532349|P1|NOT COMPLETED|Overall Study||0
222097|NCT00683449|532345|P5|COMPLETED|Overall Study||2
222098|NCT00683449|532346|P4|COMPLETED|Overall Study||6
222099|NCT00683449|532347|P3|COMPLETED|Overall Study||3
222100|NCT00683449|532348|P2|COMPLETED|Overall Study||12
222101|NCT00683449|532349|P1|COMPLETED|Overall Study||5
222102|NCT00683449|532345|P5|STARTED|Overall Study||2
222103|NCT00683449|532346|P4|STARTED|Overall Study||6
222104|NCT00683449|532347|P3|STARTED|Overall Study||3
222105|NCT00683449|532348|P2|STARTED|Overall Study||13
222106|NCT00683449|532349|P1|STARTED|Overall Study||5
222107|NCT00683410|532371|P1|NOT COMPLETED|Overall Study||0
222108|NCT00683410|532371|P1|COMPLETED|Overall Study||3366
222109|NCT00683410|532371|P1|Vaccinated Dose 4|Overall Study||175
222110|NCT00683410|532371|P1|Vaccinated Dose 3|Overall Study||817
222111|NCT00683410|532371|P1|Vaccinated Dose 2|Overall Study||1623
222112|NCT00683410|532371|P1|Vaccinated Dose 1|Overall Study||3240
222113|NCT00683410|532371|P1|STARTED|Overall Study||3366
222114|NCT00683384|532375|P1|NOT COMPLETED|Overall Study||2
222115|NCT00683384|532375|P1|COMPLETED|Overall Study||91
222116|NCT00683384|532375|P1|STARTED|Overall Study||93
222117|NCT00683332|532379|P1|NOT COMPLETED|Overall Study||0
222118|NCT00683332|532379|P1|COMPLETED|Overall Study||621
222119|NCT00683332|532379|P1|STARTED|Overall Study||621
222120|NCT00683293|532385|P2|NOT COMPLETED|Overall Study||3
222121|NCT00683293|532386|P1|NOT COMPLETED|Overall Study||2
222122|NCT00683293|532385|P2|COMPLETED|Overall Study||47
222123|NCT00683293|532386|P1|COMPLETED|Overall Study||48
222124|NCT00683293|532385|P2|STARTED|Overall Study||50
222125|NCT00683293|532386|P1|STARTED|Overall Study||50
222126|NCT00683163|532396|P2|NOT COMPLETED|Overall Study||0
222127|NCT00683163|532397|P1|NOT COMPLETED|Overall Study||0
222128|NCT00683163|532396|P2|COMPLETED|Overall Study||22
222129|NCT00683163|532397|P1|COMPLETED|Overall Study||22
222130|NCT00683163|532396|P2|STARTED|Overall Study||22
222131|NCT00683163|532397|P1|STARTED|Overall Study||22
222132|NCT00683085|532405|P1|NOT COMPLETED|Overall Study||0
222133|NCT00683085|532405|P1|COMPLETED|Overall Study||2
222134|NCT00683085|532405|P1|STARTED|Overall Study||2
222135|NCT00683046|532410|P1|NOT COMPLETED|Overall Study||0
222136|NCT00683046|532410|P1|COMPLETED|Overall Study||204
222137|NCT00683046|532410|P1|STARTED|Overall Study||204
222138|NCT00683020|532417|P2|NOT COMPLETED|Overall Study||55
222139|NCT00683020|532418|P1|NOT COMPLETED|Overall Study||55
222140|NCT00683020|532417|P2|COMPLETED|Overall Study||125
222141|NCT00683020|532418|P1|COMPLETED|Overall Study||127
222142|NCT00683020|532417|P2|STARTED|Overall Study||180
222143|NCT00683020|532418|P1|STARTED|Overall Study||182
222144|NCT00682929|532449|P3|NOT COMPLETED|Overall Study||2
222145|NCT00682929|532450|P2|NOT COMPLETED|Overall Study||5
222146|NCT00682929|532451|P1|NOT COMPLETED|Overall Study||6
222147|NCT00682929|532449|P3|COMPLETED|Overall Study||12
222148|NCT00682929|532450|P2|COMPLETED|Overall Study||9
222149|NCT00682929|532451|P1|COMPLETED|Overall Study||7
222150|NCT00682929|532449|P3|STARTED|Overall Study||14
222151|NCT00682929|532450|P2|STARTED|Overall Study||14
222152|NCT00682929|532451|P1|STARTED|Overall Study||13
222153|NCT00682890|532620|P2|NOT COMPLETED|Overall Study||2
222154|NCT00682890|532621|P1|NOT COMPLETED|Overall Study||2
222155|NCT00682890|532620|P2|COMPLETED|Overall Study||9
222156|NCT00682890|532621|P1|COMPLETED|Overall Study||10
222157|NCT00682890|532620|P2|STARTED|Overall Study||11
222158|NCT00682890|532621|P1|STARTED|Overall Study||12
222159|NCT00682851|532631|P2|NOT COMPLETED|Overall Study||0
222160|NCT00682851|532632|P1|NOT COMPLETED|Overall Study||0
222161|NCT00682851|532631|P2|COMPLETED|Overall Study||268
222162|NCT00682851|532632|P1|COMPLETED|Overall Study||251
222163|NCT00682851|532631|P2|STARTED|Overall Study||268
222164|NCT00682851|532632|P1|STARTED|Overall Study||251
222165|NCT00682838|532648|P4|NOT COMPLETED|Overall Study||0
222166|NCT00682838|532649|P3|NOT COMPLETED|Overall Study||0
222167|NCT00682838|532650|P2|NOT COMPLETED|Overall Study||0
222168|NCT00682838|532651|P1|NOT COMPLETED|Overall Study||0
222169|NCT00682838|532648|P4|COMPLETED|Overall Study||73
222170|NCT00682838|532649|P3|COMPLETED|Overall Study||75
222171|NCT00682838|532650|P2|COMPLETED|Overall Study||67
222172|NCT00682838|532651|P1|COMPLETED|Overall Study||65
222173|NCT00682838|532648|P4|STARTED|Overall Study||73
222174|NCT00682838|532649|P3|STARTED|Overall Study||75
222175|NCT00682838|532650|P2|STARTED|Overall Study||67
222176|NCT00682838|532651|P1|STARTED|Overall Study||65
222177|NCT00682786|532663|P2|NOT COMPLETED|Overall Study||3
222178|NCT00682786|532664|P1|NOT COMPLETED|Overall Study||2
222179|NCT00682786|532663|P2|COMPLETED|Overall Study||34
222180|NCT00682786|532664|P1|COMPLETED|Overall Study||96
222181|NCT00682786|532663|P2|STARTED|Overall Study||37
222182|NCT00682786|532664|P1|STARTED|Overall Study||98
222183|NCT00682734|532701|P3|NOT COMPLETED|48 Hour Follow-up||11
222184|NCT00682734|532702|P2|NOT COMPLETED|48 Hour Follow-up||6
222185|NCT00682734|532703|P1|NOT COMPLETED|48 Hour Follow-up||6
222186|NCT00682734|532701|P3|COMPLETED|48 Hour Follow-up||106
222187|NCT00682734|532702|P2|COMPLETED|48 Hour Follow-up||111
222188|NCT00682734|532703|P1|COMPLETED|48 Hour Follow-up||107
222189|NCT00682734|532701|P3|STARTED|48 Hour Follow-up||117
222190|NCT00682734|532702|P2|STARTED|48 Hour Follow-up||117
222191|NCT00682734|532703|P1|STARTED|48 Hour Follow-up||113
222192|NCT00682734|532701|P3|NOT COMPLETED|Emergency Department Portion||1
222193|NCT00682734|532702|P2|NOT COMPLETED|Emergency Department Portion||1
222194|NCT00682734|532703|P1|NOT COMPLETED|Emergency Department Portion||0
222195|NCT00682734|532701|P3|COMPLETED|Emergency Department Portion||117
222196|NCT00682734|532702|P2|COMPLETED|Emergency Department Portion||117
222197|NCT00682734|532703|P1|COMPLETED|Emergency Department Portion||113
222198|NCT00682734|532701|P3|STARTED|Emergency Department Portion||118
222199|NCT00682734|532702|P2|STARTED|Emergency Department Portion||118
222200|NCT00682734|532703|P1|STARTED|Emergency Department Portion||113
222201|NCT00682643|532713|P2|NOT COMPLETED|Overall Study||169
222202|NCT00682643|532714|P1|NOT COMPLETED|Overall Study||78
222203|NCT00682643|532713|P2|COMPLETED|Overall Study||199
222204|NCT00682643|532714|P1|COMPLETED|Overall Study||104
222205|NCT00682643|532713|P2|STARTED|Overall Study||368
222206|NCT00682643|532714|P1|STARTED|Overall Study||182
222207|NCT00682565|532749|P3|NOT COMPLETED|Overall Study||0
222208|NCT00682565|532750|P2|NOT COMPLETED|Overall Study||2
222209|NCT00682565|532751|P1|NOT COMPLETED|Overall Study||1
222210|NCT00682565|532749|P3|COMPLETED|Overall Study||29
222211|NCT00682565|532750|P2|COMPLETED|Overall Study||32
222212|NCT00682565|532751|P1|COMPLETED|Overall Study||30
222213|NCT00682565|532749|P3|STARTED|Overall Study||29
222214|NCT00682565|532750|P2|STARTED|Overall Study||34
222215|NCT00682565|532751|P1|STARTED|Overall Study||31
222216|NCT00682539|532775|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
222217|NCT00682539|532776|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
222218|NCT00682539|532777|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
222219|NCT00682539|532775|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
222220|NCT00682539|532776|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
222221|NCT00682539|532777|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
222222|NCT00682539|532775|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
222223|NCT00682539|532776|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
222224|NCT00682539|532777|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
222225|NCT00682539|532775|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
222226|NCT00682539|532776|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
222227|NCT00682539|532777|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
222228|NCT00682539|532775|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
222229|NCT00682539|532776|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
222230|NCT00682539|532777|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
222231|NCT00682539|532775|P3|STARTED|Bevacizumab vs Triamcinolone||0
222232|NCT00682539|532776|P2|STARTED|Bevacizumab vs Triamcinolone||16
222233|NCT00682539|532777|P1|STARTED|Bevacizumab vs Triamcinolone||18
222234|NCT00682461|532790|P2|NOT COMPLETED|Overall Study||31
222235|NCT00682461|532791|P1|NOT COMPLETED|Overall Study||25
222236|NCT00682461|532790|P2|COMPLETED|Overall Study||69
222237|NCT00682461|532791|P1|COMPLETED|Overall Study||75
222238|NCT00682461|532790|P2|STARTED|Overall Study||100
222239|NCT00682461|532791|P1|STARTED|Overall Study||100
222240|NCT00682357|532808|P3|NOT COMPLETED|Overall Study||0
222241|NCT00682357|532809|P2|NOT COMPLETED|Overall Study||0
222242|NCT00682357|532810|P1|NOT COMPLETED|Overall Study||0
222243|NCT00682357|532808|P3|COMPLETED|Overall Study||5
222244|NCT00682357|532809|P2|COMPLETED|Overall Study||10
222245|NCT00682357|532810|P1|COMPLETED|Overall Study||10
222246|NCT00682357|532808|P3|STARTED|Overall Study||5
222247|NCT00682357|532809|P2|STARTED|Overall Study||10
222248|NCT00682357|532810|P1|STARTED|Overall Study||10
222249|NCT00681889|532827|P1|NOT COMPLETED|Overall Study||0
222250|NCT00681889|532827|P1|COMPLETED|Overall Study||9
222251|NCT00681889|532827|P1|STARTED|Overall Study||9
222252|NCT00681863|532831|P1|NOT COMPLETED|Overall Study||23
222253|NCT00681863|532831|P1|COMPLETED|Overall Study||22
222254|NCT00681863|532831|P1|STARTED|Overall Study||45
222255|NCT00681824|532879|P3|NOT COMPLETED|Overall Study||1
222256|NCT00681824|532880|P2|NOT COMPLETED|Overall Study||1
222257|NCT00681824|532881|P1|NOT COMPLETED|Overall Study||1
222258|NCT00681824|532879|P3|COMPLETED|Overall Study||33
222259|NCT00681824|532880|P2|COMPLETED|Overall Study||12
222260|NCT00681824|532881|P1|COMPLETED|Overall Study||27
222261|NCT00681824|532879|P3|STARTED|Overall Study||34
222262|NCT00681824|532880|P2|STARTED|Overall Study||13
222263|NCT00681824|532881|P1|STARTED|Overall Study||28
222264|NCT00681811|532899|P2|NOT COMPLETED|Overall Study||4
222265|NCT00681811|532900|P1|NOT COMPLETED|Overall Study||3
222266|NCT00681811|532899|P2|COMPLETED|Overall Study||1
222267|NCT00681811|532900|P1|COMPLETED|Overall Study||3
222268|NCT00681811|532899|P2|STARTED|Overall Study||5
222269|NCT00681811|532900|P1|STARTED|Overall Study||6
222270|NCT00681668|532928|P1|NOT COMPLETED|Overall Study||2
222271|NCT00681668|532928|P1|COMPLETED|Overall Study||3
222272|NCT00681668|532928|P1|STARTED|Overall Study||5
222273|NCT00681629|532937|P2|NOT COMPLETED|Overall Study||2
222274|NCT00681629|532938|P1|NOT COMPLETED|Overall Study||5
222275|NCT00681629|532937|P2|COMPLETED|Overall Study||0
222276|NCT00681629|532938|P1|COMPLETED|Overall Study||0
222277|NCT00681629|532937|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
222278|NCT00681629|532938|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
222279|NCT00681590|532984|P2|NOT COMPLETED|Overall Study||12
222280|NCT00681590|532985|P1|NOT COMPLETED|Overall Study||2
222281|NCT00681590|532984|P2|COMPLETED|Overall Study||59
222282|NCT00681590|532985|P1|COMPLETED|Overall Study||32
222283|NCT00681590|532984|P2|STARTED|Overall Study||71
222284|NCT00681590|532985|P1|STARTED|Overall Study||34
222285|NCT00681564|532995|P2|NOT COMPLETED|Overall Study||8
222286|NCT00681564|532996|P1|NOT COMPLETED|Overall Study||6
222287|NCT00681564|532995|P2|COMPLETED|Overall Study||47
222288|NCT00681564|532996|P1|COMPLETED|Overall Study||41
222289|NCT00681564|532995|P2|STARTED|Overall Study||55
222290|NCT00681564|532996|P1|STARTED|Overall Study||47
222291|NCT00681538|533026|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
222292|NCT00681538|533027|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
222293|NCT00681538|533026|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
222294|NCT00681538|533027|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
222295|NCT00681538|533026|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
222296|NCT00681538|533027|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
222297|NCT00681538|533026|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
222298|NCT00681538|533027|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
222299|NCT00681538|533026|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
222300|NCT00681538|533027|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
222301|NCT00681538|533026|P2|STARTED|Phase A- 4 Weeks Single Blind||0
222302|NCT00681538|533027|P1|STARTED|Phase A- 4 Weeks Single Blind||572
222303|NCT00681473|533057|P1|NOT COMPLETED|Overall Study||0
222304|NCT00681473|533057|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
222305|NCT00681473|533057|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
222306|NCT00681291|533065|P2|NOT COMPLETED|Overall Study||27
222307|NCT00681291|533066|P1|NOT COMPLETED|Overall Study||13
222308|NCT00681291|533065|P2|COMPLETED|Overall Study||57
222309|NCT00681291|533066|P1|COMPLETED|Overall Study||75
222310|NCT00681291|533065|P2|STARTED|Overall Study||84
222311|NCT00681291|533066|P1|STARTED|Overall Study||88
222312|NCT00681265|533078|P1|NOT COMPLETED|Overall Study||0
222313|NCT00681265|533078|P1|COMPLETED|Overall Study||16
222314|NCT00681265|533078|P1|STARTED|Overall Study||16
222315|NCT00681187|533088|P2|NOT COMPLETED|Overall Study||2
222316|NCT00681187|533089|P1|NOT COMPLETED|Overall Study||1
222317|NCT00681187|533088|P2|COMPLETED|Overall Study||13
222318|NCT00681187|533089|P1|COMPLETED|Overall Study||10
222319|NCT00681187|533088|P2|STARTED|Overall Study||15
222320|NCT00681187|533089|P1|STARTED|Overall Study||11
222321|NCT00681109|533124|P3|NOT COMPLETED|Overall Study||0
222322|NCT00681109|533125|P2|NOT COMPLETED|Overall Study||6
222323|NCT00681109|533126|P1|NOT COMPLETED|Overall Study||2
222324|NCT00681109|533124|P3|COMPLETED|Overall Study||15
222325|NCT00681109|533125|P2|COMPLETED|Overall Study||24
222326|NCT00681109|533126|P1|COMPLETED|Overall Study||28
222327|NCT00681109|533124|P3|STARTED|Overall Study||15
222328|NCT00681109|533125|P2|STARTED|Overall Study||30
222329|NCT00681109|533126|P1|STARTED|Overall Study||30
222330|NCT00681044|533143|P1|NOT COMPLETED|Overall Study||0
222331|NCT00681044|533143|P1|COMPLETED|Overall Study||4
222332|NCT00681044|533143|P1|STARTED|Overall Study||4
222333|NCT00681031|533151|P1|NOT COMPLETED|Overall Study||0
222334|NCT00681031|533151|P1|COMPLETED|Overall Study||96
222335|NCT00681031|533151|P1|STARTED|Overall Study||96
222336|NCT00680953|533158|P3|NOT COMPLETED|Overall Study||47
222337|NCT00680953|533159|P2|NOT COMPLETED|Overall Study||95
222338|NCT00680953|533160|P1|NOT COMPLETED|Overall Study||86
222339|NCT00680953|533158|P3|COMPLETED|Overall Study||204
222340|NCT00680953|533159|P2|COMPLETED|Overall Study||416
222341|NCT00680953|533160|P1|COMPLETED|Overall Study||414
222342|NCT00680953|533158|P3|STARTED|Overall Study||251
222343|NCT00680953|533159|P2|STARTED|Overall Study||511
222344|NCT00680953|533160|P1|STARTED|Overall Study||500
222345|NCT00680914|533176|P2|NOT COMPLETED|Overall Study||4
222346|NCT00680914|533177|P1|NOT COMPLETED|Overall Study||10
222347|NCT00680914|533176|P2|COMPLETED|Overall Study||125
222348|NCT00680914|533177|P1|COMPLETED|Overall Study||364
222349|NCT00680914|533176|P2|STARTED|Overall Study||129
222350|NCT00680914|533177|P1|STARTED|Overall Study||374
222351|NCT00680901|533211|P2|NOT COMPLETED|Overall Study||76
222352|NCT00680901|533212|P1|NOT COMPLETED|Overall Study||73
222353|NCT00680901|533211|P2|COMPLETED|Overall Study||197
222354|NCT00680901|533212|P1|COMPLETED|Overall Study||199
222355|NCT00680901|533211|P2|Ongoing: In Follow Up|Overall Study||41
222356|NCT00680901|533212|P1|Ongoing: In Follow Up|Overall Study||45
222357|NCT00680901|533211|P2|Ongoing: On Study Treatment|Overall Study||13
222358|NCT00680901|533212|P1|Ongoing: On Study Treatment|Overall Study||16
222359|NCT00680901|533211|P2|STARTED|Overall Study||273
222360|NCT00680901|533212|P1|STARTED|Overall Study||272
222361|NCT00680862|533244|P1|NOT COMPLETED|Overall Study||0
222362|NCT00680862|533244|P1|COMPLETED|Overall Study||25
222363|NCT00680862|533244|P1|STARTED|Overall Study||25
222364|NCT00680836|533250|P2|NOT COMPLETED|Overall Study||2
222365|NCT00680836|533251|P1|NOT COMPLETED|Overall Study||8
222366|NCT00680836|533250|P2|COMPLETED|Overall Study||25
222367|NCT00680836|533251|P1|COMPLETED|Overall Study||19
222368|NCT00680836|533250|P2|STARTED|Overall Study||27
222369|NCT00680836|533251|P1|STARTED|Overall Study||27
222370|NCT00680823|533270|P3|NOT COMPLETED|Overall Study||0
222371|NCT00680823|533271|P2|NOT COMPLETED|Overall Study||0
222372|NCT00680823|533272|P1|NOT COMPLETED|Overall Study||0
222373|NCT00680823|533270|P3|COMPLETED|Overall Study||50
222374|NCT00680823|533271|P2|COMPLETED|Overall Study||50
222375|NCT00680823|533272|P1|COMPLETED|Overall Study||50
222376|NCT00680823|533270|P3|STARTED|Overall Study||50
222377|NCT00680823|533271|P2|STARTED|Overall Study||50
222378|NCT00680823|533272|P1|STARTED|Overall Study||50
222379|NCT00680797|533290|P4|NOT COMPLETED|Overall Study||0
222380|NCT00680797|533291|P3|NOT COMPLETED|Overall Study||0
222381|NCT00680797|533292|P2|NOT COMPLETED|Overall Study||0
222382|NCT00680797|533293|P1|NOT COMPLETED|Overall Study||0
222383|NCT00680797|533290|P4|COMPLETED|Overall Study||8
222384|NCT00680797|533291|P3|COMPLETED|Overall Study||8
222385|NCT00680797|533292|P2|COMPLETED|Overall Study||8
222386|NCT00680797|533293|P1|COMPLETED|Overall Study||9
222387|NCT00680797|533290|P4|STARTED|Overall Study||8
222388|NCT00680797|533291|P3|STARTED|Overall Study||8
222389|NCT00680797|533292|P2|STARTED|Overall Study||8
222390|NCT00680797|533293|P1|STARTED|Overall Study||9
222391|NCT00680771|533305|P2|NOT COMPLETED|Overall Study||2
222392|NCT00680771|533306|P1|NOT COMPLETED|Overall Study||6
222393|NCT00680771|533305|P2|COMPLETED|Overall Study||11
222394|NCT00680771|533306|P1|COMPLETED|Overall Study||9
222395|NCT00680771|533305|P2|STARTED|Overall Study||13
222396|NCT00680771|533306|P1|STARTED|Overall Study||15
222397|NCT00680745|533316|P4|NOT COMPLETED|Overall Study||13
222398|NCT00680745|533317|P3|NOT COMPLETED|Overall Study||10
222399|NCT00680745|533318|P2|NOT COMPLETED|Overall Study||13
222400|NCT00680745|533319|P1|NOT COMPLETED|Overall Study||14
222401|NCT00680745|533316|P4|COMPLETED|Overall Study||133
222402|NCT00680745|533317|P3|COMPLETED|Overall Study||141
222403|NCT00680745|533318|P2|COMPLETED|Overall Study||132
222404|NCT00680745|533319|P1|COMPLETED|Overall Study||140
222405|NCT00680745|533316|P4|STARTED|Overall Study|Safety Analysis Set|146
222406|NCT00680745|533317|P3|STARTED|Overall Study|Safety Analysis Set|151
222407|NCT00680745|533318|P2|STARTED|Overall Study|Safety Analysis Set|145
222408|NCT00680745|533319|P1|STARTED|Overall Study|Safety Analysis Set|154
222409|NCT00680706|533351|P2|NOT COMPLETED|Overall Study||5
222410|NCT00680706|533352|P1|NOT COMPLETED|Overall Study||7
222411|NCT00680706|533351|P2|COMPLETED|Overall Study||55
222412|NCT00680706|533352|P1|COMPLETED|Overall Study||63
222413|NCT00680706|533351|P2|STARTED|Overall Study||60
222414|NCT00680706|533352|P1|STARTED|Overall Study||70
222415|NCT00680628|533362|P2|NOT COMPLETED|Overall Study||0
222416|NCT00680628|533363|P1|NOT COMPLETED|Overall Study||0
222417|NCT00680628|533362|P2|COMPLETED|Overall Study||40
222418|NCT00680628|533363|P1|COMPLETED|Overall Study||43
222419|NCT00680628|533362|P2|STARTED|Overall Study||40
222420|NCT00680628|533363|P1|STARTED|Overall Study||43
222421|NCT00680524|533373|P1|NOT COMPLETED|Overall Study||3
222422|NCT00680524|533373|P1|COMPLETED|Overall Study||17
222423|NCT00680524|533373|P1|STARTED|Overall Study||20
222424|NCT00680459|533379|P2|NOT COMPLETED|Overall Study||0
222425|NCT00680459|533380|P1|NOT COMPLETED|Overall Study||0
222426|NCT00680459|533379|P2|COMPLETED|Overall Study||6
222427|NCT00680459|533380|P1|COMPLETED|Overall Study||7
222428|NCT00680459|533379|P2|STARTED|Overall Study||6
222429|NCT00680459|533380|P1|STARTED|Overall Study||7
222430|NCT00680407|533393|P3|NOT COMPLETED|Overall Study||3
222431|NCT00680407|533394|P2|NOT COMPLETED|Overall Study||5
222432|NCT00680407|533395|P1|NOT COMPLETED|Overall Study||8
222433|NCT00680407|533393|P3|COMPLETED|Overall Study||22
222434|NCT00680407|533394|P2|COMPLETED|Overall Study||22
222435|NCT00680407|533395|P1|COMPLETED|Overall Study||18
222436|NCT00680407|533393|P3|STARTED|Overall Study||25
222437|NCT00680407|533394|P2|STARTED|Overall Study||27
222438|NCT00680407|533395|P1|STARTED|Overall Study||26
222439|NCT00680368|533409|P1|NOT COMPLETED|Overall Study||15
222440|NCT00680368|533409|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
222441|NCT00680368|533409|P1|STARTED|Overall Study||112
222442|NCT00680316|533417|P2|NOT COMPLETED|Overall Study||0
222443|NCT00680316|533418|P1|NOT COMPLETED|Overall Study||0
222444|NCT00680316|533417|P2|COMPLETED|Overall Study||2
222445|NCT00680316|533418|P1|COMPLETED|Overall Study||1
222446|NCT00680316|533417|P2|STARTED|Overall Study||2
222447|NCT00680316|533418|P1|STARTED|Overall Study||1
222448|NCT00680225|533430|P1|NOT COMPLETED|Overall Study||2
222449|NCT00680225|533430|P1|COMPLETED|Overall Study||8
222450|NCT00680225|533430|P1|STARTED|Overall Study||10
222451|NCT00680186|533437|P2|NOT COMPLETED|Overall Study||116
222452|NCT00680186|533438|P1|NOT COMPLETED|Overall Study||125
222453|NCT00680186|533437|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
222454|NCT00680186|533438|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
222455|NCT00680186|533437|P2|STARTED|Overall Study|Started treatment.|1288
222456|NCT00680186|533438|P1|STARTED|Overall Study|Started treatment.|1280
222457|NCT00680121|533464|P2|NOT COMPLETED|Overall Study||23
222458|NCT00680121|533465|P1|NOT COMPLETED|Overall Study||27
222459|NCT00680121|533464|P2|COMPLETED|Overall Study||37
222460|NCT00680121|533465|P1|COMPLETED|Overall Study||33
222461|NCT00680121|533464|P2|STARTED|Overall Study||60
222462|NCT00680121|533465|P1|STARTED|Overall Study||60
222463|NCT00680056|533479|P2|NOT COMPLETED|Second Intervention||1
222464|NCT00680056|533480|P1|NOT COMPLETED|Second Intervention||3
222465|NCT00680056|533479|P2|COMPLETED|Second Intervention||14
222466|NCT00680056|533480|P1|COMPLETED|Second Intervention||12
222467|NCT00680056|533479|P2|STARTED|Second Intervention||15
222468|NCT00680056|533480|P1|STARTED|Second Intervention||15
222469|NCT00680056|533479|P2|NOT COMPLETED|Washout Period of One Week||0
222470|NCT00680056|533480|P1|NOT COMPLETED|Washout Period of One Week||0
222471|NCT00680056|533479|P2|COMPLETED|Washout Period of One Week||15
222472|NCT00680056|533480|P1|COMPLETED|Washout Period of One Week||15
222473|NCT00680056|533479|P2|STARTED|Washout Period of One Week||15
222474|NCT00680056|533480|P1|STARTED|Washout Period of One Week||15
222475|NCT00680056|533479|P2|NOT COMPLETED|First Intervention||2
222476|NCT00680056|533480|P1|NOT COMPLETED|First Intervention||1
222477|NCT00680056|533479|P2|COMPLETED|First Intervention||15
222478|NCT00680056|533480|P1|COMPLETED|First Intervention||15
222479|NCT00680056|533479|P2|STARTED|First Intervention||17
222480|NCT00680056|533480|P1|STARTED|First Intervention||16
222481|NCT00680043|533491|P3|NOT COMPLETED|Overall Study||4
222482|NCT00680043|533492|P2|NOT COMPLETED|Overall Study||1
222483|NCT00680043|533493|P1|NOT COMPLETED|Overall Study||2
222484|NCT00680043|533491|P3|COMPLETED|Overall Study||34
222485|NCT00680043|533492|P2|COMPLETED|Overall Study||36
222486|NCT00680043|533493|P1|COMPLETED|Overall Study||37
222487|NCT00680043|533491|P3|STARTED|Overall Study||38
222488|NCT00680043|533492|P2|STARTED|Overall Study||37
222489|NCT00680043|533493|P1|STARTED|Overall Study||39
222490|NCT00680017|533509|P2|NOT COMPLETED|Overall Study||12
222491|NCT00680017|533510|P1|NOT COMPLETED|Overall Study||17
222492|NCT00680017|533509|P2|COMPLETED|Overall Study||128
222493|NCT00680017|533510|P1|COMPLETED|Overall Study||123
222494|NCT00680017|533509|P2|STARTED|Overall Study||140
222495|NCT00680017|533510|P1|STARTED|Overall Study||140
222496|NCT00679952|533520|P2|NOT COMPLETED|Overall Study||0
222497|NCT00679952|533521|P1|NOT COMPLETED|Overall Study||0
222498|NCT00679952|533520|P2|COMPLETED|Overall Study||82
222499|NCT00679952|533521|P1|COMPLETED|Overall Study||86
222500|NCT00679952|533520|P2|STARTED|Overall Study||82
222501|NCT00679952|533521|P1|STARTED|Overall Study||86
222502|NCT00679939|533529|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
222503|NCT00679939|533530|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
222504|NCT00679939|533529|P2|COMPLETED|24-Week Open-Label (OL) Period||80
222505|NCT00679939|533530|P1|COMPLETED|24-Week Open-Label (OL) Period||69
222506|NCT00679939|533529|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
222507|NCT00679939|533530|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
222508|NCT00679939|533529|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
222509|NCT00679939|533530|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
222510|NCT00679939|533529|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
222511|NCT00679939|533530|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
222512|NCT00679939|533529|P2|STARTED|52-Week Double-Blind (DB) Period||112
222513|NCT00679939|533530|P1|STARTED|52-Week Double-Blind (DB) Period||114
222514|NCT00679913|533681|P2|NOT COMPLETED|Overall Study||13
222515|NCT00679913|533682|P1|NOT COMPLETED|Overall Study||18
222516|NCT00679913|533681|P2|COMPLETED|Overall Study||86
222517|NCT00679913|533682|P1|COMPLETED|Overall Study||83
222518|NCT00679913|533681|P2|STARTED|Overall Study||99
222519|NCT00679913|533682|P1|STARTED|Overall Study||101
222520|NCT00679783|533697|P7|NOT COMPLETED|Overall Study||1
222521|NCT00679783|533698|P6|NOT COMPLETED|Overall Study||0
222522|NCT00679783|533699|P5|NOT COMPLETED|Overall Study||1
222523|NCT00679783|533700|P4|NOT COMPLETED|Overall Study||20
222524|NCT00679783|533701|P3|NOT COMPLETED|Overall Study||1
222525|NCT00679783|533702|P2|NOT COMPLETED|Overall Study||3
222526|NCT00679783|533703|P1|NOT COMPLETED|Overall Study||2
222527|NCT00679783|533697|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
222528|NCT00679783|533698|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
222529|NCT00679783|533699|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
222530|NCT00679783|533700|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
222531|NCT00679783|533701|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
222532|NCT00679783|533702|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
222533|NCT00679783|533703|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
222534|NCT00679783|533697|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
222535|NCT00679783|533698|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
222536|NCT00679783|533699|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
222537|NCT00679783|533700|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
222538|NCT00679783|533701|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
222539|NCT00679783|533702|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
222540|NCT00679783|533703|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
222541|NCT00679627|533756|P2|NOT COMPLETED|Overall Study||685
222542|NCT00679627|533757|P1|NOT COMPLETED|Overall Study||699
222543|NCT00679627|533756|P2|COMPLETED|Overall Study||339
222544|NCT00679627|533757|P1|COMPLETED|Overall Study||322
222545|NCT00679627|533756|P2|STARTED|Overall Study||1024
222546|NCT00679627|533757|P1|STARTED|Overall Study||1021
222547|NCT00679432|533783|P4|NOT COMPLETED|Overall Study||32
222548|NCT00679432|533784|P3|NOT COMPLETED|Overall Study||53
222549|NCT00679432|533785|P2|NOT COMPLETED|Overall Study||38
222550|NCT00679432|533786|P1|NOT COMPLETED|Overall Study||37
222551|NCT00679432|533783|P4|COMPLETED|Overall Study||95
222552|NCT00679432|533784|P3|COMPLETED|Overall Study||76
222553|NCT00679432|533785|P2|COMPLETED|Overall Study||89
222554|NCT00679432|533786|P1|COMPLETED|Overall Study||89
222555|NCT00679432|533783|P4|STARTED|Overall Study||127
222556|NCT00679432|533784|P3|STARTED|Overall Study||129
222557|NCT00679432|533785|P2|STARTED|Overall Study||127
222558|NCT00679432|533786|P1|STARTED|Overall Study||126
222559|NCT00679380|533808|P4|NOT COMPLETED|Overall Study||28
222560|NCT00679380|533809|P3|NOT COMPLETED|Overall Study||35
222561|NCT00679380|533810|P2|NOT COMPLETED|Overall Study||33
222562|NCT00679380|533811|P1|NOT COMPLETED|Overall Study||42
222563|NCT00679380|533808|P4|COMPLETED|Overall Study||61
222564|NCT00679380|533809|P3|COMPLETED|Overall Study||68
222565|NCT00679380|533810|P2|COMPLETED|Overall Study||76
222566|NCT00679380|533811|P1|COMPLETED|Overall Study||67
222567|NCT00679380|533808|P4|STARTED|Overall Study||89
222568|NCT00679380|533809|P3|STARTED|Overall Study||103
222569|NCT00679380|533810|P2|STARTED|Overall Study||109
222570|NCT00679380|533811|P1|STARTED|Overall Study||109
222571|NCT00679367|533829|P1|NOT COMPLETED|Overall Study||12
222572|NCT00679367|533829|P1|COMPLETED|Overall Study||4
222573|NCT00679367|533829|P1|STARTED|Overall Study||16
222574|NCT00679354|533835|P1|NOT COMPLETED|Overall Study||30
222575|NCT00679354|533835|P1|COMPLETED|Overall Study||0
222576|NCT00679354|533835|P1|STARTED|Overall Study||30
222577|NCT00679341|533841|P2|NOT COMPLETED|Overall Study||51
222578|NCT00679341|533842|P1|NOT COMPLETED|Overall Study||53
222579|NCT00679341|533841|P2|COMPLETED|Overall Study||19
222580|NCT00679341|533842|P1|COMPLETED|Overall Study||14
222581|NCT00679341|533841|P2|STARTED|Overall Study||70
222582|NCT00679341|533842|P1|STARTED|Overall Study||67
222583|NCT00679302|533862|P2|NOT COMPLETED|Overall Study||4
222584|NCT00679302|533863|P1|NOT COMPLETED|Overall Study||8
222585|NCT00679302|533862|P2|COMPLETED|Overall Study||73
222586|NCT00679302|533863|P1|COMPLETED|Overall Study||76
222587|NCT00679302|533862|P2|STARTED|Overall Study||77
222588|NCT00679302|533863|P1|STARTED|Overall Study||84
222589|NCT00679289|533874|P3|NOT COMPLETED|Overall Study||23
222590|NCT00679289|533875|P2|NOT COMPLETED|Overall Study||6
222591|NCT00679289|533876|P1|NOT COMPLETED|Overall Study||5
222592|NCT00679289|533874|P3|COMPLETED|Overall Study||1
222593|NCT00679289|533875|P2|COMPLETED|Overall Study||0
222594|NCT00679289|533876|P1|COMPLETED|Overall Study||1
222595|NCT00679289|533874|P3|STARTED|Overall Study||24
222596|NCT00679289|533875|P2|STARTED|Overall Study||6
222597|NCT00679289|533876|P1|STARTED|Overall Study||6
222598|NCT00679263|533898|P3|NOT COMPLETED|Visit 2/Dose 1||0
222599|NCT00679263|533899|P2|NOT COMPLETED|Visit 2/Dose 1||1
222600|NCT00679263|533900|P1|NOT COMPLETED|Visit 2/Dose 1||2
222601|NCT00679263|533898|P3|COMPLETED|Visit 2/Dose 1||11
222602|NCT00679263|533899|P2|COMPLETED|Visit 2/Dose 1||5
222603|NCT00679263|533900|P1|COMPLETED|Visit 2/Dose 1||9
222604|NCT00679263|533898|P3|STARTED|Visit 2/Dose 1||11
222605|NCT00679263|533899|P2|STARTED|Visit 2/Dose 1||6
222606|NCT00679263|533900|P1|STARTED|Visit 2/Dose 1||11
222607|NCT00679263|533898|P3|NOT COMPLETED|Visit 3/Dose 2||0
222608|NCT00679263|533899|P2|NOT COMPLETED|Visit 3/Dose 2||5
222609|NCT00679263|533900|P1|NOT COMPLETED|Visit 3/Dose 2||1
222610|NCT00679263|533898|P3|COMPLETED|Visit 3/Dose 2||11
222611|NCT00679263|533899|P2|COMPLETED|Visit 3/Dose 2||6
222612|NCT00679263|533900|P1|COMPLETED|Visit 3/Dose 2||9
222613|NCT00679263|533898|P3|STARTED|Visit 3/Dose 2||11
222614|NCT00679263|533899|P2|STARTED|Visit 3/Dose 2||11
222615|NCT00679263|533900|P1|STARTED|Visit 3/Dose 2||10
222616|NCT00679211|533911|P1|NOT COMPLETED|Overall Study||110
222617|NCT00679211|533911|P1|COMPLETED|Overall Study||0
222618|NCT00679211|533911|P1|STARTED|Overall Study||110
222619|NCT00679172|533928|P5|NOT COMPLETED|Overall Study||0
222620|NCT00679172|533929|P4|NOT COMPLETED|Overall Study||1
222621|NCT00679172|533930|P3|NOT COMPLETED|Overall Study||1
222622|NCT00679172|533931|P2|NOT COMPLETED|Overall Study||1
222623|NCT00679172|533932|P1|NOT COMPLETED|Overall Study||1
222624|NCT00679172|533928|P5|COMPLETED|Overall Study||37
222625|NCT00679172|533929|P4|COMPLETED|Overall Study||38
222626|NCT00679172|533930|P3|COMPLETED|Overall Study||35
222627|NCT00679172|533931|P2|COMPLETED|Overall Study||37
222628|NCT00679172|533932|P1|COMPLETED|Overall Study||36
222629|NCT00679172|533928|P5|STARTED|Overall Study||37
222630|NCT00679172|533929|P4|STARTED|Overall Study||39
222631|NCT00679172|533930|P3|STARTED|Overall Study||36
222632|NCT00679172|533931|P2|STARTED|Overall Study||38
222633|NCT00679172|533932|P1|STARTED|Overall Study||37
222634|NCT00679081|533995|P1|NOT COMPLETED|Overall Study||1
222635|NCT00679081|533995|P1|COMPLETED|Overall Study||14
222636|NCT00679081|533995|P1|STARTED|Overall Study|Study design was within-subject control.|15
222637|NCT00679055|534005|P2|NOT COMPLETED|Overall Study||5
222638|NCT00679055|534006|P1|NOT COMPLETED|Overall Study||2
222639|NCT00679055|534005|P2|COMPLETED|Overall Study||1
222640|NCT00679055|534006|P1|COMPLETED|Overall Study||6
222641|NCT00679055|534005|P2|STARTED|Overall Study||6
222642|NCT00679055|534006|P1|STARTED|Overall Study||8
222643|NCT00678899|534016|P1|NOT COMPLETED|Overall Study||1
222644|NCT00678899|534016|P1|COMPLETED|Overall Study||49
222645|NCT00678899|534016|P1|STARTED|Overall Study||50
222646|NCT00678886|534025|P4|NOT COMPLETED|Overall Study||9
222647|NCT00678886|534026|P3|NOT COMPLETED|Overall Study||9
222648|NCT00678886|534027|P2|NOT COMPLETED|Overall Study||0
222649|NCT00678886|534028|P1|NOT COMPLETED|Overall Study||0
222650|NCT00678886|534025|P4|COMPLETED|Overall Study||153
222651|NCT00678886|534026|P3|COMPLETED|Overall Study||72
222652|NCT00678886|534027|P2|COMPLETED|Overall Study||19
222653|NCT00678886|534028|P1|COMPLETED|Overall Study||10
222654|NCT00678886|534025|P4|STARTED|Overall Study||162
222655|NCT00678886|534026|P3|STARTED|Overall Study||81
222656|NCT00678886|534027|P2|STARTED|Overall Study||19
222657|NCT00678886|534028|P1|STARTED|Overall Study||10
222658|NCT00678834|534075|P3|NOT COMPLETED|Overall Study||9
222659|NCT00678834|534076|P2|NOT COMPLETED|Overall Study||0
222660|NCT00678834|534077|P1|NOT COMPLETED|Overall Study||16
222661|NCT00678834|534075|P3|COMPLETED|Overall Study||16
222662|NCT00678834|534076|P2|COMPLETED|Overall Study||15
222663|NCT00678834|534077|P1|COMPLETED|Overall Study||24
222664|NCT00678834|534075|P3|STARTED|Overall Study||25
222665|NCT00678834|534076|P2|STARTED|Overall Study||15
222666|NCT00678834|534077|P1|STARTED|Overall Study||40
222667|NCT00678795|534097|P2|NOT COMPLETED|Overall Study||6
222668|NCT00678795|534098|P1|NOT COMPLETED|Overall Study||11
222669|NCT00678795|534097|P2|COMPLETED|Overall Study||62
222670|NCT00678795|534098|P1|COMPLETED|Overall Study||56
222671|NCT00678795|534097|P2|STARTED|Overall Study||68
222672|NCT00678795|534098|P1|STARTED|Overall Study||67
222673|NCT00678691|534120|P2|NOT COMPLETED|Overall Study||4
222674|NCT00678691|534121|P1|NOT COMPLETED|Overall Study||6
222675|NCT00678691|534120|P2|COMPLETED|Overall Study||24
222676|NCT00678691|534121|P1|COMPLETED|Overall Study||21
222677|NCT00678691|534120|P2|STARTED|Overall Study||28
222678|NCT00678691|534121|P1|STARTED|Overall Study||27
222679|NCT00678652|534131|P4|NOT COMPLETED|Overall Study||0
222680|NCT00678652|534132|P3|NOT COMPLETED|Overall Study||1
222681|NCT00678652|534133|P2|NOT COMPLETED|Overall Study||0
222682|NCT00678652|534134|P1|NOT COMPLETED|Overall Study||3
222683|NCT00678652|534131|P4|COMPLETED|Overall Study||9
222684|NCT00678652|534132|P3|COMPLETED|Overall Study||8
222685|NCT00678652|534133|P2|COMPLETED|Overall Study||9
222686|NCT00678652|534134|P1|COMPLETED|Overall Study||6
222687|NCT00678652|534131|P4|STARTED|Overall Study||9
222688|NCT00678652|534132|P3|STARTED|Overall Study||9
222689|NCT00678652|534133|P2|STARTED|Overall Study||9
222690|NCT00678652|534134|P1|STARTED|Overall Study||9
222691|NCT00678639|534158|P2|NOT COMPLETED|Overall Study||0
222692|NCT00678639|534159|P1|NOT COMPLETED|Overall Study||2
222693|NCT00678639|534158|P2|COMPLETED|Overall Study||57
222694|NCT00678639|534159|P1|COMPLETED|Overall Study||51
222695|NCT00678639|534158|P2|Hospital Discharge|Overall Study||57
222696|NCT00678639|534159|P1|Hospital Discharge|Overall Study||53
222697|NCT00678639|534158|P2|STARTED|Overall Study||57
222698|NCT00678639|534159|P1|STARTED|Overall Study||53
222699|NCT00678587|534174|P2|NOT COMPLETED|Overall Study||18
222700|NCT00678587|534175|P1|NOT COMPLETED|Overall Study||20
222701|NCT00678587|534174|P2|COMPLETED|Overall Study||127
222702|NCT00678587|534175|P1|COMPLETED|Overall Study||127
222703|NCT00678587|534174|P2|STARTED|Overall Study||145
222704|NCT00678587|534175|P1|STARTED|Overall Study||147
222705|NCT00678574|534209|P2|NOT COMPLETED|Overall Study||0
222706|NCT00678574|534210|P1|NOT COMPLETED|Overall Study||0
222707|NCT00678574|534209|P2|COMPLETED|Overall Study||27
222708|NCT00678574|534210|P1|COMPLETED|Overall Study||18
222709|NCT00678574|534209|P2|STARTED|Overall Study||27
222710|NCT00678574|534210|P1|STARTED|Overall Study||18
222711|NCT00678535|534218|P2|NOT COMPLETED|Overall Study||98
222712|NCT00678535|534219|P1|NOT COMPLETED|Overall Study||93
222713|NCT00678535|534218|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
222714|NCT00678535|534219|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
222715|NCT00678535|534218|P2|STARTED|Overall Study|ITT population|449
222716|NCT00678535|534219|P1|STARTED|Overall Study|ITT population|455
222717|NCT00678470|534235|P1|NOT COMPLETED|Overall Study||3
222718|NCT00678470|534235|P1|COMPLETED|Overall Study||15
222719|NCT00678470|534235|P1|STARTED|Overall Study||18
222720|NCT00678418|534241|P2|NOT COMPLETED|Part B (Open Label)||0
222721|NCT00678418|534242|P1|NOT COMPLETED|Part B (Open Label)||43
222722|NCT00678418|534241|P2|COMPLETED|Part B (Open Label)||0
222723|NCT00678418|534242|P1|COMPLETED|Part B (Open Label)||71
222724|NCT00678418|534241|P2|STARTED|Part B (Open Label)||0
222725|NCT00678418|534242|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
222726|NCT00678418|534241|P2|NOT COMPLETED|Part A (Double Blind)||77
222727|NCT00678418|534242|P1|NOT COMPLETED|Part A (Double Blind)||59
222728|NCT00678418|534241|P2|COMPLETED|Part A (Double Blind)||47
222729|NCT00678418|534242|P1|COMPLETED|Part A (Double Blind)||67
222730|NCT00678418|534241|P2|STARTED|Part A (Double Blind)||124
222731|NCT00678418|534242|P1|STARTED|Part A (Double Blind)||126
222732|NCT00678392|534258|P2|NOT COMPLETED|Overall Study||362
222733|NCT00678392|534259|P1|NOT COMPLETED|Overall Study||361
222734|NCT00678392|534258|P2|COMPLETED|Overall Study||0
222735|NCT00678392|534259|P1|COMPLETED|Overall Study||0
222736|NCT00678392|534258|P2|Treated|Overall Study||355
222737|NCT00678392|534259|P1|Treated|Overall Study||359
222738|NCT00678392|534258|P2|STARTED|Overall Study||362
222739|NCT00678392|534259|P1|STARTED|Overall Study||361
222740|NCT00678379|534294|P3|NOT COMPLETED|Overall Study||4
222741|NCT00678379|534295|P2|NOT COMPLETED|Overall Study||3
222742|NCT00678379|534296|P1|NOT COMPLETED|Overall Study||6
222743|NCT00678379|534294|P3|COMPLETED|Overall Study||36
222744|NCT00678379|534295|P2|COMPLETED|Overall Study||37
222745|NCT00678379|534296|P1|COMPLETED|Overall Study||34
222746|NCT00678379|534294|P3|STARTED|Overall Study||40
222747|NCT00678379|534295|P2|STARTED|Overall Study||40
222748|NCT00678379|534296|P1|STARTED|Overall Study||40
222749|NCT00678301|534324|P2|NOT COMPLETED|Overall Study||2
222750|NCT00678301|534325|P1|NOT COMPLETED|Overall Study||8
222751|NCT00678301|534324|P2|COMPLETED|Overall Study||116
222752|NCT00678301|534325|P1|COMPLETED|Overall Study||231
222753|NCT00678301|534324|P2|STARTED|Overall Study||118
222754|NCT00678301|534325|P1|STARTED|Overall Study||239
222755|NCT00678288|534383|P2|NOT COMPLETED|Overall Study||6
222756|NCT00678288|534384|P1|NOT COMPLETED|Overall Study||10
222757|NCT00678288|534383|P2|COMPLETED|Overall Study||0
222758|NCT00678288|534384|P1|COMPLETED|Overall Study||0
222759|NCT00678288|534383|P2|STARTED|Overall Study||6
222760|NCT00678288|534384|P1|STARTED|Overall Study||10
222761|NCT00678249|534401|P3|NOT COMPLETED|Overall Study||0
222762|NCT00678249|534402|P2|NOT COMPLETED|Overall Study||0
222763|NCT00678249|534403|P1|NOT COMPLETED|Overall Study||0
222764|NCT00678249|534401|P3|COMPLETED|Overall Study||37
222765|NCT00678249|534402|P2|COMPLETED|Overall Study||93
222766|NCT00678249|534403|P1|COMPLETED|Overall Study||97
222767|NCT00678249|534401|P3|STARTED|Overall Study||37
222768|NCT00678249|534402|P2|STARTED|Overall Study||93
222769|NCT00678249|534403|P1|STARTED|Overall Study||97
222770|NCT00678210|534439|P4|NOT COMPLETED|Overall Study||20
222771|NCT00678210|534440|P3|NOT COMPLETED|Overall Study||6
222772|NCT00678210|534441|P2|NOT COMPLETED|Overall Study||11
222773|NCT00678210|534442|P1|NOT COMPLETED|Overall Study||11
222774|NCT00678210|534439|P4|COMPLETED|Overall Study||30
222775|NCT00678210|534440|P3|COMPLETED|Overall Study||43
222776|NCT00678210|534441|P2|COMPLETED|Overall Study||38
222777|NCT00678210|534442|P1|COMPLETED|Overall Study||38
222778|NCT00678210|534439|P4|STARTED|Overall Study||50
222779|NCT00678210|534440|P3|STARTED|Overall Study||49
222780|NCT00678210|534441|P2|STARTED|Overall Study||49
222781|NCT00678210|534442|P1|STARTED|Overall Study||49
222782|NCT00678041|534478|P2|NOT COMPLETED|Overall Study||5
222783|NCT00678041|534479|P1|NOT COMPLETED|Overall Study||5
222784|NCT00678041|534478|P2|COMPLETED|Overall Study||0
222785|NCT00678041|534479|P1|COMPLETED|Overall Study||0
222786|NCT00678041|534478|P2|STARTED|Overall Study||5
222787|NCT00678041|534479|P1|STARTED|Overall Study||5
222788|NCT00678015|534491|P1|NOT COMPLETED|Overall Study||0
222789|NCT00678015|534491|P1|COMPLETED|Overall Study||12
222790|NCT00678015|534491|P1|STARTED|Overall Study||12
222791|NCT00677924|534500|P2|NOT COMPLETED|Overall Study||0
222792|NCT00677924|534501|P1|NOT COMPLETED|Overall Study||0
222793|NCT00677924|534500|P2|COMPLETED|Overall Study||6
222794|NCT00677924|534501|P1|COMPLETED|Overall Study||3
222795|NCT00677924|534500|P2|STARTED|Overall Study||6
222796|NCT00677924|534501|P1|STARTED|Overall Study||3
222797|NCT00677898|534511|P2|NOT COMPLETED|Overall Study||18
222798|NCT00677898|534512|P1|NOT COMPLETED|Overall Study||20
222799|NCT00677898|534511|P2|COMPLETED|Overall Study||102
222800|NCT00677898|534512|P1|COMPLETED|Overall Study||99
222801|NCT00677898|534511|P2|STARTED|Overall Study||120
222802|NCT00677898|534512|P1|STARTED|Overall Study||119
222803|NCT00677833|534532|P4|NOT COMPLETED|Overall Study||3
222804|NCT00677833|534533|P3|NOT COMPLETED|Overall Study||2
222805|NCT00677833|534534|P2|NOT COMPLETED|Overall Study||0
222806|NCT00677833|534535|P1|NOT COMPLETED|Overall Study||4
222807|NCT00677833|534532|P4|COMPLETED|Overall Study||128
222808|NCT00677833|534533|P3|COMPLETED|Overall Study||122
222809|NCT00677833|534534|P2|COMPLETED|Overall Study||51
222810|NCT00677833|534535|P1|COMPLETED|Overall Study||51
222811|NCT00677833|534532|P4|STARTED|Overall Study||131
222812|NCT00677833|534533|P3|STARTED|Overall Study||124
222813|NCT00677833|534534|P2|STARTED|Overall Study||51
222814|NCT00677833|534535|P1|STARTED|Overall Study||55
222815|NCT00677820|534585|P2|NOT COMPLETED|Overall Study||0
222816|NCT00677820|534586|P1|NOT COMPLETED|Overall Study||1
222817|NCT00677820|534585|P2|COMPLETED|Overall Study||60
222818|NCT00677820|534586|P1|COMPLETED|Overall Study||239
222819|NCT00677820|534585|P2|STARTED|Overall Study||60
222820|NCT00677820|534586|P1|STARTED|Overall Study||240
222821|NCT00677807|534607|P3|NOT COMPLETED|Overall Study||20
222822|NCT00677807|534608|P2|NOT COMPLETED|Overall Study||11
222823|NCT00677807|534609|P1|NOT COMPLETED|Overall Study||18
222824|NCT00677807|534607|P3|COMPLETED|Overall Study||105
222825|NCT00677807|534608|P2|COMPLETED|Overall Study||135
222826|NCT00677807|534609|P1|COMPLETED|Overall Study||126
222827|NCT00677807|534607|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
222828|NCT00677807|534608|P2|Safety/ITT: Received Study Drug|Overall Study||146
222829|NCT00677807|534609|P1|Safety/ITT: Received Study Drug|Overall Study||144
222830|NCT00677807|534607|P3|STARTED|Overall Study||125
222831|NCT00677807|534608|P2|STARTED|Overall Study||146
222832|NCT00677807|534609|P1|STARTED|Overall Study||144
222833|NCT00677690|534640|P2|NOT COMPLETED|Overall Study||0
222834|NCT00677690|534641|P1|NOT COMPLETED|Overall Study||0
222835|NCT00677690|534640|P2|COMPLETED|Overall Study||41
222836|NCT00677690|534641|P1|COMPLETED|Overall Study||42
222837|NCT00677690|534640|P2|STARTED|Overall Study||41
222838|NCT00677690|534641|P1|STARTED|Overall Study||42
222839|NCT00677534|534655|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
222840|NCT00677534|534655|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
222841|NCT00677534|534655|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
222842|NCT00677534|534655|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
222843|NCT00677534|534655|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
222844|NCT00677534|534655|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
222845|NCT00677534|534655|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
222846|NCT00677534|534655|P1|COMPLETED|Washout (Weeks 1-4)||7
222847|NCT00677534|534655|P1|STARTED|Washout (Weeks 1-4)||10
222848|NCT00677365|534663|P4|NOT COMPLETED|Overall Study||3
222849|NCT00677365|534664|P3|NOT COMPLETED|Overall Study||2
222850|NCT00677365|534665|P2|NOT COMPLETED|Overall Study||1
222851|NCT00677365|534666|P1|NOT COMPLETED|Overall Study||2
222852|NCT00677365|534663|P4|COMPLETED|Overall Study||36
222853|NCT00677365|534664|P3|COMPLETED|Overall Study||35
222854|NCT00677365|534665|P2|COMPLETED|Overall Study||37
222855|NCT00677365|534666|P1|COMPLETED|Overall Study||35
222856|NCT00677365|534663|P4|STARTED|Overall Study||39
222857|NCT00677365|534664|P3|STARTED|Overall Study||37
222858|NCT00677365|534665|P2|STARTED|Overall Study||38
222859|NCT00677365|534666|P1|STARTED|Overall Study||37
222860|NCT00677352|534698|P2|NOT COMPLETED|Tapering Phase||10
222861|NCT00677352|534699|P1|NOT COMPLETED|Tapering Phase||6
222862|NCT00677352|534698|P2|COMPLETED|Tapering Phase||112
222863|NCT00677352|534699|P1|COMPLETED|Tapering Phase||126
222864|NCT00677352|534698|P2|STARTED|Tapering Phase||122
222865|NCT00677352|534699|P1|STARTED|Tapering Phase||132
222866|NCT00677352|534698|P2|NOT COMPLETED|Treatment Phase||42
222867|NCT00677352|534699|P1|NOT COMPLETED|Treatment Phase||25
222868|NCT00677352|534698|P2|COMPLETED|Treatment Phase||122
222869|NCT00677352|534699|P1|COMPLETED|Treatment Phase||132
222870|NCT00677352|534698|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
222871|NCT00677352|534699|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
222872|NCT00677235|534719|P2|NOT COMPLETED|Overall Study||38
222873|NCT00677235|534720|P1|NOT COMPLETED|Overall Study||41
222874|NCT00677235|534719|P2|COMPLETED|Overall Study||94
222875|NCT00677235|534720|P1|COMPLETED|Overall Study||97
222876|NCT00677235|534719|P2|STARTED|Overall Study||132
222877|NCT00677235|534720|P1|STARTED|Overall Study||138
222878|NCT00677092|534760|P1|NOT COMPLETED|Overall Study||6
222879|NCT00677092|534760|P1|COMPLETED|Overall Study||6
222880|NCT00677092|534760|P1|Received Study Treatment|Overall Study||11
222881|NCT00677092|534760|P1|STARTED|Overall Study||12
222882|NCT00677014|534772|P3|NOT COMPLETED|Overall Study||49
222883|NCT00677014|534773|P2|NOT COMPLETED|Overall Study||41
222884|NCT00677014|534774|P1|NOT COMPLETED|Overall Study||44
222885|NCT00677014|534772|P3|COMPLETED|Overall Study||283
222886|NCT00677014|534773|P2|COMPLETED|Overall Study||282
222887|NCT00677014|534774|P1|COMPLETED|Overall Study||281
222888|NCT00677014|534772|P3|STARTED|Overall Study||332
222889|NCT00677014|534773|P2|STARTED|Overall Study||323
222890|NCT00677014|534774|P1|STARTED|Overall Study||325
222891|NCT00676897|534784|P2|NOT COMPLETED|Overall Study||0
222892|NCT00676897|534785|P1|NOT COMPLETED|Overall Study||0
222893|NCT00676897|534784|P2|COMPLETED|Overall Study||10
222894|NCT00676897|534785|P1|COMPLETED|Overall Study||8
222895|NCT00676897|534784|P2|STARTED|Overall Study||10
222896|NCT00676897|534785|P1|STARTED|Overall Study||8
222897|NCT00676806|534795|P2|NOT COMPLETED|Overall Study||0
222898|NCT00676806|534796|P1|NOT COMPLETED|Overall Study||0
222899|NCT00676806|534795|P2|COMPLETED|Overall Study||3
222900|NCT00676806|534796|P1|COMPLETED|Overall Study||3
222901|NCT00676806|534795|P2|STARTED|Overall Study||3
222902|NCT00676806|534796|P1|STARTED|Overall Study||3
222903|NCT00676793|534812|P1|NOT COMPLETED|Overall Study||13
222904|NCT00676793|534812|P1|COMPLETED|Overall Study||19
222905|NCT00676793|534812|P1|STARTED|Overall Study||32
222906|NCT00676780|534817|P1|NOT COMPLETED|Overall Study||7
222907|NCT00676780|534817|P1|COMPLETED|Overall Study||26
222908|NCT00676780|534817|P1|STARTED|Overall Study||33
222909|NCT00676715|534827|P4|NOT COMPLETED|Overall Study||40
222910|NCT00676715|534828|P3|NOT COMPLETED|Overall Study||41
222911|NCT00676715|534829|P2|NOT COMPLETED|Overall Study||47
222912|NCT00676715|534830|P1|NOT COMPLETED|Overall Study||40
222913|NCT00676715|534827|P4|COMPLETED|Overall Study||14
222914|NCT00676715|534828|P3|COMPLETED|Overall Study||14
222915|NCT00676715|534829|P2|COMPLETED|Overall Study||8
222916|NCT00676715|534830|P1|COMPLETED|Overall Study||14
222917|NCT00676715|534827|P4|STARTED|Overall Study||54
222918|NCT00676715|534828|P3|STARTED|Overall Study||55
222919|NCT00676715|534829|P2|STARTED|Overall Study||55
222920|NCT00676715|534830|P1|STARTED|Overall Study||54
222921|NCT00676689|534860|P1|NOT COMPLETED|Overall Study||61
222922|NCT00676689|534860|P1|COMPLETED|Overall Study||20
222923|NCT00676689|534860|P1|1 Year Follow-up|Overall Study||64
222924|NCT00676689|534860|P1|30 Day Follow-up|Overall Study||78
222925|NCT00676689|534860|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
222926|NCT00676689|534860|P1|STARTED|Overall Study||81
222927|NCT00676676|534866|P1|NOT COMPLETED|Overall Study||0
222928|NCT00676676|534866|P1|COMPLETED|Overall Study||9
222929|NCT00676676|534866|P1|STARTED|Overall Study||9
222930|NCT00676650|534872|P2|NOT COMPLETED|Overall Study||289
222931|NCT00676650|534873|P1|NOT COMPLETED|Overall Study||584
222932|NCT00676650|534872|P2|COMPLETED|Overall Study||0
222933|NCT00676650|534873|P1|COMPLETED|Overall Study||0
222934|NCT00676650|534872|P2|Treated|Overall Study||285
222935|NCT00676650|534873|P1|Treated|Overall Study||581
222936|NCT00676650|534872|P2|STARTED|Overall Study||289
222937|NCT00676650|534873|P1|STARTED|Overall Study||584
222938|NCT00676585|534893|P2|NOT COMPLETED|Overall Study||0
222939|NCT00676585|534894|P1|NOT COMPLETED|Overall Study||0
222940|NCT00676585|534893|P2|COMPLETED|Overall Study||25
222941|NCT00676585|534894|P1|COMPLETED|Overall Study||25
222942|NCT00676585|534893|P2|STARTED|Overall Study||25
222943|NCT00676585|534894|P1|STARTED|Overall Study||25
222944|NCT00676520|534904|P1|NOT COMPLETED|Overall Study||731
222945|NCT00676520|534904|P1|COMPLETED|Overall Study||7309
222946|NCT00676520|534904|P1|STARTED|Overall Study||8040
222947|NCT00676494|534961|P1|NOT COMPLETED|Overall Study||14
222948|NCT00676494|534961|P1|COMPLETED|Overall Study||158
222949|NCT00676494|534961|P1|STARTED|Overall Study||172
222950|NCT00676455|534967|P1|NOT COMPLETED|Overall Study||0
222951|NCT00676455|534967|P1|COMPLETED|Overall Study||14
222952|NCT00676455|534967|P1|STARTED|Overall Study||14
222953|NCT00676403|534978|P6|NOT COMPLETED|Overall Study||5
222954|NCT00676403|534979|P5|NOT COMPLETED|Overall Study||1
222955|NCT00676403|534980|P4|NOT COMPLETED|Overall Study||5
222956|NCT00676403|534981|P3|NOT COMPLETED|Overall Study||1
222957|NCT00676403|534982|P2|NOT COMPLETED|Overall Study||2
222958|NCT00676403|534983|P1|NOT COMPLETED|Overall Study||2
222959|NCT00676403|534978|P6|COMPLETED|Overall Study||18
222960|NCT00676403|534979|P5|COMPLETED|Overall Study||23
222961|NCT00676403|534980|P4|COMPLETED|Overall Study||17
222962|NCT00676403|534981|P3|COMPLETED|Overall Study||22
222963|NCT00676403|534982|P2|COMPLETED|Overall Study||20
222964|NCT00676403|534983|P1|COMPLETED|Overall Study||21
222965|NCT00676403|534978|P6|STARTED|Overall Study||23
222966|NCT00676403|534979|P5|STARTED|Overall Study||24
222967|NCT00676403|534980|P4|STARTED|Overall Study||22
222968|NCT00676403|534981|P3|STARTED|Overall Study||23
222969|NCT00676403|534982|P2|STARTED|Overall Study||22
222970|NCT00676403|534983|P1|STARTED|Overall Study||23
222971|NCT00676364|535113|P2|NOT COMPLETED|Overall Study||0
222972|NCT00676364|535114|P1|NOT COMPLETED|Overall Study||0
222973|NCT00676364|535113|P2|COMPLETED|Overall Study||57
222974|NCT00676364|535114|P1|COMPLETED|Overall Study||57
222975|NCT00676364|535113|P2|STARTED|Overall Study||57
222976|NCT00676364|535114|P1|STARTED|Overall Study||57
222977|NCT00676338|535126|P4|NOT COMPLETED|Overall Study||23
222978|NCT00676338|535127|P3|NOT COMPLETED|Overall Study||30
222979|NCT00676338|535128|P2|NOT COMPLETED|Overall Study||33
222980|NCT00676338|535129|P1|NOT COMPLETED|Overall Study||38
222981|NCT00676338|535126|P4|COMPLETED|Overall Study||140
222982|NCT00676338|535127|P3|COMPLETED|Overall Study||133
222983|NCT00676338|535128|P2|COMPLETED|Overall Study||213
222984|NCT00676338|535129|P1|COMPLETED|Overall Study||210
222985|NCT00676338|535126|P4|STARTED|Overall Study||163
222986|NCT00676338|535127|P3|STARTED|Overall Study||163
222987|NCT00676338|535128|P2|STARTED|Overall Study||246
222988|NCT00676338|535129|P1|STARTED|Overall Study||248
222989|NCT00676208|535181|P2|NOT COMPLETED|Overall Study||6
222990|NCT00676208|535182|P1|NOT COMPLETED|Overall Study||2
222991|NCT00676208|535181|P2|COMPLETED|Overall Study||13
222992|NCT00676208|535182|P1|COMPLETED|Overall Study||12
222993|NCT00676208|535181|P2|STARTED|Overall Study||19
222994|NCT00676208|535182|P1|STARTED|Overall Study||14
222995|NCT00676195|535190|P1|NOT COMPLETED|Overall Study||3
222996|NCT00676195|535190|P1|COMPLETED|Overall Study||21
222997|NCT00676195|535190|P1|STARTED|Overall Study||24
222998|NCT00676182|535200|P1|NOT COMPLETED|Overall Study||0
222999|NCT00676182|535200|P1|COMPLETED|Overall Study||75
223000|NCT00676182|535200|P1|STARTED|Overall Study||75
223001|NCT00676143|535215|P2|NOT COMPLETED|Overall Study||260
223002|NCT00676143|535216|P1|NOT COMPLETED|Overall Study||156
223003|NCT00676143|535215|P2|COMPLETED|Overall Study||398
223004|NCT00676143|535216|P1|COMPLETED|Overall Study||285
223005|NCT00676143|535215|P2|Treated|Overall Study||654
223006|NCT00676143|535216|P1|Treated|Overall Study||439
223007|NCT00676143|535215|P2|STARTED|Overall Study||658
223008|NCT00676143|535216|P1|STARTED|Overall Study||441
223009|NCT00676130|535256|P2|NOT COMPLETED|Overall Study||4
223010|NCT00676130|535257|P1|NOT COMPLETED|Overall Study||3
223011|NCT00676130|535256|P2|COMPLETED|Overall Study||73
223012|NCT00676130|535257|P1|COMPLETED|Overall Study||73
223013|NCT00676130|535256|P2|STARTED|Overall Study||77
223014|NCT00676130|535257|P1|STARTED|Overall Study||76
223015|NCT00676091|535267|P2|NOT COMPLETED|Toddler Dose||0
223016|NCT00676091|535268|P1|NOT COMPLETED|Toddler Dose||3
223017|NCT00676091|535267|P2|COMPLETED|Toddler Dose||156
223018|NCT00676091|535268|P1|COMPLETED|Toddler Dose||153
223019|NCT00676091|535267|P2|STARTED|Toddler Dose||156
223020|NCT00676091|535268|P1|STARTED|Toddler Dose||156
223021|NCT00676091|535267|P2|NOT COMPLETED|After Infant Series||3
223022|NCT00676091|535268|P1|NOT COMPLETED|After Infant Series||1
223023|NCT00676091|535267|P2|COMPLETED|After Infant Series||156
223024|NCT00676091|535268|P1|COMPLETED|After Infant Series||156
223025|NCT00676091|535267|P2|STARTED|After Infant Series||159
223026|NCT00676091|535268|P1|STARTED|After Infant Series||157
223027|NCT00676091|535267|P2|NOT COMPLETED|Infant Series||18
223028|NCT00676091|535268|P1|NOT COMPLETED|Infant Series||20
223029|NCT00676091|535267|P2|COMPLETED|Infant Series||159
223030|NCT00676091|535268|P1|COMPLETED|Infant Series||157
223031|NCT00676091|535267|P2|Vaccinated Dose 3|Infant Series||161
223032|NCT00676091|535268|P1|Vaccinated Dose 3|Infant Series||158
223033|NCT00676091|535267|P2|Vaccinated Dose 2|Infant Series||162
223034|NCT00676091|535268|P1|Vaccinated Dose 2|Infant Series||159
223035|NCT00676091|535267|P2|Vaccinated Dose 1|Infant Series||162
223036|NCT00676091|535268|P1|Vaccinated Dose 1|Infant Series||163
223037|NCT00676091|535267|P2|STARTED|Infant Series||177
223038|NCT00676091|535268|P1|STARTED|Infant Series||177
223039|NCT00676065|535303|P3|NOT COMPLETED|Overall Study||0
223040|NCT00676065|535304|P2|NOT COMPLETED|Overall Study||0
223041|NCT00676065|535305|P1|NOT COMPLETED|Overall Study||0
223042|NCT00676065|535303|P3|COMPLETED|Overall Study||26341
223043|NCT00676065|535304|P2|COMPLETED|Overall Study||15428
223044|NCT00676065|535305|P1|COMPLETED|Overall Study||16534
223045|NCT00676065|535303|P3|STARTED|Overall Study||26341
223046|NCT00676065|535304|P2|STARTED|Overall Study||15428
223047|NCT00676065|535305|P1|STARTED|Overall Study||16534
223048|NCT00676052|535325|P6|NOT COMPLETED|Overall Study||6
223049|NCT00676052|535326|P5|NOT COMPLETED|Overall Study||6
223050|NCT00676052|535327|P4|NOT COMPLETED|Overall Study||5
223051|NCT00676052|535328|P3|NOT COMPLETED|Overall Study||6
223052|NCT00676052|535329|P2|NOT COMPLETED|Overall Study||7
223053|NCT00676052|535330|P1|NOT COMPLETED|Overall Study||9
223054|NCT00676052|535325|P6|COMPLETED|Overall Study||91
223055|NCT00676052|535326|P5|COMPLETED|Overall Study||89
223056|NCT00676052|535327|P4|COMPLETED|Overall Study||92
223057|NCT00676052|535328|P3|COMPLETED|Overall Study||90
223058|NCT00676052|535329|P2|COMPLETED|Overall Study||88
223059|NCT00676052|535330|P1|COMPLETED|Overall Study||87
223060|NCT00676052|535325|P6|STARTED|Overall Study||97
223061|NCT00676052|535326|P5|STARTED|Overall Study||95
223062|NCT00676052|535327|P4|STARTED|Overall Study||97
223063|NCT00676052|535328|P3|STARTED|Overall Study||96
223064|NCT00676052|535329|P2|STARTED|Overall Study||95
223065|NCT00676052|535330|P1|STARTED|Overall Study||96
223066|NCT00676026|535362|P1|NOT COMPLETED|Overall Study||0
223067|NCT00676026|535362|P1|COMPLETED|Overall Study||8
223068|NCT00676026|535362|P1|STARTED|Overall Study||8
223069|NCT00675987|535368|P2|NOT COMPLETED|Overall Study||0
223070|NCT00675987|535369|P1|NOT COMPLETED|Overall Study||0
223071|NCT00675987|535368|P2|COMPLETED|Overall Study||27
223072|NCT00675987|535369|P1|COMPLETED|Overall Study||26
223073|NCT00675987|535368|P2|STARTED|Overall Study||27
223074|NCT00675987|535369|P1|STARTED|Overall Study||26
223075|NCT00675948|535379|P2|NOT COMPLETED|Overall Study||3
223076|NCT00675948|535380|P1|NOT COMPLETED|Overall Study||39
223077|NCT00675948|535379|P2|COMPLETED|Overall Study||1
223078|NCT00675948|535380|P1|COMPLETED|Overall Study||0
223079|NCT00675948|535379|P2|STARTED|Overall Study||4
223080|NCT00675948|535380|P1|STARTED|Overall Study||39
223081|NCT00675922|535390|P1|NOT COMPLETED|Overall Study||0
223082|NCT00675922|535390|P1|COMPLETED|Overall Study||98
223083|NCT00675922|535390|P1|STARTED|Overall Study||98
223084|NCT00675909|535398|P3|NOT COMPLETED|Overall Study||0
223085|NCT00675909|535399|P2|NOT COMPLETED|Overall Study||0
223086|NCT00675909|535400|P1|NOT COMPLETED|Overall Study||0
223087|NCT00675909|535398|P3|COMPLETED|Overall Study||60
223088|NCT00675909|535399|P2|COMPLETED|Overall Study||60
223089|NCT00675909|535400|P1|COMPLETED|Overall Study||60
223090|NCT00675909|535398|P3|STARTED|Overall Study||60
223091|NCT00675909|535399|P2|STARTED|Overall Study||60
223092|NCT00675909|535400|P1|STARTED|Overall Study||60
223093|NCT00675792|535410|P2|NOT COMPLETED|Overall Study||0
223094|NCT00675792|535411|P1|NOT COMPLETED|Overall Study||0
223095|NCT00675792|535410|P2|COMPLETED|Overall Study||49
223096|NCT00675792|535411|P1|COMPLETED|Overall Study||51
223097|NCT00675792|535410|P2|STARTED|Overall Study||49
223098|NCT00675792|535411|P1|STARTED|Overall Study||51
223099|NCT00675766|535431|P4|NOT COMPLETED|Overall Study||26
223100|NCT00675766|535432|P3|NOT COMPLETED|Overall Study||21
223101|NCT00675766|535433|P2|NOT COMPLETED|Overall Study||5
223102|NCT00675766|535434|P1|NOT COMPLETED|Overall Study||6
223103|NCT00675766|535431|P4|COMPLETED|Overall Study||11
223104|NCT00675766|535432|P3|COMPLETED|Overall Study||29
223105|NCT00675766|535433|P2|COMPLETED|Overall Study||25
223106|NCT00675766|535434|P1|COMPLETED|Overall Study||100
223107|NCT00675766|535431|P4|Year 3|Overall Study||11
223108|NCT00675766|535432|P3|Year 3|Overall Study||29
223109|NCT00675766|535433|P2|Year 3|Overall Study||25
223110|NCT00675766|535434|P1|Year 3|Overall Study||100
223111|NCT00675766|535431|P4|Year 2|Overall Study||20
223112|NCT00675766|535432|P3|Year 2|Overall Study||34
223113|NCT00675766|535433|P2|Year 2|Overall Study||28
223114|NCT00675766|535434|P1|Year 2|Overall Study||105
223115|NCT00675766|535431|P4|STARTED|Overall Study||37
223116|NCT00675766|535432|P3|STARTED|Overall Study||50
223117|NCT00675766|535433|P2|STARTED|Overall Study||30
223118|NCT00675766|535434|P1|STARTED|Overall Study||106
223119|NCT00675597|535444|P1|NOT COMPLETED|Overall Study||3
223120|NCT00675597|535444|P1|COMPLETED|Overall Study||23
223121|NCT00675597|535444|P1|STARTED|Overall Study||26
223122|NCT00675584|535450|P2|NOT COMPLETED|Overall Study||26
223123|NCT00675584|535451|P1|NOT COMPLETED|Overall Study||39
223124|NCT00675584|535450|P2|COMPLETED|Overall Study||113
223125|NCT00675584|535451|P1|COMPLETED|Overall Study||100
223126|NCT00675584|535450|P2|STARTED|Overall Study||139
223127|NCT00675584|535451|P1|STARTED|Overall Study||139
223128|NCT00675558|535460|P3|NOT COMPLETED|Second Operation||0
223129|NCT00675558|535461|P2|NOT COMPLETED|Second Operation||0
223130|NCT00675558|535462|P1|NOT COMPLETED|Second Operation||0
223131|NCT00675558|535460|P3|COMPLETED|Second Operation||10
223132|NCT00675558|535461|P2|COMPLETED|Second Operation||0
223133|NCT00675558|535462|P1|COMPLETED|Second Operation||0
223134|NCT00675558|535460|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
223135|NCT00675558|535461|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
223136|NCT00675558|535462|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
223137|NCT00675558|535460|P3|NOT COMPLETED|Surgery||0
223138|NCT00675558|535461|P2|NOT COMPLETED|Surgery||0
223139|NCT00675558|535462|P1|NOT COMPLETED|Surgery||0
223140|NCT00675558|535460|P3|COMPLETED|Surgery||30
223141|NCT00675558|535461|P2|COMPLETED|Surgery||10
223142|NCT00675558|535462|P1|COMPLETED|Surgery||10
223143|NCT00675558|535460|P3|STARTED|Surgery||30
223144|NCT00675558|535461|P2|STARTED|Surgery||10
223145|NCT00675558|535462|P1|STARTED|Surgery||10
223146|NCT00675506|535478|P2|NOT COMPLETED|Overall Study||12
223147|NCT00675506|535479|P1|NOT COMPLETED|Overall Study||12
223148|NCT00675506|535478|P2|COMPLETED|Overall Study||17
223149|NCT00675506|535479|P1|COMPLETED|Overall Study||19
223150|NCT00675506|535478|P2|Received Intervention|Overall Study||29
223151|NCT00675506|535479|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
223152|NCT00675506|535478|P2|STARTED|Overall Study||29
223153|NCT00675506|535479|P1|STARTED|Overall Study||31
223154|NCT00675441|535495|P1|NOT COMPLETED|Overall Study||3
223155|NCT00675441|535495|P1|COMPLETED|Overall Study||2
223156|NCT00675441|535495|P1|STARTED|Overall Study||5
223157|NCT00675428|535501|P2|NOT COMPLETED|Overall Study||3
223158|NCT00675428|535502|P1|NOT COMPLETED|Overall Study||3
223159|NCT00675428|535501|P2|COMPLETED|Overall Study||0
223160|NCT00675428|535502|P1|COMPLETED|Overall Study||0
223161|NCT00675428|535501|P2|STARTED|Overall Study||3
223162|NCT00675428|535502|P1|STARTED|Overall Study||3
223163|NCT00675415|535522|P2|NOT COMPLETED|Overall Study||8
223164|NCT00675415|535523|P1|NOT COMPLETED|Overall Study||8
223165|NCT00675415|535522|P2|COMPLETED|Overall Study||123
223166|NCT00675415|535523|P1|COMPLETED|Overall Study||124
223167|NCT00675415|535522|P2|STARTED|Overall Study||131
223168|NCT00675415|535523|P1|STARTED|Overall Study||132
223169|NCT00675259|535535|P1|NOT COMPLETED|Overall Study||14
223170|NCT00675259|535535|P1|COMPLETED|Overall Study||19
223171|NCT00675259|535535|P1|STARTED|Overall Study||33
223172|NCT00675103|535544|P1|NOT COMPLETED|Overall Study||3
223173|NCT00675103|535544|P1|COMPLETED|Overall Study||4
223174|NCT00675103|535544|P1|STARTED|Overall Study||7
223175|NCT00674986|535551|P2|NOT COMPLETED|Overall Study||81
223176|NCT00674986|535552|P1|NOT COMPLETED|Overall Study||43
223177|NCT00674986|535551|P2|COMPLETED|Overall Study||188
223178|NCT00674986|535552|P1|COMPLETED|Overall Study||187
223179|NCT00674986|535551|P2|Intent to Treat Population|Overall Study||256
223180|NCT00674986|535552|P1|Intent to Treat Population|Overall Study||227
223181|NCT00674986|535551|P2|STARTED|Overall Study||269
223182|NCT00674986|535552|P1|STARTED|Overall Study||230
223183|NCT00674973|535573|P2|NOT COMPLETED|Overall Study||102
223184|NCT00674973|535574|P1|NOT COMPLETED|Overall Study||100
223185|NCT00674973|535573|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
223186|NCT00674973|535574|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
223187|NCT00674973|535573|P2|Switch to Open-Label Erlotinib|Overall Study||0
223188|NCT00674973|535574|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
223189|NCT00674973|535573|P2|STARTED|Overall Study||104
223190|NCT00674973|535574|P1|STARTED|Overall Study||103
223191|NCT00674817|535588|P1|NOT COMPLETED|Period 6||0
223192|NCT00674817|535588|P1|COMPLETED|Period 6||38
223193|NCT00674817|535588|P1|STARTED|Period 6||38
223194|NCT00674817|535588|P1|NOT COMPLETED|Period 5||0
223195|NCT00674817|535588|P1|COMPLETED|Period 5||38
223196|NCT00674817|535588|P1|STARTED|Period 5||38
223197|NCT00674817|535588|P1|NOT COMPLETED|Period 4||1
223198|NCT00674817|535588|P1|COMPLETED|Period 4||38
223199|NCT00674817|535588|P1|STARTED|Period 4||39
223200|NCT00674817|535588|P1|NOT COMPLETED|Period 3||2
223201|NCT00674817|535588|P1|COMPLETED|Period 3||39
223202|NCT00674817|535588|P1|STARTED|Period 3||41
223203|NCT00674817|535588|P1|NOT COMPLETED|Period 2||0
223204|NCT00674817|535588|P1|COMPLETED|Period 2||41
223205|NCT00674817|535588|P1|STARTED|Period 2||41
223206|NCT00674817|535588|P1|NOT COMPLETED|Period 1||3
223207|NCT00674817|535588|P1|COMPLETED|Period 1||41
223208|NCT00674817|535588|P1|STARTED|Period 1||44
223209|NCT00674765|535736|P2|NOT COMPLETED|Overall Study||29
223210|NCT00674765|535737|P1|NOT COMPLETED|Overall Study||36
223211|NCT00674765|535736|P2|COMPLETED|Overall Study||46
223212|NCT00674765|535737|P1|COMPLETED|Overall Study||45
223213|NCT00674765|535736|P2|STARTED|Overall Study||75
223214|NCT00674765|535737|P1|STARTED|Overall Study||81
223215|NCT00674739|535746|P3|NOT COMPLETED|Overall Study||32
223216|NCT00674739|535747|P2|NOT COMPLETED|Overall Study||59
223217|NCT00674739|535748|P1|NOT COMPLETED|Overall Study||57
223218|NCT00674739|535746|P3|COMPLETED|Overall Study||65
223219|NCT00674739|535747|P2|COMPLETED|Overall Study||136
223220|NCT00674739|535748|P1|COMPLETED|Overall Study||121
223221|NCT00674739|535746|P3|STARTED|Overall Study||97
223222|NCT00674739|535747|P2|STARTED|Overall Study||195
223223|NCT00674739|535748|P1|STARTED|Overall Study||178
223224|NCT00674700|535765|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
223225|NCT00674700|535766|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
223226|NCT00674700|535767|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
223227|NCT00674700|535765|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
223228|NCT00674700|535766|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
223229|NCT00674700|535767|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
223230|NCT00674700|535765|P3|STARTED|Year 2 Follow-up Without Treatment||153
223231|NCT00674700|535766|P2|STARTED|Year 2 Follow-up Without Treatment||135
223232|NCT00674700|535767|P1|STARTED|Year 2 Follow-up Without Treatment||139
223233|NCT00674700|535765|P3|NOT COMPLETED|Year 1||17
223234|NCT00674700|535766|P2|NOT COMPLETED|Year 1||34
223235|NCT00674700|535767|P1|NOT COMPLETED|Year 1||31
223236|NCT00674700|535765|P3|COMPLETED|Year 1||153
223237|NCT00674700|535766|P2|COMPLETED|Year 1||135
223238|NCT00674700|535767|P1|COMPLETED|Year 1||139
223239|NCT00674700|535765|P3|STARTED|Year 1||170
223240|NCT00674700|535766|P2|STARTED|Year 1||169
223241|NCT00674700|535767|P1|STARTED|Year 1||170
223242|NCT00674661|535780|P2|NOT COMPLETED|Overall Study||15
223243|NCT00674661|535781|P1|NOT COMPLETED|Overall Study||11
223244|NCT00674661|535780|P2|COMPLETED|Overall Study||48
223245|NCT00674661|535781|P1|COMPLETED|Overall Study||56
223246|NCT00674661|535780|P2|STARTED|Overall Study||63
223247|NCT00674661|535781|P1|STARTED|Overall Study||67
223248|NCT00674622|535790|P3|NOT COMPLETED|Overall Study||0
223249|NCT00674622|535791|P2|NOT COMPLETED|Overall Study||4
223250|NCT00674622|535792|P1|NOT COMPLETED|Overall Study||1
223251|NCT00674622|535790|P3|COMPLETED|Overall Study||22
223252|NCT00674622|535791|P2|COMPLETED|Overall Study||18
223253|NCT00674622|535792|P1|COMPLETED|Overall Study||21
223254|NCT00674622|535790|P3|STARTED|Overall Study||22
223255|NCT00674622|535791|P2|STARTED|Overall Study||22
223256|NCT00674622|535792|P1|STARTED|Overall Study||22
223257|NCT00674609|535815|P3|NOT COMPLETED|Overall Study||8
223258|NCT00674609|535816|P2|NOT COMPLETED|Overall Study||13
223259|NCT00674609|535817|P1|NOT COMPLETED|Overall Study||12
223260|NCT00674609|535815|P3|COMPLETED|Overall Study||51
223261|NCT00674609|535816|P2|COMPLETED|Overall Study||45
223262|NCT00674609|535817|P1|COMPLETED|Overall Study||48
223263|NCT00674609|535815|P3|STARTED|Overall Study||59
223264|NCT00674609|535816|P2|STARTED|Overall Study||58
223265|NCT00674609|535817|P1|STARTED|Overall Study||60
223266|NCT00674583|535851|P2|NOT COMPLETED|Overall Study||0
223267|NCT00674583|535852|P1|NOT COMPLETED|Overall Study||0
223268|NCT00674583|535851|P2|COMPLETED|Overall Study||103
223269|NCT00674583|535852|P1|COMPLETED|Overall Study||311
223270|NCT00674583|535851|P2|STARTED|Overall Study||103
223271|NCT00674583|535852|P1|STARTED|Overall Study||311
223272|NCT00674492|535876|P1|NOT COMPLETED|Overall Study||0
223273|NCT00674492|535876|P1|COMPLETED|Overall Study||21
223274|NCT00674492|535876|P1|STARTED|Overall Study||21
223275|NCT00674466|535883|P3|NOT COMPLETED|Overall Study||9
223276|NCT00674466|535884|P2|NOT COMPLETED|Overall Study||8
223277|NCT00674466|535885|P1|NOT COMPLETED|Overall Study||7
223278|NCT00674466|535883|P3|COMPLETED|Overall Study||21
223279|NCT00674466|535884|P2|COMPLETED|Overall Study||22
223280|NCT00674466|535885|P1|COMPLETED|Overall Study||23
223281|NCT00674466|535883|P3|STARTED|Overall Study||30
223282|NCT00674466|535884|P2|STARTED|Overall Study||30
223283|NCT00674466|535885|P1|STARTED|Overall Study||30
223284|NCT00674362|535901|P2|NOT COMPLETED|Open Label||0
223285|NCT00674362|535902|P1|NOT COMPLETED|Open Label||2
223286|NCT00674362|535901|P2|COMPLETED|Open Label||7
223287|NCT00674362|535902|P1|COMPLETED|Open Label||18
223288|NCT00674362|535901|P2|STARTED|Open Label||7
223289|NCT00674362|535902|P1|STARTED|Open Label||20
223290|NCT00674362|535901|P2|NOT COMPLETED|Double Blind||18
223291|NCT00674362|535902|P1|NOT COMPLETED|Double Blind||12
223292|NCT00674362|535901|P2|COMPLETED|Double Blind||80
223293|NCT00674362|535902|P1|COMPLETED|Double Blind||84
223294|NCT00674362|535901|P2|STARTED|Double Blind||98
223295|NCT00674362|535902|P1|STARTED|Double Blind||96
223296|NCT00674323|535970|P3|NOT COMPLETED|Overall Study||0
223297|NCT00674323|535971|P2|NOT COMPLETED|Overall Study||1
223298|NCT00674323|535972|P1|NOT COMPLETED|Overall Study||1
223299|NCT00674323|535970|P3|COMPLETED|Overall Study||21
223300|NCT00674323|535971|P2|COMPLETED|Overall Study||20
223301|NCT00674323|535972|P1|COMPLETED|Overall Study||18
223302|NCT00674323|535970|P3|STARTED|Overall Study||21
223303|NCT00674323|535971|P2|STARTED|Overall Study||21
223304|NCT00674323|535972|P1|STARTED|Overall Study||19
223305|NCT00674297|535989|P4|NOT COMPLETED|Overall Study||3
223306|NCT00674297|535990|P3|NOT COMPLETED|Overall Study||4
223307|NCT00674297|535991|P2|NOT COMPLETED|Overall Study||0
223308|NCT00674297|535992|P1|NOT COMPLETED|Overall Study||10
223309|NCT00674297|535989|P4|COMPLETED|Overall Study||4
223310|NCT00674297|535990|P3|COMPLETED|Overall Study||5
223311|NCT00674297|535991|P2|COMPLETED|Overall Study||7
223312|NCT00674297|535992|P1|COMPLETED|Overall Study||8
223313|NCT00674297|535989|P4|STARTED|Overall Study||7
223314|NCT00674297|535990|P3|STARTED|Overall Study||9
223315|NCT00674297|535991|P2|STARTED|Overall Study||7
223316|NCT00674297|535992|P1|STARTED|Overall Study||18
223317|NCT00674206|536007|P1|NOT COMPLETED|Overall Study||0
223318|NCT00674206|536007|P1|COMPLETED|Overall Study||6
223319|NCT00674206|536007|P1|STARTED|Overall Study||6
223320|NCT00674154|536014|P2|NOT COMPLETED|Overall Study||3
223321|NCT00674154|536015|P1|NOT COMPLETED|Overall Study||3
223322|NCT00674154|536014|P2|COMPLETED|Overall Study||20
223323|NCT00674154|536015|P1|COMPLETED|Overall Study||20
223324|NCT00674154|536014|P2|STARTED|Overall Study||23
223325|NCT00674154|536015|P1|STARTED|Overall Study||23
223326|NCT00674128|536023|P2|NOT COMPLETED|Overall Study||23
223327|NCT00674128|536024|P1|NOT COMPLETED|Overall Study||25
223328|NCT00674128|536023|P2|COMPLETED|Overall Study||21
223329|NCT00674128|536024|P1|COMPLETED|Overall Study||25
223330|NCT00674128|536023|P2|STARTED|Overall Study||44
223331|NCT00674128|536024|P1|STARTED|Overall Study||50
223332|NCT00674115|536030|P4|NOT COMPLETED|Third Intervention||0
223333|NCT00674115|536031|P3|NOT COMPLETED|Third Intervention||0
223334|NCT00674115|536032|P2|NOT COMPLETED|Third Intervention||0
223335|NCT00674115|536033|P1|NOT COMPLETED|Third Intervention||0
223336|NCT00674115|536030|P4|COMPLETED|Third Intervention||0
223337|NCT00674115|536031|P3|COMPLETED|Third Intervention||0
223338|NCT00674115|536032|P2|COMPLETED|Third Intervention||16
223339|NCT00674115|536033|P1|COMPLETED|Third Intervention||14
223340|NCT00674115|536030|P4|STARTED|Third Intervention||0
223341|NCT00674115|536031|P3|STARTED|Third Intervention||0
223342|NCT00674115|536032|P2|STARTED|Third Intervention||16
223343|NCT00674115|536033|P1|STARTED|Third Intervention||14
223344|NCT00674115|536030|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
223345|NCT00674115|536031|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
223346|NCT00674115|536032|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
223347|NCT00674115|536033|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
223348|NCT00674115|536030|P4|COMPLETED|Washout Period of 2 Weeks||0
223349|NCT00674115|536031|P3|COMPLETED|Washout Period of 2 Weeks||0
223350|NCT00674115|536032|P2|COMPLETED|Washout Period of 2 Weeks||16
223351|NCT00674115|536033|P1|COMPLETED|Washout Period of 2 Weeks||14
223352|NCT00674115|536030|P4|STARTED|Washout Period of 2 Weeks||0
223353|NCT00674115|536031|P3|STARTED|Washout Period of 2 Weeks||0
223354|NCT00674115|536032|P2|STARTED|Washout Period of 2 Weeks||16
223355|NCT00674115|536033|P1|STARTED|Washout Period of 2 Weeks||14
223356|NCT00674115|536030|P4|NOT COMPLETED|Second Intervention||0
223357|NCT00674115|536031|P3|NOT COMPLETED|Second Intervention||0
223358|NCT00674115|536032|P2|NOT COMPLETED|Second Intervention||0
223359|NCT00674115|536033|P1|NOT COMPLETED|Second Intervention||0
223360|NCT00674115|536030|P4|COMPLETED|Second Intervention||16
223361|NCT00674115|536031|P3|COMPLETED|Second Intervention||14
223362|NCT00674115|536032|P2|COMPLETED|Second Intervention||16
223363|NCT00674115|536033|P1|COMPLETED|Second Intervention||14
223364|NCT00674115|536030|P4|STARTED|Second Intervention||16
223365|NCT00674115|536031|P3|STARTED|Second Intervention||14
223366|NCT00674115|536032|P2|STARTED|Second Intervention||16
223367|NCT00674115|536033|P1|STARTED|Second Intervention||14
223368|NCT00674115|536030|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
223369|NCT00674115|536031|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
223370|NCT00674115|536032|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
223371|NCT00674115|536033|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
223372|NCT00674115|536030|P4|COMPLETED|Washout Period of 2 Weeks||16
223373|NCT00674115|536031|P3|COMPLETED|Washout Period of 2 Weeks||14
223374|NCT00674115|536032|P2|COMPLETED|Washout Period of 2 Weeks||16
223375|NCT00674115|536033|P1|COMPLETED|Washout Period of 2 Weeks||14
223376|NCT00674115|536030|P4|STARTED|Washout Period of 2 Weeks||16
223377|NCT00674115|536031|P3|STARTED|Washout Period of 2 Weeks||14
223378|NCT00674115|536032|P2|STARTED|Washout Period of 2 Weeks||16
223379|NCT00674115|536033|P1|STARTED|Washout Period of 2 Weeks||14
223380|NCT00674115|536030|P4|NOT COMPLETED|First Intervention||0
223381|NCT00674115|536031|P3|NOT COMPLETED|First Intervention||0
223382|NCT00674115|536032|P2|NOT COMPLETED|First Intervention||0
223383|NCT00674115|536033|P1|NOT COMPLETED|First Intervention||0
223384|NCT00674115|536030|P4|COMPLETED|First Intervention||16
223385|NCT00674115|536031|P3|COMPLETED|First Intervention||14
223386|NCT00674115|536032|P2|COMPLETED|First Intervention||16
223387|NCT00674115|536033|P1|COMPLETED|First Intervention||14
223388|NCT00674115|536030|P4|STARTED|First Intervention||16
223389|NCT00674115|536031|P3|STARTED|First Intervention||14
223390|NCT00674115|536032|P2|STARTED|First Intervention||16
223391|NCT00674115|536033|P1|STARTED|First Intervention||14
223392|NCT00673959|536042|P2|NOT COMPLETED|Overall Study||0
223393|NCT00673959|536043|P1|NOT COMPLETED|Overall Study||0
223394|NCT00673959|536042|P2|COMPLETED|Overall Study||10
223395|NCT00673959|536043|P1|COMPLETED|Overall Study||10
223396|NCT00673959|536042|P2|STARTED|Overall Study||10
223397|NCT00673959|536043|P1|STARTED|Overall Study||10
223398|NCT00673933|536049|P1|NOT COMPLETED|Overall Study||3
223399|NCT00673933|536049|P1|COMPLETED|Overall Study||17
223400|NCT00673933|536049|P1|STARTED|Overall Study||20
223401|NCT00673881|536065|P1|NOT COMPLETED|Overall Study||1
223402|NCT00673881|536065|P1|COMPLETED|Overall Study||24
223403|NCT00673881|536065|P1|STARTED|Overall Study||25
223404|NCT00673855|536072|P2|NOT COMPLETED|Second Intervention||0
223405|NCT00673855|536073|P1|NOT COMPLETED|Second Intervention||0
223406|NCT00673855|536072|P2|COMPLETED|Second Intervention||10
223407|NCT00673855|536073|P1|COMPLETED|Second Intervention||10
223408|NCT00673855|536072|P2|STARTED|Second Intervention||10
223409|NCT00673855|536073|P1|STARTED|Second Intervention||10
223410|NCT00673855|536072|P2|NOT COMPLETED|First Intervention||0
223411|NCT00673855|536073|P1|NOT COMPLETED|First Intervention||0
223412|NCT00673855|536072|P2|COMPLETED|First Intervention||10
223413|NCT00673855|536073|P1|COMPLETED|First Intervention||10
223414|NCT00673855|536072|P2|STARTED|First Intervention||10
223415|NCT00673855|536073|P1|STARTED|First Intervention||10
223416|NCT00673816|536079|P1|NOT COMPLETED|Overall Study||2
223417|NCT00673816|536079|P1|COMPLETED|Overall Study||0
223418|NCT00673816|536079|P1|STARTED|Overall Study||2
223419|NCT00673764|536086|P2|NOT COMPLETED|Overall Study||0
223420|NCT00673764|536087|P1|NOT COMPLETED|Overall Study||0
223421|NCT00673764|536086|P2|COMPLETED|Overall Study||24
223422|NCT00673764|536087|P1|COMPLETED|Overall Study||24
223423|NCT00673764|536086|P2|STARTED|Overall Study||24
223424|NCT00673764|536087|P1|STARTED|Overall Study||24
223425|NCT00673738|536095|P1|NOT COMPLETED|Overall Study||0
223426|NCT00673738|536095|P1|COMPLETED|Overall Study||27
223427|NCT00673738|536095|P1|STARTED|Overall Study||27
223428|NCT00673712|536103|P2|NOT COMPLETED|Overall Study||0
223429|NCT00673712|536104|P1|NOT COMPLETED|Overall Study||0
223430|NCT00673712|536103|P2|COMPLETED|Overall Study||326
223431|NCT00673712|536104|P1|COMPLETED|Overall Study||321
223432|NCT00673712|536103|P2|STARTED|Overall Study||326
223433|NCT00673712|536104|P1|STARTED|Overall Study||321
223434|NCT00673673|536114|P1|NOT COMPLETED|Overall Study||36
223435|NCT00673673|536114|P1|COMPLETED|Overall Study||3
223436|NCT00673673|536114|P1|STARTED|Overall Study||39
223437|NCT00673660|536120|P1|NOT COMPLETED|Overall Study||107
223438|NCT00673660|536120|P1|COMPLETED|Overall Study||268
223439|NCT00673660|536120|P1|STARTED|Overall Study||375
223440|NCT00673595|536133|P2|NOT COMPLETED|Overall Study||0
223441|NCT00673595|536134|P1|NOT COMPLETED|Overall Study||0
223442|NCT00673595|536133|P2|COMPLETED|Overall Study||11
223443|NCT00673595|536134|P1|COMPLETED|Overall Study||8
223444|NCT00673595|536133|P2|STARTED|Overall Study||11
223445|NCT00673595|536134|P1|STARTED|Overall Study||8
223446|NCT00673465|536142|P12|NOT COMPLETED|Part 2 (India)||0
223447|NCT00673465|536143|P11|NOT COMPLETED|Part 2 (India)||0
223448|NCT00673465|536144|P10|NOT COMPLETED|Part 2 (India)||0
223449|NCT00673465|536145|P9|NOT COMPLETED|Part 2 (India)||0
223450|NCT00673465|536146|P8|NOT COMPLETED|Part 2 (India)||0
223451|NCT00673465|536147|P7|NOT COMPLETED|Part 2 (India)||0
223452|NCT00673465|536148|P6|NOT COMPLETED|Part 2 (India)||0
223453|NCT00673465|536149|P5|NOT COMPLETED|Part 2 (India)||0
223454|NCT00673465|536150|P4|NOT COMPLETED|Part 2 (India)||0
223455|NCT00673465|536151|P3|NOT COMPLETED|Part 2 (India)||0
223456|NCT00673465|536152|P2|NOT COMPLETED|Part 2 (India)||0
223457|NCT00673465|536153|P1|NOT COMPLETED|Part 2 (India)||0
223458|NCT00673465|536142|P12|COMPLETED|Part 2 (India)||0
223459|NCT00673465|536143|P11|COMPLETED|Part 2 (India)||0
223460|NCT00673465|536144|P10|COMPLETED|Part 2 (India)||0
223461|NCT00673465|536145|P9|COMPLETED|Part 2 (India)||0
223462|NCT00673465|536146|P8|COMPLETED|Part 2 (India)||0
223463|NCT00673465|536147|P7|COMPLETED|Part 2 (India)||0
223464|NCT00673465|536148|P6|COMPLETED|Part 2 (India)||0
223465|NCT00673465|536149|P5|COMPLETED|Part 2 (India)||0
223466|NCT00673465|536150|P4|COMPLETED|Part 2 (India)||0
223467|NCT00673465|536151|P3|COMPLETED|Part 2 (India)||0
223468|NCT00673465|536152|P2|COMPLETED|Part 2 (India)||0
223469|NCT00673465|536153|P1|COMPLETED|Part 2 (India)||0
223470|NCT00673465|536142|P12|STARTED|Part 2 (India)||0
223471|NCT00673465|536143|P11|STARTED|Part 2 (India)||0
223472|NCT00673465|536144|P10|STARTED|Part 2 (India)||0
223473|NCT00673465|536145|P9|STARTED|Part 2 (India)||0
223474|NCT00673465|536146|P8|STARTED|Part 2 (India)||0
223475|NCT00673465|536147|P7|STARTED|Part 2 (India)||0
223476|NCT00673465|536148|P6|STARTED|Part 2 (India)||0
223477|NCT00673465|536149|P5|STARTED|Part 2 (India)||0
223478|NCT00673465|536150|P4|STARTED|Part 2 (India)||0
223479|NCT00673465|536151|P3|STARTED|Part 2 (India)||0
223480|NCT00673465|536152|P2|STARTED|Part 2 (India)||0
223481|NCT00673465|536153|P1|STARTED|Part 2 (India)||0
223482|NCT00673465|536142|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
223483|NCT00673465|536143|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
223484|NCT00673465|536144|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
223485|NCT00673465|536145|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
223486|NCT00673465|536146|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
223487|NCT00673465|536147|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
223488|NCT00673465|536148|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
223489|NCT00673465|536149|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
223490|NCT00673465|536150|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
223491|NCT00673465|536151|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
223492|NCT00673465|536152|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
223493|NCT00673465|536153|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
223494|NCT00673465|536142|P12|COMPLETED|Part 1/Period 3 (United States)||0
223495|NCT00673465|536143|P11|COMPLETED|Part 1/Period 3 (United States)||0
223496|NCT00673465|536144|P10|COMPLETED|Part 1/Period 3 (United States)||0
223497|NCT00673465|536145|P9|COMPLETED|Part 1/Period 3 (United States)||0
223498|NCT00673465|536146|P8|COMPLETED|Part 1/Period 3 (United States)||0
223499|NCT00673465|536147|P7|COMPLETED|Part 1/Period 3 (United States)||0
223500|NCT00673465|536148|P6|COMPLETED|Part 1/Period 3 (United States)||1
223501|NCT00673465|536149|P5|COMPLETED|Part 1/Period 3 (United States)||1
223502|NCT00673465|536150|P4|COMPLETED|Part 1/Period 3 (United States)||3
223503|NCT00673465|536151|P3|COMPLETED|Part 1/Period 3 (United States)||3
223504|NCT00673465|536152|P2|COMPLETED|Part 1/Period 3 (United States)||3
223505|NCT00673465|536153|P1|COMPLETED|Part 1/Period 3 (United States)||3
223506|NCT00673465|536142|P12|STARTED|Part 1/Period 3 (United States)||0
223507|NCT00673465|536143|P11|STARTED|Part 1/Period 3 (United States)||0
223508|NCT00673465|536144|P10|STARTED|Part 1/Period 3 (United States)||0
223509|NCT00673465|536145|P9|STARTED|Part 1/Period 3 (United States)||0
223510|NCT00673465|536146|P8|STARTED|Part 1/Period 3 (United States)||0
223511|NCT00673465|536147|P7|STARTED|Part 1/Period 3 (United States)||0
223512|NCT00673465|536148|P6|STARTED|Part 1/Period 3 (United States)||1
223513|NCT00673465|536149|P5|STARTED|Part 1/Period 3 (United States)||1
223514|NCT00673465|536150|P4|STARTED|Part 1/Period 3 (United States)||3
223515|NCT00673465|536151|P3|STARTED|Part 1/Period 3 (United States)||3
223516|NCT00673465|536152|P2|STARTED|Part 1/Period 3 (United States)||3
223517|NCT00673465|536153|P1|STARTED|Part 1/Period 3 (United States)||3
223518|NCT00673465|536142|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
223519|NCT00673465|536143|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
223520|NCT00673465|536144|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
223521|NCT00673465|536145|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
223522|NCT00673465|536146|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
223523|NCT00673465|536147|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
223524|NCT00673465|536148|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
223525|NCT00673465|536149|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
223526|NCT00673465|536150|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
223527|NCT00673465|536151|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
223528|NCT00673465|536152|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
223529|NCT00673465|536153|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
223530|NCT00673465|536142|P12|COMPLETED|Part 1/Period 2 (United States)||0
223531|NCT00673465|536143|P11|COMPLETED|Part 1/Period 2 (United States)||0
223532|NCT00673465|536144|P10|COMPLETED|Part 1/Period 2 (United States)||0
223533|NCT00673465|536145|P9|COMPLETED|Part 1/Period 2 (United States)||0
223534|NCT00673465|536146|P8|COMPLETED|Part 1/Period 2 (United States)||0
223535|NCT00673465|536147|P7|COMPLETED|Part 1/Period 2 (United States)||0
223536|NCT00673465|536148|P6|COMPLETED|Part 1/Period 2 (United States)||1
223537|NCT00673465|536149|P5|COMPLETED|Part 1/Period 2 (United States)||1
223538|NCT00673465|536150|P4|COMPLETED|Part 1/Period 2 (United States)||3
223539|NCT00673465|536151|P3|COMPLETED|Part 1/Period 2 (United States)||3
223540|NCT00673465|536152|P2|COMPLETED|Part 1/Period 2 (United States)||3
223541|NCT00673465|536153|P1|COMPLETED|Part 1/Period 2 (United States)||3
223542|NCT00673465|536142|P12|STARTED|Part 1/Period 2 (United States)||0
223543|NCT00673465|536143|P11|STARTED|Part 1/Period 2 (United States)||0
223544|NCT00673465|536144|P10|STARTED|Part 1/Period 2 (United States)||0
223545|NCT00673465|536145|P9|STARTED|Part 1/Period 2 (United States)||0
223546|NCT00673465|536146|P8|STARTED|Part 1/Period 2 (United States)||0
223547|NCT00673465|536147|P7|STARTED|Part 1/Period 2 (United States)||0
223548|NCT00673465|536148|P6|STARTED|Part 1/Period 2 (United States)||1
223549|NCT00673465|536149|P5|STARTED|Part 1/Period 2 (United States)||2
223550|NCT00673465|536150|P4|STARTED|Part 1/Period 2 (United States)||3
223551|NCT00673465|536151|P3|STARTED|Part 1/Period 2 (United States)||3
223552|NCT00673465|536152|P2|STARTED|Part 1/Period 2 (United States)||3
223553|NCT00673465|536153|P1|STARTED|Part 1/Period 2 (United States)||3
223554|NCT00673465|536142|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
223555|NCT00673465|536143|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
223556|NCT00673465|536144|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
223557|NCT00673465|536145|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
223558|NCT00673465|536146|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
223559|NCT00673465|536147|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
223560|NCT00673465|536148|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
223561|NCT00673465|536149|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
223562|NCT00673465|536150|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
223563|NCT00673465|536151|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
223564|NCT00673465|536152|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
223565|NCT00673465|536153|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
223566|NCT00673465|536142|P12|COMPLETED|Part 1/Period 1 (United States)||0
223567|NCT00673465|536143|P11|COMPLETED|Part 1/Period 1 (United States)||0
223568|NCT00673465|536144|P10|COMPLETED|Part 1/Period 1 (United States)||0
223569|NCT00673465|536145|P9|COMPLETED|Part 1/Period 1 (United States)||0
223570|NCT00673465|536146|P8|COMPLETED|Part 1/Period 1 (United States)||0
223571|NCT00673465|536147|P7|COMPLETED|Part 1/Period 1 (United States)||0
223572|NCT00673465|536148|P6|COMPLETED|Part 1/Period 1 (United States)||1
223573|NCT00673465|536149|P5|COMPLETED|Part 1/Period 1 (United States)||2
223574|NCT00673465|536150|P4|COMPLETED|Part 1/Period 1 (United States)||3
223575|NCT00673465|536151|P3|COMPLETED|Part 1/Period 1 (United States)||3
223576|NCT00673465|536152|P2|COMPLETED|Part 1/Period 1 (United States)||3
223577|NCT00673465|536153|P1|COMPLETED|Part 1/Period 1 (United States)||3
223578|NCT00673465|536142|P12|STARTED|Part 1/Period 1 (United States)||0
223579|NCT00673465|536143|P11|STARTED|Part 1/Period 1 (United States)||0
223580|NCT00673465|536144|P10|STARTED|Part 1/Period 1 (United States)||0
223581|NCT00673465|536145|P9|STARTED|Part 1/Period 1 (United States)||0
223582|NCT00673465|536146|P8|STARTED|Part 1/Period 1 (United States)||0
223583|NCT00673465|536147|P7|STARTED|Part 1/Period 1 (United States)||0
223584|NCT00673465|536148|P6|STARTED|Part 1/Period 1 (United States)||2
223585|NCT00673465|536149|P5|STARTED|Part 1/Period 1 (United States)||3
223586|NCT00673465|536150|P4|STARTED|Part 1/Period 1 (United States)||3
223587|NCT00673465|536151|P3|STARTED|Part 1/Period 1 (United States)||3
223588|NCT00673465|536152|P2|STARTED|Part 1/Period 1 (United States)||3
223589|NCT00673465|536153|P1|STARTED|Part 1/Period 1 (United States)||3
223590|NCT00673452|536202|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
223591|NCT00673452|536203|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
223592|NCT00673452|536202|P2|COMPLETED|Continuation Double-Blind Phase||153
223593|NCT00673452|536203|P1|COMPLETED|Continuation Double-Blind Phase||151
223594|NCT00673452|536202|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
223595|NCT00673452|536203|P1|STARTED|Continuation Double-Blind Phase||176
223596|NCT00673452|536202|P2|NOT COMPLETED|Acute Double-Blind Phase||80
223597|NCT00673452|536203|P1|NOT COMPLETED|Acute Double-Blind Phase||87
223598|NCT00673452|536202|P2|COMPLETED|Acute Double-Blind Phase||187
223599|NCT00673452|536203|P1|COMPLETED|Acute Double-Blind Phase||176
223600|NCT00673452|536202|P2|STARTED|Acute Double-Blind Phase||267
223601|NCT00673452|536203|P1|STARTED|Acute Double-Blind Phase||263
223602|NCT00673439|536237|P1|NOT COMPLETED|Overall Study||0
223603|NCT00673439|536237|P1|COMPLETED|Overall Study||3
223604|NCT00673439|536237|P1|STARTED|Overall Study||3
223605|NCT00673400|536241|P1|NOT COMPLETED|Overall Study||0
223606|NCT00673400|536241|P1|COMPLETED|Overall Study||52
223607|NCT00673400|536241|P1|STARTED|Overall Study||52
223608|NCT00673387|536266|P8|NOT COMPLETED|Overall Study||35
223609|NCT00673387|536267|P7|NOT COMPLETED|Overall Study||30
223610|NCT00673387|536268|P6|NOT COMPLETED|Overall Study||34
223611|NCT00673387|536269|P5|NOT COMPLETED|Overall Study||30
223612|NCT00673387|536270|P4|NOT COMPLETED|Overall Study||26
223613|NCT00673387|536271|P3|NOT COMPLETED|Overall Study||31
223614|NCT00673387|536272|P2|NOT COMPLETED|Overall Study||23
223615|NCT00673387|536273|P1|NOT COMPLETED|Overall Study||29
223616|NCT00673387|536266|P8|COMPLETED|Overall Study||40
223617|NCT00673387|536267|P7|COMPLETED|Overall Study||48
223618|NCT00673387|536268|P6|COMPLETED|Overall Study||44
223619|NCT00673387|536269|P5|COMPLETED|Overall Study||48
223620|NCT00673387|536270|P4|COMPLETED|Overall Study||49
223621|NCT00673387|536271|P3|COMPLETED|Overall Study||41
223622|NCT00673387|536272|P2|COMPLETED|Overall Study||54
223623|NCT00673387|536273|P1|COMPLETED|Overall Study||46
223624|NCT00673387|536266|P8|STARTED|Overall Study||75
223625|NCT00673387|536267|P7|STARTED|Overall Study||78
223626|NCT00673387|536268|P6|STARTED|Overall Study||78
223627|NCT00673387|536269|P5|STARTED|Overall Study||78
223628|NCT00673387|536270|P4|STARTED|Overall Study||75
223629|NCT00673387|536271|P3|STARTED|Overall Study||72
223630|NCT00673387|536272|P2|STARTED|Overall Study||77
223631|NCT00673387|536273|P1|STARTED|Overall Study||75
223632|NCT00673361|536489|P1|NOT COMPLETED|Overall Study||2
223633|NCT00673361|536489|P1|COMPLETED|Overall Study||7
223634|NCT00673361|536489|P1|STARTED|Overall Study||9
223635|NCT00673257|536493|P1|NOT COMPLETED|Overall Study||5
223636|NCT00673257|536493|P1|COMPLETED|Overall Study||102
223637|NCT00673257|536493|P1|STARTED|Overall Study||107
223638|NCT00673231|536502|P4|NOT COMPLETED|Overall Study||18
223639|NCT00673231|536503|P3|NOT COMPLETED|Overall Study||26
223640|NCT00673231|536504|P2|NOT COMPLETED|Overall Study||22
223641|NCT00673231|536505|P1|NOT COMPLETED|Overall Study||29
223642|NCT00673231|536502|P4|COMPLETED|Overall Study||178
223643|NCT00673231|536503|P3|COMPLETED|Overall Study||186
223644|NCT00673231|536504|P2|COMPLETED|Overall Study||180
223645|NCT00673231|536505|P1|COMPLETED|Overall Study||168
223646|NCT00673231|536502|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
223647|NCT00673231|536503|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
223648|NCT00673231|536504|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
223649|NCT00673231|536505|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
223650|NCT00673179|536537|P2|NOT COMPLETED|Overall Study||0
223651|NCT00673179|536538|P1|NOT COMPLETED|Overall Study||3
223652|NCT00673179|536537|P2|COMPLETED|Overall Study||0
223653|NCT00673179|536538|P1|COMPLETED|Overall Study||4
223654|NCT00673179|536537|P2|STARTED|Overall Study||0
223655|NCT00673179|536538|P1|STARTED|Overall Study||7
223656|NCT00673153|536544|P1|NOT COMPLETED|Overall Study||1
223657|NCT00673153|536544|P1|COMPLETED|Overall Study||30
223658|NCT00673153|536544|P1|STARTED|Overall Study||31
223659|NCT00673127|536552|P1|NOT COMPLETED|Overall Study||0
223660|NCT00673127|536552|P1|COMPLETED|Overall Study||57
223661|NCT00673127|536552|P1|STARTED|Overall Study||57
223662|NCT00673114|536557|P1|NOT COMPLETED|Overall Study||0
223663|NCT00673114|536557|P1|COMPLETED|Overall Study||3
223664|NCT00673114|536557|P1|STARTED|Overall Study||3
223665|NCT00673075|536570|P2|NOT COMPLETED|Overall Study||7
223666|NCT00673075|536571|P1|NOT COMPLETED|Overall Study||9
223667|NCT00673075|536570|P2|COMPLETED|Overall Study||11
223668|NCT00673075|536571|P1|COMPLETED|Overall Study||12
223669|NCT00673075|536570|P2|STARTED|Overall Study||18
223670|NCT00673075|536571|P1|STARTED|Overall Study||21
223671|NCT00673049|536587|P4|NOT COMPLETED|After Progression on Erlotinib||83
223672|NCT00673049|536588|P3|NOT COMPLETED|After Progression on Erlotinib||0
223673|NCT00673049|536589|P2|NOT COMPLETED|After Progression on Erlotinib||0
223674|NCT00673049|536590|P1|NOT COMPLETED|After Progression on Erlotinib||0
223675|NCT00673049|536587|P4|COMPLETED|After Progression on Erlotinib||0
223676|NCT00673049|536588|P3|COMPLETED|After Progression on Erlotinib||0
223677|NCT00673049|536589|P2|COMPLETED|After Progression on Erlotinib||0
223678|NCT00673049|536590|P1|COMPLETED|After Progression on Erlotinib||0
223679|NCT00673049|536587|P4|STARTED|After Progression on Erlotinib||83
223680|NCT00673049|536588|P3|STARTED|After Progression on Erlotinib||0
223681|NCT00673049|536589|P2|STARTED|After Progression on Erlotinib||0
223682|NCT00673049|536590|P1|STARTED|After Progression on Erlotinib||0
223683|NCT00673049|536587|P4|NOT COMPLETED|Before Progression on Erlotinib||0
223684|NCT00673049|536588|P3|NOT COMPLETED|Before Progression on Erlotinib||1
223685|NCT00673049|536589|P2|NOT COMPLETED|Before Progression on Erlotinib||290
223686|NCT00673049|536590|P1|NOT COMPLETED|Before Progression on Erlotinib||292
223687|NCT00673049|536587|P4|COMPLETED|Before Progression on Erlotinib||0
223688|NCT00673049|536588|P3|COMPLETED|Before Progression on Erlotinib||0
223689|NCT00673049|536589|P2|COMPLETED|Before Progression on Erlotinib||0
223690|NCT00673049|536590|P1|COMPLETED|Before Progression on Erlotinib||0
223691|NCT00673049|536587|P4|Treated|Before Progression on Erlotinib||0
223692|NCT00673049|536588|P3|Treated|Before Progression on Erlotinib||1
223693|NCT00673049|536589|P2|Treated|Before Progression on Erlotinib||289
223694|NCT00673049|536590|P1|Treated|Before Progression on Erlotinib||289
223695|NCT00673049|536587|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
223696|NCT00673049|536588|P3|STARTED|Before Progression on Erlotinib||1
223697|NCT00673049|536589|P2|STARTED|Before Progression on Erlotinib||290
223698|NCT00673049|536590|P1|STARTED|Before Progression on Erlotinib||292
223699|NCT00672984|536614|P3|NOT COMPLETED|Third Intervention||1
223700|NCT00672984|536615|P2|NOT COMPLETED|Third Intervention||0
223701|NCT00672984|536616|P1|NOT COMPLETED|Third Intervention||1
223702|NCT00672984|536614|P3|COMPLETED|Third Intervention||23
223703|NCT00672984|536615|P2|COMPLETED|Third Intervention||17
223704|NCT00672984|536616|P1|COMPLETED|Third Intervention||21
223705|NCT00672984|536614|P3|STARTED|Third Intervention||24
223706|NCT00672984|536615|P2|STARTED|Third Intervention||17
223707|NCT00672984|536616|P1|STARTED|Third Intervention||22
223708|NCT00672984|536614|P3|NOT COMPLETED|Second Intervention||1
223709|NCT00672984|536615|P2|NOT COMPLETED|Second Intervention||6
223710|NCT00672984|536616|P1|NOT COMPLETED|Second Intervention||0
223711|NCT00672984|536614|P3|COMPLETED|Second Intervention||24
223712|NCT00672984|536615|P2|COMPLETED|Second Intervention||17
223713|NCT00672984|536616|P1|COMPLETED|Second Intervention||22
223714|NCT00672984|536614|P3|STARTED|Second Intervention||25
223715|NCT00672984|536615|P2|STARTED|Second Intervention||23
223716|NCT00672984|536616|P1|STARTED|Second Intervention||22
223717|NCT00672984|536614|P3|NOT COMPLETED|First Intervention||2
223718|NCT00672984|536615|P2|NOT COMPLETED|First Intervention||2
223719|NCT00672984|536616|P1|NOT COMPLETED|First Intervention||9
223720|NCT00672984|536614|P3|COMPLETED|First Intervention||25
223721|NCT00672984|536615|P2|COMPLETED|First Intervention||23
223722|NCT00672984|536616|P1|COMPLETED|First Intervention||22
223723|NCT00672984|536614|P3|STARTED|First Intervention||27
223724|NCT00672984|536615|P2|STARTED|First Intervention||25
223725|NCT00672984|536616|P1|STARTED|First Intervention||31
223726|NCT00672958|536667|P2|NOT COMPLETED|Overall Study||56
223727|NCT00672958|536668|P1|NOT COMPLETED|Overall Study||64
223728|NCT00672958|536667|P2|COMPLETED|Overall Study||244
223729|NCT00672958|536668|P1|COMPLETED|Overall Study||236
223730|NCT00672958|536667|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
223731|NCT00672958|536668|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
223732|NCT00672958|536667|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
223733|NCT00672958|536668|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
223734|NCT00672958|536667|P2|STARTED|Overall Study||300
223735|NCT00672958|536668|P1|STARTED|Overall Study||300
223736|NCT00672932|536700|P2|NOT COMPLETED|Overall Study||0
223737|NCT00672932|536701|P1|NOT COMPLETED|Overall Study||0
223738|NCT00672932|536700|P2|COMPLETED|Overall Study||9
223739|NCT00672932|536701|P1|COMPLETED|Overall Study||9
223740|NCT00672932|536700|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
223741|NCT00672932|536701|P1|Rolled Over to Raltegravir|Overall Study||0
223742|NCT00672932|536700|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
223743|NCT00672932|536701|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
223744|NCT00672932|536700|P2|Completed Initial 12-week Assignment|Overall Study||9
223745|NCT00672932|536701|P1|Completed Initial 12-week Assignment|Overall Study||9
223746|NCT00672932|536700|P2|STARTED|Overall Study||9
223747|NCT00672932|536701|P1|STARTED|Overall Study||9
223748|NCT00672854|536711|P2|NOT COMPLETED|Overall Study||0
223749|NCT00672854|536712|P1|NOT COMPLETED|Overall Study||0
223750|NCT00672854|536711|P2|COMPLETED|Overall Study||51
223751|NCT00672854|536712|P1|COMPLETED|Overall Study||49
223752|NCT00672854|536711|P2|STARTED|Overall Study||51
223753|NCT00672854|536712|P1|STARTED|Overall Study||49
223754|NCT00672841|536720|P2|NOT COMPLETED|Overall Study||15
223755|NCT00672841|536721|P1|NOT COMPLETED|Overall Study||1
223756|NCT00672841|536720|P2|COMPLETED|Overall Study||32
223757|NCT00672841|536721|P1|COMPLETED|Overall Study||16
223758|NCT00672841|536720|P2|STARTED|Overall Study||47
223759|NCT00672841|536721|P1|STARTED|Overall Study||17
223760|NCT00672737|536733|P1|NOT COMPLETED|Overall Study||8
223761|NCT00672737|536733|P1|COMPLETED|Overall Study||48
223762|NCT00672737|536733|P1|STARTED|Overall Study||56
223763|NCT00672646|536743|P3|NOT COMPLETED|Overall Study||3
223764|NCT00672646|536744|P2|NOT COMPLETED|Overall Study||1
223765|NCT00672646|536745|P1|NOT COMPLETED|Overall Study||0
223766|NCT00672646|536743|P3|COMPLETED|Overall Study||37
223767|NCT00672646|536744|P2|COMPLETED|Overall Study||22
223768|NCT00672646|536745|P1|COMPLETED|Overall Study||40
223769|NCT00672646|536743|P3|STARTED|Overall Study||40
223770|NCT00672646|536744|P2|STARTED|Overall Study||23
223771|NCT00672646|536745|P1|STARTED|Overall Study||40
223772|NCT00672633|536770|P2|NOT COMPLETED|Overall Study||1
223773|NCT00672633|536771|P1|NOT COMPLETED|Overall Study||0
223774|NCT00672633|536770|P2|COMPLETED|Overall Study||12
223775|NCT00672633|536771|P1|COMPLETED|Overall Study||12
223776|NCT00672633|536770|P2|STARTED|Overall Study||13
223777|NCT00672633|536771|P1|STARTED|Overall Study||12
223778|NCT00672620|536785|P4|NOT COMPLETED|Overall Study||42
223779|NCT00672620|536786|P3|NOT COMPLETED|Overall Study||31
223780|NCT00672620|536787|P2|NOT COMPLETED|Overall Study||54
223781|NCT00672620|536788|P1|NOT COMPLETED|Overall Study||33
223782|NCT00672620|536785|P4|COMPLETED|Overall Study||110
223783|NCT00672620|536786|P3|COMPLETED|Overall Study||122
223784|NCT00672620|536787|P2|COMPLETED|Overall Study||99
223785|NCT00672620|536788|P1|COMPLETED|Overall Study||120
223786|NCT00672620|536785|P4|Treated|Overall Study||150
223787|NCT00672620|536786|P3|Treated|Overall Study||153
223788|NCT00672620|536787|P2|Treated|Overall Study||149
223789|NCT00672620|536788|P1|Treated|Overall Study||151
223790|NCT00672620|536785|P4|STARTED|Overall Study||152
223791|NCT00672620|536786|P3|STARTED|Overall Study||153
223792|NCT00672620|536787|P2|STARTED|Overall Study||153
223793|NCT00672620|536788|P1|STARTED|Overall Study||153
223794|NCT00672594|536842|P1|NOT COMPLETED|Overall Study||3
223795|NCT00672594|536842|P1|COMPLETED|Overall Study||27
223796|NCT00672594|536842|P1|STARTED|Overall Study||30
223797|NCT00672555|536853|P1|NOT COMPLETED|Overall Study||6
223798|NCT00672555|536853|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
223799|NCT00672555|536853|P1|STARTED|Overall Study||70
223800|NCT00672490|536864|P2|NOT COMPLETED|Overall Study||32
223801|NCT00672490|536865|P1|NOT COMPLETED|Overall Study||24
223802|NCT00672490|536864|P2|COMPLETED|Overall Study||157
223803|NCT00672490|536865|P1|COMPLETED|Overall Study||163
223804|NCT00672490|536864|P2|STARTED|Overall Study||189
223805|NCT00672490|536865|P1|STARTED|Overall Study||187
223806|NCT00672477|536889|P2|NOT COMPLETED|Overall Study||26
223807|NCT00672477|536890|P1|NOT COMPLETED|Overall Study||27
223808|NCT00672477|536889|P2|COMPLETED|Overall Study||88
223809|NCT00672477|536890|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
223810|NCT00672477|536889|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
223811|NCT00672477|536890|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
223812|NCT00672438|536900|P2|NOT COMPLETED|Infusion 2||0
223813|NCT00672438|536901|P1|NOT COMPLETED|Infusion 2||0
223814|NCT00672438|536900|P2|COMPLETED|Infusion 2||118
223815|NCT00672438|536901|P1|COMPLETED|Infusion 2||119
223816|NCT00672438|536900|P2|STARTED|Infusion 2||118
223817|NCT00672438|536901|P1|STARTED|Infusion 2||119
223818|NCT00672438|536900|P2|NOT COMPLETED|Washout||0
223819|NCT00672438|536901|P1|NOT COMPLETED|Washout||0
223820|NCT00672438|536900|P2|COMPLETED|Washout||118
223821|NCT00672438|536901|P1|COMPLETED|Washout||119
223822|NCT00672438|536900|P2|STARTED|Washout||118
223823|NCT00672438|536901|P1|STARTED|Washout||119
223824|NCT00672438|536900|P2|NOT COMPLETED|Infusion 1||0
223825|NCT00672438|536901|P1|NOT COMPLETED|Infusion 1||0
223826|NCT00672438|536900|P2|COMPLETED|Infusion 1||118
223827|NCT00672438|536901|P1|COMPLETED|Infusion 1||119
223828|NCT00672438|536900|P2|STARTED|Infusion 1||118
223829|NCT00672438|536901|P1|STARTED|Infusion 1||119
223830|NCT00672256|536932|P1|NOT COMPLETED|Overall Study||44
223831|NCT00672256|536932|P1|COMPLETED|Overall Study||18
223832|NCT00672256|536932|P1|STARTED|Overall Study|January 2007|62
223833|NCT00672243|536939|P1|NOT COMPLETED|Overall Study||0
223834|NCT00672243|536939|P1|COMPLETED|Overall Study||32
223835|NCT00672243|536939|P1|STARTED|Overall Study||32
223836|NCT00672204|536947|P1|NOT COMPLETED|Overall Study||20
223837|NCT00672204|536947|P1|COMPLETED|Overall Study||3
223838|NCT00672204|536947|P1|STARTED|Overall Study||23
223839|NCT00672178|536951|P1|NOT COMPLETED|Overall Study||0
223840|NCT00672178|536951|P1|COMPLETED|Overall Study||1
223841|NCT00672178|536951|P1|STARTED|Overall Study||1
223842|NCT00672139|536957|P2|NOT COMPLETED|Overall Study||45
223843|NCT00672139|536958|P1|NOT COMPLETED|Overall Study||30
223844|NCT00672139|536957|P2|COMPLETED|Overall Study||47
223845|NCT00672139|536958|P1|COMPLETED|Overall Study||27
223846|NCT00672139|536957|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
223847|NCT00672139|536958|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
223848|NCT00672100|536967|P3|NOT COMPLETED|Overall Study||0
223849|NCT00672100|536968|P2|NOT COMPLETED|Overall Study||0
223850|NCT00672100|536969|P1|NOT COMPLETED|Overall Study||0
223851|NCT00672100|536967|P3|COMPLETED|Overall Study||12
223852|NCT00672100|536968|P2|COMPLETED|Overall Study||12
223853|NCT00672100|536969|P1|COMPLETED|Overall Study||12
223854|NCT00672100|536967|P3|PACU (Within 8 Hours)|Overall Study||12
223855|NCT00672100|536968|P2|PACU (Within 8 Hours)|Overall Study||12
223856|NCT00672100|536969|P1|PACU (Within 8 Hours)|Overall Study||12
223857|NCT00672100|536967|P3|STARTED|Overall Study||12
223858|NCT00672100|536968|P2|STARTED|Overall Study||12
223859|NCT00672100|536969|P1|STARTED|Overall Study||12
223860|NCT00671970|536986|P2|NOT COMPLETED|Overall Study||0
223861|NCT00671970|536987|P1|NOT COMPLETED|Overall Study||0
223862|NCT00671970|536986|P2|COMPLETED|Overall Study||25
223863|NCT00671970|536987|P1|COMPLETED|Overall Study||32
223864|NCT00671970|536986|P2|STARTED|Overall Study||25
223865|NCT00671970|536987|P1|STARTED|Overall Study||32
223866|NCT00671931|537015|P5|NOT COMPLETED|Overall Study||1
223867|NCT00671931|537016|P4|NOT COMPLETED|Overall Study||2
223868|NCT00671931|537017|P3|NOT COMPLETED|Overall Study||0
223869|NCT00671931|537018|P2|NOT COMPLETED|Overall Study||0
223870|NCT00671931|537019|P1|NOT COMPLETED|Overall Study||1
223871|NCT00671931|537015|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
223872|NCT00671931|537016|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
223873|NCT00671931|537017|P3|COMPLETED|Overall Study|all completed|9
223874|NCT00671931|537018|P2|COMPLETED|Overall Study|All completed|8
223875|NCT00671931|537019|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
223876|NCT00671931|537015|P5|STARTED|Overall Study||8
223877|NCT00671931|537016|P4|STARTED|Overall Study||10
223878|NCT00671931|537017|P3|STARTED|Overall Study||9
223879|NCT00671931|537018|P2|STARTED|Overall Study||8
223880|NCT00671931|537019|P1|STARTED|Overall Study||9
223881|NCT00671918|537031|P1|NOT COMPLETED|Overall Study||17
223882|NCT00671918|537031|P1|COMPLETED|Overall Study||169
223883|NCT00671918|537031|P1|STARTED|Overall Study||186
223884|NCT00671879|537039|P3|NOT COMPLETED|Overall Study||6
223885|NCT00671879|537040|P2|NOT COMPLETED|Overall Study||4
223886|NCT00671879|537041|P1|NOT COMPLETED|Overall Study||0
223887|NCT00671879|537039|P3|COMPLETED|Overall Study||274
223888|NCT00671879|537040|P2|COMPLETED|Overall Study||275
223889|NCT00671879|537041|P1|COMPLETED|Overall Study||281
223890|NCT00671879|537039|P3|STARTED|Overall Study||280
223891|NCT00671879|537040|P2|STARTED|Overall Study||279
223892|NCT00671879|537041|P1|STARTED|Overall Study||281
223893|NCT00671853|537054|P2|NOT COMPLETED|Overall Study||27
223894|NCT00671853|537055|P1|NOT COMPLETED|Overall Study||20
223895|NCT00671853|537054|P2|COMPLETED|Overall Study||18
223896|NCT00671853|537055|P1|COMPLETED|Overall Study||26
223897|NCT00671853|537054|P2|STARTED|Overall Study||45
223898|NCT00671853|537055|P1|STARTED|Overall Study||46
223899|NCT00671788|537071|P1|NOT COMPLETED|Overall Study||14
223900|NCT00671788|537071|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
223901|NCT00671788|537071|P1|STARTED|Overall Study||35
223902|NCT00671749|537078|P1|NOT COMPLETED|Overall Study||8
223903|NCT00671749|537078|P1|COMPLETED|Overall Study||92
223904|NCT00671749|537078|P1|STARTED|Overall Study||100
223905|NCT00671723|537091|P3|NOT COMPLETED|Overall Study||0
223906|NCT00671723|537092|P2|NOT COMPLETED|Overall Study||0
223907|NCT00671723|537093|P1|NOT COMPLETED|Overall Study||0
223908|NCT00671723|537091|P3|COMPLETED|Overall Study||11
223909|NCT00671723|537092|P2|COMPLETED|Overall Study||11
223910|NCT00671723|537093|P1|COMPLETED|Overall Study||11
223911|NCT00671723|537091|P3|STARTED|Overall Study||11
223912|NCT00671723|537092|P2|STARTED|Overall Study||11
223913|NCT00671723|537093|P1|STARTED|Overall Study||11
223914|NCT00671671|537106|P2|NOT COMPLETED|Overall Study||0
223915|NCT00671671|537107|P1|NOT COMPLETED|Overall Study||0
223916|NCT00671671|537106|P2|COMPLETED|Overall Study||10
223917|NCT00671671|537107|P1|COMPLETED|Overall Study||10
223918|NCT00671671|537106|P2|STARTED|Overall Study||10
223919|NCT00671671|537107|P1|STARTED|Overall Study||10
223920|NCT00671606|537133|P1|NOT COMPLETED|Overall Study||0
223921|NCT00671606|537133|P1|COMPLETED|Overall Study||5
223922|NCT00671606|537133|P1|STARTED|Overall Study||5
223923|NCT00671554|537137|P1|NOT COMPLETED|Overall Study||3
223924|NCT00671554|537137|P1|COMPLETED|Overall Study||0
223925|NCT00671554|537137|P1|STARTED|Overall Study||3
223926|NCT00671528|537145|P3|NOT COMPLETED|Overall Study||0
223927|NCT00671528|537146|P2|NOT COMPLETED|Overall Study||0
223928|NCT00671528|537147|P1|NOT COMPLETED|Overall Study||0
223929|NCT00671528|537145|P3|COMPLETED|Overall Study||1
223930|NCT00671528|537146|P2|COMPLETED|Overall Study||1
223931|NCT00671528|537147|P1|COMPLETED|Overall Study||1
223932|NCT00671528|537145|P3|STARTED|Overall Study||1
223933|NCT00671528|537146|P2|STARTED|Overall Study||1
223934|NCT00671528|537147|P1|STARTED|Overall Study||1
223935|NCT00671515|537158|P1|NOT COMPLETED|Phase 2||4
223936|NCT00671515|537158|P1|COMPLETED|Phase 2||9
223937|NCT00671515|537158|P1|STARTED|Phase 2||13
223938|NCT00671515|537158|P1|NOT COMPLETED|Phase 1||3
223939|NCT00671515|537158|P1|COMPLETED|Phase 1||20
223940|NCT00671515|537158|P1|STARTED|Phase 1||23
223941|NCT00671502|537166|P3|NOT COMPLETED|Overall Study||27
223942|NCT00671502|537167|P2|NOT COMPLETED|Overall Study||39
223943|NCT00671502|537168|P1|NOT COMPLETED|Overall Study||39
223944|NCT00671502|537166|P3|COMPLETED|Overall Study||252
223945|NCT00671502|537167|P2|COMPLETED|Overall Study||241
223946|NCT00671502|537168|P1|COMPLETED|Overall Study||242
223947|NCT00671502|537166|P3|STARTED|Overall Study||279
223948|NCT00671502|537167|P2|STARTED|Overall Study||280
223949|NCT00671502|537168|P1|STARTED|Overall Study||281
223950|NCT00671437|537176|P1|NOT COMPLETED|Overall Study||15
223951|NCT00671437|537176|P1|COMPLETED|Overall Study||27
223952|NCT00671437|537176|P1|STARTED|Overall Study||42
223953|NCT00671177|537197|P2|NOT COMPLETED|Overall Study||1
223954|NCT00671177|537198|P1|NOT COMPLETED|Overall Study||2
223955|NCT00671177|537197|P2|COMPLETED|Overall Study||114
223956|NCT00671177|537198|P1|COMPLETED|Overall Study||112
223957|NCT00671177|537197|P2|STARTED|Overall Study||115
223958|NCT00671177|537198|P1|STARTED|Overall Study||114
223959|NCT00671060|537210|P2|NOT COMPLETED|Overall Study||1
223960|NCT00671060|537211|P1|NOT COMPLETED|Overall Study||1
223961|NCT00671060|537210|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
223962|NCT00671060|537211|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
223963|NCT00671060|537210|P2|STARTED|Overall Study||76
223964|NCT00671060|537211|P1|STARTED|Overall Study||77
223965|NCT00670982|537219|P2|NOT COMPLETED|Overall Study||0
223966|NCT00670982|537220|P1|NOT COMPLETED|Overall Study||0
223967|NCT00670982|537219|P2|COMPLETED|Overall Study||7
223968|NCT00670982|537220|P1|COMPLETED|Overall Study||22
223969|NCT00670982|537219|P2|STARTED|Overall Study||7
223970|NCT00670982|537220|P1|STARTED|Overall Study||22
223971|NCT00670956|537229|P1|NOT COMPLETED|Overall Study||0
223972|NCT00670956|537229|P1|COMPLETED|Overall Study||1
223973|NCT00670956|537229|P1|STARTED|Overall Study||1
223974|NCT00670930|537237|P2|NOT COMPLETED|Overall Study||1
223975|NCT00670930|537238|P1|NOT COMPLETED|Overall Study||1
223976|NCT00670930|537237|P2|COMPLETED|Overall Study||12
223977|NCT00670930|537238|P1|COMPLETED|Overall Study||22
223978|NCT00670930|537237|P2|Intent to Treat (ITT) Population|Overall Study||12
223979|NCT00670930|537238|P1|Intent to Treat (ITT) Population|Overall Study||23
223980|NCT00670930|537237|P2|STARTED|Overall Study||13
223981|NCT00670930|537238|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
223982|NCT00670800|537254|P2|NOT COMPLETED|Overall Study||2
223983|NCT00670800|537255|P1|NOT COMPLETED|Overall Study||0
223984|NCT00670800|537254|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
223985|NCT00670800|537255|P1|COMPLETED|Overall Study||7
223986|NCT00670800|537254|P2|STARTED|Overall Study||7
223987|NCT00670800|537255|P1|STARTED|Overall Study||7
223988|NCT00670748|537275|P4|NOT COMPLETED|Overall Study||1
223989|NCT00670748|537276|P3|NOT COMPLETED|Overall Study||2
223990|NCT00670748|537277|P2|NOT COMPLETED|Overall Study||2
223991|NCT00670748|537278|P1|NOT COMPLETED|Overall Study||3
223992|NCT00670748|537275|P4|COMPLETED|Overall Study||4
223993|NCT00670748|537276|P3|COMPLETED|Overall Study||5
223994|NCT00670748|537277|P2|COMPLETED|Overall Study||14
223995|NCT00670748|537278|P1|COMPLETED|Overall Study||14
223996|NCT00670748|537275|P4|STARTED|Overall Study||5
223997|NCT00670748|537276|P3|STARTED|Overall Study||7
223998|NCT00670748|537277|P2|STARTED|Overall Study||16
223999|NCT00670748|537278|P1|STARTED|Overall Study||17
224000|NCT00670709|537298|P2|NOT COMPLETED|Overall Study||0
224001|NCT00670709|537299|P1|NOT COMPLETED|Overall Study||0
224002|NCT00670709|537298|P2|COMPLETED|Overall Study||15
224003|NCT00670709|537299|P1|COMPLETED|Overall Study||27
224004|NCT00670709|537298|P2|STARTED|Overall Study||15
224005|NCT00670709|537299|P1|STARTED|Overall Study||27
224006|NCT00670631|537307|P1|NOT COMPLETED|Overall Study||0
224007|NCT00670631|537307|P1|COMPLETED|Overall Study||0
224008|NCT00670631|537307|P1|STARTED|Overall Study||0
224009|NCT00670540|537313|P1|NOT COMPLETED|Overall Study||3325
224010|NCT00670540|537313|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
224011|NCT00670540|537313|P1|STARTED|Overall Study||8256
224012|NCT00670462|537325|P2|NOT COMPLETED|Overall Study||31
224013|NCT00670462|537326|P1|NOT COMPLETED|Overall Study||30
224014|NCT00670462|537325|P2|COMPLETED|Overall Study||76
224015|NCT00670462|537326|P1|COMPLETED|Overall Study||76
224016|NCT00670462|537325|P2|STARTED|Overall Study||107
224017|NCT00670462|537326|P1|STARTED|Overall Study||106
224018|NCT00670449|537358|P4|NOT COMPLETED|Overall Study||8
224019|NCT00670449|537359|P3|NOT COMPLETED|Overall Study||9
224020|NCT00670449|537360|P2|NOT COMPLETED|Overall Study||10
224021|NCT00670449|537361|P1|NOT COMPLETED|Overall Study||9
224022|NCT00670449|537358|P4|COMPLETED|Overall Study||15
224023|NCT00670449|537359|P3|COMPLETED|Overall Study||18
224024|NCT00670449|537360|P2|COMPLETED|Overall Study||36
224025|NCT00670449|537361|P1|COMPLETED|Overall Study||38
224026|NCT00670449|537358|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
224027|NCT00670449|537359|P3|Switched to 0.5mg (Open Label)|Overall Study||23
224028|NCT00670449|537360|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
224029|NCT00670449|537361|P1|Switched to 0.5mg (Open Label)|Overall Study||45
224030|NCT00670449|537358|P4|STARTED|Overall Study||23
224031|NCT00670449|537359|P3|STARTED|Overall Study||27
224032|NCT00670449|537360|P2|STARTED|Overall Study||46
224033|NCT00670449|537361|P1|STARTED|Overall Study||47
224034|NCT00670306|537385|P1|NOT COMPLETED|Overall Study||55
224035|NCT00670306|537385|P1|COMPLETED|Overall Study||473
224036|NCT00670306|537385|P1|STARTED|Overall Study||528
224037|NCT00670267|537389|P1|NOT COMPLETED|Overall Study||1
224038|NCT00670267|537389|P1|COMPLETED|Overall Study||9
224039|NCT00670267|537389|P1|STARTED|Overall Study||10
224040|NCT00670241|537400|P3|NOT COMPLETED|Overall Study||27
224041|NCT00670241|537401|P2|NOT COMPLETED|Overall Study||21
224042|NCT00670241|537402|P1|NOT COMPLETED|Overall Study||12
224043|NCT00670241|537400|P3|COMPLETED|Overall Study||64
224044|NCT00670241|537401|P2|COMPLETED|Overall Study||163
224045|NCT00670241|537402|P1|COMPLETED|Overall Study||171
224046|NCT00670241|537400|P3|STARTED|Overall Study||91
224047|NCT00670241|537401|P2|STARTED|Overall Study||184
224048|NCT00670241|537402|P1|STARTED|Overall Study||183
224049|NCT00670228|537424|P2|NOT COMPLETED|Overall Study||3
224050|NCT00670228|537425|P1|NOT COMPLETED|Overall Study||5
224051|NCT00670228|537424|P2|COMPLETED|Overall Study||12
224052|NCT00670228|537425|P1|COMPLETED|Overall Study||13
224053|NCT00670228|537424|P2|STARTED|Overall Study||15
224054|NCT00670228|537425|P1|STARTED|Overall Study||18
224055|NCT00670202|537439|P2|NOT COMPLETED|Overall Study||0
224056|NCT00670202|537440|P1|NOT COMPLETED|Overall Study||0
224057|NCT00670202|537439|P2|COMPLETED|Overall Study||0
224058|NCT00670202|537440|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
224059|NCT00670202|537439|P2|STARTED|Overall Study||0
224060|NCT00670202|537440|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
224061|NCT00670111|537449|P3|NOT COMPLETED|Six Months to Twelve Months||0
224062|NCT00670111|537450|P2|NOT COMPLETED|Six Months to Twelve Months||0
224063|NCT00670111|537451|P1|NOT COMPLETED|Six Months to Twelve Months||0
224064|NCT00670111|537449|P3|COMPLETED|Six Months to Twelve Months||0
224065|NCT00670111|537450|P2|COMPLETED|Six Months to Twelve Months||8
224066|NCT00670111|537451|P1|COMPLETED|Six Months to Twelve Months||4
224067|NCT00670111|537449|P3|STARTED|Six Months to Twelve Months||0
224068|NCT00670111|537450|P2|STARTED|Six Months to Twelve Months||8
224069|NCT00670111|537451|P1|STARTED|Six Months to Twelve Months||4
224070|NCT00670111|537449|P3|NOT COMPLETED|One Month to Six Months||0
224071|NCT00670111|537450|P2|NOT COMPLETED|One Month to Six Months||0
224072|NCT00670111|537451|P1|NOT COMPLETED|One Month to Six Months||0
224073|NCT00670111|537449|P3|COMPLETED|One Month to Six Months||0
224074|NCT00670111|537450|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
224075|NCT00670111|537451|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
224076|NCT00670111|537449|P3|STARTED|One Month to Six Months||0
224077|NCT00670111|537450|P2|STARTED|One Month to Six Months||8
224078|NCT00670111|537451|P1|STARTED|One Month to Six Months||4
224079|NCT00670111|537449|P3|NOT COMPLETED|One Month Period B||0
224080|NCT00670111|537450|P2|NOT COMPLETED|One Month Period B||0
224081|NCT00670111|537451|P1|NOT COMPLETED|One Month Period B||0
224082|NCT00670111|537449|P3|COMPLETED|One Month Period B||0
224083|NCT00670111|537450|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
224084|NCT00670111|537451|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
224085|NCT00670111|537449|P3|STARTED|One Month Period B||0
224086|NCT00670111|537450|P2|STARTED|One Month Period B||8
224087|NCT00670111|537451|P1|STARTED|One Month Period B||4
224088|NCT00670111|537449|P3|NOT COMPLETED|One Month Period A||0
224089|NCT00670111|537450|P2|NOT COMPLETED|One Month Period A||0
224090|NCT00670111|537451|P1|NOT COMPLETED|One Month Period A||0
224091|NCT00670111|537449|P3|COMPLETED|One Month Period A||0
224092|NCT00670111|537450|P2|COMPLETED|One Month Period A||8
224093|NCT00670111|537451|P1|COMPLETED|One Month Period A||4
224094|NCT00670111|537449|P3|STARTED|One Month Period A||0
224095|NCT00670111|537450|P2|STARTED|One Month Period A||8
224096|NCT00670111|537451|P1|STARTED|One Month Period A||4
224097|NCT00670111|537449|P3|NOT COMPLETED|Enrollment to One Month||19
224098|NCT00670111|537450|P2|NOT COMPLETED|Enrollment to One Month||0
224099|NCT00670111|537451|P1|NOT COMPLETED|Enrollment to One Month||1
224100|NCT00670111|537449|P3|COMPLETED|Enrollment to One Month||0
224101|NCT00670111|537450|P2|COMPLETED|Enrollment to One Month||8
224102|NCT00670111|537451|P1|COMPLETED|Enrollment to One Month||4
224103|NCT00670111|537449|P3|STARTED|Enrollment to One Month||19
224104|NCT00670111|537450|P2|STARTED|Enrollment to One Month||8
224105|NCT00670111|537451|P1|STARTED|Enrollment to One Month||5
224106|NCT00670007|537459|P1|NOT COMPLETED|Overall Study||9
224107|NCT00670007|537459|P1|COMPLETED|Overall Study||131
224108|NCT00670007|537459|P1|STARTED|Overall Study||140
224109|NCT00669955|537486|P2|NOT COMPLETED|Overall Study||27
224110|NCT00669955|537487|P1|NOT COMPLETED|Overall Study||14
224111|NCT00669955|537486|P2|COMPLETED|Overall Study||195
224112|NCT00669955|537487|P1|COMPLETED|Overall Study||204
224113|NCT00669955|537486|P2|STARTED|Overall Study||222
224114|NCT00669955|537487|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
224115|NCT00669942|537517|P12|NOT COMPLETED|Healthy Volunteers||0
224116|NCT00669942|537518|P11|NOT COMPLETED|Healthy Volunteers||1
224117|NCT00669942|537519|P10|NOT COMPLETED|Healthy Volunteers||0
224118|NCT00669942|537520|P9|NOT COMPLETED|Healthy Volunteers||0
224119|NCT00669942|537521|P8|NOT COMPLETED|Healthy Volunteers||0
224120|NCT00669942|537522|P7|NOT COMPLETED|Healthy Volunteers||0
224121|NCT00669942|537523|P6|NOT COMPLETED|Healthy Volunteers||0
224122|NCT00669942|537524|P5|NOT COMPLETED|Healthy Volunteers||0
224123|NCT00669942|537525|P4|NOT COMPLETED|Healthy Volunteers||0
224124|NCT00669942|537526|P3|NOT COMPLETED|Healthy Volunteers||0
224125|NCT00669942|537527|P2|NOT COMPLETED|Healthy Volunteers||0
224126|NCT00669942|537528|P1|NOT COMPLETED|Healthy Volunteers||0
224127|NCT00669942|537517|P12|COMPLETED|Healthy Volunteers||2
224128|NCT00669942|537518|P11|COMPLETED|Healthy Volunteers||2
224129|NCT00669942|537519|P10|COMPLETED|Healthy Volunteers||3
224130|NCT00669942|537520|P9|COMPLETED|Healthy Volunteers||0
224131|NCT00669942|537521|P8|COMPLETED|Healthy Volunteers||0
224132|NCT00669942|537522|P7|COMPLETED|Healthy Volunteers||0
224133|NCT00669942|537523|P6|COMPLETED|Healthy Volunteers||0
224134|NCT00669942|537524|P5|COMPLETED|Healthy Volunteers||0
224135|NCT00669942|537525|P4|COMPLETED|Healthy Volunteers||0
224136|NCT00669942|537526|P3|COMPLETED|Healthy Volunteers||0
224137|NCT00669942|537527|P2|COMPLETED|Healthy Volunteers||0
224138|NCT00669942|537528|P1|COMPLETED|Healthy Volunteers||0
224139|NCT00669942|537517|P12|STARTED|Healthy Volunteers||2
224140|NCT00669942|537518|P11|STARTED|Healthy Volunteers||3
224141|NCT00669942|537519|P10|STARTED|Healthy Volunteers||3
224142|NCT00669942|537520|P9|STARTED|Healthy Volunteers||0
224143|NCT00669942|537521|P8|STARTED|Healthy Volunteers||0
224144|NCT00669942|537522|P7|STARTED|Healthy Volunteers||0
224145|NCT00669942|537523|P6|STARTED|Healthy Volunteers||0
224146|NCT00669942|537524|P5|STARTED|Healthy Volunteers||0
224147|NCT00669942|537525|P4|STARTED|Healthy Volunteers||0
224148|NCT00669942|537526|P3|STARTED|Healthy Volunteers||0
224149|NCT00669942|537527|P2|STARTED|Healthy Volunteers||0
224150|NCT00669942|537528|P1|STARTED|Healthy Volunteers||0
224151|NCT00669942|537517|P12|NOT COMPLETED|Parts 2 and 3||0
224152|NCT00669942|537518|P11|NOT COMPLETED|Parts 2 and 3||0
224153|NCT00669942|537519|P10|NOT COMPLETED|Parts 2 and 3||0
224154|NCT00669942|537520|P9|NOT COMPLETED|Parts 2 and 3||3
224155|NCT00669942|537521|P8|NOT COMPLETED|Parts 2 and 3||2
224156|NCT00669942|537522|P7|NOT COMPLETED|Parts 2 and 3||0
224157|NCT00669942|537523|P6|NOT COMPLETED|Parts 2 and 3||2
224158|NCT00669942|537524|P5|NOT COMPLETED|Parts 2 and 3||0
224159|NCT00669942|537525|P4|NOT COMPLETED|Parts 2 and 3||0
224160|NCT00669942|537526|P3|NOT COMPLETED|Parts 2 and 3||0
224161|NCT00669942|537527|P2|NOT COMPLETED|Parts 2 and 3||0
224162|NCT00669942|537528|P1|NOT COMPLETED|Parts 2 and 3||0
224163|NCT00669942|537517|P12|COMPLETED|Parts 2 and 3||0
224164|NCT00669942|537518|P11|COMPLETED|Parts 2 and 3||0
224165|NCT00669942|537519|P10|COMPLETED|Parts 2 and 3||0
224166|NCT00669942|537520|P9|COMPLETED|Parts 2 and 3||23
224167|NCT00669942|537521|P8|COMPLETED|Parts 2 and 3||24
224168|NCT00669942|537522|P7|COMPLETED|Parts 2 and 3||6
224169|NCT00669942|537523|P6|COMPLETED|Parts 2 and 3||4
224170|NCT00669942|537524|P5|COMPLETED|Parts 2 and 3||0
224171|NCT00669942|537525|P4|COMPLETED|Parts 2 and 3||0
224172|NCT00669942|537526|P3|COMPLETED|Parts 2 and 3||0
224173|NCT00669942|537527|P2|COMPLETED|Parts 2 and 3||0
224174|NCT00669942|537528|P1|COMPLETED|Parts 2 and 3||0
224175|NCT00669942|537517|P12|STARTED|Parts 2 and 3||0
224176|NCT00669942|537518|P11|STARTED|Parts 2 and 3||0
224177|NCT00669942|537519|P10|STARTED|Parts 2 and 3||0
224178|NCT00669942|537520|P9|STARTED|Parts 2 and 3||26
224179|NCT00669942|537521|P8|STARTED|Parts 2 and 3||26
224180|NCT00669942|537522|P7|STARTED|Parts 2 and 3||6
224181|NCT00669942|537523|P6|STARTED|Parts 2 and 3||6
224182|NCT00669942|537524|P5|STARTED|Parts 2 and 3||0
224183|NCT00669942|537525|P4|STARTED|Parts 2 and 3||0
224184|NCT00669942|537526|P3|STARTED|Parts 2 and 3||0
224185|NCT00669942|537527|P2|STARTED|Parts 2 and 3||0
224186|NCT00669942|537528|P1|STARTED|Parts 2 and 3||0
224187|NCT00669942|537517|P12|NOT COMPLETED|Part 1||0
224188|NCT00669942|537518|P11|NOT COMPLETED|Part 1||0
224189|NCT00669942|537519|P10|NOT COMPLETED|Part 1||0
224190|NCT00669942|537520|P9|NOT COMPLETED|Part 1||0
224191|NCT00669942|537521|P8|NOT COMPLETED|Part 1||0
224192|NCT00669942|537522|P7|NOT COMPLETED|Part 1||0
224193|NCT00669942|537523|P6|NOT COMPLETED|Part 1||0
224194|NCT00669942|537524|P5|NOT COMPLETED|Part 1||0
224195|NCT00669942|537525|P4|NOT COMPLETED|Part 1||0
224196|NCT00669942|537526|P3|NOT COMPLETED|Part 1||0
224197|NCT00669942|537527|P2|NOT COMPLETED|Part 1||0
224198|NCT00669942|537528|P1|NOT COMPLETED|Part 1||0
224199|NCT00669942|537517|P12|COMPLETED|Part 1||0
224200|NCT00669942|537518|P11|COMPLETED|Part 1||0
224201|NCT00669942|537519|P10|COMPLETED|Part 1||0
224202|NCT00669942|537520|P9|COMPLETED|Part 1||0
224203|NCT00669942|537521|P8|COMPLETED|Part 1||0
224204|NCT00669942|537522|P7|COMPLETED|Part 1||0
224205|NCT00669942|537523|P6|COMPLETED|Part 1||0
224206|NCT00669942|537524|P5|COMPLETED|Part 1||8
224207|NCT00669942|537525|P4|COMPLETED|Part 1||6
224208|NCT00669942|537526|P3|COMPLETED|Part 1||6
224209|NCT00669942|537527|P2|COMPLETED|Part 1||6
224210|NCT00669942|537528|P1|COMPLETED|Part 1||6
224211|NCT00669942|537517|P12|STARTED|Part 1||0
224212|NCT00669942|537518|P11|STARTED|Part 1||0
224213|NCT00669942|537519|P10|STARTED|Part 1||0
224214|NCT00669942|537520|P9|STARTED|Part 1||0
224215|NCT00669942|537521|P8|STARTED|Part 1||0
224216|NCT00669942|537522|P7|STARTED|Part 1||0
224217|NCT00669942|537523|P6|STARTED|Part 1||0
224218|NCT00669942|537524|P5|STARTED|Part 1||8
224219|NCT00669942|537525|P4|STARTED|Part 1||6
224220|NCT00669942|537526|P3|STARTED|Part 1||6
224221|NCT00669942|537527|P2|STARTED|Part 1||6
224222|NCT00669942|537528|P1|STARTED|Part 1||6
224223|NCT00669916|537592|P2|NOT COMPLETED|Overall Study||0
224224|NCT00669916|537593|P1|NOT COMPLETED|Overall Study||0
224225|NCT00669916|537592|P2|COMPLETED|Overall Study||18
224226|NCT00669916|537593|P1|COMPLETED|Overall Study||18
224227|NCT00669916|537592|P2|STARTED|Overall Study||18
224228|NCT00669916|537593|P1|STARTED|Overall Study||18
224229|NCT00669903|537611|P4|NOT COMPLETED|Overall Study||4
224230|NCT00669903|537612|P3|NOT COMPLETED|Overall Study||5
224231|NCT00669903|537613|P2|NOT COMPLETED|Overall Study||5
224232|NCT00669903|537614|P1|NOT COMPLETED|Overall Study||1
224233|NCT00669903|537611|P4|COMPLETED|Overall Study||18
224234|NCT00669903|537612|P3|COMPLETED|Overall Study||13
224235|NCT00669903|537613|P2|COMPLETED|Overall Study||32
224236|NCT00669903|537614|P1|COMPLETED|Overall Study||22
224237|NCT00669903|537611|P4|Completed Treatment Period|Overall Study||19
224238|NCT00669903|537612|P3|Completed Treatment Period|Overall Study||13
224239|NCT00669903|537613|P2|Completed Treatment Period|Overall Study||33
224240|NCT00669903|537614|P1|Completed Treatment Period|Overall Study||23
224241|NCT00669903|537611|P4|STARTED|Overall Study||22
224242|NCT00669903|537612|P3|STARTED|Overall Study||18
224243|NCT00669903|537613|P2|STARTED|Overall Study||37
224244|NCT00669903|537614|P1|STARTED|Overall Study||23
224245|NCT00669877|537644|P1|NOT COMPLETED|Overall Study||4
224246|NCT00669877|537644|P1|COMPLETED|Overall Study||52
224247|NCT00669877|537644|P1|STARTED|Overall Study||56
224248|NCT00669864|537649|P1|NOT COMPLETED|Overall Study||9
224249|NCT00669864|537649|P1|COMPLETED|Overall Study||284
224250|NCT00669864|537649|P1|STARTED|Overall Study||293
224251|NCT00669682|537658|P1|NOT COMPLETED|Overall Study||0
224252|NCT00669682|537658|P1|COMPLETED|Overall Study||9
224253|NCT00669682|537658|P1|STARTED|Overall Study||9
224254|NCT00669617|537663|P5|NOT COMPLETED|Period 5||0
224255|NCT00669617|537664|P4|NOT COMPLETED|Period 5||0
224256|NCT00669617|537665|P3|NOT COMPLETED|Period 5||0
224257|NCT00669617|537666|P2|NOT COMPLETED|Period 5||0
224258|NCT00669617|537667|P1|NOT COMPLETED|Period 5||0
224259|NCT00669617|537663|P5|COMPLETED|Period 5||17
224260|NCT00669617|537664|P4|COMPLETED|Period 5||18
224261|NCT00669617|537665|P3|COMPLETED|Period 5||17
224262|NCT00669617|537666|P2|COMPLETED|Period 5||17
224263|NCT00669617|537667|P1|COMPLETED|Period 5||17
224264|NCT00669617|537663|P5|STARTED|Period 5||17
224265|NCT00669617|537664|P4|STARTED|Period 5||18
224266|NCT00669617|537665|P3|STARTED|Period 5||17
224267|NCT00669617|537666|P2|STARTED|Period 5||17
224268|NCT00669617|537667|P1|STARTED|Period 5||17
224269|NCT00669617|537663|P5|NOT COMPLETED|Period 4||0
224270|NCT00669617|537664|P4|NOT COMPLETED|Period 4||0
224271|NCT00669617|537665|P3|NOT COMPLETED|Period 4||0
224272|NCT00669617|537666|P2|NOT COMPLETED|Period 4||0
224273|NCT00669617|537667|P1|NOT COMPLETED|Period 4||0
224274|NCT00669617|537663|P5|COMPLETED|Period 4||17
224275|NCT00669617|537664|P4|COMPLETED|Period 4||18
224276|NCT00669617|537665|P3|COMPLETED|Period 4||17
224277|NCT00669617|537666|P2|COMPLETED|Period 4||17
224278|NCT00669617|537667|P1|COMPLETED|Period 4||17
224279|NCT00669617|537663|P5|STARTED|Period 4||17
224280|NCT00669617|537664|P4|STARTED|Period 4||18
224281|NCT00669617|537665|P3|STARTED|Period 4||17
224282|NCT00669617|537666|P2|STARTED|Period 4||17
224283|NCT00669617|537667|P1|STARTED|Period 4||17
224284|NCT00669617|537663|P5|NOT COMPLETED|Period 3||0
224285|NCT00669617|537664|P4|NOT COMPLETED|Period 3||0
224286|NCT00669617|537665|P3|NOT COMPLETED|Period 3||0
224287|NCT00669617|537666|P2|NOT COMPLETED|Period 3||0
224288|NCT00669617|537667|P1|NOT COMPLETED|Period 3||1
224289|NCT00669617|537663|P5|COMPLETED|Period 3||17
224290|NCT00669617|537664|P4|COMPLETED|Period 3||18
224291|NCT00669617|537665|P3|COMPLETED|Period 3||17
224292|NCT00669617|537666|P2|COMPLETED|Period 3||17
224293|NCT00669617|537667|P1|COMPLETED|Period 3||17
224294|NCT00669617|537663|P5|STARTED|Period 3||17
224295|NCT00669617|537664|P4|STARTED|Period 3||18
224296|NCT00669617|537665|P3|STARTED|Period 3||17
224297|NCT00669617|537666|P2|STARTED|Period 3||17
224298|NCT00669617|537667|P1|STARTED|Period 3||18
224299|NCT00669617|537663|P5|NOT COMPLETED|Period 2||0
224300|NCT00669617|537664|P4|NOT COMPLETED|Period 2||0
224301|NCT00669617|537665|P3|NOT COMPLETED|Period 2||0
224302|NCT00669617|537666|P2|NOT COMPLETED|Period 2||0
224303|NCT00669617|537667|P1|NOT COMPLETED|Period 2||0
224304|NCT00669617|537663|P5|COMPLETED|Period 2||17
224305|NCT00669617|537664|P4|COMPLETED|Period 2||18
224306|NCT00669617|537665|P3|COMPLETED|Period 2||17
224307|NCT00669617|537666|P2|COMPLETED|Period 2||17
224308|NCT00669617|537667|P1|COMPLETED|Period 2||18
224309|NCT00669617|537663|P5|STARTED|Period 2||17
224310|NCT00669617|537664|P4|STARTED|Period 2||18
224311|NCT00669617|537665|P3|STARTED|Period 2||17
224312|NCT00669617|537666|P2|STARTED|Period 2||17
224313|NCT00669617|537667|P1|STARTED|Period 2||18
224314|NCT00669617|537663|P5|NOT COMPLETED|Period 1||1
224315|NCT00669617|537664|P4|NOT COMPLETED|Period 1||0
224316|NCT00669617|537665|P3|NOT COMPLETED|Period 1||1
224317|NCT00669617|537666|P2|NOT COMPLETED|Period 1||0
224318|NCT00669617|537667|P1|NOT COMPLETED|Period 1||0
224319|NCT00669617|537663|P5|COMPLETED|Period 1||17
224320|NCT00669617|537664|P4|COMPLETED|Period 1||18
224321|NCT00669617|537665|P3|COMPLETED|Period 1||17
224322|NCT00669617|537666|P2|COMPLETED|Period 1||17
224323|NCT00669617|537667|P1|COMPLETED|Period 1||18
224324|NCT00669617|537663|P5|STARTED|Period 1||18
224325|NCT00669617|537664|P4|STARTED|Period 1||18
224326|NCT00669617|537665|P3|STARTED|Period 1||18
224327|NCT00669617|537666|P2|STARTED|Period 1||17
224328|NCT00669617|537667|P1|STARTED|Period 1||18
224329|NCT00669578|537681|P2|NOT COMPLETED|Overall Study||0
224330|NCT00669578|537682|P1|NOT COMPLETED|Overall Study||0
224331|NCT00669578|537681|P2|COMPLETED|Overall Study||65
224332|NCT00669578|537682|P1|COMPLETED|Overall Study||12
224333|NCT00669578|537681|P2|STARTED|Overall Study||65
224334|NCT00669578|537682|P1|STARTED|Overall Study||12
224335|NCT00669552|537695|P1|NOT COMPLETED|Overall Study||0
224336|NCT00669552|537695|P1|COMPLETED|Overall Study||11
224337|NCT00669552|537695|P1|STARTED|Overall Study||11
224338|NCT00669539|537701|P2|NOT COMPLETED|Overall Study||9
224339|NCT00669539|537702|P1|NOT COMPLETED|Overall Study||8
224340|NCT00669539|537701|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
224341|NCT00669539|537702|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
224342|NCT00669539|537701|P2|STARTED|Overall Study||52
224343|NCT00669539|537702|P1|STARTED|Overall Study||94
224344|NCT00669461|537708|P1|NOT COMPLETED|Overall Study||0
224345|NCT00669461|537708|P1|COMPLETED|Overall Study||1
224346|NCT00669461|537708|P1|STARTED|Overall Study||1
224347|NCT00669396|537715|P2|NOT COMPLETED|Overall Study||12
224348|NCT00669396|537716|P1|NOT COMPLETED|Overall Study||10
224349|NCT00669396|537715|P2|COMPLETED|Overall Study||22
224350|NCT00669396|537716|P1|COMPLETED|Overall Study||13
224351|NCT00669396|537715|P2|STARTED|Overall Study||34
224352|NCT00669396|537716|P1|STARTED|Overall Study||23
224353|NCT00669331|537730|P2|NOT COMPLETED|Blinded Treatment Period||39
224354|NCT00669331|537731|P1|NOT COMPLETED|Blinded Treatment Period||42
224355|NCT00669331|537730|P2|COMPLETED|Blinded Treatment Period||189
224356|NCT00669331|537731|P1|COMPLETED|Blinded Treatment Period||191
224357|NCT00669331|537730|P2|STARTED|Blinded Treatment Period||228
224358|NCT00669331|537731|P1|STARTED|Blinded Treatment Period||233
224359|NCT00669331|537730|P2|NOT COMPLETED|Randomisation to First Dose||13
224360|NCT00669331|537731|P1|NOT COMPLETED|Randomisation to First Dose||11
224361|NCT00669331|537730|P2|COMPLETED|Randomisation to First Dose||228
224362|NCT00669331|537731|P1|COMPLETED|Randomisation to First Dose||233
224363|NCT00669331|537730|P2|STARTED|Randomisation to First Dose||241
224364|NCT00669331|537731|P1|STARTED|Randomisation to First Dose||244
224365|NCT00669318|537773|P1|NOT COMPLETED|Overall Study||2
224366|NCT00669318|537773|P1|COMPLETED|Overall Study||39
224367|NCT00669318|537773|P1|STARTED|Overall Study||41
224368|NCT00669279|537783|P2|NOT COMPLETED|Overall Study||0
224369|NCT00669279|537784|P1|NOT COMPLETED|Overall Study||0
224370|NCT00669279|537783|P2|COMPLETED|Overall Study||19
224371|NCT00669279|537784|P1|COMPLETED|Overall Study||22
224372|NCT00669279|537783|P2|STARTED|Overall Study||19
224373|NCT00669279|537784|P1|STARTED|Overall Study||22
224374|NCT00669240|537790|P1|NOT COMPLETED|Overall Study||165
224375|NCT00669240|537790|P1|COMPLETED|Overall Study||402
224376|NCT00669240|537790|P1|Received Treatment|Overall Study||551
224377|NCT00669240|537790|P1|Assigned to Treatment|Overall Study||566
224378|NCT00669240|537790|P1|STARTED|Overall Study||567
224379|NCT00669214|537806|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
224380|NCT00669214|537807|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
224381|NCT00669214|537806|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
224382|NCT00669214|537807|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
224383|NCT00669214|537806|P2|STARTED|Open-Label Treatment Period (Week 24)||55
224384|NCT00669214|537807|P1|STARTED|Open-Label Treatment Period (Week 24)||22
224385|NCT00669214|537806|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
224386|NCT00669214|537807|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
224387|NCT00669214|537806|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
224388|NCT00669214|537807|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
224389|NCT00669214|537806|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
224390|NCT00669214|537807|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
224391|NCT00669110|537841|P2|NOT COMPLETED|Overall Study||13
224392|NCT00669110|537842|P1|NOT COMPLETED|Overall Study||8
224393|NCT00669110|537841|P2|COMPLETED|Overall Study||7
224394|NCT00669110|537842|P1|COMPLETED|Overall Study||12
224395|NCT00669110|537841|P2|STARTED|Overall Study||20
224396|NCT00669110|537842|P1|STARTED|Overall Study||20
224397|NCT00669071|537878|P1|NOT COMPLETED|Overall Study||4
224398|NCT00669071|537878|P1|COMPLETED|Overall Study||52
224399|NCT00669071|537878|P1|STARTED|Overall Study||56
224400|NCT00669032|537899|P2|NOT COMPLETED|Overall Study||59
224401|NCT00669032|537900|P1|NOT COMPLETED|Overall Study||44
224402|NCT00669032|537899|P2|COMPLETED|Overall Study||94
224403|NCT00669032|537900|P1|COMPLETED|Overall Study||109
224404|NCT00669032|537899|P2|STARTED|Overall Study||153
224405|NCT00669032|537900|P1|STARTED|Overall Study||153
224406|NCT00669019|537928|P1|NOT COMPLETED|Overall Study||0
224407|NCT00669019|537928|P1|COMPLETED|Overall Study||23
224408|NCT00669019|537928|P1|STARTED|Overall Study||23
224409|NCT00668902|537936|P3|NOT COMPLETED|Overall Study||0
224410|NCT00668902|537937|P2|NOT COMPLETED|Overall Study||0
224411|NCT00668902|537938|P1|NOT COMPLETED|Overall Study||0
224412|NCT00668902|537936|P3|COMPLETED|Overall Study||5
224413|NCT00668902|537937|P2|COMPLETED|Overall Study||10
224414|NCT00668902|537938|P1|COMPLETED|Overall Study||10
224415|NCT00668902|537936|P3|STARTED|Overall Study||5
224416|NCT00668902|537937|P2|STARTED|Overall Study||10
224417|NCT00668902|537938|P1|STARTED|Overall Study||10
224418|NCT00668863|537946|P1|NOT COMPLETED|Overall Study||71
224419|NCT00668863|537946|P1|COMPLETED|Overall Study||0
224420|NCT00668863|537946|P1|STARTED|Overall Study||71
224421|NCT00668811|537965|P1|NOT COMPLETED|Overall Study||0
224422|NCT00668811|537965|P1|COMPLETED|Overall Study||23
224423|NCT00668811|537965|P1|STARTED|Overall Study||23
224424|NCT00668785|537970|P1|NOT COMPLETED|Overall Study||0
224425|NCT00668785|537970|P1|COMPLETED|Overall Study||6
224426|NCT00668785|537970|P1|STARTED|Overall Study||6
224427|NCT00668746|537976|P2|NOT COMPLETED|Overall Study||1
224428|NCT00668746|537977|P1|NOT COMPLETED|Overall Study||2
224429|NCT00668746|537976|P2|COMPLETED|Overall Study||11
224430|NCT00668746|537977|P1|COMPLETED|Overall Study||21
224431|NCT00668746|537976|P2|STARTED|Overall Study||12
224432|NCT00668746|537977|P1|STARTED|Overall Study||23
224433|NCT00668733|537997|P2|NOT COMPLETED|Overall Study||7
224434|NCT00668733|537998|P1|NOT COMPLETED|Overall Study||2
224435|NCT00668733|537997|P2|COMPLETED|Overall Study||83
224436|NCT00668733|537998|P1|COMPLETED|Overall Study||87
224437|NCT00668733|537997|P2|STARTED|Overall Study||90
224438|NCT00668733|537998|P1|STARTED|Overall Study||89
224439|NCT00668564|538004|P1|NOT COMPLETED|Overall Study||0
224440|NCT00668564|538004|P1|COMPLETED|Overall Study||18
224441|NCT00668564|538004|P1|STARTED|Overall Study||18
224442|NCT00668525|538012|P3|NOT COMPLETED|Overall Study||53
224443|NCT00668525|538013|P2|NOT COMPLETED|Overall Study||93
224444|NCT00668525|538014|P1|NOT COMPLETED|Overall Study||77
224445|NCT00668525|538012|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
224446|NCT00668525|538013|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
224447|NCT00668525|538014|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
224448|NCT00668525|538012|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
224449|NCT00668525|538013|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
224450|NCT00668525|538014|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
224451|NCT00668434|538027|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
224452|NCT00668434|538028|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
224453|NCT00668434|538027|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
224454|NCT00668434|538028|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
224455|NCT00668434|538027|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
224456|NCT00668434|538028|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
224457|NCT00668434|538027|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
224458|NCT00668434|538028|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
224459|NCT00668434|538027|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
224460|NCT00668434|538028|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
224461|NCT00668434|538027|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
224462|NCT00668434|538028|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
224463|NCT00668395|538043|P3|NOT COMPLETED|Overall Study||1
224464|NCT00668395|538044|P2|NOT COMPLETED|Overall Study||6
224465|NCT00668395|538045|P1|NOT COMPLETED|Overall Study||6
224466|NCT00668395|538043|P3|COMPLETED|Overall Study||5
224467|NCT00668395|538044|P2|COMPLETED|Overall Study||16
224468|NCT00668395|538045|P1|COMPLETED|Overall Study||39
224469|NCT00668395|538043|P3|STARTED|Overall Study||6
224470|NCT00668395|538044|P2|STARTED|Overall Study||22
224471|NCT00668395|538045|P1|STARTED|Overall Study||45
224472|NCT00668382|538053|P1|NOT COMPLETED|Overall Study||0
224473|NCT00668382|538053|P1|COMPLETED|Overall Study||11
224474|NCT00668382|538053|P1|STARTED|Overall Study|beginning of trial|11
224475|NCT00668317|538057|P1|NOT COMPLETED|Overall Study||2
224476|NCT00668317|538057|P1|COMPLETED|Overall Study||3
224477|NCT00668317|538057|P1|STARTED|Overall Study||5
224478|NCT00668265|538063|P2|NOT COMPLETED|Overall Study||5
224479|NCT00668265|538064|P1|NOT COMPLETED|Overall Study||9
224480|NCT00668265|538063|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
224481|NCT00668265|538064|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
224482|NCT00668265|538063|P2|STARTED|Overall Study||5
224483|NCT00668265|538064|P1|STARTED|Overall Study||9
224484|NCT00668200|538072|P1|NOT COMPLETED|Overall Study||3
224485|NCT00668200|538072|P1|COMPLETED|Overall Study||77
224486|NCT00668200|538072|P1|Intent to Treat (ITT)|Overall Study||80
224487|NCT00668200|538072|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
224488|NCT00668200|538072|P1|STARTED|Overall Study||80
224489|NCT00667992|538080|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
224490|NCT00667992|538081|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
224491|NCT00667992|538080|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
224492|NCT00667992|538081|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
224493|NCT00667992|538080|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
224494|NCT00667992|538081|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
224495|NCT00667992|538080|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
224496|NCT00667992|538081|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
224497|NCT00667992|538080|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
224498|NCT00667992|538081|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
224499|NCT00667992|538080|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
224500|NCT00667992|538081|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
224501|NCT00667992|538080|P2|NOT COMPLETED|Wash-out||5
224502|NCT00667992|538081|P1|NOT COMPLETED|Wash-out||7
224503|NCT00667992|538080|P2|COMPLETED|Wash-out||36
224504|NCT00667992|538081|P1|COMPLETED|Wash-out||34
224505|NCT00667992|538080|P2|STARTED|Wash-out||41
224506|NCT00667992|538081|P1|STARTED|Wash-out||41
224507|NCT00667992|538080|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
224508|NCT00667992|538081|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
224509|NCT00667992|538080|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
224510|NCT00667992|538081|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
224511|NCT00667992|538080|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
224512|NCT00667992|538081|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
224513|NCT00667992|538080|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
224514|NCT00667992|538081|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
224515|NCT00667992|538080|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
224516|NCT00667992|538081|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
224517|NCT00667992|538080|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
224518|NCT00667992|538081|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
224519|NCT00667875|538138|P3|NOT COMPLETED|Overall Study||13
224520|NCT00667875|538139|P2|NOT COMPLETED|Overall Study||11
224521|NCT00667875|538140|P1|NOT COMPLETED|Overall Study||10
224522|NCT00667875|538138|P3|COMPLETED|Overall Study||8
224523|NCT00667875|538139|P2|COMPLETED|Overall Study||10
224524|NCT00667875|538140|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
224525|NCT00667875|538138|P3|Subjects Included in Analysisd|Overall Study||19
224526|NCT00667875|538139|P2|Subjects Included in Analysisd|Overall Study||21
224527|NCT00667875|538140|P1|Subjects Included in Analysisd|Overall Study||20
224528|NCT00667875|538138|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
224529|NCT00667875|538139|P2|STARTED|Overall Study||21
224530|NCT00667875|538140|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
224531|NCT00667849|538159|P2|NOT COMPLETED|Overall Study||121
224532|NCT00667849|538160|P1|NOT COMPLETED|Overall Study||108
224533|NCT00667849|538159|P2|COMPLETED|Overall Study||130
224534|NCT00667849|538160|P1|COMPLETED|Overall Study||142
224535|NCT00667849|538159|P2|STARTED|Overall Study||251
224536|NCT00667849|538160|P1|STARTED|Overall Study||250
224537|NCT00667810|538174|P4|NOT COMPLETED|Overall Study||2
224538|NCT00667810|538175|P3|NOT COMPLETED|Overall Study||222
224539|NCT00667810|538176|P2|NOT COMPLETED|Overall Study||170
224540|NCT00667810|538177|P1|NOT COMPLETED|Overall Study||167
224541|NCT00667810|538174|P4|COMPLETED|Overall Study||9
224542|NCT00667810|538175|P3|COMPLETED|Overall Study||124
224543|NCT00667810|538176|P2|COMPLETED|Overall Study||94
224544|NCT00667810|538177|P1|COMPLETED|Overall Study||102
224545|NCT00667810|538174|P4|Treated|Overall Study||11
224546|NCT00667810|538175|P3|Treated|Overall Study||344
224547|NCT00667810|538176|P2|Treated|Overall Study||263
224548|NCT00667810|538177|P1|Treated|Overall Study||267
224549|NCT00667810|538174|P4|STARTED|Overall Study||11
224550|NCT00667810|538175|P3|STARTED|Overall Study||346
224551|NCT00667810|538176|P2|STARTED|Overall Study||264
224552|NCT00667810|538177|P1|STARTED|Overall Study||269
224553|NCT00667745|538236|P2|NOT COMPLETED|Overall Study||21
224554|NCT00667745|538237|P1|NOT COMPLETED|Overall Study||25
224555|NCT00667745|538236|P2|COMPLETED|Overall Study||121
224556|NCT00667745|538237|P1|COMPLETED|Overall Study||116
224557|NCT00667745|538236|P2|STARTED|Overall Study||142
224558|NCT00667745|538237|P1|STARTED|Overall Study||141
224559|NCT00667732|538253|P3|NOT COMPLETED|Extension (26 Weeks)||0
224560|NCT00667732|538254|P2|NOT COMPLETED|Extension (26 Weeks)||0
224561|NCT00667732|538255|P1|NOT COMPLETED|Extension (26 Weeks)||0
224562|NCT00667732|538253|P3|COMPLETED|Extension (26 Weeks)||17
224563|NCT00667732|538254|P2|COMPLETED|Extension (26 Weeks)||14
224564|NCT00667732|538255|P1|COMPLETED|Extension (26 Weeks)||0
224565|NCT00667732|538253|P3|STARTED|Extension (26 Weeks)||17
224566|NCT00667732|538254|P2|STARTED|Extension (26 Weeks)||14
224567|NCT00667732|538255|P1|STARTED|Extension (26 Weeks)||0
224568|NCT00667732|538253|P3|NOT COMPLETED|Randomization (24 Weeks)||0
224569|NCT00667732|538254|P2|NOT COMPLETED|Randomization (24 Weeks)||1
224570|NCT00667732|538255|P1|NOT COMPLETED|Randomization (24 Weeks)||0
224571|NCT00667732|538253|P3|COMPLETED|Randomization (24 Weeks)||17
224572|NCT00667732|538254|P2|COMPLETED|Randomization (24 Weeks)||16
224573|NCT00667732|538255|P1|COMPLETED|Randomization (24 Weeks)||0
224574|NCT00667732|538253|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
224575|NCT00667732|538254|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
224576|NCT00667732|538255|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
224577|NCT00667732|538253|P3|STARTED|Randomization (24 Weeks)||17
224578|NCT00667732|538254|P2|STARTED|Randomization (24 Weeks)||17
224579|NCT00667732|538255|P1|STARTED|Randomization (24 Weeks)||0
224580|NCT00667732|538253|P3|NOT COMPLETED|Run -In (8 Weeks)||0
224581|NCT00667732|538254|P2|NOT COMPLETED|Run -In (8 Weeks)||0
224582|NCT00667732|538255|P1|NOT COMPLETED|Run -In (8 Weeks)||7
224583|NCT00667732|538253|P3|COMPLETED|Run -In (8 Weeks)||0
224584|NCT00667732|538254|P2|COMPLETED|Run -In (8 Weeks)||0
224585|NCT00667732|538255|P1|COMPLETED|Run -In (8 Weeks)||34
224586|NCT00667732|538253|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
224587|NCT00667732|538254|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
224588|NCT00667732|538255|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
224589|NCT00667732|538253|P3|STARTED|Run -In (8 Weeks)||0
224590|NCT00667732|538254|P2|STARTED|Run -In (8 Weeks)||0
224591|NCT00667732|538255|P1|STARTED|Run -In (8 Weeks)||41
224592|NCT00667693|538268|P2|NOT COMPLETED|Overall Study||2
224593|NCT00667693|538269|P1|NOT COMPLETED|Overall Study||0
224594|NCT00667693|538268|P2|COMPLETED|Overall Study||50
224595|NCT00667693|538269|P1|COMPLETED|Overall Study||49
224596|NCT00667693|538268|P2|STARTED|Overall Study||52
224597|NCT00667693|538269|P1|STARTED|Overall Study||49
224598|NCT00667615|538275|P1|NOT COMPLETED|Overall Study||0
224599|NCT00667615|538275|P1|COMPLETED|Overall Study||30
224600|NCT00667615|538275|P1|STARTED|Overall Study||30
224601|NCT00667602|538283|P3|NOT COMPLETED|Overall Study||18
224602|NCT00667602|538284|P2|NOT COMPLETED|Overall Study||15
224603|NCT00667602|538285|P1|NOT COMPLETED|Overall Study||8
224604|NCT00667602|538283|P3|COMPLETED|Overall Study||197
224605|NCT00667602|538284|P2|COMPLETED|Overall Study||213
224606|NCT00667602|538285|P1|COMPLETED|Overall Study||211
224607|NCT00667602|538283|P3|STARTED|Overall Study||215
224608|NCT00667602|538284|P2|STARTED|Overall Study||228
224609|NCT00667602|538285|P1|STARTED|Overall Study||219
224610|NCT00667589|538335|P4|NOT COMPLETED|Overall Study||1
224611|NCT00667589|538336|P3|NOT COMPLETED|Overall Study||3
224612|NCT00667589|538337|P2|NOT COMPLETED|Overall Study||0
224613|NCT00667589|538338|P1|NOT COMPLETED|Overall Study||1
224614|NCT00667589|538335|P4|COMPLETED|Overall Study||1
224615|NCT00667589|538336|P3|COMPLETED|Overall Study||0
224616|NCT00667589|538337|P2|COMPLETED|Overall Study||0
224617|NCT00667589|538338|P1|COMPLETED|Overall Study||0
224618|NCT00667589|538335|P4|STARTED|Overall Study||2
224619|NCT00667589|538336|P3|STARTED|Overall Study||3
224620|NCT00667589|538337|P2|STARTED|Overall Study||0
224621|NCT00667589|538338|P1|STARTED|Overall Study||1
224622|NCT00667576|538353|P5|NOT COMPLETED|Overall Study||1
224623|NCT00667576|538354|P4|NOT COMPLETED|Overall Study||4
224624|NCT00667576|538355|P3|NOT COMPLETED|Overall Study||2
224625|NCT00667576|538356|P2|NOT COMPLETED|Overall Study||1
224626|NCT00667576|538357|P1|NOT COMPLETED|Overall Study||2
224627|NCT00667576|538353|P5|COMPLETED|Overall Study||29
224628|NCT00667576|538354|P4|COMPLETED|Overall Study||27
224629|NCT00667576|538355|P3|COMPLETED|Overall Study||29
224630|NCT00667576|538356|P2|COMPLETED|Overall Study||30
224631|NCT00667576|538357|P1|COMPLETED|Overall Study||28
224632|NCT00667576|538353|P5|STARTED|Overall Study||30
224633|NCT00667576|538354|P4|STARTED|Overall Study||31
224634|NCT00667576|538355|P3|STARTED|Overall Study||31
224635|NCT00667576|538356|P2|STARTED|Overall Study||31
224636|NCT00667576|538357|P1|STARTED|Overall Study||30
224637|NCT00667563|538404|P1|NOT COMPLETED|Overall Study||24
224638|NCT00667563|538404|P1|COMPLETED|Overall Study||126
224639|NCT00667563|538404|P1|STARTED|Overall Study||150
224640|NCT00667511|538414|P1|NOT COMPLETED|Intervention 2: Home NHD||4
224641|NCT00667511|538414|P1|COMPLETED|Intervention 2: Home NHD||39
224642|NCT00667511|538414|P1|STARTED|Intervention 2: Home NHD||43
224643|NCT00667511|538414|P1|NOT COMPLETED|Training/Transition Period||8
224644|NCT00667511|538414|P1|COMPLETED|Training/Transition Period||43
224645|NCT00667511|538414|P1|STARTED|Training/Transition Period||51
224646|NCT00667511|538414|P1|NOT COMPLETED|Intervention 1: Home DHD||7
224647|NCT00667511|538414|P1|COMPLETED|Intervention 1: Home DHD||51
224648|NCT00667511|538414|P1|STARTED|Intervention 1: Home DHD||58
224649|NCT00667459|538424|P2|NOT COMPLETED|Overall Study||45
224650|NCT00667459|538425|P1|NOT COMPLETED|Overall Study||8
224651|NCT00667459|538424|P2|COMPLETED|Overall Study||220
224652|NCT00667459|538425|P1|COMPLETED|Overall Study||272
224653|NCT00667459|538424|P2|STARTED|Overall Study||265
224654|NCT00667459|538425|P1|STARTED|Overall Study||280
224655|NCT00667446|538467|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
224656|NCT00667446|538468|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
224657|NCT00667446|538467|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
224658|NCT00667446|538468|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
224659|NCT00667446|538467|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
224660|NCT00667446|538468|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
224661|NCT00667446|538467|P2|NOT COMPLETED|Treatment Period (36 Months)||25
224662|NCT00667446|538468|P1|NOT COMPLETED|Treatment Period (36 Months)||23
224663|NCT00667446|538467|P2|COMPLETED|Treatment Period (36 Months)||13
224664|NCT00667446|538468|P1|COMPLETED|Treatment Period (36 Months)||11
224665|NCT00667446|538467|P2|STARTED|Treatment Period (36 Months)||38
224666|NCT00667446|538468|P1|STARTED|Treatment Period (36 Months)||34
224667|NCT00667420|538490|P1|NOT COMPLETED|Overall Study||10
224668|NCT00667420|538490|P1|COMPLETED|Overall Study||7
224669|NCT00667420|538490|P1|Completion of Surgery/Re-staging|Overall Study||11
224670|NCT00667420|538490|P1|Completion of Pre-operative EOX-P|Overall Study||15
224671|NCT00667420|538490|P1|STARTED|Overall Study||17
224672|NCT00667394|538500|P2|NOT COMPLETED|Overall Study||0
224673|NCT00667394|538501|P1|NOT COMPLETED|Overall Study||4
224674|NCT00667394|538500|P2|COMPLETED|Overall Study||1
224675|NCT00667394|538501|P1|COMPLETED|Overall Study||37
224676|NCT00667394|538500|P2|STARTED|Overall Study||1
224677|NCT00667394|538501|P1|STARTED|Overall Study||41
224678|NCT00667381|538511|P2|NOT COMPLETED|Overall Study||0
224679|NCT00667381|538512|P1|NOT COMPLETED|Overall Study||0
224680|NCT00667381|538511|P2|COMPLETED|Overall Study||503
224681|NCT00667381|538512|P1|COMPLETED|Overall Study||501
224682|NCT00667381|538511|P2|STARTED|Overall Study||503
224683|NCT00667381|538512|P1|STARTED|Overall Study||501
224684|NCT00667368|538528|P2|NOT COMPLETED|Overall Study||172
224685|NCT00667368|538529|P1|NOT COMPLETED|Overall Study||200
224686|NCT00667368|538528|P2|COMPLETED|Overall Study||511
224687|NCT00667368|538529|P1|COMPLETED|Overall Study||482
224688|NCT00667368|538528|P2|STARTED|Overall Study||683
224689|NCT00667368|538529|P1|STARTED|Overall Study||682
224690|NCT00667355|538537|P1|NOT COMPLETED|Overall Study||11
224691|NCT00667355|538537|P1|COMPLETED|Overall Study||30
224692|NCT00667355|538537|P1|STARTED|Overall Study||41
224693|NCT00667342|538562|P3|NOT COMPLETED|Overall Study||9
224694|NCT00667342|538563|P2|NOT COMPLETED|Overall Study||0
224695|NCT00667342|538564|P1|NOT COMPLETED|Overall Study||14
224696|NCT00667342|538562|P3|COMPLETED|Overall Study||3
224697|NCT00667342|538563|P2|COMPLETED|Overall Study||0
224698|NCT00667342|538564|P1|COMPLETED|Overall Study||17
224699|NCT00667342|538562|P3|STARTED|Overall Study||12
224700|NCT00667342|538563|P2|STARTED|Overall Study||0
224701|NCT00667342|538564|P1|STARTED|Overall Study||31
224702|NCT00667277|538602|P1|NOT COMPLETED|Overall Study||2
224703|NCT00667277|538602|P1|COMPLETED|Overall Study||11
224704|NCT00667277|538602|P1|STARTED|Overall Study||13
224705|NCT00667251|538609|P2|NOT COMPLETED|Overall Study||95
224706|NCT00667251|538610|P1|NOT COMPLETED|Overall Study||70
224707|NCT00667251|538609|P2|COMPLETED|Overall Study||231
224708|NCT00667251|538610|P1|COMPLETED|Overall Study||256
224709|NCT00667251|538609|P2|Not Started|Overall Study||1
224710|NCT00667251|538610|P1|Not Started|Overall Study||4
224711|NCT00667251|538609|P2|Monotherapy|Overall Study||232
224712|NCT00667251|538610|P1|Monotherapy|Overall Study||225
224713|NCT00667251|538609|P2|Combination Rx|Overall Study||325
224714|NCT00667251|538610|P1|Combination Rx|Overall Study||322
224715|NCT00667251|538609|P2|STARTED|Overall Study||326
224716|NCT00667251|538610|P1|STARTED|Overall Study||326
224717|NCT00667225|538636|P2|NOT COMPLETED|Overall Study||1
224718|NCT00667225|538637|P1|NOT COMPLETED|Overall Study||1
224719|NCT00667225|538636|P2|COMPLETED|Overall Study||12
224720|NCT00667225|538637|P1|COMPLETED|Overall Study||15
224721|NCT00667225|538636|P2|STARTED|Overall Study||13
224722|NCT00667225|538637|P1|STARTED|Overall Study||16
224723|NCT00667186|538647|P2|NOT COMPLETED|Overall Study||0
224724|NCT00667186|538648|P1|NOT COMPLETED|Overall Study||0
224725|NCT00667186|538647|P2|COMPLETED|Overall Study||4880
224726|NCT00667186|538648|P1|COMPLETED|Overall Study||4692
224727|NCT00667186|538647|P2|STARTED|Overall Study||4880
224728|NCT00667186|538648|P1|STARTED|Overall Study||4692
224729|NCT00667095|538658|P2|NOT COMPLETED|Overall Study||1
224730|NCT00667095|538659|P1|NOT COMPLETED|Overall Study||0
224731|NCT00667095|538658|P2|COMPLETED|Overall Study||9
224732|NCT00667095|538659|P1|COMPLETED|Overall Study||11
224733|NCT00667095|538658|P2|STARTED|Overall Study||10
224734|NCT00667095|538659|P1|STARTED|Overall Study||11
224735|NCT00666978|538677|P2|NOT COMPLETED|Overall Study||83
224736|NCT00666978|538678|P1|NOT COMPLETED|Overall Study||78
224737|NCT00666978|538677|P2|COMPLETED|Overall Study||187
224738|NCT00666978|538678|P1|COMPLETED|Overall Study||192
224739|NCT00666978|538677|P2|STARTED|Overall Study||270
224740|NCT00666978|538678|P1|STARTED|Overall Study||270
224741|NCT00666965|538691|P4|NOT COMPLETED|Overall Study||15
224742|NCT00666965|538692|P3|NOT COMPLETED|Overall Study||2
224743|NCT00666965|538693|P2|NOT COMPLETED|Overall Study||4
224744|NCT00666965|538694|P1|NOT COMPLETED|Overall Study||3
224745|NCT00666965|538691|P4|COMPLETED|Overall Study||42
224746|NCT00666965|538692|P3|COMPLETED|Overall Study||56
224747|NCT00666965|538693|P2|COMPLETED|Overall Study||53
224748|NCT00666965|538694|P1|COMPLETED|Overall Study||55
224749|NCT00666965|538691|P4|STARTED|Overall Study||57
224750|NCT00666965|538692|P3|STARTED|Overall Study||58
224751|NCT00666965|538693|P2|STARTED|Overall Study||57
224752|NCT00666965|538694|P1|STARTED|Overall Study||58
224753|NCT00666926|538724|P16|NOT COMPLETED|Overall Study||8
224754|NCT00666926|538725|P15|NOT COMPLETED|Overall Study||7
224755|NCT00666926|538726|P14|NOT COMPLETED|Overall Study||4
224756|NCT00666926|538727|P13|NOT COMPLETED|Overall Study||3
224757|NCT00666926|538728|P12|NOT COMPLETED|Overall Study||33
224758|NCT00666926|538729|P11|NOT COMPLETED|Overall Study||6
224759|NCT00666926|538730|P10|NOT COMPLETED|Overall Study||10
224760|NCT00666926|538731|P9|NOT COMPLETED|Overall Study||3
224761|NCT00666926|538732|P8|NOT COMPLETED|Overall Study||1
224762|NCT00666926|538733|P7|NOT COMPLETED|Overall Study||4
224763|NCT00666926|538734|P6|NOT COMPLETED|Overall Study||4
224764|NCT00666926|538735|P5|NOT COMPLETED|Overall Study||3
224765|NCT00666926|538736|P4|NOT COMPLETED|Overall Study||4
224766|NCT00666926|538737|P3|NOT COMPLETED|Overall Study||3
224767|NCT00666926|538738|P2|NOT COMPLETED|Overall Study||4
224768|NCT00666926|538739|P1|NOT COMPLETED|Overall Study||2
224769|NCT00666926|538724|P16|COMPLETED|Overall Study||0
224770|NCT00666926|538725|P15|COMPLETED|Overall Study||0
224771|NCT00666926|538726|P14|COMPLETED|Overall Study||0
224772|NCT00666926|538727|P13|COMPLETED|Overall Study||0
224773|NCT00666926|538728|P12|COMPLETED|Overall Study||0
224774|NCT00666926|538729|P11|COMPLETED|Overall Study||0
224775|NCT00666926|538730|P10|COMPLETED|Overall Study||0
224776|NCT00666926|538731|P9|COMPLETED|Overall Study||0
224777|NCT00666926|538732|P8|COMPLETED|Overall Study||0
224778|NCT00666926|538733|P7|COMPLETED|Overall Study||0
224779|NCT00666926|538734|P6|COMPLETED|Overall Study||0
224780|NCT00666926|538735|P5|COMPLETED|Overall Study||0
224781|NCT00666926|538736|P4|COMPLETED|Overall Study||0
224782|NCT00666926|538737|P3|COMPLETED|Overall Study||0
224783|NCT00666926|538738|P2|COMPLETED|Overall Study||0
224784|NCT00666926|538739|P1|COMPLETED|Overall Study||0
224785|NCT00666926|538724|P16|STARTED|Overall Study||8
224786|NCT00666926|538725|P15|STARTED|Overall Study||7
224787|NCT00666926|538726|P14|STARTED|Overall Study||4
224788|NCT00666926|538727|P13|STARTED|Overall Study||3
224789|NCT00666926|538728|P12|STARTED|Overall Study||33
224790|NCT00666926|538729|P11|STARTED|Overall Study||6
224791|NCT00666926|538730|P10|STARTED|Overall Study||10
224792|NCT00666926|538731|P9|STARTED|Overall Study||3
224793|NCT00666926|538732|P8|STARTED|Overall Study||1
224794|NCT00666926|538733|P7|STARTED|Overall Study||4
224795|NCT00666926|538734|P6|STARTED|Overall Study||4
224796|NCT00666926|538735|P5|STARTED|Overall Study||3
224797|NCT00666926|538736|P4|STARTED|Overall Study||4
224798|NCT00666926|538737|P3|STARTED|Overall Study||3
224799|NCT00666926|538738|P2|STARTED|Overall Study||4
224800|NCT00666926|538739|P1|STARTED|Overall Study||2
224801|NCT00666848|539033|P3|NOT COMPLETED|Overall Study||0
224802|NCT00666848|539034|P2|NOT COMPLETED|Overall Study||0
224803|NCT00666848|539035|P1|NOT COMPLETED|Overall Study||0
224804|NCT00666848|539033|P3|COMPLETED|Overall Study|finished Aim 3|7
224805|NCT00666848|539034|P2|COMPLETED|Overall Study|finished Aim 1|9
224806|NCT00666848|539035|P1|COMPLETED|Overall Study|finished Aim 2|8
224807|NCT00666848|539033|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
224808|NCT00666848|539034|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
224809|NCT00666848|539035|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
224810|NCT00666835|539048|P2|NOT COMPLETED|Overall Study||22
224811|NCT00666835|539049|P1|NOT COMPLETED|Overall Study||53
224812|NCT00666835|539048|P2|COMPLETED|Overall Study||142
224813|NCT00666835|539049|P1|COMPLETED|Overall Study||261
224814|NCT00666835|539048|P2|STARTED|Overall Study||164
224815|NCT00666835|539049|P1|STARTED|Overall Study||314
224816|NCT00666757|539059|P2|NOT COMPLETED|Overall Study||97
224817|NCT00666757|539060|P1|NOT COMPLETED|Overall Study||100
224818|NCT00666757|539059|P2|COMPLETED|Overall Study||281
224819|NCT00666757|539060|P1|COMPLETED|Overall Study||272
224820|NCT00666757|539059|P2|STARTED|Overall Study||378
224821|NCT00666757|539060|P1|STARTED|Overall Study||372
224822|NCT00666718|539119|P2|NOT COMPLETED|Overall Study||18
224823|NCT00666718|539120|P1|NOT COMPLETED|Overall Study||12
224824|NCT00666718|539119|P2|COMPLETED|Overall Study||169
224825|NCT00666718|539120|P1|COMPLETED|Overall Study||175
224826|NCT00666718|539119|P2|STARTED|Overall Study||187
224827|NCT00666718|539120|P1|STARTED|Overall Study||187
224828|NCT00666705|539146|P1|NOT COMPLETED|Overall Study||1
224829|NCT00666705|539146|P1|COMPLETED|Overall Study||17
224830|NCT00666705|539146|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
224831|NCT00666705|539146|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
224832|NCT00666705|539146|P1|Washout (Days 4 - 5)|Overall Study||18
224833|NCT00666705|539146|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
224834|NCT00666705|539146|P1|STARTED|Overall Study||18
224835|NCT00666679|539165|P2|NOT COMPLETED|Second Intervention||1
224836|NCT00666679|539166|P1|NOT COMPLETED|Second Intervention||1
224837|NCT00666679|539165|P2|COMPLETED|Second Intervention||64
224838|NCT00666679|539166|P1|COMPLETED|Second Intervention||61
224839|NCT00666679|539165|P2|STARTED|Second Intervention||65
224840|NCT00666679|539166|P1|STARTED|Second Intervention||62
224841|NCT00666679|539165|P2|NOT COMPLETED|Washout Period of 1 Week||2
224842|NCT00666679|539166|P1|NOT COMPLETED|Washout Period of 1 Week||0
224843|NCT00666679|539165|P2|COMPLETED|Washout Period of 1 Week||65
224844|NCT00666679|539166|P1|COMPLETED|Washout Period of 1 Week||62
224845|NCT00666679|539165|P2|STARTED|Washout Period of 1 Week||67
224846|NCT00666679|539166|P1|STARTED|Washout Period of 1 Week||62
224847|NCT00666679|539165|P2|NOT COMPLETED|First Intervention||1
224848|NCT00666679|539166|P1|NOT COMPLETED|First Intervention||4
224849|NCT00666679|539165|P2|COMPLETED|First Intervention||67
224850|NCT00666679|539166|P1|COMPLETED|First Intervention||62
224851|NCT00666679|539165|P2|STARTED|First Intervention||68
224852|NCT00666679|539166|P1|STARTED|First Intervention||66
224853|NCT00666666|539186|P1|NOT COMPLETED|Overall Study||0
224854|NCT00666666|539186|P1|COMPLETED|Overall Study||55
224855|NCT00666666|539186|P1|STARTED|Overall Study||55
224856|NCT00666588|539196|P4|NOT COMPLETED|Overall Study||2
224857|NCT00666588|539197|P3|NOT COMPLETED|Overall Study||0
224858|NCT00666588|539198|P2|NOT COMPLETED|Overall Study||0
224859|NCT00666588|539199|P1|NOT COMPLETED|Overall Study||4
224860|NCT00666588|539196|P4|COMPLETED|Overall Study||20
224861|NCT00666588|539197|P3|COMPLETED|Overall Study||6
224862|NCT00666588|539198|P2|COMPLETED|Overall Study||6
224863|NCT00666588|539199|P1|COMPLETED|Overall Study||14
224864|NCT00666588|539196|P4|STARTED|Overall Study||22
224865|NCT00666588|539197|P3|STARTED|Overall Study||6
224866|NCT00666588|539198|P2|STARTED|Overall Study||6
224867|NCT00666588|539199|P1|STARTED|Overall Study||18
224868|NCT00666562|539232|P3|NOT COMPLETED|Overall Study||0
224869|NCT00666562|539233|P2|NOT COMPLETED|Overall Study||2
224870|NCT00666562|539234|P1|NOT COMPLETED|Overall Study||0
224871|NCT00666562|539232|P3|COMPLETED|Overall Study||10
224872|NCT00666562|539233|P2|COMPLETED|Overall Study||8
224873|NCT00666562|539234|P1|COMPLETED|Overall Study||11
224874|NCT00666562|539232|P3|STARTED|Overall Study||10
224875|NCT00666562|539233|P2|STARTED|Overall Study||10
224876|NCT00666562|539234|P1|STARTED|Overall Study||11
224877|NCT00666536|539281|P2|NOT COMPLETED|Overall Study||37
224878|NCT00666536|539282|P1|NOT COMPLETED|Overall Study||33
224879|NCT00666536|539281|P2|COMPLETED|Overall Study||322
224880|NCT00666536|539282|P1|COMPLETED|Overall Study||336
224881|NCT00666536|539281|P2|STARTED|Overall Study||359
224882|NCT00666536|539282|P1|STARTED|Overall Study||369
224883|NCT00666458|539300|P2|NOT COMPLETED|Overall Study||24
224884|NCT00666458|539301|P1|NOT COMPLETED|Overall Study||38
224885|NCT00666458|539300|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
224886|NCT00666458|539301|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
224887|NCT00666458|539300|P2|STARTED|Overall Study|Randomized and treated|398
224888|NCT00666458|539301|P1|STARTED|Overall Study|Randomized and treated|403
224889|NCT00666406|539313|P2|NOT COMPLETED|Second PK Infusion||0
224890|NCT00666406|539314|P1|NOT COMPLETED|Second PK Infusion||0
224891|NCT00666406|539313|P2|COMPLETED|Second PK Infusion||3
224892|NCT00666406|539314|P1|COMPLETED|Second PK Infusion||6
224893|NCT00666406|539313|P2|STARTED|Second PK Infusion||3
224894|NCT00666406|539314|P1|STARTED|Second PK Infusion||6
224895|NCT00666406|539313|P2|NOT COMPLETED|First PK Infusion||0
224896|NCT00666406|539314|P1|NOT COMPLETED|First PK Infusion||0
224897|NCT00666406|539313|P2|COMPLETED|First PK Infusion||3
224898|NCT00666406|539314|P1|COMPLETED|First PK Infusion||6
224899|NCT00666406|539313|P2|STARTED|First PK Infusion||3
224900|NCT00666406|539314|P1|STARTED|First PK Infusion||6
224901|NCT00666328|539389|P1|NOT COMPLETED|Overall Study||5
224902|NCT00666328|539389|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
224903|NCT00666328|539389|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
224904|NCT00666328|539389|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
224905|NCT00666276|539402|P1|NOT COMPLETED|Overall Study||34
224906|NCT00666276|539402|P1|COMPLETED|Overall Study||970
224907|NCT00666276|539402|P1|STARTED|Overall Study||1004
224908|NCT00666263|539426|P2|NOT COMPLETED|End of Study Visit||0
224909|NCT00666263|539427|P1|NOT COMPLETED|End of Study Visit||0
224910|NCT00666263|539426|P2|COMPLETED|End of Study Visit||22
224911|NCT00666263|539427|P1|COMPLETED|End of Study Visit||22
224912|NCT00666263|539426|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
224913|NCT00666263|539427|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
224914|NCT00666263|539426|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
224915|NCT00666263|539427|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
224916|NCT00666263|539426|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
224917|NCT00666263|539427|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
224918|NCT00666263|539426|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
224919|NCT00666263|539427|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
224920|NCT00666263|539426|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
224921|NCT00666263|539427|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
224922|NCT00666263|539426|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
224923|NCT00666263|539427|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
224924|NCT00666263|539426|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
224925|NCT00666263|539427|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
224926|NCT00666263|539426|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
224927|NCT00666263|539427|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
224928|NCT00666263|539426|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
224929|NCT00666263|539427|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
224930|NCT00666263|539426|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
224931|NCT00666263|539427|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
224932|NCT00666263|539426|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
224933|NCT00666263|539427|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
224934|NCT00666263|539426|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
224935|NCT00666263|539427|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
224936|NCT00666263|539426|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
224937|NCT00666263|539427|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
224938|NCT00666263|539426|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
224939|NCT00666263|539427|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
224940|NCT00666263|539426|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
224941|NCT00666263|539427|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
224942|NCT00666263|539426|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
224943|NCT00666263|539427|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
224944|NCT00666224|539571|P2|NOT COMPLETED|Open-Label||85
224945|NCT00666224|539572|P1|NOT COMPLETED|Open-Label||35
224946|NCT00666224|539571|P2|COMPLETED|Open-Label||126
224947|NCT00666224|539572|P1|COMPLETED|Open-Label||163
224948|NCT00666224|539571|P2|STARTED|Open-Label||211
225038|NCT00664742|540266|P1|COMPLETED|Overall Study||481
224949|NCT00666224|539572|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
224950|NCT00666224|539571|P2|NOT COMPLETED|Double-Blind||27
224951|NCT00666224|539572|P1|NOT COMPLETED|Double-Blind||45
224952|NCT00666224|539571|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
224953|NCT00666224|539572|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
224954|NCT00666224|539571|P2|STARTED|Double-Blind||238
224955|NCT00666224|539572|P1|STARTED|Double-Blind||243
224956|NCT00666211|539591|P2|NOT COMPLETED|Overall Study||38
224957|NCT00666211|539592|P1|NOT COMPLETED|Overall Study||20
224958|NCT00666211|539591|P2|COMPLETED|Overall Study||18
224959|NCT00666211|539592|P1|COMPLETED|Overall Study||22
224960|NCT00666211|539591|P2|STARTED|Overall Study||56
224961|NCT00666211|539592|P1|STARTED|Overall Study||42
224962|NCT00666198|539610|P1|NOT COMPLETED|Overall Study||33
224963|NCT00666198|539610|P1|COMPLETED|Overall Study||3304
224964|NCT00666198|539610|P1|STARTED|Overall Study||3337
224965|NCT00666029|539625|P2|NOT COMPLETED|Overall Study||0
224966|NCT00666029|539626|P1|NOT COMPLETED|Overall Study||1
224967|NCT00666029|539625|P2|COMPLETED|Overall Study||20
224968|NCT00666029|539626|P1|COMPLETED|Overall Study||19
224969|NCT00666029|539625|P2|STARTED|Overall Study||20
224970|NCT00666029|539626|P1|STARTED|Overall Study||20
224971|NCT00665925|539638|P4|NOT COMPLETED|Overall Study||21
224972|NCT00665925|539639|P3|NOT COMPLETED|Overall Study||26
224973|NCT00665925|539640|P2|NOT COMPLETED|Overall Study||17
224974|NCT00665925|539641|P1|NOT COMPLETED|Overall Study||15
224975|NCT00665925|539638|P4|COMPLETED|Overall Study|Participants completed the study|131
224976|NCT00665925|539639|P3|COMPLETED|Overall Study|Participants completed the study|126
224977|NCT00665925|539640|P2|COMPLETED|Overall Study|Participants completed the study|59
224978|NCT00665925|539641|P1|COMPLETED|Overall Study|Participants completed the study|62
224979|NCT00665925|539638|P4|STARTED|Overall Study|Participants randomized|152
224980|NCT00665925|539639|P3|STARTED|Overall Study|Participants randomized|152
224981|NCT00665925|539640|P2|STARTED|Overall Study|Participants randomized|76
224982|NCT00665925|539641|P1|STARTED|Overall Study|Participants randomized|77
224983|NCT00665847|540052|P1|NOT COMPLETED|Overall Study||25
224984|NCT00665847|540052|P1|COMPLETED|Overall Study||76
224985|NCT00665847|540052|P1|STARTED|Overall Study||101
224986|NCT00665704|540064|P1|NOT COMPLETED|Overall Study||0
224987|NCT00665704|540064|P1|COMPLETED|Overall Study||9
224988|NCT00665704|540064|P1|STARTED|Overall Study||9
224989|NCT00665626|540071|P2|NOT COMPLETED|Overall Study||22
224990|NCT00665626|540072|P1|NOT COMPLETED|Overall Study||10
224991|NCT00665626|540071|P2|COMPLETED|Overall Study|Participants completed the study|124
224992|NCT00665626|540072|P1|COMPLETED|Overall Study|Participants completed the study|63
224993|NCT00665626|540071|P2|STARTED|Overall Study|Participants randomized|146
224994|NCT00665626|540072|P1|STARTED|Overall Study|Participants randomized|73
224995|NCT00665470|540140|P2|NOT COMPLETED|Overall Study||0
224996|NCT00665470|540141|P1|NOT COMPLETED|Overall Study||0
224997|NCT00665470|540140|P2|COMPLETED|Overall Study||0
224998|NCT00665470|540141|P1|COMPLETED|Overall Study||10
224999|NCT00665470|540140|P2|STARTED|Overall Study||0
225000|NCT00665470|540141|P1|STARTED|Overall Study||10
225001|NCT00665444|540149|P1|NOT COMPLETED|Overall Study||2
225002|NCT00665444|540149|P1|COMPLETED|Overall Study||1
225003|NCT00665444|540149|P1|STARTED|Overall Study||3
225004|NCT00665431|540161|P3|NOT COMPLETED|Overall Study||24
225005|NCT00665431|540162|P2|NOT COMPLETED|Overall Study||57
225006|NCT00665431|540163|P1|NOT COMPLETED|Overall Study||40
225007|NCT00665431|540161|P3|COMPLETED|Overall Study||98
225008|NCT00665431|540162|P2|COMPLETED|Overall Study||188
225009|NCT00665431|540163|P1|COMPLETED|Overall Study||203
225010|NCT00665431|540161|P3|STARTED|Overall Study|Safety population|122
225011|NCT00665431|540162|P2|STARTED|Overall Study|Safety population|245
225012|NCT00665431|540163|P1|STARTED|Overall Study|Safety population|243
225013|NCT00665366|540206|P2|NOT COMPLETED|Overall Study||59
225014|NCT00665366|540207|P1|NOT COMPLETED|Overall Study||58
225015|NCT00665366|540206|P2|COMPLETED|Overall Study||122
225016|NCT00665366|540207|P1|COMPLETED|Overall Study||131
225017|NCT00665366|540206|P2|STARTED|Overall Study|Participants randomized|181
225018|NCT00665366|540207|P1|STARTED|Overall Study|Participants randomized|189
225019|NCT00665353|540235|P1|NOT COMPLETED|Study Step 2||14
225020|NCT00665353|540235|P1|COMPLETED|Study Step 2||2
225021|NCT00665353|540235|P1|STARTED|Study Step 2||16
225022|NCT00665353|540235|P1|NOT COMPLETED|Study Step 1||3
225023|NCT00665353|540235|P1|COMPLETED|Study Step 1||16
225024|NCT00665353|540235|P1|STARTED|Study Step 1||19
225025|NCT00665132|540245|P1|NOT COMPLETED|Overall Study||0
225026|NCT00665132|540245|P1|COMPLETED|Overall Study||10
225027|NCT00665132|540245|P1|STARTED|Overall Study||10
225028|NCT00665002|540252|P1|NOT COMPLETED|Overall Study||12
225029|NCT00665002|540252|P1|COMPLETED|Overall Study||4
225030|NCT00665002|540252|P1|STARTED|Overall Study||16
225031|NCT00664755|540259|P2|NOT COMPLETED|Overall Study||0
225032|NCT00664755|540260|P1|NOT COMPLETED|Overall Study||0
225033|NCT00664755|540259|P2|COMPLETED|Overall Study||73
225034|NCT00664755|540260|P1|COMPLETED|Overall Study||67
225035|NCT00664755|540259|P2|STARTED|Overall Study||73
225036|NCT00664755|540260|P1|STARTED|Overall Study||67
225037|NCT00664742|540266|P1|NOT COMPLETED|Overall Study||126
225039|NCT00664742|540266|P1|STARTED|Overall Study||607
225040|NCT00664560|540274|P3|NOT COMPLETED|Overall Study||19
225041|NCT00664560|540275|P2|NOT COMPLETED|Overall Study||35
225042|NCT00664560|540276|P1|NOT COMPLETED|Overall Study||39
225043|NCT00664560|540274|P3|COMPLETED|Overall Study||105
225044|NCT00664560|540275|P2|COMPLETED|Overall Study||208
225045|NCT00664560|540276|P1|COMPLETED|Overall Study||208
225046|NCT00664560|540274|P3|STARTED|Overall Study|Safety Population|124
225047|NCT00664560|540275|P2|STARTED|Overall Study|Safety Population|243
225048|NCT00664560|540276|P1|STARTED|Overall Study|Safety Population|247
225049|NCT00664534|540319|P2|NOT COMPLETED|Overall Study||33
225050|NCT00664534|540320|P1|NOT COMPLETED|Overall Study||41
225051|NCT00664534|540319|P2|COMPLETED|Overall Study||138
225052|NCT00664534|540320|P1|COMPLETED|Overall Study||132
225053|NCT00664534|540319|P2|STARTED|Overall Study||171
225054|NCT00664534|540320|P1|STARTED|Overall Study||173
225055|NCT00664521|540348|P2|NOT COMPLETED|Overall Study||1
225056|NCT00664521|540349|P1|NOT COMPLETED|Overall Study||6
225057|NCT00664521|540348|P2|COMPLETED|Overall Study||8
225058|NCT00664521|540349|P1|COMPLETED|Overall Study||12
225059|NCT00664521|540348|P2|STARTED|Overall Study||9
225060|NCT00664521|540349|P1|STARTED|Overall Study||18
225061|NCT00664430|540369|P1|NOT COMPLETED|Overall Study||13
225062|NCT00664430|540369|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
225063|NCT00664430|540369|P1|STARTED|Overall Study||13
225064|NCT00664326|540375|P1|NOT COMPLETED|Overall Study||24
225065|NCT00664326|540375|P1|COMPLETED|Overall Study||25
225066|NCT00664326|540375|P1|STARTED|Overall Study||49
225067|NCT00664209|540394|P1|NOT COMPLETED|Study Treatment Period||6
225068|NCT00664209|540394|P1|COMPLETED|Study Treatment Period||0
225069|NCT00664209|540394|P1|STARTED|Study Treatment Period||6
225070|NCT00664209|540394|P1|NOT COMPLETED|Motor Fluctuations Screen||7
225071|NCT00664209|540394|P1|COMPLETED|Motor Fluctuations Screen||6
225072|NCT00664209|540394|P1|STARTED|Motor Fluctuations Screen||13
225073|NCT00664105|540402|P1|NOT COMPLETED|Overall Study||24
225074|NCT00664105|540402|P1|COMPLETED|Overall Study||39
225075|NCT00664105|540402|P1|STARTED|Overall Study||63
225076|NCT00664066|540409|P1|NOT COMPLETED|Overall Study||3
225077|NCT00664066|540409|P1|COMPLETED|Overall Study||0
225078|NCT00664066|540409|P1|STARTED|Overall Study||3
225079|NCT00663962|540415|P2|NOT COMPLETED|Overall Study||0
225080|NCT00663962|540416|P1|NOT COMPLETED|Overall Study||1
225081|NCT00663962|540415|P2|COMPLETED|Overall Study||8
225082|NCT00663962|540416|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
225083|NCT00663962|540415|P2|STARTED|Overall Study||8
225084|NCT00663962|540416|P1|STARTED|Overall Study||7
225085|NCT00663923|540422|P1|NOT COMPLETED|Overall Study||2
225086|NCT00663923|540422|P1|COMPLETED|Overall Study||48
225087|NCT00663923|540422|P1|STARTED|Overall Study||50
225088|NCT00663858|540439|P3|NOT COMPLETED|Overall Study||20
225089|NCT00663858|540440|P2|NOT COMPLETED|Overall Study||10
225090|NCT00663858|540441|P1|NOT COMPLETED|Overall Study||34
225091|NCT00663858|540439|P3|COMPLETED|Overall Study||82
225092|NCT00663858|540440|P2|COMPLETED|Overall Study||96
225093|NCT00663858|540441|P1|COMPLETED|Overall Study||178
225094|NCT00663858|540439|P3|STARTED|Overall Study||102
225095|NCT00663858|540440|P2|STARTED|Overall Study||106
225096|NCT00663858|540441|P1|STARTED|Overall Study||212
225097|NCT00663819|540451|P2|NOT COMPLETED|Overall Study||0
225098|NCT00663819|540452|P1|NOT COMPLETED|Overall Study||0
225099|NCT00663819|540451|P2|COMPLETED|Overall Study||135
225100|NCT00663819|540452|P1|COMPLETED|Overall Study||123
225101|NCT00663819|540451|P2|STARTED|Overall Study||135
225102|NCT00663819|540452|P1|STARTED|Overall Study||123
225103|NCT00663793|540466|P2|NOT COMPLETED|Overall Study||0
225104|NCT00663793|540467|P1|NOT COMPLETED|Overall Study||0
225105|NCT00663793|540466|P2|COMPLETED|Overall Study||8
225106|NCT00663793|540467|P1|COMPLETED|Overall Study||8
225107|NCT00663793|540466|P2|STARTED|Overall Study||8
225108|NCT00663793|540467|P1|STARTED|Overall Study||8
225109|NCT00663702|540479|P2|NOT COMPLETED|Overall Study||10
225110|NCT00663702|540480|P1|NOT COMPLETED|Overall Study||18
225111|NCT00663702|540479|P2|COMPLETED|Overall Study||61
225112|NCT00663702|540480|P1|COMPLETED|Overall Study||34
225113|NCT00663702|540479|P2|STARTED|Overall Study||71
225114|NCT00663702|540480|P1|STARTED|Overall Study||52
225115|NCT00663403|540503|P1|NOT COMPLETED|Overall Study||0
225116|NCT00663403|540503|P1|COMPLETED|Overall Study||8
225117|NCT00663403|540503|P1|STARTED|Overall Study||8
225118|NCT00663260|540516|P3|NOT COMPLETED|Overall Study||16
225119|NCT00663260|540517|P2|NOT COMPLETED|Overall Study||11
225120|NCT00663260|540518|P1|NOT COMPLETED|Overall Study||21
225121|NCT00663260|540516|P3|COMPLETED|Overall Study||69
225122|NCT00663260|540517|P2|COMPLETED|Overall Study||72
225123|NCT00663260|540518|P1|COMPLETED|Overall Study||63
225124|NCT00663260|540516|P3|STARTED|Overall Study||85
225125|NCT00663260|540517|P2|STARTED|Overall Study||83
225126|NCT00663260|540518|P1|STARTED|Overall Study||84
225127|NCT00663234|540532|P1|NOT COMPLETED|Overall Study||1
225128|NCT00663234|540532|P1|COMPLETED|Overall Study||27
225129|NCT00663234|540532|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
225130|NCT00663234|540532|P1|STARTED|Overall Study||28
225131|NCT00663208|540565|P7|NOT COMPLETED|Follow-up Period||1
225132|NCT00663208|540566|P6|NOT COMPLETED|Follow-up Period||0
225133|NCT00663208|540567|P5|NOT COMPLETED|Follow-up Period||0
225134|NCT00663208|540568|P4|NOT COMPLETED|Follow-up Period||2
225135|NCT00663208|540569|P3|NOT COMPLETED|Follow-up Period||3
225136|NCT00663208|540570|P2|NOT COMPLETED|Follow-up Period||0
225137|NCT00663208|540571|P1|NOT COMPLETED|Follow-up Period||3
225138|NCT00663208|540565|P7|COMPLETED|Follow-up Period||5
225139|NCT00663208|540566|P6|COMPLETED|Follow-up Period||4
225140|NCT00663208|540567|P5|COMPLETED|Follow-up Period||4
225141|NCT00663208|540568|P4|COMPLETED|Follow-up Period||2
225142|NCT00663208|540569|P3|COMPLETED|Follow-up Period||1
225143|NCT00663208|540570|P2|COMPLETED|Follow-up Period||3
225144|NCT00663208|540571|P1|COMPLETED|Follow-up Period||1
225145|NCT00663208|540565|P7|STARTED|Follow-up Period||6
225146|NCT00663208|540566|P6|STARTED|Follow-up Period||4
225147|NCT00663208|540567|P5|STARTED|Follow-up Period||4
225148|NCT00663208|540568|P4|STARTED|Follow-up Period||4
225149|NCT00663208|540569|P3|STARTED|Follow-up Period||4
225150|NCT00663208|540570|P2|STARTED|Follow-up Period||3
225151|NCT00663208|540571|P1|STARTED|Follow-up Period||4
225152|NCT00663208|540565|P7|NOT COMPLETED|Treatment Period||0
225153|NCT00663208|540566|P6|NOT COMPLETED|Treatment Period||0
225154|NCT00663208|540567|P5|NOT COMPLETED|Treatment Period||0
225155|NCT00663208|540568|P4|NOT COMPLETED|Treatment Period||0
225156|NCT00663208|540569|P3|NOT COMPLETED|Treatment Period||0
225157|NCT00663208|540570|P2|NOT COMPLETED|Treatment Period||1
225158|NCT00663208|540571|P1|NOT COMPLETED|Treatment Period||0
225159|NCT00663208|540565|P7|COMPLETED|Treatment Period||6
225160|NCT00663208|540566|P6|COMPLETED|Treatment Period||4
225161|NCT00663208|540567|P5|COMPLETED|Treatment Period||4
225162|NCT00663208|540568|P4|COMPLETED|Treatment Period||4
225163|NCT00663208|540569|P3|COMPLETED|Treatment Period||4
225164|NCT00663208|540570|P2|COMPLETED|Treatment Period||3
225165|NCT00663208|540571|P1|COMPLETED|Treatment Period||4
225166|NCT00663208|540565|P7|STARTED|Treatment Period||6
225167|NCT00663208|540566|P6|STARTED|Treatment Period||4
225168|NCT00663208|540567|P5|STARTED|Treatment Period||4
225169|NCT00663208|540568|P4|STARTED|Treatment Period||4
225170|NCT00663208|540569|P3|STARTED|Treatment Period||4
225171|NCT00663208|540570|P2|STARTED|Treatment Period||4
225172|NCT00663208|540571|P1|STARTED|Treatment Period||4
225173|NCT00663169|540723|P2|NOT COMPLETED|Overall Study||0
225174|NCT00663169|540724|P1|NOT COMPLETED|Overall Study||0
225175|NCT00663169|540723|P2|COMPLETED|Overall Study||3
225176|NCT00663169|540724|P1|COMPLETED|Overall Study||3
225177|NCT00663169|540723|P2|STARTED|Overall Study||3
225178|NCT00663169|540724|P1|STARTED|Overall Study||3
225179|NCT00663117|540749|P2|NOT COMPLETED|Overall Study||0
225180|NCT00663117|540750|P1|NOT COMPLETED|Overall Study||1
225181|NCT00663117|540749|P2|COMPLETED|Overall Study||20
225182|NCT00663117|540750|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
225183|NCT00663117|540749|P2|STARTED|Overall Study||20
225184|NCT00663117|540750|P1|STARTED|Overall Study||20
225185|NCT00663052|540764|P2|NOT COMPLETED|Overall Study||10
225186|NCT00663052|540765|P1|NOT COMPLETED|Overall Study||12
225187|NCT00663052|540764|P2|COMPLETED|Overall Study||127
225188|NCT00663052|540765|P1|COMPLETED|Overall Study||124
225189|NCT00663052|540764|P2|STARTED|Overall Study||137
225190|NCT00663052|540765|P1|STARTED|Overall Study||136
225191|NCT00663026|540848|P3|NOT COMPLETED|Overall Study||4
225192|NCT00663026|540849|P2|NOT COMPLETED|Overall Study||6
225193|NCT00663026|540850|P1|NOT COMPLETED|Overall Study||2
225194|NCT00663026|540848|P3|COMPLETED|Overall Study||27
225195|NCT00663026|540849|P2|COMPLETED|Overall Study||23
225196|NCT00663026|540850|P1|COMPLETED|Overall Study||17
225197|NCT00663026|540848|P3|STARTED|Overall Study||31
225198|NCT00663026|540849|P2|STARTED|Overall Study||29
225199|NCT00663026|540850|P1|STARTED|Overall Study||19
225200|NCT00662909|540873|P3|NOT COMPLETED|Overall Study||53
225201|NCT00662909|540874|P2|NOT COMPLETED|Overall Study||59
225202|NCT00662909|540875|P1|NOT COMPLETED|Overall Study||69
225203|NCT00662909|540873|P3|COMPLETED|Overall Study||380
225204|NCT00662909|540874|P2|COMPLETED|Overall Study||383
225205|NCT00662909|540875|P1|COMPLETED|Overall Study||385
225206|NCT00662909|540873|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
225207|NCT00662909|540874|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
225208|NCT00662909|540875|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
225209|NCT00662909|540873|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
225210|NCT00662909|540874|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
225211|NCT00662909|540875|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
225212|NCT00662909|540873|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
225213|NCT00662909|540874|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
225214|NCT00662909|540875|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
225215|NCT00662909|540873|P3|STARTED|Overall Study||433
225216|NCT00662909|540874|P2|STARTED|Overall Study||442
225217|NCT00662909|540875|P1|STARTED|Overall Study||454
225218|NCT00662857|540973|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
225219|NCT00662857|540974|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
225220|NCT00662857|540973|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
225221|NCT00662857|540974|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
225222|NCT00662857|540973|P2|STARTED|Lispro Dosing Period (1 Day)||14
225223|NCT00662857|540974|P1|STARTED|Lispro Dosing Period (1 Day)||12
225224|NCT00662857|540973|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
225225|NCT00662857|540974|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
225226|NCT00662857|540973|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
225227|NCT00662857|540974|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
225228|NCT00662857|540973|P2|STARTED|Washout 2 (3 - 14 Days)||14
225229|NCT00662857|540974|P1|STARTED|Washout 2 (3 - 14 Days)||13
225230|NCT00662857|540973|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
225231|NCT00662857|540974|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
225232|NCT00662857|540973|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
225233|NCT00662857|540974|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
225234|NCT00662857|540973|P2|STARTED|TI Dosing Period 2 (1 Day)||14
225235|NCT00662857|540974|P1|STARTED|TI Dosing Period 2 (1 Day)||13
225236|NCT00662857|540973|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
225237|NCT00662857|540974|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
225238|NCT00662857|540973|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
225239|NCT00662857|540974|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
225240|NCT00662857|540973|P2|STARTED|Washout 1 (3 - 14 Days)||16
225241|NCT00662857|540974|P1|STARTED|Washout 1 (3 - 14 Days)||13
225242|NCT00662857|540973|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
225243|NCT00662857|540974|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
225244|NCT00662857|540973|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
225245|NCT00662857|540974|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
225246|NCT00662857|540973|P2|STARTED|TI Dosing Period 1 (1 Day)||16
225247|NCT00662857|540974|P1|STARTED|TI Dosing Period 1 (1 Day)||13
225248|NCT00662831|540989|P2|NOT COMPLETED|Overall Study||59
225249|NCT00662831|540990|P1|NOT COMPLETED|Overall Study||106
225250|NCT00662831|540989|P2|COMPLETED|Overall Study||33
225251|NCT00662831|540990|P1|COMPLETED|Overall Study||78
225252|NCT00662831|540989|P2|STARTED|Overall Study||92
225253|NCT00662831|540990|P1|STARTED|Overall Study||184
225254|NCT00662818|541030|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
225255|NCT00662818|541031|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
225256|NCT00662818|541030|P2|COMPLETED|Period 2 (6 Weeks)||41
225257|NCT00662818|541031|P1|COMPLETED|Period 2 (6 Weeks)||38
225258|NCT00662818|541030|P2|STARTED|Period 2 (6 Weeks)||53
225259|NCT00662818|541031|P1|STARTED|Period 2 (6 Weeks)||51
225260|NCT00662818|541030|P2|NOT COMPLETED|Wash-Out (14 Days)||5
225261|NCT00662818|541031|P1|NOT COMPLETED|Wash-Out (14 Days)||5
225262|NCT00662818|541030|P2|COMPLETED|Wash-Out (14 Days)||53
225263|NCT00662818|541031|P1|COMPLETED|Wash-Out (14 Days)||51
225264|NCT00662818|541030|P2|STARTED|Wash-Out (14 Days)||58
225265|NCT00662818|541031|P1|STARTED|Wash-Out (14 Days)||56
225266|NCT00662818|541030|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
225267|NCT00662818|541031|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
225268|NCT00662818|541030|P2|COMPLETED|Period 1 (6 Weeks)||58
225269|NCT00662818|541031|P1|COMPLETED|Period 1 (6 Weeks)||56
225270|NCT00662818|541030|P2|Treated|Period 1 (6 Weeks)||58
225271|NCT00662818|541031|P1|Treated|Period 1 (6 Weeks)||56
225272|NCT00662818|541030|P2|STARTED|Period 1 (6 Weeks)||81
225273|NCT00662818|541031|P1|STARTED|Period 1 (6 Weeks)||84
225274|NCT00662675|541055|P2|NOT COMPLETED|Overall Study||0
225275|NCT00662675|541056|P1|NOT COMPLETED|Overall Study||0
225276|NCT00662675|541055|P2|COMPLETED|Overall Study||20
225277|NCT00662675|541056|P1|COMPLETED|Overall Study||20
225278|NCT00662675|541055|P2|STARTED|Overall Study||20
225279|NCT00662675|541056|P1|STARTED|Overall Study||20
225280|NCT00662649|541070|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
225281|NCT00662649|541071|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
225282|NCT00662649|541072|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
225283|NCT00662649|541073|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
225284|NCT00662649|541074|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
225285|NCT00662649|541070|P5|COMPLETED|Extension Study (Month 24 to 60)||126
225286|NCT00662649|541071|P4|COMPLETED|Extension Study (Month 24 to 60)||112
225287|NCT00662649|541072|P3|COMPLETED|Extension Study (Month 24 to 60)||0
225288|NCT00662649|541073|P2|COMPLETED|Extension Study (Month 24 to 60)||290
225289|NCT00662649|541074|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
225290|NCT00662649|541070|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
225291|NCT00662649|541071|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
225292|NCT00662649|541072|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
225293|NCT00662649|541073|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
225294|NCT00662649|541074|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
225295|NCT00662649|541070|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
225296|NCT00662649|541071|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
225297|NCT00662649|541072|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
225298|NCT00662649|541073|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
225299|NCT00662649|541074|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
225300|NCT00662649|541070|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
225301|NCT00662649|541071|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
225302|NCT00662649|541072|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
225303|NCT00662649|541073|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
225304|NCT00662649|541074|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
225305|NCT00662649|541070|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
225306|NCT00662649|541071|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
225307|NCT00662649|541072|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
225308|NCT00662649|541073|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
225309|NCT00662649|541074|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
225310|NCT00662649|541070|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
225311|NCT00662649|541071|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
225312|NCT00662649|541072|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
225313|NCT00662649|541073|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
225314|NCT00662649|541074|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
225315|NCT00662649|541070|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
225316|NCT00662649|541071|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
225317|NCT00662649|541072|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
225318|NCT00662649|541073|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
225319|NCT00662649|541074|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
225320|NCT00662649|541070|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
225321|NCT00662649|541071|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
225322|NCT00662649|541072|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
225323|NCT00662649|541073|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
225324|NCT00662649|541074|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
225325|NCT00662649|541070|P5|STARTED|Extension Study (Month 24 to 60)||155
225326|NCT00662649|541071|P4|STARTED|Extension Study (Month 24 to 60)||145
225327|NCT00662649|541072|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
225328|NCT00662649|541073|P2|STARTED|Extension Study (Month 24 to 60)||331
225329|NCT00662649|541074|P1|STARTED|Extension Study (Month 24 to 60)||289
225330|NCT00662649|541070|P5|NOT COMPLETED|Core Study (24 Months)||0
225331|NCT00662649|541071|P4|NOT COMPLETED|Core Study (24 Months)||0
225332|NCT00662649|541072|P3|NOT COMPLETED|Core Study (24 Months)||86
225333|NCT00662649|541073|P2|NOT COMPLETED|Core Study (24 Months)||56
225334|NCT00662649|541074|P1|NOT COMPLETED|Core Study (24 Months)||97
225335|NCT00662649|541070|P5|COMPLETED|Core Study (24 Months)||0
225336|NCT00662649|541071|P4|COMPLETED|Core Study (24 Months)||0
225337|NCT00662649|541072|P3|COMPLETED|Core Study (24 Months)||332
225338|NCT00662649|541073|P2|COMPLETED|Core Study (24 Months)||369
225339|NCT00662649|541074|P1|COMPLETED|Core Study (24 Months)||332
225340|NCT00662649|541070|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
225341|NCT00662649|541071|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
225342|NCT00662649|541072|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
225343|NCT00662649|541073|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
225344|NCT00662649|541074|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
225345|NCT00662649|541070|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
225346|NCT00662649|541071|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
225347|NCT00662649|541072|P3|STARTED|Core Study (24 Months)||418
225348|NCT00662649|541073|P2|STARTED|Core Study (24 Months)||425
225349|NCT00662649|541074|P1|STARTED|Core Study (24 Months)||429
225350|NCT00662558|541114|P2|NOT COMPLETED|Overall Study||110
225351|NCT00662558|541115|P1|NOT COMPLETED|Overall Study||56
225352|NCT00662558|541114|P2|COMPLETED|Overall Study||294
225353|NCT00662558|541115|P1|COMPLETED|Overall Study||342
225354|NCT00662558|541114|P2|Received Treatment|Overall Study||396
225355|NCT00662558|541115|P1|Received Treatment|Overall Study||396
225356|NCT00662558|541114|P2|STARTED|Overall Study||404
225357|NCT00662558|541115|P1|STARTED|Overall Study||398
225358|NCT00662545|541149|P2|NOT COMPLETED|Overall Study||0
225359|NCT00662545|541150|P1|NOT COMPLETED|Overall Study||0
225360|NCT00662545|541149|P2|COMPLETED|Overall Study||5
225361|NCT00662545|541150|P1|COMPLETED|Overall Study||5
225362|NCT00662545|541149|P2|STARTED|Overall Study||5
225363|NCT00662545|541150|P1|STARTED|Overall Study||5
225364|NCT00662532|541166|P2|NOT COMPLETED|Overall Study||2
225365|NCT00662532|541167|P1|NOT COMPLETED|Overall Study||0
225366|NCT00662532|541166|P2|COMPLETED|Overall Study||20
225367|NCT00662532|541167|P1|COMPLETED|Overall Study||22
225368|NCT00662532|541166|P2|STARTED|Overall Study||22
225369|NCT00662532|541167|P1|STARTED|Overall Study||22
225370|NCT00662389|541177|P1|NOT COMPLETED|Overall Study||0
225371|NCT00662389|541177|P1|COMPLETED|Overall Study||4
225372|NCT00662389|541177|P1|STARTED|Overall Study||4
225373|NCT00662363|541182|P2|NOT COMPLETED|Overall Study||10
225374|NCT00662363|541183|P1|NOT COMPLETED|Overall Study||11
225375|NCT00662363|541182|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
225471|NCT00661713|541415|P4|STARTED|Overall Study||247
225376|NCT00662363|541183|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
225377|NCT00662363|541182|P2|STARTED|Overall Study||32
225378|NCT00662363|541183|P1|STARTED|Overall Study||32
225379|NCT00662311|541194|P3|NOT COMPLETED|Overall Study||0
225380|NCT00662311|541195|P2|NOT COMPLETED|Overall Study||0
225381|NCT00662311|541196|P1|NOT COMPLETED|Overall Study||1
225382|NCT00662311|541194|P3|COMPLETED|Overall Study||0
225383|NCT00662311|541195|P2|COMPLETED|Overall Study||0
225384|NCT00662311|541196|P1|COMPLETED|Overall Study||4
225385|NCT00662311|541194|P3|STARTED|Overall Study||0
225386|NCT00662311|541195|P2|STARTED|Overall Study||0
225387|NCT00662311|541196|P1|STARTED|Overall Study||5
225388|NCT00662207|541219|P1|NOT COMPLETED|Overall Study||0
225389|NCT00662207|541219|P1|COMPLETED|Overall Study||3
225390|NCT00662207|541219|P1|STARTED|Overall Study||3
225391|NCT00662155|541230|P4|NOT COMPLETED|Overall Study||4
225392|NCT00662155|541231|P3|NOT COMPLETED|Overall Study||7
225393|NCT00662155|541232|P2|NOT COMPLETED|Overall Study||5
225394|NCT00662155|541233|P1|NOT COMPLETED|Overall Study||3
225395|NCT00662155|541230|P4|COMPLETED|Overall Study||14
225396|NCT00662155|541231|P3|COMPLETED|Overall Study||13
225397|NCT00662155|541232|P2|COMPLETED|Overall Study||15
225398|NCT00662155|541233|P1|COMPLETED|Overall Study||13
225399|NCT00662155|541230|P4|STARTED|Overall Study||18
225400|NCT00662155|541231|P3|STARTED|Overall Study||20
225401|NCT00662155|541232|P2|STARTED|Overall Study||20
225402|NCT00662155|541233|P1|STARTED|Overall Study||16
225403|NCT00662129|541247|P1|NOT COMPLETED|Overall Study||3
225404|NCT00662129|541247|P1|COMPLETED|Overall Study||47
225405|NCT00662129|541247|P1|STARTED|Overall Study||50
225406|NCT00662038|541257|P1|NOT COMPLETED|Overall Study||631
225407|NCT00662038|541257|P1|COMPLETED|Overall Study||427
225408|NCT00662038|541257|P1|STARTED|Overall Study||1058
225409|NCT00662025|541261|P1|NOT COMPLETED|Overall Study||63
225410|NCT00662025|541261|P1|COMPLETED|Overall Study||0
225411|NCT00662025|541261|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
225412|NCT00662012|541281|P1|NOT COMPLETED|Overall Study||87
225413|NCT00662012|541281|P1|COMPLETED|Overall Study||327
225414|NCT00662012|541281|P1|STARTED|Overall Study||414
225415|NCT00661999|541289|P3|NOT COMPLETED|Overall Study||57
225416|NCT00661999|541290|P2|NOT COMPLETED|Overall Study||50
225417|NCT00661999|541291|P1|NOT COMPLETED|Overall Study||59
225418|NCT00661999|541289|P3|COMPLETED|Overall Study||106
225419|NCT00661999|541290|P2|COMPLETED|Overall Study||113
225420|NCT00661999|541291|P1|COMPLETED|Overall Study||105
225421|NCT00661999|541289|P3|STARTED|Overall Study||163
225422|NCT00661999|541290|P2|STARTED|Overall Study||163
225423|NCT00661999|541291|P1|STARTED|Overall Study||164
225424|NCT00661960|541347|P3|NOT COMPLETED|Overall Study||1
225425|NCT00661960|541348|P2|NOT COMPLETED|Overall Study||3
225426|NCT00661960|541349|P1|NOT COMPLETED|Overall Study||0
225427|NCT00661960|541347|P3|COMPLETED|Overall Study||9
225428|NCT00661960|541348|P2|COMPLETED|Overall Study||7
225429|NCT00661960|541349|P1|COMPLETED|Overall Study||5
225430|NCT00661960|541347|P3|STARTED|Overall Study||10
225431|NCT00661960|541348|P2|STARTED|Overall Study||10
225432|NCT00661960|541349|P1|STARTED|Overall Study||5
225433|NCT00661895|541359|P2|NOT COMPLETED|Overall Study||0
225434|NCT00661895|541360|P1|NOT COMPLETED|Overall Study||0
225435|NCT00661895|541359|P2|COMPLETED|Overall Study||50
225436|NCT00661895|541360|P1|COMPLETED|Overall Study||49
225437|NCT00661895|541359|P2|STARTED|Overall Study||50
225438|NCT00661895|541360|P1|STARTED|Overall Study||49
225439|NCT00661830|541368|P2|NOT COMPLETED|Overall Study||42
225440|NCT00661830|541369|P1|NOT COMPLETED|Overall Study||40
225441|NCT00661830|541368|P2|COMPLETED|Overall Study||6
225442|NCT00661830|541369|P1|COMPLETED|Overall Study||9
225443|NCT00661830|541368|P2|STARTED|Overall Study||48
225444|NCT00661830|541369|P1|STARTED|Overall Study||49
225445|NCT00661778|541381|P1|NOT COMPLETED|Overall Study||50
225446|NCT00661778|541381|P1|COMPLETED|Overall Study||0
225447|NCT00661778|541381|P1|STARTED|Overall Study||50
225448|NCT00661726|541388|P1|NOT COMPLETED|Overall Study||1
225449|NCT00661726|541388|P1|COMPLETED|Overall Study||5
225450|NCT00661726|541388|P1|STARTED|Overall Study||6
225451|NCT00661713|541411|P8|NOT COMPLETED|Overall Study||11
225452|NCT00661713|541412|P7|NOT COMPLETED|Overall Study||64
225453|NCT00661713|541413|P6|NOT COMPLETED|Overall Study||37
225454|NCT00661713|541414|P5|NOT COMPLETED|Overall Study||20
225455|NCT00661713|541415|P4|NOT COMPLETED|Overall Study||28
225456|NCT00661713|541416|P3|NOT COMPLETED|Overall Study||17
225457|NCT00661713|541417|P2|NOT COMPLETED|Overall Study||39
225458|NCT00661713|541418|P1|NOT COMPLETED|Overall Study||16
225459|NCT00661713|541411|P8|COMPLETED|Overall Study||117
225460|NCT00661713|541412|P7|COMPLETED|Overall Study||309
225461|NCT00661713|541413|P6|COMPLETED|Overall Study||216
225462|NCT00661713|541414|P5|COMPLETED|Overall Study||107
225463|NCT00661713|541415|P4|COMPLETED|Overall Study||219
225464|NCT00661713|541416|P3|COMPLETED|Overall Study||111
225465|NCT00661713|541417|P2|COMPLETED|Overall Study||208
225466|NCT00661713|541418|P1|COMPLETED|Overall Study||112
225467|NCT00661713|541411|P8|STARTED|Overall Study||128
225468|NCT00661713|541412|P7|STARTED|Overall Study||373
225469|NCT00661713|541413|P6|STARTED|Overall Study||253
225470|NCT00661713|541414|P5|STARTED|Overall Study||127
225472|NCT00661713|541416|P3|STARTED|Overall Study||128
225473|NCT00661713|541417|P2|STARTED|Overall Study||247
225474|NCT00661713|541418|P1|STARTED|Overall Study||128
225475|NCT00661687|541508|P1|NOT COMPLETED|Overall Study||15
225476|NCT00661687|541508|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
225477|NCT00661687|541508|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
225478|NCT00661674|541518|P6|NOT COMPLETED|Overall Study||0
225479|NCT00661674|541519|P5|NOT COMPLETED|Overall Study||0
225480|NCT00661674|541520|P4|NOT COMPLETED|Overall Study||0
225481|NCT00661674|541521|P3|NOT COMPLETED|Overall Study||0
225482|NCT00661674|541522|P2|NOT COMPLETED|Overall Study||0
225483|NCT00661674|541523|P1|NOT COMPLETED|Overall Study||0
225484|NCT00661674|541518|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
225485|NCT00661674|541519|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
225486|NCT00661674|541520|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
225487|NCT00661674|541521|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
225488|NCT00661674|541522|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
225489|NCT00661674|541523|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
225490|NCT00661674|541518|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
225491|NCT00661674|541519|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
225492|NCT00661674|541520|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
225493|NCT00661674|541521|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
225494|NCT00661674|541522|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
225495|NCT00661674|541523|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
225496|NCT00661661|541536|P2|NOT COMPLETED|Overall Study||39
225497|NCT00661661|541537|P1|NOT COMPLETED|Overall Study||140
225498|NCT00661661|541536|P2|COMPLETED|Overall Study||66
225499|NCT00661661|541537|P1|COMPLETED|Overall Study||242
225500|NCT00661661|541536|P2|STARTED|Overall Study||105
225501|NCT00661661|541537|P1|STARTED|Overall Study||382
225502|NCT00661622|541613|P2|NOT COMPLETED|Overall Study||0
225503|NCT00661622|541614|P1|NOT COMPLETED|Overall Study||1
225504|NCT00661622|541613|P2|COMPLETED|Overall Study||27
225505|NCT00661622|541614|P1|COMPLETED|Overall Study||25
225506|NCT00661622|541613|P2|STARTED|Overall Study||27
225507|NCT00661622|541614|P1|STARTED|Overall Study||26
225508|NCT00661609|541628|P1|NOT COMPLETED|Overall Study||41
225509|NCT00661609|541628|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
225510|NCT00661609|541628|P1|STARTED|Overall Study|All dosed patients|41
225511|NCT00661583|541638|P3|NOT COMPLETED|Overall Study||0
225512|NCT00661583|541639|P2|NOT COMPLETED|Overall Study||0
225513|NCT00661583|541640|P1|NOT COMPLETED|Overall Study||0
225514|NCT00661583|541638|P3|COMPLETED|Overall Study||10
225515|NCT00661583|541639|P2|COMPLETED|Overall Study||10
225516|NCT00661583|541640|P1|COMPLETED|Overall Study||10
225517|NCT00661583|541638|P3|STARTED|Overall Study||10
225518|NCT00661583|541639|P2|STARTED|Overall Study||10
225519|NCT00661583|541640|P1|STARTED|Overall Study||10
225520|NCT00661570|541657|P1|NOT COMPLETED|Overall Study||0
225521|NCT00661570|541657|P1|COMPLETED|Overall Study||26
225522|NCT00661570|541657|P1|STARTED|Overall Study||26
225523|NCT00661544|541664|P1|NOT COMPLETED|Overall Study||0
225524|NCT00661544|541664|P1|COMPLETED|Overall Study||48
225525|NCT00661544|541664|P1|STARTED|Overall Study||48
225526|NCT00661531|541668|P1|NOT COMPLETED|Overall Study||3
225527|NCT00661531|541668|P1|COMPLETED|Overall Study||8
225528|NCT00661531|541668|P1|STARTED|Overall Study||11
225529|NCT00661505|541673|P1|NOT COMPLETED|Overall Study||30
225530|NCT00661505|541673|P1|COMPLETED|Overall Study||102
225531|NCT00661505|541673|P1|STARTED|Overall Study||132
225532|NCT00661492|541701|P2|NOT COMPLETED|Overall Study||29
225533|NCT00661492|541702|P1|NOT COMPLETED|Overall Study||68
225534|NCT00661492|541701|P2|COMPLETED|Overall Study||11
225535|NCT00661492|541702|P1|COMPLETED|Overall Study||7
225536|NCT00661492|541701|P2|STARTED|Overall Study||40
225537|NCT00661492|541702|P1|STARTED|Overall Study||75
225538|NCT00661479|541726|P4|NOT COMPLETED|Overall Study||0
225539|NCT00661479|541727|P3|NOT COMPLETED|Overall Study||0
225540|NCT00661479|541728|P2|NOT COMPLETED|Overall Study||0
225541|NCT00661479|541729|P1|NOT COMPLETED|Overall Study||0
225542|NCT00661479|541726|P4|COMPLETED|Overall Study||3
225543|NCT00661479|541727|P3|COMPLETED|Overall Study||3
225544|NCT00661479|541728|P2|COMPLETED|Overall Study||3
225545|NCT00661479|541729|P1|COMPLETED|Overall Study||12
225546|NCT00661479|541726|P4|STARTED|Overall Study||3
225547|NCT00661479|541727|P3|STARTED|Overall Study||3
225548|NCT00661479|541728|P2|STARTED|Overall Study||3
225549|NCT00661479|541729|P1|STARTED|Overall Study||12
225550|NCT00661453|541742|P1|NOT COMPLETED|Overall Study||13
225551|NCT00661453|541742|P1|COMPLETED|Overall Study||25
225552|NCT00661453|541742|P1|STARTED|Overall Study||38
225553|NCT00661427|541748|P2|NOT COMPLETED|Overall Study||7
225554|NCT00661427|541749|P1|NOT COMPLETED|Overall Study||5
225555|NCT00661427|541748|P2|COMPLETED|Overall Study||19
225556|NCT00661427|541749|P1|COMPLETED|Overall Study||30
225557|NCT00661427|541748|P2|STARTED|Overall Study||26
225558|NCT00661427|541749|P1|STARTED|Overall Study||35
225559|NCT00661388|541757|P1|NOT COMPLETED|Overall Study||24
225560|NCT00661388|541757|P1|COMPLETED|Overall Study||51
225561|NCT00661388|541757|P1|STARTED|Overall Study||75
225562|NCT00661362|541780|P2|NOT COMPLETED|Overall Study||40
225563|NCT00661362|541781|P1|NOT COMPLETED|Overall Study||29
225564|NCT00661362|541780|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
225565|NCT00661362|541781|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
225566|NCT00661362|541780|P2|STARTED|Overall Study|Randomized and treated|287
225567|NCT00661362|541781|P1|STARTED|Overall Study|Randomized and treated|283
225568|NCT00661258|541799|P2|NOT COMPLETED|Overall Study||1
225569|NCT00661258|541800|P1|NOT COMPLETED|Overall Study||3
225570|NCT00661258|541799|P2|COMPLETED|Overall Study||33
225571|NCT00661258|541800|P1|COMPLETED|Overall Study||31
225572|NCT00661258|541799|P2|STARTED|Overall Study||34
225573|NCT00661258|541800|P1|STARTED|Overall Study||34
225574|NCT00661193|541810|P2|NOT COMPLETED|Overall Study||26
225575|NCT00661193|541811|P1|NOT COMPLETED|Overall Study||33
225576|NCT00661193|541810|P2|COMPLETED|Overall Study||0
225577|NCT00661193|541811|P1|COMPLETED|Overall Study||0
225578|NCT00661193|541810|P2|STARTED|Overall Study||26
225579|NCT00661193|541811|P1|STARTED|Overall Study||33
225580|NCT00661141|541822|P6|NOT COMPLETED|Overall Study||0
225581|NCT00661141|541823|P5|NOT COMPLETED|Overall Study||0
225582|NCT00661141|541824|P4|NOT COMPLETED|Overall Study||0
225583|NCT00661141|541825|P3|NOT COMPLETED|Overall Study||0
225584|NCT00661141|541826|P2|NOT COMPLETED|Overall Study||0
225585|NCT00661141|541827|P1|NOT COMPLETED|Overall Study||0
225586|NCT00661141|541822|P6|COMPLETED|Overall Study||4
225587|NCT00661141|541823|P5|COMPLETED|Overall Study||4
225588|NCT00661141|541824|P4|COMPLETED|Overall Study||4
225589|NCT00661141|541825|P3|COMPLETED|Overall Study||4
225590|NCT00661141|541826|P2|COMPLETED|Overall Study||8
225591|NCT00661141|541827|P1|COMPLETED|Overall Study||8
225592|NCT00661141|541822|P6|Administered 30 Minutes After Ethanol|Overall Study||0
225593|NCT00661141|541823|P5|Administered 30 Minutes After Ethanol|Overall Study||0
225594|NCT00661141|541824|P4|Administered 30 Minutes After Ethanol|Overall Study||2
225595|NCT00661141|541825|P3|Administered 30 Minutes After Ethanol|Overall Study||2
225596|NCT00661141|541826|P2|Administered 30 Minutes After Ethanol|Overall Study||2
225597|NCT00661141|541827|P1|Administered 30 Minutes After Ethanol|Overall Study||2
225598|NCT00661141|541822|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
225599|NCT00661141|541823|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
225600|NCT00661141|541824|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
225601|NCT00661141|541825|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
225602|NCT00661141|541826|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
225603|NCT00661141|541827|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
225604|NCT00661141|541822|P6|STARTED|Overall Study||4
225605|NCT00661141|541823|P5|STARTED|Overall Study||4
225606|NCT00661141|541824|P4|STARTED|Overall Study||4
225607|NCT00661141|541825|P3|STARTED|Overall Study||4
225608|NCT00661141|541826|P2|STARTED|Overall Study||8
225609|NCT00661141|541827|P1|STARTED|Overall Study||8
225610|NCT00661089|542036|P2|NOT COMPLETED|Overall Study||2
225611|NCT00661089|542037|P1|NOT COMPLETED|Overall Study||0
225612|NCT00661089|542036|P2|COMPLETED|Overall Study||9
225613|NCT00661089|542037|P1|COMPLETED|Overall Study||10
225614|NCT00661089|542036|P2|STARTED|Overall Study||11
225615|NCT00661089|542037|P1|STARTED|Overall Study||10
225616|NCT00661037|542047|P2|NOT COMPLETED|Overall Study||257
225617|NCT00661037|542048|P1|NOT COMPLETED|Overall Study||154
225618|NCT00661037|542047|P2|COMPLETED|Overall Study||1027
225619|NCT00661037|542048|P1|COMPLETED|Overall Study||682
225620|NCT00661037|542047|P2|Deaths|Overall Study||188
225621|NCT00661037|542048|P1|Deaths|Overall Study||108
225622|NCT00661037|542047|P2|Witdrawn|Overall Study||68
225623|NCT00661037|542048|P1|Witdrawn|Overall Study||47
225624|NCT00661037|542047|P2|STARTED|Overall Study||1284
225625|NCT00661037|542048|P1|STARTED|Overall Study||836
225626|NCT00660985|542060|P2|NOT COMPLETED|Overall Study||0
225627|NCT00660985|542061|P1|NOT COMPLETED|Overall Study||1
225628|NCT00660985|542060|P2|COMPLETED|Overall Study||25
225629|NCT00660985|542061|P1|COMPLETED|Overall Study||25
225630|NCT00660985|542060|P2|STARTED|Overall Study||25
225631|NCT00660985|542061|P1|STARTED|Overall Study||26
225632|NCT00660907|542085|P2|NOT COMPLETED|Overall Study||94
225633|NCT00660907|542086|P1|NOT COMPLETED|Overall Study||84
225634|NCT00660907|542085|P2|COMPLETED|Overall Study||314
225635|NCT00660907|542086|P1|COMPLETED|Overall Study||322
225636|NCT00660907|542085|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
225637|NCT00660907|542086|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
225638|NCT00660829|542100|P2|NOT COMPLETED|Overall Study||19
225639|NCT00660829|542101|P1|NOT COMPLETED|Overall Study||18
225640|NCT00660829|542100|P2|COMPLETED|Overall Study||249
225641|NCT00660829|542101|P1|COMPLETED|Overall Study||250
225642|NCT00660829|542100|P2|STARTED|Overall Study|2 subjects were randomized in error|268
225643|NCT00660829|542101|P1|STARTED|Overall Study|2 subjects were randomized in error|268
225644|NCT00660816|542119|P2|NOT COMPLETED|Overall Study||19
225645|NCT00660816|542120|P1|NOT COMPLETED|Overall Study||20
225646|NCT00660816|542119|P2|COMPLETED|Overall Study||3
225647|NCT00660816|542120|P1|COMPLETED|Overall Study||4
225648|NCT00660816|542119|P2|STARTED|Overall Study||22
225649|NCT00660816|542120|P1|STARTED|Overall Study||24
225650|NCT00660699|542132|P1|NOT COMPLETED|Overall Study||2
225651|NCT00660699|542132|P1|COMPLETED|Overall Study||48
225652|NCT00660699|542132|P1|STARTED|Overall Study||50
225653|NCT00660660|542148|P2|NOT COMPLETED|Overall Study||9
225654|NCT00660660|542149|P1|NOT COMPLETED|Overall Study||5
225655|NCT00660660|542148|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
225656|NCT00660660|542149|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
225657|NCT00660660|542148|P2|Met Criteria for MITT Population|Overall Study||125
225658|NCT00660660|542149|P1|Met Criteria for MITT Population|Overall Study||137
225659|NCT00660660|542148|P2|STARTED|Overall Study|Randomized|133
225660|NCT00660660|542149|P1|STARTED|Overall Study|Randomized|143
225661|NCT00660595|542249|P2|NOT COMPLETED|Overall Study||9
225662|NCT00660595|542250|P1|NOT COMPLETED|Overall Study||18
225663|NCT00660595|542249|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
225664|NCT00660595|542250|P1|COMPLETED|Overall Study||1
225665|NCT00660595|542249|P2|STARTED|Overall Study||10
225666|NCT00660595|542250|P1|STARTED|Overall Study||19
225667|NCT00660543|542262|P1|NOT COMPLETED|Overall Study||0
225668|NCT00660543|542262|P1|COMPLETED|Overall Study||14
225669|NCT00660543|542262|P1|STARTED|Overall Study||14
225670|NCT00660517|542275|P4|NOT COMPLETED|Overall Study||7
225671|NCT00660517|542276|P3|NOT COMPLETED|Overall Study||7
225672|NCT00660517|542277|P2|NOT COMPLETED|Overall Study||8
225673|NCT00660517|542278|P1|NOT COMPLETED|Overall Study||8
225674|NCT00660517|542275|P4|COMPLETED|Overall Study||144
225675|NCT00660517|542276|P3|COMPLETED|Overall Study||144
225676|NCT00660517|542277|P2|COMPLETED|Overall Study||144
225677|NCT00660517|542278|P1|COMPLETED|Overall Study||145
225678|NCT00660517|542275|P4|STARTED|Overall Study||151
225679|NCT00660517|542276|P3|STARTED|Overall Study||151
225680|NCT00660517|542277|P2|STARTED|Overall Study||152
225681|NCT00660517|542278|P1|STARTED|Overall Study||153
225682|NCT00660504|542298|P2|NOT COMPLETED|Overall Study||1
225683|NCT00660504|542299|P1|NOT COMPLETED|Overall Study||0
225684|NCT00660504|542298|P2|COMPLETED|Overall Study||150
225685|NCT00660504|542299|P1|COMPLETED|Overall Study||149
225686|NCT00660504|542298|P2|STARTED|Overall Study||151
225687|NCT00660504|542299|P1|STARTED|Overall Study||149
225688|NCT00660400|542311|P1|NOT COMPLETED|Overall Study||4
225689|NCT00660400|542311|P1|COMPLETED|Overall Study||21
225690|NCT00660400|542311|P1|STARTED|Overall Study||25
225691|NCT00660387|542320|P2|NOT COMPLETED|Overall Study||3
225692|NCT00660387|542321|P1|NOT COMPLETED|Overall Study||2
225693|NCT00660387|542320|P2|COMPLETED|Overall Study||31
225694|NCT00660387|542321|P1|COMPLETED|Overall Study||35
225695|NCT00660387|542320|P2|STARTED|Overall Study||34
225696|NCT00660387|542321|P1|STARTED|Overall Study||37
225697|NCT00660348|542375|P2|NOT COMPLETED|Overall Study||0
225698|NCT00660348|542376|P1|NOT COMPLETED|Overall Study||1
225699|NCT00660348|542375|P2|COMPLETED|Overall Study||0
225700|NCT00660348|542376|P1|COMPLETED|Overall Study||0
225701|NCT00660348|542375|P2|STARTED|Overall Study||0
225702|NCT00660348|542376|P1|STARTED|Overall Study||1
225703|NCT00660309|542384|P2|NOT COMPLETED|Overall Study||3
225704|NCT00660309|542385|P1|NOT COMPLETED|Overall Study||2
225705|NCT00660309|542384|P2|COMPLETED|Overall Study||19
225706|NCT00660309|542385|P1|COMPLETED|Overall Study||21
225707|NCT00660309|542384|P2|Pharmacodynamic Analysis Set|Overall Study||20
225708|NCT00660309|542385|P1|Pharmacodynamic Analysis Set|Overall Study||22
225709|NCT00660309|542384|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
225710|NCT00660309|542385|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
225711|NCT00660309|542384|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
225712|NCT00660309|542385|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
225713|NCT00660192|542426|P2|NOT COMPLETED|Overall Study||3
225714|NCT00660192|542427|P1|NOT COMPLETED|Overall Study||2
225715|NCT00660192|542426|P2|COMPLETED|Overall Study||10
225716|NCT00660192|542427|P1|COMPLETED|Overall Study||10
225717|NCT00660192|542426|P2|STARTED|Overall Study||13
225718|NCT00660192|542427|P1|STARTED|Overall Study||12
225719|NCT00660179|542438|P3|NOT COMPLETED|Overall Study||41
225720|NCT00660179|542439|P2|NOT COMPLETED|Overall Study||58
225721|NCT00660179|542440|P1|NOT COMPLETED|Overall Study||56
225722|NCT00660179|542438|P3|COMPLETED|Overall Study||201
225723|NCT00660179|542439|P2|COMPLETED|Overall Study||192
225724|NCT00660179|542440|P1|COMPLETED|Overall Study||194
225725|NCT00660179|542438|P3|STARTED|Overall Study||242
225726|NCT00660179|542439|P2|STARTED|Overall Study||250
225727|NCT00660179|542440|P1|STARTED|Overall Study||250
225728|NCT00660075|542474|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
225729|NCT00660075|542475|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
225730|NCT00660075|542474|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
225731|NCT00660075|542475|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
225732|NCT00660075|542474|P2|STARTED|Second Intervention (Week 11 to Week 16||18
225733|NCT00660075|542475|P1|STARTED|Second Intervention (Week 11 to Week 16||18
225734|NCT00660075|542474|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
225735|NCT00660075|542475|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
225736|NCT00660075|542474|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
225737|NCT00660075|542475|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
225738|NCT00660075|542474|P2|STARTED|Washout Period (Week 7 to Week 10)||18
225739|NCT00660075|542475|P1|STARTED|Washout Period (Week 7 to Week 10)||18
225740|NCT00660075|542474|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
225741|NCT00660075|542475|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
225742|NCT00660075|542474|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
225743|NCT00660075|542475|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
225744|NCT00660075|542474|P2|STARTED|First Intervention (Week 1 to Week 6)||18
225745|NCT00660075|542475|P1|STARTED|First Intervention (Week 1 to Week 6)||18
225746|NCT00660049|542481|P1|NOT COMPLETED|Overall Study||6
225747|NCT00660049|542481|P1|COMPLETED|Overall Study||6
225748|NCT00660049|542481|P1|STARTED|Overall Study||12
225749|NCT00660023|542485|P1|NOT COMPLETED|Overall Study||29
225750|NCT00660023|542485|P1|COMPLETED|Overall Study||95
225751|NCT00660023|542485|P1|Treated|Overall Study||114
225752|NCT00660023|542485|P1|STARTED|Overall Study||124
225753|NCT00660010|542496|P1|NOT COMPLETED|Overall Study||9
225754|NCT00660010|542496|P1|COMPLETED|Overall Study||46
225755|NCT00660010|542496|P1|STARTED|Overall Study||55
225756|NCT00659984|542510|P1|NOT COMPLETED|Overall Study||1
225757|NCT00659984|542510|P1|COMPLETED|Overall Study||14
225758|NCT00659984|542510|P1|STARTED|Overall Study||15
225759|NCT00659945|542523|P2|NOT COMPLETED|Overall Study||0
225760|NCT00659945|542524|P1|NOT COMPLETED|Overall Study||0
225761|NCT00659945|542523|P2|COMPLETED|Overall Study||75
225762|NCT00659945|542524|P1|COMPLETED|Overall Study||75
225763|NCT00659945|542523|P2|STARTED|Overall Study||75
225764|NCT00659945|542524|P1|STARTED|Overall Study||75
225765|NCT00659880|542530|P1|NOT COMPLETED|Overall Study||5
225766|NCT00659880|542530|P1|COMPLETED|Overall Study|60 months|4
225767|NCT00659880|542530|P1|24 Months|Overall Study||6
225768|NCT00659880|542530|P1|12 Months|Overall Study||7
225769|NCT00659880|542530|P1|6 Months|Overall Study||9
225770|NCT00659880|542530|P1|6 Weeks|Overall Study||9
225771|NCT00659880|542530|P1|STARTED|Overall Study||9
225772|NCT00659815|542537|P2|NOT COMPLETED|Overall Study||4
225773|NCT00659815|542538|P1|NOT COMPLETED|Overall Study||4
225774|NCT00659815|542537|P2|COMPLETED|Overall Study||147
225775|NCT00659815|542538|P1|COMPLETED|Overall Study||153
225776|NCT00659815|542537|P2|STARTED|Overall Study||151
225777|NCT00659815|542538|P1|STARTED|Overall Study||157
225778|NCT00659789|542550|P2|NOT COMPLETED|Overall Study||7
225779|NCT00659789|542551|P1|NOT COMPLETED|Overall Study||7
225780|NCT00659789|542550|P2|COMPLETED|Overall Study||36
225781|NCT00659789|542551|P1|COMPLETED|Overall Study||86
225782|NCT00659789|542550|P2|STARTED|Overall Study||43
225783|NCT00659789|542551|P1|STARTED|Overall Study||93
225784|NCT00659737|542569|P2|NOT COMPLETED|Overall Study||0
225785|NCT00659737|542570|P1|NOT COMPLETED|Overall Study||0
225786|NCT00659737|542569|P2|COMPLETED|Overall Study||58
225787|NCT00659737|542570|P1|COMPLETED|Overall Study||57
225788|NCT00659737|542569|P2|STARTED|Overall Study||58
225789|NCT00659737|542570|P1|STARTED|Overall Study||57
225790|NCT00659724|542576|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
225791|NCT00659724|542576|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
225792|NCT00659724|542576|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
225793|NCT00659724|542576|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
225794|NCT00659724|542576|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
225795|NCT00659724|542576|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
225796|NCT00659633|542594|P1|NOT COMPLETED|Overall Study||0
225797|NCT00659633|542594|P1|COMPLETED|Overall Study||10
225798|NCT00659633|542594|P1|STARTED|Overall Study||10
225799|NCT00659607|542598|P1|NOT COMPLETED|Overall Study||316
225800|NCT00659607|542598|P1|COMPLETED|Overall Study||3616
225801|NCT00659607|542598|P1|STARTED|Overall Study||3932
225802|NCT00659581|542616|P1|NOT COMPLETED|Overall Study||8582
225803|NCT00659581|542616|P1|COMPLETED|Overall Study||12412
225804|NCT00659581|542616|P1|STARTED|Overall Study||20994
225805|NCT00659529|542628|P1|NOT COMPLETED|Overall Study||16
225806|NCT00659529|542628|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
225807|NCT00659529|542628|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
225808|NCT00659529|542628|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
225809|NCT00659490|542635|P3|NOT COMPLETED|Overall Study||1
225810|NCT00659490|542636|P2|NOT COMPLETED|Overall Study||0
225811|NCT00659490|542637|P1|NOT COMPLETED|Overall Study||2
225812|NCT00659490|542635|P3|COMPLETED|Overall Study||30
225813|NCT00659490|542636|P2|COMPLETED|Overall Study||59
225814|NCT00659490|542637|P1|COMPLETED|Overall Study||59
225815|NCT00659490|542635|P3|STARTED|Overall Study||31
225816|NCT00659490|542636|P2|STARTED|Overall Study||59
225817|NCT00659490|542637|P1|STARTED|Overall Study||61
225818|NCT00659438|542710|P2|NOT COMPLETED|Overall Study||8
225819|NCT00659438|542711|P1|NOT COMPLETED|Overall Study||14
225820|NCT00659438|542710|P2|COMPLETED|Overall Study||40
225821|NCT00659438|542711|P1|COMPLETED|Overall Study||33
225822|NCT00659438|542710|P2|Safety Analysis Set|Overall Study||47
225823|NCT00659438|542711|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
225824|NCT00659438|542710|P2|Secondary Analysis Set|Overall Study||48
225825|NCT00659438|542711|P1|Secondary Analysis Set|Overall Study||47
225826|NCT00659438|542710|P2|Assessable Set : Primary Analysis|Overall Study||45
225827|NCT00659438|542711|P1|Assessable Set : Primary Analysis|Overall Study||44
225828|NCT00659438|542710|P2|STARTED|Overall Study||48
225829|NCT00659438|542711|P1|STARTED|Overall Study||47
225830|NCT00659425|542743|P10|NOT COMPLETED|Overall Study||13
225831|NCT00659425|542744|P9|NOT COMPLETED|Overall Study||6
225832|NCT00659425|542745|P8|NOT COMPLETED|Overall Study||11
225833|NCT00659425|542746|P7|NOT COMPLETED|Overall Study||8
225834|NCT00659425|542747|P6|NOT COMPLETED|Overall Study||4
225835|NCT00659425|542748|P5|NOT COMPLETED|Overall Study||4
225836|NCT00659425|542749|P4|NOT COMPLETED|Overall Study||4
225837|NCT00659425|542750|P3|NOT COMPLETED|Overall Study||1
225838|NCT00659425|542751|P2|NOT COMPLETED|Overall Study||1
225839|NCT00659425|542752|P1|NOT COMPLETED|Overall Study||1
225840|NCT00659425|542743|P10|COMPLETED|Overall Study||1
225841|NCT00659425|542744|P9|COMPLETED|Overall Study||0
225842|NCT00659425|542745|P8|COMPLETED|Overall Study||0
225843|NCT00659425|542746|P7|COMPLETED|Overall Study||0
225844|NCT00659425|542747|P6|COMPLETED|Overall Study||1
225845|NCT00659425|542748|P5|COMPLETED|Overall Study||0
225846|NCT00659425|542749|P4|COMPLETED|Overall Study||0
225847|NCT00659425|542750|P3|COMPLETED|Overall Study||0
225848|NCT00659425|542751|P2|COMPLETED|Overall Study||0
225849|NCT00659425|542752|P1|COMPLETED|Overall Study||0
225850|NCT00659425|542743|P10|STARTED|Overall Study||14
225851|NCT00659425|542744|P9|STARTED|Overall Study||6
225852|NCT00659425|542745|P8|STARTED|Overall Study||11
225853|NCT00659425|542746|P7|STARTED|Overall Study||8
225854|NCT00659425|542747|P6|STARTED|Overall Study||5
225855|NCT00659425|542748|P5|STARTED|Overall Study||4
225856|NCT00659425|542749|P4|STARTED|Overall Study||4
225857|NCT00659425|542750|P3|STARTED|Overall Study||1
225858|NCT00659425|542751|P2|STARTED|Overall Study||1
225859|NCT00659425|542752|P1|STARTED|Overall Study||1
225860|NCT00659373|542983|P2|NOT COMPLETED|Overall Study||7
225861|NCT00659373|542984|P1|NOT COMPLETED|Overall Study||5
225862|NCT00659373|542983|P2|COMPLETED|Overall Study||54
225863|NCT00659373|542984|P1|COMPLETED|Overall Study||20
225864|NCT00659373|542983|P2|STARTED|Overall Study||61
225865|NCT00659373|542984|P1|STARTED|Overall Study||25
225866|NCT00659360|542990|P1|NOT COMPLETED|Overall Study||0
225867|NCT00659360|542990|P1|COMPLETED|Overall Study||17
225868|NCT00659360|542990|P1|STARTED|Overall Study||17
225869|NCT00659334|543005|P7|NOT COMPLETED|Overall Study||1
225870|NCT00659334|543006|P6|NOT COMPLETED|Overall Study||0
225871|NCT00659334|543007|P5|NOT COMPLETED|Overall Study||0
225872|NCT00659334|543008|P4|NOT COMPLETED|Overall Study||0
225873|NCT00659334|543009|P3|NOT COMPLETED|Overall Study||0
225874|NCT00659334|543010|P2|NOT COMPLETED|Overall Study||5
225875|NCT00659334|543011|P1|NOT COMPLETED|Overall Study||8
225876|NCT00659334|543005|P7|COMPLETED|Overall Study|1 screen failure|20
225877|NCT00659334|543006|P6|COMPLETED|Overall Study||0
225878|NCT00659334|543007|P5|COMPLETED|Overall Study||1
225879|NCT00659334|543008|P4|COMPLETED|Overall Study||2
225880|NCT00659334|543009|P3|COMPLETED|Overall Study||5
225881|NCT00659334|543010|P2|COMPLETED|Overall Study|5 Screen failures|36
225882|NCT00659334|543011|P1|COMPLETED|Overall Study|8 Screen failures|38
225883|NCT00659334|543005|P7|STARTED|Overall Study||21
225884|NCT00659334|543006|P6|STARTED|Overall Study||0
225885|NCT00659334|543007|P5|STARTED|Overall Study||1
225886|NCT00659334|543008|P4|STARTED|Overall Study||2
225887|NCT00659334|543009|P3|STARTED|Overall Study||5
225888|NCT00659334|543010|P2|STARTED|Overall Study||41
225889|NCT00659334|543011|P1|STARTED|Overall Study||46
225890|NCT00659295|543029|P2|NOT COMPLETED|Overall Study||5603
225891|NCT00659295|543030|P1|NOT COMPLETED|Overall Study||2708
225892|NCT00659295|543029|P2|COMPLETED|Overall Study||32038
225893|NCT00659295|543030|P1|COMPLETED|Overall Study||10821
225894|NCT00659295|543029|P2|STARTED|Overall Study||37641
225895|NCT00659295|543030|P1|STARTED|Overall Study||13529
225896|NCT00659269|543038|P2|NOT COMPLETED|Overall Study||1
225897|NCT00659269|543039|P1|NOT COMPLETED|Overall Study||1
225898|NCT00659269|543038|P2|COMPLETED|Overall Study||161
225899|NCT00659269|543039|P1|COMPLETED|Overall Study||156
225900|NCT00659269|543038|P2|Group 3 (Taxanes)|Overall Study||97
225901|NCT00659269|543039|P1|Group 3 (Taxanes)|Overall Study||92
225902|NCT00659269|543038|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
225903|NCT00659269|543039|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
225904|NCT00659269|543038|P2|Group 1 (Heavy Metals)|Overall Study||52
225905|NCT00659269|543039|P1|Group 1 (Heavy Metals)|Overall Study||52
225906|NCT00659269|543038|P2|STARTED|Overall Study||162
225907|NCT00659269|543039|P1|STARTED|Overall Study||157
225908|NCT00659230|543069|P2|NOT COMPLETED|Overall Study||12
225909|NCT00659230|543070|P1|NOT COMPLETED|Overall Study||9
225910|NCT00659230|543069|P2|COMPLETED|Overall Study||37
225911|NCT00659230|543070|P1|COMPLETED|Overall Study||42
225912|NCT00659230|543069|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
225913|NCT00659230|543070|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
225914|NCT00659165|543084|P2|NOT COMPLETED|Overall Study||0
225915|NCT00659165|543085|P1|NOT COMPLETED|Overall Study||0
225916|NCT00659165|543084|P2|COMPLETED|Overall Study||5
225917|NCT00659165|543085|P1|COMPLETED|Overall Study||5
225918|NCT00659165|543084|P2|STARTED|Overall Study||5
225919|NCT00659165|543085|P1|STARTED|Overall Study||5
225920|NCT00659061|543093|P2|NOT COMPLETED|Overall Study||15
225921|NCT00659061|543094|P1|NOT COMPLETED|Overall Study||21
225922|NCT00659061|543093|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
225923|NCT00659061|543094|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
225924|NCT00659061|543093|P2|STARTED|Overall Study||302
225925|NCT00659061|543094|P1|STARTED|Overall Study||308
225926|NCT00658996|543112|P2|NOT COMPLETED|Second Intervention||1
225927|NCT00658996|543113|P1|NOT COMPLETED|Second Intervention||1
225928|NCT00658996|543112|P2|COMPLETED|Second Intervention||104
225929|NCT00658996|543113|P1|COMPLETED|Second Intervention||105
225930|NCT00658996|543112|P2|STARTED|Second Intervention||105
225931|NCT00658996|543113|P1|STARTED|Second Intervention||106
225932|NCT00658996|543112|P2|NOT COMPLETED|Crossover Period||1
225933|NCT00658996|543113|P1|NOT COMPLETED|Crossover Period||2
225934|NCT00658996|543112|P2|COMPLETED|Crossover Period||105
225935|NCT00658996|543113|P1|COMPLETED|Crossover Period||106
225936|NCT00658996|543112|P2|STARTED|Crossover Period||106
225937|NCT00658996|543113|P1|STARTED|Crossover Period||108
225938|NCT00658996|543112|P2|NOT COMPLETED|First Intervention||1
225939|NCT00658996|543113|P1|NOT COMPLETED|First Intervention||1
225940|NCT00658996|543112|P2|COMPLETED|First Intervention||106
225941|NCT00658996|543113|P1|COMPLETED|First Intervention||108
225942|NCT00658996|543112|P2|STARTED|First Intervention||107
225943|NCT00658996|543113|P1|STARTED|First Intervention||109
225944|NCT00658814|543125|P2|NOT COMPLETED|Maintenance Therapy||1
225945|NCT00658814|543126|P1|NOT COMPLETED|Maintenance Therapy||3
225946|NCT00658814|543125|P2|COMPLETED|Maintenance Therapy||7
225947|NCT00658814|543126|P1|COMPLETED|Maintenance Therapy||17
225948|NCT00658814|543125|P2|Eligible|Maintenance Therapy||8
225949|NCT00658814|543126|P1|Eligible|Maintenance Therapy||19
225950|NCT00658814|543125|P2|STARTED|Maintenance Therapy||8
225951|NCT00658814|543126|P1|STARTED|Maintenance Therapy||20
225952|NCT00658814|543125|P2|NOT COMPLETED|Consolidation Therapy||3
225953|NCT00658814|543126|P1|NOT COMPLETED|Consolidation Therapy||2
225954|NCT00658814|543125|P2|COMPLETED|Consolidation Therapy||10
225955|NCT00658814|543126|P1|COMPLETED|Consolidation Therapy||22
225956|NCT00658814|543125|P2|Eligible|Consolidation Therapy||11
225957|NCT00658814|543126|P1|Eligible|Consolidation Therapy||22
225958|NCT00658814|543125|P2|STARTED|Consolidation Therapy||13
225959|NCT00658814|543126|P1|STARTED|Consolidation Therapy||24
225960|NCT00658814|543125|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
225961|NCT00658814|543126|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
225962|NCT00658814|543125|P2|COMPLETED|Remission Induction Chemotherapy||41
225963|NCT00658814|543126|P1|COMPLETED|Remission Induction Chemotherapy||75
225964|NCT00658814|543125|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
225965|NCT00658814|543126|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
225966|NCT00658814|543125|P2|Eligible|Remission Induction Chemotherapy||57
225967|NCT00658814|543126|P1|Eligible|Remission Induction Chemotherapy||82
225968|NCT00658814|543125|P2|STARTED|Remission Induction Chemotherapy||59
225969|NCT00658814|543126|P1|STARTED|Remission Induction Chemotherapy||83
225970|NCT00658788|543140|P1|NOT COMPLETED|Overall Study||74
225971|NCT00658788|543140|P1|COMPLETED|Overall Study||231
225972|NCT00658788|543140|P1|STARTED|Overall Study||305
225973|NCT00658775|543195|P2|NOT COMPLETED|Overall Study||43
225974|NCT00658775|543196|P1|NOT COMPLETED|Overall Study||42
225975|NCT00658775|543195|P2|COMPLETED|Overall Study||485
225976|NCT00658775|543196|P1|COMPLETED|Overall Study||495
225977|NCT00658775|543195|P2|STARTED|Overall Study|Treated|528
225978|NCT00658775|543196|P1|STARTED|Overall Study|Treated|537
225979|NCT00658736|543208|P2|NOT COMPLETED|Overall Study||2
225980|NCT00658736|543209|P1|NOT COMPLETED|Overall Study||6
225981|NCT00658736|543208|P2|COMPLETED|Overall Study||19
225982|NCT00658736|543209|P1|COMPLETED|Overall Study||13
225983|NCT00658736|543208|P2|STARTED|Overall Study||21
225984|NCT00658736|543209|P1|STARTED|Overall Study||19
225985|NCT00658723|543219|P3|NOT COMPLETED|Overall Study||7
225986|NCT00658723|543220|P2|NOT COMPLETED|Overall Study||4
225987|NCT00658723|543221|P1|NOT COMPLETED|Overall Study||4
225988|NCT00658723|543219|P3|COMPLETED|Overall Study||44
225989|NCT00658723|543220|P2|COMPLETED|Overall Study||26
225990|NCT00658723|543221|P1|COMPLETED|Overall Study||56
225991|NCT00658723|543219|P3|STARTED|Overall Study||51
225992|NCT00658723|543220|P2|STARTED|Overall Study||30
225993|NCT00658723|543221|P1|STARTED|Overall Study||60
225994|NCT00658697|543248|P1|NOT COMPLETED|Overall Study||0
225995|NCT00658697|543248|P1|COMPLETED|Overall Study||41
225996|NCT00658697|543248|P1|STARTED|Overall Study||41
225997|NCT00658684|543259|P4|NOT COMPLETED|Overall Study||1
225998|NCT00658684|543260|P3|NOT COMPLETED|Overall Study||3
225999|NCT00658684|543261|P2|NOT COMPLETED|Overall Study||15
226000|NCT00658684|543262|P1|NOT COMPLETED|Overall Study||19
226001|NCT00658684|543259|P4|COMPLETED|Overall Study||27
226002|NCT00658684|543260|P3|COMPLETED|Overall Study||22
226003|NCT00658684|543261|P2|COMPLETED|Overall Study||84
226004|NCT00658684|543262|P1|COMPLETED|Overall Study||133
226005|NCT00658684|543259|P4|STARTED|Overall Study||28
226006|NCT00658684|543260|P3|STARTED|Overall Study||25
226007|NCT00658684|543261|P2|STARTED|Overall Study||99
226008|NCT00658684|543262|P1|STARTED|Overall Study||152
226009|NCT00658658|543317|P5|NOT COMPLETED|Overall Study||5
226010|NCT00658658|543318|P4|NOT COMPLETED|Overall Study||2
226011|NCT00658658|543319|P3|NOT COMPLETED|Overall Study||0
226012|NCT00658658|543320|P2|NOT COMPLETED|Overall Study||2
226013|NCT00658658|543321|P1|NOT COMPLETED|Overall Study||5
226014|NCT00658658|543317|P5|COMPLETED|Overall Study||3
226015|NCT00658658|543318|P4|COMPLETED|Overall Study||4
226016|NCT00658658|543319|P3|COMPLETED|Overall Study||4
226017|NCT00658658|543320|P2|COMPLETED|Overall Study||5
226018|NCT00658658|543321|P1|COMPLETED|Overall Study||1
226019|NCT00658658|543317|P5|STARTED|Overall Study||8
226020|NCT00658658|543318|P4|STARTED|Overall Study||6
226021|NCT00658658|543319|P3|STARTED|Overall Study||4
226022|NCT00658658|543320|P2|STARTED|Overall Study||7
226023|NCT00658658|543321|P1|STARTED|Overall Study||6
226024|NCT00658632|543380|P2|NOT COMPLETED|Overall Study||65
226025|NCT00658632|543381|P1|NOT COMPLETED|Overall Study||64
226026|NCT00658632|543380|P2|COMPLETED|Overall Study||633
226027|NCT00658632|543381|P1|COMPLETED|Overall Study||618
226028|NCT00658632|543380|P2|STARTED|Overall Study|Treated|698
226029|NCT00658632|543381|P1|STARTED|Overall Study|Treated|682
226030|NCT00658619|543396|P5|NOT COMPLETED|Overall Study||2
226031|NCT00658619|543397|P4|NOT COMPLETED|Overall Study||12
226032|NCT00658619|543398|P3|NOT COMPLETED|Overall Study||10
226033|NCT00658619|543399|P2|NOT COMPLETED|Overall Study||1
226034|NCT00658619|543400|P1|NOT COMPLETED|Overall Study||0
226035|NCT00658619|543396|P5|COMPLETED|Overall Study||21
226036|NCT00658619|543397|P4|COMPLETED|Overall Study||37
226037|NCT00658619|543398|P3|COMPLETED|Overall Study||31
226038|NCT00658619|543399|P2|COMPLETED|Overall Study||2
226039|NCT00658619|543400|P1|COMPLETED|Overall Study||3
226040|NCT00658619|543396|P5|STARTED|Overall Study||23
226041|NCT00658619|543397|P4|STARTED|Overall Study||49
226042|NCT00658619|543398|P3|STARTED|Overall Study||41
226043|NCT00658619|543399|P2|STARTED|Overall Study||3
226044|NCT00658619|543400|P1|STARTED|Overall Study||3
226045|NCT00658606|543422|P2|NOT COMPLETED|Overall Study||23
226046|NCT00658606|543423|P1|NOT COMPLETED|Overall Study||16
226047|NCT00658606|543422|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
226048|NCT00658606|543423|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
226049|NCT00658606|543422|P2|Completed Treatment|Overall Study||44
226050|NCT00658606|543423|P1|Completed Treatment|Overall Study||42
226051|NCT00658606|543422|P2|STARTED|Overall Study||49
226052|NCT00658606|543423|P1|STARTED|Overall Study||49
226053|NCT00658567|543452|P3|NOT COMPLETED|Overall Study||6
226054|NCT00658567|543453|P2|NOT COMPLETED|Overall Study||4
226055|NCT00658567|543454|P1|NOT COMPLETED|Overall Study||8
226056|NCT00658567|543452|P3|COMPLETED|Overall Study||35
226057|NCT00658567|543453|P2|COMPLETED|Overall Study||38
226058|NCT00658567|543454|P1|COMPLETED|Overall Study||32
226059|NCT00658567|543452|P3|STARTED|Overall Study||41
226060|NCT00658567|543453|P2|STARTED|Overall Study||42
226061|NCT00658567|543454|P1|STARTED|Overall Study||40
226062|NCT00658541|543465|P2|NOT COMPLETED|Second Intervention||0
226063|NCT00658541|543466|P1|NOT COMPLETED|Second Intervention||0
226064|NCT00658541|543465|P2|COMPLETED|Second Intervention||17
226065|NCT00658541|543466|P1|COMPLETED|Second Intervention||18
226066|NCT00658541|543465|P2|STARTED|Second Intervention||17
226067|NCT00658541|543466|P1|STARTED|Second Intervention||18
226068|NCT00658541|543465|P2|NOT COMPLETED|Washout Period of 7 Days||2
226069|NCT00658541|543466|P1|NOT COMPLETED|Washout Period of 7 Days||1
226070|NCT00658541|543465|P2|COMPLETED|Washout Period of 7 Days||17
226071|NCT00658541|543466|P1|COMPLETED|Washout Period of 7 Days||18
226072|NCT00658541|543465|P2|STARTED|Washout Period of 7 Days||19
226073|NCT00658541|543466|P1|STARTED|Washout Period of 7 Days||19
226074|NCT00658541|543465|P2|NOT COMPLETED|First Intervention||0
226075|NCT00658541|543466|P1|NOT COMPLETED|First Intervention||0
226076|NCT00658541|543465|P2|COMPLETED|First Intervention||19
226077|NCT00658541|543466|P1|COMPLETED|First Intervention||19
226078|NCT00658541|543465|P2|STARTED|First Intervention||19
226079|NCT00658541|543466|P1|STARTED|First Intervention||19
226080|NCT00658528|543478|P2|NOT COMPLETED|Overall Study||45
226081|NCT00658528|543479|P1|NOT COMPLETED|Overall Study||40
226082|NCT00658528|543478|P2|COMPLETED|Overall Study||479
226083|NCT00658528|543479|P1|COMPLETED|Overall Study||491
226084|NCT00658528|543478|P2|STARTED|Overall Study|Treated|524
226085|NCT00658528|543479|P1|STARTED|Overall Study|Treated|531
226086|NCT00658411|543489|P1|NOT COMPLETED|Overall Study||0
226087|NCT00658411|543489|P1|COMPLETED|Overall Study||5
226088|NCT00658411|543489|P1|STARTED|Overall Study||5
226089|NCT00658385|543497|P1|NOT COMPLETED|Overall Study||0
226090|NCT00658385|543497|P1|COMPLETED|Overall Study||5
226091|NCT00658385|543497|P1|STARTED|Overall Study||5
226092|NCT00658359|543504|P3|NOT COMPLETED|Overall Study||46
226093|NCT00658359|543505|P2|NOT COMPLETED|Overall Study||45
226094|NCT00658359|543506|P1|NOT COMPLETED|Overall Study||28
226095|NCT00658359|543504|P3|COMPLETED|Overall Study||8
226096|NCT00658359|543505|P2|COMPLETED|Overall Study||15
226097|NCT00658359|543506|P1|COMPLETED|Overall Study||36
226098|NCT00658359|543504|P3|STARTED|Overall Study||54
226099|NCT00658359|543505|P2|STARTED|Overall Study||60
226100|NCT00658359|543506|P1|STARTED|Overall Study||64
226101|NCT00658333|543594|P2|NOT COMPLETED|Overall Study||1
226102|NCT00658333|543595|P1|NOT COMPLETED|Overall Study||2
226103|NCT00658333|543594|P2|COMPLETED|Overall Study||14
226104|NCT00658333|543595|P1|COMPLETED|Overall Study||13
226105|NCT00658333|543594|P2|STARTED|Overall Study||15
226106|NCT00658333|543595|P1|STARTED|Overall Study||15
226107|NCT00658320|543605|P2|NOT COMPLETED|Extension Study: After Month 24||0
226108|NCT00658320|543606|P1|NOT COMPLETED|Extension Study: After Month 24||2
226109|NCT00658320|543605|P2|COMPLETED|Extension Study: After Month 24||0
226110|NCT00658320|543606|P1|COMPLETED|Extension Study: After Month 24||42
226111|NCT00658320|543605|P2|STARTED|Extension Study: After Month 24||0
226112|NCT00658320|543606|P1|STARTED|Extension Study: After Month 24||44
226113|NCT00658320|543605|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
226114|NCT00658320|543606|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
226115|NCT00658320|543605|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
226116|NCT00658320|543606|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
226117|NCT00658320|543605|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
226118|NCT00658320|543606|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
226119|NCT00658320|543605|P2|STARTED|Extension Study: Month 12 to Month 24||57
226120|NCT00658320|543606|P1|STARTED|Extension Study: Month 12 to Month 24||53
226121|NCT00658320|543605|P2|NOT COMPLETED|Core Study: 12 Months||3
226122|NCT00658320|543606|P1|NOT COMPLETED|Core Study: 12 Months||5
226123|NCT00658320|543605|P2|COMPLETED|Core Study: 12 Months||58
226124|NCT00658320|543606|P1|COMPLETED|Core Study: 12 Months||56
226125|NCT00658320|543605|P2|STARTED|Core Study: 12 Months||61
226126|NCT00658320|543606|P1|STARTED|Core Study: 12 Months||61
226127|NCT00658138|543629|P1|NOT COMPLETED|Overall Study||21
226128|NCT00658138|543629|P1|COMPLETED|Overall Study||40
226129|NCT00658138|543629|P1|STARTED|Overall Study||61
226130|NCT00658112|543634|P1|NOT COMPLETED|Overall Study||9
226131|NCT00658112|543634|P1|COMPLETED|Overall Study||11
226132|NCT00658112|543634|P1|STARTED|Overall Study||20
226133|NCT00657709|543643|P5|NOT COMPLETED|Overall Study||33
226134|NCT00657709|543644|P4|NOT COMPLETED|Overall Study||14
226135|NCT00657709|543645|P3|NOT COMPLETED|Overall Study||28
226136|NCT00657709|543646|P2|NOT COMPLETED|Overall Study||33
226137|NCT00657709|543647|P1|NOT COMPLETED|Overall Study||23
226138|NCT00657709|543643|P5|COMPLETED|Overall Study||457
226139|NCT00657709|543644|P4|COMPLETED|Overall Study||645
226140|NCT00657709|543645|P3|COMPLETED|Overall Study||792
226141|NCT00657709|543646|P2|COMPLETED|Overall Study||795
226142|NCT00657709|543647|P1|COMPLETED|Overall Study||810
226143|NCT00657709|543643|P5|STARTED|Overall Study||490
226144|NCT00657709|543644|P4|STARTED|Overall Study||659
226145|NCT00657709|543645|P3|STARTED|Overall Study||820
226146|NCT00657709|543646|P2|STARTED|Overall Study||828
226147|NCT00657709|543647|P1|STARTED|Overall Study||833
226148|NCT00657657|543688|P1|NOT COMPLETED|Overall Study||0
226149|NCT00657657|543688|P1|COMPLETED|Overall Study||29
226150|NCT00657657|543688|P1|STARTED|Overall Study||29
226151|NCT00657618|543696|P1|NOT COMPLETED|Overall Study||43
226152|NCT00657618|543696|P1|COMPLETED|Overall Study||34
226153|NCT00657618|543696|P1|STARTED|Overall Study||77
226154|NCT00657553|543703|P2|NOT COMPLETED|Overall Study||5
226155|NCT00657553|543704|P1|NOT COMPLETED|Overall Study||5
226156|NCT00657553|543703|P2|COMPLETED|Overall Study||0
226157|NCT00657553|543704|P1|COMPLETED|Overall Study||0
226158|NCT00657553|543703|P2|STARTED|Overall Study||5
226159|NCT00657553|543704|P1|STARTED|Overall Study||5
226160|NCT00657540|543712|P2|NOT COMPLETED|Overall Study||4
226161|NCT00657540|543713|P1|NOT COMPLETED|Overall Study||1
226162|NCT00657540|543712|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
226163|NCT00657540|543713|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
226164|NCT00657540|543712|P2|STARTED|Overall Study||31
226165|NCT00657540|543713|P1|STARTED|Overall Study||29
226166|NCT00657371|543727|P1|NOT COMPLETED|Overall Study||39
226167|NCT00657371|543727|P1|COMPLETED|Overall Study||249
226168|NCT00657371|543727|P1|STARTED|Overall Study||288
226169|NCT00657358|543732|P1|NOT COMPLETED|Overall Study||6
226170|NCT00657358|543732|P1|COMPLETED|Overall Study||16
226171|NCT00657358|543732|P1|STARTED|Overall Study||22
226172|NCT00657280|543740|P1|NOT COMPLETED|Overall Study||0
226173|NCT00657280|543740|P1|COMPLETED|Overall Study||16
226174|NCT00657280|543740|P1|STARTED|Overall Study||16
226175|NCT00657267|543744|P1|NOT COMPLETED|Overall Study||54
226176|NCT00657267|543744|P1|COMPLETED|Overall Study||4
226177|NCT00657267|543744|P1|STARTED|Overall Study||58
226178|NCT00657150|543754|P2|NOT COMPLETED|Treatment||97
226179|NCT00657150|543755|P1|NOT COMPLETED|Treatment||107
226180|NCT00657150|543754|P2|COMPLETED|Treatment||906
226181|NCT00657150|543755|P1|COMPLETED|Treatment||903
226182|NCT00657150|543754|P2|STARTED|Treatment||1003
226183|NCT00657150|543755|P1|STARTED|Treatment||1010
226184|NCT00657150|543754|P2|NOT COMPLETED|Overall Study||93
226185|NCT00657150|543755|P1|NOT COMPLETED|Overall Study||115
226186|NCT00657150|543754|P2|COMPLETED|Overall Study||910
226187|NCT00657150|543755|P1|COMPLETED|Overall Study||895
226188|NCT00657150|543754|P2|STARTED|Overall Study||1003
226189|NCT00657150|543755|P1|STARTED|Overall Study||1010
226190|NCT00657046|543786|P3|NOT COMPLETED|Overall Study||2
226191|NCT00657046|543787|P2|NOT COMPLETED|Overall Study||3
226192|NCT00657046|543788|P1|NOT COMPLETED|Overall Study||4
226193|NCT00657046|543786|P3|COMPLETED|Overall Study||21
226194|NCT00657046|543787|P2|COMPLETED|Overall Study||29
226195|NCT00657046|543788|P1|COMPLETED|Overall Study||26
226196|NCT00657046|543786|P3|Had Visits up to Visit 18|Overall Study||23
226197|NCT00657046|543787|P2|Had Visits up to Visit 18|Overall Study||30
226198|NCT00657046|543788|P1|Had Visits up to Visit 18|Overall Study||28
226199|NCT00657046|543786|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
226200|NCT00657046|543787|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
226201|NCT00657046|543788|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
226202|NCT00657046|543786|P3|STARTED|Overall Study||23
226203|NCT00657046|543787|P2|STARTED|Overall Study||32
226204|NCT00657046|543788|P1|STARTED|Overall Study||30
226205|NCT00657020|543820|P2|NOT COMPLETED|PERIOD 2||0
226206|NCT00657020|543821|P1|NOT COMPLETED|PERIOD 2||0
226207|NCT00657020|543820|P2|COMPLETED|PERIOD 2||11
226208|NCT00657020|543821|P1|COMPLETED|PERIOD 2||11
226209|NCT00657020|543820|P2|STARTED|PERIOD 2||11
226210|NCT00657020|543821|P1|STARTED|PERIOD 2||11
226211|NCT00657020|543820|P2|NOT COMPLETED|PERIOD 1||1
226212|NCT00657020|543821|P1|NOT COMPLETED|PERIOD 1||0
226213|NCT00657020|543820|P2|COMPLETED|PERIOD 1||11
226214|NCT00657020|543821|P1|COMPLETED|PERIOD 1||11
226215|NCT00657020|543820|P2|STARTED|PERIOD 1||12
226216|NCT00657020|543821|P1|STARTED|PERIOD 1||11
226217|NCT00656968|543851|P2|NOT COMPLETED|Overall Study||0
226218|NCT00656968|543852|P1|NOT COMPLETED|Overall Study||0
226219|NCT00656968|543851|P2|COMPLETED|Overall Study||117
226220|NCT00656968|543852|P1|COMPLETED|Overall Study||115
226221|NCT00656968|543851|P2|STARTED|Overall Study||117
226222|NCT00656968|543852|P1|STARTED|Overall Study||115
226223|NCT00656916|543862|P2|NOT COMPLETED|Overall Study||0
226224|NCT00656916|543863|P1|NOT COMPLETED|Overall Study||0
226225|NCT00656916|543862|P2|COMPLETED|Overall Study||0
226226|NCT00656916|543863|P1|COMPLETED|Overall Study||1
226227|NCT00656916|543862|P2|STARTED|Overall Study||0
226228|NCT00656916|543863|P1|STARTED|Overall Study||1
226229|NCT00656851|543871|P2|NOT COMPLETED|Overall Study||4
226230|NCT00656851|543872|P1|NOT COMPLETED|Overall Study||0
226231|NCT00656851|543871|P2|COMPLETED|Overall Study||8
226232|NCT00656851|543872|P1|COMPLETED|Overall Study||12
226233|NCT00656851|543871|P2|STARTED|Overall Study||12
226234|NCT00656851|543872|P1|STARTED|Overall Study||12
226235|NCT00656799|543894|P1|NOT COMPLETED|Overall Study||2
226236|NCT00656799|543894|P1|COMPLETED|Overall Study||4
226237|NCT00656799|543894|P1|STARTED|Overall Study||6
226238|NCT00656669|543916|P1|NOT COMPLETED|AC (Cycles 6-9)||2
226239|NCT00656669|543916|P1|COMPLETED|AC (Cycles 6-9)||15
226240|NCT00656669|543916|P1|STARTED|AC (Cycles 6-9)||17
226241|NCT00656669|543916|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
226242|NCT00656669|543916|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
226243|NCT00656669|543916|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
226244|NCT00656669|543916|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
226245|NCT00656669|543916|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
226246|NCT00656669|543916|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
226247|NCT00656656|543925|P1|NOT COMPLETED|Overall Study||0
226248|NCT00656656|543925|P1|COMPLETED|Overall Study||23
226249|NCT00656656|543925|P1|STARTED|Overall Study||23
226250|NCT00656630|543933|P3|NOT COMPLETED|Overall Study||2
226251|NCT00656630|543934|P2|NOT COMPLETED|Overall Study||2
226252|NCT00656630|543935|P1|NOT COMPLETED|Overall Study||2
226253|NCT00656630|543933|P3|COMPLETED|Overall Study||17
226254|NCT00656630|543934|P2|COMPLETED|Overall Study||25
226255|NCT00656630|543935|P1|COMPLETED|Overall Study||20
226256|NCT00656630|543933|P3|STARTED|Overall Study||19
226257|NCT00656630|543934|P2|STARTED|Overall Study||27
226258|NCT00656630|543935|P1|STARTED|Overall Study||22
226259|NCT00656617|543955|P1|NOT COMPLETED|Overall Study||7
226260|NCT00656617|543955|P1|COMPLETED|Overall Study||99
226261|NCT00656617|543955|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
226262|NCT00656617|543955|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
226263|NCT00656617|543955|P1|STARTED|Overall Study||106
226264|NCT00656513|543964|P3|NOT COMPLETED|Overall Study||22
226265|NCT00656513|543965|P2|NOT COMPLETED|Overall Study||30
226266|NCT00656513|543966|P1|NOT COMPLETED|Overall Study||4
226267|NCT00656513|543964|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
226268|NCT00656513|543965|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
226269|NCT00656513|543966|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
226270|NCT00656513|543964|P3|STARTED|Overall Study||75
226271|NCT00656513|543965|P2|STARTED|Overall Study||73
226272|NCT00656513|543966|P1|STARTED|Overall Study||48
226273|NCT00656487|543988|P3|NOT COMPLETED|Overall Study||0
226274|NCT00656487|543989|P2|NOT COMPLETED|Overall Study||4
226275|NCT00656487|543990|P1|NOT COMPLETED|Overall Study||2
226276|NCT00656487|543988|P3|COMPLETED|Overall Study||20
226277|NCT00656487|543989|P2|COMPLETED|Overall Study||19
226278|NCT00656487|543990|P1|COMPLETED|Overall Study||21
226279|NCT00656487|543988|P3|STARTED|Overall Study||20
226280|NCT00656487|543989|P2|STARTED|Overall Study||23
226281|NCT00656487|543990|P1|STARTED|Overall Study||23
226282|NCT00656474|544013|P1|NOT COMPLETED|Overall Study||1
226283|NCT00656474|544013|P1|COMPLETED|Overall Study||11
226284|NCT00656474|544013|P1|STARTED|Overall Study||12
226285|NCT00656448|544022|P2|NOT COMPLETED|Overall Study||0
226286|NCT00656448|544023|P1|NOT COMPLETED|Overall Study||0
226287|NCT00656448|544022|P2|COMPLETED|Overall Study||25
226288|NCT00656448|544023|P1|COMPLETED|Overall Study||25
226289|NCT00656448|544022|P2|STARTED|Overall Study||25
226290|NCT00656448|544023|P1|STARTED|Overall Study||25
226291|NCT00656370|544031|P1|NOT COMPLETED|Overall Study||10
226292|NCT00656370|544031|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1.|15
226293|NCT00656370|544031|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
226294|NCT00656292|544039|P2|NOT COMPLETED|Overall Study||5
226295|NCT00656292|544040|P1|NOT COMPLETED|Overall Study||3
226296|NCT00656292|544039|P2|COMPLETED|Overall Study||24
226297|NCT00656292|544040|P1|COMPLETED|Overall Study||29
226298|NCT00656292|544039|P2|STARTED|Overall Study||29
226299|NCT00656292|544040|P1|STARTED|Overall Study||32
226300|NCT00656201|544058|P2|NOT COMPLETED|Overall Study||32
226301|NCT00656201|544059|P1|NOT COMPLETED|Overall Study||29
226302|NCT00656201|544058|P2|COMPLETED|Overall Study||201
226303|NCT00656201|544059|P1|COMPLETED|Overall Study||206
226304|NCT00656201|544058|P2|STARTED|Overall Study||233
226305|NCT00656201|544059|P1|STARTED|Overall Study||235
226306|NCT00656175|544067|P2|NOT COMPLETED|Overall Study||1
226307|NCT00656175|544068|P1|NOT COMPLETED|Overall Study||1
226308|NCT00656175|544067|P2|COMPLETED|Overall Study||20
226309|NCT00656175|544068|P1|COMPLETED|Overall Study||17
226310|NCT00656175|544067|P2|STARTED|Overall Study||21
226311|NCT00656175|544068|P1|STARTED|Overall Study||18
226312|NCT00656136|544076|P2|NOT COMPLETED|Overall Study||390
226313|NCT00656136|544077|P1|NOT COMPLETED|Overall Study||195
226314|NCT00656136|544076|P2|COMPLETED|Overall Study||0
226315|NCT00656136|544077|P1|COMPLETED|Overall Study||0
226316|NCT00656136|544076|P2|STARTED|Overall Study|Randomised patients.|390
226317|NCT00656136|544077|P1|STARTED|Overall Study|Randomised patients.|195
226318|NCT00656084|544087|P1|NOT COMPLETED|Overall Study||7
226319|NCT00656084|544087|P1|COMPLETED|Overall Study||9
226320|NCT00656084|544087|P1|STARTED|Overall Study||16
226321|NCT00656058|544094|P1|NOT COMPLETED|Overall Study||6
226322|NCT00656058|544094|P1|COMPLETED|Overall Study||19
226323|NCT00656058|544094|P1|STARTED|Overall Study||25
226324|NCT00656019|544107|P4|NOT COMPLETED|Overall Study||0
226325|NCT00656019|544108|P3|NOT COMPLETED|Overall Study||0
226326|NCT00656019|544109|P2|NOT COMPLETED|Overall Study||1
226327|NCT00656019|544110|P1|NOT COMPLETED|Overall Study||14
226328|NCT00656019|544107|P4|COMPLETED|Overall Study||4
226329|NCT00656019|544108|P3|COMPLETED|Overall Study||11
226330|NCT00656019|544109|P2|COMPLETED|Overall Study||18
226331|NCT00656019|544110|P1|COMPLETED|Overall Study||15
226332|NCT00656019|544107|P4|STARTED|Overall Study||4
226333|NCT00656019|544108|P3|STARTED|Overall Study||11
226334|NCT00656019|544109|P2|STARTED|Overall Study||19
226335|NCT00656019|544110|P1|STARTED|Overall Study||29
226336|NCT00655889|544120|P1|NOT COMPLETED|Overall Study||2
226337|NCT00655889|544120|P1|COMPLETED|Overall Study||11
226338|NCT00655889|544120|P1|STARTED|Overall Study||13
226339|NCT00655876|544127|P2|NOT COMPLETED|Overall Study||7
226340|NCT00655876|544128|P1|NOT COMPLETED|Overall Study||9
226341|NCT00655876|544127|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
226342|NCT00655876|544128|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
226343|NCT00655876|544127|P2|STARTED|Overall Study||176
226344|NCT00655876|544128|P1|STARTED|Overall Study||168
226345|NCT00655863|544147|P3|NOT COMPLETED|Overall Study||1
226346|NCT00655863|544148|P2|NOT COMPLETED|Overall Study||0
226347|NCT00655863|544149|P1|NOT COMPLETED|Overall Study||0
226348|NCT00655863|544147|P3|COMPLETED|Overall Study||21
226349|NCT00655863|544148|P2|COMPLETED|Overall Study||25
226350|NCT00655863|544149|P1|COMPLETED|Overall Study||24
226351|NCT00655863|544147|P3|STARTED|Overall Study||22
226352|NCT00655863|544148|P2|STARTED|Overall Study||25
226353|NCT00655863|544149|P1|STARTED|Overall Study||24
226354|NCT00655850|544208|P1|NOT COMPLETED|Overall Study||3
226355|NCT00655850|544208|P1|COMPLETED|Overall Study||36
226356|NCT00655850|544208|P1|STARTED|Overall Study||39
226357|NCT00655824|544215|P1|NOT COMPLETED|Overall Study||84
226358|NCT00655824|544215|P1|COMPLETED|Overall Study||8
226359|NCT00655824|544215|P1|STARTED|Overall Study||92
226360|NCT00655811|544249|P1|NOT COMPLETED|Overall Study||0
226361|NCT00655811|544249|P1|COMPLETED|Overall Study||40
226362|NCT00655811|544249|P1|STARTED|Overall Study||40
226363|NCT00655746|544263|P1|NOT COMPLETED|Overall Study||1
226364|NCT00655746|544263|P1|COMPLETED|Overall Study||13
226365|NCT00655746|544263|P1|STARTED|Overall Study||14
226366|NCT00655733|544282|P2|NOT COMPLETED|Overall Study||8
226367|NCT00655733|544283|P1|NOT COMPLETED|Overall Study||7
226368|NCT00655733|544282|P2|COMPLETED|Overall Study||42
226369|NCT00655733|544283|P1|COMPLETED|Overall Study||44
226370|NCT00655733|544282|P2|STARTED|Overall Study||50
226371|NCT00655733|544283|P1|STARTED|Overall Study||51
226372|NCT00655668|544289|P1|NOT COMPLETED|Overall Study||54
226373|NCT00655668|544289|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
226374|NCT00655668|544289|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
226375|NCT00655642|544301|P4|NOT COMPLETED|Overall Study||2
226376|NCT00655642|544302|P3|NOT COMPLETED|Overall Study||2
226377|NCT00655642|544303|P2|NOT COMPLETED|Overall Study||3
226378|NCT00655642|544304|P1|NOT COMPLETED|Overall Study||1
226379|NCT00655642|544301|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
226380|NCT00655642|544302|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
226381|NCT00655642|544303|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
226382|NCT00655642|544304|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
226383|NCT00655642|544301|P4|STARTED|Overall Study||41
226384|NCT00655642|544302|P3|STARTED|Overall Study||45
226385|NCT00655642|544303|P2|STARTED|Overall Study||43
226386|NCT00655642|544304|P1|STARTED|Overall Study||42
226387|NCT00655629|544316|P2|NOT COMPLETED|Overall Study||23
226388|NCT00655629|544317|P1|NOT COMPLETED|Overall Study||21
226389|NCT00655629|544316|P2|COMPLETED|Overall Study||144
226390|NCT00655629|544317|P1|COMPLETED|Overall Study||151
226391|NCT00655629|544316|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
226392|NCT00655629|544317|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
226393|NCT00655629|544316|P2|STARTED|Overall Study||167
226394|NCT00655629|544317|P1|STARTED|Overall Study||172
226395|NCT00655564|544353|P1|NOT COMPLETED|Overall Study||3
226396|NCT00655564|544353|P1|COMPLETED|Overall Study||12
226397|NCT00655564|544353|P1|STARTED|Overall Study||15
226398|NCT00655551|544361|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
226399|NCT00655551|544362|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
226400|NCT00655551|544363|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
226401|NCT00655551|544361|P3|COMPLETED|Period 4 (up to 7 Days)||0
226402|NCT00655551|544362|P2|COMPLETED|Period 4 (up to 7 Days)||23
226403|NCT00655551|544363|P1|COMPLETED|Period 4 (up to 7 Days)||0
226404|NCT00655551|544361|P3|STARTED|Period 4 (up to 7 Days)||0
226405|NCT00655551|544362|P2|STARTED|Period 4 (up to 7 Days)||25
226406|NCT00655551|544363|P1|STARTED|Period 4 (up to 7 Days)||0
226407|NCT00655551|544361|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
226408|NCT00655551|544362|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
226409|NCT00655551|544363|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
226410|NCT00655551|544361|P3|COMPLETED|Period 3 (up to 7 Days)||21
226411|NCT00655551|544362|P2|COMPLETED|Period 3 (up to 7 Days)||0
226412|NCT00655551|544363|P1|COMPLETED|Period 3 (up to 7 Days)||0
226413|NCT00655551|544361|P3|STARTED|Period 3 (up to 7 Days)||25
226414|NCT00655551|544362|P2|STARTED|Period 3 (up to 7 Days)||0
226415|NCT00655551|544363|P1|STARTED|Period 3 (up to 7 Days)||0
226416|NCT00655551|544361|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
226417|NCT00655551|544362|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
226418|NCT00655551|544363|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
226419|NCT00655551|544361|P3|COMPLETED|Period 2 (up to 7 Days)||0
226420|NCT00655551|544362|P2|COMPLETED|Period 2 (up to 7 Days)||24
226421|NCT00655551|544363|P1|COMPLETED|Period 2 (up to 7 Days)||0
226422|NCT00655551|544361|P3|STARTED|Period 2 (up to 7 Days)||0
226423|NCT00655551|544362|P2|STARTED|Period 2 (up to 7 Days)||25
226424|NCT00655551|544363|P1|STARTED|Period 2 (up to 7 Days)||0
226425|NCT00655551|544361|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
226426|NCT00655551|544362|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
226427|NCT00655551|544363|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
226428|NCT00655551|544361|P3|COMPLETED|Period 1 (up to 7 Days)||0
226429|NCT00655551|544362|P2|COMPLETED|Period 1 (up to 7 Days)||0
226430|NCT00655551|544363|P1|COMPLETED|Period 1 (up to 7 Days)||25
226431|NCT00655551|544361|P3|STARTED|Period 1 (up to 7 Days)||0
226432|NCT00655551|544362|P2|STARTED|Period 1 (up to 7 Days)||0
226433|NCT00655551|544363|P1|STARTED|Period 1 (up to 7 Days)||25
226434|NCT00655551|544361|P3|NOT COMPLETED|All Periods Combined||4
226435|NCT00655551|544362|P2|NOT COMPLETED|All Periods Combined||3
226436|NCT00655551|544363|P1|NOT COMPLETED|All Periods Combined||0
226437|NCT00655551|544361|P3|COMPLETED|All Periods Combined||21
226438|NCT00655551|544362|P2|COMPLETED|All Periods Combined||47
226439|NCT00655551|544363|P1|COMPLETED|All Periods Combined||25
226440|NCT00655551|544361|P3|STARTED|All Periods Combined||25
226441|NCT00655551|544362|P2|STARTED|All Periods Combined||50
226442|NCT00655551|544363|P1|STARTED|All Periods Combined||25
226443|NCT00655486|544377|P1|NOT COMPLETED|Overall Study||28
226444|NCT00655486|544377|P1|COMPLETED|Overall Study||69
226445|NCT00655486|544377|P1|STARTED|Overall Study||97
226446|NCT00655356|544384|P2|NOT COMPLETED|Overall Study||10
226447|NCT00655356|544385|P1|NOT COMPLETED|Overall Study||17
226448|NCT00655356|544384|P2|COMPLETED|Overall Study||98
226449|NCT00655356|544385|P1|COMPLETED|Overall Study||93
226450|NCT00655356|544384|P2|STARTED|Overall Study||108
226451|NCT00655356|544385|P1|STARTED|Overall Study||110
226452|NCT00655083|544399|P2|NOT COMPLETED|Overall Study||0
226453|NCT00655083|544400|P1|NOT COMPLETED|Overall Study||0
226454|NCT00655083|544399|P2|COMPLETED|Overall Study||8
226455|NCT00655083|544400|P1|COMPLETED|Overall Study||12
226456|NCT00655083|544399|P2|STARTED|Overall Study||8
226457|NCT00655083|544400|P1|STARTED|Overall Study||12
226458|NCT00654992|544414|P2|NOT COMPLETED|Overall Study||0
226459|NCT00654992|544415|P1|NOT COMPLETED|Overall Study||0
226460|NCT00654992|544414|P2|COMPLETED|Overall Study||35
226461|NCT00654992|544415|P1|COMPLETED|Overall Study||36
226462|NCT00654992|544414|P2|STARTED|Overall Study||35
226463|NCT00654992|544415|P1|STARTED|Overall Study||36
226464|NCT00654953|544424|P3|NOT COMPLETED|Overall Study||22
226465|NCT00654953|544425|P2|NOT COMPLETED|Overall Study||28
226466|NCT00654953|544426|P1|NOT COMPLETED|Overall Study||30
226467|NCT00654953|544424|P3|COMPLETED|Overall Study||8
226468|NCT00654953|544425|P2|COMPLETED|Overall Study||8
226469|NCT00654953|544426|P1|COMPLETED|Overall Study||6
226470|NCT00654953|544424|P3|STARTED|Overall Study||30
226471|NCT00654953|544425|P2|STARTED|Overall Study||36
226472|NCT00654953|544426|P1|STARTED|Overall Study||36
226473|NCT00654940|544436|P2|NOT COMPLETED|Period 2||0
226474|NCT00654940|544437|P1|NOT COMPLETED|Period 2||0
226475|NCT00654940|544436|P2|COMPLETED|Period 2||11
226476|NCT00654940|544437|P1|COMPLETED|Period 2||12
226477|NCT00654940|544436|P2|STARTED|Period 2||11
226478|NCT00654940|544437|P1|STARTED|Period 2||12
226479|NCT00654940|544436|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
226480|NCT00654940|544437|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
226481|NCT00654940|544436|P2|COMPLETED|Washout Period of 2 Weeks||11
226482|NCT00654940|544437|P1|COMPLETED|Washout Period of 2 Weeks||12
226483|NCT00654940|544436|P2|STARTED|Washout Period of 2 Weeks||11
226484|NCT00654940|544437|P1|STARTED|Washout Period of 2 Weeks||12
226485|NCT00654940|544436|P2|NOT COMPLETED|Period 1||1
226486|NCT00654940|544437|P1|NOT COMPLETED|Period 1||1
226487|NCT00654940|544436|P2|COMPLETED|Period 1||11
226488|NCT00654940|544437|P1|COMPLETED|Period 1||12
226489|NCT00654940|544436|P2|Received Study Treatment|Period 1||12
226490|NCT00654940|544437|P1|Received Study Treatment|Period 1||12
226491|NCT00654940|544436|P2|STARTED|Period 1|Assigned to study treatment.|12
226492|NCT00654940|544437|P1|STARTED|Period 1|Assigned to study treatment.|13
226493|NCT00654927|544449|P1|NOT COMPLETED|Overall Study||107
226494|NCT00654927|544449|P1|COMPLETED|Overall Study||70
226495|NCT00654927|544449|P1|STARTED|Overall Study||177
226496|NCT00654901|544461|P4|NOT COMPLETED|Overall Study||0
226497|NCT00654901|544462|P3|NOT COMPLETED|Overall Study||2
226498|NCT00654901|544463|P2|NOT COMPLETED|Overall Study||0
226499|NCT00654901|544464|P1|NOT COMPLETED|Overall Study||4
226500|NCT00654901|544461|P4|COMPLETED|Overall Study||113
226501|NCT00654901|544462|P3|COMPLETED|Overall Study||250
226502|NCT00654901|544463|P2|COMPLETED|Overall Study||262
226503|NCT00654901|544464|P1|COMPLETED|Overall Study||250
226504|NCT00654901|544461|P4|STARTED|Overall Study||113
226505|NCT00654901|544462|P3|STARTED|Overall Study||252
226506|NCT00654901|544463|P2|STARTED|Overall Study||262
226507|NCT00654901|544464|P1|STARTED|Overall Study||254
226508|NCT00654875|544484|P2|NOT COMPLETED|Overall Study||17
226509|NCT00654875|544485|P1|NOT COMPLETED|Overall Study||17
226510|NCT00654875|544484|P2|COMPLETED|Overall Study||147
226511|NCT00654875|544485|P1|COMPLETED|Overall Study||147
226512|NCT00654875|544484|P2|STARTED|Overall Study||164
226513|NCT00654875|544485|P1|STARTED|Overall Study||164
226514|NCT00654836|544503|P1|NOT COMPLETED|Overall Study||0
226515|NCT00654836|544503|P1|COMPLETED|Overall Study||32
226516|NCT00654836|544503|P1|STARTED|Overall Study||32
226517|NCT00654784|544511|P2|NOT COMPLETED|Overall Study||0
226518|NCT00654784|544512|P1|NOT COMPLETED|Overall Study||0
226519|NCT00654784|544511|P2|COMPLETED|Overall Study||8
226520|NCT00654784|544512|P1|COMPLETED|Overall Study||13
226521|NCT00654784|544511|P2|STARTED|Overall Study||8
226522|NCT00654784|544512|P1|STARTED|Overall Study||13
226523|NCT00654745|544518|P1|NOT COMPLETED|Overall Study||43
226524|NCT00654745|544518|P1|COMPLETED|Overall Study||164
226525|NCT00654745|544518|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
226526|NCT00654654|544556|P1|NOT COMPLETED|Overall Study||7
226527|NCT00654654|544556|P1|COMPLETED|Overall Study||43
226528|NCT00654654|544556|P1|STARTED|Overall Study||50
226529|NCT00654641|544563|P2|NOT COMPLETED|Overall Study||3
226530|NCT00654641|544564|P1|NOT COMPLETED|Overall Study||2
226531|NCT00654641|544563|P2|COMPLETED|Overall Study||23
226532|NCT00654641|544564|P1|COMPLETED|Overall Study||26
226533|NCT00654641|544563|P2|STARTED|Overall Study||26
226534|NCT00654641|544564|P1|STARTED|Overall Study||28
226535|NCT00654628|544570|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
226536|NCT00654628|544570|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
226537|NCT00654628|544570|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
226538|NCT00654628|544570|P1|NOT COMPLETED|6-week Active Treatment Period||21
226539|NCT00654628|544570|P1|COMPLETED|6-week Active Treatment Period||152
226540|NCT00654628|544570|P1|STARTED|6-week Active Treatment Period||173
226541|NCT00654615|544587|P2|NOT COMPLETED|Overall Study||7
226542|NCT00654615|544588|P1|NOT COMPLETED|Overall Study||8
226543|NCT00654615|544587|P2|COMPLETED|Overall Study||23
226544|NCT00654615|544588|P1|COMPLETED|Overall Study||22
226545|NCT00654615|544587|P2|STARTED|Overall Study||30
226546|NCT00654615|544588|P1|STARTED|Overall Study||30
226547|NCT00654511|544600|P4|NOT COMPLETED|Overall Study||0
226548|NCT00654511|544601|P3|NOT COMPLETED|Overall Study||0
226549|NCT00654511|544602|P2|NOT COMPLETED|Overall Study||0
226550|NCT00654511|544603|P1|NOT COMPLETED|Overall Study||0
226551|NCT00654511|544600|P4|COMPLETED|Overall Study||25
226552|NCT00654511|544601|P3|COMPLETED|Overall Study||25
226553|NCT00654511|544602|P2|COMPLETED|Overall Study||25
226554|NCT00654511|544603|P1|COMPLETED|Overall Study||26
226555|NCT00654511|544600|P4|STARTED|Overall Study||25
226556|NCT00654511|544601|P3|STARTED|Overall Study||25
226557|NCT00654511|544602|P2|STARTED|Overall Study||25
226558|NCT00654511|544603|P1|STARTED|Overall Study||26
226559|NCT00654498|544619|P2|NOT COMPLETED|Overall Study||12
226560|NCT00654498|544620|P1|NOT COMPLETED|Overall Study||14
226561|NCT00654498|544619|P2|COMPLETED|Overall Study||91
226562|NCT00654498|544620|P1|COMPLETED|Overall Study||189
226563|NCT00654498|544619|P2|STARTED|Overall Study||103
226564|NCT00654498|544620|P1|STARTED|Overall Study||203
226565|NCT00654420|544652|P4|NOT COMPLETED|Phase II||38
226566|NCT00654420|544653|P3|NOT COMPLETED|Phase II||37
226567|NCT00654420|544654|P2|NOT COMPLETED|Phase II||0
226568|NCT00654420|544655|P1|NOT COMPLETED|Phase II||0
226569|NCT00654420|544652|P4|COMPLETED|Phase II||0
226570|NCT00654420|544653|P3|COMPLETED|Phase II||0
226571|NCT00654420|544654|P2|COMPLETED|Phase II||0
226572|NCT00654420|544655|P1|COMPLETED|Phase II||0
226573|NCT00654420|544652|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
226574|NCT00654420|544653|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
226575|NCT00654420|544654|P2|STARTED|Phase II||0
226576|NCT00654420|544655|P1|STARTED|Phase II||0
226577|NCT00654420|544652|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
226578|NCT00654420|544653|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
226579|NCT00654420|544654|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
226580|NCT00654420|544655|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
226581|NCT00654420|544652|P4|COMPLETED|Phase I (Dose Escalation)||0
226582|NCT00654420|544653|P3|COMPLETED|Phase I (Dose Escalation)||0
226583|NCT00654420|544654|P2|COMPLETED|Phase I (Dose Escalation)||0
226584|NCT00654420|544655|P1|COMPLETED|Phase I (Dose Escalation)||0
226585|NCT00654420|544652|P4|STARTED|Phase I (Dose Escalation)||0
226586|NCT00654420|544653|P3|STARTED|Phase I (Dose Escalation)||0
226587|NCT00654420|544654|P2|STARTED|Phase I (Dose Escalation)||16
226588|NCT00654420|544655|P1|STARTED|Phase I (Dose Escalation)||4
226589|NCT00654381|544681|P6|NOT COMPLETED|Extension Stage||3
226590|NCT00654381|544682|P5|NOT COMPLETED|Extension Stage||3
226591|NCT00654381|544683|P4|NOT COMPLETED|Extension Stage||9
226592|NCT00654381|544684|P3|NOT COMPLETED|Extension Stage||11
226593|NCT00654381|544685|P2|NOT COMPLETED|Extension Stage||2
226594|NCT00654381|544686|P1|NOT COMPLETED|Extension Stage||1
226595|NCT00654381|544681|P6|COMPLETED|Extension Stage||73
226596|NCT00654381|544682|P5|COMPLETED|Extension Stage||68
226597|NCT00654381|544683|P4|COMPLETED|Extension Stage||142
226598|NCT00654381|544684|P3|COMPLETED|Extension Stage||142
226599|NCT00654381|544685|P2|COMPLETED|Extension Stage||36
226600|NCT00654381|544686|P1|COMPLETED|Extension Stage||33
226601|NCT00654381|544681|P6|STARTED|Extension Stage||76
226602|NCT00654381|544682|P5|STARTED|Extension Stage||71
226603|NCT00654381|544683|P4|STARTED|Extension Stage||151
226604|NCT00654381|544684|P3|STARTED|Extension Stage||153
226605|NCT00654381|544685|P2|STARTED|Extension Stage||38
226606|NCT00654381|544686|P1|STARTED|Extension Stage||34
226607|NCT00654381|544681|P6|NOT COMPLETED|2nd Stage||3
226608|NCT00654381|544682|P5|NOT COMPLETED|2nd Stage||8
226609|NCT00654381|544683|P4|NOT COMPLETED|2nd Stage||4
226610|NCT00654381|544684|P3|NOT COMPLETED|2nd Stage||3
226611|NCT00654381|544685|P2|NOT COMPLETED|2nd Stage||0
226612|NCT00654381|544686|P1|NOT COMPLETED|2nd Stage||2
226613|NCT00654381|544681|P6|COMPLETED|2nd Stage||76
226614|NCT00654381|544682|P5|COMPLETED|2nd Stage||71
226615|NCT00654381|544683|P4|COMPLETED|2nd Stage||151
226616|NCT00654381|544684|P3|COMPLETED|2nd Stage||153
226617|NCT00654381|544685|P2|COMPLETED|2nd Stage||38
226618|NCT00654381|544686|P1|COMPLETED|2nd Stage||34
226619|NCT00654381|544681|P6|STARTED|2nd Stage||79
226620|NCT00654381|544682|P5|STARTED|2nd Stage||79
226621|NCT00654381|544683|P4|STARTED|2nd Stage||155
226622|NCT00654381|544684|P3|STARTED|2nd Stage||156
226623|NCT00654381|544685|P2|STARTED|2nd Stage||38
226624|NCT00654381|544686|P1|STARTED|2nd Stage||36
226625|NCT00654381|544681|P6|NOT COMPLETED|1st Stage||2
226626|NCT00654381|544682|P5|NOT COMPLETED|1st Stage||2
226627|NCT00654381|544683|P4|NOT COMPLETED|1st Stage||5
226628|NCT00654381|544684|P3|NOT COMPLETED|1st Stage||3
226629|NCT00654381|544685|P2|NOT COMPLETED|1st Stage||3
226630|NCT00654381|544686|P1|NOT COMPLETED|1st Stage||3
226631|NCT00654381|544681|P6|COMPLETED|1st Stage||79
226632|NCT00654381|544682|P5|COMPLETED|1st Stage||79
226633|NCT00654381|544683|P4|COMPLETED|1st Stage||155
226634|NCT00654381|544684|P3|COMPLETED|1st Stage||156
226635|NCT00654381|544685|P2|COMPLETED|1st Stage||38
226636|NCT00654381|544686|P1|COMPLETED|1st Stage||36
226637|NCT00654381|544681|P6|STARTED|1st Stage||81
226638|NCT00654381|544682|P5|STARTED|1st Stage||81
226639|NCT00654381|544683|P4|STARTED|1st Stage||160
226640|NCT00654381|544684|P3|STARTED|1st Stage||159
226641|NCT00654381|544685|P2|STARTED|1st Stage||41
226642|NCT00654381|544686|P1|STARTED|1st Stage||39
226643|NCT00654368|544723|P3|NOT COMPLETED|Overall Study||32
226644|NCT00654368|544724|P2|NOT COMPLETED|Overall Study||48
226645|NCT00654368|544725|P1|NOT COMPLETED|Overall Study||53
226646|NCT00654368|544723|P3|COMPLETED|Overall Study||75
226647|NCT00654368|544724|P2|COMPLETED|Overall Study||50
226648|NCT00654368|544725|P1|COMPLETED|Overall Study||0
226649|NCT00654368|544723|P3|STARTED|Overall Study||107
226650|NCT00654368|544724|P2|STARTED|Overall Study||98
226651|NCT00654368|544725|P1|STARTED|Overall Study||53
226652|NCT00654355|544758|P2|NOT COMPLETED|Overall Study||2
226653|NCT00654355|544759|P1|NOT COMPLETED|Overall Study||2
226654|NCT00654355|544758|P2|COMPLETED|Overall Study||13
226655|NCT00654355|544759|P1|COMPLETED|Overall Study||13
226656|NCT00654355|544758|P2|STARTED|Overall Study||15
226657|NCT00654355|544759|P1|STARTED|Overall Study||15
226658|NCT00654329|544773|P4|NOT COMPLETED|Overall Study||0
226659|NCT00654329|544774|P3|NOT COMPLETED|Overall Study||0
226660|NCT00654329|544775|P2|NOT COMPLETED|Overall Study||0
226661|NCT00654329|544776|P1|NOT COMPLETED|Overall Study||0
226662|NCT00654329|544773|P4|COMPLETED|Overall Study||27
226663|NCT00654329|544774|P3|COMPLETED|Overall Study||23
226664|NCT00654329|544775|P2|COMPLETED|Overall Study||28
226665|NCT00654329|544776|P1|COMPLETED|Overall Study||23
226666|NCT00654329|544773|P4|STARTED|Overall Study||27
226667|NCT00654329|544774|P3|STARTED|Overall Study||23
226668|NCT00654329|544775|P2|STARTED|Overall Study||28
226669|NCT00654329|544776|P1|STARTED|Overall Study||23
226670|NCT00654186|544790|P1|NOT COMPLETED|Overall Study||5
226671|NCT00654186|544790|P1|COMPLETED|Overall Study||27
226672|NCT00654186|544790|P1|STARTED|Overall Study||32
226673|NCT00654147|544798|P2|NOT COMPLETED|Overall Study||4
226674|NCT00654147|544799|P1|NOT COMPLETED|Overall Study||2
226675|NCT00654147|544798|P2|COMPLETED|Overall Study||19
226676|NCT00654147|544799|P1|COMPLETED|Overall Study||19
226677|NCT00654147|544798|P2|STARTED|Overall Study||23
226678|NCT00654147|544799|P1|STARTED|Overall Study||21
226679|NCT00654095|544815|P1|NOT COMPLETED|Overall Study||32
226680|NCT00654095|544815|P1|COMPLETED|Overall Study||114
226681|NCT00654095|544815|P1|STARTED|Overall Study||146
226682|NCT00654030|544819|P1|NOT COMPLETED|Overall Study||1
226683|NCT00654030|544819|P1|COMPLETED|Overall Study||11
226684|NCT00654030|544819|P1|STARTED|Overall Study||12
226685|NCT00654004|544825|P2|NOT COMPLETED|Overall Study||0
226686|NCT00654004|544826|P1|NOT COMPLETED|Overall Study||1
226687|NCT00654004|544825|P2|COMPLETED|Overall Study||12
226688|NCT00654004|544826|P1|COMPLETED|Overall Study||13
226689|NCT00654004|544825|P2|STARTED|Overall Study||12
226690|NCT00654004|544826|P1|STARTED|Overall Study||14
226691|NCT00653939|544842|P2|NOT COMPLETED|Overall Study||15
226692|NCT00653939|544843|P1|NOT COMPLETED|Overall Study||12
226693|NCT00653939|544842|P2|COMPLETED|Overall Study||17
226694|NCT00653939|544843|P1|COMPLETED|Overall Study||19
226695|NCT00653939|544842|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
226696|NCT00653939|544843|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
226697|NCT00653861|544859|P1|NOT COMPLETED|Overall Study||0
226698|NCT00653861|544859|P1|COMPLETED|Overall Study||72
226699|NCT00653861|544859|P1|STARTED|Overall Study||72
226700|NCT00653523|544868|P1|NOT COMPLETED|Overall Study||19
226701|NCT00653523|544868|P1|COMPLETED|Overall Study||132
226702|NCT00653523|544868|P1|STARTED|Overall Study||151
226703|NCT00653328|544872|P1|NOT COMPLETED|Overall Study||15
226704|NCT00653328|544872|P1|COMPLETED|Overall Study||0
226705|NCT00653328|544872|P1|STARTED|Overall Study||15
226706|NCT00653263|544879|P1|NOT COMPLETED|Overall Study||2
226707|NCT00653263|544879|P1|COMPLETED|Overall Study||6
226708|NCT00653263|544879|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
226709|NCT00653224|544887|P2|NOT COMPLETED|Overall Study||7
226710|NCT00653224|544888|P1|NOT COMPLETED|Overall Study||7
226711|NCT00653224|544887|P2|COMPLETED|Overall Study||280
226712|NCT00653224|544888|P1|COMPLETED|Overall Study||286
226713|NCT00653224|544887|P2|STARTED|Overall Study||287
226714|NCT00653224|544888|P1|STARTED|Overall Study||293
226715|NCT00653159|545074|P2|NOT COMPLETED|Overall Study||3
226716|NCT00653159|545075|P1|NOT COMPLETED|Overall Study||5
226717|NCT00653159|545074|P2|COMPLETED|Overall Study||9
226718|NCT00653159|545075|P1|COMPLETED|Overall Study||6
226719|NCT00653159|545074|P2|STARTED|Overall Study||12
226720|NCT00653159|545075|P1|STARTED|Overall Study||11
226721|NCT00653133|545091|P2|NOT COMPLETED|Overall Study||0
226722|NCT00653133|545092|P1|NOT COMPLETED|Overall Study||0
226723|NCT00653133|545091|P2|COMPLETED|Overall Study||497
226724|NCT00653133|545092|P1|COMPLETED|Overall Study||1324
226725|NCT00653133|545091|P2|STARTED|Overall Study||497
226726|NCT00653133|545092|P1|STARTED|Overall Study||1324
226727|NCT00653068|545102|P1|NOT COMPLETED|Overall Study||50
226728|NCT00653068|545102|P1|COMPLETED|Overall Study||20
226729|NCT00653068|545102|P1|STARTED|Overall Study||70
226730|NCT00652938|545116|P3|NOT COMPLETED|Overall Study||5
226731|NCT00652938|545117|P2|NOT COMPLETED|Overall Study||7
226732|NCT00652938|545118|P1|NOT COMPLETED|Overall Study||1
226733|NCT00652938|545116|P3|COMPLETED|Overall Study||242
226734|NCT00652938|545117|P2|COMPLETED|Overall Study||240
226735|NCT00652938|545118|P1|COMPLETED|Overall Study||246
226736|NCT00652938|545116|P3|STARTED|Overall Study||247
226737|NCT00652938|545117|P2|STARTED|Overall Study||247
226738|NCT00652938|545118|P1|STARTED|Overall Study||247
226739|NCT00652899|545183|P1|NOT COMPLETED|Overall Study||2
226740|NCT00652899|545183|P1|COMPLETED|Overall Study||12
226741|NCT00652899|545183|P1|STARTED|Overall Study||14
226742|NCT00652834|545193|P1|NOT COMPLETED|Overall Study||5
226743|NCT00652834|545193|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
226744|NCT00652834|545193|P1|STARTED|Overall Study||23
226745|NCT00652626|545204|P7|NOT COMPLETED|Extension Phase||3
226746|NCT00652626|545205|P6|NOT COMPLETED|Extension Phase||12
226747|NCT00652626|545206|P5|NOT COMPLETED|Extension Phase||0
226748|NCT00652626|545207|P4|NOT COMPLETED|Extension Phase||0
226749|NCT00652626|545208|P3|NOT COMPLETED|Extension Phase||0
226750|NCT00652626|545209|P2|NOT COMPLETED|Extension Phase||0
226751|NCT00652626|545210|P1|NOT COMPLETED|Extension Phase||0
226752|NCT00652626|545204|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
226753|NCT00652626|545205|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
226754|NCT00652626|545206|P5|COMPLETED|Extension Phase||0
226755|NCT00652626|545207|P4|COMPLETED|Extension Phase||0
226756|NCT00652626|545208|P3|COMPLETED|Extension Phase||0
226757|NCT00652626|545209|P2|COMPLETED|Extension Phase||0
226758|NCT00652626|545210|P1|COMPLETED|Extension Phase||0
226759|NCT00652626|545204|P7|STARTED|Extension Phase||4
226760|NCT00652626|545205|P6|STARTED|Extension Phase||14
226761|NCT00652626|545206|P5|STARTED|Extension Phase||0
226762|NCT00652626|545207|P4|STARTED|Extension Phase||0
226763|NCT00652626|545208|P3|STARTED|Extension Phase||0
226764|NCT00652626|545209|P2|STARTED|Extension Phase||0
226765|NCT00652626|545210|P1|STARTED|Extension Phase||0
226766|NCT00652626|545204|P7|NOT COMPLETED|Initial Treatment Phase||0
226767|NCT00652626|545205|P6|NOT COMPLETED|Initial Treatment Phase||0
226768|NCT00652626|545206|P5|NOT COMPLETED|Initial Treatment Phase||3
226769|NCT00652626|545207|P4|NOT COMPLETED|Initial Treatment Phase||1
226770|NCT00652626|545208|P3|NOT COMPLETED|Initial Treatment Phase||1
226771|NCT00652626|545209|P2|NOT COMPLETED|Initial Treatment Phase||0
226772|NCT00652626|545210|P1|NOT COMPLETED|Initial Treatment Phase||0
226773|NCT00652626|545204|P7|COMPLETED|Initial Treatment Phase||0
226774|NCT00652626|545205|P6|COMPLETED|Initial Treatment Phase||0
226775|NCT00652626|545206|P5|COMPLETED|Initial Treatment Phase||5
226776|NCT00652626|545207|P4|COMPLETED|Initial Treatment Phase||5
226777|NCT00652626|545208|P3|COMPLETED|Initial Treatment Phase||6
226778|NCT00652626|545209|P2|COMPLETED|Initial Treatment Phase||5
226779|NCT00652626|545210|P1|COMPLETED|Initial Treatment Phase||5
226780|NCT00652626|545204|P7|Received Study Drug|Initial Treatment Phase||0
226781|NCT00652626|545205|P6|Received Study Drug|Initial Treatment Phase||0
226782|NCT00652626|545206|P5|Received Study Drug|Initial Treatment Phase||6
226783|NCT00652626|545207|P4|Received Study Drug|Initial Treatment Phase||5
226784|NCT00652626|545208|P3|Received Study Drug|Initial Treatment Phase||6
226785|NCT00652626|545209|P2|Received Study Drug|Initial Treatment Phase||5
226786|NCT00652626|545210|P1|Received Study Drug|Initial Treatment Phase||5
226787|NCT00652626|545204|P7|STARTED|Initial Treatment Phase||0
226788|NCT00652626|545205|P6|STARTED|Initial Treatment Phase||0
226789|NCT00652626|545206|P5|STARTED|Initial Treatment Phase||8
226790|NCT00652626|545207|P4|STARTED|Initial Treatment Phase||6
226791|NCT00652626|545208|P3|STARTED|Initial Treatment Phase||7
226792|NCT00652626|545209|P2|STARTED|Initial Treatment Phase||5
226793|NCT00652626|545210|P1|STARTED|Initial Treatment Phase||5
226794|NCT00652366|545279|P5|NOT COMPLETED|Overall Study||36
226795|NCT00652366|545280|P4|NOT COMPLETED|Overall Study||179
226796|NCT00652366|545281|P3|NOT COMPLETED|Overall Study||71
226797|NCT00652366|545282|P2|NOT COMPLETED|Overall Study||75
226798|NCT00652366|545283|P1|NOT COMPLETED|Overall Study||106
226799|NCT00652366|545279|P5|COMPLETED|Overall Study||0
226800|NCT00652366|545280|P4|COMPLETED|Overall Study||0
226801|NCT00652366|545281|P3|COMPLETED|Overall Study||0
226802|NCT00652366|545282|P2|COMPLETED|Overall Study||0
226803|NCT00652366|545283|P1|COMPLETED|Overall Study||0
226804|NCT00652366|545279|P5|STARTED|Overall Study||36
226805|NCT00652366|545280|P4|STARTED|Overall Study||179
226806|NCT00652366|545281|P3|STARTED|Overall Study||71
226807|NCT00652366|545282|P2|STARTED|Overall Study||75
226808|NCT00652366|545283|P1|STARTED|Overall Study||106
226809|NCT00652340|545318|P2|NOT COMPLETED|Overall Study||3
226810|NCT00652340|545319|P1|NOT COMPLETED|Overall Study||4
226811|NCT00652340|545318|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
226812|NCT00652340|545319|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
226813|NCT00652340|545318|P2|STARTED|Overall Study||42
226814|NCT00652340|545319|P1|STARTED|Overall Study||78
226815|NCT00652327|545329|P2|NOT COMPLETED|Overall Study||5
226816|NCT00652327|545330|P1|NOT COMPLETED|Overall Study||0
226817|NCT00652327|545329|P2|COMPLETED|Overall Study||36
226818|NCT00652327|545330|P1|COMPLETED|Overall Study||42
226819|NCT00652327|545329|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
226820|NCT00652327|545330|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
226821|NCT00652314|545338|P2|NOT COMPLETED|Overall Study||9
226822|NCT00652314|545339|P1|NOT COMPLETED|Overall Study||9
226823|NCT00652314|545338|P2|COMPLETED|Overall Study||26
226824|NCT00652314|545339|P1|COMPLETED|Overall Study||53
226825|NCT00652314|545338|P2|STARTED|Overall Study||35
226826|NCT00652314|545339|P1|STARTED|Overall Study||62
226827|NCT00652145|545355|P2|NOT COMPLETED|Overall Study||0
226828|NCT00652145|545356|P1|NOT COMPLETED|Overall Study||0
226829|NCT00652145|545355|P2|COMPLETED|Overall Study||26
226830|NCT00652145|545356|P1|COMPLETED|Overall Study||26
226831|NCT00652145|545355|P2|STARTED|Overall Study||26
226832|NCT00652145|545356|P1|STARTED|Overall Study||26
226833|NCT00652093|545372|P6|NOT COMPLETED|Overall Study||0
226834|NCT00652093|545373|P5|NOT COMPLETED|Overall Study||2
226835|NCT00652093|545374|P4|NOT COMPLETED|Overall Study||0
226836|NCT00652093|545375|P3|NOT COMPLETED|Overall Study||1
226837|NCT00652093|545376|P2|NOT COMPLETED|Overall Study||0
226838|NCT00652093|545377|P1|NOT COMPLETED|Overall Study||0
226839|NCT00652093|545372|P6|COMPLETED|Overall Study||4
226840|NCT00652093|545373|P5|COMPLETED|Overall Study||2
226841|NCT00652093|545374|P4|COMPLETED|Overall Study||4
226842|NCT00652093|545375|P3|COMPLETED|Overall Study||3
226843|NCT00652093|545376|P2|COMPLETED|Overall Study||4
226844|NCT00652093|545377|P1|COMPLETED|Overall Study||4
226845|NCT00652093|545372|P6|STARTED|Overall Study||4
226846|NCT00652093|545373|P5|STARTED|Overall Study||4
226847|NCT00652093|545374|P4|STARTED|Overall Study||4
226848|NCT00652093|545375|P3|STARTED|Overall Study||4
226849|NCT00652093|545376|P2|STARTED|Overall Study||4
226850|NCT00652093|545377|P1|STARTED|Overall Study||4
226851|NCT00652028|545461|P4|NOT COMPLETED|Overall Study||0
226852|NCT00652028|545462|P3|NOT COMPLETED|Overall Study||1
226853|NCT00652028|545463|P2|NOT COMPLETED|Overall Study||1
226854|NCT00652028|545464|P1|NOT COMPLETED|Overall Study||1
226855|NCT00652028|545461|P4|COMPLETED|Overall Study||14
226856|NCT00652028|545462|P3|COMPLETED|Overall Study||14
226857|NCT00652028|545463|P2|COMPLETED|Overall Study||13
226858|NCT00652028|545464|P1|COMPLETED|Overall Study||15
226859|NCT00652028|545461|P4|STARTED|Overall Study||14
226860|NCT00652028|545462|P3|STARTED|Overall Study||15
226861|NCT00652028|545463|P2|STARTED|Overall Study||14
226862|NCT00652028|545464|P1|STARTED|Overall Study||16
226863|NCT00651924|545508|P2|NOT COMPLETED|Overall Study||7
226864|NCT00651924|545509|P1|NOT COMPLETED|Overall Study||0
226865|NCT00651924|545508|P2|COMPLETED|Overall Study||2
226866|NCT00651924|545509|P1|COMPLETED|Overall Study||18
226867|NCT00651924|545508|P2|STARTED|Overall Study||9
226868|NCT00651924|545509|P1|STARTED|Overall Study||18
226869|NCT00651820|545515|P1|NOT COMPLETED|Overall Study||2
226870|NCT00651820|545515|P1|COMPLETED|Overall Study||26
226871|NCT00651820|545515|P1|STARTED|Overall Study||28
226872|NCT00651794|545525|P3|NOT COMPLETED|Overall Study||21
226873|NCT00651794|545526|P2|NOT COMPLETED|Overall Study||22
226874|NCT00651794|545527|P1|NOT COMPLETED|Overall Study||21
226875|NCT00651794|545525|P3|COMPLETED|Overall Study||10
226876|NCT00651794|545526|P2|COMPLETED|Overall Study||9
226877|NCT00651794|545527|P1|COMPLETED|Overall Study||15
226878|NCT00651794|545525|P3|STARTED|Overall Study||31
226879|NCT00651794|545526|P2|STARTED|Overall Study||31
226880|NCT00651794|545527|P1|STARTED|Overall Study||36
226881|NCT00651755|545547|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
226882|NCT00651755|545548|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
226883|NCT00651755|545547|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
226884|NCT00651755|545548|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
226885|NCT00651755|545547|P2|STARTED|Cycle 2 (Second 21 Days)||9
226886|NCT00651755|545548|P1|STARTED|Cycle 2 (Second 21 Days)||10
226887|NCT00651755|545547|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
226888|NCT00651755|545548|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
226889|NCT00651755|545547|P2|COMPLETED|Cycle 1 (First 21 Days)||9
226890|NCT00651755|545548|P1|COMPLETED|Cycle 1 (First 21 Days)||10
226891|NCT00651755|545547|P2|STARTED|Cycle 1 (First 21 Days)||9
226892|NCT00651755|545548|P1|STARTED|Cycle 1 (First 21 Days)||11
226893|NCT00651625|545566|P2|NOT COMPLETED|Overall Study||0
226894|NCT00651625|545567|P1|NOT COMPLETED|Overall Study||0
226895|NCT00651625|545566|P2|COMPLETED|Overall Study||218
226896|NCT00651625|545567|P1|COMPLETED|Overall Study||219
226897|NCT00651625|545566|P2|STARTED|Overall Study||218
226898|NCT00651625|545567|P1|STARTED|Overall Study||219
226899|NCT00651482|545579|P1|NOT COMPLETED|Overall Study||0
226900|NCT00651482|545579|P1|COMPLETED|Overall Study||10
226901|NCT00651482|545579|P1|STARTED|Overall Study||10
226902|NCT00651313|545593|P2|NOT COMPLETED|Overall Study||6
226903|NCT00651313|545594|P1|NOT COMPLETED|Overall Study||6
226904|NCT00651313|545593|P2|COMPLETED|Overall Study||37
226905|NCT00651313|545594|P1|COMPLETED|Overall Study||35
226906|NCT00651313|545593|P2|STARTED|Overall Study||43
226907|NCT00651313|545594|P1|STARTED|Overall Study||41
226908|NCT00651261|545602|P2|NOT COMPLETED|Overall Study||306
226909|NCT00651261|545603|P1|NOT COMPLETED|Overall Study||291
226910|NCT00651261|545602|P2|COMPLETED|Overall Study||51
226911|NCT00651261|545603|P1|COMPLETED|Overall Study||69
226912|NCT00651261|545602|P2|STARTED|Overall Study||357
226913|NCT00651261|545603|P1|STARTED|Overall Study||360
226914|NCT00651183|545619|P2|NOT COMPLETED|Overall Study||10
226915|NCT00651183|545620|P1|NOT COMPLETED|Overall Study||20
226916|NCT00651183|545619|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
227007|NCT00650091|546341|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
226917|NCT00651183|545620|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
226918|NCT00651183|545619|P2|STARTED|Overall Study||97
226919|NCT00651183|545620|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
226920|NCT00651157|545632|P1|NOT COMPLETED|Overall Study||2
226921|NCT00651157|545632|P1|COMPLETED|Overall Study||21
226922|NCT00651157|545632|P1|STARTED|Overall Study||23
226923|NCT00651118|545642|P4|NOT COMPLETED|Overall Study||7
226924|NCT00651118|545643|P3|NOT COMPLETED|Overall Study||11
226925|NCT00651118|545644|P2|NOT COMPLETED|Overall Study||7
226926|NCT00651118|545645|P1|NOT COMPLETED|Overall Study||9
226927|NCT00651118|545642|P4|COMPLETED|Overall Study||203
226928|NCT00651118|545643|P3|COMPLETED|Overall Study||197
226929|NCT00651118|545644|P2|COMPLETED|Overall Study||200
226930|NCT00651118|545645|P1|COMPLETED|Overall Study||198
226931|NCT00651118|545642|P4|STARTED|Overall Study||210
226932|NCT00651118|545643|P3|STARTED|Overall Study||208
226933|NCT00651118|545644|P2|STARTED|Overall Study||207
226934|NCT00651118|545645|P1|STARTED|Overall Study||207
226935|NCT00651040|545665|P2|NOT COMPLETED|Overall Study||1
226936|NCT00651040|545666|P1|NOT COMPLETED|Overall Study||3
226937|NCT00651040|545665|P2|COMPLETED|Overall Study||14
226938|NCT00651040|545666|P1|COMPLETED|Overall Study||13
226939|NCT00651040|545665|P2|STARTED|Overall Study||15
226940|NCT00651040|545666|P1|STARTED|Overall Study||16
226941|NCT00650858|545675|P3|NOT COMPLETED|Overall Study||0
226942|NCT00650858|545676|P2|NOT COMPLETED|Overall Study||0
226943|NCT00650858|545677|P1|NOT COMPLETED|Overall Study||0
226944|NCT00650858|545675|P3|COMPLETED|Overall Study||36
226945|NCT00650858|545676|P2|COMPLETED|Overall Study||8
226946|NCT00650858|545677|P1|COMPLETED|Overall Study||8
226947|NCT00650858|545675|P3|STARTED|Overall Study||36
226948|NCT00650858|545676|P2|STARTED|Overall Study||8
226949|NCT00650858|545677|P1|STARTED|Overall Study||8
226950|NCT00650845|545708|P2|NOT COMPLETED|Overall Study||13
226951|NCT00650845|545709|P1|NOT COMPLETED|Overall Study||5
226952|NCT00650845|545708|P2|COMPLETED|Overall Study||44
226953|NCT00650845|545709|P1|COMPLETED|Overall Study||70
226954|NCT00650845|545708|P2|STARTED|Overall Study||57
226955|NCT00650845|545709|P1|STARTED|Overall Study||75
226956|NCT00650806|545729|P4|NOT COMPLETED|Overall Study||26
226957|NCT00650806|545730|P3|NOT COMPLETED|Overall Study||29
226958|NCT00650806|545731|P2|NOT COMPLETED|Overall Study||21
226959|NCT00650806|545732|P1|NOT COMPLETED|Overall Study||18
226960|NCT00650806|545729|P4|COMPLETED|Overall Study||70
226961|NCT00650806|545730|P3|COMPLETED|Overall Study||64
226962|NCT00650806|545731|P2|COMPLETED|Overall Study||77
226963|NCT00650806|545732|P1|COMPLETED|Overall Study||71
226964|NCT00650806|545729|P4|STARTED|Overall Study||96
226965|NCT00650806|545730|P3|STARTED|Overall Study||93
226966|NCT00650806|545731|P2|STARTED|Overall Study||98
226967|NCT00650806|545732|P1|STARTED|Overall Study||89
226968|NCT00650767|545774|P4|NOT COMPLETED|Overall Study||11
226969|NCT00650767|545775|P3|NOT COMPLETED|Overall Study||14
226970|NCT00650767|545776|P2|NOT COMPLETED|Overall Study||9
226971|NCT00650767|545777|P1|NOT COMPLETED|Overall Study||5
226972|NCT00650767|545774|P4|COMPLETED|Overall Study||39
226973|NCT00650767|545775|P3|COMPLETED|Overall Study||36
226974|NCT00650767|545776|P2|COMPLETED|Overall Study||41
226975|NCT00650767|545777|P1|COMPLETED|Overall Study||46
226976|NCT00650767|545774|P4|STARTED|Overall Study||50
226977|NCT00650767|545775|P3|STARTED|Overall Study||50
226978|NCT00650767|545776|P2|STARTED|Overall Study||50
226979|NCT00650767|545777|P1|STARTED|Overall Study||51
226980|NCT00650585|546281|P2|NOT COMPLETED|Overall Study||1477
226981|NCT00650585|546282|P1|NOT COMPLETED|Overall Study||1797
226982|NCT00650585|546281|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
226983|NCT00650585|546282|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
226984|NCT00650585|546281|P2|STARTED|Overall Study||3990
226985|NCT00650585|546282|P1|STARTED|Overall Study||4348
226986|NCT00650546|546302|P1|NOT COMPLETED|Overall Study||0
226987|NCT00650546|546302|P1|COMPLETED|Overall Study||8
226988|NCT00650546|546302|P1|STARTED|Overall Study||8
226989|NCT00650260|546309|P2|NOT COMPLETED|Overall Study||0
226990|NCT00650260|546310|P1|NOT COMPLETED|Overall Study||0
226991|NCT00650260|546309|P2|COMPLETED|Overall Study||21
226992|NCT00650260|546310|P1|COMPLETED|Overall Study||21
226993|NCT00650260|546309|P2|STARTED|Overall Study||21
226994|NCT00650260|546310|P1|STARTED|Overall Study||21
226995|NCT00650104|546326|P1|NOT COMPLETED|Overall Study||41
226996|NCT00650104|546326|P1|COMPLETED|Overall Study||42
226997|NCT00650104|546326|P1|STARTED|Overall Study||83
226998|NCT00650091|546341|P3|NOT COMPLETED|Amended Study Design||0
226999|NCT00650091|546342|P2|NOT COMPLETED|Amended Study Design||20
227000|NCT00650091|546343|P1|NOT COMPLETED|Amended Study Design||23
227001|NCT00650091|546341|P3|COMPLETED|Amended Study Design||0
227002|NCT00650091|546342|P2|COMPLETED|Amended Study Design||111
227003|NCT00650091|546343|P1|COMPLETED|Amended Study Design||110
227004|NCT00650091|546341|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
227005|NCT00650091|546342|P2|STARTED|Amended Study Design||131
227006|NCT00650091|546343|P1|STARTED|Amended Study Design||133
227190|NCT00645944|546711|P1|COMPLETED|Randomized||19
227008|NCT00650091|546342|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
227009|NCT00650091|546343|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
227010|NCT00650091|546341|P3|COMPLETED|Initial Study Design - Interim Analysis||77
227011|NCT00650091|546342|P2|COMPLETED|Initial Study Design - Interim Analysis||78
227012|NCT00650091|546343|P1|COMPLETED|Initial Study Design - Interim Analysis||81
227013|NCT00650091|546341|P3|STARTED|Initial Study Design - Interim Analysis||77
227014|NCT00650091|546342|P2|STARTED|Initial Study Design - Interim Analysis||78
227015|NCT00650091|546343|P1|STARTED|Initial Study Design - Interim Analysis||81
227016|NCT00650078|546363|P2|NOT COMPLETED|Overall Study||13
227017|NCT00650078|546364|P1|NOT COMPLETED|Overall Study||14
227018|NCT00650078|546363|P2|COMPLETED|Overall Study||106
227019|NCT00650078|546364|P1|COMPLETED|Overall Study||217
227020|NCT00650078|546363|P2|STARTED|Overall Study||119
227021|NCT00650078|546364|P1|STARTED|Overall Study||231
227022|NCT00649961|546372|P1|NOT COMPLETED|Overall Study||0
227023|NCT00649961|546372|P1|COMPLETED|Overall Study||18
227024|NCT00649961|546372|P1|STARTED|Overall Study||18
227025|NCT00649792|546376|P1|NOT COMPLETED|Overall Study||68
227026|NCT00649792|546376|P1|COMPLETED|Overall Study||146
227027|NCT00649792|546376|P1|STARTED|Overall Study||214
227028|NCT00649428|546386|P2|NOT COMPLETED|Overall Study||15
227029|NCT00649428|546387|P1|NOT COMPLETED|Overall Study||20
227030|NCT00649428|546386|P2|COMPLETED|Overall Study||88
227031|NCT00649428|546387|P1|COMPLETED|Overall Study||80
227032|NCT00649428|546386|P2|STARTED|Overall Study||103
227033|NCT00649428|546387|P1|STARTED|Overall Study||100
227034|NCT00649389|546403|P4|NOT COMPLETED|Overall Study||111
227035|NCT00649389|546404|P3|NOT COMPLETED|Overall Study||88
227036|NCT00649389|546405|P2|NOT COMPLETED|Overall Study||106
227037|NCT00649389|546406|P1|NOT COMPLETED|Overall Study||71
227038|NCT00649389|546403|P4|COMPLETED|Overall Study||516
227039|NCT00649389|546404|P3|COMPLETED|Overall Study||512
227040|NCT00649389|546405|P2|COMPLETED|Overall Study||531
227041|NCT00649389|546406|P1|COMPLETED|Overall Study||557
227042|NCT00649389|546403|P4|STARTED|Overall Study||627
227043|NCT00649389|546404|P3|STARTED|Overall Study||600
227044|NCT00649389|546405|P2|STARTED|Overall Study||637
227045|NCT00649389|546406|P1|STARTED|Overall Study||628
227046|NCT00649220|546428|P1|NOT COMPLETED|Overall Study||3
227047|NCT00649220|546428|P1|COMPLETED|Overall Study||16
227048|NCT00649220|546428|P1|STARTED|Overall Study||19
227049|NCT00648908|546439|P1|NOT COMPLETED|Overall Study||115
227050|NCT00648908|546439|P1|COMPLETED|Overall Study||154
227051|NCT00648908|546439|P1|STARTED|Overall Study||269
227052|NCT00648895|546449|P2|NOT COMPLETED|Overall Study||1
227053|NCT00648895|546450|P1|NOT COMPLETED|Overall Study||0
227054|NCT00648895|546449|P2|COMPLETED|Overall Study||5
227055|NCT00648895|546450|P1|COMPLETED|Overall Study||6
227056|NCT00648895|546449|P2|STARTED|Overall Study||6
227057|NCT00648895|546450|P1|STARTED|Overall Study||6
227058|NCT00648167|546456|P1|NOT COMPLETED|Overall Study||7
227059|NCT00648167|546456|P1|COMPLETED|Overall Study||48
227060|NCT00648167|546456|P1|Start Dose 6 g/Day|Overall Study||21
227061|NCT00648167|546456|P1|Start Dose 4.5 g/Day|Overall Study||34
227062|NCT00648167|546456|P1|STARTED|Overall Study||55
227063|NCT00648115|546463|P3|NOT COMPLETED|Overall Study||0
227064|NCT00648115|546464|P2|NOT COMPLETED|Overall Study||0
227065|NCT00648115|546465|P1|NOT COMPLETED|Overall Study||0
227066|NCT00648115|546463|P3|COMPLETED|Overall Study||27
227067|NCT00648115|546464|P2|COMPLETED|Overall Study||42
227068|NCT00648115|546465|P1|COMPLETED|Overall Study||42
227069|NCT00648115|546463|P3|STARTED|Overall Study||27
227070|NCT00648115|546464|P2|STARTED|Overall Study||42
227071|NCT00648115|546465|P1|STARTED|Overall Study||42
227072|NCT00648037|546476|P1|NOT COMPLETED|Overall Study||16
227073|NCT00648037|546476|P1|COMPLETED|Overall Study||10
227074|NCT00648037|546476|P1|STARTED|Overall Study||26
227075|NCT00647998|546482|P2|NOT COMPLETED|Overall Study||0
227076|NCT00647998|546483|P1|NOT COMPLETED|Overall Study||0
227077|NCT00647998|546482|P2|COMPLETED|Overall Study||9
227078|NCT00647998|546483|P1|COMPLETED|Overall Study||9
227079|NCT00647998|546482|P2|STARTED|Overall Study||9
227080|NCT00647998|546483|P1|STARTED|Overall Study||9
227081|NCT00647699|546495|P2|NOT COMPLETED|Overall Study||12
227082|NCT00647699|546496|P1|NOT COMPLETED|Overall Study||8
227083|NCT00647699|546495|P2|COMPLETED|Overall Study||62
227084|NCT00647699|546496|P1|COMPLETED|Overall Study||65
227085|NCT00647699|546495|P2|STARTED|Overall Study||74
227086|NCT00647699|546496|P1|STARTED|Overall Study||73
227087|NCT00647556|546504|P2|NOT COMPLETED|Overall Study||2
227088|NCT00647556|546505|P1|NOT COMPLETED|Overall Study||3
227089|NCT00647556|546504|P2|COMPLETED|Overall Study||13
227090|NCT00647556|546505|P1|COMPLETED|Overall Study||12
227091|NCT00647556|546504|P2|STARTED|Overall Study||15
227092|NCT00647556|546505|P1|STARTED|Overall Study||15
227093|NCT00647400|546521|P2|NOT COMPLETED|Overall Study||13
227094|NCT00647400|546522|P1|NOT COMPLETED|Overall Study||22
227095|NCT00647400|546521|P2|COMPLETED|Overall Study||45
227096|NCT00647400|546522|P1|COMPLETED|Overall Study||67
227097|NCT00647400|546521|P2|STARTED|Overall Study||58
227098|NCT00647400|546522|P1|STARTED|Overall Study||89
227099|NCT00647270|546535|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
227100|NCT00647270|546536|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
227101|NCT00647270|546537|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
227102|NCT00647270|546535|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
227103|NCT00647270|546536|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
227104|NCT00647270|546537|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
227105|NCT00647270|546535|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
227106|NCT00647270|546536|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
227107|NCT00647270|546537|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
227108|NCT00647270|546535|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
227109|NCT00647270|546536|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
227110|NCT00647270|546537|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
227111|NCT00647270|546535|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
227112|NCT00647270|546536|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
227113|NCT00647270|546537|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
227114|NCT00647270|546535|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
227115|NCT00647270|546536|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
227116|NCT00647270|546537|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
227117|NCT00646958|546563|P3|NOT COMPLETED|Overall Study||9
227118|NCT00646958|546564|P2|NOT COMPLETED|Overall Study||9
227119|NCT00646958|546565|P1|NOT COMPLETED|Overall Study||11
227120|NCT00646958|546563|P3|COMPLETED|Overall Study||40
227121|NCT00646958|546564|P2|COMPLETED|Overall Study||41
227122|NCT00646958|546565|P1|COMPLETED|Overall Study||40
227123|NCT00646958|546563|P3|STARTED|Overall Study|No. Participants Randomized|49
227124|NCT00646958|546564|P2|STARTED|Overall Study|No. Participants Randomized|50
227125|NCT00646958|546565|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
227126|NCT00646776|546578|P2|NOT COMPLETED|Overall Study||13
227127|NCT00646776|546579|P1|NOT COMPLETED|Overall Study||1
227128|NCT00646776|546578|P2|COMPLETED|Overall Study||5
227129|NCT00646776|546579|P1|COMPLETED|Overall Study||14
227130|NCT00646776|546578|P2|STARTED|Overall Study|Treated on Day 1|18
227131|NCT00646776|546579|P1|STARTED|Overall Study|Treated on Day 1|15
227132|NCT00646763|546628|P2|NOT COMPLETED|Overall Study||0
227133|NCT00646763|546629|P1|NOT COMPLETED|Overall Study||0
227134|NCT00646763|546628|P2|COMPLETED|Overall Study||17
227135|NCT00646763|546629|P1|COMPLETED|Overall Study||18
227136|NCT00646763|546628|P2|STARTED|Overall Study||17
227137|NCT00646763|546629|P1|STARTED|Overall Study||18
227138|NCT00646646|546643|P4|NOT COMPLETED|Overall Study||0
227139|NCT00646646|546644|P3|NOT COMPLETED|Overall Study||0
227140|NCT00646646|546645|P2|NOT COMPLETED|Overall Study||0
227141|NCT00646646|546646|P1|NOT COMPLETED|Overall Study||0
227142|NCT00646646|546643|P4|COMPLETED|Overall Study||20
227143|NCT00646646|546644|P3|COMPLETED|Overall Study||15
227144|NCT00646646|546645|P2|COMPLETED|Overall Study||15
227145|NCT00646646|546646|P1|COMPLETED|Overall Study||15
227146|NCT00646646|546643|P4|STARTED|Overall Study||20
227147|NCT00646646|546644|P3|STARTED|Overall Study||15
227148|NCT00646646|546645|P2|STARTED|Overall Study||15
227149|NCT00646646|546646|P1|STARTED|Overall Study||15
227150|NCT00646581|546658|P2|NOT COMPLETED|Overall Study||0
227151|NCT00646581|546659|P1|NOT COMPLETED|Overall Study||0
227152|NCT00646581|546658|P2|COMPLETED|Overall Study||15
227153|NCT00646581|546659|P1|COMPLETED|Overall Study||15
227154|NCT00646581|546658|P2|STARTED|Overall Study||15
227155|NCT00646581|546659|P1|STARTED|Overall Study||15
227156|NCT00646399|546677|P2|NOT COMPLETED|Overall Study||74
227157|NCT00646399|546678|P1|NOT COMPLETED|Overall Study||83
227158|NCT00646399|546677|P2|COMPLETED|Overall Study||713
227159|NCT00646399|546678|P1|COMPLETED|Overall Study||709
227160|NCT00646399|546677|P2|STARTED|Overall Study||787
227161|NCT00646399|546678|P1|STARTED|Overall Study||792
227162|NCT00646282|546686|P2|NOT COMPLETED|Overall Study||4
227163|NCT00646282|546687|P1|NOT COMPLETED|Overall Study||4
227164|NCT00646282|546686|P2|COMPLETED|Overall Study||0
227165|NCT00646282|546687|P1|COMPLETED|Overall Study||0
227166|NCT00646282|546686|P2|STARTED|Overall Study||4
227167|NCT00646282|546687|P1|STARTED|Overall Study||4
227168|NCT00646048|546693|P1|NOT COMPLETED|Overall Study||16
227169|NCT00646048|546693|P1|COMPLETED|Overall Study||27
227170|NCT00646048|546693|P1|STARTED|Overall Study||43
227171|NCT00645970|546701|P2|NOT COMPLETED|Overall Study||186
227172|NCT00645970|546702|P1|NOT COMPLETED|Overall Study||109
227173|NCT00645970|546701|P2|COMPLETED|Overall Study||32
227174|NCT00645970|546702|P1|COMPLETED|Overall Study||32
227175|NCT00645970|546701|P2|1 Year|Overall Study||42
227176|NCT00645970|546702|P1|1 Year|Overall Study||37
227177|NCT00645970|546701|P2|6 Months|Overall Study||97
227178|NCT00645970|546702|P1|6 Months|Overall Study||58
227179|NCT00645970|546701|P2|STARTED|Overall Study||218
227180|NCT00645970|546702|P1|STARTED|Overall Study||141
227181|NCT00645944|546710|P2|NOT COMPLETED|Received Medication||3
227182|NCT00645944|546711|P1|NOT COMPLETED|Received Medication||6
227183|NCT00645944|546710|P2|COMPLETED|Received Medication||14
227184|NCT00645944|546711|P1|COMPLETED|Received Medication||13
227185|NCT00645944|546710|P2|STARTED|Received Medication||17
227186|NCT00645944|546711|P1|STARTED|Received Medication||19
227187|NCT00645944|546710|P2|NOT COMPLETED|Randomized||2
227188|NCT00645944|546711|P1|NOT COMPLETED|Randomized||1
227189|NCT00645944|546710|P2|COMPLETED|Randomized||17
227191|NCT00645944|546710|P2|STARTED|Randomized||19
227192|NCT00645944|546711|P1|STARTED|Randomized||20
227193|NCT00645853|546719|P2|NOT COMPLETED|Overall Study||57
227194|NCT00645853|546720|P1|NOT COMPLETED|Overall Study||92
227195|NCT00645853|546719|P2|COMPLETED|Overall Study||178
227196|NCT00645853|546720|P1|COMPLETED|Overall Study||196
227197|NCT00645853|546719|P2|AZ Study Closure in Hungary|Overall Study||40
227198|NCT00645853|546720|P1|AZ Study Closure in Hungary|Overall Study||60
227199|NCT00645853|546719|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
227200|NCT00645853|546720|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
227201|NCT00645853|546719|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
227202|NCT00645853|546720|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
227203|NCT00645853|546719|P2|STARTED|Overall Study||235
227204|NCT00645853|546720|P1|STARTED|Overall Study||288
227205|NCT00645827|546740|P2|NOT COMPLETED|Overall Study||0
227206|NCT00645827|546741|P1|NOT COMPLETED|Overall Study||0
227207|NCT00645827|546740|P2|COMPLETED|Overall Study||17
227208|NCT00645827|546741|P1|COMPLETED|Overall Study||14
227209|NCT00645827|546740|P2|STARTED|Overall Study||17
227210|NCT00645827|546741|P1|STARTED|Overall Study||14
227211|NCT00645788|546751|P4|NOT COMPLETED|Overall Study||14
227212|NCT00645788|546752|P3|NOT COMPLETED|Overall Study||18
227213|NCT00645788|546753|P2|NOT COMPLETED|Overall Study||27
227214|NCT00645788|546754|P1|NOT COMPLETED|Overall Study||20
227215|NCT00645788|546751|P4|COMPLETED|Overall Study||21
227216|NCT00645788|546752|P3|COMPLETED|Overall Study||47
227217|NCT00645788|546753|P2|COMPLETED|Overall Study||67
227218|NCT00645788|546754|P1|COMPLETED|Overall Study||74
227219|NCT00645788|546751|P4|Participants Receive Treatment|Overall Study||35
227220|NCT00645788|546752|P3|Participants Receive Treatment|Overall Study||65
227221|NCT00645788|546753|P2|Participants Receive Treatment|Overall Study||93
227222|NCT00645788|546754|P1|Participants Receive Treatment|Overall Study||93
227223|NCT00645788|546751|P4|STARTED|Overall Study||35
227224|NCT00645788|546752|P3|STARTED|Overall Study||65
227225|NCT00645788|546753|P2|STARTED|Overall Study||94
227226|NCT00645788|546754|P1|STARTED|Overall Study||94
227227|NCT00645762|546804|P1|NOT COMPLETED|Overall Study||4
227228|NCT00645762|546804|P1|COMPLETED|Overall Study||67
227229|NCT00645762|546804|P1|STARTED|Overall Study||71
227230|NCT00645671|546812|P2|NOT COMPLETED|Overall Study||6
227231|NCT00645671|546813|P1|NOT COMPLETED|Overall Study||1
227232|NCT00645671|546812|P2|COMPLETED|Overall Study||193
227233|NCT00645671|546813|P1|COMPLETED|Overall Study||200
227234|NCT00645671|546812|P2|STARTED|Overall Study||199
227235|NCT00645671|546813|P1|STARTED|Overall Study||201
227236|NCT00645593|546827|P2|NOT COMPLETED|Overall Study||0
227237|NCT00645593|546828|P1|NOT COMPLETED|Overall Study||1
227238|NCT00645593|546827|P2|COMPLETED|Overall Study||60
227239|NCT00645593|546828|P1|COMPLETED|Overall Study||28
227240|NCT00645593|546827|P2|STARTED|Overall Study||60
227241|NCT00645593|546828|P1|STARTED|Overall Study||29
227242|NCT00645567|546840|P1|NOT COMPLETED|Overall Study||1
227243|NCT00645567|546840|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
227244|NCT00645567|546840|P1|STARTED|Overall Study||5
227245|NCT00645528|546848|P1|NOT COMPLETED|Overall Study||7
227246|NCT00645528|546848|P1|COMPLETED|Overall Study||32
227247|NCT00645528|546848|P1|STARTED|Overall Study||39
227248|NCT00645411|546861|P4|NOT COMPLETED|Overall Study||103
227249|NCT00645411|546862|P3|NOT COMPLETED|Overall Study||151
227250|NCT00645411|546863|P2|NOT COMPLETED|Overall Study||6
227251|NCT00645411|546864|P1|NOT COMPLETED|Overall Study||13
227252|NCT00645411|546861|P4|COMPLETED|Overall Study||919
227253|NCT00645411|546862|P3|COMPLETED|Overall Study||1457
227254|NCT00645411|546863|P2|COMPLETED|Overall Study||312
227255|NCT00645411|546864|P1|COMPLETED|Overall Study||643
227256|NCT00645411|546861|P4|STARTED|Overall Study||1022
227257|NCT00645411|546862|P3|STARTED|Overall Study||1608
227258|NCT00645411|546863|P2|STARTED|Overall Study||318
227259|NCT00645411|546864|P1|STARTED|Overall Study||656
227260|NCT00645359|546896|P1|NOT COMPLETED|Overall Study||0
227261|NCT00645359|546896|P1|COMPLETED|Overall Study||9
227262|NCT00645359|546896|P1|STARTED|Overall Study||9
227263|NCT00645333|546901|P1|NOT COMPLETED|Overall Study||0
227264|NCT00645333|546901|P1|COMPLETED|Overall Study||30
227265|NCT00645333|546901|P1|STARTED|Overall Study||30
227266|NCT00645164|546906|P1|NOT COMPLETED|Overall Study||7
227267|NCT00645164|546906|P1|COMPLETED|Overall Study||52
227268|NCT00645164|546906|P1|STARTED|Overall Study||59
227269|NCT00645099|546912|P2|NOT COMPLETED|Overall Study||42
227270|NCT00645099|546913|P1|NOT COMPLETED|Overall Study||71
227271|NCT00645099|546912|P2|COMPLETED|Overall Study||178
227272|NCT00645099|546913|P1|COMPLETED|Overall Study||168
227273|NCT00645099|546912|P2|STARTED|Overall Study||220
227274|NCT00645099|546913|P1|STARTED|Overall Study||239
227275|NCT00645047|546957|P2|NOT COMPLETED|Overall Study||39
227276|NCT00645047|546958|P1|NOT COMPLETED|Overall Study||43
227277|NCT00645047|546957|P2|COMPLETED|Overall Study||65
227278|NCT00645047|546958|P1|COMPLETED|Overall Study|6 month follow up|60
227279|NCT00645047|546957|P2|Post|Overall Study||80
227280|NCT00645047|546958|P1|Post|Overall Study||74
227281|NCT00645047|546957|P2|STARTED|Overall Study||104
227282|NCT00645047|546958|P1|STARTED|Overall Study||103
227283|NCT00644995|546982|P2|NOT COMPLETED|Overall Study||4
227284|NCT00644995|546983|P1|NOT COMPLETED|Overall Study||2
227285|NCT00644995|546982|P2|COMPLETED|Overall Study||23
227286|NCT00644995|546983|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
227287|NCT00644995|546982|P2|Completed 4 Month Assessment|Overall Study||24
227288|NCT00644995|546983|P1|Completed 4 Month Assessment|Overall Study||23
227289|NCT00644995|546982|P2|STARTED|Overall Study||27
227290|NCT00644995|546983|P1|STARTED|Overall Study||25
227291|NCT00644969|547003|P2|NOT COMPLETED|Post Treatment Phase||3
227292|NCT00644969|547004|P1|NOT COMPLETED|Post Treatment Phase||10
227293|NCT00644969|547003|P2|COMPLETED|Post Treatment Phase||37
227294|NCT00644969|547004|P1|COMPLETED|Post Treatment Phase||61
227295|NCT00644969|547003|P2|STARTED|Post Treatment Phase||40
227296|NCT00644969|547004|P1|STARTED|Post Treatment Phase||71
227297|NCT00644969|547003|P2|NOT COMPLETED|Treatment Phase||3
227298|NCT00644969|547004|P1|NOT COMPLETED|Treatment Phase||14
227299|NCT00644969|547003|P2|COMPLETED|Treatment Phase||40
227300|NCT00644969|547004|P1|COMPLETED|Treatment Phase||71
227301|NCT00644969|547003|P2|STARTED|Treatment Phase||43
227302|NCT00644969|547004|P1|STARTED|Treatment Phase||85
227303|NCT00644917|547050|P1|NOT COMPLETED|Overall Study||2
227304|NCT00644917|547050|P1|COMPLETED|Overall Study||36
227305|NCT00644917|547050|P1|STARTED|Overall Study||38
227306|NCT00644787|547058|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
227307|NCT00644787|547059|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
227308|NCT00644787|547060|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
227309|NCT00644787|547058|P3|COMPLETED|Period 2: Double Blind Phase||55
227310|NCT00644787|547059|P2|COMPLETED|Period 2: Double Blind Phase||49
227311|NCT00644787|547060|P1|COMPLETED|Period 2: Double Blind Phase||0
227312|NCT00644787|547058|P3|STARTED|Period 2: Double Blind Phase||62
227313|NCT00644787|547059|P2|STARTED|Period 2: Double Blind Phase||58
227314|NCT00644787|547060|P1|STARTED|Period 2: Double Blind Phase||0
227315|NCT00644787|547058|P3|NOT COMPLETED|Period 1: Titration Phase||0
227316|NCT00644787|547059|P2|NOT COMPLETED|Period 1: Titration Phase||0
227317|NCT00644787|547060|P1|NOT COMPLETED|Period 1: Titration Phase||27
227318|NCT00644787|547058|P3|COMPLETED|Period 1: Titration Phase||0
227319|NCT00644787|547059|P2|COMPLETED|Period 1: Titration Phase||0
227320|NCT00644787|547060|P1|COMPLETED|Period 1: Titration Phase||129
227321|NCT00644787|547058|P3|STARTED|Period 1: Titration Phase||0
227322|NCT00644787|547059|P2|STARTED|Period 1: Titration Phase||0
227323|NCT00644787|547060|P1|STARTED|Period 1: Titration Phase||156
227324|NCT00644657|547088|P1|NOT COMPLETED|Overall Study||0
227325|NCT00644657|547088|P1|COMPLETED|Overall Study||27
227326|NCT00644657|547088|P1|STARTED|Overall Study||27
227327|NCT00644592|547095|P2|NOT COMPLETED|Overall Study||0
227328|NCT00644592|547096|P1|NOT COMPLETED|Overall Study||0
227329|NCT00644592|547095|P2|COMPLETED|Overall Study||6
227330|NCT00644592|547096|P1|COMPLETED|Overall Study||5
227331|NCT00644592|547095|P2|STARTED|Overall Study||6
227332|NCT00644592|547096|P1|STARTED|Overall Study||5
227333|NCT00644358|547102|P1|NOT COMPLETED|Overall Study||362
227334|NCT00644358|547102|P1|COMPLETED|Overall Study||254
227335|NCT00644358|547102|P1|STARTED|Overall Study||616
227336|NCT00644332|547109|P1|NOT COMPLETED|Overall Study||21
227337|NCT00644332|547109|P1|COMPLETED|Overall Study||150
227338|NCT00644332|547109|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
227339|NCT00644280|547124|P2|NOT COMPLETED|Overall Study||0
227340|NCT00644280|547125|P1|NOT COMPLETED|Overall Study||0
227341|NCT00644280|547124|P2|COMPLETED|Overall Study||5
227342|NCT00644280|547125|P1|COMPLETED|Overall Study||6
227343|NCT00644280|547124|P2|STARTED|Overall Study||5
227344|NCT00644280|547125|P1|STARTED|Overall Study||6
227345|NCT00644228|547135|P2|NOT COMPLETED|Maintenance||135
227346|NCT00644228|547136|P1|NOT COMPLETED|Maintenance||143
227347|NCT00644228|547135|P2|COMPLETED|Maintenance||0
227348|NCT00644228|547136|P1|COMPLETED|Maintenance||0
227349|NCT00644228|547135|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
227350|NCT00644228|547136|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
227351|NCT00644228|547135|P2|NOT COMPLETED|Induction Therapy||105
227352|NCT00644228|547136|P1|NOT COMPLETED|Induction Therapy||83
227353|NCT00644228|547135|P2|COMPLETED|Induction Therapy||137
227354|NCT00644228|547136|P1|COMPLETED|Induction Therapy||146
227355|NCT00644228|547135|P2|STARTED|Induction Therapy||242
227356|NCT00644228|547136|P1|STARTED|Induction Therapy||229
227357|NCT00644228|547135|P2|NOT COMPLETED|Randomization & Eligibility||22
227358|NCT00644228|547136|P1|NOT COMPLETED|Randomization & Eligibility||32
227359|NCT00644228|547135|P2|COMPLETED|Randomization & Eligibility||242
227360|NCT00644228|547136|P1|COMPLETED|Randomization & Eligibility||229
227361|NCT00644228|547135|P2|Eligible and Analyzable|Randomization & Eligibility||242
227362|NCT00644228|547136|P1|Eligible and Analyzable|Randomization & Eligibility||229
227363|NCT00644228|547135|P2|STARTED|Randomization & Eligibility||264
227364|NCT00644228|547136|P1|STARTED|Randomization & Eligibility||261
227365|NCT00644189|547146|P4|NOT COMPLETED|Phase II||0
227366|NCT00644189|547147|P3|NOT COMPLETED|Phase II||0
227367|NCT00644189|547148|P2|NOT COMPLETED|Phase II||0
227368|NCT00644189|547149|P1|NOT COMPLETED|Phase II||0
227369|NCT00644189|547146|P4|COMPLETED|Phase II||50
227370|NCT00644189|547147|P3|COMPLETED|Phase II||0
227371|NCT00644189|547148|P2|COMPLETED|Phase II||0
227372|NCT00644189|547149|P1|COMPLETED|Phase II||0
227373|NCT00644189|547146|P4|Completed All 6 Cycles of Treatment|Phase II||19
227374|NCT00644189|547147|P3|Completed All 6 Cycles of Treatment|Phase II||0
227375|NCT00644189|547148|P2|Completed All 6 Cycles of Treatment|Phase II||0
227376|NCT00644189|547149|P1|Completed All 6 Cycles of Treatment|Phase II||0
227377|NCT00644189|547146|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
227378|NCT00644189|547147|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
227379|NCT00644189|547148|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
227380|NCT00644189|547149|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
227381|NCT00644189|547146|P4|NOT COMPLETED|Phase I||0
227382|NCT00644189|547147|P3|NOT COMPLETED|Phase I||0
227383|NCT00644189|547148|P2|NOT COMPLETED|Phase I||0
227384|NCT00644189|547149|P1|NOT COMPLETED|Phase I||0
227385|NCT00644189|547146|P4|COMPLETED|Phase I||18
227386|NCT00644189|547147|P3|COMPLETED|Phase I||6
227387|NCT00644189|547148|P2|COMPLETED|Phase I||3
227388|NCT00644189|547149|P1|COMPLETED|Phase I||3
227389|NCT00644189|547146|P4|STARTED|Phase I||18
227390|NCT00644189|547147|P3|STARTED|Phase I||6
227391|NCT00644189|547148|P2|STARTED|Phase I||3
227392|NCT00644189|547149|P1|STARTED|Phase I||3
227393|NCT00644059|547165|P3|NOT COMPLETED|Overall Study||65
227394|NCT00644059|547166|P2|NOT COMPLETED|Overall Study||123
227395|NCT00644059|547167|P1|NOT COMPLETED|Overall Study||124
227396|NCT00644059|547165|P3|COMPLETED|Overall Study||969
227397|NCT00644059|547166|P2|COMPLETED|Overall Study||1726
227398|NCT00644059|547167|P1|COMPLETED|Overall Study||1895
227399|NCT00644059|547165|P3|STARTED|Overall Study||1034
227400|NCT00644059|547166|P2|STARTED|Overall Study||1849
227401|NCT00644059|547167|P1|STARTED|Overall Study||2019
227402|NCT00643916|547257|P6|NOT COMPLETED|Overall Study||1
227403|NCT00643916|547258|P5|NOT COMPLETED|Overall Study||2
227404|NCT00643916|547259|P4|NOT COMPLETED|Overall Study||2
227405|NCT00643916|547260|P3|NOT COMPLETED|Overall Study||6
227406|NCT00643916|547261|P2|NOT COMPLETED|Overall Study||6
227407|NCT00643916|547262|P1|NOT COMPLETED|Overall Study||4
227408|NCT00643916|547257|P6|COMPLETED|Overall Study||66
227409|NCT00643916|547258|P5|COMPLETED|Overall Study||57
227410|NCT00643916|547259|P4|COMPLETED|Overall Study||60
227411|NCT00643916|547260|P3|COMPLETED|Overall Study||62
227412|NCT00643916|547261|P2|COMPLETED|Overall Study||61
227413|NCT00643916|547262|P1|COMPLETED|Overall Study||51
227414|NCT00643916|547257|P6|STARTED|Overall Study||67
227415|NCT00643916|547258|P5|STARTED|Overall Study||59
227416|NCT00643916|547259|P4|STARTED|Overall Study||62
227417|NCT00643916|547260|P3|STARTED|Overall Study||68
227418|NCT00643916|547261|P2|STARTED|Overall Study||67
227419|NCT00643916|547262|P1|STARTED|Overall Study||55
227420|NCT00643851|547285|P3|NOT COMPLETED|Overall Study||30
227421|NCT00643851|547286|P2|NOT COMPLETED|Overall Study||33
227422|NCT00643851|547287|P1|NOT COMPLETED|Overall Study||17
227423|NCT00643851|547285|P3|COMPLETED|Overall Study||171
227424|NCT00643851|547286|P2|COMPLETED|Overall Study||170
227425|NCT00643851|547287|P1|COMPLETED|Overall Study||177
227426|NCT00643851|547285|P3|STARTED|Overall Study||201
227427|NCT00643851|547286|P2|STARTED|Overall Study||203
227428|NCT00643851|547287|P1|STARTED|Overall Study||194
227429|NCT00643760|547315|P5|NOT COMPLETED|Overall Study||19
227430|NCT00643760|547316|P4|NOT COMPLETED|Overall Study||38
227431|NCT00643760|547317|P3|NOT COMPLETED|Overall Study||19
227432|NCT00643760|547318|P2|NOT COMPLETED|Overall Study||15
227433|NCT00643760|547319|P1|NOT COMPLETED|Overall Study||30
227434|NCT00643760|547315|P5|COMPLETED|Overall Study||47
227435|NCT00643760|547316|P4|COMPLETED|Overall Study||79
227436|NCT00643760|547317|P3|COMPLETED|Overall Study||37
227437|NCT00643760|547318|P2|COMPLETED|Overall Study||47
227438|NCT00643760|547319|P1|COMPLETED|Overall Study||90
227439|NCT00643760|547315|P5|ITT Population|Overall Study||66
227440|NCT00643760|547316|P4|ITT Population|Overall Study||116
227441|NCT00643760|547317|P3|ITT Population|Overall Study||56
227442|NCT00643760|547318|P2|ITT Population|Overall Study||62
227443|NCT00643760|547319|P1|ITT Population|Overall Study||120
227444|NCT00643760|547315|P5|Safety Population/Treated With Drug|Overall Study||66
227445|NCT00643760|547316|P4|Safety Population/Treated With Drug|Overall Study||116
227446|NCT00643760|547317|P3|Safety Population/Treated With Drug|Overall Study||56
227447|NCT00643760|547318|P2|Safety Population/Treated With Drug|Overall Study||62
227448|NCT00643760|547319|P1|Safety Population/Treated With Drug|Overall Study||120
227449|NCT00643760|547315|P5|STARTED|Overall Study||66
227450|NCT00643760|547316|P4|STARTED|Overall Study||117
227451|NCT00643760|547317|P3|STARTED|Overall Study||56
227452|NCT00643760|547318|P2|STARTED|Overall Study||62
227453|NCT00643760|547319|P1|STARTED|Overall Study||120
227454|NCT00643682|547423|P2|NOT COMPLETED|Overall Study||509
227455|NCT00643682|547424|P1|NOT COMPLETED|Overall Study||522
227456|NCT00643682|547423|P2|COMPLETED|Overall Study||492
227457|NCT00643682|547424|P1|COMPLETED|Overall Study||477
227458|NCT00643682|547423|P2|STARTED|Overall Study||1001
227459|NCT00643682|547424|P1|STARTED|Overall Study||999
227460|NCT00643604|547436|P1|NOT COMPLETED|Overall Study||1
227461|NCT00643604|547436|P1|COMPLETED|Overall Study||6
227462|NCT00643604|547436|P1|STARTED|Overall Study||7
227463|NCT00643578|547453|P2|NOT COMPLETED|Overall Study||0
227464|NCT00643578|547454|P1|NOT COMPLETED|Overall Study||2
227465|NCT00643578|547453|P2|COMPLETED|Overall Study||6
227466|NCT00643578|547454|P1|COMPLETED|Overall Study||4
227467|NCT00643578|547453|P2|STARTED|Overall Study||6
227468|NCT00643578|547454|P1|STARTED|Overall Study||6
227469|NCT00643565|547464|P2|NOT COMPLETED|Overall Study||74
227470|NCT00643565|547465|P1|NOT COMPLETED|Overall Study||80
227471|NCT00643565|547464|P2|COMPLETED|Overall Study||0
227472|NCT00643565|547465|P1|COMPLETED|Overall Study||0
227473|NCT00643565|547464|P2|STARTED|Overall Study||74
227474|NCT00643565|547465|P1|STARTED|Overall Study||80
227475|NCT00643487|547487|P1|NOT COMPLETED|Overall Study||3
227476|NCT00643487|547487|P1|COMPLETED|Overall Study||5
227477|NCT00643487|547487|P1|STARTED|Overall Study||8
227478|NCT00643448|547494|P3|NOT COMPLETED|Overall Study||6
227479|NCT00643448|547495|P2|NOT COMPLETED|Overall Study||5
227480|NCT00643448|547496|P1|NOT COMPLETED|Overall Study||4
227481|NCT00643448|547494|P3|COMPLETED|Overall Study||16
227482|NCT00643448|547495|P2|COMPLETED|Overall Study||17
227483|NCT00643448|547496|P1|COMPLETED|Overall Study||17
227484|NCT00643448|547494|P3|STARTED|Overall Study||22
227485|NCT00643448|547495|P2|STARTED|Overall Study||22
227486|NCT00643448|547496|P1|STARTED|Overall Study||21
227487|NCT00643201|547513|P2|NOT COMPLETED|Completed Study Follow Up||79
227488|NCT00643201|547514|P1|NOT COMPLETED|Completed Study Follow Up||70
227489|NCT00643201|547513|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
227490|NCT00643201|547514|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
227491|NCT00643201|547513|P2|STARTED|Completed Study Follow Up||2639
227492|NCT00643201|547514|P1|STARTED|Completed Study Follow Up||2617
227493|NCT00643201|547513|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
227494|NCT00643201|547514|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
227495|NCT00643201|547513|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
227496|NCT00643201|547514|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
227497|NCT00643201|547513|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
227498|NCT00643201|547514|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
227499|NCT00643123|547562|P2|NOT COMPLETED|Overall Study||1
227500|NCT00643123|547563|P1|NOT COMPLETED|Overall Study||5
227501|NCT00643123|547562|P2|COMPLETED|Overall Study||11
227502|NCT00643123|547563|P1|COMPLETED|Overall Study||10
227503|NCT00643123|547562|P2|STARTED|Overall Study||12
227504|NCT00643123|547563|P1|STARTED|Overall Study||15
227505|NCT00643097|547572|P3|NOT COMPLETED|Overall Study||0
227506|NCT00643097|547573|P2|NOT COMPLETED|Overall Study||0
227507|NCT00643097|547574|P1|NOT COMPLETED|Overall Study||0
227508|NCT00643097|547572|P3|COMPLETED|Overall Study||10
227509|NCT00643097|547573|P2|COMPLETED|Overall Study||12
227510|NCT00643097|547574|P1|COMPLETED|Overall Study||18
227511|NCT00643097|547572|P3|STARTED|Overall Study||10
227512|NCT00643097|547573|P2|STARTED|Overall Study||12
227513|NCT00643097|547574|P1|STARTED|Overall Study||18
227514|NCT00643006|547593|P2|NOT COMPLETED|Overall Study||4
227515|NCT00643006|547594|P1|NOT COMPLETED|Overall Study||5
227516|NCT00643006|547593|P2|COMPLETED|Overall Study||29
227517|NCT00643006|547594|P1|COMPLETED|Overall Study||29
227518|NCT00643006|547593|P2|STARTED|Overall Study||33
227519|NCT00643006|547594|P1|STARTED|Overall Study||34
227520|NCT00642993|547604|P2|NOT COMPLETED|Overall Study||16
227521|NCT00642993|547605|P1|NOT COMPLETED|Overall Study||106
227522|NCT00642993|547604|P2|COMPLETED|Overall Study||118
227523|NCT00642993|547605|P1|COMPLETED|Overall Study||161
227524|NCT00642993|547604|P2|STARTED|Overall Study||134
227525|NCT00642993|547605|P1|STARTED|Overall Study||267
227526|NCT00642902|547623|P4|NOT COMPLETED|Overall Study||40
227527|NCT00642902|547624|P3|NOT COMPLETED|Overall Study||43
227528|NCT00642902|547625|P2|NOT COMPLETED|Overall Study||42
227529|NCT00642902|547626|P1|NOT COMPLETED|Overall Study||40
227530|NCT00642902|547623|P4|COMPLETED|Overall Study||25
227531|NCT00642902|547624|P3|COMPLETED|Overall Study||21
227532|NCT00642902|547625|P2|COMPLETED|Overall Study||21
227533|NCT00642902|547626|P1|COMPLETED|Overall Study||23
227534|NCT00642902|547623|P4|Treated|Overall Study||65
227535|NCT00642902|547624|P3|Treated|Overall Study||63
227536|NCT00642902|547625|P2|Treated|Overall Study||63
227537|NCT00642902|547626|P1|Treated|Overall Study||63
227538|NCT00642902|547623|P4|STARTED|Overall Study||65
227539|NCT00642902|547624|P3|STARTED|Overall Study||64
227540|NCT00642902|547625|P2|STARTED|Overall Study||63
227541|NCT00642902|547626|P1|STARTED|Overall Study||63
227542|NCT00642850|547648|P1|NOT COMPLETED|Overall Study||33
227543|NCT00642850|547648|P1|COMPLETED|Overall Study||155
227544|NCT00642850|547648|P1|STARTED|Overall Study||188
227545|NCT00642811|547664|P6|NOT COMPLETED|Overall Study||1
227546|NCT00642811|547665|P5|NOT COMPLETED|Overall Study||1
227547|NCT00642811|547666|P4|NOT COMPLETED|Overall Study||1
227548|NCT00642811|547667|P3|NOT COMPLETED|Overall Study||0
227549|NCT00642811|547668|P2|NOT COMPLETED|Overall Study||4
227550|NCT00642811|547669|P1|NOT COMPLETED|Overall Study||3
227551|NCT00642811|547664|P6|COMPLETED|Overall Study||13
227552|NCT00642811|547665|P5|COMPLETED|Overall Study||13
227553|NCT00642811|547666|P4|COMPLETED|Overall Study||15
227554|NCT00642811|547667|P3|COMPLETED|Overall Study||13
227555|NCT00642811|547668|P2|COMPLETED|Overall Study||17
227556|NCT00642811|547669|P1|COMPLETED|Overall Study||17
227557|NCT00642811|547664|P6|STARTED|Overall Study||14
227558|NCT00642811|547665|P5|STARTED|Overall Study||14
227559|NCT00642811|547666|P4|STARTED|Overall Study||16
227560|NCT00642811|547667|P3|STARTED|Overall Study||13
227561|NCT00642811|547668|P2|STARTED|Overall Study||21
227562|NCT00642811|547669|P1|STARTED|Overall Study||20
227563|NCT00642772|547691|P1|NOT COMPLETED|Overall Study||10
227564|NCT00642772|547691|P1|COMPLETED|Overall Study||14
227565|NCT00642772|547691|P1|STARTED|Overall Study||24
227566|NCT00642759|547695|P1|NOT COMPLETED|Overall Study||1
227567|NCT00642759|547695|P1|COMPLETED|Overall Study||35
227568|NCT00642759|547695|P1|STARTED|Overall Study||36
227569|NCT00642746|547704|P2|NOT COMPLETED|Overall Study||0
227570|NCT00642746|547705|P1|NOT COMPLETED|Overall Study||1
227571|NCT00642746|547704|P2|COMPLETED|Overall Study||1
227572|NCT00642746|547705|P1|COMPLETED|Overall Study||9
227573|NCT00642746|547704|P2|STARTED|Overall Study||1
227574|NCT00642746|547705|P1|STARTED|Overall Study||10
227575|NCT00642707|547719|P4|NOT COMPLETED|Overall Study||2
227576|NCT00642707|547720|P3|NOT COMPLETED|Overall Study||0
227577|NCT00642707|547721|P2|NOT COMPLETED|Overall Study||0
227578|NCT00642707|547722|P1|NOT COMPLETED|Overall Study||1
227579|NCT00642707|547719|P4|COMPLETED|Overall Study||8
227580|NCT00642707|547720|P3|COMPLETED|Overall Study||12
227581|NCT00642707|547721|P2|COMPLETED|Overall Study||11
227582|NCT00642707|547722|P1|COMPLETED|Overall Study||10
227583|NCT00642707|547719|P4|STARTED|Overall Study||10
227584|NCT00642707|547720|P3|STARTED|Overall Study||12
227585|NCT00642707|547721|P2|STARTED|Overall Study||11
227586|NCT00642707|547722|P1|STARTED|Overall Study||11
227587|NCT00642694|547734|P2|NOT COMPLETED|Overall Study||4
227588|NCT00642694|547735|P1|NOT COMPLETED|Overall Study||6
227589|NCT00642694|547734|P2|COMPLETED|Overall Study||11
227590|NCT00642694|547735|P1|COMPLETED|Overall Study||8
227591|NCT00642694|547734|P2|STARTED|Overall Study||15
227592|NCT00642694|547735|P1|STARTED|Overall Study||14
227593|NCT00642668|547743|P1|NOT COMPLETED|Overall Study||14
227594|NCT00642668|547743|P1|COMPLETED|Overall Study||21
227595|NCT00642668|547743|P1|STARTED|Overall Study||35
227596|NCT00642642|547751|P1|NOT COMPLETED|Treatment & Follow Up||17
227597|NCT00642642|547751|P1|COMPLETED|Treatment & Follow Up||92
227598|NCT00642642|547751|P1|STARTED|Treatment & Follow Up||109
227599|NCT00642642|547751|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
227600|NCT00642642|547751|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
227601|NCT00642642|547751|P1|STARTED|Biopsy & Product Manufacture||122
227602|NCT00642616|547768|P4|NOT COMPLETED|Overall Study||7
227603|NCT00642616|547769|P3|NOT COMPLETED|Overall Study||9
227604|NCT00642616|547770|P2|NOT COMPLETED|Overall Study||7
227605|NCT00642616|547771|P1|NOT COMPLETED|Overall Study||9
227606|NCT00642616|547768|P4|COMPLETED|Overall Study||1
227607|NCT00642616|547769|P3|COMPLETED|Overall Study||0
227608|NCT00642616|547770|P2|COMPLETED|Overall Study||1
227609|NCT00642616|547771|P1|COMPLETED|Overall Study||0
227610|NCT00642616|547768|P4|STARTED|Overall Study||8
227611|NCT00642616|547769|P3|STARTED|Overall Study||9
227612|NCT00642616|547770|P2|STARTED|Overall Study||8
227613|NCT00642616|547771|P1|STARTED|Overall Study||9
227614|NCT00642603|547795|P2|NOT COMPLETED|Overall Study||18
227615|NCT00642603|547796|P1|NOT COMPLETED|Overall Study||21
227616|NCT00642603|547795|P2|COMPLETED|Overall Study||2
227617|NCT00642603|547796|P1|COMPLETED|Overall Study||0
227618|NCT00642603|547795|P2|Safety Population|Overall Study||20
227619|NCT00642603|547796|P1|Safety Population|Overall Study||19
227620|NCT00642603|547795|P2|STARTED|Overall Study||20
227621|NCT00642603|547796|P1|STARTED|Overall Study||21
227622|NCT00642473|547804|P2|NOT COMPLETED|Overall Study||11
227623|NCT00642473|547805|P1|NOT COMPLETED|Overall Study||4
227624|NCT00642473|547804|P2|COMPLETED|Overall Study||5
227625|NCT00642473|547805|P1|COMPLETED|Overall Study||14
227626|NCT00642473|547804|P2|STARTED|Overall Study||16
227627|NCT00642473|547805|P1|STARTED|Overall Study||18
227628|NCT00642460|547819|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
227629|NCT00642460|547820|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
227630|NCT00642460|547821|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
227631|NCT00642460|547822|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
227632|NCT00642460|547823|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
227633|NCT00642460|547824|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
227634|NCT00642460|547819|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
227635|NCT00642460|547820|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
227636|NCT00642460|547821|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
227637|NCT00642460|547822|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
227638|NCT00642460|547823|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
227639|NCT00642460|547824|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
227640|NCT00642460|547819|P6|STARTED|Part III: Open-Label Up to Week 260||59
227641|NCT00642460|547820|P5|STARTED|Part III: Open-Label Up to Week 260||53
227642|NCT00642460|547821|P4|STARTED|Part III: Open-Label Up to Week 260||0
227643|NCT00642460|547822|P3|STARTED|Part III: Open-Label Up to Week 260||0
227644|NCT00642460|547823|P2|STARTED|Part III: Open-Label Up to Week 260||0
227645|NCT00642460|547824|P1|STARTED|Part III: Open-Label Up to Week 260||0
227646|NCT00642460|547819|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
227647|NCT00642460|547820|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
227648|NCT00642460|547821|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
227649|NCT00642460|547822|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
227650|NCT00642460|547823|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
227651|NCT00642460|547824|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
227652|NCT00642460|547819|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
227653|NCT00642460|547820|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
227654|NCT00642460|547821|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
227655|NCT00642460|547822|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
227656|NCT00642460|547823|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
227657|NCT00642460|547824|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
227658|NCT00642460|547819|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
227659|NCT00642460|547820|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
227660|NCT00642460|547821|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
227661|NCT00642460|547822|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
227662|NCT00642460|547823|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
227663|NCT00642460|547824|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
227664|NCT00642460|547819|P6|STARTED|Part II: Open-Label Up to Week 92||0
227665|NCT00642460|547820|P5|STARTED|Part II: Open-Label Up to Week 92||0
227666|NCT00642460|547821|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
227667|NCT00642460|547822|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
227668|NCT00642460|547823|P2|STARTED|Part II: Open-Label Up to Week 92||40
227669|NCT00642460|547824|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
227670|NCT00642460|547819|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
227671|NCT00642460|547820|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
227672|NCT00642460|547821|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
227673|NCT00642460|547822|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
227674|NCT00642460|547823|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
227675|NCT00642460|547824|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
227676|NCT00642460|547819|P6|COMPLETED|Part I: 12 Week Double-Blind||0
227677|NCT00642460|547820|P5|COMPLETED|Part I: 12 Week Double-Blind||0
227678|NCT00642460|547821|P4|COMPLETED|Part I: 12 Week Double-Blind||0
227679|NCT00642460|547822|P3|COMPLETED|Part I: 12 Week Double-Blind||36
227680|NCT00642460|547823|P2|COMPLETED|Part I: 12 Week Double-Blind||37
227681|NCT00642460|547824|P1|COMPLETED|Part I: 12 Week Double-Blind||36
227682|NCT00642460|547819|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
227683|NCT00642460|547820|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
227684|NCT00642460|547821|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
227685|NCT00642460|547822|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
227686|NCT00642460|547823|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
227687|NCT00642460|547824|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
227688|NCT00642460|547819|P6|STARTED|Part I: 12 Week Double-Blind||0
227689|NCT00642460|547820|P5|STARTED|Part I: 12 Week Double-Blind||0
227690|NCT00642460|547821|P4|STARTED|Part I: 12 Week Double-Blind||0
227691|NCT00642460|547822|P3|STARTED|Part I: 12 Week Double-Blind||37
227692|NCT00642460|547823|P2|STARTED|Part I: 12 Week Double-Blind||38
227693|NCT00642460|547824|P1|STARTED|Part I: 12 Week Double-Blind||37
227694|NCT00642382|547890|P2|NOT COMPLETED|Overall Study||0
227695|NCT00642382|547891|P1|NOT COMPLETED|Overall Study||0
227696|NCT00642382|547890|P2|COMPLETED|Overall Study||0
227697|NCT00642382|547891|P1|COMPLETED|Overall Study||0
227698|NCT00642382|547890|P2|STARTED|Overall Study||0
227699|NCT00642382|547891|P1|STARTED|Overall Study||0
227700|NCT00642369|547899|P2|NOT COMPLETED|Overall Study||6
227701|NCT00642369|547900|P1|NOT COMPLETED|Overall Study||5
227702|NCT00642369|547899|P2|COMPLETED|Overall Study||24
227703|NCT00642369|547900|P1|COMPLETED|Overall Study||25
227704|NCT00642369|547899|P2|STARTED|Overall Study||30
227705|NCT00642369|547900|P1|STARTED|Overall Study||30
227706|NCT00642356|547910|P2|NOT COMPLETED|Overall Study||3
227707|NCT00642356|547911|P1|NOT COMPLETED|Overall Study||2
227708|NCT00642356|547910|P2|COMPLETED|Overall Study||4
227709|NCT00642356|547911|P1|COMPLETED|Overall Study||5
227710|NCT00642356|547910|P2|STARTED|Overall Study||7
227711|NCT00642356|547911|P1|STARTED|Overall Study||7
227712|NCT00642304|547919|P1|NOT COMPLETED|Overall Study||6
227713|NCT00642304|547919|P1|COMPLETED|Overall Study||14
227714|NCT00642304|547919|P1|STARTED|Overall Study||20
227715|NCT00642278|547935|P7|NOT COMPLETED|Overall Study||5
227716|NCT00642278|547936|P6|NOT COMPLETED|Overall Study||7
227717|NCT00642278|547937|P5|NOT COMPLETED|Overall Study||8
227718|NCT00642278|547938|P4|NOT COMPLETED|Overall Study||9
227719|NCT00642278|547939|P3|NOT COMPLETED|Overall Study||5
227720|NCT00642278|547940|P2|NOT COMPLETED|Overall Study||5
227721|NCT00642278|547941|P1|NOT COMPLETED|Overall Study||10
227722|NCT00642278|547935|P7|COMPLETED|Overall Study||60
227723|NCT00642278|547936|P6|COMPLETED|Overall Study||57
227724|NCT00642278|547937|P5|COMPLETED|Overall Study||56
227725|NCT00642278|547938|P4|COMPLETED|Overall Study||56
227726|NCT00642278|547939|P3|COMPLETED|Overall Study||59
227727|NCT00642278|547940|P2|COMPLETED|Overall Study||59
227728|NCT00642278|547941|P1|COMPLETED|Overall Study||55
227729|NCT00642278|547935|P7|STARTED|Overall Study||65
227730|NCT00642278|547936|P6|STARTED|Overall Study||64
227731|NCT00642278|547937|P5|STARTED|Overall Study||64
227732|NCT00642278|547938|P4|STARTED|Overall Study||65
227733|NCT00642278|547939|P3|STARTED|Overall Study||64
227734|NCT00642278|547940|P2|STARTED|Overall Study||64
227735|NCT00642278|547941|P1|STARTED|Overall Study||65
227736|NCT00642174|547994|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
227737|NCT00642174|547995|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
227738|NCT00642174|547994|P2|COMPLETED|Period 2 - Crossover Drug||16
227739|NCT00642174|547995|P1|COMPLETED|Period 2 - Crossover Drug||18
227740|NCT00642174|547994|P2|STARTED|Period 2 - Crossover Drug||16
227741|NCT00642174|547995|P1|STARTED|Period 2 - Crossover Drug||18
227742|NCT00642174|547994|P2|NOT COMPLETED|Period 1 - Initial Drug||1
227743|NCT00642174|547995|P1|NOT COMPLETED|Period 1 - Initial Drug||0
227744|NCT00642174|547994|P2|COMPLETED|Period 1 - Initial Drug||16
227745|NCT00642174|547995|P1|COMPLETED|Period 1 - Initial Drug||18
227746|NCT00642174|547994|P2|STARTED|Period 1 - Initial Drug||17
227747|NCT00642174|547995|P1|STARTED|Period 1 - Initial Drug||18
227748|NCT00641862|548011|P2|NOT COMPLETED|Overall Study||38
227749|NCT00641862|548012|P1|NOT COMPLETED|Overall Study||44
227750|NCT00641862|548011|P2|COMPLETED|Overall Study||145
227751|NCT00641862|548012|P1|COMPLETED|Overall Study||139
227752|NCT00641862|548011|P2|STARTED|Overall Study||183
227753|NCT00641862|548012|P1|STARTED|Overall Study||183
227754|NCT00641797|548020|P2|NOT COMPLETED|Overall Study||0
227755|NCT00641797|548021|P1|NOT COMPLETED|Overall Study||0
227756|NCT00641797|548020|P2|COMPLETED|Overall Study||15
227757|NCT00641797|548021|P1|COMPLETED|Overall Study||11
227758|NCT00641797|548020|P2|STARTED|Overall Study||15
227759|NCT00641797|548021|P1|STARTED|Overall Study||11
227760|NCT00641745|548029|P2|NOT COMPLETED|Overall Study||113
227761|NCT00641745|548030|P1|NOT COMPLETED|Overall Study||280
227762|NCT00641745|548029|P2|COMPLETED|Overall Study||89
227763|NCT00641745|548030|P1|COMPLETED|Overall Study||147
227764|NCT00641745|548029|P2|STARTED|Overall Study||202
227765|NCT00641745|548030|P1|STARTED|Overall Study||427
227766|NCT00641719|548038|P2|NOT COMPLETED|Overall Study||37
227767|NCT00641719|548039|P1|NOT COMPLETED|Overall Study||30
227768|NCT00641719|548038|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
227769|NCT00641719|548039|P1|COMPLETED|Overall Study||99
227770|NCT00641719|548038|P2|STARTED|Overall Study||129
227771|NCT00641719|548039|P1|STARTED|Overall Study||129
227772|NCT00641706|548063|P2|NOT COMPLETED|Overall Study||3
227773|NCT00641706|548064|P1|NOT COMPLETED|Overall Study||9
227774|NCT00641706|548063|P2|COMPLETED|Overall Study||4
227775|NCT00641706|548064|P1|COMPLETED|Overall Study||28
227776|NCT00641706|548063|P2|STARTED|Overall Study||7
227777|NCT00641706|548064|P1|STARTED|Overall Study||37
227778|NCT00641667|548076|P1|NOT COMPLETED|Overall Study||6
227779|NCT00641667|548076|P1|COMPLETED|Overall Study||60
227780|NCT00641667|548076|P1|STARTED|Overall Study||66
227781|NCT00641641|548086|P1|NOT COMPLETED|Overall Study||0
227782|NCT00641641|548086|P1|COMPLETED|Overall Study||16
227783|NCT00641641|548086|P1|STARTED|Overall Study||16
227784|NCT00641563|548090|P2|NOT COMPLETED|Infusion 2||0
227785|NCT00641563|548091|P1|NOT COMPLETED|Infusion 2||0
227786|NCT00641563|548090|P2|COMPLETED|Infusion 2||5
227787|NCT00641563|548091|P1|COMPLETED|Infusion 2||5
227788|NCT00641563|548090|P2|STARTED|Infusion 2||5
227789|NCT00641563|548091|P1|STARTED|Infusion 2||5
227790|NCT00641563|548090|P2|NOT COMPLETED|Infusion 1||0
227791|NCT00641563|548091|P1|NOT COMPLETED|Infusion 1||0
227792|NCT00641563|548090|P2|COMPLETED|Infusion 1||5
227793|NCT00641563|548091|P1|COMPLETED|Infusion 1||5
227794|NCT00641563|548090|P2|STARTED|Infusion 1||5
227795|NCT00641563|548091|P1|STARTED|Infusion 1||5
227796|NCT00641537|548104|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
227797|NCT00641537|548105|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
227798|NCT00641537|548106|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
227799|NCT00641537|548107|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
227800|NCT00641537|548108|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
227801|NCT00641537|548109|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
227802|NCT00641537|548110|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
227803|NCT00641537|548111|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
227804|NCT00641537|548104|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
227805|NCT00641537|548105|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
227806|NCT00641537|548106|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
227807|NCT00641537|548107|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
227808|NCT00641537|548108|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
227809|NCT00641537|548109|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
227810|NCT00641537|548110|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
227811|NCT00641537|548111|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
227812|NCT00641537|548104|P8|STARTED|24-Week Supplemental Follow-up Period||11
227813|NCT00641537|548105|P7|STARTED|24-Week Supplemental Follow-up Period||9
227814|NCT00641537|548106|P6|STARTED|24-Week Supplemental Follow-up Period||15
227815|NCT00641537|548107|P5|STARTED|24-Week Supplemental Follow-up Period||198
227816|NCT00641537|548108|P4|STARTED|24-Week Supplemental Follow-up Period||151
227817|NCT00641537|548109|P3|STARTED|24-Week Supplemental Follow-up Period||143
227818|NCT00641537|548110|P2|STARTED|24-Week Supplemental Follow-up Period||69
227819|NCT00641537|548111|P1|STARTED|24-Week Supplemental Follow-up Period||75
227820|NCT00641537|548104|P8|NOT COMPLETED|96-week Period||6
227821|NCT00641537|548105|P7|NOT COMPLETED|96-week Period||5
227822|NCT00641537|548106|P6|NOT COMPLETED|96-week Period||7
227823|NCT00641537|548107|P5|NOT COMPLETED|96-week Period||18
227824|NCT00641537|548108|P4|NOT COMPLETED|96-week Period||12
227825|NCT00641537|548109|P3|NOT COMPLETED|96-week Period||20
227826|NCT00641537|548110|P2|NOT COMPLETED|96-week Period||10
227827|NCT00641537|548111|P1|NOT COMPLETED|96-week Period||9
227828|NCT00641537|548104|P8|COMPLETED|96-week Period||16
227829|NCT00641537|548105|P7|COMPLETED|96-week Period||12
227830|NCT00641537|548106|P6|COMPLETED|96-week Period||15
227831|NCT00641537|548107|P5|COMPLETED|96-week Period||226
227832|NCT00641537|548108|P4|COMPLETED|96-week Period||174
227833|NCT00641537|548109|P3|COMPLETED|96-week Period||166
227834|NCT00641537|548110|P2|COMPLETED|96-week Period||82
227835|NCT00641537|548111|P1|COMPLETED|96-week Period||89
227836|NCT00641537|548104|P8|STARTED|96-week Period||22
227837|NCT00641537|548105|P7|STARTED|96-week Period||17
227838|NCT00641537|548106|P6|STARTED|96-week Period||22
227839|NCT00641537|548107|P5|STARTED|96-week Period||244
227840|NCT00641537|548108|P4|STARTED|96-week Period||186
227841|NCT00641537|548109|P3|STARTED|96-week Period||186
227842|NCT00641537|548110|P2|STARTED|96-week Period||92
227843|NCT00641537|548111|P1|STARTED|96-week Period||98
227844|NCT00641147|548166|P2|NOT COMPLETED|Completed 16 Months.||0
227845|NCT00641147|548167|P1|NOT COMPLETED|Completed 16 Months.||2
227846|NCT00641147|548166|P2|COMPLETED|Completed 16 Months.||19
227847|NCT00641147|548167|P1|COMPLETED|Completed 16 Months.||13
227848|NCT00641147|548166|P2|STARTED|Completed 16 Months.||19
227849|NCT00641147|548167|P1|STARTED|Completed 16 Months.||15
227850|NCT00641147|548166|P2|NOT COMPLETED|Completed 12 Months.||2
227851|NCT00641147|548167|P1|NOT COMPLETED|Completed 12 Months.||1
227852|NCT00641147|548166|P2|COMPLETED|Completed 12 Months.||19
227853|NCT00641147|548167|P1|COMPLETED|Completed 12 Months.||15
227854|NCT00641147|548166|P2|STARTED|Completed 12 Months.||21
227855|NCT00641147|548167|P1|STARTED|Completed 12 Months.||16
227856|NCT00641147|548166|P2|NOT COMPLETED|Completed 8 Months.||2
227857|NCT00641147|548167|P1|NOT COMPLETED|Completed 8 Months.||3
227858|NCT00641147|548166|P2|COMPLETED|Completed 8 Months.||21
227859|NCT00641147|548167|P1|COMPLETED|Completed 8 Months.||16
227860|NCT00641147|548166|P2|STARTED|Completed 8 Months.||23
227861|NCT00641147|548167|P1|STARTED|Completed 8 Months.||19
227862|NCT00641147|548166|P2|NOT COMPLETED|Completed 4 Months.||0
227863|NCT00641147|548167|P1|NOT COMPLETED|Completed 4 Months.||2
227864|NCT00641147|548166|P2|COMPLETED|Completed 4 Months.||23
227865|NCT00641147|548167|P1|COMPLETED|Completed 4 Months.||19
227866|NCT00641147|548166|P2|STARTED|Completed 4 Months.||23
227867|NCT00641147|548167|P1|STARTED|Completed 4 Months.||21
227868|NCT00641056|548211|P2|NOT COMPLETED|Overall Study||25
227869|NCT00641056|548212|P1|NOT COMPLETED|Overall Study||29
227870|NCT00641056|548211|P2|COMPLETED|Overall Study||209
227871|NCT00641056|548212|P1|COMPLETED|Overall Study||204
227872|NCT00641056|548211|P2|Intent to Treat (ITT)|Overall Study||223
227873|NCT00641056|548212|P1|Intent to Treat (ITT)|Overall Study||233
227874|NCT00641056|548211|P2|STARTED|Overall Study||234
227875|NCT00641056|548212|P1|STARTED|Overall Study||233
227876|NCT00641043|548240|P2|NOT COMPLETED|Overall Study||15
227877|NCT00641043|548241|P1|NOT COMPLETED|Overall Study||19
227878|NCT00641043|548240|P2|COMPLETED|Overall Study|number who completed treatment|244
227879|NCT00641043|548241|P1|COMPLETED|Overall Study|number who completed treatment|111
227880|NCT00641043|548240|P2|STARTED|Overall Study|number who started treatment|259
227881|NCT00641043|548241|P1|STARTED|Overall Study|number who started treatment|130
227882|NCT00640978|548271|P1|NOT COMPLETED|Overall Study||0
227883|NCT00640978|548271|P1|COMPLETED|Overall Study||15
227884|NCT00640978|548271|P1|STARTED|Overall Study||15
227885|NCT00640926|548278|P3|NOT COMPLETED|Overall Study||8
227886|NCT00640926|548279|P2|NOT COMPLETED|Overall Study||6
227887|NCT00640926|548280|P1|NOT COMPLETED|Overall Study||8
227888|NCT00640926|548278|P3|COMPLETED|Overall Study||45
227889|NCT00640926|548279|P2|COMPLETED|Overall Study||46
227890|NCT00640926|548280|P1|COMPLETED|Overall Study||45
227891|NCT00640926|548278|P3|STARTED|Overall Study||53
227892|NCT00640926|548279|P2|STARTED|Overall Study||52
227893|NCT00640926|548280|P1|STARTED|Overall Study||53
227894|NCT00640835|548293|P2|NOT COMPLETED|Overall Study||57
227895|NCT00640835|548294|P1|NOT COMPLETED|Overall Study||76
227896|NCT00640835|548293|P2|COMPLETED|Overall Study||131
227897|NCT00640835|548294|P1|COMPLETED|Overall Study||118
227898|NCT00640835|548293|P2|STARTED|Overall Study||188
227899|NCT00640835|548294|P1|STARTED|Overall Study||194
227900|NCT00640822|548305|P3|NOT COMPLETED|Overall Study||25
227901|NCT00640822|548306|P2|NOT COMPLETED|Overall Study||59
227902|NCT00640822|548307|P1|NOT COMPLETED|Overall Study||43
227903|NCT00640822|548305|P3|COMPLETED|Overall Study||77
227904|NCT00640822|548306|P2|COMPLETED|Overall Study||258
227905|NCT00640822|548307|P1|COMPLETED|Overall Study||279
227906|NCT00640822|548305|P3|STARTED|Overall Study||102
227907|NCT00640822|548306|P2|STARTED|Overall Study||317
227908|NCT00640822|548307|P1|STARTED|Overall Study||322
227909|NCT00640653|548320|P5|NOT COMPLETED|Overall Study||5
227910|NCT00640653|548321|P4|NOT COMPLETED|Overall Study||2
227911|NCT00640653|548322|P3|NOT COMPLETED|Overall Study||0
227912|NCT00640653|548323|P2|NOT COMPLETED|Overall Study||3
227913|NCT00640653|548324|P1|NOT COMPLETED|Overall Study||3
227914|NCT00640653|548320|P5|COMPLETED|Overall Study||129
227915|NCT00640653|548321|P4|COMPLETED|Overall Study||132
227916|NCT00640653|548322|P3|COMPLETED|Overall Study||129
227917|NCT00640653|548323|P2|COMPLETED|Overall Study||131
227918|NCT00640653|548324|P1|COMPLETED|Overall Study||128
227919|NCT00640653|548320|P5|Followed-up at 24 mo|Overall Study||112
227920|NCT00640653|548321|P4|Followed-up at 24 mo|Overall Study||112
227921|NCT00640653|548322|P3|Followed-up at 24 mo|Overall Study||105
227922|NCT00640653|548323|P2|Followed-up at 24 mo|Overall Study||116
227923|NCT00640653|548324|P1|Followed-up at 24 mo|Overall Study||114
227924|NCT00640653|548320|P5|Followed-up at 18 mo|Overall Study||117
227925|NCT00640653|548321|P4|Followed-up at 18 mo|Overall Study||117
227926|NCT00640653|548322|P3|Followed-up at 18 mo|Overall Study||113
227927|NCT00640653|548323|P2|Followed-up at 18 mo|Overall Study||112
227928|NCT00640653|548324|P1|Followed-up at 18 mo|Overall Study||118
227929|NCT00640653|548320|P5|Followed-up at 12 mo|Overall Study||116
227930|NCT00640653|548321|P4|Followed-up at 12 mo|Overall Study||122
227931|NCT00640653|548322|P3|Followed-up at 12 mo|Overall Study||115
227932|NCT00640653|548323|P2|Followed-up at 12 mo|Overall Study||121
227933|NCT00640653|548324|P1|Followed-up at 12 mo|Overall Study||124
227934|NCT00640653|548320|P5|Followed-up at 6 mo|Overall Study||125
227935|NCT00640653|548321|P4|Followed-up at 6 mo|Overall Study||130
227936|NCT00640653|548322|P3|Followed-up at 6 mo|Overall Study||124
227937|NCT00640653|548323|P2|Followed-up at 6 mo|Overall Study||130
227938|NCT00640653|548324|P1|Followed-up at 6 mo|Overall Study||127
227939|NCT00640653|548320|P5|Followed-up at 3 mo|Overall Study||126
227940|NCT00640653|548321|P4|Followed-up at 3 mo|Overall Study||129
227941|NCT00640653|548322|P3|Followed-up at 3 mo|Overall Study||125
227942|NCT00640653|548323|P2|Followed-up at 3 mo|Overall Study||127
227943|NCT00640653|548324|P1|Followed-up at 3 mo|Overall Study||126
227944|NCT00640653|548320|P5|STARTED|Overall Study||134
227945|NCT00640653|548321|P4|STARTED|Overall Study||134
227946|NCT00640653|548322|P3|STARTED|Overall Study||129
227947|NCT00640653|548323|P2|STARTED|Overall Study||134
227948|NCT00640653|548324|P1|STARTED|Overall Study||131
227949|NCT00640614|548358|P2|NOT COMPLETED|Overall Study||0
227950|NCT00640614|548359|P1|NOT COMPLETED|Overall Study||1
227951|NCT00640614|548358|P2|COMPLETED|Overall Study||110
227952|NCT00640614|548359|P1|COMPLETED|Overall Study||124
227953|NCT00640614|548358|P2|STARTED|Overall Study||110
227954|NCT00640614|548359|P1|STARTED|Overall Study||125
227955|NCT00640601|548401|P1|NOT COMPLETED|Overall Study||112
227956|NCT00640601|548401|P1|COMPLETED|Overall Study||183
227957|NCT00640601|548401|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
227958|NCT00640562|548417|P2|NOT COMPLETED|Overall Study||26
227959|NCT00640562|548418|P1|NOT COMPLETED|Overall Study||18
227960|NCT00640562|548417|P2|COMPLETED|Overall Study||81
227961|NCT00640562|548418|P1|COMPLETED|Overall Study||91
227962|NCT00640562|548417|P2|STARTED|Overall Study||107
227963|NCT00640562|548418|P1|STARTED|Overall Study||109
227964|NCT00640510|548446|P2|NOT COMPLETED|Overall Study||2
227965|NCT00640510|548447|P1|NOT COMPLETED|Overall Study||1
227966|NCT00640510|548446|P2|COMPLETED|Overall Study||15
227967|NCT00640510|548447|P1|COMPLETED|Overall Study||16
227968|NCT00640510|548446|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
227969|NCT00640510|548447|P1|STARTED|Overall Study||17
227970|NCT00640393|548459|P3|NOT COMPLETED|Part 2||3
227971|NCT00640393|548460|P2|NOT COMPLETED|Part 2||10
227972|NCT00640393|548461|P1|NOT COMPLETED|Part 2||0
227973|NCT00640393|548459|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
227974|NCT00640393|548460|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
227975|NCT00640393|548461|P1|COMPLETED|Part 2||0
227976|NCT00640393|548459|P3|STARTED|Part 2||38
227977|NCT00640393|548460|P2|STARTED|Part 2||37
227978|NCT00640393|548461|P1|STARTED|Part 2||0
227979|NCT00640393|548459|P3|NOT COMPLETED|Randomization||0
227980|NCT00640393|548460|P2|NOT COMPLETED|Randomization||0
227981|NCT00640393|548461|P1|NOT COMPLETED|Randomization||19
227982|NCT00640393|548459|P3|COMPLETED|Randomization||0
227983|NCT00640393|548460|P2|COMPLETED|Randomization||0
227984|NCT00640393|548461|P1|COMPLETED|Randomization||75
227985|NCT00640393|548459|P3|STARTED|Randomization||0
227986|NCT00640393|548460|P2|STARTED|Randomization||0
227987|NCT00640393|548461|P1|STARTED|Randomization||94
227988|NCT00640393|548459|P3|NOT COMPLETED|Part 1||0
227989|NCT00640393|548460|P2|NOT COMPLETED|Part 1||0
227990|NCT00640393|548461|P1|NOT COMPLETED|Part 1||5
227991|NCT00640393|548459|P3|COMPLETED|Part 1||0
227992|NCT00640393|548460|P2|COMPLETED|Part 1||0
227993|NCT00640393|548461|P1|COMPLETED|Part 1||94
227994|NCT00640393|548459|P3|STARTED|Part 1||0
227995|NCT00640393|548460|P2|STARTED|Part 1||0
227996|NCT00640393|548461|P1|STARTED|Part 1||99
227997|NCT00640341|548526|P3|NOT COMPLETED|Overall Study||7
227998|NCT00640341|548527|P2|NOT COMPLETED|Overall Study||5
227999|NCT00640341|548528|P1|NOT COMPLETED|Overall Study||21
228000|NCT00640341|548526|P3|COMPLETED|Overall Study||163
228001|NCT00640341|548527|P2|COMPLETED|Overall Study||165
228002|NCT00640341|548528|P1|COMPLETED|Overall Study||149
228003|NCT00640341|548526|P3|Eligible Participants at Baseline|Overall Study||168
228004|NCT00640341|548527|P2|Eligible Participants at Baseline|Overall Study||167
228005|NCT00640341|548528|P1|Eligible Participants at Baseline|Overall Study||165
228006|NCT00640341|548526|P3|STARTED|Overall Study||170
228007|NCT00640341|548527|P2|STARTED|Overall Study||170
228008|NCT00640341|548528|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
228009|NCT00640328|548548|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
228010|NCT00640328|548549|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
228011|NCT00640328|548550|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
228012|NCT00640328|548551|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
228013|NCT00640328|548552|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
228014|NCT00640328|548553|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
228015|NCT00640328|548548|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
228016|NCT00640328|548549|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
228017|NCT00640328|548550|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
228018|NCT00640328|548551|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
228019|NCT00640328|548552|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
228020|NCT00640328|548553|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
228021|NCT00640328|548548|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
228022|NCT00640328|548549|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
228023|NCT00640328|548550|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
228024|NCT00640328|548551|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
228025|NCT00640328|548552|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
228026|NCT00640328|548553|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
228027|NCT00640328|548548|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
228028|NCT00640328|548549|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
228029|NCT00640328|548550|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
228030|NCT00640328|548551|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
228031|NCT00640328|548552|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
228032|NCT00640328|548553|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
228033|NCT00640328|548548|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
228034|NCT00640328|548549|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
228035|NCT00640328|548550|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
228036|NCT00640328|548551|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
228037|NCT00640328|548552|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
228038|NCT00640328|548553|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
228039|NCT00640328|548548|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
228040|NCT00640328|548549|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
228041|NCT00640328|548550|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
228042|NCT00640328|548551|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
228043|NCT00640328|548552|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
228044|NCT00640328|548553|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
228045|NCT00640328|548548|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
228046|NCT00640328|548549|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
228047|NCT00640328|548550|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
228048|NCT00640328|548551|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
228049|NCT00640328|548552|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
228050|NCT00640328|548553|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
228051|NCT00640328|548548|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
228052|NCT00640328|548549|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
228053|NCT00640328|548550|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
228054|NCT00640328|548551|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
228055|NCT00640328|548552|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
228056|NCT00640328|548553|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
228057|NCT00640328|548548|P6|STARTED|First Treatment Period (Weeks 0-24)||4
228058|NCT00640328|548549|P5|STARTED|First Treatment Period (Weeks 0-24)||4
228059|NCT00640328|548550|P4|STARTED|First Treatment Period (Weeks 0-24)||4
228060|NCT00640328|548551|P3|STARTED|First Treatment Period (Weeks 0-24)||7
228061|NCT00640328|548552|P2|STARTED|First Treatment Period (Weeks 0-24)||11
228062|NCT00640328|548553|P1|STARTED|First Treatment Period (Weeks 0-24)||8
228063|NCT00640315|548719|P2|NOT COMPLETED|Overall Study||1
228064|NCT00640315|548720|P1|NOT COMPLETED|Overall Study||0
228065|NCT00640315|548719|P2|COMPLETED|Overall Study||12
228066|NCT00640315|548720|P1|COMPLETED|Overall Study||10
228067|NCT00640315|548719|P2|Participants Received Treatment|Overall Study||13
228068|NCT00640315|548720|P1|Participants Received Treatment|Overall Study||10
228069|NCT00640315|548719|P2|STARTED|Overall Study||13
228070|NCT00640315|548720|P1|STARTED|Overall Study||10
228071|NCT00640250|548846|P1|NOT COMPLETED|Overall Study||0
228072|NCT00640250|548846|P1|COMPLETED|Overall Study||48
228073|NCT00640250|548846|P1|STARTED|Overall Study||48
228074|NCT00640224|548953|P4|NOT COMPLETED|Overall Study||0
228075|NCT00640224|548954|P3|NOT COMPLETED|Overall Study||0
228076|NCT00640224|548955|P2|NOT COMPLETED|Overall Study||3
228077|NCT00640224|548956|P1|NOT COMPLETED|Overall Study||6
228078|NCT00640224|548953|P4|COMPLETED|Overall Study||0
228079|NCT00640224|548954|P3|COMPLETED|Overall Study||0
228080|NCT00640224|548955|P2|COMPLETED|Overall Study||20
228081|NCT00640224|548956|P1|COMPLETED|Overall Study||17
228082|NCT00640224|548953|P4|STARTED|Overall Study||0
228083|NCT00640224|548954|P3|STARTED|Overall Study||0
228084|NCT00640224|548955|P2|STARTED|Overall Study||23
228085|NCT00640224|548956|P1|STARTED|Overall Study||23
228086|NCT00640042|549054|P1|NOT COMPLETED|Treatment||926
228087|NCT00640042|549054|P1|COMPLETED|Treatment||561
228088|NCT00640042|549054|P1|STARTED|Treatment||1487
228089|NCT00640042|549054|P1|NOT COMPLETED|Enrollment||83
228090|NCT00640042|549054|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
228091|NCT00640042|549054|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
228092|NCT00640016|549070|P4|NOT COMPLETED|Overall Study||3
228093|NCT00640016|549071|P3|NOT COMPLETED|Overall Study||3
228094|NCT00640016|549072|P2|NOT COMPLETED|Overall Study||2
228095|NCT00640016|549073|P1|NOT COMPLETED|Overall Study||2
228096|NCT00640016|549070|P4|COMPLETED|Overall Study||1
228097|NCT00640016|549071|P3|COMPLETED|Overall Study||1
228098|NCT00640016|549072|P2|COMPLETED|Overall Study||1
228099|NCT00640016|549073|P1|COMPLETED|Overall Study||1
228100|NCT00640016|549070|P4|Treated|Overall Study||4
228101|NCT00640016|549071|P3|Treated|Overall Study||4
228102|NCT00640016|549072|P2|Treated|Overall Study||2
228103|NCT00640016|549073|P1|Treated|Overall Study||3
228104|NCT00640016|549070|P4|STARTED|Overall Study||4
228105|NCT00640016|549071|P3|STARTED|Overall Study||4
228106|NCT00640016|549072|P2|STARTED|Overall Study||3
228107|NCT00640016|549073|P1|STARTED|Overall Study||3
228108|NCT00639860|549117|P1|NOT COMPLETED|Overall Study||0
228109|NCT00639860|549117|P1|COMPLETED|Overall Study||10
228110|NCT00639860|549117|P1|STARTED|Overall Study||10
228111|NCT00639769|549125|P1|NOT COMPLETED|Overall Study||40
228112|NCT00639769|549125|P1|COMPLETED|Overall Study||0
228113|NCT00639769|549125|P1|STARTED|Overall Study||40
228114|NCT00639717|549130|P1|NOT COMPLETED|Overall Study||0
228115|NCT00639717|549130|P1|COMPLETED|Overall Study||48
228116|NCT00639717|549130|P1|STARTED|Overall Study||48
228117|NCT00639678|549142|P4|NOT COMPLETED|Overall Study||0
228118|NCT00639678|549143|P3|NOT COMPLETED|Overall Study||11
228119|NCT00639678|549144|P2|NOT COMPLETED|Overall Study||1
228120|NCT00639678|549145|P1|NOT COMPLETED|Overall Study||4
228121|NCT00639678|549142|P4|COMPLETED|Overall Study||23
228122|NCT00639678|549143|P3|COMPLETED|Overall Study||206
228123|NCT00639678|549144|P2|COMPLETED|Overall Study||5
228124|NCT00639678|549145|P1|COMPLETED|Overall Study||70
228125|NCT00639678|549142|P4|STARTED|Overall Study||23
228126|NCT00639678|549143|P3|STARTED|Overall Study||217
228127|NCT00639678|549144|P2|STARTED|Overall Study||6
228128|NCT00639678|549145|P1|STARTED|Overall Study||74
228129|NCT00639626|549205|P1|NOT COMPLETED|Overall Study||0
228130|NCT00639626|549205|P1|COMPLETED|Overall Study||0
228131|NCT00639626|549205|P1|STARTED|Overall Study||0
228132|NCT00639509|549210|P1|NOT COMPLETED|Overall Study||1
228133|NCT00639509|549210|P1|COMPLETED|Overall Study||23
228134|NCT00639509|549210|P1|STARTED|Overall Study||24
228135|NCT00639457|549218|P2|NOT COMPLETED|Overall Study||3
228136|NCT00639457|549219|P1|NOT COMPLETED|Overall Study||2
228137|NCT00639457|549218|P2|COMPLETED|Overall Study||19
228138|NCT00639457|549219|P1|COMPLETED|Overall Study||20
228139|NCT00639457|549218|P2|STARTED|Overall Study||22
228140|NCT00639457|549219|P1|STARTED|Overall Study||22
228141|NCT00639418|549257|P4|NOT COMPLETED|Overall Study||0
228142|NCT00639418|549258|P3|NOT COMPLETED|Overall Study||0
228143|NCT00639418|549259|P2|NOT COMPLETED|Overall Study||0
228144|NCT00639418|549260|P1|NOT COMPLETED|Overall Study||0
228145|NCT00639418|549257|P4|COMPLETED|Overall Study||46930
228146|NCT00639418|549258|P3|COMPLETED|Overall Study||36496
228147|NCT00639418|549259|P2|COMPLETED|Overall Study||35967
228148|NCT00639418|549260|P1|COMPLETED|Overall Study||28101
228149|NCT00639418|549257|P4|STARTED|Overall Study||46930
228150|NCT00639418|549258|P3|STARTED|Overall Study||36496
228151|NCT00639418|549259|P2|STARTED|Overall Study||35967
228152|NCT00639418|549260|P1|STARTED|Overall Study||28101
228153|NCT00639379|549278|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
228154|NCT00639379|549279|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
228155|NCT00639379|549278|P2|COMPLETED|Period 2 - 2 Weeks||45
228156|NCT00639379|549279|P1|COMPLETED|Period 2 - 2 Weeks||39
228157|NCT00639379|549278|P2|STARTED|Period 2 - 2 Weeks||45
228158|NCT00639379|549279|P1|STARTED|Period 2 - 2 Weeks||39
228159|NCT00639379|549278|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
228160|NCT00639379|549279|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
228161|NCT00639379|549278|P2|COMPLETED|Period 1 - 2 Weeks||45
228162|NCT00639379|549279|P1|COMPLETED|Period 1 - 2 Weeks||39
228163|NCT00639379|549278|P2|STARTED|Period 1 - 2 Weeks||45
228164|NCT00639379|549279|P1|STARTED|Period 1 - 2 Weeks||44
228165|NCT00639223|549295|P2|NOT COMPLETED|Overall Study||2
228166|NCT00639223|549296|P1|NOT COMPLETED|Overall Study||0
228167|NCT00639223|549295|P2|COMPLETED|Overall Study||19
228168|NCT00639223|549296|P1|COMPLETED|Overall Study||22
228169|NCT00639223|549295|P2|STARTED|Overall Study||21
228170|NCT00639223|549296|P1|STARTED|Overall Study||22
228171|NCT00639158|549306|P2|NOT COMPLETED|Overall Study||30
228172|NCT00639158|549307|P1|NOT COMPLETED|Overall Study||26
228173|NCT00639158|549306|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
228174|NCT00639158|549307|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
228175|NCT00639158|549306|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
228176|NCT00639158|549307|P1|STARTED|Overall Study|All randomized subjects were treated.|272
228177|NCT00639093|549329|P2|NOT COMPLETED|Overall Study||0
228178|NCT00639093|549330|P1|NOT COMPLETED|Overall Study||0
228179|NCT00639093|549329|P2|COMPLETED|Overall Study|46|46
228180|NCT00639093|549330|P1|COMPLETED|Overall Study|45|45
228181|NCT00639093|549329|P2|STARTED|Overall Study|46|46
228182|NCT00639093|549330|P1|STARTED|Overall Study|45|45
228183|NCT00639002|549336|P1|NOT COMPLETED|Overall Study||13
228184|NCT00639002|549336|P1|COMPLETED|Overall Study||0
228185|NCT00639002|549336|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
228186|NCT00639002|549336|P1|Received Ruxolitinib|Overall Study||13
228187|NCT00639002|549336|P1|STARTED|Overall Study||13
228188|NCT00638989|549345|P3|NOT COMPLETED|Overall Study||1
228189|NCT00638989|549346|P2|NOT COMPLETED|Overall Study||0
228190|NCT00638989|549347|P1|NOT COMPLETED|Overall Study||0
228191|NCT00638989|549345|P3|COMPLETED|Overall Study||9
228192|NCT00638989|549346|P2|COMPLETED|Overall Study||10
228193|NCT00638989|549347|P1|COMPLETED|Overall Study||10
228194|NCT00638989|549345|P3|STARTED|Overall Study||10
228195|NCT00638989|549346|P2|STARTED|Overall Study||10
228196|NCT00638989|549347|P1|STARTED|Overall Study||10
228197|NCT00638963|549387|P2|NOT COMPLETED|Overall Study||0
228198|NCT00638963|549388|P1|NOT COMPLETED|Overall Study||1
228199|NCT00638963|549387|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
228200|NCT00638963|549388|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
228201|NCT00638963|549387|P2|STARTED|Overall Study|Received randomized treatment assignment|3
228202|NCT00638963|549388|P1|STARTED|Overall Study|Received randomized treatment assignment|3
228203|NCT00638937|549407|P1|NOT COMPLETED|Overall Study||0
228204|NCT00638937|549407|P1|COMPLETED|Overall Study||37
228205|NCT00638937|549407|P1|STARTED|Overall Study||37
228206|NCT00638924|549417|P1|NOT COMPLETED|Overall Study||0
228207|NCT00638924|549417|P1|COMPLETED|Overall Study||40
228208|NCT00638924|549417|P1|2 Months|Overall Study||40
228209|NCT00638924|549417|P1|STARTED|Overall Study||40
228210|NCT00638885|549422|P1|NOT COMPLETED|Overall Study||0
228211|NCT00638885|549422|P1|COMPLETED|Overall Study||142
228212|NCT00638885|549422|P1|STARTED|Overall Study||142
228213|NCT00638846|549428|P2|NOT COMPLETED|Overall Study||6
228214|NCT00638846|549429|P1|NOT COMPLETED|Overall Study||4
228215|NCT00638846|549428|P2|COMPLETED|Overall Study||133
228216|NCT00638846|549429|P1|COMPLETED|Overall Study||133
228217|NCT00638846|549428|P2|STARTED|Overall Study||139
228218|NCT00638846|549429|P1|STARTED|Overall Study||137
228219|NCT00638820|549445|P1|NOT COMPLETED|Overall Study||0
228220|NCT00638820|549445|P1|COMPLETED|Overall Study||3
228221|NCT00638820|549445|P1|STARTED|Overall Study||3
228222|NCT00638716|549455|P3|NOT COMPLETED|Overall Study||12
228223|NCT00638716|549456|P2|NOT COMPLETED|Overall Study||15
228224|NCT00638716|549457|P1|NOT COMPLETED|Overall Study||7
228225|NCT00638716|549455|P3|COMPLETED|Overall Study||46
228226|NCT00638716|549456|P2|COMPLETED|Overall Study||37
228227|NCT00638716|549457|P1|COMPLETED|Overall Study||43
228228|NCT00638716|549455|P3|STARTED|Overall Study||58
228229|NCT00638716|549456|P2|STARTED|Overall Study||52
228230|NCT00638716|549457|P1|STARTED|Overall Study||50
228231|NCT00638690|549473|P2|NOT COMPLETED|Overall Study||342
228232|NCT00638690|549474|P1|NOT COMPLETED|Overall Study||681
228233|NCT00638690|549473|P2|COMPLETED|Overall Study||56
228234|NCT00638690|549474|P1|COMPLETED|Overall Study||116
228235|NCT00638690|549473|P2|STARTED|Overall Study||398
228236|NCT00638690|549474|P1|STARTED|Overall Study||797
228237|NCT00638651|549487|P1|NOT COMPLETED|Overall Study||0
228238|NCT00638651|549487|P1|COMPLETED|Overall Study||3
228239|NCT00638651|549487|P1|STARTED|Overall Study||3
228240|NCT00638443|549492|P2|NOT COMPLETED|Second Intervention||0
228241|NCT00638443|549493|P1|NOT COMPLETED|Second Intervention||0
228242|NCT00638443|549492|P2|COMPLETED|Second Intervention||14
228243|NCT00638443|549493|P1|COMPLETED|Second Intervention||12
228244|NCT00638443|549492|P2|STARTED|Second Intervention||14
228245|NCT00638443|549493|P1|STARTED|Second Intervention||12
228246|NCT00638443|549492|P2|NOT COMPLETED|Washout||0
228247|NCT00638443|549493|P1|NOT COMPLETED|Washout||0
228248|NCT00638443|549492|P2|COMPLETED|Washout||14
228249|NCT00638443|549493|P1|COMPLETED|Washout||12
228250|NCT00638443|549492|P2|STARTED|Washout||14
228251|NCT00638443|549493|P1|STARTED|Washout||12
228252|NCT00638443|549492|P2|NOT COMPLETED|First Intervention||1
228253|NCT00638443|549493|P1|NOT COMPLETED|First Intervention||2
228254|NCT00638443|549492|P2|COMPLETED|First Intervention||14
228255|NCT00638443|549493|P1|COMPLETED|First Intervention||12
228256|NCT00638443|549492|P2|STARTED|First Intervention||15
228257|NCT00638443|549493|P1|STARTED|First Intervention||14
228258|NCT00638378|549521|P1|NOT COMPLETED|Overall Study||22
228259|NCT00638378|549521|P1|COMPLETED|Overall Study||0
228260|NCT00638378|549521|P1|STARTED|Overall Study||22
228261|NCT00638365|549531|P3|NOT COMPLETED|Overall Study||0
228262|NCT00638365|549532|P2|NOT COMPLETED|Overall Study||0
228263|NCT00638365|549533|P1|NOT COMPLETED|Overall Study||0
228264|NCT00638365|549531|P3|COMPLETED|Overall Study||8
228265|NCT00638365|549532|P2|COMPLETED|Overall Study||10
228266|NCT00638365|549533|P1|COMPLETED|Overall Study||9
228267|NCT00638365|549531|P3|STARTED|Overall Study||8
228268|NCT00638365|549532|P2|STARTED|Overall Study||10
228269|NCT00638365|549533|P1|STARTED|Overall Study||9
228270|NCT00638235|549550|P9|NOT COMPLETED|Overall Study||18
228271|NCT00638235|549551|P8|NOT COMPLETED|Overall Study||1
228272|NCT00638235|549552|P7|NOT COMPLETED|Overall Study||0
228273|NCT00638235|549553|P6|NOT COMPLETED|Overall Study||26
228274|NCT00638235|549554|P5|NOT COMPLETED|Overall Study||13
228275|NCT00638235|549555|P4|NOT COMPLETED|Overall Study||10
228276|NCT00638235|549556|P3|NOT COMPLETED|Overall Study||18
228277|NCT00638235|549557|P2|NOT COMPLETED|Overall Study||3
228278|NCT00638235|549558|P1|NOT COMPLETED|Overall Study||31
228279|NCT00638235|549550|P9|COMPLETED|Overall Study||124
228280|NCT00638235|549551|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
228281|NCT00638235|549552|P7|COMPLETED|Overall Study||23
228282|NCT00638235|549553|P6|COMPLETED|Overall Study||113
228283|NCT00638235|549554|P5|COMPLETED|Overall Study||42
228284|NCT00638235|549555|P4|COMPLETED|Overall Study||46
228285|NCT00638235|549556|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
228286|NCT00638235|549557|P2|COMPLETED|Overall Study||23
228287|NCT00638235|549558|P1|COMPLETED|Overall Study||110
228288|NCT00638235|549550|P9|STARTED|Overall Study||142
228289|NCT00638235|549551|P8|STARTED|Overall Study||35
228290|NCT00638235|549552|P7|STARTED|Overall Study||23
228291|NCT00638235|549553|P6|STARTED|Overall Study||139
228292|NCT00638235|549554|P5|STARTED|Overall Study||55
228293|NCT00638235|549555|P4|STARTED|Overall Study||56
228294|NCT00638235|549556|P3|STARTED|Overall Study||81
228295|NCT00638235|549557|P2|STARTED|Overall Study||26
228296|NCT00638235|549558|P1|STARTED|Overall Study||141
228297|NCT00638222|549959|P3|NOT COMPLETED|Overall Study||0
228298|NCT00638222|549960|P2|NOT COMPLETED|Overall Study||0
228299|NCT00638222|549961|P1|NOT COMPLETED|Overall Study||0
228300|NCT00638222|549959|P3|COMPLETED|Overall Study||6
228301|NCT00638222|549960|P2|COMPLETED|Overall Study||0
228302|NCT00638222|549961|P1|COMPLETED|Overall Study||0
228303|NCT00638222|549959|P3|STARTED|Overall Study||6
228304|NCT00638222|549960|P2|STARTED|Overall Study||0
228305|NCT00638222|549961|P1|STARTED|Overall Study||0
228306|NCT00638183|549968|P1|NOT COMPLETED|Overall Study||119
228307|NCT00638183|549968|P1|COMPLETED|Overall Study||266
228308|NCT00638183|549968|P1|STARTED|Overall Study||385
228309|NCT00638157|549977|P2|NOT COMPLETED|Overall Study||4
228310|NCT00638157|549978|P1|NOT COMPLETED|Overall Study||7
228311|NCT00638157|549977|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
228312|NCT00638157|549978|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
228313|NCT00638157|549977|P2|Treated|Overall Study||12
228314|NCT00638157|549978|P1|Treated|Overall Study||10
228315|NCT00638157|549977|P2|STARTED|Overall Study||12
228316|NCT00638157|549978|P1|STARTED|Overall Study||12
228317|NCT00638027|549988|P2|NOT COMPLETED|Overall Study||2
228318|NCT00638027|549989|P1|NOT COMPLETED|Overall Study||0
228319|NCT00638027|549988|P2|COMPLETED|Overall Study|all 10 included in analyses|8
228320|NCT00638027|549989|P1|COMPLETED|Overall Study||11
228321|NCT00638027|549988|P2|STARTED|Overall Study||10
228322|NCT00638027|549989|P1|STARTED|Overall Study||11
228323|NCT00638014|550001|P2|NOT COMPLETED|Overall Study||0
228324|NCT00638014|550002|P1|NOT COMPLETED|Overall Study||0
228325|NCT00638014|550001|P2|COMPLETED|Overall Study||28
228326|NCT00638014|550002|P1|COMPLETED|Overall Study||23
228327|NCT00638014|550001|P2|STARTED|Overall Study||28
228328|NCT00638014|550002|P1|STARTED|Overall Study||23
228329|NCT00637923|550012|P2|NOT COMPLETED|Overall Study||19
228330|NCT00637923|550013|P1|NOT COMPLETED|Overall Study||30
228331|NCT00637923|550012|P2|COMPLETED|Overall Study||18
228332|NCT00637923|550013|P1|COMPLETED|Overall Study||45
228333|NCT00637923|550012|P2|STARTED|Overall Study||37
228334|NCT00637923|550013|P1|STARTED|Overall Study||75
228335|NCT00637806|550036|P4|NOT COMPLETED|Extension Phase||1
228336|NCT00637806|550037|P3|NOT COMPLETED|Extension Phase||0
228337|NCT00637806|550038|P2|NOT COMPLETED|Extension Phase||0
228338|NCT00637806|550039|P1|NOT COMPLETED|Extension Phase||0
228339|NCT00637806|550036|P4|COMPLETED|Extension Phase||0
228340|NCT00637806|550037|P3|COMPLETED|Extension Phase||0
228341|NCT00637806|550038|P2|COMPLETED|Extension Phase||0
228342|NCT00637806|550039|P1|COMPLETED|Extension Phase||0
228343|NCT00637806|550036|P4|STARTED|Extension Phase||1
228344|NCT00637806|550037|P3|STARTED|Extension Phase||0
228345|NCT00637806|550038|P2|STARTED|Extension Phase||0
228346|NCT00637806|550039|P1|STARTED|Extension Phase||0
228347|NCT00637806|550036|P4|NOT COMPLETED|Double-blind Phase||0
228348|NCT00637806|550037|P3|NOT COMPLETED|Double-blind Phase||1
228349|NCT00637806|550038|P2|NOT COMPLETED|Double-blind Phase||0
228350|NCT00637806|550039|P1|NOT COMPLETED|Double-blind Phase||2
228351|NCT00637806|550036|P4|COMPLETED|Double-blind Phase||0
228352|NCT00637806|550037|P3|COMPLETED|Double-blind Phase||1
228353|NCT00637806|550038|P2|COMPLETED|Double-blind Phase||0
228354|NCT00637806|550039|P1|COMPLETED|Double-blind Phase||0
228355|NCT00637806|550036|P4|STARTED|Double-blind Phase||0
228356|NCT00637806|550037|P3|STARTED|Double-blind Phase||2
228357|NCT00637806|550038|P2|STARTED|Double-blind Phase||0
228358|NCT00637806|550039|P1|STARTED|Double-blind Phase||2
228359|NCT00637780|550057|P1|NOT COMPLETED|Overall Study||0
228360|NCT00637780|550057|P1|COMPLETED|Overall Study||2
228361|NCT00637780|550057|P1|STARTED|Overall Study||2
228362|NCT00637728|550074|P3|NOT COMPLETED|Extension Phase||0
228363|NCT00637728|550075|P2|NOT COMPLETED|Extension Phase||0
228364|NCT00637728|550076|P1|NOT COMPLETED|Extension Phase||0
228365|NCT00637728|550074|P3|COMPLETED|Extension Phase||0
228366|NCT00637728|550075|P2|COMPLETED|Extension Phase||0
228367|NCT00637728|550076|P1|COMPLETED|Extension Phase||0
228368|NCT00637728|550074|P3|STARTED|Extension Phase||0
228369|NCT00637728|550075|P2|STARTED|Extension Phase||0
228370|NCT00637728|550076|P1|STARTED|Extension Phase||0
228371|NCT00637728|550074|P3|NOT COMPLETED|Double-blind Phase||0
228372|NCT00637728|550075|P2|NOT COMPLETED|Double-blind Phase||1
228373|NCT00637728|550076|P1|NOT COMPLETED|Double-blind Phase||4
228374|NCT00637728|550074|P3|COMPLETED|Double-blind Phase||0
228375|NCT00637728|550075|P2|COMPLETED|Double-blind Phase||0
228376|NCT00637728|550076|P1|COMPLETED|Double-blind Phase||0
228377|NCT00637728|550074|P3|STARTED|Double-blind Phase||0
228378|NCT00637728|550075|P2|STARTED|Double-blind Phase||1
228379|NCT00637728|550076|P1|STARTED|Double-blind Phase||4
228380|NCT00637572|550091|P2|NOT COMPLETED|Overall Study||7
228381|NCT00637572|550092|P1|NOT COMPLETED|Overall Study||3
228382|NCT00637572|550091|P2|COMPLETED|Overall Study||24
228383|NCT00637572|550092|P1|COMPLETED|Overall Study||29
228384|NCT00637572|550091|P2|STARTED|Overall Study||31
228385|NCT00637572|550092|P1|STARTED|Overall Study||32
228386|NCT00637494|550120|P2|NOT COMPLETED|Overall Study||43
228387|NCT00637494|550121|P1|NOT COMPLETED|Overall Study||32
228388|NCT00637494|550120|P2|COMPLETED|Overall Study||108
228389|NCT00637494|550121|P1|COMPLETED|Overall Study||109
228390|NCT00637494|550120|P2|STARTED|Overall Study||151
228391|NCT00637494|550121|P1|STARTED|Overall Study||141
228392|NCT00637416|550131|P2|NOT COMPLETED|Overall Study||2
228393|NCT00637416|550132|P1|NOT COMPLETED|Overall Study||1
228394|NCT00637416|550131|P2|COMPLETED|Overall Study||3
228395|NCT00637416|550132|P1|COMPLETED|Overall Study||3
228396|NCT00637416|550131|P2|STARTED|Overall Study||5
228397|NCT00637416|550132|P1|STARTED|Overall Study||4
228398|NCT00637377|550142|P4|NOT COMPLETED|Overall Study||29
228399|NCT00637377|550143|P3|NOT COMPLETED|Overall Study||37
228400|NCT00637377|550144|P2|NOT COMPLETED|Overall Study||32
228401|NCT00637377|550145|P1|NOT COMPLETED|Overall Study||27
228402|NCT00637377|550142|P4|COMPLETED|Overall Study||284
228403|NCT00637377|550143|P3|COMPLETED|Overall Study||274
228404|NCT00637377|550144|P2|COMPLETED|Overall Study||281
228405|NCT00637377|550145|P1|COMPLETED|Overall Study||276
228406|NCT00637377|550142|P4|Participants Treated (FAS)|Overall Study||306
228407|NCT00637377|550143|P3|Participants Treated (FAS)|Overall Study||296
228408|NCT00637377|550144|P2|Participants Treated (FAS)|Overall Study||309
228409|NCT00637377|550145|P1|Participants Treated (FAS)|Overall Study||291
228410|NCT00637377|550142|P4|Participants Received Treatment|Overall Study|safety population|307
228411|NCT00637377|550143|P3|Participants Received Treatment|Overall Study|safety population|297
228412|NCT00637377|550144|P2|Participants Received Treatment|Overall Study|safety population|309
228413|NCT00637377|550145|P1|Participants Received Treatment|Overall Study|safety population|291
228414|NCT00637377|550142|P4|STARTED|Overall Study||313
228415|NCT00637377|550143|P3|STARTED|Overall Study||311
228416|NCT00637377|550144|P2|STARTED|Overall Study||313
228417|NCT00637377|550145|P1|STARTED|Overall Study||303
228418|NCT00637312|550173|P2|NOT COMPLETED|Overall Study||17
228419|NCT00637312|550174|P1|NOT COMPLETED|Overall Study||42
228420|NCT00637312|550173|P2|COMPLETED|Overall Study||19
228421|NCT00637312|550174|P1|COMPLETED|Overall Study||30
228422|NCT00637312|550173|P2|STARTED|Overall Study||36
228423|NCT00637312|550174|P1|STARTED|Overall Study||72
228424|NCT00637299|550182|P2|NOT COMPLETED|Overall Study||0
228425|NCT00637299|550183|P1|NOT COMPLETED|Overall Study||0
228426|NCT00637299|550182|P2|COMPLETED|Overall Study||10
228427|NCT00637299|550183|P1|COMPLETED|Overall Study||10
228428|NCT00637299|550182|P2|STARTED|Overall Study||10
228429|NCT00637299|550183|P1|STARTED|Overall Study||10
228430|NCT00637273|550194|P3|NOT COMPLETED|Overall Study||41
228431|NCT00637273|550195|P2|NOT COMPLETED|Overall Study||28
228432|NCT00637273|550196|P1|NOT COMPLETED|Overall Study||43
228433|NCT00637273|550194|P3|COMPLETED|Overall Study||131
228434|NCT00637273|550195|P2|COMPLETED|Overall Study||144
228435|NCT00637273|550196|P1|COMPLETED|Overall Study||127
228436|NCT00637273|550194|P3|Intent to Treat (ITT)|Overall Study||165
228437|NCT00637273|550195|P2|Intent to Treat (ITT)|Overall Study||166
228438|NCT00637273|550196|P1|Intent to Treat (ITT)|Overall Study||160
228439|NCT00637273|550194|P3|STARTED|Overall Study||172
228440|NCT00637273|550195|P2|STARTED|Overall Study||172
228441|NCT00637273|550196|P1|STARTED|Overall Study||170
228442|NCT00637247|550239|P2|NOT COMPLETED|Overall Study||0
228443|NCT00637247|550240|P1|NOT COMPLETED|Overall Study||0
228444|NCT00637247|550239|P2|COMPLETED|Overall Study||70
228445|NCT00637247|550240|P1|COMPLETED|Overall Study||72
228446|NCT00637247|550239|P2|STARTED|Overall Study||70
228447|NCT00637247|550240|P1|STARTED|Overall Study||72
228448|NCT00637195|550252|P2|NOT COMPLETED|Overall Study||1
228449|NCT00637195|550253|P1|NOT COMPLETED|Overall Study||3
228450|NCT00637195|550252|P2|COMPLETED|Overall Study||75
228451|NCT00637195|550253|P1|COMPLETED|Overall Study||73
228452|NCT00637195|550252|P2|STARTED|Overall Study||76
228453|NCT00637195|550253|P1|STARTED|Overall Study||76
228454|NCT00637156|550289|P2|NOT COMPLETED|Overall Study||24
228455|NCT00637156|550290|P1|NOT COMPLETED|Overall Study||10
228456|NCT00637156|550289|P2|COMPLETED|Overall Study||164
228457|NCT00637156|550290|P1|COMPLETED|Overall Study||199
228458|NCT00637156|550289|P2|STARTED|Overall Study||188
228459|NCT00637156|550290|P1|STARTED|Overall Study||209
228460|NCT00637000|550332|P2|NOT COMPLETED|Overall Study||3
228461|NCT00637000|550333|P1|NOT COMPLETED|Overall Study||4
228462|NCT00637000|550332|P2|COMPLETED|Overall Study||15
228463|NCT00637000|550333|P1|COMPLETED|Overall Study||16
228464|NCT00637000|550332|P2|Evaluable|Overall Study||16
228465|NCT00637000|550333|P1|Evaluable|Overall Study||18
228466|NCT00637000|550332|P2|STARTED|Overall Study|Randomized and treated|18
228467|NCT00637000|550333|P1|STARTED|Overall Study|Randomized and treated|20
228468|NCT00636987|550373|P1|NOT COMPLETED|Overall Study||189
228469|NCT00636987|550373|P1|COMPLETED|Overall Study||108
228470|NCT00636987|550373|P1|STARTED|Overall Study||297
228471|NCT00636961|550383|P2|NOT COMPLETED|Period 2||0
228472|NCT00636961|550384|P1|NOT COMPLETED|Period 2||1
228473|NCT00636961|550383|P2|COMPLETED|Period 2||12
228474|NCT00636961|550384|P1|COMPLETED|Period 2||12
228475|NCT00636961|550383|P2|STARTED|Period 2||12
228476|NCT00636961|550384|P1|STARTED|Period 2||13
228477|NCT00636961|550383|P2|NOT COMPLETED|Period 1||1
228478|NCT00636961|550384|P1|NOT COMPLETED|Period 1||1
228479|NCT00636961|550383|P2|COMPLETED|Period 1||12
228480|NCT00636961|550384|P1|COMPLETED|Period 1||13
228481|NCT00636961|550383|P2|STARTED|Period 1||13
228482|NCT00636961|550384|P1|STARTED|Period 1||14
228483|NCT00636818|550398|P1|NOT COMPLETED|Overall Study||11
228484|NCT00636818|550398|P1|COMPLETED|Overall Study||34
228485|NCT00636818|550398|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
228486|NCT00636818|550398|P1|STARTED|Overall Study||45
228487|NCT00636805|550413|P1|NOT COMPLETED|Overall Study||0
228488|NCT00636805|550413|P1|COMPLETED|Overall Study||63
228489|NCT00636805|550413|P1|STARTED|Overall Study||63
228490|NCT00636792|550423|P1|NOT COMPLETED|Overall Study||33
228491|NCT00636792|550423|P1|COMPLETED|Overall Study||40
228492|NCT00636792|550423|P1|STARTED|Overall Study||73
228493|NCT00636701|550430|P2|NOT COMPLETED|Overall Study||0
228494|NCT00636701|550431|P1|NOT COMPLETED|Overall Study||0
228495|NCT00636701|550430|P2|COMPLETED|Overall Study||2
228496|NCT00636701|550431|P1|COMPLETED|Overall Study||2
228497|NCT00636701|550430|P2|STARTED|Overall Study||2
228498|NCT00636701|550431|P1|STARTED|Overall Study||2
228499|NCT00636649|550439|P2|NOT COMPLETED|Overall Study||0
228500|NCT00636649|550440|P1|NOT COMPLETED|Overall Study||0
228501|NCT00636649|550439|P2|COMPLETED|Overall Study||20
228502|NCT00636649|550440|P1|COMPLETED|Overall Study||20
228503|NCT00636649|550439|P2|STARTED|Overall Study||20
228504|NCT00636649|550440|P1|STARTED|Overall Study||20
228505|NCT00636636|550470|P2|NOT COMPLETED|Overall Study||39
228506|NCT00636636|550471|P1|NOT COMPLETED|Overall Study||36
228507|NCT00636636|550470|P2|COMPLETED|Overall Study||192
228508|NCT00636636|550471|P1|COMPLETED|Overall Study||185
228509|NCT00636636|550470|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
228510|NCT00636636|550471|P1|379|Overall Study||186
228511|NCT00636636|550470|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
228512|NCT00636636|550471|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
228513|NCT00636636|550470|P2|STARTED|Overall Study||231
228514|NCT00636636|550471|P1|STARTED|Overall Study||221
228515|NCT00636610|550487|P2|NOT COMPLETED|Overall Study||83
228516|NCT00636610|550488|P1|NOT COMPLETED|Overall Study||92
228517|NCT00636610|550487|P2|COMPLETED|Overall Study||18
228518|NCT00636610|550488|P1|COMPLETED|Overall Study||6
228519|NCT00636610|550487|P2|STARTED|Overall Study||101
228520|NCT00636610|550488|P1|STARTED|Overall Study||98
228521|NCT00636441|550505|P7|NOT COMPLETED|Overall Study||18
228522|NCT00636441|550506|P6|NOT COMPLETED|Overall Study||1
228523|NCT00636441|550507|P5|NOT COMPLETED|Overall Study||0
228524|NCT00636441|550508|P4|NOT COMPLETED|Overall Study||0
228525|NCT00636441|550509|P3|NOT COMPLETED|Overall Study||1
228526|NCT00636441|550510|P2|NOT COMPLETED|Overall Study||1
228527|NCT00636441|550511|P1|NOT COMPLETED|Overall Study||0
228528|NCT00636441|550505|P7|COMPLETED|Overall Study||0
228529|NCT00636441|550506|P6|COMPLETED|Overall Study||6
228530|NCT00636441|550507|P5|COMPLETED|Overall Study||6
228531|NCT00636441|550508|P4|COMPLETED|Overall Study||6
228532|NCT00636441|550509|P3|COMPLETED|Overall Study||5
228533|NCT00636441|550510|P2|COMPLETED|Overall Study||6
228534|NCT00636441|550511|P1|COMPLETED|Overall Study||6
228535|NCT00636441|550505|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
228536|NCT00636441|550506|P6|Assigned Treatment|Overall Study||7
228537|NCT00636441|550507|P5|Assigned Treatment|Overall Study||6
228538|NCT00636441|550508|P4|Assigned Treatment|Overall Study||6
228539|NCT00636441|550509|P3|Assigned Treatment|Overall Study||6
228540|NCT00636441|550510|P2|Assigned Treatment|Overall Study||7
228541|NCT00636441|550511|P1|Assigned Treatment|Overall Study||6
228542|NCT00636441|550505|P7|STARTED|Overall Study||18
228543|NCT00636441|550506|P6|STARTED|Overall Study||7
228544|NCT00636441|550507|P5|STARTED|Overall Study||6
228545|NCT00636441|550508|P4|STARTED|Overall Study||6
228546|NCT00636441|550509|P3|STARTED|Overall Study||6
228547|NCT00636441|550510|P2|STARTED|Overall Study||7
228548|NCT00636441|550511|P1|STARTED|Overall Study||6
228549|NCT00636389|550540|P2|NOT COMPLETED|Period 2 - 1 Week||0
228550|NCT00636389|550541|P1|NOT COMPLETED|Period 2 - 1 Week||0
228551|NCT00636389|550540|P2|COMPLETED|Period 2 - 1 Week||5
228552|NCT00636389|550541|P1|COMPLETED|Period 2 - 1 Week||7
228553|NCT00636389|550540|P2|STARTED|Period 2 - 1 Week||5
228554|NCT00636389|550541|P1|STARTED|Period 2 - 1 Week||7
228555|NCT00636389|550540|P2|NOT COMPLETED|Period 1 - 1 Week||0
228556|NCT00636389|550541|P1|NOT COMPLETED|Period 1 - 1 Week||0
228557|NCT00636389|550540|P2|COMPLETED|Period 1 - 1 Week||5
228558|NCT00636389|550541|P1|COMPLETED|Period 1 - 1 Week||7
228559|NCT00636389|550540|P2|STARTED|Period 1 - 1 Week||5
228560|NCT00636389|550541|P1|STARTED|Period 1 - 1 Week||7
228561|NCT00636363|550554|P3|NOT COMPLETED|Overall Study||18
228562|NCT00636363|550555|P2|NOT COMPLETED|Overall Study||20
228563|NCT00636363|550556|P1|NOT COMPLETED|Overall Study||13
228564|NCT00636363|550554|P3|COMPLETED|Overall Study||163
228565|NCT00636363|550555|P2|COMPLETED|Overall Study||156
228566|NCT00636363|550556|P1|COMPLETED|Overall Study||165
228567|NCT00636363|550554|P3|STARTED|Overall Study||181
228568|NCT00636363|550555|P2|STARTED|Overall Study||176
228569|NCT00636363|550556|P1|STARTED|Overall Study||178
228570|NCT00636220|550570|P1|NOT COMPLETED|Overall Study||0
228571|NCT00636220|550570|P1|COMPLETED|Overall Study||101
228572|NCT00636220|550570|P1|STARTED|Overall Study||101
228573|NCT00636207|550577|P7|NOT COMPLETED|Overall Study||0
228574|NCT00636207|550578|P6|NOT COMPLETED|Overall Study||0
228575|NCT00636207|550579|P5|NOT COMPLETED|Overall Study||1
228576|NCT00636207|550580|P4|NOT COMPLETED|Overall Study||0
228577|NCT00636207|550581|P3|NOT COMPLETED|Overall Study||0
228578|NCT00636207|550582|P2|NOT COMPLETED|Overall Study||1
228579|NCT00636207|550583|P1|NOT COMPLETED|Overall Study||1
228580|NCT00636207|550577|P7|COMPLETED|Overall Study||3
228581|NCT00636207|550578|P6|COMPLETED|Overall Study||1
228582|NCT00636207|550579|P5|COMPLETED|Overall Study||8
228583|NCT00636207|550580|P4|COMPLETED|Overall Study||6
228584|NCT00636207|550581|P3|COMPLETED|Overall Study||18
228585|NCT00636207|550582|P2|COMPLETED|Overall Study||7
228586|NCT00636207|550583|P1|COMPLETED|Overall Study||0
228587|NCT00636207|550577|P7|STARTED|Overall Study||3
228588|NCT00636207|550578|P6|STARTED|Overall Study||1
228589|NCT00636207|550579|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
228590|NCT00636207|550580|P4|STARTED|Overall Study||6
228591|NCT00636207|550581|P3|STARTED|Overall Study||18
228592|NCT00636207|550582|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
228593|NCT00636207|550583|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
228594|NCT00636194|550647|P2|NOT COMPLETED|Overall Study||0
228595|NCT00636194|550648|P1|NOT COMPLETED|Overall Study||3
228596|NCT00636194|550647|P2|COMPLETED|Overall Study||175
228597|NCT00636194|550648|P1|COMPLETED|Overall Study||172
228598|NCT00636194|550647|P2|STARTED|Overall Study||175
228599|NCT00636194|550648|P1|STARTED|Overall Study||175
228600|NCT00636168|550660|P2|NOT COMPLETED|Treated With Study Drug||411
228601|NCT00636168|550661|P1|NOT COMPLETED|Treated With Study Drug||447
228602|NCT00636168|550660|P2|COMPLETED|Treated With Study Drug||63
228603|NCT00636168|550661|P1|COMPLETED|Treated With Study Drug||24
228604|NCT00636168|550660|P2|STARTED|Treated With Study Drug||474
228605|NCT00636168|550661|P1|STARTED|Treated With Study Drug||471
228606|NCT00636168|550660|P2|NOT COMPLETED|Randomized to Study Drug||2
228607|NCT00636168|550661|P1|NOT COMPLETED|Randomized to Study Drug||4
228608|NCT00636168|550660|P2|COMPLETED|Randomized to Study Drug||474
228609|NCT00636168|550661|P1|COMPLETED|Randomized to Study Drug||471
228610|NCT00636168|550660|P2|STARTED|Randomized to Study Drug||476
228611|NCT00636168|550661|P1|STARTED|Randomized to Study Drug||475
228612|NCT00636155|550681|P1|NOT COMPLETED|Overall Study||18
228613|NCT00636155|550681|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
228614|NCT00636155|550681|P1|STARTED|Overall Study||20
228615|NCT00636077|550687|P4|NOT COMPLETED|Week 4||0
228616|NCT00636077|550688|P3|NOT COMPLETED|Week 4||0
228617|NCT00636077|550689|P2|NOT COMPLETED|Week 4||0
228618|NCT00636077|550690|P1|NOT COMPLETED|Week 4||0
228619|NCT00636077|550687|P4|COMPLETED|Week 4||3
228620|NCT00636077|550688|P3|COMPLETED|Week 4||3
228621|NCT00636077|550689|P2|COMPLETED|Week 4||3
228622|NCT00636077|550690|P1|COMPLETED|Week 4||3
228623|NCT00636077|550687|P4|STARTED|Week 4||3
228624|NCT00636077|550688|P3|STARTED|Week 4||3
228625|NCT00636077|550689|P2|STARTED|Week 4||3
228626|NCT00636077|550690|P1|STARTED|Week 4||3
228627|NCT00636077|550687|P4|NOT COMPLETED|Week 3||0
228628|NCT00636077|550688|P3|NOT COMPLETED|Week 3||0
228629|NCT00636077|550689|P2|NOT COMPLETED|Week 3||0
228630|NCT00636077|550690|P1|NOT COMPLETED|Week 3||0
228631|NCT00636077|550687|P4|COMPLETED|Week 3||3
228632|NCT00636077|550688|P3|COMPLETED|Week 3||3
228633|NCT00636077|550689|P2|COMPLETED|Week 3||3
228634|NCT00636077|550690|P1|COMPLETED|Week 3||3
228635|NCT00636077|550687|P4|STARTED|Week 3||3
228636|NCT00636077|550688|P3|STARTED|Week 3||3
228637|NCT00636077|550689|P2|STARTED|Week 3||3
228638|NCT00636077|550690|P1|STARTED|Week 3||3
228639|NCT00636077|550687|P4|NOT COMPLETED|Week 2||0
228640|NCT00636077|550688|P3|NOT COMPLETED|Week 2||0
228641|NCT00636077|550689|P2|NOT COMPLETED|Week 2||0
228642|NCT00636077|550690|P1|NOT COMPLETED|Week 2||0
228643|NCT00636077|550687|P4|COMPLETED|Week 2||3
228644|NCT00636077|550688|P3|COMPLETED|Week 2||3
228645|NCT00636077|550689|P2|COMPLETED|Week 2||3
228646|NCT00636077|550690|P1|COMPLETED|Week 2||3
228647|NCT00636077|550687|P4|STARTED|Week 2||3
228648|NCT00636077|550688|P3|STARTED|Week 2||3
228649|NCT00636077|550689|P2|STARTED|Week 2||3
228650|NCT00636077|550690|P1|STARTED|Week 2||3
228651|NCT00636077|550687|P4|NOT COMPLETED|Week 1||0
228652|NCT00636077|550688|P3|NOT COMPLETED|Week 1||0
228653|NCT00636077|550689|P2|NOT COMPLETED|Week 1||0
228654|NCT00636077|550690|P1|NOT COMPLETED|Week 1||0
228655|NCT00636077|550687|P4|COMPLETED|Week 1||3
228656|NCT00636077|550688|P3|COMPLETED|Week 1||3
228657|NCT00636077|550689|P2|COMPLETED|Week 1||3
228658|NCT00636077|550690|P1|COMPLETED|Week 1||3
228659|NCT00636077|550687|P4|STARTED|Week 1||3
228660|NCT00636077|550688|P3|STARTED|Week 1||3
228661|NCT00636077|550689|P2|STARTED|Week 1||3
228662|NCT00636077|550690|P1|STARTED|Week 1||3
228663|NCT00635999|550723|P3|NOT COMPLETED|Overall Study||1
228664|NCT00635999|550724|P2|NOT COMPLETED|Overall Study||2
228665|NCT00635999|550725|P1|NOT COMPLETED|Overall Study||4
228666|NCT00635999|550723|P3|COMPLETED|Overall Study||23
228667|NCT00635999|550724|P2|COMPLETED|Overall Study||23
228668|NCT00635999|550725|P1|COMPLETED|Overall Study||23
228669|NCT00635999|550723|P3|STARTED|Overall Study||24
228670|NCT00635999|550724|P2|STARTED|Overall Study||25
228671|NCT00635999|550725|P1|STARTED|Overall Study||27
228672|NCT00635882|550742|P6|NOT COMPLETED|Overall Study||0
228673|NCT00635882|550743|P5|NOT COMPLETED|Overall Study||0
228674|NCT00635882|550744|P4|NOT COMPLETED|Overall Study||0
228675|NCT00635882|550745|P3|NOT COMPLETED|Overall Study||0
228676|NCT00635882|550746|P2|NOT COMPLETED|Overall Study||0
228677|NCT00635882|550747|P1|NOT COMPLETED|Overall Study||1
228678|NCT00635882|550742|P6|COMPLETED|Overall Study||13
228679|NCT00635882|550743|P5|COMPLETED|Overall Study||16
228680|NCT00635882|550744|P4|COMPLETED|Overall Study||15
228681|NCT00635882|550745|P3|COMPLETED|Overall Study||12
228682|NCT00635882|550746|P2|COMPLETED|Overall Study||17
228683|NCT00635882|550747|P1|COMPLETED|Overall Study||19
228684|NCT00635882|550742|P6|STARTED|Overall Study||13
228685|NCT00635882|550743|P5|STARTED|Overall Study||16
228686|NCT00635882|550744|P4|STARTED|Overall Study||15
228687|NCT00635882|550745|P3|STARTED|Overall Study||12
228688|NCT00635882|550746|P2|STARTED|Overall Study||17
228689|NCT00635882|550747|P1|STARTED|Overall Study||20
228690|NCT00635830|550811|P2|NOT COMPLETED|Overall Study||0
228691|NCT00635830|550812|P1|NOT COMPLETED|Overall Study||0
228692|NCT00635830|550811|P2|COMPLETED|Overall Study||20
228693|NCT00635830|550812|P1|COMPLETED|Overall Study||20
228694|NCT00635830|550811|P2|STARTED|Overall Study||20
228695|NCT00635830|550812|P1|STARTED|Overall Study||20
228696|NCT00635817|550822|P4|NOT COMPLETED|Overall Study||0
228697|NCT00635817|550823|P3|NOT COMPLETED|Overall Study||2
228698|NCT00635817|550824|P2|NOT COMPLETED|Overall Study||2
228699|NCT00635817|550825|P1|NOT COMPLETED|Overall Study||6
228700|NCT00635817|550822|P4|COMPLETED|Overall Study||21
228701|NCT00635817|550823|P3|COMPLETED|Overall Study||19
228702|NCT00635817|550824|P2|COMPLETED|Overall Study||19
228703|NCT00635817|550825|P1|COMPLETED|Overall Study||15
228704|NCT00635817|550822|P4|STARTED|Overall Study||21
228705|NCT00635817|550823|P3|STARTED|Overall Study||21
228706|NCT00635817|550824|P2|STARTED|Overall Study||21
228707|NCT00635817|550825|P1|STARTED|Overall Study||21
228708|NCT00635804|550877|P8|NOT COMPLETED|Overall Study||0
228709|NCT00635804|550878|P7|NOT COMPLETED|Overall Study||0
228710|NCT00635804|550879|P6|NOT COMPLETED|Overall Study||1
228711|NCT00635804|550880|P5|NOT COMPLETED|Overall Study||0
228712|NCT00635804|550881|P4|NOT COMPLETED|Overall Study||0
228713|NCT00635804|550882|P3|NOT COMPLETED|Overall Study||0
228714|NCT00635804|550883|P2|NOT COMPLETED|Overall Study||0
228715|NCT00635804|550884|P1|NOT COMPLETED|Overall Study||1
228716|NCT00635804|550877|P8|COMPLETED|Overall Study||14
228717|NCT00635804|550878|P7|COMPLETED|Overall Study||3
228718|NCT00635804|550879|P6|COMPLETED|Overall Study||11
228719|NCT00635804|550880|P5|COMPLETED|Overall Study||6
228720|NCT00635804|550881|P4|COMPLETED|Overall Study||6
228721|NCT00635804|550882|P3|COMPLETED|Overall Study||6
228722|NCT00635804|550883|P2|COMPLETED|Overall Study||6
228723|NCT00635804|550884|P1|COMPLETED|Overall Study||6
228724|NCT00635804|550877|P8|STARTED|Overall Study||14
228725|NCT00635804|550878|P7|STARTED|Overall Study||3
228726|NCT00635804|550879|P6|STARTED|Overall Study||12
228727|NCT00635804|550880|P5|STARTED|Overall Study||6
228728|NCT00635804|550881|P4|STARTED|Overall Study||6
228729|NCT00635804|550882|P3|STARTED|Overall Study||6
228730|NCT00635804|550883|P2|STARTED|Overall Study||6
228731|NCT00635804|550884|P1|STARTED|Overall Study||7
228732|NCT00635700|550983|P2|NOT COMPLETED|Overall Study||14
228733|NCT00635700|550984|P1|NOT COMPLETED|Overall Study||15
228734|NCT00635700|550983|P2|COMPLETED|Overall Study||13
228735|NCT00635700|550984|P1|COMPLETED|Overall Study||9
228736|NCT00635700|550983|P2|STARTED|Overall Study||27
228737|NCT00635700|550984|P1|STARTED|Overall Study||24
228738|NCT00635661|550990|P1|NOT COMPLETED|Overall Study||4
228739|NCT00635661|550990|P1|COMPLETED|Overall Study||30
228740|NCT00635661|550990|P1|STARTED|Overall Study||34
228741|NCT00635648|550994|P1|NOT COMPLETED|Overall Study||37
228742|NCT00635648|550994|P1|COMPLETED|Overall Study||26
228743|NCT00635648|550994|P1|STARTED|Overall Study||63
228744|NCT00635609|551003|P2|NOT COMPLETED|Overall Study||3
228745|NCT00635609|551004|P1|NOT COMPLETED|Overall Study||7
228746|NCT00635609|551003|P2|COMPLETED|Overall Study||42
228747|NCT00635609|551004|P1|COMPLETED|Overall Study||41
228748|NCT00635609|551003|P2|STARTED|Overall Study||45
228749|NCT00635609|551004|P1|STARTED|Overall Study||48
228750|NCT00635570|551016|P2|NOT COMPLETED|Overall Study||11
228751|NCT00635570|551017|P1|NOT COMPLETED|Overall Study||15
228752|NCT00635570|551016|P2|COMPLETED|Overall Study||126
228753|NCT00635570|551017|P1|COMPLETED|Overall Study||121
228754|NCT00635570|551016|P2|STARTED|Overall Study||137
228755|NCT00635570|551017|P1|STARTED|Overall Study||136
228756|NCT00635492|551031|P2|NOT COMPLETED|Overall Study||282
228757|NCT00635492|551032|P1|NOT COMPLETED|Overall Study||279
228758|NCT00635492|551031|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
228759|NCT00635492|551032|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
228760|NCT00635492|551031|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
228761|NCT00635492|551032|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
228762|NCT00635479|551078|P2|NOT COMPLETED|Overall Study||18
228763|NCT00635479|551079|P1|NOT COMPLETED|Overall Study||6
228764|NCT00635479|551078|P2|COMPLETED|Overall Study||42
228765|NCT00635479|551079|P1|COMPLETED|Overall Study||49
228766|NCT00635479|551078|P2|STARTED|Overall Study||60
228767|NCT00635479|551079|P1|STARTED|Overall Study||55
228768|NCT00635427|551090|P5|NOT COMPLETED|Overall Study||8
228769|NCT00635427|551091|P4|NOT COMPLETED|Overall Study||9
228770|NCT00635427|551092|P3|NOT COMPLETED|Overall Study||11
228771|NCT00635427|551093|P2|NOT COMPLETED|Overall Study||6
228772|NCT00635427|551094|P1|NOT COMPLETED|Overall Study||12
228773|NCT00635427|551090|P5|COMPLETED|Overall Study||30
228774|NCT00635427|551091|P4|COMPLETED|Overall Study||7
228775|NCT00635427|551092|P3|COMPLETED|Overall Study||5
228776|NCT00635427|551093|P2|COMPLETED|Overall Study||6
228777|NCT00635427|551094|P1|COMPLETED|Overall Study||1
228778|NCT00635427|551090|P5|STARTED|Overall Study||38
228779|NCT00635427|551091|P4|STARTED|Overall Study||16
228780|NCT00635427|551092|P3|STARTED|Overall Study||16
228781|NCT00635427|551093|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
228782|NCT00635427|551094|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
228783|NCT00635362|551116|P2|NOT COMPLETED|Overall Study||8
228784|NCT00635362|551117|P1|NOT COMPLETED|Overall Study||13
228785|NCT00635362|551116|P2|COMPLETED|Overall Study||12
228786|NCT00635362|551117|P1|COMPLETED|Overall Study||9
228787|NCT00635362|551116|P2|STARTED|Overall Study||20
228788|NCT00635362|551117|P1|STARTED|Overall Study||22
228789|NCT00635349|551133|P2|NOT COMPLETED|Overall Study||48
228790|NCT00635349|551134|P1|NOT COMPLETED|Overall Study||44
228791|NCT00635349|551133|P2|COMPLETED|Overall Study||19
228792|NCT00635349|551134|P1|COMPLETED|Overall Study||29
228793|NCT00635349|551133|P2|STARTED|Overall Study||67
228794|NCT00635349|551134|P1|STARTED|Overall Study||73
228795|NCT00635232|551157|P5|NOT COMPLETED|Overall Study||8
228796|NCT00635232|551158|P4|NOT COMPLETED|Overall Study||10
228797|NCT00635232|551159|P3|NOT COMPLETED|Overall Study||3
228798|NCT00635232|551160|P2|NOT COMPLETED|Overall Study||20
228799|NCT00635232|551161|P1|NOT COMPLETED|Overall Study||14
228800|NCT00635232|551157|P5|COMPLETED|Overall Study||20
228801|NCT00635232|551158|P4|COMPLETED|Overall Study||48
228802|NCT00635232|551159|P3|COMPLETED|Overall Study||55
228803|NCT00635232|551160|P2|COMPLETED|Overall Study||39
228804|NCT00635232|551161|P1|COMPLETED|Overall Study||44
228805|NCT00635232|551157|P5|STARTED|Overall Study||28
228806|NCT00635232|551158|P4|STARTED|Overall Study||58
228807|NCT00635232|551159|P3|STARTED|Overall Study||58
228808|NCT00635232|551160|P2|STARTED|Overall Study||59
228809|NCT00635232|551161|P1|STARTED|Overall Study||58
228810|NCT00635219|551188|P5|NOT COMPLETED|Overall Study||42
228811|NCT00635219|551189|P4|NOT COMPLETED|Overall Study||34
228812|NCT00635219|551190|P3|NOT COMPLETED|Overall Study||35
228813|NCT00635219|551191|P2|NOT COMPLETED|Overall Study||25
228814|NCT00635219|551192|P1|NOT COMPLETED|Overall Study||25
228815|NCT00635219|551188|P5|COMPLETED|Overall Study||113
228816|NCT00635219|551189|P4|COMPLETED|Overall Study||117
228817|NCT00635219|551190|P3|COMPLETED|Overall Study||122
228818|NCT00635219|551191|P2|COMPLETED|Overall Study||130
228819|NCT00635219|551192|P1|COMPLETED|Overall Study||123
228820|NCT00635219|551188|P5|STARTED|Overall Study||155
228821|NCT00635219|551189|P4|STARTED|Overall Study||151
228822|NCT00635219|551190|P3|STARTED|Overall Study||157
228823|NCT00635219|551191|P2|STARTED|Overall Study||155
228824|NCT00635219|551192|P1|STARTED|Overall Study||148
228825|NCT00635154|551249|P1|NOT COMPLETED|Overall Study||33
228826|NCT00635154|551249|P1|COMPLETED|Overall Study||21
228827|NCT00635154|551249|P1|STARTED|Overall Study||54
228828|NCT00635128|551261|P2|NOT COMPLETED|Overall Study||0
228829|NCT00635128|551262|P1|NOT COMPLETED|Overall Study||0
228830|NCT00635128|551261|P2|COMPLETED|Overall Study||64
228831|NCT00635128|551262|P1|COMPLETED|Overall Study||351
228832|NCT00635128|551261|P2|STARTED|Overall Study||64
228833|NCT00635128|551262|P1|STARTED|Overall Study||351
228834|NCT00635102|551292|P2|NOT COMPLETED|Overall Study||8
228835|NCT00635102|551293|P1|NOT COMPLETED|Overall Study||7
228836|NCT00635102|551292|P2|COMPLETED|Overall Study||22
228837|NCT00635102|551293|P1|COMPLETED|Overall Study||20
228838|NCT00635102|551292|P2|STARTED|Overall Study||30
228839|NCT00635102|551293|P1|STARTED|Overall Study||27
228840|NCT00635089|551387|P1|NOT COMPLETED|Overall Study||78
228841|NCT00635089|551387|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
228842|NCT00635089|551387|P1|Completed >/= 16 Weeks of Study|Overall Study||181
228843|NCT00635089|551387|P1|STARTED|Overall Study||190
228844|NCT00635050|551414|P1|NOT COMPLETED|Overall Study||1
228845|NCT00635050|551414|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
228846|NCT00635050|551414|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
228847|NCT00635024|551421|P1|NOT COMPLETED|Overall Study||1
228848|NCT00635024|551421|P1|COMPLETED|Overall Study||0
228849|NCT00635024|551421|P1|STARTED|Overall Study||1
228850|NCT00634933|551432|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
228851|NCT00634933|551433|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
228852|NCT00634933|551434|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
228853|NCT00634933|551435|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
228854|NCT00634933|551436|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
228855|NCT00634933|551432|P5|COMPLETED|Part B: Week 24 to Week 52||22
228856|NCT00634933|551433|P4|COMPLETED|Part B: Week 24 to Week 52||25
228857|NCT00634933|551434|P3|COMPLETED|Part B: Week 24 to Week 52||33
228858|NCT00634933|551435|P2|COMPLETED|Part B: Week 24 to Week 52||42
228859|NCT00634933|551436|P1|COMPLETED|Part B: Week 24 to Week 52||0
228860|NCT00634933|551432|P5|STARTED|Part B: Week 24 to Week 52||32
228861|NCT00634933|551433|P4|STARTED|Part B: Week 24 to Week 52||31
228862|NCT00634933|551434|P3|STARTED|Part B: Week 24 to Week 52||55
228863|NCT00634933|551435|P2|STARTED|Part B: Week 24 to Week 52||56
228864|NCT00634933|551436|P1|STARTED|Part B: Week 24 to Week 52||0
228865|NCT00634933|551432|P5|NOT COMPLETED|Between Part A and Part B||0
228866|NCT00634933|551433|P4|NOT COMPLETED|Between Part A and Part B||0
228867|NCT00634933|551434|P3|NOT COMPLETED|Between Part A and Part B||0
228868|NCT00634933|551435|P2|NOT COMPLETED|Between Part A and Part B||1
228869|NCT00634933|551436|P1|NOT COMPLETED|Between Part A and Part B||0
228870|NCT00634933|551432|P5|COMPLETED|Between Part A and Part B||32
228871|NCT00634933|551433|P4|COMPLETED|Between Part A and Part B||31
228872|NCT00634933|551434|P3|COMPLETED|Between Part A and Part B||55
228873|NCT00634933|551435|P2|COMPLETED|Between Part A and Part B||56
228874|NCT00634933|551436|P1|COMPLETED|Between Part A and Part B||0
228875|NCT00634933|551432|P5|STARTED|Between Part A and Part B||32
228876|NCT00634933|551433|P4|STARTED|Between Part A and Part B||31
228877|NCT00634933|551434|P3|STARTED|Between Part A and Part B||55
228878|NCT00634933|551435|P2|STARTED|Between Part A and Part B||57
228879|NCT00634933|551436|P1|STARTED|Between Part A and Part B||0
228880|NCT00634933|551432|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
228881|NCT00634933|551433|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
228882|NCT00634933|551434|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
228883|NCT00634933|551435|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
228884|NCT00634933|551436|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
228885|NCT00634933|551432|P5|COMPLETED|Part A: Baseline to Week 24||0
228886|NCT00634933|551433|P4|COMPLETED|Part A: Baseline to Week 24||0
228887|NCT00634933|551434|P3|COMPLETED|Part A: Baseline to Week 24||55
228888|NCT00634933|551435|P2|COMPLETED|Part A: Baseline to Week 24||57
228889|NCT00634933|551436|P1|COMPLETED|Part A: Baseline to Week 24||63
228890|NCT00634933|551432|P5|STARTED|Part A: Baseline to Week 24||0
228891|NCT00634933|551433|P4|STARTED|Part A: Baseline to Week 24||0
228892|NCT00634933|551434|P3|STARTED|Part A: Baseline to Week 24||73
228893|NCT00634933|551435|P2|STARTED|Part A: Baseline to Week 24||75
228894|NCT00634933|551436|P1|STARTED|Part A: Baseline to Week 24||74
228895|NCT00634920|551505|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
228896|NCT00634920|551506|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
228897|NCT00634920|551507|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
228898|NCT00634920|551505|P3|COMPLETED|Period 2 - Post-Randomization||0
228899|NCT00634920|551506|P2|COMPLETED|Period 2 - Post-Randomization||68
228900|NCT00634920|551507|P1|COMPLETED|Period 2 - Post-Randomization||43
228901|NCT00634920|551505|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
228902|NCT00634920|551506|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
228903|NCT00634920|551507|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
228987|NCT00634504|551667|P2|NOT COMPLETED|Overall Study||0
228904|NCT00634920|551505|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
228905|NCT00634920|551506|P2|STARTED|Period 2 - Post-Randomization||100
228906|NCT00634920|551507|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
228907|NCT00634920|551505|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
228908|NCT00634920|551506|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
228909|NCT00634920|551507|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
228910|NCT00634920|551505|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
228911|NCT00634920|551506|P2|COMPLETED|Period 1 - Pre-Randomization||0
228912|NCT00634920|551507|P1|COMPLETED|Period 1 - Pre-Randomization||0
228913|NCT00634920|551505|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
228914|NCT00634920|551506|P2|STARTED|Period 1 - Pre-Randomization||0
228915|NCT00634920|551507|P1|STARTED|Period 1 - Pre-Randomization||0
228916|NCT00634907|551551|P2|NOT COMPLETED|Overall Study||17
228917|NCT00634907|551552|P1|NOT COMPLETED|Overall Study||17
228918|NCT00634907|551551|P2|COMPLETED|Overall Study||115
228919|NCT00634907|551552|P1|COMPLETED|Overall Study||114
228920|NCT00634907|551551|P2|STARTED|Overall Study||132
228921|NCT00634907|551552|P1|STARTED|Overall Study||131
228922|NCT00634842|551576|P2|NOT COMPLETED|Overall Study||18
228923|NCT00634842|551577|P1|NOT COMPLETED|Overall Study||15
228924|NCT00634842|551576|P2|COMPLETED|Overall Study||104
228925|NCT00634842|551577|P1|COMPLETED|Overall Study||107
228926|NCT00634842|551576|P2|STARTED|Overall Study||122
228927|NCT00634842|551577|P1|STARTED|Overall Study||122
228928|NCT00634751|551593|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
228929|NCT00634751|551594|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
228930|NCT00634751|551595|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
228931|NCT00634751|551596|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
228932|NCT00634751|551593|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
228933|NCT00634751|551594|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
228934|NCT00634751|551595|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
228935|NCT00634751|551596|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
228936|NCT00634751|551593|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
228937|NCT00634751|551594|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
228938|NCT00634751|551595|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
228939|NCT00634751|551596|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
228940|NCT00634751|551593|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
228941|NCT00634751|551594|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
228942|NCT00634751|551595|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
228943|NCT00634751|551596|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
228944|NCT00634751|551593|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
228945|NCT00634751|551594|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
228946|NCT00634751|551595|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
228947|NCT00634751|551596|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
228948|NCT00634751|551593|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
228949|NCT00634751|551594|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
228950|NCT00634751|551595|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
228951|NCT00634751|551596|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
228952|NCT00634751|551593|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
228953|NCT00634751|551594|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
228954|NCT00634751|551595|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
228955|NCT00634751|551596|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
228956|NCT00634751|551593|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
228957|NCT00634751|551594|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
228958|NCT00634751|551595|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
228959|NCT00634751|551596|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
228960|NCT00634751|551593|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
228961|NCT00634751|551594|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
228962|NCT00634751|551595|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
228963|NCT00634751|551596|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
228964|NCT00634647|551614|P1|NOT COMPLETED|Overall Study||9
228965|NCT00634647|551614|P1|COMPLETED|Overall Study||15
228966|NCT00634647|551614|P1|STARTED|Overall Study||24
228967|NCT00634621|551619|P1|NOT COMPLETED|Overall Study||0
228968|NCT00634621|551619|P1|COMPLETED|Overall Study||283
228969|NCT00634621|551619|P1|STARTED|Overall Study||283
228970|NCT00634582|551627|P1|NOT COMPLETED|Overall Study||0
228971|NCT00634582|551627|P1|COMPLETED|Overall Study||2
228972|NCT00634582|551627|P1|STARTED|Overall Study||2
228973|NCT00634569|551633|P2|NOT COMPLETED|Overall Study||5
228974|NCT00634569|551634|P1|NOT COMPLETED|Overall Study||0
228975|NCT00634569|551633|P2|COMPLETED|Overall Study||5
228976|NCT00634569|551634|P1|COMPLETED|Overall Study||14
228977|NCT00634569|551633|P2|STARTED|Overall Study||10
228978|NCT00634569|551634|P1|STARTED|Overall Study||14
228979|NCT00634543|551648|P2|NOT COMPLETED|Overall Study||21
228980|NCT00634543|551649|P1|NOT COMPLETED|Overall Study||19
228981|NCT00634543|551648|P2|COMPLETED|Overall Study||63
228982|NCT00634543|551649|P1|COMPLETED|Overall Study||59
228983|NCT00634543|551648|P2|Treated|Overall Study||80
228984|NCT00634543|551649|P1|Treated|Overall Study||76
228985|NCT00634543|551648|P2|STARTED|Overall Study||84
228986|NCT00634543|551649|P1|STARTED|Overall Study||78
228988|NCT00634504|551668|P1|NOT COMPLETED|Overall Study||1
228989|NCT00634504|551667|P2|COMPLETED|Overall Study||9
228990|NCT00634504|551668|P1|COMPLETED|Overall Study||10
228991|NCT00634504|551667|P2|STARTED|Overall Study||9
228992|NCT00634504|551668|P1|STARTED|Overall Study||11
228993|NCT00634322|551677|P3|NOT COMPLETED|Overall Study||0
228994|NCT00634322|551678|P2|NOT COMPLETED|Overall Study||0
228995|NCT00634322|551679|P1|NOT COMPLETED|Overall Study||0
228996|NCT00634322|551677|P3|COMPLETED|Overall Study||5
228997|NCT00634322|551678|P2|COMPLETED|Overall Study||1
228998|NCT00634322|551679|P1|COMPLETED|Overall Study||1
228999|NCT00634322|551677|P3|STARTED|Overall Study||5
229000|NCT00634322|551678|P2|STARTED|Overall Study||1
229001|NCT00634322|551679|P1|STARTED|Overall Study||1
229002|NCT00634270|551689|P2|NOT COMPLETED|Overall Study||1
229003|NCT00634270|551690|P1|NOT COMPLETED|Overall Study||3
229004|NCT00634270|551689|P2|COMPLETED|Overall Study||12
229005|NCT00634270|551690|P1|COMPLETED|Overall Study||46
229006|NCT00634270|551689|P2|STARTED|Overall Study||13
229007|NCT00634270|551690|P1|STARTED|Overall Study|February 12, 2008|49
229008|NCT00634244|551719|P3|NOT COMPLETED|Overall Study||0
229009|NCT00634244|551720|P2|NOT COMPLETED|Overall Study||13
229010|NCT00634244|551721|P1|NOT COMPLETED|Overall Study||1
229011|NCT00634244|551719|P3|COMPLETED|Overall Study||20
229012|NCT00634244|551720|P2|COMPLETED|Overall Study||24
229013|NCT00634244|551721|P1|COMPLETED|Overall Study||34
229014|NCT00634244|551719|P3|Eligible and Treated|Overall Study||20
229015|NCT00634244|551720|P2|Eligible and Treated|Overall Study||36
229016|NCT00634244|551721|P1|Eligible and Treated|Overall Study||35
229017|NCT00634244|551719|P3|STARTED|Overall Study||20
229018|NCT00634244|551720|P2|STARTED|Overall Study||37
229019|NCT00634244|551721|P1|STARTED|Overall Study||35
229020|NCT00634179|551732|P1|NOT COMPLETED|Phase II: Maintenance||1
229021|NCT00634179|551732|P1|COMPLETED|Phase II: Maintenance||29
229022|NCT00634179|551732|P1|STARTED|Phase II: Maintenance||30
229023|NCT00634179|551732|P1|NOT COMPLETED|Phase I: Induction||0
229024|NCT00634179|551732|P1|COMPLETED|Phase I: Induction||19
229025|NCT00634179|551732|P1|STARTED|Phase I: Induction||19
229026|NCT00634166|551741|P2|NOT COMPLETED|Overall Study||60
229027|NCT00634166|551742|P1|NOT COMPLETED|Overall Study||60
229028|NCT00634166|551741|P2|COMPLETED|Overall Study||78
229029|NCT00634166|551742|P1|COMPLETED|Overall Study||22
229030|NCT00634166|551741|P2|STARTED|Overall Study||138
229031|NCT00634166|551742|P1|STARTED|Overall Study||82
229032|NCT00634114|551751|P3|NOT COMPLETED|Overall Study||39
229033|NCT00634114|551752|P2|NOT COMPLETED|Overall Study||35
229034|NCT00634114|551753|P1|NOT COMPLETED|Overall Study||28
229035|NCT00634114|551751|P3|COMPLETED|Overall Study|Completed|148
229036|NCT00634114|551752|P2|COMPLETED|Overall Study|Completed|154
229037|NCT00634114|551753|P1|COMPLETED|Overall Study|Completed|160
229038|NCT00634114|551751|P3|STARTED|Overall Study|Randomised|187
229039|NCT00634114|551752|P2|STARTED|Overall Study|Randomised|189
229040|NCT00634114|551753|P1|STARTED|Overall Study|Randomised|188
229041|NCT00634088|551771|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
229042|NCT00634088|551772|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
229043|NCT00634088|551773|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
229044|NCT00634088|551774|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
229045|NCT00634088|551771|P4|COMPLETED|Time Period 4: Triplet Combination||0
229046|NCT00634088|551772|P3|COMPLETED|Time Period 4: Triplet Combination||0
229047|NCT00634088|551773|P2|COMPLETED|Time Period 4: Triplet Combination||0
229048|NCT00634088|551774|P1|COMPLETED|Time Period 4: Triplet Combination||0
229049|NCT00634088|551771|P4|STARTED|Time Period 4: Triplet Combination||0
229050|NCT00634088|551772|P3|STARTED|Time Period 4: Triplet Combination||0
229051|NCT00634088|551773|P2|STARTED|Time Period 4: Triplet Combination||0
229052|NCT00634088|551774|P1|STARTED|Time Period 4: Triplet Combination||0
229053|NCT00634088|551771|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
229054|NCT00634088|551772|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
229055|NCT00634088|551773|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
229056|NCT00634088|551774|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
229057|NCT00634088|551771|P4|COMPLETED|Time Period 3: Dose Level 3||0
229058|NCT00634088|551772|P3|COMPLETED|Time Period 3: Dose Level 3||0
229059|NCT00634088|551773|P2|COMPLETED|Time Period 3: Dose Level 3||0
229060|NCT00634088|551774|P1|COMPLETED|Time Period 3: Dose Level 3||0
229061|NCT00634088|551771|P4|STARTED|Time Period 3: Dose Level 3||0
229062|NCT00634088|551772|P3|STARTED|Time Period 3: Dose Level 3||1
229063|NCT00634088|551773|P2|STARTED|Time Period 3: Dose Level 3||0
229064|NCT00634088|551774|P1|STARTED|Time Period 3: Dose Level 3||0
229065|NCT00634088|551771|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
229066|NCT00634088|551772|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
229067|NCT00634088|551773|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
229068|NCT00634088|551774|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
229069|NCT00634088|551771|P4|COMPLETED|Time Period 2: Dose Level 2||0
229070|NCT00634088|551772|P3|COMPLETED|Time Period 2: Dose Level 2||0
229071|NCT00634088|551773|P2|COMPLETED|Time Period 2: Dose Level 2||0
229072|NCT00634088|551774|P1|COMPLETED|Time Period 2: Dose Level 2||0
229073|NCT00634088|551771|P4|STARTED|Time Period 2: Dose Level 2||0
229074|NCT00634088|551772|P3|STARTED|Time Period 2: Dose Level 2||0
229075|NCT00634088|551773|P2|STARTED|Time Period 2: Dose Level 2||3
229076|NCT00634088|551774|P1|STARTED|Time Period 2: Dose Level 2||0
229077|NCT00634088|551771|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
229078|NCT00634088|551772|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
229079|NCT00634088|551773|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
229080|NCT00634088|551774|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
229081|NCT00634088|551771|P4|COMPLETED|Time Period 1: Dose Level 1||0
229082|NCT00634088|551772|P3|COMPLETED|Time Period 1: Dose Level 1||0
229083|NCT00634088|551773|P2|COMPLETED|Time Period 1: Dose Level 1||0
229084|NCT00634088|551774|P1|COMPLETED|Time Period 1: Dose Level 1||0
229085|NCT00634088|551771|P4|STARTED|Time Period 1: Dose Level 1||0
229086|NCT00634088|551772|P3|STARTED|Time Period 1: Dose Level 1||0
229087|NCT00634088|551773|P2|STARTED|Time Period 1: Dose Level 1||0
229088|NCT00634088|551774|P1|STARTED|Time Period 1: Dose Level 1||6
229089|NCT00634049|551825|P1|NOT COMPLETED|Overall Study||3
229090|NCT00634049|551825|P1|COMPLETED|Overall Study||146
229091|NCT00634049|551825|P1|STARTED|Overall Study||149
229092|NCT00634036|551904|P2|NOT COMPLETED|Overall Study||2
229093|NCT00634036|551905|P1|NOT COMPLETED|Overall Study||2
229094|NCT00634036|551904|P2|COMPLETED|Overall Study||9
229095|NCT00634036|551905|P1|COMPLETED|Overall Study||10
229096|NCT00634036|551904|P2|STARTED|Overall Study||11
229097|NCT00634036|551905|P1|STARTED|Overall Study||12
229098|NCT00634010|551919|P2|NOT COMPLETED|Overall Study||14
229099|NCT00634010|551920|P1|NOT COMPLETED|Overall Study||10
229100|NCT00634010|551919|P2|COMPLETED|Overall Study||4
229101|NCT00634010|551920|P1|COMPLETED|Overall Study||8
229102|NCT00634010|551919|P2|STARTED|Overall Study||18
229103|NCT00634010|551920|P1|STARTED|Overall Study||18
229104|NCT00633984|551928|P2|NOT COMPLETED|Overall Study||13
229105|NCT00633984|551929|P1|NOT COMPLETED|Overall Study||9
229106|NCT00633984|551928|P2|COMPLETED|Overall Study||69
229107|NCT00633984|551929|P1|COMPLETED|Overall Study||78
229108|NCT00633984|551928|P2|STARTED|Overall Study||82
229109|NCT00633984|551929|P1|STARTED|Overall Study||87
229110|NCT00633932|551940|P3|NOT COMPLETED|Overall Study||11
229111|NCT00633932|551941|P2|NOT COMPLETED|Overall Study||14
229112|NCT00633932|551942|P1|NOT COMPLETED|Overall Study||12
229113|NCT00633932|551940|P3|COMPLETED|Overall Study||180
229114|NCT00633932|551941|P2|COMPLETED|Overall Study||176
229115|NCT00633932|551942|P1|COMPLETED|Overall Study||179
229116|NCT00633932|551940|P3|STARTED|Overall Study|Randomised|191
229117|NCT00633932|551941|P2|STARTED|Overall Study|Randomised|190
229118|NCT00633932|551942|P1|STARTED|Overall Study|Randomised|191
229119|NCT00633919|551955|P2|NOT COMPLETED|Overall Study||22
229120|NCT00633919|551956|P1|NOT COMPLETED|Overall Study||27
229121|NCT00633919|551955|P2|COMPLETED|Overall Study||39
229122|NCT00633919|551956|P1|COMPLETED|Overall Study||36
229123|NCT00633919|551955|P2|STARTED|Overall Study||61
229124|NCT00633919|551956|P1|STARTED|Overall Study||63
229125|NCT00633893|551973|P3|NOT COMPLETED|Overall Study||188
229126|NCT00633893|551974|P2|NOT COMPLETED|Overall Study||129
229127|NCT00633893|551975|P1|NOT COMPLETED|Overall Study||114
229128|NCT00633893|551973|P3|COMPLETED|Overall Study||641
229129|NCT00633893|551974|P2|COMPLETED|Overall Study||684
229130|NCT00633893|551975|P1|COMPLETED|Overall Study||726
229131|NCT00633893|551973|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
229132|NCT00633893|551974|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
229133|NCT00633893|551975|P1|STARTED|Overall Study||840
229134|NCT00633880|552049|P3|NOT COMPLETED|Randomized Double Blind||0
229135|NCT00633880|552050|P2|NOT COMPLETED|Randomized Double Blind||0
229136|NCT00633880|552051|P1|NOT COMPLETED|Randomized Double Blind||0
229137|NCT00633880|552049|P3|COMPLETED|Randomized Double Blind||51
229138|NCT00633880|552050|P2|COMPLETED|Randomized Double Blind||50
229139|NCT00633880|552051|P1|COMPLETED|Randomized Double Blind||0
229140|NCT00633880|552049|P3|STARTED|Randomized Double Blind||51
229141|NCT00633880|552050|P2|STARTED|Randomized Double Blind||50
229142|NCT00633880|552051|P1|STARTED|Randomized Double Blind||0
229143|NCT00633880|552049|P3|NOT COMPLETED|Open Label Titration||0
229144|NCT00633880|552050|P2|NOT COMPLETED|Open Label Titration||0
229145|NCT00633880|552051|P1|NOT COMPLETED|Open Label Titration||80
229146|NCT00633880|552049|P3|COMPLETED|Open Label Titration||0
229147|NCT00633880|552050|P2|COMPLETED|Open Label Titration||0
229148|NCT00633880|552051|P1|COMPLETED|Open Label Titration||101
229149|NCT00633880|552049|P3|STARTED|Open Label Titration||0
229150|NCT00633880|552050|P2|STARTED|Open Label Titration||0
229151|NCT00633880|552051|P1|STARTED|Open Label Titration||181
229152|NCT00633867|552080|P2|NOT COMPLETED|Overall Study||0
229153|NCT00633867|552081|P1|NOT COMPLETED|Overall Study||0
229154|NCT00633867|552080|P2|COMPLETED|Overall Study||60
229155|NCT00633867|552081|P1|COMPLETED|Overall Study||60
229156|NCT00633867|552080|P2|STARTED|Overall Study||60
229157|NCT00633867|552081|P1|STARTED|Overall Study||60
229158|NCT00633750|552087|P1|NOT COMPLETED|Overall Study||5
229159|NCT00633750|552087|P1|COMPLETED|Overall Study||42
229160|NCT00633750|552087|P1|STARTED|Overall Study||47
229161|NCT00633594|552096|P3|NOT COMPLETED|Overall Study||10
229162|NCT00633594|552097|P2|NOT COMPLETED|Overall Study||5
229163|NCT00633594|552098|P1|NOT COMPLETED|Overall Study||0
229164|NCT00633594|552096|P3|COMPLETED|Overall Study||16
229165|NCT00633594|552097|P2|COMPLETED|Overall Study||3
229166|NCT00633594|552098|P1|COMPLETED|Overall Study||5
229167|NCT00633594|552096|P3|STARTED|Overall Study||26
229168|NCT00633594|552097|P2|STARTED|Overall Study||8
229169|NCT00633594|552098|P1|STARTED|Overall Study||5
229170|NCT00633477|552127|P2|NOT COMPLETED|Overall Study||0
229171|NCT00633477|552128|P1|NOT COMPLETED|Overall Study||2
229172|NCT00633477|552127|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
229173|NCT00633477|552128|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
229174|NCT00633477|552127|P2|Completed Study Through Day 28|Overall Study||8
229175|NCT00633477|552128|P1|Completed Study Through Day 28|Overall Study||4
229176|NCT00633477|552127|P2|Prematurely Discontinued Study Drug|Overall Study||0
229177|NCT00633477|552128|P1|Prematurely Discontinued Study Drug|Overall Study||1
229178|NCT00633477|552127|P2|Randomized But Not Treated|Overall Study||0
229179|NCT00633477|552128|P1|Randomized But Not Treated|Overall Study||1
229180|NCT00633477|552127|P2|STARTED|Overall Study||11
229181|NCT00633477|552128|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
229182|NCT00633464|552144|P2|NOT COMPLETED|Overall Study||2
229183|NCT00633464|552145|P1|NOT COMPLETED|Overall Study||0
229184|NCT00633464|552144|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
229185|NCT00633464|552145|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
229186|NCT00633464|552144|P2|Treated|Overall Study||37
229187|NCT00633464|552145|P1|Treated|Overall Study||40
229188|NCT00633464|552144|P2|STARTED|Overall Study||39
229189|NCT00633464|552145|P1|STARTED|Overall Study||40
229190|NCT00633399|552167|P2|NOT COMPLETED|Overall Study||15
229191|NCT00633399|552168|P1|NOT COMPLETED|Overall Study||22
229192|NCT00633399|552167|P2|COMPLETED|Overall Study||53
229193|NCT00633399|552168|P1|COMPLETED|Overall Study||49
229194|NCT00633399|552167|P2|STARTED|Overall Study||68
229195|NCT00633399|552168|P1|STARTED|Overall Study||71
229196|NCT00633360|552180|P2|NOT COMPLETED|Overall Study||3
229197|NCT00633360|552181|P1|NOT COMPLETED|Overall Study||4
229198|NCT00633360|552180|P2|COMPLETED|Overall Study||13
229199|NCT00633360|552181|P1|COMPLETED|Overall Study||12
229200|NCT00633360|552180|P2|STARTED|Overall Study||16
229201|NCT00633360|552181|P1|STARTED|Overall Study||16
229202|NCT00633256|552191|P2|NOT COMPLETED|Overall Study||3
229203|NCT00633256|552192|P1|NOT COMPLETED|Overall Study||4
229204|NCT00633256|552191|P2|COMPLETED|Overall Study||10
229205|NCT00633256|552192|P1|COMPLETED|Overall Study||8
229206|NCT00633256|552191|P2|STARTED|Overall Study||13
229207|NCT00633256|552192|P1|STARTED|Overall Study||12
229208|NCT00633243|552204|P2|NOT COMPLETED|Overall Study||7
229209|NCT00633243|552205|P1|NOT COMPLETED|Overall Study||1
229210|NCT00633243|552204|P2|COMPLETED|Overall Study||2
229211|NCT00633243|552205|P1|COMPLETED|Overall Study||11
229212|NCT00633243|552204|P2|STARTED|Overall Study||9
229213|NCT00633243|552205|P1|STARTED|Overall Study||12
229214|NCT00633217|552213|P2|NOT COMPLETED|Overall Study||23
229215|NCT00633217|552214|P1|NOT COMPLETED|Overall Study||15
229216|NCT00633217|552213|P2|COMPLETED|Overall Study||103
229217|NCT00633217|552214|P1|COMPLETED|Overall Study||106
229218|NCT00633217|552213|P2|STARTED|Overall Study||126
229219|NCT00633217|552214|P1|STARTED|Overall Study||121
229220|NCT00633152|552226|P2|NOT COMPLETED|Overall Study||6
229221|NCT00633152|552227|P1|NOT COMPLETED|Overall Study||14
229222|NCT00633152|552226|P2|COMPLETED|Overall Study||41
229223|NCT00633152|552227|P1|COMPLETED|Overall Study||89
229224|NCT00633152|552226|P2|Clinically Evaluable Population|Overall Study||39
229225|NCT00633152|552227|P1|Clinically Evaluable Population|Overall Study||86
229226|NCT00633152|552226|P2|MITT and Safety Population|Overall Study||45
229227|NCT00633152|552227|P1|MITT and Safety Population|Overall Study||98
229228|NCT00633152|552226|P2|STARTED|Overall Study||47
229229|NCT00633152|552227|P1|STARTED|Overall Study||103
229230|NCT00633139|552238|P3|NOT COMPLETED|Overall Study||1
229231|NCT00633139|552239|P2|NOT COMPLETED|Overall Study||1
229232|NCT00633139|552240|P1|NOT COMPLETED|Overall Study||0
229233|NCT00633139|552238|P3|COMPLETED|Overall Study||3
229234|NCT00633139|552239|P2|COMPLETED|Overall Study||4
229235|NCT00633139|552240|P1|COMPLETED|Overall Study||4
229236|NCT00633139|552238|P3|STARTED|Overall Study||4
229237|NCT00633139|552239|P2|STARTED|Overall Study||5
229238|NCT00633139|552240|P1|STARTED|Overall Study||4
229239|NCT00633126|552254|P1|NOT COMPLETED|Overall Study||1
229240|NCT00633126|552254|P1|COMPLETED|Overall Study||8
229241|NCT00633126|552254|P1|STARTED|Overall Study||9
229242|NCT00633087|552259|P1|NOT COMPLETED|Overall Study||0
229243|NCT00633087|552259|P1|COMPLETED|Overall Study||12
229244|NCT00633087|552259|P1|STARTED|Overall Study||12
229245|NCT00633074|552268|P2|NOT COMPLETED|Overall Study||0
229246|NCT00633074|552269|P1|NOT COMPLETED|Overall Study||1
229247|NCT00633074|552268|P2|COMPLETED|Overall Study||360
229248|NCT00633074|552269|P1|COMPLETED|Overall Study||359
229249|NCT00633074|552268|P2|STARTED|Overall Study||360
229250|NCT00633074|552269|P1|STARTED|Overall Study||360
229251|NCT00633009|552300|P3|NOT COMPLETED|Overall Study||1
229252|NCT00633009|552301|P2|NOT COMPLETED|Overall Study||4
229253|NCT00633009|552302|P1|NOT COMPLETED|Overall Study||4
229254|NCT00633009|552300|P3|COMPLETED|Overall Study||10
229255|NCT00633009|552301|P2|COMPLETED|Overall Study||23
229256|NCT00633009|552302|P1|COMPLETED|Overall Study||8
229257|NCT00633009|552300|P3|STARTED|Overall Study||11
229258|NCT00633009|552301|P2|STARTED|Overall Study||27
229259|NCT00633009|552302|P1|STARTED|Overall Study||12
229260|NCT00632970|552315|P2|NOT COMPLETED|Overall Study||0
229261|NCT00632970|552316|P1|NOT COMPLETED|Overall Study||0
229262|NCT00632970|552315|P2|COMPLETED|Overall Study||3
229263|NCT00632970|552316|P1|COMPLETED|Overall Study||3
229264|NCT00632970|552315|P2|STARTED|Overall Study||3
229265|NCT00632970|552316|P1|STARTED|Overall Study||3
229266|NCT00632931|552322|P3|NOT COMPLETED|Part 2||24
229267|NCT00632931|552323|P2|NOT COMPLETED|Part 2||0
229268|NCT00632931|552324|P1|NOT COMPLETED|Part 2||0
229269|NCT00632931|552322|P3|COMPLETED|Part 2||0
229270|NCT00632931|552323|P2|COMPLETED|Part 2||0
229271|NCT00632931|552324|P1|COMPLETED|Part 2||0
229272|NCT00632931|552322|P3|STARTED|Part 2||24
229273|NCT00632931|552323|P2|STARTED|Part 2||0
229274|NCT00632931|552324|P1|STARTED|Part 2||0
229275|NCT00632931|552322|P3|NOT COMPLETED|Post-Part 1 Washout||0
229276|NCT00632931|552323|P2|NOT COMPLETED|Post-Part 1 Washout||0
229277|NCT00632931|552324|P1|NOT COMPLETED|Post-Part 1 Washout||0
229278|NCT00632931|552322|P3|COMPLETED|Post-Part 1 Washout||0
229279|NCT00632931|552323|P2|COMPLETED|Post-Part 1 Washout||12
229280|NCT00632931|552324|P1|COMPLETED|Post-Part 1 Washout||12
229281|NCT00632931|552322|P3|STARTED|Post-Part 1 Washout||0
229282|NCT00632931|552323|P2|STARTED|Post-Part 1 Washout||12
229283|NCT00632931|552324|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
229284|NCT00632931|552322|P3|NOT COMPLETED|Part 1, Period 2||0
229285|NCT00632931|552323|P2|NOT COMPLETED|Part 1, Period 2||0
229286|NCT00632931|552324|P1|NOT COMPLETED|Part 1, Period 2||0
229287|NCT00632931|552322|P3|COMPLETED|Part 1, Period 2||0
229288|NCT00632931|552323|P2|COMPLETED|Part 1, Period 2||12
229289|NCT00632931|552324|P1|COMPLETED|Part 1, Period 2||11
229290|NCT00632931|552322|P3|STARTED|Part 1, Period 2||0
229291|NCT00632931|552323|P2|STARTED|Part 1, Period 2||12
229292|NCT00632931|552324|P1|STARTED|Part 1, Period 2||11
229293|NCT00632931|552322|P3|NOT COMPLETED|Part 1, Washout||0
229294|NCT00632931|552323|P2|NOT COMPLETED|Part 1, Washout||0
229295|NCT00632931|552324|P1|NOT COMPLETED|Part 1, Washout||0
229296|NCT00632931|552322|P3|COMPLETED|Part 1, Washout||0
229297|NCT00632931|552323|P2|COMPLETED|Part 1, Washout||12
229298|NCT00632931|552324|P1|COMPLETED|Part 1, Washout||11
229299|NCT00632931|552322|P3|STARTED|Part 1, Washout||0
229300|NCT00632931|552323|P2|STARTED|Part 1, Washout||12
229301|NCT00632931|552324|P1|STARTED|Part 1, Washout||11
229302|NCT00632931|552322|P3|NOT COMPLETED|Part 1, Period 1||0
229303|NCT00632931|552323|P2|NOT COMPLETED|Part 1, Period 1||0
229304|NCT00632931|552324|P1|NOT COMPLETED|Part 1, Period 1||2
229305|NCT00632931|552322|P3|COMPLETED|Part 1, Period 1||0
229306|NCT00632931|552323|P2|COMPLETED|Part 1, Period 1||12
229307|NCT00632931|552324|P1|COMPLETED|Part 1, Period 1||11
229308|NCT00632931|552322|P3|STARTED|Part 1, Period 1||0
229309|NCT00632931|552323|P2|STARTED|Part 1, Period 1||12
229310|NCT00632931|552324|P1|STARTED|Part 1, Period 1||13
229311|NCT00632814|552346|P3|NOT COMPLETED|Overall Study||0
229312|NCT00632814|552347|P2|NOT COMPLETED|Overall Study||0
229313|NCT00632814|552348|P1|NOT COMPLETED|Overall Study||0
229314|NCT00632814|552346|P3|COMPLETED|Overall Study||8
229315|NCT00632814|552347|P2|COMPLETED|Overall Study||13
229316|NCT00632814|552348|P1|COMPLETED|Overall Study||11
229317|NCT00632814|552346|P3|STARTED|Overall Study||8
229318|NCT00632814|552347|P2|STARTED|Overall Study||13
229319|NCT00632814|552348|P1|STARTED|Overall Study||11
229320|NCT00632749|552394|P14|NOT COMPLETED|Overall Study||6
229321|NCT00632749|552395|P13|NOT COMPLETED|Overall Study||3
229322|NCT00632749|552396|P12|NOT COMPLETED|Overall Study||4
229323|NCT00632749|552397|P11|NOT COMPLETED|Overall Study||7
229324|NCT00632749|552398|P10|NOT COMPLETED|Overall Study||3
229325|NCT00632749|552399|P9|NOT COMPLETED|Overall Study||5
229326|NCT00632749|552400|P8|NOT COMPLETED|Overall Study||4
229327|NCT00632749|552401|P7|NOT COMPLETED|Overall Study||5
229328|NCT00632749|552402|P6|NOT COMPLETED|Overall Study||8
229329|NCT00632749|552403|P5|NOT COMPLETED|Overall Study||7
229330|NCT00632749|552404|P4|NOT COMPLETED|Overall Study||4
229331|NCT00632749|552405|P3|NOT COMPLETED|Overall Study||3
229332|NCT00632749|552406|P2|NOT COMPLETED|Overall Study||5
229333|NCT00632749|552407|P1|NOT COMPLETED|Overall Study||4
229334|NCT00632749|552394|P14|COMPLETED|Overall Study||0
229335|NCT00632749|552395|P13|COMPLETED|Overall Study||0
229336|NCT00632749|552396|P12|COMPLETED|Overall Study||0
229337|NCT00632749|552397|P11|COMPLETED|Overall Study||0
229338|NCT00632749|552398|P10|COMPLETED|Overall Study||0
229339|NCT00632749|552399|P9|COMPLETED|Overall Study||0
229340|NCT00632749|552400|P8|COMPLETED|Overall Study||0
229341|NCT00632749|552401|P7|COMPLETED|Overall Study||0
229342|NCT00632749|552402|P6|COMPLETED|Overall Study||0
229343|NCT00632749|552403|P5|COMPLETED|Overall Study||0
229344|NCT00632749|552404|P4|COMPLETED|Overall Study||0
229345|NCT00632749|552405|P3|COMPLETED|Overall Study||0
229346|NCT00632749|552406|P2|COMPLETED|Overall Study||0
229347|NCT00632749|552407|P1|COMPLETED|Overall Study||0
229348|NCT00632749|552394|P14|Not Treated|Overall Study||0
229349|NCT00632749|552395|P13|Not Treated|Overall Study||0
229350|NCT00632749|552396|P12|Not Treated|Overall Study||0
229351|NCT00632749|552397|P11|Not Treated|Overall Study||0
229352|NCT00632749|552398|P10|Not Treated|Overall Study||0
229353|NCT00632749|552399|P9|Not Treated|Overall Study||0
229354|NCT00632749|552400|P8|Not Treated|Overall Study||0
229355|NCT00632749|552401|P7|Not Treated|Overall Study||1
229356|NCT00632749|552402|P6|Not Treated|Overall Study||1
229357|NCT00632749|552403|P5|Not Treated|Overall Study||0
229358|NCT00632749|552404|P4|Not Treated|Overall Study||0
229359|NCT00632749|552405|P3|Not Treated|Overall Study||0
229360|NCT00632749|552406|P2|Not Treated|Overall Study||2
229361|NCT00632749|552407|P1|Not Treated|Overall Study||0
229362|NCT00632749|552394|P14|Treated|Overall Study||6
229363|NCT00632749|552395|P13|Treated|Overall Study||3
229364|NCT00632749|552396|P12|Treated|Overall Study||4
229365|NCT00632749|552397|P11|Treated|Overall Study||7
229366|NCT00632749|552398|P10|Treated|Overall Study||3
229367|NCT00632749|552399|P9|Treated|Overall Study||5
229368|NCT00632749|552400|P8|Treated|Overall Study||4
229369|NCT00632749|552401|P7|Treated|Overall Study||4
229370|NCT00632749|552402|P6|Treated|Overall Study||7
229371|NCT00632749|552403|P5|Treated|Overall Study||7
229372|NCT00632749|552404|P4|Treated|Overall Study||4
229373|NCT00632749|552405|P3|Treated|Overall Study||3
229374|NCT00632749|552406|P2|Treated|Overall Study||3
229375|NCT00632749|552407|P1|Treated|Overall Study||4
229376|NCT00632749|552394|P14|STARTED|Overall Study||6
229377|NCT00632749|552395|P13|STARTED|Overall Study||3
229378|NCT00632749|552396|P12|STARTED|Overall Study||4
229379|NCT00632749|552397|P11|STARTED|Overall Study||7
229380|NCT00632749|552398|P10|STARTED|Overall Study||3
229381|NCT00632749|552399|P9|STARTED|Overall Study||5
229382|NCT00632749|552400|P8|STARTED|Overall Study||4
229383|NCT00632749|552401|P7|STARTED|Overall Study||5
229384|NCT00632749|552402|P6|STARTED|Overall Study||8
229385|NCT00632749|552403|P5|STARTED|Overall Study||7
229386|NCT00632749|552404|P4|STARTED|Overall Study||4
229387|NCT00632749|552405|P3|STARTED|Overall Study||3
229388|NCT00632749|552406|P2|STARTED|Overall Study||5
229389|NCT00632749|552407|P1|STARTED|Overall Study||4
229390|NCT00632736|552701|P1|NOT COMPLETED|Overall Study||268
229391|NCT00632736|552701|P1|COMPLETED|Overall Study||151
229392|NCT00632736|552701|P1|STARTED|Overall Study||419
229393|NCT00632632|552708|P2|NOT COMPLETED|Overall Study||3
229394|NCT00632632|552709|P1|NOT COMPLETED|Overall Study||0
229395|NCT00632632|552708|P2|COMPLETED|Overall Study||9
229396|NCT00632632|552709|P1|COMPLETED|Overall Study||13
229397|NCT00632632|552708|P2|STARTED|Overall Study||12
229398|NCT00632632|552709|P1|STARTED|Overall Study||13
229399|NCT00632619|552721|P2|NOT COMPLETED|Overall Study||4
229400|NCT00632619|552722|P1|NOT COMPLETED|Overall Study||8
229401|NCT00632619|552721|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
229402|NCT00632619|552722|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
229403|NCT00632619|552721|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
229404|NCT00632619|552722|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
229405|NCT00632541|552736|P1|NOT COMPLETED|Overall Study||7
229406|NCT00632541|552736|P1|COMPLETED|Overall Study||11
229407|NCT00632541|552736|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
229408|NCT00632502|552745|P2|NOT COMPLETED|Overall Study||1
229409|NCT00632502|552746|P1|NOT COMPLETED|Overall Study||3
229410|NCT00632502|552745|P2|COMPLETED|Overall Study||11
229411|NCT00632502|552746|P1|COMPLETED|Overall Study||22
229412|NCT00632502|552745|P2|Completed Treatment|Overall Study||9
229413|NCT00632502|552746|P1|Completed Treatment|Overall Study||19
229414|NCT00632502|552745|P2|Treated|Overall Study||12
229415|NCT00632502|552746|P1|Treated|Overall Study||22
229416|NCT00632502|552745|P2|STARTED|Overall Study||12
229417|NCT00632502|552746|P1|STARTED|Overall Study||25
229418|NCT00632489|552774|P3|NOT COMPLETED|Overall Study||0
229419|NCT00632489|552775|P2|NOT COMPLETED|Overall Study||5
229420|NCT00632489|552776|P1|NOT COMPLETED|Overall Study||15
229421|NCT00632489|552774|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
229422|NCT00632489|552775|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
229423|NCT00632489|552776|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
229424|NCT00632489|552774|P3|STARTED|Overall Study||0
229425|NCT00632489|552775|P2|STARTED|Overall Study||5
229426|NCT00632489|552776|P1|STARTED|Overall Study||15
229427|NCT00632463|552790|P3|NOT COMPLETED|Overall Study||0
229428|NCT00632463|552791|P2|NOT COMPLETED|Overall Study||1
229429|NCT00632463|552792|P1|NOT COMPLETED|Overall Study||0
229430|NCT00632463|552790|P3|COMPLETED|Overall Study||7
229431|NCT00632463|552791|P2|COMPLETED|Overall Study||6
229432|NCT00632463|552792|P1|COMPLETED|Overall Study||7
229433|NCT00632463|552790|P3|STARTED|Overall Study||7
229434|NCT00632463|552791|P2|STARTED|Overall Study||7
229435|NCT00632463|552792|P1|STARTED|Overall Study||7
229436|NCT00632424|552809|P1|NOT COMPLETED|Overall Study||18
229437|NCT00632424|552809|P1|COMPLETED|Overall Study||0
229438|NCT00632424|552809|P1|STARTED|Overall Study||18
229439|NCT00632411|552833|P2|NOT COMPLETED|Overall Study||176
229440|NCT00632411|552834|P1|NOT COMPLETED|Overall Study||160
229441|NCT00632411|552833|P2|COMPLETED|Overall Study||473
229442|NCT00632411|552834|P1|COMPLETED|Overall Study||489
229443|NCT00632411|552833|P2|STARTED|Overall Study||649
229444|NCT00632411|552834|P1|STARTED|Overall Study||649
229445|NCT00632281|552840|P1|NOT COMPLETED|Overall Study||0
229446|NCT00632281|552840|P1|COMPLETED|Overall Study||38
229447|NCT00632281|552840|P1|STARTED|Overall Study||38
229448|NCT00632229|552847|P2|NOT COMPLETED|Overall Study||6
229449|NCT00632229|552848|P1|NOT COMPLETED|Overall Study||6
229450|NCT00632229|552847|P2|COMPLETED|Overall Study||11
229451|NCT00632229|552848|P1|COMPLETED|Overall Study||11
229452|NCT00632229|552847|P2|STARTED|Overall Study||17
229453|NCT00632229|552848|P1|STARTED|Overall Study||17
229454|NCT00632203|552858|P2|NOT COMPLETED|Overall Study||0
229455|NCT00632203|552859|P1|NOT COMPLETED|Overall Study||1
229456|NCT00632203|552858|P2|COMPLETED|Overall Study||27
229457|NCT00632203|552859|P1|COMPLETED|Overall Study||25
229458|NCT00632203|552858|P2|STARTED|Overall Study||27
229459|NCT00632203|552859|P1|STARTED|Overall Study||26
229460|NCT00632125|552877|P1|NOT COMPLETED|Overall Study||302
229461|NCT00632125|552877|P1|COMPLETED|Overall Study||1393
229462|NCT00632125|552877|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
229463|NCT00632099|552883|P2|NOT COMPLETED|Overall Study||3
229464|NCT00632099|552884|P1|NOT COMPLETED|Overall Study||3
229465|NCT00632099|552883|P2|COMPLETED|Overall Study||8
229466|NCT00632099|552884|P1|COMPLETED|Overall Study||7
229467|NCT00632099|552883|P2|STARTED|Overall Study||11
229468|NCT00632099|552884|P1|STARTED|Overall Study||10
229469|NCT00632021|552892|P2|NOT COMPLETED|Overall Study||7
229470|NCT00632021|552893|P1|NOT COMPLETED|Overall Study||4
229471|NCT00632021|552892|P2|COMPLETED|Overall Study||423
229472|NCT00632021|552893|P1|COMPLETED|Overall Study||428
229473|NCT00632021|552892|P2|STARTED|Overall Study||430
229474|NCT00632021|552893|P1|STARTED|Overall Study||432
229475|NCT00631969|552903|P2|NOT COMPLETED|Overall Study||21
229476|NCT00631969|552904|P1|NOT COMPLETED|Overall Study||15
229477|NCT00631969|552903|P2|COMPLETED|Overall Study||155
229478|NCT00631969|552904|P1|COMPLETED|Overall Study||171
229479|NCT00631969|552903|P2|Received Treatment|Overall Study|safety population|174
229480|NCT00631969|552904|P1|Received Treatment|Overall Study|safety population|184
229481|NCT00631969|552903|P2|STARTED|Overall Study||176
229482|NCT00631969|552904|P1|STARTED|Overall Study||186
229483|NCT00631917|552950|P2|NOT COMPLETED|Overall Study||108
229484|NCT00631917|552951|P1|NOT COMPLETED|Overall Study||88
229485|NCT00631917|552950|P2|COMPLETED|Overall Study||291
229486|NCT00631917|552951|P1|COMPLETED|Overall Study||287
229487|NCT00631917|552950|P2|STARTED|Overall Study||399
229488|NCT00631917|552951|P1|STARTED|Overall Study||375
229489|NCT00631748|552967|P2|NOT COMPLETED|Overall Study||22
229490|NCT00631748|552968|P1|NOT COMPLETED|Overall Study||18
229491|NCT00631748|552967|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
229492|NCT00631748|552968|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
229493|NCT00631748|552967|P2|STARTED|Overall Study||31
229494|NCT00631748|552968|P1|STARTED|Overall Study||29
229495|NCT00631696|552978|P2|NOT COMPLETED|Overall Study||40
229496|NCT00631696|552979|P1|NOT COMPLETED|Overall Study||37
229497|NCT00631696|552978|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
229498|NCT00631696|552979|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
229499|NCT00631696|552978|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
229500|NCT00631696|552979|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
229501|NCT00631696|552978|P2|Received Study Treatment (Tx)|Overall Study||109
229502|NCT00631696|552979|P1|Received Study Treatment (Tx)|Overall Study||111
229503|NCT00631696|552978|P2|STARTED|Overall Study||110
229504|NCT00631696|552979|P1|STARTED|Overall Study||112
229505|NCT00631670|553005|P2|NOT COMPLETED|Overall Study||0
229506|NCT00631670|553006|P1|NOT COMPLETED|Overall Study||0
229507|NCT00631670|553005|P2|COMPLETED|Overall Study||0
229508|NCT00631670|553006|P1|COMPLETED|Overall Study||21
229509|NCT00631670|553005|P2|STARTED|Overall Study||0
229510|NCT00631670|553006|P1|STARTED|Overall Study||21
229511|NCT00631657|553022|P3|NOT COMPLETED|7-Day Discontinuation Period||1
229512|NCT00631657|553023|P2|NOT COMPLETED|7-Day Discontinuation Period||1
229513|NCT00631657|553024|P1|NOT COMPLETED|7-Day Discontinuation Period||2
229514|NCT00631657|553022|P3|COMPLETED|7-Day Discontinuation Period||65
229515|NCT00631657|553023|P2|COMPLETED|7-Day Discontinuation Period||136
229516|NCT00631657|553024|P1|COMPLETED|7-Day Discontinuation Period||65
229517|NCT00631657|553022|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
229518|NCT00631657|553023|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
229519|NCT00631657|553024|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
229520|NCT00631657|553022|P3|STARTED|7-Day Discontinuation Period||66
229521|NCT00631657|553023|P2|STARTED|7-Day Discontinuation Period||137
229522|NCT00631657|553024|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
229523|NCT00631657|553022|P3|NOT COMPLETED|6-Month Treatment Period||50
229524|NCT00631657|553023|P2|NOT COMPLETED|6-Month Treatment Period||0
229525|NCT00631657|553024|P1|NOT COMPLETED|6-Month Treatment Period||141
229526|NCT00631657|553022|P3|COMPLETED|6-Month Treatment Period||66
229527|NCT00631657|553023|P2|COMPLETED|6-Month Treatment Period||0
229528|NCT00631657|553024|P1|COMPLETED|6-Month Treatment Period||203
229529|NCT00631657|553022|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
229530|NCT00631657|553023|P2|Treated|6-Month Treatment Period||0
229531|NCT00631657|553024|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
229532|NCT00631657|553022|P3|STARTED|6-Month Treatment Period||116
229533|NCT00631657|553023|P2|STARTED|6-Month Treatment Period||0
229534|NCT00631657|553024|P1|STARTED|6-Month Treatment Period||344
229535|NCT00631540|553051|P1|NOT COMPLETED|Overall Study||14
229536|NCT00631540|553051|P1|COMPLETED|Overall Study||86
229537|NCT00631540|553051|P1|STARTED|Overall Study||100
229538|NCT00631488|553063|P3|NOT COMPLETED|Overall Study||2
229539|NCT00631488|553064|P2|NOT COMPLETED|Overall Study||2
229540|NCT00631488|553065|P1|NOT COMPLETED|Overall Study||4
229541|NCT00631488|553063|P3|COMPLETED|Overall Study||47
229542|NCT00631488|553064|P2|COMPLETED|Overall Study||47
229543|NCT00631488|553065|P1|COMPLETED|Overall Study||44
229544|NCT00631488|553063|P3|Completed Post-Treatment Period|Overall Study||47
229545|NCT00631488|553064|P2|Completed Post-Treatment Period|Overall Study||47
229546|NCT00631488|553065|P1|Completed Post-Treatment Period|Overall Study||44
229547|NCT00631488|553063|P3|STARTED|Overall Study||49
229548|NCT00631488|553064|P2|STARTED|Overall Study||49
229549|NCT00631488|553065|P1|STARTED|Overall Study||48
229550|NCT00631475|553085|P1|NOT COMPLETED|Overall Study||45
229551|NCT00631475|553085|P1|COMPLETED|Overall Study||83
229552|NCT00631475|553085|P1|STARTED|Overall Study||128
229553|NCT00631449|553095|P2|NOT COMPLETED|Overall Study||0
229554|NCT00631449|553096|P1|NOT COMPLETED|Overall Study||0
229555|NCT00631449|553095|P2|COMPLETED|Overall Study||15
229556|NCT00631449|553096|P1|COMPLETED|Overall Study||15
229557|NCT00631449|553095|P2|STARTED|Overall Study||15
229558|NCT00631449|553096|P1|STARTED|Overall Study||15
229559|NCT00631410|553104|P2|NOT COMPLETED|Overall Study||6
229560|NCT00631410|553105|P1|NOT COMPLETED|Overall Study||6
229561|NCT00631410|553104|P2|COMPLETED|Overall Study||0
229562|NCT00631410|553105|P1|COMPLETED|Overall Study||0
229563|NCT00631410|553104|P2|STARTED|Overall Study||6
229564|NCT00631410|553105|P1|STARTED|Overall Study||6
229565|NCT00631371|553124|P2|NOT COMPLETED|Overall Study||391
229566|NCT00631371|553125|P1|NOT COMPLETED|Overall Study||400
229567|NCT00631371|553124|P2|COMPLETED|Overall Study||0
229568|NCT00631371|553125|P1|COMPLETED|Overall Study||0
229569|NCT00631371|553124|P2|Treated|Overall Study||391
229570|NCT00631371|553125|P1|Treated|Overall Study||393
229571|NCT00631371|553124|P2|STARTED|Overall Study||391
229572|NCT00631371|553125|P1|STARTED|Overall Study||400
229573|NCT00631358|553139|P2|NOT COMPLETED|Overall Study||2
229574|NCT00631358|553140|P1|NOT COMPLETED|Overall Study||6
229575|NCT00631358|553139|P2|COMPLETED|Overall Study||45
229576|NCT00631358|553140|P1|COMPLETED|Overall Study||44
229577|NCT00631358|553139|P2|STARTED|Overall Study||47
229578|NCT00631358|553140|P1|STARTED|Overall Study||50
229579|NCT00631189|553158|P4|NOT COMPLETED|Treatment Phase||7
229580|NCT00631189|553159|P3|NOT COMPLETED|Treatment Phase||11
229581|NCT00631189|553160|P2|NOT COMPLETED|Treatment Phase||7
229582|NCT00631189|553161|P1|NOT COMPLETED|Treatment Phase||0
229583|NCT00631189|553158|P4|COMPLETED|Treatment Phase||103
229584|NCT00631189|553159|P3|COMPLETED|Treatment Phase||92
229585|NCT00631189|553160|P2|COMPLETED|Treatment Phase||97
229586|NCT00631189|553161|P1|COMPLETED|Treatment Phase||0
229587|NCT00631189|553158|P4|STARTED|Treatment Phase||110
229588|NCT00631189|553159|P3|STARTED|Treatment Phase||103
229589|NCT00631189|553160|P2|STARTED|Treatment Phase||104
229590|NCT00631189|553161|P1|STARTED|Treatment Phase||0
229591|NCT00631189|553158|P4|NOT COMPLETED|Initial Phase||0
229592|NCT00631189|553159|P3|NOT COMPLETED|Initial Phase||0
229593|NCT00631189|553160|P2|NOT COMPLETED|Initial Phase||0
229594|NCT00631189|553161|P1|NOT COMPLETED|Initial Phase||351
229595|NCT00631189|553158|P4|COMPLETED|Initial Phase||0
229596|NCT00631189|553159|P3|COMPLETED|Initial Phase||0
229597|NCT00631189|553160|P2|COMPLETED|Initial Phase||0
229598|NCT00631189|553161|P1|COMPLETED|Initial Phase||317
229599|NCT00631189|553158|P4|STARTED|Initial Phase||0
229600|NCT00631189|553159|P3|STARTED|Initial Phase||0
229601|NCT00631189|553160|P2|STARTED|Initial Phase||0
229602|NCT00631189|553161|P1|STARTED|Initial Phase||668
229603|NCT00631020|553203|P1|NOT COMPLETED|Overall Study||8
229604|NCT00631020|553203|P1|COMPLETED|Overall Study||26
229605|NCT00631020|553203|P1|STARTED|Overall Study||34
229606|NCT00631007|553218|P6|NOT COMPLETED|Overall Study||15
229607|NCT00631007|553219|P5|NOT COMPLETED|Overall Study||12
229608|NCT00631007|553220|P4|NOT COMPLETED|Overall Study||9
229609|NCT00631007|553221|P3|NOT COMPLETED|Overall Study||10
229610|NCT00631007|553222|P2|NOT COMPLETED|Overall Study||11
229611|NCT00631007|553223|P1|NOT COMPLETED|Overall Study||11
229612|NCT00631007|553218|P6|COMPLETED|Overall Study||46
229613|NCT00631007|553219|P5|COMPLETED|Overall Study||48
229614|NCT00631007|553220|P4|COMPLETED|Overall Study||53
229615|NCT00631007|553221|P3|COMPLETED|Overall Study||53
229616|NCT00631007|553222|P2|COMPLETED|Overall Study||50
229617|NCT00631007|553223|P1|COMPLETED|Overall Study||49
229618|NCT00631007|553218|P6|STARTED|Overall Study||61
229619|NCT00631007|553219|P5|STARTED|Overall Study||60
229620|NCT00631007|553220|P4|STARTED|Overall Study||62
229621|NCT00631007|553221|P3|STARTED|Overall Study||63
229622|NCT00631007|553222|P2|STARTED|Overall Study||61
229623|NCT00631007|553223|P1|STARTED|Overall Study||60
229624|NCT00630994|553243|P1|NOT COMPLETED|Overall Study||4
229625|NCT00630994|553243|P1|COMPLETED|Overall Study||0
229626|NCT00630994|553243|P1|STARTED|Overall Study||4
229627|NCT00630955|553254|P3|NOT COMPLETED|Overall Study||12
229628|NCT00630955|553255|P2|NOT COMPLETED|Overall Study||6
229629|NCT00630955|553256|P1|NOT COMPLETED|Overall Study||3
229630|NCT00630955|553254|P3|COMPLETED|Overall Study||28
229631|NCT00630955|553255|P2|COMPLETED|Overall Study||31
229632|NCT00630955|553256|P1|COMPLETED|Overall Study||31
229633|NCT00630955|553254|P3|STARTED|Overall Study||40
229634|NCT00630955|553255|P2|STARTED|Overall Study||37
229635|NCT00630955|553256|P1|STARTED|Overall Study||34
229636|NCT00630916|553273|P1|NOT COMPLETED|Overall Study||210
229637|NCT00630916|553273|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
229638|NCT00630916|553273|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
229639|NCT00630916|553273|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
229640|NCT00630877|553283|P3|NOT COMPLETED|Overall Study||10
229641|NCT00630877|553284|P2|NOT COMPLETED|Overall Study||15
229642|NCT00630877|553285|P1|NOT COMPLETED|Overall Study||19
229643|NCT00630877|553283|P3|COMPLETED|Overall Study||80
229644|NCT00630877|553284|P2|COMPLETED|Overall Study||75
229645|NCT00630877|553285|P1|COMPLETED|Overall Study||72
229646|NCT00630877|553283|P3|STARTED|Overall Study||90
229647|NCT00630877|553284|P2|STARTED|Overall Study||90
229648|NCT00630877|553285|P1|STARTED|Overall Study|For all arms, started means treated.|91
229649|NCT00630864|553303|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
229650|NCT00630864|553303|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
229651|NCT00630864|553303|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
229652|NCT00630864|553303|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
229653|NCT00630864|553303|P1|COMPLETED|Part 1 (up to Week 6)||20
229654|NCT00630864|553303|P1|STARTED|Part 1 (up to Week 6)||21
229655|NCT00630838|553342|P2|NOT COMPLETED|Overall Study||2
229656|NCT00630838|553343|P1|NOT COMPLETED|Overall Study||0
229657|NCT00630838|553342|P2|COMPLETED|Overall Study||28
229658|NCT00630838|553343|P1|COMPLETED|Overall Study||32
229659|NCT00630838|553342|P2|STARTED|Overall Study||30
229660|NCT00630838|553343|P1|STARTED|Overall Study||32
229661|NCT00630825|553355|P4|NOT COMPLETED|Overall Study||6
229662|NCT00630825|553356|P3|NOT COMPLETED|Overall Study||8
229663|NCT00630825|553357|P2|NOT COMPLETED|Overall Study||7
229664|NCT00630825|553358|P1|NOT COMPLETED|Overall Study||9
229665|NCT00630825|553355|P4|COMPLETED|Overall Study||60
229666|NCT00630825|553356|P3|COMPLETED|Overall Study||58
229667|NCT00630825|553357|P2|COMPLETED|Overall Study||58
229668|NCT00630825|553358|P1|COMPLETED|Overall Study||56
229669|NCT00630825|553355|P4|Received at Least One Dose of Study Drug|Overall Study||66
229670|NCT00630825|553356|P3|Received at Least One Dose of Study Drug|Overall Study||66
229671|NCT00630825|553357|P2|Received at Least One Dose of Study Drug|Overall Study||65
229672|NCT00630825|553358|P1|Received at Least One Dose of Study Drug|Overall Study||65
229673|NCT00630825|553355|P4|STARTED|Overall Study||66
229674|NCT00630825|553356|P3|STARTED|Overall Study||66
229675|NCT00630825|553357|P2|STARTED|Overall Study||65
229676|NCT00630825|553358|P1|STARTED|Overall Study||65
229677|NCT00630786|553430|P3|NOT COMPLETED|Overall Study||2
229678|NCT00630786|553431|P2|NOT COMPLETED|Overall Study||2
229679|NCT00630786|553432|P1|NOT COMPLETED|Overall Study||1
229680|NCT00630786|553430|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
229681|NCT00630786|553431|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
229682|NCT00630786|553432|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
229683|NCT00630786|553430|P3|Received Study Medication|Overall Study||8
229684|NCT00630786|553431|P2|Received Study Medication|Overall Study||25
229685|NCT00630786|553432|P1|Received Study Medication|Overall Study||19
229686|NCT00630786|553430|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
229687|NCT00630786|553431|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
229688|NCT00630786|553432|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
229689|NCT00630747|553451|P1|NOT COMPLETED|Overall Study||9
229690|NCT00630747|553451|P1|COMPLETED|Overall Study||85
229691|NCT00630747|553451|P1|Participants Treated in Phase I of Study|Overall Study||94
229692|NCT00630747|553451|P1|STARTED|Overall Study||94
229693|NCT00630734|553463|P3|NOT COMPLETED|Overall Study||1
229694|NCT00630734|553464|P2|NOT COMPLETED|Overall Study||1
229695|NCT00630734|553465|P1|NOT COMPLETED|Overall Study||2
229696|NCT00630734|553463|P3|COMPLETED|Overall Study||7
229697|NCT00630734|553464|P2|COMPLETED|Overall Study||12
229698|NCT00630734|553465|P1|COMPLETED|Overall Study||9
229699|NCT00630734|553463|P3|STARTED|Overall Study||8
229700|NCT00630734|553464|P2|STARTED|Overall Study||13
229701|NCT00630734|553465|P1|STARTED|Overall Study||11
229702|NCT00630539|553504|P4|NOT COMPLETED|Overall Study||3
229703|NCT00630539|553505|P3|NOT COMPLETED|Overall Study||1
229704|NCT00630539|553506|P2|NOT COMPLETED|Overall Study||4
229705|NCT00630539|553507|P1|NOT COMPLETED|Overall Study||1
229706|NCT00630539|553504|P4|COMPLETED|Overall Study||27
229707|NCT00630539|553505|P3|COMPLETED|Overall Study||28
229708|NCT00630539|553506|P2|COMPLETED|Overall Study||29
229709|NCT00630539|553507|P1|COMPLETED|Overall Study||33
229710|NCT00630539|553504|P4|STARTED|Overall Study||30
229711|NCT00630539|553505|P3|STARTED|Overall Study||29
229712|NCT00630539|553506|P2|STARTED|Overall Study||33
229713|NCT00630539|553507|P1|STARTED|Overall Study||34
229714|NCT00630487|553563|P2|NOT COMPLETED|Overall Study||0
229715|NCT00630487|553564|P1|NOT COMPLETED|Overall Study||0
229716|NCT00630487|553563|P2|COMPLETED|Overall Study||0
229717|NCT00630487|553564|P1|COMPLETED|Overall Study||0
229718|NCT00630487|553563|P2|STARTED|Overall Study||0
229719|NCT00630487|553564|P1|STARTED|Overall Study||0
229720|NCT00630409|553598|P1|NOT COMPLETED|Overall Study||1
229721|NCT00630409|553598|P1|COMPLETED|Overall Study||4
229722|NCT00630409|553598|P1|STARTED|Overall Study||5
229723|NCT00630396|553603|P1|NOT COMPLETED|Overall Study||7
229724|NCT00630396|553603|P1|COMPLETED|Overall Study||53
229725|NCT00630396|553603|P1|STARTED|Overall Study||60
229726|NCT00630344|553609|P1|NOT COMPLETED|Overall Study||36
229727|NCT00630344|553609|P1|COMPLETED|Overall Study||0
229728|NCT00630344|553609|P1|STARTED|Overall Study||36
229729|NCT00630331|553621|P3|NOT COMPLETED|Overall Study||188
229730|NCT00630331|553622|P2|NOT COMPLETED|Overall Study||166
229731|NCT00630331|553623|P1|NOT COMPLETED|Overall Study||206
229732|NCT00630331|553621|P3|COMPLETED|Overall Study||3712
229733|NCT00630331|553622|P2|COMPLETED|Overall Study||3510
229734|NCT00630331|553623|P1|COMPLETED|Overall Study||3622
229735|NCT00630331|553621|P3|STARTED|Overall Study||3900
229736|NCT00630331|553622|P2|STARTED|Overall Study||3676
229737|NCT00630331|553623|P1|STARTED|Overall Study||3828
229738|NCT00630305|553664|P1|NOT COMPLETED|Overall Study||2
229739|NCT00630305|553664|P1|COMPLETED|Overall Study||35
229740|NCT00630305|553664|P1|STARTED|Overall Study||37
229741|NCT00630292|553686|P1|NOT COMPLETED|Overall Study||1
229742|NCT00630292|553686|P1|COMPLETED|Overall Study||5
229743|NCT00630292|553686|P1|STARTED|Overall Study||6
229744|NCT00630058|553692|P2|NOT COMPLETED|Overall Study||4
229745|NCT00630058|553693|P1|NOT COMPLETED|Overall Study||4
229746|NCT00630058|553692|P2|COMPLETED|Overall Study||6
229747|NCT00630058|553693|P1|COMPLETED|Overall Study||6
229748|NCT00630058|553692|P2|STARTED|Overall Study||10
229749|NCT00630058|553693|P1|STARTED|Overall Study||10
229750|NCT00629850|553711|P2|NOT COMPLETED|Overall Study||0
229751|NCT00629850|553712|P1|NOT COMPLETED|Overall Study||0
229752|NCT00629850|553711|P2|COMPLETED|Overall Study||0
229753|NCT00629850|553712|P1|COMPLETED|Overall Study||1
229754|NCT00629850|553711|P2|STARTED|Overall Study||0
229755|NCT00629850|553712|P1|STARTED|Overall Study||1
229756|NCT00629772|553724|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
229757|NCT00629772|553725|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
229758|NCT00629772|553724|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
229759|NCT00629772|553725|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
229760|NCT00629772|553724|P2|STARTED|Second Intervention Week 14 - Week 26||12
229761|NCT00629772|553725|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
229762|NCT00629772|553724|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
229763|NCT00629772|553725|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
229764|NCT00629772|553724|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
229765|NCT00629772|553725|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
229766|NCT00629772|553724|P2|STARTED|First Intervention - Day 0 - Week 14||12
229767|NCT00629772|553725|P1|STARTED|First Intervention - Day 0 - Week 14||12
229768|NCT00629707|553745|P2|NOT COMPLETED|Overall Study||2
229769|NCT00629707|553746|P1|NOT COMPLETED|Overall Study||0
229770|NCT00629707|553745|P2|COMPLETED|Overall Study||8
229771|NCT00629707|553746|P1|COMPLETED|Overall Study||10
229772|NCT00629707|553745|P2|STARTED|Overall Study||10
229773|NCT00629707|553746|P1|STARTED|Overall Study||10
229774|NCT00629525|553752|P1|NOT COMPLETED|Overall Study||3
229775|NCT00629525|553752|P1|COMPLETED|Overall Study||32
229776|NCT00629525|553752|P1|STARTED|Overall Study||35
229777|NCT00629499|553760|P1|NOT COMPLETED|Overall Study||0
229778|NCT00629499|553760|P1|COMPLETED|Overall Study||63
229779|NCT00629499|553760|P1|STARTED|Overall Study||63
229780|NCT00629265|553766|P2|NOT COMPLETED|Overall Study||20
229781|NCT00629265|553767|P1|NOT COMPLETED|Overall Study||32
229782|NCT00629265|553766|P2|COMPLETED|Overall Study||34
229783|NCT00629265|553767|P1|COMPLETED|Overall Study||84
229784|NCT00629265|553766|P2|STARTED|Overall Study||54
229785|NCT00629265|553767|P1|STARTED|Overall Study||116
229786|NCT00629239|553777|P2|NOT COMPLETED|Overall Study||4
229787|NCT00629239|553778|P1|NOT COMPLETED|Overall Study||8
229788|NCT00629239|553777|P2|COMPLETED|Overall Study||28
229789|NCT00629239|553778|P1|COMPLETED|Overall Study||26
229790|NCT00629239|553777|P2|STARTED|Overall Study||32
229791|NCT00629239|553778|P1|STARTED|Overall Study||34
229792|NCT00629122|553812|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
229793|NCT00629122|553813|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
229794|NCT00629122|553812|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
229795|NCT00629122|553813|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
229796|NCT00629122|553812|P2|STARTED|Third Period: Day 6-8 (Oral)||3
229797|NCT00629122|553813|P1|STARTED|Third Period: Day 6-8 (Oral)||2
229798|NCT00629122|553812|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
229799|NCT00629122|553813|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
229800|NCT00629122|553812|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
229801|NCT00629122|553813|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
229802|NCT00629122|553812|P2|STARTED|Second Period: Day 3-5 (Washout)||3
229803|NCT00629122|553813|P1|STARTED|Second Period: Day 3-5 (Washout)||2
229804|NCT00629122|553812|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
229805|NCT00629122|553813|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
229806|NCT00629122|553812|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
229807|NCT00629122|553813|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
229808|NCT00629122|553812|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
229809|NCT00629122|553813|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
229810|NCT00629018|553831|P2|NOT COMPLETED|Overall Study||0
229811|NCT00629018|553832|P1|NOT COMPLETED|Overall Study||0
229812|NCT00629018|553831|P2|COMPLETED|Overall Study||55
229813|NCT00629018|553832|P1|COMPLETED|Overall Study||55
229814|NCT00629018|553831|P2|STARTED|Overall Study||55
229815|NCT00629018|553832|P1|STARTED|Overall Study||55
229816|NCT00628927|553842|P2|NOT COMPLETED|Overall Study||0
229817|NCT00628927|553843|P1|NOT COMPLETED|Overall Study||8
229818|NCT00628927|553842|P2|COMPLETED|Overall Study||30
229819|NCT00628927|553843|P1|COMPLETED|Overall Study||175
229820|NCT00628927|553842|P2|STARTED|Overall Study||30
229821|NCT00628927|553843|P1|STARTED|Overall Study||183
229822|NCT00628901|553856|P2|NOT COMPLETED|Overall Study||1
229823|NCT00628901|553857|P1|NOT COMPLETED|Overall Study||3
229824|NCT00628901|553856|P2|COMPLETED|Overall Study||29
229825|NCT00628901|553857|P1|COMPLETED|Overall Study||27
229826|NCT00628901|553856|P2|STARTED|Overall Study||30
229827|NCT00628901|553857|P1|STARTED|Overall Study||30
229828|NCT00628862|553888|P3|NOT COMPLETED|Overall Study||22
229829|NCT00628862|553889|P2|NOT COMPLETED|Overall Study||17
229830|NCT00628862|553890|P1|NOT COMPLETED|Overall Study||11
229831|NCT00628862|553888|P3|COMPLETED|Overall Study|randomised patients|186
229832|NCT00628862|553889|P2|COMPLETED|Overall Study|randomised patients|182
229833|NCT00628862|553890|P1|COMPLETED|Overall Study|randomised patients|195
229834|NCT00628862|553888|P3|STARTED|Overall Study|randomised patients|208
229835|NCT00628862|553889|P2|STARTED|Overall Study|randomised patients|199
229836|NCT00628862|553890|P1|STARTED|Overall Study|randomised patients|206
229837|NCT00628758|553936|P2|NOT COMPLETED|Overall Study||42
229838|NCT00628758|553937|P1|NOT COMPLETED|Overall Study||44
229839|NCT00628758|553936|P2|COMPLETED|Overall Study||179
229840|NCT00628758|553937|P1|COMPLETED|Overall Study||165
229841|NCT00628758|553936|P2|STARTED|Overall Study||221
229842|NCT00628758|553937|P1|STARTED|Overall Study||209
229843|NCT00628628|553951|P2|NOT COMPLETED|Overall Study||0
229844|NCT00628628|553952|P1|NOT COMPLETED|Overall Study||0
229845|NCT00628628|553951|P2|COMPLETED|Overall Study||40
229846|NCT00628628|553952|P1|COMPLETED|Overall Study||40
229847|NCT00628628|553951|P2|STARTED|Overall Study||40
229848|NCT00628628|553952|P1|STARTED|Overall Study||40
229849|NCT00628589|553961|P3|NOT COMPLETED|Overall Study||3
229850|NCT00628589|553962|P2|NOT COMPLETED|Overall Study||2
229851|NCT00628589|553963|P1|NOT COMPLETED|Overall Study||1
229852|NCT00628589|553961|P3|COMPLETED|Overall Study||110
229853|NCT00628589|553962|P2|COMPLETED|Overall Study||114
229854|NCT00628589|553963|P1|COMPLETED|Overall Study||114
229855|NCT00628589|553961|P3|STARTED|Overall Study||113
229856|NCT00628589|553962|P2|STARTED|Overall Study||116
229857|NCT00628589|553963|P1|STARTED|Overall Study||115
229858|NCT00628498|553977|P1|NOT COMPLETED|Overall Study||52
229859|NCT00628498|553977|P1|COMPLETED|Overall Study||1154
229860|NCT00628498|553977|P1|STARTED|Overall Study||1206
229861|NCT00628446|553981|P1|NOT COMPLETED|Overall Study||7
229862|NCT00628446|553981|P1|COMPLETED|Overall Study||38
229863|NCT00628446|553981|P1|STARTED|Overall Study||45
229864|NCT00628407|553986|P1|NOT COMPLETED|Overall Study||0
229865|NCT00628407|553986|P1|COMPLETED|Overall Study||13
229866|NCT00628407|553986|P1|STARTED|Overall Study||13
229867|NCT00628355|553992|P2|NOT COMPLETED|Overall Study||1
229868|NCT00628355|553993|P1|NOT COMPLETED|Overall Study||1
229869|NCT00628355|553992|P2|COMPLETED|Overall Study||14
229870|NCT00628355|553993|P1|COMPLETED|Overall Study||14
229871|NCT00628355|553992|P2|STARTED|Overall Study||15
229872|NCT00628355|553993|P1|STARTED|Overall Study||15
229873|NCT00628251|554004|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
229874|NCT00628251|554005|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
229875|NCT00628251|554006|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
229876|NCT00628251|554004|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
229877|NCT00628251|554005|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
229878|NCT00628251|554006|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
229879|NCT00628251|554004|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
229880|NCT00628251|554005|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
229881|NCT00628251|554006|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
229882|NCT00628251|554004|P3|NOT COMPLETED|Randomised Part||8
229883|NCT00628251|554005|P2|NOT COMPLETED|Randomised Part||0
229884|NCT00628251|554006|P1|NOT COMPLETED|Randomised Part||0
229885|NCT00628251|554004|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
229886|NCT00628251|554005|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
229887|NCT00628251|554006|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
229888|NCT00628251|554004|P3|STARTED|Randomised Part|Patients randomised|33
229889|NCT00628251|554005|P2|STARTED|Randomised Part|Patients randomised|32
229890|NCT00628251|554006|P1|STARTED|Randomised Part|Patients randomised|32
229891|NCT00628212|554049|P4|NOT COMPLETED|Overall Study||5
229892|NCT00628212|554050|P3|NOT COMPLETED|Overall Study||3
229893|NCT00628212|554051|P2|NOT COMPLETED|Overall Study||1
229894|NCT00628212|554052|P1|NOT COMPLETED|Overall Study||3
229895|NCT00628212|554049|P4|COMPLETED|Overall Study||76
229896|NCT00628212|554050|P3|COMPLETED|Overall Study||76
229897|NCT00628212|554051|P2|COMPLETED|Overall Study||83
229898|NCT00628212|554052|P1|COMPLETED|Overall Study||77
229899|NCT00628212|554049|P4|STARTED|Overall Study||81
229900|NCT00628212|554050|P3|STARTED|Overall Study||79
229901|NCT00628212|554051|P2|STARTED|Overall Study||84
229902|NCT00628212|554052|P1|STARTED|Overall Study||80
229903|NCT00628147|554076|P2|NOT COMPLETED|Overall Study||1
229904|NCT00628147|554077|P1|NOT COMPLETED|Overall Study||7
229905|NCT00628147|554076|P2|COMPLETED|Overall Study||141
229906|NCT00628147|554077|P1|COMPLETED|Overall Study||135
229907|NCT00628147|554076|P2|STARTED|Overall Study||142
229908|NCT00628147|554077|P1|STARTED|Overall Study||142
229909|NCT00628134|554089|P2|NOT COMPLETED|Overall Study||0
229910|NCT00628134|554090|P1|NOT COMPLETED|Overall Study||0
229911|NCT00628134|554089|P2|COMPLETED|Overall Study||4
229912|NCT00628134|554090|P1|COMPLETED|Overall Study||4
229913|NCT00628134|554089|P2|STARTED|Overall Study||4
229914|NCT00628134|554090|P1|STARTED|Overall Study||4
229915|NCT00628108|554100|P2|NOT COMPLETED|Overall Study||3
229916|NCT00628108|554101|P1|NOT COMPLETED|Overall Study||1
229917|NCT00628108|554100|P2|COMPLETED|Overall Study||43
229918|NCT00628108|554101|P1|COMPLETED|Overall Study||22
229919|NCT00628108|554100|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
229920|NCT00628108|554101|P1|Safety Population|Overall Study||24
229921|NCT00628108|554100|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
229922|NCT00628108|554101|P1|STARTED|Overall Study||23
229923|NCT00628030|554133|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
229924|NCT00628030|554134|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
229925|NCT00628030|554133|P2|COMPLETED|Post to 6 Month Follow-up||33
229926|NCT00628030|554134|P1|COMPLETED|Post to 6 Month Follow-up||27
229927|NCT00628030|554133|P2|STARTED|Post to 6 Month Follow-up||63
229928|NCT00628030|554134|P1|STARTED|Post to 6 Month Follow-up||59
229929|NCT00628030|554133|P2|NOT COMPLETED|Baseline to Post-Assessment||29
229930|NCT00628030|554134|P1|NOT COMPLETED|Baseline to Post-Assessment||33
229931|NCT00628030|554133|P2|COMPLETED|Baseline to Post-Assessment||63
229932|NCT00628030|554134|P1|COMPLETED|Baseline to Post-Assessment||59
229933|NCT00628030|554133|P2|STARTED|Baseline to Post-Assessment||92
229934|NCT00628030|554134|P1|STARTED|Baseline to Post-Assessment||92
229935|NCT00627978|554150|P2|NOT COMPLETED|Overall Study||0
229936|NCT00627978|554151|P1|NOT COMPLETED|Overall Study||0
229937|NCT00627978|554150|P2|COMPLETED|Overall Study||5
229938|NCT00627978|554151|P1|COMPLETED|Overall Study||10
229939|NCT00627978|554150|P2|STARTED|Overall Study||5
229940|NCT00627978|554151|P1|STARTED|Overall Study||10
229941|NCT00627926|554160|P3|NOT COMPLETED|Overall Study||95
229942|NCT00627926|554161|P2|NOT COMPLETED|Overall Study||104
229943|NCT00627926|554162|P1|NOT COMPLETED|Overall Study||159
229944|NCT00627926|554160|P3|COMPLETED|Overall Study||268
229945|NCT00627926|554161|P2|COMPLETED|Overall Study||260
229946|NCT00627926|554162|P1|COMPLETED|Overall Study||202
229947|NCT00627926|554160|P3|STARTED|Overall Study||363
229948|NCT00627926|554161|P2|STARTED|Overall Study||364
229949|NCT00627926|554162|P1|STARTED|Overall Study||361
229950|NCT00627861|554206|P1|NOT COMPLETED|Overall Study||0
229951|NCT00627861|554206|P1|COMPLETED|Overall Study||1
229952|NCT00627861|554206|P1|STARTED|Overall Study||1
229953|NCT00627705|554214|P2|NOT COMPLETED|Overall Study||6
229954|NCT00627705|554215|P1|NOT COMPLETED|Overall Study||2
229955|NCT00627705|554214|P2|COMPLETED|Overall Study||12
229956|NCT00627705|554215|P1|COMPLETED|Overall Study||13
229957|NCT00627705|554214|P2|STARTED|Overall Study||18
229958|NCT00627705|554215|P1|STARTED|Overall Study||15
229959|NCT00627679|554235|P4|NOT COMPLETED|Overall Study||0
229960|NCT00627679|554236|P3|NOT COMPLETED|Overall Study||0
229961|NCT00627679|554237|P2|NOT COMPLETED|Overall Study||0
229962|NCT00627679|554238|P1|NOT COMPLETED|Overall Study||0
229963|NCT00627679|554235|P4|COMPLETED|Overall Study||4
229964|NCT00627679|554236|P3|COMPLETED|Overall Study||4
229965|NCT00627679|554237|P2|COMPLETED|Overall Study||4
229966|NCT00627679|554238|P1|COMPLETED|Overall Study||4
229967|NCT00627679|554235|P4|STARTED|Overall Study||4
229968|NCT00627679|554236|P3|STARTED|Overall Study||4
229969|NCT00627679|554237|P2|STARTED|Overall Study||4
229970|NCT00627679|554238|P1|STARTED|Overall Study||4
229971|NCT00627523|554266|P2|NOT COMPLETED|Overall Study||2
229972|NCT00627523|554267|P1|NOT COMPLETED|Overall Study||2
229973|NCT00627523|554266|P2|COMPLETED|Overall Study||20
229974|NCT00627523|554267|P1|COMPLETED|Overall Study||19
229975|NCT00627523|554266|P2|STARTED|Overall Study||22
229976|NCT00627523|554267|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
229977|NCT00627497|554295|P4|NOT COMPLETED|Overall Study||0
229978|NCT00627497|554296|P3|NOT COMPLETED|Overall Study||0
229979|NCT00627497|554297|P2|NOT COMPLETED|Overall Study||1
229980|NCT00627497|554298|P1|NOT COMPLETED|Overall Study||1
229981|NCT00627497|554295|P4|COMPLETED|Overall Study||2
229982|NCT00627497|554296|P3|COMPLETED|Overall Study||4
229983|NCT00627497|554297|P2|COMPLETED|Overall Study||11
229984|NCT00627497|554298|P1|COMPLETED|Overall Study||13
229985|NCT00627497|554295|P4|STARTED|Overall Study||2
229986|NCT00627497|554296|P3|STARTED|Overall Study||4
229987|NCT00627497|554297|P2|STARTED|Overall Study||12
229988|NCT00627497|554298|P1|STARTED|Overall Study||14
229989|NCT00627458|554359|P3|NOT COMPLETED|Overall Study||6
229990|NCT00627458|554360|P2|NOT COMPLETED|Overall Study||7
229991|NCT00627458|554361|P1|NOT COMPLETED|Overall Study||4
229992|NCT00627458|554359|P3|COMPLETED|Overall Study||133
229993|NCT00627458|554360|P2|COMPLETED|Overall Study||130
229994|NCT00627458|554361|P1|COMPLETED|Overall Study||123
229995|NCT00627458|554359|P3|STARTED|Overall Study||139
229996|NCT00627458|554360|P2|STARTED|Overall Study||137
229997|NCT00627458|554361|P1|STARTED|Overall Study||127
229998|NCT00627445|554436|P2|NOT COMPLETED|Overall Study||12
229999|NCT00627445|554437|P1|NOT COMPLETED|Overall Study||9
230000|NCT00627445|554436|P2|COMPLETED|Overall Study||210
230001|NCT00627445|554437|P1|COMPLETED|Overall Study||210
230002|NCT00627445|554436|P2|Exposed to Study Drug|Overall Study||222
230003|NCT00627445|554437|P1|Exposed to Study Drug|Overall Study||219
230004|NCT00627445|554436|P2|STARTED|Overall Study||222
230005|NCT00627445|554437|P1|STARTED|Overall Study||219
230006|NCT00627406|554461|P4|NOT COMPLETED|Overall Study||0
230007|NCT00627406|554462|P3|NOT COMPLETED|Overall Study||0
230008|NCT00627406|554463|P2|NOT COMPLETED|Overall Study||0
230009|NCT00627406|554464|P1|NOT COMPLETED|Overall Study||0
230010|NCT00627406|554461|P4|COMPLETED|Overall Study||141
230011|NCT00627406|554462|P3|COMPLETED|Overall Study||125
230012|NCT00627406|554463|P2|COMPLETED|Overall Study||58
230013|NCT00627406|554464|P1|COMPLETED|Overall Study||60
230014|NCT00627406|554461|P4|STARTED|Overall Study||141
230015|NCT00627406|554462|P3|STARTED|Overall Study||125
230016|NCT00627406|554463|P2|STARTED|Overall Study||58
230017|NCT00627406|554464|P1|STARTED|Overall Study||60
230018|NCT00627393|554480|P2|NOT COMPLETED|Per-Protocol Analysis||13
230019|NCT00627393|554481|P1|NOT COMPLETED|Per-Protocol Analysis||10
230020|NCT00627393|554480|P2|COMPLETED|Per-Protocol Analysis||35
230021|NCT00627393|554481|P1|COMPLETED|Per-Protocol Analysis||39
230022|NCT00627393|554480|P2|STARTED|Per-Protocol Analysis||48
230023|NCT00627393|554481|P1|STARTED|Per-Protocol Analysis||49
230024|NCT00627393|554480|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
230025|NCT00627393|554481|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
230026|NCT00627393|554480|P2|COMPLETED|Intention-To-Treat Analysis||48
230027|NCT00627393|554481|P1|COMPLETED|Intention-To-Treat Analysis||49
230028|NCT00627393|554480|P2|STARTED|Intention-To-Treat Analysis||56
230029|NCT00627393|554481|P1|STARTED|Intention-To-Treat Analysis||58
230030|NCT00627367|554502|P2|NOT COMPLETED|Overall Study||0
230031|NCT00627367|554503|P1|NOT COMPLETED|Overall Study||0
230032|NCT00627367|554502|P2|COMPLETED|Overall Study||112
230033|NCT00627367|554503|P1|COMPLETED|Overall Study||112
230034|NCT00627367|554502|P2|STARTED|Overall Study||112
230035|NCT00627367|554503|P1|STARTED|Overall Study||112
230036|NCT00627094|554517|P2|NOT COMPLETED|Overall Study||15
230037|NCT00627094|554518|P1|NOT COMPLETED|Overall Study||12
230038|NCT00627094|554517|P2|COMPLETED|Overall Study||45
230039|NCT00627094|554518|P1|COMPLETED|Overall Study||48
230040|NCT00627094|554517|P2|STARTED|Overall Study||60
230041|NCT00627094|554518|P1|STARTED|Overall Study||60
230042|NCT00627042|554530|P1|NOT COMPLETED|Overall Study||2
230043|NCT00627042|554530|P1|COMPLETED|Overall Study||40
230044|NCT00627042|554530|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
230045|NCT00627042|554530|P1|STARTED|Overall Study||42
230046|NCT00627016|554542|P2|NOT COMPLETED|Overall Study||6
230047|NCT00627016|554543|P1|NOT COMPLETED|Overall Study||6
230048|NCT00627016|554542|P2|COMPLETED|Overall Study||146
230049|NCT00627016|554543|P1|COMPLETED|Overall Study||147
230050|NCT00627016|554542|P2|STARTED|Overall Study||152
230051|NCT00627016|554543|P1|STARTED|Overall Study||153
230052|NCT00626925|554555|P2|NOT COMPLETED|Overall Study||9
230053|NCT00626925|554556|P1|NOT COMPLETED|Overall Study||12
230054|NCT00626925|554555|P2|COMPLETED|Overall Study||62
230055|NCT00626925|554556|P1|COMPLETED|Overall Study||55
230056|NCT00626925|554555|P2|STARTED|Overall Study||71
230057|NCT00626925|554556|P1|STARTED|Overall Study||67
230058|NCT00626821|554588|P1|NOT COMPLETED|Overall Study||221
230059|NCT00626821|554588|P1|COMPLETED|Overall Study||2796
230060|NCT00626821|554588|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
230061|NCT00626821|554588|P1|STARTED|Overall Study||3017
230062|NCT00626808|554596|P4|NOT COMPLETED|Overall Study||0
230063|NCT00626808|554597|P3|NOT COMPLETED|Overall Study||0
230064|NCT00626808|554598|P2|NOT COMPLETED|Overall Study||0
230065|NCT00626808|554599|P1|NOT COMPLETED|Overall Study||0
230066|NCT00626808|554596|P4|COMPLETED|Overall Study||2906
230067|NCT00626808|554597|P3|COMPLETED|Overall Study||30011
230068|NCT00626808|554598|P2|COMPLETED|Overall Study||34316
230069|NCT00626808|554599|P1|COMPLETED|Overall Study||254464
230070|NCT00626808|554596|P4|STARTED|Overall Study||2906
230071|NCT00626808|554597|P3|STARTED|Overall Study||30011
230072|NCT00626808|554598|P2|STARTED|Overall Study||34316
230073|NCT00626808|554599|P1|STARTED|Overall Study||254464
230074|NCT00626782|554667|P2|NOT COMPLETED|Overall Study||0
230075|NCT00626782|554668|P1|NOT COMPLETED|Overall Study||0
230076|NCT00626782|554667|P2|COMPLETED|Overall Study||12
230077|NCT00626782|554668|P1|COMPLETED|Overall Study||12
230078|NCT00626782|554667|P2|STARTED|Overall Study||12
230079|NCT00626782|554668|P1|STARTED|Overall Study||12
230080|NCT00626743|554678|P2|NOT COMPLETED|Treatment Period 2||0
230081|NCT00626743|554679|P1|NOT COMPLETED|Treatment Period 2||0
230082|NCT00626743|554678|P2|COMPLETED|Treatment Period 2||6
230083|NCT00626743|554679|P1|COMPLETED|Treatment Period 2||6
230084|NCT00626743|554678|P2|STARTED|Treatment Period 2||6
230085|NCT00626743|554679|P1|STARTED|Treatment Period 2||6
230086|NCT00626743|554678|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
230087|NCT00626743|554679|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
230088|NCT00626743|554678|P2|COMPLETED|Wash-out Period of 6 Days||6
230089|NCT00626743|554679|P1|COMPLETED|Wash-out Period of 6 Days||6
230090|NCT00626743|554678|P2|STARTED|Wash-out Period of 6 Days||6
230091|NCT00626743|554679|P1|STARTED|Wash-out Period of 6 Days||6
230092|NCT00626743|554678|P2|NOT COMPLETED|Treatment Period 1||1
230093|NCT00626743|554679|P1|NOT COMPLETED|Treatment Period 1||0
230094|NCT00626743|554678|P2|COMPLETED|Treatment Period 1||6
230095|NCT00626743|554679|P1|COMPLETED|Treatment Period 1||6
230096|NCT00626743|554678|P2|STARTED|Treatment Period 1||7
230097|NCT00626743|554679|P1|STARTED|Treatment Period 1||6
230098|NCT00626639|554689|P2|NOT COMPLETED|Overall Study||2
230099|NCT00626639|554690|P1|NOT COMPLETED|Overall Study||2
230100|NCT00626639|554689|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
230101|NCT00626639|554690|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
230102|NCT00626639|554689|P2|STARTED|Overall Study||3
230103|NCT00626639|554690|P1|STARTED|Overall Study||2
230104|NCT00626626|554710|P2|NOT COMPLETED|Overall Study||0
230105|NCT00626626|554711|P1|NOT COMPLETED|Overall Study||0
230106|NCT00626626|554710|P2|COMPLETED|Overall Study||3
230107|NCT00626626|554711|P1|COMPLETED|Overall Study||5
230108|NCT00626626|554710|P2|STARTED|Overall Study||3
230109|NCT00626626|554711|P1|STARTED|Overall Study||5
230110|NCT00626574|554723|P2|NOT COMPLETED|Overall Study||0
230111|NCT00626574|554724|P1|NOT COMPLETED|Overall Study||0
230112|NCT00626574|554723|P2|COMPLETED|Overall Study||1
230113|NCT00626574|554724|P1|COMPLETED|Overall Study||2
230114|NCT00626574|554723|P2|STARTED|Overall Study||1
230115|NCT00626574|554724|P1|STARTED|Overall Study||2
230116|NCT00626561|554730|P1|NOT COMPLETED|Overall Study||4
230117|NCT00626561|554730|P1|COMPLETED|Overall Study||0
230118|NCT00626561|554730|P1|STARTED|Overall Study||4
230119|NCT00626548|554736|P2|NOT COMPLETED|Overall Study||716
230120|NCT00626548|554737|P1|NOT COMPLETED|Overall Study||705
230121|NCT00626548|554736|P2|COMPLETED|Overall Study||0
230122|NCT00626548|554737|P1|COMPLETED|Overall Study||0
230123|NCT00626548|554736|P2|Patients Received Treatment|Overall Study||712
230124|NCT00626548|554737|P1|Patients Received Treatment|Overall Study||703
230125|NCT00626548|554736|P2|STARTED|Overall Study||716
230126|NCT00626548|554737|P1|STARTED|Overall Study||705
230127|NCT00626522|554751|P6|NOT COMPLETED|Overall Study||2
230128|NCT00626522|554752|P5|NOT COMPLETED|Overall Study||7
230129|NCT00626522|554753|P4|NOT COMPLETED|Overall Study||2
230130|NCT00626522|554754|P3|NOT COMPLETED|Overall Study||8
230131|NCT00626522|554755|P2|NOT COMPLETED|Overall Study||7
230132|NCT00626522|554756|P1|NOT COMPLETED|Overall Study||6
230133|NCT00626522|554751|P6|COMPLETED|Overall Study||57
230134|NCT00626522|554752|P5|COMPLETED|Overall Study||58
230135|NCT00626522|554753|P4|COMPLETED|Overall Study||74
230136|NCT00626522|554754|P3|COMPLETED|Overall Study||117
230137|NCT00626522|554755|P2|COMPLETED|Overall Study||113
230138|NCT00626522|554756|P1|COMPLETED|Overall Study||115
230139|NCT00626522|554751|P6|STARTED|Overall Study||59
230140|NCT00626522|554752|P5|STARTED|Overall Study||65
230141|NCT00626522|554753|P4|STARTED|Overall Study||76
230142|NCT00626522|554754|P3|STARTED|Overall Study||125
230143|NCT00626522|554755|P2|STARTED|Overall Study||120
230144|NCT00626522|554756|P1|STARTED|Overall Study||121
230145|NCT00626444|554794|P1|NOT COMPLETED|Overall Study||0
230146|NCT00626444|554794|P1|COMPLETED|Overall Study||2
230147|NCT00626444|554794|P1|STARTED|Overall Study||2
230148|NCT00626431|554801|P2|NOT COMPLETED|Overall Study||45
230149|NCT00626431|554802|P1|NOT COMPLETED|Overall Study||17
230150|NCT00626431|554801|P2|COMPLETED|Overall Study||114
230151|NCT00626431|554802|P1|COMPLETED|Overall Study||134
230152|NCT00626431|554801|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
230153|NCT00626431|554802|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
230154|NCT00626405|554819|P2|NOT COMPLETED|Overall Study||1
230155|NCT00626405|554820|P1|NOT COMPLETED|Overall Study||1
230156|NCT00626405|554819|P2|COMPLETED|Overall Study||51
230157|NCT00626405|554820|P1|COMPLETED|Overall Study||42
230158|NCT00626405|554819|P2|STARTED|Overall Study||52
230159|NCT00626405|554820|P1|STARTED|Overall Study||43
230160|NCT00626392|554836|P6|NOT COMPLETED|Coadministration Period||6
230161|NCT00626392|554837|P5|NOT COMPLETED|Coadministration Period||5
230162|NCT00626392|554838|P4|NOT COMPLETED|Coadministration Period||7
230163|NCT00626392|554839|P3|NOT COMPLETED|Coadministration Period||10
230164|NCT00626392|554840|P2|NOT COMPLETED|Coadministration Period||5
230165|NCT00626392|554841|P1|NOT COMPLETED|Coadministration Period||4
230166|NCT00626392|554836|P6|COMPLETED|Coadministration Period||38
230167|NCT00626392|554837|P5|COMPLETED|Coadministration Period||36
230168|NCT00626392|554838|P4|COMPLETED|Coadministration Period||36
230169|NCT00626392|554839|P3|COMPLETED|Coadministration Period||31
230170|NCT00626392|554840|P2|COMPLETED|Coadministration Period||38
230171|NCT00626392|554841|P1|COMPLETED|Coadministration Period||40
230172|NCT00626392|554836|P6|STARTED|Coadministration Period||44
230173|NCT00626392|554837|P5|STARTED|Coadministration Period||41
230174|NCT00626392|554838|P4|STARTED|Coadministration Period||43
230175|NCT00626392|554839|P3|STARTED|Coadministration Period||41
230176|NCT00626392|554840|P2|STARTED|Coadministration Period||43
230177|NCT00626392|554841|P1|STARTED|Coadministration Period||44
230178|NCT00626392|554836|P6|NOT COMPLETED|Run-in Period||1
230179|NCT00626392|554837|P5|NOT COMPLETED|Run-in Period||4
230180|NCT00626392|554838|P4|NOT COMPLETED|Run-in Period||1
230181|NCT00626392|554839|P3|NOT COMPLETED|Run-in Period||3
230182|NCT00626392|554840|P2|NOT COMPLETED|Run-in Period||1
230183|NCT00626392|554841|P1|NOT COMPLETED|Run-in Period||1
230184|NCT00626392|554836|P6|COMPLETED|Run-in Period||44
230185|NCT00626392|554837|P5|COMPLETED|Run-in Period||41
230186|NCT00626392|554838|P4|COMPLETED|Run-in Period||43
230187|NCT00626392|554839|P3|COMPLETED|Run-in Period||41
230188|NCT00626392|554840|P2|COMPLETED|Run-in Period||43
230189|NCT00626392|554841|P1|COMPLETED|Run-in Period||44
230190|NCT00626392|554836|P6|STARTED|Run-in Period||45
230191|NCT00626392|554837|P5|STARTED|Run-in Period||45
230192|NCT00626392|554838|P4|STARTED|Run-in Period||44
230193|NCT00626392|554839|P3|STARTED|Run-in Period||44
230194|NCT00626392|554840|P2|STARTED|Run-in Period||44
230195|NCT00626392|554841|P1|STARTED|Run-in Period||45
230196|NCT00626340|554853|P1|NOT COMPLETED|Overall Study||0
230197|NCT00626340|554853|P1|COMPLETED|Overall Study||18
230198|NCT00626340|554853|P1|STARTED|Overall Study||18
230199|NCT00626327|554860|P3|NOT COMPLETED|Overall Study||88
230200|NCT00626327|554861|P2|NOT COMPLETED|Overall Study||59
230201|NCT00626327|554862|P1|NOT COMPLETED|Overall Study||78
230202|NCT00626327|554860|P3|COMPLETED|Overall Study||422
230203|NCT00626327|554861|P2|COMPLETED|Overall Study||557
230204|NCT00626327|554862|P1|COMPLETED|Overall Study||426
230205|NCT00626327|554860|P3|STARTED|Overall Study||510
230206|NCT00626327|554861|P2|STARTED|Overall Study||616
230207|NCT00626327|554862|P1|STARTED|Overall Study||504
230208|NCT00626275|554888|P8|NOT COMPLETED|Part B||1
230209|NCT00626275|554889|P7|NOT COMPLETED|Part B||1
230210|NCT00626275|554890|P6|NOT COMPLETED|Part B||0
230211|NCT00626275|554891|P5|NOT COMPLETED|Part B||0
230212|NCT00626275|554892|P4|NOT COMPLETED|Part B||0
230213|NCT00626275|554893|P3|NOT COMPLETED|Part B||0
230214|NCT00626275|554894|P2|NOT COMPLETED|Part B||0
230215|NCT00626275|554895|P1|NOT COMPLETED|Part B||0
230216|NCT00626275|554888|P8|COMPLETED|Part B||23
230217|NCT00626275|554889|P7|COMPLETED|Part B||19
230218|NCT00626275|554890|P6|COMPLETED|Part B||0
230219|NCT00626275|554891|P5|COMPLETED|Part B||0
230220|NCT00626275|554892|P4|COMPLETED|Part B||0
230221|NCT00626275|554893|P3|COMPLETED|Part B||0
230222|NCT00626275|554894|P2|COMPLETED|Part B||0
230223|NCT00626275|554895|P1|COMPLETED|Part B||0
230224|NCT00626275|554888|P8|STARTED|Part B||24
230225|NCT00626275|554889|P7|STARTED|Part B||20
230226|NCT00626275|554890|P6|STARTED|Part B||0
230227|NCT00626275|554891|P5|STARTED|Part B||0
230228|NCT00626275|554892|P4|STARTED|Part B||0
230229|NCT00626275|554893|P3|STARTED|Part B||0
230230|NCT00626275|554894|P2|STARTED|Part B||0
230231|NCT00626275|554895|P1|STARTED|Part B||0
230232|NCT00626275|554888|P8|NOT COMPLETED|Re-randomization Period for Part B||0
230233|NCT00626275|554889|P7|NOT COMPLETED|Re-randomization Period for Part B||0
230234|NCT00626275|554890|P6|NOT COMPLETED|Re-randomization Period for Part B||0
230235|NCT00626275|554891|P5|NOT COMPLETED|Re-randomization Period for Part B||0
230236|NCT00626275|554892|P4|NOT COMPLETED|Re-randomization Period for Part B||0
230237|NCT00626275|554893|P3|NOT COMPLETED|Re-randomization Period for Part B||0
230238|NCT00626275|554894|P2|NOT COMPLETED|Re-randomization Period for Part B||0
230239|NCT00626275|554895|P1|NOT COMPLETED|Re-randomization Period for Part B||0
230240|NCT00626275|554888|P8|COMPLETED|Re-randomization Period for Part B||24
230241|NCT00626275|554889|P7|COMPLETED|Re-randomization Period for Part B||20
230242|NCT00626275|554890|P6|COMPLETED|Re-randomization Period for Part B||0
230243|NCT00626275|554891|P5|COMPLETED|Re-randomization Period for Part B||0
230244|NCT00626275|554892|P4|COMPLETED|Re-randomization Period for Part B||0
230245|NCT00626275|554893|P3|COMPLETED|Re-randomization Period for Part B||0
230246|NCT00626275|554894|P2|COMPLETED|Re-randomization Period for Part B||0
230247|NCT00626275|554895|P1|COMPLETED|Re-randomization Period for Part B||0
230248|NCT00626275|554888|P8|STARTED|Re-randomization Period for Part B||24
230249|NCT00626275|554889|P7|STARTED|Re-randomization Period for Part B||20
230250|NCT00626275|554890|P6|STARTED|Re-randomization Period for Part B||0
230251|NCT00626275|554891|P5|STARTED|Re-randomization Period for Part B||0
230252|NCT00626275|554892|P4|STARTED|Re-randomization Period for Part B||0
230253|NCT00626275|554893|P3|STARTED|Re-randomization Period for Part B||0
230254|NCT00626275|554894|P2|STARTED|Re-randomization Period for Part B||0
230255|NCT00626275|554895|P1|STARTED|Re-randomization Period for Part B||0
230256|NCT00626275|554888|P8|NOT COMPLETED|Part A - Treatment Period 3||0
230257|NCT00626275|554889|P7|NOT COMPLETED|Part A - Treatment Period 3||0
230258|NCT00626275|554890|P6|NOT COMPLETED|Part A - Treatment Period 3||0
230259|NCT00626275|554891|P5|NOT COMPLETED|Part A - Treatment Period 3||0
230260|NCT00626275|554892|P4|NOT COMPLETED|Part A - Treatment Period 3||0
230261|NCT00626275|554893|P3|NOT COMPLETED|Part A - Treatment Period 3||0
230262|NCT00626275|554894|P2|NOT COMPLETED|Part A - Treatment Period 3||0
230263|NCT00626275|554895|P1|NOT COMPLETED|Part A - Treatment Period 3||0
230264|NCT00626275|554888|P8|COMPLETED|Part A - Treatment Period 3||0
230265|NCT00626275|554889|P7|COMPLETED|Part A - Treatment Period 3||0
230266|NCT00626275|554890|P6|COMPLETED|Part A - Treatment Period 3||8
230267|NCT00626275|554891|P5|COMPLETED|Part A - Treatment Period 3||9
230268|NCT00626275|554892|P4|COMPLETED|Part A - Treatment Period 3||8
230269|NCT00626275|554893|P3|COMPLETED|Part A - Treatment Period 3||6
230270|NCT00626275|554894|P2|COMPLETED|Part A - Treatment Period 3||7
230271|NCT00626275|554895|P1|COMPLETED|Part A - Treatment Period 3||6
230272|NCT00626275|554888|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
230273|NCT00626275|554889|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
230274|NCT00626275|554890|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
230275|NCT00626275|554891|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
230276|NCT00626275|554892|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
230277|NCT00626275|554893|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
230278|NCT00626275|554894|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
230279|NCT00626275|554895|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
230280|NCT00626275|554888|P8|STARTED|Part A - Treatment Period 3||0
230281|NCT00626275|554889|P7|STARTED|Part A - Treatment Period 3||0
230282|NCT00626275|554890|P6|STARTED|Part A - Treatment Period 3||8
230283|NCT00626275|554891|P5|STARTED|Part A - Treatment Period 3||9
230284|NCT00626275|554892|P4|STARTED|Part A - Treatment Period 3||8
230285|NCT00626275|554893|P3|STARTED|Part A - Treatment Period 3||6
230286|NCT00626275|554894|P2|STARTED|Part A - Treatment Period 3||7
230287|NCT00626275|554895|P1|STARTED|Part A - Treatment Period 3||6
230288|NCT00626275|554888|P8|NOT COMPLETED|Part A - Washout Period 2||0
230289|NCT00626275|554889|P7|NOT COMPLETED|Part A - Washout Period 2||0
230290|NCT00626275|554890|P6|NOT COMPLETED|Part A - Washout Period 2||0
230291|NCT00626275|554891|P5|NOT COMPLETED|Part A - Washout Period 2||0
230292|NCT00626275|554892|P4|NOT COMPLETED|Part A - Washout Period 2||0
230293|NCT00626275|554893|P3|NOT COMPLETED|Part A - Washout Period 2||0
230294|NCT00626275|554894|P2|NOT COMPLETED|Part A - Washout Period 2||0
230295|NCT00626275|554895|P1|NOT COMPLETED|Part A - Washout Period 2||0
230296|NCT00626275|554888|P8|COMPLETED|Part A - Washout Period 2||0
230297|NCT00626275|554889|P7|COMPLETED|Part A - Washout Period 2||0
230298|NCT00626275|554890|P6|COMPLETED|Part A - Washout Period 2||8
230299|NCT00626275|554891|P5|COMPLETED|Part A - Washout Period 2||9
230300|NCT00626275|554892|P4|COMPLETED|Part A - Washout Period 2||8
230301|NCT00626275|554893|P3|COMPLETED|Part A - Washout Period 2||6
230302|NCT00626275|554894|P2|COMPLETED|Part A - Washout Period 2||7
230303|NCT00626275|554895|P1|COMPLETED|Part A - Washout Period 2||6
230304|NCT00626275|554888|P8|STARTED|Part A - Washout Period 2||0
230305|NCT00626275|554889|P7|STARTED|Part A - Washout Period 2||0
230306|NCT00626275|554890|P6|STARTED|Part A - Washout Period 2||8
230307|NCT00626275|554891|P5|STARTED|Part A - Washout Period 2||9
230308|NCT00626275|554892|P4|STARTED|Part A - Washout Period 2||8
230309|NCT00626275|554893|P3|STARTED|Part A - Washout Period 2||6
230310|NCT00626275|554894|P2|STARTED|Part A - Washout Period 2||7
230311|NCT00626275|554895|P1|STARTED|Part A - Washout Period 2||6
230312|NCT00626275|554888|P8|NOT COMPLETED|Part A - Treatment Period 2||0
230313|NCT00626275|554889|P7|NOT COMPLETED|Part A - Treatment Period 2||0
230314|NCT00626275|554890|P6|NOT COMPLETED|Part A - Treatment Period 2||0
230315|NCT00626275|554891|P5|NOT COMPLETED|Part A - Treatment Period 2||0
230316|NCT00626275|554892|P4|NOT COMPLETED|Part A - Treatment Period 2||0
230317|NCT00626275|554893|P3|NOT COMPLETED|Part A - Treatment Period 2||0
230318|NCT00626275|554894|P2|NOT COMPLETED|Part A - Treatment Period 2||0
230319|NCT00626275|554895|P1|NOT COMPLETED|Part A - Treatment Period 2||0
230320|NCT00626275|554888|P8|COMPLETED|Part A - Treatment Period 2||0
230321|NCT00626275|554889|P7|COMPLETED|Part A - Treatment Period 2||0
230322|NCT00626275|554890|P6|COMPLETED|Part A - Treatment Period 2||8
230323|NCT00626275|554891|P5|COMPLETED|Part A - Treatment Period 2||9
230324|NCT00626275|554892|P4|COMPLETED|Part A - Treatment Period 2||8
230325|NCT00626275|554893|P3|COMPLETED|Part A - Treatment Period 2||6
230326|NCT00626275|554894|P2|COMPLETED|Part A - Treatment Period 2||7
230327|NCT00626275|554895|P1|COMPLETED|Part A - Treatment Period 2||6
230328|NCT00626275|554888|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
230329|NCT00626275|554889|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
230330|NCT00626275|554890|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
230331|NCT00626275|554891|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
230332|NCT00626275|554892|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
230333|NCT00626275|554893|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
230334|NCT00626275|554894|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
230335|NCT00626275|554895|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
230336|NCT00626275|554888|P8|STARTED|Part A - Treatment Period 2||0
230337|NCT00626275|554889|P7|STARTED|Part A - Treatment Period 2||0
230338|NCT00626275|554890|P6|STARTED|Part A - Treatment Period 2||8
230339|NCT00626275|554891|P5|STARTED|Part A - Treatment Period 2||9
230340|NCT00626275|554892|P4|STARTED|Part A - Treatment Period 2||8
230341|NCT00626275|554893|P3|STARTED|Part A - Treatment Period 2||6
230342|NCT00626275|554894|P2|STARTED|Part A - Treatment Period 2||7
230343|NCT00626275|554895|P1|STARTED|Part A - Treatment Period 2||6
230344|NCT00626275|554888|P8|NOT COMPLETED|Part A - Washout Period 1||0
230345|NCT00626275|554889|P7|NOT COMPLETED|Part A - Washout Period 1||0
230346|NCT00626275|554890|P6|NOT COMPLETED|Part A - Washout Period 1||0
230347|NCT00626275|554891|P5|NOT COMPLETED|Part A - Washout Period 1||0
230348|NCT00626275|554892|P4|NOT COMPLETED|Part A - Washout Period 1||0
230349|NCT00626275|554893|P3|NOT COMPLETED|Part A - Washout Period 1||0
230350|NCT00626275|554894|P2|NOT COMPLETED|Part A - Washout Period 1||0
230351|NCT00626275|554895|P1|NOT COMPLETED|Part A - Washout Period 1||0
230352|NCT00626275|554888|P8|COMPLETED|Part A - Washout Period 1||0
230353|NCT00626275|554889|P7|COMPLETED|Part A - Washout Period 1||0
230354|NCT00626275|554890|P6|COMPLETED|Part A - Washout Period 1||8
230355|NCT00626275|554891|P5|COMPLETED|Part A - Washout Period 1||9
230356|NCT00626275|554892|P4|COMPLETED|Part A - Washout Period 1||8
230357|NCT00626275|554893|P3|COMPLETED|Part A - Washout Period 1||6
230358|NCT00626275|554894|P2|COMPLETED|Part A - Washout Period 1||7
230359|NCT00626275|554895|P1|COMPLETED|Part A - Washout Period 1||6
230360|NCT00626275|554888|P8|STARTED|Part A - Washout Period 1||0
230361|NCT00626275|554889|P7|STARTED|Part A - Washout Period 1||0
230362|NCT00626275|554890|P6|STARTED|Part A - Washout Period 1||8
230363|NCT00626275|554891|P5|STARTED|Part A - Washout Period 1||9
230364|NCT00626275|554892|P4|STARTED|Part A - Washout Period 1||8
230365|NCT00626275|554893|P3|STARTED|Part A - Washout Period 1||6
230366|NCT00626275|554894|P2|STARTED|Part A - Washout Period 1||7
230367|NCT00626275|554895|P1|STARTED|Part A - Washout Period 1||6
230368|NCT00626275|554888|P8|NOT COMPLETED|Part A - Treatment Period 1||0
230369|NCT00626275|554889|P7|NOT COMPLETED|Part A - Treatment Period 1||0
230370|NCT00626275|554890|P6|NOT COMPLETED|Part A - Treatment Period 1||0
230371|NCT00626275|554891|P5|NOT COMPLETED|Part A - Treatment Period 1||0
230372|NCT00626275|554892|P4|NOT COMPLETED|Part A - Treatment Period 1||0
230373|NCT00626275|554893|P3|NOT COMPLETED|Part A - Treatment Period 1||1
230374|NCT00626275|554894|P2|NOT COMPLETED|Part A - Treatment Period 1||0
230375|NCT00626275|554895|P1|NOT COMPLETED|Part A - Treatment Period 1||1
230376|NCT00626275|554888|P8|COMPLETED|Part A - Treatment Period 1||0
230377|NCT00626275|554889|P7|COMPLETED|Part A - Treatment Period 1||0
230378|NCT00626275|554890|P6|COMPLETED|Part A - Treatment Period 1||8
230379|NCT00626275|554891|P5|COMPLETED|Part A - Treatment Period 1||9
230380|NCT00626275|554892|P4|COMPLETED|Part A - Treatment Period 1||8
230381|NCT00626275|554893|P3|COMPLETED|Part A - Treatment Period 1||6
230382|NCT00626275|554894|P2|COMPLETED|Part A - Treatment Period 1||7
230383|NCT00626275|554895|P1|COMPLETED|Part A - Treatment Period 1||6
230384|NCT00626275|554888|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
230385|NCT00626275|554889|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
230386|NCT00626275|554890|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
230387|NCT00626275|554891|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
230388|NCT00626275|554892|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
230389|NCT00626275|554893|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
230390|NCT00626275|554894|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
230391|NCT00626275|554895|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
230392|NCT00626275|554888|P8|STARTED|Part A - Treatment Period 1||0
230393|NCT00626275|554889|P7|STARTED|Part A - Treatment Period 1||0
230394|NCT00626275|554890|P6|STARTED|Part A - Treatment Period 1||8
230395|NCT00626275|554891|P5|STARTED|Part A - Treatment Period 1||9
230396|NCT00626275|554892|P4|STARTED|Part A - Treatment Period 1||8
230397|NCT00626275|554893|P3|STARTED|Part A - Treatment Period 1||7
230398|NCT00626275|554894|P2|STARTED|Part A - Treatment Period 1||7
230399|NCT00626275|554895|P1|STARTED|Part A - Treatment Period 1||7
230400|NCT00626210|554935|P1|NOT COMPLETED|Overall Study||0
230401|NCT00626210|554935|P1|COMPLETED|Overall Study||2
230402|NCT00626210|554935|P1|STARTED|Overall Study||2
230403|NCT00626093|554939|P1|NOT COMPLETED|Overall Study||23
230404|NCT00626093|554939|P1|COMPLETED|Overall Study||54
230405|NCT00626093|554939|P1|STARTED|Overall Study||77
230406|NCT00626028|554946|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
230407|NCT00626028|554947|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
230408|NCT00626028|554946|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
230409|NCT00626028|554947|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
230410|NCT00626028|554946|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
230411|NCT00626028|554947|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
230412|NCT00626028|554946|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
230413|NCT00626028|554947|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
230414|NCT00626028|554946|P2|COMPLETED|Washout Period of 10 Minutes||59
230415|NCT00626028|554947|P1|COMPLETED|Washout Period of 10 Minutes||62
230416|NCT00626028|554946|P2|STARTED|Washout Period of 10 Minutes||59
230417|NCT00626028|554947|P1|STARTED|Washout Period of 10 Minutes||62
230418|NCT00626028|554946|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
230419|NCT00626028|554947|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
230420|NCT00626028|554946|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
230421|NCT00626028|554947|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
230422|NCT00626028|554946|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
230423|NCT00626028|554947|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
230424|NCT00626028|554946|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
230425|NCT00626028|554947|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
230426|NCT00626028|554946|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
230427|NCT00626028|554947|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
230428|NCT00626028|554946|P2|STARTED|Treatment 1 NO First, O2 Last||68
230429|NCT00626028|554947|P1|STARTED|Treatment 1 NO First, O2 Last||68
230430|NCT00625989|554957|P2|NOT COMPLETED|Overall Study||0
230431|NCT00625989|554958|P1|NOT COMPLETED|Overall Study||0
230432|NCT00625989|554957|P2|COMPLETED|Overall Study||6
230433|NCT00625989|554958|P1|COMPLETED|Overall Study||6
230434|NCT00625989|554957|P2|STARTED|Overall Study||6
230435|NCT00625989|554958|P1|STARTED|Overall Study||6
230436|NCT00625872|554967|P2|NOT COMPLETED|Overall Study||6
230437|NCT00625872|554968|P1|NOT COMPLETED|Overall Study||4
230438|NCT00625872|554967|P2|COMPLETED|Overall Study||5
230439|NCT00625872|554968|P1|COMPLETED|Overall Study||8
230440|NCT00625872|554967|P2|Treated|Overall Study||10
230441|NCT00625872|554968|P1|Treated|Overall Study||12
230442|NCT00625872|554967|P2|STARTED|Overall Study||11
230443|NCT00625872|554968|P1|STARTED|Overall Study||12
230444|NCT00625820|555078|P1|NOT COMPLETED|Overall Study||1
230445|NCT00625820|555078|P1|COMPLETED|Overall Study||16
230446|NCT00625820|555078|P1|STARTED|Overall Study||17
230447|NCT00625742|555084|P1|NOT COMPLETED|Overall Study||12
230448|NCT00625742|555084|P1|COMPLETED|Overall Study||3
230449|NCT00625742|555084|P1|STARTED|Overall Study||15
230450|NCT00625729|555089|P1|NOT COMPLETED|Overall Study||0
230451|NCT00625729|555089|P1|COMPLETED|Overall Study||6
230452|NCT00625729|555089|P1|STARTED|Overall Study||6
230453|NCT00625586|555098|P1|NOT COMPLETED|Overall Study||1
230454|NCT00625586|555098|P1|COMPLETED|Overall Study||1
230455|NCT00625586|555098|P1|STARTED|Overall Study||2
230456|NCT00625443|555111|P3|NOT COMPLETED|Overall Study||5
230457|NCT00625443|555112|P2|NOT COMPLETED|Overall Study||11
230458|NCT00625443|555113|P1|NOT COMPLETED|Overall Study||2
230459|NCT00625443|555111|P3|COMPLETED|Overall Study||10
230460|NCT00625443|555112|P2|COMPLETED|Overall Study||15
230461|NCT00625443|555113|P1|COMPLETED|Overall Study||10
230462|NCT00625443|555111|P3|STARTED|Overall Study||15
230463|NCT00625443|555112|P2|STARTED|Overall Study||26
230464|NCT00625443|555113|P1|STARTED|Overall Study||12
230465|NCT00625404|555143|P2|NOT COMPLETED|Overall Study||173
230466|NCT00625404|555144|P1|NOT COMPLETED|Overall Study||207
230467|NCT00625404|555143|P2|COMPLETED|Overall Study||885
230468|NCT00625404|555144|P1|COMPLETED|Overall Study||855
230469|NCT00625404|555143|P2|STARTED|Overall Study||1058
230470|NCT00625404|555144|P1|STARTED|Overall Study||1062
230471|NCT00625391|555176|P4|NOT COMPLETED|Overall Study||1
230472|NCT00625391|555177|P3|NOT COMPLETED|Overall Study||5
230473|NCT00625391|555178|P2|NOT COMPLETED|Overall Study||8
230474|NCT00625391|555179|P1|NOT COMPLETED|Overall Study||7
230475|NCT00625391|555176|P4|COMPLETED|Overall Study||37
230476|NCT00625391|555177|P3|COMPLETED|Overall Study||37
230477|NCT00625391|555178|P2|COMPLETED|Overall Study||39
230478|NCT00625391|555179|P1|COMPLETED|Overall Study||37
230479|NCT00625391|555176|P4|STARTED|Overall Study||38
230480|NCT00625391|555177|P3|STARTED|Overall Study||42
230481|NCT00625391|555178|P2|STARTED|Overall Study||47
230482|NCT00625391|555179|P1|STARTED|Overall Study||44
230483|NCT00625365|555193|P1|NOT COMPLETED|Overall Study||7
230484|NCT00625365|555193|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
230485|NCT00625365|555193|P1|STARTED|Overall Study||1060
230486|NCT00625183|555199|P1|NOT COMPLETED|Overall Study||1
230487|NCT00625183|555199|P1|COMPLETED|Overall Study||4
230488|NCT00625183|555199|P1|STARTED|Overall Study||5
230489|NCT00625131|555210|P3|NOT COMPLETED|Overall Study||5
230490|NCT00625131|555211|P2|NOT COMPLETED|Overall Study||2
230491|NCT00625131|555212|P1|NOT COMPLETED|Overall Study||4
230492|NCT00625131|555210|P3|COMPLETED|Overall Study||0
230493|NCT00625131|555211|P2|COMPLETED|Overall Study||42
230494|NCT00625131|555212|P1|COMPLETED|Overall Study||34
230495|NCT00625131|555210|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
230496|NCT00625131|555211|P2|STARTED|Overall Study||44
230497|NCT00625131|555212|P1|STARTED|Overall Study||38
230498|NCT00624923|555224|P2|NOT COMPLETED|Overall Study||23
230499|NCT00624923|555225|P1|NOT COMPLETED|Overall Study||38
230500|NCT00624923|555224|P2|COMPLETED|Overall Study||101
230501|NCT00624923|555225|P1|COMPLETED|Overall Study||89
230502|NCT00624923|555224|P2|STARTED|Overall Study||124
230503|NCT00624923|555225|P1|STARTED|Overall Study||127
230504|NCT00624832|555235|P4|NOT COMPLETED|Overall Study||1
230505|NCT00624832|555236|P3|NOT COMPLETED|Overall Study||0
230506|NCT00624832|555237|P2|NOT COMPLETED|Overall Study||1
230507|NCT00624832|555238|P1|NOT COMPLETED|Overall Study||2
230508|NCT00624832|555235|P4|COMPLETED|Overall Study||15
230509|NCT00624832|555236|P3|COMPLETED|Overall Study||10
230510|NCT00624832|555237|P2|COMPLETED|Overall Study||15
230511|NCT00624832|555238|P1|COMPLETED|Overall Study||16
230512|NCT00624832|555235|P4|STARTED|Overall Study||16
230513|NCT00624832|555236|P3|STARTED|Overall Study||10
230514|NCT00624832|555237|P2|STARTED|Overall Study||16
230515|NCT00624832|555238|P1|STARTED|Overall Study||18
230516|NCT00624806|555252|P2|NOT COMPLETED|Overall Study||0
230517|NCT00624806|555253|P1|NOT COMPLETED|Overall Study||0
230518|NCT00624806|555252|P2|COMPLETED|Overall Study||8
230519|NCT00624806|555253|P1|COMPLETED|Overall Study||10
230520|NCT00624806|555252|P2|STARTED|Overall Study||8
230521|NCT00624806|555253|P1|STARTED|Overall Study||10
230522|NCT00624780|555269|P6|NOT COMPLETED|Follow-up (Week 26)||0
230523|NCT00624780|555270|P5|NOT COMPLETED|Follow-up (Week 26)||2
230524|NCT00624780|555271|P4|NOT COMPLETED|Follow-up (Week 26)||0
230525|NCT00624780|555272|P3|NOT COMPLETED|Follow-up (Week 26)||2
230526|NCT00624780|555273|P2|NOT COMPLETED|Follow-up (Week 26)||1
230527|NCT00624780|555274|P1|NOT COMPLETED|Follow-up (Week 26)||2
230528|NCT00624780|555269|P6|COMPLETED|Follow-up (Week 26)||29
230529|NCT00624780|555270|P5|COMPLETED|Follow-up (Week 26)||93
230530|NCT00624780|555271|P4|COMPLETED|Follow-up (Week 26)||26
230531|NCT00624780|555272|P3|COMPLETED|Follow-up (Week 26)||89
230532|NCT00624780|555273|P2|COMPLETED|Follow-up (Week 26)||27
230533|NCT00624780|555274|P1|COMPLETED|Follow-up (Week 26)||102
230534|NCT00624780|555269|P6|STARTED|Follow-up (Week 26)||29
230535|NCT00624780|555270|P5|STARTED|Follow-up (Week 26)||95
230536|NCT00624780|555271|P4|STARTED|Follow-up (Week 26)||26
230537|NCT00624780|555272|P3|STARTED|Follow-up (Week 26)||91
230538|NCT00624780|555273|P2|STARTED|Follow-up (Week 26)||28
230539|NCT00624780|555274|P1|STARTED|Follow-up (Week 26)||104
230540|NCT00624780|555269|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
230541|NCT00624780|555270|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
230542|NCT00624780|555271|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
230543|NCT00624780|555272|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
230544|NCT00624780|555273|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
230545|NCT00624780|555274|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
230546|NCT00624780|555269|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
230547|NCT00624780|555270|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
230548|NCT00624780|555271|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
230549|NCT00624780|555272|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
230550|NCT00624780|555273|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
230551|NCT00624780|555274|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
230552|NCT00624780|555269|P6|STARTED|Treatment Discontinuation (Week 25)||30
230553|NCT00624780|555270|P5|STARTED|Treatment Discontinuation (Week 25)||95
230554|NCT00624780|555271|P4|STARTED|Treatment Discontinuation (Week 25)||27
230555|NCT00624780|555272|P3|STARTED|Treatment Discontinuation (Week 25)||94
230556|NCT00624780|555273|P2|STARTED|Treatment Discontinuation (Week 25)||28
230557|NCT00624780|555274|P1|STARTED|Treatment Discontinuation (Week 25)||106
230558|NCT00624780|555269|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
230559|NCT00624780|555270|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
230560|NCT00624780|555271|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
230561|NCT00624780|555272|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
230562|NCT00624780|555273|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
230563|NCT00624780|555274|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
230564|NCT00624780|555269|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
230565|NCT00624780|555270|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
230566|NCT00624780|555271|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
230567|NCT00624780|555272|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
230568|NCT00624780|555273|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
230569|NCT00624780|555274|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
230570|NCT00624780|555269|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
230571|NCT00624780|555270|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
230572|NCT00624780|555271|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
230573|NCT00624780|555272|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
230574|NCT00624780|555273|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
230575|NCT00624780|555274|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
230576|NCT00624780|555269|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
230577|NCT00624780|555270|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
230578|NCT00624780|555271|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
230579|NCT00624780|555272|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
230580|NCT00624780|555273|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
230581|NCT00624780|555274|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
230582|NCT00624780|555269|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
230583|NCT00624780|555270|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
230584|NCT00624780|555271|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
230585|NCT00624780|555272|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
230586|NCT00624780|555273|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
230587|NCT00624780|555274|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
230588|NCT00624780|555269|P6|STARTED|Treatment Optimization (Up to Week 12)||50
230589|NCT00624780|555270|P5|STARTED|Treatment Optimization (Up to Week 12)||153
230590|NCT00624780|555271|P4|STARTED|Treatment Optimization (Up to Week 12)||52
230591|NCT00624780|555272|P3|STARTED|Treatment Optimization (Up to Week 12)||154
230592|NCT00624780|555273|P2|STARTED|Treatment Optimization (Up to Week 12)||52
230593|NCT00624780|555274|P1|STARTED|Treatment Optimization (Up to Week 12)||154
230594|NCT00624585|555456|P1|NOT COMPLETED|Overall Study||12
230595|NCT00624585|555456|P1|COMPLETED|Overall Study||6
230596|NCT00624585|555456|P1|STARTED|Overall Study||18
230597|NCT00624559|555467|P4|NOT COMPLETED|Overall Study||0
230598|NCT00624559|555468|P3|NOT COMPLETED|Overall Study||0
230599|NCT00624559|555469|P2|NOT COMPLETED|Overall Study||0
230600|NCT00624559|555470|P1|NOT COMPLETED|Overall Study||0
230601|NCT00624559|555467|P4|COMPLETED|Overall Study||3
230602|NCT00624559|555468|P3|COMPLETED|Overall Study||3
230603|NCT00624559|555469|P2|COMPLETED|Overall Study||3
230604|NCT00624559|555470|P1|COMPLETED|Overall Study||3
230605|NCT00624559|555467|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
230606|NCT00624559|555468|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
230607|NCT00624559|555469|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
230608|NCT00624559|555470|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
230609|NCT00624520|555486|P2|NOT COMPLETED|Overall Study||8
230610|NCT00624520|555487|P1|NOT COMPLETED|Overall Study||12
230611|NCT00624520|555486|P2|COMPLETED|Overall Study||39
230612|NCT00624520|555487|P1|COMPLETED|Overall Study||44
230613|NCT00624520|555486|P2|STARTED|Overall Study||47
230614|NCT00624520|555487|P1|STARTED|Overall Study||56
230615|NCT00624468|555514|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
230616|NCT00624468|555515|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
230617|NCT00624468|555516|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
230618|NCT00624468|555517|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
230619|NCT00624468|555514|P4|COMPLETED|Safety Follow-up (SFU) Period||11
230620|NCT00624468|555515|P3|COMPLETED|Safety Follow-up (SFU) Period||11
230621|NCT00624468|555516|P2|COMPLETED|Safety Follow-up (SFU) Period||0
230622|NCT00624468|555517|P1|COMPLETED|Safety Follow-up (SFU) Period||0
230623|NCT00624468|555514|P4|STARTED|Safety Follow-up (SFU) Period||14
230624|NCT00624468|555515|P3|STARTED|Safety Follow-up (SFU) Period||13
230625|NCT00624468|555516|P2|STARTED|Safety Follow-up (SFU) Period||0
230626|NCT00624468|555517|P1|STARTED|Safety Follow-up (SFU) Period||0
230627|NCT00624468|555514|P4|NOT COMPLETED|Double-blind Period||0
230628|NCT00624468|555515|P3|NOT COMPLETED|Double-blind Period||0
230629|NCT00624468|555516|P2|NOT COMPLETED|Double-blind Period||13
230630|NCT00624468|555517|P1|NOT COMPLETED|Double-blind Period||14
230631|NCT00624468|555514|P4|COMPLETED|Double-blind Period||0
230632|NCT00624468|555515|P3|COMPLETED|Double-blind Period||0
230633|NCT00624468|555516|P2|COMPLETED|Double-blind Period||4
230634|NCT00624468|555517|P1|COMPLETED|Double-blind Period||3
230635|NCT00624468|555514|P4|STARTED|Double-blind Period||0
230636|NCT00624468|555515|P3|STARTED|Double-blind Period||0
230637|NCT00624468|555516|P2|STARTED|Double-blind Period||17
230638|NCT00624468|555517|P1|STARTED|Double-blind Period||17
230639|NCT00624442|555548|P5|NOT COMPLETED|Overall Study||2
230640|NCT00624442|555549|P4|NOT COMPLETED|Overall Study||0
230641|NCT00624442|555550|P3|NOT COMPLETED|Overall Study||2
230642|NCT00624442|555551|P2|NOT COMPLETED|Overall Study||1
230643|NCT00624442|555552|P1|NOT COMPLETED|Overall Study||0
230644|NCT00624442|555548|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
230645|NCT00624442|555549|P4|COMPLETED|Overall Study||8
230646|NCT00624442|555550|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
230647|NCT00624442|555551|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
230648|NCT00624442|555552|P1|COMPLETED|Overall Study||8
230649|NCT00624442|555548|P5|STARTED|Overall Study||10
230650|NCT00624442|555549|P4|STARTED|Overall Study||8
230651|NCT00624442|555550|P3|STARTED|Overall Study||10
230652|NCT00624442|555551|P2|STARTED|Overall Study||9
230653|NCT00624442|555552|P1|STARTED|Overall Study||8
230654|NCT00624416|555578|P1|NOT COMPLETED|Overall Study||0
230655|NCT00624416|555578|P1|COMPLETED|Overall Study||10
230656|NCT00624416|555578|P1|STARTED|Overall Study||10
230657|NCT00624377|555584|P1|NOT COMPLETED|Overall Study||644
230658|NCT00624377|555584|P1|COMPLETED|Overall Study||1387
230659|NCT00624377|555584|P1|STARTED|Overall Study||2031
230660|NCT00624338|555598|P3|NOT COMPLETED|Overall Study||46
230661|NCT00624338|555599|P2|NOT COMPLETED|Overall Study||83
230662|NCT00624338|555600|P1|NOT COMPLETED|Overall Study||47
230663|NCT00624338|555598|P3|COMPLETED|Overall Study||111
230664|NCT00624338|555599|P2|COMPLETED|Overall Study||62
230665|NCT00624338|555600|P1|COMPLETED|Overall Study||112
230666|NCT00624338|555598|P3|Treated|Overall Study||154
230667|NCT00624338|555599|P2|Treated|Overall Study||144
230668|NCT00624338|555600|P1|Treated|Overall Study||157
230669|NCT00624338|555598|P3|STARTED|Overall Study||157
230670|NCT00624338|555599|P2|STARTED|Overall Study||145
230671|NCT00624338|555600|P1|STARTED|Overall Study||159
230672|NCT00624286|555622|P2|NOT COMPLETED|Overall Study||27
230673|NCT00624286|555623|P1|NOT COMPLETED|Overall Study||25
230674|NCT00624286|555622|P2|COMPLETED|Overall Study||178
230675|NCT00624286|555623|P1|COMPLETED|Overall Study||186
230676|NCT00624286|555622|P2|STARTED|Overall Study||205
230677|NCT00624286|555623|P1|STARTED|Overall Study||211
230678|NCT00624234|555637|P6|NOT COMPLETED|Overall Study||0
230679|NCT00624234|555638|P5|NOT COMPLETED|Overall Study||0
230680|NCT00624234|555639|P4|NOT COMPLETED|Overall Study||0
230681|NCT00624234|555640|P3|NOT COMPLETED|Overall Study||0
230682|NCT00624234|555641|P2|NOT COMPLETED|Overall Study||0
230683|NCT00624234|555642|P1|NOT COMPLETED|Overall Study||0
230684|NCT00624234|555637|P6|COMPLETED|Overall Study||14
230685|NCT00624234|555638|P5|COMPLETED|Overall Study||18
230686|NCT00624234|555639|P4|COMPLETED|Overall Study||14
230687|NCT00624234|555640|P3|COMPLETED|Overall Study||26
230688|NCT00624234|555641|P2|COMPLETED|Overall Study||9
230689|NCT00624234|555642|P1|COMPLETED|Overall Study||8
230690|NCT00624234|555637|P6|STARTED|Overall Study||14
230691|NCT00624234|555638|P5|STARTED|Overall Study||18
230692|NCT00624234|555639|P4|STARTED|Overall Study||14
230693|NCT00624234|555640|P3|STARTED|Overall Study||26
230694|NCT00624234|555641|P2|STARTED|Overall Study||9
230695|NCT00624234|555642|P1|STARTED|Overall Study||8
230696|NCT00624221|555658|P2|NOT COMPLETED|Overall Study||0
230697|NCT00624221|555659|P1|NOT COMPLETED|Overall Study||0
230698|NCT00624221|555658|P2|COMPLETED|Overall Study||20
230699|NCT00624221|555659|P1|COMPLETED|Overall Study||20
230700|NCT00624221|555658|P2|STARTED|Overall Study||20
230701|NCT00624221|555659|P1|STARTED|Overall Study||20
230702|NCT00624195|555667|P2|NOT COMPLETED|Overall Study||7
230703|NCT00624195|555668|P1|NOT COMPLETED|Overall Study||3
230704|NCT00624195|555667|P2|COMPLETED|Overall Study||23
230705|NCT00624195|555668|P1|COMPLETED|Overall Study||26
230706|NCT00624195|555667|P2|STARTED|Overall Study||30
230707|NCT00624195|555668|P1|STARTED|Overall Study||29
230708|NCT00624065|555676|P2|NOT COMPLETED|Overall Study||24
230709|NCT00624065|555677|P1|NOT COMPLETED|Overall Study||19
230710|NCT00624065|555676|P2|COMPLETED|Overall Study||192
230711|NCT00624065|555677|P1|COMPLETED|Overall Study||197
230712|NCT00624065|555676|P2|STARTED|Overall Study||216
230713|NCT00624065|555677|P1|STARTED|Overall Study||216
230714|NCT00624052|555689|P4|NOT COMPLETED|Overall Study||4
230715|NCT00624052|555690|P3|NOT COMPLETED|Overall Study||3
230716|NCT00624052|555691|P2|NOT COMPLETED|Overall Study||14
230717|NCT00624052|555692|P1|NOT COMPLETED|Overall Study||15
230718|NCT00624052|555689|P4|COMPLETED|Overall Study||88
230719|NCT00624052|555690|P3|COMPLETED|Overall Study||88
230720|NCT00624052|555691|P2|COMPLETED|Overall Study||422
230721|NCT00624052|555692|P1|COMPLETED|Overall Study||204
230722|NCT00624052|555689|P4|STARTED|Overall Study||92
230723|NCT00624052|555690|P3|STARTED|Overall Study||91
230724|NCT00624052|555691|P2|STARTED|Overall Study||436
230725|NCT00624052|555692|P1|STARTED|Overall Study||219
230726|NCT00624013|555743|P2|NOT COMPLETED|Overall Study||6
230727|NCT00624013|555744|P1|NOT COMPLETED|Overall Study||8
230728|NCT00624013|555743|P2|COMPLETED|Overall Study||39
230729|NCT00624013|555744|P1|COMPLETED|Overall Study||36
230730|NCT00624013|555743|P2|STARTED|Overall Study||45
230731|NCT00624013|555744|P1|STARTED|Overall Study||44
230732|NCT00623974|555756|P4|NOT COMPLETED|Overall Study||0
230733|NCT00623974|555757|P3|NOT COMPLETED|Overall Study||0
230734|NCT00623974|555758|P2|NOT COMPLETED|Overall Study||0
230735|NCT00623974|555759|P1|NOT COMPLETED|Overall Study||0
230736|NCT00623974|555756|P4|COMPLETED|Overall Study||0
230737|NCT00623974|555757|P3|COMPLETED|Overall Study||0
230738|NCT00623974|555758|P2|COMPLETED|Overall Study||0
230739|NCT00623974|555759|P1|COMPLETED|Overall Study||0
230740|NCT00623974|555756|P4|STARTED|Overall Study||0
230741|NCT00623974|555757|P3|STARTED|Overall Study||0
230742|NCT00623974|555758|P2|STARTED|Overall Study||0
230743|NCT00623974|555759|P1|STARTED|Overall Study||0
230744|NCT00623935|555769|P1|NOT COMPLETED|Overall Study||2
230745|NCT00623935|555769|P1|COMPLETED|Overall Study||54
230746|NCT00623935|555769|P1|STARTED|Overall Study||56
230747|NCT00623831|555776|P2|NOT COMPLETED|Overall Study||1
230748|NCT00623831|555777|P1|NOT COMPLETED|Overall Study||1
230749|NCT00623831|555776|P2|COMPLETED|Overall Study||3
230750|NCT00623831|555777|P1|COMPLETED|Overall Study||12
230751|NCT00623831|555776|P2|STARTED|Overall Study||4
230752|NCT00623831|555777|P1|STARTED|Overall Study||13
230753|NCT00623805|555789|P2|NOT COMPLETED|Overall Study||22
230754|NCT00623805|555790|P1|NOT COMPLETED|Overall Study||20
230755|NCT00623805|555789|P2|COMPLETED|Overall Study||39
230756|NCT00623805|555790|P1|COMPLETED|Overall Study||42
230757|NCT00623805|555789|P2|STARTED|Overall Study||61
230758|NCT00623805|555790|P1|STARTED|Overall Study||62
230759|NCT00623779|555807|P3|NOT COMPLETED|Overall Study||1
230760|NCT00623779|555808|P2|NOT COMPLETED|Overall Study||3
230761|NCT00623779|555809|P1|NOT COMPLETED|Overall Study||3
230762|NCT00623779|555807|P3|COMPLETED|Overall Study||44
230763|NCT00623779|555808|P2|COMPLETED|Overall Study||39
230764|NCT00623779|555809|P1|COMPLETED|Overall Study||38
230765|NCT00623779|555807|P3|STARTED|Overall Study||45
230766|NCT00623779|555808|P2|STARTED|Overall Study||42
230767|NCT00623779|555809|P1|STARTED|Overall Study||41
230768|NCT00623766|555858|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
230769|NCT00623766|555859|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
230770|NCT00623766|555858|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
230771|NCT00623766|555859|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
230772|NCT00623766|555858|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
230773|NCT00623766|555859|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
230774|NCT00623766|555858|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
230775|NCT00623766|555859|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
230776|NCT00623766|555858|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
230777|NCT00623766|555859|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
230778|NCT00623766|555858|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
230779|NCT00623766|555859|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
230780|NCT00623727|555883|P2|NOT COMPLETED|Open Label Extension Period||0
230781|NCT00623727|555884|P1|NOT COMPLETED|Open Label Extension Period||0
230782|NCT00623727|555883|P2|COMPLETED|Open Label Extension Period||0
230783|NCT00623727|555884|P1|COMPLETED|Open Label Extension Period||20
230784|NCT00623727|555883|P2|STARTED|Open Label Extension Period||0
230785|NCT00623727|555884|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
230786|NCT00623727|555883|P2|NOT COMPLETED|Open Label Follow-up||8
230787|NCT00623727|555884|P1|NOT COMPLETED|Open Label Follow-up||0
230788|NCT00623727|555883|P2|COMPLETED|Open Label Follow-up||18
230789|NCT00623727|555884|P1|COMPLETED|Open Label Follow-up||0
230790|NCT00623727|555883|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
230791|NCT00623727|555884|P1|STARTED|Open Label Follow-up||0
230792|NCT00623727|555883|P2|NOT COMPLETED|Double Blind (DB)||32
230793|NCT00623727|555884|P1|NOT COMPLETED|Double Blind (DB)||36
230794|NCT00623727|555883|P2|COMPLETED|Double Blind (DB)||41
230795|NCT00623727|555884|P1|COMPLETED|Double Blind (DB)||34
230796|NCT00623727|555883|P2|Participants Received Treatment|Double Blind (DB)||72
230797|NCT00623727|555884|P1|Participants Received Treatment|Double Blind (DB)||67
230798|NCT00623727|555883|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
230799|NCT00623727|555884|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
230800|NCT00623714|555904|P2|NOT COMPLETED|Period 2||0
230801|NCT00623714|555905|P1|NOT COMPLETED|Period 2||0
230802|NCT00623714|555904|P2|COMPLETED|Period 2||7
230803|NCT00623714|555905|P1|COMPLETED|Period 2||6
230804|NCT00623714|555904|P2|STARTED|Period 2||7
230805|NCT00623714|555905|P1|STARTED|Period 2||6
230806|NCT00623714|555904|P2|NOT COMPLETED|Period 1||0
230807|NCT00623714|555905|P1|NOT COMPLETED|Period 1||0
230808|NCT00623714|555904|P2|COMPLETED|Period 1||7
230809|NCT00623714|555905|P1|COMPLETED|Period 1||6
230810|NCT00623714|555904|P2|STARTED|Period 1||7
230811|NCT00623714|555905|P1|STARTED|Period 1||6
230812|NCT00623636|555915|P2|NOT COMPLETED|Open Label||412
230813|NCT00623636|555916|P1|NOT COMPLETED|Open Label||0
230814|NCT00623636|555915|P2|COMPLETED|Open Label||263
230815|NCT00623636|555916|P1|COMPLETED|Open Label||0
230816|NCT00623636|555915|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
230817|NCT00623636|555916|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
230818|NCT00623636|555915|P2|NOT COMPLETED|Double Blind||28
230819|NCT00623636|555916|P1|NOT COMPLETED|Double Blind||33
230820|NCT00623636|555915|P2|COMPLETED|Double Blind||422
230821|NCT00623636|555916|P1|COMPLETED|Double Blind||419
230822|NCT00623636|555915|P2|STARTED|Double Blind||450
230823|NCT00623636|555916|P1|STARTED|Double Blind||452
230824|NCT00623597|555939|P2|NOT COMPLETED|Overall Study||0
230825|NCT00623597|555940|P1|NOT COMPLETED|Overall Study||1
230826|NCT00623597|555939|P2|COMPLETED|Overall Study||13
230827|NCT00623597|555940|P1|COMPLETED|Overall Study||4
230828|NCT00623597|555939|P2|STARTED|Overall Study||13
230829|NCT00623597|555940|P1|STARTED|Overall Study||5
230830|NCT00623545|556003|P1|NOT COMPLETED|Overall Study||10
230831|NCT00623545|556003|P1|COMPLETED|Overall Study||18
230832|NCT00623545|556003|P1|STARTED|Overall Study||28
230833|NCT00623506|556010|P2|NOT COMPLETED|Overall Study||4
230834|NCT00623506|556011|P1|NOT COMPLETED|Overall Study||4
230835|NCT00623506|556010|P2|COMPLETED|Overall Study||11
230836|NCT00623506|556011|P1|COMPLETED|Overall Study||11
230837|NCT00623506|556010|P2|Week 4|Overall Study||11
230838|NCT00623506|556011|P1|Week 4|Overall Study||11
230839|NCT00623506|556010|P2|STARTED|Overall Study||15
230840|NCT00623506|556011|P1|STARTED|Overall Study||15
230841|NCT00623480|556023|P2|NOT COMPLETED|Overall Study||7
230842|NCT00623480|556024|P1|NOT COMPLETED|Overall Study||7
230843|NCT00623480|556023|P2|COMPLETED|Overall Study||35
230844|NCT00623480|556024|P1|COMPLETED|Overall Study||35
230845|NCT00623480|556023|P2|STARTED|Overall Study||42
230846|NCT00623480|556024|P1|STARTED|Overall Study||42
230847|NCT00623467|556036|P1|NOT COMPLETED|Overall Study||7
230848|NCT00623467|556036|P1|COMPLETED|Overall Study||336
230849|NCT00623467|556036|P1|STARTED|Overall Study||343
230850|NCT00623441|556100|P1|NOT COMPLETED|Overall Study||0
230851|NCT00623441|556100|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
230852|NCT00623441|556100|P1|STARTED|Overall Study||8314
230853|NCT00623428|556106|P2|NOT COMPLETED|Follow-up Period||15
230854|NCT00623428|556107|P1|NOT COMPLETED|Follow-up Period||29
230855|NCT00623428|556106|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
230856|NCT00623428|556107|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
230857|NCT00623428|556106|P2|STARTED|Follow-up Period||93
230858|NCT00623428|556107|P1|STARTED|Follow-up Period||95
230859|NCT00623428|556106|P2|NOT COMPLETED|Treatment Period||27
230860|NCT00623428|556107|P1|NOT COMPLETED|Treatment Period||0
230861|NCT00623428|556106|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
230862|NCT00623428|556107|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
230863|NCT00623428|556106|P2|STARTED|Treatment Period||93
230864|NCT00623428|556107|P1|STARTED|Treatment Period||95
230865|NCT00623233|556125|P1|NOT COMPLETED|Overall Study||24
230866|NCT00623233|556125|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
230867|NCT00623233|556125|P1|STARTED|Overall Study||52
230868|NCT00623194|556132|P1|NOT COMPLETED|Overall Study||5
230869|NCT00623194|556132|P1|COMPLETED|Overall Study||141
230870|NCT00623194|556132|P1|STARTED|Overall Study||146
230871|NCT00623181|556154|P2|NOT COMPLETED|Overall Study||0
230872|NCT00623181|556155|P1|NOT COMPLETED|Overall Study||0
230873|NCT00623181|556154|P2|COMPLETED|Overall Study||54
230874|NCT00623181|556155|P1|COMPLETED|Overall Study||56
230875|NCT00623181|556154|P2|STARTED|Overall Study||54
230876|NCT00623181|556155|P1|STARTED|Overall Study||56
230877|NCT00623103|556169|P2|NOT COMPLETED|Overall Study||113
230878|NCT00623103|556170|P1|NOT COMPLETED|Overall Study||111
230879|NCT00623103|556169|P2|COMPLETED|Overall Study||175
230880|NCT00623103|556170|P1|COMPLETED|Overall Study||184
230881|NCT00623103|556169|P2|Safety Set: Received Study Drug|Overall Study||288
230882|NCT00623103|556170|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
230883|NCT00623103|556169|P2|STARTED|Overall Study||288
230884|NCT00623103|556170|P1|STARTED|Overall Study||295
230885|NCT00623012|556190|P1|NOT COMPLETED|Overall Study||0
230886|NCT00623012|556190|P1|COMPLETED|Overall Study||2
230887|NCT00623012|556190|P1|STARTED|Overall Study||2
230888|NCT00622908|556198|P2|NOT COMPLETED|Overall Study||10
230889|NCT00622908|556199|P1|NOT COMPLETED|Overall Study||3
230890|NCT00622908|556198|P2|COMPLETED|Overall Study||122
230891|NCT00622908|556199|P1|COMPLETED|Overall Study||134
230892|NCT00622908|556198|P2|STARTED|Overall Study|Intent to treat population|132
230893|NCT00622908|556199|P1|STARTED|Overall Study|Intent to treat population|137
230894|NCT00622869|556214|P3|NOT COMPLETED|Overall Study||39
230895|NCT00622869|556215|P2|NOT COMPLETED|Overall Study||57
230896|NCT00622869|556216|P1|NOT COMPLETED|Overall Study||43
230897|NCT00622869|556214|P3|COMPLETED|Overall Study||204
230898|NCT00622869|556215|P2|COMPLETED|Overall Study||174
230899|NCT00622869|556216|P1|COMPLETED|Overall Study||202
230900|NCT00622869|556214|P3|STARTED|Overall Study||243
230901|NCT00622869|556215|P2|STARTED|Overall Study||231
230902|NCT00622869|556216|P1|STARTED|Overall Study||245
230903|NCT00622739|556235|P2|NOT COMPLETED|Overall Study||6
230904|NCT00622739|556236|P1|NOT COMPLETED|Overall Study||2
230905|NCT00622739|556235|P2|COMPLETED|Overall Study||9
230906|NCT00622739|556236|P1|COMPLETED|Overall Study||11
230907|NCT00622739|556235|P2|STARTED|Overall Study||15
230908|NCT00622739|556236|P1|STARTED|Overall Study||13
230909|NCT00622726|556244|P2|NOT COMPLETED|August, 2010 to April, 2013||5
230910|NCT00622726|556245|P1|NOT COMPLETED|August, 2010 to April, 2013||1
230911|NCT00622726|556244|P2|COMPLETED|August, 2010 to April, 2013||68
230912|NCT00622726|556245|P1|COMPLETED|August, 2010 to April, 2013||69
230913|NCT00622726|556244|P2|STARTED|August, 2010 to April, 2013||73
230914|NCT00622726|556245|P1|STARTED|August, 2010 to April, 2013||70
230915|NCT00622726|556244|P2|NOT COMPLETED|March, 2008 to August, 2010||2
230916|NCT00622726|556245|P1|NOT COMPLETED|March, 2008 to August, 2010||5
230917|NCT00622726|556244|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
230918|NCT00622726|556245|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
230919|NCT00622726|556244|P2|STARTED|March, 2008 to August, 2010||75
230920|NCT00622726|556245|P1|STARTED|March, 2008 to August, 2010||75
230921|NCT00622713|556255|P1|NOT COMPLETED|Overall Study||59
230922|NCT00622713|556255|P1|COMPLETED|Overall Study||169
230923|NCT00622713|556255|P1|Intent to Treat (ITT) Population|Overall Study||218
230924|NCT00622713|556255|P1|Exposed to Study Drug|Overall Study||226
230925|NCT00622713|556255|P1|STARTED|Overall Study||228
230926|NCT00622700|556266|P7|NOT COMPLETED|Extension Treatment Period||30
230927|NCT00622700|556267|P6|NOT COMPLETED|Extension Treatment Period||17
230928|NCT00622700|556268|P5|NOT COMPLETED|Extension Treatment Period||39
230929|NCT00622700|556269|P4|NOT COMPLETED|Extension Treatment Period||21
230930|NCT00622700|556270|P3|NOT COMPLETED|Extension Treatment Period||0
230931|NCT00622700|556271|P2|NOT COMPLETED|Extension Treatment Period||0
230932|NCT00622700|556272|P1|NOT COMPLETED|Extension Treatment Period||0
230933|NCT00622700|556266|P7|COMPLETED|Extension Treatment Period||120
230934|NCT00622700|556267|P6|COMPLETED|Extension Treatment Period||50
230935|NCT00622700|556268|P5|COMPLETED|Extension Treatment Period||103
230936|NCT00622700|556269|P4|COMPLETED|Extension Treatment Period||43
230937|NCT00622700|556270|P3|COMPLETED|Extension Treatment Period||0
230938|NCT00622700|556271|P2|COMPLETED|Extension Treatment Period||0
230939|NCT00622700|556272|P1|COMPLETED|Extension Treatment Period||0
230940|NCT00622700|556266|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
230941|NCT00622700|556267|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
230942|NCT00622700|556268|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
230943|NCT00622700|556269|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
230944|NCT00622700|556270|P3|STARTED|Extension Treatment Period||0
230945|NCT00622700|556271|P2|STARTED|Extension Treatment Period||0
230946|NCT00622700|556272|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
230947|NCT00622700|556266|P7|NOT COMPLETED|Core Treatment Period||0
230948|NCT00622700|556267|P6|NOT COMPLETED|Core Treatment Period||0
230949|NCT00622700|556268|P5|NOT COMPLETED|Core Treatment Period||0
230950|NCT00622700|556269|P4|NOT COMPLETED|Core Treatment Period||0
230951|NCT00622700|556270|P3|NOT COMPLETED|Core Treatment Period||53
230952|NCT00622700|556271|P2|NOT COMPLETED|Core Treatment Period||55
230953|NCT00622700|556272|P1|NOT COMPLETED|Core Treatment Period||56
230954|NCT00622700|556266|P7|COMPLETED|Core Treatment Period||0
230955|NCT00622700|556267|P6|COMPLETED|Core Treatment Period||0
230956|NCT00622700|556268|P5|COMPLETED|Core Treatment Period||0
230957|NCT00622700|556269|P4|COMPLETED|Core Treatment Period||0
230958|NCT00622700|556270|P3|COMPLETED|Core Treatment Period||163
230959|NCT00622700|556271|P2|COMPLETED|Core Treatment Period||150
230960|NCT00622700|556272|P1|COMPLETED|Core Treatment Period||141
230961|NCT00622700|556266|P7|Treated|Core Treatment Period||0
230962|NCT00622700|556267|P6|Treated|Core Treatment Period||0
230963|NCT00622700|556268|P5|Treated|Core Treatment Period||0
230964|NCT00622700|556269|P4|Treated|Core Treatment Period||0
230965|NCT00622700|556270|P3|Treated|Core Treatment Period||214
230966|NCT00622700|556271|P2|Treated|Core Treatment Period||203
230967|NCT00622700|556272|P1|Treated|Core Treatment Period||197
230968|NCT00622700|556266|P7|STARTED|Core Treatment Period||0
230969|NCT00622700|556267|P6|STARTED|Core Treatment Period||0
230970|NCT00622700|556268|P5|STARTED|Core Treatment Period||0
230971|NCT00622700|556269|P4|STARTED|Core Treatment Period||0
230972|NCT00622700|556270|P3|STARTED|Core Treatment Period||216
230973|NCT00622700|556271|P2|STARTED|Core Treatment Period||205
230974|NCT00622700|556272|P1|STARTED|Core Treatment Period||197
230975|NCT00622635|556331|P6|NOT COMPLETED|Treatment Period 3||0
230976|NCT00622635|556332|P5|NOT COMPLETED|Treatment Period 3||0
230977|NCT00622635|556333|P4|NOT COMPLETED|Treatment Period 3||3
230978|NCT00622635|556334|P3|NOT COMPLETED|Treatment Period 3||0
230979|NCT00622635|556335|P2|NOT COMPLETED|Treatment Period 3||0
230980|NCT00622635|556336|P1|NOT COMPLETED|Treatment Period 3||0
230981|NCT00622635|556331|P6|COMPLETED|Treatment Period 3||10
230982|NCT00622635|556332|P5|COMPLETED|Treatment Period 3||9
230983|NCT00622635|556333|P4|COMPLETED|Treatment Period 3||10
230984|NCT00622635|556334|P3|COMPLETED|Treatment Period 3||10
230985|NCT00622635|556335|P2|COMPLETED|Treatment Period 3||10
230986|NCT00622635|556336|P1|COMPLETED|Treatment Period 3||12
230987|NCT00622635|556331|P6|STARTED|Treatment Period 3||10
230988|NCT00622635|556332|P5|STARTED|Treatment Period 3||9
230989|NCT00622635|556333|P4|STARTED|Treatment Period 3||13
230990|NCT00622635|556334|P3|STARTED|Treatment Period 3||10
230991|NCT00622635|556335|P2|STARTED|Treatment Period 3||10
230992|NCT00622635|556336|P1|STARTED|Treatment Period 3||12
230993|NCT00622635|556331|P6|NOT COMPLETED|Treatment Period 2||0
230994|NCT00622635|556332|P5|NOT COMPLETED|Treatment Period 2||0
230995|NCT00622635|556333|P4|NOT COMPLETED|Treatment Period 2||0
230996|NCT00622635|556334|P3|NOT COMPLETED|Treatment Period 2||0
230997|NCT00622635|556335|P2|NOT COMPLETED|Treatment Period 2||0
230998|NCT00622635|556336|P1|NOT COMPLETED|Treatment Period 2||1
230999|NCT00622635|556331|P6|COMPLETED|Treatment Period 2||10
231000|NCT00622635|556332|P5|COMPLETED|Treatment Period 2||9
231001|NCT00622635|556333|P4|COMPLETED|Treatment Period 2||13
231002|NCT00622635|556334|P3|COMPLETED|Treatment Period 2||10
231003|NCT00622635|556335|P2|COMPLETED|Treatment Period 2||10
231004|NCT00622635|556336|P1|COMPLETED|Treatment Period 2||12
231005|NCT00622635|556331|P6|STARTED|Treatment Period 2||10
231006|NCT00622635|556332|P5|STARTED|Treatment Period 2||9
231007|NCT00622635|556333|P4|STARTED|Treatment Period 2||13
231008|NCT00622635|556334|P3|STARTED|Treatment Period 2||10
231009|NCT00622635|556335|P2|STARTED|Treatment Period 2||10
231010|NCT00622635|556336|P1|STARTED|Treatment Period 2||13
231011|NCT00622635|556331|P6|NOT COMPLETED|Treatment Period 1||0
231012|NCT00622635|556332|P5|NOT COMPLETED|Treatment Period 1||1
231013|NCT00622635|556333|P4|NOT COMPLETED|Treatment Period 1||0
231014|NCT00622635|556334|P3|NOT COMPLETED|Treatment Period 1||1
231015|NCT00622635|556335|P2|NOT COMPLETED|Treatment Period 1||1
231016|NCT00622635|556336|P1|NOT COMPLETED|Treatment Period 1||0
231017|NCT00622635|556331|P6|COMPLETED|Treatment Period 1||10
231018|NCT00622635|556332|P5|COMPLETED|Treatment Period 1||9
231019|NCT00622635|556333|P4|COMPLETED|Treatment Period 1||13
231020|NCT00622635|556334|P3|COMPLETED|Treatment Period 1||10
231021|NCT00622635|556335|P2|COMPLETED|Treatment Period 1||10
231022|NCT00622635|556336|P1|COMPLETED|Treatment Period 1||13
231023|NCT00622635|556331|P6|STARTED|Treatment Period 1||10
231024|NCT00622635|556332|P5|STARTED|Treatment Period 1||10
231025|NCT00622635|556333|P4|STARTED|Treatment Period 1||13
231026|NCT00622635|556334|P3|STARTED|Treatment Period 1||11
231027|NCT00622635|556335|P2|STARTED|Treatment Period 1||11
231028|NCT00622635|556336|P1|STARTED|Treatment Period 1||13
231029|NCT00622518|556403|P2|NOT COMPLETED|Overall Study||0
231030|NCT00622518|556404|P1|NOT COMPLETED|Overall Study||0
231031|NCT00622518|556403|P2|COMPLETED|Overall Study||60
231032|NCT00622518|556404|P1|COMPLETED|Overall Study||59
231033|NCT00622518|556403|P2|STARTED|Overall Study||60
231034|NCT00622518|556404|P1|STARTED|Overall Study||59
231035|NCT00622440|556414|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
231036|NCT00622440|556415|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
231037|NCT00622440|556414|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
231038|NCT00622440|556415|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
231039|NCT00622440|556414|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
231040|NCT00622440|556415|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
231041|NCT00622440|556414|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
231042|NCT00622440|556415|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
231043|NCT00622440|556414|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
231044|NCT00622440|556415|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
231045|NCT00622440|556414|P2|STARTED|Week 12 - Week 48 (Treatment)||34
231046|NCT00622440|556415|P1|STARTED|Week 12 - Week 48 (Treatment)||31
231047|NCT00622440|556414|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
231048|NCT00622440|556415|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
231049|NCT00622440|556414|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
231050|NCT00622440|556415|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
231051|NCT00622440|556414|P2|STARTED|Baseline - Week 12 (Treatment)||35
231052|NCT00622440|556415|P1|STARTED|Baseline - Week 12 (Treatment)||35
231053|NCT00622427|556429|P2|NOT COMPLETED|Overall Study||0
231054|NCT00622427|556430|P1|NOT COMPLETED|Overall Study||0
231055|NCT00622427|556429|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
231056|NCT00622427|556430|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
231057|NCT00622427|556429|P2|STARTED|Overall Study||16
231058|NCT00622427|556430|P1|STARTED|Overall Study||16
231059|NCT00622401|556441|P3|NOT COMPLETED|Overall Study||0
231060|NCT00622401|556442|P2|NOT COMPLETED|Overall Study||2
231061|NCT00622401|556443|P1|NOT COMPLETED|Overall Study||3
231062|NCT00622401|556441|P3|COMPLETED|Overall Study||0
231063|NCT00622401|556442|P2|COMPLETED|Overall Study||0
231064|NCT00622401|556443|P1|COMPLETED|Overall Study||3
231065|NCT00622401|556441|P3|STARTED|Overall Study|Never Opened|0
231066|NCT00622401|556442|P2|STARTED|Overall Study||2
231067|NCT00622401|556443|P1|STARTED|Overall Study||6
231068|NCT00622388|556450|P1|NOT COMPLETED|Overall Study||72
231069|NCT00622388|556450|P1|COMPLETED|Overall Study||9
231070|NCT00622388|556450|P1|STARTED|Overall Study||81
231071|NCT00622336|556468|P1|NOT COMPLETED|Extension Phase||21
231072|NCT00622336|556468|P1|COMPLETED|Extension Phase||0
231073|NCT00622336|556468|P1|STARTED|Extension Phase||21
231074|NCT00622336|556468|P1|NOT COMPLETED|Treatment Phase||309
231075|NCT00622336|556468|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
231076|NCT00622336|556468|P1|Safety Population|Treatment Phase||330
231077|NCT00622336|556468|P1|STARTED|Treatment Phase||330
231078|NCT00622284|556479|P2|NOT COMPLETED|Overall Study||171
231079|NCT00622284|556480|P1|NOT COMPLETED|Overall Study||189
231080|NCT00622284|556479|P2|COMPLETED|Overall Study|Number who completed treatment.|604
231081|NCT00622284|556480|P1|COMPLETED|Overall Study|Number who completed treatment.|587
231082|NCT00622284|556479|P2|STARTED|Overall Study|Number who started treatment.|775
231083|NCT00622284|556480|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
231084|NCT00622167|556542|P1|NOT COMPLETED|Overall Study||20
231085|NCT00622167|556542|P1|COMPLETED|Overall Study||4
231086|NCT00622167|556542|P1|STARTED|Overall Study||24
231087|NCT00621985|556546|P1|NOT COMPLETED|Dexamethasone Admission||1
231088|NCT00621985|556546|P1|COMPLETED|Dexamethasone Admission||4
231089|NCT00621985|556546|P1|STARTED|Dexamethasone Admission||5
231090|NCT00621985|556546|P1|NOT COMPLETED|Hydrocortisone Admission||0
231091|NCT00621985|556546|P1|COMPLETED|Hydrocortisone Admission||5
231092|NCT00621985|556546|P1|STARTED|Hydrocortisone Admission||5
231093|NCT00621959|556554|P2|NOT COMPLETED|Overall Study||9
231094|NCT00621959|556555|P1|NOT COMPLETED|Overall Study||7
231095|NCT00621959|556554|P2|COMPLETED|Overall Study||292
231096|NCT00621959|556555|P1|COMPLETED|Overall Study||288
231097|NCT00621959|556554|P2|STARTED|Overall Study||301
231098|NCT00621959|556555|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
231099|NCT00621946|556565|P2|NOT COMPLETED|Overall Study||1
231100|NCT00621946|556566|P1|NOT COMPLETED|Overall Study||0
231101|NCT00621946|556565|P2|COMPLETED|Overall Study||12
231102|NCT00621946|556566|P1|COMPLETED|Overall Study||13
231103|NCT00621946|556565|P2|STARTED|Overall Study||13
231104|NCT00621946|556566|P1|STARTED|Overall Study||13
231105|NCT00621933|556582|P1|NOT COMPLETED|Overall Study||0
231106|NCT00621933|556582|P1|COMPLETED|Overall Study||399
231107|NCT00621933|556582|P1|STARTED|Overall Study||399
231108|NCT00621855|556594|P5|NOT COMPLETED|Overall Study||55
231109|NCT00621855|556595|P4|NOT COMPLETED|Overall Study||67
231110|NCT00621855|556596|P3|NOT COMPLETED|Overall Study||81
231111|NCT00621855|556597|P2|NOT COMPLETED|Overall Study||61
231112|NCT00621855|556598|P1|NOT COMPLETED|Overall Study||76
231113|NCT00621855|556594|P5|COMPLETED|Overall Study|Completed means completed treatment|318
231114|NCT00621855|556595|P4|COMPLETED|Overall Study|Completed means completed treatment|284
231115|NCT00621855|556596|P3|COMPLETED|Overall Study|Completed means completed treatment|330
231116|NCT00621855|556597|P2|COMPLETED|Overall Study|Completed means completed treatment|310
231117|NCT00621855|556598|P1|COMPLETED|Overall Study|Completed means completed treatment|296
231118|NCT00621855|556594|P5|STARTED|Overall Study|Started means randomised to treatment|373
231119|NCT00621855|556595|P4|STARTED|Overall Study|Started means randomised to treatment|351
231120|NCT00621855|556596|P3|STARTED|Overall Study|Started means randomised to treatment|411
231121|NCT00621855|556597|P2|STARTED|Overall Study|Started means randomised to treatment|371
231122|NCT00621855|556598|P1|STARTED|Overall Study|Started means randomised to treatment|372
231123|NCT00621842|556640|P1|NOT COMPLETED|Overall Study||19
231124|NCT00621842|556640|P1|COMPLETED|Overall Study||38
231125|NCT00621842|556640|P1|STARTED|Overall Study||57
231126|NCT00621777|556657|P2|NOT COMPLETED|Randomized Phase||19
231127|NCT00621777|556658|P1|NOT COMPLETED|Randomized Phase||7
231128|NCT00621777|556657|P2|COMPLETED|Randomized Phase||28
231129|NCT00621777|556658|P1|COMPLETED|Randomized Phase||33
231130|NCT00621777|556657|P2|STARTED|Randomized Phase||47
231131|NCT00621777|556658|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
231132|NCT00621777|556657|P2|NOT COMPLETED|Open Phase||0
231133|NCT00621777|556658|P1|NOT COMPLETED|Open Phase||116
231134|NCT00621777|556657|P2|COMPLETED|Open Phase||0
231135|NCT00621777|556658|P1|COMPLETED|Open Phase||87
231136|NCT00621777|556657|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
231137|NCT00621777|556658|P1|STARTED|Open Phase||203
231138|NCT00621764|556673|P4|NOT COMPLETED|Overall Study||1
231139|NCT00621764|556674|P3|NOT COMPLETED|Overall Study||0
231140|NCT00621764|556675|P2|NOT COMPLETED|Overall Study||0
231141|NCT00621764|556676|P1|NOT COMPLETED|Overall Study||0
231142|NCT00621764|556673|P4|COMPLETED|Overall Study||98
231143|NCT00621764|556674|P3|COMPLETED|Overall Study||101
231144|NCT00621764|556675|P2|COMPLETED|Overall Study||50
231145|NCT00621764|556676|P1|COMPLETED|Overall Study||50
231146|NCT00621764|556673|P4|STARTED|Overall Study||99
231147|NCT00621764|556674|P3|STARTED|Overall Study||101
231148|NCT00621764|556675|P2|STARTED|Overall Study||50
231149|NCT00621764|556676|P1|STARTED|Overall Study||50
231150|NCT00621686|556708|P2|NOT COMPLETED|Overall Study||0
231151|NCT00621686|556709|P1|NOT COMPLETED|Overall Study||0
231152|NCT00621686|556708|P2|COMPLETED|Overall Study||35
231153|NCT00621686|556709|P1|COMPLETED|Overall Study||19
231154|NCT00621686|556708|P2|STARTED|Overall Study||35
231155|NCT00621686|556709|P1|STARTED|Overall Study||19
231156|NCT00621621|556722|P2|NOT COMPLETED|Overall Study||0
231157|NCT00621621|556723|P1|NOT COMPLETED|Overall Study||30
231158|NCT00621621|556722|P2|COMPLETED|Overall Study||705
231159|NCT00621621|556723|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
231160|NCT00621621|556722|P2|STARTED|Overall Study||705
231161|NCT00621621|556723|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
231162|NCT00621582|556731|P1|NOT COMPLETED|Overall Study||106
231163|NCT00621582|556731|P1|COMPLETED|Overall Study||4812
231164|NCT00621582|556731|P1|STARTED|Overall Study||4918
231165|NCT00621543|556738|P1|NOT COMPLETED|Overall Study||23
231166|NCT00621543|556738|P1|COMPLETED|Overall Study||97
231167|NCT00621543|556738|P1|STARTED|Overall Study||120
231168|NCT00621530|556745|P2|NOT COMPLETED|Overall Study||3
231169|NCT00621530|556746|P1|NOT COMPLETED|Overall Study||2
231170|NCT00621530|556745|P2|COMPLETED|Overall Study||29
231171|NCT00621530|556746|P1|COMPLETED|Overall Study||28
231172|NCT00621530|556745|P2|STARTED|Overall Study||32
231173|NCT00621530|556746|P1|STARTED|Overall Study||30
231174|NCT00621517|556762|P2|NOT COMPLETED|Overall Study||7
231175|NCT00621517|556763|P1|NOT COMPLETED|Overall Study||7
231176|NCT00621517|556762|P2|COMPLETED|Overall Study||24
231177|NCT00621517|556763|P1|COMPLETED|Overall Study||22
231178|NCT00621517|556762|P2|STARTED|Overall Study||31
231179|NCT00621517|556763|P1|STARTED|Overall Study||29
231180|NCT00621504|556771|P2|NOT COMPLETED|Overall Study||25
231181|NCT00621504|556772|P1|NOT COMPLETED|Overall Study||26
231182|NCT00621504|556771|P2|COMPLETED|Overall Study||282
231183|NCT00621504|556772|P1|COMPLETED|Overall Study||273
231184|NCT00621504|556771|P2|STARTED|Overall Study||307
231185|NCT00621504|556772|P1|STARTED|Overall Study||299
231186|NCT00621348|556781|P3|NOT COMPLETED|Overall Study||0
231187|NCT00621348|556782|P2|NOT COMPLETED|Overall Study||0
231188|NCT00621348|556783|P1|NOT COMPLETED|Overall Study||0
231189|NCT00621348|556781|P3|COMPLETED|Overall Study||56
231190|NCT00621348|556782|P2|COMPLETED|Overall Study||53
231191|NCT00621348|556783|P1|COMPLETED|Overall Study||58
231192|NCT00621348|556781|P3|STARTED|Overall Study||56
231193|NCT00621348|556782|P2|STARTED|Overall Study||53
231194|NCT00621348|556783|P1|STARTED|Overall Study||58
231195|NCT00621322|556806|P6|NOT COMPLETED|Overall Study||4
231196|NCT00621322|556807|P5|NOT COMPLETED|Overall Study||1
231197|NCT00621322|556808|P4|NOT COMPLETED|Overall Study||3
231198|NCT00621322|556809|P3|NOT COMPLETED|Overall Study||2
231199|NCT00621322|556810|P2|NOT COMPLETED|Overall Study||0
231200|NCT00621322|556811|P1|NOT COMPLETED|Overall Study||1
231201|NCT00621322|556806|P6|COMPLETED|Overall Study||36
231202|NCT00621322|556807|P5|COMPLETED|Overall Study||39
231203|NCT00621322|556808|P4|COMPLETED|Overall Study||37
231204|NCT00621322|556809|P3|COMPLETED|Overall Study||38
231205|NCT00621322|556810|P2|COMPLETED|Overall Study||10
231206|NCT00621322|556811|P1|COMPLETED|Overall Study||9
231207|NCT00621322|556806|P6|STARTED|Overall Study||40
231208|NCT00621322|556807|P5|STARTED|Overall Study||40
231209|NCT00621322|556808|P4|STARTED|Overall Study||40
231210|NCT00621322|556809|P3|STARTED|Overall Study||40
231211|NCT00621322|556810|P2|STARTED|Overall Study||10
231212|NCT00621322|556811|P1|STARTED|Overall Study||10
231213|NCT00621296|556891|P1|NOT COMPLETED|Overall Study||14
231214|NCT00621296|556891|P1|COMPLETED|Overall Study||1
231215|NCT00621296|556891|P1|STARTED|Overall Study||15
231216|NCT00621257|556900|P5|NOT COMPLETED|Overall Study||9
231217|NCT00621257|556901|P4|NOT COMPLETED|Overall Study||6
231218|NCT00621257|556902|P3|NOT COMPLETED|Overall Study||3
231219|NCT00621257|556903|P2|NOT COMPLETED|Overall Study||3
231220|NCT00621257|556904|P1|NOT COMPLETED|Overall Study||4
231221|NCT00621257|556900|P5|COMPLETED|Overall Study||22
231222|NCT00621257|556901|P4|COMPLETED|Overall Study||26
231223|NCT00621257|556902|P3|COMPLETED|Overall Study||20
231224|NCT00621257|556903|P2|COMPLETED|Overall Study||21
231225|NCT00621257|556904|P1|COMPLETED|Overall Study||20
231226|NCT00621257|556900|P5|STARTED|Overall Study||31
231227|NCT00621257|556901|P4|STARTED|Overall Study||32
231228|NCT00621257|556902|P3|STARTED|Overall Study||23
231229|NCT00621257|556903|P2|STARTED|Overall Study||24
231230|NCT00621257|556904|P1|STARTED|Overall Study||24
231231|NCT00621244|556920|P4|NOT COMPLETED|Overall Study||23
231232|NCT00621244|556921|P3|NOT COMPLETED|Overall Study||33
231233|NCT00621244|556922|P2|NOT COMPLETED|Overall Study||34
231234|NCT00621244|556923|P1|NOT COMPLETED|Overall Study||86
231235|NCT00621244|556920|P4|COMPLETED|Overall Study||0
231236|NCT00621244|556921|P3|COMPLETED|Overall Study||0
231237|NCT00621244|556922|P2|COMPLETED|Overall Study||0
231238|NCT00621244|556923|P1|COMPLETED|Overall Study||0
231239|NCT00621244|556920|P4|STARTED|Overall Study||23
231240|NCT00621244|556921|P3|STARTED|Overall Study||33
231241|NCT00621244|556922|P2|STARTED|Overall Study||34
231242|NCT00621244|556923|P1|STARTED|Overall Study||86
231243|NCT00621192|557027|P4|NOT COMPLETED|Overall Study||3
231244|NCT00621192|557028|P3|NOT COMPLETED|Overall Study||5
231245|NCT00621192|557029|P2|NOT COMPLETED|Overall Study||9
231246|NCT00621192|557030|P1|NOT COMPLETED|Overall Study||4
231247|NCT00621192|557027|P4|COMPLETED|Overall Study||24
231248|NCT00621192|557028|P3|COMPLETED|Overall Study||26
231249|NCT00621192|557029|P2|COMPLETED|Overall Study||94
231250|NCT00621192|557030|P1|COMPLETED|Overall Study||35
231251|NCT00621192|557027|P4|Efficacy Population|Overall Study||27
231252|NCT00621192|557028|P3|Efficacy Population|Overall Study||28
231253|NCT00621192|557029|P2|Efficacy Population|Overall Study||101
231254|NCT00621192|557030|P1|Efficacy Population|Overall Study||39
231255|NCT00621192|557027|P4|Safety Population|Overall Study||27
231256|NCT00621192|557028|P3|Safety Population|Overall Study||31
231257|NCT00621192|557029|P2|Safety Population|Overall Study||103
231258|NCT00621192|557030|P1|Safety Population|Overall Study||39
231259|NCT00621192|557027|P4|STARTED|Overall Study||27
231260|NCT00621192|557028|P3|STARTED|Overall Study||31
231261|NCT00621192|557029|P2|STARTED|Overall Study||103
231262|NCT00621192|557030|P1|STARTED|Overall Study||39
231263|NCT00621153|557054|P2|NOT COMPLETED|Overall Study||15
231264|NCT00621153|557055|P1|NOT COMPLETED|Overall Study||20
231265|NCT00621153|557054|P2|COMPLETED|Overall Study|completed|101
231266|NCT00621153|557055|P1|COMPLETED|Overall Study|completed|97
231267|NCT00621153|557054|P2|Discontinued|Overall Study||15
231268|NCT00621153|557055|P1|Discontinued|Overall Study||20
231269|NCT00621153|557054|P2|STARTED|Overall Study|randomised|116
231270|NCT00621153|557055|P1|STARTED|Overall Study|randomised|117
231271|NCT00621140|557063|P2|NOT COMPLETED|Overall Study||18
231272|NCT00621140|557064|P1|NOT COMPLETED|Overall Study||15
231273|NCT00621140|557063|P2|COMPLETED|Overall Study|number who completed treatment|318
231274|NCT00621140|557064|P1|COMPLETED|Overall Study|number who completed treatment|152
231275|NCT00621140|557063|P2|STARTED|Overall Study|number who started treatment|336
231276|NCT00621140|557064|P1|STARTED|Overall Study|number who started treatment|167
231277|NCT00621049|557098|P2|NOT COMPLETED|Maintenance Treatment||0
231278|NCT00621049|557099|P1|NOT COMPLETED|Maintenance Treatment||15
231279|NCT00621049|557098|P2|COMPLETED|Maintenance Treatment||0
231280|NCT00621049|557099|P1|COMPLETED|Maintenance Treatment||34
231281|NCT00621049|557098|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
231282|NCT00621049|557099|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
231283|NCT00621049|557098|P2|NOT COMPLETED|Adjuvant Treatment||10
231284|NCT00621049|557099|P1|NOT COMPLETED|Adjuvant Treatment||3
231285|NCT00621049|557098|P2|COMPLETED|Adjuvant Treatment||47
231286|NCT00621049|557099|P1|COMPLETED|Adjuvant Treatment||52
231287|NCT00621049|557098|P2|STARTED|Adjuvant Treatment||57
231288|NCT00621049|557099|P1|STARTED|Adjuvant Treatment||55
231289|NCT00621023|557111|P1|NOT COMPLETED|Overall Study||6
231290|NCT00621023|557111|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
231291|NCT00621023|557111|P1|STARTED|Overall Study||6
231292|NCT00620945|557117|P1|NOT COMPLETED|Overall Study||0
231293|NCT00620945|557117|P1|COMPLETED|Overall Study||87
231294|NCT00620945|557117|P1|STARTED|Overall Study|Total number in the study|87
231295|NCT00620854|557128|P6|NOT COMPLETED|Period 3||0
231296|NCT00620854|557129|P5|NOT COMPLETED|Period 3||0
231297|NCT00620854|557130|P4|NOT COMPLETED|Period 3||0
231298|NCT00620854|557131|P3|NOT COMPLETED|Period 3||0
231299|NCT00620854|557132|P2|NOT COMPLETED|Period 3||0
231300|NCT00620854|557133|P1|NOT COMPLETED|Period 3||0
231301|NCT00620854|557128|P6|COMPLETED|Period 3||4
231302|NCT00620854|557129|P5|COMPLETED|Period 3||4
231303|NCT00620854|557130|P4|COMPLETED|Period 3||3
231304|NCT00620854|557131|P3|COMPLETED|Period 3||3
231305|NCT00620854|557132|P2|COMPLETED|Period 3||4
231306|NCT00620854|557133|P1|COMPLETED|Period 3||4
231307|NCT00620854|557128|P6|STARTED|Period 3||4
231308|NCT00620854|557129|P5|STARTED|Period 3||4
231309|NCT00620854|557130|P4|STARTED|Period 3||3
231310|NCT00620854|557131|P3|STARTED|Period 3||3
231311|NCT00620854|557132|P2|STARTED|Period 3||4
231312|NCT00620854|557133|P1|STARTED|Period 3||4
231313|NCT00620854|557128|P6|NOT COMPLETED|Washout 2||0
231314|NCT00620854|557129|P5|NOT COMPLETED|Washout 2||0
231315|NCT00620854|557130|P4|NOT COMPLETED|Washout 2||0
231316|NCT00620854|557131|P3|NOT COMPLETED|Washout 2||0
231317|NCT00620854|557132|P2|NOT COMPLETED|Washout 2||0
231318|NCT00620854|557133|P1|NOT COMPLETED|Washout 2||0
231319|NCT00620854|557128|P6|COMPLETED|Washout 2||4
231320|NCT00620854|557129|P5|COMPLETED|Washout 2||4
231321|NCT00620854|557130|P4|COMPLETED|Washout 2||3
231322|NCT00620854|557131|P3|COMPLETED|Washout 2||3
231323|NCT00620854|557132|P2|COMPLETED|Washout 2||4
231324|NCT00620854|557133|P1|COMPLETED|Washout 2||4
231325|NCT00620854|557128|P6|STARTED|Washout 2||4
231326|NCT00620854|557129|P5|STARTED|Washout 2||4
231327|NCT00620854|557130|P4|STARTED|Washout 2||3
231328|NCT00620854|557131|P3|STARTED|Washout 2||3
231329|NCT00620854|557132|P2|STARTED|Washout 2||4
231330|NCT00620854|557133|P1|STARTED|Washout 2||4
231331|NCT00620854|557128|P6|NOT COMPLETED|Period 2||0
231332|NCT00620854|557129|P5|NOT COMPLETED|Period 2||0
231333|NCT00620854|557130|P4|NOT COMPLETED|Period 2||0
231334|NCT00620854|557131|P3|NOT COMPLETED|Period 2||0
231335|NCT00620854|557132|P2|NOT COMPLETED|Period 2||0
231336|NCT00620854|557133|P1|NOT COMPLETED|Period 2||0
231337|NCT00620854|557128|P6|COMPLETED|Period 2||4
231338|NCT00620854|557129|P5|COMPLETED|Period 2||4
231339|NCT00620854|557130|P4|COMPLETED|Period 2||3
231340|NCT00620854|557131|P3|COMPLETED|Period 2||3
231341|NCT00620854|557132|P2|COMPLETED|Period 2||4
231342|NCT00620854|557133|P1|COMPLETED|Period 2||4
231343|NCT00620854|557128|P6|STARTED|Period 2||4
231344|NCT00620854|557129|P5|STARTED|Period 2||4
231345|NCT00620854|557130|P4|STARTED|Period 2||3
231346|NCT00620854|557131|P3|STARTED|Period 2||3
231347|NCT00620854|557132|P2|STARTED|Period 2||4
231348|NCT00620854|557133|P1|STARTED|Period 2||4
231349|NCT00620854|557128|P6|NOT COMPLETED|Washout 1||0
231350|NCT00620854|557129|P5|NOT COMPLETED|Washout 1||0
231351|NCT00620854|557130|P4|NOT COMPLETED|Washout 1||1
231352|NCT00620854|557131|P3|NOT COMPLETED|Washout 1||1
231353|NCT00620854|557132|P2|NOT COMPLETED|Washout 1||0
231354|NCT00620854|557133|P1|NOT COMPLETED|Washout 1||0
231355|NCT00620854|557128|P6|COMPLETED|Washout 1||4
231356|NCT00620854|557129|P5|COMPLETED|Washout 1||4
231357|NCT00620854|557130|P4|COMPLETED|Washout 1||3
231358|NCT00620854|557131|P3|COMPLETED|Washout 1||3
231359|NCT00620854|557132|P2|COMPLETED|Washout 1||4
231360|NCT00620854|557133|P1|COMPLETED|Washout 1||4
231361|NCT00620854|557128|P6|STARTED|Washout 1||4
231362|NCT00620854|557129|P5|STARTED|Washout 1||4
231363|NCT00620854|557130|P4|STARTED|Washout 1||4
231364|NCT00620854|557131|P3|STARTED|Washout 1||4
231365|NCT00620854|557132|P2|STARTED|Washout 1||4
231366|NCT00620854|557133|P1|STARTED|Washout 1||4
231367|NCT00620854|557128|P6|NOT COMPLETED|Period 1||0
231368|NCT00620854|557129|P5|NOT COMPLETED|Period 1||0
231369|NCT00620854|557130|P4|NOT COMPLETED|Period 1||0
231370|NCT00620854|557131|P3|NOT COMPLETED|Period 1||0
231371|NCT00620854|557132|P2|NOT COMPLETED|Period 1||0
231372|NCT00620854|557133|P1|NOT COMPLETED|Period 1||0
231373|NCT00620854|557128|P6|COMPLETED|Period 1||4
231374|NCT00620854|557129|P5|COMPLETED|Period 1||4
231375|NCT00620854|557130|P4|COMPLETED|Period 1||4
231376|NCT00620854|557131|P3|COMPLETED|Period 1||4
231377|NCT00620854|557132|P2|COMPLETED|Period 1||4
231378|NCT00620854|557133|P1|COMPLETED|Period 1||4
231379|NCT00620854|557128|P6|STARTED|Period 1||4
231380|NCT00620854|557129|P5|STARTED|Period 1||4
231381|NCT00620854|557130|P4|STARTED|Period 1||4
231382|NCT00620854|557131|P3|STARTED|Period 1||4
231383|NCT00620854|557132|P2|STARTED|Period 1||4
231384|NCT00620854|557133|P1|STARTED|Period 1||4
231385|NCT00620828|557146|P2|NOT COMPLETED|Overall Study||0
231386|NCT00620828|557147|P1|NOT COMPLETED|Overall Study||0
231387|NCT00620828|557146|P2|COMPLETED|Overall Study||35
231388|NCT00620828|557147|P1|COMPLETED|Overall Study||32
231389|NCT00620828|557146|P2|Number of Subjects Enrolled = 67|Overall Study||35
231390|NCT00620828|557147|P1|Number of Subjects Enrolled = 67|Overall Study||32
231391|NCT00620828|557146|P2|STARTED|Overall Study||35
231392|NCT00620828|557147|P1|STARTED|Overall Study||32
231393|NCT00620815|557164|P3|NOT COMPLETED|Overall Study||7
231394|NCT00620815|557165|P2|NOT COMPLETED|Overall Study||11
231395|NCT00620815|557166|P1|NOT COMPLETED|Overall Study||4
231396|NCT00620815|557164|P3|COMPLETED|Overall Study||192
231397|NCT00620815|557165|P2|COMPLETED|Overall Study||192
231398|NCT00620815|557166|P1|COMPLETED|Overall Study||195
231399|NCT00620815|557164|P3|STARTED|Overall Study||199
231400|NCT00620815|557165|P2|STARTED|Overall Study||203
231401|NCT00620815|557166|P1|STARTED|Overall Study||199
231402|NCT00620776|557206|P2|NOT COMPLETED|Overall Study||16
231403|NCT00620776|557207|P1|NOT COMPLETED|Overall Study||12
231404|NCT00620776|557206|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
231405|NCT00620776|557207|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
231406|NCT00620776|557206|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
231407|NCT00620776|557207|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
231408|NCT00620776|557206|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
231409|NCT00620776|557207|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
231410|NCT00620763|557235|P2|NOT COMPLETED|Period: Second Intervention||0
231411|NCT00620763|557236|P1|NOT COMPLETED|Period: Second Intervention||1
231412|NCT00620763|557235|P2|COMPLETED|Period: Second Intervention||7
231413|NCT00620763|557236|P1|COMPLETED|Period: Second Intervention||9
231414|NCT00620763|557235|P2|STARTED|Period: Second Intervention||7
231415|NCT00620763|557236|P1|STARTED|Period: Second Intervention||10
231416|NCT00620763|557235|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
231417|NCT00620763|557236|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
231418|NCT00620763|557235|P2|COMPLETED|Period: Washout Period of 1 Week||7
231419|NCT00620763|557236|P1|COMPLETED|Period: Washout Period of 1 Week||10
231420|NCT00620763|557235|P2|STARTED|Period: Washout Period of 1 Week||7
231421|NCT00620763|557236|P1|STARTED|Period: Washout Period of 1 Week||10
231422|NCT00620763|557235|P2|NOT COMPLETED|Period: First Intervention||5
231423|NCT00620763|557236|P1|NOT COMPLETED|Period: First Intervention||0
231424|NCT00620763|557235|P2|COMPLETED|Period: First Intervention||7
231425|NCT00620763|557236|P1|COMPLETED|Period: First Intervention||10
231426|NCT00620763|557235|P2|STARTED|Period: First Intervention||12
231427|NCT00620763|557236|P1|STARTED|Period: First Intervention||10
231428|NCT00620750|557242|P1|NOT COMPLETED|Overall Study||25
231429|NCT00620750|557242|P1|COMPLETED|Overall Study||40
231430|NCT00620750|557242|P1|STARTED|Overall Study||65
231431|NCT00620711|557246|P1|NOT COMPLETED|Overall Study||0
231432|NCT00620711|557246|P1|COMPLETED|Overall Study||4
231433|NCT00620711|557246|P1|STARTED|Overall Study||4
231434|NCT00620698|557251|P1|NOT COMPLETED|Overall Study||29
231435|NCT00620698|557251|P1|COMPLETED|Overall Study||60
231436|NCT00620698|557251|P1|STARTED|Overall Study||89
231437|NCT00620659|557257|P6|NOT COMPLETED|Treatment Period 3||0
231438|NCT00620659|557258|P5|NOT COMPLETED|Treatment Period 3||0
231439|NCT00620659|557259|P4|NOT COMPLETED|Treatment Period 3||1
231440|NCT00620659|557260|P3|NOT COMPLETED|Treatment Period 3||0
231441|NCT00620659|557261|P2|NOT COMPLETED|Treatment Period 3||2
231442|NCT00620659|557262|P1|NOT COMPLETED|Treatment Period 3||0
231443|NCT00620659|557257|P6|COMPLETED|Treatment Period 3||20
231444|NCT00620659|557258|P5|COMPLETED|Treatment Period 3||15
231445|NCT00620659|557259|P4|COMPLETED|Treatment Period 3||17
231446|NCT00620659|557260|P3|COMPLETED|Treatment Period 3||19
231447|NCT00620659|557261|P2|COMPLETED|Treatment Period 3||16
231448|NCT00620659|557262|P1|COMPLETED|Treatment Period 3||16
231449|NCT00620659|557257|P6|STARTED|Treatment Period 3||20
231450|NCT00620659|557258|P5|STARTED|Treatment Period 3||15
231451|NCT00620659|557259|P4|STARTED|Treatment Period 3||18
231452|NCT00620659|557260|P3|STARTED|Treatment Period 3||19
231453|NCT00620659|557261|P2|STARTED|Treatment Period 3||18
231454|NCT00620659|557262|P1|STARTED|Treatment Period 3||16
231455|NCT00620659|557257|P6|NOT COMPLETED|Placebo Washout Period 2||0
231456|NCT00620659|557258|P5|NOT COMPLETED|Placebo Washout Period 2||0
231457|NCT00620659|557259|P4|NOT COMPLETED|Placebo Washout Period 2||0
231458|NCT00620659|557260|P3|NOT COMPLETED|Placebo Washout Period 2||0
231459|NCT00620659|557261|P2|NOT COMPLETED|Placebo Washout Period 2||0
231460|NCT00620659|557262|P1|NOT COMPLETED|Placebo Washout Period 2||2
231461|NCT00620659|557257|P6|COMPLETED|Placebo Washout Period 2||20
231462|NCT00620659|557258|P5|COMPLETED|Placebo Washout Period 2||15
231463|NCT00620659|557259|P4|COMPLETED|Placebo Washout Period 2||18
231464|NCT00620659|557260|P3|COMPLETED|Placebo Washout Period 2||19
231465|NCT00620659|557261|P2|COMPLETED|Placebo Washout Period 2||18
231466|NCT00620659|557262|P1|COMPLETED|Placebo Washout Period 2||16
231467|NCT00620659|557257|P6|STARTED|Placebo Washout Period 2||20
231468|NCT00620659|557258|P5|STARTED|Placebo Washout Period 2||15
231469|NCT00620659|557259|P4|STARTED|Placebo Washout Period 2||18
231470|NCT00620659|557260|P3|STARTED|Placebo Washout Period 2||19
231471|NCT00620659|557261|P2|STARTED|Placebo Washout Period 2||18
231472|NCT00620659|557262|P1|STARTED|Placebo Washout Period 2||18
231473|NCT00620659|557257|P6|NOT COMPLETED|Treatment Period 2||0
231474|NCT00620659|557258|P5|NOT COMPLETED|Treatment Period 2||5
231475|NCT00620659|557259|P4|NOT COMPLETED|Treatment Period 2||0
231476|NCT00620659|557260|P3|NOT COMPLETED|Treatment Period 2||1
231477|NCT00620659|557261|P2|NOT COMPLETED|Treatment Period 2||3
231478|NCT00620659|557262|P1|NOT COMPLETED|Treatment Period 2||0
231479|NCT00620659|557257|P6|COMPLETED|Treatment Period 2||20
231480|NCT00620659|557258|P5|COMPLETED|Treatment Period 2||15
231481|NCT00620659|557259|P4|COMPLETED|Treatment Period 2||18
231482|NCT00620659|557260|P3|COMPLETED|Treatment Period 2||19
231483|NCT00620659|557261|P2|COMPLETED|Treatment Period 2||18
231484|NCT00620659|557262|P1|COMPLETED|Treatment Period 2||18
231485|NCT00620659|557257|P6|STARTED|Treatment Period 2||20
231486|NCT00620659|557258|P5|STARTED|Treatment Period 2||20
231487|NCT00620659|557259|P4|STARTED|Treatment Period 2||18
231488|NCT00620659|557260|P3|STARTED|Treatment Period 2||20
231489|NCT00620659|557261|P2|STARTED|Treatment Period 2||21
231490|NCT00620659|557262|P1|STARTED|Treatment Period 2||18
231491|NCT00620659|557257|P6|NOT COMPLETED|Placebo Washout Period 1||0
231492|NCT00620659|557258|P5|NOT COMPLETED|Placebo Washout Period 1||0
231493|NCT00620659|557259|P4|NOT COMPLETED|Placebo Washout Period 1||1
231494|NCT00620659|557260|P3|NOT COMPLETED|Placebo Washout Period 1||0
231495|NCT00620659|557261|P2|NOT COMPLETED|Placebo Washout Period 1||0
231496|NCT00620659|557262|P1|NOT COMPLETED|Placebo Washout Period 1||0
231497|NCT00620659|557257|P6|COMPLETED|Placebo Washout Period 1||20
231498|NCT00620659|557258|P5|COMPLETED|Placebo Washout Period 1||20
231499|NCT00620659|557259|P4|COMPLETED|Placebo Washout Period 1||18
231500|NCT00620659|557260|P3|COMPLETED|Placebo Washout Period 1||20
231501|NCT00620659|557261|P2|COMPLETED|Placebo Washout Period 1||21
231502|NCT00620659|557262|P1|COMPLETED|Placebo Washout Period 1||18
231503|NCT00620659|557257|P6|STARTED|Placebo Washout Period 1||20
231504|NCT00620659|557258|P5|STARTED|Placebo Washout Period 1||20
231505|NCT00620659|557259|P4|STARTED|Placebo Washout Period 1||19
231506|NCT00620659|557260|P3|STARTED|Placebo Washout Period 1||20
231507|NCT00620659|557261|P2|STARTED|Placebo Washout Period 1||21
231508|NCT00620659|557262|P1|STARTED|Placebo Washout Period 1||18
231509|NCT00620659|557257|P6|NOT COMPLETED|Treatment Period 1||0
231510|NCT00620659|557258|P5|NOT COMPLETED|Treatment Period 1||1
231511|NCT00620659|557259|P4|NOT COMPLETED|Treatment Period 1||3
231512|NCT00620659|557260|P3|NOT COMPLETED|Treatment Period 1||1
231513|NCT00620659|557261|P2|NOT COMPLETED|Treatment Period 1||0
231514|NCT00620659|557262|P1|NOT COMPLETED|Treatment Period 1||3
231515|NCT00620659|557257|P6|COMPLETED|Treatment Period 1||20
231516|NCT00620659|557258|P5|COMPLETED|Treatment Period 1||20
231517|NCT00620659|557259|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
231518|NCT00620659|557260|P3|COMPLETED|Treatment Period 1||20
231519|NCT00620659|557261|P2|COMPLETED|Treatment Period 1||21
231520|NCT00620659|557262|P1|COMPLETED|Treatment Period 1||18
231521|NCT00620659|557257|P6|STARTED|Treatment Period 1||20
231522|NCT00620659|557258|P5|STARTED|Treatment Period 1||21
231523|NCT00620659|557259|P4|STARTED|Treatment Period 1||21
231524|NCT00620659|557260|P3|STARTED|Treatment Period 1||21
231525|NCT00620659|557261|P2|STARTED|Treatment Period 1||21
231526|NCT00620659|557262|P1|STARTED|Treatment Period 1||21
231527|NCT00620555|557280|P1|NOT COMPLETED|Overall Study||21
231528|NCT00620555|557280|P1|COMPLETED|Overall Study||44
231529|NCT00620555|557280|P1|STARTED|Overall Study||65
231530|NCT00620542|557289|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
231531|NCT00620542|557290|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
231532|NCT00620542|557291|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
231533|NCT00620542|557292|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
231534|NCT00620542|557289|P4|COMPLETED|Part B (2 Year Core Study)||547
231535|NCT00620542|557290|P3|COMPLETED|Part B (2 Year Core Study)||546
231536|NCT00620542|557291|P2|COMPLETED|Part B (2 Year Core Study)||0
231537|NCT00620542|557292|P1|COMPLETED|Part B (2 Year Core Study)||0
231538|NCT00620542|557289|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
231539|NCT00620542|557290|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
231540|NCT00620542|557291|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
231541|NCT00620542|557292|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
231542|NCT00620542|557289|P4|Received Treatment|Part B (2 Year Core Study)||689
231543|NCT00620542|557290|P3|Received Treatment|Part B (2 Year Core Study)||691
231544|NCT00620542|557291|P2|Received Treatment|Part B (2 Year Core Study)||0
231545|NCT00620542|557292|P1|Received Treatment|Part B (2 Year Core Study)||0
231546|NCT00620542|557289|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
231547|NCT00620542|557290|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
231548|NCT00620542|557291|P2|STARTED|Part B (2 Year Core Study)||0
231549|NCT00620542|557292|P1|STARTED|Part B (2 Year Core Study)||0
231550|NCT00620542|557289|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
231551|NCT00620542|557290|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
231552|NCT00620542|557291|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
231553|NCT00620542|557292|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
231554|NCT00620542|557289|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
231555|NCT00620542|557290|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
231556|NCT00620542|557291|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
231557|NCT00620542|557292|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
231558|NCT00620542|557289|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
231559|NCT00620542|557290|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
231560|NCT00620542|557291|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
231561|NCT00620542|557292|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
231562|NCT00620542|557289|P4|STARTED|Part A (Run-in - 2 Weeks)||0
231563|NCT00620542|557290|P3|STARTED|Part A (Run-in - 2 Weeks)||0
231564|NCT00620542|557291|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
231565|NCT00620542|557292|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
231566|NCT00620464|557332|P2|NOT COMPLETED|Overall Study||24
231567|NCT00620464|557333|P1|NOT COMPLETED|Overall Study||20
231568|NCT00620464|557332|P2|COMPLETED|Overall Study||32
231569|NCT00620464|557333|P1|COMPLETED|Overall Study||32
231570|NCT00620464|557332|P2|STARTED|Overall Study||56
231571|NCT00620464|557333|P1|STARTED|Overall Study||52
231572|NCT00620425|557341|P1|NOT COMPLETED|Overall Study||0
231573|NCT00620425|557341|P1|COMPLETED|Overall Study||18
231574|NCT00620425|557341|P1|STARTED|Overall Study||18
231575|NCT00620373|557352|P1|NOT COMPLETED|Overall Study||33
231576|NCT00620373|557352|P1|COMPLETED|Overall Study||936
231577|NCT00620373|557352|P1|STARTED|Overall Study||969
231578|NCT00620282|557371|P3|NOT COMPLETED|Overall Study||1
231579|NCT00620282|557372|P2|NOT COMPLETED|Overall Study||2
231580|NCT00620282|557373|P1|NOT COMPLETED|Overall Study||0
231581|NCT00620282|557371|P3|COMPLETED|Overall Study||16
231582|NCT00620282|557372|P2|COMPLETED|Overall Study||14
231583|NCT00620282|557373|P1|COMPLETED|Overall Study||16
231584|NCT00620282|557371|P3|STARTED|Overall Study||17
231585|NCT00620282|557372|P2|STARTED|Overall Study||16
231586|NCT00620282|557373|P1|STARTED|Overall Study||16
231587|NCT00620126|557422|P2|NOT COMPLETED|Overall Study||5
231588|NCT00620126|557423|P1|NOT COMPLETED|Overall Study||11
231589|NCT00620126|557422|P2|COMPLETED|Overall Study||17
231590|NCT00620126|557423|P1|COMPLETED|Overall Study||14
231591|NCT00620126|557422|P2|STARTED|Overall Study||22
231592|NCT00620126|557423|P1|STARTED|Overall Study||25
231593|NCT00620113|557437|P4|NOT COMPLETED|Overall Study||10
231594|NCT00620113|557438|P3|NOT COMPLETED|Overall Study||5
231595|NCT00620113|557439|P2|NOT COMPLETED|Overall Study||7
231596|NCT00620113|557440|P1|NOT COMPLETED|Overall Study||13
231597|NCT00620113|557437|P4|COMPLETED|Overall Study||59
231598|NCT00620113|557438|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
231599|NCT00620113|557439|P2|COMPLETED|Overall Study||67
231600|NCT00620113|557440|P1|COMPLETED|Overall Study||60
231601|NCT00620113|557437|P4|Efficacy/Safety Population|Overall Study||69
231602|NCT00620113|557438|P3|Efficacy/Safety Population|Overall Study||70
231603|NCT00620113|557439|P2|Efficacy/Safety Population|Overall Study||74
231604|NCT00620113|557440|P1|Efficacy/Safety Population|Overall Study||73
231605|NCT00620113|557437|P4|STARTED|Overall Study||69
231606|NCT00620113|557438|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
231607|NCT00620113|557439|P2|STARTED|Overall Study||74
231608|NCT00620113|557440|P1|STARTED|Overall Study||73
231609|NCT00620074|557490|P1|NOT COMPLETED|Overall Study||1
231610|NCT00620074|557490|P1|COMPLETED|Overall Study||5
231611|NCT00620074|557490|P1|STARTED|Overall Study||6
231612|NCT00620035|557498|P1|NOT COMPLETED|Overall Study||145
231613|NCT00620035|557498|P1|COMPLETED|Overall Study||156
231614|NCT00620035|557498|P1|STARTED|Overall Study||301
231615|NCT00620022|557508|P2|NOT COMPLETED|Treatment Period 2||2
231616|NCT00620022|557509|P1|NOT COMPLETED|Treatment Period 2||2
231617|NCT00620022|557508|P2|COMPLETED|Treatment Period 2||35
231618|NCT00620022|557509|P1|COMPLETED|Treatment Period 2||39
231619|NCT00620022|557508|P2|STARTED|Treatment Period 2||37
231620|NCT00620022|557509|P1|STARTED|Treatment Period 2||41
231621|NCT00620022|557508|P2|NOT COMPLETED|Treatment Period 1||6
231622|NCT00620022|557509|P1|NOT COMPLETED|Treatment Period 1||5
231623|NCT00620022|557508|P2|COMPLETED|Treatment Period 1||37
231624|NCT00620022|557509|P1|COMPLETED|Treatment Period 1||41
231625|NCT00620022|557508|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
231626|NCT00620022|557509|P1|STARTED|Treatment Period 1||46
231627|NCT00619983|557521|P4|NOT COMPLETED|Gabapentin Alone||0
231628|NCT00619983|557522|P3|NOT COMPLETED|Gabapentin Alone||0
231629|NCT00619983|557523|P2|NOT COMPLETED|Gabapentin Alone||0
231630|NCT00619983|557524|P1|NOT COMPLETED|Gabapentin Alone||0
231631|NCT00619983|557521|P4|COMPLETED|Gabapentin Alone||3
231632|NCT00619983|557522|P3|COMPLETED|Gabapentin Alone||4
231633|NCT00619983|557523|P2|COMPLETED|Gabapentin Alone||4
231634|NCT00619983|557524|P1|COMPLETED|Gabapentin Alone||3
231635|NCT00619983|557521|P4|STARTED|Gabapentin Alone||3
231636|NCT00619983|557522|P3|STARTED|Gabapentin Alone||4
231637|NCT00619983|557523|P2|STARTED|Gabapentin Alone||4
231638|NCT00619983|557524|P1|STARTED|Gabapentin Alone||3
231639|NCT00619983|557521|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
231640|NCT00619983|557522|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
231641|NCT00619983|557523|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
231642|NCT00619983|557524|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
231643|NCT00619983|557521|P4|COMPLETED|Test Drug Plus Gabapentin||3
231644|NCT00619983|557522|P3|COMPLETED|Test Drug Plus Gabapentin||4
231645|NCT00619983|557523|P2|COMPLETED|Test Drug Plus Gabapentin||4
231646|NCT00619983|557524|P1|COMPLETED|Test Drug Plus Gabapentin||3
231647|NCT00619983|557521|P4|STARTED|Test Drug Plus Gabapentin||3
231648|NCT00619983|557522|P3|STARTED|Test Drug Plus Gabapentin||4
231649|NCT00619983|557523|P2|STARTED|Test Drug Plus Gabapentin||4
231650|NCT00619983|557524|P1|STARTED|Test Drug Plus Gabapentin||3
231651|NCT00619983|557521|P4|NOT COMPLETED|Test Drug Alone||3
231652|NCT00619983|557522|P3|NOT COMPLETED|Test Drug Alone||2
231653|NCT00619983|557523|P2|NOT COMPLETED|Test Drug Alone||1
231654|NCT00619983|557524|P1|NOT COMPLETED|Test Drug Alone||2
231655|NCT00619983|557521|P4|COMPLETED|Test Drug Alone||3
231656|NCT00619983|557522|P3|COMPLETED|Test Drug Alone||4
231657|NCT00619983|557523|P2|COMPLETED|Test Drug Alone||4
231658|NCT00619983|557524|P1|COMPLETED|Test Drug Alone||3
231659|NCT00619983|557521|P4|STARTED|Test Drug Alone||6
231660|NCT00619983|557522|P3|STARTED|Test Drug Alone||6
231661|NCT00619983|557523|P2|STARTED|Test Drug Alone||5
231662|NCT00619983|557524|P1|STARTED|Test Drug Alone||5
231663|NCT00619970|557537|P3|NOT COMPLETED|Overall Study||2
231664|NCT00619970|557538|P2|NOT COMPLETED|Overall Study||3
231665|NCT00619970|557539|P1|NOT COMPLETED|Overall Study||0
231666|NCT00619970|557537|P3|COMPLETED|Overall Study||24
231667|NCT00619970|557538|P2|COMPLETED|Overall Study||46
231668|NCT00619970|557539|P1|COMPLETED|Overall Study||40
231669|NCT00619970|557537|P3|STARTED|Overall Study||26
231670|NCT00619970|557538|P2|STARTED|Overall Study||49
231671|NCT00619970|557539|P1|STARTED|Overall Study||40
231672|NCT00619957|557551|P2|NOT COMPLETED|Month 48 Open-Label||17
231673|NCT00619957|557552|P1|NOT COMPLETED|Month 48 Open-Label||12
231674|NCT00619957|557551|P2|COMPLETED|Month 48 Open-Label||134
231675|NCT00619957|557552|P1|COMPLETED|Month 48 Open-Label||55
231676|NCT00619957|557551|P2|STARTED|Month 48 Open-Label||151
231677|NCT00619957|557552|P1|STARTED|Month 48 Open-Label||67
231678|NCT00619957|557551|P2|NOT COMPLETED|Month 24 Double-Blind||17
231679|NCT00619957|557552|P1|NOT COMPLETED|Month 24 Double-Blind||18
231680|NCT00619957|557551|P2|COMPLETED|Month 24 Double-Blind||175
231681|NCT00619957|557552|P1|COMPLETED|Month 24 Double-Blind||75
231682|NCT00619957|557551|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
231683|NCT00619957|557552|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
231684|NCT00619957|557551|P2|STARTED|Month 24 Double-Blind||192
231685|NCT00619957|557552|P1|STARTED|Month 24 Double-Blind||93
231686|NCT00619918|557634|P2|NOT COMPLETED|Overall Study||22
231687|NCT00619918|557635|P1|NOT COMPLETED|Overall Study||20
231688|NCT00619918|557634|P2|COMPLETED|Overall Study||195
231689|NCT00619918|557635|P1|COMPLETED|Overall Study||210
231690|NCT00619918|557634|P2|STARTED|Overall Study||217
231691|NCT00619918|557635|P1|STARTED|Overall Study||230
231692|NCT00619892|557645|P2|NOT COMPLETED|Overall Study||2
231693|NCT00619892|557646|P1|NOT COMPLETED|Overall Study||3
231694|NCT00619892|557645|P2|COMPLETED|Overall Study||11
231695|NCT00619892|557646|P1|COMPLETED|Overall Study||10
231696|NCT00619892|557645|P2|STARTED|Overall Study||13
231697|NCT00619892|557646|P1|STARTED|Overall Study||13
231698|NCT00619827|557656|P2|NOT COMPLETED|Overall Study||4
231699|NCT00619827|557657|P1|NOT COMPLETED|Overall Study||3
231700|NCT00619827|557656|P2|COMPLETED|Overall Study||40
231701|NCT00619827|557657|P1|COMPLETED|Overall Study||42
231702|NCT00619827|557656|P2|STARTED|Overall Study||44
231703|NCT00619827|557657|P1|STARTED|Overall Study||45
231704|NCT00619801|557665|P2|NOT COMPLETED|Overall Study||3
231705|NCT00619801|557666|P1|NOT COMPLETED|Overall Study||1
231706|NCT00619801|557665|P2|COMPLETED|Overall Study||111
231707|NCT00619801|557666|P1|COMPLETED|Overall Study||58
231708|NCT00619801|557665|P2|Safety Population|Overall Study||114
231709|NCT00619801|557666|P1|Safety Population|Overall Study||59
231710|NCT00619801|557665|P2|STARTED|Overall Study||114
231711|NCT00619801|557666|P1|STARTED|Overall Study||59
231712|NCT00619762|557696|P1|NOT COMPLETED|Overall Study||3
231713|NCT00619762|557696|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
231714|NCT00619762|557696|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
231715|NCT00619723|557703|P2|NOT COMPLETED|Overall Study||6
231716|NCT00619723|557704|P1|NOT COMPLETED|Overall Study||2
231717|NCT00619723|557703|P2|COMPLETED|Overall Study||61
231718|NCT00619723|557704|P1|COMPLETED|Overall Study||61
231719|NCT00619723|557703|P2|STARTED|Overall Study||67
231720|NCT00619723|557704|P1|STARTED|Overall Study||63
231721|NCT00619684|557714|P1|NOT COMPLETED|Overall Study||0
231722|NCT00619684|557714|P1|COMPLETED|Overall Study||18
231723|NCT00619684|557714|P1|STARTED|Overall Study||18
231724|NCT00619645|557723|P1|NOT COMPLETED|Overall Study||1
231725|NCT00619645|557723|P1|COMPLETED|Overall Study||7
231726|NCT00619645|557723|P1|STARTED|Overall Study||8
231727|NCT00619619|557737|P8|NOT COMPLETED|Overall Study||3
231728|NCT00619619|557738|P7|NOT COMPLETED|Overall Study||1
231729|NCT00619619|557739|P6|NOT COMPLETED|Overall Study||0
231730|NCT00619619|557740|P5|NOT COMPLETED|Overall Study||2
231731|NCT00619619|557741|P4|NOT COMPLETED|Overall Study||1
231732|NCT00619619|557742|P3|NOT COMPLETED|Overall Study||1
231733|NCT00619619|557743|P2|NOT COMPLETED|Overall Study||0
231734|NCT00619619|557744|P1|NOT COMPLETED|Overall Study||0
231735|NCT00619619|557737|P8|COMPLETED|Overall Study||5
231736|NCT00619619|557738|P7|COMPLETED|Overall Study||7
231737|NCT00619619|557739|P6|COMPLETED|Overall Study||7
231738|NCT00619619|557740|P5|COMPLETED|Overall Study||5
231739|NCT00619619|557741|P4|COMPLETED|Overall Study||6
231740|NCT00619619|557742|P3|COMPLETED|Overall Study||8
231741|NCT00619619|557743|P2|COMPLETED|Overall Study||7
231742|NCT00619619|557744|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
231743|NCT00619619|557737|P8|Entered the Extension Study|Overall Study||7
231744|NCT00619619|557738|P7|Entered the Extension Study|Overall Study||6
231745|NCT00619619|557739|P6|Entered the Extension Study|Overall Study||6
231746|NCT00619619|557740|P5|Entered the Extension Study|Overall Study||7
231747|NCT00619619|557741|P4|Entered the Extension Study|Overall Study||3
231748|NCT00619619|557742|P3|Entered the Extension Study|Overall Study||8
231749|NCT00619619|557743|P2|Entered the Extension Study|Overall Study||5
231750|NCT00619619|557744|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
231751|NCT00619619|557737|P8|STARTED|Overall Study||8
231752|NCT00619619|557738|P7|STARTED|Overall Study||8
231753|NCT00619619|557739|P6|STARTED|Overall Study||7
231754|NCT00619619|557740|P5|STARTED|Overall Study||7
231755|NCT00619619|557741|P4|STARTED|Overall Study||7
231756|NCT00619619|557742|P3|STARTED|Overall Study||9
231757|NCT00619619|557743|P2|STARTED|Overall Study||7
231758|NCT00619619|557744|P1|STARTED|Overall Study||6
231759|NCT00619502|557831|P2|NOT COMPLETED|Overall Study||10
231760|NCT00619502|557832|P1|NOT COMPLETED|Overall Study||8
231761|NCT00619502|557831|P2|COMPLETED|Overall Study||114
231762|NCT00619502|557832|P1|COMPLETED|Overall Study||122
231763|NCT00619502|557831|P2|STARTED|Overall Study||124
231764|NCT00619502|557832|P1|STARTED|Overall Study||130
231765|NCT00619489|557844|P2|NOT COMPLETED|Overall Study||34
231766|NCT00619489|557845|P1|NOT COMPLETED|Overall Study||23
231767|NCT00619489|557844|P2|COMPLETED|Overall Study||1
231768|NCT00619489|557845|P1|COMPLETED|Overall Study||14
231769|NCT00619489|557844|P2|STARTED|Overall Study||35
231770|NCT00619489|557845|P1|STARTED|Overall Study||37
231771|NCT00619476|557867|P4|NOT COMPLETED|Overall Study||34
231772|NCT00619476|557868|P3|NOT COMPLETED|Overall Study||24
231773|NCT00619476|557869|P2|NOT COMPLETED|Overall Study||22
231774|NCT00619476|557870|P1|NOT COMPLETED|Overall Study||31
231775|NCT00619476|557867|P4|COMPLETED|Overall Study||56
231776|NCT00619476|557868|P3|COMPLETED|Overall Study||60
231777|NCT00619476|557869|P2|COMPLETED|Overall Study||85
231778|NCT00619476|557870|P1|COMPLETED|Overall Study||64
231779|NCT00619476|557867|P4|Safety Population|Overall Study||87
231780|NCT00619476|557868|P3|Safety Population|Overall Study||82
231781|NCT00619476|557869|P2|Safety Population|Overall Study||107
231782|NCT00619476|557870|P1|Safety Population|Overall Study||95
231783|NCT00619476|557867|P4|Intent-to-Treat Population|Overall Study||87
231784|NCT00619476|557868|P3|Intent-to-Treat Population|Overall Study||82
231785|NCT00619476|557869|P2|Intent-to-Treat Population|Overall Study||107
231786|NCT00619476|557870|P1|Intent-to-Treat Population|Overall Study||95
231787|NCT00619476|557867|P4|STARTED|Overall Study||90
231788|NCT00619476|557868|P3|STARTED|Overall Study||84
231789|NCT00619476|557869|P2|STARTED|Overall Study||107
231790|NCT00619476|557870|P1|STARTED|Overall Study||95
231791|NCT00619385|557955|P3|NOT COMPLETED|Overall Study||4
231792|NCT00619385|557956|P2|NOT COMPLETED|Overall Study||2
231793|NCT00619385|557957|P1|NOT COMPLETED|Overall Study||1
231794|NCT00619385|557955|P3|COMPLETED|Overall Study||6
231795|NCT00619385|557956|P2|COMPLETED|Overall Study||6
231796|NCT00619385|557957|P1|COMPLETED|Overall Study||6
231797|NCT00619385|557955|P3|STARTED|Overall Study||10
231798|NCT00619385|557956|P2|STARTED|Overall Study||8
231799|NCT00619385|557957|P1|STARTED|Overall Study||7
231800|NCT00619359|557972|P2|NOT COMPLETED|Overall Study||81
231801|NCT00619359|557973|P1|NOT COMPLETED|Overall Study||67
231802|NCT00619359|557972|P2|COMPLETED|Overall Study||1094
231803|NCT00619359|557973|P1|COMPLETED|Overall Study||1080
231804|NCT00619359|557972|P2|STARTED|Overall Study||1175
231805|NCT00619359|557973|P1|STARTED|Overall Study||1147
231806|NCT00619307|557985|P2|NOT COMPLETED|Overall Study||4
231807|NCT00619307|557986|P1|NOT COMPLETED|Overall Study||4
231808|NCT00619307|557985|P2|COMPLETED|Overall Study||53
231809|NCT00619307|557986|P1|COMPLETED|Overall Study||56
231810|NCT00619307|557985|P2|STARTED|Overall Study||57
231811|NCT00619307|557986|P1|STARTED|Overall Study||60
231812|NCT00619255|558002|P2|NOT COMPLETED|Overall Study||0
231813|NCT00619255|558003|P1|NOT COMPLETED|Overall Study||2
231814|NCT00619255|558002|P2|COMPLETED|Overall Study||61
231815|NCT00619255|558003|P1|COMPLETED|Overall Study||57
231816|NCT00619255|558002|P2|STARTED|Overall Study||61
231817|NCT00619255|558003|P1|STARTED|Overall Study||59
231818|NCT00619242|558017|P1|NOT COMPLETED|Overall Study||0
231819|NCT00619242|558017|P1|COMPLETED|Overall Study||3
231820|NCT00619242|558017|P1|STARTED|Overall Study||3
231821|NCT00619229|558023|P2|NOT COMPLETED|Overall Study||2
231822|NCT00619229|558024|P1|NOT COMPLETED|Overall Study||4
231823|NCT00619229|558023|P2|COMPLETED|Overall Study||16
231824|NCT00619229|558024|P1|COMPLETED|Overall Study||14
231825|NCT00619229|558023|P2|Full Analysis Set (FAS)|Overall Study||17
231826|NCT00619229|558024|P1|Full Analysis Set (FAS)|Overall Study||16
231827|NCT00619229|558023|P2|STARTED|Overall Study||18
231828|NCT00619229|558024|P1|STARTED|Overall Study||18
231829|NCT00619190|558052|P2|NOT COMPLETED|Overall Study||0
231830|NCT00619190|558053|P1|NOT COMPLETED|Overall Study||1
231831|NCT00619190|558052|P2|COMPLETED|Overall Study||9
231832|NCT00619190|558053|P1|COMPLETED|Overall Study||20
231833|NCT00619190|558052|P2|STARTED|Overall Study||9
231834|NCT00619190|558053|P1|STARTED|Overall Study||21
231835|NCT00619177|558063|P1|NOT COMPLETED|Overall Study||508
231836|NCT00619177|558063|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
231837|NCT00619177|558063|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
231838|NCT00619151|558073|P2|NOT COMPLETED|Overall Study||0
231839|NCT00619151|558074|P1|NOT COMPLETED|Overall Study||1
231840|NCT00619151|558073|P2|COMPLETED|Overall Study||0
231841|NCT00619151|558074|P1|COMPLETED|Overall Study||1
231842|NCT00619151|558073|P2|STARTED|Overall Study||0
231843|NCT00619151|558074|P1|STARTED|Overall Study||2
231844|NCT00619112|558084|P2|NOT COMPLETED|Overall Study||2
231845|NCT00619112|558085|P1|NOT COMPLETED|Overall Study||1
231846|NCT00619112|558084|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
231847|NCT00619112|558085|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
231848|NCT00619112|558084|P2|STARTED|Overall Study||20
231849|NCT00619112|558085|P1|STARTED|Overall Study||40
231850|NCT00619099|558106|P2|NOT COMPLETED|Overall Study||19
231851|NCT00619099|558107|P1|NOT COMPLETED|Overall Study||33
231852|NCT00619099|558106|P2|COMPLETED|Overall Study||4
231853|NCT00619099|558107|P1|COMPLETED|Overall Study||11
231854|NCT00619099|558106|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
231855|NCT00619099|558107|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
231856|NCT00619099|558106|P2|STARTED|Overall Study|All randomized subjects|23
231857|NCT00619099|558107|P1|STARTED|Overall Study|All randomized subjects|44
231858|NCT00619073|558113|P2|NOT COMPLETED|Second Intervention - 60 Days||0
231859|NCT00619073|558114|P1|NOT COMPLETED|Second Intervention - 60 Days||0
231860|NCT00619073|558113|P2|COMPLETED|Second Intervention - 60 Days||8
231861|NCT00619073|558114|P1|COMPLETED|Second Intervention - 60 Days||8
231862|NCT00619073|558113|P2|STARTED|Second Intervention - 60 Days||8
231863|NCT00619073|558114|P1|STARTED|Second Intervention - 60 Days||8
231864|NCT00619073|558113|P2|NOT COMPLETED|Washout Period (30 Days)||0
231865|NCT00619073|558114|P1|NOT COMPLETED|Washout Period (30 Days)||0
231866|NCT00619073|558113|P2|COMPLETED|Washout Period (30 Days)||8
231867|NCT00619073|558114|P1|COMPLETED|Washout Period (30 Days)||8
231868|NCT00619073|558113|P2|STARTED|Washout Period (30 Days)||8
231869|NCT00619073|558114|P1|STARTED|Washout Period (30 Days)||8
231870|NCT00619073|558113|P2|NOT COMPLETED|First Intervention - 60 Days||0
231871|NCT00619073|558114|P1|NOT COMPLETED|First Intervention - 60 Days||0
231872|NCT00619073|558113|P2|COMPLETED|First Intervention - 60 Days||8
231873|NCT00619073|558114|P1|COMPLETED|First Intervention - 60 Days||8
231874|NCT00619073|558113|P2|STARTED|First Intervention - 60 Days||8
231875|NCT00619073|558114|P1|STARTED|First Intervention - 60 Days||8
231876|NCT00619060|558120|P2|NOT COMPLETED|Overall Study||0
231877|NCT00619060|558121|P1|NOT COMPLETED|Overall Study||0
231878|NCT00619060|558120|P2|COMPLETED|Overall Study||12
231879|NCT00619060|558121|P1|COMPLETED|Overall Study||10
231880|NCT00619060|558120|P2|STARTED|Overall Study||12
231881|NCT00619060|558121|P1|STARTED|Overall Study||10
231882|NCT00618995|558129|P4|NOT COMPLETED|Period 4||0
231883|NCT00618995|558130|P3|NOT COMPLETED|Period 4||0
231884|NCT00618995|558131|P2|NOT COMPLETED|Period 4||0
231885|NCT00618995|558132|P1|NOT COMPLETED|Period 4||1
231886|NCT00618995|558129|P4|COMPLETED|Period 4||6
231887|NCT00618995|558130|P3|COMPLETED|Period 4||4
231888|NCT00618995|558131|P2|COMPLETED|Period 4||6
231889|NCT00618995|558132|P1|COMPLETED|Period 4||5
231890|NCT00618995|558129|P4|STARTED|Period 4||6
231891|NCT00618995|558130|P3|STARTED|Period 4||4
231892|NCT00618995|558131|P2|STARTED|Period 4||6
231893|NCT00618995|558132|P1|STARTED|Period 4||6
231894|NCT00618995|558129|P4|NOT COMPLETED|Period 3||0
231895|NCT00618995|558130|P3|NOT COMPLETED|Period 3||0
231896|NCT00618995|558131|P2|NOT COMPLETED|Period 3||0
231897|NCT00618995|558132|P1|NOT COMPLETED|Period 3||0
231898|NCT00618995|558129|P4|COMPLETED|Period 3||6
231899|NCT00618995|558130|P3|COMPLETED|Period 3||4
231900|NCT00618995|558131|P2|COMPLETED|Period 3||6
231901|NCT00618995|558132|P1|COMPLETED|Period 3||6
231902|NCT00618995|558129|P4|STARTED|Period 3||6
231903|NCT00618995|558130|P3|STARTED|Period 3||4
231904|NCT00618995|558131|P2|STARTED|Period 3||6
231905|NCT00618995|558132|P1|STARTED|Period 3||6
231906|NCT00618995|558129|P4|NOT COMPLETED|Period 2||0
231907|NCT00618995|558130|P3|NOT COMPLETED|Period 2||1
231908|NCT00618995|558131|P2|NOT COMPLETED|Period 2||0
231909|NCT00618995|558132|P1|NOT COMPLETED|Period 2||0
231910|NCT00618995|558129|P4|COMPLETED|Period 2||6
231911|NCT00618995|558130|P3|COMPLETED|Period 2||4
231912|NCT00618995|558131|P2|COMPLETED|Period 2||6
231913|NCT00618995|558132|P1|COMPLETED|Period 2||6
231914|NCT00618995|558129|P4|STARTED|Period 2||6
231915|NCT00618995|558130|P3|STARTED|Period 2||5
231916|NCT00618995|558131|P2|STARTED|Period 2||6
231917|NCT00618995|558132|P1|STARTED|Period 2||6
231918|NCT00618995|558129|P4|NOT COMPLETED|Period 1||0
231919|NCT00618995|558130|P3|NOT COMPLETED|Period 1||2
231920|NCT00618995|558131|P2|NOT COMPLETED|Period 1||1
231921|NCT00618995|558132|P1|NOT COMPLETED|Period 1||0
231922|NCT00618995|558129|P4|COMPLETED|Period 1||6
231923|NCT00618995|558130|P3|COMPLETED|Period 1||5
231924|NCT00618995|558131|P2|COMPLETED|Period 1||6
231925|NCT00618995|558132|P1|COMPLETED|Period 1||6
231926|NCT00618995|558129|P4|STARTED|Period 1||6
231927|NCT00618995|558130|P3|STARTED|Period 1||7
231928|NCT00618995|558131|P2|STARTED|Period 1||7
231929|NCT00618995|558132|P1|STARTED|Period 1||6
231930|NCT00618982|558146|P1|NOT COMPLETED|Overall Study||50
231931|NCT00618982|558146|P1|COMPLETED|Overall Study||33
231932|NCT00618982|558146|P1|STARTED|Overall Study||83
231933|NCT00618956|558169|P2|NOT COMPLETED|Overall Study||50
231934|NCT00618956|558170|P1|NOT COMPLETED|Overall Study||25
231935|NCT00618956|558169|P2|COMPLETED|Overall Study||160
231936|NCT00618956|558170|P1|COMPLETED|Overall Study||86
231937|NCT00618956|558169|P2|STARTED|Overall Study||210
231938|NCT00618956|558170|P1|STARTED|Overall Study||111
231939|NCT00618839|558186|P1|NOT COMPLETED|Overall Study||0
231940|NCT00618839|558186|P1|COMPLETED|Overall Study||15
231941|NCT00618839|558186|P1|STARTED|Overall Study||15
231942|NCT00618826|558195|P1|NOT COMPLETED|Overall Study||1
231943|NCT00618826|558195|P1|COMPLETED|Overall Study||13
231944|NCT00618826|558195|P1|STARTED|Overall Study||14
231945|NCT00618813|558200|P1|NOT COMPLETED|Overall Study||4
231946|NCT00618813|558200|P1|COMPLETED|Overall Study||31
231947|NCT00618813|558200|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
231948|NCT00618813|558200|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
231949|NCT00618813|558200|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
231950|NCT00618813|558200|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
231951|NCT00618813|558200|P1|STARTED|Overall Study||35
231952|NCT00618787|558210|P2|NOT COMPLETED|Overall Study||2
231953|NCT00618787|558211|P1|NOT COMPLETED|Overall Study||3
231954|NCT00618787|558210|P2|COMPLETED|Overall Study||21
231955|NCT00618787|558211|P1|COMPLETED|Overall Study||19
231956|NCT00618787|558210|P2|STARTED|Overall Study||23
231957|NCT00618787|558211|P1|STARTED|Overall Study||22
231958|NCT00618774|558219|P2|NOT COMPLETED|Overall Study||3
231959|NCT00618774|558220|P1|NOT COMPLETED|Overall Study||6
231960|NCT00618774|558219|P2|COMPLETED|Overall Study||45
231961|NCT00618774|558220|P1|COMPLETED|Overall Study||205
231962|NCT00618774|558219|P2|STARTED|Overall Study||48
231963|NCT00618774|558220|P1|STARTED|Overall Study||211
231964|NCT00618748|558253|P3|NOT COMPLETED|Overall Study||14
231965|NCT00618748|558254|P2|NOT COMPLETED|Overall Study||5
231966|NCT00618748|558255|P1|NOT COMPLETED|Overall Study||11
231967|NCT00618748|558253|P3|COMPLETED|Overall Study||6
231968|NCT00618748|558254|P2|COMPLETED|Overall Study||20
231969|NCT00618748|558255|P1|COMPLETED|Overall Study||45
231970|NCT00618748|558253|P3|STARTED|Overall Study||20
231971|NCT00618748|558254|P2|STARTED|Overall Study||25
231972|NCT00618748|558255|P1|STARTED|Overall Study||56
231973|NCT00618722|558300|P4|NOT COMPLETED|Overall Study||4
231974|NCT00618722|558301|P3|NOT COMPLETED|Overall Study||3
231975|NCT00618722|558302|P2|NOT COMPLETED|Overall Study||2
231976|NCT00618722|558303|P1|NOT COMPLETED|Overall Study||3
231977|NCT00618722|558300|P4|COMPLETED|Overall Study||18
231978|NCT00618722|558301|P3|COMPLETED|Overall Study||19
231979|NCT00618722|558302|P2|COMPLETED|Overall Study||18
231980|NCT00618722|558303|P1|COMPLETED|Overall Study||18
231981|NCT00618722|558300|P4|Received Treatment|Overall Study||22
231982|NCT00618722|558301|P3|Received Treatment|Overall Study||22
231983|NCT00618722|558302|P2|Received Treatment|Overall Study||20
231984|NCT00618722|558303|P1|Received Treatment|Overall Study||20
231985|NCT00618722|558300|P4|STARTED|Overall Study||22
231986|NCT00618722|558301|P3|STARTED|Overall Study||22
231987|NCT00618722|558302|P2|STARTED|Overall Study||20
231988|NCT00618722|558303|P1|STARTED|Overall Study||21
231989|NCT00618618|558341|P4|NOT COMPLETED|Overall Study||1
231990|NCT00618618|558342|P3|NOT COMPLETED|Overall Study||3
231991|NCT00618618|558343|P2|NOT COMPLETED|Overall Study||3
231992|NCT00618618|558344|P1|NOT COMPLETED|Overall Study||4
231993|NCT00618618|558341|P4|COMPLETED|Overall Study||13
231994|NCT00618618|558342|P3|COMPLETED|Overall Study||18
231995|NCT00618618|558343|P2|COMPLETED|Overall Study||11
231996|NCT00618618|558344|P1|COMPLETED|Overall Study||20
231997|NCT00618618|558341|P4|Received Treatment|Overall Study||14
231998|NCT00618618|558342|P3|Received Treatment|Overall Study||20
231999|NCT00618618|558343|P2|Received Treatment|Overall Study||13
232000|NCT00618618|558344|P1|Received Treatment|Overall Study||24
232001|NCT00618618|558341|P4|STARTED|Overall Study||14
232002|NCT00618618|558342|P3|STARTED|Overall Study||21
232003|NCT00618618|558343|P2|STARTED|Overall Study||14
232004|NCT00618618|558344|P1|STARTED|Overall Study||24
232005|NCT00618540|558390|P1|NOT COMPLETED|Overall Study||0
232006|NCT00618540|558390|P1|COMPLETED|Overall Study||1
232007|NCT00618540|558390|P1|STARTED|Overall Study||1
232008|NCT00618514|558403|P3|NOT COMPLETED|Overall Study||4
232009|NCT00618514|558404|P2|NOT COMPLETED|Overall Study||12
232010|NCT00618514|558405|P1|NOT COMPLETED|Overall Study||11
232011|NCT00618514|558403|P3|COMPLETED|Overall Study||12
232012|NCT00618514|558404|P2|COMPLETED|Overall Study||26
232013|NCT00618514|558405|P1|COMPLETED|Overall Study||25
232014|NCT00618514|558403|P3|STARTED|Overall Study||16
232015|NCT00618514|558404|P2|STARTED|Overall Study||38
232016|NCT00618514|558405|P1|STARTED|Overall Study||36
232017|NCT00618449|558425|P2|NOT COMPLETED|Overall Study||110
232018|NCT00618449|558426|P1|NOT COMPLETED|Overall Study||98
232019|NCT00618449|558425|P2|COMPLETED|Overall Study||558
232020|NCT00618449|558426|P1|COMPLETED|Overall Study||581
232021|NCT00618449|558425|P2|1-year, Post-treatment|Overall Study||558
232022|NCT00618449|558426|P1|1-year, Post-treatment|Overall Study||581
232023|NCT00618449|558425|P2|1-month, Post-treatment|Overall Study||656
232024|NCT00618449|558426|P1|1-month, Post-treatment|Overall Study||666
232025|NCT00618449|558425|P2|STARTED|Overall Study||668
232026|NCT00618449|558426|P1|STARTED|Overall Study||679
232027|NCT00618436|558434|P2|NOT COMPLETED|Overall Study||0
232028|NCT00618436|558435|P1|NOT COMPLETED|Overall Study||0
232029|NCT00618436|558434|P2|COMPLETED|Overall Study||18
232030|NCT00618436|558435|P1|COMPLETED|Overall Study||34
232031|NCT00618436|558434|P2|STARTED|Overall Study||18
232032|NCT00618436|558435|P1|STARTED|Overall Study||34
232033|NCT00618410|558445|P2|NOT COMPLETED|Second Intervention||0
232034|NCT00618410|558446|P1|NOT COMPLETED|Second Intervention||0
232035|NCT00618410|558445|P2|COMPLETED|Second Intervention||5
232036|NCT00618410|558446|P1|COMPLETED|Second Intervention||7
232037|NCT00618410|558445|P2|STARTED|Second Intervention||5
232038|NCT00618410|558446|P1|STARTED|Second Intervention||7
232039|NCT00618410|558445|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
232040|NCT00618410|558446|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
232041|NCT00618410|558445|P2|COMPLETED|Washout Period (2 Weeks)||5
232042|NCT00618410|558446|P1|COMPLETED|Washout Period (2 Weeks)||7
232043|NCT00618410|558445|P2|STARTED|Washout Period (2 Weeks)||6
232044|NCT00618410|558446|P1|STARTED|Washout Period (2 Weeks)||7
232045|NCT00618410|558445|P2|NOT COMPLETED|First Intervention||0
232046|NCT00618410|558446|P1|NOT COMPLETED|First Intervention||0
232047|NCT00618410|558445|P2|COMPLETED|First Intervention||6
232048|NCT00618410|558446|P1|COMPLETED|First Intervention||7
232049|NCT00618410|558445|P2|STARTED|First Intervention||6
232050|NCT00618410|558446|P1|STARTED|First Intervention||7
232051|NCT00618371|558462|P1|NOT COMPLETED|Overall Study||2
232052|NCT00618371|558462|P1|COMPLETED|Overall Study||10
232053|NCT00618371|558462|P1|STARTED|Overall Study||12
232054|NCT00618332|558469|P2|NOT COMPLETED|Overall Study||0
232055|NCT00618332|558470|P1|NOT COMPLETED|Overall Study||0
232056|NCT00618332|558469|P2|COMPLETED|Overall Study||20
232057|NCT00618332|558470|P1|COMPLETED|Overall Study||20
232058|NCT00618332|558469|P2|STARTED|Overall Study||20
232059|NCT00618332|558470|P1|STARTED|Overall Study||20
232060|NCT00618072|558495|P3|NOT COMPLETED|Overall Study||4
232061|NCT00618072|558496|P2|NOT COMPLETED|Overall Study||1
232062|NCT00618072|558497|P1|NOT COMPLETED|Overall Study||2
232063|NCT00618072|558495|P3|COMPLETED|Overall Study||11
232064|NCT00618072|558496|P2|COMPLETED|Overall Study||14
232065|NCT00618072|558497|P1|COMPLETED|Overall Study||14
232066|NCT00618072|558495|P3|STARTED|Overall Study||15
232067|NCT00618072|558496|P2|STARTED|Overall Study||15
232068|NCT00618072|558497|P1|STARTED|Overall Study||16
232069|NCT00617981|558531|P2|NOT COMPLETED|Overall Study||102
232070|NCT00617981|558532|P1|NOT COMPLETED|Overall Study||110
232071|NCT00617981|558531|P2|COMPLETED|Overall Study||245
232072|NCT00617981|558532|P1|COMPLETED|Overall Study||244
232073|NCT00617981|558531|P2|STARTED|Overall Study||347
232074|NCT00617981|558532|P1|STARTED|Overall Study||354
232075|NCT00617942|558540|P2|NOT COMPLETED|Overall Study||4
232076|NCT00617942|558541|P1|NOT COMPLETED|Overall Study||8
232077|NCT00617942|558540|P2|COMPLETED|Overall Study||19
232078|NCT00617942|558541|P1|COMPLETED|Overall Study||29
232079|NCT00617942|558540|P2|STARTED|Overall Study||23
232080|NCT00617942|558541|P1|STARTED|Overall Study||37
232081|NCT00617929|558553|P1|NOT COMPLETED|Overall Study||1
232082|NCT00617929|558553|P1|COMPLETED|Overall Study||11
232083|NCT00617929|558553|P1|STARTED|Overall Study||12
232084|NCT00617903|558565|P2|NOT COMPLETED|Overall Study||7
232085|NCT00617903|558566|P1|NOT COMPLETED|Overall Study||3
232086|NCT00617903|558565|P2|COMPLETED|Overall Study||35
232087|NCT00617903|558566|P1|COMPLETED|Overall Study||38
232088|NCT00617903|558565|P2|STARTED|Overall Study||42
232089|NCT00617903|558566|P1|STARTED|Overall Study||41
232090|NCT00617890|558612|P4|NOT COMPLETED|Overall Study||115
232091|NCT00617890|558613|P3|NOT COMPLETED|Overall Study||35
232092|NCT00617890|558614|P2|NOT COMPLETED|Overall Study||28
232093|NCT00617890|558615|P1|NOT COMPLETED|Overall Study||31
232094|NCT00617890|558612|P4|COMPLETED|Overall Study||1
232095|NCT00617890|558613|P3|COMPLETED|Overall Study||0
232096|NCT00617890|558614|P2|COMPLETED|Overall Study||5
232097|NCT00617890|558615|P1|COMPLETED|Overall Study||4
232098|NCT00617890|558612|P4|Received Treatment|Overall Study||115
232099|NCT00617890|558613|P3|Received Treatment|Overall Study||34
232100|NCT00617890|558614|P2|Received Treatment|Overall Study||33
232101|NCT00617890|558615|P1|Received Treatment|Overall Study||34
232102|NCT00617890|558612|P4|STARTED|Overall Study||116
232103|NCT00617890|558613|P3|STARTED|Overall Study||35
232104|NCT00617890|558614|P2|STARTED|Overall Study||33
232105|NCT00617890|558615|P1|STARTED|Overall Study||35
232106|NCT00617851|558651|P4|NOT COMPLETED|Overall Study||25
232107|NCT00617851|558652|P3|NOT COMPLETED|Overall Study||45
232108|NCT00617851|558653|P2|NOT COMPLETED|Overall Study||40
232109|NCT00617851|558654|P1|NOT COMPLETED|Overall Study||47
232110|NCT00617851|558651|P4|COMPLETED|Overall Study||192
232111|NCT00617851|558652|P3|COMPLETED|Overall Study||384
232112|NCT00617851|558653|P2|COMPLETED|Overall Study||391
232113|NCT00617851|558654|P1|COMPLETED|Overall Study||383
232114|NCT00617851|558651|P4|STARTED|Overall Study||217
232115|NCT00617851|558652|P3|STARTED|Overall Study||429
232116|NCT00617851|558653|P2|STARTED|Overall Study||431
232117|NCT00617851|558654|P1|STARTED|Overall Study||430
232118|NCT00617773|558692|P1|NOT COMPLETED|Overall Study||24
232119|NCT00617773|558692|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
232120|NCT00617773|558692|P1|STARTED|Overall Study||31
232121|NCT00617734|558709|P2|NOT COMPLETED|Overall Study||6
232122|NCT00617734|558710|P1|NOT COMPLETED|Overall Study||8
232123|NCT00617734|558709|P2|COMPLETED|Overall Study||42
232124|NCT00617734|558710|P1|COMPLETED|Overall Study||41
232125|NCT00617734|558709|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
232126|NCT00617734|558710|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
232127|NCT00617734|558709|P2|STARTED|Overall Study||48
232128|NCT00617734|558710|P1|STARTED|Overall Study||49
232129|NCT00617708|558731|P3|NOT COMPLETED|Overall Study||64
232130|NCT00617708|558732|P2|NOT COMPLETED|Overall Study||60
232131|NCT00617708|558733|P1|NOT COMPLETED|Overall Study||10
232132|NCT00617708|558731|P3|COMPLETED|Overall Study||0
232133|NCT00617708|558732|P2|COMPLETED|Overall Study||0
232134|NCT00617708|558733|P1|COMPLETED|Overall Study||0
232135|NCT00617708|558731|P3|Eligible and Began Protocol Therapy|Overall Study||59
232136|NCT00617708|558732|P2|Eligible and Began Protocol Therapy|Overall Study||57
232137|NCT00617708|558733|P1|Eligible and Began Protocol Therapy|Overall Study||9
232138|NCT00617708|558731|P3|STARTED|Overall Study||64
232139|NCT00617708|558732|P2|STARTED|Overall Study||60
232140|NCT00617708|558733|P1|STARTED|Overall Study||10
232141|NCT00617669|558750|P2|NOT COMPLETED|Overall Study||451
232142|NCT00617669|558751|P1|NOT COMPLETED|Overall Study||430
232143|NCT00617669|558750|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
232144|NCT00617669|558751|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
232145|NCT00617669|558750|P2|Patients Who Received IP|Overall Study||525
232146|NCT00617669|558751|P1|Patients Who Received IP|Overall Study||522
232147|NCT00617669|558750|P2|STARTED|Overall Study||528
232148|NCT00617669|558751|P1|STARTED|Overall Study||524
232149|NCT00617604|558773|P2|NOT COMPLETED|Overall Study||20
232150|NCT00617604|558774|P1|NOT COMPLETED|Overall Study||18
232151|NCT00617604|558773|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
232152|NCT00617604|558774|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
232153|NCT00617604|558773|P2|Completed 12 Weeks of Treatment|Overall Study||83
232154|NCT00617604|558774|P1|Completed 12 Weeks of Treatment|Overall Study||89
232155|NCT00617604|558773|P2|Received Treatment|Overall Study||105
232156|NCT00617604|558774|P1|Received Treatment|Overall Study||107
232157|NCT00617604|558773|P2|STARTED|Overall Study||108
232158|NCT00617604|558774|P1|STARTED|Overall Study||110
232159|NCT00617591|558818|P1|NOT COMPLETED|Overall Study||10
232160|NCT00617591|558818|P1|COMPLETED|Overall Study||47
232161|NCT00617591|558818|P1|STARTED|Overall Study||57
232162|NCT00617539|558826|P1|NOT COMPLETED|Overall Study||0
232163|NCT00617539|558826|P1|COMPLETED|Overall Study||30
232164|NCT00617539|558826|P1|STARTED|Overall Study||30
232165|NCT00617461|558834|P2|NOT COMPLETED|6-Day Down-Titration Period||2
232166|NCT00617461|558835|P1|NOT COMPLETED|6-Day Down-Titration Period||2
232167|NCT00617461|558834|P2|COMPLETED|6-Day Down-Titration Period||35
232168|NCT00617461|558835|P1|COMPLETED|6-Day Down-Titration Period||39
232169|NCT00617461|558834|P2|STARTED|6-Day Down-Titration Period||37
232170|NCT00617461|558835|P1|STARTED|6-Day Down-Titration Period||41
232171|NCT00617461|558834|P2|NOT COMPLETED|Second Treatment Intervention Period||4
232172|NCT00617461|558835|P1|NOT COMPLETED|Second Treatment Intervention Period||0
232173|NCT00617461|558834|P2|COMPLETED|Second Treatment Intervention Period||37
232174|NCT00617461|558835|P1|COMPLETED|Second Treatment Intervention Period||41
232175|NCT00617461|558834|P2|STARTED|Second Treatment Intervention Period||41
232176|NCT00617461|558835|P1|STARTED|Second Treatment Intervention Period||41
232177|NCT00617461|558834|P2|NOT COMPLETED|4-Day Crossover Period||0
232178|NCT00617461|558835|P1|NOT COMPLETED|4-Day Crossover Period||1
232179|NCT00617461|558834|P2|COMPLETED|4-Day Crossover Period||40
232180|NCT00617461|558835|P1|COMPLETED|4-Day Crossover Period||41
232269|NCT00617058|559130|P3|NOT COMPLETED|Overall Study||0
232181|NCT00617461|558834|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
232182|NCT00617461|558835|P1|STARTED|4-Day Crossover Period||42
232183|NCT00617461|558834|P2|NOT COMPLETED|First Treatment Intervention Period||3
232184|NCT00617461|558835|P1|NOT COMPLETED|First Treatment Intervention Period||10
232185|NCT00617461|558834|P2|COMPLETED|First Treatment Intervention Period||41
232186|NCT00617461|558835|P1|COMPLETED|First Treatment Intervention Period||42
232187|NCT00617461|558834|P2|STARTED|First Treatment Intervention Period||44
232188|NCT00617461|558835|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
232189|NCT00617409|558891|P3|NOT COMPLETED|Overall Study||27
232190|NCT00617409|558892|P2|NOT COMPLETED|Overall Study||18
232191|NCT00617409|558893|P1|NOT COMPLETED|Overall Study||16
232192|NCT00617409|558891|P3|COMPLETED|Overall Study||4
232193|NCT00617409|558892|P2|COMPLETED|Overall Study||2
232194|NCT00617409|558893|P1|COMPLETED|Overall Study||2
232195|NCT00617409|558891|P3|STARTED|Overall Study||31
232196|NCT00617409|558892|P2|STARTED|Overall Study||20
232197|NCT00617409|558893|P1|STARTED|Overall Study||18
232198|NCT00617396|558904|P1|NOT COMPLETED|Overall Study||0
232199|NCT00617396|558904|P1|COMPLETED|Overall Study||25
232200|NCT00617396|558904|P1|STARTED|Overall Study||25
232201|NCT00617357|558908|P1|NOT COMPLETED|Overall Study||16
232202|NCT00617357|558908|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
232203|NCT00617357|558908|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
232204|NCT00617305|558921|P3|NOT COMPLETED|Overall Study||1
232205|NCT00617305|558922|P2|NOT COMPLETED|Overall Study||0
232206|NCT00617305|558923|P1|NOT COMPLETED|Overall Study||8
232207|NCT00617305|558921|P3|COMPLETED|Overall Study||0
232208|NCT00617305|558922|P2|COMPLETED|Overall Study||4
232209|NCT00617305|558923|P1|COMPLETED|Overall Study||25
232210|NCT00617305|558921|P3|Completed 24-week Primary Analysis|Overall Study||0
232211|NCT00617305|558922|P2|Completed 24-week Primary Analysis|Overall Study||4
232212|NCT00617305|558923|P1|Completed 24-week Primary Analysis|Overall Study||31
232213|NCT00617305|558921|P3|STARTED|Overall Study||1
232214|NCT00617305|558922|P2|STARTED|Overall Study||4
232215|NCT00617305|558923|P1|STARTED|Overall Study||33
232216|NCT00617279|558979|P2|NOT COMPLETED|Overall Study||17
232217|NCT00617279|558980|P1|NOT COMPLETED|Overall Study||14
232218|NCT00617279|558979|P2|COMPLETED|Overall Study||0
232219|NCT00617279|558980|P1|COMPLETED|Overall Study||0
232220|NCT00617279|558979|P2|STARTED|Overall Study||17
232221|NCT00617279|558980|P1|STARTED|Overall Study||14
232222|NCT00617240|559036|P2|NOT COMPLETED|Overall Study||0
232223|NCT00617240|559037|P1|NOT COMPLETED|Overall Study||1
232224|NCT00617240|559036|P2|COMPLETED|Overall Study||4
232225|NCT00617240|559037|P1|COMPLETED|Overall Study||4
232226|NCT00617240|559036|P2|STARTED|Overall Study||4
232227|NCT00617240|559037|P1|STARTED|Overall Study||5
232228|NCT00617201|559057|P2|NOT COMPLETED|Overall Study||13
232229|NCT00617201|559058|P1|NOT COMPLETED|Overall Study||9
232230|NCT00617201|559057|P2|COMPLETED|Overall Study||12
232231|NCT00617201|559058|P1|COMPLETED|Overall Study||16
232232|NCT00617201|559057|P2|STARTED|Overall Study||25
232233|NCT00617201|559058|P1|STARTED|Overall Study||25
232234|NCT00617188|559066|P1|NOT COMPLETED|Overall Study||0
232235|NCT00617188|559066|P1|COMPLETED|Overall Study||26
232236|NCT00617188|559066|P1|STARTED|Overall Study||26
232237|NCT00617175|559077|P2|NOT COMPLETED|Overall Study||0
232238|NCT00617175|559078|P1|NOT COMPLETED|Overall Study||0
232239|NCT00617175|559077|P2|COMPLETED|Overall Study||948
232240|NCT00617175|559078|P1|COMPLETED|Overall Study||954
232241|NCT00617175|559077|P2|STARTED|Overall Study||948
232242|NCT00617175|559078|P1|STARTED|Overall Study||954
232243|NCT00617123|559086|P2|NOT COMPLETED|Study Treatment Period||16
232244|NCT00617123|559087|P1|NOT COMPLETED|Study Treatment Period||17
232245|NCT00617123|559086|P2|COMPLETED|Study Treatment Period||79
232246|NCT00617123|559087|P1|COMPLETED|Study Treatment Period||81
232247|NCT00617123|559086|P2|Treated|Study Treatment Period||95
232248|NCT00617123|559087|P1|Treated|Study Treatment Period|1 participant was not treated|97
232249|NCT00617123|559086|P2|STARTED|Study Treatment Period||95
232250|NCT00617123|559087|P1|STARTED|Study Treatment Period||98
232251|NCT00617123|559086|P2|NOT COMPLETED|Referral Screening Period||26
232252|NCT00617123|559087|P1|NOT COMPLETED|Referral Screening Period||39
232253|NCT00617123|559086|P2|COMPLETED|Referral Screening Period||95
232254|NCT00617123|559087|P1|COMPLETED|Referral Screening Period||98
232255|NCT00617123|559086|P2|STARTED|Referral Screening Period||121
232256|NCT00617123|559087|P1|STARTED|Referral Screening Period||137
232257|NCT00617097|559103|P2|NOT COMPLETED|Overall Study||0
232258|NCT00617097|559104|P1|NOT COMPLETED|Overall Study||0
232259|NCT00617097|559103|P2|COMPLETED|Overall Study||25
232260|NCT00617097|559104|P1|COMPLETED|Overall Study||25
232261|NCT00617097|559103|P2|STARTED|Overall Study||25
232262|NCT00617097|559104|P1|STARTED|Overall Study||25
232263|NCT00617084|559118|P2|NOT COMPLETED|Overall Study||26
232264|NCT00617084|559119|P1|NOT COMPLETED|Overall Study||21
232265|NCT00617084|559118|P2|COMPLETED|Overall Study||1126
232266|NCT00617084|559119|P1|COMPLETED|Overall Study||1119
232267|NCT00617084|559118|P2|STARTED|Overall Study||1152
232268|NCT00617084|559119|P1|STARTED|Overall Study||1140
232270|NCT00617058|559131|P2|NOT COMPLETED|Overall Study||0
232271|NCT00617058|559132|P1|NOT COMPLETED|Overall Study||0
232272|NCT00617058|559130|P3|COMPLETED|Overall Study||0
232273|NCT00617058|559131|P2|COMPLETED|Overall Study||0
232274|NCT00617058|559132|P1|COMPLETED|Overall Study||1
232275|NCT00617058|559130|P3|STARTED|Overall Study||0
232276|NCT00617058|559131|P2|STARTED|Overall Study||0
232277|NCT00617058|559132|P1|STARTED|Overall Study||1
232278|NCT00616967|559172|P3|NOT COMPLETED|Overall Study||1
232279|NCT00616967|559173|P2|NOT COMPLETED|Overall Study||0
232280|NCT00616967|559174|P1|NOT COMPLETED|Overall Study||0
232281|NCT00616967|559172|P3|COMPLETED|Overall Study||30
232282|NCT00616967|559173|P2|COMPLETED|Overall Study||31
232283|NCT00616967|559174|P1|COMPLETED|Overall Study||6
232284|NCT00616967|559172|P3|STARTED|Overall Study||31
232285|NCT00616967|559173|P2|STARTED|Overall Study||31
232286|NCT00616967|559174|P1|STARTED|Overall Study||6
232287|NCT00616928|559187|P4|NOT COMPLETED|Overall Study||7
232288|NCT00616928|559188|P3|NOT COMPLETED|Overall Study||17
232289|NCT00616928|559189|P2|NOT COMPLETED|Overall Study||18
232290|NCT00616928|559190|P1|NOT COMPLETED|Overall Study||62
232291|NCT00616928|559187|P4|COMPLETED|Overall Study||364
232292|NCT00616928|559188|P3|COMPLETED|Overall Study||1101
232293|NCT00616928|559189|P2|COMPLETED|Overall Study||750
232294|NCT00616928|559190|P1|COMPLETED|Overall Study||2242
232295|NCT00616928|559187|P4|STARTED|Overall Study||371
232296|NCT00616928|559188|P3|STARTED|Overall Study||1118
232297|NCT00616928|559189|P2|STARTED|Overall Study||768
232298|NCT00616928|559190|P1|STARTED|Overall Study||2304
232299|NCT00616902|559254|P2|NOT COMPLETED|Overall Study||6
232300|NCT00616902|559255|P1|NOT COMPLETED|Overall Study||6
232301|NCT00616902|559254|P2|COMPLETED|Overall Study||0
232302|NCT00616902|559255|P1|COMPLETED|Overall Study||0
232303|NCT00616902|559254|P2|STARTED|Overall Study||6
232304|NCT00616902|559255|P1|STARTED|Overall Study||6
232305|NCT00616772|559281|P2|NOT COMPLETED|Overall Study||102
232306|NCT00616772|559282|P1|NOT COMPLETED|Overall Study||115
232307|NCT00616772|559281|P2|COMPLETED|Overall Study||240
232308|NCT00616772|559282|P1|COMPLETED|Overall Study||225
232309|NCT00616772|559281|P2|Treated|Overall Study||339
232310|NCT00616772|559282|P1|Treated|Overall Study||337
232311|NCT00616772|559281|P2|STARTED|Overall Study||342
232312|NCT00616772|559282|P1|STARTED|Overall Study||340
232313|NCT00616759|559298|P2|NOT COMPLETED|Overall Study||2
232314|NCT00616759|559299|P1|NOT COMPLETED|Overall Study||3
232315|NCT00616759|559298|P2|COMPLETED|Overall Study||8
232316|NCT00616759|559299|P1|COMPLETED|Overall Study||7
232317|NCT00616759|559298|P2|STARTED|Overall Study||10
232318|NCT00616759|559299|P1|STARTED|Overall Study||10
232319|NCT00616655|559308|P3|NOT COMPLETED|Overall Study||48
232320|NCT00616655|559309|P2|NOT COMPLETED|Overall Study||41
232321|NCT00616655|559310|P1|NOT COMPLETED|Overall Study||35
232322|NCT00616655|559308|P3|COMPLETED|Overall Study||103
232323|NCT00616655|559309|P2|COMPLETED|Overall Study||112
232324|NCT00616655|559310|P1|COMPLETED|Overall Study||117
232325|NCT00616655|559308|P3|STARTED|Overall Study||151
232326|NCT00616655|559309|P2|STARTED|Overall Study||153
232327|NCT00616655|559310|P1|STARTED|Overall Study||152
232328|NCT00616642|559350|P2|NOT COMPLETED|Overall Study||1
232329|NCT00616642|559351|P1|NOT COMPLETED|Overall Study||0
232330|NCT00616642|559350|P2|COMPLETED|Overall Study||0
232331|NCT00616642|559351|P1|COMPLETED|Overall Study||0
232332|NCT00616642|559350|P2|STARTED|Overall Study||1
232333|NCT00616642|559351|P1|STARTED|Overall Study||0
232334|NCT00616629|559362|P5|NOT COMPLETED|Overall Study||0
232335|NCT00616629|559363|P4|NOT COMPLETED|Overall Study||0
232336|NCT00616629|559364|P3|NOT COMPLETED|Overall Study||1
232337|NCT00616629|559365|P2|NOT COMPLETED|Overall Study||2
232338|NCT00616629|559366|P1|NOT COMPLETED|Overall Study||2
232339|NCT00616629|559362|P5|COMPLETED|Overall Study||12
232340|NCT00616629|559363|P4|COMPLETED|Overall Study||2
232341|NCT00616629|559364|P3|COMPLETED|Overall Study||13
232342|NCT00616629|559365|P2|COMPLETED|Overall Study||12
232343|NCT00616629|559366|P1|COMPLETED|Overall Study||11
232344|NCT00616629|559362|P5|STARTED|Overall Study||12
232345|NCT00616629|559363|P4|STARTED|Overall Study||2
232346|NCT00616629|559364|P3|STARTED|Overall Study|One patient never received study drug|14
232347|NCT00616629|559365|P2|STARTED|Overall Study|Two patients never received study drug|14
232348|NCT00616629|559366|P1|STARTED|Overall Study|Two patients never received study drug|13
232349|NCT00616603|559411|P3|NOT COMPLETED|Overall Study||2
232350|NCT00616603|559412|P2|NOT COMPLETED|Overall Study||0
232351|NCT00616603|559413|P1|NOT COMPLETED|Overall Study||2
232352|NCT00616603|559411|P3|COMPLETED|Overall Study||13
232353|NCT00616603|559412|P2|COMPLETED|Overall Study||14
232354|NCT00616603|559413|P1|COMPLETED|Overall Study||12
232355|NCT00616603|559411|P3|STARTED|Overall Study||15
232356|NCT00616603|559412|P2|STARTED|Overall Study||14
232357|NCT00616603|559413|P1|STARTED|Overall Study||14
232358|NCT00616577|559424|P3|NOT COMPLETED|Overall Study||0
232359|NCT00616577|559425|P2|NOT COMPLETED|Overall Study||0
232360|NCT00616577|559426|P1|NOT COMPLETED|Overall Study||0
232361|NCT00616577|559424|P3|COMPLETED|Overall Study||7
232362|NCT00616577|559425|P2|COMPLETED|Overall Study||9
232363|NCT00616577|559426|P1|COMPLETED|Overall Study||6
232364|NCT00616577|559424|P3|STARTED|Overall Study||7
232365|NCT00616577|559425|P2|STARTED|Overall Study||9
232366|NCT00616577|559426|P1|STARTED|Overall Study||6
232367|NCT00616434|559436|P2|NOT COMPLETED|Overall Study||8
232368|NCT00616434|559437|P1|NOT COMPLETED|Overall Study||6
232369|NCT00616434|559436|P2|COMPLETED|Overall Study||53
232370|NCT00616434|559437|P1|COMPLETED|Overall Study||56
232371|NCT00616434|559436|P2|STARTED|Overall Study||61
232372|NCT00616434|559437|P1|STARTED|Overall Study||62
232373|NCT00616421|559450|P3|NOT COMPLETED|Overall Study||41
232374|NCT00616421|559451|P2|NOT COMPLETED|Overall Study||38
232375|NCT00616421|559452|P1|NOT COMPLETED|Overall Study||26
232376|NCT00616421|559450|P3|COMPLETED|Overall Study||1229
232377|NCT00616421|559451|P2|COMPLETED|Overall Study||1240
232378|NCT00616421|559452|P1|COMPLETED|Overall Study||333
232379|NCT00616421|559450|P3|STARTED|Overall Study||1270
232380|NCT00616421|559451|P2|STARTED|Overall Study||1278
232381|NCT00616421|559452|P1|STARTED|Overall Study||359
232382|NCT00616343|559489|P1|NOT COMPLETED|Overall Study||0
232383|NCT00616343|559489|P1|COMPLETED|Overall Study||9
232384|NCT00616343|559489|P1|STARTED|Overall Study||9
232385|NCT00616239|559493|P1|NOT COMPLETED|Overall Study||2
232386|NCT00616239|559493|P1|COMPLETED|Overall Study||18
232387|NCT00616239|559493|P1|STARTED|Overall Study||20
232388|NCT00616200|559497|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
232389|NCT00616200|559497|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
232390|NCT00616200|559497|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
232391|NCT00616200|559497|P1|NOT COMPLETED|Two Week Standard Diet||1
232392|NCT00616200|559497|P1|COMPLETED|Two Week Standard Diet||16
232393|NCT00616200|559497|P1|STARTED|Two Week Standard Diet||17
232394|NCT00616122|559503|P1|NOT COMPLETED|Overall Study||7
232395|NCT00616122|559503|P1|COMPLETED|Overall Study||25
232396|NCT00616122|559503|P1|STARTED|Overall Study||32
232397|NCT00616109|559510|P1|NOT COMPLETED|Overall Study||0
232398|NCT00616109|559510|P1|COMPLETED|Overall Study||16
232399|NCT00616109|559510|P1|STARTED|Overall Study||16
232400|NCT00616018|559517|P1|NOT COMPLETED|Overall Study||3
232401|NCT00616018|559517|P1|COMPLETED|Overall Study||24
232402|NCT00616018|559517|P1|STARTED|Overall Study||27
232403|NCT00615992|559522|P1|NOT COMPLETED|Overall Study||67
232404|NCT00615992|559522|P1|COMPLETED|Overall Study||687
232405|NCT00615992|559522|P1|STARTED|Overall Study||754
232406|NCT00615927|559533|P2|NOT COMPLETED|Overall Study||0
232407|NCT00615927|559534|P1|NOT COMPLETED|Overall Study||0
232408|NCT00615927|559533|P2|COMPLETED|Overall Study||32
232409|NCT00615927|559534|P1|COMPLETED|Overall Study||32
232410|NCT00615927|559533|P2|STARTED|Overall Study||32
232411|NCT00615927|559534|P1|STARTED|Overall Study||32
232412|NCT00615914|559548|P1|NOT COMPLETED|Overall Study||637
232413|NCT00615914|559548|P1|COMPLETED|Overall Study||1008
232414|NCT00615914|559548|P1|STARTED|Overall Study|The number of patients enrolled|1645
232415|NCT00615901|559555|P1|NOT COMPLETED|Overall Study||9
232416|NCT00615901|559555|P1|COMPLETED|Overall Study||29
232417|NCT00615901|559555|P1|STARTED|Overall Study||38
232418|NCT00615836|559563|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
232419|NCT00615836|559564|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
232420|NCT00615836|559565|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
232421|NCT00615836|559566|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
232422|NCT00615836|559567|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
232423|NCT00615836|559563|P5|COMPLETED|Extension Study (FE992026 CS31)||0
232424|NCT00615836|559564|P4|COMPLETED|Extension Study (FE992026 CS31)||53
232425|NCT00615836|559565|P3|COMPLETED|Extension Study (FE992026 CS31)||59
232426|NCT00615836|559566|P2|COMPLETED|Extension Study (FE992026 CS31)||58
232427|NCT00615836|559567|P1|COMPLETED|Extension Study (FE992026 CS31)||0
232428|NCT00615836|559563|P5|STARTED|Extension Study (FE992026 CS31)||0
232429|NCT00615836|559564|P4|STARTED|Extension Study (FE992026 CS31)||137
232430|NCT00615836|559565|P3|STARTED|Extension Study (FE992026 CS31)||132
232431|NCT00615836|559566|P2|STARTED|Extension Study (FE992026 CS31)||144
232432|NCT00615836|559567|P1|STARTED|Extension Study (FE992026 CS31)||141
232433|NCT00615836|559563|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
232434|NCT00615836|559564|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
232435|NCT00615836|559565|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
232436|NCT00615836|559566|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
232437|NCT00615836|559567|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
232438|NCT00615836|559563|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
232439|NCT00615836|559564|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
232440|NCT00615836|559565|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
232441|NCT00615836|559566|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
232442|NCT00615836|559567|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
232443|NCT00615836|559563|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
232444|NCT00615836|559564|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
232445|NCT00615836|559565|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
232446|NCT00615836|559566|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
232539|NCT00615199|559733|P1|COMPLETED|Overall Study||26
232540|NCT00615199|559730|P4|STARTED|Overall Study||35
232447|NCT00615836|559567|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
232448|NCT00615836|559563|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
232449|NCT00615836|559564|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
232450|NCT00615836|559565|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
232451|NCT00615836|559566|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
232452|NCT00615836|559567|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
232453|NCT00615719|559627|P1|NOT COMPLETED|Overall Study||5
232454|NCT00615719|559627|P1|COMPLETED|Overall Study||30
232455|NCT00615719|559627|P1|STARTED|Overall Study||35
232456|NCT00615589|559631|P1|NOT COMPLETED|Overall Study||0
232457|NCT00615589|559631|P1|COMPLETED|Overall Study||22
232458|NCT00615589|559631|P1|STARTED|Overall Study||22
232459|NCT00615550|559641|P2|NOT COMPLETED|Overall Study||1
232460|NCT00615550|559642|P1|NOT COMPLETED|Overall Study||6
232461|NCT00615550|559641|P2|COMPLETED|Overall Study||235
232462|NCT00615550|559642|P1|COMPLETED|Overall Study||223
232463|NCT00615550|559641|P2|STARTED|Overall Study||236
232464|NCT00615550|559642|P1|STARTED|Overall Study||229
232465|NCT00615472|559658|P2|NOT COMPLETED|Overall Study||0
232466|NCT00615472|559659|P1|NOT COMPLETED|Overall Study||0
232467|NCT00615472|559658|P2|COMPLETED|Overall Study||28
232468|NCT00615472|559659|P1|COMPLETED|Overall Study||30
232469|NCT00615472|559658|P2|STARTED|Overall Study||28
232470|NCT00615472|559659|P1|STARTED|Overall Study||30
232471|NCT00615459|559665|P4|NOT COMPLETED|Period III||0
232472|NCT00615459|559666|P3|NOT COMPLETED|Period III||1
232473|NCT00615459|559667|P2|NOT COMPLETED|Period III||3
232474|NCT00615459|559668|P1|NOT COMPLETED|Period III||0
232475|NCT00615459|559665|P4|COMPLETED|Period III||41
232476|NCT00615459|559666|P3|COMPLETED|Period III||39
232477|NCT00615459|559667|P2|COMPLETED|Period III||37
232478|NCT00615459|559668|P1|COMPLETED|Period III||36
232479|NCT00615459|559665|P4|STARTED|Period III||41
232480|NCT00615459|559666|P3|STARTED|Period III||40
232481|NCT00615459|559667|P2|STARTED|Period III||40
232482|NCT00615459|559668|P1|STARTED|Period III||36
232483|NCT00615459|559665|P4|NOT COMPLETED|Period II||1
232484|NCT00615459|559666|P3|NOT COMPLETED|Period II||0
232485|NCT00615459|559667|P2|NOT COMPLETED|Period II||0
232486|NCT00615459|559668|P1|NOT COMPLETED|Period II||1
232487|NCT00615459|559665|P4|COMPLETED|Period II||41
232488|NCT00615459|559666|P3|COMPLETED|Period II||40
232489|NCT00615459|559667|P2|COMPLETED|Period II||40
232490|NCT00615459|559668|P1|COMPLETED|Period II||36
232491|NCT00615459|559665|P4|STARTED|Period II||42
232492|NCT00615459|559666|P3|STARTED|Period II||40
232493|NCT00615459|559667|P2|STARTED|Period II||40
232494|NCT00615459|559668|P1|STARTED|Period II||37
232495|NCT00615459|559665|P4|NOT COMPLETED|Period I||1
232496|NCT00615459|559666|P3|NOT COMPLETED|Period I||2
232497|NCT00615459|559667|P2|NOT COMPLETED|Period I||1
232498|NCT00615459|559668|P1|NOT COMPLETED|Period I||4
232499|NCT00615459|559665|P4|COMPLETED|Period I||42
232500|NCT00615459|559666|P3|COMPLETED|Period I||40
232501|NCT00615459|559667|P2|COMPLETED|Period I||40
232502|NCT00615459|559668|P1|COMPLETED|Period I||37
232503|NCT00615459|559665|P4|STARTED|Period I||43
232504|NCT00615459|559666|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
232505|NCT00615459|559667|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
232506|NCT00615459|559668|P1|STARTED|Period I||41
232507|NCT00615433|559686|P4|NOT COMPLETED|Overall Study||45
232508|NCT00615433|559687|P3|NOT COMPLETED|Overall Study||39
232509|NCT00615433|559688|P2|NOT COMPLETED|Overall Study||53
232510|NCT00615433|559689|P1|NOT COMPLETED|Overall Study||43
232511|NCT00615433|559686|P4|COMPLETED|Overall Study||71
232512|NCT00615433|559687|P3|COMPLETED|Overall Study||84
232513|NCT00615433|559688|P2|COMPLETED|Overall Study||66
232514|NCT00615433|559689|P1|COMPLETED|Overall Study||77
232515|NCT00615433|559686|P4|STARTED|Overall Study||116
232516|NCT00615433|559687|P3|STARTED|Overall Study||123
232517|NCT00615433|559688|P2|STARTED|Overall Study||119
232518|NCT00615433|559689|P1|STARTED|Overall Study||120
232519|NCT00615290|559703|P1|NOT COMPLETED|Overall Study||8
232520|NCT00615290|559703|P1|COMPLETED|Overall Study||34
232521|NCT00615290|559703|P1|STARTED|Overall Study||42
232522|NCT00615264|559717|P2|NOT COMPLETED|Overall Study||52
232523|NCT00615264|559718|P1|NOT COMPLETED|Overall Study||50
232524|NCT00615264|559717|P2|COMPLETED|Overall Study||180
232525|NCT00615264|559718|P1|COMPLETED|Overall Study||175
232526|NCT00615264|559717|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
232527|NCT00615264|559718|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
232528|NCT00615264|559717|P2|Received at Least One Dose (ITT)|Overall Study||231
232529|NCT00615264|559718|P1|Received at Least One Dose (ITT)|Overall Study||225
232530|NCT00615264|559717|P2|STARTED|Overall Study||232
232531|NCT00615264|559718|P1|STARTED|Overall Study||225
232532|NCT00615199|559730|P4|NOT COMPLETED|Overall Study||2
232533|NCT00615199|559731|P3|NOT COMPLETED|Overall Study||1
232534|NCT00615199|559732|P2|NOT COMPLETED|Overall Study||2
232535|NCT00615199|559733|P1|NOT COMPLETED|Overall Study||8
232536|NCT00615199|559730|P4|COMPLETED|Overall Study||33
232537|NCT00615199|559731|P3|COMPLETED|Overall Study||33
232538|NCT00615199|559732|P2|COMPLETED|Overall Study||34
232541|NCT00615199|559731|P3|STARTED|Overall Study||34
232542|NCT00615199|559732|P2|STARTED|Overall Study||36
232543|NCT00615199|559733|P1|STARTED|Overall Study||34
232544|NCT00615108|559767|P1|NOT COMPLETED|Overall Study||507
232545|NCT00615108|559767|P1|COMPLETED|Overall Study||2641
232546|NCT00615108|559767|P1|STARTED|Overall Study||3148
232547|NCT00615069|559782|P1|NOT COMPLETED|Overall Study||16
232548|NCT00615069|559782|P1|COMPLETED|Overall Study||19
232549|NCT00615069|559782|P1|STARTED|Overall Study||35
232550|NCT00615056|559791|P4|NOT COMPLETED|Overall Study||35
232551|NCT00615056|559792|P3|NOT COMPLETED|Overall Study||36
232552|NCT00615056|559793|P2|NOT COMPLETED|Overall Study||51
232553|NCT00615056|559794|P1|NOT COMPLETED|Overall Study||49
232554|NCT00615056|559791|P4|COMPLETED|Overall Study||0
232555|NCT00615056|559792|P3|COMPLETED|Overall Study||0
232556|NCT00615056|559793|P2|COMPLETED|Overall Study||0
232557|NCT00615056|559794|P1|COMPLETED|Overall Study||0
232558|NCT00615056|559791|P4|Treated|Overall Study||35
232559|NCT00615056|559792|P3|Treated|Overall Study||36
232560|NCT00615056|559793|P2|Treated|Overall Study||51
232561|NCT00615056|559794|P1|Treated|Overall Study||46
232562|NCT00615056|559791|P4|STARTED|Overall Study||35
232563|NCT00615056|559792|P3|STARTED|Overall Study||36
232564|NCT00615056|559793|P2|STARTED|Overall Study||51
232565|NCT00615056|559794|P1|STARTED|Overall Study||49
232566|NCT00615030|559824|P12|NOT COMPLETED|Period III||0
232567|NCT00615030|559825|P11|NOT COMPLETED|Period III||0
232568|NCT00615030|559826|P10|NOT COMPLETED|Period III||0
232569|NCT00615030|559827|P9|NOT COMPLETED|Period III||0
232570|NCT00615030|559828|P8|NOT COMPLETED|Period III||0
232571|NCT00615030|559829|P7|NOT COMPLETED|Period III||0
232572|NCT00615030|559830|P6|NOT COMPLETED|Period III||0
232573|NCT00615030|559831|P5|NOT COMPLETED|Period III||0
232574|NCT00615030|559832|P4|NOT COMPLETED|Period III||1
232575|NCT00615030|559833|P3|NOT COMPLETED|Period III||0
232576|NCT00615030|559834|P2|NOT COMPLETED|Period III||0
232577|NCT00615030|559835|P1|NOT COMPLETED|Period III||1
232578|NCT00615030|559824|P12|COMPLETED|Period III||6
232579|NCT00615030|559825|P11|COMPLETED|Period III||7
232580|NCT00615030|559826|P10|COMPLETED|Period III||8
232581|NCT00615030|559827|P9|COMPLETED|Period III||7
232582|NCT00615030|559828|P8|COMPLETED|Period III||7
232583|NCT00615030|559829|P7|COMPLETED|Period III||6
232584|NCT00615030|559830|P6|COMPLETED|Period III||5
232585|NCT00615030|559831|P5|COMPLETED|Period III||8
232586|NCT00615030|559832|P4|COMPLETED|Period III||6
232587|NCT00615030|559833|P3|COMPLETED|Period III||8
232588|NCT00615030|559834|P2|COMPLETED|Period III||8
232589|NCT00615030|559835|P1|COMPLETED|Period III||7
232590|NCT00615030|559824|P12|STARTED|Period III||6
232591|NCT00615030|559825|P11|STARTED|Period III||7
232592|NCT00615030|559826|P10|STARTED|Period III||8
232593|NCT00615030|559827|P9|STARTED|Period III||7
232594|NCT00615030|559828|P8|STARTED|Period III||7
232595|NCT00615030|559829|P7|STARTED|Period III||6
232596|NCT00615030|559830|P6|STARTED|Period III||5
232597|NCT00615030|559831|P5|STARTED|Period III||8
232598|NCT00615030|559832|P4|STARTED|Period III||7
232599|NCT00615030|559833|P3|STARTED|Period III||8
232600|NCT00615030|559834|P2|STARTED|Period III||8
232601|NCT00615030|559835|P1|STARTED|Period III||8
232602|NCT00615030|559824|P12|NOT COMPLETED|Period II||0
232603|NCT00615030|559825|P11|NOT COMPLETED|Period II||0
232604|NCT00615030|559826|P10|NOT COMPLETED|Period II||0
232605|NCT00615030|559827|P9|NOT COMPLETED|Period II||1
232606|NCT00615030|559828|P8|NOT COMPLETED|Period II||0
232607|NCT00615030|559829|P7|NOT COMPLETED|Period II||1
232608|NCT00615030|559830|P6|NOT COMPLETED|Period II||0
232609|NCT00615030|559831|P5|NOT COMPLETED|Period II||0
232610|NCT00615030|559832|P4|NOT COMPLETED|Period II||1
232611|NCT00615030|559833|P3|NOT COMPLETED|Period II||1
232612|NCT00615030|559834|P2|NOT COMPLETED|Period II||0
232613|NCT00615030|559835|P1|NOT COMPLETED|Period II||0
232614|NCT00615030|559824|P12|COMPLETED|Period II||6
232615|NCT00615030|559825|P11|COMPLETED|Period II||7
232616|NCT00615030|559826|P10|COMPLETED|Period II||8
232617|NCT00615030|559827|P9|COMPLETED|Period II||7
232618|NCT00615030|559828|P8|COMPLETED|Period II||7
232619|NCT00615030|559829|P7|COMPLETED|Period II||6
232620|NCT00615030|559830|P6|COMPLETED|Period II||5
232621|NCT00615030|559831|P5|COMPLETED|Period II||8
232622|NCT00615030|559832|P4|COMPLETED|Period II||7
232623|NCT00615030|559833|P3|COMPLETED|Period II||8
232624|NCT00615030|559834|P2|COMPLETED|Period II||8
232625|NCT00615030|559835|P1|COMPLETED|Period II||8
232626|NCT00615030|559824|P12|STARTED|Period II||6
232627|NCT00615030|559825|P11|STARTED|Period II||7
232628|NCT00615030|559826|P10|STARTED|Period II||8
232629|NCT00615030|559827|P9|STARTED|Period II||8
232630|NCT00615030|559828|P8|STARTED|Period II||7
232631|NCT00615030|559829|P7|STARTED|Period II||7
232632|NCT00615030|559830|P6|STARTED|Period II||5
232633|NCT00615030|559831|P5|STARTED|Period II||8
232634|NCT00615030|559832|P4|STARTED|Period II||8
232635|NCT00615030|559833|P3|STARTED|Period II||9
232636|NCT00615030|559834|P2|STARTED|Period II||8
232637|NCT00615030|559835|P1|STARTED|Period II||8
232638|NCT00615030|559824|P12|NOT COMPLETED|Period I||1
232639|NCT00615030|559825|P11|NOT COMPLETED|Period I||1
232640|NCT00615030|559826|P10|NOT COMPLETED|Period I||0
232641|NCT00615030|559827|P9|NOT COMPLETED|Period I||1
232642|NCT00615030|559828|P8|NOT COMPLETED|Period I||0
232643|NCT00615030|559829|P7|NOT COMPLETED|Period I||0
232644|NCT00615030|559830|P6|NOT COMPLETED|Period I||1
232645|NCT00615030|559831|P5|NOT COMPLETED|Period I||1
232646|NCT00615030|559832|P4|NOT COMPLETED|Period I||0
232647|NCT00615030|559833|P3|NOT COMPLETED|Period I||0
232648|NCT00615030|559834|P2|NOT COMPLETED|Period I||0
232649|NCT00615030|559835|P1|NOT COMPLETED|Period I||1
232650|NCT00615030|559824|P12|COMPLETED|Period I||6
232651|NCT00615030|559825|P11|COMPLETED|Period I||7
232652|NCT00615030|559826|P10|COMPLETED|Period I||8
232653|NCT00615030|559827|P9|COMPLETED|Period I||8
232654|NCT00615030|559828|P8|COMPLETED|Period I||7
232655|NCT00615030|559829|P7|COMPLETED|Period I||7
232656|NCT00615030|559830|P6|COMPLETED|Period I||5
232657|NCT00615030|559831|P5|COMPLETED|Period I||8
232658|NCT00615030|559832|P4|COMPLETED|Period I||8
232659|NCT00615030|559833|P3|COMPLETED|Period I||9
232660|NCT00615030|559834|P2|COMPLETED|Period I||8
232661|NCT00615030|559835|P1|COMPLETED|Period I||8
232662|NCT00615030|559824|P12|STARTED|Period I||7
232663|NCT00615030|559825|P11|STARTED|Period I||8
232664|NCT00615030|559826|P10|STARTED|Period I||8
232665|NCT00615030|559827|P9|STARTED|Period I||9
232666|NCT00615030|559828|P8|STARTED|Period I||7
232667|NCT00615030|559829|P7|STARTED|Period I||7
232668|NCT00615030|559830|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
232669|NCT00615030|559831|P5|STARTED|Period I||9
232670|NCT00615030|559832|P4|STARTED|Period I||8
232671|NCT00615030|559833|P3|STARTED|Period I||9
232672|NCT00615030|559834|P2|STARTED|Period I||8
232673|NCT00615030|559835|P1|STARTED|Period I||9
232674|NCT00615017|559855|P6|NOT COMPLETED|Overall Study||3
232675|NCT00615017|559856|P5|NOT COMPLETED|Overall Study||1
232676|NCT00615017|559857|P4|NOT COMPLETED|Overall Study||1
232677|NCT00615017|559858|P3|NOT COMPLETED|Overall Study||5
232678|NCT00615017|559859|P2|NOT COMPLETED|Overall Study||1
232679|NCT00615017|559860|P1|NOT COMPLETED|Overall Study||0
232680|NCT00615017|559855|P6|COMPLETED|Overall Study|Patient completed the study drug|20
232681|NCT00615017|559856|P5|COMPLETED|Overall Study|Patient completed the study drug|7
232682|NCT00615017|559857|P4|COMPLETED|Overall Study|Patient completed the study drug|9
232683|NCT00615017|559858|P3|COMPLETED|Overall Study|Patient completed the study drug|7
232684|NCT00615017|559859|P2|COMPLETED|Overall Study|Patient completed the study drug|8
232685|NCT00615017|559860|P1|COMPLETED|Overall Study|Patient completed the study drug|8
232686|NCT00615017|559855|P6|STARTED|Overall Study|Patients received treatment|23
232687|NCT00615017|559856|P5|STARTED|Overall Study|Patients received treatment|8
232688|NCT00615017|559857|P4|STARTED|Overall Study|Patients received treatment|10
232689|NCT00615017|559858|P3|STARTED|Overall Study|Patients received treatment|12
232690|NCT00615017|559859|P2|STARTED|Overall Study|Patients received treatment|9
232691|NCT00615017|559860|P1|STARTED|Overall Study|Patients received treatment|8
232692|NCT00614991|560018|P6|NOT COMPLETED|Overall Study||0
232693|NCT00614991|560019|P5|NOT COMPLETED|Overall Study||1
232694|NCT00614991|560020|P4|NOT COMPLETED|Overall Study||0
232695|NCT00614991|560021|P3|NOT COMPLETED|Overall Study||0
232696|NCT00614991|560022|P2|NOT COMPLETED|Overall Study||3
232697|NCT00614991|560023|P1|NOT COMPLETED|Overall Study||3
232698|NCT00614991|560018|P6|COMPLETED|Overall Study||6
232699|NCT00614991|560019|P5|COMPLETED|Overall Study||6
232700|NCT00614991|560020|P4|COMPLETED|Overall Study||7
232701|NCT00614991|560021|P3|COMPLETED|Overall Study||7
232702|NCT00614991|560022|P2|COMPLETED|Overall Study||6
232703|NCT00614991|560023|P1|COMPLETED|Overall Study||5
232704|NCT00614991|560018|P6|STARTED|Overall Study||6
232705|NCT00614991|560019|P5|STARTED|Overall Study||7
232706|NCT00614991|560020|P4|STARTED|Overall Study||7
232707|NCT00614991|560021|P3|STARTED|Overall Study||7
232708|NCT00614991|560022|P2|STARTED|Overall Study||9
232709|NCT00614991|560023|P1|STARTED|Overall Study||8
232710|NCT00614939|560057|P2|NOT COMPLETED|Overall Study||43
232711|NCT00614939|560058|P1|NOT COMPLETED|Overall Study||35
232712|NCT00614939|560057|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
232713|NCT00614939|560058|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
232714|NCT00614939|560057|P2|STARTED|Overall Study|Randomized and treated|85
232715|NCT00614939|560058|P1|STARTED|Overall Study|Randomized and treated|85
232716|NCT00614926|560092|P2|NOT COMPLETED|Overall Study||0
232717|NCT00614926|560093|P1|NOT COMPLETED|Overall Study||4
232718|NCT00614926|560092|P2|COMPLETED|Overall Study||7
232719|NCT00614926|560093|P1|COMPLETED|Overall Study||21
232720|NCT00614926|560092|P2|STARTED|Overall Study||7
232721|NCT00614926|560093|P1|STARTED|Overall Study||25
232722|NCT00614913|560101|P1|NOT COMPLETED|Overall Study||0
232723|NCT00614913|560101|P1|COMPLETED|Overall Study||76
232724|NCT00614913|560101|P1|STARTED|Overall Study||76
232725|NCT00614874|560106|P1|NOT COMPLETED|Overall Study||2
232726|NCT00614874|560106|P1|COMPLETED|Overall Study||14
232727|NCT00614874|560106|P1|STARTED|Overall Study||16
232728|NCT00614744|560115|P2|NOT COMPLETED|Overall Study||6
232729|NCT00614744|560116|P1|NOT COMPLETED|Overall Study||5
232730|NCT00614744|560115|P2|COMPLETED|Overall Study||79
232731|NCT00614744|560116|P1|COMPLETED|Overall Study||78
232732|NCT00614744|560115|P2|STARTED|Overall Study||85
232733|NCT00614744|560116|P1|STARTED|Overall Study||83
232734|NCT00614614|560142|P5|NOT COMPLETED|Booster Vaccination Phase||13
232735|NCT00614614|560143|P4|NOT COMPLETED|Booster Vaccination Phase||19
232736|NCT00614614|560144|P3|NOT COMPLETED|Booster Vaccination Phase||27
232737|NCT00614614|560145|P2|NOT COMPLETED|Booster Vaccination Phase||6
232738|NCT00614614|560146|P1|NOT COMPLETED|Booster Vaccination Phase||0
232739|NCT00614614|560142|P5|COMPLETED|Booster Vaccination Phase||396
232740|NCT00614614|560143|P4|COMPLETED|Booster Vaccination Phase||210
232741|NCT00614614|560144|P3|COMPLETED|Booster Vaccination Phase||405
232742|NCT00614614|560145|P2|COMPLETED|Booster Vaccination Phase||227
232743|NCT00614614|560146|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
232744|NCT00614614|560142|P5|STARTED|Booster Vaccination Phase||409
232745|NCT00614614|560143|P4|STARTED|Booster Vaccination Phase||229
232746|NCT00614614|560144|P3|STARTED|Booster Vaccination Phase||432
232747|NCT00614614|560145|P2|STARTED|Booster Vaccination Phase||233
232748|NCT00614614|560146|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
232749|NCT00614614|560142|P5|NOT COMPLETED|Primary Vaccination Phase||0
232750|NCT00614614|560143|P4|NOT COMPLETED|Primary Vaccination Phase||0
232751|NCT00614614|560144|P3|NOT COMPLETED|Primary Vaccination Phase||0
232752|NCT00614614|560145|P2|NOT COMPLETED|Primary Vaccination Phase||17
232753|NCT00614614|560146|P1|NOT COMPLETED|Primary Vaccination Phase||90
232754|NCT00614614|560142|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
232755|NCT00614614|560143|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
232756|NCT00614614|560144|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
232757|NCT00614614|560145|P2|COMPLETED|Primary Vaccination Phase||265
232758|NCT00614614|560146|P1|COMPLETED|Primary Vaccination Phase||1182
232759|NCT00614614|560142|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
232760|NCT00614614|560143|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
232761|NCT00614614|560144|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
232762|NCT00614614|560145|P2|STARTED|Primary Vaccination Phase||282
232763|NCT00614614|560146|P1|STARTED|Primary Vaccination Phase||1272
232764|NCT00614575|560269|P1|NOT COMPLETED|Overall Study||228
232765|NCT00614575|560269|P1|COMPLETED|Overall Study||861
232766|NCT00614575|560269|P1|STARTED|Overall Study|The number of patients enrolled.|1089
232767|NCT00614523|560280|P2|NOT COMPLETED|Overall Study||131
232768|NCT00614523|560281|P1|NOT COMPLETED|Overall Study||63
232769|NCT00614523|560280|P2|COMPLETED|Overall Study||36
232770|NCT00614523|560281|P1|COMPLETED|Overall Study||20
232771|NCT00614523|560280|P2|STARTED|Overall Study||167
232772|NCT00614523|560281|P1|STARTED|Overall Study||83
232773|NCT00614484|560305|P1|NOT COMPLETED|Overall Study||0
232774|NCT00614484|560305|P1|COMPLETED|Overall Study||28
232775|NCT00614484|560305|P1|STARTED|Overall Study||28
232776|NCT00614458|560310|P1|NOT COMPLETED|Overall Study||0
232777|NCT00614458|560310|P1|COMPLETED|Overall Study||6
232778|NCT00614458|560310|P1|STARTED|Overall Study||6
232779|NCT00614445|560316|P2|NOT COMPLETED|Overall Study||49
232780|NCT00614445|560317|P1|NOT COMPLETED|Overall Study||28
232781|NCT00614445|560316|P2|COMPLETED|Overall Study||91
232782|NCT00614445|560317|P1|COMPLETED|Overall Study||112
232783|NCT00614445|560316|P2|STARTED|Overall Study||140
232784|NCT00614445|560317|P1|STARTED|Overall Study||140
232785|NCT00614406|560325|P2|NOT COMPLETED|Overall Study||0
232786|NCT00614406|560326|P1|NOT COMPLETED|Overall Study||0
232787|NCT00614406|560325|P2|COMPLETED|Overall Study||4
232788|NCT00614406|560326|P1|COMPLETED|Overall Study||7
232789|NCT00614406|560325|P2|STARTED|Overall Study||4
232790|NCT00614406|560326|P1|STARTED|Overall Study||7
232791|NCT00614393|560337|P5|NOT COMPLETED|Overall Study||180
232792|NCT00614393|560338|P4|NOT COMPLETED|Overall Study||180
232793|NCT00614393|560339|P3|NOT COMPLETED|Overall Study||10
232794|NCT00614393|560340|P2|NOT COMPLETED|Overall Study||8
232795|NCT00614393|560341|P1|NOT COMPLETED|Overall Study||180
232796|NCT00614393|560337|P5|COMPLETED|Overall Study||0
232797|NCT00614393|560338|P4|COMPLETED|Overall Study||0
232798|NCT00614393|560339|P3|COMPLETED|Overall Study||0
232799|NCT00614393|560340|P2|COMPLETED|Overall Study||0
232800|NCT00614393|560341|P1|COMPLETED|Overall Study||0
232801|NCT00614393|560337|P5|Treated|Overall Study||178
232802|NCT00614393|560338|P4|Treated|Overall Study||180
232803|NCT00614393|560339|P3|Treated|Overall Study||10
232804|NCT00614393|560340|P2|Treated|Overall Study||8
232805|NCT00614393|560341|P1|Treated|Overall Study||180
232806|NCT00614393|560337|P5|STARTED|Overall Study||180
232807|NCT00614393|560338|P4|STARTED|Overall Study||180
232808|NCT00614393|560339|P3|STARTED|Overall Study||10
232809|NCT00614393|560340|P2|STARTED|Overall Study||8
232810|NCT00614393|560341|P1|STARTED|Overall Study||180
232811|NCT00614380|560387|P4|NOT COMPLETED|Overall Study||2
232812|NCT00614380|560388|P3|NOT COMPLETED|Overall Study||1
232813|NCT00614380|560389|P2|NOT COMPLETED|Overall Study||8
232814|NCT00614380|560390|P1|NOT COMPLETED|Overall Study||35
232815|NCT00614380|560387|P4|COMPLETED|Overall Study||179
232816|NCT00614380|560388|P3|COMPLETED|Overall Study||24
232817|NCT00614380|560389|P2|COMPLETED|Overall Study||198
232818|NCT00614380|560390|P1|COMPLETED|Overall Study||529
232819|NCT00614380|560387|P4|STARTED|Overall Study||181
232820|NCT00614380|560388|P3|STARTED|Overall Study||25
232821|NCT00614380|560389|P2|STARTED|Overall Study||206
232822|NCT00614380|560390|P1|STARTED|Overall Study||564
232823|NCT00614315|560439|P1|NOT COMPLETED|Overall Study||0
232824|NCT00614315|560439|P1|COMPLETED|Overall Study||30
232825|NCT00614315|560439|P1|STARTED|Overall Study||30
232826|NCT00614198|560446|P2|NOT COMPLETED|Stage 2||12
232827|NCT00614198|560447|P1|NOT COMPLETED|Stage 2||8
232828|NCT00614198|560446|P2|COMPLETED|Stage 2||17
232829|NCT00614198|560447|P1|COMPLETED|Stage 2||18
232830|NCT00614198|560446|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
232831|NCT00614198|560447|P1|STARTED|Stage 2||26
232832|NCT00614198|560446|P2|NOT COMPLETED|Stage 1||5
232833|NCT00614198|560447|P1|NOT COMPLETED|Stage 1||12
232834|NCT00614198|560446|P2|COMPLETED|Stage 1||29
232835|NCT00614198|560447|P1|COMPLETED|Stage 1||26
232836|NCT00614198|560446|P2|STARTED|Stage 1||34
232837|NCT00614198|560447|P1|STARTED|Stage 1||38
232838|NCT00614120|560457|P4|NOT COMPLETED|Overall Study||16
232839|NCT00614120|560458|P3|NOT COMPLETED|Overall Study||59
232840|NCT00614120|560459|P2|NOT COMPLETED|Overall Study||46
232841|NCT00614120|560460|P1|NOT COMPLETED|Overall Study||29
232842|NCT00614120|560457|P4|COMPLETED|Overall Study||215
232843|NCT00614120|560458|P3|COMPLETED|Overall Study||175
232844|NCT00614120|560459|P2|COMPLETED|Overall Study||187
232845|NCT00614120|560460|P1|COMPLETED|Overall Study||202
232846|NCT00614120|560457|P4|Exposed to Study Drug|Overall Study||231
232847|NCT00614120|560458|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
232848|NCT00614120|560459|P2|Exposed to Study Drug|Overall Study||233
232849|NCT00614120|560460|P1|Exposed to Study Drug|Overall Study||231
232850|NCT00614120|560457|P4|STARTED|Overall Study|Randomised|231
232851|NCT00614120|560458|P3|STARTED|Overall Study|Randomised|234
232852|NCT00614120|560459|P2|STARTED|Overall Study|Randomised|233
232853|NCT00614120|560460|P1|STARTED|Overall Study|Randomised|231
232854|NCT00614055|560501|P3|NOT COMPLETED|Overall Study||5
232855|NCT00614055|560502|P2|NOT COMPLETED|Overall Study||6
232856|NCT00614055|560503|P1|NOT COMPLETED|Overall Study||4
232857|NCT00614055|560501|P3|COMPLETED|Overall Study||55
232858|NCT00614055|560502|P2|COMPLETED|Overall Study||53
232859|NCT00614055|560503|P1|COMPLETED|Overall Study||55
232860|NCT00614055|560501|P3|Exposed|Overall Study||60
232861|NCT00614055|560502|P2|Exposed|Overall Study||59
232862|NCT00614055|560503|P1|Exposed|Overall Study||59
232863|NCT00614055|560501|P3|STARTED|Overall Study||60
232864|NCT00614055|560502|P2|STARTED|Overall Study||59
232865|NCT00614055|560503|P1|STARTED|Overall Study||59
232866|NCT00613951|560550|P3|NOT COMPLETED|Overall Study||5
232867|NCT00613951|560551|P2|NOT COMPLETED|Overall Study||5
232868|NCT00613951|560552|P1|NOT COMPLETED|Overall Study||7
232869|NCT00613951|560550|P3|COMPLETED|Overall Study||57
232870|NCT00613951|560551|P2|COMPLETED|Overall Study||54
232871|NCT00613951|560552|P1|COMPLETED|Overall Study||54
232872|NCT00613951|560550|P3|Exposed|Overall Study||62
232873|NCT00613951|560551|P2|Exposed|Overall Study||59
232874|NCT00613951|560552|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
232875|NCT00613951|560550|P3|STARTED|Overall Study||62
232876|NCT00613951|560551|P2|STARTED|Overall Study||59
232877|NCT00613951|560552|P1|STARTED|Overall Study||61
232878|NCT00613938|560597|P4|NOT COMPLETED|Overall Study||26
232879|NCT00613938|560598|P3|NOT COMPLETED|Overall Study||23
232880|NCT00613938|560599|P2|NOT COMPLETED|Overall Study||28
232881|NCT00613938|560600|P1|NOT COMPLETED|Overall Study||20
232882|NCT00613938|560597|P4|COMPLETED|Overall Study||253
232883|NCT00613938|560598|P3|COMPLETED|Overall Study||255
232884|NCT00613938|560599|P2|COMPLETED|Overall Study||247
232885|NCT00613938|560600|P1|COMPLETED|Overall Study||49
232886|NCT00613938|560597|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
232887|NCT00613938|560598|P3|STARTED|Overall Study||278
232888|NCT00613938|560599|P2|STARTED|Overall Study||275
232889|NCT00613938|560600|P1|STARTED|Overall Study||69
232890|NCT00613925|560632|P2|NOT COMPLETED|Overall Study||1
232891|NCT00613925|560633|P1|NOT COMPLETED|Overall Study||0
232892|NCT00613925|560632|P2|COMPLETED|Overall Study||32
232893|NCT00613925|560633|P1|COMPLETED|Overall Study||37
232894|NCT00613925|560632|P2|STARTED|Overall Study||33
232895|NCT00613925|560633|P1|STARTED|Overall Study||37
232896|NCT00613821|560643|P2|NOT COMPLETED|Overall Study||1
232897|NCT00613821|560644|P1|NOT COMPLETED|Overall Study||2
232898|NCT00613821|560643|P2|COMPLETED|Overall Study||39
232899|NCT00613821|560644|P1|COMPLETED|Overall Study||38
232900|NCT00613821|560643|P2|STARTED|Overall Study||40
232901|NCT00613821|560644|P1|STARTED|Overall Study||40
232902|NCT00613730|560650|P1|NOT COMPLETED|Overall Study||3
232903|NCT00613730|560650|P1|COMPLETED|Overall Study||0
232904|NCT00613730|560650|P1|STARTED|Overall Study||3
232905|NCT00613626|560659|P3|NOT COMPLETED|Overall Study||0
232906|NCT00613626|560660|P2|NOT COMPLETED|Overall Study||1
232907|NCT00613626|560661|P1|NOT COMPLETED|Overall Study||0
232908|NCT00613626|560659|P3|COMPLETED|Overall Study||7
232909|NCT00613626|560660|P2|COMPLETED|Overall Study||33
232910|NCT00613626|560661|P1|COMPLETED|Overall Study||33
232911|NCT00613626|560659|P3|1st Dose ZD6474|Overall Study||7
232912|NCT00613626|560660|P2|1st Dose ZD6474|Overall Study||34
232913|NCT00613626|560661|P1|1st Dose ZD6474|Overall Study||33
232914|NCT00613626|560659|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
232915|NCT00613626|560660|P2|STARTED|Overall Study||34
232916|NCT00613626|560661|P1|STARTED|Overall Study||33
232917|NCT00613574|560677|P1|NOT COMPLETED|Overall Study||6
232918|NCT00613574|560677|P1|COMPLETED|Overall Study||401
232919|NCT00613574|560677|P1|STARTED|Overall Study||407
232920|NCT00613509|560689|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
232921|NCT00613509|560690|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
232922|NCT00613509|560689|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
232923|NCT00613509|560690|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
232924|NCT00613509|560689|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
232925|NCT00613509|560690|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
232926|NCT00613509|560689|P2|NOT COMPLETED|Cycle 1||8
232927|NCT00613509|560690|P1|NOT COMPLETED|Cycle 1||5
232928|NCT00613509|560689|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
232929|NCT00613509|560690|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
232930|NCT00613509|560689|P2|STARTED|Cycle 1||12
232931|NCT00613509|560690|P1|STARTED|Cycle 1||11
232932|NCT00613405|560714|P2|NOT COMPLETED|Overall Study||0
232933|NCT00613405|560715|P1|NOT COMPLETED|Overall Study||0
232934|NCT00613405|560714|P2|COMPLETED|Overall Study||42
232935|NCT00613405|560715|P1|COMPLETED|Overall Study||45
232936|NCT00613405|560714|P2|STARTED|Overall Study||42
232937|NCT00613405|560715|P1|STARTED|Overall Study||45
232938|NCT00613379|560724|P3|NOT COMPLETED|Overall Study||0
232939|NCT00613379|560725|P2|NOT COMPLETED|Overall Study||0
232940|NCT00613379|560726|P1|NOT COMPLETED|Overall Study||0
232941|NCT00613379|560724|P3|COMPLETED|Overall Study||11
232942|NCT00613379|560725|P2|COMPLETED|Overall Study||10
232943|NCT00613379|560726|P1|COMPLETED|Overall Study||10
232944|NCT00613379|560724|P3|STARTED|Overall Study||11
232945|NCT00613379|560725|P2|STARTED|Overall Study||10
232946|NCT00613379|560726|P1|STARTED|Overall Study||10
232947|NCT00613366|560736|P2|NOT COMPLETED|Overall Study||2
232948|NCT00613366|560737|P1|NOT COMPLETED|Overall Study||3
232949|NCT00613366|560736|P2|COMPLETED|Overall Study||18
232950|NCT00613366|560737|P1|COMPLETED|Overall Study||17
232951|NCT00613366|560736|P2|STARTED|Overall Study||20
232952|NCT00613366|560737|P1|STARTED|Overall Study||20
232953|NCT00613327|560745|P1|NOT COMPLETED|Overall Study||101
232954|NCT00613327|560745|P1|COMPLETED|Overall Study||244
232955|NCT00613327|560745|P1|STARTED|Overall Study||345
232956|NCT00613314|560764|P1|NOT COMPLETED|Overall Study||155
232957|NCT00613314|560764|P1|COMPLETED|Overall Study||15113
232958|NCT00613314|560764|P1|STARTED|Overall Study||15268
232959|NCT00613301|560772|P1|NOT COMPLETED|Overall Study||228
232960|NCT00613301|560772|P1|COMPLETED|Overall Study||188
232961|NCT00613301|560772|P1|STARTED|Overall Study||416
232962|NCT00613106|560781|P2|NOT COMPLETED|Overall Study||9
232963|NCT00613106|560782|P1|NOT COMPLETED|Overall Study||20
232964|NCT00613106|560781|P2|COMPLETED|Overall Study||38
232965|NCT00613106|560782|P1|COMPLETED|Overall Study||112
232966|NCT00613106|560781|P2|STARTED|Overall Study||47
232967|NCT00613106|560782|P1|STARTED|Overall Study||132
232968|NCT00613080|560788|P1|NOT COMPLETED|Overall Study||11
232969|NCT00613080|560788|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
232970|NCT00613080|560788|P1|STARTED|Overall Study||79
232971|NCT00613028|560794|P2|NOT COMPLETED|Overall Study||1
232972|NCT00613028|560795|P1|NOT COMPLETED|Overall Study||0
232973|NCT00613028|560794|P2|COMPLETED|Overall Study||12
232974|NCT00613028|560795|P1|COMPLETED|Overall Study||10
232975|NCT00613028|560794|P2|STARTED|Overall Study||13
232976|NCT00613028|560795|P1|STARTED|Overall Study||10
232977|NCT00613015|560815|P6|NOT COMPLETED|Overall Study||3
232978|NCT00613015|560816|P5|NOT COMPLETED|Overall Study||2
232979|NCT00613015|560817|P4|NOT COMPLETED|Overall Study||3
232980|NCT00613015|560818|P3|NOT COMPLETED|Overall Study||3
232981|NCT00613015|560819|P2|NOT COMPLETED|Overall Study||1
232982|NCT00613015|560820|P1|NOT COMPLETED|Overall Study||0
232983|NCT00613015|560815|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
232984|NCT00613015|560816|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
232985|NCT00613015|560817|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
232986|NCT00613015|560818|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
232987|NCT00613015|560819|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
232988|NCT00613015|560820|P1|COMPLETED|Overall Study||13
232989|NCT00613015|560815|P6|STARTED|Overall Study||19
232990|NCT00613015|560816|P5|STARTED|Overall Study||15
232991|NCT00613015|560817|P4|STARTED|Overall Study||24
232992|NCT00613015|560818|P3|STARTED|Overall Study||26
232993|NCT00613015|560819|P2|STARTED|Overall Study||12
232994|NCT00613015|560820|P1|STARTED|Overall Study||13
232995|NCT00612924|560842|P2|NOT COMPLETED|Overall Study||9
232996|NCT00612924|560843|P1|NOT COMPLETED|Overall Study||7
232997|NCT00612924|560842|P2|COMPLETED|Overall Study||85
232998|NCT00612924|560843|P1|COMPLETED|Overall Study||94
232999|NCT00612924|560842|P2|STARTED|Overall Study||94
233000|NCT00612924|560843|P1|STARTED|Overall Study||101
233001|NCT00612807|560856|P2|NOT COMPLETED|Overall Study||0
233002|NCT00612807|560857|P1|NOT COMPLETED|Overall Study||2
233003|NCT00612807|560856|P2|COMPLETED|Overall Study||28
233004|NCT00612807|560857|P1|COMPLETED|Overall Study||12
233005|NCT00612807|560856|P2|STARTED|Overall Study||28
233006|NCT00612807|560857|P1|STARTED|Overall Study||14
233007|NCT00612768|560865|P1|NOT COMPLETED|Overall Study||0
233008|NCT00612768|560865|P1|COMPLETED|Overall Study||50
233009|NCT00612768|560865|P1|STARTED|Overall Study||50
233010|NCT00612690|560892|P2|NOT COMPLETED|Overall Study||118
233011|NCT00612690|560893|P1|NOT COMPLETED|Overall Study||115
233012|NCT00612690|560892|P2|COMPLETED|Overall Study||89
233013|NCT00612690|560893|P1|COMPLETED|Overall Study||160
233014|NCT00612690|560892|P2|STARTED|Overall Study||207
233015|NCT00612690|560893|P1|STARTED|Overall Study||275
233016|NCT00612677|560901|P1|NOT COMPLETED|Overall Study||1
233017|NCT00612677|560901|P1|COMPLETED|Overall Study||0
233018|NCT00612677|560901|P1|STARTED|Overall Study||1
233019|NCT00612573|560911|P4|NOT COMPLETED|Overall Study||13
233020|NCT00612573|560912|P3|NOT COMPLETED|Overall Study||9
233021|NCT00612573|560913|P2|NOT COMPLETED|Overall Study||14
233022|NCT00612573|560914|P1|NOT COMPLETED|Overall Study||12
233023|NCT00612573|560911|P4|COMPLETED|Overall Study||54
233024|NCT00612573|560912|P3|COMPLETED|Overall Study||52
233025|NCT00612573|560913|P2|COMPLETED|Overall Study||51
233026|NCT00612573|560914|P1|COMPLETED|Overall Study||52
233027|NCT00612573|560911|P4|STARTED|Overall Study||67
233028|NCT00612573|560912|P3|STARTED|Overall Study||61
233029|NCT00612573|560913|P2|STARTED|Overall Study||65
233030|NCT00612573|560914|P1|STARTED|Overall Study||64
233031|NCT00612560|560940|P4|NOT COMPLETED|Overall Study||0
233032|NCT00612560|560941|P3|NOT COMPLETED|Overall Study||0
233033|NCT00612560|560942|P2|NOT COMPLETED|Overall Study||0
233034|NCT00612560|560943|P1|NOT COMPLETED|Overall Study||0
233035|NCT00612560|560940|P4|COMPLETED|Overall Study||6
233036|NCT00612560|560941|P3|COMPLETED|Overall Study||8
233037|NCT00612560|560942|P2|COMPLETED|Overall Study||7
233038|NCT00612560|560943|P1|COMPLETED|Overall Study||7
233039|NCT00612560|560940|P4|STARTED|Overall Study||6
233040|NCT00612560|560941|P3|STARTED|Overall Study||8
233041|NCT00612560|560942|P2|STARTED|Overall Study||7
233042|NCT00612560|560943|P1|STARTED|Overall Study||7
233043|NCT00612534|560969|P4|NOT COMPLETED|Overall Study||17
233044|NCT00612534|560970|P3|NOT COMPLETED|Overall Study||7
233045|NCT00612534|560971|P2|NOT COMPLETED|Overall Study||17
233046|NCT00612534|560972|P1|NOT COMPLETED|Overall Study||13
233047|NCT00612534|560969|P4|COMPLETED|Overall Study||7
233048|NCT00612534|560970|P3|COMPLETED|Overall Study||13
233049|NCT00612534|560971|P2|COMPLETED|Overall Study||9
233050|NCT00612534|560972|P1|COMPLETED|Overall Study||11
233051|NCT00612534|560969|P4|STARTED|Overall Study||24
233052|NCT00612534|560970|P3|STARTED|Overall Study||20
233053|NCT00612534|560971|P2|STARTED|Overall Study||26
233054|NCT00612534|560972|P1|STARTED|Overall Study||24
233055|NCT00612508|560984|P2|NOT COMPLETED|Overall Study||4
233056|NCT00612508|560985|P1|NOT COMPLETED|Overall Study||3
233057|NCT00612508|560984|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
233058|NCT00612508|560985|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
233059|NCT00612508|560984|P2|STARTED|Overall Study||7
233060|NCT00612508|560985|P1|STARTED|Overall Study||7
233061|NCT00612456|560996|P3|NOT COMPLETED|Overall Study||0
233062|NCT00612456|560997|P2|NOT COMPLETED|Overall Study||2
233063|NCT00612456|560998|P1|NOT COMPLETED|Overall Study||2
233064|NCT00612456|560996|P3|COMPLETED|Overall Study||16
233065|NCT00612456|560997|P2|COMPLETED|Overall Study||25
233066|NCT00612456|560998|P1|COMPLETED|Overall Study||25
233067|NCT00612456|560996|P3|STARTED|Overall Study||16
233068|NCT00612456|560997|P2|STARTED|Overall Study||27
233069|NCT00612456|560998|P1|STARTED|Overall Study||27
233070|NCT00612430|561044|P2|NOT COMPLETED|Overall Study||0
233071|NCT00612430|561045|P1|NOT COMPLETED|Overall Study||0
233072|NCT00612430|561044|P2|COMPLETED|Overall Study||27
233073|NCT00612430|561045|P1|COMPLETED|Overall Study||32
233074|NCT00612430|561044|P2|STARTED|Overall Study||27
233075|NCT00612430|561045|P1|STARTED|Overall Study||32
233076|NCT00612352|561061|P2|NOT COMPLETED|Overall Study||6
233077|NCT00612352|561062|P1|NOT COMPLETED|Overall Study||9
233078|NCT00612352|561061|P2|COMPLETED|Overall Study||109
233079|NCT00612352|561062|P1|COMPLETED|Overall Study||56
233080|NCT00612352|561061|P2|Placebo|Overall Study||4
233081|NCT00612352|561062|P1|Placebo|Overall Study||4
233082|NCT00612352|561061|P2|40%mg|Overall Study||0
233083|NCT00612352|561062|P1|40%mg|Overall Study||1
233084|NCT00612352|561061|P2|100%mg|Overall Study||1
233085|NCT00612352|561062|P1|100%mg|Overall Study||2
233086|NCT00612352|561061|P2|Placebo & 100%mg|Overall Study||0
233087|NCT00612352|561062|P1|Placebo & 100%mg|Overall Study||1
233088|NCT00612352|561061|P2|40%mg & 100%mg|Overall Study||1
233089|NCT00612352|561062|P1|40%mg & 100%mg|Overall Study||1
233090|NCT00612352|561061|P2|STARTED|Overall Study||115
233091|NCT00612352|561062|P1|STARTED|Overall Study||65
233092|NCT00612339|561176|P1|NOT COMPLETED|Overall Study||0
233093|NCT00612339|561176|P1|COMPLETED|Overall Study||41
233094|NCT00612339|561176|P1|STARTED|Overall Study||41
233095|NCT00612313|561182|P2|NOT COMPLETED|Overall Study||13
233096|NCT00612313|561183|P1|NOT COMPLETED|Overall Study||17
233097|NCT00612313|561182|P2|COMPLETED|Overall Study||62
233098|NCT00612313|561183|P1|COMPLETED|Overall Study||52
233099|NCT00612313|561182|P2|STARTED|Overall Study||75
233100|NCT00612313|561183|P1|STARTED|Overall Study||69
233101|NCT00612222|561199|P1|NOT COMPLETED|Overall Study||0
233102|NCT00612222|561199|P1|COMPLETED|Overall Study||4
233103|NCT00612222|561199|P1|STARTED|Overall Study||4
233104|NCT00612105|561207|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
233105|NCT00612105|561208|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
233106|NCT00612105|561207|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
233107|NCT00612105|561208|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
233108|NCT00612105|561207|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
233109|NCT00612105|561208|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
233110|NCT00612105|561207|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
233111|NCT00612105|561208|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
233112|NCT00612105|561207|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
233113|NCT00612105|561208|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
233114|NCT00612105|561207|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
233115|NCT00612105|561208|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
233116|NCT00612105|561207|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
233117|NCT00612105|561208|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
233118|NCT00612105|561207|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
233119|NCT00612105|561208|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
233120|NCT00612105|561207|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
233121|NCT00612105|561208|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
233122|NCT00612066|561258|P1|NOT COMPLETED|Overall Study||1
233123|NCT00612066|561258|P1|COMPLETED|Overall Study||1
233124|NCT00612066|561258|P1|STARTED|Overall Study||2
233125|NCT00612040|561265|P3|NOT COMPLETED|Overall Study||7
233126|NCT00612040|561266|P2|NOT COMPLETED|Overall Study||7
233127|NCT00612040|561267|P1|NOT COMPLETED|Overall Study||5
233128|NCT00612040|561265|P3|COMPLETED|Overall Study||52
233129|NCT00612040|561266|P2|COMPLETED|Overall Study||52
233130|NCT00612040|561267|P1|COMPLETED|Overall Study||55
233131|NCT00612040|561265|P3|Exposed|Overall Study||59
233132|NCT00612040|561266|P2|Exposed|Overall Study||59
233133|NCT00612040|561267|P1|Exposed|Overall Study||60
233134|NCT00612040|561265|P3|STARTED|Overall Study||59
233135|NCT00612040|561266|P2|STARTED|Overall Study||59
233136|NCT00612040|561267|P1|STARTED|Overall Study||60
233137|NCT00611897|561311|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
233138|NCT00611897|561312|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
233139|NCT00611897|561311|P2|COMPLETED|Day 2: Crossover Treatment||8
233140|NCT00611897|561312|P1|COMPLETED|Day 2: Crossover Treatment||8
233141|NCT00611897|561311|P2|STARTED|Day 2: Crossover Treatment||8
233142|NCT00611897|561312|P1|STARTED|Day 2: Crossover Treatment||8
233143|NCT00611897|561311|P2|NOT COMPLETED|Day 1: Initial Treatment||0
233144|NCT00611897|561312|P1|NOT COMPLETED|Day 1: Initial Treatment||0
233145|NCT00611897|561311|P2|COMPLETED|Day 1: Initial Treatment||8
233146|NCT00611897|561312|P1|COMPLETED|Day 1: Initial Treatment||8
233147|NCT00611897|561311|P2|STARTED|Day 1: Initial Treatment||8
233148|NCT00611897|561312|P1|STARTED|Day 1: Initial Treatment||8
233149|NCT00611884|561340|P4|NOT COMPLETED|Overall Study||6
233150|NCT00611884|561341|P3|NOT COMPLETED|Overall Study||4
233151|NCT00611884|561342|P2|NOT COMPLETED|Overall Study||9
233152|NCT00611884|561343|P1|NOT COMPLETED|Overall Study||9
233153|NCT00611884|561340|P4|COMPLETED|Overall Study||56
233154|NCT00611884|561341|P3|COMPLETED|Overall Study||58
233155|NCT00611884|561342|P2|COMPLETED|Overall Study||51
233156|NCT00611884|561343|P1|COMPLETED|Overall Study||52
233157|NCT00611884|561340|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
233158|NCT00611884|561341|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
233159|NCT00611884|561342|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
233160|NCT00611884|561343|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
233161|NCT00611884|561340|P4|STARTED|Overall Study||62
233162|NCT00611884|561341|P3|STARTED|Overall Study||62
233163|NCT00611884|561342|P2|STARTED|Overall Study||60
233164|NCT00611884|561343|P1|STARTED|Overall Study||61
233165|NCT00611806|561399|P2|NOT COMPLETED|Overall Study||3
233166|NCT00611806|561400|P1|NOT COMPLETED|Overall Study||16
233167|NCT00611806|561399|P2|COMPLETED|Overall Study||43
233168|NCT00611806|561400|P1|COMPLETED|Overall Study||78
233169|NCT00611806|561399|P2|STARTED|Overall Study||46
233170|NCT00611806|561400|P1|STARTED|Overall Study||94
233171|NCT00611767|561414|P2|NOT COMPLETED|Overall Study||2
233172|NCT00611767|561415|P1|NOT COMPLETED|Overall Study||9
233173|NCT00611767|561414|P2|COMPLETED|Overall Study||22
233174|NCT00611767|561415|P1|COMPLETED|Overall Study||40
233175|NCT00611767|561414|P2|Placebo Test Day|Overall Study||1
233176|NCT00611767|561415|P1|Placebo Test Day|Overall Study||6
233177|NCT00611767|561414|P2|Thiopental Test Day|Overall Study||1
233178|NCT00611767|561415|P1|Thiopental Test Day|Overall Study||3
233179|NCT00611767|561414|P2|STARTED|Overall Study||24
233180|NCT00611767|561415|P1|STARTED|Overall Study||49
233181|NCT00611715|561577|P2|NOT COMPLETED|Overall Study||6
233182|NCT00611715|561578|P1|NOT COMPLETED|Overall Study||41
233183|NCT00611715|561577|P2|COMPLETED|Overall Study||0
233184|NCT00611715|561578|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
233185|NCT00611715|561577|P2|STARTED|Overall Study||6
233186|NCT00611715|561578|P1|STARTED|Overall Study||42
233187|NCT00611624|561590|P1|NOT COMPLETED|Overall Study||0
233188|NCT00611624|561590|P1|COMPLETED|Overall Study||28
233189|NCT00611624|561590|P1|STARTED|Overall Study||28
233190|NCT00611559|561598|P3|NOT COMPLETED|Overall Study||1
233191|NCT00611559|561599|P2|NOT COMPLETED|Overall Study||1
233192|NCT00611559|561600|P1|NOT COMPLETED|Overall Study||1
233193|NCT00611559|561598|P3|COMPLETED|Overall Study||56
233194|NCT00611559|561599|P2|COMPLETED|Overall Study||114
233195|NCT00611559|561600|P1|COMPLETED|Overall Study||110
233196|NCT00611559|561598|P3|STARTED|Overall Study||57
233197|NCT00611559|561599|P2|STARTED|Overall Study||115
233198|NCT00611559|561600|P1|STARTED|Overall Study||111
233199|NCT00611533|561659|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
233200|NCT00611533|561660|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
233201|NCT00611533|561659|P2|COMPLETED|Second Intervention (6 Weeks)||4
233202|NCT00611533|561660|P1|COMPLETED|Second Intervention (6 Weeks)||8
233203|NCT00611533|561659|P2|STARTED|Second Intervention (6 Weeks)||6
233204|NCT00611533|561660|P1|STARTED|Second Intervention (6 Weeks)||8
233205|NCT00611533|561659|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
233206|NCT00611533|561660|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
233207|NCT00611533|561659|P2|COMPLETED|First Intervention (6 Weeks)||6
233208|NCT00611533|561660|P1|COMPLETED|First Intervention (6 Weeks)||8
233209|NCT00611533|561659|P2|STARTED|First Intervention (6 Weeks)||8
233210|NCT00611533|561660|P1|STARTED|First Intervention (6 Weeks)||8
233211|NCT00611468|561679|P4|NOT COMPLETED|Overall Study||0
233212|NCT00611468|561680|P3|NOT COMPLETED|Overall Study||0
233213|NCT00611468|561681|P2|NOT COMPLETED|Overall Study||1
233214|NCT00611468|561682|P1|NOT COMPLETED|Overall Study||0
233215|NCT00611468|561679|P4|COMPLETED|Overall Study||13
233216|NCT00611468|561680|P3|COMPLETED|Overall Study||6
233217|NCT00611468|561681|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
233218|NCT00611468|561682|P1|COMPLETED|Overall Study||3
233219|NCT00611468|561679|P4|STARTED|Overall Study||13
233220|NCT00611468|561680|P3|STARTED|Overall Study||6
233221|NCT00611468|561681|P2|STARTED|Overall Study||7
233222|NCT00611468|561682|P1|STARTED|Overall Study||3
233223|NCT00611455|561694|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
233224|NCT00611455|561695|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
233225|NCT00611455|561696|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
233226|NCT00611455|561694|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
233227|NCT00611455|561695|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
233228|NCT00611455|561696|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
233229|NCT00611455|561694|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
233230|NCT00611455|561695|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
233231|NCT00611455|561696|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
233232|NCT00611455|561694|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
233233|NCT00611455|561695|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
233234|NCT00611455|561696|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
233235|NCT00611455|561694|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
233236|NCT00611455|561695|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
233237|NCT00611455|561696|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
233238|NCT00611455|561694|P3|STARTED|OL Treatment Period (120 Weeks)||0
233239|NCT00611455|561695|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
233240|NCT00611455|561696|P1|STARTED|OL Treatment Period (120 Weeks)||0
233241|NCT00611455|561694|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
233242|NCT00611455|561695|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
233243|NCT00611455|561696|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
233244|NCT00611455|561694|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
233245|NCT00611455|561695|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
233246|NCT00611455|561696|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
233247|NCT00611455|561694|P3|STARTED|DB Treatment Period (24 Weeks)||0
233248|NCT00611455|561695|P2|STARTED|DB Treatment Period (24 Weeks)||131
233249|NCT00611455|561696|P1|STARTED|DB Treatment Period (24 Weeks)||134
233250|NCT00611442|561824|P2|NOT COMPLETED|Overall Study||2
233251|NCT00611442|561825|P1|NOT COMPLETED|Overall Study||1
233252|NCT00611442|561824|P2|COMPLETED|Overall Study||94
233253|NCT00611442|561825|P1|COMPLETED|Overall Study||94
233254|NCT00611442|561824|P2|STARTED|Overall Study||96
233255|NCT00611442|561825|P1|STARTED|Overall Study||95
233256|NCT00611403|561839|P2|NOT COMPLETED|Post Treatment Extension Phase||1
233257|NCT00611403|561840|P1|NOT COMPLETED|Post Treatment Extension Phase||4
233258|NCT00611403|561839|P2|COMPLETED|Post Treatment Extension Phase||24
233259|NCT00611403|561840|P1|COMPLETED|Post Treatment Extension Phase||22
233349|NCT00610649|562055|P11|NOT COMPLETED|Overall Study||1
233350|NCT00610649|562056|P10|NOT COMPLETED|Overall Study||1
233260|NCT00611403|561839|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
233261|NCT00611403|561840|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
233262|NCT00611403|561839|P2|NOT COMPLETED|Treatment Phase||11
233263|NCT00611403|561840|P1|NOT COMPLETED|Treatment Phase||6
233264|NCT00611403|561839|P2|COMPLETED|Treatment Phase||58
233265|NCT00611403|561840|P1|COMPLETED|Treatment Phase||62
233266|NCT00611403|561839|P2|STARTED|Treatment Phase||69
233267|NCT00611403|561840|P1|STARTED|Treatment Phase||68
233268|NCT00611351|561850|P1|NOT COMPLETED|Overall Study||2
233269|NCT00611351|561850|P1|COMPLETED|Overall Study||3
233270|NCT00611351|561850|P1|STARTED|Overall Study||5
233271|NCT00611325|561859|P2|NOT COMPLETED|Overall Study||0
233272|NCT00611325|561860|P1|NOT COMPLETED|Overall Study||0
233273|NCT00611325|561859|P2|COMPLETED|Overall Study||28
233274|NCT00611325|561860|P1|COMPLETED|Overall Study||28
233275|NCT00611325|561859|P2|STARTED|Overall Study||28
233276|NCT00611325|561860|P1|STARTED|Overall Study||28
233277|NCT00611247|561876|P2|NOT COMPLETED|Overall Study||21
233278|NCT00611247|561877|P1|NOT COMPLETED|Overall Study||2
233279|NCT00611247|561876|P2|COMPLETED|Overall Study||10
233280|NCT00611247|561877|P1|COMPLETED|Overall Study||3
233281|NCT00611247|561876|P2|STARTED|Overall Study||31
233282|NCT00611247|561877|P1|STARTED|Overall Study||5
233283|NCT00611130|561889|P2|NOT COMPLETED|Overall Study||47
233284|NCT00611130|561890|P1|NOT COMPLETED|Overall Study||49
233285|NCT00611130|561889|P2|COMPLETED|Overall Study||47
233286|NCT00611130|561890|P1|COMPLETED|Overall Study||43
233287|NCT00611130|561889|P2|Completed 12 Week Treatment Phase|Overall Study||64
233288|NCT00611130|561890|P1|Completed 12 Week Treatment Phase|Overall Study||61
233289|NCT00611130|561889|P2|STARTED|Overall Study||94
233290|NCT00611130|561890|P1|STARTED|Overall Study||92
233291|NCT00611026|561900|P3|NOT COMPLETED|Double-blind Treatment Period||98
233292|NCT00611026|561901|P2|NOT COMPLETED|Double-blind Treatment Period||88
233293|NCT00611026|561902|P1|NOT COMPLETED|Double-blind Treatment Period||47
233294|NCT00611026|561900|P3|COMPLETED|Double-blind Treatment Period||862
233295|NCT00611026|561901|P2|COMPLETED|Double-blind Treatment Period||885
233296|NCT00611026|561902|P1|COMPLETED|Double-blind Treatment Period||431
233297|NCT00611026|561900|P3|STARTED|Double-blind Treatment Period||960
233298|NCT00611026|561901|P2|STARTED|Double-blind Treatment Period||973
233299|NCT00611026|561902|P1|STARTED|Double-blind Treatment Period||478
233300|NCT00611026|561900|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
233301|NCT00611026|561901|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
233302|NCT00611026|561902|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
233303|NCT00611026|561900|P3|COMPLETED|Randomized to Double-blind Treatment||960
233304|NCT00611026|561901|P2|COMPLETED|Randomized to Double-blind Treatment||973
233305|NCT00611026|561902|P1|COMPLETED|Randomized to Double-blind Treatment||478
233306|NCT00611026|561900|P3|STARTED|Randomized to Double-blind Treatment||963
233307|NCT00611026|561901|P2|STARTED|Randomized to Double-blind Treatment||974
233308|NCT00611026|561902|P1|STARTED|Randomized to Double-blind Treatment||480
233309|NCT00610987|561968|P2|NOT COMPLETED|Overall Study||0
233310|NCT00610987|561969|P1|NOT COMPLETED|Overall Study||0
233311|NCT00610987|561968|P2|COMPLETED|Overall Study||71
233312|NCT00610987|561969|P1|COMPLETED|Overall Study||75
233313|NCT00610987|561968|P2|STARTED|Overall Study||71
233314|NCT00610987|561969|P1|STARTED|Overall Study||75
233315|NCT00610883|561975|P1|NOT COMPLETED|Overall Study||0
233316|NCT00610883|561975|P1|COMPLETED|Overall Study||17
233317|NCT00610883|561975|P1|STARTED|Overall Study||17
233318|NCT00610857|561979|P1|NOT COMPLETED|Overall Study||2
233319|NCT00610857|561979|P1|COMPLETED|Overall Study||35
233320|NCT00610857|561979|P1|STARTED|Overall Study||37
233321|NCT00610740|561986|P1|NOT COMPLETED|Overall Study||0
233322|NCT00610740|561986|P1|COMPLETED|Overall Study||18
233323|NCT00610740|561986|P1|STARTED|Overall Study||18
233324|NCT00610714|561994|P2|NOT COMPLETED|Overall Study||24
233325|NCT00610714|561995|P1|NOT COMPLETED|Overall Study||26
233326|NCT00610714|561994|P2|COMPLETED|Overall Study||82
233327|NCT00610714|561995|P1|COMPLETED|Overall Study||79
233328|NCT00610714|561994|P2|STARTED|Overall Study||106
233329|NCT00610714|561995|P1|STARTED|Overall Study||105
233330|NCT00610701|562007|P2|NOT COMPLETED|Overall Study||11
233331|NCT00610701|562008|P1|NOT COMPLETED|Overall Study||10
233332|NCT00610701|562007|P2|COMPLETED|Overall Study||9
233333|NCT00610701|562008|P1|COMPLETED|Overall Study||5
233334|NCT00610701|562007|P2|STARTED|Overall Study||20
233335|NCT00610701|562008|P1|STARTED|Overall Study||15
233336|NCT00610688|562017|P3|NOT COMPLETED|Overall Study||8
233337|NCT00610688|562018|P2|NOT COMPLETED|Overall Study||13
233338|NCT00610688|562019|P1|NOT COMPLETED|Overall Study||9
233339|NCT00610688|562017|P3|COMPLETED|Overall Study||55
233340|NCT00610688|562018|P2|COMPLETED|Overall Study||52
233341|NCT00610688|562019|P1|COMPLETED|Overall Study||55
233342|NCT00610688|562017|P3|STARTED|Overall Study||63
233343|NCT00610688|562018|P2|STARTED|Overall Study||65
233344|NCT00610688|562019|P1|STARTED|Overall Study||64
233345|NCT00610675|562033|P1|NOT COMPLETED|Overall Study||220
233346|NCT00610675|562033|P1|COMPLETED|Overall Study||126
233347|NCT00610675|562033|P1|Treated|Overall Study||342
233348|NCT00610675|562033|P1|STARTED|Overall Study||346
233351|NCT00610649|562057|P9|NOT COMPLETED|Overall Study||0
233352|NCT00610649|562058|P8|NOT COMPLETED|Overall Study||0
233353|NCT00610649|562059|P7|NOT COMPLETED|Overall Study||0
233354|NCT00610649|562060|P6|NOT COMPLETED|Overall Study||0
233355|NCT00610649|562061|P5|NOT COMPLETED|Overall Study||0
233356|NCT00610649|562062|P4|NOT COMPLETED|Overall Study||0
233357|NCT00610649|562063|P3|NOT COMPLETED|Overall Study||0
233358|NCT00610649|562064|P2|NOT COMPLETED|Overall Study||1
233359|NCT00610649|562065|P1|NOT COMPLETED|Overall Study||1
233360|NCT00610649|562055|P11|COMPLETED|Overall Study||9
233361|NCT00610649|562056|P10|COMPLETED|Overall Study||9
233362|NCT00610649|562057|P9|COMPLETED|Overall Study||10
233363|NCT00610649|562058|P8|COMPLETED|Overall Study||2
233364|NCT00610649|562059|P7|COMPLETED|Overall Study||4
233365|NCT00610649|562060|P6|COMPLETED|Overall Study||2
233366|NCT00610649|562061|P5|COMPLETED|Overall Study||4
233367|NCT00610649|562062|P4|COMPLETED|Overall Study||2
233368|NCT00610649|562063|P3|COMPLETED|Overall Study||4
233369|NCT00610649|562064|P2|COMPLETED|Overall Study||1
233370|NCT00610649|562065|P1|COMPLETED|Overall Study||3
233371|NCT00610649|562055|P11|STARTED|Overall Study||10
233372|NCT00610649|562056|P10|STARTED|Overall Study||10
233373|NCT00610649|562057|P9|STARTED|Overall Study||10
233374|NCT00610649|562058|P8|STARTED|Overall Study||2
233375|NCT00610649|562059|P7|STARTED|Overall Study||4
233376|NCT00610649|562060|P6|STARTED|Overall Study||2
233377|NCT00610649|562061|P5|STARTED|Overall Study||4
233378|NCT00610649|562062|P4|STARTED|Overall Study||2
233379|NCT00610649|562063|P3|STARTED|Overall Study||4
233380|NCT00610649|562064|P2|STARTED|Overall Study||2
233381|NCT00610649|562065|P1|STARTED|Overall Study||4
233382|NCT00610532|562119|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
233383|NCT00610532|562119|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
233384|NCT00610532|562119|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
233385|NCT00610532|562119|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
233386|NCT00610532|562119|P1|COMPLETED|Intravenous Phenytoin Alone||8
233387|NCT00610532|562119|P1|STARTED|Intravenous Phenytoin Alone||8
233388|NCT00610441|562129|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
233389|NCT00610441|562130|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
233390|NCT00610441|562131|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
233391|NCT00610441|562132|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
233392|NCT00610441|562129|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
233393|NCT00610441|562130|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
233394|NCT00610441|562131|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
233395|NCT00610441|562132|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
233396|NCT00610441|562129|P4|STARTED|Treatment Period 2 - 3 Weeks||16
233397|NCT00610441|562130|P3|STARTED|Treatment Period 2 - 3 Weeks||9
233398|NCT00610441|562131|P2|STARTED|Treatment Period 2 - 3 Weeks||13
233399|NCT00610441|562132|P1|STARTED|Treatment Period 2 - 3 Weeks||12
233400|NCT00610441|562129|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
233401|NCT00610441|562130|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
233402|NCT00610441|562131|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
233403|NCT00610441|562132|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
233404|NCT00610441|562129|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
233405|NCT00610441|562130|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
233406|NCT00610441|562131|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
233407|NCT00610441|562132|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
233408|NCT00610441|562129|P4|STARTED|Placebo Washout Period - 2 Weeks||16
233409|NCT00610441|562130|P3|STARTED|Placebo Washout Period - 2 Weeks||11
233410|NCT00610441|562131|P2|STARTED|Placebo Washout Period - 2 Weeks||14
233411|NCT00610441|562132|P1|STARTED|Placebo Washout Period - 2 Weeks||12
233412|NCT00610441|562129|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
233413|NCT00610441|562130|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
233414|NCT00610441|562131|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
233415|NCT00610441|562132|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
233416|NCT00610441|562129|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
233417|NCT00610441|562130|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
233418|NCT00610441|562131|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
233419|NCT00610441|562132|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
233420|NCT00610441|562129|P4|STARTED|Treatment Period 1 - 3 Weeks||18
233421|NCT00610441|562130|P3|STARTED|Treatment Period 1 - 3 Weeks||18
233422|NCT00610441|562131|P2|STARTED|Treatment Period 1 - 3 Weeks||16
233423|NCT00610441|562132|P1|STARTED|Treatment Period 1 - 3 Weeks||15
233424|NCT00610428|562226|P3|NOT COMPLETED|Overall Study||2
233425|NCT00610428|562227|P2|NOT COMPLETED|Overall Study||1
233426|NCT00610428|562228|P1|NOT COMPLETED|Overall Study||0
233427|NCT00610428|562226|P3|COMPLETED|Overall Study||25
233428|NCT00610428|562227|P2|COMPLETED|Overall Study||23
233429|NCT00610428|562228|P1|COMPLETED|Overall Study||24
233430|NCT00610428|562226|P3|STARTED|Overall Study||27
233431|NCT00610428|562227|P2|STARTED|Overall Study||24
233432|NCT00610428|562228|P1|STARTED|Overall Study||24
233433|NCT00610363|562241|P2|NOT COMPLETED|Overall Study||3
233434|NCT00610363|562242|P1|NOT COMPLETED|Overall Study||11
233435|NCT00610363|562241|P2|COMPLETED|Overall Study||38
233436|NCT00610363|562242|P1|COMPLETED|Overall Study||31
233437|NCT00610363|562241|P2|STARTED|Overall Study||41
233438|NCT00610363|562242|P1|STARTED|Overall Study||42
233439|NCT00610311|562260|P1|NOT COMPLETED|Overall Study||0
233440|NCT00610311|562260|P1|COMPLETED|Overall Study||3
233441|NCT00610311|562260|P1|STARTED|Overall Study||3
233442|NCT00610207|562267|P1|NOT COMPLETED|Overall Study||3
233443|NCT00610207|562267|P1|COMPLETED|Overall Study||18
233444|NCT00610207|562267|P1|STARTED|Overall Study||21
233445|NCT00610168|562274|P2|NOT COMPLETED|Overall Study||0
233446|NCT00610168|562275|P1|NOT COMPLETED|Overall Study||2
233447|NCT00610168|562274|P2|COMPLETED|Overall Study||7
233448|NCT00610168|562275|P1|COMPLETED|Overall Study||73
233449|NCT00610168|562274|P2|STARTED|Overall Study||7
233450|NCT00610168|562275|P1|STARTED|Overall Study||75
233451|NCT00610155|562294|P6|NOT COMPLETED|Period 3||0
233452|NCT00610155|562295|P5|NOT COMPLETED|Period 3||0
233453|NCT00610155|562296|P4|NOT COMPLETED|Period 3||0
233454|NCT00610155|562297|P3|NOT COMPLETED|Period 3||0
233455|NCT00610155|562298|P2|NOT COMPLETED|Period 3||0
233456|NCT00610155|562299|P1|NOT COMPLETED|Period 3||1
233457|NCT00610155|562294|P6|COMPLETED|Period 3||1
233458|NCT00610155|562295|P5|COMPLETED|Period 3||3
233459|NCT00610155|562296|P4|COMPLETED|Period 3||3
233460|NCT00610155|562297|P3|COMPLETED|Period 3||3
233461|NCT00610155|562298|P2|COMPLETED|Period 3||3
233462|NCT00610155|562299|P1|COMPLETED|Period 3||3
233463|NCT00610155|562294|P6|STARTED|Period 3||1
233464|NCT00610155|562295|P5|STARTED|Period 3||3
233465|NCT00610155|562296|P4|STARTED|Period 3||3
233466|NCT00610155|562297|P3|STARTED|Period 3||3
233467|NCT00610155|562298|P2|STARTED|Period 3||3
233468|NCT00610155|562299|P1|STARTED|Period 3||4
233469|NCT00610155|562294|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
233470|NCT00610155|562295|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
233471|NCT00610155|562296|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
233472|NCT00610155|562297|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
233473|NCT00610155|562298|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
233474|NCT00610155|562299|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
233475|NCT00610155|562294|P6|COMPLETED|Washout Period 2 (7 Days)||1
233476|NCT00610155|562295|P5|COMPLETED|Washout Period 2 (7 Days)||3
233477|NCT00610155|562296|P4|COMPLETED|Washout Period 2 (7 Days)||3
233478|NCT00610155|562297|P3|COMPLETED|Washout Period 2 (7 Days)||3
233479|NCT00610155|562298|P2|COMPLETED|Washout Period 2 (7 Days)||3
233480|NCT00610155|562299|P1|COMPLETED|Washout Period 2 (7 Days)||4
233481|NCT00610155|562294|P6|STARTED|Washout Period 2 (7 Days)||1
233482|NCT00610155|562295|P5|STARTED|Washout Period 2 (7 Days)||3
233483|NCT00610155|562296|P4|STARTED|Washout Period 2 (7 Days)||3
233484|NCT00610155|562297|P3|STARTED|Washout Period 2 (7 Days)||3
233485|NCT00610155|562298|P2|STARTED|Washout Period 2 (7 Days)||3
233486|NCT00610155|562299|P1|STARTED|Washout Period 2 (7 Days)||4
233487|NCT00610155|562294|P6|NOT COMPLETED|Period 2||0
233488|NCT00610155|562295|P5|NOT COMPLETED|Period 2||0
233489|NCT00610155|562296|P4|NOT COMPLETED|Period 2||0
233490|NCT00610155|562297|P3|NOT COMPLETED|Period 2||0
233491|NCT00610155|562298|P2|NOT COMPLETED|Period 2||0
233492|NCT00610155|562299|P1|NOT COMPLETED|Period 2||0
233493|NCT00610155|562294|P6|COMPLETED|Period 2||1
233494|NCT00610155|562295|P5|COMPLETED|Period 2||3
233495|NCT00610155|562296|P4|COMPLETED|Period 2||3
233496|NCT00610155|562297|P3|COMPLETED|Period 2||3
233497|NCT00610155|562298|P2|COMPLETED|Period 2||3
233498|NCT00610155|562299|P1|COMPLETED|Period 2||4
233499|NCT00610155|562294|P6|STARTED|Period 2||1
233500|NCT00610155|562295|P5|STARTED|Period 2||3
233501|NCT00610155|562296|P4|STARTED|Period 2||3
233502|NCT00610155|562297|P3|STARTED|Period 2||3
233503|NCT00610155|562298|P2|STARTED|Period 2||3
233504|NCT00610155|562299|P1|STARTED|Period 2||4
233505|NCT00610155|562294|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
233506|NCT00610155|562295|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
233507|NCT00610155|562296|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
233508|NCT00610155|562297|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
233509|NCT00610155|562298|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
233510|NCT00610155|562299|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
233511|NCT00610155|562294|P6|COMPLETED|Washout Period 1 (7 Days)||1
233512|NCT00610155|562295|P5|COMPLETED|Washout Period 1 (7 Days)||3
233513|NCT00610155|562296|P4|COMPLETED|Washout Period 1 (7 Days)||3
233514|NCT00610155|562297|P3|COMPLETED|Washout Period 1 (7 Days)||3
233515|NCT00610155|562298|P2|COMPLETED|Washout Period 1 (7 Days)||3
233516|NCT00610155|562299|P1|COMPLETED|Washout Period 1 (7 Days)||4
233517|NCT00610155|562294|P6|STARTED|Washout Period 1 (7 Days)||1
233518|NCT00610155|562295|P5|STARTED|Washout Period 1 (7 Days)||3
233519|NCT00610155|562296|P4|STARTED|Washout Period 1 (7 Days)||3
233520|NCT00610155|562297|P3|STARTED|Washout Period 1 (7 Days)||3
233521|NCT00610155|562298|P2|STARTED|Washout Period 1 (7 Days)||3
233522|NCT00610155|562299|P1|STARTED|Washout Period 1 (7 Days)||4
233523|NCT00610155|562294|P6|NOT COMPLETED|Period 1||0
233524|NCT00610155|562295|P5|NOT COMPLETED|Period 1||0
233525|NCT00610155|562296|P4|NOT COMPLETED|Period 1||0
233526|NCT00610155|562297|P3|NOT COMPLETED|Period 1||1
233527|NCT00610155|562298|P2|NOT COMPLETED|Period 1||0
233528|NCT00610155|562299|P1|NOT COMPLETED|Period 1||0
233529|NCT00610155|562294|P6|COMPLETED|Period 1||1
233530|NCT00610155|562295|P5|COMPLETED|Period 1||3
233531|NCT00610155|562296|P4|COMPLETED|Period 1||3
233532|NCT00610155|562297|P3|COMPLETED|Period 1||3
233533|NCT00610155|562298|P2|COMPLETED|Period 1||3
233534|NCT00610155|562299|P1|COMPLETED|Period 1||4
233535|NCT00610155|562294|P6|STARTED|Period 1||1
233536|NCT00610155|562295|P5|STARTED|Period 1||3
233537|NCT00610155|562296|P4|STARTED|Period 1||3
233538|NCT00610155|562297|P3|STARTED|Period 1||4
233539|NCT00610155|562298|P2|STARTED|Period 1||3
233540|NCT00610155|562299|P1|STARTED|Period 1||4
233541|NCT00610129|562346|P1|NOT COMPLETED|Overall Study||3
233542|NCT00610129|562346|P1|COMPLETED|Overall Study||25
233543|NCT00610129|562346|P1|STARTED|Overall Study||28
233544|NCT00609986|562352|P2|NOT COMPLETED|Overall Study||3
233545|NCT00609986|562353|P1|NOT COMPLETED|Overall Study||8
233546|NCT00609986|562352|P2|COMPLETED|Overall Study||49
233547|NCT00609986|562353|P1|COMPLETED|Overall Study||44
233548|NCT00609986|562352|P2|Received Transplant|Overall Study||49
233549|NCT00609986|562353|P1|Received Transplant|Overall Study||44
233550|NCT00609986|562352|P2|STARTED|Overall Study||52
233551|NCT00609986|562353|P1|STARTED|Overall Study||52
233552|NCT00609973|562367|P2|NOT COMPLETED|Overall Study||6
233553|NCT00609973|562368|P1|NOT COMPLETED|Overall Study||8
233554|NCT00609973|562367|P2|COMPLETED|Overall Study||10
233555|NCT00609973|562368|P1|COMPLETED|Overall Study||9
233556|NCT00609973|562367|P2|STARTED|Overall Study||16
233557|NCT00609973|562368|P1|STARTED|Overall Study||17
233558|NCT00609947|562376|P1|NOT COMPLETED|Overall Study||1
233559|NCT00609947|562376|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
233560|NCT00609947|562376|P1|STARTED|Overall Study||241
233561|NCT00609869|562381|P1|NOT COMPLETED|Overall Study||11
233562|NCT00609869|562381|P1|COMPLETED|Overall Study||18
233563|NCT00609869|562381|P1|STARTED|Overall Study||29
233564|NCT00609804|562389|P2|NOT COMPLETED|Overall Study||28
233565|NCT00609804|562390|P1|NOT COMPLETED|Overall Study||25
233566|NCT00609804|562389|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
233567|NCT00609804|562390|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
233568|NCT00609804|562389|P2|STARTED|Overall Study||28
233569|NCT00609804|562390|P1|STARTED|Overall Study||25
233570|NCT00609765|562400|P1|NOT COMPLETED|Overall Study||1
233571|NCT00609765|562400|P1|COMPLETED|Overall Study||0
233572|NCT00609765|562400|P1|STARTED|Overall Study||1
233573|NCT00609739|562405|P1|NOT COMPLETED|Overall Study||0
233574|NCT00609739|562405|P1|COMPLETED|Overall Study||1
233575|NCT00609739|562405|P1|STARTED|Overall Study||1
233576|NCT00609674|562414|P2|NOT COMPLETED|Overall Study||7
233577|NCT00609674|562415|P1|NOT COMPLETED|Overall Study||7
233578|NCT00609674|562414|P2|COMPLETED|Overall Study||153
233579|NCT00609674|562415|P1|COMPLETED|Overall Study||148
233580|NCT00609674|562414|P2|STARTED|Overall Study||160
233581|NCT00609674|562415|P1|STARTED|Overall Study||155
233582|NCT00609622|562451|P2|NOT COMPLETED|Overall Study||95
233583|NCT00609622|562452|P1|NOT COMPLETED|Overall Study||96
233584|NCT00609622|562451|P2|COMPLETED|Overall Study||0
233585|NCT00609622|562452|P1|COMPLETED|Overall Study||0
233586|NCT00609622|562451|P2|STARTED|Overall Study||95
233587|NCT00609622|562452|P1|STARTED|Overall Study||96
233588|NCT00609518|562474|P2|NOT COMPLETED|Overall Study||40
233589|NCT00609518|562475|P1|NOT COMPLETED|Overall Study||43
233590|NCT00609518|562474|P2|COMPLETED|Overall Study||17
233591|NCT00609518|562475|P1|COMPLETED|Overall Study||11
233592|NCT00609518|562474|P2|Completed 6 Treatment Cycles|Overall Study||22
233593|NCT00609518|562475|P1|Completed 6 Treatment Cycles|Overall Study||19
233594|NCT00609518|562474|P2|STARTED|Overall Study||57
233595|NCT00609518|562475|P1|STARTED|Overall Study||54
233596|NCT00609492|562490|P3|NOT COMPLETED|Overall Study||7
233597|NCT00609492|562491|P2|NOT COMPLETED|Overall Study||3
233598|NCT00609492|562492|P1|NOT COMPLETED|Overall Study||1
233599|NCT00609492|562490|P3|COMPLETED|Overall Study||122
233600|NCT00609492|562491|P2|COMPLETED|Overall Study||69
233601|NCT00609492|562492|P1|COMPLETED|Overall Study||43
233602|NCT00609492|562490|P3|STARTED|Overall Study||129
233603|NCT00609492|562491|P2|STARTED|Overall Study||72
233604|NCT00609492|562492|P1|STARTED|Overall Study||44
233605|NCT00609466|562577|P3|NOT COMPLETED|Overall Study||4
233606|NCT00609466|562578|P2|NOT COMPLETED|Overall Study||6
233607|NCT00609466|562579|P1|NOT COMPLETED|Overall Study||2
233608|NCT00609466|562577|P3|COMPLETED|Overall Study||95
233609|NCT00609466|562578|P2|COMPLETED|Overall Study||90
233610|NCT00609466|562579|P1|COMPLETED|Overall Study||94
233611|NCT00609466|562577|P3|STARTED|Overall Study||99
233612|NCT00609466|562578|P2|STARTED|Overall Study||96
233613|NCT00609466|562579|P1|STARTED|Overall Study||96
233614|NCT00609362|562607|P2|NOT COMPLETED|Overall Study||1
233615|NCT00609362|562608|P1|NOT COMPLETED|Overall Study||3
233616|NCT00609362|562607|P2|COMPLETED|Overall Study||27
233617|NCT00609362|562608|P1|COMPLETED|Overall Study||26
233618|NCT00609362|562607|P2|STARTED|Overall Study||28
233619|NCT00609362|562608|P1|STARTED|Overall Study||29
233620|NCT00609336|562618|P1|NOT COMPLETED|Overall Study||13
233621|NCT00609336|562618|P1|COMPLETED|Overall Study||22
233622|NCT00609336|562618|P1|Surgery|Overall Study||22
233623|NCT00609336|562618|P1|STARTED|Overall Study||35
233624|NCT00609245|562630|P1|NOT COMPLETED|Overall Study||1
233625|NCT00609245|562630|P1|COMPLETED|Overall Study||12
233626|NCT00609245|562630|P1|STARTED|Overall Study||13
233627|NCT00609167|562638|P2|NOT COMPLETED|Overall Study||7
233628|NCT00609167|562639|P1|NOT COMPLETED|Overall Study||8
233629|NCT00609167|562638|P2|COMPLETED|Overall Study||23
233630|NCT00609167|562639|P1|COMPLETED|Overall Study||25
233631|NCT00609167|562638|P2|STARTED|Overall Study||30
233632|NCT00609167|562639|P1|STARTED|Overall Study||33
233633|NCT00608985|562665|P4|NOT COMPLETED|Overall Study||9
233634|NCT00608985|562666|P3|NOT COMPLETED|Overall Study||6
233635|NCT00608985|562667|P2|NOT COMPLETED|Overall Study||13
233636|NCT00608985|562668|P1|NOT COMPLETED|Overall Study||16
233637|NCT00608985|562665|P4|COMPLETED|Overall Study|Completed follow-up|159
233638|NCT00608985|562666|P3|COMPLETED|Overall Study|Completed follow-up|170
233639|NCT00608985|562667|P2|COMPLETED|Overall Study|Completed follow-up|173
233640|NCT00608985|562668|P1|COMPLETED|Overall Study|Completed follow-up|161
233641|NCT00608985|562665|P4|Completed Double-blind Treatment|Overall Study||161
233642|NCT00608985|562666|P3|Completed Double-blind Treatment|Overall Study||171
233643|NCT00608985|562667|P2|Completed Double-blind Treatment|Overall Study||174
233644|NCT00608985|562668|P1|Completed Double-blind Treatment|Overall Study||163
233645|NCT00608985|562665|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
233646|NCT00608985|562666|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
233647|NCT00608985|562667|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
233648|NCT00608985|562668|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
233649|NCT00608959|562700|P1|NOT COMPLETED|Part 2||0
233650|NCT00608959|562700|P1|COMPLETED|Part 2||25
233651|NCT00608959|562700|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
233652|NCT00608959|562700|P1|NOT COMPLETED|Part 1||1
233653|NCT00608959|562700|P1|COMPLETED|Part 1||24
233654|NCT00608959|562700|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
233655|NCT00608907|562713|P3|NOT COMPLETED|Overall Study||1
233656|NCT00608907|562714|P2|NOT COMPLETED|Overall Study||0
233657|NCT00608907|562715|P1|NOT COMPLETED|Overall Study||12
233658|NCT00608907|562713|P3|COMPLETED|Overall Study||17
233659|NCT00608907|562714|P2|COMPLETED|Overall Study||13
233660|NCT00608907|562715|P1|COMPLETED|Overall Study||18
233661|NCT00608907|562713|P3|STARTED|Overall Study||18
233662|NCT00608907|562714|P2|STARTED|Overall Study||13
233663|NCT00608907|562715|P1|STARTED|Overall Study||30
233664|NCT00608881|562725|P2|NOT COMPLETED|Overall Study||66
233665|NCT00608881|562726|P1|NOT COMPLETED|Overall Study||79
233666|NCT00608881|562725|P2|COMPLETED|Overall Study||240
233667|NCT00608881|562726|P1|COMPLETED|Overall Study||224
233668|NCT00608881|562725|P2|STARTED|Overall Study||306
233669|NCT00608881|562726|P1|STARTED|Overall Study||303
233670|NCT00608868|562760|P1|NOT COMPLETED|Overall Study||15
233671|NCT00608868|562760|P1|COMPLETED|Overall Study||141
233672|NCT00608868|562760|P1|Per Protocol (PP) Population|Overall Study||121
233673|NCT00608868|562760|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
233674|NCT00608868|562760|P1|Treatment Completed|Overall Study||141
233675|NCT00608868|562760|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
233676|NCT00608868|562760|P1|Enrolled|Overall Study||156
233677|NCT00608868|562760|P1|STARTED|Overall Study||156
233678|NCT00608842|562771|P4|NOT COMPLETED|Overall Study||1
233679|NCT00608842|562772|P3|NOT COMPLETED|Overall Study||2
233680|NCT00608842|562773|P2|NOT COMPLETED|Overall Study||1
233681|NCT00608842|562774|P1|NOT COMPLETED|Overall Study||1
233682|NCT00608842|562771|P4|COMPLETED|Overall Study||16
233683|NCT00608842|562772|P3|COMPLETED|Overall Study||13
233684|NCT00608842|562773|P2|COMPLETED|Overall Study||14
233685|NCT00608842|562774|P1|COMPLETED|Overall Study||14
233686|NCT00608842|562771|P4|STARTED|Overall Study||17
233687|NCT00608842|562772|P3|STARTED|Overall Study||15
233688|NCT00608842|562773|P2|STARTED|Overall Study||15
233689|NCT00608842|562774|P1|STARTED|Overall Study||15
233690|NCT00608829|562808|P1|NOT COMPLETED|Overall Study||15
233691|NCT00608829|562808|P1|COMPLETED|Overall Study||8
233692|NCT00608829|562808|P1|STARTED|Overall Study||23
233693|NCT00608777|562812|P1|NOT COMPLETED|Overall Study||0
233694|NCT00608777|562812|P1|COMPLETED|Overall Study||6
233695|NCT00608777|562812|P1|STARTED|Overall Study||6
233696|NCT00608634|562819|P3|NOT COMPLETED|Overall Study||1
233697|NCT00608634|562820|P2|NOT COMPLETED|Overall Study||1
233698|NCT00608634|562821|P1|NOT COMPLETED|Overall Study||2
233699|NCT00608634|562819|P3|COMPLETED|Overall Study||27
233700|NCT00608634|562820|P2|COMPLETED|Overall Study||26
233701|NCT00608634|562821|P1|COMPLETED|Overall Study||26
233702|NCT00608634|562819|P3|STARTED|Overall Study||28
233703|NCT00608634|562820|P2|STARTED|Overall Study||27
233704|NCT00608634|562821|P1|STARTED|Overall Study||28
233705|NCT00608582|562834|P2|NOT COMPLETED|Overall Study||4
233706|NCT00608582|562835|P1|NOT COMPLETED|Overall Study||4
233707|NCT00608582|562834|P2|COMPLETED|Overall Study||7
233708|NCT00608582|562835|P1|COMPLETED|Overall Study||10
233709|NCT00608582|562834|P2|STARTED|Overall Study||11
233710|NCT00608582|562835|P1|STARTED|Overall Study||14
233711|NCT00608569|562845|P2|NOT COMPLETED|Overall Study||9
233712|NCT00608569|562846|P1|NOT COMPLETED|Overall Study||10
233713|NCT00608569|562845|P2|COMPLETED|Overall Study||119
233714|NCT00608569|562846|P1|COMPLETED|Overall Study||119
233715|NCT00608569|562845|P2|STARTED|Overall Study||128
233716|NCT00608569|562846|P1|STARTED|Overall Study||129
233717|NCT00608543|562866|P1|NOT COMPLETED|Overall Study||4
233718|NCT00608543|562866|P1|COMPLETED|Overall Study||13
233719|NCT00608543|562866|P1|STARTED|Overall Study||17
233720|NCT00608530|562879|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
233721|NCT00608530|562880|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
233722|NCT00608530|562881|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
233723|NCT00608530|562882|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
233724|NCT00608530|562879|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
233725|NCT00608530|562880|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
233726|NCT00608530|562881|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
233727|NCT00608530|562882|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
233728|NCT00608530|562879|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
233729|NCT00608530|562880|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
233730|NCT00608530|562881|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
233731|NCT00608530|562882|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
233732|NCT00608530|562879|P4|STARTED|Study 2 Nurse-delivered Treatments||34
233733|NCT00608530|562880|P3|STARTED|Study 2 Nurse-delivered Treatments||33
233734|NCT00608530|562881|P2|STARTED|Study 2 Nurse-delivered Treatments||0
233735|NCT00608530|562882|P1|STARTED|Study 2 Nurse-delivered Treatments||0
233736|NCT00608530|562879|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
233737|NCT00608530|562880|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
233738|NCT00608530|562881|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
233739|NCT00608530|562882|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
233740|NCT00608530|562879|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
233741|NCT00608530|562880|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
233742|NCT00608530|562881|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
233743|NCT00608530|562882|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
233744|NCT00608530|562879|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
233745|NCT00608530|562880|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
233746|NCT00608530|562881|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
233747|NCT00608530|562882|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
233748|NCT00608530|562879|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
233749|NCT00608530|562880|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
233750|NCT00608530|562881|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
233751|NCT00608530|562882|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
233752|NCT00608517|562903|P3|NOT COMPLETED|Overall Study||0
233753|NCT00608517|562904|P2|NOT COMPLETED|Overall Study||0
233754|NCT00608517|562905|P1|NOT COMPLETED|Overall Study||1
233755|NCT00608517|562903|P3|COMPLETED|Overall Study||1
233756|NCT00608517|562904|P2|COMPLETED|Overall Study||3
233757|NCT00608517|562905|P1|COMPLETED|Overall Study||1
233758|NCT00608517|562903|P3|STARTED|Overall Study||1
233759|NCT00608517|562904|P2|STARTED|Overall Study||3
233760|NCT00608517|562905|P1|STARTED|Overall Study||2
233761|NCT00608491|562933|P2|NOT COMPLETED|Overall Study||22
233762|NCT00608491|562934|P1|NOT COMPLETED|Overall Study||21
233763|NCT00608491|562933|P2|COMPLETED|Overall Study||72
233764|NCT00608491|562934|P1|COMPLETED|Overall Study||73
233765|NCT00608491|562933|P2|STARTED|Overall Study||94
233766|NCT00608491|562934|P1|STARTED|Overall Study||94
233767|NCT00608465|563078|P1|NOT COMPLETED|Overall Study||0
233768|NCT00608465|563078|P1|COMPLETED|Overall Study||4
233769|NCT00608465|563078|P1|STARTED|Overall Study||4
233770|NCT00608426|563085|P2|NOT COMPLETED|Overall Study||905
233771|NCT00608426|563086|P1|NOT COMPLETED|Overall Study||836
233772|NCT00608426|563085|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
233773|NCT00608426|563086|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
233774|NCT00608426|563085|P2|STARTED|Overall Study||2519
233775|NCT00608426|563086|P1|STARTED|Overall Study||2604
233776|NCT00608322|563098|P2|NOT COMPLETED|Overall Study||1
233777|NCT00608322|563099|P1|NOT COMPLETED|Overall Study||2
233778|NCT00608322|563098|P2|COMPLETED|Overall Study||22
233779|NCT00608322|563099|P1|COMPLETED|Overall Study||24
233780|NCT00608322|563098|P2|STARTED|Overall Study||23
233781|NCT00608322|563099|P1|STARTED|Overall Study||26
233782|NCT00608244|563105|P1|NOT COMPLETED|Overall Study||2
233783|NCT00608244|563105|P1|COMPLETED|Overall Study||57
233784|NCT00608244|563105|P1|STARTED|Overall Study||59
233785|NCT00608205|563116|P2|NOT COMPLETED|Overall Study||3
233786|NCT00608205|563117|P1|NOT COMPLETED|Overall Study||3
233787|NCT00608205|563116|P2|COMPLETED|Overall Study||31
233788|NCT00608205|563117|P1|COMPLETED|Overall Study||32
233789|NCT00608205|563116|P2|STARTED|Overall Study||34
233790|NCT00608205|563117|P1|STARTED|Overall Study||35
233791|NCT00608140|563207|P2|NOT COMPLETED|Overall Study||1
233792|NCT00608140|563208|P1|NOT COMPLETED|Overall Study||1
233793|NCT00608140|563207|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
233794|NCT00608140|563208|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
233795|NCT00608140|563207|P2|STARTED|Overall Study||1
233796|NCT00608140|563208|P1|STARTED|Overall Study||1
233797|NCT00608023|563234|P3|NOT COMPLETED|Overall Study||14
233798|NCT00608023|563235|P2|NOT COMPLETED|Overall Study||22
233799|NCT00608023|563236|P1|NOT COMPLETED|Overall Study||12
233800|NCT00608023|563234|P3|COMPLETED|Overall Study||72
233801|NCT00608023|563235|P2|COMPLETED|Overall Study||63
233802|NCT00608023|563236|P1|COMPLETED|Overall Study||80
233803|NCT00608023|563234|P3|STARTED|Overall Study||86
233804|NCT00608023|563235|P2|STARTED|Overall Study||85
233805|NCT00608023|563236|P1|STARTED|Overall Study||92
233806|NCT00607997|563260|P4|NOT COMPLETED|Overall Study||16
233807|NCT00607997|563261|P3|NOT COMPLETED|Overall Study||24
233808|NCT00607997|563262|P2|NOT COMPLETED|Overall Study||27
233809|NCT00607997|563263|P1|NOT COMPLETED|Overall Study||27
233810|NCT00607997|563260|P4|COMPLETED|Overall Study||4
233811|NCT00607997|563261|P3|COMPLETED|Overall Study||5
233812|NCT00607997|563262|P2|COMPLETED|Overall Study||8
233813|NCT00607997|563263|P1|COMPLETED|Overall Study||2
233814|NCT00607997|563260|P4|STARTED|Overall Study||20
233815|NCT00607997|563261|P3|STARTED|Overall Study||29
233816|NCT00607997|563262|P2|STARTED|Overall Study||35
233817|NCT00607997|563263|P1|STARTED|Overall Study||29
233818|NCT00607919|563321|P2|NOT COMPLETED|Open-Label Phase||12
233819|NCT00607919|563322|P1|NOT COMPLETED|Open-Label Phase||10
233820|NCT00607919|563321|P2|COMPLETED|Open-Label Phase||59
233821|NCT00607919|563322|P1|COMPLETED|Open-Label Phase||74
233822|NCT00607919|563321|P2|STARTED|Open-Label Phase||71
233823|NCT00607919|563322|P1|STARTED|Open-Label Phase||84
233824|NCT00607919|563321|P2|NOT COMPLETED|Acute Phase||16
233825|NCT00607919|563322|P1|NOT COMPLETED|Acute Phase||34
233826|NCT00607919|563321|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
233827|NCT00607919|563322|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
233828|NCT00607919|563321|P2|STARTED|Acute Phase||89
233829|NCT00607919|563322|P1|STARTED|Acute Phase||120
233830|NCT00607893|563380|P2|NOT COMPLETED|Overall Study||4
233831|NCT00607893|563381|P1|NOT COMPLETED|Overall Study||6
233832|NCT00607893|563380|P2|COMPLETED|Overall Study||72
233833|NCT00607893|563381|P1|COMPLETED|Overall Study||71
233834|NCT00607893|563380|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
233835|NCT00607893|563381|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
233836|NCT00607893|563380|P2|Completed 8 Week Visit|Overall Study||72
233837|NCT00607893|563381|P1|Completed 8 Week Visit|Overall Study||71
233838|NCT00607893|563380|P2|Completed Baseline Visit|Overall Study||75
233839|NCT00607893|563381|P1|Completed Baseline Visit|Overall Study||74
233840|NCT00607893|563380|P2|STARTED|Overall Study||76
233841|NCT00607893|563381|P1|STARTED|Overall Study||77
233842|NCT00607880|563409|P2|NOT COMPLETED|Overall Study||0
233843|NCT00607880|563410|P1|NOT COMPLETED|Overall Study||1
233844|NCT00607880|563409|P2|COMPLETED|Overall Study||50
233845|NCT00607880|563410|P1|COMPLETED|Overall Study||49
233846|NCT00607880|563409|P2|STARTED|Overall Study||50
233847|NCT00607880|563410|P1|STARTED|Overall Study||50
233848|NCT00607867|563424|P2|NOT COMPLETED|Overall Study||0
233849|NCT00607867|563425|P1|NOT COMPLETED|Overall Study||0
233850|NCT00607867|563424|P2|COMPLETED|Overall Study||7
233851|NCT00607867|563425|P1|COMPLETED|Overall Study||7
233852|NCT00607867|563424|P2|STARTED|Overall Study||7
233853|NCT00607867|563425|P1|STARTED|Overall Study||7
233854|NCT00607815|563443|P2|NOT COMPLETED|Overall Study||11
233855|NCT00607815|563444|P1|NOT COMPLETED|Overall Study||23
233856|NCT00607815|563443|P2|COMPLETED|Overall Study||25
233857|NCT00607815|563444|P1|COMPLETED|Overall Study||20
233858|NCT00607815|563443|P2|STARTED|Overall Study||36
233859|NCT00607815|563444|P1|STARTED|Overall Study||43
233860|NCT00607789|563460|P2|NOT COMPLETED|Overall Study||6
233861|NCT00607789|563461|P1|NOT COMPLETED|Overall Study||7
233862|NCT00607789|563460|P2|COMPLETED|Overall Study||14
233863|NCT00607789|563461|P1|COMPLETED|Overall Study||13
233864|NCT00607789|563460|P2|STARTED|Overall Study||20
233865|NCT00607789|563461|P1|STARTED|Overall Study|20 participants were randomized in each group|20
233866|NCT00607724|563476|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
233867|NCT00607724|563477|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
233868|NCT00607724|563478|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
233869|NCT00607724|563479|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
233870|NCT00607724|563480|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
233871|NCT00607724|563481|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
233872|NCT00607724|563482|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
233873|NCT00607724|563476|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
233874|NCT00607724|563477|P6|COMPLETED|Stage 2: Expanded Cohort||0
233875|NCT00607724|563478|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
233876|NCT00607724|563479|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
233877|NCT00607724|563480|P3|COMPLETED|Stage 2: Expanded Cohort||0
233878|NCT00607724|563481|P2|COMPLETED|Stage 2: Expanded Cohort||0
233879|NCT00607724|563482|P1|COMPLETED|Stage 2: Expanded Cohort||0
233880|NCT00607724|563476|P7|STARTED|Stage 2: Expanded Cohort||16
233881|NCT00607724|563477|P6|STARTED|Stage 2: Expanded Cohort||12
233882|NCT00607724|563478|P5|STARTED|Stage 2: Expanded Cohort||14
233883|NCT00607724|563479|P4|STARTED|Stage 2: Expanded Cohort||6
233884|NCT00607724|563480|P3|STARTED|Stage 2: Expanded Cohort||0
233885|NCT00607724|563481|P2|STARTED|Stage 2: Expanded Cohort||0
233886|NCT00607724|563482|P1|STARTED|Stage 2: Expanded Cohort||0
233887|NCT00607724|563476|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
233888|NCT00607724|563477|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
233889|NCT00607724|563478|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
233890|NCT00607724|563479|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
233891|NCT00607724|563480|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
233892|NCT00607724|563481|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
233893|NCT00607724|563482|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
233894|NCT00607724|563476|P7|COMPLETED|Stage 1: Dose Escalation||0
233895|NCT00607724|563477|P6|COMPLETED|Stage 1: Dose Escalation||0
233896|NCT00607724|563478|P5|COMPLETED|Stage 1: Dose Escalation||0
233897|NCT00607724|563479|P4|COMPLETED|Stage 1: Dose Escalation||0
233898|NCT00607724|563480|P3|COMPLETED|Stage 1: Dose Escalation||0
233899|NCT00607724|563481|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
233900|NCT00607724|563482|P1|COMPLETED|Stage 1: Dose Escalation||0
233901|NCT00607724|563476|P7|STARTED|Stage 1: Dose Escalation||0
233902|NCT00607724|563477|P6|STARTED|Stage 1: Dose Escalation||0
233903|NCT00607724|563478|P5|STARTED|Stage 1: Dose Escalation||0
233904|NCT00607724|563479|P4|STARTED|Stage 1: Dose Escalation||0
233905|NCT00607724|563480|P3|STARTED|Stage 1: Dose Escalation||4
233906|NCT00607724|563481|P2|STARTED|Stage 1: Dose Escalation||9
233907|NCT00607724|563482|P1|STARTED|Stage 1: Dose Escalation||7
233908|NCT00607672|563561|P3|NOT COMPLETED|Overall Study||5
233909|NCT00607672|563562|P2|NOT COMPLETED|Overall Study||3
233910|NCT00607672|563563|P1|NOT COMPLETED|Overall Study||4
233911|NCT00607672|563561|P3|COMPLETED|Overall Study||22
233912|NCT00607672|563562|P2|COMPLETED|Overall Study||24
233913|NCT00607672|563563|P1|COMPLETED|Overall Study||28
233914|NCT00607672|563561|P3|STARTED|Overall Study||27
233915|NCT00607672|563562|P2|STARTED|Overall Study||27
233916|NCT00607672|563563|P1|STARTED|Overall Study||32
233917|NCT00607620|563609|P2|NOT COMPLETED|Overall Study||0
233918|NCT00607620|563610|P1|NOT COMPLETED|Overall Study||0
233919|NCT00607620|563609|P2|COMPLETED|Overall Study||469
233920|NCT00607620|563610|P1|COMPLETED|Overall Study||409
233921|NCT00607620|563609|P2|STARTED|Overall Study||469
233922|NCT00607620|563610|P1|STARTED|Overall Study||409
233923|NCT00607594|563624|P1|NOT COMPLETED|Overall Study||0
233924|NCT00607594|563624|P1|COMPLETED|Overall Study||21
233925|NCT00607594|563624|P1|STARTED|Overall Study||21
233926|NCT00607477|563633|P2|NOT COMPLETED|Overall Study||0
233927|NCT00607477|563634|P1|NOT COMPLETED|Overall Study||0
233928|NCT00607477|563633|P2|COMPLETED|Overall Study||2
233929|NCT00607477|563634|P1|COMPLETED|Overall Study||0
233930|NCT00607477|563633|P2|STARTED|Overall Study||2
233931|NCT00607477|563634|P1|STARTED|Overall Study||0
233932|NCT00607386|563640|P1|NOT COMPLETED|Overall Study||1
233933|NCT00607386|563640|P1|COMPLETED|Overall Study||27
233934|NCT00607386|563640|P1|STARTED|Overall Study||28
233935|NCT00607373|563655|P2|NOT COMPLETED|Follow-up Period||5
233936|NCT00607373|563656|P1|NOT COMPLETED|Follow-up Period||1
233937|NCT00607373|563655|P2|COMPLETED|Follow-up Period||6
233938|NCT00607373|563656|P1|COMPLETED|Follow-up Period||0
233939|NCT00607373|563655|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
233940|NCT00607373|563656|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
233941|NCT00607373|563655|P2|NOT COMPLETED|Treatment Period||6
233942|NCT00607373|563656|P1|NOT COMPLETED|Treatment Period||0
233943|NCT00607373|563655|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
233944|NCT00607373|563656|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
233945|NCT00607373|563655|P2|STARTED|Treatment Period||34
233946|NCT00607373|563656|P1|STARTED|Treatment Period||17
233947|NCT00607321|563700|P1|NOT COMPLETED|Overall Study||0
233948|NCT00607321|563700|P1|COMPLETED|Overall Study||60
233949|NCT00607321|563700|P1|STARTED|Overall Study||60
233950|NCT00607269|563710|P2|NOT COMPLETED|Overall Study||0
233951|NCT00607269|563711|P1|NOT COMPLETED|Overall Study||0
233952|NCT00607269|563710|P2|COMPLETED|Overall Study||64
233953|NCT00607269|563711|P1|COMPLETED|Overall Study||67
233954|NCT00607269|563710|P2|STARTED|Overall Study||64
233955|NCT00607269|563711|P1|STARTED|Overall Study||67
233956|NCT00607243|563725|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
233957|NCT00607243|563726|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
233958|NCT00607243|563725|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
233959|NCT00607243|563726|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
233960|NCT00607243|563725|P2|STARTED|Telephone Safety Assessment Period||41
233961|NCT00607243|563726|P1|STARTED|Telephone Safety Assessment Period||82
233962|NCT00607243|563725|P2|NOT COMPLETED|Initial Post-vaccination Period||0
233963|NCT00607243|563726|P1|NOT COMPLETED|Initial Post-vaccination Period||0
233964|NCT00607243|563725|P2|COMPLETED|Initial Post-vaccination Period||41
233965|NCT00607243|563726|P1|COMPLETED|Initial Post-vaccination Period||82
233966|NCT00607243|563725|P2|STARTED|Initial Post-vaccination Period||41
233967|NCT00607243|563726|P1|STARTED|Initial Post-vaccination Period||82
233968|NCT00607126|563734|P2|NOT COMPLETED|Overall Study||0
233969|NCT00607126|563735|P1|NOT COMPLETED|Overall Study||0
233970|NCT00607126|563734|P2|COMPLETED|Overall Study||19
233971|NCT00607126|563735|P1|COMPLETED|Overall Study||17
233972|NCT00607126|563734|P2|STARTED|Overall Study||19
233973|NCT00607126|563735|P1|STARTED|Overall Study||17
233974|NCT00607113|563749|P2|NOT COMPLETED|Overall Study||0
233975|NCT00607113|563750|P1|NOT COMPLETED|Overall Study||0
233976|NCT00607113|563749|P2|COMPLETED|Overall Study||20
233977|NCT00607113|563750|P1|COMPLETED|Overall Study||19
233978|NCT00607113|563749|P2|STARTED|Overall Study||20
233979|NCT00607113|563750|P1|STARTED|Overall Study||19
233980|NCT00607087|563758|P3|NOT COMPLETED|Period 3||0
233981|NCT00607087|563759|P2|NOT COMPLETED|Period 3||2
233982|NCT00607087|563760|P1|NOT COMPLETED|Period 3||2
233983|NCT00607087|563758|P3|COMPLETED|Period 3||84
233984|NCT00607087|563759|P2|COMPLETED|Period 3||84
233985|NCT00607087|563760|P1|COMPLETED|Period 3||84
233986|NCT00607087|563758|P3|STARTED|Period 3||84
233987|NCT00607087|563759|P2|STARTED|Period 3||86
233988|NCT00607087|563760|P1|STARTED|Period 3||86
233989|NCT00607087|563758|P3|NOT COMPLETED|Period 2||5
233990|NCT00607087|563759|P2|NOT COMPLETED|Period 2||3
233991|NCT00607087|563760|P1|NOT COMPLETED|Period 2||1
233992|NCT00607087|563758|P3|COMPLETED|Period 2||84
233993|NCT00607087|563759|P2|COMPLETED|Period 2||86
233994|NCT00607087|563760|P1|COMPLETED|Period 2||86
233995|NCT00607087|563758|P3|STARTED|Period 2||89
233996|NCT00607087|563759|P2|STARTED|Period 2||89
233997|NCT00607087|563760|P1|STARTED|Period 2||87
233998|NCT00607087|563758|P3|NOT COMPLETED|Period 1||5
233999|NCT00607087|563759|P2|NOT COMPLETED|Period 1||6
234000|NCT00607087|563760|P1|NOT COMPLETED|Period 1||12
234001|NCT00607087|563758|P3|COMPLETED|Period 1||89
234002|NCT00607087|563759|P2|COMPLETED|Period 1||89
234003|NCT00607087|563760|P1|COMPLETED|Period 1||87
234004|NCT00607087|563758|P3|STARTED|Period 1||94
234005|NCT00607087|563759|P2|STARTED|Period 1||95
234006|NCT00607087|563760|P1|STARTED|Period 1||99
234007|NCT00607087|563758|P3|NOT COMPLETED|Overall Study||10
234008|NCT00607087|563759|P2|NOT COMPLETED|Overall Study||11
234009|NCT00607087|563760|P1|NOT COMPLETED|Overall Study||15
234010|NCT00607087|563758|P3|COMPLETED|Overall Study||84
234011|NCT00607087|563759|P2|COMPLETED|Overall Study||84
234012|NCT00607087|563760|P1|COMPLETED|Overall Study||84
234013|NCT00607087|563758|P3|STARTED|Overall Study||94
234014|NCT00607087|563759|P2|STARTED|Overall Study||95
234015|NCT00607087|563760|P1|STARTED|Overall Study||99
234016|NCT00607048|563818|P6|NOT COMPLETED|Overall Study||5
234017|NCT00607048|563819|P5|NOT COMPLETED|Overall Study||6
234018|NCT00607048|563820|P4|NOT COMPLETED|Overall Study||3
234019|NCT00607048|563821|P3|NOT COMPLETED|Overall Study||4
234020|NCT00607048|563822|P2|NOT COMPLETED|Overall Study||4
234021|NCT00607048|563823|P1|NOT COMPLETED|Overall Study||3
234022|NCT00607048|563818|P6|COMPLETED|Overall Study||2
234023|NCT00607048|563819|P5|COMPLETED|Overall Study||0
234024|NCT00607048|563820|P4|COMPLETED|Overall Study||0
234025|NCT00607048|563821|P3|COMPLETED|Overall Study||3
234026|NCT00607048|563822|P2|COMPLETED|Overall Study||2
234027|NCT00607048|563823|P1|COMPLETED|Overall Study||0
234028|NCT00607048|563818|P6|STARTED|Overall Study||7
234029|NCT00607048|563819|P5|STARTED|Overall Study||6
234030|NCT00607048|563820|P4|STARTED|Overall Study||3
234031|NCT00607048|563821|P3|STARTED|Overall Study||7
234032|NCT00607048|563822|P2|STARTED|Overall Study||6
234033|NCT00607048|563823|P1|STARTED|Overall Study||3
234034|NCT00606944|563907|P2|NOT COMPLETED|Overall Study||0
234035|NCT00606944|563908|P1|NOT COMPLETED|Overall Study||0
234036|NCT00606944|563907|P2|COMPLETED|Overall Study||100
234037|NCT00606944|563908|P1|COMPLETED|Overall Study||98
234038|NCT00606944|563907|P2|STARTED|Overall Study||100
234039|NCT00606944|563908|P1|STARTED|Overall Study||98
234040|NCT00606931|563914|P1|NOT COMPLETED|Overall Study||3
234041|NCT00606931|563914|P1|COMPLETED|Overall Study||19
234042|NCT00606931|563914|P1|STARTED|Overall Study||22
234043|NCT00606905|563922|P2|NOT COMPLETED|Overall Study||15
234044|NCT00606905|563923|P1|NOT COMPLETED|Overall Study||15
234045|NCT00606905|563922|P2|COMPLETED|Overall Study||24
234046|NCT00606905|563923|P1|COMPLETED|Overall Study||23
234047|NCT00606905|563922|P2|Pregnancy|Overall Study||33
234048|NCT00606905|563923|P1|Pregnancy|Overall Study||29
234049|NCT00606905|563922|P2|STARTED|Overall Study||39
234050|NCT00606905|563923|P1|STARTED|Overall Study||38
234051|NCT00606892|563929|P2|NOT COMPLETED|Second Intervention||0
234052|NCT00606892|563930|P1|NOT COMPLETED|Second Intervention||0
234053|NCT00606892|563929|P2|COMPLETED|Second Intervention||4
234054|NCT00606892|563930|P1|COMPLETED|Second Intervention||8
234055|NCT00606892|563929|P2|STARTED|Second Intervention||4
234056|NCT00606892|563930|P1|STARTED|Second Intervention||8
234057|NCT00606892|563929|P2|NOT COMPLETED|Washout Period||0
234058|NCT00606892|563930|P1|NOT COMPLETED|Washout Period||0
234059|NCT00606892|563929|P2|COMPLETED|Washout Period||4
234060|NCT00606892|563930|P1|COMPLETED|Washout Period||8
234061|NCT00606892|563929|P2|STARTED|Washout Period||4
234062|NCT00606892|563930|P1|STARTED|Washout Period||8
234063|NCT00606892|563929|P2|NOT COMPLETED|First Intervention||4
234064|NCT00606892|563930|P1|NOT COMPLETED|First Intervention||1
234065|NCT00606892|563929|P2|COMPLETED|First Intervention||4
234066|NCT00606892|563930|P1|COMPLETED|First Intervention||8
234067|NCT00606892|563929|P2|STARTED|First Intervention||8
234068|NCT00606892|563930|P1|STARTED|First Intervention||9
234069|NCT00606892|563929|P2|NOT COMPLETED|Adaptation||0
234070|NCT00606892|563930|P1|NOT COMPLETED|Adaptation||0
234071|NCT00606892|563929|P2|COMPLETED|Adaptation||8
234072|NCT00606892|563930|P1|COMPLETED|Adaptation||9
234073|NCT00606892|563929|P2|STARTED|Adaptation||8
234074|NCT00606892|563930|P1|STARTED|Adaptation||9
234075|NCT00606801|563964|P2|NOT COMPLETED|Intervention||3
234076|NCT00606801|563965|P1|NOT COMPLETED|Intervention||3
234077|NCT00606801|563964|P2|COMPLETED|Intervention||14
234078|NCT00606801|563965|P1|COMPLETED|Intervention||14
234079|NCT00606801|563964|P2|STARTED|Intervention||17
234080|NCT00606801|563965|P1|STARTED|Intervention||17
234081|NCT00606801|563964|P2|NOT COMPLETED|Adaptation||0
234082|NCT00606801|563965|P1|NOT COMPLETED|Adaptation||0
234083|NCT00606801|563964|P2|COMPLETED|Adaptation||17
234084|NCT00606801|563965|P1|COMPLETED|Adaptation||17
234085|NCT00606801|563964|P2|STARTED|Adaptation||17
234086|NCT00606801|563965|P1|STARTED|Adaptation||17
234087|NCT00606684|563993|P7|NOT COMPLETED|Double-Blind Treatment Period||8
234088|NCT00606684|563994|P6|NOT COMPLETED|Double-Blind Treatment Period||9
234089|NCT00606684|563995|P5|NOT COMPLETED|Double-Blind Treatment Period||9
234090|NCT00606684|563996|P4|NOT COMPLETED|Double-Blind Treatment Period||10
234091|NCT00606684|563997|P3|NOT COMPLETED|Double-Blind Treatment Period||11
234092|NCT00606684|563998|P2|NOT COMPLETED|Double-Blind Treatment Period||16
234093|NCT00606684|563999|P1|NOT COMPLETED|Double-Blind Treatment Period||0
234094|NCT00606684|563993|P7|COMPLETED|Double-Blind Treatment Period||91
234095|NCT00606684|563994|P6|COMPLETED|Double-Blind Treatment Period||92
234096|NCT00606684|563995|P5|COMPLETED|Double-Blind Treatment Period||92
234097|NCT00606684|563996|P4|COMPLETED|Double-Blind Treatment Period||91
234098|NCT00606684|563997|P3|COMPLETED|Double-Blind Treatment Period||88
234099|NCT00606684|563998|P2|COMPLETED|Double-Blind Treatment Period||85
234100|NCT00606684|563999|P1|COMPLETED|Double-Blind Treatment Period||0
234101|NCT00606684|563993|P7|STARTED|Double-Blind Treatment Period||99
234102|NCT00606684|563994|P6|STARTED|Double-Blind Treatment Period||101
234103|NCT00606684|563995|P5|STARTED|Double-Blind Treatment Period||101
234104|NCT00606684|563996|P4|STARTED|Double-Blind Treatment Period||101
234105|NCT00606684|563997|P3|STARTED|Double-Blind Treatment Period||99
234106|NCT00606684|563998|P2|STARTED|Double-Blind Treatment Period||101
234107|NCT00606684|563999|P1|STARTED|Double-Blind Treatment Period||0
234108|NCT00606684|563993|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
234109|NCT00606684|563994|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
234110|NCT00606684|563995|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
234111|NCT00606684|563996|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
234112|NCT00606684|563997|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
234113|NCT00606684|563998|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
234114|NCT00606684|563999|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
234115|NCT00606684|563993|P7|COMPLETED|2-week Single-Blind Run-in Period||0
234116|NCT00606684|563994|P6|COMPLETED|2-week Single-Blind Run-in Period||0
234117|NCT00606684|563995|P5|COMPLETED|2-week Single-Blind Run-in Period||0
234118|NCT00606684|563996|P4|COMPLETED|2-week Single-Blind Run-in Period||0
234119|NCT00606684|563997|P3|COMPLETED|2-week Single-Blind Run-in Period||0
234120|NCT00606684|563998|P2|COMPLETED|2-week Single-Blind Run-in Period||0
234121|NCT00606684|563999|P1|COMPLETED|2-week Single-Blind Run-in Period||605
234122|NCT00606684|563993|P7|STARTED|2-week Single-Blind Run-in Period||0
234123|NCT00606684|563994|P6|STARTED|2-week Single-Blind Run-in Period||0
234124|NCT00606684|563995|P5|STARTED|2-week Single-Blind Run-in Period||0
234125|NCT00606684|563996|P4|STARTED|2-week Single-Blind Run-in Period||0
234126|NCT00606684|563997|P3|STARTED|2-week Single-Blind Run-in Period||0
234127|NCT00606684|563998|P2|STARTED|2-week Single-Blind Run-in Period||0
234128|NCT00606684|563999|P1|STARTED|2-week Single-Blind Run-in Period||851
234129|NCT00606632|564031|P1|NOT COMPLETED|Overall Study||22
234130|NCT00606632|564031|P1|COMPLETED|Overall Study||204
234131|NCT00606632|564031|P1|STARTED|Overall Study||226
234132|NCT00606593|564038|P10|NOT COMPLETED|Overall Study||0
234133|NCT00606593|564039|P9|NOT COMPLETED|Overall Study||1
234134|NCT00606593|564040|P8|NOT COMPLETED|Overall Study||2
234135|NCT00606593|564041|P7|NOT COMPLETED|Overall Study||1
234136|NCT00606593|564042|P6|NOT COMPLETED|Overall Study||0
234137|NCT00606593|564043|P5|NOT COMPLETED|Overall Study||1
234138|NCT00606593|564044|P4|NOT COMPLETED|Overall Study||1
234139|NCT00606593|564045|P3|NOT COMPLETED|Overall Study||2
234140|NCT00606593|564046|P2|NOT COMPLETED|Overall Study||0
234141|NCT00606593|564047|P1|NOT COMPLETED|Overall Study||1
234142|NCT00606593|564038|P10|COMPLETED|Overall Study||11
234143|NCT00606593|564039|P9|COMPLETED|Overall Study||11
234144|NCT00606593|564040|P8|COMPLETED|Overall Study||9
234145|NCT00606593|564041|P7|COMPLETED|Overall Study||10
234146|NCT00606593|564042|P6|COMPLETED|Overall Study||11
234147|NCT00606593|564043|P5|COMPLETED|Overall Study||11
234148|NCT00606593|564044|P4|COMPLETED|Overall Study||10
234149|NCT00606593|564045|P3|COMPLETED|Overall Study||9
234150|NCT00606593|564046|P2|COMPLETED|Overall Study||11
234151|NCT00606593|564047|P1|COMPLETED|Overall Study||10
234152|NCT00606593|564038|P10|5th Double-blind Treatment|Overall Study||11
234153|NCT00606593|564039|P9|5th Double-blind Treatment|Overall Study||11
234154|NCT00606593|564040|P8|5th Double-blind Treatment|Overall Study||9
234155|NCT00606593|564041|P7|5th Double-blind Treatment|Overall Study||10
234156|NCT00606593|564042|P6|5th Double-blind Treatment|Overall Study||11
234157|NCT00606593|564043|P5|5th Double-blind Treatment|Overall Study||11
234158|NCT00606593|564044|P4|5th Double-blind Treatment|Overall Study||10
234159|NCT00606593|564045|P3|5th Double-blind Treatment|Overall Study||9
234160|NCT00606593|564046|P2|5th Double-blind Treatment|Overall Study||11
234161|NCT00606593|564047|P1|5th Double-blind Treatment|Overall Study||10
234162|NCT00606593|564038|P10|4th Double-blind Treatment|Overall Study||11
234163|NCT00606593|564039|P9|4th Double-blind Treatment|Overall Study||11
234164|NCT00606593|564040|P8|4th Double-blind Treatment|Overall Study||9
234165|NCT00606593|564041|P7|4th Double-blind Treatment|Overall Study||10
234166|NCT00606593|564042|P6|4th Double-blind Treatment|Overall Study||11
234167|NCT00606593|564043|P5|4th Double-blind Treatment|Overall Study||11
234168|NCT00606593|564044|P4|4th Double-blind Treatment|Overall Study||10
234169|NCT00606593|564045|P3|4th Double-blind Treatment|Overall Study||10
234170|NCT00606593|564046|P2|4th Double-blind Treatment|Overall Study||11
234171|NCT00606593|564047|P1|4th Double-blind Treatment|Overall Study||10
234172|NCT00606593|564038|P10|3rd Double-blind Treatment|Overall Study||11
234173|NCT00606593|564039|P9|3rd Double-blind Treatment|Overall Study||12
234174|NCT00606593|564040|P8|3rd Double-blind Treatment|Overall Study||9
234175|NCT00606593|564041|P7|3rd Double-blind Treatment|Overall Study||10
234176|NCT00606593|564042|P6|3rd Double-blind Treatment|Overall Study||11
234177|NCT00606593|564043|P5|3rd Double-blind Treatment|Overall Study||11
234178|NCT00606593|564044|P4|3rd Double-blind Treatment|Overall Study||10
234179|NCT00606593|564045|P3|3rd Double-blind Treatment|Overall Study||10
234180|NCT00606593|564046|P2|3rd Double-blind Treatment|Overall Study||11
234181|NCT00606593|564047|P1|3rd Double-blind Treatment|Overall Study||11
234182|NCT00606593|564038|P10|2nd Double-blind Treatment|Overall Study||11
234183|NCT00606593|564039|P9|2nd Double-blind Treatment|Overall Study||12
234184|NCT00606593|564040|P8|2nd Double-blind Treatment|Overall Study||9
234185|NCT00606593|564041|P7|2nd Double-blind Treatment|Overall Study||10
234186|NCT00606593|564042|P6|2nd Double-blind Treatment|Overall Study||11
234187|NCT00606593|564043|P5|2nd Double-blind Treatment|Overall Study||12
234188|NCT00606593|564044|P4|2nd Double-blind Treatment|Overall Study||10
234189|NCT00606593|564045|P3|2nd Double-blind Treatment|Overall Study||11
234190|NCT00606593|564046|P2|2nd Double-blind Treatment|Overall Study||11
234191|NCT00606593|564047|P1|2nd Double-blind Treatment|Overall Study||11
234192|NCT00606593|564038|P10|1st Double-blind Treatment|Overall Study||11
234193|NCT00606593|564039|P9|1st Double-blind Treatment|Overall Study||12
234194|NCT00606593|564040|P8|1st Double-blind Treatment|Overall Study||11
234195|NCT00606593|564041|P7|1st Double-blind Treatment|Overall Study||11
234196|NCT00606593|564042|P6|1st Double-blind Treatment|Overall Study||11
234197|NCT00606593|564043|P5|1st Double-blind Treatment|Overall Study||12
234198|NCT00606593|564044|P4|1st Double-blind Treatment|Overall Study||11
234199|NCT00606593|564045|P3|1st Double-blind Treatment|Overall Study||11
234200|NCT00606593|564046|P2|1st Double-blind Treatment|Overall Study||11
234201|NCT00606593|564047|P1|1st Double-blind Treatment|Overall Study||11
234202|NCT00606593|564038|P10|STARTED|Overall Study|Randomized participants|11
234203|NCT00606593|564039|P9|STARTED|Overall Study|Randomized participants|12
234204|NCT00606593|564040|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
234205|NCT00606593|564041|P7|STARTED|Overall Study|Randomized participants|11
234206|NCT00606593|564042|P6|STARTED|Overall Study|Randomized participants|11
234207|NCT00606593|564043|P5|STARTED|Overall Study|Randomized participants|12
234208|NCT00606593|564044|P4|STARTED|Overall Study|Randomized participants|11
234209|NCT00606593|564045|P3|STARTED|Overall Study|Randomized participants|11
234210|NCT00606593|564046|P2|STARTED|Overall Study|Randomized participants|11
234211|NCT00606593|564047|P1|STARTED|Overall Study|Randomized participants|11
234212|NCT00606580|564068|P3|NOT COMPLETED|Overall Study||22
234213|NCT00606580|564069|P2|NOT COMPLETED|Overall Study||3
234214|NCT00606580|564070|P1|NOT COMPLETED|Overall Study||2
234215|NCT00606580|564068|P3|COMPLETED|Overall Study||103
234216|NCT00606580|564069|P2|COMPLETED|Overall Study||122
234217|NCT00606580|564070|P1|COMPLETED|Overall Study||123
234218|NCT00606580|564068|P3|STARTED|Overall Study||125
234219|NCT00606580|564069|P2|STARTED|Overall Study||125
234220|NCT00606580|564070|P1|STARTED|Overall Study||125
234221|NCT00606554|564113|P2|NOT COMPLETED|Overall Study||0
234222|NCT00606554|564114|P1|NOT COMPLETED|Overall Study||0
234223|NCT00606554|564113|P2|COMPLETED|Overall Study||18
234224|NCT00606554|564114|P1|COMPLETED|Overall Study||15
234225|NCT00606554|564113|P2|STARTED|Overall Study||18
234226|NCT00606554|564114|P1|STARTED|Overall Study||15
234227|NCT00606502|564136|P2|NOT COMPLETED|Treatment||3
234228|NCT00606502|564137|P1|NOT COMPLETED|Treatment||0
234229|NCT00606502|564136|P2|COMPLETED|Treatment||98
234230|NCT00606502|564137|P1|COMPLETED|Treatment||97
234231|NCT00606502|564136|P2|STARTED|Treatment||101
234232|NCT00606502|564137|P1|STARTED|Treatment||97
234233|NCT00606502|564136|P2|NOT COMPLETED|Randomization||0
234234|NCT00606502|564137|P1|NOT COMPLETED|Randomization||3
234235|NCT00606502|564136|P2|COMPLETED|Randomization||101
234236|NCT00606502|564137|P1|COMPLETED|Randomization||97
234237|NCT00606502|564136|P2|STARTED|Randomization||101
234238|NCT00606502|564137|P1|STARTED|Randomization||100
234239|NCT00606489|564151|P2|NOT COMPLETED|Overall Study||0
234240|NCT00606489|564152|P1|NOT COMPLETED|Overall Study||0
234241|NCT00606489|564151|P2|COMPLETED|Overall Study||40
234242|NCT00606489|564152|P1|COMPLETED|Overall Study||21
234243|NCT00606489|564151|P2|STARTED|Overall Study||40
234244|NCT00606489|564152|P1|STARTED|Overall Study||21
234245|NCT00606320|564158|P1|NOT COMPLETED|Overall Study||37
234246|NCT00606320|564158|P1|COMPLETED|Overall Study||22
234247|NCT00606320|564158|P1|STARTED|Overall Study||59
234248|NCT00606281|564165|P2|NOT COMPLETED|Overall Study||66
234249|NCT00606281|564166|P1|NOT COMPLETED|Overall Study||56
234250|NCT00606281|564165|P2|COMPLETED|Overall Study||64
234251|NCT00606281|564166|P1|COMPLETED|Overall Study||72
234252|NCT00606281|564165|P2|STARTED|Overall Study||130
234253|NCT00606281|564166|P1|STARTED|Overall Study||128
234254|NCT00606229|564174|P1|NOT COMPLETED|Overall Study||22
234255|NCT00606229|564174|P1|COMPLETED|Overall Study||19
234256|NCT00606229|564174|P1|STARTED|Overall Study||41
234257|NCT00606177|564181|P2|NOT COMPLETED|Overall Study||25
234258|NCT00606177|564182|P1|NOT COMPLETED|Overall Study||27
234259|NCT00606177|564181|P2|COMPLETED|Overall Study||19
234260|NCT00606177|564182|P1|COMPLETED|Overall Study||28
234261|NCT00606177|564181|P2|STARTED|Overall Study||44
234262|NCT00606177|564182|P1|STARTED|Overall Study||55
234263|NCT00606138|564192|P2|NOT COMPLETED|Overall Study||0
234264|NCT00606138|564193|P1|NOT COMPLETED|Overall Study||0
234265|NCT00606138|564192|P2|COMPLETED|Overall Study||2
234266|NCT00606138|564193|P1|COMPLETED|Overall Study||6
234267|NCT00606138|564192|P2|STARTED|Overall Study||2
234268|NCT00606138|564193|P1|STARTED|Overall Study||6
234269|NCT00606086|564209|P2|NOT COMPLETED|Overall Study||15
234270|NCT00606086|564210|P1|NOT COMPLETED|Overall Study||12
234271|NCT00606086|564209|P2|COMPLETED|Overall Study||53
234272|NCT00606086|564210|P1|COMPLETED|Overall Study||60
234273|NCT00606086|564209|P2|STARTED|Overall Study||68
234274|NCT00606086|564210|P1|STARTED|Overall Study||72
234275|NCT00606034|564216|P1|NOT COMPLETED|Overall Study||1
234276|NCT00606034|564216|P1|COMPLETED|Overall Study||20
234277|NCT00606034|564216|P1|STARTED|Overall Study||21
234278|NCT00606021|564224|P3|NOT COMPLETED|Maintenance Phase||17
234279|NCT00606021|564225|P2|NOT COMPLETED|Maintenance Phase||23
234280|NCT00606021|564226|P1|NOT COMPLETED|Maintenance Phase||0
234281|NCT00606021|564224|P3|COMPLETED|Maintenance Phase||10
234282|NCT00606021|564225|P2|COMPLETED|Maintenance Phase||5
234283|NCT00606021|564226|P1|COMPLETED|Maintenance Phase||0
234284|NCT00606021|564224|P3|STARTED|Maintenance Phase||27
234285|NCT00606021|564225|P2|STARTED|Maintenance Phase||28
234286|NCT00606021|564226|P1|STARTED|Maintenance Phase||0
234287|NCT00606021|564224|P3|NOT COMPLETED|Induction Phase||0
234288|NCT00606021|564225|P2|NOT COMPLETED|Induction Phase||0
234289|NCT00606021|564226|P1|NOT COMPLETED|Induction Phase||87
234290|NCT00606021|564224|P3|COMPLETED|Induction Phase||0
234291|NCT00606021|564225|P2|COMPLETED|Induction Phase||0
234292|NCT00606021|564226|P1|COMPLETED|Induction Phase||19
234293|NCT00606021|564224|P3|STARTED|Induction Phase||0
234294|NCT00606021|564225|P2|STARTED|Induction Phase||0
234295|NCT00606021|564226|P1|STARTED|Induction Phase||106
234296|NCT00606008|564244|P1|NOT COMPLETED|Overall Study||5
234297|NCT00606008|564244|P1|COMPLETED|Overall Study||25
234298|NCT00606008|564244|P1|STARTED|Overall Study||30
234299|NCT00605917|564258|P1|NOT COMPLETED|Overall Study||79
234300|NCT00605917|564258|P1|COMPLETED|Overall Study||908
234301|NCT00605917|564258|P1|STARTED|Overall Study||987
234302|NCT00605904|564299|P2|NOT COMPLETED|Infusion Sessions||3
234303|NCT00605904|564300|P1|NOT COMPLETED|Infusion Sessions||1
234304|NCT00605904|564299|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
234305|NCT00605904|564300|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
234306|NCT00605904|564299|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
234307|NCT00605904|564300|P1|Yohimbine Infusion|Infusion Sessions||12
234308|NCT00605904|564299|P2|mCPP Infusion|Infusion Sessions||13
234309|NCT00605904|564300|P1|mCPP Infusion|Infusion Sessions||12
234310|NCT00605904|564299|P2|Saline Infusion|Infusion Sessions||14
234311|NCT00605904|564300|P1|Saline Infusion|Infusion Sessions||13
234312|NCT00605904|564299|P2|STARTED|Infusion Sessions||16
234313|NCT00605904|564300|P1|STARTED|Infusion Sessions||13
234314|NCT00605904|564299|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
234315|NCT00605904|564300|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
234316|NCT00605904|564299|P2|COMPLETED|Baseline Data Collection and Dosing||16
234317|NCT00605904|564300|P1|COMPLETED|Baseline Data Collection and Dosing||13
234318|NCT00605904|564299|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
234319|NCT00605904|564300|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
234320|NCT00605865|564310|P1|NOT COMPLETED|Overall Study||115
234321|NCT00605865|564310|P1|COMPLETED|Overall Study||2157
234322|NCT00605865|564310|P1|STARTED|Overall Study||2272
234323|NCT00605839|564352|P3|NOT COMPLETED|Overall Study||0
234324|NCT00605839|564353|P2|NOT COMPLETED|Overall Study||0
234325|NCT00605839|564354|P1|NOT COMPLETED|Overall Study||1
234326|NCT00605839|564352|P3|COMPLETED|Overall Study||28
234327|NCT00605839|564353|P2|COMPLETED|Overall Study||37
234422|NCT00605280|564673|P1|NOT COMPLETED|Year 3 Extension||8
234328|NCT00605839|564354|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
234329|NCT00605839|564352|P3|STARTED|Overall Study||28
234330|NCT00605839|564353|P2|STARTED|Overall Study||37
234331|NCT00605839|564354|P1|STARTED|Overall Study||40
234332|NCT00605813|564362|P1|NOT COMPLETED|Overall Study||25
234333|NCT00605813|564362|P1|COMPLETED|Overall Study||517
234334|NCT00605813|564362|P1|STARTED|Overall Study||542
234335|NCT00605722|564375|P1|NOT COMPLETED|Overall Study||51
234336|NCT00605722|564375|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
234337|NCT00605722|564375|P1|STARTED|Overall Study||51
234338|NCT00605696|564387|P2|NOT COMPLETED|Overall Study||0
234339|NCT00605696|564388|P1|NOT COMPLETED|Overall Study||0
234340|NCT00605696|564387|P2|COMPLETED|Overall Study||11
234341|NCT00605696|564388|P1|COMPLETED|Overall Study||7
234342|NCT00605696|564387|P2|STARTED|Overall Study||11
234343|NCT00605696|564388|P1|STARTED|Overall Study||7
234344|NCT00605657|564396|P1|NOT COMPLETED|Overall Study||2
234345|NCT00605657|564396|P1|COMPLETED|Overall Study||3
234346|NCT00605657|564396|P1|STARTED|Overall Study||5
234347|NCT00605540|564401|P1|NOT COMPLETED|Overall Study||38
234348|NCT00605540|564401|P1|COMPLETED|Overall Study||95
234349|NCT00605540|564401|P1|STARTED|Overall Study||133
234350|NCT00605475|564419|P10|NOT COMPLETED|Overall Study||2
234351|NCT00605475|564420|P9|NOT COMPLETED|Overall Study||2
234352|NCT00605475|564421|P8|NOT COMPLETED|Overall Study||0
234353|NCT00605475|564422|P7|NOT COMPLETED|Overall Study||1
234354|NCT00605475|564423|P6|NOT COMPLETED|Overall Study||2
234355|NCT00605475|564424|P5|NOT COMPLETED|Overall Study||1
234356|NCT00605475|564425|P4|NOT COMPLETED|Overall Study||0
234357|NCT00605475|564426|P3|NOT COMPLETED|Overall Study||0
234358|NCT00605475|564427|P2|NOT COMPLETED|Overall Study||0
234359|NCT00605475|564428|P1|NOT COMPLETED|Overall Study||0
234360|NCT00605475|564419|P10|COMPLETED|Overall Study||8
234361|NCT00605475|564420|P9|COMPLETED|Overall Study||18
234362|NCT00605475|564421|P8|COMPLETED|Overall Study||24
234363|NCT00605475|564422|P7|COMPLETED|Overall Study||22
234364|NCT00605475|564423|P6|COMPLETED|Overall Study||22
234365|NCT00605475|564424|P5|COMPLETED|Overall Study||24
234366|NCT00605475|564425|P4|COMPLETED|Overall Study||45
234367|NCT00605475|564426|P3|COMPLETED|Overall Study||45
234368|NCT00605475|564427|P2|COMPLETED|Overall Study||5
234369|NCT00605475|564428|P1|COMPLETED|Overall Study||10
234370|NCT00605475|564419|P10|STARTED|Overall Study||10
234371|NCT00605475|564420|P9|STARTED|Overall Study||20
234372|NCT00605475|564421|P8|STARTED|Overall Study||24
234373|NCT00605475|564422|P7|STARTED|Overall Study||23
234374|NCT00605475|564423|P6|STARTED|Overall Study||24
234375|NCT00605475|564424|P5|STARTED|Overall Study||25
234376|NCT00605475|564425|P4|STARTED|Overall Study||45
234377|NCT00605475|564426|P3|STARTED|Overall Study||45
234378|NCT00605475|564427|P2|STARTED|Overall Study||5
234379|NCT00605475|564428|P1|STARTED|Overall Study||10
234380|NCT00605423|564552|P2|NOT COMPLETED|Overall Study||0
234381|NCT00605423|564553|P1|NOT COMPLETED|Overall Study||0
234382|NCT00605423|564552|P2|COMPLETED|Overall Study||2
234383|NCT00605423|564553|P1|COMPLETED|Overall Study||4
234384|NCT00605423|564552|P2|STARTED|Overall Study||2
234385|NCT00605423|564553|P1|STARTED|Overall Study||4
234386|NCT00605384|564565|P2|NOT COMPLETED|Overall Study||1
234387|NCT00605384|564566|P1|NOT COMPLETED|Overall Study||1
234388|NCT00605384|564565|P2|COMPLETED|Overall Study|study terminated early|0
234389|NCT00605384|564566|P1|COMPLETED|Overall Study|study terminated early|0
234390|NCT00605384|564565|P2|STARTED|Overall Study||1
234391|NCT00605384|564566|P1|STARTED|Overall Study||1
234392|NCT00605358|564596|P2|NOT COMPLETED|Overall Study||0
234393|NCT00605358|564597|P1|NOT COMPLETED|Overall Study||0
234394|NCT00605358|564596|P2|COMPLETED|Overall Study||80
234395|NCT00605358|564597|P1|COMPLETED|Overall Study||81
234396|NCT00605358|564596|P2|STARTED|Overall Study||80
234397|NCT00605358|564597|P1|STARTED|Overall Study||81
234398|NCT00605345|564605|P2|NOT COMPLETED|Overall Study||3
234399|NCT00605345|564606|P1|NOT COMPLETED|Overall Study||1
234400|NCT00605345|564605|P2|COMPLETED|Overall Study||22
234401|NCT00605345|564606|P1|COMPLETED|Overall Study||45
234402|NCT00605345|564605|P2|STARTED|Overall Study||25
234403|NCT00605345|564606|P1|STARTED|Overall Study||46
234404|NCT00605319|564622|P1|NOT COMPLETED|Overall Study||6
234405|NCT00605319|564622|P1|COMPLETED|Overall Study||11
234406|NCT00605319|564622|P1|STARTED|Overall Study||17
234407|NCT00605306|564634|P2|NOT COMPLETED|Overall Study||1
234408|NCT00605306|564635|P1|NOT COMPLETED|Overall Study||0
234409|NCT00605306|564634|P2|COMPLETED|Overall Study||13
234410|NCT00605306|564635|P1|COMPLETED|Overall Study||14
234411|NCT00605306|564634|P2|STARTED|Overall Study||14
234412|NCT00605306|564635|P1|STARTED|Overall Study||14
234413|NCT00605293|564649|P2|NOT COMPLETED|Overall Study||5
234414|NCT00605293|564650|P1|NOT COMPLETED|Overall Study||17
234415|NCT00605293|564649|P2|COMPLETED|Overall Study||31
234416|NCT00605293|564650|P1|COMPLETED|Overall Study||48
234417|NCT00605293|564649|P2|STARTED|Overall Study||36
234418|NCT00605293|564650|P1|STARTED|Overall Study||65
234419|NCT00605280|564670|P4|NOT COMPLETED|Year 3 Extension||9
234420|NCT00605280|564671|P3|NOT COMPLETED|Year 3 Extension||0
234421|NCT00605280|564672|P2|NOT COMPLETED|Year 3 Extension||0
234423|NCT00605280|564670|P4|COMPLETED|Year 3 Extension||45
234424|NCT00605280|564671|P3|COMPLETED|Year 3 Extension||0
234425|NCT00605280|564672|P2|COMPLETED|Year 3 Extension||0
234426|NCT00605280|564673|P1|COMPLETED|Year 3 Extension||38
234427|NCT00605280|564670|P4|Received 0.3 mg Treatment|Year 3 Extension||54
234428|NCT00605280|564671|P3|Received 0.3 mg Treatment|Year 3 Extension||0
234429|NCT00605280|564672|P2|Received 0.3 mg Treatment|Year 3 Extension||0
234430|NCT00605280|564673|P1|Received 0.3 mg Treatment|Year 3 Extension||46
234431|NCT00605280|564670|P4|STARTED|Year 3 Extension||54
234432|NCT00605280|564671|P3|STARTED|Year 3 Extension||0
234433|NCT00605280|564672|P2|STARTED|Year 3 Extension||0
234434|NCT00605280|564673|P1|STARTED|Year 3 Extension||46
234435|NCT00605280|564670|P4|NOT COMPLETED|Year 2||22
234436|NCT00605280|564671|P3|NOT COMPLETED|Year 2||6
234437|NCT00605280|564672|P2|NOT COMPLETED|Year 2||6
234438|NCT00605280|564673|P1|NOT COMPLETED|Year 2||24
234439|NCT00605280|564670|P4|COMPLETED|Year 2||102
234440|NCT00605280|564671|P3|COMPLETED|Year 2||0
234441|NCT00605280|564672|P2|COMPLETED|Year 2||5
234442|NCT00605280|564673|P1|COMPLETED|Year 2||102
234443|NCT00605280|564670|P4|Received 0.3 mg Treatment|Year 2||0
234444|NCT00605280|564671|P3|Received 0.3 mg Treatment|Year 2||2
234445|NCT00605280|564672|P2|Received 0.3 mg Treatment|Year 2||3
234446|NCT00605280|564673|P1|Received 0.3 mg Treatment|Year 2||126
234447|NCT00605280|564670|P4|STARTED|Year 2||124
234448|NCT00605280|564671|P3|STARTED|Year 2||6
234449|NCT00605280|564672|P2|STARTED|Year 2||11
234450|NCT00605280|564673|P1|STARTED|Year 2||126
234451|NCT00605280|564670|P4|NOT COMPLETED|Year 1||19
234452|NCT00605280|564671|P3|NOT COMPLETED|Year 1||1
234453|NCT00605280|564672|P2|NOT COMPLETED|Year 1||11
234454|NCT00605280|564673|P1|NOT COMPLETED|Year 1||19
234455|NCT00605280|564670|P4|COMPLETED|Year 1||124
234456|NCT00605280|564671|P3|COMPLETED|Year 1||6
234457|NCT00605280|564672|P2|COMPLETED|Year 1||11
234458|NCT00605280|564673|P1|COMPLETED|Year 1||126
234459|NCT00605280|564670|P4|Received 0.3 mg Treatment|Year 1||0
234460|NCT00605280|564671|P3|Received 0.3 mg Treatment|Year 1||3
234461|NCT00605280|564672|P2|Received 0.3 mg Treatment|Year 1||13
234462|NCT00605280|564673|P1|Received 0.3 mg Treatment|Year 1||144
234463|NCT00605280|564670|P4|STARTED|Year 1||143
234464|NCT00605280|564671|P3|STARTED|Year 1||7
234465|NCT00605280|564672|P2|STARTED|Year 1||22
234466|NCT00605280|564673|P1|STARTED|Year 1||145
234467|NCT00605267|564707|P2|NOT COMPLETED|Overall Study||9
234468|NCT00605267|564708|P1|NOT COMPLETED|Overall Study||3
234469|NCT00605267|564707|P2|COMPLETED|Overall Study|Breast surgery performed|90
234470|NCT00605267|564708|P1|COMPLETED|Overall Study|Breast surgery performed|95
234471|NCT00605267|564707|P2|STARTED|Overall Study||99
234472|NCT00605267|564708|P1|STARTED|Overall Study||98
234473|NCT00605202|564746|P2|NOT COMPLETED|Second Intervention||0
234474|NCT00605202|564747|P1|NOT COMPLETED|Second Intervention||0
234475|NCT00605202|564746|P2|COMPLETED|Second Intervention||5
234476|NCT00605202|564747|P1|COMPLETED|Second Intervention||5
234477|NCT00605202|564746|P2|STARTED|Second Intervention||5
234478|NCT00605202|564747|P1|STARTED|Second Intervention||5
234479|NCT00605202|564746|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
234480|NCT00605202|564747|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
234481|NCT00605202|564746|P2|COMPLETED|Washout Period of 3 Weeks||5
234482|NCT00605202|564747|P1|COMPLETED|Washout Period of 3 Weeks||5
234483|NCT00605202|564746|P2|STARTED|Washout Period of 3 Weeks||5
234484|NCT00605202|564747|P1|STARTED|Washout Period of 3 Weeks||5
234485|NCT00605202|564746|P2|NOT COMPLETED|First Intervention||0
234486|NCT00605202|564747|P1|NOT COMPLETED|First Intervention||0
234487|NCT00605202|564746|P2|COMPLETED|First Intervention||5
234488|NCT00605202|564747|P1|COMPLETED|First Intervention||5
234489|NCT00605202|564746|P2|STARTED|First Intervention||5
234490|NCT00605202|564747|P1|STARTED|First Intervention||5
234491|NCT00605176|564756|P3|NOT COMPLETED|Overall Study||9
234492|NCT00605176|564757|P2|NOT COMPLETED|Overall Study||6
234493|NCT00605176|564758|P1|NOT COMPLETED|Overall Study||11
234494|NCT00605176|564756|P3|COMPLETED|Overall Study||150
234495|NCT00605176|564757|P2|COMPLETED|Overall Study||154
234496|NCT00605176|564758|P1|COMPLETED|Overall Study||149
234497|NCT00605176|564756|P3|STARTED|Overall Study||159
234498|NCT00605176|564757|P2|STARTED|Overall Study||160
234499|NCT00605176|564758|P1|STARTED|Overall Study||160
234500|NCT00605150|564775|P1|NOT COMPLETED|Overall Study||1
234501|NCT00605150|564775|P1|COMPLETED|Overall Study||10
234502|NCT00605150|564775|P1|STARTED|Overall Study|11 started|11
234503|NCT00605085|564781|P2|NOT COMPLETED|Overall Study||25
234504|NCT00605085|564782|P1|NOT COMPLETED|Overall Study||50
234505|NCT00605085|564781|P2|COMPLETED|Overall Study||638
234506|NCT00605085|564782|P1|COMPLETED|Overall Study||1962
234507|NCT00605085|564781|P2|STARTED|Overall Study||663
234508|NCT00605085|564782|P1|STARTED|Overall Study||2012
234509|NCT00605072|564791|P3|NOT COMPLETED|Overall Study||4
234510|NCT00605072|564792|P2|NOT COMPLETED|Overall Study||11
234511|NCT00605072|564793|P1|NOT COMPLETED|Overall Study||7
234512|NCT00605072|564791|P3|COMPLETED|Overall Study||11
234513|NCT00605072|564792|P2|COMPLETED|Overall Study||9
234514|NCT00605072|564793|P1|COMPLETED|Overall Study||11
234515|NCT00605072|564791|P3|STARTED|Overall Study||15
234516|NCT00605072|564792|P2|STARTED|Overall Study||20
234517|NCT00605072|564793|P1|STARTED|Overall Study||18
234518|NCT00605033|564815|P2|NOT COMPLETED|Overall Study||8
234519|NCT00605033|564816|P1|NOT COMPLETED|Overall Study||7
234520|NCT00605033|564815|P2|COMPLETED|Overall Study||90
234521|NCT00605033|564816|P1|COMPLETED|Overall Study||136
234522|NCT00605033|564815|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
234523|NCT00605033|564816|P1|STARTED|Overall Study||143
234524|NCT00604968|564822|P1|NOT COMPLETED|Overall Study||0
234525|NCT00604968|564822|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
234526|NCT00604968|564822|P1|STARTED|Overall Study||25
234527|NCT00604825|564839|P4|NOT COMPLETED|Overall Study||11
234528|NCT00604825|564840|P3|NOT COMPLETED|Overall Study||16
234529|NCT00604825|564841|P2|NOT COMPLETED|Overall Study||15
234530|NCT00604825|564842|P1|NOT COMPLETED|Overall Study||9
234531|NCT00604825|564839|P4|COMPLETED|Overall Study||79
234532|NCT00604825|564840|P3|COMPLETED|Overall Study||73
234533|NCT00604825|564841|P2|COMPLETED|Overall Study||72
234534|NCT00604825|564842|P1|COMPLETED|Overall Study||81
234535|NCT00604825|564839|P4|STARTED|Overall Study||90
234536|NCT00604825|564840|P3|STARTED|Overall Study||89
234537|NCT00604825|564841|P2|STARTED|Overall Study||87
234538|NCT00604825|564842|P1|STARTED|Overall Study||90
234539|NCT00604812|565043|P6|NOT COMPLETED|Overall Study||0
234540|NCT00604812|565044|P5|NOT COMPLETED|Overall Study||0
234541|NCT00604812|565045|P4|NOT COMPLETED|Overall Study||0
234542|NCT00604812|565046|P3|NOT COMPLETED|Overall Study||0
234543|NCT00604812|565047|P2|NOT COMPLETED|Overall Study||0
234544|NCT00604812|565048|P1|NOT COMPLETED|Overall Study||0
234545|NCT00604812|565043|P6|COMPLETED|Overall Study||1
234546|NCT00604812|565044|P5|COMPLETED|Overall Study||5
234547|NCT00604812|565045|P4|COMPLETED|Overall Study||3
234548|NCT00604812|565046|P3|COMPLETED|Overall Study||10
234549|NCT00604812|565047|P2|COMPLETED|Overall Study||3
234550|NCT00604812|565048|P1|COMPLETED|Overall Study||9
234551|NCT00604812|565043|P6|STARTED|Overall Study||1
234552|NCT00604812|565044|P5|STARTED|Overall Study||5
234553|NCT00604812|565045|P4|STARTED|Overall Study||3
234554|NCT00604812|565046|P3|STARTED|Overall Study||10
234555|NCT00604812|565047|P2|STARTED|Overall Study||3
234556|NCT00604812|565048|P1|STARTED|Overall Study||9
234557|NCT00604786|565070|P2|NOT COMPLETED|Overall Study||0
234558|NCT00604786|565071|P1|NOT COMPLETED|Overall Study||2
234559|NCT00604786|565070|P2|COMPLETED|Overall Study||4
234560|NCT00604786|565071|P1|COMPLETED|Overall Study||12
234561|NCT00604786|565070|P2|STARTED|Overall Study||4
234562|NCT00604786|565071|P1|STARTED|Overall Study||14
234563|NCT00604721|565077|P1|NOT COMPLETED|Overall Study||2
234564|NCT00604721|565077|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
234565|NCT00604721|565077|P1|STARTED|Overall Study||19
234566|NCT00604708|565085|P2|NOT COMPLETED|Overall Study||40
234567|NCT00604708|565086|P1|NOT COMPLETED|Overall Study||31
234568|NCT00604708|565085|P2|COMPLETED|Overall Study||397
234569|NCT00604708|565086|P1|COMPLETED|Overall Study||399
234570|NCT00604708|565085|P2|STARTED|Overall Study||437
234571|NCT00604708|565086|P1|STARTED|Overall Study||430
234572|NCT00604695|565096|P2|NOT COMPLETED|Overall Study||4
234573|NCT00604695|565097|P1|NOT COMPLETED|Overall Study||0
234574|NCT00604695|565096|P2|COMPLETED|Overall Study||16
234575|NCT00604695|565097|P1|COMPLETED|Overall Study||20
234576|NCT00604695|565096|P2|STARTED|Overall Study||20
234577|NCT00604695|565097|P1|STARTED|Overall Study||20
234578|NCT00604669|565119|P1|NOT COMPLETED|Overall Study||7
234579|NCT00604669|565119|P1|COMPLETED|Overall Study||163
234580|NCT00604669|565119|P1|STARTED|Overall Study||170
234581|NCT00604565|565125|P2|NOT COMPLETED|Overall Study||3
234582|NCT00604565|565126|P1|NOT COMPLETED|Overall Study||0
234583|NCT00604565|565125|P2|COMPLETED|Overall Study||4
234584|NCT00604565|565126|P1|COMPLETED|Overall Study||4
234585|NCT00604565|565125|P2|STARTED|Overall Study||7
234586|NCT00604565|565126|P1|STARTED|Overall Study||4
234587|NCT00604552|565136|P2|NOT COMPLETED|Overall Study||0
234588|NCT00604552|565137|P1|NOT COMPLETED|Overall Study||0
234589|NCT00604552|565136|P2|COMPLETED|Overall Study||160
234590|NCT00604552|565137|P1|COMPLETED|Overall Study||189
234591|NCT00604552|565136|P2|STARTED|Overall Study||160
234592|NCT00604552|565137|P1|STARTED|Overall Study||189
234593|NCT00604500|565145|P1|NOT COMPLETED|Overall Study||11
234594|NCT00604500|565145|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
234595|NCT00604500|565145|P1|STARTED|Overall Study||272
234596|NCT00604461|565152|P1|NOT COMPLETED|Overall Study||1
234597|NCT00604461|565152|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
234598|NCT00604461|565152|P1|STARTED|Overall Study||13
234599|NCT00604383|565159|P2|NOT COMPLETED|Overall Study||84
234600|NCT00604383|565160|P1|NOT COMPLETED|Overall Study||87
234601|NCT00604383|565159|P2|COMPLETED|Overall Study||256
234602|NCT00604383|565160|P1|COMPLETED|Overall Study||258
234603|NCT00604383|565159|P2|Received Extended Treatment|Overall Study||141
234604|NCT00604383|565160|P1|Received Extended Treatment|Overall Study||136
234605|NCT00604383|565159|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
234606|NCT00604383|565160|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
234607|NCT00604383|565159|P2|STARTED|Overall Study||340
234608|NCT00604383|565160|P1|STARTED|Overall Study||345
234609|NCT00604279|565176|P2|NOT COMPLETED|Overall Study||38
234610|NCT00604279|565177|P1|NOT COMPLETED|Overall Study||64
234611|NCT00604279|565176|P2|COMPLETED|Overall Study||185
234612|NCT00604279|565177|P1|COMPLETED|Overall Study||165
234613|NCT00604279|565176|P2|STARTED|Overall Study||223
234614|NCT00604279|565177|P1|STARTED|Overall Study||229
234615|NCT00604214|565193|P2|NOT COMPLETED|Day 91 to Day 180||32
234616|NCT00604214|565194|P1|NOT COMPLETED|Day 91 to Day 180||26
234617|NCT00604214|565193|P2|COMPLETED|Day 91 to Day 180||521
234618|NCT00604214|565194|P1|COMPLETED|Day 91 to Day 180||529
234619|NCT00604214|565193|P2|STARTED|Day 91 to Day 180||553
234620|NCT00604214|565194|P1|STARTED|Day 91 to Day 180||555
234621|NCT00604214|565193|P2|NOT COMPLETED|Day 29 to Day 90||79
234622|NCT00604214|565194|P1|NOT COMPLETED|Day 29 to Day 90||68
234623|NCT00604214|565193|P2|COMPLETED|Day 29 to Day 90||553
234624|NCT00604214|565194|P1|COMPLETED|Day 29 to Day 90||555
234625|NCT00604214|565193|P2|STARTED|Day 29 to Day 90||632
234626|NCT00604214|565194|P1|STARTED|Day 29 to Day 90||623
234627|NCT00604214|565193|P2|NOT COMPLETED|Baseline to Day 28||213
234628|NCT00604214|565194|P1|NOT COMPLETED|Baseline to Day 28||228
234629|NCT00604214|565193|P2|COMPLETED|Baseline to Day 28||632
234630|NCT00604214|565194|P1|COMPLETED|Baseline to Day 28||623
234631|NCT00604214|565193|P2|Received Study Drug|Baseline to Day 28||833
234632|NCT00604214|565194|P1|Received Study Drug|Baseline to Day 28||833
234633|NCT00604214|565193|P2|STARTED|Baseline to Day 28||845
234634|NCT00604214|565194|P1|STARTED|Baseline to Day 28||851
234635|NCT00604188|565226|P2|NOT COMPLETED|Overall Study||25
234636|NCT00604188|565227|P1|NOT COMPLETED|Overall Study||27
234637|NCT00604188|565226|P2|COMPLETED|Overall Study||70
234638|NCT00604188|565227|P1|COMPLETED|Overall Study||66
234639|NCT00604188|565226|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
234640|NCT00604188|565227|P1|STARTED|Overall Study||93
234641|NCT00604175|565250|P3|NOT COMPLETED|Week 29 Through Week 72||4
234642|NCT00604175|565251|P2|NOT COMPLETED|Week 29 Through Week 72||7
234643|NCT00604175|565252|P1|NOT COMPLETED|Week 29 Through Week 72||12
234644|NCT00604175|565250|P3|COMPLETED|Week 29 Through Week 72||89
234645|NCT00604175|565251|P2|COMPLETED|Week 29 Through Week 72||85
234646|NCT00604175|565252|P1|COMPLETED|Week 29 Through Week 72||108
234647|NCT00604175|565250|P3|STARTED|Week 29 Through Week 72||93
234648|NCT00604175|565251|P2|STARTED|Week 29 Through Week 72||92
234649|NCT00604175|565252|P1|STARTED|Week 29 Through Week 72||120
234650|NCT00604175|565250|P3|NOT COMPLETED|Entry Through Week 28||1
234651|NCT00604175|565251|P2|NOT COMPLETED|Entry Through Week 28||3
234652|NCT00604175|565252|P1|NOT COMPLETED|Entry Through Week 28||10
234653|NCT00604175|565250|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
234654|NCT00604175|565251|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
234655|NCT00604175|565252|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
234656|NCT00604175|565250|P3|STARTED|Entry Through Week 28||94
234657|NCT00604175|565251|P2|STARTED|Entry Through Week 28||95
234658|NCT00604175|565252|P1|STARTED|Entry Through Week 28||130
234659|NCT00604162|565305|P1|NOT COMPLETED|Overall Study||4
234660|NCT00604162|565305|P1|COMPLETED|Overall Study||328
234661|NCT00604162|565305|P1|STARTED|Overall Study||332
234662|NCT00604045|565318|P2|NOT COMPLETED|Overall Study||1
234663|NCT00604045|565319|P1|NOT COMPLETED|Overall Study||1
234664|NCT00604045|565318|P2|COMPLETED|Overall Study||9
234665|NCT00604045|565319|P1|COMPLETED|Overall Study||14
234666|NCT00604045|565318|P2|STARTED|Overall Study||10
234667|NCT00604045|565319|P1|STARTED|Overall Study||15
234668|NCT00604019|565327|P2|NOT COMPLETED|Overall Study||0
234669|NCT00604019|565328|P1|NOT COMPLETED|Overall Study||0
234670|NCT00604019|565327|P2|COMPLETED|Overall Study||118
234671|NCT00604019|565328|P1|COMPLETED|Overall Study||134
234672|NCT00604019|565327|P2|STARTED|Overall Study||118
234673|NCT00604019|565328|P1|STARTED|Overall Study||134
234674|NCT00603993|565334|P1|NOT COMPLETED|Overall Study||20
234675|NCT00603993|565334|P1|COMPLETED|Overall Study||68
234676|NCT00603993|565334|P1|STARTED|Overall Study||88
234677|NCT00603915|565347|P1|NOT COMPLETED|Overall Study||1
234678|NCT00603915|565347|P1|COMPLETED|Overall Study||19
234679|NCT00603915|565347|P1|STARTED|Overall Study||20
234680|NCT00603902|565355|P3|NOT COMPLETED|Overall Study||769
234681|NCT00603902|565356|P2|NOT COMPLETED|Overall Study||686
234682|NCT00603902|565357|P1|NOT COMPLETED|Overall Study||329
234683|NCT00603902|565355|P3|COMPLETED|Overall Study||834
234684|NCT00603902|565356|P2|COMPLETED|Overall Study||917
234685|NCT00603902|565357|P1|COMPLETED|Overall Study||473
234686|NCT00603902|565355|P3|STARTED|Overall Study||1603
234687|NCT00603902|565356|P2|STARTED|Overall Study||1603
234688|NCT00603902|565357|P1|STARTED|Overall Study||802
234689|NCT00603889|565368|P1|NOT COMPLETED|Overall Study||0
234690|NCT00603889|565368|P1|COMPLETED|Overall Study||12
234691|NCT00603889|565368|P1|STARTED|Overall Study||12
234692|NCT00603837|565377|P2|NOT COMPLETED|Overall Study||0
234693|NCT00603837|565378|P1|NOT COMPLETED|Overall Study||3
234694|NCT00603837|565377|P2|COMPLETED|Overall Study||19
234695|NCT00603837|565378|P1|COMPLETED|Overall Study||17
234696|NCT00603837|565377|P2|STARTED|Overall Study||19
234697|NCT00603837|565378|P1|STARTED|Overall Study||20
234698|NCT00603798|565387|P3|NOT COMPLETED|Overall Study||10
234699|NCT00603798|565388|P2|NOT COMPLETED|Overall Study||7
234700|NCT00603798|565389|P1|NOT COMPLETED|Overall Study||10
234701|NCT00603798|565387|P3|COMPLETED|Overall Study||154
234702|NCT00603798|565388|P2|COMPLETED|Overall Study||157
234703|NCT00603798|565389|P1|COMPLETED|Overall Study||152
234704|NCT00603798|565387|P3|STARTED|Overall Study||164
234705|NCT00603798|565388|P2|STARTED|Overall Study||164
234706|NCT00603798|565389|P1|STARTED|Overall Study||162
234707|NCT00603746|565412|P6|NOT COMPLETED|Overall Study||13
234708|NCT00603746|565413|P5|NOT COMPLETED|Overall Study||17
234709|NCT00603746|565414|P4|NOT COMPLETED|Overall Study||13
234710|NCT00603746|565415|P3|NOT COMPLETED|Overall Study||8
234711|NCT00603746|565416|P2|NOT COMPLETED|Overall Study||18
234712|NCT00603746|565417|P1|NOT COMPLETED|Overall Study||38
234713|NCT00603746|565412|P6|COMPLETED|Overall Study||97
234714|NCT00603746|565413|P5|COMPLETED|Overall Study||85
234715|NCT00603746|565414|P4|COMPLETED|Overall Study||94
234716|NCT00603746|565415|P3|COMPLETED|Overall Study||93
234717|NCT00603746|565416|P2|COMPLETED|Overall Study||81
234718|NCT00603746|565417|P1|COMPLETED|Overall Study||65
234719|NCT00603746|565412|P6|STARTED|Overall Study||110
234720|NCT00603746|565413|P5|STARTED|Overall Study||102
234721|NCT00603746|565414|P4|STARTED|Overall Study||107
234722|NCT00603746|565415|P3|STARTED|Overall Study||101
234723|NCT00603746|565416|P2|STARTED|Overall Study||99
234724|NCT00603746|565417|P1|STARTED|Overall Study||103
234725|NCT00603733|565565|P2|NOT COMPLETED|Maintenance Phase ITT||16
234726|NCT00603733|565566|P1|NOT COMPLETED|Maintenance Phase ITT||10
234727|NCT00603733|565565|P2|COMPLETED|Maintenance Phase ITT||66
234728|NCT00603733|565566|P1|COMPLETED|Maintenance Phase ITT||61
234729|NCT00603733|565565|P2|STARTED|Maintenance Phase ITT||82
234730|NCT00603733|565566|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
234731|NCT00603733|565565|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
234732|NCT00603733|565566|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
234733|NCT00603733|565565|P2|COMPLETED|Run-In Phase - 4 Weeks||36
234734|NCT00603733|565566|P1|COMPLETED|Run-In Phase - 4 Weeks||35
234735|NCT00603733|565565|P2|STARTED|Run-In Phase - 4 Weeks||49
234736|NCT00603733|565566|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
234737|NCT00603733|565565|P2|NOT COMPLETED|Active Phase ITT||17
234738|NCT00603733|565566|P1|NOT COMPLETED|Active Phase ITT||11
234739|NCT00603733|565565|P2|COMPLETED|Active Phase ITT||78
234740|NCT00603733|565566|P1|COMPLETED|Active Phase ITT||84
234741|NCT00603733|565565|P2|STARTED|Active Phase ITT||95
234742|NCT00603733|565566|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
234743|NCT00603642|565578|P2|NOT COMPLETED|Overall Study||0
234744|NCT00603642|565579|P1|NOT COMPLETED|Overall Study||0
234745|NCT00603642|565578|P2|COMPLETED|Overall Study||22
234746|NCT00603642|565579|P1|COMPLETED|Overall Study||12
234747|NCT00603642|565578|P2|STARTED|Overall Study||22
234748|NCT00603642|565579|P1|STARTED|Overall Study||12
234749|NCT00603590|565595|P2|NOT COMPLETED|Overall Study||51
234750|NCT00603590|565596|P1|NOT COMPLETED|Overall Study||76
234751|NCT00603590|565595|P2|COMPLETED|Overall Study||183
234752|NCT00603590|565596|P1|COMPLETED|Overall Study||165
234753|NCT00603590|565595|P2|Eight Months|Overall Study||194
234754|NCT00603590|565596|P1|Eight Months|Overall Study||178
234755|NCT00603590|565595|P2|Four Months|Overall Study||200
234756|NCT00603590|565596|P1|Four Months|Overall Study||187
234757|NCT00603590|565595|P2|One Month|Overall Study||212
234758|NCT00603590|565596|P1|One Month|Overall Study||204
234759|NCT00603590|565595|P2|STARTED|Overall Study||234
234760|NCT00603590|565596|P1|STARTED|Overall Study||241
234761|NCT00603564|565608|P2|NOT COMPLETED|Overall Study||0
234762|NCT00603564|565609|P1|NOT COMPLETED|Overall Study||0
234763|NCT00603564|565608|P2|COMPLETED|Overall Study|February 2008|27
234764|NCT00603564|565609|P1|COMPLETED|Overall Study|February 2008|20
234765|NCT00603564|565608|P2|STARTED|Overall Study|January 2006|27
234766|NCT00603564|565609|P1|STARTED|Overall Study|January 2006|20
234767|NCT00603538|565620|P3|NOT COMPLETED|Overall Study||2
234768|NCT00603538|565621|P2|NOT COMPLETED|Overall Study||4
234769|NCT00603538|565622|P1|NOT COMPLETED|Overall Study||3
234770|NCT00603538|565620|P3|COMPLETED|Overall Study||4
234771|NCT00603538|565621|P2|COMPLETED|Overall Study||3
234772|NCT00603538|565622|P1|COMPLETED|Overall Study||3
234773|NCT00603538|565620|P3|STARTED|Overall Study||6
234774|NCT00603538|565621|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
234775|NCT00603538|565622|P1|STARTED|Overall Study||6
234776|NCT00603525|565662|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
234777|NCT00603525|565663|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
234778|NCT00603525|565664|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
234779|NCT00603525|565662|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
234780|NCT00603525|565663|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
234781|NCT00603525|565664|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
234782|NCT00603525|565662|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
234783|NCT00603525|565663|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
234784|NCT00603525|565664|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
234785|NCT00603525|565662|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
234786|NCT00603525|565663|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
234787|NCT00603525|565664|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
234788|NCT00603525|565662|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
234789|NCT00603525|565663|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
234790|NCT00603525|565664|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
234791|NCT00603525|565662|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
234792|NCT00603525|565663|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
234793|NCT00603525|565664|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
234794|NCT00603525|565662|P3|STARTED|OL Treatment Period (120 Weeks)||0
234795|NCT00603525|565663|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
234796|NCT00603525|565664|P1|STARTED|OL Treatment Period (120 Weeks)||0
234797|NCT00603525|565662|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
234798|NCT00603525|565663|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
234799|NCT00603525|565664|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
234800|NCT00603525|565662|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
234801|NCT00603525|565663|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
234802|NCT00603525|565664|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
234803|NCT00603525|565662|P3|STARTED|DB Treatment Period (24 Weeks)||0
234804|NCT00603525|565663|P2|STARTED|DB Treatment Period (24 Weeks)||85
234805|NCT00603525|565664|P1|STARTED|DB Treatment Period (24 Weeks)||84
234806|NCT00603512|565796|P5|NOT COMPLETED|Overall Study||5
234807|NCT00603512|565797|P4|NOT COMPLETED|Overall Study||7
234808|NCT00603512|565798|P3|NOT COMPLETED|Overall Study||5
234809|NCT00603512|565799|P2|NOT COMPLETED|Overall Study||5
234810|NCT00603512|565800|P1|NOT COMPLETED|Overall Study||2
234811|NCT00603512|565796|P5|COMPLETED|Overall Study||23
234812|NCT00603512|565797|P4|COMPLETED|Overall Study||21
234813|NCT00603512|565798|P3|COMPLETED|Overall Study||23
234814|NCT00603512|565799|P2|COMPLETED|Overall Study||23
234815|NCT00603512|565800|P1|COMPLETED|Overall Study||26
234816|NCT00603512|565796|P5|Treated|Overall Study||28
234817|NCT00603512|565797|P4|Treated|Overall Study||26
234818|NCT00603512|565798|P3|Treated|Overall Study||27
234819|NCT00603512|565799|P2|Treated|Overall Study||27
234820|NCT00603512|565800|P1|Treated|Overall Study||28
234821|NCT00603512|565796|P5|STARTED|Overall Study||28
234822|NCT00603512|565797|P4|STARTED|Overall Study||28
234823|NCT00603512|565798|P3|STARTED|Overall Study||28
234824|NCT00603512|565799|P2|STARTED|Overall Study||28
234825|NCT00603512|565800|P1|STARTED|Overall Study||28
234826|NCT00603473|565942|P1|NOT COMPLETED|Overall Study||9
234827|NCT00603473|565942|P1|COMPLETED|Overall Study||80
234828|NCT00603473|565942|P1|STARTED|Overall Study||89
234829|NCT00603447|565955|P7|NOT COMPLETED|Overall Study||24
234830|NCT00603447|565956|P6|NOT COMPLETED|Overall Study||2
234831|NCT00603447|565957|P5|NOT COMPLETED|Overall Study||5
234832|NCT00603447|565958|P4|NOT COMPLETED|Overall Study||2
234833|NCT00603447|565959|P3|NOT COMPLETED|Overall Study||2
234834|NCT00603447|565960|P2|NOT COMPLETED|Overall Study||3
234835|NCT00603447|565961|P1|NOT COMPLETED|Overall Study||0
234836|NCT00603447|565955|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
234837|NCT00603447|565956|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
234838|NCT00603447|565957|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
234839|NCT00603447|565958|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
234840|NCT00603447|565959|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
234841|NCT00603447|565960|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
234842|NCT00603447|565961|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
234843|NCT00603447|565955|P7|STARTED|Overall Study||44
234844|NCT00603447|565956|P6|STARTED|Overall Study||8
234845|NCT00603447|565957|P5|STARTED|Overall Study||6
234846|NCT00603447|565958|P4|STARTED|Overall Study||6
234847|NCT00603447|565959|P3|STARTED|Overall Study||8
234848|NCT00603447|565960|P2|STARTED|Overall Study||6
234849|NCT00603447|565961|P1|STARTED|Overall Study||6
234850|NCT00603408|565983|P1|NOT COMPLETED|Overall Study||0
234851|NCT00603408|565983|P1|COMPLETED|Overall Study||5
234852|NCT00603408|565983|P1|STARTED|Overall Study||5
234853|NCT00603382|566000|P6|NOT COMPLETED|Overall Study||18
234854|NCT00603382|566001|P5|NOT COMPLETED|Overall Study||9
234855|NCT00603382|566002|P4|NOT COMPLETED|Overall Study||12
234856|NCT00603382|566003|P3|NOT COMPLETED|Overall Study||9
234857|NCT00603382|566004|P2|NOT COMPLETED|Overall Study||14
234858|NCT00603382|566005|P1|NOT COMPLETED|Overall Study||18
234859|NCT00603382|566000|P6|COMPLETED|Overall Study||84
234860|NCT00603382|566001|P5|COMPLETED|Overall Study||86
234861|NCT00603382|566002|P4|COMPLETED|Overall Study||98
234862|NCT00603382|566003|P3|COMPLETED|Overall Study||91
234863|NCT00603382|566004|P2|COMPLETED|Overall Study||83
234864|NCT00603382|566005|P1|COMPLETED|Overall Study||76
234865|NCT00603382|566000|P6|STARTED|Overall Study||102
234866|NCT00603382|566001|P5|STARTED|Overall Study||95
234867|NCT00603382|566002|P4|STARTED|Overall Study||110
234868|NCT00603382|566003|P3|STARTED|Overall Study||100
234869|NCT00603382|566004|P2|STARTED|Overall Study||97
234870|NCT00603382|566005|P1|STARTED|Overall Study||94
234871|NCT00603304|566153|P2|NOT COMPLETED|Overall Study||31
234872|NCT00603304|566154|P1|NOT COMPLETED|Overall Study||32
234873|NCT00603304|566153|P2|COMPLETED|Overall Study||155
234874|NCT00603304|566154|P1|COMPLETED|Overall Study||151
234875|NCT00603304|566153|P2|STARTED|Overall Study||186
234876|NCT00603304|566154|P1|STARTED|Overall Study||183
234877|NCT00603291|566191|P3|NOT COMPLETED|Overall Study||96
234878|NCT00603291|566192|P2|NOT COMPLETED|Overall Study||87
234879|NCT00603291|566193|P1|NOT COMPLETED|Overall Study||20
234880|NCT00603291|566191|P3|COMPLETED|Overall Study||157
234881|NCT00603291|566192|P2|COMPLETED|Overall Study||169
234882|NCT00603291|566193|P1|COMPLETED|Overall Study||75
234883|NCT00603291|566191|P3|STARTED|Overall Study||253
234884|NCT00603291|566192|P2|STARTED|Overall Study||256
234885|NCT00603291|566193|P1|STARTED|Overall Study||95
234886|NCT00603278|566210|P6|NOT COMPLETED|Overall Study||19
234887|NCT00603278|566211|P5|NOT COMPLETED|Overall Study||13
234888|NCT00603278|566212|P4|NOT COMPLETED|Overall Study||11
234889|NCT00603278|566213|P3|NOT COMPLETED|Overall Study||14
234890|NCT00603278|566214|P2|NOT COMPLETED|Overall Study||17
234891|NCT00603278|566215|P1|NOT COMPLETED|Overall Study||41
234892|NCT00603278|566210|P6|COMPLETED|Overall Study||81
234893|NCT00603278|566211|P5|COMPLETED|Overall Study||86
234894|NCT00603278|566212|P4|COMPLETED|Overall Study||92
234895|NCT00603278|566213|P3|COMPLETED|Overall Study||87
234896|NCT00603278|566214|P2|COMPLETED|Overall Study||88
234897|NCT00603278|566215|P1|COMPLETED|Overall Study||66
234898|NCT00603278|566210|P6|STARTED|Overall Study||100
234899|NCT00603278|566211|P5|STARTED|Overall Study||99
234900|NCT00603278|566212|P4|STARTED|Overall Study||103
234901|NCT00603278|566213|P3|STARTED|Overall Study||101
234902|NCT00603278|566214|P2|STARTED|Overall Study||105
234903|NCT00603278|566215|P1|STARTED|Overall Study||107
234904|NCT00603265|566364|P3|NOT COMPLETED|Overall Study||5
234905|NCT00603265|566365|P2|NOT COMPLETED|Overall Study||16
234906|NCT00603265|566366|P1|NOT COMPLETED|Overall Study||7
234907|NCT00603265|566364|P3|COMPLETED|Overall Study||67
234908|NCT00603265|566365|P2|COMPLETED|Overall Study||62
234909|NCT00603265|566366|P1|COMPLETED|Overall Study||69
234910|NCT00603265|566364|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
234911|NCT00603265|566365|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
234912|NCT00603265|566366|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
234913|NCT00603265|566364|P3|STARTED|Overall Study||72
234914|NCT00603265|566365|P2|STARTED|Overall Study||78
234915|NCT00603265|566366|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
234916|NCT00603239|566394|P2|NOT COMPLETED|Overall Study||4
234917|NCT00603239|566395|P1|NOT COMPLETED|Overall Study||15
234918|NCT00603239|566394|P2|COMPLETED|Overall Study||50
234919|NCT00603239|566395|P1|COMPLETED|Overall Study||96
234920|NCT00603239|566394|P2|STARTED|Overall Study||54
234921|NCT00603239|566395|P1|STARTED|Overall Study||111
234922|NCT00603187|566421|P1|NOT COMPLETED|Overall Study||0
234923|NCT00603187|566421|P1|COMPLETED|Overall Study||4
234924|NCT00603187|566421|P1|STARTED|Overall Study||4
234925|NCT00603044|566429|P2|NOT COMPLETED|Overall Study||0
234926|NCT00603044|566430|P1|NOT COMPLETED|Overall Study||0
234927|NCT00603044|566429|P2|COMPLETED|Overall Study||13
234928|NCT00603044|566430|P1|COMPLETED|Overall Study||11
234929|NCT00603044|566429|P2|STARTED|Overall Study||13
234930|NCT00603044|566430|P1|STARTED|Overall Study||11
234931|NCT00603018|566446|P1|NOT COMPLETED|Overall Study||0
234932|NCT00603018|566446|P1|COMPLETED|Overall Study||23
234933|NCT00603018|566446|P1|STARTED|Overall Study||23
234934|NCT00602979|566456|P5|NOT COMPLETED|Overall Study||3
234935|NCT00602979|566457|P4|NOT COMPLETED|Overall Study||3
234936|NCT00602979|566458|P3|NOT COMPLETED|Overall Study||3
234937|NCT00602979|566459|P2|NOT COMPLETED|Overall Study||3
234938|NCT00602979|566460|P1|NOT COMPLETED|Overall Study||3
234939|NCT00602979|566456|P5|COMPLETED|Overall Study||45
234940|NCT00602979|566457|P4|COMPLETED|Overall Study||45
234941|NCT00602979|566458|P3|COMPLETED|Overall Study||45
234942|NCT00602979|566459|P2|COMPLETED|Overall Study||45
234943|NCT00602979|566460|P1|COMPLETED|Overall Study||45
234944|NCT00602979|566456|P5|STARTED|Overall Study||48
234945|NCT00602979|566457|P4|STARTED|Overall Study||48
234946|NCT00602979|566458|P3|STARTED|Overall Study||48
234947|NCT00602979|566459|P2|STARTED|Overall Study||48
234948|NCT00602979|566460|P1|STARTED|Overall Study||48
234949|NCT00602953|566477|P5|NOT COMPLETED|Overall Study||0
234950|NCT00602953|566478|P4|NOT COMPLETED|Overall Study||0
234951|NCT00602953|566479|P3|NOT COMPLETED|Overall Study||0
234952|NCT00602953|566480|P2|NOT COMPLETED|Overall Study||0
234953|NCT00602953|566481|P1|NOT COMPLETED|Overall Study||0
234954|NCT00602953|566477|P5|COMPLETED|Overall Study||0
234955|NCT00602953|566478|P4|COMPLETED|Overall Study||13
234956|NCT00602953|566479|P3|COMPLETED|Overall Study||47
234957|NCT00602953|566480|P2|COMPLETED|Overall Study||26
234958|NCT00602953|566481|P1|COMPLETED|Overall Study||15
234959|NCT00602953|566477|P5|STARTED|Overall Study||0
234960|NCT00602953|566478|P4|STARTED|Overall Study||13
234961|NCT00602953|566479|P3|STARTED|Overall Study||47
234962|NCT00602953|566480|P2|STARTED|Overall Study||26
234963|NCT00602953|566481|P1|STARTED|Overall Study||15
234964|NCT00602927|566510|P2|NOT COMPLETED|Period 3: 13 Days||3
234965|NCT00602927|566511|P1|NOT COMPLETED|Period 3: 13 Days||2
234966|NCT00602927|566510|P2|COMPLETED|Period 3: 13 Days||9
234967|NCT00602927|566511|P1|COMPLETED|Period 3: 13 Days||13
234968|NCT00602927|566510|P2|STARTED|Period 3: 13 Days||12
234969|NCT00602927|566511|P1|STARTED|Period 3: 13 Days||15
234970|NCT00602927|566510|P2|NOT COMPLETED|Period 2: 14 Days||2
234971|NCT00602927|566511|P1|NOT COMPLETED|Period 2: 14 Days||0
234972|NCT00602927|566510|P2|COMPLETED|Period 2: 14 Days||12
234973|NCT00602927|566511|P1|COMPLETED|Period 2: 14 Days||15
234974|NCT00602927|566510|P2|STARTED|Period 2: 14 Days||14
234975|NCT00602927|566511|P1|STARTED|Period 2: 14 Days||15
234976|NCT00602927|566510|P2|NOT COMPLETED|Period 1: 13 Days||5
234977|NCT00602927|566511|P1|NOT COMPLETED|Period 1: 13 Days||4
234978|NCT00602927|566510|P2|COMPLETED|Period 1: 13 Days||14
234979|NCT00602927|566511|P1|COMPLETED|Period 1: 13 Days||15
234980|NCT00602927|566510|P2|STARTED|Period 1: 13 Days||19
234981|NCT00602927|566511|P1|STARTED|Period 1: 13 Days||19
234982|NCT00602836|566519|P1|NOT COMPLETED|Overall Study||5
234983|NCT00602836|566519|P1|COMPLETED|Overall Study||39
234984|NCT00602836|566519|P1|STARTED|Overall Study||44
234985|NCT00602797|566523|P1|NOT COMPLETED|Overall Study||1
234986|NCT00602797|566523|P1|COMPLETED|Overall Study||19
234987|NCT00602797|566523|P1|STARTED|Overall Study||20
234988|NCT00602771|566531|P2|NOT COMPLETED|Overall Study||0
234989|NCT00602771|566532|P1|NOT COMPLETED|Overall Study||1
234990|NCT00602771|566531|P2|COMPLETED|Overall Study||21
234991|NCT00602771|566532|P1|COMPLETED|Overall Study||62
234992|NCT00602771|566531|P2|STARTED|Overall Study||21
234993|NCT00602771|566532|P1|STARTED|Overall Study||63
234994|NCT00602641|566540|P2|NOT COMPLETED|Overall Study||152
234995|NCT00602641|566541|P1|NOT COMPLETED|Overall Study||154
234996|NCT00602641|566540|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
234997|NCT00602641|566541|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
234998|NCT00602641|566540|P2|Started Protocol Therapy|Overall Study||150
234999|NCT00602641|566541|P1|Started Protocol Therapy|Overall Study||148
235000|NCT00602641|566540|P2|STARTED|Overall Study||152
235001|NCT00602641|566541|P1|STARTED|Overall Study||154
235002|NCT00602537|566555|P2|NOT COMPLETED|Follow Up Study Comparison||3
235003|NCT00602537|566556|P1|NOT COMPLETED|Follow Up Study Comparison||11
235004|NCT00602537|566555|P2|COMPLETED|Follow Up Study Comparison||14
235005|NCT00602537|566556|P1|COMPLETED|Follow Up Study Comparison||31
235006|NCT00602537|566555|P2|STARTED|Follow Up Study Comparison||17
235007|NCT00602537|566556|P1|STARTED|Follow Up Study Comparison||42
235008|NCT00602537|566555|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
235009|NCT00602537|566556|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
235010|NCT00602537|566555|P2|COMPLETED|12 Week Double Blind Comparison||17
235011|NCT00602537|566556|P1|COMPLETED|12 Week Double Blind Comparison||42
235012|NCT00602537|566555|P2|Responded|12 Week Double Blind Comparison||22
235013|NCT00602537|566556|P1|Responded|12 Week Double Blind Comparison||44
235014|NCT00602537|566555|P2|STARTED|12 Week Double Blind Comparison||64
235015|NCT00602537|566556|P1|STARTED|12 Week Double Blind Comparison||65
235016|NCT00602472|566566|P2|NOT COMPLETED|Overall Study||58
235017|NCT00602472|566567|P1|NOT COMPLETED|Overall Study||21
235018|NCT00602472|566566|P2|COMPLETED|Overall Study|number who completed treatment|734
235019|NCT00602472|566567|P1|COMPLETED|Overall Study|number who completed treatment|242
235020|NCT00602472|566566|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
235021|NCT00602472|566567|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
235022|NCT00602459|566601|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
235023|NCT00602459|566602|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
235024|NCT00602459|566603|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
235025|NCT00602459|566604|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
235026|NCT00602459|566601|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
235027|NCT00602459|566602|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
235028|NCT00602459|566603|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
235029|NCT00602459|566604|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
235030|NCT00602459|566601|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
235031|NCT00602459|566602|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
235032|NCT00602459|566603|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
235033|NCT00602459|566604|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
235034|NCT00602459|566601|P4|NOT COMPLETED|Initial Registration/Randomization||0
235035|NCT00602459|566602|P3|NOT COMPLETED|Initial Registration/Randomization||3
235036|NCT00602459|566603|P2|NOT COMPLETED|Initial Registration/Randomization||10
235037|NCT00602459|566604|P1|NOT COMPLETED|Initial Registration/Randomization||5
235038|NCT00602459|566601|P4|COMPLETED|Initial Registration/Randomization||0
235039|NCT00602459|566602|P3|COMPLETED|Initial Registration/Randomization||137
235040|NCT00602459|566603|P2|COMPLETED|Initial Registration/Randomization||130
235041|NCT00602459|566604|P1|COMPLETED|Initial Registration/Randomization||133
235042|NCT00602459|566601|P4|STARTED|Initial Registration/Randomization||0
235043|NCT00602459|566602|P3|STARTED|Initial Registration/Randomization||140
235044|NCT00602459|566603|P2|STARTED|Initial Registration/Randomization||140
235045|NCT00602459|566604|P1|STARTED|Initial Registration/Randomization||138
235046|NCT00602446|566620|P1|NOT COMPLETED|Overall Study||0
235047|NCT00602446|566620|P1|COMPLETED|Overall Study||3
235048|NCT00602446|566620|P1|STARTED|Overall Study||3
235049|NCT00602420|566627|P2|NOT COMPLETED|Overall Study||24
235050|NCT00602420|566628|P1|NOT COMPLETED|Overall Study||25
235051|NCT00602420|566627|P2|COMPLETED|Overall Study||229
235052|NCT00602420|566628|P1|COMPLETED|Overall Study||232
235053|NCT00602420|566627|P2|STARTED|Overall Study||253
235054|NCT00602420|566628|P1|STARTED|Overall Study||257
235055|NCT00602355|566637|P3|NOT COMPLETED|Overall Study||10
235056|NCT00602355|566638|P2|NOT COMPLETED|Overall Study||18
235057|NCT00602355|566639|P1|NOT COMPLETED|Overall Study||9
235058|NCT00602355|566637|P3|COMPLETED|Overall Study||43
235059|NCT00602355|566638|P2|COMPLETED|Overall Study||38
235060|NCT00602355|566639|P1|COMPLETED|Overall Study||44
235061|NCT00602355|566637|P3|STARTED|Overall Study||53
235062|NCT00602355|566638|P2|STARTED|Overall Study||56
235063|NCT00602355|566639|P1|STARTED|Overall Study||53
235064|NCT00602290|566662|P3|NOT COMPLETED|Overall Study||1
235065|NCT00602290|566663|P2|NOT COMPLETED|Overall Study||2
235066|NCT00602290|566664|P1|NOT COMPLETED|Overall Study||2
235067|NCT00602290|566662|P3|COMPLETED|Overall Study||46
235068|NCT00602290|566663|P2|COMPLETED|Overall Study||46
235069|NCT00602290|566664|P1|COMPLETED|Overall Study||46
235070|NCT00602290|566662|P3|STARTED|Overall Study||47
235071|NCT00602290|566663|P2|STARTED|Overall Study||48
235072|NCT00602290|566664|P1|STARTED|Overall Study||48
235073|NCT00602225|566675|P1|NOT COMPLETED|Overall Study||0
235074|NCT00602225|566675|P1|COMPLETED|Overall Study||50
235075|NCT00602225|566675|P1|STARTED|Overall Study||50
235076|NCT00602043|566688|P1|NOT COMPLETED|Overall Study||5
235077|NCT00602043|566688|P1|COMPLETED|Overall Study||15
235078|NCT00602043|566688|P1|STARTED|Overall Study||20
235079|NCT00601965|566702|P4|NOT COMPLETED|Overall Study||1
235080|NCT00601965|566703|P3|NOT COMPLETED|Overall Study||0
235081|NCT00601965|566704|P2|NOT COMPLETED|Overall Study||2
235082|NCT00601965|566705|P1|NOT COMPLETED|Overall Study||0
235083|NCT00601965|566702|P4|COMPLETED|Overall Study||17
235084|NCT00601965|566703|P3|COMPLETED|Overall Study||19
235085|NCT00601965|566704|P2|COMPLETED|Overall Study||16
235086|NCT00601965|566705|P1|COMPLETED|Overall Study||18
235087|NCT00601965|566702|P4|STARTED|Overall Study||18
235088|NCT00601965|566703|P3|STARTED|Overall Study||19
235089|NCT00601965|566704|P2|STARTED|Overall Study||18
235090|NCT00601965|566705|P1|STARTED|Overall Study||18
235091|NCT00601952|566721|P2|NOT COMPLETED|Overall Study||0
235092|NCT00601952|566722|P1|NOT COMPLETED|Overall Study||2
235093|NCT00601952|566721|P2|COMPLETED|Overall Study||17
235094|NCT00601952|566722|P1|COMPLETED|Overall Study||12
235095|NCT00601952|566721|P2|STARTED|Overall Study||17
235096|NCT00601952|566722|P1|STARTED|Overall Study||14
235097|NCT00601926|566728|P1|NOT COMPLETED|Overall Study||0
235098|NCT00601926|566728|P1|COMPLETED|Overall Study||5
235099|NCT00601926|566728|P1|STARTED|Overall Study||5
235100|NCT00601900|566736|P2|NOT COMPLETED|Overall Study||3
235101|NCT00601900|566737|P1|NOT COMPLETED|Overall Study||0
235102|NCT00601900|566736|P2|COMPLETED|Overall Study||196
235103|NCT00601900|566737|P1|COMPLETED|Overall Study||195
235104|NCT00601900|566736|P2|STARTED|Overall Study||199
235105|NCT00601900|566737|P1|STARTED|Overall Study||195
235106|NCT00601835|566753|P2|NOT COMPLETED|Overall Study||14
235107|NCT00601835|566754|P1|NOT COMPLETED|Overall Study||60
235108|NCT00601835|566753|P2|COMPLETED|Overall Study||686
235109|NCT00601835|566754|P1|COMPLETED|Overall Study||2890
235110|NCT00601835|566753|P2|STARTED|Overall Study||700
235111|NCT00601835|566754|P1|STARTED|Overall Study||2950
235112|NCT00601796|566764|P1|NOT COMPLETED|Overall Study||0
235113|NCT00601796|566764|P1|COMPLETED|Overall Study||24
235114|NCT00601796|566764|P1|STARTED|Overall Study||24
235115|NCT00601731|566783|P4|NOT COMPLETED|Overall Study||1
235116|NCT00601731|566784|P3|NOT COMPLETED|Overall Study||15
235117|NCT00601731|566785|P2|NOT COMPLETED|Overall Study||0
235118|NCT00601731|566786|P1|NOT COMPLETED|Overall Study||23
235119|NCT00601731|566783|P4|COMPLETED|Overall Study||29
235120|NCT00601731|566784|P3|COMPLETED|Overall Study||151
235121|NCT00601731|566785|P2|COMPLETED|Overall Study||43
235122|NCT00601731|566786|P1|COMPLETED|Overall Study||120
235123|NCT00601731|566783|P4|STARTED|Overall Study||30
235124|NCT00601731|566784|P3|STARTED|Overall Study||166
235125|NCT00601731|566785|P2|STARTED|Overall Study||43
235126|NCT00601731|566786|P1|STARTED|Overall Study||143
235127|NCT00601718|566836|P1|NOT COMPLETED|Overall Study||0
235128|NCT00601718|566836|P1|COMPLETED|Overall Study||29
235129|NCT00601718|566836|P1|STARTED|Overall Study||29
235130|NCT00601640|566846|P3|NOT COMPLETED|Overall Study||10
235131|NCT00601640|566847|P2|NOT COMPLETED|Overall Study||5
235132|NCT00601640|566848|P1|NOT COMPLETED|Overall Study||5
235133|NCT00601640|566846|P3|COMPLETED|Overall Study||42
235134|NCT00601640|566847|P2|COMPLETED|Overall Study||47
235135|NCT00601640|566848|P1|COMPLETED|Overall Study||47
235136|NCT00601640|566846|P3|STARTED|Overall Study||52
235137|NCT00601640|566847|P2|STARTED|Overall Study||52
235138|NCT00601640|566848|P1|STARTED|Overall Study||52
235139|NCT00601627|566862|P1|NOT COMPLETED|Overall Study||0
235140|NCT00601627|566862|P1|COMPLETED|Overall Study||51
235141|NCT00601627|566862|P1|STARTED|Overall Study||51
235142|NCT00601523|566873|P2|NOT COMPLETED|Overall Study||26
235143|NCT00601523|566874|P1|NOT COMPLETED|Overall Study||77
235144|NCT00601523|566873|P2|COMPLETED|Overall Study||117
235145|NCT00601523|566874|P1|COMPLETED|Overall Study||291
235146|NCT00601523|566873|P2|STARTED|Overall Study||143
235147|NCT00601523|566874|P1|STARTED|Overall Study||368
235148|NCT00601458|566909|P3|NOT COMPLETED|Overall Study||2
235149|NCT00601458|566910|P2|NOT COMPLETED|Overall Study||5
235150|NCT00601458|566911|P1|NOT COMPLETED|Overall Study||4
235151|NCT00601458|566909|P3|COMPLETED|Overall Study||28
235152|NCT00601458|566910|P2|COMPLETED|Overall Study||29
235153|NCT00601458|566911|P1|COMPLETED|Overall Study||32
235154|NCT00601458|566909|P3|STARTED|Overall Study||30
235155|NCT00601458|566910|P2|STARTED|Overall Study||34
235156|NCT00601458|566911|P1|STARTED|Overall Study||36
235157|NCT00601419|566922|P1|NOT COMPLETED|Overall Study||4
235158|NCT00601419|566922|P1|COMPLETED|Overall Study||226
235159|NCT00601419|566922|P1|STARTED|Overall Study||230
235160|NCT00601367|566946|P1|NOT COMPLETED|Overall Study||187
235161|NCT00601367|566946|P1|COMPLETED|Overall Study||293
235162|NCT00601367|566946|P1|STARTED|Overall Study||480
235163|NCT00601354|566952|P2|NOT COMPLETED|Overall Study||5
235164|NCT00601354|566953|P1|NOT COMPLETED|Overall Study||4
235165|NCT00601354|566952|P2|COMPLETED|Overall Study||4
235166|NCT00601354|566953|P1|COMPLETED|Overall Study||4
235167|NCT00601354|566952|P2|STARTED|Overall Study||9
235168|NCT00601354|566953|P1|STARTED|Overall Study||8
235169|NCT00601250|566965|P2|NOT COMPLETED|Overall Study||39
235170|NCT00601250|566966|P1|NOT COMPLETED|Overall Study||14
235171|NCT00601250|566965|P2|COMPLETED|Overall Study|number who completed treatment|484
235172|NCT00601250|566966|P1|COMPLETED|Overall Study|number who completed treatment|163
235173|NCT00601250|566965|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
235174|NCT00601250|566966|P1|STARTED|Overall Study|number who started treatment|177
235175|NCT00601172|567002|P2|NOT COMPLETED|Overall Study||127
235176|NCT00601172|567003|P1|NOT COMPLETED|Overall Study||141
235177|NCT00601172|567002|P2|COMPLETED|Overall Study||228
235178|NCT00601172|567003|P1|COMPLETED|Overall Study||214
235179|NCT00601172|567002|P2|STARTED|Overall Study||355
235180|NCT00601172|567003|P1|STARTED|Overall Study||355
235181|NCT00601146|567052|P1|NOT COMPLETED|Overall Study||161
235182|NCT00601146|567052|P1|COMPLETED|Overall Study||39
235183|NCT00601146|567052|P1|STARTED|Overall Study||200
235184|NCT00601107|567060|P4|NOT COMPLETED|Overall Study||12
235185|NCT00601107|567061|P3|NOT COMPLETED|Overall Study||12
235186|NCT00601107|567062|P2|NOT COMPLETED|Overall Study||9
235187|NCT00601107|567063|P1|NOT COMPLETED|Overall Study||13
235188|NCT00601107|567060|P4|COMPLETED|Overall Study||13
235189|NCT00601107|567061|P3|COMPLETED|Overall Study||16
235190|NCT00601107|567062|P2|COMPLETED|Overall Study||22
235191|NCT00601107|567063|P1|COMPLETED|Overall Study||14
235192|NCT00601107|567060|P4|Treated|Overall Study||25
235193|NCT00601107|567061|P3|Treated|Overall Study||28
235194|NCT00601107|567062|P2|Treated|Overall Study||31
235195|NCT00601107|567063|P1|Treated|Overall Study||27
235196|NCT00601107|567060|P4|STARTED|Overall Study||25
235197|NCT00601107|567061|P3|STARTED|Overall Study||28
235198|NCT00601107|567062|P2|STARTED|Overall Study||31
235199|NCT00601107|567063|P1|STARTED|Overall Study|Randomized.|27
235200|NCT00600938|567083|P4|NOT COMPLETED|Extension Study||1
235201|NCT00600938|567084|P3|NOT COMPLETED|Extension Study||9
235202|NCT00600938|567085|P2|NOT COMPLETED|Extension Study||5
235203|NCT00600938|567086|P1|NOT COMPLETED|Extension Study||9
235204|NCT00600938|567083|P4|COMPLETED|Extension Study||0
235205|NCT00600938|567084|P3|COMPLETED|Extension Study||33
235206|NCT00600938|567085|P2|COMPLETED|Extension Study||24
235207|NCT00600938|567086|P1|COMPLETED|Extension Study||65
235208|NCT00600938|567083|P4|Extension Safety Set|Extension Study||1
235209|NCT00600938|567084|P3|Extension Safety Set|Extension Study||42
235210|NCT00600938|567085|P2|Extension Safety Set|Extension Study||29
235211|NCT00600938|567086|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
235212|NCT00600938|567083|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
235213|NCT00600938|567084|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
235214|NCT00600938|567085|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
235215|NCT00600938|567086|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
235216|NCT00600938|567083|P4|NOT COMPLETED|Core Study||0
235217|NCT00600938|567084|P3|NOT COMPLETED|Core Study||0
235218|NCT00600938|567085|P2|NOT COMPLETED|Core Study||21
235219|NCT00600938|567086|P1|NOT COMPLETED|Core Study||16
235220|NCT00600938|567083|P4|COMPLETED|Core Study||0
235221|NCT00600938|567084|P3|COMPLETED|Core Study||0
235222|NCT00600938|567085|P2|COMPLETED|Core Study||78
235223|NCT00600938|567086|P1|COMPLETED|Core Study||82
235224|NCT00600938|567083|P4|Per Protocol Set (PPS)|Core Study||0
235225|NCT00600938|567084|P3|Per Protocol Set (PPS)|Core Study||0
235226|NCT00600938|567085|P2|Per Protocol Set (PPS)|Core Study||81
235227|NCT00600938|567086|P1|Per Protocol Set (PPS)|Core Study||91
235228|NCT00600938|567083|P4|Core Safety Set|Core Study||0
235229|NCT00600938|567084|P3|Core Safety Set|Core Study||0
235230|NCT00600938|567085|P2|Core Safety Set|Core Study||91
235231|NCT00600938|567086|P1|Core Safety Set|Core Study||96
235232|NCT00600938|567083|P4|STARTED|Core Study||0
235233|NCT00600938|567084|P3|STARTED|Core Study||0
235234|NCT00600938|567085|P2|STARTED|Core Study||99
235235|NCT00600938|567086|P1|STARTED|Core Study||98
235236|NCT00600886|567150|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
235237|NCT00600886|567151|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
235238|NCT00600886|567150|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
235239|NCT00600886|567151|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
235240|NCT00600886|567150|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
235241|NCT00600886|567151|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
235242|NCT00600886|567150|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
235243|NCT00600886|567151|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
235244|NCT00600886|567150|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
235245|NCT00600886|567151|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
235246|NCT00600886|567150|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
235247|NCT00600886|567151|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
235248|NCT00600886|567150|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
235249|NCT00600886|567151|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
235250|NCT00600886|567150|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
235251|NCT00600886|567151|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
235252|NCT00600886|567150|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
235253|NCT00600886|567151|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
235254|NCT00600886|567150|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
235255|NCT00600886|567151|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
235256|NCT00600886|567150|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
235257|NCT00600886|567151|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
235258|NCT00600886|567150|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
235259|NCT00600886|567151|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
235260|NCT00600886|567150|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
235261|NCT00600886|567151|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
235262|NCT00600886|567150|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
235263|NCT00600886|567151|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
235264|NCT00600886|567150|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
235265|NCT00600886|567151|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
235266|NCT00600886|567150|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
235267|NCT00600886|567151|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
235268|NCT00600886|567150|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
235269|NCT00600886|567151|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
235270|NCT00600886|567150|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
235271|NCT00600886|567151|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
235272|NCT00600886|567150|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
235273|NCT00600886|567151|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
235274|NCT00600886|567150|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
235275|NCT00600886|567151|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
235276|NCT00600821|567215|P2|NOT COMPLETED|Overall Study||60
235277|NCT00600821|567216|P1|NOT COMPLETED|Overall Study||58
235278|NCT00600821|567215|P2|COMPLETED|Overall Study||0
235279|NCT00600821|567216|P1|COMPLETED|Overall Study||0
235280|NCT00600821|567215|P2|Treated|Overall Study||59
235281|NCT00600821|567216|P1|Treated|Overall Study||58
235282|NCT00600821|567215|P2|STARTED|Overall Study||60
235283|NCT00600821|567216|P1|STARTED|Overall Study||58
235284|NCT00600756|567244|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
235285|NCT00600756|567245|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
235286|NCT00600756|567244|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
235374|NCT00600119|567461|P3|COMPLETED|Double-blind Treatment Period||27
235287|NCT00600756|567245|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
235288|NCT00600756|567244|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
235289|NCT00600756|567245|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
235290|NCT00600756|567244|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
235291|NCT00600756|567245|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
235292|NCT00600756|567244|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
235293|NCT00600756|567245|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
235294|NCT00600756|567244|P2|STARTED|Overall Study Analysis After 12 Months||403
235295|NCT00600756|567245|P1|STARTED|Overall Study Analysis After 12 Months||395
235296|NCT00600756|567244|P2|NOT COMPLETED|Analysis After 6 Months||120
235297|NCT00600756|567245|P1|NOT COMPLETED|Analysis After 6 Months||131
235298|NCT00600756|567244|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
235299|NCT00600756|567245|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
235300|NCT00600756|567244|P2|STARTED|Analysis After 6 Months||403
235301|NCT00600756|567245|P1|STARTED|Analysis After 6 Months||395
235302|NCT00600743|567315|P4|NOT COMPLETED|Overall Study||0
235303|NCT00600743|567316|P3|NOT COMPLETED|Overall Study||0
235304|NCT00600743|567317|P2|NOT COMPLETED|Overall Study||0
235305|NCT00600743|567318|P1|NOT COMPLETED|Overall Study||0
235306|NCT00600743|567315|P4|COMPLETED|Overall Study||7
235307|NCT00600743|567316|P3|COMPLETED|Overall Study||8
235308|NCT00600743|567317|P2|COMPLETED|Overall Study||4
235309|NCT00600743|567318|P1|COMPLETED|Overall Study||4
235310|NCT00600743|567315|P4|STARTED|Overall Study||7
235311|NCT00600743|567316|P3|STARTED|Overall Study||8
235312|NCT00600743|567317|P2|STARTED|Overall Study||4
235313|NCT00600743|567318|P1|STARTED|Overall Study||4
235314|NCT00600704|567347|P2|NOT COMPLETED|Overall Study||0
235315|NCT00600704|567348|P1|NOT COMPLETED|Overall Study||0
235316|NCT00600704|567347|P2|COMPLETED|Overall Study||92
235317|NCT00600704|567348|P1|COMPLETED|Overall Study||100
235318|NCT00600704|567347|P2|STARTED|Overall Study||92
235319|NCT00600704|567348|P1|STARTED|Overall Study||100
235320|NCT00600613|567354|P1|NOT COMPLETED|Overall Study||1
235321|NCT00600613|567354|P1|COMPLETED|Overall Study||5
235322|NCT00600613|567354|P1|STARTED|Overall Study||6
235323|NCT00600353|567360|P2|NOT COMPLETED|Overall Study||1
235324|NCT00600353|567361|P1|NOT COMPLETED|Overall Study||1
235325|NCT00600353|567360|P2|COMPLETED|Overall Study||9
235326|NCT00600353|567361|P1|COMPLETED|Overall Study||9
235327|NCT00600353|567360|P2|STARTED|Overall Study||10
235328|NCT00600353|567361|P1|STARTED|Overall Study||10
235329|NCT00600171|567379|P6|NOT COMPLETED|Overall Study||5
235330|NCT00600171|567380|P5|NOT COMPLETED|Overall Study||8
235331|NCT00600171|567381|P4|NOT COMPLETED|Overall Study||12
235332|NCT00600171|567382|P3|NOT COMPLETED|Overall Study||10
235333|NCT00600171|567383|P2|NOT COMPLETED|Overall Study||17
235334|NCT00600171|567384|P1|NOT COMPLETED|Overall Study||16
235335|NCT00600171|567379|P6|COMPLETED|Overall Study||97
235336|NCT00600171|567380|P5|COMPLETED|Overall Study||93
235337|NCT00600171|567381|P4|COMPLETED|Overall Study||88
235338|NCT00600171|567382|P3|COMPLETED|Overall Study||91
235339|NCT00600171|567383|P2|COMPLETED|Overall Study||84
235340|NCT00600171|567384|P1|COMPLETED|Overall Study||86
235341|NCT00600171|567379|P6|STARTED|Overall Study||102
235342|NCT00600171|567380|P5|STARTED|Overall Study||101
235343|NCT00600171|567381|P4|STARTED|Overall Study||100
235344|NCT00600171|567382|P3|STARTED|Overall Study||101
235345|NCT00600171|567383|P2|STARTED|Overall Study||101
235346|NCT00600171|567384|P1|STARTED|Overall Study||102
235347|NCT00600119|567458|P6|NOT COMPLETED|Follow-up Period||1
235348|NCT00600119|567459|P5|NOT COMPLETED|Follow-up Period||0
235349|NCT00600119|567460|P4|NOT COMPLETED|Follow-up Period||0
235350|NCT00600119|567461|P3|NOT COMPLETED|Follow-up Period||0
235351|NCT00600119|567462|P2|NOT COMPLETED|Follow-up Period||0
235352|NCT00600119|567463|P1|NOT COMPLETED|Follow-up Period||1
235353|NCT00600119|567458|P6|COMPLETED|Follow-up Period||20
235354|NCT00600119|567459|P5|COMPLETED|Follow-up Period||31
235355|NCT00600119|567460|P4|COMPLETED|Follow-up Period||28
235356|NCT00600119|567461|P3|COMPLETED|Follow-up Period||27
235357|NCT00600119|567462|P2|COMPLETED|Follow-up Period||28
235358|NCT00600119|567463|P1|COMPLETED|Follow-up Period||26
235359|NCT00600119|567458|P6|STARTED|Follow-up Period||21
235360|NCT00600119|567459|P5|STARTED|Follow-up Period||31
235361|NCT00600119|567460|P4|STARTED|Follow-up Period||28
235362|NCT00600119|567461|P3|STARTED|Follow-up Period||27
235363|NCT00600119|567462|P2|STARTED|Follow-up Period||28
235364|NCT00600119|567463|P1|STARTED|Follow-up Period||27
235365|NCT00600119|567458|P6|NOT COMPLETED|Double-blind Treatment Period||14
235366|NCT00600119|567459|P5|NOT COMPLETED|Double-blind Treatment Period||6
235367|NCT00600119|567460|P4|NOT COMPLETED|Double-blind Treatment Period||2
235368|NCT00600119|567461|P3|NOT COMPLETED|Double-blind Treatment Period||0
235369|NCT00600119|567462|P2|NOT COMPLETED|Double-blind Treatment Period||5
235370|NCT00600119|567463|P1|NOT COMPLETED|Double-blind Treatment Period||5
235371|NCT00600119|567458|P6|COMPLETED|Double-blind Treatment Period||21
235372|NCT00600119|567459|P5|COMPLETED|Double-blind Treatment Period||31
235373|NCT00600119|567460|P4|COMPLETED|Double-blind Treatment Period||28
235375|NCT00600119|567462|P2|COMPLETED|Double-blind Treatment Period||28
235376|NCT00600119|567463|P1|COMPLETED|Double-blind Treatment Period||27
235377|NCT00600119|567458|P6|STARTED|Double-blind Treatment Period||35
235378|NCT00600119|567459|P5|STARTED|Double-blind Treatment Period||37
235379|NCT00600119|567460|P4|STARTED|Double-blind Treatment Period||30
235380|NCT00600119|567461|P3|STARTED|Double-blind Treatment Period||27
235381|NCT00600119|567462|P2|STARTED|Double-blind Treatment Period||33
235382|NCT00600119|567463|P1|STARTED|Double-blind Treatment Period||32
235383|NCT00600119|567458|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
235384|NCT00600119|567459|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
235385|NCT00600119|567460|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
235386|NCT00600119|567461|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
235387|NCT00600119|567462|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
235388|NCT00600119|567463|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
235389|NCT00600119|567458|P6|COMPLETED|Single-blind Placebo run-in Period||35
235390|NCT00600119|567459|P5|COMPLETED|Single-blind Placebo run-in Period||37
235391|NCT00600119|567460|P4|COMPLETED|Single-blind Placebo run-in Period||30
235392|NCT00600119|567461|P3|COMPLETED|Single-blind Placebo run-in Period||27
235393|NCT00600119|567462|P2|COMPLETED|Single-blind Placebo run-in Period||33
235394|NCT00600119|567463|P1|COMPLETED|Single-blind Placebo run-in Period||32
235395|NCT00600119|567458|P6|STARTED|Single-blind Placebo run-in Period||37
235396|NCT00600119|567459|P5|STARTED|Single-blind Placebo run-in Period||39
235397|NCT00600119|567460|P4|STARTED|Single-blind Placebo run-in Period||31
235398|NCT00600119|567461|P3|STARTED|Single-blind Placebo run-in Period||29
235399|NCT00600119|567462|P2|STARTED|Single-blind Placebo run-in Period||35
235400|NCT00600119|567463|P1|STARTED|Single-blind Placebo run-in Period||36
235401|NCT00600106|567497|P2|NOT COMPLETED|Overall Study||1
235402|NCT00600106|567498|P1|NOT COMPLETED|Overall Study||1
235403|NCT00600106|567497|P2|COMPLETED|Overall Study||18
235404|NCT00600106|567498|P1|COMPLETED|Overall Study||17
235405|NCT00600106|567497|P2|STARTED|Overall Study||19
235406|NCT00600106|567498|P1|STARTED|Overall Study||18
235407|NCT00600080|567530|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
235408|NCT00600080|567531|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
235409|NCT00600080|567530|P2|COMPLETED|Period 2: One-week to Two-weeks||32
235410|NCT00600080|567531|P1|COMPLETED|Period 2: One-week to Two-weeks||28
235411|NCT00600080|567530|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
235412|NCT00600080|567531|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
235413|NCT00600080|567530|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
235414|NCT00600080|567531|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
235415|NCT00600080|567530|P2|COMPLETED|Period 1: Baseline to One-week||32
235416|NCT00600080|567531|P1|COMPLETED|Period 1: Baseline to One-week||28
235417|NCT00600080|567530|P2|STARTED|Period 1: Baseline to One-week||32
235418|NCT00600080|567531|P1|STARTED|Period 1: Baseline to One-week||28
235419|NCT00600067|567545|P2|NOT COMPLETED|Overall Study||7
235420|NCT00600067|567546|P1|NOT COMPLETED|Overall Study||3
235421|NCT00600067|567545|P2|COMPLETED|Overall Study||68
235422|NCT00600067|567546|P1|COMPLETED|Overall Study||52
235423|NCT00600067|567545|P2|STARTED|Overall Study||75
235424|NCT00600067|567546|P1|STARTED|Overall Study||55
235425|NCT00600028|567556|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
235426|NCT00600028|567557|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
235427|NCT00600028|567556|P2|COMPLETED|Second Intervention (12 Weeks)||8
235428|NCT00600028|567557|P1|COMPLETED|Second Intervention (12 Weeks)||12
235429|NCT00600028|567556|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
235430|NCT00600028|567557|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
235431|NCT00600028|567556|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
235432|NCT00600028|567557|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
235433|NCT00600028|567556|P2|COMPLETED|First Intervention (12 Weeks)||10
235434|NCT00600028|567557|P1|COMPLETED|First Intervention (12 Weeks)||12
235435|NCT00600028|567556|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
235436|NCT00600028|567557|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
235437|NCT00600015|567571|P2|NOT COMPLETED|Overall Study||35
235438|NCT00600015|567572|P1|NOT COMPLETED|Overall Study||60
235439|NCT00600015|567571|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
235440|NCT00600015|567572|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
235441|NCT00600015|567571|P2|STARTED|Overall Study||55
235442|NCT00600015|567572|P1|STARTED|Overall Study||111
235443|NCT00599924|567587|P7|NOT COMPLETED|Overall Study||5
235444|NCT00599924|567588|P6|NOT COMPLETED|Overall Study||4
235445|NCT00599924|567589|P5|NOT COMPLETED|Overall Study||6
235446|NCT00599924|567590|P4|NOT COMPLETED|Overall Study||8
235447|NCT00599924|567591|P3|NOT COMPLETED|Overall Study||2
235448|NCT00599924|567592|P2|NOT COMPLETED|Overall Study||5
235449|NCT00599924|567593|P1|NOT COMPLETED|Overall Study||3
235450|NCT00599924|567587|P7|COMPLETED|Overall Study||3
235451|NCT00599924|567588|P6|COMPLETED|Overall Study||2
235452|NCT00599924|567589|P5|COMPLETED|Overall Study||3
235453|NCT00599924|567590|P4|COMPLETED|Overall Study||4
235454|NCT00599924|567591|P3|COMPLETED|Overall Study||3
235455|NCT00599924|567592|P2|COMPLETED|Overall Study||4
235456|NCT00599924|567593|P1|COMPLETED|Overall Study||1
235457|NCT00599924|567587|P7|STARTED|Overall Study||8
235458|NCT00599924|567588|P6|STARTED|Overall Study||6
235459|NCT00599924|567589|P5|STARTED|Overall Study||9
235460|NCT00599924|567590|P4|STARTED|Overall Study||12
235461|NCT00599924|567591|P3|STARTED|Overall Study||5
235462|NCT00599924|567592|P2|STARTED|Overall Study||9
235463|NCT00599924|567593|P1|STARTED|Overall Study||4
235464|NCT00599872|567680|P2|NOT COMPLETED|Overall Study||33
235465|NCT00599872|567681|P1|NOT COMPLETED|Overall Study||49
235466|NCT00599872|567680|P2|COMPLETED|Overall Study||181
235467|NCT00599872|567681|P1|COMPLETED|Overall Study||167
235468|NCT00599872|567680|P2|STARTED|Overall Study||214
235469|NCT00599872|567681|P1|STARTED|Overall Study||216
235470|NCT00599755|567697|P1|NOT COMPLETED|Overall Study||19
235471|NCT00599755|567697|P1|COMPLETED|Overall Study||49
235472|NCT00599755|567697|P1|STARTED|Overall Study||68
235473|NCT00599521|567708|P2|NOT COMPLETED|Overall Study||69
235474|NCT00599521|567709|P1|NOT COMPLETED|Overall Study||60
235475|NCT00599521|567708|P2|COMPLETED|Overall Study||462
235476|NCT00599521|567709|P1|COMPLETED|Overall Study||475
235477|NCT00599521|567708|P2|STARTED|Overall Study||531
235478|NCT00599521|567709|P1|STARTED|Overall Study||535
235479|NCT00599339|567723|P1|NOT COMPLETED|Overall Study||664
235480|NCT00599339|567723|P1|COMPLETED|Overall Study||1531
235481|NCT00599339|567723|P1|Safety Set|Overall Study||2179
235482|NCT00599339|567723|P1|STARTED|Overall Study||2195
235483|NCT00599326|567825|P1|NOT COMPLETED|Overall Study||2
235484|NCT00599326|567825|P1|COMPLETED|Overall Study||8
235485|NCT00599326|567825|P1|STARTED|Overall Study||10
235486|NCT00599313|567830|P1|NOT COMPLETED|Overall Study||36
235487|NCT00599313|567830|P1|COMPLETED|Overall Study||0
235488|NCT00599313|567830|P1|STARTED|Overall Study||36
235489|NCT00599248|567841|P4|NOT COMPLETED|Overall Study||0
235490|NCT00599248|567842|P3|NOT COMPLETED|Overall Study||0
235491|NCT00599248|567843|P2|NOT COMPLETED|Overall Study||0
235492|NCT00599248|567844|P1|NOT COMPLETED|Overall Study||0
235493|NCT00599248|567841|P4|COMPLETED|Overall Study||3
235494|NCT00599248|567842|P3|COMPLETED|Overall Study||3
235495|NCT00599248|567843|P2|COMPLETED|Overall Study||3
235496|NCT00599248|567844|P1|COMPLETED|Overall Study||3
235497|NCT00599248|567841|P4|STARTED|Overall Study||3
235498|NCT00599248|567842|P3|STARTED|Overall Study||3
235499|NCT00599248|567843|P2|STARTED|Overall Study||3
235500|NCT00599248|567844|P1|STARTED|Overall Study||3
235501|NCT00599196|567872|P1|NOT COMPLETED|Overall Study||381
235502|NCT00599196|567872|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
235503|NCT00599196|567872|P1|STARTED|Overall Study||381
235504|NCT00599131|567878|P1|NOT COMPLETED|Overall Study||0
235505|NCT00599131|567878|P1|COMPLETED|Overall Study||4
235506|NCT00599131|567878|P1|STARTED|Overall Study||4
235507|NCT00599053|567888|P2|NOT COMPLETED|Overall Study||0
235508|NCT00599053|567889|P1|NOT COMPLETED|Overall Study||0
235509|NCT00599053|567888|P2|COMPLETED|Overall Study||2
235510|NCT00599053|567889|P1|COMPLETED|Overall Study||5
235511|NCT00599053|567888|P2|STARTED|Overall Study||2
235512|NCT00599053|567889|P1|STARTED|Overall Study||5
235513|NCT00599027|567903|P2|NOT COMPLETED|Overall Study||3
235514|NCT00599027|567904|P1|NOT COMPLETED|Overall Study||1
235515|NCT00599027|567903|P2|COMPLETED|Overall Study||22
235516|NCT00599027|567904|P1|COMPLETED|Overall Study||25
235517|NCT00599027|567903|P2|STARTED|Overall Study||25
235518|NCT00599027|567904|P1|STARTED|Overall Study||26
235519|NCT00599014|567910|P1|NOT COMPLETED|Overall Study||0
235520|NCT00599014|567910|P1|COMPLETED|Overall Study||335
235521|NCT00599014|567910|P1|STARTED|Overall Study||335
235522|NCT00598871|567917|P2|NOT COMPLETED|Overall Study||1
235523|NCT00598871|567918|P1|NOT COMPLETED|Overall Study||0
235524|NCT00598871|567917|P2|COMPLETED|Overall Study||8
235525|NCT00598871|567918|P1|COMPLETED|Overall Study||3
235526|NCT00598871|567917|P2|STARTED|Overall Study||9
235527|NCT00598871|567918|P1|STARTED|Overall Study||3
235528|NCT00598832|567928|P2|NOT COMPLETED|Overall Study||82
235529|NCT00598832|567929|P1|NOT COMPLETED|Overall Study||62
235530|NCT00598832|567928|P2|COMPLETED|Overall Study||460
235531|NCT00598832|567929|P1|COMPLETED|Overall Study||471
235532|NCT00598832|567928|P2|STARTED|Overall Study||542
235533|NCT00598832|567929|P1|STARTED|Overall Study||533
235534|NCT00598819|567943|P1|NOT COMPLETED|Overall Study||0
235535|NCT00598819|567943|P1|COMPLETED|Overall Study||14
235536|NCT00598819|567943|P1|STARTED|Overall Study||14
235537|NCT00598806|567953|P2|NOT COMPLETED|Overall Study||64
235538|NCT00598806|567954|P1|NOT COMPLETED|Overall Study||73
235539|NCT00598806|567953|P2|COMPLETED|Overall Study||346
235540|NCT00598806|567954|P1|COMPLETED|Overall Study||329
235541|NCT00598806|567953|P2|STARTED|Overall Study||410
235542|NCT00598806|567954|P1|STARTED|Overall Study||402
235543|NCT00598702|567982|P8|NOT COMPLETED|Overall Study||0
235544|NCT00598702|567983|P7|NOT COMPLETED|Overall Study||1
235545|NCT00598702|567984|P6|NOT COMPLETED|Overall Study||12
235546|NCT00598702|567985|P5|NOT COMPLETED|Overall Study||3
235547|NCT00598702|567986|P4|NOT COMPLETED|Overall Study||8
235548|NCT00598702|567987|P3|NOT COMPLETED|Overall Study||2
235549|NCT00598702|567988|P2|NOT COMPLETED|Overall Study||2
235550|NCT00598702|567989|P1|NOT COMPLETED|Overall Study||0
235551|NCT00598702|567982|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
235552|NCT00598702|567983|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
235553|NCT00598702|567984|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
235554|NCT00598702|567985|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
235555|NCT00598702|567986|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
235556|NCT00598702|567987|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
235557|NCT00598702|567988|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
235558|NCT00598702|567989|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
235559|NCT00598702|567982|P8|STARTED|Overall Study||4
235560|NCT00598702|567983|P7|STARTED|Overall Study||1
235561|NCT00598702|567984|P6|STARTED|Overall Study||42
235562|NCT00598702|567985|P5|STARTED|Overall Study||9
235563|NCT00598702|567986|P4|STARTED|Overall Study||33
235564|NCT00598702|567987|P3|STARTED|Overall Study||7
235565|NCT00598702|567988|P2|STARTED|Overall Study||3
235566|NCT00598702|567989|P1|STARTED|Overall Study||1
235567|NCT00598689|568033|P2|NOT COMPLETED|Overall Study||0
235568|NCT00598689|568034|P1|NOT COMPLETED|Overall Study||0
235569|NCT00598689|568033|P2|COMPLETED|Overall Study||40
235570|NCT00598689|568034|P1|COMPLETED|Overall Study||40
235571|NCT00598689|568033|P2|STARTED|Overall Study||40
235572|NCT00598689|568034|P1|STARTED|Overall Study||40
235573|NCT00598650|568044|P1|NOT COMPLETED|Overall Study||27
235574|NCT00598650|568044|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
235575|NCT00598650|568044|P1|STARTED|Overall Study||108
235576|NCT00598585|568053|P2|NOT COMPLETED|Overall Study||0
235577|NCT00598585|568054|P1|NOT COMPLETED|Overall Study||1
235578|NCT00598585|568053|P2|COMPLETED|Overall Study||6
235579|NCT00598585|568054|P1|COMPLETED|Overall Study||5
235580|NCT00598585|568053|P2|STARTED|Overall Study||6
235581|NCT00598585|568054|P1|STARTED|Overall Study||6
235582|NCT00598559|568063|P3|NOT COMPLETED|Overall Study||3
235583|NCT00598559|568064|P2|NOT COMPLETED|Overall Study||28
235584|NCT00598559|568065|P1|NOT COMPLETED|Overall Study||27
235585|NCT00598559|568063|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
235586|NCT00598559|568064|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
235587|NCT00598559|568065|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
235588|NCT00598559|568063|P3|STARTED|Overall Study||30
235589|NCT00598559|568064|P2|STARTED|Overall Study||91
235590|NCT00598559|568065|P1|STARTED|Overall Study||92
235591|NCT00598507|568082|P1|NOT COMPLETED|Overall Study||0
235592|NCT00598507|568082|P1|COMPLETED|Overall Study||35
235593|NCT00598507|568082|P1|STARTED|Overall Study||35
235594|NCT00598442|568092|P3|NOT COMPLETED|Overall Study||24
235595|NCT00598442|568093|P2|NOT COMPLETED|Overall Study||39
235596|NCT00598442|568094|P1|NOT COMPLETED|Overall Study||43
235597|NCT00598442|568092|P3|COMPLETED|Overall Study||139
235598|NCT00598442|568093|P2|COMPLETED|Overall Study||124
235599|NCT00598442|568094|P1|COMPLETED|Overall Study||124
235600|NCT00598442|568092|P3|STARTED|Overall Study||163
235601|NCT00598442|568093|P2|STARTED|Overall Study||163
235602|NCT00598442|568094|P1|STARTED|Overall Study||167
235603|NCT00598273|568111|P3|NOT COMPLETED|Overall Study||39
235604|NCT00598273|568112|P2|NOT COMPLETED|Overall Study||38
235605|NCT00598273|568113|P1|NOT COMPLETED|Overall Study||41
235606|NCT00598273|568111|P3|COMPLETED|Overall Study||125
235607|NCT00598273|568112|P2|COMPLETED|Overall Study||127
235608|NCT00598273|568113|P1|COMPLETED|Overall Study||120
235609|NCT00598273|568111|P3|STARTED|Overall Study||164
235610|NCT00598273|568112|P2|STARTED|Overall Study||165
235611|NCT00598273|568113|P1|STARTED|Overall Study||161
235612|NCT00598078|568127|P2|NOT COMPLETED|Period 3 (Day 3)||0
235613|NCT00598078|568128|P1|NOT COMPLETED|Period 3 (Day 3)||0
235614|NCT00598078|568127|P2|COMPLETED|Period 3 (Day 3)||10
235615|NCT00598078|568128|P1|COMPLETED|Period 3 (Day 3)||9
235616|NCT00598078|568127|P2|STARTED|Period 3 (Day 3)||10
235617|NCT00598078|568128|P1|STARTED|Period 3 (Day 3)||9
235618|NCT00598078|568127|P2|NOT COMPLETED|Period 2 (Day 2)||0
235619|NCT00598078|568128|P1|NOT COMPLETED|Period 2 (Day 2)||1
235620|NCT00598078|568127|P2|COMPLETED|Period 2 (Day 2)||10
235621|NCT00598078|568128|P1|COMPLETED|Period 2 (Day 2)||9
235622|NCT00598078|568127|P2|STARTED|Period 2 (Day 2)||10
235623|NCT00598078|568128|P1|STARTED|Period 2 (Day 2)||10
235624|NCT00598078|568127|P2|NOT COMPLETED|Period 1 (Day 1)||0
235625|NCT00598078|568128|P1|NOT COMPLETED|Period 1 (Day 1)||0
235626|NCT00598078|568127|P2|COMPLETED|Period 1 (Day 1)||10
235627|NCT00598078|568128|P1|COMPLETED|Period 1 (Day 1)||10
235628|NCT00598078|568127|P2|STARTED|Period 1 (Day 1)||10
235629|NCT00598078|568128|P1|STARTED|Period 1 (Day 1)||10
235630|NCT00597909|568139|P3|NOT COMPLETED|Overall Study||0
235631|NCT00597909|568140|P2|NOT COMPLETED|Overall Study||0
235632|NCT00597909|568141|P1|NOT COMPLETED|Overall Study||0
235633|NCT00597909|568139|P3|COMPLETED|Overall Study||0
235634|NCT00597909|568140|P2|COMPLETED|Overall Study||0
235635|NCT00597909|568141|P1|COMPLETED|Overall Study||0
235636|NCT00597909|568139|P3|STARTED|Overall Study||0
235637|NCT00597909|568140|P2|STARTED|Overall Study||0
235638|NCT00597909|568141|P1|STARTED|Overall Study||0
235639|NCT00597896|568151|P2|NOT COMPLETED|Overall Study||2
235640|NCT00597896|568152|P1|NOT COMPLETED|Overall Study||3
235641|NCT00597896|568151|P2|COMPLETED|Overall Study||24
235642|NCT00597896|568152|P1|COMPLETED|Overall Study||21
235643|NCT00597896|568151|P2|STARTED|Overall Study||26
235644|NCT00597896|568152|P1|STARTED|Overall Study||24
235645|NCT00597766|568181|P3|NOT COMPLETED|Follow-up 3, Week 12||0
235646|NCT00597766|568182|P2|NOT COMPLETED|Follow-up 3, Week 12||0
235647|NCT00597766|568183|P1|NOT COMPLETED|Follow-up 3, Week 12||0
235648|NCT00597766|568181|P3|COMPLETED|Follow-up 3, Week 12||9
235649|NCT00597766|568182|P2|COMPLETED|Follow-up 3, Week 12||9
235650|NCT00597766|568183|P1|COMPLETED|Follow-up 3, Week 12||8
235651|NCT00597766|568181|P3|STARTED|Follow-up 3, Week 12||9
235652|NCT00597766|568182|P2|STARTED|Follow-up 3, Week 12||9
235653|NCT00597766|568183|P1|STARTED|Follow-up 3, Week 12||8
235654|NCT00597766|568181|P3|NOT COMPLETED|Follow-up 2, Week 8||1
235655|NCT00597766|568182|P2|NOT COMPLETED|Follow-up 2, Week 8||0
235656|NCT00597766|568183|P1|NOT COMPLETED|Follow-up 2, Week 8||0
235657|NCT00597766|568181|P3|COMPLETED|Follow-up 2, Week 8||9
235658|NCT00597766|568182|P2|COMPLETED|Follow-up 2, Week 8||9
235659|NCT00597766|568183|P1|COMPLETED|Follow-up 2, Week 8||8
235660|NCT00597766|568181|P3|STARTED|Follow-up 2, Week 8||10
235661|NCT00597766|568182|P2|STARTED|Follow-up 2, Week 8||9
235662|NCT00597766|568183|P1|STARTED|Follow-up 2, Week 8||8
235663|NCT00597766|568181|P3|NOT COMPLETED|Follow-up 1, Week 4||0
235664|NCT00597766|568182|P2|NOT COMPLETED|Follow-up 1, Week 4||0
235665|NCT00597766|568183|P1|NOT COMPLETED|Follow-up 1, Week 4||1
235666|NCT00597766|568181|P3|COMPLETED|Follow-up 1, Week 4||10
235667|NCT00597766|568182|P2|COMPLETED|Follow-up 1, Week 4||9
235668|NCT00597766|568183|P1|COMPLETED|Follow-up 1, Week 4||8
235669|NCT00597766|568181|P3|STARTED|Follow-up 1, Week 4||10
235670|NCT00597766|568182|P2|STARTED|Follow-up 1, Week 4||9
235671|NCT00597766|568183|P1|STARTED|Follow-up 1, Week 4||9
235672|NCT00597766|568181|P3|NOT COMPLETED|Enrolled||0
235673|NCT00597766|568182|P2|NOT COMPLETED|Enrolled||0
235674|NCT00597766|568183|P1|NOT COMPLETED|Enrolled||0
235675|NCT00597766|568181|P3|COMPLETED|Enrolled||10
235676|NCT00597766|568182|P2|COMPLETED|Enrolled||9
235677|NCT00597766|568183|P1|COMPLETED|Enrolled||9
235678|NCT00597766|568181|P3|STARTED|Enrolled||10
235679|NCT00597766|568182|P2|STARTED|Enrolled||9
235680|NCT00597766|568183|P1|STARTED|Enrolled||9
235681|NCT00597753|568202|P2|NOT COMPLETED|Overall Study||69
235682|NCT00597753|568203|P1|NOT COMPLETED|Overall Study||166
235683|NCT00597753|568202|P2|COMPLETED|Overall Study||202
235684|NCT00597753|568203|P1|COMPLETED|Overall Study||366
235685|NCT00597753|568202|P2|STARTED|Overall Study||271
235686|NCT00597753|568203|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
235687|NCT00597727|568217|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
235688|NCT00597727|568218|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
235689|NCT00597727|568219|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
235690|NCT00597727|568220|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
235691|NCT00597727|568221|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
235692|NCT00597727|568217|P5|COMPLETED|Open-label Extended Maintenance Phase||1
235693|NCT00597727|568218|P4|COMPLETED|Open-label Extended Maintenance Phase||14
235694|NCT00597727|568219|P3|COMPLETED|Open-label Extended Maintenance Phase||23
235695|NCT00597727|568220|P2|COMPLETED|Open-label Extended Maintenance Phase||0
235696|NCT00597727|568221|P1|COMPLETED|Open-label Extended Maintenance Phase||0
235697|NCT00597727|568217|P5|STARTED|Open-label Extended Maintenance Phase||3
235698|NCT00597727|568218|P4|STARTED|Open-label Extended Maintenance Phase||17
235699|NCT00597727|568219|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
235700|NCT00597727|568220|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
235701|NCT00597727|568221|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
235702|NCT00597727|568217|P5|NOT COMPLETED|12 Month Blinded Phase||1
235703|NCT00597727|568218|P4|NOT COMPLETED|12 Month Blinded Phase||10
235704|NCT00597727|568219|P3|NOT COMPLETED|12 Month Blinded Phase||0
235705|NCT00597727|568220|P2|NOT COMPLETED|12 Month Blinded Phase||0
235706|NCT00597727|568221|P1|NOT COMPLETED|12 Month Blinded Phase||0
235707|NCT00597727|568217|P5|COMPLETED|12 Month Blinded Phase||3
235708|NCT00597727|568218|P4|COMPLETED|12 Month Blinded Phase||17
235709|NCT00597727|568219|P3|COMPLETED|12 Month Blinded Phase||0
235710|NCT00597727|568220|P2|COMPLETED|12 Month Blinded Phase||15
235711|NCT00597727|568221|P1|COMPLETED|12 Month Blinded Phase||14
235712|NCT00597727|568217|P5|STARTED|12 Month Blinded Phase||4
235713|NCT00597727|568218|P4|STARTED|12 Month Blinded Phase||27
235714|NCT00597727|568219|P3|STARTED|12 Month Blinded Phase||0
235715|NCT00597727|568220|P2|STARTED|12 Month Blinded Phase||15
235716|NCT00597727|568221|P1|STARTED|12 Month Blinded Phase||14
235717|NCT00597714|568237|P3|NOT COMPLETED|Overall Study||10
235718|NCT00597714|568238|P2|NOT COMPLETED|Overall Study||46
235719|NCT00597714|568239|P1|NOT COMPLETED|Overall Study||56
235720|NCT00597714|568237|P3|COMPLETED|Overall Study||84
235721|NCT00597714|568238|P2|COMPLETED|Overall Study||11
235722|NCT00597714|568239|P1|COMPLETED|Overall Study||24
235723|NCT00597714|568237|P3|STARTED|Overall Study||94
235724|NCT00597714|568238|P2|STARTED|Overall Study||57
235725|NCT00597714|568239|P1|STARTED|Overall Study||80
235726|NCT00597701|568251|P2|NOT COMPLETED|Overall Study||8
235727|NCT00597701|568252|P1|NOT COMPLETED|Overall Study||7
235728|NCT00597701|568251|P2|COMPLETED|Overall Study||13
235729|NCT00597701|568252|P1|COMPLETED|Overall Study||18
235730|NCT00597701|568251|P2|STARTED|Overall Study||21
235731|NCT00597701|568252|P1|STARTED|Overall Study||25
235732|NCT00597675|568260|P2|NOT COMPLETED|Open Label Phase||0
235733|NCT00597675|568261|P1|NOT COMPLETED|Open Label Phase||0
235734|NCT00597675|568260|P2|COMPLETED|Open Label Phase||5
235735|NCT00597675|568261|P1|COMPLETED|Open Label Phase||2
235736|NCT00597675|568260|P2|STARTED|Open Label Phase||5
235737|NCT00597675|568261|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
235738|NCT00597675|568260|P2|NOT COMPLETED|Blinded Phase||1
235739|NCT00597675|568261|P1|NOT COMPLETED|Blinded Phase||2
235740|NCT00597675|568260|P2|COMPLETED|Blinded Phase||5
235741|NCT00597675|568261|P1|COMPLETED|Blinded Phase||2
235742|NCT00597675|568260|P2|STARTED|Blinded Phase||6
235743|NCT00597675|568261|P1|STARTED|Blinded Phase||4
235744|NCT00597584|568274|P2|NOT COMPLETED|Overall Study||63
235745|NCT00597584|568275|P1|NOT COMPLETED|Overall Study||128
235746|NCT00597584|568274|P2|COMPLETED|Overall Study||211
235747|NCT00597584|568275|P1|COMPLETED|Overall Study||421
235748|NCT00597584|568274|P2|STARTED|Overall Study||274
235749|NCT00597584|568275|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
235750|NCT00597558|568285|P1|NOT COMPLETED|Overall Study||4
235751|NCT00597558|568285|P1|COMPLETED|Overall Study||9
235752|NCT00597558|568285|P1|STARTED|Overall Study||13
235753|NCT00597545|568293|P2|NOT COMPLETED|Overall Study||0
235754|NCT00597545|568294|P1|NOT COMPLETED|Overall Study||0
235755|NCT00597545|568293|P2|COMPLETED|Overall Study||6
235756|NCT00597545|568294|P1|COMPLETED|Overall Study||4
235757|NCT00597545|568293|P2|STARTED|Overall Study||6
235758|NCT00597545|568294|P1|STARTED|Overall Study||4
235759|NCT00597519|568300|P1|NOT COMPLETED|Overall Study||1
235760|NCT00597519|568300|P1|COMPLETED|Overall Study||27
235761|NCT00597519|568300|P1|STARTED|Overall Study||28
235762|NCT00597506|568304|P1|NOT COMPLETED|Overall Study||1
235763|NCT00597506|568304|P1|COMPLETED|Overall Study||49
235764|NCT00597506|568304|P1|STARTED|Overall Study||50
235765|NCT00597493|568309|P1|NOT COMPLETED|Overall Study||0
235766|NCT00597493|568309|P1|COMPLETED|Overall Study||32
235767|NCT00597493|568309|P1|STARTED|Overall Study||32
235768|NCT00597428|568328|P2|NOT COMPLETED|Overall Study||71
235769|NCT00597428|568329|P1|NOT COMPLETED|Overall Study||61
235770|NCT00597428|568328|P2|COMPLETED|Overall Study||152
235771|NCT00597428|568329|P1|COMPLETED|Overall Study||153
235772|NCT00597428|568328|P2|STARTED|Overall Study||223
235773|NCT00597428|568329|P1|STARTED|Overall Study||214
235774|NCT00597402|568345|P1|NOT COMPLETED|Overall Study||0
235775|NCT00597402|568345|P1|COMPLETED|Overall Study||125
235776|NCT00597402|568345|P1|STARTED|Overall Study||125
235777|NCT00597376|568354|P2|NOT COMPLETED|Overall Study||4
235778|NCT00597376|568355|P1|NOT COMPLETED|Overall Study||8
235779|NCT00597376|568354|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
235780|NCT00597376|568355|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
235781|NCT00597376|568354|P2|STARTED|Overall Study||53
235782|NCT00597376|568355|P1|STARTED|Overall Study||51
235783|NCT00597272|568372|P7|NOT COMPLETED|Overall Study||0
235784|NCT00597272|568373|P6|NOT COMPLETED|Overall Study||0
235785|NCT00597272|568374|P5|NOT COMPLETED|Overall Study||0
235786|NCT00597272|568375|P4|NOT COMPLETED|Overall Study||0
235787|NCT00597272|568376|P3|NOT COMPLETED|Overall Study||0
235788|NCT00597272|568377|P2|NOT COMPLETED|Overall Study||0
235789|NCT00597272|568378|P1|NOT COMPLETED|Overall Study||0
235790|NCT00597272|568372|P7|COMPLETED|Overall Study||10
235791|NCT00597272|568373|P6|COMPLETED|Overall Study||10
235792|NCT00597272|568374|P5|COMPLETED|Overall Study||1
235793|NCT00597272|568375|P4|COMPLETED|Overall Study||1
235794|NCT00597272|568376|P3|COMPLETED|Overall Study||10
235795|NCT00597272|568377|P2|COMPLETED|Overall Study||1
235796|NCT00597272|568378|P1|COMPLETED|Overall Study||1
235797|NCT00597272|568372|P7|STARTED|Overall Study||10
235798|NCT00597272|568373|P6|STARTED|Overall Study||10
235799|NCT00597272|568374|P5|STARTED|Overall Study||1
235800|NCT00597272|568375|P4|STARTED|Overall Study||1
235801|NCT00597272|568376|P3|STARTED|Overall Study||10
235802|NCT00597272|568377|P2|STARTED|Overall Study||1
235803|NCT00597272|568378|P1|STARTED|Overall Study||1
235804|NCT00597207|568396|P2|NOT COMPLETED|Overall Study||7
235805|NCT00597207|568397|P1|NOT COMPLETED|Overall Study||5
235806|NCT00597207|568396|P2|COMPLETED|Overall Study||2125
235807|NCT00597207|568397|P1|COMPLETED|Overall Study||2094
235808|NCT00597207|568396|P2|STARTED|Overall Study||2132
235809|NCT00597207|568397|P1|STARTED|Overall Study||2099
235810|NCT00597116|568405|P2|NOT COMPLETED|Overall Study||11
235811|NCT00597116|568406|P1|NOT COMPLETED|Overall Study||14
235812|NCT00597116|568405|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
235899|NCT00596453|568644|P2|NOT COMPLETED|Overall Study||3
235813|NCT00597116|568406|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
235814|NCT00597116|568405|P2|STARTED|Overall Study||11
235815|NCT00597116|568406|P1|STARTED|Overall Study||14
235816|NCT00597038|568420|P2|NOT COMPLETED|Overall Study||4
235817|NCT00597038|568421|P1|NOT COMPLETED|Overall Study||2
235818|NCT00597038|568420|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
235819|NCT00597038|568421|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
235820|NCT00597038|568420|P2|STARTED|Overall Study||34
235821|NCT00597038|568421|P1|STARTED|Overall Study||16
235822|NCT00597012|568432|P2|NOT COMPLETED|Overall Study||8
235823|NCT00597012|568433|P1|NOT COMPLETED|Overall Study||13
235824|NCT00597012|568432|P2|COMPLETED|Overall Study||169
235825|NCT00597012|568433|P1|COMPLETED|Overall Study||161
235826|NCT00597012|568432|P2|STARTED|Overall Study||177
235827|NCT00597012|568433|P1|STARTED|Overall Study||174
235828|NCT00596960|568445|P2|NOT COMPLETED|Overall Study||9
235829|NCT00596960|568446|P1|NOT COMPLETED|Overall Study||11
235830|NCT00596960|568445|P2|COMPLETED|Overall Study||60
235831|NCT00596960|568446|P1|COMPLETED|Overall Study||59
235832|NCT00596960|568445|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
235833|NCT00596960|568446|P1|STARTED|Overall Study||70
235834|NCT00596947|568458|P2|NOT COMPLETED|Overall Study||3
235835|NCT00596947|568459|P1|NOT COMPLETED|Overall Study||6
235836|NCT00596947|568458|P2|COMPLETED|Overall Study||6
235837|NCT00596947|568459|P1|COMPLETED|Overall Study||3
235838|NCT00596947|568458|P2|STARTED|Overall Study||9
235839|NCT00596947|568459|P1|STARTED|Overall Study||9
235840|NCT00596934|568499|P1|NOT COMPLETED|Overall Study||2
235841|NCT00596934|568499|P1|COMPLETED|Overall Study||7
235842|NCT00596934|568499|P1|STARTED|Overall Study||9
235843|NCT00596830|568512|P2|NOT COMPLETED|Overall Study||339
235844|NCT00596830|568513|P1|NOT COMPLETED|Overall Study||342
235845|NCT00596830|568512|P2|COMPLETED|Overall Study||0
235846|NCT00596830|568513|P1|COMPLETED|Overall Study||0
235847|NCT00596830|568512|P2|Treated|Overall Study||332
235848|NCT00596830|568513|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
235849|NCT00596830|568512|P2|STARTED|Overall Study||339
235850|NCT00596830|568513|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
235851|NCT00596817|568539|P2|NOT COMPLETED|Double-blind Period||79
235852|NCT00596817|568540|P1|NOT COMPLETED|Double-blind Period||88
235853|NCT00596817|568539|P2|COMPLETED|Double-blind Period||125
235854|NCT00596817|568540|P1|COMPLETED|Double-blind Period||104
235855|NCT00596817|568539|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
235856|NCT00596817|568540|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
235857|NCT00596817|568539|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
235858|NCT00596817|568540|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
235859|NCT00596817|568539|P2|COMPLETED|Open-label Period to Double-blind Period||400
235860|NCT00596817|568540|P1|COMPLETED|Open-label Period to Double-blind Period||0
235861|NCT00596817|568539|P2|STARTED|Open-label Period to Double-blind Period||492
235862|NCT00596817|568540|P1|STARTED|Open-label Period to Double-blind Period||0
235863|NCT00596817|568539|P2|NOT COMPLETED|Open-label Period||147
235864|NCT00596817|568540|P1|NOT COMPLETED|Open-label Period||0
235865|NCT00596817|568539|P2|COMPLETED|Open-label Period||492
235866|NCT00596817|568540|P1|COMPLETED|Open-label Period||0
235867|NCT00596817|568539|P2|STARTED|Open-label Period||639
235868|NCT00596817|568540|P1|STARTED|Open-label Period||0
235869|NCT00596752|568565|P2|NOT COMPLETED|Overall Study||143
235870|NCT00596752|568566|P1|NOT COMPLETED|Overall Study||126
235871|NCT00596752|568565|P2|COMPLETED|Overall Study||282
235872|NCT00596752|568566|P1|COMPLETED|Overall Study||289
235873|NCT00596752|568565|P2|Randomized and Treated|Overall Study||424
235874|NCT00596752|568566|P1|Randomized and Treated|Overall Study||415
235875|NCT00596752|568565|P2|STARTED|Overall Study||425
235876|NCT00596752|568566|P1|STARTED|Overall Study||415
235877|NCT00596687|568596|P2|NOT COMPLETED|Overall Study||9
235878|NCT00596687|568597|P1|NOT COMPLETED|Overall Study||14
235879|NCT00596687|568596|P2|COMPLETED|Overall Study||107
235880|NCT00596687|568597|P1|COMPLETED|Overall Study||104
235881|NCT00596687|568596|P2|STARTED|Overall Study||116
235882|NCT00596687|568597|P1|STARTED|Overall Study||118
235883|NCT00596635|568608|P3|NOT COMPLETED|Overall Study||8
235884|NCT00596635|568609|P2|NOT COMPLETED|Overall Study||13
235885|NCT00596635|568610|P1|NOT COMPLETED|Overall Study||7
235886|NCT00596635|568608|P3|COMPLETED|Overall Study||11
235887|NCT00596635|568609|P2|COMPLETED|Overall Study||7
235888|NCT00596635|568610|P1|COMPLETED|Overall Study||10
235889|NCT00596635|568608|P3|STARTED|Overall Study||19
235890|NCT00596635|568609|P2|STARTED|Overall Study||20
235891|NCT00596635|568610|P1|STARTED|Overall Study||17
235892|NCT00596622|568627|P1|NOT COMPLETED|Overall Study||13
235893|NCT00596622|568627|P1|COMPLETED|Overall Study||33
235894|NCT00596622|568627|P1|STARTED|Overall Study||46
235895|NCT00596466|568636|P1|NOT COMPLETED|Overall Study||17
235896|NCT00596466|568636|P1|COMPLETED|Overall Study||58
235897|NCT00596466|568636|P1|Enrolled, Treated|Overall Study||73
235898|NCT00596466|568636|P1|STARTED|Overall Study||75
235900|NCT00596453|568645|P1|NOT COMPLETED|Overall Study||1
235901|NCT00596453|568644|P2|COMPLETED|Overall Study||12
235902|NCT00596453|568645|P1|COMPLETED|Overall Study||12
235903|NCT00596453|568644|P2|STARTED|Overall Study||15
235904|NCT00596453|568645|P1|STARTED|Overall Study||13
235905|NCT00596440|568653|P2|NOT COMPLETED|Overall Study||80
235906|NCT00596440|568654|P1|NOT COMPLETED|Overall Study||65
235907|NCT00596440|568653|P2|COMPLETED|Overall Study||41
235908|NCT00596440|568654|P1|COMPLETED|Overall Study||48
235909|NCT00596440|568653|P2|Showed to First Treatment Session|Overall Study||52
235910|NCT00596440|568654|P1|Showed to First Treatment Session|Overall Study||61
235911|NCT00596440|568653|P2|Showed to Eligibility Visit|Overall Study||72
235912|NCT00596440|568654|P1|Showed to Eligibility Visit|Overall Study||85
235913|NCT00596440|568653|P2|STARTED|Overall Study||121
235914|NCT00596440|568654|P1|STARTED|Overall Study||113
235915|NCT00596427|568666|P2|NOT COMPLETED|Overall Study||2
235916|NCT00596427|568667|P1|NOT COMPLETED|Overall Study||4
235917|NCT00596427|568666|P2|COMPLETED|Overall Study||28
235918|NCT00596427|568667|P1|COMPLETED|Overall Study||26
235919|NCT00596427|568666|P2|STARTED|Overall Study||30
235920|NCT00596427|568667|P1|STARTED|Overall Study||30
235921|NCT00596362|568695|P1|NOT COMPLETED|Overall Study||1
235922|NCT00596362|568695|P1|COMPLETED|Overall Study||0
235923|NCT00596362|568695|P1|STARTED|Overall Study||1
235924|NCT00596271|568702|P3|NOT COMPLETED|Overall Study||1
235925|NCT00596271|568703|P2|NOT COMPLETED|Overall Study||6
235926|NCT00596271|568704|P1|NOT COMPLETED|Overall Study||5
235927|NCT00596271|568702|P3|COMPLETED|Overall Study||61
235928|NCT00596271|568703|P2|COMPLETED|Overall Study||59
235929|NCT00596271|568704|P1|COMPLETED|Overall Study||60
235930|NCT00596271|568702|P3|STARTED|Overall Study||62
235931|NCT00596271|568703|P2|STARTED|Overall Study||65
235932|NCT00596271|568704|P1|STARTED|Overall Study||65
235933|NCT00596167|568713|P1|NOT COMPLETED|Overall Study||0
235934|NCT00596167|568713|P1|COMPLETED|Overall Study||6
235935|NCT00596167|568713|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
235936|NCT00596102|568720|P3|NOT COMPLETED|Up to Month 60||637
235937|NCT00596102|568721|P2|NOT COMPLETED|Up to Month 60||338
235938|NCT00596102|568722|P1|NOT COMPLETED|Up to Month 60||2181
235939|NCT00596102|568720|P3|COMPLETED|Up to Month 60||0
235940|NCT00596102|568721|P2|COMPLETED|Up to Month 60||0
235941|NCT00596102|568722|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
235942|NCT00596102|568720|P3|STARTED|Up to Month 60||637
235943|NCT00596102|568721|P2|STARTED|Up to Month 60||338
235944|NCT00596102|568722|P1|STARTED|Up to Month 60||2283
235945|NCT00596102|568720|P3|NOT COMPLETED|Up to Month 6||0
235946|NCT00596102|568721|P2|NOT COMPLETED|Up to Month 6||0
235947|NCT00596102|568722|P1|NOT COMPLETED|Up to Month 6||0
235948|NCT00596102|568720|P3|COMPLETED|Up to Month 6||637
235949|NCT00596102|568721|P2|COMPLETED|Up to Month 6||338
235950|NCT00596102|568722|P1|COMPLETED|Up to Month 6||2283
235951|NCT00596102|568720|P3|STARTED|Up to Month 6||637
235952|NCT00596102|568721|P2|STARTED|Up to Month 6||338
235953|NCT00596102|568722|P1|STARTED|Up to Month 6||2283
235954|NCT00596011|568731|P2|NOT COMPLETED|Overall Study||10
235955|NCT00596011|568732|P1|NOT COMPLETED|Overall Study||13
235956|NCT00596011|568731|P2|COMPLETED|Overall Study||38
235957|NCT00596011|568732|P1|COMPLETED|Overall Study||36
235958|NCT00596011|568731|P2|STARTED|Overall Study||48
235959|NCT00596011|568732|P1|STARTED|Overall Study||49
235960|NCT00595959|568748|P1|NOT COMPLETED|Overall Study||2
235961|NCT00595959|568748|P1|COMPLETED|Overall Study||63
235962|NCT00595959|568748|P1|STARTED|Overall Study||65
235963|NCT00595946|568765|P2|NOT COMPLETED|Overall Study||69
235964|NCT00595946|568766|P1|NOT COMPLETED|Overall Study||64
235965|NCT00595946|568765|P2|COMPLETED|Overall Study||152
235966|NCT00595946|568766|P1|COMPLETED|Overall Study||154
235967|NCT00595946|568765|P2|STARTED|Overall Study||221
235968|NCT00595946|568766|P1|STARTED|Overall Study||218
235969|NCT00595920|568782|P1|NOT COMPLETED|Overall Study||116
235970|NCT00595920|568782|P1|COMPLETED|Overall Study||0
235971|NCT00595920|568782|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
235972|NCT00595920|568782|P1|STARTED|Overall Study||116
235973|NCT00595881|568786|P1|NOT COMPLETED|Overall Study||0
235974|NCT00595881|568786|P1|COMPLETED|Overall Study||420
235975|NCT00595881|568786|P1|STARTED|Overall Study||420
235976|NCT00595868|568793|P2|NOT COMPLETED|Overall Study||50
235977|NCT00595868|568794|P1|NOT COMPLETED|Overall Study||45
235978|NCT00595868|568793|P2|COMPLETED|Overall Study||61
235979|NCT00595868|568794|P1|COMPLETED|Overall Study||62
235980|NCT00595868|568793|P2|STARTED|Overall Study||111
235981|NCT00595868|568794|P1|STARTED|Overall Study||107
235982|NCT00595790|568805|P3|NOT COMPLETED|Overall Study||3
235983|NCT00595790|568806|P2|NOT COMPLETED|Overall Study||1
235984|NCT00595790|568807|P1|NOT COMPLETED|Overall Study||2
235985|NCT00595790|568805|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
235986|NCT00595790|568806|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
235987|NCT00595790|568807|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
235988|NCT00595790|568805|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
235989|NCT00595790|568806|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
235990|NCT00595790|568807|P1|STARTED|Overall Study||125
235991|NCT00595764|568817|P2|NOT COMPLETED|Overall Study||43
235992|NCT00595764|568818|P1|NOT COMPLETED|Overall Study||39
235993|NCT00595764|568817|P2|COMPLETED|Overall Study||27
235994|NCT00595764|568818|P1|COMPLETED|Overall Study||32
235995|NCT00595764|568817|P2|STARTED|Overall Study||70
235996|NCT00595764|568818|P1|STARTED|Overall Study||71
235997|NCT00595582|568832|P1|NOT COMPLETED|Overall Study||10
235998|NCT00595582|568832|P1|COMPLETED|Overall Study||0
235999|NCT00595582|568832|P1|STARTED|Overall Study||10
236000|NCT00595556|568838|P2|NOT COMPLETED|Overall Study||1
236001|NCT00595556|568839|P1|NOT COMPLETED|Overall Study||3
236002|NCT00595556|568838|P2|COMPLETED|Overall Study||19
236003|NCT00595556|568839|P1|COMPLETED|Overall Study||17
236004|NCT00595556|568838|P2|STARTED|Overall Study||20
236005|NCT00595556|568839|P1|STARTED|Overall Study||20
236006|NCT00595530|568853|P1|NOT COMPLETED|Overall Study||0
236007|NCT00595530|568853|P1|COMPLETED|Overall Study||3
236008|NCT00595530|568853|P1|STARTED|Overall Study||3
236009|NCT00595517|568857|P1|NOT COMPLETED|Overall Study||19
236010|NCT00595517|568857|P1|COMPLETED|Overall Study||111
236011|NCT00595517|568857|P1|STARTED|Overall Study||130
236012|NCT00595504|568866|P2|NOT COMPLETED|Overall Study||3
236013|NCT00595504|568867|P1|NOT COMPLETED|Overall Study||2
236014|NCT00595504|568866|P2|COMPLETED|Overall Study||6
236015|NCT00595504|568867|P1|COMPLETED|Overall Study||14
236016|NCT00595504|568866|P2|STARTED|Overall Study||9
236017|NCT00595504|568867|P1|STARTED|Overall Study||16
236018|NCT00595478|568879|P2|NOT COMPLETED|36-week Follow-up Period||8
236019|NCT00595478|568880|P1|NOT COMPLETED|36-week Follow-up Period||9
236020|NCT00595478|568879|P2|COMPLETED|36-week Follow-up Period||30
236021|NCT00595478|568880|P1|COMPLETED|36-week Follow-up Period||28
236022|NCT00595478|568879|P2|STARTED|36-week Follow-up Period||38
236023|NCT00595478|568880|P1|STARTED|36-week Follow-up Period||37
236024|NCT00595478|568879|P2|NOT COMPLETED|Treatment||0
236025|NCT00595478|568880|P1|NOT COMPLETED|Treatment||0
236026|NCT00595478|568879|P2|COMPLETED|Treatment||38
236027|NCT00595478|568880|P1|COMPLETED|Treatment||37
236028|NCT00595478|568879|P2|STARTED|Treatment||38
236029|NCT00595478|568880|P1|STARTED|Treatment||37
236030|NCT00595465|568891|P3|NOT COMPLETED|Overall Study||7
236031|NCT00595465|568892|P2|NOT COMPLETED|Overall Study||4
236032|NCT00595465|568893|P1|NOT COMPLETED|Overall Study||6
236033|NCT00595465|568891|P3|COMPLETED|Overall Study||121
236034|NCT00595465|568892|P2|COMPLETED|Overall Study||125
236035|NCT00595465|568893|P1|COMPLETED|Overall Study||124
236036|NCT00595465|568891|P3|STARTED|Overall Study||128
236037|NCT00595465|568892|P2|STARTED|Overall Study||129
236038|NCT00595465|568893|P1|STARTED|Overall Study||130
236039|NCT00595413|568905|P4|NOT COMPLETED|Overall Study||4
236040|NCT00595413|568906|P3|NOT COMPLETED|Overall Study||8
236041|NCT00595413|568907|P2|NOT COMPLETED|Overall Study||5
236042|NCT00595413|568908|P1|NOT COMPLETED|Overall Study||7
236043|NCT00595413|568905|P4|COMPLETED|Overall Study||75
236044|NCT00595413|568906|P3|COMPLETED|Overall Study||70
236045|NCT00595413|568907|P2|COMPLETED|Overall Study||73
236046|NCT00595413|568908|P1|COMPLETED|Overall Study||69
236047|NCT00595413|568905|P4|STARTED|Overall Study||79
236048|NCT00595413|568906|P3|STARTED|Overall Study||78
236049|NCT00595413|568907|P2|STARTED|Overall Study||78
236050|NCT00595413|568908|P1|STARTED|Overall Study||76
236051|NCT00595361|568936|P2|NOT COMPLETED|Overall Study||0
236052|NCT00595361|568937|P1|NOT COMPLETED|Overall Study||0
236053|NCT00595361|568936|P2|COMPLETED|Overall Study||18
236054|NCT00595361|568937|P1|COMPLETED|Overall Study||12
236055|NCT00595361|568936|P2|STARTED|Overall Study||18
236056|NCT00595361|568937|P1|STARTED|Overall Study||12
236057|NCT00595335|568949|P2|NOT COMPLETED|Six Months to Twelve Months||1
236058|NCT00595335|568950|P1|NOT COMPLETED|Six Months to Twelve Months||1
236059|NCT00595335|568949|P2|COMPLETED|Six Months to Twelve Months||9
236060|NCT00595335|568950|P1|COMPLETED|Six Months to Twelve Months||10
236061|NCT00595335|568949|P2|STARTED|Six Months to Twelve Months||10
236062|NCT00595335|568950|P1|STARTED|Six Months to Twelve Months||11
236063|NCT00595335|568949|P2|NOT COMPLETED|Baseline to Six Months||2
236064|NCT00595335|568950|P1|NOT COMPLETED|Baseline to Six Months||2
236065|NCT00595335|568949|P2|COMPLETED|Baseline to Six Months||10
236066|NCT00595335|568950|P1|COMPLETED|Baseline to Six Months||11
236067|NCT00595335|568949|P2|STARTED|Baseline to Six Months||12
236068|NCT00595335|568950|P1|STARTED|Baseline to Six Months||13
236069|NCT00595309|568970|P1|NOT COMPLETED|Overall Study||4
236070|NCT00595309|568970|P1|COMPLETED|Overall Study||194
236071|NCT00595309|568970|P1|STARTED|Overall Study||198
236072|NCT00595270|568977|P3|NOT COMPLETED|Overall Study||8
236073|NCT00595270|568978|P2|NOT COMPLETED|Overall Study||10
236074|NCT00595270|568979|P1|NOT COMPLETED|Overall Study||6
236075|NCT00595270|568977|P3|COMPLETED|Overall Study||108
236076|NCT00595270|568978|P2|COMPLETED|Overall Study||107
236077|NCT00595270|568979|P1|COMPLETED|Overall Study||110
236078|NCT00595270|568977|P3|STARTED|Overall Study||116
236079|NCT00595270|568978|P2|STARTED|Overall Study||117
236080|NCT00595270|568979|P1|STARTED|Overall Study||116
236081|NCT00595153|568990|P3|NOT COMPLETED|Overall Study||25
236082|NCT00595153|568991|P2|NOT COMPLETED|Overall Study||16
236083|NCT00595153|568992|P1|NOT COMPLETED|Overall Study||4
236084|NCT00595153|568990|P3|COMPLETED|Overall Study||36
236085|NCT00595153|568991|P2|COMPLETED|Overall Study||26
236086|NCT00595153|568992|P1|COMPLETED|Overall Study||20
236087|NCT00595153|568990|P3|STARTED|Overall Study||61
236088|NCT00595153|568991|P2|STARTED|Overall Study||42
236089|NCT00595153|568992|P1|STARTED|Overall Study||24
236090|NCT00595127|569000|P1|NOT COMPLETED|Overall Study||10
236091|NCT00595127|569000|P1|COMPLETED|Overall Study||11
236092|NCT00595127|569000|P1|STARTED|Overall Study||21
236093|NCT00595114|569006|P2|NOT COMPLETED|Overall Study||0
236094|NCT00595114|569007|P1|NOT COMPLETED|Overall Study||0
236095|NCT00595114|569006|P2|COMPLETED|Overall Study||19
236096|NCT00595114|569007|P1|COMPLETED|Overall Study||24
236097|NCT00595114|569006|P2|STARTED|Overall Study||19
236098|NCT00595114|569007|P1|STARTED|Overall Study||24
236099|NCT00595088|569013|P1|NOT COMPLETED|Overall Study||40
236100|NCT00595088|569013|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
236101|NCT00595088|569013|P1|STARTED|Overall Study||47
236102|NCT00595075|569022|P2|NOT COMPLETED|Overall Study||0
236103|NCT00595075|569023|P1|NOT COMPLETED|Overall Study||1
236104|NCT00595075|569022|P2|COMPLETED|Overall Study||5
236105|NCT00595075|569023|P1|COMPLETED|Overall Study||5
236106|NCT00595075|569022|P2|STARTED|Overall Study||5
236107|NCT00595075|569023|P1|STARTED|Overall Study||6
236108|NCT00594958|569044|P3|NOT COMPLETED|Overall Study||10
236109|NCT00594958|569045|P2|NOT COMPLETED|Overall Study||3
236110|NCT00594958|569046|P1|NOT COMPLETED|Overall Study||14
236111|NCT00594958|569044|P3|COMPLETED|Overall Study||202
236112|NCT00594958|569045|P2|COMPLETED|Overall Study||210
236113|NCT00594958|569046|P1|COMPLETED|Overall Study||200
236114|NCT00594958|569044|P3|Randomized and at Least 1 Vaccination|Overall Study||211
236115|NCT00594958|569045|P2|Randomized and at Least 1 Vaccination|Overall Study||213
236116|NCT00594958|569046|P1|Randomized and at Least 1 Vaccination|Overall Study||212
236117|NCT00594958|569044|P3|STARTED|Overall Study||212
236118|NCT00594958|569045|P2|STARTED|Overall Study||213
236119|NCT00594958|569046|P1|STARTED|Overall Study||214
236120|NCT00594945|569057|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
236121|NCT00594945|569058|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
236122|NCT00594945|569059|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
236123|NCT00594945|569057|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
236124|NCT00594945|569058|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
236125|NCT00594945|569059|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
236126|NCT00594945|569057|P3|STARTED|Cohort 2 / Treatment Period 2||2
236127|NCT00594945|569058|P2|STARTED|Cohort 2 / Treatment Period 2||3
236128|NCT00594945|569059|P1|STARTED|Cohort 2 / Treatment Period 2||0
236129|NCT00594945|569057|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
236130|NCT00594945|569058|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
236131|NCT00594945|569059|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
236132|NCT00594945|569057|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
236133|NCT00594945|569058|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
236134|NCT00594945|569059|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
236135|NCT00594945|569057|P3|STARTED|Cohort 1 / Treatment Period 1||2
236136|NCT00594945|569058|P2|STARTED|Cohort 1 / Treatment Period 1||0
236137|NCT00594945|569059|P1|STARTED|Cohort 1 / Treatment Period 1||4
236138|NCT00594906|569067|P2|NOT COMPLETED|Overall Study||2
236139|NCT00594906|569068|P1|NOT COMPLETED|Overall Study||1
236140|NCT00594906|569067|P2|COMPLETED|Overall Study||1
236141|NCT00594906|569068|P1|COMPLETED|Overall Study||6
236142|NCT00594906|569067|P2|STARTED|Overall Study||3
236143|NCT00594906|569068|P1|STARTED|Overall Study||7
236144|NCT00594880|569076|P2|NOT COMPLETED|Overall Study||1
236145|NCT00594880|569077|P1|NOT COMPLETED|Overall Study||2
236146|NCT00594880|569076|P2|COMPLETED|Overall Study||10
236147|NCT00594880|569077|P1|COMPLETED|Overall Study||10
236148|NCT00594880|569076|P2|STARTED|Overall Study||11
236149|NCT00594880|569077|P1|STARTED|Overall Study||12
236150|NCT00594854|569089|P2|NOT COMPLETED|Overall Study||10
236151|NCT00594854|569090|P1|NOT COMPLETED|Overall Study||7
236152|NCT00594854|569089|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
236153|NCT00594854|569090|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
236154|NCT00594854|569089|P2|STARTED|Overall Study||11
236155|NCT00594854|569090|P1|STARTED|Overall Study||9
236156|NCT00594815|569100|P1|NOT COMPLETED|Overall Study||9
236157|NCT00594815|569100|P1|COMPLETED|Overall Study||43
236158|NCT00594815|569100|P1|STARTED|Overall Study||52
236159|NCT00594685|569105|P1|NOT COMPLETED|Overall Study||0
236160|NCT00594685|569105|P1|COMPLETED|Overall Study||10
236161|NCT00594685|569105|P1|STARTED|Overall Study||10
236162|NCT00594659|569125|P3|NOT COMPLETED|Overall Study||7
236163|NCT00594659|569126|P2|NOT COMPLETED|Overall Study||9
236164|NCT00594659|569127|P1|NOT COMPLETED|Overall Study||13
236165|NCT00594659|569125|P3|COMPLETED|Overall Study||9
236166|NCT00594659|569126|P2|COMPLETED|Overall Study||21
236167|NCT00594659|569127|P1|COMPLETED|Overall Study||16
236168|NCT00594659|569125|P3|STARTED|Overall Study||16
236169|NCT00594659|569126|P2|STARTED|Overall Study||30
236170|NCT00594659|569127|P1|STARTED|Overall Study||29
236171|NCT00594646|569138|P1|NOT COMPLETED|Overall Study||16
236172|NCT00594646|569138|P1|COMPLETED|Overall Study||84
236173|NCT00594646|569138|P1|STARTED|Overall Study||100
236174|NCT00594568|569146|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
236175|NCT00594568|569147|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
236176|NCT00594568|569148|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
236177|NCT00594568|569146|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
236178|NCT00594568|569147|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
236179|NCT00594568|569148|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
236180|NCT00594568|569146|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
236181|NCT00594568|569147|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
236182|NCT00594568|569148|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
236183|NCT00594568|569146|P3|NOT COMPLETED|Delayed Start||66
236184|NCT00594568|569147|P2|NOT COMPLETED|Delayed Start||77
236185|NCT00594568|569148|P1|NOT COMPLETED|Delayed Start||98
236186|NCT00594568|569146|P3|COMPLETED|Delayed Start||55
236187|NCT00594568|569147|P2|COMPLETED|Delayed Start||76
236188|NCT00594568|569148|P1|COMPLETED|Delayed Start||91
236189|NCT00594568|569146|P3|STARTED|Delayed Start||121
236190|NCT00594568|569147|P2|STARTED|Delayed Start||153
236191|NCT00594568|569148|P1|STARTED|Delayed Start||189
236192|NCT00594568|569146|P3|NOT COMPLETED|Initial Treatment||408
236193|NCT00594568|569147|P2|NOT COMPLETED|Initial Treatment||354
236194|NCT00594568|569148|P1|NOT COMPLETED|Initial Treatment||312
236195|NCT00594568|569146|P3|COMPLETED|Initial Treatment||121
236196|NCT00594568|569147|P2|COMPLETED|Initial Treatment||153
236197|NCT00594568|569148|P1|COMPLETED|Initial Treatment||189
236198|NCT00594568|569146|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
236199|NCT00594568|569147|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
236200|NCT00594568|569148|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
236201|NCT00594568|569146|P3|STARTED|Initial Treatment||529
236202|NCT00594568|569147|P2|STARTED|Initial Treatment||507
236203|NCT00594568|569148|P1|STARTED|Initial Treatment||501
236204|NCT00594516|569236|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
236205|NCT00594516|569237|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
236206|NCT00594516|569238|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
236207|NCT00594516|569236|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
236208|NCT00594516|569237|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
236209|NCT00594516|569238|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
236210|NCT00594516|569236|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
236211|NCT00594516|569237|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
236212|NCT00594516|569238|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
236213|NCT00594516|569236|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
236214|NCT00594516|569237|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
236215|NCT00594516|569238|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
236216|NCT00594516|569236|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
236217|NCT00594516|569237|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
236218|NCT00594516|569238|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
236219|NCT00594516|569236|P3|STARTED|Open Label (OL): Tapentadol IR||0
236220|NCT00594516|569237|P2|STARTED|Open Label (OL): Tapentadol IR||0
236221|NCT00594516|569238|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
236222|NCT00594464|569246|P1|NOT COMPLETED|Overall Study||3
236223|NCT00594464|569246|P1|COMPLETED|Overall Study||11
236224|NCT00594464|569246|P1|STARTED|Overall Study||14
236225|NCT00594425|569261|P3|NOT COMPLETED|Overall Study||10
236226|NCT00594425|569262|P2|NOT COMPLETED|Overall Study||14
236227|NCT00594425|569263|P1|NOT COMPLETED|Overall Study||7
236228|NCT00594425|569261|P3|COMPLETED|Overall Study||42
236229|NCT00594425|569262|P2|COMPLETED|Overall Study||34
236230|NCT00594425|569263|P1|COMPLETED|Overall Study||43
236231|NCT00594425|569261|P3|STARTED|Overall Study||52
236232|NCT00594425|569262|P2|STARTED|Overall Study||48
236233|NCT00594425|569263|P1|STARTED|Overall Study||50
236234|NCT00594399|569375|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
236235|NCT00594399|569376|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
236236|NCT00594399|569377|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
236237|NCT00594399|569375|P3|COMPLETED|Rerandomization Arm 1 Only||82
236238|NCT00594399|569376|P2|COMPLETED|Rerandomization Arm 1 Only||114
236239|NCT00594399|569377|P1|COMPLETED|Rerandomization Arm 1 Only||79
236240|NCT00594399|569375|P3|Rerandomization|Rerandomization Arm 1 Only||82
236241|NCT00594399|569376|P2|Rerandomization|Rerandomization Arm 1 Only||114
236242|NCT00594399|569377|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
236243|NCT00594399|569375|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
236244|NCT00594399|569376|P2|STARTED|Rerandomization Arm 1 Only||118
236245|NCT00594399|569377|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
236246|NCT00594399|569375|P3|NOT COMPLETED|Initial 3 Month Counseling||0
236247|NCT00594399|569376|P2|NOT COMPLETED|Initial 3 Month Counseling||4
236248|NCT00594399|569377|P1|NOT COMPLETED|Initial 3 Month Counseling||17
236249|NCT00594399|569375|P3|COMPLETED|Initial 3 Month Counseling||0
236250|NCT00594399|569376|P2|COMPLETED|Initial 3 Month Counseling||118
236251|NCT00594399|569377|P1|COMPLETED|Initial 3 Month Counseling||163
236252|NCT00594399|569375|P3|STARTED|Initial 3 Month Counseling||0
236253|NCT00594399|569376|P2|STARTED|Initial 3 Month Counseling||122
236254|NCT00594399|569377|P1|STARTED|Initial 3 Month Counseling||180
236255|NCT00594386|569399|P1|NOT COMPLETED|Overall Study||258
236256|NCT00594386|569399|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
236257|NCT00594386|569399|P1|STARTED|Overall Study||258
236258|NCT00594308|569405|P1|NOT COMPLETED|Overall Study||0
236259|NCT00594308|569405|P1|COMPLETED|Overall Study||10
236260|NCT00594308|569405|P1|STARTED|Overall Study||10
236261|NCT00594256|569413|P1|NOT COMPLETED|Overall Study||0
236262|NCT00594256|569413|P1|COMPLETED|Overall Study||8
236263|NCT00594256|569413|P1|STARTED|Overall Study||8
236264|NCT00594230|569423|P2|NOT COMPLETED|Overall Study||9
236265|NCT00594230|569424|P1|NOT COMPLETED|Overall Study||15
236266|NCT00594230|569423|P2|COMPLETED|Overall Study||1
236267|NCT00594230|569424|P1|COMPLETED|Overall Study||1
236268|NCT00594230|569423|P2|STARTED|Overall Study||10
236269|NCT00594230|569424|P1|STARTED|Overall Study||16
236270|NCT00594204|569432|P2|NOT COMPLETED|Overall Study||45
236271|NCT00594204|569433|P1|NOT COMPLETED|Overall Study||58
236272|NCT00594204|569432|P2|COMPLETED|Overall Study||154
236273|NCT00594204|569433|P1|COMPLETED|Overall Study||336
236274|NCT00594204|569432|P2|Received Treatment|Overall Study||198
236275|NCT00594204|569433|P1|Received Treatment|Overall Study||390
236276|NCT00594204|569432|P2|STARTED|Overall Study||199
236277|NCT00594204|569433|P1|STARTED|Overall Study||394
236278|NCT00594178|569443|P1|NOT COMPLETED|Overall Study||5
236279|NCT00594178|569443|P1|COMPLETED|Overall Study||12
236280|NCT00594178|569443|P1|STARTED|Overall Study||17
236281|NCT00594165|569448|P1|NOT COMPLETED|Overall Study||217
236282|NCT00594165|569448|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
236283|NCT00594165|569448|P1|STARTED|Overall Study||217
236284|NCT00594100|569454|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
236285|NCT00594100|569454|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
236286|NCT00594100|569454|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
236287|NCT00594100|569454|P1|NOT COMPLETED|Procedure||9
236288|NCT00594100|569454|P1|COMPLETED|Procedure||236
236289|NCT00594100|569454|P1|STARTED|Procedure||245
236290|NCT00594061|569463|P1|NOT COMPLETED|Overall Study||0
236291|NCT00594061|569463|P1|COMPLETED|Overall Study||9
236292|NCT00594061|569463|P1|STARTED|Overall Study||9
236293|NCT00594035|569470|P2|NOT COMPLETED|Overall Study||3
236294|NCT00594035|569471|P1|NOT COMPLETED|Overall Study||2
236295|NCT00594035|569470|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
236296|NCT00594035|569471|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
236297|NCT00594035|569470|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
236298|NCT00594035|569471|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
236299|NCT00594022|569479|P2|NOT COMPLETED|Overall Study||0
236300|NCT00594022|569480|P1|NOT COMPLETED|Overall Study||0
236301|NCT00594022|569479|P2|COMPLETED|Overall Study||173
236302|NCT00594022|569480|P1|COMPLETED|Overall Study||176
236303|NCT00594022|569479|P2|STARTED|Overall Study||173
236304|NCT00594022|569480|P1|STARTED|Overall Study||176
236305|NCT00593957|569497|P3|NOT COMPLETED|Overall Study||2
236306|NCT00593957|569498|P2|NOT COMPLETED|Overall Study||1
236307|NCT00593957|569499|P1|NOT COMPLETED|Overall Study||0
236308|NCT00593957|569497|P3|COMPLETED|Overall Study||10
236309|NCT00593957|569498|P2|COMPLETED|Overall Study||12
236310|NCT00593957|569499|P1|COMPLETED|Overall Study||13
236311|NCT00593957|569497|P3|STARTED|Overall Study||12
236312|NCT00593957|569498|P2|STARTED|Overall Study||13
236313|NCT00593957|569499|P1|STARTED|Overall Study||13
236314|NCT00593918|569523|P2|NOT COMPLETED|Overall Study||24
236315|NCT00593918|569524|P1|NOT COMPLETED|Overall Study||5
236316|NCT00593918|569523|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
236317|NCT00593918|569524|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
236318|NCT00593918|569523|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
236319|NCT00593918|569524|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
236320|NCT00593866|569532|P1|NOT COMPLETED|Overall Study||0
236321|NCT00593866|569532|P1|COMPLETED|Overall Study||50
236322|NCT00593866|569532|P1|STARTED|Overall Study||50
236323|NCT00593840|569537|P1|NOT COMPLETED|Overall Study||1
236324|NCT00593840|569537|P1|COMPLETED|Overall Study||72
236325|NCT00593840|569537|P1|STARTED|Overall Study||73
236326|NCT00593827|569549|P2|NOT COMPLETED|Overall Study||2
236327|NCT00593827|569550|P1|NOT COMPLETED|Overall Study||0
236328|NCT00593827|569549|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
236329|NCT00593827|569550|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
236330|NCT00593827|569549|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
236412|NCT00593333|570120|P2|NOT COMPLETED|Overall Study||11
236413|NCT00593333|570121|P1|NOT COMPLETED|Overall Study||10
236331|NCT00593827|569550|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
236332|NCT00593827|569549|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
236333|NCT00593827|569550|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
236334|NCT00593827|569549|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
236335|NCT00593827|569550|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
236336|NCT00593814|569574|P2|NOT COMPLETED|Overall Study||0
236337|NCT00593814|569575|P1|NOT COMPLETED|Overall Study||24
236338|NCT00593814|569574|P2|COMPLETED|Overall Study||120
236339|NCT00593814|569575|P1|COMPLETED|Overall Study||115
236340|NCT00593814|569574|P2|STARTED|Overall Study||120
236341|NCT00593814|569575|P1|STARTED|Overall Study||139
236342|NCT00593736|569587|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
236343|NCT00593736|569588|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
236344|NCT00593736|569589|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
236345|NCT00593736|569590|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
236346|NCT00593736|569587|P4|COMPLETED|Treatment Period and Placebo Run-out||28
236347|NCT00593736|569588|P3|COMPLETED|Treatment Period and Placebo Run-out||30
236348|NCT00593736|569589|P2|COMPLETED|Treatment Period and Placebo Run-out||31
236349|NCT00593736|569590|P1|COMPLETED|Treatment Period and Placebo Run-out||29
236350|NCT00593736|569587|P4|STARTED|Treatment Period and Placebo Run-out||32
236351|NCT00593736|569588|P3|STARTED|Treatment Period and Placebo Run-out||35
236352|NCT00593736|569589|P2|STARTED|Treatment Period and Placebo Run-out||33
236353|NCT00593736|569590|P1|STARTED|Treatment Period and Placebo Run-out||32
236354|NCT00593736|569587|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
236355|NCT00593736|569588|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
236356|NCT00593736|569589|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
236357|NCT00593736|569590|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
236358|NCT00593736|569587|P4|COMPLETED|Screening Period and Placebo Run-in||132
236359|NCT00593736|569588|P3|COMPLETED|Screening Period and Placebo Run-in||0
236360|NCT00593736|569589|P2|COMPLETED|Screening Period and Placebo Run-in||0
236361|NCT00593736|569590|P1|COMPLETED|Screening Period and Placebo Run-in||0
236362|NCT00593736|569587|P4|STARTED|Screening Period and Placebo Run-in||549
236363|NCT00593736|569588|P3|STARTED|Screening Period and Placebo Run-in||0
236364|NCT00593736|569589|P2|STARTED|Screening Period and Placebo Run-in||0
236365|NCT00593736|569590|P1|STARTED|Screening Period and Placebo Run-in||0
236366|NCT00593684|569838|P2|NOT COMPLETED|Overall Study||1
236367|NCT00593684|569839|P1|NOT COMPLETED|Overall Study||2
236368|NCT00593684|569838|P2|COMPLETED|Overall Study||24
236369|NCT00593684|569839|P1|COMPLETED|Overall Study||23
236370|NCT00593684|569838|P2|STARTED|Overall Study||25
236371|NCT00593684|569839|P1|STARTED|Overall Study||25
236372|NCT00593645|569851|P1|NOT COMPLETED|Overall Study||0
236373|NCT00593645|569851|P1|COMPLETED|Overall Study||7
236374|NCT00593645|569851|P1|STARTED|Overall Study||7
236375|NCT00593606|569865|P1|NOT COMPLETED|Overall Study||27
236376|NCT00593606|569865|P1|COMPLETED|Overall Study||97
236377|NCT00593606|569865|P1|Treatment Period Completed|Overall Study||99
236378|NCT00593606|569865|P1|Full Analysis Set|Overall Study||114
236379|NCT00593606|569865|P1|Start of Treatment - Safety Set|Overall Study||116
236380|NCT00593606|569865|P1|STARTED|Overall Study||124
236381|NCT00593554|569963|P2|NOT COMPLETED|Overall Study||5
236382|NCT00593554|569964|P1|NOT COMPLETED|Overall Study||3
236383|NCT00593554|569963|P2|COMPLETED|Overall Study||0
236384|NCT00593554|569964|P1|COMPLETED|Overall Study||0
236385|NCT00593554|569963|P2|STARTED|Overall Study||5
236386|NCT00593554|569964|P1|STARTED|Overall Study||3
236387|NCT00593450|569986|P4|NOT COMPLETED|Overall Study||29
236388|NCT00593450|569987|P3|NOT COMPLETED|Overall Study||13
236389|NCT00593450|569988|P2|NOT COMPLETED|Overall Study||21
236390|NCT00593450|569989|P1|NOT COMPLETED|Overall Study||17
236391|NCT00593450|569986|P4|COMPLETED|Overall Study||271
236392|NCT00593450|569987|P3|COMPLETED|Overall Study||285
236393|NCT00593450|569988|P2|COMPLETED|Overall Study||265
236394|NCT00593450|569989|P1|COMPLETED|Overall Study||284
236395|NCT00593450|569986|P4|STARTED|Overall Study||300
236396|NCT00593450|569987|P3|STARTED|Overall Study||298
236397|NCT00593450|569988|P2|STARTED|Overall Study||286
236398|NCT00593450|569989|P1|STARTED|Overall Study||301
236399|NCT00593385|570059|P1|NOT COMPLETED|Overall Study||40
236400|NCT00593385|570059|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
236401|NCT00593385|570059|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
236402|NCT00593385|570059|P1|STARTED|Overall Study||165
236403|NCT00593372|570096|P2|NOT COMPLETED|Overall Study||0
236404|NCT00593372|570097|P1|NOT COMPLETED|Overall Study||0
236405|NCT00593372|570096|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
236406|NCT00593372|570097|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
236407|NCT00593372|570096|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
236408|NCT00593372|570097|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
236409|NCT00593346|570103|P1|NOT COMPLETED|Overall Study||0
236410|NCT00593346|570103|P1|COMPLETED|Overall Study||151
236411|NCT00593346|570103|P1|STARTED|Overall Study||151
236414|NCT00593333|570120|P2|COMPLETED|Overall Study||45
236415|NCT00593333|570121|P1|COMPLETED|Overall Study||44
236416|NCT00593333|570120|P2|STARTED|Overall Study||56
236417|NCT00593333|570121|P1|STARTED|Overall Study||54
236418|NCT00593320|570129|P2|NOT COMPLETED|Overall Study||0
236419|NCT00593320|570130|P1|NOT COMPLETED|Overall Study||0
236420|NCT00593320|570129|P2|COMPLETED|Overall Study||1
236421|NCT00593320|570130|P1|COMPLETED|Overall Study||1
236422|NCT00593320|570129|P2|STARTED|Overall Study||1
236423|NCT00593320|570130|P1|STARTED|Overall Study||1
236424|NCT00593112|570144|P2|NOT COMPLETED|Overall Study||0
236425|NCT00593112|570145|P1|NOT COMPLETED|Overall Study||10
236426|NCT00593112|570144|P2|COMPLETED|Overall Study||12
236427|NCT00593112|570145|P1|COMPLETED|Overall Study||17
236428|NCT00593112|570144|P2|STARTED|Overall Study||12
236429|NCT00593112|570145|P1|STARTED|Overall Study||27
236430|NCT00592943|570157|P2|NOT COMPLETED|Overall Study||0
236431|NCT00592943|570158|P1|NOT COMPLETED|Overall Study||0
236432|NCT00592943|570157|P2|COMPLETED|Overall Study||6
236433|NCT00592943|570158|P1|COMPLETED|Overall Study||6
236434|NCT00592943|570157|P2|STARTED|Overall Study||6
236435|NCT00592943|570158|P1|STARTED|Overall Study||6
236436|NCT00592904|570172|P4|NOT COMPLETED|Overall Study||11
236437|NCT00592904|570173|P3|NOT COMPLETED|Overall Study||17
236438|NCT00592904|570174|P2|NOT COMPLETED|Overall Study||55
236439|NCT00592904|570175|P1|NOT COMPLETED|Overall Study||25
236440|NCT00592904|570172|P4|COMPLETED|Overall Study||19
236441|NCT00592904|570173|P3|COMPLETED|Overall Study||10
236442|NCT00592904|570174|P2|COMPLETED|Overall Study||93
236443|NCT00592904|570175|P1|COMPLETED|Overall Study||32
236444|NCT00592904|570172|P4|STARTED|Overall Study||30
236445|NCT00592904|570173|P3|STARTED|Overall Study||27
236446|NCT00592904|570174|P2|STARTED|Overall Study||148
236447|NCT00592904|570175|P1|STARTED|Overall Study||57
236448|NCT00592852|570201|P1|NOT COMPLETED|Overall Study||6
236449|NCT00592852|570201|P1|COMPLETED|Overall Study||7
236450|NCT00592852|570201|P1|STARTED|Overall Study||13
236451|NCT00592839|570209|P3|NOT COMPLETED|Overall Study||6
236452|NCT00592839|570210|P2|NOT COMPLETED|Overall Study||4
236453|NCT00592839|570211|P1|NOT COMPLETED|Overall Study||2
236454|NCT00592839|570209|P3|COMPLETED|Overall Study||46
236455|NCT00592839|570210|P2|COMPLETED|Overall Study||48
236456|NCT00592839|570211|P1|COMPLETED|Overall Study||51
236457|NCT00592839|570209|P3|STARTED|Overall Study||52
236458|NCT00592839|570210|P2|STARTED|Overall Study||52
236459|NCT00592839|570211|P1|STARTED|Overall Study||53
236460|NCT00592774|570239|P5|NOT COMPLETED|Overall Study||14
236461|NCT00592774|570240|P4|NOT COMPLETED|Overall Study||14
236462|NCT00592774|570241|P3|NOT COMPLETED|Overall Study||4
236463|NCT00592774|570242|P2|NOT COMPLETED|Overall Study||32
236464|NCT00592774|570243|P1|NOT COMPLETED|Overall Study||11
236465|NCT00592774|570239|P5|COMPLETED|Overall Study||9
236466|NCT00592774|570240|P4|COMPLETED|Overall Study||8
236467|NCT00592774|570241|P3|COMPLETED|Overall Study||18
236468|NCT00592774|570242|P2|COMPLETED|Overall Study||21
236469|NCT00592774|570243|P1|COMPLETED|Overall Study||15
236470|NCT00592774|570239|P5|STARTED|Overall Study||23
236471|NCT00592774|570240|P4|STARTED|Overall Study||22
236472|NCT00592774|570241|P3|STARTED|Overall Study||22
236473|NCT00592774|570242|P2|STARTED|Overall Study||53
236474|NCT00592774|570243|P1|STARTED|Overall Study||26
236475|NCT00592761|570300|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
236476|NCT00592761|570301|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
236477|NCT00592761|570300|P2|COMPLETED|Second Intervention (2 Weeks)||9
236478|NCT00592761|570301|P1|COMPLETED|Second Intervention (2 Weeks)||9
236479|NCT00592761|570300|P2|STARTED|Second Intervention (2 Weeks)||9
236480|NCT00592761|570301|P1|STARTED|Second Intervention (2 Weeks)||9
236481|NCT00592761|570300|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
236482|NCT00592761|570301|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
236483|NCT00592761|570300|P2|COMPLETED|First Intervention (2 Weeks)||9
236484|NCT00592761|570301|P1|COMPLETED|First Intervention (2 Weeks)||9
236485|NCT00592761|570300|P2|STARTED|First Intervention (2 Weeks)||9
236486|NCT00592761|570301|P1|STARTED|First Intervention (2 Weeks)||9
236487|NCT00592683|570315|P2|NOT COMPLETED|Overall Study||4
236488|NCT00592683|570316|P1|NOT COMPLETED|Overall Study||4
236489|NCT00592683|570315|P2|COMPLETED|Overall Study||6
236490|NCT00592683|570316|P1|COMPLETED|Overall Study||6
236491|NCT00592683|570315|P2|STARTED|Overall Study||10
236492|NCT00592683|570316|P1|STARTED|Overall Study||10
236493|NCT00592631|570326|P2|NOT COMPLETED|Overall Study||2
236494|NCT00592631|570327|P1|NOT COMPLETED|Overall Study||0
236495|NCT00592631|570326|P2|COMPLETED|Overall Study||9
236496|NCT00592631|570327|P1|COMPLETED|Overall Study||16
236497|NCT00592631|570326|P2|STARTED|Overall Study||11
236498|NCT00592631|570327|P1|STARTED|Overall Study||16
236499|NCT00592488|570335|P2|NOT COMPLETED|Overall Study||0
236500|NCT00592488|570336|P1|NOT COMPLETED|Overall Study||0
236501|NCT00592488|570335|P2|COMPLETED|Overall Study||7
236502|NCT00592488|570336|P1|COMPLETED|Overall Study||6
236503|NCT00592488|570335|P2|STARTED|Overall Study||7
236504|NCT00592488|570336|P1|STARTED|Overall Study||6
236505|NCT00592475|570349|P3|NOT COMPLETED|Overall Study||0
236506|NCT00592475|570350|P2|NOT COMPLETED|Overall Study||0
236507|NCT00592475|570351|P1|NOT COMPLETED|Overall Study||0
236508|NCT00592475|570349|P3|COMPLETED|Overall Study||5
236509|NCT00592475|570350|P2|COMPLETED|Overall Study||9
236510|NCT00592475|570351|P1|COMPLETED|Overall Study||6
236511|NCT00592475|570349|P3|STARTED|Overall Study||5
236512|NCT00592475|570350|P2|STARTED|Overall Study||9
236513|NCT00592475|570351|P1|STARTED|Overall Study||6
236514|NCT00592384|570376|P2|NOT COMPLETED|Overall Study||6
236515|NCT00592384|570377|P1|NOT COMPLETED|Overall Study||5
236516|NCT00592384|570376|P2|COMPLETED|Overall Study||63
236517|NCT00592384|570377|P1|COMPLETED|Overall Study||59
236518|NCT00592384|570376|P2|STARTED|Overall Study||69
236519|NCT00592384|570377|P1|STARTED|Overall Study||64
236520|NCT00592358|570385|P1|NOT COMPLETED|Overall Study||6
236521|NCT00592358|570385|P1|COMPLETED|Overall Study||11
236522|NCT00592358|570385|P1|STARTED|Overall Study||17
236523|NCT00592319|570392|P2|NOT COMPLETED|Overall Study||3
236524|NCT00592319|570393|P1|NOT COMPLETED|Overall Study||0
236525|NCT00592319|570392|P2|COMPLETED|Overall Study||5
236526|NCT00592319|570393|P1|COMPLETED|Overall Study||2
236527|NCT00592319|570392|P2|STARTED|Overall Study||8
236528|NCT00592319|570393|P1|STARTED|Overall Study||2
236529|NCT00592176|570401|P1|NOT COMPLETED|Overall Study||0
236530|NCT00592176|570401|P1|COMPLETED|Overall Study||5
236531|NCT00592176|570401|P1|STARTED|Overall Study||5
236532|NCT00592124|570412|P6|NOT COMPLETED|Overall Study||3
236533|NCT00592124|570413|P5|NOT COMPLETED|Overall Study||3
236534|NCT00592124|570414|P4|NOT COMPLETED|Overall Study||3
236535|NCT00592124|570415|P3|NOT COMPLETED|Overall Study||6
236536|NCT00592124|570416|P2|NOT COMPLETED|Overall Study||5
236537|NCT00592124|570417|P1|NOT COMPLETED|Overall Study||4
236538|NCT00592124|570412|P6|COMPLETED|Overall Study||24
236539|NCT00592124|570413|P5|COMPLETED|Overall Study||24
236540|NCT00592124|570414|P4|COMPLETED|Overall Study||24
236541|NCT00592124|570415|P3|COMPLETED|Overall Study||24
236542|NCT00592124|570416|P2|COMPLETED|Overall Study||24
236543|NCT00592124|570417|P1|COMPLETED|Overall Study||24
236544|NCT00592124|570412|P6|STARTED|Overall Study||27
236545|NCT00592124|570413|P5|STARTED|Overall Study||27
236546|NCT00592124|570414|P4|STARTED|Overall Study||27
236547|NCT00592124|570415|P3|STARTED|Overall Study||30
236548|NCT00592124|570416|P2|STARTED|Overall Study||29
236549|NCT00592124|570417|P1|STARTED|Overall Study||28
236550|NCT00592072|570468|P2|NOT COMPLETED|Second Sequence||0
236551|NCT00592072|570469|P1|NOT COMPLETED|Second Sequence||0
236552|NCT00592072|570468|P2|COMPLETED|Second Sequence||5
236553|NCT00592072|570469|P1|COMPLETED|Second Sequence||5
236554|NCT00592072|570468|P2|STARTED|Second Sequence||5
236555|NCT00592072|570469|P1|STARTED|Second Sequence||5
236556|NCT00592072|570468|P2|NOT COMPLETED|Wash Out Period||1
236557|NCT00592072|570469|P1|NOT COMPLETED|Wash Out Period||1
236558|NCT00592072|570468|P2|COMPLETED|Wash Out Period||5
236559|NCT00592072|570469|P1|COMPLETED|Wash Out Period||5
236560|NCT00592072|570468|P2|STARTED|Wash Out Period||6
236561|NCT00592072|570469|P1|STARTED|Wash Out Period||6
236562|NCT00592072|570468|P2|NOT COMPLETED|First Sequence||0
236563|NCT00592072|570469|P1|NOT COMPLETED|First Sequence||0
236564|NCT00592072|570468|P2|COMPLETED|First Sequence||6
236565|NCT00592072|570469|P1|COMPLETED|First Sequence||6
236566|NCT00592072|570468|P2|STARTED|First Sequence||6
236567|NCT00592072|570469|P1|STARTED|First Sequence||6
236568|NCT00592007|570491|P1|NOT COMPLETED|Overall Study||2
236569|NCT00592007|570491|P1|COMPLETED|Overall Study||5
236570|NCT00592007|570491|P1|STARTED|Overall Study||7
236571|NCT00591942|570496|P2|NOT COMPLETED|Overall Study||0
236572|NCT00591942|570497|P1|NOT COMPLETED|Overall Study||0
236573|NCT00591942|570496|P2|COMPLETED|Overall Study||36
236574|NCT00591942|570497|P1|COMPLETED|Overall Study||36
236575|NCT00591942|570496|P2|STARTED|Overall Study||36
236576|NCT00591942|570497|P1|STARTED|Overall Study||36
236577|NCT00591864|570503|P1|NOT COMPLETED|Overall Study||5
236578|NCT00591864|570503|P1|COMPLETED|Overall Study||84
236579|NCT00591864|570503|P1|STARTED|Overall Study||89
236580|NCT00591851|570509|P1|NOT COMPLETED|Overall Study||6
236581|NCT00591851|570509|P1|COMPLETED|Overall Study||64
236582|NCT00591851|570509|P1|STARTED|Overall Study||70
236583|NCT00591825|570517|P4|NOT COMPLETED|Overall Study||0
236584|NCT00591825|570518|P3|NOT COMPLETED|Overall Study||0
236585|NCT00591825|570519|P2|NOT COMPLETED|Overall Study||0
236586|NCT00591825|570520|P1|NOT COMPLETED|Overall Study||0
236587|NCT00591825|570517|P4|COMPLETED|Overall Study||14
236588|NCT00591825|570518|P3|COMPLETED|Overall Study||13
236589|NCT00591825|570519|P2|COMPLETED|Overall Study||13
236590|NCT00591825|570520|P1|COMPLETED|Overall Study||14
236591|NCT00591825|570517|P4|STARTED|Overall Study||14
236592|NCT00591825|570518|P3|STARTED|Overall Study||13
236593|NCT00591825|570519|P2|STARTED|Overall Study||13
236594|NCT00591825|570520|P1|STARTED|Overall Study||14
236595|NCT00591773|570549|P3|NOT COMPLETED|Overall Study||16
236596|NCT00591773|570550|P2|NOT COMPLETED|Overall Study||24
236597|NCT00591773|570551|P1|NOT COMPLETED|Overall Study||16
236598|NCT00591773|570549|P3|COMPLETED|Overall Study||168
236599|NCT00591773|570550|P2|COMPLETED|Overall Study||158
236600|NCT00591773|570551|P1|COMPLETED|Overall Study||169
236601|NCT00591773|570549|P3|STARTED|Overall Study||184
236602|NCT00591773|570550|P2|STARTED|Overall Study||182
236603|NCT00591773|570551|P1|STARTED|Overall Study||185
236604|NCT00591760|570603|P2|NOT COMPLETED|Overall Study||0
236605|NCT00591760|570604|P1|NOT COMPLETED|Overall Study||0
236606|NCT00591760|570603|P2|COMPLETED|Overall Study||28
236607|NCT00591760|570604|P1|COMPLETED|Overall Study||28
236608|NCT00591760|570603|P2|STARTED|Overall Study||28
236609|NCT00591760|570604|P1|STARTED|Overall Study||28
236610|NCT00591734|570610|P1|NOT COMPLETED|Overall Study||53
236611|NCT00591734|570610|P1|COMPLETED|Overall Study||4
236612|NCT00591734|570610|P1|STARTED|Overall Study||57
236613|NCT00591721|570616|P2|NOT COMPLETED|Overall Study||22
236614|NCT00591721|570617|P1|NOT COMPLETED|Overall Study||21
236615|NCT00591721|570616|P2|COMPLETED|Overall Study||70
236616|NCT00591721|570617|P1|COMPLETED|Overall Study||68
236617|NCT00591721|570616|P2|STARTED|Overall Study||92
236618|NCT00591721|570617|P1|STARTED|Overall Study||89
236619|NCT00591591|570625|P2|NOT COMPLETED|Overall Study||39
236620|NCT00591591|570626|P1|NOT COMPLETED|Overall Study||11
236621|NCT00591591|570625|P2|COMPLETED|Overall Study||94
236622|NCT00591591|570626|P1|COMPLETED|Overall Study||165
236623|NCT00591591|570625|P2|STARTED|Overall Study||133
236624|NCT00591591|570626|P1|STARTED|Overall Study||176
236625|NCT00591578|570643|P3|NOT COMPLETED|Open-Label Extension Phase||0
236626|NCT00591578|570644|P2|NOT COMPLETED|Open-Label Extension Phase||10
236627|NCT00591578|570645|P1|NOT COMPLETED|Open-Label Extension Phase||6
236628|NCT00591578|570643|P3|COMPLETED|Open-Label Extension Phase||0
236629|NCT00591578|570644|P2|COMPLETED|Open-Label Extension Phase||105
236630|NCT00591578|570645|P1|COMPLETED|Open-Label Extension Phase||49
236631|NCT00591578|570643|P3|STARTED|Open-Label Extension Phase||0
236632|NCT00591578|570644|P2|STARTED|Open-Label Extension Phase||115
236633|NCT00591578|570645|P1|STARTED|Open-Label Extension Phase||55
236634|NCT00591578|570643|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
236635|NCT00591578|570644|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
236636|NCT00591578|570645|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
236637|NCT00591578|570643|P3|COMPLETED|Double-Blind Treatment Phase||244
236638|NCT00591578|570644|P2|COMPLETED|Double-Blind Treatment Phase||249
236639|NCT00591578|570645|P1|COMPLETED|Double-Blind Treatment Phase||249
236640|NCT00591578|570643|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
236641|NCT00591578|570644|P2|STARTED|Double-Blind Treatment Phase||329
236642|NCT00591578|570645|P1|STARTED|Double-Blind Treatment Phase||327
236643|NCT00591565|570696|P1|NOT COMPLETED|Overall Study||5
236644|NCT00591565|570696|P1|COMPLETED|Overall Study||8
236645|NCT00591565|570696|P1|STARTED|Overall Study||13
236646|NCT00591370|570700|P1|NOT COMPLETED|Overall Study||2
236647|NCT00591370|570700|P1|COMPLETED|Overall Study||49
236648|NCT00591370|570700|P1|STARTED|Overall Study||51
236649|NCT00591344|570708|P2|NOT COMPLETED|Overall Study||8
236650|NCT00591344|570709|P1|NOT COMPLETED|Overall Study||5
236651|NCT00591344|570708|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
236652|NCT00591344|570709|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
236653|NCT00591344|570708|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
236654|NCT00591344|570709|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
236655|NCT00591344|570708|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
236656|NCT00591344|570709|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
236657|NCT00591305|570721|P2|NOT COMPLETED|Overall Study||0
236658|NCT00591305|570722|P1|NOT COMPLETED|Overall Study||0
236659|NCT00591305|570721|P2|COMPLETED|Overall Study||0
236660|NCT00591305|570722|P1|COMPLETED|Overall Study||1
236661|NCT00591305|570721|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
236662|NCT00591305|570722|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
236663|NCT00591305|570721|P2|STARTED|Overall Study||0
236664|NCT00591305|570722|P1|STARTED|Overall Study||1
236665|NCT00591266|570735|P3|NOT COMPLETED|Overall Study||14
236666|NCT00591266|570736|P2|NOT COMPLETED|Overall Study||11
236667|NCT00591266|570737|P1|NOT COMPLETED|Overall Study||9
236668|NCT00591266|570735|P3|COMPLETED|Overall Study||175
236669|NCT00591266|570736|P2|COMPLETED|Overall Study||177
236670|NCT00591266|570737|P1|COMPLETED|Overall Study||180
236671|NCT00591266|570735|P3|STARTED|Overall Study|Randomized only|189
236672|NCT00591266|570736|P2|STARTED|Overall Study|Randomized only|188
236673|NCT00591266|570737|P1|STARTED|Overall Study|Randomized only|189
236674|NCT00591253|570790|P3|NOT COMPLETED|Overall Study||15
236675|NCT00591253|570791|P2|NOT COMPLETED|Overall Study||21
236676|NCT00591253|570792|P1|NOT COMPLETED|Overall Study||14
236677|NCT00591253|570790|P3|COMPLETED|Overall Study||123
236678|NCT00591253|570791|P2|COMPLETED|Overall Study||116
236679|NCT00591253|570792|P1|COMPLETED|Overall Study||126
236680|NCT00591253|570790|P3|STARTED|Overall Study|Randomized or Treated|138
236681|NCT00591253|570791|P2|STARTED|Overall Study|Randomized or Treated|137
236682|NCT00591253|570792|P1|STARTED|Overall Study|Randomized or Treated|140
236683|NCT00591240|570844|P2|NOT COMPLETED|Overall Study||0
236684|NCT00591240|570845|P1|NOT COMPLETED|Overall Study||0
236685|NCT00591240|570844|P2|COMPLETED|Overall Study||222
236686|NCT00591240|570845|P1|COMPLETED|Overall Study||116
236687|NCT00591240|570844|P2|STARTED|Overall Study||222
236688|NCT00591240|570845|P1|STARTED|Overall Study||116
236689|NCT00591227|570853|P2|NOT COMPLETED|Overall Study||0
236690|NCT00591227|570854|P1|NOT COMPLETED|Overall Study||0
236691|NCT00591227|570853|P2|COMPLETED|Overall Study||87
236692|NCT00591227|570854|P1|COMPLETED|Overall Study||89
236693|NCT00591227|570853|P2|STARTED|Overall Study||87
236694|NCT00591227|570854|P1|STARTED|Overall Study||89
236695|NCT00591214|570860|P1|NOT COMPLETED|Overall Study||8
236696|NCT00591214|570860|P1|COMPLETED|Overall Study||2
236697|NCT00591214|570860|P1|STARTED|Overall Study||10
236698|NCT00591149|570869|P1|NOT COMPLETED|Overall Study||5
236699|NCT00591149|570869|P1|COMPLETED|Overall Study||11
236700|NCT00591149|570869|P1|STARTED|Overall Study||16
236701|NCT00591019|570873|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
236702|NCT00591019|570874|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
236703|NCT00591019|570873|P2|COMPLETED|Intevention 2 (14 Days)||3
236704|NCT00591019|570874|P1|COMPLETED|Intevention 2 (14 Days)||2
236705|NCT00591019|570873|P2|STARTED|Intevention 2 (14 Days)||3
236706|NCT00591019|570874|P1|STARTED|Intevention 2 (14 Days)||2
236707|NCT00591019|570873|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
236708|NCT00591019|570874|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
236709|NCT00591019|570873|P2|COMPLETED|Intervention 1 (14 Days)||3
236710|NCT00591019|570874|P1|COMPLETED|Intervention 1 (14 Days)||2
236711|NCT00591019|570873|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
236712|NCT00591019|570874|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
236713|NCT00591019|570873|P2|NOT COMPLETED|Baseline (1 Day)||0
236714|NCT00591019|570874|P1|NOT COMPLETED|Baseline (1 Day)||0
236715|NCT00591019|570873|P2|COMPLETED|Baseline (1 Day)||4
236716|NCT00591019|570874|P1|COMPLETED|Baseline (1 Day)||3
236717|NCT00591019|570873|P2|STARTED|Baseline (1 Day)||4
236718|NCT00591019|570874|P1|STARTED|Baseline (1 Day)||3
236719|NCT00591006|570885|P24|NOT COMPLETED|Overall Study||1
236720|NCT00591006|570886|P23|NOT COMPLETED|Overall Study||1
236721|NCT00591006|570887|P22|NOT COMPLETED|Overall Study||0
236722|NCT00591006|570888|P21|NOT COMPLETED|Overall Study||0
236723|NCT00591006|570889|P20|NOT COMPLETED|Overall Study||0
236724|NCT00591006|570890|P19|NOT COMPLETED|Overall Study||0
236725|NCT00591006|570891|P18|NOT COMPLETED|Overall Study||0
236726|NCT00591006|570892|P17|NOT COMPLETED|Overall Study||0
236727|NCT00591006|570893|P16|NOT COMPLETED|Overall Study||1
236728|NCT00591006|570894|P15|NOT COMPLETED|Overall Study||0
236729|NCT00591006|570895|P14|NOT COMPLETED|Overall Study||0
236730|NCT00591006|570896|P13|NOT COMPLETED|Overall Study||0
236731|NCT00591006|570897|P12|NOT COMPLETED|Overall Study||0
236732|NCT00591006|570898|P11|NOT COMPLETED|Overall Study||0
236733|NCT00591006|570899|P10|NOT COMPLETED|Overall Study||0
236734|NCT00591006|570900|P9|NOT COMPLETED|Overall Study||0
236735|NCT00591006|570901|P8|NOT COMPLETED|Overall Study||0
236736|NCT00591006|570902|P7|NOT COMPLETED|Overall Study||0
236737|NCT00591006|570903|P6|NOT COMPLETED|Overall Study||0
236738|NCT00591006|570904|P5|NOT COMPLETED|Overall Study||0
236739|NCT00591006|570905|P4|NOT COMPLETED|Overall Study||0
236740|NCT00591006|570906|P3|NOT COMPLETED|Overall Study||0
236741|NCT00591006|570907|P2|NOT COMPLETED|Overall Study||0
236742|NCT00591006|570908|P1|NOT COMPLETED|Overall Study||0
236743|NCT00591006|570885|P24|COMPLETED|Overall Study||0
236744|NCT00591006|570886|P23|COMPLETED|Overall Study||0
236745|NCT00591006|570887|P22|COMPLETED|Overall Study||1
236746|NCT00591006|570888|P21|COMPLETED|Overall Study||0
236747|NCT00591006|570889|P20|COMPLETED|Overall Study||1
236748|NCT00591006|570890|P19|COMPLETED|Overall Study||0
236749|NCT00591006|570891|P18|COMPLETED|Overall Study||1
236750|NCT00591006|570892|P17|COMPLETED|Overall Study||0
236751|NCT00591006|570893|P16|COMPLETED|Overall Study||0
236752|NCT00591006|570894|P15|COMPLETED|Overall Study||0
236753|NCT00591006|570895|P14|COMPLETED|Overall Study||2
236754|NCT00591006|570896|P13|COMPLETED|Overall Study||1
236755|NCT00591006|570897|P12|COMPLETED|Overall Study||1
236756|NCT00591006|570898|P11|COMPLETED|Overall Study||0
236757|NCT00591006|570899|P10|COMPLETED|Overall Study||1
236758|NCT00591006|570900|P9|COMPLETED|Overall Study||1
236759|NCT00591006|570901|P8|COMPLETED|Overall Study||0
236760|NCT00591006|570902|P7|COMPLETED|Overall Study||1
236761|NCT00591006|570903|P6|COMPLETED|Overall Study||0
236762|NCT00591006|570904|P5|COMPLETED|Overall Study||1
236763|NCT00591006|570905|P4|COMPLETED|Overall Study||1
236764|NCT00591006|570906|P3|COMPLETED|Overall Study||1
236765|NCT00591006|570907|P2|COMPLETED|Overall Study||0
236766|NCT00591006|570908|P1|COMPLETED|Overall Study||1
236767|NCT00591006|570885|P24|Treatment #4|Overall Study||0
236768|NCT00591006|570886|P23|Treatment #4|Overall Study||0
236769|NCT00591006|570887|P22|Treatment #4|Overall Study||1
236770|NCT00591006|570888|P21|Treatment #4|Overall Study||0
236771|NCT00591006|570889|P20|Treatment #4|Overall Study||1
236772|NCT00591006|570890|P19|Treatment #4|Overall Study||0
236773|NCT00591006|570891|P18|Treatment #4|Overall Study||1
236774|NCT00591006|570892|P17|Treatment #4|Overall Study||0
236775|NCT00591006|570893|P16|Treatment #4|Overall Study||0
236776|NCT00591006|570894|P15|Treatment #4|Overall Study||0
236777|NCT00591006|570895|P14|Treatment #4|Overall Study||2
236778|NCT00591006|570896|P13|Treatment #4|Overall Study||1
236779|NCT00591006|570897|P12|Treatment #4|Overall Study||1
236780|NCT00591006|570898|P11|Treatment #4|Overall Study||0
236781|NCT00591006|570899|P10|Treatment #4|Overall Study||1
236782|NCT00591006|570900|P9|Treatment #4|Overall Study||1
236783|NCT00591006|570901|P8|Treatment #4|Overall Study||0
236784|NCT00591006|570902|P7|Treatment #4|Overall Study||1
236785|NCT00591006|570903|P6|Treatment #4|Overall Study||0
236786|NCT00591006|570904|P5|Treatment #4|Overall Study||1
236787|NCT00591006|570905|P4|Treatment #4|Overall Study||1
236788|NCT00591006|570906|P3|Treatment #4|Overall Study||1
236789|NCT00591006|570907|P2|Treatment #4|Overall Study||0
236790|NCT00591006|570908|P1|Treatment #4|Overall Study||1
236791|NCT00591006|570885|P24|Treatment #3|Overall Study||1
236792|NCT00591006|570886|P23|Treatment #3|Overall Study||1
236793|NCT00591006|570887|P22|Treatment #3|Overall Study||1
236794|NCT00591006|570888|P21|Treatment #3|Overall Study||0
236795|NCT00591006|570889|P20|Treatment #3|Overall Study||1
236796|NCT00591006|570890|P19|Treatment #3|Overall Study||0
236797|NCT00591006|570891|P18|Treatment #3|Overall Study||1
236798|NCT00591006|570892|P17|Treatment #3|Overall Study||0
236799|NCT00591006|570893|P16|Treatment #3|Overall Study||0
236800|NCT00591006|570894|P15|Treatment #3|Overall Study||0
236801|NCT00591006|570895|P14|Treatment #3|Overall Study||2
236802|NCT00591006|570896|P13|Treatment #3|Overall Study||1
236803|NCT00591006|570897|P12|Treatment #3|Overall Study||1
236804|NCT00591006|570898|P11|Treatment #3|Overall Study||0
236805|NCT00591006|570899|P10|Treatment #3|Overall Study||1
236806|NCT00591006|570900|P9|Treatment #3|Overall Study||1
236807|NCT00591006|570901|P8|Treatment #3|Overall Study||0
236808|NCT00591006|570902|P7|Treatment #3|Overall Study||1
236809|NCT00591006|570903|P6|Treatment #3|Overall Study||0
236810|NCT00591006|570904|P5|Treatment #3|Overall Study||1
236811|NCT00591006|570905|P4|Treatment #3|Overall Study||1
236812|NCT00591006|570906|P3|Treatment #3|Overall Study||1
236813|NCT00591006|570907|P2|Treatment #3|Overall Study||0
236814|NCT00591006|570908|P1|Treatment #3|Overall Study||1
236815|NCT00591006|570885|P24|Treatment #2|Overall Study||1
236816|NCT00591006|570886|P23|Treatment #2|Overall Study||1
236817|NCT00591006|570887|P22|Treatment #2|Overall Study||1
236818|NCT00591006|570888|P21|Treatment #2|Overall Study||0
236819|NCT00591006|570889|P20|Treatment #2|Overall Study||1
236820|NCT00591006|570890|P19|Treatment #2|Overall Study||0
236821|NCT00591006|570891|P18|Treatment #2|Overall Study||1
236822|NCT00591006|570892|P17|Treatment #2|Overall Study||0
236823|NCT00591006|570893|P16|Treatment #2|Overall Study||0
236824|NCT00591006|570894|P15|Treatment #2|Overall Study||0
236825|NCT00591006|570895|P14|Treatment #2|Overall Study||2
236826|NCT00591006|570896|P13|Treatment #2|Overall Study||1
236827|NCT00591006|570897|P12|Treatment #2|Overall Study||1
236828|NCT00591006|570898|P11|Treatment #2|Overall Study||0
236829|NCT00591006|570899|P10|Treatment #2|Overall Study||1
236830|NCT00591006|570900|P9|Treatment #2|Overall Study||1
236831|NCT00591006|570901|P8|Treatment #2|Overall Study||0
236832|NCT00591006|570902|P7|Treatment #2|Overall Study||1
236833|NCT00591006|570903|P6|Treatment #2|Overall Study||0
236834|NCT00591006|570904|P5|Treatment #2|Overall Study||1
236835|NCT00591006|570905|P4|Treatment #2|Overall Study||1
236836|NCT00591006|570906|P3|Treatment #2|Overall Study||1
236837|NCT00591006|570907|P2|Treatment #2|Overall Study||0
236838|NCT00591006|570908|P1|Treatment #2|Overall Study||1
236839|NCT00591006|570885|P24|STARTED|Overall Study||1
236840|NCT00591006|570886|P23|STARTED|Overall Study||1
236841|NCT00591006|570887|P22|STARTED|Overall Study||1
236842|NCT00591006|570888|P21|STARTED|Overall Study||0
236843|NCT00591006|570889|P20|STARTED|Overall Study||1
236844|NCT00591006|570890|P19|STARTED|Overall Study||0
236845|NCT00591006|570891|P18|STARTED|Overall Study||1
236846|NCT00591006|570892|P17|STARTED|Overall Study||0
236847|NCT00591006|570893|P16|STARTED|Overall Study||1
236848|NCT00591006|570894|P15|STARTED|Overall Study||0
236849|NCT00591006|570895|P14|STARTED|Overall Study||2
236850|NCT00591006|570896|P13|STARTED|Overall Study||1
236851|NCT00591006|570897|P12|STARTED|Overall Study||1
236852|NCT00591006|570898|P11|STARTED|Overall Study||0
236853|NCT00591006|570899|P10|STARTED|Overall Study||1
236854|NCT00591006|570900|P9|STARTED|Overall Study||1
236855|NCT00591006|570901|P8|STARTED|Overall Study||0
236856|NCT00591006|570902|P7|STARTED|Overall Study||1
236857|NCT00591006|570903|P6|STARTED|Overall Study||0
236858|NCT00591006|570904|P5|STARTED|Overall Study||1
236859|NCT00591006|570905|P4|STARTED|Overall Study||1
236860|NCT00591006|570906|P3|STARTED|Overall Study||1
236861|NCT00591006|570907|P2|STARTED|Overall Study||0
236862|NCT00591006|570908|P1|STARTED|Overall Study||1
236863|NCT00590980|570926|P1|NOT COMPLETED|Overall Study||10
236864|NCT00590980|570926|P1|COMPLETED|Overall Study||72
236865|NCT00590980|570926|P1|STARTED|Overall Study||82
236866|NCT00590967|570932|P2|NOT COMPLETED|Overall Study||5
236867|NCT00590967|570933|P1|NOT COMPLETED|Overall Study||3
236868|NCT00590967|570932|P2|COMPLETED|Overall Study||20
236869|NCT00590967|570933|P1|COMPLETED|Overall Study||41
236870|NCT00590967|570932|P2|STARTED|Overall Study||25
236871|NCT00590967|570933|P1|STARTED|Overall Study||44
236872|NCT00590902|570945|P1|NOT COMPLETED|Overall Study||1
236873|NCT00590902|570945|P1|COMPLETED|Overall Study||80
236874|NCT00590902|570945|P1|STARTED|Overall Study||81
236875|NCT00590889|570951|P2|NOT COMPLETED|Overall Study||299
236876|NCT00590889|570952|P1|NOT COMPLETED|Overall Study||286
236877|NCT00590889|570951|P2|COMPLETED|Overall Study||104
236878|NCT00590889|570952|P1|COMPLETED|Overall Study||118
236879|NCT00590889|570951|P2|STARTED|Overall Study||403
236880|NCT00590889|570952|P1|STARTED|Overall Study||404
236881|NCT00590863|570961|P3|NOT COMPLETED|Overall Study||78
236882|NCT00590863|570962|P2|NOT COMPLETED|Overall Study||82
236883|NCT00590863|570963|P1|NOT COMPLETED|Overall Study||84
236884|NCT00590863|570961|P3|COMPLETED|Overall Study||146
236885|NCT00590863|570962|P2|COMPLETED|Overall Study||138
236886|NCT00590863|570963|P1|COMPLETED|Overall Study||137
236887|NCT00590863|570961|P3|STARTED|Overall Study||224
236888|NCT00590863|570962|P2|STARTED|Overall Study||220
236889|NCT00590863|570963|P1|STARTED|Overall Study||221
236890|NCT00590772|570974|P1|NOT COMPLETED|Overall Study||0
236891|NCT00590772|570974|P1|COMPLETED|Overall Study||31
236892|NCT00590772|570974|P1|STARTED|Overall Study||31
236893|NCT00590759|570980|P1|NOT COMPLETED|Overall Study||80
236894|NCT00590759|570980|P1|COMPLETED|Overall Study||70
236895|NCT00590759|570980|P1|STARTED|Overall Study||150
236896|NCT00590720|570987|P2|NOT COMPLETED|Overall Study||1
236897|NCT00590720|570988|P1|NOT COMPLETED|Overall Study||1
236898|NCT00590720|570987|P2|COMPLETED|Overall Study||6
236899|NCT00590720|570988|P1|COMPLETED|Overall Study||3
236900|NCT00590720|570987|P2|STARTED|Overall Study||7
236901|NCT00590720|570988|P1|STARTED|Overall Study||4
236902|NCT00590590|571033|P3|NOT COMPLETED|Overall Study||6
236903|NCT00590590|571034|P2|NOT COMPLETED|Overall Study||6
236904|NCT00590590|571035|P1|NOT COMPLETED|Overall Study||7
236905|NCT00590590|571033|P3|COMPLETED|Overall Study||21
236906|NCT00590590|571034|P2|COMPLETED|Overall Study||33
236907|NCT00590590|571035|P1|COMPLETED|Overall Study||32
236908|NCT00590590|571033|P3|STARTED|Overall Study||27
236909|NCT00590590|571034|P2|STARTED|Overall Study||39
236910|NCT00590590|571035|P1|STARTED|Overall Study||39
236911|NCT00590577|571062|P4|NOT COMPLETED|Overall Study||93
236912|NCT00590577|571063|P3|NOT COMPLETED|Overall Study||73
236913|NCT00590577|571064|P2|NOT COMPLETED|Overall Study||76
236914|NCT00590577|571065|P1|NOT COMPLETED|Overall Study||77
236915|NCT00590577|571062|P4|COMPLETED|Overall Study||71
236916|NCT00590577|571063|P3|COMPLETED|Overall Study||90
236917|NCT00590577|571064|P2|COMPLETED|Overall Study||89
236918|NCT00590577|571065|P1|COMPLETED|Overall Study||83
236919|NCT00590577|571062|P4|STARTED|Overall Study||164
236920|NCT00590577|571063|P3|STARTED|Overall Study||163
236921|NCT00590577|571064|P2|STARTED|Overall Study||165
236922|NCT00590577|571065|P1|STARTED|Overall Study||160
236923|NCT00590564|571083|P1|NOT COMPLETED|Overall Study||18
236924|NCT00590564|571083|P1|COMPLETED|Overall Study||24
236925|NCT00590564|571083|P1|STARTED|Overall Study||42
236926|NCT00590538|571087|P1|NOT COMPLETED|Overall Study||2
236927|NCT00590538|571087|P1|COMPLETED|Overall Study||7
236928|NCT00590538|571087|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
236929|NCT00590460|571095|P1|NOT COMPLETED|Overall Study||0
236930|NCT00590460|571095|P1|COMPLETED|Overall Study||5
236931|NCT00590460|571095|P1|STARTED|Overall Study||5
236932|NCT00590369|571110|P2|NOT COMPLETED|Overall Study||0
236933|NCT00590369|571111|P1|NOT COMPLETED|Overall Study||0
236934|NCT00590369|571110|P2|COMPLETED|Overall Study||5
236935|NCT00590369|571111|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
236936|NCT00590369|571110|P2|STARTED|Overall Study||5
236937|NCT00590369|571111|P1|STARTED|Overall Study||6
236938|NCT00590317|571129|P2|NOT COMPLETED|Overall Study||5
236939|NCT00590317|571130|P1|NOT COMPLETED|Overall Study||1
236940|NCT00590317|571129|P2|COMPLETED|Overall Study||27
236941|NCT00590317|571130|P1|COMPLETED|Overall Study||31
236942|NCT00590317|571129|P2|STARTED|Overall Study||32
236943|NCT00590317|571130|P1|STARTED|Overall Study||32
236944|NCT00590226|571142|P2|NOT COMPLETED|Overall Study||0
236945|NCT00590226|571143|P1|NOT COMPLETED|Overall Study||0
236946|NCT00590226|571142|P2|COMPLETED|Overall Study||63
236947|NCT00590226|571143|P1|COMPLETED|Overall Study||67
236948|NCT00590226|571142|P2|STARTED|Overall Study||63
236949|NCT00590226|571143|P1|STARTED|Overall Study||67
236950|NCT00590161|571153|P2|NOT COMPLETED|Overall Study||3
236951|NCT00590161|571154|P1|NOT COMPLETED|Overall Study||3
236952|NCT00590161|571153|P2|COMPLETED|Overall Study||26
236953|NCT00590161|571154|P1|COMPLETED|Overall Study||23
236954|NCT00590161|571153|P2|STARTED|Overall Study||29
236955|NCT00590161|571154|P1|STARTED|Overall Study||26
236956|NCT00590135|571160|P1|NOT COMPLETED|Overall Study||59
236957|NCT00590135|571160|P1|COMPLETED|Overall Study||0
236958|NCT00590135|571160|P1|STARTED|Overall Study||59
236959|NCT00590044|571170|P2|NOT COMPLETED|Overall Study||2
236960|NCT00590044|571171|P1|NOT COMPLETED|Overall Study||4
236961|NCT00590044|571170|P2|COMPLETED|Overall Study||34
236962|NCT00590044|571171|P1|COMPLETED|Overall Study||34
236963|NCT00590044|571170|P2|STARTED|Overall Study||36
236964|NCT00590044|571171|P1|STARTED|Overall Study||38
236965|NCT00590031|571177|P1|NOT COMPLETED|Overall Study||6
236966|NCT00590031|571177|P1|COMPLETED|Overall Study||55
236967|NCT00590031|571177|P1|STARTED|Overall Study||61
236968|NCT00590018|571184|P2|NOT COMPLETED|Overall Study||0
236969|NCT00590018|571185|P1|NOT COMPLETED|Overall Study||0
236970|NCT00590018|571184|P2|COMPLETED|Overall Study||9
236971|NCT00590018|571185|P1|COMPLETED|Overall Study||9
236972|NCT00590018|571184|P2|STARTED|Overall Study||9
236973|NCT00590018|571185|P1|STARTED|Overall Study||9
236974|NCT00590005|571193|P2|NOT COMPLETED|Overall Study||0
236975|NCT00590005|571194|P1|NOT COMPLETED|Overall Study||0
236976|NCT00590005|571193|P2|COMPLETED|Overall Study||119
236977|NCT00590005|571194|P1|COMPLETED|Overall Study||106
236978|NCT00590005|571193|P2|STARTED|Overall Study||119
236979|NCT00590005|571194|P1|STARTED|Overall Study||106
236980|NCT00589979|571204|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
236981|NCT00589979|571205|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
236982|NCT00589979|571206|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
236983|NCT00589979|571204|P3|COMPLETED|Double-Blind Treatment Period 3||38
236984|NCT00589979|571205|P2|COMPLETED|Double-Blind Treatment Period 3||46
236985|NCT00589979|571206|P1|COMPLETED|Double-Blind Treatment Period 3||0
236986|NCT00589979|571204|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
236987|NCT00589979|571205|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
236988|NCT00589979|571206|P1|STARTED|Double-Blind Treatment Period 3||0
236989|NCT00589979|571204|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
236990|NCT00589979|571205|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
236991|NCT00589979|571206|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
236992|NCT00589979|571204|P3|COMPLETED|Double-Blind Treatment Period 2||39
236993|NCT00589979|571205|P2|COMPLETED|Double-Blind Treatment Period 2||47
236994|NCT00589979|571206|P1|COMPLETED|Double-Blind Treatment Period 2||0
236995|NCT00589979|571204|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
236996|NCT00589979|571205|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
236997|NCT00589979|571206|P1|STARTED|Double-Blind Treatment Period 2||0
236998|NCT00589979|571204|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
236999|NCT00589979|571205|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
237000|NCT00589979|571206|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
237001|NCT00589979|571204|P3|COMPLETED|Double-Blind Treatment Period 1||41
237002|NCT00589979|571205|P2|COMPLETED|Double-Blind Treatment Period 1||48
237003|NCT00589979|571206|P1|COMPLETED|Double-Blind Treatment Period 1||0
237004|NCT00589979|571204|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
237005|NCT00589979|571205|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
237006|NCT00589979|571206|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
237007|NCT00589979|571204|P3|NOT COMPLETED|Run-In Period||0
237008|NCT00589979|571205|P2|NOT COMPLETED|Run-In Period||0
237009|NCT00589979|571206|P1|NOT COMPLETED|Run-In Period||76
237010|NCT00589979|571204|P3|COMPLETED|Run-In Period||0
237011|NCT00589979|571205|P2|COMPLETED|Run-In Period||0
237012|NCT00589979|571206|P1|COMPLETED|Run-In Period||93
237013|NCT00589979|571204|P3|STARTED|Run-In Period||0
237014|NCT00589979|571205|P2|STARTED|Run-In Period||0
237015|NCT00589979|571206|P1|STARTED|Run-In Period||169
237016|NCT00589914|571245|P2|NOT COMPLETED|Overall Study||137
237017|NCT00589914|571246|P1|NOT COMPLETED|Overall Study||150
237018|NCT00589914|571245|P2|COMPLETED|Overall Study||471
237019|NCT00589914|571246|P1|COMPLETED|Overall Study||456
237020|NCT00589914|571245|P2|STARTED|Overall Study||608
237021|NCT00589914|571246|P1|STARTED|Overall Study||606
237022|NCT00589888|571256|P5|NOT COMPLETED|64-gram Oral Fat Load||0
237023|NCT00589888|571257|P4|NOT COMPLETED|64-gram Oral Fat Load||0
237024|NCT00589888|571258|P3|NOT COMPLETED|64-gram Oral Fat Load||0
237025|NCT00589888|571259|P2|NOT COMPLETED|64-gram Oral Fat Load||0
237026|NCT00589888|571260|P1|NOT COMPLETED|64-gram Oral Fat Load||0
237027|NCT00589888|571256|P5|COMPLETED|64-gram Oral Fat Load||13
237028|NCT00589888|571257|P4|COMPLETED|64-gram Oral Fat Load||0
237029|NCT00589888|571258|P3|COMPLETED|64-gram Oral Fat Load||0
237030|NCT00589888|571259|P2|COMPLETED|64-gram Oral Fat Load||0
237031|NCT00589888|571260|P1|COMPLETED|64-gram Oral Fat Load||0
237032|NCT00589888|571256|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
237033|NCT00589888|571257|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
237034|NCT00589888|571258|P3|STARTED|64-gram Oral Fat Load||0
237035|NCT00589888|571259|P2|STARTED|64-gram Oral Fat Load||0
237036|NCT00589888|571260|P1|STARTED|64-gram Oral Fat Load||0
237037|NCT00589888|571256|P5|NOT COMPLETED|32-gram Oral Fat Load||0
237038|NCT00589888|571257|P4|NOT COMPLETED|32-gram Oral Fat Load||0
237039|NCT00589888|571258|P3|NOT COMPLETED|32-gram Oral Fat Load||0
237040|NCT00589888|571259|P2|NOT COMPLETED|32-gram Oral Fat Load||0
237041|NCT00589888|571260|P1|NOT COMPLETED|32-gram Oral Fat Load||0
237042|NCT00589888|571256|P5|COMPLETED|32-gram Oral Fat Load||0
237043|NCT00589888|571257|P4|COMPLETED|32-gram Oral Fat Load||13
237044|NCT00589888|571258|P3|COMPLETED|32-gram Oral Fat Load||0
237045|NCT00589888|571259|P2|COMPLETED|32-gram Oral Fat Load||0
237046|NCT00589888|571260|P1|COMPLETED|32-gram Oral Fat Load||0
237047|NCT00589888|571256|P5|STARTED|32-gram Oral Fat Load||0
237048|NCT00589888|571257|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
237049|NCT00589888|571258|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
237050|NCT00589888|571259|P2|STARTED|32-gram Oral Fat Load||0
237051|NCT00589888|571260|P1|STARTED|32-gram Oral Fat Load||0
237052|NCT00589888|571256|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
237053|NCT00589888|571257|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
237054|NCT00589888|571258|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
237055|NCT00589888|571259|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
237056|NCT00589888|571260|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
237057|NCT00589888|571256|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
237058|NCT00589888|571257|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
237059|NCT00589888|571258|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
237060|NCT00589888|571259|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
237061|NCT00589888|571260|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
237062|NCT00589888|571256|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
237063|NCT00589888|571257|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
237064|NCT00589888|571258|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
237065|NCT00589888|571259|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
237066|NCT00589888|571260|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
237067|NCT00589888|571256|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
237068|NCT00589888|571257|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
237069|NCT00589888|571258|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
237070|NCT00589888|571259|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
237071|NCT00589888|571260|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
237072|NCT00589888|571256|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
237073|NCT00589888|571257|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
237074|NCT00589888|571258|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
237075|NCT00589888|571259|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
237076|NCT00589888|571260|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
237077|NCT00589888|571256|P5|STARTED|Intralipid 20% @ 20cc/hr||0
237078|NCT00589888|571257|P4|STARTED|Intralipid 20% @ 20cc/hr||0
237079|NCT00589888|571258|P3|STARTED|Intralipid 20% @ 20cc/hr||0
237080|NCT00589888|571259|P2|STARTED|Intralipid 20% @ 20cc/hr||13
237081|NCT00589888|571260|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
237082|NCT00589888|571256|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
237083|NCT00589888|571257|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
237084|NCT00589888|571258|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
237085|NCT00589888|571259|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
237086|NCT00589888|571260|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
237087|NCT00589888|571256|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
237088|NCT00589888|571257|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
237089|NCT00589888|571258|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
237090|NCT00589888|571259|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
237091|NCT00589888|571260|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
237092|NCT00589888|571256|P5|STARTED|Normal Saline @ 40cc/Hour||0
237093|NCT00589888|571257|P4|STARTED|Normal Saline @ 40cc/Hour||0
237094|NCT00589888|571258|P3|STARTED|Normal Saline @ 40cc/Hour||0
237095|NCT00589888|571259|P2|STARTED|Normal Saline @ 40cc/Hour||0
237096|NCT00589888|571260|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
237097|NCT00589849|571272|P1|NOT COMPLETED|Overall Study||0
237098|NCT00589849|571272|P1|COMPLETED|Overall Study||32
237099|NCT00589849|571272|P1|STARTED|Overall Study||32
237100|NCT00589836|571276|P1|NOT COMPLETED|Overall Study||0
237101|NCT00589836|571276|P1|COMPLETED|Overall Study||20
237102|NCT00589836|571276|P1|STARTED|Overall Study||20
237103|NCT00589784|571282|P2|NOT COMPLETED|Overall Study||10
237104|NCT00589784|571283|P1|NOT COMPLETED|Overall Study||1
237105|NCT00589784|571282|P2|COMPLETED|Overall Study||4
237106|NCT00589784|571283|P1|COMPLETED|Overall Study||35
237107|NCT00589784|571282|P2|STARTED|Overall Study||14
237108|NCT00589784|571283|P1|STARTED|Overall Study||36
237109|NCT00589693|571290|P2|NOT COMPLETED|Overall Study||29
237110|NCT00589693|571291|P1|NOT COMPLETED|Overall Study||44
237111|NCT00589693|571290|P2|COMPLETED|Overall Study||83
237112|NCT00589693|571291|P1|COMPLETED|Overall Study||71
237113|NCT00589693|571290|P2|STARTED|Overall Study||112
237114|NCT00589693|571291|P1|STARTED|Overall Study||115
237115|NCT00589667|571305|P1|NOT COMPLETED|Overall Study||3
237116|NCT00589667|571305|P1|COMPLETED|Overall Study||23
237117|NCT00589667|571305|P1|STARTED|Overall Study||26
237118|NCT00589628|571312|P2|NOT COMPLETED|Overall Study||1
237119|NCT00589628|571313|P1|NOT COMPLETED|Overall Study||0
237120|NCT00589628|571312|P2|COMPLETED|Overall Study||5
237121|NCT00589628|571313|P1|COMPLETED|Overall Study||7
237122|NCT00589628|571312|P2|STARTED|Overall Study||6
237123|NCT00589628|571313|P1|STARTED|Overall Study||7
237124|NCT00589602|571319|P1|NOT COMPLETED|Overall Study||1
237125|NCT00589602|571319|P1|COMPLETED|Overall Study||12
237126|NCT00589602|571319|P1|STARTED|Overall Study||13
237127|NCT00589563|571327|P1|NOT COMPLETED|Overall Study||0
237128|NCT00589563|571327|P1|COMPLETED|Overall Study||32
237129|NCT00589563|571327|P1|STARTED|Overall Study||32
237130|NCT00589550|571344|P1|NOT COMPLETED|Overall Study||1
237131|NCT00589550|571344|P1|COMPLETED|Overall Study||0
237132|NCT00589550|571344|P1|Withdrew From Study|Overall Study||1
237133|NCT00589550|571344|P1|STARTED|Overall Study||1
237134|NCT00589472|571354|P1|NOT COMPLETED|Overall Study||1
237135|NCT00589472|571354|P1|COMPLETED|Overall Study||18
237136|NCT00589472|571354|P1|STARTED|Overall Study||19
237137|NCT00589303|571366|P2|NOT COMPLETED|Overall Study||1
237138|NCT00589303|571367|P1|NOT COMPLETED|Overall Study||2
237139|NCT00589303|571366|P2|COMPLETED|Overall Study||12
237140|NCT00589303|571367|P1|COMPLETED|Overall Study||12
237141|NCT00589303|571366|P2|STARTED|Overall Study||13
237142|NCT00589303|571367|P1|STARTED|Overall Study||14
237143|NCT00589290|571373|P1|NOT COMPLETED|Overall Study||1
237144|NCT00589290|571373|P1|COMPLETED|Overall Study||40
237145|NCT00589290|571373|P1|STARTED|Overall Study||41
237146|NCT00589277|571383|P2|NOT COMPLETED|Overall Study||286
237147|NCT00589277|571384|P1|NOT COMPLETED|Overall Study||460
237148|NCT00589277|571383|P2|COMPLETED|Overall Study||524
237149|NCT00589277|571384|P1|COMPLETED|Overall Study||762
237150|NCT00589277|571383|P2|Completed 3 Month Follow Up|Overall Study||524
237151|NCT00589277|571384|P1|Completed 3 Month Follow Up|Overall Study||762
237152|NCT00589277|571383|P2|Completed 2 Week Follow Up|Overall Study||424
237153|NCT00589277|571384|P1|Completed 2 Week Follow Up|Overall Study||603
237154|NCT00589277|571383|P2|STARTED|Overall Study||810
237155|NCT00589277|571384|P1|STARTED|Overall Study||1222
237156|NCT00589121|571396|P2|NOT COMPLETED|Overall Study||7
237157|NCT00589121|571397|P1|NOT COMPLETED|Overall Study||2
237158|NCT00589121|571396|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
237159|NCT00589121|571397|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
237160|NCT00589121|571396|P2|STARTED|Overall Study||86
237161|NCT00589121|571397|P1|STARTED|Overall Study||12
237162|NCT00589108|571417|P3|NOT COMPLETED|Overall Study||5
237163|NCT00589108|571418|P2|NOT COMPLETED|Overall Study||4
237164|NCT00589108|571419|P1|NOT COMPLETED|Overall Study||4
237165|NCT00589108|571417|P3|COMPLETED|Overall Study||75
237166|NCT00589108|571418|P2|COMPLETED|Overall Study||76
237167|NCT00589108|571419|P1|COMPLETED|Overall Study||76
237168|NCT00589108|571417|P3|STARTED|Overall Study||80
237169|NCT00589108|571418|P2|STARTED|Overall Study||80
237170|NCT00589108|571419|P1|STARTED|Overall Study||80
237171|NCT00588965|571439|P1|NOT COMPLETED|Overall Study||0
237172|NCT00588965|571439|P1|COMPLETED|Overall Study||35
237173|NCT00588965|571439|P1|STARTED|Overall Study||35
237174|NCT00588952|571449|P2|NOT COMPLETED|Overall Study||7
237175|NCT00588952|571450|P1|NOT COMPLETED|Overall Study||3
237176|NCT00588952|571449|P2|COMPLETED|Overall Study||63
237177|NCT00588952|571450|P1|COMPLETED|Overall Study||26
237178|NCT00588952|571449|P2|STARTED|Overall Study||70
237179|NCT00588952|571450|P1|STARTED|Overall Study||29
237180|NCT00588900|571470|P1|NOT COMPLETED|Overall Study||0
237181|NCT00588900|571470|P1|COMPLETED|Overall Study||5
237182|NCT00588900|571470|P1|STARTED|Overall Study||5
237183|NCT00588861|571478|P2|NOT COMPLETED|10 Years||114
237184|NCT00588861|571479|P1|NOT COMPLETED|10 Years||107
237185|NCT00588861|571478|P2|COMPLETED|10 Years||0
237186|NCT00588861|571479|P1|COMPLETED|10 Years||0
237187|NCT00588861|571478|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
237188|NCT00588861|571479|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
237189|NCT00588861|571478|P2|NOT COMPLETED|8 Years||114
237190|NCT00588861|571479|P1|NOT COMPLETED|8 Years||105
237191|NCT00588861|571478|P2|COMPLETED|8 Years||0
237192|NCT00588861|571479|P1|COMPLETED|8 Years||2
237193|NCT00588861|571478|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
237194|NCT00588861|571479|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
237195|NCT00588861|571478|P2|NOT COMPLETED|6 Years||109
237196|NCT00588861|571479|P1|NOT COMPLETED|6 Years||104
237197|NCT00588861|571478|P2|COMPLETED|6 Years||5
237198|NCT00588861|571479|P1|COMPLETED|6 Years||3
237199|NCT00588861|571478|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
237200|NCT00588861|571479|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
237201|NCT00588861|571478|P2|NOT COMPLETED|4 Years||103
237202|NCT00588861|571479|P1|NOT COMPLETED|4 Years||91
237203|NCT00588861|571478|P2|COMPLETED|4 Years||11
237204|NCT00588861|571479|P1|COMPLETED|4 Years||16
237205|NCT00588861|571478|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
237206|NCT00588861|571479|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
237207|NCT00588861|571478|P2|NOT COMPLETED|2 Years||87
237208|NCT00588861|571479|P1|NOT COMPLETED|2 Years||92
237209|NCT00588861|571478|P2|COMPLETED|2 Years||27
237210|NCT00588861|571479|P1|COMPLETED|2 Years||15
237211|NCT00588861|571478|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
237212|NCT00588861|571479|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
237213|NCT00588861|571478|P2|NOT COMPLETED|1 Year||82
237214|NCT00588861|571479|P1|NOT COMPLETED|1 Year||89
237215|NCT00588861|571478|P2|COMPLETED|1 Year||32
237216|NCT00588861|571479|P1|COMPLETED|1 Year||18
237217|NCT00588861|571478|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
237218|NCT00588861|571479|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
237219|NCT00588861|571478|P2|NOT COMPLETED|6 Months||73
237220|NCT00588861|571479|P1|NOT COMPLETED|6 Months||98
237221|NCT00588861|571478|P2|COMPLETED|6 Months||41
237222|NCT00588861|571479|P1|COMPLETED|6 Months||9
237223|NCT00588861|571478|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
237224|NCT00588861|571479|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
237225|NCT00588861|571478|P2|NOT COMPLETED|Pre-Operative||86
237226|NCT00588861|571479|P1|NOT COMPLETED|Pre-Operative||95
237227|NCT00588861|571478|P2|COMPLETED|Pre-Operative||114
237228|NCT00588861|571479|P1|COMPLETED|Pre-Operative||107
237229|NCT00588861|571478|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
237230|NCT00588861|571479|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
237231|NCT00588848|571489|P2|NOT COMPLETED|Overall Study||0
237232|NCT00588848|571490|P1|NOT COMPLETED|Overall Study||0
237233|NCT00588848|571489|P2|COMPLETED|Overall Study||8
237234|NCT00588848|571490|P1|COMPLETED|Overall Study||3
237235|NCT00588848|571489|P2|STARTED|Overall Study||8
237236|NCT00588848|571490|P1|STARTED|Overall Study||3
237237|NCT00588822|571500|P1|NOT COMPLETED|Overall Study||8
237238|NCT00588822|571500|P1|COMPLETED|Overall Study||13
237239|NCT00588822|571500|P1|STARTED|Overall Study||21
237240|NCT00588809|571509|P1|NOT COMPLETED|Overall Study||0
237241|NCT00588809|571509|P1|COMPLETED|Overall Study||47
237242|NCT00588809|571509|P1|STARTED|Overall Study||47
237243|NCT00588731|571520|P2|NOT COMPLETED|Overall Study||2
237244|NCT00588731|571521|P1|NOT COMPLETED|Overall Study||3
237245|NCT00588731|571520|P2|COMPLETED|Overall Study||18
237246|NCT00588731|571521|P1|COMPLETED|Overall Study||18
237247|NCT00588731|571520|P2|STARTED|Overall Study||20
237248|NCT00588731|571521|P1|STARTED|Overall Study||21
237249|NCT00588692|571531|P2|NOT COMPLETED|Overall Study||3
237250|NCT00588692|571532|P1|NOT COMPLETED|Overall Study||7
237251|NCT00588692|571531|P2|COMPLETED|Overall Study||27
237252|NCT00588692|571532|P1|COMPLETED|Overall Study||23
237253|NCT00588692|571531|P2|STARTED|Overall Study||30
237254|NCT00588692|571532|P1|STARTED|Overall Study||30
237255|NCT00588666|571568|P1|NOT COMPLETED|Overall Study||4
237256|NCT00588666|571568|P1|COMPLETED|Overall Study||47
237257|NCT00588666|571568|P1|STARTED|Overall Study||51
237258|NCT00588640|571573|P1|NOT COMPLETED|Overall Study||2
237259|NCT00588640|571573|P1|COMPLETED|Overall Study||8
237260|NCT00588640|571573|P1|STARTED|Overall Study||10
237261|NCT00588536|571577|P1|NOT COMPLETED|Overall Study||0
237262|NCT00588536|571577|P1|COMPLETED|Overall Study||5
237263|NCT00588536|571577|P1|STARTED|Overall Study||5
237264|NCT00588471|571583|P2|NOT COMPLETED|Overall Study||0
237265|NCT00588471|571584|P1|NOT COMPLETED|Overall Study||0
237266|NCT00588471|571583|P2|COMPLETED|Overall Study||29
237267|NCT00588471|571584|P1|COMPLETED|Overall Study||28
237268|NCT00588471|571583|P2|STARTED|Overall Study||29
237269|NCT00588471|571584|P1|STARTED|Overall Study||28
237270|NCT00588445|571592|P1|NOT COMPLETED|Overall Study||15
237271|NCT00588445|571592|P1|COMPLETED|Overall Study||50
237272|NCT00588445|571592|P1|STARTED|Overall Study||65
237273|NCT00588406|571600|P2|NOT COMPLETED|Overall Study||0
237274|NCT00588406|571601|P1|NOT COMPLETED|Overall Study||0
237275|NCT00588406|571600|P2|COMPLETED|Overall Study||49
237276|NCT00588406|571601|P1|COMPLETED|Overall Study||46
237277|NCT00588406|571600|P2|STARTED|Overall Study||49
237278|NCT00588406|571601|P1|STARTED|Overall Study||46
237279|NCT00588380|571609|P1|NOT COMPLETED|Overall Study||0
237280|NCT00588380|571609|P1|COMPLETED|Overall Study||88
237281|NCT00588380|571609|P1|STARTED|Overall Study||88
237282|NCT00588354|571616|P2|NOT COMPLETED|Baseline to 4 Weeks||1
237283|NCT00588354|571617|P1|NOT COMPLETED|Baseline to 4 Weeks||0
237284|NCT00588354|571616|P2|COMPLETED|Baseline to 4 Weeks||14
237285|NCT00588354|571617|P1|COMPLETED|Baseline to 4 Weeks||9
237286|NCT00588354|571616|P2|STARTED|Baseline to 4 Weeks||15
237287|NCT00588354|571617|P1|STARTED|Baseline to 4 Weeks||9
237288|NCT00588354|571616|P2|NOT COMPLETED|Baseline to 2 Weeks||0
237289|NCT00588354|571617|P1|NOT COMPLETED|Baseline to 2 Weeks||2
237290|NCT00588354|571616|P2|COMPLETED|Baseline to 2 Weeks||15
237291|NCT00588354|571617|P1|COMPLETED|Baseline to 2 Weeks||9
237292|NCT00588354|571616|P2|STARTED|Baseline to 2 Weeks||15
237293|NCT00588354|571617|P1|STARTED|Baseline to 2 Weeks||11
237294|NCT00588341|571637|P1|NOT COMPLETED|Overall Study||5
237295|NCT00588341|571637|P1|COMPLETED|Overall Study||19
237296|NCT00588341|571637|P1|STARTED|Overall Study||24
237297|NCT00588237|571641|P1|NOT COMPLETED|Overall Study||4
237298|NCT00588237|571641|P1|COMPLETED|Overall Study||38
237299|NCT00588237|571641|P1|STARTED|Overall Study||42
237300|NCT00588159|571647|P2|NOT COMPLETED|Overall Study||11
237301|NCT00588159|571648|P1|NOT COMPLETED|Overall Study||15
237302|NCT00588159|571647|P2|COMPLETED|Overall Study||63
237303|NCT00588159|571648|P1|COMPLETED|Overall Study||57
237304|NCT00588159|571647|P2|STARTED|Overall Study||74
237305|NCT00588159|571648|P1|STARTED|Overall Study||72
237306|NCT00588146|571664|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
237307|NCT00588146|571665|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
237308|NCT00588146|571664|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
237309|NCT00588146|571665|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
237310|NCT00588146|571664|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
237311|NCT00588146|571665|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
237312|NCT00588146|571664|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
237313|NCT00588146|571665|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
237314|NCT00588146|571664|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
237315|NCT00588146|571665|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
237316|NCT00588146|571664|P2|STARTED|First Intervention (Baseline to 6 mo)||5
237317|NCT00588146|571665|P1|STARTED|First Intervention (Baseline to 6 mo)||5
237318|NCT00588094|571671|P1|NOT COMPLETED|Overall Study||5
237319|NCT00588094|571671|P1|COMPLETED|Overall Study||15
237320|NCT00588094|571671|P1|STARTED|Overall Study||20
237321|NCT00587990|571678|P3|NOT COMPLETED|Overall Study||0
237322|NCT00587990|571679|P2|NOT COMPLETED|Overall Study||0
237323|NCT00587990|571680|P1|NOT COMPLETED|Overall Study||0
237324|NCT00587990|571678|P3|COMPLETED|Overall Study||3
237325|NCT00587990|571679|P2|COMPLETED|Overall Study||4
237326|NCT00587990|571680|P1|COMPLETED|Overall Study||2
237327|NCT00587990|571678|P3|STARTED|Overall Study||3
237328|NCT00587990|571679|P2|STARTED|Overall Study||4
237329|NCT00587990|571680|P1|STARTED|Overall Study||2
237330|NCT00587964|571694|P1|NOT COMPLETED|Overall Study||12
237331|NCT00587964|571694|P1|COMPLETED|Overall Study||39
237332|NCT00587964|571694|P1|STARTED|Overall Study||51
237333|NCT00587860|571700|P2|NOT COMPLETED|Overall Study||5
237334|NCT00587860|571701|P1|NOT COMPLETED|Overall Study||5
237335|NCT00587860|571700|P2|COMPLETED|Overall Study||30
237336|NCT00587860|571701|P1|COMPLETED|Overall Study||30
237337|NCT00587860|571700|P2|STARTED|Overall Study||35
237338|NCT00587860|571701|P1|STARTED|Overall Study||35
237339|NCT00587847|571721|P1|NOT COMPLETED|Overall Study||7
237340|NCT00587847|571721|P1|COMPLETED|Overall Study||5
237341|NCT00587847|571721|P1|STARTED|Overall Study||12
237342|NCT00587834|571726|P1|NOT COMPLETED|Overall Study||0
237343|NCT00587834|571726|P1|COMPLETED|Overall Study||96
237344|NCT00587834|571726|P1|STARTED|Overall Study||96
237345|NCT00587795|571744|P2|NOT COMPLETED|Overall Study||0
237346|NCT00587795|571745|P1|NOT COMPLETED|Overall Study||1
237347|NCT00587795|571744|P2|COMPLETED|Overall Study||0
237348|NCT00587795|571745|P1|COMPLETED|Overall Study||0
237349|NCT00587795|571744|P2|STARTED|Overall Study||0
237350|NCT00587795|571745|P1|STARTED|Overall Study||1
237351|NCT00587769|571751|P1|NOT COMPLETED|Overall Study||0
237352|NCT00587769|571751|P1|COMPLETED|Overall Study||38
237353|NCT00587769|571751|P1|STARTED|Overall Study||38
237354|NCT00587678|571759|P3|NOT COMPLETED|Overall Study||8
237355|NCT00587678|571760|P2|NOT COMPLETED|Overall Study||4
237356|NCT00587678|571761|P1|NOT COMPLETED|Overall Study||6
237357|NCT00587678|571759|P3|COMPLETED|Overall Study||33
237358|NCT00587678|571760|P2|COMPLETED|Overall Study||18
237359|NCT00587678|571761|P1|COMPLETED|Overall Study||16
237360|NCT00587678|571759|P3|STARTED|Overall Study||41
237361|NCT00587678|571760|P2|STARTED|Overall Study||22
237362|NCT00587678|571761|P1|STARTED|Overall Study||22
237363|NCT00587639|571799|P1|NOT COMPLETED|Overall Study||1
237364|NCT00587639|571799|P1|COMPLETED|Overall Study||7
237365|NCT00587639|571799|P1|STARTED|Overall Study||8
237366|NCT00587587|571806|P2|NOT COMPLETED|Overall Study||1
237367|NCT00587587|571807|P1|NOT COMPLETED|Overall Study||6
237368|NCT00587587|571806|P2|COMPLETED|Overall Study||12
237369|NCT00587587|571807|P1|COMPLETED|Overall Study||11
237370|NCT00587587|571806|P2|STARTED|Overall Study||13
237371|NCT00587587|571807|P1|STARTED|Overall Study||17
237372|NCT00587483|571830|P3|NOT COMPLETED|Overall Study||0
237373|NCT00587483|571831|P2|NOT COMPLETED|Overall Study||0
237374|NCT00587483|571832|P1|NOT COMPLETED|Overall Study||0
237375|NCT00587483|571830|P3|COMPLETED|Overall Study||112
237376|NCT00587483|571831|P2|COMPLETED|Overall Study||115
237377|NCT00587483|571832|P1|COMPLETED|Overall Study||115
237378|NCT00587483|571830|P3|STARTED|Overall Study||112
237379|NCT00587483|571831|P2|STARTED|Overall Study||115
237380|NCT00587483|571832|P1|STARTED|Overall Study||115
237381|NCT00587457|571861|P3|NOT COMPLETED|Overall Study||5
237382|NCT00587457|571862|P2|NOT COMPLETED|Overall Study||3
237383|NCT00587457|571863|P1|NOT COMPLETED|Overall Study||3
237384|NCT00587457|571861|P3|COMPLETED|Overall Study||0
237385|NCT00587457|571862|P2|COMPLETED|Overall Study||0
237386|NCT00587457|571863|P1|COMPLETED|Overall Study||0
237387|NCT00587457|571861|P3|STARTED|Overall Study||5
237388|NCT00587457|571862|P2|STARTED|Overall Study||3
237389|NCT00587457|571863|P1|STARTED|Overall Study||3
237390|NCT00587431|571900|P2|NOT COMPLETED|Overall Study||1
237391|NCT00587431|571901|P1|NOT COMPLETED|Overall Study||1
237392|NCT00587431|571900|P2|COMPLETED|Overall Study||38
237393|NCT00587431|571901|P1|COMPLETED|Overall Study||62
237394|NCT00587431|571900|P2|STARTED|Overall Study||39
237395|NCT00587431|571901|P1|STARTED|Overall Study||63
237396|NCT00587288|571912|P2|NOT COMPLETED|Overall Study||9
237397|NCT00587288|571913|P1|NOT COMPLETED|Overall Study||3
237398|NCT00587288|571912|P2|COMPLETED|Overall Study||44
237399|NCT00587288|571913|P1|COMPLETED|Overall Study||50
237400|NCT00587288|571912|P2|STARTED|Overall Study||53
237401|NCT00587288|571913|P1|STARTED|Overall Study||53
237402|NCT00587223|571931|P1|NOT COMPLETED|Overall Study||1
237403|NCT00587223|571931|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
237404|NCT00587223|571931|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
237405|NCT00587171|571948|P2|NOT COMPLETED|Overall Study||1
237406|NCT00587171|571949|P1|NOT COMPLETED|Overall Study||1
237407|NCT00587171|571948|P2|COMPLETED|Overall Study||9
237408|NCT00587171|571949|P1|COMPLETED|Overall Study||8
237409|NCT00587171|571948|P2|STARTED|Overall Study||10
237410|NCT00587171|571949|P1|STARTED|Overall Study||9
237411|NCT00587158|571979|P2|NOT COMPLETED|Overall Study||8
237412|NCT00587158|571980|P1|NOT COMPLETED|Overall Study||5
237413|NCT00587158|571979|P2|COMPLETED|Overall Study||43
237414|NCT00587158|571980|P1|COMPLETED|Overall Study||44
237415|NCT00587158|571979|P2|Continued in Study|Overall Study||46
237416|NCT00587158|571980|P1|Continued in Study|Overall Study||45
237417|NCT00587158|571979|P2|STARTED|Overall Study||51
237418|NCT00587158|571980|P1|STARTED|Overall Study||49
237419|NCT00587132|572014|P4|NOT COMPLETED|Overall Study||0
237420|NCT00587132|572015|P3|NOT COMPLETED|Overall Study||0
237421|NCT00587132|572016|P2|NOT COMPLETED|Overall Study||0
237422|NCT00587132|572017|P1|NOT COMPLETED|Overall Study||0
237423|NCT00587132|572014|P4|COMPLETED|Overall Study||0
237424|NCT00587132|572015|P3|COMPLETED|Overall Study||0
237425|NCT00587132|572016|P2|COMPLETED|Overall Study||0
237426|NCT00587132|572017|P1|COMPLETED|Overall Study||4
237427|NCT00587132|572014|P4|STARTED|Overall Study||0
237428|NCT00587132|572015|P3|STARTED|Overall Study||0
237429|NCT00587132|572016|P2|STARTED|Overall Study||0
237430|NCT00587132|572017|P1|STARTED|Overall Study||4
237431|NCT00587067|572027|P1|NOT COMPLETED|Overall Study||0
237432|NCT00587067|572027|P1|COMPLETED|Overall Study||34
237433|NCT00587067|572027|P1|STARTED|Overall Study||34
237434|NCT00587054|572033|P1|NOT COMPLETED|Overall Study||9
237435|NCT00587054|572033|P1|COMPLETED|Overall Study||120
237436|NCT00587054|572033|P1|STARTED|Overall Study||129
237437|NCT00587041|572040|P3|NOT COMPLETED|Overall Study||0
237438|NCT00587041|572041|P2|NOT COMPLETED|Overall Study||0
237439|NCT00587041|572042|P1|NOT COMPLETED|Overall Study||0
237440|NCT00587041|572040|P3|COMPLETED|Overall Study||14
237441|NCT00587041|572041|P2|COMPLETED|Overall Study||14
237442|NCT00587041|572042|P1|COMPLETED|Overall Study||12
237443|NCT00587041|572040|P3|STARTED|Overall Study||14
237444|NCT00587041|572041|P2|STARTED|Overall Study||14
237445|NCT00587041|572042|P1|STARTED|Overall Study||12
237446|NCT00586898|572053|P1|NOT COMPLETED|Overall Study||7
237447|NCT00586898|572053|P1|COMPLETED|Overall Study||29
237448|NCT00586898|572053|P1|STARTED|Overall Study||36
237449|NCT00586846|572057|P1|NOT COMPLETED|Overall Study||6
237450|NCT00586846|572057|P1|COMPLETED|Overall Study||34
237451|NCT00586846|572057|P1|STARTED|Overall Study||40
237452|NCT00586820|572063|P2|NOT COMPLETED|Overall Study||0
237453|NCT00586820|572064|P1|NOT COMPLETED|Overall Study||1
237454|NCT00586820|572063|P2|COMPLETED|Overall Study||11
237455|NCT00586820|572064|P1|COMPLETED|Overall Study||11
237456|NCT00586820|572063|P2|STARTED|Overall Study||11
237457|NCT00586820|572064|P1|STARTED|Overall Study||12
237458|NCT00586729|572074|P2|NOT COMPLETED|Overall Study||1
237459|NCT00586729|572075|P1|NOT COMPLETED|Overall Study||3
237460|NCT00586729|572074|P2|COMPLETED|Overall Study||8
237461|NCT00586729|572075|P1|COMPLETED|Overall Study||11
237462|NCT00586729|572074|P2|STARTED|Overall Study||9
237463|NCT00586729|572075|P1|STARTED|Overall Study||14
237464|NCT00586716|572087|P2|NOT COMPLETED|Overall Study||0
237465|NCT00586716|572088|P1|NOT COMPLETED|Overall Study||0
237466|NCT00586716|572087|P2|COMPLETED|Overall Study||8
237467|NCT00586716|572088|P1|COMPLETED|Overall Study||14
237468|NCT00586716|572087|P2|STARTED|Overall Study||8
237469|NCT00586716|572088|P1|STARTED|Overall Study||14
237470|NCT00586703|572095|P1|NOT COMPLETED|Overall Study||12
237471|NCT00586703|572095|P1|COMPLETED|Overall Study||4
237472|NCT00586703|572095|P1|STARTED|Overall Study||16
237473|NCT00586690|572102|P2|NOT COMPLETED|Overall Study||0
237474|NCT00586690|572103|P1|NOT COMPLETED|Overall Study||16
237475|NCT00586690|572102|P2|COMPLETED|Overall Study||22
237476|NCT00586690|572103|P1|COMPLETED|Overall Study||5
237477|NCT00586690|572102|P2|STARTED|Overall Study||22
237478|NCT00586690|572103|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
237479|NCT00586664|572113|P3|NOT COMPLETED|Overall Study||1
237480|NCT00586664|572114|P2|NOT COMPLETED|Overall Study||7
237481|NCT00586664|572115|P1|NOT COMPLETED|Overall Study||5
237482|NCT00586664|572113|P3|COMPLETED|Overall Study||43
237483|NCT00586664|572114|P2|COMPLETED|Overall Study||36
237484|NCT00586664|572115|P1|COMPLETED|Overall Study||38
237485|NCT00586664|572113|P3|STARTED|Overall Study||44
237486|NCT00586664|572114|P2|STARTED|Overall Study||43
237487|NCT00586664|572115|P1|STARTED|Overall Study||43
237488|NCT00586625|572161|P2|NOT COMPLETED|Overall Study||17
237489|NCT00586625|572162|P1|NOT COMPLETED|Overall Study||43
237490|NCT00586625|572161|P2|COMPLETED|Overall Study||269
237491|NCT00586625|572162|P1|COMPLETED|Overall Study||532
237492|NCT00586625|572161|P2|STARTED|Overall Study||286
237493|NCT00586625|572162|P1|STARTED|Overall Study||575
237494|NCT00586612|572170|P2|NOT COMPLETED|Booster Phase||1
237495|NCT00586612|572171|P1|NOT COMPLETED|Booster Phase||3
237496|NCT00586612|572170|P2|COMPLETED|Booster Phase||143
237497|NCT00586612|572171|P1|COMPLETED|Booster Phase||151
237498|NCT00586612|572170|P2|STARTED|Booster Phase||144
237499|NCT00586612|572171|P1|STARTED|Booster Phase||154
237500|NCT00586612|572170|P2|NOT COMPLETED|Primary Phase||3
237501|NCT00586612|572171|P1|NOT COMPLETED|Primary Phase||1
237502|NCT00586612|572170|P2|COMPLETED|Primary Phase||147
237503|NCT00586612|572171|P1|COMPLETED|Primary Phase||162
237504|NCT00586612|572170|P2|STARTED|Primary Phase||150
237505|NCT00586612|572171|P1|STARTED|Primary Phase||163
237506|NCT00586573|572237|P1|NOT COMPLETED|Overall Study||6
237507|NCT00586573|572237|P1|COMPLETED|Overall Study||28
237508|NCT00586573|572237|P1|STARTED|Overall Study||34
237509|NCT00586521|572241|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
237510|NCT00586521|572241|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
237511|NCT00586521|572241|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
237512|NCT00586521|572241|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
237513|NCT00586521|572241|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
237514|NCT00586521|572241|P1|STARTED|On Demand Treatment (Months 1-6)||20
237515|NCT00586495|572248|P1|NOT COMPLETED|Follow-up||92
237516|NCT00586495|572248|P1|COMPLETED|Follow-up||0
237517|NCT00586495|572248|P1|STARTED|Follow-up||92
237518|NCT00586495|572248|P1|NOT COMPLETED|Treatment Period||95
237519|NCT00586495|572248|P1|COMPLETED|Treatment Period||0
237520|NCT00586495|572248|P1|STARTED|Treatment Period||95
237521|NCT00586482|572260|P2|NOT COMPLETED|Overall Study||0
237522|NCT00586482|572261|P1|NOT COMPLETED|Overall Study||0
237523|NCT00586482|572260|P2|COMPLETED|Overall Study||24
237524|NCT00586482|572261|P1|COMPLETED|Overall Study||22
237525|NCT00586482|572260|P2|STARTED|Overall Study||24
237526|NCT00586482|572261|P1|STARTED|Overall Study||22
237527|NCT00586469|572277|P2|NOT COMPLETED|Overall Study||1
237528|NCT00586469|572278|P1|NOT COMPLETED|Overall Study||0
237529|NCT00586469|572277|P2|COMPLETED|Overall Study||499
237530|NCT00586469|572278|P1|COMPLETED|Overall Study||500
237531|NCT00586469|572277|P2|STARTED|Overall Study||500
237532|NCT00586469|572278|P1|STARTED|Overall Study||500
237533|NCT00586339|572305|P3|NOT COMPLETED|Overall Study||6
237534|NCT00586339|572306|P2|NOT COMPLETED|Overall Study||7
237535|NCT00586339|572307|P1|NOT COMPLETED|Overall Study||7
237536|NCT00586339|572305|P3|COMPLETED|Overall Study||24
237537|NCT00586339|572306|P2|COMPLETED|Overall Study||52
237538|NCT00586339|572307|P1|COMPLETED|Overall Study||54
237539|NCT00586339|572305|P3|STARTED|Overall Study||30
237540|NCT00586339|572306|P2|STARTED|Overall Study||59
237541|NCT00586339|572307|P1|STARTED|Overall Study||61
237542|NCT00586326|572405|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
237543|NCT00586326|572405|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
237544|NCT00586326|572405|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
237545|NCT00586326|572405|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
237546|NCT00586326|572405|P1|COMPLETED|Device Placed toTreatment-ITT||100
237547|NCT00586326|572405|P1|STARTED|Device Placed toTreatment-ITT||118
237548|NCT00586326|572405|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
237549|NCT00586326|572405|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
237550|NCT00586326|572405|P1|STARTED|Enrollment to Device Placement-Enrolled||133
237551|NCT00586313|572416|P1|NOT COMPLETED|Overall Study||2
237552|NCT00586313|572416|P1|COMPLETED|Overall Study||19
237553|NCT00586313|572416|P1|STARTED|Overall Study||21
237554|NCT00586261|572423|P2|NOT COMPLETED|Overall Study||0
237555|NCT00586261|572424|P1|NOT COMPLETED|Overall Study||0
237556|NCT00586261|572423|P2|COMPLETED|Overall Study||19
237557|NCT00586261|572424|P1|COMPLETED|Overall Study||17
237558|NCT00586261|572423|P2|STARTED|Overall Study||19
237559|NCT00586261|572424|P1|STARTED|Overall Study||17
237560|NCT00586196|572432|P2|NOT COMPLETED|Overall Study||0
237561|NCT00586196|572433|P1|NOT COMPLETED|Overall Study||0
237562|NCT00586196|572432|P2|COMPLETED|Overall Study||9
237563|NCT00586196|572433|P1|COMPLETED|Overall Study||7
237564|NCT00586196|572432|P2|STARTED|Overall Study||9
237565|NCT00586196|572433|P1|STARTED|Overall Study||7
237566|NCT00586170|572443|P2|NOT COMPLETED|Overall Study||0
237567|NCT00586170|572444|P1|NOT COMPLETED|Overall Study||0
237568|NCT00586170|572443|P2|COMPLETED|Overall Study||3
237569|NCT00586170|572444|P1|COMPLETED|Overall Study||5
237570|NCT00586170|572443|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
237571|NCT00586170|572444|P1|STARTED|Overall Study||5
237572|NCT00586157|572452|P2|NOT COMPLETED|Second Intervention||1
237573|NCT00586157|572453|P1|NOT COMPLETED|Second Intervention||2
237574|NCT00586157|572452|P2|COMPLETED|Second Intervention||14
237575|NCT00586157|572453|P1|COMPLETED|Second Intervention||12
237576|NCT00586157|572452|P2|STARTED|Second Intervention||15
237577|NCT00586157|572453|P1|STARTED|Second Intervention||14
237578|NCT00586157|572452|P2|NOT COMPLETED|First Intervention||0
237579|NCT00586157|572453|P1|NOT COMPLETED|First Intervention||1
237580|NCT00586157|572452|P2|COMPLETED|First Intervention||15
237581|NCT00586157|572453|P1|COMPLETED|First Intervention||14
237582|NCT00586157|572452|P2|STARTED|First Intervention||15
237583|NCT00586157|572453|P1|STARTED|First Intervention||15
237584|NCT00586105|572463|P1|NOT COMPLETED|Overall Study||39
237585|NCT00586105|572463|P1|COMPLETED|Overall Study||0
237586|NCT00586105|572463|P1|STARTED|Overall Study||39
237587|NCT00586066|572478|P2|NOT COMPLETED|Overall Study||10
237588|NCT00586066|572479|P1|NOT COMPLETED|Overall Study||18
237589|NCT00586066|572478|P2|COMPLETED|Overall Study||14
237590|NCT00586066|572479|P1|COMPLETED|Overall Study||30
237591|NCT00586066|572478|P2|STARTED|Overall Study||24
237592|NCT00586066|572479|P1|STARTED|Overall Study||48
237593|NCT00585975|572491|P2|NOT COMPLETED|Overall Study||13
237594|NCT00585975|572492|P1|NOT COMPLETED|Overall Study||15
237595|NCT00585975|572491|P2|COMPLETED|Overall Study||278
237596|NCT00585975|572492|P1|COMPLETED|Overall Study||262
237597|NCT00585975|572491|P2|STARTED|Overall Study||291
237598|NCT00585975|572492|P1|STARTED|Overall Study||277
237599|NCT00585923|572502|P2|NOT COMPLETED|Overall Study||33
237600|NCT00585923|572503|P1|NOT COMPLETED|Overall Study||31
237601|NCT00585923|572502|P2|COMPLETED|Overall Study||26
237602|NCT00585923|572503|P1|COMPLETED|Overall Study||25
237603|NCT00585923|572502|P2|STARTED|Overall Study||59
237604|NCT00585923|572503|P1|STARTED|Overall Study||56
237605|NCT00585910|572517|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
237606|NCT00585910|572517|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
237607|NCT00585910|572517|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
237608|NCT00585910|572517|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
237609|NCT00585910|572517|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
237610|NCT00585910|572517|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
237611|NCT00585715|572525|P2|NOT COMPLETED|Overall Study||0
237612|NCT00585715|572526|P1|NOT COMPLETED|Overall Study||3
237613|NCT00585715|572525|P2|COMPLETED|Overall Study||11
237614|NCT00585715|572526|P1|COMPLETED|Overall Study||8
237615|NCT00585715|572525|P2|STARTED|Overall Study||11
237616|NCT00585715|572526|P1|STARTED|Overall Study||11
237617|NCT00585689|572534|P1|NOT COMPLETED|Overall Study||7
237618|NCT00585689|572534|P1|COMPLETED|Overall Study||22
237619|NCT00585689|572534|P1|STARTED|Overall Study||29
237620|NCT00585650|572540|P2|NOT COMPLETED|Overall Study||0
237621|NCT00585650|572541|P1|NOT COMPLETED|Overall Study||0
237622|NCT00585650|572540|P2|COMPLETED|Overall Study||12
237623|NCT00585650|572541|P1|COMPLETED|Overall Study||8
237624|NCT00585650|572540|P2|STARTED|Overall Study||12
237625|NCT00585650|572541|P1|STARTED|Overall Study||8
237626|NCT00585637|572551|P4|NOT COMPLETED|6-month Time Point||6
237627|NCT00585637|572552|P3|NOT COMPLETED|6-month Time Point||11
237628|NCT00585637|572553|P2|NOT COMPLETED|6-month Time Point||13
237629|NCT00585637|572554|P1|NOT COMPLETED|6-month Time Point||6
237630|NCT00585637|572551|P4|COMPLETED|6-month Time Point||77
237631|NCT00585637|572552|P3|COMPLETED|6-month Time Point||72
237632|NCT00585637|572553|P2|COMPLETED|6-month Time Point||68
237633|NCT00585637|572554|P1|COMPLETED|6-month Time Point||75
237634|NCT00585637|572551|P4|STARTED|6-month Time Point||83
237635|NCT00585637|572552|P3|STARTED|6-month Time Point||83
237636|NCT00585637|572553|P2|STARTED|6-month Time Point||81
237637|NCT00585637|572554|P1|STARTED|6-month Time Point||81
237638|NCT00585637|572551|P4|NOT COMPLETED|3-month Time Point||5
237639|NCT00585637|572552|P3|NOT COMPLETED|3-month Time Point||7
237640|NCT00585637|572553|P2|NOT COMPLETED|3-month Time Point||14
237641|NCT00585637|572554|P1|NOT COMPLETED|3-month Time Point||10
237642|NCT00585637|572551|P4|COMPLETED|3-month Time Point||78
237643|NCT00585637|572552|P3|COMPLETED|3-month Time Point||76
237644|NCT00585637|572553|P2|COMPLETED|3-month Time Point||67
237645|NCT00585637|572554|P1|COMPLETED|3-month Time Point||71
237646|NCT00585637|572551|P4|STARTED|3-month Time Point||83
237647|NCT00585637|572552|P3|STARTED|3-month Time Point||83
237648|NCT00585637|572553|P2|STARTED|3-month Time Point||81
237649|NCT00585637|572554|P1|STARTED|3-month Time Point||81
237650|NCT00585637|572551|P4|NOT COMPLETED|Baseline||0
237651|NCT00585637|572552|P3|NOT COMPLETED|Baseline||0
237652|NCT00585637|572553|P2|NOT COMPLETED|Baseline||0
237653|NCT00585637|572554|P1|NOT COMPLETED|Baseline||0
237654|NCT00585637|572551|P4|COMPLETED|Baseline||83
237655|NCT00585637|572552|P3|COMPLETED|Baseline||83
237656|NCT00585637|572553|P2|COMPLETED|Baseline||81
237657|NCT00585637|572554|P1|COMPLETED|Baseline||81
237658|NCT00585637|572551|P4|STARTED|Baseline||83
237659|NCT00585637|572552|P3|STARTED|Baseline||83
237660|NCT00585637|572553|P2|STARTED|Baseline||81
237661|NCT00585637|572554|P1|STARTED|Baseline||81
237662|NCT00585585|572580|P1|NOT COMPLETED|Overall Study||1
237663|NCT00585585|572580|P1|COMPLETED|Overall Study||0
237664|NCT00585585|572580|P1|Patients Receiving Drug|Overall Study||1
237665|NCT00585585|572580|P1|STARTED|Overall Study||1
237666|NCT00585546|572584|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
237667|NCT00585546|572584|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
237668|NCT00585546|572584|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
237669|NCT00585546|572584|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
237670|NCT00585546|572584|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
237671|NCT00585546|572584|P1|STARTED|LVAD Implantation Required for 4 Months||18
237672|NCT00585533|572598|P1|NOT COMPLETED|Overall Study||9
237673|NCT00585533|572598|P1|COMPLETED|Overall Study||31
237674|NCT00585533|572598|P1|STARTED|Overall Study||40
237675|NCT00585494|572603|P1|NOT COMPLETED|Overall Study||56
237676|NCT00585494|572603|P1|COMPLETED|Overall Study||244
237677|NCT00585494|572603|P1|STARTED|Overall Study||300
237678|NCT00585468|572607|P2|NOT COMPLETED|Second Intervention||0
237679|NCT00585468|572608|P1|NOT COMPLETED|Second Intervention||0
237680|NCT00585468|572607|P2|COMPLETED|Second Intervention||10
237681|NCT00585468|572608|P1|COMPLETED|Second Intervention||9
237682|NCT00585468|572607|P2|STARTED|Second Intervention||10
237683|NCT00585468|572608|P1|STARTED|Second Intervention||9
237684|NCT00585468|572607|P2|NOT COMPLETED|First Intervention||1
237685|NCT00585468|572608|P1|NOT COMPLETED|First Intervention||1
237686|NCT00585468|572607|P2|COMPLETED|First Intervention||10
237687|NCT00585468|572608|P1|COMPLETED|First Intervention||9
237688|NCT00585468|572607|P2|STARTED|First Intervention||11
237689|NCT00585468|572608|P1|STARTED|First Intervention||10
237690|NCT00585377|572628|P1|NOT COMPLETED|Overall Study||0
237691|NCT00585377|572628|P1|COMPLETED|Overall Study||50
237692|NCT00585377|572628|P1|STARTED|Overall Study||50
237693|NCT00585351|572640|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
237694|NCT00585351|572641|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
237695|NCT00585351|572642|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
237696|NCT00585351|572643|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
237697|NCT00585351|572644|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
237698|NCT00585351|572645|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
237699|NCT00585351|572646|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
237700|NCT00585351|572647|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
237701|NCT00585351|572640|P8|COMPLETED|Enrollment Period (Intervention)||2
237702|NCT00585351|572641|P7|COMPLETED|Enrollment Period (Intervention)||5
237703|NCT00585351|572642|P6|COMPLETED|Enrollment Period (Intervention)||5
237704|NCT00585351|572643|P5|COMPLETED|Enrollment Period (Intervention)||3
237705|NCT00585351|572644|P4|COMPLETED|Enrollment Period (Intervention)||15
237706|NCT00585351|572645|P3|COMPLETED|Enrollment Period (Intervention)||15
237707|NCT00585351|572646|P2|COMPLETED|Enrollment Period (Intervention)||0
237708|NCT00585351|572647|P1|COMPLETED|Enrollment Period (Intervention)||0
237709|NCT00585351|572640|P8|STARTED|Enrollment Period (Intervention)||3
237710|NCT00585351|572641|P7|STARTED|Enrollment Period (Intervention)||7
237711|NCT00585351|572642|P6|STARTED|Enrollment Period (Intervention)||7
237712|NCT00585351|572643|P5|STARTED|Enrollment Period (Intervention)||5
237713|NCT00585351|572644|P4|STARTED|Enrollment Period (Intervention)||15
237714|NCT00585351|572645|P3|STARTED|Enrollment Period (Intervention)||15
237715|NCT00585351|572646|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
237716|NCT00585351|572647|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
237717|NCT00585351|572640|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
237718|NCT00585351|572641|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
237719|NCT00585351|572642|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
237720|NCT00585351|572643|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
237721|NCT00585351|572644|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
237722|NCT00585351|572645|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
237723|NCT00585351|572646|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
237724|NCT00585351|572647|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
237725|NCT00585351|572640|P8|COMPLETED|Notification Period (Informed Consent)||0
237726|NCT00585351|572641|P7|COMPLETED|Notification Period (Informed Consent)||0
237727|NCT00585351|572642|P6|COMPLETED|Notification Period (Informed Consent)||0
237728|NCT00585351|572643|P5|COMPLETED|Notification Period (Informed Consent)||0
237729|NCT00585351|572644|P4|COMPLETED|Notification Period (Informed Consent)||0
237730|NCT00585351|572645|P3|COMPLETED|Notification Period (Informed Consent)||0
237731|NCT00585351|572646|P2|COMPLETED|Notification Period (Informed Consent)||25
237732|NCT00585351|572647|P1|COMPLETED|Notification Period (Informed Consent)||27
237733|NCT00585351|572640|P8|STARTED|Notification Period (Informed Consent)||0
237734|NCT00585351|572641|P7|STARTED|Notification Period (Informed Consent)||0
237735|NCT00585351|572642|P6|STARTED|Notification Period (Informed Consent)||0
237736|NCT00585351|572643|P5|STARTED|Notification Period (Informed Consent)||0
237737|NCT00585351|572644|P4|STARTED|Notification Period (Informed Consent)||0
237738|NCT00585351|572645|P3|STARTED|Notification Period (Informed Consent)||0
237739|NCT00585351|572646|P2|STARTED|Notification Period (Informed Consent)||50
237740|NCT00585351|572647|P1|STARTED|Notification Period (Informed Consent)||50
237741|NCT00585325|572663|P2|NOT COMPLETED|Overall Study||1
237742|NCT00585325|572664|P1|NOT COMPLETED|Overall Study||1
237743|NCT00585325|572663|P2|COMPLETED|Overall Study||12
237744|NCT00585325|572664|P1|COMPLETED|Overall Study||9
237745|NCT00585325|572663|P2|STARTED|Overall Study||13
237746|NCT00585325|572664|P1|STARTED|Overall Study||10
237747|NCT00585312|572672|P2|NOT COMPLETED|Overall Study||44
237748|NCT00585312|572673|P1|NOT COMPLETED|Overall Study||51
237749|NCT00585312|572672|P2|COMPLETED|Overall Study||7
237750|NCT00585312|572673|P1|COMPLETED|Overall Study||4
237751|NCT00585312|572672|P2|Treated|Overall Study||48
237752|NCT00585312|572673|P1|Treated|Overall Study||53
237753|NCT00585312|572672|P2|STARTED|Overall Study|STARTED=Randomized|51
237754|NCT00585312|572673|P1|STARTED|Overall Study|STARTED=Randomized|55
237755|NCT00585286|572685|P1|NOT COMPLETED|Overall Study||1
237756|NCT00585286|572685|P1|COMPLETED|Overall Study||14
237757|NCT00585286|572685|P1|STARTED|Overall Study||15
237758|NCT00585247|572694|P2|NOT COMPLETED|Overall Study||0
237759|NCT00585247|572695|P1|NOT COMPLETED|Overall Study||0
237760|NCT00585247|572694|P2|COMPLETED|Overall Study||13
237761|NCT00585247|572695|P1|COMPLETED|Overall Study||14
237762|NCT00585247|572694|P2|STARTED|Overall Study||13
237763|NCT00585247|572695|P1|STARTED|Overall Study||14
237764|NCT00585221|572701|P1|NOT COMPLETED|Overall Study||8
237765|NCT00585221|572701|P1|COMPLETED|Overall Study||0
237766|NCT00585221|572701|P1|STARTED|Overall Study||8
237767|NCT00585182|572706|P1|NOT COMPLETED|Overall Study||0
237768|NCT00585182|572706|P1|COMPLETED|Overall Study||28
237769|NCT00585182|572706|P1|STARTED|Overall Study||28
237770|NCT00585169|572711|P1|NOT COMPLETED|Overall Study||1
237771|NCT00585169|572711|P1|COMPLETED|Overall Study||28
237772|NCT00585169|572711|P1|STARTED|Overall Study||29
237773|NCT00585104|572717|P1|NOT COMPLETED|Overall Study||4
237774|NCT00585104|572717|P1|COMPLETED|Overall Study||6
237775|NCT00585104|572717|P1|STARTED|Overall Study||10
237776|NCT00585078|572721|P1|NOT COMPLETED|Overall Study||40
237777|NCT00585078|572721|P1|COMPLETED|Overall Study||0
237778|NCT00585078|572721|P1|Response Evaluable|Overall Study||24
237779|NCT00585078|572721|P1|Toxicity Evaluable|Overall Study||36
237780|NCT00585078|572721|P1|Treated|Overall Study||37
237781|NCT00585078|572721|P1|STARTED|Overall Study||40
237782|NCT00585052|572728|P1|NOT COMPLETED|Overall Study||1
237783|NCT00585052|572728|P1|COMPLETED|Overall Study||10
237784|NCT00585052|572728|P1|STARTED|Overall Study||11
237785|NCT00585039|572735|P2|NOT COMPLETED|Overall Study||0
237786|NCT00585039|572736|P1|NOT COMPLETED|Overall Study||2
237787|NCT00585039|572735|P2|COMPLETED|Overall Study||44
237788|NCT00585039|572736|P1|COMPLETED|Overall Study||55
237789|NCT00585039|572735|P2|STARTED|Overall Study||44
237790|NCT00585039|572736|P1|STARTED|Overall Study||57
237791|NCT00585013|572746|P2|NOT COMPLETED|Overall Study||0
237792|NCT00585013|572747|P1|NOT COMPLETED|Overall Study||0
237793|NCT00585013|572746|P2|COMPLETED|Overall Study||8
237794|NCT00585013|572747|P1|COMPLETED|Overall Study||8
237795|NCT00585013|572746|P2|STARTED|Overall Study||8
237796|NCT00585013|572747|P1|STARTED|Overall Study||8
237797|NCT00584987|572765|P4|NOT COMPLETED|Overall Study||1
237798|NCT00584987|572766|P3|NOT COMPLETED|Overall Study||1
237799|NCT00584987|572767|P2|NOT COMPLETED|Overall Study||1
237800|NCT00584987|572768|P1|NOT COMPLETED|Overall Study||1
237801|NCT00584987|572765|P4|COMPLETED|Overall Study||15
237802|NCT00584987|572766|P3|COMPLETED|Overall Study||16
237803|NCT00584987|572767|P2|COMPLETED|Overall Study||15
237804|NCT00584987|572768|P1|COMPLETED|Overall Study||14
237805|NCT00584987|572765|P4|STARTED|Overall Study||16
237806|NCT00584987|572766|P3|STARTED|Overall Study||17
237807|NCT00584987|572767|P2|STARTED|Overall Study||16
237808|NCT00584987|572768|P1|STARTED|Overall Study||15
237809|NCT00584948|572800|P2|NOT COMPLETED|Overall Study||11
237810|NCT00584948|572801|P1|NOT COMPLETED|Overall Study||13
237811|NCT00584948|572800|P2|COMPLETED|Overall Study||36
237812|NCT00584948|572801|P1|COMPLETED|Overall Study||34
237813|NCT00584948|572800|P2|STARTED|Overall Study||47
237814|NCT00584948|572801|P1|STARTED|Overall Study||47
237815|NCT00584935|572809|P1|NOT COMPLETED|Overall Study||0
237816|NCT00584935|572809|P1|COMPLETED|Overall Study||3
237817|NCT00584935|572809|P1|STARTED|Overall Study||3
237818|NCT00584909|572816|P1|NOT COMPLETED|Overall Study||4
237819|NCT00584909|572816|P1|COMPLETED|Overall Study||9
237820|NCT00584909|572816|P1|STARTED|Overall Study||13
237821|NCT00584857|572821|P1|NOT COMPLETED|Overall Study||0
237822|NCT00584857|572821|P1|COMPLETED|Overall Study||30
237823|NCT00584857|572821|P1|STARTED|Overall Study||30
237824|NCT00584844|572826|P1|NOT COMPLETED|Overall Study||79
237825|NCT00584844|572826|P1|COMPLETED|Overall Study||405
237826|NCT00584844|572826|P1|STARTED|Overall Study||484
237827|NCT00584831|572836|P19|NOT COMPLETED|Intervention 4||0
237828|NCT00584831|572837|P18|NOT COMPLETED|Intervention 4||0
237829|NCT00584831|572838|P17|NOT COMPLETED|Intervention 4||0
237830|NCT00584831|572839|P16|NOT COMPLETED|Intervention 4||0
237831|NCT00584831|572840|P15|NOT COMPLETED|Intervention 4||0
237832|NCT00584831|572841|P14|NOT COMPLETED|Intervention 4||0
237833|NCT00584831|572842|P13|NOT COMPLETED|Intervention 4||0
237834|NCT00584831|572843|P12|NOT COMPLETED|Intervention 4||0
237835|NCT00584831|572844|P11|NOT COMPLETED|Intervention 4||0
237836|NCT00584831|572845|P10|NOT COMPLETED|Intervention 4||0
237837|NCT00584831|572846|P9|NOT COMPLETED|Intervention 4||0
237838|NCT00584831|572847|P8|NOT COMPLETED|Intervention 4||0
237839|NCT00584831|572848|P7|NOT COMPLETED|Intervention 4||0
237840|NCT00584831|572849|P6|NOT COMPLETED|Intervention 4||0
237841|NCT00584831|572850|P5|NOT COMPLETED|Intervention 4||0
237842|NCT00584831|572851|P4|NOT COMPLETED|Intervention 4||0
237843|NCT00584831|572852|P3|NOT COMPLETED|Intervention 4||0
237844|NCT00584831|572853|P2|NOT COMPLETED|Intervention 4||0
237845|NCT00584831|572854|P1|NOT COMPLETED|Intervention 4||0
237846|NCT00584831|572836|P19|COMPLETED|Intervention 4||1
237847|NCT00584831|572837|P18|COMPLETED|Intervention 4||1
237848|NCT00584831|572838|P17|COMPLETED|Intervention 4||4
237849|NCT00584831|572839|P16|COMPLETED|Intervention 4||1
237850|NCT00584831|572840|P15|COMPLETED|Intervention 4||2
237851|NCT00584831|572841|P14|COMPLETED|Intervention 4||1
237852|NCT00584831|572842|P13|COMPLETED|Intervention 4||2
237853|NCT00584831|572843|P12|COMPLETED|Intervention 4||1
237854|NCT00584831|572844|P11|COMPLETED|Intervention 4||2
237855|NCT00584831|572845|P10|COMPLETED|Intervention 4||2
237856|NCT00584831|572846|P9|COMPLETED|Intervention 4||3
237857|NCT00584831|572847|P8|COMPLETED|Intervention 4||2
237858|NCT00584831|572848|P7|COMPLETED|Intervention 4||6
237859|NCT00584831|572849|P6|COMPLETED|Intervention 4||1
237860|NCT00584831|572850|P5|COMPLETED|Intervention 4||2
237861|NCT00584831|572851|P4|COMPLETED|Intervention 4||1
237862|NCT00584831|572852|P3|COMPLETED|Intervention 4||2
237863|NCT00584831|572853|P2|COMPLETED|Intervention 4||3
237864|NCT00584831|572854|P1|COMPLETED|Intervention 4||1
237865|NCT00584831|572836|P19|STARTED|Intervention 4||1
237866|NCT00584831|572837|P18|STARTED|Intervention 4||1
237867|NCT00584831|572838|P17|STARTED|Intervention 4||4
237868|NCT00584831|572839|P16|STARTED|Intervention 4||1
237869|NCT00584831|572840|P15|STARTED|Intervention 4||2
237870|NCT00584831|572841|P14|STARTED|Intervention 4||1
237871|NCT00584831|572842|P13|STARTED|Intervention 4||2
237872|NCT00584831|572843|P12|STARTED|Intervention 4||1
237873|NCT00584831|572844|P11|STARTED|Intervention 4||2
237874|NCT00584831|572845|P10|STARTED|Intervention 4||2
237875|NCT00584831|572846|P9|STARTED|Intervention 4||3
237876|NCT00584831|572847|P8|STARTED|Intervention 4||2
237877|NCT00584831|572848|P7|STARTED|Intervention 4||6
237878|NCT00584831|572849|P6|STARTED|Intervention 4||1
237879|NCT00584831|572850|P5|STARTED|Intervention 4||2
237880|NCT00584831|572851|P4|STARTED|Intervention 4||1
237881|NCT00584831|572852|P3|STARTED|Intervention 4||2
237882|NCT00584831|572853|P2|STARTED|Intervention 4||3
237883|NCT00584831|572854|P1|STARTED|Intervention 4||1
237884|NCT00584831|572836|P19|NOT COMPLETED|Intervention 3||0
237885|NCT00584831|572837|P18|NOT COMPLETED|Intervention 3||0
237886|NCT00584831|572838|P17|NOT COMPLETED|Intervention 3||0
237887|NCT00584831|572839|P16|NOT COMPLETED|Intervention 3||0
237888|NCT00584831|572840|P15|NOT COMPLETED|Intervention 3||0
237889|NCT00584831|572841|P14|NOT COMPLETED|Intervention 3||0
237890|NCT00584831|572842|P13|NOT COMPLETED|Intervention 3||0
237891|NCT00584831|572843|P12|NOT COMPLETED|Intervention 3||0
237892|NCT00584831|572844|P11|NOT COMPLETED|Intervention 3||0
237893|NCT00584831|572845|P10|NOT COMPLETED|Intervention 3||0
237894|NCT00584831|572846|P9|NOT COMPLETED|Intervention 3||0
237895|NCT00584831|572847|P8|NOT COMPLETED|Intervention 3||0
237896|NCT00584831|572848|P7|NOT COMPLETED|Intervention 3||0
237897|NCT00584831|572849|P6|NOT COMPLETED|Intervention 3||0
237898|NCT00584831|572850|P5|NOT COMPLETED|Intervention 3||0
237899|NCT00584831|572851|P4|NOT COMPLETED|Intervention 3||0
237900|NCT00584831|572852|P3|NOT COMPLETED|Intervention 3||0
237901|NCT00584831|572853|P2|NOT COMPLETED|Intervention 3||0
237902|NCT00584831|572854|P1|NOT COMPLETED|Intervention 3||0
237903|NCT00584831|572836|P19|COMPLETED|Intervention 3||1
237904|NCT00584831|572837|P18|COMPLETED|Intervention 3||1
237905|NCT00584831|572838|P17|COMPLETED|Intervention 3||4
237906|NCT00584831|572839|P16|COMPLETED|Intervention 3||1
237907|NCT00584831|572840|P15|COMPLETED|Intervention 3||3
237908|NCT00584831|572841|P14|COMPLETED|Intervention 3||1
237909|NCT00584831|572842|P13|COMPLETED|Intervention 3||2
237910|NCT00584831|572843|P12|COMPLETED|Intervention 3||1
237911|NCT00584831|572844|P11|COMPLETED|Intervention 3||2
237912|NCT00584831|572845|P10|COMPLETED|Intervention 3||2
237913|NCT00584831|572846|P9|COMPLETED|Intervention 3||4
237914|NCT00584831|572847|P8|COMPLETED|Intervention 3||2
237915|NCT00584831|572848|P7|COMPLETED|Intervention 3||6
237916|NCT00584831|572849|P6|COMPLETED|Intervention 3||1
237917|NCT00584831|572850|P5|COMPLETED|Intervention 3||2
237918|NCT00584831|572851|P4|COMPLETED|Intervention 3||1
237919|NCT00584831|572852|P3|COMPLETED|Intervention 3||2
237920|NCT00584831|572853|P2|COMPLETED|Intervention 3||3
237921|NCT00584831|572854|P1|COMPLETED|Intervention 3||1
237922|NCT00584831|572836|P19|STARTED|Intervention 3||1
237923|NCT00584831|572837|P18|STARTED|Intervention 3||1
237924|NCT00584831|572838|P17|STARTED|Intervention 3||4
237925|NCT00584831|572839|P16|STARTED|Intervention 3||1
237926|NCT00584831|572840|P15|STARTED|Intervention 3||3
237927|NCT00584831|572841|P14|STARTED|Intervention 3||1
237928|NCT00584831|572842|P13|STARTED|Intervention 3||2
237929|NCT00584831|572843|P12|STARTED|Intervention 3||1
237930|NCT00584831|572844|P11|STARTED|Intervention 3||2
237931|NCT00584831|572845|P10|STARTED|Intervention 3||2
237932|NCT00584831|572846|P9|STARTED|Intervention 3||4
237933|NCT00584831|572847|P8|STARTED|Intervention 3||2
237934|NCT00584831|572848|P7|STARTED|Intervention 3||6
237935|NCT00584831|572849|P6|STARTED|Intervention 3||1
237936|NCT00584831|572850|P5|STARTED|Intervention 3||2
237937|NCT00584831|572851|P4|STARTED|Intervention 3||1
237938|NCT00584831|572852|P3|STARTED|Intervention 3||2
237939|NCT00584831|572853|P2|STARTED|Intervention 3||3
237940|NCT00584831|572854|P1|STARTED|Intervention 3||1
237941|NCT00584831|572836|P19|NOT COMPLETED|Intervention 2||0
237942|NCT00584831|572837|P18|NOT COMPLETED|Intervention 2||0
237943|NCT00584831|572838|P17|NOT COMPLETED|Intervention 2||0
237944|NCT00584831|572839|P16|NOT COMPLETED|Intervention 2||0
237945|NCT00584831|572840|P15|NOT COMPLETED|Intervention 2||0
237946|NCT00584831|572841|P14|NOT COMPLETED|Intervention 2||0
237947|NCT00584831|572842|P13|NOT COMPLETED|Intervention 2||0
237948|NCT00584831|572843|P12|NOT COMPLETED|Intervention 2||0
237949|NCT00584831|572844|P11|NOT COMPLETED|Intervention 2||0
237950|NCT00584831|572845|P10|NOT COMPLETED|Intervention 2||0
237951|NCT00584831|572846|P9|NOT COMPLETED|Intervention 2||0
237952|NCT00584831|572847|P8|NOT COMPLETED|Intervention 2||0
237953|NCT00584831|572848|P7|NOT COMPLETED|Intervention 2||0
237954|NCT00584831|572849|P6|NOT COMPLETED|Intervention 2||0
237955|NCT00584831|572850|P5|NOT COMPLETED|Intervention 2||0
237956|NCT00584831|572851|P4|NOT COMPLETED|Intervention 2||0
237957|NCT00584831|572852|P3|NOT COMPLETED|Intervention 2||0
237958|NCT00584831|572853|P2|NOT COMPLETED|Intervention 2||0
237959|NCT00584831|572854|P1|NOT COMPLETED|Intervention 2||0
237960|NCT00584831|572836|P19|COMPLETED|Intervention 2||1
237961|NCT00584831|572837|P18|COMPLETED|Intervention 2||1
237962|NCT00584831|572838|P17|COMPLETED|Intervention 2||4
237963|NCT00584831|572839|P16|COMPLETED|Intervention 2||1
237964|NCT00584831|572840|P15|COMPLETED|Intervention 2||3
237965|NCT00584831|572841|P14|COMPLETED|Intervention 2||1
237966|NCT00584831|572842|P13|COMPLETED|Intervention 2||2
237967|NCT00584831|572843|P12|COMPLETED|Intervention 2||1
237968|NCT00584831|572844|P11|COMPLETED|Intervention 2||2
237969|NCT00584831|572845|P10|COMPLETED|Intervention 2||2
237970|NCT00584831|572846|P9|COMPLETED|Intervention 2||4
237971|NCT00584831|572847|P8|COMPLETED|Intervention 2||2
237972|NCT00584831|572848|P7|COMPLETED|Intervention 2||6
237973|NCT00584831|572849|P6|COMPLETED|Intervention 2||1
237974|NCT00584831|572850|P5|COMPLETED|Intervention 2||2
237975|NCT00584831|572851|P4|COMPLETED|Intervention 2||1
237976|NCT00584831|572852|P3|COMPLETED|Intervention 2||2
237977|NCT00584831|572853|P2|COMPLETED|Intervention 2||3
237978|NCT00584831|572854|P1|COMPLETED|Intervention 2||1
237979|NCT00584831|572836|P19|STARTED|Intervention 2||1
237980|NCT00584831|572837|P18|STARTED|Intervention 2||1
237981|NCT00584831|572838|P17|STARTED|Intervention 2||4
237982|NCT00584831|572839|P16|STARTED|Intervention 2||1
237983|NCT00584831|572840|P15|STARTED|Intervention 2||3
237984|NCT00584831|572841|P14|STARTED|Intervention 2||1
237985|NCT00584831|572842|P13|STARTED|Intervention 2||2
237986|NCT00584831|572843|P12|STARTED|Intervention 2||1
237987|NCT00584831|572844|P11|STARTED|Intervention 2||2
237988|NCT00584831|572845|P10|STARTED|Intervention 2||2
237989|NCT00584831|572846|P9|STARTED|Intervention 2||4
237990|NCT00584831|572847|P8|STARTED|Intervention 2||2
237991|NCT00584831|572848|P7|STARTED|Intervention 2||6
237992|NCT00584831|572849|P6|STARTED|Intervention 2||1
237993|NCT00584831|572850|P5|STARTED|Intervention 2||2
237994|NCT00584831|572851|P4|STARTED|Intervention 2||1
237995|NCT00584831|572852|P3|STARTED|Intervention 2||2
237996|NCT00584831|572853|P2|STARTED|Intervention 2||3
237997|NCT00584831|572854|P1|STARTED|Intervention 2||1
237998|NCT00584831|572836|P19|NOT COMPLETED|Intervention 1||0
237999|NCT00584831|572837|P18|NOT COMPLETED|Intervention 1||0
238000|NCT00584831|572838|P17|NOT COMPLETED|Intervention 1||0
238001|NCT00584831|572839|P16|NOT COMPLETED|Intervention 1||0
238002|NCT00584831|572840|P15|NOT COMPLETED|Intervention 1||0
238003|NCT00584831|572841|P14|NOT COMPLETED|Intervention 1||0
238004|NCT00584831|572842|P13|NOT COMPLETED|Intervention 1||0
238005|NCT00584831|572843|P12|NOT COMPLETED|Intervention 1||0
238006|NCT00584831|572844|P11|NOT COMPLETED|Intervention 1||0
238007|NCT00584831|572845|P10|NOT COMPLETED|Intervention 1||0
238008|NCT00584831|572846|P9|NOT COMPLETED|Intervention 1||0
238009|NCT00584831|572847|P8|NOT COMPLETED|Intervention 1||0
238010|NCT00584831|572848|P7|NOT COMPLETED|Intervention 1||0
238011|NCT00584831|572849|P6|NOT COMPLETED|Intervention 1||0
238012|NCT00584831|572850|P5|NOT COMPLETED|Intervention 1||0
238013|NCT00584831|572851|P4|NOT COMPLETED|Intervention 1||0
238014|NCT00584831|572852|P3|NOT COMPLETED|Intervention 1||0
238015|NCT00584831|572853|P2|NOT COMPLETED|Intervention 1||0
238016|NCT00584831|572854|P1|NOT COMPLETED|Intervention 1||0
238017|NCT00584831|572836|P19|COMPLETED|Intervention 1||1
238018|NCT00584831|572837|P18|COMPLETED|Intervention 1||1
238019|NCT00584831|572838|P17|COMPLETED|Intervention 1||4
238020|NCT00584831|572839|P16|COMPLETED|Intervention 1||1
238021|NCT00584831|572840|P15|COMPLETED|Intervention 1||3
238022|NCT00584831|572841|P14|COMPLETED|Intervention 1||1
238023|NCT00584831|572842|P13|COMPLETED|Intervention 1||2
238024|NCT00584831|572843|P12|COMPLETED|Intervention 1||1
238025|NCT00584831|572844|P11|COMPLETED|Intervention 1||2
238026|NCT00584831|572845|P10|COMPLETED|Intervention 1||2
238027|NCT00584831|572846|P9|COMPLETED|Intervention 1||4
238028|NCT00584831|572847|P8|COMPLETED|Intervention 1||2
238029|NCT00584831|572848|P7|COMPLETED|Intervention 1||6
238030|NCT00584831|572849|P6|COMPLETED|Intervention 1||1
238031|NCT00584831|572850|P5|COMPLETED|Intervention 1||2
238032|NCT00584831|572851|P4|COMPLETED|Intervention 1||1
238033|NCT00584831|572852|P3|COMPLETED|Intervention 1||2
238034|NCT00584831|572853|P2|COMPLETED|Intervention 1||3
238035|NCT00584831|572854|P1|COMPLETED|Intervention 1||1
238036|NCT00584831|572836|P19|STARTED|Intervention 1||1
238037|NCT00584831|572837|P18|STARTED|Intervention 1||1
238038|NCT00584831|572838|P17|STARTED|Intervention 1||4
238039|NCT00584831|572839|P16|STARTED|Intervention 1||1
238040|NCT00584831|572840|P15|STARTED|Intervention 1||3
238041|NCT00584831|572841|P14|STARTED|Intervention 1||1
238042|NCT00584831|572842|P13|STARTED|Intervention 1||2
238043|NCT00584831|572843|P12|STARTED|Intervention 1||1
238044|NCT00584831|572844|P11|STARTED|Intervention 1||2
238045|NCT00584831|572845|P10|STARTED|Intervention 1||2
238046|NCT00584831|572846|P9|STARTED|Intervention 1||4
238047|NCT00584831|572847|P8|STARTED|Intervention 1||2
238048|NCT00584831|572848|P7|STARTED|Intervention 1||6
238049|NCT00584831|572849|P6|STARTED|Intervention 1||1
238050|NCT00584831|572850|P5|STARTED|Intervention 1||2
238051|NCT00584831|572851|P4|STARTED|Intervention 1||1
238052|NCT00584831|572852|P3|STARTED|Intervention 1||2
238053|NCT00584831|572853|P2|STARTED|Intervention 1||3
238054|NCT00584831|572854|P1|STARTED|Intervention 1||1
238055|NCT00584740|572878|P2|NOT COMPLETED|Overall Study||6
238056|NCT00584740|572879|P1|NOT COMPLETED|Overall Study||12
238057|NCT00584740|572878|P2|COMPLETED|Overall Study||14
238058|NCT00584740|572879|P1|COMPLETED|Overall Study||27
238059|NCT00584740|572878|P2|STARTED|Overall Study||20
238060|NCT00584740|572879|P1|STARTED|Overall Study||39
238061|NCT00584727|572897|P6|NOT COMPLETED|Third Intervention||2
238062|NCT00584727|572898|P5|NOT COMPLETED|Third Intervention||4
238063|NCT00584727|572899|P4|NOT COMPLETED|Third Intervention||0
238064|NCT00584727|572900|P3|NOT COMPLETED|Third Intervention||1
238065|NCT00584727|572901|P2|NOT COMPLETED|Third Intervention||0
238066|NCT00584727|572902|P1|NOT COMPLETED|Third Intervention||0
238067|NCT00584727|572897|P6|COMPLETED|Third Intervention||14
238068|NCT00584727|572898|P5|COMPLETED|Third Intervention||12
238069|NCT00584727|572899|P4|COMPLETED|Third Intervention||14
238070|NCT00584727|572900|P3|COMPLETED|Third Intervention||14
238071|NCT00584727|572901|P2|COMPLETED|Third Intervention||17
238072|NCT00584727|572902|P1|COMPLETED|Third Intervention||17
238073|NCT00584727|572897|P6|STARTED|Third Intervention||16
238074|NCT00584727|572898|P5|STARTED|Third Intervention||16
238075|NCT00584727|572899|P4|STARTED|Third Intervention||14
238076|NCT00584727|572900|P3|STARTED|Third Intervention||15
238077|NCT00584727|572901|P2|STARTED|Third Intervention||17
238078|NCT00584727|572902|P1|STARTED|Third Intervention||17
238079|NCT00584727|572897|P6|NOT COMPLETED|Second Intervention||0
238080|NCT00584727|572898|P5|NOT COMPLETED|Second Intervention||0
238081|NCT00584727|572899|P4|NOT COMPLETED|Second Intervention||0
238082|NCT00584727|572900|P3|NOT COMPLETED|Second Intervention||0
238083|NCT00584727|572901|P2|NOT COMPLETED|Second Intervention||0
238084|NCT00584727|572902|P1|NOT COMPLETED|Second Intervention||0
238085|NCT00584727|572897|P6|COMPLETED|Second Intervention||16
238086|NCT00584727|572898|P5|COMPLETED|Second Intervention||16
238087|NCT00584727|572899|P4|COMPLETED|Second Intervention||14
238088|NCT00584727|572900|P3|COMPLETED|Second Intervention||15
238089|NCT00584727|572901|P2|COMPLETED|Second Intervention||17
238090|NCT00584727|572902|P1|COMPLETED|Second Intervention||17
238091|NCT00584727|572897|P6|STARTED|Second Intervention||16
238092|NCT00584727|572898|P5|STARTED|Second Intervention||16
238093|NCT00584727|572899|P4|STARTED|Second Intervention||14
238094|NCT00584727|572900|P3|STARTED|Second Intervention||15
238095|NCT00584727|572901|P2|STARTED|Second Intervention||17
238096|NCT00584727|572902|P1|STARTED|Second Intervention||17
238097|NCT00584727|572897|P6|NOT COMPLETED|First Intervention||0
238098|NCT00584727|572898|P5|NOT COMPLETED|First Intervention||0
238099|NCT00584727|572899|P4|NOT COMPLETED|First Intervention||0
238100|NCT00584727|572900|P3|NOT COMPLETED|First Intervention||1
238101|NCT00584727|572901|P2|NOT COMPLETED|First Intervention||0
238102|NCT00584727|572902|P1|NOT COMPLETED|First Intervention||0
238103|NCT00584727|572897|P6|COMPLETED|First Intervention||16
238104|NCT00584727|572898|P5|COMPLETED|First Intervention||16
238105|NCT00584727|572899|P4|COMPLETED|First Intervention||14
238106|NCT00584727|572900|P3|COMPLETED|First Intervention||15
238107|NCT00584727|572901|P2|COMPLETED|First Intervention||17
238108|NCT00584727|572902|P1|COMPLETED|First Intervention||17
238109|NCT00584727|572897|P6|STARTED|First Intervention||16
238110|NCT00584727|572898|P5|STARTED|First Intervention||16
238111|NCT00584727|572899|P4|STARTED|First Intervention||14
238112|NCT00584727|572900|P3|STARTED|First Intervention||16
238113|NCT00584727|572901|P2|STARTED|First Intervention||17
238114|NCT00584727|572902|P1|STARTED|First Intervention||17
238115|NCT00584701|572926|P1|NOT COMPLETED|Follow-up||12
238116|NCT00584701|572926|P1|COMPLETED|Follow-up||34
238117|NCT00584701|572926|P1|STARTED|Follow-up||46
238118|NCT00584701|572926|P1|NOT COMPLETED|Active Risperidone||3
238119|NCT00584701|572926|P1|COMPLETED|Active Risperidone||46
238120|NCT00584701|572926|P1|STARTED|Active Risperidone||49
238121|NCT00584558|572931|P1|NOT COMPLETED|Overall Study||0
238122|NCT00584558|572931|P1|COMPLETED|Overall Study||2420
238123|NCT00584558|572931|P1|STARTED|Overall Study||2420
238124|NCT00584480|572936|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
238125|NCT00584480|572936|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
238126|NCT00584480|572936|P1|STARTED|Second 8 Weeks (40 Treatments)||10
238127|NCT00584480|572936|P1|NOT COMPLETED|4-Week Break From Treatment||0
238128|NCT00584480|572936|P1|COMPLETED|4-Week Break From Treatment||10
238129|NCT00584480|572936|P1|STARTED|4-Week Break From Treatment||10
238130|NCT00584480|572936|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
238131|NCT00584480|572936|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
238132|NCT00584480|572936|P1|STARTED|First 8 Weeks (40 Treatments)||10
238133|NCT00584454|572940|P1|NOT COMPLETED|Overall Study||4
238134|NCT00584454|572940|P1|COMPLETED|Overall Study||6
238135|NCT00584454|572940|P1|STARTED|Overall Study||10
238136|NCT00584415|572944|P1|NOT COMPLETED|Overall Study||7
238137|NCT00584415|572944|P1|COMPLETED|Overall Study||112
238138|NCT00584415|572944|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
238139|NCT00584402|572949|P1|NOT COMPLETED|Overall Study||0
238140|NCT00584402|572949|P1|COMPLETED|Overall Study||8
238141|NCT00584402|572949|P1|STARTED|Overall Study||8
238142|NCT00584220|572954|P2|NOT COMPLETED|Second Period||0
238143|NCT00584220|572955|P1|NOT COMPLETED|Second Period||0
238144|NCT00584220|572954|P2|COMPLETED|Second Period||39
238145|NCT00584220|572955|P1|COMPLETED|Second Period||48
238146|NCT00584220|572954|P2|STARTED|Second Period||39
238147|NCT00584220|572955|P1|STARTED|Second Period||48
238148|NCT00584220|572954|P2|NOT COMPLETED|First Period||0
238149|NCT00584220|572955|P1|NOT COMPLETED|First Period||0
238150|NCT00584220|572954|P2|COMPLETED|First Period||39
238151|NCT00584220|572955|P1|COMPLETED|First Period||48
238152|NCT00584220|572954|P2|STARTED|First Period||39
238153|NCT00584220|572955|P1|STARTED|First Period||48
238154|NCT00584194|572963|P1|NOT COMPLETED|Overall Study||135
238155|NCT00584194|572963|P1|COMPLETED|Overall Study||143
238156|NCT00584194|572963|P1|STARTED|Overall Study||278
238157|NCT00584077|572971|P1|NOT COMPLETED|Overall Study||0
238158|NCT00584077|572971|P1|COMPLETED|Overall Study||15
238159|NCT00584077|572971|P1|STARTED|Overall Study||15
238160|NCT00583947|572977|P2|NOT COMPLETED|Open Label Period||0
238161|NCT00583947|572978|P1|NOT COMPLETED|Open Label Period||0
238162|NCT00583947|572977|P2|COMPLETED|Open Label Period||24
238163|NCT00583947|572978|P1|COMPLETED|Open Label Period||22
238164|NCT00583947|572977|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
238165|NCT00583947|572978|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
238166|NCT00583947|572977|P2|NOT COMPLETED|Washout||0
238167|NCT00583947|572978|P1|NOT COMPLETED|Washout||0
238168|NCT00583947|572977|P2|COMPLETED|Washout||24
238169|NCT00583947|572978|P1|COMPLETED|Washout||22
238170|NCT00583947|572977|P2|STARTED|Washout||24
238171|NCT00583947|572978|P1|STARTED|Washout||22
238172|NCT00583947|572977|P2|NOT COMPLETED|Cross-over Period||2
238173|NCT00583947|572978|P1|NOT COMPLETED|Cross-over Period||5
238174|NCT00583947|572977|P2|COMPLETED|Cross-over Period||24
238175|NCT00583947|572978|P1|COMPLETED|Cross-over Period||22
238176|NCT00583947|572977|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
238177|NCT00583947|572978|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
238178|NCT00583908|573028|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
238179|NCT00583908|573029|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
238180|NCT00583908|573030|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
238181|NCT00583908|573031|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
238182|NCT00583908|573032|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
238183|NCT00583908|573033|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
238184|NCT00583908|573034|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
238185|NCT00583908|573035|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
238186|NCT00583908|573036|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
238187|NCT00583908|573037|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
238188|NCT00583908|573038|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
238189|NCT00583908|573039|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
238190|NCT00583908|573028|P12|COMPLETED|Period 4 - Fourth Intervention||1
238191|NCT00583908|573029|P11|COMPLETED|Period 4 - Fourth Intervention||1
238192|NCT00583908|573030|P10|COMPLETED|Period 4 - Fourth Intervention||1
238193|NCT00583908|573031|P9|COMPLETED|Period 4 - Fourth Intervention||1
238194|NCT00583908|573032|P8|COMPLETED|Period 4 - Fourth Intervention||1
238195|NCT00583908|573033|P7|COMPLETED|Period 4 - Fourth Intervention||1
238196|NCT00583908|573034|P6|COMPLETED|Period 4 - Fourth Intervention||1
238197|NCT00583908|573035|P5|COMPLETED|Period 4 - Fourth Intervention||2
238198|NCT00583908|573036|P4|COMPLETED|Period 4 - Fourth Intervention||1
238199|NCT00583908|573037|P3|COMPLETED|Period 4 - Fourth Intervention||1
238200|NCT00583908|573038|P2|COMPLETED|Period 4 - Fourth Intervention||2
238201|NCT00583908|573039|P1|COMPLETED|Period 4 - Fourth Intervention||1
238202|NCT00583908|573028|P12|STARTED|Period 4 - Fourth Intervention||1
238203|NCT00583908|573029|P11|STARTED|Period 4 - Fourth Intervention||1
238204|NCT00583908|573030|P10|STARTED|Period 4 - Fourth Intervention||1
238205|NCT00583908|573031|P9|STARTED|Period 4 - Fourth Intervention||1
238206|NCT00583908|573032|P8|STARTED|Period 4 - Fourth Intervention||1
238207|NCT00583908|573033|P7|STARTED|Period 4 - Fourth Intervention||1
238208|NCT00583908|573034|P6|STARTED|Period 4 - Fourth Intervention||1
238209|NCT00583908|573035|P5|STARTED|Period 4 - Fourth Intervention||2
238210|NCT00583908|573036|P4|STARTED|Period 4 - Fourth Intervention||1
238211|NCT00583908|573037|P3|STARTED|Period 4 - Fourth Intervention||1
238212|NCT00583908|573038|P2|STARTED|Period 4 - Fourth Intervention||2
238213|NCT00583908|573039|P1|STARTED|Period 4 - Fourth Intervention||1
238214|NCT00583908|573028|P12|NOT COMPLETED|Period 3 - Third Intervention||0
238215|NCT00583908|573029|P11|NOT COMPLETED|Period 3 - Third Intervention||0
238216|NCT00583908|573030|P10|NOT COMPLETED|Period 3 - Third Intervention||0
238217|NCT00583908|573031|P9|NOT COMPLETED|Period 3 - Third Intervention||0
238218|NCT00583908|573032|P8|NOT COMPLETED|Period 3 - Third Intervention||0
238219|NCT00583908|573033|P7|NOT COMPLETED|Period 3 - Third Intervention||0
238220|NCT00583908|573034|P6|NOT COMPLETED|Period 3 - Third Intervention||0
238221|NCT00583908|573035|P5|NOT COMPLETED|Period 3 - Third Intervention||0
238222|NCT00583908|573036|P4|NOT COMPLETED|Period 3 - Third Intervention||0
238223|NCT00583908|573037|P3|NOT COMPLETED|Period 3 - Third Intervention||0
238224|NCT00583908|573038|P2|NOT COMPLETED|Period 3 - Third Intervention||0
238225|NCT00583908|573039|P1|NOT COMPLETED|Period 3 - Third Intervention||0
238226|NCT00583908|573028|P12|COMPLETED|Period 3 - Third Intervention||1
238227|NCT00583908|573029|P11|COMPLETED|Period 3 - Third Intervention||1
238228|NCT00583908|573030|P10|COMPLETED|Period 3 - Third Intervention||1
238229|NCT00583908|573031|P9|COMPLETED|Period 3 - Third Intervention||1
238230|NCT00583908|573032|P8|COMPLETED|Period 3 - Third Intervention||1
238231|NCT00583908|573033|P7|COMPLETED|Period 3 - Third Intervention||1
238232|NCT00583908|573034|P6|COMPLETED|Period 3 - Third Intervention||1
238233|NCT00583908|573035|P5|COMPLETED|Period 3 - Third Intervention||2
238234|NCT00583908|573036|P4|COMPLETED|Period 3 - Third Intervention||1
238235|NCT00583908|573037|P3|COMPLETED|Period 3 - Third Intervention||1
238236|NCT00583908|573038|P2|COMPLETED|Period 3 - Third Intervention||2
238237|NCT00583908|573039|P1|COMPLETED|Period 3 - Third Intervention||1
238238|NCT00583908|573028|P12|STARTED|Period 3 - Third Intervention||1
238239|NCT00583908|573029|P11|STARTED|Period 3 - Third Intervention||1
238240|NCT00583908|573030|P10|STARTED|Period 3 - Third Intervention||1
238241|NCT00583908|573031|P9|STARTED|Period 3 - Third Intervention||1
238242|NCT00583908|573032|P8|STARTED|Period 3 - Third Intervention||1
238243|NCT00583908|573033|P7|STARTED|Period 3 - Third Intervention||1
238244|NCT00583908|573034|P6|STARTED|Period 3 - Third Intervention||1
238245|NCT00583908|573035|P5|STARTED|Period 3 - Third Intervention||2
238246|NCT00583908|573036|P4|STARTED|Period 3 - Third Intervention||1
238247|NCT00583908|573037|P3|STARTED|Period 3 - Third Intervention||1
238248|NCT00583908|573038|P2|STARTED|Period 3 - Third Intervention||2
238249|NCT00583908|573039|P1|STARTED|Period 3 - Third Intervention||1
238250|NCT00583908|573028|P12|NOT COMPLETED|Period 2 - Second Intervention||0
238251|NCT00583908|573029|P11|NOT COMPLETED|Period 2 - Second Intervention||0
238252|NCT00583908|573030|P10|NOT COMPLETED|Period 2 - Second Intervention||0
238253|NCT00583908|573031|P9|NOT COMPLETED|Period 2 - Second Intervention||0
238254|NCT00583908|573032|P8|NOT COMPLETED|Period 2 - Second Intervention||0
238255|NCT00583908|573033|P7|NOT COMPLETED|Period 2 - Second Intervention||0
238256|NCT00583908|573034|P6|NOT COMPLETED|Period 2 - Second Intervention||0
238257|NCT00583908|573035|P5|NOT COMPLETED|Period 2 - Second Intervention||0
238258|NCT00583908|573036|P4|NOT COMPLETED|Period 2 - Second Intervention||0
238259|NCT00583908|573037|P3|NOT COMPLETED|Period 2 - Second Intervention||0
238260|NCT00583908|573038|P2|NOT COMPLETED|Period 2 - Second Intervention||0
238261|NCT00583908|573039|P1|NOT COMPLETED|Period 2 - Second Intervention||0
238262|NCT00583908|573028|P12|COMPLETED|Period 2 - Second Intervention||1
238263|NCT00583908|573029|P11|COMPLETED|Period 2 - Second Intervention||1
238264|NCT00583908|573030|P10|COMPLETED|Period 2 - Second Intervention||1
238265|NCT00583908|573031|P9|COMPLETED|Period 2 - Second Intervention||1
238266|NCT00583908|573032|P8|COMPLETED|Period 2 - Second Intervention||1
238267|NCT00583908|573033|P7|COMPLETED|Period 2 - Second Intervention||1
238268|NCT00583908|573034|P6|COMPLETED|Period 2 - Second Intervention||1
238269|NCT00583908|573035|P5|COMPLETED|Period 2 - Second Intervention||2
238270|NCT00583908|573036|P4|COMPLETED|Period 2 - Second Intervention||1
238271|NCT00583908|573037|P3|COMPLETED|Period 2 - Second Intervention||1
238272|NCT00583908|573038|P2|COMPLETED|Period 2 - Second Intervention||2
238273|NCT00583908|573039|P1|COMPLETED|Period 2 - Second Intervention||1
238274|NCT00583908|573028|P12|STARTED|Period 2 - Second Intervention||1
238275|NCT00583908|573029|P11|STARTED|Period 2 - Second Intervention||1
238276|NCT00583908|573030|P10|STARTED|Period 2 - Second Intervention||1
238277|NCT00583908|573031|P9|STARTED|Period 2 - Second Intervention||1
238278|NCT00583908|573032|P8|STARTED|Period 2 - Second Intervention||1
238279|NCT00583908|573033|P7|STARTED|Period 2 - Second Intervention||1
238280|NCT00583908|573034|P6|STARTED|Period 2 - Second Intervention||1
238281|NCT00583908|573035|P5|STARTED|Period 2 - Second Intervention||2
238282|NCT00583908|573036|P4|STARTED|Period 2 - Second Intervention||1
238283|NCT00583908|573037|P3|STARTED|Period 2 - Second Intervention||1
238284|NCT00583908|573038|P2|STARTED|Period 2 - Second Intervention||2
238285|NCT00583908|573039|P1|STARTED|Period 2 - Second Intervention||1
238286|NCT00583908|573028|P12|NOT COMPLETED|Period 1 - First Intervention||0
238287|NCT00583908|573029|P11|NOT COMPLETED|Period 1 - First Intervention||0
238288|NCT00583908|573030|P10|NOT COMPLETED|Period 1 - First Intervention||0
238289|NCT00583908|573031|P9|NOT COMPLETED|Period 1 - First Intervention||0
238290|NCT00583908|573032|P8|NOT COMPLETED|Period 1 - First Intervention||0
238291|NCT00583908|573033|P7|NOT COMPLETED|Period 1 - First Intervention||0
238292|NCT00583908|573034|P6|NOT COMPLETED|Period 1 - First Intervention||0
238293|NCT00583908|573035|P5|NOT COMPLETED|Period 1 - First Intervention||0
238294|NCT00583908|573036|P4|NOT COMPLETED|Period 1 - First Intervention||0
238295|NCT00583908|573037|P3|NOT COMPLETED|Period 1 - First Intervention||0
238296|NCT00583908|573038|P2|NOT COMPLETED|Period 1 - First Intervention||0
238297|NCT00583908|573039|P1|NOT COMPLETED|Period 1 - First Intervention||0
238298|NCT00583908|573028|P12|COMPLETED|Period 1 - First Intervention||1
238299|NCT00583908|573029|P11|COMPLETED|Period 1 - First Intervention||1
238300|NCT00583908|573030|P10|COMPLETED|Period 1 - First Intervention||1
238301|NCT00583908|573031|P9|COMPLETED|Period 1 - First Intervention||1
238302|NCT00583908|573032|P8|COMPLETED|Period 1 - First Intervention||1
238303|NCT00583908|573033|P7|COMPLETED|Period 1 - First Intervention||1
238304|NCT00583908|573034|P6|COMPLETED|Period 1 - First Intervention||1
238305|NCT00583908|573035|P5|COMPLETED|Period 1 - First Intervention||2
238306|NCT00583908|573036|P4|COMPLETED|Period 1 - First Intervention||1
238307|NCT00583908|573037|P3|COMPLETED|Period 1 - First Intervention||1
238308|NCT00583908|573038|P2|COMPLETED|Period 1 - First Intervention||2
238309|NCT00583908|573039|P1|COMPLETED|Period 1 - First Intervention||1
238310|NCT00583908|573028|P12|STARTED|Period 1 - First Intervention||1
238311|NCT00583908|573029|P11|STARTED|Period 1 - First Intervention||1
238312|NCT00583908|573030|P10|STARTED|Period 1 - First Intervention||1
238313|NCT00583908|573031|P9|STARTED|Period 1 - First Intervention||1
238314|NCT00583908|573032|P8|STARTED|Period 1 - First Intervention||1
238315|NCT00583908|573033|P7|STARTED|Period 1 - First Intervention||1
238316|NCT00583908|573034|P6|STARTED|Period 1 - First Intervention||1
238317|NCT00583908|573035|P5|STARTED|Period 1 - First Intervention||2
238318|NCT00583908|573036|P4|STARTED|Period 1 - First Intervention||1
238319|NCT00583908|573037|P3|STARTED|Period 1 - First Intervention||1
238320|NCT00583908|573038|P2|STARTED|Period 1 - First Intervention||2
238321|NCT00583908|573039|P1|STARTED|Period 1 - First Intervention||1
238322|NCT00583713|573096|P3|NOT COMPLETED|Overall Study||0
238323|NCT00583713|573097|P2|NOT COMPLETED|Overall Study||0
238324|NCT00583713|573098|P1|NOT COMPLETED|Overall Study||0
238325|NCT00583713|573096|P3|COMPLETED|Overall Study||6
238326|NCT00583713|573097|P2|COMPLETED|Overall Study||6
238327|NCT00583713|573098|P1|COMPLETED|Overall Study||6
238328|NCT00583713|573096|P3|STARTED|Overall Study||6
238329|NCT00583713|573097|P2|STARTED|Overall Study||6
238330|NCT00583713|573098|P1|STARTED|Overall Study||6
238331|NCT00583700|573123|P2|NOT COMPLETED|Overall Study||4
238332|NCT00583700|573124|P1|NOT COMPLETED|Overall Study||3
238333|NCT00583700|573123|P2|COMPLETED|Overall Study||23
238334|NCT00583700|573124|P1|COMPLETED|Overall Study||24
238335|NCT00583700|573123|P2|STARTED|Overall Study||27
238336|NCT00583700|573124|P1|STARTED|Overall Study||27
238337|NCT00583661|573132|P1|NOT COMPLETED|Overall Study||0
238338|NCT00583661|573132|P1|COMPLETED|Overall Study||48
238339|NCT00583661|573132|P1|STARTED|Overall Study||48
238340|NCT00583622|573139|P1|NOT COMPLETED|Overall Study||0
238341|NCT00583622|573139|P1|COMPLETED|Overall Study||12
238342|NCT00583622|573139|P1|STARTED|Overall Study||12
238343|NCT00583596|573144|P1|NOT COMPLETED|Overall Study||284
238344|NCT00583596|573144|P1|COMPLETED|Overall Study||152
238345|NCT00583596|573144|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
238346|NCT00583557|573149|P1|NOT COMPLETED|Overall Study||70
238347|NCT00583557|573149|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
238348|NCT00583557|573149|P1|Received at Least 1 Dose Belimumab|Overall Study||153
238349|NCT00583557|573149|P1|STARTED|Overall Study||155
238350|NCT00583492|573155|P2|NOT COMPLETED|Overall Study||0
238351|NCT00583492|573156|P1|NOT COMPLETED|Overall Study||0
238352|NCT00583492|573155|P2|COMPLETED|Overall Study||23
238353|NCT00583492|573156|P1|COMPLETED|Overall Study||21
238354|NCT00583492|573155|P2|STARTED|Overall Study||23
238355|NCT00583492|573156|P1|STARTED|Overall Study||21
238356|NCT00583466|573172|P1|NOT COMPLETED|Overall Study||0
238357|NCT00583466|573172|P1|COMPLETED|Overall Study||18
238358|NCT00583466|573172|P1|STARTED|Overall Study||18
238359|NCT00583453|573180|P2|NOT COMPLETED|Overall Study||2
238360|NCT00583453|573181|P1|NOT COMPLETED|Overall Study||0
238361|NCT00583453|573180|P2|COMPLETED|Overall Study||6
238362|NCT00583453|573181|P1|COMPLETED|Overall Study||9
238363|NCT00583453|573180|P2|STARTED|Overall Study||8
238364|NCT00583453|573181|P1|STARTED|Overall Study||9
238365|NCT00583375|573197|P2|NOT COMPLETED|Overall Study||0
238366|NCT00583375|573198|P1|NOT COMPLETED|Overall Study||0
238367|NCT00583375|573197|P2|COMPLETED|Overall Study||272
238368|NCT00583375|573198|P1|COMPLETED|Overall Study||142
238369|NCT00583375|573197|P2|STARTED|Overall Study||272
238370|NCT00583375|573198|P1|STARTED|Overall Study||142
238371|NCT00583362|573214|P1|NOT COMPLETED|Overall Study||202
238372|NCT00583362|573214|P1|COMPLETED|Overall Study||96
238373|NCT00583362|573214|P1|STARTED|Overall Study||298
238374|NCT00583219|573238|P1|NOT COMPLETED|Phase 2||1
238375|NCT00583219|573238|P1|COMPLETED|Phase 2||21
238376|NCT00583219|573238|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
238377|NCT00583219|573238|P1|NOT COMPLETED|Phase 1||0
238378|NCT00583219|573238|P1|COMPLETED|Phase 1||9
238379|NCT00583219|573238|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
238380|NCT00583115|573255|P1|NOT COMPLETED|Overall Study||1
238381|NCT00583115|573255|P1|COMPLETED|Overall Study||0
238382|NCT00583115|573255|P1|STARTED|Overall Study||1
238383|NCT00583102|573260|P1|NOT COMPLETED|Overall Study||3
238384|NCT00583102|573260|P1|COMPLETED|Overall Study||20
238385|NCT00583102|573260|P1|STARTED|Overall Study||23
238386|NCT00582972|573264|P1|NOT COMPLETED|Overall Study||2
238387|NCT00582972|573264|P1|COMPLETED|Overall Study||21
238388|NCT00582972|573264|P1|STARTED|Overall Study||23
238389|NCT00582946|573269|P1|NOT COMPLETED|Overall Study||0
238390|NCT00582946|573269|P1|COMPLETED|Overall Study||16
238391|NCT00582946|573269|P1|STARTED|Overall Study||16
238392|NCT00582933|573273|P1|NOT COMPLETED|Overall Study||3
238393|NCT00582933|573273|P1|COMPLETED|Overall Study||92
238394|NCT00582933|573273|P1|STARTED|Overall Study||95
238395|NCT00582907|573277|P4|NOT COMPLETED|4th Course||0
238396|NCT00582907|573278|P3|NOT COMPLETED|4th Course||0
238397|NCT00582907|573279|P2|NOT COMPLETED|4th Course||0
238398|NCT00582907|573280|P1|NOT COMPLETED|4th Course||0
238399|NCT00582907|573277|P4|COMPLETED|4th Course||3
238400|NCT00582907|573278|P3|COMPLETED|4th Course||3
238401|NCT00582907|573279|P2|COMPLETED|4th Course||3
238402|NCT00582907|573280|P1|COMPLETED|4th Course||2
238403|NCT00582907|573277|P4|STARTED|4th Course||3
238404|NCT00582907|573278|P3|STARTED|4th Course||3
238405|NCT00582907|573279|P2|STARTED|4th Course||3
238406|NCT00582907|573280|P1|STARTED|4th Course||2
238407|NCT00582907|573277|P4|NOT COMPLETED|3rd Course||0
238408|NCT00582907|573278|P3|NOT COMPLETED|3rd Course||0
238409|NCT00582907|573279|P2|NOT COMPLETED|3rd Course||0
238410|NCT00582907|573280|P1|NOT COMPLETED|3rd Course||0
238411|NCT00582907|573277|P4|COMPLETED|3rd Course||3
238412|NCT00582907|573278|P3|COMPLETED|3rd Course||3
238413|NCT00582907|573279|P2|COMPLETED|3rd Course||3
238414|NCT00582907|573280|P1|COMPLETED|3rd Course||2
238415|NCT00582907|573277|P4|STARTED|3rd Course||3
238416|NCT00582907|573278|P3|STARTED|3rd Course||3
238417|NCT00582907|573279|P2|STARTED|3rd Course||3
238418|NCT00582907|573280|P1|STARTED|3rd Course||2
238419|NCT00582907|573277|P4|NOT COMPLETED|2nd Course||0
238420|NCT00582907|573278|P3|NOT COMPLETED|2nd Course||0
238421|NCT00582907|573279|P2|NOT COMPLETED|2nd Course||0
238422|NCT00582907|573280|P1|NOT COMPLETED|2nd Course||1
238423|NCT00582907|573277|P4|COMPLETED|2nd Course||3
238424|NCT00582907|573278|P3|COMPLETED|2nd Course||3
238425|NCT00582907|573279|P2|COMPLETED|2nd Course||3
238426|NCT00582907|573280|P1|COMPLETED|2nd Course||2
238427|NCT00582907|573277|P4|STARTED|2nd Course||3
238428|NCT00582907|573278|P3|STARTED|2nd Course||3
238429|NCT00582907|573279|P2|STARTED|2nd Course||3
238430|NCT00582907|573280|P1|STARTED|2nd Course||3
238431|NCT00582907|573277|P4|NOT COMPLETED|1st Course||1
238432|NCT00582907|573278|P3|NOT COMPLETED|1st Course||0
238433|NCT00582907|573279|P2|NOT COMPLETED|1st Course||0
238434|NCT00582907|573280|P1|NOT COMPLETED|1st Course||1
238435|NCT00582907|573277|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
238436|NCT00582907|573278|P3|COMPLETED|1st Course||3
238437|NCT00582907|573279|P2|COMPLETED|1st Course||3
238438|NCT00582907|573280|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
238439|NCT00582907|573277|P4|STARTED|1st Course||4
238440|NCT00582907|573278|P3|STARTED|1st Course||3
238441|NCT00582907|573279|P2|STARTED|1st Course||3
238442|NCT00582907|573280|P1|STARTED|1st Course||4
238443|NCT00582894|573312|P1|NOT COMPLETED|Overall Study||0
238444|NCT00582894|573312|P1|COMPLETED|Overall Study||17
238445|NCT00582894|573312|P1|Day 100 Post Transplant|Overall Study||17
238446|NCT00582894|573312|P1|STARTED|Overall Study||17
238447|NCT00582816|573319|P1|NOT COMPLETED|Overall Study||3
238448|NCT00582816|573319|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
238449|NCT00582816|573319|P1|STARTED|Overall Study||9
238450|NCT00582790|573329|P1|NOT COMPLETED|Overall Study||1
238451|NCT00582790|573329|P1|COMPLETED|Overall Study||11
238452|NCT00582790|573329|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
238453|NCT00582738|573338|P2|NOT COMPLETED|Overall Study||18
238454|NCT00582738|573339|P1|NOT COMPLETED|Overall Study||9
238455|NCT00582738|573338|P2|COMPLETED|Overall Study||4
238456|NCT00582738|573339|P1|COMPLETED|Overall Study||12
238457|NCT00582738|573338|P2|STARTED|Overall Study||22
238458|NCT00582738|573339|P1|STARTED|Overall Study||21
238459|NCT00582712|573363|P1|NOT COMPLETED|Overall Study||4
238460|NCT00582712|573363|P1|COMPLETED|Overall Study||1
238461|NCT00582712|573363|P1|STARTED|Overall Study||5
238462|NCT00582660|573369|P2|NOT COMPLETED|Overall Study||0
238463|NCT00582660|573370|P1|NOT COMPLETED|Overall Study||0
238464|NCT00582660|573369|P2|COMPLETED|Overall Study||20
238465|NCT00582660|573370|P1|COMPLETED|Overall Study||20
238466|NCT00582660|573369|P2|STARTED|Overall Study||20
238467|NCT00582660|573370|P1|STARTED|Overall Study||20
238468|NCT00582608|573378|P1|NOT COMPLETED|Overall Study||12
238469|NCT00582608|573378|P1|COMPLETED|Overall Study||0
238470|NCT00582608|573378|P1|STARTED|Overall Study||12
238471|NCT00582556|573385|P3|NOT COMPLETED|Overall Study||2
238472|NCT00582556|573386|P2|NOT COMPLETED|Overall Study||1
238473|NCT00582556|573387|P1|NOT COMPLETED|Overall Study||0
238474|NCT00582556|573385|P3|COMPLETED|Overall Study||12
238475|NCT00582556|573386|P2|COMPLETED|Overall Study||14
238476|NCT00582556|573387|P1|COMPLETED|Overall Study||14
238477|NCT00582556|573385|P3|STARTED|Overall Study||14
238478|NCT00582556|573386|P2|STARTED|Overall Study||15
238479|NCT00582556|573387|P1|STARTED|Overall Study||14
238480|NCT00582517|573406|P2|NOT COMPLETED|Overall Study||0
238481|NCT00582517|573407|P1|NOT COMPLETED|Overall Study||0
238482|NCT00582517|573406|P2|COMPLETED|Overall Study||55
238483|NCT00582517|573407|P1|COMPLETED|Overall Study||45
238484|NCT00582517|573406|P2|STARTED|Overall Study||55
238485|NCT00582517|573407|P1|STARTED|Overall Study||45
238486|NCT00582491|573415|P2|NOT COMPLETED|Overall Study||0
238487|NCT00582491|573416|P1|NOT COMPLETED|Overall Study||1
238488|NCT00582491|573415|P2|COMPLETED|Overall Study||10
238489|NCT00582491|573416|P1|COMPLETED|Overall Study||10
238490|NCT00582491|573415|P2|STARTED|Overall Study||10
238491|NCT00582491|573416|P1|STARTED|Overall Study||11
238492|NCT00582426|573440|P2|NOT COMPLETED|Overall Study||13
238493|NCT00582426|573441|P1|NOT COMPLETED|Overall Study||20
238494|NCT00582426|573440|P2|COMPLETED|Overall Study||58
238495|NCT00582426|573441|P1|COMPLETED|Overall Study||48
238496|NCT00582426|573440|P2|STARTED|Overall Study||71
238497|NCT00582426|573441|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
238498|NCT00582400|573467|P1|NOT COMPLETED|Overall Study||3
238499|NCT00582400|573467|P1|COMPLETED|Overall Study||6
238500|NCT00582400|573467|P1|STARTED|Overall Study||9
238501|NCT00582361|573476|P2|NOT COMPLETED|Overall Study||0
238502|NCT00582361|573477|P1|NOT COMPLETED|Overall Study||0
238503|NCT00582361|573476|P2|COMPLETED|Overall Study||38
238504|NCT00582361|573477|P1|COMPLETED|Overall Study||25
238505|NCT00582361|573476|P2|STARTED|Overall Study||38
238506|NCT00582361|573477|P1|STARTED|Overall Study||25
238507|NCT00582309|573488|P3|NOT COMPLETED|Overall Study||2
238508|NCT00582309|573489|P2|NOT COMPLETED|Overall Study||0
238509|NCT00582309|573490|P1|NOT COMPLETED|Overall Study||0
238510|NCT00582309|573488|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
238511|NCT00582309|573489|P2|COMPLETED|Overall Study||49
238512|NCT00582309|573490|P1|COMPLETED|Overall Study||56
238513|NCT00582309|573488|P3|STARTED|Overall Study||46
238514|NCT00582309|573489|P2|STARTED|Overall Study||49
238515|NCT00582309|573490|P1|STARTED|Overall Study||56
238516|NCT00582205|573498|P1|NOT COMPLETED|Overall Study||10
238517|NCT00582205|573498|P1|COMPLETED|Overall Study||11
238518|NCT00582205|573498|P1|STARTED|Overall Study||21
238519|NCT00582114|573505|P2|NOT COMPLETED|Overall Study||54
238520|NCT00582114|573506|P1|NOT COMPLETED|Overall Study||42
238521|NCT00582114|573505|P2|COMPLETED|Overall Study||46
238522|NCT00582114|573506|P1|COMPLETED|Overall Study||58
238523|NCT00582114|573505|P2|STARTED|Overall Study||100
238524|NCT00582114|573506|P1|STARTED|Overall Study||100
238525|NCT00582075|573514|P1|NOT COMPLETED|Overall Study||0
238526|NCT00582075|573514|P1|COMPLETED|Overall Study||25
238527|NCT00582075|573514|P1|STARTED|Overall Study||25
238528|NCT00582036|573521|P2|NOT COMPLETED|Overall Study||1
238529|NCT00582036|573522|P1|NOT COMPLETED|Overall Study||0
238530|NCT00582036|573521|P2|COMPLETED|Overall Study|One patient withdrew consent|5
238531|NCT00582036|573522|P1|COMPLETED|Overall Study||5
238532|NCT00582036|573521|P2|STARTED|Overall Study||6
238533|NCT00582036|573522|P1|STARTED|Overall Study||5
238534|NCT00582010|573530|P2|NOT COMPLETED|Overall Study||1
238535|NCT00582010|573531|P1|NOT COMPLETED|Overall Study||0
238536|NCT00582010|573530|P2|COMPLETED|Overall Study||39
238537|NCT00582010|573531|P1|COMPLETED|Overall Study||40
238538|NCT00582010|573530|P2|STARTED|Overall Study||40
238539|NCT00582010|573531|P1|STARTED|Overall Study||40
238540|NCT00581971|573553|P1|NOT COMPLETED|Overall Study||0
238541|NCT00581971|573553|P1|COMPLETED|Overall Study||30
238542|NCT00581971|573553|P1|STARTED|Overall Study||30
238543|NCT00581945|573560|P2|NOT COMPLETED|Overall Study||10
238544|NCT00581945|573561|P1|NOT COMPLETED|Overall Study||9
238545|NCT00581945|573560|P2|COMPLETED|Overall Study||63
238546|NCT00581945|573561|P1|COMPLETED|Overall Study||65
238547|NCT00581945|573560|P2|STARTED|Overall Study||73
238548|NCT00581945|573561|P1|STARTED|Overall Study||74
238549|NCT00581919|573577|P1|NOT COMPLETED|Overall Study||24
238550|NCT00581919|573577|P1|COMPLETED|Overall Study||8
238551|NCT00581919|573577|P1|STARTED|Overall Study||32
238552|NCT00581867|573583|P2|NOT COMPLETED|Second Intervention||0
238553|NCT00581867|573584|P1|NOT COMPLETED|Second Intervention||0
238554|NCT00581867|573583|P2|COMPLETED|Second Intervention||14
238555|NCT00581867|573584|P1|COMPLETED|Second Intervention||15
238556|NCT00581867|573583|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
238557|NCT00581867|573584|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
238558|NCT00581867|573583|P2|NOT COMPLETED|First Intervention||0
238559|NCT00581867|573584|P1|NOT COMPLETED|First Intervention||0
238560|NCT00581867|573583|P2|COMPLETED|First Intervention||15
238561|NCT00581867|573584|P1|COMPLETED|First Intervention||16
238562|NCT00581867|573583|P2|STARTED|First Intervention||15
238563|NCT00581867|573584|P1|STARTED|First Intervention||16
238564|NCT00581854|573592|P1|NOT COMPLETED|Overall Study||0
238565|NCT00581854|573592|P1|COMPLETED|Overall Study||22
238566|NCT00581854|573592|P1|STARTED|Overall Study||22
238567|NCT00581828|573596|P1|NOT COMPLETED|Overall Study||1
238568|NCT00581828|573596|P1|COMPLETED|Overall Study||18
238569|NCT00581828|573596|P1|STARTED|Overall Study||19
238570|NCT00581776|573600|P1|NOT COMPLETED|Overall Study||3
238571|NCT00581776|573600|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
238572|NCT00581776|573600|P1|STARTED|Overall Study||30
238573|NCT00581581|573609|P2|NOT COMPLETED|Overall Study||0
238574|NCT00581581|573610|P1|NOT COMPLETED|Overall Study||0
238575|NCT00581581|573609|P2|COMPLETED|Overall Study||30
238576|NCT00581581|573610|P1|COMPLETED|Overall Study||32
238577|NCT00581581|573609|P2|STARTED|Overall Study||30
238578|NCT00581581|573610|P1|STARTED|Overall Study||32
238579|NCT00581555|573618|P2|NOT COMPLETED|Overall Study||20
238580|NCT00581555|573619|P1|NOT COMPLETED|Overall Study||43
238581|NCT00581555|573618|P2|COMPLETED|Overall Study||38
238582|NCT00581555|573619|P1|COMPLETED|Overall Study||19
238583|NCT00581555|573618|P2|STARTED|Overall Study||58
238584|NCT00581555|573619|P1|STARTED|Overall Study||62
238585|NCT00581542|573643|P2|NOT COMPLETED|Overall Study||23
238586|NCT00581542|573644|P1|NOT COMPLETED|Overall Study||11
238587|NCT00581542|573643|P2|COMPLETED|Overall Study||39
238588|NCT00581542|573644|P1|COMPLETED|Overall Study||51
238589|NCT00581542|573643|P2|STARTED|Overall Study||62
238590|NCT00581542|573644|P1|STARTED|Overall Study||62
238591|NCT00581529|573652|P1|NOT COMPLETED|Overall Study||0
238592|NCT00581529|573652|P1|COMPLETED|Overall Study||34
238593|NCT00581529|573652|P1|STARTED|Overall Study||34
238594|NCT00581399|573661|P2|NOT COMPLETED|Overall Study||0
238595|NCT00581399|573662|P1|NOT COMPLETED|Overall Study||0
238596|NCT00581399|573661|P2|COMPLETED|Overall Study||48
238597|NCT00581399|573662|P1|COMPLETED|Overall Study||46
238598|NCT00581399|573661|P2|STARTED|Overall Study||48
238599|NCT00581399|573662|P1|STARTED|Overall Study||46
238600|NCT00581386|573673|P3|NOT COMPLETED|Overall Study||0
238601|NCT00581386|573674|P2|NOT COMPLETED|Overall Study||0
238602|NCT00581386|573675|P1|NOT COMPLETED|Overall Study||0
238603|NCT00581386|573673|P3|COMPLETED|Overall Study|04/15/2009|72
238604|NCT00581386|573674|P2|COMPLETED|Overall Study|04/15/2009|73
238605|NCT00581386|573675|P1|COMPLETED|Overall Study|04/15/2009|73
238606|NCT00581386|573673|P3|STARTED|Overall Study|05/30/2007|72
238607|NCT00581386|573674|P2|STARTED|Overall Study|05/30/2007|73
238608|NCT00581386|573675|P1|STARTED|Overall Study|05/30/2007|73
238609|NCT00581360|573698|P1|NOT COMPLETED|Overall Study||1
238610|NCT00581360|573698|P1|COMPLETED|Overall Study||9
238611|NCT00581360|573698|P1|STARTED|Overall Study||10
238612|NCT00581347|573708|P2|NOT COMPLETED|Overall Study||0
238613|NCT00581347|573709|P1|NOT COMPLETED|Overall Study||0
238614|NCT00581347|573708|P2|COMPLETED|Overall Study||3707
238615|NCT00581347|573709|P1|COMPLETED|Overall Study||3839
238616|NCT00581347|573708|P2|STARTED|Overall Study||3707
238617|NCT00581347|573709|P1|STARTED|Overall Study||3839
238618|NCT00581308|573717|P1|NOT COMPLETED|60 Months||3
238619|NCT00581308|573717|P1|COMPLETED|60 Months||158
238620|NCT00581308|573717|P1|STARTED|60 Months||161
238621|NCT00581308|573717|P1|NOT COMPLETED|48 Months||9
238622|NCT00581308|573717|P1|COMPLETED|48 Months||161
238623|NCT00581308|573717|P1|STARTED|48 Months||170
238624|NCT00581308|573717|P1|NOT COMPLETED|36 Months||6
238625|NCT00581308|573717|P1|COMPLETED|36 Months||170
238626|NCT00581308|573717|P1|STARTED|36 Months||176
238627|NCT00581308|573717|P1|NOT COMPLETED|24 Months||6
238628|NCT00581308|573717|P1|COMPLETED|24 Months||176
238629|NCT00581308|573717|P1|STARTED|24 Months||182
238630|NCT00581308|573717|P1|NOT COMPLETED|Month 12||20
238631|NCT00581308|573717|P1|COMPLETED|Month 12||182
238632|NCT00581308|573717|P1|STARTED|Month 12||202
238633|NCT00581308|573717|P1|NOT COMPLETED|Month 6||3
238634|NCT00581308|573717|P1|COMPLETED|Month 6||202
238635|NCT00581308|573717|P1|STARTED|Month 6||205
238636|NCT00581308|573717|P1|NOT COMPLETED|Month 1||8
238637|NCT00581308|573717|P1|COMPLETED|Month 1||205
238638|NCT00581308|573717|P1|STARTED|Month 1||213
238639|NCT00581308|573717|P1|NOT COMPLETED|Pre Discharge||2
238640|NCT00581308|573717|P1|COMPLETED|Pre Discharge||213
238641|NCT00581308|573717|P1|STARTED|Pre Discharge||215
238642|NCT00581256|573726|P2|NOT COMPLETED|Overall Study||0
238643|NCT00581256|573727|P1|NOT COMPLETED|Overall Study||0
238644|NCT00581256|573726|P2|COMPLETED|Overall Study||26
238645|NCT00581256|573727|P1|COMPLETED|Overall Study||28
238646|NCT00581256|573726|P2|STARTED|Overall Study||26
238647|NCT00581256|573727|P1|STARTED|Overall Study||28
238648|NCT00581230|573739|P1|NOT COMPLETED|Overall Study||0
238649|NCT00581230|573739|P1|COMPLETED|Overall Study||51
238650|NCT00581230|573739|P1|Laryngoscopy With RAMP|Overall Study||51
238651|NCT00581230|573739|P1|Laryngoscopy Without RAMP|Overall Study||51
238652|NCT00581230|573739|P1|STARTED|Overall Study||51
238653|NCT00581113|573748|P2|NOT COMPLETED|Overall Study||1
238654|NCT00581113|573749|P1|NOT COMPLETED|Overall Study||0
238655|NCT00581113|573748|P2|COMPLETED|Overall Study||3
238656|NCT00581113|573749|P1|COMPLETED|Overall Study||4
238657|NCT00581113|573748|P2|STARTED|Overall Study||4
238658|NCT00581113|573749|P1|STARTED|Overall Study||4
238659|NCT00581100|573759|P2|NOT COMPLETED|Overall Study||5
238660|NCT00581100|573760|P1|NOT COMPLETED|Overall Study||7
238661|NCT00581100|573759|P2|COMPLETED|Overall Study||29
238662|NCT00581100|573760|P1|COMPLETED|Overall Study||31
238663|NCT00581100|573759|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
238664|NCT00581100|573760|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
238665|NCT00581100|573759|P2|STARTED|Overall Study||34
238666|NCT00581100|573760|P1|STARTED|Overall Study||38
238667|NCT00581061|573796|P1|NOT COMPLETED|Overall Study||0
238668|NCT00581061|573796|P1|COMPLETED|Overall Study||13
238669|NCT00581061|573796|P1|STARTED|Overall Study||13
238670|NCT00581048|573802|P1|NOT COMPLETED|Overall Study||0
238671|NCT00581048|573802|P1|COMPLETED|Overall Study||33
238672|NCT00581048|573802|P1|STARTED|Overall Study||33
238673|NCT00580983|573813|P1|NOT COMPLETED|Overall Study||7
238674|NCT00580983|573813|P1|COMPLETED|Overall Study||73
238675|NCT00580983|573813|P1|STARTED|Overall Study||80
238676|NCT00580970|573820|P1|NOT COMPLETED|Treatment (Lovastatin)||19
238677|NCT00580970|573820|P1|COMPLETED|Treatment (Lovastatin)||53
238678|NCT00580970|573820|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
238679|NCT00580970|573820|P1|STARTED|Treatment (Lovastatin)||72
238680|NCT00580970|573820|P1|NOT COMPLETED|Pre-treatment||1
238681|NCT00580970|573820|P1|COMPLETED|Pre-treatment||72
238682|NCT00580970|573820|P1|STARTED|Pre-treatment||73
238683|NCT00580957|573826|P2|NOT COMPLETED|Overall Study||7
238684|NCT00580957|573827|P1|NOT COMPLETED|Overall Study||7
238685|NCT00580957|573826|P2|COMPLETED|Overall Study||21
238686|NCT00580957|573827|P1|COMPLETED|Overall Study||21
238687|NCT00580957|573826|P2|STARTED|Overall Study||28
238688|NCT00580957|573827|P1|STARTED|Overall Study||28
238689|NCT00580866|573835|P2|NOT COMPLETED|Overall Study||2
238690|NCT00580866|573836|P1|NOT COMPLETED|Overall Study||2
238691|NCT00580866|573835|P2|COMPLETED|Overall Study||5
238692|NCT00580866|573836|P1|COMPLETED|Overall Study||8
238693|NCT00580866|573835|P2|STARTED|Overall Study||7
238694|NCT00580866|573836|P1|STARTED|Overall Study||10
238695|NCT00580853|573847|P3|NOT COMPLETED|Overall Study||0
238696|NCT00580853|573848|P2|NOT COMPLETED|Overall Study||0
238697|NCT00580853|573849|P1|NOT COMPLETED|Overall Study||0
238698|NCT00580853|573847|P3|COMPLETED|Overall Study||21
238699|NCT00580853|573848|P2|COMPLETED|Overall Study||21
238700|NCT00580853|573849|P1|COMPLETED|Overall Study||20
238701|NCT00580853|573847|P3|STARTED|Overall Study||21
238702|NCT00580853|573848|P2|STARTED|Overall Study||21
238703|NCT00580853|573849|P1|STARTED|Overall Study||20
238704|NCT00580840|573860|P4|NOT COMPLETED|Double-Blind||15
238705|NCT00580840|573861|P3|NOT COMPLETED|Double-Blind||9
238706|NCT00580840|573862|P2|NOT COMPLETED|Double-Blind||7
238707|NCT00580840|573863|P1|NOT COMPLETED|Double-Blind||0
238708|NCT00580840|573860|P4|COMPLETED|Double-Blind||54
238709|NCT00580840|573861|P3|COMPLETED|Double-Blind||61
238710|NCT00580840|573862|P2|COMPLETED|Double-Blind||63
238711|NCT00580840|573863|P1|COMPLETED|Double-Blind||0
238712|NCT00580840|573860|P4|STARTED|Double-Blind||69
238713|NCT00580840|573861|P3|STARTED|Double-Blind||70
238714|NCT00580840|573862|P2|STARTED|Double-Blind||70
238715|NCT00580840|573863|P1|STARTED|Double-Blind||0
238716|NCT00580840|573860|P4|NOT COMPLETED|Run-in||0
238717|NCT00580840|573861|P3|NOT COMPLETED|Run-in||0
238718|NCT00580840|573862|P2|NOT COMPLETED|Run-in||0
238719|NCT00580840|573863|P1|NOT COMPLETED|Run-in||124
238720|NCT00580840|573860|P4|COMPLETED|Run-in||0
238721|NCT00580840|573861|P3|COMPLETED|Run-in||0
238722|NCT00580840|573862|P2|COMPLETED|Run-in||0
238723|NCT00580840|573863|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
238724|NCT00580840|573860|P4|STARTED|Run-in||0
238725|NCT00580840|573861|P3|STARTED|Run-in||0
238726|NCT00580840|573862|P2|STARTED|Run-in||0
238727|NCT00580840|573863|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
238728|NCT00580801|573971|P3|NOT COMPLETED|Overall Study||3
238729|NCT00580801|573972|P2|NOT COMPLETED|Overall Study||1
238730|NCT00580801|573973|P1|NOT COMPLETED|Overall Study||6
238731|NCT00580801|573971|P3|COMPLETED|Overall Study||5
238732|NCT00580801|573972|P2|COMPLETED|Overall Study||7
238733|NCT00580801|573973|P1|COMPLETED|Overall Study||2
238734|NCT00580801|573971|P3|STARTED|Overall Study||8
238735|NCT00580801|573972|P2|STARTED|Overall Study||8
238736|NCT00580801|573973|P1|STARTED|Overall Study||8
238737|NCT00580788|574012|P4|NOT COMPLETED|Overall Study||1
238738|NCT00580788|574013|P3|NOT COMPLETED|Overall Study||0
238739|NCT00580788|574014|P2|NOT COMPLETED|Overall Study||0
238740|NCT00580788|574015|P1|NOT COMPLETED|Overall Study||0
238741|NCT00580788|574012|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
238742|NCT00580788|574013|P3|COMPLETED|Overall Study||3
238743|NCT00580788|574014|P2|COMPLETED|Overall Study||6
238744|NCT00580788|574015|P1|COMPLETED|Overall Study||3
238745|NCT00580788|574012|P4|STARTED|Overall Study||2
238746|NCT00580788|574013|P3|STARTED|Overall Study||3
238747|NCT00580788|574014|P2|STARTED|Overall Study||6
238748|NCT00580788|574015|P1|STARTED|Overall Study||3
238749|NCT00580723|574073|P1|NOT COMPLETED|Overall Study||8
238750|NCT00580723|574073|P1|COMPLETED|Overall Study||16
238751|NCT00580723|574073|P1|STARTED|Overall Study||24
238752|NCT00580671|574082|P3|NOT COMPLETED|Overall Study||17
238753|NCT00580671|574083|P2|NOT COMPLETED|Overall Study||16
238754|NCT00580671|574084|P1|NOT COMPLETED|Overall Study||16
238755|NCT00580671|574082|P3|COMPLETED|Overall Study||34
238756|NCT00580671|574083|P2|COMPLETED|Overall Study||35
238757|NCT00580671|574084|P1|COMPLETED|Overall Study||35
238758|NCT00580671|574082|P3|STARTED|Overall Study||51
238759|NCT00580671|574083|P2|STARTED|Overall Study||51
238760|NCT00580671|574084|P1|STARTED|Overall Study||51
238761|NCT00580645|574101|P3|NOT COMPLETED|Overall Study||0
238762|NCT00580645|574102|P2|NOT COMPLETED|Overall Study||0
238763|NCT00580645|574103|P1|NOT COMPLETED|Overall Study||0
238764|NCT00580645|574101|P3|COMPLETED|Overall Study||20
238765|NCT00580645|574102|P2|COMPLETED|Overall Study||20
238766|NCT00580645|574103|P1|COMPLETED|Overall Study||20
238767|NCT00580645|574101|P3|STARTED|Overall Study||20
238768|NCT00580645|574102|P2|STARTED|Overall Study||20
238769|NCT00580645|574103|P1|STARTED|Overall Study||20
238770|NCT00580606|574116|P2|NOT COMPLETED|Open Label (OL)||12
238771|NCT00580606|574117|P1|NOT COMPLETED|Open Label (OL)||9
238772|NCT00580606|574116|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
238773|NCT00580606|574117|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
238774|NCT00580606|574116|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
238775|NCT00580606|574117|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
238776|NCT00580606|574116|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
238777|NCT00580606|574117|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
238778|NCT00580606|574116|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
238779|NCT00580606|574117|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
238780|NCT00580606|574116|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
238781|NCT00580606|574117|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
238782|NCT00580606|574116|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
238783|NCT00580606|574117|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
238784|NCT00580606|574116|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
238785|NCT00580606|574117|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
238786|NCT00580606|574116|P2|NOT COMPLETED|Double Blind (DB)||0
238787|NCT00580606|574117|P1|NOT COMPLETED|Double Blind (DB)||0
238788|NCT00580606|574116|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
238789|NCT00580606|574117|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
238790|NCT00580606|574116|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
238791|NCT00580606|574117|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
238792|NCT00580606|574116|P2|STARTED|Double Blind (DB)||20
238793|NCT00580606|574117|P1|STARTED|Double Blind (DB)||20
238794|NCT00580502|574135|P1|NOT COMPLETED|Overall Study||0
238795|NCT00580502|574135|P1|COMPLETED|Overall Study||50
238796|NCT00580502|574135|P1|STARTED|Overall Study||50
238797|NCT00580398|574144|P2|NOT COMPLETED|Overall Study||0
238798|NCT00580398|574145|P1|NOT COMPLETED|Overall Study||0
238799|NCT00580398|574144|P2|COMPLETED|Overall Study||32
238800|NCT00580398|574145|P1|COMPLETED|Overall Study||17
238801|NCT00580398|574144|P2|STARTED|Overall Study||32
238802|NCT00580398|574145|P1|STARTED|Overall Study||17
238803|NCT00580372|574153|P1|NOT COMPLETED|Overall Study||0
238804|NCT00580372|574153|P1|COMPLETED|Overall Study||231
238805|NCT00580372|574153|P1|STARTED|Overall Study||231
238806|NCT00580333|574157|P1|NOT COMPLETED|Overall Study||0
238807|NCT00580333|574157|P1|COMPLETED|Overall Study||51
238808|NCT00580333|574157|P1|STARTED|Overall Study||51
238809|NCT00580294|574164|P1|NOT COMPLETED|Overall Study||0
238810|NCT00580294|574164|P1|COMPLETED|Overall Study||12
238811|NCT00580294|574164|P1|STARTED|Overall Study||12
238812|NCT00580229|574168|P1|NOT COMPLETED|Overall Study||0
238813|NCT00580229|574168|P1|COMPLETED|Overall Study||50
238814|NCT00580229|574168|P1|STARTED|Overall Study||50
238815|NCT00580151|574174|P2|NOT COMPLETED|Overall Study||0
238816|NCT00580151|574175|P1|NOT COMPLETED|Overall Study||0
238817|NCT00580151|574174|P2|COMPLETED|Overall Study||0
238818|NCT00580151|574175|P1|COMPLETED|Overall Study||9
238819|NCT00580151|574174|P2|STARTED|Overall Study||0
238820|NCT00580151|574175|P1|STARTED|Overall Study||9
238821|NCT00580138|574183|P1|NOT COMPLETED|Overall Study||0
238822|NCT00580138|574183|P1|COMPLETED|Overall Study||30
238823|NCT00580138|574183|P1|STARTED|Overall Study||30
238824|NCT00580073|574187|P1|NOT COMPLETED|Overall Study||0
238825|NCT00580073|574187|P1|COMPLETED|Overall Study||6
238826|NCT00580073|574187|P1|STARTED|Overall Study||6
238827|NCT00580047|574196|P3|NOT COMPLETED|Overall Study||2
238828|NCT00580047|574197|P2|NOT COMPLETED|Overall Study||2
238829|NCT00580047|574198|P1|NOT COMPLETED|Overall Study||3
238830|NCT00580047|574196|P3|COMPLETED|Overall Study||10
238831|NCT00580047|574197|P2|COMPLETED|Overall Study||21
238832|NCT00580047|574198|P1|COMPLETED|Overall Study||21
238833|NCT00580047|574196|P3|STARTED|Overall Study||12
238834|NCT00580047|574197|P2|STARTED|Overall Study||23
238835|NCT00580047|574198|P1|STARTED|Overall Study||24
238836|NCT00580034|574209|P2|NOT COMPLETED|Overall Study||0
238837|NCT00580034|574210|P1|NOT COMPLETED|Overall Study||10
238838|NCT00580034|574209|P2|COMPLETED|Overall Study||88
238839|NCT00580034|574210|P1|COMPLETED|Overall Study||78
238840|NCT00580034|574209|P2|STARTED|Overall Study||88
238841|NCT00580034|574210|P1|STARTED|Overall Study||88
238842|NCT00579982|574216|P1|NOT COMPLETED|Overall Study||8
238843|NCT00579982|574216|P1|COMPLETED|Overall Study||89
238844|NCT00579982|574216|P1|STARTED|Overall Study||97
238845|NCT00579826|574237|P2|NOT COMPLETED|Overall Study||3
238846|NCT00579826|574238|P1|NOT COMPLETED|Overall Study||5
238847|NCT00579826|574237|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
238848|NCT00579826|574238|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
238849|NCT00579826|574237|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
238850|NCT00579826|574238|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
238851|NCT00579826|574237|P2|STARTED|Overall Study||26
238852|NCT00579826|574238|P1|STARTED|Overall Study||29
238853|NCT00579813|574250|P2|NOT COMPLETED|Overall Study||0
238854|NCT00579813|574251|P1|NOT COMPLETED|Overall Study||0
238855|NCT00579813|574250|P2|COMPLETED|Overall Study||10
238856|NCT00579813|574251|P1|COMPLETED|Overall Study||60
238857|NCT00579813|574250|P2|STARTED|Overall Study||10
238858|NCT00579813|574251|P1|STARTED|Overall Study||60
238859|NCT00579670|574272|P5|NOT COMPLETED|Overall Study||0
238860|NCT00579670|574273|P4|NOT COMPLETED|Overall Study||22
238861|NCT00579670|574274|P3|NOT COMPLETED|Overall Study||4
238862|NCT00579670|574275|P2|NOT COMPLETED|Overall Study||1
238863|NCT00579670|574276|P1|NOT COMPLETED|Overall Study||2
238864|NCT00579670|574272|P5|COMPLETED|Overall Study||5
238865|NCT00579670|574273|P4|COMPLETED|Overall Study||263
238866|NCT00579670|574274|P3|COMPLETED|Overall Study||84
238867|NCT00579670|574275|P2|COMPLETED|Overall Study||56
238868|NCT00579670|574276|P1|COMPLETED|Overall Study||13
238869|NCT00579670|574272|P5|Population: Within SmPC (Completed)|Overall Study||0
238870|NCT00579670|574273|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
238871|NCT00579670|574274|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
238872|NCT00579670|574275|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
238873|NCT00579670|574276|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
238874|NCT00579670|574272|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
238875|NCT00579670|574273|P4|Population: Within SmPC (Started)|Overall Study||159
238876|NCT00579670|574274|P3|Population: Within SmPC (Started)|Overall Study||83
238877|NCT00579670|574275|P2|Population: Within SmPC (Started)|Overall Study||56
238878|NCT00579670|574276|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
238879|NCT00579670|574272|P5|STARTED|Overall Study||5
238880|NCT00579670|574273|P4|STARTED|Overall Study||285
238881|NCT00579670|574274|P3|STARTED|Overall Study||88
238882|NCT00579670|574275|P2|STARTED|Overall Study||57
238883|NCT00579670|574276|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
238884|NCT00579501|574488|P1|NOT COMPLETED|Overall Study||29
238885|NCT00579501|574488|P1|COMPLETED|Overall Study||0
238886|NCT00579501|574488|P1|STARTED|Overall Study||29
238887|NCT00579436|574495|P2|NOT COMPLETED|Overall Study||0
238888|NCT00579436|574496|P1|NOT COMPLETED|Overall Study||0
238889|NCT00579436|574495|P2|COMPLETED|Overall Study||14
238890|NCT00579436|574496|P1|COMPLETED|Overall Study||19
238891|NCT00579436|574495|P2|STARTED|Overall Study||14
238892|NCT00579436|574496|P1|STARTED|Overall Study||19
238893|NCT00579345|574516|P8|NOT COMPLETED|Overall Study||2
238894|NCT00579345|574517|P7|NOT COMPLETED|Overall Study||0
238895|NCT00579345|574518|P6|NOT COMPLETED|Overall Study||0
238896|NCT00579345|574519|P5|NOT COMPLETED|Overall Study||0
238897|NCT00579345|574520|P4|NOT COMPLETED|Overall Study||1
238898|NCT00579345|574521|P3|NOT COMPLETED|Overall Study||2
238899|NCT00579345|574522|P2|NOT COMPLETED|Overall Study||1
238900|NCT00579345|574523|P1|NOT COMPLETED|Overall Study||5
238901|NCT00579345|574516|P8|COMPLETED|Overall Study||42
238902|NCT00579345|574517|P7|COMPLETED|Overall Study||57
238903|NCT00579345|574518|P6|COMPLETED|Overall Study||78
238904|NCT00579345|574519|P5|COMPLETED|Overall Study||90
238905|NCT00579345|574520|P4|COMPLETED|Overall Study||143
238906|NCT00579345|574521|P3|COMPLETED|Overall Study||389
238907|NCT00579345|574522|P2|COMPLETED|Overall Study||168
238908|NCT00579345|574523|P1|COMPLETED|Overall Study||544
238909|NCT00579345|574516|P8|STARTED|Overall Study||44
238910|NCT00579345|574517|P7|STARTED|Overall Study||57
238911|NCT00579345|574518|P6|STARTED|Overall Study||78
238912|NCT00579345|574519|P5|STARTED|Overall Study||90
238913|NCT00579345|574520|P4|STARTED|Overall Study||144
238914|NCT00579345|574521|P3|STARTED|Overall Study||391
238915|NCT00579345|574522|P2|STARTED|Overall Study||169
238916|NCT00579345|574523|P1|STARTED|Overall Study||549
238917|NCT00579254|574555|P1|NOT COMPLETED|Overall Study||112
238918|NCT00579254|574555|P1|COMPLETED|Overall Study||0
238919|NCT00579254|574555|P1|STARTED|Overall Study||112
238920|NCT00579137|574559|P1|NOT COMPLETED|Overall Study||0
238921|NCT00579137|574559|P1|COMPLETED|Overall Study||3
238922|NCT00579137|574559|P1|STARTED|Overall Study||3
238923|NCT00579111|574568|P2|NOT COMPLETED|Overall Study||1
238924|NCT00579111|574569|P1|NOT COMPLETED|Overall Study||2
238925|NCT00579111|574568|P2|COMPLETED|Overall Study||0
238926|NCT00579111|574569|P1|COMPLETED|Overall Study||1
238927|NCT00579111|574568|P2|STARTED|Overall Study||1
238928|NCT00579111|574569|P1|STARTED|Overall Study||3
238929|NCT00579098|574579|P2|NOT COMPLETED|Overall Study||8
238930|NCT00579098|574580|P1|NOT COMPLETED|Overall Study||9
238931|NCT00579098|574579|P2|COMPLETED|Overall Study||55
238932|NCT00579098|574580|P1|COMPLETED|Overall Study||53
238933|NCT00579098|574579|P2|STARTED|Overall Study||63
238934|NCT00579098|574580|P1|STARTED|Overall Study||62
238935|NCT00579059|574596|P2|NOT COMPLETED|Overall Study||10
238936|NCT00579059|574597|P1|NOT COMPLETED|Overall Study||21
238937|NCT00579059|574596|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
238938|NCT00579059|574597|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
238939|NCT00579059|574596|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
238940|NCT00579059|574597|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
238941|NCT00579059|574596|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
238942|NCT00579059|574597|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
238943|NCT00579059|574596|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
238944|NCT00579059|574597|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
238945|NCT00579059|574596|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
238946|NCT00579059|574597|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
238947|NCT00579059|574596|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
238948|NCT00579059|574597|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
238949|NCT00579059|574596|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
238950|NCT00579059|574597|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
238951|NCT00578968|574608|P3|NOT COMPLETED|Intervention||0
238952|NCT00578968|574609|P2|NOT COMPLETED|Intervention||0
238953|NCT00578968|574610|P1|NOT COMPLETED|Intervention||0
238954|NCT00578968|574608|P3|COMPLETED|Intervention||0
238955|NCT00578968|574609|P2|COMPLETED|Intervention||12
238956|NCT00578968|574610|P1|COMPLETED|Intervention||12
238957|NCT00578968|574608|P3|STARTED|Intervention||0
238958|NCT00578968|574609|P2|STARTED|Intervention||12
238959|NCT00578968|574610|P1|STARTED|Intervention||12
238960|NCT00578968|574608|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
238961|NCT00578968|574609|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
238962|NCT00578968|574610|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
238963|NCT00578968|574608|P3|COMPLETED|Baseline (Prior to Intervention)||12
238964|NCT00578968|574609|P2|COMPLETED|Baseline (Prior to Intervention)||12
238965|NCT00578968|574610|P1|COMPLETED|Baseline (Prior to Intervention)||12
238966|NCT00578968|574608|P3|STARTED|Baseline (Prior to Intervention)||12
238967|NCT00578968|574609|P2|STARTED|Baseline (Prior to Intervention)||12
238968|NCT00578968|574610|P1|STARTED|Baseline (Prior to Intervention)||12
238969|NCT00578942|574671|P1|NOT COMPLETED|Overall Study||1
238970|NCT00578942|574671|P1|COMPLETED|Overall Study||47
238971|NCT00578942|574671|P1|STARTED|Overall Study||48
238972|NCT00578929|574681|P4|NOT COMPLETED|Randomized Period||14
238973|NCT00578929|574682|P3|NOT COMPLETED|Randomized Period||8
238974|NCT00578929|574683|P2|NOT COMPLETED|Randomized Period||14
238975|NCT00578929|574684|P1|NOT COMPLETED|Randomized Period||17
238976|NCT00578929|574681|P4|COMPLETED|Randomized Period||283
238977|NCT00578929|574682|P3|COMPLETED|Randomized Period||288
238978|NCT00578929|574683|P2|COMPLETED|Randomized Period||283
238979|NCT00578929|574684|P1|COMPLETED|Randomized Period||281
238980|NCT00578929|574681|P4|STARTED|Randomized Period||297
238981|NCT00578929|574682|P3|STARTED|Randomized Period||296
238982|NCT00578929|574683|P2|STARTED|Randomized Period||297
238983|NCT00578929|574684|P1|STARTED|Randomized Period||298
238984|NCT00578929|574681|P4|NOT COMPLETED|Vehicle Run-In Period||0
238985|NCT00578929|574682|P3|NOT COMPLETED|Vehicle Run-In Period||0
238986|NCT00578929|574683|P2|NOT COMPLETED|Vehicle Run-In Period||0
238987|NCT00578929|574684|P1|NOT COMPLETED|Vehicle Run-In Period||0
238988|NCT00578929|574681|P4|COMPLETED|Vehicle Run-In Period||0
238989|NCT00578929|574682|P3|COMPLETED|Vehicle Run-In Period||0
238990|NCT00578929|574683|P2|COMPLETED|Vehicle Run-In Period||2388
238991|NCT00578929|574684|P1|COMPLETED|Vehicle Run-In Period||0
238992|NCT00578929|574681|P4|STARTED|Vehicle Run-In Period||0
238993|NCT00578929|574682|P3|STARTED|Vehicle Run-In Period||0
238994|NCT00578929|574683|P2|STARTED|Vehicle Run-In Period||2388
238995|NCT00578929|574684|P1|STARTED|Vehicle Run-In Period||0
238996|NCT00578903|574699|P1|NOT COMPLETED|Overall Study||0
238997|NCT00578903|574699|P1|COMPLETED|Overall Study||22
238998|NCT00578903|574699|P1|STARTED|Overall Study||22
238999|NCT00578877|574710|P2|NOT COMPLETED|Overall Study||128
239000|NCT00578877|574711|P1|NOT COMPLETED|Overall Study||81
239001|NCT00578877|574710|P2|COMPLETED|Overall Study||172
239002|NCT00578877|574711|P1|COMPLETED|Overall Study||69
239003|NCT00578877|574710|P2|STARTED|Overall Study||300
239004|NCT00578877|574711|P1|STARTED|Overall Study||150
239005|NCT00578864|574719|P2|NOT COMPLETED|Overall Study||0
239006|NCT00578864|574720|P1|NOT COMPLETED|Overall Study||1
239007|NCT00578864|574719|P2|COMPLETED|Overall Study||6
239008|NCT00578864|574720|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
239009|NCT00578864|574719|P2|STARTED|Overall Study||6
239010|NCT00578864|574720|P1|STARTED|Overall Study||7
239011|NCT00578812|574736|P2|NOT COMPLETED|Overall Study||7
239012|NCT00578812|574737|P1|NOT COMPLETED|Overall Study||6
239013|NCT00578812|574736|P2|COMPLETED|Overall Study||185
239014|NCT00578812|574737|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
239015|NCT00578812|574736|P2|STARTED|Overall Study||192
239016|NCT00578812|574737|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
239017|NCT00578786|574776|P3|NOT COMPLETED|Overall Study||30
239018|NCT00578786|574777|P2|NOT COMPLETED|Overall Study||66
239019|NCT00578786|574778|P1|NOT COMPLETED|Overall Study||39
239020|NCT00578786|574776|P3|COMPLETED|Overall Study||67
239021|NCT00578786|574777|P2|COMPLETED|Overall Study||124
239022|NCT00578786|574778|P1|COMPLETED|Overall Study||57
239023|NCT00578786|574776|P3|STARTED|Overall Study||97
239024|NCT00578786|574777|P2|STARTED|Overall Study||190
239025|NCT00578786|574778|P1|STARTED|Overall Study||96
239026|NCT00578734|574859|P2|NOT COMPLETED|Overall Study||0
239027|NCT00578734|574860|P1|NOT COMPLETED|Overall Study||0
239028|NCT00578734|574859|P2|COMPLETED|Overall Study||81
239029|NCT00578734|574860|P1|COMPLETED|Overall Study||84
239030|NCT00578734|574859|P2|STARTED|Overall Study||81
239031|NCT00578734|574860|P1|STARTED|Overall Study||84
239032|NCT00578617|574870|P2|NOT COMPLETED|Overall Study||0
239033|NCT00578617|574871|P1|NOT COMPLETED|Overall Study||0
239034|NCT00578617|574870|P2|COMPLETED|Overall Study||29
239035|NCT00578617|574871|P1|COMPLETED|Overall Study||31
239036|NCT00578617|574870|P2|STARTED|Overall Study||29
239037|NCT00578617|574871|P1|STARTED|Overall Study||31
239038|NCT00578565|574877|P1|NOT COMPLETED|Overall Study||3
239039|NCT00578565|574877|P1|COMPLETED|Overall Study||7
239040|NCT00578565|574877|P1|STARTED|Overall Study||10
239041|NCT00578552|574889|P3|NOT COMPLETED|Overall Study||15
239042|NCT00578552|574890|P2|NOT COMPLETED|Overall Study||14
239043|NCT00578552|574891|P1|NOT COMPLETED|Overall Study||15
239044|NCT00578552|574889|P3|COMPLETED|Overall Study||11
239045|NCT00578552|574890|P2|COMPLETED|Overall Study||13
239046|NCT00578552|574891|P1|COMPLETED|Overall Study||12
239047|NCT00578552|574889|P3|STARTED|Overall Study||26
239048|NCT00578552|574890|P2|STARTED|Overall Study||27
239049|NCT00578552|574891|P1|STARTED|Overall Study||27
239050|NCT00578539|574899|P1|NOT COMPLETED|Overall Study||0
239051|NCT00578539|574899|P1|COMPLETED|Overall Study||24
239052|NCT00578539|574899|P1|STARTED|Overall Study||24
239053|NCT00578461|574903|P1|NOT COMPLETED|Overall Study||0
239054|NCT00578461|574903|P1|COMPLETED|Overall Study||26
239055|NCT00578461|574903|P1|STARTED|Overall Study||26
239056|NCT00578448|574907|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
239057|NCT00578448|574907|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
239058|NCT00578448|574907|P1|STARTED|1 Year Long Term Extension (LTE)||9
239059|NCT00578448|574907|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
239060|NCT00578448|574907|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
239061|NCT00578448|574907|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
239062|NCT00578383|574925|P4|NOT COMPLETED|Overall Study||6
239063|NCT00578383|574926|P3|NOT COMPLETED|Overall Study||6
239064|NCT00578383|574927|P2|NOT COMPLETED|Overall Study||16
239065|NCT00578383|574928|P1|NOT COMPLETED|Overall Study||16
239066|NCT00578383|574925|P4|COMPLETED|Overall Study||9
239067|NCT00578383|574926|P3|COMPLETED|Overall Study||13
239068|NCT00578383|574927|P2|COMPLETED|Overall Study||20
239069|NCT00578383|574928|P1|COMPLETED|Overall Study||21
239070|NCT00578383|574925|P4|STARTED|Overall Study||15
239071|NCT00578383|574926|P3|STARTED|Overall Study||19
239072|NCT00578383|574927|P2|STARTED|Overall Study||36
239073|NCT00578383|574928|P1|STARTED|Overall Study||37
239074|NCT00578331|574960|P2|NOT COMPLETED|Overall Study||125
239075|NCT00578331|574961|P1|NOT COMPLETED|Overall Study||116
239076|NCT00578331|574960|P2|COMPLETED|Overall Study||320
239077|NCT00578331|574961|P1|COMPLETED|Overall Study||329
239078|NCT00578331|574960|P2|STARTED|Overall Study||445
239079|NCT00578331|574961|P1|STARTED|Overall Study||445
239080|NCT00578318|574971|P2|NOT COMPLETED|Overall Study||0
239081|NCT00578318|574972|P1|NOT COMPLETED|Overall Study||3
239082|NCT00578318|574971|P2|COMPLETED|Overall Study||8
239083|NCT00578318|574972|P1|COMPLETED|Overall Study||5
239084|NCT00578318|574971|P2|STARTED|Overall Study||8
239085|NCT00578318|574972|P1|STARTED|Overall Study||8
239086|NCT00578305|574981|P3|NOT COMPLETED|Safety Follow-up Phase||46
239087|NCT00578305|574982|P2|NOT COMPLETED|Safety Follow-up Phase||45
239088|NCT00578305|574983|P1|NOT COMPLETED|Safety Follow-up Phase||46
239089|NCT00578305|574981|P3|COMPLETED|Safety Follow-up Phase||8
239090|NCT00578305|574982|P2|COMPLETED|Safety Follow-up Phase||9
239091|NCT00578305|574983|P1|COMPLETED|Safety Follow-up Phase||11
239092|NCT00578305|574981|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
239093|NCT00578305|574982|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
239094|NCT00578305|574983|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
239095|NCT00578305|574981|P3|NOT COMPLETED|Extension Phase||3
239096|NCT00578305|574982|P2|NOT COMPLETED|Extension Phase||1
239097|NCT00578305|574983|P1|NOT COMPLETED|Extension Phase||4
239098|NCT00578305|574981|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
239099|NCT00578305|574982|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
239100|NCT00578305|574983|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
239101|NCT00578305|574981|P3|STARTED|Extension Phase||43
239102|NCT00578305|574982|P2|STARTED|Extension Phase||50
239103|NCT00578305|574983|P1|STARTED|Extension Phase||53
239104|NCT00578305|574981|P3|NOT COMPLETED|Double-blind Treatment Phase||14
239105|NCT00578305|574982|P2|NOT COMPLETED|Double-blind Treatment Phase||4
239106|NCT00578305|574983|P1|NOT COMPLETED|Double-blind Treatment Phase||3
239107|NCT00578305|574981|P3|COMPLETED|Double-blind Treatment Phase||49
239108|NCT00578305|574982|P2|COMPLETED|Double-blind Treatment Phase||56
239109|NCT00578305|574983|P1|COMPLETED|Double-blind Treatment Phase||59
239110|NCT00578305|574981|P3|Treated|Double-blind Treatment Phase||63
239111|NCT00578305|574982|P2|Treated|Double-blind Treatment Phase||60
239112|NCT00578305|574983|P1|Treated|Double-blind Treatment Phase||62
239113|NCT00578305|574981|P3|STARTED|Double-blind Treatment Phase||63
239114|NCT00578305|574982|P2|STARTED|Double-blind Treatment Phase||60
239115|NCT00578305|574983|P1|STARTED|Double-blind Treatment Phase||62
239116|NCT00578279|575044|P2|NOT COMPLETED|Overall Study||0
239117|NCT00578279|575045|P1|NOT COMPLETED|Overall Study||0
239118|NCT00578279|575044|P2|COMPLETED|Overall Study||10
239119|NCT00578279|575045|P1|COMPLETED|Overall Study||10
239120|NCT00578279|575044|P2|STARTED|Overall Study||10
239121|NCT00578279|575045|P1|STARTED|Overall Study||10
239122|NCT00578227|575054|P3|NOT COMPLETED|Overall Study||4
239123|NCT00578227|575055|P2|NOT COMPLETED|Overall Study||2
239124|NCT00578227|575056|P1|NOT COMPLETED|Overall Study||5
239125|NCT00578227|575054|P3|COMPLETED|Overall Study||267
239126|NCT00578227|575055|P2|COMPLETED|Overall Study||268
239127|NCT00578227|575056|P1|COMPLETED|Overall Study||267
239128|NCT00578227|575054|P3|STARTED|Overall Study||271
239129|NCT00578227|575055|P2|STARTED|Overall Study||270
239130|NCT00578227|575056|P1|STARTED|Overall Study||272
239131|NCT00578214|575129|P3|NOT COMPLETED|Overall Study||0
239132|NCT00578214|575130|P2|NOT COMPLETED|Overall Study||0
239133|NCT00578214|575131|P1|NOT COMPLETED|Overall Study||0
239134|NCT00578214|575129|P3|COMPLETED|Overall Study||31
239135|NCT00578214|575130|P2|COMPLETED|Overall Study||22
239136|NCT00578214|575131|P1|COMPLETED|Overall Study||22
239137|NCT00578214|575129|P3|STARTED|Overall Study||31
239138|NCT00578214|575130|P2|STARTED|Overall Study||22
239139|NCT00578214|575131|P1|STARTED|Overall Study||22
239140|NCT00578175|575181|P3|NOT COMPLETED|Overall Study||24
239141|NCT00578175|575182|P2|NOT COMPLETED|Overall Study||43
239142|NCT00578175|575183|P1|NOT COMPLETED|Overall Study||70
239143|NCT00578175|575181|P3|COMPLETED|Overall Study||365
239144|NCT00578175|575182|P2|COMPLETED|Overall Study||646
239145|NCT00578175|575183|P1|COMPLETED|Overall Study||635
239146|NCT00578175|575181|P3|STARTED|Overall Study||389
239147|NCT00578175|575182|P2|STARTED|Overall Study||689
239148|NCT00578175|575183|P1|STARTED|Overall Study||705
239149|NCT00578136|575262|P2|NOT COMPLETED|Overall Study||1
239150|NCT00578136|575263|P1|NOT COMPLETED|Overall Study||1
239151|NCT00578136|575262|P2|COMPLETED|Overall Study||26
239152|NCT00578136|575263|P1|COMPLETED|Overall Study||26
239153|NCT00578136|575262|P2|STARTED|Overall Study||27
239154|NCT00578136|575263|P1|STARTED|Overall Study||27
239155|NCT00578071|575271|P1|NOT COMPLETED|Overall Study||0
239156|NCT00578071|575271|P1|COMPLETED|Overall Study||29
239157|NCT00578071|575271|P1|STARTED|Overall Study||29
239158|NCT00577889|575281|P3|NOT COMPLETED|Overall Study||0
239159|NCT00577889|575282|P2|NOT COMPLETED|Overall Study||0
239160|NCT00577889|575283|P1|NOT COMPLETED|Overall Study||1
239161|NCT00577889|575281|P3|COMPLETED|Overall Study||6
239162|NCT00577889|575282|P2|COMPLETED|Overall Study||6
239163|NCT00577889|575283|P1|COMPLETED|Overall Study||8
239164|NCT00577889|575281|P3|STARTED|Overall Study||6
239165|NCT00577889|575282|P2|STARTED|Overall Study||6
239166|NCT00577889|575283|P1|STARTED|Overall Study||9
239167|NCT00577863|575302|P2|NOT COMPLETED|Overall Study||14
239168|NCT00577863|575303|P1|NOT COMPLETED|Overall Study||10
239169|NCT00577863|575302|P2|COMPLETED|Overall Study||94
239170|NCT00577863|575303|P1|COMPLETED|Overall Study||82
239171|NCT00577863|575302|P2|Received at Least One Injection|Overall Study||107
239172|NCT00577863|575303|P1|Received at Least One Injection|Overall Study||92
239173|NCT00577863|575302|P2|STARTED|Overall Study||108
239174|NCT00577863|575303|P1|STARTED|Overall Study||92
239175|NCT00577824|575345|P3|NOT COMPLETED|Overall Study||2
239176|NCT00577824|575346|P2|NOT COMPLETED|Overall Study||20
239177|NCT00577824|575347|P1|NOT COMPLETED|Overall Study||7
239178|NCT00577824|575345|P3|COMPLETED|Overall Study||34
239179|NCT00577824|575346|P2|COMPLETED|Overall Study||53
239180|NCT00577824|575347|P1|COMPLETED|Overall Study||65
239181|NCT00577824|575345|P3|Full Analysis Set|Overall Study||35
239182|NCT00577824|575346|P2|Full Analysis Set|Overall Study||72
239183|NCT00577824|575347|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
239184|NCT00577824|575345|P3|STARTED|Overall Study||36
239185|NCT00577824|575346|P2|STARTED|Overall Study||73
239186|NCT00577824|575347|P1|STARTED|Overall Study|Started=Randomized|72
239187|NCT00577772|575405|P2|NOT COMPLETED|Overall Study||1
239188|NCT00577772|575406|P1|NOT COMPLETED|Overall Study||0
239189|NCT00577772|575405|P2|COMPLETED|Overall Study||6
239190|NCT00577772|575406|P1|COMPLETED|Overall Study||10
239191|NCT00577772|575405|P2|STARTED|Overall Study||7
239192|NCT00577772|575406|P1|STARTED|Overall Study||10
239193|NCT00577720|575416|P4|NOT COMPLETED|Overall Study||7
239194|NCT00577720|575417|P3|NOT COMPLETED|Overall Study||1
239195|NCT00577720|575418|P2|NOT COMPLETED|Overall Study||1
239196|NCT00577720|575419|P1|NOT COMPLETED|Overall Study||4
239197|NCT00577720|575416|P4|COMPLETED|Overall Study||65
239198|NCT00577720|575417|P3|COMPLETED|Overall Study||35
239199|NCT00577720|575418|P2|COMPLETED|Overall Study||35
239200|NCT00577720|575419|P1|COMPLETED|Overall Study||33
239201|NCT00577720|575416|P4|ITT (Intent to Treat) Population|Overall Study||65
239202|NCT00577720|575417|P3|ITT (Intent to Treat) Population|Overall Study||35
239203|NCT00577720|575418|P2|ITT (Intent to Treat) Population|Overall Study||35
239204|NCT00577720|575419|P1|ITT (Intent to Treat) Population|Overall Study||34
239205|NCT00577720|575416|P4|STARTED|Overall Study||72
239206|NCT00577720|575417|P3|STARTED|Overall Study||36
239207|NCT00577720|575418|P2|STARTED|Overall Study||36
239208|NCT00577720|575419|P1|STARTED|Overall Study||37
239209|NCT00577707|575437|P1|NOT COMPLETED|Overall Study||3
239210|NCT00577707|575437|P1|COMPLETED|Overall Study||6
239211|NCT00577707|575437|P1|STARTED|Overall Study||9
239212|NCT00577655|575445|P2|NOT COMPLETED|Overall Study||4
239213|NCT00577655|575446|P1|NOT COMPLETED|Overall Study||1
239214|NCT00577655|575445|P2|COMPLETED|Overall Study||47
239215|NCT00577655|575446|P1|COMPLETED|Overall Study||51
239216|NCT00577655|575445|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
239217|NCT00577655|575446|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
239218|NCT00577642|575484|P1|NOT COMPLETED|Overall Study||1
239219|NCT00577642|575484|P1|COMPLETED|Overall Study||28
239220|NCT00577642|575484|P1|STARTED|Overall Study||29
239221|NCT00577629|575488|P1|NOT COMPLETED|Long Term Follow-Up||25
239222|NCT00577629|575488|P1|COMPLETED|Long Term Follow-Up||13
239223|NCT00577629|575488|P1|STARTED|Long Term Follow-Up||38
239224|NCT00577629|575488|P1|NOT COMPLETED|Treatment Period||1
239225|NCT00577629|575488|P1|COMPLETED|Treatment Period||38
239226|NCT00577629|575488|P1|STARTED|Treatment Period||39
239227|NCT00577512|575496|P1|NOT COMPLETED|Overall Study||4
239228|NCT00577512|575496|P1|COMPLETED|Overall Study||0
239229|NCT00577512|575496|P1|STARTED|Overall Study||4
239230|NCT00577473|575502|P2|NOT COMPLETED|Overall Study||24
239231|NCT00577473|575503|P1|NOT COMPLETED|Overall Study||21
239232|NCT00577473|575502|P2|COMPLETED|Overall Study||123
239233|NCT00577473|575503|P1|COMPLETED|Overall Study||133
239234|NCT00577473|575502|P2|ITT Population|Overall Study||136
239235|NCT00577473|575503|P1|ITT Population|Overall Study||150
239236|NCT00577473|575502|P2|STARTED|Overall Study||147
239237|NCT00577473|575503|P1|STARTED|Overall Study||154
239238|NCT00577460|575534|P3|NOT COMPLETED|Overall Study||27
239239|NCT00577460|575535|P2|NOT COMPLETED|Overall Study||19
239240|NCT00577460|575536|P1|NOT COMPLETED|Overall Study||16
239241|NCT00577460|575534|P3|COMPLETED|Overall Study||112
239242|NCT00577460|575535|P2|COMPLETED|Overall Study||104
239243|NCT00577460|575536|P1|COMPLETED|Overall Study||113
239244|NCT00577460|575534|P3|STARTED|Overall Study||139
239245|NCT00577460|575535|P2|STARTED|Overall Study||123
239246|NCT00577460|575536|P1|STARTED|Overall Study||129
239247|NCT00577408|575645|P2|NOT COMPLETED|Overall Study||23
239248|NCT00577408|575646|P1|NOT COMPLETED|Overall Study||12
239249|NCT00577408|575645|P2|COMPLETED|Overall Study||9
239250|NCT00577408|575646|P1|COMPLETED|Overall Study||16
239251|NCT00577408|575645|P2|STARTED|Overall Study||32
239252|NCT00577408|575646|P1|STARTED|Overall Study||28
239253|NCT00577395|575654|P2|NOT COMPLETED|Overall Study||6
239254|NCT00577395|575655|P1|NOT COMPLETED|Overall Study||7
239255|NCT00577395|575654|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
239256|NCT00577395|575655|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
239257|NCT00577395|575654|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
239258|NCT00577395|575655|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
239259|NCT00577382|575665|P2|NOT COMPLETED|Overall Study||31
239260|NCT00577382|575666|P1|NOT COMPLETED|Overall Study||21
239261|NCT00577382|575665|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
239262|NCT00577382|575666|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
239263|NCT00577382|575665|P2|STARTED|Overall Study||31
239264|NCT00577382|575666|P1|STARTED|Overall Study||21
239265|NCT00577356|575678|P1|NOT COMPLETED|Overall Study||0
239266|NCT00577356|575678|P1|COMPLETED|Overall Study||6
239267|NCT00577356|575678|P1|STARTED|Overall Study||6
239268|NCT00577135|575686|P4|NOT COMPLETED|Overall Study||0
239269|NCT00577135|575687|P3|NOT COMPLETED|Overall Study||0
239270|NCT00577135|575688|P2|NOT COMPLETED|Overall Study||0
239271|NCT00577135|575689|P1|NOT COMPLETED|Overall Study||0
239272|NCT00577135|575686|P4|COMPLETED|Overall Study||75
239273|NCT00577135|575687|P3|COMPLETED|Overall Study||77
239274|NCT00577135|575688|P2|COMPLETED|Overall Study||82
239275|NCT00577135|575689|P1|COMPLETED|Overall Study||74
239276|NCT00577135|575686|P4|STARTED|Overall Study||75
239277|NCT00577135|575687|P3|STARTED|Overall Study||77
239278|NCT00577135|575688|P2|STARTED|Overall Study||82
239279|NCT00577135|575689|P1|STARTED|Overall Study||74
239280|NCT00577122|575809|P2|NOT COMPLETED|Overall Study||16
239281|NCT00577122|575810|P1|NOT COMPLETED|Overall Study||14
239282|NCT00577122|575809|P2|COMPLETED|Overall Study||0
239283|NCT00577122|575810|P1|COMPLETED|Overall Study||0
239284|NCT00577122|575809|P2|STARTED|Overall Study||16
239285|NCT00577122|575810|P1|STARTED|Overall Study||14
239286|NCT00577096|575824|P2|NOT COMPLETED|Long Term Participation||0
239287|NCT00577096|575825|P1|NOT COMPLETED|Long Term Participation||0
239288|NCT00577096|575824|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
239289|NCT00577096|575825|P1|COMPLETED|Long Term Participation||34
239290|NCT00577096|575824|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
239291|NCT00577096|575825|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
239292|NCT00577096|575824|P2|NOT COMPLETED|Short Term Participation||8
239293|NCT00577096|575825|P1|NOT COMPLETED|Short Term Participation||7
239294|NCT00577096|575824|P2|COMPLETED|Short Term Participation||58
239295|NCT00577096|575825|P1|COMPLETED|Short Term Participation||62
239296|NCT00577096|575824|P2|STARTED|Short Term Participation||66
239297|NCT00577096|575825|P1|STARTED|Short Term Participation||69
239298|NCT00577083|575851|P2|NOT COMPLETED|Second Intervention (14days)||0
239299|NCT00577083|575852|P1|NOT COMPLETED|Second Intervention (14days)||0
239300|NCT00577083|575851|P2|COMPLETED|Second Intervention (14days)||52
239301|NCT00577083|575852|P1|COMPLETED|Second Intervention (14days)||48
239302|NCT00577083|575851|P2|STARTED|Second Intervention (14days)||52
239303|NCT00577083|575852|P1|STARTED|Second Intervention (14days)||48
239304|NCT00577083|575851|P2|NOT COMPLETED|Washout (14 Days)||0
239305|NCT00577083|575852|P1|NOT COMPLETED|Washout (14 Days)||0
239306|NCT00577083|575851|P2|COMPLETED|Washout (14 Days)||52
239307|NCT00577083|575852|P1|COMPLETED|Washout (14 Days)||48
239308|NCT00577083|575851|P2|STARTED|Washout (14 Days)||52
239309|NCT00577083|575852|P1|STARTED|Washout (14 Days)||48
239310|NCT00577083|575851|P2|NOT COMPLETED|First Intervention (14 Days)||0
239311|NCT00577083|575852|P1|NOT COMPLETED|First Intervention (14 Days)||0
239312|NCT00577083|575851|P2|COMPLETED|First Intervention (14 Days)||52
239313|NCT00577083|575852|P1|COMPLETED|First Intervention (14 Days)||48
239314|NCT00577083|575851|P2|STARTED|First Intervention (14 Days)||52
239315|NCT00577083|575852|P1|STARTED|First Intervention (14 Days)||48
239316|NCT00577031|575858|P1|NOT COMPLETED|Overall Study||205
239317|NCT00577031|575858|P1|COMPLETED|Overall Study||0
239318|NCT00577031|575858|P1|STARTED|Overall Study||205
239319|NCT00577005|575879|P2|NOT COMPLETED|Overall Study||3
239320|NCT00577005|575880|P1|NOT COMPLETED|Overall Study||5
239321|NCT00577005|575879|P2|COMPLETED|Overall Study||9
239322|NCT00577005|575880|P1|COMPLETED|Overall Study||11
239323|NCT00577005|575879|P2|STARTED|Overall Study||12
239324|NCT00577005|575880|P1|STARTED|Overall Study||16
239325|NCT00576927|575894|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
239326|NCT00576927|575894|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
239327|NCT00576927|575894|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
239328|NCT00576927|575894|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
239329|NCT00576927|575894|P1|COMPLETED|Sleep Hygiene With Study Drug||22
239330|NCT00576927|575894|P1|STARTED|Sleep Hygiene With Study Drug||22
239331|NCT00576927|575894|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
239332|NCT00576927|575894|P1|COMPLETED|Sleep Hygiene With the Placebo||22
239333|NCT00576927|575894|P1|STARTED|Sleep Hygiene With the Placebo||23
239334|NCT00576927|575894|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
239335|NCT00576927|575894|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
239336|NCT00576927|575894|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
239337|NCT00576927|575894|P1|NOT COMPLETED|Baseline||13
239338|NCT00576927|575894|P1|COMPLETED|Baseline||30
239339|NCT00576927|575894|P1|STARTED|Baseline||43
239340|NCT00576927|575894|P1|NOT COMPLETED|Clinical Assessment||36
239341|NCT00576927|575894|P1|COMPLETED|Clinical Assessment||43
239342|NCT00576927|575894|P1|STARTED|Clinical Assessment||79
239343|NCT00576901|575906|P1|NOT COMPLETED|Overall Study||3
239344|NCT00576901|575906|P1|COMPLETED|Overall Study||20
239345|NCT00576901|575906|P1|STARTED|Overall Study||23
239346|NCT00576823|575917|P3|NOT COMPLETED|40-week Safety Extension Phase||0
239347|NCT00576823|575918|P2|NOT COMPLETED|40-week Safety Extension Phase||0
239348|NCT00576823|575919|P1|NOT COMPLETED|40-week Safety Extension Phase||1
239349|NCT00576823|575917|P3|COMPLETED|40-week Safety Extension Phase||6
239350|NCT00576823|575918|P2|COMPLETED|40-week Safety Extension Phase||6
239351|NCT00576823|575919|P1|COMPLETED|40-week Safety Extension Phase||10
239352|NCT00576823|575917|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
239353|NCT00576823|575918|P2|STARTED|40-week Safety Extension Phase||6
239354|NCT00576823|575919|P1|STARTED|40-week Safety Extension Phase||11
239355|NCT00576823|575917|P3|NOT COMPLETED|12-week Efficacy Phase||0
239356|NCT00576823|575918|P2|NOT COMPLETED|12-week Efficacy Phase||0
239357|NCT00576823|575919|P1|NOT COMPLETED|12-week Efficacy Phase||1
239358|NCT00576823|575917|P3|COMPLETED|12-week Efficacy Phase||7
239359|NCT00576823|575918|P2|COMPLETED|12-week Efficacy Phase||6
239360|NCT00576823|575919|P1|COMPLETED|12-week Efficacy Phase||11
239361|NCT00576823|575917|P3|STARTED|12-week Efficacy Phase||7
239362|NCT00576823|575918|P2|STARTED|12-week Efficacy Phase||6
239363|NCT00576823|575919|P1|STARTED|12-week Efficacy Phase||12
239364|NCT00576758|575935|P2|NOT COMPLETED|Follow-up Period||17
239365|NCT00576758|575936|P1|NOT COMPLETED|Follow-up Period||27
239366|NCT00576758|575935|P2|COMPLETED|Follow-up Period||34
239367|NCT00576758|575936|P1|COMPLETED|Follow-up Period||28
239368|NCT00576758|575935|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
239369|NCT00576758|575936|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
239370|NCT00576758|575935|P2|NOT COMPLETED|Extension Treatment Period||43
239371|NCT00576758|575936|P1|NOT COMPLETED|Extension Treatment Period||42
239372|NCT00576758|575935|P2|COMPLETED|Extension Treatment Period||30
239373|NCT00576758|575936|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
239374|NCT00576758|575935|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
239375|NCT00576758|575936|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
239376|NCT00576758|575935|P2|NOT COMPLETED|Induction Treatment Period||5
239377|NCT00576758|575936|P1|NOT COMPLETED|Induction Treatment Period||8
239378|NCT00576758|575935|P2|COMPLETED|Induction Treatment Period||83
239379|NCT00576758|575936|P1|COMPLETED|Induction Treatment Period||79
239380|NCT00576758|575935|P2|Received Treatment|Induction Treatment Period||87
239381|NCT00576758|575936|P1|Received Treatment|Induction Treatment Period||86
239382|NCT00576758|575935|P2|STARTED|Induction Treatment Period||88
239383|NCT00576758|575936|P1|STARTED|Induction Treatment Period||87
239384|NCT00576732|575982|P6|NOT COMPLETED|OPEN LABEL||8
239385|NCT00576732|575983|P5|NOT COMPLETED|OPEN LABEL||4
239386|NCT00576732|575984|P4|NOT COMPLETED|OPEN LABEL||11
239387|NCT00576732|575985|P3|NOT COMPLETED|OPEN LABEL||0
239388|NCT00576732|575986|P2|NOT COMPLETED|OPEN LABEL||0
239389|NCT00576732|575987|P1|NOT COMPLETED|OPEN LABEL||0
239390|NCT00576732|575982|P6|COMPLETED|OPEN LABEL||17
239391|NCT00576732|575983|P5|COMPLETED|OPEN LABEL||20
239392|NCT00576732|575984|P4|COMPLETED|OPEN LABEL||19
239393|NCT00576732|575985|P3|COMPLETED|OPEN LABEL||0
239394|NCT00576732|575986|P2|COMPLETED|OPEN LABEL||0
239395|NCT00576732|575987|P1|COMPLETED|OPEN LABEL||0
239396|NCT00576732|575982|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
239397|NCT00576732|575983|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
239398|NCT00576732|575984|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
239399|NCT00576732|575985|P3|STARTED|OPEN LABEL||0
239400|NCT00576732|575986|P2|STARTED|OPEN LABEL||0
239401|NCT00576732|575987|P1|STARTED|OPEN LABEL||0
239402|NCT00576732|575982|P6|NOT COMPLETED|DOUBLE BLIND||0
239403|NCT00576732|575983|P5|NOT COMPLETED|DOUBLE BLIND||0
239404|NCT00576732|575984|P4|NOT COMPLETED|DOUBLE BLIND||0
239405|NCT00576732|575985|P3|NOT COMPLETED|DOUBLE BLIND||6
239406|NCT00576732|575986|P2|NOT COMPLETED|DOUBLE BLIND||5
239407|NCT00576732|575987|P1|NOT COMPLETED|DOUBLE BLIND||8
239408|NCT00576732|575982|P6|COMPLETED|DOUBLE BLIND||0
239409|NCT00576732|575983|P5|COMPLETED|DOUBLE BLIND||0
239410|NCT00576732|575984|P4|COMPLETED|DOUBLE BLIND||0
239411|NCT00576732|575985|P3|COMPLETED|DOUBLE BLIND||25
239412|NCT00576732|575986|P2|COMPLETED|DOUBLE BLIND||25
239413|NCT00576732|575987|P1|COMPLETED|DOUBLE BLIND||27
239414|NCT00576732|575982|P6|STARTED|DOUBLE BLIND||0
239415|NCT00576732|575983|P5|STARTED|DOUBLE BLIND||0
239416|NCT00576732|575984|P4|STARTED|DOUBLE BLIND||0
239417|NCT00576732|575985|P3|STARTED|DOUBLE BLIND||31
239418|NCT00576732|575986|P2|STARTED|DOUBLE BLIND||30
239419|NCT00576732|575987|P1|STARTED|DOUBLE BLIND||35
239420|NCT00576693|576019|P2|NOT COMPLETED|Overall Study||24
239421|NCT00576693|576020|P1|NOT COMPLETED|Overall Study||10
239422|NCT00576693|576019|P2|COMPLETED|Overall Study||203
239423|NCT00576693|576020|P1|COMPLETED|Overall Study||214
239424|NCT00576693|576019|P2|STARTED|Overall Study||227
239425|NCT00576693|576020|P1|STARTED|Overall Study||224
239426|NCT00576628|576026|P1|NOT COMPLETED|Overall Study||43
239427|NCT00576628|576026|P1|COMPLETED|Overall Study||82
239428|NCT00576628|576026|P1|STARTED|Overall Study||125
239429|NCT00576576|576046|P1|NOT COMPLETED|Overall Study||7
239430|NCT00576576|576046|P1|COMPLETED|Overall Study||20
239431|NCT00576576|576046|P1|STARTED|Overall Study||27
239432|NCT00576524|576054|P2|NOT COMPLETED|Overall Study||0
239433|NCT00576524|576055|P1|NOT COMPLETED|Overall Study||0
239434|NCT00576524|576054|P2|COMPLETED|Overall Study||0
239435|NCT00576524|576055|P1|COMPLETED|Overall Study||2
239436|NCT00576524|576054|P2|STARTED|Overall Study||0
239437|NCT00576524|576055|P1|STARTED|Overall Study||2
239438|NCT00576472|576080|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
239439|NCT00576472|576081|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
239440|NCT00576472|576082|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
239441|NCT00576472|576083|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
239442|NCT00576472|576084|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
239443|NCT00576472|576085|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
239444|NCT00576472|576086|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
239445|NCT00576472|576087|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
239446|NCT00576472|576088|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
239447|NCT00576472|576089|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
239448|NCT00576472|576090|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
239449|NCT00576472|576091|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
239450|NCT00576472|576092|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
239451|NCT00576472|576093|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
239452|NCT00576472|576094|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
239453|NCT00576472|576080|P15|COMPLETED|MPH Home Maintenance Phase||68
239454|NCT00576472|576081|P14|COMPLETED|MPH Home Maintenance Phase||0
239455|NCT00576472|576082|P13|COMPLETED|MPH Home Maintenance Phase||0
239456|NCT00576472|576083|P12|COMPLETED|MPH Home Maintenance Phase||0
239457|NCT00576472|576084|P11|COMPLETED|MPH Home Maintenance Phase||0
239458|NCT00576472|576085|P10|COMPLETED|MPH Home Maintenance Phase||0
239459|NCT00576472|576086|P9|COMPLETED|MPH Home Maintenance Phase||0
239460|NCT00576472|576087|P8|COMPLETED|MPH Home Maintenance Phase||0
239461|NCT00576472|576088|P7|COMPLETED|MPH Home Maintenance Phase||0
239462|NCT00576472|576089|P6|COMPLETED|MPH Home Maintenance Phase||0
239463|NCT00576472|576090|P5|COMPLETED|MPH Home Maintenance Phase||0
239464|NCT00576472|576091|P4|COMPLETED|MPH Home Maintenance Phase||0
239465|NCT00576472|576092|P3|COMPLETED|MPH Home Maintenance Phase||0
239466|NCT00576472|576093|P2|COMPLETED|MPH Home Maintenance Phase||0
239467|NCT00576472|576094|P1|COMPLETED|MPH Home Maintenance Phase||0
239468|NCT00576472|576080|P15|STARTED|MPH Home Maintenance Phase||91
239469|NCT00576472|576081|P14|STARTED|MPH Home Maintenance Phase||27
239470|NCT00576472|576082|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239471|NCT00576472|576083|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239472|NCT00576472|576084|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239473|NCT00576472|576085|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239474|NCT00576472|576086|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239475|NCT00576472|576087|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239476|NCT00576472|576088|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239477|NCT00576472|576089|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239478|NCT00576472|576090|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239479|NCT00576472|576091|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239480|NCT00576472|576092|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239481|NCT00576472|576093|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239482|NCT00576472|576094|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
239483|NCT00576472|576080|P15|NOT COMPLETED|MPH Cross Over Phase||0
239484|NCT00576472|576081|P14|NOT COMPLETED|MPH Cross Over Phase||0
239485|NCT00576472|576082|P13|NOT COMPLETED|MPH Cross Over Phase||0
239486|NCT00576472|576083|P12|NOT COMPLETED|MPH Cross Over Phase||1
239487|NCT00576472|576084|P11|NOT COMPLETED|MPH Cross Over Phase||1
239488|NCT00576472|576085|P10|NOT COMPLETED|MPH Cross Over Phase||0
239489|NCT00576472|576086|P9|NOT COMPLETED|MPH Cross Over Phase||2
239490|NCT00576472|576087|P8|NOT COMPLETED|MPH Cross Over Phase||0
239491|NCT00576472|576088|P7|NOT COMPLETED|MPH Cross Over Phase||12
239492|NCT00576472|576089|P6|NOT COMPLETED|MPH Cross Over Phase||0
239493|NCT00576472|576090|P5|NOT COMPLETED|MPH Cross Over Phase||0
239494|NCT00576472|576091|P4|NOT COMPLETED|MPH Cross Over Phase||0
239495|NCT00576472|576092|P3|NOT COMPLETED|MPH Cross Over Phase||0
239496|NCT00576472|576093|P2|NOT COMPLETED|MPH Cross Over Phase||0
239497|NCT00576472|576094|P1|NOT COMPLETED|MPH Cross Over Phase||0
239498|NCT00576472|576080|P15|COMPLETED|MPH Cross Over Phase||0
239499|NCT00576472|576081|P14|COMPLETED|MPH Cross Over Phase||0
239500|NCT00576472|576082|P13|COMPLETED|MPH Cross Over Phase||21
239501|NCT00576472|576083|P12|COMPLETED|MPH Cross Over Phase||17
239502|NCT00576472|576084|P11|COMPLETED|MPH Cross Over Phase||22
239503|NCT00576472|576085|P10|COMPLETED|MPH Cross Over Phase||22
239504|NCT00576472|576086|P9|COMPLETED|MPH Cross Over Phase||16
239505|NCT00576472|576087|P8|COMPLETED|MPH Cross Over Phase||20
239506|NCT00576472|576088|P7|COMPLETED|MPH Cross Over Phase||0
239507|NCT00576472|576089|P6|COMPLETED|MPH Cross Over Phase||0
239508|NCT00576472|576090|P5|COMPLETED|MPH Cross Over Phase||0
239509|NCT00576472|576091|P4|COMPLETED|MPH Cross Over Phase||0
239510|NCT00576472|576092|P3|COMPLETED|MPH Cross Over Phase||0
239511|NCT00576472|576093|P2|COMPLETED|MPH Cross Over Phase||0
239512|NCT00576472|576094|P1|COMPLETED|MPH Cross Over Phase||0
239513|NCT00576472|576080|P15|STARTED|MPH Cross Over Phase||0
239514|NCT00576472|576081|P14|STARTED|MPH Cross Over Phase||0
239515|NCT00576472|576082|P13|STARTED|MPH Cross Over Phase||21
239516|NCT00576472|576083|P12|STARTED|MPH Cross Over Phase||18
239517|NCT00576472|576084|P11|STARTED|MPH Cross Over Phase||23
239518|NCT00576472|576085|P10|STARTED|MPH Cross Over Phase||22
239519|NCT00576472|576086|P9|STARTED|MPH Cross Over Phase||18
239520|NCT00576472|576087|P8|STARTED|MPH Cross Over Phase||20
239521|NCT00576472|576088|P7|STARTED|MPH Cross Over Phase||12
239522|NCT00576472|576089|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
239523|NCT00576472|576090|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
239524|NCT00576472|576091|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
239525|NCT00576472|576092|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
239526|NCT00576472|576093|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
239527|NCT00576472|576094|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
239528|NCT00576472|576080|P15|NOT COMPLETED|MPH In-Lab Phase||0
239529|NCT00576472|576081|P14|NOT COMPLETED|MPH In-Lab Phase||0
239530|NCT00576472|576082|P13|NOT COMPLETED|MPH In-Lab Phase||0
239531|NCT00576472|576083|P12|NOT COMPLETED|MPH In-Lab Phase||0
239532|NCT00576472|576084|P11|NOT COMPLETED|MPH In-Lab Phase||0
239533|NCT00576472|576085|P10|NOT COMPLETED|MPH In-Lab Phase||0
239534|NCT00576472|576086|P9|NOT COMPLETED|MPH In-Lab Phase||0
239535|NCT00576472|576087|P8|NOT COMPLETED|MPH In-Lab Phase||0
239536|NCT00576472|576088|P7|NOT COMPLETED|MPH In-Lab Phase||0
239537|NCT00576472|576089|P6|NOT COMPLETED|MPH In-Lab Phase||0
239538|NCT00576472|576090|P5|NOT COMPLETED|MPH In-Lab Phase||0
239539|NCT00576472|576091|P4|NOT COMPLETED|MPH In-Lab Phase||335
239540|NCT00576472|576092|P3|NOT COMPLETED|MPH In-Lab Phase||0
239541|NCT00576472|576093|P2|NOT COMPLETED|MPH In-Lab Phase||0
239542|NCT00576472|576094|P1|NOT COMPLETED|MPH In-Lab Phase||0
239543|NCT00576472|576080|P15|COMPLETED|MPH In-Lab Phase||0
239544|NCT00576472|576081|P14|COMPLETED|MPH In-Lab Phase||0
239545|NCT00576472|576082|P13|COMPLETED|MPH In-Lab Phase||0
239546|NCT00576472|576083|P12|COMPLETED|MPH In-Lab Phase||0
239547|NCT00576472|576084|P11|COMPLETED|MPH In-Lab Phase||0
239548|NCT00576472|576085|P10|COMPLETED|MPH In-Lab Phase||0
239549|NCT00576472|576086|P9|COMPLETED|MPH In-Lab Phase||0
239550|NCT00576472|576087|P8|COMPLETED|MPH In-Lab Phase||0
239551|NCT00576472|576088|P7|COMPLETED|MPH In-Lab Phase||0
239552|NCT00576472|576089|P6|COMPLETED|MPH In-Lab Phase||67
239553|NCT00576472|576090|P5|COMPLETED|MPH In-Lab Phase||67
239554|NCT00576472|576091|P4|COMPLETED|MPH In-Lab Phase||0
239555|NCT00576472|576092|P3|COMPLETED|MPH In-Lab Phase||0
239556|NCT00576472|576093|P2|COMPLETED|MPH In-Lab Phase||0
239557|NCT00576472|576094|P1|COMPLETED|MPH In-Lab Phase||0
239558|NCT00576472|576080|P15|STARTED|MPH In-Lab Phase||0
239559|NCT00576472|576081|P14|STARTED|MPH In-Lab Phase||0
239560|NCT00576472|576082|P13|STARTED|MPH In-Lab Phase||0
239561|NCT00576472|576083|P12|STARTED|MPH In-Lab Phase||0
239562|NCT00576472|576084|P11|STARTED|MPH In-Lab Phase||0
239563|NCT00576472|576085|P10|STARTED|MPH In-Lab Phase||0
239564|NCT00576472|576086|P9|STARTED|MPH In-Lab Phase||0
239565|NCT00576472|576087|P8|STARTED|MPH In-Lab Phase||0
239566|NCT00576472|576088|P7|STARTED|MPH In-Lab Phase||0
239567|NCT00576472|576089|P6|STARTED|MPH In-Lab Phase||67
239568|NCT00576472|576090|P5|STARTED|MPH In-Lab Phase||67
239569|NCT00576472|576091|P4|STARTED|MPH In-Lab Phase||335
239570|NCT00576472|576092|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
239571|NCT00576472|576093|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
239572|NCT00576472|576094|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
239573|NCT00576472|576080|P15|NOT COMPLETED|Initial Screening||0
239574|NCT00576472|576081|P14|NOT COMPLETED|Initial Screening||0
239575|NCT00576472|576082|P13|NOT COMPLETED|Initial Screening||0
239576|NCT00576472|576083|P12|NOT COMPLETED|Initial Screening||0
239577|NCT00576472|576084|P11|NOT COMPLETED|Initial Screening||0
239578|NCT00576472|576085|P10|NOT COMPLETED|Initial Screening||0
239579|NCT00576472|576086|P9|NOT COMPLETED|Initial Screening||0
239580|NCT00576472|576087|P8|NOT COMPLETED|Initial Screening||0
239581|NCT00576472|576088|P7|NOT COMPLETED|Initial Screening||0
239582|NCT00576472|576089|P6|NOT COMPLETED|Initial Screening||0
239583|NCT00576472|576090|P5|NOT COMPLETED|Initial Screening||0
239584|NCT00576472|576091|P4|NOT COMPLETED|Initial Screening||0
239585|NCT00576472|576092|P3|NOT COMPLETED|Initial Screening||0
239586|NCT00576472|576093|P2|NOT COMPLETED|Initial Screening||0
239587|NCT00576472|576094|P1|NOT COMPLETED|Initial Screening||0
239588|NCT00576472|576080|P15|COMPLETED|Initial Screening||0
239589|NCT00576472|576081|P14|COMPLETED|Initial Screening||0
239590|NCT00576472|576082|P13|COMPLETED|Initial Screening||0
239591|NCT00576472|576083|P12|COMPLETED|Initial Screening||0
239592|NCT00576472|576084|P11|COMPLETED|Initial Screening||0
239593|NCT00576472|576085|P10|COMPLETED|Initial Screening||0
239594|NCT00576472|576086|P9|COMPLETED|Initial Screening||0
239595|NCT00576472|576087|P8|COMPLETED|Initial Screening||0
239596|NCT00576472|576088|P7|COMPLETED|Initial Screening||0
239597|NCT00576472|576089|P6|COMPLETED|Initial Screening||0
239598|NCT00576472|576090|P5|COMPLETED|Initial Screening||0
239599|NCT00576472|576091|P4|COMPLETED|Initial Screening||0
239600|NCT00576472|576092|P3|COMPLETED|Initial Screening||199
239601|NCT00576472|576093|P2|COMPLETED|Initial Screening||40
239602|NCT00576472|576094|P1|COMPLETED|Initial Screening||230
239603|NCT00576472|576080|P15|STARTED|Initial Screening||0
239604|NCT00576472|576081|P14|STARTED|Initial Screening||0
239605|NCT00576472|576082|P13|STARTED|Initial Screening||0
239606|NCT00576472|576083|P12|STARTED|Initial Screening||0
239607|NCT00576472|576084|P11|STARTED|Initial Screening||0
239608|NCT00576472|576085|P10|STARTED|Initial Screening||0
239609|NCT00576472|576086|P9|STARTED|Initial Screening||0
239610|NCT00576472|576087|P8|STARTED|Initial Screening||0
239611|NCT00576472|576088|P7|STARTED|Initial Screening||0
239612|NCT00576472|576089|P6|STARTED|Initial Screening||0
239613|NCT00576472|576090|P5|STARTED|Initial Screening||0
239614|NCT00576472|576091|P4|STARTED|Initial Screening||0
239615|NCT00576472|576092|P3|STARTED|Initial Screening||199
239616|NCT00576472|576093|P2|STARTED|Initial Screening||40
239617|NCT00576472|576094|P1|STARTED|Initial Screening||230
239618|NCT00576420|576187|P3|NOT COMPLETED|Overall Study||1
239619|NCT00576420|576188|P2|NOT COMPLETED|Overall Study||0
239620|NCT00576420|576189|P1|NOT COMPLETED|Overall Study||0
239621|NCT00576420|576187|P3|COMPLETED|Overall Study||22
239622|NCT00576420|576188|P2|COMPLETED|Overall Study||24
239623|NCT00576420|576189|P1|COMPLETED|Overall Study||26
239624|NCT00576420|576187|P3|STARTED|Overall Study||23
239625|NCT00576420|576188|P2|STARTED|Overall Study||24
239626|NCT00576420|576189|P1|STARTED|Overall Study||26
239627|NCT00576381|576354|P1|NOT COMPLETED|Overall Study||7
239628|NCT00576381|576354|P1|COMPLETED|Overall Study||23
239629|NCT00576381|576354|P1|STARTED|Overall Study||30
239630|NCT00576316|576358|P1|NOT COMPLETED|Overall Study||20
239631|NCT00576316|576358|P1|COMPLETED|Overall Study|Number of patients who completed study|181
239632|NCT00576316|576358|P1|STARTED|Overall Study|Number of patients recruited|201
239633|NCT00576303|576363|P1|NOT COMPLETED|Long Term Safety Period||16
239634|NCT00576303|576363|P1|COMPLETED|Long Term Safety Period||162
239635|NCT00576303|576363|P1|STARTED|Long Term Safety Period||178
239636|NCT00576303|576363|P1|NOT COMPLETED|Efficacy Evaluation Period||5
239637|NCT00576303|576363|P1|COMPLETED|Efficacy Evaluation Period||178
239638|NCT00576303|576363|P1|STARTED|Efficacy Evaluation Period||183
239639|NCT00576303|576363|P1|NOT COMPLETED|Dose Titration Period||17
239640|NCT00576303|576363|P1|COMPLETED|Dose Titration Period||183
239641|NCT00576303|576363|P1|STARTED|Dose Titration Period||200
239642|NCT00576251|576374|P2|NOT COMPLETED|Overall Study||1
239643|NCT00576251|576375|P1|NOT COMPLETED|Overall Study||1
239644|NCT00576251|576374|P2|COMPLETED|Overall Study||111
239645|NCT00576251|576375|P1|COMPLETED|Overall Study||108
239646|NCT00576251|576374|P2|STARTED|Overall Study||112
239647|NCT00576251|576375|P1|STARTED|Overall Study||109
239648|NCT00576199|576381|P1|NOT COMPLETED|Overall Study||30
239649|NCT00576199|576381|P1|COMPLETED|Overall Study||0
239650|NCT00576199|576381|P1|STARTED|Overall Study||30
239651|NCT00576147|576390|P1|NOT COMPLETED|Overall Study||0
239652|NCT00576147|576390|P1|COMPLETED|Overall Study||431
239653|NCT00576147|576390|P1|STARTED|Overall Study||431
239654|NCT00576056|576394|P1|NOT COMPLETED|Overall Study||14
239655|NCT00576056|576394|P1|COMPLETED|Overall Study||5
239656|NCT00576056|576394|P1|STARTED|Overall Study||19
239657|NCT00575965|576399|P1|NOT COMPLETED|Overall Study||0
239658|NCT00575965|576399|P1|COMPLETED|Overall Study||18
239659|NCT00575965|576399|P1|STARTED|Overall Study||18
239660|NCT00575887|576404|P1|NOT COMPLETED|Overall Study||0
239661|NCT00575887|576404|P1|COMPLETED|Overall Study||25
239662|NCT00575887|576404|P1|STARTED|Overall Study||25
239663|NCT00575666|576410|P2|NOT COMPLETED|Overall Study||3
239664|NCT00575666|576411|P1|NOT COMPLETED|Overall Study||4
239665|NCT00575666|576410|P2|COMPLETED|Overall Study||21
239666|NCT00575666|576411|P1|COMPLETED|Overall Study||17
239667|NCT00575666|576410|P2|STARTED|Overall Study||24
239668|NCT00575666|576411|P1|STARTED|Overall Study||21
239669|NCT00575588|576451|P2|NOT COMPLETED|Overall Study||283
239670|NCT00575588|576452|P1|NOT COMPLETED|Overall Study||263
239671|NCT00575588|576451|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
239672|NCT00575588|576452|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
239673|NCT00575588|576451|P2|STARTED|Overall Study|Randomized and treated|430
239674|NCT00575588|576452|P1|STARTED|Overall Study|Randomized and treated|428
239675|NCT00575510|576475|P3|NOT COMPLETED|Overall Study||17
239676|NCT00575510|576476|P2|NOT COMPLETED|Overall Study||13
239677|NCT00575510|576477|P1|NOT COMPLETED|Overall Study||12
239678|NCT00575510|576475|P3|COMPLETED|Overall Study||96
239679|NCT00575510|576476|P2|COMPLETED|Overall Study||101
239680|NCT00575510|576477|P1|COMPLETED|Overall Study||102
239681|NCT00575510|576475|P3|STARTED|Overall Study||113
239682|NCT00575510|576476|P2|STARTED|Overall Study||114
239683|NCT00575510|576477|P1|STARTED|Overall Study||114
239684|NCT00575380|576490|P2|NOT COMPLETED|Overall Study||3
239685|NCT00575380|576491|P1|NOT COMPLETED|Overall Study||1
239686|NCT00575380|576490|P2|COMPLETED|Overall Study||55
239687|NCT00575380|576491|P1|COMPLETED|Overall Study||57
239688|NCT00575380|576490|P2|STARTED|Overall Study||58
239689|NCT00575380|576491|P1|STARTED|Overall Study||58
239690|NCT00575367|576501|P2|NOT COMPLETED|Overall Study||0
239691|NCT00575367|576502|P1|NOT COMPLETED|Overall Study||0
239692|NCT00575367|576501|P2|COMPLETED|Overall Study||18
239693|NCT00575367|576502|P1|COMPLETED|Overall Study||19
239694|NCT00575367|576501|P2|STARTED|Overall Study||18
239695|NCT00575367|576502|P1|STARTED|Overall Study||19
239696|NCT00575185|576510|P2|NOT COMPLETED|Overall Study||0
239697|NCT00575185|576511|P1|NOT COMPLETED|Overall Study||0
239698|NCT00575185|576510|P2|COMPLETED|Overall Study||11
239699|NCT00575185|576511|P1|COMPLETED|Overall Study||12
239700|NCT00575185|576510|P2|STARTED|Overall Study||11
239701|NCT00575185|576511|P1|STARTED|Overall Study||12
239702|NCT00575159|576519|P1|NOT COMPLETED|Overall Study||0
239703|NCT00575159|576519|P1|COMPLETED|Overall Study||10
239704|NCT00575159|576519|P1|STARTED|Overall Study||10
239705|NCT00575146|576627|P1|NOT COMPLETED|Overall Study||3
239706|NCT00575146|576627|P1|COMPLETED|Overall Study||17
239707|NCT00575146|576627|P1|STARTED|Overall Study||20
239708|NCT00575094|576633|P1|NOT COMPLETED|Overall Study||3
239709|NCT00575094|576633|P1|COMPLETED|Overall Study||6
239710|NCT00575094|576633|P1|STARTED|Overall Study||9
239711|NCT00575042|576637|P1|NOT COMPLETED|Overall Study||3
239712|NCT00575042|576637|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
239713|NCT00575042|576637|P1|STARTED|Overall Study||20
239714|NCT00575029|576642|P1|NOT COMPLETED|Overall Study||0
239715|NCT00575029|576642|P1|COMPLETED|Overall Study||7
239716|NCT00575029|576642|P1|STARTED|Overall Study||7
239717|NCT00575016|576651|P4|NOT COMPLETED|Treatment Cycle 2||0
239718|NCT00575016|576652|P3|NOT COMPLETED|Treatment Cycle 2||0
239719|NCT00575016|576653|P2|NOT COMPLETED|Treatment Cycle 2||0
239720|NCT00575016|576654|P1|NOT COMPLETED|Treatment Cycle 2||1
239721|NCT00575016|576651|P4|COMPLETED|Treatment Cycle 2||0
239722|NCT00575016|576652|P3|COMPLETED|Treatment Cycle 2||0
239723|NCT00575016|576653|P2|COMPLETED|Treatment Cycle 2||0
239724|NCT00575016|576654|P1|COMPLETED|Treatment Cycle 2||30
239725|NCT00575016|576651|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
239726|NCT00575016|576652|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
239727|NCT00575016|576653|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
239728|NCT00575016|576654|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
239729|NCT00575016|576651|P4|NOT COMPLETED|Treatment Cycle 1||5
239730|NCT00575016|576652|P3|NOT COMPLETED|Treatment Cycle 1||4
239731|NCT00575016|576653|P2|NOT COMPLETED|Treatment Cycle 1||5
239732|NCT00575016|576654|P1|NOT COMPLETED|Treatment Cycle 1||9
239733|NCT00575016|576651|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
239734|NCT00575016|576652|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
239735|NCT00575016|576653|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
239736|NCT00575016|576654|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
239737|NCT00575016|576651|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
239738|NCT00575016|576652|P3|STARTED|Treatment Cycle 1||19
239739|NCT00575016|576653|P2|STARTED|Treatment Cycle 1||21
239740|NCT00575016|576654|P1|STARTED|Treatment Cycle 1||17
239741|NCT00574990|576675|P3|NOT COMPLETED|Overall Study||0
239742|NCT00574990|576676|P2|NOT COMPLETED|Overall Study||0
239743|NCT00574990|576677|P1|NOT COMPLETED|Overall Study||0
239744|NCT00574990|576675|P3|COMPLETED|Overall Study||8
239745|NCT00574990|576676|P2|COMPLETED|Overall Study||19
239746|NCT00574990|576677|P1|COMPLETED|Overall Study||12
239747|NCT00574990|576675|P3|STARTED|Overall Study||8
239748|NCT00574990|576676|P2|STARTED|Overall Study||19
239749|NCT00574990|576677|P1|STARTED|Overall Study||12
239750|NCT00574951|576688|P1|NOT COMPLETED|Overall Study||1
239751|NCT00574951|576688|P1|COMPLETED|Overall Study||22
239752|NCT00574951|576688|P1|STARTED|Overall Study||23
239753|NCT00574912|576696|P1|NOT COMPLETED|Overall Study||8
239754|NCT00574912|576696|P1|COMPLETED|Overall Study||12
239755|NCT00574912|576696|P1|Completed 2.0|Overall Study||12
239756|NCT00574912|576696|P1|Completed 1.5|Overall Study||12
239757|NCT00574912|576696|P1|Completed 1.0|Overall Study||12
239758|NCT00574912|576696|P1|Completed 0.5|Overall Study||12
239759|NCT00574912|576696|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
239760|NCT00574912|576696|P1|STARTED|Overall Study||20
239761|NCT00574873|576710|P2|NOT COMPLETED|Overall Study||251
239762|NCT00574873|576711|P1|NOT COMPLETED|Overall Study||238
239763|NCT00574873|576710|P2|COMPLETED|Overall Study||1
239764|NCT00574873|576711|P1|COMPLETED|Overall Study||12
239765|NCT00574873|576710|P2|Treated|Overall Study||251
239766|NCT00574873|576711|P1|Treated|Overall Study||248
239767|NCT00574873|576710|P2|STARTED|Overall Study||252
239768|NCT00574873|576711|P1|STARTED|Overall Study||250
239769|NCT00574847|576729|P2|NOT COMPLETED|Overall Study||7
239770|NCT00574847|576730|P1|NOT COMPLETED|Overall Study||8
239771|NCT00574847|576729|P2|COMPLETED|Overall Study||56
239772|NCT00574847|576730|P1|COMPLETED|Overall Study||56
239773|NCT00574847|576729|P2|STARTED|Overall Study||63
239774|NCT00574847|576730|P1|STARTED|Overall Study||64
239775|NCT00574834|576765|P3|NOT COMPLETED|Overall Study||0
239776|NCT00574834|576766|P2|NOT COMPLETED|Overall Study||0
239777|NCT00574834|576767|P1|NOT COMPLETED|Overall Study||0
239778|NCT00574834|576765|P3|COMPLETED|Overall Study||4
239779|NCT00574834|576766|P2|COMPLETED|Overall Study||4
239780|NCT00574834|576767|P1|COMPLETED|Overall Study||9
239781|NCT00574834|576765|P3|STARTED|Overall Study||4
239782|NCT00574834|576766|P2|STARTED|Overall Study||4
239783|NCT00574834|576767|P1|STARTED|Overall Study||9
239784|NCT00574795|576775|P1|NOT COMPLETED|Toddler Dose||1
239785|NCT00574795|576775|P1|COMPLETED|Toddler Dose||184
239786|NCT00574795|576775|P1|STARTED|Toddler Dose||185
239787|NCT00574795|576775|P1|NOT COMPLETED|After Infant Series||3
239788|NCT00574795|576775|P1|COMPLETED|After Infant Series||185
239789|NCT00574795|576775|P1|STARTED|After Infant Series||188
239790|NCT00574795|576775|P1|NOT COMPLETED|Infant Series||5
239791|NCT00574795|576775|P1|COMPLETED|Infant Series||188
239792|NCT00574795|576775|P1|Vaccinated Dose 3|Infant Series||190
239793|NCT00574795|576775|P1|Vaccinated Dose 2|Infant Series||190
239794|NCT00574795|576775|P1|Vaccinated Dose 1|Infant Series||193
239795|NCT00574795|576775|P1|STARTED|Infant Series||193
239796|NCT00574704|576796|P4|NOT COMPLETED|Overall Study||0
239797|NCT00574704|576797|P3|NOT COMPLETED|Overall Study||1
239798|NCT00574704|576798|P2|NOT COMPLETED|Overall Study||0
239799|NCT00574704|576799|P1|NOT COMPLETED|Overall Study||0
239800|NCT00574704|576796|P4|COMPLETED|Overall Study||10
239801|NCT00574704|576797|P3|COMPLETED|Overall Study||9
239802|NCT00574704|576798|P2|COMPLETED|Overall Study||10
239803|NCT00574704|576799|P1|COMPLETED|Overall Study||10
239804|NCT00574704|576796|P4|STARTED|Overall Study||10
239805|NCT00574704|576797|P3|STARTED|Overall Study||10
239806|NCT00574704|576798|P2|STARTED|Overall Study||10
239807|NCT00574704|576799|P1|STARTED|Overall Study||10
239808|NCT00574548|576811|P2|NOT COMPLETED|Overall Study||16
239809|NCT00574548|576812|P1|NOT COMPLETED|Overall Study||61
239810|NCT00574548|576811|P2|COMPLETED|Overall Study||222
239811|NCT00574548|576812|P1|COMPLETED|Overall Study||421
239812|NCT00574548|576811|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
239813|NCT00574548|576812|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
239814|NCT00574548|576811|P2|Received Vax 2|Overall Study||223
239815|NCT00574548|576812|P1|Received Vax 2|Overall Study||427
239816|NCT00574548|576811|P2|Withdrawn Before Vax 2|Overall Study||11
239817|NCT00574548|576812|P1|Withdrawn Before Vax 2|Overall Study||41
239818|NCT00574548|576811|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
239819|NCT00574548|576812|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
239820|NCT00574548|576811|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
239821|NCT00574548|576812|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
239822|NCT00574548|576811|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
239823|NCT00574548|576812|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
239824|NCT00574548|576811|P2|STARTED|Overall Study||238
239825|NCT00574548|576812|P1|STARTED|Overall Study||482
239826|NCT00574405|576858|P2|NOT COMPLETED|Overall Study||2
239827|NCT00574405|576859|P1|NOT COMPLETED|Overall Study||3
239828|NCT00574405|576858|P2|COMPLETED|Overall Study||10
239829|NCT00574405|576859|P1|COMPLETED|Overall Study||9
239830|NCT00574405|576858|P2|STARTED|Overall Study||12
239831|NCT00574405|576859|P1|STARTED|Overall Study||12
239832|NCT00574340|576865|P2|NOT COMPLETED|Study 2 (2 Days)||0
239833|NCT00574340|576866|P1|NOT COMPLETED|Study 2 (2 Days)||0
239834|NCT00574340|576865|P2|COMPLETED|Study 2 (2 Days)||6
239835|NCT00574340|576866|P1|COMPLETED|Study 2 (2 Days)||6
239836|NCT00574340|576865|P2|STARTED|Study 2 (2 Days)||6
239837|NCT00574340|576866|P1|STARTED|Study 2 (2 Days)||6
239838|NCT00574340|576865|P2|NOT COMPLETED|Study 1 (2 Days)||0
239839|NCT00574340|576866|P1|NOT COMPLETED|Study 1 (2 Days)||0
239840|NCT00574340|576865|P2|COMPLETED|Study 1 (2 Days)||10
239841|NCT00574340|576866|P1|COMPLETED|Study 1 (2 Days)||10
239842|NCT00574340|576865|P2|STARTED|Study 1 (2 Days)||10
239843|NCT00574340|576866|P1|STARTED|Study 1 (2 Days)||10
239844|NCT00574288|576879|P7|NOT COMPLETED|Overall Study||28
239845|NCT00574288|576880|P6|NOT COMPLETED|Overall Study||26
239846|NCT00574288|576881|P5|NOT COMPLETED|Overall Study||2
239847|NCT00574288|576882|P4|NOT COMPLETED|Overall Study||2
239848|NCT00574288|576883|P3|NOT COMPLETED|Overall Study||3
239849|NCT00574288|576884|P2|NOT COMPLETED|Overall Study||3
239850|NCT00574288|576885|P1|NOT COMPLETED|Overall Study||20
239851|NCT00574288|576879|P7|COMPLETED|Overall Study||14
239852|NCT00574288|576880|P6|COMPLETED|Overall Study||4
239853|NCT00574288|576881|P5|COMPLETED|Overall Study||1
239854|NCT00574288|576882|P4|COMPLETED|Overall Study||1
239855|NCT00574288|576883|P3|COMPLETED|Overall Study||0
239856|NCT00574288|576884|P2|COMPLETED|Overall Study||0
239857|NCT00574288|576885|P1|COMPLETED|Overall Study||0
239858|NCT00574288|576879|P7|STARTED|Overall Study||42
239859|NCT00574288|576880|P6|STARTED|Overall Study||30
239860|NCT00574288|576881|P5|STARTED|Overall Study||3
239861|NCT00574288|576882|P4|STARTED|Overall Study||3
239862|NCT00574288|576883|P3|STARTED|Overall Study||3
239863|NCT00574288|576884|P2|STARTED|Overall Study||3
239864|NCT00574288|576885|P1|STARTED|Overall Study||20
239865|NCT00574275|576923|P2|NOT COMPLETED|Overall Study||271
239866|NCT00574275|576924|P1|NOT COMPLETED|Overall Study||275
239867|NCT00574275|576923|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
239868|NCT00574275|576924|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
239869|NCT00574275|576923|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
239870|NCT00574275|576924|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
239871|NCT00574275|576923|P2|TREATED|Overall Study||268
239872|NCT00574275|576924|P1|TREATED|Overall Study||273
239873|NCT00574275|576923|P2|STARTED|Overall Study||271
239874|NCT00574275|576924|P1|STARTED|Overall Study||275
239875|NCT00574249|576942|P2|NOT COMPLETED|Overall Study||28
239876|NCT00574249|576943|P1|NOT COMPLETED|Overall Study||26
239877|NCT00574249|576942|P2|COMPLETED|Overall Study||338
239878|NCT00574249|576943|P1|COMPLETED|Overall Study||338
239879|NCT00574249|576942|P2|STARTED|Overall Study||366
239880|NCT00574249|576943|P1|STARTED|Overall Study||364
239881|NCT00574236|576983|P1|NOT COMPLETED|Overall Study||0
239882|NCT00574236|576983|P1|COMPLETED|Overall Study||4
239883|NCT00574236|576983|P1|STARTED|Overall Study||4
239884|NCT00574171|576988|P1|NOT COMPLETED|Overall Study||0
239885|NCT00574171|576988|P1|COMPLETED|Overall Study||29
239886|NCT00574171|576988|P1|STARTED|Overall Study||29
239887|NCT00574145|576994|P2|NOT COMPLETED|Overall Study||1
239888|NCT00574145|576995|P1|NOT COMPLETED|Overall Study||2
239889|NCT00574145|576994|P2|COMPLETED|Overall Study||21
239890|NCT00574145|576995|P1|COMPLETED|Overall Study||20
239891|NCT00574145|576994|P2|STARTED|Overall Study||22
239892|NCT00574145|576995|P1|STARTED|Overall Study||22
239893|NCT00574080|577007|P2|NOT COMPLETED|Overall Study||10
239894|NCT00574080|577008|P1|NOT COMPLETED|Overall Study||10
239895|NCT00574080|577007|P2|COMPLETED|Overall Study||0
239896|NCT00574080|577008|P1|COMPLETED|Overall Study||0
239897|NCT00574080|577007|P2|STARTED|Overall Study||10
239898|NCT00574080|577008|P1|STARTED|Overall Study||10
239899|NCT00574067|577018|P4|NOT COMPLETED|Overall Study||0
239900|NCT00574067|577019|P3|NOT COMPLETED|Overall Study||0
239901|NCT00574067|577020|P2|NOT COMPLETED|Overall Study||1
239902|NCT00574067|577021|P1|NOT COMPLETED|Overall Study||1
239903|NCT00574067|577018|P4|COMPLETED|Overall Study||53
239904|NCT00574067|577019|P3|COMPLETED|Overall Study||54
239905|NCT00574067|577020|P2|COMPLETED|Overall Study||52
239906|NCT00574067|577021|P1|COMPLETED|Overall Study||52
239907|NCT00574067|577018|P4|STARTED|Overall Study||53
239908|NCT00574067|577019|P3|STARTED|Overall Study||54
239909|NCT00574067|577020|P2|STARTED|Overall Study||53
239910|NCT00574067|577021|P1|STARTED|Overall Study||53
239911|NCT00573937|577057|P2|NOT COMPLETED|Overall Study||1
239912|NCT00573937|577058|P1|NOT COMPLETED|Overall Study||0
239913|NCT00573937|577057|P2|COMPLETED|Overall Study||0
239914|NCT00573937|577058|P1|COMPLETED|Overall Study||0
239915|NCT00573937|577057|P2|STARTED|Overall Study||1
239916|NCT00573937|577058|P1|STARTED|Overall Study||0
239917|NCT00573872|577066|P1|NOT COMPLETED|Overall Study||11
239918|NCT00573872|577066|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
239919|NCT00573872|577066|P1|STARTED|Overall Study|# of patients that signed consent|43
239920|NCT00573859|577072|P1|NOT COMPLETED|Smoking Versus Abstinence||12
239921|NCT00573859|577072|P1|COMPLETED|Smoking Versus Abstinence||15
239922|NCT00573859|577072|P1|STARTED|Smoking Versus Abstinence||27
239923|NCT00573859|577072|P1|NOT COMPLETED|Medication Versus Placebo||12
239924|NCT00573859|577072|P1|COMPLETED|Medication Versus Placebo||15
239925|NCT00573859|577072|P1|STARTED|Medication Versus Placebo||27
239926|NCT00573833|577078|P1|NOT COMPLETED|Overall Study||2
239927|NCT00573833|577078|P1|COMPLETED|Overall Study||21
239928|NCT00573833|577078|P1|STARTED|Overall Study||23
239929|NCT00573794|577085|P1|NOT COMPLETED|Overall Study||330
239930|NCT00573794|577085|P1|COMPLETED|Overall Study||255
239931|NCT00573794|577085|P1|STARTED|Overall Study||585
239932|NCT00573768|577116|P3|NOT COMPLETED|Overall Study||4
239933|NCT00573768|577117|P2|NOT COMPLETED|Overall Study||2
239934|NCT00573768|577118|P1|NOT COMPLETED|Overall Study||2
239935|NCT00573768|577116|P3|COMPLETED|Overall Study||87
239936|NCT00573768|577117|P2|COMPLETED|Overall Study||89
239937|NCT00573768|577118|P1|COMPLETED|Overall Study||87
239938|NCT00573768|577116|P3|STARTED|Overall Study||91
239939|NCT00573768|577117|P2|STARTED|Overall Study||91
239940|NCT00573768|577118|P1|STARTED|Overall Study||89
239941|NCT00573755|577128|P2|NOT COMPLETED|Overall Study||0
239942|NCT00573755|577129|P1|NOT COMPLETED|Overall Study||1
239943|NCT00573755|577128|P2|COMPLETED|Overall Study||2
239944|NCT00573755|577129|P1|COMPLETED|Overall Study||1
239945|NCT00573755|577128|P2|STARTED|Overall Study||2
239946|NCT00573755|577129|P1|STARTED|Overall Study||2
239947|NCT00573534|577145|P1|NOT COMPLETED|Overall Study||3
239948|NCT00573534|577145|P1|COMPLETED|Overall Study||5
239949|NCT00573534|577145|P1|STARTED|Overall Study||8
239950|NCT00573508|577152|P2|NOT COMPLETED|Overall Study||41
239951|NCT00573508|577153|P1|NOT COMPLETED|Overall Study||64
239952|NCT00573508|577152|P2|COMPLETED|Overall Study||345
239953|NCT00573508|577153|P1|COMPLETED|Overall Study||318
239954|NCT00573508|577152|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
239955|NCT00573508|577153|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
239956|NCT00573508|577152|P2|STARTED|Overall Study||386
239957|NCT00573508|577153|P1|STARTED|Overall Study||382
239958|NCT00573469|577186|P3|NOT COMPLETED|Overall Study||4
239959|NCT00573469|577187|P2|NOT COMPLETED|Overall Study||4
239960|NCT00573469|577188|P1|NOT COMPLETED|Overall Study||6
239961|NCT00573469|577186|P3|COMPLETED|Overall Study||22
239962|NCT00573469|577187|P2|COMPLETED|Overall Study||21
239963|NCT00573469|577188|P1|COMPLETED|Overall Study||20
239964|NCT00573469|577186|P3|STARTED|Overall Study||26
239965|NCT00573469|577187|P2|STARTED|Overall Study||25
239966|NCT00573469|577188|P1|STARTED|Overall Study||26
239967|NCT00573443|577211|P3|NOT COMPLETED|Open-Label Extension Phase||0
239968|NCT00573443|577212|P2|NOT COMPLETED|Open-Label Extension Phase||0
239969|NCT00573443|577213|P1|NOT COMPLETED|Open-Label Extension Phase||18
239970|NCT00573443|577211|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
239971|NCT00573443|577212|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
239972|NCT00573443|577213|P1|COMPLETED|Open-Label Extension Phase||235
239973|NCT00573443|577211|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
239974|NCT00573443|577212|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
239975|NCT00573443|577213|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
239976|NCT00573443|577211|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
240062|NCT00573170|577353|P6|STARTED|Third Treatment Period||53
239977|NCT00573443|577212|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
239978|NCT00573443|577213|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
239979|NCT00573443|577211|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
239980|NCT00573443|577212|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
239981|NCT00573443|577213|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
239982|NCT00573443|577211|P3|NOT COMPLETED|Double-Blind Phase||15
239983|NCT00573443|577212|P2|NOT COMPLETED|Double-Blind Phase||19
239984|NCT00573443|577213|P1|NOT COMPLETED|Double-Blind Phase||9
239985|NCT00573443|577211|P3|COMPLETED|Double-Blind Phase||94
239986|NCT00573443|577212|P2|COMPLETED|Double-Blind Phase||88
239987|NCT00573443|577213|P1|COMPLETED|Double-Blind Phase||101
239988|NCT00573443|577211|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
239989|NCT00573443|577212|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
239990|NCT00573443|577213|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
239991|NCT00573443|577211|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
239992|NCT00573443|577212|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
239993|NCT00573443|577213|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
239994|NCT00573443|577211|P3|STARTED|Double-Blind Phase||109
239995|NCT00573443|577212|P2|STARTED|Double-Blind Phase||107
239996|NCT00573443|577213|P1|STARTED|Double-Blind Phase||110
239997|NCT00573430|577243|P3|NOT COMPLETED|Overall Study||10
239998|NCT00573430|577244|P2|NOT COMPLETED|Overall Study||5
239999|NCT00573430|577245|P1|NOT COMPLETED|Overall Study||1
240000|NCT00573430|577243|P3|COMPLETED|Overall Study||33
240001|NCT00573430|577244|P2|COMPLETED|Overall Study||40
240002|NCT00573430|577245|P1|COMPLETED|Overall Study||39
240003|NCT00573430|577243|P3|STARTED|Overall Study|randomized|43
240004|NCT00573430|577244|P2|STARTED|Overall Study|randomized|45
240005|NCT00573430|577245|P1|STARTED|Overall Study|randomized|40
240006|NCT00573391|577267|P2|NOT COMPLETED|Overall Study||2
240007|NCT00573391|577268|P1|NOT COMPLETED|Overall Study||3
240008|NCT00573391|577267|P2|COMPLETED|Overall Study||0
240009|NCT00573391|577268|P1|COMPLETED|Overall Study||0
240010|NCT00573391|577267|P2|STARTED|Overall Study||2
240011|NCT00573391|577268|P1|STARTED|Overall Study||3
240012|NCT00573313|577278|P4|NOT COMPLETED|Overall Study||0
240013|NCT00573313|577279|P3|NOT COMPLETED|Overall Study||6
240014|NCT00573313|577280|P2|NOT COMPLETED|Overall Study||0
240015|NCT00573313|577281|P1|NOT COMPLETED|Overall Study||5
240016|NCT00573313|577278|P4|COMPLETED|Overall Study||26
240017|NCT00573313|577279|P3|COMPLETED|Overall Study||13
240018|NCT00573313|577280|P2|COMPLETED|Overall Study||28
240019|NCT00573313|577281|P1|COMPLETED|Overall Study||13
240020|NCT00573313|577278|P4|STARTED|Overall Study||26
240021|NCT00573313|577279|P3|STARTED|Overall Study|Nineteen recruited to start.|19
240022|NCT00573313|577280|P2|STARTED|Overall Study||28
240023|NCT00573313|577281|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
240024|NCT00573287|577291|P2|NOT COMPLETED|Overall Study||3
240025|NCT00573287|577292|P1|NOT COMPLETED|Overall Study||4
240026|NCT00573287|577291|P2|COMPLETED|Overall Study||4
240027|NCT00573287|577292|P1|COMPLETED|Overall Study||3
240028|NCT00573287|577291|P2|STARTED|Overall Study||7
240029|NCT00573287|577292|P1|STARTED|Overall Study||7
240030|NCT00573261|577300|P2|NOT COMPLETED|Overall Study||5
240031|NCT00573261|577301|P1|NOT COMPLETED|Overall Study||6
240032|NCT00573261|577300|P2|COMPLETED|Overall Study||15
240033|NCT00573261|577301|P1|COMPLETED|Overall Study||14
240034|NCT00573261|577300|P2|STARTED|Overall Study||20
240035|NCT00573261|577301|P1|STARTED|Overall Study||20
240036|NCT00573248|577329|P2|NOT COMPLETED|Overall Study||11
240037|NCT00573248|577330|P1|NOT COMPLETED|Overall Study||15
240038|NCT00573248|577329|P2|COMPLETED|Overall Study||27
240039|NCT00573248|577330|P1|COMPLETED|Overall Study||25
240040|NCT00573248|577329|P2|Nicotine Patches and Placebo Patches|Overall Study||27
240041|NCT00573248|577330|P1|Nicotine Patches and Placebo Patches|Overall Study||25
240042|NCT00573248|577329|P2|STARTED|Overall Study||38
240043|NCT00573248|577330|P1|STARTED|Overall Study||40
240044|NCT00573183|577344|P2|NOT COMPLETED|Overall Study||63
240045|NCT00573183|577345|P1|NOT COMPLETED|Overall Study||72
240046|NCT00573183|577344|P2|COMPLETED|Overall Study||174
240047|NCT00573183|577345|P1|COMPLETED|Overall Study||162
240048|NCT00573183|577344|P2|STARTED|Overall Study||237
240049|NCT00573183|577345|P1|STARTED|Overall Study||234
240050|NCT00573170|577353|P6|NOT COMPLETED|Third Treatment Period||2
240051|NCT00573170|577354|P5|NOT COMPLETED|Third Treatment Period||0
240052|NCT00573170|577355|P4|NOT COMPLETED|Third Treatment Period||0
240053|NCT00573170|577356|P3|NOT COMPLETED|Third Treatment Period||0
240054|NCT00573170|577357|P2|NOT COMPLETED|Third Treatment Period||0
240055|NCT00573170|577358|P1|NOT COMPLETED|Third Treatment Period||1
240056|NCT00573170|577353|P6|COMPLETED|Third Treatment Period||51
240057|NCT00573170|577354|P5|COMPLETED|Third Treatment Period||51
240058|NCT00573170|577355|P4|COMPLETED|Third Treatment Period||56
240059|NCT00573170|577356|P3|COMPLETED|Third Treatment Period||55
240060|NCT00573170|577357|P2|COMPLETED|Third Treatment Period||54
240061|NCT00573170|577358|P1|COMPLETED|Third Treatment Period||50
240063|NCT00573170|577354|P5|STARTED|Third Treatment Period||51
240064|NCT00573170|577355|P4|STARTED|Third Treatment Period||56
240065|NCT00573170|577356|P3|STARTED|Third Treatment Period||55
240066|NCT00573170|577357|P2|STARTED|Third Treatment Period||54
240067|NCT00573170|577358|P1|STARTED|Third Treatment Period||51
240068|NCT00573170|577353|P6|NOT COMPLETED|Second Washout Period||2
240069|NCT00573170|577354|P5|NOT COMPLETED|Second Washout Period||8
240070|NCT00573170|577355|P4|NOT COMPLETED|Second Washout Period||5
240071|NCT00573170|577356|P3|NOT COMPLETED|Second Washout Period||4
240072|NCT00573170|577357|P2|NOT COMPLETED|Second Washout Period||4
240073|NCT00573170|577358|P1|NOT COMPLETED|Second Washout Period||5
240074|NCT00573170|577353|P6|COMPLETED|Second Washout Period||53
240075|NCT00573170|577354|P5|COMPLETED|Second Washout Period||51
240076|NCT00573170|577355|P4|COMPLETED|Second Washout Period||56
240077|NCT00573170|577356|P3|COMPLETED|Second Washout Period||55
240078|NCT00573170|577357|P2|COMPLETED|Second Washout Period||54
240079|NCT00573170|577358|P1|COMPLETED|Second Washout Period||51
240080|NCT00573170|577353|P6|STARTED|Second Washout Period||55
240081|NCT00573170|577354|P5|STARTED|Second Washout Period||59
240082|NCT00573170|577355|P4|STARTED|Second Washout Period||61
240083|NCT00573170|577356|P3|STARTED|Second Washout Period||59
240084|NCT00573170|577357|P2|STARTED|Second Washout Period||58
240085|NCT00573170|577358|P1|STARTED|Second Washout Period||56
240086|NCT00573170|577353|P6|NOT COMPLETED|Second Treatment Period||0
240087|NCT00573170|577354|P5|NOT COMPLETED|Second Treatment Period||0
240088|NCT00573170|577355|P4|NOT COMPLETED|Second Treatment Period||0
240089|NCT00573170|577356|P3|NOT COMPLETED|Second Treatment Period||0
240090|NCT00573170|577357|P2|NOT COMPLETED|Second Treatment Period||0
240091|NCT00573170|577358|P1|NOT COMPLETED|Second Treatment Period||0
240092|NCT00573170|577353|P6|COMPLETED|Second Treatment Period||55
240093|NCT00573170|577354|P5|COMPLETED|Second Treatment Period||59
240094|NCT00573170|577355|P4|COMPLETED|Second Treatment Period||61
240095|NCT00573170|577356|P3|COMPLETED|Second Treatment Period||59
240096|NCT00573170|577357|P2|COMPLETED|Second Treatment Period||58
240097|NCT00573170|577358|P1|COMPLETED|Second Treatment Period||56
240098|NCT00573170|577353|P6|STARTED|Second Treatment Period||55
240099|NCT00573170|577354|P5|STARTED|Second Treatment Period||59
240100|NCT00573170|577355|P4|STARTED|Second Treatment Period||61
240101|NCT00573170|577356|P3|STARTED|Second Treatment Period||59
240102|NCT00573170|577357|P2|STARTED|Second Treatment Period||58
240103|NCT00573170|577358|P1|STARTED|Second Treatment Period||56
240104|NCT00573170|577353|P6|NOT COMPLETED|First Washout Period||7
240105|NCT00573170|577354|P5|NOT COMPLETED|First Washout Period||3
240106|NCT00573170|577355|P4|NOT COMPLETED|First Washout Period||5
240107|NCT00573170|577356|P3|NOT COMPLETED|First Washout Period||1
240108|NCT00573170|577357|P2|NOT COMPLETED|First Washout Period||2
240109|NCT00573170|577358|P1|NOT COMPLETED|First Washout Period||8
240110|NCT00573170|577353|P6|COMPLETED|First Washout Period||55
240111|NCT00573170|577354|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
240112|NCT00573170|577355|P4|COMPLETED|First Washout Period||61
240113|NCT00573170|577356|P3|COMPLETED|First Washout Period||59
240114|NCT00573170|577357|P2|COMPLETED|First Washout Period||58
240115|NCT00573170|577358|P1|COMPLETED|First Washout Period||56
240116|NCT00573170|577353|P6|STARTED|First Washout Period||62
240117|NCT00573170|577354|P5|STARTED|First Washout Period||62
240118|NCT00573170|577355|P4|STARTED|First Washout Period||66
240119|NCT00573170|577356|P3|STARTED|First Washout Period||60
240120|NCT00573170|577357|P2|STARTED|First Washout Period||60
240121|NCT00573170|577358|P1|STARTED|First Washout Period||64
240122|NCT00573170|577353|P6|NOT COMPLETED|First Treatment Period||0
240123|NCT00573170|577354|P5|NOT COMPLETED|First Treatment Period||1
240124|NCT00573170|577355|P4|NOT COMPLETED|First Treatment Period||0
240125|NCT00573170|577356|P3|NOT COMPLETED|First Treatment Period||0
240126|NCT00573170|577357|P2|NOT COMPLETED|First Treatment Period||0
240127|NCT00573170|577358|P1|NOT COMPLETED|First Treatment Period||0
240128|NCT00573170|577353|P6|COMPLETED|First Treatment Period||62
240129|NCT00573170|577354|P5|COMPLETED|First Treatment Period||62
240130|NCT00573170|577355|P4|COMPLETED|First Treatment Period||66
240131|NCT00573170|577356|P3|COMPLETED|First Treatment Period||60
240132|NCT00573170|577357|P2|COMPLETED|First Treatment Period||60
240133|NCT00573170|577358|P1|COMPLETED|First Treatment Period||64
240134|NCT00573170|577353|P6|STARTED|First Treatment Period||62
240135|NCT00573170|577354|P5|STARTED|First Treatment Period||63
240136|NCT00573170|577355|P4|STARTED|First Treatment Period||66
240137|NCT00573170|577356|P3|STARTED|First Treatment Period||60
240138|NCT00573170|577357|P2|STARTED|First Treatment Period||60
240139|NCT00573170|577358|P1|STARTED|First Treatment Period||64
240140|NCT00573157|577434|P2|NOT COMPLETED|Overall Study||2
240141|NCT00573157|577435|P1|NOT COMPLETED|Overall Study||4
240142|NCT00573157|577434|P2|COMPLETED|Overall Study||0
240143|NCT00573157|577435|P1|COMPLETED|Overall Study||0
240144|NCT00573157|577434|P2|STARTED|Overall Study||2
240145|NCT00573157|577435|P1|STARTED|Overall Study||4
240146|NCT00573144|577447|P2|NOT COMPLETED|Overall Study||3
240147|NCT00573144|577448|P1|NOT COMPLETED|Overall Study||2
240148|NCT00573144|577447|P2|COMPLETED|Overall Study||25
240149|NCT00573144|577448|P1|COMPLETED|Overall Study||28
240150|NCT00573144|577447|P2|STARTED|Overall Study||28
240151|NCT00573144|577448|P1|STARTED|Overall Study||30
240152|NCT00573131|577460|P2|NOT COMPLETED|Overall Study||8
240153|NCT00573131|577461|P1|NOT COMPLETED|Overall Study||10
240154|NCT00573131|577460|P2|COMPLETED|Overall Study||57
240155|NCT00573131|577461|P1|COMPLETED|Overall Study||62
240156|NCT00573131|577460|P2|STARTED|Overall Study||65
240157|NCT00573131|577461|P1|STARTED|Overall Study||72
240158|NCT00573066|577467|P1|NOT COMPLETED|Overall Study||20
240159|NCT00573066|577467|P1|COMPLETED|Overall Study||36
240160|NCT00573066|577467|P1|STARTED|Overall Study||56
240161|NCT00572936|577471|P6|NOT COMPLETED|Third Intervention||0
240162|NCT00572936|577472|P5|NOT COMPLETED|Third Intervention||0
240163|NCT00572936|577473|P4|NOT COMPLETED|Third Intervention||0
240164|NCT00572936|577474|P3|NOT COMPLETED|Third Intervention||0
240165|NCT00572936|577475|P2|NOT COMPLETED|Third Intervention||0
240166|NCT00572936|577476|P1|NOT COMPLETED|Third Intervention||0
240167|NCT00572936|577471|P6|COMPLETED|Third Intervention||5
240168|NCT00572936|577472|P5|COMPLETED|Third Intervention||3
240169|NCT00572936|577473|P4|COMPLETED|Third Intervention||5
240170|NCT00572936|577474|P3|COMPLETED|Third Intervention||4
240171|NCT00572936|577475|P2|COMPLETED|Third Intervention||3
240172|NCT00572936|577476|P1|COMPLETED|Third Intervention||4
240173|NCT00572936|577471|P6|STARTED|Third Intervention||5
240174|NCT00572936|577472|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
240175|NCT00572936|577473|P4|STARTED|Third Intervention||5
240176|NCT00572936|577474|P3|STARTED|Third Intervention||4
240177|NCT00572936|577475|P2|STARTED|Third Intervention||3
240178|NCT00572936|577476|P1|STARTED|Third Intervention||4
240179|NCT00572936|577471|P6|NOT COMPLETED|Second Intervention||0
240180|NCT00572936|577472|P5|NOT COMPLETED|Second Intervention||0
240181|NCT00572936|577473|P4|NOT COMPLETED|Second Intervention||0
240182|NCT00572936|577474|P3|NOT COMPLETED|Second Intervention||0
240183|NCT00572936|577475|P2|NOT COMPLETED|Second Intervention||0
240184|NCT00572936|577476|P1|NOT COMPLETED|Second Intervention||0
240185|NCT00572936|577471|P6|COMPLETED|Second Intervention||5
240186|NCT00572936|577472|P5|COMPLETED|Second Intervention||4
240187|NCT00572936|577473|P4|COMPLETED|Second Intervention||5
240188|NCT00572936|577474|P3|COMPLETED|Second Intervention||4
240189|NCT00572936|577475|P2|COMPLETED|Second Intervention||3
240190|NCT00572936|577476|P1|COMPLETED|Second Intervention||4
240191|NCT00572936|577471|P6|STARTED|Second Intervention||5
240192|NCT00572936|577472|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
240193|NCT00572936|577473|P4|STARTED|Second Intervention||5
240194|NCT00572936|577474|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
240195|NCT00572936|577475|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
240196|NCT00572936|577476|P1|STARTED|Second Intervention||4
240197|NCT00572936|577471|P6|NOT COMPLETED|First Intervention||0
240198|NCT00572936|577472|P5|NOT COMPLETED|First Intervention||0
240199|NCT00572936|577473|P4|NOT COMPLETED|First Intervention||0
240200|NCT00572936|577474|P3|NOT COMPLETED|First Intervention||0
240201|NCT00572936|577475|P2|NOT COMPLETED|First Intervention||0
240202|NCT00572936|577476|P1|NOT COMPLETED|First Intervention||0
240203|NCT00572936|577471|P6|COMPLETED|First Intervention||5
240204|NCT00572936|577472|P5|COMPLETED|First Intervention||5
240205|NCT00572936|577473|P4|COMPLETED|First Intervention||5
240206|NCT00572936|577474|P3|COMPLETED|First Intervention||5
240207|NCT00572936|577475|P2|COMPLETED|First Intervention||4
240208|NCT00572936|577476|P1|COMPLETED|First Intervention||4
240209|NCT00572936|577471|P6|STARTED|First Intervention||5
240210|NCT00572936|577472|P5|STARTED|First Intervention||5
240211|NCT00572936|577473|P4|STARTED|First Intervention||5
240212|NCT00572936|577474|P3|STARTED|First Intervention||5
240213|NCT00572936|577475|P2|STARTED|First Intervention||4
240214|NCT00572936|577476|P1|STARTED|First Intervention||4
240215|NCT00572910|577511|P11|NOT COMPLETED|Overall Study||3
240216|NCT00572910|577512|P10|NOT COMPLETED|Overall Study||6
240217|NCT00572910|577513|P9|NOT COMPLETED|Overall Study||3
240218|NCT00572910|577514|P8|NOT COMPLETED|Overall Study||4
240219|NCT00572910|577515|P7|NOT COMPLETED|Overall Study||4
240220|NCT00572910|577516|P6|NOT COMPLETED|Overall Study||3
240221|NCT00572910|577517|P5|NOT COMPLETED|Overall Study||2
240222|NCT00572910|577518|P4|NOT COMPLETED|Overall Study||4
240223|NCT00572910|577519|P3|NOT COMPLETED|Overall Study||2
240224|NCT00572910|577520|P2|NOT COMPLETED|Overall Study||3
240225|NCT00572910|577521|P1|NOT COMPLETED|Overall Study||4
240226|NCT00572910|577511|P11|COMPLETED|Overall Study||15
240227|NCT00572910|577512|P10|COMPLETED|Overall Study||13
240228|NCT00572910|577513|P9|COMPLETED|Overall Study||16
240229|NCT00572910|577514|P8|COMPLETED|Overall Study||15
240230|NCT00572910|577515|P7|COMPLETED|Overall Study||15
240231|NCT00572910|577516|P6|COMPLETED|Overall Study||16
240232|NCT00572910|577517|P5|COMPLETED|Overall Study||17
240233|NCT00572910|577518|P4|COMPLETED|Overall Study||14
240234|NCT00572910|577519|P3|COMPLETED|Overall Study||17
240235|NCT00572910|577520|P2|COMPLETED|Overall Study||15
240236|NCT00572910|577521|P1|COMPLETED|Overall Study||15
240237|NCT00572910|577511|P11|STARTED|Overall Study||18
240238|NCT00572910|577512|P10|STARTED|Overall Study||19
240239|NCT00572910|577513|P9|STARTED|Overall Study||19
240240|NCT00572910|577514|P8|STARTED|Overall Study||19
240241|NCT00572910|577515|P7|STARTED|Overall Study||19
240242|NCT00572910|577516|P6|STARTED|Overall Study||19
240243|NCT00572910|577517|P5|STARTED|Overall Study||19
240244|NCT00572910|577518|P4|STARTED|Overall Study||18
240245|NCT00572910|577519|P3|STARTED|Overall Study||19
240246|NCT00572910|577520|P2|STARTED|Overall Study||18
240247|NCT00572910|577521|P1|STARTED|Overall Study||19
240248|NCT00572897|577569|P2|NOT COMPLETED|Overall Study||0
240249|NCT00572897|577570|P1|NOT COMPLETED|Overall Study||0
240250|NCT00572897|577569|P2|COMPLETED|Overall Study||34
240251|NCT00572897|577570|P1|COMPLETED|Overall Study||32
240252|NCT00572897|577569|P2|STARTED|Overall Study||34
240253|NCT00572897|577570|P1|STARTED|Overall Study||32
240254|NCT00572832|577588|P2|NOT COMPLETED|Overall Study||12
240255|NCT00572832|577589|P1|NOT COMPLETED|Overall Study||0
240256|NCT00572832|577588|P2|COMPLETED|Overall Study||88
240257|NCT00572832|577589|P1|COMPLETED|Overall Study||100
240258|NCT00572832|577588|P2|STARTED|Overall Study||100
240259|NCT00572832|577589|P1|STARTED|Overall Study||100
240260|NCT00572728|577595|P1|NOT COMPLETED|Overall Study||39
240261|NCT00572728|577595|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
240262|NCT00572728|577595|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
240263|NCT00572728|577595|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
240264|NCT00572728|577595|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
240265|NCT00572728|577595|P1|Pathology Complete|Overall Study||51
240266|NCT00572728|577595|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
240267|NCT00572728|577595|P1|Second Chemotherapy Initiated|Overall Study||59
240268|NCT00572728|577595|P1|Completed FLT2 Scan|Overall Study||60
240269|NCT00572728|577595|P1|First Therapy Initiated|Overall Study||65
240270|NCT00572728|577595|P1|Completed FLT1 Scan|Overall Study||67
240271|NCT00572728|577595|P1|On Study|Overall Study||71
240272|NCT00572728|577595|P1|Did Not Withdraw|Overall Study||72
240273|NCT00572728|577595|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
240274|NCT00572728|577595|P1|Eligible|Overall Study||87
240275|NCT00572728|577595|P1|STARTED|Overall Study|Registered|90
240276|NCT00572624|577609|P2|NOT COMPLETED|Overall Study||4
240277|NCT00572624|577610|P1|NOT COMPLETED|Overall Study||17
240278|NCT00572624|577609|P2|COMPLETED|Overall Study||10
240279|NCT00572624|577610|P1|COMPLETED|Overall Study||20
240280|NCT00572624|577609|P2|STARTED|Overall Study||14
240281|NCT00572624|577610|P1|STARTED|Overall Study||37
240282|NCT00572572|577638|P2|NOT COMPLETED|Overall Study||6
240283|NCT00572572|577639|P1|NOT COMPLETED|Overall Study||3
240284|NCT00572572|577638|P2|COMPLETED|Overall Study||28
240285|NCT00572572|577639|P1|COMPLETED|Overall Study||32
240286|NCT00572572|577638|P2|STARTED|Overall Study||34
240287|NCT00572572|577639|P1|STARTED|Overall Study||35
240288|NCT00572533|577657|P2|NOT COMPLETED|Overall Study||3
240289|NCT00572533|577658|P1|NOT COMPLETED|Overall Study||7
240290|NCT00572533|577657|P2|COMPLETED|Overall Study||28
240291|NCT00572533|577658|P1|COMPLETED|Overall Study||24
240292|NCT00572533|577657|P2|STARTED|Overall Study||31
240293|NCT00572533|577658|P1|STARTED|Overall Study||31
240294|NCT00572468|577680|P2|NOT COMPLETED|Overall Study||4
240295|NCT00572468|577681|P1|NOT COMPLETED|Overall Study||2
240296|NCT00572468|577680|P2|COMPLETED|Overall Study||16
240297|NCT00572468|577681|P1|COMPLETED|Overall Study||20
240298|NCT00572468|577680|P2|STARTED|Overall Study||20
240299|NCT00572468|577681|P1|STARTED|Overall Study||22
240300|NCT00572260|577689|P1|NOT COMPLETED|Overall Study||0
240301|NCT00572260|577689|P1|COMPLETED|Overall Study||11
240302|NCT00572260|577689|P1|STARTED|Overall Study||11
240303|NCT00572156|577697|P4|NOT COMPLETED|Overall Study||25
240304|NCT00572156|577698|P3|NOT COMPLETED|Overall Study||27
240305|NCT00572156|577699|P2|NOT COMPLETED|Overall Study||26
240306|NCT00572156|577700|P1|NOT COMPLETED|Overall Study||26
240307|NCT00572156|577697|P4|COMPLETED|Overall Study||1
240308|NCT00572156|577698|P3|COMPLETED|Overall Study||0
240309|NCT00572156|577699|P2|COMPLETED|Overall Study||1
240310|NCT00572156|577700|P1|COMPLETED|Overall Study||0
240311|NCT00572156|577697|P4|STARTED|Overall Study||26
240312|NCT00572156|577698|P3|STARTED|Overall Study||27
240313|NCT00572156|577699|P2|STARTED|Overall Study||27
240314|NCT00572156|577700|P1|STARTED|Overall Study||26
240315|NCT00572117|577760|P2|NOT COMPLETED|Overall Study||2
240316|NCT00572117|577761|P1|NOT COMPLETED|Overall Study||2
240317|NCT00572117|577760|P2|COMPLETED|Overall Study||5
240318|NCT00572117|577761|P1|COMPLETED|Overall Study||3
240319|NCT00572117|577760|P2|STARTED|Overall Study||7
240320|NCT00572117|577761|P1|STARTED|Overall Study||5
240321|NCT00572039|577771|P2|NOT COMPLETED|Overall Study||10
240322|NCT00572039|577772|P1|NOT COMPLETED|Overall Study||16
240323|NCT00572039|577771|P2|COMPLETED|Overall Study||110
240324|NCT00572039|577772|P1|COMPLETED|Overall Study||105
240325|NCT00572039|577771|P2|STARTED|Overall Study||120
240326|NCT00572039|577772|P1|STARTED|Overall Study||121
240327|NCT00571987|577784|P1|NOT COMPLETED|Overall Study||7
240328|NCT00571987|577784|P1|COMPLETED|Overall Study||100
240329|NCT00571987|577784|P1|STARTED|Overall Study||107
240330|NCT00571974|577791|P2|NOT COMPLETED|Phase II||4
240331|NCT00571974|577792|P1|NOT COMPLETED|Phase II||0
240332|NCT00571974|577791|P2|COMPLETED|Phase II||17
240333|NCT00571974|577792|P1|COMPLETED|Phase II||0
240334|NCT00571974|577791|P2|STARTED|Phase II|3 participants are from phase I|21
240335|NCT00571974|577792|P1|STARTED|Phase II||0
240336|NCT00571974|577791|P2|NOT COMPLETED|Phase I||0
240337|NCT00571974|577792|P1|NOT COMPLETED|Phase I||0
240338|NCT00571974|577791|P2|COMPLETED|Phase I||0
240339|NCT00571974|577792|P1|COMPLETED|Phase I||9
240340|NCT00571974|577791|P2|STARTED|Phase I||0
240341|NCT00571974|577792|P1|STARTED|Phase I||9
240342|NCT00571961|577798|P1|NOT COMPLETED|Overall Study||0
240343|NCT00571961|577798|P1|COMPLETED|Overall Study||12
240344|NCT00571961|577798|P1|STARTED|Overall Study||12
240345|NCT00571948|577804|P2|NOT COMPLETED|Overall Study||14
240346|NCT00571948|577805|P1|NOT COMPLETED|Overall Study||11
240347|NCT00571948|577804|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
240348|NCT00571948|577805|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
240349|NCT00571948|577804|P2|STARTED|Overall Study||66
240350|NCT00571948|577805|P1|STARTED|Overall Study||66
240351|NCT00571922|577813|P2|NOT COMPLETED|Overall Study||36
240352|NCT00571922|577814|P1|NOT COMPLETED|Overall Study||36
240353|NCT00571922|577813|P2|COMPLETED|Overall Study||0
240354|NCT00571922|577814|P1|COMPLETED|Overall Study||0
240355|NCT00571922|577813|P2|STARTED|Overall Study||36
240356|NCT00571922|577814|P1|STARTED|Overall Study||36
240357|NCT00571701|577824|P2|NOT COMPLETED|Second Intervention 12 Months||1
240358|NCT00571701|577825|P1|NOT COMPLETED|Second Intervention 12 Months||3
240359|NCT00571701|577824|P2|COMPLETED|Second Intervention 12 Months||20
240360|NCT00571701|577825|P1|COMPLETED|Second Intervention 12 Months||13
240361|NCT00571701|577824|P2|STARTED|Second Intervention 12 Months||21
240362|NCT00571701|577825|P1|STARTED|Second Intervention 12 Months||16
240363|NCT00571701|577824|P2|NOT COMPLETED|First Intervention 12 Months||1
240364|NCT00571701|577825|P1|NOT COMPLETED|First Intervention 12 Months||3
240365|NCT00571701|577824|P2|COMPLETED|First Intervention 12 Months||21
240366|NCT00571701|577825|P1|COMPLETED|First Intervention 12 Months||16
240367|NCT00571701|577824|P2|STARTED|First Intervention 12 Months||22
240368|NCT00571701|577825|P1|STARTED|First Intervention 12 Months||19
240369|NCT00571688|577851|P2|NOT COMPLETED|Overall Study||6
240370|NCT00571688|577852|P1|NOT COMPLETED|Overall Study||5
240371|NCT00571688|577851|P2|COMPLETED|Overall Study||19
240372|NCT00571688|577852|P1|COMPLETED|Overall Study||20
240373|NCT00571688|577851|P2|STARTED|Overall Study||25
240374|NCT00571688|577852|P1|STARTED|Overall Study||25
240375|NCT00571662|577858|P1|NOT COMPLETED|Overall Study||8
240376|NCT00571662|577858|P1|COMPLETED|Overall Study||68
240377|NCT00571662|577858|P1|STARTED|Overall Study||76
240378|NCT00571649|577866|P2|NOT COMPLETED|Follow-up Period||528
240379|NCT00571649|577867|P1|NOT COMPLETED|Follow-up Period||545
240380|NCT00571649|577866|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
240381|NCT00571649|577867|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
240382|NCT00571649|577866|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
240383|NCT00571649|577867|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
240384|NCT00571649|577866|P2|NOT COMPLETED|Treatment Period||1004
240385|NCT00571649|577867|P1|NOT COMPLETED|Treatment Period||1092
240386|NCT00571649|577866|P2|COMPLETED|Treatment Period||3047
240387|NCT00571649|577867|P1|COMPLETED|Treatment Period||2958
240388|NCT00571649|577866|P2|Day 35|Treatment Period||3115
240389|NCT00571649|577867|P1|Day 35|Treatment Period||3033
240390|NCT00571649|577866|P2|Day 10|Treatment Period||3499
240391|NCT00571649|577867|P1|Day 10|Treatment Period||3454
240392|NCT00571649|577866|P2|Participants Received Treatment|Treatment Period||4001
240393|NCT00571649|577867|P1|Participants Received Treatment|Treatment Period||3997
240394|NCT00571649|577866|P2|STARTED|Treatment Period||4051
240395|NCT00571649|577867|P1|STARTED|Treatment Period||4050
240396|NCT00571428|577901|P2|NOT COMPLETED|Overall Study||0
240397|NCT00571428|577902|P1|NOT COMPLETED|Overall Study||0
240398|NCT00571428|577901|P2|COMPLETED|Overall Study||18
240399|NCT00571428|577902|P1|COMPLETED|Overall Study||15
240400|NCT00571428|577901|P2|STARTED|Overall Study||18
240401|NCT00571428|577902|P1|STARTED|Overall Study||15
240402|NCT00571324|577934|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
240403|NCT00571324|577935|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
240404|NCT00571324|577934|P2|COMPLETED|Intervention 2 (7 Hours)||4
240405|NCT00571324|577935|P1|COMPLETED|Intervention 2 (7 Hours)||5
240406|NCT00571324|577934|P2|STARTED|Intervention 2 (7 Hours)||4
240407|NCT00571324|577935|P1|STARTED|Intervention 2 (7 Hours)||5
240408|NCT00571324|577934|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
240409|NCT00571324|577935|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
240410|NCT00571324|577934|P2|COMPLETED|Intervention 1 (7 Hours)||4
240411|NCT00571324|577935|P1|COMPLETED|Intervention 1 (7 Hours)||5
240412|NCT00571324|577934|P2|STARTED|Intervention 1 (7 Hours)||4
240413|NCT00571324|577935|P1|STARTED|Intervention 1 (7 Hours)||5
240414|NCT00571194|577947|P1|NOT COMPLETED|Overall Study||0
240415|NCT00571194|577947|P1|COMPLETED|Overall Study||7
240416|NCT00571194|577947|P1|STARTED|Overall Study||7
240417|NCT00571103|577951|P1|NOT COMPLETED|Overall Study||2
240418|NCT00571103|577951|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
240419|NCT00571103|577951|P1|STARTED|Overall Study||28
240420|NCT00571064|577956|P1|NOT COMPLETED|Overall Study||21
240421|NCT00571064|577956|P1|COMPLETED|Overall Study||76
240422|NCT00571064|577956|P1|STARTED|Overall Study||97
240423|NCT00571038|577971|P2|NOT COMPLETED|Overall Study||14
240424|NCT00571038|577972|P1|NOT COMPLETED|Overall Study||11
240425|NCT00571038|577971|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
240426|NCT00571038|577972|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
240427|NCT00571038|577971|P2|18 Month Survey Only|Overall Study||163
240428|NCT00571038|577972|P1|18 Month Survey Only|Overall Study||199
240429|NCT00571038|577971|P2|6 Month Follow up|Overall Study||176
240430|NCT00571038|577972|P1|6 Month Follow up|Overall Study||208
240431|NCT00571038|577971|P2|STARTED|Overall Study||185
240432|NCT00571038|577972|P1|STARTED|Overall Study||219
240433|NCT00570960|578020|P2|NOT COMPLETED|Overall Study||0
240434|NCT00570960|578021|P1|NOT COMPLETED|Overall Study||0
240435|NCT00570960|578020|P2|COMPLETED|Overall Study||4
240436|NCT00570960|578021|P1|COMPLETED|Overall Study||4
240437|NCT00570960|578020|P2|STARTED|Overall Study||4
240438|NCT00570960|578021|P1|STARTED|Overall Study||4
240439|NCT00570921|578027|P1|NOT COMPLETED|Overall Study||2
240440|NCT00570921|578027|P1|COMPLETED|Overall Study||31
240441|NCT00570921|578027|P1|STARTED|Overall Study||33
240442|NCT00570908|578033|P1|NOT COMPLETED|Overall Study||7
240443|NCT00570908|578033|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
240444|NCT00570908|578033|P1|STARTED|Overall Study||12
240445|NCT00570778|578037|P4|NOT COMPLETED|Overall Study||4
240446|NCT00570778|578038|P3|NOT COMPLETED|Overall Study||7
240447|NCT00570778|578039|P2|NOT COMPLETED|Overall Study||4
240448|NCT00570778|578040|P1|NOT COMPLETED|Overall Study||4
240449|NCT00570778|578037|P4|COMPLETED|Overall Study||34
240450|NCT00570778|578038|P3|COMPLETED|Overall Study||30
240451|NCT00570778|578039|P2|COMPLETED|Overall Study||34
240452|NCT00570778|578040|P1|COMPLETED|Overall Study||37
240453|NCT00570778|578037|P4|Modified Intent-to-treat Population|Overall Study||37
240454|NCT00570778|578038|P3|Modified Intent-to-treat Population|Overall Study||35
240455|NCT00570778|578039|P2|Modified Intent-to-treat Population|Overall Study||37
240456|NCT00570778|578040|P1|Modified Intent-to-treat Population|Overall Study||40
240457|NCT00570778|578037|P4|Safety Population: Received Study Drug|Overall Study||38
240458|NCT00570778|578038|P3|Safety Population: Received Study Drug|Overall Study||36
240459|NCT00570778|578039|P2|Safety Population: Received Study Drug|Overall Study||38
240460|NCT00570778|578040|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
240461|NCT00570778|578037|P4|STARTED|Overall Study||38
240462|NCT00570778|578038|P3|STARTED|Overall Study||37
240463|NCT00570778|578039|P2|STARTED|Overall Study||38
240464|NCT00570778|578040|P1|STARTED|Overall Study||41
240465|NCT00570765|578061|P3|NOT COMPLETED|Overall Study||0
240466|NCT00570765|578062|P2|NOT COMPLETED|Overall Study||7
240467|NCT00570765|578063|P1|NOT COMPLETED|Overall Study||4
240468|NCT00570765|578061|P3|COMPLETED|Overall Study||23
240469|NCT00570765|578062|P2|COMPLETED|Overall Study||9
240470|NCT00570765|578063|P1|COMPLETED|Overall Study||16
240471|NCT00570765|578061|P3|STARTED|Overall Study||23
240472|NCT00570765|578062|P2|STARTED|Overall Study||16
240473|NCT00570765|578063|P1|STARTED|Overall Study||20
240474|NCT00570739|578081|P4|NOT COMPLETED|Overall Study||12
240475|NCT00570739|578082|P3|NOT COMPLETED|Overall Study||16
240476|NCT00570739|578083|P2|NOT COMPLETED|Overall Study||21
240477|NCT00570739|578084|P1|NOT COMPLETED|Overall Study||21
240478|NCT00570739|578081|P4|COMPLETED|Overall Study||96
240479|NCT00570739|578082|P3|COMPLETED|Overall Study||92
240480|NCT00570739|578083|P2|COMPLETED|Overall Study||124
240481|NCT00570739|578084|P1|COMPLETED|Overall Study||120
240482|NCT00570739|578081|P4|STARTED|Overall Study||108
240483|NCT00570739|578082|P3|STARTED|Overall Study||108
240484|NCT00570739|578083|P2|STARTED|Overall Study||145
240485|NCT00570739|578084|P1|STARTED|Overall Study||141
240486|NCT00570713|578236|P2|NOT COMPLETED|Overall Study||77
240487|NCT00570713|578237|P1|NOT COMPLETED|Overall Study||78
240488|NCT00570713|578236|P2|COMPLETED|Overall Study||0
240489|NCT00570713|578237|P1|COMPLETED|Overall Study||0
240490|NCT00570713|578236|P2|STARTED|Overall Study||77
240491|NCT00570713|578237|P1|STARTED|Overall Study||78
240492|NCT00570700|578247|P1|NOT COMPLETED|Overall Study||11
240493|NCT00570700|578247|P1|COMPLETED|Overall Study||27
240494|NCT00570700|578247|P1|STARTED|Overall Study||38
240495|NCT00570687|578255|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240496|NCT00570687|578256|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240497|NCT00570687|578257|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240498|NCT00570687|578258|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240499|NCT00570687|578259|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240500|NCT00570687|578260|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240501|NCT00570687|578261|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240502|NCT00570687|578262|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240503|NCT00570687|578263|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240504|NCT00570687|578264|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240505|NCT00570687|578255|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240506|NCT00570687|578256|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240507|NCT00570687|578257|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240508|NCT00570687|578258|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240509|NCT00570687|578259|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240510|NCT00570687|578260|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
240511|NCT00570687|578261|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
240512|NCT00570687|578262|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
240513|NCT00570687|578263|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
240514|NCT00570687|578264|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
240515|NCT00570687|578255|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
240516|NCT00570687|578256|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
240517|NCT00570687|578257|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
240518|NCT00570687|578258|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
240519|NCT00570687|578259|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
240520|NCT00570687|578260|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
240521|NCT00570687|578261|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
240522|NCT00570687|578262|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
240523|NCT00570687|578263|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
240524|NCT00570687|578264|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
240525|NCT00570687|578255|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240526|NCT00570687|578256|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240527|NCT00570687|578257|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240528|NCT00570687|578258|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240529|NCT00570687|578259|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240530|NCT00570687|578260|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240531|NCT00570687|578261|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240532|NCT00570687|578262|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240533|NCT00570687|578263|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240534|NCT00570687|578264|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240535|NCT00570687|578255|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240536|NCT00570687|578256|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240537|NCT00570687|578257|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240538|NCT00570687|578258|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240539|NCT00570687|578259|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240540|NCT00570687|578260|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
240541|NCT00570687|578261|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
240542|NCT00570687|578262|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
240543|NCT00570687|578263|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
240544|NCT00570687|578264|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
240545|NCT00570687|578255|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
240546|NCT00570687|578256|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
240547|NCT00570687|578257|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
240548|NCT00570687|578258|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
240549|NCT00570687|578259|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
240550|NCT00570687|578260|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
240551|NCT00570687|578261|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
240552|NCT00570687|578262|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
240553|NCT00570687|578263|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
240554|NCT00570687|578264|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
240555|NCT00570687|578255|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240556|NCT00570687|578256|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240557|NCT00570687|578257|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240558|NCT00570687|578258|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240559|NCT00570687|578259|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240560|NCT00570687|578260|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240561|NCT00570687|578261|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240562|NCT00570687|578262|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240563|NCT00570687|578263|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240564|NCT00570687|578264|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240565|NCT00570687|578255|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240566|NCT00570687|578256|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240567|NCT00570687|578257|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240568|NCT00570687|578258|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240569|NCT00570687|578259|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240570|NCT00570687|578260|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
240571|NCT00570687|578261|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
240572|NCT00570687|578262|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
240573|NCT00570687|578263|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
240574|NCT00570687|578264|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
240575|NCT00570687|578255|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
240576|NCT00570687|578256|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
240577|NCT00570687|578257|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
240578|NCT00570687|578258|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
240579|NCT00570687|578259|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
240580|NCT00570687|578260|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
240581|NCT00570687|578261|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
240582|NCT00570687|578262|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
240583|NCT00570687|578263|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
240584|NCT00570687|578264|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
240585|NCT00570687|578255|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240586|NCT00570687|578256|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240587|NCT00570687|578257|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240588|NCT00570687|578258|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240589|NCT00570687|578259|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240590|NCT00570687|578260|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240591|NCT00570687|578261|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240592|NCT00570687|578262|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240593|NCT00570687|578263|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240594|NCT00570687|578264|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240595|NCT00570687|578255|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240596|NCT00570687|578256|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240597|NCT00570687|578257|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240598|NCT00570687|578258|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240599|NCT00570687|578259|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240600|NCT00570687|578260|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
240601|NCT00570687|578261|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
240602|NCT00570687|578262|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
240603|NCT00570687|578263|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
240604|NCT00570687|578264|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
240605|NCT00570687|578255|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
240606|NCT00570687|578256|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
240607|NCT00570687|578257|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
240608|NCT00570687|578258|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
240609|NCT00570687|578259|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
240610|NCT00570687|578260|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
240611|NCT00570687|578261|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
240612|NCT00570687|578262|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
240613|NCT00570687|578263|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
240614|NCT00570687|578264|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
240615|NCT00570687|578255|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240616|NCT00570687|578256|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240617|NCT00570687|578257|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240618|NCT00570687|578258|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240619|NCT00570687|578259|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240620|NCT00570687|578260|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240621|NCT00570687|578261|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240622|NCT00570687|578262|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240623|NCT00570687|578263|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240624|NCT00570687|578264|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240625|NCT00570687|578255|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240626|NCT00570687|578256|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240627|NCT00570687|578257|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240628|NCT00570687|578258|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240629|NCT00570687|578259|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240630|NCT00570687|578260|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
240631|NCT00570687|578261|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
240632|NCT00570687|578262|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
240633|NCT00570687|578263|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
240634|NCT00570687|578264|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
240635|NCT00570687|578255|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
240636|NCT00570687|578256|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
240637|NCT00570687|578257|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
240638|NCT00570687|578258|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
240639|NCT00570687|578259|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
240640|NCT00570687|578260|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
240641|NCT00570687|578261|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
240642|NCT00570687|578262|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
240643|NCT00570687|578263|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
240644|NCT00570687|578264|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
240645|NCT00570687|578255|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240646|NCT00570687|578256|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240647|NCT00570687|578257|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240648|NCT00570687|578258|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240649|NCT00570687|578259|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240650|NCT00570687|578260|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240651|NCT00570687|578261|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240652|NCT00570687|578262|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240653|NCT00570687|578263|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240654|NCT00570687|578264|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240655|NCT00570687|578255|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240656|NCT00570687|578256|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240657|NCT00570687|578257|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240658|NCT00570687|578258|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240659|NCT00570687|578259|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240660|NCT00570687|578260|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
240661|NCT00570687|578261|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
240662|NCT00570687|578262|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
240663|NCT00570687|578263|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
240664|NCT00570687|578264|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
240665|NCT00570687|578255|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
240666|NCT00570687|578256|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
240667|NCT00570687|578257|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
240668|NCT00570687|578258|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
240669|NCT00570687|578259|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
240670|NCT00570687|578260|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
240671|NCT00570687|578261|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
240672|NCT00570687|578262|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
240673|NCT00570687|578263|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
240674|NCT00570687|578264|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
240675|NCT00570687|578255|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240676|NCT00570687|578256|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240677|NCT00570687|578257|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240678|NCT00570687|578258|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240679|NCT00570687|578259|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240680|NCT00570687|578260|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240681|NCT00570687|578261|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240682|NCT00570687|578262|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240683|NCT00570687|578263|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240684|NCT00570687|578264|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240685|NCT00570687|578255|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240686|NCT00570687|578256|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240687|NCT00570687|578257|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240688|NCT00570687|578258|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240689|NCT00570687|578259|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240690|NCT00570687|578260|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
240691|NCT00570687|578261|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
240692|NCT00570687|578262|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
240693|NCT00570687|578263|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
240694|NCT00570687|578264|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
240695|NCT00570687|578255|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
240696|NCT00570687|578256|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
240697|NCT00570687|578257|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
240698|NCT00570687|578258|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
240699|NCT00570687|578259|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
240700|NCT00570687|578260|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
240701|NCT00570687|578261|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
240702|NCT00570687|578262|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
240703|NCT00570687|578263|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
240704|NCT00570687|578264|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
240705|NCT00570687|578255|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240706|NCT00570687|578256|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240707|NCT00570687|578257|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240708|NCT00570687|578258|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
240709|NCT00570687|578259|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240710|NCT00570687|578260|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240711|NCT00570687|578261|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240712|NCT00570687|578262|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240713|NCT00570687|578263|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240714|NCT00570687|578264|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240715|NCT00570687|578255|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240716|NCT00570687|578256|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240717|NCT00570687|578257|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240718|NCT00570687|578258|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240719|NCT00570687|578259|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240720|NCT00570687|578260|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240721|NCT00570687|578261|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240722|NCT00570687|578262|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240723|NCT00570687|578263|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240724|NCT00570687|578264|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
240725|NCT00570687|578255|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240726|NCT00570687|578256|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240727|NCT00570687|578257|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240728|NCT00570687|578258|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
240729|NCT00570687|578259|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240730|NCT00570687|578260|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240731|NCT00570687|578261|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240732|NCT00570687|578262|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240733|NCT00570687|578263|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240734|NCT00570687|578264|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
240735|NCT00570687|578255|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240736|NCT00570687|578256|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240737|NCT00570687|578257|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240738|NCT00570687|578258|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240739|NCT00570687|578259|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240740|NCT00570687|578260|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240741|NCT00570687|578261|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240742|NCT00570687|578262|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240743|NCT00570687|578263|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240744|NCT00570687|578264|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240745|NCT00570687|578255|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240746|NCT00570687|578256|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240747|NCT00570687|578257|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240748|NCT00570687|578258|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
240749|NCT00570687|578259|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240750|NCT00570687|578260|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240751|NCT00570687|578261|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240752|NCT00570687|578262|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240753|NCT00570687|578263|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240754|NCT00570687|578264|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
240755|NCT00570687|578255|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240756|NCT00570687|578256|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240757|NCT00570687|578257|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240758|NCT00570687|578258|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
240759|NCT00570687|578259|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240760|NCT00570687|578260|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240761|NCT00570687|578261|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240762|NCT00570687|578262|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240763|NCT00570687|578263|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240764|NCT00570687|578264|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
240765|NCT00570687|578255|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240766|NCT00570687|578256|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
240767|NCT00570687|578257|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240768|NCT00570687|578258|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240769|NCT00570687|578259|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240770|NCT00570687|578260|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240771|NCT00570687|578261|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240772|NCT00570687|578262|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240773|NCT00570687|578263|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240774|NCT00570687|578264|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240775|NCT00570687|578255|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240776|NCT00570687|578256|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240777|NCT00570687|578257|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240778|NCT00570687|578258|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
240779|NCT00570687|578259|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240780|NCT00570687|578260|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240781|NCT00570687|578261|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240782|NCT00570687|578262|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240783|NCT00570687|578263|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240784|NCT00570687|578264|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
240785|NCT00570687|578255|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240786|NCT00570687|578256|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
240787|NCT00570687|578257|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240788|NCT00570687|578258|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
240789|NCT00570687|578259|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240790|NCT00570687|578260|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240791|NCT00570687|578261|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240792|NCT00570687|578262|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240793|NCT00570687|578263|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240794|NCT00570687|578264|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
240795|NCT00570687|578255|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240796|NCT00570687|578256|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240797|NCT00570687|578257|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240798|NCT00570687|578258|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240799|NCT00570687|578259|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240800|NCT00570687|578260|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240801|NCT00570687|578261|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240802|NCT00570687|578262|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240803|NCT00570687|578263|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240804|NCT00570687|578264|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240805|NCT00570687|578255|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240806|NCT00570687|578256|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
240807|NCT00570687|578257|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240808|NCT00570687|578258|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
240809|NCT00570687|578259|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240810|NCT00570687|578260|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240811|NCT00570687|578261|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240812|NCT00570687|578262|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240813|NCT00570687|578263|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240814|NCT00570687|578264|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
240815|NCT00570687|578255|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240816|NCT00570687|578256|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
240817|NCT00570687|578257|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240818|NCT00570687|578258|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
240819|NCT00570687|578259|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240820|NCT00570687|578260|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240821|NCT00570687|578261|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240822|NCT00570687|578262|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240823|NCT00570687|578263|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240824|NCT00570687|578264|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
240825|NCT00570687|578255|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
240826|NCT00570687|578256|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
240827|NCT00570687|578257|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
240828|NCT00570687|578258|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
240829|NCT00570687|578259|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
240830|NCT00570687|578260|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
240831|NCT00570687|578261|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240832|NCT00570687|578262|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240833|NCT00570687|578263|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240834|NCT00570687|578264|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240835|NCT00570687|578255|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240836|NCT00570687|578256|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
240837|NCT00570687|578257|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240838|NCT00570687|578258|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
240839|NCT00570687|578259|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240840|NCT00570687|578260|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240841|NCT00570687|578261|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240842|NCT00570687|578262|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240843|NCT00570687|578263|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240844|NCT00570687|578264|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
240845|NCT00570687|578255|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
240846|NCT00570687|578256|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
240847|NCT00570687|578257|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
240848|NCT00570687|578258|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
240849|NCT00570687|578259|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
240850|NCT00570687|578260|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
240851|NCT00570687|578261|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
240852|NCT00570687|578262|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
240853|NCT00570687|578263|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
240854|NCT00570687|578264|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
240855|NCT00570687|578255|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240856|NCT00570687|578256|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240857|NCT00570687|578257|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240858|NCT00570687|578258|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240859|NCT00570687|578259|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240860|NCT00570687|578260|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240861|NCT00570687|578261|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240862|NCT00570687|578262|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240863|NCT00570687|578263|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240864|NCT00570687|578264|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240865|NCT00570687|578255|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240866|NCT00570687|578256|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240867|NCT00570687|578257|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240868|NCT00570687|578258|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240869|NCT00570687|578259|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240870|NCT00570687|578260|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240871|NCT00570687|578261|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240872|NCT00570687|578262|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240873|NCT00570687|578263|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240874|NCT00570687|578264|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240875|NCT00570687|578255|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240876|NCT00570687|578256|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240877|NCT00570687|578257|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240878|NCT00570687|578258|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240879|NCT00570687|578259|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240880|NCT00570687|578260|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
240881|NCT00570687|578261|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240882|NCT00570687|578262|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240883|NCT00570687|578263|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240884|NCT00570687|578264|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
240885|NCT00570687|578255|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240886|NCT00570687|578256|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240887|NCT00570687|578257|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240888|NCT00570687|578258|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240889|NCT00570687|578259|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240890|NCT00570687|578260|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240891|NCT00570687|578261|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240892|NCT00570687|578262|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240893|NCT00570687|578263|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240894|NCT00570687|578264|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240895|NCT00570687|578255|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
240896|NCT00570687|578256|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
240897|NCT00570687|578257|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
240898|NCT00570687|578258|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
240899|NCT00570687|578259|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
240900|NCT00570687|578260|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
240901|NCT00570687|578261|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240902|NCT00570687|578262|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240903|NCT00570687|578263|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240904|NCT00570687|578264|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
240905|NCT00570687|578255|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
240906|NCT00570687|578256|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
240907|NCT00570687|578257|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
240908|NCT00570687|578258|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
240909|NCT00570687|578259|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
240910|NCT00570687|578260|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
240911|NCT00570687|578261|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
240912|NCT00570687|578262|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
240913|NCT00570687|578263|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
240914|NCT00570687|578264|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
240915|NCT00570687|578255|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240916|NCT00570687|578256|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240917|NCT00570687|578257|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240918|NCT00570687|578258|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240919|NCT00570687|578259|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240920|NCT00570687|578260|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240921|NCT00570687|578261|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240922|NCT00570687|578262|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240923|NCT00570687|578263|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240924|NCT00570687|578264|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240925|NCT00570687|578255|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240926|NCT00570687|578256|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240927|NCT00570687|578257|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240928|NCT00570687|578258|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240929|NCT00570687|578259|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240930|NCT00570687|578260|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240931|NCT00570687|578261|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240932|NCT00570687|578262|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240933|NCT00570687|578263|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240934|NCT00570687|578264|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240935|NCT00570687|578255|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240936|NCT00570687|578256|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240937|NCT00570687|578257|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240938|NCT00570687|578258|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240939|NCT00570687|578259|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240940|NCT00570687|578260|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
240941|NCT00570687|578261|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240942|NCT00570687|578262|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240943|NCT00570687|578263|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240944|NCT00570687|578264|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
240945|NCT00570687|578255|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240946|NCT00570687|578256|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240947|NCT00570687|578257|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240948|NCT00570687|578258|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240949|NCT00570687|578259|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240950|NCT00570687|578260|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240951|NCT00570687|578261|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240952|NCT00570687|578262|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240953|NCT00570687|578263|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240954|NCT00570687|578264|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240955|NCT00570687|578255|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
240956|NCT00570687|578256|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
240957|NCT00570687|578257|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
240958|NCT00570687|578258|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
240959|NCT00570687|578259|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
240960|NCT00570687|578260|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
240961|NCT00570687|578261|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240962|NCT00570687|578262|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240963|NCT00570687|578263|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240964|NCT00570687|578264|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
240965|NCT00570687|578255|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
240966|NCT00570687|578256|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
240967|NCT00570687|578257|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
240968|NCT00570687|578258|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
240969|NCT00570687|578259|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
240970|NCT00570687|578260|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
240971|NCT00570687|578261|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
240972|NCT00570687|578262|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
240973|NCT00570687|578263|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
240974|NCT00570687|578264|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
240975|NCT00570687|578255|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240976|NCT00570687|578256|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240977|NCT00570687|578257|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240978|NCT00570687|578258|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240979|NCT00570687|578259|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240980|NCT00570687|578260|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240981|NCT00570687|578261|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240982|NCT00570687|578262|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240983|NCT00570687|578263|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240984|NCT00570687|578264|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240985|NCT00570687|578255|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240986|NCT00570687|578256|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240987|NCT00570687|578257|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240988|NCT00570687|578258|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240989|NCT00570687|578259|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240990|NCT00570687|578260|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240991|NCT00570687|578261|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240992|NCT00570687|578262|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240993|NCT00570687|578263|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240994|NCT00570687|578264|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
240995|NCT00570687|578255|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240996|NCT00570687|578256|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240997|NCT00570687|578257|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240998|NCT00570687|578258|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
240999|NCT00570687|578259|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
241000|NCT00570687|578260|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
241001|NCT00570687|578261|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
241002|NCT00570687|578262|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
241003|NCT00570687|578263|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
241004|NCT00570687|578264|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
241005|NCT00570674|578290|P7|NOT COMPLETED|Overall Study||0
241006|NCT00570674|578291|P6|NOT COMPLETED|Overall Study||0
241007|NCT00570674|578292|P5|NOT COMPLETED|Overall Study||0
241008|NCT00570674|578293|P4|NOT COMPLETED|Overall Study||0
241009|NCT00570674|578294|P3|NOT COMPLETED|Overall Study||1
241010|NCT00570674|578295|P2|NOT COMPLETED|Overall Study||0
241011|NCT00570674|578296|P1|NOT COMPLETED|Overall Study||0
241012|NCT00570674|578290|P7|COMPLETED|Overall Study||0
241013|NCT00570674|578291|P6|COMPLETED|Overall Study||10
241014|NCT00570674|578292|P5|COMPLETED|Overall Study||3
241015|NCT00570674|578293|P4|COMPLETED|Overall Study||3
241016|NCT00570674|578294|P3|COMPLETED|Overall Study||3
241017|NCT00570674|578295|P2|COMPLETED|Overall Study||3
241018|NCT00570674|578296|P1|COMPLETED|Overall Study||6
241019|NCT00570674|578290|P7|PEG Evaluable|Overall Study||0
241020|NCT00570674|578291|P6|PEG Evaluable|Overall Study||10
241021|NCT00570674|578292|P5|PEG Evaluable|Overall Study||2
241022|NCT00570674|578293|P4|PEG Evaluable|Overall Study||3
241023|NCT00570674|578294|P3|PEG Evaluable|Overall Study||3
241024|NCT00570674|578295|P2|PEG Evaluable|Overall Study||3
241025|NCT00570674|578296|P1|PEG Evaluable|Overall Study||6
241026|NCT00570674|578290|P7|Treated|Overall Study||0
241027|NCT00570674|578291|P6|Treated|Overall Study||10
241028|NCT00570674|578292|P5|Treated|Overall Study||3
241029|NCT00570674|578293|P4|Treated|Overall Study||3
241030|NCT00570674|578294|P3|Treated|Overall Study||3
241031|NCT00570674|578295|P2|Treated|Overall Study||3
241032|NCT00570674|578296|P1|Treated|Overall Study||6
241033|NCT00570674|578290|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
241034|NCT00570674|578291|P6|STARTED|Overall Study||10
241035|NCT00570674|578292|P5|STARTED|Overall Study||3
241036|NCT00570674|578293|P4|STARTED|Overall Study||3
241037|NCT00570674|578294|P3|STARTED|Overall Study||4
241038|NCT00570674|578295|P2|STARTED|Overall Study||3
241039|NCT00570674|578296|P1|STARTED|Overall Study||6
241040|NCT00570531|578313|P1|NOT COMPLETED|Overall Study||0
241041|NCT00570531|578313|P1|COMPLETED|Overall Study||6
241042|NCT00570531|578313|P1|STARTED|Overall Study||6
241043|NCT00570505|578319|P1|NOT COMPLETED|Overall Study||41
241044|NCT00570505|578319|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
241045|NCT00570505|578319|P1|STARTED|Overall Study||149
241046|NCT00570492|578332|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
241047|NCT00570492|578333|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
241048|NCT00570492|578334|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
241049|NCT00570492|578332|P3|COMPLETED|52-week Double-blind Treatment Period||186
241050|NCT00570492|578333|P2|COMPLETED|52-week Double-blind Treatment Period||187
241051|NCT00570492|578334|P1|COMPLETED|52-week Double-blind Treatment Period||0
241052|NCT00570492|578332|P3|STARTED|52-week Double-blind Treatment Period||237
241053|NCT00570492|578333|P2|STARTED|52-week Double-blind Treatment Period||237
241054|NCT00570492|578334|P1|STARTED|52-week Double-blind Treatment Period||0
241055|NCT00570492|578332|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
241056|NCT00570492|578333|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
241057|NCT00570492|578334|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
241058|NCT00570492|578332|P3|COMPLETED|16-week Single-blind Baseline Period||0
241059|NCT00570492|578333|P2|COMPLETED|16-week Single-blind Baseline Period||0
241060|NCT00570492|578334|P1|COMPLETED|16-week Single-blind Baseline Period||474
241061|NCT00570492|578332|P3|STARTED|16-week Single-blind Baseline Period||0
241062|NCT00570492|578333|P2|STARTED|16-week Single-blind Baseline Period||0
241063|NCT00570492|578334|P1|STARTED|16-week Single-blind Baseline Period||910
241064|NCT00570401|578372|P1|NOT COMPLETED|Overall Study||2
241065|NCT00570401|578372|P1|COMPLETED|Overall Study||19
241066|NCT00570401|578372|P1|STARTED|Overall Study||21
241067|NCT00570362|578378|P2|NOT COMPLETED|Overall Study||0
241068|NCT00570362|578379|P1|NOT COMPLETED|Overall Study||0
241069|NCT00570362|578378|P2|COMPLETED|Overall Study||30
241070|NCT00570362|578379|P1|COMPLETED|Overall Study||19
241071|NCT00570362|578378|P2|STARTED|Overall Study||30
241072|NCT00570362|578379|P1|STARTED|Overall Study||19
241073|NCT00570349|578388|P3|NOT COMPLETED|Overall Study||0
241074|NCT00570349|578389|P2|NOT COMPLETED|Overall Study||0
241075|NCT00570349|578390|P1|NOT COMPLETED|Overall Study||0
241076|NCT00570349|578388|P3|COMPLETED|Overall Study||6
241077|NCT00570349|578389|P2|COMPLETED|Overall Study||6
241078|NCT00570349|578390|P1|COMPLETED|Overall Study||6
241079|NCT00570349|578388|P3|STARTED|Overall Study||6
241080|NCT00570349|578389|P2|STARTED|Overall Study||6
241081|NCT00570349|578390|P1|STARTED|Overall Study||6
241082|NCT00570310|578406|P2|NOT COMPLETED|Overall Study||6
241083|NCT00570310|578407|P1|NOT COMPLETED|Overall Study||2
241084|NCT00570310|578406|P2|COMPLETED|Overall Study||45
241085|NCT00570310|578407|P1|COMPLETED|Overall Study||51
241086|NCT00570310|578406|P2|STARTED|Overall Study||51
241087|NCT00570310|578407|P1|STARTED|Overall Study||53
241088|NCT00570232|578415|P1|NOT COMPLETED|Overall Study||23
241089|NCT00570232|578415|P1|COMPLETED|Overall Study||8
241090|NCT00570232|578415|P1|STARTED|Overall Study||31
241091|NCT00570141|578421|P1|NOT COMPLETED|Overall Study||3
241092|NCT00570141|578421|P1|COMPLETED|Overall Study||10
241093|NCT00570141|578421|P1|STARTED|Overall Study||13
241094|NCT00570089|578426|P2|NOT COMPLETED|Perod 2||0
241095|NCT00570089|578427|P1|NOT COMPLETED|Perod 2||0
241096|NCT00570089|578426|P2|COMPLETED|Perod 2||10
241097|NCT00570089|578427|P1|COMPLETED|Perod 2||10
241098|NCT00570089|578426|P2|STARTED|Perod 2||10
241099|NCT00570089|578427|P1|STARTED|Perod 2||10
241100|NCT00570089|578426|P2|NOT COMPLETED|Period 1||0
241101|NCT00570089|578427|P1|NOT COMPLETED|Period 1||0
241102|NCT00570089|578426|P2|COMPLETED|Period 1||10
241103|NCT00570089|578427|P1|COMPLETED|Period 1||10
241104|NCT00570089|578426|P2|STARTED|Period 1||10
241105|NCT00570089|578427|P1|STARTED|Period 1||10
241106|NCT00570063|578437|P2|NOT COMPLETED|Overall Study||8
241107|NCT00570063|578438|P1|NOT COMPLETED|Overall Study||15
241108|NCT00570063|578437|P2|COMPLETED|Overall Study||3
241109|NCT00570063|578438|P1|COMPLETED|Overall Study||9
241110|NCT00570063|578437|P2|STARTED|Overall Study||11
241111|NCT00570063|578438|P1|STARTED|Overall Study||24
241112|NCT00570037|578504|P2|NOT COMPLETED|Overall Study||69
241113|NCT00570037|578505|P1|NOT COMPLETED|Overall Study||44
241114|NCT00570037|578504|P2|COMPLETED|Overall Study||237
241115|NCT00570037|578505|P1|COMPLETED|Overall Study||194
241116|NCT00570037|578504|P2|STARTED|Overall Study||306
241117|NCT00570037|578505|P1|STARTED|Overall Study||238
241118|NCT00569946|578515|P1|NOT COMPLETED|Overall Study||59
241119|NCT00569946|578515|P1|COMPLETED|Overall Study||5
241120|NCT00569946|578515|P1|STARTED|Overall Study||64
241121|NCT00569868|578531|P1|NOT COMPLETED|Overall Study||0
241122|NCT00569868|578531|P1|COMPLETED|Overall Study||11
241123|NCT00569868|578531|P1|STARTED|Overall Study||11
241124|NCT00569855|578535|P1|NOT COMPLETED|Overall Study||0
241125|NCT00569855|578535|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
241126|NCT00569855|578535|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
241127|NCT00569803|578547|P8|NOT COMPLETED|Overall Study||1
241128|NCT00569803|578548|P7|NOT COMPLETED|Overall Study||0
241129|NCT00569803|578549|P6|NOT COMPLETED|Overall Study||0
241130|NCT00569803|578550|P5|NOT COMPLETED|Overall Study||0
241131|NCT00569803|578551|P4|NOT COMPLETED|Overall Study||1
241132|NCT00569803|578552|P3|NOT COMPLETED|Overall Study||0
241133|NCT00569803|578553|P2|NOT COMPLETED|Overall Study||0
241134|NCT00569803|578554|P1|NOT COMPLETED|Overall Study||1
241135|NCT00569803|578547|P8|COMPLETED|Overall Study||5
241136|NCT00569803|578548|P7|COMPLETED|Overall Study||10
241137|NCT00569803|578549|P6|COMPLETED|Overall Study||5
241138|NCT00569803|578550|P5|COMPLETED|Overall Study||5
241139|NCT00569803|578551|P4|COMPLETED|Overall Study||5
241140|NCT00569803|578552|P3|COMPLETED|Overall Study||5
241141|NCT00569803|578553|P2|COMPLETED|Overall Study||5
241142|NCT00569803|578554|P1|COMPLETED|Overall Study||4
241143|NCT00569803|578547|P8|STARTED|Overall Study||6
241144|NCT00569803|578548|P7|STARTED|Overall Study||10
241145|NCT00569803|578549|P6|STARTED|Overall Study||5
241146|NCT00569803|578550|P5|STARTED|Overall Study||5
241147|NCT00569803|578551|P4|STARTED|Overall Study||6
241148|NCT00569803|578552|P3|STARTED|Overall Study||5
241149|NCT00569803|578553|P2|STARTED|Overall Study||5
241150|NCT00569803|578554|P1|STARTED|Overall Study||5
241151|NCT00569777|578681|P2|NOT COMPLETED|Overall Study||3
241152|NCT00569777|578682|P1|NOT COMPLETED|Overall Study||10
241153|NCT00569777|578681|P2|COMPLETED|Overall Study||101
241154|NCT00569777|578682|P1|COMPLETED|Overall Study||196
241155|NCT00569777|578681|P2|STARTED|Overall Study||104
241156|NCT00569777|578682|P1|STARTED|Overall Study||206
241157|NCT00569673|578724|P1|NOT COMPLETED|Overall Study||0
241158|NCT00569673|578724|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
241159|NCT00569673|578724|P1|STARTED|Overall Study|Total number participants enrolled on study|71
241160|NCT00569660|578728|P1|NOT COMPLETED|Overall Study||0
241161|NCT00569660|578728|P1|COMPLETED|Overall Study||34
241162|NCT00569660|578728|P1|STARTED|Overall Study||34
241163|NCT00569582|578732|P1|NOT COMPLETED|Overall Study||16
241164|NCT00569582|578732|P1|COMPLETED|Overall Study||34
241165|NCT00569582|578732|P1|STARTED|Overall Study||50
241166|NCT00569530|578739|P2|NOT COMPLETED|Overall Study||0
241167|NCT00569530|578740|P1|NOT COMPLETED|Overall Study||0
241168|NCT00569530|578739|P2|COMPLETED|Overall Study||42
241169|NCT00569530|578740|P1|COMPLETED|Overall Study||43
241170|NCT00569530|578739|P2|STARTED|Overall Study||42
241171|NCT00569530|578740|P1|STARTED|Overall Study||43
241172|NCT00569374|578748|P1|NOT COMPLETED|Overall Study||4
241173|NCT00569374|578748|P1|COMPLETED|Overall Study||4
241174|NCT00569374|578748|P1|STARTED|Overall Study||8
241175|NCT00569309|578758|P1|NOT COMPLETED|Overall Study||0
241176|NCT00569309|578758|P1|COMPLETED|Overall Study||30
241177|NCT00569309|578758|P1|STARTED|Overall Study||30
241178|NCT00569270|578767|P2|NOT COMPLETED|Period: Second Intervention||0
241179|NCT00569270|578768|P1|NOT COMPLETED|Period: Second Intervention||0
241180|NCT00569270|578767|P2|COMPLETED|Period: Second Intervention||14
241181|NCT00569270|578768|P1|COMPLETED|Period: Second Intervention||15
241182|NCT00569270|578767|P2|29 Days|Period: Second Intervention||14
241183|NCT00569270|578768|P1|29 Days|Period: Second Intervention||15
241184|NCT00569270|578767|P2|STARTED|Period: Second Intervention||14
241185|NCT00569270|578768|P1|STARTED|Period: Second Intervention||15
241186|NCT00569270|578767|P2|NOT COMPLETED|Period: First Intervention||1
241187|NCT00569270|578768|P1|NOT COMPLETED|Period: First Intervention||0
241188|NCT00569270|578767|P2|COMPLETED|Period: First Intervention||14
241189|NCT00569270|578768|P1|COMPLETED|Period: First Intervention||15
241190|NCT00569270|578767|P2|STARTED|Period: First Intervention||15
241191|NCT00569270|578768|P1|STARTED|Period: First Intervention|randomized cross over study|15
241192|NCT00569231|578803|P1|NOT COMPLETED|Overall Study||7
241193|NCT00569231|578803|P1|COMPLETED|Overall Study||11
241194|NCT00569231|578803|P1|STARTED|Overall Study||18
241195|NCT00569192|578813|P3|NOT COMPLETED|Overall Study||25
241196|NCT00569192|578814|P2|NOT COMPLETED|Overall Study||20
241197|NCT00569192|578815|P1|NOT COMPLETED|Overall Study||23
241198|NCT00569192|578813|P3|COMPLETED|Overall Study||99
241199|NCT00569192|578814|P2|COMPLETED|Overall Study||105
241200|NCT00569192|578815|P1|COMPLETED|Overall Study||88
241201|NCT00569192|578813|P3|STARTED|Overall Study||124
241202|NCT00569192|578814|P2|STARTED|Overall Study||125
241203|NCT00569192|578815|P1|STARTED|Overall Study||111
241204|NCT00569166|578841|P3|NOT COMPLETED|Overall Study||4
241205|NCT00569166|578842|P2|NOT COMPLETED|Overall Study||6
241206|NCT00569166|578843|P1|NOT COMPLETED|Overall Study||9
241207|NCT00569166|578841|P3|COMPLETED|Overall Study||27
241208|NCT00569166|578842|P2|COMPLETED|Overall Study||25
241209|NCT00569166|578843|P1|COMPLETED|Overall Study||21
241210|NCT00569166|578841|P3|STARTED|Overall Study||31
241211|NCT00569166|578842|P2|STARTED|Overall Study||31
241212|NCT00569166|578843|P1|STARTED|Overall Study||30
241213|NCT00569127|578877|P2|NOT COMPLETED|Overall Study||213
241214|NCT00569127|578878|P1|NOT COMPLETED|Overall Study||214
241215|NCT00569127|578877|P2|COMPLETED|Overall Study||0
241216|NCT00569127|578878|P1|COMPLETED|Overall Study||0
241217|NCT00569127|578877|P2|Eligible|Overall Study||202
241218|NCT00569127|578878|P1|Eligible|Overall Study||200
241219|NCT00569127|578877|P2|STARTED|Overall Study||213
241220|NCT00569127|578878|P1|STARTED|Overall Study||214
241221|NCT00569010|578898|P4|NOT COMPLETED|Overall Study||0
241222|NCT00569010|578899|P3|NOT COMPLETED|Overall Study||0
241223|NCT00569010|578900|P2|NOT COMPLETED|Overall Study||0
241224|NCT00569010|578901|P1|NOT COMPLETED|Overall Study||0
241225|NCT00569010|578898|P4|COMPLETED|Overall Study||11
241226|NCT00569010|578899|P3|COMPLETED|Overall Study||11
241227|NCT00569010|578900|P2|COMPLETED|Overall Study||6
241228|NCT00569010|578901|P1|COMPLETED|Overall Study||6
241229|NCT00569010|578898|P4|STARTED|Overall Study||11
241230|NCT00569010|578899|P3|STARTED|Overall Study||11
241231|NCT00569010|578900|P2|STARTED|Overall Study||6
241232|NCT00569010|578901|P1|STARTED|Overall Study||6
241233|NCT00568958|578913|P2|NOT COMPLETED|Follow-Up||4
241234|NCT00568958|578914|P1|NOT COMPLETED|Follow-Up||8
241235|NCT00568958|578913|P2|COMPLETED|Follow-Up||63
241236|NCT00568958|578914|P1|COMPLETED|Follow-Up||53
241237|NCT00568958|578913|P2|STARTED|Follow-Up||67
241238|NCT00568958|578914|P1|STARTED|Follow-Up||61
241239|NCT00568958|578913|P2|NOT COMPLETED|Allocation||3
241240|NCT00568958|578914|P1|NOT COMPLETED|Allocation||9
241241|NCT00568958|578913|P2|COMPLETED|Allocation||67
241242|NCT00568958|578914|P1|COMPLETED|Allocation||61
241243|NCT00568958|578913|P2|STARTED|Allocation||70
241244|NCT00568958|578914|P1|STARTED|Allocation||70
241245|NCT00568854|578934|P2|NOT COMPLETED|Overall Study||0
241246|NCT00568854|578935|P1|NOT COMPLETED|Overall Study||0
241247|NCT00568854|578934|P2|COMPLETED|Overall Study||4
241248|NCT00568854|578935|P1|COMPLETED|Overall Study||6
241249|NCT00568854|578934|P2|STARTED|Overall Study||4
241250|NCT00568854|578935|P1|STARTED|Overall Study||6
241251|NCT00568776|578947|P4|NOT COMPLETED|Overall Study||72
241252|NCT00568776|578948|P3|NOT COMPLETED|Overall Study||74
241253|NCT00568776|578949|P2|NOT COMPLETED|Overall Study||36
241254|NCT00568776|578950|P1|NOT COMPLETED|Overall Study||30
241255|NCT00568776|578947|P4|COMPLETED|Overall Study||19
241256|NCT00568776|578948|P3|COMPLETED|Overall Study||15
241257|NCT00568776|578949|P2|COMPLETED|Overall Study||52
241258|NCT00568776|578950|P1|COMPLETED|Overall Study||53
241259|NCT00568776|578947|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
241260|NCT00568776|578948|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
241261|NCT00568776|578949|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
241262|NCT00568776|578950|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
241263|NCT00568685|578987|P3|NOT COMPLETED|Overall Study||5
241264|NCT00568685|578988|P2|NOT COMPLETED|Overall Study||5
241265|NCT00568685|578989|P1|NOT COMPLETED|Overall Study||10
241266|NCT00568685|578987|P3|COMPLETED|Overall Study||46
241267|NCT00568685|578988|P2|COMPLETED|Overall Study||46
241268|NCT00568685|578989|P1|COMPLETED|Overall Study||41
241269|NCT00568685|578987|P3|STARTED|Overall Study||51
241270|NCT00568685|578988|P2|STARTED|Overall Study||51
241271|NCT00568685|578989|P1|STARTED|Overall Study||51
241272|NCT00568555|579023|P2|NOT COMPLETED|Overall Study||1
241273|NCT00568555|579024|P1|NOT COMPLETED|Overall Study||1
241274|NCT00568555|579023|P2|COMPLETED|Overall Study||14
241275|NCT00568555|579024|P1|COMPLETED|Overall Study||15
241276|NCT00568555|579023|P2|STARTED|Overall Study||15
241277|NCT00568555|579024|P1|STARTED|Overall Study||16
241278|NCT00568451|579042|P4|NOT COMPLETED|Overall Study||7
241279|NCT00568451|579043|P3|NOT COMPLETED|Overall Study||2
241280|NCT00568451|579044|P2|NOT COMPLETED|Overall Study||0
241281|NCT00568451|579045|P1|NOT COMPLETED|Overall Study||0
241282|NCT00568451|579042|P4|COMPLETED|Overall Study||2
241283|NCT00568451|579043|P3|COMPLETED|Overall Study||0
241284|NCT00568451|579044|P2|COMPLETED|Overall Study||0
241285|NCT00568451|579045|P1|COMPLETED|Overall Study||0
241286|NCT00568451|579042|P4|STARTED|Overall Study||9
241287|NCT00568451|579043|P3|STARTED|Overall Study||2
241288|NCT00568451|579044|P2|STARTED|Overall Study||0
241289|NCT00568451|579045|P1|STARTED|Overall Study||0
241290|NCT00568399|579061|P1|NOT COMPLETED|Overall Study||15
241291|NCT00568399|579061|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
241292|NCT00568399|579061|P1|STARTED|Overall Study||37
241293|NCT00568386|579067|P2|NOT COMPLETED|Overall Study||0
241294|NCT00568386|579068|P1|NOT COMPLETED|Overall Study||0
241295|NCT00568386|579067|P2|COMPLETED|Overall Study||20
241296|NCT00568386|579068|P1|COMPLETED|Overall Study||20
241297|NCT00568386|579067|P2|STARTED|Overall Study||20
241298|NCT00568386|579068|P1|STARTED|Overall Study||20
241299|NCT00568334|579076|P2|NOT COMPLETED|Overall Study||1
241300|NCT00568334|579077|P1|NOT COMPLETED|Overall Study||1
241301|NCT00568334|579076|P2|COMPLETED|Overall Study||121
241302|NCT00568334|579077|P1|COMPLETED|Overall Study||121
241303|NCT00568334|579076|P2|STARTED|Overall Study||122
241304|NCT00568334|579077|P1|STARTED|Overall Study||122
241305|NCT00568178|579103|P6|NOT COMPLETED|Open Label Extension||80
241306|NCT00568178|579104|P5|NOT COMPLETED|Open Label Extension||79
241307|NCT00568178|579105|P4|NOT COMPLETED|Open Label Extension||0
241308|NCT00568178|579106|P3|NOT COMPLETED|Open Label Extension||0
241309|NCT00568178|579107|P2|NOT COMPLETED|Open Label Extension||0
241310|NCT00568178|579108|P1|NOT COMPLETED|Open Label Extension||0
241311|NCT00568178|579103|P6|COMPLETED|Open Label Extension||54
241312|NCT00568178|579104|P5|COMPLETED|Open Label Extension||55
241313|NCT00568178|579105|P4|COMPLETED|Open Label Extension||0
241314|NCT00568178|579106|P3|COMPLETED|Open Label Extension||0
241315|NCT00568178|579107|P2|COMPLETED|Open Label Extension||0
241316|NCT00568178|579108|P1|COMPLETED|Open Label Extension||0
241317|NCT00568178|579103|P6|STARTED|Open Label Extension||134
241318|NCT00568178|579104|P5|STARTED|Open Label Extension||134
241319|NCT00568178|579105|P4|STARTED|Open Label Extension||0
241320|NCT00568178|579106|P3|STARTED|Open Label Extension||0
241321|NCT00568178|579107|P2|STARTED|Open Label Extension||0
241322|NCT00568178|579108|P1|STARTED|Open Label Extension||0
241323|NCT00568178|579103|P6|NOT COMPLETED|Double Blind Base Study||0
241324|NCT00568178|579104|P5|NOT COMPLETED|Double Blind Base Study||0
241325|NCT00568178|579105|P4|NOT COMPLETED|Double Blind Base Study||5
241326|NCT00568178|579106|P3|NOT COMPLETED|Double Blind Base Study||1
241327|NCT00568178|579107|P2|NOT COMPLETED|Double Blind Base Study||6
241328|NCT00568178|579108|P1|NOT COMPLETED|Double Blind Base Study||6
241329|NCT00568178|579103|P6|COMPLETED|Double Blind Base Study||0
241330|NCT00568178|579104|P5|COMPLETED|Double Blind Base Study||0
241331|NCT00568178|579105|P4|COMPLETED|Double Blind Base Study||25
241332|NCT00568178|579106|P3|COMPLETED|Double Blind Base Study||29
241333|NCT00568178|579107|P2|COMPLETED|Double Blind Base Study||118
241334|NCT00568178|579108|P1|COMPLETED|Double Blind Base Study||116
241335|NCT00568178|579103|P6|STARTED|Double Blind Base Study||0
241336|NCT00568178|579104|P5|STARTED|Double Blind Base Study||0
241337|NCT00568178|579105|P4|STARTED|Double Blind Base Study||30
241338|NCT00568178|579106|P3|STARTED|Double Blind Base Study||30
241339|NCT00568178|579107|P2|STARTED|Double Blind Base Study||124
241340|NCT00568178|579108|P1|STARTED|Double Blind Base Study||122
241341|NCT00568087|579126|P2|NOT COMPLETED|Overall Study||7
241342|NCT00568087|579127|P1|NOT COMPLETED|Overall Study||7
241343|NCT00568087|579126|P2|COMPLETED|Overall Study||17
241344|NCT00568087|579127|P1|COMPLETED|Overall Study||15
241345|NCT00568087|579126|P2|Received Intervention|Overall Study||23
241346|NCT00568087|579127|P1|Received Intervention|Overall Study||21
241347|NCT00568087|579126|P2|STARTED|Overall Study||24
241348|NCT00568087|579127|P1|STARTED|Overall Study||22
241349|NCT00568061|579139|P2|NOT COMPLETED|Overall Study||2
241350|NCT00568061|579140|P1|NOT COMPLETED|Overall Study||5
241351|NCT00568061|579139|P2|COMPLETED|Overall Study||14
241352|NCT00568061|579140|P1|COMPLETED|Overall Study||8
241353|NCT00568061|579139|P2|STARTED|Overall Study||16
241354|NCT00568061|579140|P1|STARTED|Overall Study||13
241355|NCT00568022|579149|P3|NOT COMPLETED|Overall Study||0
241356|NCT00568022|579150|P2|NOT COMPLETED|Overall Study||0
241357|NCT00568022|579151|P1|NOT COMPLETED|Overall Study||0
241358|NCT00568022|579149|P3|COMPLETED|Overall Study||3
241359|NCT00568022|579150|P2|COMPLETED|Overall Study||3
241360|NCT00568022|579151|P1|COMPLETED|Overall Study||3
241361|NCT00568022|579149|P3|STARTED|Overall Study||3
241362|NCT00568022|579150|P2|STARTED|Overall Study||3
241363|NCT00568022|579151|P1|STARTED|Overall Study||3
241364|NCT00567996|579184|P3|NOT COMPLETED|Overall Study||70
241365|NCT00567996|579185|P2|NOT COMPLETED|Overall Study||50
241366|NCT00567996|579186|P1|NOT COMPLETED|Overall Study||44
241367|NCT00567996|579184|P3|COMPLETED|Overall Study||265
241368|NCT00567996|579185|P2|COMPLETED|Overall Study||284
241369|NCT00567996|579186|P1|COMPLETED|Overall Study||289
241370|NCT00567996|579184|P3|Intent-to-treat: Received Study Drug|Overall Study||335
241371|NCT00567996|579185|P2|Intent-to-treat: Received Study Drug|Overall Study||333
241372|NCT00567996|579186|P1|Intent-to-treat: Received Study Drug|Overall Study||330
241373|NCT00567996|579184|P3|STARTED|Overall Study||335
241374|NCT00567996|579185|P2|STARTED|Overall Study||334
241375|NCT00567996|579186|P1|STARTED|Overall Study|Randomized participants|333
241376|NCT00567892|579202|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
241377|NCT00567892|579203|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
241378|NCT00567892|579204|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
241379|NCT00567892|579205|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
241380|NCT00567892|579202|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
241381|NCT00567892|579203|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
241382|NCT00567892|579204|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
241383|NCT00567892|579205|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
241384|NCT00567892|579202|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
241385|NCT00567892|579203|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
241386|NCT00567892|579204|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
241387|NCT00567892|579205|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
241388|NCT00567892|579202|P4|NOT COMPLETED|Washout (2 Weeks)||0
241389|NCT00567892|579203|P3|NOT COMPLETED|Washout (2 Weeks)||0
241390|NCT00567892|579204|P2|NOT COMPLETED|Washout (2 Weeks)||0
241391|NCT00567892|579205|P1|NOT COMPLETED|Washout (2 Weeks)||0
241392|NCT00567892|579202|P4|COMPLETED|Washout (2 Weeks)||6
241393|NCT00567892|579203|P3|COMPLETED|Washout (2 Weeks)||9
241394|NCT00567892|579204|P2|COMPLETED|Washout (2 Weeks)||7
241395|NCT00567892|579205|P1|COMPLETED|Washout (2 Weeks)||7
241396|NCT00567892|579202|P4|STARTED|Washout (2 Weeks)||6
241397|NCT00567892|579203|P3|STARTED|Washout (2 Weeks)||9
241398|NCT00567892|579204|P2|STARTED|Washout (2 Weeks)||7
241399|NCT00567892|579205|P1|STARTED|Washout (2 Weeks)||7
241400|NCT00567892|579202|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
241401|NCT00567892|579203|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
241402|NCT00567892|579204|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
241403|NCT00567892|579205|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
241404|NCT00567892|579202|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
241405|NCT00567892|579203|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
241406|NCT00567892|579204|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
241407|NCT00567892|579205|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
241408|NCT00567892|579202|P4|STARTED|First Treatment (2 or 4 Weeks)||10
241409|NCT00567892|579203|P3|STARTED|First Treatment (2 or 4 Weeks)||10
241410|NCT00567892|579204|P2|STARTED|First Treatment (2 or 4 Weeks)||7
241411|NCT00567892|579205|P1|STARTED|First Treatment (2 or 4 Weeks)||7
241412|NCT00567879|579223|P6|NOT COMPLETED|Overall Study||3
241413|NCT00567879|579224|P5|NOT COMPLETED|Overall Study||12
241414|NCT00567879|579225|P4|NOT COMPLETED|Overall Study||6
241415|NCT00567879|579226|P3|NOT COMPLETED|Overall Study||21
241416|NCT00567879|579227|P2|NOT COMPLETED|Overall Study||7
241417|NCT00567879|579228|P1|NOT COMPLETED|Overall Study||7
241418|NCT00567879|579223|P6|COMPLETED|Overall Study||0
241419|NCT00567879|579224|P5|COMPLETED|Overall Study||0
241420|NCT00567879|579225|P4|COMPLETED|Overall Study||0
241421|NCT00567879|579226|P3|COMPLETED|Overall Study||0
241422|NCT00567879|579227|P2|COMPLETED|Overall Study||0
241423|NCT00567879|579228|P1|COMPLETED|Overall Study||0
241424|NCT00567879|579223|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
241425|NCT00567879|579224|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
241426|NCT00567879|579225|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
241427|NCT00567879|579226|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
241428|NCT00567879|579227|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
241429|NCT00567879|579228|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
241430|NCT00567879|579223|P6|STARTED|Overall Study||3
241431|NCT00567879|579224|P5|STARTED|Overall Study||12
241432|NCT00567879|579225|P4|STARTED|Overall Study||6
241433|NCT00567879|579226|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
241434|NCT00567879|579227|P2|STARTED|Overall Study||7
241435|NCT00567879|579228|P1|STARTED|Overall Study||7
241436|NCT00567840|579254|P5|NOT COMPLETED|Overall Study||0
241437|NCT00567840|579255|P4|NOT COMPLETED|Overall Study||1
241438|NCT00567840|579256|P3|NOT COMPLETED|Overall Study||1
241439|NCT00567840|579257|P2|NOT COMPLETED|Overall Study||0
241440|NCT00567840|579258|P1|NOT COMPLETED|Overall Study||2
241441|NCT00567840|579254|P5|COMPLETED|Overall Study||8
241442|NCT00567840|579255|P4|COMPLETED|Overall Study||14
241443|NCT00567840|579256|P3|COMPLETED|Overall Study||15
241444|NCT00567840|579257|P2|COMPLETED|Overall Study||15
241445|NCT00567840|579258|P1|COMPLETED|Overall Study||13
241446|NCT00567840|579254|P5|STARTED|Overall Study||8
241447|NCT00567840|579255|P4|STARTED|Overall Study||15
241448|NCT00567840|579256|P3|STARTED|Overall Study||16
241449|NCT00567840|579257|P2|STARTED|Overall Study||15
241450|NCT00567840|579258|P1|STARTED|Overall Study||15
241451|NCT00567593|579295|P1|NOT COMPLETED|Overall Study||2
241452|NCT00567593|579295|P1|COMPLETED|Overall Study||10
241453|NCT00567593|579295|P1|STARTED|Overall Study||12
241454|NCT00567567|579302|P3|NOT COMPLETED|Overall Study||278
241455|NCT00567567|579303|P2|NOT COMPLETED|Overall Study||134
241456|NCT00567567|579304|P1|NOT COMPLETED|Overall Study||152
241457|NCT00567567|579302|P3|COMPLETED|Overall Study||1
241458|NCT00567567|579303|P2|COMPLETED|Overall Study||42
241459|NCT00567567|579304|P1|COMPLETED|Overall Study||58
241460|NCT00567567|579302|P3|STARTED|Overall Study||279
241461|NCT00567567|579303|P2|STARTED|Overall Study||176
241462|NCT00567567|579304|P1|STARTED|Overall Study||210
241463|NCT00567541|579330|P2|NOT COMPLETED|Overall Study||1
241464|NCT00567541|579331|P1|NOT COMPLETED|Overall Study||0
241465|NCT00567541|579330|P2|COMPLETED|Overall Study||8
241466|NCT00567541|579331|P1|COMPLETED|Overall Study||7
241467|NCT00567541|579330|P2|STARTED|Overall Study||9
241468|NCT00567541|579331|P1|STARTED|Overall Study||7
241469|NCT00567502|579341|P4|NOT COMPLETED|Overall Study||87
241470|NCT00567502|579342|P3|NOT COMPLETED|Overall Study||908
241471|NCT00567502|579343|P2|NOT COMPLETED|Overall Study||33
241472|NCT00567502|579344|P1|NOT COMPLETED|Overall Study||241
241473|NCT00567502|579341|P4|COMPLETED|Overall Study||23
241474|NCT00567502|579342|P3|COMPLETED|Overall Study||1758
241475|NCT00567502|579343|P2|COMPLETED|Overall Study||108
241476|NCT00567502|579344|P1|COMPLETED|Overall Study||563
241477|NCT00567502|579341|P4|Initiated Treatment|Overall Study||38
241478|NCT00567502|579342|P3|Initiated Treatment|Overall Study||2666
241479|NCT00567502|579343|P2|Initiated Treatment|Overall Study||141
241480|NCT00567502|579344|P1|Initiated Treatment|Overall Study||804
241481|NCT00567502|579341|P4|STARTED|Overall Study||110
241482|NCT00567502|579342|P3|STARTED|Overall Study||2666
241483|NCT00567502|579343|P2|STARTED|Overall Study||141
241484|NCT00567502|579344|P1|STARTED|Overall Study||804
241485|NCT00567476|579381|P2|NOT COMPLETED|Overall Study||4
241486|NCT00567476|579382|P1|NOT COMPLETED|Overall Study||8
241487|NCT00567476|579381|P2|COMPLETED|Overall Study||34
241488|NCT00567476|579382|P1|COMPLETED|Overall Study||70
241489|NCT00567476|579381|P2|STARTED|Overall Study||38
241490|NCT00567476|579382|P1|STARTED|Overall Study||78
241491|NCT00567320|579408|P2|NOT COMPLETED|Overall Study||0
241492|NCT00567320|579409|P1|NOT COMPLETED|Overall Study||0
241493|NCT00567320|579408|P2|COMPLETED|Overall Study||18
241494|NCT00567320|579409|P1|COMPLETED|Overall Study||13
241495|NCT00567320|579408|P2|STARTED|Overall Study||18
241496|NCT00567320|579409|P1|STARTED|Overall Study||13
241497|NCT00567307|579417|P2|NOT COMPLETED|Overall Study||1
241498|NCT00567307|579418|P1|NOT COMPLETED|Overall Study||12
241499|NCT00567307|579417|P2|COMPLETED|Overall Study||104
241500|NCT00567307|579418|P1|COMPLETED|Overall Study||99
241501|NCT00567307|579417|P2|STARTED|Overall Study||105
241502|NCT00567307|579418|P1|STARTED|Overall Study||111
241503|NCT00567268|579424|P1|NOT COMPLETED|Overall Study||50
241504|NCT00567268|579424|P1|COMPLETED|Overall Study||1144
241505|NCT00567268|579424|P1|STARTED|Overall Study||1194
241506|NCT00567255|579475|P2|NOT COMPLETED|Overall Study||228
241507|NCT00567255|579476|P1|NOT COMPLETED|Overall Study||463
241508|NCT00567255|579475|P2|COMPLETED|Overall Study||267
241509|NCT00567255|579476|P1|COMPLETED|Overall Study||538
241510|NCT00567255|579475|P2|STARTED|Overall Study||495
241511|NCT00567255|579476|P1|STARTED|Overall Study||1001
241512|NCT00567242|579522|P2|NOT COMPLETED|Overall Study||0
241513|NCT00567242|579523|P1|NOT COMPLETED|Overall Study||0
241514|NCT00567242|579522|P2|COMPLETED|Overall Study||7
241515|NCT00567242|579523|P1|COMPLETED|Overall Study||7
241516|NCT00567242|579522|P2|STARTED|Overall Study||7
241517|NCT00567242|579523|P1|STARTED|Overall Study||7
241518|NCT00567229|579533|P1|NOT COMPLETED|Overall Study||0
241519|NCT00567229|579533|P1|COMPLETED|Overall Study||3
241520|NCT00567229|579533|P1|STARTED|Overall Study||3
241521|NCT00567190|579539|P2|NOT COMPLETED|Overall Study||264
241522|NCT00567190|579540|P1|NOT COMPLETED|Overall Study||210
241523|NCT00567190|579539|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
241524|NCT00567190|579540|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
241525|NCT00567190|579539|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
241526|NCT00567190|579540|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
241527|NCT00567164|579560|P3|NOT COMPLETED|Overall Study||72
241528|NCT00567164|579561|P2|NOT COMPLETED|Overall Study||73
241529|NCT00567164|579562|P1|NOT COMPLETED|Overall Study||546
241530|NCT00567164|579560|P3|COMPLETED|Overall Study||160
241531|NCT00567164|579561|P2|COMPLETED|Overall Study||161
241532|NCT00567164|579562|P1|COMPLETED|Overall Study||875
241533|NCT00567164|579560|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
241534|NCT00567164|579561|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
241535|NCT00567164|579562|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
241536|NCT00567164|579560|P3|STARTED|Overall Study||232
241537|NCT00567164|579561|P2|STARTED|Overall Study||234
241538|NCT00567164|579562|P1|STARTED|Overall Study||1421
241539|NCT00567112|579634|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
241540|NCT00567112|579635|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
241541|NCT00567112|579636|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
241542|NCT00567112|579634|P3|COMPLETED|Treatment Period 4 (3 Days)||3
241543|NCT00567112|579635|P2|COMPLETED|Treatment Period 4 (3 Days)||7
241544|NCT00567112|579636|P1|COMPLETED|Treatment Period 4 (3 Days)||4
241545|NCT00567112|579634|P3|STARTED|Treatment Period 4 (3 Days)||3
241546|NCT00567112|579635|P2|STARTED|Treatment Period 4 (3 Days)||7
241547|NCT00567112|579636|P1|STARTED|Treatment Period 4 (3 Days)||4
241548|NCT00567112|579634|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
241549|NCT00567112|579635|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
241550|NCT00567112|579636|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
241551|NCT00567112|579634|P3|COMPLETED|Washout Period 3 (3 Days)||3
241552|NCT00567112|579635|P2|COMPLETED|Washout Period 3 (3 Days)||7
241553|NCT00567112|579636|P1|COMPLETED|Washout Period 3 (3 Days)||4
241554|NCT00567112|579634|P3|STARTED|Washout Period 3 (3 Days)||3
241555|NCT00567112|579635|P2|STARTED|Washout Period 3 (3 Days)||7
241556|NCT00567112|579636|P1|STARTED|Washout Period 3 (3 Days)||7
241557|NCT00567112|579634|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
241558|NCT00567112|579635|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
241559|NCT00567112|579636|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
241560|NCT00567112|579634|P3|COMPLETED|Treatment Period 3 (3 Days)||3
241561|NCT00567112|579635|P2|COMPLETED|Treatment Period 3 (3 Days)||7
241562|NCT00567112|579636|P1|COMPLETED|Treatment Period 3 (3 Days)||7
241563|NCT00567112|579634|P3|STARTED|Treatment Period 3 (3 Days)||3
241564|NCT00567112|579635|P2|STARTED|Treatment Period 3 (3 Days)||7
241565|NCT00567112|579636|P1|STARTED|Treatment Period 3 (3 Days)||7
241566|NCT00567112|579634|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
241567|NCT00567112|579635|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
241568|NCT00567112|579636|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
241569|NCT00567112|579634|P3|COMPLETED|Washout Period 2 (3 Days)||3
241570|NCT00567112|579635|P2|COMPLETED|Washout Period 2 (3 Days)||7
241571|NCT00567112|579636|P1|COMPLETED|Washout Period 2 (3 Days)||7
241572|NCT00567112|579634|P3|STARTED|Washout Period 2 (3 Days)||3
241573|NCT00567112|579635|P2|STARTED|Washout Period 2 (3 Days)||7
241574|NCT00567112|579636|P1|STARTED|Washout Period 2 (3 Days)||7
241575|NCT00567112|579634|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
241576|NCT00567112|579635|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
241577|NCT00567112|579636|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
241578|NCT00567112|579634|P3|COMPLETED|Treatment Period 2 (3 Days)||3
241579|NCT00567112|579635|P2|COMPLETED|Treatment Period 2 (3 Days)||7
241580|NCT00567112|579636|P1|COMPLETED|Treatment Period 2 (3 Days)||7
241581|NCT00567112|579634|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
241582|NCT00567112|579635|P2|STARTED|Treatment Period 2 (3 Days)||8
241583|NCT00567112|579636|P1|STARTED|Treatment Period 2 (3 Days)||7
241584|NCT00567112|579634|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
241585|NCT00567112|579635|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
241586|NCT00567112|579636|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
241587|NCT00567112|579634|P3|COMPLETED|Washout Period 1 (3 Days)||0
241588|NCT00567112|579635|P2|COMPLETED|Washout Period 1 (3 Days)||8
241589|NCT00567112|579636|P1|COMPLETED|Washout Period 1 (3 Days)||7
241590|NCT00567112|579634|P3|STARTED|Washout Period 1 (3 Days)||0
241591|NCT00567112|579635|P2|STARTED|Washout Period 1 (3 Days)||8
241592|NCT00567112|579636|P1|STARTED|Washout Period 1 (3 Days)||7
241593|NCT00567112|579634|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
241594|NCT00567112|579635|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
241595|NCT00567112|579636|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
241596|NCT00567112|579634|P3|COMPLETED|Treatment Period 1 (3 Days)||0
241597|NCT00567112|579635|P2|COMPLETED|Treatment Period 1 (3 Days)||8
241598|NCT00567112|579636|P1|COMPLETED|Treatment Period 1 (3 Days)||7
241599|NCT00567112|579634|P3|STARTED|Treatment Period 1 (3 Days)||0
241600|NCT00567112|579635|P2|STARTED|Treatment Period 1 (3 Days)||8
241601|NCT00567112|579636|P1|STARTED|Treatment Period 1 (3 Days)||7
241602|NCT00567008|579660|P2|NOT COMPLETED|Overall Study||1
241603|NCT00567008|579661|P1|NOT COMPLETED|Overall Study||1
241604|NCT00567008|579660|P2|COMPLETED|Overall Study||18
241605|NCT00567008|579661|P1|COMPLETED|Overall Study||17
241606|NCT00567008|579660|P2|STARTED|Overall Study||19
241607|NCT00567008|579661|P1|STARTED|Overall Study||18
241608|NCT00566995|579667|P1|NOT COMPLETED|Overall Study||8
241609|NCT00566995|579667|P1|COMPLETED|Overall Study||29
241610|NCT00566995|579667|P1|STARTED|Overall Study||37
241611|NCT00566982|579674|P2|NOT COMPLETED|Overall Study||69
241612|NCT00566982|579675|P1|NOT COMPLETED|Overall Study||8
241613|NCT00566982|579674|P2|COMPLETED|Overall Study||294
241614|NCT00566982|579675|P1|COMPLETED|Overall Study||55
241615|NCT00566982|579674|P2|STARTED|Overall Study||363
241616|NCT00566982|579675|P1|STARTED|Overall Study||63
241617|NCT00566969|579700|P3|NOT COMPLETED|Overall Study||12
241618|NCT00566969|579701|P2|NOT COMPLETED|Overall Study||9
241619|NCT00566969|579702|P1|NOT COMPLETED|Overall Study||15
241620|NCT00566969|579700|P3|COMPLETED|Overall Study||23
241621|NCT00566969|579701|P2|COMPLETED|Overall Study||28
241622|NCT00566969|579702|P1|COMPLETED|Overall Study||19
241623|NCT00566969|579700|P3|STARTED|Overall Study||35
241624|NCT00566969|579701|P2|STARTED|Overall Study||37
241625|NCT00566969|579702|P1|STARTED|Overall Study||34
241626|NCT00566943|579712|P2|NOT COMPLETED|Overall Study||0
241627|NCT00566943|579713|P1|NOT COMPLETED|Overall Study||0
241628|NCT00566943|579712|P2|COMPLETED|Overall Study||49
241629|NCT00566943|579713|P1|COMPLETED|Overall Study||52
241630|NCT00566943|579712|P2|STARTED|Overall Study||49
241631|NCT00566943|579713|P1|STARTED|Overall Study||52
241632|NCT00566930|579728|P3|NOT COMPLETED|Overall Study||1
241633|NCT00566930|579729|P2|NOT COMPLETED|Overall Study||4
241634|NCT00566930|579730|P1|NOT COMPLETED|Overall Study||2
241635|NCT00566930|579728|P3|COMPLETED|Overall Study||32
241636|NCT00566930|579729|P2|COMPLETED|Overall Study||32
241637|NCT00566930|579730|P1|COMPLETED|Overall Study||27
241638|NCT00566930|579728|P3|STARTED|Overall Study||33
241639|NCT00566930|579729|P2|STARTED|Overall Study||36
241640|NCT00566930|579730|P1|STARTED|Overall Study||29
241641|NCT00566852|579740|P2|NOT COMPLETED|Overall Study||198
241642|NCT00566852|579741|P1|NOT COMPLETED|Overall Study||207
241643|NCT00566852|579740|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
241644|NCT00566852|579741|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
241645|NCT00566852|579740|P2|STARTED|Overall Study||276
241646|NCT00566852|579741|P1|STARTED|Overall Study||278
241647|NCT00566735|579759|P2|NOT COMPLETED|Overall Study||7
241648|NCT00566735|579760|P1|NOT COMPLETED|Overall Study||2
241649|NCT00566735|579759|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
241650|NCT00566735|579760|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
241651|NCT00566735|579759|P2|Withdrew Before Baseline Measures|Overall Study||7
241652|NCT00566735|579760|P1|Withdrew Before Baseline Measures|Overall Study||2
241653|NCT00566735|579759|P2|STARTED|Overall Study||19
241654|NCT00566735|579760|P1|STARTED|Overall Study||20
241655|NCT00566722|579773|P3|NOT COMPLETED|Overall Study||9
241656|NCT00566722|579774|P2|NOT COMPLETED|Overall Study||5
241657|NCT00566722|579775|P1|NOT COMPLETED|Overall Study||2
241658|NCT00566722|579773|P3|COMPLETED|Overall Study||73
241659|NCT00566722|579774|P2|COMPLETED|Overall Study||24
241660|NCT00566722|579775|P1|COMPLETED|Overall Study||39
241661|NCT00566722|579773|P3|STARTED|Overall Study||82
241662|NCT00566722|579774|P2|STARTED|Overall Study||29
241663|NCT00566722|579775|P1|STARTED|Overall Study||41
241664|NCT00566709|579821|P2|NOT COMPLETED|Overall Study||0
241665|NCT00566709|579822|P1|NOT COMPLETED|Overall Study||5
241666|NCT00566709|579821|P2|COMPLETED|Overall Study||51
241667|NCT00566709|579822|P1|COMPLETED|Overall Study||46
241668|NCT00566709|579821|P2|STARTED|Overall Study||51
241669|NCT00566709|579822|P1|STARTED|Overall Study||51
241670|NCT00566696|579838|P1|NOT COMPLETED|Overall Study||42
241671|NCT00566696|579838|P1|COMPLETED|Overall Study||31
241672|NCT00566696|579838|P1|STARTED|Overall Study||73
241673|NCT00566631|579846|P1|NOT COMPLETED|Part 2: Extension Phase||82
241674|NCT00566631|579846|P1|COMPLETED|Part 2: Extension Phase||57
241675|NCT00566631|579846|P1|STARTED|Part 2: Extension Phase||139
241676|NCT00566631|579846|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
241677|NCT00566631|579846|P1|COMPLETED|Between Treatment and Extension Phase||139
241678|NCT00566631|579846|P1|STARTED|Between Treatment and Extension Phase||234
241679|NCT00566631|579846|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
241680|NCT00566631|579846|P1|COMPLETED|Part 1: Core Treatment Phase||234
241681|NCT00566631|579846|P1|STARTED|Part 1: Core Treatment Phase||294
241682|NCT00566579|579863|P2|NOT COMPLETED|Overall Study||0
241683|NCT00566579|579864|P1|NOT COMPLETED|Overall Study||0
241684|NCT00566579|579863|P2|COMPLETED|Overall Study||31
241685|NCT00566579|579864|P1|COMPLETED|Overall Study||29
241686|NCT00566579|579863|P2|STARTED|Overall Study||31
241687|NCT00566579|579864|P1|STARTED|Overall Study||29
241688|NCT00566527|579873|P3|NOT COMPLETED|Overall Study||78
241689|NCT00566527|579874|P2|NOT COMPLETED|Overall Study||66
241690|NCT00566527|579875|P1|NOT COMPLETED|Overall Study||17
241691|NCT00566527|579873|P3|COMPLETED|Overall Study||461
241692|NCT00566527|579874|P2|COMPLETED|Overall Study||474
241693|NCT00566527|579875|P1|COMPLETED|Overall Study||524
241694|NCT00566527|579873|P3|Received ProQuad® Dose 2|Overall Study||462
241695|NCT00566527|579874|P2|Received ProQuad® Dose 2|Overall Study||478
241696|NCT00566527|579875|P1|Received ProQuad® Dose 2|Overall Study||525
241697|NCT00566527|579873|P3|Received ProQuad® Dose 1|Overall Study||470
241698|NCT00566527|579874|P2|Received ProQuad® Dose 1|Overall Study||484
241699|NCT00566527|579875|P1|Received ProQuad® Dose 1|Overall Study||529
241700|NCT00566527|579873|P3|STARTED|Overall Study|Number randomized.|539
241701|NCT00566527|579874|P2|STARTED|Overall Study|Number randomized.|540
241702|NCT00566527|579875|P1|STARTED|Overall Study|Number randomized.|541
241703|NCT00566501|579916|P2|NOT COMPLETED|Overall Study||126
241704|NCT00566501|579917|P1|NOT COMPLETED|Overall Study||156
241705|NCT00566501|579916|P2|COMPLETED|Overall Study||210
241706|NCT00566501|579917|P1|COMPLETED|Overall Study||423
241707|NCT00566501|579916|P2|Not Determined|Overall Study||0
241708|NCT00566501|579917|P1|Not Determined|Overall Study||1
241709|NCT00566501|579916|P2|Other ( Not Specified)|Overall Study||21
241710|NCT00566501|579917|P1|Other ( Not Specified)|Overall Study||24
241711|NCT00566501|579916|P2|Medication Non-compliance|Overall Study||0
241712|NCT00566501|579917|P1|Medication Non-compliance|Overall Study||5
241713|NCT00566501|579916|P2|Protocol Violation|Overall Study||2
241714|NCT00566501|579917|P1|Protocol Violation|Overall Study||2
241715|NCT00566501|579916|P2|Request of Investigator or Sponsor|Overall Study||7
241716|NCT00566501|579917|P1|Request of Investigator or Sponsor|Overall Study||6
241717|NCT00566501|579916|P2|Withdraw of Consent by Subject|Overall Study||30
241718|NCT00566501|579917|P1|Withdraw of Consent by Subject|Overall Study||33
241719|NCT00566501|579916|P2|Lack of Efficacy|Overall Study||3
241720|NCT00566501|579917|P1|Lack of Efficacy|Overall Study||8
241721|NCT00566501|579916|P2|Adverse Event|Overall Study||59
241722|NCT00566501|579917|P1|Adverse Event|Overall Study||68
241723|NCT00566501|579916|P2|Discontinued|Overall Study||122
241724|NCT00566501|579917|P1|Discontinued|Overall Study||146
241725|NCT00566501|579916|P2|Safety Population|Overall Study||332
241726|NCT00566501|579917|P1|Safety Population|Overall Study||570
241727|NCT00566501|579916|P2|STARTED|Overall Study||336
241728|NCT00566501|579917|P1|STARTED|Overall Study||579
241729|NCT00566462|579925|P2|NOT COMPLETED|Overall Study||0
241730|NCT00566462|579926|P1|NOT COMPLETED|Overall Study||0
241731|NCT00566462|579925|P2|COMPLETED|Overall Study||0
241732|NCT00566462|579926|P1|COMPLETED|Overall Study||1
241733|NCT00566462|579925|P2|STARTED|Overall Study||0
241734|NCT00566462|579926|P1|STARTED|Overall Study||1
241735|NCT00566254|579936|P2|NOT COMPLETED|Overall Study||14
241736|NCT00566254|579937|P1|NOT COMPLETED|Overall Study||10
241737|NCT00566254|579936|P2|COMPLETED|Overall Study||93
241738|NCT00566254|579937|P1|COMPLETED|Overall Study||90
241739|NCT00566254|579936|P2|STARTED|Overall Study||107
241740|NCT00566254|579937|P1|STARTED|Overall Study||100
241741|NCT00566150|579951|P2|NOT COMPLETED|Overall Study||5
241742|NCT00566150|579952|P1|NOT COMPLETED|Overall Study||9
241743|NCT00566150|579951|P2|COMPLETED|Overall Study||11
241744|NCT00566150|579952|P1|COMPLETED|Overall Study||10
241745|NCT00566150|579951|P2|STARTED|Overall Study||16
241746|NCT00566150|579952|P1|STARTED|Overall Study||19
241747|NCT00566111|579966|P2|NOT COMPLETED|Overall Study||2
241748|NCT00566111|579967|P1|NOT COMPLETED|Overall Study||0
241749|NCT00566111|579966|P2|COMPLETED|Overall Study||1
241750|NCT00566111|579967|P1|COMPLETED|Overall Study||2
241751|NCT00566111|579966|P2|STARTED|Overall Study||3
241752|NCT00566111|579967|P1|STARTED|Overall Study||2
241753|NCT00566020|579981|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
241754|NCT00566020|579982|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
241755|NCT00566020|579981|P2|COMPLETED|46-week Long-term Administration Phase||68
241756|NCT00566020|579982|P1|COMPLETED|46-week Long-term Administration Phase||0
241757|NCT00566020|579981|P2|STARTED|46-week Long-term Administration Phase||85
241758|NCT00566020|579982|P1|STARTED|46-week Long-term Administration Phase||0
241759|NCT00566020|579981|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
241760|NCT00566020|579982|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
241761|NCT00566020|579981|P2|COMPLETED|6-week Dosage Adjustment Phase||0
241762|NCT00566020|579982|P1|COMPLETED|6-week Dosage Adjustment Phase||85
241763|NCT00566020|579981|P2|STARTED|6-week Dosage Adjustment Phase||0
241764|NCT00566020|579982|P1|STARTED|6-week Dosage Adjustment Phase||92
241765|NCT00565812|580010|P3|NOT COMPLETED|Overall Study||130
241766|NCT00565812|580011|P2|NOT COMPLETED|Overall Study||135
241767|NCT00565812|580012|P1|NOT COMPLETED|Overall Study||144
241768|NCT00565812|580010|P3|COMPLETED|Overall Study||356
241769|NCT00565812|580011|P2|COMPLETED|Overall Study||351
241770|NCT00565812|580012|P1|COMPLETED|Overall Study||341
241771|NCT00565812|580010|P3|STARTED|Overall Study||486
241772|NCT00565812|580011|P2|STARTED|Overall Study||486
241773|NCT00565812|580012|P1|STARTED|Overall Study||485
241774|NCT00565747|580151|P2|NOT COMPLETED|Overall Study||73
241775|NCT00565747|580152|P1|NOT COMPLETED|Overall Study||67
241776|NCT00565747|580151|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
241777|NCT00565747|580152|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
241778|NCT00565747|580151|P2|STARTED|Overall Study||678
241779|NCT00565747|580152|P1|STARTED|Overall Study||654
241780|NCT00565721|580162|P1|NOT COMPLETED|Overall Study||17
241781|NCT00565721|580162|P1|COMPLETED|Overall Study||16
241782|NCT00565721|580162|P1|STARTED|Overall Study||33
241783|NCT00565643|580183|P2|NOT COMPLETED|Overall Study||0
241784|NCT00565643|580184|P1|NOT COMPLETED|Overall Study||0
241785|NCT00565643|580183|P2|COMPLETED|Overall Study||373
241786|NCT00565643|580184|P1|COMPLETED|Overall Study||380
241787|NCT00565643|580183|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
241788|NCT00565643|580184|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
241789|NCT00565643|580183|P2|Safety Data|Overall Study||373
241790|NCT00565643|580184|P1|Safety Data|Overall Study||380
241791|NCT00565643|580183|P2|STARTED|Overall Study||373
241792|NCT00565643|580184|P1|STARTED|Overall Study||380
241793|NCT00565617|580202|P1|NOT COMPLETED|Overall Study||1
241794|NCT00565617|580202|P1|COMPLETED|Overall Study||5
241795|NCT00565617|580202|P1|STARTED|Overall Study||6
241796|NCT00565604|580206|P1|NOT COMPLETED|Overall Study||4
241797|NCT00565604|580206|P1|COMPLETED|Overall Study||39
241798|NCT00565604|580206|P1|6 Month|Overall Study||39
241799|NCT00565604|580206|P1|6 Week|Overall Study||39
241800|NCT00565604|580206|P1|2 Week|Overall Study||41
241801|NCT00565604|580206|P1|7 Day|Overall Study||41
241802|NCT00565604|580206|P1|STARTED|Overall Study||43
241803|NCT00565461|580217|P4|NOT COMPLETED|Overall Study||3
241804|NCT00565461|580218|P3|NOT COMPLETED|Overall Study||1
241805|NCT00565461|580219|P2|NOT COMPLETED|Overall Study||1
241806|NCT00565461|580220|P1|NOT COMPLETED|Overall Study||0
241807|NCT00565461|580217|P4|COMPLETED|Overall Study||37
241808|NCT00565461|580218|P3|COMPLETED|Overall Study||39
241809|NCT00565461|580219|P2|COMPLETED|Overall Study||39
241810|NCT00565461|580220|P1|COMPLETED|Overall Study||40
241811|NCT00565461|580217|P4|STARTED|Overall Study||40
241812|NCT00565461|580218|P3|STARTED|Overall Study||40
241813|NCT00565461|580219|P2|STARTED|Overall Study||40
241814|NCT00565461|580220|P1|STARTED|Overall Study||40
241815|NCT00565448|580234|P2|NOT COMPLETED|Overall Study||2
241816|NCT00565448|580235|P1|NOT COMPLETED|Overall Study||3
241817|NCT00565448|580234|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
241818|NCT00565448|580235|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
241819|NCT00565448|580234|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
241820|NCT00565448|580235|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
241821|NCT00565409|580246|P4|NOT COMPLETED|Period 2 Double-Blind||59
241822|NCT00565409|580247|P3|NOT COMPLETED|Period 2 Double-Blind||27
241823|NCT00565409|580248|P2|NOT COMPLETED|Period 2 Double-Blind||21
241824|NCT00565409|580249|P1|NOT COMPLETED|Period 2 Double-Blind||0
241825|NCT00565409|580246|P4|COMPLETED|Period 2 Double-Blind||141
241826|NCT00565409|580247|P3|COMPLETED|Period 2 Double-Blind||175
241827|NCT00565409|580248|P2|COMPLETED|Period 2 Double-Blind||181
241828|NCT00565409|580249|P1|COMPLETED|Period 2 Double-Blind||0
241829|NCT00565409|580246|P4|STARTED|Period 2 Double-Blind||200
241830|NCT00565409|580247|P3|STARTED|Period 2 Double-Blind||202
241831|NCT00565409|580248|P2|STARTED|Period 2 Double-Blind||202
241832|NCT00565409|580249|P1|STARTED|Period 2 Double-Blind||0
241833|NCT00565409|580246|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
241834|NCT00565409|580247|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
241835|NCT00565409|580248|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
241836|NCT00565409|580249|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
241837|NCT00565409|580246|P4|COMPLETED|After Period 1, Prior to Period 2||0
241838|NCT00565409|580247|P3|COMPLETED|After Period 1, Prior to Period 2||0
241839|NCT00565409|580248|P2|COMPLETED|After Period 1, Prior to Period 2||0
241840|NCT00565409|580249|P1|COMPLETED|After Period 1, Prior to Period 2||604
241841|NCT00565409|580246|P4|STARTED|After Period 1, Prior to Period 2||0
241842|NCT00565409|580247|P3|STARTED|After Period 1, Prior to Period 2||0
241843|NCT00565409|580248|P2|STARTED|After Period 1, Prior to Period 2||0
241844|NCT00565409|580249|P1|STARTED|After Period 1, Prior to Period 2||756
241845|NCT00565409|580246|P4|NOT COMPLETED|Period 1 Open Label||0
241846|NCT00565409|580247|P3|NOT COMPLETED|Period 1 Open Label||0
241847|NCT00565409|580248|P2|NOT COMPLETED|Period 1 Open Label||0
241848|NCT00565409|580249|P1|NOT COMPLETED|Period 1 Open Label||78
241849|NCT00565409|580246|P4|COMPLETED|Period 1 Open Label||0
241850|NCT00565409|580247|P3|COMPLETED|Period 1 Open Label||0
241851|NCT00565409|580248|P2|COMPLETED|Period 1 Open Label||0
241852|NCT00565409|580249|P1|COMPLETED|Period 1 Open Label||756
241853|NCT00565409|580246|P4|STARTED|Period 1 Open Label||0
241854|NCT00565409|580247|P3|STARTED|Period 1 Open Label||0
241855|NCT00565409|580248|P2|STARTED|Period 1 Open Label||0
241856|NCT00565409|580249|P1|STARTED|Period 1 Open Label||834
241857|NCT00565370|580351|P1|NOT COMPLETED|Overall Study||0
241858|NCT00565370|580351|P1|COMPLETED|Overall Study||21
241859|NCT00565370|580351|P1|STARTED|Overall Study||21
241860|NCT00565266|580359|P1|NOT COMPLETED|Overall Study||36
241861|NCT00565266|580359|P1|COMPLETED|Overall Study||174
241862|NCT00565266|580359|P1|STARTED|Overall Study||210
241863|NCT00565136|580385|P1|NOT COMPLETED|Overall Study||3
241864|NCT00565136|580385|P1|COMPLETED|Overall Study||26
241865|NCT00565136|580385|P1|STARTED|Overall Study||29
241866|NCT00565110|580405|P2|NOT COMPLETED|Overall Study||131
241867|NCT00565110|580406|P1|NOT COMPLETED|Overall Study||131
241868|NCT00565110|580405|P2|COMPLETED|Overall Study||111
241869|NCT00565110|580406|P1|COMPLETED|Overall Study||99
241870|NCT00565110|580405|P2|12-Month|Overall Study||144
241871|NCT00565110|580406|P1|12-Month|Overall Study||114
241872|NCT00565110|580405|P2|STARTED|Overall Study||242
241873|NCT00565110|580406|P1|STARTED|Overall Study||230
241874|NCT00565084|580414|P3|NOT COMPLETED|Third Treatment Period||0
241875|NCT00565084|580415|P2|NOT COMPLETED|Third Treatment Period||0
241876|NCT00565084|580416|P1|NOT COMPLETED|Third Treatment Period||0
241877|NCT00565084|580414|P3|COMPLETED|Third Treatment Period||11
241878|NCT00565084|580415|P2|COMPLETED|Third Treatment Period||11
241879|NCT00565084|580416|P1|COMPLETED|Third Treatment Period||11
241880|NCT00565084|580414|P3|STARTED|Third Treatment Period||11
241881|NCT00565084|580415|P2|STARTED|Third Treatment Period||11
241882|NCT00565084|580416|P1|STARTED|Third Treatment Period||11
241883|NCT00565084|580414|P3|NOT COMPLETED|Second Treatment Period||0
241884|NCT00565084|580415|P2|NOT COMPLETED|Second Treatment Period||0
241885|NCT00565084|580416|P1|NOT COMPLETED|Second Treatment Period||0
241886|NCT00565084|580414|P3|COMPLETED|Second Treatment Period||11
241887|NCT00565084|580415|P2|COMPLETED|Second Treatment Period||11
241888|NCT00565084|580416|P1|COMPLETED|Second Treatment Period||11
241889|NCT00565084|580414|P3|STARTED|Second Treatment Period||11
241890|NCT00565084|580415|P2|STARTED|Second Treatment Period||11
241891|NCT00565084|580416|P1|STARTED|Second Treatment Period||11
241892|NCT00565084|580414|P3|NOT COMPLETED|First Treatment Period||0
241893|NCT00565084|580415|P2|NOT COMPLETED|First Treatment Period||0
241894|NCT00565084|580416|P1|NOT COMPLETED|First Treatment Period||0
241895|NCT00565084|580414|P3|COMPLETED|First Treatment Period||11
241896|NCT00565084|580415|P2|COMPLETED|First Treatment Period||11
241897|NCT00565084|580416|P1|COMPLETED|First Treatment Period||11
241898|NCT00565084|580414|P3|STARTED|First Treatment Period||11
241899|NCT00565084|580415|P2|STARTED|First Treatment Period||11
241900|NCT00565084|580416|P1|STARTED|First Treatment Period||11
241901|NCT00565058|580426|P2|NOT COMPLETED|Overall Study||0
241902|NCT00565058|580427|P1|NOT COMPLETED|Overall Study||1
241903|NCT00565058|580426|P2|COMPLETED|Overall Study||15
241904|NCT00565058|580427|P1|COMPLETED|Overall Study||9
241905|NCT00565058|580426|P2|STARTED|Overall Study||15
241906|NCT00565058|580427|P1|STARTED|Overall Study||10
241907|NCT00565045|580437|P2|NOT COMPLETED|Overall Study||3
241908|NCT00565045|580438|P1|NOT COMPLETED|Overall Study||1
241909|NCT00565045|580437|P2|COMPLETED|Overall Study||8
241910|NCT00565045|580438|P1|COMPLETED|Overall Study||9
241911|NCT00565045|580437|P2|STARTED|Overall Study||11
241912|NCT00565045|580438|P1|STARTED|Overall Study||10
241913|NCT00564954|580454|P2|NOT COMPLETED|Period 2- 1 Week||0
241914|NCT00564954|580455|P1|NOT COMPLETED|Period 2- 1 Week||0
241915|NCT00564954|580454|P2|COMPLETED|Period 2- 1 Week||42
241916|NCT00564954|580455|P1|COMPLETED|Period 2- 1 Week||44
241917|NCT00564954|580454|P2|STARTED|Period 2- 1 Week||42
241918|NCT00564954|580455|P1|STARTED|Period 2- 1 Week||44
241919|NCT00564954|580454|P2|NOT COMPLETED|Period 1- 1 Week||0
241920|NCT00564954|580455|P1|NOT COMPLETED|Period 1- 1 Week||0
241921|NCT00564954|580454|P2|COMPLETED|Period 1- 1 Week||42
241922|NCT00564954|580455|P1|COMPLETED|Period 1- 1 Week||44
241923|NCT00564954|580454|P2|STARTED|Period 1- 1 Week||42
241924|NCT00564954|580455|P1|STARTED|Period 1- 1 Week||44
241925|NCT00564902|580474|P3|NOT COMPLETED|Overall Study||4
241926|NCT00564902|580475|P2|NOT COMPLETED|Overall Study||4
241927|NCT00564902|580476|P1|NOT COMPLETED|Overall Study||1
241928|NCT00564902|580474|P3|COMPLETED|Overall Study||21
241929|NCT00564902|580475|P2|COMPLETED|Overall Study||21
241930|NCT00564902|580476|P1|COMPLETED|Overall Study||9
241931|NCT00564902|580474|P3|12 Months|Overall Study||21
241932|NCT00564902|580475|P2|12 Months|Overall Study||21
241933|NCT00564902|580476|P1|12 Months|Overall Study||9
241934|NCT00564902|580474|P3|8 Months|Overall Study||21
241935|NCT00564902|580475|P2|8 Months|Overall Study||22
241936|NCT00564902|580476|P1|8 Months|Overall Study||9
241937|NCT00564902|580474|P3|4 Months|Overall Study||23
241938|NCT00564902|580475|P2|4 Months|Overall Study||24
241939|NCT00564902|580476|P1|4 Months|Overall Study||9
241940|NCT00564902|580474|P3|STARTED|Overall Study||25
241941|NCT00564902|580475|P2|STARTED|Overall Study||25
241942|NCT00564902|580476|P1|STARTED|Overall Study||10
241943|NCT00564889|580508|P1|NOT COMPLETED|Overall Study||29
241944|NCT00564889|580508|P1|COMPLETED|Overall Study||6
241945|NCT00564889|580508|P1|STARTED|Overall Study||35
241946|NCT00564876|580516|P1|NOT COMPLETED|Overall Study||0
241947|NCT00564876|580516|P1|COMPLETED|Overall Study||2
241948|NCT00564876|580516|P1|STARTED|Overall Study||2
241949|NCT00564850|580523|P1|NOT COMPLETED|Overall Study||2
241950|NCT00564850|580523|P1|COMPLETED|Overall Study||35
241951|NCT00564850|580523|P1|STARTED|Overall Study||37
241952|NCT00564733|580541|P1|NOT COMPLETED|Overall Study||9
241953|NCT00564733|580541|P1|COMPLETED|Overall Study||46
241954|NCT00564733|580541|P1|STARTED|Overall Study||55
241955|NCT00564681|580549|P4|NOT COMPLETED|Overall Study||2
241956|NCT00564681|580550|P3|NOT COMPLETED|Overall Study||3
241957|NCT00564681|580551|P2|NOT COMPLETED|Overall Study||3
241958|NCT00564681|580552|P1|NOT COMPLETED|Overall Study||11
241959|NCT00564681|580549|P4|COMPLETED|Overall Study||19
241960|NCT00564681|580550|P3|COMPLETED|Overall Study||40
241961|NCT00564681|580551|P2|COMPLETED|Overall Study||58
241962|NCT00564681|580552|P1|COMPLETED|Overall Study||106
241963|NCT00564681|580549|P4|STARTED|Overall Study||21
241964|NCT00564681|580550|P3|STARTED|Overall Study||43
241965|NCT00564681|580551|P2|STARTED|Overall Study||61
241966|NCT00564681|580552|P1|STARTED|Overall Study||117
241967|NCT00564629|580575|P2|NOT COMPLETED|Overall Study||9
241968|NCT00564629|580576|P1|NOT COMPLETED|Overall Study||15
241969|NCT00564629|580575|P2|COMPLETED|Overall Study||45
241970|NCT00564629|580576|P1|COMPLETED|Overall Study||36
241971|NCT00564629|580575|P2|STARTED|Overall Study||54
241972|NCT00564629|580576|P1|STARTED|Overall Study||51
241973|NCT00564486|580601|P4|NOT COMPLETED|Overall Study||7
241974|NCT00564486|580602|P3|NOT COMPLETED|Overall Study||3
241975|NCT00564486|580603|P2|NOT COMPLETED|Overall Study||1
241976|NCT00564486|580604|P1|NOT COMPLETED|Overall Study||7
241977|NCT00564486|580601|P4|COMPLETED|Overall Study||60
241978|NCT00564486|580602|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
241979|NCT00564486|580603|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
241980|NCT00564486|580604|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
241981|NCT00564486|580601|P4|STARTED|Overall Study||67
241982|NCT00564486|580602|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
241983|NCT00564486|580603|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
241984|NCT00564486|580604|P1|STARTED|Overall Study||43
241985|NCT00564447|580628|P8|NOT COMPLETED|Overall Study||0
241986|NCT00564447|580629|P7|NOT COMPLETED|Overall Study||0
241987|NCT00564447|580630|P6|NOT COMPLETED|Overall Study||0
241988|NCT00564447|580631|P5|NOT COMPLETED|Overall Study||0
241989|NCT00564447|580632|P4|NOT COMPLETED|Overall Study||0
241990|NCT00564447|580633|P3|NOT COMPLETED|Overall Study||0
241991|NCT00564447|580634|P2|NOT COMPLETED|Overall Study||0
241992|NCT00564447|580635|P1|NOT COMPLETED|Overall Study||0
241993|NCT00564447|580628|P8|COMPLETED|Overall Study||6
241994|NCT00564447|580629|P7|COMPLETED|Overall Study||6
241995|NCT00564447|580630|P6|COMPLETED|Overall Study||6
241996|NCT00564447|580631|P5|COMPLETED|Overall Study||6
241997|NCT00564447|580632|P4|COMPLETED|Overall Study||6
241998|NCT00564447|580633|P3|COMPLETED|Overall Study||6
241999|NCT00564447|580634|P2|COMPLETED|Overall Study||6
242000|NCT00564447|580635|P1|COMPLETED|Overall Study||6
242001|NCT00564447|580628|P8|STARTED|Overall Study||6
242002|NCT00564447|580629|P7|STARTED|Overall Study||6
242003|NCT00564447|580630|P6|STARTED|Overall Study||6
242004|NCT00564447|580631|P5|STARTED|Overall Study||6
242005|NCT00564447|580632|P4|STARTED|Overall Study||6
242006|NCT00564447|580633|P3|STARTED|Overall Study||6
242007|NCT00564447|580634|P2|STARTED|Overall Study||6
242008|NCT00564447|580635|P1|STARTED|Overall Study||6
242009|NCT00564278|580655|P2|NOT COMPLETED|Overall Study||42
242010|NCT00564278|580656|P1|NOT COMPLETED|Overall Study||47
242011|NCT00564278|580655|P2|COMPLETED|Overall Study||56
242012|NCT00564278|580656|P1|COMPLETED|Overall Study||50
242013|NCT00564278|580655|P2|STARTED|Overall Study||98
242014|NCT00564278|580656|P1|STARTED|Overall Study||97
242015|NCT00564265|580672|P1|NOT COMPLETED|Overall Study||0
242016|NCT00564265|580672|P1|COMPLETED|Overall Study||24
242017|NCT00564265|580672|P1|STARTED|Overall Study||24
242018|NCT00564070|580678|P2|NOT COMPLETED|Overall Study||7
242019|NCT00564070|580679|P1|NOT COMPLETED|Overall Study||12
242020|NCT00564070|580678|P2|COMPLETED|Overall Study||38
242021|NCT00564070|580679|P1|COMPLETED|Overall Study||30
242022|NCT00564070|580678|P2|STARTED|Overall Study||45
242023|NCT00564070|580679|P1|STARTED|Overall Study||42
242024|NCT00563797|580705|P2|NOT COMPLETED|Overall Study||2
242025|NCT00563797|580706|P1|NOT COMPLETED|Overall Study||7
242026|NCT00563797|580705|P2|COMPLETED|Overall Study||8
242027|NCT00563797|580706|P1|COMPLETED|Overall Study||4
242028|NCT00563797|580705|P2|Follow-Up|Overall Study||10
242029|NCT00563797|580706|P1|Follow-Up|Overall Study||11
242030|NCT00563797|580705|P2|Received Allocated Intervention|Overall Study||10
242031|NCT00563797|580706|P1|Received Allocated Intervention|Overall Study||11
242032|NCT00563797|580705|P2|STARTED|Overall Study||10
242033|NCT00563797|580706|P1|STARTED|Overall Study||11
242034|NCT00563706|580727|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242035|NCT00563706|580728|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242036|NCT00563706|580729|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242037|NCT00563706|580730|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242038|NCT00563706|580731|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242039|NCT00563706|580732|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242040|NCT00563706|580733|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242041|NCT00563706|580734|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242042|NCT00563706|580735|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
242043|NCT00563706|580727|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
242044|NCT00563706|580728|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
242045|NCT00563706|580729|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
242046|NCT00563706|580730|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
242047|NCT00563706|580731|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
242048|NCT00563706|580732|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
242049|NCT00563706|580733|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
242050|NCT00563706|580734|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
242051|NCT00563706|580735|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
242052|NCT00563706|580727|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
242053|NCT00563706|580728|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
242054|NCT00563706|580729|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
242055|NCT00563706|580730|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
242056|NCT00563706|580731|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
242057|NCT00563706|580732|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
242058|NCT00563706|580733|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
242059|NCT00563706|580734|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
242060|NCT00563706|580735|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
242061|NCT00563706|580727|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
242062|NCT00563706|580728|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
242063|NCT00563706|580729|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
242064|NCT00563706|580730|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
242065|NCT00563706|580731|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
242066|NCT00563706|580732|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
242067|NCT00563706|580733|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
242068|NCT00563706|580734|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
242069|NCT00563706|580735|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
242070|NCT00563706|580727|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
242071|NCT00563706|580728|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
242072|NCT00563706|580729|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
242073|NCT00563706|580730|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
242074|NCT00563706|580731|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
242075|NCT00563706|580732|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
242076|NCT00563706|580733|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
242077|NCT00563706|580734|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
242078|NCT00563706|580735|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
242079|NCT00563706|580727|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
242080|NCT00563706|580728|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
242081|NCT00563706|580729|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
242082|NCT00563706|580730|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
242083|NCT00563706|580731|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
242084|NCT00563706|580732|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
242085|NCT00563706|580733|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
242086|NCT00563706|580734|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
242087|NCT00563706|580735|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
242088|NCT00563576|580838|P2|NOT COMPLETED|Overall Study||14
242089|NCT00563576|580839|P1|NOT COMPLETED|Overall Study||14
242090|NCT00563576|580838|P2|COMPLETED|Overall Study||22
242091|NCT00563576|580839|P1|COMPLETED|Overall Study||21
242092|NCT00563576|580838|P2|STARTED|Overall Study||36
242093|NCT00563576|580839|P1|STARTED|Overall Study||35
242094|NCT00563381|580851|P2|NOT COMPLETED|Overall Study||648
242095|NCT00563381|580852|P1|NOT COMPLETED|Overall Study||585
242096|NCT00563381|580851|P2|COMPLETED|Overall Study|Completed treatment|3021
242097|NCT00563381|580852|P1|COMPLETED|Overall Study|Completed treatment|3122
242098|NCT00563381|580851|P2|STARTED|Overall Study|Started treatment|3669
242099|NCT00563381|580852|P1|STARTED|Overall Study|Started treatment|3707
242100|NCT00563368|580925|P7|NOT COMPLETED|Overall Study||33
242101|NCT00563368|580926|P6|NOT COMPLETED|Overall Study||30
242102|NCT00563368|580927|P5|NOT COMPLETED|Overall Study||28
242103|NCT00563368|580928|P4|NOT COMPLETED|Overall Study||29
242104|NCT00563368|580929|P3|NOT COMPLETED|Overall Study||30
242105|NCT00563368|580930|P2|NOT COMPLETED|Overall Study||30
242106|NCT00563368|580931|P1|NOT COMPLETED|Overall Study||35
242107|NCT00563368|580925|P7|COMPLETED|Overall Study||75
242108|NCT00563368|580926|P6|COMPLETED|Overall Study||77
242109|NCT00563368|580927|P5|COMPLETED|Overall Study||80
242110|NCT00563368|580928|P4|COMPLETED|Overall Study||78
242111|NCT00563368|580929|P3|COMPLETED|Overall Study||78
242112|NCT00563368|580930|P2|COMPLETED|Overall Study||79
242113|NCT00563368|580931|P1|COMPLETED|Overall Study||74
242114|NCT00563368|580925|P7|STARTED|Overall Study||108
242115|NCT00563368|580926|P6|STARTED|Overall Study||107
242116|NCT00563368|580927|P5|STARTED|Overall Study||108
242117|NCT00563368|580928|P4|STARTED|Overall Study||107
242118|NCT00563368|580929|P3|STARTED|Overall Study||108
242119|NCT00563368|580930|P2|STARTED|Overall Study||109
242120|NCT00563368|580931|P1|STARTED|Overall Study||109
242121|NCT00563316|580954|P1|NOT COMPLETED|Overall Study||12
242122|NCT00563316|580954|P1|COMPLETED|Overall Study||16
242123|NCT00563316|580954|P1|Received Investigational Product|Overall Study||27
242124|NCT00563316|580954|P1|STARTED|Overall Study||28
242125|NCT00563290|580967|P2|NOT COMPLETED|Overall Study||0
242126|NCT00563290|580968|P1|NOT COMPLETED|Overall Study||0
242127|NCT00563290|580967|P2|COMPLETED|Overall Study||4
242128|NCT00563290|580968|P1|COMPLETED|Overall Study||3
242129|NCT00563290|580967|P2|STARTED|Overall Study||4
242130|NCT00563290|580968|P1|STARTED|Overall Study||3
242131|NCT00562965|580979|P2|NOT COMPLETED|Overall Study||6
242132|NCT00562965|580980|P1|NOT COMPLETED|Overall Study||3
242133|NCT00562965|580979|P2|COMPLETED|Overall Study||8
242134|NCT00562965|580980|P1|COMPLETED|Overall Study||12
242135|NCT00562965|580979|P2|Treated|Overall Study||13
242136|NCT00562965|580980|P1|Treated|Overall Study||15
242137|NCT00562965|580979|P2|STARTED|Overall Study||14
242138|NCT00562965|580980|P1|STARTED|Overall Study||15
242139|NCT00562861|581001|P2|NOT COMPLETED|Overall Study||11
242140|NCT00562861|581002|P1|NOT COMPLETED|Overall Study||20
242141|NCT00562861|581001|P2|COMPLETED|Overall Study||48
242142|NCT00562861|581002|P1|COMPLETED|Overall Study||40
242143|NCT00562861|581001|P2|STARTED|Overall Study||59
242144|NCT00562861|581002|P1|STARTED|Overall Study||60
242145|NCT00562627|581011|P3|NOT COMPLETED|Overall Study||1
242146|NCT00562627|581012|P2|NOT COMPLETED|Overall Study||1
242147|NCT00562627|581013|P1|NOT COMPLETED|Overall Study||1
242148|NCT00562627|581011|P3|COMPLETED|Overall Study||33
242149|NCT00562627|581012|P2|COMPLETED|Overall Study||33
242150|NCT00562627|581013|P1|COMPLETED|Overall Study||33
242151|NCT00562627|581011|P3|STARTED|Overall Study||34
242152|NCT00562627|581012|P2|STARTED|Overall Study||34
242153|NCT00562627|581013|P1|STARTED|Overall Study||34
242154|NCT00562588|581029|P2|NOT COMPLETED|Overall Study||99
242155|NCT00562588|581030|P1|NOT COMPLETED|Overall Study||92
242156|NCT00562588|581029|P2|COMPLETED|Overall Study||184
242157|NCT00562588|581030|P1|COMPLETED|Overall Study||168
242158|NCT00562588|581029|P2|STARTED|Overall Study||283
242159|NCT00562588|581030|P1|STARTED|Overall Study||260
242160|NCT00562484|581060|P2|NOT COMPLETED|Overall Study||104
242161|NCT00562484|581061|P1|NOT COMPLETED|Overall Study||206
242162|NCT00562484|581060|P2|COMPLETED|Overall Study||4907
242163|NCT00562484|581061|P1|COMPLETED|Overall Study||9827
242164|NCT00562484|581060|P2|STARTED|Overall Study||5011
242165|NCT00562484|581061|P1|STARTED|Overall Study||10033
242166|NCT00562354|581093|P2|NOT COMPLETED|Overall Study||2
242167|NCT00562354|581094|P1|NOT COMPLETED|Overall Study||0
242168|NCT00562354|581093|P2|COMPLETED|Overall Study||135
242169|NCT00562354|581094|P1|COMPLETED|Overall Study||134
242170|NCT00562354|581093|P2|Evaluable Immunogenicity Population|Overall Study||134
242171|NCT00562354|581094|P1|Evaluable Immunogenicity Population|Overall Study||134
242172|NCT00562354|581093|P2|Received Study Treatment|Overall Study||136
242173|NCT00562354|581094|P1|Received Study Treatment|Overall Study||134
242174|NCT00562354|581093|P2|STARTED|Overall Study||137
242175|NCT00562354|581094|P1|STARTED|Overall Study||134
242176|NCT00562328|581135|P1|NOT COMPLETED|Overall Study||0
242177|NCT00562328|581135|P1|COMPLETED|Overall Study||33
242178|NCT00562328|581135|P1|STARTED|Overall Study||33
242179|NCT00562315|581139|P1|NOT COMPLETED|Overall Study||0
242180|NCT00562315|581139|P1|COMPLETED|Overall Study||93
242181|NCT00562315|581139|P1|STARTED|Overall Study||93
242182|NCT00562302|581156|P2|NOT COMPLETED|Overall Study||32
242183|NCT00562302|581157|P1|NOT COMPLETED|Overall Study||20
242184|NCT00562302|581156|P2|COMPLETED|Overall Study||137
242185|NCT00562302|581157|P1|COMPLETED|Overall Study||150
242186|NCT00562302|581156|P2|STARTED|Overall Study||169
242187|NCT00562302|581157|P1|STARTED|Overall Study||170
242188|NCT00562159|581179|P2|NOT COMPLETED|Overall Study||33
242189|NCT00562159|581180|P1|NOT COMPLETED|Overall Study||38
242190|NCT00562159|581179|P2|COMPLETED|Overall Study||192
242191|NCT00562159|581180|P1|COMPLETED|Overall Study||175
242192|NCT00562159|581179|P2|STARTED|Overall Study||225
242193|NCT00562159|581180|P1|STARTED|Overall Study||213
242194|NCT00562120|581192|P4|NOT COMPLETED|Fourth Intervention Period||0
242195|NCT00562120|581193|P3|NOT COMPLETED|Fourth Intervention Period||0
242196|NCT00562120|581194|P2|NOT COMPLETED|Fourth Intervention Period||0
242197|NCT00562120|581195|P1|NOT COMPLETED|Fourth Intervention Period||0
242198|NCT00562120|581192|P4|COMPLETED|Fourth Intervention Period||5
242199|NCT00562120|581193|P3|COMPLETED|Fourth Intervention Period||5
242200|NCT00562120|581194|P2|COMPLETED|Fourth Intervention Period||5
242201|NCT00562120|581195|P1|COMPLETED|Fourth Intervention Period||4
242202|NCT00562120|581192|P4|STARTED|Fourth Intervention Period||5
242203|NCT00562120|581193|P3|STARTED|Fourth Intervention Period||5
242204|NCT00562120|581194|P2|STARTED|Fourth Intervention Period||5
242205|NCT00562120|581195|P1|STARTED|Fourth Intervention Period||4
242206|NCT00562120|581192|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
242207|NCT00562120|581193|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
242208|NCT00562120|581194|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
242209|NCT00562120|581195|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
242210|NCT00562120|581192|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
242211|NCT00562120|581193|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
242212|NCT00562120|581194|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
242213|NCT00562120|581195|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
242214|NCT00562120|581192|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
242215|NCT00562120|581193|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
242216|NCT00562120|581194|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
242217|NCT00562120|581195|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
242218|NCT00562120|581192|P4|NOT COMPLETED|Third Intervention Period||0
242219|NCT00562120|581193|P3|NOT COMPLETED|Third Intervention Period||0
242220|NCT00562120|581194|P2|NOT COMPLETED|Third Intervention Period||0
242221|NCT00562120|581195|P1|NOT COMPLETED|Third Intervention Period||0
242222|NCT00562120|581192|P4|COMPLETED|Third Intervention Period||5
242223|NCT00562120|581193|P3|COMPLETED|Third Intervention Period||5
242224|NCT00562120|581194|P2|COMPLETED|Third Intervention Period||5
242225|NCT00562120|581195|P1|COMPLETED|Third Intervention Period||4
242226|NCT00562120|581192|P4|STARTED|Third Intervention Period||5
242227|NCT00562120|581193|P3|STARTED|Third Intervention Period||5
242228|NCT00562120|581194|P2|STARTED|Third Intervention Period||5
242229|NCT00562120|581195|P1|STARTED|Third Intervention Period||4
242230|NCT00562120|581192|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
242231|NCT00562120|581193|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
242232|NCT00562120|581194|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
242233|NCT00562120|581195|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
242234|NCT00562120|581192|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
242235|NCT00562120|581193|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
242236|NCT00562120|581194|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
242237|NCT00562120|581195|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
242238|NCT00562120|581192|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
242239|NCT00562120|581193|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
242240|NCT00562120|581194|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
242241|NCT00562120|581195|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
242242|NCT00562120|581192|P4|NOT COMPLETED|Second Intervention Period||0
242243|NCT00562120|581193|P3|NOT COMPLETED|Second Intervention Period||0
242244|NCT00562120|581194|P2|NOT COMPLETED|Second Intervention Period||0
242245|NCT00562120|581195|P1|NOT COMPLETED|Second Intervention Period||0
242246|NCT00562120|581192|P4|COMPLETED|Second Intervention Period||5
242247|NCT00562120|581193|P3|COMPLETED|Second Intervention Period||5
242248|NCT00562120|581194|P2|COMPLETED|Second Intervention Period||5
242249|NCT00562120|581195|P1|COMPLETED|Second Intervention Period||4
242250|NCT00562120|581192|P4|STARTED|Second Intervention Period||5
242251|NCT00562120|581193|P3|STARTED|Second Intervention Period||5
242252|NCT00562120|581194|P2|STARTED|Second Intervention Period||5
242253|NCT00562120|581195|P1|STARTED|Second Intervention Period||4
242254|NCT00562120|581192|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
242255|NCT00562120|581193|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
242256|NCT00562120|581194|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
242257|NCT00562120|581195|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
242258|NCT00562120|581192|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
242259|NCT00562120|581193|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
242260|NCT00562120|581194|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
242261|NCT00562120|581195|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
242262|NCT00562120|581192|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
242263|NCT00562120|581193|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
242264|NCT00562120|581194|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
242265|NCT00562120|581195|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
242266|NCT00562120|581192|P4|NOT COMPLETED|First Intervention Period||0
242267|NCT00562120|581193|P3|NOT COMPLETED|First Intervention Period||0
242268|NCT00562120|581194|P2|NOT COMPLETED|First Intervention Period||0
242269|NCT00562120|581195|P1|NOT COMPLETED|First Intervention Period||2
242270|NCT00562120|581192|P4|COMPLETED|First Intervention Period||5
242271|NCT00562120|581193|P3|COMPLETED|First Intervention Period||5
242272|NCT00562120|581194|P2|COMPLETED|First Intervention Period||5
242273|NCT00562120|581195|P1|COMPLETED|First Intervention Period||4
242274|NCT00562120|581192|P4|Treated|First Intervention Period||5
242275|NCT00562120|581193|P3|Treated|First Intervention Period||5
242276|NCT00562120|581194|P2|Treated|First Intervention Period||5
242277|NCT00562120|581195|P1|Treated|First Intervention Period||5
242278|NCT00562120|581192|P4|STARTED|First Intervention Period||5
242279|NCT00562120|581193|P3|STARTED|First Intervention Period||5
242280|NCT00562120|581194|P2|STARTED|First Intervention Period||5
242281|NCT00562120|581195|P1|STARTED|First Intervention Period||6
242282|NCT00562094|581227|P1|NOT COMPLETED|Overall Study||62
242283|NCT00562094|581227|P1|COMPLETED|Overall Study||8554
242284|NCT00562094|581227|P1|STARTED|Overall Study||8616
242285|NCT00561977|581242|P3|NOT COMPLETED|Overall Study||2
242286|NCT00561977|581243|P2|NOT COMPLETED|Overall Study||3
242287|NCT00561977|581244|P1|NOT COMPLETED|Overall Study||0
242288|NCT00561977|581242|P3|COMPLETED|Overall Study||10
242289|NCT00561977|581243|P2|COMPLETED|Overall Study||9
242290|NCT00561977|581244|P1|COMPLETED|Overall Study||12
242291|NCT00561977|581242|P3|STARTED|Overall Study||12
242292|NCT00561977|581243|P2|STARTED|Overall Study||12
242293|NCT00561977|581244|P1|STARTED|Overall Study||12
242294|NCT00561951|581270|P3|NOT COMPLETED|Overall Study||32
242295|NCT00561951|581271|P2|NOT COMPLETED|Overall Study||34
242296|NCT00561951|581272|P1|NOT COMPLETED|Overall Study||33
242297|NCT00561951|581270|P3|COMPLETED|Overall Study||281
242298|NCT00561951|581271|P2|COMPLETED|Overall Study||286
242299|NCT00561951|581272|P1|COMPLETED|Overall Study||285
242300|NCT00561951|581270|P3|STARTED|Overall Study||313
242301|NCT00561951|581271|P2|STARTED|Overall Study||320
242302|NCT00561951|581272|P1|STARTED|Overall Study||318
242303|NCT00561925|581328|P5|NOT COMPLETED|Open-Label Extension Period||50
242304|NCT00561925|581329|P4|NOT COMPLETED|Open-Label Extension Period||43
242305|NCT00561925|581330|P3|NOT COMPLETED|Open-Label Extension Period||0
242306|NCT00561925|581331|P2|NOT COMPLETED|Open-Label Extension Period||0
242307|NCT00561925|581332|P1|NOT COMPLETED|Open-Label Extension Period||0
242308|NCT00561925|581328|P5|COMPLETED|Open-Label Extension Period||328
242309|NCT00561925|581329|P4|COMPLETED|Open-Label Extension Period||315
242310|NCT00561925|581330|P3|COMPLETED|Open-Label Extension Period||0
242311|NCT00561925|581331|P2|COMPLETED|Open-Label Extension Period||1
242312|NCT00561925|581332|P1|COMPLETED|Open-Label Extension Period||0
242313|NCT00561925|581328|P5|STARTED|Open-Label Extension Period||378
242314|NCT00561925|581329|P4|STARTED|Open-Label Extension Period||358
242315|NCT00561925|581330|P3|STARTED|Open-Label Extension Period||0
242316|NCT00561925|581331|P2|STARTED|Open-Label Extension Period||1
242317|NCT00561925|581332|P1|STARTED|Open-Label Extension Period||0
242318|NCT00561925|581328|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
242319|NCT00561925|581329|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
242320|NCT00561925|581330|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
242321|NCT00561925|581331|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
242322|NCT00561925|581332|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
242323|NCT00561925|581328|P5|COMPLETED|144-week Double-blind, Double-dummy||0
242324|NCT00561925|581329|P4|COMPLETED|144-week Double-blind, Double-dummy||0
242325|NCT00561925|581330|P3|COMPLETED|144-week Double-blind, Double-dummy||378
242326|NCT00561925|581331|P2|COMPLETED|144-week Double-blind, Double-dummy||358
242327|NCT00561925|581332|P1|COMPLETED|144-week Double-blind, Double-dummy||0
242328|NCT00561925|581328|P5|STARTED|144-week Double-blind, Double-dummy||0
242329|NCT00561925|581329|P4|STARTED|144-week Double-blind, Double-dummy||0
242330|NCT00561925|581330|P3|STARTED|144-week Double-blind, Double-dummy||505
242331|NCT00561925|581331|P2|STARTED|144-week Double-blind, Double-dummy||508
242332|NCT00561925|581332|P1|STARTED|144-week Double-blind, Double-dummy||0
242333|NCT00561925|581328|P5|NOT COMPLETED|14 Day Lead-In Period||0
242334|NCT00561925|581329|P4|NOT COMPLETED|14 Day Lead-In Period||0
242335|NCT00561925|581330|P3|NOT COMPLETED|14 Day Lead-In Period||0
242336|NCT00561925|581331|P2|NOT COMPLETED|14 Day Lead-In Period||0
242337|NCT00561925|581332|P1|NOT COMPLETED|14 Day Lead-In Period||55
242338|NCT00561925|581328|P5|COMPLETED|14 Day Lead-In Period||0
242339|NCT00561925|581329|P4|COMPLETED|14 Day Lead-In Period||0
242340|NCT00561925|581330|P3|COMPLETED|14 Day Lead-In Period||0
242341|NCT00561925|581331|P2|COMPLETED|14 Day Lead-In Period||0
242342|NCT00561925|581332|P1|COMPLETED|14 Day Lead-In Period||1013
242343|NCT00561925|581328|P5|STARTED|14 Day Lead-In Period||0
242344|NCT00561925|581329|P4|STARTED|14 Day Lead-In Period||0
242345|NCT00561925|581330|P3|STARTED|14 Day Lead-In Period||0
242346|NCT00561925|581331|P2|STARTED|14 Day Lead-In Period||0
242347|NCT00561925|581332|P1|STARTED|14 Day Lead-In Period||1068
242348|NCT00561912|581381|P1|NOT COMPLETED|Overall Study||1
242349|NCT00561912|581381|P1|COMPLETED|Overall Study||1
242350|NCT00561912|581381|P1|STARTED|Overall Study||2
242351|NCT00561834|581385|P1|NOT COMPLETED|Overall Study||0
242352|NCT00561834|581385|P1|COMPLETED|Overall Study||2
242353|NCT00561834|581385|P1|STARTED|Overall Study||2
242354|NCT00561821|581393|P4|NOT COMPLETED|Overall Study||3
242355|NCT00561821|581394|P3|NOT COMPLETED|Overall Study||2
242356|NCT00561821|581395|P2|NOT COMPLETED|Overall Study||6
242357|NCT00561821|581396|P1|NOT COMPLETED|Overall Study||5
242358|NCT00561821|581393|P4|COMPLETED|Overall Study||133
242359|NCT00561821|581394|P3|COMPLETED|Overall Study||132
242360|NCT00561821|581395|P2|COMPLETED|Overall Study||130
242361|NCT00561821|581396|P1|COMPLETED|Overall Study||127
242362|NCT00561821|581393|P4|Treated|Overall Study||136
242363|NCT00561821|581394|P3|Treated|Overall Study||133
242364|NCT00561821|581395|P2|Treated|Overall Study||136
242365|NCT00561821|581396|P1|Treated|Overall Study||132
242366|NCT00561821|581393|P4|STARTED|Overall Study||136
242367|NCT00561821|581394|P3|STARTED|Overall Study||134
242368|NCT00561821|581395|P2|STARTED|Overall Study||136
242369|NCT00561821|581396|P1|STARTED|Overall Study||132
242370|NCT00561795|581472|P4|NOT COMPLETED|Overall Study||0
242371|NCT00561795|581473|P3|NOT COMPLETED|Overall Study||0
242372|NCT00561795|581474|P2|NOT COMPLETED|Overall Study||6
242373|NCT00561795|581475|P1|NOT COMPLETED|Overall Study||4
242374|NCT00561795|581472|P4|COMPLETED|Overall Study||0
242375|NCT00561795|581473|P3|COMPLETED|Overall Study||0
242376|NCT00561795|581474|P2|COMPLETED|Overall Study||0
242377|NCT00561795|581475|P1|COMPLETED|Overall Study||2
242378|NCT00561795|581472|P4|STARTED|Overall Study||0
242379|NCT00561795|581473|P3|STARTED|Overall Study||0
242380|NCT00561795|581474|P2|STARTED|Overall Study||6
242381|NCT00561795|581475|P1|STARTED|Overall Study||6
242382|NCT00561730|581495|P1|NOT COMPLETED|Overall Study||9
242383|NCT00561730|581495|P1|COMPLETED|Overall Study||1986
242384|NCT00561730|581495|P1|STARTED|Overall Study||1995
242385|NCT00561678|581511|P2|NOT COMPLETED|Overall Study||6
242386|NCT00561678|581512|P1|NOT COMPLETED|Overall Study||8
242387|NCT00561678|581511|P2|COMPLETED|Overall Study||201
242388|NCT00561678|581512|P1|COMPLETED|Overall Study||189
242389|NCT00561678|581511|P2|STARTED|Overall Study||207
242390|NCT00561678|581512|P1|STARTED|Overall Study||197
242391|NCT00561652|581530|P2|NOT COMPLETED|Overall Study||1
242392|NCT00561652|581531|P1|NOT COMPLETED|Overall Study||0
242393|NCT00561652|581530|P2|COMPLETED|Overall Study||19
242394|NCT00561652|581531|P1|COMPLETED|Overall Study||10
242395|NCT00561652|581530|P2|STARTED|Overall Study||20
242396|NCT00561652|581531|P1|STARTED|Overall Study||10
242397|NCT00561600|581551|P2|NOT COMPLETED|Overall Study||16
242398|NCT00561600|581552|P1|NOT COMPLETED|Overall Study||18
242399|NCT00561600|581551|P2|COMPLETED|Overall Study||119
242400|NCT00561600|581552|P1|COMPLETED|Overall Study||112
242401|NCT00561600|581551|P2|STARTED|Overall Study||135
242402|NCT00561600|581552|P1|STARTED|Overall Study||130
242403|NCT00561574|581614|P2|NOT COMPLETED|Overall Study||58
242404|NCT00561574|581615|P1|NOT COMPLETED|Overall Study||48
242405|NCT00561574|581614|P2|COMPLETED|Overall Study||73
242406|NCT00561574|581615|P1|COMPLETED|Overall Study||80
242407|NCT00561574|581614|P2|STARTED|Overall Study||131
242408|NCT00561574|581615|P1|STARTED|Overall Study||128
242409|NCT00561470|581641|P2|NOT COMPLETED|Overall Study||612
242410|NCT00561470|581642|P1|NOT COMPLETED|Overall Study||614
242411|NCT00561470|581641|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
242412|NCT00561470|581642|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
242413|NCT00561470|581641|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
242414|NCT00561470|581642|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
242415|NCT00561470|581641|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
242416|NCT00561470|581642|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
242417|NCT00561470|581641|P2|TREATED|Overall Study||607
242418|NCT00561470|581642|P1|TREATED|Overall Study||609
242419|NCT00561470|581641|P2|STARTED|Overall Study||612
242420|NCT00561470|581642|P1|STARTED|Overall Study||614
242421|NCT00561457|581656|P1|NOT COMPLETED|Overall Study||24
242422|NCT00561457|581656|P1|COMPLETED|Overall Study||110
242423|NCT00561457|581656|P1|STARTED|Overall Study||134
242424|NCT00561431|581662|P2|NOT COMPLETED|Overall Study||0
242425|NCT00561431|581663|P1|NOT COMPLETED|Overall Study||0
242426|NCT00561431|581662|P2|COMPLETED|Overall Study||100
242427|NCT00561431|581663|P1|COMPLETED|Overall Study||100
242428|NCT00561431|581662|P2|STARTED|Overall Study||100
242429|NCT00561431|581663|P1|STARTED|Overall Study||100
242430|NCT00561418|581671|P1|NOT COMPLETED|Overall Study||0
242431|NCT00561418|581671|P1|COMPLETED|Overall Study||23
242432|NCT00561418|581671|P1|STARTED|Overall Study||23
242433|NCT00561392|581678|P1|NOT COMPLETED|Overall Study||53
242434|NCT00561392|581678|P1|COMPLETED|Overall Study||155
242435|NCT00561392|581678|P1|STARTED|Overall Study||208
242436|NCT00561353|581700|P10|NOT COMPLETED|Overall Study||2
242437|NCT00561353|581701|P9|NOT COMPLETED|Overall Study||7
242438|NCT00561353|581702|P8|NOT COMPLETED|Overall Study||4
242439|NCT00561353|581703|P7|NOT COMPLETED|Overall Study||6
242440|NCT00561353|581704|P6|NOT COMPLETED|Overall Study||6
242441|NCT00561353|581705|P5|NOT COMPLETED|Overall Study||1
242442|NCT00561353|581706|P4|NOT COMPLETED|Overall Study||6
242443|NCT00561353|581707|P3|NOT COMPLETED|Overall Study||3
242444|NCT00561353|581708|P2|NOT COMPLETED|Overall Study||3
242445|NCT00561353|581709|P1|NOT COMPLETED|Overall Study||5
242446|NCT00561353|581700|P10|COMPLETED|Overall Study||3
242447|NCT00561353|581701|P9|COMPLETED|Overall Study||2
242448|NCT00561353|581702|P8|COMPLETED|Overall Study||6
242449|NCT00561353|581703|P7|COMPLETED|Overall Study||3
242450|NCT00561353|581704|P6|COMPLETED|Overall Study||3
242451|NCT00561353|581705|P5|COMPLETED|Overall Study||5
242452|NCT00561353|581706|P4|COMPLETED|Overall Study||12
242453|NCT00561353|581707|P3|COMPLETED|Overall Study||10
242454|NCT00561353|581708|P2|COMPLETED|Overall Study||16
242455|NCT00561353|581709|P1|COMPLETED|Overall Study||13
242456|NCT00561353|581700|P10|STARTED|Overall Study||5
242457|NCT00561353|581701|P9|STARTED|Overall Study||9
242458|NCT00561353|581702|P8|STARTED|Overall Study||10
242459|NCT00561353|581703|P7|STARTED|Overall Study||9
242460|NCT00561353|581704|P6|STARTED|Overall Study||9
242461|NCT00561353|581705|P5|STARTED|Overall Study||6
242462|NCT00561353|581706|P4|STARTED|Overall Study||18
242463|NCT00561353|581707|P3|STARTED|Overall Study||13
242464|NCT00561353|581708|P2|STARTED|Overall Study||19
242465|NCT00561353|581709|P1|STARTED|Overall Study||18
242466|NCT00561340|581864|P2|NOT COMPLETED|Overall Study||0
242467|NCT00561340|581865|P1|NOT COMPLETED|Overall Study||6
242468|NCT00561340|581864|P2|COMPLETED|Overall Study||16
242469|NCT00561340|581865|P1|COMPLETED|Overall Study||7
242470|NCT00561340|581864|P2|STARTED|Overall Study||16
242471|NCT00561340|581865|P1|STARTED|Overall Study||13
242472|NCT00561145|581875|P2|NOT COMPLETED|Overall Study||0
242473|NCT00561145|581876|P1|NOT COMPLETED|Overall Study||0
242474|NCT00561145|581875|P2|COMPLETED|Overall Study||17
242475|NCT00561145|581876|P1|COMPLETED|Overall Study||15
242476|NCT00561145|581875|P2|STARTED|Overall Study||17
242477|NCT00561145|581876|P1|STARTED|Overall Study||15
242478|NCT00561080|581885|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
242479|NCT00561080|581886|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
242480|NCT00561080|581887|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
242481|NCT00561080|581885|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
242482|NCT00561080|581886|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
242483|NCT00561080|581887|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
242484|NCT00561080|581885|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
242485|NCT00561080|581886|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
242486|NCT00561080|581887|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
242487|NCT00561080|581885|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
242488|NCT00561080|581886|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
242489|NCT00561080|581887|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
242490|NCT00561080|581885|P3|COMPLETED|24-month Post Last Dose Follow-up||0
242491|NCT00561080|581886|P2|COMPLETED|24-month Post Last Dose Follow-up||0
242492|NCT00561080|581887|P1|COMPLETED|24-month Post Last Dose Follow-up||0
242493|NCT00561080|581885|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
242494|NCT00561080|581886|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
242495|NCT00561080|581887|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
242496|NCT00561080|581885|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
242497|NCT00561080|581886|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
242498|NCT00561080|581887|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
242499|NCT00561080|581885|P3|COMPLETED|12-month Post Last Dose Follow-up||215
242500|NCT00561080|581886|P2|COMPLETED|12-month Post Last Dose Follow-up||220
242501|NCT00561080|581887|P1|COMPLETED|12-month Post Last Dose Follow-up||243
242502|NCT00561080|581885|P3|STARTED|12-month Post Last Dose Follow-up||225
242503|NCT00561080|581886|P2|STARTED|12-month Post Last Dose Follow-up||229
242504|NCT00561080|581887|P1|STARTED|12-month Post Last Dose Follow-up||250
242505|NCT00561080|581885|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
242506|NCT00561080|581886|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
242507|NCT00561080|581887|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
242508|NCT00561080|581885|P3|COMPLETED|Vaccination Period (up to Month 4)||225
242509|NCT00561080|581886|P2|COMPLETED|Vaccination Period (up to Month 4)||229
242510|NCT00561080|581887|P1|COMPLETED|Vaccination Period (up to Month 4)||250
242511|NCT00561080|581885|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
242512|NCT00561080|581886|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
242513|NCT00561080|581887|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
242514|NCT00561080|581885|P3|STARTED|Vaccination Period (up to Month 4)||251
242515|NCT00561080|581886|P2|STARTED|Vaccination Period (up to Month 4)||255
242516|NCT00561080|581887|P1|STARTED|Vaccination Period (up to Month 4)||253
242517|NCT00561015|581964|P6|NOT COMPLETED|Overall Study||3
242518|NCT00561015|581965|P5|NOT COMPLETED|Overall Study||1
242519|NCT00561015|581966|P4|NOT COMPLETED|Overall Study||1
242520|NCT00561015|581967|P3|NOT COMPLETED|Overall Study||0
242521|NCT00561015|581968|P2|NOT COMPLETED|Overall Study||0
242522|NCT00561015|581969|P1|NOT COMPLETED|Overall Study||4
242523|NCT00561015|581964|P6|COMPLETED|Overall Study||6
242524|NCT00561015|581965|P5|COMPLETED|Overall Study||8
242525|NCT00561015|581966|P4|COMPLETED|Overall Study||7
242526|NCT00561015|581967|P3|COMPLETED|Overall Study||9
242527|NCT00561015|581968|P2|COMPLETED|Overall Study||5
242528|NCT00561015|581969|P1|COMPLETED|Overall Study||5
242529|NCT00561015|581964|P6|STARTED|Overall Study||9
242530|NCT00561015|581965|P5|STARTED|Overall Study||9
242531|NCT00561015|581966|P4|STARTED|Overall Study||8
242532|NCT00561015|581967|P3|STARTED|Overall Study||9
242533|NCT00561015|581968|P2|STARTED|Overall Study||5
242534|NCT00561015|581969|P1|STARTED|Overall Study||9
242535|NCT00561002|582045|P2|NOT COMPLETED|Overall Study||0
242536|NCT00561002|582046|P1|NOT COMPLETED|Overall Study||0
242537|NCT00561002|582045|P2|COMPLETED|Overall Study||9
242538|NCT00561002|582046|P1|COMPLETED|Overall Study||23
242539|NCT00561002|582045|P2|STARTED|Overall Study||9
242540|NCT00561002|582046|P1|STARTED|Overall Study||23
242541|NCT00560950|582060|P2|NOT COMPLETED|Overall Study||0
242542|NCT00560950|582061|P1|NOT COMPLETED|Overall Study||1
242543|NCT00560950|582060|P2|COMPLETED|Overall Study||71
242544|NCT00560950|582061|P1|COMPLETED|Overall Study||71
242545|NCT00560950|582060|P2|STARTED|Overall Study||71
242546|NCT00560950|582061|P1|STARTED|Overall Study||72
242547|NCT00560937|582099|P2|NOT COMPLETED|Overall Study||2
242548|NCT00560937|582100|P1|NOT COMPLETED|Overall Study||1
242549|NCT00560937|582099|P2|COMPLETED|Overall Study||9
242550|NCT00560937|582100|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
242551|NCT00560937|582099|P2|STARTED|Overall Study||11
242552|NCT00560937|582100|P1|STARTED|Overall Study||10
242553|NCT00560885|582116|P1|NOT COMPLETED|Overall Study||8
242554|NCT00560885|582116|P1|COMPLETED|Overall Study||47
242555|NCT00560885|582116|P1|2 Year Follow-up|Overall Study||47
242556|NCT00560885|582116|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
242557|NCT00560885|582116|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
242558|NCT00560885|582116|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
242559|NCT00560885|582116|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
242560|NCT00560885|582116|P1|STARTED|Overall Study||55
242561|NCT00560859|582125|P2|NOT COMPLETED|Overall Study||24
242562|NCT00560859|582126|P1|NOT COMPLETED|Overall Study||32
242563|NCT00560859|582125|P2|COMPLETED|Overall Study||203
242564|NCT00560859|582126|P1|COMPLETED|Overall Study||194
242565|NCT00560859|582125|P2|STARTED|Overall Study||227
242566|NCT00560859|582126|P1|STARTED|Overall Study||226
242567|NCT00560833|582141|P5|NOT COMPLETED|Overall Study||42
242568|NCT00560833|582142|P4|NOT COMPLETED|Overall Study||31
242569|NCT00560833|582143|P3|NOT COMPLETED|Overall Study||39
242570|NCT00560833|582144|P2|NOT COMPLETED|Overall Study||26
242571|NCT00560833|582145|P1|NOT COMPLETED|Overall Study||44
242572|NCT00560833|582141|P5|COMPLETED|Overall Study||114
242573|NCT00560833|582142|P4|COMPLETED|Overall Study||124
242574|NCT00560833|582143|P3|COMPLETED|Overall Study||121
242575|NCT00560833|582144|P2|COMPLETED|Overall Study||129
242576|NCT00560833|582145|P1|COMPLETED|Overall Study||273
242577|NCT00560833|582141|P5|Treated|Overall Study|One participant was randomized but not treated|155
242578|NCT00560833|582142|P4|Treated|Overall Study||155
242579|NCT00560833|582143|P3|Treated|Overall Study||160
242580|NCT00560833|582144|P2|Treated|Overall Study|One participant was randomized but not treated|154
242581|NCT00560833|582145|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
242582|NCT00560833|582141|P5|STARTED|Overall Study||156
242583|NCT00560833|582142|P4|STARTED|Overall Study||155
242584|NCT00560833|582143|P3|STARTED|Overall Study||160
242585|NCT00560833|582144|P2|STARTED|Overall Study||155
242586|NCT00560833|582145|P1|STARTED|Overall Study||317
242587|NCT00560794|582177|P1|NOT COMPLETED|Overall Study||11
242588|NCT00560794|582177|P1|COMPLETED|Overall Study||10
242589|NCT00560794|582177|P1|Completed 1 Treatment Cycle|Overall Study||20
242590|NCT00560794|582177|P1|STARTED|Overall Study||21
242591|NCT00560755|582194|P1|NOT COMPLETED|Overall Study||60
242592|NCT00560755|582194|P1|COMPLETED|Overall Study||3328
242593|NCT00560755|582194|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
242594|NCT00560755|582194|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
242595|NCT00560703|582215|P2|NOT COMPLETED|Overall Study||6
242596|NCT00560703|582216|P1|NOT COMPLETED|Overall Study||0
242597|NCT00560703|582215|P2|COMPLETED|Overall Study||18
242598|NCT00560703|582216|P1|COMPLETED|Overall Study||46
242599|NCT00560703|582215|P2|STARTED|Overall Study||24
242600|NCT00560703|582216|P1|STARTED|Overall Study||46
242601|NCT00560612|582226|P2|NOT COMPLETED|Overall Study||0
242602|NCT00560612|582227|P1|NOT COMPLETED|Overall Study||0
242603|NCT00560612|582226|P2|COMPLETED|Overall Study||7
242604|NCT00560612|582227|P1|COMPLETED|Overall Study||5
242605|NCT00560612|582226|P2|STARTED|Overall Study||7
242606|NCT00560612|582227|P1|STARTED|Overall Study||5
242607|NCT00560573|582233|P6|NOT COMPLETED|Overall Study||13
242608|NCT00560573|582234|P5|NOT COMPLETED|Overall Study||7
242609|NCT00560573|582235|P4|NOT COMPLETED|Overall Study||10
242610|NCT00560573|582236|P3|NOT COMPLETED|Overall Study||6
242611|NCT00560573|582237|P2|NOT COMPLETED|Overall Study||3
242612|NCT00560573|582238|P1|NOT COMPLETED|Overall Study||6
242613|NCT00560573|582233|P6|COMPLETED|Overall Study||0
242614|NCT00560573|582234|P5|COMPLETED|Overall Study||1
242615|NCT00560573|582235|P4|COMPLETED|Overall Study||0
242616|NCT00560573|582236|P3|COMPLETED|Overall Study||0
242617|NCT00560573|582237|P2|COMPLETED|Overall Study||0
242618|NCT00560573|582238|P1|COMPLETED|Overall Study||0
242619|NCT00560573|582233|P6|Treated|Overall Study||13
242620|NCT00560573|582234|P5|Treated|Overall Study||7
242621|NCT00560573|582235|P4|Treated|Overall Study||10
242622|NCT00560573|582236|P3|Treated|Overall Study||6
242623|NCT00560573|582237|P2|Treated|Overall Study||3
242624|NCT00560573|582238|P1|Treated|Overall Study||6
242625|NCT00560573|582233|P6|STARTED|Overall Study||13
242626|NCT00560573|582234|P5|STARTED|Overall Study||8
242627|NCT00560573|582235|P4|STARTED|Overall Study||10
242628|NCT00560573|582236|P3|STARTED|Overall Study||6
242629|NCT00560573|582237|P2|STARTED|Overall Study||3
242630|NCT00560573|582238|P1|STARTED|Overall Study||6
242631|NCT00560560|582292|P2|NOT COMPLETED|Overall Study||83
242632|NCT00560560|582293|P1|NOT COMPLETED|Overall Study||85
242633|NCT00560560|582292|P2|COMPLETED|Overall Study||0
242634|NCT00560560|582293|P1|COMPLETED|Overall Study||0
242635|NCT00560560|582292|P2|STARTED|Overall Study||83
242636|NCT00560560|582293|P1|STARTED|Overall Study||85
242637|NCT00560508|582315|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
242725|NCT00560066|582606|P2|COMPLETED|Overall Study||980
242638|NCT00560508|582316|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
242639|NCT00560508|582315|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
242640|NCT00560508|582316|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
242641|NCT00560508|582315|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
242642|NCT00560508|582316|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
242643|NCT00560508|582315|P2|NOT COMPLETED|12 Week Double-blind Period||3
242644|NCT00560508|582316|P1|NOT COMPLETED|12 Week Double-blind Period||5
242645|NCT00560508|582315|P2|COMPLETED|12 Week Double-blind Period||53
242646|NCT00560508|582316|P1|COMPLETED|12 Week Double-blind Period||51
242647|NCT00560508|582315|P2|STARTED|12 Week Double-blind Period||56
242648|NCT00560508|582316|P1|STARTED|12 Week Double-blind Period||56
242649|NCT00560417|582375|P2|NOT COMPLETED|Overall Study||17
242650|NCT00560417|582376|P1|NOT COMPLETED|Overall Study||17
242651|NCT00560417|582375|P2|COMPLETED|Overall Study||151
242652|NCT00560417|582376|P1|COMPLETED|Overall Study||154
242653|NCT00560417|582375|P2|Intention to Treat (ITT) Population|Overall Study||167
242654|NCT00560417|582376|P1|Intention to Treat (ITT) Population|Overall Study||170
242655|NCT00560417|582375|P2|STARTED|Overall Study||168
242656|NCT00560417|582376|P1|STARTED|Overall Study||171
242657|NCT00560404|582404|P2|NOT COMPLETED|Overall Study||21
242658|NCT00560404|582405|P1|NOT COMPLETED|Overall Study||36
242659|NCT00560404|582404|P2|COMPLETED|Overall Study||100
242660|NCT00560404|582405|P1|COMPLETED|Overall Study||76
242661|NCT00560404|582404|P2|STARTED|Overall Study||121
242662|NCT00560404|582405|P1|STARTED|Overall Study||112
242663|NCT00560391|582452|P5|NOT COMPLETED|Overall Study||2
242664|NCT00560391|582453|P4|NOT COMPLETED|Overall Study||1
242665|NCT00560391|582454|P3|NOT COMPLETED|Overall Study||0
242666|NCT00560391|582455|P2|NOT COMPLETED|Overall Study||0
242667|NCT00560391|582456|P1|NOT COMPLETED|Overall Study||0
242668|NCT00560391|582452|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
242669|NCT00560391|582453|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
242670|NCT00560391|582454|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
242671|NCT00560391|582455|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
242672|NCT00560391|582456|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
242673|NCT00560391|582452|P5|STARTED|Overall Study|Participants who received treatment|17
242674|NCT00560391|582453|P4|STARTED|Overall Study|Participants who received treatment|6
242675|NCT00560391|582454|P3|STARTED|Overall Study|Participants who received treatment|3
242676|NCT00560391|582455|P2|STARTED|Overall Study|Participants who received treatment|3
242677|NCT00560391|582456|P1|STARTED|Overall Study|Participants who received treatment|6
242678|NCT00560352|582512|P3|NOT COMPLETED|Overall Study||4
242679|NCT00560352|582513|P2|NOT COMPLETED|Overall Study||3
242680|NCT00560352|582514|P1|NOT COMPLETED|Overall Study||7
242681|NCT00560352|582512|P3|COMPLETED|Overall Study||0
242682|NCT00560352|582513|P2|COMPLETED|Overall Study||0
242683|NCT00560352|582514|P1|COMPLETED|Overall Study||0
242684|NCT00560352|582512|P3|STARTED|Overall Study||4
242685|NCT00560352|582513|P2|STARTED|Overall Study||3
242686|NCT00560352|582514|P1|STARTED|Overall Study||7
242687|NCT00560313|582531|P1|NOT COMPLETED|Overall Study||6
242688|NCT00560313|582531|P1|COMPLETED|Overall Study||48
242689|NCT00560313|582531|P1|STARTED|Overall Study||54
242690|NCT00560235|582558|P3|NOT COMPLETED|Phase 2||97
242691|NCT00560235|582559|P2|NOT COMPLETED|Phase 2||0
242692|NCT00560235|582560|P1|NOT COMPLETED|Phase 2||0
242693|NCT00560235|582558|P3|COMPLETED|Phase 2||10
242694|NCT00560235|582559|P2|COMPLETED|Phase 2||0
242695|NCT00560235|582560|P1|COMPLETED|Phase 2||0
242696|NCT00560235|582558|P3|STARTED|Phase 2||107
242697|NCT00560235|582559|P2|STARTED|Phase 2||0
242698|NCT00560235|582560|P1|STARTED|Phase 2||0
242699|NCT00560235|582558|P3|NOT COMPLETED|Phase 1B||0
242700|NCT00560235|582559|P2|NOT COMPLETED|Phase 1B||19
242701|NCT00560235|582560|P1|NOT COMPLETED|Phase 1B||0
242702|NCT00560235|582558|P3|COMPLETED|Phase 1B||0
242703|NCT00560235|582559|P2|COMPLETED|Phase 1B||2
242704|NCT00560235|582560|P1|COMPLETED|Phase 1B||0
242705|NCT00560235|582558|P3|STARTED|Phase 1B||0
242706|NCT00560235|582559|P2|STARTED|Phase 1B||21
242707|NCT00560235|582560|P1|STARTED|Phase 1B||0
242708|NCT00560235|582558|P3|NOT COMPLETED|Phase 1||0
242709|NCT00560235|582559|P2|NOT COMPLETED|Phase 1||0
242710|NCT00560235|582560|P1|NOT COMPLETED|Phase 1||8
242711|NCT00560235|582558|P3|COMPLETED|Phase 1||0
242712|NCT00560235|582559|P2|COMPLETED|Phase 1||0
242713|NCT00560235|582560|P1|COMPLETED|Phase 1||2
242714|NCT00560235|582558|P3|STARTED|Phase 1||0
242715|NCT00560235|582559|P2|STARTED|Phase 1||0
242716|NCT00560235|582560|P1|STARTED|Phase 1||10
242717|NCT00560105|582591|P2|NOT COMPLETED|Overall Study||2
242718|NCT00560105|582592|P1|NOT COMPLETED|Overall Study||1
242719|NCT00560105|582591|P2|COMPLETED|Overall Study||18
242720|NCT00560105|582592|P1|COMPLETED|Overall Study||19
242721|NCT00560105|582591|P2|STARTED|Overall Study||20
242722|NCT00560105|582592|P1|STARTED|Overall Study||20
242723|NCT00560066|582606|P2|NOT COMPLETED|Overall Study||22
242724|NCT00560066|582607|P1|NOT COMPLETED|Overall Study||6
242726|NCT00560066|582607|P1|COMPLETED|Overall Study||390
242727|NCT00560066|582606|P2|STARTED|Overall Study||1002
242728|NCT00560066|582607|P1|STARTED|Overall Study||396
242729|NCT00559988|582639|P2|NOT COMPLETED|Overall Study||352
242730|NCT00559988|582640|P1|NOT COMPLETED|Overall Study||351
242731|NCT00559988|582639|P2|COMPLETED|Overall Study||1009
242732|NCT00559988|582640|P1|COMPLETED|Overall Study||1006
242733|NCT00559988|582639|P2|STARTED|Overall Study||1361
242734|NCT00559988|582640|P1|STARTED|Overall Study||1357
242735|NCT00559962|582670|P8|NOT COMPLETED|Overall Study||4
242736|NCT00559962|582671|P7|NOT COMPLETED|Overall Study||5
242737|NCT00559962|582672|P6|NOT COMPLETED|Overall Study||5
242738|NCT00559962|582673|P5|NOT COMPLETED|Overall Study||14
242739|NCT00559962|582674|P4|NOT COMPLETED|Overall Study||5
242740|NCT00559962|582675|P3|NOT COMPLETED|Overall Study||10
242741|NCT00559962|582676|P2|NOT COMPLETED|Overall Study||9
242742|NCT00559962|582677|P1|NOT COMPLETED|Overall Study||2
242743|NCT00559962|582670|P8|COMPLETED|Overall Study||25
242744|NCT00559962|582671|P7|COMPLETED|Overall Study||28
242745|NCT00559962|582672|P6|COMPLETED|Overall Study||23
242746|NCT00559962|582673|P5|COMPLETED|Overall Study||21
242747|NCT00559962|582674|P4|COMPLETED|Overall Study||29
242748|NCT00559962|582675|P3|COMPLETED|Overall Study||24
242749|NCT00559962|582676|P2|COMPLETED|Overall Study||25
242750|NCT00559962|582677|P1|COMPLETED|Overall Study||31
242751|NCT00559962|582670|P8|STARTED|Overall Study||29
242752|NCT00559962|582671|P7|STARTED|Overall Study||33
242753|NCT00559962|582672|P6|STARTED|Overall Study||28
242754|NCT00559962|582673|P5|STARTED|Overall Study||35
242755|NCT00559962|582674|P4|STARTED|Overall Study||34
242756|NCT00559962|582675|P3|STARTED|Overall Study||34
242757|NCT00559962|582676|P2|STARTED|Overall Study||34
242758|NCT00559962|582677|P1|STARTED|Overall Study||33
242759|NCT00559949|582697|P1|NOT COMPLETED|Overall Study||7
242760|NCT00559949|582697|P1|COMPLETED|Overall Study||32
242761|NCT00559949|582697|P1|STARTED|Overall Study||39
242762|NCT00559936|582704|P1|NOT COMPLETED|Overall Study||4
242763|NCT00559936|582704|P1|COMPLETED|Overall Study||20
242764|NCT00559936|582704|P1|STARTED|Overall Study||24
242765|NCT00559897|582709|P1|NOT COMPLETED|Overall Study||0
242766|NCT00559897|582709|P1|COMPLETED|Overall Study||6
242767|NCT00559897|582709|P1|STARTED|Overall Study||6
242768|NCT00559845|582713|P1|NOT COMPLETED|Overall Study||7
242769|NCT00559845|582713|P1|COMPLETED|Overall Study||49
242770|NCT00559845|582713|P1|STARTED|Overall Study||56
242771|NCT00559754|582722|P1|NOT COMPLETED|Overall Study||11
242772|NCT00559754|582722|P1|COMPLETED|Overall Study||61
242773|NCT00559754|582722|P1|STARTED|Overall Study||72
242774|NCT00559637|582746|P1|NOT COMPLETED|Overall Study||54
242775|NCT00559637|582746|P1|COMPLETED|Overall Study||130
242776|NCT00559637|582746|P1|STARTED|Overall Study||184
242777|NCT00559585|582759|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
242778|NCT00559585|582760|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
242779|NCT00559585|582759|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
242780|NCT00559585|582760|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
242781|NCT00559585|582759|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
242782|NCT00559585|582760|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
242783|NCT00559585|582759|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
242784|NCT00559585|582760|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
242785|NCT00559585|582759|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
242786|NCT00559585|582760|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
242787|NCT00559585|582759|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
242788|NCT00559585|582760|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
242789|NCT00559585|582759|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
242790|NCT00559585|582760|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
242791|NCT00559585|582759|P2|COMPLETED|Double Blind ST Period Main Study||676
242792|NCT00559585|582760|P1|COMPLETED|Double Blind ST Period Main Study||693
242793|NCT00559585|582759|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
242794|NCT00559585|582760|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
242795|NCT00559507|582820|P1|NOT COMPLETED|Overall Study||3
242796|NCT00559507|582820|P1|COMPLETED|Overall Study||9
242797|NCT00559507|582820|P1|STARTED|Overall Study||12
242798|NCT00559377|582826|P1|NOT COMPLETED|Overall Study||9
242799|NCT00559377|582826|P1|COMPLETED|Overall Study||7
242800|NCT00559377|582826|P1|STARTED|Overall Study||16
242801|NCT00559364|582836|P2|NOT COMPLETED|Overall Study||0
242802|NCT00559364|582837|P1|NOT COMPLETED|Overall Study||1
242803|NCT00559364|582836|P2|COMPLETED|Overall Study||20
242804|NCT00559364|582837|P1|COMPLETED|Overall Study||29
242805|NCT00559364|582836|P2|STARTED|Overall Study||20
242806|NCT00559364|582837|P1|STARTED|Overall Study||30
242807|NCT00559273|582849|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
242808|NCT00559273|582850|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
242809|NCT00559273|582849|P2|COMPLETED|Evaluation Period (8 Weeks)||137
242810|NCT00559273|582850|P1|COMPLETED|Evaluation Period (8 Weeks)||141
242811|NCT00559273|582849|P2|STARTED|Evaluation Period (8 Weeks)||142
242812|NCT00559273|582850|P1|STARTED|Evaluation Period (8 Weeks)||144
242813|NCT00559273|582849|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
242814|NCT00559273|582850|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
242815|NCT00559273|582849|P2|COMPLETED|Correction Period (20 Weeks)||142
242816|NCT00559273|582850|P1|COMPLETED|Correction Period (20 Weeks)||144
242817|NCT00559273|582849|P2|Treated|Correction Period (20 Weeks)||154
242818|NCT00559273|582850|P1|Treated|Correction Period (20 Weeks)||151
242819|NCT00559273|582849|P2|STARTED|Correction Period (20 Weeks)||154
242820|NCT00559273|582850|P1|STARTED|Correction Period (20 Weeks)||153
242821|NCT00559104|582872|P2|NOT COMPLETED|Overall Study||0
242822|NCT00559104|582873|P1|NOT COMPLETED|Overall Study||9
242823|NCT00559104|582872|P2|COMPLETED|Overall Study||5
242824|NCT00559104|582873|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
242825|NCT00559104|582872|P2|STARTED|Overall Study||5
242826|NCT00559104|582873|P1|STARTED|Overall Study||55
242827|NCT00559013|582883|P1|NOT COMPLETED|Overall Study||0
242828|NCT00559013|582883|P1|COMPLETED|Overall Study||38
242829|NCT00559013|582883|P1|STARTED|Overall Study||38
242830|NCT00558896|582894|P7|NOT COMPLETED|Overall Study||24
242831|NCT00558896|582895|P6|NOT COMPLETED|Overall Study||52
242832|NCT00558896|582896|P5|NOT COMPLETED|Overall Study||23
242833|NCT00558896|582897|P4|NOT COMPLETED|Overall Study||12
242834|NCT00558896|582898|P3|NOT COMPLETED|Overall Study||5
242835|NCT00558896|582899|P2|NOT COMPLETED|Overall Study||7
242836|NCT00558896|582900|P1|NOT COMPLETED|Overall Study||21
242837|NCT00558896|582894|P7|COMPLETED|Overall Study||9
242838|NCT00558896|582895|P6|COMPLETED|Overall Study||68
242839|NCT00558896|582896|P5|COMPLETED|Overall Study||37
242840|NCT00558896|582897|P4|COMPLETED|Overall Study||23
242841|NCT00558896|582898|P3|COMPLETED|Overall Study||30
242842|NCT00558896|582899|P2|COMPLETED|Overall Study||27
242843|NCT00558896|582900|P1|COMPLETED|Overall Study||39
242844|NCT00558896|582894|P7|STARTED|Overall Study||33
242845|NCT00558896|582895|P6|STARTED|Overall Study||120
242846|NCT00558896|582896|P5|STARTED|Overall Study||60
242847|NCT00558896|582897|P4|STARTED|Overall Study||35
242848|NCT00558896|582898|P3|STARTED|Overall Study||35
242849|NCT00558896|582899|P2|STARTED|Overall Study||34
242850|NCT00558896|582900|P1|STARTED|Overall Study||60
242851|NCT00558870|582932|P2|NOT COMPLETED|Overall Study||0
242852|NCT00558870|582933|P1|NOT COMPLETED|Overall Study||0
242853|NCT00558870|582932|P2|COMPLETED|Overall Study||2
242854|NCT00558870|582933|P1|COMPLETED|Overall Study||2
242855|NCT00558870|582932|P2|STARTED|Overall Study||2
242856|NCT00558870|582933|P1|STARTED|Overall Study||2
242857|NCT00558831|582941|P1|NOT COMPLETED|Overall Study||1
242858|NCT00558831|582941|P1|COMPLETED|Overall Study||10
242859|NCT00558831|582941|P1|STARTED|Overall Study||11
242860|NCT00558792|582950|P3|NOT COMPLETED|Overall Study||0
242861|NCT00558792|582951|P2|NOT COMPLETED|Overall Study||0
242862|NCT00558792|582952|P1|NOT COMPLETED|Overall Study||0
242863|NCT00558792|582950|P3|COMPLETED|Overall Study||60
242864|NCT00558792|582951|P2|COMPLETED|Overall Study||63
242865|NCT00558792|582952|P1|COMPLETED|Overall Study||68
242866|NCT00558792|582950|P3|STARTED|Overall Study||60
242867|NCT00558792|582951|P2|STARTED|Overall Study||63
242868|NCT00558792|582952|P1|STARTED|Overall Study||68
242869|NCT00558753|582998|P2|NOT COMPLETED|Overall Study||7
242870|NCT00558753|582999|P1|NOT COMPLETED|Overall Study||5
242871|NCT00558753|582998|P2|COMPLETED|Overall Study||113
242872|NCT00558753|582999|P1|COMPLETED|Overall Study||115
242873|NCT00558753|582998|P2|STARTED|Overall Study||120
242874|NCT00558753|582999|P1|STARTED|Overall Study||120
242875|NCT00558701|583011|P2|NOT COMPLETED|Overall Study||4
242876|NCT00558701|583012|P1|NOT COMPLETED|Overall Study||1
242877|NCT00558701|583011|P2|COMPLETED|Overall Study||11
242878|NCT00558701|583012|P1|COMPLETED|Overall Study||14
242879|NCT00558701|583011|P2|STARTED|Overall Study||15
242880|NCT00558701|583012|P1|STARTED|Overall Study||15
242881|NCT00558636|583020|P2|NOT COMPLETED|Follow-up||7
242882|NCT00558636|583021|P1|NOT COMPLETED|Follow-up||12
242883|NCT00558636|583020|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
242884|NCT00558636|583021|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
242885|NCT00558636|583020|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
242886|NCT00558636|583021|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
242887|NCT00558636|583020|P2|NOT COMPLETED|Treatment||44
242888|NCT00558636|583021|P1|NOT COMPLETED|Treatment||47
242889|NCT00558636|583020|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
242890|NCT00558636|583021|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
242891|NCT00558636|583020|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
242892|NCT00558636|583021|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
242893|NCT00558636|583020|P2|STARTED|Treatment||44
242894|NCT00558636|583021|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
242895|NCT00558571|583043|P4|NOT COMPLETED|Overall Study||0
242896|NCT00558571|583044|P3|NOT COMPLETED|Overall Study||0
242897|NCT00558571|583045|P2|NOT COMPLETED|Overall Study||0
242898|NCT00558571|583046|P1|NOT COMPLETED|Overall Study||0
242899|NCT00558571|583043|P4|COMPLETED|Overall Study||30
242900|NCT00558571|583044|P3|COMPLETED|Overall Study||16
242901|NCT00558571|583045|P2|COMPLETED|Overall Study||16
242902|NCT00558571|583046|P1|COMPLETED|Overall Study||16
242903|NCT00558571|583043|P4|STARTED|Overall Study||30
242904|NCT00558571|583044|P3|STARTED|Overall Study||16
242905|NCT00558571|583045|P2|STARTED|Overall Study||16
242906|NCT00558571|583046|P1|STARTED|Overall Study||16
242907|NCT00558558|583121|P1|NOT COMPLETED|Overall Study||6
242908|NCT00558558|583121|P1|COMPLETED|Overall Study||0
242909|NCT00558558|583121|P1|STARTED|Overall Study||6
242910|NCT00558467|583127|P2|NOT COMPLETED|Overall Study||4
242911|NCT00558467|583128|P1|NOT COMPLETED|Overall Study||1
242912|NCT00558467|583127|P2|COMPLETED|Overall Study||39
242913|NCT00558467|583128|P1|COMPLETED|Overall Study||19
242914|NCT00558467|583127|P2|STARTED|Overall Study||43
242915|NCT00558467|583128|P1|STARTED|Overall Study||20
242916|NCT00558428|583188|P4|NOT COMPLETED|Overall Study||11
242917|NCT00558428|583189|P3|NOT COMPLETED|Overall Study||4
242918|NCT00558428|583190|P2|NOT COMPLETED|Overall Study||24
242919|NCT00558428|583191|P1|NOT COMPLETED|Overall Study||12
242920|NCT00558428|583188|P4|COMPLETED|Overall Study||266
242921|NCT00558428|583189|P3|COMPLETED|Overall Study||273
242922|NCT00558428|583190|P2|COMPLETED|Overall Study||252
242923|NCT00558428|583191|P1|COMPLETED|Overall Study||255
242924|NCT00558428|583188|P4|STARTED|Overall Study||277
242925|NCT00558428|583189|P3|STARTED|Overall Study||277
242926|NCT00558428|583190|P2|STARTED|Overall Study||276
242927|NCT00558428|583191|P1|STARTED|Overall Study||267
242928|NCT00558363|583231|P2|NOT COMPLETED|Overall Study||36
242929|NCT00558363|583232|P1|NOT COMPLETED|Overall Study||71
242930|NCT00558363|583231|P2|COMPLETED|Overall Study||111
242931|NCT00558363|583232|P1|COMPLETED|Overall Study||76
242932|NCT00558363|583231|P2|STARTED|Overall Study||147
242933|NCT00558363|583232|P1|STARTED|Overall Study||147
242934|NCT00558285|583287|P5|NOT COMPLETED|Overall Study||4
242935|NCT00558285|583288|P4|NOT COMPLETED|Overall Study||4
242936|NCT00558285|583289|P3|NOT COMPLETED|Overall Study||5
242937|NCT00558285|583290|P2|NOT COMPLETED|Overall Study||3
242938|NCT00558285|583291|P1|NOT COMPLETED|Overall Study||6
242939|NCT00558285|583287|P5|COMPLETED|Overall Study||49
242940|NCT00558285|583288|P4|COMPLETED|Overall Study||48
242941|NCT00558285|583289|P3|COMPLETED|Overall Study||46
242942|NCT00558285|583290|P2|COMPLETED|Overall Study||48
242943|NCT00558285|583291|P1|COMPLETED|Overall Study||44
242944|NCT00558285|583287|P5|Safety: Received Study Drug|Overall Study||53
242945|NCT00558285|583288|P4|Safety: Received Study Drug|Overall Study||51
242946|NCT00558285|583289|P3|Safety: Received Study Drug|Overall Study||51
242947|NCT00558285|583290|P2|Safety: Received Study Drug|Overall Study||51
242948|NCT00558285|583291|P1|Safety: Received Study Drug|Overall Study||49
242949|NCT00558285|583287|P5|STARTED|Overall Study||53
242950|NCT00558285|583288|P4|STARTED|Overall Study||52
242951|NCT00558285|583289|P3|STARTED|Overall Study||51
242952|NCT00558285|583290|P2|STARTED|Overall Study||51
242953|NCT00558285|583291|P1|STARTED|Overall Study||50
242954|NCT00558272|583335|P2|NOT COMPLETED|Overall Study||2
242955|NCT00558272|583336|P1|NOT COMPLETED|Overall Study||13
242956|NCT00558272|583335|P2|COMPLETED|Overall Study|4-week treatment period|68
242957|NCT00558272|583336|P1|COMPLETED|Overall Study|4-week treatment period|56
242958|NCT00558272|583335|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
242959|NCT00558272|583336|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
242960|NCT00558272|583335|P2|STARTED|Overall Study|Randomised|70
242961|NCT00558272|583336|P1|STARTED|Overall Study|Randomised|69
242962|NCT00558259|583376|P2|NOT COMPLETED|Overall Study||99
242963|NCT00558259|583377|P1|NOT COMPLETED|Overall Study||71
242964|NCT00558259|583376|P2|COMPLETED|Overall Study|Completed treatment.|563
242965|NCT00558259|583377|P1|COMPLETED|Overall Study|Completed treatment.|610
242966|NCT00558259|583376|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
242967|NCT00558259|583377|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
242968|NCT00558246|583397|P1|NOT COMPLETED|Overall Study||0
242969|NCT00558246|583397|P1|COMPLETED|Overall Study||79
242970|NCT00558246|583397|P1|STARTED|Overall Study||79
242971|NCT00558103|583417|P6|NOT COMPLETED|Monotherapy Extension Phase||9
242972|NCT00558103|583418|P5|NOT COMPLETED|Monotherapy Extension Phase||0
242973|NCT00558103|583419|P4|NOT COMPLETED|Monotherapy Extension Phase||0
242974|NCT00558103|583420|P3|NOT COMPLETED|Monotherapy Extension Phase||0
242975|NCT00558103|583421|P2|NOT COMPLETED|Monotherapy Extension Phase||0
242976|NCT00558103|583422|P1|NOT COMPLETED|Monotherapy Extension Phase||0
242977|NCT00558103|583417|P6|COMPLETED|Monotherapy Extension Phase||0
242978|NCT00558103|583418|P5|COMPLETED|Monotherapy Extension Phase||0
242979|NCT00558103|583419|P4|COMPLETED|Monotherapy Extension Phase||0
242980|NCT00558103|583420|P3|COMPLETED|Monotherapy Extension Phase||0
242981|NCT00558103|583421|P2|COMPLETED|Monotherapy Extension Phase||0
242982|NCT00558103|583422|P1|COMPLETED|Monotherapy Extension Phase||0
242983|NCT00558103|583417|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
242984|NCT00558103|583418|P5|STARTED|Monotherapy Extension Phase||0
242985|NCT00558103|583419|P4|STARTED|Monotherapy Extension Phase||0
242986|NCT00558103|583420|P3|STARTED|Monotherapy Extension Phase||0
242987|NCT00558103|583421|P2|STARTED|Monotherapy Extension Phase||0
242988|NCT00558103|583422|P1|STARTED|Monotherapy Extension Phase||0
242989|NCT00558103|583417|P6|NOT COMPLETED|Randomized Treatment Phase||0
242990|NCT00558103|583418|P5|NOT COMPLETED|Randomized Treatment Phase||5
242991|NCT00558103|583419|P4|NOT COMPLETED|Randomized Treatment Phase||2
242992|NCT00558103|583420|P3|NOT COMPLETED|Randomized Treatment Phase||3
242993|NCT00558103|583421|P2|NOT COMPLETED|Randomized Treatment Phase||4
242994|NCT00558103|583422|P1|NOT COMPLETED|Randomized Treatment Phase||5
242995|NCT00558103|583417|P6|COMPLETED|Randomized Treatment Phase||0
242996|NCT00558103|583418|P5|COMPLETED|Randomized Treatment Phase||33
242997|NCT00558103|583419|P4|COMPLETED|Randomized Treatment Phase||11
242998|NCT00558103|583420|P3|COMPLETED|Randomized Treatment Phase||33
242999|NCT00558103|583421|P2|COMPLETED|Randomized Treatment Phase||34
243000|NCT00558103|583422|P1|COMPLETED|Randomized Treatment Phase||33
243001|NCT00558103|583417|P6|STARTED|Randomized Treatment Phase||0
243002|NCT00558103|583418|P5|STARTED|Randomized Treatment Phase||38
243003|NCT00558103|583419|P4|STARTED|Randomized Treatment Phase||13
243004|NCT00558103|583420|P3|STARTED|Randomized Treatment Phase||36
243005|NCT00558103|583421|P2|STARTED|Randomized Treatment Phase||38
243006|NCT00558103|583422|P1|STARTED|Randomized Treatment Phase||38
243007|NCT00558064|583452|P2|NOT COMPLETED|Overall Study||5
243008|NCT00558064|583453|P1|NOT COMPLETED|Overall Study||5
243009|NCT00558064|583452|P2|COMPLETED|Overall Study||257
243010|NCT00558064|583453|P1|COMPLETED|Overall Study||264
243011|NCT00558064|583452|P2|STARTED|Overall Study||262
243012|NCT00558064|583453|P1|STARTED|Overall Study||269
243013|NCT00558025|583475|P2|NOT COMPLETED|Overall Study||3
243014|NCT00558025|583476|P1|NOT COMPLETED|Overall Study||4
243015|NCT00558025|583475|P2|COMPLETED|Overall Study||49
243016|NCT00558025|583476|P1|COMPLETED|Overall Study||100
243017|NCT00558025|583475|P2|STARTED|Overall Study||52
243018|NCT00558025|583476|P1|STARTED|Overall Study||104
243019|NCT00558012|583500|P2|NOT COMPLETED|Overall Study||18
243020|NCT00558012|583501|P1|NOT COMPLETED|Overall Study||25
243021|NCT00558012|583500|P2|COMPLETED|Overall Study||74
243022|NCT00558012|583501|P1|COMPLETED|Overall Study||64
243023|NCT00558012|583500|P2|STARTED|Overall Study||92
243024|NCT00558012|583501|P1|STARTED|Overall Study||89
243025|NCT00557947|583507|P1|NOT COMPLETED|Overall Study||0
243026|NCT00557947|583507|P1|COMPLETED|Overall Study||83
243027|NCT00557947|583507|P1|STARTED|Overall Study||83
243028|NCT00557856|583523|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
243029|NCT00557856|583524|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
243030|NCT00557856|583525|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
243031|NCT00557856|583526|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
243032|NCT00557856|583527|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
243033|NCT00557856|583528|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
243034|NCT00557856|583529|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
243035|NCT00557856|583530|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
243036|NCT00557856|583531|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
243037|NCT00557856|583523|P9|COMPLETED|Part 2: Exploratory Phase||0
243038|NCT00557856|583524|P8|COMPLETED|Part 2: Exploratory Phase||0
243039|NCT00557856|583525|P7|COMPLETED|Part 2: Exploratory Phase||0
243040|NCT00557856|583526|P6|COMPLETED|Part 2: Exploratory Phase||0
243041|NCT00557856|583527|P5|COMPLETED|Part 2: Exploratory Phase||0
243042|NCT00557856|583528|P4|COMPLETED|Part 2: Exploratory Phase||0
243043|NCT00557856|583529|P3|COMPLETED|Part 2: Exploratory Phase||0
243044|NCT00557856|583530|P2|COMPLETED|Part 2: Exploratory Phase||0
243045|NCT00557856|583531|P1|COMPLETED|Part 2: Exploratory Phase||0
243046|NCT00557856|583523|P9|STARTED|Part 2: Exploratory Phase||24
243047|NCT00557856|583524|P8|STARTED|Part 2: Exploratory Phase||0
243048|NCT00557856|583525|P7|STARTED|Part 2: Exploratory Phase||0
243049|NCT00557856|583526|P6|STARTED|Part 2: Exploratory Phase||0
243050|NCT00557856|583527|P5|STARTED|Part 2: Exploratory Phase||0
243051|NCT00557856|583528|P4|STARTED|Part 2: Exploratory Phase||0
243052|NCT00557856|583529|P3|STARTED|Part 2: Exploratory Phase||0
243053|NCT00557856|583530|P2|STARTED|Part 2: Exploratory Phase||0
243054|NCT00557856|583531|P1|STARTED|Part 2: Exploratory Phase||0
243055|NCT00557856|583523|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
243056|NCT00557856|583524|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
243057|NCT00557856|583525|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
243058|NCT00557856|583526|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
243059|NCT00557856|583527|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
243060|NCT00557856|583528|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
243061|NCT00557856|583529|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
243062|NCT00557856|583530|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
243063|NCT00557856|583531|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
243064|NCT00557856|583523|P9|COMPLETED|Part 1: Dose Escalation Phase||0
243065|NCT00557856|583524|P8|COMPLETED|Part 1: Dose Escalation Phase||0
243066|NCT00557856|583525|P7|COMPLETED|Part 1: Dose Escalation Phase||0
243067|NCT00557856|583526|P6|COMPLETED|Part 1: Dose Escalation Phase||0
243068|NCT00557856|583527|P5|COMPLETED|Part 1: Dose Escalation Phase||0
243069|NCT00557856|583528|P4|COMPLETED|Part 1: Dose Escalation Phase||0
243070|NCT00557856|583529|P3|COMPLETED|Part 1: Dose Escalation Phase||0
243071|NCT00557856|583530|P2|COMPLETED|Part 1: Dose Escalation Phase||0
243072|NCT00557856|583531|P1|COMPLETED|Part 1: Dose Escalation Phase||0
243073|NCT00557856|583523|P9|Treated|Part 1: Dose Escalation Phase||0
243074|NCT00557856|583524|P8|Treated|Part 1: Dose Escalation Phase||6
243075|NCT00557856|583525|P7|Treated|Part 1: Dose Escalation Phase||7
243076|NCT00557856|583526|P6|Treated|Part 1: Dose Escalation Phase||8
243077|NCT00557856|583527|P5|Treated|Part 1: Dose Escalation Phase||4
243078|NCT00557856|583528|P4|Treated|Part 1: Dose Escalation Phase||3
243079|NCT00557856|583529|P3|Treated|Part 1: Dose Escalation Phase||6
243080|NCT00557856|583530|P2|Treated|Part 1: Dose Escalation Phase||5
243081|NCT00557856|583531|P1|Treated|Part 1: Dose Escalation Phase||5
243082|NCT00557856|583523|P9|STARTED|Part 1: Dose Escalation Phase||0
243083|NCT00557856|583524|P8|STARTED|Part 1: Dose Escalation Phase||6
243084|NCT00557856|583525|P7|STARTED|Part 1: Dose Escalation Phase||7
243085|NCT00557856|583526|P6|STARTED|Part 1: Dose Escalation Phase||8
243086|NCT00557856|583527|P5|STARTED|Part 1: Dose Escalation Phase||4
243087|NCT00557856|583528|P4|STARTED|Part 1: Dose Escalation Phase||3
243088|NCT00557856|583529|P3|STARTED|Part 1: Dose Escalation Phase||6
243089|NCT00557856|583530|P2|STARTED|Part 1: Dose Escalation Phase||5
243090|NCT00557856|583531|P1|STARTED|Part 1: Dose Escalation Phase||7
243091|NCT00557830|583730|P3|NOT COMPLETED|Treatment Phase||0
243092|NCT00557830|583731|P2|NOT COMPLETED|Treatment Phase||0
243093|NCT00557830|583732|P1|NOT COMPLETED|Treatment Phase||0
243094|NCT00557830|583730|P3|COMPLETED|Treatment Phase||2
243095|NCT00557830|583731|P2|COMPLETED|Treatment Phase||4
243096|NCT00557830|583732|P1|COMPLETED|Treatment Phase||0
243097|NCT00557830|583730|P3|STARTED|Treatment Phase||2
243098|NCT00557830|583731|P2|STARTED|Treatment Phase||4
243099|NCT00557830|583732|P1|STARTED|Treatment Phase||0
243100|NCT00557830|583730|P3|NOT COMPLETED|Screening Treatment Phase||0
243101|NCT00557830|583731|P2|NOT COMPLETED|Screening Treatment Phase||0
243102|NCT00557830|583732|P1|NOT COMPLETED|Screening Treatment Phase||6
243103|NCT00557830|583730|P3|COMPLETED|Screening Treatment Phase||0
243104|NCT00557830|583731|P2|COMPLETED|Screening Treatment Phase||0
243105|NCT00557830|583732|P1|COMPLETED|Screening Treatment Phase||6
243106|NCT00557830|583730|P3|STARTED|Screening Treatment Phase||0
243107|NCT00557830|583731|P2|STARTED|Screening Treatment Phase||0
243108|NCT00557830|583732|P1|STARTED|Screening Treatment Phase||12
243109|NCT00557622|583754|P2|NOT COMPLETED|12-Week Treatment Phase||1
243110|NCT00557622|583755|P1|NOT COMPLETED|12-Week Treatment Phase||0
243111|NCT00557622|583754|P2|COMPLETED|12-Week Treatment Phase||1
243112|NCT00557622|583755|P1|COMPLETED|12-Week Treatment Phase||1
243113|NCT00557622|583754|P2|STARTED|12-Week Treatment Phase||2
243114|NCT00557622|583755|P1|STARTED|12-Week Treatment Phase||1
243115|NCT00557622|583754|P2|NOT COMPLETED|4-Week Run-in Phase||0
243116|NCT00557622|583755|P1|NOT COMPLETED|4-Week Run-in Phase||2
243117|NCT00557622|583754|P2|COMPLETED|4-Week Run-in Phase||0
243118|NCT00557622|583755|P1|COMPLETED|4-Week Run-in Phase||3
243119|NCT00557622|583754|P2|STARTED|4-Week Run-in Phase||0
243120|NCT00557622|583755|P1|STARTED|4-Week Run-in Phase||5
243121|NCT00557505|583784|P9|NOT COMPLETED|Overall Study||17
243122|NCT00557505|583785|P8|NOT COMPLETED|Overall Study||5
243123|NCT00557505|583786|P7|NOT COMPLETED|Overall Study||3
243124|NCT00557505|583787|P6|NOT COMPLETED|Overall Study||3
243125|NCT00557505|583788|P5|NOT COMPLETED|Overall Study||2
243126|NCT00557505|583789|P4|NOT COMPLETED|Overall Study||3
243127|NCT00557505|583790|P3|NOT COMPLETED|Overall Study||4
243128|NCT00557505|583791|P2|NOT COMPLETED|Overall Study||3
243129|NCT00557505|583792|P1|NOT COMPLETED|Overall Study||3
243130|NCT00557505|583784|P9|COMPLETED|Overall Study||0
243131|NCT00557505|583785|P8|COMPLETED|Overall Study||0
243132|NCT00557505|583786|P7|COMPLETED|Overall Study||0
243133|NCT00557505|583787|P6|COMPLETED|Overall Study||0
243134|NCT00557505|583788|P5|COMPLETED|Overall Study||0
243135|NCT00557505|583789|P4|COMPLETED|Overall Study||0
243136|NCT00557505|583790|P3|COMPLETED|Overall Study||0
243137|NCT00557505|583791|P2|COMPLETED|Overall Study||0
243138|NCT00557505|583792|P1|COMPLETED|Overall Study||0
243139|NCT00557505|583784|P9|STARTED|Overall Study||17
243140|NCT00557505|583785|P8|STARTED|Overall Study||5
243141|NCT00557505|583786|P7|STARTED|Overall Study||3
243142|NCT00557505|583787|P6|STARTED|Overall Study||3
243143|NCT00557505|583788|P5|STARTED|Overall Study||2
243144|NCT00557505|583789|P4|STARTED|Overall Study||3
243145|NCT00557505|583790|P3|STARTED|Overall Study||4
243146|NCT00557505|583791|P2|STARTED|Overall Study||3
243147|NCT00557505|583792|P1|STARTED|Overall Study||3
243148|NCT00557492|583956|P1|NOT COMPLETED|Overall Study||1
243149|NCT00557492|583956|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
243150|NCT00557492|583956|P1|STARTED|Overall Study||59
243151|NCT00557466|583974|P6|NOT COMPLETED|Overall Study||6
243152|NCT00557466|583975|P5|NOT COMPLETED|Overall Study||3
243153|NCT00557466|583976|P4|NOT COMPLETED|Overall Study||4
243154|NCT00557466|583977|P3|NOT COMPLETED|Overall Study||6
243155|NCT00557466|583978|P2|NOT COMPLETED|Overall Study||5
243156|NCT00557466|583979|P1|NOT COMPLETED|Overall Study||4
243157|NCT00557466|583974|P6|COMPLETED|Overall Study||85
243158|NCT00557466|583975|P5|COMPLETED|Overall Study||87
243159|NCT00557466|583976|P4|COMPLETED|Overall Study||92
243160|NCT00557466|583977|P3|COMPLETED|Overall Study||95
243161|NCT00557466|583978|P2|COMPLETED|Overall Study||87
243162|NCT00557466|583979|P1|COMPLETED|Overall Study||94
243163|NCT00557466|583974|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
243164|NCT00557466|583975|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
243165|NCT00557466|583976|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
243166|NCT00557466|583977|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
243167|NCT00557466|583978|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
243168|NCT00557466|583979|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
243169|NCT00557466|583974|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
243170|NCT00557466|583975|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
243171|NCT00557466|583976|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
243172|NCT00557466|583977|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
243173|NCT00557466|583978|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
243174|NCT00557466|583979|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
243175|NCT00557466|583974|P6|STARTED|Overall Study||91
243176|NCT00557466|583975|P5|STARTED|Overall Study||90
243177|NCT00557466|583976|P4|STARTED|Overall Study||96
243178|NCT00557466|583977|P3|STARTED|Overall Study||101
243179|NCT00557466|583978|P2|STARTED|Overall Study||92
243180|NCT00557466|583979|P1|STARTED|Overall Study||98
243181|NCT00557440|584032|P3|NOT COMPLETED|Treatment Period 3||0
243182|NCT00557440|584033|P2|NOT COMPLETED|Treatment Period 3||0
243183|NCT00557440|584034|P1|NOT COMPLETED|Treatment Period 3||0
243184|NCT00557440|584032|P3|COMPLETED|Treatment Period 3||12
243185|NCT00557440|584033|P2|COMPLETED|Treatment Period 3||12
243186|NCT00557440|584034|P1|COMPLETED|Treatment Period 3||12
243187|NCT00557440|584032|P3|STARTED|Treatment Period 3||12
243188|NCT00557440|584033|P2|STARTED|Treatment Period 3||12
243189|NCT00557440|584034|P1|STARTED|Treatment Period 3||12
243190|NCT00557440|584032|P3|NOT COMPLETED|Treatment Period 2||0
243191|NCT00557440|584033|P2|NOT COMPLETED|Treatment Period 2||0
243192|NCT00557440|584034|P1|NOT COMPLETED|Treatment Period 2||0
243193|NCT00557440|584032|P3|COMPLETED|Treatment Period 2||12
243194|NCT00557440|584033|P2|COMPLETED|Treatment Period 2||12
243195|NCT00557440|584034|P1|COMPLETED|Treatment Period 2||12
243196|NCT00557440|584032|P3|STARTED|Treatment Period 2||12
243197|NCT00557440|584033|P2|STARTED|Treatment Period 2||12
243198|NCT00557440|584034|P1|STARTED|Treatment Period 2||12
243199|NCT00557440|584032|P3|NOT COMPLETED|Treatment Period 1||1
243200|NCT00557440|584033|P2|NOT COMPLETED|Treatment Period 1||0
243201|NCT00557440|584034|P1|NOT COMPLETED|Treatment Period 1||0
243202|NCT00557440|584032|P3|COMPLETED|Treatment Period 1||12
243203|NCT00557440|584033|P2|COMPLETED|Treatment Period 1||12
243204|NCT00557440|584034|P1|COMPLETED|Treatment Period 1||12
243205|NCT00557440|584032|P3|STARTED|Treatment Period 1||13
243206|NCT00557440|584033|P2|STARTED|Treatment Period 1||12
243207|NCT00557440|584034|P1|STARTED|Treatment Period 1||12
243208|NCT00557362|584058|P4|NOT COMPLETED|Overall Study||3
243209|NCT00557362|584059|P3|NOT COMPLETED|Overall Study||4
243210|NCT00557362|584060|P2|NOT COMPLETED|Overall Study||2
243211|NCT00557362|584061|P1|NOT COMPLETED|Overall Study||2
243212|NCT00557362|584058|P4|COMPLETED|Overall Study||27
243213|NCT00557362|584059|P3|COMPLETED|Overall Study||26
243214|NCT00557362|584060|P2|COMPLETED|Overall Study||28
243215|NCT00557362|584061|P1|COMPLETED|Overall Study||28
243216|NCT00557362|584058|P4|STARTED|Overall Study||30
243217|NCT00557362|584059|P3|STARTED|Overall Study||30
243218|NCT00557362|584060|P2|STARTED|Overall Study||30
243219|NCT00557362|584061|P1|STARTED|Overall Study||30
243220|NCT00557349|584079|P2|NOT COMPLETED|Overall Study||5
243221|NCT00557349|584080|P1|NOT COMPLETED|Overall Study||5
243222|NCT00557349|584079|P2|COMPLETED|Overall Study||13
243223|NCT00557349|584080|P1|COMPLETED|Overall Study||17
243224|NCT00557349|584079|P2|STARTED|Overall Study||18
243225|NCT00557349|584080|P1|STARTED|Overall Study|omeprazole/bicarb|22
243226|NCT00557323|584088|P1|NOT COMPLETED|Overall Study||7
243227|NCT00557323|584088|P1|COMPLETED|Overall Study||27
243228|NCT00557323|584088|P1|STARTED|Overall Study||34
243229|NCT00557310|584093|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
243230|NCT00557310|584093|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
243231|NCT00557310|584093|P1|STARTED|Extension Phase (18 - 24 Months)||30
243232|NCT00557310|584093|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
243233|NCT00557310|584093|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
243234|NCT00557310|584093|P1|STARTED|Main Study (0 - 18 Months)||35
243235|NCT00557284|584115|P2|NOT COMPLETED|Overall Study||0
243236|NCT00557284|584116|P1|NOT COMPLETED|Overall Study||0
243237|NCT00557284|584115|P2|COMPLETED|Overall Study||11
243238|NCT00557284|584116|P1|COMPLETED|Overall Study||9
243239|NCT00557284|584115|P2|STARTED|Overall Study||11
243240|NCT00557284|584116|P1|STARTED|Overall Study||9
243241|NCT00557245|584139|P3|NOT COMPLETED|Overall Study||12
243242|NCT00557245|584140|P2|NOT COMPLETED|Overall Study||12
243243|NCT00557245|584141|P1|NOT COMPLETED|Overall Study||12
243244|NCT00557245|584139|P3|COMPLETED|Overall Study||1574
243245|NCT00557245|584140|P2|COMPLETED|Overall Study||1571
243246|NCT00557245|584141|P1|COMPLETED|Overall Study||1577
243247|NCT00557245|584139|P3|STARTED|Overall Study||1586
243248|NCT00557245|584140|P2|STARTED|Overall Study||1583
243249|NCT00557245|584141|P1|STARTED|Overall Study||1589
243250|NCT00557076|584181|P2|NOT COMPLETED|Overall Study||1
243251|NCT00557076|584182|P1|NOT COMPLETED|Overall Study||0
243252|NCT00557076|584181|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
243253|NCT00557076|584182|P1|COMPLETED|Overall Study||8
243254|NCT00557076|584181|P2|STARTED|Overall Study||8
243255|NCT00557076|584182|P1|STARTED|Overall Study||8
243256|NCT00556998|584190|P1|NOT COMPLETED|Voriconazole Oral||2
243257|NCT00556998|584190|P1|COMPLETED|Voriconazole Oral||20
243258|NCT00556998|584190|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
243259|NCT00556998|584190|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
243260|NCT00556998|584190|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
243261|NCT00556998|584190|P1|Treated|Voriconazole Intravenous (IV)||26
243262|NCT00556998|584190|P1|STARTED|Voriconazole Intravenous (IV)||26
243263|NCT00556972|584210|P1|NOT COMPLETED|Overall Study||0
243264|NCT00556972|584210|P1|COMPLETED|Overall Study||4
243265|NCT00556972|584210|P1|STARTED|Overall Study||4
243266|NCT00556946|584217|P1|NOT COMPLETED|Overall Study||1
243267|NCT00556946|584217|P1|COMPLETED|Overall Study||16
243268|NCT00556946|584217|P1|STARTED|Overall Study||17
243269|NCT00556933|584225|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
243270|NCT00556933|584226|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
243271|NCT00556933|584227|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
243272|NCT00556933|584228|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
243273|NCT00556933|584225|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
243274|NCT00556933|584226|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
243275|NCT00556933|584227|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
243276|NCT00556933|584228|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
243277|NCT00556933|584225|P4|STARTED|CNI Withdrawal vs. Minimization||43
243278|NCT00556933|584226|P3|STARTED|CNI Withdrawal vs. Minimization||39
243279|NCT00556933|584227|P2|STARTED|CNI Withdrawal vs. Minimization||37
243280|NCT00556933|584228|P1|STARTED|CNI Withdrawal vs. Minimization||43
243281|NCT00556933|584225|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
243282|NCT00556933|584226|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
243283|NCT00556933|584227|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
243284|NCT00556933|584228|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
243285|NCT00556933|584225|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
243286|NCT00556933|584226|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
243287|NCT00556933|584227|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
243288|NCT00556933|584228|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
243289|NCT00556933|584225|P4|STARTED|Single vs. Divided-dose rATG Induction||45
243290|NCT00556933|584226|P3|STARTED|Single vs. Divided-dose rATG Induction||45
243291|NCT00556933|584227|P2|STARTED|Single vs. Divided-dose rATG Induction||45
243292|NCT00556933|584228|P1|STARTED|Single vs. Divided-dose rATG Induction||45
243293|NCT00556894|584285|P3|NOT COMPLETED|Overall Study||19
243294|NCT00556894|584286|P2|NOT COMPLETED|Overall Study||19
243295|NCT00556894|584287|P1|NOT COMPLETED|Overall Study||16
243296|NCT00556894|584285|P3|COMPLETED|Overall Study||65
243297|NCT00556894|584286|P2|COMPLETED|Overall Study||68
243298|NCT00556894|584287|P1|COMPLETED|Overall Study||66
243299|NCT00556894|584285|P3|STARTED|Overall Study||84
243300|NCT00556894|584286|P2|STARTED|Overall Study||87
243301|NCT00556894|584287|P1|STARTED|Overall Study||82
243302|NCT00556712|584297|P2|NOT COMPLETED|Overall Study||438
243303|NCT00556712|584298|P1|NOT COMPLETED|Overall Study||451
243304|NCT00556712|584297|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
243305|NCT00556712|584298|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
243306|NCT00556712|584297|P2|STARTED|Overall Study||438
243307|NCT00556712|584298|P1|STARTED|Overall Study||451
243308|NCT00556673|584376|P2|NOT COMPLETED|Overall Study||2
243309|NCT00556673|584377|P1|NOT COMPLETED|Overall Study||3
243310|NCT00556673|584376|P2|COMPLETED|Overall Study||13
243311|NCT00556673|584377|P1|COMPLETED|Overall Study||13
243312|NCT00556673|584376|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
243313|NCT00556673|584377|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
243314|NCT00556673|584376|P2|STARTED|Overall Study||15
243315|NCT00556673|584377|P1|STARTED|Overall Study||16
243316|NCT00556543|584413|P1|NOT COMPLETED|Overall Study||0
243317|NCT00556543|584413|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
243318|NCT00556543|584413|P1|STARTED|Overall Study||10
243319|NCT00556504|584431|P2|NOT COMPLETED|Overall Study||9
243320|NCT00556504|584432|P1|NOT COMPLETED|Overall Study||8
243321|NCT00556504|584431|P2|COMPLETED|Overall Study||33
243322|NCT00556504|584432|P1|COMPLETED|Overall Study||34
243323|NCT00556504|584431|P2|Safety Population|Overall Study||42
243324|NCT00556504|584432|P1|Safety Population|Overall Study||41
243325|NCT00556504|584431|P2|Intend-to Treat Population|Overall Study||42
243326|NCT00556504|584432|P1|Intend-to Treat Population|Overall Study||42
243327|NCT00556504|584431|P2|STARTED|Overall Study||42
243328|NCT00556504|584432|P1|STARTED|Overall Study||42
243329|NCT00556491|584452|P2|NOT COMPLETED|Overall Study||1
243330|NCT00556491|584453|P1|NOT COMPLETED|Overall Study||1
243331|NCT00556491|584452|P2|COMPLETED|Overall Study||19
243332|NCT00556491|584453|P1|COMPLETED|Overall Study||19
243333|NCT00556491|584452|P2|STARTED|Overall Study||20
243334|NCT00556491|584453|P1|STARTED|Overall Study|January 2008|20
243335|NCT00556478|584471|P2|NOT COMPLETED|Open-Label Phase||10
243336|NCT00556478|584472|P1|NOT COMPLETED|Open-Label Phase||14
243337|NCT00556478|584471|P2|COMPLETED|Open-Label Phase||67
243338|NCT00556478|584472|P1|COMPLETED|Open-Label Phase||132
243339|NCT00556478|584471|P2|Treated in Open-label|Open-Label Phase||71
243340|NCT00556478|584472|P1|Treated in Open-label|Open-Label Phase||142
243341|NCT00556478|584471|P2|STARTED|Open-Label Phase||77
243342|NCT00556478|584472|P1|STARTED|Open-Label Phase||146
243343|NCT00556478|584471|P2|NOT COMPLETED|Double-blind Phase||8
243344|NCT00556478|584472|P1|NOT COMPLETED|Double-blind Phase||21
243345|NCT00556478|584471|P2|COMPLETED|Double-blind Phase||77
243346|NCT00556478|584472|P1|COMPLETED|Double-blind Phase||150
243347|NCT00556478|584471|P2|ITT|Double-blind Phase||82
243348|NCT00556478|584472|P1|ITT|Double-blind Phase||167
243349|NCT00556478|584471|P2|STARTED|Double-blind Phase||85
243350|NCT00556478|584472|P1|STARTED|Double-blind Phase||171
243351|NCT00556452|584500|P3|NOT COMPLETED|Overall Study||0
243352|NCT00556452|584501|P2|NOT COMPLETED|Overall Study||0
243353|NCT00556452|584502|P1|NOT COMPLETED|Overall Study||0
243354|NCT00556452|584500|P3|COMPLETED|Overall Study||19
243355|NCT00556452|584501|P2|COMPLETED|Overall Study||21
243356|NCT00556452|584502|P1|COMPLETED|Overall Study||6
243357|NCT00556452|584500|P3|STARTED|Overall Study||19
243358|NCT00556452|584501|P2|STARTED|Overall Study||21
243359|NCT00556452|584502|P1|STARTED|Overall Study||6
243360|NCT00556439|584513|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
243361|NCT00556439|584514|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
243362|NCT00556439|584515|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
243363|NCT00556439|584516|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
243364|NCT00556439|584513|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
243365|NCT00556439|584514|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
243366|NCT00556439|584515|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
243367|NCT00556439|584516|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
243368|NCT00556439|584513|P4|STARTED|After Week 12 (Randomized Study Period)||15
243369|NCT00556439|584514|P3|STARTED|After Week 12 (Randomized Study Period)||11
243370|NCT00556439|584515|P2|STARTED|After Week 12 (Randomized Study Period)||21
243371|NCT00556439|584516|P1|STARTED|After Week 12 (Randomized Study Period)||20
243372|NCT00556439|584513|P4|NOT COMPLETED|Study Entry to Week 12||0
243373|NCT00556439|584514|P3|NOT COMPLETED|Study Entry to Week 12||8
243374|NCT00556439|584515|P2|NOT COMPLETED|Study Entry to Week 12||0
243375|NCT00556439|584516|P1|NOT COMPLETED|Study Entry to Week 12||8
243376|NCT00556439|584513|P4|COMPLETED|Study Entry to Week 12||0
243377|NCT00556439|584514|P3|COMPLETED|Study Entry to Week 12||26
243378|NCT00556439|584515|P2|COMPLETED|Study Entry to Week 12||0
243379|NCT00556439|584516|P1|COMPLETED|Study Entry to Week 12||41
243380|NCT00556439|584513|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
243381|NCT00556439|584514|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
243382|NCT00556439|584515|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
243383|NCT00556439|584516|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
243384|NCT00556426|584526|P1|NOT COMPLETED|Overall Study||9
243385|NCT00556426|584526|P1|COMPLETED|Overall Study||91
243386|NCT00556426|584526|P1|STARTED|Overall Study||100
243387|NCT00556400|584536|P2|NOT COMPLETED|Overall Study||0
243388|NCT00556400|584537|P1|NOT COMPLETED|Overall Study||0
243389|NCT00556400|584536|P2|COMPLETED|Overall Study||0
243390|NCT00556400|584537|P1|COMPLETED|Overall Study||1
243391|NCT00556400|584536|P2|STARTED|Overall Study||0
243392|NCT00556400|584537|P1|STARTED|Overall Study||1
243393|NCT00556374|584548|P2|NOT COMPLETED|Overall Study||220
243394|NCT00556374|584549|P1|NOT COMPLETED|Overall Study||247
243395|NCT00556374|584548|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
243396|NCT00556374|584549|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
243397|NCT00556374|584548|P2|Received Study Drug|Overall Study||1700
243398|NCT00556374|584549|P1|Received Study Drug|Overall Study||1699
243399|NCT00556374|584548|P2|STARTED|Overall Study||1711
243400|NCT00556374|584549|P1|STARTED|Overall Study||1709
243401|NCT00556322|584567|P2|NOT COMPLETED|Overall Study||203
243402|NCT00556322|584568|P1|NOT COMPLETED|Overall Study||221
243403|NCT00556322|584567|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
243404|NCT00556322|584568|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
243405|NCT00556322|584567|P2|STARTED|Overall Study||203
243406|NCT00556322|584568|P1|STARTED|Overall Study||221
243407|NCT00556166|584616|P1|NOT COMPLETED|Overall Study||1
243408|NCT00556166|584616|P1|COMPLETED|Overall Study||3
243409|NCT00556166|584616|P1|STARTED|Overall Study||4
243410|NCT00556140|584621|P1|NOT COMPLETED|Overall Study||3
243411|NCT00556140|584621|P1|COMPLETED|Overall Study||13
243412|NCT00556140|584621|P1|STARTED|Overall Study||16
243413|NCT00556075|584629|P3|NOT COMPLETED|Overall Study||8
243414|NCT00556075|584630|P2|NOT COMPLETED|Overall Study||9
243415|NCT00556075|584631|P1|NOT COMPLETED|Overall Study||13
243416|NCT00556075|584629|P3|COMPLETED|Overall Study||15
243417|NCT00556075|584630|P2|COMPLETED|Overall Study||13
243418|NCT00556075|584631|P1|COMPLETED|Overall Study||9
243419|NCT00556075|584629|P3|STARTED|Overall Study||23
243420|NCT00556075|584630|P2|STARTED|Overall Study||22
243421|NCT00556075|584631|P1|STARTED|Overall Study||22
243422|NCT00556049|584654|P1|NOT COMPLETED|Overall Study||0
243423|NCT00556049|584654|P1|COMPLETED|Overall Study||72
243424|NCT00556049|584654|P1|STARTED|Overall Study||72
243425|NCT00555997|584661|P4|NOT COMPLETED|Phase 2 SPCD||3
243426|NCT00555997|584662|P3|NOT COMPLETED|Phase 2 SPCD||7
243427|NCT00555997|584663|P2|NOT COMPLETED|Phase 2 SPCD||0
243428|NCT00555997|584664|P1|NOT COMPLETED|Phase 2 SPCD||0
243429|NCT00555997|584661|P4|COMPLETED|Phase 2 SPCD||22
243430|NCT00555997|584662|P3|COMPLETED|Phase 2 SPCD||31
243431|NCT00555997|584663|P2|COMPLETED|Phase 2 SPCD||0
243432|NCT00555997|584664|P1|COMPLETED|Phase 2 SPCD||0
243433|NCT00555997|584661|P4|STARTED|Phase 2 SPCD||25
243434|NCT00555997|584662|P3|STARTED|Phase 2 SPCD||38
243435|NCT00555997|584663|P2|STARTED|Phase 2 SPCD||0
243436|NCT00555997|584664|P1|STARTED|Phase 2 SPCD||0
243437|NCT00555997|584661|P4|NOT COMPLETED|Phase 1 SPCD||0
243438|NCT00555997|584662|P3|NOT COMPLETED|Phase 1 SPCD||0
243439|NCT00555997|584663|P2|NOT COMPLETED|Phase 1 SPCD||15
243440|NCT00555997|584664|P1|NOT COMPLETED|Phase 1 SPCD||12
243441|NCT00555997|584661|P4|COMPLETED|Phase 1 SPCD||0
243442|NCT00555997|584662|P3|COMPLETED|Phase 1 SPCD||0
243443|NCT00555997|584663|P2|COMPLETED|Phase 1 SPCD||76
243444|NCT00555997|584664|P1|COMPLETED|Phase 1 SPCD||17
243445|NCT00555997|584661|P4|STARTED|Phase 1 SPCD||0
243446|NCT00555997|584662|P3|STARTED|Phase 1 SPCD||0
243447|NCT00555997|584663|P2|STARTED|Phase 1 SPCD||91
243448|NCT00555997|584664|P1|STARTED|Phase 1 SPCD||29
243449|NCT00555906|584683|P5|NOT COMPLETED|Phase 2||32
243450|NCT00555906|584684|P4|NOT COMPLETED|Phase 2||0
243451|NCT00555906|584685|P3|NOT COMPLETED|Phase 2||0
243452|NCT00555906|584686|P2|NOT COMPLETED|Phase 2||0
243453|NCT00555906|584687|P1|NOT COMPLETED|Phase 2||0
243454|NCT00555906|584683|P5|COMPLETED|Phase 2||0
243455|NCT00555906|584684|P4|COMPLETED|Phase 2||0
243456|NCT00555906|584685|P3|COMPLETED|Phase 2||0
243457|NCT00555906|584686|P2|COMPLETED|Phase 2||0
243458|NCT00555906|584687|P1|COMPLETED|Phase 2||0
243459|NCT00555906|584683|P5|Treated|Phase 2||30
243460|NCT00555906|584684|P4|Treated|Phase 2||0
243461|NCT00555906|584685|P3|Treated|Phase 2||0
243462|NCT00555906|584686|P2|Treated|Phase 2||0
243463|NCT00555906|584687|P1|Treated|Phase 2||0
243464|NCT00555906|584683|P5|STARTED|Phase 2||32
243465|NCT00555906|584684|P4|STARTED|Phase 2||0
243466|NCT00555906|584685|P3|STARTED|Phase 2||0
243467|NCT00555906|584686|P2|STARTED|Phase 2||0
243468|NCT00555906|584687|P1|STARTED|Phase 2||0
243469|NCT00555906|584683|P5|NOT COMPLETED|Phase 1||0
243470|NCT00555906|584684|P4|NOT COMPLETED|Phase 1||5
243471|NCT00555906|584685|P3|NOT COMPLETED|Phase 1||7
243472|NCT00555906|584686|P2|NOT COMPLETED|Phase 1||6
243473|NCT00555906|584687|P1|NOT COMPLETED|Phase 1||3
243474|NCT00555906|584683|P5|COMPLETED|Phase 1||0
243475|NCT00555906|584684|P4|COMPLETED|Phase 1||0
243476|NCT00555906|584685|P3|COMPLETED|Phase 1||0
243477|NCT00555906|584686|P2|COMPLETED|Phase 1||0
243478|NCT00555906|584687|P1|COMPLETED|Phase 1||0
243479|NCT00555906|584683|P5|STARTED|Phase 1||0
243480|NCT00555906|584684|P4|STARTED|Phase 1||5
243481|NCT00555906|584685|P3|STARTED|Phase 1||7
243482|NCT00555906|584686|P2|STARTED|Phase 1||6
243483|NCT00555906|584687|P1|STARTED|Phase 1||3
243484|NCT00555893|584719|P2|NOT COMPLETED|Overall Study||0
243485|NCT00555893|584720|P1|NOT COMPLETED|Overall Study||0
243486|NCT00555893|584719|P2|COMPLETED|Overall Study||63
243487|NCT00555893|584720|P1|COMPLETED|Overall Study||130
243488|NCT00555893|584719|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
243489|NCT00555893|584720|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
243490|NCT00555893|584719|P2|STARTED|Overall Study||63
243491|NCT00555893|584720|P1|STARTED|Overall Study||130
243492|NCT00555880|584730|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
243493|NCT00555880|584731|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
243494|NCT00555880|584730|P2|COMPLETED|Treatment Period 2 (1 Day)||11
243495|NCT00555880|584731|P1|COMPLETED|Treatment Period 2 (1 Day)||13
243496|NCT00555880|584730|P2|STARTED|Treatment Period 2 (1 Day)||11
243497|NCT00555880|584731|P1|STARTED|Treatment Period 2 (1 Day)||13
243498|NCT00555880|584730|P2|NOT COMPLETED|Washout (1 Day)||0
243499|NCT00555880|584731|P1|NOT COMPLETED|Washout (1 Day)||0
243500|NCT00555880|584730|P2|COMPLETED|Washout (1 Day)||11
243501|NCT00555880|584731|P1|COMPLETED|Washout (1 Day)||13
243502|NCT00555880|584730|P2|STARTED|Washout (1 Day)||11
243503|NCT00555880|584731|P1|STARTED|Washout (1 Day)||13
243504|NCT00555880|584730|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
243505|NCT00555880|584731|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
243506|NCT00555880|584730|P2|COMPLETED|Treatment Period 1 (1 Day)||11
243507|NCT00555880|584731|P1|COMPLETED|Treatment Period 1 (1 Day)||13
243508|NCT00555880|584730|P2|STARTED|Treatment Period 1 (1 Day)||11
243509|NCT00555880|584731|P1|STARTED|Treatment Period 1 (1 Day)||13
243510|NCT00555750|584770|P2|NOT COMPLETED|Overall Study||0
243511|NCT00555750|584771|P1|NOT COMPLETED|Overall Study||0
243512|NCT00555750|584770|P2|COMPLETED|Overall Study||10
243513|NCT00555750|584771|P1|COMPLETED|Overall Study||10
243514|NCT00555750|584770|P2|STARTED|Overall Study||10
243515|NCT00555750|584771|P1|STARTED|Overall Study||10
243516|NCT00555672|584803|P2|NOT COMPLETED|Overall Study||10
243517|NCT00555672|584804|P1|NOT COMPLETED|Overall Study||24
243518|NCT00555672|584803|P2|COMPLETED|Overall Study||0
243519|NCT00555672|584804|P1|COMPLETED|Overall Study||0
243520|NCT00555672|584803|P2|STARTED|Overall Study||10
243521|NCT00555672|584804|P1|STARTED|Overall Study||24
243522|NCT00555620|584829|P6|NOT COMPLETED|Overall Study||22
243523|NCT00555620|584830|P5|NOT COMPLETED|Overall Study||3
243524|NCT00555620|584831|P4|NOT COMPLETED|Overall Study||23
243525|NCT00555620|584832|P3|NOT COMPLETED|Overall Study||15
243526|NCT00555620|584833|P2|NOT COMPLETED|Overall Study||7
243527|NCT00555620|584834|P1|NOT COMPLETED|Overall Study||6
243528|NCT00555620|584829|P6|COMPLETED|Overall Study||0
243529|NCT00555620|584830|P5|COMPLETED|Overall Study||0
243530|NCT00555620|584831|P4|COMPLETED|Overall Study||0
243531|NCT00555620|584832|P3|COMPLETED|Overall Study||0
243532|NCT00555620|584833|P2|COMPLETED|Overall Study||0
243533|NCT00555620|584834|P1|COMPLETED|Overall Study||0
243534|NCT00555620|584829|P6|STARTED|Overall Study||22
243535|NCT00555620|584830|P5|STARTED|Overall Study||3
243536|NCT00555620|584831|P4|STARTED|Overall Study||23
243537|NCT00555620|584832|P3|STARTED|Overall Study||15
243538|NCT00555620|584833|P2|STARTED|Overall Study||7
243539|NCT00555620|584834|P1|STARTED|Overall Study||6
243540|NCT00555581|584946|P1|NOT COMPLETED|Overall Study||6
243541|NCT00555581|584946|P1|COMPLETED|Overall Study||24
243542|NCT00555581|584946|P1|STARTED|Overall Study||30
243543|NCT00555568|584958|P3|NOT COMPLETED|Overall Study||16
243544|NCT00555568|584959|P2|NOT COMPLETED|Overall Study||16
243545|NCT00555568|584960|P1|NOT COMPLETED|Overall Study||26
243546|NCT00555568|584958|P3|COMPLETED|Overall Study||84
243547|NCT00555568|584959|P2|COMPLETED|Overall Study||82
243548|NCT00555568|584960|P1|COMPLETED|Overall Study||74
243549|NCT00555568|584958|P3|STARTED|Overall Study||100
243550|NCT00555568|584959|P2|STARTED|Overall Study||98
243551|NCT00555568|584960|P1|STARTED|Overall Study||100
243552|NCT00555477|584982|P2|NOT COMPLETED|Overall Study||13
243553|NCT00555477|584983|P1|NOT COMPLETED|Overall Study||2
243554|NCT00555477|584982|P2|COMPLETED|Overall Study||32
243555|NCT00555477|584983|P1|COMPLETED|Overall Study||12
243556|NCT00555477|584982|P2|STARTED|Overall Study||45
243557|NCT00555477|584983|P1|STARTED|Overall Study||14
243558|NCT00555464|584990|P2|NOT COMPLETED|Overall Study||3
243559|NCT00555464|584991|P1|NOT COMPLETED|Overall Study||0
243560|NCT00555464|584990|P2|COMPLETED|Overall Study||1
243561|NCT00555464|584991|P1|COMPLETED|Overall Study||4
243562|NCT00555464|584990|P2|STARTED|Overall Study||4
243563|NCT00555464|584991|P1|STARTED|Overall Study||4
243564|NCT00555438|584999|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
243565|NCT00555438|584999|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
243566|NCT00555438|584999|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
243567|NCT00555438|584999|P1|NOT COMPLETED|10 Days Post-operative||4
243568|NCT00555438|584999|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
243569|NCT00555438|584999|P1|STARTED|10 Days Post-operative||442
243570|NCT00555425|585009|P2|NOT COMPLETED|Overall Study||19
243571|NCT00555425|585010|P1|NOT COMPLETED|Overall Study||51
243572|NCT00555425|585009|P2|COMPLETED|Overall Study||37
243573|NCT00555425|585010|P1|COMPLETED|Overall Study||6
243574|NCT00555425|585009|P2|STARTED|Overall Study||56
243575|NCT00555425|585010|P1|STARTED|Overall Study||57
243576|NCT00555360|585030|P2|NOT COMPLETED|Overall Study||36
243577|NCT00555360|585031|P1|NOT COMPLETED|Overall Study||27
243578|NCT00555360|585030|P2|COMPLETED|Overall Study||153
243579|NCT00555360|585031|P1|COMPLETED|Overall Study||156
243580|NCT00555360|585030|P2|STARTED|Overall Study||189
243581|NCT00555360|585031|P1|STARTED|Overall Study||183
243582|NCT00555321|585046|P5|NOT COMPLETED|Long-term Extension Phase||26
243583|NCT00555321|585047|P4|NOT COMPLETED|Long-term Extension Phase||38
243584|NCT00555321|585048|P3|NOT COMPLETED|Long-term Extension Phase||24
243585|NCT00555321|585049|P2|NOT COMPLETED|Long-term Extension Phase||27
243586|NCT00555321|585050|P1|NOT COMPLETED|Long-term Extension Phase||30
243587|NCT00555321|585046|P5|COMPLETED|Long-term Extension Phase||0
243588|NCT00555321|585047|P4|COMPLETED|Long-term Extension Phase||0
243589|NCT00555321|585048|P3|COMPLETED|Long-term Extension Phase||0
243590|NCT00555321|585049|P2|COMPLETED|Long-term Extension Phase||0
243591|NCT00555321|585050|P1|COMPLETED|Long-term Extension Phase||0
243592|NCT00555321|585046|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
243593|NCT00555321|585047|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
243594|NCT00555321|585048|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
243595|NCT00555321|585049|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
243596|NCT00555321|585050|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
243597|NCT00555321|585046|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
243598|NCT00555321|585047|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
243599|NCT00555321|585048|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
243600|NCT00555321|585049|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
243601|NCT00555321|585050|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
243602|NCT00555321|585046|P5|COMPLETED|Treatment Phase up to 12-months||32
243603|NCT00555321|585047|P4|COMPLETED|Treatment Phase up to 12-months||46
243604|NCT00555321|585048|P3|COMPLETED|Treatment Phase up to 12-months||26
243605|NCT00555321|585049|P2|COMPLETED|Treatment Phase up to 12-months||29
243606|NCT00555321|585050|P1|COMPLETED|Treatment Phase up to 12-months||31
243607|NCT00555321|585046|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
243608|NCT00555321|585047|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
243609|NCT00555321|585048|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
243610|NCT00555321|585049|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
243611|NCT00555321|585050|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
243612|NCT00555321|585046|P5|STARTED|Treatment Phase up to 12-months||54
243613|NCT00555321|585047|P4|STARTED|Treatment Phase up to 12-months||53
243614|NCT00555321|585048|P3|STARTED|Treatment Phase up to 12-months||50
243615|NCT00555321|585049|P2|STARTED|Treatment Phase up to 12-months||51
243616|NCT00555321|585050|P1|STARTED|Treatment Phase up to 12-months||52
243617|NCT00555217|585354|P2|NOT COMPLETED|Overall Study||68
243618|NCT00555217|585355|P1|NOT COMPLETED|Overall Study||75
243619|NCT00555217|585354|P2|COMPLETED|Overall Study||656
243620|NCT00555217|585355|P1|COMPLETED|Overall Study||649
243621|NCT00555217|585354|P2|STARTED|Overall Study||724
243622|NCT00555217|585355|P1|STARTED|Overall Study||724
243623|NCT00555152|585367|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
243624|NCT00555152|585368|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
243625|NCT00555152|585369|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
243626|NCT00555152|585370|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
243627|NCT00555152|585367|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
243628|NCT00555152|585368|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
243629|NCT00555152|585369|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
243630|NCT00555152|585370|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
243631|NCT00555152|585367|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
243632|NCT00555152|585368|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
243633|NCT00555152|585369|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
243634|NCT00555152|585370|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
243635|NCT00555152|585367|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
243636|NCT00555152|585368|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
243637|NCT00555152|585369|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
243638|NCT00555152|585370|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
243639|NCT00555152|585367|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
243640|NCT00555152|585368|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
243641|NCT00555152|585369|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
243642|NCT00555152|585370|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
243643|NCT00555152|585367|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
243644|NCT00555152|585368|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
243645|NCT00555152|585369|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
243646|NCT00555152|585370|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
243647|NCT00555061|585392|P1|NOT COMPLETED|Overall Study||9
243648|NCT00555061|585392|P1|COMPLETED|Overall Study||78
243649|NCT00555061|585392|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
243650|NCT00555048|585399|P1|NOT COMPLETED|Overall Study||0
243651|NCT00555048|585399|P1|COMPLETED|Overall Study||1
243652|NCT00555048|585399|P1|STARTED|Overall Study||1
243653|NCT00555009|585411|P2|NOT COMPLETED|Overall Study||6
243654|NCT00555009|585412|P1|NOT COMPLETED|Overall Study||2
243655|NCT00555009|585411|P2|COMPLETED|Overall Study||0
243656|NCT00555009|585412|P1|COMPLETED|Overall Study||2
243657|NCT00555009|585411|P2|STARTED|Overall Study||6
243658|NCT00555009|585412|P1|STARTED|Overall Study||4
243659|NCT00554996|585434|P1|NOT COMPLETED|Overall Study||0
243660|NCT00554996|585434|P1|COMPLETED|Overall Study||10
243661|NCT00554996|585434|P1|STARTED|Overall Study||10
243662|NCT00554970|585442|P4|NOT COMPLETED|Period 2||0
243663|NCT00554970|585443|P3|NOT COMPLETED|Period 2||1
243664|NCT00554970|585444|P2|NOT COMPLETED|Period 2||0
243665|NCT00554970|585445|P1|NOT COMPLETED|Period 2||0
243666|NCT00554970|585442|P4|COMPLETED|Period 2||8
243667|NCT00554970|585443|P3|COMPLETED|Period 2||7
243668|NCT00554970|585444|P2|COMPLETED|Period 2||8
243669|NCT00554970|585445|P1|COMPLETED|Period 2||7
243670|NCT00554970|585442|P4|STARTED|Period 2||8
243671|NCT00554970|585443|P3|STARTED|Period 2||8
243672|NCT00554970|585444|P2|STARTED|Period 2||8
243673|NCT00554970|585445|P1|STARTED|Period 2||7
243674|NCT00554970|585442|P4|NOT COMPLETED|Period 1||0
243675|NCT00554970|585443|P3|NOT COMPLETED|Period 1||0
243676|NCT00554970|585444|P2|NOT COMPLETED|Period 1||0
243677|NCT00554970|585445|P1|NOT COMPLETED|Period 1||1
243678|NCT00554970|585442|P4|COMPLETED|Period 1||8
243679|NCT00554970|585443|P3|COMPLETED|Period 1||8
243680|NCT00554970|585444|P2|COMPLETED|Period 1||8
243681|NCT00554970|585445|P1|COMPLETED|Period 1||7
243682|NCT00554970|585442|P4|STARTED|Period 1||8
243683|NCT00554970|585443|P3|STARTED|Period 1||8
243684|NCT00554970|585444|P2|STARTED|Period 1||8
243685|NCT00554970|585445|P1|STARTED|Period 1||8
243686|NCT00554853|585477|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
243687|NCT00554853|585478|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
243688|NCT00554853|585477|P2|COMPLETED|Crossover Arm (3 Months)||55
243689|NCT00554853|585478|P1|COMPLETED|Crossover Arm (3 Months)||53
243690|NCT00554853|585477|P2|STARTED|Crossover Arm (3 Months)||57
243691|NCT00554853|585478|P1|STARTED|Crossover Arm (3 Months)||56
243692|NCT00554853|585477|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
243693|NCT00554853|585478|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
243694|NCT00554853|585477|P2|COMPLETED|Washout Period (2 Weeks)||57
243695|NCT00554853|585478|P1|COMPLETED|Washout Period (2 Weeks)||56
243696|NCT00554853|585477|P2|STARTED|Washout Period (2 Weeks)||64
243697|NCT00554853|585478|P1|STARTED|Washout Period (2 Weeks)||56
243698|NCT00554853|585477|P2|NOT COMPLETED|First Arm of Study||7
243699|NCT00554853|585478|P1|NOT COMPLETED|First Arm of Study||16
243700|NCT00554853|585477|P2|COMPLETED|First Arm of Study||64
243701|NCT00554853|585478|P1|COMPLETED|First Arm of Study||56
243702|NCT00554853|585477|P2|STARTED|First Arm of Study||71
243703|NCT00554853|585478|P1|STARTED|First Arm of Study||72
243704|NCT00554840|585492|P2|NOT COMPLETED|Overall Study||1
243705|NCT00554840|585493|P1|NOT COMPLETED|Overall Study||0
243706|NCT00554840|585492|P2|COMPLETED|Overall Study||4
243707|NCT00554840|585493|P1|COMPLETED|Overall Study||4
243708|NCT00554840|585492|P2|STARTED|Overall Study||5
243709|NCT00554840|585493|P1|STARTED|Overall Study||4
243710|NCT00554801|585511|P2|NOT COMPLETED|Overall Study||0
243711|NCT00554801|585512|P1|NOT COMPLETED|Overall Study||19
243712|NCT00554801|585511|P2|COMPLETED|Overall Study||29
243713|NCT00554801|585512|P1|COMPLETED|Overall Study||36
243714|NCT00554801|585511|P2|STARTED|Overall Study||29
243715|NCT00554801|585512|P1|STARTED|Overall Study||55
243716|NCT00554749|585518|P1|NOT COMPLETED|Overall Study||0
243717|NCT00554749|585518|P1|COMPLETED|Overall Study||7
243718|NCT00554749|585518|P1|STARTED|Overall Study||7
243719|NCT00554671|585525|P2|NOT COMPLETED|Overall Study||16
243720|NCT00554671|585526|P1|NOT COMPLETED|Overall Study||20
243721|NCT00554671|585525|P2|COMPLETED|Overall Study||117
243722|NCT00554671|585526|P1|COMPLETED|Overall Study||97
243723|NCT00554671|585525|P2|STARTED|Overall Study||133
243724|NCT00554671|585526|P1|STARTED|Overall Study||117
243725|NCT00554619|585534|P1|NOT COMPLETED|Overall Study||3
243726|NCT00554619|585534|P1|COMPLETED|Overall Study||18
243727|NCT00554619|585534|P1|STARTED|Overall Study||21
243728|NCT00554515|585546|P1|NOT COMPLETED|Overall Study||118
243729|NCT00554515|585546|P1|COMPLETED|Overall Study||5
243730|NCT00554515|585546|P1|Treated|Overall Study||120
243731|NCT00554515|585546|P1|STARTED|Overall Study||123
243732|NCT00554463|585575|P1|NOT COMPLETED|Overall Study||0
243733|NCT00554463|585575|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|5
243734|NCT00554463|585575|P1|STARTED|Overall Study||5
243735|NCT00554372|585581|P2|NOT COMPLETED|Overall Study||0
243736|NCT00554372|585582|P1|NOT COMPLETED|Overall Study||0
243737|NCT00554372|585581|P2|COMPLETED|Overall Study||16
243738|NCT00554372|585582|P1|COMPLETED|Overall Study||14
243739|NCT00554372|585581|P2|STARTED|Overall Study||16
243740|NCT00554372|585582|P1|STARTED|Overall Study||14
243741|NCT00554294|585596|P2|NOT COMPLETED|Overall Study||80
243742|NCT00554294|585597|P1|NOT COMPLETED|Overall Study||160
243743|NCT00554294|585596|P2|COMPLETED|Overall Study||1641
243744|NCT00554294|585597|P1|COMPLETED|Overall Study||1309
243745|NCT00554294|585596|P2|STARTED|Overall Study||1721
243746|NCT00554294|585597|P1|STARTED|Overall Study||1469
243747|NCT00554229|585603|P2|NOT COMPLETED|Overall Study||225
243748|NCT00554229|585604|P1|NOT COMPLETED|Overall Study||226
243749|NCT00554229|585603|P2|COMPLETED|Overall Study||70
243750|NCT00554229|585604|P1|COMPLETED|Overall Study||73
243751|NCT00554229|585603|P2|Patients Who Received Treatment|Overall Study||295
243752|NCT00554229|585604|P1|Patients Who Received Treatment|Overall Study||298
243753|NCT00554229|585603|P2|STARTED|Overall Study||295
243754|NCT00554229|585604|P1|STARTED|Overall Study||299
243755|NCT00554216|585629|P3|NOT COMPLETED|Overall Study||172
243756|NCT00554216|585630|P2|NOT COMPLETED|Overall Study||94
243757|NCT00554216|585631|P1|NOT COMPLETED|Overall Study||242
243758|NCT00554216|585629|P3|COMPLETED|Overall Study||340
243759|NCT00554216|585630|P2|COMPLETED|Overall Study||147
243760|NCT00554216|585631|P1|COMPLETED|Overall Study||272
243761|NCT00554216|585629|P3|STARTED|Overall Study||512
243762|NCT00554216|585630|P2|STARTED|Overall Study||241
243763|NCT00554216|585631|P1|STARTED|Overall Study||514
243764|NCT00554190|585642|P1|NOT COMPLETED|Overall Study||10
243765|NCT00554190|585642|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
243766|NCT00554190|585642|P1|STARTED|Overall Study|29 subjects treated.|29
243767|NCT00554099|585651|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
243768|NCT00554099|585652|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
243769|NCT00554099|585653|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
243770|NCT00554099|585651|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
243771|NCT00554099|585652|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
243772|NCT00554099|585653|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
243773|NCT00554099|585651|P3|STARTED|Non-Treatment Phase (9 Months)||27
243774|NCT00554099|585652|P2|STARTED|Non-Treatment Phase (9 Months)||32
243775|NCT00554099|585653|P1|STARTED|Non-Treatment Phase (9 Months)||29
243776|NCT00554099|585651|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
243777|NCT00554099|585652|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
243778|NCT00554099|585653|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
243779|NCT00554099|585651|P3|COMPLETED|Treatment Period (12 Weeks)||27
243780|NCT00554099|585652|P2|COMPLETED|Treatment Period (12 Weeks)||32
243781|NCT00554099|585653|P1|COMPLETED|Treatment Period (12 Weeks)||29
243782|NCT00554099|585651|P3|STARTED|Treatment Period (12 Weeks)||36
243783|NCT00554099|585652|P2|STARTED|Treatment Period (12 Weeks)||40
243784|NCT00554099|585653|P1|STARTED|Treatment Period (12 Weeks)||41
243785|NCT00553969|585686|P4|NOT COMPLETED|Overall Study||1
243786|NCT00553969|585687|P3|NOT COMPLETED|Overall Study||1
243787|NCT00553969|585688|P2|NOT COMPLETED|Overall Study||0
243788|NCT00553969|585689|P1|NOT COMPLETED|Overall Study||8
243789|NCT00553969|585686|P4|COMPLETED|Overall Study||23
243790|NCT00553969|585687|P3|COMPLETED|Overall Study||21
243791|NCT00553969|585688|P2|COMPLETED|Overall Study||24
243792|NCT00553969|585689|P1|COMPLETED|Overall Study||23
243793|NCT00553969|585686|P4|STARTED|Overall Study||24
243794|NCT00553969|585687|P3|STARTED|Overall Study||22
243795|NCT00553969|585688|P2|STARTED|Overall Study||24
243796|NCT00553969|585689|P1|STARTED|Overall Study||31
243797|NCT00553839|585699|P1|NOT COMPLETED|Overall Study||0
243798|NCT00553839|585699|P1|COMPLETED|Overall Study||21
243799|NCT00553839|585699|P1|STARTED|Overall Study||21
243800|NCT00553787|585708|P3|NOT COMPLETED|Overall Study||262
243801|NCT00553787|585709|P2|NOT COMPLETED|Overall Study||124
243802|NCT00553787|585710|P1|NOT COMPLETED|Overall Study||378
243803|NCT00553787|585708|P3|COMPLETED|Overall Study||733
243804|NCT00553787|585709|P2|COMPLETED|Overall Study||374
243805|NCT00553787|585710|P1|COMPLETED|Overall Study||616
243806|NCT00553787|585708|P3|STARTED|Overall Study||995
243807|NCT00553787|585709|P2|STARTED|Overall Study||498
243808|NCT00553787|585710|P1|STARTED|Overall Study||994
243809|NCT00553735|585721|P1|NOT COMPLETED|Overall Study||7
243810|NCT00553735|585721|P1|COMPLETED|Overall Study||1
243811|NCT00553735|585721|P1|STARTED|Overall Study||8
243812|NCT00553696|585742|P4|NOT COMPLETED|Overall Study||1
243813|NCT00553696|585743|P3|NOT COMPLETED|Overall Study||6
243814|NCT00553696|585744|P2|NOT COMPLETED|Overall Study||16
243815|NCT00553696|585745|P1|NOT COMPLETED|Overall Study||4
243816|NCT00553696|585742|P4|COMPLETED|Overall Study||0
243817|NCT00553696|585743|P3|COMPLETED|Overall Study||0
243818|NCT00553696|585744|P2|COMPLETED|Overall Study||0
243819|NCT00553696|585745|P1|COMPLETED|Overall Study||0
243820|NCT00553696|585742|P4|STARTED|Overall Study||1
243821|NCT00553696|585743|P3|STARTED|Overall Study||6
243822|NCT00553696|585744|P2|STARTED|Overall Study||16
243823|NCT00553696|585745|P1|STARTED|Overall Study||4
243824|NCT00553644|585783|P1|NOT COMPLETED|Overall Study||28
243825|NCT00553644|585783|P1|COMPLETED|Overall Study||25
243826|NCT00553644|585783|P1|STARTED|Overall Study||53
243827|NCT00553631|585792|P2|NOT COMPLETED|Overall Study||1
243828|NCT00553631|585793|P1|NOT COMPLETED|Overall Study||1
243829|NCT00553631|585792|P2|COMPLETED|Overall Study||16
243830|NCT00553631|585793|P1|COMPLETED|Overall Study||16
243831|NCT00553631|585792|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
243832|NCT00553631|585793|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
243833|NCT00553605|585815|P2|NOT COMPLETED|Overall Study||3
243834|NCT00553605|585816|P1|NOT COMPLETED|Overall Study||4
243835|NCT00553605|585815|P2|COMPLETED|Overall Study||161
243836|NCT00553605|585816|P1|COMPLETED|Overall Study||172
243837|NCT00553605|585815|P2|Treated|Overall Study||164
243838|NCT00553605|585816|P1|Treated|Overall Study||174
243839|NCT00553605|585815|P2|STARTED|Overall Study||164
243840|NCT00553605|585816|P1|STARTED|Overall Study||176
243841|NCT00553514|585845|P5|NOT COMPLETED|Overall Study||7
243842|NCT00553514|585846|P4|NOT COMPLETED|Overall Study||7
243843|NCT00553514|585847|P3|NOT COMPLETED|Overall Study||6
243844|NCT00553514|585848|P2|NOT COMPLETED|Overall Study||8
243845|NCT00553514|585849|P1|NOT COMPLETED|Overall Study||8
243846|NCT00553514|585845|P5|COMPLETED|Overall Study||8
243847|NCT00553514|585846|P4|COMPLETED|Overall Study||6
243848|NCT00553514|585847|P3|COMPLETED|Overall Study||9
243849|NCT00553514|585848|P2|COMPLETED|Overall Study||6
243850|NCT00553514|585849|P1|COMPLETED|Overall Study||6
243851|NCT00553514|585845|P5|STARTED|Overall Study||15
243852|NCT00553514|585846|P4|STARTED|Overall Study||13
243853|NCT00553514|585847|P3|STARTED|Overall Study||15
243854|NCT00553514|585848|P2|STARTED|Overall Study||14
243855|NCT00553514|585849|P1|STARTED|Overall Study||14
243856|NCT00553501|585886|P1|NOT COMPLETED|Overall Study||4
243857|NCT00553501|585886|P1|COMPLETED|Overall Study||55
243858|NCT00553501|585886|P1|STARTED|Overall Study||59
243859|NCT00553475|585895|P3|NOT COMPLETED|Overall Study||13
243860|NCT00553475|585896|P2|NOT COMPLETED|Overall Study||20
243861|NCT00553475|585897|P1|NOT COMPLETED|Overall Study||16
243862|NCT00553475|585895|P3|COMPLETED|Overall Study||32
243863|NCT00553475|585896|P2|COMPLETED|Overall Study||114
243864|NCT00553475|585897|P1|COMPLETED|Overall Study||119
243865|NCT00553475|585895|P3|STARTED|Overall Study||45
243866|NCT00553475|585896|P2|STARTED|Overall Study||134
243867|NCT00553475|585897|P1|STARTED|Overall Study||135
243868|NCT00553462|586019|P1|NOT COMPLETED|Overall Study||14
243869|NCT00553462|586019|P1|COMPLETED|Overall Study||61
243870|NCT00553462|586019|P1|STARTED|Overall Study||75
243871|NCT00553436|586025|P1|NOT COMPLETED|Overall Study||1
243872|NCT00553436|586025|P1|COMPLETED|Overall Study|09 April 2009|6
243873|NCT00553436|586025|P1|STARTED|Overall Study|20 August 2007|7
243874|NCT00553358|586034|P3|NOT COMPLETED|Overall Study||60
243875|NCT00553358|586035|P2|NOT COMPLETED|Overall Study||12
243876|NCT00553358|586036|P1|NOT COMPLETED|Overall Study||53
243877|NCT00553358|586034|P3|COMPLETED|Overall Study||92
243878|NCT00553358|586035|P2|COMPLETED|Overall Study||137
243879|NCT00553358|586036|P1|COMPLETED|Overall Study||101
243880|NCT00553358|586034|P3|STARTED|Overall Study||152
243881|NCT00553358|586035|P2|STARTED|Overall Study||149
243882|NCT00553358|586036|P1|STARTED|Overall Study||154
243883|NCT00553332|586062|P1|NOT COMPLETED|Overall Study||1
243884|NCT00553332|586062|P1|COMPLETED|Overall Study|evaluable for response|28
243885|NCT00553332|586062|P1|STARTED|Overall Study||29
243886|NCT00553319|586074|P3|NOT COMPLETED|Overall Study||9
243887|NCT00553319|586075|P2|NOT COMPLETED|Overall Study||10
243888|NCT00553319|586076|P1|NOT COMPLETED|Overall Study||14
243889|NCT00553319|586074|P3|COMPLETED|Overall Study||34
243890|NCT00553319|586075|P2|COMPLETED|Overall Study||30
243891|NCT00553319|586076|P1|COMPLETED|Overall Study||29
243892|NCT00553319|586074|P3|STARTED|Overall Study||43
243893|NCT00553319|586075|P2|STARTED|Overall Study||40
243894|NCT00553319|586076|P1|STARTED|Overall Study||43
243895|NCT00553280|586087|P1|NOT COMPLETED|Overall Study||26
243896|NCT00553280|586087|P1|COMPLETED|Overall Study||97
243897|NCT00553280|586087|P1|STARTED|Overall Study||123
243898|NCT00553267|586099|P3|NOT COMPLETED|Overall Study||10
243899|NCT00553267|586100|P2|NOT COMPLETED|Overall Study||18
243900|NCT00553267|586101|P1|NOT COMPLETED|Overall Study||14
243901|NCT00553267|586099|P3|COMPLETED|Overall Study||307
243902|NCT00553267|586100|P2|COMPLETED|Overall Study||297
243903|NCT00553267|586101|P1|COMPLETED|Overall Study||301
243904|NCT00553267|586099|P3|STARTED|Overall Study||317
243905|NCT00553267|586100|P2|STARTED|Overall Study||315
243906|NCT00553267|586101|P1|STARTED|Overall Study||315
243907|NCT00553202|586136|P1|NOT COMPLETED|Overall Study||68
243908|NCT00553202|586136|P1|COMPLETED|Overall Study||90
243909|NCT00553202|586136|P1|STARTED|Overall Study||158
243910|NCT00553150|586146|P4|NOT COMPLETED|Overall Study||4
243911|NCT00553150|586147|P3|NOT COMPLETED|Overall Study||0
243912|NCT00553150|586148|P2|NOT COMPLETED|Overall Study||0
243913|NCT00553150|586149|P1|NOT COMPLETED|Overall Study||0
243914|NCT00553150|586146|P4|COMPLETED|Overall Study||100
243915|NCT00553150|586147|P3|COMPLETED|Overall Study||6
243916|NCT00553150|586148|P2|COMPLETED|Overall Study||6
243917|NCT00553150|586149|P1|COMPLETED|Overall Study||6
243918|NCT00553150|586146|P4|STARTED|Overall Study||104
243919|NCT00553150|586147|P3|STARTED|Overall Study||6
243920|NCT00553150|586148|P2|STARTED|Overall Study||6
243921|NCT00553150|586149|P1|STARTED|Overall Study||6
243922|NCT00553098|586161|P1|NOT COMPLETED|Overall Study||1
243923|NCT00553098|586161|P1|COMPLETED|Overall Study||28
243924|NCT00553098|586161|P1|STARTED|Overall Study||29
243925|NCT00552812|586175|P1|NOT COMPLETED|Overall Study||20
243926|NCT00552812|586175|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
243927|NCT00552812|586175|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
243928|NCT00552786|586183|P2|NOT COMPLETED|Second Intervention||0
243929|NCT00552786|586184|P1|NOT COMPLETED|Second Intervention||0
243930|NCT00552786|586183|P2|COMPLETED|Second Intervention||28
243931|NCT00552786|586184|P1|COMPLETED|Second Intervention||25
243932|NCT00552786|586183|P2|STARTED|Second Intervention||28
243933|NCT00552786|586184|P1|STARTED|Second Intervention||25
243934|NCT00552786|586183|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
243935|NCT00552786|586184|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
243936|NCT00552786|586183|P2|COMPLETED|Washout Period of 2 Weeks||28
243937|NCT00552786|586184|P1|COMPLETED|Washout Period of 2 Weeks||25
243938|NCT00552786|586183|P2|STARTED|Washout Period of 2 Weeks||28
243939|NCT00552786|586184|P1|STARTED|Washout Period of 2 Weeks||25
243940|NCT00552786|586183|P2|NOT COMPLETED|First Intervention||0
243941|NCT00552786|586184|P1|NOT COMPLETED|First Intervention||0
243942|NCT00552786|586183|P2|COMPLETED|First Intervention||28
243943|NCT00552786|586184|P1|COMPLETED|First Intervention||25
243944|NCT00552786|586183|P2|Medication and Hearing Evaluation|First Intervention||28
243945|NCT00552786|586184|P1|Medication and Hearing Evaluation|First Intervention||25
243946|NCT00552786|586183|P2|STARTED|First Intervention||28
243947|NCT00552786|586184|P1|STARTED|First Intervention||25
243948|NCT00552760|586194|P2|NOT COMPLETED|Overall Study||33
243949|NCT00552760|586195|P1|NOT COMPLETED|Overall Study||26
243950|NCT00552760|586194|P2|COMPLETED|Overall Study||8
243951|NCT00552760|586195|P1|COMPLETED|Overall Study||16
243952|NCT00552760|586194|P2|STARTED|Overall Study||41
243953|NCT00552760|586195|P1|STARTED|Overall Study||42
243954|NCT00552695|586211|P2|NOT COMPLETED|Overall Study||0
243955|NCT00552695|586212|P1|NOT COMPLETED|Overall Study||0
243956|NCT00552695|586211|P2|COMPLETED|Overall Study|September 2007|23
243957|NCT00552695|586212|P1|COMPLETED|Overall Study|September 2007|22
243958|NCT00552695|586211|P2|STARTED|Overall Study|August 2007|23
243959|NCT00552695|586212|P1|STARTED|Overall Study|August 2007|22
243960|NCT00552669|586222|P2|NOT COMPLETED|Overall Study||7
243961|NCT00552669|586223|P1|NOT COMPLETED|Overall Study||3
243962|NCT00552669|586222|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
243963|NCT00552669|586223|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
243964|NCT00552669|586222|P2|STARTED|Overall Study|patients|100
243965|NCT00552669|586223|P1|STARTED|Overall Study|patients|100
243966|NCT00552578|586235|P2|NOT COMPLETED|Overall Study||1
243967|NCT00552578|586236|P1|NOT COMPLETED|Overall Study||1
243968|NCT00552578|586235|P2|COMPLETED|Overall Study||5
243969|NCT00552578|586236|P1|COMPLETED|Overall Study||5
243970|NCT00552578|586235|P2|STARTED|Overall Study||6
243971|NCT00552578|586236|P1|STARTED|Overall Study||6
243972|NCT00552513|586248|P2|NOT COMPLETED|Overall Study||1
243973|NCT00552513|586249|P1|NOT COMPLETED|Overall Study||5
243974|NCT00552513|586248|P2|COMPLETED|Overall Study||1437
243975|NCT00552513|586249|P1|COMPLETED|Overall Study||1588
243976|NCT00552513|586248|P2|STARTED|Overall Study||1438
243977|NCT00552513|586249|P1|STARTED|Overall Study||1593
243978|NCT00552448|586261|P2|NOT COMPLETED|Overall Study||0
243979|NCT00552448|586262|P1|NOT COMPLETED|Overall Study||1
243980|NCT00552448|586261|P2|COMPLETED|Overall Study||16
243981|NCT00552448|586262|P1|COMPLETED|Overall Study||19
243982|NCT00552448|586261|P2|STARTED|Overall Study||16
243983|NCT00552448|586262|P1|STARTED|Overall Study||20
243984|NCT00552422|586274|P1|NOT COMPLETED|Overall Study||0
243985|NCT00552422|586274|P1|COMPLETED|Overall Study||6
243986|NCT00552422|586274|P1|STARTED|Overall Study||6
243987|NCT00552409|586280|P2|NOT COMPLETED|Overall Study||2
243988|NCT00552409|586281|P1|NOT COMPLETED|Overall Study||1
243989|NCT00552409|586280|P2|COMPLETED|Overall Study||9
243990|NCT00552409|586281|P1|COMPLETED|Overall Study||10
243991|NCT00552409|586280|P2|STARTED|Overall Study||11
243992|NCT00552409|586281|P1|STARTED|Overall Study||11
243993|NCT00552396|586294|P7|NOT COMPLETED|Overall Study||9
243994|NCT00552396|586295|P6|NOT COMPLETED|Overall Study||3
243995|NCT00552396|586296|P5|NOT COMPLETED|Overall Study||3
243996|NCT00552396|586297|P4|NOT COMPLETED|Overall Study||6
243997|NCT00552396|586298|P3|NOT COMPLETED|Overall Study||3
243998|NCT00552396|586299|P2|NOT COMPLETED|Overall Study||3
243999|NCT00552396|586300|P1|NOT COMPLETED|Overall Study||3
244000|NCT00552396|586294|P7|COMPLETED|Overall Study||1
244001|NCT00552396|586295|P6|COMPLETED|Overall Study||0
244002|NCT00552396|586296|P5|COMPLETED|Overall Study||0
244003|NCT00552396|586297|P4|COMPLETED|Overall Study||0
244004|NCT00552396|586298|P3|COMPLETED|Overall Study||0
244005|NCT00552396|586299|P2|COMPLETED|Overall Study||0
244006|NCT00552396|586300|P1|COMPLETED|Overall Study||1
244007|NCT00552396|586294|P7|STARTED|Overall Study||10
244008|NCT00552396|586295|P6|STARTED|Overall Study||3
244009|NCT00552396|586296|P5|STARTED|Overall Study||3
244010|NCT00552396|586297|P4|STARTED|Overall Study||6
244011|NCT00552396|586298|P3|STARTED|Overall Study||3
244012|NCT00552396|586299|P2|STARTED|Overall Study||3
244013|NCT00552396|586300|P1|STARTED|Overall Study||4
244014|NCT00552344|586337|P1|NOT COMPLETED|Overall Study||315
244015|NCT00552344|586337|P1|COMPLETED|Overall Study||87
244016|NCT00552344|586337|P1|STARTED|Overall Study||402
244017|NCT00552305|586346|P1|NOT COMPLETED|Overall Study||250
244018|NCT00552305|586346|P1|COMPLETED|Overall Study||120
244019|NCT00552305|586346|P1|STARTED|Overall Study||370
244020|NCT00552279|586356|P2|NOT COMPLETED|Overall Study||3
244021|NCT00552279|586357|P1|NOT COMPLETED|Overall Study||14
244022|NCT00552279|586356|P2|COMPLETED|Overall Study||398
244023|NCT00552279|586357|P1|COMPLETED|Overall Study||389
244024|NCT00552279|586356|P2|STARTED|Overall Study||401
244025|NCT00552279|586357|P1|STARTED|Overall Study||403
244026|NCT00552240|586383|P2|NOT COMPLETED|Overall Study||18
244027|NCT00552240|586384|P1|NOT COMPLETED|Overall Study||24
244028|NCT00552240|586383|P2|COMPLETED|Overall Study||59
244029|NCT00552240|586384|P1|COMPLETED|Overall Study||51
244030|NCT00552240|586383|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
244031|NCT00552240|586384|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
244032|NCT00552188|586486|P2|NOT COMPLETED|Overall Study||5
244033|NCT00552188|586487|P1|NOT COMPLETED|Overall Study||2
244034|NCT00552188|586486|P2|COMPLETED|Overall Study||21
244035|NCT00552188|586487|P1|COMPLETED|Overall Study||24
244036|NCT00552188|586486|P2|STARTED|Overall Study||26
244037|NCT00552188|586487|P1|STARTED|Overall Study||26
244038|NCT00552175|586498|P3|NOT COMPLETED|Overall Study||14
244039|NCT00552175|586499|P2|NOT COMPLETED|Overall Study||13
244040|NCT00552175|586500|P1|NOT COMPLETED|Overall Study||17
244041|NCT00552175|586498|P3|COMPLETED|Overall Study||72
244042|NCT00552175|586499|P2|COMPLETED|Overall Study||73
244043|NCT00552175|586500|P1|COMPLETED|Overall Study||150
244044|NCT00552175|586498|P3|Full Analysis Set Population|Overall Study||86
244045|NCT00552175|586499|P2|Full Analysis Set Population|Overall Study||85
244046|NCT00552175|586500|P1|Full Analysis Set Population|Overall Study||167
244047|NCT00552175|586498|P3|STARTED|Overall Study||86
244048|NCT00552175|586499|P2|STARTED|Overall Study||86
244049|NCT00552175|586500|P1|STARTED|Overall Study||167
244050|NCT00552110|586540|P5|NOT COMPLETED|Overall Study||9
244051|NCT00552110|586541|P4|NOT COMPLETED|Overall Study||8
244052|NCT00552110|586542|P3|NOT COMPLETED|Overall Study||2
244053|NCT00552110|586543|P2|NOT COMPLETED|Overall Study||5
244054|NCT00552110|586544|P1|NOT COMPLETED|Overall Study||4
244055|NCT00552110|586540|P5|COMPLETED|Overall Study||133
244056|NCT00552110|586541|P4|COMPLETED|Overall Study||133
244057|NCT00552110|586542|P3|COMPLETED|Overall Study||137
244058|NCT00552110|586543|P2|COMPLETED|Overall Study||134
244059|NCT00552110|586544|P1|COMPLETED|Overall Study||142
244060|NCT00552110|586540|P5|STARTED|Overall Study||142
244061|NCT00552110|586541|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
244062|NCT00552110|586542|P3|STARTED|Overall Study||139
244063|NCT00552110|586543|P2|STARTED|Overall Study||139
244064|NCT00552110|586544|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
244065|NCT00552084|586563|P2|NOT COMPLETED|Overall Study||9
244066|NCT00552084|586564|P1|NOT COMPLETED|Overall Study||8
244067|NCT00552084|586563|P2|COMPLETED|Overall Study||55
244068|NCT00552084|586564|P1|COMPLETED|Overall Study||118
244069|NCT00552084|586563|P2|STARTED|Overall Study||64
244070|NCT00552084|586564|P1|STARTED|Overall Study||126
244071|NCT00552058|586572|P2|NOT COMPLETED|Overall Study||24
244072|NCT00552058|586573|P1|NOT COMPLETED|Overall Study||16
244073|NCT00552058|586572|P2|COMPLETED|Overall Study||192
244074|NCT00552058|586573|P1|COMPLETED|Overall Study||207
244075|NCT00552058|586572|P2|STARTED|Overall Study||216
244076|NCT00552058|586573|P1|STARTED|Overall Study||223
244077|NCT00552032|586613|P2|NOT COMPLETED|Overall Study||19
244078|NCT00552032|586614|P1|NOT COMPLETED|Overall Study||17
244079|NCT00552032|586613|P2|COMPLETED|Overall Study||47
244080|NCT00552032|586614|P1|COMPLETED|Overall Study||49
244081|NCT00552032|586613|P2|STARTED|Overall Study||66
244082|NCT00552032|586614|P1|STARTED|Overall Study||66
244083|NCT00551759|586658|P1|NOT COMPLETED|Overall Study||13
244084|NCT00551759|586658|P1|COMPLETED|Overall Study||9
244085|NCT00551759|586658|P1|Received Adjuvant Therapy|Overall Study||12
244086|NCT00551759|586658|P1|Underwent Surgery|Overall Study||17
244087|NCT00551759|586658|P1|Eligible and Began Treatment|Overall Study||21
244088|NCT00551759|586658|P1|STARTED|Overall Study||22
244089|NCT00551746|586664|P2|NOT COMPLETED|Overall Study||8
244090|NCT00551746|586665|P1|NOT COMPLETED|Overall Study||11
244091|NCT00551746|586664|P2|COMPLETED|Overall Study||26
244092|NCT00551746|586665|P1|COMPLETED|Overall Study||25
244093|NCT00551746|586664|P2|STARTED|Overall Study||34
244094|NCT00551746|586665|P1|STARTED|Overall Study||36
244095|NCT00551707|586676|P5|NOT COMPLETED|Overall Study||1
244096|NCT00551707|586677|P4|NOT COMPLETED|Overall Study||4
244097|NCT00551707|586678|P3|NOT COMPLETED|Overall Study||3
244098|NCT00551707|586679|P2|NOT COMPLETED|Overall Study||6
244099|NCT00551707|586680|P1|NOT COMPLETED|Overall Study||0
244100|NCT00551707|586676|P5|COMPLETED|Overall Study||3
244101|NCT00551707|586677|P4|COMPLETED|Overall Study||4
244102|NCT00551707|586678|P3|COMPLETED|Overall Study||10
244103|NCT00551707|586679|P2|COMPLETED|Overall Study||16
244104|NCT00551707|586680|P1|COMPLETED|Overall Study||4
244105|NCT00551707|586676|P5|STARTED|Overall Study||4
244106|NCT00551707|586677|P4|STARTED|Overall Study||8
244107|NCT00551707|586678|P3|STARTED|Overall Study||13
244108|NCT00551707|586679|P2|STARTED|Overall Study||22
244109|NCT00551707|586680|P1|STARTED|Overall Study||4
244110|NCT00551642|586699|P2|NOT COMPLETED|Overall Study||63
244111|NCT00551642|586700|P1|NOT COMPLETED|Overall Study||61
244112|NCT00551642|586699|P2|COMPLETED|Overall Study||338
244113|NCT00551642|586700|P1|COMPLETED|Overall Study||338
244114|NCT00551642|586699|P2|STARTED|Overall Study||401
244115|NCT00551642|586700|P1|STARTED|Overall Study||399
244116|NCT00551525|586706|P1|NOT COMPLETED|Overall Study||5
244117|NCT00551525|586706|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
244118|NCT00551525|586706|P1|STARTED|Overall Study||67
244119|NCT00551460|586715|P1|NOT COMPLETED|Overall Study||18
244120|NCT00551460|586715|P1|COMPLETED|Overall Study||60
244121|NCT00551460|586715|P1|STARTED|Overall Study||78
244122|NCT00551421|586721|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
244123|NCT00551421|586721|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
244124|NCT00551421|586721|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
244125|NCT00551421|586721|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
244126|NCT00551421|586721|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
244127|NCT00551421|586721|P1|STARTED|Original Protocol, Dose Level 1||3
244128|NCT00551369|586728|P1|NOT COMPLETED|Overall Study||7
244129|NCT00551369|586728|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
244130|NCT00551369|586728|P1|STARTED|Overall Study||33
244131|NCT00551291|586736|P1|NOT COMPLETED|Overall Study||1
244132|NCT00551291|586736|P1|COMPLETED|Overall Study||9
244133|NCT00551291|586736|P1|STARTED|Overall Study||10
244134|NCT00551213|586744|P2|NOT COMPLETED|Overall Study||17
244135|NCT00551213|586745|P1|NOT COMPLETED|Overall Study||50
244136|NCT00551213|586744|P2|COMPLETED|Overall Study||0
244137|NCT00551213|586745|P1|COMPLETED|Overall Study||0
244138|NCT00551213|586744|P2|Treated|Overall Study||15
244139|NCT00551213|586745|P1|Treated|Overall Study||49
244140|NCT00551213|586744|P2|STARTED|Overall Study||17
244141|NCT00551213|586745|P1|STARTED|Overall Study||50
244142|NCT00551200|586761|P1|NOT COMPLETED|Overall Study||4
244143|NCT00551200|586761|P1|COMPLETED|Overall Study||10
244144|NCT00551200|586761|P1|STARTED|Overall Study||14
244145|NCT00551174|586776|P2|NOT COMPLETED|Overall Study||6
244146|NCT00551174|586777|P1|NOT COMPLETED|Overall Study||19
244147|NCT00551174|586776|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
244148|NCT00551174|586777|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
244149|NCT00551174|586776|P2|STARTED|Overall Study||400
244150|NCT00551174|586777|P1|STARTED|Overall Study||381
244151|NCT00551161|586789|P1|NOT COMPLETED|Overall Study||1
244152|NCT00551161|586789|P1|COMPLETED|Overall Study||11
244153|NCT00551161|586789|P1|STARTED|Overall Study||12
244154|NCT00551135|586797|P4|NOT COMPLETED|Overall Study||5
244155|NCT00551135|586798|P3|NOT COMPLETED|Overall Study||5
244156|NCT00551135|586799|P2|NOT COMPLETED|Overall Study||2
244157|NCT00551135|586800|P1|NOT COMPLETED|Overall Study||5
244158|NCT00551135|586797|P4|COMPLETED|Overall Study||103
244159|NCT00551135|586798|P3|COMPLETED|Overall Study||98
244160|NCT00551135|586799|P2|COMPLETED|Overall Study||104
244161|NCT00551135|586800|P1|COMPLETED|Overall Study||103
244162|NCT00551135|586797|P4|STARTED|Overall Study||108
244163|NCT00551135|586798|P3|STARTED|Overall Study||103
244164|NCT00551135|586799|P2|STARTED|Overall Study||106
244165|NCT00551135|586800|P1|STARTED|Overall Study||108
244166|NCT00551070|586914|P1|NOT COMPLETED|Overall Study||0
244167|NCT00551070|586914|P1|COMPLETED|Overall Study||52
244168|NCT00551070|586914|P1|STARTED|Overall Study||52
244169|NCT00551031|586929|P5|NOT COMPLETED|Overall Study||1
244170|NCT00551031|586930|P4|NOT COMPLETED|Overall Study||3
244171|NCT00551031|586931|P3|NOT COMPLETED|Overall Study||2
244172|NCT00551031|586932|P2|NOT COMPLETED|Overall Study||11
244173|NCT00551031|586933|P1|NOT COMPLETED|Overall Study||2
244174|NCT00551031|586929|P5|COMPLETED|Overall Study||185
244175|NCT00551031|586930|P4|COMPLETED|Overall Study||317
244176|NCT00551031|586931|P3|COMPLETED|Overall Study||317
244177|NCT00551031|586932|P2|COMPLETED|Overall Study||625
244178|NCT00551031|586933|P1|COMPLETED|Overall Study||635
244179|NCT00551031|586929|P5|STARTED|Overall Study||186
244180|NCT00551031|586930|P4|STARTED|Overall Study||320
244181|NCT00551031|586931|P3|STARTED|Overall Study||319
244182|NCT00551031|586932|P2|STARTED|Overall Study||636
244183|NCT00551031|586933|P1|STARTED|Overall Study||637
244184|NCT00550953|586962|P2|NOT COMPLETED|Overall Study||6
244185|NCT00550953|586963|P1|NOT COMPLETED|Overall Study||6
244186|NCT00550953|586962|P2|COMPLETED|Overall Study||152
244187|NCT00550953|586963|P1|COMPLETED|Overall Study||150
244188|NCT00550953|586962|P2|STARTED|Overall Study||158
244189|NCT00550953|586963|P1|STARTED|Overall Study||156
244190|NCT00550862|586987|P4|NOT COMPLETED|Overall Study||1
244191|NCT00550862|586988|P3|NOT COMPLETED|Overall Study||16
244192|NCT00550862|586989|P2|NOT COMPLETED|Overall Study||6
244193|NCT00550862|586990|P1|NOT COMPLETED|Overall Study||6
244194|NCT00550862|586987|P4|COMPLETED|Overall Study||37
244195|NCT00550862|586988|P3|COMPLETED|Overall Study||25
244196|NCT00550862|586989|P2|COMPLETED|Overall Study||42
244197|NCT00550862|586990|P1|COMPLETED|Overall Study||32
244198|NCT00550862|586987|P4|STARTED|Overall Study||38
244199|NCT00550862|586988|P3|STARTED|Overall Study||41
244200|NCT00550862|586989|P2|STARTED|Overall Study||48
244201|NCT00550862|586990|P1|STARTED|Overall Study||38
244202|NCT00550836|587010|P2|NOT COMPLETED|Overall Study||9
244203|NCT00550836|587011|P1|NOT COMPLETED|Overall Study||3
244204|NCT00550836|587010|P2|COMPLETED|Overall Study||46
244205|NCT00550836|587011|P1|COMPLETED|Overall Study||46
244206|NCT00550836|587010|P2|STARTED|Overall Study||55
244207|NCT00550836|587011|P1|STARTED|Overall Study||49
244208|NCT00550771|587027|P2|NOT COMPLETED|Overall Study||10
244209|NCT00550771|587028|P1|NOT COMPLETED|Overall Study||17
244210|NCT00550771|587027|P2|COMPLETED|Overall Study||50
244211|NCT00550771|587028|P1|COMPLETED|Overall Study||104
244212|NCT00550771|587027|P2|STARTED|Overall Study||60
244213|NCT00550771|587028|P1|STARTED|Overall Study||121
244214|NCT00550745|587042|P2|NOT COMPLETED|Overall Study||60
244215|NCT00550745|587043|P1|NOT COMPLETED|Overall Study||87
244216|NCT00550745|587042|P2|COMPLETED|Overall Study||5939
244217|NCT00550745|587043|P1|COMPLETED|Overall Study||5913
244218|NCT00550745|587042|P2|STARTED|Overall Study||5999
244219|NCT00550745|587043|P1|STARTED|Overall Study||6000
244220|NCT00550732|587051|P1|NOT COMPLETED|Overall Study||11
244221|NCT00550732|587051|P1|COMPLETED|Overall Study||29
244222|NCT00550732|587051|P1|STARTED|Overall Study||40
244223|NCT00550680|587062|P1|NOT COMPLETED|Overall Study||56
244224|NCT00550680|587062|P1|COMPLETED|Overall Study||152
244225|NCT00550680|587062|P1|STARTED|Overall Study||208
244226|NCT00550654|587071|P1|NOT COMPLETED|Overall Study||0
244227|NCT00550654|587071|P1|COMPLETED|Overall Study||1
244228|NCT00550654|587071|P1|STARTED|Overall Study||1
244229|NCT00550589|587081|P1|NOT COMPLETED|Overall Study||0
244230|NCT00550589|587081|P1|COMPLETED|Overall Study||33
244231|NCT00550589|587081|P1|STARTED|Overall Study||33
244232|NCT00550550|587094|P2|NOT COMPLETED|Overall Study||29
244233|NCT00550550|587095|P1|NOT COMPLETED|Overall Study||34
244234|NCT00550550|587094|P2|COMPLETED|Overall Study||140
244235|NCT00550550|587095|P1|COMPLETED|Overall Study||142
244236|NCT00550550|587094|P2|Number Treated|Overall Study||169
244237|NCT00550550|587095|P1|Number Treated|Overall Study||175
244238|NCT00550550|587094|P2|STARTED|Overall Study||169
244239|NCT00550550|587095|P1|STARTED|Overall Study||176
244240|NCT00550537|587107|P1|NOT COMPLETED|Overall Study||104
244241|NCT00550537|587107|P1|COMPLETED|Overall Study||12
244242|NCT00550537|587107|P1|STARTED|Overall Study||116
244243|NCT00550459|587124|P2|NOT COMPLETED|Overall Study||3
244244|NCT00550459|587125|P1|NOT COMPLETED|Overall Study||1
244245|NCT00550459|587124|P2|COMPLETED|Overall Study||26
244246|NCT00550459|587125|P1|COMPLETED|Overall Study||27
244247|NCT00550459|587124|P2|STARTED|Overall Study||29
244248|NCT00550459|587125|P1|STARTED|Overall Study||28
244249|NCT00550446|587194|P11|NOT COMPLETED|Post Week 12||1
244250|NCT00550446|587195|P10|NOT COMPLETED|Post Week 12||7
244251|NCT00550446|587196|P9|NOT COMPLETED|Post Week 12||2
244252|NCT00550446|587197|P8|NOT COMPLETED|Post Week 12||1
244253|NCT00550446|587198|P7|NOT COMPLETED|Post Week 12||2
244254|NCT00550446|587199|P6|NOT COMPLETED|Post Week 12||1
244255|NCT00550446|587200|P5|NOT COMPLETED|Post Week 12||2
244256|NCT00550446|587201|P4|NOT COMPLETED|Post Week 12||3
244257|NCT00550446|587202|P3|NOT COMPLETED|Post Week 12||3
244258|NCT00550446|587203|P2|NOT COMPLETED|Post Week 12||2
244259|NCT00550446|587204|P1|NOT COMPLETED|Post Week 12||3
244260|NCT00550446|587194|P11|COMPLETED|Post Week 12||24
244261|NCT00550446|587195|P10|COMPLETED|Post Week 12||37
244262|NCT00550446|587196|P9|COMPLETED|Post Week 12||15
244263|NCT00550446|587197|P8|COMPLETED|Post Week 12||16
244264|NCT00550446|587198|P7|COMPLETED|Post Week 12||19
244265|NCT00550446|587199|P6|COMPLETED|Post Week 12||0
244266|NCT00550446|587200|P5|COMPLETED|Post Week 12||52
244267|NCT00550446|587201|P4|COMPLETED|Post Week 12||55
244268|NCT00550446|587202|P3|COMPLETED|Post Week 12||43
244269|NCT00550446|587203|P2|COMPLETED|Post Week 12||28
244270|NCT00550446|587204|P1|COMPLETED|Post Week 12||24
244271|NCT00550446|587194|P11|STARTED|Post Week 12||25
244272|NCT00550446|587195|P10|STARTED|Post Week 12||44
244273|NCT00550446|587196|P9|STARTED|Post Week 12||17
244274|NCT00550446|587197|P8|STARTED|Post Week 12||17
244275|NCT00550446|587198|P7|STARTED|Post Week 12||21
244276|NCT00550446|587199|P6|STARTED|Post Week 12||1
244277|NCT00550446|587200|P5|STARTED|Post Week 12||54
244278|NCT00550446|587201|P4|STARTED|Post Week 12||58
244279|NCT00550446|587202|P3|STARTED|Post Week 12||46
244280|NCT00550446|587203|P2|STARTED|Post Week 12||30
244281|NCT00550446|587204|P1|STARTED|Post Week 12||27
244282|NCT00550446|587194|P11|NOT COMPLETED|Up To Week 12||0
244283|NCT00550446|587195|P10|NOT COMPLETED|Up To Week 12||0
244284|NCT00550446|587196|P9|NOT COMPLETED|Up To Week 12||0
244285|NCT00550446|587197|P8|NOT COMPLETED|Up To Week 12||0
244286|NCT00550446|587198|P7|NOT COMPLETED|Up To Week 12||13
244287|NCT00550446|587199|P6|NOT COMPLETED|Up To Week 12||8
244288|NCT00550446|587200|P5|NOT COMPLETED|Up To Week 12||3
244289|NCT00550446|587201|P4|NOT COMPLETED|Up To Week 12||3
244290|NCT00550446|587202|P3|NOT COMPLETED|Up To Week 12||4
244291|NCT00550446|587203|P2|NOT COMPLETED|Up To Week 12||5
244292|NCT00550446|587204|P1|NOT COMPLETED|Up To Week 12||10
244293|NCT00550446|587194|P11|COMPLETED|Up To Week 12||0
244294|NCT00550446|587195|P10|COMPLETED|Up To Week 12||0
244295|NCT00550446|587196|P9|COMPLETED|Up To Week 12||0
244296|NCT00550446|587197|P8|COMPLETED|Up To Week 12||0
244297|NCT00550446|587198|P7|COMPLETED|Up To Week 12||46
244298|NCT00550446|587199|P6|COMPLETED|Up To Week 12||45
244299|NCT00550446|587200|P5|COMPLETED|Up To Week 12||54
244300|NCT00550446|587201|P4|COMPLETED|Up To Week 12||58
244301|NCT00550446|587202|P3|COMPLETED|Up To Week 12||46
244302|NCT00550446|587203|P2|COMPLETED|Up To Week 12||47
244303|NCT00550446|587204|P1|COMPLETED|Up To Week 12||44
244304|NCT00550446|587194|P11|Treated|Up To Week 12||0
244305|NCT00550446|587195|P10|Treated|Up To Week 12||0
244306|NCT00550446|587196|P9|Treated|Up To Week 12||0
244307|NCT00550446|587197|P8|Treated|Up To Week 12||0
244308|NCT00550446|587198|P7|Treated|Up To Week 12||59
244309|NCT00550446|587199|P6|Treated|Up To Week 12||53
244310|NCT00550446|587200|P5|Treated|Up To Week 12||57
244311|NCT00550446|587201|P4|Treated|Up To Week 12||61
244312|NCT00550446|587202|P3|Treated|Up To Week 12||49
244313|NCT00550446|587203|P2|Treated|Up To Week 12||51
244314|NCT00550446|587204|P1|Treated|Up To Week 12||54
244315|NCT00550446|587194|P11|STARTED|Up To Week 12||0
244316|NCT00550446|587195|P10|STARTED|Up To Week 12||0
244317|NCT00550446|587196|P9|STARTED|Up To Week 12||0
244318|NCT00550446|587197|P8|STARTED|Up To Week 12||0
244319|NCT00550446|587198|P7|STARTED|Up To Week 12||59
244320|NCT00550446|587199|P6|STARTED|Up To Week 12||53
244321|NCT00550446|587200|P5|STARTED|Up To Week 12||57
244322|NCT00550446|587201|P4|STARTED|Up To Week 12||61
244323|NCT00550446|587202|P3|STARTED|Up To Week 12||50
244324|NCT00550446|587203|P2|STARTED|Up To Week 12||52
244325|NCT00550446|587204|P1|STARTED|Up To Week 12||54
244326|NCT00550420|587636|P1|NOT COMPLETED|Overall Study||305
244327|NCT00550420|587636|P1|COMPLETED|Overall Study||26
244328|NCT00550420|587636|P1|STARTED|Overall Study||331
244329|NCT00550407|587659|P3|NOT COMPLETED|26-Week Randomized Phase||24
244330|NCT00550407|587660|P2|NOT COMPLETED|26-Week Randomized Phase||43
244331|NCT00550407|587661|P1|NOT COMPLETED|26-Week Randomized Phase||0
244332|NCT00550407|587659|P3|COMPLETED|26-Week Randomized Phase||21
244333|NCT00550407|587660|P2|COMPLETED|26-Week Randomized Phase||15
244334|NCT00550407|587661|P1|COMPLETED|26-Week Randomized Phase||0
244335|NCT00550407|587659|P3|STARTED|26-Week Randomized Phase||45
244336|NCT00550407|587660|P2|STARTED|26-Week Randomized Phase||58
244337|NCT00550407|587661|P1|STARTED|26-Week Randomized Phase||0
244338|NCT00550407|587659|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
244339|NCT00550407|587660|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
244340|NCT00550407|587661|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
244341|NCT00550407|587659|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
244342|NCT00550407|587660|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
244343|NCT00550407|587661|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
244344|NCT00550407|587659|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
244345|NCT00550407|587660|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
244346|NCT00550407|587661|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
244347|NCT00550394|587696|P2|NOT COMPLETED|Overall Study||13
244348|NCT00550394|587697|P1|NOT COMPLETED|Overall Study||12
244349|NCT00550394|587696|P2|COMPLETED|Overall Study||5
244350|NCT00550394|587697|P1|COMPLETED|Overall Study||9
244351|NCT00550394|587696|P2|STARTED|Overall Study||18
244352|NCT00550394|587697|P1|STARTED|Overall Study||21
244353|NCT00550368|587711|P2|NOT COMPLETED|Overall Study||0
244354|NCT00550368|587712|P1|NOT COMPLETED|Overall Study||0
244355|NCT00550368|587711|P2|COMPLETED|Overall Study||19
244356|NCT00550368|587712|P1|COMPLETED|Overall Study||26
244357|NCT00550368|587711|P2|STARTED|Overall Study||19
244358|NCT00550368|587712|P1|STARTED|Overall Study||26
244359|NCT00550277|587720|P1|NOT COMPLETED|Overall Study||9
244360|NCT00550277|587720|P1|COMPLETED|Overall Study||11
244361|NCT00550277|587720|P1|STARTED|Overall Study||20
244362|NCT00550173|587727|P3|NOT COMPLETED|Overall Study||73
244363|NCT00550173|587728|P2|NOT COMPLETED|Overall Study||63
244364|NCT00550173|587729|P1|NOT COMPLETED|Overall Study||72
244365|NCT00550173|587727|P3|COMPLETED|Overall Study||11
244366|NCT00550173|587728|P2|COMPLETED|Overall Study||19
244367|NCT00550173|587729|P1|COMPLETED|Overall Study||9
244368|NCT00550173|587727|P3|Not Discontinued at 18 Months|Overall Study||11
244369|NCT00550173|587728|P2|Not Discontinued at 18 Months|Overall Study||19
244370|NCT00550173|587729|P1|Not Discontinued at 18 Months|Overall Study||9
244371|NCT00550173|587727|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
244372|NCT00550173|587728|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
244373|NCT00550173|587729|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
244374|NCT00550173|587727|P3|STARTED|Overall Study||84
244375|NCT00550173|587728|P2|STARTED|Overall Study||82
244376|NCT00550173|587729|P1|STARTED|Overall Study||81
244377|NCT00550147|587758|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
244378|NCT00550147|587758|P1|COMPLETED|Quetiapine Addition Treatment Period||18
244379|NCT00550147|587758|P1|STARTED|Quetiapine Addition Treatment Period||24
244380|NCT00550147|587758|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
244381|NCT00550147|587758|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
244382|NCT00550147|587758|P1|STARTED|OROS Methylphenidate Monotherapy||30
244383|NCT00550043|587781|P5|NOT COMPLETED|Overall Study||1
244384|NCT00550043|587782|P4|NOT COMPLETED|Overall Study||2
244385|NCT00550043|587783|P3|NOT COMPLETED|Overall Study||1
244386|NCT00550043|587784|P2|NOT COMPLETED|Overall Study||3
244387|NCT00550043|587785|P1|NOT COMPLETED|Overall Study||0
244388|NCT00550043|587781|P5|COMPLETED|Overall Study||9
244389|NCT00550043|587782|P4|COMPLETED|Overall Study||8
244390|NCT00550043|587783|P3|COMPLETED|Overall Study||8
244391|NCT00550043|587784|P2|COMPLETED|Overall Study||9
244392|NCT00550043|587785|P1|COMPLETED|Overall Study||9
244393|NCT00550043|587781|P5|STARTED|Overall Study||10
244394|NCT00550043|587782|P4|STARTED|Overall Study||10
244395|NCT00550043|587783|P3|STARTED|Overall Study||9
244396|NCT00550043|587784|P2|STARTED|Overall Study||12
244397|NCT00550043|587785|P1|STARTED|Overall Study||9
244398|NCT00549939|587840|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
244399|NCT00549939|587841|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
244400|NCT00549939|587842|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
244401|NCT00549939|587840|P3|COMPLETED|40-week Open Label Treatment Period||78
244402|NCT00549939|587841|P2|COMPLETED|40-week Open Label Treatment Period||75
244403|NCT00549939|587842|P1|COMPLETED|40-week Open Label Treatment Period||0
244404|NCT00549939|587840|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
244405|NCT00549939|587841|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
244406|NCT00549939|587842|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
244407|NCT00549939|587840|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
244408|NCT00549939|587841|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
244409|NCT00549939|587842|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
244410|NCT00549939|587840|P3|COMPLETED|12-week Double Blind Treatment Period||56
244411|NCT00549939|587841|P2|COMPLETED|12-week Double Blind Treatment Period||55
244412|NCT00549939|587842|P1|COMPLETED|12-week Double Blind Treatment Period||56
244413|NCT00549939|587840|P3|STARTED|12-week Double Blind Treatment Period||58
244414|NCT00549939|587841|P2|STARTED|12-week Double Blind Treatment Period||57
244415|NCT00549939|587842|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
244416|NCT00549900|587869|P1|NOT COMPLETED|Overall Study||1
244417|NCT00549900|587869|P1|COMPLETED|Overall Study||29
244418|NCT00549900|587869|P1|STARTED|Overall Study||30
244419|NCT00549822|587878|P1|NOT COMPLETED|Overall Study||0
244420|NCT00549822|587878|P1|COMPLETED|Overall Study||3
244421|NCT00549822|587878|P1|STARTED|Overall Study||3
244422|NCT00549783|587886|P2|NOT COMPLETED|Overall Study||13
244423|NCT00549783|587887|P1|NOT COMPLETED|Overall Study||8
244424|NCT00549783|587886|P2|COMPLETED|Overall Study||122
244425|NCT00549783|587887|P1|COMPLETED|Overall Study||131
244426|NCT00549783|587886|P2|STARTED|Overall Study||135
244427|NCT00549783|587887|P1|STARTED|Overall Study||139
244428|NCT00549770|587925|P8|NOT COMPLETED|Overall Study||25
244429|NCT00549770|587926|P7|NOT COMPLETED|Overall Study||14
244430|NCT00549770|587927|P6|NOT COMPLETED|Overall Study||13
244431|NCT00549770|587928|P5|NOT COMPLETED|Overall Study||17
244432|NCT00549770|587929|P4|NOT COMPLETED|Overall Study||16
244433|NCT00549770|587930|P3|NOT COMPLETED|Overall Study||10
244434|NCT00549770|587931|P2|NOT COMPLETED|Overall Study||11
244435|NCT00549770|587932|P1|NOT COMPLETED|Overall Study||7
244436|NCT00549770|587925|P8|COMPLETED|Overall Study||148
244437|NCT00549770|587926|P7|COMPLETED|Overall Study||151
244438|NCT00549770|587927|P6|COMPLETED|Overall Study||151
244439|NCT00549770|587928|P5|COMPLETED|Overall Study||149
244440|NCT00549770|587929|P4|COMPLETED|Overall Study||147
244441|NCT00549770|587930|P3|COMPLETED|Overall Study||162
244442|NCT00549770|587931|P2|COMPLETED|Overall Study||158
244443|NCT00549770|587932|P1|COMPLETED|Overall Study||149
244444|NCT00549770|587925|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
244445|NCT00549770|587926|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
244446|NCT00549770|587927|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
244447|NCT00549770|587928|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
244448|NCT00549770|587929|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
244449|NCT00549770|587930|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
244450|NCT00549770|587931|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
244451|NCT00549770|587932|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
244452|NCT00549770|587925|P8|Intent-to-treat Population|Overall Study||172
244453|NCT00549770|587926|P7|Intent-to-treat Population|Overall Study||164
244454|NCT00549770|587927|P6|Intent-to-treat Population|Overall Study||163
244455|NCT00549770|587928|P5|Intent-to-treat Population|Overall Study||163
244456|NCT00549770|587929|P4|Intent-to-treat Population|Overall Study||163
244457|NCT00549770|587930|P3|Intent-to-treat Population|Overall Study||170
244458|NCT00549770|587931|P2|Intent-to-treat Population|Overall Study||168
244459|NCT00549770|587932|P1|Intent-to-treat Population|Overall Study||154
244460|NCT00549770|587925|P8|STARTED|Overall Study||173
244461|NCT00549770|587926|P7|STARTED|Overall Study||165
244462|NCT00549770|587927|P6|STARTED|Overall Study||164
244463|NCT00549770|587928|P5|STARTED|Overall Study||166
244464|NCT00549770|587929|P4|STARTED|Overall Study||163
244465|NCT00549770|587930|P3|STARTED|Overall Study||172
244466|NCT00549770|587931|P2|STARTED|Overall Study||169
244467|NCT00549770|587932|P1|STARTED|Overall Study||156
244468|NCT00549757|588016|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
244469|NCT00549757|588017|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
244470|NCT00549757|588016|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
244471|NCT00549757|588017|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
244472|NCT00549757|588016|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
244473|NCT00549757|588017|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
244474|NCT00549757|588016|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
244475|NCT00549757|588017|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
244476|NCT00549757|588016|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
244477|NCT00549757|588017|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
244478|NCT00549757|588016|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
244479|NCT00549757|588017|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
244480|NCT00549757|588016|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
244481|NCT00549757|588017|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
244482|NCT00549757|588016|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
244483|NCT00549757|588017|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
244484|NCT00549718|588079|P4|NOT COMPLETED|Overall Study||55
244485|NCT00549718|588080|P3|NOT COMPLETED|Overall Study||39
244486|NCT00549718|588081|P2|NOT COMPLETED|Overall Study||37
244487|NCT00549718|588082|P1|NOT COMPLETED|Overall Study||41
244488|NCT00549718|588079|P4|COMPLETED|Overall Study||73
244489|NCT00549718|588080|P3|COMPLETED|Overall Study||85
244490|NCT00549718|588081|P2|COMPLETED|Overall Study||86
244491|NCT00549718|588082|P1|COMPLETED|Overall Study||84
244492|NCT00549718|588079|P4|STARTED|Overall Study||128
244493|NCT00549718|588080|P3|STARTED|Overall Study||124
244494|NCT00549718|588081|P2|STARTED|Overall Study||123
244495|NCT00549718|588082|P1|STARTED|Overall Study||125
244496|NCT00549640|588098|P2|NOT COMPLETED|Overall Study||16
244497|NCT00549640|588099|P1|NOT COMPLETED|Overall Study||18
244498|NCT00549640|588098|P2|COMPLETED|Overall Study||24
244499|NCT00549640|588099|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
244500|NCT00549640|588098|P2|STARTED|Overall Study||40
244501|NCT00549640|588099|P1|STARTED|Overall Study||40
244502|NCT00549601|588112|P3|NOT COMPLETED|Received Study Drug||4
244503|NCT00549601|588113|P2|NOT COMPLETED|Received Study Drug||11
244504|NCT00549601|588114|P1|NOT COMPLETED|Received Study Drug||7
244505|NCT00549601|588112|P3|COMPLETED|Received Study Drug||45
244506|NCT00549601|588113|P2|COMPLETED|Received Study Drug||36
244507|NCT00549601|588114|P1|COMPLETED|Received Study Drug||36
244508|NCT00549601|588112|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
244509|NCT00549601|588113|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
244510|NCT00549601|588114|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
244511|NCT00549601|588112|P3|NOT COMPLETED|Randomized||2
244512|NCT00549601|588113|P2|NOT COMPLETED|Randomized||1
244513|NCT00549601|588114|P1|NOT COMPLETED|Randomized||0
244514|NCT00549601|588112|P3|COMPLETED|Randomized||49
244515|NCT00549601|588113|P2|COMPLETED|Randomized||47
244516|NCT00549601|588114|P1|COMPLETED|Randomized||43
244517|NCT00549601|588112|P3|STARTED|Randomized||51
244518|NCT00549601|588113|P2|STARTED|Randomized||48
244519|NCT00549601|588114|P1|STARTED|Randomized||43
244520|NCT00549562|588136|P1|NOT COMPLETED|Overall Study||2
244521|NCT00549562|588136|P1|COMPLETED|Overall Study||23
244522|NCT00549562|588136|P1|STARTED|Overall Study||25
244523|NCT00549549|588148|P4|NOT COMPLETED|Overall Study||25
244524|NCT00549549|588149|P3|NOT COMPLETED|Overall Study||17
244525|NCT00549549|588150|P2|NOT COMPLETED|Overall Study||22
244526|NCT00549549|588151|P1|NOT COMPLETED|Overall Study||24
244527|NCT00549549|588148|P4|COMPLETED|Overall Study||78
244528|NCT00549549|588149|P3|COMPLETED|Overall Study||82
244529|NCT00549549|588150|P2|COMPLETED|Overall Study||77
244530|NCT00549549|588151|P1|COMPLETED|Overall Study||77
244531|NCT00549549|588148|P4|Treated|Overall Study||102
244532|NCT00549549|588149|P3|Treated|Overall Study||98
244533|NCT00549549|588150|P2|Treated|Overall Study||99
244534|NCT00549549|588151|P1|Treated|Overall Study||101
244535|NCT00549549|588148|P4|STARTED|Overall Study||103
244536|NCT00549549|588149|P3|STARTED|Overall Study||99
244537|NCT00549549|588150|P2|STARTED|Overall Study||99
244538|NCT00549549|588151|P1|STARTED|Overall Study||101
244539|NCT00549445|588219|P2|NOT COMPLETED|Overall Study||17
244540|NCT00549445|588220|P1|NOT COMPLETED|Overall Study||15
244541|NCT00549445|588219|P2|COMPLETED|Overall Study||13
244542|NCT00549445|588220|P1|COMPLETED|Overall Study||8
244543|NCT00549445|588219|P2|STARTED|Overall Study||30
244544|NCT00549445|588220|P1|STARTED|Overall Study||23
244545|NCT00549393|588228|P2|NOT COMPLETED|Period 3 (6 Months)||0
244546|NCT00549393|588229|P1|NOT COMPLETED|Period 3 (6 Months)||0
244547|NCT00549393|588228|P2|COMPLETED|Period 3 (6 Months)||1326
244548|NCT00549393|588229|P1|COMPLETED|Period 3 (6 Months)||1103
244549|NCT00549393|588228|P2|Per Protocol|Period 3 (6 Months)||1326
244550|NCT00549393|588229|P1|Per Protocol|Period 3 (6 Months)||667
244551|NCT00549393|588228|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
244552|NCT00549393|588229|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
244553|NCT00549393|588228|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
244554|NCT00549393|588229|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
244555|NCT00549393|588228|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
244556|NCT00549393|588229|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
244557|NCT00549393|588228|P2|STARTED|Period 2 Washout (2 Weeks)||0
244558|NCT00549393|588229|P1|STARTED|Period 2 Washout (2 Weeks)||0
244559|NCT00549393|588228|P2|NOT COMPLETED|Period 1 (6 Months)||0
244560|NCT00549393|588229|P1|NOT COMPLETED|Period 1 (6 Months)||0
244561|NCT00549393|588228|P2|COMPLETED|Period 1 (6 Months)||1199
244562|NCT00549393|588229|P1|COMPLETED|Period 1 (6 Months)||1319
244563|NCT00549393|588228|P2|Per Protocol|Period 1 (6 Months)||1199
244564|NCT00549393|588229|P1|Per Protocol|Period 1 (6 Months)||880
244565|NCT00549393|588228|P2|STARTED|Period 1 (6 Months)|ITT|1199
244566|NCT00549393|588229|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
244567|NCT00549328|588239|P1|NOT COMPLETED|Overall Study||14
244568|NCT00549328|588239|P1|COMPLETED|Overall Study||0
244569|NCT00549328|588239|P1|STARTED|Overall Study||14
244570|NCT00549302|588250|P3|NOT COMPLETED|Open-Label||69
244571|NCT00549302|588251|P2|NOT COMPLETED|Open-Label||0
244572|NCT00549302|588252|P1|NOT COMPLETED|Open-Label||0
244573|NCT00549302|588250|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
244574|NCT00549302|588251|P2|COMPLETED|Open-Label||0
244575|NCT00549302|588252|P1|COMPLETED|Open-Label||0
244576|NCT00549302|588250|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
244577|NCT00549302|588251|P2|STARTED|Open-Label||0
244578|NCT00549302|588252|P1|STARTED|Open-Label||0
244579|NCT00549302|588250|P3|NOT COMPLETED|Double-Blind||0
244580|NCT00549302|588251|P2|NOT COMPLETED|Double-Blind||53
244581|NCT00549302|588252|P1|NOT COMPLETED|Double-Blind||11
244582|NCT00549302|588250|P3|COMPLETED|Double-Blind||0
244583|NCT00549302|588251|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
244584|NCT00549302|588252|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
244585|NCT00549302|588250|P3|Received at Least One Dose of Study Drug|Double-Blind||0
244586|NCT00549302|588251|P2|Received at Least One Dose of Study Drug|Double-Blind||294
244587|NCT00549302|588252|P1|Received at Least One Dose of Study Drug|Double-Blind||63
244588|NCT00549302|588250|P3|STARTED|Double-Blind||0
244589|NCT00549302|588251|P2|STARTED|Double-Blind||294
244590|NCT00549302|588252|P1|STARTED|Double-Blind||63
244591|NCT00549198|588264|P2|NOT COMPLETED|Overall Study||63
244592|NCT00549198|588265|P1|NOT COMPLETED|Overall Study||80
244593|NCT00549198|588264|P2|COMPLETED|Overall Study||134
244594|NCT00549198|588265|P1|COMPLETED|Overall Study||115
244595|NCT00549198|588264|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
244596|NCT00549198|588265|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
244597|NCT00549172|588387|P2|NOT COMPLETED|Overall Study||0
244598|NCT00549172|588388|P1|NOT COMPLETED|Overall Study||0
244599|NCT00549172|588387|P2|COMPLETED|Overall Study||76
244600|NCT00549172|588388|P1|COMPLETED|Overall Study||70
244601|NCT00549172|588387|P2|STARTED|Overall Study||76
244602|NCT00549172|588388|P1|STARTED|Overall Study||70
244603|NCT00549055|588402|P1|NOT COMPLETED|Overall Study||35
244604|NCT00549055|588402|P1|COMPLETED|Overall Study||3
244605|NCT00549055|588402|P1|STARTED|Overall Study||38
244606|NCT00548886|588412|P1|NOT COMPLETED|Overall Study||0
244607|NCT00548886|588412|P1|COMPLETED|Overall Study||7
244608|NCT00548886|588412|P1|STARTED|Overall Study||7
244609|NCT00548860|588419|P2|NOT COMPLETED|Overall Study||175
244610|NCT00548860|588420|P1|NOT COMPLETED|Overall Study||136
244611|NCT00548860|588419|P2|COMPLETED|Overall Study||847
244612|NCT00548860|588420|P1|COMPLETED|Overall Study||860
244613|NCT00548860|588419|P2|STARTED|Overall Study||1022
244614|NCT00548860|588420|P1|STARTED|Overall Study||996
244615|NCT00548847|588426|P1|NOT COMPLETED|Overall Study||7
244616|NCT00548847|588426|P1|COMPLETED|Overall Study||8
244617|NCT00548847|588426|P1|STARTED|Overall Study||15
244618|NCT00548808|588433|P2|NOT COMPLETED|Overall Study||26
244619|NCT00548808|588434|P1|NOT COMPLETED|Overall Study||42
244620|NCT00548808|588433|P2|COMPLETED|Overall Study||186
244621|NCT00548808|588434|P1|COMPLETED|Overall Study||172
244622|NCT00548808|588433|P2|Per-Protocol Set|Overall Study||184
244623|NCT00548808|588434|P1|Per-Protocol Set|Overall Study||177
244624|NCT00548808|588433|P2|Full Analysis Set|Overall Study||212
244625|NCT00548808|588434|P1|Full Analysis Set|Overall Study||211
244626|NCT00548808|588433|P2|STARTED|Overall Study||212
244627|NCT00548808|588434|P1|STARTED|Overall Study||214
244628|NCT00548717|588458|P2|NOT COMPLETED|Overall Study||2
244629|NCT00548717|588459|P1|NOT COMPLETED|Overall Study||9
244630|NCT00548717|588458|P2|COMPLETED|Overall Study||0
244631|NCT00548717|588459|P1|COMPLETED|Overall Study||4
244632|NCT00548717|588458|P2|STARTED|Overall Study||2
244633|NCT00548717|588459|P1|STARTED|Overall Study||13
244634|NCT00548691|588478|P2|NOT COMPLETED|Overall Study||9
244635|NCT00548691|588479|P1|NOT COMPLETED|Overall Study||7
244636|NCT00548691|588478|P2|COMPLETED|Overall Study||250
244637|NCT00548691|588479|P1|COMPLETED|Overall Study||251
244638|NCT00548691|588478|P2|STARTED|Overall Study||259
244639|NCT00548691|588479|P1|STARTED|Overall Study||258
244640|NCT00548548|588487|P2|NOT COMPLETED|Overall Study||366
244641|NCT00548548|588488|P1|NOT COMPLETED|Overall Study||362
244642|NCT00548548|588487|P2|COMPLETED|Overall Study||21
244643|NCT00548548|588488|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
244644|NCT00548548|588487|P2|Safety Population|Overall Study||381
244645|NCT00548548|588488|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
244646|NCT00548548|588487|P2|Treated|Overall Study||384
244647|NCT00548548|588488|P1|Treated|Overall Study||383
244648|NCT00548548|588487|P2|STARTED|Overall Study||387
244649|NCT00548548|588488|P1|STARTED|Overall Study||387
244650|NCT00548470|588508|P1|NOT COMPLETED|Overall Study||2
244651|NCT00548470|588508|P1|COMPLETED|Overall Study||12
244652|NCT00548470|588508|P1|STARTED|Overall Study||14
244653|NCT00548431|588516|P1|NOT COMPLETED|Overall Study||0
244654|NCT00548431|588516|P1|COMPLETED|Overall Study||38
244655|NCT00548431|588516|P1|STARTED|Overall Study||38
244656|NCT00548418|588520|P1|NOT COMPLETED|Overall Study||0
244657|NCT00548418|588520|P1|COMPLETED|Overall Study||27
244658|NCT00548418|588520|P1|STARTED|Overall Study||27
244659|NCT00548405|588531|P3|NOT COMPLETED|Overall Study||9
244660|NCT00548405|588532|P2|NOT COMPLETED|Overall Study||20
244661|NCT00548405|588533|P1|NOT COMPLETED|Overall Study||56
244662|NCT00548405|588531|P3|COMPLETED|Overall Study||164
244663|NCT00548405|588532|P2|COMPLETED|Overall Study||416
244664|NCT00548405|588533|P1|COMPLETED|Overall Study||175
244665|NCT00548405|588531|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
244666|NCT00548405|588532|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
244667|NCT00548405|588533|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
244668|NCT00548405|588531|P3|STARTED|Overall Study|Randomized.|173
244669|NCT00548405|588532|P2|STARTED|Overall Study|Randomized.|436
244670|NCT00548405|588533|P1|STARTED|Overall Study|Randomized.|231
244671|NCT00548340|588554|P3|NOT COMPLETED|Overall Study||9
244672|NCT00548340|588555|P2|NOT COMPLETED|Overall Study||11
244673|NCT00548340|588556|P1|NOT COMPLETED|Overall Study||8
244674|NCT00548340|588554|P3|COMPLETED|Overall Study||95
244675|NCT00548340|588555|P2|COMPLETED|Overall Study||98
244676|NCT00548340|588556|P1|COMPLETED|Overall Study||101
244677|NCT00548340|588554|P3|STARTED|Overall Study||104
244678|NCT00548340|588555|P2|STARTED|Overall Study||109
244679|NCT00548340|588556|P1|STARTED|Overall Study||109
244680|NCT00548327|588575|P2|NOT COMPLETED|Overall Study||1
244681|NCT00548327|588576|P1|NOT COMPLETED|Overall Study||0
244682|NCT00548327|588575|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
244683|NCT00548327|588576|P1|COMPLETED|Overall Study||6
244684|NCT00548327|588575|P2|STARTED|Overall Study||5
244685|NCT00548327|588576|P1|STARTED|Overall Study||6
244686|NCT00548262|588594|P1|NOT COMPLETED|Overall Study||32
244687|NCT00548262|588594|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
244688|NCT00548262|588594|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
244689|NCT00548249|588624|P5|NOT COMPLETED|Overall Study||21
244690|NCT00548249|588625|P4|NOT COMPLETED|Overall Study||13
244691|NCT00548249|588626|P3|NOT COMPLETED|Overall Study||20
244692|NCT00548249|588627|P2|NOT COMPLETED|Overall Study||13
244693|NCT00548249|588628|P1|NOT COMPLETED|Overall Study||16
244694|NCT00548249|588624|P5|COMPLETED|Overall Study||7
244695|NCT00548249|588625|P4|COMPLETED|Overall Study||9
244696|NCT00548249|588626|P3|COMPLETED|Overall Study||9
244697|NCT00548249|588627|P2|COMPLETED|Overall Study||13
244698|NCT00548249|588628|P1|COMPLETED|Overall Study||10
244699|NCT00548249|588624|P5|STARTED|Overall Study||28
244700|NCT00548249|588625|P4|STARTED|Overall Study||22
244701|NCT00548249|588626|P3|STARTED|Overall Study||29
244702|NCT00548249|588627|P2|STARTED|Overall Study||26
244703|NCT00548249|588628|P1|STARTED|Overall Study||26
244704|NCT00548184|588665|P1|NOT COMPLETED|Overall Study||5
244705|NCT00548184|588665|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
244706|NCT00548184|588665|P1|STARTED|Overall Study||65
244707|NCT00548145|588671|P2|NOT COMPLETED|Overall Study||4
244708|NCT00548145|588672|P1|NOT COMPLETED|Overall Study||1
244709|NCT00548145|588671|P2|COMPLETED|Overall Study||16
244710|NCT00548145|588672|P1|COMPLETED|Overall Study||17
244711|NCT00548145|588671|P2|STARTED|Overall Study||20
244712|NCT00548145|588672|P1|STARTED|Overall Study||18
244713|NCT00548132|588680|P2|NOT COMPLETED|Overall Study||0
244714|NCT00548132|588681|P1|NOT COMPLETED|Overall Study||0
244715|NCT00548132|588680|P2|COMPLETED|Overall Study||554
244716|NCT00548132|588681|P1|COMPLETED|Overall Study||534
244717|NCT00548132|588680|P2|Consented to Study|Overall Study||554
244718|NCT00548132|588681|P1|Consented to Study|Overall Study||534
244719|NCT00548132|588680|P2|STARTED|Overall Study||554
244720|NCT00548132|588681|P1|STARTED|Overall Study||534
244721|NCT00548041|588689|P1|NOT COMPLETED|Overall Study||0
244722|NCT00548041|588689|P1|COMPLETED|Overall Study||100
244723|NCT00548041|588689|P1|STARTED|Overall Study||100
244724|NCT00547911|588697|P6|NOT COMPLETED|Overall Study||0
244725|NCT00547911|588698|P5|NOT COMPLETED|Overall Study||0
244726|NCT00547911|588699|P4|NOT COMPLETED|Overall Study||1
244727|NCT00547911|588700|P3|NOT COMPLETED|Overall Study||0
244728|NCT00547911|588701|P2|NOT COMPLETED|Overall Study||0
244729|NCT00547911|588702|P1|NOT COMPLETED|Overall Study||0
244730|NCT00547911|588697|P6|COMPLETED|Overall Study||3
244731|NCT00547911|588698|P5|COMPLETED|Overall Study||3
244732|NCT00547911|588699|P4|COMPLETED|Overall Study||1
244733|NCT00547911|588700|P3|COMPLETED|Overall Study||2
244734|NCT00547911|588701|P2|COMPLETED|Overall Study||2
244735|NCT00547911|588702|P1|COMPLETED|Overall Study||2
244736|NCT00547911|588697|P6|STARTED|Overall Study||3
244737|NCT00547911|588698|P5|STARTED|Overall Study||3
244738|NCT00547911|588699|P4|STARTED|Overall Study||2
244739|NCT00547911|588700|P3|STARTED|Overall Study||2
244740|NCT00547911|588701|P2|STARTED|Overall Study||2
244741|NCT00547911|588702|P1|STARTED|Overall Study||2
244742|NCT00547703|588733|P2|NOT COMPLETED|Overall Study||0
244743|NCT00547703|588734|P1|NOT COMPLETED|Overall Study||1
244744|NCT00547703|588733|P2|COMPLETED|Overall Study||1
244745|NCT00547703|588734|P1|COMPLETED|Overall Study||3
244746|NCT00547703|588733|P2|STARTED|Overall Study||1
244747|NCT00547703|588734|P1|STARTED|Overall Study||4
244748|NCT00547638|588742|P2|NOT COMPLETED|Overall Study||14
244749|NCT00547638|588743|P1|NOT COMPLETED|Overall Study||24
244750|NCT00547638|588742|P2|COMPLETED|Overall Study||59
244751|NCT00547638|588743|P1|COMPLETED|Overall Study||119
244752|NCT00547638|588742|P2|STARTED|Overall Study||73
244753|NCT00547638|588743|P1|STARTED|Overall Study||143
244754|NCT00547534|588759|P1|NOT COMPLETED|Overall Study||11
244755|NCT00547534|588759|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
244837|NCT00546910|588928|P2|COMPLETED|Overall Study||51
244756|NCT00547534|588759|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
244757|NCT00547521|588767|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
244758|NCT00547521|588768|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
244759|NCT00547521|588767|P2|COMPLETED|Long Term Extension (LTE) Study||59
244760|NCT00547521|588768|P1|COMPLETED|Long Term Extension (LTE) Study||0
244761|NCT00547521|588767|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
244762|NCT00547521|588768|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
244763|NCT00547521|588767|P2|NOT COMPLETED|Short Term Study (4 Months)||4
244764|NCT00547521|588768|P1|NOT COMPLETED|Short Term Study (4 Months)||1
244765|NCT00547521|588767|P2|COMPLETED|Short Term Study (4 Months)||45
244766|NCT00547521|588768|P1|COMPLETED|Short Term Study (4 Months)||50
244767|NCT00547521|588767|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
244768|NCT00547521|588768|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
244769|NCT00547456|588838|P1|NOT COMPLETED|Overall Study||0
244770|NCT00547456|588838|P1|COMPLETED|Overall Study||20
244771|NCT00547456|588838|P1|STARTED|Overall Study||20
244772|NCT00547378|588845|P3|NOT COMPLETED|All Implanted Cohort||70
244773|NCT00547378|588846|P2|NOT COMPLETED|All Implanted Cohort||18
244774|NCT00547378|588847|P1|NOT COMPLETED|All Implanted Cohort||15
244775|NCT00547378|588845|P3|COMPLETED|All Implanted Cohort||111
244776|NCT00547378|588846|P2|COMPLETED|All Implanted Cohort||22
244777|NCT00547378|588847|P1|COMPLETED|All Implanted Cohort||36
244778|NCT00547378|588845|P3|Month 60|All Implanted Cohort||114
244779|NCT00547378|588846|P2|Month 60|All Implanted Cohort||23
244780|NCT00547378|588847|P1|Month 60|All Implanted Cohort||36
244781|NCT00547378|588845|P3|Month 48|All Implanted Cohort||136
244782|NCT00547378|588846|P2|Month 48|All Implanted Cohort||27
244783|NCT00547378|588847|P1|Month 48|All Implanted Cohort||38
244784|NCT00547378|588845|P3|Month 36|All Implanted Cohort||146
244785|NCT00547378|588846|P2|Month 36|All Implanted Cohort||29
244786|NCT00547378|588847|P1|Month 36|All Implanted Cohort||42
244787|NCT00547378|588845|P3|Month 24|All Implanted Cohort||161
244788|NCT00547378|588846|P2|Month 24|All Implanted Cohort||30
244789|NCT00547378|588847|P1|Month 24|All Implanted Cohort||42
244790|NCT00547378|588845|P3|Month 12|All Implanted Cohort||175
244791|NCT00547378|588846|P2|Month 12|All Implanted Cohort||32
244792|NCT00547378|588847|P1|Month 12|All Implanted Cohort||48
244793|NCT00547378|588845|P3|Month 6|All Implanted Cohort||178
244794|NCT00547378|588846|P2|Month 6|All Implanted Cohort||36
244795|NCT00547378|588847|P1|Month 6|All Implanted Cohort||50
244796|NCT00547378|588845|P3|Month 3|All Implanted Cohort||178
244797|NCT00547378|588846|P2|Month 3|All Implanted Cohort||39
244798|NCT00547378|588847|P1|Month 3|All Implanted Cohort||51
244799|NCT00547378|588845|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
244800|NCT00547378|588846|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
244801|NCT00547378|588847|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
244802|NCT00547378|588845|P3|NOT COMPLETED|Randomized Cohort||0
244803|NCT00547378|588846|P2|NOT COMPLETED|Randomized Cohort||6
244804|NCT00547378|588847|P1|NOT COMPLETED|Randomized Cohort||11
244805|NCT00547378|588845|P3|COMPLETED|Randomized Cohort||0
244806|NCT00547378|588846|P2|COMPLETED|Randomized Cohort||71
244807|NCT00547378|588847|P1|COMPLETED|Randomized Cohort||59
244808|NCT00547378|588845|P3|Month 6|Randomized Cohort||0
244809|NCT00547378|588846|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
244810|NCT00547378|588847|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
244811|NCT00547378|588845|P3|Month 3|Randomized Cohort||0
244812|NCT00547378|588846|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
244813|NCT00547378|588847|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
244814|NCT00547378|588845|P3|STARTED|Randomized Cohort||0
244815|NCT00547378|588846|P2|STARTED|Randomized Cohort||77
244816|NCT00547378|588847|P1|STARTED|Randomized Cohort||70
244817|NCT00547365|588857|P1|NOT COMPLETED|Overall Study||8
244818|NCT00547365|588857|P1|COMPLETED|Overall Study||2
244819|NCT00547365|588857|P1|STARTED|Overall Study||10
244820|NCT00547157|588864|P2|NOT COMPLETED|Overall Study||23
244821|NCT00547157|588865|P1|NOT COMPLETED|Overall Study||49
244822|NCT00547157|588864|P2|COMPLETED|Overall Study||39
244823|NCT00547157|588865|P1|COMPLETED|Overall Study||41
244824|NCT00547157|588864|P2|STARTED|Overall Study||62
244825|NCT00547157|588865|P1|STARTED|Overall Study||90
244826|NCT00547118|588883|P2|NOT COMPLETED|Overall Study||9
244827|NCT00547118|588884|P1|NOT COMPLETED|Overall Study||8
244828|NCT00547118|588883|P2|COMPLETED|Overall Study||0
244829|NCT00547118|588884|P1|COMPLETED|Overall Study||0
244830|NCT00547118|588883|P2|STARTED|Overall Study||9
244831|NCT00547118|588884|P1|STARTED|Overall Study||8
244832|NCT00547105|588916|P1|NOT COMPLETED|Overall Study||0
244833|NCT00547105|588916|P1|COMPLETED|Overall Study||24
244834|NCT00547105|588916|P1|STARTED|Overall Study||24
244835|NCT00546910|588928|P2|NOT COMPLETED|Overall Study||11
244836|NCT00546910|588929|P1|NOT COMPLETED|Overall Study||9
244838|NCT00546910|588929|P1|COMPLETED|Overall Study||54
244839|NCT00546910|588928|P2|STARTED|Overall Study||62
244840|NCT00546910|588929|P1|STARTED|Overall Study||63
244841|NCT00546897|588949|P2|NOT COMPLETED|Overall Study||0
244842|NCT00546897|588950|P1|NOT COMPLETED|Overall Study||0
244843|NCT00546897|588949|P2|COMPLETED|Overall Study||33
244844|NCT00546897|588950|P1|COMPLETED|Overall Study||15
244845|NCT00546897|588949|P2|STARTED|Overall Study||33
244846|NCT00546897|588950|P1|STARTED|Overall Study||15
244847|NCT00546884|588988|P2|NOT COMPLETED|Overall Study||0
244848|NCT00546884|588989|P1|NOT COMPLETED|Overall Study||0
244849|NCT00546884|588988|P2|COMPLETED|Overall Study||117
244850|NCT00546884|588989|P1|COMPLETED|Overall Study||145
244851|NCT00546884|588988|P2|STARTED|Overall Study||117
244852|NCT00546884|588989|P1|STARTED|Overall Study||145
244853|NCT00546871|588995|P2|NOT COMPLETED|Study Extension Period||1
244854|NCT00546871|588996|P1|NOT COMPLETED|Study Extension Period||1
244855|NCT00546871|588995|P2|COMPLETED|Study Extension Period||25
244856|NCT00546871|588996|P1|COMPLETED|Study Extension Period||9
244857|NCT00546871|588995|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
244858|NCT00546871|588996|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
244859|NCT00546871|588995|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
244860|NCT00546871|588996|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
244861|NCT00546871|588995|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
244862|NCT00546871|588996|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
244863|NCT00546871|588995|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
244864|NCT00546871|588996|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
244865|NCT00546871|588995|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
244866|NCT00546871|588996|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
244867|NCT00546871|588995|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
244868|NCT00546871|588996|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
244869|NCT00546871|588995|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
244870|NCT00546871|588996|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
244871|NCT00546871|588995|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
244872|NCT00546871|588996|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
244873|NCT00546871|588995|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
244874|NCT00546871|588996|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
244875|NCT00546871|588995|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
244876|NCT00546871|588996|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
244877|NCT00546871|588995|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
244878|NCT00546871|588996|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
244879|NCT00546871|588995|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
244880|NCT00546871|588996|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
244881|NCT00546871|588995|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
244882|NCT00546871|588996|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
244883|NCT00546819|589101|P2|NOT COMPLETED|Overall Study||6
244884|NCT00546819|589102|P1|NOT COMPLETED|Overall Study||8
244885|NCT00546819|589101|P2|COMPLETED|Overall Study||96
244886|NCT00546819|589102|P1|COMPLETED|Overall Study||199
244887|NCT00546819|589101|P2|VACCINATED|Overall Study||100
244888|NCT00546819|589102|P1|VACCINATED|Overall Study||206
244889|NCT00546819|589101|P2|STARTED|Overall Study||102
244890|NCT00546819|589102|P1|STARTED|Overall Study||207
244891|NCT00546754|589114|P2|NOT COMPLETED|Overall Study||49
244892|NCT00546754|589115|P1|NOT COMPLETED|Overall Study||50
244893|NCT00546754|589114|P2|COMPLETED|Overall Study||334
244894|NCT00546754|589115|P1|COMPLETED|Overall Study||375
244895|NCT00546754|589114|P2|Week 12|Overall Study||334
244896|NCT00546754|589115|P1|Week 12|Overall Study||375
244897|NCT00546754|589114|P2|Week 6|Overall Study||347
244898|NCT00546754|589115|P1|Week 6|Overall Study||396
244899|NCT00546754|589114|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
244900|NCT00546754|589115|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
244901|NCT00546754|589114|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
244902|NCT00546754|589115|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
244903|NCT00546728|589147|P2|NOT COMPLETED|Overall Study||0
244904|NCT00546728|589148|P1|NOT COMPLETED|Overall Study||0
244905|NCT00546728|589147|P2|COMPLETED|Overall Study||25
244906|NCT00546728|589148|P1|COMPLETED|Overall Study||25
244907|NCT00546728|589147|P2|STARTED|Overall Study||25
244908|NCT00546728|589148|P1|STARTED|Overall Study||25
244909|NCT00546715|589158|P4|NOT COMPLETED|Overall Study||0
244910|NCT00546715|589159|P3|NOT COMPLETED|Overall Study||0
244911|NCT00546715|589160|P2|NOT COMPLETED|Overall Study||1
244912|NCT00546715|589161|P1|NOT COMPLETED|Overall Study||0
244913|NCT00546715|589158|P4|COMPLETED|Overall Study||2
244914|NCT00546715|589159|P3|COMPLETED|Overall Study||5
244915|NCT00546715|589160|P2|COMPLETED|Overall Study||4
244916|NCT00546715|589161|P1|COMPLETED|Overall Study||6
244917|NCT00546715|589158|P4|STARTED|Overall Study||2
244918|NCT00546715|589159|P3|STARTED|Overall Study||5
244919|NCT00546715|589160|P2|STARTED|Overall Study||5
244920|NCT00546715|589161|P1|STARTED|Overall Study||6
244921|NCT00546637|589216|P2|NOT COMPLETED|Overall Study||49
244922|NCT00546637|589217|P1|NOT COMPLETED|Overall Study||73
244923|NCT00546637|589216|P2|COMPLETED|Overall Study||424
244924|NCT00546637|589217|P1|COMPLETED|Overall Study||401
244925|NCT00546637|589216|P2|Received Treatment|Overall Study||472
244926|NCT00546637|589217|P1|Received Treatment|Overall Study||471
244927|NCT00546637|589216|P2|STARTED|Overall Study||473
244928|NCT00546637|589217|P1|STARTED|Overall Study||474
244929|NCT00546572|589291|P2|NOT COMPLETED|Vax 2 / Year 1||2
244930|NCT00546572|589292|P1|NOT COMPLETED|Vax 2 / Year 1||4
244931|NCT00546572|589291|P2|COMPLETED|Vax 2 / Year 1||402
244932|NCT00546572|589292|P1|COMPLETED|Vax 2 / Year 1||387
244933|NCT00546572|589291|P2|Received Vax 2|Vax 2 / Year 1||404
244934|NCT00546572|589292|P1|Received Vax 2|Vax 2 / Year 1||391
244935|NCT00546572|589291|P2|STARTED|Vax 2 / Year 1||404
244936|NCT00546572|589292|P1|STARTED|Vax 2 / Year 1||391
244937|NCT00546572|589291|P2|NOT COMPLETED|Vax 1 / Year 0||70
244938|NCT00546572|589292|P1|NOT COMPLETED|Vax 1 / Year 0||73
244939|NCT00546572|589291|P2|COMPLETED|Vax 1 / Year 0||404
244940|NCT00546572|589292|P1|COMPLETED|Vax 1 / Year 0||391
244941|NCT00546572|589291|P2|Received Vax 1|Vax 1 / Year 0||473
244942|NCT00546572|589292|P1|Received Vax 1|Vax 1 / Year 0||463
244943|NCT00546572|589291|P2|STARTED|Vax 1 / Year 0||474
244944|NCT00546572|589292|P1|STARTED|Vax 1 / Year 0||464
244945|NCT00546481|589336|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
244946|NCT00546481|589337|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
244947|NCT00546481|589338|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
244948|NCT00546481|589336|P3|COMPLETED|Maintenance Phase (CERA)||50
244949|NCT00546481|589337|P2|COMPLETED|Maintenance Phase (CERA)||0
244950|NCT00546481|589338|P1|COMPLETED|Maintenance Phase (CERA)||0
244951|NCT00546481|589336|P3|STARTED|Maintenance Phase (CERA)||54
244952|NCT00546481|589337|P2|STARTED|Maintenance Phase (CERA)||0
244953|NCT00546481|589338|P1|STARTED|Maintenance Phase (CERA)||0
244954|NCT00546481|589336|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
244955|NCT00546481|589337|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
244956|NCT00546481|589338|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
244957|NCT00546481|589336|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
244958|NCT00546481|589337|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
244959|NCT00546481|589338|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
244960|NCT00546481|589336|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
244961|NCT00546481|589337|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
244962|NCT00546481|589338|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
244963|NCT00546429|589361|P1|NOT COMPLETED|Overall Study||30
244964|NCT00546429|589361|P1|COMPLETED|Overall Study||32
244965|NCT00546429|589361|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
244966|NCT00546377|589365|P1|NOT COMPLETED|Overall Study||7
244967|NCT00546377|589365|P1|COMPLETED|Overall Study||43
244968|NCT00546377|589365|P1|STARTED|Overall Study||50
244969|NCT00546364|589373|P3|NOT COMPLETED|Overall Study||17
244970|NCT00546364|589374|P2|NOT COMPLETED|Overall Study||18
244971|NCT00546364|589375|P1|NOT COMPLETED|Overall Study||17
244972|NCT00546364|589373|P3|COMPLETED|Overall Study|Still on treatment|3
244973|NCT00546364|589374|P2|COMPLETED|Overall Study|Still on treatment|4
244974|NCT00546364|589375|P1|COMPLETED|Overall Study|Still on treatment|3
244975|NCT00546364|589373|P3|Never Treated|Overall Study||0
244976|NCT00546364|589374|P2|Never Treated|Overall Study||0
244977|NCT00546364|589375|P1|Never Treated|Overall Study||0
244978|NCT00546364|589373|P3|STARTED|Overall Study||20
244979|NCT00546364|589374|P2|STARTED|Overall Study||22
244980|NCT00546364|589375|P1|STARTED|Overall Study||20
244981|NCT00546351|589410|P1|NOT COMPLETED|Overall Study||236
244982|NCT00546351|589410|P1|COMPLETED|Overall Study||385
244983|NCT00546351|589410|P1|STARTED|Overall Study||621
244984|NCT00546273|589443|P5|NOT COMPLETED|IV||0
244985|NCT00546273|589444|P4|NOT COMPLETED|IV||0
244986|NCT00546273|589445|P3|NOT COMPLETED|IV||0
244987|NCT00546273|589446|P2|NOT COMPLETED|IV||0
244988|NCT00546273|589447|P1|NOT COMPLETED|IV||0
244989|NCT00546273|589443|P5|COMPLETED|IV||2
244990|NCT00546273|589444|P4|COMPLETED|IV||4
244991|NCT00546273|589445|P3|COMPLETED|IV||0
244992|NCT00546273|589446|P2|COMPLETED|IV||0
244993|NCT00546273|589447|P1|COMPLETED|IV||0
244994|NCT00546273|589443|P5|STARTED|IV||2
244995|NCT00546273|589444|P4|STARTED|IV||4
244996|NCT00546273|589445|P3|STARTED|IV||0
244997|NCT00546273|589446|P2|STARTED|IV||0
244998|NCT00546273|589447|P1|STARTED|IV||0
244999|NCT00546273|589443|P5|NOT COMPLETED|III||0
245000|NCT00546273|589444|P4|NOT COMPLETED|III||0
245001|NCT00546273|589445|P3|NOT COMPLETED|III||0
245002|NCT00546273|589446|P2|NOT COMPLETED|III||0
245003|NCT00546273|589447|P1|NOT COMPLETED|III||0
245004|NCT00546273|589443|P5|COMPLETED|III||2
245005|NCT00546273|589444|P4|COMPLETED|III||0
245006|NCT00546273|589445|P3|COMPLETED|III||4
245007|NCT00546273|589446|P2|COMPLETED|III||0
245008|NCT00546273|589447|P1|COMPLETED|III||0
245009|NCT00546273|589443|P5|STARTED|III||2
245010|NCT00546273|589444|P4|STARTED|III||0
245011|NCT00546273|589445|P3|STARTED|III||4
245012|NCT00546273|589446|P2|STARTED|III||0
245013|NCT00546273|589447|P1|STARTED|III||0
245014|NCT00546273|589443|P5|NOT COMPLETED|II||0
245015|NCT00546273|589444|P4|NOT COMPLETED|II||0
245016|NCT00546273|589445|P3|NOT COMPLETED|II||0
245017|NCT00546273|589446|P2|NOT COMPLETED|II||0
245018|NCT00546273|589447|P1|NOT COMPLETED|II||0
245019|NCT00546273|589443|P5|COMPLETED|II||2
245020|NCT00546273|589444|P4|COMPLETED|II||0
245021|NCT00546273|589445|P3|COMPLETED|II||0
245022|NCT00546273|589446|P2|COMPLETED|II||4
245023|NCT00546273|589447|P1|COMPLETED|II||0
245024|NCT00546273|589443|P5|STARTED|II||2
245025|NCT00546273|589444|P4|STARTED|II||0
245026|NCT00546273|589445|P3|STARTED|II||0
245027|NCT00546273|589446|P2|STARTED|II||4
245028|NCT00546273|589447|P1|STARTED|II||0
245029|NCT00546273|589443|P5|NOT COMPLETED|I||0
245030|NCT00546273|589444|P4|NOT COMPLETED|I||0
245031|NCT00546273|589445|P3|NOT COMPLETED|I||0
245032|NCT00546273|589446|P2|NOT COMPLETED|I||0
245033|NCT00546273|589447|P1|NOT COMPLETED|I||0
245034|NCT00546273|589443|P5|COMPLETED|I||2
245035|NCT00546273|589444|P4|COMPLETED|I||0
245036|NCT00546273|589445|P3|COMPLETED|I||0
245037|NCT00546273|589446|P2|COMPLETED|I||0
245038|NCT00546273|589447|P1|COMPLETED|I||4
245039|NCT00546273|589443|P5|STARTED|I||2
245040|NCT00546273|589444|P4|STARTED|I||0
245041|NCT00546273|589445|P3|STARTED|I||0
245042|NCT00546273|589446|P2|STARTED|I||0
245043|NCT00546273|589447|P1|STARTED|I||4
245044|NCT00546260|589456|P2|NOT COMPLETED|Overall Study||2
245045|NCT00546260|589457|P1|NOT COMPLETED|Overall Study||8
245046|NCT00546260|589456|P2|COMPLETED|Overall Study||32
245047|NCT00546260|589457|P1|COMPLETED|Overall Study||28
245048|NCT00546260|589456|P2|STARTED|Overall Study||34
245049|NCT00546260|589457|P1|STARTED|Overall Study||36
245050|NCT00546156|589469|P2|NOT COMPLETED|Overall Study||1
245051|NCT00546156|589470|P1|NOT COMPLETED|Overall Study||14
245052|NCT00546156|589469|P2|COMPLETED|Overall Study||19
245053|NCT00546156|589470|P1|COMPLETED|Overall Study||70
245054|NCT00546156|589469|P2|STARTED|Overall Study||20
245055|NCT00546156|589470|P1|STARTED|Overall Study||84
245056|NCT00546117|589479|P2|NOT COMPLETED|Overall Study||0
245057|NCT00546117|589480|P1|NOT COMPLETED|Overall Study||4
245058|NCT00546117|589479|P2|COMPLETED|Overall Study||7
245059|NCT00546117|589480|P1|COMPLETED|Overall Study||5
245060|NCT00546117|589479|P2|STARTED|Overall Study||7
245061|NCT00546117|589480|P1|STARTED|Overall Study||9
245062|NCT00546104|589488|P1|NOT COMPLETED|Overall Study||0
245063|NCT00546104|589488|P1|COMPLETED|Overall Study||31
245064|NCT00546104|589488|P1|STARTED|Overall Study||31
245065|NCT00546078|589499|P2|NOT COMPLETED|Overall Study||7
245066|NCT00546078|589500|P1|NOT COMPLETED|Overall Study||4
245067|NCT00546078|589499|P2|COMPLETED|Overall Study||43
245068|NCT00546078|589500|P1|COMPLETED|Overall Study||61
245069|NCT00546078|589499|P2|Month 18|Overall Study||45
245070|NCT00546078|589500|P1|Month 18|Overall Study||61
245071|NCT00546078|589499|P2|STARTED|Overall Study||50
245072|NCT00546078|589500|P1|STARTED|Overall Study||65
245073|NCT00546052|589538|P1|NOT COMPLETED|Overall Study||227
245074|NCT00546052|589538|P1|COMPLETED|Overall Study||1511
245075|NCT00546052|589538|P1|Week 52|Overall Study||1511
245076|NCT00546052|589538|P1|Week 32|Overall Study||1583
245077|NCT00546052|589538|P1|Week 12|Overall Study||1650
245078|NCT00546052|589538|P1|Week 8|Overall Study||1680
245079|NCT00546052|589538|P1|Week 4|Overall Study||1714
245080|NCT00546052|589538|P1|STARTED|Overall Study||1738
245081|NCT00546000|589556|P1|NOT COMPLETED|Overall Study||4
245082|NCT00546000|589556|P1|COMPLETED|Overall Study||52
245083|NCT00546000|589556|P1|STARTED|Overall Study||56
245084|NCT00545974|589563|P2|NOT COMPLETED|Overall Study||3
245085|NCT00545974|589564|P1|NOT COMPLETED|Overall Study||2
245086|NCT00545974|589563|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
245087|NCT00545974|589564|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
245088|NCT00545974|589563|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
245089|NCT00545974|589564|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
245090|NCT00545948|589575|P3|NOT COMPLETED|Overall Study||7
245091|NCT00545948|589576|P2|NOT COMPLETED|Overall Study||1
245092|NCT00545948|589577|P1|NOT COMPLETED|Overall Study||1
245093|NCT00545948|589575|P3|COMPLETED|Overall Study||0
245094|NCT00545948|589576|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
245095|NCT00545948|589577|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
245096|NCT00545948|589575|P3|Assigned Treatment|Overall Study||0
245097|NCT00545948|589576|P2|Assigned Treatment|Overall Study||15
245098|NCT00545948|589577|P1|Assigned Treatment|Overall Study||9
245099|NCT00545948|589575|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
245100|NCT00545948|589576|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
245101|NCT00545948|589577|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
245102|NCT00545844|589587|P1|NOT COMPLETED|Overall Study||12
245103|NCT00545844|589587|P1|COMPLETED|Overall Study||301
245104|NCT00545844|589587|P1|STARTED|Overall Study||313
245105|NCT00545792|589601|P1|NOT COMPLETED|Overall Study||1
245106|NCT00545792|589601|P1|COMPLETED|Overall Study||20
245107|NCT00545792|589601|P1|STARTED|Overall Study||21
245108|NCT00545779|589606|P1|NOT COMPLETED|Overall Study||44
245109|NCT00545779|589606|P1|COMPLETED|Overall Study||633
245110|NCT00545779|589606|P1|STARTED|Overall Study||677
245111|NCT00545766|589619|P1|NOT COMPLETED|Overall Study||5
245112|NCT00545766|589619|P1|COMPLETED|Overall Study||36
245113|NCT00545766|589619|P1|STARTED|Overall Study||41
245114|NCT00545753|589626|P3|NOT COMPLETED|Overall Study||26
245115|NCT00545753|589627|P2|NOT COMPLETED|Overall Study||5
245116|NCT00545753|589628|P1|NOT COMPLETED|Overall Study||16
245117|NCT00545753|589626|P3|COMPLETED|Overall Study||230
245118|NCT00545753|589627|P2|COMPLETED|Overall Study||54
245119|NCT00545753|589628|P1|COMPLETED|Overall Study||227
245120|NCT00545753|589626|P3|STARTED|Overall Study||256
245121|NCT00545753|589627|P2|STARTED|Overall Study||59
245122|NCT00545753|589628|P1|STARTED|Overall Study||243
245123|NCT00545740|589641|P4|NOT COMPLETED|Overall Study||71
245124|NCT00545740|589642|P3|NOT COMPLETED|Overall Study||96
245125|NCT00545740|589643|P2|NOT COMPLETED|Overall Study||83
245126|NCT00545740|589644|P1|NOT COMPLETED|Overall Study||75
245127|NCT00545740|589641|P4|COMPLETED|Overall Study||78
245128|NCT00545740|589642|P3|COMPLETED|Overall Study||55
245129|NCT00545740|589643|P2|COMPLETED|Overall Study||62
245130|NCT00545740|589644|P1|COMPLETED|Overall Study||70
245131|NCT00545740|589641|P4|STARTED|Overall Study||149
245132|NCT00545740|589642|P3|STARTED|Overall Study||151
245133|NCT00545740|589643|P2|STARTED|Overall Study||145
245134|NCT00545740|589644|P1|STARTED|Overall Study||145
245135|NCT00545688|589682|P4|NOT COMPLETED|Follow-Up Period||27
245136|NCT00545688|589683|P3|NOT COMPLETED|Follow-Up Period||20
245137|NCT00545688|589684|P2|NOT COMPLETED|Follow-Up Period||19
245138|NCT00545688|589685|P1|NOT COMPLETED|Follow-Up Period||21
245139|NCT00545688|589682|P4|COMPLETED|Follow-Up Period||60
245140|NCT00545688|589683|P3|COMPLETED|Follow-Up Period||78
245141|NCT00545688|589684|P2|COMPLETED|Follow-Up Period||83
245142|NCT00545688|589685|P1|COMPLETED|Follow-Up Period||77
245143|NCT00545688|589682|P4|STARTED|Follow-Up Period||87
245144|NCT00545688|589683|P3|STARTED|Follow-Up Period||98
245145|NCT00545688|589684|P2|STARTED|Follow-Up Period||102
245146|NCT00545688|589685|P1|STARTED|Follow-Up Period||98
245147|NCT00545688|589682|P4|NOT COMPLETED|Adjuvant Treatment Period||14
245148|NCT00545688|589683|P3|NOT COMPLETED|Adjuvant Treatment Period||4
245149|NCT00545688|589684|P2|NOT COMPLETED|Adjuvant Treatment Period||8
245150|NCT00545688|589685|P1|NOT COMPLETED|Adjuvant Treatment Period||5
245151|NCT00545688|589682|P4|COMPLETED|Adjuvant Treatment Period||74
245152|NCT00545688|589683|P3|COMPLETED|Adjuvant Treatment Period||90
245153|NCT00545688|589684|P2|COMPLETED|Adjuvant Treatment Period||94
245154|NCT00545688|589685|P1|COMPLETED|Adjuvant Treatment Period||98
245155|NCT00545688|589682|P4|STARTED|Adjuvant Treatment Period||88
245156|NCT00545688|589683|P3|STARTED|Adjuvant Treatment Period||94
245157|NCT00545688|589684|P2|STARTED|Adjuvant Treatment Period||102
245158|NCT00545688|589685|P1|STARTED|Adjuvant Treatment Period||103
245159|NCT00545688|589682|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
245160|NCT00545688|589683|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
245161|NCT00545688|589684|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
245162|NCT00545688|589685|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
245163|NCT00545688|589682|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
245164|NCT00545688|589683|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
245165|NCT00545688|589684|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
245166|NCT00545688|589685|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
245167|NCT00545688|589682|P4|STARTED|Neo-Adjuvant Treatment Period||94
245168|NCT00545688|589683|P3|STARTED|Neo-Adjuvant Treatment Period||108
245169|NCT00545688|589684|P2|STARTED|Neo-Adjuvant Treatment Period||107
245170|NCT00545688|589685|P1|STARTED|Neo-Adjuvant Treatment Period||107
245171|NCT00545662|589757|P2|NOT COMPLETED|Overall Study||79
245172|NCT00545662|589758|P1|NOT COMPLETED|Overall Study||85
245173|NCT00545662|589757|P2|COMPLETED|Overall Study||528
245174|NCT00545662|589758|P1|COMPLETED|Overall Study||521
245175|NCT00545662|589757|P2|STARTED|Overall Study||607
245176|NCT00545662|589758|P1|STARTED|Overall Study||606
245177|NCT00545623|589768|P4|NOT COMPLETED|Overall Study||11
245178|NCT00545623|589769|P3|NOT COMPLETED|Overall Study||13
245179|NCT00545623|589770|P2|NOT COMPLETED|Overall Study||10
245180|NCT00545623|589771|P1|NOT COMPLETED|Overall Study||7
245181|NCT00545623|589768|P4|COMPLETED|Overall Study||23
245182|NCT00545623|589769|P3|COMPLETED|Overall Study||20
245183|NCT00545623|589770|P2|COMPLETED|Overall Study||21
245184|NCT00545623|589771|P1|COMPLETED|Overall Study||25
245185|NCT00545623|589768|P4|STARTED|Overall Study||34
245186|NCT00545623|589769|P3|STARTED|Overall Study||33
245187|NCT00545623|589770|P2|STARTED|Overall Study||31
245188|NCT00545623|589771|P1|STARTED|Overall Study||32
245189|NCT00545584|589784|P3|NOT COMPLETED|Overall Study||56
245190|NCT00545584|589785|P2|NOT COMPLETED|Overall Study||80
245191|NCT00545584|589786|P1|NOT COMPLETED|Overall Study||79
245192|NCT00545584|589784|P3|COMPLETED|Overall Study||250
245193|NCT00545584|589785|P2|COMPLETED|Overall Study||334
245194|NCT00545584|589786|P1|COMPLETED|Overall Study||333
245195|NCT00545584|589784|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
245196|NCT00545584|589785|P2|STARTED|Overall Study||414
245197|NCT00545584|589786|P1|STARTED|Overall Study||412
245198|NCT00545571|589797|P1|NOT COMPLETED|Overall Study||67
245199|NCT00545571|589797|P1|COMPLETED|Overall Study||53
245200|NCT00545571|589797|P1|STARTED|Overall Study||120
245201|NCT00545506|589812|P2|NOT COMPLETED|Overall Study||0
245202|NCT00545506|589813|P1|NOT COMPLETED|Overall Study||0
245203|NCT00545506|589812|P2|COMPLETED|Overall Study||3
245204|NCT00545506|589813|P1|COMPLETED|Overall Study||3
245205|NCT00545506|589812|P2|STARTED|Overall Study||3
245206|NCT00545506|589813|P1|STARTED|Overall Study||3
245207|NCT00545441|589821|P2|NOT COMPLETED|Overall Study||16
245208|NCT00545441|589822|P1|NOT COMPLETED|Overall Study||18
245209|NCT00545441|589821|P2|COMPLETED|Overall Study||26
245210|NCT00545441|589822|P1|COMPLETED|Overall Study||26
245211|NCT00545441|589821|P2|STARTED|Overall Study||42
245212|NCT00545441|589822|P1|STARTED|Overall Study||44
245213|NCT00545402|589830|P2|NOT COMPLETED|Overall Study||29
245214|NCT00545402|589831|P1|NOT COMPLETED|Overall Study||34
245215|NCT00545402|589830|P2|COMPLETED|Overall Study||61
245216|NCT00545402|589831|P1|COMPLETED|Overall Study||56
245217|NCT00545402|589830|P2|STARTED|Overall Study||90
245218|NCT00545402|589831|P1|STARTED|Overall Study||90
245219|NCT00545363|589849|P2|NOT COMPLETED|Overall Study||15
245220|NCT00545363|589850|P1|NOT COMPLETED|Overall Study||19
245221|NCT00545363|589849|P2|COMPLETED|Overall Study||343
245222|NCT00545363|589850|P1|COMPLETED|Overall Study||339
245223|NCT00545363|589849|P2|Treated|Overall Study||357
245224|NCT00545363|589850|P1|Treated|Overall Study||354
245225|NCT00545363|589849|P2|STARTED|Overall Study||358
245226|NCT00545363|589850|P1|STARTED|Overall Study||358
245227|NCT00545298|589865|P3|NOT COMPLETED|Overall Study||1
245228|NCT00545298|589866|P2|NOT COMPLETED|Overall Study||0
245229|NCT00545298|589867|P1|NOT COMPLETED|Overall Study||2
245230|NCT00545298|589865|P3|COMPLETED|Overall Study||0
245231|NCT00545298|589866|P2|COMPLETED|Overall Study||1
245232|NCT00545298|589867|P1|COMPLETED|Overall Study||0
245233|NCT00545298|589865|P3|STARTED|Overall Study||1
245234|NCT00545298|589866|P2|STARTED|Overall Study||1
245235|NCT00545298|589867|P1|STARTED|Overall Study||2
245236|NCT00545272|589884|P6|NOT COMPLETED|Overall Study||3
245237|NCT00545272|589885|P5|NOT COMPLETED|Overall Study||2
245238|NCT00545272|589886|P4|NOT COMPLETED|Overall Study||1
245239|NCT00545272|589887|P3|NOT COMPLETED|Overall Study||1
245240|NCT00545272|589888|P2|NOT COMPLETED|Overall Study||1
245241|NCT00545272|589889|P1|NOT COMPLETED|Overall Study||0
245242|NCT00545272|589884|P6|COMPLETED|Overall Study||59
245243|NCT00545272|589885|P5|COMPLETED|Overall Study||62
245244|NCT00545272|589886|P4|COMPLETED|Overall Study||71
245245|NCT00545272|589887|P3|COMPLETED|Overall Study||64
245246|NCT00545272|589888|P2|COMPLETED|Overall Study||67
245247|NCT00545272|589889|P1|COMPLETED|Overall Study||61
245248|NCT00545272|589884|P6|STARTED|Overall Study||62
245249|NCT00545272|589885|P5|STARTED|Overall Study||64
245250|NCT00545272|589886|P4|STARTED|Overall Study||72
245251|NCT00545272|589887|P3|STARTED|Overall Study||65
245252|NCT00545272|589888|P2|STARTED|Overall Study||68
245253|NCT00545272|589889|P1|STARTED|Overall Study||61
245254|NCT00545233|589941|P2|NOT COMPLETED|Overall Study||35
245255|NCT00545233|589942|P1|NOT COMPLETED|Overall Study||46
245256|NCT00545233|589941|P2|COMPLETED|Overall Study||41
245257|NCT00545233|589942|P1|COMPLETED|Overall Study||33
245258|NCT00545233|589941|P2|Intent-to-Treat (ITT)|Overall Study||73
245259|NCT00545233|589942|P1|Intent-to-Treat (ITT)|Overall Study||77
245260|NCT00545233|589941|P2|Safety Set|Overall Study||75
245261|NCT00545233|589942|P1|Safety Set|Overall Study||77
245262|NCT00545233|589941|P2|STARTED|Overall Study||76
245263|NCT00545233|589942|P1|STARTED|Overall Study||79
245264|NCT00545181|589991|P2|NOT COMPLETED|Overall Study||0
245265|NCT00545181|589992|P1|NOT COMPLETED|Overall Study||0
245266|NCT00545181|589991|P2|COMPLETED|Overall Study||25
245267|NCT00545181|589992|P1|COMPLETED|Overall Study||29
245268|NCT00545181|589991|P2|STARTED|Overall Study||25
245269|NCT00545181|589992|P1|STARTED|Overall Study||29
245270|NCT00545168|590001|P3|NOT COMPLETED|Overall Study||21
245271|NCT00545168|590002|P2|NOT COMPLETED|Overall Study||5
245272|NCT00545168|590003|P1|NOT COMPLETED|Overall Study||16
245273|NCT00545168|590001|P3|COMPLETED|Overall Study||193
245274|NCT00545168|590002|P2|COMPLETED|Overall Study||58
245275|NCT00545168|590003|P1|COMPLETED|Overall Study||187
245276|NCT00545168|590001|P3|STARTED|Overall Study||214
245277|NCT00545168|590002|P2|STARTED|Overall Study||63
245278|NCT00545168|590003|P1|STARTED|Overall Study||203
245279|NCT00545155|590012|P1|NOT COMPLETED|Overall Study||0
245280|NCT00545155|590012|P1|COMPLETED|Overall Study||187
245281|NCT00545155|590012|P1|STARTED|Overall Study||187
245282|NCT00545103|590029|P4|NOT COMPLETED|Overall Study||70
245283|NCT00545103|590030|P3|NOT COMPLETED|Overall Study||76
245284|NCT00545103|590031|P2|NOT COMPLETED|Overall Study||78
245285|NCT00545103|590032|P1|NOT COMPLETED|Overall Study||75
245286|NCT00545103|590029|P4|COMPLETED|Overall Study||76
245287|NCT00545103|590030|P3|COMPLETED|Overall Study||74
245288|NCT00545103|590031|P2|COMPLETED|Overall Study||70
245289|NCT00545103|590032|P1|COMPLETED|Overall Study||73
245290|NCT00545103|590029|P4|STARTED|Overall Study||146
245291|NCT00545103|590030|P3|STARTED|Overall Study||150
245292|NCT00545103|590031|P2|STARTED|Overall Study||148
245293|NCT00545103|590032|P1|STARTED|Overall Study||148
245294|NCT00545064|590066|P1|NOT COMPLETED|Overall Study||8
245295|NCT00545064|590066|P1|COMPLETED|Overall Study||170
245296|NCT00545064|590066|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
245297|NCT00545064|590066|P1|Visit 2 (Week 4)|Overall Study||169
245298|NCT00545064|590066|P1|Visit 1 (Baseline)|Overall Study||178
245299|NCT00545064|590066|P1|STARTED|Overall Study||178
245300|NCT00545051|590077|P2|NOT COMPLETED|Overall Study||7
245301|NCT00545051|590078|P1|NOT COMPLETED|Overall Study||9
245302|NCT00545051|590077|P2|COMPLETED|Overall Study||65
245303|NCT00545051|590078|P1|COMPLETED|Overall Study||59
245304|NCT00545051|590077|P2|STARTED|Overall Study||72
245305|NCT00545051|590078|P1|STARTED|Overall Study||68
245306|NCT00545025|590094|P2|NOT COMPLETED|Overall Study||0
245307|NCT00545025|590095|P1|NOT COMPLETED|Overall Study||0
245308|NCT00545025|590094|P2|COMPLETED|Overall Study||83
245309|NCT00545025|590095|P1|COMPLETED|Overall Study||160
245310|NCT00545025|590094|P2|STARTED|Overall Study||83
245311|NCT00545025|590095|P1|STARTED|Overall Study||160
245312|NCT00544908|590115|P1|NOT COMPLETED|Overall Study||0
245313|NCT00544908|590115|P1|COMPLETED|Overall Study||7
245314|NCT00544908|590115|P1|STARTED|Overall Study||7
245315|NCT00544882|590122|P3|NOT COMPLETED|Cycle 3: Follow-up||0
245316|NCT00544882|590123|P2|NOT COMPLETED|Cycle 3: Follow-up||2
245317|NCT00544882|590124|P1|NOT COMPLETED|Cycle 3: Follow-up||0
245318|NCT00544882|590122|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
245319|NCT00544882|590123|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
245320|NCT00544882|590124|P1|COMPLETED|Cycle 3: Follow-up||0
245321|NCT00544882|590122|P3|STARTED|Cycle 3: Follow-up||28
245322|NCT00544882|590123|P2|STARTED|Cycle 3: Follow-up||28
245323|NCT00544882|590124|P1|STARTED|Cycle 3: Follow-up||0
245324|NCT00544882|590122|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
245325|NCT00544882|590123|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
245326|NCT00544882|590124|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
245327|NCT00544882|590122|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
245328|NCT00544882|590123|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
245329|NCT00544882|590124|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
245330|NCT00544882|590122|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
245331|NCT00544882|590123|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
245332|NCT00544882|590124|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
245333|NCT00544882|590122|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
245334|NCT00544882|590123|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
245335|NCT00544882|590124|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
245336|NCT00544882|590122|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
245337|NCT00544882|590123|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
245338|NCT00544882|590124|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
245339|NCT00544882|590122|P3|COMPLETED|Cycle 1: Run-in Cycle||0
245340|NCT00544882|590123|P2|COMPLETED|Cycle 1: Run-in Cycle||0
245341|NCT00544882|590124|P1|COMPLETED|Cycle 1: Run-in Cycle||58
245342|NCT00544882|590122|P3|STARTED|Cycle 1: Run-in Cycle||0
245343|NCT00544882|590123|P2|STARTED|Cycle 1: Run-in Cycle||0
245344|NCT00544882|590124|P1|STARTED|Cycle 1: Run-in Cycle||61
245345|NCT00544869|590149|P3|NOT COMPLETED|Overall Study||0
245346|NCT00544869|590150|P2|NOT COMPLETED|Overall Study||2
245347|NCT00544869|590151|P1|NOT COMPLETED|Overall Study||12
245348|NCT00544869|590149|P3|COMPLETED|Overall Study||2
245349|NCT00544869|590150|P2|COMPLETED|Overall Study||12
245350|NCT00544869|590151|P1|COMPLETED|Overall Study||24
245351|NCT00544869|590149|P3|STARTED|Overall Study||2
245352|NCT00544869|590150|P2|STARTED|Overall Study||14
245353|NCT00544869|590151|P1|STARTED|Overall Study||36
245354|NCT00544817|590159|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
245355|NCT00544817|590159|P1|COMPLETED|Follow-up Systemic Therapy||9
245356|NCT00544817|590159|P1|STARTED|Follow-up Systemic Therapy||28
245357|NCT00544817|590159|P1|NOT COMPLETED|No Treatment Interval||12
245358|NCT00544817|590159|P1|COMPLETED|No Treatment Interval||28
245359|NCT00544817|590159|P1|STARTED|No Treatment Interval||40
245360|NCT00544817|590159|P1|NOT COMPLETED|Combined Modality||7
245361|NCT00544817|590159|P1|COMPLETED|Combined Modality||40
245362|NCT00544817|590159|P1|STARTED|Combined Modality||47
245363|NCT00544778|590165|P1|NOT COMPLETED|Overall Study||0
245364|NCT00544778|590165|P1|COMPLETED|Overall Study||7
245365|NCT00544778|590165|P1|STARTED|Overall Study||7
245366|NCT00544713|590171|P2|NOT COMPLETED|Overall Study||5
245367|NCT00544713|590172|P1|NOT COMPLETED|Overall Study||3
245368|NCT00544713|590171|P2|COMPLETED|Overall Study||109
245369|NCT00544713|590172|P1|COMPLETED|Overall Study||111
245370|NCT00544713|590171|P2|STARTED|Overall Study||114
245371|NCT00544713|590172|P1|STARTED|Overall Study||114
245372|NCT00544674|590202|P1|NOT COMPLETED|Overall Study||1
245373|NCT00544674|590202|P1|COMPLETED|Overall Study||4
245374|NCT00544674|590202|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
245375|NCT00544648|590208|P2|NOT COMPLETED|Overall Study||1
245376|NCT00544648|590209|P1|NOT COMPLETED|Overall Study||3
245377|NCT00544648|590208|P2|COMPLETED|Overall Study||1
245378|NCT00544648|590209|P1|COMPLETED|Overall Study||8
245379|NCT00544648|590208|P2|STARTED|Overall Study||2
245380|NCT00544648|590209|P1|STARTED|Overall Study||11
245381|NCT00544557|590223|P1|NOT COMPLETED|Overall Study||434
245382|NCT00544557|590223|P1|COMPLETED|Overall Study||1251
245383|NCT00544557|590223|P1|STARTED|Overall Study||1685
245384|NCT00544544|590254|P1|NOT COMPLETED|Overall Study||3
245385|NCT00544544|590254|P1|COMPLETED|Overall Study||11
245386|NCT00544544|590254|P1|STARTED|Overall Study||14
245387|NCT00544440|590258|P1|NOT COMPLETED|Overall Study||57
245388|NCT00544440|590258|P1|COMPLETED|Overall Study||0
245389|NCT00544440|590258|P1|STARTED|Overall Study||57
245390|NCT00544167|590265|P1|NOT COMPLETED|Overall Study||29
245391|NCT00544167|590265|P1|COMPLETED|Overall Study||16
245392|NCT00544167|590265|P1|STARTED|Overall Study||45
245393|NCT00543985|590269|P1|NOT COMPLETED|Overall Study||4
245394|NCT00543985|590269|P1|COMPLETED|Overall Study||32
245395|NCT00543985|590269|P1|STARTED|Overall Study||36
245396|NCT00543855|590280|P4|NOT COMPLETED|Overall Study||4
245397|NCT00543855|590281|P3|NOT COMPLETED|Overall Study||6
245398|NCT00543855|590282|P2|NOT COMPLETED|Overall Study||2
245399|NCT00543855|590283|P1|NOT COMPLETED|Overall Study||4
245400|NCT00543855|590280|P4|COMPLETED|Overall Study||30
245401|NCT00543855|590281|P3|COMPLETED|Overall Study||31
245402|NCT00543855|590282|P2|COMPLETED|Overall Study||31
245403|NCT00543855|590283|P1|COMPLETED|Overall Study||31
245404|NCT00543855|590280|P4|STARTED|Overall Study||34
245405|NCT00543855|590281|P3|STARTED|Overall Study||37
245406|NCT00543855|590282|P2|STARTED|Overall Study||33
245407|NCT00543855|590283|P1|STARTED|Overall Study||35
245408|NCT00543803|590305|P1|NOT COMPLETED|Overall Study||142
245409|NCT00543803|590305|P1|COMPLETED|Overall Study||192
245410|NCT00543803|590305|P1|STARTED|Overall Study||334
245411|NCT00543764|590324|P2|NOT COMPLETED|Overall Study||0
245412|NCT00543764|590325|P1|NOT COMPLETED|Overall Study||0
245413|NCT00543764|590324|P2|COMPLETED|Overall Study||50
245414|NCT00543764|590325|P1|COMPLETED|Overall Study||100
245415|NCT00543764|590324|P2|STARTED|Overall Study||50
245416|NCT00543764|590325|P1|STARTED|Overall Study||100
245417|NCT00543725|590333|P2|NOT COMPLETED|Overall Study||74
245418|NCT00543725|590334|P1|NOT COMPLETED|Overall Study||68
245419|NCT00543725|590333|P2|COMPLETED|Overall Study||264
245420|NCT00543725|590334|P1|COMPLETED|Overall Study||272
245421|NCT00543725|590333|P2|STARTED|Overall Study||338
245422|NCT00543725|590334|P1|STARTED|Overall Study||340
245423|NCT00543569|590360|P4|NOT COMPLETED|Overall Study||9
245424|NCT00543569|590361|P3|NOT COMPLETED|Overall Study||20
245425|NCT00543569|590362|P2|NOT COMPLETED|Overall Study||8
245426|NCT00543569|590363|P1|NOT COMPLETED|Overall Study||12
245427|NCT00543569|590360|P4|COMPLETED|Overall Study||72
245428|NCT00543569|590361|P3|COMPLETED|Overall Study||60
245429|NCT00543569|590362|P2|COMPLETED|Overall Study||72
245430|NCT00543569|590363|P1|COMPLETED|Overall Study||70
245431|NCT00543569|590360|P4|Received Treatment|Overall Study||78
245432|NCT00543569|590361|P3|Received Treatment|Overall Study||75
245433|NCT00543569|590362|P2|Received Treatment|Overall Study||77
245434|NCT00543569|590363|P1|Received Treatment|Overall Study||79
245435|NCT00543569|590360|P4|STARTED|Overall Study||81
245436|NCT00543569|590361|P3|STARTED|Overall Study||80
245437|NCT00543569|590362|P2|STARTED|Overall Study||80
245438|NCT00543569|590363|P1|STARTED|Overall Study||82
245439|NCT00543543|590469|P4|NOT COMPLETED|Extension Study||226
245440|NCT00543543|590470|P3|NOT COMPLETED|Extension Study||0
245441|NCT00543543|590471|P2|NOT COMPLETED|Extension Study||0
245442|NCT00543543|590472|P1|NOT COMPLETED|Extension Study||0
245443|NCT00543543|590469|P4|COMPLETED|Extension Study||2824
245444|NCT00543543|590470|P3|COMPLETED|Extension Study||0
245445|NCT00543543|590471|P2|COMPLETED|Extension Study||150
245446|NCT00543543|590472|P1|COMPLETED|Extension Study||0
245447|NCT00543543|590469|P4|STARTED|Extension Study|Cohort 2|3050
245448|NCT00543543|590470|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
245449|NCT00543543|590471|P2|STARTED|Extension Study|Cohort 1|150
245450|NCT00543543|590472|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
245451|NCT00543543|590469|P4|NOT COMPLETED|Base Study||1222
245452|NCT00543543|590470|P3|NOT COMPLETED|Base Study||14
245453|NCT00543543|590471|P2|NOT COMPLETED|Base Study||1252
245454|NCT00543543|590472|P1|NOT COMPLETED|Base Study||20
245455|NCT00543543|590469|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
245456|NCT00543543|590470|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
245457|NCT00543543|590471|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
245458|NCT00543543|590472|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
245459|NCT00543543|590469|P4|Completed 3 Vaccinations|Base Study||6934
245460|NCT00543543|590470|P3|Completed 3 Vaccinations|Base Study||297
245461|NCT00543543|590471|P2|Completed 3 Vaccinations|Base Study||6928
245462|NCT00543543|590472|P1|Completed 3 Vaccinations|Base Study||300
245463|NCT00543543|590469|P4|STARTED|Base Study||7109
245464|NCT00543543|590470|P3|STARTED|Base Study||310
245465|NCT00543543|590471|P2|STARTED|Base Study||7106
245466|NCT00543543|590472|P1|STARTED|Base Study||315
245467|NCT00543400|590517|P4|NOT COMPLETED|Overall Study||5
245468|NCT00543400|590518|P3|NOT COMPLETED|Overall Study||4
245469|NCT00543400|590519|P2|NOT COMPLETED|Overall Study||1
245470|NCT00543400|590520|P1|NOT COMPLETED|Overall Study||5
245471|NCT00543400|590517|P4|COMPLETED|Overall Study||151
245472|NCT00543400|590518|P3|COMPLETED|Overall Study||148
245473|NCT00543400|590519|P2|COMPLETED|Overall Study||43
245474|NCT00543400|590520|P1|COMPLETED|Overall Study||146
245475|NCT00543400|590517|P4|STARTED|Overall Study||156
245476|NCT00543400|590518|P3|STARTED|Overall Study||152
245477|NCT00543400|590519|P2|STARTED|Overall Study||44
245478|NCT00543400|590520|P1|STARTED|Overall Study||151
245479|NCT00543296|590530|P1|NOT COMPLETED|Overall Study||7
245480|NCT00543296|590530|P1|COMPLETED|Overall Study||14
245481|NCT00543296|590530|P1|STARTED|Overall Study||21
245482|NCT00543140|590537|P1|NOT COMPLETED|Overall Study||72
245483|NCT00543140|590537|P1|COMPLETED|Overall Study||231
245484|NCT00543140|590537|P1|STARTED|Overall Study||303
245485|NCT00543101|590547|P2|NOT COMPLETED|Overall Study||0
245486|NCT00543101|590548|P1|NOT COMPLETED|Overall Study||0
245487|NCT00543101|590547|P2|COMPLETED|Overall Study||12
245488|NCT00543101|590548|P1|COMPLETED|Overall Study||12
245489|NCT00543101|590547|P2|STARTED|Overall Study||12
245490|NCT00543101|590548|P1|STARTED|Overall Study||12
245491|NCT00542997|590560|P1|NOT COMPLETED|Efficacy Period||3
245492|NCT00542997|590560|P1|COMPLETED|Efficacy Period||43
245493|NCT00542997|590560|P1|STARTED|Efficacy Period||46
245494|NCT00542997|590560|P1|NOT COMPLETED|Wash in / Wash Out Period||5
245495|NCT00542997|590560|P1|COMPLETED|Wash in / Wash Out Period||46
245496|NCT00542997|590560|P1|STARTED|Wash in / Wash Out Period||51
245497|NCT00542971|590575|P1|NOT COMPLETED|Overall Study||0
245498|NCT00542971|590575|P1|COMPLETED|Overall Study||75
245499|NCT00542971|590575|P1|STARTED|Overall Study||75
245500|NCT00542880|590582|P2|NOT COMPLETED|Period 3||2
245501|NCT00542880|590583|P1|NOT COMPLETED|Period 3||0
245502|NCT00542880|590582|P2|COMPLETED|Period 3||201
245503|NCT00542880|590583|P1|COMPLETED|Period 3||204
245504|NCT00542880|590582|P2|STARTED|Period 3||203
245505|NCT00542880|590583|P1|STARTED|Period 3||204
245506|NCT00542880|590582|P2|NOT COMPLETED|Period 2||10
245507|NCT00542880|590583|P1|NOT COMPLETED|Period 2||7
245508|NCT00542880|590582|P2|COMPLETED|Period 2||203
245509|NCT00542880|590583|P1|COMPLETED|Period 2||204
245510|NCT00542880|590582|P2|STARTED|Period 2||213
245511|NCT00542880|590583|P1|STARTED|Period 2||211
245512|NCT00542880|590582|P2|NOT COMPLETED|Period 1||12
245513|NCT00542880|590583|P1|NOT COMPLETED|Period 1||6
245514|NCT00542880|590582|P2|COMPLETED|Period 1||213
245515|NCT00542880|590583|P1|COMPLETED|Period 1||211
245516|NCT00542880|590582|P2|STARTED|Period 1||225
245517|NCT00542880|590583|P1|STARTED|Period 1|This was a cross-over study|217
245518|NCT00542828|590619|P1|NOT COMPLETED|Overall Study||13
245519|NCT00542828|590619|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
245520|NCT00542828|590619|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
245521|NCT00542815|590637|P3|NOT COMPLETED|Overall Study||32
245522|NCT00542815|590638|P2|NOT COMPLETED|Overall Study||32
245523|NCT00542815|590639|P1|NOT COMPLETED|Overall Study||106
245524|NCT00542815|590637|P3|COMPLETED|Overall Study||92
245525|NCT00542815|590638|P2|COMPLETED|Overall Study||44
245526|NCT00542815|590639|P1|COMPLETED|Overall Study||326
245527|NCT00542815|590637|P3|STARTED|Overall Study||124
245528|NCT00542815|590638|P2|STARTED|Overall Study||76
245529|NCT00542815|590639|P1|STARTED|Overall Study||432
245530|NCT00542789|590652|P2|NOT COMPLETED|Overall Study||78
245531|NCT00542789|590653|P1|NOT COMPLETED|Overall Study||41
245532|NCT00542789|590652|P2|COMPLETED|Overall Study||90
245533|NCT00542789|590653|P1|COMPLETED|Overall Study||134
245534|NCT00542789|590652|P2|STARTED|Overall Study|Randomised|168
245535|NCT00542789|590653|P1|STARTED|Overall Study|Randomised|175
245536|NCT00542750|590663|P1|NOT COMPLETED|Overall Study||0
245537|NCT00542750|590663|P1|COMPLETED|Overall Study||24
245538|NCT00542750|590663|P1|STARTED|Overall Study||24
245539|NCT00542620|590669|P2|NOT COMPLETED|Overall Study||0
245540|NCT00542620|590670|P1|NOT COMPLETED|Overall Study||0
245541|NCT00542620|590669|P2|COMPLETED|Overall Study||12
245542|NCT00542620|590670|P1|COMPLETED|Overall Study||13
245543|NCT00542620|590669|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
245544|NCT00542620|590670|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
245545|NCT00542620|590669|P2|STARTED|Overall Study||12
245546|NCT00542620|590670|P1|STARTED|Overall Study||13
245547|NCT00542542|590736|P2|NOT COMPLETED|Overall Study||0
245548|NCT00542542|590737|P1|NOT COMPLETED|Overall Study||0
245549|NCT00542542|590736|P2|COMPLETED|Overall Study||44
245550|NCT00542542|590737|P1|COMPLETED|Overall Study||44
245551|NCT00542542|590736|P2|STARTED|Overall Study||44
245552|NCT00542542|590737|P1|STARTED|Overall Study||44
245553|NCT00542490|590743|P1|NOT COMPLETED|Overall Study||2
245554|NCT00542490|590743|P1|COMPLETED|Overall Study||21
245555|NCT00542490|590743|P1|STARTED|Overall Study||23
245556|NCT00542425|590753|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
245557|NCT00542425|590754|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
245558|NCT00542425|590755|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
245559|NCT00542425|590756|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
245560|NCT00542425|590757|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
245561|NCT00542425|590753|P5|COMPLETED|Extended 24 Weeks of Treatment||13
245562|NCT00542425|590754|P4|COMPLETED|Extended 24 Weeks of Treatment||6
245563|NCT00542425|590755|P3|COMPLETED|Extended 24 Weeks of Treatment||8
245564|NCT00542425|590756|P2|COMPLETED|Extended 24 Weeks of Treatment||11
245565|NCT00542425|590757|P1|COMPLETED|Extended 24 Weeks of Treatment||10
245566|NCT00542425|590753|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
245567|NCT00542425|590754|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
245568|NCT00542425|590755|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
245569|NCT00542425|590756|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
245570|NCT00542425|590757|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
245571|NCT00542425|590753|P5|NOT COMPLETED|Initial 24 Weeks||6
245572|NCT00542425|590754|P4|NOT COMPLETED|Initial 24 Weeks||11
245573|NCT00542425|590755|P3|NOT COMPLETED|Initial 24 Weeks||7
245574|NCT00542425|590756|P2|NOT COMPLETED|Initial 24 Weeks||10
245575|NCT00542425|590757|P1|NOT COMPLETED|Initial 24 Weeks||4
245576|NCT00542425|590753|P5|COMPLETED|Initial 24 Weeks||39
245577|NCT00542425|590754|P4|COMPLETED|Initial 24 Weeks||34
245578|NCT00542425|590755|P3|COMPLETED|Initial 24 Weeks||36
245579|NCT00542425|590756|P2|COMPLETED|Initial 24 Weeks||33
245580|NCT00542425|590757|P1|COMPLETED|Initial 24 Weeks||42
245581|NCT00542425|590753|P5|STARTED|Initial 24 Weeks||45
245582|NCT00542425|590754|P4|STARTED|Initial 24 Weeks||45
245583|NCT00542425|590755|P3|STARTED|Initial 24 Weeks||43
245584|NCT00542425|590756|P2|STARTED|Initial 24 Weeks||43
245585|NCT00542425|590757|P1|STARTED|Initial 24 Weeks||46
245586|NCT00542386|590795|P6|NOT COMPLETED|Overall Study||50
245587|NCT00542386|590796|P5|NOT COMPLETED|Overall Study||40
245588|NCT00542386|590797|P4|NOT COMPLETED|Overall Study||38
245589|NCT00542386|590798|P3|NOT COMPLETED|Overall Study||33
245590|NCT00542386|590799|P2|NOT COMPLETED|Overall Study||28
245591|NCT00542386|590800|P1|NOT COMPLETED|Overall Study||43
245592|NCT00542386|590795|P6|COMPLETED|Overall Study||82
245593|NCT00542386|590796|P5|COMPLETED|Overall Study||62
245594|NCT00542386|590797|P4|COMPLETED|Overall Study||65
245595|NCT00542386|590798|P3|COMPLETED|Overall Study||66
245596|NCT00542386|590799|P2|COMPLETED|Overall Study||74
245597|NCT00542386|590800|P1|COMPLETED|Overall Study||61
245598|NCT00542386|590795|P6|STARTED|Overall Study||132
245599|NCT00542386|590796|P5|STARTED|Overall Study||102
245600|NCT00542386|590797|P4|STARTED|Overall Study||103
245601|NCT00542386|590798|P3|STARTED|Overall Study||99
245602|NCT00542386|590799|P2|STARTED|Overall Study||102
245603|NCT00542386|590800|P1|STARTED|Overall Study||104
245604|NCT00542321|590822|P2|NOT COMPLETED|Overall Study||1
245605|NCT00542321|590823|P1|NOT COMPLETED|Overall Study||0
245606|NCT00542321|590822|P2|COMPLETED|Overall Study||7
245607|NCT00542321|590823|P1|COMPLETED|Overall Study||8
245608|NCT00542321|590822|P2|STARTED|Overall Study||8
245609|NCT00542321|590823|P1|STARTED|Overall Study||8
245610|NCT00542308|590837|P1|NOT COMPLETED|Overall Study||0
245611|NCT00542308|590837|P1|COMPLETED|Overall Study||90
245612|NCT00542308|590837|P1|STARTED|Overall Study||90
245613|NCT00542269|590845|P3|NOT COMPLETED|Overall Study||6
245614|NCT00542269|590846|P2|NOT COMPLETED|Overall Study||6
245615|NCT00542269|590847|P1|NOT COMPLETED|Overall Study||13
245616|NCT00542269|590845|P3|COMPLETED|Overall Study||51
245617|NCT00542269|590846|P2|COMPLETED|Overall Study||54
245618|NCT00542269|590847|P1|COMPLETED|Overall Study||48
245619|NCT00542269|590845|P3|STARTED|Overall Study||57
245620|NCT00542269|590846|P2|STARTED|Overall Study||60
245621|NCT00542269|590847|P1|STARTED|Overall Study||61
245622|NCT00542178|590882|P8|NOT COMPLETED|Overall Study||85
245623|NCT00542178|590883|P7|NOT COMPLETED|Overall Study||87
245624|NCT00542178|590884|P6|NOT COMPLETED|Overall Study||89
245625|NCT00542178|590885|P5|NOT COMPLETED|Overall Study||64
245626|NCT00542178|590886|P4|NOT COMPLETED|Overall Study||62
245627|NCT00542178|590887|P3|NOT COMPLETED|Overall Study||74
245628|NCT00542178|590888|P2|NOT COMPLETED|Overall Study||80
245629|NCT00542178|590889|P1|NOT COMPLETED|Overall Study||75
245630|NCT00542178|590882|P8|COMPLETED|Overall Study||381
245631|NCT00542178|590883|P7|COMPLETED|Overall Study||406
245632|NCT00542178|590884|P6|COMPLETED|Overall Study||406
245633|NCT00542178|590885|P5|COMPLETED|Overall Study||400
245634|NCT00542178|590886|P4|COMPLETED|Overall Study||308
245635|NCT00542178|590887|P3|COMPLETED|Overall Study||308
245636|NCT00542178|590888|P2|COMPLETED|Overall Study||332
245637|NCT00542178|590889|P1|COMPLETED|Overall Study||315
245638|NCT00542178|590882|P8|STARTED|Overall Study||466
245639|NCT00542178|590883|P7|STARTED|Overall Study||493
245640|NCT00542178|590884|P6|STARTED|Overall Study||495
245641|NCT00542178|590885|P5|STARTED|Overall Study||464
245642|NCT00542178|590886|P4|STARTED|Overall Study||370
245643|NCT00542178|590887|P3|STARTED|Overall Study||382
245644|NCT00542178|590888|P2|STARTED|Overall Study||412
245645|NCT00542178|590889|P1|STARTED|Overall Study||390
245646|NCT00541970|590907|P4|NOT COMPLETED|Month 60||72
245647|NCT00541970|590908|P3|NOT COMPLETED|Month 60||82
245648|NCT00541970|590909|P2|NOT COMPLETED|Month 60||77
245649|NCT00541970|590910|P1|NOT COMPLETED|Month 60||78
245650|NCT00541970|590907|P4|COMPLETED|Month 60||167
245651|NCT00541970|590908|P3|COMPLETED|Month 60||158
245652|NCT00541970|590909|P2|COMPLETED|Month 60||164
245653|NCT00541970|590910|P1|COMPLETED|Month 60||162
245654|NCT00541970|590907|P4|STARTED|Month 60||239
245655|NCT00541970|590908|P3|STARTED|Month 60||240
245656|NCT00541970|590909|P2|STARTED|Month 60||241
245657|NCT00541970|590910|P1|STARTED|Month 60||240
245658|NCT00541970|590907|P4|NOT COMPLETED|Month 48||75
245659|NCT00541970|590908|P3|NOT COMPLETED|Month 48||73
245660|NCT00541970|590909|P2|NOT COMPLETED|Month 48||73
245661|NCT00541970|590910|P1|NOT COMPLETED|Month 48||71
245662|NCT00541970|590907|P4|COMPLETED|Month 48||164
245663|NCT00541970|590908|P3|COMPLETED|Month 48||167
245664|NCT00541970|590909|P2|COMPLETED|Month 48||168
245665|NCT00541970|590910|P1|COMPLETED|Month 48||169
245666|NCT00541970|590907|P4|STARTED|Month 48||239
245667|NCT00541970|590908|P3|STARTED|Month 48||240
245668|NCT00541970|590909|P2|STARTED|Month 48||241
245669|NCT00541970|590910|P1|STARTED|Month 48||240
245670|NCT00541970|590907|P4|NOT COMPLETED|Month 36||60
245671|NCT00541970|590908|P3|NOT COMPLETED|Month 36||66
245672|NCT00541970|590909|P2|NOT COMPLETED|Month 36||66
245673|NCT00541970|590910|P1|NOT COMPLETED|Month 36||61
245674|NCT00541970|590907|P4|COMPLETED|Month 36||179
245675|NCT00541970|590908|P3|COMPLETED|Month 36||174
245676|NCT00541970|590909|P2|COMPLETED|Month 36||175
245677|NCT00541970|590910|P1|COMPLETED|Month 36||179
245678|NCT00541970|590907|P4|STARTED|Month 36||239
245679|NCT00541970|590908|P3|STARTED|Month 36||240
245680|NCT00541970|590909|P2|STARTED|Month 36||241
245681|NCT00541970|590910|P1|STARTED|Month 36||240
245682|NCT00541970|590907|P4|NOT COMPLETED|Month 24||22
245683|NCT00541970|590908|P3|NOT COMPLETED|Month 24||32
245684|NCT00541970|590909|P2|NOT COMPLETED|Month 24||32
245685|NCT00541970|590910|P1|NOT COMPLETED|Month 24||29
245686|NCT00541970|590907|P4|COMPLETED|Month 24||217
245687|NCT00541970|590908|P3|COMPLETED|Month 24||208
245688|NCT00541970|590909|P2|COMPLETED|Month 24||209
245689|NCT00541970|590910|P1|COMPLETED|Month 24||211
245690|NCT00541970|590907|P4|STARTED|Month 24||239
245691|NCT00541970|590908|P3|STARTED|Month 24||240
245692|NCT00541970|590909|P2|STARTED|Month 24||241
245693|NCT00541970|590910|P1|STARTED|Month 24||240
245694|NCT00541970|590907|P4|NOT COMPLETED|Month 18||17
245695|NCT00541970|590908|P3|NOT COMPLETED|Month 18||25
245696|NCT00541970|590909|P2|NOT COMPLETED|Month 18||24
245697|NCT00541970|590910|P1|NOT COMPLETED|Month 18||14
245698|NCT00541970|590907|P4|COMPLETED|Month 18||222
245699|NCT00541970|590908|P3|COMPLETED|Month 18||215
245700|NCT00541970|590909|P2|COMPLETED|Month 18||217
245701|NCT00541970|590910|P1|COMPLETED|Month 18||226
245702|NCT00541970|590907|P4|STARTED|Month 18||239
245703|NCT00541970|590908|P3|STARTED|Month 18||240
245704|NCT00541970|590909|P2|STARTED|Month 18||241
245705|NCT00541970|590910|P1|STARTED|Month 18||240
245706|NCT00541970|590907|P4|NOT COMPLETED|Month 12||16
245707|NCT00541970|590908|P3|NOT COMPLETED|Month 12||21
245708|NCT00541970|590909|P2|NOT COMPLETED|Month 12||22
245709|NCT00541970|590910|P1|NOT COMPLETED|Month 12||12
245710|NCT00541970|590907|P4|COMPLETED|Month 12||223
245711|NCT00541970|590908|P3|COMPLETED|Month 12||219
245712|NCT00541970|590909|P2|COMPLETED|Month 12||219
245713|NCT00541970|590910|P1|COMPLETED|Month 12||228
245714|NCT00541970|590907|P4|STARTED|Month 12||239
245715|NCT00541970|590908|P3|STARTED|Month 12||240
245716|NCT00541970|590909|P2|STARTED|Month 12||241
245717|NCT00541970|590910|P1|STARTED|Month 12||240
245718|NCT00541970|590907|P4|NOT COMPLETED|Month 7||5
245719|NCT00541970|590908|P3|NOT COMPLETED|Month 7||11
245720|NCT00541970|590909|P2|NOT COMPLETED|Month 7||13
245721|NCT00541970|590910|P1|NOT COMPLETED|Month 7||9
245722|NCT00541970|590907|P4|COMPLETED|Month 7||234
245723|NCT00541970|590908|P3|COMPLETED|Month 7||229
245724|NCT00541970|590909|P2|COMPLETED|Month 7||228
245725|NCT00541970|590910|P1|COMPLETED|Month 7||231
245726|NCT00541970|590907|P4|STARTED|Month 7||239
245727|NCT00541970|590908|P3|STARTED|Month 7||240
245728|NCT00541970|590909|P2|STARTED|Month 7||241
245729|NCT00541970|590910|P1|STARTED|Month 7||240
245730|NCT00541931|591061|P2|NOT COMPLETED|Overall Study||4
245731|NCT00541931|591062|P1|NOT COMPLETED|Overall Study||5
245732|NCT00541931|591061|P2|COMPLETED|Overall Study||11
245733|NCT00541931|591062|P1|COMPLETED|Overall Study||17
245734|NCT00541931|591061|P2|STARTED|Overall Study||15
245735|NCT00541931|591062|P1|STARTED|Overall Study||22
245736|NCT00541866|591075|P5|NOT COMPLETED|Overall Study||15
245737|NCT00541866|591076|P4|NOT COMPLETED|Overall Study||16
245738|NCT00541866|591077|P3|NOT COMPLETED|Overall Study||15
245739|NCT00541866|591078|P2|NOT COMPLETED|Overall Study||18
245740|NCT00541866|591079|P1|NOT COMPLETED|Overall Study||34
245741|NCT00541866|591075|P5|COMPLETED|Overall Study||3
245742|NCT00541866|591076|P4|COMPLETED|Overall Study||0
245743|NCT00541866|591077|P3|COMPLETED|Overall Study||2
245744|NCT00541866|591078|P2|COMPLETED|Overall Study||0
245745|NCT00541866|591079|P1|COMPLETED|Overall Study||7
245746|NCT00541866|591075|P5|STARTED|Overall Study||18
245747|NCT00541866|591076|P4|STARTED|Overall Study||16
245748|NCT00541866|591077|P3|STARTED|Overall Study||17
245749|NCT00541866|591078|P2|STARTED|Overall Study||18
245750|NCT00541866|591079|P1|STARTED|Overall Study|41 started, but only 39 treated|41
245751|NCT00541775|591120|P3|NOT COMPLETED|Overall Study||8
245752|NCT00541775|591121|P2|NOT COMPLETED|Overall Study||2
245753|NCT00541775|591122|P1|NOT COMPLETED|Overall Study||9
245754|NCT00541775|591120|P3|COMPLETED|Overall Study||84
245755|NCT00541775|591121|P2|COMPLETED|Overall Study||85
245756|NCT00541775|591122|P1|COMPLETED|Overall Study||85
245757|NCT00541775|591120|P3|STARTED|Overall Study||92
245758|NCT00541775|591121|P2|STARTED|Overall Study||87
245759|NCT00541775|591122|P1|STARTED|Overall Study||94
245760|NCT00541671|591138|P2|NOT COMPLETED|Overall Study||0
245761|NCT00541671|591139|P1|NOT COMPLETED|Overall Study||0
245762|NCT00541671|591138|P2|COMPLETED|Overall Study||12
245763|NCT00541671|591139|P1|COMPLETED|Overall Study||13
245764|NCT00541671|591138|P2|STARTED|Overall Study||12
245765|NCT00541671|591139|P1|STARTED|Overall Study||13
245766|NCT00541658|591148|P3|NOT COMPLETED|Overall Study||68
245767|NCT00541658|591149|P2|NOT COMPLETED|Overall Study||73
245768|NCT00541658|591150|P1|NOT COMPLETED|Overall Study||60
245769|NCT00541658|591148|P3|COMPLETED|Overall Study||240
245770|NCT00541658|591149|P2|COMPLETED|Overall Study||234
245771|NCT00541658|591150|P1|COMPLETED|Overall Study||248
245772|NCT00541658|591148|P3|ITT Population|Overall Study||308
245773|NCT00541658|591149|P2|ITT Population|Overall Study||307
245774|NCT00541658|591150|P1|ITT Population|Overall Study||307
245775|NCT00541658|591148|P3|STARTED|Overall Study||308
245776|NCT00541658|591149|P2|STARTED|Overall Study||307
245777|NCT00541658|591150|P1|STARTED|Overall Study||308
245778|NCT00541593|591307|P1|NOT COMPLETED|Overall Study||0
245779|NCT00541593|591307|P1|COMPLETED|Overall Study||5
245780|NCT00541593|591307|P1|STARTED|Overall Study||5
245781|NCT00541450|591313|P2|NOT COMPLETED|Phase B||31
245782|NCT00541450|591314|P1|NOT COMPLETED|Phase B||37
245783|NCT00541450|591313|P2|COMPLETED|Phase B||200
245784|NCT00541450|591314|P1|COMPLETED|Phase B||187
245785|NCT00541450|591313|P2|STARTED|Phase B||231
245786|NCT00541450|591314|P1|STARTED|Phase B||224
245787|NCT00541450|591313|P2|NOT COMPLETED|Phase A||17
245788|NCT00541450|591314|P1|NOT COMPLETED|Phase A||20
245789|NCT00541450|591313|P2|COMPLETED|Phase A||231
245790|NCT00541450|591314|P1|COMPLETED|Phase A||224
245791|NCT00541450|591313|P2|STARTED|Phase A||248
245792|NCT00541450|591314|P1|STARTED|Phase A||244
245793|NCT00541346|591332|P1|NOT COMPLETED|Follow-up||1
245794|NCT00541346|591332|P1|COMPLETED|Follow-up||15
245795|NCT00541346|591332|P1|STARTED|Follow-up||16
245796|NCT00541346|591332|P1|NOT COMPLETED|Baseline||0
245797|NCT00541346|591332|P1|COMPLETED|Baseline||16
245798|NCT00541346|591332|P1|STARTED|Baseline||16
245799|NCT00541307|591346|P1|NOT COMPLETED|Overall Study||24
245800|NCT00541307|591346|P1|COMPLETED|Overall Study||95
245801|NCT00541307|591346|P1|STARTED|Overall Study||119
245802|NCT00541242|591356|P2|NOT COMPLETED|Treatment Period 2||7
245803|NCT00541242|591357|P1|NOT COMPLETED|Treatment Period 2||9
245804|NCT00541242|591356|P2|COMPLETED|Treatment Period 2||266
245805|NCT00541242|591357|P1|COMPLETED|Treatment Period 2||261
245806|NCT00541242|591356|P2|STARTED|Treatment Period 2||273
245807|NCT00541242|591357|P1|STARTED|Treatment Period 2||270
245808|NCT00541242|591356|P2|NOT COMPLETED|Treatment Period 1||0
245809|NCT00541242|591357|P1|NOT COMPLETED|Treatment Period 1||0
245810|NCT00541242|591356|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
245811|NCT00541242|591357|P1|COMPLETED|Treatment Period 1||0
245812|NCT00541242|591356|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
245813|NCT00541242|591357|P1|STARTED|Treatment Period 1||0
245814|NCT00541229|591371|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
245815|NCT00541229|591372|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
245816|NCT00541229|591373|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
245817|NCT00541229|591374|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
245818|NCT00541229|591375|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
245819|NCT00541229|591376|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
245820|NCT00541229|591371|P6|COMPLETED|Treatment Period III (Week 11)||4
245821|NCT00541229|591372|P5|COMPLETED|Treatment Period III (Week 11)||6
245822|NCT00541229|591373|P4|COMPLETED|Treatment Period III (Week 11)||8
245823|NCT00541229|591374|P3|COMPLETED|Treatment Period III (Week 11)||9
245824|NCT00541229|591375|P2|COMPLETED|Treatment Period III (Week 11)||8
245825|NCT00541229|591376|P1|COMPLETED|Treatment Period III (Week 11)||7
245826|NCT00541229|591371|P6|STARTED|Treatment Period III (Week 11)||5
245827|NCT00541229|591372|P5|STARTED|Treatment Period III (Week 11)||7
245828|NCT00541229|591373|P4|STARTED|Treatment Period III (Week 11)||8
245829|NCT00541229|591374|P3|STARTED|Treatment Period III (Week 11)||10
245830|NCT00541229|591375|P2|STARTED|Treatment Period III (Week 11)||8
245831|NCT00541229|591376|P1|STARTED|Treatment Period III (Week 11)||7
245832|NCT00541229|591371|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
245833|NCT00541229|591372|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
245834|NCT00541229|591373|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
245835|NCT00541229|591374|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
245836|NCT00541229|591375|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
245837|NCT00541229|591376|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
245838|NCT00541229|591371|P6|COMPLETED|Washout Period II (Week 7-10)||5
245839|NCT00541229|591372|P5|COMPLETED|Washout Period II (Week 7-10)||7
245840|NCT00541229|591373|P4|COMPLETED|Washout Period II (Week 7-10)||8
245841|NCT00541229|591374|P3|COMPLETED|Washout Period II (Week 7-10)||10
245842|NCT00541229|591375|P2|COMPLETED|Washout Period II (Week 7-10)||8
245843|NCT00541229|591376|P1|COMPLETED|Washout Period II (Week 7-10)||7
245844|NCT00541229|591371|P6|STARTED|Washout Period II (Week 7-10)||8
245845|NCT00541229|591372|P5|STARTED|Washout Period II (Week 7-10)||11
245846|NCT00541229|591373|P4|STARTED|Washout Period II (Week 7-10)||12
245847|NCT00541229|591374|P3|STARTED|Washout Period II (Week 7-10)||12
245848|NCT00541229|591375|P2|STARTED|Washout Period II (Week 7-10)||12
245849|NCT00541229|591376|P1|STARTED|Washout Period II (Week 7-10)||11
245850|NCT00541229|591371|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
245851|NCT00541229|591372|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
245852|NCT00541229|591373|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
245853|NCT00541229|591374|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
245854|NCT00541229|591375|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
245855|NCT00541229|591376|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
245856|NCT00541229|591371|P6|COMPLETED|Treatment Period II (Week 6)||8
245857|NCT00541229|591372|P5|COMPLETED|Treatment Period II (Week 6)||11
245858|NCT00541229|591373|P4|COMPLETED|Treatment Period II (Week 6)||12
245859|NCT00541229|591374|P3|COMPLETED|Treatment Period II (Week 6)||12
245860|NCT00541229|591375|P2|COMPLETED|Treatment Period II (Week 6)||12
245861|NCT00541229|591376|P1|COMPLETED|Treatment Period II (Week 6)||11
245862|NCT00541229|591371|P6|STARTED|Treatment Period II (Week 6)||11
245863|NCT00541229|591372|P5|STARTED|Treatment Period II (Week 6)||13
245864|NCT00541229|591373|P4|STARTED|Treatment Period II (Week 6)||13
245865|NCT00541229|591374|P3|STARTED|Treatment Period II (Week 6)||13
245866|NCT00541229|591375|P2|STARTED|Treatment Period II (Week 6)||13
245867|NCT00541229|591376|P1|STARTED|Treatment Period II (Week 6)||13
245868|NCT00541229|591371|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
245869|NCT00541229|591372|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
245870|NCT00541229|591373|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
245871|NCT00541229|591374|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
245872|NCT00541229|591375|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
245873|NCT00541229|591376|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
245874|NCT00541229|591371|P6|COMPLETED|Washout Period I (Week 2-5)||11
245875|NCT00541229|591372|P5|COMPLETED|Washout Period I (Week 2-5)||13
245876|NCT00541229|591373|P4|COMPLETED|Washout Period I (Week 2-5)||13
245877|NCT00541229|591374|P3|COMPLETED|Washout Period I (Week 2-5)||13
245878|NCT00541229|591375|P2|COMPLETED|Washout Period I (Week 2-5)||13
245879|NCT00541229|591376|P1|COMPLETED|Washout Period I (Week 2-5)||13
245880|NCT00541229|591371|P6|STARTED|Washout Period I (Week 2-5)||16
245881|NCT00541229|591372|P5|STARTED|Washout Period I (Week 2-5)||14
245882|NCT00541229|591373|P4|STARTED|Washout Period I (Week 2-5)||17
245883|NCT00541229|591374|P3|STARTED|Washout Period I (Week 2-5)||17
245884|NCT00541229|591375|P2|STARTED|Washout Period I (Week 2-5)||15
245885|NCT00541229|591376|P1|STARTED|Washout Period I (Week 2-5)||17
245886|NCT00541229|591371|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
245887|NCT00541229|591372|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
245888|NCT00541229|591373|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
245889|NCT00541229|591374|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
245890|NCT00541229|591375|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
245891|NCT00541229|591376|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
245892|NCT00541229|591371|P6|COMPLETED|Treatment Period I (Week 1)||16
245893|NCT00541229|591372|P5|COMPLETED|Treatment Period I (Week 1)||14
245894|NCT00541229|591373|P4|COMPLETED|Treatment Period I (Week 1)||17
245895|NCT00541229|591374|P3|COMPLETED|Treatment Period I (Week 1)||17
245896|NCT00541229|591375|P2|COMPLETED|Treatment Period I (Week 1)||15
245897|NCT00541229|591376|P1|COMPLETED|Treatment Period I (Week 1)||17
245898|NCT00541229|591371|P6|STARTED|Treatment Period I (Week 1)||18
245899|NCT00541229|591372|P5|STARTED|Treatment Period I (Week 1)||14
245900|NCT00541229|591373|P4|STARTED|Treatment Period I (Week 1)||18
245901|NCT00541229|591374|P3|STARTED|Treatment Period I (Week 1)||20
245902|NCT00541229|591375|P2|STARTED|Treatment Period I (Week 1)||16
245903|NCT00541229|591376|P1|STARTED|Treatment Period I (Week 1)||17
245904|NCT00541190|591386|P2|NOT COMPLETED|Overall Study||0
245905|NCT00541190|591387|P1|NOT COMPLETED|Overall Study||0
245906|NCT00541190|591386|P2|COMPLETED|Overall Study||11
245907|NCT00541190|591387|P1|COMPLETED|Overall Study||10
245908|NCT00541190|591386|P2|STARTED|Overall Study||11
245909|NCT00541190|591387|P1|STARTED|Overall Study||10
245910|NCT00541099|591395|P1|NOT COMPLETED|Overall Study||3
245911|NCT00541099|591395|P1|COMPLETED|Overall Study||8
245912|NCT00541099|591395|P1|STARTED|Overall Study||11
245913|NCT00541034|591401|P1|NOT COMPLETED|Overall Study||3
245914|NCT00541034|591401|P1|COMPLETED|Overall Study||46
245915|NCT00541034|591401|P1|STARTED|Overall Study||49
245916|NCT00540969|591407|P2|NOT COMPLETED|Overall Study||0
245917|NCT00540969|591408|P1|NOT COMPLETED|Overall Study||0
245918|NCT00540969|591407|P2|COMPLETED|Overall Study||1
245919|NCT00540969|591408|P1|COMPLETED|Overall Study||2
245920|NCT00540969|591407|P2|STARTED|Overall Study||1
245921|NCT00540969|591408|P1|STARTED|Overall Study||2
245922|NCT00540722|591418|P1|NOT COMPLETED|Overall Study||0
245923|NCT00540722|591418|P1|COMPLETED|Overall Study||56
245924|NCT00540722|591418|P1|STARTED|Overall Study||56
245925|NCT00540644|591428|P2|NOT COMPLETED|Overall Study||9
245926|NCT00540644|591429|P1|NOT COMPLETED|Overall Study||9
245927|NCT00540644|591428|P2|COMPLETED|Overall Study||13
245928|NCT00540644|591429|P1|COMPLETED|Overall Study||39
245929|NCT00540644|591428|P2|STARTED|Overall Study||22
245930|NCT00540644|591429|P1|STARTED|Overall Study||48
245931|NCT00540592|591449|P10|NOT COMPLETED|Overall Study||2
245932|NCT00540592|591450|P9|NOT COMPLETED|Overall Study||1
245933|NCT00540592|591451|P8|NOT COMPLETED|Overall Study||1
245934|NCT00540592|591452|P7|NOT COMPLETED|Overall Study||0
245935|NCT00540592|591453|P6|NOT COMPLETED|Overall Study||0
245936|NCT00540592|591454|P5|NOT COMPLETED|Overall Study||1
245937|NCT00540592|591455|P4|NOT COMPLETED|Overall Study||1
245938|NCT00540592|591456|P3|NOT COMPLETED|Overall Study||1
245939|NCT00540592|591457|P2|NOT COMPLETED|Overall Study||1
245940|NCT00540592|591458|P1|NOT COMPLETED|Overall Study||2
245941|NCT00540592|591449|P10|COMPLETED|Overall Study||201
245942|NCT00540592|591450|P9|COMPLETED|Overall Study||199
245943|NCT00540592|591451|P8|COMPLETED|Overall Study||198
245944|NCT00540592|591452|P7|COMPLETED|Overall Study||198
245945|NCT00540592|591453|P6|COMPLETED|Overall Study||198
245946|NCT00540592|591454|P5|COMPLETED|Overall Study||198
245947|NCT00540592|591455|P4|COMPLETED|Overall Study||201
245948|NCT00540592|591456|P3|COMPLETED|Overall Study||201
245949|NCT00540592|591457|P2|COMPLETED|Overall Study||201
245950|NCT00540592|591458|P1|COMPLETED|Overall Study||202
245951|NCT00540592|591449|P10|Completed at Day 180|Overall Study||189
245952|NCT00540592|591450|P9|Completed at Day 180|Overall Study||198
245953|NCT00540592|591451|P8|Completed at Day 180|Overall Study||193
245954|NCT00540592|591452|P7|Completed at Day 180|Overall Study||196
245955|NCT00540592|591453|P6|Completed at Day 180|Overall Study||198
245956|NCT00540592|591454|P5|Completed at Day 180|Overall Study||195
245957|NCT00540592|591455|P4|Completed at Day 180|Overall Study||197
245958|NCT00540592|591456|P3|Completed at Day 180|Overall Study||197
245959|NCT00540592|591457|P2|Completed at Day 180|Overall Study||201
245960|NCT00540592|591458|P1|Completed at Day 180|Overall Study||200
245961|NCT00540592|591449|P10|STARTED|Overall Study||203
245962|NCT00540592|591450|P9|STARTED|Overall Study||200
245963|NCT00540592|591451|P8|STARTED|Overall Study||199
245964|NCT00540592|591452|P7|STARTED|Overall Study||198
245965|NCT00540592|591453|P6|STARTED|Overall Study||198
245966|NCT00540592|591454|P5|STARTED|Overall Study||199
245967|NCT00540592|591455|P4|STARTED|Overall Study||202
245968|NCT00540592|591456|P3|STARTED|Overall Study||202
245969|NCT00540592|591457|P2|STARTED|Overall Study||202
245970|NCT00540592|591458|P1|STARTED|Overall Study||204
245971|NCT00540579|591690|P1|NOT COMPLETED|Overall Study||0
245972|NCT00540579|591690|P1|COMPLETED|Overall Study||23
245973|NCT00540579|591690|P1|STARTED|Overall Study||23
245974|NCT00540514|591697|P2|NOT COMPLETED|Overall Study||266
245975|NCT00540514|591698|P1|NOT COMPLETED|Overall Study||246
245976|NCT00540514|591697|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
245977|NCT00540514|591698|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
245978|NCT00540514|591697|P2|Biomarker Population|Overall Study||36
245979|NCT00540514|591698|P1|Biomarker Population|Overall Study||35
245980|NCT00540514|591697|P2|Treated|Overall Study||524
245981|NCT00540514|591698|P1|Treated|Overall Study||514
245982|NCT00540514|591697|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
245983|NCT00540514|591698|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
245984|NCT00540449|591730|P2|NOT COMPLETED|Overall Study||78
245985|NCT00540449|591731|P1|NOT COMPLETED|Overall Study||84
245986|NCT00540449|591730|P2|COMPLETED|Overall Study||266
245987|NCT00540449|591731|P1|COMPLETED|Overall Study||262
245988|NCT00540449|591730|P2|STARTED|Overall Study||344
245989|NCT00540449|591731|P1|STARTED|Overall Study||346
245990|NCT00540436|591753|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
245991|NCT00540436|591753|P1|COMPLETED|Second 12-Week Treatment Period||21
245992|NCT00540436|591753|P1|STARTED|Second 12-Week Treatment Period||22
245993|NCT00540436|591753|P1|NOT COMPLETED|First 12-Week Treatment Period||3
245994|NCT00540436|591753|P1|COMPLETED|First 12-Week Treatment Period||22
245995|NCT00540436|591753|P1|STARTED|First 12-Week Treatment Period||25
245996|NCT00540423|591768|P3|NOT COMPLETED|Open-Label Treatment Period||2
245997|NCT00540423|591769|P2|NOT COMPLETED|Open-Label Treatment Period||0
245998|NCT00540423|591770|P1|NOT COMPLETED|Open-Label Treatment Period||0
245999|NCT00540423|591768|P3|COMPLETED|Open-Label Treatment Period||20
246000|NCT00540423|591769|P2|COMPLETED|Open-Label Treatment Period||0
246001|NCT00540423|591770|P1|COMPLETED|Open-Label Treatment Period||0
246002|NCT00540423|591768|P3|STARTED|Open-Label Treatment Period||22
246003|NCT00540423|591769|P2|STARTED|Open-Label Treatment Period||0
246004|NCT00540423|591770|P1|STARTED|Open-Label Treatment Period||0
246005|NCT00540423|591768|P3|NOT COMPLETED|Double-Blind Treatment Period||0
246006|NCT00540423|591769|P2|NOT COMPLETED|Double-Blind Treatment Period||1
246007|NCT00540423|591770|P1|NOT COMPLETED|Double-Blind Treatment Period||0
246008|NCT00540423|591768|P3|COMPLETED|Double-Blind Treatment Period||0
246009|NCT00540423|591769|P2|COMPLETED|Double-Blind Treatment Period||14
246010|NCT00540423|591770|P1|COMPLETED|Double-Blind Treatment Period||8
246011|NCT00540423|591768|P3|STARTED|Double-Blind Treatment Period||0
246012|NCT00540423|591769|P2|STARTED|Double-Blind Treatment Period||15
246013|NCT00540423|591770|P1|STARTED|Double-Blind Treatment Period||8
246014|NCT00540293|591820|P1|NOT COMPLETED|Overall Study||35
246015|NCT00540293|591820|P1|COMPLETED|Overall Study||390
246016|NCT00540293|591820|P1|STARTED|Overall Study||425
246017|NCT00540228|591868|P5|NOT COMPLETED|Overall Study||0
246018|NCT00540228|591869|P4|NOT COMPLETED|Overall Study||0
246019|NCT00540228|591870|P3|NOT COMPLETED|Overall Study||0
246020|NCT00540228|591871|P2|NOT COMPLETED|Overall Study||1
246021|NCT00540228|591872|P1|NOT COMPLETED|Overall Study||3
246022|NCT00540228|591868|P5|COMPLETED|Overall Study||202
246023|NCT00540228|591869|P4|COMPLETED|Overall Study||202
246024|NCT00540228|591870|P3|COMPLETED|Overall Study||204
246025|NCT00540228|591871|P2|COMPLETED|Overall Study||197
246026|NCT00540228|591872|P1|COMPLETED|Overall Study||197
246027|NCT00540228|591868|P5|STARTED|Overall Study||202
246028|NCT00540228|591869|P4|STARTED|Overall Study||202
246029|NCT00540228|591870|P3|STARTED|Overall Study||204
246030|NCT00540228|591871|P2|STARTED|Overall Study||198
246031|NCT00540228|591872|P1|STARTED|Overall Study||200
246032|NCT00540124|591942|P3|NOT COMPLETED|Overall Study||1
246033|NCT00540124|591943|P2|NOT COMPLETED|Overall Study||3
246034|NCT00540124|591944|P1|NOT COMPLETED|Overall Study||4
246035|NCT00540124|591942|P3|COMPLETED|Overall Study||48
246036|NCT00540124|591943|P2|COMPLETED|Overall Study||48
246037|NCT00540124|591944|P1|COMPLETED|Overall Study||47
246038|NCT00540124|591942|P3|STARTED|Overall Study||49
246039|NCT00540124|591943|P2|STARTED|Overall Study||51
246040|NCT00540124|591944|P1|STARTED|Overall Study||51
246041|NCT00540046|591990|P2|NOT COMPLETED|Overall Study||23
246042|NCT00540046|591991|P1|NOT COMPLETED|Overall Study||33
246043|NCT00540046|591990|P2|COMPLETED|Overall Study||88
246044|NCT00540046|591991|P1|COMPLETED|Overall Study||71
246045|NCT00540046|591990|P2|STARTED|Overall Study||111
246046|NCT00540046|591991|P1|STARTED|Overall Study||104
246047|NCT00540007|592001|P2|NOT COMPLETED|Overall Study||0
246048|NCT00540007|592002|P1|NOT COMPLETED|Overall Study||0
246049|NCT00540007|592001|P2|COMPLETED|Overall Study||42
246050|NCT00540007|592002|P1|COMPLETED|Overall Study||38
246051|NCT00540007|592001|P2|STARTED|Overall Study||42
246052|NCT00540007|592002|P1|STARTED|Overall Study||38
246053|NCT00539994|592027|P3|NOT COMPLETED|Overall Study||2
246054|NCT00539994|592028|P2|NOT COMPLETED|Overall Study||1
246055|NCT00539994|592029|P1|NOT COMPLETED|Overall Study||3
246056|NCT00539994|592027|P3|COMPLETED|Overall Study||13
246057|NCT00539994|592028|P2|COMPLETED|Overall Study||18
246058|NCT00539994|592029|P1|COMPLETED|Overall Study||20
246059|NCT00539994|592027|P3|STARTED|Overall Study||15
246060|NCT00539994|592028|P2|STARTED|Overall Study||19
246061|NCT00539994|592029|P1|STARTED|Overall Study||23
246062|NCT00539942|592068|P2|NOT COMPLETED|Overall Study||0
246063|NCT00539942|592069|P1|NOT COMPLETED|Overall Study||0
246064|NCT00539942|592068|P2|COMPLETED|Overall Study||3
246065|NCT00539942|592069|P1|COMPLETED|Overall Study||4
246066|NCT00539942|592068|P2|STARTED|Overall Study||3
246067|NCT00539942|592069|P1|STARTED|Overall Study||4
246068|NCT00539864|592079|P2|NOT COMPLETED|Overall Study||2
246069|NCT00539864|592080|P1|NOT COMPLETED|Overall Study||1
246070|NCT00539864|592079|P2|COMPLETED|Overall Study||300
246071|NCT00539864|592080|P1|COMPLETED|Overall Study||299
246072|NCT00539864|592079|P2|STARTED|Overall Study||302
246073|NCT00539864|592080|P1|STARTED|Overall Study||300
246074|NCT00539734|592092|P1|NOT COMPLETED|Overall Study||1
246075|NCT00539734|592092|P1|COMPLETED|Overall Study||25
246076|NCT00539734|592092|P1|STARTED|Overall Study||26
246077|NCT00539695|592097|P1|NOT COMPLETED|Overall Study||13
246078|NCT00539695|592097|P1|COMPLETED|Overall Study||12
246079|NCT00539695|592097|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
246080|NCT00539695|592097|P1|STARTED|Overall Study||25
246081|NCT00539617|592103|P1|NOT COMPLETED|Treatment Period||0
246082|NCT00539617|592103|P1|COMPLETED|Treatment Period||3
246083|NCT00539617|592103|P1|STARTED|Treatment Period||3
246084|NCT00539617|592103|P1|NOT COMPLETED|Run-In Period||1
246085|NCT00539617|592103|P1|COMPLETED|Run-In Period||3
246086|NCT00539617|592103|P1|STARTED|Run-In Period||4
246087|NCT00539617|592103|P1|NOT COMPLETED|Pre-screening Period||3
246088|NCT00539617|592103|P1|COMPLETED|Pre-screening Period||4
246089|NCT00539617|592103|P1|STARTED|Pre-screening Period||7
246090|NCT00539591|592111|P3|NOT COMPLETED|Overall Study||3
246091|NCT00539591|592112|P2|NOT COMPLETED|Overall Study||2
246092|NCT00539591|592113|P1|NOT COMPLETED|Overall Study||5
246093|NCT00539591|592111|P3|COMPLETED|Overall Study||1
246094|NCT00539591|592112|P2|COMPLETED|Overall Study||0
246095|NCT00539591|592113|P1|COMPLETED|Overall Study||18
246096|NCT00539591|592111|P3|STARTED|Overall Study||4
246097|NCT00539591|592112|P2|STARTED|Overall Study||2
246098|NCT00539591|592113|P1|STARTED|Overall Study||23
246099|NCT00539539|592223|P2|NOT COMPLETED|Overall Study||0
246100|NCT00539539|592224|P1|NOT COMPLETED|Overall Study||0
246101|NCT00539539|592223|P2|COMPLETED|Overall Study||771
246102|NCT00539539|592224|P1|COMPLETED|Overall Study||815
246103|NCT00539539|592223|P2|STARTED|Overall Study||771
246104|NCT00539539|592224|P1|STARTED|Overall Study||815
246105|NCT00539526|592247|P3|NOT COMPLETED|Overall Study||2
246106|NCT00539526|592248|P2|NOT COMPLETED|Overall Study||2
246107|NCT00539526|592249|P1|NOT COMPLETED|Overall Study||3
246108|NCT00539526|592247|P3|COMPLETED|Overall Study||36
246109|NCT00539526|592248|P2|COMPLETED|Overall Study||31
246110|NCT00539526|592249|P1|COMPLETED|Overall Study||32
246111|NCT00539526|592247|P3|STARTED|Overall Study||38
246112|NCT00539526|592248|P2|STARTED|Overall Study||33
246113|NCT00539526|592249|P1|STARTED|Overall Study||35
246114|NCT00539513|592265|P2|NOT COMPLETED|Overall Study||2
246115|NCT00539513|592266|P1|NOT COMPLETED|Overall Study||2
246116|NCT00539513|592265|P2|COMPLETED|Overall Study||3
246117|NCT00539513|592266|P1|COMPLETED|Overall Study||3
246118|NCT00539513|592265|P2|Received Allocated Intervention|Overall Study||4
246119|NCT00539513|592266|P1|Received Allocated Intervention|Overall Study||3
246120|NCT00539513|592265|P2|STARTED|Overall Study||5
246121|NCT00539513|592266|P1|STARTED|Overall Study||5
246122|NCT00539305|592280|P2|NOT COMPLETED|Overall Study||2
246123|NCT00539305|592281|P1|NOT COMPLETED|Overall Study||1
246124|NCT00539305|592280|P2|COMPLETED|Overall Study||10
246125|NCT00539305|592281|P1|COMPLETED|Overall Study||9
246126|NCT00539305|592280|P2|STARTED|Overall Study||12
246127|NCT00539305|592281|P1|STARTED|Overall Study||10
246128|NCT00539279|592295|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
246129|NCT00539279|592296|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
246130|NCT00539279|592295|P2|COMPLETED|6-Month Follow-Up Assessment||22
246131|NCT00539279|592296|P1|COMPLETED|6-Month Follow-Up Assessment||17
246132|NCT00539279|592295|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
246133|NCT00539279|592296|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
246134|NCT00539279|592295|P2|NOT COMPLETED|Post-Treatment Assessment||9
246135|NCT00539279|592296|P1|NOT COMPLETED|Post-Treatment Assessment||12
246136|NCT00539279|592295|P2|COMPLETED|Post-Treatment Assessment||29
246137|NCT00539279|592296|P1|COMPLETED|Post-Treatment Assessment||18
246138|NCT00539279|592295|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
246139|NCT00539279|592296|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
246140|NCT00539279|592295|P2|NOT COMPLETED|Treatment||8
246141|NCT00539279|592296|P1|NOT COMPLETED|Treatment||11
246142|NCT00539279|592295|P2|COMPLETED|Treatment||38
246143|NCT00539279|592296|P1|COMPLETED|Treatment||30
246144|NCT00539279|592295|P2|STARTED|Treatment||46
246145|NCT00539279|592296|P1|STARTED|Treatment||41
246146|NCT00539253|592314|P1|NOT COMPLETED|Overall Study||26
246147|NCT00539253|592314|P1|COMPLETED|Overall Study||19
246148|NCT00539253|592314|P1|STARTED|Overall Study||45
246149|NCT00539240|592322|P3|NOT COMPLETED|Overall Study||15
246150|NCT00539240|592323|P2|NOT COMPLETED|Overall Study||7
246151|NCT00539240|592324|P1|NOT COMPLETED|Overall Study||6
246152|NCT00539240|592322|P3|COMPLETED|Overall Study||39
246153|NCT00539240|592323|P2|COMPLETED|Overall Study||48
246154|NCT00539240|592324|P1|COMPLETED|Overall Study||53
246155|NCT00539240|592322|P3|STARTED|Overall Study||54
246156|NCT00539240|592323|P2|STARTED|Overall Study||55
246157|NCT00539240|592324|P1|STARTED|Overall Study||59
246158|NCT00539188|592343|P2|NOT COMPLETED|Overall Study||1
246159|NCT00539188|592344|P1|NOT COMPLETED|Overall Study||3
246160|NCT00539188|592343|P2|COMPLETED|Overall Study||1
246161|NCT00539188|592344|P1|COMPLETED|Overall Study||1
246162|NCT00539188|592343|P2|Received Allocated Intervention|Overall Study||2
246163|NCT00539188|592344|P1|Received Allocated Intervention|Overall Study||3
246164|NCT00539188|592343|P2|STARTED|Overall Study||2
246165|NCT00539188|592344|P1|STARTED|Overall Study||4
246166|NCT00539110|592358|P2|NOT COMPLETED|Overall Study||0
246167|NCT00539110|592359|P1|NOT COMPLETED|Overall Study||0
246168|NCT00539110|592358|P2|COMPLETED|Overall Study||5
246169|NCT00539110|592359|P1|COMPLETED|Overall Study||5
246170|NCT00539110|592358|P2|STARTED|Overall Study||5
246171|NCT00539110|592359|P1|STARTED|Overall Study||5
246172|NCT00539032|592367|P2|NOT COMPLETED|Overall Study||1
246173|NCT00539032|592368|P1|NOT COMPLETED|Overall Study||2
246174|NCT00539032|592367|P2|COMPLETED|Overall Study||84
246175|NCT00539032|592368|P1|COMPLETED|Overall Study||151
246176|NCT00539032|592367|P2|STARTED|Overall Study||85
246177|NCT00539032|592368|P1|STARTED|Overall Study||153
246178|NCT00539006|592382|P4|NOT COMPLETED|Post-Study||0
246179|NCT00539006|592383|P3|NOT COMPLETED|Post-Study||0
246180|NCT00539006|592384|P2|NOT COMPLETED|Post-Study||0
246181|NCT00539006|592385|P1|NOT COMPLETED|Post-Study||0
246182|NCT00539006|592382|P4|COMPLETED|Post-Study||81
246183|NCT00539006|592383|P3|COMPLETED|Post-Study||77
246184|NCT00539006|592384|P2|COMPLETED|Post-Study||83
246185|NCT00539006|592385|P1|COMPLETED|Post-Study||75
246186|NCT00539006|592382|P4|STARTED|Post-Study||81
246187|NCT00539006|592383|P3|STARTED|Post-Study||77
246188|NCT00539006|592384|P2|STARTED|Post-Study||83
246189|NCT00539006|592385|P1|STARTED|Post-Study||75
246190|NCT00539006|592382|P4|NOT COMPLETED|Treatment Period 2||0
246191|NCT00539006|592383|P3|NOT COMPLETED|Treatment Period 2||0
246192|NCT00539006|592384|P2|NOT COMPLETED|Treatment Period 2||1
246193|NCT00539006|592385|P1|NOT COMPLETED|Treatment Period 2||1
246194|NCT00539006|592382|P4|COMPLETED|Treatment Period 2||81
246195|NCT00539006|592383|P3|COMPLETED|Treatment Period 2||77
246196|NCT00539006|592384|P2|COMPLETED|Treatment Period 2||83
246197|NCT00539006|592385|P1|COMPLETED|Treatment Period 2||75
246198|NCT00539006|592382|P4|STARTED|Treatment Period 2||81
246199|NCT00539006|592383|P3|STARTED|Treatment Period 2||77
246200|NCT00539006|592384|P2|STARTED|Treatment Period 2||84
246201|NCT00539006|592385|P1|STARTED|Treatment Period 2||76
246202|NCT00539006|592382|P4|NOT COMPLETED|Washout||9
246203|NCT00539006|592383|P3|NOT COMPLETED|Washout||16
246204|NCT00539006|592384|P2|NOT COMPLETED|Washout||10
246205|NCT00539006|592385|P1|NOT COMPLETED|Washout||20
246206|NCT00539006|592382|P4|COMPLETED|Washout||81
246207|NCT00539006|592383|P3|COMPLETED|Washout||77
246208|NCT00539006|592384|P2|COMPLETED|Washout||84
246209|NCT00539006|592385|P1|COMPLETED|Washout||76
246210|NCT00539006|592382|P4|STARTED|Washout||90
246211|NCT00539006|592383|P3|STARTED|Washout||93
246212|NCT00539006|592384|P2|STARTED|Washout||94
246213|NCT00539006|592385|P1|STARTED|Washout||96
246214|NCT00539006|592382|P4|NOT COMPLETED|Treatment Period 1||1
246215|NCT00539006|592383|P3|NOT COMPLETED|Treatment Period 1||2
246216|NCT00539006|592384|P2|NOT COMPLETED|Treatment Period 1||0
246217|NCT00539006|592385|P1|NOT COMPLETED|Treatment Period 1||0
246218|NCT00539006|592382|P4|COMPLETED|Treatment Period 1||90
246219|NCT00539006|592383|P3|COMPLETED|Treatment Period 1||93
246220|NCT00539006|592384|P2|COMPLETED|Treatment Period 1||94
246221|NCT00539006|592385|P1|COMPLETED|Treatment Period 1||96
246222|NCT00539006|592382|P4|STARTED|Treatment Period 1||91
246223|NCT00539006|592383|P3|STARTED|Treatment Period 1||95
246224|NCT00539006|592384|P2|STARTED|Treatment Period 1||94
246225|NCT00539006|592385|P1|STARTED|Treatment Period 1||96
246226|NCT00539006|592382|P4|NOT COMPLETED|Pre-treatment||0
246227|NCT00539006|592383|P3|NOT COMPLETED|Pre-treatment||0
246228|NCT00539006|592384|P2|NOT COMPLETED|Pre-treatment||1
246229|NCT00539006|592385|P1|NOT COMPLETED|Pre-treatment||0
246230|NCT00539006|592382|P4|COMPLETED|Pre-treatment||91
246231|NCT00539006|592383|P3|COMPLETED|Pre-treatment||95
246232|NCT00539006|592384|P2|COMPLETED|Pre-treatment||94
246233|NCT00539006|592385|P1|COMPLETED|Pre-treatment||96
246234|NCT00539006|592382|P4|STARTED|Pre-treatment||91
246235|NCT00539006|592383|P3|STARTED|Pre-treatment||95
246236|NCT00539006|592384|P2|STARTED|Pre-treatment||95
246237|NCT00539006|592385|P1|STARTED|Pre-treatment||96
246238|NCT00538980|592415|P1|NOT COMPLETED|Overall Study||10
246239|NCT00538980|592415|P1|COMPLETED|Overall Study||0
246240|NCT00538980|592415|P1|STARTED|Overall Study||10
246241|NCT00538915|592423|P1|NOT COMPLETED|Overall Study||11
246242|NCT00538915|592423|P1|COMPLETED|Overall Study||52
246243|NCT00538915|592423|P1|STARTED|Overall Study||63
246244|NCT00538902|592430|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
246245|NCT00538902|592431|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
246246|NCT00538902|592432|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
246247|NCT00538902|592430|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
246248|NCT00538902|592431|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
246249|NCT00538902|592432|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
246250|NCT00538902|592430|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
246251|NCT00538902|592431|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
246252|NCT00538902|592432|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
246253|NCT00538902|592430|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
246254|NCT00538902|592431|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
246255|NCT00538902|592432|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
246256|NCT00538902|592430|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
246257|NCT00538902|592431|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
246258|NCT00538902|592432|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
246259|NCT00538902|592430|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
246260|NCT00538902|592431|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
246261|NCT00538902|592432|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
246262|NCT00538863|592467|P1|NOT COMPLETED|Open-label Maintenance||106
246263|NCT00538863|592467|P1|COMPLETED|Open-label Maintenance||163
246264|NCT00538863|592467|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
246265|NCT00538863|592467|P1|NOT COMPLETED|Open-label Titration||45
246266|NCT00538863|592467|P1|COMPLETED|Open-label Titration||184
246267|NCT00538863|592467|P1|STARTED|Open-label Titration||229
246268|NCT00538850|592473|P3|NOT COMPLETED|Placebo - Double-blind||3
246269|NCT00538850|592474|P2|NOT COMPLETED|Placebo - Double-blind||0
246270|NCT00538850|592475|P1|NOT COMPLETED|Placebo - Double-blind||0
246271|NCT00538850|592473|P3|COMPLETED|Placebo - Double-blind||95
246272|NCT00538850|592474|P2|COMPLETED|Placebo - Double-blind||0
246273|NCT00538850|592475|P1|COMPLETED|Placebo - Double-blind||0
246274|NCT00538850|592473|P3|STARTED|Placebo - Double-blind||98
246275|NCT00538850|592474|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
246276|NCT00538850|592475|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
246277|NCT00538850|592473|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
246278|NCT00538850|592474|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
246279|NCT00538850|592475|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
246280|NCT00538850|592473|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
246281|NCT00538850|592474|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
246282|NCT00538850|592475|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
246283|NCT00538850|592473|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
246284|NCT00538850|592474|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
246285|NCT00538850|592475|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
246286|NCT00538850|592473|P3|NOT COMPLETED|Titration Period||0
246287|NCT00538850|592474|P2|NOT COMPLETED|Titration Period||0
246288|NCT00538850|592475|P1|NOT COMPLETED|Titration Period||32
246289|NCT00538850|592473|P3|COMPLETED|Titration Period||0
246290|NCT00538850|592474|P2|COMPLETED|Titration Period||0
246291|NCT00538850|592475|P1|COMPLETED|Titration Period||98
246292|NCT00538850|592473|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
246383|NCT00537979|592799|P2|COMPLETED|Overall Study||89
246293|NCT00538850|592474|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
246294|NCT00538850|592475|P1|STARTED|Titration Period||130
246295|NCT00538824|592487|P1|NOT COMPLETED|Overall Study||0
246296|NCT00538824|592487|P1|COMPLETED|Overall Study||5
246297|NCT00538824|592487|P1|Progression of Disease|Overall Study||2
246298|NCT00538824|592487|P1|STARTED|Overall Study||5
246299|NCT00538785|592493|P2|NOT COMPLETED|Overall Study||17
246300|NCT00538785|592494|P1|NOT COMPLETED|Overall Study||19
246301|NCT00538785|592493|P2|COMPLETED|Overall Study||595
246302|NCT00538785|592494|P1|COMPLETED|Overall Study||604
246303|NCT00538785|592493|P2|STARTED|Overall Study||612
246304|NCT00538785|592494|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
246305|NCT00538733|592515|P1|NOT COMPLETED|Overall Study||12
246306|NCT00538733|592515|P1|COMPLETED|Overall Study||14
246307|NCT00538733|592515|P1|Removed to Pursue Alternative Theray|Overall Study||2
246308|NCT00538733|592515|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
246309|NCT00538733|592515|P1|Removed Due to Progression of Disease|Overall Study||1
246310|NCT00538733|592515|P1|STARTED|Overall Study||26
246311|NCT00538642|592524|P2|NOT COMPLETED|Overall Study||5
246312|NCT00538642|592525|P1|NOT COMPLETED|Overall Study||1
246313|NCT00538642|592524|P2|COMPLETED|Overall Study||9
246314|NCT00538642|592525|P1|COMPLETED|Overall Study||9
246315|NCT00538642|592524|P2|STARTED|Overall Study||14
246316|NCT00538642|592525|P1|STARTED|Overall Study||10
246317|NCT00538629|592565|P1|NOT COMPLETED|Overall Study||22
246318|NCT00538629|592565|P1|COMPLETED|Overall Study||449
246319|NCT00538629|592565|P1|STARTED|Overall Study||471
246320|NCT00538616|592612|P2|NOT COMPLETED|Overall Study||0
246321|NCT00538616|592613|P1|NOT COMPLETED|Overall Study||0
246322|NCT00538616|592612|P2|COMPLETED|Overall Study||3
246323|NCT00538616|592613|P1|COMPLETED|Overall Study||5
246324|NCT00538616|592612|P2|STARTED|Overall Study||3
246325|NCT00538616|592613|P1|STARTED|Overall Study||5
246326|NCT00538590|592621|P2|NOT COMPLETED|Overall Study||0
246327|NCT00538590|592622|P1|NOT COMPLETED|Overall Study||1
246328|NCT00538590|592621|P2|COMPLETED|Overall Study||10
246329|NCT00538590|592622|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
246330|NCT00538590|592621|P2|STARTED|Overall Study||10
246331|NCT00538590|592622|P1|STARTED|Overall Study||10
246332|NCT00538512|592639|P3|NOT COMPLETED|Overall Study||13
246333|NCT00538512|592640|P2|NOT COMPLETED|Overall Study||30
246334|NCT00538512|592641|P1|NOT COMPLETED|Overall Study||27
246335|NCT00538512|592639|P3|COMPLETED|Overall Study||312
246336|NCT00538512|592640|P2|COMPLETED|Overall Study||783
246337|NCT00538512|592641|P1|COMPLETED|Overall Study||787
246338|NCT00538512|592639|P3|STARTED|Overall Study||325
246339|NCT00538512|592640|P2|STARTED|Overall Study||813
246340|NCT00538512|592641|P1|STARTED|Overall Study||814
246341|NCT00538473|592660|P2|NOT COMPLETED|Overall Study||0
246342|NCT00538473|592661|P1|NOT COMPLETED|Overall Study||1
246343|NCT00538473|592660|P2|COMPLETED|Overall Study||35
246344|NCT00538473|592661|P1|COMPLETED|Overall Study||32
246345|NCT00538473|592660|P2|STARTED|Overall Study||35
246346|NCT00538473|592661|P1|STARTED|Overall Study||33
246347|NCT00538434|592697|P4|NOT COMPLETED|Overall Study||6
246348|NCT00538434|592698|P3|NOT COMPLETED|Overall Study||7
246349|NCT00538434|592699|P2|NOT COMPLETED|Overall Study||11
246350|NCT00538434|592700|P1|NOT COMPLETED|Overall Study||9
246351|NCT00538434|592697|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
246352|NCT00538434|592698|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
246353|NCT00538434|592699|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
246354|NCT00538434|592700|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
246355|NCT00538434|592697|P4|Intent-to-treat (ITT) Population|Overall Study||57
246356|NCT00538434|592698|P3|Intent-to-treat (ITT) Population|Overall Study||57
246357|NCT00538434|592699|P2|Intent-to-treat (ITT) Population|Overall Study||57
246358|NCT00538434|592700|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
246359|NCT00538434|592697|P4|STARTED|Overall Study||57
246360|NCT00538434|592698|P3|STARTED|Overall Study||57
246361|NCT00538434|592699|P2|STARTED|Overall Study||57
246362|NCT00538434|592700|P1|STARTED|Overall Study||56
246363|NCT00538304|592724|P2|NOT COMPLETED|Overall Study||5
246364|NCT00538304|592725|P1|NOT COMPLETED|Overall Study||7
246365|NCT00538304|592724|P2|COMPLETED|Overall Study||66
246366|NCT00538304|592725|P1|COMPLETED|Overall Study||144
246367|NCT00538304|592724|P2|STARTED|Overall Study||71
246368|NCT00538304|592725|P1|STARTED|Overall Study||151
246369|NCT00538291|592741|P1|NOT COMPLETED|Overall Study||3
246370|NCT00538291|592741|P1|COMPLETED|Overall Study||10
246371|NCT00538291|592741|P1|STARTED|Overall Study||13
246372|NCT00538213|592748|P3|NOT COMPLETED|Overall Study||0
246373|NCT00538213|592749|P2|NOT COMPLETED|Overall Study||0
246374|NCT00538213|592750|P1|NOT COMPLETED|Overall Study||0
246375|NCT00538213|592748|P3|COMPLETED|Overall Study||38
246376|NCT00538213|592749|P2|COMPLETED|Overall Study||40
246377|NCT00538213|592750|P1|COMPLETED|Overall Study||55
246378|NCT00538213|592748|P3|STARTED|Overall Study||38
246379|NCT00538213|592749|P2|STARTED|Overall Study||40
246380|NCT00538213|592750|P1|STARTED|Overall Study||55
246381|NCT00537979|592799|P2|NOT COMPLETED|Overall Study||20
246382|NCT00537979|592800|P1|NOT COMPLETED|Overall Study||6
246384|NCT00537979|592800|P1|COMPLETED|Overall Study||32
246385|NCT00537979|592799|P2|STARTED|Overall Study||109
246386|NCT00537979|592800|P1|STARTED|Overall Study||38
246387|NCT00537940|592816|P2|NOT COMPLETED|Overall Study||179
246388|NCT00537940|592817|P1|NOT COMPLETED|Overall Study||183
246389|NCT00537940|592816|P2|COMPLETED|Overall Study||62
246390|NCT00537940|592817|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
246391|NCT00537940|592816|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
246392|NCT00537940|592817|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
246393|NCT00537940|592816|P2|Completed Maintenance Phase|Overall Study||172
246394|NCT00537940|592817|P1|Completed Maintenance Phase|Overall Study||187
246395|NCT00537940|592816|P2|Completed Titration Phase|Overall Study||210
246396|NCT00537940|592817|P1|Completed Titration Phase|Overall Study||213
246397|NCT00537940|592816|P2|STARTED|Overall Study||241
246398|NCT00537940|592817|P1|STARTED|Overall Study||241
246399|NCT00537823|592841|P2|NOT COMPLETED|Overall Study||0
246400|NCT00537823|592842|P1|NOT COMPLETED|Overall Study||2
246401|NCT00537823|592841|P2|COMPLETED|Overall Study||2
246402|NCT00537823|592842|P1|COMPLETED|Overall Study||5
246403|NCT00537823|592841|P2|STARTED|Overall Study||2
246404|NCT00537823|592842|P1|STARTED|Overall Study||7
246405|NCT00537810|592868|P4|NOT COMPLETED|Overall Study||4
246406|NCT00537810|592869|P3|NOT COMPLETED|Overall Study||4
246407|NCT00537810|592870|P2|NOT COMPLETED|Overall Study||13
246408|NCT00537810|592871|P1|NOT COMPLETED|Overall Study||6
246409|NCT00537810|592868|P4|COMPLETED|Overall Study||22
246410|NCT00537810|592869|P3|COMPLETED|Overall Study||21
246411|NCT00537810|592870|P2|COMPLETED|Overall Study||14
246412|NCT00537810|592871|P1|COMPLETED|Overall Study||20
246413|NCT00537810|592868|P4|STARTED|Overall Study||26
246414|NCT00537810|592869|P3|STARTED|Overall Study||25
246415|NCT00537810|592870|P2|STARTED|Overall Study||27
246416|NCT00537810|592871|P1|STARTED|Overall Study||26
246417|NCT00537771|592887|P2|NOT COMPLETED|Overall Study||61
246418|NCT00537771|592888|P1|NOT COMPLETED|Overall Study||29
246419|NCT00537771|592887|P2|COMPLETED|Overall Study||114
246420|NCT00537771|592888|P1|COMPLETED|Overall Study||149
246421|NCT00537771|592887|P2|STARTED|Overall Study||175
246422|NCT00537771|592888|P1|STARTED|Overall Study||178
246423|NCT00537745|592898|P1|NOT COMPLETED|Overall Study||5
246424|NCT00537745|592898|P1|COMPLETED|Overall Study||9
246425|NCT00537745|592898|P1|Began Intervention|Overall Study||11
246426|NCT00537745|592898|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
246427|NCT00537680|592906|P3|NOT COMPLETED|Overall Study||0
246428|NCT00537680|592907|P2|NOT COMPLETED|Overall Study||2
246429|NCT00537680|592908|P1|NOT COMPLETED|Overall Study||0
246430|NCT00537680|592906|P3|COMPLETED|Overall Study||24
246431|NCT00537680|592907|P2|COMPLETED|Overall Study||22
246432|NCT00537680|592908|P1|COMPLETED|Overall Study||22
246433|NCT00537680|592906|P3|STARTED|Overall Study||24
246434|NCT00537680|592907|P2|STARTED|Overall Study||24
246435|NCT00537680|592908|P1|STARTED|Overall Study||22
246436|NCT00537511|592916|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
246437|NCT00537511|592916|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
246438|NCT00537511|592916|P1|STARTED|Maintenance Phase (Monotherapy)||8
246439|NCT00537511|592916|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
246440|NCT00537511|592916|P1|COMPLETED|Recovery Period (Monotherapy)||3
246441|NCT00537511|592916|P1|STARTED|Recovery Period (Monotherapy)||11
246442|NCT00537511|592916|P1|NOT COMPLETED|Extension Period (Combination)||6
246443|NCT00537511|592916|P1|COMPLETED|Extension Period (Combination)||11
246444|NCT00537511|592916|P1|STARTED|Extension Period (Combination)||17
246445|NCT00537511|592916|P1|NOT COMPLETED|Treatment Period (Combination)||5
246446|NCT00537511|592916|P1|COMPLETED|Treatment Period (Combination)||17
246447|NCT00537511|592916|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
246448|NCT00537511|592916|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
246449|NCT00537511|592916|P1|STARTED|Treatment Period (Combination)||22
246450|NCT00537485|592943|P2|NOT COMPLETED|Overall Study||10
246451|NCT00537485|592944|P1|NOT COMPLETED|Overall Study||15
246452|NCT00537485|592943|P2|COMPLETED|Overall Study||80
246453|NCT00537485|592944|P1|COMPLETED|Overall Study||75
246454|NCT00537485|592943|P2|STARTED|Overall Study||90
246455|NCT00537485|592944|P1|STARTED|Overall Study||90
246456|NCT00537407|592973|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
246457|NCT00537407|592974|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
246458|NCT00537407|592975|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
246459|NCT00537407|592976|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
246460|NCT00537407|592977|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
246461|NCT00537407|592973|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
246462|NCT00537407|592974|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
246463|NCT00537407|592975|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
246464|NCT00537407|592976|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
246465|NCT00537407|592977|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
246466|NCT00537407|592973|P5|STARTED|Part 2 Weeks 5-48 or 72||10
246467|NCT00537407|592974|P4|STARTED|Part 2 Weeks 5-48 or 72||10
246468|NCT00537407|592975|P3|STARTED|Part 2 Weeks 5-48 or 72||11
246469|NCT00537407|592976|P2|STARTED|Part 2 Weeks 5-48 or 72||9
246470|NCT00537407|592977|P1|STARTED|Part 2 Weeks 5-48 or 72||10
246471|NCT00537407|592973|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
246472|NCT00537407|592974|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
246473|NCT00537407|592975|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
246474|NCT00537407|592976|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
246475|NCT00537407|592977|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
246476|NCT00537407|592973|P5|COMPLETED|Part 1 Weeks 1-4||10
246477|NCT00537407|592974|P4|COMPLETED|Part 1 Weeks 1-4||10
246478|NCT00537407|592975|P3|COMPLETED|Part 1 Weeks 1-4||11
246479|NCT00537407|592976|P2|COMPLETED|Part 1 Weeks 1-4||9
246480|NCT00537407|592977|P1|COMPLETED|Part 1 Weeks 1-4||10
246481|NCT00537407|592973|P5|STARTED|Part 1 Weeks 1-4||10
246482|NCT00537407|592974|P4|STARTED|Part 1 Weeks 1-4||10
246483|NCT00537407|592975|P3|STARTED|Part 1 Weeks 1-4||11
246484|NCT00537407|592976|P2|STARTED|Part 1 Weeks 1-4||9
246485|NCT00537407|592977|P1|STARTED|Part 1 Weeks 1-4||10
246486|NCT00537394|593017|P3|NOT COMPLETED|2nd Year of Follow-up||6
246487|NCT00537394|593018|P2|NOT COMPLETED|2nd Year of Follow-up||9
246488|NCT00537394|593019|P1|NOT COMPLETED|2nd Year of Follow-up||11
246489|NCT00537394|593017|P3|COMPLETED|2nd Year of Follow-up||44
246490|NCT00537394|593018|P2|COMPLETED|2nd Year of Follow-up||159
246491|NCT00537394|593019|P1|COMPLETED|2nd Year of Follow-up||158
246492|NCT00537394|593017|P3|STARTED|2nd Year of Follow-up||50
246493|NCT00537394|593018|P2|STARTED|2nd Year of Follow-up||168
246494|NCT00537394|593019|P1|STARTED|2nd Year of Follow-up||169
246495|NCT00537394|593017|P3|NOT COMPLETED|First Year of Follow-up||3
246496|NCT00537394|593018|P2|NOT COMPLETED|First Year of Follow-up||11
246497|NCT00537394|593019|P1|NOT COMPLETED|First Year of Follow-up||12
246498|NCT00537394|593017|P3|COMPLETED|First Year of Follow-up||50
246499|NCT00537394|593018|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
246500|NCT00537394|593019|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
246501|NCT00537394|593017|P3|STARTED|First Year of Follow-up||53
246502|NCT00537394|593018|P2|STARTED|First Year of Follow-up||179
246503|NCT00537394|593019|P1|STARTED|First Year of Follow-up||181
246504|NCT00537381|593055|P2|NOT COMPLETED|Overall Study||62
246505|NCT00537381|593056|P1|NOT COMPLETED|Overall Study||56
246506|NCT00537381|593055|P2|COMPLETED|Overall Study||4
246507|NCT00537381|593056|P1|COMPLETED|Overall Study||9
246508|NCT00537381|593055|P2|STARTED|Overall Study||66
246509|NCT00537381|593056|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
246510|NCT00537329|593076|P1|NOT COMPLETED|Overall Study||26
246511|NCT00537329|593076|P1|COMPLETED|Overall Study||17
246512|NCT00537329|593076|P1|STARTED|Overall Study||43
246513|NCT00537316|593096|P7|NOT COMPLETED|Part 2||2
246514|NCT00537316|593097|P6|NOT COMPLETED|Part 2||4
246515|NCT00537316|593098|P5|NOT COMPLETED|Part 2||1
246516|NCT00537316|593099|P4|NOT COMPLETED|Part 2||3
246517|NCT00537316|593100|P3|NOT COMPLETED|Part 2||32
246518|NCT00537316|593101|P2|NOT COMPLETED|Part 2||9
246519|NCT00537316|593102|P1|NOT COMPLETED|Part 2||26
246520|NCT00537316|593096|P7|COMPLETED|Part 2||0
246521|NCT00537316|593097|P6|COMPLETED|Part 2||0
246522|NCT00537316|593098|P5|COMPLETED|Part 2||1
246523|NCT00537316|593099|P4|COMPLETED|Part 2||2
246524|NCT00537316|593100|P3|COMPLETED|Part 2||16
246525|NCT00537316|593101|P2|COMPLETED|Part 2||1
246526|NCT00537316|593102|P1|COMPLETED|Part 2||11
246527|NCT00537316|593096|P7|STARTED|Part 2||2
246528|NCT00537316|593097|P6|STARTED|Part 2||4
246529|NCT00537316|593098|P5|STARTED|Part 2||2
246530|NCT00537316|593099|P4|STARTED|Part 2||5
246531|NCT00537316|593100|P3|STARTED|Part 2||48
246532|NCT00537316|593101|P2|STARTED|Part 2||10
246533|NCT00537316|593102|P1|STARTED|Part 2||37
246534|NCT00537316|593096|P7|NOT COMPLETED|Part 1||0
246535|NCT00537316|593097|P6|NOT COMPLETED|Part 1||0
246536|NCT00537316|593098|P5|NOT COMPLETED|Part 1||0
246537|NCT00537316|593099|P4|NOT COMPLETED|Part 1||0
246538|NCT00537316|593100|P3|NOT COMPLETED|Part 1||17
246539|NCT00537316|593101|P2|NOT COMPLETED|Part 1||27
246540|NCT00537316|593102|P1|NOT COMPLETED|Part 1||14
246541|NCT00537316|593096|P7|COMPLETED|Part 1||0
246542|NCT00537316|593097|P6|COMPLETED|Part 1||0
246543|NCT00537316|593098|P5|COMPLETED|Part 1||0
246544|NCT00537316|593099|P4|COMPLETED|Part 1||0
246545|NCT00537316|593100|P3|COMPLETED|Part 1||63
246546|NCT00537316|593101|P2|COMPLETED|Part 1||53
246547|NCT00537316|593102|P1|COMPLETED|Part 1||65
246548|NCT00537316|593096|P7|STARTED|Part 1||0
246549|NCT00537316|593097|P6|STARTED|Part 1||0
246550|NCT00537316|593098|P5|STARTED|Part 1||0
246551|NCT00537316|593099|P4|STARTED|Part 1||0
246552|NCT00537316|593100|P3|STARTED|Part 1||80
246553|NCT00537316|593101|P2|STARTED|Part 1||80
246554|NCT00537316|593102|P1|STARTED|Part 1||79
246555|NCT00537303|593129|P2|NOT COMPLETED|Overall Study||25
246556|NCT00537303|593130|P1|NOT COMPLETED|Overall Study||26
246557|NCT00537303|593129|P2|COMPLETED|Overall Study||125
246558|NCT00537303|593130|P1|COMPLETED|Overall Study||120
246559|NCT00537303|593129|P2|STARTED|Overall Study||150
246560|NCT00537303|593130|P1|STARTED|Overall Study||146
246561|NCT00537290|593146|P1|NOT COMPLETED|Overall Study||0
246562|NCT00537290|593146|P1|COMPLETED|Overall Study||19
246563|NCT00537290|593146|P1|STARTED|Overall Study||19
246564|NCT00537277|593151|P1|NOT COMPLETED|Overall Study||49
246565|NCT00537277|593151|P1|COMPLETED|Overall Study||112
246566|NCT00537277|593151|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
246567|NCT00537277|593151|P1|STARTED|Overall Study||161
246568|NCT00537238|593162|P2|NOT COMPLETED|Overall Study||173
246569|NCT00537238|593163|P1|NOT COMPLETED|Overall Study||174
246570|NCT00537238|593162|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
246571|NCT00537238|593163|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
246572|NCT00537238|593162|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
246573|NCT00537238|593163|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
246574|NCT00537238|593162|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
246575|NCT00537238|593163|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
246576|NCT00537238|593162|P2|Completed Titration Phase|Overall Study||236
246577|NCT00537238|593163|P1|Completed Titration Phase|Overall Study||226
246578|NCT00537238|593162|P2|STARTED|Overall Study||255
246579|NCT00537238|593163|P1|STARTED|Overall Study||254
246580|NCT00537199|593183|P1|NOT COMPLETED|Overall Study||1
246581|NCT00537199|593183|P1|COMPLETED|Overall Study||0
246582|NCT00537199|593183|P1|STARTED|Overall Study||1
246583|NCT00537095|593189|P2|NOT COMPLETED|Overall Study||57
246584|NCT00537095|593190|P1|NOT COMPLETED|Overall Study||51
246585|NCT00537095|593189|P2|COMPLETED|Overall Study||16
246586|NCT00537095|593190|P1|COMPLETED|Overall Study||21
246587|NCT00537095|593189|P2|STARTED|Overall Study||73
246588|NCT00537095|593190|P1|STARTED|Overall Study||72
246589|NCT00537082|593205|P3|NOT COMPLETED|Overall Study||6
246590|NCT00537082|593206|P2|NOT COMPLETED|Overall Study||9
246591|NCT00537082|593207|P1|NOT COMPLETED|Overall Study||9
246592|NCT00537082|593205|P3|COMPLETED|Overall Study||51
246593|NCT00537082|593206|P2|COMPLETED|Overall Study||48
246594|NCT00537082|593207|P1|COMPLETED|Overall Study||48
246595|NCT00537082|593205|P3|STARTED|Overall Study||57
246596|NCT00537082|593206|P2|STARTED|Overall Study||57
246597|NCT00537082|593207|P1|STARTED|Overall Study||57
246598|NCT00537056|593224|P1|NOT COMPLETED|12-month Follow-up||0
246599|NCT00537056|593224|P1|COMPLETED|12-month Follow-up||17
246600|NCT00537056|593224|P1|STARTED|12-month Follow-up||17
246601|NCT00537056|593224|P1|NOT COMPLETED|Interim PET/CT||5
246602|NCT00537056|593224|P1|COMPLETED|Interim PET/CT||12
246603|NCT00537056|593224|P1|STARTED|Interim PET/CT||17
246604|NCT00537056|593224|P1|NOT COMPLETED|Baseline PET/CT||0
246605|NCT00537056|593224|P1|COMPLETED|Baseline PET/CT||17
246606|NCT00537056|593224|P1|STARTED|Baseline PET/CT||17
246607|NCT00537030|593236|P1|NOT COMPLETED|Overall Study||16
246608|NCT00537030|593236|P1|COMPLETED|Overall Study||43
246609|NCT00537030|593236|P1|STARTED|Overall Study||59
246610|NCT00537017|593240|P1|NOT COMPLETED|Follow-up Phase||9
246611|NCT00537017|593240|P1|COMPLETED|Follow-up Phase||126
246612|NCT00537017|593240|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
246613|NCT00537017|593240|P1|NOT COMPLETED|Treatment Phase||34
246614|NCT00537017|593240|P1|COMPLETED|Treatment Phase||106
246615|NCT00537017|593240|P1|STARTED|Treatment Phase||140
246616|NCT00536991|593251|P1|NOT COMPLETED|Overall Study||13
246617|NCT00536991|593251|P1|COMPLETED|Overall Study||38
246618|NCT00536991|593251|P1|STARTED|Overall Study||51
246619|NCT00536978|593258|P1|NOT COMPLETED|Overall Study||22
246620|NCT00536978|593258|P1|COMPLETED|Overall Study||0
246621|NCT00536978|593258|P1|STARTED|Overall Study||22
246622|NCT00536913|593264|P2|NOT COMPLETED|Overall Study||0
246623|NCT00536913|593265|P1|NOT COMPLETED|Overall Study||0
246624|NCT00536913|593264|P2|COMPLETED|Overall Study||52
246625|NCT00536913|593265|P1|COMPLETED|Overall Study||55
246626|NCT00536913|593264|P2|STARTED|Overall Study||52
246627|NCT00536913|593265|P1|STARTED|Overall Study||55
246628|NCT00536874|593287|P1|NOT COMPLETED|Overall Study||4
246629|NCT00536874|593287|P1|COMPLETED|Overall Study||35
246630|NCT00536874|593287|P1|STARTED|Overall Study||39
246631|NCT00536809|593297|P1|NOT COMPLETED|Phase II||2
246632|NCT00536809|593297|P1|COMPLETED|Phase II||0
246633|NCT00536809|593297|P1|STARTED|Phase II||2
246634|NCT00536809|593297|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
246635|NCT00536809|593297|P1|COMPLETED|Phase I (Dose-finding Phase)||10
246636|NCT00536809|593297|P1|STARTED|Phase I (Dose-finding Phase)||10
246637|NCT00536744|593320|P2|NOT COMPLETED|Overall Study||28
246638|NCT00536744|593321|P1|NOT COMPLETED|Overall Study||29
246639|NCT00536744|593320|P2|COMPLETED|Overall Study||71
246640|NCT00536744|593321|P1|COMPLETED|Overall Study||78
246641|NCT00536744|593320|P2|STARTED|Overall Study||99
246642|NCT00536744|593321|P1|STARTED|Overall Study||107
246643|NCT00536731|593330|P3|NOT COMPLETED|Overall Study||5
246644|NCT00536731|593331|P2|NOT COMPLETED|Overall Study||5
246645|NCT00536731|593332|P1|NOT COMPLETED|Overall Study||4
246646|NCT00536731|593330|P3|COMPLETED|Overall Study||238
246647|NCT00536731|593331|P2|COMPLETED|Overall Study||241
246648|NCT00536731|593332|P1|COMPLETED|Overall Study||249
246649|NCT00536731|593330|P3|STARTED|Overall Study||243
246650|NCT00536731|593331|P2|STARTED|Overall Study||246
246651|NCT00536731|593332|P1|STARTED|Overall Study||253
246652|NCT00536575|593376|P1|NOT COMPLETED|Overall Study||2
246653|NCT00536575|593376|P1|COMPLETED|Overall Study||11
246654|NCT00536575|593376|P1|STARTED|Overall Study||13
246655|NCT00536510|593382|P2|NOT COMPLETED|Overall Study||29
246656|NCT00536510|593383|P1|NOT COMPLETED|Overall Study||82
246657|NCT00536510|593382|P2|COMPLETED|Overall Study||295
246658|NCT00536510|593383|P1|COMPLETED|Overall Study||240
246659|NCT00536510|593382|P2|STARTED|Overall Study||324
246660|NCT00536510|593383|P1|STARTED|Overall Study||322
246661|NCT00536484|593393|P2|NOT COMPLETED|Overall Study||56
246662|NCT00536484|593394|P1|NOT COMPLETED|Overall Study||60
246663|NCT00536484|593393|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
246664|NCT00536484|593394|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
246665|NCT00536484|593393|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
246666|NCT00536484|593394|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
246667|NCT00536471|593428|P4|NOT COMPLETED|Overall Study||74
246668|NCT00536471|593429|P3|NOT COMPLETED|Overall Study||139
246669|NCT00536471|593430|P2|NOT COMPLETED|Overall Study||84
246670|NCT00536471|593431|P1|NOT COMPLETED|Overall Study||156
246671|NCT00536471|593428|P4|COMPLETED|Overall Study||57
246672|NCT00536471|593429|P3|COMPLETED|Overall Study||122
246673|NCT00536471|593430|P2|COMPLETED|Overall Study||43
246674|NCT00536471|593431|P1|COMPLETED|Overall Study||101
246675|NCT00536471|593428|P4|STARTED|Overall Study||131
246676|NCT00536471|593429|P3|STARTED|Overall Study||261
246677|NCT00536471|593430|P2|STARTED|Overall Study||127
246678|NCT00536471|593431|P1|STARTED|Overall Study||257
246679|NCT00536380|593676|P3|NOT COMPLETED|Overall Study||10
246680|NCT00536380|593677|P2|NOT COMPLETED|Overall Study||9
246681|NCT00536380|593678|P1|NOT COMPLETED|Overall Study||12
246682|NCT00536380|593676|P3|COMPLETED|Overall Study||94
246683|NCT00536380|593677|P2|COMPLETED|Overall Study||95
246684|NCT00536380|593678|P1|COMPLETED|Overall Study||94
246685|NCT00536380|593676|P3|STARTED|Overall Study||104
246686|NCT00536380|593677|P2|STARTED|Overall Study||104
246687|NCT00536380|593678|P1|STARTED|Overall Study||106
246688|NCT00536341|593688|P2|NOT COMPLETED|Overall Study||11
246689|NCT00536341|593689|P1|NOT COMPLETED|Overall Study||5
246690|NCT00536341|593688|P2|COMPLETED|Overall Study||43
246691|NCT00536341|593689|P1|COMPLETED|Overall Study||5
246692|NCT00536341|593688|P2|STARTED|Overall Study||54
246693|NCT00536341|593689|P1|STARTED|Overall Study||10
246694|NCT00536263|593702|P3|NOT COMPLETED|Overall Study||21
246695|NCT00536263|593703|P2|NOT COMPLETED|Overall Study||14
246696|NCT00536263|593704|P1|NOT COMPLETED|Overall Study||11
246697|NCT00536263|593702|P3|COMPLETED|Overall Study||204
246698|NCT00536263|593703|P2|COMPLETED|Overall Study||207
246699|NCT00536263|593704|P1|COMPLETED|Overall Study||214
246700|NCT00536263|593702|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
246701|NCT00536263|593703|P2|STARTED|Overall Study||221
246702|NCT00536263|593704|P1|STARTED|Overall Study||225
246703|NCT00536198|593744|P2|NOT COMPLETED|Overall Study||39
246704|NCT00536198|593745|P1|NOT COMPLETED|Overall Study||37
246705|NCT00536198|593744|P2|COMPLETED|Overall Study||88
246706|NCT00536198|593745|P1|COMPLETED|Overall Study||88
246707|NCT00536198|593744|P2|Cycle 6|Overall Study||88
246708|NCT00536198|593745|P1|Cycle 6|Overall Study||88
246709|NCT00536198|593744|P2|Cycle 5|Overall Study||85
246710|NCT00536198|593745|P1|Cycle 5|Overall Study||88
246711|NCT00536198|593744|P2|Cycle 4|Overall Study||98
246712|NCT00536198|593745|P1|Cycle 4|Overall Study||95
246713|NCT00536198|593744|P2|Cycle 3|Overall Study||101
246714|NCT00536198|593745|P1|Cycle 3|Overall Study||100
246715|NCT00536198|593744|P2|Cycle 2|Overall Study||112
246716|NCT00536198|593745|P1|Cycle 2|Overall Study||104
246717|NCT00536198|593744|P2|Cycle 1|Overall Study||123
246718|NCT00536198|593745|P1|Cycle 1|Overall Study||110
246719|NCT00536198|593744|P2|STARTED|Overall Study||127
246720|NCT00536198|593745|P1|STARTED|Overall Study||125
246721|NCT00536172|593775|P2|NOT COMPLETED|Overall Study||9
246722|NCT00536172|593776|P1|NOT COMPLETED|Overall Study||14
246723|NCT00536172|593775|P2|COMPLETED|Overall Study||65
246724|NCT00536172|593776|P1|COMPLETED|Overall Study||60
246725|NCT00536172|593775|P2|STARTED|Overall Study||74
246726|NCT00536172|593776|P1|STARTED|Overall Study||74
246727|NCT00536120|593784|P2|NOT COMPLETED|Overall Study||3
246728|NCT00536120|593785|P1|NOT COMPLETED|Overall Study||6
246729|NCT00536120|593784|P2|COMPLETED|Overall Study||27
246730|NCT00536120|593785|P1|COMPLETED|Overall Study||24
246731|NCT00536120|593784|P2|STARTED|Overall Study||30
246732|NCT00536120|593785|P1|STARTED|Overall Study||30
246733|NCT00536107|593799|P2|NOT COMPLETED|Overall Study||6
246734|NCT00536107|593800|P1|NOT COMPLETED|Overall Study||8
246735|NCT00536107|593799|P2|COMPLETED|Overall Study||0
246736|NCT00536107|593800|P1|COMPLETED|Overall Study||0
246737|NCT00536107|593799|P2|STARTED|Overall Study||6
246738|NCT00536107|593800|P1|STARTED|Overall Study||8
246739|NCT00535938|593810|P2|NOT COMPLETED|Overall Study||462
246740|NCT00535938|593811|P1|NOT COMPLETED|Overall Study||391
246741|NCT00535938|593810|P2|COMPLETED|Overall Study||404
246742|NCT00535938|593811|P1|COMPLETED|Overall Study||115
246743|NCT00535938|593810|P2|STARTED|Overall Study||866
246744|NCT00535938|593811|P1|STARTED|Overall Study||506
246745|NCT00535873|593847|P1|NOT COMPLETED|Overall Study||0
246746|NCT00535873|593847|P1|COMPLETED|Overall Study||60
246747|NCT00535873|593847|P1|STARTED|Overall Study||60
246748|NCT00535847|593854|P3|NOT COMPLETED|Overall Study||2
246749|NCT00535847|593855|P2|NOT COMPLETED|Overall Study||14
246750|NCT00535847|593856|P1|NOT COMPLETED|Overall Study||22
246751|NCT00535847|593854|P3|COMPLETED|Overall Study||0
246752|NCT00535847|593855|P2|COMPLETED|Overall Study||20
246753|NCT00535847|593856|P1|COMPLETED|Overall Study||59
246754|NCT00535847|593854|P3|STARTED|Overall Study||2
246755|NCT00535847|593855|P2|STARTED|Overall Study||34
246756|NCT00535847|593856|P1|STARTED|Overall Study||81
246757|NCT00535821|593882|P2|NOT COMPLETED|Overall Study||0
246758|NCT00535821|593883|P1|NOT COMPLETED|Overall Study||0
246759|NCT00535821|593882|P2|COMPLETED|Overall Study||3
246760|NCT00535821|593883|P1|COMPLETED|Overall Study||2
246761|NCT00535821|593882|P2|STARTED|Overall Study||3
246762|NCT00535821|593883|P1|STARTED|Overall Study||2
246763|NCT00535782|593891|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
246764|NCT00535782|593892|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
246765|NCT00535782|593893|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
246766|NCT00535782|593891|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
246767|NCT00535782|593892|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
246768|NCT00535782|593893|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
246769|NCT00535782|593891|P3|STARTED|Part 2: 80-Week Open-label Period||124
246770|NCT00535782|593892|P2|STARTED|Part 2: 80-Week Open-label Period||0
246771|NCT00535782|593893|P1|STARTED|Part 2: 80-Week Open-label Period||0
246772|NCT00535782|593891|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
246773|NCT00535782|593892|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
246774|NCT00535782|593893|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
246775|NCT00535782|593891|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
246776|NCT00535782|593892|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
246777|NCT00535782|593893|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
246778|NCT00535782|593891|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
246779|NCT00535782|593892|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
246780|NCT00535782|593893|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
246781|NCT00535782|593891|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
246782|NCT00535782|593892|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
246783|NCT00535782|593893|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
246784|NCT00535782|593891|P3|STARTED|Part 1: 24-Week Double-blind Period||0
246785|NCT00535782|593892|P2|STARTED|Part 1: 24-Week Double-blind Period||63
246786|NCT00535782|593893|P1|STARTED|Part 1: 24-Week Double-blind Period||69
246787|NCT00535769|593910|P2|NOT COMPLETED|Overall Study||0
246788|NCT00535769|593911|P1|NOT COMPLETED|Overall Study||0
246789|NCT00535769|593910|P2|COMPLETED|Overall Study||35
246790|NCT00535769|593911|P1|COMPLETED|Overall Study||35
246791|NCT00535769|593910|P2|STARTED|Overall Study||35
246792|NCT00535769|593911|P1|STARTED|Overall Study||35
246793|NCT00535730|593922|P2|NOT COMPLETED|Overall Study||7
246794|NCT00535730|593923|P1|NOT COMPLETED|Overall Study||2
246795|NCT00535730|593922|P2|COMPLETED|Overall Study||230
246796|NCT00535730|593923|P1|COMPLETED|Overall Study||234
246797|NCT00535730|593922|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
246798|NCT00535730|593923|P1|STARTED|Overall Study||236
246799|NCT00535652|593940|P1|NOT COMPLETED|Overall Study||3
246800|NCT00535652|593940|P1|COMPLETED|Overall Study||20
246801|NCT00535652|593940|P1|STARTED|Overall Study||23
246802|NCT00535626|593944|P1|NOT COMPLETED|Overall Study||105
246803|NCT00535626|593944|P1|COMPLETED|Overall Study||85
246804|NCT00535626|593944|P1|STARTED|Overall Study||190
246805|NCT00535587|593958|P4|NOT COMPLETED|Overall Study||13
246806|NCT00535587|593959|P3|NOT COMPLETED|Overall Study||8
246807|NCT00535587|593960|P2|NOT COMPLETED|Overall Study||11
246808|NCT00535587|593961|P1|NOT COMPLETED|Overall Study||10
246809|NCT00535587|593958|P4|COMPLETED|Overall Study||41
246810|NCT00535587|593959|P3|COMPLETED|Overall Study||39
246811|NCT00535587|593960|P2|COMPLETED|Overall Study||42
246812|NCT00535587|593961|P1|COMPLETED|Overall Study||43
246813|NCT00535587|593958|P4|STARTED|Overall Study||54
246814|NCT00535587|593959|P3|STARTED|Overall Study||47
246815|NCT00535587|593960|P2|STARTED|Overall Study||53
246816|NCT00535587|593961|P1|STARTED|Overall Study||53
246817|NCT00535496|593971|P4|NOT COMPLETED|Overall Study||0
246818|NCT00535496|593972|P3|NOT COMPLETED|Overall Study||0
246819|NCT00535496|593973|P2|NOT COMPLETED|Overall Study||2
246820|NCT00535496|593974|P1|NOT COMPLETED|Overall Study||0
246821|NCT00535496|593971|P4|COMPLETED|Overall Study||31
246822|NCT00535496|593972|P3|COMPLETED|Overall Study||30
246823|NCT00535496|593973|P2|COMPLETED|Overall Study||13
246824|NCT00535496|593974|P1|COMPLETED|Overall Study||15
246825|NCT00535496|593971|P4|All-Subjects-Treated (AST) Group|Overall Study||31
246826|NCT00535496|593972|P3|All-Subjects-Treated (AST) Group|Overall Study||30
246827|NCT00535496|593973|P2|All-Subjects-Treated (AST) Group|Overall Study||14
246828|NCT00535496|593974|P1|All-Subjects-Treated (AST) Group|Overall Study||15
246829|NCT00535496|593971|P4|STARTED|Overall Study||31
246830|NCT00535496|593972|P3|STARTED|Overall Study||30
246831|NCT00535496|593973|P2|STARTED|Overall Study||15
246832|NCT00535496|593974|P1|STARTED|Overall Study||15
246833|NCT00535405|593994|P5|NOT COMPLETED|Overall Study||16
246834|NCT00535405|593995|P4|NOT COMPLETED|Overall Study||22
246835|NCT00535405|593996|P3|NOT COMPLETED|Overall Study||18
246836|NCT00535405|593997|P2|NOT COMPLETED|Overall Study||26
246837|NCT00535405|593998|P1|NOT COMPLETED|Overall Study||17
246838|NCT00535405|593994|P5|COMPLETED|Overall Study||241
246839|NCT00535405|593995|P4|COMPLETED|Overall Study||235
246840|NCT00535405|593996|P3|COMPLETED|Overall Study||241
246841|NCT00535405|593997|P2|COMPLETED|Overall Study||233
246842|NCT00535405|593998|P1|COMPLETED|Overall Study||240
246843|NCT00535405|593994|P5|STARTED|Overall Study||257
246844|NCT00535405|593995|P4|STARTED|Overall Study||257
246845|NCT00535405|593996|P3|STARTED|Overall Study||259
246846|NCT00535405|593997|P2|STARTED|Overall Study||259
246847|NCT00535405|593998|P1|STARTED|Overall Study||257
246848|NCT00535392|594035|P1|NOT COMPLETED|Overall Study||0
246849|NCT00535392|594035|P1|COMPLETED|Overall Study||33
246850|NCT00535392|594035|P1|STARTED|Overall Study||33
246851|NCT00535301|594043|P2|NOT COMPLETED|Overall Study||5
246852|NCT00535301|594044|P1|NOT COMPLETED|Overall Study||5
246853|NCT00535301|594043|P2|COMPLETED|Overall Study||33
246854|NCT00535301|594044|P1|COMPLETED|Overall Study||33
246855|NCT00535301|594043|P2|STARTED|Overall Study||38
246856|NCT00535301|594044|P1|STARTED|Overall Study||38
246857|NCT00535288|594059|P5|NOT COMPLETED|Overall Study||42
246858|NCT00535288|594060|P4|NOT COMPLETED|Overall Study||29
246859|NCT00535288|594061|P3|NOT COMPLETED|Overall Study||33
246860|NCT00535288|594062|P2|NOT COMPLETED|Overall Study||32
246861|NCT00535288|594063|P1|NOT COMPLETED|Overall Study||54
246862|NCT00535288|594059|P5|COMPLETED|Overall Study||116
246863|NCT00535288|594060|P4|COMPLETED|Overall Study||122
246864|NCT00535288|594061|P3|COMPLETED|Overall Study||127
246865|NCT00535288|594062|P2|COMPLETED|Overall Study||130
246866|NCT00535288|594063|P1|COMPLETED|Overall Study||260
246867|NCT00535288|594059|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
246868|NCT00535288|594060|P4|STARTED|Overall Study||151
246869|NCT00535288|594061|P3|STARTED|Overall Study||160
246870|NCT00535288|594062|P2|STARTED|Overall Study||162
246871|NCT00535288|594063|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
246872|NCT00535262|594140|P1|NOT COMPLETED|Overall Study||3
246873|NCT00535262|594140|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
246874|NCT00535262|594140|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
246875|NCT00535223|594146|P2|NOT COMPLETED|Overall Study||1
246876|NCT00535223|594147|P1|NOT COMPLETED|Overall Study||4
246877|NCT00535223|594146|P2|COMPLETED|Overall Study||39
246878|NCT00535223|594147|P1|COMPLETED|Overall Study||37
246879|NCT00535223|594146|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
246880|NCT00535223|594147|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
246881|NCT00535145|594155|P1|NOT COMPLETED|Phase II||15
246882|NCT00535145|594155|P1|COMPLETED|Phase II||69
246883|NCT00535145|594155|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
246884|NCT00535145|594155|P1|NOT COMPLETED|Phase I||29
246885|NCT00535145|594155|P1|COMPLETED|Phase I||85
246886|NCT00535145|594155|P1|STARTED|Phase I||114
246887|NCT00535132|594167|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
246888|NCT00535132|594168|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
246889|NCT00535132|594167|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
246890|NCT00535132|594168|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
246891|NCT00535132|594167|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
246892|NCT00535132|594168|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
246893|NCT00535132|594167|P2|NOT COMPLETED|Safety Analysis Set||2
246894|NCT00535132|594168|P1|NOT COMPLETED|Safety Analysis Set||2
246895|NCT00535132|594167|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
246896|NCT00535132|594168|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
246897|NCT00535132|594167|P2|STARTED|Safety Analysis Set||101
246898|NCT00535132|594168|P1|STARTED|Safety Analysis Set||100
246899|NCT00535132|594167|P2|NOT COMPLETED|Randomized Population||0
246900|NCT00535132|594168|P1|NOT COMPLETED|Randomized Population||0
246901|NCT00535132|594167|P2|COMPLETED|Randomized Population||101
246902|NCT00535132|594168|P1|COMPLETED|Randomized Population||100
246903|NCT00535132|594167|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
246904|NCT00535132|594168|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
246905|NCT00535002|594226|P8|NOT COMPLETED|Overall Study||0
246906|NCT00535002|594227|P7|NOT COMPLETED|Overall Study||0
246907|NCT00535002|594228|P6|NOT COMPLETED|Overall Study||0
246908|NCT00535002|594229|P5|NOT COMPLETED|Overall Study||0
246909|NCT00535002|594230|P4|NOT COMPLETED|Overall Study||0
246910|NCT00535002|594231|P3|NOT COMPLETED|Overall Study||0
246911|NCT00535002|594232|P2|NOT COMPLETED|Overall Study||0
246912|NCT00535002|594233|P1|NOT COMPLETED|Overall Study||0
246913|NCT00535002|594226|P8|COMPLETED|Overall Study||16
246914|NCT00535002|594227|P7|COMPLETED|Overall Study||12
246915|NCT00535002|594228|P6|COMPLETED|Overall Study||17
246916|NCT00535002|594229|P5|COMPLETED|Overall Study||9
246917|NCT00535002|594230|P4|COMPLETED|Overall Study||14
246918|NCT00535002|594231|P3|COMPLETED|Overall Study||13
246919|NCT00535002|594232|P2|COMPLETED|Overall Study||12
246920|NCT00535002|594233|P1|COMPLETED|Overall Study||19
246921|NCT00535002|594226|P8|STARTED|Overall Study||16
246922|NCT00535002|594227|P7|STARTED|Overall Study||12
246923|NCT00535002|594228|P6|STARTED|Overall Study||17
246924|NCT00535002|594229|P5|STARTED|Overall Study||9
246925|NCT00535002|594230|P4|STARTED|Overall Study||14
246926|NCT00535002|594231|P3|STARTED|Overall Study||13
246927|NCT00535002|594232|P2|STARTED|Overall Study||12
246928|NCT00535002|594233|P1|STARTED|Overall Study||19
246929|NCT00534976|594249|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
246930|NCT00534976|594250|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
246931|NCT00534976|594249|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
246932|NCT00534976|594250|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
246933|NCT00534976|594249|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
246934|NCT00534976|594250|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
246935|NCT00534976|594249|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
246936|NCT00534976|594250|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
246937|NCT00534976|594249|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
246938|NCT00534976|594250|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
246939|NCT00534976|594249|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
246940|NCT00534976|594250|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
246941|NCT00534976|594249|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
246942|NCT00534976|594250|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
246943|NCT00534976|594249|P2|COMPLETED|Period 1: Placebo Run-in||33
246944|NCT00534976|594250|P1|COMPLETED|Period 1: Placebo Run-in||33
246945|NCT00534976|594249|P2|STARTED|Period 1: Placebo Run-in||33
246946|NCT00534976|594250|P1|STARTED|Period 1: Placebo Run-in||33
246947|NCT00534937|594272|P2|NOT COMPLETED|Overall Study||12
246948|NCT00534937|594273|P1|NOT COMPLETED|Overall Study||8
246949|NCT00534937|594272|P2|COMPLETED|Overall Study||35
246950|NCT00534937|594273|P1|COMPLETED|Overall Study||34
246951|NCT00534937|594272|P2|STARTED|Overall Study||47
246952|NCT00534937|594273|P1|STARTED|Overall Study||42
246953|NCT00534833|594287|P2|NOT COMPLETED|Overall Study||0
246954|NCT00534833|594288|P1|NOT COMPLETED|Overall Study||0
246955|NCT00534833|594287|P2|COMPLETED|Overall Study||180
246956|NCT00534833|594288|P1|COMPLETED|Overall Study||182
246957|NCT00534833|594287|P2|STARTED|Overall Study||180
246958|NCT00534833|594288|P1|STARTED|Overall Study||182
246959|NCT00534794|594300|P2|NOT COMPLETED|Overall Study||0
246960|NCT00534794|594301|P1|NOT COMPLETED|Overall Study||0
246961|NCT00534794|594300|P2|COMPLETED|Overall Study||39
246962|NCT00534794|594301|P1|COMPLETED|Overall Study||40
246963|NCT00534794|594300|P2|STARTED|Overall Study||39
246964|NCT00534794|594301|P1|STARTED|Overall Study||40
246965|NCT00534638|594311|P2|NOT COMPLETED|Overall Study||11791
246966|NCT00534638|594312|P1|NOT COMPLETED|Overall Study||6491
246967|NCT00534638|594311|P2|COMPLETED|Overall Study||5547
246968|NCT00534638|594312|P1|COMPLETED|Overall Study||8346
246969|NCT00534638|594311|P2|STARTED|Overall Study||17338
246970|NCT00534638|594312|P1|STARTED|Overall Study||14837
246971|NCT00534599|594347|P2|NOT COMPLETED|Overall Study||32
246972|NCT00534599|594348|P1|NOT COMPLETED|Overall Study||57
246973|NCT00534599|594347|P2|COMPLETED|Overall Study||168
246974|NCT00534599|594348|P1|COMPLETED|Overall Study||152
246975|NCT00534599|594347|P2|STARTED|Overall Study|Randomized|200
246976|NCT00534599|594348|P1|STARTED|Overall Study|Randomized|209
246977|NCT00534495|594384|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
246978|NCT00534495|594385|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
246979|NCT00534495|594386|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
246980|NCT00534495|594384|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
246981|NCT00534495|594385|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
246982|NCT00534495|594386|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
246983|NCT00534495|594384|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
246984|NCT00534495|594385|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
246985|NCT00534495|594386|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
246986|NCT00534495|594384|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
246987|NCT00534495|594385|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
246988|NCT00534495|594386|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
246989|NCT00534495|594384|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
246990|NCT00534495|594385|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
246991|NCT00534495|594386|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
246992|NCT00534495|594384|P3|STARTED|All Active Treatment Phase Week 4-24||0
246993|NCT00534495|594385|P2|STARTED|All Active Treatment Phase Week 4-24||34
246994|NCT00534495|594386|P1|STARTED|All Active Treatment Phase Week 4-24||36
246995|NCT00534495|594384|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
246996|NCT00534495|594385|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
246997|NCT00534495|594386|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
246998|NCT00534495|594384|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
246999|NCT00534495|594385|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
247000|NCT00534495|594386|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
247001|NCT00534495|594384|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
247002|NCT00534495|594385|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
247003|NCT00534495|594386|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
247004|NCT00534417|594409|P1|NOT COMPLETED|Overall Study||0
247005|NCT00534417|594409|P1|COMPLETED|Overall Study||41
247006|NCT00534417|594409|P1|STARTED|Overall Study||41
247007|NCT00534404|594424|P3|NOT COMPLETED|Overall Study||242
247008|NCT00534404|594425|P2|NOT COMPLETED|Overall Study||143
247009|NCT00534404|594426|P1|NOT COMPLETED|Overall Study||180
247010|NCT00534404|594424|P3|COMPLETED|Overall Study||586
247011|NCT00534404|594425|P2|COMPLETED|Overall Study||687
247012|NCT00534404|594426|P1|COMPLETED|Overall Study||647
247013|NCT00534404|594424|P3|3-month Follow up Completed|Overall Study||593
247014|NCT00534404|594425|P2|3-month Follow up Completed|Overall Study||731
247015|NCT00534404|594426|P1|3-month Follow up Completed|Overall Study||682
247016|NCT00534404|594424|P3|1-month Follow up Completed|Overall Study||626
247017|NCT00534404|594425|P2|1-month Follow up Completed|Overall Study||781
247018|NCT00534404|594426|P1|1-month Follow up Completed|Overall Study||742
247019|NCT00534404|594424|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
247020|NCT00534404|594425|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
247021|NCT00534404|594426|P1|Completed at Least 1 Counseling Call|Overall Study||813
247022|NCT00534404|594424|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
247023|NCT00534404|594425|P2|Completed Second NRT Order|Overall Study||789
247024|NCT00534404|594426|P1|Completed Second NRT Order|Overall Study||640
247025|NCT00534404|594424|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
247026|NCT00534404|594425|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
247027|NCT00534404|594426|P1|Completed First NRT Order|Overall Study||765
247028|NCT00534404|594424|P3|Completed at Least 1 Online Session|Overall Study||658
247029|NCT00534404|594425|P2|Completed at Least 1 Online Session|Overall Study||813
247030|NCT00534404|594426|P1|Completed at Least 1 Online Session|Overall Study||781
247031|NCT00534404|594424|P3|STARTED|Overall Study||828
247032|NCT00534404|594425|P2|STARTED|Overall Study||830
247033|NCT00534404|594426|P1|STARTED|Overall Study||827
247034|NCT00534365|594442|P2|NOT COMPLETED|Overall Study||7
247035|NCT00534365|594443|P1|NOT COMPLETED|Overall Study||0
247036|NCT00534365|594442|P2|COMPLETED|Overall Study||129
247037|NCT00534365|594443|P1|COMPLETED|Overall Study||127
247038|NCT00534365|594442|P2|Included in Intent to Treat Analysis|Overall Study||136
247039|NCT00534365|594443|P1|Included in Intent to Treat Analysis|Overall Study||127
247040|NCT00534365|594442|P2|Follow up at 12 Months or More|Overall Study||128
247041|NCT00534365|594443|P1|Follow up at 12 Months or More|Overall Study||119
247042|NCT00534365|594442|P2|Any Follow up|Overall Study||135
247043|NCT00534365|594443|P1|Any Follow up|Overall Study||126
247044|NCT00534365|594442|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
247045|NCT00534365|594443|P1|Received Procedure|Overall Study||127
247046|NCT00534365|594442|P2|STARTED|Overall Study||136
247047|NCT00534365|594443|P1|STARTED|Overall Study||127
247048|NCT00534352|594457|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
247049|NCT00534352|594457|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
247050|NCT00534352|594457|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
247051|NCT00534352|594457|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
247052|NCT00534352|594457|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
247053|NCT00534352|594457|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
247054|NCT00534352|594457|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
247055|NCT00534352|594457|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
247056|NCT00534352|594457|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
247057|NCT00534352|594457|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
247058|NCT00534352|594457|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
247059|NCT00534352|594457|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
247060|NCT00534313|594501|P4|NOT COMPLETED|Long-term Period||33
247061|NCT00534313|594502|P3|NOT COMPLETED|Long-term Period||43
247062|NCT00534313|594503|P2|NOT COMPLETED|Long-term Period||34
247063|NCT00534313|594504|P1|NOT COMPLETED|Long-term Period||37
247064|NCT00534313|594501|P4|COMPLETED|Long-term Period||0
247065|NCT00534313|594502|P3|COMPLETED|Long-term Period||0
247066|NCT00534313|594503|P2|COMPLETED|Long-term Period||0
247067|NCT00534313|594504|P1|COMPLETED|Long-term Period||0
247068|NCT00534313|594501|P4|STARTED|Long-term Period||33
247069|NCT00534313|594502|P3|STARTED|Long-term Period||43
247070|NCT00534313|594503|P2|STARTED|Long-term Period||34
247071|NCT00534313|594504|P1|STARTED|Long-term Period||37
247072|NCT00534313|594501|P4|NOT COMPLETED|Short-term Period||9
247073|NCT00534313|594502|P3|NOT COMPLETED|Short-term Period||2
247074|NCT00534313|594503|P2|NOT COMPLETED|Short-term Period||6
247075|NCT00534313|594504|P1|NOT COMPLETED|Short-term Period||6
247076|NCT00534313|594501|P4|COMPLETED|Short-term Period|Completed the short-term study|33
247077|NCT00534313|594502|P3|COMPLETED|Short-term Period|Completed the short-term study|43
247078|NCT00534313|594503|P2|COMPLETED|Short-term Period|Completed the short-term study|34
247079|NCT00534313|594504|P1|COMPLETED|Short-term Period|Completed the short-term study|37
247080|NCT00534313|594501|P4|STARTED|Short-term Period||42
247081|NCT00534313|594502|P3|STARTED|Short-term Period||45
247082|NCT00534313|594503|P2|STARTED|Short-term Period||40
247083|NCT00534313|594504|P1|STARTED|Short-term Period||43
247084|NCT00534248|594599|P2|NOT COMPLETED|Overall Study||673
247085|NCT00534248|594600|P1|NOT COMPLETED|Overall Study||661
247086|NCT00534248|594599|P2|COMPLETED|Overall Study||10555
247087|NCT00534248|594600|P1|COMPLETED|Overall Study||10550
247088|NCT00534248|594599|P2|VACCINATED|Overall Study||11210
247089|NCT00534248|594600|P1|VACCINATED|Overall Study||11186
247090|NCT00534248|594599|P2|STARTED|Overall Study||11228
247091|NCT00534248|594600|P1|STARTED|Overall Study||11211
247092|NCT00534209|594610|P1|NOT COMPLETED|Overall Study||0
247093|NCT00534209|594610|P1|COMPLETED|Overall Study||1
247094|NCT00534209|594610|P1|STARTED|Overall Study||1
247095|NCT00534105|594630|P2|NOT COMPLETED|Overall Study||39
247096|NCT00534105|594631|P1|NOT COMPLETED|Overall Study||23
247097|NCT00534105|594630|P2|COMPLETED|Overall Study||20
247098|NCT00534105|594631|P1|COMPLETED|Overall Study||24
247099|NCT00534105|594630|P2|STARTED|Overall Study||59
247100|NCT00534105|594631|P1|STARTED|Overall Study||47
247101|NCT00534092|594645|P2|NOT COMPLETED|Overall Study||0
247102|NCT00534092|594646|P1|NOT COMPLETED|Overall Study||2
247103|NCT00534092|594645|P2|COMPLETED|Overall Study||14
247104|NCT00534092|594646|P1|COMPLETED|Overall Study||53
247105|NCT00534092|594645|P2|STARTED|Overall Study||14
247106|NCT00534092|594646|P1|STARTED|Overall Study||55
247107|NCT00534001|594671|P2|NOT COMPLETED|Overall Study||4
247108|NCT00534001|594672|P1|NOT COMPLETED|Overall Study||5
247109|NCT00534001|594671|P2|COMPLETED|Overall Study||43
247110|NCT00534001|594672|P1|COMPLETED|Overall Study||43
247111|NCT00534001|594671|P2|STARTED|Overall Study||47
247112|NCT00534001|594672|P1|STARTED|Overall Study||48
247113|NCT00533949|594684|P4|NOT COMPLETED|Overall Study||10
247114|NCT00533949|594685|P3|NOT COMPLETED|Overall Study||10
247115|NCT00533949|594686|P2|NOT COMPLETED|Overall Study||14
247116|NCT00533949|594687|P1|NOT COMPLETED|Overall Study||15
247117|NCT00533949|594684|P4|COMPLETED|Overall Study||100
247118|NCT00533949|594685|P3|COMPLETED|Overall Study||137
247119|NCT00533949|594686|P2|COMPLETED|Overall Study||107
247120|NCT00533949|594687|P1|COMPLETED|Overall Study||151
247121|NCT00533949|594684|P4|STARTED|Overall Study||110
247122|NCT00533949|594685|P3|STARTED|Overall Study||147
247123|NCT00533949|594686|P2|STARTED|Overall Study||121
247124|NCT00533949|594687|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
247125|NCT00533897|594718|P8|NOT COMPLETED|Long Term Extension (LTE)||25
247126|NCT00533897|594719|P7|NOT COMPLETED|Long Term Extension (LTE)||13
247127|NCT00533897|594720|P6|NOT COMPLETED|Long Term Extension (LTE)||0
247128|NCT00533897|594721|P5|NOT COMPLETED|Long Term Extension (LTE)||0
247129|NCT00533897|594722|P4|NOT COMPLETED|Long Term Extension (LTE)||0
247130|NCT00533897|594723|P3|NOT COMPLETED|Long Term Extension (LTE)||0
247131|NCT00533897|594724|P2|NOT COMPLETED|Long Term Extension (LTE)||0
247132|NCT00533897|594725|P1|NOT COMPLETED|Long Term Extension (LTE)||0
247133|NCT00533897|594718|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
247134|NCT00533897|594719|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
247135|NCT00533897|594720|P6|COMPLETED|Long Term Extension (LTE)||0
247136|NCT00533897|594721|P5|COMPLETED|Long Term Extension (LTE)||0
247137|NCT00533897|594722|P4|COMPLETED|Long Term Extension (LTE)||0
247138|NCT00533897|594723|P3|COMPLETED|Long Term Extension (LTE)||0
247139|NCT00533897|594724|P2|COMPLETED|Long Term Extension (LTE)||0
247140|NCT00533897|594725|P1|COMPLETED|Long Term Extension (LTE)||0
247141|NCT00533897|594718|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
247142|NCT00533897|594719|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
247143|NCT00533897|594720|P6|STARTED|Long Term Extension (LTE)||0
247144|NCT00533897|594721|P5|STARTED|Long Term Extension (LTE)||0
247145|NCT00533897|594722|P4|STARTED|Long Term Extension (LTE)||0
247146|NCT00533897|594723|P3|STARTED|Long Term Extension (LTE)||0
247147|NCT00533897|594724|P2|STARTED|Long Term Extension (LTE)||0
247148|NCT00533897|594725|P1|STARTED|Long Term Extension (LTE)||0
247149|NCT00533897|594718|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
247150|NCT00533897|594719|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
247151|NCT00533897|594720|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
247152|NCT00533897|594721|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
247153|NCT00533897|594722|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
247154|NCT00533897|594723|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
247155|NCT00533897|594724|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
247156|NCT00533897|594725|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
247157|NCT00533897|594718|P8|COMPLETED|Re-introduction (RI) Period 3||0
247158|NCT00533897|594719|P7|COMPLETED|Re-introduction (RI) Period 3||0
247159|NCT00533897|594720|P6|COMPLETED|Re-introduction (RI) Period 3||42
247160|NCT00533897|594721|P5|COMPLETED|Re-introduction (RI) Period 3||35
247161|NCT00533897|594722|P4|COMPLETED|Re-introduction (RI) Period 3||40
247162|NCT00533897|594723|P3|COMPLETED|Re-introduction (RI) Period 3||0
247163|NCT00533897|594724|P2|COMPLETED|Re-introduction (RI) Period 3||0
247164|NCT00533897|594725|P1|COMPLETED|Re-introduction (RI) Period 3||0
247165|NCT00533897|594718|P8|STARTED|Re-introduction (RI) Period 3||0
247166|NCT00533897|594719|P7|STARTED|Re-introduction (RI) Period 3||0
247243|NCT00533442|594918|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
247167|NCT00533897|594720|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
247168|NCT00533897|594721|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
247169|NCT00533897|594722|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
247170|NCT00533897|594723|P3|STARTED|Re-introduction (RI) Period 3||0
247171|NCT00533897|594724|P2|STARTED|Re-introduction (RI) Period 3||0
247172|NCT00533897|594725|P1|STARTED|Re-introduction (RI) Period 3||0
247173|NCT00533897|594718|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247174|NCT00533897|594719|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247175|NCT00533897|594720|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247176|NCT00533897|594721|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247177|NCT00533897|594722|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247178|NCT00533897|594723|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
247179|NCT00533897|594724|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
247180|NCT00533897|594725|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247181|NCT00533897|594718|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247182|NCT00533897|594719|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247183|NCT00533897|594720|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247184|NCT00533897|594721|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247185|NCT00533897|594722|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247186|NCT00533897|594723|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
247187|NCT00533897|594724|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
247188|NCT00533897|594725|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
247189|NCT00533897|594718|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
247190|NCT00533897|594719|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
247191|NCT00533897|594720|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
247192|NCT00533897|594721|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
247193|NCT00533897|594722|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
247194|NCT00533897|594723|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
247195|NCT00533897|594724|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
247196|NCT00533897|594725|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
247197|NCT00533897|594718|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
247198|NCT00533897|594719|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
247199|NCT00533897|594720|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
247200|NCT00533897|594721|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
247201|NCT00533897|594722|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
247202|NCT00533897|594723|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
247203|NCT00533897|594724|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
247204|NCT00533897|594725|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
247205|NCT00533897|594718|P8|COMPLETED|Lead-in (LI) Period 1||0
247206|NCT00533897|594719|P7|COMPLETED|Lead-in (LI) Period 1||0
247207|NCT00533897|594720|P6|COMPLETED|Lead-in (LI) Period 1||0
247208|NCT00533897|594721|P5|COMPLETED|Lead-in (LI) Period 1||0
247209|NCT00533897|594722|P4|COMPLETED|Lead-in (LI) Period 1||0
247210|NCT00533897|594723|P3|COMPLETED|Lead-in (LI) Period 1||0
247211|NCT00533897|594724|P2|COMPLETED|Lead-in (LI) Period 1||0
247212|NCT00533897|594725|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
247213|NCT00533897|594718|P8|STARTED|Lead-in (LI) Period 1||0
247214|NCT00533897|594719|P7|STARTED|Lead-in (LI) Period 1||0
247215|NCT00533897|594720|P6|STARTED|Lead-in (LI) Period 1||0
247216|NCT00533897|594721|P5|STARTED|Lead-in (LI) Period 1||0
247217|NCT00533897|594722|P4|STARTED|Lead-in (LI) Period 1||0
247218|NCT00533897|594723|P3|STARTED|Lead-in (LI) Period 1||0
247219|NCT00533897|594724|P2|STARTED|Lead-in (LI) Period 1||0
247220|NCT00533897|594725|P1|STARTED|Lead-in (LI) Period 1||167
247221|NCT00533702|594865|P2|NOT COMPLETED|Overall Study||2
247222|NCT00533702|594866|P1|NOT COMPLETED|Overall Study||5
247223|NCT00533702|594865|P2|COMPLETED|Overall Study||50
247224|NCT00533702|594866|P1|COMPLETED|Overall Study||49
247225|NCT00533702|594865|P2|Received Any Quantity of Study Drug|Overall Study||50
247226|NCT00533702|594866|P1|Received Any Quantity of Study Drug|Overall Study||52
247227|NCT00533702|594865|P2|STARTED|Overall Study||52
247228|NCT00533702|594866|P1|STARTED|Overall Study||54
247229|NCT00533546|594890|P1|NOT COMPLETED|Overall Study||0
247230|NCT00533546|594890|P1|COMPLETED|Overall Study||12
247231|NCT00533546|594890|P1|STARTED|Overall Study||12
247232|NCT00533507|594897|P1|NOT COMPLETED|Overall Study||1
247233|NCT00533507|594897|P1|COMPLETED|Overall Study||229
247234|NCT00533507|594897|P1|STARTED|Overall Study||230
247235|NCT00533442|594918|P2|NOT COMPLETED|Follow-up||10
247236|NCT00533442|594919|P1|NOT COMPLETED|Follow-up||9
247237|NCT00533442|594918|P2|COMPLETED|Follow-up||74
247238|NCT00533442|594919|P1|COMPLETED|Follow-up||77
247239|NCT00533442|594918|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
247240|NCT00533442|594919|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
247241|NCT00533442|594918|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
247242|NCT00533442|594919|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
247244|NCT00533442|594919|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
247245|NCT00533442|594918|P2|STARTED|Allocation and Intent to Treat Analysis||84
247246|NCT00533442|594919|P1|STARTED|Allocation and Intent to Treat Analysis||86
247247|NCT00533351|594931|P2|NOT COMPLETED|Period 3||0
247248|NCT00533351|594932|P1|NOT COMPLETED|Period 3||0
247249|NCT00533351|594931|P2|COMPLETED|Period 3||0
247250|NCT00533351|594932|P1|COMPLETED|Period 3||3
247251|NCT00533351|594931|P2|STARTED|Period 3|No patients continued to Period 3|0
247252|NCT00533351|594932|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
247253|NCT00533351|594931|P2|NOT COMPLETED|Period 2||0
247254|NCT00533351|594932|P1|NOT COMPLETED|Period 2||0
247255|NCT00533351|594931|P2|COMPLETED|Period 2||1
247256|NCT00533351|594932|P1|COMPLETED|Period 2||5
247257|NCT00533351|594931|P2|STARTED|Period 2||1
247258|NCT00533351|594932|P1|STARTED|Period 2||5
247259|NCT00533351|594931|P2|NOT COMPLETED|Period 1||1
247260|NCT00533351|594932|P1|NOT COMPLETED|Period 1||2
247261|NCT00533351|594931|P2|COMPLETED|Period 1||1
247262|NCT00533351|594932|P1|COMPLETED|Period 1||5
247263|NCT00533351|594931|P2|STARTED|Period 1||2
247264|NCT00533351|594932|P1|STARTED|Period 1||7
247265|NCT00533273|594942|P2|NOT COMPLETED|Open-label||0
247266|NCT00533273|594943|P1|NOT COMPLETED|Open-label||6
247267|NCT00533273|594942|P2|COMPLETED|Open-label||0
247268|NCT00533273|594943|P1|COMPLETED|Open-label||58
247269|NCT00533273|594942|P2|STARTED|Open-label|no placebo - this phase was open label|0
247270|NCT00533273|594943|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
247271|NCT00533273|594942|P2|NOT COMPLETED|Double-blind||2
247272|NCT00533273|594943|P1|NOT COMPLETED|Double-blind||0
247273|NCT00533273|594942|P2|COMPLETED|Double-blind||19
247274|NCT00533273|594943|P1|COMPLETED|Double-blind||45
247275|NCT00533273|594942|P2|STARTED|Double-blind||21
247276|NCT00533273|594943|P1|STARTED|Double-blind||45
247277|NCT00533117|594978|P4|NOT COMPLETED|Overall Study||5
247278|NCT00533117|594979|P3|NOT COMPLETED|Overall Study||6
247279|NCT00533117|594980|P2|NOT COMPLETED|Overall Study||5
247280|NCT00533117|594981|P1|NOT COMPLETED|Overall Study||4
247281|NCT00533117|594978|P4|COMPLETED|Overall Study||13
247282|NCT00533117|594979|P3|COMPLETED|Overall Study||14
247283|NCT00533117|594980|P2|COMPLETED|Overall Study||14
247284|NCT00533117|594981|P1|COMPLETED|Overall Study||14
247285|NCT00533117|594978|P4|STARTED|Overall Study||18
247286|NCT00533117|594979|P3|STARTED|Overall Study||20
247287|NCT00533117|594980|P2|STARTED|Overall Study||19
247288|NCT00533117|594981|P1|STARTED|Overall Study||18
247289|NCT00532948|594992|P3|NOT COMPLETED|Overall Study||4
247290|NCT00532948|594993|P2|NOT COMPLETED|Overall Study||5
247291|NCT00532948|594994|P1|NOT COMPLETED|Overall Study||4
247292|NCT00532948|594992|P3|COMPLETED|Overall Study||2
247293|NCT00532948|594993|P2|COMPLETED|Overall Study||9
247294|NCT00532948|594994|P1|COMPLETED|Overall Study||0
247295|NCT00532948|594992|P3|STARTED|Overall Study||6
247296|NCT00532948|594993|P2|STARTED|Overall Study||14
247297|NCT00532948|594994|P1|STARTED|Overall Study||4
247298|NCT00532935|595026|P2|NOT COMPLETED|Overall Study||52
247299|NCT00532935|595027|P1|NOT COMPLETED|Overall Study||51
247300|NCT00532935|595026|P2|COMPLETED|Overall Study||204
247301|NCT00532935|595027|P1|COMPLETED|Overall Study||210
247302|NCT00532935|595026|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
247303|NCT00532935|595027|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
247304|NCT00532883|595045|P4|NOT COMPLETED|Overall Study||5
247305|NCT00532883|595046|P3|NOT COMPLETED|Overall Study||4
247306|NCT00532883|595047|P2|NOT COMPLETED|Overall Study||7
247307|NCT00532883|595048|P1|NOT COMPLETED|Overall Study||6
247308|NCT00532883|595045|P4|COMPLETED|Overall Study|Study terminated early.|6
247309|NCT00532883|595046|P3|COMPLETED|Overall Study|Study terminated early.|6
247310|NCT00532883|595047|P2|COMPLETED|Overall Study|Study terminated early.|5
247311|NCT00532883|595048|P1|COMPLETED|Overall Study|Study terminated early.|5
247312|NCT00532883|595045|P4|STARTED|Overall Study||11
247313|NCT00532883|595046|P3|STARTED|Overall Study||10
247314|NCT00532883|595047|P2|STARTED|Overall Study||12
247315|NCT00532883|595048|P1|STARTED|Overall Study||11
247316|NCT00532779|595061|P3|NOT COMPLETED|Overall Study||291
247317|NCT00532779|595062|P2|NOT COMPLETED|Overall Study||287
247318|NCT00532779|595063|P1|NOT COMPLETED|Overall Study||294
247319|NCT00532779|595061|P3|COMPLETED|Overall Study||290
247320|NCT00532779|595062|P2|COMPLETED|Overall Study||296
247321|NCT00532779|595063|P1|COMPLETED|Overall Study||284
247322|NCT00532779|595061|P3|STARTED|Overall Study||581
247323|NCT00532779|595062|P2|STARTED|Overall Study||583
247324|NCT00532779|595063|P1|STARTED|Overall Study||578
247325|NCT00532493|595124|P2|NOT COMPLETED|Overall Study||29
247326|NCT00532493|595125|P1|NOT COMPLETED|Overall Study||30
247327|NCT00532493|595124|P2|COMPLETED|Overall Study||123
247328|NCT00532493|595125|P1|COMPLETED|Overall Study||122
247329|NCT00532493|595124|P2|STARTED|Overall Study||152
247330|NCT00532493|595125|P1|STARTED|Overall Study||152
247331|NCT00532480|595155|P1|NOT COMPLETED|Overall Study||3
247332|NCT00532480|595155|P1|COMPLETED|Overall Study||7
247333|NCT00532480|595155|P1|STARTED|Overall Study||10
247334|NCT00532441|595159|P2|NOT COMPLETED|Overall Study||0
247335|NCT00532441|595160|P1|NOT COMPLETED|Overall Study||1
247336|NCT00532441|595159|P2|COMPLETED|Overall Study||11
247337|NCT00532441|595160|P1|COMPLETED|Overall Study||13
247338|NCT00532441|595159|P2|STARTED|Overall Study||11
247339|NCT00532441|595160|P1|STARTED|Overall Study||14
247340|NCT00532298|595175|P6|NOT COMPLETED|Overall Study||2
247341|NCT00532298|595176|P5|NOT COMPLETED|Overall Study||1
247342|NCT00532298|595177|P4|NOT COMPLETED|Overall Study||0
247343|NCT00532298|595178|P3|NOT COMPLETED|Overall Study||1
247344|NCT00532298|595179|P2|NOT COMPLETED|Overall Study||1
247345|NCT00532298|595180|P1|NOT COMPLETED|Overall Study||2
247346|NCT00532298|595175|P6|COMPLETED|Overall Study||261
247347|NCT00532298|595176|P5|COMPLETED|Overall Study||267
247348|NCT00532298|595177|P4|COMPLETED|Overall Study||264
247349|NCT00532298|595178|P3|COMPLETED|Overall Study||263
247350|NCT00532298|595179|P2|COMPLETED|Overall Study||265
247351|NCT00532298|595180|P1|COMPLETED|Overall Study||267
247352|NCT00532298|595175|P6|STARTED|Overall Study||263
247353|NCT00532298|595176|P5|STARTED|Overall Study||268
247354|NCT00532298|595177|P4|STARTED|Overall Study||264
247355|NCT00532298|595178|P3|STARTED|Overall Study||264
247356|NCT00532298|595179|P2|STARTED|Overall Study||266
247357|NCT00532298|595180|P1|STARTED|Overall Study||269
247358|NCT00532259|595260|P1|NOT COMPLETED|Overall Study||32
247359|NCT00532259|595260|P1|COMPLETED|Overall Study||40
247360|NCT00532259|595260|P1|STARTED|Overall Study||72
247361|NCT00532155|595267|P2|NOT COMPLETED|Overall Study||456
247362|NCT00532155|595268|P1|NOT COMPLETED|Overall Study||457
247363|NCT00532155|595267|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
247364|NCT00532155|595268|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
247365|NCT00532155|595267|P2|SAFETY POPULATION|Overall Study||450
247366|NCT00532155|595268|P1|SAFETY POPULATION|Overall Study||455
247367|NCT00532155|595267|P2|STARTED|Overall Study||456
247368|NCT00532155|595268|P1|STARTED|Overall Study||457
247369|NCT00532129|595282|P1|NOT COMPLETED|Follow-up Period||65
247370|NCT00532129|595282|P1|COMPLETED|Follow-up Period||33
247371|NCT00532129|595282|P1|STARTED|Follow-up Period||98
247372|NCT00532129|595282|P1|NOT COMPLETED|Treatment Period||49
247373|NCT00532129|595282|P1|COMPLETED|Treatment Period||51
247374|NCT00532129|595282|P1|STARTED|Treatment Period||100
247375|NCT00531960|595302|P2|NOT COMPLETED|Overall Study||63
247376|NCT00531960|595303|P1|NOT COMPLETED|Overall Study||61
247377|NCT00531960|595302|P2|COMPLETED|Overall Study||0
247378|NCT00531960|595303|P1|COMPLETED|Overall Study||0
247379|NCT00531960|595302|P2|STARTED|Overall Study||63
247380|NCT00531960|595303|P1|STARTED|Overall Study||61
247381|NCT00531947|595321|P2|NOT COMPLETED|Overall Study||51
247382|NCT00531947|595322|P1|NOT COMPLETED|Overall Study||42
247383|NCT00531947|595321|P2|COMPLETED|Overall Study||101
247384|NCT00531947|595322|P1|COMPLETED|Overall Study||114
247385|NCT00531947|595321|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
247386|NCT00531947|595322|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
247387|NCT00531934|595366|P2|NOT COMPLETED|Overall Study||63
247388|NCT00531934|595367|P1|NOT COMPLETED|Overall Study||66
247389|NCT00531934|595366|P2|COMPLETED|Overall Study||11
247390|NCT00531934|595367|P1|COMPLETED|Overall Study||7
247391|NCT00531934|595366|P2|STARTED|Overall Study||74
247392|NCT00531934|595367|P1|STARTED|Overall Study||73
247393|NCT00531882|595438|P3|NOT COMPLETED|Overall Study||0
247394|NCT00531882|595439|P2|NOT COMPLETED|Overall Study||0
247395|NCT00531882|595440|P1|NOT COMPLETED|Overall Study||0
247396|NCT00531882|595438|P3|COMPLETED|Overall Study||5
247397|NCT00531882|595439|P2|COMPLETED|Overall Study||10
247398|NCT00531882|595440|P1|COMPLETED|Overall Study||10
247399|NCT00531882|595438|P3|STARTED|Overall Study||5
247400|NCT00531882|595439|P2|STARTED|Overall Study||10
247401|NCT00531882|595440|P1|STARTED|Overall Study||10
247402|NCT00531843|595450|P2|NOT COMPLETED|Overall Study||0
247403|NCT00531843|595451|P1|NOT COMPLETED|Overall Study||0
247404|NCT00531843|595450|P2|COMPLETED|Overall Study||6
247405|NCT00531843|595451|P1|COMPLETED|Overall Study||81
247406|NCT00531843|595450|P2|STARTED|Overall Study||6
247407|NCT00531843|595451|P1|STARTED|Overall Study||81
247408|NCT00531817|595463|P2|NOT COMPLETED|Entered Extended Treatment Period||57
247409|NCT00531817|595464|P1|NOT COMPLETED|Entered Extended Treatment Period||137
247410|NCT00531817|595463|P2|COMPLETED|Entered Extended Treatment Period||113
247411|NCT00531817|595464|P1|COMPLETED|Entered Extended Treatment Period||206
247412|NCT00531817|595463|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
247413|NCT00531817|595464|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
247414|NCT00531817|595463|P2|NOT COMPLETED|Randomized||34
247415|NCT00531817|595464|P1|NOT COMPLETED|Randomized||59
247416|NCT00531817|595463|P2|COMPLETED|Randomized||173
247417|NCT00531817|595464|P1|COMPLETED|Randomized||353
247418|NCT00531817|595463|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
247419|NCT00531817|595464|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
247420|NCT00531817|595463|P2|STARTED|Randomized||207
247421|NCT00531817|595464|P1|STARTED|Randomized||412
247422|NCT00531752|595495|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
247423|NCT00531752|595496|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
247424|NCT00531752|595497|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
247425|NCT00531752|595498|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
247426|NCT00531752|595495|P4|COMPLETED|Second Double-blind Intervention Period||11
247427|NCT00531752|595496|P3|COMPLETED|Second Double-blind Intervention Period||9
247428|NCT00531752|595497|P2|COMPLETED|Second Double-blind Intervention Period||11
247429|NCT00531752|595498|P1|COMPLETED|Second Double-blind Intervention Period||9
247430|NCT00531752|595495|P4|STARTED|Second Double-blind Intervention Period||13
247431|NCT00531752|595496|P3|STARTED|Second Double-blind Intervention Period||9
247432|NCT00531752|595497|P2|STARTED|Second Double-blind Intervention Period||13
247433|NCT00531752|595498|P1|STARTED|Second Double-blind Intervention Period||11
247434|NCT00531752|595495|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
247435|NCT00531752|595496|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
247436|NCT00531752|595497|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
247437|NCT00531752|595498|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
247438|NCT00531752|595495|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
247439|NCT00531752|595496|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
247440|NCT00531752|595497|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
247441|NCT00531752|595498|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
247442|NCT00531752|595495|P4|STARTED|Wash-out Period (at Least 7 Days)||13
247443|NCT00531752|595496|P3|STARTED|Wash-out Period (at Least 7 Days)||9
247444|NCT00531752|595497|P2|STARTED|Wash-out Period (at Least 7 Days)||13
247445|NCT00531752|595498|P1|STARTED|Wash-out Period (at Least 7 Days)||11
247446|NCT00531752|595495|P4|NOT COMPLETED|First Double-blind Intervention Period||3
247447|NCT00531752|595496|P3|NOT COMPLETED|First Double-blind Intervention Period||7
247448|NCT00531752|595497|P2|NOT COMPLETED|First Double-blind Intervention Period||4
247449|NCT00531752|595498|P1|NOT COMPLETED|First Double-blind Intervention Period||6
247450|NCT00531752|595495|P4|COMPLETED|First Double-blind Intervention Period||13
247451|NCT00531752|595496|P3|COMPLETED|First Double-blind Intervention Period||9
247452|NCT00531752|595497|P2|COMPLETED|First Double-blind Intervention Period||13
247453|NCT00531752|595498|P1|COMPLETED|First Double-blind Intervention Period||11
247454|NCT00531752|595495|P4|Treated|First Double-blind Intervention Period||16
247455|NCT00531752|595496|P3|Treated|First Double-blind Intervention Period||16
247456|NCT00531752|595497|P2|Treated|First Double-blind Intervention Period||17
247457|NCT00531752|595498|P1|Treated|First Double-blind Intervention Period||16
247458|NCT00531752|595495|P4|STARTED|First Double-blind Intervention Period||16
247459|NCT00531752|595496|P3|STARTED|First Double-blind Intervention Period||16
247460|NCT00531752|595497|P2|STARTED|First Double-blind Intervention Period||17
247461|NCT00531752|595498|P1|STARTED|First Double-blind Intervention Period||17
247462|NCT00531661|595577|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
247463|NCT00531661|595578|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
247464|NCT00531661|595577|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
247465|NCT00531661|595578|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
247466|NCT00531661|595577|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
247467|NCT00531661|595578|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
247468|NCT00531661|595577|P2|NOT COMPLETED|6 Months||26
247469|NCT00531661|595578|P1|NOT COMPLETED|6 Months||26
247470|NCT00531661|595577|P2|COMPLETED|6 Months||254
247471|NCT00531661|595578|P1|COMPLETED|6 Months||244
247472|NCT00531661|595577|P2|STARTED|6 Months||280
247473|NCT00531661|595578|P1|STARTED|6 Months||270
247474|NCT00531518|595600|P2|NOT COMPLETED|Overall Study||71
247475|NCT00531518|595601|P1|NOT COMPLETED|Overall Study||32
247476|NCT00531518|595600|P2|COMPLETED|Overall Study||134
247477|NCT00531518|595601|P1|COMPLETED|Overall Study||55
247478|NCT00531518|595600|P2|STARTED|Overall Study||205
247479|NCT00531518|595601|P1|STARTED|Overall Study||87
247480|NCT00531479|595609|P2|NOT COMPLETED|Overall Study||83
247481|NCT00531479|595610|P1|NOT COMPLETED|Overall Study||76
247482|NCT00531479|595609|P2|COMPLETED|Overall Study||146
247483|NCT00531479|595610|P1|COMPLETED|Overall Study||154
247484|NCT00531479|595609|P2|Treated|Overall Study||226
247485|NCT00531479|595610|P1|Treated|Overall Study||228
247486|NCT00531479|595609|P2|STARTED|Overall Study||229
247487|NCT00531479|595610|P1|STARTED|Overall Study||230
247488|NCT00531453|595630|P2|NOT COMPLETED|Overall Study||0
247489|NCT00531453|595631|P1|NOT COMPLETED|Overall Study||0
247490|NCT00531453|595630|P2|COMPLETED|Overall Study|10 April 2009|49
247491|NCT00531453|595631|P1|COMPLETED|Overall Study|10 April 2009|49
247492|NCT00531453|595630|P2|STARTED|Overall Study|02 October 2007|49
247493|NCT00531453|595631|P1|STARTED|Overall Study|02 October 2007|49
247494|NCT00531427|595641|P2|NOT COMPLETED|Overall Study||94
247495|NCT00531427|595642|P1|NOT COMPLETED|Overall Study||73
247496|NCT00531427|595641|P2|COMPLETED|Overall Study||191
247497|NCT00531427|595642|P1|COMPLETED|Overall Study||209
247498|NCT00531427|595641|P2|STARTED|Overall Study||285
247499|NCT00531427|595642|P1|STARTED|Overall Study||282
247500|NCT00531284|595670|P17|NOT COMPLETED|Overall Study||8
247501|NCT00531284|595671|P16|NOT COMPLETED|Overall Study||12
247502|NCT00531284|595672|P15|NOT COMPLETED|Overall Study||4
247503|NCT00531284|595673|P14|NOT COMPLETED|Overall Study||3
247504|NCT00531284|595674|P13|NOT COMPLETED|Overall Study||2
247505|NCT00531284|595675|P12|NOT COMPLETED|Overall Study||24
247506|NCT00531284|595676|P11|NOT COMPLETED|Overall Study||3
247507|NCT00531284|595677|P10|NOT COMPLETED|Overall Study||4
247508|NCT00531284|595678|P9|NOT COMPLETED|Overall Study||11
247509|NCT00531284|595679|P8|NOT COMPLETED|Overall Study||10
247510|NCT00531284|595680|P7|NOT COMPLETED|Overall Study||6
247511|NCT00531284|595681|P6|NOT COMPLETED|Overall Study||7
247512|NCT00531284|595682|P5|NOT COMPLETED|Overall Study||6
247513|NCT00531284|595683|P4|NOT COMPLETED|Overall Study||63
247514|NCT00531284|595684|P3|NOT COMPLETED|Overall Study||6
247515|NCT00531284|595685|P2|NOT COMPLETED|Overall Study||4
247516|NCT00531284|595686|P1|NOT COMPLETED|Overall Study||3
247517|NCT00531284|595670|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247518|NCT00531284|595671|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
247519|NCT00531284|595672|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
247520|NCT00531284|595673|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247521|NCT00531284|595674|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247522|NCT00531284|595675|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247523|NCT00531284|595676|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247524|NCT00531284|595677|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247525|NCT00531284|595678|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247526|NCT00531284|595679|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247527|NCT00531284|595680|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247528|NCT00531284|595681|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247529|NCT00531284|595682|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
247530|NCT00531284|595683|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
247531|NCT00531284|595684|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
247532|NCT00531284|595685|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
247533|NCT00531284|595686|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
247534|NCT00531284|595670|P17|STARTED|Overall Study||8
247535|NCT00531284|595671|P16|STARTED|Overall Study||14
247536|NCT00531284|595672|P15|STARTED|Overall Study||7
247537|NCT00531284|595673|P14|STARTED|Overall Study||3
247538|NCT00531284|595674|P13|STARTED|Overall Study||2
247539|NCT00531284|595675|P12|STARTED|Overall Study||24
247540|NCT00531284|595676|P11|STARTED|Overall Study||3
247541|NCT00531284|595677|P10|STARTED|Overall Study||4
247542|NCT00531284|595678|P9|STARTED|Overall Study||11
247543|NCT00531284|595679|P8|STARTED|Overall Study||10
247544|NCT00531284|595680|P7|STARTED|Overall Study||6
247545|NCT00531284|595681|P6|STARTED|Overall Study||7
247546|NCT00531284|595682|P5|STARTED|Overall Study||6
247547|NCT00531284|595683|P4|STARTED|Overall Study||65
247548|NCT00531284|595684|P3|STARTED|Overall Study||7
247549|NCT00531284|595685|P2|STARTED|Overall Study||4
247550|NCT00531284|595686|P1|STARTED|Overall Study||3
247551|NCT00531206|595836|P1|NOT COMPLETED|Overall Study||20
247552|NCT00531206|595836|P1|COMPLETED|Overall Study||45
247553|NCT00531206|595836|P1|STARTED|Overall Study||65
247554|NCT00531050|595866|P6|NOT COMPLETED|Part 2: Period 3||1
247555|NCT00531050|595867|P5|NOT COMPLETED|Part 2: Period 3||0
247556|NCT00531050|595868|P4|NOT COMPLETED|Part 2: Period 3||0
247557|NCT00531050|595869|P3|NOT COMPLETED|Part 2: Period 3||0
247558|NCT00531050|595870|P2|NOT COMPLETED|Part 2: Period 3||0
247559|NCT00531050|595871|P1|NOT COMPLETED|Part 2: Period 3||1
247560|NCT00531050|595866|P6|COMPLETED|Part 2: Period 3||3
247561|NCT00531050|595867|P5|COMPLETED|Part 2: Period 3||4
247562|NCT00531050|595868|P4|COMPLETED|Part 2: Period 3||4
247563|NCT00531050|595869|P3|COMPLETED|Part 2: Period 3||4
247564|NCT00531050|595870|P2|COMPLETED|Part 2: Period 3||4
247565|NCT00531050|595871|P1|COMPLETED|Part 2: Period 3||2
247566|NCT00531050|595866|P6|STARTED|Part 2: Period 3||4
247567|NCT00531050|595867|P5|STARTED|Part 2: Period 3||4
247568|NCT00531050|595868|P4|STARTED|Part 2: Period 3||4
247569|NCT00531050|595869|P3|STARTED|Part 2: Period 3||4
247570|NCT00531050|595870|P2|STARTED|Part 2: Period 3||4
247571|NCT00531050|595871|P1|STARTED|Part 2: Period 3||3
247572|NCT00531050|595866|P6|NOT COMPLETED|Part 2: Period 2||0
247573|NCT00531050|595867|P5|NOT COMPLETED|Part 2: Period 2||0
247574|NCT00531050|595868|P4|NOT COMPLETED|Part 2: Period 2||0
247575|NCT00531050|595869|P3|NOT COMPLETED|Part 2: Period 2||0
247576|NCT00531050|595870|P2|NOT COMPLETED|Part 2: Period 2||0
247577|NCT00531050|595871|P1|NOT COMPLETED|Part 2: Period 2||0
247578|NCT00531050|595866|P6|COMPLETED|Part 2: Period 2||4
247579|NCT00531050|595867|P5|COMPLETED|Part 2: Period 2||4
247580|NCT00531050|595868|P4|COMPLETED|Part 2: Period 2||4
247581|NCT00531050|595869|P3|COMPLETED|Part 2: Period 2||4
247582|NCT00531050|595870|P2|COMPLETED|Part 2: Period 2||4
247583|NCT00531050|595871|P1|COMPLETED|Part 2: Period 2||3
247584|NCT00531050|595866|P6|STARTED|Part 2: Period 2||4
247585|NCT00531050|595867|P5|STARTED|Part 2: Period 2||4
247586|NCT00531050|595868|P4|STARTED|Part 2: Period 2||4
247587|NCT00531050|595869|P3|STARTED|Part 2: Period 2||4
247588|NCT00531050|595870|P2|STARTED|Part 2: Period 2||4
247589|NCT00531050|595871|P1|STARTED|Part 2: Period 2||3
247590|NCT00531050|595866|P6|NOT COMPLETED|Part 2: Period 1||1
247591|NCT00531050|595867|P5|NOT COMPLETED|Part 2: Period 1||0
247592|NCT00531050|595868|P4|NOT COMPLETED|Part 2: Period 1||0
247593|NCT00531050|595869|P3|NOT COMPLETED|Part 2: Period 1||0
247594|NCT00531050|595870|P2|NOT COMPLETED|Part 2: Period 1||0
247595|NCT00531050|595871|P1|NOT COMPLETED|Part 2: Period 1||0
247596|NCT00531050|595866|P6|COMPLETED|Part 2: Period 1||4
247597|NCT00531050|595867|P5|COMPLETED|Part 2: Period 1||4
247598|NCT00531050|595868|P4|COMPLETED|Part 2: Period 1||4
247599|NCT00531050|595869|P3|COMPLETED|Part 2: Period 1||4
247600|NCT00531050|595870|P2|COMPLETED|Part 2: Period 1||4
247601|NCT00531050|595871|P1|COMPLETED|Part 2: Period 1||3
247602|NCT00531050|595866|P6|STARTED|Part 2: Period 1||5
247603|NCT00531050|595867|P5|STARTED|Part 2: Period 1||4
247604|NCT00531050|595868|P4|STARTED|Part 2: Period 1||4
247605|NCT00531050|595869|P3|STARTED|Part 2: Period 1||4
247606|NCT00531050|595870|P2|STARTED|Part 2: Period 1||4
247607|NCT00531050|595871|P1|STARTED|Part 2: Period 1||3
247608|NCT00531050|595866|P6|NOT COMPLETED|Part 1: Period 3||0
247609|NCT00531050|595867|P5|NOT COMPLETED|Part 1: Period 3||0
247610|NCT00531050|595868|P4|NOT COMPLETED|Part 1: Period 3||0
247611|NCT00531050|595869|P3|NOT COMPLETED|Part 1: Period 3||0
247612|NCT00531050|595870|P2|NOT COMPLETED|Part 1: Period 3||0
247613|NCT00531050|595871|P1|NOT COMPLETED|Part 1: Period 3||1
247614|NCT00531050|595866|P6|COMPLETED|Part 1: Period 3||5
247615|NCT00531050|595867|P5|COMPLETED|Part 1: Period 3||4
247616|NCT00531050|595868|P4|COMPLETED|Part 1: Period 3||4
247617|NCT00531050|595869|P3|COMPLETED|Part 1: Period 3||4
247618|NCT00531050|595870|P2|COMPLETED|Part 1: Period 3||4
247619|NCT00531050|595871|P1|COMPLETED|Part 1: Period 3||3
247620|NCT00531050|595866|P6|STARTED|Part 1: Period 3||5
247621|NCT00531050|595867|P5|STARTED|Part 1: Period 3||4
247622|NCT00531050|595868|P4|STARTED|Part 1: Period 3||4
247623|NCT00531050|595869|P3|STARTED|Part 1: Period 3||4
247624|NCT00531050|595870|P2|STARTED|Part 1: Period 3||4
247625|NCT00531050|595871|P1|STARTED|Part 1: Period 3||4
247626|NCT00531050|595866|P6|NOT COMPLETED|Part 1: Period 2||0
247627|NCT00531050|595867|P5|NOT COMPLETED|Part 1: Period 2||0
247628|NCT00531050|595868|P4|NOT COMPLETED|Part 1: Period 2||0
247629|NCT00531050|595869|P3|NOT COMPLETED|Part 1: Period 2||0
247630|NCT00531050|595870|P2|NOT COMPLETED|Part 1: Period 2||0
247631|NCT00531050|595871|P1|NOT COMPLETED|Part 1: Period 2||0
247632|NCT00531050|595866|P6|COMPLETED|Part 1: Period 2||5
247633|NCT00531050|595867|P5|COMPLETED|Part 1: Period 2||4
247634|NCT00531050|595868|P4|COMPLETED|Part 1: Period 2||4
247635|NCT00531050|595869|P3|COMPLETED|Part 1: Period 2||4
247636|NCT00531050|595870|P2|COMPLETED|Part 1: Period 2||4
247637|NCT00531050|595871|P1|COMPLETED|Part 1: Period 2||4
247638|NCT00531050|595866|P6|STARTED|Part 1: Period 2||5
247639|NCT00531050|595867|P5|STARTED|Part 1: Period 2||4
247640|NCT00531050|595868|P4|STARTED|Part 1: Period 2||4
247641|NCT00531050|595869|P3|STARTED|Part 1: Period 2||4
247642|NCT00531050|595870|P2|STARTED|Part 1: Period 2||4
247643|NCT00531050|595871|P1|STARTED|Part 1: Period 2||4
247644|NCT00531050|595866|P6|NOT COMPLETED|Part 1: Period 1||0
247645|NCT00531050|595867|P5|NOT COMPLETED|Part 1: Period 1||0
247646|NCT00531050|595868|P4|NOT COMPLETED|Part 1: Period 1||1
247647|NCT00531050|595869|P3|NOT COMPLETED|Part 1: Period 1||0
247648|NCT00531050|595870|P2|NOT COMPLETED|Part 1: Period 1||1
247649|NCT00531050|595871|P1|NOT COMPLETED|Part 1: Period 1||0
247650|NCT00531050|595866|P6|COMPLETED|Part 1: Period 1||5
247651|NCT00531050|595867|P5|COMPLETED|Part 1: Period 1||4
247652|NCT00531050|595868|P4|COMPLETED|Part 1: Period 1||4
247653|NCT00531050|595869|P3|COMPLETED|Part 1: Period 1||4
247654|NCT00531050|595870|P2|COMPLETED|Part 1: Period 1||4
247655|NCT00531050|595871|P1|COMPLETED|Part 1: Period 1||4
247656|NCT00531050|595866|P6|STARTED|Part 1: Period 1||5
247657|NCT00531050|595867|P5|STARTED|Part 1: Period 1||4
247658|NCT00531050|595868|P4|STARTED|Part 1: Period 1||5
247659|NCT00531050|595869|P3|STARTED|Part 1: Period 1||4
247660|NCT00531050|595870|P2|STARTED|Part 1: Period 1||5
247661|NCT00531050|595871|P1|STARTED|Part 1: Period 1||4
247662|NCT00531011|595900|P2|NOT COMPLETED|Overall Study||7
247663|NCT00531011|595901|P1|NOT COMPLETED|Overall Study||4
247664|NCT00531011|595900|P2|COMPLETED|Overall Study||90
247665|NCT00531011|595901|P1|COMPLETED|Overall Study||99
247666|NCT00531011|595900|P2|STARTED|Overall Study||97
247667|NCT00531011|595901|P1|STARTED|Overall Study||103
247668|NCT00530946|595947|P4|NOT COMPLETED|Overall Study||2
247669|NCT00530946|595948|P3|NOT COMPLETED|Overall Study||1
247670|NCT00530946|595949|P2|NOT COMPLETED|Overall Study||2
247671|NCT00530946|595950|P1|NOT COMPLETED|Overall Study||2
247672|NCT00530946|595947|P4|COMPLETED|Overall Study||38
247673|NCT00530946|595948|P3|COMPLETED|Overall Study||40
247674|NCT00530946|595949|P2|COMPLETED|Overall Study||39
247675|NCT00530946|595950|P1|COMPLETED|Overall Study||41
247676|NCT00530946|595947|P4|STARTED|Overall Study||40
247677|NCT00530946|595948|P3|STARTED|Overall Study||41
247678|NCT00530946|595949|P2|STARTED|Overall Study||41
247679|NCT00530946|595950|P1|STARTED|Overall Study||43
247680|NCT00530920|596003|P3|NOT COMPLETED|Overall Study||4
247681|NCT00530920|596004|P2|NOT COMPLETED|Overall Study||2
247682|NCT00530920|596005|P1|NOT COMPLETED|Overall Study||0
247683|NCT00530920|596003|P3|COMPLETED|Overall Study||24
247684|NCT00530920|596004|P2|COMPLETED|Overall Study||25
247685|NCT00530920|596005|P1|COMPLETED|Overall Study||30
247686|NCT00530920|596003|P3|STARTED|Overall Study||28
247687|NCT00530920|596004|P2|STARTED|Overall Study||27
247688|NCT00530920|596005|P1|STARTED|Overall Study||30
247689|NCT00530894|596065|P4|NOT COMPLETED|Overall Study||94
247690|NCT00530894|596066|P3|NOT COMPLETED|Overall Study||55
247691|NCT00530894|596067|P2|NOT COMPLETED|Overall Study||115
247692|NCT00530894|596068|P1|NOT COMPLETED|Overall Study||88
247693|NCT00530894|596065|P4|COMPLETED|Overall Study||85
247694|NCT00530894|596066|P3|COMPLETED|Overall Study||124
247695|NCT00530894|596067|P2|COMPLETED|Overall Study||236
247696|NCT00530894|596068|P1|COMPLETED|Overall Study||260
247697|NCT00530894|596065|P4|STARTED|Overall Study||179
247698|NCT00530894|596066|P3|STARTED|Overall Study||179
247699|NCT00530894|596067|P2|STARTED|Overall Study||351
247700|NCT00530894|596068|P1|STARTED|Overall Study||348
247701|NCT00530855|596096|P1|NOT COMPLETED|Overall Study||112
247702|NCT00530855|596096|P1|COMPLETED|Overall Study||210
247703|NCT00530855|596096|P1|STARTED|Overall Study||322
247704|NCT00530842|596105|P2|NOT COMPLETED|Period 2||9
247705|NCT00530842|596106|P1|NOT COMPLETED|Period 2||8
247706|NCT00530842|596105|P2|COMPLETED|Period 2||151
247707|NCT00530842|596106|P1|COMPLETED|Period 2||149
247708|NCT00530842|596105|P2|STARTED|Period 2||160
247709|NCT00530842|596106|P1|STARTED|Period 2||157
247710|NCT00530842|596105|P2|NOT COMPLETED|Period 1||11
247711|NCT00530842|596106|P1|NOT COMPLETED|Period 1||14
247712|NCT00530842|596105|P2|COMPLETED|Period 1||161
247713|NCT00530842|596106|P1|COMPLETED|Period 1||158
247714|NCT00530842|596105|P2|STARTED|Period 1||172
247715|NCT00530842|596106|P1|STARTED|Period 1||172
247716|NCT00530842|596105|P2|NOT COMPLETED|Overall Study||21
247717|NCT00530842|596106|P1|NOT COMPLETED|Overall Study||23
247718|NCT00530842|596105|P2|COMPLETED|Overall Study||151
247719|NCT00530842|596106|P1|COMPLETED|Overall Study||149
247720|NCT00530842|596105|P2|STARTED|Overall Study||172
247721|NCT00530842|596106|P1|STARTED|Overall Study||172
247722|NCT00530816|596233|P3|NOT COMPLETED|Overall Study||41
247723|NCT00530816|596234|P2|NOT COMPLETED|Overall Study||42
247724|NCT00530816|596235|P1|NOT COMPLETED|Overall Study||26
247725|NCT00530816|596233|P3|COMPLETED|Overall Study||29
247726|NCT00530816|596234|P2|COMPLETED|Overall Study||17
247727|NCT00530816|596235|P1|COMPLETED|Overall Study||9
247728|NCT00530816|596233|P3|STARTED|Overall Study||70
247729|NCT00530816|596234|P2|STARTED|Overall Study||59
247730|NCT00530816|596235|P1|STARTED|Overall Study||35
247731|NCT00530790|596261|P1|NOT COMPLETED|Overall Study||5
247732|NCT00530790|596261|P1|COMPLETED|Overall Study||30
247733|NCT00530790|596261|P1|STARTED|Overall Study||35
247734|NCT00530777|596283|P2|NOT COMPLETED|Overall Study||5
247735|NCT00530777|596284|P1|NOT COMPLETED|Overall Study||7
247736|NCT00530777|596283|P2|COMPLETED|Overall Study||69
247737|NCT00530777|596284|P1|COMPLETED|Overall Study||67
247738|NCT00530777|596283|P2|STARTED|Overall Study||74
247739|NCT00530777|596284|P1|STARTED|Overall Study||74
247740|NCT00530764|596296|P4|NOT COMPLETED|Overall Study||25
247741|NCT00530764|596297|P3|NOT COMPLETED|Overall Study||20
247742|NCT00530764|596298|P2|NOT COMPLETED|Overall Study||21
247743|NCT00530764|596299|P1|NOT COMPLETED|Overall Study||31
247744|NCT00530764|596296|P4|COMPLETED|Overall Study||66
247745|NCT00530764|596297|P3|COMPLETED|Overall Study||71
247746|NCT00530764|596298|P2|COMPLETED|Overall Study||67
247747|NCT00530764|596299|P1|COMPLETED|Overall Study||59
247748|NCT00530764|596296|P4|STARTED|Overall Study||91
247749|NCT00530764|596297|P3|STARTED|Overall Study||91
247750|NCT00530764|596298|P2|STARTED|Overall Study||88
247751|NCT00530764|596299|P1|STARTED|Overall Study||90
247752|NCT00530712|596341|P1|NOT COMPLETED|12 Month Follow-up Visit||24
247753|NCT00530712|596341|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
247754|NCT00530712|596341|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
247755|NCT00530712|596341|P1|NOT COMPLETED|6 Month Follow-up Visit||12
247756|NCT00530712|596341|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
247757|NCT00530712|596341|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
247758|NCT00530712|596341|P1|NOT COMPLETED|30 Day Follow-up Visit||7
247759|NCT00530712|596341|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
247760|NCT00530712|596341|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
247761|NCT00530712|596341|P1|NOT COMPLETED|Enrollment||0
247762|NCT00530712|596341|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
247763|NCT00530712|596341|P1|STARTED|Enrollment|Total Enrolled Subjects|287
247764|NCT00530634|596356|P1|NOT COMPLETED|Overall Study||0
247765|NCT00530634|596356|P1|COMPLETED|Overall Study||3
247766|NCT00530634|596356|P1|STARTED|Overall Study||3
247767|NCT00530504|596360|P1|NOT COMPLETED|Overall Study||152
247768|NCT00530504|596360|P1|COMPLETED|Overall Study||1348
247769|NCT00530504|596360|P1|STARTED|Overall Study||1500
247770|NCT00530439|596366|P2|NOT COMPLETED|Overall Study||26
247771|NCT00530439|596367|P1|NOT COMPLETED|Overall Study||30
247772|NCT00530439|596366|P2|COMPLETED|Overall Study||154
247773|NCT00530439|596367|P1|COMPLETED|Overall Study||150
247774|NCT00530439|596366|P2|STARTED|Overall Study||180
247775|NCT00530439|596367|P1|STARTED|Overall Study||180
247776|NCT00530348|596375|P2|NOT COMPLETED|Overall Study||19
247777|NCT00530348|596376|P1|NOT COMPLETED|Overall Study||22
247778|NCT00530348|596375|P2|COMPLETED|Overall Study||367
247779|NCT00530348|596376|P1|COMPLETED|Overall Study||173
247780|NCT00530348|596375|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
247781|NCT00530348|596376|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
247782|NCT00530348|596375|P2|STARTED|Overall Study|Randomized.|386
247783|NCT00530348|596376|P1|STARTED|Overall Study|Randomized.|195
247784|NCT00530335|596392|P1|NOT COMPLETED|Overall Study||6
247785|NCT00530335|596392|P1|COMPLETED|Overall Study||39
247786|NCT00530335|596392|P1|STARTED|Overall Study||45
247787|NCT00530270|596409|P2|NOT COMPLETED|Overall Study||0
247788|NCT00530270|596410|P1|NOT COMPLETED|Overall Study||1
247789|NCT00530270|596409|P2|COMPLETED|Overall Study||6
247790|NCT00530270|596410|P1|COMPLETED|Overall Study||5
247791|NCT00530270|596409|P2|STARTED|Overall Study||6
247792|NCT00530270|596410|P1|STARTED|Overall Study||6
247793|NCT00530257|596424|P1|NOT COMPLETED|Overall Study||1
247794|NCT00530257|596424|P1|COMPLETED|Overall Study||30
247795|NCT00530257|596424|P1|STARTED|Overall Study||31
247796|NCT00530218|596452|P1|NOT COMPLETED|Overall Study||25
247797|NCT00530218|596452|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
247798|NCT00530218|596452|P1|STARTED|Overall Study||61
247799|NCT00530088|596459|P1|NOT COMPLETED|Overall Study||10
247800|NCT00530088|596459|P1|COMPLETED|Overall Study||20
247801|NCT00530088|596459|P1|STARTED|Overall Study||30
247802|NCT00530075|596464|P1|NOT COMPLETED|Overall Study||7
247803|NCT00530075|596464|P1|COMPLETED|Overall Study||38
247804|NCT00530075|596464|P1|STARTED|Overall Study||45
247805|NCT00530023|596477|P2|NOT COMPLETED|Overall Study||1
247806|NCT00530023|596478|P1|NOT COMPLETED|Overall Study||0
247807|NCT00530023|596477|P2|COMPLETED|Overall Study||14
247808|NCT00530023|596478|P1|COMPLETED|Overall Study||14
247809|NCT00530023|596477|P2|STARTED|Overall Study||15
247810|NCT00530023|596478|P1|STARTED|Overall Study||14
247811|NCT00529802|596492|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
247812|NCT00529802|596492|P1|COMPLETED|Evaluable for Secondary Endpoint||48
247813|NCT00529802|596492|P1|STARTED|Evaluable for Secondary Endpoint||50
247814|NCT00529802|596492|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
247815|NCT00529802|596492|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
247816|NCT00529802|596492|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
247817|NCT00529789|596498|P1|NOT COMPLETED|Study Period IV||6
247818|NCT00529789|596498|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
247819|NCT00529789|596498|P1|STARTED|Study Period IV||48
247820|NCT00529789|596498|P1|NOT COMPLETED|Study Period II/III||24
247821|NCT00529789|596498|P1|COMPLETED|Study Period II/III||48
247822|NCT00529789|596498|P1|STARTED|Study Period II/III||72
247823|NCT00529763|596523|P3|NOT COMPLETED|Overall Study||7
247824|NCT00529763|596524|P2|NOT COMPLETED|Overall Study||33
247825|NCT00529763|596525|P1|NOT COMPLETED|Overall Study||10
247826|NCT00529763|596523|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
247827|NCT00529763|596524|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
247828|NCT00529763|596525|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
247829|NCT00529763|596523|P3|STARTED|Overall Study||59
247830|NCT00529763|596524|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
247831|NCT00529763|596525|P1|STARTED|Overall Study||25
247832|NCT00529659|596563|P2|NOT COMPLETED|Overall Study||23
247833|NCT00529659|596564|P1|NOT COMPLETED|Overall Study||11
247834|NCT00529659|596563|P2|COMPLETED|Overall Study||66
247835|NCT00529659|596564|P1|COMPLETED|Overall Study||70
247836|NCT00529659|596563|P2|STARTED|Overall Study||89
247837|NCT00529659|596564|P1|STARTED|Overall Study||81
247838|NCT00529633|596582|P2|NOT COMPLETED|Overall Study||1
247839|NCT00529633|596583|P1|NOT COMPLETED|Overall Study||1
247840|NCT00529633|596582|P2|COMPLETED|Overall Study||1
247841|NCT00529633|596583|P1|COMPLETED|Overall Study||1
247842|NCT00529633|596582|P2|STARTED|Overall Study||2
247843|NCT00529633|596583|P1|STARTED|Overall Study||2
247844|NCT00529568|596595|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
247845|NCT00529568|596596|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
247846|NCT00529568|596597|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
247847|NCT00529568|596595|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
247848|NCT00529568|596596|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
247849|NCT00529568|596597|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
247850|NCT00529568|596595|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
247851|NCT00529568|596596|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
247852|NCT00529568|596597|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
247853|NCT00529568|596595|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
247854|NCT00529568|596596|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
247855|NCT00529568|596597|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
247856|NCT00529568|596595|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
247857|NCT00529568|596596|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
247858|NCT00529568|596597|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
247859|NCT00529568|596595|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
247860|NCT00529568|596596|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
247861|NCT00529568|596597|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
247862|NCT00529555|596648|P3|NOT COMPLETED|Overall Study||26
247863|NCT00529555|596649|P2|NOT COMPLETED|Overall Study||30
247864|NCT00529555|596650|P1|NOT COMPLETED|Overall Study||29
247865|NCT00529555|596648|P3|COMPLETED|Overall Study||174
247866|NCT00529555|596649|P2|COMPLETED|Overall Study||172
247867|NCT00529555|596650|P1|COMPLETED|Overall Study||171
247868|NCT00529555|596648|P3|STARTED|Overall Study||200
247869|NCT00529555|596649|P2|STARTED|Overall Study||202
247870|NCT00529555|596650|P1|STARTED|Overall Study||200
247871|NCT00529542|596660|P2|NOT COMPLETED|Overall Study||1
247872|NCT00529542|596661|P1|NOT COMPLETED|Overall Study||1
247873|NCT00529542|596660|P2|COMPLETED|Overall Study||10
247874|NCT00529542|596661|P1|COMPLETED|Overall Study||8
247875|NCT00529542|596660|P2|STARTED|Overall Study||11
247876|NCT00529542|596661|P1|STARTED|Overall Study||9
247877|NCT00529529|596704|P3|NOT COMPLETED|Overall Study||31
247878|NCT00529529|596705|P2|NOT COMPLETED|Overall Study||43
247879|NCT00529529|596706|P1|NOT COMPLETED|Overall Study||43
247880|NCT00529529|596704|P3|COMPLETED|Overall Study||238
247881|NCT00529529|596705|P2|COMPLETED|Overall Study||225
247882|NCT00529529|596706|P1|COMPLETED|Overall Study||225
247883|NCT00529529|596704|P3|STARTED|Overall Study||269
247884|NCT00529529|596705|P2|STARTED|Overall Study||268
247885|NCT00529529|596706|P1|STARTED|Overall Study||268
247886|NCT00529516|596765|P3|NOT COMPLETED|Overall Study||1
247887|NCT00529516|596766|P2|NOT COMPLETED|Overall Study||2
247888|NCT00529516|596767|P1|NOT COMPLETED|Overall Study||3
247889|NCT00529516|596765|P3|COMPLETED|Overall Study||288
247890|NCT00529516|596766|P2|COMPLETED|Overall Study||486
247891|NCT00529516|596767|P1|COMPLETED|Overall Study||472
247892|NCT00529516|596765|P3|STARTED|Overall Study||289
247893|NCT00529516|596766|P2|STARTED|Overall Study||488
247894|NCT00529516|596767|P1|STARTED|Overall Study||475
247895|NCT00529464|596838|P3|NOT COMPLETED|Overall Study||0
247896|NCT00529464|596839|P2|NOT COMPLETED|Overall Study||0
247897|NCT00529464|596840|P1|NOT COMPLETED|Overall Study||0
247898|NCT00529464|596838|P3|COMPLETED|Overall Study||0
247899|NCT00529464|596839|P2|COMPLETED|Overall Study||0
247900|NCT00529464|596840|P1|COMPLETED|Overall Study||0
247901|NCT00529464|596838|P3|STARTED|Overall Study||0
247902|NCT00529464|596839|P2|STARTED|Overall Study||0
247903|NCT00529464|596840|P1|STARTED|Overall Study||0
247904|NCT00529451|596852|P4|NOT COMPLETED|Overall Study||31
247905|NCT00529451|596853|P3|NOT COMPLETED|Overall Study||40
247906|NCT00529451|596854|P2|NOT COMPLETED|Overall Study||48
247907|NCT00529451|596855|P1|NOT COMPLETED|Overall Study||37
247908|NCT00529451|596852|P4|COMPLETED|Overall Study||299
247909|NCT00529451|596853|P3|COMPLETED|Overall Study||292
247910|NCT00529451|596854|P2|COMPLETED|Overall Study||275
247911|NCT00529451|596855|P1|COMPLETED|Overall Study||294
247912|NCT00529451|596852|P4|STARTED|Overall Study||330
247913|NCT00529451|596853|P3|STARTED|Overall Study||332
247914|NCT00529451|596854|P2|STARTED|Overall Study||323
247915|NCT00529451|596855|P1|STARTED|Overall Study||331
247916|NCT00529399|596882|P3|NOT COMPLETED|Overall Study||2
247917|NCT00529399|596883|P2|NOT COMPLETED|Overall Study||1
247918|NCT00529399|596884|P1|NOT COMPLETED|Overall Study||2
247919|NCT00529399|596882|P3|COMPLETED|Overall Study||46
247920|NCT00529399|596883|P2|COMPLETED|Overall Study||48
247921|NCT00529399|596884|P1|COMPLETED|Overall Study||46
247922|NCT00529399|596882|P3|STARTED|Overall Study||48
247923|NCT00529399|596883|P2|STARTED|Overall Study||49
247924|NCT00529399|596884|P1|STARTED|Overall Study||48
247925|NCT00529308|596894|P2|NOT COMPLETED|Overall Study||1
247926|NCT00529308|596895|P1|NOT COMPLETED|Overall Study||1
247927|NCT00529308|596894|P2|COMPLETED|Overall Study||10
247928|NCT00529308|596895|P1|COMPLETED|Overall Study||8
247929|NCT00529308|596894|P2|STARTED|Overall Study||11
247930|NCT00529308|596895|P1|STARTED|Overall Study||9
247931|NCT00529282|596911|P2|NOT COMPLETED|Overall Study||0
247932|NCT00529282|596912|P1|NOT COMPLETED|Overall Study||0
247933|NCT00529282|596911|P2|COMPLETED|Overall Study||2
247934|NCT00529282|596912|P1|COMPLETED|Overall Study||0
247935|NCT00529282|596911|P2|STARTED|Overall Study||2
247936|NCT00529282|596912|P1|STARTED|Overall Study||0
247937|NCT00529243|596924|P1|NOT COMPLETED|Overall Study||3
247938|NCT00529243|596924|P1|COMPLETED|Overall Study||49
247939|NCT00529243|596924|P1|STARTED|Overall Study||52
247940|NCT00529217|596929|P1|NOT COMPLETED|Overall Study||4
247941|NCT00529217|596929|P1|COMPLETED|Overall Study||8
247942|NCT00529217|596929|P1|STARTED|Overall Study||12
247943|NCT00529204|596934|P1|NOT COMPLETED|Overall Study||0
247944|NCT00529204|596934|P1|COMPLETED|Overall Study||1
247945|NCT00529204|596934|P1|STARTED|Overall Study||1
247946|NCT00529191|596942|P2|NOT COMPLETED|Overall Study||0
247947|NCT00529191|596943|P1|NOT COMPLETED|Overall Study||3
247948|NCT00529191|596942|P2|COMPLETED|Overall Study||13
247949|NCT00529191|596943|P1|COMPLETED|Overall Study||24
247950|NCT00529191|596942|P2|STARTED|Overall Study||13
247951|NCT00529191|596943|P1|STARTED|Overall Study||27
247952|NCT00529152|596965|P1|NOT COMPLETED|Overall Study||5
247953|NCT00529152|596965|P1|COMPLETED|Overall Study||95
247954|NCT00529152|596965|P1|STARTED|Overall Study||100
247955|NCT00529126|596973|P4|NOT COMPLETED|Overall Study||0
247956|NCT00529126|596974|P3|NOT COMPLETED|Overall Study||0
247957|NCT00529126|596975|P2|NOT COMPLETED|Overall Study||0
247958|NCT00529126|596976|P1|NOT COMPLETED|Overall Study||0
247959|NCT00529126|596973|P4|COMPLETED|Overall Study||26
247960|NCT00529126|596974|P3|COMPLETED|Overall Study||24
247961|NCT00529126|596975|P2|COMPLETED|Overall Study||25
247962|NCT00529126|596976|P1|COMPLETED|Overall Study||25
247963|NCT00529126|596973|P4|STARTED|Overall Study||26
247964|NCT00529126|596974|P3|STARTED|Overall Study||24
247965|NCT00529126|596975|P2|STARTED|Overall Study||25
247966|NCT00529126|596976|P1|STARTED|Overall Study||25
247967|NCT00529100|596989|P2|NOT COMPLETED|Overall Study||9
247968|NCT00529100|596990|P1|NOT COMPLETED|Overall Study||0
247969|NCT00529100|596989|P2|COMPLETED|Overall Study||24
247970|NCT00529100|596990|P1|COMPLETED|Overall Study||16
247971|NCT00529100|596989|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
247972|NCT00529100|596990|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
247973|NCT00529100|596989|P2|STARTED|Overall Study||33
247974|NCT00529100|596990|P1|STARTED|Overall Study||16
247975|NCT00529087|597007|P3|NOT COMPLETED|Overall Study||16
247976|NCT00529087|597008|P2|NOT COMPLETED|Overall Study||28
247977|NCT00529087|597009|P1|NOT COMPLETED|Overall Study||28
247978|NCT00529087|597007|P3|COMPLETED|Overall Study||146
247979|NCT00529087|597008|P2|COMPLETED|Overall Study||120
247980|NCT00529087|597009|P1|COMPLETED|Overall Study||122
247981|NCT00529087|597007|P3|STARTED|Overall Study||162
247982|NCT00529087|597008|P2|STARTED|Overall Study||148
247983|NCT00529087|597009|P1|STARTED|Overall Study||150
247984|NCT00529035|597073|P1|NOT COMPLETED|Overall Study||1
247985|NCT00529035|597073|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
247986|NCT00529035|597073|P1|STARTED|Overall Study|29 enrolled|29
247987|NCT00528957|597086|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
247988|NCT00528957|597087|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
247989|NCT00528957|597086|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
247990|NCT00528957|597087|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
247991|NCT00528957|597086|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
247992|NCT00528957|597087|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
247993|NCT00528957|597086|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
247994|NCT00528957|597087|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
247995|NCT00528957|597086|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
247996|NCT00528957|597087|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
247997|NCT00528957|597086|P2|STARTED|Third Extension (Week 240 to Week 336)||37
247998|NCT00528957|597087|P1|STARTED|Third Extension (Week 240 to Week 336)||27
247999|NCT00528957|597086|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
248000|NCT00528957|597087|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
248001|NCT00528957|597086|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
248002|NCT00528957|597087|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
248003|NCT00528957|597086|P2|STARTED|Second Extension (Week 144 to Week 240)||40
248004|NCT00528957|597087|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
248005|NCT00528957|597086|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
248006|NCT00528957|597087|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
248007|NCT00528957|597086|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
248008|NCT00528957|597087|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
248009|NCT00528957|597086|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
248010|NCT00528957|597087|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
248011|NCT00528957|597086|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
248012|NCT00528957|597087|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
248013|NCT00528957|597086|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
248014|NCT00528957|597087|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
248015|NCT00528957|597086|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
248016|NCT00528957|597087|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
248017|NCT00528931|597228|P1|NOT COMPLETED|Overall Study||1
248018|NCT00528931|597228|P1|COMPLETED|Overall Study||15
248019|NCT00528931|597228|P1|STARTED|Overall Study||16
248020|NCT00528879|597240|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
248021|NCT00528879|597241|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
248022|NCT00528879|597242|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
248023|NCT00528879|597243|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
248024|NCT00528879|597240|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
248025|NCT00528879|597241|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
248026|NCT00528879|597242|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
248027|NCT00528879|597243|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
248028|NCT00528879|597240|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
248029|NCT00528879|597241|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
248030|NCT00528879|597242|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
248031|NCT00528879|597243|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
248032|NCT00528879|597240|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
248033|NCT00528879|597241|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
248034|NCT00528879|597242|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
248035|NCT00528879|597243|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
248036|NCT00528879|597240|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
248037|NCT00528879|597241|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
248038|NCT00528879|597242|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
248039|NCT00528879|597243|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
248040|NCT00528879|597240|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
248041|NCT00528879|597241|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
248042|NCT00528879|597242|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
248043|NCT00528879|597243|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
248044|NCT00528879|597240|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
248045|NCT00528879|597241|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
248046|NCT00528879|597242|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
248047|NCT00528879|597243|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
248048|NCT00528866|597309|P1|NOT COMPLETED|Overall Study||6
248049|NCT00528866|597309|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
248050|NCT00528866|597309|P1|STARTED|Overall Study||80
248051|NCT00528840|597321|P1|NOT COMPLETED|Overall Study||33
248052|NCT00528840|597321|P1|COMPLETED|Overall Study||168
248053|NCT00528840|597321|P1|STARTED|Overall Study||201
248054|NCT00528801|597335|P2|NOT COMPLETED|Overall Study||11
248055|NCT00528801|597336|P1|NOT COMPLETED|Overall Study||27
248056|NCT00528801|597335|P2|COMPLETED|Overall Study||41
248057|NCT00528801|597336|P1|COMPLETED|Overall Study||133
248058|NCT00528801|597335|P2|STARTED|Overall Study||52
248059|NCT00528801|597336|P1|STARTED|Overall Study||160
248060|NCT00528788|597346|P1|NOT COMPLETED|Overall Study||4
248061|NCT00528788|597346|P1|COMPLETED|Overall Study||20
248062|NCT00528788|597346|P1|STARTED|Overall Study||24
248063|NCT00528775|597350|P1|NOT COMPLETED|Overall Study||1
248064|NCT00528775|597350|P1|COMPLETED|Overall Study||5
248065|NCT00528775|597350|P1|STARTED|Overall Study||6
248066|NCT00528645|597358|P1|NOT COMPLETED|Overall Study||3
248067|NCT00528645|597358|P1|COMPLETED|Overall Study||20
248068|NCT00528645|597358|P1|STARTED|Overall Study||23
248069|NCT00528606|597367|P2|NOT COMPLETED|Overall Study||4
248070|NCT00528606|597368|P1|NOT COMPLETED|Overall Study||13
248071|NCT00528606|597367|P2|COMPLETED|Overall Study||100
248072|NCT00528606|597368|P1|COMPLETED|Overall Study||191
248073|NCT00528606|597367|P2|STARTED|Overall Study||104
248074|NCT00528606|597368|P1|STARTED|Overall Study||204
248075|NCT00528567|597392|P2|NOT COMPLETED|Overall Study||308
248076|NCT00528567|597393|P1|NOT COMPLETED|Overall Study||431
248077|NCT00528567|597392|P2|COMPLETED|Overall Study||982
248078|NCT00528567|597393|P1|COMPLETED|Overall Study||870
248079|NCT00528567|597392|P2|Safety Population|Overall Study||1271
248080|NCT00528567|597393|P1|Safety Population|Overall Study||1288
248081|NCT00528567|597392|P2|Intention to Treat|Overall Study||1290
248082|NCT00528567|597393|P1|Intention to Treat|Overall Study||1301
248083|NCT00528567|597392|P2|STARTED|Overall Study||1290
248084|NCT00528567|597393|P1|STARTED|Overall Study||1301
248085|NCT00528541|597433|P2|NOT COMPLETED|Overall Study||1
248086|NCT00528541|597434|P1|NOT COMPLETED|Overall Study||2
248087|NCT00528541|597433|P2|COMPLETED|Overall Study||69
248088|NCT00528541|597434|P1|COMPLETED|Overall Study||73
248089|NCT00528541|597433|P2|STARTED|Overall Study||70
248090|NCT00528541|597434|P1|STARTED|Overall Study||75
248091|NCT00528528|597460|P4|NOT COMPLETED|Overall Study||3
248092|NCT00528528|597461|P3|NOT COMPLETED|Overall Study||3
248093|NCT00528528|597462|P2|NOT COMPLETED|Overall Study||3
248094|NCT00528528|597463|P1|NOT COMPLETED|Overall Study||3
248095|NCT00528528|597460|P4|COMPLETED|Overall Study||36
248096|NCT00528528|597461|P3|COMPLETED|Overall Study||37
248097|NCT00528528|597462|P2|COMPLETED|Overall Study||39
248098|NCT00528528|597463|P1|COMPLETED|Overall Study||37
248099|NCT00528528|597460|P4|Ongoing at Time of Cut-off|Overall Study||0
248100|NCT00528528|597461|P3|Ongoing at Time of Cut-off|Overall Study||1
248101|NCT00528528|597462|P2|Ongoing at Time of Cut-off|Overall Study||0
248102|NCT00528528|597463|P1|Ongoing at Time of Cut-off|Overall Study||0
248103|NCT00528528|597460|P4|STARTED|Overall Study||39
248104|NCT00528528|597461|P3|STARTED|Overall Study||40
248105|NCT00528528|597462|P2|STARTED|Overall Study||42
248106|NCT00528528|597463|P1|STARTED|Overall Study||40
248107|NCT00528450|597497|P1|NOT COMPLETED|Overall Study||0
248108|NCT00528450|597497|P1|COMPLETED|Overall Study||1
248109|NCT00528450|597497|P1|STARTED|Overall Study||1
248110|NCT00528424|597501|P1|NOT COMPLETED|Overall Study||29
248111|NCT00528424|597501|P1|COMPLETED|Overall Study||257
248112|NCT00528424|597501|P1|STARTED|Overall Study||286
248113|NCT00528411|597516|P3|NOT COMPLETED|Overall Study||1
248114|NCT00528411|597517|P2|NOT COMPLETED|Overall Study||3
248115|NCT00528411|597518|P1|NOT COMPLETED|Overall Study||5
248116|NCT00528411|597516|P3|COMPLETED|Overall Study||11
248117|NCT00528411|597517|P2|COMPLETED|Overall Study||51
248118|NCT00528411|597518|P1|COMPLETED|Overall Study||52
248119|NCT00528411|597516|P3|STARTED|Overall Study||12
248120|NCT00528411|597517|P2|STARTED|Overall Study||54
248121|NCT00528411|597518|P1|STARTED|Overall Study||57
248122|NCT00528398|597641|P1|NOT COMPLETED|Overall Study||0
248123|NCT00528398|597641|P1|COMPLETED|Overall Study||111
248124|NCT00528398|597641|P1|STARTED|Overall Study||111
248125|NCT00528372|597655|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
248126|NCT00528372|597656|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
248127|NCT00528372|597657|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
248128|NCT00528372|597658|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
248129|NCT00528372|597659|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
248130|NCT00528372|597660|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
248131|NCT00528372|597661|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
248132|NCT00528372|597662|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
248133|NCT00528372|597663|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
248134|NCT00528372|597655|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
248135|NCT00528372|597656|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
248136|NCT00528372|597657|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
248137|NCT00528372|597658|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
248138|NCT00528372|597659|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
248139|NCT00528372|597660|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
248140|NCT00528372|597661|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
248141|NCT00528372|597662|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
248142|NCT00528372|597663|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
248143|NCT00528372|597655|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
248144|NCT00528372|597656|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
248145|NCT00528372|597657|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
248146|NCT00528372|597658|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
248147|NCT00528372|597659|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
248148|NCT00528372|597660|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
248149|NCT00528372|597661|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
248150|NCT00528372|597662|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
248151|NCT00528372|597663|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
248152|NCT00528372|597655|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
248153|NCT00528372|597656|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
248154|NCT00528372|597657|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
248155|NCT00528372|597658|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
248156|NCT00528372|597659|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
248157|NCT00528372|597660|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
248158|NCT00528372|597661|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
248159|NCT00528372|597662|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
248160|NCT00528372|597663|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
248161|NCT00528372|597655|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
248162|NCT00528372|597656|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
248163|NCT00528372|597657|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
248164|NCT00528372|597658|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
248165|NCT00528372|597659|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
248166|NCT00528372|597660|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
248167|NCT00528372|597661|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
248168|NCT00528372|597662|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
248169|NCT00528372|597663|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
248170|NCT00528372|597655|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
248171|NCT00528372|597656|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
248172|NCT00528372|597657|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
248173|NCT00528372|597658|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
248174|NCT00528372|597659|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
248175|NCT00528372|597660|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
248176|NCT00528372|597661|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
248177|NCT00528372|597662|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
248178|NCT00528372|597663|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
248179|NCT00528268|597777|P2|NOT COMPLETED|Overall Study||1
248180|NCT00528268|597778|P1|NOT COMPLETED|Overall Study||1
248181|NCT00528268|597777|P2|COMPLETED|Overall Study||7
248182|NCT00528268|597778|P1|COMPLETED|Overall Study||5
248183|NCT00528268|597777|P2|STARTED|Overall Study||8
248184|NCT00528268|597778|P1|STARTED|Overall Study||6
248185|NCT00528190|597786|P2|NOT COMPLETED|Overall Study||1
248186|NCT00528190|597787|P1|NOT COMPLETED|Overall Study||0
248187|NCT00528190|597786|P2|COMPLETED|Overall Study||16
248188|NCT00528190|597787|P1|COMPLETED|Overall Study||18
248189|NCT00528190|597786|P2|STARTED|Overall Study||17
248190|NCT00528190|597787|P1|STARTED|Overall Study||18
248191|NCT00528112|597795|P2|NOT COMPLETED|Extension Phase||157
248192|NCT00528112|597796|P1|NOT COMPLETED|Extension Phase||0
248193|NCT00528112|597795|P2|COMPLETED|Extension Phase||550
248194|NCT00528112|597796|P1|COMPLETED|Extension Phase||0
248195|NCT00528112|597795|P2|STARTED|Extension Phase||707
248196|NCT00528112|597796|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
248197|NCT00528112|597795|P2|NOT COMPLETED|Treatment up to 3 Years||583
248198|NCT00528112|597796|P1|NOT COMPLETED|Treatment up to 3 Years||613
248199|NCT00528112|597795|P2|COMPLETED|Treatment up to 3 Years||870
248200|NCT00528112|597796|P1|COMPLETED|Treatment up to 3 Years||819
248201|NCT00528112|597795|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
248202|NCT00528112|597796|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
248203|NCT00528112|597795|P2|STARTED|Treatment up to 3 Years||1453
248204|NCT00528112|597796|P1|STARTED|Treatment up to 3 Years||1432
248205|NCT00528021|597854|P4|NOT COMPLETED|Overall Study||9
248206|NCT00528021|597855|P3|NOT COMPLETED|Overall Study||7
248207|NCT00528021|597856|P2|NOT COMPLETED|Overall Study||13
248208|NCT00528021|597857|P1|NOT COMPLETED|Overall Study||17
248209|NCT00528021|597854|P4|COMPLETED|Overall Study||47
248210|NCT00528021|597855|P3|COMPLETED|Overall Study||49
248211|NCT00528021|597856|P2|COMPLETED|Overall Study||46
248212|NCT00528021|597857|P1|COMPLETED|Overall Study||42
248213|NCT00528021|597854|P4|STARTED|Overall Study||56
248214|NCT00528021|597855|P3|STARTED|Overall Study||56
248215|NCT00528021|597856|P2|STARTED|Overall Study||59
248216|NCT00528021|597857|P1|STARTED|Overall Study||59
248217|NCT00527982|597869|P2|NOT COMPLETED|Overall Study||0
248218|NCT00527982|597870|P1|NOT COMPLETED|Overall Study||1
248219|NCT00527982|597869|P2|COMPLETED|Overall Study||0
248220|NCT00527982|597870|P1|COMPLETED|Overall Study||0
248221|NCT00527982|597869|P2|STARTED|Overall Study||0
248222|NCT00527982|597870|P1|STARTED|Overall Study||1
248223|NCT00527943|597878|P2|NOT COMPLETED|Overall Study||146
248224|NCT00527943|597879|P1|NOT COMPLETED|Overall Study||160
248225|NCT00527943|597878|P2|COMPLETED|Overall Study||6327
248226|NCT00527943|597879|P1|COMPLETED|Overall Study||6311
248227|NCT00527943|597878|P2|Received Treatment|Overall Study||6446
248228|NCT00527943|597879|P1|Received Treatment|Overall Study||6441
248229|NCT00527943|597878|P2|STARTED|Overall Study||6473
248230|NCT00527943|597879|P1|STARTED|Overall Study||6471
248231|NCT00527904|597911|P1|NOT COMPLETED|Overall Study||96
248232|NCT00527904|597911|P1|COMPLETED|Overall Study||143
248233|NCT00527904|597911|P1|STARTED|Overall Study||239
248234|NCT00527878|597915|P2|NOT COMPLETED|Intervention 2||0
248235|NCT00527878|597916|P1|NOT COMPLETED|Intervention 2||0
248236|NCT00527878|597915|P2|COMPLETED|Intervention 2||4
248237|NCT00527878|597916|P1|COMPLETED|Intervention 2||5
248238|NCT00527878|597915|P2|STARTED|Intervention 2||4
248239|NCT00527878|597916|P1|STARTED|Intervention 2||5
248240|NCT00527878|597915|P2|NOT COMPLETED|Intervention 1||3
248241|NCT00527878|597916|P1|NOT COMPLETED|Intervention 1||2
248242|NCT00527878|597915|P2|COMPLETED|Intervention 1||4
248243|NCT00527878|597916|P1|COMPLETED|Intervention 1||5
248244|NCT00527878|597915|P2|STARTED|Intervention 1||7
248245|NCT00527878|597916|P1|STARTED|Intervention 1||7
248246|NCT00527826|597930|P2|NOT COMPLETED|Overall Study||26
248247|NCT00527826|597931|P1|NOT COMPLETED|Overall Study||21
248248|NCT00527826|597930|P2|COMPLETED|Overall Study||80
248249|NCT00527826|597931|P1|COMPLETED|Overall Study||87
248250|NCT00527826|597930|P2|STARTED|Overall Study||106
248251|NCT00527826|597931|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
248252|NCT00527787|597980|P2|NOT COMPLETED|Overall Study||63
248253|NCT00527787|597981|P1|NOT COMPLETED|Overall Study||38
248254|NCT00527787|597980|P2|COMPLETED|Overall Study||153
248255|NCT00527787|597981|P1|COMPLETED|Overall Study||180
248256|NCT00527787|597980|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
248257|NCT00527787|597981|P1|STARTED|Overall Study||218
248258|NCT00527748|598003|P1|NOT COMPLETED|Overall Study||3
248259|NCT00527748|598003|P1|COMPLETED|Overall Study||23
248260|NCT00527748|598003|P1|STARTED|Overall Study||26
248261|NCT00527735|598010|P3|NOT COMPLETED|Overall Study||107
248262|NCT00527735|598011|P2|NOT COMPLETED|Overall Study||107
248263|NCT00527735|598012|P1|NOT COMPLETED|Overall Study||108
248264|NCT00527735|598010|P3|COMPLETED|Overall Study|Still on treatment|2
248265|NCT00527735|598011|P2|COMPLETED|Overall Study|Still on treatment|2
248266|NCT00527735|598012|P1|COMPLETED|Overall Study|Still on treatment|5
248267|NCT00527735|598010|P3|STARTED|Overall Study|Treated|109
248268|NCT00527735|598011|P2|STARTED|Overall Study|Treated|109
248269|NCT00527735|598012|P1|STARTED|Overall Study|Treated|113
248270|NCT00527722|598086|P2|NOT COMPLETED|Overall Study||0
248271|NCT00527722|598087|P1|NOT COMPLETED|Overall Study||0
248272|NCT00527722|598086|P2|COMPLETED|Overall Study||25
248273|NCT00527722|598087|P1|COMPLETED|Overall Study||22
248274|NCT00527722|598086|P2|STARTED|Overall Study||25
248275|NCT00527722|598087|P1|STARTED|Overall Study||22
248276|NCT00527644|598093|P1|NOT COMPLETED|Overall Study||0
248277|NCT00527644|598093|P1|COMPLETED|Overall Study||14
248278|NCT00527644|598093|P1|STARTED|Overall Study||14
248279|NCT00527618|598098|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
248280|NCT00527618|598099|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
248281|NCT00527618|598098|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
248282|NCT00527618|598099|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
248283|NCT00527618|598098|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
248284|NCT00527618|598099|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
248285|NCT00527618|598098|P2|NOT COMPLETED|Week 13-14 (Washout)||0
248286|NCT00527618|598099|P1|NOT COMPLETED|Week 13-14 (Washout)||1
248287|NCT00527618|598098|P2|COMPLETED|Week 13-14 (Washout)||16
248288|NCT00527618|598099|P1|COMPLETED|Week 13-14 (Washout)||12
248289|NCT00527618|598098|P2|STARTED|Week 13-14 (Washout)||16
248290|NCT00527618|598099|P1|STARTED|Week 13-14 (Washout)||13
248291|NCT00527618|598098|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
248292|NCT00527618|598099|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
248293|NCT00527618|598098|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
248294|NCT00527618|598099|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
248295|NCT00527618|598098|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
248296|NCT00527618|598099|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
248297|NCT00527605|598114|P2|NOT COMPLETED|Overall Study||11
248298|NCT00527605|598115|P1|NOT COMPLETED|Overall Study||13
248299|NCT00527605|598114|P2|COMPLETED|Overall Study||116
248300|NCT00527605|598115|P1|COMPLETED|Overall Study||113
248301|NCT00527605|598114|P2|STARTED|Overall Study||127
248302|NCT00527605|598115|P1|STARTED|Overall Study||126
248303|NCT00527592|598151|P1|NOT COMPLETED|Overall Study||0
248304|NCT00527592|598151|P1|COMPLETED|Overall Study||54
248305|NCT00527592|598151|P1|STARTED|Overall Study||54
248306|NCT00527566|598157|P1|NOT COMPLETED|Overall Study||0
248307|NCT00527566|598157|P1|COMPLETED|Overall Study||10
248308|NCT00527566|598157|P1|STARTED|Overall Study||10
248309|NCT00527514|598166|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
248310|NCT00527514|598166|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
248311|NCT00527514|598166|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
248312|NCT00527514|598166|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
248313|NCT00527514|598166|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
248314|NCT00527514|598166|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
248315|NCT00527514|598166|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
248316|NCT00527514|598166|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
248317|NCT00527514|598166|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
248318|NCT00527514|598166|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
248319|NCT00527514|598166|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
248320|NCT00527514|598166|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
248321|NCT00527488|598182|P4|NOT COMPLETED|Overall Study||0
248322|NCT00527488|598183|P3|NOT COMPLETED|Overall Study||1
248323|NCT00527488|598184|P2|NOT COMPLETED|Overall Study||1
248324|NCT00527488|598185|P1|NOT COMPLETED|Overall Study||0
248325|NCT00527488|598182|P4|COMPLETED|Overall Study||13
248326|NCT00527488|598183|P3|COMPLETED|Overall Study||12
248327|NCT00527488|598184|P2|COMPLETED|Overall Study||12
248328|NCT00527488|598185|P1|COMPLETED|Overall Study||13
248329|NCT00527488|598182|P4|STARTED|Overall Study||13
248330|NCT00527488|598183|P3|STARTED|Overall Study||13
248331|NCT00527488|598184|P2|STARTED|Overall Study||13
248332|NCT00527488|598185|P1|STARTED|Overall Study||13
248333|NCT00527475|598261|P2|NOT COMPLETED|Overall Study||1
248334|NCT00527475|598262|P1|NOT COMPLETED|Overall Study||3
248335|NCT00527475|598261|P2|COMPLETED|Overall Study||29
248336|NCT00527475|598262|P1|COMPLETED|Overall Study||27
248337|NCT00527475|598261|P2|STARTED|Overall Study||30
248338|NCT00527475|598262|P1|STARTED|Overall Study||30
248339|NCT00527423|598268|P1|NOT COMPLETED|Overall Study||37
248340|NCT00527423|598268|P1|COMPLETED|Overall Study||120
248341|NCT00527423|598268|P1|STARTED|Overall Study||157
248342|NCT00527397|598274|P1|NOT COMPLETED|Overall Study||24
248343|NCT00527397|598274|P1|COMPLETED|Overall Study||0
248344|NCT00527397|598274|P1|STARTED|Overall Study||24
248345|NCT00527332|598300|P2|NOT COMPLETED|Overall Study||9
248346|NCT00527332|598301|P1|NOT COMPLETED|Overall Study||9
248347|NCT00527332|598300|P2|COMPLETED|Overall Study||80
248348|NCT00527332|598301|P1|COMPLETED|Overall Study||82
248349|NCT00527332|598300|P2|STARTED|Overall Study||89
248350|NCT00527332|598301|P1|STARTED|Overall Study||91
248351|NCT00527319|598310|P3|NOT COMPLETED|Overall Study||6
248352|NCT00527319|598311|P2|NOT COMPLETED|Overall Study||4
248353|NCT00527319|598312|P1|NOT COMPLETED|Overall Study||6
248354|NCT00527319|598310|P3|COMPLETED|Overall Study||7
248355|NCT00527319|598311|P2|COMPLETED|Overall Study||8
248356|NCT00527319|598312|P1|COMPLETED|Overall Study||6
248357|NCT00527319|598310|P3|STARTED|Overall Study||13
248358|NCT00527319|598311|P2|STARTED|Overall Study||12
248359|NCT00527319|598312|P1|STARTED|Overall Study||12
248360|NCT00527124|598325|P2|NOT COMPLETED|Overall Study||0
248361|NCT00527124|598326|P1|NOT COMPLETED|Overall Study||0
248362|NCT00527124|598325|P2|COMPLETED|Overall Study||28
248363|NCT00527124|598326|P1|COMPLETED|Overall Study||29
248364|NCT00527124|598325|P2|STARTED|Overall Study||28
248365|NCT00527124|598326|P1|STARTED|Overall Study||29
248366|NCT00527111|598342|P2|NOT COMPLETED|Overall Study||22
248367|NCT00527111|598343|P1|NOT COMPLETED|Overall Study||20
248368|NCT00527111|598342|P2|COMPLETED|Overall Study||47
248369|NCT00527111|598343|P1|COMPLETED|Overall Study||50
248370|NCT00527111|598342|P2|STARTED|Overall Study||69
248371|NCT00527111|598343|P1|STARTED|Overall Study||70
248372|NCT00527098|598359|P2|NOT COMPLETED|Overall Study||0
248373|NCT00527098|598360|P1|NOT COMPLETED|Overall Study||0
248374|NCT00527098|598359|P2|COMPLETED|Overall Study||83
248375|NCT00527098|598360|P1|COMPLETED|Overall Study||36
248376|NCT00527098|598359|P2|STARTED|Overall Study||83
248377|NCT00527098|598360|P1|STARTED|Overall Study||36
248378|NCT00527072|598365|P1|NOT COMPLETED|Overall Study||36
248379|NCT00527072|598365|P1|COMPLETED|Overall Study||179
248380|NCT00527072|598365|P1|STARTED|Overall Study||215
248381|NCT00526994|598374|P3|NOT COMPLETED|Overall Study||107
248382|NCT00526994|598375|P2|NOT COMPLETED|Overall Study||121
248383|NCT00526994|598376|P1|NOT COMPLETED|Overall Study||108
248384|NCT00526994|598374|P3|COMPLETED|Overall Study||791
248385|NCT00526994|598375|P2|COMPLETED|Overall Study||772
248386|NCT00526994|598376|P1|COMPLETED|Overall Study||801
248387|NCT00526994|598374|P3|STARTED|Overall Study||898
248388|NCT00526994|598375|P2|STARTED|Overall Study||893
248389|NCT00526994|598376|P1|STARTED|Overall Study||909
248390|NCT00526890|598393|P1|NOT COMPLETED|Overall Study||2
248391|NCT00526890|598393|P1|COMPLETED|Overall Study||14
248392|NCT00526890|598393|P1|STARTED|Overall Study||16
248393|NCT00526799|598405|P2|NOT COMPLETED|Overall Study||1
248394|NCT00526799|598406|P1|NOT COMPLETED|Overall Study||1
248395|NCT00526799|598405|P2|COMPLETED|Overall Study||13
248396|NCT00526799|598406|P1|COMPLETED|Overall Study||15
248397|NCT00526799|598405|P2|STARTED|Overall Study||14
248398|NCT00526799|598406|P1|STARTED|Overall Study||16
248399|NCT00526669|598414|P2|NOT COMPLETED|Combined Treatment Phase||8
248400|NCT00526669|598415|P1|NOT COMPLETED|Combined Treatment Phase||0
248401|NCT00526669|598414|P2|COMPLETED|Combined Treatment Phase||59
248402|NCT00526669|598415|P1|COMPLETED|Combined Treatment Phase||0
248403|NCT00526669|598414|P2|STARTED|Combined Treatment Phase||67
248404|NCT00526669|598415|P1|STARTED|Combined Treatment Phase||0
248405|NCT00526669|598414|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
248406|NCT00526669|598415|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
248407|NCT00526669|598414|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
248408|NCT00526669|598415|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
248409|NCT00526669|598414|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
248410|NCT00526669|598415|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
248411|NCT00526630|598444|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
248412|NCT00526630|598445|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
248413|NCT00526630|598444|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
248414|NCT00526630|598445|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
248415|NCT00526630|598444|P2|STARTED|Second Intervention Period - 12 Weeks||8
248416|NCT00526630|598445|P1|STARTED|Second Intervention Period - 12 Weeks||12
248417|NCT00526630|598444|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
248418|NCT00526630|598445|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
248419|NCT00526630|598444|P2|COMPLETED|First Intervention Period - 12 Weeks||8
248420|NCT00526630|598445|P1|COMPLETED|First Intervention Period - 12 Weeks||12
248421|NCT00526630|598444|P2|STARTED|First Intervention Period - 12 Weeks||11
248422|NCT00526630|598445|P1|STARTED|First Intervention Period - 12 Weeks||12
248423|NCT00526474|598475|P2|NOT COMPLETED|Overall Study||272
248424|NCT00526474|598476|P1|NOT COMPLETED|Overall Study||292
248425|NCT00526474|598475|P2|COMPLETED|Overall Study||12953
248426|NCT00526474|598476|P1|COMPLETED|Overall Study||12932
248427|NCT00526474|598475|P2|Received Study Drug|Overall Study||13186
248428|NCT00526474|598476|P1|Received Study Drug|Overall Study||13166
248429|NCT00526474|598475|P2|STARTED|Overall Study||13225
248430|NCT00526474|598476|P1|STARTED|Overall Study||13224
248431|NCT00526331|598544|P1|NOT COMPLETED|Overall Study||55
248432|NCT00526331|598544|P1|COMPLETED|Overall Study||0
248433|NCT00526331|598544|P1|STARTED|Overall Study||55
248434|NCT00526292|598548|P1|NOT COMPLETED|Overall Study||0
248435|NCT00526292|598548|P1|COMPLETED|Overall Study||6
248436|NCT00526292|598548|P1|STARTED|Overall Study||6
248437|NCT00526227|598552|P1|NOT COMPLETED|Overall Study||2
248438|NCT00526227|598552|P1|COMPLETED|Overall Study||79
248439|NCT00526227|598552|P1|STARTED|Overall Study||81
248440|NCT00526188|598557|P1|NOT COMPLETED|Overall Study||0
248441|NCT00526188|598557|P1|COMPLETED|Overall Study||234
248442|NCT00526188|598557|P1|STARTED|Overall Study||234
248443|NCT00526162|598563|P1|NOT COMPLETED|Overall Study||3
248444|NCT00526162|598563|P1|COMPLETED|Overall Study||80
248445|NCT00526162|598563|P1|STARTED|Overall Study||83
248446|NCT00526123|598570|P2|NOT COMPLETED|Overall Study||246
248447|NCT00526123|598571|P1|NOT COMPLETED|Overall Study||264
248448|NCT00526123|598570|P2|COMPLETED|Overall Study||50
248449|NCT00526123|598571|P1|COMPLETED|Overall Study||39
248450|NCT00526123|598570|P2|STARTED|Overall Study|Intent-to-Treat population|296
248451|NCT00526123|598571|P1|STARTED|Overall Study|Intent-to-Treat population|303
248452|NCT00526110|598593|P2|NOT COMPLETED|Overall Study||41
248453|NCT00526110|598594|P1|NOT COMPLETED|Overall Study||2
248454|NCT00526110|598593|P2|COMPLETED|Overall Study||4
248455|NCT00526110|598594|P1|COMPLETED|Overall Study||51
248456|NCT00526110|598593|P2|STARTED|Overall Study||45
248457|NCT00526110|598594|P1|STARTED|Overall Study||53
248458|NCT00526097|598603|P2|NOT COMPLETED|Overall Study||56
248459|NCT00526097|598604|P1|NOT COMPLETED|Overall Study||15
248460|NCT00526097|598603|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
248461|NCT00526097|598604|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
248462|NCT00526097|598603|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
248463|NCT00526097|598604|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
248464|NCT00526058|598782|P2|NOT COMPLETED|Period: Second Intervention||0
248465|NCT00526058|598783|P1|NOT COMPLETED|Period: Second Intervention||0
248466|NCT00526058|598782|P2|COMPLETED|Period: Second Intervention||9
248467|NCT00526058|598783|P1|COMPLETED|Period: Second Intervention||9
248468|NCT00526058|598782|P2|STARTED|Period: Second Intervention||9
248469|NCT00526058|598783|P1|STARTED|Period: Second Intervention||9
248470|NCT00526058|598782|P2|NOT COMPLETED|Period: First Intervention||0
248471|NCT00526058|598783|P1|NOT COMPLETED|Period: First Intervention||0
248472|NCT00526058|598782|P2|COMPLETED|Period: First Intervention||9
248473|NCT00526058|598783|P1|COMPLETED|Period: First Intervention||9
248474|NCT00526058|598782|P2|STARTED|Period: First Intervention||9
248475|NCT00526058|598783|P1|STARTED|Period: First Intervention||9
248476|NCT00525915|598791|P2|NOT COMPLETED|Overall Study||9
248477|NCT00525915|598792|P1|NOT COMPLETED|Overall Study||8
248478|NCT00525915|598791|P2|COMPLETED|Overall Study||54
248479|NCT00525915|598792|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
248480|NCT00525915|598791|P2|STARTED|Overall Study||63
248481|NCT00525915|598792|P1|STARTED|Overall Study||63
248482|NCT00525902|598798|P1|NOT COMPLETED|Overall Study||1
248483|NCT00525902|598798|P1|COMPLETED|Overall Study||30
248484|NCT00525902|598798|P1|50 Weeks|Overall Study||12
248485|NCT00525902|598798|P1|10 Weeks|Overall Study||30
248486|NCT00525902|598798|P1|STARTED|Overall Study||31
248487|NCT00525876|598805|P2|NOT COMPLETED|Overall Study||0
248488|NCT00525876|598806|P1|NOT COMPLETED|Overall Study||0
248489|NCT00525876|598805|P2|COMPLETED|Overall Study||20
248490|NCT00525876|598806|P1|COMPLETED|Overall Study||16
248491|NCT00525876|598805|P2|STARTED|Overall Study||20
248492|NCT00525876|598806|P1|STARTED|Overall Study||16
248493|NCT00525837|598812|P1|NOT COMPLETED|Overall Study||4
248494|NCT00525837|598812|P1|COMPLETED|Overall Study||14
248495|NCT00525837|598812|P1|STARTED|Overall Study||18
248496|NCT00525824|598820|P4|NOT COMPLETED|Overall Study||15
248497|NCT00525824|598821|P3|NOT COMPLETED|Overall Study||19
248498|NCT00525824|598822|P2|NOT COMPLETED|Overall Study||28
248499|NCT00525824|598823|P1|NOT COMPLETED|Overall Study||19
248500|NCT00525824|598820|P4|COMPLETED|Overall Study||188
248501|NCT00525824|598821|P3|COMPLETED|Overall Study||183
248502|NCT00525824|598822|P2|COMPLETED|Overall Study||186
248503|NCT00525824|598823|P1|COMPLETED|Overall Study||195
248504|NCT00525824|598820|P4|STARTED|Overall Study|Randomized population|203
248505|NCT00525824|598821|P3|STARTED|Overall Study|Randomized population|202
248506|NCT00525824|598822|P2|STARTED|Overall Study|Randomized population|214
248507|NCT00525824|598823|P1|STARTED|Overall Study|Randomized population|214
248508|NCT00525798|598887|P2|NOT COMPLETED|Overall Study||599
248509|NCT00525798|598888|P1|NOT COMPLETED|Overall Study||756
248510|NCT00525798|598887|P2|COMPLETED|Overall Study||1732
248511|NCT00525798|598888|P1|COMPLETED|Overall Study||1578
248512|NCT00525798|598887|P2|STARTED|Overall Study||2331
248513|NCT00525798|598888|P1|STARTED|Overall Study||2334
248514|NCT00525733|598898|P2|NOT COMPLETED|Overall Study||3
248515|NCT00525733|598899|P1|NOT COMPLETED|Overall Study||3
248516|NCT00525733|598898|P2|COMPLETED|Overall Study||23
248517|NCT00525733|598899|P1|COMPLETED|Overall Study||11
248518|NCT00525733|598898|P2|STARTED|Overall Study||26
248519|NCT00525733|598899|P1|STARTED|Overall Study||14
248520|NCT00525629|598905|P2|NOT COMPLETED|Second Intervention||15
248521|NCT00525629|598906|P1|NOT COMPLETED|Second Intervention||15
248522|NCT00525629|598905|P2|COMPLETED|Second Intervention||0
248523|NCT00525629|598906|P1|COMPLETED|Second Intervention||0
248524|NCT00525629|598905|P2|STARTED|Second Intervention||15
248525|NCT00525629|598906|P1|STARTED|Second Intervention||15
248526|NCT00525629|598905|P2|NOT COMPLETED|Washout||0
248527|NCT00525629|598906|P1|NOT COMPLETED|Washout||0
248528|NCT00525629|598905|P2|COMPLETED|Washout||15
248529|NCT00525629|598906|P1|COMPLETED|Washout||15
248530|NCT00525629|598905|P2|STARTED|Washout||15
248531|NCT00525629|598906|P1|STARTED|Washout||15
248532|NCT00525629|598905|P2|NOT COMPLETED|First Intervention||5
248533|NCT00525629|598906|P1|NOT COMPLETED|First Intervention||5
248534|NCT00525629|598905|P2|COMPLETED|First Intervention||15
248535|NCT00525629|598906|P1|COMPLETED|First Intervention||15
248536|NCT00525629|598905|P2|STARTED|First Intervention||20
248537|NCT00525629|598906|P1|STARTED|First Intervention||20
248538|NCT00525603|598912|P1|NOT COMPLETED|Overall Study||0
248539|NCT00525603|598912|P1|COMPLETED|Overall Study||60
248540|NCT00525603|598912|P1|STARTED|Overall Study||60
248541|NCT00525525|598918|P2|NOT COMPLETED|Overall Study||0
248542|NCT00525525|598919|P1|NOT COMPLETED|Overall Study||0
248543|NCT00525525|598918|P2|COMPLETED|Overall Study||15
248544|NCT00525525|598919|P1|COMPLETED|Overall Study||59
248545|NCT00525525|598918|P2|STARTED|Overall Study||15
248546|NCT00525525|598919|P1|STARTED|Overall Study||59
248547|NCT00525512|598928|P4|NOT COMPLETED|Open-Label Phase||5
248548|NCT00525512|598929|P3|NOT COMPLETED|Open-Label Phase||6
248549|NCT00525512|598930|P2|NOT COMPLETED|Open-Label Phase||0
248550|NCT00525512|598931|P1|NOT COMPLETED|Open-Label Phase||0
248551|NCT00525512|598928|P4|COMPLETED|Open-Label Phase||189
248552|NCT00525512|598929|P3|COMPLETED|Open-Label Phase||158
248553|NCT00525512|598930|P2|COMPLETED|Open-Label Phase||0
248554|NCT00525512|598931|P1|COMPLETED|Open-Label Phase||0
248555|NCT00525512|598928|P4|STARTED|Open-Label Phase||194
248556|NCT00525512|598929|P3|STARTED|Open-Label Phase||164
248557|NCT00525512|598930|P2|STARTED|Open-Label Phase||0
248558|NCT00525512|598931|P1|STARTED|Open-Label Phase||0
248559|NCT00525512|598928|P4|NOT COMPLETED|Double-Blind Phase||0
248560|NCT00525512|598929|P3|NOT COMPLETED|Double-Blind Phase||0
248561|NCT00525512|598930|P2|NOT COMPLETED|Double-Blind Phase||66
248562|NCT00525512|598931|P1|NOT COMPLETED|Double-Blind Phase||96
248563|NCT00525512|598928|P4|COMPLETED|Double-Blind Phase||0
248564|NCT00525512|598929|P3|COMPLETED|Double-Blind Phase||0
248565|NCT00525512|598930|P2|COMPLETED|Double-Blind Phase||194
248566|NCT00525512|598931|P1|COMPLETED|Double-Blind Phase||163
248567|NCT00525512|598928|P4|STARTED|Double-Blind Phase||0
248568|NCT00525512|598929|P3|STARTED|Double-Blind Phase||0
248569|NCT00525512|598930|P2|STARTED|Double-Blind Phase||260
248570|NCT00525512|598931|P1|STARTED|Double-Blind Phase||259
248571|NCT00525499|599073|P4|NOT COMPLETED|Overall Study||7
248572|NCT00525499|599074|P3|NOT COMPLETED|Overall Study||7
248573|NCT00525499|599075|P2|NOT COMPLETED|Overall Study||7
248574|NCT00525499|599076|P1|NOT COMPLETED|Overall Study||7
248575|NCT00525499|599073|P4|COMPLETED|Overall Study||39
248576|NCT00525499|599074|P3|COMPLETED|Overall Study||40
248577|NCT00525499|599075|P2|COMPLETED|Overall Study||39
248578|NCT00525499|599076|P1|COMPLETED|Overall Study||40
248579|NCT00525499|599073|P4|STARTED|Overall Study||46
248580|NCT00525499|599074|P3|STARTED|Overall Study||47
248581|NCT00525499|599075|P2|STARTED|Overall Study||46
248582|NCT00525499|599076|P1|STARTED|Overall Study||47
248583|NCT00525421|599092|P2|NOT COMPLETED|Overall Study||0
248584|NCT00525421|599093|P1|NOT COMPLETED|Overall Study||0
248585|NCT00525421|599092|P2|COMPLETED|Overall Study||10
248586|NCT00525421|599093|P1|COMPLETED|Overall Study||10
248587|NCT00525421|599092|P2|STARTED|Overall Study||10
248588|NCT00525421|599093|P1|STARTED|Overall Study|Enrollment started october 2007|10
248589|NCT00525265|599103|P2|NOT COMPLETED|Overall Study||0
248590|NCT00525265|599104|P1|NOT COMPLETED|Overall Study||1
248591|NCT00525265|599103|P2|COMPLETED|Overall Study||10
248592|NCT00525265|599104|P1|COMPLETED|Overall Study||9
248593|NCT00525265|599103|P2|STARTED|Overall Study||10
248594|NCT00525265|599104|P1|STARTED|Overall Study||10
248595|NCT00525174|599112|P2|NOT COMPLETED|Overall Study||8
248596|NCT00525174|599113|P1|NOT COMPLETED|Overall Study||9
248597|NCT00525174|599112|P2|COMPLETED|Overall Study||81
248598|NCT00525174|599113|P1|COMPLETED|Overall Study||88
248599|NCT00525174|599112|P2|STARTED|Overall Study||89
248600|NCT00525174|599113|P1|STARTED|Overall Study||97
248601|NCT00525161|599161|P1|NOT COMPLETED|Overall Study||1
248602|NCT00525161|599161|P1|COMPLETED|Overall Study||10
248603|NCT00525161|599161|P1|STARTED|Overall Study||11
248604|NCT00525148|599171|P4|NOT COMPLETED|Overall Study||61
248605|NCT00525148|599172|P3|NOT COMPLETED|Overall Study||7
248606|NCT00525148|599173|P2|NOT COMPLETED|Overall Study||38
248607|NCT00525148|599174|P1|NOT COMPLETED|Overall Study||23
248608|NCT00525148|599171|P4|COMPLETED|Overall Study||0
248609|NCT00525148|599172|P3|COMPLETED|Overall Study||0
248610|NCT00525148|599173|P2|COMPLETED|Overall Study||0
248611|NCT00525148|599174|P1|COMPLETED|Overall Study||0
248612|NCT00525148|599171|P4|STARTED|Overall Study|entered and treated|61
248613|NCT00525148|599172|P3|STARTED|Overall Study|entered and treated|7
248614|NCT00525148|599173|P2|STARTED|Overall Study|entered and treated|38
248615|NCT00525148|599174|P1|STARTED|Overall Study|entered and treated|23
248616|NCT00525135|599192|P1|NOT COMPLETED|Overall Study||0
248617|NCT00525135|599192|P1|COMPLETED|Overall Study||5
248618|NCT00525135|599192|P1|STARTED|Overall Study||5
248619|NCT00525031|599202|P2|NOT COMPLETED|Overall Study||1
248620|NCT00525031|599203|P1|NOT COMPLETED|Overall Study||1
248621|NCT00525031|599202|P2|COMPLETED|Overall Study||24
248622|NCT00525031|599203|P1|COMPLETED|Overall Study||26
248623|NCT00525031|599202|P2|STARTED|Overall Study||25
248624|NCT00525031|599203|P1|STARTED|Overall Study||27
248625|NCT00524940|599210|P1|NOT COMPLETED|Overall Study||0
248626|NCT00524940|599210|P1|COMPLETED|Overall Study||124
248627|NCT00524940|599210|P1|STARTED|Overall Study||124
248628|NCT00524771|599217|P2|NOT COMPLETED|Overall Study||585
248629|NCT00524771|599218|P1|NOT COMPLETED|Overall Study||220
248630|NCT00524771|599217|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
248631|NCT00524771|599218|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
248632|NCT00524771|599217|P2|STARTED|Overall Study||17016
248633|NCT00524771|599218|P1|STARTED|Overall Study||17084
248634|NCT00524745|599232|P4|NOT COMPLETED|Overall Study||22
248635|NCT00524745|599233|P3|NOT COMPLETED|Overall Study||29
248636|NCT00524745|599234|P2|NOT COMPLETED|Overall Study||13
248637|NCT00524745|599235|P1|NOT COMPLETED|Overall Study||34
248638|NCT00524745|599232|P4|COMPLETED|Overall Study||205
248639|NCT00524745|599233|P3|COMPLETED|Overall Study||212
248640|NCT00524745|599234|P2|COMPLETED|Overall Study||193
248641|NCT00524745|599235|P1|COMPLETED|Overall Study||195
248642|NCT00524745|599232|P4|STARTED|Overall Study||227
248643|NCT00524745|599233|P3|STARTED|Overall Study||241
248644|NCT00524745|599234|P2|STARTED|Overall Study||206
248645|NCT00524745|599235|P1|STARTED|Overall Study||229
248646|NCT00524680|599261|P4|NOT COMPLETED|Overall Study||6
248647|NCT00524680|599262|P3|NOT COMPLETED|Overall Study||3
248648|NCT00524680|599263|P2|NOT COMPLETED|Overall Study||1
248649|NCT00524680|599264|P1|NOT COMPLETED|Overall Study||3
248650|NCT00524680|599261|P4|COMPLETED|Overall Study||34
248651|NCT00524680|599262|P3|COMPLETED|Overall Study||33
248652|NCT00524680|599263|P2|COMPLETED|Overall Study||34
248653|NCT00524680|599264|P1|COMPLETED|Overall Study||34
248654|NCT00524680|599261|P4|STARTED|Overall Study||40
248655|NCT00524680|599262|P3|STARTED|Overall Study||36
248656|NCT00524680|599263|P2|STARTED|Overall Study||35
248657|NCT00524680|599264|P1|STARTED|Overall Study||37
248658|NCT00524589|599286|P1|NOT COMPLETED|Overall Study||18
248659|NCT00524589|599286|P1|COMPLETED|Overall Study||0
248660|NCT00524589|599286|P1|STARTED|Overall Study||18
248661|NCT00524576|599293|P2|NOT COMPLETED|Overall Study||0
248662|NCT00524576|599294|P1|NOT COMPLETED|Overall Study||0
248663|NCT00524576|599293|P2|COMPLETED|Overall Study||47
248664|NCT00524576|599294|P1|COMPLETED|Overall Study||97
248665|NCT00524576|599293|P2|STARTED|Overall Study||47
248666|NCT00524576|599294|P1|STARTED|Overall Study||97
248667|NCT00524537|599312|P1|NOT COMPLETED|Overall Study||2574
248668|NCT00524537|599312|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
248669|NCT00524537|599312|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
248670|NCT00524537|599312|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
248671|NCT00524537|599312|P1|Discontinued|Overall Study|Discontinued from study|2811
248672|NCT00524537|599312|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
248673|NCT00524511|599328|P2|NOT COMPLETED|Overall Study||7
248674|NCT00524511|599329|P1|NOT COMPLETED|Overall Study||4
248675|NCT00524511|599328|P2|COMPLETED|Overall Study||61
248676|NCT00524511|599329|P1|COMPLETED|Overall Study||64
248677|NCT00524511|599328|P2|STARTED|Overall Study||68
248678|NCT00524511|599329|P1|STARTED|Overall Study||68
248679|NCT00524485|599337|P1|NOT COMPLETED|Overall Study||5
248680|NCT00524485|599337|P1|COMPLETED|Overall Study||7
248681|NCT00524485|599337|P1|STARTED|Overall Study||12
248682|NCT00524459|599347|P1|NOT COMPLETED|Overall Study||2
248683|NCT00524459|599347|P1|COMPLETED|Overall Study||4
248684|NCT00524459|599347|P1|STARTED|Overall Study||6
248685|NCT00524420|599357|P2|NOT COMPLETED|Overall Study||0
248686|NCT00524420|599358|P1|NOT COMPLETED|Overall Study||1
248687|NCT00524420|599357|P2|COMPLETED|Overall Study||11
248688|NCT00524420|599358|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
248689|NCT00524420|599357|P2|STARTED|Overall Study||11
248690|NCT00524420|599358|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
248691|NCT00524394|599370|P1|NOT COMPLETED|Overall Study||1
248692|NCT00524394|599370|P1|COMPLETED|Overall Study||1
248693|NCT00524394|599370|P1|STARTED|Overall Study||2
248694|NCT00524368|599376|P2|NOT COMPLETED|Overall Study||48
248695|NCT00524368|599377|P1|NOT COMPLETED|Overall Study||41
248696|NCT00524368|599376|P2|COMPLETED|Overall Study||248
248697|NCT00524368|599377|P1|COMPLETED|Overall Study||253
248698|NCT00524368|599376|P2|STARTED|Overall Study||296
248699|NCT00524368|599377|P1|STARTED|Overall Study||294
248700|NCT00524342|599405|P1|NOT COMPLETED|Overall Study||0
248701|NCT00524342|599405|P1|COMPLETED|Overall Study||7
248702|NCT00524342|599405|P1|STARTED|Overall Study||7
248703|NCT00524316|599411|P1|NOT COMPLETED|Overall Study||16
248704|NCT00524316|599411|P1|COMPLETED|Overall Study||0
248705|NCT00524316|599411|P1|STARTED|Overall Study||16
248706|NCT00524303|599423|P3|NOT COMPLETED|Overall Study||18
248707|NCT00524303|599424|P2|NOT COMPLETED|Overall Study||10
248708|NCT00524303|599425|P1|NOT COMPLETED|Overall Study||12
248709|NCT00524303|599423|P3|COMPLETED|Overall Study||15
248710|NCT00524303|599424|P2|COMPLETED|Overall Study||24
248711|NCT00524303|599425|P1|COMPLETED|Overall Study||21
248712|NCT00524303|599423|P3|STARTED|Overall Study||33
248713|NCT00524303|599424|P2|STARTED|Overall Study||34
248714|NCT00524303|599425|P1|STARTED|Overall Study||33
248715|NCT00524264|599455|P2|NOT COMPLETED|Overall Study||27
248716|NCT00524264|599456|P1|NOT COMPLETED|Overall Study||20
248717|NCT00524264|599455|P2|COMPLETED|Overall Study||57
248718|NCT00524264|599456|P1|COMPLETED|Overall Study||144
248719|NCT00524264|599455|P2|STARTED|Overall Study||84
248720|NCT00524264|599456|P1|STARTED|Overall Study||164
248721|NCT00524225|599468|P1|NOT COMPLETED|Overall Study||0
248722|NCT00524225|599468|P1|COMPLETED|Overall Study||3
248723|NCT00524225|599468|P1|STARTED|Overall Study||3
248724|NCT00524173|599477|P2|NOT COMPLETED|Overall Study||2
248725|NCT00524173|599478|P1|NOT COMPLETED|Overall Study||5
248726|NCT00524173|599477|P2|COMPLETED|Overall Study||13
248727|NCT00524173|599478|P1|COMPLETED|Overall Study||12
248728|NCT00524173|599477|P2|STARTED|Overall Study||15
248729|NCT00524173|599478|P1|STARTED|Overall Study||17
248730|NCT00524134|599490|P1|NOT COMPLETED|Overall Study||2
248731|NCT00524134|599490|P1|COMPLETED|Overall Study||4
248732|NCT00524134|599490|P1|STARTED|Overall Study||6
248733|NCT00524121|599497|P1|NOT COMPLETED|Overall Study||19
248734|NCT00524121|599497|P1|COMPLETED|Overall Study||3
248735|NCT00524121|599497|P1|STARTED|Overall Study||22
248736|NCT00524043|599517|P3|NOT COMPLETED|Overall Study||31
248737|NCT00524043|599518|P2|NOT COMPLETED|Overall Study||28
248738|NCT00524043|599519|P1|NOT COMPLETED|Overall Study||30
248739|NCT00524043|599517|P3|COMPLETED|Overall Study||35
248740|NCT00524043|599518|P2|COMPLETED|Overall Study||42
248741|NCT00524043|599519|P1|COMPLETED|Overall Study||34
248742|NCT00524043|599517|P3|STARTED|Overall Study||66
248743|NCT00524043|599518|P2|STARTED|Overall Study||70
248744|NCT00524043|599519|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
248745|NCT00524030|599541|P2|NOT COMPLETED|Overall Study||59
248746|NCT00524030|599542|P1|NOT COMPLETED|Overall Study||17
248747|NCT00524030|599541|P2|COMPLETED|Overall Study||70
248748|NCT00524030|599542|P1|COMPLETED|Overall Study||15
248749|NCT00524030|599541|P2|Completed Taper/Titration Phase|Overall Study||70
248750|NCT00524030|599542|P1|Completed Taper/Titration Phase|Overall Study||15
248751|NCT00524030|599541|P2|Completed Double-Blind Treatment Phase|Overall Study||70
248752|NCT00524030|599542|P1|Completed Double-Blind Treatment Phase|Overall Study||15
248753|NCT00524030|599541|P2|STARTED|Overall Study||129
248754|NCT00524030|599542|P1|STARTED|Overall Study||32
248755|NCT00523991|599560|P2|NOT COMPLETED|Overall Study||27
248756|NCT00523991|599561|P1|NOT COMPLETED|Overall Study||21
248757|NCT00523991|599560|P2|COMPLETED|Overall Study||211
248758|NCT00523991|599561|P1|COMPLETED|Overall Study||198
248759|NCT00523991|599560|P2|STARTED|Overall Study||238
248760|NCT00523991|599561|P1|STARTED|Overall Study||219
248761|NCT00523978|599841|P2|NOT COMPLETED|Overall Study||8
248762|NCT00523978|599842|P1|NOT COMPLETED|Overall Study||9
248763|NCT00523978|599841|P2|COMPLETED|Overall Study||79
248764|NCT00523978|599842|P1|COMPLETED|Overall Study||162
248765|NCT00523978|599841|P2|STARTED|Overall Study||87
248766|NCT00523978|599842|P1|STARTED|Overall Study||171
248767|NCT00523939|599856|P2|NOT COMPLETED|Overall Study||0
248768|NCT00523939|599857|P1|NOT COMPLETED|Overall Study||0
248769|NCT00523939|599856|P2|COMPLETED|Overall Study||2
248770|NCT00523939|599857|P1|COMPLETED|Overall Study||2
248771|NCT00523939|599856|P2|STARTED|Overall Study||2
248772|NCT00523939|599857|P1|STARTED|Overall Study||2
248773|NCT00523848|599864|P1|NOT COMPLETED|Overall Study||24
248774|NCT00523848|599864|P1|COMPLETED|Overall Study||22
248775|NCT00523848|599864|P1|Treated With Study Therapy|Overall Study||44
248776|NCT00523848|599864|P1|STARTED|Overall Study||46
248777|NCT00523809|599870|P1|NOT COMPLETED|Overall Study||0
248778|NCT00523809|599870|P1|COMPLETED|Overall Study||5
248779|NCT00523809|599870|P1|STARTED|Overall Study||5
248780|NCT00523744|599874|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
248781|NCT00523744|599874|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
248782|NCT00523744|599874|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
248783|NCT00523744|599874|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
248784|NCT00523744|599874|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
248785|NCT00523744|599874|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
248786|NCT00523744|599874|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
248787|NCT00523744|599874|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
248788|NCT00523744|599874|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
248789|NCT00523718|599893|P2|NOT COMPLETED|Overall Study||0
248790|NCT00523718|599894|P1|NOT COMPLETED|Overall Study||3
248791|NCT00523718|599893|P2|COMPLETED|Overall Study||18
248792|NCT00523718|599894|P1|COMPLETED|Overall Study||17
248793|NCT00523718|599893|P2|STARTED|Overall Study||18
248794|NCT00523718|599894|P1|STARTED|Overall Study||20
248795|NCT00523705|599908|P2|NOT COMPLETED|Overall Study||1
248796|NCT00523705|599909|P1|NOT COMPLETED|Overall Study||0
248797|NCT00523705|599908|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
248798|NCT00523705|599909|P1|COMPLETED|Overall Study||7
248799|NCT00523705|599908|P2|STARTED|Overall Study||4
248800|NCT00523705|599909|P1|STARTED|Overall Study||7
248801|NCT00523640|599921|P1|NOT COMPLETED|Overall Study||1
248802|NCT00523640|599921|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
248803|NCT00523640|599921|P1|STARTED|Overall Study||30
248804|NCT00523614|599929|P2|NOT COMPLETED|Overall Study||0
248805|NCT00523614|599930|P1|NOT COMPLETED|Overall Study||0
248806|NCT00523614|599929|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
248807|NCT00523614|599930|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
248808|NCT00523614|599929|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
248809|NCT00523614|599930|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
248810|NCT00523549|599938|P2|NOT COMPLETED|Overall Study||16
248811|NCT00523549|599939|P1|NOT COMPLETED|Overall Study||19
248812|NCT00523549|599938|P2|COMPLETED|Overall Study||99
248813|NCT00523549|599939|P1|COMPLETED|Overall Study||95
248814|NCT00523549|599938|P2|STARTED|Overall Study||115
248815|NCT00523549|599939|P1|STARTED|Overall Study||114
248816|NCT00523419|599957|P1|NOT COMPLETED|Overall Study||32
248817|NCT00523419|599957|P1|COMPLETED|Overall Study||0
248818|NCT00523419|599957|P1|STARTED|Overall Study||32
248819|NCT00523367|599967|P1|NOT COMPLETED|Overall Study||23
248820|NCT00523367|599967|P1|COMPLETED|Overall Study||2
248821|NCT00523367|599967|P1|STARTED|Overall Study||25
248822|NCT00523341|599973|P2|NOT COMPLETED|Overall Study||1000
248823|NCT00523341|599974|P1|NOT COMPLETED|Overall Study||924
248824|NCT00523341|599973|P2|COMPLETED|Overall Study||1343
248825|NCT00523341|599974|P1|COMPLETED|Overall Study||1283
248826|NCT00523341|599973|P2|Received Treatment|Overall Study||2343
248827|NCT00523341|599974|P1|Received Treatment|Overall Study||2206
248828|NCT00523341|599973|P2|STARTED|Overall Study||2343
248829|NCT00523341|599974|P1|STARTED|Overall Study||2207
248830|NCT00523237|600074|P1|NOT COMPLETED|Overall Study||0
248831|NCT00523237|600074|P1|COMPLETED|Overall Study||14
248832|NCT00523237|600074|P1|STARTED|Overall Study||14
248833|NCT00522951|600078|P2|NOT COMPLETED|Period 2||1
248834|NCT00522951|600079|P1|NOT COMPLETED|Period 2||2
248835|NCT00522951|600078|P2|COMPLETED|Period 2||75
248836|NCT00522951|600079|P1|COMPLETED|Period 2||84
248837|NCT00522951|600078|P2|Subjects Received Treatment|Period 2||75
248838|NCT00522951|600079|P1|Subjects Received Treatment|Period 2||84
248839|NCT00522951|600078|P2|STARTED|Period 2||76
248840|NCT00522951|600079|P1|STARTED|Period 2||86
248841|NCT00522951|600078|P2|NOT COMPLETED|Washout Period||2
248842|NCT00522951|600079|P1|NOT COMPLETED|Washout Period||0
248843|NCT00522951|600078|P2|COMPLETED|Washout Period||76
248844|NCT00522951|600079|P1|COMPLETED|Washout Period||86
248845|NCT00522951|600078|P2|STARTED|Washout Period||78
248846|NCT00522951|600079|P1|STARTED|Washout Period||86
248847|NCT00522951|600078|P2|NOT COMPLETED|Period 1||1
248848|NCT00522951|600079|P1|NOT COMPLETED|Period 1||0
248849|NCT00522951|600078|P2|COMPLETED|Period 1||78
248850|NCT00522951|600079|P1|COMPLETED|Period 1||86
248851|NCT00522951|600078|P2|Received Treatment|Period 1||78
248852|NCT00522951|600079|P1|Received Treatment|Period 1||86
248853|NCT00522951|600078|P2|STARTED|Period 1||79
248854|NCT00522951|600079|P1|STARTED|Period 1||86
248855|NCT00522925|600122|P3|NOT COMPLETED|Overall Study||2
248856|NCT00522925|600123|P2|NOT COMPLETED|Overall Study||1
248857|NCT00522925|600124|P1|NOT COMPLETED|Overall Study||8
248858|NCT00522925|600122|P3|COMPLETED|Overall Study||36
248859|NCT00522925|600123|P2|COMPLETED|Overall Study||38
248860|NCT00522925|600124|P1|COMPLETED|Overall Study||28
248861|NCT00522925|600122|P3|STARTED|Overall Study||38
248862|NCT00522925|600123|P2|STARTED|Overall Study||39
248863|NCT00522925|600124|P1|STARTED|Overall Study||36
248864|NCT00522873|600134|P2|NOT COMPLETED|Overall Study||44
248865|NCT00522873|600135|P1|NOT COMPLETED|Overall Study||96
248866|NCT00522873|600134|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
248867|NCT00522873|600135|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
248868|NCT00522873|600134|P2|Received Treatment|Overall Study||172
248869|NCT00522873|600135|P1|Received Treatment|Overall Study||489
248870|NCT00522873|600134|P2|STARTED|Overall Study||172
248871|NCT00522873|600135|P1|STARTED|Overall Study||490
248872|NCT00522795|600144|P1|NOT COMPLETED|Overall Study||0
248873|NCT00522795|600144|P1|COMPLETED|Overall Study||40
248874|NCT00522795|600144|P1|STARTED|Overall Study||40
248875|NCT00522626|600148|P1|NOT COMPLETED|Overall Study||7
248876|NCT00522626|600148|P1|COMPLETED|Overall Study||12
248877|NCT00522626|600148|P1|STARTED|Overall Study||19
248878|NCT00522548|600154|P2|NOT COMPLETED|Overall Study||4
248879|NCT00522548|600155|P1|NOT COMPLETED|Overall Study||2
248880|NCT00522548|600154|P2|COMPLETED|Overall Study||15
248881|NCT00522548|600155|P1|COMPLETED|Overall Study||16
248882|NCT00522548|600154|P2|Completed 2/2 PK Visits|Overall Study||5
248883|NCT00522548|600155|P1|Completed 2/2 PK Visits|Overall Study||7
248884|NCT00522548|600154|P2|Completed 1/2 PK Visits|Overall Study||1
248885|NCT00522548|600155|P1|Completed 1/2 PK Visits|Overall Study||1
248886|NCT00522548|600154|P2|Completed 0/2 PK Visits|Overall Study||4
248887|NCT00522548|600155|P1|Completed 0/2 PK Visits|Overall Study||3
248888|NCT00522548|600154|P2|Consented to Pharmacokinetic Study|Overall Study||10
248889|NCT00522548|600155|P1|Consented to Pharmacokinetic Study|Overall Study||11
248890|NCT00522548|600154|P2|STARTED|Overall Study||19
248891|NCT00522548|600155|P1|STARTED|Overall Study||18
248892|NCT00522457|600183|P1|NOT COMPLETED|Overall Study||18
248893|NCT00522457|600183|P1|COMPLETED|Overall Study||1
248894|NCT00522457|600183|P1|STARTED|Overall Study||19
248895|NCT00522431|600189|P1|NOT COMPLETED|Overall Study||11
248896|NCT00522431|600189|P1|COMPLETED|Overall Study||138
248897|NCT00522431|600189|P1|STARTED|Overall Study||149
248898|NCT00522418|600196|P2|NOT COMPLETED|Overall Study||58
248899|NCT00522418|600197|P1|NOT COMPLETED|Overall Study||57
248900|NCT00522418|600196|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
248901|NCT00522418|600197|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
248902|NCT00522418|600196|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
248903|NCT00522418|600197|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
248904|NCT00522418|600196|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
248905|NCT00522418|600197|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
248992|NCT00521599|600455|P2|NOT COMPLETED|Overall Study||29
248906|NCT00522418|600196|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
248907|NCT00522418|600197|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
248908|NCT00522418|600196|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
248909|NCT00522418|600197|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
248910|NCT00522418|600196|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
248911|NCT00522418|600197|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
248912|NCT00522418|600196|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
248913|NCT00522418|600197|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
248914|NCT00522418|600196|P2|STARTED|Overall Study||63
248915|NCT00522418|600197|P1|STARTED|Overall Study||59
248916|NCT00522392|600245|P2|NOT COMPLETED|Overall Study||13
248917|NCT00522392|600246|P1|NOT COMPLETED|Overall Study||8
248918|NCT00522392|600245|P2|COMPLETED|Overall Study||12
248919|NCT00522392|600246|P1|COMPLETED|Overall Study||15
248920|NCT00522392|600245|P2|Pts w/ QOL Assessments Complete|Overall Study||8
248921|NCT00522392|600246|P1|Pts w/ QOL Assessments Complete|Overall Study||12
248922|NCT00522392|600245|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
248923|NCT00522392|600246|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
248924|NCT00522392|600245|P2|STARTED|Overall Study||25
248925|NCT00522392|600246|P1|STARTED|Overall Study||23
248926|NCT00522379|600263|P5|NOT COMPLETED|Overall Study||27
248927|NCT00522379|600264|P4|NOT COMPLETED|Overall Study||14
248928|NCT00522379|600265|P3|NOT COMPLETED|Overall Study||22
248929|NCT00522379|600266|P2|NOT COMPLETED|Overall Study||23
248930|NCT00522379|600267|P1|NOT COMPLETED|Overall Study||22
248931|NCT00522379|600263|P5|COMPLETED|Overall Study||81
248932|NCT00522379|600264|P4|COMPLETED|Overall Study||80
248933|NCT00522379|600265|P3|COMPLETED|Overall Study||82
248934|NCT00522379|600266|P2|COMPLETED|Overall Study||84
248935|NCT00522379|600267|P1|COMPLETED|Overall Study||79
248936|NCT00522379|600263|P5|STARTED|Overall Study||108
248937|NCT00522379|600264|P4|STARTED|Overall Study||94
248938|NCT00522379|600265|P3|STARTED|Overall Study||104
248939|NCT00522379|600266|P2|STARTED|Overall Study||107
248940|NCT00522379|600267|P1|STARTED|Overall Study||101
248941|NCT00522301|600369|P1|NOT COMPLETED|Overall Study||6
248942|NCT00522301|600369|P1|COMPLETED|Overall Study||0
248943|NCT00522301|600369|P1|STARTED|Overall Study||6
248944|NCT00522275|600373|P1|NOT COMPLETED|Overall Study||170
248945|NCT00522275|600373|P1|COMPLETED|Overall Study||138
248946|NCT00522275|600373|P1|STARTED|Overall Study||308
248947|NCT00522171|600383|P2|NOT COMPLETED|Overall Study||0
248948|NCT00522171|600384|P1|NOT COMPLETED|Overall Study||0
248949|NCT00522171|600383|P2|COMPLETED|Overall Study||15
248950|NCT00522171|600384|P1|COMPLETED|Overall Study||15
248951|NCT00522171|600383|P2|STARTED|Overall Study||15
248952|NCT00522171|600384|P1|STARTED|Overall Study||15
248953|NCT00522041|600394|P2|NOT COMPLETED|Overall Study||12
248954|NCT00522041|600395|P1|NOT COMPLETED|Overall Study||17
248955|NCT00522041|600394|P2|COMPLETED|Overall Study||113
248956|NCT00522041|600395|P1|COMPLETED|Overall Study||106
248957|NCT00522041|600394|P2|Received Treatment|Overall Study||124
248958|NCT00522041|600395|P1|Received Treatment|Overall Study||123
248959|NCT00522041|600394|P2|STARTED|Overall Study||125
248960|NCT00522041|600395|P1|STARTED|Overall Study||123
248961|NCT00521989|600410|P5|NOT COMPLETED|Overall Study||23
248962|NCT00521989|600411|P4|NOT COMPLETED|Overall Study||12
248963|NCT00521989|600412|P3|NOT COMPLETED|Overall Study||16
248964|NCT00521989|600413|P2|NOT COMPLETED|Overall Study||17
248965|NCT00521989|600414|P1|NOT COMPLETED|Overall Study||20
248966|NCT00521989|600410|P5|COMPLETED|Overall Study||35
248967|NCT00521989|600411|P4|COMPLETED|Overall Study||42
248968|NCT00521989|600412|P3|COMPLETED|Overall Study||41
248969|NCT00521989|600413|P2|COMPLETED|Overall Study||37
248970|NCT00521989|600414|P1|COMPLETED|Overall Study||36
248971|NCT00521989|600410|P5|STARTED|Overall Study||58
248972|NCT00521989|600411|P4|STARTED|Overall Study||54
248973|NCT00521989|600412|P3|STARTED|Overall Study||57
248974|NCT00521989|600413|P2|STARTED|Overall Study||54
248975|NCT00521989|600414|P1|STARTED|Overall Study||56
248976|NCT00521976|600426|P1|NOT COMPLETED|Overall Study||0
248977|NCT00521976|600426|P1|COMPLETED|Overall Study||871
248978|NCT00521976|600426|P1|STARTED|Overall Study||871
248979|NCT00521924|600433|P2|NOT COMPLETED|Overall Study||4
248980|NCT00521924|600434|P1|NOT COMPLETED|Overall Study||4
248981|NCT00521924|600433|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
248982|NCT00521924|600434|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
248983|NCT00521924|600433|P2|STARTED|Overall Study|Subjects randomized|4
248984|NCT00521924|600434|P1|STARTED|Overall Study|Subjects randomized|4
248985|NCT00521885|600442|P2|NOT COMPLETED|Overall Study||0
248986|NCT00521885|600443|P1|NOT COMPLETED|Overall Study||0
248987|NCT00521885|600442|P2|COMPLETED|Overall Study||0
248988|NCT00521885|600443|P1|COMPLETED|Overall Study||0
248989|NCT00521885|600442|P2|STARTED|Overall Study||0
248990|NCT00521885|600443|P1|STARTED|Overall Study||0
248991|NCT00521599|600454|P3|NOT COMPLETED|Overall Study||36
248993|NCT00521599|600456|P1|NOT COMPLETED|Overall Study||25
248994|NCT00521599|600454|P3|COMPLETED|Overall Study||100
248995|NCT00521599|600455|P2|COMPLETED|Overall Study||239
248996|NCT00521599|600456|P1|COMPLETED|Overall Study||243
248997|NCT00521599|600454|P3|STARTED|Overall Study||136
248998|NCT00521599|600455|P2|STARTED|Overall Study||268
248999|NCT00521599|600456|P1|STARTED|Overall Study||268
249000|NCT00521586|600467|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
249001|NCT00521586|600468|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
249002|NCT00521586|600467|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
249003|NCT00521586|600468|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
249004|NCT00521586|600467|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
249005|NCT00521586|600468|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
249006|NCT00521586|600467|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
249007|NCT00521586|600468|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
249008|NCT00521586|600467|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
249009|NCT00521586|600468|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
249010|NCT00521586|600467|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
249011|NCT00521586|600468|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
249012|NCT00521586|600467|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
249013|NCT00521586|600468|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
249014|NCT00521586|600467|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
249015|NCT00521586|600468|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
249016|NCT00521586|600467|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
249017|NCT00521586|600468|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
249018|NCT00521586|600467|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
249019|NCT00521586|600468|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
249020|NCT00521586|600467|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
249021|NCT00521586|600468|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
249022|NCT00521586|600467|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
249023|NCT00521586|600468|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
249024|NCT00521586|600467|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
249025|NCT00521586|600468|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
249026|NCT00521586|600467|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
249027|NCT00521586|600468|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
249028|NCT00521586|600467|P2|STARTED|Initial Vaccination (Year 0)||562
249029|NCT00521586|600468|P1|STARTED|Initial Vaccination (Year 0)||554
249030|NCT00521456|600528|P2|NOT COMPLETED|Overall Study||28
249031|NCT00521456|600529|P1|NOT COMPLETED|Overall Study||13
249032|NCT00521456|600528|P2|COMPLETED|Overall Study||59
249033|NCT00521456|600529|P1|COMPLETED|Overall Study||163
249034|NCT00521456|600528|P2|STARTED|Overall Study||87
249035|NCT00521456|600529|P1|STARTED|Overall Study||176
249036|NCT00521365|600541|P1|NOT COMPLETED|Overall Study||20
249037|NCT00521365|600541|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
249038|NCT00521365|600541|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
249039|NCT00521365|600541|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
249040|NCT00521365|600541|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
249041|NCT00521365|600541|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
249042|NCT00521352|600560|P2|NOT COMPLETED|Overall Study||3
249043|NCT00521352|600561|P1|NOT COMPLETED|Overall Study||1
249044|NCT00521352|600560|P2|COMPLETED|Overall Study||10
249045|NCT00521352|600561|P1|COMPLETED|Overall Study||11
249046|NCT00521352|600560|P2|STARTED|Overall Study||13
249047|NCT00521352|600561|P1|STARTED|Overall Study||12
249048|NCT00521339|600571|P3|NOT COMPLETED|Observational Follow Up Phase||0
249049|NCT00521339|600572|P2|NOT COMPLETED|Observational Follow Up Phase||0
249050|NCT00521339|600573|P1|NOT COMPLETED|Observational Follow Up Phase||0
249051|NCT00521339|600571|P3|COMPLETED|Observational Follow Up Phase||4
249052|NCT00521339|600572|P2|COMPLETED|Observational Follow Up Phase||4
249053|NCT00521339|600573|P1|COMPLETED|Observational Follow Up Phase||14
249054|NCT00521339|600571|P3|STARTED|Observational Follow Up Phase||4
249055|NCT00521339|600572|P2|STARTED|Observational Follow Up Phase||4
249056|NCT00521339|600573|P1|STARTED|Observational Follow Up Phase||14
249057|NCT00521339|600571|P3|NOT COMPLETED|Treatment Extension Phase||3
249058|NCT00521339|600572|P2|NOT COMPLETED|Treatment Extension Phase||0
249059|NCT00521339|600573|P1|NOT COMPLETED|Treatment Extension Phase||0
249060|NCT00521339|600571|P3|COMPLETED|Treatment Extension Phase||4
249061|NCT00521339|600572|P2|COMPLETED|Treatment Extension Phase||4
249062|NCT00521339|600573|P1|COMPLETED|Treatment Extension Phase||0
249063|NCT00521339|600571|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
249064|NCT00521339|600572|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
249065|NCT00521339|600573|P1|STARTED|Treatment Extension Phase||0
249066|NCT00521339|600571|P3|NOT COMPLETED|Treatment Phase||0
249067|NCT00521339|600572|P2|NOT COMPLETED|Treatment Phase||0
249068|NCT00521339|600573|P1|NOT COMPLETED|Treatment Phase||12
249069|NCT00521339|600571|P3|COMPLETED|Treatment Phase||0
249070|NCT00521339|600572|P2|COMPLETED|Treatment Phase||0
249071|NCT00521339|600573|P1|COMPLETED|Treatment Phase||19
249072|NCT00521339|600571|P3|Received Apremilast|Treatment Phase||0
249073|NCT00521339|600572|P2|Received Apremilast|Treatment Phase||0
249074|NCT00521339|600573|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
249075|NCT00521339|600571|P3|STARTED|Treatment Phase||0
249076|NCT00521339|600572|P2|STARTED|Treatment Phase||0
249077|NCT00521339|600573|P1|STARTED|Treatment Phase||31
249078|NCT00521144|600641|P5|NOT COMPLETED|Overall Study||7
249079|NCT00521144|600642|P4|NOT COMPLETED|Overall Study||1
249080|NCT00521144|600643|P3|NOT COMPLETED|Overall Study||2
249081|NCT00521144|600644|P2|NOT COMPLETED|Overall Study||3
249082|NCT00521144|600645|P1|NOT COMPLETED|Overall Study||4
249083|NCT00521144|600641|P5|COMPLETED|Overall Study||0
249084|NCT00521144|600642|P4|COMPLETED|Overall Study||0
249085|NCT00521144|600643|P3|COMPLETED|Overall Study||1
249086|NCT00521144|600644|P2|COMPLETED|Overall Study||2
249087|NCT00521144|600645|P1|COMPLETED|Overall Study||2
249088|NCT00521144|600641|P5|STARTED|Overall Study||7
249089|NCT00521144|600642|P4|STARTED|Overall Study||1
249090|NCT00521144|600643|P3|STARTED|Overall Study||3
249091|NCT00521144|600644|P2|STARTED|Overall Study||5
249092|NCT00521144|600645|P1|STARTED|Overall Study||6
249093|NCT00521079|600659|P2|NOT COMPLETED|Overall Study||5
249094|NCT00521079|600660|P1|NOT COMPLETED|Overall Study||14
249095|NCT00521079|600659|P2|COMPLETED|Overall Study||97
249096|NCT00521079|600660|P1|COMPLETED|Overall Study||178
249097|NCT00521079|600659|P2|Surgical Roll-In|Overall Study||5
249098|NCT00521079|600660|P1|Surgical Roll-In|Overall Study||9
249099|NCT00521079|600659|P2|STARTED|Overall Study||102
249100|NCT00521079|600660|P1|STARTED|Overall Study||192
249101|NCT00521053|600670|P1|NOT COMPLETED|Observation Phase||68
249102|NCT00521053|600670|P1|COMPLETED|Observation Phase||12
249103|NCT00521053|600670|P1|STARTED|Observation Phase||80
249104|NCT00521053|600670|P1|NOT COMPLETED|Treatment Phase||0
249105|NCT00521053|600670|P1|COMPLETED|Treatment Phase||80
249106|NCT00521053|600670|P1|Received 4 Cycles of PV-10|Treatment Phase||3
249107|NCT00521053|600670|P1|Received 3 Cycles of PV-10|Treatment Phase||16
249108|NCT00521053|600670|P1|Received 2 Cycles of PV-10|Treatment Phase||26
249109|NCT00521053|600670|P1|Received 1 Cycle of PV-10|Treatment Phase||35
249110|NCT00521053|600670|P1|STARTED|Treatment Phase||80
249111|NCT00521014|600680|P1|NOT COMPLETED|Overall Study||1
249112|NCT00521014|600680|P1|COMPLETED|Overall Study||13
249113|NCT00521014|600680|P1|STARTED|Overall Study||14
249114|NCT00521001|600684|P1|NOT COMPLETED|Overall Study||1
249115|NCT00521001|600684|P1|COMPLETED|Overall Study||48
249116|NCT00521001|600684|P1|STARTED|Overall Study||49
249117|NCT00520975|600693|P2|NOT COMPLETED|Overall Study||48
249118|NCT00520975|600694|P1|NOT COMPLETED|Overall Study||48
249119|NCT00520975|600693|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
249120|NCT00520975|600694|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
249121|NCT00520975|600693|P2|Treated and Reported Adverse Events Data|Overall Study||45
249122|NCT00520975|600694|P1|Treated and Reported Adverse Events Data|Overall Study||47
249123|NCT00520975|600693|P2|STARTED|Overall Study||48
249124|NCT00520975|600694|P1|STARTED|Overall Study||48
249125|NCT00520936|600726|P8|NOT COMPLETED|Overall Study||1
249126|NCT00520936|600727|P7|NOT COMPLETED|Overall Study||4
249127|NCT00520936|600728|P6|NOT COMPLETED|Overall Study||0
249128|NCT00520936|600729|P5|NOT COMPLETED|Overall Study||1
249129|NCT00520936|600730|P4|NOT COMPLETED|Overall Study||0
249130|NCT00520936|600731|P3|NOT COMPLETED|Overall Study||2
249131|NCT00520936|600732|P2|NOT COMPLETED|Overall Study||4
249132|NCT00520936|600733|P1|NOT COMPLETED|Overall Study||0
249133|NCT00520936|600726|P8|COMPLETED|Overall Study||9
249134|NCT00520936|600727|P7|COMPLETED|Overall Study||7
249135|NCT00520936|600728|P6|COMPLETED|Overall Study||10
249136|NCT00520936|600729|P5|COMPLETED|Overall Study||5
249137|NCT00520936|600730|P4|COMPLETED|Overall Study||5
249138|NCT00520936|600731|P3|COMPLETED|Overall Study||7
249139|NCT00520936|600732|P2|COMPLETED|Overall Study||7
249140|NCT00520936|600733|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
249141|NCT00520936|600726|P8|STARTED|Overall Study||10
249142|NCT00520936|600727|P7|STARTED|Overall Study||11
249143|NCT00520936|600728|P6|STARTED|Overall Study||10
249144|NCT00520936|600729|P5|STARTED|Overall Study||6
249145|NCT00520936|600730|P4|STARTED|Overall Study||5
249146|NCT00520936|600731|P3|STARTED|Overall Study||9
249147|NCT00520936|600732|P2|STARTED|Overall Study||11
249148|NCT00520936|600733|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
249149|NCT00520845|600760|P1|NOT COMPLETED|Overall Study||22
249150|NCT00520845|600760|P1|COMPLETED|Overall Study||1
249151|NCT00520845|600760|P1|STARTED|Overall Study||23
249152|NCT00520767|600768|P1|NOT COMPLETED|Overall Study||2
249153|NCT00520767|600768|P1|COMPLETED|Overall Study||33
249154|NCT00520767|600768|P1|STARTED|Overall Study||35
249155|NCT00520741|600774|P2|NOT COMPLETED|Overall Study||125
249156|NCT00520741|600775|P1|NOT COMPLETED|Overall Study||37
249157|NCT00520741|600774|P2|COMPLETED|Overall Study||194
249158|NCT00520741|600775|P1|COMPLETED|Overall Study||69
249159|NCT00520741|600774|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
249160|NCT00520741|600775|P1|STARTED|Overall Study||106
249161|NCT00520676|600793|P2|NOT COMPLETED|Overall Study||103
249162|NCT00520676|600794|P1|NOT COMPLETED|Overall Study||101
249163|NCT00520676|600793|P2|COMPLETED|Overall Study||29
249164|NCT00520676|600794|P1|COMPLETED|Overall Study||27
249165|NCT00520676|600793|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
249166|NCT00520676|600794|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
249167|NCT00520676|600793|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
249168|NCT00520676|600794|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
249169|NCT00520676|600793|P2|STARTED|Overall Study||132
249170|NCT00520676|600794|P1|STARTED|Overall Study||128
249171|NCT00520572|600820|P6|NOT COMPLETED|Overall Study||2
249172|NCT00520572|600821|P5|NOT COMPLETED|Overall Study||12
249173|NCT00520572|600822|P4|NOT COMPLETED|Overall Study||14
249174|NCT00520572|600823|P3|NOT COMPLETED|Overall Study||15
249175|NCT00520572|600824|P2|NOT COMPLETED|Overall Study||14
249176|NCT00520572|600825|P1|NOT COMPLETED|Overall Study||12
249177|NCT00520572|600820|P6|COMPLETED|Overall Study|Participants completed the study.|62
249178|NCT00520572|600821|P5|COMPLETED|Overall Study|Participants completed the study.|53
249179|NCT00520572|600822|P4|COMPLETED|Overall Study|Participants completed the study.|50
249180|NCT00520572|600823|P3|COMPLETED|Overall Study|Participants completed the study.|49
249181|NCT00520572|600824|P2|COMPLETED|Overall Study|Participants completed the study.|50
249182|NCT00520572|600825|P1|COMPLETED|Overall Study|Participants completed the study.|52
249183|NCT00520572|600820|P6|STARTED|Overall Study|Participants randomised.|64
249184|NCT00520572|600821|P5|STARTED|Overall Study|Participants randomised.|65
249185|NCT00520572|600822|P4|STARTED|Overall Study|Participants randomised.|64
249186|NCT00520572|600823|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
249187|NCT00520572|600824|P2|STARTED|Overall Study|Participants randomised.|64
249188|NCT00520572|600825|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
249189|NCT00520546|600863|P1|NOT COMPLETED|Overall Study||6
249190|NCT00520546|600863|P1|COMPLETED|Overall Study||38
249191|NCT00520546|600863|P1|STARTED|Overall Study||44
249192|NCT00520494|600878|P1|NOT COMPLETED|Overall Study||1
249193|NCT00520494|600878|P1|COMPLETED|Overall Study||17
249194|NCT00520494|600878|P1|STARTED|Overall Study||18
249195|NCT00520468|600901|P1|NOT COMPLETED|Overall Study||0
249196|NCT00520468|600901|P1|COMPLETED|Overall Study||14
249197|NCT00520468|600901|P1|STARTED|Overall Study||14
249198|NCT00520403|600905|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
249199|NCT00520403|600905|P1|COMPLETED|Bevacizumab Monotherapy||0
249200|NCT00520403|600905|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
249201|NCT00520403|600905|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
249202|NCT00520403|600905|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
249203|NCT00520403|600905|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
249204|NCT00520351|600914|P2|NOT COMPLETED|Second Intervention||0
249205|NCT00520351|600915|P1|NOT COMPLETED|Second Intervention||0
249206|NCT00520351|600914|P2|COMPLETED|Second Intervention||14
249207|NCT00520351|600915|P1|COMPLETED|Second Intervention||14
249208|NCT00520351|600914|P2|STARTED|Second Intervention||14
249209|NCT00520351|600915|P1|STARTED|Second Intervention||14
249210|NCT00520351|600914|P2|NOT COMPLETED|First Intervention||1
249211|NCT00520351|600915|P1|NOT COMPLETED|First Intervention||1
249212|NCT00520351|600914|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
249213|NCT00520351|600915|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
249214|NCT00520351|600914|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
249215|NCT00520351|600915|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
249216|NCT00520299|600930|P3|NOT COMPLETED|Overall Study||6
249217|NCT00520299|600931|P2|NOT COMPLETED|Overall Study||3
249218|NCT00520299|600932|P1|NOT COMPLETED|Overall Study||0
249219|NCT00520299|600930|P3|COMPLETED|Overall Study||13
249220|NCT00520299|600931|P2|COMPLETED|Overall Study||3
249221|NCT00520299|600932|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
249222|NCT00520299|600930|P3|STARTED|Overall Study||19
249223|NCT00520299|600931|P2|STARTED|Overall Study||6
249224|NCT00520299|600932|P1|STARTED|Overall Study||6
249225|NCT00520286|600963|P2|NOT COMPLETED|Overall Study||32
249226|NCT00520286|600964|P1|NOT COMPLETED|Overall Study||66
249227|NCT00520286|600963|P2|COMPLETED|Overall Study||36
249228|NCT00520286|600964|P1|COMPLETED|Overall Study||76
249229|NCT00520286|600963|P2|STARTED|Overall Study||68
249230|NCT00520286|600964|P1|STARTED|Overall Study||142
249231|NCT00520234|600974|P2|NOT COMPLETED|Overall Study||2
249232|NCT00520234|600975|P1|NOT COMPLETED|Overall Study||1
249233|NCT00520234|600974|P2|COMPLETED|Overall Study||102
249234|NCT00520234|600975|P1|COMPLETED|Overall Study||117
249235|NCT00520234|600974|P2|STARTED|Overall Study||104
249236|NCT00520234|600975|P1|STARTED|Overall Study||118
249237|NCT00520130|600987|P2|NOT COMPLETED|Overall Study||1
249238|NCT00520130|600988|P1|NOT COMPLETED|Overall Study||5
249239|NCT00520130|600987|P2|COMPLETED|Overall Study||44
249240|NCT00520130|600988|P1|COMPLETED|Overall Study||39
249241|NCT00520130|600987|P2|STARTED|Overall Study||45
249242|NCT00520130|600988|P1|STARTED|Overall Study||44
249243|NCT00520039|601030|P2|NOT COMPLETED|Overall Study||5
249244|NCT00520039|601031|P1|NOT COMPLETED|Overall Study||7
249245|NCT00520039|601030|P2|COMPLETED|Overall Study||19
249246|NCT00520039|601031|P1|COMPLETED|Overall Study||21
249247|NCT00520039|601030|P2|STARTED|Overall Study||24
249248|NCT00520039|601031|P1|STARTED|Overall Study||28
249249|NCT00520013|601044|P3|NOT COMPLETED|Overall Study||11
249250|NCT00520013|601045|P2|NOT COMPLETED|Overall Study||15
249251|NCT00520013|601046|P1|NOT COMPLETED|Overall Study||12
249252|NCT00520013|601044|P3|COMPLETED|Overall Study||0
249253|NCT00520013|601045|P2|COMPLETED|Overall Study||10
249254|NCT00520013|601046|P1|COMPLETED|Overall Study||11
249255|NCT00520013|601044|P3|Treated|Overall Study||11
249256|NCT00520013|601045|P2|Treated|Overall Study||25
249257|NCT00520013|601046|P1|Treated|Overall Study||23
249258|NCT00520013|601044|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
249259|NCT00520013|601045|P2|STARTED|Overall Study||25
249260|NCT00520013|601046|P1|STARTED|Overall Study||23
249261|NCT00519896|601056|P1|NOT COMPLETED|Overall Study||2
249262|NCT00519896|601056|P1|COMPLETED|Overall Study||33
249263|NCT00519896|601056|P1|STARTED|Overall Study||35
249264|NCT00519831|601062|P1|NOT COMPLETED|Overall Study||3
249265|NCT00519831|601062|P1|COMPLETED|Overall Study||13
249266|NCT00519831|601062|P1|STARTED|Overall Study||16
249267|NCT00519818|601069|P1|NOT COMPLETED|Overall Study||0
249268|NCT00519818|601069|P1|COMPLETED|Overall Study||14
249269|NCT00519818|601069|P1|STARTED|Overall Study||14
249270|NCT00519779|601079|P2|NOT COMPLETED|Overall Study||1
249271|NCT00519779|601080|P1|NOT COMPLETED|Overall Study||0
249272|NCT00519779|601079|P2|COMPLETED|Overall Study||33
249273|NCT00519779|601080|P1|COMPLETED|Overall Study||34
249274|NCT00519779|601079|P2|STARTED|Overall Study||34
249275|NCT00519779|601080|P1|STARTED|Overall Study||34
249276|NCT00519649|601096|P1|NOT COMPLETED|Overall Study||1
249277|NCT00519649|601096|P1|COMPLETED|Overall Study||299
249278|NCT00519649|601096|P1|STARTED|Overall Study||300
249279|NCT00519636|601109|P4|NOT COMPLETED|Post Study Period||1
249280|NCT00519636|601110|P3|NOT COMPLETED|Post Study Period||0
249281|NCT00519636|601111|P2|NOT COMPLETED|Post Study Period||0
249282|NCT00519636|601112|P1|NOT COMPLETED|Post Study Period||0
249283|NCT00519636|601109|P4|COMPLETED|Post Study Period||85
249284|NCT00519636|601110|P3|COMPLETED|Post Study Period||74
249285|NCT00519636|601111|P2|COMPLETED|Post Study Period||71
249286|NCT00519636|601112|P1|COMPLETED|Post Study Period||69
249287|NCT00519636|601109|P4|STARTED|Post Study Period||86
249288|NCT00519636|601110|P3|STARTED|Post Study Period||74
249289|NCT00519636|601111|P2|STARTED|Post Study Period||71
249290|NCT00519636|601112|P1|STARTED|Post Study Period||69
249291|NCT00519636|601109|P4|NOT COMPLETED|Treatment Period 2||2
249292|NCT00519636|601110|P3|NOT COMPLETED|Treatment Period 2||1
249293|NCT00519636|601111|P2|NOT COMPLETED|Treatment Period 2||1
249294|NCT00519636|601112|P1|NOT COMPLETED|Treatment Period 2||0
249295|NCT00519636|601109|P4|COMPLETED|Treatment Period 2||86
249296|NCT00519636|601110|P3|COMPLETED|Treatment Period 2||74
249297|NCT00519636|601111|P2|COMPLETED|Treatment Period 2||71
249298|NCT00519636|601112|P1|COMPLETED|Treatment Period 2||69
249299|NCT00519636|601109|P4|STARTED|Treatment Period 2||88
249300|NCT00519636|601110|P3|STARTED|Treatment Period 2||75
249301|NCT00519636|601111|P2|STARTED|Treatment Period 2||72
249302|NCT00519636|601112|P1|STARTED|Treatment Period 2||69
249303|NCT00519636|601109|P4|NOT COMPLETED|Washout Period||5
249304|NCT00519636|601110|P3|NOT COMPLETED|Washout Period||14
249305|NCT00519636|601111|P2|NOT COMPLETED|Washout Period||14
249306|NCT00519636|601112|P1|NOT COMPLETED|Washout Period||20
249307|NCT00519636|601109|P4|COMPLETED|Washout Period||88
249308|NCT00519636|601110|P3|COMPLETED|Washout Period||75
249309|NCT00519636|601111|P2|COMPLETED|Washout Period||72
249310|NCT00519636|601112|P1|COMPLETED|Washout Period||69
249311|NCT00519636|601109|P4|STARTED|Washout Period||93
249312|NCT00519636|601110|P3|STARTED|Washout Period||89
249313|NCT00519636|601111|P2|STARTED|Washout Period||86
249314|NCT00519636|601112|P1|STARTED|Washout Period||89
249315|NCT00519636|601109|P4|NOT COMPLETED|Treatment Period 1||0
249316|NCT00519636|601110|P3|NOT COMPLETED|Treatment Period 1||1
249317|NCT00519636|601111|P2|NOT COMPLETED|Treatment Period 1||0
249318|NCT00519636|601112|P1|NOT COMPLETED|Treatment Period 1||2
249319|NCT00519636|601109|P4|COMPLETED|Treatment Period 1||93
249320|NCT00519636|601110|P3|COMPLETED|Treatment Period 1||89
249321|NCT00519636|601111|P2|COMPLETED|Treatment Period 1||86
249322|NCT00519636|601112|P1|COMPLETED|Treatment Period 1||89
249323|NCT00519636|601109|P4|STARTED|Treatment Period 1||93
249324|NCT00519636|601110|P3|STARTED|Treatment Period 1||90
249325|NCT00519636|601111|P2|STARTED|Treatment Period 1||86
249326|NCT00519636|601112|P1|STARTED|Treatment Period 1||91
249327|NCT00519623|601142|P1|NOT COMPLETED|Overall Study||1
249328|NCT00519623|601142|P1|COMPLETED|Overall Study||8
249329|NCT00519623|601142|P1|STARTED|Overall Study||9
249330|NCT00519584|601151|P4|NOT COMPLETED|Overall Study||0
249331|NCT00519584|601152|P3|NOT COMPLETED|Overall Study||0
249332|NCT00519584|601153|P2|NOT COMPLETED|Overall Study||0
249333|NCT00519584|601154|P1|NOT COMPLETED|Overall Study||0
249334|NCT00519584|601151|P4|COMPLETED|Overall Study||56
249335|NCT00519584|601152|P3|COMPLETED|Overall Study||54
249336|NCT00519584|601153|P2|COMPLETED|Overall Study||54
249337|NCT00519584|601154|P1|COMPLETED|Overall Study||54
249338|NCT00519584|601151|P4|STARTED|Overall Study||56
249339|NCT00519584|601152|P3|STARTED|Overall Study||54
249340|NCT00519584|601153|P2|STARTED|Overall Study||54
249341|NCT00519584|601154|P1|STARTED|Overall Study||54
249342|NCT00519532|601176|P1|NOT COMPLETED|Overall Study||18
249343|NCT00519532|601176|P1|COMPLETED|Overall Study||66
249344|NCT00519532|601176|P1|STARTED|Overall Study||84
249345|NCT00519428|601186|P3|NOT COMPLETED|Overall Study||25
249346|NCT00519428|601187|P2|NOT COMPLETED|Overall Study||15
249347|NCT00519428|601188|P1|NOT COMPLETED|Overall Study||21
249348|NCT00519428|601186|P3|COMPLETED|Overall Study||58
249349|NCT00519428|601187|P2|COMPLETED|Overall Study||69
249350|NCT00519428|601188|P1|COMPLETED|Overall Study||57
249351|NCT00519428|601186|P3|STARTED|Overall Study||83
249352|NCT00519428|601187|P2|STARTED|Overall Study||84
249353|NCT00519428|601188|P1|STARTED|Overall Study||78
249354|NCT00519376|601208|P16|NOT COMPLETED|Treatment Period 4||0
249355|NCT00519376|601209|P15|NOT COMPLETED|Treatment Period 4||0
249356|NCT00519376|601210|P14|NOT COMPLETED|Treatment Period 4||0
249357|NCT00519376|601211|P13|NOT COMPLETED|Treatment Period 4||0
249358|NCT00519376|601212|P12|NOT COMPLETED|Treatment Period 4||0
249359|NCT00519376|601213|P11|NOT COMPLETED|Treatment Period 4||0
249360|NCT00519376|601214|P10|NOT COMPLETED|Treatment Period 4||0
249361|NCT00519376|601215|P9|NOT COMPLETED|Treatment Period 4||0
249362|NCT00519376|601216|P8|NOT COMPLETED|Treatment Period 4||0
249363|NCT00519376|601217|P7|NOT COMPLETED|Treatment Period 4||0
249364|NCT00519376|601218|P6|NOT COMPLETED|Treatment Period 4||0
249365|NCT00519376|601219|P5|NOT COMPLETED|Treatment Period 4||0
249366|NCT00519376|601220|P4|NOT COMPLETED|Treatment Period 4||0
249367|NCT00519376|601221|P3|NOT COMPLETED|Treatment Period 4||1
249368|NCT00519376|601222|P2|NOT COMPLETED|Treatment Period 4||0
249369|NCT00519376|601223|P1|NOT COMPLETED|Treatment Period 4||0
249370|NCT00519376|601208|P16|COMPLETED|Treatment Period 4||1
249371|NCT00519376|601209|P15|COMPLETED|Treatment Period 4||1
249372|NCT00519376|601210|P14|COMPLETED|Treatment Period 4||1
249373|NCT00519376|601211|P13|COMPLETED|Treatment Period 4||0
249374|NCT00519376|601212|P12|COMPLETED|Treatment Period 4||1
249375|NCT00519376|601213|P11|COMPLETED|Treatment Period 4||1
249376|NCT00519376|601214|P10|COMPLETED|Treatment Period 4||1
249377|NCT00519376|601215|P9|COMPLETED|Treatment Period 4||1
249378|NCT00519376|601216|P8|COMPLETED|Treatment Period 4||1
249379|NCT00519376|601217|P7|COMPLETED|Treatment Period 4||1
249380|NCT00519376|601218|P6|COMPLETED|Treatment Period 4||1
249381|NCT00519376|601219|P5|COMPLETED|Treatment Period 4||1
249382|NCT00519376|601220|P4|COMPLETED|Treatment Period 4||2
249383|NCT00519376|601221|P3|COMPLETED|Treatment Period 4||1
249384|NCT00519376|601222|P2|COMPLETED|Treatment Period 4||2
249385|NCT00519376|601223|P1|COMPLETED|Treatment Period 4||2
249386|NCT00519376|601208|P16|STARTED|Treatment Period 4||1
249387|NCT00519376|601209|P15|STARTED|Treatment Period 4||1
249388|NCT00519376|601210|P14|STARTED|Treatment Period 4||1
249389|NCT00519376|601211|P13|STARTED|Treatment Period 4||0
249390|NCT00519376|601212|P12|STARTED|Treatment Period 4||1
249391|NCT00519376|601213|P11|STARTED|Treatment Period 4||1
249392|NCT00519376|601214|P10|STARTED|Treatment Period 4||1
249393|NCT00519376|601215|P9|STARTED|Treatment Period 4||1
249394|NCT00519376|601216|P8|STARTED|Treatment Period 4||1
249395|NCT00519376|601217|P7|STARTED|Treatment Period 4||1
249396|NCT00519376|601218|P6|STARTED|Treatment Period 4||1
249397|NCT00519376|601219|P5|STARTED|Treatment Period 4||1
249398|NCT00519376|601220|P4|STARTED|Treatment Period 4||2
249399|NCT00519376|601221|P3|STARTED|Treatment Period 4||2
249400|NCT00519376|601222|P2|STARTED|Treatment Period 4||2
249401|NCT00519376|601223|P1|STARTED|Treatment Period 4||2
249402|NCT00519376|601208|P16|NOT COMPLETED|Washout Period 3||0
249403|NCT00519376|601209|P15|NOT COMPLETED|Washout Period 3||0
249404|NCT00519376|601210|P14|NOT COMPLETED|Washout Period 3||0
249405|NCT00519376|601211|P13|NOT COMPLETED|Washout Period 3||0
249406|NCT00519376|601212|P12|NOT COMPLETED|Washout Period 3||0
249407|NCT00519376|601213|P11|NOT COMPLETED|Washout Period 3||0
249408|NCT00519376|601214|P10|NOT COMPLETED|Washout Period 3||0
249409|NCT00519376|601215|P9|NOT COMPLETED|Washout Period 3||0
249410|NCT00519376|601216|P8|NOT COMPLETED|Washout Period 3||0
249411|NCT00519376|601217|P7|NOT COMPLETED|Washout Period 3||0
249412|NCT00519376|601218|P6|NOT COMPLETED|Washout Period 3||0
249413|NCT00519376|601219|P5|NOT COMPLETED|Washout Period 3||0
249414|NCT00519376|601220|P4|NOT COMPLETED|Washout Period 3||0
249415|NCT00519376|601221|P3|NOT COMPLETED|Washout Period 3||0
249416|NCT00519376|601222|P2|NOT COMPLETED|Washout Period 3||0
249417|NCT00519376|601223|P1|NOT COMPLETED|Washout Period 3||0
249418|NCT00519376|601208|P16|COMPLETED|Washout Period 3||1
249419|NCT00519376|601209|P15|COMPLETED|Washout Period 3||1
249420|NCT00519376|601210|P14|COMPLETED|Washout Period 3||1
249421|NCT00519376|601211|P13|COMPLETED|Washout Period 3||0
249422|NCT00519376|601212|P12|COMPLETED|Washout Period 3||1
249423|NCT00519376|601213|P11|COMPLETED|Washout Period 3||1
249424|NCT00519376|601214|P10|COMPLETED|Washout Period 3||1
249425|NCT00519376|601215|P9|COMPLETED|Washout Period 3||1
249426|NCT00519376|601216|P8|COMPLETED|Washout Period 3||1
249427|NCT00519376|601217|P7|COMPLETED|Washout Period 3||1
249428|NCT00519376|601218|P6|COMPLETED|Washout Period 3||1
249429|NCT00519376|601219|P5|COMPLETED|Washout Period 3||1
249430|NCT00519376|601220|P4|COMPLETED|Washout Period 3||2
249431|NCT00519376|601221|P3|COMPLETED|Washout Period 3||2
249432|NCT00519376|601222|P2|COMPLETED|Washout Period 3||2
249433|NCT00519376|601223|P1|COMPLETED|Washout Period 3||2
249434|NCT00519376|601208|P16|STARTED|Washout Period 3||1
249435|NCT00519376|601209|P15|STARTED|Washout Period 3||1
249436|NCT00519376|601210|P14|STARTED|Washout Period 3||1
249437|NCT00519376|601211|P13|STARTED|Washout Period 3||0
249438|NCT00519376|601212|P12|STARTED|Washout Period 3||1
249439|NCT00519376|601213|P11|STARTED|Washout Period 3||1
249440|NCT00519376|601214|P10|STARTED|Washout Period 3||1
249441|NCT00519376|601215|P9|STARTED|Washout Period 3||1
249442|NCT00519376|601216|P8|STARTED|Washout Period 3||1
249443|NCT00519376|601217|P7|STARTED|Washout Period 3||1
249444|NCT00519376|601218|P6|STARTED|Washout Period 3||1
249445|NCT00519376|601219|P5|STARTED|Washout Period 3||1
249446|NCT00519376|601220|P4|STARTED|Washout Period 3||2
249447|NCT00519376|601221|P3|STARTED|Washout Period 3||2
249448|NCT00519376|601222|P2|STARTED|Washout Period 3||2
249449|NCT00519376|601223|P1|STARTED|Washout Period 3||2
249450|NCT00519376|601208|P16|NOT COMPLETED|Treatment Period 3||0
249451|NCT00519376|601209|P15|NOT COMPLETED|Treatment Period 3||0
249452|NCT00519376|601210|P14|NOT COMPLETED|Treatment Period 3||0
249453|NCT00519376|601211|P13|NOT COMPLETED|Treatment Period 3||0
249454|NCT00519376|601212|P12|NOT COMPLETED|Treatment Period 3||0
249455|NCT00519376|601213|P11|NOT COMPLETED|Treatment Period 3||0
249456|NCT00519376|601214|P10|NOT COMPLETED|Treatment Period 3||0
249457|NCT00519376|601215|P9|NOT COMPLETED|Treatment Period 3||0
249458|NCT00519376|601216|P8|NOT COMPLETED|Treatment Period 3||0
249459|NCT00519376|601217|P7|NOT COMPLETED|Treatment Period 3||0
249460|NCT00519376|601218|P6|NOT COMPLETED|Treatment Period 3||0
249461|NCT00519376|601219|P5|NOT COMPLETED|Treatment Period 3||0
249462|NCT00519376|601220|P4|NOT COMPLETED|Treatment Period 3||0
249463|NCT00519376|601221|P3|NOT COMPLETED|Treatment Period 3||0
249464|NCT00519376|601222|P2|NOT COMPLETED|Treatment Period 3||0
249465|NCT00519376|601223|P1|NOT COMPLETED|Treatment Period 3||0
249466|NCT00519376|601208|P16|COMPLETED|Treatment Period 3||1
249467|NCT00519376|601209|P15|COMPLETED|Treatment Period 3||1
249468|NCT00519376|601210|P14|COMPLETED|Treatment Period 3||1
249469|NCT00519376|601211|P13|COMPLETED|Treatment Period 3||0
249470|NCT00519376|601212|P12|COMPLETED|Treatment Period 3||1
249471|NCT00519376|601213|P11|COMPLETED|Treatment Period 3||1
249472|NCT00519376|601214|P10|COMPLETED|Treatment Period 3||1
249473|NCT00519376|601215|P9|COMPLETED|Treatment Period 3||1
249474|NCT00519376|601216|P8|COMPLETED|Treatment Period 3||1
249475|NCT00519376|601217|P7|COMPLETED|Treatment Period 3||1
249476|NCT00519376|601218|P6|COMPLETED|Treatment Period 3||1
249477|NCT00519376|601219|P5|COMPLETED|Treatment Period 3||1
249478|NCT00519376|601220|P4|COMPLETED|Treatment Period 3||2
249479|NCT00519376|601221|P3|COMPLETED|Treatment Period 3||2
249480|NCT00519376|601222|P2|COMPLETED|Treatment Period 3||2
249481|NCT00519376|601223|P1|COMPLETED|Treatment Period 3||2
249482|NCT00519376|601208|P16|STARTED|Treatment Period 3||1
249483|NCT00519376|601209|P15|STARTED|Treatment Period 3||1
249484|NCT00519376|601210|P14|STARTED|Treatment Period 3||1
249485|NCT00519376|601211|P13|STARTED|Treatment Period 3||0
249486|NCT00519376|601212|P12|STARTED|Treatment Period 3||1
249487|NCT00519376|601213|P11|STARTED|Treatment Period 3||1
249488|NCT00519376|601214|P10|STARTED|Treatment Period 3||1
249489|NCT00519376|601215|P9|STARTED|Treatment Period 3||1
249490|NCT00519376|601216|P8|STARTED|Treatment Period 3||1
249491|NCT00519376|601217|P7|STARTED|Treatment Period 3||1
249492|NCT00519376|601218|P6|STARTED|Treatment Period 3||1
249493|NCT00519376|601219|P5|STARTED|Treatment Period 3||1
249494|NCT00519376|601220|P4|STARTED|Treatment Period 3||2
249495|NCT00519376|601221|P3|STARTED|Treatment Period 3||2
249496|NCT00519376|601222|P2|STARTED|Treatment Period 3||2
249497|NCT00519376|601223|P1|STARTED|Treatment Period 3||2
249498|NCT00519376|601208|P16|NOT COMPLETED|Washout Period 2||0
249499|NCT00519376|601209|P15|NOT COMPLETED|Washout Period 2||0
249500|NCT00519376|601210|P14|NOT COMPLETED|Washout Period 2||0
249501|NCT00519376|601211|P13|NOT COMPLETED|Washout Period 2||0
249502|NCT00519376|601212|P12|NOT COMPLETED|Washout Period 2||0
249503|NCT00519376|601213|P11|NOT COMPLETED|Washout Period 2||0
249504|NCT00519376|601214|P10|NOT COMPLETED|Washout Period 2||0
249505|NCT00519376|601215|P9|NOT COMPLETED|Washout Period 2||0
249506|NCT00519376|601216|P8|NOT COMPLETED|Washout Period 2||0
249507|NCT00519376|601217|P7|NOT COMPLETED|Washout Period 2||0
249508|NCT00519376|601218|P6|NOT COMPLETED|Washout Period 2||0
249509|NCT00519376|601219|P5|NOT COMPLETED|Washout Period 2||0
249510|NCT00519376|601220|P4|NOT COMPLETED|Washout Period 2||0
249511|NCT00519376|601221|P3|NOT COMPLETED|Washout Period 2||0
249512|NCT00519376|601222|P2|NOT COMPLETED|Washout Period 2||0
249513|NCT00519376|601223|P1|NOT COMPLETED|Washout Period 2||0
249514|NCT00519376|601208|P16|COMPLETED|Washout Period 2||1
249515|NCT00519376|601209|P15|COMPLETED|Washout Period 2||1
249516|NCT00519376|601210|P14|COMPLETED|Washout Period 2||1
249517|NCT00519376|601211|P13|COMPLETED|Washout Period 2||0
249518|NCT00519376|601212|P12|COMPLETED|Washout Period 2||1
249519|NCT00519376|601213|P11|COMPLETED|Washout Period 2||1
249520|NCT00519376|601214|P10|COMPLETED|Washout Period 2||1
249521|NCT00519376|601215|P9|COMPLETED|Washout Period 2||1
249522|NCT00519376|601216|P8|COMPLETED|Washout Period 2||1
249523|NCT00519376|601217|P7|COMPLETED|Washout Period 2||1
249524|NCT00519376|601218|P6|COMPLETED|Washout Period 2||1
249525|NCT00519376|601219|P5|COMPLETED|Washout Period 2||1
249526|NCT00519376|601220|P4|COMPLETED|Washout Period 2||2
249527|NCT00519376|601221|P3|COMPLETED|Washout Period 2||2
249528|NCT00519376|601222|P2|COMPLETED|Washout Period 2||2
249529|NCT00519376|601223|P1|COMPLETED|Washout Period 2||2
249530|NCT00519376|601208|P16|STARTED|Washout Period 2||1
249531|NCT00519376|601209|P15|STARTED|Washout Period 2||1
249532|NCT00519376|601210|P14|STARTED|Washout Period 2||1
249533|NCT00519376|601211|P13|STARTED|Washout Period 2||0
249534|NCT00519376|601212|P12|STARTED|Washout Period 2||1
249535|NCT00519376|601213|P11|STARTED|Washout Period 2||1
249536|NCT00519376|601214|P10|STARTED|Washout Period 2||1
249537|NCT00519376|601215|P9|STARTED|Washout Period 2||1
249538|NCT00519376|601216|P8|STARTED|Washout Period 2||1
249539|NCT00519376|601217|P7|STARTED|Washout Period 2||1
249540|NCT00519376|601218|P6|STARTED|Washout Period 2||1
249541|NCT00519376|601219|P5|STARTED|Washout Period 2||1
249542|NCT00519376|601220|P4|STARTED|Washout Period 2||2
249543|NCT00519376|601221|P3|STARTED|Washout Period 2||2
249544|NCT00519376|601222|P2|STARTED|Washout Period 2||2
249545|NCT00519376|601223|P1|STARTED|Washout Period 2||2
249546|NCT00519376|601208|P16|NOT COMPLETED|Treatment Period 2||0
249547|NCT00519376|601209|P15|NOT COMPLETED|Treatment Period 2||0
249548|NCT00519376|601210|P14|NOT COMPLETED|Treatment Period 2||0
249549|NCT00519376|601211|P13|NOT COMPLETED|Treatment Period 2||1
249550|NCT00519376|601212|P12|NOT COMPLETED|Treatment Period 2||0
249551|NCT00519376|601213|P11|NOT COMPLETED|Treatment Period 2||0
249552|NCT00519376|601214|P10|NOT COMPLETED|Treatment Period 2||0
249553|NCT00519376|601215|P9|NOT COMPLETED|Treatment Period 2||0
249554|NCT00519376|601216|P8|NOT COMPLETED|Treatment Period 2||0
249555|NCT00519376|601217|P7|NOT COMPLETED|Treatment Period 2||0
249556|NCT00519376|601218|P6|NOT COMPLETED|Treatment Period 2||0
249557|NCT00519376|601219|P5|NOT COMPLETED|Treatment Period 2||0
249558|NCT00519376|601220|P4|NOT COMPLETED|Treatment Period 2||0
249559|NCT00519376|601221|P3|NOT COMPLETED|Treatment Period 2||0
249560|NCT00519376|601222|P2|NOT COMPLETED|Treatment Period 2||0
249561|NCT00519376|601223|P1|NOT COMPLETED|Treatment Period 2||0
249562|NCT00519376|601208|P16|COMPLETED|Treatment Period 2||1
249563|NCT00519376|601209|P15|COMPLETED|Treatment Period 2||1
249564|NCT00519376|601210|P14|COMPLETED|Treatment Period 2||1
249565|NCT00519376|601211|P13|COMPLETED|Treatment Period 2||0
249566|NCT00519376|601212|P12|COMPLETED|Treatment Period 2||1
249567|NCT00519376|601213|P11|COMPLETED|Treatment Period 2||1
249568|NCT00519376|601214|P10|COMPLETED|Treatment Period 2||1
249569|NCT00519376|601215|P9|COMPLETED|Treatment Period 2||1
249570|NCT00519376|601216|P8|COMPLETED|Treatment Period 2||1
249571|NCT00519376|601217|P7|COMPLETED|Treatment Period 2||1
249572|NCT00519376|601218|P6|COMPLETED|Treatment Period 2||1
249573|NCT00519376|601219|P5|COMPLETED|Treatment Period 2||1
249574|NCT00519376|601220|P4|COMPLETED|Treatment Period 2||2
249575|NCT00519376|601221|P3|COMPLETED|Treatment Period 2||2
249576|NCT00519376|601222|P2|COMPLETED|Treatment Period 2||2
249577|NCT00519376|601223|P1|COMPLETED|Treatment Period 2||2
249578|NCT00519376|601208|P16|STARTED|Treatment Period 2||1
249579|NCT00519376|601209|P15|STARTED|Treatment Period 2||1
249580|NCT00519376|601210|P14|STARTED|Treatment Period 2||1
249581|NCT00519376|601211|P13|STARTED|Treatment Period 2||1
249582|NCT00519376|601212|P12|STARTED|Treatment Period 2||1
249583|NCT00519376|601213|P11|STARTED|Treatment Period 2||1
249584|NCT00519376|601214|P10|STARTED|Treatment Period 2||1
249585|NCT00519376|601215|P9|STARTED|Treatment Period 2||1
249586|NCT00519376|601216|P8|STARTED|Treatment Period 2||1
249587|NCT00519376|601217|P7|STARTED|Treatment Period 2||1
249588|NCT00519376|601218|P6|STARTED|Treatment Period 2||1
249589|NCT00519376|601219|P5|STARTED|Treatment Period 2||1
249590|NCT00519376|601220|P4|STARTED|Treatment Period 2||2
249591|NCT00519376|601221|P3|STARTED|Treatment Period 2||2
249592|NCT00519376|601222|P2|STARTED|Treatment Period 2||2
249593|NCT00519376|601223|P1|STARTED|Treatment Period 2||2
249594|NCT00519376|601208|P16|NOT COMPLETED|Washout Period 1||0
249595|NCT00519376|601209|P15|NOT COMPLETED|Washout Period 1||0
249596|NCT00519376|601210|P14|NOT COMPLETED|Washout Period 1||0
249597|NCT00519376|601211|P13|NOT COMPLETED|Washout Period 1||0
249598|NCT00519376|601212|P12|NOT COMPLETED|Washout Period 1||0
249599|NCT00519376|601213|P11|NOT COMPLETED|Washout Period 1||0
249600|NCT00519376|601214|P10|NOT COMPLETED|Washout Period 1||0
249601|NCT00519376|601215|P9|NOT COMPLETED|Washout Period 1||0
249602|NCT00519376|601216|P8|NOT COMPLETED|Washout Period 1||0
249603|NCT00519376|601217|P7|NOT COMPLETED|Washout Period 1||0
249604|NCT00519376|601218|P6|NOT COMPLETED|Washout Period 1||0
249605|NCT00519376|601219|P5|NOT COMPLETED|Washout Period 1||0
249606|NCT00519376|601220|P4|NOT COMPLETED|Washout Period 1||0
249607|NCT00519376|601221|P3|NOT COMPLETED|Washout Period 1||0
249608|NCT00519376|601222|P2|NOT COMPLETED|Washout Period 1||0
249609|NCT00519376|601223|P1|NOT COMPLETED|Washout Period 1||0
249610|NCT00519376|601208|P16|COMPLETED|Washout Period 1||1
249611|NCT00519376|601209|P15|COMPLETED|Washout Period 1||1
249612|NCT00519376|601210|P14|COMPLETED|Washout Period 1||1
249613|NCT00519376|601211|P13|COMPLETED|Washout Period 1||1
249614|NCT00519376|601212|P12|COMPLETED|Washout Period 1||1
249615|NCT00519376|601213|P11|COMPLETED|Washout Period 1||1
249616|NCT00519376|601214|P10|COMPLETED|Washout Period 1||1
249617|NCT00519376|601215|P9|COMPLETED|Washout Period 1||1
249618|NCT00519376|601216|P8|COMPLETED|Washout Period 1||1
249619|NCT00519376|601217|P7|COMPLETED|Washout Period 1||1
249620|NCT00519376|601218|P6|COMPLETED|Washout Period 1||1
249621|NCT00519376|601219|P5|COMPLETED|Washout Period 1||1
249622|NCT00519376|601220|P4|COMPLETED|Washout Period 1||2
249623|NCT00519376|601221|P3|COMPLETED|Washout Period 1||2
249624|NCT00519376|601222|P2|COMPLETED|Washout Period 1||2
249625|NCT00519376|601223|P1|COMPLETED|Washout Period 1||2
249626|NCT00519376|601208|P16|STARTED|Washout Period 1||1
249627|NCT00519376|601209|P15|STARTED|Washout Period 1||1
249628|NCT00519376|601210|P14|STARTED|Washout Period 1||1
249629|NCT00519376|601211|P13|STARTED|Washout Period 1||1
249630|NCT00519376|601212|P12|STARTED|Washout Period 1||1
249631|NCT00519376|601213|P11|STARTED|Washout Period 1||1
249632|NCT00519376|601214|P10|STARTED|Washout Period 1||1
249633|NCT00519376|601215|P9|STARTED|Washout Period 1||1
249634|NCT00519376|601216|P8|STARTED|Washout Period 1||1
249635|NCT00519376|601217|P7|STARTED|Washout Period 1||1
249636|NCT00519376|601218|P6|STARTED|Washout Period 1||1
249637|NCT00519376|601219|P5|STARTED|Washout Period 1||1
249638|NCT00519376|601220|P4|STARTED|Washout Period 1||2
249639|NCT00519376|601221|P3|STARTED|Washout Period 1||2
249640|NCT00519376|601222|P2|STARTED|Washout Period 1||2
249641|NCT00519376|601223|P1|STARTED|Washout Period 1||2
249642|NCT00519376|601208|P16|NOT COMPLETED|Treatment Period 1||0
249643|NCT00519376|601209|P15|NOT COMPLETED|Treatment Period 1||0
249644|NCT00519376|601210|P14|NOT COMPLETED|Treatment Period 1||0
249645|NCT00519376|601211|P13|NOT COMPLETED|Treatment Period 1||0
249646|NCT00519376|601212|P12|NOT COMPLETED|Treatment Period 1||0
249647|NCT00519376|601213|P11|NOT COMPLETED|Treatment Period 1||0
249648|NCT00519376|601214|P10|NOT COMPLETED|Treatment Period 1||0
249649|NCT00519376|601215|P9|NOT COMPLETED|Treatment Period 1||0
249650|NCT00519376|601216|P8|NOT COMPLETED|Treatment Period 1||0
249651|NCT00519376|601217|P7|NOT COMPLETED|Treatment Period 1||0
249652|NCT00519376|601218|P6|NOT COMPLETED|Treatment Period 1||0
249653|NCT00519376|601219|P5|NOT COMPLETED|Treatment Period 1||0
249654|NCT00519376|601220|P4|NOT COMPLETED|Treatment Period 1||0
249655|NCT00519376|601221|P3|NOT COMPLETED|Treatment Period 1||0
249656|NCT00519376|601222|P2|NOT COMPLETED|Treatment Period 1||0
249657|NCT00519376|601223|P1|NOT COMPLETED|Treatment Period 1||0
249658|NCT00519376|601208|P16|COMPLETED|Treatment Period 1||1
249659|NCT00519376|601209|P15|COMPLETED|Treatment Period 1||1
249660|NCT00519376|601210|P14|COMPLETED|Treatment Period 1||1
249661|NCT00519376|601211|P13|COMPLETED|Treatment Period 1||1
249662|NCT00519376|601212|P12|COMPLETED|Treatment Period 1||1
249663|NCT00519376|601213|P11|COMPLETED|Treatment Period 1||1
249664|NCT00519376|601214|P10|COMPLETED|Treatment Period 1||1
249665|NCT00519376|601215|P9|COMPLETED|Treatment Period 1||1
249666|NCT00519376|601216|P8|COMPLETED|Treatment Period 1||1
249667|NCT00519376|601217|P7|COMPLETED|Treatment Period 1||1
249668|NCT00519376|601218|P6|COMPLETED|Treatment Period 1||1
249669|NCT00519376|601219|P5|COMPLETED|Treatment Period 1||1
249670|NCT00519376|601220|P4|COMPLETED|Treatment Period 1||2
249671|NCT00519376|601221|P3|COMPLETED|Treatment Period 1||2
249672|NCT00519376|601222|P2|COMPLETED|Treatment Period 1||2
249673|NCT00519376|601223|P1|COMPLETED|Treatment Period 1||2
249674|NCT00519376|601208|P16|STARTED|Treatment Period 1||1
249675|NCT00519376|601209|P15|STARTED|Treatment Period 1||1
249676|NCT00519376|601210|P14|STARTED|Treatment Period 1||1
249677|NCT00519376|601211|P13|STARTED|Treatment Period 1||1
249678|NCT00519376|601212|P12|STARTED|Treatment Period 1||1
249679|NCT00519376|601213|P11|STARTED|Treatment Period 1||1
249680|NCT00519376|601214|P10|STARTED|Treatment Period 1||1
249681|NCT00519376|601215|P9|STARTED|Treatment Period 1||1
249682|NCT00519376|601216|P8|STARTED|Treatment Period 1||1
249683|NCT00519376|601217|P7|STARTED|Treatment Period 1||1
249684|NCT00519376|601218|P6|STARTED|Treatment Period 1||1
249685|NCT00519376|601219|P5|STARTED|Treatment Period 1||1
249686|NCT00519376|601220|P4|STARTED|Treatment Period 1||2
249687|NCT00519376|601221|P3|STARTED|Treatment Period 1||2
249688|NCT00519376|601222|P2|STARTED|Treatment Period 1||2
249689|NCT00519376|601223|P1|STARTED|Treatment Period 1||2
249690|NCT00519285|601347|P2|NOT COMPLETED|Overall Study||612
249691|NCT00519285|601348|P1|NOT COMPLETED|Overall Study||612
249692|NCT00519285|601347|P2|COMPLETED|Overall Study||0
249693|NCT00519285|601348|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
249694|NCT00519285|601347|P2|Still Treated at Cut-off Date|Overall Study||2
249695|NCT00519285|601348|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
249696|NCT00519285|601347|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
249697|NCT00519285|601348|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
249698|NCT00519285|601347|P2|STARTED|Overall Study|Randomized|612
249699|NCT00519285|601348|P1|STARTED|Overall Study|Randomized|612
249700|NCT00519194|601374|P1|NOT COMPLETED|Overall Study||21
249701|NCT00519194|601374|P1|COMPLETED|Overall Study||91
249702|NCT00519194|601374|P1|STARTED|Overall Study||112
249703|NCT00519090|601380|P2|NOT COMPLETED|Overall Study||0
249704|NCT00519090|601381|P1|NOT COMPLETED|Overall Study||0
249705|NCT00519090|601380|P2|COMPLETED|Overall Study||4
249706|NCT00519090|601381|P1|COMPLETED|Overall Study||2
249707|NCT00519090|601380|P2|STARTED|Overall Study||4
249708|NCT00519090|601381|P1|STARTED|Overall Study||2
249709|NCT00519077|601389|P1|NOT COMPLETED|Overall Study||8
249710|NCT00519077|601389|P1|COMPLETED|Overall Study||36
249711|NCT00519077|601389|P1|STARTED|Overall Study||44
249712|NCT00518986|601396|P2|NOT COMPLETED|Overall Study||26
249713|NCT00518986|601397|P1|NOT COMPLETED|Overall Study||26
249714|NCT00518986|601396|P2|COMPLETED|Overall Study||98
249715|NCT00518986|601397|P1|COMPLETED|Overall Study||99
249716|NCT00518986|601396|P2|STARTED|Overall Study||124
249717|NCT00518986|601397|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
249718|NCT00518882|601523|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
249719|NCT00518882|601524|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
249720|NCT00518882|601523|P2|COMPLETED|Open-Label Extension, Week 26-78||138
249721|NCT00518882|601524|P1|COMPLETED|Open-Label Extension, Week 26-78||161
249722|NCT00518882|601523|P2|STARTED|Open-Label Extension, Week 26-78||187
249723|NCT00518882|601524|P1|STARTED|Open-Label Extension, Week 26-78||202
249724|NCT00518882|601523|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
249725|NCT00518882|601524|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
249726|NCT00518882|601523|P2|COMPLETED|Double-Blind, Week 0-26||187
249727|NCT00518882|601524|P1|COMPLETED|Double-Blind, Week 0-26||202
249728|NCT00518882|601523|P2|Randomised|Double-Blind, Week 0-26||231
249729|NCT00518882|601524|P1|Randomised|Double-Blind, Week 0-26||233
249730|NCT00518882|601523|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
249731|NCT00518882|601524|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
249732|NCT00518713|601642|P4|NOT COMPLETED|Overall Study||18
249733|NCT00518713|601643|P3|NOT COMPLETED|Overall Study||18
249734|NCT00518713|601644|P2|NOT COMPLETED|Overall Study||17
249735|NCT00518713|601645|P1|NOT COMPLETED|Overall Study||8
249736|NCT00518713|601642|P4|COMPLETED|Overall Study||41
249737|NCT00518713|601643|P3|COMPLETED|Overall Study||41
249738|NCT00518713|601644|P2|COMPLETED|Overall Study||45
249739|NCT00518713|601645|P1|COMPLETED|Overall Study||50
249740|NCT00518713|601642|P4|Modified Intent-to-Treat Population|Overall Study||57
249741|NCT00518713|601643|P3|Modified Intent-to-Treat Population|Overall Study||49
249742|NCT00518713|601644|P2|Modified Intent-to-Treat Population|Overall Study||58
249743|NCT00518713|601645|P1|Modified Intent-to-Treat Population|Overall Study||53
249744|NCT00518713|601642|P4|STARTED|Overall Study||59
249745|NCT00518713|601643|P3|STARTED|Overall Study||59
249746|NCT00518713|601644|P2|STARTED|Overall Study||62
249747|NCT00518713|601645|P1|STARTED|Overall Study||58
249748|NCT00518687|601705|P2|NOT COMPLETED|Overall Study||1420
249749|NCT00518687|601706|P1|NOT COMPLETED|Overall Study||1437
249750|NCT00518687|601705|P2|COMPLETED|Overall Study||2585
249751|NCT00518687|601706|P1|COMPLETED|Overall Study||2568
249752|NCT00518687|601705|P2|Vaccinated|Overall Study||3982
249753|NCT00518687|601706|P1|Vaccinated|Overall Study||3981
249754|NCT00518687|601705|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
249755|NCT00518687|601706|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
249756|NCT00518622|601726|P8|NOT COMPLETED|Overall Study||0
249757|NCT00518622|601727|P7|NOT COMPLETED|Overall Study||0
249758|NCT00518622|601728|P6|NOT COMPLETED|Overall Study||0
249759|NCT00518622|601729|P5|NOT COMPLETED|Overall Study||0
249760|NCT00518622|601730|P4|NOT COMPLETED|Overall Study||0
249761|NCT00518622|601731|P3|NOT COMPLETED|Overall Study||1
249762|NCT00518622|601732|P2|NOT COMPLETED|Overall Study||1
249763|NCT00518622|601733|P1|NOT COMPLETED|Overall Study||0
249764|NCT00518622|601726|P8|COMPLETED|Overall Study||5
249765|NCT00518622|601727|P7|COMPLETED|Overall Study||4
249766|NCT00518622|601728|P6|COMPLETED|Overall Study||5
249767|NCT00518622|601729|P5|COMPLETED|Overall Study||6
249768|NCT00518622|601730|P4|COMPLETED|Overall Study||5
249769|NCT00518622|601731|P3|COMPLETED|Overall Study||5
249770|NCT00518622|601732|P2|COMPLETED|Overall Study||5
249771|NCT00518622|601733|P1|COMPLETED|Overall Study||3
249772|NCT00518622|601726|P8|Discontinued Therapy|Overall Study||0
249773|NCT00518622|601727|P7|Discontinued Therapy|Overall Study||0
249774|NCT00518622|601728|P6|Discontinued Therapy|Overall Study||0
249775|NCT00518622|601729|P5|Discontinued Therapy|Overall Study||0
249776|NCT00518622|601730|P4|Discontinued Therapy|Overall Study||0
249777|NCT00518622|601731|P3|Discontinued Therapy|Overall Study||0
249778|NCT00518622|601732|P2|Discontinued Therapy|Overall Study||1
249779|NCT00518622|601733|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
249780|NCT00518622|601726|P8|Completed Therapy|Overall Study||5
249781|NCT00518622|601727|P7|Completed Therapy|Overall Study||4
249782|NCT00518622|601728|P6|Completed Therapy|Overall Study||5
249783|NCT00518622|601729|P5|Completed Therapy|Overall Study||6
249784|NCT00518622|601730|P4|Completed Therapy|Overall Study||5
249785|NCT00518622|601731|P3|Completed Therapy|Overall Study||6
249786|NCT00518622|601732|P2|Completed Therapy|Overall Study||5
249787|NCT00518622|601733|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
249788|NCT00518622|601726|P8|STARTED|Overall Study||5
249789|NCT00518622|601727|P7|STARTED|Overall Study||4
249790|NCT00518622|601728|P6|STARTED|Overall Study||5
249791|NCT00518622|601729|P5|STARTED|Overall Study||6
249792|NCT00518622|601730|P4|STARTED|Overall Study||5
249793|NCT00518622|601731|P3|STARTED|Overall Study||6
249794|NCT00518622|601732|P2|STARTED|Overall Study||6
249795|NCT00518622|601733|P1|STARTED|Overall Study||3
249796|NCT00518531|601761|P2|NOT COMPLETED|Treatment Period 2||20
249797|NCT00518531|601762|P1|NOT COMPLETED|Treatment Period 2||3
249798|NCT00518531|601761|P2|COMPLETED|Treatment Period 2||95
249799|NCT00518531|601762|P1|COMPLETED|Treatment Period 2||103
249800|NCT00518531|601761|P2|Received Treatment|Treatment Period 2||110
249801|NCT00518531|601762|P1|Received Treatment|Treatment Period 2||106
249802|NCT00518531|601761|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
249803|NCT00518531|601762|P1|STARTED|Treatment Period 2||106
249804|NCT00518531|601761|P2|NOT COMPLETED|Treatment Period 1||12
249805|NCT00518531|601762|P1|NOT COMPLETED|Treatment Period 1||18
249806|NCT00518531|601761|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
249807|NCT00518531|601762|P1|COMPLETED|Treatment Period 1||106
249808|NCT00518531|601761|P2|Received Treatment|Treatment Period 1||124
249809|NCT00518531|601762|P1|Received Treatment|Treatment Period 1||119
249810|NCT00518531|601761|P2|STARTED|Treatment Period 1||126
249811|NCT00518531|601762|P1|STARTED|Treatment Period 1||124
249812|NCT00518349|601798|P2|NOT COMPLETED|Overall Study||0
249813|NCT00518349|601799|P1|NOT COMPLETED|Overall Study||0
249814|NCT00518349|601798|P2|COMPLETED|Overall Study||60
249815|NCT00518349|601799|P1|COMPLETED|Overall Study||60
249816|NCT00518349|601798|P2|STARTED|Overall Study||60
249817|NCT00518349|601799|P1|STARTED|Overall Study||60
249818|NCT00518336|601807|P2|NOT COMPLETED|Year 9||1
249819|NCT00518336|601808|P1|NOT COMPLETED|Year 9||5
249820|NCT00518336|601807|P2|COMPLETED|Year 9||212
249821|NCT00518336|601808|P1|COMPLETED|Year 9||219
249822|NCT00518336|601807|P2|STARTED|Year 9||213
249823|NCT00518336|601808|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
249824|NCT00518336|601807|P2|NOT COMPLETED|Year 8||2
249825|NCT00518336|601808|P1|NOT COMPLETED|Year 8||1
249826|NCT00518336|601807|P2|COMPLETED|Year 8||211
249827|NCT00518336|601808|P1|COMPLETED|Year 8||222
249828|NCT00518336|601807|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
249829|NCT00518336|601808|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
249830|NCT00518336|601807|P2|NOT COMPLETED|Year 7||3
249831|NCT00518336|601808|P1|NOT COMPLETED|Year 7||2
249832|NCT00518336|601807|P2|COMPLETED|Year 7||208
249833|NCT00518336|601808|P1|COMPLETED|Year 7||220
249834|NCT00518336|601807|P2|STARTED|Year 7||211
249835|NCT00518336|601808|P1|STARTED|Year 7||222
249836|NCT00518323|601974|P4|NOT COMPLETED|Overall Study||25
249837|NCT00518323|601975|P3|NOT COMPLETED|Overall Study||11
249838|NCT00518323|601976|P2|NOT COMPLETED|Overall Study||8
249839|NCT00518323|601977|P1|NOT COMPLETED|Overall Study||19
249840|NCT00518323|601974|P4|COMPLETED|Overall Study||26
249841|NCT00518323|601975|P3|COMPLETED|Overall Study||37
249842|NCT00518323|601976|P2|COMPLETED|Overall Study||40
249843|NCT00518323|601977|P1|COMPLETED|Overall Study||35
249844|NCT00518323|601974|P4|STARTED|Overall Study||51
249845|NCT00518323|601975|P3|STARTED|Overall Study||48
249846|NCT00518323|601976|P2|STARTED|Overall Study||48
249847|NCT00518323|601977|P1|STARTED|Overall Study||54
249848|NCT00518284|602007|P4|NOT COMPLETED|Overall Study||2
249849|NCT00518284|602008|P3|NOT COMPLETED|Overall Study||1
249850|NCT00518284|602009|P2|NOT COMPLETED|Overall Study||3
249851|NCT00518284|602010|P1|NOT COMPLETED|Overall Study||0
249852|NCT00518284|602007|P4|COMPLETED|Overall Study||0
249853|NCT00518284|602008|P3|COMPLETED|Overall Study||0
249854|NCT00518284|602009|P2|COMPLETED|Overall Study||0
249855|NCT00518284|602010|P1|COMPLETED|Overall Study||0
249856|NCT00518284|602007|P4|STARTED|Overall Study||2
249857|NCT00518284|602008|P3|STARTED|Overall Study||1
249858|NCT00518284|602009|P2|STARTED|Overall Study||3
249859|NCT00518284|602010|P1|STARTED|Overall Study||0
249860|NCT00518206|602066|P2|NOT COMPLETED|Overall Study||6
249861|NCT00518206|602067|P1|NOT COMPLETED|Overall Study||11
249862|NCT00518206|602066|P2|COMPLETED|Overall Study||13
249863|NCT00518206|602067|P1|COMPLETED|Overall Study||16
249864|NCT00518206|602066|P2|STARTED|Overall Study||19
249865|NCT00518206|602067|P1|STARTED|Overall Study||27
249866|NCT00518180|602084|P3|NOT COMPLETED|Overall Study||82
249867|NCT00518180|602085|P2|NOT COMPLETED|Overall Study||69
249868|NCT00518180|602086|P1|NOT COMPLETED|Overall Study||65
249869|NCT00518180|602084|P3|COMPLETED|Overall Study||457
249870|NCT00518180|602085|P2|COMPLETED|Overall Study||472
249871|NCT00518180|602086|P1|COMPLETED|Overall Study||475
249872|NCT00518180|602084|P3|STARTED|Overall Study||539
249873|NCT00518180|602085|P2|STARTED|Overall Study||541
249874|NCT00518180|602086|P1|STARTED|Overall Study||540
249875|NCT00518115|602138|P10|NOT COMPLETED|Overall Study||15
249876|NCT00518115|602139|P9|NOT COMPLETED|Overall Study||5
249877|NCT00518115|602140|P8|NOT COMPLETED|Overall Study||15
249878|NCT00518115|602141|P7|NOT COMPLETED|Overall Study||8
249879|NCT00518115|602142|P6|NOT COMPLETED|Overall Study||15
249880|NCT00518115|602143|P5|NOT COMPLETED|Overall Study||10
249881|NCT00518115|602144|P4|NOT COMPLETED|Overall Study||11
249882|NCT00518115|602145|P3|NOT COMPLETED|Overall Study||17
249883|NCT00518115|602146|P2|NOT COMPLETED|Overall Study||6
249884|NCT00518115|602147|P1|NOT COMPLETED|Overall Study||12
249885|NCT00518115|602138|P10|COMPLETED|Overall Study||20
249886|NCT00518115|602139|P9|COMPLETED|Overall Study||30
249887|NCT00518115|602140|P8|COMPLETED|Overall Study||20
249888|NCT00518115|602141|P7|COMPLETED|Overall Study||25
249889|NCT00518115|602142|P6|COMPLETED|Overall Study||19
249890|NCT00518115|602143|P5|COMPLETED|Overall Study||21
249891|NCT00518115|602144|P4|COMPLETED|Overall Study||24
249892|NCT00518115|602145|P3|COMPLETED|Overall Study||19
249893|NCT00518115|602146|P2|COMPLETED|Overall Study||29
249894|NCT00518115|602147|P1|COMPLETED|Overall Study||40
249895|NCT00518115|602138|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
249896|NCT00518115|602139|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
249897|NCT00518115|602140|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
249898|NCT00518115|602141|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
249899|NCT00518115|602142|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
249900|NCT00518115|602143|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
249901|NCT00518115|602144|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
249902|NCT00518115|602145|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
249903|NCT00518115|602146|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
249904|NCT00518115|602147|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
249905|NCT00518115|602138|P10|STARTED|Overall Study||35
249906|NCT00518115|602139|P9|STARTED|Overall Study||35
249907|NCT00518115|602140|P8|STARTED|Overall Study||35
249908|NCT00518115|602141|P7|STARTED|Overall Study||33
249909|NCT00518115|602142|P6|STARTED|Overall Study||34
249910|NCT00518115|602143|P5|STARTED|Overall Study||31
249911|NCT00518115|602144|P4|STARTED|Overall Study||35
249912|NCT00518115|602145|P3|STARTED|Overall Study||36
249913|NCT00518115|602146|P2|STARTED|Overall Study||35
249914|NCT00518115|602147|P1|STARTED|Overall Study||52
249915|NCT00518089|602305|P2|NOT COMPLETED|Overall Study||31
249916|NCT00518089|602306|P1|NOT COMPLETED|Overall Study||28
249917|NCT00518089|602305|P2|COMPLETED|Overall Study||398
249918|NCT00518089|602306|P1|COMPLETED|Overall Study||402
249919|NCT00518089|602305|P2|STARTED|Overall Study||429
249920|NCT00518089|602306|P1|STARTED|Overall Study||430
249921|NCT00518011|602322|P2|NOT COMPLETED|Overall Study||8
249922|NCT00518011|602323|P1|NOT COMPLETED|Overall Study||9
249923|NCT00518011|602322|P2|COMPLETED|Overall Study||0
249924|NCT00518011|602323|P1|COMPLETED|Overall Study||0
249925|NCT00518011|602322|P2|STARTED|Overall Study||8
249926|NCT00518011|602323|P1|STARTED|Overall Study||9
249927|NCT00517933|602345|P2|NOT COMPLETED|Period 2||13
249928|NCT00517933|602346|P1|NOT COMPLETED|Period 2||6
249929|NCT00517933|602345|P2|COMPLETED|Period 2||70
249930|NCT00517933|602346|P1|COMPLETED|Period 2||73
249931|NCT00517933|602345|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
249932|NCT00517933|602346|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
249933|NCT00517933|602345|P2|NOT COMPLETED|Period 1||6
249934|NCT00517933|602346|P1|NOT COMPLETED|Period 1||8
249935|NCT00517933|602345|P2|COMPLETED|Period 1||85
249936|NCT00517933|602346|P1|COMPLETED|Period 1||81
249937|NCT00517933|602345|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
249938|NCT00517933|602346|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
249939|NCT00517881|602410|P1|NOT COMPLETED|Overall Study||5
249940|NCT00517881|602410|P1|COMPLETED|Overall Study||24
249941|NCT00517881|602410|P1|STARTED|Overall Study||29
249942|NCT00517829|602422|P2|NOT COMPLETED|Overall Study||75
249943|NCT00517829|602423|P1|NOT COMPLETED|Overall Study||75
249944|NCT00517829|602422|P2|COMPLETED|Overall Study||0
249945|NCT00517829|602423|P1|COMPLETED|Overall Study||0
249946|NCT00517829|602422|P2|STARTED|Overall Study||75
249947|NCT00517829|602423|P1|STARTED|Overall Study||75
249948|NCT00517751|602437|P1|NOT COMPLETED|Overall Study||129
249949|NCT00517751|602437|P1|COMPLETED|Overall Study||33
249950|NCT00517751|602437|P1|STARTED|Overall Study||162
249951|NCT00517699|602460|P1|NOT COMPLETED|Overall Study||5
249952|NCT00517699|602460|P1|COMPLETED|Overall Study||0
249953|NCT00517699|602460|P1|STARTED|Overall Study||5
249954|NCT00517634|602468|P6|NOT COMPLETED|Third Treatment Period||0
249955|NCT00517634|602469|P5|NOT COMPLETED|Third Treatment Period||0
249956|NCT00517634|602470|P4|NOT COMPLETED|Third Treatment Period||0
249957|NCT00517634|602471|P3|NOT COMPLETED|Third Treatment Period||0
249958|NCT00517634|602472|P2|NOT COMPLETED|Third Treatment Period||0
249959|NCT00517634|602473|P1|NOT COMPLETED|Third Treatment Period||0
249960|NCT00517634|602468|P6|COMPLETED|Third Treatment Period||4
249961|NCT00517634|602469|P5|COMPLETED|Third Treatment Period||3
249962|NCT00517634|602470|P4|COMPLETED|Third Treatment Period||3
249963|NCT00517634|602471|P3|COMPLETED|Third Treatment Period||4
249964|NCT00517634|602472|P2|COMPLETED|Third Treatment Period||4
249965|NCT00517634|602473|P1|COMPLETED|Third Treatment Period||4
249966|NCT00517634|602468|P6|STARTED|Third Treatment Period||4
249967|NCT00517634|602469|P5|STARTED|Third Treatment Period||3
249968|NCT00517634|602470|P4|STARTED|Third Treatment Period||3
249969|NCT00517634|602471|P3|STARTED|Third Treatment Period||4
249970|NCT00517634|602472|P2|STARTED|Third Treatment Period||4
249971|NCT00517634|602473|P1|STARTED|Third Treatment Period||4
249972|NCT00517634|602468|P6|NOT COMPLETED|Second Treatment Period||0
249973|NCT00517634|602469|P5|NOT COMPLETED|Second Treatment Period||1
249974|NCT00517634|602470|P4|NOT COMPLETED|Second Treatment Period||0
249975|NCT00517634|602471|P3|NOT COMPLETED|Second Treatment Period||0
249976|NCT00517634|602472|P2|NOT COMPLETED|Second Treatment Period||0
249977|NCT00517634|602473|P1|NOT COMPLETED|Second Treatment Period||0
249978|NCT00517634|602468|P6|COMPLETED|Second Treatment Period||4
249979|NCT00517634|602469|P5|COMPLETED|Second Treatment Period||3
249980|NCT00517634|602470|P4|COMPLETED|Second Treatment Period||3
249981|NCT00517634|602471|P3|COMPLETED|Second Treatment Period||4
249982|NCT00517634|602472|P2|COMPLETED|Second Treatment Period||4
249983|NCT00517634|602473|P1|COMPLETED|Second Treatment Period||4
249984|NCT00517634|602468|P6|STARTED|Second Treatment Period||4
249985|NCT00517634|602469|P5|STARTED|Second Treatment Period||4
249986|NCT00517634|602470|P4|STARTED|Second Treatment Period||3
249987|NCT00517634|602471|P3|STARTED|Second Treatment Period||4
249988|NCT00517634|602472|P2|STARTED|Second Treatment Period||4
249989|NCT00517634|602473|P1|STARTED|Second Treatment Period||4
249990|NCT00517634|602468|P6|NOT COMPLETED|First Treatment Period||0
249991|NCT00517634|602469|P5|NOT COMPLETED|First Treatment Period||0
249992|NCT00517634|602470|P4|NOT COMPLETED|First Treatment Period||0
249993|NCT00517634|602471|P3|NOT COMPLETED|First Treatment Period||0
249994|NCT00517634|602472|P2|NOT COMPLETED|First Treatment Period||0
249995|NCT00517634|602473|P1|NOT COMPLETED|First Treatment Period||0
249996|NCT00517634|602468|P6|COMPLETED|First Treatment Period||4
249997|NCT00517634|602469|P5|COMPLETED|First Treatment Period||4
249998|NCT00517634|602470|P4|COMPLETED|First Treatment Period||3
249999|NCT00517634|602471|P3|COMPLETED|First Treatment Period||4
250000|NCT00517634|602472|P2|COMPLETED|First Treatment Period||4
250001|NCT00517634|602473|P1|COMPLETED|First Treatment Period||4
250002|NCT00517634|602468|P6|STARTED|First Treatment Period||4
250003|NCT00517634|602469|P5|STARTED|First Treatment Period||4
250004|NCT00517634|602470|P4|STARTED|First Treatment Period||3
250005|NCT00517634|602471|P3|STARTED|First Treatment Period||4
250006|NCT00517634|602472|P2|STARTED|First Treatment Period||4
250007|NCT00517634|602473|P1|STARTED|First Treatment Period||4
250008|NCT00517595|602484|P1|NOT COMPLETED|Overall Study||0
250009|NCT00517595|602484|P1|COMPLETED|Overall Study||48
250010|NCT00517595|602484|P1|STARTED|Overall Study||48
250011|NCT00517556|602495|P2|NOT COMPLETED|Overall Study||5
250012|NCT00517556|602496|P1|NOT COMPLETED|Overall Study||4
250013|NCT00517556|602495|P2|COMPLETED|Overall Study||14
250014|NCT00517556|602496|P1|COMPLETED|Overall Study||15
250015|NCT00517556|602495|P2|STARTED|Overall Study||19
250016|NCT00517556|602496|P1|STARTED|Overall Study||19
250017|NCT00517530|602509|P7|NOT COMPLETED|Overall Study||19
250018|NCT00517530|602510|P6|NOT COMPLETED|Overall Study||19
250019|NCT00517530|602511|P5|NOT COMPLETED|Overall Study||20
250020|NCT00517530|602512|P4|NOT COMPLETED|Overall Study||21
250021|NCT00517530|602513|P3|NOT COMPLETED|Overall Study||18
250022|NCT00517530|602514|P2|NOT COMPLETED|Overall Study||13
250023|NCT00517530|602515|P1|NOT COMPLETED|Overall Study||19
250024|NCT00517530|602509|P7|COMPLETED|Overall Study||1
250025|NCT00517530|602510|P6|COMPLETED|Overall Study||0
250026|NCT00517530|602511|P5|COMPLETED|Overall Study||1
250027|NCT00517530|602512|P4|COMPLETED|Overall Study||1
250028|NCT00517530|602513|P3|COMPLETED|Overall Study||0
250029|NCT00517530|602514|P2|COMPLETED|Overall Study||0
250030|NCT00517530|602515|P1|COMPLETED|Overall Study||2
250031|NCT00517530|602509|P7|Retreated Population|Overall Study||0
250032|NCT00517530|602510|P6|Retreated Population|Overall Study||2
250033|NCT00517530|602511|P5|Retreated Population|Overall Study||2
250034|NCT00517530|602512|P4|Retreated Population|Overall Study||4
250035|NCT00517530|602513|P3|Retreated Population|Overall Study||1
250036|NCT00517530|602514|P2|Retreated Population|Overall Study||2
250037|NCT00517530|602515|P1|Retreated Population|Overall Study||2
250038|NCT00517530|602509|P7|Completed Follow-up|Overall Study||1
250039|NCT00517530|602510|P6|Completed Follow-up|Overall Study||0
250040|NCT00517530|602511|P5|Completed Follow-up|Overall Study||0
250041|NCT00517530|602512|P4|Completed Follow-up|Overall Study||1
250042|NCT00517530|602513|P3|Completed Follow-up|Overall Study||0
250043|NCT00517530|602514|P2|Completed Follow-up|Overall Study||0
250044|NCT00517530|602515|P1|Completed Follow-up|Overall Study||2
250045|NCT00517530|602509|P7|Started Follow-up|Overall Study||19
250046|NCT00517530|602510|P6|Started Follow-up|Overall Study||16
250047|NCT00517530|602511|P5|Started Follow-up|Overall Study||17
250048|NCT00517530|602512|P4|Started Follow-up|Overall Study||21
250049|NCT00517530|602513|P3|Started Follow-up|Overall Study||17
250050|NCT00517530|602514|P2|Started Follow-up|Overall Study||13
250051|NCT00517530|602515|P1|Started Follow-up|Overall Study||20
250052|NCT00517530|602509|P7|Completed Treatment|Overall Study||13
250053|NCT00517530|602510|P6|Completed Treatment|Overall Study||9
250054|NCT00517530|602511|P5|Completed Treatment|Overall Study||9
250055|NCT00517530|602512|P4|Completed Treatment|Overall Study||18
250056|NCT00517530|602513|P3|Completed Treatment|Overall Study||13
250057|NCT00517530|602514|P2|Completed Treatment|Overall Study||13
250058|NCT00517530|602515|P1|Completed Treatment|Overall Study||11
250059|NCT00517530|602509|P7|STARTED|Overall Study||20
250060|NCT00517530|602510|P6|STARTED|Overall Study||19
250061|NCT00517530|602511|P5|STARTED|Overall Study||21
250062|NCT00517530|602512|P4|STARTED|Overall Study||22
250063|NCT00517530|602513|P3|STARTED|Overall Study||18
250064|NCT00517530|602514|P2|STARTED|Overall Study||13
250065|NCT00517530|602515|P1|STARTED|Overall Study||21
250066|NCT00517413|602575|P1|NOT COMPLETED|Overall Study||61
250067|NCT00517413|602575|P1|COMPLETED|Overall Study||102
250068|NCT00517413|602575|P1|STARTED|Overall Study||163
250069|NCT00517361|602596|P1|NOT COMPLETED|Overall Study||11
250070|NCT00517361|602596|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
250071|NCT00517361|602596|P1|STARTED|Overall Study||11
250072|NCT00517296|602605|P2|NOT COMPLETED|Overall Study||0
250073|NCT00517296|602606|P1|NOT COMPLETED|Overall Study||1
250074|NCT00517296|602605|P2|COMPLETED|Overall Study||11
250075|NCT00517296|602606|P1|COMPLETED|Overall Study||9
250076|NCT00517296|602605|P2|STARTED|Overall Study||11
250077|NCT00517296|602606|P1|STARTED|Overall Study||10
250078|NCT00517192|602618|P2|NOT COMPLETED|Overall Study||20
250079|NCT00517192|602619|P1|NOT COMPLETED|Overall Study||19
250080|NCT00517192|602618|P2|COMPLETED|Overall Study||0
250081|NCT00517192|602619|P1|COMPLETED|Overall Study||0
250082|NCT00517192|602618|P2|STARTED|Overall Study||20
250083|NCT00517192|602619|P1|STARTED|Overall Study||19
250084|NCT00517075|602671|P4|NOT COMPLETED|Overall Study||0
250085|NCT00517075|602672|P3|NOT COMPLETED|Overall Study||0
250086|NCT00517075|602673|P2|NOT COMPLETED|Overall Study||0
250087|NCT00517075|602674|P1|NOT COMPLETED|Overall Study||0
250088|NCT00517075|602671|P4|COMPLETED|Overall Study||0
250089|NCT00517075|602672|P3|COMPLETED|Overall Study||0
250090|NCT00517075|602673|P2|COMPLETED|Overall Study||0
250091|NCT00517075|602674|P1|COMPLETED|Overall Study||0
250092|NCT00517075|602671|P4|STARTED|Overall Study||0
250093|NCT00517075|602672|P3|STARTED|Overall Study||0
250094|NCT00517075|602673|P2|STARTED|Overall Study||0
250095|NCT00517075|602674|P1|STARTED|Overall Study||0
250096|NCT00517010|602712|P1|NOT COMPLETED|Overall Study||1
250097|NCT00517010|602712|P1|COMPLETED|Overall Study||5
250098|NCT00517010|602712|P1|STARTED|Overall Study||6
250099|NCT00516919|602717|P2|NOT COMPLETED|Overall Study||7
250100|NCT00516919|602718|P1|NOT COMPLETED|Overall Study||10
250101|NCT00516919|602717|P2|COMPLETED|Overall Study||32
250102|NCT00516919|602718|P1|COMPLETED|Overall Study||30
250103|NCT00516919|602717|P2|STARTED|Overall Study||39
250104|NCT00516919|602718|P1|STARTED|Overall Study||40
250105|NCT00516906|602726|P2|NOT COMPLETED|Overall Study||2
250106|NCT00516906|602727|P1|NOT COMPLETED|Overall Study||6
250107|NCT00516906|602726|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
250108|NCT00516906|602727|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
250109|NCT00516906|602726|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
250110|NCT00516906|602727|P1|STARTED|Overall Study||36
250111|NCT00516893|602737|P1|NOT COMPLETED|Overall Study||21
250112|NCT00516893|602737|P1|COMPLETED|Overall Study||92
250113|NCT00516893|602737|P1|Received Study Treatment|Overall Study||112
250114|NCT00516893|602737|P1|STARTED|Overall Study||113
250115|NCT00516737|602746|P2|NOT COMPLETED|Overall Study||8
250116|NCT00516737|602747|P1|NOT COMPLETED|Overall Study||11
250117|NCT00516737|602746|P2|COMPLETED|Overall Study||96
250118|NCT00516737|602747|P1|COMPLETED|Overall Study||92
250119|NCT00516737|602746|P2|STARTED|Overall Study||104
250120|NCT00516737|602747|P1|STARTED|Overall Study||103
250121|NCT00516503|602767|P2|NOT COMPLETED|Overall Study||0
250122|NCT00516503|602768|P1|NOT COMPLETED|Overall Study||0
250123|NCT00516503|602767|P2|COMPLETED|Overall Study||102
250124|NCT00516503|602768|P1|COMPLETED|Overall Study||101
250125|NCT00516503|602767|P2|STARTED|Overall Study||102
250126|NCT00516503|602768|P1|STARTED|Overall Study||101
250127|NCT00516386|602786|P1|NOT COMPLETED|Overall Study||6
250128|NCT00516386|602786|P1|COMPLETED|Overall Study||10
250129|NCT00516386|602786|P1|STARTED|Overall Study||16
250130|NCT00516321|602793|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
250131|NCT00516321|602794|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
250132|NCT00516321|602795|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
250133|NCT00516321|602793|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
250134|NCT00516321|602794|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
250135|NCT00516321|602795|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
250136|NCT00516321|602793|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
250137|NCT00516321|602794|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
250138|NCT00516321|602795|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
250139|NCT00516321|602793|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
250140|NCT00516321|602794|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
250141|NCT00516321|602795|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
250142|NCT00516321|602793|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
250143|NCT00516321|602794|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
250144|NCT00516321|602795|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
250145|NCT00516321|602793|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
250146|NCT00516321|602794|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
250147|NCT00516321|602795|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
250148|NCT00516295|602846|P3|NOT COMPLETED|Overall Study||0
250149|NCT00516295|602847|P2|NOT COMPLETED|Overall Study||0
250150|NCT00516295|602848|P1|NOT COMPLETED|Overall Study||3
250151|NCT00516295|602846|P3|COMPLETED|Overall Study||0
250152|NCT00516295|602847|P2|COMPLETED|Overall Study||0
250153|NCT00516295|602848|P1|COMPLETED|Overall Study||4
250154|NCT00516295|602846|P3|STARTED|Overall Study||0
250155|NCT00516295|602847|P2|STARTED|Overall Study||0
250156|NCT00516295|602848|P1|STARTED|Overall Study||7
250157|NCT00516269|602861|P2|NOT COMPLETED|Overall Study||3
250158|NCT00516269|602862|P1|NOT COMPLETED|Overall Study||2
250159|NCT00516269|602861|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
250160|NCT00516269|602862|P1|COMPLETED|Overall Study|2 patients had an early termination|17
250161|NCT00516269|602861|P2|STARTED|Overall Study||19
250162|NCT00516269|602862|P1|STARTED|Overall Study||19
250163|NCT00516217|602868|P1|NOT COMPLETED|Overall Study||0
250164|NCT00516217|602868|P1|COMPLETED|Overall Study||29
250165|NCT00516217|602868|P1|STARTED|Overall Study||29
250166|NCT00516165|602874|P1|NOT COMPLETED|Overall Study||0
250167|NCT00516165|602874|P1|COMPLETED|Overall Study||28
250168|NCT00516165|602874|P1|STARTED|Overall Study||28
250169|NCT00516139|602883|P1|NOT COMPLETED|Overall Study||38
250170|NCT00516139|602883|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
250171|NCT00516139|602883|P1|STARTED|Overall Study||122
250172|NCT00516074|602914|P2|NOT COMPLETED|Overall Study||3
250173|NCT00516074|602915|P1|NOT COMPLETED|Overall Study||6
250174|NCT00516074|602914|P2|COMPLETED|Overall Study||23
250175|NCT00516074|602915|P1|COMPLETED|Overall Study||22
250176|NCT00516074|602914|P2|STARTED|Overall Study||26
250177|NCT00516074|602915|P1|STARTED|Overall Study||28
250178|NCT00516048|602933|P3|NOT COMPLETED|Overall Study||1
250179|NCT00516048|602934|P2|NOT COMPLETED|Overall Study||2
250180|NCT00516048|602935|P1|NOT COMPLETED|Overall Study||0
250181|NCT00516048|602933|P3|COMPLETED|Overall Study||0
250182|NCT00516048|602934|P2|COMPLETED|Overall Study||40
250183|NCT00516048|602935|P1|COMPLETED|Overall Study||15
250184|NCT00516048|602933|P3|STARTED|Overall Study||1
250185|NCT00516048|602934|P2|STARTED|Overall Study||42
250186|NCT00516048|602935|P1|STARTED|Overall Study||15
250187|NCT00515879|602951|P2|NOT COMPLETED|Overall Study||20
250188|NCT00515879|602952|P1|NOT COMPLETED|Overall Study||25
250189|NCT00515879|602951|P2|COMPLETED|Overall Study||62
250190|NCT00515879|602952|P1|COMPLETED|Overall Study||62
250191|NCT00515879|602951|P2|STARTED|Overall Study||82
250192|NCT00515879|602952|P1|STARTED|Overall Study||87
250193|NCT00515827|602962|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
250194|NCT00515827|602963|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
250195|NCT00515827|602962|P2|COMPLETED|Second Intervention (12 Weeks)||25
250196|NCT00515827|602963|P1|COMPLETED|Second Intervention (12 Weeks)||25
250197|NCT00515827|602962|P2|STARTED|Second Intervention (12 Weeks)||25
250198|NCT00515827|602963|P1|STARTED|Second Intervention (12 Weeks)||26
250199|NCT00515827|602962|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
250200|NCT00515827|602963|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
250201|NCT00515827|602962|P2|COMPLETED|First Intervention (12 Weeks)||25
250202|NCT00515827|602963|P1|COMPLETED|First Intervention (12 Weeks)||26
250203|NCT00515827|602962|P2|STARTED|First Intervention (12 Weeks)||26
250204|NCT00515827|602963|P1|STARTED|First Intervention (12 Weeks)||27
250205|NCT00515697|602985|P1|NOT COMPLETED|Overall Study||0
250206|NCT00515697|602985|P1|COMPLETED|Overall Study||39
250207|NCT00515697|602985|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
250208|NCT00515697|602985|P1|STARTED|Overall Study||39
250209|NCT00515671|602998|P2|NOT COMPLETED|Overall Study||17
250210|NCT00515671|602999|P1|NOT COMPLETED|Overall Study||17
250211|NCT00515671|602998|P2|COMPLETED|Overall Study||41
250212|NCT00515671|602999|P1|COMPLETED|Overall Study||43
250213|NCT00515671|602998|P2|STARTED|Overall Study||58
250214|NCT00515671|602999|P1|STARTED|Overall Study||60
250215|NCT00515619|603007|P1|NOT COMPLETED|Overall Study||216
250216|NCT00515619|603007|P1|COMPLETED|Overall Study||160
250217|NCT00515619|603007|P1|Safety Set|Overall Study||376
250218|NCT00515619|603007|P1|STARTED|Overall Study||376
250219|NCT00515541|603019|P4|NOT COMPLETED|Overall Study||5
250220|NCT00515541|603020|P3|NOT COMPLETED|Overall Study||0
250221|NCT00515541|603021|P2|NOT COMPLETED|Overall Study||5
250222|NCT00515541|603022|P1|NOT COMPLETED|Overall Study||0
250223|NCT00515541|603019|P4|COMPLETED|Overall Study||6
250224|NCT00515541|603020|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
250225|NCT00515541|603021|P2|COMPLETED|Overall Study||7
250226|NCT00515541|603022|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
250227|NCT00515541|603019|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
250228|NCT00515541|603020|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
250229|NCT00515541|603021|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
250230|NCT00515541|603022|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
250231|NCT00515541|603019|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
250232|NCT00515541|603020|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
250233|NCT00515541|603021|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
250234|NCT00515541|603022|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
250235|NCT00515541|603019|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
250236|NCT00515541|603020|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
250237|NCT00515541|603021|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
250238|NCT00515541|603022|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
250239|NCT00515541|603019|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
250240|NCT00515541|603020|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
250241|NCT00515541|603021|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
250242|NCT00515541|603022|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
250243|NCT00515541|603019|P4|STARTED|Overall Study||11
250244|NCT00515541|603020|P3|STARTED|Overall Study||10
250245|NCT00515541|603021|P2|STARTED|Overall Study||12
250246|NCT00515541|603022|P1|STARTED|Overall Study||10
250247|NCT00515502|603044|P12|NOT COMPLETED|Treatment Period 4||0
250248|NCT00515502|603045|P11|NOT COMPLETED|Treatment Period 4||0
250249|NCT00515502|603046|P10|NOT COMPLETED|Treatment Period 4||0
250250|NCT00515502|603047|P9|NOT COMPLETED|Treatment Period 4||0
250251|NCT00515502|603048|P8|NOT COMPLETED|Treatment Period 4||0
250252|NCT00515502|603049|P7|NOT COMPLETED|Treatment Period 4||0
250253|NCT00515502|603050|P6|NOT COMPLETED|Treatment Period 4||0
250254|NCT00515502|603051|P5|NOT COMPLETED|Treatment Period 4||0
250255|NCT00515502|603052|P4|NOT COMPLETED|Treatment Period 4||0
250256|NCT00515502|603053|P3|NOT COMPLETED|Treatment Period 4||0
250257|NCT00515502|603054|P2|NOT COMPLETED|Treatment Period 4||0
250258|NCT00515502|603055|P1|NOT COMPLETED|Treatment Period 4||0
250259|NCT00515502|603044|P12|COMPLETED|Treatment Period 4||0
250260|NCT00515502|603045|P11|COMPLETED|Treatment Period 4||1
250261|NCT00515502|603046|P10|COMPLETED|Treatment Period 4||2
250262|NCT00515502|603047|P9|COMPLETED|Treatment Period 4||0
250263|NCT00515502|603048|P8|COMPLETED|Treatment Period 4||1
250264|NCT00515502|603049|P7|COMPLETED|Treatment Period 4||1
250265|NCT00515502|603050|P6|COMPLETED|Treatment Period 4||1
250266|NCT00515502|603051|P5|COMPLETED|Treatment Period 4||3
250267|NCT00515502|603052|P4|COMPLETED|Treatment Period 4||3
250268|NCT00515502|603053|P3|COMPLETED|Treatment Period 4||4
250269|NCT00515502|603054|P2|COMPLETED|Treatment Period 4||3
250270|NCT00515502|603055|P1|COMPLETED|Treatment Period 4||1
250271|NCT00515502|603044|P12|STARTED|Treatment Period 4||0
250272|NCT00515502|603045|P11|STARTED|Treatment Period 4||1
250273|NCT00515502|603046|P10|STARTED|Treatment Period 4||2
250274|NCT00515502|603047|P9|STARTED|Treatment Period 4||0
250275|NCT00515502|603048|P8|STARTED|Treatment Period 4||1
250276|NCT00515502|603049|P7|STARTED|Treatment Period 4||1
250277|NCT00515502|603050|P6|STARTED|Treatment Period 4||1
250278|NCT00515502|603051|P5|STARTED|Treatment Period 4||3
250279|NCT00515502|603052|P4|STARTED|Treatment Period 4||3
250280|NCT00515502|603053|P3|STARTED|Treatment Period 4||4
250281|NCT00515502|603054|P2|STARTED|Treatment Period 4||3
250282|NCT00515502|603055|P1|STARTED|Treatment Period 4||1
250283|NCT00515502|603044|P12|NOT COMPLETED|Washout Period 3||0
250284|NCT00515502|603045|P11|NOT COMPLETED|Washout Period 3||0
250285|NCT00515502|603046|P10|NOT COMPLETED|Washout Period 3||0
250286|NCT00515502|603047|P9|NOT COMPLETED|Washout Period 3||0
250287|NCT00515502|603048|P8|NOT COMPLETED|Washout Period 3||0
250288|NCT00515502|603049|P7|NOT COMPLETED|Washout Period 3||0
250289|NCT00515502|603050|P6|NOT COMPLETED|Washout Period 3||0
250290|NCT00515502|603051|P5|NOT COMPLETED|Washout Period 3||0
250291|NCT00515502|603052|P4|NOT COMPLETED|Washout Period 3||0
250292|NCT00515502|603053|P3|NOT COMPLETED|Washout Period 3||0
250293|NCT00515502|603054|P2|NOT COMPLETED|Washout Period 3||0
250294|NCT00515502|603055|P1|NOT COMPLETED|Washout Period 3||0
250295|NCT00515502|603044|P12|COMPLETED|Washout Period 3||0
250296|NCT00515502|603045|P11|COMPLETED|Washout Period 3||1
250297|NCT00515502|603046|P10|COMPLETED|Washout Period 3||2
250298|NCT00515502|603047|P9|COMPLETED|Washout Period 3||0
250299|NCT00515502|603048|P8|COMPLETED|Washout Period 3||1
250300|NCT00515502|603049|P7|COMPLETED|Washout Period 3||1
250301|NCT00515502|603050|P6|COMPLETED|Washout Period 3||1
250302|NCT00515502|603051|P5|COMPLETED|Washout Period 3||3
250303|NCT00515502|603052|P4|COMPLETED|Washout Period 3||3
250304|NCT00515502|603053|P3|COMPLETED|Washout Period 3||4
250305|NCT00515502|603054|P2|COMPLETED|Washout Period 3||3
250306|NCT00515502|603055|P1|COMPLETED|Washout Period 3||1
250307|NCT00515502|603044|P12|STARTED|Washout Period 3||0
250308|NCT00515502|603045|P11|STARTED|Washout Period 3||1
250309|NCT00515502|603046|P10|STARTED|Washout Period 3||2
250310|NCT00515502|603047|P9|STARTED|Washout Period 3||0
250311|NCT00515502|603048|P8|STARTED|Washout Period 3||1
250312|NCT00515502|603049|P7|STARTED|Washout Period 3||1
250313|NCT00515502|603050|P6|STARTED|Washout Period 3||1
250314|NCT00515502|603051|P5|STARTED|Washout Period 3||3
250315|NCT00515502|603052|P4|STARTED|Washout Period 3||3
250316|NCT00515502|603053|P3|STARTED|Washout Period 3||4
250317|NCT00515502|603054|P2|STARTED|Washout Period 3||3
250318|NCT00515502|603055|P1|STARTED|Washout Period 3||1
250319|NCT00515502|603044|P12|NOT COMPLETED|Treatment Period 3||0
250320|NCT00515502|603045|P11|NOT COMPLETED|Treatment Period 3||0
250321|NCT00515502|603046|P10|NOT COMPLETED|Treatment Period 3||0
250322|NCT00515502|603047|P9|NOT COMPLETED|Treatment Period 3||0
250323|NCT00515502|603048|P8|NOT COMPLETED|Treatment Period 3||0
250324|NCT00515502|603049|P7|NOT COMPLETED|Treatment Period 3||0
250325|NCT00515502|603050|P6|NOT COMPLETED|Treatment Period 3||0
250326|NCT00515502|603051|P5|NOT COMPLETED|Treatment Period 3||0
250327|NCT00515502|603052|P4|NOT COMPLETED|Treatment Period 3||0
250328|NCT00515502|603053|P3|NOT COMPLETED|Treatment Period 3||0
250329|NCT00515502|603054|P2|NOT COMPLETED|Treatment Period 3||0
250330|NCT00515502|603055|P1|NOT COMPLETED|Treatment Period 3||0
250331|NCT00515502|603044|P12|COMPLETED|Treatment Period 3||0
250332|NCT00515502|603045|P11|COMPLETED|Treatment Period 3||1
250333|NCT00515502|603046|P10|COMPLETED|Treatment Period 3||2
250334|NCT00515502|603047|P9|COMPLETED|Treatment Period 3||0
250335|NCT00515502|603048|P8|COMPLETED|Treatment Period 3||1
250336|NCT00515502|603049|P7|COMPLETED|Treatment Period 3||1
250337|NCT00515502|603050|P6|COMPLETED|Treatment Period 3||1
250338|NCT00515502|603051|P5|COMPLETED|Treatment Period 3||3
250339|NCT00515502|603052|P4|COMPLETED|Treatment Period 3||3
250340|NCT00515502|603053|P3|COMPLETED|Treatment Period 3||4
250341|NCT00515502|603054|P2|COMPLETED|Treatment Period 3||3
250342|NCT00515502|603055|P1|COMPLETED|Treatment Period 3||1
250343|NCT00515502|603044|P12|STARTED|Treatment Period 3||0
250344|NCT00515502|603045|P11|STARTED|Treatment Period 3||1
250345|NCT00515502|603046|P10|STARTED|Treatment Period 3||2
250346|NCT00515502|603047|P9|STARTED|Treatment Period 3||0
250347|NCT00515502|603048|P8|STARTED|Treatment Period 3||1
250348|NCT00515502|603049|P7|STARTED|Treatment Period 3||1
250349|NCT00515502|603050|P6|STARTED|Treatment Period 3||1
250350|NCT00515502|603051|P5|STARTED|Treatment Period 3||3
250351|NCT00515502|603052|P4|STARTED|Treatment Period 3||3
250352|NCT00515502|603053|P3|STARTED|Treatment Period 3||4
250353|NCT00515502|603054|P2|STARTED|Treatment Period 3||3
250354|NCT00515502|603055|P1|STARTED|Treatment Period 3||1
250355|NCT00515502|603044|P12|NOT COMPLETED|Washout Period 2||0
250356|NCT00515502|603045|P11|NOT COMPLETED|Washout Period 2||0
250357|NCT00515502|603046|P10|NOT COMPLETED|Washout Period 2||0
250358|NCT00515502|603047|P9|NOT COMPLETED|Washout Period 2||0
250359|NCT00515502|603048|P8|NOT COMPLETED|Washout Period 2||0
250360|NCT00515502|603049|P7|NOT COMPLETED|Washout Period 2||0
250361|NCT00515502|603050|P6|NOT COMPLETED|Washout Period 2||0
250362|NCT00515502|603051|P5|NOT COMPLETED|Washout Period 2||0
250363|NCT00515502|603052|P4|NOT COMPLETED|Washout Period 2||0
250364|NCT00515502|603053|P3|NOT COMPLETED|Washout Period 2||0
250365|NCT00515502|603054|P2|NOT COMPLETED|Washout Period 2||0
250366|NCT00515502|603055|P1|NOT COMPLETED|Washout Period 2||0
250367|NCT00515502|603044|P12|COMPLETED|Washout Period 2||0
250368|NCT00515502|603045|P11|COMPLETED|Washout Period 2||1
250369|NCT00515502|603046|P10|COMPLETED|Washout Period 2||2
250370|NCT00515502|603047|P9|COMPLETED|Washout Period 2||0
250371|NCT00515502|603048|P8|COMPLETED|Washout Period 2||1
250372|NCT00515502|603049|P7|COMPLETED|Washout Period 2||1
250373|NCT00515502|603050|P6|COMPLETED|Washout Period 2||1
250374|NCT00515502|603051|P5|COMPLETED|Washout Period 2||3
250375|NCT00515502|603052|P4|COMPLETED|Washout Period 2||3
250376|NCT00515502|603053|P3|COMPLETED|Washout Period 2||4
250377|NCT00515502|603054|P2|COMPLETED|Washout Period 2||3
250378|NCT00515502|603055|P1|COMPLETED|Washout Period 2||1
250379|NCT00515502|603044|P12|STARTED|Washout Period 2||0
250380|NCT00515502|603045|P11|STARTED|Washout Period 2||1
250381|NCT00515502|603046|P10|STARTED|Washout Period 2||2
250382|NCT00515502|603047|P9|STARTED|Washout Period 2||0
250383|NCT00515502|603048|P8|STARTED|Washout Period 2||1
250384|NCT00515502|603049|P7|STARTED|Washout Period 2||1
250385|NCT00515502|603050|P6|STARTED|Washout Period 2||1
250386|NCT00515502|603051|P5|STARTED|Washout Period 2||3
250387|NCT00515502|603052|P4|STARTED|Washout Period 2||3
250388|NCT00515502|603053|P3|STARTED|Washout Period 2||4
250389|NCT00515502|603054|P2|STARTED|Washout Period 2||3
250390|NCT00515502|603055|P1|STARTED|Washout Period 2||1
250391|NCT00515502|603044|P12|NOT COMPLETED|Treatment Period 2||0
250392|NCT00515502|603045|P11|NOT COMPLETED|Treatment Period 2||0
250393|NCT00515502|603046|P10|NOT COMPLETED|Treatment Period 2||0
250394|NCT00515502|603047|P9|NOT COMPLETED|Treatment Period 2||0
250395|NCT00515502|603048|P8|NOT COMPLETED|Treatment Period 2||0
250396|NCT00515502|603049|P7|NOT COMPLETED|Treatment Period 2||0
250397|NCT00515502|603050|P6|NOT COMPLETED|Treatment Period 2||0
250398|NCT00515502|603051|P5|NOT COMPLETED|Treatment Period 2||0
250399|NCT00515502|603052|P4|NOT COMPLETED|Treatment Period 2||0
250400|NCT00515502|603053|P3|NOT COMPLETED|Treatment Period 2||0
250401|NCT00515502|603054|P2|NOT COMPLETED|Treatment Period 2||1
250402|NCT00515502|603055|P1|NOT COMPLETED|Treatment Period 2||0
250403|NCT00515502|603044|P12|COMPLETED|Treatment Period 2||0
250404|NCT00515502|603045|P11|COMPLETED|Treatment Period 2||1
250405|NCT00515502|603046|P10|COMPLETED|Treatment Period 2||2
250406|NCT00515502|603047|P9|COMPLETED|Treatment Period 2||0
250407|NCT00515502|603048|P8|COMPLETED|Treatment Period 2||1
250408|NCT00515502|603049|P7|COMPLETED|Treatment Period 2||1
250409|NCT00515502|603050|P6|COMPLETED|Treatment Period 2||1
250410|NCT00515502|603051|P5|COMPLETED|Treatment Period 2||3
250411|NCT00515502|603052|P4|COMPLETED|Treatment Period 2||3
250412|NCT00515502|603053|P3|COMPLETED|Treatment Period 2||4
250413|NCT00515502|603054|P2|COMPLETED|Treatment Period 2||3
250414|NCT00515502|603055|P1|COMPLETED|Treatment Period 2||1
250415|NCT00515502|603044|P12|STARTED|Treatment Period 2||0
250416|NCT00515502|603045|P11|STARTED|Treatment Period 2||1
250417|NCT00515502|603046|P10|STARTED|Treatment Period 2||2
250418|NCT00515502|603047|P9|STARTED|Treatment Period 2||0
250419|NCT00515502|603048|P8|STARTED|Treatment Period 2||1
250420|NCT00515502|603049|P7|STARTED|Treatment Period 2||1
250421|NCT00515502|603050|P6|STARTED|Treatment Period 2||1
250422|NCT00515502|603051|P5|STARTED|Treatment Period 2||3
250423|NCT00515502|603052|P4|STARTED|Treatment Period 2||3
250424|NCT00515502|603053|P3|STARTED|Treatment Period 2||4
250425|NCT00515502|603054|P2|STARTED|Treatment Period 2||4
250426|NCT00515502|603055|P1|STARTED|Treatment Period 2||1
250427|NCT00515502|603044|P12|NOT COMPLETED|Washout Period 1||0
250428|NCT00515502|603045|P11|NOT COMPLETED|Washout Period 1||0
250429|NCT00515502|603046|P10|NOT COMPLETED|Washout Period 1||0
250430|NCT00515502|603047|P9|NOT COMPLETED|Washout Period 1||0
250431|NCT00515502|603048|P8|NOT COMPLETED|Washout Period 1||0
250432|NCT00515502|603049|P7|NOT COMPLETED|Washout Period 1||0
250433|NCT00515502|603050|P6|NOT COMPLETED|Washout Period 1||0
250434|NCT00515502|603051|P5|NOT COMPLETED|Washout Period 1||0
250435|NCT00515502|603052|P4|NOT COMPLETED|Washout Period 1||0
250436|NCT00515502|603053|P3|NOT COMPLETED|Washout Period 1||0
250437|NCT00515502|603054|P2|NOT COMPLETED|Washout Period 1||0
250438|NCT00515502|603055|P1|NOT COMPLETED|Washout Period 1||0
250439|NCT00515502|603044|P12|COMPLETED|Washout Period 1||0
250440|NCT00515502|603045|P11|COMPLETED|Washout Period 1||1
250441|NCT00515502|603046|P10|COMPLETED|Washout Period 1||2
250442|NCT00515502|603047|P9|COMPLETED|Washout Period 1||0
250443|NCT00515502|603048|P8|COMPLETED|Washout Period 1||1
250444|NCT00515502|603049|P7|COMPLETED|Washout Period 1||1
250445|NCT00515502|603050|P6|COMPLETED|Washout Period 1||1
250446|NCT00515502|603051|P5|COMPLETED|Washout Period 1||3
250447|NCT00515502|603052|P4|COMPLETED|Washout Period 1||3
250448|NCT00515502|603053|P3|COMPLETED|Washout Period 1||4
250449|NCT00515502|603054|P2|COMPLETED|Washout Period 1||4
250450|NCT00515502|603055|P1|COMPLETED|Washout Period 1||1
250451|NCT00515502|603044|P12|STARTED|Washout Period 1||0
250452|NCT00515502|603045|P11|STARTED|Washout Period 1||1
250453|NCT00515502|603046|P10|STARTED|Washout Period 1||2
250454|NCT00515502|603047|P9|STARTED|Washout Period 1||0
250455|NCT00515502|603048|P8|STARTED|Washout Period 1||1
250456|NCT00515502|603049|P7|STARTED|Washout Period 1||1
250457|NCT00515502|603050|P6|STARTED|Washout Period 1||1
250458|NCT00515502|603051|P5|STARTED|Washout Period 1||3
250459|NCT00515502|603052|P4|STARTED|Washout Period 1||3
250460|NCT00515502|603053|P3|STARTED|Washout Period 1||4
250461|NCT00515502|603054|P2|STARTED|Washout Period 1||4
250462|NCT00515502|603055|P1|STARTED|Washout Period 1||1
250463|NCT00515502|603044|P12|NOT COMPLETED|Treatment Period 1||1
250464|NCT00515502|603045|P11|NOT COMPLETED|Treatment Period 1||0
250465|NCT00515502|603046|P10|NOT COMPLETED|Treatment Period 1||0
250466|NCT00515502|603047|P9|NOT COMPLETED|Treatment Period 1||1
250467|NCT00515502|603048|P8|NOT COMPLETED|Treatment Period 1||0
250468|NCT00515502|603049|P7|NOT COMPLETED|Treatment Period 1||1
250469|NCT00515502|603050|P6|NOT COMPLETED|Treatment Period 1||0
250470|NCT00515502|603051|P5|NOT COMPLETED|Treatment Period 1||0
250471|NCT00515502|603052|P4|NOT COMPLETED|Treatment Period 1||0
250472|NCT00515502|603053|P3|NOT COMPLETED|Treatment Period 1||0
250473|NCT00515502|603054|P2|NOT COMPLETED|Treatment Period 1||0
250474|NCT00515502|603055|P1|NOT COMPLETED|Treatment Period 1||0
250475|NCT00515502|603044|P12|COMPLETED|Treatment Period 1||0
250476|NCT00515502|603045|P11|COMPLETED|Treatment Period 1||1
250477|NCT00515502|603046|P10|COMPLETED|Treatment Period 1||2
250478|NCT00515502|603047|P9|COMPLETED|Treatment Period 1||0
250479|NCT00515502|603048|P8|COMPLETED|Treatment Period 1||1
250480|NCT00515502|603049|P7|COMPLETED|Treatment Period 1||1
250481|NCT00515502|603050|P6|COMPLETED|Treatment Period 1||1
250482|NCT00515502|603051|P5|COMPLETED|Treatment Period 1||3
250483|NCT00515502|603052|P4|COMPLETED|Treatment Period 1||3
250484|NCT00515502|603053|P3|COMPLETED|Treatment Period 1||4
250485|NCT00515502|603054|P2|COMPLETED|Treatment Period 1||4
250486|NCT00515502|603055|P1|COMPLETED|Treatment Period 1||1
250487|NCT00515502|603044|P12|STARTED|Treatment Period 1||1
250488|NCT00515502|603045|P11|STARTED|Treatment Period 1||1
250489|NCT00515502|603046|P10|STARTED|Treatment Period 1||2
250490|NCT00515502|603047|P9|STARTED|Treatment Period 1||1
250491|NCT00515502|603048|P8|STARTED|Treatment Period 1||1
250492|NCT00515502|603049|P7|STARTED|Treatment Period 1||2
250493|NCT00515502|603050|P6|STARTED|Treatment Period 1||1
250494|NCT00515502|603051|P5|STARTED|Treatment Period 1||3
250495|NCT00515502|603052|P4|STARTED|Treatment Period 1||3
250496|NCT00515502|603053|P3|STARTED|Treatment Period 1||4
250497|NCT00515502|603054|P2|STARTED|Treatment Period 1||4
250498|NCT00515502|603055|P1|STARTED|Treatment Period 1||1
250499|NCT00515463|603215|P2|NOT COMPLETED|Overall Study||14
250500|NCT00515463|603216|P1|NOT COMPLETED|Overall Study||14
250501|NCT00515463|603215|P2|COMPLETED|Overall Study||142
250502|NCT00515463|603216|P1|COMPLETED|Overall Study||141
250503|NCT00515463|603215|P2|Received Study Medication|Overall Study||156
250504|NCT00515463|603216|P1|Received Study Medication|Overall Study||154
250505|NCT00515463|603215|P2|STARTED|Overall Study||156
250506|NCT00515463|603216|P1|STARTED|Overall Study||155
250507|NCT00515437|603370|P4|NOT COMPLETED|Overall Study||1
250508|NCT00515437|603371|P3|NOT COMPLETED|Overall Study||0
250509|NCT00515437|603372|P2|NOT COMPLETED|Overall Study||0
250510|NCT00515437|603373|P1|NOT COMPLETED|Overall Study||0
250511|NCT00515437|603370|P4|COMPLETED|Overall Study||14
250512|NCT00515437|603371|P3|COMPLETED|Overall Study||13
250513|NCT00515437|603372|P2|COMPLETED|Overall Study||12
250514|NCT00515437|603373|P1|COMPLETED|Overall Study||14
250515|NCT00515437|603370|P4|STARTED|Overall Study||15
250516|NCT00515437|603371|P3|STARTED|Overall Study||13
250517|NCT00515437|603372|P2|STARTED|Overall Study||12
250518|NCT00515437|603373|P1|STARTED|Overall Study||14
250519|NCT00515294|603399|P4|NOT COMPLETED|Overall Study||4
250520|NCT00515294|603400|P3|NOT COMPLETED|Overall Study||11
250521|NCT00515294|603401|P2|NOT COMPLETED|Overall Study||3
250522|NCT00515294|603402|P1|NOT COMPLETED|Overall Study||9
250523|NCT00515294|603399|P4|COMPLETED|Overall Study||35
250524|NCT00515294|603400|P3|COMPLETED|Overall Study||27
250525|NCT00515294|603401|P2|COMPLETED|Overall Study||36
250526|NCT00515294|603402|P1|COMPLETED|Overall Study||29
250527|NCT00515294|603399|P4|STARTED|Overall Study||39
250528|NCT00515294|603400|P3|STARTED|Overall Study||38
250529|NCT00515294|603401|P2|STARTED|Overall Study||39
250530|NCT00515294|603402|P1|STARTED|Overall Study||38
250531|NCT00515216|603416|P1|NOT COMPLETED|Overall Study||1
250532|NCT00515216|603416|P1|COMPLETED|Overall Study||25
250533|NCT00515216|603416|P1|STARTED|Overall Study||26
250534|NCT00515203|603440|P2|NOT COMPLETED|Overall Study||0
250535|NCT00515203|603441|P1|NOT COMPLETED|Overall Study||0
250536|NCT00515203|603440|P2|COMPLETED|Overall Study||5
250537|NCT00515203|603441|P1|COMPLETED|Overall Study||17
250538|NCT00515203|603440|P2|STARTED|Overall Study||5
250539|NCT00515203|603441|P1|STARTED|Overall Study||17
250540|NCT00515177|603459|P2|NOT COMPLETED|Overall Study||1
250541|NCT00515177|603460|P1|NOT COMPLETED|Overall Study||2
250542|NCT00515177|603459|P2|COMPLETED|Overall Study||9
250543|NCT00515177|603460|P1|COMPLETED|Overall Study||18
250544|NCT00515177|603459|P2|STARTED|Overall Study||10
250545|NCT00515177|603460|P1|STARTED|Overall Study||20
250546|NCT00515112|603478|P2|NOT COMPLETED|Overall Study||3
250547|NCT00515112|603479|P1|NOT COMPLETED|Overall Study||3
250548|NCT00515112|603478|P2|COMPLETED|Overall Study||0
250549|NCT00515112|603479|P1|COMPLETED|Overall Study||0
250550|NCT00515112|603478|P2|STARTED|Overall Study||3
250551|NCT00515112|603479|P1|STARTED|Overall Study||3
250552|NCT00515099|603489|P2|NOT COMPLETED|Overall Study||4
250553|NCT00515099|603490|P1|NOT COMPLETED|Overall Study||3
250554|NCT00515099|603489|P2|COMPLETED|Overall Study||16
250555|NCT00515099|603490|P1|COMPLETED|Overall Study||35
250556|NCT00515099|603489|P2|STARTED|Overall Study||20
250557|NCT00515099|603490|P1|STARTED|Overall Study||38
250558|NCT00515086|603512|P4|NOT COMPLETED|Overall Study||6
250559|NCT00515086|603513|P3|NOT COMPLETED|Overall Study||5
250560|NCT00515086|603514|P2|NOT COMPLETED|Overall Study||6
250561|NCT00515086|603515|P1|NOT COMPLETED|Overall Study||24
250562|NCT00515086|603512|P4|COMPLETED|Overall Study||0
250563|NCT00515086|603513|P3|COMPLETED|Overall Study||0
250564|NCT00515086|603514|P2|COMPLETED|Overall Study||0
250565|NCT00515086|603515|P1|COMPLETED|Overall Study||0
250566|NCT00515086|603512|P4|STARTED|Overall Study||6
250567|NCT00515086|603513|P3|STARTED|Overall Study||5
250568|NCT00515086|603514|P2|STARTED|Overall Study||6
250569|NCT00515086|603515|P1|STARTED|Overall Study||24
250570|NCT00515073|603542|P1|NOT COMPLETED|Overall Study||2
250571|NCT00515073|603542|P1|COMPLETED|Overall Study||28
250572|NCT00515073|603542|P1|STARTED|Overall Study||30
250573|NCT00515034|603550|P4|NOT COMPLETED|Overall Study||5
250574|NCT00515034|603551|P3|NOT COMPLETED|Overall Study||8
250575|NCT00515034|603552|P2|NOT COMPLETED|Overall Study||2
250576|NCT00515034|603553|P1|NOT COMPLETED|Overall Study||8
250577|NCT00515034|603550|P4|COMPLETED|Overall Study||15
250578|NCT00515034|603551|P3|COMPLETED|Overall Study||54
250579|NCT00515034|603552|P2|COMPLETED|Overall Study||13
250580|NCT00515034|603553|P1|COMPLETED|Overall Study||41
250581|NCT00515034|603550|P4|TREATED|Overall Study||19
250582|NCT00515034|603551|P3|TREATED|Overall Study||61
250583|NCT00515034|603552|P2|TREATED|Overall Study||15
250584|NCT00515034|603553|P1|TREATED|Overall Study||48
250585|NCT00515034|603550|P4|STARTED|Overall Study||20
250586|NCT00515034|603551|P3|STARTED|Overall Study||62
250587|NCT00515034|603552|P2|STARTED|Overall Study||15
250588|NCT00515034|603553|P1|STARTED|Overall Study||49
250589|NCT00515008|603573|P2|NOT COMPLETED|Overall Study||4
250590|NCT00515008|603574|P1|NOT COMPLETED|Overall Study||3
250591|NCT00515008|603573|P2|COMPLETED|Overall Study||29
250592|NCT00515008|603574|P1|COMPLETED|Overall Study||30
250593|NCT00515008|603573|P2|Completed 12 Week Evaluation|Overall Study||29
250594|NCT00515008|603574|P1|Completed 12 Week Evaluation|Overall Study||32
250595|NCT00515008|603573|P2|STARTED|Overall Study||33
250596|NCT00515008|603574|P1|STARTED|Overall Study||33
250597|NCT00514943|603598|P2|NOT COMPLETED|Stage 2||36
250598|NCT00514943|603599|P1|NOT COMPLETED|Stage 2||32
250599|NCT00514943|603598|P2|COMPLETED|Stage 2||0
250600|NCT00514943|603599|P1|COMPLETED|Stage 2||0
250601|NCT00514943|603598|P2|STARTED|Stage 2||36
250602|NCT00514943|603599|P1|STARTED|Stage 2||32
250603|NCT00514943|603598|P2|NOT COMPLETED|Stage 1||26
250604|NCT00514943|603599|P1|NOT COMPLETED|Stage 1||30
250605|NCT00514943|603598|P2|COMPLETED|Stage 1||36
250606|NCT00514943|603599|P1|COMPLETED|Stage 1||32
250607|NCT00514943|603598|P2|STARTED|Stage 1|2 randomized patients were not treated|62
250608|NCT00514943|603599|P1|STARTED|Stage 1|1 randomized patient was not treated|62
250609|NCT00514917|603657|P2|NOT COMPLETED|Overall Study||115
250610|NCT00514917|603658|P1|NOT COMPLETED|Overall Study||126
250611|NCT00514917|603657|P2|COMPLETED|Overall Study||91
250612|NCT00514917|603658|P1|COMPLETED|Overall Study||81
250613|NCT00514917|603657|P2|Testosterone-Specific Evaluable|Overall Study||124
250614|NCT00514917|603658|P1|Testosterone-Specific Evaluable|Overall Study||122
250615|NCT00514917|603657|P2|Completed Study Treatment|Overall Study||182
250616|NCT00514917|603658|P1|Completed Study Treatment|Overall Study||170
250617|NCT00514917|603657|P2|Treated|Overall Study||204
250618|NCT00514917|603658|P1|Treated|Overall Study||196
250619|NCT00514917|603657|P2|STARTED|Overall Study||206
250620|NCT00514917|603658|P1|STARTED|Overall Study||207
250621|NCT00514904|603686|P2|NOT COMPLETED|Overall Study||5
250622|NCT00514904|603687|P1|NOT COMPLETED|Overall Study||24
250623|NCT00514904|603686|P2|COMPLETED|Overall Study||371
250624|NCT00514904|603687|P1|COMPLETED|Overall Study||1101
250625|NCT00514904|603686|P2|STARTED|Overall Study||376
250626|NCT00514904|603687|P1|STARTED|Overall Study||1125
250627|NCT00514852|603723|P2|NOT COMPLETED|Overall Study||5
250628|NCT00514852|603724|P1|NOT COMPLETED|Overall Study||5
250629|NCT00514852|603723|P2|COMPLETED|Overall Study||154
250630|NCT00514852|603724|P1|COMPLETED|Overall Study||152
250631|NCT00514852|603723|P2|STARTED|Overall Study||159
250632|NCT00514852|603724|P1|STARTED|Overall Study||157
250633|NCT00514813|603752|P4|NOT COMPLETED|Overall Study||4
250634|NCT00514813|603753|P3|NOT COMPLETED|Overall Study||47
250635|NCT00514813|603754|P2|NOT COMPLETED|Overall Study||86
250636|NCT00514813|603755|P1|NOT COMPLETED|Overall Study||15
250637|NCT00514813|603752|P4|COMPLETED|Overall Study||0
250638|NCT00514813|603753|P3|COMPLETED|Overall Study||0
250639|NCT00514813|603754|P2|COMPLETED|Overall Study||0
250640|NCT00514813|603755|P1|COMPLETED|Overall Study||0
250641|NCT00514813|603752|P4|STARTED|Overall Study||4
250642|NCT00514813|603753|P3|STARTED|Overall Study||47
250643|NCT00514813|603754|P2|STARTED|Overall Study||86
250644|NCT00514813|603755|P1|STARTED|Overall Study||15
250645|NCT00514735|603775|P2|NOT COMPLETED|Overall Study||6
250646|NCT00514735|603776|P1|NOT COMPLETED|Overall Study||14
250647|NCT00514735|603775|P2|COMPLETED|Overall Study||66
250648|NCT00514735|603776|P1|COMPLETED|Overall Study||124
250649|NCT00514735|603775|P2|STARTED|Overall Study||72
250650|NCT00514735|603776|P1|STARTED|Overall Study||138
250651|NCT00514709|603796|P2|NOT COMPLETED|Overall Study||0
250652|NCT00514709|603797|P1|NOT COMPLETED|Overall Study||0
250653|NCT00514709|603796|P2|COMPLETED|Overall Study||613
250654|NCT00514709|603797|P1|COMPLETED|Overall Study||1230
250655|NCT00514709|603796|P2|STARTED|Overall Study||613
250656|NCT00514709|603797|P1|STARTED|Overall Study||1230
250657|NCT00514683|603812|P5|NOT COMPLETED|Overall Study||33
250658|NCT00514683|603813|P4|NOT COMPLETED|Overall Study||14
250659|NCT00514683|603814|P3|NOT COMPLETED|Overall Study||18
250660|NCT00514683|603815|P2|NOT COMPLETED|Overall Study||25
250661|NCT00514683|603816|P1|NOT COMPLETED|Overall Study||26
250662|NCT00514683|603812|P5|COMPLETED|Overall Study||53
250663|NCT00514683|603813|P4|COMPLETED|Overall Study||72
250664|NCT00514683|603814|P3|COMPLETED|Overall Study||68
250665|NCT00514683|603815|P2|COMPLETED|Overall Study||62
250666|NCT00514683|603816|P1|COMPLETED|Overall Study||61
250667|NCT00514683|603812|P5|STARTED|Overall Study|Randomised|86
250668|NCT00514683|603813|P4|STARTED|Overall Study|Randomised|86
250669|NCT00514683|603814|P3|STARTED|Overall Study|Randomised|86
250670|NCT00514683|603815|P2|STARTED|Overall Study|Randomised|87
250671|NCT00514683|603816|P1|STARTED|Overall Study|Randomised|87
250672|NCT00514592|604007|P1|NOT COMPLETED|Overall Study||0
250673|NCT00514592|604007|P1|COMPLETED|Overall Study||230
250674|NCT00514592|604007|P1|STARTED|Overall Study||230
250675|NCT00514514|604015|P3|NOT COMPLETED|Extension - 4 Years||21
250676|NCT00514514|604016|P2|NOT COMPLETED|Extension - 4 Years||22
250677|NCT00514514|604017|P1|NOT COMPLETED|Extension - 4 Years||37
250678|NCT00514514|604015|P3|COMPLETED|Extension - 4 Years||113
250679|NCT00514514|604016|P2|COMPLETED|Extension - 4 Years||117
250680|NCT00514514|604017|P1|COMPLETED|Extension - 4 Years||108
250681|NCT00514514|604015|P3|Non-randomized (Followed)|Extension - 4 Years||0
250682|NCT00514514|604016|P2|Non-randomized (Followed)|Extension - 4 Years||0
250773|NCT00513617|604162|P1|NOT COMPLETED|Overall Study||11
250774|NCT00513617|604160|P3|COMPLETED|Overall Study||30
250683|NCT00514514|604017|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
250684|NCT00514514|604015|P3|STARTED|Extension - 4 Years||134
250685|NCT00514514|604016|P2|STARTED|Extension - 4 Years||139
250686|NCT00514514|604017|P1|STARTED|Extension - 4 Years||145
250687|NCT00514514|604015|P3|NOT COMPLETED|Randomized - 9 Month||38
250688|NCT00514514|604016|P2|NOT COMPLETED|Randomized - 9 Month||61
250689|NCT00514514|604017|P1|NOT COMPLETED|Randomized - 9 Month||39
250690|NCT00514514|604015|P3|COMPLETED|Randomized - 9 Month||124
250691|NCT00514514|604016|P2|COMPLETED|Randomized - 9 Month||110
250692|NCT00514514|604017|P1|COMPLETED|Randomized - 9 Month||127
250693|NCT00514514|604015|P3|Randomized - Received Treatment|Randomized - 9 Month||161
250694|NCT00514514|604016|P2|Randomized - Received Treatment|Randomized - 9 Month||171
250695|NCT00514514|604017|P1|Randomized - Received Treatment|Randomized - 9 Month||165
250696|NCT00514514|604015|P3|STARTED|Randomized - 9 Month||162
250697|NCT00514514|604016|P2|STARTED|Randomized - 9 Month||171
250698|NCT00514514|604017|P1|STARTED|Randomized - 9 Month||166
250699|NCT00514514|604015|P3|NOT COMPLETED|Pre-phase||0
250700|NCT00514514|604016|P2|NOT COMPLETED|Pre-phase||0
250701|NCT00514514|604017|P1|NOT COMPLETED|Pre-phase||303
250702|NCT00514514|604015|P3|COMPLETED|Pre-phase||0
250703|NCT00514514|604016|P2|COMPLETED|Pre-phase||0
250704|NCT00514514|604017|P1|COMPLETED|Pre-phase||499
250705|NCT00514514|604015|P3|STARTED|Pre-phase||0
250706|NCT00514514|604016|P2|STARTED|Pre-phase||0
250707|NCT00514514|604017|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
250708|NCT00514501|604061|P1|NOT COMPLETED|Overall Study||3
250709|NCT00514501|604061|P1|COMPLETED|Overall Study||507
250710|NCT00514501|604061|P1|STARTED|Overall Study||510
250711|NCT00514449|604069|P2|NOT COMPLETED|Overall Study||4
250712|NCT00514449|604070|P1|NOT COMPLETED|Overall Study||3
250713|NCT00514449|604069|P2|COMPLETED|Overall Study||8
250714|NCT00514449|604070|P1|COMPLETED|Overall Study||9
250715|NCT00514449|604069|P2|STARTED|Overall Study||12
250716|NCT00514449|604070|P1|STARTED|Overall Study||12
250717|NCT00514215|604080|P1|NOT COMPLETED|Overall Study||0
250718|NCT00514215|604080|P1|COMPLETED|Overall Study||8
250719|NCT00514215|604080|P1|STARTED|Overall Study||8
250720|NCT00514137|604084|P1|NOT COMPLETED|Overall Study||0
250721|NCT00514137|604084|P1|COMPLETED|Overall Study||13
250722|NCT00514137|604084|P1|STARTED|Overall Study||13
250723|NCT00514020|604091|P1|NOT COMPLETED|Overall Study||28
250724|NCT00514020|604091|P1|COMPLETED|Overall Study||5
250725|NCT00514020|604091|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
250726|NCT00513799|604099|P4|NOT COMPLETED|Four-Month Follow-Up||3
250727|NCT00513799|604100|P3|NOT COMPLETED|Four-Month Follow-Up||7
250728|NCT00513799|604101|P2|NOT COMPLETED|Four-Month Follow-Up||5
250729|NCT00513799|604102|P1|NOT COMPLETED|Four-Month Follow-Up||0
250730|NCT00513799|604099|P4|COMPLETED|Four-Month Follow-Up||51
250731|NCT00513799|604100|P3|COMPLETED|Four-Month Follow-Up||57
250732|NCT00513799|604101|P2|COMPLETED|Four-Month Follow-Up||57
250733|NCT00513799|604102|P1|COMPLETED|Four-Month Follow-Up||64
250734|NCT00513799|604099|P4|STARTED|Four-Month Follow-Up||54
250735|NCT00513799|604100|P3|STARTED|Four-Month Follow-Up||64
250736|NCT00513799|604101|P2|STARTED|Four-Month Follow-Up||62
250737|NCT00513799|604102|P1|STARTED|Four-Month Follow-Up||64
250738|NCT00513799|604099|P4|NOT COMPLETED|One-Month Follow-Up||21
250739|NCT00513799|604100|P3|NOT COMPLETED|One-Month Follow-Up||11
250740|NCT00513799|604101|P2|NOT COMPLETED|One-Month Follow-Up||13
250741|NCT00513799|604102|P1|NOT COMPLETED|One-Month Follow-Up||11
250742|NCT00513799|604099|P4|COMPLETED|One-Month Follow-Up||54
250743|NCT00513799|604100|P3|COMPLETED|One-Month Follow-Up||64
250744|NCT00513799|604101|P2|COMPLETED|One-Month Follow-Up||62
250745|NCT00513799|604102|P1|COMPLETED|One-Month Follow-Up||64
250746|NCT00513799|604099|P4|STARTED|One-Month Follow-Up||75
250747|NCT00513799|604100|P3|STARTED|One-Month Follow-Up||75
250748|NCT00513799|604101|P2|STARTED|One-Month Follow-Up||75
250749|NCT00513799|604102|P1|STARTED|One-Month Follow-Up||75
250750|NCT00513708|604123|P3|NOT COMPLETED|Overall Study||4
250751|NCT00513708|604124|P2|NOT COMPLETED|Overall Study||4
250752|NCT00513708|604125|P1|NOT COMPLETED|Overall Study||4
250753|NCT00513708|604123|P3|COMPLETED|Overall Study||46
250754|NCT00513708|604124|P2|COMPLETED|Overall Study||46
250755|NCT00513708|604125|P1|COMPLETED|Overall Study||46
250756|NCT00513708|604123|P3|STARTED|Overall Study||50
250757|NCT00513708|604124|P2|STARTED|Overall Study||50
250758|NCT00513708|604125|P1|STARTED|Overall Study||50
250759|NCT00513695|604139|P1|NOT COMPLETED|Overall Study||5
250760|NCT00513695|604139|P1|COMPLETED|Overall Study||63
250761|NCT00513695|604139|P1|STARTED|Overall Study||68
250762|NCT00513682|604148|P1|NOT COMPLETED|Treatment Phase||0
250763|NCT00513682|604148|P1|COMPLETED|Treatment Phase||7
250764|NCT00513682|604148|P1|STARTED|Treatment Phase||7
250765|NCT00513682|604148|P1|NOT COMPLETED|Washout Phase||2
250766|NCT00513682|604148|P1|COMPLETED|Washout Phase||7
250767|NCT00513682|604148|P1|STARTED|Washout Phase||9
250768|NCT00513682|604148|P1|NOT COMPLETED|Screening Phase||0
250769|NCT00513682|604148|P1|COMPLETED|Screening Phase||9
250770|NCT00513682|604148|P1|STARTED|Screening Phase||9
250771|NCT00513617|604160|P3|NOT COMPLETED|Overall Study||8
250772|NCT00513617|604161|P2|NOT COMPLETED|Overall Study||10
250775|NCT00513617|604161|P2|COMPLETED|Overall Study||25
250776|NCT00513617|604162|P1|COMPLETED|Overall Study||25
250777|NCT00513617|604160|P3|STARTED|Overall Study||38
250778|NCT00513617|604161|P2|STARTED|Overall Study||35
250779|NCT00513617|604162|P1|STARTED|Overall Study||36
250780|NCT00513604|604178|P5|NOT COMPLETED|Overall Study||0
250781|NCT00513604|604179|P4|NOT COMPLETED|Overall Study||0
250782|NCT00513604|604180|P3|NOT COMPLETED|Overall Study||3
250783|NCT00513604|604181|P2|NOT COMPLETED|Overall Study||3
250784|NCT00513604|604182|P1|NOT COMPLETED|Overall Study||2
250785|NCT00513604|604178|P5|COMPLETED|Overall Study||35
250786|NCT00513604|604179|P4|COMPLETED|Overall Study||34
250787|NCT00513604|604180|P3|COMPLETED|Overall Study||21
250788|NCT00513604|604181|P2|COMPLETED|Overall Study||36
250789|NCT00513604|604182|P1|COMPLETED|Overall Study||24
250790|NCT00513604|604178|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
250791|NCT00513604|604179|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
250792|NCT00513604|604180|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
250793|NCT00513604|604181|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
250794|NCT00513604|604182|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
250795|NCT00513526|604199|P1|NOT COMPLETED|Overall Study||17
250796|NCT00513526|604199|P1|COMPLETED|Overall Study||92
250797|NCT00513526|604199|P1|STARTED|Overall Study||109
250798|NCT00513500|604216|P2|NOT COMPLETED|Overall Study||54
250799|NCT00513500|604217|P1|NOT COMPLETED|Overall Study||41
250800|NCT00513500|604216|P2|COMPLETED|Overall Study||2054
250801|NCT00513500|604217|P1|COMPLETED|Overall Study||976
250802|NCT00513500|604216|P2|STARTED|Overall Study||2108
250803|NCT00513500|604217|P1|STARTED|Overall Study||1017
250804|NCT00513474|604229|P2|NOT COMPLETED|Overall Study||9
250805|NCT00513474|604230|P1|NOT COMPLETED|Overall Study||7
250806|NCT00513474|604229|P2|COMPLETED|Overall Study||12
250807|NCT00513474|604230|P1|COMPLETED|Overall Study||18
250808|NCT00513474|604229|P2|Received Rasburicase Per Protocol|Overall Study||0
250809|NCT00513474|604230|P1|Received Rasburicase Per Protocol|Overall Study||24
250810|NCT00513474|604229|P2|STARTED|Overall Study||21
250811|NCT00513474|604230|P1|STARTED|Overall Study||25
250812|NCT00513435|604242|P1|NOT COMPLETED|Overall Study||0
250813|NCT00513435|604242|P1|COMPLETED|Overall Study||9
250814|NCT00513435|604242|P1|STARTED|Overall Study||9
250815|NCT00513409|604249|P2|NOT COMPLETED|Overall Study||6
250816|NCT00513409|604250|P1|NOT COMPLETED|Overall Study||2
250817|NCT00513409|604249|P2|COMPLETED|Overall Study||73
250818|NCT00513409|604250|P1|COMPLETED|Overall Study||82
250819|NCT00513409|604249|P2|STARTED|Overall Study||79
250820|NCT00513409|604250|P1|STARTED|Overall Study||84
250821|NCT00513370|604276|P1|NOT COMPLETED|Overall Study||24
250822|NCT00513370|604276|P1|COMPLETED|Overall Study||179
250823|NCT00513370|604276|P1|STARTED|Overall Study||203
250824|NCT00513357|604306|P2|NOT COMPLETED|Overall Study||10
250825|NCT00513357|604307|P1|NOT COMPLETED|Overall Study||15
250826|NCT00513357|604306|P2|COMPLETED|Overall Study||25
250827|NCT00513357|604307|P1|COMPLETED|Overall Study||23
250828|NCT00513357|604306|P2|STARTED|Overall Study||35
250829|NCT00513357|604307|P1|STARTED|Overall Study||38
250830|NCT00513344|604313|P1|NOT COMPLETED|3rd Intervention 1 Day||0
250831|NCT00513344|604313|P1|COMPLETED|3rd Intervention 1 Day||5
250832|NCT00513344|604313|P1|STARTED|3rd Intervention 1 Day||5
250833|NCT00513344|604313|P1|NOT COMPLETED|Washout Period 3 Days||0
250834|NCT00513344|604313|P1|COMPLETED|Washout Period 3 Days||5
250835|NCT00513344|604313|P1|STARTED|Washout Period 3 Days||5
250836|NCT00513344|604313|P1|NOT COMPLETED|2nd Intervention 1 Day||0
250837|NCT00513344|604313|P1|COMPLETED|2nd Intervention 1 Day||5
250838|NCT00513344|604313|P1|STARTED|2nd Intervention 1 Day||5
250839|NCT00513344|604313|P1|NOT COMPLETED|Washout Period 3 Days||0
250840|NCT00513344|604313|P1|COMPLETED|Washout Period 3 Days||5
250841|NCT00513344|604313|P1|STARTED|Washout Period 3 Days||5
250842|NCT00513344|604313|P1|NOT COMPLETED|1st Intervention 1 Day||0
250843|NCT00513344|604313|P1|COMPLETED|1st Intervention 1 Day||5
250844|NCT00513344|604313|P1|STARTED|1st Intervention 1 Day||5
250845|NCT00513344|604313|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
250846|NCT00513344|604313|P1|COMPLETED|Diet Restriction (3 Days)||5
250847|NCT00513344|604313|P1|STARTED|Diet Restriction (3 Days)||5
250848|NCT00513305|604326|P2|NOT COMPLETED|Overall Study||27
250849|NCT00513305|604327|P1|NOT COMPLETED|Overall Study||28
250850|NCT00513305|604326|P2|COMPLETED|Overall Study||7
250851|NCT00513305|604327|P1|COMPLETED|Overall Study||5
250852|NCT00513305|604326|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
250853|NCT00513305|604327|P1|STARTED|Overall Study||33
250854|NCT00513292|604345|P2|NOT COMPLETED|Overall Study||0
250855|NCT00513292|604346|P1|NOT COMPLETED|Overall Study||0
250856|NCT00513292|604345|P2|COMPLETED|Overall Study||142
250857|NCT00513292|604346|P1|COMPLETED|Overall Study||138
250858|NCT00513292|604345|P2|STARTED|Overall Study||142
250859|NCT00513292|604346|P1|STARTED|Overall Study||138
250860|NCT00513240|604364|P2|NOT COMPLETED|Overall Study||7
250861|NCT00513240|604365|P1|NOT COMPLETED|Overall Study||13
250862|NCT00513240|604364|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
250949|NCT00511836|604571|P2|NOT COMPLETED|Double-blind Period||0
250863|NCT00513240|604365|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
250864|NCT00513240|604364|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
250865|NCT00513240|604365|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
250866|NCT00513240|604364|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
250867|NCT00513240|604365|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
250868|NCT00513071|604372|P1|NOT COMPLETED|Overall Study||5
250869|NCT00513071|604372|P1|COMPLETED|Overall Study||23
250870|NCT00513071|604372|P1|STARTED|Overall Study||28
250871|NCT00513019|604384|P2|NOT COMPLETED|Overall Study||5
250872|NCT00513019|604385|P1|NOT COMPLETED|Overall Study||5
250873|NCT00513019|604384|P2|COMPLETED|Overall Study||13
250874|NCT00513019|604385|P1|COMPLETED|Overall Study||12
250875|NCT00513019|604384|P2|STARTED|Overall Study||18
250876|NCT00513019|604385|P1|STARTED|Overall Study||17
250877|NCT00512902|604391|P1|NOT COMPLETED|Overall Study||8
250878|NCT00512902|604391|P1|COMPLETED|Overall Study||12
250879|NCT00512902|604391|P1|STARTED|Overall Study||20
250880|NCT00512876|604399|P1|NOT COMPLETED|Overall Study||4
250881|NCT00512876|604399|P1|COMPLETED|Overall Study||20
250882|NCT00512876|604399|P1|STARTED|Overall Study||24
250883|NCT00512798|604406|P2|NOT COMPLETED|Overall Study||27
250884|NCT00512798|604407|P1|NOT COMPLETED|Overall Study||19
250885|NCT00512798|604406|P2|COMPLETED|Overall Study||1
250886|NCT00512798|604407|P1|COMPLETED|Overall Study||0
250887|NCT00512798|604406|P2|STARTED|Overall Study||28
250888|NCT00512798|604407|P1|STARTED|Overall Study||19
250889|NCT00512707|604418|P2|NOT COMPLETED|Overall Study||12
250890|NCT00512707|604419|P1|NOT COMPLETED|Overall Study||10
250891|NCT00512707|604418|P2|COMPLETED|Overall Study||58
250892|NCT00512707|604419|P1|COMPLETED|Overall Study||60
250893|NCT00512707|604418|P2|STARTED|Overall Study||70
250894|NCT00512707|604419|P1|STARTED|Overall Study||70
250895|NCT00512278|604451|P2|NOT COMPLETED|Overall Study||17
250896|NCT00512278|604452|P1|NOT COMPLETED|Overall Study||28
250897|NCT00512278|604451|P2|COMPLETED|Overall Study||56
250898|NCT00512278|604452|P1|COMPLETED|Overall Study||45
250899|NCT00512278|604451|P2|STARTED|Overall Study||73
250900|NCT00512278|604452|P1|STARTED|Overall Study||73
250901|NCT00512252|604469|P3|NOT COMPLETED|Overall Study||3
250902|NCT00512252|604470|P2|NOT COMPLETED|Overall Study||0
250903|NCT00512252|604471|P1|NOT COMPLETED|Overall Study||0
250904|NCT00512252|604469|P3|COMPLETED|Overall Study||43
250905|NCT00512252|604470|P2|COMPLETED|Overall Study||3
250906|NCT00512252|604471|P1|COMPLETED|Overall Study||3
250907|NCT00512252|604469|P3|STARTED|Overall Study||46
250908|NCT00512252|604470|P2|STARTED|Overall Study||3
250909|NCT00512252|604471|P1|STARTED|Overall Study||3
250910|NCT00512148|604499|P1|NOT COMPLETED|Long Term Follow Up Period||6
250911|NCT00512148|604499|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
250912|NCT00512148|604499|P1|STARTED|Long Term Follow Up Period||6
250913|NCT00512148|604499|P1|NOT COMPLETED|Primay Study Period||1
250914|NCT00512148|604499|P1|COMPLETED|Primay Study Period||6
250915|NCT00512148|604499|P1|STARTED|Primay Study Period||7
250916|NCT00512096|604504|P1|NOT COMPLETED|Overall Study||7
250917|NCT00512096|604504|P1|COMPLETED|Overall Study||23
250918|NCT00512096|604504|P1|STARTED|Overall Study||30
250919|NCT00511992|604508|P1|NOT COMPLETED|Overall Study||7
250920|NCT00511992|604508|P1|COMPLETED|Overall Study||13
250921|NCT00511992|604508|P1|STARTED|Overall Study||20
250922|NCT00511914|604515|P2|NOT COMPLETED|Overall Study||0
250923|NCT00511914|604516|P1|NOT COMPLETED|Overall Study||0
250924|NCT00511914|604515|P2|COMPLETED|Overall Study||67
250925|NCT00511914|604516|P1|COMPLETED|Overall Study||68
250926|NCT00511914|604515|P2|STARTED|Overall Study||67
250927|NCT00511914|604516|P1|STARTED|Overall Study||68
250928|NCT00511901|604532|P2|NOT COMPLETED|Overall Study||3
250929|NCT00511901|604533|P1|NOT COMPLETED|Overall Study||1
250930|NCT00511901|604532|P2|COMPLETED|Overall Study||8
250931|NCT00511901|604533|P1|COMPLETED|Overall Study||10
250932|NCT00511901|604532|P2|STARTED|Overall Study||11
250933|NCT00511901|604533|P1|STARTED|Overall Study||11
250934|NCT00511862|604556|P3|NOT COMPLETED|Overall Study||0
250935|NCT00511862|604557|P2|NOT COMPLETED|Overall Study||0
250936|NCT00511862|604558|P1|NOT COMPLETED|Overall Study||0
250937|NCT00511862|604556|P3|COMPLETED|Overall Study||47
250938|NCT00511862|604557|P2|COMPLETED|Overall Study||43
250939|NCT00511862|604558|P1|COMPLETED|Overall Study||61
250940|NCT00511862|604556|P3|STARTED|Overall Study||47
250941|NCT00511862|604557|P2|STARTED|Overall Study||43
250942|NCT00511862|604558|P1|STARTED|Overall Study||61
250943|NCT00511836|604571|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
250944|NCT00511836|604572|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
250945|NCT00511836|604571|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
250946|NCT00511836|604572|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
250947|NCT00511836|604571|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
250948|NCT00511836|604572|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
250950|NCT00511836|604572|P1|NOT COMPLETED|Double-blind Period||1
250951|NCT00511836|604571|P2|COMPLETED|Double-blind Period||15
250952|NCT00511836|604572|P1|COMPLETED|Double-blind Period||15
250953|NCT00511836|604571|P2|STARTED|Double-blind Period||15
250954|NCT00511836|604572|P1|STARTED|Double-blind Period||16
250955|NCT00511810|604589|P2|NOT COMPLETED|Overall Study||5
250956|NCT00511810|604590|P1|NOT COMPLETED|Overall Study||1
250957|NCT00511810|604589|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
250958|NCT00511810|604590|P1|COMPLETED|Overall Study||7
250959|NCT00511810|604589|P2|STARTED|Overall Study||12
250960|NCT00511810|604590|P1|STARTED|Overall Study||8
250961|NCT00511797|604600|P4|NOT COMPLETED|Overall Study||15
250962|NCT00511797|604601|P3|NOT COMPLETED|Overall Study||11
250963|NCT00511797|604602|P2|NOT COMPLETED|Overall Study||8
250964|NCT00511797|604603|P1|NOT COMPLETED|Overall Study||7
250965|NCT00511797|604600|P4|COMPLETED|Overall Study||47
250966|NCT00511797|604601|P3|COMPLETED|Overall Study||51
250967|NCT00511797|604602|P2|COMPLETED|Overall Study||55
250968|NCT00511797|604603|P1|COMPLETED|Overall Study||55
250969|NCT00511797|604600|P4|Subjects Received Treatment|Overall Study|FAS|58
250970|NCT00511797|604601|P3|Subjects Received Treatment|Overall Study|FAS|61
250971|NCT00511797|604602|P2|Subjects Received Treatment|Overall Study|FAS|62
250972|NCT00511797|604603|P1|Subjects Received Treatment|Overall Study|FAS|61
250973|NCT00511797|604600|P4|Subjects Dispensed Drugs|Overall Study||59
250974|NCT00511797|604601|P3|Subjects Dispensed Drugs|Overall Study||61
250975|NCT00511797|604602|P2|Subjects Dispensed Drugs|Overall Study||63
250976|NCT00511797|604603|P1|Subjects Dispensed Drugs|Overall Study||61
250977|NCT00511797|604600|P4|STARTED|Overall Study||62
250978|NCT00511797|604601|P3|STARTED|Overall Study||62
250979|NCT00511797|604602|P2|STARTED|Overall Study||63
250980|NCT00511797|604603|P1|STARTED|Overall Study||62
250981|NCT00511706|604707|P2|NOT COMPLETED|Overall Study||5
250982|NCT00511706|604708|P1|NOT COMPLETED|Overall Study||8
250983|NCT00511706|604707|P2|COMPLETED|Overall Study||115
250984|NCT00511706|604708|P1|COMPLETED|Overall Study||115
250985|NCT00511706|604707|P2|STARTED|Overall Study||120
250986|NCT00511706|604708|P1|STARTED|Overall Study||123
250987|NCT00511667|604722|P2|NOT COMPLETED|Overall Study||3
250988|NCT00511667|604723|P1|NOT COMPLETED|Overall Study||12
250989|NCT00511667|604722|P2|COMPLETED|Overall Study||15
250990|NCT00511667|604723|P1|COMPLETED|Overall Study||40
250991|NCT00511667|604722|P2|STARTED|Overall Study||18
250992|NCT00511667|604723|P1|STARTED|Overall Study||52
250993|NCT00511472|604758|P2|NOT COMPLETED|Overall Study||6
250994|NCT00511472|604759|P1|NOT COMPLETED|Overall Study||3
250995|NCT00511472|604758|P2|COMPLETED|Overall Study||17
250996|NCT00511472|604759|P1|COMPLETED|Overall Study||44
250997|NCT00511472|604758|P2|STARTED|Overall Study||23
250998|NCT00511472|604759|P1|STARTED|Overall Study||47
250999|NCT00511433|604778|P2|NOT COMPLETED|Overall Study||1
251000|NCT00511433|604779|P1|NOT COMPLETED|Overall Study||6
251001|NCT00511433|604778|P2|COMPLETED|Overall Study||15
251002|NCT00511433|604779|P1|COMPLETED|Overall Study||26
251003|NCT00511433|604778|P2|STARTED|Overall Study||16
251004|NCT00511433|604779|P1|STARTED|Overall Study||32
251005|NCT00511355|604819|P2|NOT COMPLETED|Overall Study||9
251006|NCT00511355|604820|P1|NOT COMPLETED|Overall Study||7
251007|NCT00511355|604819|P2|COMPLETED|Overall Study||52
251008|NCT00511355|604820|P1|COMPLETED|Overall Study||53
251009|NCT00511355|604819|P2|STARTED|Overall Study||61
251010|NCT00511355|604820|P1|STARTED|Overall Study||60
251011|NCT00511342|604920|P2|NOT COMPLETED|Overall Study||22
251012|NCT00511342|604921|P1|NOT COMPLETED|Overall Study||13
251013|NCT00511342|604920|P2|COMPLETED|Overall Study||32
251014|NCT00511342|604921|P1|COMPLETED|Overall Study||43
251015|NCT00511342|604920|P2|STARTED|Overall Study||54
251016|NCT00511342|604921|P1|STARTED|Overall Study||56
251017|NCT00511329|604945|P1|NOT COMPLETED|Overall Study||0
251018|NCT00511329|604945|P1|COMPLETED|Overall Study||0
251019|NCT00511329|604945|P1|STARTED|Overall Study||0
251020|NCT00511238|604952|P2|NOT COMPLETED|Overall Study||226
251021|NCT00511238|604953|P1|NOT COMPLETED|Overall Study||42
251022|NCT00511238|604952|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
251023|NCT00511238|604953|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
251024|NCT00511238|604952|P2|STARTED|Overall Study||266
251025|NCT00511238|604953|P1|STARTED|Overall Study||46
251026|NCT00511199|604972|P2|NOT COMPLETED|Overall Study||125
251027|NCT00511199|604973|P1|NOT COMPLETED|Overall Study||449
251028|NCT00511199|604972|P2|COMPLETED|Overall Study||410
251029|NCT00511199|604973|P1|COMPLETED|Overall Study||1142
251030|NCT00511199|604972|P2|STARTED|Overall Study||535
251031|NCT00511199|604973|P1|STARTED|Overall Study||1591
251032|NCT00511173|604997|P1|NOT COMPLETED|Overall Study||0
251033|NCT00511173|604997|P1|COMPLETED|Overall Study||102
251034|NCT00511173|604997|P1|STARTED|Overall Study||102
251035|NCT00511147|605002|P1|NOT COMPLETED|Overall Study||7
251036|NCT00511147|605002|P1|COMPLETED|Overall Study||57
251037|NCT00511147|605002|P1|STARTED|Overall Study||64
251038|NCT00511134|605011|P2|NOT COMPLETED|Overall Study||2
251039|NCT00511134|605012|P1|NOT COMPLETED|Overall Study||0
251040|NCT00511134|605011|P2|COMPLETED|Overall Study||1
251041|NCT00511134|605012|P1|COMPLETED|Overall Study||1
251042|NCT00511134|605011|P2|STARTED|Overall Study||3
251043|NCT00511134|605012|P1|STARTED|Overall Study||1
251044|NCT00511108|605024|P4|NOT COMPLETED|Overall Study||5
251045|NCT00511108|605025|P3|NOT COMPLETED|Overall Study||5
251046|NCT00511108|605026|P2|NOT COMPLETED|Overall Study||2
251047|NCT00511108|605027|P1|NOT COMPLETED|Overall Study||6
251048|NCT00511108|605024|P4|COMPLETED|Overall Study||48
251049|NCT00511108|605025|P3|COMPLETED|Overall Study||47
251050|NCT00511108|605026|P2|COMPLETED|Overall Study||52
251051|NCT00511108|605027|P1|COMPLETED|Overall Study||46
251052|NCT00511108|605024|P4|STARTED|Overall Study||53
251053|NCT00511108|605025|P3|STARTED|Overall Study||52
251054|NCT00511108|605026|P2|STARTED|Overall Study||54
251055|NCT00511108|605027|P1|STARTED|Overall Study||52
251056|NCT00511095|605045|P1|NOT COMPLETED|Overall Study||11
251057|NCT00511095|605045|P1|COMPLETED|Overall Study||196
251058|NCT00511095|605045|P1|STARTED|Overall Study||207
251059|NCT00511004|605054|P3|NOT COMPLETED|Overall Study||4
251060|NCT00511004|605055|P2|NOT COMPLETED|Overall Study||0
251061|NCT00511004|605056|P1|NOT COMPLETED|Overall Study||0
251062|NCT00511004|605054|P3|COMPLETED|Overall Study||10
251063|NCT00511004|605055|P2|COMPLETED|Overall Study||13
251064|NCT00511004|605056|P1|COMPLETED|Overall Study||13
251065|NCT00511004|605054|P3|STARTED|Overall Study||14
251066|NCT00511004|605055|P2|STARTED|Overall Study||13
251067|NCT00511004|605056|P1|STARTED|Overall Study||13
251068|NCT00510952|605075|P2|NOT COMPLETED|Overall Study||16
251069|NCT00510952|605076|P1|NOT COMPLETED|Overall Study||26
251070|NCT00510952|605075|P2|COMPLETED|Overall Study||220
251071|NCT00510952|605076|P1|COMPLETED|Overall Study||209
251072|NCT00510952|605075|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
251073|NCT00510952|605076|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
251074|NCT00510952|605075|P2|STARTED|Overall Study||236
251075|NCT00510952|605076|P1|STARTED|Overall Study||235
251076|NCT00510887|605102|P1|NOT COMPLETED|Overall Study||1
251077|NCT00510887|605102|P1|COMPLETED|Overall Study||11
251078|NCT00510887|605102|P1|STARTED|Overall Study||12
251079|NCT00510874|605118|P7|NOT COMPLETED|Overall Study||1
251080|NCT00510874|605119|P6|NOT COMPLETED|Overall Study||0
251081|NCT00510874|605120|P5|NOT COMPLETED|Overall Study||7
251082|NCT00510874|605121|P4|NOT COMPLETED|Overall Study||3
251083|NCT00510874|605122|P3|NOT COMPLETED|Overall Study||1
251084|NCT00510874|605123|P2|NOT COMPLETED|Overall Study||4
251085|NCT00510874|605124|P1|NOT COMPLETED|Overall Study||3
251086|NCT00510874|605118|P7|COMPLETED|Overall Study|Upto Day 182|49
251087|NCT00510874|605119|P6|COMPLETED|Overall Study|Upto Day 182|50
251088|NCT00510874|605120|P5|COMPLETED|Overall Study|Upto Day 182|141
251089|NCT00510874|605121|P4|COMPLETED|Overall Study|Upto Day 182|148
251090|NCT00510874|605122|P3|COMPLETED|Overall Study|Upto Day 182|150
251091|NCT00510874|605123|P2|COMPLETED|Overall Study|Upto Day 182|148
251092|NCT00510874|605124|P1|COMPLETED|Overall Study|Upto Day 182|75
251093|NCT00510874|605118|P7|STARTED|Overall Study||50
251094|NCT00510874|605119|P6|STARTED|Overall Study||50
251095|NCT00510874|605120|P5|STARTED|Overall Study||148
251096|NCT00510874|605121|P4|STARTED|Overall Study||151
251097|NCT00510874|605122|P3|STARTED|Overall Study||151
251098|NCT00510874|605123|P2|STARTED|Overall Study||152
251099|NCT00510874|605124|P1|STARTED|Overall Study||78
251100|NCT00510835|605227|P3|NOT COMPLETED|Overall Study||2
251101|NCT00510835|605228|P2|NOT COMPLETED|Overall Study||2
251102|NCT00510835|605229|P1|NOT COMPLETED|Overall Study||6
251103|NCT00510835|605227|P3|COMPLETED|Overall Study||456
251104|NCT00510835|605228|P2|COMPLETED|Overall Study||446
251105|NCT00510835|605229|P1|COMPLETED|Overall Study||439
251106|NCT00510835|605227|P3|STARTED|Overall Study||458
251107|NCT00510835|605228|P2|STARTED|Overall Study||448
251108|NCT00510835|605229|P1|STARTED|Overall Study||445
251109|NCT00510809|605240|P3|NOT COMPLETED|Overall Study||0
251110|NCT00510809|605241|P2|NOT COMPLETED|Overall Study||0
251111|NCT00510809|605242|P1|NOT COMPLETED|Overall Study||0
251112|NCT00510809|605240|P3|COMPLETED|Overall Study||18
251113|NCT00510809|605241|P2|COMPLETED|Overall Study||18
251114|NCT00510809|605242|P1|COMPLETED|Overall Study||18
251115|NCT00510809|605240|P3|STARTED|Overall Study||18
251116|NCT00510809|605241|P2|STARTED|Overall Study||18
251117|NCT00510809|605242|P1|STARTED|Overall Study||18
251118|NCT00510783|605255|P2|NOT COMPLETED|Overall Study||29
251119|NCT00510783|605256|P1|NOT COMPLETED|Overall Study||31
251120|NCT00510783|605255|P2|COMPLETED|Overall Study||47
251121|NCT00510783|605256|P1|COMPLETED|Overall Study||51
251122|NCT00510783|605255|P2|STARTED|Overall Study||76
251123|NCT00510783|605256|P1|STARTED|Overall Study||82
251124|NCT00510744|605262|P1|NOT COMPLETED|Overall Study||0
251125|NCT00510744|605262|P1|COMPLETED|Overall Study||5
251126|NCT00510744|605262|P1|STARTED|Overall Study||5
251127|NCT00510692|605268|P2|NOT COMPLETED|Overall Study||3
251128|NCT00510692|605269|P1|NOT COMPLETED|Overall Study||2
251129|NCT00510692|605268|P2|COMPLETED|Overall Study||26
251130|NCT00510692|605269|P1|COMPLETED|Overall Study||27
251131|NCT00510692|605268|P2|STARTED|Overall Study||29
251132|NCT00510692|605269|P1|STARTED|Overall Study||29
251133|NCT00510653|605283|P1|NOT COMPLETED|Overall Study||11
251134|NCT00510653|605283|P1|COMPLETED|Overall Study||13
251135|NCT00510653|605283|P1|STARTED|Overall Study||24
251136|NCT00510510|605290|P3|NOT COMPLETED|Overall Study||17
251137|NCT00510510|605291|P2|NOT COMPLETED|Overall Study||9
251138|NCT00510510|605292|P1|NOT COMPLETED|Overall Study||5
251139|NCT00510510|605290|P3|COMPLETED|Overall Study||74
251140|NCT00510510|605291|P2|COMPLETED|Overall Study||89
251141|NCT00510510|605292|P1|COMPLETED|Overall Study||87
251142|NCT00510510|605290|P3|STARTED|Overall Study||91
251143|NCT00510510|605291|P2|STARTED|Overall Study||98
251144|NCT00510510|605292|P1|STARTED|Overall Study||92
251145|NCT00510497|605303|P1|NOT COMPLETED|Overall Study||3
251146|NCT00510497|605303|P1|COMPLETED|Overall Study||8
251147|NCT00510497|605303|P1|STARTED|Overall Study||11
251148|NCT00510484|605310|P2|NOT COMPLETED|Period 2||0
251149|NCT00510484|605311|P1|NOT COMPLETED|Period 2||0
251150|NCT00510484|605310|P2|COMPLETED|Period 2||15
251151|NCT00510484|605311|P1|COMPLETED|Period 2||16
251152|NCT00510484|605310|P2|STARTED|Period 2||15
251153|NCT00510484|605311|P1|STARTED|Period 2||16
251154|NCT00510484|605310|P2|NOT COMPLETED|Wash-out Period||1
251155|NCT00510484|605311|P1|NOT COMPLETED|Wash-out Period||0
251156|NCT00510484|605310|P2|COMPLETED|Wash-out Period||15
251157|NCT00510484|605311|P1|COMPLETED|Wash-out Period||16
251158|NCT00510484|605310|P2|STARTED|Wash-out Period||16
251159|NCT00510484|605311|P1|STARTED|Wash-out Period||16
251160|NCT00510484|605310|P2|NOT COMPLETED|Period 1||0
251161|NCT00510484|605311|P1|NOT COMPLETED|Period 1||0
251162|NCT00510484|605310|P2|COMPLETED|Period 1||16
251163|NCT00510484|605311|P1|COMPLETED|Period 1||16
251164|NCT00510484|605310|P2|STARTED|Period 1||16
251165|NCT00510484|605311|P1|STARTED|Period 1||16
251166|NCT00510458|605331|P1|NOT COMPLETED|Overall Study||47
251167|NCT00510458|605331|P1|COMPLETED|Overall Study||27
251168|NCT00510458|605331|P1|STARTED|Overall Study||74
251169|NCT00510289|605344|P1|NOT COMPLETED|Overall Study||12
251170|NCT00510289|605344|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
251171|NCT00510289|605344|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
251172|NCT00510289|605344|P1|STARTED|Overall Study|All patients who consented|19
251173|NCT00510276|605354|P2|NOT COMPLETED|Extension Open-Label Phase||48
251174|NCT00510276|605355|P1|NOT COMPLETED|Extension Open-Label Phase||33
251175|NCT00510276|605354|P2|COMPLETED|Extension Open-Label Phase||81
251176|NCT00510276|605355|P1|COMPLETED|Extension Open-Label Phase||78
251177|NCT00510276|605354|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
251178|NCT00510276|605355|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
251179|NCT00510276|605354|P2|NOT COMPLETED|Acute Double-Blind Phase||95
251180|NCT00510276|605355|P1|NOT COMPLETED|Acute Double-Blind Phase||105
251181|NCT00510276|605354|P2|COMPLETED|Acute Double-Blind Phase||130
251182|NCT00510276|605355|P1|COMPLETED|Acute Double-Blind Phase||115
251183|NCT00510276|605354|P2|STARTED|Acute Double-Blind Phase||225
251184|NCT00510276|605355|P1|STARTED|Acute Double-Blind Phase||220
251185|NCT00510224|605440|P1|NOT COMPLETED|Overall Study||3
251186|NCT00510224|605440|P1|COMPLETED|Overall Study||10
251187|NCT00510224|605440|P1|STARTED|Overall Study||13
251188|NCT00510146|605449|P2|NOT COMPLETED|Open-Label Treatment||26
251189|NCT00510146|605450|P1|NOT COMPLETED|Open-Label Treatment||71
251190|NCT00510146|605449|P2|COMPLETED|Open-Label Treatment||96
251191|NCT00510146|605450|P1|COMPLETED|Open-Label Treatment||196
251192|NCT00510146|605449|P2|STARTED|Open-Label Treatment||122
251193|NCT00510146|605450|P1|STARTED|Open-Label Treatment||267
251194|NCT00510146|605449|P2|NOT COMPLETED|Double-Blind Treatment||49
251195|NCT00510146|605450|P1|NOT COMPLETED|Double-Blind Treatment||76
251196|NCT00510146|605449|P2|COMPLETED|Double-Blind Treatment||122
251197|NCT00510146|605450|P1|COMPLETED|Double-Blind Treatment||267
251198|NCT00510146|605449|P2|STARTED|Double-Blind Treatment||171
251199|NCT00510146|605450|P1|STARTED|Double-Blind Treatment||343
251200|NCT00510068|605539|P2|NOT COMPLETED|Open-label Period||0
251201|NCT00510068|605540|P1|NOT COMPLETED|Open-label Period||225
251202|NCT00510068|605539|P2|COMPLETED|Open-label Period||0
251203|NCT00510068|605540|P1|COMPLETED|Open-label Period||0
251204|NCT00510068|605539|P2|STARTED|Open-label Period||0
251205|NCT00510068|605540|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
251206|NCT00510068|605539|P2|NOT COMPLETED|Double-blind Period||203
251207|NCT00510068|605540|P1|NOT COMPLETED|Double-blind Period||207
251208|NCT00510068|605539|P2|COMPLETED|Double-blind Period||0
251209|NCT00510068|605540|P1|COMPLETED|Double-blind Period||0
251210|NCT00510068|605539|P2|Safety Population|Double-blind Period||203
251211|NCT00510068|605540|P1|Safety Population|Double-blind Period||204
251212|NCT00510068|605539|P2|STARTED|Double-blind Period||203
251213|NCT00510068|605540|P1|STARTED|Double-blind Period||207
251214|NCT00509925|605581|P2|NOT COMPLETED|Overall Study||1
251215|NCT00509925|605582|P1|NOT COMPLETED|Overall Study||0
251216|NCT00509925|605581|P2|COMPLETED|Overall Study||10
251217|NCT00509925|605582|P1|COMPLETED|Overall Study||12
251218|NCT00509925|605581|P2|STARTED|Overall Study||11
251219|NCT00509925|605582|P1|STARTED|Overall Study||12
251220|NCT00509899|605630|P8|NOT COMPLETED|Overall Study||1
251221|NCT00509899|605631|P7|NOT COMPLETED|Overall Study||1
251222|NCT00509899|605632|P6|NOT COMPLETED|Overall Study||10
251223|NCT00509899|605633|P5|NOT COMPLETED|Overall Study||5
251224|NCT00509899|605634|P4|NOT COMPLETED|Overall Study||4
251225|NCT00509899|605635|P3|NOT COMPLETED|Overall Study||20
251226|NCT00509899|605636|P2|NOT COMPLETED|Overall Study||9
251227|NCT00509899|605637|P1|NOT COMPLETED|Overall Study||16
251228|NCT00509899|605630|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
251229|NCT00509899|605631|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
251230|NCT00509899|605632|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
251231|NCT00509899|605633|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
251232|NCT00509899|605634|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
251233|NCT00509899|605635|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
251234|NCT00509899|605636|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
251235|NCT00509899|605637|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
251236|NCT00509899|605630|P8|STARTED|Overall Study||3
251237|NCT00509899|605631|P7|STARTED|Overall Study||6
251238|NCT00509899|605632|P6|STARTED|Overall Study||22
251239|NCT00509899|605633|P5|STARTED|Overall Study||6
251240|NCT00509899|605634|P4|STARTED|Overall Study||5
251241|NCT00509899|605635|P3|STARTED|Overall Study||47
251242|NCT00509899|605636|P2|STARTED|Overall Study||35
251243|NCT00509899|605637|P1|STARTED|Overall Study||30
251244|NCT00509873|605677|P2|NOT COMPLETED|Overall Study||15
251245|NCT00509873|605678|P1|NOT COMPLETED|Overall Study||11
251246|NCT00509873|605677|P2|COMPLETED|Overall Study||276
251247|NCT00509873|605678|P1|COMPLETED|Overall Study||276
251248|NCT00509873|605677|P2|STARTED|Overall Study||291
251249|NCT00509873|605678|P1|STARTED|Overall Study||287
251250|NCT00509795|605696|P4|NOT COMPLETED|Overall Study||27
251251|NCT00509795|605697|P3|NOT COMPLETED|Overall Study||27
251252|NCT00509795|605698|P2|NOT COMPLETED|Overall Study||11
251253|NCT00509795|605699|P1|NOT COMPLETED|Overall Study||22
251254|NCT00509795|605696|P4|COMPLETED|Overall Study||276
251255|NCT00509795|605697|P3|COMPLETED|Overall Study||277
251256|NCT00509795|605698|P2|COMPLETED|Overall Study||293
251257|NCT00509795|605699|P1|COMPLETED|Overall Study||284
251258|NCT00509795|605696|P4|Per Protocol Set (PPS) Population|Overall Study||265
251259|NCT00509795|605697|P3|Per Protocol Set (PPS) Population|Overall Study||270
251260|NCT00509795|605698|P2|Per Protocol Set (PPS) Population|Overall Study||285
251261|NCT00509795|605699|P1|Per Protocol Set (PPS) Population|Overall Study||269
251262|NCT00509795|605696|P4|Full Analysis Set (FAS) Population|Overall Study||301
251263|NCT00509795|605697|P3|Full Analysis Set (FAS) Population|Overall Study||301
251264|NCT00509795|605698|P2|Full Analysis Set (FAS) Population|Overall Study||304
251265|NCT00509795|605699|P1|Full Analysis Set (FAS) Population|Overall Study||304
251266|NCT00509795|605696|P4|Patients Received Treatment (SAF)|Overall Study||303
251267|NCT00509795|605697|P3|Patients Received Treatment (SAF)|Overall Study||304
251268|NCT00509795|605698|P2|Patients Received Treatment (SAF)|Overall Study||304
251269|NCT00509795|605699|P1|Patients Received Treatment (SAF)|Overall Study||304
251270|NCT00509795|605696|P4|STARTED|Overall Study||303
251271|NCT00509795|605697|P3|STARTED|Overall Study||304
251272|NCT00509795|605698|P2|STARTED|Overall Study||304
251273|NCT00509795|605699|P1|STARTED|Overall Study||306
251274|NCT00509769|605730|P1|NOT COMPLETED|Overall Study||91
251275|NCT00509769|605730|P1|COMPLETED|Overall Study||21
251276|NCT00509769|605730|P1|STARTED|Overall Study||112
251277|NCT00509600|605739|P1|NOT COMPLETED|Overall Study||1
251278|NCT00509600|605739|P1|COMPLETED|Overall Study||0
251279|NCT00509600|605739|P1|STARTED|Overall Study||1
251280|NCT00509587|605743|P1|NOT COMPLETED|Overall Study||0
251281|NCT00509587|605743|P1|COMPLETED|Overall Study||21
251282|NCT00509587|605743|P1|STARTED|Overall Study||21
251283|NCT00509496|605753|P2|NOT COMPLETED|Overall Study||0
251284|NCT00509496|605754|P1|NOT COMPLETED|Overall Study||0
251285|NCT00509496|605753|P2|COMPLETED|Overall Study||2
251286|NCT00509496|605754|P1|COMPLETED|Overall Study||19
251287|NCT00509496|605753|P2|STARTED|Overall Study||2
251288|NCT00509496|605754|P1|STARTED|Overall Study||19
251289|NCT00509392|605764|P3|NOT COMPLETED|Overall Study||0
251290|NCT00509392|605765|P2|NOT COMPLETED|Overall Study||0
251291|NCT00509392|605766|P1|NOT COMPLETED|Overall Study||0
251292|NCT00509392|605764|P3|COMPLETED|Overall Study||4
251293|NCT00509392|605765|P2|COMPLETED|Overall Study||33
251294|NCT00509392|605766|P1|COMPLETED|Overall Study||32
251295|NCT00509392|605764|P3|STARTED|Overall Study||4
251296|NCT00509392|605765|P2|STARTED|Overall Study||33
251297|NCT00509392|605766|P1|STARTED|Overall Study||32
251298|NCT00509366|605817|P5|NOT COMPLETED|Overall Study||0
251299|NCT00509366|605818|P4|NOT COMPLETED|Overall Study||0
251300|NCT00509366|605819|P3|NOT COMPLETED|Overall Study||1
251301|NCT00509366|605820|P2|NOT COMPLETED|Overall Study||1
251302|NCT00509366|605821|P1|NOT COMPLETED|Overall Study||1
251303|NCT00509366|605817|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
251304|NCT00509366|605818|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
251305|NCT00509366|605819|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
251393|NCT00508820|605998|P1|COMPLETED|Overall Study||113
251306|NCT00509366|605820|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
251307|NCT00509366|605821|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
251308|NCT00509366|605817|P5|Assigned Treatment|Overall Study||0
251309|NCT00509366|605818|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
251310|NCT00509366|605819|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
251311|NCT00509366|605820|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
251312|NCT00509366|605821|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
251313|NCT00509366|605817|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
251314|NCT00509366|605818|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
251315|NCT00509366|605819|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
251316|NCT00509366|605820|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
251317|NCT00509366|605821|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
251318|NCT00509288|605834|P2|NOT COMPLETED|Overall Study||0
251319|NCT00509288|605835|P1|NOT COMPLETED|Overall Study||0
251320|NCT00509288|605834|P2|COMPLETED|Overall Study||3
251321|NCT00509288|605835|P1|COMPLETED|Overall Study||21
251322|NCT00509288|605834|P2|STARTED|Overall Study||3
251323|NCT00509288|605835|P1|STARTED|Overall Study||21
251324|NCT00509262|605845|P2|NOT COMPLETED|Overall Study||42
251325|NCT00509262|605846|P1|NOT COMPLETED|Overall Study||47
251326|NCT00509262|605845|P2|COMPLETED|Overall Study||170
251327|NCT00509262|605846|P1|COMPLETED|Overall Study||164
251328|NCT00509262|605845|P2|STARTED|Overall Study||212
251329|NCT00509262|605846|P1|STARTED|Overall Study||211
251330|NCT00509249|605858|P1|NOT COMPLETED|Overall Study||0
251331|NCT00509249|605858|P1|COMPLETED|Overall Study||18
251332|NCT00509249|605858|P1|STARTED|Overall Study||18
251333|NCT00509236|605864|P2|NOT COMPLETED|Overall Study||20
251334|NCT00509236|605865|P1|NOT COMPLETED|Overall Study||17
251335|NCT00509236|605864|P2|COMPLETED|Overall Study||45
251336|NCT00509236|605865|P1|COMPLETED|Overall Study||47
251337|NCT00509236|605864|P2|STARTED|Overall Study||65
251338|NCT00509236|605865|P1|STARTED|Overall Study||64
251339|NCT00509223|605880|P2|NOT COMPLETED|Overall Study||72
251340|NCT00509223|605881|P1|NOT COMPLETED|Overall Study||88
251341|NCT00509223|605880|P2|COMPLETED|Overall Study||137
251342|NCT00509223|605881|P1|COMPLETED|Overall Study||119
251343|NCT00509223|605880|P2|STARTED|Overall Study||209
251344|NCT00509223|605881|P1|STARTED|Overall Study||207
251345|NCT00509197|605889|P2|NOT COMPLETED|Overall Study||0
251346|NCT00509197|605890|P1|NOT COMPLETED|Overall Study||0
251347|NCT00509197|605889|P2|COMPLETED|Overall Study||6
251348|NCT00509197|605890|P1|COMPLETED|Overall Study||6
251349|NCT00509197|605889|P2|STARTED|Overall Study||6
251350|NCT00509197|605890|P1|STARTED|Overall Study||6
251351|NCT00509106|605904|P2|NOT COMPLETED|Overall Study||29
251352|NCT00509106|605905|P1|NOT COMPLETED|Overall Study||31
251353|NCT00509106|605904|P2|COMPLETED|Overall Study||278
251354|NCT00509106|605905|P1|COMPLETED|Overall Study||284
251355|NCT00509106|605904|P2|STARTED|Overall Study||307
251356|NCT00509106|605905|P1|STARTED|Overall Study||315
251357|NCT00509067|605913|P2|NOT COMPLETED|Overall Study||5
251358|NCT00509067|605914|P1|NOT COMPLETED|Overall Study||4
251359|NCT00509067|605913|P2|COMPLETED|Overall Study||19
251360|NCT00509067|605914|P1|COMPLETED|Overall Study||15
251361|NCT00509067|605913|P2|STARTED|Overall Study||24
251362|NCT00509067|605914|P1|STARTED|Overall Study||19
251363|NCT00509041|605924|P1|NOT COMPLETED|Overall Study||0
251364|NCT00509041|605924|P1|COMPLETED|Overall Study||43
251365|NCT00509041|605924|P1|STARTED|Overall Study||43
251366|NCT00509028|605933|P2|NOT COMPLETED|Overall Study||7
251367|NCT00509028|605934|P1|NOT COMPLETED|Overall Study||12
251368|NCT00509028|605933|P2|COMPLETED|Overall Study||113
251369|NCT00509028|605934|P1|COMPLETED|Overall Study||109
251370|NCT00509028|605933|P2|STARTED|Overall Study||120
251371|NCT00509028|605934|P1|STARTED|Overall Study||121
251372|NCT00509002|605966|P1|NOT COMPLETED|Overall Study||0
251373|NCT00509002|605966|P1|COMPLETED|Overall Study||37
251374|NCT00509002|605966|P1|STARTED|Overall Study||37
251375|NCT00508924|605974|P4|NOT COMPLETED|Overall Study||1
251376|NCT00508924|605975|P3|NOT COMPLETED|Overall Study||1
251377|NCT00508924|605976|P2|NOT COMPLETED|Overall Study||0
251378|NCT00508924|605977|P1|NOT COMPLETED|Overall Study||0
251379|NCT00508924|605974|P4|COMPLETED|Overall Study||33
251380|NCT00508924|605975|P3|COMPLETED|Overall Study||31
251381|NCT00508924|605976|P2|COMPLETED|Overall Study||38
251382|NCT00508924|605977|P1|COMPLETED|Overall Study||36
251383|NCT00508924|605974|P4|STARTED|Overall Study||34
251384|NCT00508924|605975|P3|STARTED|Overall Study||32
251385|NCT00508924|605976|P2|STARTED|Overall Study||38
251386|NCT00508924|605977|P1|STARTED|Overall Study||36
251387|NCT00508872|605991|P1|NOT COMPLETED|Overall Study||2
251388|NCT00508872|605991|P1|COMPLETED|Overall Study||0
251389|NCT00508872|605991|P1|STARTED|Overall Study||2
251390|NCT00508820|605997|P2|NOT COMPLETED|Overall Study||64
251391|NCT00508820|605998|P1|NOT COMPLETED|Overall Study||55
251392|NCT00508820|605997|P2|COMPLETED|Overall Study||175
251394|NCT00508820|605997|P2|STARTED|Overall Study||239
251395|NCT00508820|605998|P1|STARTED|Overall Study||168
251396|NCT00508755|606008|P1|NOT COMPLETED|Overall Study||1
251397|NCT00508755|606008|P1|COMPLETED|Overall Study||5
251398|NCT00508755|606008|P1|STARTED|Overall Study||6
251399|NCT00508742|606016|P2|NOT COMPLETED|Period 3: Toddler Dose||15
251400|NCT00508742|606017|P1|NOT COMPLETED|Period 3: Toddler Dose||25
251401|NCT00508742|606016|P2|COMPLETED|Period 3: Toddler Dose||863
251402|NCT00508742|606017|P1|COMPLETED|Period 3: Toddler Dose||858
251403|NCT00508742|606016|P2|STARTED|Period 3: Toddler Dose||878
251404|NCT00508742|606017|P1|STARTED|Period 3: Toddler Dose||883
251405|NCT00508742|606016|P2|NOT COMPLETED|Period 2: After Infant Series||11
251406|NCT00508742|606017|P1|NOT COMPLETED|Period 2: After Infant Series||7
251407|NCT00508742|606016|P2|COMPLETED|Period 2: After Infant Series||878
251408|NCT00508742|606017|P1|COMPLETED|Period 2: After Infant Series||883
251409|NCT00508742|606016|P2|STARTED|Period 2: After Infant Series||889
251410|NCT00508742|606017|P1|STARTED|Period 2: After Infant Series||890
251411|NCT00508742|606016|P2|NOT COMPLETED|Period 1: Infant Series||45
251412|NCT00508742|606017|P1|NOT COMPLETED|Period 1: Infant Series||42
251413|NCT00508742|606016|P2|COMPLETED|Period 1: Infant Series||889
251414|NCT00508742|606017|P1|COMPLETED|Period 1: Infant Series||890
251415|NCT00508742|606016|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
251416|NCT00508742|606017|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
251417|NCT00508742|606016|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
251418|NCT00508742|606017|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
251419|NCT00508742|606016|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
251420|NCT00508742|606017|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
251421|NCT00508742|606016|P2|STARTED|Period 1: Infant Series||934
251422|NCT00508742|606017|P1|STARTED|Period 1: Infant Series||932
251423|NCT00508716|606033|P2|NOT COMPLETED|Overall Study||0
251424|NCT00508716|606034|P1|NOT COMPLETED|Overall Study||0
251425|NCT00508716|606033|P2|COMPLETED|Overall Study||63
251426|NCT00508716|606034|P1|COMPLETED|Overall Study||61
251427|NCT00508716|606033|P2|STARTED|Overall Study||63
251428|NCT00508716|606034|P1|STARTED|Overall Study||61
251429|NCT00508651|606042|P2|NOT COMPLETED|Overall Study||2
251430|NCT00508651|606043|P1|NOT COMPLETED|Overall Study||4
251431|NCT00508651|606042|P2|COMPLETED|Overall Study||8
251432|NCT00508651|606043|P1|COMPLETED|Overall Study||16
251433|NCT00508651|606042|P2|STARTED|Overall Study||10
251434|NCT00508651|606043|P1|STARTED|Overall Study||20
251435|NCT00508521|606117|P1|NOT COMPLETED|Overall Study||0
251436|NCT00508521|606117|P1|COMPLETED|Overall Study||4
251437|NCT00508521|606117|P1|STARTED|Overall Study||4
251438|NCT00508482|606124|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
251439|NCT00508482|606125|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
251440|NCT00508482|606126|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
251441|NCT00508482|606124|P3|COMPLETED|at the 12th Week of Follow-up||98
251442|NCT00508482|606125|P2|COMPLETED|at the 12th Week of Follow-up||96
251443|NCT00508482|606126|P1|COMPLETED|at the 12th Week of Follow-up||196
251444|NCT00508482|606124|P3|STARTED|at the 12th Week of Follow-up||98
251445|NCT00508482|606125|P2|STARTED|at the 12th Week of Follow-up||96
251446|NCT00508482|606126|P1|STARTED|at the 12th Week of Follow-up||196
251447|NCT00508482|606124|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
251448|NCT00508482|606125|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
251449|NCT00508482|606126|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
251450|NCT00508482|606124|P3|COMPLETED|at the 4th Week of Follow-up||98
251451|NCT00508482|606125|P2|COMPLETED|at the 4th Week of Follow-up||96
251452|NCT00508482|606126|P1|COMPLETED|at the 4th Week of Follow-up||196
251453|NCT00508482|606124|P3|STARTED|at the 4th Week of Follow-up||99
251454|NCT00508482|606125|P2|STARTED|at the 4th Week of Follow-up||102
251455|NCT00508482|606126|P1|STARTED|at the 4th Week of Follow-up||216
251456|NCT00508482|606124|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
251457|NCT00508482|606125|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
251458|NCT00508482|606126|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
251459|NCT00508482|606124|P3|COMPLETED|Over 4 Weeks of Treatment||99
251460|NCT00508482|606125|P2|COMPLETED|Over 4 Weeks of Treatment||102
251461|NCT00508482|606126|P1|COMPLETED|Over 4 Weeks of Treatment||216
251462|NCT00508482|606124|P3|STARTED|Over 4 Weeks of Treatment||119
251463|NCT00508482|606125|P2|STARTED|Over 4 Weeks of Treatment||119
251464|NCT00508482|606126|P1|STARTED|Over 4 Weeks of Treatment||237
251465|NCT00508469|606163|P2|NOT COMPLETED|Overall Study||10
251466|NCT00508469|606164|P1|NOT COMPLETED|Overall Study||17
251467|NCT00508469|606163|P2|COMPLETED|Overall Study||40
251468|NCT00508469|606164|P1|COMPLETED|Overall Study||35
251469|NCT00508469|606163|P2|STARTED|Overall Study||50
251470|NCT00508469|606164|P1|STARTED|Overall Study||52
251471|NCT00508404|606170|P1|NOT COMPLETED|Overall Study||42
251472|NCT00508404|606170|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
251473|NCT00508404|606170|P1|STARTED|Overall Study||154
251474|NCT00508391|606197|P2|NOT COMPLETED|Second Treatment||0
251475|NCT00508391|606198|P1|NOT COMPLETED|Second Treatment||2
251476|NCT00508391|606197|P2|COMPLETED|Second Treatment||59
251477|NCT00508391|606198|P1|COMPLETED|Second Treatment||52
251478|NCT00508391|606197|P2|STARTED|Second Treatment||59
251479|NCT00508391|606198|P1|STARTED|Second Treatment||54
251480|NCT00508391|606197|P2|NOT COMPLETED|First Treatment||3
251481|NCT00508391|606198|P1|NOT COMPLETED|First Treatment||6
251482|NCT00508391|606197|P2|COMPLETED|First Treatment||59
251483|NCT00508391|606198|P1|COMPLETED|First Treatment||54
251484|NCT00508391|606197|P2|STARTED|First Treatment||62
251485|NCT00508391|606198|P1|STARTED|First Treatment||60
251486|NCT00508274|606209|P1|NOT COMPLETED|Overall Study||2
251487|NCT00508274|606209|P1|COMPLETED|Overall Study||50
251488|NCT00508274|606209|P1|STARTED|Overall Study||52
251489|NCT00508183|606220|P2|NOT COMPLETED|Overall Study||8
251490|NCT00508183|606221|P1|NOT COMPLETED|Overall Study||9
251491|NCT00508183|606220|P2|COMPLETED|Overall Study||34
251492|NCT00508183|606221|P1|COMPLETED|Overall Study||39
251493|NCT00508183|606220|P2|STARTED|Overall Study||42
251494|NCT00508183|606221|P1|STARTED|Overall Study||48
251495|NCT00508157|606237|P2|NOT COMPLETED|Overall Study||3
251496|NCT00508157|606238|P1|NOT COMPLETED|Overall Study||2
251497|NCT00508157|606237|P2|COMPLETED|Overall Study||23
251498|NCT00508157|606238|P1|COMPLETED|Overall Study||24
251499|NCT00508157|606237|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
251500|NCT00508157|606238|P1|Safety Sample|Overall Study||26
251501|NCT00508157|606237|P2|Randomized Sample|Overall Study||26
251502|NCT00508157|606238|P1|Randomized Sample|Overall Study||26
251503|NCT00508157|606237|P2|STARTED|Overall Study||26
251504|NCT00508157|606238|P1|STARTED|Overall Study||26
251505|NCT00508144|606260|P1|NOT COMPLETED|Overall Study||11
251506|NCT00508144|606260|P1|COMPLETED|Overall Study||53
251507|NCT00508144|606260|P1|STARTED|Overall Study||64
251508|NCT00508118|606266|P2|NOT COMPLETED|Overall Study||0
251509|NCT00508118|606267|P1|NOT COMPLETED|Overall Study||0
251510|NCT00508118|606266|P2|COMPLETED|Overall Study||4
251511|NCT00508118|606267|P1|COMPLETED|Overall Study||3
251512|NCT00508118|606266|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
251513|NCT00508118|606267|P1|STARTED|Overall Study||3
251514|NCT00508027|606286|P1|NOT COMPLETED|Dose Level 3||0
251515|NCT00508027|606286|P1|COMPLETED|Dose Level 3||2
251516|NCT00508027|606286|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
251517|NCT00508027|606286|P1|NOT COMPLETED|Dose Level 2||4
251518|NCT00508027|606286|P1|COMPLETED|Dose Level 2||16
251519|NCT00508027|606286|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
251520|NCT00508027|606286|P1|NOT COMPLETED|Dose Level 1||8
251521|NCT00508027|606286|P1|COMPLETED|Dose Level 1||12
251522|NCT00508027|606286|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
251523|NCT00508001|606327|P3|NOT COMPLETED|Overall Study||7
251524|NCT00508001|606328|P2|NOT COMPLETED|Overall Study||12
251525|NCT00508001|606329|P1|NOT COMPLETED|Overall Study||19
251526|NCT00508001|606327|P3|COMPLETED|Overall Study||16
251527|NCT00508001|606328|P2|COMPLETED|Overall Study||13
251528|NCT00508001|606329|P1|COMPLETED|Overall Study||0
251529|NCT00508001|606327|P3|Secondary Treatment Phase|Overall Study||16
251530|NCT00508001|606328|P2|Secondary Treatment Phase|Overall Study||13
251531|NCT00508001|606329|P1|Secondary Treatment Phase|Overall Study||0
251532|NCT00508001|606327|P3|STARTED|Overall Study||23
251533|NCT00508001|606328|P2|STARTED|Overall Study||25
251534|NCT00508001|606329|P1|STARTED|Overall Study||19
251535|NCT00507819|606346|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
251536|NCT00507819|606347|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
251537|NCT00507819|606346|P2|COMPLETED|Second Intervention (6 Weeks)||14
251538|NCT00507819|606347|P1|COMPLETED|Second Intervention (6 Weeks)||13
251539|NCT00507819|606346|P2|STARTED|Second Intervention (6 Weeks)||14
251540|NCT00507819|606347|P1|STARTED|Second Intervention (6 Weeks)||13
251541|NCT00507819|606346|P2|NOT COMPLETED|Washout (6 Weeks)||0
251542|NCT00507819|606347|P1|NOT COMPLETED|Washout (6 Weeks)||1
251543|NCT00507819|606346|P2|COMPLETED|Washout (6 Weeks)||14
251544|NCT00507819|606347|P1|COMPLETED|Washout (6 Weeks)||13
251545|NCT00507819|606346|P2|STARTED|Washout (6 Weeks)||14
251546|NCT00507819|606347|P1|STARTED|Washout (6 Weeks)||14
251547|NCT00507819|606346|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
251548|NCT00507819|606347|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
251549|NCT00507819|606346|P2|COMPLETED|First Intervention (6 Weeks)||14
251550|NCT00507819|606347|P1|COMPLETED|First Intervention (6 Weeks)||14
251551|NCT00507819|606346|P2|STARTED|First Intervention (6 Weeks)||14
251552|NCT00507819|606347|P1|STARTED|First Intervention (6 Weeks)||14
251553|NCT00507767|606359|P1|NOT COMPLETED|Overall Study||0
251554|NCT00507767|606359|P1|COMPLETED|Overall Study||15
251555|NCT00507767|606359|P1|STARTED|Overall Study||15
251556|NCT00507689|606366|P2|NOT COMPLETED|Randomized Period||2
251557|NCT00507689|606367|P1|NOT COMPLETED|Randomized Period||1
251558|NCT00507689|606366|P2|COMPLETED|Randomized Period||16
251559|NCT00507689|606367|P1|COMPLETED|Randomized Period||18
251560|NCT00507689|606366|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
251561|NCT00507689|606367|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
251562|NCT00507689|606366|P2|NOT COMPLETED|Pre-Randomization Period||0
251563|NCT00507689|606367|P1|NOT COMPLETED|Pre-Randomization Period||3
251564|NCT00507689|606366|P2|COMPLETED|Pre-Randomization Period||0
251565|NCT00507689|606367|P1|COMPLETED|Pre-Randomization Period||37
251566|NCT00507689|606366|P2|STARTED|Pre-Randomization Period||0
251567|NCT00507689|606367|P1|STARTED|Pre-Randomization Period||40
251568|NCT00507559|606384|P1|NOT COMPLETED|Overall Study||71
251569|NCT00507559|606384|P1|COMPLETED|Overall Study||84
251570|NCT00507559|606384|P1|STARTED|Overall Study||155
251571|NCT00507546|606399|P2|NOT COMPLETED|Overall Study||1
251572|NCT00507546|606400|P1|NOT COMPLETED|Overall Study||2
251573|NCT00507546|606399|P2|COMPLETED|Overall Study||3
251574|NCT00507546|606400|P1|COMPLETED|Overall Study||2
251575|NCT00507546|606399|P2|STARTED|Overall Study||4
251576|NCT00507546|606400|P1|STARTED|Overall Study||4
251577|NCT00507507|606410|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
251578|NCT00507507|606411|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
251579|NCT00507507|606410|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
251580|NCT00507507|606411|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
251581|NCT00507507|606410|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
251582|NCT00507507|606411|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
251583|NCT00507507|606410|P2|NOT COMPLETED|Treatment Period||53
251584|NCT00507507|606411|P1|NOT COMPLETED|Treatment Period||52
251585|NCT00507507|606410|P2|COMPLETED|Treatment Period||9
251586|NCT00507507|606411|P1|COMPLETED|Treatment Period||12
251587|NCT00507507|606410|P2|Completed 192 Weeks of Treatment|Treatment Period||52
251588|NCT00507507|606411|P1|Completed 192 Weeks of Treatment|Treatment Period||52
251589|NCT00507507|606410|P2|STARTED|Treatment Period||62
251590|NCT00507507|606411|P1|STARTED|Treatment Period||64
251591|NCT00507455|606446|P3|NOT COMPLETED|Overall Study||12
251592|NCT00507455|606447|P2|NOT COMPLETED|Overall Study||6
251593|NCT00507455|606448|P1|NOT COMPLETED|Overall Study||12
251594|NCT00507455|606446|P3|COMPLETED|Overall Study||62
251595|NCT00507455|606447|P2|COMPLETED|Overall Study||68
251596|NCT00507455|606448|P1|COMPLETED|Overall Study||62
251597|NCT00507455|606446|P3|STARTED|Overall Study||74
251598|NCT00507455|606447|P2|STARTED|Overall Study||74
251599|NCT00507455|606448|P1|STARTED|Overall Study||74
251600|NCT00507442|606511|P4|NOT COMPLETED|Overall Study||5
251601|NCT00507442|606512|P3|NOT COMPLETED|Overall Study||15
251602|NCT00507442|606513|P2|NOT COMPLETED|Overall Study||27
251603|NCT00507442|606514|P1|NOT COMPLETED|Overall Study||16
251604|NCT00507442|606511|P4|COMPLETED|Overall Study||12
251605|NCT00507442|606512|P3|COMPLETED|Overall Study||18
251606|NCT00507442|606513|P2|COMPLETED|Overall Study||39
251607|NCT00507442|606514|P1|COMPLETED|Overall Study||26
251608|NCT00507442|606511|P4|STARTED|Overall Study||17
251609|NCT00507442|606512|P3|STARTED|Overall Study||33
251610|NCT00507442|606513|P2|STARTED|Overall Study||66
251611|NCT00507442|606514|P1|STARTED|Overall Study||42
251612|NCT00507429|606566|P2|NOT COMPLETED|Maintenance Phase||0
251613|NCT00507429|606567|P1|NOT COMPLETED|Maintenance Phase||14
251614|NCT00507429|606566|P2|COMPLETED|Maintenance Phase||0
251615|NCT00507429|606567|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
251616|NCT00507429|606566|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
251617|NCT00507429|606567|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
251618|NCT00507429|606566|P2|NOT COMPLETED|Treatment Phase||18
251619|NCT00507429|606567|P1|NOT COMPLETED|Treatment Phase||37
251620|NCT00507429|606566|P2|COMPLETED|Treatment Phase||7
251621|NCT00507429|606567|P1|COMPLETED|Treatment Phase||18
251622|NCT00507429|606566|P2|STARTED|Treatment Phase|Randomized|25
251623|NCT00507429|606567|P1|STARTED|Treatment Phase|Randomized|55
251624|NCT00507416|606578|P3|NOT COMPLETED|Overall Study||114
251625|NCT00507416|606579|P2|NOT COMPLETED|Overall Study||125
251626|NCT00507416|606580|P1|NOT COMPLETED|Overall Study||118
251627|NCT00507416|606578|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
251628|NCT00507416|606579|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
251629|NCT00507416|606580|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
251630|NCT00507416|606578|P3|Completed 8 Treatment Cycles|Overall Study||69
251631|NCT00507416|606579|P2|Completed 8 Treatment Cycles|Overall Study||60
251632|NCT00507416|606580|P1|Completed 8 Treatment Cycles|Overall Study||82
251633|NCT00507416|606578|P3|Treated (Safety Population)|Overall Study||163
251634|NCT00507416|606579|P2|Treated (Safety Population)|Overall Study||158
251635|NCT00507416|606580|P1|Treated (Safety Population)|Overall Study||165
251636|NCT00507416|606578|P3|STARTED|Overall Study||167
251637|NCT00507416|606579|P2|STARTED|Overall Study||167
251638|NCT00507416|606580|P1|STARTED|Overall Study||168
251639|NCT00507208|606611|P2|NOT COMPLETED|Overall Study||0
251640|NCT00507208|606612|P1|NOT COMPLETED|Overall Study||0
251641|NCT00507208|606611|P2|COMPLETED|Overall Study||26
251642|NCT00507208|606612|P1|COMPLETED|Overall Study||27
251643|NCT00507208|606611|P2|Received Dynasplint in Crossover|Overall Study||3
251644|NCT00507208|606612|P1|Received Dynasplint in Crossover|Overall Study||0
251645|NCT00507208|606611|P2|STARTED|Overall Study||26
251646|NCT00507208|606612|P1|STARTED|Overall Study||27
251647|NCT00507130|606622|P4|NOT COMPLETED|Overall Study||1
251648|NCT00507130|606623|P3|NOT COMPLETED|Overall Study||1
251649|NCT00507130|606624|P2|NOT COMPLETED|Overall Study||0
251650|NCT00507130|606625|P1|NOT COMPLETED|Overall Study||1
251651|NCT00507130|606622|P4|COMPLETED|Overall Study||8
251652|NCT00507130|606623|P3|COMPLETED|Overall Study||8
251653|NCT00507130|606624|P2|COMPLETED|Overall Study||9
251654|NCT00507130|606625|P1|COMPLETED|Overall Study||8
251655|NCT00507130|606622|P4|STARTED|Overall Study||9
251656|NCT00507130|606623|P3|STARTED|Overall Study||9
251657|NCT00507130|606624|P2|STARTED|Overall Study||9
251658|NCT00507130|606625|P1|STARTED|Overall Study||9
251659|NCT00506948|606667|P1|NOT COMPLETED|Overall Study||10
251660|NCT00506948|606667|P1|COMPLETED|Overall Study||0
251661|NCT00506948|606667|P1|STARTED|Overall Study||10
251662|NCT00506922|606676|P5|NOT COMPLETED|Overall Study||1
251663|NCT00506922|606677|P4|NOT COMPLETED|Overall Study||2
251664|NCT00506922|606678|P3|NOT COMPLETED|Overall Study||0
251665|NCT00506922|606679|P2|NOT COMPLETED|Overall Study||0
251666|NCT00506922|606680|P1|NOT COMPLETED|Overall Study||0
251667|NCT00506922|606676|P5|COMPLETED|Overall Study||10
251668|NCT00506922|606677|P4|COMPLETED|Overall Study||61
251669|NCT00506922|606678|P3|COMPLETED|Overall Study||29
251670|NCT00506922|606679|P2|COMPLETED|Overall Study||10
251671|NCT00506922|606680|P1|COMPLETED|Overall Study||37
251672|NCT00506922|606676|P5|STARTED|Overall Study||11
251673|NCT00506922|606677|P4|STARTED|Overall Study||63
251674|NCT00506922|606678|P3|STARTED|Overall Study||29
251675|NCT00506922|606679|P2|STARTED|Overall Study||10
251676|NCT00506922|606680|P1|STARTED|Overall Study||37
251677|NCT00506883|606691|P3|NOT COMPLETED|Overall Study||4
251678|NCT00506883|606692|P2|NOT COMPLETED|Overall Study||3
251679|NCT00506883|606693|P1|NOT COMPLETED|Overall Study||7
251680|NCT00506883|606691|P3|COMPLETED|Overall Study||55
251681|NCT00506883|606692|P2|COMPLETED|Overall Study||71
251682|NCT00506883|606693|P1|COMPLETED|Overall Study||45
251683|NCT00506883|606691|P3|STARTED|Overall Study||59
251684|NCT00506883|606692|P2|STARTED|Overall Study||74
251685|NCT00506883|606693|P1|STARTED|Overall Study||52
251686|NCT00506857|606701|P1|NOT COMPLETED|Overall Study||0
251687|NCT00506857|606701|P1|COMPLETED|Overall Study||80
251688|NCT00506857|606701|P1|STARTED|Overall Study||80
251689|NCT00506831|606706|P1|NOT COMPLETED|Overall Study||2
251690|NCT00506831|606706|P1|COMPLETED|Overall Study||7
251691|NCT00506831|606706|P1|STARTED|Overall Study||9
251692|NCT00506714|606712|P2|NOT COMPLETED|Overall Study||0
251693|NCT00506714|606713|P1|NOT COMPLETED|Overall Study||0
251694|NCT00506714|606712|P2|COMPLETED|Overall Study||13
251695|NCT00506714|606713|P1|COMPLETED|Overall Study||13
251696|NCT00506714|606712|P2|STARTED|Overall Study||13
251697|NCT00506714|606713|P1|STARTED|Overall Study||13
251698|NCT00506675|606723|P2|NOT COMPLETED|Overall Study||0
251699|NCT00506675|606724|P1|NOT COMPLETED|Overall Study||0
251700|NCT00506675|606723|P2|COMPLETED|Overall Study||28
251701|NCT00506675|606724|P1|COMPLETED|Overall Study||27
251702|NCT00506675|606723|P2|STARTED|Overall Study||28
251703|NCT00506675|606724|P1|STARTED|Overall Study||27
251704|NCT00506662|606738|P2|NOT COMPLETED|Overall Study||28
251705|NCT00506662|606739|P1|NOT COMPLETED|Overall Study||17
251706|NCT00506662|606738|P2|COMPLETED|Overall Study||20
251707|NCT00506662|606739|P1|COMPLETED|Overall Study||21
251708|NCT00506662|606738|P2|STARTED|Overall Study||48
251709|NCT00506662|606739|P1|STARTED|Overall Study||38
251710|NCT00506597|606769|P1|NOT COMPLETED|Overall Study||0
251711|NCT00506597|606769|P1|COMPLETED|Overall Study||33
251712|NCT00506597|606769|P1|STARTED|Overall Study||33
251713|NCT00506493|606773|P1|NOT COMPLETED|Overall Study||11
251714|NCT00506493|606773|P1|COMPLETED|Overall Study||64
251715|NCT00506493|606773|P1|STARTED|Overall Study||75
251716|NCT00506454|606782|P2|NOT COMPLETED|Overall Study||1
251717|NCT00506454|606783|P1|NOT COMPLETED|Overall Study||1
251718|NCT00506454|606782|P2|COMPLETED|Overall Study||10
251719|NCT00506454|606783|P1|COMPLETED|Overall Study||10
251720|NCT00506454|606782|P2|STARTED|Overall Study||11
251721|NCT00506454|606783|P1|STARTED|Overall Study||11
251722|NCT00506441|606789|P2|NOT COMPLETED|Period 2; Double-blind Period||5
251723|NCT00506441|606790|P1|NOT COMPLETED|Period 2; Double-blind Period||3
251724|NCT00506441|606789|P2|COMPLETED|Period 2; Double-blind Period||79
251725|NCT00506441|606790|P1|COMPLETED|Period 2; Double-blind Period||82
251726|NCT00506441|606789|P2|STARTED|Period 2; Double-blind Period||84
251727|NCT00506441|606790|P1|STARTED|Period 2; Double-blind Period||85
251728|NCT00506441|606789|P2|NOT COMPLETED|Period 1; Open-label Period||0
251729|NCT00506441|606790|P1|NOT COMPLETED|Period 1; Open-label Period||76
251730|NCT00506441|606789|P2|COMPLETED|Period 1; Open-label Period||0
251731|NCT00506441|606790|P1|COMPLETED|Period 1; Open-label Period||169
251732|NCT00506441|606789|P2|STARTED|Period 1; Open-label Period||0
251733|NCT00506441|606790|P1|STARTED|Period 1; Open-label Period||245
251734|NCT00506415|606798|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
251735|NCT00506415|606799|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
251736|NCT00506415|606800|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
251737|NCT00506415|606801|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
251738|NCT00506415|606798|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
251739|NCT00506415|606799|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
251740|NCT00506415|606800|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
251741|NCT00506415|606801|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
251742|NCT00506415|606798|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
251743|NCT00506415|606799|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
251744|NCT00506415|606800|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
251745|NCT00506415|606801|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
251746|NCT00506415|606798|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
251747|NCT00506415|606799|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
251748|NCT00506415|606800|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
251749|NCT00506415|606801|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
251750|NCT00506415|606798|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
251751|NCT00506415|606799|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
251752|NCT00506415|606800|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
251753|NCT00506415|606801|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
251754|NCT00506415|606798|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
251755|NCT00506415|606799|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
251756|NCT00506415|606800|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
251757|NCT00506415|606801|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
251758|NCT00506415|606798|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
251759|NCT00506415|606799|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
251760|NCT00506415|606800|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
251761|NCT00506415|606801|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
251762|NCT00506415|606798|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
251763|NCT00506415|606799|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
251764|NCT00506415|606800|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
251765|NCT00506415|606801|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
251766|NCT00506415|606798|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
251767|NCT00506415|606799|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
251768|NCT00506415|606800|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
251769|NCT00506415|606801|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
251770|NCT00506415|606798|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
251771|NCT00506415|606799|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
251772|NCT00506415|606800|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
251773|NCT00506415|606801|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
251774|NCT00506389|606826|P3|NOT COMPLETED|Follow-up Period||0
251775|NCT00506389|606827|P2|NOT COMPLETED|Follow-up Period||0
251776|NCT00506389|606828|P1|NOT COMPLETED|Follow-up Period||0
251777|NCT00506389|606826|P3|COMPLETED|Follow-up Period||136
251778|NCT00506389|606827|P2|COMPLETED|Follow-up Period||138
251779|NCT00506389|606828|P1|COMPLETED|Follow-up Period||139
251780|NCT00506389|606826|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
251781|NCT00506389|606827|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
251782|NCT00506389|606828|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
251783|NCT00506389|606826|P3|NOT COMPLETED|In-treatment Period||12
251784|NCT00506389|606827|P2|NOT COMPLETED|In-treatment Period||15
251785|NCT00506389|606828|P1|NOT COMPLETED|In-treatment Period||26
251786|NCT00506389|606826|P3|COMPLETED|In-treatment Period||125
251787|NCT00506389|606827|P2|COMPLETED|In-treatment Period||124
251788|NCT00506389|606828|P1|COMPLETED|In-treatment Period||117
251789|NCT00506389|606826|P3|All Participants Treated|In-treatment Period||136
251790|NCT00506389|606827|P2|All Participants Treated|In-treatment Period||138
251791|NCT00506389|606828|P1|All Participants Treated|In-treatment Period||139
251792|NCT00506389|606826|P3|STARTED|In-treatment Period||137
251793|NCT00506389|606827|P2|STARTED|In-treatment Period||139
251794|NCT00506389|606828|P1|STARTED|In-treatment Period||143
251795|NCT00506350|606854|P9|NOT COMPLETED|Overall Study||5
251796|NCT00506350|606855|P8|NOT COMPLETED|Overall Study||5
251797|NCT00506350|606856|P7|NOT COMPLETED|Overall Study||2
251798|NCT00506350|606857|P6|NOT COMPLETED|Overall Study||2
251799|NCT00506350|606858|P5|NOT COMPLETED|Overall Study||10
251800|NCT00506350|606859|P4|NOT COMPLETED|Overall Study||2
251801|NCT00506350|606860|P3|NOT COMPLETED|Overall Study||6
251802|NCT00506350|606861|P2|NOT COMPLETED|Overall Study||3
251803|NCT00506350|606862|P1|NOT COMPLETED|Overall Study||3
251804|NCT00506350|606854|P9|COMPLETED|Overall Study||30
251805|NCT00506350|606855|P8|COMPLETED|Overall Study||36
251806|NCT00506350|606856|P7|COMPLETED|Overall Study||33
251807|NCT00506350|606857|P6|COMPLETED|Overall Study||38
251808|NCT00506350|606858|P5|COMPLETED|Overall Study||40
251809|NCT00506350|606859|P4|COMPLETED|Overall Study||34
251810|NCT00506350|606860|P3|COMPLETED|Overall Study||31
251811|NCT00506350|606861|P2|COMPLETED|Overall Study||37
251812|NCT00506350|606862|P1|COMPLETED|Overall Study||33
251813|NCT00506350|606854|P9|STARTED|Overall Study||35
251814|NCT00506350|606855|P8|STARTED|Overall Study||41
251815|NCT00506350|606856|P7|STARTED|Overall Study||35
251816|NCT00506350|606857|P6|STARTED|Overall Study||40
251817|NCT00506350|606858|P5|STARTED|Overall Study||50
251818|NCT00506350|606859|P4|STARTED|Overall Study||36
251819|NCT00506350|606860|P3|STARTED|Overall Study||37
251820|NCT00506350|606861|P2|STARTED|Overall Study||40
251821|NCT00506350|606862|P1|STARTED|Overall Study||36
251822|NCT00506285|607009|P2|NOT COMPLETED|6-month Open Label Phase||12
251823|NCT00506285|607010|P1|NOT COMPLETED|6-month Open Label Phase||10
251824|NCT00506285|607009|P2|COMPLETED|6-month Open Label Phase||19
251825|NCT00506285|607010|P1|COMPLETED|6-month Open Label Phase||10
251826|NCT00506285|607009|P2|STARTED|6-month Open Label Phase||31
251827|NCT00506285|607010|P1|STARTED|6-month Open Label Phase||20
251828|NCT00506285|607009|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
251829|NCT00506285|607010|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
251830|NCT00506285|607009|P2|COMPLETED|Double Blind Cross-Over Phase||31
251831|NCT00506285|607010|P1|COMPLETED|Double Blind Cross-Over Phase||20
251832|NCT00506285|607009|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
251833|NCT00506285|607010|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
251834|NCT00506285|607009|P2|STARTED|Double Blind Cross-Over Phase||36
251835|NCT00506285|607010|P1|STARTED|Double Blind Cross-Over Phase||29
251836|NCT00506285|607009|P2|NOT COMPLETED|3 Week Screening Phase||10
251837|NCT00506285|607010|P1|NOT COMPLETED|3 Week Screening Phase||17
251838|NCT00506285|607009|P2|COMPLETED|3 Week Screening Phase||36
251839|NCT00506285|607010|P1|COMPLETED|3 Week Screening Phase||29
251840|NCT00506285|607009|P2|STARTED|3 Week Screening Phase||46
251841|NCT00506285|607010|P1|STARTED|3 Week Screening Phase||46
251842|NCT00506155|607018|P1|NOT COMPLETED|Overall Study||0
251843|NCT00506155|607018|P1|COMPLETED|Overall Study||60
251844|NCT00506155|607018|P1|STARTED|Overall Study||60
251845|NCT00506077|607025|P2|NOT COMPLETED|Treatment Period 2||1
251846|NCT00506077|607026|P1|NOT COMPLETED|Treatment Period 2||1
251847|NCT00506077|607025|P2|COMPLETED|Treatment Period 2||23
251848|NCT00506077|607026|P1|COMPLETED|Treatment Period 2||23
251849|NCT00506077|607025|P2|STARTED|Treatment Period 2||24
251850|NCT00506077|607026|P1|STARTED|Treatment Period 2||24
251851|NCT00506077|607025|P2|NOT COMPLETED|Washout||0
251852|NCT00506077|607026|P1|NOT COMPLETED|Washout||0
251853|NCT00506077|607025|P2|COMPLETED|Washout||24
251854|NCT00506077|607026|P1|COMPLETED|Washout||24
251855|NCT00506077|607025|P2|STARTED|Washout||24
251856|NCT00506077|607026|P1|STARTED|Washout||24
251857|NCT00506077|607025|P2|NOT COMPLETED|Treatment Period 1||3
251858|NCT00506077|607026|P1|NOT COMPLETED|Treatment Period 1||4
251859|NCT00506077|607025|P2|COMPLETED|Treatment Period 1||24
251860|NCT00506077|607026|P1|COMPLETED|Treatment Period 1||24
251861|NCT00506077|607025|P2|STARTED|Treatment Period 1||27
251862|NCT00506077|607026|P1|STARTED|Treatment Period 1||28
251863|NCT00506064|607048|P2|NOT COMPLETED|Overall Study||0
251864|NCT00506064|607049|P1|NOT COMPLETED|Overall Study||0
251865|NCT00506064|607048|P2|COMPLETED|Overall Study||0
251866|NCT00506064|607049|P1|COMPLETED|Overall Study||1
251867|NCT00506064|607048|P2|STARTED|Overall Study||0
251868|NCT00506064|607049|P1|STARTED|Overall Study||1
251869|NCT00506025|607058|P3|NOT COMPLETED|Overall Study||0
251870|NCT00506025|607059|P2|NOT COMPLETED|Overall Study||0
251871|NCT00506025|607060|P1|NOT COMPLETED|Overall Study||0
251872|NCT00506025|607058|P3|COMPLETED|Overall Study||8
251873|NCT00506025|607059|P2|COMPLETED|Overall Study||9
251874|NCT00506025|607060|P1|COMPLETED|Overall Study||10
251875|NCT00506025|607058|P3|STARTED|Overall Study||8
251876|NCT00506025|607059|P2|STARTED|Overall Study||9
251877|NCT00506025|607060|P1|STARTED|Overall Study||10
251878|NCT00505934|607068|P1|NOT COMPLETED|Overall Study||3
251879|NCT00505934|607068|P1|COMPLETED|Overall Study||16
251880|NCT00505934|607068|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
251881|NCT00505921|607074|P1|NOT COMPLETED|Overall Study||9
251882|NCT00505921|607074|P1|COMPLETED|Overall Study||18
251883|NCT00505921|607074|P1|STARTED|Overall Study||27
251884|NCT00505895|607080|P2|NOT COMPLETED|Overall Study||0
251885|NCT00505895|607081|P1|NOT COMPLETED|Overall Study||0
251886|NCT00505895|607080|P2|COMPLETED|Overall Study||23
251887|NCT00505895|607081|P1|COMPLETED|Overall Study||27
251888|NCT00505895|607080|P2|STARTED|Overall Study||23
251889|NCT00505895|607081|P1|STARTED|Overall Study||27
251890|NCT00505778|607091|P2|NOT COMPLETED|Overall Study||135
251891|NCT00505778|607092|P1|NOT COMPLETED|Overall Study||134
251892|NCT00505778|607091|P2|COMPLETED|Overall Study||378
251893|NCT00505778|607092|P1|COMPLETED|Overall Study||380
251894|NCT00505778|607091|P2|Intent to Treat (ITT) Population|Overall Study||511
251895|NCT00505778|607092|P1|Intent to Treat (ITT) Population|Overall Study||512
251896|NCT00505778|607091|P2|STARTED|Overall Study||513
251897|NCT00505778|607092|P1|STARTED|Overall Study||514
251898|NCT00505765|607111|P3|NOT COMPLETED|Overall Study||3
251899|NCT00505765|607112|P2|NOT COMPLETED|Overall Study||3
251900|NCT00505765|607113|P1|NOT COMPLETED|Overall Study||2
251901|NCT00505765|607111|P3|COMPLETED|Overall Study||19
251902|NCT00505765|607112|P2|COMPLETED|Overall Study||17
251903|NCT00505765|607113|P1|COMPLETED|Overall Study||19
251904|NCT00505765|607111|P3|Mid-Point Assessment|Overall Study||21
251905|NCT00505765|607112|P2|Mid-Point Assessment|Overall Study||19
251906|NCT00505765|607113|P1|Mid-Point Assessment|Overall Study||20
251907|NCT00505765|607111|P3|STARTED|Overall Study||22
251908|NCT00505765|607112|P2|STARTED|Overall Study||20
251909|NCT00505765|607113|P1|STARTED|Overall Study||21
251910|NCT00505752|607140|P4|NOT COMPLETED|Overall Study||6
251911|NCT00505752|607141|P3|NOT COMPLETED|Overall Study||8
251912|NCT00505752|607142|P2|NOT COMPLETED|Overall Study||9
251913|NCT00505752|607143|P1|NOT COMPLETED|Overall Study||6
251914|NCT00505752|607140|P4|COMPLETED|Overall Study||126
251915|NCT00505752|607141|P3|COMPLETED|Overall Study||120
251916|NCT00505752|607142|P2|COMPLETED|Overall Study||119
251917|NCT00505752|607143|P1|COMPLETED|Overall Study||126
251918|NCT00505752|607140|P4|STARTED|Overall Study||132
251919|NCT00505752|607141|P3|STARTED|Overall Study||128
251920|NCT00505752|607142|P2|STARTED|Overall Study||128
251921|NCT00505752|607143|P1|STARTED|Overall Study||132
251922|NCT00505687|607157|P1|NOT COMPLETED|Overall Study||95
251923|NCT00505687|607157|P1|COMPLETED|Overall Study||91
251924|NCT00505687|607157|P1|STARTED|Overall Study||186
251925|NCT00505661|607163|P1|NOT COMPLETED|Overall Study||4
251926|NCT00505661|607163|P1|COMPLETED|Overall Study||12
251927|NCT00505661|607163|P1|STARTED|Overall Study||16
251928|NCT00505635|607167|P1|NOT COMPLETED|Overall Study||0
251929|NCT00505635|607167|P1|COMPLETED|Overall Study||5
251930|NCT00505635|607167|P1|STARTED|Overall Study||5
251931|NCT00505622|607174|P3|NOT COMPLETED|Overall Study||96
251932|NCT00505622|607175|P2|NOT COMPLETED|Overall Study||108
251933|NCT00505622|607176|P1|NOT COMPLETED|Overall Study||121
251934|NCT00505622|607174|P3|COMPLETED|Overall Study||0
251935|NCT00505622|607175|P2|COMPLETED|Overall Study||0
251936|NCT00505622|607176|P1|COMPLETED|Overall Study||0
251937|NCT00505622|607174|P3|STARTED|Overall Study||96
251938|NCT00505622|607175|P2|STARTED|Overall Study||108
251939|NCT00505622|607176|P1|STARTED|Overall Study||121
251940|NCT00505518|607193|P1|NOT COMPLETED|Overall Study||0
251941|NCT00505518|607193|P1|COMPLETED|Overall Study||9
251942|NCT00505518|607193|P1|STARTED|Overall Study||9
251943|NCT00505414|607201|P5|NOT COMPLETED|Maintenance Phase||0
251944|NCT00505414|607202|P4|NOT COMPLETED|Maintenance Phase||0
251945|NCT00505414|607203|P3|NOT COMPLETED|Maintenance Phase||8
251946|NCT00505414|607204|P2|NOT COMPLETED|Maintenance Phase||5
251947|NCT00505414|607205|P1|NOT COMPLETED|Maintenance Phase||6
251948|NCT00505414|607201|P5|COMPLETED|Maintenance Phase||0
251949|NCT00505414|607202|P4|COMPLETED|Maintenance Phase||0
251950|NCT00505414|607203|P3|COMPLETED|Maintenance Phase||6
251951|NCT00505414|607204|P2|COMPLETED|Maintenance Phase||10
251952|NCT00505414|607205|P1|COMPLETED|Maintenance Phase||12
251953|NCT00505414|607201|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
251954|NCT00505414|607202|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
251955|NCT00505414|607203|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
251956|NCT00505414|607204|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
251957|NCT00505414|607205|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
251958|NCT00505414|607201|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
251959|NCT00505414|607202|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
251960|NCT00505414|607203|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
251961|NCT00505414|607204|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
251962|NCT00505414|607205|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
251963|NCT00505414|607201|P5|NOT COMPLETED|Titration Phase||12
251964|NCT00505414|607202|P4|NOT COMPLETED|Titration Phase||30
251965|NCT00505414|607203|P3|NOT COMPLETED|Titration Phase||0
251966|NCT00505414|607204|P2|NOT COMPLETED|Titration Phase||0
251967|NCT00505414|607205|P1|NOT COMPLETED|Titration Phase||0
251968|NCT00505414|607201|P5|COMPLETED|Titration Phase||19
251969|NCT00505414|607202|P4|COMPLETED|Titration Phase||32
251970|NCT00505414|607203|P3|COMPLETED|Titration Phase||0
251971|NCT00505414|607204|P2|COMPLETED|Titration Phase||0
251972|NCT00505414|607205|P1|COMPLETED|Titration Phase||0
251973|NCT00505414|607201|P5|STARTED|Titration Phase||31
251974|NCT00505414|607202|P4|STARTED|Titration Phase||62
251975|NCT00505414|607203|P3|STARTED|Titration Phase||0
251976|NCT00505414|607204|P2|STARTED|Titration Phase||0
251977|NCT00505414|607205|P1|STARTED|Titration Phase||0
251978|NCT00505375|607222|P2|NOT COMPLETED|Overall Study||5
251979|NCT00505375|607223|P1|NOT COMPLETED|Overall Study||4
251980|NCT00505375|607222|P2|COMPLETED|Overall Study||30
251981|NCT00505375|607223|P1|COMPLETED|Overall Study||73
251982|NCT00505375|607222|P2|STARTED|Overall Study||35
251983|NCT00505375|607223|P1|STARTED|Overall Study||77
251984|NCT00505362|607231|P2|NOT COMPLETED|Overall Study||0
251985|NCT00505362|607232|P1|NOT COMPLETED|Overall Study||0
251986|NCT00505362|607231|P2|COMPLETED|Overall Study||28
251987|NCT00505362|607232|P1|COMPLETED|Overall Study||35
251988|NCT00505362|607231|P2|STARTED|Overall Study||28
251989|NCT00505362|607232|P1|STARTED|Overall Study||35
251990|NCT00505284|607245|P5|NOT COMPLETED|Overall Study||33
251991|NCT00505284|607246|P4|NOT COMPLETED|Overall Study||19
251992|NCT00505284|607247|P3|NOT COMPLETED|Overall Study||12
251993|NCT00505284|607248|P2|NOT COMPLETED|Overall Study||16
251994|NCT00505284|607249|P1|NOT COMPLETED|Overall Study||10
251995|NCT00505284|607245|P5|COMPLETED|Overall Study||37
251996|NCT00505284|607246|P4|COMPLETED|Overall Study||49
251997|NCT00505284|607247|P3|COMPLETED|Overall Study||57
251998|NCT00505284|607248|P2|COMPLETED|Overall Study||56
251999|NCT00505284|607249|P1|COMPLETED|Overall Study||63
252000|NCT00505284|607245|P5|STARTED|Overall Study||70
252001|NCT00505284|607246|P4|STARTED|Overall Study||68
252002|NCT00505284|607247|P3|STARTED|Overall Study||69
252003|NCT00505284|607248|P2|STARTED|Overall Study||72
252004|NCT00505284|607249|P1|STARTED|Overall Study||73
252005|NCT00505076|607319|P3|NOT COMPLETED|Overall Study||5
252006|NCT00505076|607320|P2|NOT COMPLETED|Overall Study||2
252007|NCT00505076|607321|P1|NOT COMPLETED|Overall Study||3
252008|NCT00505076|607319|P3|COMPLETED|Overall Study||17
252009|NCT00505076|607320|P2|COMPLETED|Overall Study||17
252010|NCT00505076|607321|P1|COMPLETED|Overall Study||19
252011|NCT00505076|607319|P3|STARTED|Overall Study||22
252012|NCT00505076|607320|P2|STARTED|Overall Study||19
252013|NCT00505076|607321|P1|STARTED|Overall Study||22
252014|NCT00504985|607335|P1|NOT COMPLETED|Overall Study||0
252015|NCT00504985|607335|P1|COMPLETED|Overall Study||14
252016|NCT00504985|607335|P1|STARTED|Overall Study||14
252017|NCT00504894|607341|P2|NOT COMPLETED|Overall Study||0
252018|NCT00504894|607342|P1|NOT COMPLETED|Overall Study||0
252019|NCT00504894|607341|P2|COMPLETED|Overall Study||18
252020|NCT00504894|607342|P1|COMPLETED|Overall Study||17
252021|NCT00504894|607341|P2|STARTED|Overall Study||18
252022|NCT00504894|607342|P1|STARTED|Overall Study||17
252023|NCT00504881|607350|P2|NOT COMPLETED|Overall Study||36
252024|NCT00504881|607351|P1|NOT COMPLETED|Overall Study||10
252025|NCT00504881|607350|P2|COMPLETED|Overall Study||323
252026|NCT00504881|607351|P1|COMPLETED|Overall Study||111
252027|NCT00504881|607350|P2|STARTED|Overall Study||359
252028|NCT00504881|607351|P1|STARTED|Overall Study||121
252029|NCT00504777|607401|P1|NOT COMPLETED|Overall Study||1
252030|NCT00504777|607401|P1|COMPLETED|Overall Study||35
252031|NCT00504777|607401|P1|STARTED|Overall Study||36
252032|NCT00504751|607408|P1|NOT COMPLETED|Overall Study||0
252033|NCT00504751|607408|P1|COMPLETED|Overall Study||15
252034|NCT00504751|607408|P1|STARTED|Overall Study||15
252035|NCT00504725|607414|P2|NOT COMPLETED|Overall Study||0
252036|NCT00504725|607415|P1|NOT COMPLETED|Overall Study||1
252037|NCT00504725|607414|P2|COMPLETED|Overall Study||20
252038|NCT00504725|607415|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
252039|NCT00504725|607414|P2|STARTED|Overall Study||20
252040|NCT00504725|607415|P1|STARTED|Overall Study||21
252041|NCT00504660|607427|P2|NOT COMPLETED|Overall Study||0
252042|NCT00504660|607428|P1|NOT COMPLETED|Overall Study||0
252043|NCT00504660|607427|P2|COMPLETED|Overall Study||43
252044|NCT00504660|607428|P1|COMPLETED|Overall Study||31
252045|NCT00504660|607427|P2|STARTED|Overall Study||43
252046|NCT00504660|607428|P1|STARTED|Overall Study||31
252047|NCT00504595|607438|P4|NOT COMPLETED|Overall Study||0
252048|NCT00504595|607439|P3|NOT COMPLETED|Overall Study||2
252049|NCT00504595|607440|P2|NOT COMPLETED|Overall Study||0
252050|NCT00504595|607441|P1|NOT COMPLETED|Overall Study||1
252051|NCT00504595|607438|P4|COMPLETED|Overall Study||10
252052|NCT00504595|607439|P3|COMPLETED|Overall Study||8
252053|NCT00504595|607440|P2|COMPLETED|Overall Study||10
252054|NCT00504595|607441|P1|COMPLETED|Overall Study||49
252055|NCT00504595|607438|P4|STARTED|Overall Study||10
252056|NCT00504595|607439|P3|STARTED|Overall Study||10
252057|NCT00504595|607440|P2|STARTED|Overall Study||10
252058|NCT00504595|607441|P1|STARTED|Overall Study||50
252059|NCT00504556|607458|P5|NOT COMPLETED|Overall Study||25
252060|NCT00504556|607459|P4|NOT COMPLETED|Overall Study||128
252061|NCT00504556|607460|P3|NOT COMPLETED|Overall Study||31
252062|NCT00504556|607461|P2|NOT COMPLETED|Overall Study||38
252063|NCT00504556|607462|P1|NOT COMPLETED|Overall Study||35
252064|NCT00504556|607458|P5|COMPLETED|Overall Study||226
252065|NCT00504556|607459|P4|COMPLETED|Overall Study||52
252066|NCT00504556|607460|P3|COMPLETED|Overall Study||204
252067|NCT00504556|607461|P2|COMPLETED|Overall Study||207
252068|NCT00504556|607462|P1|COMPLETED|Overall Study||200
252069|NCT00504556|607458|P5|Pharmacodynamic Analysis Set|Overall Study||244
252070|NCT00504556|607459|P4|Pharmacodynamic Analysis Set|Overall Study||170
252071|NCT00504556|607460|P3|Pharmacodynamic Analysis Set|Overall Study||228
252072|NCT00504556|607461|P2|Pharmacodynamic Analysis Set|Overall Study||236
252073|NCT00504556|607462|P1|Pharmacodynamic Analysis Set|Overall Study||230
252074|NCT00504556|607458|P5|Per Protocol Analysis Set|Overall Study||250
252075|NCT00504556|607459|P4|Per Protocol Analysis Set|Overall Study||180
252076|NCT00504556|607460|P3|Per Protocol Analysis Set|Overall Study||234
252077|NCT00504556|607461|P2|Per Protocol Analysis Set|Overall Study||243
252078|NCT00504556|607462|P1|Per Protocol Analysis Set|Overall Study||235
252079|NCT00504556|607458|P5|Safety Analysis Set|Overall Study||250
252080|NCT00504556|607459|P4|Safety Analysis Set|Overall Study||180
252081|NCT00504556|607460|P3|Safety Analysis Set|Overall Study||234
252082|NCT00504556|607461|P2|Safety Analysis Set|Overall Study||244
252083|NCT00504556|607462|P1|Safety Analysis Set|Overall Study||235
252084|NCT00504556|607458|P5|STARTED|Overall Study||251
252085|NCT00504556|607459|P4|STARTED|Overall Study||180
252086|NCT00504556|607460|P3|STARTED|Overall Study||235
252087|NCT00504556|607461|P2|STARTED|Overall Study||245
252088|NCT00504556|607462|P1|STARTED|Overall Study||235
252089|NCT00504504|607522|P1|NOT COMPLETED|Overall Study||0
252090|NCT00504504|607522|P1|COMPLETED|Overall Study||82
252091|NCT00504504|607522|P1|STARTED|Overall Study||82
252092|NCT00504426|607530|P4|NOT COMPLETED|Overall Study||0
252093|NCT00504426|607531|P3|NOT COMPLETED|Overall Study||4
252094|NCT00504426|607532|P2|NOT COMPLETED|Overall Study||1
252095|NCT00504426|607533|P1|NOT COMPLETED|Overall Study||3
252096|NCT00504426|607530|P4|COMPLETED|Overall Study||24
252097|NCT00504426|607531|P3|COMPLETED|Overall Study||18
252098|NCT00504426|607532|P2|COMPLETED|Overall Study||22
252099|NCT00504426|607533|P1|COMPLETED|Overall Study||29
252100|NCT00504426|607530|P4|STARTED|Overall Study||24
252101|NCT00504426|607531|P3|STARTED|Overall Study||22
252102|NCT00504426|607532|P2|STARTED|Overall Study||23
252103|NCT00504426|607533|P1|STARTED|Overall Study||32
252104|NCT00504309|607553|P6|NOT COMPLETED|Overall Study||0
252105|NCT00504309|607554|P5|NOT COMPLETED|Overall Study||1
252106|NCT00504309|607555|P4|NOT COMPLETED|Overall Study||0
252107|NCT00504309|607556|P3|NOT COMPLETED|Overall Study||1
252108|NCT00504309|607557|P2|NOT COMPLETED|Overall Study||0
252109|NCT00504309|607558|P1|NOT COMPLETED|Overall Study||0
252110|NCT00504309|607553|P6|COMPLETED|Overall Study||3
252111|NCT00504309|607554|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
252112|NCT00504309|607555|P4|COMPLETED|Overall Study||3
252113|NCT00504309|607556|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
252114|NCT00504309|607557|P2|COMPLETED|Overall Study||5
252115|NCT00504309|607558|P1|COMPLETED|Overall Study||7
252116|NCT00504309|607553|P6|STARTED|Overall Study||3
252117|NCT00504309|607554|P5|STARTED|Overall Study||8
252118|NCT00504309|607555|P4|STARTED|Overall Study||3
252119|NCT00504309|607556|P3|STARTED|Overall Study||2
252120|NCT00504309|607557|P2|STARTED|Overall Study||5
252121|NCT00504309|607558|P1|STARTED|Overall Study||7
252122|NCT00504257|607596|P1|NOT COMPLETED|Overall Study||4
252123|NCT00504257|607596|P1|COMPLETED|Overall Study||41
252124|NCT00504257|607596|P1|STARTED|Overall Study||45
252125|NCT00504231|607608|P4|NOT COMPLETED|Overall Study||0
252126|NCT00504231|607609|P3|NOT COMPLETED|Overall Study||1
252127|NCT00504231|607610|P2|NOT COMPLETED|Overall Study||0
252128|NCT00504231|607611|P1|NOT COMPLETED|Overall Study||0
252129|NCT00504231|607608|P4|COMPLETED|Overall Study||65
252130|NCT00504231|607609|P3|COMPLETED|Overall Study||63
252131|NCT00504231|607610|P2|COMPLETED|Overall Study||64
252132|NCT00504231|607611|P1|COMPLETED|Overall Study||65
252133|NCT00504231|607608|P4|STARTED|Overall Study||65
252134|NCT00504231|607609|P3|STARTED|Overall Study||64
252135|NCT00504231|607610|P2|STARTED|Overall Study||64
252136|NCT00504231|607611|P1|STARTED|Overall Study||65
252137|NCT00504166|607631|P2|NOT COMPLETED|Overall Study||14
252138|NCT00504166|607632|P1|NOT COMPLETED|Overall Study||6
252139|NCT00504166|607631|P2|COMPLETED|Overall Study||13
252140|NCT00504166|607632|P1|COMPLETED|Overall Study||20
252141|NCT00504166|607631|P2|STARTED|Overall Study||27
252142|NCT00504166|607632|P1|STARTED|Overall Study||26
252143|NCT00504153|607638|P1|NOT COMPLETED|Overall Study||6
252144|NCT00504153|607638|P1|COMPLETED|Overall Study||13
252145|NCT00504153|607638|P1|STARTED|Overall Study||19
252146|NCT00504075|607646|P1|NOT COMPLETED|Overall Study||8
252147|NCT00504075|607646|P1|COMPLETED|Overall Study||27
252148|NCT00504075|607646|P1|STARTED|Overall Study||35
252149|NCT00504023|607652|P1|NOT COMPLETED|Overall Study||0
252150|NCT00504023|607652|P1|COMPLETED|Overall Study||8
252151|NCT00504023|607652|P1|STARTED|Overall Study||8
252152|NCT00503997|607656|P1|NOT COMPLETED|Overall Study||8
252153|NCT00503997|607656|P1|COMPLETED|Overall Study||34
252154|NCT00503997|607656|P1|STARTED|Overall Study||42
252155|NCT00503984|607662|P6|NOT COMPLETED|Overall Study||0
252156|NCT00503984|607663|P5|NOT COMPLETED|Overall Study||1
252157|NCT00503984|607664|P4|NOT COMPLETED|Overall Study||0
252158|NCT00503984|607665|P3|NOT COMPLETED|Overall Study||0
252159|NCT00503984|607666|P2|NOT COMPLETED|Overall Study||2
252160|NCT00503984|607667|P1|NOT COMPLETED|Overall Study||0
252161|NCT00503984|607662|P6|COMPLETED|Overall Study||1
252162|NCT00503984|607663|P5|COMPLETED|Overall Study||5
252163|NCT00503984|607664|P4|COMPLETED|Overall Study||6
252164|NCT00503984|607665|P3|COMPLETED|Overall Study||3
252165|NCT00503984|607666|P2|COMPLETED|Overall Study||1
252166|NCT00503984|607667|P1|COMPLETED|Overall Study||3
252167|NCT00503984|607662|P6|STARTED|Overall Study||1
252168|NCT00503984|607663|P5|STARTED|Overall Study||6
252169|NCT00503984|607664|P4|STARTED|Overall Study||6
252170|NCT00503984|607665|P3|STARTED|Overall Study||3
252171|NCT00503984|607666|P2|STARTED|Overall Study||3
252172|NCT00503984|607667|P1|STARTED|Overall Study||3
252173|NCT00503906|607693|P1|NOT COMPLETED|Overall Study||1
252174|NCT00503906|607693|P1|COMPLETED|Overall Study||29
252175|NCT00503906|607693|P1|STARTED|Overall Study||30
252176|NCT00503880|607702|P5|NOT COMPLETED|Overall Study||0
252177|NCT00503880|607703|P4|NOT COMPLETED|Overall Study||0
252178|NCT00503880|607704|P3|NOT COMPLETED|Overall Study||0
252179|NCT00503880|607705|P2|NOT COMPLETED|Overall Study||0
252180|NCT00503880|607706|P1|NOT COMPLETED|Overall Study||2
252181|NCT00503880|607702|P5|COMPLETED|Overall Study||0
252182|NCT00503880|607703|P4|COMPLETED|Overall Study||0
252183|NCT00503880|607704|P3|COMPLETED|Overall Study||0
252184|NCT00503880|607705|P2|COMPLETED|Overall Study||0
252185|NCT00503880|607706|P1|COMPLETED|Overall Study||0
252186|NCT00503880|607702|P5|STARTED|Overall Study||0
252187|NCT00503880|607703|P4|STARTED|Overall Study||0
252188|NCT00503880|607704|P3|STARTED|Overall Study||0
252189|NCT00503880|607705|P2|STARTED|Overall Study||0
252190|NCT00503880|607706|P1|STARTED|Overall Study||2
252191|NCT00503841|607715|P1|NOT COMPLETED|Overall Study||44
252192|NCT00503841|607715|P1|COMPLETED|Overall Study||0
252193|NCT00503841|607715|P1|STARTED|Overall Study||44
252194|NCT00503776|607723|P4|NOT COMPLETED|Overall Study||2
252195|NCT00503776|607724|P3|NOT COMPLETED|Overall Study||2
252196|NCT00503776|607725|P2|NOT COMPLETED|Overall Study||0
252197|NCT00503776|607726|P1|NOT COMPLETED|Overall Study||1
252198|NCT00503776|607723|P4|COMPLETED|Overall Study||8
252199|NCT00503776|607724|P3|COMPLETED|Overall Study||10
252200|NCT00503776|607725|P2|COMPLETED|Overall Study||12
252201|NCT00503776|607726|P1|COMPLETED|Overall Study||7
252202|NCT00503776|607723|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
252203|NCT00503776|607724|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
252204|NCT00503776|607725|P2|STARTED|Overall Study||12
252205|NCT00503776|607726|P1|STARTED|Overall Study||8
252206|NCT00503750|607752|P1|NOT COMPLETED|Overall Study||0
252207|NCT00503750|607752|P1|COMPLETED|Overall Study||27
252208|NCT00503750|607752|P1|STARTED|Overall Study||27
252209|NCT00503698|607759|P2|NOT COMPLETED|Overall Study||355
252210|NCT00503698|607760|P1|NOT COMPLETED|Overall Study||357
252211|NCT00503698|607759|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
252212|NCT00503698|607760|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
252213|NCT00503698|607759|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
252214|NCT00503698|607760|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
252215|NCT00503698|607759|P2|STARTED|Overall Study|Randomised|355
252216|NCT00503698|607760|P1|STARTED|Overall Study|Randomised|357
252217|NCT00503425|607774|P1|NOT COMPLETED|Overall Study||54
252218|NCT00503425|607774|P1|COMPLETED|Overall Study||161
252219|NCT00503425|607774|P1|STARTED|Overall Study||215
252220|NCT00503399|607784|P2|NOT COMPLETED|Overall Study||8
252221|NCT00503399|607785|P1|NOT COMPLETED|Overall Study||7
252222|NCT00503399|607784|P2|COMPLETED|Overall Study||39
252223|NCT00503399|607785|P1|COMPLETED|Overall Study||38
252224|NCT00503399|607784|P2|STARTED|Overall Study||47
252225|NCT00503399|607785|P1|STARTED|Overall Study||45
252226|NCT00503308|607809|P2|NOT COMPLETED|Overall Study||1
252227|NCT00503308|607810|P1|NOT COMPLETED|Overall Study||2
252228|NCT00503308|607809|P2|COMPLETED|Overall Study||134
252229|NCT00503308|607810|P1|COMPLETED|Overall Study||144
252230|NCT00503308|607809|P2|STARTED|Overall Study||135
252231|NCT00503308|607810|P1|STARTED|Overall Study||146
252232|NCT00503139|607816|P1|NOT COMPLETED|Overall Study||8
252233|NCT00503139|607816|P1|COMPLETED|Overall Study||676
252234|NCT00503139|607816|P1|STARTED|Overall Study||684
252235|NCT00503113|607830|P3|NOT COMPLETED|Overall Study||28
252236|NCT00503113|607831|P2|NOT COMPLETED|Overall Study||28
252237|NCT00503113|607832|P1|NOT COMPLETED|Overall Study||33
252238|NCT00503113|607830|P3|COMPLETED|Overall Study||241
252239|NCT00503113|607831|P2|COMPLETED|Overall Study||236
252240|NCT00503113|607832|P1|COMPLETED|Overall Study||235
252241|NCT00503113|607830|P3|Safety Population|Overall Study||267
252242|NCT00503113|607831|P2|Safety Population|Overall Study||263
252243|NCT00503113|607832|P1|Safety Population|Overall Study||263
252244|NCT00503113|607830|P3|Per Protocol Population (PP)|Overall Study||241
252245|NCT00503113|607831|P2|Per Protocol Population (PP)|Overall Study||243
252246|NCT00503113|607832|P1|Per Protocol Population (PP)|Overall Study||246
252247|NCT00503113|607830|P3|Intent to Treat Population (ITT)|Overall Study||268
252248|NCT00503113|607831|P2|Intent to Treat Population (ITT)|Overall Study||261
252249|NCT00503113|607832|P1|Intent to Treat Population (ITT)|Overall Study||262
252250|NCT00503113|607830|P3|STARTED|Overall Study||269
252251|NCT00503113|607831|P2|STARTED|Overall Study||264
252252|NCT00503113|607832|P1|STARTED|Overall Study||268
252253|NCT00503009|607864|P3|NOT COMPLETED|Overall Study||3
252254|NCT00503009|607865|P2|NOT COMPLETED|Overall Study||2
252255|NCT00503009|607866|P1|NOT COMPLETED|Overall Study||1
252256|NCT00503009|607864|P3|COMPLETED|Overall Study||3
252257|NCT00503009|607865|P2|COMPLETED|Overall Study||3
252258|NCT00503009|607866|P1|COMPLETED|Overall Study||4
252259|NCT00503009|607864|P3|STARTED|Overall Study||6
252260|NCT00503009|607865|P2|STARTED|Overall Study||5
252261|NCT00503009|607866|P1|STARTED|Overall Study||5
252262|NCT00502996|607883|P1|NOT COMPLETED|Overall Study||44
252263|NCT00502996|607883|P1|COMPLETED|Overall Study||188
252264|NCT00502996|607883|P1|STARTED|Overall Study||232
252265|NCT00502944|607909|P2|NOT COMPLETED|Overall Study||1766
252266|NCT00502944|607910|P1|NOT COMPLETED|Overall Study||1064
252267|NCT00502944|607909|P2|COMPLETED|Overall Study||643
252268|NCT00502944|607910|P1|COMPLETED|Overall Study||1382
252269|NCT00502944|607909|P2|STARTED|Overall Study||2409
252270|NCT00502944|607910|P1|STARTED|Overall Study||2446
252271|NCT00502905|607922|P1|NOT COMPLETED|Overall Study||0
252272|NCT00502905|607922|P1|COMPLETED|Overall Study||196
252273|NCT00502905|607922|P1|STARTED|Overall Study||196
252274|NCT00502853|607926|P1|NOT COMPLETED|Overall Study||0
252275|NCT00502853|607926|P1|COMPLETED|Overall Study||10
252276|NCT00502853|607926|P1|STARTED|Overall Study||10
252277|NCT00502840|607951|P1|NOT COMPLETED|Overall Study||100
252278|NCT00502840|607951|P1|COMPLETED|Overall Study||93
252279|NCT00502840|607951|P1|STARTED|Overall Study||193
252280|NCT00502801|607979|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
252281|NCT00502801|607979|P1|COMPLETED|End of Therapy to Test of Cure||121
252282|NCT00502801|607979|P1|STARTED|End of Therapy to Test of Cure||129
252283|NCT00502801|607979|P1|NOT COMPLETED|Treatment Period||54
252284|NCT00502801|607979|P1|COMPLETED|Treatment Period||129
252285|NCT00502801|607979|P1|STARTED|Treatment Period||183
252286|NCT00502775|607987|P3|NOT COMPLETED|Overall Study||13
252287|NCT00502775|607988|P2|NOT COMPLETED|Overall Study||15
252288|NCT00502775|607989|P1|NOT COMPLETED|Overall Study||10
252289|NCT00502775|607987|P3|COMPLETED|Overall Study||214
252290|NCT00502775|607988|P2|COMPLETED|Overall Study||209
252291|NCT00502775|607989|P1|COMPLETED|Overall Study||219
252292|NCT00502775|607987|P3|STARTED|Overall Study||227
252293|NCT00502775|607988|P2|STARTED|Overall Study||224
252294|NCT00502775|607989|P1|STARTED|Overall Study||229
252295|NCT00502697|608032|P2|NOT COMPLETED|Overall Study||12
252296|NCT00502697|608033|P1|NOT COMPLETED|Overall Study||13
252297|NCT00502697|608032|P2|COMPLETED|Overall Study||102
252298|NCT00502697|608033|P1|COMPLETED|Overall Study||109
252299|NCT00502697|608032|P2|STARTED|Overall Study||114
252300|NCT00502697|608033|P1|STARTED|Overall Study||122
252301|NCT00502671|608041|P1|NOT COMPLETED|Overall Study||77
252302|NCT00502671|608041|P1|COMPLETED|Overall Study||151
252303|NCT00502671|608041|P1|STARTED|Overall Study||228
252304|NCT00502593|608058|P12|NOT COMPLETED|Overall Study||0
252305|NCT00502593|608059|P11|NOT COMPLETED|Overall Study||2
252306|NCT00502593|608060|P10|NOT COMPLETED|Overall Study||0
252307|NCT00502593|608061|P9|NOT COMPLETED|Overall Study||6
252308|NCT00502593|608062|P8|NOT COMPLETED|Overall Study||0
252309|NCT00502593|608063|P7|NOT COMPLETED|Overall Study||5
252310|NCT00502593|608064|P6|NOT COMPLETED|Overall Study||0
252311|NCT00502593|608065|P5|NOT COMPLETED|Overall Study||4
252312|NCT00502593|608066|P4|NOT COMPLETED|Overall Study||4
252313|NCT00502593|608067|P3|NOT COMPLETED|Overall Study||10
252314|NCT00502593|608068|P2|NOT COMPLETED|Overall Study||2
252315|NCT00502593|608069|P1|NOT COMPLETED|Overall Study||3
252316|NCT00502593|608058|P12|COMPLETED|Overall Study||18
252317|NCT00502593|608059|P11|COMPLETED|Overall Study||47
252318|NCT00502593|608060|P10|COMPLETED|Overall Study||17
252319|NCT00502593|608061|P9|COMPLETED|Overall Study||43
252320|NCT00502593|608062|P8|COMPLETED|Overall Study||17
252321|NCT00502593|608063|P7|COMPLETED|Overall Study||44
252322|NCT00502593|608064|P6|COMPLETED|Overall Study||17
252323|NCT00502593|608065|P5|COMPLETED|Overall Study||47
252324|NCT00502593|608066|P4|COMPLETED|Overall Study||14
252325|NCT00502593|608067|P3|COMPLETED|Overall Study||41
252326|NCT00502593|608068|P2|COMPLETED|Overall Study||16
252327|NCT00502593|608069|P1|COMPLETED|Overall Study||48
252328|NCT00502593|608058|P12|STARTED|Overall Study||18
252329|NCT00502593|608059|P11|STARTED|Overall Study||49
252330|NCT00502593|608060|P10|STARTED|Overall Study||17
252331|NCT00502593|608061|P9|STARTED|Overall Study||49
252332|NCT00502593|608062|P8|STARTED|Overall Study||17
252333|NCT00502593|608063|P7|STARTED|Overall Study||49
252334|NCT00502593|608064|P6|STARTED|Overall Study||17
252335|NCT00502593|608065|P5|STARTED|Overall Study||51
252336|NCT00502593|608066|P4|STARTED|Overall Study||18
252337|NCT00502593|608067|P3|STARTED|Overall Study||51
252338|NCT00502593|608068|P2|STARTED|Overall Study||18
252339|NCT00502593|608069|P1|STARTED|Overall Study||51
252340|NCT00502320|608585|P2|NOT COMPLETED|Overall Study||7
252341|NCT00502320|608586|P1|NOT COMPLETED|Overall Study||6
252342|NCT00502320|608585|P2|COMPLETED|Overall Study||18
252343|NCT00502320|608586|P1|COMPLETED|Overall Study||19
252344|NCT00502320|608585|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
252345|NCT00502320|608586|P1|Screening Visit|Overall Study||25
252346|NCT00502320|608585|P2|STARTED|Overall Study||25
252347|NCT00502320|608586|P1|STARTED|Overall Study||25
252348|NCT00502242|608598|P2|NOT COMPLETED|Overall Study||56
252349|NCT00502242|608599|P1|NOT COMPLETED|Overall Study||51
252350|NCT00502242|608598|P2|COMPLETED|Overall Study||84
252351|NCT00502242|608599|P1|COMPLETED|Overall Study||104
252352|NCT00502242|608598|P2|STARTED|Overall Study||140
252353|NCT00502242|608599|P1|STARTED|Overall Study||155
252354|NCT00502216|608652|P2|NOT COMPLETED|Overall Study||0
252355|NCT00502216|608653|P1|NOT COMPLETED|Overall Study||0
252356|NCT00502216|608652|P2|COMPLETED|Overall Study||19
252357|NCT00502216|608653|P1|COMPLETED|Overall Study||21
252358|NCT00502216|608652|P2|STARTED|Overall Study||19
252359|NCT00502216|608653|P1|STARTED|Overall Study||21
252360|NCT00502203|608663|P1|NOT COMPLETED|Overall Study||1
252361|NCT00502203|608663|P1|COMPLETED|Overall Study||22
252362|NCT00502203|608663|P1|STARTED|Overall Study||23
252363|NCT00501995|608667|P1|NOT COMPLETED|Overall Study||1
252364|NCT00501995|608667|P1|COMPLETED|Overall Study||5
252365|NCT00501995|608667|P1|STARTED|Overall Study||6
252366|NCT00501969|608672|P1|NOT COMPLETED|Overall Study||206
252367|NCT00501969|608672|P1|COMPLETED|Overall Study||189
252368|NCT00501969|608672|P1|STARTED|Overall Study||395
252369|NCT00501943|608680|P2|NOT COMPLETED|Overall Study||3
252370|NCT00501943|608681|P1|NOT COMPLETED|Overall Study||2
252371|NCT00501943|608680|P2|COMPLETED|Overall Study||18
252372|NCT00501943|608681|P1|COMPLETED|Overall Study||20
252373|NCT00501943|608680|P2|STARTED|Overall Study||21
252374|NCT00501943|608681|P1|STARTED|Overall Study||22
252375|NCT00501891|608697|P1|NOT COMPLETED|Overall Study||0
252376|NCT00501891|608697|P1|COMPLETED|Overall Study||32
252377|NCT00501891|608697|P1|STARTED|Overall Study||32
252378|NCT00501852|608704|P1|NOT COMPLETED|Overall Study||5
252379|NCT00501852|608704|P1|COMPLETED|Overall Study||78
252380|NCT00501852|608704|P1|Tiotropium|Overall Study||55
252381|NCT00501852|608704|P1|Placebo|Overall Study||55
252382|NCT00501852|608704|P1|NVA237 100µg|Overall Study||54
252383|NCT00501852|608704|P1|NVA237 50µg|Overall Study||53
252384|NCT00501852|608704|P1|NVA237 25µg|Overall Study||51
252385|NCT00501852|608704|P1|NVA237 12.5µg|Overall Study||55
252386|NCT00501852|608704|P1|STARTED|Overall Study||83
252387|NCT00501644|608724|P1|NOT COMPLETED|Overall Study||5
252388|NCT00501644|608724|P1|COMPLETED|Overall Study||54
252389|NCT00501644|608724|P1|STARTED|Overall Study||59
252390|NCT00501631|608730|P2|NOT COMPLETED|Part B (Open-label Period)||51
252391|NCT00501631|608731|P1|NOT COMPLETED|Part B (Open-label Period)||53
252392|NCT00501631|608730|P2|COMPLETED|Part B (Open-label Period)||48
252393|NCT00501631|608731|P1|COMPLETED|Part B (Open-label Period)||37
252394|NCT00501631|608730|P2|STARTED|Part B (Open-label Period)||99
252395|NCT00501631|608731|P1|STARTED|Part B (Open-label Period)||90
252396|NCT00501631|608730|P2|NOT COMPLETED|Part A (Double-blind Period)||49
252397|NCT00501631|608731|P1|NOT COMPLETED|Part A (Double-blind Period)||62
252398|NCT00501631|608730|P2|COMPLETED|Part A (Double-blind Period)||99
252399|NCT00501631|608731|P1|COMPLETED|Part A (Double-blind Period)||90
252400|NCT00501631|608730|P2|STARTED|Part A (Double-blind Period)||148
252401|NCT00501631|608731|P1|STARTED|Part A (Double-blind Period)||152
252402|NCT00501592|608740|P3|NOT COMPLETED|Overall Study||3
252403|NCT00501592|608741|P2|NOT COMPLETED|Overall Study||5
252404|NCT00501592|608742|P1|NOT COMPLETED|Overall Study||0
252405|NCT00501592|608740|P3|COMPLETED|Overall Study||20
252406|NCT00501592|608741|P2|COMPLETED|Overall Study||16
252407|NCT00501592|608742|P1|COMPLETED|Overall Study||20
252408|NCT00501592|608740|P3|STARTED|Overall Study||23
252409|NCT00501592|608741|P2|STARTED|Overall Study||21
252410|NCT00501592|608742|P1|STARTED|Overall Study||20
252411|NCT00501540|608753|P1|NOT COMPLETED|Overall Study||5
252412|NCT00501540|608753|P1|COMPLETED|Overall Study||10
252413|NCT00501540|608753|P1|STARTED|Overall Study||15
252414|NCT00501345|608759|P1|NOT COMPLETED|Overall Study||0
252415|NCT00501345|608759|P1|COMPLETED|Overall Study||5
252416|NCT00501345|608759|P1|STARTED|Overall Study||5
252417|NCT00501293|608765|P2|NOT COMPLETED|Maintenance Period||28
252418|NCT00501293|608766|P1|NOT COMPLETED|Maintenance Period||46
252419|NCT00501293|608765|P2|COMPLETED|Maintenance Period||25
252420|NCT00501293|608766|P1|COMPLETED|Maintenance Period||63
252421|NCT00501293|608765|P2|STARTED|Maintenance Period||53
252422|NCT00501293|608766|P1|STARTED|Maintenance Period||109
252423|NCT00501293|608765|P2|NOT COMPLETED|Optimization Period||0
252424|NCT00501293|608766|P1|NOT COMPLETED|Optimization Period||1
252425|NCT00501293|608765|P2|COMPLETED|Optimization Period||53
252426|NCT00501293|608766|P1|COMPLETED|Optimization Period||109
252427|NCT00501293|608765|P2|STARTED|Optimization Period||53
252428|NCT00501293|608766|P1|STARTED|Optimization Period||110
252429|NCT00501228|608793|P1|NOT COMPLETED|Overall Study||1
252430|NCT00501228|608793|P1|COMPLETED|Overall Study||1
252431|NCT00501228|608793|P1|STARTED|Overall Study||2
252432|NCT00501085|608797|P1|NOT COMPLETED|Overall Study||432
252433|NCT00501085|608797|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
252434|NCT00501085|608797|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
252435|NCT00501059|608807|P2|NOT COMPLETED|Overall Study||1892
252436|NCT00501059|608808|P1|NOT COMPLETED|Overall Study||1868
252437|NCT00501059|608807|P2|COMPLETED|Overall Study||4384
252438|NCT00501059|608808|P1|COMPLETED|Overall Study||4402
252439|NCT00501059|608807|P2|STARTED|Overall Study||6276
252440|NCT00501059|608808|P1|STARTED|Overall Study||6270
252441|NCT00501046|608828|P2|NOT COMPLETED|Overall Study||294
252442|NCT00501046|608829|P1|NOT COMPLETED|Overall Study||270
252443|NCT00501046|608828|P2|COMPLETED|Overall Study||213
252444|NCT00501046|608829|P1|COMPLETED|Overall Study||238
252445|NCT00501046|608828|P2|STARTED|Overall Study||507
252446|NCT00501046|608829|P1|STARTED|Overall Study||508
252447|NCT00501007|608835|P2|NOT COMPLETED|Overall Study||25
252448|NCT00501007|608836|P1|NOT COMPLETED|Overall Study||29
252449|NCT00501007|608835|P2|COMPLETED|Overall Study||78
252450|NCT00501007|608836|P1|COMPLETED|Overall Study||71
252451|NCT00501007|608835|P2|STARTED|Overall Study||103
252452|NCT00501007|608836|P1|STARTED|Overall Study||100
252453|NCT00500760|608844|P2|NOT COMPLETED|Overall Study||24
252454|NCT00500760|608845|P1|NOT COMPLETED|Overall Study||43
252455|NCT00500760|608844|P2|COMPLETED|Overall Study||40
252456|NCT00500760|608845|P1|COMPLETED|Overall Study||46
252457|NCT00500760|608844|P2|Received Treatment|Overall Study||63
252458|NCT00500760|608845|P1|Received Treatment|Overall Study||87
252459|NCT00500760|608844|P2|STARTED|Overall Study||64
252460|NCT00500760|608845|P1|STARTED|Overall Study||89
252461|NCT00500682|608865|P2|NOT COMPLETED|Overall Study||287
252462|NCT00500682|608866|P1|NOT COMPLETED|Overall Study||306
252463|NCT00500682|608865|P2|COMPLETED|Overall Study||223
252464|NCT00500682|608866|P1|COMPLETED|Overall Study||204
252465|NCT00500682|608865|P2|STARTED|Overall Study||510
252466|NCT00500682|608866|P1|STARTED|Overall Study||510
252467|NCT00500656|608876|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
252468|NCT00500656|608877|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
252469|NCT00500656|608878|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
252470|NCT00500656|608879|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
252471|NCT00500656|608876|P4|COMPLETED|Open Label Extension (OLE) Phase||6
252472|NCT00500656|608877|P3|COMPLETED|Open Label Extension (OLE) Phase||1
252473|NCT00500656|608878|P2|COMPLETED|Open Label Extension (OLE) Phase||9
252474|NCT00500656|608879|P1|COMPLETED|Open Label Extension (OLE) Phase||16
252475|NCT00500656|608876|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
252476|NCT00500656|608877|P3|STARTED|Open Label Extension (OLE) Phase||2
252477|NCT00500656|608878|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
252478|NCT00500656|608879|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
252479|NCT00500656|608876|P4|NOT COMPLETED|Controlled Phase||8
252480|NCT00500656|608877|P3|NOT COMPLETED|Controlled Phase||1
252481|NCT00500656|608878|P2|NOT COMPLETED|Controlled Phase||10
252482|NCT00500656|608879|P1|NOT COMPLETED|Controlled Phase||10
252483|NCT00500656|608876|P4|COMPLETED|Controlled Phase||0
252484|NCT00500656|608877|P3|COMPLETED|Controlled Phase||2
252485|NCT00500656|608878|P2|COMPLETED|Controlled Phase||28
252486|NCT00500656|608879|P1|COMPLETED|Controlled Phase||26
252487|NCT00500656|608876|P4|STARTED|Controlled Phase||8
252488|NCT00500656|608877|P3|STARTED|Controlled Phase||3
252489|NCT00500656|608878|P2|STARTED|Controlled Phase||38
252490|NCT00500656|608879|P1|STARTED|Controlled Phase||36
252491|NCT00500578|608893|P2|NOT COMPLETED|Overall Study||0
252492|NCT00500578|608894|P1|NOT COMPLETED|Overall Study||0
252493|NCT00500578|608893|P2|COMPLETED|Overall Study|All completed|32
252494|NCT00500578|608894|P1|COMPLETED|Overall Study|All completed|18
252495|NCT00500578|608893|P2|STARTED|Overall Study||32
252496|NCT00500578|608894|P1|STARTED|Overall Study||18
252497|NCT00500539|608900|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
252498|NCT00500539|608900|P1|COMPLETED|Follow-up Period (16 Weeks)||136
252499|NCT00500539|608900|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
252500|NCT00500539|608900|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
252501|NCT00500539|608900|P1|COMPLETED|Treatment Period (24 Weeks)||140
252502|NCT00500539|608900|P1|STARTED|Treatment Period (24 Weeks)||155
252503|NCT00500448|608909|P2|NOT COMPLETED|Overall Study||0
252504|NCT00500448|608910|P1|NOT COMPLETED|Overall Study||0
252505|NCT00500448|608909|P2|COMPLETED|Overall Study||16
252506|NCT00500448|608910|P1|COMPLETED|Overall Study||14
252507|NCT00500448|608909|P2|STARTED|Overall Study||16
252508|NCT00500448|608910|P1|STARTED|Overall Study||14
252509|NCT00500370|608926|P2|NOT COMPLETED|Overall Study||34
252510|NCT00500370|608927|P1|NOT COMPLETED|Overall Study||33
252511|NCT00500370|608926|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
252512|NCT00500370|608927|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
252513|NCT00500370|608926|P2|Treatment Complete (Week 24)|Overall Study||54
252514|NCT00500370|608927|P1|Treatment Complete (Week 24)|Overall Study||48
252515|NCT00500370|608926|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
252516|NCT00500370|608927|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
252517|NCT00500370|608926|P2|STARTED|Overall Study||83
252518|NCT00500370|608927|P1|STARTED|Overall Study||80
252519|NCT00500357|608963|P1|NOT COMPLETED|Overall Study||1
252520|NCT00500357|608963|P1|COMPLETED|Overall Study||104
252521|NCT00500357|608963|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
252522|NCT00500357|608963|P1|Received 13vPnC (Vax 3)|Overall Study||105
252523|NCT00500357|608963|P1|STARTED|Overall Study||105
252524|NCT00500331|608989|P7|NOT COMPLETED|Overall Study||2
252525|NCT00500331|608990|P6|NOT COMPLETED|Overall Study||5
252526|NCT00500331|608991|P5|NOT COMPLETED|Overall Study||4
252527|NCT00500331|608992|P4|NOT COMPLETED|Overall Study||10
252528|NCT00500331|608993|P3|NOT COMPLETED|Overall Study||5
252529|NCT00500331|608994|P2|NOT COMPLETED|Overall Study||5
252530|NCT00500331|608995|P1|NOT COMPLETED|Overall Study||15
252531|NCT00500331|608989|P7|COMPLETED|Overall Study||46
252532|NCT00500331|608990|P6|COMPLETED|Overall Study||42
252533|NCT00500331|608991|P5|COMPLETED|Overall Study||44
252534|NCT00500331|608992|P4|COMPLETED|Overall Study||38
252535|NCT00500331|608993|P3|COMPLETED|Overall Study||43
252536|NCT00500331|608994|P2|COMPLETED|Overall Study||42
252537|NCT00500331|608995|P1|COMPLETED|Overall Study||33
252538|NCT00500331|608989|P7|STARTED|Overall Study||48
252539|NCT00500331|608990|P6|STARTED|Overall Study||47
252540|NCT00500331|608991|P5|STARTED|Overall Study||48
252541|NCT00500331|608992|P4|STARTED|Overall Study||48
252542|NCT00500331|608993|P3|STARTED|Overall Study||48
252543|NCT00500331|608994|P2|STARTED|Overall Study||47
252544|NCT00500331|608995|P1|STARTED|Overall Study||48
252545|NCT00500318|609132|P2|NOT COMPLETED|Overall Study||17
252546|NCT00500318|609133|P1|NOT COMPLETED|Overall Study||5
252547|NCT00500318|609132|P2|COMPLETED|Overall Study||78
252548|NCT00500318|609133|P1|COMPLETED|Overall Study||81
252549|NCT00500318|609132|P2|STARTED|Overall Study||95
252550|NCT00500318|609133|P1|STARTED|Overall Study||86
252551|NCT00500292|609150|P3|NOT COMPLETED|Overall Study||27
252552|NCT00500292|609151|P2|NOT COMPLETED|Overall Study||31
252553|NCT00500292|609152|P1|NOT COMPLETED|Overall Study||25
252554|NCT00500292|609150|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
252555|NCT00500292|609151|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
252556|NCT00500292|609152|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
252557|NCT00500292|609150|P3|STARTED|Overall Study|randomised patients|37
252558|NCT00500292|609151|P2|STARTED|Overall Study|randomised patients|35
252559|NCT00500292|609152|P1|STARTED|Overall Study|randomised patients|32
252560|NCT00500240|609162|P2|NOT COMPLETED|Overall Study||0
252561|NCT00500240|609163|P1|NOT COMPLETED|Overall Study||0
252562|NCT00500240|609162|P2|COMPLETED|Overall Study||26
252563|NCT00500240|609163|P1|COMPLETED|Overall Study||25
252564|NCT00500240|609162|P2|STARTED|Overall Study||26
252565|NCT00500240|609163|P1|STARTED|Overall Study||25
252566|NCT00500149|609173|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
252567|NCT00500149|609174|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
252568|NCT00500149|609173|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
252569|NCT00500149|609174|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
252570|NCT00500149|609173|P2|STARTED|Second Intervention (Cross-over Phase)||57
252571|NCT00500149|609174|P1|STARTED|Second Intervention (Cross-over Phase)||56
252572|NCT00500149|609173|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
252573|NCT00500149|609174|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
252574|NCT00500149|609173|P2|COMPLETED|First Intervention (Cross-over Phase)||57
252575|NCT00500149|609174|P1|COMPLETED|First Intervention (Cross-over Phase)||56
252576|NCT00500149|609173|P2|STARTED|First Intervention (Cross-over Phase)||59
252577|NCT00500149|609174|P1|STARTED|First Intervention (Cross-over Phase)||58
252578|NCT00500149|609173|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
252579|NCT00500149|609174|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
252580|NCT00500149|609173|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
252581|NCT00500149|609174|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
252582|NCT00500149|609173|P2|STARTED|Enrolled (Dose-optimization Phase)||0
252583|NCT00500149|609174|P1|STARTED|Enrolled (Dose-optimization Phase)||129
252584|NCT00500110|609182|P1|NOT COMPLETED|Overall Study||3
252585|NCT00500110|609182|P1|COMPLETED|Overall Study||36
252586|NCT00500110|609182|P1|STARTED|Overall Study||39
252587|NCT00500071|609186|P1|NOT COMPLETED|30-day Safety Follow-up||17
252588|NCT00500071|609186|P1|COMPLETED|30-day Safety Follow-up||278
252589|NCT00500071|609186|P1|STARTED|30-day Safety Follow-up||295
252590|NCT00500071|609186|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
252591|NCT00500071|609186|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
252592|NCT00500071|609186|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
252593|NCT00500071|609186|P1|NOT COMPLETED|Screening and Washout Phase||1
252594|NCT00500071|609186|P1|COMPLETED|Screening and Washout Phase||317
252595|NCT00500071|609186|P1|STARTED|Screening and Washout Phase||318
252596|NCT00499915|609197|P2|NOT COMPLETED|Overall Study||6
252597|NCT00499915|609198|P1|NOT COMPLETED|Overall Study||15
252598|NCT00499915|609197|P2|COMPLETED|Overall Study||76
252599|NCT00499915|609198|P1|COMPLETED|Overall Study||68
252600|NCT00499915|609197|P2|STARTED|Overall Study||82
252601|NCT00499915|609198|P1|STARTED|Overall Study||83
252602|NCT00499889|609204|P1|NOT COMPLETED|Overall Study||1
252603|NCT00499889|609204|P1|COMPLETED|Overall Study||41
252604|NCT00499889|609204|P1|STARTED|Overall Study||42
252605|NCT00499863|609212|P2|NOT COMPLETED|Overall Study||43
252606|NCT00499863|609213|P1|NOT COMPLETED|Overall Study||50
252607|NCT00499863|609212|P2|COMPLETED|Overall Study||29
252608|NCT00499863|609213|P1|COMPLETED|Overall Study||95
252609|NCT00499863|609212|P2|STARTED|Overall Study||72
252610|NCT00499863|609213|P1|STARTED|Overall Study||145
252611|NCT00500266|609241|P1|NOT COMPLETED|Overall Study||13
252612|NCT00500266|609241|P1|COMPLETED|Overall Study||1040
252613|NCT00500266|609241|P1|Treated|Overall Study||1049
252614|NCT00500266|609241|P1|STARTED|Overall Study||1053
252615|NCT00499746|609248|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
252616|NCT00499746|609248|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
252617|NCT00499746|609248|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
252618|NCT00499746|609248|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
252619|NCT00499746|609248|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
252620|NCT00499746|609248|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
252621|NCT00499746|609248|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
252622|NCT00499746|609248|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
252623|NCT00499746|609248|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
252624|NCT00499694|609317|P1|NOT COMPLETED|Overall Study||1
252625|NCT00499694|609317|P1|COMPLETED|Overall Study||30
252626|NCT00499694|609317|P1|STARTED|Overall Study||31
252627|NCT00499681|609326|P2|NOT COMPLETED|Overall Study||2
252628|NCT00499681|609327|P1|NOT COMPLETED|Overall Study||0
252629|NCT00499681|609326|P2|COMPLETED|Overall Study||0
252630|NCT00499681|609327|P1|COMPLETED|Overall Study||4
252631|NCT00499681|609326|P2|STARTED|Overall Study||2
252632|NCT00499681|609327|P1|STARTED|Overall Study||4
252633|NCT00499655|609335|P2|NOT COMPLETED|Overall Study||0
252634|NCT00499655|609336|P1|NOT COMPLETED|Overall Study||0
252635|NCT00499655|609335|P2|COMPLETED|Overall Study||54
252636|NCT00499655|609336|P1|COMPLETED|Overall Study||53
252637|NCT00499655|609335|P2|STARTED|Overall Study||54
252638|NCT00499655|609336|P1|STARTED|Overall Study||53
252639|NCT00499616|609354|P4|NOT COMPLETED|Overall Study||57
252640|NCT00499616|609355|P3|NOT COMPLETED|Overall Study||36
252641|NCT00499616|609356|P2|NOT COMPLETED|Overall Study||28
252642|NCT00499616|609357|P1|NOT COMPLETED|Overall Study||15
252643|NCT00499616|609354|P4|COMPLETED|Overall Study||0
252644|NCT00499616|609355|P3|COMPLETED|Overall Study||53
252645|NCT00499616|609356|P2|COMPLETED|Overall Study||114
252646|NCT00499616|609357|P1|COMPLETED|Overall Study||161
252647|NCT00499616|609354|P4|STARTED|Overall Study||57
252648|NCT00499616|609355|P3|STARTED|Overall Study||89
252649|NCT00499616|609356|P2|STARTED|Overall Study||142
252650|NCT00499616|609357|P1|STARTED|Overall Study||176
252651|NCT00499603|609394|P2|NOT COMPLETED|Overall Study||1
252652|NCT00499603|609395|P1|NOT COMPLETED|Overall Study||0
252653|NCT00499603|609394|P2|COMPLETED|Overall Study||22
252654|NCT00499603|609395|P1|COMPLETED|Overall Study||27
252655|NCT00499603|609394|P2|STARTED|Overall Study||23
252656|NCT00499603|609395|P1|STARTED|Overall Study||27
252657|NCT00499590|609408|P3|NOT COMPLETED|Overall Study||113
252658|NCT00499590|609409|P2|NOT COMPLETED|Overall Study||112
252659|NCT00499590|609410|P1|NOT COMPLETED|Overall Study||113
252660|NCT00499590|609408|P3|COMPLETED|Overall Study||0
252661|NCT00499590|609409|P2|COMPLETED|Overall Study||0
252662|NCT00499590|609410|P1|COMPLETED|Overall Study||0
252663|NCT00499590|609408|P3|STARTED|Overall Study||113
252664|NCT00499590|609409|P2|STARTED|Overall Study||112
252665|NCT00499590|609410|P1|STARTED|Overall Study||113
252666|NCT00499486|609421|P1|NOT COMPLETED|Overall Study||16
252667|NCT00499486|609421|P1|COMPLETED|Overall Study||31
252668|NCT00499486|609421|P1|STARTED|Overall Study||47
252669|NCT00499473|609429|P2|NOT COMPLETED|Overall Study||0
252670|NCT00499473|609430|P1|NOT COMPLETED|Overall Study||6
252671|NCT00499473|609429|P2|COMPLETED|Overall Study||4
252672|NCT00499473|609430|P1|COMPLETED|Overall Study|Patients evaluable|21
252673|NCT00499473|609429|P2|STARTED|Overall Study||4
252674|NCT00499473|609430|P1|STARTED|Overall Study||27
252675|NCT00499460|609448|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
252676|NCT00499460|609449|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
252677|NCT00499460|609448|P2|COMPLETED|Intervention 2 (30 Days)||6
252678|NCT00499460|609449|P1|COMPLETED|Intervention 2 (30 Days)||6
252679|NCT00499460|609448|P2|STARTED|Intervention 2 (30 Days)||7
252680|NCT00499460|609449|P1|STARTED|Intervention 2 (30 Days)||6
252681|NCT00499460|609448|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
252682|NCT00499460|609449|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
252683|NCT00499460|609448|P2|COMPLETED|Intervention 1 (30 Days)||7
252684|NCT00499460|609449|P1|COMPLETED|Intervention 1 (30 Days)||6
252685|NCT00499460|609448|P2|STARTED|Intervention 1 (30 Days)||7
252686|NCT00499460|609449|P1|STARTED|Intervention 1 (30 Days)||8
252687|NCT00499447|609465|P1|NOT COMPLETED|Overall Study||0
252688|NCT00499447|609465|P1|COMPLETED|Overall Study||13
252689|NCT00499447|609465|P1|STARTED|Overall Study||13
252690|NCT00499408|609469|P1|NOT COMPLETED|Overall Study||0
252691|NCT00499408|609469|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
252692|NCT00499408|609469|P1|STARTED|Overall Study||26
252693|NCT00499369|609478|P5|NOT COMPLETED|Overall Study||12
252694|NCT00499369|609479|P4|NOT COMPLETED|Overall Study||9
252695|NCT00499369|609480|P3|NOT COMPLETED|Overall Study||17
252696|NCT00499369|609481|P2|NOT COMPLETED|Overall Study||18
252697|NCT00499369|609482|P1|NOT COMPLETED|Overall Study||16
252698|NCT00499369|609478|P5|COMPLETED|Overall Study||0
252699|NCT00499369|609479|P4|COMPLETED|Overall Study||0
252700|NCT00499369|609480|P3|COMPLETED|Overall Study||0
252701|NCT00499369|609481|P2|COMPLETED|Overall Study||0
252702|NCT00499369|609482|P1|COMPLETED|Overall Study||0
252703|NCT00499369|609478|P5|Eligible|Overall Study||12
252704|NCT00499369|609479|P4|Eligible|Overall Study||8
252705|NCT00499369|609480|P3|Eligible|Overall Study||16
252706|NCT00499369|609481|P2|Eligible|Overall Study||16
252707|NCT00499369|609482|P1|Eligible|Overall Study||14
252708|NCT00499369|609478|P5|STARTED|Overall Study||12
252709|NCT00499369|609479|P4|STARTED|Overall Study||9
252710|NCT00499369|609480|P3|STARTED|Overall Study||17
252711|NCT00499369|609481|P2|STARTED|Overall Study||18
252712|NCT00499369|609482|P1|STARTED|Overall Study||16
252713|NCT00499343|609511|P2|NOT COMPLETED|Overall Study||0
252714|NCT00499343|609512|P1|NOT COMPLETED|Overall Study||0
252715|NCT00499343|609511|P2|COMPLETED|Overall Study||43
252716|NCT00499343|609512|P1|COMPLETED|Overall Study||41
252717|NCT00499343|609511|P2|STARTED|Overall Study||43
252718|NCT00499343|609512|P1|STARTED|Overall Study||41
252719|NCT00499252|609518|P1|NOT COMPLETED|Overall Study||12
252720|NCT00499252|609518|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
252721|NCT00499252|609518|P1|STARTED|Overall Study||51
252722|NCT00499122|609528|P1|NOT COMPLETED|Overall Study||2
252723|NCT00499122|609528|P1|COMPLETED|Overall Study||39
252724|NCT00499122|609528|P1|STARTED|Overall Study||41
252725|NCT00499109|609536|P2|NOT COMPLETED|Overall Study||7
252726|NCT00499109|609537|P1|NOT COMPLETED|Overall Study||18
252727|NCT00499109|609536|P2|COMPLETED|Overall Study||85
252728|NCT00499109|609537|P1|COMPLETED|Overall Study||165
252729|NCT00499109|609536|P2|STARTED|Overall Study||92
252730|NCT00499109|609537|P1|STARTED|Overall Study||183
252731|NCT00499096|609552|P2|NOT COMPLETED|Overall Study||20
252732|NCT00499096|609553|P1|NOT COMPLETED|Overall Study||23
252733|NCT00499096|609552|P2|COMPLETED|Overall Study||40
252734|NCT00499096|609553|P1|COMPLETED|Overall Study||35
252735|NCT00499096|609552|P2|STARTED|Overall Study||60
252736|NCT00499096|609553|P1|STARTED|Overall Study||58
252737|NCT00499031|609571|P1|NOT COMPLETED|Overall Study||3
252738|NCT00499031|609571|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
252739|NCT00499031|609571|P1|STARTED|Overall Study|Total number participants enrolled on study|38
252740|NCT00498940|609578|P2|NOT COMPLETED|Overall Study||0
252741|NCT00498940|609579|P1|NOT COMPLETED|Overall Study||0
252742|NCT00498940|609578|P2|COMPLETED|Overall Study||31
252743|NCT00498940|609579|P1|COMPLETED|Overall Study||30
252744|NCT00498940|609578|P2|STARTED|Overall Study||31
252745|NCT00498940|609579|P1|STARTED|Overall Study||30
252746|NCT00498927|609587|P1|NOT COMPLETED|Overall Study||0
252747|NCT00498927|609587|P1|COMPLETED|Overall Study||47
252748|NCT00498927|609587|P1|STARTED|Overall Study||47
252749|NCT00498797|609594|P2|NOT COMPLETED|Overall Study||29
252750|NCT00498797|609595|P1|NOT COMPLETED|Overall Study||38
252751|NCT00498797|609594|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
252752|NCT00498797|609595|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
252753|NCT00498797|609594|P2|STARTED|Overall Study|randomised patients|43
252754|NCT00498797|609595|P1|STARTED|Overall Study|randomised patients|43
252755|NCT00498706|609605|P2|NOT COMPLETED|Overall Study||0
252756|NCT00498706|609606|P1|NOT COMPLETED|Overall Study||0
252757|NCT00498706|609605|P2|COMPLETED|Overall Study||162
252758|NCT00498706|609606|P1|COMPLETED|Overall Study||163
252759|NCT00498706|609605|P2|Post Treatment Week 18|Overall Study||162
252760|NCT00498706|609606|P1|Post Treatment Week 18|Overall Study||163
252761|NCT00498706|609605|P2|STARTED|Overall Study||162
252762|NCT00498706|609606|P1|STARTED|Overall Study||163
252763|NCT00498628|609620|P2|NOT COMPLETED|Overall Study||21
252764|NCT00498628|609621|P1|NOT COMPLETED|Overall Study||15
252765|NCT00498628|609620|P2|COMPLETED|Overall Study||92
252766|NCT00498628|609621|P1|COMPLETED|Overall Study||90
252767|NCT00498628|609620|P2|STARTED|Overall Study||113
252768|NCT00498628|609621|P1|STARTED|Overall Study||105
252769|NCT00498615|609627|P6|NOT COMPLETED|Placebo||0
252770|NCT00498615|609628|P5|NOT COMPLETED|Placebo||0
252771|NCT00498615|609629|P4|NOT COMPLETED|Placebo||0
252772|NCT00498615|609630|P3|NOT COMPLETED|Placebo||0
252773|NCT00498615|609631|P2|NOT COMPLETED|Placebo||0
252774|NCT00498615|609632|P1|NOT COMPLETED|Placebo||0
252775|NCT00498615|609627|P6|COMPLETED|Placebo||3
252776|NCT00498615|609628|P5|COMPLETED|Placebo||3
252777|NCT00498615|609629|P4|COMPLETED|Placebo||2
252778|NCT00498615|609630|P3|COMPLETED|Placebo||3
252779|NCT00498615|609631|P2|COMPLETED|Placebo||4
252780|NCT00498615|609632|P1|COMPLETED|Placebo||2
252781|NCT00498615|609627|P6|STARTED|Placebo||3
252782|NCT00498615|609628|P5|STARTED|Placebo||3
252783|NCT00498615|609629|P4|STARTED|Placebo||2
252784|NCT00498615|609630|P3|STARTED|Placebo||3
252785|NCT00498615|609631|P2|STARTED|Placebo||4
252786|NCT00498615|609632|P1|STARTED|Placebo||2
252787|NCT00498615|609627|P6|NOT COMPLETED|Fasudil 40mg||0
252788|NCT00498615|609628|P5|NOT COMPLETED|Fasudil 40mg||0
252789|NCT00498615|609629|P4|NOT COMPLETED|Fasudil 40mg||0
252790|NCT00498615|609630|P3|NOT COMPLETED|Fasudil 40mg||0
252791|NCT00498615|609631|P2|NOT COMPLETED|Fasudil 40mg||0
252792|NCT00498615|609632|P1|NOT COMPLETED|Fasudil 40mg||0
252793|NCT00498615|609627|P6|COMPLETED|Fasudil 40mg||3
252794|NCT00498615|609628|P5|COMPLETED|Fasudil 40mg||3
252795|NCT00498615|609629|P4|COMPLETED|Fasudil 40mg||2
252796|NCT00498615|609630|P3|COMPLETED|Fasudil 40mg||3
252797|NCT00498615|609631|P2|COMPLETED|Fasudil 40mg||4
252798|NCT00498615|609632|P1|COMPLETED|Fasudil 40mg||2
252799|NCT00498615|609627|P6|STARTED|Fasudil 40mg||3
252800|NCT00498615|609628|P5|STARTED|Fasudil 40mg||3
252801|NCT00498615|609629|P4|STARTED|Fasudil 40mg||2
252802|NCT00498615|609630|P3|STARTED|Fasudil 40mg||3
252803|NCT00498615|609631|P2|STARTED|Fasudil 40mg||4
252804|NCT00498615|609632|P1|STARTED|Fasudil 40mg||2
252805|NCT00498615|609627|P6|NOT COMPLETED|Fasudil 80mg||0
252806|NCT00498615|609628|P5|NOT COMPLETED|Fasudil 80mg||0
252807|NCT00498615|609629|P4|NOT COMPLETED|Fasudil 80mg||0
252808|NCT00498615|609630|P3|NOT COMPLETED|Fasudil 80mg||0
252809|NCT00498615|609631|P2|NOT COMPLETED|Fasudil 80mg||0
252810|NCT00498615|609632|P1|NOT COMPLETED|Fasudil 80mg||0
252811|NCT00498615|609627|P6|COMPLETED|Fasudil 80mg||3
252812|NCT00498615|609628|P5|COMPLETED|Fasudil 80mg||3
252813|NCT00498615|609629|P4|COMPLETED|Fasudil 80mg||2
252814|NCT00498615|609630|P3|COMPLETED|Fasudil 80mg||3
252815|NCT00498615|609631|P2|COMPLETED|Fasudil 80mg||4
252816|NCT00498615|609632|P1|COMPLETED|Fasudil 80mg||2
252817|NCT00498615|609627|P6|STARTED|Fasudil 80mg||3
252818|NCT00498615|609628|P5|STARTED|Fasudil 80mg||3
252819|NCT00498615|609629|P4|STARTED|Fasudil 80mg||2
252820|NCT00498615|609630|P3|STARTED|Fasudil 80mg||3
252821|NCT00498615|609631|P2|STARTED|Fasudil 80mg||4
252822|NCT00498615|609632|P1|STARTED|Fasudil 80mg||2
252823|NCT00498602|609653|P7|NOT COMPLETED|Overall Study||2
252824|NCT00498602|609654|P6|NOT COMPLETED|Overall Study||13
252825|NCT00498602|609655|P5|NOT COMPLETED|Overall Study||4
252826|NCT00498602|609656|P4|NOT COMPLETED|Overall Study||5
252827|NCT00498602|609657|P3|NOT COMPLETED|Overall Study||8
252828|NCT00498602|609658|P2|NOT COMPLETED|Overall Study||10
252829|NCT00498602|609659|P1|NOT COMPLETED|Overall Study||10
252830|NCT00498602|609653|P7|COMPLETED|Overall Study||15
252831|NCT00498602|609654|P6|COMPLETED|Overall Study||31
252832|NCT00498602|609655|P5|COMPLETED|Overall Study||8
252833|NCT00498602|609656|P4|COMPLETED|Overall Study||30
252834|NCT00498602|609657|P3|COMPLETED|Overall Study||32
252835|NCT00498602|609658|P2|COMPLETED|Overall Study||51
252836|NCT00498602|609659|P1|COMPLETED|Overall Study||26
252837|NCT00498602|609653|P7|Treated|Overall Study||17
252838|NCT00498602|609654|P6|Treated|Overall Study||44
252839|NCT00498602|609655|P5|Treated|Overall Study||12
252840|NCT00498602|609656|P4|Treated|Overall Study||35
252841|NCT00498602|609657|P3|Treated|Overall Study||40
252842|NCT00498602|609658|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
252843|NCT00498602|609659|P1|Treated|Overall Study||36
252844|NCT00498602|609653|P7|STARTED|Overall Study||17
252845|NCT00498602|609654|P6|STARTED|Overall Study||44
252846|NCT00498602|609655|P5|STARTED|Overall Study||12
252847|NCT00498602|609656|P4|STARTED|Overall Study||35
252848|NCT00498602|609657|P3|STARTED|Overall Study||40
252849|NCT00498602|609658|P2|STARTED|Overall Study||61
252850|NCT00498602|609659|P1|STARTED|Overall Study||36
252851|NCT00498550|609698|P2|NOT COMPLETED|Overall Study||1
252852|NCT00498550|609699|P1|NOT COMPLETED|Overall Study||0
252853|NCT00498550|609698|P2|COMPLETED|Overall Study||15
252854|NCT00498550|609699|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
252855|NCT00498550|609698|P2|STARTED|Overall Study||16
252856|NCT00498550|609699|P1|STARTED|Overall Study||15
252857|NCT00498485|609707|P2|NOT COMPLETED|Overall Study||5
252858|NCT00498485|609708|P1|NOT COMPLETED|Overall Study||1
252859|NCT00498485|609707|P2|COMPLETED|Overall Study||5
252860|NCT00498485|609708|P1|COMPLETED|Overall Study||6
252861|NCT00498485|609707|P2|STARTED|Overall Study||10
252862|NCT00498485|609708|P1|STARTED|Overall Study||7
252863|NCT00498433|609719|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
252864|NCT00498433|609720|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
252865|NCT00498433|609721|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
252866|NCT00498433|609719|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
252867|NCT00498433|609720|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
252868|NCT00498433|609721|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
252869|NCT00498433|609719|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
252870|NCT00498433|609720|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
252871|NCT00498433|609721|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
252872|NCT00498433|609719|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
252873|NCT00498433|609720|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
252874|NCT00498433|609721|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
252875|NCT00498433|609719|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
252876|NCT00498433|609720|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
252877|NCT00498433|609721|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
252878|NCT00498433|609719|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
252879|NCT00498433|609720|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
252880|NCT00498433|609721|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
252881|NCT00498433|609719|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
252882|NCT00498433|609720|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
252883|NCT00498433|609721|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
252884|NCT00498433|609719|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
252885|NCT00498433|609720|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
252886|NCT00498433|609721|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
252887|NCT00498433|609719|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
252888|NCT00498433|609720|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
252889|NCT00498433|609721|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
252890|NCT00498433|609719|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
252891|NCT00498433|609720|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
252892|NCT00498433|609721|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
252893|NCT00498433|609719|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
252894|NCT00498433|609720|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
252895|NCT00498433|609721|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
252896|NCT00498433|609719|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
252897|NCT00498433|609720|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
252898|NCT00498433|609721|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
252899|NCT00498433|609719|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
252900|NCT00498433|609720|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
252901|NCT00498433|609721|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
252902|NCT00498433|609719|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
252903|NCT00498433|609720|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
252904|NCT00498433|609721|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
252905|NCT00498433|609719|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
252906|NCT00498433|609720|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
252907|NCT00498433|609721|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
252908|NCT00498368|609766|P2|NOT COMPLETED|Overall Study||2
252909|NCT00498368|609767|P1|NOT COMPLETED|Overall Study||3
252910|NCT00498368|609766|P2|COMPLETED|Overall Study||15
252911|NCT00498368|609767|P1|COMPLETED|Overall Study||14
252912|NCT00498368|609766|P2|STARTED|Overall Study||17
252913|NCT00498368|609767|P1|STARTED|Overall Study||17
252914|NCT00498355|609779|P1|NOT COMPLETED|Overall Study||1
252915|NCT00498355|609779|P1|COMPLETED|Overall Study||6
252916|NCT00498355|609779|P1|STARTED|Overall Study||7
252917|NCT00498186|609787|P1|NOT COMPLETED|Overall Study||173
252918|NCT00498186|609787|P1|COMPLETED|Overall Study||122
252919|NCT00498186|609787|P1|STARTED|Overall Study||295
252920|NCT00498173|609794|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
252921|NCT00498173|609795|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
252922|NCT00498173|609796|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
252923|NCT00498173|609794|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
252924|NCT00498173|609795|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
252925|NCT00498173|609796|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
252926|NCT00498173|609794|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
252927|NCT00498173|609795|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
252928|NCT00498173|609796|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
252929|NCT00498173|609794|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
252930|NCT00498173|609795|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
252931|NCT00498173|609796|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
252932|NCT00498173|609794|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
252933|NCT00498173|609795|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
252934|NCT00498173|609796|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
252935|NCT00498173|609794|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
252936|NCT00498173|609795|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
252937|NCT00498173|609796|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
252938|NCT00497874|609826|P2|NOT COMPLETED|Overall Study||116
252939|NCT00497874|609827|P1|NOT COMPLETED|Overall Study||147
252940|NCT00497874|609826|P2|COMPLETED|Overall Study||343
252941|NCT00497874|609827|P1|COMPLETED|Overall Study||296
252942|NCT00497874|609826|P2|STARTED|Overall Study||459
252943|NCT00497874|609827|P1|STARTED|Overall Study||443
252944|NCT00497796|609845|P2|NOT COMPLETED|Overall Study||59
252945|NCT00497796|609846|P1|NOT COMPLETED|Overall Study||85
252946|NCT00497796|609845|P2|COMPLETED|Overall Study||101
252947|NCT00497796|609846|P1|COMPLETED|Overall Study||62
252948|NCT00497796|609845|P2|STARTED|Overall Study||160
252949|NCT00497796|609846|P1|STARTED|Overall Study||147
252950|NCT00497770|609878|P4|NOT COMPLETED|Overall Study||0
252951|NCT00497770|609879|P3|NOT COMPLETED|Overall Study||0
252952|NCT00497770|609880|P2|NOT COMPLETED|Overall Study||0
252953|NCT00497770|609881|P1|NOT COMPLETED|Overall Study||0
252954|NCT00497770|609878|P4|COMPLETED|Overall Study||28
252955|NCT00497770|609879|P3|COMPLETED|Overall Study||37
252956|NCT00497770|609880|P2|COMPLETED|Overall Study||65
252957|NCT00497770|609881|P1|COMPLETED|Overall Study||304
252958|NCT00497770|609878|P4|STARTED|Overall Study||28
252959|NCT00497770|609879|P3|STARTED|Overall Study||37
252960|NCT00497770|609880|P2|STARTED|Overall Study||65
252961|NCT00497770|609881|P1|STARTED|Overall Study||304
252962|NCT00497198|609933|P2|NOT COMPLETED|Overall Study||5
252963|NCT00497198|609934|P1|NOT COMPLETED|Overall Study||5
252964|NCT00497198|609933|P2|COMPLETED|Overall Study||86
252965|NCT00497198|609934|P1|COMPLETED|Overall Study||87
252966|NCT00497198|609933|P2|STARTED|Overall Study||91
252967|NCT00497198|609934|P1|STARTED|Overall Study||92
252968|NCT00497146|609950|P2|NOT COMPLETED|Long-term Follow-up Period||6
252969|NCT00497146|609951|P1|NOT COMPLETED|Long-term Follow-up Period||15
252970|NCT00497146|609950|P2|COMPLETED|Long-term Follow-up Period||66
252971|NCT00497146|609951|P1|COMPLETED|Long-term Follow-up Period||50
252972|NCT00497146|609950|P2|STARTED|Long-term Follow-up Period||72
252973|NCT00497146|609951|P1|STARTED|Long-term Follow-up Period||65
252974|NCT00497146|609950|P2|NOT COMPLETED|Treatment Period||21
252975|NCT00497146|609951|P1|NOT COMPLETED|Treatment Period||27
252976|NCT00497146|609950|P2|COMPLETED|Treatment Period||91
252977|NCT00497146|609951|P1|COMPLETED|Treatment Period||88
252978|NCT00497146|609950|P2|STARTED|Treatment Period||112
252979|NCT00497146|609951|P1|STARTED|Treatment Period||115
252980|NCT00497081|609993|P2|NOT COMPLETED|Overall Study||2
252981|NCT00497081|609994|P1|NOT COMPLETED|Overall Study||2
252982|NCT00497081|609993|P2|COMPLETED|Overall Study||28
252983|NCT00497081|609994|P1|COMPLETED|Overall Study||28
252984|NCT00497081|609993|P2|STARTED|Overall Study||30
252985|NCT00497081|609994|P1|STARTED|Overall Study||30
252986|NCT00497055|610006|P2|NOT COMPLETED|Overall Study||5
252987|NCT00497055|610007|P1|NOT COMPLETED|Overall Study||10
252988|NCT00497055|610006|P2|COMPLETED|Overall Study||40
252989|NCT00497055|610007|P1|COMPLETED|Overall Study||35
252990|NCT00497055|610006|P2|STARTED|Overall Study||45
252991|NCT00497055|610007|P1|STARTED|Overall Study||45
252992|NCT00496964|610019|P2|NOT COMPLETED|Overall Study||1
252993|NCT00496964|610020|P1|NOT COMPLETED|Overall Study||0
252994|NCT00496964|610019|P2|COMPLETED|Overall Study||3
252995|NCT00496964|610020|P1|COMPLETED|Overall Study||1
252996|NCT00496964|610019|P2|STARTED|Overall Study||4
252997|NCT00496964|610020|P1|STARTED|Overall Study||1
252998|NCT00496873|610038|P1|NOT COMPLETED|Overall Study||7
252999|NCT00496873|610038|P1|COMPLETED|Overall Study||78
253000|NCT00496873|610038|P1|STARTED|Overall Study||85
253001|NCT00496860|610047|P3|NOT COMPLETED|Overall Study||0
253002|NCT00496860|610048|P2|NOT COMPLETED|Overall Study||1
253003|NCT00496860|610049|P1|NOT COMPLETED|Overall Study||1
253004|NCT00496860|610047|P3|COMPLETED|Overall Study||6
253005|NCT00496860|610048|P2|COMPLETED|Overall Study||15
253006|NCT00496860|610049|P1|COMPLETED|Overall Study||3
253007|NCT00496860|610047|P3|STARTED|Overall Study||6
253008|NCT00496860|610048|P2|STARTED|Overall Study||16
253009|NCT00496860|610049|P1|STARTED|Overall Study||4
253010|NCT00496834|610071|P2|NOT COMPLETED|Overall Study||13
253011|NCT00496834|610072|P1|NOT COMPLETED|Overall Study||18
253012|NCT00496834|610071|P2|COMPLETED|Overall Study||87
253013|NCT00496834|610072|P1|COMPLETED|Overall Study||83
253014|NCT00496834|610071|P2|STARTED|Overall Study||100
253015|NCT00496834|610072|P1|STARTED|Overall Study||101
253016|NCT00496808|610084|P1|NOT COMPLETED|Overall Study||0
253017|NCT00496808|610084|P1|COMPLETED|Overall Study||69
253018|NCT00496808|610084|P1|STARTED|Overall Study||69
253019|NCT00496782|610091|P2|NOT COMPLETED|Overall Study||2
253020|NCT00496782|610092|P1|NOT COMPLETED|Overall Study||1
253021|NCT00496782|610091|P2|COMPLETED|Overall Study||5
253022|NCT00496782|610092|P1|COMPLETED|Overall Study||8
253023|NCT00496782|610091|P2|STARTED|Overall Study||7
253024|NCT00496782|610092|P1|STARTED|Overall Study||9
253025|NCT00496769|610126|P2|NOT COMPLETED|Overall Study||649
253026|NCT00496769|610127|P1|NOT COMPLETED|Overall Study||558
253027|NCT00496769|610126|P2|COMPLETED|Overall Study||2142
253028|NCT00496769|610127|P1|COMPLETED|Overall Study||2249
253029|NCT00496769|610126|P2|Received Treatment|Overall Study||2708
253030|NCT00496769|610127|P1|Received Treatment|Overall Study||2798
253031|NCT00496769|610126|P2|STARTED|Overall Study|Randomized|2791
253032|NCT00496769|610127|P1|STARTED|Overall Study|Randomized|2807
253033|NCT00496730|610151|P2|NOT COMPLETED|Overall Study||5
253034|NCT00496730|610152|P1|NOT COMPLETED|Overall Study||6
253035|NCT00496730|610151|P2|COMPLETED|Overall Study||121
253036|NCT00496730|610152|P1|COMPLETED|Overall Study||124
253037|NCT00496730|610151|P2|STARTED|Overall Study||126
253038|NCT00496730|610152|P1|STARTED|Overall Study||130
253039|NCT00496626|610164|P2|NOT COMPLETED|Overall Study||6
253040|NCT00496626|610165|P1|NOT COMPLETED|Overall Study||6
253041|NCT00496626|610164|P2|COMPLETED|Overall Study||292
253042|NCT00496626|610165|P1|COMPLETED|Overall Study||296
253043|NCT00496626|610164|P2|STARTED|Overall Study||298
253044|NCT00496626|610165|P1|STARTED|Overall Study||302
253045|NCT00496587|610177|P1|NOT COMPLETED|Overall Study||31
253046|NCT00496587|610177|P1|COMPLETED|Overall Study||3
253047|NCT00496587|610177|P1|STARTED|Overall Study||34
253048|NCT00496483|610183|P1|NOT COMPLETED|Overall Study||12
253049|NCT00496483|610183|P1|COMPLETED|Overall Study||48
253050|NCT00496483|610183|P1|Dosed|Overall Study||51
253051|NCT00496483|610183|P1|STARTED|Overall Study||60
253052|NCT00496470|610200|P2|NOT COMPLETED|Overall Study||29
253053|NCT00496470|610201|P1|NOT COMPLETED|Overall Study||26
253054|NCT00496470|610200|P2|COMPLETED|Overall Study||302
253055|NCT00496470|610201|P1|COMPLETED|Overall Study||303
253056|NCT00496470|610200|P2|Received Study Medication|Overall Study||330
253057|NCT00496470|610201|P1|Received Study Medication|Overall Study||329
253058|NCT00496470|610200|P2|STARTED|Overall Study||331
253059|NCT00496470|610201|P1|STARTED|Overall Study||329
253060|NCT00496379|610279|P1|NOT COMPLETED|Overall Study||0
253061|NCT00496379|610279|P1|COMPLETED|Overall Study||15
253062|NCT00496379|610279|P1|STARTED|Overall Study||15
253063|NCT00496366|610287|P1|NOT COMPLETED|Overall Study||1
253064|NCT00496366|610287|P1|COMPLETED|Overall Study||10
253065|NCT00496366|610287|P1|STARTED|Overall Study||11
253066|NCT00496340|610292|P1|NOT COMPLETED|Overall Study||0
253067|NCT00496340|610292|P1|COMPLETED|Overall Study||42
253068|NCT00496340|610292|P1|STARTED|Overall Study||42
253069|NCT00496262|610305|P1|NOT COMPLETED|Overall Study||0
253070|NCT00496262|610305|P1|COMPLETED|Overall Study||15
253071|NCT00496262|610305|P1|STARTED|Overall Study||15
253072|NCT00496197|610318|P1|NOT COMPLETED|Overall Study||122
253073|NCT00496197|610318|P1|COMPLETED|Overall Study||160
253074|NCT00496197|610318|P1|STARTED|Overall Study||282
253075|NCT00496080|610345|P1|NOT COMPLETED|Overall Study||27
253076|NCT00496080|610345|P1|COMPLETED|Overall Study||60
253077|NCT00496080|610345|P1|STARTED|Overall Study||87
253078|NCT00496054|610355|P1|NOT COMPLETED|Overall Study||8
253079|NCT00496054|610355|P1|COMPLETED|Overall Study||102
253080|NCT00496054|610355|P1|STARTED|Overall Study||110
253081|NCT00495820|610384|P2|NOT COMPLETED|Overall Study||1
253082|NCT00495820|610385|P1|NOT COMPLETED|Overall Study||1
253083|NCT00495820|610384|P2|COMPLETED|Overall Study||29
253084|NCT00495820|610385|P1|COMPLETED|Overall Study||29
253085|NCT00495820|610384|P2|STARTED|Overall Study||30
253086|NCT00495820|610385|P1|STARTED|Overall Study||30
253087|NCT00495794|610397|P2|NOT COMPLETED|Overall Study||0
253088|NCT00495794|610398|P1|NOT COMPLETED|Overall Study||522
253089|NCT00495794|610397|P2|COMPLETED|Overall Study||2303
253090|NCT00495794|610398|P1|COMPLETED|Overall Study||1797
253091|NCT00495794|610397|P2|STARTED|Overall Study||2303
253092|NCT00495794|610398|P1|STARTED|Overall Study||2319
253093|NCT00495755|610408|P1|NOT COMPLETED|Overall Study||3
253094|NCT00495755|610408|P1|COMPLETED|Overall Study||10
253095|NCT00495755|610408|P1|STARTED|Overall Study||13
253096|NCT00495677|610420|P7|NOT COMPLETED|Stage 2 (25 Days)||0
253097|NCT00495677|610421|P6|NOT COMPLETED|Stage 2 (25 Days)||0
253098|NCT00495677|610422|P5|NOT COMPLETED|Stage 2 (25 Days)||0
253099|NCT00495677|610423|P4|NOT COMPLETED|Stage 2 (25 Days)||0
253100|NCT00495677|610424|P3|NOT COMPLETED|Stage 2 (25 Days)||0
253101|NCT00495677|610425|P2|NOT COMPLETED|Stage 2 (25 Days)||0
253102|NCT00495677|610426|P1|NOT COMPLETED|Stage 2 (25 Days)||0
253103|NCT00495677|610420|P7|COMPLETED|Stage 2 (25 Days)||7
253104|NCT00495677|610421|P6|COMPLETED|Stage 2 (25 Days)||8
253105|NCT00495677|610422|P5|COMPLETED|Stage 2 (25 Days)||8
253106|NCT00495677|610423|P4|COMPLETED|Stage 2 (25 Days)||0
253107|NCT00495677|610424|P3|COMPLETED|Stage 2 (25 Days)||0
253108|NCT00495677|610425|P2|COMPLETED|Stage 2 (25 Days)||0
253109|NCT00495677|610426|P1|COMPLETED|Stage 2 (25 Days)||0
253110|NCT00495677|610420|P7|STARTED|Stage 2 (25 Days)||7
253111|NCT00495677|610421|P6|STARTED|Stage 2 (25 Days)||8
253112|NCT00495677|610422|P5|STARTED|Stage 2 (25 Days)||8
253113|NCT00495677|610423|P4|STARTED|Stage 2 (25 Days)||0
253114|NCT00495677|610424|P3|STARTED|Stage 2 (25 Days)||0
253115|NCT00495677|610425|P2|STARTED|Stage 2 (25 Days)||0
253116|NCT00495677|610426|P1|STARTED|Stage 2 (25 Days)||0
253117|NCT00495677|610420|P7|NOT COMPLETED|Stage 1 (25 Days)||0
253118|NCT00495677|610421|P6|NOT COMPLETED|Stage 1 (25 Days)||0
253119|NCT00495677|610422|P5|NOT COMPLETED|Stage 1 (25 Days)||0
253120|NCT00495677|610423|P4|NOT COMPLETED|Stage 1 (25 Days)||0
253121|NCT00495677|610424|P3|NOT COMPLETED|Stage 1 (25 Days)||1
253122|NCT00495677|610425|P2|NOT COMPLETED|Stage 1 (25 Days)||0
253123|NCT00495677|610426|P1|NOT COMPLETED|Stage 1 (25 Days)||0
253124|NCT00495677|610420|P7|COMPLETED|Stage 1 (25 Days)||0
253125|NCT00495677|610421|P6|COMPLETED|Stage 1 (25 Days)||0
253126|NCT00495677|610422|P5|COMPLETED|Stage 1 (25 Days)||0
253127|NCT00495677|610423|P4|COMPLETED|Stage 1 (25 Days)||6
253128|NCT00495677|610424|P3|COMPLETED|Stage 1 (25 Days)||5
253129|NCT00495677|610425|P2|COMPLETED|Stage 1 (25 Days)||6
253130|NCT00495677|610426|P1|COMPLETED|Stage 1 (25 Days)||2
253131|NCT00495677|610420|P7|STARTED|Stage 1 (25 Days)||0
253132|NCT00495677|610421|P6|STARTED|Stage 1 (25 Days)||0
253133|NCT00495677|610422|P5|STARTED|Stage 1 (25 Days)||0
253134|NCT00495677|610423|P4|STARTED|Stage 1 (25 Days)||6
253135|NCT00495677|610424|P3|STARTED|Stage 1 (25 Days)||6
253136|NCT00495677|610425|P2|STARTED|Stage 1 (25 Days)||6
253137|NCT00495677|610426|P1|STARTED|Stage 1 (25 Days)||2
253138|NCT00495625|610481|P1|NOT COMPLETED|Overall Study||10
253139|NCT00495625|610481|P1|COMPLETED|Overall Study||23
253140|NCT00495625|610481|P1|STARTED|Overall Study||33
253141|NCT00495612|610492|P2|NOT COMPLETED|Overall Study||0
253142|NCT00495612|610493|P1|NOT COMPLETED|Overall Study||4
253143|NCT00495612|610492|P2|COMPLETED|Overall Study||33
253144|NCT00495612|610493|P1|COMPLETED|Overall Study||32
253145|NCT00495612|610492|P2|STARTED|Overall Study||33
253146|NCT00495612|610493|P1|STARTED|Overall Study||36
253147|NCT00495586|610511|P2|NOT COMPLETED|Overall Study||4
253148|NCT00495586|610512|P1|NOT COMPLETED|Overall Study||4
253149|NCT00495586|610511|P2|COMPLETED|Overall Study||158
253150|NCT00495586|610512|P1|COMPLETED|Overall Study||152
253151|NCT00495586|610511|P2|STARTED|Overall Study||162
253152|NCT00495586|610512|P1|STARTED|Overall Study||156
253153|NCT00495521|610522|P2|NOT COMPLETED|Overall Study||1
253154|NCT00495521|610523|P1|NOT COMPLETED|Overall Study||0
253155|NCT00495521|610522|P2|COMPLETED|Overall Study||0
253156|NCT00495521|610523|P1|COMPLETED|Overall Study||1
253157|NCT00495521|610522|P2|STARTED|Overall Study||1
253158|NCT00495521|610523|P1|STARTED|Overall Study||1
253159|NCT00495495|610553|P1|NOT COMPLETED|Overall Study||99
253160|NCT00495495|610553|P1|COMPLETED|Overall Study||295
253161|NCT00495495|610553|P1|STARTED|Overall Study||394
253162|NCT00495469|610573|P7|NOT COMPLETED|Overall Study||5
253163|NCT00495469|610574|P6|NOT COMPLETED|Overall Study||5
253164|NCT00495469|610575|P5|NOT COMPLETED|Overall Study||5
253165|NCT00495469|610576|P4|NOT COMPLETED|Overall Study||4
253166|NCT00495469|610577|P3|NOT COMPLETED|Overall Study||7
253167|NCT00495469|610578|P2|NOT COMPLETED|Overall Study||7
253168|NCT00495469|610579|P1|NOT COMPLETED|Overall Study||6
253169|NCT00495469|610573|P7|COMPLETED|Overall Study||30
253170|NCT00495469|610574|P6|COMPLETED|Overall Study||31
253171|NCT00495469|610575|P5|COMPLETED|Overall Study||31
253172|NCT00495469|610576|P4|COMPLETED|Overall Study||32
253173|NCT00495469|610577|P3|COMPLETED|Overall Study||27
253174|NCT00495469|610578|P2|COMPLETED|Overall Study||30
253175|NCT00495469|610579|P1|COMPLETED|Overall Study||30
253176|NCT00495469|610573|P7|STARTED|Overall Study||35
253177|NCT00495469|610574|P6|STARTED|Overall Study||36
253178|NCT00495469|610575|P5|STARTED|Overall Study||36
253179|NCT00495469|610576|P4|STARTED|Overall Study||36
253180|NCT00495469|610577|P3|STARTED|Overall Study||34
253181|NCT00495469|610578|P2|STARTED|Overall Study||37
253182|NCT00495469|610579|P1|STARTED|Overall Study||36
253183|NCT00495391|610723|P2|NOT COMPLETED|Overall Study||21
253184|NCT00495391|610724|P1|NOT COMPLETED|Overall Study||36
253185|NCT00495391|610723|P2|COMPLETED|Overall Study||1
253186|NCT00495391|610724|P1|COMPLETED|Overall Study||6
253187|NCT00495391|610723|P2|From Baseline to End of Follow up|Overall Study||1
253188|NCT00495391|610724|P1|From Baseline to End of Follow up|Overall Study||6
253189|NCT00495391|610723|P2|From Baseline to End of Treatment|Overall Study||1
253190|NCT00495391|610724|P1|From Baseline to End of Treatment|Overall Study||6
253191|NCT00495391|610723|P2|From Baseline to Week 16|Overall Study||11
253192|NCT00495391|610724|P1|From Baseline to Week 16|Overall Study||24
253193|NCT00495391|610723|P2|From Baseline to Week 8|Overall Study||20
253194|NCT00495391|610724|P1|From Baseline to Week 8|Overall Study||31
253195|NCT00495391|610723|P2|STARTED|Overall Study||22
253196|NCT00495391|610724|P1|STARTED|Overall Study||42
253197|NCT00495222|610744|P1|NOT COMPLETED|Overall Study||0
253198|NCT00495222|610744|P1|COMPLETED|Overall Study||9
253199|NCT00495222|610744|P1|STARTED|Overall Study||9
253200|NCT00495157|610750|P3|NOT COMPLETED|Overall Study||13
253201|NCT00495157|610751|P2|NOT COMPLETED|Overall Study||23
253202|NCT00495157|610752|P1|NOT COMPLETED|Overall Study||16
253203|NCT00495157|610750|P3|COMPLETED|Overall Study||101
253204|NCT00495157|610751|P2|COMPLETED|Overall Study||92
253205|NCT00495157|610752|P1|COMPLETED|Overall Study||97
253206|NCT00495157|610750|P3|STARTED|Overall Study||114
253207|NCT00495157|610751|P2|STARTED|Overall Study||115
253208|NCT00495157|610752|P1|STARTED|Overall Study||113
253209|NCT00495131|610762|P2|NOT COMPLETED|Overall Study||6
253210|NCT00495131|610763|P1|NOT COMPLETED|Overall Study||7
253211|NCT00495131|610762|P2|COMPLETED|Overall Study||148
253212|NCT00495131|610763|P1|COMPLETED|Overall Study||147
253213|NCT00495131|610762|P2|STARTED|Overall Study||154
253214|NCT00495131|610763|P1|STARTED|Overall Study||154
253215|NCT00495079|610773|P1|NOT COMPLETED|Overall Study||0
253216|NCT00495079|610773|P1|COMPLETED|Overall Study||65
253217|NCT00495079|610773|P1|STARTED|Overall Study||65
253218|NCT00494975|610782|P2|NOT COMPLETED|Overall Study||1
253219|NCT00494975|610783|P1|NOT COMPLETED|Overall Study||2
253220|NCT00494975|610782|P2|COMPLETED|Overall Study||10
253221|NCT00494975|610783|P1|COMPLETED|Overall Study||8
253222|NCT00494975|610782|P2|STARTED|Overall Study||11
253223|NCT00494975|610783|P1|STARTED|Overall Study||10
253224|NCT00494871|610791|P2|NOT COMPLETED|Follow-up (FU) Period||23
253225|NCT00494871|610792|P1|NOT COMPLETED|Follow-up (FU) Period||29
253226|NCT00494871|610791|P2|COMPLETED|Follow-up (FU) Period||616
253227|NCT00494871|610792|P1|COMPLETED|Follow-up (FU) Period||610
253228|NCT00494871|610791|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
253229|NCT00494871|610792|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
253230|NCT00494871|610791|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
253231|NCT00494871|610792|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
253232|NCT00494871|610791|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
253233|NCT00494871|610792|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
253234|NCT00494871|610791|P2|COMPLETED|Double-blind (DB) Treatment Period||468
253235|NCT00494871|610792|P1|COMPLETED|Double-blind (DB) Treatment Period||480
253236|NCT00494871|610791|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
253237|NCT00494871|610792|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
253238|NCT00494871|610791|P2|STARTED|Double-blind (DB) Treatment Period||640
253239|NCT00494871|610792|P1|STARTED|Double-blind (DB) Treatment Period||640
253240|NCT00494806|610824|P2|NOT COMPLETED|Overall Study||0
253241|NCT00494806|610825|P1|NOT COMPLETED|Overall Study||0
253242|NCT00494806|610824|P2|COMPLETED|Overall Study||32
253243|NCT00494806|610825|P1|COMPLETED|Overall Study||34
253244|NCT00494806|610824|P2|STARTED|Overall Study||32
253245|NCT00494806|610825|P1|STARTED|Overall Study||34
253246|NCT00494780|610833|P2|NOT COMPLETED|Overall Study||13
253247|NCT00494780|610834|P1|NOT COMPLETED|Overall Study||11
253248|NCT00494780|610833|P2|COMPLETED|Overall Study||17
253249|NCT00494780|610834|P1|COMPLETED|Overall Study||18
253250|NCT00494780|610833|P2|STARTED|Overall Study||30
253251|NCT00494780|610834|P1|STARTED|Overall Study||29
253252|NCT00494676|610872|P2|NOT COMPLETED|Second Intervention||1
253253|NCT00494676|610873|P1|NOT COMPLETED|Second Intervention||1
253254|NCT00494676|610872|P2|COMPLETED|Second Intervention||28
253255|NCT00494676|610873|P1|COMPLETED|Second Intervention||33
253256|NCT00494676|610872|P2|STARTED|Second Intervention||29
253257|NCT00494676|610873|P1|STARTED|Second Intervention||34
253258|NCT00494676|610872|P2|NOT COMPLETED|First Intervention||3
253259|NCT00494676|610873|P1|NOT COMPLETED|First Intervention||1
253260|NCT00494676|610872|P2|COMPLETED|First Intervention||29
253261|NCT00494676|610873|P1|COMPLETED|First Intervention||34
253262|NCT00494676|610872|P2|STARTED|First Intervention||32
253263|NCT00494676|610873|P1|STARTED|First Intervention||35
253264|NCT00494676|610872|P2|NOT COMPLETED|Allocation||4
253265|NCT00494676|610873|P1|NOT COMPLETED|Allocation||2
253266|NCT00494676|610872|P2|COMPLETED|Allocation||32
253267|NCT00494676|610873|P1|COMPLETED|Allocation||35
253268|NCT00494676|610872|P2|STARTED|Allocation||36
253269|NCT00494676|610873|P1|STARTED|Allocation||37
253270|NCT00494585|610880|P1|NOT COMPLETED|Overall Study||0
253271|NCT00494585|610880|P1|COMPLETED|Overall Study||22
253272|NCT00494585|610880|P1|STARTED|Overall Study||22
253273|NCT00494507|610888|P4|NOT COMPLETED|Open-Label Phase||5
253274|NCT00494507|610889|P3|NOT COMPLETED|Open-Label Phase||5
253275|NCT00494507|610890|P2|NOT COMPLETED|Open-Label Phase||1
253276|NCT00494507|610891|P1|NOT COMPLETED|Open-Label Phase||0
253277|NCT00494507|610888|P4|COMPLETED|Open-Label Phase||14
253278|NCT00494507|610889|P3|COMPLETED|Open-Label Phase||17
253279|NCT00494507|610890|P2|COMPLETED|Open-Label Phase||7
253280|NCT00494507|610891|P1|COMPLETED|Open-Label Phase||9
253281|NCT00494507|610888|P4|STARTED|Open-Label Phase||19
253282|NCT00494507|610889|P3|STARTED|Open-Label Phase||22
253283|NCT00494507|610890|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
253284|NCT00494507|610891|P1|STARTED|Open-Label Phase||9
253285|NCT00494507|610888|P4|NOT COMPLETED|Double-Blind Phase||1
253286|NCT00494507|610889|P3|NOT COMPLETED|Double-Blind Phase||2
253287|NCT00494507|610890|P2|NOT COMPLETED|Double-Blind Phase||0
253288|NCT00494507|610891|P1|NOT COMPLETED|Double-Blind Phase||3
253289|NCT00494507|610888|P4|COMPLETED|Double-Blind Phase||19
253290|NCT00494507|610889|P3|COMPLETED|Double-Blind Phase||22
253291|NCT00494507|610890|P2|COMPLETED|Double-Blind Phase||9
253292|NCT00494507|610891|P1|COMPLETED|Double-Blind Phase||9
253293|NCT00494507|610888|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
253294|NCT00494507|610889|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
253295|NCT00494507|610890|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
253296|NCT00494507|610891|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
253297|NCT00494507|610888|P4|STARTED|Double-Blind Phase||20
253298|NCT00494507|610889|P3|STARTED|Double-Blind Phase||24
253299|NCT00494507|610890|P2|STARTED|Double-Blind Phase||9
253300|NCT00494507|610891|P1|STARTED|Double-Blind Phase||12
253301|NCT00494494|610941|P2|NOT COMPLETED|Overall Study||0
253302|NCT00494494|610942|P1|NOT COMPLETED|Overall Study||0
253303|NCT00494494|610941|P2|COMPLETED|Overall Study||39
253304|NCT00494494|610942|P1|COMPLETED|Overall Study||40
253305|NCT00494494|610941|P2|STARTED|Overall Study||39
253306|NCT00494494|610942|P1|STARTED|Overall Study||40
253307|NCT00494481|610958|P2|NOT COMPLETED|Overall Study||24
253308|NCT00494481|610959|P1|NOT COMPLETED|Overall Study||29
253309|NCT00494481|610958|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
253310|NCT00494481|610959|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
253311|NCT00494481|610958|P2|STARTED|Overall Study|randomised patients|29
253312|NCT00494481|610959|P1|STARTED|Overall Study|randomised patients|35
253313|NCT00494442|610967|P2|NOT COMPLETED|Overall Study||16
253314|NCT00494442|610968|P1|NOT COMPLETED|Overall Study||17
253315|NCT00494442|610967|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
253316|NCT00494442|610968|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
253317|NCT00494442|610967|P2|STARTED|Overall Study|Patients received treatment|33
253318|NCT00494442|610968|P1|STARTED|Overall Study|Patients received treatment|24
253319|NCT00494299|610984|P2|NOT COMPLETED|Overall Study||229
253320|NCT00494299|610985|P1|NOT COMPLETED|Overall Study||229
253321|NCT00494299|610984|P2|COMPLETED|Overall Study||0
253322|NCT00494299|610985|P1|COMPLETED|Overall Study||0
253323|NCT00494299|610984|P2|Received Treatment|Overall Study||227
253324|NCT00494299|610985|P1|Received Treatment|Overall Study||229
253325|NCT00494299|610984|P2|STARTED|Overall Study||229
253326|NCT00494299|610985|P1|STARTED|Overall Study||229
253327|NCT00494234|610997|P2|NOT COMPLETED|Overall Study||10
253328|NCT00494234|610998|P1|NOT COMPLETED|Overall Study||15
253329|NCT00494234|610997|P2|COMPLETED|Overall Study||17
253330|NCT00494234|610998|P1|COMPLETED|Overall Study||12
253331|NCT00494234|610997|P2|STARTED|Overall Study||27
253332|NCT00494234|610998|P1|STARTED|Overall Study||27
253333|NCT00494221|611017|P3|NOT COMPLETED|Overall Study||14
253334|NCT00494221|611018|P2|NOT COMPLETED|Overall Study||11
253335|NCT00494221|611019|P1|NOT COMPLETED|Overall Study||16
253336|NCT00494221|611017|P3|COMPLETED|Overall Study||44
253337|NCT00494221|611018|P2|COMPLETED|Overall Study||45
253338|NCT00494221|611019|P1|COMPLETED|Overall Study||42
253339|NCT00494221|611017|P3|STARTED|Overall Study||58
253340|NCT00494221|611018|P2|STARTED|Overall Study||56
253341|NCT00494221|611019|P1|STARTED|Overall Study||58
253342|NCT00494143|611039|P6|NOT COMPLETED|Overall Study||0
253343|NCT00494143|611040|P5|NOT COMPLETED|Overall Study||0
253344|NCT00494143|611041|P4|NOT COMPLETED|Overall Study||0
253345|NCT00494143|611042|P3|NOT COMPLETED|Overall Study||0
253346|NCT00494143|611043|P2|NOT COMPLETED|Overall Study||0
253347|NCT00494143|611044|P1|NOT COMPLETED|Overall Study||0
253348|NCT00494143|611039|P6|COMPLETED|Overall Study||0
253349|NCT00494143|611040|P5|COMPLETED|Overall Study||1
253350|NCT00494143|611041|P4|COMPLETED|Overall Study||0
253351|NCT00494143|611042|P3|COMPLETED|Overall Study||3
253352|NCT00494143|611043|P2|COMPLETED|Overall Study||2
253353|NCT00494143|611044|P1|COMPLETED|Overall Study||1
253354|NCT00494143|611039|P6|STARTED|Overall Study||0
253355|NCT00494143|611040|P5|STARTED|Overall Study||1
253356|NCT00494143|611041|P4|STARTED|Overall Study||0
253357|NCT00494143|611042|P3|STARTED|Overall Study||3
253358|NCT00494143|611043|P2|STARTED|Overall Study||2
253359|NCT00494143|611044|P1|STARTED|Overall Study||1
253360|NCT00494091|611060|P2|NOT COMPLETED|Overall Study||76
253361|NCT00494091|611061|P1|NOT COMPLETED|Overall Study||6
253362|NCT00494091|611060|P2|COMPLETED|Overall Study||0
253363|NCT00494091|611061|P1|COMPLETED|Overall Study||0
253364|NCT00494091|611060|P2|STARTED|Overall Study||76
253365|NCT00494091|611061|P1|STARTED|Overall Study||6
253366|NCT00494026|611083|P1|NOT COMPLETED|Overall Study||4
253367|NCT00494026|611083|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
253368|NCT00494026|611083|P1|STARTED|Overall Study||4
253369|NCT00494013|611093|P2|NOT COMPLETED|Overall Study||36
253370|NCT00494013|611094|P1|NOT COMPLETED|Overall Study||30
253371|NCT00494013|611093|P2|COMPLETED|Overall Study||183
253372|NCT00494013|611094|P1|COMPLETED|Overall Study||193
253373|NCT00494013|611093|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
253374|NCT00494013|611094|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
253375|NCT00494013|611093|P2|STARTED|Overall Study||219
253376|NCT00494013|611094|P1|STARTED|Overall Study||223
253377|NCT00493974|611124|P2|NOT COMPLETED|Overall Study||14
253378|NCT00493974|611125|P1|NOT COMPLETED|Overall Study||13
253379|NCT00493974|611124|P2|COMPLETED|Overall Study||45
253380|NCT00493974|611125|P1|COMPLETED|Overall Study||47
253381|NCT00493974|611124|P2|STARTED|Overall Study||59
253382|NCT00493974|611125|P1|STARTED|Overall Study||60
253383|NCT00493805|611143|P2|NOT COMPLETED|Overall Study||0
253384|NCT00493805|611144|P1|NOT COMPLETED|Overall Study||0
253385|NCT00493805|611143|P2|COMPLETED|Overall Study||42
253386|NCT00493805|611144|P1|COMPLETED|Overall Study||17
253387|NCT00493805|611143|P2|STARTED|Overall Study||42
253388|NCT00493805|611144|P1|STARTED|Overall Study||17
253389|NCT00493779|611152|P1|NOT COMPLETED|Overall Study||1
253390|NCT00493779|611152|P1|COMPLETED|Overall Study|Completed follow-up phase|97
253391|NCT00493779|611152|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
253392|NCT00493649|611159|P1|NOT COMPLETED|Overall Study||82
253393|NCT00493649|611159|P1|COMPLETED|Overall Study||411
253394|NCT00493649|611159|P1|STARTED|Overall Study||493
253395|NCT00493636|611172|P2|NOT COMPLETED|Overall Study||2
253396|NCT00493636|611173|P1|NOT COMPLETED|Overall Study||2
253397|NCT00493636|611172|P2|COMPLETED|Overall Study||77
253398|NCT00493636|611173|P1|COMPLETED|Overall Study||79
253399|NCT00493636|611172|P2|STARTED|Overall Study||79
253400|NCT00493636|611173|P1|STARTED|Overall Study||81
253401|NCT00493454|611187|P1|NOT COMPLETED|Overall Study||1
253402|NCT00493454|611187|P1|COMPLETED|Overall Study||5
253403|NCT00493454|611187|P1|STARTED|Overall Study||6
253404|NCT00493311|611193|P2|NOT COMPLETED|Overall Study||2
253405|NCT00493311|611194|P1|NOT COMPLETED|Overall Study||2
253406|NCT00493311|611193|P2|COMPLETED|Overall Study||29
253407|NCT00493311|611194|P1|COMPLETED|Overall Study||27
253408|NCT00493311|611193|P2|STARTED|Overall Study||31
253409|NCT00493311|611194|P1|STARTED|Overall Study||29
253410|NCT00493285|611214|P6|NOT COMPLETED|Overall Study||0
253411|NCT00493285|611215|P5|NOT COMPLETED|Overall Study||1
253412|NCT00493285|611216|P4|NOT COMPLETED|Overall Study||0
253413|NCT00493285|611217|P3|NOT COMPLETED|Overall Study||0
253414|NCT00493285|611218|P2|NOT COMPLETED|Overall Study||0
253415|NCT00493285|611219|P1|NOT COMPLETED|Overall Study||0
253416|NCT00493285|611214|P6|COMPLETED|Overall Study||5
253417|NCT00493285|611215|P5|COMPLETED|Overall Study||9
253418|NCT00493285|611216|P4|COMPLETED|Overall Study||6
253419|NCT00493285|611217|P3|COMPLETED|Overall Study||9
253420|NCT00493285|611218|P2|COMPLETED|Overall Study||6
253421|NCT00493285|611219|P1|COMPLETED|Overall Study||13
253422|NCT00493285|611214|P6|STARTED|Overall Study||5
253423|NCT00493285|611215|P5|STARTED|Overall Study||10
253424|NCT00493285|611216|P4|STARTED|Overall Study||6
253425|NCT00493285|611217|P3|STARTED|Overall Study||9
253426|NCT00493285|611218|P2|STARTED|Overall Study||6
253427|NCT00493285|611219|P1|STARTED|Overall Study||13
253428|NCT00493246|611451|P8|NOT COMPLETED|Overall Study||0
253429|NCT00493246|611452|P7|NOT COMPLETED|Overall Study||1
253430|NCT00493246|611453|P6|NOT COMPLETED|Overall Study||1
253431|NCT00493246|611454|P5|NOT COMPLETED|Overall Study||1
253432|NCT00493246|611455|P4|NOT COMPLETED|Overall Study||0
253433|NCT00493246|611456|P3|NOT COMPLETED|Overall Study||0
253434|NCT00493246|611457|P2|NOT COMPLETED|Overall Study||0
253435|NCT00493246|611458|P1|NOT COMPLETED|Overall Study||0
253436|NCT00493246|611451|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
253437|NCT00493246|611452|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
253438|NCT00493246|611453|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
253439|NCT00493246|611454|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
253440|NCT00493246|611455|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
253441|NCT00493246|611456|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
253442|NCT00493246|611457|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
253443|NCT00493246|611458|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
253444|NCT00493246|611451|P8|STARTED|Overall Study|All subjects who were randomized.|10
253445|NCT00493246|611452|P7|STARTED|Overall Study|All subjects who were randomized.|12
253446|NCT00493246|611453|P6|STARTED|Overall Study|All subjects who were randomized.|16
253617|NCT00492856|611611|P4|NOT COMPLETED|Induction||0
253447|NCT00493246|611454|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
253448|NCT00493246|611455|P4|STARTED|Overall Study||13
253449|NCT00493246|611456|P3|STARTED|Overall Study||12
253450|NCT00493246|611457|P2|STARTED|Overall Study||1
253451|NCT00493246|611458|P1|STARTED|Overall Study||2
253452|NCT00493220|611522|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
253453|NCT00493220|611523|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
253454|NCT00493220|611524|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
253455|NCT00493220|611525|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
253456|NCT00493220|611526|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
253457|NCT00493220|611527|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
253458|NCT00493220|611522|P6|COMPLETED|Final 7-Day Safety Follow-up||5
253459|NCT00493220|611523|P5|COMPLETED|Final 7-Day Safety Follow-up||5
253460|NCT00493220|611524|P4|COMPLETED|Final 7-Day Safety Follow-up||5
253461|NCT00493220|611525|P3|COMPLETED|Final 7-Day Safety Follow-up||5
253462|NCT00493220|611526|P2|COMPLETED|Final 7-Day Safety Follow-up||5
253463|NCT00493220|611527|P1|COMPLETED|Final 7-Day Safety Follow-up||4
253464|NCT00493220|611522|P6|STARTED|Final 7-Day Safety Follow-up||5
253465|NCT00493220|611523|P5|STARTED|Final 7-Day Safety Follow-up||5
253466|NCT00493220|611524|P4|STARTED|Final 7-Day Safety Follow-up||5
253467|NCT00493220|611525|P3|STARTED|Final 7-Day Safety Follow-up||5
253468|NCT00493220|611526|P2|STARTED|Final 7-Day Safety Follow-up||5
253469|NCT00493220|611527|P1|STARTED|Final 7-Day Safety Follow-up||4
253470|NCT00493220|611522|P6|NOT COMPLETED|Third Intervention||0
253471|NCT00493220|611523|P5|NOT COMPLETED|Third Intervention||0
253472|NCT00493220|611524|P4|NOT COMPLETED|Third Intervention||0
253473|NCT00493220|611525|P3|NOT COMPLETED|Third Intervention||0
253474|NCT00493220|611526|P2|NOT COMPLETED|Third Intervention||0
253475|NCT00493220|611527|P1|NOT COMPLETED|Third Intervention||1
253476|NCT00493220|611522|P6|COMPLETED|Third Intervention||5
253477|NCT00493220|611523|P5|COMPLETED|Third Intervention||5
253478|NCT00493220|611524|P4|COMPLETED|Third Intervention||5
253479|NCT00493220|611525|P3|COMPLETED|Third Intervention||5
253480|NCT00493220|611526|P2|COMPLETED|Third Intervention||5
253481|NCT00493220|611527|P1|COMPLETED|Third Intervention||4
253482|NCT00493220|611522|P6|STARTED|Third Intervention||5
253483|NCT00493220|611523|P5|STARTED|Third Intervention||5
253484|NCT00493220|611524|P4|STARTED|Third Intervention||5
253485|NCT00493220|611525|P3|STARTED|Third Intervention||5
253486|NCT00493220|611526|P2|STARTED|Third Intervention||5
253487|NCT00493220|611527|P1|STARTED|Third Intervention||5
253488|NCT00493220|611522|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
253489|NCT00493220|611523|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
253490|NCT00493220|611524|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
253491|NCT00493220|611525|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
253492|NCT00493220|611526|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
253493|NCT00493220|611527|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
253494|NCT00493220|611522|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
253495|NCT00493220|611523|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
253496|NCT00493220|611524|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
253497|NCT00493220|611525|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
253498|NCT00493220|611526|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
253499|NCT00493220|611527|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
253500|NCT00493220|611522|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
253501|NCT00493220|611523|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
253502|NCT00493220|611524|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
253503|NCT00493220|611525|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
253504|NCT00493220|611526|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
253505|NCT00493220|611527|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
253506|NCT00493220|611522|P6|NOT COMPLETED|Second Intervention||0
253507|NCT00493220|611523|P5|NOT COMPLETED|Second Intervention||0
253508|NCT00493220|611524|P4|NOT COMPLETED|Second Intervention||0
253509|NCT00493220|611525|P3|NOT COMPLETED|Second Intervention||0
253510|NCT00493220|611526|P2|NOT COMPLETED|Second Intervention||0
253511|NCT00493220|611527|P1|NOT COMPLETED|Second Intervention||0
253512|NCT00493220|611522|P6|COMPLETED|Second Intervention||5
253513|NCT00493220|611523|P5|COMPLETED|Second Intervention||5
253514|NCT00493220|611524|P4|COMPLETED|Second Intervention||5
253515|NCT00493220|611525|P3|COMPLETED|Second Intervention||5
253516|NCT00493220|611526|P2|COMPLETED|Second Intervention||5
253517|NCT00493220|611527|P1|COMPLETED|Second Intervention||5
253518|NCT00493220|611522|P6|STARTED|Second Intervention||5
253519|NCT00493220|611523|P5|STARTED|Second Intervention||5
253520|NCT00493220|611524|P4|STARTED|Second Intervention||5
253521|NCT00493220|611525|P3|STARTED|Second Intervention||5
253522|NCT00493220|611526|P2|STARTED|Second Intervention||5
253523|NCT00493220|611527|P1|STARTED|Second Intervention||5
253524|NCT00493220|611522|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
253525|NCT00493220|611523|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
253526|NCT00493220|611524|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
253527|NCT00493220|611525|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
253528|NCT00493220|611526|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
253529|NCT00493220|611527|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
253530|NCT00493220|611522|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
253531|NCT00493220|611523|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
253532|NCT00493220|611524|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
253533|NCT00493220|611525|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
253534|NCT00493220|611526|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
253535|NCT00493220|611527|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
253536|NCT00493220|611522|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
253537|NCT00493220|611523|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
253538|NCT00493220|611524|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
253539|NCT00493220|611525|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
253540|NCT00493220|611526|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
253541|NCT00493220|611527|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
253542|NCT00493220|611522|P6|NOT COMPLETED|First Intervention||0
253543|NCT00493220|611523|P5|NOT COMPLETED|First Intervention||0
253544|NCT00493220|611524|P4|NOT COMPLETED|First Intervention||0
253545|NCT00493220|611525|P3|NOT COMPLETED|First Intervention||0
253546|NCT00493220|611526|P2|NOT COMPLETED|First Intervention||0
253547|NCT00493220|611527|P1|NOT COMPLETED|First Intervention||0
253548|NCT00493220|611522|P6|COMPLETED|First Intervention||5
253549|NCT00493220|611523|P5|COMPLETED|First Intervention||5
253550|NCT00493220|611524|P4|COMPLETED|First Intervention||5
253551|NCT00493220|611525|P3|COMPLETED|First Intervention||5
253552|NCT00493220|611526|P2|COMPLETED|First Intervention||5
253553|NCT00493220|611527|P1|COMPLETED|First Intervention||5
253554|NCT00493220|611522|P6|STARTED|First Intervention||5
253555|NCT00493220|611523|P5|STARTED|First Intervention||5
253556|NCT00493220|611524|P4|STARTED|First Intervention||5
253557|NCT00493220|611525|P3|STARTED|First Intervention||5
253558|NCT00493220|611526|P2|STARTED|First Intervention||5
253559|NCT00493220|611527|P1|STARTED|First Intervention||5
253560|NCT00493181|611544|P1|NOT COMPLETED|Overall Study||0
253561|NCT00493181|611544|P1|COMPLETED|Overall Study||8
253562|NCT00493181|611544|P1|STARTED|Overall Study||8
253563|NCT00493038|611550|P2|NOT COMPLETED|Follow-up||0
253564|NCT00493038|611551|P1|NOT COMPLETED|Follow-up||1
253565|NCT00493038|611550|P2|COMPLETED|Follow-up||126
253566|NCT00493038|611551|P1|COMPLETED|Follow-up||122
253567|NCT00493038|611550|P2|STARTED|Follow-up||126
253568|NCT00493038|611551|P1|STARTED|Follow-up||123
253569|NCT00493038|611550|P2|NOT COMPLETED|Treatment||20
253570|NCT00493038|611551|P1|NOT COMPLETED|Treatment||24
253571|NCT00493038|611550|P2|COMPLETED|Treatment||126
253572|NCT00493038|611551|P1|COMPLETED|Treatment||123
253573|NCT00493038|611550|P2|Test-of-Cure Visit|Treatment||126
253574|NCT00493038|611551|P1|Test-of-Cure Visit|Treatment||123
253575|NCT00493038|611550|P2|Treated With Study Medication|Treatment||142
253576|NCT00493038|611551|P1|Treated With Study Medication|Treatment||145
253577|NCT00493038|611550|P2|Randomization|Treatment||146
253578|NCT00493038|611551|P1|Randomization|Treatment||147
253579|NCT00493038|611550|P2|STARTED|Treatment||146
253580|NCT00493038|611551|P1|STARTED|Treatment||147
253581|NCT00493012|611567|P2|NOT COMPLETED|Overall Study||17
253582|NCT00493012|611568|P1|NOT COMPLETED|Overall Study||18
253583|NCT00493012|611567|P2|COMPLETED|Overall Study||83
253584|NCT00493012|611568|P1|COMPLETED|Overall Study||82
253585|NCT00493012|611567|P2|STARTED|Overall Study||100
253586|NCT00493012|611568|P1|STARTED|Overall Study||100
253587|NCT00492973|611596|P2|NOT COMPLETED|Overall Study||1
253588|NCT00492973|611597|P1|NOT COMPLETED|Overall Study||0
253589|NCT00492973|611596|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
253590|NCT00492973|611597|P1|COMPLETED|Overall Study||37
253591|NCT00492973|611596|P2|STARTED|Overall Study||39
253592|NCT00492973|611597|P1|STARTED|Overall Study||37
253593|NCT00492856|611611|P4|NOT COMPLETED|Post-consolidation||1
253594|NCT00492856|611612|P3|NOT COMPLETED|Post-consolidation||27
253595|NCT00492856|611613|P2|NOT COMPLETED|Post-consolidation||12
253596|NCT00492856|611614|P1|NOT COMPLETED|Post-consolidation||0
253597|NCT00492856|611611|P4|COMPLETED|Post-consolidation||0
253598|NCT00492856|611612|P3|COMPLETED|Post-consolidation||0
253599|NCT00492856|611613|P2|COMPLETED|Post-consolidation||29
253600|NCT00492856|611614|P1|COMPLETED|Post-consolidation||0
253601|NCT00492856|611611|P4|STARTED|Post-consolidation||1
253602|NCT00492856|611612|P3|STARTED|Post-consolidation||27
253603|NCT00492856|611613|P2|STARTED|Post-consolidation||41
253604|NCT00492856|611614|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
253605|NCT00492856|611611|P4|NOT COMPLETED|Consolidation||0
253606|NCT00492856|611612|P3|NOT COMPLETED|Consolidation||0
253607|NCT00492856|611613|P2|NOT COMPLETED|Consolidation||0
253608|NCT00492856|611614|P1|NOT COMPLETED|Consolidation||9
253609|NCT00492856|611611|P4|COMPLETED|Consolidation||0
253610|NCT00492856|611612|P3|COMPLETED|Consolidation||0
253611|NCT00492856|611613|P2|COMPLETED|Consolidation||0
253612|NCT00492856|611614|P1|COMPLETED|Consolidation||83
253613|NCT00492856|611611|P4|STARTED|Consolidation||0
253614|NCT00492856|611612|P3|STARTED|Consolidation||0
253615|NCT00492856|611613|P2|STARTED|Consolidation||0
253616|NCT00492856|611614|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
253618|NCT00492856|611612|P3|NOT COMPLETED|Induction||0
253619|NCT00492856|611613|P2|NOT COMPLETED|Induction||0
253620|NCT00492856|611614|P1|NOT COMPLETED|Induction||6
253621|NCT00492856|611611|P4|COMPLETED|Induction||0
253622|NCT00492856|611612|P3|COMPLETED|Induction||0
253623|NCT00492856|611613|P2|COMPLETED|Induction||0
253624|NCT00492856|611614|P1|COMPLETED|Induction||99
253625|NCT00492856|611611|P4|STARTED|Induction||0
253626|NCT00492856|611612|P3|STARTED|Induction||0
253627|NCT00492856|611613|P2|STARTED|Induction||0
253628|NCT00492856|611614|P1|STARTED|Induction||105
253629|NCT00492752|611628|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
253630|NCT00492752|611629|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
253631|NCT00492752|611630|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
253632|NCT00492752|611631|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
253633|NCT00492752|611628|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
253634|NCT00492752|611629|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
253635|NCT00492752|611630|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
253636|NCT00492752|611631|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
253637|NCT00492752|611628|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
253638|NCT00492752|611629|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
253639|NCT00492752|611630|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
253640|NCT00492752|611631|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
253641|NCT00492752|611628|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
253642|NCT00492752|611629|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
253643|NCT00492752|611630|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
253644|NCT00492752|611631|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
253645|NCT00492752|611628|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
253646|NCT00492752|611629|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
253647|NCT00492752|611630|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
253648|NCT00492752|611631|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
253649|NCT00492752|611628|P4|NOT COMPLETED|Double Blind Treatment||0
253650|NCT00492752|611629|P3|NOT COMPLETED|Double Blind Treatment||3
253651|NCT00492752|611630|P2|NOT COMPLETED|Double Blind Treatment||0
253652|NCT00492752|611631|P1|NOT COMPLETED|Double Blind Treatment||14
253653|NCT00492752|611628|P4|COMPLETED|Double Blind Treatment||6
253654|NCT00492752|611629|P3|COMPLETED|Double Blind Treatment||67
253655|NCT00492752|611630|P2|COMPLETED|Double Blind Treatment||16
253656|NCT00492752|611631|P1|COMPLETED|Double Blind Treatment||120
253657|NCT00492752|611628|P4|Received Treatment|Double Blind Treatment|Safety Population|6
253658|NCT00492752|611629|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
253659|NCT00492752|611630|P2|Received Treatment|Double Blind Treatment|Safety Population|16
253660|NCT00492752|611631|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
253661|NCT00492752|611628|P4|STARTED|Double Blind Treatment||6
253662|NCT00492752|611629|P3|STARTED|Double Blind Treatment||70
253663|NCT00492752|611630|P2|STARTED|Double Blind Treatment||16
253664|NCT00492752|611631|P1|STARTED|Double Blind Treatment||134
253665|NCT00492726|611666|P2|NOT COMPLETED|Overall Study||36
253666|NCT00492726|611667|P1|NOT COMPLETED|Overall Study||50
253667|NCT00492726|611666|P2|COMPLETED|Overall Study||358
253668|NCT00492726|611667|P1|COMPLETED|Overall Study||360
253669|NCT00492726|611666|P2|End of Study|Overall Study||358
253670|NCT00492726|611667|P1|End of Study|Overall Study||360
253671|NCT00492726|611666|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
253672|NCT00492726|611667|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
253673|NCT00492726|611666|P2|STARTED|Overall Study||394
253674|NCT00492726|611667|P1|STARTED|Overall Study||410
253675|NCT00492622|611691|P1|NOT COMPLETED|Overall Study||0
253676|NCT00492622|611691|P1|COMPLETED|Overall Study||12
253677|NCT00492622|611691|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
253678|NCT00492583|611703|P2|NOT COMPLETED|Overall Study||0
253679|NCT00492583|611704|P1|NOT COMPLETED|Overall Study||0
253680|NCT00492583|611703|P2|COMPLETED|Overall Study||87
253681|NCT00492583|611704|P1|COMPLETED|Overall Study||95
253682|NCT00492583|611703|P2|STARTED|Overall Study||87
253683|NCT00492583|611704|P1|STARTED|Overall Study||95
253684|NCT00492557|611712|P2|NOT COMPLETED|Overall Study||23
253685|NCT00492557|611713|P1|NOT COMPLETED|Overall Study||24
253686|NCT00492557|611712|P2|COMPLETED|Overall Study||557
253687|NCT00492557|611713|P1|COMPLETED|Overall Study||556
253688|NCT00492557|611712|P2|Vaccinated Dose 2|Overall Study||558
253689|NCT00492557|611713|P1|Vaccinated Dose 2|Overall Study||560
253690|NCT00492557|611712|P2|Vaccinated Dose 1|Overall Study||575
253691|NCT00492557|611713|P1|Vaccinated Dose 1|Overall Study||577
253692|NCT00492557|611712|P2|STARTED|Overall Study||580
253693|NCT00492557|611713|P1|STARTED|Overall Study||580
253694|NCT00492544|611729|P1|NOT COMPLETED|Overall Study||0
253695|NCT00492544|611729|P1|COMPLETED|Overall Study||100
253696|NCT00492544|611729|P1|STARTED|Overall Study||100
253697|NCT00492531|611743|P2|NOT COMPLETED|Overall Study||23
253698|NCT00492531|611744|P1|NOT COMPLETED|Overall Study||22
253699|NCT00492531|611743|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
253700|NCT00492531|611744|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
253701|NCT00492531|611743|P2|STARTED|Overall Study||37
253702|NCT00492531|611744|P1|STARTED|Overall Study||37
253703|NCT00492401|611756|P1|NOT COMPLETED|Overall Study||0
253704|NCT00492401|611756|P1|COMPLETED|Overall Study||55
253705|NCT00492401|611756|P1|STARTED|Overall Study||55
253706|NCT00492349|611767|P2|NOT COMPLETED|Overall Study||7
253707|NCT00492349|611768|P1|NOT COMPLETED|Overall Study||3
253708|NCT00492349|611767|P2|COMPLETED|Overall Study||27
253709|NCT00492349|611768|P1|COMPLETED|Overall Study||32
253710|NCT00492349|611767|P2|Week 8|Overall Study||27
253711|NCT00492349|611768|P1|Week 8|Overall Study||32
253712|NCT00492349|611767|P2|Week 2|Overall Study||33
253713|NCT00492349|611768|P1|Week 2|Overall Study||32
253714|NCT00492349|611767|P2|STARTED|Overall Study||34
253715|NCT00492349|611768|P1|STARTED|Overall Study||35
253716|NCT00492336|611790|P2|NOT COMPLETED|Overall Study||6
253717|NCT00492336|611791|P1|NOT COMPLETED|Overall Study||2
253718|NCT00492336|611790|P2|COMPLETED|Overall Study||23
253719|NCT00492336|611791|P1|COMPLETED|Overall Study||26
253720|NCT00492336|611790|P2|STARTED|Overall Study||29
253721|NCT00492336|611791|P1|STARTED|Overall Study||28
253722|NCT00492297|611817|P1|NOT COMPLETED|Survival Only Follow-up||59
253723|NCT00492297|611817|P1|COMPLETED|Survival Only Follow-up||0
253724|NCT00492297|611817|P1|STARTED|Survival Only Follow-up||59
253725|NCT00492297|611817|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
253726|NCT00492297|611817|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
253727|NCT00492297|611817|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
253728|NCT00492297|611817|P1|NOT COMPLETED|Treatment||5
253729|NCT00492297|611817|P1|COMPLETED|Treatment||78
253730|NCT00492297|611817|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
253731|NCT00492297|611817|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
253732|NCT00492297|611817|P1|STARTED|Treatment||83
253733|NCT00492284|611835|P4|NOT COMPLETED|Overall Study||10
253734|NCT00492284|611836|P3|NOT COMPLETED|Overall Study||6
253735|NCT00492284|611837|P2|NOT COMPLETED|Overall Study||4
253736|NCT00492284|611838|P1|NOT COMPLETED|Overall Study||1
253737|NCT00492284|611835|P4|COMPLETED|Overall Study||31
253738|NCT00492284|611836|P3|COMPLETED|Overall Study||37
253739|NCT00492284|611837|P2|COMPLETED|Overall Study||35
253740|NCT00492284|611838|P1|COMPLETED|Overall Study||38
253741|NCT00492284|611835|P4|STARTED|Overall Study||41
253742|NCT00492284|611836|P3|STARTED|Overall Study||43
253743|NCT00492284|611837|P2|STARTED|Overall Study||39
253744|NCT00492284|611838|P1|STARTED|Overall Study||39
253745|NCT00492232|611882|P2|NOT COMPLETED|Open-Label Treatment||0
253746|NCT00492232|611883|P1|NOT COMPLETED|Open-Label Treatment||1
253747|NCT00492232|611882|P2|COMPLETED|Open-Label Treatment||0
253748|NCT00492232|611883|P1|COMPLETED|Open-Label Treatment||88
253749|NCT00492232|611882|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
253750|NCT00492232|611883|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
253751|NCT00492232|611882|P2|NOT COMPLETED|Double-Blind Treatment||25
253752|NCT00492232|611883|P1|NOT COMPLETED|Double-Blind Treatment||18
253753|NCT00492232|611882|P2|COMPLETED|Double-Blind Treatment||45
253754|NCT00492232|611883|P1|COMPLETED|Double-Blind Treatment||47
253755|NCT00492232|611882|P2|STARTED|Double-Blind Treatment||70
253756|NCT00492232|611883|P1|STARTED|Double-Blind Treatment||65
253757|NCT00492232|611882|P2|NOT COMPLETED|Placebo Run-in||70
253758|NCT00492232|611883|P1|NOT COMPLETED|Placebo Run-in||0
253759|NCT00492232|611882|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
253760|NCT00492232|611883|P1|COMPLETED|Placebo Run-in||0
253761|NCT00492232|611882|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
253762|NCT00492232|611883|P1|STARTED|Placebo Run-in||0
253763|NCT00492206|611915|P1|NOT COMPLETED|Overall Study||0
253764|NCT00492206|611915|P1|COMPLETED|Overall Study||40
253765|NCT00492206|611915|P1|STARTED|Overall Study||40
253766|NCT00492089|611924|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
253767|NCT00492089|611925|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
253768|NCT00492089|611924|P2|COMPLETED|Second Intervention (6 Weeks)||6
253769|NCT00492089|611925|P1|COMPLETED|Second Intervention (6 Weeks)||5
253770|NCT00492089|611924|P2|STARTED|Second Intervention (6 Weeks)||6
253771|NCT00492089|611925|P1|STARTED|Second Intervention (6 Weeks)||5
253772|NCT00492089|611924|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
253773|NCT00492089|611925|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
253774|NCT00492089|611924|P2|COMPLETED|First Intervention (6 Weeks)||6
253775|NCT00492089|611925|P1|COMPLETED|First Intervention (6 Weeks)||5
253776|NCT00492089|611924|P2|STARTED|First Intervention (6 Weeks)||6
253777|NCT00492089|611925|P1|STARTED|First Intervention (6 Weeks)||5
253778|NCT00492063|611935|P4|NOT COMPLETED|Overall Study||10
253779|NCT00492063|611936|P3|NOT COMPLETED|Overall Study||11
253780|NCT00492063|611937|P2|NOT COMPLETED|Overall Study||14
253781|NCT00492063|611938|P1|NOT COMPLETED|Overall Study||10
253782|NCT00492063|611935|P4|COMPLETED|Overall Study||666
253783|NCT00492063|611936|P3|COMPLETED|Overall Study||667
253784|NCT00492063|611937|P2|COMPLETED|Overall Study||634
253785|NCT00492063|611938|P1|COMPLETED|Overall Study||642
253786|NCT00492063|611935|P4|STARTED|Overall Study||676
253787|NCT00492063|611936|P3|STARTED|Overall Study||678
253788|NCT00492063|611937|P2|STARTED|Overall Study||648
253789|NCT00492063|611938|P1|STARTED|Overall Study||652
253790|NCT00492024|611962|P2|NOT COMPLETED|Follow up||2
253791|NCT00492024|611963|P1|NOT COMPLETED|Follow up||1
253792|NCT00492024|611962|P2|COMPLETED|Follow up||99
253793|NCT00492024|611963|P1|COMPLETED|Follow up||221
253794|NCT00492024|611962|P2|STARTED|Follow up||101
253795|NCT00492024|611963|P1|STARTED|Follow up||222
253796|NCT00492024|611962|P2|NOT COMPLETED|Treatment||22
253797|NCT00492024|611963|P1|NOT COMPLETED|Treatment||29
253798|NCT00492024|611962|P2|COMPLETED|Treatment||101
253799|NCT00492024|611963|P1|COMPLETED|Treatment||222
253800|NCT00492024|611962|P2|STARTED|Treatment||123
253801|NCT00492024|611963|P1|STARTED|Treatment||251
253802|NCT00491894|611979|P1|NOT COMPLETED|Overall Study||34
253803|NCT00491894|611979|P1|COMPLETED|Overall Study||103
253804|NCT00491894|611979|P1|STARTED|Overall Study||137
253805|NCT00491829|611990|P3|NOT COMPLETED|Overall Study||75
253806|NCT00491829|611991|P2|NOT COMPLETED|Overall Study||114
253807|NCT00491829|611992|P1|NOT COMPLETED|Overall Study||95
253808|NCT00491829|611990|P3|COMPLETED|Overall Study||243
253809|NCT00491829|611991|P2|COMPLETED|Overall Study||202
253810|NCT00491829|611992|P1|COMPLETED|Overall Study||216
253811|NCT00491829|611990|P3|STARTED|Overall Study||318
253812|NCT00491829|611991|P2|STARTED|Overall Study||316
253813|NCT00491829|611992|P1|STARTED|Overall Study||311
253814|NCT00491764|612006|P6|NOT COMPLETED|Overall Study||9
253815|NCT00491764|612007|P5|NOT COMPLETED|Overall Study||3
253816|NCT00491764|612008|P4|NOT COMPLETED|Overall Study||8
253817|NCT00491764|612009|P3|NOT COMPLETED|Overall Study||8
253818|NCT00491764|612010|P2|NOT COMPLETED|Overall Study||7
253819|NCT00491764|612011|P1|NOT COMPLETED|Overall Study||5
253820|NCT00491764|612006|P6|COMPLETED|Overall Study||27
253821|NCT00491764|612007|P5|COMPLETED|Overall Study||33
253822|NCT00491764|612008|P4|COMPLETED|Overall Study||28
253823|NCT00491764|612009|P3|COMPLETED|Overall Study||28
253824|NCT00491764|612010|P2|COMPLETED|Overall Study||30
253825|NCT00491764|612011|P1|COMPLETED|Overall Study||32
253826|NCT00491764|612006|P6|STARTED|Overall Study||36
253827|NCT00491764|612007|P5|STARTED|Overall Study||36
253828|NCT00491764|612008|P4|STARTED|Overall Study||36
253829|NCT00491764|612009|P3|STARTED|Overall Study||36
253830|NCT00491764|612010|P2|STARTED|Overall Study||37
253831|NCT00491764|612011|P1|STARTED|Overall Study||37
253832|NCT00491738|612039|P2|NOT COMPLETED|Overall Study||0
253833|NCT00491738|612040|P1|NOT COMPLETED|Overall Study||0
253834|NCT00491738|612039|P2|COMPLETED|Overall Study||9
253835|NCT00491738|612040|P1|COMPLETED|Overall Study||7
253836|NCT00491738|612039|P2|STARTED|Overall Study||9
253837|NCT00491738|612040|P1|STARTED|Overall Study||7
253838|NCT00491608|612044|P1|NOT COMPLETED|Overall Study||3
253839|NCT00491608|612044|P1|COMPLETED|Overall Study||206
253840|NCT00491608|612044|P1|STARTED|Overall Study|Participants who received treatment|209
253841|NCT00491556|612055|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
253842|NCT00491556|612056|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
253843|NCT00491556|612055|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
253844|NCT00491556|612056|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
253845|NCT00491556|612055|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
253846|NCT00491556|612056|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
253847|NCT00491556|612055|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
253848|NCT00491556|612056|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
253849|NCT00491556|612055|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
253850|NCT00491556|612056|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
253851|NCT00491556|612055|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
253852|NCT00491556|612056|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
253853|NCT00491556|612055|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
253854|NCT00491556|612056|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
253855|NCT00491530|612115|P3|NOT COMPLETED|Overall Study||5
253856|NCT00491530|612116|P2|NOT COMPLETED|Overall Study||6
253857|NCT00491530|612117|P1|NOT COMPLETED|Overall Study||12
253858|NCT00491530|612115|P3|COMPLETED|Overall Study||81
253859|NCT00491530|612116|P2|COMPLETED|Overall Study||44
253860|NCT00491530|612117|P1|COMPLETED|Overall Study||162
253861|NCT00491530|612115|P3|STARTED|Overall Study||86
253862|NCT00491530|612116|P2|STARTED|Overall Study||50
253863|NCT00491530|612117|P1|STARTED|Overall Study||174
253864|NCT00491504|612147|P4|NOT COMPLETED|Overall Study||4
253865|NCT00491504|612148|P3|NOT COMPLETED|Overall Study||4
253866|NCT00491504|612149|P2|NOT COMPLETED|Overall Study||1
253867|NCT00491504|612150|P1|NOT COMPLETED|Overall Study||0
253868|NCT00491504|612147|P4|COMPLETED|Overall Study||73
253869|NCT00491504|612148|P3|COMPLETED|Overall Study||74
253870|NCT00491504|612149|P2|COMPLETED|Overall Study||77
253871|NCT00491504|612150|P1|COMPLETED|Overall Study||77
253872|NCT00491504|612147|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
253873|NCT00491504|612148|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
253874|NCT00491504|612149|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
253875|NCT00491504|612150|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
253876|NCT00491400|612160|P2|NOT COMPLETED|Overall Study||4
253877|NCT00491400|612161|P1|NOT COMPLETED|Overall Study||5
253878|NCT00491400|612160|P2|COMPLETED|Overall Study||9
253879|NCT00491400|612161|P1|COMPLETED|Overall Study||10
253880|NCT00491400|612160|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
253881|NCT00491400|612161|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
253882|NCT00491400|612160|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
253883|NCT00491400|612161|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
253884|NCT00491400|612160|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
253885|NCT00491400|612161|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
253886|NCT00491400|612160|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
253887|NCT00491400|612161|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
253888|NCT00491400|612160|P2|STARTED|Overall Study||13
253889|NCT00491400|612161|P1|STARTED|Overall Study||15
253890|NCT00491387|612169|P1|NOT COMPLETED|Overall Study||20
253891|NCT00491387|612169|P1|COMPLETED|Overall Study||4
253892|NCT00491387|612169|P1|Study Enrollment|Overall Study||24
253893|NCT00491387|612169|P1|STARTED|Overall Study||24
253894|NCT00491374|612175|P2|NOT COMPLETED|Overall Study||0
253895|NCT00491374|612176|P1|NOT COMPLETED|Overall Study||0
253896|NCT00491374|612175|P2|COMPLETED|Overall Study||0
253897|NCT00491374|612176|P1|COMPLETED|Overall Study||0
253898|NCT00491374|612175|P2|STARTED|Overall Study||0
253899|NCT00491374|612176|P1|STARTED|Overall Study||0
253900|NCT00491322|612184|P2|NOT COMPLETED|Overall Study||1
253901|NCT00491322|612185|P1|NOT COMPLETED|Overall Study||1
253902|NCT00491322|612184|P2|COMPLETED|Overall Study||50
253903|NCT00491322|612185|P1|COMPLETED|Overall Study||40
253904|NCT00491322|612184|P2|STARTED|Overall Study||51
253905|NCT00491322|612185|P1|STARTED|Overall Study||41
253906|NCT00491244|612193|P2|NOT COMPLETED|Overall Study||20
253907|NCT00491244|612194|P1|NOT COMPLETED|Overall Study||27
253908|NCT00491244|612193|P2|COMPLETED|Overall Study||168
253909|NCT00491244|612194|P1|COMPLETED|Overall Study||162
253910|NCT00491244|612193|P2|STARTED|Overall Study||188
253911|NCT00491244|612194|P1|STARTED|Overall Study||189
253912|NCT00491179|612204|P2|NOT COMPLETED|Overall Study||2
253913|NCT00491179|612205|P1|NOT COMPLETED|Overall Study||7
253914|NCT00491179|612204|P2|COMPLETED|Overall Study||8
253915|NCT00491179|612205|P1|COMPLETED|Overall Study||18
253916|NCT00491179|612204|P2|STARTED|Overall Study||10
253917|NCT00491179|612205|P1|STARTED|Overall Study||25
253918|NCT00491075|612213|P1|NOT COMPLETED|Overall Study||2
253919|NCT00491075|612213|P1|COMPLETED|Overall Study||14
253920|NCT00491075|612213|P1|STARTED|Overall Study||16
253921|NCT00490971|612219|P5|NOT COMPLETED|Maintenance||39
253922|NCT00490971|612220|P4|NOT COMPLETED|Maintenance||53
253923|NCT00490971|612221|P3|NOT COMPLETED|Maintenance||51
253924|NCT00490971|612222|P2|NOT COMPLETED|Maintenance||0
253925|NCT00490971|612223|P1|NOT COMPLETED|Maintenance||0
253926|NCT00490971|612219|P5|COMPLETED|Maintenance||44
253927|NCT00490971|612220|P4|COMPLETED|Maintenance||96
253928|NCT00490971|612221|P3|COMPLETED|Maintenance||96
253929|NCT00490971|612222|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
253930|NCT00490971|612223|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
253931|NCT00490971|612219|P5|STARTED|Maintenance||83
253932|NCT00490971|612220|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
253933|NCT00490971|612221|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
253934|NCT00490971|612222|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
253935|NCT00490971|612223|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
253936|NCT00490971|612219|P5|NOT COMPLETED|Acute/Continuation||0
253937|NCT00490971|612220|P4|NOT COMPLETED|Acute/Continuation||0
253938|NCT00490971|612221|P3|NOT COMPLETED|Acute/Continuation||0
253939|NCT00490971|612222|P2|NOT COMPLETED|Acute/Continuation||62
253940|NCT00490971|612223|P1|NOT COMPLETED|Acute/Continuation||306
253941|NCT00490971|612219|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
253942|NCT00490971|612220|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
253943|NCT00490971|612221|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
253944|NCT00490971|612222|P2|COMPLETED|Acute/Continuation||86
253945|NCT00490971|612223|P1|COMPLETED|Acute/Continuation||308
253946|NCT00490971|612219|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
253947|NCT00490971|612220|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
253948|NCT00490971|612221|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
253949|NCT00490971|612222|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
254039|NCT00490555|612492|P4|STARTED|Overall Study||7
253950|NCT00490971|612223|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
253951|NCT00490945|612270|P5|NOT COMPLETED|Overall Study||0
253952|NCT00490945|612271|P4|NOT COMPLETED|Overall Study||0
253953|NCT00490945|612272|P3|NOT COMPLETED|Overall Study||0
253954|NCT00490945|612273|P2|NOT COMPLETED|Overall Study||1
253955|NCT00490945|612274|P1|NOT COMPLETED|Overall Study||0
253956|NCT00490945|612270|P5|COMPLETED|Overall Study||7
253957|NCT00490945|612271|P4|COMPLETED|Overall Study||7
253958|NCT00490945|612272|P3|COMPLETED|Overall Study||8
253959|NCT00490945|612273|P2|COMPLETED|Overall Study||8
253960|NCT00490945|612274|P1|COMPLETED|Overall Study||8
253961|NCT00490945|612270|P5|STARTED|Overall Study||7
253962|NCT00490945|612271|P4|STARTED|Overall Study||7
253963|NCT00490945|612272|P3|STARTED|Overall Study||8
253964|NCT00490945|612273|P2|STARTED|Overall Study||9
253965|NCT00490945|612274|P1|STARTED|Overall Study||8
253966|NCT00490919|612310|P3|NOT COMPLETED|Double-blind Phase||84
253967|NCT00490919|612311|P2|NOT COMPLETED|Double-blind Phase||86
253968|NCT00490919|612312|P1|NOT COMPLETED|Double-blind Phase||0
253969|NCT00490919|612310|P3|COMPLETED|Double-blind Phase||199
253970|NCT00490919|612311|P2|COMPLETED|Double-blind Phase||170
253971|NCT00490919|612312|P1|COMPLETED|Double-blind Phase||0
253972|NCT00490919|612310|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
253973|NCT00490919|612311|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
253974|NCT00490919|612312|P1|STARTED|Double-blind Phase||0
253975|NCT00490919|612310|P3|NOT COMPLETED|Open-label Run-in Period||0
253976|NCT00490919|612311|P2|NOT COMPLETED|Open-label Run-in Period||0
253977|NCT00490919|612312|P1|NOT COMPLETED|Open-label Run-in Period||483
253978|NCT00490919|612310|P3|COMPLETED|Open-label Run-in Period||0
253979|NCT00490919|612311|P2|COMPLETED|Open-label Run-in Period||0
253980|NCT00490919|612312|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
253981|NCT00490919|612310|P3|STARTED|Open-label Run-in Period||0
253982|NCT00490919|612311|P2|STARTED|Open-label Run-in Period||0
253983|NCT00490919|612312|P1|STARTED|Open-label Run-in Period||1024
253984|NCT00490841|612323|P1|NOT COMPLETED|Overall Study||13
253985|NCT00490841|612323|P1|COMPLETED|Overall Study||189
253986|NCT00490841|612323|P1|STARTED|Overall Study||202
253987|NCT00490815|612345|P2|NOT COMPLETED|Overall Study||9
253988|NCT00490815|612346|P1|NOT COMPLETED|Overall Study||8
253989|NCT00490815|612345|P2|COMPLETED|Overall Study||8
253990|NCT00490815|612346|P1|COMPLETED|Overall Study||12
253991|NCT00490815|612345|P2|STARTED|Overall Study||17
253992|NCT00490815|612346|P1|STARTED|Overall Study||20
253993|NCT00490802|612356|P2|NOT COMPLETED|Overall Study||2
253994|NCT00490802|612357|P1|NOT COMPLETED|Overall Study||1
253995|NCT00490802|612356|P2|COMPLETED|Overall Study||7
253996|NCT00490802|612357|P1|COMPLETED|Overall Study||9
253997|NCT00490802|612356|P2|STARTED|Overall Study||9
253998|NCT00490802|612357|P1|STARTED|Overall Study||10
253999|NCT00490724|612374|P3|NOT COMPLETED|Period II||3
254000|NCT00490724|612375|P2|NOT COMPLETED|Period II||1
254001|NCT00490724|612376|P1|NOT COMPLETED|Period II||3
254002|NCT00490724|612374|P3|COMPLETED|Period II||16
254003|NCT00490724|612375|P2|COMPLETED|Period II||19
254004|NCT00490724|612376|P1|COMPLETED|Period II||18
254005|NCT00490724|612374|P3|STARTED|Period II||19
254006|NCT00490724|612375|P2|STARTED|Period II||20
254007|NCT00490724|612376|P1|STARTED|Period II||21
254008|NCT00490724|612374|P3|NOT COMPLETED|Period I||1
254009|NCT00490724|612375|P2|NOT COMPLETED|Period I||0
254010|NCT00490724|612376|P1|NOT COMPLETED|Period I||0
254011|NCT00490724|612374|P3|COMPLETED|Period I||19
254012|NCT00490724|612375|P2|COMPLETED|Period I||20
254013|NCT00490724|612376|P1|COMPLETED|Period I||21
254014|NCT00490724|612374|P3|STARTED|Period I||20
254015|NCT00490724|612375|P2|STARTED|Period I||20
254016|NCT00490724|612376|P1|STARTED|Period I||21
254017|NCT00490698|612441|P1|NOT COMPLETED|Overall Study||10
254018|NCT00490698|612441|P1|COMPLETED|Overall Study||1
254019|NCT00490698|612441|P1|STARTED|Overall Study||11
254020|NCT00490646|612447|P2|NOT COMPLETED|Overall Study||2
254021|NCT00490646|612448|P1|NOT COMPLETED|Overall Study||2
254022|NCT00490646|612447|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
254023|NCT00490646|612448|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
254024|NCT00490646|612447|P2|Treated|Overall Study||24
254025|NCT00490646|612448|P1|Treated|Overall Study||24
254026|NCT00490646|612447|P2|STARTED|Overall Study||25
254027|NCT00490646|612448|P1|STARTED|Overall Study||25
254028|NCT00490568|612468|P1|NOT COMPLETED|Overall Study||1364
254029|NCT00490568|612468|P1|COMPLETED|Overall Study||97
254030|NCT00490568|612468|P1|STARTED|Overall Study||1461
254031|NCT00490555|612492|P4|NOT COMPLETED|Overall Study||0
254032|NCT00490555|612493|P3|NOT COMPLETED|Overall Study||2
254033|NCT00490555|612494|P2|NOT COMPLETED|Overall Study||0
254034|NCT00490555|612495|P1|NOT COMPLETED|Overall Study||0
254035|NCT00490555|612492|P4|COMPLETED|Overall Study||7
254036|NCT00490555|612493|P3|COMPLETED|Overall Study||7
254037|NCT00490555|612494|P2|COMPLETED|Overall Study||8
254038|NCT00490555|612495|P1|COMPLETED|Overall Study||8
254040|NCT00490555|612493|P3|STARTED|Overall Study||9
254041|NCT00490555|612494|P2|STARTED|Overall Study||8
254042|NCT00490555|612495|P1|STARTED|Overall Study||8
254043|NCT00490542|612523|P2|NOT COMPLETED|Overall Study||4
254044|NCT00490542|612524|P1|NOT COMPLETED|Overall Study||7
254045|NCT00490542|612523|P2|COMPLETED|Overall Study||31
254046|NCT00490542|612524|P1|COMPLETED|Overall Study||31
254047|NCT00490542|612523|P2|STARTED|Overall Study||35
254048|NCT00490542|612524|P1|STARTED|Overall Study||38
254049|NCT00490490|612530|P1|NOT COMPLETED|Completed Assessment for TTP||3
254050|NCT00490490|612530|P1|COMPLETED|Completed Assessment for TTP||5
254051|NCT00490490|612530|P1|STARTED|Completed Assessment for TTP||8
254052|NCT00490490|612530|P1|NOT COMPLETED|Completed Assessment for CR||0
254053|NCT00490490|612530|P1|COMPLETED|Completed Assessment for CR||8
254054|NCT00490490|612530|P1|STARTED|Completed Assessment for CR||8
254055|NCT00490477|612538|P2|NOT COMPLETED|Overall Study||0
254056|NCT00490477|612539|P1|NOT COMPLETED|Overall Study||0
254057|NCT00490477|612538|P2|COMPLETED|Overall Study||8
254058|NCT00490477|612539|P1|COMPLETED|Overall Study||8
254059|NCT00490477|612538|P2|STARTED|Overall Study||8
254060|NCT00490477|612539|P1|STARTED|Overall Study||8
254061|NCT00490451|612547|P2|NOT COMPLETED|Overall Study||38
254062|NCT00490451|612548|P1|NOT COMPLETED|Overall Study||63
254063|NCT00490451|612547|P2|COMPLETED|Overall Study||0
254064|NCT00490451|612548|P1|COMPLETED|Overall Study||0
254065|NCT00490451|612547|P2|STARTED|Overall Study||38
254066|NCT00490451|612548|P1|STARTED|Overall Study||63
254067|NCT00490269|612570|P2|NOT COMPLETED|Placebo Then Dronabinol||0
254068|NCT00490269|612571|P1|NOT COMPLETED|Placebo Then Dronabinol||0
254069|NCT00490269|612570|P2|COMPLETED|Placebo Then Dronabinol||6
254070|NCT00490269|612571|P1|COMPLETED|Placebo Then Dronabinol||6
254071|NCT00490269|612570|P2|STARTED|Placebo Then Dronabinol||6
254072|NCT00490269|612571|P1|STARTED|Placebo Then Dronabinol||6
254073|NCT00490269|612570|P2|NOT COMPLETED|Dronabinol Then Placebo||0
254074|NCT00490269|612571|P1|NOT COMPLETED|Dronabinol Then Placebo||0
254075|NCT00490269|612570|P2|COMPLETED|Dronabinol Then Placebo||6
254076|NCT00490269|612571|P1|COMPLETED|Dronabinol Then Placebo||6
254077|NCT00490269|612570|P2|STARTED|Dronabinol Then Placebo||6
254078|NCT00490269|612571|P1|STARTED|Dronabinol Then Placebo||6
254079|NCT00490256|612579|P2|NOT COMPLETED|Overall Study||0
254080|NCT00490256|612580|P1|NOT COMPLETED|Overall Study||0
254081|NCT00490256|612579|P2|COMPLETED|Overall Study||7
254082|NCT00490256|612580|P1|COMPLETED|Overall Study||7
254083|NCT00490256|612579|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
254084|NCT00490256|612580|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
254085|NCT00490256|612579|P2|STARTED|Overall Study||7
254086|NCT00490256|612580|P1|STARTED|Overall Study||7
254087|NCT00490139|612590|P4|NOT COMPLETED|Overall Study||307
254088|NCT00490139|612591|P3|NOT COMPLETED|Overall Study||434
254089|NCT00490139|612592|P2|NOT COMPLETED|Overall Study||275
254090|NCT00490139|612593|P1|NOT COMPLETED|Overall Study||308
254091|NCT00490139|612590|P4|COMPLETED|Overall Study||1790
254092|NCT00490139|612591|P3|COMPLETED|Overall Study||1666
254093|NCT00490139|612592|P2|COMPLETED|Overall Study||1816
254094|NCT00490139|612593|P1|COMPLETED|Overall Study||1785
254095|NCT00490139|612590|P4|STARTED|Overall Study||2097
254096|NCT00490139|612591|P3|STARTED|Overall Study||2100
254097|NCT00490139|612592|P2|STARTED|Overall Study||2091
254098|NCT00490139|612593|P1|STARTED|Overall Study||2093
254099|NCT00490100|612623|P1|NOT COMPLETED|Overall Study||3
254100|NCT00490100|612623|P1|COMPLETED|Overall Study||3
254101|NCT00490100|612623|P1|STARTED|Overall Study||6
254102|NCT00490061|612628|P1|NOT COMPLETED|Overall Study||1
254103|NCT00490061|612628|P1|COMPLETED|Overall Study||16
254104|NCT00490061|612628|P1|STARTED|Overall Study||17
254105|NCT00490035|612637|P4|NOT COMPLETED|Overall Study||6
254106|NCT00490035|612638|P3|NOT COMPLETED|Overall Study||12
254107|NCT00490035|612639|P2|NOT COMPLETED|Overall Study||6
254108|NCT00490035|612640|P1|NOT COMPLETED|Overall Study||8
254109|NCT00490035|612637|P4|COMPLETED|Overall Study||94
254110|NCT00490035|612638|P3|COMPLETED|Overall Study||88
254111|NCT00490035|612639|P2|COMPLETED|Overall Study||93
254112|NCT00490035|612640|P1|COMPLETED|Overall Study||92
254113|NCT00490035|612637|P4|STARTED|Overall Study||100
254114|NCT00490035|612638|P3|STARTED|Overall Study||100
254115|NCT00490035|612639|P2|STARTED|Overall Study||99
254116|NCT00490035|612640|P1|STARTED|Overall Study||100
254117|NCT00490022|612740|P2|NOT COMPLETED|Overall Study||3
254118|NCT00490022|612741|P1|NOT COMPLETED|Overall Study||1
254119|NCT00490022|612740|P2|COMPLETED|Overall Study||12
254120|NCT00490022|612741|P1|COMPLETED|Overall Study||15
254121|NCT00490022|612740|P2|STARTED|Overall Study||15
254122|NCT00490022|612741|P1|STARTED|Overall Study||16
254123|NCT00490009|612749|P1|NOT COMPLETED|Overall Study||0
254124|NCT00490009|612749|P1|COMPLETED|Overall Study||9
254125|NCT00490009|612749|P1|STARTED|Overall Study||9
254126|NCT00489970|612757|P2|NOT COMPLETED|Persistence Year 5||0
254127|NCT00489970|612758|P1|NOT COMPLETED|Persistence Year 5||0
254128|NCT00489970|612757|P2|COMPLETED|Persistence Year 5||401
254129|NCT00489970|612758|P1|COMPLETED|Persistence Year 5||856
254130|NCT00489970|612757|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
254131|NCT00489970|612758|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
254132|NCT00489970|612757|P2|NOT COMPLETED|Persistence Year 3||0
254133|NCT00489970|612758|P1|NOT COMPLETED|Persistence Year 3||0
254134|NCT00489970|612757|P2|COMPLETED|Persistence Year 3||486
254135|NCT00489970|612758|P1|COMPLETED|Persistence Year 3||1019
254136|NCT00489970|612757|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
254137|NCT00489970|612758|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
254138|NCT00489970|612757|P2|NOT COMPLETED|Persistence Year 1||0
254139|NCT00489970|612758|P1|NOT COMPLETED|Persistence Year 1||0
254140|NCT00489970|612757|P2|COMPLETED|Persistence Year 1||523
254141|NCT00489970|612758|P1|COMPLETED|Persistence Year 1||1069
254142|NCT00489970|612757|P2|STARTED|Persistence Year 1||523
254143|NCT00489970|612758|P1|STARTED|Persistence Year 1||1069
254144|NCT00489866|612784|P2|NOT COMPLETED|Overall Study||0
254145|NCT00489866|612785|P1|NOT COMPLETED|Overall Study||2
254146|NCT00489866|612784|P2|COMPLETED|Overall Study||7
254147|NCT00489866|612785|P1|COMPLETED|Overall Study||5
254148|NCT00489866|612784|P2|STARTED|Overall Study||7
254149|NCT00489866|612785|P1|STARTED|Overall Study||7
254150|NCT00489853|612799|P3|NOT COMPLETED|Follow-up Period||0
254151|NCT00489853|612800|P2|NOT COMPLETED|Follow-up Period||0
254152|NCT00489853|612801|P1|NOT COMPLETED|Follow-up Period||0
254153|NCT00489853|612799|P3|COMPLETED|Follow-up Period||33
254154|NCT00489853|612800|P2|COMPLETED|Follow-up Period||29
254155|NCT00489853|612801|P1|COMPLETED|Follow-up Period||29
254156|NCT00489853|612799|P3|STARTED|Follow-up Period||33
254157|NCT00489853|612800|P2|STARTED|Follow-up Period||29
254158|NCT00489853|612801|P1|STARTED|Follow-up Period||29
254159|NCT00489853|612799|P3|NOT COMPLETED|Treatment Period 3||0
254160|NCT00489853|612800|P2|NOT COMPLETED|Treatment Period 3||1
254161|NCT00489853|612801|P1|NOT COMPLETED|Treatment Period 3||0
254162|NCT00489853|612799|P3|COMPLETED|Treatment Period 3||33
254163|NCT00489853|612800|P2|COMPLETED|Treatment Period 3||29
254164|NCT00489853|612801|P1|COMPLETED|Treatment Period 3||29
254165|NCT00489853|612799|P3|STARTED|Treatment Period 3||33
254166|NCT00489853|612800|P2|STARTED|Treatment Period 3||30
254167|NCT00489853|612801|P1|STARTED|Treatment Period 3||29
254168|NCT00489853|612799|P3|NOT COMPLETED|Wash-out Period 2||2
254169|NCT00489853|612800|P2|NOT COMPLETED|Wash-out Period 2||3
254170|NCT00489853|612801|P1|NOT COMPLETED|Wash-out Period 2||4
254171|NCT00489853|612799|P3|COMPLETED|Wash-out Period 2||31
254172|NCT00489853|612800|P2|COMPLETED|Wash-out Period 2||32
254173|NCT00489853|612801|P1|COMPLETED|Wash-out Period 2||29
254174|NCT00489853|612799|P3|STARTED|Wash-out Period 2||33
254175|NCT00489853|612800|P2|STARTED|Wash-out Period 2||35
254176|NCT00489853|612801|P1|STARTED|Wash-out Period 2||33
254177|NCT00489853|612799|P3|NOT COMPLETED|Treatment Period 2||0
254178|NCT00489853|612800|P2|NOT COMPLETED|Treatment Period 2||0
254179|NCT00489853|612801|P1|NOT COMPLETED|Treatment Period 2||0
254180|NCT00489853|612799|P3|COMPLETED|Treatment Period 2||33
254181|NCT00489853|612800|P2|COMPLETED|Treatment Period 2||35
254182|NCT00489853|612801|P1|COMPLETED|Treatment Period 2||33
254183|NCT00489853|612799|P3|STARTED|Treatment Period 2||33
254184|NCT00489853|612800|P2|STARTED|Treatment Period 2||35
254185|NCT00489853|612801|P1|STARTED|Treatment Period 2||33
254186|NCT00489853|612799|P3|NOT COMPLETED|Wash-out Period 1||6
254187|NCT00489853|612800|P2|NOT COMPLETED|Wash-out Period 1||3
254188|NCT00489853|612801|P1|NOT COMPLETED|Wash-out Period 1||1
254189|NCT00489853|612799|P3|COMPLETED|Wash-out Period 1||32
254190|NCT00489853|612800|P2|COMPLETED|Wash-out Period 1||34
254191|NCT00489853|612801|P1|COMPLETED|Wash-out Period 1||35
254192|NCT00489853|612799|P3|STARTED|Wash-out Period 1||38
254193|NCT00489853|612800|P2|STARTED|Wash-out Period 1||37
254194|NCT00489853|612801|P1|STARTED|Wash-out Period 1||36
254195|NCT00489853|612799|P3|NOT COMPLETED|Treatment Period 1||0
254196|NCT00489853|612800|P2|NOT COMPLETED|Treatment Period 1||0
254197|NCT00489853|612801|P1|NOT COMPLETED|Treatment Period 1||0
254198|NCT00489853|612799|P3|COMPLETED|Treatment Period 1||38
254199|NCT00489853|612800|P2|COMPLETED|Treatment Period 1||37
254200|NCT00489853|612801|P1|COMPLETED|Treatment Period 1||36
254201|NCT00489853|612799|P3|STARTED|Treatment Period 1||38
254202|NCT00489853|612800|P2|STARTED|Treatment Period 1||37
254203|NCT00489853|612801|P1|STARTED|Treatment Period 1||36
254204|NCT00489736|612898|P2|NOT COMPLETED|Overall Study||69
254205|NCT00489736|612899|P1|NOT COMPLETED|Overall Study||96
254206|NCT00489736|612898|P2|COMPLETED|Overall Study|completed study drug period|186
254207|NCT00489736|612899|P1|COMPLETED|Overall Study|completed study drug period|153
254208|NCT00489736|612898|P2|STARTED|Overall Study|Randomized and treated patients|255
254209|NCT00489736|612899|P1|STARTED|Overall Study|Randomized and treated patients|249
254210|NCT00489554|612909|P1|NOT COMPLETED|Overall Study||4
254211|NCT00489554|612909|P1|COMPLETED|Overall Study||226
254212|NCT00489554|612909|P1|STARTED|Overall Study||230
254213|NCT00489541|612929|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
254214|NCT00489541|612930|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
254215|NCT00489541|612929|P2|COMPLETED|9-Month Angiographic Follow-up||108
254216|NCT00489541|612930|P1|COMPLETED|9-Month Angiographic Follow-up||197
254217|NCT00489541|612929|P2|STARTED|9-Month Angiographic Follow-up||125
254218|NCT00489541|612930|P1|STARTED|9-Month Angiographic Follow-up||224
254219|NCT00489541|612929|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
254220|NCT00489541|612930|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
254221|NCT00489541|612929|P2|COMPLETED|12-Month Clinical Follow-up||120
254222|NCT00489541|612930|P1|COMPLETED|12-Month Clinical Follow-up||215
254223|NCT00489541|612929|P2|STARTED|12-Month Clinical Follow-up||125
254224|NCT00489541|612930|P1|STARTED|12-Month Clinical Follow-up||224
254225|NCT00489489|612941|P3|NOT COMPLETED|Overall Study||3
254226|NCT00489489|612942|P2|NOT COMPLETED|Overall Study||5
254227|NCT00489489|612943|P1|NOT COMPLETED|Overall Study||3
254228|NCT00489489|612941|P3|COMPLETED|Overall Study|completed treatment period|37
254229|NCT00489489|612942|P2|COMPLETED|Overall Study|completed treatment period|32
254230|NCT00489489|612943|P1|COMPLETED|Overall Study|completed treatment period|38
254231|NCT00489489|612941|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
254232|NCT00489489|612942|P2|Treated|Overall Study||36
254233|NCT00489489|612943|P1|Treated|Overall Study||41
254234|NCT00489489|612941|P3|STARTED|Overall Study|randomized|40
254235|NCT00489489|612942|P2|STARTED|Overall Study|randomized|37
254236|NCT00489489|612943|P1|STARTED|Overall Study|randomized|41
254237|NCT00489476|612975|P4|NOT COMPLETED|Overall Study||0
254238|NCT00489476|612976|P3|NOT COMPLETED|Overall Study||0
254239|NCT00489476|612977|P2|NOT COMPLETED|Overall Study||1
254240|NCT00489476|612978|P1|NOT COMPLETED|Overall Study||0
254241|NCT00489476|612975|P4|COMPLETED|Overall Study||43
254242|NCT00489476|612976|P3|COMPLETED|Overall Study||43
254243|NCT00489476|612977|P2|COMPLETED|Overall Study||42
254244|NCT00489476|612978|P1|COMPLETED|Overall Study||39
254245|NCT00489476|612975|P4|STARTED|Overall Study||43
254246|NCT00489476|612976|P3|STARTED|Overall Study||43
254247|NCT00489476|612977|P2|STARTED|Overall Study||43
254248|NCT00489476|612978|P1|STARTED|Overall Study||39
254249|NCT00489424|612999|P3|NOT COMPLETED|Overall Study||5
254250|NCT00489424|613000|P2|NOT COMPLETED|Overall Study||5
254251|NCT00489424|613001|P1|NOT COMPLETED|Overall Study||4
254252|NCT00489424|612999|P3|COMPLETED|Overall Study||257
254253|NCT00489424|613000|P2|COMPLETED|Overall Study||259
254254|NCT00489424|613001|P1|COMPLETED|Overall Study||263
254255|NCT00489424|612999|P3|STARTED|Overall Study||262
254256|NCT00489424|613000|P2|STARTED|Overall Study||264
254257|NCT00489424|613001|P1|STARTED|Overall Study||267
254258|NCT00489411|613032|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
254259|NCT00489411|613033|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
254260|NCT00489411|613032|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
254261|NCT00489411|613033|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
254262|NCT00489411|613032|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
254263|NCT00489411|613033|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
254264|NCT00489411|613032|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
254265|NCT00489411|613033|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
254266|NCT00489411|613032|P2|COMPLETED|Washout Period (Weeks 6-7)||93
254267|NCT00489411|613033|P1|COMPLETED|Washout Period (Weeks 6-7)||85
254268|NCT00489411|613032|P2|STARTED|Washout Period (Weeks 6-7)||94
254269|NCT00489411|613033|P1|STARTED|Washout Period (Weeks 6-7)||87
254270|NCT00489411|613032|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
254271|NCT00489411|613033|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
254272|NCT00489411|613032|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
254273|NCT00489411|613033|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
254274|NCT00489411|613032|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
254275|NCT00489411|613033|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
254276|NCT00489359|613047|P2|NOT COMPLETED|Overall Study||29
254277|NCT00489359|613048|P1|NOT COMPLETED|Overall Study||7
254278|NCT00489359|613047|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
254279|NCT00489359|613048|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
254280|NCT00489359|613047|P2|STARTED|Overall Study||66
254281|NCT00489359|613048|P1|STARTED|Overall Study||20
254282|NCT00489268|613076|P5|NOT COMPLETED|Overall Study||20
254283|NCT00489268|613077|P4|NOT COMPLETED|Overall Study||0
254284|NCT00489268|613078|P3|NOT COMPLETED|Overall Study||1
254285|NCT00489268|613079|P2|NOT COMPLETED|Overall Study||0
254286|NCT00489268|613080|P1|NOT COMPLETED|Overall Study||0
254287|NCT00489268|613076|P5|COMPLETED|Overall Study||50
254288|NCT00489268|613077|P4|COMPLETED|Overall Study||11
254289|NCT00489268|613078|P3|COMPLETED|Overall Study||9
254290|NCT00489268|613079|P2|COMPLETED|Overall Study||10
254291|NCT00489268|613080|P1|COMPLETED|Overall Study||1
254292|NCT00489268|613076|P5|STARTED|Overall Study||70
254293|NCT00489268|613077|P4|STARTED|Overall Study||11
254294|NCT00489268|613078|P3|STARTED|Overall Study||10
254295|NCT00489268|613079|P2|STARTED|Overall Study||10
254296|NCT00489268|613080|P1|STARTED|Overall Study||1
254297|NCT00489255|613109|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
254298|NCT00489255|613110|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
254299|NCT00489255|613109|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
254300|NCT00489255|613110|P1|COMPLETED|Period 3: Days 57 to 84||24
254301|NCT00489255|613109|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
254302|NCT00489255|613110|P1|STARTED|Period 3: Days 57 to 84||28
254303|NCT00489255|613109|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
254304|NCT00489255|613110|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
254305|NCT00489255|613109|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
254306|NCT00489255|613110|P1|COMPLETED|Period 2: Days 29 to 56||61
254307|NCT00489255|613109|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
254308|NCT00489255|613110|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
254309|NCT00489255|613109|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
254310|NCT00489255|613110|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
254311|NCT00489255|613109|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
254312|NCT00489255|613110|P1|STARTED|Period 2: Days 29 to 56||64
254313|NCT00489255|613109|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
254314|NCT00489255|613110|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
254315|NCT00489255|613109|P2|COMPLETED|Period 1: Days 1 to 28||34
254316|NCT00489255|613110|P1|COMPLETED|Period 1: Days 1 to 28||107
254317|NCT00489255|613109|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
254318|NCT00489255|613110|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
254319|NCT00489255|613109|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
254320|NCT00489255|613110|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
254321|NCT00489255|613109|P2|STARTED|Period 1: Days 1 to 28||46
254322|NCT00489255|613110|P1|STARTED|Period 1: Days 1 to 28||136
254323|NCT00489255|613109|P2|NOT COMPLETED|Screening and Initial Randomization||3
254324|NCT00489255|613110|P1|NOT COMPLETED|Screening and Initial Randomization||9
254325|NCT00489255|613109|P2|COMPLETED|Screening and Initial Randomization||46
254326|NCT00489255|613110|P1|COMPLETED|Screening and Initial Randomization||136
254327|NCT00489255|613109|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
254328|NCT00489255|613110|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
254329|NCT00489216|613158|P1|NOT COMPLETED|Overall Study||1
254330|NCT00489216|613158|P1|COMPLETED|Overall Study||1
254331|NCT00489216|613158|P1|STARTED|Overall Study||2
254332|NCT00489086|613167|P1|NOT COMPLETED|Overall Study||23
254333|NCT00489086|613167|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
254334|NCT00489086|613167|P1|STARTED|Overall Study||36
254335|NCT00488865|613171|P1|NOT COMPLETED|Overall Study||0
254336|NCT00488865|613171|P1|COMPLETED|Overall Study||100
254337|NCT00488865|613171|P1|STARTED|Overall Study||100
254338|NCT00488826|613180|P3|NOT COMPLETED|Overall Study||26
254339|NCT00488826|613181|P2|NOT COMPLETED|Overall Study||52
254340|NCT00488826|613182|P1|NOT COMPLETED|Overall Study||56
254341|NCT00488826|613180|P3|COMPLETED|Overall Study||178
254342|NCT00488826|613181|P2|COMPLETED|Overall Study||244
254343|NCT00488826|613182|P1|COMPLETED|Overall Study||244
254344|NCT00488826|613180|P3|STARTED|Overall Study||204
254345|NCT00488826|613181|P2|STARTED|Overall Study||296
254346|NCT00488826|613182|P1|STARTED|Overall Study||300
254347|NCT00488774|613197|P4|NOT COMPLETED|Overall Study||3
254348|NCT00488774|613198|P3|NOT COMPLETED|Overall Study||5
254349|NCT00488774|613199|P2|NOT COMPLETED|Overall Study||5
254350|NCT00488774|613200|P1|NOT COMPLETED|Overall Study||8
254351|NCT00488774|613197|P4|COMPLETED|Overall Study||74
254352|NCT00488774|613198|P3|COMPLETED|Overall Study||70
254353|NCT00488774|613199|P2|COMPLETED|Overall Study||57
254354|NCT00488774|613200|P1|COMPLETED|Overall Study||69
254355|NCT00488774|613197|P4|STARTED|Overall Study||77
254356|NCT00488774|613198|P3|STARTED|Overall Study||75
254357|NCT00488774|613199|P2|STARTED|Overall Study||62
254358|NCT00488774|613200|P1|STARTED|Overall Study||77
254359|NCT00488683|613217|P3|NOT COMPLETED|Overall Study||2
254360|NCT00488683|613218|P2|NOT COMPLETED|Overall Study||6
254361|NCT00488683|613219|P1|NOT COMPLETED|Overall Study||12
254362|NCT00488683|613217|P3|COMPLETED|Overall Study||52
254363|NCT00488683|613218|P2|COMPLETED|Overall Study||48
254364|NCT00488683|613219|P1|COMPLETED|Overall Study||96
254365|NCT00488683|613217|P3|STARTED|Overall Study||54
254366|NCT00488683|613218|P2|STARTED|Overall Study||54
254367|NCT00488683|613219|P1|STARTED|Overall Study||108
254368|NCT00488644|613278|P1|NOT COMPLETED|Overall Study||2
254369|NCT00488644|613278|P1|COMPLETED|Overall Study||10
254370|NCT00488644|613278|P1|STARTED|Overall Study||12
254371|NCT00488631|613288|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
254372|NCT00488631|613289|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
254373|NCT00488631|613290|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
254374|NCT00488631|613291|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
254375|NCT00488631|613292|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
254376|NCT00488631|613293|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
254377|NCT00488631|613294|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
254378|NCT00488631|613295|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
254379|NCT00488631|613296|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
254380|NCT00488631|613297|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
254381|NCT00488631|613288|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
254382|NCT00488631|613289|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
254383|NCT00488631|613290|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
254384|NCT00488631|613291|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
254385|NCT00488631|613292|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
254386|NCT00488631|613293|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
254387|NCT00488631|613294|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
254388|NCT00488631|613295|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
254389|NCT00488631|613296|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
254390|NCT00488631|613297|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
254391|NCT00488631|613288|P10|STARTED|Open Label Study Extension (Week 54-228)||7
254392|NCT00488631|613289|P9|STARTED|Open Label Study Extension (Week 54-228)||470
254393|NCT00488631|613290|P8|STARTED|Open Label Study Extension (Week 54-228)||93
254394|NCT00488631|613291|P7|STARTED|Open Label Study Extension (Week 54-228)||96
254395|NCT00488631|613292|P6|STARTED|Open Label Study Extension (Week 54-228)||0
254396|NCT00488631|613293|P5|STARTED|Open Label Study Extension (Week 54-228)||0
254397|NCT00488631|613294|P4|STARTED|Open Label Study Extension (Week 54-228)||0
254398|NCT00488631|613295|P3|STARTED|Open Label Study Extension (Week 54-228)||0
254399|NCT00488631|613296|P2|STARTED|Open Label Study Extension (Week 54-228)||0
254400|NCT00488631|613297|P1|STARTED|Open Label Study Extension (Week 54-228)||0
254401|NCT00488631|613288|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
254402|NCT00488631|613289|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
254403|NCT00488631|613290|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
254404|NCT00488631|613291|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
254405|NCT00488631|613292|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
254406|NCT00488631|613293|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
254407|NCT00488631|613294|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
254408|NCT00488631|613295|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
254409|NCT00488631|613296|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
254410|NCT00488631|613297|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
254411|NCT00488631|613288|P10|COMPLETED|Double Blind Period (Week 0-54)||0
254412|NCT00488631|613289|P9|COMPLETED|Double Blind Period (Week 0-54)||0
254413|NCT00488631|613290|P8|COMPLETED|Double Blind Period (Week 0-54)||0
254414|NCT00488631|613291|P7|COMPLETED|Double Blind Period (Week 0-54)||0
254415|NCT00488631|613292|P6|COMPLETED|Double Blind Period (Week 0-54)||189
254416|NCT00488631|613293|P5|COMPLETED|Double Blind Period (Week 0-54)||127
254417|NCT00488631|613294|P4|COMPLETED|Double Blind Period (Week 0-54)||88
254418|NCT00488631|613295|P3|COMPLETED|Double Blind Period (Week 0-54)||109
254419|NCT00488631|613296|P2|COMPLETED|Double Blind Period (Week 0-54)||111
254420|NCT00488631|613297|P1|COMPLETED|Double Blind Period (Week 0-54)||113
254421|NCT00488631|613288|P10|STARTED|Double Blind Period (Week 0-54)||0
254422|NCT00488631|613289|P9|STARTED|Double Blind Period (Week 0-54)||0
254423|NCT00488631|613290|P8|STARTED|Double Blind Period (Week 0-54)||0
254424|NCT00488631|613291|P7|STARTED|Double Blind Period (Week 0-54)||0
254425|NCT00488631|613292|P6|STARTED|Double Blind Period (Week 0-54)||405
254426|NCT00488631|613293|P5|STARTED|Double Blind Period (Week 0-54)||230
254427|NCT00488631|613294|P4|STARTED|Double Blind Period (Week 0-54)||129
254428|NCT00488631|613295|P3|STARTED|Double Blind Period (Week 0-54)||154
254429|NCT00488631|613296|P2|STARTED|Double Blind Period (Week 0-54)||154
254430|NCT00488631|613297|P1|STARTED|Double Blind Period (Week 0-54)||156
254431|NCT00488618|613334|P2|NOT COMPLETED|Overall Study||43
254432|NCT00488618|613335|P1|NOT COMPLETED|Overall Study||47
254433|NCT00488618|613334|P2|COMPLETED|Overall Study||75
254434|NCT00488618|613335|P1|COMPLETED|Overall Study||73
254435|NCT00488618|613334|P2|Safety Population: Received Study Drug|Overall Study||118
254436|NCT00488618|613335|P1|Safety Population: Received Study Drug|Overall Study||118
254437|NCT00488618|613334|P2|STARTED|Overall Study||118
254438|NCT00488618|613335|P1|STARTED|Overall Study||120
254439|NCT00488592|613343|P1|NOT COMPLETED|Overall Study||3
254440|NCT00488592|613343|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
254441|NCT00488592|613343|P1|STARTED|Overall Study|10 subjects were accrued|10
254442|NCT00488514|613347|P1|NOT COMPLETED|Overall Study||293
254443|NCT00488514|613347|P1|COMPLETED|Overall Study||363
254444|NCT00488514|613347|P1|STARTED|Overall Study||656
254445|NCT00488488|613420|P1|NOT COMPLETED|Overall Study||268
254446|NCT00488488|613420|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
254447|NCT00488488|613420|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
254448|NCT00488488|613420|P1|STARTED|Overall Study||1028
254449|NCT00488475|613435|P1|NOT COMPLETED|Overall Study||1754
254450|NCT00488475|613435|P1|COMPLETED|Overall Study||3191
254451|NCT00488475|613435|P1|STARTED|Overall Study||4945
254452|NCT00488345|613464|P3|NOT COMPLETED|Overall Study||3
254453|NCT00488345|613465|P2|NOT COMPLETED|Overall Study||4
254454|NCT00488345|613466|P1|NOT COMPLETED|Overall Study||0
254455|NCT00488345|613464|P3|COMPLETED|Overall Study||17
254456|NCT00488345|613465|P2|COMPLETED|Overall Study||17
254457|NCT00488345|613466|P1|COMPLETED|Overall Study||17
254458|NCT00488345|613464|P3|STARTED|Overall Study||20
254459|NCT00488345|613465|P2|STARTED|Overall Study||21
254460|NCT00488345|613466|P1|STARTED|Overall Study||17
254461|NCT00488319|613492|P3|NOT COMPLETED|Overall Study||122
254462|NCT00488319|613493|P2|NOT COMPLETED|Overall Study||43
254463|NCT00488319|613494|P1|NOT COMPLETED|Overall Study||15
254464|NCT00488319|613492|P3|COMPLETED|Overall Study||121
254465|NCT00488319|613493|P2|COMPLETED|Overall Study||75
254466|NCT00488319|613494|P1|COMPLETED|Overall Study||24
254467|NCT00488319|613492|P3|STARTED|Overall Study||243
254468|NCT00488319|613493|P2|STARTED|Overall Study||118
254469|NCT00488319|613494|P1|STARTED|Overall Study||39
254470|NCT00488293|613581|P2|NOT COMPLETED|Overall Study||30
254471|NCT00488293|613582|P1|NOT COMPLETED|Overall Study||36
254472|NCT00488293|613581|P2|COMPLETED|Overall Study||166
254473|NCT00488293|613582|P1|COMPLETED|Overall Study||160
254474|NCT00488293|613581|P2|STARTED|Overall Study||196
254475|NCT00488293|613582|P1|STARTED|Overall Study||196
254476|NCT00488059|613606|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
254477|NCT00488059|613607|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
254478|NCT00488059|613608|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
254479|NCT00488059|613606|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
254480|NCT00488059|613607|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
254481|NCT00488059|613608|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
254482|NCT00488059|613606|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
254483|NCT00488059|613607|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
254484|NCT00488059|613608|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
254485|NCT00488059|613606|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
254486|NCT00488059|613607|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
254487|NCT00488059|613608|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
254488|NCT00488059|613606|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
254489|NCT00488059|613607|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
254490|NCT00488059|613608|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
254491|NCT00488059|613606|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
254492|NCT00488059|613607|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
254493|NCT00488059|613608|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
254494|NCT00488059|613606|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
254495|NCT00488059|613607|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
254496|NCT00488059|613608|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
254497|NCT00488059|613606|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
254498|NCT00488059|613607|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
254499|NCT00488059|613608|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
254500|NCT00488059|613606|P3|STARTED|Phase I: ENF 90mg SC BID||0
254501|NCT00488059|613607|P2|STARTED|Phase I: ENF 90mg SC BID||0
254502|NCT00488059|613608|P1|STARTED|Phase I: ENF 90mg SC BID||29
254503|NCT00488033|613627|P2|NOT COMPLETED|Overall Study||0
254504|NCT00488033|613628|P1|NOT COMPLETED|Overall Study||1
254505|NCT00488033|613627|P2|COMPLETED|Overall Study||452
254506|NCT00488033|613628|P1|COMPLETED|Overall Study||447
254507|NCT00488033|613627|P2|STARTED|Overall Study||452
254508|NCT00488033|613628|P1|STARTED|Overall Study||448
254509|NCT00487981|613644|P1|NOT COMPLETED|Overall Study||1
254510|NCT00487981|613644|P1|COMPLETED|Overall Study||0
254511|NCT00487981|613644|P1|STARTED|Overall Study||1
254512|NCT00487942|613652|P4|NOT COMPLETED|Overall Study||2
254513|NCT00487942|613653|P3|NOT COMPLETED|Overall Study||3
254514|NCT00487942|613654|P2|NOT COMPLETED|Overall Study||3
254515|NCT00487942|613655|P1|NOT COMPLETED|Overall Study||3
254516|NCT00487942|613652|P4|COMPLETED|Overall Study||13
254517|NCT00487942|613653|P3|COMPLETED|Overall Study||12
254518|NCT00487942|613654|P2|COMPLETED|Overall Study||12
254519|NCT00487942|613655|P1|COMPLETED|Overall Study||12
254520|NCT00487942|613652|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
254521|NCT00487942|613653|P3|STARTED|Overall Study||15
254522|NCT00487942|613654|P2|STARTED|Overall Study||15
254523|NCT00487942|613655|P1|STARTED|Overall Study||15
254524|NCT00487825|614039|P2|NOT COMPLETED|Overall Study||5
254525|NCT00487825|614040|P1|NOT COMPLETED|Overall Study||6
254526|NCT00487825|614039|P2|COMPLETED|Overall Study||21
254527|NCT00487825|614040|P1|COMPLETED|Overall Study||46
254528|NCT00487825|614039|P2|STARTED|Overall Study||26
254529|NCT00487825|614040|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
254530|NCT00487747|614052|P1|NOT COMPLETED|Overall Study||11
254531|NCT00487747|614052|P1|COMPLETED|Overall Study||7
254532|NCT00487747|614052|P1|STARTED|Overall Study||18
254533|NCT00487721|614063|P2|NOT COMPLETED|Overall Study||0
254534|NCT00487721|614064|P1|NOT COMPLETED|Overall Study||0
254535|NCT00487721|614063|P2|COMPLETED|Overall Study||6
254536|NCT00487721|614064|P1|COMPLETED|Overall Study||6
254537|NCT00487721|614063|P2|STARTED|Overall Study||6
254538|NCT00487721|614064|P1|STARTED|Overall Study||6
254539|NCT00487695|614069|P2|NOT COMPLETED|Second Procedure||3
254540|NCT00487695|614070|P1|NOT COMPLETED|Second Procedure||1
254541|NCT00487695|614069|P2|COMPLETED|Second Procedure||20
254542|NCT00487695|614070|P1|COMPLETED|Second Procedure||19
254543|NCT00487695|614069|P2|STARTED|Second Procedure||23
254544|NCT00487695|614070|P1|STARTED|Second Procedure||20
254545|NCT00487695|614069|P2|NOT COMPLETED|First Procedure||0
254546|NCT00487695|614070|P1|NOT COMPLETED|First Procedure||3
254547|NCT00487695|614069|P2|COMPLETED|First Procedure||23
254548|NCT00487695|614070|P1|COMPLETED|First Procedure||20
254549|NCT00487695|614069|P2|STARTED|First Procedure||23
254550|NCT00487695|614070|P1|STARTED|First Procedure||23
254551|NCT00487669|614086|P1|NOT COMPLETED|Overall Study||0
254552|NCT00487669|614086|P1|COMPLETED|Overall Study||12
254553|NCT00487669|614086|P1|STARTED|Overall Study||12
254554|NCT00487578|614098|P2|NOT COMPLETED|Overall Study||4
254555|NCT00487578|614099|P1|NOT COMPLETED|Overall Study||1
254556|NCT00487578|614098|P2|COMPLETED|Overall Study||5
254557|NCT00487578|614099|P1|COMPLETED|Overall Study||2
254558|NCT00487578|614098|P2|STARTED|Overall Study||9
254559|NCT00487578|614099|P1|STARTED|Overall Study||3
254560|NCT00487565|614115|P1|NOT COMPLETED|Overall Study||28
254561|NCT00487565|614115|P1|COMPLETED|Overall Study||182
254562|NCT00487565|614115|P1|STARTED|Overall Study||210
254563|NCT00487552|614119|P1|NOT COMPLETED|Overall Study||6
254564|NCT00487552|614119|P1|COMPLETED|Overall Study||12
254565|NCT00487552|614119|P1|STARTED|Overall Study||18
254566|NCT00487539|614128|P4|NOT COMPLETED|Overall Study||4
254567|NCT00487539|614129|P3|NOT COMPLETED|Overall Study||3
254568|NCT00487539|614130|P2|NOT COMPLETED|Overall Study||3
254569|NCT00487539|614131|P1|NOT COMPLETED|Overall Study||7
254570|NCT00487539|614128|P4|COMPLETED|Overall Study||327
254571|NCT00487539|614129|P3|COMPLETED|Overall Study||328
254572|NCT00487539|614130|P2|COMPLETED|Overall Study||69
254573|NCT00487539|614131|P1|COMPLETED|Overall Study||324
254574|NCT00487539|614128|P4|STARTED|Overall Study||331
254575|NCT00487539|614129|P3|STARTED|Overall Study||331
254576|NCT00487539|614130|P2|STARTED|Overall Study||72
254577|NCT00487539|614131|P1|STARTED|Overall Study||331
254578|NCT00487461|614152|P3|NOT COMPLETED|Overall Study||4
254579|NCT00487461|614153|P2|NOT COMPLETED|Overall Study||2
254580|NCT00487461|614154|P1|NOT COMPLETED|Overall Study||0
254581|NCT00487461|614152|P3|COMPLETED|Overall Study||7
254582|NCT00487461|614153|P2|COMPLETED|Overall Study||10
254583|NCT00487461|614154|P1|COMPLETED|Overall Study||2
254584|NCT00487461|614152|P3|STARTED|Overall Study||11
254585|NCT00487461|614153|P2|STARTED|Overall Study||12
254586|NCT00487461|614154|P1|STARTED|Overall Study||2
254587|NCT00487435|614165|P1|NOT COMPLETED|Overall Study||485
254588|NCT00487435|614165|P1|COMPLETED|Overall Study||669
254589|NCT00487435|614165|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
254590|NCT00487396|614170|P1|NOT COMPLETED|Overall Study||3
254591|NCT00487396|614170|P1|COMPLETED|Overall Study||95
254592|NCT00487396|614170|P1|STARTED|Overall Study||98
254593|NCT00487279|614178|P2|NOT COMPLETED|Overall Study||2
254594|NCT00487279|614179|P1|NOT COMPLETED|Overall Study||1
254595|NCT00487279|614178|P2|COMPLETED|Overall Study||35
254596|NCT00487279|614179|P1|COMPLETED|Overall Study||43
254597|NCT00487279|614178|P2|STARTED|Overall Study||37
254598|NCT00487279|614179|P1|STARTED|Overall Study||44
254599|NCT00487240|614189|P2|NOT COMPLETED|Overall Study||26
254600|NCT00487240|614190|P1|NOT COMPLETED|Overall Study||31
254601|NCT00487240|614189|P2|COMPLETED|Overall Study||166
254602|NCT00487240|614190|P1|COMPLETED|Overall Study||164
254603|NCT00487240|614189|P2|Full Analysis Set (ITT Population)|Overall Study||189
254604|NCT00487240|614190|P1|Full Analysis Set (ITT Population)|Overall Study||192
254605|NCT00487240|614189|P2|STARTED|Overall Study||192
254606|NCT00487240|614190|P1|STARTED|Overall Study||195
254607|NCT00487188|614218|P3|NOT COMPLETED|Maintenance Phase||1
254608|NCT00487188|614219|P2|NOT COMPLETED|Maintenance Phase||0
254609|NCT00487188|614220|P1|NOT COMPLETED|Maintenance Phase||3
254610|NCT00487188|614218|P3|COMPLETED|Maintenance Phase||8
254611|NCT00487188|614219|P2|COMPLETED|Maintenance Phase||8
254612|NCT00487188|614220|P1|COMPLETED|Maintenance Phase||7
254613|NCT00487188|614218|P3|STARTED|Maintenance Phase||9
254614|NCT00487188|614219|P2|STARTED|Maintenance Phase||8
254615|NCT00487188|614220|P1|STARTED|Maintenance Phase||10
254616|NCT00487188|614218|P3|NOT COMPLETED|Induction Phase||0
254617|NCT00487188|614219|P2|NOT COMPLETED|Induction Phase||7
254618|NCT00487188|614220|P1|NOT COMPLETED|Induction Phase||9
254619|NCT00487188|614218|P3|COMPLETED|Induction Phase||0
254620|NCT00487188|614219|P2|COMPLETED|Induction Phase||9
254621|NCT00487188|614220|P1|COMPLETED|Induction Phase||22
254622|NCT00487188|614218|P3|Safety Population|Induction Phase||0
254623|NCT00487188|614219|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
254624|NCT00487188|614220|P1|Safety Population|Induction Phase||29
254625|NCT00487188|614218|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
254626|NCT00487188|614219|P2|STARTED|Induction Phase||16
254627|NCT00487188|614220|P1|STARTED|Induction Phase||31
254628|NCT00487162|614259|P2|NOT COMPLETED|Overall Study||5
254629|NCT00487162|614260|P1|NOT COMPLETED|Overall Study||2
254630|NCT00487162|614259|P2|COMPLETED|Overall Study||21
254631|NCT00487162|614260|P1|COMPLETED|Overall Study||28
254632|NCT00487162|614259|P2|STARTED|Overall Study||26
254633|NCT00487162|614260|P1|STARTED|Overall Study||30
254634|NCT00487084|614271|P3|NOT COMPLETED|Overall Study||5
254635|NCT00487084|614272|P2|NOT COMPLETED|Overall Study||3
254636|NCT00487084|614273|P1|NOT COMPLETED|Overall Study||4
254637|NCT00487084|614271|P3|COMPLETED|Overall Study||28
254638|NCT00487084|614272|P2|COMPLETED|Overall Study||30
254639|NCT00487084|614273|P1|COMPLETED|Overall Study||29
254640|NCT00487084|614271|P3|STARTED|Overall Study||33
254641|NCT00487084|614272|P2|STARTED|Overall Study||33
254642|NCT00487084|614273|P1|STARTED|Overall Study||33
254643|NCT00486954|614294|P5|NOT COMPLETED|Randomized Part||14
254644|NCT00486954|614295|P4|NOT COMPLETED|Randomized Part||20
254645|NCT00486954|614296|P3|NOT COMPLETED|Randomized Part||0
254646|NCT00486954|614297|P2|NOT COMPLETED|Randomized Part||0
254647|NCT00486954|614298|P1|NOT COMPLETED|Randomized Part||0
254648|NCT00486954|614294|P5|COMPLETED|Randomized Part||115
254649|NCT00486954|614295|P4|COMPLETED|Randomized Part||112
254650|NCT00486954|614296|P3|COMPLETED|Randomized Part||0
254651|NCT00486954|614297|P2|COMPLETED|Randomized Part||0
254652|NCT00486954|614298|P1|COMPLETED|Randomized Part||0
254653|NCT00486954|614294|P5|STARTED|Randomized Part||129
254654|NCT00486954|614295|P4|STARTED|Randomized Part||132
254655|NCT00486954|614296|P3|STARTED|Randomized Part||0
254656|NCT00486954|614297|P2|STARTED|Randomized Part||0
254657|NCT00486954|614298|P1|STARTED|Randomized Part||0
254658|NCT00486954|614294|P5|NOT COMPLETED|Pilot Part||0
254659|NCT00486954|614295|P4|NOT COMPLETED|Pilot Part||0
254660|NCT00486954|614296|P3|NOT COMPLETED|Pilot Part||6
254661|NCT00486954|614297|P2|NOT COMPLETED|Pilot Part||0
254662|NCT00486954|614298|P1|NOT COMPLETED|Pilot Part||6
254663|NCT00486954|614294|P5|COMPLETED|Pilot Part||0
254664|NCT00486954|614295|P4|COMPLETED|Pilot Part||0
254665|NCT00486954|614296|P3|COMPLETED|Pilot Part||0
254666|NCT00486954|614297|P2|COMPLETED|Pilot Part||0
254667|NCT00486954|614298|P1|COMPLETED|Pilot Part||0
254668|NCT00486954|614294|P5|STARTED|Pilot Part||0
254669|NCT00486954|614295|P4|STARTED|Pilot Part||0
254670|NCT00486954|614296|P3|STARTED|Pilot Part||6
254671|NCT00486954|614297|P2|STARTED|Pilot Part||0
254672|NCT00486954|614298|P1|STARTED|Pilot Part||6
254673|NCT00486902|614396|P2|NOT COMPLETED|Overall Study||5
254674|NCT00486902|614397|P1|NOT COMPLETED|Overall Study||9
254675|NCT00486902|614396|P2|COMPLETED|Overall Study||89
254676|NCT00486902|614397|P1|COMPLETED|Overall Study||85
254677|NCT00486902|614396|P2|STARTED|Overall Study||94
254678|NCT00486902|614397|P1|STARTED|Overall Study||94
254679|NCT00486863|614419|P2|NOT COMPLETED|Overall Study||3
254680|NCT00486863|614420|P1|NOT COMPLETED|Overall Study||1
254681|NCT00486863|614419|P2|COMPLETED|Overall Study||183
254682|NCT00486863|614420|P1|COMPLETED|Overall Study||183
254683|NCT00486863|614419|P2|STARTED|Overall Study||186
254684|NCT00486863|614420|P1|STARTED|Overall Study||184
254685|NCT00486837|614464|P2|NOT COMPLETED|Overall Study||7
254686|NCT00486837|614465|P1|NOT COMPLETED|Overall Study||9
254687|NCT00486837|614464|P2|COMPLETED|Overall Study||28
254688|NCT00486837|614465|P1|COMPLETED|Overall Study||28
254689|NCT00486837|614464|P2|STARTED|Overall Study||35
254690|NCT00486837|614465|P1|STARTED|Overall Study||37
254691|NCT00486811|614484|P3|NOT COMPLETED|Overall Study||214
254692|NCT00486811|614485|P2|NOT COMPLETED|Overall Study||141
254693|NCT00486811|614486|P1|NOT COMPLETED|Overall Study||122
254694|NCT00486811|614484|P3|COMPLETED|Overall Study||119
254695|NCT00486811|614485|P2|COMPLETED|Overall Study||179
254696|NCT00486811|614486|P1|COMPLETED|Overall Study||215
254697|NCT00486811|614484|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
254698|NCT00486811|614485|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
254699|NCT00486811|614486|P1|STARTED|Overall Study||337
254700|NCT00486759|614529|P2|NOT COMPLETED|Safety Follow-up||118
254701|NCT00486759|614530|P1|NOT COMPLETED|Safety Follow-up||139
254702|NCT00486759|614529|P2|COMPLETED|Safety Follow-up||142
254703|NCT00486759|614530|P1|COMPLETED|Safety Follow-up||64
254704|NCT00486759|614529|P2|STARTED|Safety Follow-up||260
254705|NCT00486759|614530|P1|STARTED|Safety Follow-up||203
254706|NCT00486759|614529|P2|NOT COMPLETED|Treatment||137
254707|NCT00486759|614530|P1|NOT COMPLETED|Treatment||187
254708|NCT00486759|614529|P2|COMPLETED|Treatment||260
254709|NCT00486759|614530|P1|COMPLETED|Treatment||203
254710|NCT00486759|614529|P2|STARTED|Treatment||397
254711|NCT00486759|614530|P1|STARTED|Treatment||390
254712|NCT00486720|614542|P2|NOT COMPLETED|Overall Study||12
254713|NCT00486720|614543|P1|NOT COMPLETED|Overall Study||10
254714|NCT00486720|614542|P2|COMPLETED|Overall Study||0
254715|NCT00486720|614543|P1|COMPLETED|Overall Study||0
254716|NCT00486720|614542|P2|STARTED|Overall Study||12
254717|NCT00486720|614543|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
254718|NCT00486642|614553|P2|NOT COMPLETED|Overall Study||0
254719|NCT00486642|614554|P1|NOT COMPLETED|Overall Study||0
254720|NCT00486642|614553|P2|COMPLETED|Overall Study||13
254721|NCT00486642|614554|P1|COMPLETED|Overall Study||10
254722|NCT00486642|614553|P2|STARTED|Overall Study||13
254723|NCT00486642|614554|P1|STARTED|Overall Study||10
254724|NCT00486525|614578|P2|NOT COMPLETED|Overall Study||13
254725|NCT00486525|614579|P1|NOT COMPLETED|Overall Study||6
254726|NCT00486525|614578|P2|COMPLETED|Overall Study||87
254727|NCT00486525|614579|P1|COMPLETED|Overall Study||94
254728|NCT00486525|614578|P2|STARTED|Overall Study||100
254729|NCT00486525|614579|P1|STARTED|Overall Study||100
254730|NCT00486447|614595|P1|NOT COMPLETED|Overall Study||0
254731|NCT00486447|614595|P1|COMPLETED|Overall Study||249
254732|NCT00486447|614595|P1|STARTED|Overall Study||249
254733|NCT00486434|614602|P2|NOT COMPLETED|Overall Study||134
254734|NCT00486434|614603|P1|NOT COMPLETED|Overall Study||194
254735|NCT00486434|614602|P2|COMPLETED|Overall Study||454
254736|NCT00486434|614603|P1|COMPLETED|Overall Study||394
254737|NCT00486434|614602|P2|STARTED|Overall Study||588
254738|NCT00486434|614603|P1|STARTED|Overall Study||588
254739|NCT00486330|614613|P1|NOT COMPLETED|Overall Study||2
254740|NCT00486330|614613|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
254741|NCT00486330|614613|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
254742|NCT00486291|614619|P2|NOT COMPLETED|Overall Study||29
254743|NCT00486291|614620|P1|NOT COMPLETED|Overall Study||16
254744|NCT00486291|614619|P2|COMPLETED|Overall Study||76
254745|NCT00486291|614620|P1|COMPLETED|Overall Study||89
254746|NCT00486291|614619|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
254747|NCT00486291|614620|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
254748|NCT00486278|614628|P1|NOT COMPLETED|Overall Study||9
254749|NCT00486278|614628|P1|COMPLETED|Overall Study||42
254750|NCT00486278|614628|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
254751|NCT00486265|614762|P1|NOT COMPLETED|Overall Study||9
254752|NCT00486265|614762|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
254753|NCT00486265|614762|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
254754|NCT00486252|614766|P1|NOT COMPLETED|Overall Study||58
254755|NCT00486252|614766|P1|COMPLETED|Overall Study||938
254756|NCT00486252|614766|P1|STARTED|Overall Study||996
254757|NCT00486226|614781|P1|NOT COMPLETED|Overall Study||13
254758|NCT00486226|614781|P1|COMPLETED|Overall Study||92
254759|NCT00486226|614781|P1|STARTED|Overall Study||105
254760|NCT00486044|614791|P2|NOT COMPLETED|Overall Study||3
254761|NCT00486044|614792|P1|NOT COMPLETED|Overall Study||2
254762|NCT00486044|614791|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
254763|NCT00486044|614792|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
254764|NCT00486044|614791|P2|STARTED|Overall Study|23 in MRI sub-study|49
254765|NCT00486044|614792|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
254766|NCT00486031|614804|P1|NOT COMPLETED|Overall Study||3
254767|NCT00486031|614804|P1|COMPLETED|Overall Study||440
254768|NCT00486031|614804|P1|STARTED|Overall Study||443
254769|NCT00486018|614811|P3|NOT COMPLETED|Overall Study||6
254770|NCT00486018|614812|P2|NOT COMPLETED|Overall Study||6
254771|NCT00486018|614813|P1|NOT COMPLETED|Overall Study||9
254772|NCT00486018|614811|P3|COMPLETED|Overall Study||125
254773|NCT00486018|614812|P2|COMPLETED|Overall Study||128
254774|NCT00486018|614813|P1|COMPLETED|Overall Study||123
254775|NCT00486018|614811|P3|Received Drug (Safety Population)|Overall Study||130
254776|NCT00486018|614812|P2|Received Drug (Safety Population)|Overall Study||134
254777|NCT00486018|614813|P1|Received Drug (Safety Population)|Overall Study||131
254778|NCT00486018|614811|P3|STARTED|Overall Study||131
254779|NCT00486018|614812|P2|STARTED|Overall Study||134
254780|NCT00486018|614813|P1|STARTED|Overall Study||132
254781|NCT00485953|614841|P2|NOT COMPLETED|Overall Study||7
254782|NCT00485953|614842|P1|NOT COMPLETED|Overall Study||7
254783|NCT00485953|614841|P2|COMPLETED|Overall Study||47
254784|NCT00485953|614842|P1|COMPLETED|Overall Study||48
254785|NCT00485953|614841|P2|STARTED|Overall Study||54
254786|NCT00485953|614842|P1|STARTED|Overall Study||55
254787|NCT00485836|614855|P3|NOT COMPLETED|Overall Study||11
254788|NCT00485836|614856|P2|NOT COMPLETED|Overall Study||3
254789|NCT00485836|614857|P1|NOT COMPLETED|Overall Study||15
254790|NCT00485836|614855|P3|COMPLETED|Overall Study||119
254791|NCT00485836|614856|P2|COMPLETED|Overall Study||129
254792|NCT00485836|614857|P1|COMPLETED|Overall Study||115
254793|NCT00485836|614855|P3|Received Study Drug (Safety Population)|Overall Study||129
254794|NCT00485836|614856|P2|Received Study Drug (Safety Population)|Overall Study||132
254795|NCT00485836|614857|P1|Received Study Drug (Safety Population)|Overall Study||129
254796|NCT00485836|614855|P3|STARTED|Overall Study||130
254797|NCT00485836|614856|P2|STARTED|Overall Study||132
254798|NCT00485836|614857|P1|STARTED|Overall Study||130
254799|NCT00485758|614885|P2|NOT COMPLETED|Overall Study||65
254800|NCT00485758|614886|P1|NOT COMPLETED|Overall Study||156
254801|NCT00485758|614885|P2|COMPLETED|Overall Study||277
254802|NCT00485758|614886|P1|COMPLETED|Overall Study||298
254803|NCT00485758|614885|P2|STARTED|Overall Study||342
254804|NCT00485758|614886|P1|STARTED|Overall Study||454
254805|NCT00485732|614898|P2|NOT COMPLETED|Overall Study||9
254806|NCT00485732|614899|P1|NOT COMPLETED|Overall Study||8
254807|NCT00485732|614898|P2|COMPLETED|Overall Study||67
254808|NCT00485732|614899|P1|COMPLETED|Overall Study||141
254809|NCT00485732|614898|P2|STARTED|Overall Study||76
254810|NCT00485732|614899|P1|STARTED|Overall Study||149
254811|NCT00485693|614921|P2|NOT COMPLETED|Overall Study||0
254812|NCT00485693|614922|P1|NOT COMPLETED|Overall Study||0
254813|NCT00485693|614921|P2|COMPLETED|Overall Study||104
254814|NCT00485693|614922|P1|COMPLETED|Overall Study||34
254815|NCT00485693|614921|P2|STARTED|Overall Study||104
254816|NCT00485693|614922|P1|STARTED|Overall Study||34
254817|NCT00485485|614931|P1|NOT COMPLETED|Overall Study||0
254818|NCT00485485|614931|P1|COMPLETED|Overall Study||7
254819|NCT00485485|614931|P1|STARTED|Overall Study||7
254820|NCT00485472|614937|P2|NOT COMPLETED|Overall Study||12
254821|NCT00485472|614938|P1|NOT COMPLETED|Overall Study||16
254822|NCT00485472|614937|P2|COMPLETED|Overall Study||64
254823|NCT00485472|614938|P1|COMPLETED|Overall Study||57
254824|NCT00485472|614937|P2|Entered Maintenance Phase|Overall Study||67
254825|NCT00485472|614938|P1|Entered Maintenance Phase|Overall Study||65
254826|NCT00485472|614937|P2|STARTED|Overall Study||76
254827|NCT00485472|614938|P1|STARTED|Overall Study||73
254828|NCT00485433|614964|P4|NOT COMPLETED|Overall Study||0
254829|NCT00485433|614965|P3|NOT COMPLETED|Overall Study||0
254830|NCT00485433|614966|P2|NOT COMPLETED|Overall Study||0
254831|NCT00485433|614967|P1|NOT COMPLETED|Overall Study||0
254832|NCT00485433|614964|P4|COMPLETED|Overall Study||25
254833|NCT00485433|614965|P3|COMPLETED|Overall Study||24
254834|NCT00485433|614966|P2|COMPLETED|Overall Study||25
254835|NCT00485433|614967|P1|COMPLETED|Overall Study||24
254836|NCT00485433|614964|P4|STARTED|Overall Study||25
254837|NCT00485433|614965|P3|STARTED|Overall Study||24
254838|NCT00485433|614966|P2|STARTED|Overall Study||25
254839|NCT00485433|614967|P1|STARTED|Overall Study||24
254840|NCT00485303|614975|P1|NOT COMPLETED|Overall Study||56
254841|NCT00485303|614975|P1|COMPLETED|Overall Study||2
254842|NCT00485303|614975|P1|STARTED|Overall Study||58
254843|NCT00485264|614993|P6|NOT COMPLETED|Overall Study||7
254844|NCT00485264|614994|P5|NOT COMPLETED|Overall Study||6
254845|NCT00485264|614995|P4|NOT COMPLETED|Overall Study||4
254846|NCT00485264|614996|P3|NOT COMPLETED|Overall Study||6
254847|NCT00485264|614997|P2|NOT COMPLETED|Overall Study||7
254848|NCT00485264|614998|P1|NOT COMPLETED|Overall Study||36
254849|NCT00485264|614993|P6|COMPLETED|Overall Study||5
254850|NCT00485264|614994|P5|COMPLETED|Overall Study||9
254851|NCT00485264|614995|P4|COMPLETED|Overall Study||17
254852|NCT00485264|614996|P3|COMPLETED|Overall Study||12
254853|NCT00485264|614997|P2|COMPLETED|Overall Study||9
254854|NCT00485264|614998|P1|COMPLETED|Overall Study||35
254855|NCT00485264|614993|P6|Completed Week 24|Overall Study||11
254856|NCT00485264|614994|P5|Completed Week 24|Overall Study||14
254857|NCT00485264|614995|P4|Completed Week 24|Overall Study||21
254858|NCT00485264|614996|P3|Completed Week 24|Overall Study||18
254859|NCT00485264|614997|P2|Completed Week 24|Overall Study||16
254860|NCT00485264|614998|P1|Completed Week 24|Overall Study||67
254861|NCT00485264|614993|P6|STARTED|Overall Study||12
254862|NCT00485264|614994|P5|STARTED|Overall Study||15
254863|NCT00485264|614995|P4|STARTED|Overall Study||21
254864|NCT00485264|614996|P3|STARTED|Overall Study||18
254865|NCT00485264|614997|P2|STARTED|Overall Study||16
254866|NCT00485264|614998|P1|STARTED|Overall Study||71
254867|NCT00485173|615086|P2|NOT COMPLETED|Overall Study||64
254868|NCT00485173|615087|P1|NOT COMPLETED|Overall Study||36
254869|NCT00485173|615086|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
254870|NCT00485173|615087|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
254871|NCT00485173|615086|P2|STARTED|Overall Study||486
254872|NCT00485173|615087|P1|STARTED|Overall Study||224
254873|NCT00485134|615135|P8|NOT COMPLETED|Overall Study||1
254874|NCT00485134|615136|P7|NOT COMPLETED|Overall Study||3
254875|NCT00485134|615137|P6|NOT COMPLETED|Overall Study||4
254876|NCT00485134|615138|P5|NOT COMPLETED|Overall Study||3
254877|NCT00485134|615139|P4|NOT COMPLETED|Overall Study||1
254878|NCT00485134|615140|P3|NOT COMPLETED|Overall Study||3
254879|NCT00485134|615141|P2|NOT COMPLETED|Overall Study||2
254880|NCT00485134|615142|P1|NOT COMPLETED|Overall Study||1
254881|NCT00485134|615135|P8|COMPLETED|Overall Study||20
254882|NCT00485134|615136|P7|COMPLETED|Overall Study||28
254883|NCT00485134|615137|P6|COMPLETED|Overall Study||3
254884|NCT00485134|615138|P5|COMPLETED|Overall Study||7
254885|NCT00485134|615139|P4|COMPLETED|Overall Study||7
254886|NCT00485134|615140|P3|COMPLETED|Overall Study||9
254887|NCT00485134|615141|P2|COMPLETED|Overall Study||10
254888|NCT00485134|615142|P1|COMPLETED|Overall Study||11
254889|NCT00485134|615135|P8|STARTED|Overall Study||21
254890|NCT00485134|615136|P7|STARTED|Overall Study||31
254891|NCT00485134|615137|P6|STARTED|Overall Study||7
254892|NCT00485134|615138|P5|STARTED|Overall Study||10
254893|NCT00485134|615139|P4|STARTED|Overall Study||8
254894|NCT00485134|615140|P3|STARTED|Overall Study||12
254895|NCT00485134|615141|P2|STARTED|Overall Study||12
254896|NCT00485134|615142|P1|STARTED|Overall Study||12
254897|NCT00485069|615164|P2|NOT COMPLETED|Overall Study||12
254898|NCT00485069|615165|P1|NOT COMPLETED|Overall Study||18
254899|NCT00485069|615164|P2|COMPLETED|Overall Study||46
254900|NCT00485069|615165|P1|COMPLETED|Overall Study||47
254901|NCT00485069|615164|P2|STARTED|Overall Study||58
254902|NCT00485069|615165|P1|STARTED|Overall Study||65
254903|NCT00484939|615210|P2|NOT COMPLETED|Overall Study||140
254904|NCT00484939|615211|P1|NOT COMPLETED|Overall Study||140
254905|NCT00484939|615210|P2|COMPLETED|Overall Study||0
254906|NCT00484939|615211|P1|COMPLETED|Overall Study||0
254907|NCT00484939|615210|P2|STARTED|Overall Study||140
254908|NCT00484939|615211|P1|STARTED|Overall Study||140
254909|NCT00484679|615231|P1|NOT COMPLETED|Overall Study||3
254910|NCT00484679|615231|P1|COMPLETED|Overall Study||15
254911|NCT00484679|615231|P1|STARTED|Overall Study||18
254912|NCT00484419|615238|P3|NOT COMPLETED|Overall Study||11
254913|NCT00484419|615239|P2|NOT COMPLETED|Overall Study||5
254914|NCT00484419|615240|P1|NOT COMPLETED|Overall Study||12
254915|NCT00484419|615238|P3|COMPLETED|Overall Study||45
254916|NCT00484419|615239|P2|COMPLETED|Overall Study||51
254917|NCT00484419|615240|P1|COMPLETED|Overall Study||45
254918|NCT00484419|615238|P3|STARTED|Overall Study||56
254919|NCT00484419|615239|P2|STARTED|Overall Study||56
254920|NCT00484419|615240|P1|STARTED|Overall Study||57
254921|NCT00484393|615298|P2|NOT COMPLETED|Overall Study||0
254922|NCT00484393|615299|P1|NOT COMPLETED|Overall Study||0
254923|NCT00484393|615298|P2|COMPLETED|Overall Study||3
254924|NCT00484393|615299|P1|COMPLETED|Overall Study||4
254925|NCT00484393|615298|P2|STARTED|Overall Study||3
254926|NCT00484393|615299|P1|STARTED|Overall Study||4
254927|NCT00484315|615307|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
254928|NCT00484315|615308|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
254929|NCT00484315|615307|P2|COMPLETED|9-Month Angiographic Follow-up||61
254930|NCT00484315|615308|P1|COMPLETED|9-Month Angiographic Follow-up||228
254931|NCT00484315|615307|P2|STARTED|9-Month Angiographic Follow-up||74
254932|NCT00484315|615308|P1|STARTED|9-Month Angiographic Follow-up||256
254933|NCT00484315|615307|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
254934|NCT00484315|615308|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
254935|NCT00484315|615307|P2|COMPLETED|12-Month Clinical Follow-up||311
254936|NCT00484315|615308|P1|COMPLETED|12-Month Clinical Follow-up||914
254937|NCT00484315|615307|P2|STARTED|12-Month Clinical Follow-up||320
254938|NCT00484315|615308|P1|STARTED|12-Month Clinical Follow-up||942
254939|NCT00484289|615319|P3|NOT COMPLETED|Post Marketing Phase||0
254940|NCT00484289|615320|P2|NOT COMPLETED|Post Marketing Phase||1
254941|NCT00484289|615321|P1|NOT COMPLETED|Post Marketing Phase||0
254942|NCT00484289|615319|P3|COMPLETED|Post Marketing Phase||10
254943|NCT00484289|615320|P2|COMPLETED|Post Marketing Phase||141
254944|NCT00484289|615321|P1|COMPLETED|Post Marketing Phase||10
254945|NCT00484289|615319|P3|STARTED|Post Marketing Phase||10
254946|NCT00484289|615320|P2|STARTED|Post Marketing Phase||142
254947|NCT00484289|615321|P1|STARTED|Post Marketing Phase||10
254948|NCT00484289|615319|P3|NOT COMPLETED|Long Term Phase||16
254949|NCT00484289|615320|P2|NOT COMPLETED|Long Term Phase||36
254950|NCT00484289|615321|P1|NOT COMPLETED|Long Term Phase||3
254951|NCT00484289|615319|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
254952|NCT00484289|615320|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
254953|NCT00484289|615321|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
254954|NCT00484289|615319|P3|STARTED|Long Term Phase||26
254955|NCT00484289|615320|P2|STARTED|Long Term Phase||178
254956|NCT00484289|615321|P1|STARTED|Long Term Phase||13
254957|NCT00484185|615393|P1|NOT COMPLETED|Overall Study||71
254958|NCT00484185|615393|P1|COMPLETED|Overall Study||112
254959|NCT00484185|615393|P1|Treated|Overall Study||178
254960|NCT00484185|615393|P1|STARTED|Overall Study||183
254961|NCT00484159|615415|P3|NOT COMPLETED|Overall Study||0
254962|NCT00484159|615416|P2|NOT COMPLETED|Overall Study||1
254963|NCT00484159|615417|P1|NOT COMPLETED|Overall Study||1
254964|NCT00484159|615415|P3|COMPLETED|Overall Study||51
254965|NCT00484159|615416|P2|COMPLETED|Overall Study||49
254966|NCT00484159|615417|P1|COMPLETED|Overall Study||49
254967|NCT00484159|615415|P3|STARTED|Overall Study||51
254968|NCT00484159|615416|P2|STARTED|Overall Study||50
254969|NCT00484159|615417|P1|STARTED|Overall Study||50
254970|NCT00484094|615428|P1|NOT COMPLETED|Overall Study||42
254971|NCT00484094|615428|P1|COMPLETED|Overall Study||167
254972|NCT00484094|615428|P1|STARTED|Overall Study||209
254973|NCT00483938|615444|P7|NOT COMPLETED|Overall Study||40
254974|NCT00483938|615445|P6|NOT COMPLETED|Overall Study||8
254975|NCT00483938|615446|P5|NOT COMPLETED|Overall Study||2
254976|NCT00483938|615447|P4|NOT COMPLETED|Overall Study||6
254977|NCT00483938|615448|P3|NOT COMPLETED|Overall Study||0
254978|NCT00483938|615449|P2|NOT COMPLETED|Overall Study||19
254979|NCT00483938|615450|P1|NOT COMPLETED|Overall Study||5
254980|NCT00483938|615444|P7|COMPLETED|Overall Study||0
254981|NCT00483938|615445|P6|COMPLETED|Overall Study||18
254982|NCT00483938|615446|P5|COMPLETED|Overall Study||23
254983|NCT00483938|615447|P4|COMPLETED|Overall Study||25
254984|NCT00483938|615448|P3|COMPLETED|Overall Study||30
254985|NCT00483938|615449|P2|COMPLETED|Overall Study||24
254986|NCT00483938|615450|P1|COMPLETED|Overall Study||36
254987|NCT00483938|615444|P7|STARTED|Overall Study||40
254988|NCT00483938|615445|P6|STARTED|Overall Study||26
254989|NCT00483938|615446|P5|STARTED|Overall Study||25
254990|NCT00483938|615447|P4|STARTED|Overall Study||31
254991|NCT00483938|615448|P3|STARTED|Overall Study||30
254992|NCT00483938|615449|P2|STARTED|Overall Study||43
254993|NCT00483938|615450|P1|STARTED|Overall Study||41
254994|NCT00483756|615474|P3|NOT COMPLETED|Overall Study||52
254995|NCT00483756|615475|P2|NOT COMPLETED|Overall Study||50
254996|NCT00483756|615476|P1|NOT COMPLETED|Overall Study||33
254997|NCT00483756|615474|P3|COMPLETED|Overall Study||59
254998|NCT00483756|615475|P2|COMPLETED|Overall Study||60
254999|NCT00483756|615476|P1|COMPLETED|Overall Study||77
255000|NCT00483756|615474|P3|Treated|Overall Study||107
255001|NCT00483756|615475|P2|Treated|Overall Study||106
255002|NCT00483756|615476|P1|Treated|Overall Study||109
255003|NCT00483756|615474|P3|STARTED|Overall Study||111
255004|NCT00483756|615475|P2|STARTED|Overall Study||110
255005|NCT00483756|615476|P1|STARTED|Overall Study||110
255006|NCT00483717|615540|P2|NOT COMPLETED|Overall Study||21
255007|NCT00483717|615541|P1|NOT COMPLETED|Overall Study||24
255008|NCT00483717|615540|P2|COMPLETED|Overall Study||65
255009|NCT00483717|615541|P1|COMPLETED|Overall Study||63
255010|NCT00483717|615540|P2|STARTED|Overall Study||86
255011|NCT00483717|615541|P1|STARTED|Overall Study||87
255012|NCT00483704|615564|P3|NOT COMPLETED|Treatment||156
255013|NCT00483704|615565|P2|NOT COMPLETED|Treatment||129
255014|NCT00483704|615566|P1|NOT COMPLETED|Treatment||129
255015|NCT00483704|615564|P3|COMPLETED|Treatment||399
255016|NCT00483704|615565|P2|COMPLETED|Treatment||420
255017|NCT00483704|615566|P1|COMPLETED|Treatment||444
255018|NCT00483704|615564|P3|STARTED|Treatment||555
255019|NCT00483704|615565|P2|STARTED|Treatment||549
255020|NCT00483704|615566|P1|STARTED|Treatment||573
255021|NCT00483704|615564|P3|NOT COMPLETED|Randomization||91
255022|NCT00483704|615565|P2|NOT COMPLETED|Randomization||96
255023|NCT00483704|615566|P1|NOT COMPLETED|Randomization||71
255024|NCT00483704|615564|P3|COMPLETED|Randomization||555
255025|NCT00483704|615565|P2|COMPLETED|Randomization||549
255026|NCT00483704|615566|P1|COMPLETED|Randomization||573
255027|NCT00483704|615564|P3|STARTED|Randomization||646
255028|NCT00483704|615565|P2|STARTED|Randomization||645
255029|NCT00483704|615566|P1|STARTED|Randomization||644
255030|NCT00483652|615612|P2|NOT COMPLETED|Post-study Follow-up||0
255031|NCT00483652|615613|P1|NOT COMPLETED|Post-study Follow-up||0
255032|NCT00483652|615612|P2|COMPLETED|Post-study Follow-up||114
255033|NCT00483652|615613|P1|COMPLETED|Post-study Follow-up||113
255034|NCT00483652|615612|P2|STARTED|Post-study Follow-up||114
255035|NCT00483652|615613|P1|STARTED|Post-study Follow-up||113
255036|NCT00483652|615612|P2|NOT COMPLETED|Double-blind Treatment Period||5
255037|NCT00483652|615613|P1|NOT COMPLETED|Double-blind Treatment Period||7
255038|NCT00483652|615612|P2|COMPLETED|Double-blind Treatment Period||114
255039|NCT00483652|615613|P1|COMPLETED|Double-blind Treatment Period||113
255040|NCT00483652|615612|P2|STARTED|Double-blind Treatment Period||119
255041|NCT00483652|615613|P1|STARTED|Double-blind Treatment Period||120
255042|NCT00483574|615623|P2|NOT COMPLETED|Overall Study||13
255043|NCT00483574|615624|P1|NOT COMPLETED|Overall Study||102
255044|NCT00483574|615623|P2|COMPLETED|Overall Study||308
255045|NCT00483574|615624|P1|COMPLETED|Overall Study||951
255046|NCT00483574|615623|P2|STARTED|Overall Study||321
255047|NCT00483574|615624|P1|STARTED|Overall Study||1053
255048|NCT00483548|615634|P2|NOT COMPLETED|Overall Study||46
255049|NCT00483548|615635|P1|NOT COMPLETED|Overall Study||60
255050|NCT00483548|615634|P2|COMPLETED|Overall Study||104
255051|NCT00483548|615635|P1|COMPLETED|Overall Study||88
255052|NCT00483548|615634|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
255053|NCT00483548|615635|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
255054|NCT00483548|615634|P2|STARTED|Overall Study||150
255055|NCT00483548|615635|P1|STARTED|Overall Study||148
255056|NCT00483496|615673|P1|NOT COMPLETED|Overall Study||1
255057|NCT00483496|615673|P1|COMPLETED|Overall Study||15
255058|NCT00483496|615673|P1|STARTED|Overall Study||16
255059|NCT00483405|615685|P1|NOT COMPLETED|Overall Study||28
255060|NCT00483405|615685|P1|COMPLETED|Overall Study||0
255061|NCT00483405|615685|P1|STARTED|Overall Study||28
255062|NCT00483379|615694|P2|NOT COMPLETED|Extension Period||0
255063|NCT00483379|615695|P1|NOT COMPLETED|Extension Period||0
255064|NCT00483379|615694|P2|COMPLETED|Extension Period||2
255065|NCT00483379|615695|P1|COMPLETED|Extension Period||1
255066|NCT00483379|615694|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
255067|NCT00483379|615695|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
255068|NCT00483379|615694|P2|NOT COMPLETED|Treatment Period||0
255069|NCT00483379|615695|P1|NOT COMPLETED|Treatment Period||2
255070|NCT00483379|615694|P2|COMPLETED|Treatment Period||7
255071|NCT00483379|615695|P1|COMPLETED|Treatment Period||4
255072|NCT00483379|615694|P2|STARTED|Treatment Period||7
255073|NCT00483379|615695|P1|STARTED|Treatment Period||6
255074|NCT00483327|615731|P1|NOT COMPLETED|Overall Study||10
255075|NCT00483327|615731|P1|COMPLETED|Overall Study||20
255076|NCT00483327|615731|P1|STARTED|Overall Study||30
255077|NCT00483262|615742|P2|NOT COMPLETED|Overall Study||0
255078|NCT00483262|615743|P1|NOT COMPLETED|Overall Study||0
255079|NCT00483262|615742|P2|COMPLETED|Overall Study||43
255080|NCT00483262|615743|P1|COMPLETED|Overall Study||20
255081|NCT00483262|615742|P2|STARTED|Overall Study||43
255082|NCT00483262|615743|P1|STARTED|Overall Study||20
255083|NCT00483223|615753|P1|NOT COMPLETED|Overall Study||0
255084|NCT00483223|615753|P1|COMPLETED|Overall Study||86
255085|NCT00483223|615753|P1|STARTED|Overall Study||86
255086|NCT00483184|615763|P3|NOT COMPLETED|Overall Study||3
255087|NCT00483184|615764|P2|NOT COMPLETED|Overall Study||4
255088|NCT00483184|615765|P1|NOT COMPLETED|Overall Study||5
255089|NCT00483184|615763|P3|COMPLETED|Overall Study||23
255090|NCT00483184|615764|P2|COMPLETED|Overall Study||27
255091|NCT00483184|615765|P1|COMPLETED|Overall Study||22
255092|NCT00483184|615763|P3|STARTED|Overall Study||26
255093|NCT00483184|615764|P2|STARTED|Overall Study||31
255094|NCT00483184|615765|P1|STARTED|Overall Study||27
255095|NCT00483119|615775|P2|NOT COMPLETED|Overall Study||1
255096|NCT00483119|615776|P1|NOT COMPLETED|Overall Study||1
255097|NCT00483119|615775|P2|COMPLETED|Overall Study||3
255098|NCT00483119|615776|P1|COMPLETED|Overall Study||4
255099|NCT00483119|615775|P2|STARTED|Overall Study||4
255100|NCT00483119|615776|P1|STARTED|Overall Study||5
255101|NCT00483041|615790|P2|NOT COMPLETED|Overall Study||1
255102|NCT00483041|615791|P1|NOT COMPLETED|Overall Study||0
255103|NCT00483041|615790|P2|COMPLETED|Overall Study||5
255104|NCT00483041|615791|P1|COMPLETED|Overall Study||5
255105|NCT00483041|615790|P2|STARTED|Overall Study||6
255106|NCT00483041|615791|P1|STARTED|Overall Study||5
255107|NCT00483002|615821|P1|NOT COMPLETED|Overall Study||2554
255108|NCT00483002|615821|P1|COMPLETED|Overall Study||1165
255109|NCT00483002|615821|P1|STARTED|Overall Study||3719
255110|NCT00482911|615829|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
255111|NCT00482911|615830|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
255112|NCT00482911|615829|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
255113|NCT00482911|615830|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
255114|NCT00482911|615829|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
255115|NCT00482911|615830|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
255116|NCT00482911|615829|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
255117|NCT00482911|615830|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
255118|NCT00482911|615829|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
255119|NCT00482911|615830|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
255120|NCT00482911|615829|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
255121|NCT00482911|615830|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
255122|NCT00482911|615829|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
255123|NCT00482911|615830|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
255124|NCT00482911|615829|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
255125|NCT00482911|615830|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
255126|NCT00482911|615829|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
255127|NCT00482911|615830|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
255128|NCT00482729|615846|P2|NOT COMPLETED|Overall Study||218
255129|NCT00482729|615847|P1|NOT COMPLETED|Overall Study||217
255130|NCT00482729|615846|P2|COMPLETED|Overall Study||406
255131|NCT00482729|615847|P1|COMPLETED|Overall Study||409
255132|NCT00482729|615846|P2|Completed Phase B|Overall Study||406
255133|NCT00482729|615847|P1|Completed Phase B|Overall Study||409
255134|NCT00482729|615846|P2|Completed Phase A|Overall Study||482
255135|NCT00482729|615847|P1|Completed Phase A|Overall Study||484
255136|NCT00482729|615846|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
255137|NCT00482729|615847|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
255138|NCT00482703|615863|P2|NOT COMPLETED|Overall Study||0
255139|NCT00482703|615864|P1|NOT COMPLETED|Overall Study||1
255140|NCT00482703|615863|P2|COMPLETED|Overall Study||12
255141|NCT00482703|615864|P1|COMPLETED|Overall Study||10
255142|NCT00482703|615863|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
255143|NCT00482703|615864|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
255144|NCT00482677|615911|P2|NOT COMPLETED|Overall Study||0
255145|NCT00482677|615912|P1|NOT COMPLETED|Overall Study||0
255146|NCT00482677|615911|P2|COMPLETED|Overall Study||281
255147|NCT00482677|615912|P1|COMPLETED|Overall Study||281
255148|NCT00482677|615911|P2|STARTED|Overall Study||281
255149|NCT00482677|615912|P1|STARTED|Overall Study||281
255150|NCT00482625|615922|P1|NOT COMPLETED|Overall Study||0
255151|NCT00482625|615922|P1|COMPLETED|Overall Study||6
255152|NCT00482625|615922|P1|STARTED|Overall Study||6
255153|NCT00482612|615935|P4|NOT COMPLETED|Follow-up Period||8
255154|NCT00482612|615936|P3|NOT COMPLETED|Follow-up Period||22
255155|NCT00482612|615937|P2|NOT COMPLETED|Follow-up Period||18
255156|NCT00482612|615938|P1|NOT COMPLETED|Follow-up Period||14
255157|NCT00482612|615935|P4|COMPLETED|Follow-up Period||127
255158|NCT00482612|615936|P3|COMPLETED|Follow-up Period||106
255159|NCT00482612|615937|P2|COMPLETED|Follow-up Period||107
255160|NCT00482612|615938|P1|COMPLETED|Follow-up Period||123
255161|NCT00482612|615935|P4|STARTED|Follow-up Period||135
255162|NCT00482612|615936|P3|STARTED|Follow-up Period||128
255163|NCT00482612|615937|P2|STARTED|Follow-up Period||125
255164|NCT00482612|615938|P1|STARTED|Follow-up Period||137
255165|NCT00482612|615935|P4|NOT COMPLETED|In-treatment Period||0
255166|NCT00482612|615936|P3|NOT COMPLETED|In-treatment Period||1
255167|NCT00482612|615937|P2|NOT COMPLETED|In-treatment Period||0
255168|NCT00482612|615938|P1|NOT COMPLETED|In-treatment Period||0
255169|NCT00482612|615935|P4|COMPLETED|In-treatment Period||135
255170|NCT00482612|615936|P3|COMPLETED|In-treatment Period||128
255171|NCT00482612|615937|P2|COMPLETED|In-treatment Period||125
255172|NCT00482612|615938|P1|COMPLETED|In-treatment Period||137
255173|NCT00482612|615935|P4|Treated|In-treatment Period||135
255174|NCT00482612|615936|P3|Treated|In-treatment Period||128
255175|NCT00482612|615937|P2|Treated|In-treatment Period||125
255176|NCT00482612|615938|P1|Treated|In-treatment Period||137
255177|NCT00482612|615935|P4|STARTED|In-treatment Period||135
255178|NCT00482612|615936|P3|STARTED|In-treatment Period||129
255179|NCT00482612|615937|P2|STARTED|In-treatment Period||125
255180|NCT00482612|615938|P1|STARTED|In-treatment Period||137
255181|NCT00482547|615966|P2|NOT COMPLETED|Overall Study||161
255182|NCT00482547|615967|P1|NOT COMPLETED|Overall Study||173
255183|NCT00482547|615966|P2|COMPLETED|Overall Study||428
255184|NCT00482547|615967|P1|COMPLETED|Overall Study||426
255185|NCT00482547|615966|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
255186|NCT00482547|615967|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
255187|NCT00482547|615966|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
255276|NCT00481676|616256|P1|COMPLETED|Overall Study||25
255188|NCT00482547|615967|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
255189|NCT00482547|615966|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
255190|NCT00482547|615967|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
255191|NCT00482391|615987|P1|NOT COMPLETED|Overall Study||3
255192|NCT00482391|615987|P1|COMPLETED|Overall Study||92
255193|NCT00482391|615987|P1|STARTED|Overall Study||95
255194|NCT00482274|615992|P1|NOT COMPLETED|Overall Study||1
255195|NCT00482274|615992|P1|COMPLETED|Overall Study||2
255196|NCT00482274|615992|P1|STARTED|Overall Study||3
255197|NCT00482170|616002|P2|NOT COMPLETED|Overall Study||20
255198|NCT00482170|616003|P1|NOT COMPLETED|Overall Study||15
255199|NCT00482170|616002|P2|COMPLETED|Overall Study||194
255200|NCT00482170|616003|P1|COMPLETED|Overall Study||192
255201|NCT00482170|616002|P2|Treated|Overall Study||211
255202|NCT00482170|616003|P1|Treated|Overall Study||207
255203|NCT00482170|616002|P2|STARTED|Overall Study||214
255204|NCT00482170|616003|P1|STARTED|Overall Study||207
255205|NCT00482053|616121|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
255206|NCT00482053|616121|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
255207|NCT00482053|616121|P1|STARTED|Allogeneic Peripheral Stem Cells||2
255208|NCT00482053|616121|P1|NOT COMPLETED|Inter-treatment Period||1
255209|NCT00482053|616121|P1|COMPLETED|Inter-treatment Period||2
255210|NCT00482053|616121|P1|STARTED|Inter-treatment Period||3
255211|NCT00482053|616121|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
255212|NCT00482053|616121|P1|COMPLETED|Autologous Peripheral Stem Cells||3
255213|NCT00482053|616121|P1|STARTED|Autologous Peripheral Stem Cells||3
255214|NCT00482014|616135|P4|NOT COMPLETED|Overall Study||23
255215|NCT00482014|616136|P3|NOT COMPLETED|Overall Study||11
255216|NCT00482014|616137|P2|NOT COMPLETED|Overall Study||6
255217|NCT00482014|616138|P1|NOT COMPLETED|Overall Study||7
255218|NCT00482014|616135|P4|COMPLETED|Overall Study||29
255219|NCT00482014|616136|P3|COMPLETED|Overall Study||35
255220|NCT00482014|616137|P2|COMPLETED|Overall Study||7
255221|NCT00482014|616138|P1|COMPLETED|Overall Study||2
255222|NCT00482014|616135|P4|STARTED|Overall Study||52
255223|NCT00482014|616136|P3|STARTED|Overall Study||46
255224|NCT00482014|616137|P2|STARTED|Overall Study||13
255225|NCT00482014|616138|P1|STARTED|Overall Study||9
255226|NCT00481988|616162|P2|NOT COMPLETED|Overall Study||1
255227|NCT00481988|616163|P1|NOT COMPLETED|Overall Study||1
255228|NCT00481988|616162|P2|COMPLETED|Overall Study||8
255229|NCT00481988|616163|P1|COMPLETED|Overall Study||11
255230|NCT00481988|616162|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
255231|NCT00481988|616163|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
255232|NCT00481988|616162|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
255233|NCT00481988|616163|P1|STARTED|Overall Study||12
255234|NCT00481871|616176|P5|NOT COMPLETED|Overall Study||0
255235|NCT00481871|616177|P4|NOT COMPLETED|Overall Study||0
255236|NCT00481871|616178|P3|NOT COMPLETED|Overall Study||1
255237|NCT00481871|616179|P2|NOT COMPLETED|Overall Study||0
255238|NCT00481871|616180|P1|NOT COMPLETED|Overall Study||0
255239|NCT00481871|616176|P5|COMPLETED|Overall Study||34
255240|NCT00481871|616177|P4|COMPLETED|Overall Study||38
255241|NCT00481871|616178|P3|COMPLETED|Overall Study||17
255242|NCT00481871|616179|P2|COMPLETED|Overall Study||10
255243|NCT00481871|616180|P1|COMPLETED|Overall Study||7
255244|NCT00481871|616176|P5|STARTED|Overall Study||34
255245|NCT00481871|616177|P4|STARTED|Overall Study||38
255246|NCT00481871|616178|P3|STARTED|Overall Study||18
255247|NCT00481871|616179|P2|STARTED|Overall Study||10
255248|NCT00481871|616180|P1|STARTED|Overall Study||7
255249|NCT00481845|616196|P2|NOT COMPLETED|Overall Study||0
255250|NCT00481845|616197|P1|NOT COMPLETED|Overall Study||0
255251|NCT00481845|616196|P2|COMPLETED|Overall Study||0
255252|NCT00481845|616197|P1|COMPLETED|Overall Study||1
255253|NCT00481845|616196|P2|STARTED|Overall Study||0
255254|NCT00481845|616197|P1|STARTED|Overall Study||1
255255|NCT00481832|616205|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
255256|NCT00481832|616205|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
255257|NCT00481832|616205|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
255258|NCT00481832|616205|P1|NOT COMPLETED|Inter-transplant Period||27
255259|NCT00481832|616205|P1|COMPLETED|Inter-transplant Period||13
255260|NCT00481832|616205|P1|STARTED|Inter-transplant Period||40
255261|NCT00481832|616205|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
255262|NCT00481832|616205|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
255263|NCT00481832|616205|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
255264|NCT00481832|616205|P1|NOT COMPLETED|Enrollment||10
255265|NCT00481832|616205|P1|COMPLETED|Enrollment||40
255266|NCT00481832|616205|P1|STARTED|Enrollment||50
255267|NCT00481767|616220|P2|NOT COMPLETED|Overall Study||21
255268|NCT00481767|616221|P1|NOT COMPLETED|Overall Study||32
255269|NCT00481767|616220|P2|COMPLETED|Overall Study||205
255270|NCT00481767|616221|P1|COMPLETED|Overall Study||418
255271|NCT00481767|616220|P2|STARTED|Overall Study||226
255272|NCT00481767|616221|P1|STARTED|Overall Study||450
255273|NCT00481676|616255|P2|NOT COMPLETED|Overall Study||5
255274|NCT00481676|616256|P1|NOT COMPLETED|Overall Study||2
255275|NCT00481676|616255|P2|COMPLETED|Overall Study||17
255277|NCT00481676|616255|P2|STARTED|Overall Study||22
255278|NCT00481676|616256|P1|STARTED|Overall Study||27
255279|NCT00481507|616280|P2|NOT COMPLETED|Overall Study||0
255280|NCT00481507|616281|P1|NOT COMPLETED|Overall Study||0
255281|NCT00481507|616280|P2|COMPLETED|Overall Study||61
255282|NCT00481507|616281|P1|COMPLETED|Overall Study||64
255283|NCT00481507|616280|P2|STARTED|Overall Study||61
255284|NCT00481507|616281|P1|STARTED|Overall Study||64
255285|NCT00481351|616289|P2|NOT COMPLETED|Overall Study||0
255286|NCT00481351|616290|P1|NOT COMPLETED|Overall Study||0
255287|NCT00481351|616289|P2|COMPLETED|Overall Study||12
255288|NCT00481351|616290|P1|COMPLETED|Overall Study||13
255289|NCT00481351|616289|P2|STARTED|Overall Study||12
255290|NCT00481351|616290|P1|STARTED|Overall Study||13
255291|NCT00481247|616306|P2|NOT COMPLETED|Overall Study||260
255292|NCT00481247|616307|P1|NOT COMPLETED|Overall Study||259
255293|NCT00481247|616306|P2|COMPLETED|Overall Study||0
255294|NCT00481247|616307|P1|COMPLETED|Overall Study||0
255295|NCT00481247|616306|P2|Received Treatment|Overall Study||258
255296|NCT00481247|616307|P1|Received Treatment|Overall Study||258
255297|NCT00481247|616306|P2|STARTED|Overall Study|Randomized|260
255298|NCT00481247|616307|P1|STARTED|Overall Study|Randomized|259
255299|NCT00481195|616331|P2|NOT COMPLETED|Overall Study||39
255300|NCT00481195|616332|P1|NOT COMPLETED|Overall Study||39
255301|NCT00481195|616331|P2|COMPLETED|Overall Study||90
255302|NCT00481195|616332|P1|COMPLETED|Overall Study||89
255303|NCT00481195|616331|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
255304|NCT00481195|616332|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
255305|NCT00481078|616418|P2|NOT COMPLETED|Overall Study||20
255306|NCT00481078|616419|P1|NOT COMPLETED|Overall Study||42
255307|NCT00481078|616418|P2|COMPLETED|Overall Study||12
255308|NCT00481078|616419|P1|COMPLETED|Overall Study||20
255309|NCT00481078|616418|P2|STARTED|Overall Study||32
255310|NCT00481078|616419|P1|STARTED|Overall Study||62
255311|NCT00481065|616437|P8|NOT COMPLETED|Overall Study||19
255312|NCT00481065|616438|P7|NOT COMPLETED|Overall Study||16
255313|NCT00481065|616439|P6|NOT COMPLETED|Overall Study||24
255314|NCT00481065|616440|P5|NOT COMPLETED|Overall Study||23
255315|NCT00481065|616441|P4|NOT COMPLETED|Overall Study||15
255316|NCT00481065|616442|P3|NOT COMPLETED|Overall Study||19
255317|NCT00481065|616443|P2|NOT COMPLETED|Overall Study||17
255318|NCT00481065|616444|P1|NOT COMPLETED|Overall Study||22
255319|NCT00481065|616437|P8|COMPLETED|Overall Study||30
255320|NCT00481065|616438|P7|COMPLETED|Overall Study||34
255321|NCT00481065|616439|P6|COMPLETED|Overall Study||27
255322|NCT00481065|616440|P5|COMPLETED|Overall Study||28
255323|NCT00481065|616441|P4|COMPLETED|Overall Study||37
255324|NCT00481065|616442|P3|COMPLETED|Overall Study||32
255325|NCT00481065|616443|P2|COMPLETED|Overall Study||33
255326|NCT00481065|616444|P1|COMPLETED|Overall Study||29
255327|NCT00481065|616437|P8|STARTED|Overall Study||49
255328|NCT00481065|616438|P7|STARTED|Overall Study||50
255329|NCT00481065|616439|P6|STARTED|Overall Study||51
255330|NCT00481065|616440|P5|STARTED|Overall Study||51
255331|NCT00481065|616441|P4|STARTED|Overall Study||52
255332|NCT00481065|616442|P3|STARTED|Overall Study||51
255333|NCT00481065|616443|P2|STARTED|Overall Study||50
255334|NCT00481065|616444|P1|STARTED|Overall Study||51
255335|NCT00480987|616530|P1|NOT COMPLETED|Overall Study||0
255336|NCT00480987|616530|P1|COMPLETED|Overall Study||27
255337|NCT00480987|616530|P1|STARTED|Overall Study||27
255338|NCT00480857|616534|P1|NOT COMPLETED|Overall Study||2
255339|NCT00480857|616534|P1|COMPLETED|Overall Study||17
255340|NCT00480857|616534|P1|STARTED|Overall Study||19
255341|NCT00480779|616544|P2|NOT COMPLETED|Overall Study||3
255342|NCT00480779|616545|P1|NOT COMPLETED|Overall Study||2
255343|NCT00480779|616544|P2|COMPLETED|Overall Study||19
255344|NCT00480779|616545|P1|COMPLETED|Overall Study||24
255345|NCT00480779|616544|P2|STARTED|Overall Study||22
255346|NCT00480779|616545|P1|STARTED|Overall Study||26
255347|NCT00480740|616572|P3|NOT COMPLETED|Overall Study||0
255348|NCT00480740|616573|P2|NOT COMPLETED|Overall Study||0
255349|NCT00480740|616574|P1|NOT COMPLETED|Overall Study||0
255350|NCT00480740|616572|P3|COMPLETED|Overall Study||6
255351|NCT00480740|616573|P2|COMPLETED|Overall Study||9
255352|NCT00480740|616574|P1|COMPLETED|Overall Study||26
255353|NCT00480740|616572|P3|STARTED|Overall Study||6
255354|NCT00480740|616573|P2|STARTED|Overall Study||9
255355|NCT00480740|616574|P1|STARTED|Overall Study||26
255356|NCT00480636|616582|P1|NOT COMPLETED|Overall Study||19
255357|NCT00480636|616582|P1|COMPLETED|Overall Study||83
255358|NCT00480636|616582|P1|STARTED|Overall Study||102
255359|NCT00480532|616594|P4|NOT COMPLETED|Overall Study||1
255360|NCT00480532|616595|P3|NOT COMPLETED|Overall Study||4
255361|NCT00480532|616596|P2|NOT COMPLETED|Overall Study||4
255362|NCT00480532|616597|P1|NOT COMPLETED|Overall Study||2
255363|NCT00480532|616594|P4|COMPLETED|Overall Study||31
255364|NCT00480532|616595|P3|COMPLETED|Overall Study||29
255365|NCT00480532|616596|P2|COMPLETED|Overall Study||29
255366|NCT00480532|616597|P1|COMPLETED|Overall Study||31
255367|NCT00480532|616594|P4|STARTED|Overall Study||32
255368|NCT00480532|616595|P3|STARTED|Overall Study||33
255369|NCT00480532|616596|P2|STARTED|Overall Study||33
255370|NCT00480532|616597|P1|STARTED|Overall Study||33
255371|NCT00480493|616617|P2|NOT COMPLETED|Overall Study||7
255372|NCT00480493|616618|P1|NOT COMPLETED|Overall Study||2
255373|NCT00480493|616617|P2|COMPLETED|Overall Study||21
255374|NCT00480493|616618|P1|COMPLETED|Overall Study||30
255375|NCT00480493|616617|P2|Randomized|Overall Study||28
255376|NCT00480493|616618|P1|Randomized|Overall Study||32
255377|NCT00480493|616617|P2|STARTED|Overall Study||28
255378|NCT00480493|616618|P1|STARTED|Overall Study||32
255379|NCT00480324|616630|P2|NOT COMPLETED|Overall Study||16
255380|NCT00480324|616631|P1|NOT COMPLETED|Overall Study||32
255381|NCT00480324|616630|P2|COMPLETED|Overall Study||241
255382|NCT00480324|616631|P1|COMPLETED|Overall Study||476
255383|NCT00480324|616630|P2|STARTED|Overall Study||257
255384|NCT00480324|616631|P1|STARTED|Overall Study||508
255385|NCT00479882|616661|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
255386|NCT00479882|616662|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
255387|NCT00479882|616663|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
255388|NCT00479882|616664|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
255389|NCT00479882|616661|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
255390|NCT00479882|616662|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
255391|NCT00479882|616663|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
255392|NCT00479882|616664|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
255393|NCT00479882|616661|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
255394|NCT00479882|616662|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
255395|NCT00479882|616663|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
255396|NCT00479882|616664|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
255397|NCT00479882|616661|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
255398|NCT00479882|616662|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
255399|NCT00479882|616663|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
255400|NCT00479882|616664|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
255401|NCT00479882|616661|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
255402|NCT00479882|616662|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
255403|NCT00479882|616663|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
255404|NCT00479882|616664|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
255405|NCT00479882|616661|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
255406|NCT00479882|616662|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
255407|NCT00479882|616663|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
255408|NCT00479882|616664|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
255409|NCT00479856|616794|P1|NOT COMPLETED|Overall Study||3
255410|NCT00479856|616794|P1|COMPLETED|Overall Study||6
255411|NCT00479856|616794|P1|STARTED|Overall Study||9
255412|NCT00479765|616803|P1|NOT COMPLETED|Overall Study||4
255413|NCT00479765|616803|P1|COMPLETED|Overall Study||0
255414|NCT00479765|616803|P1|STARTED|Overall Study||4
255415|NCT00479713|616809|P2|NOT COMPLETED|Overall Study||9
255416|NCT00479713|616810|P1|NOT COMPLETED|Overall Study||13
255417|NCT00479713|616809|P2|COMPLETED|Overall Study||295
255418|NCT00479713|616810|P1|COMPLETED|Overall Study||301
255419|NCT00479713|616809|P2|STARTED|Overall Study||304
255420|NCT00479713|616810|P1|STARTED|Overall Study||314
255421|NCT00479674|616834|P1|NOT COMPLETED|Overall Study||41
255422|NCT00479674|616834|P1|COMPLETED|Overall Study||0
255423|NCT00479674|616834|P1|STARTED|Overall Study||41
255424|NCT00479557|616849|P7|NOT COMPLETED|Overall Study||2
255425|NCT00479557|616850|P6|NOT COMPLETED|Overall Study||13
255426|NCT00479557|616851|P5|NOT COMPLETED|Overall Study||4
255427|NCT00479557|616852|P4|NOT COMPLETED|Overall Study||5
255428|NCT00479557|616853|P3|NOT COMPLETED|Overall Study||8
255429|NCT00479557|616854|P2|NOT COMPLETED|Overall Study||10
255430|NCT00479557|616855|P1|NOT COMPLETED|Overall Study||10
255431|NCT00479557|616849|P7|COMPLETED|Overall Study||15
255432|NCT00479557|616850|P6|COMPLETED|Overall Study||31
255433|NCT00479557|616851|P5|COMPLETED|Overall Study||8
255434|NCT00479557|616852|P4|COMPLETED|Overall Study||30
255435|NCT00479557|616853|P3|COMPLETED|Overall Study||32
255436|NCT00479557|616854|P2|COMPLETED|Overall Study||51
255437|NCT00479557|616855|P1|COMPLETED|Overall Study||26
255438|NCT00479557|616849|P7|Treated|Overall Study||17
255439|NCT00479557|616850|P6|Treated|Overall Study||44
255440|NCT00479557|616851|P5|Treated|Overall Study||12
255441|NCT00479557|616852|P4|Treated|Overall Study||35
255442|NCT00479557|616853|P3|Treated|Overall Study||40
255443|NCT00479557|616854|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
255444|NCT00479557|616855|P1|Treated|Overall Study||36
255445|NCT00479557|616849|P7|STARTED|Overall Study||17
255446|NCT00479557|616850|P6|STARTED|Overall Study||44
255447|NCT00479557|616851|P5|STARTED|Overall Study||12
255448|NCT00479557|616852|P4|STARTED|Overall Study||35
255449|NCT00479557|616853|P3|STARTED|Overall Study||40
255450|NCT00479557|616854|P2|STARTED|Overall Study||61
255451|NCT00479557|616855|P1|STARTED|Overall Study||36
255452|NCT00479466|616898|P6|NOT COMPLETED|Overall Study||4
255453|NCT00479466|616899|P5|NOT COMPLETED|Overall Study||8
255454|NCT00479466|616900|P4|NOT COMPLETED|Overall Study||3
255455|NCT00479466|616901|P3|NOT COMPLETED|Overall Study||3
255456|NCT00479466|616902|P2|NOT COMPLETED|Overall Study||8
255457|NCT00479466|616903|P1|NOT COMPLETED|Overall Study||13
255458|NCT00479466|616898|P6|COMPLETED|Overall Study||53
255459|NCT00479466|616899|P5|COMPLETED|Overall Study||48
255460|NCT00479466|616900|P4|COMPLETED|Overall Study||55
255461|NCT00479466|616901|P3|COMPLETED|Overall Study||54
255462|NCT00479466|616902|P2|COMPLETED|Overall Study||49
255463|NCT00479466|616903|P1|COMPLETED|Overall Study||44
255464|NCT00479466|616898|P6|STARTED|Overall Study||57
255465|NCT00479466|616899|P5|STARTED|Overall Study||56
255466|NCT00479466|616900|P4|STARTED|Overall Study||58
255467|NCT00479466|616901|P3|STARTED|Overall Study||57
255468|NCT00479466|616902|P2|STARTED|Overall Study||57
255469|NCT00479466|616903|P1|STARTED|Overall Study||57
255470|NCT00479401|616932|P3|NOT COMPLETED|Overall Study||12
255471|NCT00479401|616933|P2|NOT COMPLETED|Overall Study||37
255472|NCT00479401|616934|P1|NOT COMPLETED|Overall Study||49
255473|NCT00479401|616932|P3|COMPLETED|Overall Study||91
255474|NCT00479401|616933|P2|COMPLETED|Overall Study||176
255475|NCT00479401|616934|P1|COMPLETED|Overall Study||174
255476|NCT00479401|616932|P3|STARTED|Overall Study||103
255477|NCT00479401|616933|P2|STARTED|Overall Study||213
255478|NCT00479401|616934|P1|STARTED|Overall Study||223
255479|NCT00479388|616989|P2|NOT COMPLETED|Overall Study||73
255480|NCT00479388|616990|P1|NOT COMPLETED|Overall Study||132
255481|NCT00479388|616989|P2|COMPLETED|Overall Study||537
255482|NCT00479388|616990|P1|COMPLETED|Overall Study||474
255483|NCT00479388|616989|P2|STARTED|Overall Study||610
255484|NCT00479388|616990|P1|STARTED|Overall Study||606
255485|NCT00479336|617004|P4|NOT COMPLETED|Overall Study||5
255486|NCT00479336|617005|P3|NOT COMPLETED|Overall Study||1
255487|NCT00479336|617006|P2|NOT COMPLETED|Overall Study||6
255488|NCT00479336|617007|P1|NOT COMPLETED|Overall Study||4
255489|NCT00479336|617004|P4|COMPLETED|Overall Study||21
255490|NCT00479336|617005|P3|COMPLETED|Overall Study||24
255491|NCT00479336|617006|P2|COMPLETED|Overall Study||20
255492|NCT00479336|617007|P1|COMPLETED|Overall Study||23
255493|NCT00479336|617004|P4|STARTED|Overall Study||26
255494|NCT00479336|617005|P3|STARTED|Overall Study||25
255495|NCT00479336|617006|P2|STARTED|Overall Study||26
255496|NCT00479336|617007|P1|STARTED|Overall Study||27
255497|NCT00479258|617023|P2|NOT COMPLETED|Overall Study||0
255498|NCT00479258|617024|P1|NOT COMPLETED|Overall Study||0
255499|NCT00479258|617023|P2|COMPLETED|Overall Study||0
255500|NCT00479258|617024|P1|COMPLETED|Overall Study||0
255501|NCT00479258|617023|P2|STARTED|Overall Study||0
255502|NCT00479258|617024|P1|STARTED|Overall Study||0
255503|NCT00479232|617030|P6|NOT COMPLETED|Overall Study||30
255504|NCT00479232|617031|P5|NOT COMPLETED|Overall Study||4
255505|NCT00479232|617032|P4|NOT COMPLETED|Overall Study||3
255506|NCT00479232|617033|P3|NOT COMPLETED|Overall Study||28
255507|NCT00479232|617034|P2|NOT COMPLETED|Overall Study||3
255508|NCT00479232|617035|P1|NOT COMPLETED|Overall Study||3
255509|NCT00479232|617030|P6|COMPLETED|Overall Study||0
255510|NCT00479232|617031|P5|COMPLETED|Overall Study||0
255511|NCT00479232|617032|P4|COMPLETED|Overall Study||0
255512|NCT00479232|617033|P3|COMPLETED|Overall Study||0
255513|NCT00479232|617034|P2|COMPLETED|Overall Study||0
255514|NCT00479232|617035|P1|COMPLETED|Overall Study||0
255515|NCT00479232|617030|P6|STARTED|Overall Study||30
255516|NCT00479232|617031|P5|STARTED|Overall Study||4
255517|NCT00479232|617032|P4|STARTED|Overall Study||3
255518|NCT00479232|617033|P3|STARTED|Overall Study||28
255519|NCT00479232|617034|P2|STARTED|Overall Study||3
255520|NCT00479232|617035|P1|STARTED|Overall Study||3
255521|NCT00479154|617055|P2|NOT COMPLETED|Overall Study||0
255522|NCT00479154|617056|P1|NOT COMPLETED|Overall Study||0
255523|NCT00479154|617055|P2|COMPLETED|Overall Study||3
255524|NCT00479154|617056|P1|COMPLETED|Overall Study||3
255525|NCT00479154|617055|P2|STARTED|Overall Study||3
255526|NCT00479154|617056|P1|STARTED|Overall Study||3
255527|NCT00479089|617064|P2|NOT COMPLETED|Overall Study||0
255528|NCT00479089|617065|P1|NOT COMPLETED|Overall Study||0
255529|NCT00479089|617064|P2|COMPLETED|Overall Study||25
255530|NCT00479089|617065|P1|COMPLETED|Overall Study||25
255531|NCT00479089|617064|P2|STARTED|Overall Study||25
255532|NCT00479089|617065|P1|STARTED|Overall Study||25
255533|NCT00479037|617077|P2|NOT COMPLETED|Overall Study||6
255534|NCT00479037|617078|P1|NOT COMPLETED|Overall Study||3
255535|NCT00479037|617077|P2|COMPLETED|Overall Study||34
255536|NCT00479037|617078|P1|COMPLETED|Overall Study||38
255537|NCT00479037|617077|P2|STARTED|Overall Study||40
255538|NCT00479037|617078|P1|STARTED|Overall Study||41
255539|NCT00478933|617088|P1|NOT COMPLETED|Overall Study||78
255540|NCT00478933|617088|P1|COMPLETED|Overall Study||1145
255541|NCT00478933|617088|P1|STARTED|Overall Study||1223
255542|NCT00478881|617114|P2|NOT COMPLETED|Overall Study||22
255543|NCT00478881|617115|P1|NOT COMPLETED|Overall Study||39
255544|NCT00478881|617114|P2|COMPLETED|Overall Study||176
255545|NCT00478881|617115|P1|COMPLETED|Overall Study||160
255546|NCT00478881|617114|P2|Received Medication|Overall Study||198
255547|NCT00478881|617115|P1|Received Medication|Overall Study||198
255548|NCT00478881|617114|P2|STARTED|Overall Study||198
255549|NCT00478881|617115|P1|STARTED|Overall Study||199
255550|NCT00478777|617139|P1|NOT COMPLETED|Overall Study||77
255551|NCT00478777|617139|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
255552|NCT00478777|617139|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
255553|NCT00478777|617139|P1|STARTED|Overall Study||150
255554|NCT00478673|617146|P1|NOT COMPLETED|12-Months Post-Procedure||64
255555|NCT00478673|617146|P1|COMPLETED|12-Months Post-Procedure||231
255556|NCT00478673|617146|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
255557|NCT00478673|617146|P1|NOT COMPLETED|30-Days Post-Procedure||10
255558|NCT00478673|617146|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
255559|NCT00478673|617146|P1|STARTED|30-Days Post-Procedure||298
255560|NCT00478647|617151|P1|NOT COMPLETED|Overall Study||2
255561|NCT00478647|617151|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
255562|NCT00478647|617151|P1|STARTED|Overall Study||40
255563|NCT00478608|617159|P1|NOT COMPLETED|Overall Study||20
255564|NCT00478608|617159|P1|COMPLETED|Overall Study||59
255565|NCT00478608|617159|P1|STARTED|Overall Study||79
255566|NCT00478569|617167|P1|NOT COMPLETED|Overall Study||409
255567|NCT00478569|617167|P1|COMPLETED|Overall Study||761
255568|NCT00478569|617167|P1|STARTED|Overall Study||1170
255569|NCT00478556|617183|P2|NOT COMPLETED|Overall Study||0
255570|NCT00478556|617184|P1|NOT COMPLETED|Overall Study||0
255571|NCT00478556|617183|P2|COMPLETED|Overall Study||149
255572|NCT00478556|617184|P1|COMPLETED|Overall Study||151
255573|NCT00478556|617183|P2|STARTED|Overall Study||149
255574|NCT00478556|617184|P1|STARTED|Overall Study||151
255575|NCT00478335|617194|P2|NOT COMPLETED|Period 2 (4 Days)||0
255576|NCT00478335|617195|P1|NOT COMPLETED|Period 2 (4 Days)||0
255577|NCT00478335|617194|P2|COMPLETED|Period 2 (4 Days)||2
255578|NCT00478335|617195|P1|COMPLETED|Period 2 (4 Days)||2
255579|NCT00478335|617194|P2|STARTED|Period 2 (4 Days)||2
255580|NCT00478335|617195|P1|STARTED|Period 2 (4 Days)||2
255581|NCT00478335|617194|P2|NOT COMPLETED|Period 1 (4 Days)||0
255582|NCT00478335|617195|P1|NOT COMPLETED|Period 1 (4 Days)||0
255583|NCT00478335|617194|P2|COMPLETED|Period 1 (4 Days)||2
255584|NCT00478335|617195|P1|COMPLETED|Period 1 (4 Days)||2
255585|NCT00478335|617194|P2|STARTED|Period 1 (4 Days)||2
255586|NCT00478335|617195|P1|STARTED|Period 1 (4 Days)||2
255587|NCT00478257|617203|P2|NOT COMPLETED|Overall Study||3
255588|NCT00478257|617204|P1|NOT COMPLETED|Overall Study||8
255589|NCT00478257|617203|P2|COMPLETED|Overall Study||13
255590|NCT00478257|617204|P1|COMPLETED|Overall Study||15
255591|NCT00478257|617203|P2|STARTED|Overall Study||16
255592|NCT00478257|617204|P1|STARTED|Overall Study||23
255593|NCT00478244|617210|P1|NOT COMPLETED|Overall Study||1
255594|NCT00478244|617210|P1|COMPLETED|Overall Study||6
255595|NCT00478244|617210|P1|STARTED|Overall Study||7
255596|NCT00478231|617223|P1|NOT COMPLETED|Overall Study||84
255597|NCT00478231|617223|P1|COMPLETED|Overall Study||125
255598|NCT00478231|617223|P1|Treated|Overall Study||206
255599|NCT00478231|617223|P1|STARTED|Overall Study||209
255600|NCT00478218|617244|P2|NOT COMPLETED|Overall Study||0
255601|NCT00478218|617245|P1|NOT COMPLETED|Overall Study||0
255602|NCT00478218|617244|P2|COMPLETED|Overall Study||19
255603|NCT00478218|617245|P1|COMPLETED|Overall Study||34
255604|NCT00478218|617244|P2|STARTED|Overall Study||19
255605|NCT00478218|617245|P1|STARTED|Overall Study||34
255606|NCT00478205|617259|P2|NOT COMPLETED|Overall Study||87
255607|NCT00478205|617260|P1|NOT COMPLETED|Overall Study||296
255608|NCT00478205|617259|P2|COMPLETED|Overall Study||399
255609|NCT00478205|617260|P1|COMPLETED|Overall Study||685
255610|NCT00478205|617259|P2|STARTED|Overall Study||486
255611|NCT00478205|617260|P1|STARTED|Overall Study||981
255612|NCT00478192|617275|P3|NOT COMPLETED|Overall Study||2
255613|NCT00478192|617276|P2|NOT COMPLETED|Overall Study||5
255614|NCT00478192|617277|P1|NOT COMPLETED|Overall Study||4
255615|NCT00478192|617275|P3|COMPLETED|Overall Study||8
255616|NCT00478192|617276|P2|COMPLETED|Overall Study||15
255617|NCT00478192|617277|P1|COMPLETED|Overall Study||16
255618|NCT00478192|617275|P3|End of Treatment|Overall Study||8
255619|NCT00478192|617276|P2|End of Treatment|Overall Study||16
255620|NCT00478192|617277|P1|End of Treatment|Overall Study||18
255621|NCT00478192|617275|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
255622|NCT00478192|617276|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
255623|NCT00478192|617277|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
255624|NCT00478192|617275|P3|STARTED|Overall Study||10
255625|NCT00478192|617276|P2|STARTED|Overall Study||20
255626|NCT00478192|617277|P1|STARTED|Overall Study||20
255627|NCT00478140|617304|P1|NOT COMPLETED|Overall Study||3
255628|NCT00478140|617304|P1|COMPLETED|Overall Study||1
255629|NCT00478140|617304|P1|STARTED|Overall Study||4
255630|NCT00478062|617308|P1|NOT COMPLETED|Overall Study||0
255631|NCT00478062|617308|P1|COMPLETED|Overall Study||1
255632|NCT00478062|617308|P1|STARTED|Overall Study||1
255633|NCT00478036|617318|P3|NOT COMPLETED|Overall Study||0
255634|NCT00478036|617319|P2|NOT COMPLETED|Overall Study||0
255635|NCT00478036|617320|P1|NOT COMPLETED|Overall Study||0
255636|NCT00478036|617318|P3|COMPLETED|Overall Study||14
255637|NCT00478036|617319|P2|COMPLETED|Overall Study||7
255638|NCT00478036|617320|P1|COMPLETED|Overall Study||10
255639|NCT00478036|617318|P3|STARTED|Overall Study||14
255640|NCT00478036|617319|P2|STARTED|Overall Study||7
255641|NCT00478036|617320|P1|STARTED|Overall Study||10
255642|NCT00478023|617333|P5|NOT COMPLETED|Overall Study||55
255643|NCT00478023|617334|P4|NOT COMPLETED|Overall Study||30
255644|NCT00478023|617335|P3|NOT COMPLETED|Overall Study||20
255645|NCT00478023|617336|P2|NOT COMPLETED|Overall Study||24
255646|NCT00478023|617337|P1|NOT COMPLETED|Overall Study||35
255647|NCT00478023|617333|P5|COMPLETED|Overall Study||114
255648|NCT00478023|617334|P4|COMPLETED|Overall Study||146
255649|NCT00478023|617335|P3|COMPLETED|Overall Study||151
255650|NCT00478023|617336|P2|COMPLETED|Overall Study||144
255651|NCT00478023|617337|P1|COMPLETED|Overall Study||135
255652|NCT00478023|617333|P5|STARTED|Overall Study||169
255653|NCT00478023|617334|P4|STARTED|Overall Study||176
255654|NCT00478023|617335|P3|STARTED|Overall Study||171
255655|NCT00478023|617336|P2|STARTED|Overall Study||168
255656|NCT00478023|617337|P1|STARTED|Overall Study||170
255657|NCT00477971|617356|P2|NOT COMPLETED|Overall Study||6
255658|NCT00477971|617357|P1|NOT COMPLETED|Overall Study||17
255659|NCT00477971|617356|P2|COMPLETED|Overall Study||49
255660|NCT00477971|617357|P1|COMPLETED|Overall Study||17
255661|NCT00477971|617356|P2|STARTED|Overall Study||55
255662|NCT00477971|617357|P1|STARTED|Overall Study||34
255663|NCT00477750|617369|P1|NOT COMPLETED|Overall Study||11
255664|NCT00477750|617369|P1|COMPLETED|Overall Study||15
255665|NCT00477750|617369|P1|STARTED|Overall Study||26
255666|NCT00477685|617373|P1|NOT COMPLETED|Overall Study||0
255667|NCT00477685|617373|P1|COMPLETED|Overall Study||10
255668|NCT00477685|617373|P1|STARTED|Overall Study||10
255669|NCT00477672|617381|P3|NOT COMPLETED|Overall Study||16
255670|NCT00477672|617382|P2|NOT COMPLETED|Overall Study||16
255671|NCT00477672|617383|P1|NOT COMPLETED|Overall Study||7
255672|NCT00477672|617381|P3|COMPLETED|Overall Study||83
255673|NCT00477672|617382|P2|COMPLETED|Overall Study||85
255674|NCT00477672|617383|P1|COMPLETED|Overall Study||91
255675|NCT00477672|617381|P3|STARTED|Overall Study||99
255676|NCT00477672|617382|P2|STARTED|Overall Study||101
255677|NCT00477672|617383|P1|STARTED|Overall Study||98
255678|NCT00477633|617394|P1|NOT COMPLETED|Overall Study||709
255679|NCT00477633|617394|P1|COMPLETED|Overall Study||991
255680|NCT00477633|617394|P1|STARTED|Overall Study||1700
255681|NCT00477607|617402|P2|NOT COMPLETED|Overall Study||7
255682|NCT00477607|617403|P1|NOT COMPLETED|Overall Study||7
255683|NCT00477607|617402|P2|COMPLETED|Overall Study||13
255684|NCT00477607|617403|P1|COMPLETED|Overall Study||12
255685|NCT00477607|617402|P2|STARTED|Overall Study||20
255686|NCT00477607|617403|P1|STARTED|Overall Study||19
255687|NCT00477594|617415|P2|NOT COMPLETED|Follow-up Period||1
255688|NCT00477594|617416|P1|NOT COMPLETED|Follow-up Period||3
255689|NCT00477594|617415|P2|COMPLETED|Follow-up Period||4
255690|NCT00477594|617416|P1|COMPLETED|Follow-up Period||13
255691|NCT00477594|617415|P2|STARTED|Follow-up Period||5
255692|NCT00477594|617416|P1|STARTED|Follow-up Period||16
255693|NCT00477594|617415|P2|NOT COMPLETED|Year 3||0
255694|NCT00477594|617416|P1|NOT COMPLETED|Year 3||2
255695|NCT00477594|617415|P2|COMPLETED|Year 3||0
255696|NCT00477594|617416|P1|COMPLETED|Year 3||2
255697|NCT00477594|617415|P2|STARTED|Year 3||0
255698|NCT00477594|617416|P1|STARTED|Year 3||4
255699|NCT00477594|617415|P2|NOT COMPLETED|Year 1 and Year 2||4
255700|NCT00477594|617416|P1|NOT COMPLETED|Year 1 and Year 2||9
255701|NCT00477594|617415|P2|COMPLETED|Year 1 and Year 2||1
255702|NCT00477594|617416|P1|COMPLETED|Year 1 and Year 2||7
255703|NCT00477594|617415|P2|STARTED|Year 1 and Year 2||5
255704|NCT00477594|617416|P1|STARTED|Year 1 and Year 2||16
255705|NCT00477490|617477|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
255706|NCT00477490|617478|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
255707|NCT00477490|617479|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
255708|NCT00477490|617480|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
255709|NCT00477490|617481|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
255710|NCT00477490|617482|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
255711|NCT00477490|617483|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
255712|NCT00477490|617484|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
255713|NCT00477490|617485|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
255714|NCT00477490|617477|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
255715|NCT00477490|617478|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
255716|NCT00477490|617479|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
255717|NCT00477490|617480|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
255718|NCT00477490|617481|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
255719|NCT00477490|617482|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
255720|NCT00477490|617483|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
255721|NCT00477490|617484|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
255722|NCT00477490|617485|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
255723|NCT00477490|617477|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
255724|NCT00477490|617478|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
255725|NCT00477490|617479|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
255726|NCT00477490|617480|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
255727|NCT00477490|617481|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
255728|NCT00477490|617482|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
255729|NCT00477490|617483|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
255730|NCT00477490|617484|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
255731|NCT00477490|617485|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
255732|NCT00477490|617477|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
255733|NCT00477490|617478|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
255734|NCT00477490|617479|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
255735|NCT00477490|617480|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
255736|NCT00477490|617481|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
255737|NCT00477490|617482|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
255738|NCT00477490|617483|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
255739|NCT00477490|617484|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
255740|NCT00477490|617485|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
255741|NCT00477490|617477|P9|COMPLETED|Part I: 4 Week Efficacy||0
255742|NCT00477490|617478|P8|COMPLETED|Part I: 4 Week Efficacy||0
255743|NCT00477490|617479|P7|COMPLETED|Part I: 4 Week Efficacy||0
255744|NCT00477490|617480|P6|COMPLETED|Part I: 4 Week Efficacy||0
255745|NCT00477490|617481|P5|COMPLETED|Part I: 4 Week Efficacy||135
255746|NCT00477490|617482|P4|COMPLETED|Part I: 4 Week Efficacy||138
255747|NCT00477490|617483|P3|COMPLETED|Part I: 4 Week Efficacy||148
255748|NCT00477490|617484|P2|COMPLETED|Part I: 4 Week Efficacy||144
255749|NCT00477490|617485|P1|COMPLETED|Part I: 4 Week Efficacy||145
255750|NCT00477490|617477|P9|ITT Population|Part I: 4 Week Efficacy||0
255751|NCT00477490|617478|P8|ITT Population|Part I: 4 Week Efficacy||0
255752|NCT00477490|617479|P7|ITT Population|Part I: 4 Week Efficacy||0
255753|NCT00477490|617480|P6|ITT Population|Part I: 4 Week Efficacy||0
255754|NCT00477490|617481|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
255755|NCT00477490|617482|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
255756|NCT00477490|617483|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
255757|NCT00477490|617484|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
255758|NCT00477490|617485|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
255759|NCT00477490|617477|P9|STARTED|Part I: 4 Week Efficacy||0
255760|NCT00477490|617478|P8|STARTED|Part I: 4 Week Efficacy||0
255761|NCT00477490|617479|P7|STARTED|Part I: 4 Week Efficacy||0
255762|NCT00477490|617480|P6|STARTED|Part I: 4 Week Efficacy||0
255763|NCT00477490|617481|P5|STARTED|Part I: 4 Week Efficacy||160
255764|NCT00477490|617482|P4|STARTED|Part I: 4 Week Efficacy||158
255765|NCT00477490|617483|P3|STARTED|Part I: 4 Week Efficacy||158
255766|NCT00477490|617484|P2|STARTED|Part I: 4 Week Efficacy||163
255767|NCT00477490|617485|P1|STARTED|Part I: 4 Week Efficacy||160
255768|NCT00477464|617569|P1|NOT COMPLETED|Overall Study||51
255769|NCT00477464|617569|P1|COMPLETED|Overall Study||0
255770|NCT00477464|617569|P1|STARTED|Overall Study||51
255771|NCT00477451|617596|P4|NOT COMPLETED|Overall Study||0
255772|NCT00477451|617597|P3|NOT COMPLETED|Overall Study||0
255773|NCT00477451|617598|P2|NOT COMPLETED|Overall Study||0
255774|NCT00477451|617599|P1|NOT COMPLETED|Overall Study||0
255775|NCT00477451|617596|P4|COMPLETED|Overall Study||2
255776|NCT00477451|617597|P3|COMPLETED|Overall Study||7
255777|NCT00477451|617598|P2|COMPLETED|Overall Study||20
255778|NCT00477451|617599|P1|COMPLETED|Overall Study||20
255779|NCT00477451|617596|P4|STARTED|Overall Study||2
255780|NCT00477451|617597|P3|STARTED|Overall Study||7
255781|NCT00477451|617598|P2|STARTED|Overall Study||20
255782|NCT00477451|617599|P1|STARTED|Overall Study||20
255783|NCT00477386|617613|P2|NOT COMPLETED|Overall Study||17
255784|NCT00477386|617614|P1|NOT COMPLETED|Overall Study||11
255785|NCT00477386|617613|P2|COMPLETED|Overall Study||0
255786|NCT00477386|617614|P1|COMPLETED|Overall Study||0
255787|NCT00477386|617613|P2|STARTED|Overall Study||17
255788|NCT00477386|617614|P1|STARTED|Overall Study||11
255789|NCT00477334|617624|P2|NOT COMPLETED|Overall Study||76
255790|NCT00477334|617625|P1|NOT COMPLETED|Overall Study||170
255791|NCT00477334|617624|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
255792|NCT00477334|617625|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
255793|NCT00477334|617624|P2|Modified Intent to Treat Population|Overall Study||78
255794|NCT00477334|617625|P1|Modified Intent to Treat Population|Overall Study||152
255795|NCT00477334|617624|P2|Participants Completing First Recurrence|Overall Study||92
255796|NCT00477334|617625|P1|Participants Completing First Recurrence|Overall Study||187
255797|NCT00477334|617624|P2|Intent to Treat Population|Overall Study||98
255798|NCT00477334|617625|P1|Intent to Treat Population|Overall Study||201
255799|NCT00477334|617624|P2|Randomized and Took Study Drug|Overall Study||98
255800|NCT00477334|617625|P1|Randomized and Took Study Drug|Overall Study||206
255801|NCT00477334|617624|P2|STARTED|Overall Study||151
255802|NCT00477334|617625|P1|STARTED|Overall Study||312
255803|NCT00477295|617651|P2|NOT COMPLETED|Overall Study||109
255804|NCT00477295|617652|P1|NOT COMPLETED|Overall Study||121
255805|NCT00477295|617651|P2|COMPLETED|Overall Study||192
255806|NCT00477295|617652|P1|COMPLETED|Overall Study||161
255807|NCT00477295|617651|P2|STARTED|Overall Study||301
255808|NCT00477295|617652|P1|STARTED|Overall Study||282
255809|NCT00477269|617680|P3|NOT COMPLETED|Open Label Extension||13
255810|NCT00477269|617681|P2|NOT COMPLETED|Open Label Extension||0
255811|NCT00477269|617682|P1|NOT COMPLETED|Open Label Extension||0
255812|NCT00477269|617680|P3|COMPLETED|Open Label Extension||9
255813|NCT00477269|617681|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
255814|NCT00477269|617682|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
255815|NCT00477269|617680|P3|STARTED|Open Label Extension||22
255816|NCT00477269|617681|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
255817|NCT00477269|617682|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
255818|NCT00477269|617680|P3|NOT COMPLETED|Core Study||0
255819|NCT00477269|617681|P2|NOT COMPLETED|Core Study||8
255820|NCT00477269|617682|P1|NOT COMPLETED|Core Study||9
255821|NCT00477269|617680|P3|COMPLETED|Core Study||0
255822|NCT00477269|617681|P2|COMPLETED|Core Study||23
255823|NCT00477269|617682|P1|COMPLETED|Core Study||19
255824|NCT00477269|617680|P3|STARTED|Core Study||0
255825|NCT00477269|617681|P2|STARTED|Core Study||31
255826|NCT00477269|617682|P1|STARTED|Core Study||28
255827|NCT00477230|617736|P2|NOT COMPLETED|Overall Study||31
255828|NCT00477230|617737|P1|NOT COMPLETED|Overall Study||20
255829|NCT00477230|617736|P2|COMPLETED|Overall Study||1
255830|NCT00477230|617737|P1|COMPLETED|Overall Study||12
255831|NCT00477230|617736|P2|STARTED|Overall Study||32
255832|NCT00477230|617737|P1|STARTED|Overall Study||32
255833|NCT00477204|617745|P2|NOT COMPLETED|Overall Study||0
255834|NCT00477204|617746|P1|NOT COMPLETED|Overall Study||0
255835|NCT00477204|617745|P2|COMPLETED|Overall Study||5
255836|NCT00477204|617746|P1|COMPLETED|Overall Study||4
255837|NCT00477204|617745|P2|STARTED|Overall Study||5
255838|NCT00477204|617746|P1|STARTED|Overall Study||4
255839|NCT00477191|617752|P1|NOT COMPLETED|Overall Study||5
255840|NCT00477191|617752|P1|COMPLETED|Overall Study||13
255841|NCT00477191|617752|P1|STARTED|Overall Study||18
255842|NCT00477165|617761|P2|NOT COMPLETED|Overall Study||2
255843|NCT00477165|617762|P1|NOT COMPLETED|Overall Study||7
255844|NCT00477165|617761|P2|COMPLETED|Overall Study||25
255845|NCT00477165|617762|P1|COMPLETED|Overall Study||20
255846|NCT00477165|617761|P2|STARTED|Overall Study||27
255847|NCT00477165|617762|P1|STARTED|Overall Study||27
255848|NCT00477152|617774|P1|NOT COMPLETED|Overall Study||3
255849|NCT00477152|617774|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
255850|NCT00477152|617774|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
255851|NCT00477087|617781|P1|NOT COMPLETED|Overall Study||0
255852|NCT00477087|617781|P1|COMPLETED|Overall Study||10
255853|NCT00477087|617781|P1|STARTED|Overall Study||10
255854|NCT00476957|617789|P2|NOT COMPLETED|Overall Study||193
255855|NCT00476957|617790|P1|NOT COMPLETED|Overall Study||176
255856|NCT00476957|617789|P2|COMPLETED|Overall Study||4159
255857|NCT00476957|617790|P1|COMPLETED|Overall Study||4181
255858|NCT00476957|617789|P2|STARTED|Overall Study||4352
255859|NCT00476957|617790|P1|STARTED|Overall Study||4357
255860|NCT00476827|617804|P6|NOT COMPLETED|Overall Study||0
255861|NCT00476827|617805|P5|NOT COMPLETED|Overall Study||0
255862|NCT00476827|617806|P4|NOT COMPLETED|Overall Study||0
255863|NCT00476827|617807|P3|NOT COMPLETED|Overall Study||0
255864|NCT00476827|617808|P2|NOT COMPLETED|Overall Study||0
255865|NCT00476827|617809|P1|NOT COMPLETED|Overall Study||0
255866|NCT00476827|617804|P6|COMPLETED|Overall Study||2
255867|NCT00476827|617805|P5|COMPLETED|Overall Study||2
255868|NCT00476827|617806|P4|COMPLETED|Overall Study||0
255869|NCT00476827|617807|P3|COMPLETED|Overall Study||1
255870|NCT00476827|617808|P2|COMPLETED|Overall Study||0
255871|NCT00476827|617809|P1|COMPLETED|Overall Study||3
255872|NCT00476827|617804|P6|STARTED|Overall Study||2
255873|NCT00476827|617805|P5|STARTED|Overall Study||2
255874|NCT00476827|617806|P4|STARTED|Overall Study||0
255875|NCT00476827|617807|P3|STARTED|Overall Study||1
255876|NCT00476827|617808|P2|STARTED|Overall Study||0
255877|NCT00476827|617809|P1|STARTED|Overall Study||3
255878|NCT00476788|617839|P1|NOT COMPLETED|Overall Study||3
255879|NCT00476788|617839|P1|COMPLETED|Overall Study||11
255880|NCT00476788|617839|P1|STARTED|Overall Study||14
255881|NCT00476645|617844|P1|NOT COMPLETED|Overall Study||0
255882|NCT00476645|617844|P1|COMPLETED|Overall Study||10
255883|NCT00476645|617844|P1|STARTED|Overall Study||10
255884|NCT00476593|617854|P4|NOT COMPLETED|Overall Study||22
255885|NCT00476593|617855|P3|NOT COMPLETED|Overall Study||8
255886|NCT00476593|617856|P2|NOT COMPLETED|Overall Study||2
255887|NCT00476593|617857|P1|NOT COMPLETED|Overall Study||10
255888|NCT00476593|617854|P4|COMPLETED|Overall Study||107
255889|NCT00476593|617855|P3|COMPLETED|Overall Study||30
255890|NCT00476593|617856|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
255891|NCT00476593|617857|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
255892|NCT00476593|617854|P4|STARTED|Overall Study||129
255893|NCT00476593|617855|P3|STARTED|Overall Study||38
255894|NCT00476593|617856|P2|STARTED|Overall Study||19
255895|NCT00476593|617857|P1|STARTED|Overall Study||32
255896|NCT00476476|617869|P2|NOT COMPLETED|Overall Study||24
255897|NCT00476476|617870|P1|NOT COMPLETED|Overall Study||2
255898|NCT00476476|617869|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
255899|NCT00476476|617870|P1|COMPLETED|Overall Study||15
255900|NCT00476476|617869|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
255901|NCT00476476|617870|P1|Response Evaluable|Overall Study||17
255902|NCT00476476|617869|P2|STARTED|Overall Study||24
255903|NCT00476476|617870|P1|STARTED|Overall Study||17
255904|NCT00476242|617877|P2|NOT COMPLETED|Overall Study||16
255905|NCT00476242|617878|P1|NOT COMPLETED|Overall Study||8
255906|NCT00476242|617877|P2|COMPLETED|Overall Study||12
255907|NCT00476242|617878|P1|COMPLETED|Overall Study||19
255908|NCT00476242|617877|P2|STARTED|Overall Study||28
255909|NCT00476242|617878|P1|STARTED|Overall Study||27
255910|NCT00476229|617886|P1|NOT COMPLETED|Overall Study||1
255911|NCT00476229|617886|P1|COMPLETED|Overall Study||19
255912|NCT00476229|617886|P1|STARTED|Overall Study||20
255913|NCT00476151|617892|P2|NOT COMPLETED|Overall Study||7
255914|NCT00476151|617893|P1|NOT COMPLETED|Overall Study||3
255915|NCT00476151|617892|P2|COMPLETED|Overall Study||107
255916|NCT00476151|617893|P1|COMPLETED|Overall Study||109
255917|NCT00476151|617892|P2|STARTED|Overall Study||114
255918|NCT00476151|617893|P1|STARTED|Overall Study||112
255919|NCT00476086|617899|P1|NOT COMPLETED|Overall Study||5
255920|NCT00476086|617899|P1|COMPLETED|Overall Study||15
255921|NCT00476086|617899|P1|Received Radiation|Overall Study||15
255922|NCT00476086|617899|P1|Received Chemotherapy|Overall Study||19
255923|NCT00476086|617899|P1|STARTED|Overall Study||20
255924|NCT00476047|617905|P1|NOT COMPLETED|Overall Study||1
255925|NCT00476047|617905|P1|COMPLETED|Overall Study||15
255926|NCT00476047|617905|P1|Completed Treatment|Overall Study||16
255927|NCT00476047|617905|P1|STARTED|Overall Study||16
255928|NCT00476021|617914|P2|NOT COMPLETED|Overall Study||0
255929|NCT00476021|617915|P1|NOT COMPLETED|Overall Study||0
255930|NCT00476021|617914|P2|COMPLETED|Overall Study||51
255931|NCT00476021|617915|P1|COMPLETED|Overall Study||51
255932|NCT00476021|617914|P2|STARTED|Overall Study||51
255933|NCT00476021|617915|P1|STARTED|Overall Study||51
255934|NCT00476008|617931|P2|NOT COMPLETED|Overall Study||8
255935|NCT00476008|617932|P1|NOT COMPLETED|Overall Study||9
255936|NCT00476008|617931|P2|COMPLETED|Overall Study||13
255937|NCT00476008|617932|P1|COMPLETED|Overall Study||13
255938|NCT00476008|617931|P2|6 Month Testing|Overall Study||14
255939|NCT00476008|617932|P1|6 Month Testing|Overall Study||15
255940|NCT00476008|617931|P2|STARTED|Overall Study||21
255941|NCT00476008|617932|P1|STARTED|Overall Study||22
255942|NCT00475904|617959|P3|NOT COMPLETED|Overall Study||4
255943|NCT00475904|617960|P2|NOT COMPLETED|Overall Study||13
255944|NCT00475904|617961|P1|NOT COMPLETED|Overall Study||15
255945|NCT00475904|617959|P3|COMPLETED|Overall Study||72
255946|NCT00475904|617960|P2|COMPLETED|Overall Study||131
255947|NCT00475904|617961|P1|COMPLETED|Overall Study||125
255948|NCT00475904|617959|P3|STARTED|Overall Study||76
255949|NCT00475904|617960|P2|STARTED|Overall Study||144
255950|NCT00475904|617961|P1|STARTED|Overall Study||140
255951|NCT00475878|617974|P2|NOT COMPLETED|Overall Study||0
255952|NCT00475878|617975|P1|NOT COMPLETED|Overall Study||0
255953|NCT00475878|617974|P2|COMPLETED|Overall Study||72
255954|NCT00475878|617975|P1|COMPLETED|Overall Study||75
255955|NCT00475878|617974|P2|STARTED|Overall Study||72
255956|NCT00475878|617975|P1|STARTED|Overall Study||75
255957|NCT00475865|617986|P3|NOT COMPLETED|Overall Study||6
255958|NCT00475865|617987|P2|NOT COMPLETED|Overall Study||5
255959|NCT00475865|617988|P1|NOT COMPLETED|Overall Study||2
255960|NCT00475865|617986|P3|COMPLETED|Overall Study|completed treatment period|34
255961|NCT00475865|617987|P2|COMPLETED|Overall Study|completed treatment period|37
255962|NCT00475865|617988|P1|COMPLETED|Overall Study||39
255963|NCT00475865|617986|P3|Treated|Overall Study||40
255964|NCT00475865|617987|P2|Treated|Overall Study||42
255965|NCT00475865|617988|P1|Treated|Overall Study|completed treatment period|41
255966|NCT00475865|617986|P3|STARTED|Overall Study|randomized|40
255967|NCT00475865|617987|P2|STARTED|Overall Study|randomized|42
255968|NCT00475865|617988|P1|STARTED|Overall Study|randomized|41
255969|NCT00475852|618018|P2|NOT COMPLETED|Overall Study||548
255970|NCT00475852|618019|P1|NOT COMPLETED|Overall Study||517
255971|NCT00475852|618018|P2|COMPLETED|Overall Study||3029
255972|NCT00475852|618019|P1|COMPLETED|Overall Study||3047
255973|NCT00475852|618018|P2|STARTED|Overall Study||3577
255974|NCT00475852|618019|P1|STARTED|Overall Study||3564
255975|NCT00475787|618049|P2|NOT COMPLETED|Overall Study||7
255976|NCT00475787|618050|P1|NOT COMPLETED|Overall Study||8
255977|NCT00475787|618049|P2|COMPLETED|Overall Study||60
255978|NCT00475787|618050|P1|COMPLETED|Overall Study||61
255979|NCT00475787|618049|P2|STARTED|Overall Study||67
255980|NCT00475787|618050|P1|STARTED|Overall Study||69
255981|NCT00475735|618070|P6|NOT COMPLETED|Treatment Period 2||1
255982|NCT00475735|618071|P5|NOT COMPLETED|Treatment Period 2||1
255983|NCT00475735|618072|P4|NOT COMPLETED|Treatment Period 2||2
255984|NCT00475735|618073|P3|NOT COMPLETED|Treatment Period 2||0
255985|NCT00475735|618074|P2|NOT COMPLETED|Treatment Period 2||1
255986|NCT00475735|618075|P1|NOT COMPLETED|Treatment Period 2||0
255987|NCT00475735|618070|P6|COMPLETED|Treatment Period 2||13
255988|NCT00475735|618071|P5|COMPLETED|Treatment Period 2||15
255989|NCT00475735|618072|P4|COMPLETED|Treatment Period 2||4
255990|NCT00475735|618073|P3|COMPLETED|Treatment Period 2||7
255991|NCT00475735|618074|P2|COMPLETED|Treatment Period 2||9
255992|NCT00475735|618075|P1|COMPLETED|Treatment Period 2||10
255993|NCT00475735|618070|P6|STARTED|Treatment Period 2||14
255994|NCT00475735|618071|P5|STARTED|Treatment Period 2||16
255995|NCT00475735|618072|P4|STARTED|Treatment Period 2||6
255996|NCT00475735|618073|P3|STARTED|Treatment Period 2||7
255997|NCT00475735|618074|P2|STARTED|Treatment Period 2||10
255998|NCT00475735|618075|P1|STARTED|Treatment Period 2||10
255999|NCT00475735|618070|P6|NOT COMPLETED|Treatment Washout||0
256000|NCT00475735|618071|P5|NOT COMPLETED|Treatment Washout||0
256001|NCT00475735|618072|P4|NOT COMPLETED|Treatment Washout||0
256002|NCT00475735|618073|P3|NOT COMPLETED|Treatment Washout||0
256003|NCT00475735|618074|P2|NOT COMPLETED|Treatment Washout||2
256004|NCT00475735|618075|P1|NOT COMPLETED|Treatment Washout||0
256005|NCT00475735|618070|P6|COMPLETED|Treatment Washout||14
256006|NCT00475735|618071|P5|COMPLETED|Treatment Washout||16
256007|NCT00475735|618072|P4|COMPLETED|Treatment Washout||6
256008|NCT00475735|618073|P3|COMPLETED|Treatment Washout||7
256009|NCT00475735|618074|P2|COMPLETED|Treatment Washout||10
256010|NCT00475735|618075|P1|COMPLETED|Treatment Washout||10
256011|NCT00475735|618070|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
256012|NCT00475735|618071|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
256013|NCT00475735|618072|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
256014|NCT00475735|618073|P3|STARTED|Treatment Washout||7
256015|NCT00475735|618074|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
256016|NCT00475735|618075|P1|STARTED|Treatment Washout||10
256017|NCT00475735|618070|P6|NOT COMPLETED|Treatment Period 1||3
256018|NCT00475735|618071|P5|NOT COMPLETED|Treatment Period 1||2
256019|NCT00475735|618072|P4|NOT COMPLETED|Treatment Period 1||2
256020|NCT00475735|618073|P3|NOT COMPLETED|Treatment Period 1||0
256021|NCT00475735|618074|P2|NOT COMPLETED|Treatment Period 1||2
256022|NCT00475735|618075|P1|NOT COMPLETED|Treatment Period 1||4
256023|NCT00475735|618070|P6|COMPLETED|Treatment Period 1||12
256024|NCT00475735|618071|P5|COMPLETED|Treatment Period 1||14
256025|NCT00475735|618072|P4|COMPLETED|Treatment Period 1||5
256026|NCT00475735|618073|P3|COMPLETED|Treatment Period 1||7
256027|NCT00475735|618074|P2|COMPLETED|Treatment Period 1||11
256028|NCT00475735|618075|P1|COMPLETED|Treatment Period 1||10
256029|NCT00475735|618070|P6|STARTED|Treatment Period 1||15
256030|NCT00475735|618071|P5|STARTED|Treatment Period 1||16
256031|NCT00475735|618072|P4|STARTED|Treatment Period 1||7
256032|NCT00475735|618073|P3|STARTED|Treatment Period 1||7
256033|NCT00475735|618074|P2|STARTED|Treatment Period 1||13
256034|NCT00475735|618075|P1|STARTED|Treatment Period 1||14
256035|NCT00475722|618088|P2|NOT COMPLETED|Overall Study||12
256036|NCT00475722|618089|P1|NOT COMPLETED|Overall Study||15
256037|NCT00475722|618088|P2|COMPLETED|Overall Study||47
256038|NCT00475722|618089|P1|COMPLETED|Overall Study||46
256039|NCT00475722|618088|P2|STARTED|Overall Study||59
256040|NCT00475722|618089|P1|STARTED|Overall Study||61
256041|NCT00475709|618095|P1|NOT COMPLETED|Overall Study||76
256042|NCT00475709|618095|P1|COMPLETED|Overall Study||946
256043|NCT00475709|618095|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
256044|NCT00475709|618095|P1|STARTED|Overall Study||1022
256045|NCT00475670|618103|P2|NOT COMPLETED|Overall Study||41
256046|NCT00475670|618104|P1|NOT COMPLETED|Overall Study||3
256047|NCT00475670|618103|P2|COMPLETED|Overall Study||0
256048|NCT00475670|618104|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
256049|NCT00475670|618103|P2|STARTED|Overall Study||41
256050|NCT00475670|618104|P1|STARTED|Overall Study||3
256051|NCT00475657|618128|P1|NOT COMPLETED|Overall Study||4
256052|NCT00475657|618128|P1|COMPLETED|Overall Study||1
256053|NCT00475657|618128|P1|STARTED|Overall Study||5
256054|NCT00475501|618140|P4|NOT COMPLETED|Overall Study||4
256055|NCT00475501|618141|P3|NOT COMPLETED|Overall Study||4
256056|NCT00475501|618142|P2|NOT COMPLETED|Overall Study||5
256057|NCT00475501|618143|P1|NOT COMPLETED|Overall Study||7
256058|NCT00475501|618140|P4|COMPLETED|Overall Study||12
256059|NCT00475501|618141|P3|COMPLETED|Overall Study||13
256060|NCT00475501|618142|P2|COMPLETED|Overall Study||8
256061|NCT00475501|618143|P1|COMPLETED|Overall Study||7
256062|NCT00475501|618140|P4|STARTED|Overall Study||16
256063|NCT00475501|618141|P3|STARTED|Overall Study||17
256064|NCT00475501|618142|P2|STARTED|Overall Study||13
256065|NCT00475501|618143|P1|STARTED|Overall Study||14
256066|NCT00475423|618193|P1|NOT COMPLETED|Overall Study||32
256067|NCT00475423|618193|P1|COMPLETED|Overall Study||90
256068|NCT00475423|618193|P1|STARTED|Overall Study||122
256069|NCT00475332|618214|P1|NOT COMPLETED|Overall Study||0
256070|NCT00475332|618214|P1|COMPLETED|Overall Study||2
256071|NCT00475332|618214|P1|STARTED|Overall Study||2
256072|NCT00475319|618222|P3|NOT COMPLETED|Overall Study||4
256073|NCT00475319|618223|P2|NOT COMPLETED|Overall Study||1
256074|NCT00475319|618224|P1|NOT COMPLETED|Overall Study||2
256075|NCT00475319|618222|P3|COMPLETED|Overall Study||99
256076|NCT00475319|618223|P2|COMPLETED|Overall Study||101
256077|NCT00475319|618224|P1|COMPLETED|Overall Study||101
256078|NCT00475319|618222|P3|STARTED|Overall Study||103
256079|NCT00475319|618223|P2|STARTED|Overall Study||102
256080|NCT00475319|618224|P1|STARTED|Overall Study||103
256081|NCT00475306|618239|P4|NOT COMPLETED|Overall Study||1
256082|NCT00475306|618240|P3|NOT COMPLETED|Overall Study||0
256083|NCT00475306|618241|P2|NOT COMPLETED|Overall Study||1
256084|NCT00475306|618242|P1|NOT COMPLETED|Overall Study||1
256085|NCT00475306|618239|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
256086|NCT00475306|618240|P3|COMPLETED|Overall Study||72
256087|NCT00475306|618241|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
256088|NCT00475306|618242|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
256089|NCT00475306|618239|P4|STARTED|Overall Study||72
256090|NCT00475306|618240|P3|STARTED|Overall Study||72
256091|NCT00475306|618241|P2|STARTED|Overall Study||72
256092|NCT00475306|618242|P1|STARTED|Overall Study||73
256093|NCT00475241|618258|P2|NOT COMPLETED|Overall Study||3
256094|NCT00475241|618259|P1|NOT COMPLETED|Overall Study||7
256095|NCT00475241|618258|P2|COMPLETED|Overall Study||15
256096|NCT00475241|618259|P1|COMPLETED|Overall Study||11
256097|NCT00475241|618258|P2|STARTED|Overall Study||18
256098|NCT00475241|618259|P1|STARTED|Overall Study||18
256099|NCT00475228|618267|P2|NOT COMPLETED|Overall Study||17
256100|NCT00475228|618268|P1|NOT COMPLETED|Overall Study||17
256101|NCT00475228|618267|P2|COMPLETED|Overall Study||27
256102|NCT00475228|618268|P1|COMPLETED|Overall Study||27
256103|NCT00475228|618267|P2|STARTED|Overall Study||44
256104|NCT00475228|618268|P1|STARTED|Overall Study||44
256105|NCT00475176|618278|P1|NOT COMPLETED|Overall Study||4
256106|NCT00475176|618278|P1|COMPLETED|Overall Study||20
256107|NCT00475176|618278|P1|STARTED|Overall Study||24
256108|NCT00475150|618285|P2|NOT COMPLETED|Overall Study||0
256109|NCT00475150|618286|P1|NOT COMPLETED|Overall Study||0
256110|NCT00475150|618285|P2|COMPLETED|Overall Study||16
256111|NCT00475150|618286|P1|COMPLETED|Overall Study||23
256112|NCT00475150|618285|P2|STARTED|Overall Study||16
256113|NCT00475150|618286|P1|STARTED|Overall Study||23
256114|NCT00475085|618303|P4|NOT COMPLETED|Overall Study||20
256115|NCT00475085|618304|P3|NOT COMPLETED|Overall Study||19
256116|NCT00475085|618305|P2|NOT COMPLETED|Overall Study||20
256117|NCT00475085|618306|P1|NOT COMPLETED|Overall Study||18
256118|NCT00475085|618303|P4|COMPLETED|Overall Study||234
256119|NCT00475085|618304|P3|COMPLETED|Overall Study||241
256120|NCT00475085|618305|P2|COMPLETED|Overall Study||234
256121|NCT00475085|618306|P1|COMPLETED|Overall Study||235
256122|NCT00475085|618303|P4|STARTED|Overall Study||254
256123|NCT00475085|618304|P3|STARTED|Overall Study||260
256124|NCT00475085|618305|P2|STARTED|Overall Study||254
256125|NCT00475085|618306|P1|STARTED|Overall Study||253
256126|NCT00475033|618318|P2|NOT COMPLETED|Toddler Dose||0
256127|NCT00475033|618319|P1|NOT COMPLETED|Toddler Dose||4
256128|NCT00475033|618318|P2|COMPLETED|Toddler Dose||282
256129|NCT00475033|618319|P1|COMPLETED|Toddler Dose||283
256130|NCT00475033|618318|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
256131|NCT00475033|618319|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
256132|NCT00475033|618318|P2|NOT COMPLETED|After the Infant Series||8
256133|NCT00475033|618319|P1|NOT COMPLETED|After the Infant Series||6
256134|NCT00475033|618318|P2|COMPLETED|After the Infant Series||282
256135|NCT00475033|618319|P1|COMPLETED|After the Infant Series||287
256136|NCT00475033|618318|P2|Withdrawn After Infant Series|After the Infant Series||8
256137|NCT00475033|618319|P1|Withdrawn After Infant Series|After the Infant Series||6
256138|NCT00475033|618318|P2|STARTED|After the Infant Series||290
256139|NCT00475033|618319|P1|STARTED|After the Infant Series||293
256140|NCT00475033|618318|P2|NOT COMPLETED|Infant Series||13
256141|NCT00475033|618319|P1|NOT COMPLETED|Infant Series||7
256142|NCT00475033|618318|P2|COMPLETED|Infant Series||290
256143|NCT00475033|618319|P1|COMPLETED|Infant Series||293
256144|NCT00475033|618318|P2|Vaccinated Dose 3|Infant Series||294
256145|NCT00475033|618319|P1|Vaccinated Dose 3|Infant Series||293
256146|NCT00475033|618318|P2|Vaccinated Dose 2|Infant Series||296
256147|NCT00475033|618319|P1|Vaccinated Dose 2|Infant Series||297
256148|NCT00475033|618318|P2|Vaccinated Dose 1|Infant Series||303
256149|NCT00475033|618319|P1|Vaccinated Dose 1|Infant Series||300
256150|NCT00475033|618318|P2|STARTED|Infant Series||303
256151|NCT00475033|618319|P1|STARTED|Infant Series||300
256152|NCT00474994|618367|P1|NOT COMPLETED|Overall Study||5
256153|NCT00474994|618367|P1|COMPLETED|Overall Study||48
256154|NCT00474994|618367|P1|STARTED|Overall Study||53
256155|NCT00474968|618373|P2|NOT COMPLETED|Overall Study||16
256156|NCT00474968|618374|P1|NOT COMPLETED|Overall Study||18
256157|NCT00474968|618373|P2|COMPLETED|Overall Study||355
256158|NCT00474968|618374|P1|COMPLETED|Overall Study||348
256159|NCT00474968|618373|P2|STARTED|Overall Study||371
256160|NCT00474968|618374|P1|STARTED|Overall Study||366
256161|NCT00474955|618384|P1|NOT COMPLETED|Overall Study||8
256162|NCT00474955|618384|P1|COMPLETED|Overall Study||19
256163|NCT00474955|618384|P1|STARTED|Overall Study||27
256164|NCT00474929|618400|P5|NOT COMPLETED|Overall Study||0
256165|NCT00474929|618401|P4|NOT COMPLETED|Overall Study||2
256166|NCT00474929|618402|P3|NOT COMPLETED|Overall Study||2
256167|NCT00474929|618403|P2|NOT COMPLETED|Overall Study||1
256168|NCT00474929|618404|P1|NOT COMPLETED|Overall Study||0
256169|NCT00474929|618400|P5|COMPLETED|Overall Study||77
256170|NCT00474929|618401|P4|COMPLETED|Overall Study||5
256171|NCT00474929|618402|P3|COMPLETED|Overall Study||5
256172|NCT00474929|618403|P2|COMPLETED|Overall Study||5
256173|NCT00474929|618404|P1|COMPLETED|Overall Study||6
256174|NCT00474929|618400|P5|STARTED|Overall Study||77
256175|NCT00474929|618401|P4|STARTED|Overall Study||7
256176|NCT00474929|618402|P3|STARTED|Overall Study||7
256177|NCT00474929|618403|P2|STARTED|Overall Study||6
256178|NCT00474929|618404|P1|STARTED|Overall Study||6
256179|NCT00474903|618421|P3|NOT COMPLETED|Overall Study||2
256180|NCT00474903|618422|P2|NOT COMPLETED|Overall Study||5
256181|NCT00474903|618423|P1|NOT COMPLETED|Overall Study||1
256182|NCT00474903|618421|P3|COMPLETED|Overall Study||43
256183|NCT00474903|618422|P2|COMPLETED|Overall Study||42
256184|NCT00474903|618423|P1|COMPLETED|Overall Study||29
256185|NCT00474903|618421|P3|STARTED|Overall Study||45
256186|NCT00474903|618422|P2|STARTED|Overall Study||47
256187|NCT00474903|618423|P1|STARTED|Overall Study||30
256188|NCT00474851|618436|P2|NOT COMPLETED|Overall Study||11
256189|NCT00474851|618437|P1|NOT COMPLETED|Overall Study||8
256190|NCT00474851|618436|P2|COMPLETED|Overall Study||16
256191|NCT00474851|618437|P1|COMPLETED|Overall Study||18
256192|NCT00474851|618436|P2|Completed Baseline|Overall Study||26
256193|NCT00474851|618437|P1|Completed Baseline|Overall Study||25
256194|NCT00474851|618436|P2|STARTED|Overall Study||27
256195|NCT00474851|618437|P1|STARTED|Overall Study||26
256196|NCT00474812|618445|P1|NOT COMPLETED|Overall Study||7
256197|NCT00474812|618445|P1|COMPLETED|Overall Study||44
256198|NCT00474812|618445|P1|STARTED|Overall Study||51
256199|NCT00474786|618455|P2|NOT COMPLETED|Overall Study||253
256200|NCT00474786|618456|P1|NOT COMPLETED|Overall Study||259
256201|NCT00474786|618455|P2|COMPLETED|Overall Study||0
256202|NCT00474786|618456|P1|COMPLETED|Overall Study||0
256203|NCT00474786|618455|P2|STARTED|Overall Study||253
256204|NCT00474786|618456|P1|STARTED|Overall Study||259
256205|NCT00474760|618481|P7|NOT COMPLETED|Overall Study||10
256206|NCT00474760|618482|P6|NOT COMPLETED|Overall Study||29
256207|NCT00474760|618483|P5|NOT COMPLETED|Overall Study||12
256208|NCT00474760|618484|P4|NOT COMPLETED|Overall Study||3
256209|NCT00474760|618485|P3|NOT COMPLETED|Overall Study||3
256210|NCT00474760|618486|P2|NOT COMPLETED|Overall Study||3
256211|NCT00474760|618487|P1|NOT COMPLETED|Overall Study||3
256212|NCT00474760|618481|P7|COMPLETED|Overall Study||1
256213|NCT00474760|618482|P6|COMPLETED|Overall Study||0
256214|NCT00474760|618483|P5|COMPLETED|Overall Study||1
256215|NCT00474760|618484|P4|COMPLETED|Overall Study||0
256216|NCT00474760|618485|P3|COMPLETED|Overall Study||0
256217|NCT00474760|618486|P2|COMPLETED|Overall Study||0
256218|NCT00474760|618487|P1|COMPLETED|Overall Study||0
256219|NCT00474760|618481|P7|STARTED|Overall Study||11
256220|NCT00474760|618482|P6|STARTED|Overall Study||29
256221|NCT00474760|618483|P5|STARTED|Overall Study||13
256222|NCT00474760|618484|P4|STARTED|Overall Study||3
256223|NCT00474760|618485|P3|STARTED|Overall Study||3
256224|NCT00474760|618486|P2|STARTED|Overall Study||3
256225|NCT00474760|618487|P1|STARTED|Overall Study||3
256226|NCT00474708|618594|P2|NOT COMPLETED|Overall Study||25
256227|NCT00474708|618595|P1|NOT COMPLETED|Overall Study||57
256228|NCT00474708|618594|P2|COMPLETED|Overall Study||342
256229|NCT00474708|618595|P1|COMPLETED|Overall Study||734
256230|NCT00474708|618594|P2|STARTED|Overall Study||367
256231|NCT00474708|618595|P1|STARTED|Overall Study||791
256232|NCT00474630|618605|P2|NOT COMPLETED|Overall Study||70
256233|NCT00474630|618606|P1|NOT COMPLETED|Overall Study||160
256234|NCT00474630|618605|P2|COMPLETED|Overall Study||100
256235|NCT00474630|618606|P1|COMPLETED|Overall Study||175
256236|NCT00474630|618605|P2|STARTED|Overall Study||170
256237|NCT00474630|618606|P1|STARTED|Overall Study||335
256238|NCT00474539|618662|P2|NOT COMPLETED|Toddler Dose||0
256239|NCT00474539|618663|P1|NOT COMPLETED|Toddler Dose||1
256240|NCT00474539|618662|P2|COMPLETED|Toddler Dose||220
256241|NCT00474539|618663|P1|COMPLETED|Toddler Dose||208
256242|NCT00474539|618662|P2|STARTED|Toddler Dose||220
256243|NCT00474539|618663|P1|STARTED|Toddler Dose||209
256244|NCT00474539|618662|P2|NOT COMPLETED|After Infant Series||0
256245|NCT00474539|618663|P1|NOT COMPLETED|After Infant Series||4
256246|NCT00474539|618662|P2|COMPLETED|After Infant Series||220
256247|NCT00474539|618663|P1|COMPLETED|After Infant Series||209
256248|NCT00474539|618662|P2|STARTED|After Infant Series||220
256249|NCT00474539|618663|P1|STARTED|After Infant Series||213
256250|NCT00474539|618662|P2|NOT COMPLETED|Infant Series||6
256251|NCT00474539|618663|P1|NOT COMPLETED|Infant Series||10
256252|NCT00474539|618662|P2|COMPLETED|Infant Series||220
256253|NCT00474539|618663|P1|COMPLETED|Infant Series||213
256254|NCT00474539|618662|P2|Vaccinated Dose 3|Infant Series||221
256255|NCT00474539|618663|P1|Vaccinated Dose 3|Infant Series||214
256256|NCT00474539|618662|P2|Vaccinated Dose 2|Infant Series||222
256257|NCT00474539|618663|P1|Vaccinated Dose 2|Infant Series||217
256258|NCT00474539|618662|P2|Vaccinated Dose 1|Infant Series||226
256259|NCT00474539|618663|P1|Vaccinated Dose 1|Infant Series||218
256260|NCT00474539|618662|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
256261|NCT00474539|618663|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
256262|NCT00474526|618728|P17|NOT COMPLETED|Overall Study||9
256263|NCT00474526|618729|P16|NOT COMPLETED|Overall Study||18
256264|NCT00474526|618730|P15|NOT COMPLETED|Overall Study||77
256265|NCT00474526|618731|P14|NOT COMPLETED|Overall Study||156
256266|NCT00474526|618732|P13|NOT COMPLETED|Overall Study||15
256267|NCT00474526|618733|P12|NOT COMPLETED|Overall Study||11
256268|NCT00474526|618734|P11|NOT COMPLETED|Overall Study||10
256269|NCT00474526|618735|P10|NOT COMPLETED|Overall Study||27
256270|NCT00474526|618736|P9|NOT COMPLETED|Overall Study||6
256271|NCT00474526|618737|P8|NOT COMPLETED|Overall Study||6
256272|NCT00474526|618738|P7|NOT COMPLETED|Overall Study||25
256273|NCT00474526|618739|P6|NOT COMPLETED|Overall Study||16
256274|NCT00474526|618740|P5|NOT COMPLETED|Overall Study||68
256275|NCT00474526|618741|P4|NOT COMPLETED|Overall Study||119
256276|NCT00474526|618742|P3|NOT COMPLETED|Overall Study||49
256277|NCT00474526|618743|P2|NOT COMPLETED|Overall Study||46
256278|NCT00474526|618744|P1|NOT COMPLETED|Overall Study||33
256279|NCT00474526|618728|P17|COMPLETED|Overall Study||174
256280|NCT00474526|618729|P16|COMPLETED|Overall Study||152
256281|NCT00474526|618730|P15|COMPLETED|Overall Study||281
256282|NCT00474526|618731|P14|COMPLETED|Overall Study||1270
256283|NCT00474526|618732|P13|COMPLETED|Overall Study||135
256284|NCT00474526|618733|P12|COMPLETED|Overall Study||139
256285|NCT00474526|618734|P11|COMPLETED|Overall Study||141
256286|NCT00474526|618735|P10|COMPLETED|Overall Study||121
256287|NCT00474526|618736|P9|COMPLETED|Overall Study||144
256288|NCT00474526|618737|P8|COMPLETED|Overall Study||145
256289|NCT00474526|618738|P7|COMPLETED|Overall Study||178
256290|NCT00474526|618739|P6|COMPLETED|Overall Study||54
256291|NCT00474526|618740|P5|COMPLETED|Overall Study||8
256292|NCT00474526|618741|P4|COMPLETED|Overall Study||561
256293|NCT00474526|618742|P3|COMPLETED|Overall Study||110
256294|NCT00474526|618743|P2|COMPLETED|Overall Study||120
256295|NCT00474526|618744|P1|COMPLETED|Overall Study||121
256296|NCT00474526|618728|P17|STARTED|Overall Study||183
256297|NCT00474526|618729|P16|STARTED|Overall Study||170
256298|NCT00474526|618730|P15|STARTED|Overall Study||358
256299|NCT00474526|618731|P14|STARTED|Overall Study||1426
256300|NCT00474526|618732|P13|STARTED|Overall Study||150
256301|NCT00474526|618733|P12|STARTED|Overall Study||150
256302|NCT00474526|618734|P11|STARTED|Overall Study||151
256303|NCT00474526|618735|P10|STARTED|Overall Study||148
256304|NCT00474526|618736|P9|STARTED|Overall Study||150
256305|NCT00474526|618737|P8|STARTED|Overall Study||151
256306|NCT00474526|618738|P7|STARTED|Overall Study||203
256307|NCT00474526|618739|P6|STARTED|Overall Study||70
256308|NCT00474526|618740|P5|STARTED|Overall Study||76
256309|NCT00474526|618741|P4|STARTED|Overall Study||680
256310|NCT00474526|618742|P3|STARTED|Overall Study||159
256311|NCT00474526|618743|P2|STARTED|Overall Study||166
256312|NCT00474526|618744|P1|STARTED|Overall Study||154
256313|NCT00474487|618909|P4|NOT COMPLETED|Overall Study||0
256314|NCT00474487|618910|P3|NOT COMPLETED|Overall Study||14
256315|NCT00474487|618911|P2|NOT COMPLETED|Overall Study||2
256316|NCT00474487|618912|P1|NOT COMPLETED|Overall Study||30
256317|NCT00474487|618909|P4|COMPLETED|Overall Study||109
256318|NCT00474487|618910|P3|COMPLETED|Overall Study||885
256319|NCT00474487|618911|P2|COMPLETED|Overall Study||215
256320|NCT00474487|618912|P1|COMPLETED|Overall Study||1576
256321|NCT00474487|618909|P4|STARTED|Overall Study||109
256322|NCT00474487|618910|P3|STARTED|Overall Study||899
256323|NCT00474487|618911|P2|STARTED|Overall Study||217
256324|NCT00474487|618912|P1|STARTED|Overall Study||1606
256325|NCT00474383|618932|P2|NOT COMPLETED|Extension||5
256326|NCT00474383|618933|P1|NOT COMPLETED|Extension||0
256327|NCT00474383|618932|P2|COMPLETED|Extension||0
256328|NCT00474383|618933|P1|COMPLETED|Extension||0
256329|NCT00474383|618932|P2|STARTED|Extension||5
256330|NCT00474383|618933|P1|STARTED|Extension||0
256331|NCT00474383|618932|P2|NOT COMPLETED|Between Main Study and Extension||0
256332|NCT00474383|618933|P1|NOT COMPLETED|Between Main Study and Extension||6
256333|NCT00474383|618932|P2|COMPLETED|Between Main Study and Extension||0
256334|NCT00474383|618933|P1|COMPLETED|Between Main Study and Extension||5
256335|NCT00474383|618932|P2|STARTED|Between Main Study and Extension||0
256336|NCT00474383|618933|P1|STARTED|Between Main Study and Extension||11
256337|NCT00474383|618932|P2|NOT COMPLETED|Main Study||0
256338|NCT00474383|618933|P1|NOT COMPLETED|Main Study||36
256339|NCT00474383|618932|P2|COMPLETED|Main Study||0
256340|NCT00474383|618933|P1|COMPLETED|Main Study||11
256341|NCT00474383|618932|P2|STARTED|Main Study||0
256342|NCT00474383|618933|P1|STARTED|Main Study||47
256343|NCT00474266|618948|P4|NOT COMPLETED|Overall Study||7
256344|NCT00474266|618949|P3|NOT COMPLETED|Overall Study||4
256345|NCT00474266|618950|P2|NOT COMPLETED|Overall Study||20
256346|NCT00474266|618951|P1|NOT COMPLETED|Overall Study||7
256347|NCT00474266|618948|P4|COMPLETED|Overall Study||118
256348|NCT00474266|618949|P3|COMPLETED|Overall Study||122
256349|NCT00474266|618950|P2|COMPLETED|Overall Study||354
256350|NCT00474266|618951|P1|COMPLETED|Overall Study||368
256351|NCT00474266|618948|P4|STARTED|Overall Study||125
256352|NCT00474266|618949|P3|STARTED|Overall Study||126
256353|NCT00474266|618950|P2|STARTED|Overall Study||374
256354|NCT00474266|618951|P1|STARTED|Overall Study||375
256355|NCT00474240|619059|P6|NOT COMPLETED|Overall Study||18
256356|NCT00474240|619060|P5|NOT COMPLETED|Overall Study||8
256357|NCT00474240|619061|P4|NOT COMPLETED|Overall Study||16
256358|NCT00474240|619062|P3|NOT COMPLETED|Overall Study||9
256359|NCT00474240|619063|P2|NOT COMPLETED|Overall Study||1
256360|NCT00474240|619064|P1|NOT COMPLETED|Overall Study||1
256361|NCT00474240|619059|P6|COMPLETED|Overall Study||8
256362|NCT00474240|619060|P5|COMPLETED|Overall Study||18
256363|NCT00474240|619061|P4|COMPLETED|Overall Study||10
256364|NCT00474240|619062|P3|COMPLETED|Overall Study||17
256365|NCT00474240|619063|P2|COMPLETED|Overall Study||25
256366|NCT00474240|619064|P1|COMPLETED|Overall Study||26
256367|NCT00474240|619059|P6|STARTED|Overall Study||26
256368|NCT00474240|619060|P5|STARTED|Overall Study||26
256369|NCT00474240|619061|P4|STARTED|Overall Study||26
256370|NCT00474240|619062|P3|STARTED|Overall Study||26
256371|NCT00474240|619063|P2|STARTED|Overall Study||26
256372|NCT00474240|619064|P1|STARTED|Overall Study||27
256373|NCT00474201|619084|P1|NOT COMPLETED|Overall Study||0
256374|NCT00474201|619084|P1|COMPLETED|Overall Study||15
256375|NCT00474201|619084|P1|STARTED|Overall Study||15
256376|NCT00474188|619089|P1|NOT COMPLETED|Overall Study||6
256377|NCT00474188|619089|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
256378|NCT00474188|619089|P1|STARTED|Overall Study||26
256379|NCT00474175|619099|P3|NOT COMPLETED|Overall Study||4
256380|NCT00474175|619100|P2|NOT COMPLETED|Overall Study||7
256381|NCT00474175|619101|P1|NOT COMPLETED|Overall Study||1
256382|NCT00474175|619099|P3|COMPLETED|Overall Study||225
256383|NCT00474175|619100|P2|COMPLETED|Overall Study||226
256384|NCT00474175|619101|P1|COMPLETED|Overall Study||114
256385|NCT00474175|619099|P3|Treated|Overall Study||228
256386|NCT00474175|619100|P2|Treated|Overall Study||233
256387|NCT00474175|619101|P1|Treated|Overall Study||115
256388|NCT00474175|619099|P3|STARTED|Overall Study||229
256389|NCT00474175|619100|P2|STARTED|Overall Study||233
256390|NCT00474175|619101|P1|STARTED|Overall Study||115
256391|NCT00474123|619138|P2|NOT COMPLETED|Overall Study||0
256392|NCT00474123|619139|P1|NOT COMPLETED|Overall Study||0
256393|NCT00474123|619138|P2|COMPLETED|Overall Study||40
256394|NCT00474123|619139|P1|COMPLETED|Overall Study||38
256395|NCT00474123|619138|P2|STARTED|Overall Study||40
256396|NCT00474123|619139|P1|STARTED|Overall Study||38
256397|NCT00474058|619165|P2|NOT COMPLETED|Overall Study||17
256398|NCT00474058|619166|P1|NOT COMPLETED|Overall Study||24
256399|NCT00474058|619165|P2|COMPLETED|Overall Study||80
256400|NCT00474058|619166|P1|COMPLETED|Overall Study||166
256401|NCT00474058|619165|P2|STARTED|Overall Study||97
256402|NCT00474058|619166|P1|STARTED|Overall Study||190
256403|NCT00474045|619180|P2|NOT COMPLETED|Overall Study||101
256404|NCT00474045|619181|P1|NOT COMPLETED|Overall Study||106
256405|NCT00474045|619180|P2|COMPLETED|Overall Study||136
256406|NCT00474045|619181|P1|COMPLETED|Overall Study||127
256407|NCT00474045|619180|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
256408|NCT00474045|619181|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
256409|NCT00474045|619180|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
256410|NCT00474045|619181|P1|Exposed-Pregnant Subjects|Overall Study||152
256411|NCT00474045|619180|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
256412|NCT00474045|619181|P1|Exposed-All Subjects|Overall Study||233
256413|NCT00474045|619180|P2|STARTED|Overall Study||237
256414|NCT00474045|619181|P1|STARTED|Overall Study||233
256415|NCT00473889|619281|P2|NOT COMPLETED|Overall Study||64
256416|NCT00473889|619282|P1|NOT COMPLETED|Overall Study||83
256417|NCT00473889|619281|P2|COMPLETED|Overall Study||63
256418|NCT00473889|619282|P1|COMPLETED|Overall Study||43
256419|NCT00473889|619281|P2|STARTED|Overall Study||127
256420|NCT00473889|619282|P1|STARTED|Overall Study||126
256421|NCT00473876|619294|P2|NOT COMPLETED|Overall Study||1
256422|NCT00473876|619295|P1|NOT COMPLETED|Overall Study||3
256423|NCT00473876|619294|P2|COMPLETED|Overall Study||22
256424|NCT00473876|619295|P1|COMPLETED|Overall Study||36
256425|NCT00473876|619294|P2|STARTED|Overall Study||23
256426|NCT00473876|619295|P1|STARTED|Overall Study||39
256427|NCT00473837|619305|P2|NOT COMPLETED|Overall Study||3
256428|NCT00473837|619306|P1|NOT COMPLETED|Overall Study||1
256429|NCT00473837|619305|P2|COMPLETED|Overall Study||43
256430|NCT00473837|619306|P1|COMPLETED|Overall Study||49
256431|NCT00473837|619305|P2|STARTED|Overall Study||46
256432|NCT00473837|619306|P1|STARTED|Overall Study||50
256433|NCT00473824|619314|P2|NOT COMPLETED|Overall Study||0
256434|NCT00473824|619315|P1|NOT COMPLETED|Overall Study||5
256435|NCT00473824|619314|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
256436|NCT00473824|619315|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
256437|NCT00473824|619314|P2|STARTED|Overall Study||2
256438|NCT00473824|619315|P1|STARTED|Overall Study||5
256439|NCT00473746|619326|P5|NOT COMPLETED|Period 2 (Phase 2)||27
256440|NCT00473746|619327|P4|NOT COMPLETED|Period 2 (Phase 2)||0
256441|NCT00473746|619328|P3|NOT COMPLETED|Period 2 (Phase 2)||0
256442|NCT00473746|619329|P2|NOT COMPLETED|Period 2 (Phase 2)||0
256443|NCT00473746|619330|P1|NOT COMPLETED|Period 2 (Phase 2)||0
256444|NCT00473746|619326|P5|COMPLETED|Period 2 (Phase 2)||6
256445|NCT00473746|619327|P4|COMPLETED|Period 2 (Phase 2)||0
256446|NCT00473746|619328|P3|COMPLETED|Period 2 (Phase 2)||0
256447|NCT00473746|619329|P2|COMPLETED|Period 2 (Phase 2)||0
256448|NCT00473746|619330|P1|COMPLETED|Period 2 (Phase 2)||0
256449|NCT00473746|619326|P5|STARTED|Period 2 (Phase 2)||33
256450|NCT00473746|619327|P4|STARTED|Period 2 (Phase 2)||0
256451|NCT00473746|619328|P3|STARTED|Period 2 (Phase 2)||0
256452|NCT00473746|619329|P2|STARTED|Period 2 (Phase 2)||0
256453|NCT00473746|619330|P1|STARTED|Period 2 (Phase 2)||0
256454|NCT00473746|619326|P5|NOT COMPLETED|Period 1 (Phase 1)||0
256455|NCT00473746|619327|P4|NOT COMPLETED|Period 1 (Phase 1)||10
256456|NCT00473746|619328|P3|NOT COMPLETED|Period 1 (Phase 1)||6
256457|NCT00473746|619329|P2|NOT COMPLETED|Period 1 (Phase 1)||9
256458|NCT00473746|619330|P1|NOT COMPLETED|Period 1 (Phase 1)||6
256459|NCT00473746|619326|P5|COMPLETED|Period 1 (Phase 1)||0
256460|NCT00473746|619327|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
256461|NCT00473746|619328|P3|COMPLETED|Period 1 (Phase 1)||0
256462|NCT00473746|619329|P2|COMPLETED|Period 1 (Phase 1)||0
256463|NCT00473746|619330|P1|COMPLETED|Period 1 (Phase 1)||0
256464|NCT00473746|619326|P5|STARTED|Period 1 (Phase 1)||0
256465|NCT00473746|619327|P4|STARTED|Period 1 (Phase 1)||12
256466|NCT00473746|619328|P3|STARTED|Period 1 (Phase 1)||6
256467|NCT00473746|619329|P2|STARTED|Period 1 (Phase 1)||9
256468|NCT00473746|619330|P1|STARTED|Period 1 (Phase 1)||6
256469|NCT00473668|619378|P3|NOT COMPLETED|Overall Study||10
256470|NCT00473668|619379|P2|NOT COMPLETED|Overall Study||11
256471|NCT00473668|619380|P1|NOT COMPLETED|Overall Study||5
256472|NCT00473668|619378|P3|COMPLETED|Overall Study||89
256473|NCT00473668|619379|P2|COMPLETED|Overall Study||89
256474|NCT00473668|619380|P1|COMPLETED|Overall Study||95
256475|NCT00473668|619378|P3|STARTED|Overall Study||99
256476|NCT00473668|619379|P2|STARTED|Overall Study||100
256477|NCT00473668|619380|P1|STARTED|Overall Study||100
256478|NCT00473655|619433|P3|NOT COMPLETED|Overall Study||8
256479|NCT00473655|619434|P2|NOT COMPLETED|Overall Study||5
256480|NCT00473655|619435|P1|NOT COMPLETED|Overall Study||9
256481|NCT00473655|619433|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
256482|NCT00473655|619434|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
256483|NCT00473655|619435|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
256484|NCT00473655|619433|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
256485|NCT00473655|619434|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
256486|NCT00473655|619435|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
256487|NCT00473642|619470|P3|NOT COMPLETED|Overall Study||2
256488|NCT00473642|619471|P2|NOT COMPLETED|Overall Study||1
256489|NCT00473642|619472|P1|NOT COMPLETED|Overall Study||2
256490|NCT00473642|619470|P3|COMPLETED|Overall Study||8
256491|NCT00473642|619471|P2|COMPLETED|Overall Study||10
256492|NCT00473642|619472|P1|COMPLETED|Overall Study||8
256493|NCT00473642|619470|P3|STARTED|Overall Study||10
256494|NCT00473642|619471|P2|STARTED|Overall Study||11
256495|NCT00473642|619472|P1|STARTED|Overall Study||10
256496|NCT00473590|619482|P2|NOT COMPLETED|Overall Study||38
256497|NCT00473590|619483|P1|NOT COMPLETED|Overall Study||45
256498|NCT00473590|619482|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
256499|NCT00473590|619483|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
256500|NCT00473590|619482|P2|Safety Population|Overall Study||50
256501|NCT00473590|619483|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
256502|NCT00473590|619482|P2|Treated|Overall Study||48
256503|NCT00473590|619483|P1|Treated|Overall Study||52
256504|NCT00473590|619482|P2|STARTED|Overall Study||49
256505|NCT00473590|619483|P1|STARTED|Overall Study||53
256506|NCT00473564|619499|P1|NOT COMPLETED|Overall Study||23
256507|NCT00473564|619499|P1|COMPLETED|Overall Study||147
256508|NCT00473564|619499|P1|STARTED|Overall Study||170
256509|NCT00473512|619509|P5|NOT COMPLETED|Period 2 (Phase 2)||2
256510|NCT00473512|619510|P4|NOT COMPLETED|Period 2 (Phase 2)||23
256511|NCT00473512|619511|P3|NOT COMPLETED|Period 2 (Phase 2)||2
256512|NCT00473512|619512|P2|NOT COMPLETED|Period 2 (Phase 2)||2
256513|NCT00473512|619513|P1|NOT COMPLETED|Period 2 (Phase 2)||1
256514|NCT00473512|619509|P5|COMPLETED|Period 2 (Phase 2)||0
256515|NCT00473512|619510|P4|COMPLETED|Period 2 (Phase 2)||0
256516|NCT00473512|619511|P3|COMPLETED|Period 2 (Phase 2)||0
256517|NCT00473512|619512|P2|COMPLETED|Period 2 (Phase 2)||0
256518|NCT00473512|619513|P1|COMPLETED|Period 2 (Phase 2)||0
256519|NCT00473512|619509|P5|STARTED|Period 2 (Phase 2)||2
256520|NCT00473512|619510|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
256521|NCT00473512|619511|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
256522|NCT00473512|619512|P2|STARTED|Period 2 (Phase 2)||2
256523|NCT00473512|619513|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
256524|NCT00473512|619509|P5|NOT COMPLETED|Period 1 (Phase 1)||1
256525|NCT00473512|619510|P4|NOT COMPLETED|Period 1 (Phase 1)||17
256526|NCT00473512|619511|P3|NOT COMPLETED|Period 1 (Phase 1)||0
256527|NCT00473512|619512|P2|NOT COMPLETED|Period 1 (Phase 1)||1
256528|NCT00473512|619513|P1|NOT COMPLETED|Period 1 (Phase 1)||1
256529|NCT00473512|619509|P5|COMPLETED|Period 1 (Phase 1)||2
256530|NCT00473512|619510|P4|COMPLETED|Period 1 (Phase 1)||25
256531|NCT00473512|619511|P3|COMPLETED|Period 1 (Phase 1)||3
256532|NCT00473512|619512|P2|COMPLETED|Period 1 (Phase 1)||2
256533|NCT00473512|619513|P1|COMPLETED|Period 1 (Phase 1)||2
256534|NCT00473512|619509|P5|STARTED|Period 1 (Phase 1)||3
256535|NCT00473512|619510|P4|STARTED|Period 1 (Phase 1)||42
256536|NCT00473512|619511|P3|STARTED|Period 1 (Phase 1)||3
256537|NCT00473512|619512|P2|STARTED|Period 1 (Phase 1)||3
256538|NCT00473512|619513|P1|STARTED|Period 1 (Phase 1)||3
256539|NCT00473434|619571|P1|NOT COMPLETED|Overall Study||32
256540|NCT00473434|619571|P1|COMPLETED|Overall Study||32
256541|NCT00473434|619571|P1|STARTED|Overall Study||64
256542|NCT00473382|619636|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
256543|NCT00473382|619637|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
256544|NCT00473382|619638|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
256545|NCT00473382|619636|P3|COMPLETED|Open-label Extension Through Month 60||2
256546|NCT00473382|619637|P2|COMPLETED|Open-label Extension Through Month 60||1
256547|NCT00473382|619638|P1|COMPLETED|Open-label Extension Through Month 60||2
256548|NCT00473382|619636|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
256549|NCT00473382|619637|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
256550|NCT00473382|619638|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
256551|NCT00473382|619636|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
256552|NCT00473382|619637|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
256553|NCT00473382|619638|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
256554|NCT00473382|619636|P3|COMPLETED|Open-label Extension Through Month 48||37
256555|NCT00473382|619637|P2|COMPLETED|Open-label Extension Through Month 48||42
256556|NCT00473382|619638|P1|COMPLETED|Open-label Extension Through Month 48||38
256557|NCT00473382|619636|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
256558|NCT00473382|619637|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
256559|NCT00473382|619638|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
256560|NCT00473382|619636|P3|NOT COMPLETED|Core Study||29
256561|NCT00473382|619637|P2|NOT COMPLETED|Core Study||27
256562|NCT00473382|619638|P1|NOT COMPLETED|Core Study||28
256563|NCT00473382|619636|P3|COMPLETED|Core Study||98
256564|NCT00473382|619637|P2|COMPLETED|Core Study||98
256565|NCT00473382|619638|P1|COMPLETED|Core Study||102
256566|NCT00473382|619636|P3|STARTED|Core Study||127
256567|NCT00473382|619637|P2|STARTED|Core Study||125
256568|NCT00473382|619638|P1|STARTED|Core Study||130
256569|NCT00473330|619696|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
256570|NCT00473330|619697|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
256571|NCT00473330|619698|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
256572|NCT00473330|619696|P3|COMPLETED|Open-label Extension Through Month 60||0
256573|NCT00473330|619697|P2|COMPLETED|Open-label Extension Through Month 60||1
256574|NCT00473330|619698|P1|COMPLETED|Open-label Extension Through Month 60||1
256575|NCT00473330|619696|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
256576|NCT00473330|619697|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
256577|NCT00473330|619698|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
256578|NCT00473330|619696|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
256579|NCT00473330|619697|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
256580|NCT00473330|619698|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
256581|NCT00473330|619696|P3|COMPLETED|Open-label Extension Through Month 48||50
256582|NCT00473330|619697|P2|COMPLETED|Open-label Extension Through Month 48||59
256583|NCT00473330|619698|P1|COMPLETED|Open-label Extension Through Month 48||63
256584|NCT00473330|619696|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
256585|NCT00473330|619697|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
256586|NCT00473330|619698|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
256587|NCT00473330|619696|P3|NOT COMPLETED|Core Study||41
256588|NCT00473330|619697|P2|NOT COMPLETED|Core Study||25
256589|NCT00473330|619698|P1|NOT COMPLETED|Core Study||27
256590|NCT00473330|619696|P3|COMPLETED|Core Study||86
256591|NCT00473330|619697|P2|COMPLETED|Core Study||100
256592|NCT00473330|619698|P1|COMPLETED|Core Study||98
256593|NCT00473330|619696|P3|STARTED|Core Study||127
256594|NCT00473330|619697|P2|STARTED|Core Study||125
256595|NCT00473330|619698|P1|STARTED|Core Study||125
256596|NCT00473265|619753|P1|NOT COMPLETED|Overall Study||20
256597|NCT00473265|619753|P1|COMPLETED|Overall Study||48
256598|NCT00473265|619753|P1|STARTED|Overall Study||68
256599|NCT00473083|619765|P3|NOT COMPLETED|Overall Study||0
256600|NCT00473083|619766|P2|NOT COMPLETED|Overall Study||0
256601|NCT00473083|619767|P1|NOT COMPLETED|Overall Study||1
256602|NCT00473083|619765|P3|COMPLETED|Overall Study||50
256603|NCT00473083|619766|P2|COMPLETED|Overall Study||50
256604|NCT00473083|619767|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
256605|NCT00473083|619765|P3|STARTED|Overall Study||50
256606|NCT00473083|619766|P2|STARTED|Overall Study||50
256607|NCT00473083|619767|P1|STARTED|Overall Study||50
256608|NCT00472849|619795|P2|NOT COMPLETED|Overall Study||0
256609|NCT00472849|619796|P1|NOT COMPLETED|Overall Study||0
256610|NCT00472849|619795|P2|COMPLETED|Overall Study||78
256611|NCT00472849|619796|P1|COMPLETED|Overall Study||12
256612|NCT00472849|619795|P2|STARTED|Overall Study||78
256613|NCT00472849|619796|P1|STARTED|Overall Study||12
256614|NCT00472797|619804|P2|NOT COMPLETED|Overall Study||1
256615|NCT00472797|619805|P1|NOT COMPLETED|Overall Study||4
256616|NCT00472797|619804|P2|COMPLETED|Overall Study||112
256617|NCT00472797|619805|P1|COMPLETED|Overall Study||115
256618|NCT00472797|619804|P2|STARTED|Overall Study||113
256619|NCT00472797|619805|P1|STARTED|Overall Study||119
256620|NCT00472732|619831|P2|NOT COMPLETED|Overall Study||0
256621|NCT00472732|619832|P1|NOT COMPLETED|Overall Study||0
256622|NCT00472732|619831|P2|COMPLETED|Overall Study||22
256623|NCT00472732|619832|P1|COMPLETED|Overall Study||24
256624|NCT00472732|619831|P2|STARTED|Overall Study||22
256625|NCT00472732|619832|P1|STARTED|Overall Study||24
256626|NCT00472641|619842|P1|NOT COMPLETED|Overall Study||7
256627|NCT00472641|619842|P1|COMPLETED|Overall Study||18
256628|NCT00472641|619842|P1|STARTED|Overall Study||25
256629|NCT00472576|619849|P2|NOT COMPLETED|Second Intervention||0
256630|NCT00472576|619850|P1|NOT COMPLETED|Second Intervention||0
256631|NCT00472576|619849|P2|COMPLETED|Second Intervention||3
256632|NCT00472576|619850|P1|COMPLETED|Second Intervention||2
256633|NCT00472576|619849|P2|STARTED|Second Intervention||3
256634|NCT00472576|619850|P1|STARTED|Second Intervention||2
256635|NCT00472576|619849|P2|NOT COMPLETED|First Intervention||0
256636|NCT00472576|619850|P1|NOT COMPLETED|First Intervention||0
256637|NCT00472576|619849|P2|COMPLETED|First Intervention||3
256638|NCT00472576|619850|P1|COMPLETED|First Intervention||2
256639|NCT00472576|619849|P2|STARTED|First Intervention||3
256640|NCT00472576|619850|P1|STARTED|First Intervention||2
256641|NCT00472446|619862|P4|NOT COMPLETED|Overall Study||6
256642|NCT00472446|619863|P3|NOT COMPLETED|Overall Study||7
256643|NCT00472446|619864|P2|NOT COMPLETED|Overall Study||6
256644|NCT00472446|619865|P1|NOT COMPLETED|Overall Study||5
256645|NCT00472446|619862|P4|COMPLETED|Overall Study||39
256646|NCT00472446|619863|P3|COMPLETED|Overall Study||38
256647|NCT00472446|619864|P2|COMPLETED|Overall Study||41
256648|NCT00472446|619865|P1|COMPLETED|Overall Study||41
256649|NCT00472446|619862|P4|STARTED|Overall Study||45
256650|NCT00472446|619863|P3|STARTED|Overall Study||45
256651|NCT00472446|619864|P2|STARTED|Overall Study||47
256652|NCT00472446|619865|P1|STARTED|Overall Study||46
256653|NCT00472420|619895|P1|NOT COMPLETED|Follow-up Period||17
256654|NCT00472420|619895|P1|COMPLETED|Follow-up Period||15
256655|NCT00472420|619895|P1|STARTED|Follow-up Period||32
256656|NCT00472420|619895|P1|NOT COMPLETED|Induction Treatment Period||16
256657|NCT00472420|619895|P1|COMPLETED|Induction Treatment Period||32
256658|NCT00472420|619895|P1|STARTED|Induction Treatment Period||48
256659|NCT00472303|619903|P3|NOT COMPLETED|Maintenance Phase||17
256660|NCT00472303|619904|P2|NOT COMPLETED|Maintenance Phase||16
256661|NCT00472303|619905|P1|NOT COMPLETED|Maintenance Phase||17
256662|NCT00472303|619903|P3|COMPLETED|Maintenance Phase||95
256663|NCT00472303|619904|P2|COMPLETED|Maintenance Phase||93
256664|NCT00472303|619905|P1|COMPLETED|Maintenance Phase||89
256665|NCT00472303|619903|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
256666|NCT00472303|619904|P2|STARTED|Maintenance Phase||109
256667|NCT00472303|619905|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
256668|NCT00472303|619903|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
256669|NCT00472303|619904|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
256670|NCT00472303|619905|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
256671|NCT00472303|619903|P3|COMPLETED|Discontinuations After Titration Phase||0
256672|NCT00472303|619904|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
256673|NCT00472303|619905|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
256674|NCT00472303|619903|P3|STARTED|Discontinuations After Titration Phase||0
256675|NCT00472303|619904|P2|STARTED|Discontinuations After Titration Phase||129
256676|NCT00472303|619905|P1|STARTED|Discontinuations After Titration Phase||279
256677|NCT00472303|619903|P3|NOT COMPLETED|Titration Phase||0
256678|NCT00472303|619904|P2|NOT COMPLETED|Titration Phase||29
256679|NCT00472303|619905|P1|NOT COMPLETED|Titration Phase||59
256680|NCT00472303|619903|P3|COMPLETED|Titration Phase||0
256681|NCT00472303|619904|P2|COMPLETED|Titration Phase||129
256682|NCT00472303|619905|P1|COMPLETED|Titration Phase||279
256683|NCT00472303|619903|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
256684|NCT00472303|619904|P2|STARTED|Titration Phase||158
256685|NCT00472303|619905|P1|STARTED|Titration Phase||338
256686|NCT00472290|619968|P1|NOT COMPLETED|Overall Study||72
256687|NCT00472290|619968|P1|COMPLETED|Overall Study||0
256688|NCT00472290|619968|P1|STARTED|Overall Study||72
256689|NCT00472199|619980|P2|NOT COMPLETED|Overall Study||60
256690|NCT00472199|619981|P1|NOT COMPLETED|Overall Study||35
256691|NCT00472199|619980|P2|COMPLETED|Overall Study||103
256692|NCT00472199|619981|P1|COMPLETED|Overall Study||131
256693|NCT00472199|619980|P2|STARTED|Overall Study||163
256694|NCT00472199|619981|P1|STARTED|Overall Study||166
256695|NCT00472082|620047|P1|NOT COMPLETED|Overall Study||5
256696|NCT00472082|620047|P1|COMPLETED|Overall Study||0
256697|NCT00472082|620047|P1|STARTED|Overall Study||5
256698|NCT00472056|620056|P4|NOT COMPLETED|Overall Study||0
256699|NCT00472056|620057|P3|NOT COMPLETED|Overall Study||0
256700|NCT00472056|620058|P2|NOT COMPLETED|Overall Study||0
256701|NCT00472056|620059|P1|NOT COMPLETED|Overall Study||0
256702|NCT00472056|620056|P4|COMPLETED|Overall Study||17
256703|NCT00472056|620057|P3|COMPLETED|Overall Study||32
256704|NCT00472056|620058|P2|COMPLETED|Overall Study||19
256705|NCT00472056|620059|P1|COMPLETED|Overall Study||25
256706|NCT00472056|620056|P4|STARTED|Overall Study||17
256707|NCT00472056|620057|P3|STARTED|Overall Study||32
256708|NCT00472056|620058|P2|STARTED|Overall Study||19
256709|NCT00472056|620059|P1|STARTED|Overall Study||25
256710|NCT00472030|620069|P2|NOT COMPLETED|Overall Study||0
256711|NCT00472030|620070|P1|NOT COMPLETED|Overall Study||1
256712|NCT00472030|620069|P2|COMPLETED|Overall Study||0
256713|NCT00472030|620070|P1|COMPLETED|Overall Study||1
256714|NCT00472030|620069|P2|STARTED|Overall Study||0
256715|NCT00472030|620070|P1|STARTED|Overall Study||2
256716|NCT00471822|620086|P1|NOT COMPLETED|Overall Study||2
256717|NCT00471822|620086|P1|COMPLETED|Overall Study||9705
256718|NCT00471822|620086|P1|Treated|Overall Study||9705
256719|NCT00471822|620086|P1|STARTED|Overall Study||9707
256720|NCT00471718|620094|P1|NOT COMPLETED|Overall Study||27
256721|NCT00471718|620094|P1|COMPLETED|Overall Study||0
256722|NCT00471718|620094|P1|STARTED|Overall Study||27
256723|NCT00471705|620106|P3|NOT COMPLETED|Overall Study||15
256724|NCT00471705|620107|P2|NOT COMPLETED|Overall Study||22
256725|NCT00471705|620108|P1|NOT COMPLETED|Overall Study||24
256726|NCT00471705|620106|P3|COMPLETED|Overall Study||134
256727|NCT00471705|620107|P2|COMPLETED|Overall Study||121
256728|NCT00471705|620108|P1|COMPLETED|Overall Study||121
256729|NCT00471705|620106|P3|STARTED|Overall Study||149
256730|NCT00471705|620107|P2|STARTED|Overall Study||143
256731|NCT00471705|620108|P1|STARTED|Overall Study||145
256732|NCT00471536|620122|P1|NOT COMPLETED|Overall Study||1
256733|NCT00471536|620122|P1|COMPLETED|Overall Study||18
256734|NCT00471536|620122|P1|STARTED|Overall Study||19
256735|NCT00471497|620134|P3|NOT COMPLETED|Overall Study||40
256736|NCT00471497|620135|P2|NOT COMPLETED|Overall Study||35
256737|NCT00471497|620136|P1|NOT COMPLETED|Overall Study||46
256738|NCT00471497|620134|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
256739|NCT00471497|620135|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
256740|NCT00471497|620136|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
256741|NCT00471497|620134|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
256742|NCT00471497|620135|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
256743|NCT00471497|620136|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
256744|NCT00471497|620134|P3|STARTED|Overall Study||281
256745|NCT00471497|620135|P2|STARTED|Overall Study||282
256746|NCT00471497|620136|P1|STARTED|Overall Study||283
256747|NCT00471445|620146|P2|NOT COMPLETED|Overall Study||2
256748|NCT00471445|620147|P1|NOT COMPLETED|Overall Study||2
256749|NCT00471445|620146|P2|COMPLETED|Overall Study||231
256750|NCT00471445|620147|P1|COMPLETED|Overall Study||227
256751|NCT00471445|620146|P2|STARTED|Overall Study||233
256752|NCT00471445|620147|P1|STARTED|Overall Study||229
256753|NCT00471380|620153|P2|NOT COMPLETED|Third Intervention||2
256754|NCT00471380|620154|P1|NOT COMPLETED|Third Intervention||1
256755|NCT00471380|620153|P2|COMPLETED|Third Intervention||14
256756|NCT00471380|620154|P1|COMPLETED|Third Intervention||17
256757|NCT00471380|620153|P2|STARTED|Third Intervention||16
256758|NCT00471380|620154|P1|STARTED|Third Intervention||18
256759|NCT00471380|620153|P2|NOT COMPLETED|Second Intervention||4
256760|NCT00471380|620154|P1|NOT COMPLETED|Second Intervention||0
256761|NCT00471380|620153|P2|COMPLETED|Second Intervention||16
256762|NCT00471380|620154|P1|COMPLETED|Second Intervention||18
256763|NCT00471380|620153|P2|STARTED|Second Intervention||20
256764|NCT00471380|620154|P1|STARTED|Second Intervention||18
256765|NCT00471380|620153|P2|NOT COMPLETED|First Intervention||4
256766|NCT00471380|620154|P1|NOT COMPLETED|First Intervention||4
256767|NCT00471380|620153|P2|COMPLETED|First Intervention||20
256768|NCT00471380|620154|P1|COMPLETED|First Intervention||18
256769|NCT00471380|620153|P2|STARTED|First Intervention||24
256770|NCT00471380|620154|P1|STARTED|First Intervention||22
256771|NCT00471354|620160|P1|NOT COMPLETED|Overall Study||52
256772|NCT00471354|620160|P1|COMPLETED|Overall Study||176
256773|NCT00471354|620160|P1|STARTED|Overall Study||228
256774|NCT00471328|620172|P2|NOT COMPLETED|Extension Phase||67
256775|NCT00471328|620173|P1|NOT COMPLETED|Extension Phase||41
256776|NCT00471328|620172|P2|COMPLETED|Extension Phase||0
256777|NCT00471328|620173|P1|COMPLETED|Extension Phase||0
256778|NCT00471328|620172|P2|Started:CrossOver During Extension|Extension Phase||10
256779|NCT00471328|620173|P1|Started:CrossOver During Extension|Extension Phase||0
256780|NCT00471328|620172|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
256781|NCT00471328|620173|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
256782|NCT00471328|620172|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
256783|NCT00471328|620173|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
256784|NCT00471328|620172|P2|STARTED|Extension Phase||67
256785|NCT00471328|620173|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
256786|NCT00471328|620172|P2|NOT COMPLETED|Core Phase||67
256787|NCT00471328|620173|P1|NOT COMPLETED|Core Phase||107
256788|NCT00471328|620172|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
256789|NCT00471328|620173|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
256790|NCT00471328|620172|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
256791|NCT00471328|620173|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
256792|NCT00471328|620172|P2|STARTED|Core Phase||83
256793|NCT00471328|620173|P1|STARTED|Core Phase||165
256794|NCT00471315|620192|P1|NOT COMPLETED|Overall Study||8
256795|NCT00471315|620192|P1|COMPLETED|Overall Study||10
256796|NCT00471315|620192|P1|STARTED|Overall Study||18
256797|NCT00471276|620197|P1|NOT COMPLETED|Overall Study||83
256798|NCT00471276|620197|P1|COMPLETED|Overall Study||0
256799|NCT00471276|620197|P1|STARTED|Overall Study||83
256800|NCT00471237|620227|P7|NOT COMPLETED|Overall Study||3
256801|NCT00471237|620228|P6|NOT COMPLETED|Overall Study||39
256802|NCT00471237|620229|P5|NOT COMPLETED|Overall Study||41
256803|NCT00471237|620230|P4|NOT COMPLETED|Overall Study||45
256804|NCT00471237|620231|P3|NOT COMPLETED|Overall Study||34
256805|NCT00471237|620232|P2|NOT COMPLETED|Overall Study||42
256806|NCT00471237|620233|P1|NOT COMPLETED|Overall Study||41
256807|NCT00471237|620227|P7|COMPLETED|Overall Study||38
256808|NCT00471237|620228|P6|COMPLETED|Overall Study||50
256809|NCT00471237|620229|P5|COMPLETED|Overall Study||46
256810|NCT00471237|620230|P4|COMPLETED|Overall Study||43
256811|NCT00471237|620231|P3|COMPLETED|Overall Study||48
256812|NCT00471237|620232|P2|COMPLETED|Overall Study||45
256813|NCT00471237|620233|P1|COMPLETED|Overall Study||49
256814|NCT00471237|620227|P7|STARTED|Overall Study||41
256815|NCT00471237|620228|P6|STARTED|Overall Study||89
256816|NCT00471237|620229|P5|STARTED|Overall Study||87
256817|NCT00471237|620230|P4|STARTED|Overall Study||88
256818|NCT00471237|620231|P3|STARTED|Overall Study||82
256819|NCT00471237|620232|P2|STARTED|Overall Study||87
256820|NCT00471237|620233|P1|STARTED|Overall Study||90
256821|NCT00471146|620383|P2|NOT COMPLETED|Overall Study||174
256822|NCT00471146|620384|P1|NOT COMPLETED|Overall Study||172
256823|NCT00471146|620383|P2|COMPLETED|Overall Study||142
256824|NCT00471146|620384|P1|COMPLETED|Overall Study||142
256825|NCT00471146|620383|P2|Treated|Overall Study||308
256826|NCT00471146|620384|P1|Treated|Overall Study||305
256827|NCT00471146|620383|P2|STARTED|Overall Study||316
256828|NCT00471146|620384|P1|STARTED|Overall Study||314
256829|NCT00471107|620409|P3|NOT COMPLETED|Overall Study||3
256830|NCT00471107|620410|P2|NOT COMPLETED|Overall Study||1
256831|NCT00471107|620411|P1|NOT COMPLETED|Overall Study||3
256832|NCT00471107|620409|P3|COMPLETED|Overall Study||12
256833|NCT00471107|620410|P2|COMPLETED|Overall Study||14
256834|NCT00471107|620411|P1|COMPLETED|Overall Study||12
256835|NCT00471107|620409|P3|STARTED|Overall Study||15
256836|NCT00471107|620410|P2|STARTED|Overall Study||15
256837|NCT00471107|620411|P1|STARTED|Overall Study||15
256838|NCT00471068|620421|P2|NOT COMPLETED|Overall Study||1
256839|NCT00471068|620422|P1|NOT COMPLETED|Overall Study||1
256840|NCT00471068|620421|P2|COMPLETED|Overall Study||24
256841|NCT00471068|620422|P1|COMPLETED|Overall Study||20
256842|NCT00471068|620421|P2|STARTED|Overall Study||25
256843|NCT00471068|620422|P1|STARTED|Overall Study||21
256844|NCT00470847|620428|P1|NOT COMPLETED|Overall Study||1
256845|NCT00470847|620428|P1|COMPLETED|Overall Study||34
256846|NCT00470847|620428|P1|STARTED|Overall Study||35
256847|NCT00470834|620441|P2|NOT COMPLETED|Extension Period (24 Months)||23
256848|NCT00470834|620442|P1|NOT COMPLETED|Extension Period (24 Months)||15
256849|NCT00470834|620441|P2|COMPLETED|Extension Period (24 Months)||7
256850|NCT00470834|620442|P1|COMPLETED|Extension Period (24 Months)||11
256851|NCT00470834|620441|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
256852|NCT00470834|620442|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
256853|NCT00470834|620441|P2|NOT COMPLETED|Treatment Period (18 Months)||31
256854|NCT00470834|620442|P1|NOT COMPLETED|Treatment Period (18 Months)||38
256855|NCT00470834|620441|P2|COMPLETED|Treatment Period (18 Months)||31
256856|NCT00470834|620442|P1|COMPLETED|Treatment Period (18 Months)||27
256857|NCT00470834|620441|P2|STARTED|Treatment Period (18 Months)||62
256858|NCT00470834|620442|P1|STARTED|Treatment Period (18 Months)||65
256859|NCT00470626|620456|P1|NOT COMPLETED|Overall Study||17
256860|NCT00470626|620456|P1|COMPLETED|Overall Study||112
256861|NCT00470626|620456|P1|STARTED|Overall Study||129
256862|NCT00470600|620464|P2|NOT COMPLETED|Overall Study||0
256863|NCT00470600|620465|P1|NOT COMPLETED|Overall Study||0
256864|NCT00470600|620464|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
256865|NCT00470600|620465|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
256866|NCT00470600|620464|P2|STARTED|Overall Study||99
256867|NCT00470600|620465|P1|STARTED|Overall Study||86
256868|NCT00470548|620477|P4|NOT COMPLETED|Overall Study||0
256869|NCT00470548|620478|P3|NOT COMPLETED|Overall Study||0
256870|NCT00470548|620479|P2|NOT COMPLETED|Overall Study||0
256871|NCT00470548|620480|P1|NOT COMPLETED|Overall Study||0
256872|NCT00470548|620477|P4|COMPLETED|Overall Study||37
256873|NCT00470548|620478|P3|COMPLETED|Overall Study||6
256874|NCT00470548|620479|P2|COMPLETED|Overall Study||3
256875|NCT00470548|620480|P1|COMPLETED|Overall Study||3
256876|NCT00470548|620477|P4|STARTED|Overall Study||37
256877|NCT00470548|620478|P3|STARTED|Overall Study||6
256878|NCT00470548|620479|P2|STARTED|Overall Study||3
256879|NCT00470548|620480|P1|STARTED|Overall Study||3
256880|NCT00470535|620498|P1|NOT COMPLETED|Overall Study||18
256881|NCT00470535|620498|P1|COMPLETED|Overall Study||0
256882|NCT00470535|620498|P1|STARTED|Overall Study||18
256883|NCT00470470|620507|P1|NOT COMPLETED|Overall Study||5
256884|NCT00470470|620507|P1|COMPLETED|Overall Study||25
256885|NCT00470470|620507|P1|STARTED|Overall Study||30
256886|NCT00470418|620514|P2|NOT COMPLETED|Overall Study||0
256887|NCT00470418|620515|P1|NOT COMPLETED|Overall Study||1
256888|NCT00470418|620514|P2|COMPLETED|Overall Study||3
256889|NCT00470418|620515|P1|COMPLETED|Overall Study||6
256890|NCT00470418|620514|P2|STARTED|Overall Study||3
256891|NCT00470418|620515|P1|STARTED|Overall Study||7
256892|NCT00470392|620525|P2|NOT COMPLETED|Overall Study||0
256893|NCT00470392|620526|P1|NOT COMPLETED|Overall Study||0
256894|NCT00470392|620525|P2|COMPLETED|Overall Study||2
256895|NCT00470392|620526|P1|COMPLETED|Overall Study||7
256896|NCT00470392|620525|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
256897|NCT00470392|620526|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
256898|NCT00470366|620536|P1|NOT COMPLETED|Overall Study||4
256899|NCT00470366|620536|P1|COMPLETED|Overall Study||56
256900|NCT00470366|620536|P1|STARTED|Overall Study||60
256901|NCT00470301|620543|P1|NOT COMPLETED|Overall Study||5
256902|NCT00470301|620543|P1|COMPLETED|Overall Study||55
256903|NCT00470301|620543|P1|STARTED|Overall Study||60
256904|NCT00470275|620547|P1|NOT COMPLETED|Overall Study||10
256905|NCT00470275|620547|P1|COMPLETED|Overall Study||0
256906|NCT00470275|620547|P1|STARTED|Overall Study||10
256907|NCT00470262|620553|P2|NOT COMPLETED|Overall Study||0
256908|NCT00470262|620554|P1|NOT COMPLETED|Overall Study||2
256909|NCT00470262|620553|P2|COMPLETED|Overall Study||12
256910|NCT00470262|620554|P1|COMPLETED|Overall Study||13
256911|NCT00470262|620553|P2|STARTED|Overall Study||12
256912|NCT00470262|620554|P1|STARTED|Overall Study||15
256913|NCT00470184|620562|P1|NOT COMPLETED|Overall Study||22
256914|NCT00470184|620562|P1|COMPLETED|Overall Study||19
256915|NCT00470184|620562|P1|Treated With Study Therapy|Overall Study||36
256916|NCT00470184|620562|P1|STARTED|Overall Study||41
256917|NCT00470158|620574|P5|NOT COMPLETED|Overall Study||6
256918|NCT00470158|620575|P4|NOT COMPLETED|Overall Study||5
256919|NCT00470158|620576|P3|NOT COMPLETED|Overall Study||8
256920|NCT00470158|620577|P2|NOT COMPLETED|Overall Study||8
256921|NCT00470158|620578|P1|NOT COMPLETED|Overall Study||8
256922|NCT00470158|620574|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
256923|NCT00470158|620575|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
256924|NCT00470158|620576|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
256925|NCT00470158|620577|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
256926|NCT00470158|620578|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
256927|NCT00470158|620574|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
256928|NCT00470158|620575|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
256929|NCT00470158|620576|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
256930|NCT00470158|620577|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
256931|NCT00470158|620578|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
256932|NCT00470106|620594|P4|NOT COMPLETED|Overall Study||2
256933|NCT00470106|620595|P3|NOT COMPLETED|Overall Study||7
256934|NCT00470106|620596|P2|NOT COMPLETED|Overall Study||5
256935|NCT00470106|620597|P1|NOT COMPLETED|Overall Study||3
256936|NCT00470106|620594|P4|COMPLETED|Overall Study||19
256937|NCT00470106|620595|P3|COMPLETED|Overall Study||14
256938|NCT00470106|620596|P2|COMPLETED|Overall Study||19
256939|NCT00470106|620597|P1|COMPLETED|Overall Study||16
256940|NCT00470106|620594|P4|STARTED|Overall Study||21
256941|NCT00470106|620595|P3|STARTED|Overall Study||21
256942|NCT00470106|620596|P2|STARTED|Overall Study||24
256943|NCT00470106|620597|P1|STARTED|Overall Study||19
256944|NCT00470067|620611|P1|NOT COMPLETED|Overall Study||7
256945|NCT00470067|620611|P1|COMPLETED|Overall Study||2
256946|NCT00470067|620611|P1|STARTED|Overall Study||9
256947|NCT00470054|620615|P1|NOT COMPLETED|Overall Study||1
256948|NCT00470054|620615|P1|COMPLETED|Overall Study||43
256949|NCT00470054|620615|P1|STARTED|Overall Study||44
256950|NCT00469898|620623|P1|NOT COMPLETED|Overall Study||25
256951|NCT00469898|620623|P1|COMPLETED|Overall Study||25
256952|NCT00469898|620623|P1|STARTED|Overall Study||50
256953|NCT00469859|620632|P2|NOT COMPLETED|Overall Study||2
256954|NCT00469859|620633|P1|NOT COMPLETED|Overall Study||0
256955|NCT00469859|620632|P2|COMPLETED|Overall Study||6
256956|NCT00469859|620633|P1|COMPLETED|Overall Study||6
256957|NCT00469859|620632|P2|STARTED|Overall Study||8
256958|NCT00469859|620633|P1|STARTED|Overall Study||6
256959|NCT00469833|620641|P1|NOT COMPLETED|Overall Study||2
256960|NCT00469833|620641|P1|COMPLETED|Overall Study||15
256961|NCT00469833|620641|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
256962|NCT00469508|620653|P2|NOT COMPLETED|Overall Study||24
256963|NCT00469508|620654|P1|NOT COMPLETED|Overall Study||20
256964|NCT00469508|620653|P2|COMPLETED|Overall Study||13
256965|NCT00469508|620654|P1|COMPLETED|Overall Study||14
256966|NCT00469508|620653|P2|STARTED|Overall Study||37
256967|NCT00469508|620654|P1|STARTED|Overall Study||34
256968|NCT00469456|620668|P2|NOT COMPLETED|Overall Study||4
256969|NCT00469456|620669|P1|NOT COMPLETED|Overall Study||9
256970|NCT00469456|620668|P2|COMPLETED|Overall Study||131
256971|NCT00469456|620669|P1|COMPLETED|Overall Study||120
256972|NCT00469456|620668|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
256973|NCT00469456|620669|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
256974|NCT00469391|620679|P2|NOT COMPLETED|Overall Study||5
256975|NCT00469391|620680|P1|NOT COMPLETED|Overall Study||14
256976|NCT00469391|620679|P2|COMPLETED|Overall Study||24
256977|NCT00469391|620680|P1|COMPLETED|Overall Study||13
256978|NCT00469391|620679|P2|Patient Preference|Overall Study||1
256979|NCT00469391|620680|P1|Patient Preference|Overall Study||0
256980|NCT00469391|620679|P2|Lost to Follow up|Overall Study||1
256981|NCT00469391|620680|P1|Lost to Follow up|Overall Study||0
256982|NCT00469391|620679|P2|Adverse Event|Overall Study||0
256983|NCT00469391|620680|P1|Adverse Event|Overall Study||8
256984|NCT00469391|620679|P2|Unsuccessful Implant Procedure|Overall Study||0
256985|NCT00469391|620680|P1|Unsuccessful Implant Procedure|Overall Study||4
256986|NCT00469391|620679|P2|Discontinued Prior to Procedure|Overall Study||3
256987|NCT00469391|620680|P1|Discontinued Prior to Procedure|Overall Study||2
256988|NCT00469391|620679|P2|STARTED|Overall Study||29
256989|NCT00469391|620680|P1|STARTED|Overall Study||27
256990|NCT00469274|620688|P2|NOT COMPLETED|Overall Study||0
256991|NCT00469274|620689|P1|NOT COMPLETED|Overall Study||0
256992|NCT00469274|620688|P2|COMPLETED|Overall Study||42
256993|NCT00469274|620689|P1|COMPLETED|Overall Study||44
256994|NCT00469274|620688|P2|STARTED|Overall Study||42
256995|NCT00469274|620689|P1|STARTED|Overall Study||44
256996|NCT00469209|620698|P3|NOT COMPLETED|Overall Study||1
256997|NCT00469209|620699|P2|NOT COMPLETED|Overall Study||0
256998|NCT00469209|620700|P1|NOT COMPLETED|Overall Study||1
256999|NCT00469209|620698|P3|COMPLETED|Overall Study||19
257000|NCT00469209|620699|P2|COMPLETED|Overall Study||20
257001|NCT00469209|620700|P1|COMPLETED|Overall Study||19
257002|NCT00469209|620698|P3|STARTED|Overall Study||20
257003|NCT00469209|620699|P2|STARTED|Overall Study||20
257004|NCT00469209|620700|P1|STARTED|Overall Study||20
257005|NCT00469092|620710|P2|NOT COMPLETED|Overall Study||21
257006|NCT00469092|620711|P1|NOT COMPLETED|Overall Study||26
257007|NCT00469092|620710|P2|COMPLETED|Overall Study||220
257008|NCT00469092|620711|P1|COMPLETED|Overall Study||213
257009|NCT00469092|620710|P2|Exposed to Study Drug|Overall Study||238
257010|NCT00469092|620711|P1|Exposed to Study Drug|Overall Study||231
257011|NCT00469092|620710|P2|STARTED|Overall Study||241
257012|NCT00469092|620711|P1|STARTED|Overall Study||239
257013|NCT00469079|620730|P3|NOT COMPLETED|Overall Study||19
257014|NCT00469079|620731|P2|NOT COMPLETED|Overall Study||22
257015|NCT00469079|620732|P1|NOT COMPLETED|Overall Study||9
257016|NCT00469079|620730|P3|COMPLETED|Overall Study||32
257017|NCT00469079|620731|P2|COMPLETED|Overall Study||30
257018|NCT00469079|620732|P1|COMPLETED|Overall Study||18
257019|NCT00469079|620730|P3|STARTED|Overall Study||51
257020|NCT00469079|620731|P2|STARTED|Overall Study||52
257021|NCT00469079|620732|P1|STARTED|Overall Study||27
257022|NCT00468910|620751|P2|NOT COMPLETED|Overall Study||3
257023|NCT00468910|620752|P1|NOT COMPLETED|Overall Study||4
257024|NCT00468910|620751|P2|COMPLETED|Overall Study||36
257025|NCT00468910|620752|P1|COMPLETED|Overall Study||36
257026|NCT00468910|620751|P2|Follow-up|Overall Study||36
257027|NCT00468910|620752|P1|Follow-up|Overall Study||36
257028|NCT00468910|620751|P2|Post-Treatment Biopsy|Overall Study||36
257029|NCT00468910|620752|P1|Post-Treatment Biopsy|Overall Study||36
257030|NCT00468910|620751|P2|Treatment|Overall Study||36
257031|NCT00468910|620752|P1|Treatment|Overall Study||36
257032|NCT00468910|620751|P2|Randomization|Overall Study||39
257033|NCT00468910|620752|P1|Randomization|Overall Study||40
257034|NCT00468910|620751|P2|STARTED|Overall Study||39
257035|NCT00468910|620752|P1|STARTED|Overall Study||40
257036|NCT00468858|620771|P3|NOT COMPLETED|Overall Study||14
257037|NCT00468858|620772|P2|NOT COMPLETED|Overall Study||10
257038|NCT00468858|620773|P1|NOT COMPLETED|Overall Study||9
257039|NCT00468858|620771|P3|COMPLETED|Overall Study||199
257040|NCT00468858|620772|P2|COMPLETED|Overall Study||202
257041|NCT00468858|620773|P1|COMPLETED|Overall Study||202
257042|NCT00468858|620771|P3|STARTED|Overall Study||213
257043|NCT00468858|620772|P2|STARTED|Overall Study||212
257044|NCT00468858|620773|P1|STARTED|Overall Study||211
257045|NCT00468845|620894|P3|NOT COMPLETED|Overall Study||30
257046|NCT00468845|620895|P2|NOT COMPLETED|Overall Study||34
257047|NCT00468845|620896|P1|NOT COMPLETED|Overall Study||21
257048|NCT00468845|620894|P3|COMPLETED|Overall Study||139
257049|NCT00468845|620895|P2|COMPLETED|Overall Study||136
257050|NCT00468845|620896|P1|COMPLETED|Overall Study||141
257051|NCT00468845|620894|P3|Received Treatment|Overall Study||167
257052|NCT00468845|620895|P2|Received Treatment|Overall Study||166
257053|NCT00468845|620896|P1|Received Treatment|Overall Study||161
257054|NCT00468845|620894|P3|STARTED|Overall Study||169
257055|NCT00468845|620895|P2|STARTED|Overall Study||170
257056|NCT00468845|620896|P1|STARTED|Overall Study||162
257057|NCT00468819|621033|P3|NOT COMPLETED|Overall Study||2
257058|NCT00468819|621034|P2|NOT COMPLETED|Overall Study||0
257059|NCT00468819|621035|P1|NOT COMPLETED|Overall Study||6
257060|NCT00468819|621033|P3|COMPLETED|Overall Study||46
257061|NCT00468819|621034|P2|COMPLETED|Overall Study||44
257062|NCT00468819|621035|P1|COMPLETED|Overall Study||42
257063|NCT00468819|621033|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
257064|NCT00468819|621034|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
257065|NCT00468819|621035|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
257066|NCT00468819|621033|P3|STARTED|Overall Study|Enrolled participants|48
257067|NCT00468819|621034|P2|STARTED|Overall Study|Enrolled participants|44
257068|NCT00468819|621035|P1|STARTED|Overall Study|Enrolled participants|48
257069|NCT00468728|621115|P2|NOT COMPLETED|Follow-up||31
257070|NCT00468728|621116|P1|NOT COMPLETED|Follow-up||34
257071|NCT00468728|621115|P2|COMPLETED|Follow-up||222
257072|NCT00468728|621116|P1|COMPLETED|Follow-up||222
257073|NCT00468728|621115|P2|STARTED|Follow-up||253
257074|NCT00468728|621116|P1|STARTED|Follow-up||256
257075|NCT00468728|621115|P2|NOT COMPLETED|Treatment||11
257076|NCT00468728|621116|P1|NOT COMPLETED|Treatment||4
257077|NCT00468728|621115|P2|COMPLETED|Treatment||253
257078|NCT00468728|621116|P1|COMPLETED|Treatment||256
257079|NCT00468728|621115|P2|STARTED|Treatment||264
257080|NCT00468728|621116|P1|STARTED|Treatment||260
257081|NCT00468728|621115|P2|NOT COMPLETED|Enrollment||7
257082|NCT00468728|621116|P1|NOT COMPLETED|Enrollment||4
257083|NCT00468728|621115|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
257084|NCT00468728|621116|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
257085|NCT00468728|621115|P2|STARTED|Enrollment||271
257086|NCT00468728|621116|P1|STARTED|Enrollment||264
257087|NCT00468676|621128|P2|NOT COMPLETED|Overall Study||12
257088|NCT00468676|621129|P1|NOT COMPLETED|Overall Study||16
257089|NCT00468676|621128|P2|COMPLETED|Overall Study||94
257090|NCT00468676|621129|P1|COMPLETED|Overall Study||92
257091|NCT00468676|621128|P2|STARTED|Overall Study||106
257092|NCT00468676|621129|P1|STARTED|Overall Study||108
257093|NCT00468650|621146|P1|NOT COMPLETED|Overall Study||7
257094|NCT00468650|621146|P1|COMPLETED|Overall Study||110
257095|NCT00468650|621146|P1|STARTED|Overall Study||117
257096|NCT00468585|621194|P4|NOT COMPLETED|Overall Study||1
257097|NCT00468585|621195|P3|NOT COMPLETED|Overall Study||5
257098|NCT00468585|621196|P2|NOT COMPLETED|Overall Study||0
257099|NCT00468585|621197|P1|NOT COMPLETED|Overall Study||1
257100|NCT00468585|621194|P4|COMPLETED|Overall Study||5
257101|NCT00468585|621195|P3|COMPLETED|Overall Study||45
257102|NCT00468585|621196|P2|COMPLETED|Overall Study||3
257103|NCT00468585|621197|P1|COMPLETED|Overall Study||3
257104|NCT00468585|621194|P4|STARTED|Overall Study||6
257105|NCT00468585|621195|P3|STARTED|Overall Study||50
257106|NCT00468585|621196|P2|STARTED|Overall Study||3
257107|NCT00468585|621197|P1|STARTED|Overall Study||4
257108|NCT00468559|621209|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
257109|NCT00468559|621210|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
257110|NCT00468559|621211|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
257111|NCT00468559|621209|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
257112|NCT00468559|621210|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
257113|NCT00468559|621211|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
257114|NCT00468559|621209|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
257115|NCT00468559|621210|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
257116|NCT00468559|621211|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
257117|NCT00468559|621209|P3|NOT COMPLETED|Open-label Treatment Phase||0
257118|NCT00468559|621210|P2|NOT COMPLETED|Open-label Treatment Phase||0
257119|NCT00468559|621211|P1|NOT COMPLETED|Open-label Treatment Phase||18
257120|NCT00468559|621209|P3|COMPLETED|Open-label Treatment Phase||0
257121|NCT00468559|621210|P2|COMPLETED|Open-label Treatment Phase||0
257122|NCT00468559|621211|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
257123|NCT00468559|621209|P3|STARTED|Open-label Treatment Phase||0
257124|NCT00468559|621210|P2|STARTED|Open-label Treatment Phase||0
257125|NCT00468559|621211|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
257126|NCT00468546|621239|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
257127|NCT00468546|621240|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
257128|NCT00468546|621239|P2|COMPLETED|Week 24 to Week 104 Analysis||83
257129|NCT00468546|621240|P1|COMPLETED|Week 24 to Week 104 Analysis||103
257130|NCT00468546|621239|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
257131|NCT00468546|621240|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
257132|NCT00468546|621239|P2|NOT COMPLETED|Week 24 Analysis||55
257133|NCT00468546|621240|P1|NOT COMPLETED|Week 24 Analysis||97
257134|NCT00468546|621239|P2|COMPLETED|Week 24 Analysis||253
257135|NCT00468546|621240|P1|COMPLETED|Week 24 Analysis||111
257136|NCT00468546|621239|P2|STARTED|Week 24 Analysis||308
257137|NCT00468546|621240|P1|STARTED|Week 24 Analysis||208
257138|NCT00468481|621270|P2|NOT COMPLETED|Overall Study||24
257139|NCT00468481|621271|P1|NOT COMPLETED|Overall Study||88
257140|NCT00468481|621270|P2|COMPLETED|Overall Study||70
257141|NCT00468481|621271|P1|COMPLETED|Overall Study||203
257142|NCT00468481|621270|P2|Subjects Treated|Overall Study||94
257143|NCT00468481|621271|P1|Subjects Treated|Overall Study||285
257144|NCT00468481|621270|P2|STARTED|Overall Study||94
257145|NCT00468481|621271|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
257146|NCT00468312|621371|P2|NOT COMPLETED|Overall Study||5
257147|NCT00468312|621372|P1|NOT COMPLETED|Overall Study||4
257148|NCT00468312|621371|P2|COMPLETED|Overall Study||204
257149|NCT00468312|621372|P1|COMPLETED|Overall Study||216
257150|NCT00468312|621371|P2|STARTED|Overall Study||209
257151|NCT00468312|621372|P1|STARTED|Overall Study||220
257152|NCT00468299|621388|P2|NOT COMPLETED|Overall Study||1
257153|NCT00468299|621389|P1|NOT COMPLETED|Overall Study||0
257154|NCT00468299|621388|P2|COMPLETED|Overall Study||7
257155|NCT00468299|621389|P1|COMPLETED|Overall Study||9
257156|NCT00468299|621388|P2|STARTED|Overall Study||8
257157|NCT00468299|621389|P1|STARTED|Overall Study||9
257158|NCT00468286|621399|P2|NOT COMPLETED|Overall Study||12
257159|NCT00468286|621400|P1|NOT COMPLETED|Overall Study||7
257160|NCT00468286|621399|P2|COMPLETED|Overall Study||54
257161|NCT00468286|621400|P1|COMPLETED|Overall Study||60
257162|NCT00468286|621399|P2|STARTED|Overall Study||66
257163|NCT00468286|621400|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
257164|NCT00468208|621422|P1|NOT COMPLETED|Overall Study||0
257165|NCT00468208|621422|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
257166|NCT00468208|621422|P1|STARTED|Overall Study||20
257167|NCT00468143|621430|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
257168|NCT00468143|621431|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
257169|NCT00468143|621430|P2|COMPLETED|Second Intervention (3 Weeks)||24
257170|NCT00468143|621431|P1|COMPLETED|Second Intervention (3 Weeks)||25
257171|NCT00468143|621430|P2|STARTED|Second Intervention (3 Weeks)||27
257172|NCT00468143|621431|P1|STARTED|Second Intervention (3 Weeks)||28
257173|NCT00468143|621430|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
257174|NCT00468143|621431|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
257175|NCT00468143|621430|P2|COMPLETED|First Intervention (3 Weeks)||27
257176|NCT00468143|621431|P1|COMPLETED|First Intervention (3 Weeks)||28
257177|NCT00468143|621430|P2|STARTED|First Intervention (3 Weeks)||31
257178|NCT00468143|621431|P1|STARTED|First Intervention (3 Weeks)||31
257179|NCT00468104|621445|P2|NOT COMPLETED|Second Intervention||4
257180|NCT00468104|621446|P1|NOT COMPLETED|Second Intervention||5
257181|NCT00468104|621445|P2|COMPLETED|Second Intervention||37
257182|NCT00468104|621446|P1|COMPLETED|Second Intervention||3
257183|NCT00468104|621445|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
257184|NCT00468104|621446|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
257185|NCT00468104|621445|P2|NOT COMPLETED|First Intervention||1
257186|NCT00468104|621446|P1|NOT COMPLETED|First Intervention||9
257187|NCT00468104|621445|P2|COMPLETED|First Intervention||45
257188|NCT00468104|621446|P1|COMPLETED|First Intervention||45
257189|NCT00468104|621445|P2|STARTED|First Intervention||46
257190|NCT00468104|621446|P1|STARTED|First Intervention||54
257191|NCT00468052|621463|P2|NOT COMPLETED|Overall Study||8
257192|NCT00468052|621464|P1|NOT COMPLETED|Overall Study||7
257193|NCT00468052|621463|P2|COMPLETED|Overall Study||61
257194|NCT00468052|621464|P1|COMPLETED|Overall Study||61
257195|NCT00468052|621463|P2|Target Enrollment|Overall Study||70
257196|NCT00468052|621464|P1|Target Enrollment|Overall Study||70
257197|NCT00468052|621463|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
257198|NCT00468052|621464|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
257199|NCT00467961|621482|P1|NOT COMPLETED|Overall Study||7
257200|NCT00467961|621482|P1|COMPLETED|Overall Study||24
257201|NCT00467961|621482|P1|STARTED|Overall Study||31
257202|NCT00467896|621486|P1|NOT COMPLETED|Overall Study||51
257203|NCT00467896|621486|P1|COMPLETED|Overall Study||11
257204|NCT00467896|621486|P1|STARTED|Overall Study||62
257205|NCT00467870|621512|P6|NOT COMPLETED|Overall Study||2
257206|NCT00467870|621513|P5|NOT COMPLETED|Overall Study||37
257207|NCT00467870|621514|P4|NOT COMPLETED|Overall Study||33
257208|NCT00467870|621515|P3|NOT COMPLETED|Overall Study||4
257209|NCT00467870|621516|P2|NOT COMPLETED|Overall Study||43
257210|NCT00467870|621517|P1|NOT COMPLETED|Overall Study||45
257211|NCT00467870|621512|P6|COMPLETED|Overall Study||21
257212|NCT00467870|621513|P5|COMPLETED|Overall Study||93
257213|NCT00467870|621514|P4|COMPLETED|Overall Study||79
257214|NCT00467870|621515|P3|COMPLETED|Overall Study||18
257215|NCT00467870|621516|P2|COMPLETED|Overall Study||74
257216|NCT00467870|621517|P1|COMPLETED|Overall Study||75
257217|NCT00467870|621512|P6|STARTED|Overall Study||23
257218|NCT00467870|621513|P5|STARTED|Overall Study||130
257219|NCT00467870|621514|P4|STARTED|Overall Study||112
257220|NCT00467870|621515|P3|STARTED|Overall Study||22
257221|NCT00467870|621516|P2|STARTED|Overall Study||117
257222|NCT00467870|621517|P1|STARTED|Overall Study||120
257223|NCT00467857|621560|P2|NOT COMPLETED|Overall Study||8
257224|NCT00467857|621561|P1|NOT COMPLETED|Overall Study||3
257225|NCT00467857|621560|P2|COMPLETED|Overall Study||139
257226|NCT00467857|621561|P1|COMPLETED|Overall Study||143
257227|NCT00467857|621560|P2|STARTED|Overall Study||147
257228|NCT00467857|621561|P1|STARTED|Overall Study||146
257229|NCT00467844|621596|P3|NOT COMPLETED|Overall Study||14
257230|NCT00467844|621597|P2|NOT COMPLETED|Overall Study||20
257231|NCT00467844|621598|P1|NOT COMPLETED|Overall Study||19
257232|NCT00467844|621596|P3|COMPLETED|Overall Study||38
257233|NCT00467844|621597|P2|COMPLETED|Overall Study||34
257234|NCT00467844|621598|P1|COMPLETED|Overall Study||34
257235|NCT00467844|621596|P3|STARTED|Overall Study||52
257236|NCT00467844|621597|P2|STARTED|Overall Study||54
257237|NCT00467844|621598|P1|STARTED|Overall Study||53
257238|NCT00467831|621609|P1|NOT COMPLETED|Overall Study||3
257239|NCT00467831|621609|P1|COMPLETED|Overall Study||0
257240|NCT00467831|621609|P1|STARTED|Overall Study||3
257241|NCT00467779|621628|P15|NOT COMPLETED|Stage 3||17
257242|NCT00467779|621629|P14|NOT COMPLETED|Stage 3||0
257243|NCT00467779|621630|P13|NOT COMPLETED|Stage 3||0
257244|NCT00467779|621631|P12|NOT COMPLETED|Stage 3||0
257245|NCT00467779|621632|P11|NOT COMPLETED|Stage 3||0
257246|NCT00467779|621633|P10|NOT COMPLETED|Stage 3||0
257247|NCT00467779|621634|P9|NOT COMPLETED|Stage 3||0
257248|NCT00467779|621635|P8|NOT COMPLETED|Stage 3||0
257249|NCT00467779|621636|P7|NOT COMPLETED|Stage 3||0
257250|NCT00467779|621637|P6|NOT COMPLETED|Stage 3||0
257251|NCT00467779|621638|P5|NOT COMPLETED|Stage 3||0
257252|NCT00467779|621639|P4|NOT COMPLETED|Stage 3||0
257253|NCT00467779|621640|P3|NOT COMPLETED|Stage 3||0
257254|NCT00467779|621641|P2|NOT COMPLETED|Stage 3||0
257255|NCT00467779|621642|P1|NOT COMPLETED|Stage 3||0
257256|NCT00467779|621628|P15|COMPLETED|Stage 3||3
257257|NCT00467779|621629|P14|COMPLETED|Stage 3||0
257258|NCT00467779|621630|P13|COMPLETED|Stage 3||0
257259|NCT00467779|621631|P12|COMPLETED|Stage 3||0
257260|NCT00467779|621632|P11|COMPLETED|Stage 3||0
257261|NCT00467779|621633|P10|COMPLETED|Stage 3||0
257262|NCT00467779|621634|P9|COMPLETED|Stage 3||0
257263|NCT00467779|621635|P8|COMPLETED|Stage 3||0
257264|NCT00467779|621636|P7|COMPLETED|Stage 3||0
257265|NCT00467779|621637|P6|COMPLETED|Stage 3||0
257266|NCT00467779|621638|P5|COMPLETED|Stage 3||0
257267|NCT00467779|621639|P4|COMPLETED|Stage 3||0
257268|NCT00467779|621640|P3|COMPLETED|Stage 3||0
257269|NCT00467779|621641|P2|COMPLETED|Stage 3||0
257270|NCT00467779|621642|P1|COMPLETED|Stage 3||0
257271|NCT00467779|621628|P15|STARTED|Stage 3||20
257272|NCT00467779|621629|P14|STARTED|Stage 3||0
257273|NCT00467779|621630|P13|STARTED|Stage 3||0
257274|NCT00467779|621631|P12|STARTED|Stage 3||0
257275|NCT00467779|621632|P11|STARTED|Stage 3||0
257276|NCT00467779|621633|P10|STARTED|Stage 3||0
257277|NCT00467779|621634|P9|STARTED|Stage 3||0
257278|NCT00467779|621635|P8|STARTED|Stage 3||0
257279|NCT00467779|621636|P7|STARTED|Stage 3||0
257280|NCT00467779|621637|P6|STARTED|Stage 3||0
257281|NCT00467779|621638|P5|STARTED|Stage 3||0
257282|NCT00467779|621639|P4|STARTED|Stage 3||0
257283|NCT00467779|621640|P3|STARTED|Stage 3||0
257284|NCT00467779|621641|P2|STARTED|Stage 3||0
257285|NCT00467779|621642|P1|STARTED|Stage 3||0
257286|NCT00467779|621628|P15|NOT COMPLETED|Stage 2A||0
257287|NCT00467779|621629|P14|NOT COMPLETED|Stage 2A||21
257288|NCT00467779|621630|P13|NOT COMPLETED|Stage 2A||0
257289|NCT00467779|621631|P12|NOT COMPLETED|Stage 2A||0
257290|NCT00467779|621632|P11|NOT COMPLETED|Stage 2A||0
257291|NCT00467779|621633|P10|NOT COMPLETED|Stage 2A||0
257292|NCT00467779|621634|P9|NOT COMPLETED|Stage 2A||0
257293|NCT00467779|621635|P8|NOT COMPLETED|Stage 2A||0
257294|NCT00467779|621636|P7|NOT COMPLETED|Stage 2A||0
257295|NCT00467779|621637|P6|NOT COMPLETED|Stage 2A||0
257296|NCT00467779|621638|P5|NOT COMPLETED|Stage 2A||0
257297|NCT00467779|621639|P4|NOT COMPLETED|Stage 2A||0
257298|NCT00467779|621640|P3|NOT COMPLETED|Stage 2A||0
257299|NCT00467779|621641|P2|NOT COMPLETED|Stage 2A||0
257300|NCT00467779|621642|P1|NOT COMPLETED|Stage 2A||0
257301|NCT00467779|621628|P15|COMPLETED|Stage 2A||0
257302|NCT00467779|621629|P14|COMPLETED|Stage 2A||1
257303|NCT00467779|621630|P13|COMPLETED|Stage 2A||0
257304|NCT00467779|621631|P12|COMPLETED|Stage 2A||0
257305|NCT00467779|621632|P11|COMPLETED|Stage 2A||0
257306|NCT00467779|621633|P10|COMPLETED|Stage 2A||0
257307|NCT00467779|621634|P9|COMPLETED|Stage 2A||0
257308|NCT00467779|621635|P8|COMPLETED|Stage 2A||0
257309|NCT00467779|621636|P7|COMPLETED|Stage 2A||0
257310|NCT00467779|621637|P6|COMPLETED|Stage 2A||0
257311|NCT00467779|621638|P5|COMPLETED|Stage 2A||0
257312|NCT00467779|621639|P4|COMPLETED|Stage 2A||0
257313|NCT00467779|621640|P3|COMPLETED|Stage 2A||0
257314|NCT00467779|621641|P2|COMPLETED|Stage 2A||0
257315|NCT00467779|621642|P1|COMPLETED|Stage 2A||0
257316|NCT00467779|621628|P15|STARTED|Stage 2A||0
257317|NCT00467779|621629|P14|STARTED|Stage 2A||22
257318|NCT00467779|621630|P13|STARTED|Stage 2A||0
257319|NCT00467779|621631|P12|STARTED|Stage 2A||0
257320|NCT00467779|621632|P11|STARTED|Stage 2A||0
257321|NCT00467779|621633|P10|STARTED|Stage 2A||0
257322|NCT00467779|621634|P9|STARTED|Stage 2A||0
257323|NCT00467779|621635|P8|STARTED|Stage 2A||0
257324|NCT00467779|621636|P7|STARTED|Stage 2A||0
257325|NCT00467779|621637|P6|STARTED|Stage 2A||0
257326|NCT00467779|621638|P5|STARTED|Stage 2A||0
257327|NCT00467779|621639|P4|STARTED|Stage 2A||0
257328|NCT00467779|621640|P3|STARTED|Stage 2A||0
257329|NCT00467779|621641|P2|STARTED|Stage 2A||0
257330|NCT00467779|621642|P1|STARTED|Stage 2A||0
257331|NCT00467779|621628|P15|NOT COMPLETED|Stage 2||0
257332|NCT00467779|621629|P14|NOT COMPLETED|Stage 2||0
257333|NCT00467779|621630|P13|NOT COMPLETED|Stage 2||0
257334|NCT00467779|621631|P12|NOT COMPLETED|Stage 2||0
257335|NCT00467779|621632|P11|NOT COMPLETED|Stage 2||0
257336|NCT00467779|621633|P10|NOT COMPLETED|Stage 2||0
257337|NCT00467779|621634|P9|NOT COMPLETED|Stage 2||21
257338|NCT00467779|621635|P8|NOT COMPLETED|Stage 2||0
257339|NCT00467779|621636|P7|NOT COMPLETED|Stage 2||0
257340|NCT00467779|621637|P6|NOT COMPLETED|Stage 2||0
257341|NCT00467779|621638|P5|NOT COMPLETED|Stage 2||0
257342|NCT00467779|621639|P4|NOT COMPLETED|Stage 2||0
257343|NCT00467779|621640|P3|NOT COMPLETED|Stage 2||0
257344|NCT00467779|621641|P2|NOT COMPLETED|Stage 2||0
257345|NCT00467779|621642|P1|NOT COMPLETED|Stage 2||0
257346|NCT00467779|621628|P15|COMPLETED|Stage 2||0
257347|NCT00467779|621629|P14|COMPLETED|Stage 2||0
257348|NCT00467779|621630|P13|COMPLETED|Stage 2||0
257349|NCT00467779|621631|P12|COMPLETED|Stage 2||0
257350|NCT00467779|621632|P11|COMPLETED|Stage 2||0
257351|NCT00467779|621633|P10|COMPLETED|Stage 2||0
257352|NCT00467779|621634|P9|COMPLETED|Stage 2||0
257353|NCT00467779|621635|P8|COMPLETED|Stage 2||0
257354|NCT00467779|621636|P7|COMPLETED|Stage 2||0
257355|NCT00467779|621637|P6|COMPLETED|Stage 2||0
257356|NCT00467779|621638|P5|COMPLETED|Stage 2||0
257357|NCT00467779|621639|P4|COMPLETED|Stage 2||0
257358|NCT00467779|621640|P3|COMPLETED|Stage 2||0
257359|NCT00467779|621641|P2|COMPLETED|Stage 2||0
257360|NCT00467779|621642|P1|COMPLETED|Stage 2||0
257361|NCT00467779|621628|P15|STARTED|Stage 2||0
257362|NCT00467779|621629|P14|STARTED|Stage 2||0
257363|NCT00467779|621630|P13|STARTED|Stage 2||0
257364|NCT00467779|621631|P12|STARTED|Stage 2||0
257365|NCT00467779|621632|P11|STARTED|Stage 2||0
257366|NCT00467779|621633|P10|STARTED|Stage 2||0
257367|NCT00467779|621634|P9|STARTED|Stage 2||21
257368|NCT00467779|621635|P8|STARTED|Stage 2||0
257369|NCT00467779|621636|P7|STARTED|Stage 2||0
257370|NCT00467779|621637|P6|STARTED|Stage 2||0
257371|NCT00467779|621638|P5|STARTED|Stage 2||0
257372|NCT00467779|621639|P4|STARTED|Stage 2||0
257373|NCT00467779|621640|P3|STARTED|Stage 2||0
257374|NCT00467779|621641|P2|STARTED|Stage 2||0
257375|NCT00467779|621642|P1|STARTED|Stage 2||0
257376|NCT00467779|621628|P15|NOT COMPLETED|Stage 1A||0
257377|NCT00467779|621629|P14|NOT COMPLETED|Stage 1A||0
257378|NCT00467779|621630|P13|NOT COMPLETED|Stage 1A||6
257379|NCT00467779|621631|P12|NOT COMPLETED|Stage 1A||8
257380|NCT00467779|621632|P11|NOT COMPLETED|Stage 1A||3
257381|NCT00467779|621633|P10|NOT COMPLETED|Stage 1A||3
257382|NCT00467779|621634|P9|NOT COMPLETED|Stage 1A||0
257383|NCT00467779|621635|P8|NOT COMPLETED|Stage 1A||0
257384|NCT00467779|621636|P7|NOT COMPLETED|Stage 1A||0
257385|NCT00467779|621637|P6|NOT COMPLETED|Stage 1A||0
257386|NCT00467779|621638|P5|NOT COMPLETED|Stage 1A||0
257387|NCT00467779|621639|P4|NOT COMPLETED|Stage 1A||0
257388|NCT00467779|621640|P3|NOT COMPLETED|Stage 1A||0
257389|NCT00467779|621641|P2|NOT COMPLETED|Stage 1A||0
257390|NCT00467779|621642|P1|NOT COMPLETED|Stage 1A||0
257391|NCT00467779|621628|P15|COMPLETED|Stage 1A||0
257392|NCT00467779|621629|P14|COMPLETED|Stage 1A||0
257393|NCT00467779|621630|P13|COMPLETED|Stage 1A||0
257394|NCT00467779|621631|P12|COMPLETED|Stage 1A||0
257395|NCT00467779|621632|P11|COMPLETED|Stage 1A||0
257396|NCT00467779|621633|P10|COMPLETED|Stage 1A||0
257397|NCT00467779|621634|P9|COMPLETED|Stage 1A||0
257398|NCT00467779|621635|P8|COMPLETED|Stage 1A||0
257399|NCT00467779|621636|P7|COMPLETED|Stage 1A||0
257400|NCT00467779|621637|P6|COMPLETED|Stage 1A||0
257401|NCT00467779|621638|P5|COMPLETED|Stage 1A||0
257402|NCT00467779|621639|P4|COMPLETED|Stage 1A||0
257403|NCT00467779|621640|P3|COMPLETED|Stage 1A||0
257404|NCT00467779|621641|P2|COMPLETED|Stage 1A||0
257405|NCT00467779|621642|P1|COMPLETED|Stage 1A||0
257406|NCT00467779|621628|P15|STARTED|Stage 1A||0
257407|NCT00467779|621629|P14|STARTED|Stage 1A||0
257408|NCT00467779|621630|P13|STARTED|Stage 1A||6
257409|NCT00467779|621631|P12|STARTED|Stage 1A||8
257410|NCT00467779|621632|P11|STARTED|Stage 1A||3
257411|NCT00467779|621633|P10|STARTED|Stage 1A||3
257412|NCT00467779|621634|P9|STARTED|Stage 1A||0
257413|NCT00467779|621635|P8|STARTED|Stage 1A||0
257414|NCT00467779|621636|P7|STARTED|Stage 1A||0
257415|NCT00467779|621637|P6|STARTED|Stage 1A||0
257416|NCT00467779|621638|P5|STARTED|Stage 1A||0
257417|NCT00467779|621639|P4|STARTED|Stage 1A||0
257418|NCT00467779|621640|P3|STARTED|Stage 1A||0
257419|NCT00467779|621641|P2|STARTED|Stage 1A||0
257420|NCT00467779|621642|P1|STARTED|Stage 1A||0
257421|NCT00467779|621628|P15|NOT COMPLETED|Stage 1||0
257422|NCT00467779|621629|P14|NOT COMPLETED|Stage 1||0
257423|NCT00467779|621630|P13|NOT COMPLETED|Stage 1||0
257424|NCT00467779|621631|P12|NOT COMPLETED|Stage 1||0
257425|NCT00467779|621632|P11|NOT COMPLETED|Stage 1||0
257426|NCT00467779|621633|P10|NOT COMPLETED|Stage 1||0
257427|NCT00467779|621634|P9|NOT COMPLETED|Stage 1||0
257428|NCT00467779|621635|P8|NOT COMPLETED|Stage 1||7
257429|NCT00467779|621636|P7|NOT COMPLETED|Stage 1||7
257430|NCT00467779|621637|P6|NOT COMPLETED|Stage 1||5
257431|NCT00467779|621638|P5|NOT COMPLETED|Stage 1||3
257432|NCT00467779|621639|P4|NOT COMPLETED|Stage 1||3
257433|NCT00467779|621640|P3|NOT COMPLETED|Stage 1||3
257434|NCT00467779|621641|P2|NOT COMPLETED|Stage 1||3
257435|NCT00467779|621642|P1|NOT COMPLETED|Stage 1||4
257436|NCT00467779|621628|P15|COMPLETED|Stage 1||0
257437|NCT00467779|621629|P14|COMPLETED|Stage 1||0
257438|NCT00467779|621630|P13|COMPLETED|Stage 1||0
257439|NCT00467779|621631|P12|COMPLETED|Stage 1||0
257440|NCT00467779|621632|P11|COMPLETED|Stage 1||0
257441|NCT00467779|621633|P10|COMPLETED|Stage 1||0
257442|NCT00467779|621634|P9|COMPLETED|Stage 1||0
257443|NCT00467779|621635|P8|COMPLETED|Stage 1||0
257444|NCT00467779|621636|P7|COMPLETED|Stage 1||0
257445|NCT00467779|621637|P6|COMPLETED|Stage 1||1
257446|NCT00467779|621638|P5|COMPLETED|Stage 1||0
257447|NCT00467779|621639|P4|COMPLETED|Stage 1||0
257448|NCT00467779|621640|P3|COMPLETED|Stage 1||0
257449|NCT00467779|621641|P2|COMPLETED|Stage 1||0
257450|NCT00467779|621642|P1|COMPLETED|Stage 1||0
257451|NCT00467779|621628|P15|STARTED|Stage 1||0
257452|NCT00467779|621629|P14|STARTED|Stage 1||0
257453|NCT00467779|621630|P13|STARTED|Stage 1||0
257454|NCT00467779|621631|P12|STARTED|Stage 1||0
257455|NCT00467779|621632|P11|STARTED|Stage 1||0
257456|NCT00467779|621633|P10|STARTED|Stage 1||0
257457|NCT00467779|621634|P9|STARTED|Stage 1||0
257458|NCT00467779|621635|P8|STARTED|Stage 1||7
257459|NCT00467779|621636|P7|STARTED|Stage 1||7
257460|NCT00467779|621637|P6|STARTED|Stage 1||6
257461|NCT00467779|621638|P5|STARTED|Stage 1||3
257462|NCT00467779|621639|P4|STARTED|Stage 1||3
257463|NCT00467779|621640|P3|STARTED|Stage 1||3
257464|NCT00467779|621641|P2|STARTED|Stage 1||3
257465|NCT00467779|621642|P1|STARTED|Stage 1||4
257466|NCT00467753|621816|P2|NOT COMPLETED|Overall Study||2
257467|NCT00467753|621817|P1|NOT COMPLETED|Overall Study||3
257468|NCT00467753|621816|P2|COMPLETED|Overall Study||0
257469|NCT00467753|621817|P1|COMPLETED|Overall Study||0
257470|NCT00467753|621816|P2|STARTED|Overall Study||2
257471|NCT00467753|621817|P1|STARTED|Overall Study||3
257472|NCT00467740|621828|P5|NOT COMPLETED|Overall Study||0
257473|NCT00467740|621829|P4|NOT COMPLETED|Overall Study||1
257474|NCT00467740|621830|P3|NOT COMPLETED|Overall Study||2
257475|NCT00467740|621831|P2|NOT COMPLETED|Overall Study||3
257476|NCT00467740|621832|P1|NOT COMPLETED|Overall Study||1
257477|NCT00467740|621828|P5|COMPLETED|Overall Study||61
257478|NCT00467740|621829|P4|COMPLETED|Overall Study||59
257479|NCT00467740|621830|P3|COMPLETED|Overall Study||58
257480|NCT00467740|621831|P2|COMPLETED|Overall Study||58
257481|NCT00467740|621832|P1|COMPLETED|Overall Study||53
257482|NCT00467740|621828|P5|STARTED|Overall Study||61
257483|NCT00467740|621829|P4|STARTED|Overall Study||60
257484|NCT00467740|621830|P3|STARTED|Overall Study||60
257485|NCT00467740|621831|P2|STARTED|Overall Study||61
257486|NCT00467740|621832|P1|STARTED|Overall Study||54
257487|NCT00467649|622021|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
257488|NCT00467649|622022|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
257489|NCT00467649|622023|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
257490|NCT00467649|622024|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
257491|NCT00467649|622025|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
257492|NCT00467649|622026|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
257493|NCT00467649|622021|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
257494|NCT00467649|622022|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
257495|NCT00467649|622023|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
257496|NCT00467649|622024|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
257497|NCT00467649|622025|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
257498|NCT00467649|622026|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
257499|NCT00467649|622021|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
257500|NCT00467649|622022|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
257501|NCT00467649|622023|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
257502|NCT00467649|622024|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
257503|NCT00467649|622025|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
257504|NCT00467649|622026|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
257505|NCT00467649|622021|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
257506|NCT00467649|622022|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
257507|NCT00467649|622023|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
257508|NCT00467649|622024|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
257509|NCT00467649|622025|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
257510|NCT00467649|622026|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
257511|NCT00467649|622021|P6|COMPLETED|Phase 1 (Randomized Population)||0
257512|NCT00467649|622022|P5|COMPLETED|Phase 1 (Randomized Population)||0
257513|NCT00467649|622023|P4|COMPLETED|Phase 1 (Randomized Population)||0
257514|NCT00467649|622024|P3|COMPLETED|Phase 1 (Randomized Population)||0
257515|NCT00467649|622025|P2|COMPLETED|Phase 1 (Randomized Population)||50
257516|NCT00467649|622026|P1|COMPLETED|Phase 1 (Randomized Population)||48
257517|NCT00467649|622021|P6|Intent to Treat|Phase 1 (Randomized Population)||0
257518|NCT00467649|622022|P5|Intent to Treat|Phase 1 (Randomized Population)||0
257519|NCT00467649|622023|P4|Intent to Treat|Phase 1 (Randomized Population)||0
257520|NCT00467649|622024|P3|Intent to Treat|Phase 1 (Randomized Population)||0
257521|NCT00467649|622025|P2|Intent to Treat|Phase 1 (Randomized Population)||56
257522|NCT00467649|622026|P1|Intent to Treat|Phase 1 (Randomized Population)||56
257523|NCT00467649|622021|P6|STARTED|Phase 1 (Randomized Population)||0
257524|NCT00467649|622022|P5|STARTED|Phase 1 (Randomized Population)||0
257525|NCT00467649|622023|P4|STARTED|Phase 1 (Randomized Population)||0
257526|NCT00467649|622024|P3|STARTED|Phase 1 (Randomized Population)||0
257527|NCT00467649|622025|P2|STARTED|Phase 1 (Randomized Population)||56
257528|NCT00467649|622026|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
257529|NCT00467610|622066|P1|NOT COMPLETED|Overall Study||1
257530|NCT00467610|622066|P1|COMPLETED|Overall Study||5
257531|NCT00467610|622066|P1|STARTED|Overall Study||6
257532|NCT00467597|622077|P2|NOT COMPLETED|Overall Study||0
257533|NCT00467597|622078|P1|NOT COMPLETED|Overall Study||2
257534|NCT00467597|622077|P2|COMPLETED|Overall Study||6
257535|NCT00467597|622078|P1|COMPLETED|Overall Study||24
257536|NCT00467597|622077|P2|STARTED|Overall Study||6
257537|NCT00467597|622078|P1|STARTED|Overall Study||26
257538|NCT00467584|622091|P3|NOT COMPLETED|Overall Study||1
257539|NCT00467584|622092|P2|NOT COMPLETED|Overall Study||5
257540|NCT00467584|622093|P1|NOT COMPLETED|Overall Study||4
257541|NCT00467584|622091|P3|COMPLETED|Overall Study||20
257542|NCT00467584|622092|P2|COMPLETED|Overall Study||15
257543|NCT00467584|622093|P1|COMPLETED|Overall Study||17
257544|NCT00467584|622091|P3|STARTED|Overall Study||21
257545|NCT00467584|622092|P2|STARTED|Overall Study||20
257546|NCT00467584|622093|P1|STARTED|Overall Study||21
257547|NCT00467558|622103|P2|NOT COMPLETED|Overall Study||0
257548|NCT00467558|622104|P1|NOT COMPLETED|Overall Study||2
257549|NCT00467558|622103|P2|COMPLETED|Overall Study||3
257550|NCT00467558|622104|P1|COMPLETED|Overall Study||2
257551|NCT00467558|622103|P2|STARTED|Overall Study||3
257552|NCT00467558|622104|P1|STARTED|Overall Study||4
257553|NCT00467519|622114|P2|NOT COMPLETED|Overall Study||23
257554|NCT00467519|622115|P1|NOT COMPLETED|Overall Study||14
257555|NCT00467519|622114|P2|COMPLETED|Overall Study||488
257556|NCT00467519|622115|P1|COMPLETED|Overall Study||517
257557|NCT00467519|622114|P2|STARTED|Overall Study||511
257558|NCT00467519|622115|P1|STARTED|Overall Study||531
257559|NCT00467389|622131|P2|NOT COMPLETED|Overall Study||0
257560|NCT00467389|622132|P1|NOT COMPLETED|Overall Study||0
257561|NCT00467389|622131|P2|COMPLETED|Overall Study||6
257562|NCT00467389|622132|P1|COMPLETED|Overall Study||6
257563|NCT00467389|622131|P2|STARTED|Overall Study||6
257564|NCT00467389|622132|P1|STARTED|Overall Study||6
257565|NCT00467363|622144|P2|NOT COMPLETED|Overall Study||70
257566|NCT00467363|622145|P1|NOT COMPLETED|Overall Study||80
257567|NCT00467363|622144|P2|COMPLETED|Overall Study||543
257568|NCT00467363|622145|P1|COMPLETED|Overall Study||535
257569|NCT00467363|622144|P2|STARTED|Overall Study||613
257570|NCT00467363|622145|P1|STARTED|Overall Study||615
257571|NCT00467298|622181|P2|NOT COMPLETED|Overall Study||6
257572|NCT00467298|622182|P1|NOT COMPLETED|Overall Study||4
257573|NCT00467298|622181|P2|COMPLETED|Overall Study||38
257574|NCT00467298|622182|P1|COMPLETED|Overall Study||42
257575|NCT00467298|622181|P2|STARTED|Overall Study||44
257576|NCT00467298|622182|P1|STARTED|Overall Study||46
257577|NCT00467285|622192|P2|NOT COMPLETED|Overall Study||4
257578|NCT00467285|622193|P1|NOT COMPLETED|Overall Study||4
257579|NCT00467285|622192|P2|COMPLETED|Overall Study||60
257580|NCT00467285|622193|P1|COMPLETED|Overall Study||28
257581|NCT00467285|622192|P2|STARTED|Overall Study||64
257582|NCT00467285|622193|P1|STARTED|Overall Study||32
257583|NCT00467259|622213|P2|NOT COMPLETED|Overall Study||242
257584|NCT00467259|622214|P1|NOT COMPLETED|Overall Study||75
257585|NCT00467259|622213|P2|COMPLETED|Overall Study||778
257586|NCT00467259|622214|P1|COMPLETED|Overall Study||176
257587|NCT00467259|622213|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
257588|NCT00467259|622214|P1|ITT Population|Overall Study||251
257589|NCT00467259|622213|P2|STARTED|Overall Study||1020
257590|NCT00467259|622214|P1|STARTED|Overall Study||251
257591|NCT00467077|622224|P1|NOT COMPLETED|Overall Study||0
257592|NCT00467077|622224|P1|COMPLETED|Overall Study||21
257593|NCT00467077|622224|P1|STARTED|Overall Study||21
257594|NCT00467051|622231|P1|NOT COMPLETED|Overall Study||2
257595|NCT00467051|622231|P1|COMPLETED|Overall Study||18
257596|NCT00467051|622231|P1|STARTED|Overall Study||20
257597|NCT00467038|622238|P2|NOT COMPLETED|Overall Study||0
257598|NCT00467038|622239|P1|NOT COMPLETED|Overall Study||0
257599|NCT00467038|622238|P2|COMPLETED|Overall Study||11
257600|NCT00467038|622239|P1|COMPLETED|Overall Study||11
257601|NCT00467038|622238|P2|STARTED|Overall Study||11
257602|NCT00467038|622239|P1|STARTED|Overall Study||11
257603|NCT00466960|622247|P1|NOT COMPLETED|Overall Study||0
257604|NCT00466960|622247|P1|COMPLETED|Overall Study||21
257605|NCT00466960|622247|P1|STARTED|Overall Study||21
257606|NCT00466947|622258|P2|NOT COMPLETED|Study End Analysis Period||2534
257607|NCT00466947|622259|P1|NOT COMPLETED|Study End Analysis Period||2496
257608|NCT00466947|622258|P2|COMPLETED|Study End Analysis Period||9265
257609|NCT00466947|622259|P1|COMPLETED|Study End Analysis Period||9302
257610|NCT00466947|622258|P2|STARTED|Study End Analysis Period||11799
257611|NCT00466947|622259|P1|STARTED|Study End Analysis Period||11798
257612|NCT00466947|622258|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
257613|NCT00466947|622259|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
257696|NCT00465972|622627|P1|NOT COMPLETED|Overall Study||2
257614|NCT00466947|622258|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
257615|NCT00466947|622259|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
257616|NCT00466947|622258|P2|Ongoing|Primary Outcome Analysis Period||11863
257617|NCT00466947|622259|P1|Ongoing|Primary Outcome Analysis Period||11875
257618|NCT00466947|622258|P2|STARTED|Primary Outcome Analysis Period||11863
257619|NCT00466947|622259|P1|STARTED|Primary Outcome Analysis Period||11875
257620|NCT00466882|622381|P1|NOT COMPLETED|Overall Study||0
257621|NCT00466882|622381|P1|COMPLETED|Overall Study||3
257622|NCT00466882|622381|P1|STARTED|Overall Study||3
257623|NCT00466817|622387|P2|NOT COMPLETED|Overall Study||4
257624|NCT00466817|622388|P1|NOT COMPLETED|Overall Study||5
257625|NCT00466817|622387|P2|COMPLETED|Overall Study||43
257626|NCT00466817|622388|P1|COMPLETED|Overall Study||44
257627|NCT00466817|622387|P2|STARTED|Overall Study||47
257628|NCT00466817|622388|P1|STARTED|Overall Study||49
257629|NCT00466752|622443|P2|NOT COMPLETED|Overall Study||0
257630|NCT00466752|622444|P1|NOT COMPLETED|Overall Study||0
257631|NCT00466752|622443|P2|COMPLETED|Overall Study||0
257632|NCT00466752|622444|P1|COMPLETED|Overall Study||5
257633|NCT00466752|622443|P2|STARTED|Overall Study||0
257634|NCT00466752|622444|P1|STARTED|Overall Study||5
257635|NCT00466687|622454|P1|NOT COMPLETED|Overall Study||34
257636|NCT00466687|622454|P1|COMPLETED|Overall Study||0
257637|NCT00466687|622454|P1|STARTED|Overall Study||34
257638|NCT00466505|622461|P1|NOT COMPLETED|Overall Study||17
257639|NCT00466505|622461|P1|COMPLETED|Overall Study||0
257640|NCT00466505|622461|P1|STARTED|Overall Study||17
257641|NCT00466323|622475|P2|NOT COMPLETED|Overall Study||23
257642|NCT00466323|622476|P1|NOT COMPLETED|Overall Study||28
257643|NCT00466323|622475|P2|COMPLETED|Overall Study||92
257644|NCT00466323|622476|P1|COMPLETED|Overall Study||89
257645|NCT00466323|622475|P2|STARTED|Overall Study||115
257646|NCT00466323|622476|P1|STARTED|Overall Study||117
257647|NCT00466310|622491|P3|NOT COMPLETED|Overall Study||0
257648|NCT00466310|622492|P2|NOT COMPLETED|Overall Study||0
257649|NCT00466310|622493|P1|NOT COMPLETED|Overall Study||0
257650|NCT00466310|622491|P3|COMPLETED|Overall Study||31
257651|NCT00466310|622492|P2|COMPLETED|Overall Study||20
257652|NCT00466310|622493|P1|COMPLETED|Overall Study||20
257653|NCT00466310|622491|P3|STARTED|Overall Study||31
257654|NCT00466310|622492|P2|STARTED|Overall Study||20
257655|NCT00466310|622493|P1|STARTED|Overall Study||20
257656|NCT00466206|622501|P1|NOT COMPLETED|Overall Study||0
257657|NCT00466206|622501|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
257658|NCT00466206|622501|P1|STARTED|Overall Study||10
257659|NCT00466193|622511|P2|NOT COMPLETED|Overall Study||8
257660|NCT00466193|622512|P1|NOT COMPLETED|Overall Study||12
257661|NCT00466193|622511|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
257662|NCT00466193|622512|P1|COMPLETED|Overall Study||138
257663|NCT00466193|622511|P2|STARTED|Overall Study||145
257664|NCT00466193|622512|P1|STARTED|Overall Study||150
257665|NCT00466167|622539|P3|NOT COMPLETED|Overall Study||21
257666|NCT00466167|622540|P2|NOT COMPLETED|Overall Study||12
257667|NCT00466167|622541|P1|NOT COMPLETED|Overall Study||20
257668|NCT00466167|622539|P3|COMPLETED|Overall Study||157
257669|NCT00466167|622540|P2|COMPLETED|Overall Study||163
257670|NCT00466167|622541|P1|COMPLETED|Overall Study||145
257671|NCT00466167|622539|P3|STARTED|Overall Study||178
257672|NCT00466167|622540|P2|STARTED|Overall Study||175
257673|NCT00466167|622541|P1|STARTED|Overall Study||165
257674|NCT00465998|622597|P1|NOT COMPLETED|Overall Study||0
257675|NCT00465998|622597|P1|COMPLETED|Overall Study||275
257676|NCT00465998|622597|P1|STARTED|Overall Study||275
257677|NCT00465985|622602|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
257678|NCT00465985|622603|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
257679|NCT00465985|622602|P2|COMPLETED|Part III - Open-label Treatment Period||0
257680|NCT00465985|622603|P1|COMPLETED|Part III - Open-label Treatment Period||29
257681|NCT00465985|622602|P2|STARTED|Part III - Open-label Treatment Period||0
257682|NCT00465985|622603|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
257683|NCT00465985|622602|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
257684|NCT00465985|622603|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
257685|NCT00465985|622602|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
257686|NCT00465985|622603|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
257687|NCT00465985|622602|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
257688|NCT00465985|622603|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
257689|NCT00465985|622602|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
257690|NCT00465985|622603|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
257691|NCT00465985|622602|P2|COMPLETED|Part I - Open-label Treatment Period||0
257692|NCT00465985|622603|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
257693|NCT00465985|622602|P2|STARTED|Part I - Open-label Treatment Period||0
257694|NCT00465985|622603|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
257695|NCT00465972|622626|P2|NOT COMPLETED|Overall Study||1
257697|NCT00465972|622626|P2|COMPLETED|Overall Study||23
257698|NCT00465972|622627|P1|COMPLETED|Overall Study||18
257699|NCT00465972|622626|P2|STARTED|Overall Study||24
257700|NCT00465972|622627|P1|STARTED|Overall Study||20
257701|NCT00465894|622637|P2|NOT COMPLETED|Overall Study||3
257702|NCT00465894|622638|P1|NOT COMPLETED|Overall Study||5
257703|NCT00465894|622637|P2|COMPLETED|Overall Study||25
257704|NCT00465894|622638|P1|COMPLETED|Overall Study||25
257705|NCT00465894|622637|P2|STARTED|Overall Study||28
257706|NCT00465894|622638|P1|STARTED|Overall Study||30
257707|NCT00465816|622647|P3|NOT COMPLETED|Overall Study||2
257708|NCT00465816|622648|P2|NOT COMPLETED|Overall Study||0
257709|NCT00465816|622649|P1|NOT COMPLETED|Overall Study||0
257710|NCT00465816|622647|P3|COMPLETED|Overall Study||120
257711|NCT00465816|622648|P2|COMPLETED|Overall Study||122
257712|NCT00465816|622649|P1|COMPLETED|Overall Study||367
257713|NCT00465816|622647|P3|STARTED|Overall Study||122
257714|NCT00465816|622648|P2|STARTED|Overall Study||122
257715|NCT00465816|622649|P1|STARTED|Overall Study||367
257716|NCT00465738|622731|P2|NOT COMPLETED|Overall Study||6
257717|NCT00465738|622732|P1|NOT COMPLETED|Overall Study||6
257718|NCT00465738|622731|P2|COMPLETED|Overall Study||89
257719|NCT00465738|622732|P1|COMPLETED|Overall Study||91
257720|NCT00465738|622731|P2|STARTED|Overall Study||95
257721|NCT00465738|622732|P1|STARTED|Overall Study||97
257722|NCT00465647|622826|P4|NOT COMPLETED|Overall Study||13
257723|NCT00465647|622827|P3|NOT COMPLETED|Overall Study||11
257724|NCT00465647|622828|P2|NOT COMPLETED|Overall Study||8
257725|NCT00465647|622829|P1|NOT COMPLETED|Overall Study||13
257726|NCT00465647|622826|P4|COMPLETED|Overall Study||12
257727|NCT00465647|622827|P3|COMPLETED|Overall Study||18
257728|NCT00465647|622828|P2|COMPLETED|Overall Study||15
257729|NCT00465647|622829|P1|COMPLETED|Overall Study||26
257730|NCT00465647|622826|P4|STARTED|Overall Study||25
257731|NCT00465647|622827|P3|STARTED|Overall Study||29
257732|NCT00465647|622828|P2|STARTED|Overall Study||23
257733|NCT00465647|622829|P1|STARTED|Overall Study||39
257734|NCT00465569|622854|P2|NOT COMPLETED|Overall Study||0
257735|NCT00465569|622855|P1|NOT COMPLETED|Overall Study||1
257736|NCT00465569|622854|P2|COMPLETED|Overall Study||7
257737|NCT00465569|622855|P1|COMPLETED|Overall Study||12
257738|NCT00465569|622854|P2|STARTED|Overall Study||7
257739|NCT00465569|622855|P1|STARTED|Overall Study||13
257740|NCT00465530|622867|P2|NOT COMPLETED|Overall Study||4
257741|NCT00465530|622868|P1|NOT COMPLETED|Overall Study||2
257742|NCT00465530|622867|P2|COMPLETED|Overall Study||15
257743|NCT00465530|622868|P1|COMPLETED|Overall Study||19
257744|NCT00465530|622867|P2|STARTED|Overall Study||19
257745|NCT00465530|622868|P1|STARTED|Overall Study||21
257746|NCT00465361|622878|P1|NOT COMPLETED|Post-Intervention Assessment||0
257747|NCT00465361|622878|P1|COMPLETED|Post-Intervention Assessment||3
257748|NCT00465361|622878|P1|STARTED|Post-Intervention Assessment||3
257749|NCT00465361|622878|P1|NOT COMPLETED|Baseline Assessment||4
257750|NCT00465361|622878|P1|COMPLETED|Baseline Assessment||3
257751|NCT00465361|622878|P1|STARTED|Baseline Assessment||7
257752|NCT00465179|622882|P1|NOT COMPLETED|Overall Study||53
257753|NCT00465179|622882|P1|COMPLETED|Overall Study||4
257754|NCT00465179|622882|P1|STARTED|Overall Study||57
257755|NCT00465101|622888|P1|NOT COMPLETED|Overall Study||59
257756|NCT00465101|622888|P1|COMPLETED|Overall Study||91
257757|NCT00465101|622888|P1|STARTED|Overall Study||150
257758|NCT00465088|622923|P2|NOT COMPLETED|Overall Study||9
257759|NCT00465088|622924|P1|NOT COMPLETED|Overall Study||32
257760|NCT00465088|622923|P2|COMPLETED|Overall Study||70
257761|NCT00465088|622924|P1|COMPLETED|Overall Study||82
257762|NCT00465088|622923|P2|STARTED|Overall Study||79
257763|NCT00465088|622924|P1|STARTED|Overall Study|For both arms, started means treated.|114
257764|NCT00464945|622958|P2|NOT COMPLETED|Toddler Dose||1
257765|NCT00464945|622959|P1|NOT COMPLETED|Toddler Dose||0
257766|NCT00464945|622958|P2|COMPLETED|Toddler Dose||130
257767|NCT00464945|622959|P1|COMPLETED|Toddler Dose||131
257768|NCT00464945|622958|P2|STARTED|Toddler Dose||131
257769|NCT00464945|622959|P1|STARTED|Toddler Dose||131
257770|NCT00464945|622958|P2|NOT COMPLETED|After Infant Series||2
257771|NCT00464945|622959|P1|NOT COMPLETED|After Infant Series||0
257772|NCT00464945|622958|P2|COMPLETED|After Infant Series||131
257773|NCT00464945|622959|P1|COMPLETED|After Infant Series||131
257774|NCT00464945|622958|P2|STARTED|After Infant Series||133
257775|NCT00464945|622959|P1|STARTED|After Infant Series||131
257776|NCT00464945|622958|P2|NOT COMPLETED|Infant Series||1
257777|NCT00464945|622959|P1|NOT COMPLETED|Infant Series||4
257778|NCT00464945|622958|P2|COMPLETED|Infant Series||133
257779|NCT00464945|622959|P1|COMPLETED|Infant Series||131
257780|NCT00464945|622958|P2|Vaccinated Dose 3|Infant Series||133
257781|NCT00464945|622959|P1|Vaccinated Dose 3|Infant Series||132
257782|NCT00464945|622958|P2|Vaccinated Dose 2|Infant Series||133
257783|NCT00464945|622959|P1|Vaccinated Dose 2|Infant Series||132
257784|NCT00464945|622958|P2|Vaccinated Dose 1|Infant Series||134
257785|NCT00464945|622959|P1|Vaccinated Dose 1|Infant Series||134
257786|NCT00464945|622958|P2|STARTED|Infant Series||134
257787|NCT00464945|622959|P1|STARTED|Infant Series||135
257788|NCT00464815|622989|P2|NOT COMPLETED|Overall Study||3
257789|NCT00464815|622990|P1|NOT COMPLETED|Overall Study||6
257790|NCT00464815|622989|P2|COMPLETED|Overall Study||254
257791|NCT00464815|622990|P1|COMPLETED|Overall Study||762
257792|NCT00464815|622989|P2|STARTED|Overall Study||257
257793|NCT00464815|622990|P1|STARTED|Overall Study||768
257794|NCT00464737|623023|P3|NOT COMPLETED|Overall Study||55
257795|NCT00464737|623024|P2|NOT COMPLETED|Overall Study||32
257796|NCT00464737|623025|P1|NOT COMPLETED|Overall Study||32
257797|NCT00464737|623023|P3|COMPLETED|Overall Study||19
257798|NCT00464737|623024|P2|COMPLETED|Overall Study||42
257799|NCT00464737|623025|P1|COMPLETED|Overall Study||50
257800|NCT00464737|623023|P3|STARTED|Overall Study||74
257801|NCT00464737|623024|P2|STARTED|Overall Study||74
257802|NCT00464737|623025|P1|STARTED|Overall Study||82
257803|NCT00464711|623072|P1|NOT COMPLETED|Overall Study||15
257804|NCT00464711|623072|P1|COMPLETED|Overall Study||25
257805|NCT00464711|623072|P1|STARTED|Overall Study||40
257806|NCT00464698|623076|P1|NOT COMPLETED|Period 3: 120mg||2
257807|NCT00464698|623076|P1|COMPLETED|Period 3: 120mg||12
257808|NCT00464698|623076|P1|STARTED|Period 3: 120mg||14
257809|NCT00464698|623076|P1|NOT COMPLETED|Period 2: 60 mg||0
257810|NCT00464698|623076|P1|COMPLETED|Period 2: 60 mg||17
257811|NCT00464698|623076|P1|STARTED|Period 2: 60 mg||17
257812|NCT00464698|623076|P1|NOT COMPLETED|Period 1: 30 mg||3
257813|NCT00464698|623076|P1|COMPLETED|Period 1: 30 mg||17
257814|NCT00464698|623076|P1|STARTED|Period 1: 30 mg||20
257815|NCT00464685|623088|P2|NOT COMPLETED|Overall Study||33
257816|NCT00464685|623089|P1|NOT COMPLETED|Overall Study||23
257817|NCT00464685|623088|P2|COMPLETED|Overall Study||94
257818|NCT00464685|623089|P1|COMPLETED|Overall Study||103
257819|NCT00464685|623088|P2|STARTED|Overall Study||127
257820|NCT00464685|623089|P1|STARTED|Overall Study||126
257821|NCT00464672|623105|P6|NOT COMPLETED|Overall Study||4
257822|NCT00464672|623106|P5|NOT COMPLETED|Overall Study||10
257823|NCT00464672|623107|P4|NOT COMPLETED|Overall Study||1
257824|NCT00464672|623108|P3|NOT COMPLETED|Overall Study||0
257825|NCT00464672|623109|P2|NOT COMPLETED|Overall Study||10
257826|NCT00464672|623110|P1|NOT COMPLETED|Overall Study||25
257827|NCT00464672|623105|P6|COMPLETED|Overall Study||195
257828|NCT00464672|623106|P5|COMPLETED|Overall Study||392
257829|NCT00464672|623107|P4|COMPLETED|Overall Study||199
257830|NCT00464672|623108|P3|COMPLETED|Overall Study||400
257831|NCT00464672|623109|P2|COMPLETED|Overall Study||222
257832|NCT00464672|623110|P1|COMPLETED|Overall Study||435
257833|NCT00464672|623105|P6|STARTED|Overall Study||199
257834|NCT00464672|623106|P5|STARTED|Overall Study||402
257835|NCT00464672|623107|P4|STARTED|Overall Study||200
257836|NCT00464672|623108|P3|STARTED|Overall Study||400
257837|NCT00464672|623109|P2|STARTED|Overall Study||232
257838|NCT00464672|623110|P1|STARTED|Overall Study||460
257839|NCT00464646|623182|P2|NOT COMPLETED|Overall Study||0
257840|NCT00464646|623183|P1|NOT COMPLETED|Overall Study||0
257841|NCT00464646|623182|P2|COMPLETED|Overall Study||29
257842|NCT00464646|623183|P1|COMPLETED|Overall Study||76
257843|NCT00464646|623182|P2|STARTED|Overall Study||29
257844|NCT00464646|623183|P1|STARTED|Overall Study||76
257845|NCT00464568|623189|P1|NOT COMPLETED|Overall Study||2
257846|NCT00464568|623189|P1|COMPLETED|Overall Study||30
257847|NCT00464568|623189|P1|STARTED|Overall Study||32
257848|NCT00464542|623262|P1|NOT COMPLETED|Post-treatment||0
257849|NCT00464542|623262|P1|COMPLETED|Post-treatment||10
257850|NCT00464542|623262|P1|STARTED|Post-treatment||10
257851|NCT00464542|623262|P1|NOT COMPLETED|Pre-treatment||2
257852|NCT00464542|623262|P1|COMPLETED|Pre-treatment||10
257853|NCT00464542|623262|P1|STARTED|Pre-treatment||12
257854|NCT00464490|623269|P2|NOT COMPLETED|Overall Study||11
257855|NCT00464490|623270|P1|NOT COMPLETED|Overall Study||11
257856|NCT00464490|623269|P2|COMPLETED|Overall Study||10
257857|NCT00464490|623270|P1|COMPLETED|Overall Study||10
257858|NCT00464490|623269|P2|STARTED|Overall Study||21
257859|NCT00464490|623270|P1|STARTED|Overall Study||21
257860|NCT00464464|623278|P2|NOT COMPLETED|Overall Study||3
257861|NCT00464464|623279|P1|NOT COMPLETED|Overall Study||5
257862|NCT00464464|623278|P2|COMPLETED|Overall Study||36
257863|NCT00464464|623279|P1|COMPLETED|Overall Study||36
257864|NCT00464464|623278|P2|STARTED|Overall Study||39
257865|NCT00464464|623279|P1|STARTED|Overall Study||41
257866|NCT00464438|623293|P2|NOT COMPLETED|Overall Study||6
257867|NCT00464438|623294|P1|NOT COMPLETED|Overall Study||2
257868|NCT00464438|623293|P2|COMPLETED|Overall Study||80
257869|NCT00464438|623294|P1|COMPLETED|Overall Study||83
257870|NCT00464438|623293|P2|STARTED|Overall Study||86
257871|NCT00464438|623294|P1|STARTED|Overall Study||85
257872|NCT00464334|623317|P11|NOT COMPLETED|Overall Study||4
257873|NCT00464334|623318|P10|NOT COMPLETED|Overall Study||1
257874|NCT00464334|623319|P9|NOT COMPLETED|Overall Study||6
257875|NCT00464334|623320|P8|NOT COMPLETED|Overall Study||1
257876|NCT00464334|623321|P7|NOT COMPLETED|Overall Study||3
257877|NCT00464334|623322|P6|NOT COMPLETED|Overall Study||4
257878|NCT00464334|623323|P5|NOT COMPLETED|Overall Study||4
257879|NCT00464334|623324|P4|NOT COMPLETED|Overall Study||4
257880|NCT00464334|623325|P3|NOT COMPLETED|Overall Study||5
257881|NCT00464334|623326|P2|NOT COMPLETED|Overall Study||8
257882|NCT00464334|623327|P1|NOT COMPLETED|Overall Study||1
257883|NCT00464334|623317|P11|COMPLETED|Overall Study||4
257884|NCT00464334|623318|P10|COMPLETED|Overall Study||4
257885|NCT00464334|623319|P9|COMPLETED|Overall Study||2
257886|NCT00464334|623320|P8|COMPLETED|Overall Study||7
257887|NCT00464334|623321|P7|COMPLETED|Overall Study||6
257888|NCT00464334|623322|P6|COMPLETED|Overall Study||3
257889|NCT00464334|623323|P5|COMPLETED|Overall Study||3
257890|NCT00464334|623324|P4|COMPLETED|Overall Study||4
257891|NCT00464334|623325|P3|COMPLETED|Overall Study||3
257892|NCT00464334|623326|P2|COMPLETED|Overall Study||5
257893|NCT00464334|623327|P1|COMPLETED|Overall Study||4
257894|NCT00464334|623317|P11|STARTED|Overall Study||8
257895|NCT00464334|623318|P10|STARTED|Overall Study||5
257896|NCT00464334|623319|P9|STARTED|Overall Study||8
257897|NCT00464334|623320|P8|STARTED|Overall Study||8
257898|NCT00464334|623321|P7|STARTED|Overall Study||9
257899|NCT00464334|623322|P6|STARTED|Overall Study||7
257900|NCT00464334|623323|P5|STARTED|Overall Study||7
257901|NCT00464334|623324|P4|STARTED|Overall Study||8
257902|NCT00464334|623325|P3|STARTED|Overall Study||8
257903|NCT00464334|623326|P2|STARTED|Overall Study||13
257904|NCT00464334|623327|P1|STARTED|Overall Study||5
257905|NCT00464308|623387|P3|NOT COMPLETED|Overall Study||59
257906|NCT00464308|623388|P2|NOT COMPLETED|Overall Study||63
257907|NCT00464308|623389|P1|NOT COMPLETED|Overall Study||69
257908|NCT00464308|623387|P3|COMPLETED|Overall Study||400
257909|NCT00464308|623388|P2|COMPLETED|Overall Study||406
257910|NCT00464308|623389|P1|COMPLETED|Overall Study||395
257911|NCT00464308|623387|P3|STARTED|Overall Study||459
257912|NCT00464308|623388|P2|STARTED|Overall Study||469
257913|NCT00464308|623389|P1|STARTED|Overall Study||464
257914|NCT00464269|623419|P4|NOT COMPLETED|Overall Study||9
257915|NCT00464269|623420|P3|NOT COMPLETED|Overall Study||7
257916|NCT00464269|623421|P2|NOT COMPLETED|Overall Study||17
257917|NCT00464269|623422|P1|NOT COMPLETED|Overall Study||6
257918|NCT00464269|623419|P4|COMPLETED|Overall Study||93
257919|NCT00464269|623420|P3|COMPLETED|Overall Study||93
257920|NCT00464269|623421|P2|COMPLETED|Overall Study||82
257921|NCT00464269|623422|P1|COMPLETED|Overall Study||93
257922|NCT00464269|623419|P4|STARTED|Overall Study||102
257923|NCT00464269|623420|P3|STARTED|Overall Study||100
257924|NCT00464269|623421|P2|STARTED|Overall Study||99
257925|NCT00464269|623422|P1|STARTED|Overall Study||99
257926|NCT00464204|623522|P2|NOT COMPLETED|Overall Study||32
257927|NCT00464204|623523|P1|NOT COMPLETED|Overall Study||49
257928|NCT00464204|623522|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
257929|NCT00464204|623523|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
257930|NCT00464204|623522|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
257931|NCT00464204|623523|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
257932|NCT00464204|623522|P2|Day 90 Follow-up Performed|Overall Study||74
257933|NCT00464204|623523|P1|Day 90 Follow-up Performed|Overall Study||69
257934|NCT00464204|623522|P2|Day 30 Follow-up Performed|Overall Study||83
257935|NCT00464204|623523|P1|Day 30 Follow-up Performed|Overall Study||89
257936|NCT00464204|623522|P2|Completed Treatment|Overall Study||83
257937|NCT00464204|623523|P1|Completed Treatment|Overall Study||81
257938|NCT00464204|623522|P2|STARTED|Overall Study||96
257939|NCT00464204|623523|P1|STARTED|Overall Study||100
257940|NCT00464087|623560|P3|NOT COMPLETED|Overall Study||29
257941|NCT00464087|623561|P2|NOT COMPLETED|Overall Study||0
257942|NCT00464087|623562|P1|NOT COMPLETED|Overall Study||0
257943|NCT00464087|623560|P3|COMPLETED|Overall Study||0
257944|NCT00464087|623561|P2|COMPLETED|Overall Study||51
257945|NCT00464087|623562|P1|COMPLETED|Overall Study||49
257946|NCT00464087|623560|P3|STARTED|Overall Study||29
257947|NCT00464087|623561|P2|STARTED|Overall Study||51
257948|NCT00464087|623562|P1|STARTED|Overall Study||49
257949|NCT00463866|623580|P2|NOT COMPLETED|Overall Study||340
257950|NCT00463866|623581|P1|NOT COMPLETED|Overall Study||309
257951|NCT00463866|623580|P2|COMPLETED|Overall Study||3705
257952|NCT00463866|623581|P1|COMPLETED|Overall Study||3699
257953|NCT00463866|623580|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
257954|NCT00463866|623581|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
257955|NCT00463840|623601|P1|NOT COMPLETED|Overall Study||12
257956|NCT00463840|623601|P1|COMPLETED|Overall Study||12
257957|NCT00463840|623601|P1|STARTED|Overall Study||24
257958|NCT00463801|623606|P1|NOT COMPLETED|Overall Study||13
257959|NCT00463801|623606|P1|COMPLETED|Overall Study||39
257960|NCT00463801|623606|P1|STARTED|Overall Study||52
257961|NCT00463788|623612|P2|NOT COMPLETED|Overall Study||54
257962|NCT00463788|623613|P1|NOT COMPLETED|Overall Study||109
257963|NCT00463788|623612|P2|COMPLETED|Overall Study||4
257964|NCT00463788|623613|P1|COMPLETED|Overall Study||6
257965|NCT00463788|623612|P2|Treated|Overall Study||57
257966|NCT00463788|623613|P1|Treated|Overall Study||114
257967|NCT00463788|623612|P2|STARTED|Overall Study||58
257968|NCT00463788|623613|P1|STARTED|Overall Study||115
257969|NCT00463606|623631|P3|NOT COMPLETED|Overall Study||20
257970|NCT00463606|623632|P2|NOT COMPLETED|Overall Study||34
257971|NCT00463606|623633|P1|NOT COMPLETED|Overall Study||41
257972|NCT00463606|623631|P3|COMPLETED|Overall Study||231
257973|NCT00463606|623632|P2|COMPLETED|Overall Study||220
257974|NCT00463606|623633|P1|COMPLETED|Overall Study||212
257975|NCT00463606|623631|P3|STARTED|Overall Study||251
257976|NCT00463606|623632|P2|STARTED|Overall Study||254
257977|NCT00463606|623633|P1|STARTED|Overall Study||253
257978|NCT00463580|623658|P2|NOT COMPLETED|Overall Study||2
257979|NCT00463580|623659|P1|NOT COMPLETED|Overall Study||3
257980|NCT00463580|623658|P2|COMPLETED|Overall Study||28
257981|NCT00463580|623659|P1|COMPLETED|Overall Study||27
257982|NCT00463580|623658|P2|STARTED|Overall Study||30
257983|NCT00463580|623659|P1|STARTED|Overall Study||30
257984|NCT00463567|623674|P7|NOT COMPLETED|Overall Study||11
257985|NCT00463567|623675|P6|NOT COMPLETED|Overall Study||21
257986|NCT00463567|623676|P5|NOT COMPLETED|Overall Study||23
257987|NCT00463567|623677|P4|NOT COMPLETED|Overall Study||131
257988|NCT00463567|623678|P3|NOT COMPLETED|Overall Study||89
257989|NCT00463567|623679|P2|NOT COMPLETED|Overall Study||77
257990|NCT00463567|623680|P1|NOT COMPLETED|Overall Study||95
257991|NCT00463567|623674|P7|COMPLETED|Overall Study||112
257992|NCT00463567|623675|P6|COMPLETED|Overall Study||102
257993|NCT00463567|623676|P5|COMPLETED|Overall Study||107
257994|NCT00463567|623677|P4|COMPLETED|Overall Study||294
257995|NCT00463567|623678|P3|COMPLETED|Overall Study||331
257996|NCT00463567|623679|P2|COMPLETED|Overall Study||341
257997|NCT00463567|623680|P1|COMPLETED|Overall Study||325
257998|NCT00463567|623674|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
257999|NCT00463567|623675|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
258000|NCT00463567|623676|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
258001|NCT00463567|623677|P4|Safety Population: Received Study Drug|Overall Study||418
258002|NCT00463567|623678|P3|Safety Population: Received Study Drug|Overall Study||415
258003|NCT00463567|623679|P2|Safety Population: Received Study Drug|Overall Study||416
258004|NCT00463567|623680|P1|Safety Population: Received Study Drug|Overall Study||416
258005|NCT00463567|623674|P7|STARTED|Overall Study||123
258006|NCT00463567|623675|P6|STARTED|Overall Study||123
258007|NCT00463567|623676|P5|STARTED|Overall Study||130
258008|NCT00463567|623677|P4|STARTED|Overall Study||425
258009|NCT00463567|623678|P3|STARTED|Overall Study||420
258010|NCT00463567|623679|P2|STARTED|Overall Study||418
258011|NCT00463567|623680|P1|STARTED|Overall Study|Randomized Participants|420
258012|NCT00463437|623715|P4|NOT COMPLETED|Overall Study||7
258013|NCT00463437|623716|P3|NOT COMPLETED|Overall Study||6
258014|NCT00463437|623717|P2|NOT COMPLETED|Overall Study||11
258015|NCT00463437|623718|P1|NOT COMPLETED|Overall Study||4
258016|NCT00463437|623715|P4|COMPLETED|Overall Study||350
258017|NCT00463437|623716|P3|COMPLETED|Overall Study||352
258018|NCT00463437|623717|P2|COMPLETED|Overall Study||352
258019|NCT00463437|623718|P1|COMPLETED|Overall Study||355
258020|NCT00463437|623715|P4|STARTED|Overall Study||357
258021|NCT00463437|623716|P3|STARTED|Overall Study||358
258022|NCT00463437|623717|P2|STARTED|Overall Study||363
258023|NCT00463437|623718|P1|STARTED|Overall Study||359
258024|NCT00463385|623784|P4|NOT COMPLETED|Overall Study||22
258025|NCT00463385|623785|P3|NOT COMPLETED|Overall Study||22
258026|NCT00463385|623786|P2|NOT COMPLETED|Overall Study||22
258027|NCT00463385|623787|P1|NOT COMPLETED|Overall Study||22
258028|NCT00463385|623784|P4|COMPLETED|Overall Study||0
258029|NCT00463385|623785|P3|COMPLETED|Overall Study||0
258030|NCT00463385|623786|P2|COMPLETED|Overall Study||0
258031|NCT00463385|623787|P1|COMPLETED|Overall Study||0
258032|NCT00463385|623784|P4|Treated|Overall Study||22
258033|NCT00463385|623785|P3|Treated|Overall Study||19
258034|NCT00463385|623786|P2|Treated|Overall Study||22
258035|NCT00463385|623787|P1|Treated|Overall Study||22
258036|NCT00463385|623784|P4|STARTED|Overall Study||22
258037|NCT00463385|623785|P3|STARTED|Overall Study||22
258038|NCT00463385|623786|P2|STARTED|Overall Study||22
258039|NCT00463385|623787|P1|STARTED|Overall Study||22
258040|NCT00463346|623839|P2|NOT COMPLETED|Overall Study||3
258041|NCT00463346|623840|P1|NOT COMPLETED|Overall Study||3
258042|NCT00463346|623839|P2|COMPLETED|Overall Study||8
258043|NCT00463346|623840|P1|COMPLETED|Overall Study||9
258044|NCT00463346|623839|P2|STARTED|Overall Study||11
258045|NCT00463346|623840|P1|STARTED|Overall Study||12
258046|NCT00463229|623850|P2|NOT COMPLETED|Overall Study||10
258047|NCT00463229|623851|P1|NOT COMPLETED|Overall Study||9
258048|NCT00463229|623850|P2|COMPLETED|Overall Study||39
258049|NCT00463229|623851|P1|COMPLETED|Overall Study||43
258050|NCT00463229|623850|P2|STARTED|Overall Study||49
258051|NCT00463229|623851|P1|STARTED|Overall Study||52
258052|NCT00463047|623857|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
258053|NCT00463047|623858|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
258054|NCT00463047|623857|P2|COMPLETED|Double-Blind Treatment Period 2||88
258055|NCT00463047|623858|P1|COMPLETED|Double-Blind Treatment Period 2||92
258056|NCT00463047|623857|P2|STARTED|Double-Blind Treatment Period 2||90
258057|NCT00463047|623858|P1|STARTED|Double-Blind Treatment Period 2||93
258058|NCT00463047|623857|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
258059|NCT00463047|623858|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
258060|NCT00463047|623857|P2|COMPLETED|Double-Blind Treatment Period 1||90
258061|NCT00463047|623858|P1|COMPLETED|Double-Blind Treatment Period 1||93
258062|NCT00463047|623857|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
258063|NCT00463047|623858|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
258064|NCT00463047|623857|P2|NOT COMPLETED|Titration Period 2||23
258065|NCT00463047|623858|P1|NOT COMPLETED|Titration Period 2||30
258066|NCT00463047|623857|P2|COMPLETED|Titration Period 2||98
258067|NCT00463047|623858|P1|COMPLETED|Titration Period 2||93
258068|NCT00463047|623857|P2|STARTED|Titration Period 2||121
258069|NCT00463047|623858|P1|STARTED|Titration Period 2||123
258070|NCT00463047|623857|P2|NOT COMPLETED|Titration Period 1||39
258071|NCT00463047|623858|P1|NOT COMPLETED|Titration Period 1||37
258072|NCT00463047|623857|P2|COMPLETED|Titration Period 1||121
258073|NCT00463047|623858|P1|COMPLETED|Titration Period 1||123
258074|NCT00463047|623857|P2|STARTED|Titration Period 1||160
258075|NCT00463047|623858|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
258076|NCT00462982|623943|P1|NOT COMPLETED|Overall Study||3
258077|NCT00462982|623943|P1|COMPLETED|Overall Study||5
258078|NCT00462982|623943|P1|STARTED|Overall Study||8
258079|NCT00462943|623950|P3|NOT COMPLETED|Overall Study||23
258080|NCT00462943|623951|P2|NOT COMPLETED|Overall Study||30
258081|NCT00462943|623952|P1|NOT COMPLETED|Overall Study||45
258082|NCT00462943|623950|P3|COMPLETED|Overall Study||0
258083|NCT00462943|623951|P2|COMPLETED|Overall Study||1
258084|NCT00462943|623952|P1|COMPLETED|Overall Study||1
258085|NCT00462943|623950|P3|STARTED|Overall Study||23
258086|NCT00462943|623951|P2|STARTED|Overall Study||31
258087|NCT00462943|623952|P1|STARTED|Overall Study||46
258088|NCT00462917|624023|P4|NOT COMPLETED|Overall Study||11
258089|NCT00462917|624024|P3|NOT COMPLETED|Overall Study||12
258090|NCT00462917|624025|P2|NOT COMPLETED|Overall Study||10
258091|NCT00462917|624026|P1|NOT COMPLETED|Overall Study||10
258092|NCT00462917|624023|P4|COMPLETED|Overall Study||66
258093|NCT00462917|624024|P3|COMPLETED|Overall Study||54
258094|NCT00462917|624025|P2|COMPLETED|Overall Study||65
258095|NCT00462917|624026|P1|COMPLETED|Overall Study||62
258096|NCT00462917|624023|P4|Completed 6 Month Follow-up|Overall Study||66
258097|NCT00462917|624024|P3|Completed 6 Month Follow-up|Overall Study||55
258098|NCT00462917|624025|P2|Completed 6 Month Follow-up|Overall Study||68
258099|NCT00462917|624026|P1|Completed 6 Month Follow-up|Overall Study||63
258100|NCT00462917|624023|P4|Completed 6 Week Follow-up|Overall Study||68
258101|NCT00462917|624024|P3|Completed 6 Week Follow-up|Overall Study||55
258102|NCT00462917|624025|P2|Completed 6 Week Follow-up|Overall Study||70
258103|NCT00462917|624026|P1|Completed 6 Week Follow-up|Overall Study||63
258104|NCT00462917|624023|P4|Received Risk Information|Overall Study||68
258105|NCT00462917|624024|P3|Received Risk Information|Overall Study||55
258106|NCT00462917|624025|P2|Received Risk Information|Overall Study||70
258107|NCT00462917|624026|P1|Received Risk Information|Overall Study||64
258108|NCT00462917|624023|P4|Met With Genetic Counselor|Overall Study||71
258109|NCT00462917|624024|P3|Met With Genetic Counselor|Overall Study||56
258110|NCT00462917|624025|P2|Met With Genetic Counselor|Overall Study||71
258111|NCT00462917|624026|P1|Met With Genetic Counselor|Overall Study||66
258112|NCT00462917|624023|P4|STARTED|Overall Study||77
258113|NCT00462917|624024|P3|STARTED|Overall Study||66
258114|NCT00462917|624025|P2|STARTED|Overall Study||75
258115|NCT00462917|624026|P1|STARTED|Overall Study||72
258116|NCT00462865|624044|P1|NOT COMPLETED|Overall Study||1
258117|NCT00462865|624044|P1|COMPLETED|Overall Study||17
258118|NCT00462865|624044|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
258119|NCT00462839|624050|P2|NOT COMPLETED|Viewed Second||0
258120|NCT00462839|624051|P1|NOT COMPLETED|Viewed Second||0
258121|NCT00462839|624050|P2|COMPLETED|Viewed Second||53
258122|NCT00462839|624051|P1|COMPLETED|Viewed Second||53
258123|NCT00462839|624050|P2|STARTED|Viewed Second||53
258124|NCT00462839|624051|P1|STARTED|Viewed Second||53
258125|NCT00462839|624050|P2|NOT COMPLETED|Viewed First||0
258126|NCT00462839|624051|P1|NOT COMPLETED|Viewed First||0
258127|NCT00462839|624050|P2|COMPLETED|Viewed First||53
258128|NCT00462839|624051|P1|COMPLETED|Viewed First||53
258129|NCT00462839|624050|P2|STARTED|Viewed First||53
258130|NCT00462839|624051|P1|STARTED|Viewed First||53
258131|NCT00462826|624063|P1|NOT COMPLETED|Overall Study||5
258132|NCT00462826|624063|P1|COMPLETED|Overall Study||44
258133|NCT00462826|624063|P1|STARTED|Overall Study||49
258134|NCT00462748|624079|P3|NOT COMPLETED|Overall Study||11
258135|NCT00462748|624080|P2|NOT COMPLETED|Overall Study||11
258136|NCT00462748|624081|P1|NOT COMPLETED|Overall Study||12
258137|NCT00462748|624079|P3|COMPLETED|Overall Study||251
258138|NCT00462748|624080|P2|COMPLETED|Overall Study||252
258139|NCT00462748|624081|P1|COMPLETED|Overall Study||249
258140|NCT00462748|624079|P3|STARTED|Overall Study||262
258141|NCT00462748|624080|P2|STARTED|Overall Study||263
258142|NCT00462748|624081|P1|STARTED|Overall Study||261
258143|NCT00462735|624089|P1|NOT COMPLETED|Overall Study||0
258144|NCT00462735|624089|P1|COMPLETED|Overall Study||33
258145|NCT00462735|624089|P1|STARTED|Overall Study||33
258146|NCT00462722|624100|P3|NOT COMPLETED|Overall Study||12
258147|NCT00462722|624101|P2|NOT COMPLETED|Overall Study||4
258148|NCT00462722|624102|P1|NOT COMPLETED|Overall Study||13
258149|NCT00462722|624100|P3|COMPLETED|Overall Study||42
258150|NCT00462722|624101|P2|COMPLETED|Overall Study||51
258151|NCT00462722|624102|P1|COMPLETED|Overall Study||37
258152|NCT00462722|624100|P3|STARTED|Overall Study||54
258153|NCT00462722|624101|P2|STARTED|Overall Study||55
258154|NCT00462722|624102|P1|STARTED|Overall Study||50
258155|NCT00462709|624134|P1|NOT COMPLETED|Overall Study||67
258156|NCT00462709|624134|P1|COMPLETED|Overall Study||79
258157|NCT00462709|624134|P1|STARTED|Overall Study||146
258158|NCT00462670|624143|P2|NOT COMPLETED|Overall Study||7
258159|NCT00462670|624144|P1|NOT COMPLETED|Overall Study||5
258160|NCT00462670|624143|P2|COMPLETED|Overall Study||46
258161|NCT00462670|624144|P1|COMPLETED|Overall Study||52
258162|NCT00462670|624143|P2|STARTED|Overall Study||53
258163|NCT00462670|624144|P1|STARTED|Overall Study||57
258164|NCT00462644|624154|P2|NOT COMPLETED|Overall Study||0
258165|NCT00462644|624155|P1|NOT COMPLETED|Overall Study||0
258166|NCT00462644|624154|P2|COMPLETED|Overall Study||12
258167|NCT00462644|624155|P1|COMPLETED|Overall Study||18
258168|NCT00462644|624154|P2|STARTED|Overall Study||12
258169|NCT00462644|624155|P1|STARTED|Overall Study||18
258170|NCT00462605|624173|P1|NOT COMPLETED|Overall Study||14
258171|NCT00462605|624173|P1|COMPLETED|Overall Study||10
258172|NCT00462605|624173|P1|STARTED|Overall Study||24
258173|NCT00462501|624181|P1|NOT COMPLETED|Overall Study||5
258174|NCT00462501|624181|P1|COMPLETED|Overall Study||30
258175|NCT00462501|624181|P1|STARTED|Overall Study||35
258176|NCT00462462|624187|P2|NOT COMPLETED|Overall Study||1
258177|NCT00462462|624188|P1|NOT COMPLETED|Overall Study||0
258178|NCT00462462|624187|P2|COMPLETED|Overall Study||13
258179|NCT00462462|624188|P1|COMPLETED|Overall Study||17
258180|NCT00462462|624187|P2|STARTED|Overall Study||14
258181|NCT00462462|624188|P1|STARTED|Overall Study||17
258182|NCT00462449|624198|P2|NOT COMPLETED|Overall Study||0
258183|NCT00462449|624199|P1|NOT COMPLETED|Overall Study||0
258184|NCT00462449|624198|P2|COMPLETED|Overall Study||10
258185|NCT00462449|624199|P1|COMPLETED|Overall Study||13
258186|NCT00462449|624198|P2|STARTED|Overall Study||10
258187|NCT00462449|624199|P1|STARTED|Overall Study||13
258188|NCT00462423|624209|P1|NOT COMPLETED|Overall Study||0
258189|NCT00462423|624209|P1|COMPLETED|Overall Study||50
258190|NCT00462423|624209|P1|STARTED|Overall Study||50
258191|NCT00462384|624216|P1|NOT COMPLETED|Overall Study||9
258192|NCT00462384|624216|P1|COMPLETED|Overall Study||30
258193|NCT00462384|624216|P1|STARTED|Overall Study||39
258194|NCT00462345|624224|P1|NOT COMPLETED|Overall Study||3
258195|NCT00462345|624224|P1|COMPLETED|Overall Study||37
258196|NCT00462345|624224|P1|Completed First Course|Overall Study||38
258197|NCT00462345|624224|P1|STARTED|Overall Study||40
258198|NCT00462332|624248|P2|NOT COMPLETED|Overall Study||0
258199|NCT00462332|624249|P1|NOT COMPLETED|Overall Study||0
258200|NCT00462332|624248|P2|COMPLETED|Overall Study||41
258201|NCT00462332|624249|P1|COMPLETED|Overall Study||45
258202|NCT00462332|624248|P2|STARTED|Overall Study||41
258203|NCT00462332|624249|P1|STARTED|Overall Study||45
258204|NCT00462306|624259|P2|NOT COMPLETED|Overall Study||13
258205|NCT00462306|624260|P1|NOT COMPLETED|Overall Study||0
258206|NCT00462306|624259|P2|COMPLETED|Overall Study||490
258207|NCT00462306|624260|P1|COMPLETED|Overall Study||4074
258208|NCT00462306|624259|P2|STARTED|Overall Study||503
258209|NCT00462306|624260|P1|STARTED|Overall Study||4074
258210|NCT00462280|624272|P4|NOT COMPLETED|Overall Study||3
258211|NCT00462280|624273|P3|NOT COMPLETED|Overall Study||0
258212|NCT00462280|624274|P2|NOT COMPLETED|Overall Study||7
258213|NCT00462280|624275|P1|NOT COMPLETED|Overall Study||10
258214|NCT00462280|624272|P4|COMPLETED|Overall Study||4
258215|NCT00462280|624273|P3|COMPLETED|Overall Study||7
258216|NCT00462280|624274|P2|COMPLETED|Overall Study||25
258217|NCT00462280|624275|P1|COMPLETED|Overall Study||24
258218|NCT00462280|624272|P4|STARTED|Overall Study||7
258219|NCT00462280|624273|P3|STARTED|Overall Study||7
258220|NCT00462280|624274|P2|STARTED|Overall Study||32
258221|NCT00462280|624275|P1|STARTED|Overall Study||34
258222|NCT00462228|624335|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
258223|NCT00462228|624335|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
258224|NCT00462228|624335|P1|STARTED|No Treatment (Washout) 4 Weeks||11
258225|NCT00462228|624335|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
258226|NCT00462228|624335|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
258227|NCT00462228|624335|P1|STARTED|Placebo or Memantine 12 Weeks||11
258228|NCT00462228|624335|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
258229|NCT00462228|624335|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
258230|NCT00462228|624335|P1|STARTED|No Treatment (Washout) 4 Weeks||11
258231|NCT00462228|624335|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
258232|NCT00462228|624335|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
258233|NCT00462228|624335|P1|STARTED|Memantine or Placebo 12 Weeks||11
258234|NCT00462072|624359|P3|NOT COMPLETED|Week 10||0
258235|NCT00462072|624360|P2|NOT COMPLETED|Week 10||0
258236|NCT00462072|624361|P1|NOT COMPLETED|Week 10||0
258237|NCT00462072|624359|P3|COMPLETED|Week 10||9
258238|NCT00462072|624360|P2|COMPLETED|Week 10||12
258239|NCT00462072|624361|P1|COMPLETED|Week 10||10
258240|NCT00462072|624359|P3|STARTED|Week 10||9
258241|NCT00462072|624360|P2|STARTED|Week 10||12
258242|NCT00462072|624361|P1|STARTED|Week 10||10
258243|NCT00462072|624359|P3|NOT COMPLETED|Baseline (Week 0)||0
258244|NCT00462072|624360|P2|NOT COMPLETED|Baseline (Week 0)||0
258245|NCT00462072|624361|P1|NOT COMPLETED|Baseline (Week 0)||0
258246|NCT00462072|624359|P3|COMPLETED|Baseline (Week 0)||9
258247|NCT00462072|624360|P2|COMPLETED|Baseline (Week 0)||12
258248|NCT00462072|624361|P1|COMPLETED|Baseline (Week 0)||10
258249|NCT00462072|624359|P3|STARTED|Baseline (Week 0)||9
258250|NCT00462072|624360|P2|STARTED|Baseline (Week 0)||12
258251|NCT00462072|624361|P1|STARTED|Baseline (Week 0)||10
258252|NCT00462020|624377|P2|NOT COMPLETED|Overall Study||0
258253|NCT00462020|624378|P1|NOT COMPLETED|Overall Study||0
258254|NCT00462020|624377|P2|COMPLETED|Overall Study||50
258255|NCT00462020|624378|P1|COMPLETED|Overall Study||52
258256|NCT00462020|624377|P2|STARTED|Overall Study||50
258257|NCT00462020|624378|P1|STARTED|Overall Study||52
258258|NCT00461981|624386|P2|NOT COMPLETED|Overall Study||9
258259|NCT00461981|624387|P1|NOT COMPLETED|Overall Study||11
258260|NCT00461981|624386|P2|COMPLETED|Overall Study||42
258261|NCT00461981|624387|P1|COMPLETED|Overall Study||39
258262|NCT00461981|624386|P2|STARTED|Overall Study||51
258263|NCT00461981|624387|P1|STARTED|Overall Study||50
258264|NCT00461851|624497|P1|NOT COMPLETED|Overall Study||0
258265|NCT00461851|624497|P1|COMPLETED|Overall Study||17
258266|NCT00461851|624497|P1|STARTED|Overall Study||17
258267|NCT00461812|624503|P1|NOT COMPLETED|Overall Study||10
258268|NCT00461812|624503|P1|COMPLETED|Overall Study||0
258269|NCT00461812|624503|P1|STARTED|Overall Study||10
258270|NCT00461786|624508|P1|NOT COMPLETED|Overall Study||3
258271|NCT00461786|624508|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
258272|NCT00461786|624508|P1|STARTED|Overall Study||51
258273|NCT00461734|624518|P2|NOT COMPLETED|Overall Study||60
258274|NCT00461734|624519|P1|NOT COMPLETED|Overall Study||58
258275|NCT00461734|624518|P2|COMPLETED|Overall Study||60
258276|NCT00461734|624519|P1|COMPLETED|Overall Study||62
258277|NCT00461734|624518|P2|STARTED|Overall Study||120
258278|NCT00461734|624519|P1|STARTED|Overall Study||120
258279|NCT00461708|624553|P2|NOT COMPLETED|Overall Study||38
258280|NCT00461708|624554|P1|NOT COMPLETED|Overall Study||115
258281|NCT00461708|624553|P2|COMPLETED|Overall Study||0
258282|NCT00461708|624554|P1|COMPLETED|Overall Study||0
258283|NCT00461708|624553|P2|STARTED|Overall Study||38
258284|NCT00461708|624554|P1|STARTED|Overall Study||115
258285|NCT00461682|624580|P1|NOT COMPLETED|Overall Study||1
258286|NCT00461682|624580|P1|COMPLETED|Overall Study||0
258287|NCT00461682|624580|P1|STARTED|Overall Study||1
258288|NCT00461630|624608|P2|NOT COMPLETED|Overall Study||827
258289|NCT00461630|624609|P1|NOT COMPLETED|Overall Study||906
258290|NCT00461630|624608|P2|COMPLETED|Overall Study||12008
258291|NCT00461630|624609|P1|COMPLETED|Overall Study||11932
258292|NCT00461630|624608|P2|STARTED|Overall Study||12835
258293|NCT00461630|624609|P1|STARTED|Overall Study||12838
258294|NCT00461591|624625|P2|NOT COMPLETED|Overall Study||85
258295|NCT00461591|624626|P1|NOT COMPLETED|Overall Study||89
258296|NCT00461591|624625|P2|COMPLETED|Overall Study||311
258297|NCT00461591|624626|P1|COMPLETED|Overall Study||317
258298|NCT00461591|624625|P2|STARTED|Overall Study||396
258299|NCT00461591|624626|P1|STARTED|Overall Study||406
258300|NCT00461513|624648|P2|NOT COMPLETED|Overall Study||27
258301|NCT00461513|624649|P1|NOT COMPLETED|Overall Study||28
258302|NCT00461513|624648|P2|COMPLETED|Overall Study||172
258303|NCT00461513|624649|P1|COMPLETED|Overall Study||165
258304|NCT00461513|624648|P2|STARTED|Overall Study||199
258305|NCT00461513|624649|P1|STARTED|Overall Study||193
258306|NCT00461500|624657|P2|NOT COMPLETED|Overall Study||6
258307|NCT00461500|624658|P1|NOT COMPLETED|Overall Study||7
258308|NCT00461500|624657|P2|COMPLETED|Overall Study||38
258309|NCT00461500|624658|P1|COMPLETED|Overall Study||30
258310|NCT00461500|624657|P2|STARTED|Overall Study||44
258311|NCT00461500|624658|P1|STARTED|Overall Study||37
258312|NCT00461331|624688|P2|NOT COMPLETED|Intervention 2||0
258313|NCT00461331|624689|P1|NOT COMPLETED|Intervention 2||0
258314|NCT00461331|624688|P2|COMPLETED|Intervention 2||10
258315|NCT00461331|624689|P1|COMPLETED|Intervention 2||10
258316|NCT00461331|624688|P2|STARTED|Intervention 2||10
258317|NCT00461331|624689|P1|STARTED|Intervention 2||10
258318|NCT00461331|624688|P2|NOT COMPLETED|Washout||0
258319|NCT00461331|624689|P1|NOT COMPLETED|Washout||0
258320|NCT00461331|624688|P2|COMPLETED|Washout||10
258321|NCT00461331|624689|P1|COMPLETED|Washout||10
258322|NCT00461331|624688|P2|STARTED|Washout||10
258323|NCT00461331|624689|P1|STARTED|Washout||10
258324|NCT00461331|624688|P2|NOT COMPLETED|Intervention 1||0
258325|NCT00461331|624689|P1|NOT COMPLETED|Intervention 1||0
258326|NCT00461331|624688|P2|COMPLETED|Intervention 1||10
258327|NCT00461331|624689|P1|COMPLETED|Intervention 1||10
258328|NCT00461331|624688|P2|STARTED|Intervention 1||10
258329|NCT00461331|624689|P1|STARTED|Intervention 1||10
258330|NCT00461305|624701|P2|NOT COMPLETED|Continued Treatment||0
258331|NCT00461305|624702|P1|NOT COMPLETED|Continued Treatment||95
258332|NCT00461305|624701|P2|COMPLETED|Continued Treatment||0
258333|NCT00461305|624702|P1|COMPLETED|Continued Treatment||254
258334|NCT00461305|624701|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
258335|NCT00461305|624702|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
258336|NCT00461305|624701|P2|NOT COMPLETED|Treatment||9
258337|NCT00461305|624702|P1|NOT COMPLETED|Treatment||101
258338|NCT00461305|624701|P2|COMPLETED|Treatment||56
258339|NCT00461305|624702|P1|COMPLETED|Treatment||254
258340|NCT00461305|624701|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
258341|NCT00461305|624702|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
258342|NCT00461305|624701|P2|Subjects Dispensed Drugs|Treatment||65
258343|NCT00461305|624702|P1|Subjects Dispensed Drugs|Treatment||350
258344|NCT00461305|624701|P2|STARTED|Treatment|Enrolled|65
258345|NCT00461305|624702|P1|STARTED|Treatment|Enrolled|355
258346|NCT00461292|624765|P3|NOT COMPLETED|Treatment Cycle 2||0
258347|NCT00461292|624766|P2|NOT COMPLETED|Treatment Cycle 2||2
258348|NCT00461292|624767|P1|NOT COMPLETED|Treatment Cycle 2||5
258349|NCT00461292|624765|P3|COMPLETED|Treatment Cycle 2||0
258350|NCT00461292|624766|P2|COMPLETED|Treatment Cycle 2||72
258351|NCT00461292|624767|P1|COMPLETED|Treatment Cycle 2||58
258352|NCT00461292|624765|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
258353|NCT00461292|624766|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
258354|NCT00461292|624767|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
258355|NCT00461292|624765|P3|NOT COMPLETED|Treatment Cycle 1||11
258356|NCT00461292|624766|P2|NOT COMPLETED|Treatment Cycle 1||12
258357|NCT00461292|624767|P1|NOT COMPLETED|Treatment Cycle 1||15
258358|NCT00461292|624765|P3|COMPLETED|Treatment Cycle 1||81
258359|NCT00461292|624766|P2|COMPLETED|Treatment Cycle 1||80
258360|NCT00461292|624767|P1|COMPLETED|Treatment Cycle 1||76
258361|NCT00461292|624765|P3|STARTED|Treatment Cycle 1||92
258362|NCT00461292|624766|P2|STARTED|Treatment Cycle 1||92
258363|NCT00461292|624767|P1|STARTED|Treatment Cycle 1||91
258364|NCT00461253|624786|P2|NOT COMPLETED|Overall Study||19798
258365|NCT00461253|624787|P1|NOT COMPLETED|Overall Study||4980
258366|NCT00461253|624786|P2|COMPLETED|Overall Study|Analyzed controls|20452
258367|NCT00461253|624787|P1|COMPLETED|Overall Study|Analyzed cases|5113
258368|NCT00461253|624786|P2|STARTED|Overall Study|Identified controls|40250
258369|NCT00461253|624787|P1|STARTED|Overall Study|Identified cases|10093
258370|NCT00461175|624795|P2|NOT COMPLETED|Overall Study||365
258371|NCT00461175|624796|P1|NOT COMPLETED|Overall Study||522
258372|NCT00461175|624795|P2|COMPLETED|Overall Study||18370
258373|NCT00461175|624796|P1|COMPLETED|Overall Study||43078
258374|NCT00461175|624795|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
258375|NCT00461175|624796|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
258376|NCT00461123|624806|P2|NOT COMPLETED|Overall Study||6
258377|NCT00461123|624807|P1|NOT COMPLETED|Overall Study||6
258378|NCT00461123|624806|P2|COMPLETED|Overall Study||19
258379|NCT00461123|624807|P1|COMPLETED|Overall Study||19
258380|NCT00461123|624806|P2|STARTED|Overall Study||25
258381|NCT00461123|624807|P1|STARTED|Overall Study||25
258382|NCT00461097|624823|P2|NOT COMPLETED|Overall Study||0
258383|NCT00461097|624824|P1|NOT COMPLETED|Overall Study||0
258384|NCT00461097|624823|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
258385|NCT00461097|624824|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
258386|NCT00461097|624823|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
258387|NCT00461097|624824|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
258388|NCT00461097|624823|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
258389|NCT00461097|624824|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
258390|NCT00461097|624823|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
258391|NCT00461097|624824|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
258392|NCT00461097|624823|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
258393|NCT00461097|624824|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
258394|NCT00461097|624823|P2|STARTED|Overall Study||15
258395|NCT00461097|624824|P1|STARTED|Overall Study||40
258396|NCT00461045|624840|P1|NOT COMPLETED|Overall Study||0
258397|NCT00461045|624840|P1|COMPLETED|Overall Study||15
258398|NCT00461045|624840|P1|STARTED|Overall Study||15
258399|NCT00461032|624852|P2|NOT COMPLETED|Overall Study||44
258400|NCT00461032|624853|P1|NOT COMPLETED|Overall Study||37
258401|NCT00461032|624852|P2|COMPLETED|Overall Study||536
258402|NCT00461032|624853|P1|COMPLETED|Overall Study||545
258403|NCT00461032|624852|P2|STARTED|Overall Study||580
258404|NCT00461032|624853|P1|STARTED|Overall Study||582
258405|NCT00460993|624867|P2|NOT COMPLETED|Phase 2 (6 Days)||0
258406|NCT00460993|624868|P1|NOT COMPLETED|Phase 2 (6 Days)||0
258407|NCT00460993|624867|P2|COMPLETED|Phase 2 (6 Days)||17
258408|NCT00460993|624868|P1|COMPLETED|Phase 2 (6 Days)||14
258409|NCT00460993|624867|P2|STARTED|Phase 2 (6 Days)||17
258410|NCT00460993|624868|P1|STARTED|Phase 2 (6 Days)||14
258411|NCT00460993|624867|P2|NOT COMPLETED|Phase 1 (6 Days)||0
258412|NCT00460993|624868|P1|NOT COMPLETED|Phase 1 (6 Days)||0
258413|NCT00460993|624867|P2|COMPLETED|Phase 1 (6 Days)||17
258414|NCT00460993|624868|P1|COMPLETED|Phase 1 (6 Days)||14
258415|NCT00460993|624867|P2|STARTED|Phase 1 (6 Days)||17
258416|NCT00460993|624868|P1|STARTED|Phase 1 (6 Days)||14
258417|NCT00460811|624879|P5|NOT COMPLETED|Overall Study||20
258418|NCT00460811|624880|P4|NOT COMPLETED|Overall Study||18
258419|NCT00460811|624881|P3|NOT COMPLETED|Overall Study||14
258420|NCT00460811|624882|P2|NOT COMPLETED|Overall Study||15
258421|NCT00460811|624883|P1|NOT COMPLETED|Overall Study||16
258422|NCT00460811|624879|P5|COMPLETED|Overall Study||65
258423|NCT00460811|624880|P4|COMPLETED|Overall Study||71
258424|NCT00460811|624881|P3|COMPLETED|Overall Study||71
258425|NCT00460811|624882|P2|COMPLETED|Overall Study||67
258426|NCT00460811|624883|P1|COMPLETED|Overall Study||63
258427|NCT00460811|624879|P5|STARTED|Overall Study||85
258428|NCT00460811|624880|P4|STARTED|Overall Study||89
258429|NCT00460811|624881|P3|STARTED|Overall Study||85
258430|NCT00460811|624882|P2|STARTED|Overall Study||82
258431|NCT00460811|624883|P1|STARTED|Overall Study||79
258432|NCT00460798|624925|P1|NOT COMPLETED|Overall Study||340
258433|NCT00460798|624925|P1|COMPLETED|Overall Study||108
258434|NCT00460798|624925|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
258435|NCT00460798|624925|P1|STARTED|Overall Study||448
258436|NCT00460746|624933|P1|NOT COMPLETED|Overall Study||2
258437|NCT00460746|624933|P1|COMPLETED|Overall Study||8
258438|NCT00460746|624933|P1|STARTED|Overall Study||10
258439|NCT00460655|624948|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
258440|NCT00460655|624949|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
258441|NCT00460655|624950|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
258442|NCT00460655|624951|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
258443|NCT00460655|624948|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
258444|NCT00460655|624949|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
258445|NCT00460655|624950|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
258446|NCT00460655|624951|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
258447|NCT00460655|624948|P4|STARTED|Open-Label Phase (36 Weeks)||61
258448|NCT00460655|624949|P3|STARTED|Open-Label Phase (36 Weeks)||52
258449|NCT00460655|624950|P2|STARTED|Open-Label Phase (36 Weeks)||0
258450|NCT00460655|624951|P1|STARTED|Open-Label Phase (36 Weeks)||0
258451|NCT00460655|624948|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258452|NCT00460655|624949|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258453|NCT00460655|624950|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
258454|NCT00460655|624951|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
258455|NCT00460655|624948|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
258456|NCT00460655|624949|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
258457|NCT00460655|624950|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
258458|NCT00460655|624951|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
258459|NCT00460655|624948|P4|STARTED|Double-Blind Phase (12 Weeks)||0
258460|NCT00460655|624949|P3|STARTED|Double-Blind Phase (12 Weeks)||0
258461|NCT00460655|624950|P2|STARTED|Double-Blind Phase (12 Weeks)||62
258462|NCT00460655|624951|P1|STARTED|Double-Blind Phase (12 Weeks)||58
258463|NCT00460603|624995|P12|NOT COMPLETED|Phase 2||41
258464|NCT00460603|624996|P11|NOT COMPLETED|Phase 2||43
258465|NCT00460603|624997|P10|NOT COMPLETED|Phase 2||42
258466|NCT00460603|624998|P9|NOT COMPLETED|Phase 2||0
258467|NCT00460603|624999|P8|NOT COMPLETED|Phase 2||0
258468|NCT00460603|625000|P7|NOT COMPLETED|Phase 2||0
258469|NCT00460603|625001|P6|NOT COMPLETED|Phase 2||0
258470|NCT00460603|625002|P5|NOT COMPLETED|Phase 2||0
258471|NCT00460603|625003|P4|NOT COMPLETED|Phase 2||0
258472|NCT00460603|625004|P3|NOT COMPLETED|Phase 2||0
258473|NCT00460603|625005|P2|NOT COMPLETED|Phase 2||0
258474|NCT00460603|625006|P1|NOT COMPLETED|Phase 2||0
258475|NCT00460603|624995|P12|COMPLETED|Phase 2||0
258476|NCT00460603|624996|P11|COMPLETED|Phase 2||0
258477|NCT00460603|624997|P10|COMPLETED|Phase 2||0
258478|NCT00460603|624998|P9|COMPLETED|Phase 2||0
258479|NCT00460603|624999|P8|COMPLETED|Phase 2||0
258480|NCT00460603|625000|P7|COMPLETED|Phase 2||0
258481|NCT00460603|625001|P6|COMPLETED|Phase 2||0
258482|NCT00460603|625002|P5|COMPLETED|Phase 2||0
258483|NCT00460603|625003|P4|COMPLETED|Phase 2||0
258484|NCT00460603|625004|P3|COMPLETED|Phase 2||0
258485|NCT00460603|625005|P2|COMPLETED|Phase 2||0
258486|NCT00460603|625006|P1|COMPLETED|Phase 2||0
258487|NCT00460603|624995|P12|Treated|Phase 2||41
258488|NCT00460603|624996|P11|Treated|Phase 2||43
258489|NCT00460603|624997|P10|Treated|Phase 2||39
258490|NCT00460603|624998|P9|Treated|Phase 2||0
258491|NCT00460603|624999|P8|Treated|Phase 2||0
258492|NCT00460603|625000|P7|Treated|Phase 2||0
258493|NCT00460603|625001|P6|Treated|Phase 2||0
258494|NCT00460603|625002|P5|Treated|Phase 2||0
258495|NCT00460603|625003|P4|Treated|Phase 2||0
258496|NCT00460603|625004|P3|Treated|Phase 2||0
258497|NCT00460603|625005|P2|Treated|Phase 2||0
258498|NCT00460603|625006|P1|Treated|Phase 2||0
258499|NCT00460603|624995|P12|STARTED|Phase 2||41
258500|NCT00460603|624996|P11|STARTED|Phase 2||43
258501|NCT00460603|624997|P10|STARTED|Phase 2||42
258502|NCT00460603|624998|P9|STARTED|Phase 2||0
258503|NCT00460603|624999|P8|STARTED|Phase 2||0
258504|NCT00460603|625000|P7|STARTED|Phase 2||0
258505|NCT00460603|625001|P6|STARTED|Phase 2||0
258506|NCT00460603|625002|P5|STARTED|Phase 2||0
258507|NCT00460603|625003|P4|STARTED|Phase 2||0
258508|NCT00460603|625004|P3|STARTED|Phase 2||0
258509|NCT00460603|625005|P2|STARTED|Phase 2||0
258510|NCT00460603|625006|P1|STARTED|Phase 2||0
258511|NCT00460603|624995|P12|NOT COMPLETED|Phase 1||0
258512|NCT00460603|624996|P11|NOT COMPLETED|Phase 1||0
258513|NCT00460603|624997|P10|NOT COMPLETED|Phase 1||0
258514|NCT00460603|624998|P9|NOT COMPLETED|Phase 1||18
258515|NCT00460603|624999|P8|NOT COMPLETED|Phase 1||3
258516|NCT00460603|625000|P7|NOT COMPLETED|Phase 1||6
258517|NCT00460603|625001|P6|NOT COMPLETED|Phase 1||4
258518|NCT00460603|625002|P5|NOT COMPLETED|Phase 1||6
258519|NCT00460603|625003|P4|NOT COMPLETED|Phase 1||8
258520|NCT00460603|625004|P3|NOT COMPLETED|Phase 1||4
258521|NCT00460603|625005|P2|NOT COMPLETED|Phase 1||6
258522|NCT00460603|625006|P1|NOT COMPLETED|Phase 1||6
258523|NCT00460603|624995|P12|COMPLETED|Phase 1||0
258524|NCT00460603|624996|P11|COMPLETED|Phase 1||0
258525|NCT00460603|624997|P10|COMPLETED|Phase 1||0
258526|NCT00460603|624998|P9|COMPLETED|Phase 1||0
258527|NCT00460603|624999|P8|COMPLETED|Phase 1||0
258528|NCT00460603|625000|P7|COMPLETED|Phase 1||0
258529|NCT00460603|625001|P6|COMPLETED|Phase 1||0
258530|NCT00460603|625002|P5|COMPLETED|Phase 1||0
258531|NCT00460603|625003|P4|COMPLETED|Phase 1||0
258532|NCT00460603|625004|P3|COMPLETED|Phase 1||0
258533|NCT00460603|625005|P2|COMPLETED|Phase 1||0
258534|NCT00460603|625006|P1|COMPLETED|Phase 1||0
258535|NCT00460603|624995|P12|STARTED|Phase 1||0
258536|NCT00460603|624996|P11|STARTED|Phase 1||0
258537|NCT00460603|624997|P10|STARTED|Phase 1||0
258538|NCT00460603|624998|P9|STARTED|Phase 1||18
258539|NCT00460603|624999|P8|STARTED|Phase 1||3
258540|NCT00460603|625000|P7|STARTED|Phase 1||6
258541|NCT00460603|625001|P6|STARTED|Phase 1||4
258542|NCT00460603|625002|P5|STARTED|Phase 1||6
258543|NCT00460603|625003|P4|STARTED|Phase 1||8
258544|NCT00460603|625004|P3|STARTED|Phase 1||4
258545|NCT00460603|625005|P2|STARTED|Phase 1||6
258546|NCT00460603|625006|P1|STARTED|Phase 1||6
258547|NCT00460577|625100|P2|NOT COMPLETED|Overall Study||6
258548|NCT00460577|625101|P1|NOT COMPLETED|Overall Study||2
258549|NCT00460577|625100|P2|COMPLETED|Overall Study||24
258550|NCT00460577|625101|P1|COMPLETED|Overall Study||28
258551|NCT00460577|625100|P2|STARTED|Overall Study||30
258552|NCT00460577|625101|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
258553|NCT00460564|625119|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
258554|NCT00460564|625120|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
258555|NCT00460564|625121|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
258556|NCT00460564|625122|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
258557|NCT00460564|625123|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
258558|NCT00460564|625124|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
258559|NCT00460564|625125|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
258560|NCT00460564|625126|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
258561|NCT00460564|625119|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
258562|NCT00460564|625120|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
258563|NCT00460564|625121|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
258564|NCT00460564|625122|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
258565|NCT00460564|625123|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
258566|NCT00460564|625124|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
258567|NCT00460564|625125|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
258568|NCT00460564|625126|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
258569|NCT00460564|625119|P8|STARTED|Open-Label Phase (36 Weeks)||11
258570|NCT00460564|625120|P7|STARTED|Open-Label Phase (36 Weeks)||21
258571|NCT00460564|625121|P6|STARTED|Open-Label Phase (36 Weeks)||25
258572|NCT00460564|625122|P5|STARTED|Open-Label Phase (36 Weeks)||47
258573|NCT00460564|625123|P4|STARTED|Open-Label Phase (36 Weeks)||0
258574|NCT00460564|625124|P3|STARTED|Open-Label Phase (36 Weeks)||0
258575|NCT00460564|625125|P2|STARTED|Open-Label Phase (36 Weeks)||0
258576|NCT00460564|625126|P1|STARTED|Open-Label Phase (36 Weeks)||0
258577|NCT00460564|625119|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258578|NCT00460564|625120|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258579|NCT00460564|625121|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258580|NCT00460564|625122|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258581|NCT00460564|625123|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258582|NCT00460564|625124|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
258583|NCT00460564|625125|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
258584|NCT00460564|625126|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
258585|NCT00460564|625119|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
258586|NCT00460564|625120|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
258587|NCT00460564|625121|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
258588|NCT00460564|625122|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
258589|NCT00460564|625123|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
258590|NCT00460564|625124|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
258591|NCT00460564|625125|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
258592|NCT00460564|625126|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
258593|NCT00460564|625119|P8|STARTED|Double-Blind Phase (12 Weeks)||0
258594|NCT00460564|625120|P7|STARTED|Double-Blind Phase (12 Weeks)||0
258595|NCT00460564|625121|P6|STARTED|Double-Blind Phase (12 Weeks)||0
258596|NCT00460564|625122|P5|STARTED|Double-Blind Phase (12 Weeks)||0
258597|NCT00460564|625123|P4|STARTED|Double-Blind Phase (12 Weeks)||11
258598|NCT00460564|625124|P3|STARTED|Double-Blind Phase (12 Weeks)||21
258599|NCT00460564|625125|P2|STARTED|Double-Blind Phase (12 Weeks)||26
258600|NCT00460564|625126|P1|STARTED|Double-Blind Phase (12 Weeks)||51
258601|NCT00460551|625220|P1|NOT COMPLETED|Overall Study||0
258602|NCT00460551|625220|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
258603|NCT00460551|625220|P1|STARTED|Overall Study||13
258604|NCT00460525|625227|P2|NOT COMPLETED|Overall Study||5
258605|NCT00460525|625228|P1|NOT COMPLETED|Overall Study||11
258606|NCT00460525|625227|P2|COMPLETED|Overall Study||194
258607|NCT00460525|625228|P1|COMPLETED|Overall Study||190
258608|NCT00460525|625227|P2|STARTED|Overall Study||199
258609|NCT00460525|625228|P1|STARTED|Overall Study||201
258610|NCT00460434|625270|P2|NOT COMPLETED|Overall Study||7
258611|NCT00460434|625271|P1|NOT COMPLETED|Overall Study||3
258612|NCT00460434|625270|P2|COMPLETED|Overall Study||165
258613|NCT00460434|625271|P1|COMPLETED|Overall Study||162
258614|NCT00460434|625270|P2|12 Months|Overall Study||165
258615|NCT00460434|625271|P1|12 Months|Overall Study||162
258616|NCT00460434|625270|P2|3 Months|Overall Study||171
258617|NCT00460434|625271|P1|3 Months|Overall Study||163
258618|NCT00460434|625270|P2|STARTED|Overall Study||172
258619|NCT00460434|625271|P1|STARTED|Overall Study||165
258620|NCT00460421|625300|P3|NOT COMPLETED|Overall Study||0
258621|NCT00460421|625301|P2|NOT COMPLETED|Overall Study||0
258622|NCT00460421|625302|P1|NOT COMPLETED|Overall Study||0
258623|NCT00460421|625300|P3|COMPLETED|Overall Study||9
258624|NCT00460421|625301|P2|COMPLETED|Overall Study||9
258625|NCT00460421|625302|P1|COMPLETED|Overall Study||9
258626|NCT00460421|625300|P3|STARTED|Overall Study||9
258627|NCT00460421|625301|P2|STARTED|Overall Study||9
258628|NCT00460421|625302|P1|STARTED|Overall Study||9
258629|NCT00460408|625350|P4|NOT COMPLETED|Overall Study||0
258630|NCT00460408|625351|P3|NOT COMPLETED|Overall Study||6
258631|NCT00460408|625352|P2|NOT COMPLETED|Overall Study||3
258632|NCT00460408|625353|P1|NOT COMPLETED|Overall Study||67
258633|NCT00460408|625350|P4|COMPLETED|Overall Study||7
258634|NCT00460408|625351|P3|COMPLETED|Overall Study||69
258635|NCT00460408|625352|P2|COMPLETED|Overall Study||13
258636|NCT00460408|625353|P1|COMPLETED|Overall Study||336
258637|NCT00460408|625350|P4|STARTED|Overall Study||7
258638|NCT00460408|625351|P3|STARTED|Overall Study||75
258639|NCT00460408|625352|P2|STARTED|Overall Study||16
258640|NCT00460408|625353|P1|STARTED|Overall Study||403
258641|NCT00460265|625390|P2|NOT COMPLETED|Overall Study||89
258642|NCT00460265|625391|P1|NOT COMPLETED|Overall Study||85
258643|NCT00460265|625390|P2|COMPLETED|Overall Study|Completed study=death|241
258644|NCT00460265|625391|P1|COMPLETED|Overall Study|Completed study=death|243
258645|NCT00460265|625390|P2|Received Study Medication|Overall Study||325
258646|NCT00460265|625391|P1|Received Study Medication|Overall Study||325
258647|NCT00460265|625390|P2|Randomized While Alive|Overall Study||330
258648|NCT00460265|625391|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
258649|NCT00460265|625390|P2|STARTED|Overall Study||330
258650|NCT00460265|625391|P1|STARTED|Overall Study||328
258651|NCT00460239|625407|P9|NOT COMPLETED|Overall Study||0
258652|NCT00460239|625408|P8|NOT COMPLETED|Overall Study||0
258653|NCT00460239|625409|P7|NOT COMPLETED|Overall Study||0
258654|NCT00460239|625410|P6|NOT COMPLETED|Overall Study||3
258655|NCT00460239|625411|P5|NOT COMPLETED|Overall Study||0
258656|NCT00460239|625412|P4|NOT COMPLETED|Overall Study||0
258657|NCT00460239|625413|P3|NOT COMPLETED|Overall Study||0
258658|NCT00460239|625414|P2|NOT COMPLETED|Overall Study||1
258659|NCT00460239|625415|P1|NOT COMPLETED|Overall Study||0
258660|NCT00460239|625407|P9|COMPLETED|Overall Study||1
258661|NCT00460239|625408|P8|COMPLETED|Overall Study||1
258662|NCT00460239|625409|P7|COMPLETED|Overall Study||1
258663|NCT00460239|625410|P6|COMPLETED|Overall Study||1
258664|NCT00460239|625411|P5|COMPLETED|Overall Study||1
258665|NCT00460239|625412|P4|COMPLETED|Overall Study||0
258666|NCT00460239|625413|P3|COMPLETED|Overall Study||1
258667|NCT00460239|625414|P2|COMPLETED|Overall Study||2
258668|NCT00460239|625415|P1|COMPLETED|Overall Study||0
258669|NCT00460239|625407|P9|STARTED|Overall Study||1
258670|NCT00460239|625408|P8|STARTED|Overall Study||1
258671|NCT00460239|625409|P7|STARTED|Overall Study||1
258672|NCT00460239|625410|P6|STARTED|Overall Study||4
258673|NCT00460239|625411|P5|STARTED|Overall Study||1
258674|NCT00460239|625412|P4|STARTED|Overall Study||0
258675|NCT00460239|625413|P3|STARTED|Overall Study||1
258676|NCT00460239|625414|P2|STARTED|Overall Study||3
258677|NCT00460239|625415|P1|STARTED|Overall Study||0
258678|NCT00460109|625484|P1|NOT COMPLETED|Overall Study||1
258679|NCT00460109|625484|P1|COMPLETED|Overall Study||23
258680|NCT00460109|625484|P1|STARTED|Overall Study||24
258681|NCT00460031|625492|P1|NOT COMPLETED|Overall Study||11
258682|NCT00460031|625492|P1|COMPLETED|Overall Study||23
258683|NCT00460031|625492|P1|STARTED|Overall Study||34
258684|NCT00459979|625500|P1|NOT COMPLETED|Overall Study||2
258685|NCT00459979|625500|P1|COMPLETED|Overall Study||28
258686|NCT00459979|625500|P1|STARTED|Overall Study||30
258687|NCT00459953|625512|P2|NOT COMPLETED|Overall Study||1
258688|NCT00459953|625513|P1|NOT COMPLETED|Overall Study||1
258689|NCT00459953|625512|P2|COMPLETED|Overall Study||70
258690|NCT00459953|625513|P1|COMPLETED|Overall Study||71
258691|NCT00459953|625512|P2|STARTED|Overall Study||71
258692|NCT00459953|625513|P1|STARTED|Overall Study||72
258693|NCT00459875|625519|P1|NOT COMPLETED|Overall Study||3
258694|NCT00459875|625519|P1|COMPLETED|Overall Study||21
258695|NCT00459875|625519|P1|STARTED|Overall Study||24
258696|NCT00459862|625523|P1|NOT COMPLETED|Overall Study||0
258697|NCT00459862|625523|P1|COMPLETED|Overall Study||34
258698|NCT00459862|625523|P1|STARTED|Overall Study||34
258699|NCT00459810|625532|P1|NOT COMPLETED|Overall Study||0
258700|NCT00459810|625532|P1|COMPLETED|Overall Study||21
258701|NCT00459810|625532|P1|STARTED|Overall Study||21
258702|NCT00459732|625542|P2|NOT COMPLETED|Overall Study||3
258703|NCT00459732|625543|P1|NOT COMPLETED|Overall Study||4
258704|NCT00459732|625542|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
258705|NCT00459732|625543|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
258706|NCT00459732|625542|P2|STARTED|Overall Study||17
258707|NCT00459732|625543|P1|STARTED|Overall Study||23
258708|NCT00459706|625555|P2|NOT COMPLETED|Overall Study||21
258709|NCT00459706|625556|P1|NOT COMPLETED|Overall Study||26
258710|NCT00459706|625555|P2|COMPLETED|Overall Study||294
258711|NCT00459706|625556|P1|COMPLETED|Overall Study||299
258712|NCT00459706|625555|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
258713|NCT00459706|625556|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
258714|NCT00459706|625555|P2|STARTED|Overall Study||315
258715|NCT00459706|625556|P1|STARTED|Overall Study||325
258716|NCT00459667|625699|P3|NOT COMPLETED|Overall Study||20
258717|NCT00459667|625700|P2|NOT COMPLETED|Overall Study||47
258718|NCT00459667|625701|P1|NOT COMPLETED|Overall Study||38
258719|NCT00459667|625699|P3|COMPLETED|Overall Study||161
258720|NCT00459667|625700|P2|COMPLETED|Overall Study||600
258721|NCT00459667|625701|P1|COMPLETED|Overall Study||554
258722|NCT00459667|625699|P3|Started Treatment|Overall Study||180
258723|NCT00459667|625700|P2|Started Treatment|Overall Study||644
258724|NCT00459667|625701|P1|Started Treatment|Overall Study||586
258725|NCT00459667|625699|P3|Study Medication Dispensed|Overall Study||180
258726|NCT00459667|625700|P2|Study Medication Dispensed|Overall Study||645
258727|NCT00459667|625701|P1|Study Medication Dispensed|Overall Study||586
258728|NCT00459667|625699|P3|STARTED|Overall Study||181
258729|NCT00459667|625700|P2|STARTED|Overall Study||647
258730|NCT00459667|625701|P1|STARTED|Overall Study||592
258731|NCT00459537|625723|P2|NOT COMPLETED|Overall Study||76
258732|NCT00459537|625724|P1|NOT COMPLETED|Overall Study||66
258733|NCT00459537|625723|P2|COMPLETED|Overall Study||446
258734|NCT00459537|625724|P1|COMPLETED|Overall Study||441
258735|NCT00459537|625723|P2|Safety Population|Overall Study||512
258736|NCT00459537|625724|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
258737|NCT00459537|625723|P2|STARTED|Overall Study||522
258738|NCT00459537|625724|P1|STARTED|Overall Study||507
258739|NCT00459381|625738|P1|NOT COMPLETED|Overall Study||0
258740|NCT00459381|625738|P1|COMPLETED|Overall Study||35
258741|NCT00459381|625738|P1|STARTED|Overall Study||35
258742|NCT00459368|625750|P2|NOT COMPLETED|Overall Study||329
258743|NCT00459368|625751|P1|NOT COMPLETED|Overall Study||295
258744|NCT00459368|625750|P2|COMPLETED|Overall Study||1034
258745|NCT00459368|625751|P1|COMPLETED|Overall Study||1040
258746|NCT00459368|625750|P2|STARTED|Overall Study||1363
258747|NCT00459368|625751|P1|STARTED|Overall Study||1335
258748|NCT00459355|625759|P2|NOT COMPLETED|Overall Study||18
258749|NCT00459355|625760|P1|NOT COMPLETED|Overall Study||20
258750|NCT00459355|625759|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
258751|NCT00459355|625760|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
258752|NCT00459355|625759|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
258753|NCT00459355|625760|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
258754|NCT00459342|625772|P1|NOT COMPLETED|Overall Study||1
258755|NCT00459342|625772|P1|COMPLETED|Overall Study||34
258756|NCT00459342|625772|P1|STARTED|Overall Study||35
258757|NCT00459316|625781|P3|NOT COMPLETED|Step 3||1
258758|NCT00459316|625782|P2|NOT COMPLETED|Step 3||0
258759|NCT00459316|625783|P1|NOT COMPLETED|Step 3||3
258760|NCT00459316|625781|P3|COMPLETED|Step 3||39
258761|NCT00459316|625782|P2|COMPLETED|Step 3||0
258762|NCT00459316|625783|P1|COMPLETED|Step 3||149
258763|NCT00459316|625781|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
258764|NCT00459316|625782|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
258765|NCT00459316|625783|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
258766|NCT00459316|625781|P3|NOT COMPLETED|Steps 1 & 2||2
258767|NCT00459316|625782|P2|NOT COMPLETED|Steps 1 & 2||7
258768|NCT00459316|625783|P1|NOT COMPLETED|Steps 1 & 2||21
258769|NCT00459316|625781|P3|COMPLETED|Steps 1 & 2||57
258770|NCT00459316|625782|P2|COMPLETED|Steps 1 & 2||32
258771|NCT00459316|625783|P1|COMPLETED|Steps 1 & 2||259
258772|NCT00459316|625781|P3|STARTED|Steps 1 & 2||59
258773|NCT00459316|625782|P2|STARTED|Steps 1 & 2||39
258774|NCT00459316|625783|P1|STARTED|Steps 1 & 2||280
258775|NCT00459303|625837|P1|NOT COMPLETED|Overall Study||0
258776|NCT00459303|625837|P1|COMPLETED|Overall Study||20
258777|NCT00459303|625837|P1|STARTED|Overall Study||20
258778|NCT00459290|625848|P1|NOT COMPLETED|Overall Study||5
258779|NCT00459290|625848|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
258780|NCT00459290|625848|P1|STARTED|Overall Study||24
258781|NCT00459186|625862|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
258782|NCT00459186|625862|P1|COMPLETED|Combination RAD001 + Docetaxel||15
258783|NCT00459186|625862|P1|STARTED|Combination RAD001 + Docetaxel||15
258784|NCT00459186|625862|P1|NOT COMPLETED|PET Imaging and Assessment||3
258785|NCT00459186|625862|P1|COMPLETED|PET Imaging and Assessment||15
258786|NCT00459186|625862|P1|STARTED|PET Imaging and Assessment||18
258787|NCT00459186|625862|P1|NOT COMPLETED|Single Agent RAD001||1
258788|NCT00459186|625862|P1|COMPLETED|Single Agent RAD001||18
258789|NCT00459186|625862|P1|STARTED|Single Agent RAD001||19
258790|NCT00459134|625869|P2|NOT COMPLETED|Overall Study||25
258791|NCT00459134|625870|P1|NOT COMPLETED|Overall Study||23
258792|NCT00459134|625869|P2|COMPLETED|Overall Study||67
258793|NCT00459134|625870|P1|COMPLETED|Overall Study||71
258794|NCT00459134|625869|P2|STARTED|Overall Study||92
258795|NCT00459134|625870|P1|STARTED|Overall Study||94
258796|NCT00459121|625878|P1|NOT COMPLETED|Overall Study||0
258797|NCT00459121|625878|P1|COMPLETED|Overall Study||2
258798|NCT00459121|625878|P1|STARTED|Overall Study||2
258799|NCT00459108|625882|P1|NOT COMPLETED|Overall Study||11
258800|NCT00459108|625882|P1|COMPLETED|Overall Study||14
258801|NCT00459108|625882|P1|STARTED|Overall Study||25
258802|NCT00459056|625892|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
258803|NCT00459056|625893|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
258804|NCT00459056|625892|P2|COMPLETED|Second Intervention (Final Three Months)||14
258805|NCT00459056|625893|P1|COMPLETED|Second Intervention (Final Three Months)||9
258806|NCT00459056|625892|P2|STARTED|Second Intervention (Final Three Months)||14
258807|NCT00459056|625893|P1|STARTED|Second Intervention (Final Three Months)||9
258808|NCT00459056|625892|P2|NOT COMPLETED|Washout (1 Month)||0
258809|NCT00459056|625893|P1|NOT COMPLETED|Washout (1 Month)||0
258810|NCT00459056|625892|P2|COMPLETED|Washout (1 Month)||14
258811|NCT00459056|625893|P1|COMPLETED|Washout (1 Month)||9
258812|NCT00459056|625892|P2|STARTED|Washout (1 Month)||14
258813|NCT00459056|625893|P1|STARTED|Washout (1 Month)||9
258814|NCT00459056|625892|P2|NOT COMPLETED|First Intervention (First Three Months)||1
258815|NCT00459056|625893|P1|NOT COMPLETED|First Intervention (First Three Months)||1
258816|NCT00459056|625892|P2|COMPLETED|First Intervention (First Three Months)||14
258817|NCT00459056|625893|P1|COMPLETED|First Intervention (First Three Months)||9
258818|NCT00459056|625892|P2|STARTED|First Intervention (First Three Months)||15
258819|NCT00459056|625893|P1|STARTED|First Intervention (First Three Months)||10
258820|NCT00459043|625901|P2|NOT COMPLETED|Overall Study||0
258821|NCT00459043|625902|P1|NOT COMPLETED|Overall Study||1
258822|NCT00459043|625901|P2|COMPLETED|Overall Study||15
258823|NCT00459043|625902|P1|COMPLETED|Overall Study||14
258824|NCT00459043|625901|P2|STARTED|Overall Study||15
258825|NCT00459043|625902|P1|STARTED|Overall Study||15
258826|NCT00458952|625914|P2|NOT COMPLETED|Overall Study||5
258827|NCT00458952|625915|P1|NOT COMPLETED|Overall Study||2
258828|NCT00458952|625914|P2|COMPLETED|Overall Study||9
258829|NCT00458952|625915|P1|COMPLETED|Overall Study||5
258830|NCT00458952|625914|P2|STARTED|Overall Study||14
258831|NCT00458952|625915|P1|STARTED|Overall Study||7
258832|NCT00458822|625919|P1|NOT COMPLETED|Overall Study||0
258833|NCT00458822|625919|P1|COMPLETED|Overall Study||40
258834|NCT00458822|625919|P1|STARTED|Overall Study||40
258835|NCT00458705|625923|P1|NOT COMPLETED|Overall Study||5
258836|NCT00458705|625923|P1|COMPLETED|Overall Study||40
258837|NCT00458705|625923|P1|STARTED|Overall Study||45
258838|NCT00458536|625927|P1|NOT COMPLETED|Overall Study||19
258839|NCT00458536|625927|P1|COMPLETED|Overall Study||19
258840|NCT00458536|625927|P1|STARTED|Overall Study||38
258841|NCT00458406|625933|P2|NOT COMPLETED|Month 3||0
258842|NCT00458406|625934|P1|NOT COMPLETED|Month 3||0
258843|NCT00458406|625933|P2|COMPLETED|Month 3||13
258844|NCT00458406|625934|P1|COMPLETED|Month 3||43
258845|NCT00458406|625933|P2|STARTED|Month 3||13
258846|NCT00458406|625934|P1|STARTED|Month 3||43
258847|NCT00458406|625933|P2|NOT COMPLETED|Month 1||0
258848|NCT00458406|625934|P1|NOT COMPLETED|Month 1||0
258849|NCT00458406|625933|P2|COMPLETED|Month 1||13
258850|NCT00458406|625934|P1|COMPLETED|Month 1||43
258851|NCT00458406|625933|P2|STARTED|Month 1||13
258852|NCT00458406|625934|P1|STARTED|Month 1||43
258853|NCT00458393|625954|P2|NOT COMPLETED|Overall Study||295
258854|NCT00458393|625955|P1|NOT COMPLETED|Overall Study||309
258855|NCT00458393|625954|P2|COMPLETED|Overall Study||953
258856|NCT00458393|625955|P1|COMPLETED|Overall Study||942
258857|NCT00458393|625954|P2|STARTED|Overall Study||1248
258858|NCT00458393|625955|P1|STARTED|Overall Study||1251
258859|NCT00458302|626003|P2|NOT COMPLETED|Overall Study||24
258860|NCT00458302|626004|P1|NOT COMPLETED|Overall Study||20
258861|NCT00458302|626003|P2|COMPLETED|Overall Study||103
258862|NCT00458302|626004|P1|COMPLETED|Overall Study||109
258863|NCT00458302|626003|P2|STARTED|Overall Study||127
258864|NCT00458302|626004|P1|STARTED|Overall Study||129
258865|NCT00458237|626038|P3|NOT COMPLETED|Overall Study||0
258866|NCT00458237|626039|P2|NOT COMPLETED|Overall Study||0
258867|NCT00458237|626040|P1|NOT COMPLETED|Overall Study||0
258868|NCT00458237|626038|P3|COMPLETED|Overall Study||5
258869|NCT00458237|626039|P2|COMPLETED|Overall Study||3
258870|NCT00458237|626040|P1|COMPLETED|Overall Study||3
258871|NCT00458237|626038|P3|STARTED|Overall Study||5
258872|NCT00458237|626039|P2|STARTED|Overall Study||3
258873|NCT00458237|626040|P1|STARTED|Overall Study||3
258874|NCT00458211|626049|P1|NOT COMPLETED|Overall Study||16
258875|NCT00458211|626049|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
258876|NCT00458211|626049|P1|STARTED|Overall Study||40
258877|NCT00457977|626062|P2|NOT COMPLETED|Overall Study||25
258878|NCT00457977|626063|P1|NOT COMPLETED|Overall Study||28
258879|NCT00457977|626062|P2|COMPLETED|Overall Study||66
258880|NCT00457977|626063|P1|COMPLETED|Overall Study||62
258881|NCT00457977|626062|P2|2-Year|Overall Study||66
258882|NCT00457977|626063|P1|2-Year|Overall Study||62
258883|NCT00457977|626062|P2|1-Year|Overall Study||76
258884|NCT00457977|626063|P1|1-Year|Overall Study||69
258885|NCT00457977|626062|P2|1-Month|Overall Study||87
258886|NCT00457977|626063|P1|1-Month|Overall Study||88
258887|NCT00457977|626062|P2|STARTED|Overall Study||91
258888|NCT00457977|626063|P1|STARTED|Overall Study||90
258889|NCT00457951|626074|P3|NOT COMPLETED|Overall Study||12
258890|NCT00457951|626075|P2|NOT COMPLETED|Overall Study||16
258891|NCT00457951|626076|P1|NOT COMPLETED|Overall Study||0
258892|NCT00457951|626074|P3|COMPLETED|Overall Study||60
258893|NCT00457951|626075|P2|COMPLETED|Overall Study||50
258894|NCT00457951|626076|P1|COMPLETED|Overall Study||13
258895|NCT00457951|626074|P3|STARTED|Overall Study||72
258896|NCT00457951|626075|P2|STARTED|Overall Study||66
258897|NCT00457951|626076|P1|STARTED|Overall Study||13
258898|NCT00457821|626091|P8|NOT COMPLETED|Part 2||1
258899|NCT00457821|626092|P7|NOT COMPLETED|Part 2||0
258900|NCT00457821|626093|P6|NOT COMPLETED|Part 2||0
258901|NCT00457821|626094|P5|NOT COMPLETED|Part 2||0
258902|NCT00457821|626095|P4|NOT COMPLETED|Part 2||0
258903|NCT00457821|626096|P3|NOT COMPLETED|Part 2||0
258904|NCT00457821|626097|P2|NOT COMPLETED|Part 2||0
258905|NCT00457821|626098|P1|NOT COMPLETED|Part 2||0
258906|NCT00457821|626091|P8|COMPLETED|Part 2||4
258907|NCT00457821|626092|P7|COMPLETED|Part 2||7
258908|NCT00457821|626093|P6|COMPLETED|Part 2||8
258909|NCT00457821|626094|P5|COMPLETED|Part 2||0
258910|NCT00457821|626095|P4|COMPLETED|Part 2||0
258911|NCT00457821|626096|P3|COMPLETED|Part 2||0
258912|NCT00457821|626097|P2|COMPLETED|Part 2||0
258913|NCT00457821|626098|P1|COMPLETED|Part 2||0
258914|NCT00457821|626091|P8|Completed Study Drug Treatment|Part 2||4
258915|NCT00457821|626092|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
258916|NCT00457821|626093|P6|Completed Study Drug Treatment|Part 2||8
258917|NCT00457821|626094|P5|Completed Study Drug Treatment|Part 2||0
258918|NCT00457821|626095|P4|Completed Study Drug Treatment|Part 2||0
258919|NCT00457821|626096|P3|Completed Study Drug Treatment|Part 2||0
258920|NCT00457821|626097|P2|Completed Study Drug Treatment|Part 2||0
258921|NCT00457821|626098|P1|Completed Study Drug Treatment|Part 2||0
258922|NCT00457821|626091|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
258923|NCT00457821|626092|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
258924|NCT00457821|626093|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
258925|NCT00457821|626094|P5|STARTED|Part 2|Arm in Part 1 only|0
258926|NCT00457821|626095|P4|STARTED|Part 2|Arm in Part 1 only|0
258927|NCT00457821|626096|P3|STARTED|Part 2|Arm in Part 1 only|0
258928|NCT00457821|626097|P2|STARTED|Part 2|Arm in Part 1 only|0
258929|NCT00457821|626098|P1|STARTED|Part 2|Arm in Part 1 only|0
258930|NCT00457821|626091|P8|NOT COMPLETED|Part 1||0
258931|NCT00457821|626092|P7|NOT COMPLETED|Part 1||0
258932|NCT00457821|626093|P6|NOT COMPLETED|Part 1||0
258933|NCT00457821|626094|P5|NOT COMPLETED|Part 1||0
258934|NCT00457821|626095|P4|NOT COMPLETED|Part 1||0
258935|NCT00457821|626096|P3|NOT COMPLETED|Part 1||1
258936|NCT00457821|626097|P2|NOT COMPLETED|Part 1||0
258937|NCT00457821|626098|P1|NOT COMPLETED|Part 1||0
258938|NCT00457821|626091|P8|COMPLETED|Part 1||0
258939|NCT00457821|626092|P7|COMPLETED|Part 1||0
258940|NCT00457821|626093|P6|COMPLETED|Part 1||0
258941|NCT00457821|626094|P5|COMPLETED|Part 1||4
258942|NCT00457821|626095|P4|COMPLETED|Part 1||4
258943|NCT00457821|626096|P3|COMPLETED|Part 1||4
258944|NCT00457821|626097|P2|COMPLETED|Part 1||4
258945|NCT00457821|626098|P1|COMPLETED|Part 1||4
258946|NCT00457821|626091|P8|STARTED|Part 1|Arm in Part 2 only|0
258947|NCT00457821|626092|P7|STARTED|Part 1|Arm in Part 2 only|0
258948|NCT00457821|626093|P6|STARTED|Part 1|Arm in Part 2 only|0
258949|NCT00457821|626094|P5|STARTED|Part 1|Number of subjects randomized|4
258950|NCT00457821|626095|P4|STARTED|Part 1|Number of subjects randomized|4
258951|NCT00457821|626096|P3|STARTED|Part 1|Number of subjects randomized|5
258952|NCT00457821|626097|P2|STARTED|Part 1|Number of subjects randomized|4
258953|NCT00457821|626098|P1|STARTED|Part 1|Number of subjects randomized|4
258954|NCT00457795|626127|P1|NOT COMPLETED|Overall Study||0
258955|NCT00457795|626127|P1|COMPLETED|Overall Study||15
258956|NCT00457795|626127|P1|STARTED|Overall Study||15
258957|NCT00457743|626137|P3|NOT COMPLETED|Overall Study||3
258958|NCT00457743|626138|P2|NOT COMPLETED|Overall Study||27
258959|NCT00457743|626139|P1|NOT COMPLETED|Overall Study||3
258960|NCT00457743|626137|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
258961|NCT00457743|626138|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
258962|NCT00457743|626139|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
258963|NCT00457743|626137|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
258964|NCT00457743|626138|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
258965|NCT00457743|626139|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
258966|NCT00457743|626137|P3|Completed Phase 1|Overall Study||3
258967|NCT00457743|626138|P2|Completed Phase 1|Overall Study||6
258968|NCT00457743|626139|P1|Completed Phase 1|Overall Study||3
258969|NCT00457743|626137|P3|Enrolled in Phase 1|Overall Study||3
258970|NCT00457743|626138|P2|Enrolled in Phase 1|Overall Study||6
258971|NCT00457743|626139|P1|Enrolled in Phase 1|Overall Study||3
258972|NCT00457743|626137|P3|STARTED|Overall Study|Overall study|3
258973|NCT00457743|626138|P2|STARTED|Overall Study|Overall study|30
258974|NCT00457743|626139|P1|STARTED|Overall Study|Overall study|3
258975|NCT00457730|626183|P2|NOT COMPLETED|Overall Study||1
258976|NCT00457730|626184|P1|NOT COMPLETED|Overall Study||4
258977|NCT00457730|626183|P2|COMPLETED|Overall Study||19
258978|NCT00457730|626184|P1|COMPLETED|Overall Study||14
258979|NCT00457730|626183|P2|STARTED|Overall Study||20
258980|NCT00457730|626184|P1|STARTED|Overall Study||18
258981|NCT00457691|626196|P2|NOT COMPLETED|Overall Study||382
258982|NCT00457691|626197|P1|NOT COMPLETED|Overall Study||386
258983|NCT00457691|626196|P2|COMPLETED|Overall Study||0
258984|NCT00457691|626197|P1|COMPLETED|Overall Study||0
258985|NCT00457691|626196|P2|STARTED|Overall Study||382
258986|NCT00457691|626197|P1|STARTED|Overall Study||386
258987|NCT00457418|626217|P1|NOT COMPLETED|Post PK Maintenance||28
258988|NCT00457418|626217|P1|COMPLETED|Post PK Maintenance||3
258989|NCT00457418|626217|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
258990|NCT00457418|626217|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
258991|NCT00457418|626217|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
258992|NCT00457418|626217|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
258993|NCT00457392|626229|P2|NOT COMPLETED|Overall Study||480
258994|NCT00457392|626230|P1|NOT COMPLETED|Overall Study||480
258995|NCT00457392|626229|P2|COMPLETED|Overall Study||0
258996|NCT00457392|626230|P1|COMPLETED|Overall Study||0
258997|NCT00457392|626229|P2|Treated|Overall Study||477
258998|NCT00457392|626230|P1|Treated|Overall Study||473
258999|NCT00457392|626229|P2|STARTED|Overall Study||480
259000|NCT00457392|626230|P1|STARTED|Overall Study||480
259001|NCT00457301|626248|P2|NOT COMPLETED|Overall Study||24
259002|NCT00457301|626249|P1|NOT COMPLETED|Overall Study||23
259003|NCT00457301|626248|P2|COMPLETED|Overall Study||84
259004|NCT00457301|626249|P1|COMPLETED|Overall Study||82
259005|NCT00457301|626248|P2|STARTED|Overall Study||108
259006|NCT00457301|626249|P1|STARTED|Overall Study||105
259007|NCT00457249|626263|P2|NOT COMPLETED|Overall Study||2
259008|NCT00457249|626264|P1|NOT COMPLETED|Overall Study||12
259009|NCT00457249|626263|P2|COMPLETED|Overall Study||389
259010|NCT00457249|626264|P1|COMPLETED|Overall Study||1158
259011|NCT00457249|626263|P2|STARTED|Overall Study||391
259012|NCT00457249|626264|P1|STARTED|Overall Study||1170
259013|NCT00457197|626278|P2|NOT COMPLETED|Overall Study||1
259014|NCT00457197|626279|P1|NOT COMPLETED|Overall Study||1
259015|NCT00457197|626278|P2|COMPLETED|Overall Study||44
259016|NCT00457197|626279|P1|COMPLETED|Overall Study||44
259017|NCT00457197|626278|P2|STARTED|Overall Study||45
259018|NCT00457197|626279|P1|STARTED|Overall Study||45
259019|NCT00457015|626303|P2|NOT COMPLETED|Overall Study||1
259020|NCT00457015|626304|P1|NOT COMPLETED|Overall Study||0
259021|NCT00457015|626303|P2|COMPLETED|Overall Study||47
259022|NCT00457015|626304|P1|COMPLETED|Overall Study||48
259023|NCT00457015|626303|P2|STARTED|Overall Study||48
259024|NCT00457015|626304|P1|STARTED|Overall Study||48
259025|NCT00457002|626320|P2|NOT COMPLETED|Overall Study||757
259026|NCT00457002|626321|P1|NOT COMPLETED|Overall Study||813
259027|NCT00457002|626320|P2|COMPLETED|Overall Study||2516
259028|NCT00457002|626321|P1|COMPLETED|Overall Study||2442
259029|NCT00457002|626320|P2|STARTED|Overall Study||3273
259030|NCT00457002|626321|P1|STARTED|Overall Study||3255
259031|NCT00456989|626389|P1|NOT COMPLETED|Overall Study||0
259032|NCT00456989|626389|P1|COMPLETED|Overall Study||39
259033|NCT00456989|626389|P1|STARTED|Overall Study||39
259034|NCT00456885|626393|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
259035|NCT00456885|626394|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
259036|NCT00456885|626393|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
259037|NCT00456885|626394|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
259038|NCT00456885|626393|P2|STARTED|Second Treatment Period, 16 Weeks||17
259039|NCT00456885|626394|P1|STARTED|Second Treatment Period, 16 Weeks||24
259040|NCT00456885|626393|P2|NOT COMPLETED|Washout, 3 Weeks||0
259041|NCT00456885|626394|P1|NOT COMPLETED|Washout, 3 Weeks||0
259042|NCT00456885|626393|P2|COMPLETED|Washout, 3 Weeks||17
259043|NCT00456885|626394|P1|COMPLETED|Washout, 3 Weeks||24
259044|NCT00456885|626393|P2|STARTED|Washout, 3 Weeks||17
259045|NCT00456885|626394|P1|STARTED|Washout, 3 Weeks||24
259046|NCT00456885|626393|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
259047|NCT00456885|626394|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
259048|NCT00456885|626393|P2|COMPLETED|First Treatment Period, 16 Weeks||17
259049|NCT00456885|626394|P1|COMPLETED|First Treatment Period, 16 Weeks||24
259050|NCT00456885|626393|P2|STARTED|First Treatment Period, 16 Weeks||17
259051|NCT00456885|626394|P1|STARTED|First Treatment Period, 16 Weeks||24
259052|NCT00456846|626425|P2|NOT COMPLETED|Overall Study||28
259053|NCT00456846|626426|P1|NOT COMPLETED|Overall Study||16
259054|NCT00456846|626425|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
259055|NCT00456846|626426|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
259056|NCT00456846|626425|P2|STARTED|Overall Study||76
259057|NCT00456846|626426|P1|STARTED|Overall Study||47
259058|NCT00456807|626448|P2|NOT COMPLETED|Overall Study||0
259059|NCT00456807|626449|P1|NOT COMPLETED|Overall Study||1
259060|NCT00456807|626448|P2|COMPLETED|Overall Study||47
259061|NCT00456807|626449|P1|COMPLETED|Overall Study||52
259062|NCT00456807|626448|P2|STARTED|Overall Study||47
259063|NCT00456807|626449|P1|STARTED|Overall Study||53
259064|NCT00456755|626467|P2|NOT COMPLETED|Overall Study||1
259065|NCT00456755|626468|P1|NOT COMPLETED|Overall Study||2
259066|NCT00456755|626467|P2|COMPLETED|Overall Study||62
259067|NCT00456755|626468|P1|COMPLETED|Overall Study||61
259068|NCT00456755|626467|P2|STARTED|Overall Study||63
259069|NCT00456755|626468|P1|STARTED|Overall Study||63
259070|NCT00456625|626476|P1|NOT COMPLETED|Overall Study||0
259071|NCT00456625|626476|P1|COMPLETED|Overall Study||76
259072|NCT00456625|626476|P1|STARTED|Overall Study||76
259073|NCT00456612|626482|P1|NOT COMPLETED|Overall Study||3
259074|NCT00456612|626482|P1|COMPLETED|Overall Study||1
259075|NCT00456612|626482|P1|STARTED|Overall Study||4
259076|NCT00456599|626487|P1|NOT COMPLETED|Overall Study||3
259077|NCT00456599|626487|P1|COMPLETED|Overall Study||68
259078|NCT00456599|626487|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
259079|NCT00456599|626487|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
259080|NCT00456599|626487|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
259081|NCT00456599|626487|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
259082|NCT00456599|626487|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
259083|NCT00456599|626487|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
259084|NCT00456599|626487|P1|STARTED|Overall Study||71
259085|NCT00456547|626495|P2|NOT COMPLETED|Overall Study||0
259086|NCT00456547|626496|P1|NOT COMPLETED|Overall Study||0
259087|NCT00456547|626495|P2|COMPLETED|Overall Study||12
259088|NCT00456547|626496|P1|COMPLETED|Overall Study||12
259089|NCT00456547|626495|P2|STARTED|Overall Study||12
259090|NCT00456547|626496|P1|STARTED|Overall Study||12
259091|NCT00456521|626510|P2|NOT COMPLETED|Overall Study||84
259092|NCT00456521|626511|P1|NOT COMPLETED|Overall Study||249
259093|NCT00456521|626510|P2|COMPLETED|Overall Study||118
259094|NCT00456521|626511|P1|COMPLETED|Overall Study||342
259095|NCT00456521|626510|P2|STARTED|Overall Study||202
259096|NCT00456521|626511|P1|STARTED|Overall Study||591
259097|NCT00456508|626551|P1|NOT COMPLETED|Overall Study||0
259098|NCT00456508|626551|P1|COMPLETED|Overall Study||147
259099|NCT00456508|626551|P1|STARTED|Overall Study||147
259100|NCT00456495|626557|P1|NOT COMPLETED|Overall Study||2
259101|NCT00456495|626557|P1|COMPLETED|Overall Study||3
259102|NCT00456495|626557|P1|STARTED|Overall Study||5
259103|NCT00456365|626564|P2|NOT COMPLETED|Overall Study||12
259104|NCT00456365|626565|P1|NOT COMPLETED|Overall Study||7
259105|NCT00456365|626564|P2|COMPLETED|Overall Study||42
259106|NCT00456365|626565|P1|COMPLETED|Overall Study||49
259107|NCT00456365|626564|P2|STARTED|Overall Study||54
259108|NCT00456365|626565|P1|STARTED|Overall Study||56
259109|NCT00456261|626579|P2|NOT COMPLETED|Maintenance Therapy||0
259110|NCT00456261|626580|P1|NOT COMPLETED|Maintenance Therapy||0
259111|NCT00456261|626579|P2|COMPLETED|Maintenance Therapy||29
259112|NCT00456261|626580|P1|COMPLETED|Maintenance Therapy||3
259113|NCT00456261|626579|P2|STARTED|Maintenance Therapy||29
259114|NCT00456261|626580|P1|STARTED|Maintenance Therapy||3
259115|NCT00456261|626579|P2|NOT COMPLETED|Combination Therapy||26
259116|NCT00456261|626580|P1|NOT COMPLETED|Combination Therapy||52
259117|NCT00456261|626579|P2|COMPLETED|Combination Therapy||29
259118|NCT00456261|626580|P1|COMPLETED|Combination Therapy||3
259119|NCT00456261|626579|P2|STARTED|Combination Therapy||55
259120|NCT00456261|626580|P1|STARTED|Combination Therapy||55
259121|NCT00456014|626590|P1|NOT COMPLETED|Tricyclic Phase||3
259122|NCT00456014|626590|P1|COMPLETED|Tricyclic Phase||1
259123|NCT00456014|626590|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
259124|NCT00456014|626590|P1|NOT COMPLETED|SSRI Phase||9
259125|NCT00456014|626590|P1|COMPLETED|SSRI Phase||28
259126|NCT00456014|626590|P1|STARTED|SSRI Phase||37
259127|NCT00455975|626598|P2|NOT COMPLETED|Overall Study||21
259128|NCT00455975|626599|P1|NOT COMPLETED|Overall Study||18
259129|NCT00455975|626598|P2|COMPLETED|Overall Study||40
259130|NCT00455975|626599|P1|COMPLETED|Overall Study||40
259131|NCT00455975|626598|P2|STARTED|Overall Study||61
259132|NCT00455975|626599|P1|STARTED|Overall Study||58
259133|NCT00455962|626613|P2|NOT COMPLETED|Overall Study||0
259134|NCT00455962|626614|P1|NOT COMPLETED|Overall Study||0
259135|NCT00455962|626613|P2|COMPLETED|Overall Study||13
259136|NCT00455962|626614|P1|COMPLETED|Overall Study||10
259137|NCT00455962|626613|P2|STARTED|Overall Study||13
259138|NCT00455962|626614|P1|STARTED|Overall Study||10
259139|NCT00455923|626622|P2|NOT COMPLETED|Overall Study||3
259140|NCT00455923|626623|P1|NOT COMPLETED|Overall Study||3
259141|NCT00455923|626622|P2|COMPLETED|Overall Study||47
259142|NCT00455923|626623|P1|COMPLETED|Overall Study||47
259143|NCT00455923|626622|P2|STARTED|Overall Study||50
259144|NCT00455923|626623|P1|STARTED|Overall Study||50
259145|NCT00455858|626639|P1|NOT COMPLETED|Overall Study||6
259146|NCT00455858|626639|P1|COMPLETED|Overall Study||81
259147|NCT00455858|626639|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
259148|NCT00455741|626649|P2|NOT COMPLETED|Overall Study||1
259149|NCT00455741|626650|P1|NOT COMPLETED|Overall Study||0
259150|NCT00455741|626649|P2|COMPLETED|Overall Study||11
259151|NCT00455741|626650|P1|COMPLETED|Overall Study||13
259152|NCT00455741|626649|P2|STARTED|Overall Study||12
259153|NCT00455741|626650|P1|STARTED|Overall Study||13
259154|NCT00455702|626668|P2|NOT COMPLETED|Overall Study||3
259155|NCT00455702|626669|P1|NOT COMPLETED|Overall Study||3
259156|NCT00455702|626668|P2|COMPLETED|Overall Study||16
259157|NCT00455702|626669|P1|COMPLETED|Overall Study||16
259158|NCT00455702|626668|P2|STARTED|Overall Study||19
259159|NCT00455702|626669|P1|STARTED|Overall Study||19
259160|NCT00455663|626680|P3|NOT COMPLETED|Overall Study||3
259161|NCT00455663|626681|P2|NOT COMPLETED|Overall Study||4
259162|NCT00455663|626682|P1|NOT COMPLETED|Overall Study||3
259163|NCT00455663|626680|P3|COMPLETED|Overall Study||29
259164|NCT00455663|626681|P2|COMPLETED|Overall Study||32
259165|NCT00455663|626682|P1|COMPLETED|Overall Study||34
259166|NCT00455663|626680|P3|STARTED|Overall Study||32
259167|NCT00455663|626681|P2|STARTED|Overall Study||36
259168|NCT00455663|626682|P1|STARTED|Overall Study||37
259169|NCT00455650|626701|P6|NOT COMPLETED|Week 3||0
259170|NCT00455650|626702|P5|NOT COMPLETED|Week 3||0
259171|NCT00455650|626703|P4|NOT COMPLETED|Week 3||0
259172|NCT00455650|626704|P3|NOT COMPLETED|Week 3||0
259173|NCT00455650|626705|P2|NOT COMPLETED|Week 3||0
259174|NCT00455650|626706|P1|NOT COMPLETED|Week 3||0
259175|NCT00455650|626701|P6|COMPLETED|Week 3||13
259176|NCT00455650|626702|P5|COMPLETED|Week 3||14
259177|NCT00455650|626703|P4|COMPLETED|Week 3||14
259178|NCT00455650|626704|P3|COMPLETED|Week 3||10
259179|NCT00455650|626705|P2|COMPLETED|Week 3||10
259180|NCT00455650|626706|P1|COMPLETED|Week 3||10
259181|NCT00455650|626701|P6|STARTED|Week 3||13
259182|NCT00455650|626702|P5|STARTED|Week 3||14
259183|NCT00455650|626703|P4|STARTED|Week 3||14
259184|NCT00455650|626704|P3|STARTED|Week 3||10
259185|NCT00455650|626705|P2|STARTED|Week 3||10
259186|NCT00455650|626706|P1|STARTED|Week 3||10
259187|NCT00455650|626701|P6|NOT COMPLETED|Week 2||0
259188|NCT00455650|626702|P5|NOT COMPLETED|Week 2||0
259189|NCT00455650|626703|P4|NOT COMPLETED|Week 2||0
259190|NCT00455650|626704|P3|NOT COMPLETED|Week 2||0
259191|NCT00455650|626705|P2|NOT COMPLETED|Week 2||0
259192|NCT00455650|626706|P1|NOT COMPLETED|Week 2||0
259193|NCT00455650|626701|P6|COMPLETED|Week 2||13
259194|NCT00455650|626702|P5|COMPLETED|Week 2||14
259195|NCT00455650|626703|P4|COMPLETED|Week 2||14
259196|NCT00455650|626704|P3|COMPLETED|Week 2||10
259197|NCT00455650|626705|P2|COMPLETED|Week 2||10
259198|NCT00455650|626706|P1|COMPLETED|Week 2||10
259199|NCT00455650|626701|P6|STARTED|Week 2||13
259200|NCT00455650|626702|P5|STARTED|Week 2||14
259201|NCT00455650|626703|P4|STARTED|Week 2||14
259202|NCT00455650|626704|P3|STARTED|Week 2||10
259203|NCT00455650|626705|P2|STARTED|Week 2||10
259204|NCT00455650|626706|P1|STARTED|Week 2||10
259205|NCT00455650|626701|P6|NOT COMPLETED|Week 1||0
259206|NCT00455650|626702|P5|NOT COMPLETED|Week 1||0
259207|NCT00455650|626703|P4|NOT COMPLETED|Week 1||0
259208|NCT00455650|626704|P3|NOT COMPLETED|Week 1||0
259209|NCT00455650|626705|P2|NOT COMPLETED|Week 1||0
259210|NCT00455650|626706|P1|NOT COMPLETED|Week 1||0
259211|NCT00455650|626701|P6|COMPLETED|Week 1||13
259212|NCT00455650|626702|P5|COMPLETED|Week 1||14
259213|NCT00455650|626703|P4|COMPLETED|Week 1||14
259214|NCT00455650|626704|P3|COMPLETED|Week 1||10
259215|NCT00455650|626705|P2|COMPLETED|Week 1||10
259216|NCT00455650|626706|P1|COMPLETED|Week 1||10
259217|NCT00455650|626701|P6|STARTED|Week 1||13
259218|NCT00455650|626702|P5|STARTED|Week 1||14
259219|NCT00455650|626703|P4|STARTED|Week 1||14
259220|NCT00455650|626704|P3|STARTED|Week 1||10
259221|NCT00455650|626705|P2|STARTED|Week 1||10
259222|NCT00455650|626706|P1|STARTED|Week 1||10
259223|NCT00455533|626736|P3|NOT COMPLETED|Period Two: Randomized Period||6
259224|NCT00455533|626737|P2|NOT COMPLETED|Period Two: Randomized Period||6
259225|NCT00455533|626738|P1|NOT COMPLETED|Period Two: Randomized Period||0
259226|NCT00455533|626736|P3|COMPLETED|Period Two: Randomized Period||138
259227|NCT00455533|626737|P2|COMPLETED|Period Two: Randomized Period||139
259228|NCT00455533|626738|P1|COMPLETED|Period Two: Randomized Period||0
259229|NCT00455533|626736|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
259230|NCT00455533|626737|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
259231|NCT00455533|626738|P1|STARTED|Period Two: Randomized Period||0
259232|NCT00455533|626736|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
259233|NCT00455533|626737|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
259234|NCT00455533|626738|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
259235|NCT00455533|626736|P3|COMPLETED|Period One: Initial Chemotherapy||0
259236|NCT00455533|626737|P2|COMPLETED|Period One: Initial Chemotherapy||0
259237|NCT00455533|626738|P1|COMPLETED|Period One: Initial Chemotherapy||295
259238|NCT00455533|626736|P3|STARTED|Period One: Initial Chemotherapy||0
259239|NCT00455533|626737|P2|STARTED|Period One: Initial Chemotherapy||0
259240|NCT00455533|626738|P1|STARTED|Period One: Initial Chemotherapy||313
259241|NCT00455520|626787|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
259242|NCT00455520|626788|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
259243|NCT00455520|626787|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
259244|NCT00455520|626788|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
259245|NCT00455520|626787|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
259246|NCT00455520|626788|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
259247|NCT00455520|626787|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
259248|NCT00455520|626788|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
259249|NCT00455520|626787|P2|COMPLETED|Open Label Tapentadol Extended Release||0
259250|NCT00455520|626788|P1|COMPLETED|Open Label Tapentadol Extended Release||395
259251|NCT00455520|626787|P2|STARTED|Open Label Tapentadol Extended Release||0
259252|NCT00455520|626788|P1|STARTED|Open Label Tapentadol Extended Release||591
259253|NCT00455455|626804|P2|NOT COMPLETED|Second Intervention||0
259254|NCT00455455|626805|P1|NOT COMPLETED|Second Intervention||0
259255|NCT00455455|626804|P2|COMPLETED|Second Intervention||24
259256|NCT00455455|626805|P1|COMPLETED|Second Intervention||24
259257|NCT00455455|626804|P2|STARTED|Second Intervention||24
259258|NCT00455455|626805|P1|STARTED|Second Intervention||24
259259|NCT00455455|626804|P2|NOT COMPLETED|Washout||0
259260|NCT00455455|626805|P1|NOT COMPLETED|Washout||1
259261|NCT00455455|626804|P2|COMPLETED|Washout||24
259262|NCT00455455|626805|P1|COMPLETED|Washout||24
259263|NCT00455455|626804|P2|STARTED|Washout||24
259264|NCT00455455|626805|P1|STARTED|Washout||25
259265|NCT00455455|626804|P2|NOT COMPLETED|First Intervention||0
259266|NCT00455455|626805|P1|NOT COMPLETED|First Intervention||0
259267|NCT00455455|626804|P2|COMPLETED|First Intervention||24
259268|NCT00455455|626805|P1|COMPLETED|First Intervention||25
259269|NCT00455455|626804|P2|STARTED|First Intervention||24
259270|NCT00455455|626805|P1|STARTED|First Intervention||25
259271|NCT00455455|626804|P2|NOT COMPLETED|Washout||1
259272|NCT00455455|626805|P1|NOT COMPLETED|Washout||0
259273|NCT00455455|626804|P2|COMPLETED|Washout||24
259274|NCT00455455|626805|P1|COMPLETED|Washout||25
259275|NCT00455455|626804|P2|STARTED|Washout||25
259276|NCT00455455|626805|P1|STARTED|Washout||25
259277|NCT00455429|626825|P4|NOT COMPLETED|Overall Study||14
259278|NCT00455429|626826|P3|NOT COMPLETED|Overall Study||1
259279|NCT00455429|626827|P2|NOT COMPLETED|Overall Study||5
259280|NCT00455429|626828|P1|NOT COMPLETED|Overall Study||2
259281|NCT00455429|626825|P4|COMPLETED|Overall Study||20
259282|NCT00455429|626826|P3|COMPLETED|Overall Study||16
259283|NCT00455429|626827|P2|COMPLETED|Overall Study||10
259284|NCT00455429|626828|P1|COMPLETED|Overall Study||16
259285|NCT00455429|626825|P4|Treated|Overall Study||32
259286|NCT00455429|626826|P3|Treated|Overall Study||17
259287|NCT00455429|626827|P2|Treated|Overall Study||15
259288|NCT00455429|626828|P1|Treated|Overall Study||18
259289|NCT00455429|626825|P4|STARTED|Overall Study||34
259290|NCT00455429|626826|P3|STARTED|Overall Study||17
259291|NCT00455429|626827|P2|STARTED|Overall Study||15
259292|NCT00455429|626828|P1|STARTED|Overall Study||18
259293|NCT00455312|626887|P2|NOT COMPLETED|Overall Study||1
259294|NCT00455312|626888|P1|NOT COMPLETED|Overall Study||0
259295|NCT00455312|626887|P2|COMPLETED|Overall Study||20
259296|NCT00455312|626888|P1|COMPLETED|Overall Study||15
259297|NCT00455312|626887|P2|STARTED|Overall Study||21
259298|NCT00455312|626888|P1|STARTED|Overall Study||15
259299|NCT00455195|626914|P2|NOT COMPLETED|Extension Study AGLU03206||0
259300|NCT00455195|626915|P1|NOT COMPLETED|Extension Study AGLU03206||0
259301|NCT00455195|626914|P2|COMPLETED|Extension Study AGLU03206||26
259302|NCT00455195|626915|P1|COMPLETED|Extension Study AGLU03206||55
259303|NCT00455195|626914|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
259304|NCT00455195|626915|P1|STARTED|Extension Study AGLU03206||55
259305|NCT00455195|626914|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
259306|NCT00455195|626915|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
259307|NCT00455195|626914|P2|COMPLETED|Double-blind Study AGLU02704||26
259308|NCT00455195|626915|P1|COMPLETED|Double-blind Study AGLU02704||55
259309|NCT00455195|626914|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
259310|NCT00455195|626915|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
259311|NCT00455013|626932|P3|NOT COMPLETED|Long Term Extension (LTE)||7
259312|NCT00455013|626933|P2|NOT COMPLETED|Long Term Extension (LTE)||3
259313|NCT00455013|626934|P1|NOT COMPLETED|Long Term Extension (LTE)||2
259314|NCT00455013|626932|P3|COMPLETED|Long Term Extension (LTE)||20
259315|NCT00455013|626933|P2|COMPLETED|Long Term Extension (LTE)||16
259316|NCT00455013|626934|P1|COMPLETED|Long Term Extension (LTE)||25
259317|NCT00455013|626932|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
259318|NCT00455013|626933|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
259319|NCT00455013|626934|P1|STARTED|Long Term Extension (LTE)||27
259320|NCT00455013|626932|P3|NOT COMPLETED|Short Term Period||2
259321|NCT00455013|626933|P2|NOT COMPLETED|Short Term Period||5
259322|NCT00455013|626934|P1|NOT COMPLETED|Short Term Period||6
259323|NCT00455013|626932|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
259324|NCT00455013|626933|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
259412|NCT00454805|627227|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
259325|NCT00455013|626934|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
259326|NCT00455013|626932|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
259327|NCT00455013|626933|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
259328|NCT00455013|626934|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
259329|NCT00454987|627002|P3|NOT COMPLETED|Year 4||0
259330|NCT00454987|627003|P2|NOT COMPLETED|Year 4||0
259331|NCT00454987|627004|P1|NOT COMPLETED|Year 4||0
259332|NCT00454987|627002|P3|COMPLETED|Year 4||0
259333|NCT00454987|627003|P2|COMPLETED|Year 4||62
259334|NCT00454987|627004|P1|COMPLETED|Year 4||206
259335|NCT00454987|627002|P3|STARTED|Year 4||0
259336|NCT00454987|627003|P2|STARTED|Year 4||62
259337|NCT00454987|627004|P1|STARTED|Year 4||206
259338|NCT00454987|627002|P3|NOT COMPLETED|Year 2||0
259339|NCT00454987|627003|P2|NOT COMPLETED|Year 2||0
259340|NCT00454987|627004|P1|NOT COMPLETED|Year 2||0
259341|NCT00454987|627002|P3|COMPLETED|Year 2||74
259342|NCT00454987|627003|P2|COMPLETED|Year 2||77
259343|NCT00454987|627004|P1|COMPLETED|Year 2||235
259344|NCT00454987|627002|P3|STARTED|Year 2||74
259345|NCT00454987|627003|P2|STARTED|Year 2||77
259346|NCT00454987|627004|P1|STARTED|Year 2||235
259347|NCT00454987|627002|P3|NOT COMPLETED|Year 1||0
259348|NCT00454987|627003|P2|NOT COMPLETED|Year 1||0
259349|NCT00454987|627004|P1|NOT COMPLETED|Year 1||0
259350|NCT00454987|627002|P3|COMPLETED|Year 1||0
259351|NCT00454987|627003|P2|COMPLETED|Year 1||67
259352|NCT00454987|627004|P1|COMPLETED|Year 1||221
259353|NCT00454987|627002|P3|STARTED|Year 1||0
259354|NCT00454987|627003|P2|STARTED|Year 1||67
259355|NCT00454987|627004|P1|STARTED|Year 1||221
259356|NCT00454987|627002|P3|NOT COMPLETED|Booster Period||0
259357|NCT00454987|627003|P2|NOT COMPLETED|Booster Period||1
259358|NCT00454987|627004|P1|NOT COMPLETED|Booster Period||2
259359|NCT00454987|627002|P3|COMPLETED|Booster Period||0
259360|NCT00454987|627003|P2|COMPLETED|Booster Period||116
259361|NCT00454987|627004|P1|COMPLETED|Booster Period||357
259362|NCT00454987|627002|P3|STARTED|Booster Period||0
259363|NCT00454987|627003|P2|STARTED|Booster Period||117
259364|NCT00454987|627004|P1|STARTED|Booster Period||359
259365|NCT00454909|627078|P3|NOT COMPLETED|Overall Study||2
259366|NCT00454909|627079|P2|NOT COMPLETED|Overall Study||3
259367|NCT00454909|627080|P1|NOT COMPLETED|Overall Study||7
259368|NCT00454909|627078|P3|COMPLETED|Overall Study||86
259369|NCT00454909|627079|P2|COMPLETED|Overall Study||194
259370|NCT00454909|627080|P1|COMPLETED|Overall Study||580
259371|NCT00454909|627078|P3|STARTED|Overall Study||88
259372|NCT00454909|627079|P2|STARTED|Overall Study||197
259373|NCT00454909|627080|P1|STARTED|Overall Study||587
259374|NCT00454857|627118|P1|NOT COMPLETED|Overall Study||54
259375|NCT00454857|627118|P1|COMPLETED|Overall Study||272
259376|NCT00454857|627118|P1|Completed ≥1 Observational Study Visit|Overall Study||319
259377|NCT00454857|627118|P1|Completed Retrospective Chart Review|Overall Study||324
259378|NCT00454857|627118|P1|STARTED|Overall Study||326
259379|NCT00454818|627143|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
259380|NCT00454818|627144|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
259381|NCT00454818|627145|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
259382|NCT00454818|627146|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
259383|NCT00454818|627147|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
259384|NCT00454818|627143|P5|COMPLETED|Phase 2: Randomized Double-blind||10
259385|NCT00454818|627144|P4|COMPLETED|Phase 2: Randomized Double-blind||8
259386|NCT00454818|627145|P3|COMPLETED|Phase 2: Randomized Double-blind||5
259387|NCT00454818|627146|P2|COMPLETED|Phase 2: Randomized Double-blind||6
259388|NCT00454818|627147|P1|COMPLETED|Phase 2: Randomized Double-blind||0
259389|NCT00454818|627143|P5|STARTED|Phase 2: Randomized Double-blind||14
259390|NCT00454818|627144|P4|STARTED|Phase 2: Randomized Double-blind||9
259391|NCT00454818|627145|P3|STARTED|Phase 2: Randomized Double-blind||8
259392|NCT00454818|627146|P2|STARTED|Phase 2: Randomized Double-blind||8
259393|NCT00454818|627147|P1|STARTED|Phase 2: Randomized Double-blind||0
259394|NCT00454818|627143|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
259395|NCT00454818|627144|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
259396|NCT00454818|627145|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
259397|NCT00454818|627146|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
259398|NCT00454818|627147|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
259399|NCT00454818|627143|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
259400|NCT00454818|627144|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
259401|NCT00454818|627145|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
259402|NCT00454818|627146|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
259403|NCT00454818|627147|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
259404|NCT00454818|627143|P5|STARTED|Phase I: Open-label Dose-escalation||0
259405|NCT00454818|627144|P4|STARTED|Phase I: Open-label Dose-escalation||3
259406|NCT00454818|627145|P3|STARTED|Phase I: Open-label Dose-escalation||3
259407|NCT00454818|627146|P2|STARTED|Phase I: Open-label Dose-escalation||3
259408|NCT00454818|627147|P1|STARTED|Phase I: Open-label Dose-escalation||3
259409|NCT00454805|627226|P2|NOT COMPLETED|Overall Study||23
259410|NCT00454805|627227|P1|NOT COMPLETED|Overall Study||26
259411|NCT00454805|627226|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
259413|NCT00454805|627226|P2|STARTED|Overall Study|Randomised|31
259414|NCT00454805|627227|P1|STARTED|Overall Study|Randomised|31
259415|NCT00454779|627243|P2|NOT COMPLETED|Second-line Treatment Phase||3
259416|NCT00454779|627244|P1|NOT COMPLETED|Second-line Treatment Phase||0
259417|NCT00454779|627243|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
259418|NCT00454779|627244|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
259419|NCT00454779|627243|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
259420|NCT00454779|627244|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
259421|NCT00454779|627243|P2|NOT COMPLETED|First-line Treatment Phase||8
259422|NCT00454779|627244|P1|NOT COMPLETED|First-line Treatment Phase||5
259423|NCT00454779|627243|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
259424|NCT00454779|627244|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
259425|NCT00454779|627243|P2|Received Study Medication|First-line Treatment Phase||55
259426|NCT00454779|627244|P1|Received Study Medication|First-line Treatment Phase||56
259427|NCT00454779|627243|P2|STARTED|First-line Treatment Phase||57
259428|NCT00454779|627244|P1|STARTED|First-line Treatment Phase||56
259429|NCT00454649|627282|P10|NOT COMPLETED|Overall Study||5
259430|NCT00454649|627283|P9|NOT COMPLETED|Overall Study||20
259431|NCT00454649|627284|P8|NOT COMPLETED|Overall Study||19
259432|NCT00454649|627285|P7|NOT COMPLETED|Overall Study||9
259433|NCT00454649|627286|P6|NOT COMPLETED|Overall Study||7
259434|NCT00454649|627287|P5|NOT COMPLETED|Overall Study||1
259435|NCT00454649|627288|P4|NOT COMPLETED|Overall Study||6
259436|NCT00454649|627289|P3|NOT COMPLETED|Overall Study||19
259437|NCT00454649|627290|P2|NOT COMPLETED|Overall Study||4
259438|NCT00454649|627291|P1|NOT COMPLETED|Overall Study||3
259439|NCT00454649|627282|P10|COMPLETED|Overall Study||1
259440|NCT00454649|627283|P9|COMPLETED|Overall Study||1
259441|NCT00454649|627284|P8|COMPLETED|Overall Study||0
259442|NCT00454649|627285|P7|COMPLETED|Overall Study||0
259443|NCT00454649|627286|P6|COMPLETED|Overall Study||0
259444|NCT00454649|627287|P5|COMPLETED|Overall Study||0
259445|NCT00454649|627288|P4|COMPLETED|Overall Study||1
259446|NCT00454649|627289|P3|COMPLETED|Overall Study||1
259447|NCT00454649|627290|P2|COMPLETED|Overall Study||1
259448|NCT00454649|627291|P1|COMPLETED|Overall Study||0
259449|NCT00454649|627282|P10|STARTED|Overall Study||6
259450|NCT00454649|627283|P9|STARTED|Overall Study||21
259451|NCT00454649|627284|P8|STARTED|Overall Study||19
259452|NCT00454649|627285|P7|STARTED|Overall Study||9
259453|NCT00454649|627286|P6|STARTED|Overall Study||7
259454|NCT00454649|627287|P5|STARTED|Overall Study||1
259455|NCT00454649|627288|P4|STARTED|Overall Study||7
259456|NCT00454649|627289|P3|STARTED|Overall Study||20
259457|NCT00454649|627290|P2|STARTED|Overall Study||5
259458|NCT00454649|627291|P1|STARTED|Overall Study||3
259459|NCT00454636|627420|P4|NOT COMPLETED|Overall Study||32
259460|NCT00454636|627421|P3|NOT COMPLETED|Overall Study||20
259461|NCT00454636|627422|P2|NOT COMPLETED|Overall Study||23
259462|NCT00454636|627423|P1|NOT COMPLETED|Overall Study||31
259463|NCT00454636|627420|P4|COMPLETED|Overall Study||26
259464|NCT00454636|627421|P3|COMPLETED|Overall Study||7
259465|NCT00454636|627422|P2|COMPLETED|Overall Study||9
259466|NCT00454636|627423|P1|COMPLETED|Overall Study||10
259467|NCT00454636|627420|P4|STARTED|Overall Study||58
259468|NCT00454636|627421|P3|STARTED|Overall Study||27
259469|NCT00454636|627422|P2|STARTED|Overall Study||32
259470|NCT00454636|627423|P1|STARTED|Overall Study||41
259471|NCT00454584|627456|P6|NOT COMPLETED|After Controlled Period||32
259472|NCT00454584|627457|P5|NOT COMPLETED|After Controlled Period||12
259473|NCT00454584|627458|P4|NOT COMPLETED|After Controlled Period||26
259474|NCT00454584|627459|P3|NOT COMPLETED|After Controlled Period||0
259475|NCT00454584|627460|P2|NOT COMPLETED|After Controlled Period||0
259476|NCT00454584|627461|P1|NOT COMPLETED|After Controlled Period||0
259477|NCT00454584|627456|P6|COMPLETED|After Controlled Period||310
259478|NCT00454584|627457|P5|COMPLETED|After Controlled Period||189
259479|NCT00454584|627458|P4|COMPLETED|After Controlled Period||310
259480|NCT00454584|627459|P3|COMPLETED|After Controlled Period||0
259481|NCT00454584|627460|P2|COMPLETED|After Controlled Period||0
259482|NCT00454584|627461|P1|COMPLETED|After Controlled Period||0
259483|NCT00454584|627456|P6|STARTED|After Controlled Period||342
259484|NCT00454584|627457|P5|STARTED|After Controlled Period||201
259485|NCT00454584|627458|P4|STARTED|After Controlled Period||336
259486|NCT00454584|627459|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
259487|NCT00454584|627460|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
259488|NCT00454584|627461|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
259489|NCT00454584|627456|P6|NOT COMPLETED|Controlled Period||0
259490|NCT00454584|627457|P5|NOT COMPLETED|Controlled Period||0
259491|NCT00454584|627458|P4|NOT COMPLETED|Controlled Period||0
259492|NCT00454584|627459|P3|NOT COMPLETED|Controlled Period||5
259493|NCT00454584|627460|P2|NOT COMPLETED|Controlled Period||8
259494|NCT00454584|627461|P1|NOT COMPLETED|Controlled Period||11
259495|NCT00454584|627456|P6|COMPLETED|Controlled Period||0
259496|NCT00454584|627457|P5|COMPLETED|Controlled Period||0
259497|NCT00454584|627458|P4|COMPLETED|Controlled Period||0
259498|NCT00454584|627459|P3|COMPLETED|Controlled Period||342
259499|NCT00454584|627460|P2|COMPLETED|Controlled Period||201
259500|NCT00454584|627461|P1|COMPLETED|Controlled Period||336
259501|NCT00454584|627456|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
259502|NCT00454584|627457|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
259503|NCT00454584|627458|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
259504|NCT00454584|627459|P3|STARTED|Controlled Period||347
259505|NCT00454584|627460|P2|STARTED|Controlled Period||209
259506|NCT00454584|627461|P1|STARTED|Controlled Period||347
259507|NCT00454571|627483|P2|NOT COMPLETED|Overall Study||6
259508|NCT00454571|627484|P1|NOT COMPLETED|Overall Study||13
259509|NCT00454571|627483|P2|COMPLETED|Overall Study||13
259510|NCT00454571|627484|P1|COMPLETED|Overall Study||5
259511|NCT00454571|627483|P2|STARTED|Overall Study||19
259512|NCT00454571|627484|P1|STARTED|Overall Study||18
259513|NCT00454532|627496|P4|NOT COMPLETED|Overall Study||0
259514|NCT00454532|627497|P3|NOT COMPLETED|Overall Study||0
259515|NCT00454532|627498|P2|NOT COMPLETED|Overall Study||0
259516|NCT00454532|627499|P1|NOT COMPLETED|Overall Study||0
259517|NCT00454532|627496|P4|COMPLETED|Overall Study||7
259518|NCT00454532|627497|P3|COMPLETED|Overall Study||3
259519|NCT00454532|627498|P2|COMPLETED|Overall Study||6
259520|NCT00454532|627499|P1|COMPLETED|Overall Study||11
259521|NCT00454532|627496|P4|STARTED|Overall Study||7
259522|NCT00454532|627497|P3|STARTED|Overall Study||3
259523|NCT00454532|627498|P2|STARTED|Overall Study||6
259524|NCT00454532|627499|P1|STARTED|Overall Study||11
259525|NCT00454363|627519|P2|NOT COMPLETED|Overall Study||2
259526|NCT00454363|627520|P1|NOT COMPLETED|Overall Study||5
259527|NCT00454363|627519|P2|COMPLETED|Overall Study||29
259528|NCT00454363|627520|P1|COMPLETED|Overall Study||15
259529|NCT00454363|627519|P2|STARTED|Overall Study||31
259530|NCT00454363|627520|P1|STARTED|Overall Study||20
259531|NCT00454324|627529|P2|NOT COMPLETED|Overall Study||0
259532|NCT00454324|627530|P1|NOT COMPLETED|Overall Study||0
259533|NCT00454324|627529|P2|COMPLETED|Overall Study||13
259534|NCT00454324|627530|P1|COMPLETED|Overall Study||14
259535|NCT00454324|627529|P2|STARTED|Overall Study||13
259536|NCT00454324|627530|P1|STARTED|Overall Study||14
259537|NCT00454246|627545|P3|NOT COMPLETED|Overall Study||9
259538|NCT00454246|627546|P2|NOT COMPLETED|Overall Study||29
259539|NCT00454246|627547|P1|NOT COMPLETED|Overall Study||73
259540|NCT00454246|627545|P3|COMPLETED|Overall Study||0
259541|NCT00454246|627546|P2|COMPLETED|Overall Study||0
259542|NCT00454246|627547|P1|COMPLETED|Overall Study||0
259543|NCT00454246|627545|P3|STARTED|Overall Study||9
259544|NCT00454246|627546|P2|STARTED|Overall Study||29
259545|NCT00454246|627547|P1|STARTED|Overall Study||73
259546|NCT00454207|627563|P2|NOT COMPLETED|Overall Study||2
259547|NCT00454207|627564|P1|NOT COMPLETED|Overall Study||4
259548|NCT00454207|627563|P2|COMPLETED|Overall Study||21
259549|NCT00454207|627564|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
259550|NCT00454207|627563|P2|STARTED|Overall Study||23
259551|NCT00454207|627564|P1|STARTED|Overall Study||21
259552|NCT00454194|627609|P2|NOT COMPLETED|Overall Study||14
259553|NCT00454194|627610|P1|NOT COMPLETED|Overall Study||22
259554|NCT00454194|627609|P2|COMPLETED|Overall Study||37
259555|NCT00454194|627610|P1|COMPLETED|Overall Study||25
259556|NCT00454194|627609|P2|STARTED|Overall Study||51
259557|NCT00454194|627610|P1|STARTED|Overall Study||47
259558|NCT00454181|627628|P2|NOT COMPLETED|Overall Study||3
259559|NCT00454181|627629|P1|NOT COMPLETED|Overall Study||15
259560|NCT00454181|627628|P2|COMPLETED|Overall Study||11
259561|NCT00454181|627629|P1|COMPLETED|Overall Study||30
259562|NCT00454181|627628|P2|STARTED|Overall Study||14
259563|NCT00454181|627629|P1|STARTED|Overall Study||45
259564|NCT00454142|627645|P1|NOT COMPLETED|Overall Study||1
259565|NCT00454142|627645|P1|COMPLETED|Overall Study||32
259566|NCT00454142|627645|P1|STARTED|Overall Study||33
259567|NCT00454116|627663|P3|NOT COMPLETED|Overall Study||28
259568|NCT00454116|627664|P2|NOT COMPLETED|Overall Study||29
259569|NCT00454116|627665|P1|NOT COMPLETED|Overall Study||27
259570|NCT00454116|627663|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
259571|NCT00454116|627664|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
259572|NCT00454116|627665|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
259573|NCT00454116|627663|P3|STARTED|Overall Study|randomised patients|35
259574|NCT00454116|627664|P2|STARTED|Overall Study|randomised patients|36
259575|NCT00454116|627665|P1|STARTED|Overall Study|randomised patients|35
259576|NCT00454051|627675|P2|NOT COMPLETED|Overall Study||3
259577|NCT00454051|627676|P1|NOT COMPLETED|Overall Study||3
259578|NCT00454051|627675|P2|COMPLETED|Overall Study||8
259579|NCT00454051|627676|P1|COMPLETED|Overall Study||17
259580|NCT00454051|627675|P2|STARTED|Overall Study||11
259581|NCT00454051|627676|P1|STARTED|Overall Study||20
259582|NCT00453999|627709|P3|NOT COMPLETED|Overall Study||3
259583|NCT00453999|627710|P2|NOT COMPLETED|Overall Study||5
259584|NCT00453999|627711|P1|NOT COMPLETED|Overall Study||5
259585|NCT00453999|627709|P3|COMPLETED|Overall Study||43
259586|NCT00453999|627710|P2|COMPLETED|Overall Study||41
259587|NCT00453999|627711|P1|COMPLETED|Overall Study||40
259588|NCT00453999|627709|P3|STARTED|Overall Study||46
259589|NCT00453999|627710|P2|STARTED|Overall Study||46
259590|NCT00453999|627711|P1|STARTED|Overall Study||45
259591|NCT00453986|627739|P5|NOT COMPLETED|Overall Study||0
259592|NCT00453986|627740|P4|NOT COMPLETED|Overall Study||2
259593|NCT00453986|627741|P3|NOT COMPLETED|Overall Study||6
259594|NCT00453986|627742|P2|NOT COMPLETED|Overall Study||5
259595|NCT00453986|627743|P1|NOT COMPLETED|Overall Study||6
259596|NCT00453986|627739|P5|COMPLETED|Overall Study||105
259597|NCT00453986|627740|P4|COMPLETED|Overall Study||310
259598|NCT00453986|627741|P3|COMPLETED|Overall Study||307
259599|NCT00453986|627742|P2|COMPLETED|Overall Study||306
259600|NCT00453986|627743|P1|COMPLETED|Overall Study||305
259601|NCT00453986|627739|P5|STARTED|Overall Study||105
259602|NCT00453986|627740|P4|STARTED|Overall Study||312
259603|NCT00453986|627741|P3|STARTED|Overall Study||313
259604|NCT00453986|627742|P2|STARTED|Overall Study||311
259605|NCT00453986|627743|P1|STARTED|Overall Study||311
259606|NCT00453973|627838|P2|NOT COMPLETED|Overall Study||48
259607|NCT00453973|627839|P1|NOT COMPLETED|Overall Study||51
259608|NCT00453973|627838|P2|COMPLETED|Overall Study||15
259609|NCT00453973|627839|P1|COMPLETED|Overall Study||0
259610|NCT00453973|627838|P2|STARTED|Overall Study||63
259611|NCT00453973|627839|P1|STARTED|Overall Study||51
259612|NCT00453479|627848|P3|NOT COMPLETED|Overall Study||0
259613|NCT00453479|627849|P2|NOT COMPLETED|Overall Study||0
259614|NCT00453479|627850|P1|NOT COMPLETED|Overall Study||0
259615|NCT00453479|627848|P3|COMPLETED|Overall Study||8
259616|NCT00453479|627849|P2|COMPLETED|Overall Study||9
259617|NCT00453479|627850|P1|COMPLETED|Overall Study||6
259618|NCT00453479|627848|P3|STARTED|Overall Study||8
259619|NCT00453479|627849|P2|STARTED|Overall Study||9
259620|NCT00453479|627850|P1|STARTED|Overall Study||6
259621|NCT00453388|627925|P4|NOT COMPLETED|Overall Study||0
259622|NCT00453388|627926|P3|NOT COMPLETED|Overall Study||0
259623|NCT00453388|627927|P2|NOT COMPLETED|Overall Study||0
259624|NCT00453388|627928|P1|NOT COMPLETED|Overall Study||0
259625|NCT00453388|627925|P4|COMPLETED|Overall Study||0
259626|NCT00453388|627926|P3|COMPLETED|Overall Study||1
259627|NCT00453388|627927|P2|COMPLETED|Overall Study||5
259628|NCT00453388|627928|P1|COMPLETED|Overall Study||0
259629|NCT00453388|627925|P4|STARTED|Overall Study||0
259630|NCT00453388|627926|P3|STARTED|Overall Study||1
259631|NCT00453388|627927|P2|STARTED|Overall Study||5
259632|NCT00453388|627928|P1|STARTED|Overall Study||0
259633|NCT00453362|627950|P1|NOT COMPLETED|Overall Study||87
259634|NCT00453362|627950|P1|COMPLETED|Overall Study||1
259635|NCT00453362|627950|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
259636|NCT00453362|627950|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
259637|NCT00453362|627950|P1|Treated With Erlotinib|Overall Study||74
259638|NCT00453362|627950|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
259639|NCT00453349|627976|P2|NOT COMPLETED|Completed Study||34
259640|NCT00453349|627977|P1|NOT COMPLETED|Completed Study||27
259641|NCT00453349|627976|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
259642|NCT00453349|627977|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
259643|NCT00453349|627976|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
259644|NCT00453349|627977|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
259645|NCT00453349|627976|P2|STARTED|Completed Study||232
259646|NCT00453349|627977|P1|STARTED|Completed Study||228
259647|NCT00453349|627976|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
259648|NCT00453349|627977|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
259649|NCT00453349|627976|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
259650|NCT00453349|627977|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
259651|NCT00453349|627976|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
259652|NCT00453349|627977|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
259653|NCT00453349|627976|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
259654|NCT00453349|627977|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
259655|NCT00453349|627976|P2|NOT COMPLETED|Randomized||23
259656|NCT00453349|627977|P1|NOT COMPLETED|Randomized||25
259657|NCT00453349|627976|P2|COMPLETED|Randomized||209
259658|NCT00453349|627977|P1|COMPLETED|Randomized||203
259659|NCT00453349|627976|P2|STARTED|Randomized||232
259660|NCT00453349|627977|P1|STARTED|Randomized||228
259661|NCT00453336|628003|P1|NOT COMPLETED|Overall Study||0
259662|NCT00453336|628003|P1|COMPLETED|Overall Study||45
259663|NCT00453336|628003|P1|STARTED|Overall Study||45
259664|NCT00453310|628008|P1|NOT COMPLETED|Overall Study||10
259665|NCT00453310|628008|P1|COMPLETED|Overall Study||0
259666|NCT00453310|628008|P1|STARTED|Overall Study||10
259667|NCT00453206|628012|P1|NOT COMPLETED|Overall Study||1
259668|NCT00453206|628012|P1|COMPLETED|Overall Study||65
259669|NCT00453206|628012|P1|STARTED|Overall Study||66
259670|NCT00453193|628016|P1|NOT COMPLETED|Overall Study||0
259671|NCT00453193|628016|P1|COMPLETED|Overall Study||24
259672|NCT00453193|628016|P1|STARTED|Overall Study||24
259673|NCT00453180|628022|P2|NOT COMPLETED|Overall Study||3
259674|NCT00453180|628023|P1|NOT COMPLETED|Overall Study||3
259675|NCT00453180|628022|P2|COMPLETED|Overall Study||12
259676|NCT00453180|628023|P1|COMPLETED|Overall Study||13
259677|NCT00453180|628022|P2|STARTED|Overall Study||15
259678|NCT00453180|628023|P1|STARTED|Overall Study||16
259679|NCT00453154|628042|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
259680|NCT00453154|628043|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
259681|NCT00453154|628044|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
259682|NCT00453154|628045|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
259683|NCT00453154|628042|P4|COMPLETED|Open Label Sunitinib Crossover||0
259684|NCT00453154|628043|P3|COMPLETED|Open Label Sunitinib Crossover||18
259685|NCT00453154|628044|P2|COMPLETED|Open Label Sunitinib Crossover||0
259686|NCT00453154|628045|P1|COMPLETED|Open Label Sunitinib Crossover||0
259687|NCT00453154|628042|P4|STARTED|Open Label Sunitinib Crossover||0
259688|NCT00453154|628043|P3|STARTED|Open Label Sunitinib Crossover||18
259689|NCT00453154|628044|P2|STARTED|Open Label Sunitinib Crossover||0
259690|NCT00453154|628045|P1|STARTED|Open Label Sunitinib Crossover||0
259691|NCT00453154|628042|P4|NOT COMPLETED|Double BIind Maintenance||49
259692|NCT00453154|628043|P3|NOT COMPLETED|Double BIind Maintenance||46
259693|NCT00453154|628044|P2|NOT COMPLETED|Double BIind Maintenance||0
259694|NCT00453154|628045|P1|NOT COMPLETED|Double BIind Maintenance||0
259695|NCT00453154|628042|P4|COMPLETED|Double BIind Maintenance||0
259696|NCT00453154|628043|P3|COMPLETED|Double BIind Maintenance||0
259697|NCT00453154|628044|P2|COMPLETED|Double BIind Maintenance||0
259698|NCT00453154|628045|P1|COMPLETED|Double BIind Maintenance||0
259699|NCT00453154|628042|P4|STARTED|Double BIind Maintenance||49
259700|NCT00453154|628043|P3|STARTED|Double BIind Maintenance||46
259701|NCT00453154|628044|P2|STARTED|Double BIind Maintenance||0
259702|NCT00453154|628045|P1|STARTED|Double BIind Maintenance||0
259703|NCT00453154|628042|P4|NOT COMPLETED|Combination Chemotherapy||0
259704|NCT00453154|628043|P3|NOT COMPLETED|Combination Chemotherapy||0
259705|NCT00453154|628044|P2|NOT COMPLETED|Combination Chemotherapy||49
259706|NCT00453154|628045|P1|NOT COMPLETED|Combination Chemotherapy||0
259707|NCT00453154|628042|P4|COMPLETED|Combination Chemotherapy||0
259708|NCT00453154|628043|P3|COMPLETED|Combination Chemotherapy||0
259709|NCT00453154|628044|P2|COMPLETED|Combination Chemotherapy||95
259710|NCT00453154|628045|P1|COMPLETED|Combination Chemotherapy||12
259711|NCT00453154|628042|P4|STARTED|Combination Chemotherapy||0
259712|NCT00453154|628043|P3|STARTED|Combination Chemotherapy||0
259713|NCT00453154|628044|P2|STARTED|Combination Chemotherapy||144
259714|NCT00453154|628045|P1|STARTED|Combination Chemotherapy||12
259715|NCT00453102|628058|P1|NOT COMPLETED|Overall Study||2
259716|NCT00453102|628058|P1|COMPLETED|Overall Study||16
259717|NCT00453102|628058|P1|STARTED|Overall Study||18
259718|NCT00453063|628069|P2|NOT COMPLETED|Overall Study||3
259719|NCT00453063|628070|P1|NOT COMPLETED|Overall Study||3
259720|NCT00453063|628069|P2|COMPLETED|Overall Study||212
259721|NCT00453063|628070|P1|COMPLETED|Overall Study||208
259722|NCT00453063|628069|P2|STARTED|Overall Study||215
259723|NCT00453063|628070|P1|STARTED|Overall Study||211
259724|NCT00452868|628084|P1|NOT COMPLETED|Overall Study||2
259725|NCT00452868|628084|P1|COMPLETED|Overall Study||11
259726|NCT00452868|628084|P1|STARTED|Overall Study||13
259727|NCT00452790|628090|P2|NOT COMPLETED|Toddler Dose||2
259728|NCT00452790|628091|P1|NOT COMPLETED|Toddler Dose||0
259729|NCT00452790|628090|P2|COMPLETED|Toddler Dose||198
259730|NCT00452790|628091|P1|COMPLETED|Toddler Dose||198
259731|NCT00452790|628090|P2|STARTED|Toddler Dose||200
259732|NCT00452790|628091|P1|STARTED|Toddler Dose||198
259733|NCT00452790|628090|P2|NOT COMPLETED|After Infant Series||14
259734|NCT00452790|628091|P1|NOT COMPLETED|After Infant Series||21
259735|NCT00452790|628090|P2|COMPLETED|After Infant Series||200
259736|NCT00452790|628091|P1|COMPLETED|After Infant Series||198
259737|NCT00452790|628090|P2|STARTED|After Infant Series||214
259738|NCT00452790|628091|P1|STARTED|After Infant Series||219
259739|NCT00452790|628090|P2|NOT COMPLETED|Infant Series||141
259740|NCT00452790|628091|P1|NOT COMPLETED|Infant Series||135
259741|NCT00452790|628090|P2|COMPLETED|Infant Series||214
259742|NCT00452790|628091|P1|COMPLETED|Infant Series||219
259743|NCT00452790|628090|P2|Vaccinated Dose 3|Infant Series||218
259744|NCT00452790|628091|P1|Vaccinated Dose 3|Infant Series||221
259745|NCT00452790|628090|P2|Vaccinated Dose 2|Infant Series||300
259746|NCT00452790|628091|P1|Vaccinated Dose 2|Infant Series||300
259747|NCT00452790|628090|P2|Vaccinated Dose 1|Infant Series||353
259748|NCT00452790|628091|P1|Vaccinated Dose 1|Infant Series||353
259749|NCT00452790|628090|P2|STARTED|Infant Series||355
259750|NCT00452790|628091|P1|STARTED|Infant Series||354
259751|NCT00452699|628127|P2|NOT COMPLETED|Overall Study||73
259752|NCT00452699|628128|P1|NOT COMPLETED|Overall Study||81
259753|NCT00452699|628127|P2|COMPLETED|Overall Study||242
259754|NCT00452699|628128|P1|COMPLETED|Overall Study||225
259755|NCT00452699|628127|P2|STARTED|Overall Study||315
259756|NCT00452699|628128|P1|STARTED|Overall Study||306
259757|NCT00452673|628144|P5|NOT COMPLETED|Dose Expansion Period||21
259758|NCT00452673|628145|P4|NOT COMPLETED|Dose Expansion Period||0
259759|NCT00452673|628146|P3|NOT COMPLETED|Dose Expansion Period||0
259760|NCT00452673|628147|P2|NOT COMPLETED|Dose Expansion Period||0
259761|NCT00452673|628148|P1|NOT COMPLETED|Dose Expansion Period||0
259762|NCT00452673|628144|P5|COMPLETED|Dose Expansion Period||0
259763|NCT00452673|628145|P4|COMPLETED|Dose Expansion Period||0
259764|NCT00452673|628146|P3|COMPLETED|Dose Expansion Period||0
259765|NCT00452673|628147|P2|COMPLETED|Dose Expansion Period||0
259766|NCT00452673|628148|P1|COMPLETED|Dose Expansion Period||0
259767|NCT00452673|628144|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
259768|NCT00452673|628145|P4|STARTED|Dose Expansion Period||0
259769|NCT00452673|628146|P3|STARTED|Dose Expansion Period||0
259770|NCT00452673|628147|P2|STARTED|Dose Expansion Period||0
259771|NCT00452673|628148|P1|STARTED|Dose Expansion Period||0
259772|NCT00452673|628144|P5|NOT COMPLETED|Dose Escalation Period||0
259773|NCT00452673|628145|P4|NOT COMPLETED|Dose Escalation Period||9
259774|NCT00452673|628146|P3|NOT COMPLETED|Dose Escalation Period||6
259775|NCT00452673|628147|P2|NOT COMPLETED|Dose Escalation Period||9
259776|NCT00452673|628148|P1|NOT COMPLETED|Dose Escalation Period||7
259777|NCT00452673|628144|P5|COMPLETED|Dose Escalation Period||0
259778|NCT00452673|628145|P4|COMPLETED|Dose Escalation Period||0
259779|NCT00452673|628146|P3|COMPLETED|Dose Escalation Period||0
259780|NCT00452673|628147|P2|COMPLETED|Dose Escalation Period||0
259781|NCT00452673|628148|P1|COMPLETED|Dose Escalation Period||0
259782|NCT00452673|628144|P5|STARTED|Dose Escalation Period||0
259783|NCT00452673|628145|P4|STARTED|Dose Escalation Period||9
259784|NCT00452673|628146|P3|STARTED|Dose Escalation Period||6
259785|NCT00452673|628147|P2|STARTED|Dose Escalation Period||9
259786|NCT00452673|628148|P1|STARTED|Dose Escalation Period||7
259787|NCT00452543|628180|P2|NOT COMPLETED|Overall Study||6
259788|NCT00452543|628181|P1|NOT COMPLETED|Overall Study||5
259789|NCT00452543|628180|P2|COMPLETED|Overall Study||5
259790|NCT00452543|628181|P1|COMPLETED|Overall Study||7
259791|NCT00452543|628180|P2|STARTED|Overall Study||11
259792|NCT00452543|628181|P1|STARTED|Overall Study||12
259793|NCT00452530|628195|P2|NOT COMPLETED|Overall Study||136
259794|NCT00452530|628196|P1|NOT COMPLETED|Overall Study||136
259795|NCT00452530|628195|P2|COMPLETED|Overall Study||1393
259796|NCT00452530|628196|P1|COMPLETED|Overall Study||1392
259797|NCT00452530|628195|P2|Primary Participants|Overall Study||997
259798|NCT00452530|628196|P1|Primary Participants|Overall Study||976
259799|NCT00452530|628195|P2|Evaluable Participants|Overall Study||921
259800|NCT00452530|628196|P1|Evaluable Participants|Overall Study||907
259801|NCT00452530|628195|P2|Received Treatment|Overall Study||1508
259802|NCT00452530|628196|P1|Received Treatment|Overall Study||1501
259803|NCT00452530|628195|P2|STARTED|Overall Study|Randomized|1529
259804|NCT00452530|628196|P1|STARTED|Overall Study|Randomized|1528
259805|NCT00452452|628217|P3|NOT COMPLETED|Overall Study||1
259806|NCT00452452|628218|P2|NOT COMPLETED|Overall Study||0
259807|NCT00452452|628219|P1|NOT COMPLETED|Overall Study||2
259808|NCT00452452|628217|P3|COMPLETED|Overall Study||152
259809|NCT00452452|628218|P2|COMPLETED|Overall Study||112
259810|NCT00452452|628219|P1|COMPLETED|Overall Study||88
259811|NCT00452452|628217|P3|Vaccinated Dose 3|Overall Study||0
259812|NCT00452452|628218|P2|Vaccinated Dose 3|Overall Study||0
259813|NCT00452452|628219|P1|Vaccinated Dose 3|Overall Study||89
259814|NCT00452452|628217|P3|Vaccinated Dose 2|Overall Study||0
259815|NCT00452452|628218|P2|Vaccinated Dose 2|Overall Study||112
259816|NCT00452452|628219|P1|Vaccinated Dose 2|Overall Study||90
259817|NCT00452452|628217|P3|Vaccinated Dose 1|Overall Study||152
259818|NCT00452452|628218|P2|Vaccinated Dose 1|Overall Study||112
259819|NCT00452452|628219|P1|Vaccinated Dose 1|Overall Study||90
259820|NCT00452452|628217|P3|STARTED|Overall Study||153
259821|NCT00452452|628218|P2|STARTED|Overall Study||112
259822|NCT00452452|628219|P1|STARTED|Overall Study||90
259823|NCT00452426|628244|P2|NOT COMPLETED|Overall Study||11
259824|NCT00452426|628245|P1|NOT COMPLETED|Overall Study||7
259825|NCT00452426|628244|P2|COMPLETED|Overall Study||493
259826|NCT00452426|628245|P1|COMPLETED|Overall Study||489
259827|NCT00452426|628244|P2|STARTED|Overall Study||504
259828|NCT00452426|628245|P1|STARTED|Overall Study||496
259829|NCT00452400|628264|P5|NOT COMPLETED|Overall Study||3
259830|NCT00452400|628265|P4|NOT COMPLETED|Overall Study||1
259831|NCT00452400|628266|P3|NOT COMPLETED|Overall Study||7
259832|NCT00452400|628267|P2|NOT COMPLETED|Overall Study||1
259833|NCT00452400|628268|P1|NOT COMPLETED|Overall Study||5
259834|NCT00452400|628264|P5|COMPLETED|Overall Study||76
259835|NCT00452400|628265|P4|COMPLETED|Overall Study||85
259836|NCT00452400|628266|P3|COMPLETED|Overall Study||73
259837|NCT00452400|628267|P2|COMPLETED|Overall Study||80
259838|NCT00452400|628268|P1|COMPLETED|Overall Study||74
259839|NCT00452400|628264|P5|STARTED|Overall Study||79
259840|NCT00452400|628265|P4|STARTED|Overall Study||86
259841|NCT00452400|628266|P3|STARTED|Overall Study||80
259842|NCT00452400|628267|P2|STARTED|Overall Study||81
259843|NCT00452400|628268|P1|STARTED|Overall Study||79
259844|NCT00452387|628440|P1|NOT COMPLETED|Overall Study||0
259845|NCT00452387|628440|P1|COMPLETED|Overall Study||22
259846|NCT00452387|628440|P1|STARTED|Overall Study||22
259847|NCT00452374|628448|P1|NOT COMPLETED|Overall Study||0
259848|NCT00452374|628448|P1|COMPLETED|Overall Study||48
259849|NCT00452374|628448|P1|STARTED|Overall Study||48
259850|NCT00452361|628455|P2|NOT COMPLETED|Overall Study||10
259851|NCT00452361|628456|P1|NOT COMPLETED|Overall Study||21
259852|NCT00452361|628455|P2|COMPLETED|Overall Study||0
259853|NCT00452361|628456|P1|COMPLETED|Overall Study||0
259854|NCT00452361|628455|P2|STARTED|Overall Study||10
259855|NCT00452361|628456|P1|STARTED|Overall Study||21
259856|NCT00452348|628500|P2|NOT COMPLETED|Overall Study||84
259857|NCT00452348|628501|P1|NOT COMPLETED|Overall Study||79
259858|NCT00452348|628500|P2|COMPLETED|Overall Study||234
259859|NCT00452348|628501|P1|COMPLETED|Overall Study||231
259860|NCT00452348|628500|P2|STARTED|Overall Study||318
259861|NCT00452348|628501|P1|STARTED|Overall Study||310
259862|NCT00452335|628516|P3|NOT COMPLETED|Overall Study||9
259863|NCT00452335|628517|P2|NOT COMPLETED|Overall Study||4
259864|NCT00452335|628518|P1|NOT COMPLETED|Overall Study||2
259865|NCT00452335|628516|P3|COMPLETED|Overall Study||23
259866|NCT00452335|628517|P2|COMPLETED|Overall Study||61
259867|NCT00452335|628518|P1|COMPLETED|Overall Study||25
259868|NCT00452335|628516|P3|STARTED|Overall Study||32
259869|NCT00452335|628517|P2|STARTED|Overall Study||65
259870|NCT00452335|628518|P1|STARTED|Overall Study||27
259871|NCT00452114|628555|P2|NOT COMPLETED|Overall Study||3
259872|NCT00452114|628556|P1|NOT COMPLETED|Overall Study||3
259873|NCT00452114|628555|P2|COMPLETED|Overall Study||10
259874|NCT00452114|628556|P1|COMPLETED|Overall Study||12
259875|NCT00452114|628555|P2|STARTED|Overall Study||13
259876|NCT00452114|628556|P1|STARTED|Overall Study||15
259877|NCT00451958|628566|P5|NOT COMPLETED|CS21A (NCT00451958)||0
259878|NCT00451958|628567|P4|NOT COMPLETED|CS21A (NCT00451958)||39
259879|NCT00451958|628568|P3|NOT COMPLETED|CS21A (NCT00451958)||42
259880|NCT00451958|628569|P2|NOT COMPLETED|CS21A (NCT00451958)||77
259881|NCT00451958|628570|P1|NOT COMPLETED|CS21A (NCT00451958)||65
259882|NCT00451958|628566|P5|COMPLETED|CS21A (NCT00451958)||0
259883|NCT00451958|628567|P4|COMPLETED|CS21A (NCT00451958)||27
259884|NCT00451958|628568|P3|COMPLETED|CS21A (NCT00451958)||27
259885|NCT00451958|628569|P2|COMPLETED|CS21A (NCT00451958)||49
259886|NCT00451958|628570|P1|COMPLETED|CS21A (NCT00451958)||60
259887|NCT00451958|628566|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
259888|NCT00451958|628567|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
259889|NCT00451958|628568|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
259890|NCT00451958|628569|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
259891|NCT00451958|628570|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
259892|NCT00451958|628566|P5|NOT COMPLETED|CS21 (NCT00295750)||32
259893|NCT00451958|628567|P4|NOT COMPLETED|CS21 (NCT00295750)||0
259894|NCT00451958|628568|P3|NOT COMPLETED|CS21 (NCT00295750)||0
259895|NCT00451958|628569|P2|NOT COMPLETED|CS21 (NCT00295750)||43
259896|NCT00451958|628570|P1|NOT COMPLETED|CS21 (NCT00295750)||41
259897|NCT00451958|628566|P5|COMPLETED|CS21 (NCT00295750)||172
259898|NCT00451958|628567|P4|COMPLETED|CS21 (NCT00295750)||0
259899|NCT00451958|628568|P3|COMPLETED|CS21 (NCT00295750)||0
259900|NCT00451958|628569|P2|COMPLETED|CS21 (NCT00295750)||163
259901|NCT00451958|628570|P1|COMPLETED|CS21 (NCT00295750)||169
259902|NCT00451958|628566|P5|STARTED|CS21 (NCT00295750)||204
259903|NCT00451958|628567|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
259904|NCT00451958|628568|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
259905|NCT00451958|628569|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
259906|NCT00451958|628570|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
259907|NCT00451906|628600|P1|NOT COMPLETED|Overall Study||2239
259908|NCT00451906|628600|P1|COMPLETED|Overall Study||13
259909|NCT00451906|628600|P1|STARTED|Overall Study||2252
259910|NCT00451698|628610|P2|NOT COMPLETED|Overall Study||0
259911|NCT00451698|628611|P1|NOT COMPLETED|Overall Study||0
259912|NCT00451698|628610|P2|COMPLETED|Overall Study||6
259913|NCT00451698|628611|P1|COMPLETED|Overall Study||3
259914|NCT00451698|628610|P2|STARTED|Overall Study||6
259915|NCT00451698|628611|P1|STARTED|Overall Study||3
259916|NCT00451451|628623|P4|NOT COMPLETED|Overall Study||58
259917|NCT00451451|628624|P3|NOT COMPLETED|Overall Study||72
259918|NCT00451451|628625|P2|NOT COMPLETED|Overall Study||75
259919|NCT00451451|628626|P1|NOT COMPLETED|Overall Study||85
259920|NCT00451451|628623|P4|COMPLETED|Overall Study||292
259921|NCT00451451|628624|P3|COMPLETED|Overall Study||273
259922|NCT00451451|628625|P2|COMPLETED|Overall Study||284
259923|NCT00451451|628626|P1|COMPLETED|Overall Study||278
259924|NCT00451451|628623|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
259925|NCT00451451|628624|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
259926|NCT00451451|628625|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
259927|NCT00451451|628626|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
259928|NCT00451321|628661|P8|NOT COMPLETED|Overall Study||6
259929|NCT00451321|628662|P7|NOT COMPLETED|Overall Study||6
259930|NCT00451321|628663|P6|NOT COMPLETED|Overall Study||9
259931|NCT00451321|628664|P5|NOT COMPLETED|Overall Study||7
259932|NCT00451321|628665|P4|NOT COMPLETED|Overall Study||12
259933|NCT00451321|628666|P3|NOT COMPLETED|Overall Study||18
259934|NCT00451321|628667|P2|NOT COMPLETED|Overall Study||5
259935|NCT00451321|628668|P1|NOT COMPLETED|Overall Study||7
259936|NCT00451321|628661|P8|COMPLETED|Overall Study||0
259937|NCT00451321|628662|P7|COMPLETED|Overall Study||0
259938|NCT00451321|628663|P6|COMPLETED|Overall Study||0
259939|NCT00451321|628664|P5|COMPLETED|Overall Study||0
259940|NCT00451321|628665|P4|COMPLETED|Overall Study||7
259941|NCT00451321|628666|P3|COMPLETED|Overall Study||0
259942|NCT00451321|628667|P2|COMPLETED|Overall Study||10
259943|NCT00451321|628668|P1|COMPLETED|Overall Study||1
259944|NCT00451321|628661|P8|STARTED|Overall Study||6
259945|NCT00451321|628662|P7|STARTED|Overall Study||6
259946|NCT00451321|628663|P6|STARTED|Overall Study||9
259947|NCT00451321|628664|P5|STARTED|Overall Study||7
259948|NCT00451321|628665|P4|STARTED|Overall Study||19
259949|NCT00451321|628666|P3|STARTED|Overall Study||18
259950|NCT00451321|628667|P2|STARTED|Overall Study||15
259951|NCT00451321|628668|P1|STARTED|Overall Study||8
259952|NCT00451282|628840|P2|NOT COMPLETED|Overall Study||5
259953|NCT00451282|628841|P1|NOT COMPLETED|Overall Study||6
259954|NCT00451282|628840|P2|COMPLETED|Overall Study||34
259955|NCT00451282|628841|P1|COMPLETED|Overall Study||40
259956|NCT00451282|628840|P2|STARTED|Overall Study||39
259957|NCT00451282|628841|P1|STARTED|Overall Study||46
259958|NCT00451204|628855|P2|NOT COMPLETED|Overall Study||20
259959|NCT00451204|628856|P1|NOT COMPLETED|Overall Study||22
259960|NCT00451204|628855|P2|COMPLETED|Overall Study||56
259961|NCT00451204|628856|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
259962|NCT00451204|628855|P2|STARTED|Overall Study||76
259963|NCT00451204|628856|P1|STARTED|Overall Study||82
259964|NCT00451191|628874|P2|NOT COMPLETED|Overall Study||11
259965|NCT00451191|628875|P1|NOT COMPLETED|Overall Study||15
259966|NCT00451191|628874|P2|COMPLETED|Overall Study||55
259967|NCT00451191|628875|P1|COMPLETED|Overall Study||53
259968|NCT00451191|628874|P2|STARTED|Overall Study||66
259969|NCT00451191|628875|P1|STARTED|Overall Study||68
259970|NCT00451048|628881|P1|NOT COMPLETED|Overall Study||0
259971|NCT00451048|628881|P1|COMPLETED|Overall Study||10
259972|NCT00451048|628881|P1|STARTED|Overall Study||10
259973|NCT00450983|628885|P1|NOT COMPLETED|Overall Study||0
259974|NCT00450983|628885|P1|COMPLETED|Overall Study||1
259975|NCT00450983|628885|P1|STARTED|Overall Study||1
259976|NCT00450866|628897|P2|NOT COMPLETED|Overall Study||3
259977|NCT00450866|628898|P1|NOT COMPLETED|Overall Study||7
259978|NCT00450866|628897|P2|COMPLETED|Overall Study||7
259979|NCT00450866|628898|P1|COMPLETED|Overall Study||38
259980|NCT00450866|628897|P2|STARTED|Overall Study||10
259981|NCT00450866|628898|P1|STARTED|Overall Study||45
259982|NCT00450801|628908|P1|NOT COMPLETED|Overall Study||1
259983|NCT00450801|628908|P1|COMPLETED|Overall Study||21
259984|NCT00450801|628908|P1|STARTED|Overall Study||22
259985|NCT00450749|628922|P3|NOT COMPLETED|Overall Study||2
259986|NCT00450749|628923|P2|NOT COMPLETED|Overall Study||1
259987|NCT00450749|628924|P1|NOT COMPLETED|Overall Study||0
259988|NCT00450749|628922|P3|COMPLETED|Overall Study||2
259989|NCT00450749|628923|P2|COMPLETED|Overall Study||2
259990|NCT00450749|628924|P1|COMPLETED|Overall Study||3
259991|NCT00450749|628922|P3|STARTED|Overall Study||4
259992|NCT00450749|628923|P2|STARTED|Overall Study||3
259993|NCT00450749|628924|P1|STARTED|Overall Study||3
259994|NCT00450723|628932|P1|NOT COMPLETED|Overall Study||5
259995|NCT00450723|628932|P1|COMPLETED|Overall Study||34
259996|NCT00450723|628932|P1|STARTED|Overall Study||39
259997|NCT00450658|628940|P2|NOT COMPLETED|Overall Study||90
259998|NCT00450658|628941|P1|NOT COMPLETED|Overall Study||143
259999|NCT00450658|628940|P2|COMPLETED|Overall Study||122
260000|NCT00450658|628941|P1|COMPLETED|Overall Study||272
260001|NCT00450658|628940|P2|STARTED|Overall Study||212
260002|NCT00450658|628941|P1|STARTED|Overall Study||415
260003|NCT00450619|628955|P2|NOT COMPLETED|Overall Study||1
260004|NCT00450619|628956|P1|NOT COMPLETED|Overall Study||4
260005|NCT00450619|628955|P2|COMPLETED|Overall Study||21
260006|NCT00450619|628956|P1|COMPLETED|Overall Study||18
260007|NCT00450619|628955|P2|STARTED|Overall Study||22
260008|NCT00450619|628956|P1|STARTED|Overall Study||22
260009|NCT00450580|628982|P2|NOT COMPLETED|Overall Study||16
260010|NCT00450580|628983|P1|NOT COMPLETED|Overall Study||16
260011|NCT00450580|628982|P2|COMPLETED|Overall Study||90
260012|NCT00450580|628983|P1|COMPLETED|Overall Study||90
260013|NCT00450580|628982|P2|STARTED|Overall Study||106
260014|NCT00450580|628983|P1|STARTED|Overall Study||106
260015|NCT00450450|629003|P2|NOT COMPLETED|Overall Study||3
260016|NCT00450450|629004|P1|NOT COMPLETED|Overall Study||5
260017|NCT00450450|629003|P2|COMPLETED|Overall Study||11
260018|NCT00450450|629004|P1|COMPLETED|Overall Study||8
260019|NCT00450450|629003|P2|STARTED|Overall Study||14
260020|NCT00450450|629004|P1|STARTED|Overall Study||13
260021|NCT00450437|629028|P4|NOT COMPLETED|Overall Study||11
260022|NCT00450437|629029|P3|NOT COMPLETED|Overall Study||24
260023|NCT00450437|629030|P2|NOT COMPLETED|Overall Study||16
260024|NCT00450437|629031|P1|NOT COMPLETED|Overall Study||46
260025|NCT00450437|629028|P4|COMPLETED|Overall Study||325
260026|NCT00450437|629029|P3|COMPLETED|Overall Study||999
260027|NCT00450437|629030|P2|COMPLETED|Overall Study||524
260028|NCT00450437|629031|P1|COMPLETED|Overall Study||1594
260029|NCT00450437|629028|P4|STARTED|Overall Study||336
260030|NCT00450437|629029|P3|STARTED|Overall Study||1023
260031|NCT00450437|629030|P2|STARTED|Overall Study||540
260032|NCT00450437|629031|P1|STARTED|Overall Study||1640
260033|NCT00450424|629055|P2|NOT COMPLETED|Overall Study||11
260034|NCT00450424|629056|P1|NOT COMPLETED|Overall Study||20
260035|NCT00450424|629055|P2|COMPLETED|Overall Study||106
260036|NCT00450424|629056|P1|COMPLETED|Overall Study||102
260037|NCT00450424|629055|P2|STARTED|Overall Study||117
260038|NCT00450424|629056|P1|STARTED|Overall Study||122
260039|NCT00450411|629062|P1|NOT COMPLETED|Overall Study||8
260040|NCT00450411|629062|P1|COMPLETED|Overall Study||92
260041|NCT00450411|629062|P1|STARTED|Overall Study||100
260042|NCT00450385|629067|P1|NOT COMPLETED|Overall Study||13
260043|NCT00450385|629067|P1|COMPLETED|Overall Study||44
260044|NCT00450385|629067|P1|STARTED|Overall Study||57
260045|NCT00450372|629076|P1|NOT COMPLETED|Overall Study||1
260046|NCT00450372|629076|P1|COMPLETED|Overall Study||37
260047|NCT00450372|629076|P1|STARTED|Overall Study||38
260048|NCT00450333|629089|P4|NOT COMPLETED|Overall Study||28
260049|NCT00450333|629090|P3|NOT COMPLETED|Overall Study||25
260050|NCT00450333|629091|P2|NOT COMPLETED|Overall Study||63
260051|NCT00450333|629092|P1|NOT COMPLETED|Overall Study||54
260052|NCT00450333|629089|P4|COMPLETED|Overall Study||74
260053|NCT00450333|629090|P3|COMPLETED|Overall Study||75
260054|NCT00450333|629091|P2|COMPLETED|Overall Study||44
260055|NCT00450333|629092|P1|COMPLETED|Overall Study||44
260056|NCT00450333|629089|P4|STARTED|Overall Study||102
260057|NCT00450333|629090|P3|STARTED|Overall Study||100
260058|NCT00450333|629091|P2|STARTED|Overall Study||107
260059|NCT00450333|629092|P1|STARTED|Overall Study||98
260060|NCT00450294|629110|P1|NOT COMPLETED|Overall Study||0
260061|NCT00450294|629110|P1|COMPLETED|Overall Study||10
260062|NCT00450294|629110|P1|STARTED|Overall Study||10
260063|NCT00450255|629115|P1|NOT COMPLETED|Overall Study||1
260064|NCT00450255|629115|P1|COMPLETED|Overall Study||40
260065|NCT00450255|629115|P1|STARTED|Overall Study||41
260066|NCT00450242|629125|P2|NOT COMPLETED|Overall Study||1
260067|NCT00450242|629126|P1|NOT COMPLETED|Overall Study||3
260068|NCT00450242|629125|P2|COMPLETED|Overall Study||6
260069|NCT00450242|629126|P1|COMPLETED|Overall Study||4
260070|NCT00450242|629125|P2|STARTED|Overall Study||7
260071|NCT00450242|629126|P1|STARTED|Overall Study||7
260072|NCT00450216|629140|P2|NOT COMPLETED|Overall Study||129
260073|NCT00450216|629141|P1|NOT COMPLETED|Overall Study||174
260074|NCT00450216|629140|P2|COMPLETED|Overall Study||170
260075|NCT00450216|629141|P1|COMPLETED|Overall Study||433
260076|NCT00450216|629140|P2|STARTED|Overall Study||299
260077|NCT00450216|629141|P1|STARTED|Overall Study||607
260078|NCT00450112|629155|P2|NOT COMPLETED|Overall Study||6
260079|NCT00450112|629156|P1|NOT COMPLETED|Overall Study||13
260080|NCT00450112|629155|P2|COMPLETED|Overall Study||71
260081|NCT00450112|629156|P1|COMPLETED|Overall Study||112
260082|NCT00450112|629155|P2|Analyzed Participants|Overall Study||74
260083|NCT00450112|629156|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
260084|NCT00450112|629155|P2|Received Injection|Overall Study||74
260085|NCT00450112|629156|P1|Received Injection|Overall Study||125
260086|NCT00450112|629155|P2|STARTED|Overall Study||77
260087|NCT00450112|629156|P1|STARTED|Overall Study||125
260088|NCT00450073|629181|P3|NOT COMPLETED|Overall Study||1
260089|NCT00450073|629182|P2|NOT COMPLETED|Overall Study||0
260090|NCT00450073|629183|P1|NOT COMPLETED|Overall Study||1
260091|NCT00450073|629181|P3|COMPLETED|Overall Study||9
260092|NCT00450073|629182|P2|COMPLETED|Overall Study||10
260093|NCT00450073|629183|P1|COMPLETED|Overall Study||9
260094|NCT00450073|629181|P3|STARTED|Overall Study||10
260095|NCT00450073|629182|P2|STARTED|Overall Study||10
260096|NCT00450073|629183|P1|STARTED|Overall Study||10
260097|NCT00449956|629194|P3|NOT COMPLETED|Overall Study||9
260098|NCT00449956|629195|P2|NOT COMPLETED|Overall Study||4
260099|NCT00449956|629196|P1|NOT COMPLETED|Overall Study||10
260100|NCT00449956|629194|P3|COMPLETED|Overall Study||184
260101|NCT00449956|629195|P2|COMPLETED|Overall Study||88
260102|NCT00449956|629196|P1|COMPLETED|Overall Study||179
260103|NCT00449956|629194|P3|STARTED|Overall Study||193
260104|NCT00449956|629195|P2|STARTED|Overall Study||92
260105|NCT00449956|629196|P1|STARTED|Overall Study||189
260106|NCT00449930|629212|P2|NOT COMPLETED|Overall Study||75
260107|NCT00449930|629213|P1|NOT COMPLETED|Overall Study||61
260108|NCT00449930|629212|P2|COMPLETED|Overall Study||447
260109|NCT00449930|629213|P1|COMPLETED|Overall Study||467
260110|NCT00449930|629212|P2|STARTED|Overall Study||522
260111|NCT00449930|629213|P1|STARTED|Overall Study||528
260112|NCT00449865|629229|P2|NOT COMPLETED|Overall Study||534
260113|NCT00449865|629230|P1|NOT COMPLETED|Overall Study||522
260114|NCT00449865|629229|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
260115|NCT00449865|629230|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
260116|NCT00449865|629229|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
260117|NCT00449865|629230|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
260118|NCT00449865|629229|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
260119|NCT00449865|629230|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
260120|NCT00449865|629229|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
260121|NCT00449865|629230|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
260122|NCT00449865|629229|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
260123|NCT00449865|629230|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
260124|NCT00449865|629229|P2|STARTED|Overall Study||874
260125|NCT00449865|629230|P1|STARTED|Overall Study||867
260126|NCT00449787|629238|P2|NOT COMPLETED|Overall Study||100
260127|NCT00449787|629239|P1|NOT COMPLETED|Overall Study||105
260128|NCT00449787|629238|P2|COMPLETED|Overall Study||98
260129|NCT00449787|629239|P1|COMPLETED|Overall Study||98
260130|NCT00449787|629238|P2|STARTED|Overall Study||198
260131|NCT00449787|629239|P1|STARTED|Overall Study||203
260132|NCT00449748|629249|P1|NOT COMPLETED|Overall Study||0
260133|NCT00449748|629249|P1|COMPLETED|Overall Study||10
260134|NCT00449748|629249|P1|STARTED|Overall Study||10
260135|NCT00449696|629255|P2|NOT COMPLETED|Overall Study||9
260136|NCT00449696|629256|P1|NOT COMPLETED|Overall Study||20
260137|NCT00449696|629255|P2|COMPLETED|Overall Study||119
260138|NCT00449696|629256|P1|COMPLETED|Overall Study||231
260139|NCT00449696|629255|P2|Analyzed Participants|Overall Study||128
260140|NCT00449696|629256|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
260141|NCT00449696|629255|P2|Received Injection|Overall Study||128
260142|NCT00449696|629256|P1|Received Injection|Overall Study||249
260143|NCT00449696|629255|P2|STARTED|Overall Study||128
260144|NCT00449696|629256|P1|STARTED|Overall Study||251
260145|NCT00449644|629282|P4|NOT COMPLETED|Overall Study||32
260146|NCT00449644|629283|P3|NOT COMPLETED|Overall Study||29
260147|NCT00449644|629284|P2|NOT COMPLETED|Overall Study||13
260148|NCT00449644|629285|P1|NOT COMPLETED|Overall Study||10
260149|NCT00449644|629282|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
260150|NCT00449644|629283|P3|COMPLETED|Overall Study||50
260151|NCT00449644|629284|P2|COMPLETED|Overall Study||11
260152|NCT00449644|629285|P1|COMPLETED|Overall Study||13
260153|NCT00449644|629282|P4|Rollover|Overall Study||1
260154|NCT00449644|629283|P3|Rollover|Overall Study||0
260155|NCT00449644|629284|P2|Rollover|Overall Study||0
260156|NCT00449644|629285|P1|Rollover|Overall Study||0
260157|NCT00449644|629282|P4|STARTED|Overall Study||81
260158|NCT00449644|629283|P3|STARTED|Overall Study||79
260159|NCT00449644|629284|P2|STARTED|Overall Study||24
260160|NCT00449644|629285|P1|STARTED|Overall Study||23
260161|NCT00449540|629305|P3|NOT COMPLETED|Treatment Phase||17
260162|NCT00449540|629306|P2|NOT COMPLETED|Treatment Phase||20
260163|NCT00449540|629307|P1|NOT COMPLETED|Treatment Phase||0
260164|NCT00449540|629305|P3|COMPLETED|Treatment Phase||82
260165|NCT00449540|629306|P2|COMPLETED|Treatment Phase||82
260166|NCT00449540|629307|P1|COMPLETED|Treatment Phase||0
260167|NCT00449540|629305|P3|STARTED|Treatment Phase||99
260168|NCT00449540|629306|P2|STARTED|Treatment Phase||102
260169|NCT00449540|629307|P1|STARTED|Treatment Phase||0
260170|NCT00449540|629305|P3|NOT COMPLETED|Pretreatment Phase||0
260171|NCT00449540|629306|P2|NOT COMPLETED|Pretreatment Phase||0
260172|NCT00449540|629307|P1|NOT COMPLETED|Pretreatment Phase||66
260173|NCT00449540|629305|P3|COMPLETED|Pretreatment Phase||0
260174|NCT00449540|629306|P2|COMPLETED|Pretreatment Phase||0
260175|NCT00449540|629307|P1|COMPLETED|Pretreatment Phase||201
260176|NCT00449540|629305|P3|STARTED|Pretreatment Phase||0
260177|NCT00449540|629306|P2|STARTED|Pretreatment Phase||0
260178|NCT00449540|629307|P1|STARTED|Pretreatment Phase||267
260179|NCT00449176|629324|P3|NOT COMPLETED|Overall Study||167
260180|NCT00449176|629325|P2|NOT COMPLETED|Overall Study||195
260181|NCT00449176|629326|P1|NOT COMPLETED|Overall Study||152
260182|NCT00449176|629324|P3|COMPLETED|Overall Study||152
260183|NCT00449176|629325|P2|COMPLETED|Overall Study||133
260184|NCT00449176|629326|P1|COMPLETED|Overall Study||166
260185|NCT00449176|629324|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
260186|NCT00449176|629325|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
260187|NCT00449176|629326|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
260188|NCT00449163|629352|P1|NOT COMPLETED|Overall Study||3
260189|NCT00449163|629352|P1|COMPLETED|Overall Study||22
260190|NCT00449163|629352|P1|STARTED|Overall Study||25
260191|NCT00449150|629362|P3|NOT COMPLETED|Overall Study||47
260192|NCT00449150|629363|P2|NOT COMPLETED|Overall Study||53
260193|NCT00449150|629364|P1|NOT COMPLETED|Overall Study||46
260194|NCT00449150|629362|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
260195|NCT00449150|629363|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
260196|NCT00449150|629364|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
260197|NCT00449150|629362|P3|STARTED|Overall Study||218
260198|NCT00449150|629363|P2|STARTED|Overall Study||230
260199|NCT00449150|629364|P1|STARTED|Overall Study||219
260200|NCT00449072|629374|P2|NOT COMPLETED|Overall Study||42
260201|NCT00449072|629375|P1|NOT COMPLETED|Overall Study||41
260202|NCT00449072|629374|P2|COMPLETED|Overall Study||109
260203|NCT00449072|629375|P1|COMPLETED|Overall Study||107
260204|NCT00449072|629374|P2|STARTED|Overall Study||151
260205|NCT00449072|629375|P1|STARTED|Overall Study||148
260206|NCT00449046|629399|P1|NOT COMPLETED|Overall Study||0
260207|NCT00449046|629399|P1|COMPLETED|Overall Study||40
260208|NCT00449046|629399|P1|STARTED|Overall Study||40
260209|NCT00449033|629412|P2|NOT COMPLETED|Follow-up Period||434
260210|NCT00449033|629413|P1|NOT COMPLETED|Follow-up Period||425
260211|NCT00449033|629412|P2|COMPLETED|Follow-up Period||0
260212|NCT00449033|629413|P1|COMPLETED|Follow-up Period||0
260213|NCT00449033|629412|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
260214|NCT00449033|629413|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
260215|NCT00449033|629412|P2|NOT COMPLETED|Treatment Period||452
260216|NCT00449033|629413|P1|NOT COMPLETED|Treatment Period||452
260217|NCT00449033|629412|P2|COMPLETED|Treatment Period||0
260218|NCT00449033|629413|P1|COMPLETED|Treatment Period||0
260219|NCT00449033|629412|P2|Received Treatment|Treatment Period||449
260220|NCT00449033|629413|P1|Received Treatment|Treatment Period||452
260221|NCT00449033|629412|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
260222|NCT00449033|629413|P1|STARTED|Treatment Period||452
260223|NCT00448916|629451|P4|NOT COMPLETED|Overall Study||6
260224|NCT00448916|629452|P3|NOT COMPLETED|Overall Study||6
260225|NCT00448916|629453|P2|NOT COMPLETED|Overall Study||6
260226|NCT00448916|629454|P1|NOT COMPLETED|Overall Study||7
260227|NCT00448916|629451|P4|COMPLETED|Overall Study||5
260228|NCT00448916|629452|P3|COMPLETED|Overall Study||6
260229|NCT00448916|629453|P2|COMPLETED|Overall Study||9
260230|NCT00448916|629454|P1|COMPLETED|Overall Study||9
260231|NCT00448916|629451|P4|STARTED|Overall Study||11
260232|NCT00448916|629452|P3|STARTED|Overall Study||12
260233|NCT00448916|629453|P2|STARTED|Overall Study||15
260234|NCT00448916|629454|P1|STARTED|Overall Study||16
260235|NCT00448864|629528|P3|NOT COMPLETED|Overall Study||1
260236|NCT00448864|629529|P2|NOT COMPLETED|Overall Study||5
260237|NCT00448864|629530|P1|NOT COMPLETED|Overall Study||5
260238|NCT00448864|629528|P3|COMPLETED|Overall Study||18
260239|NCT00448864|629529|P2|COMPLETED|Overall Study||24
260240|NCT00448864|629530|P1|COMPLETED|Overall Study||22
260241|NCT00448864|629528|P3|Completed Post-operative Period|Overall Study||18
260242|NCT00448864|629529|P2|Completed Post-operative Period|Overall Study||25
260243|NCT00448864|629530|P1|Completed Post-operative Period|Overall Study||26
260244|NCT00448864|629528|P3|Started Post-operative Period|Overall Study||18
260245|NCT00448864|629529|P2|Started Post-operative Period|Overall Study||25
260246|NCT00448864|629530|P1|Started Post-operative Period|Overall Study||26
260247|NCT00448864|629528|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
260248|NCT00448864|629529|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
260249|NCT00448864|629530|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
260250|NCT00448864|629528|P3|STARTED|Overall Study||19
260251|NCT00448864|629529|P2|STARTED|Overall Study||29
260252|NCT00448864|629530|P1|STARTED|Overall Study||27
260253|NCT00448760|629546|P1|NOT COMPLETED|Overall Study||3
260254|NCT00448760|629546|P1|COMPLETED|Overall Study||26
260255|NCT00448760|629546|P1|STARTED|Overall Study||29
260256|NCT00448708|629555|P2|NOT COMPLETED|Overall Study||31
260257|NCT00448708|629556|P1|NOT COMPLETED|Overall Study||35
260258|NCT00448708|629555|P2|COMPLETED|Overall Study||79
260259|NCT00448708|629556|P1|COMPLETED|Overall Study||77
260260|NCT00448708|629555|P2|STARTED|Overall Study||110
260261|NCT00448708|629556|P1|STARTED|Overall Study||112
260262|NCT00448682|629564|P1|NOT COMPLETED|Overall Study||0
260263|NCT00448682|629564|P1|COMPLETED|Overall Study||25
260264|NCT00448682|629564|P1|STARTED|Overall Study||25
260265|NCT00448630|629570|P1|NOT COMPLETED|Overall Study||27
260266|NCT00448630|629570|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
260267|NCT00448630|629570|P1|STARTED|Overall Study||328
260268|NCT00448591|629615|P1|NOT COMPLETED|Overall Study||2296
260269|NCT00448591|629615|P1|COMPLETED|Overall Study||0
260270|NCT00448591|629615|P1|STARTED|Overall Study||2296
260271|NCT00448539|629626|P2|NOT COMPLETED|Overall Study||152
260272|NCT00448539|629627|P1|NOT COMPLETED|Overall Study||134
260273|NCT00448539|629626|P2|COMPLETED|Overall Study||0
260274|NCT00448539|629627|P1|COMPLETED|Overall Study||0
260275|NCT00448539|629626|P2|STARTED|Overall Study||152
260276|NCT00448539|629627|P1|STARTED|Overall Study||134
260277|NCT00448448|629635|P2|NOT COMPLETED|Overall Study||41
260278|NCT00448448|629636|P1|NOT COMPLETED|Overall Study||100
260279|NCT00448448|629635|P2|COMPLETED|Overall Study||96
260280|NCT00448448|629636|P1|COMPLETED|Overall Study||146
260281|NCT00448448|629635|P2|STARTED|Overall Study||137
260282|NCT00448448|629636|P1|STARTED|Overall Study||246
260283|NCT00448435|629642|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
260284|NCT00448435|629643|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
260285|NCT00448435|629642|P2|COMPLETED|Extension Period - 20 Weeks||0
260286|NCT00448435|629643|P1|COMPLETED|Extension Period - 20 Weeks||50
260287|NCT00448435|629642|P2|STARTED|Extension Period - 20 Weeks||0
260288|NCT00448435|629643|P1|STARTED|Extension Period - 20 Weeks||50
260289|NCT00448435|629642|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
260290|NCT00448435|629643|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
260291|NCT00448435|629642|P2|COMPLETED|Treatment Period II - 4 Weeks||25
260292|NCT00448435|629643|P1|COMPLETED|Treatment Period II - 4 Weeks||25
260293|NCT00448435|629642|P2|STARTED|Treatment Period II - 4 Weeks||25
260294|NCT00448435|629643|P1|STARTED|Treatment Period II - 4 Weeks||25
260295|NCT00448435|629642|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
260296|NCT00448435|629643|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
260297|NCT00448435|629642|P2|COMPLETED|Washout Period - 2 Weeks||25
260298|NCT00448435|629643|P1|COMPLETED|Washout Period - 2 Weeks||25
260299|NCT00448435|629642|P2|STARTED|Washout Period - 2 Weeks||25
260300|NCT00448435|629643|P1|STARTED|Washout Period - 2 Weeks||26
260301|NCT00448435|629642|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
260302|NCT00448435|629643|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
260303|NCT00448435|629642|P2|COMPLETED|Treatment Period I - 4 Weeks||25
260304|NCT00448435|629643|P1|COMPLETED|Treatment Period I - 4 Weeks||26
260305|NCT00448435|629642|P2|STARTED|Treatment Period I - 4 Weeks||25
260306|NCT00448435|629643|P1|STARTED|Treatment Period I - 4 Weeks||26
260307|NCT00448357|629669|P1|NOT COMPLETED|Overall Study||0
260308|NCT00448357|629669|P1|COMPLETED|Overall Study||54
260309|NCT00448357|629669|P1|STARTED|Overall Study||54
260310|NCT00448344|629694|P2|NOT COMPLETED|Overall Study||36
260311|NCT00448344|629695|P1|NOT COMPLETED|Overall Study||30
260312|NCT00448344|629694|P2|COMPLETED|Overall Study||200
260313|NCT00448344|629695|P1|COMPLETED|Overall Study||205
260314|NCT00448344|629694|P2|STARTED|Overall Study||236
260315|NCT00448344|629695|P1|STARTED|Overall Study||235
260316|NCT00448279|629705|P2|NOT COMPLETED|Overall Study||29
260317|NCT00448279|629706|P1|NOT COMPLETED|Overall Study||29
260318|NCT00448279|629705|P2|COMPLETED|Overall Study||0
260319|NCT00448279|629706|P1|COMPLETED|Overall Study||0
260320|NCT00448279|629705|P2|STARTED|Overall Study||29
260321|NCT00448279|629706|P1|STARTED|Overall Study||29
260322|NCT00448227|629722|P1|NOT COMPLETED|Overall Study||0
260323|NCT00448227|629722|P1|COMPLETED|Overall Study||18
260324|NCT00448227|629722|P1|STARTED|Overall Study||18
260325|NCT00448201|629749|P1|NOT COMPLETED|Overall Study||0
260326|NCT00448201|629749|P1|COMPLETED|Overall Study||71
260327|NCT00448201|629749|P1|STARTED|Overall Study||71
260328|NCT00448175|629760|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
260329|NCT00448175|629761|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
260330|NCT00448175|629760|P2|COMPLETED|Continued PTNS Through 12 Months||0
260331|NCT00448175|629761|P1|COMPLETED|Continued PTNS Through 12 Months||25
260332|NCT00448175|629760|P2|STARTED|Continued PTNS Through 12 Months||0
260333|NCT00448175|629761|P1|STARTED|Continued PTNS Through 12 Months||35
260334|NCT00448175|629760|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
260335|NCT00448175|629761|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
260336|NCT00448175|629760|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
260337|NCT00448175|629761|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
260338|NCT00448175|629760|P2|STARTED|12 Weeks PTNS vs. Drug||50
260339|NCT00448175|629761|P1|STARTED|12 Weeks PTNS vs. Drug||50
260340|NCT00448136|629769|P2|NOT COMPLETED|Overall Study||8
260341|NCT00448136|629770|P1|NOT COMPLETED|Overall Study||4
260342|NCT00448136|629769|P2|COMPLETED|Overall Study||41
260343|NCT00448136|629770|P1|COMPLETED|Overall Study||30
260344|NCT00448136|629769|P2|STARTED|Overall Study||49
260345|NCT00448136|629770|P1|STARTED|Overall Study||34
260346|NCT00448123|629808|P2|NOT COMPLETED|Overall Study||12
260347|NCT00448123|629809|P1|NOT COMPLETED|Overall Study||15
260348|NCT00448123|629808|P2|COMPLETED|Overall Study||53
260349|NCT00448123|629809|P1|COMPLETED|Overall Study||47
260350|NCT00448123|629808|P2|STARTED|Overall Study||65
260351|NCT00448123|629809|P1|STARTED|Overall Study||62
260352|NCT00448019|629819|P1|NOT COMPLETED|Overall Study||7
260353|NCT00448019|629819|P1|COMPLETED|Overall Study||57
260354|NCT00448019|629819|P1|STARTED|Overall Study||64
260355|NCT00447902|629827|P2|NOT COMPLETED|Overall Study||6
260356|NCT00447902|629828|P1|NOT COMPLETED|Overall Study||4
260357|NCT00447902|629827|P2|COMPLETED|Overall Study||0
260358|NCT00447902|629828|P1|COMPLETED|Overall Study||1
260359|NCT00447902|629827|P2|STARTED|Overall Study||6
260360|NCT00447902|629828|P1|STARTED|Overall Study||5
260361|NCT00447876|629870|P2|NOT COMPLETED|Overall Study||4
260362|NCT00447876|629871|P1|NOT COMPLETED|Overall Study||3
260363|NCT00447876|629870|P2|COMPLETED|Overall Study||16
260364|NCT00447876|629871|P1|COMPLETED|Overall Study||17
260365|NCT00447876|629870|P2|STARTED|Overall Study||20
260366|NCT00447876|629871|P1|STARTED|Overall Study||20
260367|NCT00447603|629901|P3|NOT COMPLETED|Filter Period||15
260368|NCT00447603|629902|P2|NOT COMPLETED|Filter Period||4
260369|NCT00447603|629903|P1|NOT COMPLETED|Filter Period||0
260370|NCT00447603|629901|P3|COMPLETED|Filter Period||0
260371|NCT00447603|629902|P2|COMPLETED|Filter Period||0
260372|NCT00447603|629903|P1|COMPLETED|Filter Period||0
260373|NCT00447603|629901|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
260374|NCT00447603|629902|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
260375|NCT00447603|629903|P1|STARTED|Filter Period||0
260376|NCT00447603|629901|P3|NOT COMPLETED|Screening||0
260377|NCT00447603|629902|P2|NOT COMPLETED|Screening||0
260378|NCT00447603|629903|P1|NOT COMPLETED|Screening||21
260379|NCT00447603|629901|P3|COMPLETED|Screening||0
260380|NCT00447603|629902|P2|COMPLETED|Screening||0
260381|NCT00447603|629903|P1|COMPLETED|Screening||19
260382|NCT00447603|629901|P3|STARTED|Screening||0
260383|NCT00447603|629902|P2|STARTED|Screening||0
260384|NCT00447603|629903|P1|STARTED|Screening||40
260385|NCT00447590|629923|P1|NOT COMPLETED|Overall Study||60
260386|NCT00447590|629923|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
260387|NCT00447590|629923|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
260388|NCT00447499|629932|P1|NOT COMPLETED|Overall Study||7
260389|NCT00447499|629932|P1|COMPLETED|Overall Study||52
260390|NCT00447499|629932|P1|STARTED|Overall Study||59
260391|NCT00447421|629942|P1|NOT COMPLETED|Overall Study||6
260392|NCT00447421|629942|P1|COMPLETED|Overall Study||3
260393|NCT00447421|629942|P1|STARTED|Overall Study||9
260394|NCT00447382|629954|P2|NOT COMPLETED|Overall Study||6
260395|NCT00447382|629955|P1|NOT COMPLETED|Overall Study||6
260396|NCT00447382|629954|P2|COMPLETED|Overall Study||160
260397|NCT00447382|629955|P1|COMPLETED|Overall Study||158
260398|NCT00447382|629954|P2|STARTED|Overall Study||166
260399|NCT00447382|629955|P1|STARTED|Overall Study||164
260400|NCT00447330|630007|P1|NOT COMPLETED|Overall Study||2
260401|NCT00447330|630007|P1|COMPLETED|Overall Study||58
260402|NCT00447330|630007|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
260403|NCT00447278|630016|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
260404|NCT00447278|630017|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
260405|NCT00447278|630016|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
260406|NCT00447278|630017|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
260407|NCT00447278|630016|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
260408|NCT00447278|630017|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
260409|NCT00447278|630016|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
260410|NCT00447278|630017|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
260411|NCT00447278|630016|P2|COMPLETED|Period II (6 Month Open-Label)||171
260412|NCT00447278|630017|P1|COMPLETED|Period II (6 Month Open-Label)||157
260413|NCT00447278|630016|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
260414|NCT00447278|630017|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
260415|NCT00447278|630016|P2|STARTED|Period II (6 Month Open-Label)||200
260416|NCT00447278|630017|P1|STARTED|Period II (6 Month Open-Label)||199
260417|NCT00447265|630038|P2|NOT COMPLETED|Overall Study||0
260418|NCT00447265|630039|P1|NOT COMPLETED|Overall Study||1
260419|NCT00447265|630038|P2|COMPLETED|Overall Study||0
260420|NCT00447265|630039|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
260421|NCT00447265|630038|P2|STARTED|Overall Study||0
260422|NCT00447265|630039|P1|STARTED|Overall Study||1
260423|NCT00447226|630052|P2|NOT COMPLETED|Double-blind Phase||3
260424|NCT00447226|630053|P1|NOT COMPLETED|Double-blind Phase||4
260425|NCT00447226|630052|P2|COMPLETED|Double-blind Phase||0
260426|NCT00447226|630053|P1|COMPLETED|Double-blind Phase||0
260427|NCT00447226|630052|P2|STARTED|Double-blind Phase||3
260428|NCT00447226|630053|P1|STARTED|Double-blind Phase||4
260429|NCT00447226|630052|P2|NOT COMPLETED|12-Week Open-label Phase||25
260430|NCT00447226|630053|P1|NOT COMPLETED|12-Week Open-label Phase||0
260431|NCT00447226|630052|P2|COMPLETED|12-Week Open-label Phase||7
260432|NCT00447226|630053|P1|COMPLETED|12-Week Open-label Phase||0
260433|NCT00447226|630052|P2|STARTED|12-Week Open-label Phase||32
260434|NCT00447226|630053|P1|STARTED|12-Week Open-label Phase||0
260435|NCT00447122|630071|P1|NOT COMPLETED|Overall Study||2
260436|NCT00447122|630071|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
260437|NCT00447122|630071|P1|STARTED|Overall Study||31
260438|NCT00447057|630079|P4|NOT COMPLETED|Overall Study||26
260439|NCT00447057|630080|P3|NOT COMPLETED|Overall Study||19
260440|NCT00447057|630081|P2|NOT COMPLETED|Overall Study||73
260441|NCT00447057|630082|P1|NOT COMPLETED|Overall Study||83
260442|NCT00447057|630079|P4|COMPLETED|Overall Study||0
260443|NCT00447057|630080|P3|COMPLETED|Overall Study||0
260444|NCT00447057|630081|P2|COMPLETED|Overall Study||3
260445|NCT00447057|630082|P1|COMPLETED|Overall Study||0
260446|NCT00447057|630079|P4|STARTED|Overall Study||26
260447|NCT00447057|630080|P3|STARTED|Overall Study||19
260448|NCT00447057|630081|P2|STARTED|Overall Study||76
260449|NCT00447057|630082|P1|STARTED|Overall Study||83
260450|NCT00447005|630100|P1|NOT COMPLETED|Overall Study||12
260451|NCT00447005|630100|P1|COMPLETED|Overall Study||0
260452|NCT00447005|630100|P1|STARTED|Overall Study||12
260453|NCT00446992|630114|P1|NOT COMPLETED|Overall Study||16
260454|NCT00446992|630114|P1|COMPLETED|Overall Study|Intervention Completion|14
260455|NCT00446992|630114|P1|STARTED|Overall Study|Beginning of Intervention|30
260456|NCT00446849|630126|P1|NOT COMPLETED|Maintenance Phase||70
260457|NCT00446849|630126|P1|COMPLETED|Maintenance Phase||138
260458|NCT00446849|630126|P1|STARTED|Maintenance Phase||208
260459|NCT00446849|630126|P1|NOT COMPLETED|Acute Phase||82
260460|NCT00446849|630126|P1|COMPLETED|Acute Phase||56
260461|NCT00446849|630126|P1|STARTED|Acute Phase||138
260462|NCT00446797|630138|P2|NOT COMPLETED|Overall Study||12
260463|NCT00446797|630139|P1|NOT COMPLETED|Overall Study||8
260464|NCT00446797|630138|P2|COMPLETED|Overall Study||125
260465|NCT00446797|630139|P1|COMPLETED|Overall Study||133
260466|NCT00446797|630138|P2|STARTED|Overall Study||137
260467|NCT00446797|630139|P1|STARTED|Overall Study||141
260468|NCT00446654|630185|P2|NOT COMPLETED|Overall Study||0
260469|NCT00446654|630186|P1|NOT COMPLETED|Overall Study||2
260470|NCT00446654|630185|P2|COMPLETED|Overall Study||22
260471|NCT00446654|630186|P1|COMPLETED|Overall Study||19
260472|NCT00446654|630185|P2|STARTED|Overall Study||22
260473|NCT00446654|630186|P1|STARTED|Overall Study||21
260474|NCT00446641|630194|P2|NOT COMPLETED|Overall Study||10
260475|NCT00446641|630195|P1|NOT COMPLETED|Overall Study||17
260476|NCT00446641|630194|P2|COMPLETED|Overall Study||109
260477|NCT00446641|630195|P1|COMPLETED|Overall Study||108
260478|NCT00446641|630194|P2|STARTED|Overall Study||119
260479|NCT00446641|630195|P1|STARTED|Overall Study||125
260480|NCT00446563|630215|P2|NOT COMPLETED|Overall Study||9
260481|NCT00446563|630216|P1|NOT COMPLETED|Overall Study||7
260482|NCT00446563|630215|P2|COMPLETED|Overall Study||38
260483|NCT00446563|630216|P1|COMPLETED|Overall Study||36
260484|NCT00446563|630215|P2|STARTED|Overall Study||47
260485|NCT00446563|630216|P1|STARTED|Overall Study||43
260486|NCT00446511|630254|P4|NOT COMPLETED|Overall Study||6
260487|NCT00446511|630255|P3|NOT COMPLETED|Overall Study||7
260488|NCT00446511|630256|P2|NOT COMPLETED|Overall Study||2
260489|NCT00446511|630257|P1|NOT COMPLETED|Overall Study||10
260490|NCT00446511|630254|P4|COMPLETED|Overall Study||103
260491|NCT00446511|630255|P3|COMPLETED|Overall Study||96
260492|NCT00446511|630256|P2|COMPLETED|Overall Study||15
260493|NCT00446511|630257|P1|COMPLETED|Overall Study||11
260494|NCT00446511|630254|P4|STARTED|Overall Study||109
260495|NCT00446511|630255|P3|STARTED|Overall Study||103
260496|NCT00446511|630256|P2|STARTED|Overall Study||17
260497|NCT00446511|630257|P1|STARTED|Overall Study||21
260498|NCT00446459|630281|P1|NOT COMPLETED|12 Months||18
260499|NCT00446459|630281|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
260500|NCT00446459|630281|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
260501|NCT00446459|630281|P1|NOT COMPLETED|8 Months||12
260502|NCT00446459|630281|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
260503|NCT00446459|630281|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
260504|NCT00446446|630289|P1|NOT COMPLETED|Overall Study||24
260505|NCT00446446|630289|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
260506|NCT00446446|630289|P1|STARTED|Overall Study||52
260507|NCT00446290|630300|P1|NOT COMPLETED|Overall Study||0
260508|NCT00446290|630300|P1|COMPLETED|Overall Study||22
260509|NCT00446290|630300|P1|STARTED|Overall Study||22
260510|NCT00446264|630304|P1|NOT COMPLETED|Overall Study||0
260511|NCT00446264|630304|P1|COMPLETED|Overall Study||14
260512|NCT00446264|630304|P1|STARTED|Overall Study||14
260513|NCT00446251|630313|P1|NOT COMPLETED|Overall Study||5
260514|NCT00446251|630313|P1|COMPLETED|Overall Study||9
260515|NCT00446251|630313|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
260516|NCT00446199|630323|P4|NOT COMPLETED|Overall Study||30
260517|NCT00446199|630324|P3|NOT COMPLETED|Overall Study||27
260518|NCT00446199|630325|P2|NOT COMPLETED|Overall Study||20
260519|NCT00446199|630326|P1|NOT COMPLETED|Overall Study||23
260520|NCT00446199|630323|P4|COMPLETED|Overall Study||153
260521|NCT00446199|630324|P3|COMPLETED|Overall Study||158
260522|NCT00446199|630325|P2|COMPLETED|Overall Study||164
260523|NCT00446199|630326|P1|COMPLETED|Overall Study||160
260524|NCT00446199|630323|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
260525|NCT00446199|630324|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
260526|NCT00446199|630325|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
260527|NCT00446199|630326|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
260528|NCT00446199|630323|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
260529|NCT00446199|630324|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
260530|NCT00446199|630325|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
260531|NCT00446199|630326|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
260532|NCT00446199|630323|P4|STARTED|Overall Study||183
260533|NCT00446199|630324|P3|STARTED|Overall Study||185
260534|NCT00446199|630325|P2|STARTED|Overall Study||184
260535|NCT00446199|630326|P1|STARTED|Overall Study||183
260536|NCT00446147|630406|P2|NOT COMPLETED|Overall Study||14
260537|NCT00446147|630407|P1|NOT COMPLETED|Overall Study||15
260538|NCT00446147|630406|P2|COMPLETED|Overall Study||180
260539|NCT00446147|630407|P1|COMPLETED|Overall Study||180
260540|NCT00446147|630406|P2|STARTED|Overall Study||194
260541|NCT00446147|630407|P1|STARTED|Overall Study||195
260542|NCT00446134|630419|P4|NOT COMPLETED|Overall Study||45
260543|NCT00446134|630420|P3|NOT COMPLETED|Overall Study||43
260544|NCT00446134|630421|P2|NOT COMPLETED|Overall Study||45
260545|NCT00446134|630422|P1|NOT COMPLETED|Overall Study||34
260546|NCT00446134|630419|P4|COMPLETED|Overall Study||25
260547|NCT00446134|630420|P3|COMPLETED|Overall Study||26
260548|NCT00446134|630421|P2|COMPLETED|Overall Study||25
260549|NCT00446134|630422|P1|COMPLETED|Overall Study||35
260550|NCT00446134|630419|P4|STARTED|Overall Study||70
260551|NCT00446134|630420|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
260552|NCT00446134|630421|P2|STARTED|Overall Study||70
260553|NCT00446134|630422|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
260554|NCT00446095|630449|P5|NOT COMPLETED|Phase I (28 Days)||3
260555|NCT00446095|630450|P4|NOT COMPLETED|Phase I (28 Days)||1
260556|NCT00446095|630451|P3|NOT COMPLETED|Phase I (28 Days)||0
260557|NCT00446095|630452|P2|NOT COMPLETED|Phase I (28 Days)||0
260558|NCT00446095|630453|P1|NOT COMPLETED|Phase I (28 Days)||0
260559|NCT00446095|630449|P5|COMPLETED|Phase I (28 Days)||4
260560|NCT00446095|630450|P4|COMPLETED|Phase I (28 Days)||5
260561|NCT00446095|630451|P3|COMPLETED|Phase I (28 Days)||0
260562|NCT00446095|630452|P2|COMPLETED|Phase I (28 Days)||0
260563|NCT00446095|630453|P1|COMPLETED|Phase I (28 Days)||0
260564|NCT00446095|630449|P5|STARTED|Phase I (28 Days)||7
260565|NCT00446095|630450|P4|STARTED|Phase I (28 Days)||6
260566|NCT00446095|630451|P3|STARTED|Phase I (28 Days)||0
260567|NCT00446095|630452|P2|STARTED|Phase I (28 Days)||0
260568|NCT00446095|630453|P1|STARTED|Phase I (28 Days)||0
260569|NCT00446095|630449|P5|NOT COMPLETED|Phase II (8 Weeks)||0
260570|NCT00446095|630450|P4|NOT COMPLETED|Phase II (8 Weeks)||0
260571|NCT00446095|630451|P3|NOT COMPLETED|Phase II (8 Weeks)||3
260572|NCT00446095|630452|P2|NOT COMPLETED|Phase II (8 Weeks)||3
260573|NCT00446095|630453|P1|NOT COMPLETED|Phase II (8 Weeks)||12
260574|NCT00446095|630449|P5|COMPLETED|Phase II (8 Weeks)||0
260575|NCT00446095|630450|P4|COMPLETED|Phase II (8 Weeks)||0
260576|NCT00446095|630451|P3|COMPLETED|Phase II (8 Weeks)||21
260577|NCT00446095|630452|P2|COMPLETED|Phase II (8 Weeks)||18
260578|NCT00446095|630453|P1|COMPLETED|Phase II (8 Weeks)||11
260579|NCT00446095|630449|P5|STARTED|Phase II (8 Weeks)||0
260580|NCT00446095|630450|P4|STARTED|Phase II (8 Weeks)||0
260581|NCT00446095|630451|P3|STARTED|Phase II (8 Weeks)||24
260582|NCT00446095|630452|P2|STARTED|Phase II (8 Weeks)||21
260583|NCT00446095|630453|P1|STARTED|Phase II (8 Weeks)||23
260584|NCT00446030|630476|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
260585|NCT00446030|630477|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
260586|NCT00446030|630476|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
260587|NCT00446030|630477|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
260588|NCT00446030|630476|P2|STARTED|FOLLOW-UP (up to 2-years)||34
260589|NCT00446030|630477|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
260590|NCT00446030|630476|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
260591|NCT00446030|630477|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
260592|NCT00446030|630476|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
260593|NCT00446030|630477|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
260594|NCT00446030|630476|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
260595|NCT00446030|630477|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
260596|NCT00446030|630476|P2|STARTED|TREATMENT (up to 52 Weeks)||34
260597|NCT00446030|630477|P1|STARTED|TREATMENT (up to 52 Weeks)||93
260598|NCT00445939|630488|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
260599|NCT00445939|630489|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
260600|NCT00445939|630490|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
260601|NCT00445939|630491|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
260602|NCT00445939|630488|P4|COMPLETED|Period B - Week 4 - Week 8||20
260603|NCT00445939|630489|P3|COMPLETED|Period B - Week 4 - Week 8||0
260604|NCT00445939|630490|P2|COMPLETED|Period B - Week 4 - Week 8||0
260605|NCT00445939|630491|P1|COMPLETED|Period B - Week 4 - Week 8||14
260606|NCT00445939|630488|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
260607|NCT00445939|630489|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
260608|NCT00445939|630490|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
260609|NCT00445939|630491|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
260610|NCT00445939|630488|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
260611|NCT00445939|630489|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
260612|NCT00445939|630490|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
260613|NCT00445939|630491|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
260614|NCT00445939|630488|P4|COMPLETED|Period A - Week 0 - Week 4||0
260615|NCT00445939|630489|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
260616|NCT00445939|630490|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
260617|NCT00445939|630491|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
260618|NCT00445939|630488|P4|STARTED|Period A - Week 0 - Week 4||0
260619|NCT00445939|630489|P3|STARTED|Period A - Week 0 - Week 4||23
260620|NCT00445939|630490|P2|STARTED|Period A - Week 0 - Week 4||34
260621|NCT00445939|630491|P1|STARTED|Period A - Week 0 - Week 4||33
260622|NCT00445887|630516|P2|NOT COMPLETED|Overall Study||0
260623|NCT00445887|630517|P1|NOT COMPLETED|Overall Study||0
260624|NCT00445887|630516|P2|COMPLETED|Overall Study||31
260625|NCT00445887|630517|P1|COMPLETED|Overall Study||33
260626|NCT00445887|630516|P2|STARTED|Overall Study||31
260627|NCT00445887|630517|P1|STARTED|Overall Study||33
260628|NCT00445848|630539|P1|NOT COMPLETED|Overall Study||85
260629|NCT00445848|630539|P1|COMPLETED|Overall Study||0
260630|NCT00445848|630539|P1|STARTED|Overall Study||85
260631|NCT00445770|630549|P3|NOT COMPLETED|Overall Study||31
260632|NCT00445770|630550|P2|NOT COMPLETED|Overall Study||35
260633|NCT00445770|630551|P1|NOT COMPLETED|Overall Study||53
260634|NCT00445770|630549|P3|COMPLETED|Overall Study||151
260635|NCT00445770|630550|P2|COMPLETED|Overall Study||157
260636|NCT00445770|630551|P1|COMPLETED|Overall Study||123
260637|NCT00445770|630549|P3|STARTED|Overall Study||182
260638|NCT00445770|630550|P2|STARTED|Overall Study||192
260639|NCT00445770|630551|P1|STARTED|Overall Study||176
260640|NCT00445744|630618|P1|NOT COMPLETED|Overall Study||1
260641|NCT00445744|630618|P1|COMPLETED|Overall Study||51
260642|NCT00445744|630618|P1|STARTED|Overall Study||52
260643|NCT00445705|630627|P4|NOT COMPLETED|Overall Study||14
260644|NCT00445705|630628|P3|NOT COMPLETED|Overall Study||11
260645|NCT00445705|630629|P2|NOT COMPLETED|Overall Study||11
260646|NCT00445705|630630|P1|NOT COMPLETED|Overall Study||9
260647|NCT00445705|630627|P4|COMPLETED|Overall Study||39
260648|NCT00445705|630628|P3|COMPLETED|Overall Study||41
260649|NCT00445705|630629|P2|COMPLETED|Overall Study||42
260650|NCT00445705|630630|P1|COMPLETED|Overall Study||44
260651|NCT00445705|630627|P4|STARTED|Overall Study||53
260652|NCT00445705|630628|P3|STARTED|Overall Study||52
260653|NCT00445705|630629|P2|STARTED|Overall Study||53
260654|NCT00445705|630630|P1|STARTED|Overall Study||53
260655|NCT00445692|630652|P1|NOT COMPLETED|Overall Study||16
260656|NCT00445692|630652|P1|COMPLETED|Overall Study||15
260657|NCT00445692|630652|P1|STARTED|Overall Study||31
260658|NCT00445679|630662|P4|NOT COMPLETED|Overall Study||47
260659|NCT00445679|630663|P3|NOT COMPLETED|Overall Study||66
260660|NCT00445679|630664|P2|NOT COMPLETED|Overall Study||46
260661|NCT00445679|630665|P1|NOT COMPLETED|Overall Study||48
260662|NCT00445679|630662|P4|COMPLETED|Overall Study||149
260663|NCT00445679|630663|P3|COMPLETED|Overall Study||139
260664|NCT00445679|630664|P2|COMPLETED|Overall Study||157
260665|NCT00445679|630665|P1|COMPLETED|Overall Study||155
260666|NCT00445679|630662|P4|STARTED|Overall Study||196
260667|NCT00445679|630663|P3|STARTED|Overall Study||205
260668|NCT00445679|630664|P2|STARTED|Overall Study||203
260669|NCT00445679|630665|P1|STARTED|Overall Study||203
260670|NCT00445601|630701|P2|NOT COMPLETED|Overall Study||28
260671|NCT00445601|630702|P1|NOT COMPLETED|Overall Study||33
260672|NCT00445601|630701|P2|COMPLETED|Overall Study||177
260673|NCT00445601|630702|P1|COMPLETED|Overall Study||168
260674|NCT00445601|630701|P2|Received TURBT|Overall Study||193
260675|NCT00445601|630702|P1|Received TURBT|Overall Study||190
260676|NCT00445601|630701|P2|STARTED|Overall Study||205
260677|NCT00445601|630702|P1|STARTED|Overall Study||201
260678|NCT00445588|630714|P1|NOT COMPLETED|Overall Study||0
260679|NCT00445588|630714|P1|COMPLETED|Overall Study||56
260680|NCT00445588|630714|P1|STARTED|Overall Study||56
260681|NCT00445549|630719|P1|NOT COMPLETED|Overall Study||12
260682|NCT00445549|630719|P1|COMPLETED|Overall Study||0
260683|NCT00445549|630719|P1|STARTED|Overall Study||12
260684|NCT00445484|630726|P2|NOT COMPLETED|Overall Study||1
260685|NCT00445484|630727|P1|NOT COMPLETED|Overall Study||4
260686|NCT00445484|630726|P2|COMPLETED|Overall Study||10
260687|NCT00445484|630727|P1|COMPLETED|Overall Study||7
260688|NCT00445484|630726|P2|STARTED|Overall Study||11
260689|NCT00445484|630727|P1|STARTED|Overall Study||11
260690|NCT00445458|630743|P4|NOT COMPLETED|Overall Study||28
260691|NCT00445458|630744|P3|NOT COMPLETED|Overall Study||68
260692|NCT00445458|630745|P2|NOT COMPLETED|Overall Study||5
260693|NCT00445458|630746|P1|NOT COMPLETED|Overall Study||3
260694|NCT00445458|630743|P4|COMPLETED|Overall Study||3
260695|NCT00445458|630744|P3|COMPLETED|Overall Study||3
260696|NCT00445458|630745|P2|COMPLETED|Overall Study||0
260697|NCT00445458|630746|P1|COMPLETED|Overall Study||0
260698|NCT00445458|630743|P4|STARTED|Overall Study||31
260699|NCT00445458|630744|P3|STARTED|Overall Study||71
260700|NCT00445458|630745|P2|STARTED|Overall Study||5
260701|NCT00445458|630746|P1|STARTED|Overall Study||3
260702|NCT00445432|630764|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
260703|NCT00445432|630765|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
260704|NCT00445432|630766|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
260705|NCT00445432|630767|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
260706|NCT00445432|630764|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
260707|NCT00445432|630765|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
260708|NCT00445432|630766|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
260709|NCT00445432|630767|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
260710|NCT00445432|630764|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
260711|NCT00445432|630765|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
260712|NCT00445432|630766|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
260713|NCT00445432|630767|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
260714|NCT00445432|630764|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
260715|NCT00445432|630765|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
260716|NCT00445432|630766|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
260717|NCT00445432|630767|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
260718|NCT00445432|630764|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
260719|NCT00445432|630765|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
260720|NCT00445432|630766|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
260721|NCT00445432|630767|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
260722|NCT00445432|630764|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
260723|NCT00445432|630765|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
260724|NCT00445432|630766|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
260725|NCT00445432|630767|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
260726|NCT00445341|630800|P1|NOT COMPLETED|Overall Study||2
260727|NCT00445341|630800|P1|COMPLETED|Overall Study||26
260728|NCT00445341|630800|P1|STARTED|Overall Study||28
260729|NCT00445328|630807|P2|NOT COMPLETED|Overall Study||6
260730|NCT00445328|630808|P1|NOT COMPLETED|Overall Study||3
260731|NCT00445328|630807|P2|COMPLETED|Overall Study||36
260732|NCT00445328|630808|P1|COMPLETED|Overall Study||39
260733|NCT00445328|630807|P2|Received Treatment|Overall Study||42
260734|NCT00445328|630808|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
260735|NCT00445328|630807|P2|STARTED|Overall Study||42
260736|NCT00445328|630808|P1|STARTED|Overall Study||42
260737|NCT00445315|630831|P5|NOT COMPLETED|Overall Study||0
260738|NCT00445315|630832|P4|NOT COMPLETED|Overall Study||0
260739|NCT00445315|630833|P3|NOT COMPLETED|Overall Study||0
260740|NCT00445315|630834|P2|NOT COMPLETED|Overall Study||0
260741|NCT00445315|630835|P1|NOT COMPLETED|Overall Study||0
260742|NCT00445315|630831|P5|COMPLETED|Overall Study||8
260743|NCT00445315|630832|P4|COMPLETED|Overall Study||6
260744|NCT00445315|630833|P3|COMPLETED|Overall Study||6
260745|NCT00445315|630834|P2|COMPLETED|Overall Study||6
260746|NCT00445315|630835|P1|COMPLETED|Overall Study||6
260747|NCT00445315|630831|P5|STARTED|Overall Study||8
260748|NCT00445315|630832|P4|STARTED|Overall Study||6
260749|NCT00445315|630833|P3|STARTED|Overall Study||6
260750|NCT00445315|630834|P2|STARTED|Overall Study||6
260751|NCT00445315|630835|P1|STARTED|Overall Study||6
260752|NCT00445302|630929|P4|NOT COMPLETED|Overall Study||0
260753|NCT00445302|630930|P3|NOT COMPLETED|Overall Study||0
260754|NCT00445302|630931|P2|NOT COMPLETED|Overall Study||0
260755|NCT00445302|630932|P1|NOT COMPLETED|Overall Study||0
260756|NCT00445302|630929|P4|COMPLETED|Overall Study||6
260757|NCT00445302|630930|P3|COMPLETED|Overall Study||6
260758|NCT00445302|630931|P2|COMPLETED|Overall Study||5
260759|NCT00445302|630932|P1|COMPLETED|Overall Study||6
260760|NCT00445302|630929|P4|STARTED|Overall Study||6
260761|NCT00445302|630930|P3|STARTED|Overall Study||6
260762|NCT00445302|630931|P2|STARTED|Overall Study||5
260763|NCT00445302|630932|P1|STARTED|Overall Study||6
260764|NCT00445263|630960|P2|NOT COMPLETED|Overall Study||1
260765|NCT00445263|630961|P1|NOT COMPLETED|Overall Study||0
260766|NCT00445263|630960|P2|COMPLETED|Overall Study||86
260767|NCT00445263|630961|P1|COMPLETED|Overall Study||83
260768|NCT00445263|630960|P2|STARTED|Overall Study||87
260769|NCT00445263|630961|P1|STARTED|Overall Study||83
260770|NCT00445224|630969|P2|NOT COMPLETED|Combined Exercises||0
260771|NCT00445224|630970|P1|NOT COMPLETED|Combined Exercises||0
260772|NCT00445224|630969|P2|COMPLETED|Combined Exercises||13
260773|NCT00445224|630970|P1|COMPLETED|Combined Exercises||13
260774|NCT00445224|630969|P2|STARTED|Combined Exercises||13
260775|NCT00445224|630970|P1|STARTED|Combined Exercises||13
260776|NCT00445224|630969|P2|NOT COMPLETED|Specific Exercises||3
260777|NCT00445224|630970|P1|NOT COMPLETED|Specific Exercises||4
260778|NCT00445224|630969|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
260779|NCT00445224|630970|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
260780|NCT00445224|630969|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
260781|NCT00445224|630970|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
260782|NCT00445224|630969|P2|Baseline|Specific Exercises||16
260783|NCT00445224|630970|P1|Baseline|Specific Exercises||17
260784|NCT00445224|630969|P2|STARTED|Specific Exercises||16
260785|NCT00445224|630970|P1|STARTED|Specific Exercises||17
260786|NCT00445211|630982|P2|NOT COMPLETED|Overall Study||0
260787|NCT00445211|630983|P1|NOT COMPLETED|Overall Study||0
260788|NCT00445211|630982|P2|COMPLETED|Overall Study||23
260789|NCT00445211|630983|P1|COMPLETED|Overall Study||23
260790|NCT00445211|630982|P2|STARTED|Overall Study||23
260791|NCT00445211|630983|P1|STARTED|Overall Study||23
260792|NCT00445146|630997|P1|NOT COMPLETED|Overall Study||119
260793|NCT00445146|630997|P1|COMPLETED|Overall Study||73
260794|NCT00445146|630997|P1|STARTED|Overall Study||192
260795|NCT00445003|631019|P3|NOT COMPLETED|Overall Study||4
260796|NCT00445003|631020|P2|NOT COMPLETED|Overall Study||10
260797|NCT00445003|631021|P1|NOT COMPLETED|Overall Study||5
260798|NCT00445003|631019|P3|COMPLETED|Overall Study||105
260799|NCT00445003|631020|P2|COMPLETED|Overall Study||103
260800|NCT00445003|631021|P1|COMPLETED|Overall Study||118
260801|NCT00445003|631019|P3|STARTED|Overall Study||109
260802|NCT00445003|631020|P2|STARTED|Overall Study||113
260803|NCT00445003|631021|P1|STARTED|Overall Study||123
260804|NCT00444951|631053|P3|NOT COMPLETED|Overall Study||3
260805|NCT00444951|631054|P2|NOT COMPLETED|Overall Study||6
260806|NCT00444951|631055|P1|NOT COMPLETED|Overall Study||5
260807|NCT00444951|631053|P3|COMPLETED|Overall Study||160
260808|NCT00444951|631054|P2|COMPLETED|Overall Study||136
260809|NCT00444951|631055|P1|COMPLETED|Overall Study||140
260810|NCT00444951|631053|P3|STARTED|Overall Study||163
260811|NCT00444951|631054|P2|STARTED|Overall Study||142
260812|NCT00444951|631055|P1|STARTED|Overall Study||145
260813|NCT00444925|631072|P3|NOT COMPLETED|Double-blind Treatment Period||81
260814|NCT00444925|631073|P2|NOT COMPLETED|Double-blind Treatment Period||56
260815|NCT00444925|631074|P1|NOT COMPLETED|Double-blind Treatment Period||30
260816|NCT00444925|631072|P3|COMPLETED|Double-blind Treatment Period||598
260817|NCT00444925|631073|P2|COMPLETED|Double-blind Treatment Period||628
260818|NCT00444925|631074|P1|COMPLETED|Double-blind Treatment Period||304
260819|NCT00444925|631072|P3|STARTED|Double-blind Treatment Period||679
260820|NCT00444925|631073|P2|STARTED|Double-blind Treatment Period||684
260821|NCT00444925|631074|P1|STARTED|Double-blind Treatment Period||334
260822|NCT00444925|631072|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
260823|NCT00444925|631073|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
260824|NCT00444925|631074|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
260825|NCT00444925|631072|P3|COMPLETED|Randomized to Double-blind Treatment||679
260826|NCT00444925|631073|P2|COMPLETED|Randomized to Double-blind Treatment||684
260827|NCT00444925|631074|P1|COMPLETED|Randomized to Double-blind Treatment||334
260828|NCT00444925|631072|P3|STARTED|Randomized to Double-blind Treatment||685
260829|NCT00444925|631073|P2|STARTED|Randomized to Double-blind Treatment||690
260830|NCT00444925|631074|P1|STARTED|Randomized to Double-blind Treatment||337
260831|NCT00444925|631072|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
260832|NCT00444925|631073|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
260833|NCT00444925|631074|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
260834|NCT00444925|631072|P3|COMPLETED|Single-blind Placebo Run-In Period||0
260835|NCT00444925|631073|P2|COMPLETED|Single-blind Placebo Run-In Period||0
260836|NCT00444925|631074|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
260837|NCT00444925|631072|P3|STARTED|Single-blind Placebo Run-In Period||0
260838|NCT00444925|631073|P2|STARTED|Single-blind Placebo Run-In Period||0
260839|NCT00444925|631074|P1|STARTED|Single-blind Placebo Run-In Period||2446
260840|NCT00444912|631138|P2|NOT COMPLETED|Overall Study||2
260841|NCT00444912|631139|P1|NOT COMPLETED|Overall Study||3
260842|NCT00444912|631138|P2|COMPLETED|Overall Study||13
260843|NCT00444912|631139|P1|COMPLETED|Overall Study||12
260844|NCT00444912|631138|P2|Received Transplant|Overall Study||14
260845|NCT00444912|631139|P1|Received Transplant|Overall Study||14
260846|NCT00444912|631138|P2|Received Plerixafor|Overall Study||15
260847|NCT00444912|631139|P1|Received Plerixafor|Overall Study||15
260848|NCT00444912|631138|P2|STARTED|Overall Study||15
260849|NCT00444912|631139|P1|STARTED|Overall Study||15
260850|NCT00444821|631169|P2|NOT COMPLETED|Overall Study||366
260851|NCT00444821|631170|P1|NOT COMPLETED|Overall Study||362
260852|NCT00444821|631169|P2|COMPLETED|Overall Study||0
260853|NCT00444821|631170|P1|COMPLETED|Overall Study||0
260854|NCT00444821|631169|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
260855|NCT00444821|631170|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
260856|NCT00444821|631169|P2|STARTED|Overall Study||366
260857|NCT00444821|631170|P1|STARTED|Overall Study||362
260858|NCT00444795|631180|P1|NOT COMPLETED|Overall Study||3
260859|NCT00444795|631180|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
260860|NCT00444795|631180|P1|STARTED|Overall Study||620
260861|NCT00444626|631185|P1|NOT COMPLETED|Repeat Treatment Period||0
260862|NCT00444626|631185|P1|COMPLETED|Repeat Treatment Period||105
260863|NCT00444626|631185|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
260864|NCT00444626|631185|P1|NOT COMPLETED|Initial Treatment Period||12
260865|NCT00444626|631185|P1|COMPLETED|Initial Treatment Period||128
260866|NCT00444626|631185|P1|STARTED|Initial Treatment Period||140
260867|NCT00444600|631215|P4|NOT COMPLETED|Overall Study||10
260868|NCT00444600|631216|P3|NOT COMPLETED|Overall Study||10
260869|NCT00444600|631217|P2|NOT COMPLETED|Overall Study||16
260870|NCT00444600|631218|P1|NOT COMPLETED|Overall Study||19
260871|NCT00444600|631215|P4|COMPLETED|Overall Study|Number of eyes|176
260872|NCT00444600|631216|P3|COMPLETED|Overall Study|Number of eyes|178
260873|NCT00444600|631217|P2|COMPLETED|Overall Study|Number of eyes|171
260874|NCT00444600|631218|P1|COMPLETED|Overall Study|Number of eyes|274
260875|NCT00444600|631215|P4|STARTED|Overall Study|Number of eyes|186
260876|NCT00444600|631216|P3|STARTED|Overall Study|Number of eyes|188
260877|NCT00444600|631217|P2|STARTED|Overall Study|Number of eyes|187
260878|NCT00444600|631218|P1|STARTED|Overall Study|Number of eyes|293
260879|NCT00444587|631310|P2|NOT COMPLETED|Overall Study||15
260880|NCT00444587|631311|P1|NOT COMPLETED|Overall Study||83
260881|NCT00444587|631310|P2|COMPLETED|Overall Study||1
260882|NCT00444587|631311|P1|COMPLETED|Overall Study||10
260883|NCT00444587|631310|P2|STARTED|Overall Study||16
260884|NCT00444587|631311|P1|STARTED|Overall Study||93
260885|NCT00444535|631332|P1|NOT COMPLETED|Overall Study||24
260886|NCT00444535|631332|P1|COMPLETED|Overall Study||28
260887|NCT00444535|631332|P1|STARTED|Overall Study||52
260888|NCT00444457|631343|P4|NOT COMPLETED|Toddler Dose||8
260889|NCT00444457|631344|P3|NOT COMPLETED|Toddler Dose||4
260890|NCT00444457|631345|P2|NOT COMPLETED|Toddler Dose||6
260891|NCT00444457|631346|P1|NOT COMPLETED|Toddler Dose||7
260892|NCT00444457|631343|P4|COMPLETED|Toddler Dose||200
260893|NCT00444457|631344|P3|COMPLETED|Toddler Dose||404
260894|NCT00444457|631345|P2|COMPLETED|Toddler Dose||391
260895|NCT00444457|631346|P1|COMPLETED|Toddler Dose||408
260896|NCT00444457|631343|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
260897|NCT00444457|631344|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
260898|NCT00444457|631345|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
260899|NCT00444457|631346|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
260900|NCT00444457|631343|P4|NOT COMPLETED|After Infant Series||10
260901|NCT00444457|631344|P3|NOT COMPLETED|After Infant Series||19
260902|NCT00444457|631345|P2|NOT COMPLETED|After Infant Series||30
260903|NCT00444457|631346|P1|NOT COMPLETED|After Infant Series||20
260904|NCT00444457|631343|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
260905|NCT00444457|631344|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
260906|NCT00444457|631345|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
260907|NCT00444457|631346|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
260908|NCT00444457|631343|P4|STARTED|After Infant Series||218
260909|NCT00444457|631344|P3|STARTED|After Infant Series||427
260910|NCT00444457|631345|P2|STARTED|After Infant Series||427
260911|NCT00444457|631346|P1|STARTED|After Infant Series||435
260912|NCT00444457|631343|P4|NOT COMPLETED|Infant Series||28
260913|NCT00444457|631344|P3|NOT COMPLETED|Infant Series||61
260914|NCT00444457|631345|P2|NOT COMPLETED|Infant Series||61
260915|NCT00444457|631346|P1|NOT COMPLETED|Infant Series||54
260916|NCT00444457|631343|P4|COMPLETED|Infant Series||218
260917|NCT00444457|631344|P3|COMPLETED|Infant Series||428
260918|NCT00444457|631345|P2|COMPLETED|Infant Series||427
260919|NCT00444457|631346|P1|COMPLETED|Infant Series||435
260920|NCT00444457|631343|P4|Vaccinated Dose 3|Infant Series||225
260921|NCT00444457|631344|P3|Vaccinated Dose 3|Infant Series||438
260922|NCT00444457|631345|P2|Vaccinated Dose 3|Infant Series||435
260923|NCT00444457|631346|P1|Vaccinated Dose 3|Infant Series||442
260924|NCT00444457|631343|P4|Vaccinated Dose 2|Infant Series||228
260925|NCT00444457|631344|P3|Vaccinated Dose 2|Infant Series||455
260926|NCT00444457|631345|P2|Vaccinated Dose 2|Infant Series||447
260927|NCT00444457|631346|P1|Vaccinated Dose 2|Infant Series||455
260928|NCT00444457|631343|P4|Vaccinated Dose 1|Infant Series||244
260929|NCT00444457|631344|P3|Vaccinated Dose 1|Infant Series||485
260930|NCT00444457|631345|P2|Vaccinated Dose 1|Infant Series||484
260931|NCT00444457|631346|P1|Vaccinated Dose 1|Infant Series||486
260932|NCT00444457|631343|P4|STARTED|Infant Series||246
260933|NCT00444457|631344|P3|STARTED|Infant Series||489
260934|NCT00444457|631345|P2|STARTED|Infant Series||488
260935|NCT00444457|631346|P1|STARTED|Infant Series||489
260936|NCT00444275|631411|P5|NOT COMPLETED|Maintenance Treatment Phase||179
260937|NCT00444275|631412|P4|NOT COMPLETED|Maintenance Treatment Phase||133
260938|NCT00444275|631413|P3|NOT COMPLETED|Maintenance Treatment Phase||161
260939|NCT00444275|631414|P2|NOT COMPLETED|Maintenance Treatment Phase||0
260940|NCT00444275|631415|P1|NOT COMPLETED|Maintenance Treatment Phase||0
260941|NCT00444275|631411|P5|COMPLETED|Maintenance Treatment Phase||701
260942|NCT00444275|631412|P4|COMPLETED|Maintenance Treatment Phase||764
260943|NCT00444275|631413|P3|COMPLETED|Maintenance Treatment Phase||747
260944|NCT00444275|631414|P2|COMPLETED|Maintenance Treatment Phase||0
260945|NCT00444275|631415|P1|COMPLETED|Maintenance Treatment Phase||0
260946|NCT00444275|631411|P5|STARTED|Maintenance Treatment Phase||880
260947|NCT00444275|631412|P4|STARTED|Maintenance Treatment Phase||897
260948|NCT00444275|631413|P3|STARTED|Maintenance Treatment Phase||908
260949|NCT00444275|631414|P2|STARTED|Maintenance Treatment Phase||0
260950|NCT00444275|631415|P1|STARTED|Maintenance Treatment Phase||0
260951|NCT00444275|631411|P5|NOT COMPLETED|Initial Treatment Phase||0
260952|NCT00444275|631412|P4|NOT COMPLETED|Initial Treatment Phase||0
260953|NCT00444275|631413|P3|NOT COMPLETED|Initial Treatment Phase||0
260954|NCT00444275|631414|P2|NOT COMPLETED|Initial Treatment Phase||96
260955|NCT00444275|631415|P1|NOT COMPLETED|Initial Treatment Phase||248
260956|NCT00444275|631411|P5|COMPLETED|Initial Treatment Phase||0
260957|NCT00444275|631412|P4|COMPLETED|Initial Treatment Phase||0
260958|NCT00444275|631413|P3|COMPLETED|Initial Treatment Phase||0
260959|NCT00444275|631414|P2|COMPLETED|Initial Treatment Phase||777
260960|NCT00444275|631415|P1|COMPLETED|Initial Treatment Phase||1908
260961|NCT00444275|631411|P5|STARTED|Initial Treatment Phase||0
260962|NCT00444275|631412|P4|STARTED|Initial Treatment Phase||0
260963|NCT00444275|631413|P3|STARTED|Initial Treatment Phase||0
260964|NCT00444275|631414|P2|STARTED|Initial Treatment Phase||873
260965|NCT00444275|631415|P1|STARTED|Initial Treatment Phase||2156
260966|NCT00444145|631465|P1|NOT COMPLETED|Overall Study||19
260967|NCT00444145|631465|P1|COMPLETED|Overall Study||19
260968|NCT00444145|631465|P1|STARTED|Overall Study||38
260969|NCT00444106|631472|P3|NOT COMPLETED|Overall Study||1
260970|NCT00444106|631473|P2|NOT COMPLETED|Overall Study||1
260971|NCT00444106|631474|P1|NOT COMPLETED|Overall Study||2
260972|NCT00444106|631472|P3|COMPLETED|Overall Study||52
260973|NCT00444106|631473|P2|COMPLETED|Overall Study||52
260974|NCT00444106|631474|P1|COMPLETED|Overall Study||157
260975|NCT00444106|631472|P3|Completed Treatment Period|Overall Study||53
260976|NCT00444106|631473|P2|Completed Treatment Period|Overall Study||53
260977|NCT00444106|631474|P1|Completed Treatment Period|Overall Study||159
260978|NCT00444106|631472|P3|STARTED|Overall Study||53
260979|NCT00444106|631473|P2|STARTED|Overall Study||53
260980|NCT00444106|631474|P1|STARTED|Overall Study||159
260981|NCT00444067|631491|P2|NOT COMPLETED|Overall Study||1
260982|NCT00444067|631492|P1|NOT COMPLETED|Overall Study||0
260983|NCT00444067|631491|P2|COMPLETED|Overall Study||23
260984|NCT00444067|631492|P1|COMPLETED|Overall Study||74
260985|NCT00444067|631491|P2|STARTED|Overall Study||24
260986|NCT00444067|631492|P1|STARTED|Overall Study||74
260987|NCT00443898|631506|P4|NOT COMPLETED|Overall Study||18
260988|NCT00443898|631507|P3|NOT COMPLETED|Overall Study||29
260989|NCT00443898|631508|P2|NOT COMPLETED|Overall Study||25
260990|NCT00443898|631509|P1|NOT COMPLETED|Overall Study||24
260991|NCT00443898|631506|P4|COMPLETED|Overall Study||110
260992|NCT00443898|631507|P3|COMPLETED|Overall Study||107
260993|NCT00443898|631508|P2|COMPLETED|Overall Study||103
260994|NCT00443898|631509|P1|COMPLETED|Overall Study||102
260995|NCT00443898|631506|P4|STARTED|Overall Study||128
260996|NCT00443898|631507|P3|STARTED|Overall Study||136
260997|NCT00443898|631508|P2|STARTED|Overall Study||128
260998|NCT00443898|631509|P1|STARTED|Overall Study||126
260999|NCT00443872|631531|P1|NOT COMPLETED|Overall Study||17
261000|NCT00443872|631531|P1|COMPLETED|Overall Study||60
261001|NCT00443872|631531|P1|STARTED|Overall Study||77
261002|NCT00443820|631548|P4|NOT COMPLETED|Overall Study||17
261003|NCT00443820|631549|P3|NOT COMPLETED|Overall Study||18
261004|NCT00443820|631550|P2|NOT COMPLETED|Overall Study||19
261005|NCT00443820|631551|P1|NOT COMPLETED|Overall Study||21
261006|NCT00443820|631548|P4|COMPLETED|Overall Study||111
261007|NCT00443820|631549|P3|COMPLETED|Overall Study||117
261008|NCT00443820|631550|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
261009|NCT00443820|631551|P1|COMPLETED|Overall Study||112
261010|NCT00443820|631548|P4|Safety Population|Overall Study||126
261011|NCT00443820|631549|P3|Safety Population|Overall Study||134
261012|NCT00443820|631550|P2|Safety Population|Overall Study||129
261013|NCT00443820|631551|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
261014|NCT00443820|631548|P4|STARTED|Overall Study||128
261015|NCT00443820|631549|P3|STARTED|Overall Study||135
261016|NCT00443820|631550|P2|STARTED|Overall Study||130
261017|NCT00443820|631551|P1|STARTED|Overall Study||133
261018|NCT00443781|631573|P1|NOT COMPLETED|Overall Study||25
261019|NCT00443781|631573|P1|COMPLETED|Overall Study||37
261020|NCT00443781|631573|P1|STARTED|Overall Study||62
261021|NCT00443755|631579|P2|NOT COMPLETED|Overall Study||1
261022|NCT00443755|631580|P1|NOT COMPLETED|Overall Study||2
261023|NCT00443755|631579|P2|COMPLETED|Overall Study||13
261024|NCT00443755|631580|P1|COMPLETED|Overall Study||12
261025|NCT00443755|631579|P2|STARTED|Overall Study||14
261026|NCT00443755|631580|P1|STARTED|Overall Study||14
261027|NCT00443729|631614|P2|NOT COMPLETED|Overall Study||7
261028|NCT00443729|631615|P1|NOT COMPLETED|Overall Study||10
261029|NCT00443729|631614|P2|COMPLETED|Overall Study||172
261030|NCT00443729|631615|P1|COMPLETED|Overall Study||166
261031|NCT00443729|631614|P2|Treated|Overall Study||178
261032|NCT00443729|631615|P1|Treated|Overall Study||176
261033|NCT00443729|631614|P2|STARTED|Overall Study||179
261034|NCT00443729|631615|P1|STARTED|Overall Study||176
261035|NCT00443703|631663|P2|NOT COMPLETED|Overall Study||18
261036|NCT00443703|631664|P1|NOT COMPLETED|Overall Study||28
261037|NCT00443703|631663|P2|COMPLETED|Overall Study||157
261038|NCT00443703|631664|P1|COMPLETED|Overall Study||149
261039|NCT00443703|631663|P2|Treated|Overall Study||174
261040|NCT00443703|631664|P1|Treated|Overall Study||174
261041|NCT00443703|631663|P2|STARTED|Overall Study||175
261042|NCT00443703|631664|P1|STARTED|Overall Study||177
261043|NCT00443651|631716|P2|NOT COMPLETED|Overall Study||58
261044|NCT00443651|631717|P1|NOT COMPLETED|Overall Study||95
261045|NCT00443651|631716|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
261046|NCT00443651|631717|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
261047|NCT00443651|631716|P2|Week 48|Overall Study||134
261048|NCT00443651|631717|P1|Week 48|Overall Study||338
261049|NCT00443651|631716|P2|Week 24|Overall Study||160
261050|NCT00443651|631717|P1|Week 24|Overall Study||376
261051|NCT00443651|631716|P2|STARTED|Overall Study||176
261052|NCT00443651|631717|P1|STARTED|Overall Study||401
261053|NCT00443599|631737|P2|NOT COMPLETED|Overall Study||3
261054|NCT00443599|631738|P1|NOT COMPLETED|Overall Study||6
261055|NCT00443599|631737|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
261056|NCT00443599|631738|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
261057|NCT00443599|631737|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
261058|NCT00443599|631738|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
261059|NCT00443560|631772|P2|NOT COMPLETED|Overall Study||30
261060|NCT00443560|631773|P1|NOT COMPLETED|Overall Study||60
261061|NCT00443560|631772|P2|COMPLETED|Overall Study||1051
261062|NCT00443560|631773|P1|COMPLETED|Overall Study||1021
261063|NCT00443560|631772|P2|STARTED|Overall Study||1081
261064|NCT00443560|631773|P1|STARTED|Overall Study||1081
261065|NCT00443534|631783|P1|NOT COMPLETED|Overall Study||123
261066|NCT00443534|631783|P1|COMPLETED|Overall Study||0
261067|NCT00443534|631783|P1|Treated|Overall Study||122
261068|NCT00443534|631783|P1|STARTED|Overall Study||123
261069|NCT00443456|631790|P1|NOT COMPLETED|Overall Study||18
261070|NCT00443456|631790|P1|COMPLETED|Overall Study||116
261071|NCT00443456|631790|P1|STARTED|Overall Study||134
261072|NCT00443430|631825|P2|NOT COMPLETED|Overall Study||4
261073|NCT00443430|631826|P1|NOT COMPLETED|Overall Study||4
261074|NCT00443430|631825|P2|COMPLETED|Overall Study||38
261075|NCT00443430|631826|P1|COMPLETED|Overall Study||39
261076|NCT00443430|631825|P2|STARTED|Overall Study||42
261077|NCT00443430|631826|P1|STARTED|Overall Study||43
261078|NCT00443352|631836|P1|NOT COMPLETED|Overall Study||5
261079|NCT00443352|631836|P1|COMPLETED|Overall Study||22
261080|NCT00443352|631836|P1|STARTED|Overall Study||27
261081|NCT00443261|631840|P1|NOT COMPLETED|Overall Study||1
261082|NCT00443261|631840|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
261083|NCT00443261|631840|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
261084|NCT00443261|631840|P1|STARTED|Overall Study||1
261085|NCT00443209|631846|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
261086|NCT00443209|631847|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
261087|NCT00443209|631846|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
261088|NCT00443209|631847|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
261089|NCT00443209|631846|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
261090|NCT00443209|631847|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
261091|NCT00443209|631846|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
261092|NCT00443209|631847|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
261093|NCT00443209|631846|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
261094|NCT00443209|631847|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
261095|NCT00443209|631846|P2|Treated|Months 1 to 12 Treatment Period||313
261096|NCT00443209|631847|P1|Treated|Months 1 to 12 Treatment Period||641
261097|NCT00443209|631846|P2|STARTED|Months 1 to 12 Treatment Period||356
261098|NCT00443209|631847|P1|STARTED|Months 1 to 12 Treatment Period||712
261099|NCT00443118|631864|P3|NOT COMPLETED|Overall Study||0
261100|NCT00443118|631865|P2|NOT COMPLETED|Overall Study||1
261101|NCT00443118|631866|P1|NOT COMPLETED|Overall Study||4
261102|NCT00443118|631864|P3|COMPLETED|Overall Study||226
261103|NCT00443118|631865|P2|COMPLETED|Overall Study||290
261104|NCT00443118|631866|P1|COMPLETED|Overall Study||511
261105|NCT00443118|631864|P3|STARTED|Overall Study||226
261106|NCT00443118|631865|P2|STARTED|Overall Study||291
261107|NCT00443118|631866|P1|STARTED|Overall Study||515
261108|NCT00443053|631912|P2|NOT COMPLETED|Overall Study||33
261109|NCT00443053|631913|P1|NOT COMPLETED|Overall Study||21
261110|NCT00443053|631912|P2|COMPLETED|Overall Study||1467
261111|NCT00443053|631913|P1|COMPLETED|Overall Study||1481
261112|NCT00443053|631912|P2|STARTED|Overall Study||1500
261113|NCT00443053|631913|P1|STARTED|Overall Study||1502
261114|NCT00443040|631934|P3|NOT COMPLETED|Overall Study||1
261115|NCT00443040|631935|P2|NOT COMPLETED|Overall Study||0
261116|NCT00443040|631936|P1|NOT COMPLETED|Overall Study||4
261117|NCT00443040|631934|P3|COMPLETED|Overall Study||9
261118|NCT00443040|631935|P2|COMPLETED|Overall Study||11
261119|NCT00443040|631936|P1|COMPLETED|Overall Study||10
261120|NCT00443040|631934|P3|STARTED|Overall Study||10
261121|NCT00443040|631935|P2|STARTED|Overall Study||11
261122|NCT00443040|631936|P1|STARTED|Overall Study||14
261123|NCT00442962|631944|P1|NOT COMPLETED|Overall Study||8
261124|NCT00442962|631944|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
261125|NCT00442962|631944|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
261126|NCT00442962|631944|P1|STARTED|Overall Study||54
261127|NCT00442936|631962|P4|NOT COMPLETED|Overall Study||1
261128|NCT00442936|631963|P3|NOT COMPLETED|Overall Study||1
261129|NCT00442936|631964|P2|NOT COMPLETED|Overall Study||0
261130|NCT00442936|631965|P1|NOT COMPLETED|Overall Study||1
261131|NCT00442936|631962|P4|COMPLETED|Overall Study||347
261132|NCT00442936|631963|P3|COMPLETED|Overall Study||344
261133|NCT00442936|631964|P2|COMPLETED|Overall Study||354
261134|NCT00442936|631965|P1|COMPLETED|Overall Study||332
261135|NCT00442936|631962|P4|STARTED|Overall Study||348
261136|NCT00442936|631963|P3|STARTED|Overall Study||345
261137|NCT00442936|631964|P2|STARTED|Overall Study||354
261138|NCT00442936|631965|P1|STARTED|Overall Study||333
261139|NCT00442897|632013|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
261140|NCT00442897|632014|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
261141|NCT00442897|632013|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
261142|NCT00442897|632014|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
261143|NCT00442897|632013|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
261144|NCT00442897|632014|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
261145|NCT00442897|632013|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
261146|NCT00442897|632014|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
261147|NCT00442897|632013|P2|COMPLETED|Base Study (12 Week Follow-up)||99
261148|NCT00442897|632014|P1|COMPLETED|Base Study (12 Week Follow-up)||101
261149|NCT00442897|632013|P2|STARTED|Base Study (12 Week Follow-up)||111
261150|NCT00442897|632014|P1|STARTED|Base Study (12 Week Follow-up)||118
261151|NCT00442702|632024|P2|NOT COMPLETED|Evaluation Period||4
261152|NCT00442702|632025|P1|NOT COMPLETED|Evaluation Period||5
261153|NCT00442702|632024|P2|COMPLETED|Evaluation Period||107
261154|NCT00442702|632025|P1|COMPLETED|Evaluation Period||97
261155|NCT00442702|632024|P2|STARTED|Evaluation Period||111
261156|NCT00442702|632025|P1|STARTED|Evaluation Period||102
261157|NCT00442702|632024|P2|NOT COMPLETED|Titration Period||3
261158|NCT00442702|632025|P1|NOT COMPLETED|Titration Period||12
261159|NCT00442702|632024|P2|COMPLETED|Titration Period||111
261160|NCT00442702|632025|P1|COMPLETED|Titration Period||102
261161|NCT00442702|632024|P2|Safety Population|Titration Period||113
261162|NCT00442702|632025|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
261163|NCT00442702|632024|P2|STARTED|Titration Period||114
261164|NCT00442702|632025|P1|STARTED|Titration Period||114
261165|NCT00442689|632040|P3|NOT COMPLETED|Overall Study||9
261166|NCT00442689|632041|P2|NOT COMPLETED|Overall Study||11
261167|NCT00442689|632042|P1|NOT COMPLETED|Overall Study||10
261168|NCT00442689|632040|P3|COMPLETED|Overall Study||13
261169|NCT00442689|632041|P2|COMPLETED|Overall Study||13
261170|NCT00442689|632042|P1|COMPLETED|Overall Study||11
261171|NCT00442689|632040|P3|STARTED|Overall Study||22
261172|NCT00442689|632041|P2|STARTED|Overall Study||24
261173|NCT00442689|632042|P1|STARTED|Overall Study||21
261174|NCT00442611|632070|P2|NOT COMPLETED|Overall Study||0
261175|NCT00442611|632071|P1|NOT COMPLETED|Overall Study||1
261176|NCT00442611|632070|P2|COMPLETED|Overall Study||3
261177|NCT00442611|632071|P1|COMPLETED|Overall Study||6
261178|NCT00442611|632070|P2|STARTED|Overall Study||3
261179|NCT00442611|632071|P1|STARTED|Overall Study||7
261180|NCT00442598|632090|P3|NOT COMPLETED|Overall Study||0
261181|NCT00442598|632091|P2|NOT COMPLETED|Overall Study||8
261182|NCT00442598|632092|P1|NOT COMPLETED|Overall Study||6
261183|NCT00442598|632090|P3|COMPLETED|Overall Study||0
261184|NCT00442598|632091|P2|COMPLETED|Overall Study||2
261185|NCT00442598|632092|P1|COMPLETED|Overall Study||1
261186|NCT00442598|632090|P3|Two Cycles|Overall Study||0
261187|NCT00442598|632091|P2|Two Cycles|Overall Study||6
261188|NCT00442598|632092|P1|Two Cycles|Overall Study||5
261189|NCT00442598|632090|P3|STARTED|Overall Study||0
261190|NCT00442598|632091|P2|STARTED|Overall Study||10
261191|NCT00442598|632092|P1|STARTED|Overall Study||7
261192|NCT00442572|632110|P2|NOT COMPLETED|Overall Study||3
261193|NCT00442572|632111|P1|NOT COMPLETED|Overall Study||8
261194|NCT00442572|632110|P2|COMPLETED|Overall Study||1
261195|NCT00442572|632111|P1|COMPLETED|Overall Study||9
261196|NCT00442572|632110|P2|STARTED|Overall Study||4
261197|NCT00442572|632111|P1|STARTED|Overall Study||17
261198|NCT00442559|632151|P2|NOT COMPLETED|Overall Study||35
261199|NCT00442559|632152|P1|NOT COMPLETED|Overall Study||34
261200|NCT00442559|632151|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
261201|NCT00442559|632152|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
261202|NCT00442559|632151|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
261203|NCT00442559|632152|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
261204|NCT00442559|632151|P2|STARTED|Overall Study||91
261205|NCT00442559|632152|P1|STARTED|Overall Study||100
261206|NCT00442546|632167|P3|NOT COMPLETED|Overall Study||33
261207|NCT00442546|632168|P2|NOT COMPLETED|Overall Study||37
261208|NCT00442546|632169|P1|NOT COMPLETED|Overall Study||26
261209|NCT00442546|632167|P3|COMPLETED|Overall Study||71
261210|NCT00442546|632168|P2|COMPLETED|Overall Study||63
261211|NCT00442546|632169|P1|COMPLETED|Overall Study||77
261212|NCT00442546|632167|P3|Received Treatment|Overall Study||98
261213|NCT00442546|632168|P2|Received Treatment|Overall Study||96
261214|NCT00442546|632169|P1|Received Treatment|Overall Study||98
261215|NCT00442546|632167|P3|STARTED|Overall Study||104
261216|NCT00442546|632168|P2|STARTED|Overall Study||100
261217|NCT00442546|632169|P1|STARTED|Overall Study||103
261218|NCT00442507|632291|P1|NOT COMPLETED|Overall Study||0
261219|NCT00442507|632291|P1|COMPLETED|Overall Study||6
261220|NCT00442507|632291|P1|STARTED|Overall Study||6
261221|NCT00442468|632298|P1|NOT COMPLETED|Overall Study||183
261222|NCT00442468|632298|P1|COMPLETED|Overall Study||1100
261223|NCT00442468|632298|P1|STARTED|Overall Study||1283
261224|NCT00442416|632328|P2|NOT COMPLETED|Overall Study||39
261225|NCT00442416|632329|P1|NOT COMPLETED|Overall Study||37
261226|NCT00442416|632328|P2|COMPLETED|Overall Study||2
261227|NCT00442416|632329|P1|COMPLETED|Overall Study||2
261228|NCT00442416|632328|P2|STARTED|Overall Study||41
261229|NCT00442416|632329|P1|STARTED|Overall Study||39
261230|NCT00442364|632362|P1|NOT COMPLETED|Overall Study||0
261231|NCT00442364|632362|P1|COMPLETED|Overall Study||60
261232|NCT00442364|632362|P1|STARTED|Overall Study||60
261233|NCT00442351|632368|P2|NOT COMPLETED|Overall Study||6
261234|NCT00442351|632369|P1|NOT COMPLETED|Overall Study||7
261235|NCT00442351|632368|P2|COMPLETED|Overall Study||3
261236|NCT00442351|632369|P1|COMPLETED|Overall Study||10
261237|NCT00442351|632368|P2|STARTED|Overall Study||9
261238|NCT00442351|632369|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
261239|NCT00442338|632378|P3|NOT COMPLETED|Overall Study||0
261240|NCT00442338|632379|P2|NOT COMPLETED|Overall Study||0
261241|NCT00442338|632380|P1|NOT COMPLETED|Overall Study||0
261242|NCT00442338|632378|P3|COMPLETED|Overall Study||31
261243|NCT00442338|632379|P2|COMPLETED|Overall Study||30
261244|NCT00442338|632380|P1|COMPLETED|Overall Study||30
261245|NCT00442338|632378|P3|STARTED|Overall Study||31
261246|NCT00442338|632379|P2|STARTED|Overall Study||30
261247|NCT00442338|632380|P1|STARTED|Overall Study||30
261248|NCT00442286|632391|P2|NOT COMPLETED|Overall Study||2
261249|NCT00442286|632392|P1|NOT COMPLETED|Overall Study||7
261250|NCT00442286|632391|P2|COMPLETED|Overall Study||82
261251|NCT00442286|632392|P1|COMPLETED|Overall Study||174
261252|NCT00442286|632391|P2|12 Months|Overall Study||82
261253|NCT00442286|632392|P1|12 Months|Overall Study||174
261254|NCT00442286|632391|P2|6 Months|Overall Study||83
261255|NCT00442286|632392|P1|6 Months|Overall Study||177
261256|NCT00442286|632391|P2|STARTED|Overall Study||84
261257|NCT00442286|632392|P1|STARTED|Overall Study||181
261258|NCT00442169|632409|P6|NOT COMPLETED|Part 2||0
261259|NCT00442169|632410|P5|NOT COMPLETED|Part 2||0
261260|NCT00442169|632411|P4|NOT COMPLETED|Part 2||0
261261|NCT00442169|632412|P3|NOT COMPLETED|Part 2||0
261262|NCT00442169|632413|P2|NOT COMPLETED|Part 2||0
261263|NCT00442169|632414|P1|NOT COMPLETED|Part 2||0
261264|NCT00442169|632409|P6|COMPLETED|Part 2||57
261265|NCT00442169|632410|P5|COMPLETED|Part 2||25
261266|NCT00442169|632411|P4|COMPLETED|Part 2||0
261267|NCT00442169|632412|P3|COMPLETED|Part 2||0
261268|NCT00442169|632413|P2|COMPLETED|Part 2||0
261269|NCT00442169|632414|P1|COMPLETED|Part 2||0
261270|NCT00442169|632409|P6|STARTED|Part 2||57
261271|NCT00442169|632410|P5|STARTED|Part 2||25
261272|NCT00442169|632411|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
261273|NCT00442169|632412|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
261274|NCT00442169|632413|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
261275|NCT00442169|632414|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
261276|NCT00442169|632409|P6|NOT COMPLETED|Part 1||0
261277|NCT00442169|632410|P5|NOT COMPLETED|Part 1||0
261278|NCT00442169|632411|P4|NOT COMPLETED|Part 1||0
261279|NCT00442169|632412|P3|NOT COMPLETED|Part 1||0
261280|NCT00442169|632413|P2|NOT COMPLETED|Part 1||0
261281|NCT00442169|632414|P1|NOT COMPLETED|Part 1||0
261282|NCT00442169|632409|P6|COMPLETED|Part 1||0
261283|NCT00442169|632410|P5|COMPLETED|Part 1||0
261284|NCT00442169|632411|P4|COMPLETED|Part 1||31
261285|NCT00442169|632412|P3|COMPLETED|Part 1||40
261286|NCT00442169|632413|P2|COMPLETED|Part 1||24
261287|NCT00442169|632414|P1|COMPLETED|Part 1||17
261288|NCT00442169|632409|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
261289|NCT00442169|632410|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
261290|NCT00442169|632411|P4|STARTED|Part 1||31
261291|NCT00442169|632412|P3|STARTED|Part 1||40
261292|NCT00442169|632413|P2|STARTED|Part 1||24
261293|NCT00442169|632414|P1|STARTED|Part 1||17
261294|NCT00442117|632454|P2|NOT COMPLETED|Overall Study||38
261295|NCT00442117|632455|P1|NOT COMPLETED|Overall Study||38
261296|NCT00442117|632454|P2|COMPLETED|Overall Study||49
261297|NCT00442117|632455|P1|COMPLETED|Overall Study||47
261298|NCT00442117|632454|P2|STARTED|Overall Study||87
261299|NCT00442117|632455|P1|STARTED|Overall Study||85
261300|NCT00442013|632469|P2|NOT COMPLETED|Overall Study||17
261301|NCT00442013|632470|P1|NOT COMPLETED|Overall Study||26
261302|NCT00442013|632469|P2|COMPLETED|Overall Study||132
261303|NCT00442013|632470|P1|COMPLETED|Overall Study||131
261304|NCT00442013|632469|P2|STARTED|Overall Study||149
261305|NCT00442013|632470|P1|STARTED|Overall Study||157
261306|NCT00441974|632486|P1|NOT COMPLETED|Overall Study||128
261307|NCT00441974|632486|P1|COMPLETED|Overall Study||1342
261308|NCT00441974|632486|P1|STARTED|Overall Study||1470
261309|NCT00441792|632502|P2|NOT COMPLETED|Overall Study||2
261310|NCT00441792|632503|P1|NOT COMPLETED|Overall Study||0
261311|NCT00441792|632502|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
261312|NCT00441792|632503|P1|COMPLETED|Overall Study||59
261313|NCT00441792|632502|P2|STARTED|Overall Study||63
261314|NCT00441792|632503|P1|STARTED|Overall Study||59
261315|NCT00441766|632515|P4|NOT COMPLETED|Overall Study||6
261316|NCT00441766|632516|P3|NOT COMPLETED|Overall Study||9
261317|NCT00441766|632517|P2|NOT COMPLETED|Overall Study||7
261318|NCT00441766|632518|P1|NOT COMPLETED|Overall Study||14
261319|NCT00441766|632515|P4|COMPLETED|Overall Study||48
261320|NCT00441766|632516|P3|COMPLETED|Overall Study||44
261321|NCT00441766|632517|P2|COMPLETED|Overall Study||46
261322|NCT00441766|632518|P1|COMPLETED|Overall Study||39
261323|NCT00441766|632515|P4|STARTED|Overall Study||54
261324|NCT00441766|632516|P3|STARTED|Overall Study||53
261325|NCT00441766|632517|P2|STARTED|Overall Study||53
261326|NCT00441766|632518|P1|STARTED|Overall Study||53
261327|NCT00441727|632543|P3|NOT COMPLETED|Overall Study||168
261328|NCT00441727|632544|P2|NOT COMPLETED|Overall Study||118
261329|NCT00441727|632545|P1|NOT COMPLETED|Overall Study||106
261330|NCT00441727|632543|P3|COMPLETED|Overall Study|ITT/randomised|637
261331|NCT00441727|632544|P2|COMPLETED|Overall Study|ITT/randomised|686
261332|NCT00441727|632545|P1|COMPLETED|Overall Study|ITT/randomised|711
261333|NCT00441727|632543|P3|STARTED|Overall Study|ITT/randomised|805
261334|NCT00441727|632544|P2|STARTED|Overall Study|ITT/randomised|804
261335|NCT00441727|632545|P1|STARTED|Overall Study|ITT/randomised|817
261336|NCT00441701|632578|P10|NOT COMPLETED|Overall Study||0
261337|NCT00441701|632579|P9|NOT COMPLETED|Overall Study||0
261338|NCT00441701|632580|P8|NOT COMPLETED|Overall Study||0
261339|NCT00441701|632581|P7|NOT COMPLETED|Overall Study||0
261340|NCT00441701|632582|P6|NOT COMPLETED|Overall Study||3
261341|NCT00441701|632583|P5|NOT COMPLETED|Overall Study||2
261342|NCT00441701|632584|P4|NOT COMPLETED|Overall Study||3
261343|NCT00441701|632585|P3|NOT COMPLETED|Overall Study||4
261344|NCT00441701|632586|P2|NOT COMPLETED|Overall Study||4
261345|NCT00441701|632587|P1|NOT COMPLETED|Overall Study||5
261346|NCT00441701|632578|P10|COMPLETED|Overall Study||0
261347|NCT00441701|632579|P9|COMPLETED|Overall Study||0
261348|NCT00441701|632580|P8|COMPLETED|Overall Study||0
261349|NCT00441701|632581|P7|COMPLETED|Overall Study||0
261350|NCT00441701|632582|P6|COMPLETED|Overall Study||8
261351|NCT00441701|632583|P5|COMPLETED|Overall Study||20
261352|NCT00441701|632584|P4|COMPLETED|Overall Study||8
261353|NCT00441701|632585|P3|COMPLETED|Overall Study||18
261354|NCT00441701|632586|P2|COMPLETED|Overall Study||7
261355|NCT00441701|632587|P1|COMPLETED|Overall Study||17
261356|NCT00441701|632578|P10|STARTED|Overall Study||0
261357|NCT00441701|632579|P9|STARTED|Overall Study||0
261358|NCT00441701|632580|P8|STARTED|Overall Study||0
261359|NCT00441701|632581|P7|STARTED|Overall Study||0
261360|NCT00441701|632582|P6|STARTED|Overall Study||11
261361|NCT00441701|632583|P5|STARTED|Overall Study||22
261362|NCT00441701|632584|P4|STARTED|Overall Study||11
261363|NCT00441701|632585|P3|STARTED|Overall Study||22
261364|NCT00441701|632586|P2|STARTED|Overall Study||11
261365|NCT00441701|632587|P1|STARTED|Overall Study||22
261366|NCT00441584|632669|P1|NOT COMPLETED|Overall Study||105
261367|NCT00441584|632669|P1|COMPLETED|Overall Study||12
261368|NCT00441584|632669|P1|STARTED|Overall Study||117
261369|NCT00441558|632673|P1|NOT COMPLETED|Overall Study||1056
261370|NCT00441558|632673|P1|COMPLETED|Overall Study||667
261371|NCT00441558|632673|P1|STARTED|Overall Study||1723
261372|NCT00441545|632677|P2|NOT COMPLETED|Second Intervention||7
261373|NCT00441545|632678|P1|NOT COMPLETED|Second Intervention||12
261374|NCT00441545|632677|P2|COMPLETED|Second Intervention||68
261375|NCT00441545|632678|P1|COMPLETED|Second Intervention||65
261376|NCT00441545|632677|P2|STARTED|Second Intervention||75
261377|NCT00441545|632678|P1|STARTED|Second Intervention||77
261378|NCT00441545|632677|P2|NOT COMPLETED|Washout||0
261379|NCT00441545|632678|P1|NOT COMPLETED|Washout||0
261380|NCT00441545|632677|P2|COMPLETED|Washout||75
261381|NCT00441545|632678|P1|COMPLETED|Washout||77
261382|NCT00441545|632677|P2|STARTED|Washout||75
261383|NCT00441545|632678|P1|STARTED|Washout||77
261384|NCT00441545|632677|P2|NOT COMPLETED|First Intervention||12
261385|NCT00441545|632678|P1|NOT COMPLETED|First Intervention||18
261386|NCT00441545|632677|P2|COMPLETED|First Intervention||75
261387|NCT00441545|632678|P1|COMPLETED|First Intervention||77
261388|NCT00441545|632677|P2|STARTED|First Intervention||87
261389|NCT00441545|632678|P1|STARTED|First Intervention||95
261390|NCT00441480|632692|P2|NOT COMPLETED|Overall Study||4
261391|NCT00441480|632693|P1|NOT COMPLETED|Overall Study||3
261392|NCT00441480|632692|P2|COMPLETED|Overall Study||41
261393|NCT00441480|632693|P1|COMPLETED|Overall Study||43
261394|NCT00441480|632692|P2|STARTED|Overall Study||45
261395|NCT00441480|632693|P1|STARTED|Overall Study||46
261396|NCT00441467|632725|P1|NOT COMPLETED|Overall Study||18
261397|NCT00441467|632725|P1|COMPLETED|Overall Study||4
261398|NCT00441467|632725|P1|4 Cycles|Overall Study||7
261399|NCT00441467|632725|P1|2 Cycles|Overall Study||17
261400|NCT00441467|632725|P1|STARTED|Overall Study||22
261401|NCT00441441|632733|P2|NOT COMPLETED|Overall Study||14
261402|NCT00441441|632734|P1|NOT COMPLETED|Overall Study||11
261403|NCT00441441|632733|P2|COMPLETED|Overall Study||163
261404|NCT00441441|632734|P1|COMPLETED|Overall Study||162
261405|NCT00441441|632733|P2|STARTED|Overall Study||177
261406|NCT00441441|632734|P1|STARTED|Overall Study||173
261407|NCT00441363|632794|P2|NOT COMPLETED|Overall Study||15
261408|NCT00441363|632795|P1|NOT COMPLETED|Overall Study||17
261409|NCT00441363|632794|P2|COMPLETED|Overall Study||19
261410|NCT00441363|632795|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
261411|NCT00441363|632794|P2|STARTED|Overall Study||34
261412|NCT00441363|632795|P1|STARTED|Overall Study||32
261413|NCT00441337|632807|P4|NOT COMPLETED|Overall Study||21
261414|NCT00441337|632808|P3|NOT COMPLETED|Overall Study||6
261415|NCT00441337|632809|P2|NOT COMPLETED|Overall Study||6
261416|NCT00441337|632810|P1|NOT COMPLETED|Overall Study||6
261417|NCT00441337|632807|P4|COMPLETED|Overall Study||0
261418|NCT00441337|632808|P3|COMPLETED|Overall Study||0
261419|NCT00441337|632809|P2|COMPLETED|Overall Study||0
261420|NCT00441337|632810|P1|COMPLETED|Overall Study||0
261421|NCT00441337|632807|P4|STARTED|Overall Study||21
261422|NCT00441337|632808|P3|STARTED|Overall Study||6
261423|NCT00441337|632809|P2|STARTED|Overall Study||6
261424|NCT00441337|632810|P1|STARTED|Overall Study||6
261425|NCT00441285|632893|P5|NOT COMPLETED|Overall Study||0
261426|NCT00441285|632894|P4|NOT COMPLETED|Overall Study||0
261427|NCT00441285|632895|P3|NOT COMPLETED|Overall Study||0
261428|NCT00441285|632896|P2|NOT COMPLETED|Overall Study||0
261429|NCT00441285|632897|P1|NOT COMPLETED|Overall Study||0
261430|NCT00441285|632893|P5|COMPLETED|Overall Study||43
261431|NCT00441285|632894|P4|COMPLETED|Overall Study||40
261432|NCT00441285|632895|P3|COMPLETED|Overall Study||41
261433|NCT00441285|632896|P2|COMPLETED|Overall Study||16
261434|NCT00441285|632897|P1|COMPLETED|Overall Study||16
261435|NCT00441285|632893|P5|STARTED|Overall Study||43
261436|NCT00441285|632894|P4|STARTED|Overall Study||40
261437|NCT00441285|632895|P3|STARTED|Overall Study||41
261438|NCT00441285|632896|P2|STARTED|Overall Study||16
261439|NCT00441285|632897|P1|STARTED|Overall Study||16
261440|NCT00441272|632923|P2|NOT COMPLETED|Overall Study||25
261441|NCT00441272|632924|P1|NOT COMPLETED|Overall Study||25
261614|NCT00440531|633287|P3|Vaccination 1|Overall Study||172
261442|NCT00441272|632923|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
261443|NCT00441272|632924|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
261444|NCT00441272|632923|P2|STARTED|Overall Study||25
261445|NCT00441272|632924|P1|STARTED|Overall Study||25
261446|NCT00441259|632932|P2|NOT COMPLETED|Overall Study||0
261447|NCT00441259|632933|P1|NOT COMPLETED|Overall Study||0
261448|NCT00441259|632932|P2|COMPLETED|Overall Study||48
261449|NCT00441259|632933|P1|COMPLETED|Overall Study||48
261450|NCT00441259|632932|P2|STARTED|Overall Study||48
261451|NCT00441259|632933|P1|STARTED|Overall Study||48
261452|NCT00441168|632951|P2|NOT COMPLETED|Follow-up Period||9
261453|NCT00441168|632952|P1|NOT COMPLETED|Follow-up Period||12
261454|NCT00441168|632951|P2|COMPLETED|Follow-up Period||4
261455|NCT00441168|632952|P1|COMPLETED|Follow-up Period||5
261456|NCT00441168|632951|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
261457|NCT00441168|632952|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
261458|NCT00441168|632951|P2|NOT COMPLETED|Treatment Period||6
261459|NCT00441168|632952|P1|NOT COMPLETED|Treatment Period||11
261460|NCT00441168|632951|P2|COMPLETED|Treatment Period||7
261461|NCT00441168|632952|P1|COMPLETED|Treatment Period||6
261462|NCT00441168|632951|P2|TREATED|Treatment Period||13
261463|NCT00441168|632952|P1|TREATED|Treatment Period||16
261464|NCT00441168|632951|P2|STARTED|Treatment Period||13
261465|NCT00441168|632952|P1|STARTED|Treatment Period||17
261466|NCT00441142|632966|P4|NOT COMPLETED|Overall Study||68
261467|NCT00441142|632967|P3|NOT COMPLETED|Overall Study||22
261468|NCT00441142|632968|P2|NOT COMPLETED|Overall Study||7
261469|NCT00441142|632969|P1|NOT COMPLETED|Overall Study||6
261470|NCT00441142|632966|P4|COMPLETED|Overall Study||1
261471|NCT00441142|632967|P3|COMPLETED|Overall Study||7
261472|NCT00441142|632968|P2|COMPLETED|Overall Study||0
261473|NCT00441142|632969|P1|COMPLETED|Overall Study||0
261474|NCT00441142|632966|P4|STARTED|Overall Study||69
261475|NCT00441142|632967|P3|STARTED|Overall Study||29
261476|NCT00441142|632968|P2|STARTED|Overall Study||7
261477|NCT00441142|632969|P1|STARTED|Overall Study||6
261478|NCT00441116|632987|P2|NOT COMPLETED|Overall Study||2
261479|NCT00441116|632988|P1|NOT COMPLETED|Overall Study||3
261480|NCT00441116|632987|P2|COMPLETED|Overall Study||75
261481|NCT00441116|632988|P1|COMPLETED|Overall Study||73
261482|NCT00441116|632987|P2|STARTED|Overall Study||77
261483|NCT00441116|632988|P1|STARTED|Overall Study||76
261484|NCT00441103|633056|P2|NOT COMPLETED|Overall Study||4
261485|NCT00441103|633057|P1|NOT COMPLETED|Overall Study||11
261486|NCT00441103|633056|P2|COMPLETED|Overall Study||56
261487|NCT00441103|633057|P1|COMPLETED|Overall Study||109
261488|NCT00441103|633056|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
261489|NCT00441103|633057|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
261490|NCT00441090|633073|P5|NOT COMPLETED|Overall Study||0
261491|NCT00441090|633074|P4|NOT COMPLETED|Overall Study||2
261492|NCT00441090|633075|P3|NOT COMPLETED|Overall Study||2
261493|NCT00441090|633076|P2|NOT COMPLETED|Overall Study||1
261494|NCT00441090|633077|P1|NOT COMPLETED|Overall Study||2
261495|NCT00441090|633073|P5|COMPLETED|Overall Study||5
261496|NCT00441090|633074|P4|COMPLETED|Overall Study||13
261497|NCT00441090|633075|P3|COMPLETED|Overall Study||12
261498|NCT00441090|633076|P2|COMPLETED|Overall Study||14
261499|NCT00441090|633077|P1|COMPLETED|Overall Study||13
261500|NCT00441090|633073|P5|STARTED|Overall Study||5
261501|NCT00441090|633074|P4|STARTED|Overall Study||15
261502|NCT00441090|633075|P3|STARTED|Overall Study||14
261503|NCT00441090|633076|P2|STARTED|Overall Study||15
261504|NCT00441090|633077|P1|STARTED|Overall Study||15
261505|NCT00441064|633121|P2|NOT COMPLETED|Overall Study||7
261506|NCT00441064|633122|P1|NOT COMPLETED|Overall Study||10
261507|NCT00441064|633121|P2|COMPLETED|Overall Study||56
261508|NCT00441064|633122|P1|COMPLETED|Overall Study||59
261509|NCT00441064|633121|P2|Intent-to-treat (ITT) Population|Overall Study||57
261510|NCT00441064|633122|P1|Intent-to-treat (ITT) Population|Overall Study||61
261511|NCT00441064|633121|P2|Safety Population (SP)|Overall Study||63
261512|NCT00441064|633122|P1|Safety Population (SP)|Overall Study||69
261513|NCT00441064|633121|P2|STARTED|Overall Study||63
261514|NCT00441064|633122|P1|STARTED|Overall Study||69
261515|NCT00441012|633134|P2|NOT COMPLETED|Overall Study||13
261516|NCT00441012|633135|P1|NOT COMPLETED|Overall Study||18
261517|NCT00441012|633134|P2|COMPLETED|Overall Study||263
261518|NCT00441012|633135|P1|COMPLETED|Overall Study||252
261519|NCT00441012|633134|P2|Vaccination Visit 3|Overall Study||269
261520|NCT00441012|633135|P1|Vaccination Visit 3|Overall Study||265
261521|NCT00441012|633134|P2|Vaccination Visit 2|Overall Study||272
261522|NCT00441012|633135|P1|Vaccination Visit 2|Overall Study||267
261523|NCT00441012|633134|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
261524|NCT00441012|633135|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
261525|NCT00441012|633134|P2|STARTED|Overall Study||276
261526|NCT00441012|633135|P1|STARTED|Overall Study||270
261527|NCT00440947|633149|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
261528|NCT00440947|633150|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
261529|NCT00440947|633151|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
261530|NCT00440947|633152|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
261531|NCT00440947|633153|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
261532|NCT00440947|633149|P5|COMPLETED|Optional 60-Week Extension Phase||154
261533|NCT00440947|633150|P4|COMPLETED|Optional 60-Week Extension Phase||160
261534|NCT00440947|633151|P3|COMPLETED|Optional 60-Week Extension Phase||0
261535|NCT00440947|633152|P2|COMPLETED|Optional 60-Week Extension Phase||0
261536|NCT00440947|633153|P1|COMPLETED|Optional 60-Week Extension Phase||0
261537|NCT00440947|633149|P5|STARTED|Optional 60-Week Extension Phase||180
261538|NCT00440947|633150|P4|STARTED|Optional 60-Week Extension Phase||189
261539|NCT00440947|633151|P3|STARTED|Optional 60-Week Extension Phase||0
261540|NCT00440947|633152|P2|STARTED|Optional 60-Week Extension Phase||0
261541|NCT00440947|633153|P1|STARTED|Optional 60-Week Extension Phase||0
261542|NCT00440947|633149|P5|NOT COMPLETED|48-Week Randomization Phase||0
261543|NCT00440947|633150|P4|NOT COMPLETED|48-Week Randomization Phase||0
261544|NCT00440947|633151|P3|NOT COMPLETED|48-Week Randomization Phase||24
261545|NCT00440947|633152|P2|NOT COMPLETED|48-Week Randomization Phase||16
261546|NCT00440947|633153|P1|NOT COMPLETED|48-Week Randomization Phase||0
261547|NCT00440947|633149|P5|COMPLETED|48-Week Randomization Phase||0
261548|NCT00440947|633150|P4|COMPLETED|48-Week Randomization Phase||0
261549|NCT00440947|633151|P3|COMPLETED|48-Week Randomization Phase||185
261550|NCT00440947|633152|P2|COMPLETED|48-Week Randomization Phase||194
261551|NCT00440947|633153|P1|COMPLETED|48-Week Randomization Phase||0
261552|NCT00440947|633149|P5|STARTED|48-Week Randomization Phase||0
261553|NCT00440947|633150|P4|STARTED|48-Week Randomization Phase||0
261554|NCT00440947|633151|P3|STARTED|48-Week Randomization Phase||209
261555|NCT00440947|633152|P2|STARTED|48-Week Randomization Phase||210
261556|NCT00440947|633153|P1|STARTED|48-Week Randomization Phase||0
261557|NCT00440947|633149|P5|NOT COMPLETED|36-Week Induction Phase||0
261558|NCT00440947|633150|P4|NOT COMPLETED|36-Week Induction Phase||0
261559|NCT00440947|633151|P3|NOT COMPLETED|36-Week Induction Phase||0
261560|NCT00440947|633152|P2|NOT COMPLETED|36-Week Induction Phase||0
261561|NCT00440947|633153|P1|NOT COMPLETED|36-Week Induction Phase||73
261562|NCT00440947|633149|P5|COMPLETED|36-Week Induction Phase||0
261563|NCT00440947|633150|P4|COMPLETED|36-Week Induction Phase||0
261564|NCT00440947|633151|P3|COMPLETED|36-Week Induction Phase||0
261565|NCT00440947|633152|P2|COMPLETED|36-Week Induction Phase||0
261566|NCT00440947|633153|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
261567|NCT00440947|633149|P5|STARTED|36-Week Induction Phase||0
261568|NCT00440947|633150|P4|STARTED|36-Week Induction Phase||0
261569|NCT00440947|633151|P3|STARTED|36-Week Induction Phase||0
261570|NCT00440947|633152|P2|STARTED|36-Week Induction Phase||0
261571|NCT00440947|633153|P1|STARTED|36-Week Induction Phase||515
261572|NCT00440830|633208|P4|NOT COMPLETED|Overall Study||0
261573|NCT00440830|633209|P3|NOT COMPLETED|Overall Study||0
261574|NCT00440830|633210|P2|NOT COMPLETED|Overall Study||0
261575|NCT00440830|633211|P1|NOT COMPLETED|Overall Study||0
261576|NCT00440830|633208|P4|COMPLETED|Overall Study||10
261577|NCT00440830|633209|P3|COMPLETED|Overall Study||30
261578|NCT00440830|633210|P2|COMPLETED|Overall Study||8
261579|NCT00440830|633211|P1|COMPLETED|Overall Study||20
261580|NCT00440830|633208|P4|STARTED|Overall Study||10
261581|NCT00440830|633209|P3|STARTED|Overall Study||30
261582|NCT00440830|633210|P2|STARTED|Overall Study||8
261583|NCT00440830|633211|P1|STARTED|Overall Study||20
261584|NCT00440700|633228|P3|NOT COMPLETED|Overall Study||4
261585|NCT00440700|633229|P2|NOT COMPLETED|Overall Study||8
261586|NCT00440700|633230|P1|NOT COMPLETED|Overall Study||8
261587|NCT00440700|633228|P3|COMPLETED|Overall Study||120
261588|NCT00440700|633229|P2|COMPLETED|Overall Study||110
261589|NCT00440700|633230|P1|COMPLETED|Overall Study||114
261590|NCT00440700|633228|P3|STARTED|Overall Study||124
261591|NCT00440700|633229|P2|STARTED|Overall Study||118
261592|NCT00440700|633230|P1|STARTED|Overall Study||122
261593|NCT00440557|633253|P3|NOT COMPLETED|Overall Study||35
261594|NCT00440557|633254|P2|NOT COMPLETED|Overall Study||29
261595|NCT00440557|633255|P1|NOT COMPLETED|Overall Study||25
261596|NCT00440557|633253|P3|COMPLETED|Overall Study||90
261597|NCT00440557|633254|P2|COMPLETED|Overall Study||96
261598|NCT00440557|633255|P1|COMPLETED|Overall Study||98
261599|NCT00440557|633253|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
261600|NCT00440557|633254|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
261601|NCT00440557|633255|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
261602|NCT00440531|633287|P3|NOT COMPLETED|Overall Study||7
261603|NCT00440531|633288|P2|NOT COMPLETED|Overall Study||5
261604|NCT00440531|633289|P1|NOT COMPLETED|Overall Study||10
261605|NCT00440531|633287|P3|COMPLETED|Overall Study||165
261606|NCT00440531|633288|P2|COMPLETED|Overall Study||178
261607|NCT00440531|633289|P1|COMPLETED|Overall Study||175
261608|NCT00440531|633287|P3|Vaccination 3|Overall Study||166
261609|NCT00440531|633288|P2|Vaccination 3|Overall Study||178
261610|NCT00440531|633289|P1|Vaccination 3|Overall Study||176
261611|NCT00440531|633287|P3|Vaccination 2|Overall Study||171
261612|NCT00440531|633288|P2|Vaccination 2|Overall Study||182
261613|NCT00440531|633289|P1|Vaccination 2|Overall Study||181
261615|NCT00440531|633288|P2|Vaccination 1|Overall Study||183
261616|NCT00440531|633289|P1|Vaccination 1|Overall Study||183
261617|NCT00440531|633287|P3|STARTED|Overall Study||172
261618|NCT00440531|633288|P2|STARTED|Overall Study||183
261619|NCT00440531|633289|P1|STARTED|Overall Study||185
261620|NCT00440518|633306|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
261621|NCT00440518|633307|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
261622|NCT00440518|633308|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
261623|NCT00440518|633306|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
261624|NCT00440518|633307|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
261625|NCT00440518|633308|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
261626|NCT00440518|633306|P3|STARTED|Maintenance and Safety Follow-up Periods||70
261627|NCT00440518|633307|P2|STARTED|Maintenance and Safety Follow-up Periods||63
261628|NCT00440518|633308|P1|STARTED|Maintenance and Safety Follow-up Periods||59
261629|NCT00440518|633306|P3|NOT COMPLETED|Randomized /Titration Period||4
261630|NCT00440518|633307|P2|NOT COMPLETED|Randomized /Titration Period||9
261631|NCT00440518|633308|P1|NOT COMPLETED|Randomized /Titration Period||13
261632|NCT00440518|633306|P3|COMPLETED|Randomized /Titration Period||70
261633|NCT00440518|633307|P2|COMPLETED|Randomized /Titration Period||63
261634|NCT00440518|633308|P1|COMPLETED|Randomized /Titration Period||59
261635|NCT00440518|633306|P3|STARTED|Randomized /Titration Period||74
261636|NCT00440518|633307|P2|STARTED|Randomized /Titration Period||72
261637|NCT00440518|633308|P1|STARTED|Randomized /Titration Period||72
261638|NCT00440505|633328|P6|NOT COMPLETED|Third Intervention||0
261639|NCT00440505|633329|P5|NOT COMPLETED|Third Intervention||0
261640|NCT00440505|633330|P4|NOT COMPLETED|Third Intervention||1
261641|NCT00440505|633331|P3|NOT COMPLETED|Third Intervention||0
261642|NCT00440505|633332|P2|NOT COMPLETED|Third Intervention||0
261643|NCT00440505|633333|P1|NOT COMPLETED|Third Intervention||0
261644|NCT00440505|633328|P6|COMPLETED|Third Intervention||5
261645|NCT00440505|633329|P5|COMPLETED|Third Intervention||5
261646|NCT00440505|633330|P4|COMPLETED|Third Intervention||1
261647|NCT00440505|633331|P3|COMPLETED|Third Intervention||1
261648|NCT00440505|633332|P2|COMPLETED|Third Intervention||2
261649|NCT00440505|633333|P1|COMPLETED|Third Intervention||5
261650|NCT00440505|633328|P6|STARTED|Third Intervention||5
261651|NCT00440505|633329|P5|STARTED|Third Intervention||5
261652|NCT00440505|633330|P4|STARTED|Third Intervention||2
261653|NCT00440505|633331|P3|STARTED|Third Intervention||1
261654|NCT00440505|633332|P2|STARTED|Third Intervention||2
261655|NCT00440505|633333|P1|STARTED|Third Intervention||5
261656|NCT00440505|633328|P6|NOT COMPLETED|Second Intervention||0
261657|NCT00440505|633329|P5|NOT COMPLETED|Second Intervention||0
261658|NCT00440505|633330|P4|NOT COMPLETED|Second Intervention||0
261659|NCT00440505|633331|P3|NOT COMPLETED|Second Intervention||0
261660|NCT00440505|633332|P2|NOT COMPLETED|Second Intervention||0
261661|NCT00440505|633333|P1|NOT COMPLETED|Second Intervention||0
261662|NCT00440505|633328|P6|COMPLETED|Second Intervention||5
261663|NCT00440505|633329|P5|COMPLETED|Second Intervention||5
261664|NCT00440505|633330|P4|COMPLETED|Second Intervention||2
261665|NCT00440505|633331|P3|COMPLETED|Second Intervention||1
261666|NCT00440505|633332|P2|COMPLETED|Second Intervention||2
261667|NCT00440505|633333|P1|COMPLETED|Second Intervention||5
261668|NCT00440505|633328|P6|STARTED|Second Intervention||5
261669|NCT00440505|633329|P5|STARTED|Second Intervention||5
261670|NCT00440505|633330|P4|STARTED|Second Intervention||2
261671|NCT00440505|633331|P3|STARTED|Second Intervention||1
261672|NCT00440505|633332|P2|STARTED|Second Intervention||2
261673|NCT00440505|633333|P1|STARTED|Second Intervention||5
261674|NCT00440505|633328|P6|NOT COMPLETED|First Intervention||0
261675|NCT00440505|633329|P5|NOT COMPLETED|First Intervention||0
261676|NCT00440505|633330|P4|NOT COMPLETED|First Intervention||0
261677|NCT00440505|633331|P3|NOT COMPLETED|First Intervention||0
261678|NCT00440505|633332|P2|NOT COMPLETED|First Intervention||0
261679|NCT00440505|633333|P1|NOT COMPLETED|First Intervention||0
261680|NCT00440505|633328|P6|COMPLETED|First Intervention||5
261681|NCT00440505|633329|P5|COMPLETED|First Intervention||5
261682|NCT00440505|633330|P4|COMPLETED|First Intervention||2
261683|NCT00440505|633331|P3|COMPLETED|First Intervention||1
261684|NCT00440505|633332|P2|COMPLETED|First Intervention||2
261685|NCT00440505|633333|P1|COMPLETED|First Intervention||5
261686|NCT00440505|633328|P6|STARTED|First Intervention||5
261687|NCT00440505|633329|P5|STARTED|First Intervention||5
261688|NCT00440505|633330|P4|STARTED|First Intervention||2
261689|NCT00440505|633331|P3|STARTED|First Intervention||1
261690|NCT00440505|633332|P2|STARTED|First Intervention||2
261691|NCT00440505|633333|P1|STARTED|First Intervention||5
261692|NCT00440466|633353|P3|NOT COMPLETED|Overall Study||41
261693|NCT00440466|633354|P2|NOT COMPLETED|Overall Study||15
261694|NCT00440466|633355|P1|NOT COMPLETED|Overall Study||13
261695|NCT00440466|633353|P3|COMPLETED|Overall Study||174
261696|NCT00440466|633354|P2|COMPLETED|Overall Study||92
261697|NCT00440466|633355|P1|COMPLETED|Overall Study||95
261698|NCT00440466|633353|P3|STARTED|Overall Study||215
261699|NCT00440466|633354|P2|STARTED|Overall Study||107
261700|NCT00440466|633355|P1|STARTED|Overall Study||108
261701|NCT00440401|633389|P2|NOT COMPLETED|Overall Study||6
261702|NCT00440401|633390|P1|NOT COMPLETED|Overall Study||4
261703|NCT00440401|633389|P2|COMPLETED|Overall Study||54
261704|NCT00440401|633390|P1|COMPLETED|Overall Study||55
261705|NCT00440401|633389|P2|STARTED|Overall Study||60
261706|NCT00440401|633390|P1|STARTED|Overall Study||59
261707|NCT00440310|633400|P2|NOT COMPLETED|Overall Study||30
261708|NCT00440310|633401|P1|NOT COMPLETED|Overall Study||28
261709|NCT00440310|633400|P2|COMPLETED|Overall Study||209
261710|NCT00440310|633401|P1|COMPLETED|Overall Study||216
261711|NCT00440310|633400|P2|Treated|Overall Study||232
261712|NCT00440310|633401|P1|Treated|Overall Study||222
261713|NCT00440310|633400|P2|STARTED|Overall Study||239
261714|NCT00440310|633401|P1|STARTED|Overall Study||244
261715|NCT00440297|633409|P2|NOT COMPLETED|Overall Study||18
261716|NCT00440297|633410|P1|NOT COMPLETED|Overall Study||23
261717|NCT00440297|633409|P2|COMPLETED|Overall Study||120
261718|NCT00440297|633410|P1|COMPLETED|Overall Study||116
261719|NCT00440297|633409|P2|Vaccination Visit 4|Overall Study||122
261720|NCT00440297|633410|P1|Vaccination Visit 4|Overall Study||116
261721|NCT00440297|633409|P2|Vaccination Visit 3|Overall Study||125
261722|NCT00440297|633410|P1|Vaccination Visit 3|Overall Study||124
261723|NCT00440297|633409|P2|Vaccination Visit 2|Overall Study||134
261724|NCT00440297|633410|P1|Vaccination Visit 2|Overall Study||136
261725|NCT00440297|633409|P2|Vaccination Visit 1|Overall Study||138
261726|NCT00440297|633410|P1|Vaccination Visit 1|Overall Study||138
261727|NCT00440297|633409|P2|STARTED|Overall Study||138
261728|NCT00440297|633410|P1|STARTED|Overall Study||139
261729|NCT00440271|633426|P2|NOT COMPLETED|Overall Study||15
261730|NCT00440271|633427|P1|NOT COMPLETED|Overall Study||12
261731|NCT00440271|633426|P2|COMPLETED|Overall Study||3
261732|NCT00440271|633427|P1|COMPLETED|Overall Study||3
261733|NCT00440271|633426|P2|STARTED|Overall Study||18
261734|NCT00440271|633427|P1|STARTED|Overall Study||15
261735|NCT00440232|633461|P2|NOT COMPLETED|Overall Study||4
261736|NCT00440232|633462|P1|NOT COMPLETED|Overall Study||3
261737|NCT00440232|633461|P2|COMPLETED|Overall Study||34
261738|NCT00440232|633462|P1|COMPLETED|Overall Study||33
261739|NCT00440232|633461|P2|STARTED|Overall Study||38
261740|NCT00440232|633462|P1|STARTED|Overall Study||36
261741|NCT00440193|633472|P2|NOT COMPLETED|Observational Period||38
261742|NCT00440193|633473|P1|NOT COMPLETED|Observational Period||45
261743|NCT00440193|633472|P2|COMPLETED|Observational Period||1369
261744|NCT00440193|633473|P1|COMPLETED|Observational Period||1380
261745|NCT00440193|633472|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
261746|NCT00440193|633473|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
261747|NCT00440193|633472|P2|NOT COMPLETED|Treatment Period||351
261748|NCT00440193|633473|P1|NOT COMPLETED|Treatment Period||305
261749|NCT00440193|633472|P2|COMPLETED|Treatment Period||1367
261750|NCT00440193|633473|P1|COMPLETED|Treatment Period||1426
261751|NCT00440193|633472|P2|Participants Received Treatment|Treatment Period||1711
261752|NCT00440193|633473|P1|Participants Received Treatment|Treatment Period||1718
261753|NCT00440193|633472|P2|STARTED|Treatment Period||1718
261754|NCT00440193|633473|P1|STARTED|Treatment Period||1731
261755|NCT00440180|633509|P2|NOT COMPLETED|Overall Study||0
261756|NCT00440180|633510|P1|NOT COMPLETED|Overall Study||0
261757|NCT00440180|633509|P2|COMPLETED|Overall Study||10
261758|NCT00440180|633510|P1|COMPLETED|Overall Study||10
261759|NCT00440180|633509|P2|STARTED|Overall Study||10
261760|NCT00440180|633510|P1|STARTED|Overall Study||10
261761|NCT00440115|633519|P3|NOT COMPLETED|Overall Study||6
261762|NCT00440115|633520|P2|NOT COMPLETED|Overall Study||11
261763|NCT00440115|633521|P1|NOT COMPLETED|Overall Study||7
261764|NCT00440115|633519|P3|COMPLETED|Overall Study||244
261765|NCT00440115|633520|P2|COMPLETED|Overall Study||238
261766|NCT00440115|633521|P1|COMPLETED|Overall Study||244
261767|NCT00440115|633519|P3|STARTED|Overall Study||250
261768|NCT00440115|633520|P2|STARTED|Overall Study||249
261769|NCT00440115|633521|P1|STARTED|Overall Study||251
261770|NCT00440050|633537|P2|NOT COMPLETED|Overall Study||67
261771|NCT00440050|633538|P1|NOT COMPLETED|Overall Study||40
261772|NCT00440050|633537|P2|COMPLETED|Overall Study||171
261773|NCT00440050|633538|P1|COMPLETED|Overall Study||124
261774|NCT00440050|633537|P2|STARTED|Overall Study||238
261775|NCT00440050|633538|P1|STARTED|Overall Study||164
261776|NCT00440011|633552|P2|NOT COMPLETED|Overall Study||3
261777|NCT00440011|633553|P1|NOT COMPLETED|Overall Study||4
261778|NCT00440011|633552|P2|COMPLETED|Overall Study||132
261779|NCT00440011|633553|P1|COMPLETED|Overall Study||127
261780|NCT00440011|633552|P2|STARTED|Overall Study||135
261781|NCT00440011|633553|P1|STARTED|Overall Study||131
261782|NCT00439946|633561|P1|NOT COMPLETED|Overall Study||0
261783|NCT00439946|633561|P1|COMPLETED|Overall Study||8
261784|NCT00439946|633561|P1|STARTED|Overall Study||8
261785|NCT00439777|633580|P2|NOT COMPLETED|Observational Period||41
261786|NCT00439777|633581|P1|NOT COMPLETED|Observational Period||41
261787|NCT00439777|633580|P2|COMPLETED|Observational Period||2156
261788|NCT00439777|633581|P1|COMPLETED|Observational Period||2165
261789|NCT00439777|633580|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
261790|NCT00439777|633581|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
261791|NCT00439777|633580|P2|NOT COMPLETED|Treatment Period||459
261792|NCT00439777|633581|P1|NOT COMPLETED|Treatment Period||419
261793|NCT00439777|633580|P2|COMPLETED|Treatment Period||1954
261794|NCT00439777|633581|P1|COMPLETED|Treatment Period||2001
261795|NCT00439777|633580|P2|Participants Received Treatment|Treatment Period||2405
261796|NCT00439777|633581|P1|Participants Received Treatment|Treatment Period||2412
261797|NCT00439777|633580|P2|STARTED|Treatment Period||2413
261798|NCT00439777|633581|P1|STARTED|Treatment Period||2420
261799|NCT00439738|633619|P2|NOT COMPLETED|Overall Study||28
261800|NCT00439738|633620|P1|NOT COMPLETED|Overall Study||36
261801|NCT00439738|633619|P2|COMPLETED|Overall Study||178
261802|NCT00439738|633620|P1|COMPLETED|Overall Study||170
261803|NCT00439738|633619|P2|STARTED|Overall Study||206
261804|NCT00439738|633620|P1|STARTED|Overall Study||206
261805|NCT00439725|633638|P2|NOT COMPLETED|Observational Period||7
261806|NCT00439725|633639|P1|NOT COMPLETED|Observational Period||8
261807|NCT00439725|633638|P2|COMPLETED|Observational Period||553
261808|NCT00439725|633639|P1|COMPLETED|Observational Period||569
261809|NCT00439725|633638|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
261810|NCT00439725|633639|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
261811|NCT00439725|633638|P2|NOT COMPLETED|Treatment Period||246
261812|NCT00439725|633639|P1|NOT COMPLETED|Treatment Period||236
261813|NCT00439725|633638|P2|COMPLETED|Treatment Period||349
261814|NCT00439725|633639|P1|COMPLETED|Treatment Period||366
261815|NCT00439725|633638|P2|Participants Received Treatment|Treatment Period|Safety population|590
261816|NCT00439725|633639|P1|Participants Received Treatment|Treatment Period|Safety population|598
261817|NCT00439725|633638|P2|STARTED|Treatment Period||595
261818|NCT00439725|633639|P1|STARTED|Treatment Period||602
261819|NCT00439647|633685|P2|NOT COMPLETED|Overall Study||71
261820|NCT00439647|633686|P1|NOT COMPLETED|Overall Study||58
261821|NCT00439647|633685|P2|COMPLETED|Overall Study||540
261822|NCT00439647|633686|P1|COMPLETED|Overall Study||530
261823|NCT00439647|633685|P2|Modified Intent to Treat (mITT)|Overall Study||574
261824|NCT00439647|633686|P1|Modified Intent to Treat (mITT)|Overall Study||553
261825|NCT00439647|633685|P2|STARTED|Overall Study||611
261826|NCT00439647|633686|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
261827|NCT00439608|633718|P1|NOT COMPLETED|Overall Study||0
261828|NCT00439608|633718|P1|COMPLETED|Overall Study||60
261829|NCT00439608|633718|P1|STARTED|Overall Study||60
261830|NCT00439569|633722|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
261831|NCT00439569|633722|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
261832|NCT00439569|633722|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
261833|NCT00439569|633722|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
261834|NCT00439569|633722|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
261835|NCT00439569|633722|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
261836|NCT00439517|633735|P2|NOT COMPLETED|Overall Study||0
261837|NCT00439517|633736|P1|NOT COMPLETED|Overall Study||2
261838|NCT00439517|633735|P2|COMPLETED|Overall Study||150
261839|NCT00439517|633736|P1|COMPLETED|Overall Study||150
261840|NCT00439517|633735|P2|STARTED|Overall Study||150
261841|NCT00439517|633736|P1|STARTED|Overall Study||152
261842|NCT00439413|633760|P2|NOT COMPLETED|Overall Study||37
261843|NCT00439413|633761|P1|NOT COMPLETED|Overall Study||31
261844|NCT00439413|633760|P2|COMPLETED|Overall Study||88
261845|NCT00439413|633761|P1|COMPLETED|Overall Study||90
261846|NCT00439413|633760|P2|STARTED|Overall Study||125
261847|NCT00439413|633761|P1|STARTED|Overall Study||121
261848|NCT00439335|633771|P2|NOT COMPLETED|Overall Study||0
261849|NCT00439335|633772|P1|NOT COMPLETED|Overall Study||2
261850|NCT00439335|633771|P2|COMPLETED|Overall Study||114
261851|NCT00439335|633772|P1|COMPLETED|Overall Study||111
261852|NCT00439335|633771|P2|STARTED|Overall Study||114
261853|NCT00439335|633772|P1|STARTED|Overall Study||113
261854|NCT00439309|633804|P2|NOT COMPLETED|Follow-Up||2
261855|NCT00439309|633805|P1|NOT COMPLETED|Follow-Up||3
261856|NCT00439309|633804|P2|COMPLETED|Follow-Up||13
261857|NCT00439309|633805|P1|COMPLETED|Follow-Up||51
261858|NCT00439309|633804|P2|STARTED|Follow-Up||15
261859|NCT00439309|633805|P1|STARTED|Follow-Up||54
261860|NCT00439309|633804|P2|NOT COMPLETED|Treatment||0
261861|NCT00439309|633805|P1|NOT COMPLETED|Treatment||0
261862|NCT00439309|633804|P2|COMPLETED|Treatment||15
261863|NCT00439309|633805|P1|COMPLETED|Treatment||54
261864|NCT00439309|633804|P2|STARTED|Treatment||15
261865|NCT00439309|633805|P1|STARTED|Treatment||54
261866|NCT00439270|633824|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
261867|NCT00439270|633825|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
261868|NCT00439270|633826|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
261869|NCT00439270|633827|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
261870|NCT00439270|633828|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
261871|NCT00439270|633824|P5|COMPLETED|Phase 2 (51.6 Months)||0
261872|NCT00439270|633825|P4|COMPLETED|Phase 2 (51.6 Months)||0
261873|NCT00439270|633826|P3|COMPLETED|Phase 2 (51.6 Months)||0
261874|NCT00439270|633827|P2|COMPLETED|Phase 2 (51.6 Months)||0
261875|NCT00439270|633828|P1|COMPLETED|Phase 2 (51.6 Months)||0
261876|NCT00439270|633824|P5|STARTED|Phase 2 (51.6 Months)||0
261877|NCT00439270|633825|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
261878|NCT00439270|633826|P3|STARTED|Phase 2 (51.6 Months)||0
261879|NCT00439270|633827|P2|STARTED|Phase 2 (51.6 Months)||0
261880|NCT00439270|633828|P1|STARTED|Phase 2 (51.6 Months)||0
261881|NCT00439270|633824|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
261882|NCT00439270|633825|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
261883|NCT00439270|633826|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
261884|NCT00439270|633827|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
261885|NCT00439270|633828|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
261886|NCT00439270|633824|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
261887|NCT00439270|633825|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
261888|NCT00439270|633826|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
261889|NCT00439270|633827|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
261890|NCT00439270|633828|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
261891|NCT00439270|633824|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
261892|NCT00439270|633825|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
261893|NCT00439270|633826|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
261894|NCT00439270|633827|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
261895|NCT00439270|633828|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
261896|NCT00439244|633870|P3|NOT COMPLETED|Overall Study||7
261897|NCT00439244|633871|P2|NOT COMPLETED|Overall Study||6
261898|NCT00439244|633872|P1|NOT COMPLETED|Overall Study||11
261899|NCT00439244|633870|P3|COMPLETED|Overall Study||131
261900|NCT00439244|633871|P2|COMPLETED|Overall Study||131
261901|NCT00439244|633872|P1|COMPLETED|Overall Study||126
261902|NCT00439244|633870|P3|Safety Population|Overall Study||137
261903|NCT00439244|633871|P2|Safety Population|Overall Study||137
261904|NCT00439244|633872|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
261905|NCT00439244|633870|P3|STARTED|Overall Study||138
261906|NCT00439244|633871|P2|STARTED|Overall Study||137
261907|NCT00439244|633872|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
261908|NCT00439231|633892|P1|NOT COMPLETED|Overall Study||28
261909|NCT00439231|633892|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
261910|NCT00439231|633892|P1|STARTED|Overall Study||33
261911|NCT00439218|633896|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
261912|NCT00439218|633896|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
261913|NCT00439218|633896|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
261914|NCT00439218|633896|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
261915|NCT00439218|633896|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
261916|NCT00439218|633896|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
261917|NCT00439179|633911|P4|NOT COMPLETED|Overall Study||0
261918|NCT00439179|633912|P3|NOT COMPLETED|Overall Study||0
261919|NCT00439179|633913|P2|NOT COMPLETED|Overall Study||2
261920|NCT00439179|633914|P1|NOT COMPLETED|Overall Study||0
261921|NCT00439179|633911|P4|COMPLETED|Overall Study||5
261922|NCT00439179|633912|P3|COMPLETED|Overall Study||6
261923|NCT00439179|633913|P2|COMPLETED|Overall Study||11
261924|NCT00439179|633914|P1|COMPLETED|Overall Study||3
261925|NCT00439179|633911|P4|STARTED|Overall Study|2 with biliry|5
261926|NCT00439179|633912|P3|STARTED|Overall Study|2 with biliary|6
261927|NCT00439179|633913|P2|STARTED|Overall Study|2 with biliary|13
261928|NCT00439179|633914|P1|STARTED|Overall Study|1 with biliary|3
261929|NCT00439140|633931|P3|NOT COMPLETED|Treatment Cycle 2||0
261930|NCT00439140|633932|P2|NOT COMPLETED|Treatment Cycle 2||1
261931|NCT00439140|633933|P1|NOT COMPLETED|Treatment Cycle 2||2
261932|NCT00439140|633931|P3|COMPLETED|Treatment Cycle 2||0
261933|NCT00439140|633932|P2|COMPLETED|Treatment Cycle 2||6
261934|NCT00439140|633933|P1|COMPLETED|Treatment Cycle 2||11
261935|NCT00439140|633931|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
261936|NCT00439140|633932|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
261937|NCT00439140|633933|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
261938|NCT00439140|633931|P3|NOT COMPLETED|Treatment Cycle 1||1
261939|NCT00439140|633932|P2|NOT COMPLETED|Treatment Cycle 1||4
261940|NCT00439140|633933|P1|NOT COMPLETED|Treatment Cycle 1||1
261941|NCT00439140|633931|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
261942|NCT00439140|633932|P2|COMPLETED|Treatment Cycle 1||10
261943|NCT00439140|633933|P1|COMPLETED|Treatment Cycle 1||14
261944|NCT00439140|633931|P3|STARTED|Treatment Cycle 1||12
261945|NCT00439140|633932|P2|STARTED|Treatment Cycle 1||14
261946|NCT00439140|633933|P1|STARTED|Treatment Cycle 1||15
261947|NCT00438971|633962|P1|NOT COMPLETED|Overall Study||2
261948|NCT00438971|633962|P1|COMPLETED|Overall Study||15
261949|NCT00438971|633962|P1|STARTED|Overall Study||17
261950|NCT00438932|633977|P4|NOT COMPLETED|Overall Study||0
261951|NCT00438932|633978|P3|NOT COMPLETED|Overall Study||0
261952|NCT00438932|633979|P2|NOT COMPLETED|Overall Study||0
261953|NCT00438932|633980|P1|NOT COMPLETED|Overall Study||0
261954|NCT00438932|633977|P4|COMPLETED|Overall Study||4
261955|NCT00438932|633978|P3|COMPLETED|Overall Study||4
261956|NCT00438932|633979|P2|COMPLETED|Overall Study||4
261957|NCT00438932|633980|P1|COMPLETED|Overall Study||4
261958|NCT00438932|633977|P4|STARTED|Overall Study||4
261959|NCT00438932|633978|P3|STARTED|Overall Study||4
261960|NCT00438932|633979|P2|STARTED|Overall Study||4
261961|NCT00438932|633980|P1|STARTED|Overall Study||4
261962|NCT00438880|633996|P2|NOT COMPLETED|Overall Study||0
261963|NCT00438880|633997|P1|NOT COMPLETED|Overall Study||0
261964|NCT00438880|633996|P2|COMPLETED|Overall Study||8
261965|NCT00438880|633997|P1|COMPLETED|Overall Study||30
261966|NCT00438880|633996|P2|STARTED|Overall Study||8
261967|NCT00438880|633997|P1|STARTED|Overall Study||30
261968|NCT00438854|634009|P1|NOT COMPLETED|Overall Study||0
261969|NCT00438854|634009|P1|COMPLETED|Overall Study||15
261970|NCT00438854|634009|P1|STARTED|Overall Study||15
261971|NCT00438815|634016|P1|NOT COMPLETED|Overall Study||70
261972|NCT00438815|634016|P1|COMPLETED|Overall Study||43
261973|NCT00438815|634016|P1|STARTED|Overall Study||113
261974|NCT00438802|634029|P3|NOT COMPLETED|Overall Study||0
261975|NCT00438802|634030|P2|NOT COMPLETED|Overall Study||0
261976|NCT00438802|634031|P1|NOT COMPLETED|Overall Study||0
261977|NCT00438802|634029|P3|COMPLETED|Overall Study||9
261978|NCT00438802|634030|P2|COMPLETED|Overall Study||8
261979|NCT00438802|634031|P1|COMPLETED|Overall Study||6
261980|NCT00438802|634029|P3|STARTED|Overall Study||9
261981|NCT00438802|634030|P2|STARTED|Overall Study||8
261982|NCT00438802|634031|P1|STARTED|Overall Study||6
261983|NCT00438750|634045|P2|NOT COMPLETED|Overall Study||9
261984|NCT00438750|634046|P1|NOT COMPLETED|Overall Study||9
261985|NCT00438750|634045|P2|COMPLETED|Overall Study||37
261986|NCT00438750|634046|P1|COMPLETED|Overall Study||39
261987|NCT00438750|634045|P2|STARTED|Overall Study||46
261988|NCT00438750|634046|P1|STARTED|Overall Study||48
261989|NCT00438672|634066|P2|NOT COMPLETED|Overall Study||9
261990|NCT00438672|634067|P1|NOT COMPLETED|Overall Study||7
261991|NCT00438672|634066|P2|COMPLETED|Overall Study||24
261992|NCT00438672|634067|P1|COMPLETED|Overall Study||24
261993|NCT00438672|634066|P2|STARTED|Overall Study||33
261994|NCT00438672|634067|P1|STARTED|Overall Study||31
261995|NCT00438659|634077|P2|NOT COMPLETED|Overall Study||4
261996|NCT00438659|634078|P1|NOT COMPLETED|Overall Study||6
261997|NCT00438659|634077|P2|COMPLETED|Overall Study||82
261998|NCT00438659|634078|P1|COMPLETED|Overall Study||84
261999|NCT00438659|634077|P2|STARTED|Overall Study||86
262000|NCT00438659|634078|P1|STARTED|Overall Study||90
262001|NCT00438490|634102|P2|NOT COMPLETED|Overall Study||0
262002|NCT00438490|634103|P1|NOT COMPLETED|Overall Study||0
262003|NCT00438490|634102|P2|COMPLETED|Overall Study||9
262004|NCT00438490|634103|P1|COMPLETED|Overall Study||12
262005|NCT00438490|634102|P2|STARTED|Overall Study||9
262006|NCT00438490|634103|P1|STARTED|Overall Study||12
262007|NCT00438464|634117|P2|NOT COMPLETED|Overall Study||7
262008|NCT00438464|634118|P1|NOT COMPLETED|Overall Study||14
262009|NCT00438464|634117|P2|COMPLETED|Overall Study||94
262010|NCT00438464|634118|P1|COMPLETED|Overall Study||89
262011|NCT00438464|634117|P2|Received Assigned Intervention|Overall Study||94
262012|NCT00438464|634118|P1|Received Assigned Intervention|Overall Study||89
262013|NCT00438464|634117|P2|STARTED|Overall Study||101
262014|NCT00438464|634118|P1|STARTED|Overall Study||103
262015|NCT00438451|634173|P3|NOT COMPLETED|Overall Study||53
262016|NCT00438451|634174|P2|NOT COMPLETED|Overall Study||66
262017|NCT00438451|634175|P1|NOT COMPLETED|Overall Study||47
262018|NCT00438451|634173|P3|COMPLETED|Overall Study||65
262019|NCT00438451|634174|P2|COMPLETED|Overall Study||55
262020|NCT00438451|634175|P1|COMPLETED|Overall Study||75
262021|NCT00438451|634173|P3|Maintenance Phase (Week 7-58)|Overall Study||93
262022|NCT00438451|634174|P2|Maintenance Phase (Week 7-58)|Overall Study||89
262023|NCT00438451|634175|P1|Maintenance Phase (Week 7-58)|Overall Study||93
262024|NCT00438451|634173|P3|ITT Population|Overall Study||117
262025|NCT00438451|634174|P2|ITT Population|Overall Study||120
262026|NCT00438451|634175|P1|ITT Population|Overall Study||122
262027|NCT00438451|634173|P3|Safety Population|Overall Study||117
262028|NCT00438451|634174|P2|Safety Population|Overall Study||121
262029|NCT00438451|634175|P1|Safety Population|Overall Study||122
262030|NCT00438451|634173|P3|STARTED|Overall Study||118
262031|NCT00438451|634174|P2|STARTED|Overall Study||121
262032|NCT00438451|634175|P1|STARTED|Overall Study||122
262033|NCT00438399|634219|P6|NOT COMPLETED|Overall Study||6
262034|NCT00438399|634220|P5|NOT COMPLETED|Overall Study||3
262035|NCT00438399|634221|P4|NOT COMPLETED|Overall Study||4
262036|NCT00438399|634222|P3|NOT COMPLETED|Overall Study||7
262037|NCT00438399|634223|P2|NOT COMPLETED|Overall Study||8
262038|NCT00438399|634224|P1|NOT COMPLETED|Overall Study||8
262039|NCT00438399|634219|P6|COMPLETED|Overall Study||31
262040|NCT00438399|634220|P5|COMPLETED|Overall Study||30
262041|NCT00438399|634221|P4|COMPLETED|Overall Study||32
262042|NCT00438399|634222|P3|COMPLETED|Overall Study||28
262043|NCT00438399|634223|P2|COMPLETED|Overall Study||32
262044|NCT00438399|634224|P1|COMPLETED|Overall Study||30
262045|NCT00438399|634219|P6|TREATED & ANALYZED|Overall Study||31
262046|NCT00438399|634220|P5|TREATED & ANALYZED|Overall Study||30
262047|NCT00438399|634221|P4|TREATED & ANALYZED|Overall Study||32
262048|NCT00438399|634222|P3|TREATED & ANALYZED|Overall Study||28
262049|NCT00438399|634223|P2|TREATED & ANALYZED|Overall Study||32
262050|NCT00438399|634224|P1|TREATED & ANALYZED|Overall Study||30
262051|NCT00438399|634219|P6|STARTED|Overall Study||37
262052|NCT00438399|634220|P5|STARTED|Overall Study||33
262053|NCT00438399|634221|P4|STARTED|Overall Study||36
262054|NCT00438399|634222|P3|STARTED|Overall Study||35
262055|NCT00438399|634223|P2|STARTED|Overall Study||40
262056|NCT00438399|634224|P1|STARTED|Overall Study||38
262057|NCT00438360|634235|P2|NOT COMPLETED|Overall Study||43
262058|NCT00438360|634236|P1|NOT COMPLETED|Overall Study||72
262059|NCT00438360|634235|P2|COMPLETED|Overall Study||38
262060|NCT00438360|634236|P1|COMPLETED|Overall Study||90
262061|NCT00438360|634235|P2|Intention to Treat (ITT) Population|Overall Study||79
262062|NCT00438360|634236|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
262063|NCT00438360|634235|P2|STARTED|Overall Study||81
262064|NCT00438360|634236|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
262065|NCT00438204|634250|P1|NOT COMPLETED|Overall Study||0
262066|NCT00438204|634250|P1|COMPLETED|Overall Study||39
262067|NCT00438204|634250|P1|STARTED|Overall Study||39
262068|NCT00438191|634256|P2|NOT COMPLETED|Overall Study||14
262069|NCT00438191|634257|P1|NOT COMPLETED|Overall Study||11
262070|NCT00438191|634256|P2|COMPLETED|Overall Study||26
262071|NCT00438191|634257|P1|COMPLETED|Overall Study||32
262072|NCT00438191|634256|P2|STARTED|Overall Study||40
262073|NCT00438191|634257|P1|STARTED|Overall Study||43
262074|NCT00438100|634271|P2|NOT COMPLETED|Overall Study||4
262075|NCT00438100|634272|P1|NOT COMPLETED|Overall Study||2
262076|NCT00438100|634271|P2|COMPLETED|Overall Study||65
262077|NCT00438100|634272|P1|COMPLETED|Overall Study||71
262078|NCT00438100|634271|P2|STARTED|Overall Study||69
262079|NCT00438100|634272|P1|STARTED|Overall Study||73
262080|NCT00437983|634280|P2|NOT COMPLETED|Overall Study||13
262081|NCT00437983|634281|P1|NOT COMPLETED|Overall Study||13
262082|NCT00437983|634280|P2|COMPLETED|Overall Study||65
262083|NCT00437983|634281|P1|COMPLETED|Overall Study||66
262084|NCT00437983|634280|P2|STARTED|Overall Study||78
262085|NCT00437983|634281|P1|STARTED|Overall Study||79
262086|NCT00437645|634293|P2|NOT COMPLETED|Overall Study||115
262087|NCT00437645|634294|P1|NOT COMPLETED|Overall Study||35
262088|NCT00437645|634293|P2|COMPLETED|Overall Study||476
262089|NCT00437645|634294|P1|COMPLETED|Overall Study||557
262090|NCT00437645|634293|P2|STARTED|Overall Study||591
262091|NCT00437645|634294|P1|STARTED|Overall Study||592
262092|NCT00437489|634310|P2|NOT COMPLETED|Overall Study||22
262093|NCT00437489|634311|P1|NOT COMPLETED|Overall Study||23
262094|NCT00437489|634310|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
262095|NCT00437489|634311|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
262096|NCT00437489|634310|P2|STARTED|Overall Study||24
262097|NCT00437489|634311|P1|STARTED|Overall Study||25
262098|NCT00437398|634323|P1|NOT COMPLETED|Overall Study||0
262099|NCT00437398|634323|P1|COMPLETED|Overall Study||2
262100|NCT00437398|634323|P1|STARTED|Overall Study||2
262101|NCT00437281|634348|P20|NOT COMPLETED|Overall Study||1
262102|NCT00437281|634349|P19|NOT COMPLETED|Overall Study||1
262103|NCT00437281|634350|P18|NOT COMPLETED|Overall Study||0
262104|NCT00437281|634351|P17|NOT COMPLETED|Overall Study||0
262105|NCT00437281|634352|P16|NOT COMPLETED|Overall Study||0
262106|NCT00437281|634353|P15|NOT COMPLETED|Overall Study||1
262107|NCT00437281|634354|P14|NOT COMPLETED|Overall Study||1
262108|NCT00437281|634355|P13|NOT COMPLETED|Overall Study||0
262109|NCT00437281|634356|P12|NOT COMPLETED|Overall Study||0
262110|NCT00437281|634357|P11|NOT COMPLETED|Overall Study||0
262111|NCT00437281|634358|P10|NOT COMPLETED|Overall Study||1
262112|NCT00437281|634359|P9|NOT COMPLETED|Overall Study||0
262113|NCT00437281|634360|P8|NOT COMPLETED|Overall Study||0
262114|NCT00437281|634361|P7|NOT COMPLETED|Overall Study||0
262115|NCT00437281|634362|P6|NOT COMPLETED|Overall Study||1
262116|NCT00437281|634363|P5|NOT COMPLETED|Overall Study||0
262117|NCT00437281|634364|P4|NOT COMPLETED|Overall Study||1
262118|NCT00437281|634365|P3|NOT COMPLETED|Overall Study||0
262119|NCT00437281|634366|P2|NOT COMPLETED|Overall Study||0
262120|NCT00437281|634367|P1|NOT COMPLETED|Overall Study||0
262121|NCT00437281|634348|P20|COMPLETED|Overall Study||2
262122|NCT00437281|634349|P19|COMPLETED|Overall Study||1
262123|NCT00437281|634350|P18|COMPLETED|Overall Study||4
262124|NCT00437281|634351|P17|COMPLETED|Overall Study||3
262125|NCT00437281|634352|P16|COMPLETED|Overall Study||3
262126|NCT00437281|634353|P15|COMPLETED|Overall Study||4
262127|NCT00437281|634354|P14|COMPLETED|Overall Study||2
262128|NCT00437281|634355|P13|COMPLETED|Overall Study||2
262129|NCT00437281|634356|P12|COMPLETED|Overall Study||3
262130|NCT00437281|634357|P11|COMPLETED|Overall Study||3
262131|NCT00437281|634358|P10|COMPLETED|Overall Study||4
262132|NCT00437281|634359|P9|COMPLETED|Overall Study||3
262133|NCT00437281|634360|P8|COMPLETED|Overall Study||3
262134|NCT00437281|634361|P7|COMPLETED|Overall Study||3
262135|NCT00437281|634362|P6|COMPLETED|Overall Study||3
262136|NCT00437281|634363|P5|COMPLETED|Overall Study||4
262137|NCT00437281|634364|P4|COMPLETED|Overall Study||2
262138|NCT00437281|634365|P3|COMPLETED|Overall Study||3
262139|NCT00437281|634366|P2|COMPLETED|Overall Study||3
262140|NCT00437281|634367|P1|COMPLETED|Overall Study||3
262141|NCT00437281|634348|P20|STARTED|Overall Study||3
262142|NCT00437281|634349|P19|STARTED|Overall Study||2
262143|NCT00437281|634350|P18|STARTED|Overall Study||4
262144|NCT00437281|634351|P17|STARTED|Overall Study||3
262145|NCT00437281|634352|P16|STARTED|Overall Study||3
262146|NCT00437281|634353|P15|STARTED|Overall Study||5
262147|NCT00437281|634354|P14|STARTED|Overall Study||3
262148|NCT00437281|634355|P13|STARTED|Overall Study||2
262149|NCT00437281|634356|P12|STARTED|Overall Study||3
262150|NCT00437281|634357|P11|STARTED|Overall Study||3
262151|NCT00437281|634358|P10|STARTED|Overall Study||5
262152|NCT00437281|634359|P9|STARTED|Overall Study||3
262153|NCT00437281|634360|P8|STARTED|Overall Study||3
262154|NCT00437281|634361|P7|STARTED|Overall Study||3
262155|NCT00437281|634362|P6|STARTED|Overall Study||4
262156|NCT00437281|634363|P5|STARTED|Overall Study||4
262157|NCT00437281|634364|P4|STARTED|Overall Study||3
262158|NCT00437281|634365|P3|STARTED|Overall Study||3
262159|NCT00437281|634366|P2|STARTED|Overall Study||3
262160|NCT00437281|634367|P1|STARTED|Overall Study||3
262161|NCT00437203|634671|P10|NOT COMPLETED|Overall Study||4
262162|NCT00437203|634672|P9|NOT COMPLETED|Overall Study||3
262163|NCT00437203|634673|P8|NOT COMPLETED|Overall Study||3
262164|NCT00437203|634674|P7|NOT COMPLETED|Overall Study||7
262165|NCT00437203|634675|P6|NOT COMPLETED|Overall Study||3
262166|NCT00437203|634676|P5|NOT COMPLETED|Overall Study||3
262167|NCT00437203|634677|P4|NOT COMPLETED|Overall Study||3
262168|NCT00437203|634678|P3|NOT COMPLETED|Overall Study||3
262169|NCT00437203|634679|P2|NOT COMPLETED|Overall Study||8
262170|NCT00437203|634680|P1|NOT COMPLETED|Overall Study||6
262171|NCT00437203|634671|P10|COMPLETED|Overall Study||0
262172|NCT00437203|634672|P9|COMPLETED|Overall Study||0
262173|NCT00437203|634673|P8|COMPLETED|Overall Study||0
262174|NCT00437203|634674|P7|COMPLETED|Overall Study||0
262175|NCT00437203|634675|P6|COMPLETED|Overall Study||0
262176|NCT00437203|634676|P5|COMPLETED|Overall Study||0
262177|NCT00437203|634677|P4|COMPLETED|Overall Study||0
262178|NCT00437203|634678|P3|COMPLETED|Overall Study||0
262179|NCT00437203|634679|P2|COMPLETED|Overall Study||0
262180|NCT00437203|634680|P1|COMPLETED|Overall Study||0
262181|NCT00437203|634671|P10|STARTED|Overall Study||4
262182|NCT00437203|634672|P9|STARTED|Overall Study||3
262183|NCT00437203|634673|P8|STARTED|Overall Study||3
262184|NCT00437203|634674|P7|STARTED|Overall Study||7
262185|NCT00437203|634675|P6|STARTED|Overall Study||3
262186|NCT00437203|634676|P5|STARTED|Overall Study||3
262187|NCT00437203|634677|P4|STARTED|Overall Study||3
262188|NCT00437203|634678|P3|STARTED|Overall Study||3
262189|NCT00437203|634679|P2|STARTED|Overall Study||8
262190|NCT00437203|634680|P1|STARTED|Overall Study||6
262191|NCT00437125|634784|P1|NOT COMPLETED|Overall Study||32
262192|NCT00437125|634784|P1|COMPLETED|Overall Study||119
262193|NCT00437125|634784|P1|STARTED|Overall Study||151
262194|NCT00437073|634805|P2|NOT COMPLETED|Overall Study||1
262195|NCT00437073|634806|P1|NOT COMPLETED|Overall Study||1
262196|NCT00437073|634805|P2|COMPLETED|Overall Study||8
262197|NCT00437073|634806|P1|COMPLETED|Overall Study||12
262198|NCT00437073|634805|P2|STARTED|Overall Study||9
262199|NCT00437073|634806|P1|STARTED|Overall Study||13
262200|NCT00437034|634834|P1|NOT COMPLETED|Overall Study||6
262201|NCT00437034|634834|P1|COMPLETED|Overall Study||0
262202|NCT00437034|634834|P1|STARTED|Overall Study||6
262203|NCT00436982|634840|P2|NOT COMPLETED|Overall Study||4
262204|NCT00436982|634841|P1|NOT COMPLETED|Overall Study||4
262205|NCT00436982|634840|P2|COMPLETED|Overall Study||26
262206|NCT00436982|634841|P1|COMPLETED|Overall Study||26
262207|NCT00436982|634840|P2|STARTED|Overall Study||30
262208|NCT00436982|634841|P1|STARTED|Overall Study||30
262209|NCT00436969|634863|P2|NOT COMPLETED|Overall Study||52
262210|NCT00436969|634864|P1|NOT COMPLETED|Overall Study||22
262211|NCT00436969|634863|P2|COMPLETED|Overall Study||134
262212|NCT00436969|634864|P1|COMPLETED|Overall Study||66
262213|NCT00436969|634863|P2|Randomized But Not Treated|Overall Study||3
262214|NCT00436969|634864|P1|Randomized But Not Treated|Overall Study||1
262215|NCT00436969|634863|P2|STARTED|Overall Study||186
262216|NCT00436969|634864|P1|STARTED|Overall Study||88
262217|NCT00436956|634912|P2|NOT COMPLETED|Overall Study||0
262218|NCT00436956|634913|P1|NOT COMPLETED|Overall Study||1
262219|NCT00436956|634912|P2|COMPLETED|Overall Study||23
262220|NCT00436956|634913|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
262221|NCT00436956|634912|P2|STARTED|Overall Study||23
262222|NCT00436956|634913|P1|STARTED|Overall Study||36
262223|NCT00436917|634922|P1|NOT COMPLETED|Overall Study||54
262224|NCT00436917|634922|P1|COMPLETED|Overall Study||0
262225|NCT00436917|634922|P1|STARTED|Overall Study|6 participants with cancellation, protocol violation and ineligible were excluded from all analysis.|54
262226|NCT00436904|634926|P1|NOT COMPLETED|Overall Study||0
262227|NCT00436904|634926|P1|COMPLETED|Overall Study||30
262228|NCT00436904|634926|P1|STARTED|Overall Study||30
262229|NCT00436852|634937|P2|NOT COMPLETED|Overall Study||45
262230|NCT00436852|634938|P1|NOT COMPLETED|Overall Study||35
262231|NCT00436852|634937|P2|COMPLETED|Overall Study||2
262232|NCT00436852|634938|P1|COMPLETED|Overall Study||10
262233|NCT00436852|634937|P2|STARTED|Overall Study||47
262234|NCT00436852|634938|P1|STARTED|Overall Study||45
262235|NCT00436826|634948|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
262236|NCT00436826|634949|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
262237|NCT00436826|634950|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
262238|NCT00436826|634951|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
262239|NCT00436826|634952|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
262240|NCT00436826|634953|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
262241|NCT00436826|634948|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
262242|NCT00436826|634949|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
262243|NCT00436826|634950|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
262244|NCT00436826|634951|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
262245|NCT00436826|634952|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
262246|NCT00436826|634953|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
262247|NCT00436826|634948|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
262248|NCT00436826|634949|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
262249|NCT00436826|634950|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
262250|NCT00436826|634951|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
262251|NCT00436826|634952|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
262252|NCT00436826|634953|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
262253|NCT00436826|634948|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
262254|NCT00436826|634949|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
262255|NCT00436826|634950|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
262256|NCT00436826|634951|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
262257|NCT00436826|634952|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
262258|NCT00436826|634953|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
262259|NCT00436826|634948|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
262260|NCT00436826|634949|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
262261|NCT00436826|634950|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
262262|NCT00436826|634951|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
262263|NCT00436826|634952|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
262264|NCT00436826|634953|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
262265|NCT00436826|634948|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
262266|NCT00436826|634949|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
262267|NCT00436826|634950|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
262268|NCT00436826|634951|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
262269|NCT00436826|634952|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
262270|NCT00436826|634953|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
262271|NCT00436826|634948|P6|NOT COMPLETED|Double Blind Period||0
262272|NCT00436826|634949|P5|NOT COMPLETED|Double Blind Period||0
262273|NCT00436826|634950|P4|NOT COMPLETED|Double Blind Period||0
262274|NCT00436826|634951|P3|NOT COMPLETED|Double Blind Period||0
262275|NCT00436826|634952|P2|NOT COMPLETED|Double Blind Period||11
262276|NCT00436826|634953|P1|NOT COMPLETED|Double Blind Period||13
262277|NCT00436826|634948|P6|COMPLETED|Double Blind Period||0
262278|NCT00436826|634949|P5|COMPLETED|Double Blind Period||0
262279|NCT00436826|634950|P4|COMPLETED|Double Blind Period||0
262280|NCT00436826|634951|P3|COMPLETED|Double Blind Period||0
262281|NCT00436826|634952|P2|COMPLETED|Double Blind Period||37
262282|NCT00436826|634953|P1|COMPLETED|Double Blind Period||111
262283|NCT00436826|634948|P6|STARTED|Double Blind Period||0
262284|NCT00436826|634949|P5|STARTED|Double Blind Period||0
262285|NCT00436826|634950|P4|STARTED|Double Blind Period||0
262286|NCT00436826|634951|P3|STARTED|Double Blind Period||0
262287|NCT00436826|634952|P2|STARTED|Double Blind Period||48
262288|NCT00436826|634953|P1|STARTED|Double Blind Period||124
262289|NCT00436748|634975|P2|NOT COMPLETED|Overall Study||12
262290|NCT00436748|634976|P1|NOT COMPLETED|Overall Study||11
262291|NCT00436748|634975|P2|COMPLETED|Overall Study||45
262292|NCT00436748|634976|P1|COMPLETED|Overall Study||48
262293|NCT00436748|634975|P2|Received Treatment|Overall Study||56
262294|NCT00436748|634976|P1|Received Treatment|Overall Study||58
262295|NCT00436748|634975|P2|STARTED|Overall Study||57
262296|NCT00436748|634976|P1|STARTED|Overall Study||59
262297|NCT00436644|635010|P1|NOT COMPLETED|Overall Study||3
262298|NCT00436644|635010|P1|COMPLETED|Overall Study||15
262299|NCT00436644|635010|P1|STARTED|Overall Study||18
262300|NCT00436618|635020|P3|NOT COMPLETED|Overall Study||61
262301|NCT00436618|635021|P2|NOT COMPLETED|Overall Study||27
262302|NCT00436618|635022|P1|NOT COMPLETED|Overall Study||30
262303|NCT00436618|635020|P3|COMPLETED|Overall Study||46
262304|NCT00436618|635021|P2|COMPLETED|Overall Study||28
262305|NCT00436618|635022|P1|COMPLETED|Overall Study||84
262306|NCT00436618|635020|P3|STARTED|Overall Study||107
262307|NCT00436618|635021|P2|STARTED|Overall Study||55
262308|NCT00436618|635022|P1|STARTED|Overall Study||114
262309|NCT00436605|635039|P1|NOT COMPLETED|Overall Study||3
262310|NCT00436605|635039|P1|COMPLETED|Overall Study||36
262311|NCT00436605|635039|P1|STARTED|Overall Study||39
262312|NCT00436566|635044|P1|NOT COMPLETED|Overall Study||3
262313|NCT00436566|635044|P1|COMPLETED|Overall Study||109
262314|NCT00436566|635044|P1|STARTED|Overall Study||112
262315|NCT00436553|635051|P3|NOT COMPLETED|Overall Study||10
262316|NCT00436553|635052|P2|NOT COMPLETED|Overall Study||12
262317|NCT00436553|635053|P1|NOT COMPLETED|Overall Study||13
262318|NCT00436553|635051|P3|COMPLETED|Overall Study||102
262319|NCT00436553|635052|P2|COMPLETED|Overall Study||93
262320|NCT00436553|635053|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
262321|NCT00436553|635051|P3|STARTED|Overall Study||112
262322|NCT00436553|635052|P2|STARTED|Overall Study||105
262323|NCT00436553|635053|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
262324|NCT00436501|635074|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
262325|NCT00436501|635075|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
262326|NCT00436501|635074|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
262327|NCT00436501|635075|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
262328|NCT00436501|635074|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
262329|NCT00436501|635075|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
262330|NCT00436501|635074|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
262331|NCT00436501|635075|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
262332|NCT00436501|635074|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
262333|NCT00436501|635075|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
262334|NCT00436501|635074|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
262335|NCT00436501|635075|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
262336|NCT00436501|635074|P2|NOT COMPLETED|Complete Study Participation||0
262337|NCT00436501|635075|P1|NOT COMPLETED|Complete Study Participation||0
262338|NCT00436501|635074|P2|COMPLETED|Complete Study Participation||49
262339|NCT00436501|635075|P1|COMPLETED|Complete Study Participation||9
262340|NCT00436501|635074|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
262341|NCT00436501|635075|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
262342|NCT00436436|635086|P1|NOT COMPLETED|Overall Study||12
262343|NCT00436436|635086|P1|COMPLETED|Overall Study||0
262344|NCT00436436|635086|P1|STARTED|Overall Study||12
262345|NCT00436345|635097|P2|NOT COMPLETED|Overall Study||0
262346|NCT00436345|635098|P1|NOT COMPLETED|Overall Study||3
262347|NCT00436345|635097|P2|COMPLETED|Overall Study||18
262348|NCT00436345|635098|P1|COMPLETED|Overall Study||18
262349|NCT00436345|635097|P2|STARTED|Overall Study||18
262350|NCT00436345|635098|P1|STARTED|Overall Study||21
262351|NCT00436332|635151|P1|NOT COMPLETED|Overall Study||83
262352|NCT00436332|635151|P1|COMPLETED|Overall Study||1
262353|NCT00436332|635151|P1|Eligible and Began Protocol Therapy|Overall Study||79
262354|NCT00436332|635151|P1|Eligible|Overall Study||82
262355|NCT00436332|635151|P1|STARTED|Overall Study||84
262356|NCT00436215|635158|P1|NOT COMPLETED|Overall Study||4
262357|NCT00436215|635158|P1|COMPLETED|Overall Study||51
262358|NCT00436215|635158|P1|STARTED|Overall Study||55
262359|NCT00436163|635164|P1|NOT COMPLETED|Overall Study||3
262360|NCT00436163|635164|P1|COMPLETED|Overall Study||36
262361|NCT00436163|635164|P1|STARTED|Overall Study||39
262362|NCT00436046|635178|P3|NOT COMPLETED|Overall Study||0
262363|NCT00436046|635179|P2|NOT COMPLETED|Overall Study||0
262364|NCT00436046|635180|P1|NOT COMPLETED|Overall Study||0
262365|NCT00436046|635178|P3|COMPLETED|Overall Study||31
262366|NCT00436046|635179|P2|COMPLETED|Overall Study||32
262367|NCT00436046|635180|P1|COMPLETED|Overall Study||32
262368|NCT00436046|635178|P3|STARTED|Overall Study||31
262369|NCT00436046|635179|P2|STARTED|Overall Study||32
262370|NCT00436046|635180|P1|STARTED|Overall Study||32
262371|NCT00436007|635212|P3|NOT COMPLETED|Overall Study||23
262372|NCT00436007|635213|P2|NOT COMPLETED|Overall Study||14
262373|NCT00436007|635214|P1|NOT COMPLETED|Overall Study||19
262374|NCT00436007|635212|P3|COMPLETED|Overall Study||148
262375|NCT00436007|635213|P2|COMPLETED|Overall Study||156
262376|NCT00436007|635214|P1|COMPLETED|Overall Study||151
262377|NCT00436007|635212|P3|STARTED|Overall Study||171
262378|NCT00436007|635213|P2|STARTED|Overall Study||170
262379|NCT00436007|635214|P1|STARTED|Overall Study||170
262380|NCT00435994|635262|P3|NOT COMPLETED|Overall Study||0
262381|NCT00435994|635263|P2|NOT COMPLETED|Overall Study||0
262382|NCT00435994|635264|P1|NOT COMPLETED|Overall Study||7
262383|NCT00435994|635262|P3|COMPLETED|Overall Study||12
262384|NCT00435994|635263|P2|COMPLETED|Overall Study||25
262385|NCT00435994|635264|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
262386|NCT00435994|635262|P3|STARTED|Overall Study||12
262387|NCT00435994|635263|P2|STARTED|Overall Study||25
262388|NCT00435994|635264|P1|STARTED|Overall Study||22
262389|NCT00435942|635275|P2|NOT COMPLETED|Overall Study||27
262390|NCT00435942|635276|P1|NOT COMPLETED|Overall Study||23
262391|NCT00435942|635275|P2|COMPLETED|Overall Study||33
262392|NCT00435942|635276|P1|COMPLETED|Overall Study||97
262393|NCT00435942|635275|P2|STARTED|Overall Study||60
262394|NCT00435942|635276|P1|STARTED|Overall Study||120
262395|NCT00435929|635285|P2|NOT COMPLETED|Overall Study||0
262396|NCT00435929|635286|P1|NOT COMPLETED|Overall Study||0
262397|NCT00435929|635285|P2|COMPLETED|Overall Study||9
262398|NCT00435929|635286|P1|COMPLETED|Overall Study||7
262399|NCT00435929|635285|P2|STARTED|Overall Study||9
262400|NCT00435929|635286|P1|STARTED|Overall Study||7
262401|NCT00435825|635316|P4|NOT COMPLETED|Overall Study||16
262402|NCT00435825|635317|P3|NOT COMPLETED|Overall Study||11
262403|NCT00435825|635318|P2|NOT COMPLETED|Overall Study||12
262404|NCT00435825|635319|P1|NOT COMPLETED|Overall Study||18
262405|NCT00435825|635316|P4|COMPLETED|Overall Study||120
262406|NCT00435825|635317|P3|COMPLETED|Overall Study||127
262407|NCT00435825|635318|P2|COMPLETED|Overall Study||124
262408|NCT00435825|635319|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
262409|NCT00435825|635316|P4|Completed 48 Weeks Treatment|Overall Study||117
262410|NCT00435825|635317|P3|Completed 48 Weeks Treatment|Overall Study||124
262411|NCT00435825|635318|P2|Completed 48 Weeks Treatment|Overall Study||0
262412|NCT00435825|635319|P1|Completed 48 Weeks Treatment|Overall Study||0
262413|NCT00435825|635316|P4|Completed 24 Weeks Treatment|Overall Study||131
262414|NCT00435825|635317|P3|Completed 24 Weeks Treatment|Overall Study||134
262415|NCT00435825|635318|P2|Completed 24 Weeks Treatment|Overall Study||126
262416|NCT00435825|635319|P1|Completed 24 Weeks Treatment|Overall Study||128
262417|NCT00435825|635316|P4|Entered Follow-up|Overall Study||133
262418|NCT00435825|635317|P3|Entered Follow-up|Overall Study||135
262419|NCT00435825|635318|P2|Entered Follow-up|Overall Study||132
262420|NCT00435825|635319|P1|Entered Follow-up|Overall Study||140
262421|NCT00435825|635316|P4|Received Study Drug|Overall Study||136
262422|NCT00435825|635317|P3|Received Study Drug|Overall Study||136
262423|NCT00435825|635318|P2|Received Study Drug|Overall Study||136
262424|NCT00435825|635319|P1|Received Study Drug|Overall Study||140
262425|NCT00435825|635316|P4|STARTED|Overall Study||136
262426|NCT00435825|635317|P3|STARTED|Overall Study||138
262427|NCT00435825|635318|P2|STARTED|Overall Study||136
262428|NCT00435825|635319|P1|STARTED|Overall Study||141
262429|NCT00435812|635375|P2|NOT COMPLETED|Overall Study||18
262430|NCT00435812|635376|P1|NOT COMPLETED|Overall Study||63
262431|NCT00435812|635375|P2|COMPLETED|Overall Study||590
262432|NCT00435812|635376|P1|COMPLETED|Overall Study||1757
262433|NCT00435812|635375|P2|STARTED|Overall Study||608
262434|NCT00435812|635376|P1|STARTED|Overall Study||1820
262435|NCT00435591|635388|P4|NOT COMPLETED|Overall Study||11
262436|NCT00435591|635389|P3|NOT COMPLETED|Overall Study||5
262437|NCT00435591|635390|P2|NOT COMPLETED|Overall Study||4
262438|NCT00435591|635391|P1|NOT COMPLETED|Overall Study||7
262439|NCT00435591|635388|P4|COMPLETED|Overall Study||19
262440|NCT00435591|635389|P3|COMPLETED|Overall Study||25
262441|NCT00435591|635390|P2|COMPLETED|Overall Study||27
262442|NCT00435591|635391|P1|COMPLETED|Overall Study||23
262443|NCT00435591|635388|P4|End of Treatment|Overall Study||23
262444|NCT00435591|635389|P3|End of Treatment|Overall Study||27
262445|NCT00435591|635390|P2|End of Treatment|Overall Study||27
262446|NCT00435591|635391|P1|End of Treatment|Overall Study||25
262447|NCT00435591|635388|P4|Full Analysis Set|Overall Study||29
262448|NCT00435591|635389|P3|Full Analysis Set|Overall Study||30
262449|NCT00435591|635390|P2|Full Analysis Set|Overall Study||29
262450|NCT00435591|635391|P1|Full Analysis Set|Overall Study||28
262451|NCT00435591|635388|P4|Safety Analysis Set|Overall Study||29
262452|NCT00435591|635389|P3|Safety Analysis Set|Overall Study||30
262453|NCT00435591|635390|P2|Safety Analysis Set|Overall Study||30
262454|NCT00435591|635391|P1|Safety Analysis Set|Overall Study||28
262455|NCT00435591|635388|P4|STARTED|Overall Study||30
262456|NCT00435591|635389|P3|STARTED|Overall Study||30
262457|NCT00435591|635390|P2|STARTED|Overall Study||31
262458|NCT00435591|635391|P1|STARTED|Overall Study||30
262459|NCT00435539|635421|P5|NOT COMPLETED|Overall Study||0
262460|NCT00435539|635422|P4|NOT COMPLETED|Overall Study||0
262461|NCT00435539|635423|P3|NOT COMPLETED|Overall Study||0
262462|NCT00435539|635424|P2|NOT COMPLETED|Overall Study||0
262463|NCT00435539|635425|P1|NOT COMPLETED|Overall Study||0
262464|NCT00435539|635421|P5|COMPLETED|Overall Study||12
262465|NCT00435539|635422|P4|COMPLETED|Overall Study||12
262466|NCT00435539|635423|P3|COMPLETED|Overall Study||11
262467|NCT00435539|635424|P2|COMPLETED|Overall Study||13
262468|NCT00435539|635425|P1|COMPLETED|Overall Study||12
262469|NCT00435539|635421|P5|STARTED|Overall Study||12
262470|NCT00435539|635422|P4|STARTED|Overall Study||12
262471|NCT00435539|635423|P3|STARTED|Overall Study||11
262472|NCT00435539|635424|P2|STARTED|Overall Study||13
262473|NCT00435539|635425|P1|STARTED|Overall Study||12
262474|NCT00435487|635442|P2|NOT COMPLETED|Overall Study||15
262475|NCT00435487|635443|P1|NOT COMPLETED|Overall Study||12
262476|NCT00435487|635442|P2|COMPLETED|Overall Study||71
262477|NCT00435487|635443|P1|COMPLETED|Overall Study||76
262478|NCT00435487|635442|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
262479|NCT00435487|635443|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
262480|NCT00435487|635442|P2|STARTED|Overall Study||86
262481|NCT00435487|635443|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
262482|NCT00435461|635462|P3|NOT COMPLETED|Overall Study||24
262483|NCT00435461|635463|P2|NOT COMPLETED|Overall Study||14
262484|NCT00435461|635464|P1|NOT COMPLETED|Overall Study||23
262485|NCT00435461|635462|P3|COMPLETED|Overall Study||287
262486|NCT00435461|635463|P2|COMPLETED|Overall Study||298
262487|NCT00435461|635464|P1|COMPLETED|Overall Study||290
262488|NCT00435461|635462|P3|STARTED|Overall Study||311
262489|NCT00435461|635463|P2|STARTED|Overall Study||312
262490|NCT00435461|635464|P1|STARTED|Overall Study||313
262491|NCT00435409|635501|P3|NOT COMPLETED|Overall Study||78
262492|NCT00435409|635502|P2|NOT COMPLETED|Overall Study||143
262493|NCT00435409|635503|P1|NOT COMPLETED|Overall Study||221
262494|NCT00435409|635501|P3|COMPLETED|Overall Study||0
262495|NCT00435409|635502|P2|COMPLETED|Overall Study||0
262496|NCT00435409|635503|P1|COMPLETED|Overall Study||0
262497|NCT00435409|635501|P3|Treated|Overall Study||78
262498|NCT00435409|635502|P2|Treated|Overall Study||139
262499|NCT00435409|635503|P1|Treated|Overall Study||217
262500|NCT00435409|635501|P3|STARTED|Overall Study||78
262501|NCT00435409|635502|P2|STARTED|Overall Study||143
262502|NCT00435409|635503|P1|STARTED|Overall Study||221
262503|NCT00435370|635525|P2|NOT COMPLETED|Overall Study||20
262504|NCT00435370|635526|P1|NOT COMPLETED|Overall Study||22
262505|NCT00435370|635525|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
262506|NCT00435370|635526|P1|COMPLETED|Overall Study||68
262507|NCT00435370|635525|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
262508|NCT00435370|635526|P1|STARTED|Overall Study||90
262509|NCT00435188|635534|P2|NOT COMPLETED|Overall Study||23
262510|NCT00435188|635535|P1|NOT COMPLETED|Overall Study||22
262511|NCT00435188|635534|P2|COMPLETED|Overall Study||176
262512|NCT00435188|635535|P1|COMPLETED|Overall Study||177
262513|NCT00435188|635534|P2|STARTED|Overall Study||199
262514|NCT00435188|635535|P1|STARTED|Overall Study||199
262515|NCT00435162|635578|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
262516|NCT00435162|635579|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
262517|NCT00435162|635580|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
262518|NCT00435162|635581|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
262519|NCT00435162|635582|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
262520|NCT00435162|635583|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
262521|NCT00435162|635578|P6|COMPLETED|Period 2 (2 Weeks)||15
262522|NCT00435162|635579|P5|COMPLETED|Period 2 (2 Weeks)||15
262523|NCT00435162|635580|P4|COMPLETED|Period 2 (2 Weeks)||8
262524|NCT00435162|635581|P3|COMPLETED|Period 2 (2 Weeks)||6
262525|NCT00435162|635582|P2|COMPLETED|Period 2 (2 Weeks)||14
262526|NCT00435162|635583|P1|COMPLETED|Period 2 (2 Weeks)||15
262527|NCT00435162|635578|P6|STARTED|Period 2 (2 Weeks)||15
262528|NCT00435162|635579|P5|STARTED|Period 2 (2 Weeks)||15
262529|NCT00435162|635580|P4|STARTED|Period 2 (2 Weeks)||8
262530|NCT00435162|635581|P3|STARTED|Period 2 (2 Weeks)||6
262531|NCT00435162|635582|P2|STARTED|Period 2 (2 Weeks)||15
262532|NCT00435162|635583|P1|STARTED|Period 2 (2 Weeks)||15
262533|NCT00435162|635578|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
262534|NCT00435162|635579|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
262535|NCT00435162|635580|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
262536|NCT00435162|635581|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
262537|NCT00435162|635582|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
262538|NCT00435162|635583|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
262539|NCT00435162|635578|P6|COMPLETED|Period 1 (6 Weeks)||15
262540|NCT00435162|635579|P5|COMPLETED|Period 1 (6 Weeks)||15
262541|NCT00435162|635580|P4|COMPLETED|Period 1 (6 Weeks)||8
262542|NCT00435162|635581|P3|COMPLETED|Period 1 (6 Weeks)||6
262543|NCT00435162|635582|P2|COMPLETED|Period 1 (6 Weeks)||15
262544|NCT00435162|635583|P1|COMPLETED|Period 1 (6 Weeks)||15
262545|NCT00435162|635578|P6|STARTED|Period 1 (6 Weeks)||15
262546|NCT00435162|635579|P5|STARTED|Period 1 (6 Weeks)||15
262547|NCT00435162|635580|P4|STARTED|Period 1 (6 Weeks)||8
262548|NCT00435162|635581|P3|STARTED|Period 1 (6 Weeks)||6
262549|NCT00435162|635582|P2|STARTED|Period 1 (6 Weeks)||15
262550|NCT00435162|635583|P1|STARTED|Period 1 (6 Weeks)||15
262551|NCT00435045|635603|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
262552|NCT00435045|635604|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
262553|NCT00435045|635603|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
262554|NCT00435045|635604|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
262555|NCT00435045|635603|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
262556|NCT00435045|635604|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
262557|NCT00435045|635603|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
262558|NCT00435045|635604|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
262559|NCT00435045|635603|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
262560|NCT00435045|635604|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
262561|NCT00435045|635603|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
262562|NCT00435045|635604|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
262563|NCT00435045|635603|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
262564|NCT00435045|635604|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
262565|NCT00435045|635603|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
262566|NCT00435045|635604|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
262567|NCT00435045|635603|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
262568|NCT00435045|635604|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
262569|NCT00435019|635660|P2|NOT COMPLETED|Overall Study||10
262570|NCT00435019|635661|P1|NOT COMPLETED|Overall Study||13
262571|NCT00435019|635660|P2|COMPLETED|Overall Study||161
262572|NCT00435019|635661|P1|COMPLETED|Overall Study||164
262573|NCT00435019|635660|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
262574|NCT00435019|635661|P1|Exposed to Study Drug|Overall Study||177
262575|NCT00435019|635660|P2|STARTED|Overall Study|Randomised|171
262576|NCT00435019|635661|P1|STARTED|Overall Study|Randomised|177
262577|NCT00434993|635673|P2|NOT COMPLETED|Overall Study||0
262578|NCT00434993|635674|P1|NOT COMPLETED|Overall Study||0
262579|NCT00434993|635673|P2|COMPLETED|Overall Study||130
262580|NCT00434993|635674|P1|COMPLETED|Overall Study||152
262581|NCT00434993|635673|P2|STARTED|Overall Study||130
262582|NCT00434993|635674|P1|STARTED|Overall Study||152
262583|NCT00434967|635702|P4|NOT COMPLETED|Overall Study||14
262584|NCT00434967|635703|P3|NOT COMPLETED|Overall Study||9
262585|NCT00434967|635704|P2|NOT COMPLETED|Overall Study||8
262586|NCT00434967|635705|P1|NOT COMPLETED|Overall Study||7
262587|NCT00434967|635702|P4|COMPLETED|Overall Study||478
262588|NCT00434967|635703|P3|COMPLETED|Overall Study||461
262589|NCT00434967|635704|P2|COMPLETED|Overall Study||457
262590|NCT00434967|635705|P1|COMPLETED|Overall Study||90
262591|NCT00434967|635702|P4|STARTED|Overall Study||492
262592|NCT00434967|635703|P3|STARTED|Overall Study||470
262593|NCT00434967|635704|P2|STARTED|Overall Study||465
262594|NCT00434967|635705|P1|STARTED|Overall Study||97
262595|NCT00434954|635725|P2|NOT COMPLETED|Overall Study||71
262596|NCT00434954|635726|P1|NOT COMPLETED|Overall Study||82
262597|NCT00434954|635725|P2|COMPLETED|Overall Study||175
262598|NCT00434954|635726|P1|COMPLETED|Overall Study||166
262599|NCT00434954|635725|P2|Completed - Previous Treatment MET + SU|Overall Study||38
262600|NCT00434954|635726|P1|Completed - Previous Treatment MET + SU|Overall Study||31
262601|NCT00434954|635725|P2|Completed - Previous Treatment MET Only|Overall Study||137
262602|NCT00434954|635726|P1|Completed - Previous Treatment MET Only|Overall Study||135
262603|NCT00434954|635725|P2|FAS - Previous Treatment MET + SU|Overall Study||60
262604|NCT00434954|635726|P1|FAS - Previous Treatment MET + SU|Overall Study||66
262605|NCT00434954|635725|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
262606|NCT00434954|635726|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
262607|NCT00434954|635725|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
262608|NCT00434954|635726|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
262609|NCT00434954|635725|P2|Started - Previous Treatment MET + SU|Overall Study||65
262610|NCT00434954|635726|P1|Started - Previous Treatment MET + SU|Overall Study||66
262611|NCT00434954|635725|P2|Started - Previous Treatment MET Only|Overall Study||181
262612|NCT00434954|635726|P1|Started - Previous Treatment MET Only|Overall Study||182
262613|NCT00434954|635725|P2|STARTED|Overall Study||246
262614|NCT00434954|635726|P1|STARTED|Overall Study||248
262615|NCT00434876|635756|P2|NOT COMPLETED|Overall Study||1
262616|NCT00434876|635757|P1|NOT COMPLETED|Overall Study||1
262617|NCT00434876|635756|P2|COMPLETED|Overall Study||10
262618|NCT00434876|635757|P1|COMPLETED|Overall Study||10
262619|NCT00434876|635756|P2|STARTED|Overall Study||11
262620|NCT00434876|635757|P1|STARTED|Overall Study||11
262621|NCT00434759|635771|P2|NOT COMPLETED|Overall Study||5
262622|NCT00434759|635772|P1|NOT COMPLETED|Overall Study||24
262623|NCT00434759|635771|P2|COMPLETED|Overall Study||38
262624|NCT00434759|635772|P1|COMPLETED|Overall Study||22
262625|NCT00434759|635771|P2|STARTED|Overall Study||43
262626|NCT00434759|635772|P1|STARTED|Overall Study||46
262627|NCT00434642|635788|P2|NOT COMPLETED|Open-label Treatment Phase||11
262628|NCT00434642|635789|P1|NOT COMPLETED|Open-label Treatment Phase||0
262629|NCT00434642|635788|P2|COMPLETED|Open-label Treatment Phase||1
262630|NCT00434642|635789|P1|COMPLETED|Open-label Treatment Phase||0
262631|NCT00434642|635788|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
262632|NCT00434642|635789|P1|STARTED|Open-label Treatment Phase||0
262633|NCT00434642|635788|P2|NOT COMPLETED|Blinded Treatment Phase||229
262634|NCT00434642|635789|P1|NOT COMPLETED|Blinded Treatment Phase||242
262635|NCT00434642|635788|P2|COMPLETED|Blinded Treatment Phase||13
262636|NCT00434642|635789|P1|COMPLETED|Blinded Treatment Phase||0
262637|NCT00434642|635788|P2|STARTED|Blinded Treatment Phase||242
262638|NCT00434642|635789|P1|STARTED|Blinded Treatment Phase||242
262639|NCT00434590|635807|P2|NOT COMPLETED|Overall Study||5
262640|NCT00434590|635808|P1|NOT COMPLETED|Overall Study||5
262641|NCT00434590|635807|P2|COMPLETED|Overall Study||0
262642|NCT00434590|635808|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
262643|NCT00434590|635807|P2|STARTED|Overall Study||5
262644|NCT00434590|635808|P1|STARTED|Overall Study||5
262645|NCT00434434|635817|P3|NOT COMPLETED|Overall Study||1
262646|NCT00434434|635818|P2|NOT COMPLETED|Overall Study||0
262647|NCT00434434|635819|P1|NOT COMPLETED|Overall Study||2
262648|NCT00434434|635817|P3|COMPLETED|Overall Study||13
262649|NCT00434434|635818|P2|COMPLETED|Overall Study||24
262650|NCT00434434|635819|P1|COMPLETED|Overall Study||21
262651|NCT00434434|635817|P3|STARTED|Overall Study||14
262652|NCT00434434|635818|P2|STARTED|Overall Study||24
262653|NCT00434434|635819|P1|STARTED|Overall Study||23
262654|NCT00434421|635830|P1|NOT COMPLETED|Overall Study||2
262655|NCT00434421|635830|P1|COMPLETED|Overall Study||26
262656|NCT00434421|635830|P1|STARTED|Overall Study||28
262657|NCT00434356|635836|P2|NOT COMPLETED|Overall Study||23
262658|NCT00434356|635837|P1|NOT COMPLETED|Overall Study||23
262659|NCT00434356|635836|P2|COMPLETED|Overall Study||0
262660|NCT00434356|635837|P1|COMPLETED|Overall Study||0
262661|NCT00434356|635836|P2|STARTED|Overall Study||23
262662|NCT00434356|635837|P1|STARTED|Overall Study||23
262663|NCT00434330|635858|P6|NOT COMPLETED|Overall Study||1
262664|NCT00434330|635859|P5|NOT COMPLETED|Overall Study||1
262665|NCT00434330|635860|P4|NOT COMPLETED|Overall Study||2
262666|NCT00434330|635861|P3|NOT COMPLETED|Overall Study||3
262667|NCT00434330|635862|P2|NOT COMPLETED|Overall Study||0
262668|NCT00434330|635863|P1|NOT COMPLETED|Overall Study||1
262669|NCT00434330|635858|P6|COMPLETED|Overall Study||14
262670|NCT00434330|635859|P5|COMPLETED|Overall Study||14
262671|NCT00434330|635860|P4|COMPLETED|Overall Study||13
262672|NCT00434330|635861|P3|COMPLETED|Overall Study||13
262673|NCT00434330|635862|P2|COMPLETED|Overall Study||15
262674|NCT00434330|635863|P1|COMPLETED|Overall Study||14
262675|NCT00434330|635858|P6|STARTED|Overall Study||15
262676|NCT00434330|635859|P5|STARTED|Overall Study||15
262677|NCT00434330|635860|P4|STARTED|Overall Study||15
262678|NCT00434330|635861|P3|STARTED|Overall Study||16
262679|NCT00434330|635862|P2|STARTED|Overall Study||15
262680|NCT00434330|635863|P1|STARTED|Overall Study||15
262681|NCT00434304|635895|P1|NOT COMPLETED|Overall Study||20
262682|NCT00434304|635895|P1|COMPLETED|Overall Study||42
262683|NCT00434304|635895|P1|STARTED|Overall Study||62
262684|NCT00434278|635933|P2|NOT COMPLETED|Overall Study||0
262685|NCT00434278|635934|P1|NOT COMPLETED|Overall Study||2
262686|NCT00434278|635933|P2|COMPLETED|Overall Study||13
262687|NCT00434278|635934|P1|COMPLETED|Overall Study||12
262688|NCT00434278|635933|P2|STARTED|Overall Study||13
262689|NCT00434278|635934|P1|STARTED|Overall Study||14
262690|NCT00434252|635944|P2|NOT COMPLETED|Overall Study||131
262691|NCT00434252|635945|P1|NOT COMPLETED|Overall Study||64
262692|NCT00434252|635944|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
262693|NCT00434252|635945|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
262694|NCT00434252|635944|P2|Treated|Overall Study||143
262695|NCT00434252|635945|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
262696|NCT00434252|635944|P2|STARTED|Overall Study||143
262697|NCT00434252|635945|P1|STARTED|Overall Study||71
262698|NCT00434226|635967|P2|NOT COMPLETED|Overall Study||26
262699|NCT00434226|635968|P1|NOT COMPLETED|Overall Study||30
262700|NCT00434226|635967|P2|COMPLETED|Overall Study||0
262701|NCT00434226|635968|P1|COMPLETED|Overall Study||0
262702|NCT00434226|635967|P2|STARTED|Overall Study||26
262703|NCT00434226|635968|P1|STARTED|Overall Study||30
262704|NCT00434213|635979|P1|NOT COMPLETED|Overall Study||49
262705|NCT00434213|635979|P1|COMPLETED|Overall Study||260
262706|NCT00434213|635979|P1|STARTED|Overall Study||309
262707|NCT00434161|635987|P3|NOT COMPLETED|Overall Study||11
262708|NCT00434161|635988|P2|NOT COMPLETED|Overall Study||3
262709|NCT00434161|635989|P1|NOT COMPLETED|Overall Study||10
262710|NCT00434161|635987|P3|COMPLETED|Overall Study||104
262711|NCT00434161|635988|P2|COMPLETED|Overall Study||54
262712|NCT00434161|635989|P1|COMPLETED|Overall Study||99
262713|NCT00434161|635987|P3|STARTED|Overall Study||115
262714|NCT00434161|635988|P2|STARTED|Overall Study||57
262715|NCT00434161|635989|P1|STARTED|Overall Study||109
262716|NCT00434148|636033|P2|NOT COMPLETED|Overall Study||73
262717|NCT00434148|636034|P1|NOT COMPLETED|Overall Study||69
262718|NCT00434148|636033|P2|COMPLETED|Overall Study||7
262719|NCT00434148|636034|P1|COMPLETED|Overall Study||13
262720|NCT00434148|636033|P2|Completed Month 12; Entered Extension|Overall Study||32
262721|NCT00434148|636034|P1|Completed Month 12; Entered Extension|Overall Study||26
262722|NCT00434148|636033|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
262723|NCT00434148|636034|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
262724|NCT00434148|636033|P2|Completed Month 12|Overall Study||39
262725|NCT00434148|636034|P1|Completed Month 12|Overall Study||39
262726|NCT00434148|636033|P2|STARTED|Overall Study||80
262727|NCT00434148|636034|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
262728|NCT00434122|636070|P2|NOT COMPLETED|Overall Study||7
262729|NCT00434122|636071|P1|NOT COMPLETED|Overall Study||6
262730|NCT00434122|636070|P2|COMPLETED|Overall Study||36
262731|NCT00434122|636071|P1|COMPLETED|Overall Study||36
262732|NCT00434122|636070|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
262733|NCT00434122|636071|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
262734|NCT00434122|636070|P2|STARTED|Overall Study|Randomised|43
262735|NCT00434122|636071|P1|STARTED|Overall Study|Randomised|42
262736|NCT00434109|636080|P1|NOT COMPLETED|Overall Study||18
262737|NCT00434109|636080|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
262738|NCT00434109|636080|P1|STARTED|Overall Study||39
262739|NCT00434057|636089|P1|NOT COMPLETED|Overall Study||1
262740|NCT00434057|636089|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
262741|NCT00434057|636089|P1|STARTED|Overall Study||1383
262742|NCT00434018|636095|P2|NOT COMPLETED|Overall Study||12
262743|NCT00434018|636096|P1|NOT COMPLETED|Overall Study||17
262744|NCT00434018|636095|P2|COMPLETED|Overall Study||57
262745|NCT00434018|636096|P1|COMPLETED|Overall Study||52
262746|NCT00434018|636095|P2|STARTED|Overall Study||69
262747|NCT00434018|636096|P1|STARTED|Overall Study||69
262748|NCT00433992|636114|P2|NOT COMPLETED|Overall Study||8
262749|NCT00433992|636115|P1|NOT COMPLETED|Overall Study||9
262750|NCT00433992|636114|P2|COMPLETED|Overall Study||20
262751|NCT00433992|636115|P1|COMPLETED|Overall Study||19
262752|NCT00433992|636114|P2|STARTED|Overall Study||28
262753|NCT00433992|636115|P1|STARTED|Overall Study||28
262754|NCT00433966|636127|P4|NOT COMPLETED|Stent Intervention/Randomization||62
262755|NCT00433966|636128|P3|NOT COMPLETED|Stent Intervention/Randomization||154
262756|NCT00433966|636129|P2|NOT COMPLETED|Stent Intervention/Randomization||0
262757|NCT00433966|636130|P1|NOT COMPLETED|Stent Intervention/Randomization||0
262758|NCT00433966|636127|P4|COMPLETED|Stent Intervention/Randomization||687
262759|NCT00433966|636128|P3|COMPLETED|Stent Intervention/Randomization||2103
262760|NCT00433966|636129|P2|COMPLETED|Stent Intervention/Randomization||0
262761|NCT00433966|636130|P1|COMPLETED|Stent Intervention/Randomization||0
262762|NCT00433966|636127|P4|3-Year Follow-up|Stent Intervention/Randomization||687
262763|NCT00433966|636128|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
262764|NCT00433966|636129|P2|3-Year Follow-up|Stent Intervention/Randomization||0
262765|NCT00433966|636130|P1|3-Year Follow-up|Stent Intervention/Randomization||0
262766|NCT00433966|636127|P4|1-Year Follow-up|Stent Intervention/Randomization||715
262767|NCT00433966|636128|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
262768|NCT00433966|636129|P2|1-Year Follow-up|Stent Intervention/Randomization||0
262769|NCT00433966|636130|P1|1-Year Follow-up|Stent Intervention/Randomization||0
262770|NCT00433966|636127|P4|STARTED|Stent Intervention/Randomization||749
262771|NCT00433966|636128|P3|STARTED|Stent Intervention/Randomization||2257
262772|NCT00433966|636129|P2|STARTED|Stent Intervention/Randomization||0
262773|NCT00433966|636130|P1|STARTED|Stent Intervention/Randomization||0
262774|NCT00433966|636127|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
262775|NCT00433966|636128|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
262776|NCT00433966|636129|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
262777|NCT00433966|636130|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
262778|NCT00433966|636127|P4|COMPLETED|Pharmacology Intervention/Randomization||0
262779|NCT00433966|636128|P3|COMPLETED|Pharmacology Intervention/Randomization||0
262780|NCT00433966|636129|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
262781|NCT00433966|636130|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
262782|NCT00433966|636127|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
262783|NCT00433966|636128|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
262784|NCT00433966|636129|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
262785|NCT00433966|636130|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
262786|NCT00433966|636127|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
262787|NCT00433966|636128|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
262788|NCT00433966|636129|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
262789|NCT00433966|636130|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
262790|NCT00433966|636127|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
262791|NCT00433966|636128|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
262792|NCT00433966|636129|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
262793|NCT00433966|636130|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
262794|NCT00433966|636127|P4|STARTED|Pharmacology Intervention/Randomization||0
262795|NCT00433966|636128|P3|STARTED|Pharmacology Intervention/Randomization||0
262796|NCT00433966|636129|P2|STARTED|Pharmacology Intervention/Randomization||1802
262797|NCT00433966|636130|P1|STARTED|Pharmacology Intervention/Randomization||1800
262798|NCT00433914|636152|P2|NOT COMPLETED|Overall Study||3
262799|NCT00433914|636153|P1|NOT COMPLETED|Overall Study||0
262800|NCT00433914|636152|P2|COMPLETED|Overall Study||27
262801|NCT00433914|636153|P1|COMPLETED|Overall Study||30
262802|NCT00433914|636152|P2|STARTED|Overall Study||30
262803|NCT00433914|636153|P1|STARTED|Overall Study||30
262804|NCT00433836|636173|P2|NOT COMPLETED|Overall Study||6
262805|NCT00433836|636174|P1|NOT COMPLETED|Overall Study||13
262806|NCT00433836|636173|P2|COMPLETED|Overall Study||143
262807|NCT00433836|636174|P1|COMPLETED|Overall Study||138
262808|NCT00433836|636173|P2|STARTED|Overall Study||149
262809|NCT00433836|636174|P1|STARTED|Overall Study||151
262810|NCT00433771|636186|P1|NOT COMPLETED|Overall Study||19
262811|NCT00433771|636186|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
262812|NCT00433771|636186|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
262813|NCT00433745|636202|P1|NOT COMPLETED|Overall Study||0
262814|NCT00433745|636202|P1|COMPLETED|Overall Study||4
262815|NCT00433745|636202|P1|STARTED|Overall Study||4
262816|NCT00433654|636209|P2|NOT COMPLETED|Overall Study||5
262817|NCT00433654|636210|P1|NOT COMPLETED|Overall Study||15
262818|NCT00433654|636209|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
262819|NCT00433654|636210|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
262820|NCT00433654|636209|P2|STARTED|Overall Study||206
262821|NCT00433654|636210|P1|STARTED|Overall Study||258
262822|NCT00433550|636244|P3|NOT COMPLETED|Overall Study||0
262823|NCT00433550|636245|P2|NOT COMPLETED|Overall Study||0
262824|NCT00433550|636246|P1|NOT COMPLETED|Overall Study||0
262825|NCT00433550|636244|P3|COMPLETED|Overall Study||6
262826|NCT00433550|636245|P2|COMPLETED|Overall Study||10
262827|NCT00433550|636246|P1|COMPLETED|Overall Study||17
262828|NCT00433550|636244|P3|STARTED|Overall Study||6
262829|NCT00433550|636245|P2|STARTED|Overall Study||10
262830|NCT00433550|636246|P1|STARTED|Overall Study||17
262831|NCT00433537|636256|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
262832|NCT00433537|636257|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
262833|NCT00433537|636258|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
262834|NCT00433537|636256|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
262835|NCT00433537|636257|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
262836|NCT00433537|636258|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
262837|NCT00433537|636256|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
262838|NCT00433537|636257|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
262839|NCT00433537|636258|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
262840|NCT00433537|636256|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
262841|NCT00433537|636257|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
262842|NCT00433537|636258|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
262843|NCT00433537|636256|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
262844|NCT00433537|636257|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
262845|NCT00433537|636258|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
262846|NCT00433537|636256|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
262847|NCT00433537|636257|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
262848|NCT00433537|636258|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
262849|NCT00433537|636256|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
262850|NCT00433537|636257|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
262851|NCT00433537|636258|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
262852|NCT00433537|636256|P3|STARTED|Step 1 - VcR-CVAD Induction||10
262853|NCT00433537|636257|P2|STARTED|Step 1 - VcR-CVAD Induction||22
262854|NCT00433537|636258|P1|STARTED|Step 1 - VcR-CVAD Induction||45
262855|NCT00433446|636267|P1|NOT COMPLETED|Overall Study||61
262856|NCT00433446|636267|P1|COMPLETED|Overall Study||1
262857|NCT00433446|636267|P1|Eligible and Began Protocol Therapy|Overall Study||53
262858|NCT00433446|636267|P1|Eligible|Overall Study||53
262859|NCT00433446|636267|P1|STARTED|Overall Study||62
262860|NCT00433381|636277|P2|NOT COMPLETED|Overall Study||3
262861|NCT00433381|636278|P1|NOT COMPLETED|Overall Study||5
262862|NCT00433381|636277|P2|COMPLETED|Overall Study||57
262863|NCT00433381|636278|P1|COMPLETED|Overall Study|Evaluated for 6-month progression-free survival. (Applies to both arms).|58
262864|NCT00433381|636277|P2|STARTED|Overall Study||60
262865|NCT00433381|636278|P1|STARTED|Overall Study||63
262866|NCT00433329|636284|P1|NOT COMPLETED|Overall Study||21
262867|NCT00433329|636284|P1|COMPLETED|Overall Study||79
262868|NCT00433329|636284|P1|STARTED|Overall Study||100
262869|NCT00433290|636290|P2|NOT COMPLETED|Overall Study||17
262870|NCT00433290|636291|P1|NOT COMPLETED|Overall Study||35
262871|NCT00433290|636290|P2|COMPLETED|Overall Study||111
262872|NCT00433290|636291|P1|COMPLETED|Overall Study||93
262873|NCT00433290|636290|P2|STARTED|Overall Study||128
262874|NCT00433290|636291|P1|STARTED|Overall Study||128
262875|NCT00433199|636360|P2|NOT COMPLETED|Open-Label Period||34
262876|NCT00433199|636361|P1|NOT COMPLETED|Open-Label Period||0
262877|NCT00433199|636360|P2|COMPLETED|Open-Label Period||185
262878|NCT00433199|636361|P1|COMPLETED|Open-Label Period||0
262879|NCT00433199|636360|P2|STARTED|Open-Label Period||219
262880|NCT00433199|636361|P1|STARTED|Open-Label Period||0
262881|NCT00433199|636360|P2|NOT COMPLETED|Double-Blind Period||66
262882|NCT00433199|636361|P1|NOT COMPLETED|Double-Blind Period||12
262883|NCT00433199|636360|P2|COMPLETED|Double-Blind Period||168
262884|NCT00433199|636361|P1|COMPLETED|Double-Blind Period||28
262885|NCT00433199|636360|P2|STARTED|Double-Blind Period||234
262886|NCT00433199|636361|P1|STARTED|Double-Blind Period||40
262887|NCT00433160|636381|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
262888|NCT00433160|636382|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
262889|NCT00433160|636381|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
262890|NCT00433160|636382|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
262891|NCT00433160|636381|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
262892|NCT00433160|636382|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
262893|NCT00433160|636381|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
262894|NCT00433160|636382|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
262895|NCT00433160|636381|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
262896|NCT00433160|636382|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
262897|NCT00433160|636381|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
262898|NCT00433160|636382|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
262899|NCT00433160|636381|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
262900|NCT00433160|636382|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
262901|NCT00433160|636381|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
262902|NCT00433160|636382|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
262903|NCT00433160|636381|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
262904|NCT00433160|636382|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
262905|NCT00433160|636381|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
262906|NCT00433160|636382|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
262907|NCT00433160|636381|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
262908|NCT00433160|636382|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
262909|NCT00433160|636381|P2|STARTED|52-Week Double-Blind (DB) Period||70
262910|NCT00433160|636382|P1|STARTED|52-Week Double-Blind (DB) Period||137
262911|NCT00433017|636432|P2|NOT COMPLETED|Overall Study||101
262912|NCT00433017|636433|P1|NOT COMPLETED|Overall Study||96
262913|NCT00433017|636432|P2|COMPLETED|Overall Study||32
262914|NCT00433017|636433|P1|COMPLETED|Overall Study||26
262915|NCT00433017|636432|P2|Completed 12 Month Phase|Overall Study||126
262916|NCT00433017|636433|P1|Completed 12 Month Phase|Overall Study||114
262917|NCT00433017|636432|P2|STARTED|Overall Study||133
262918|NCT00433017|636433|P1|STARTED|Overall Study||122
262919|NCT00433004|636449|P2|NOT COMPLETED|Overall Study||7
262920|NCT00433004|636450|P1|NOT COMPLETED|Overall Study||5
262921|NCT00433004|636449|P2|COMPLETED|Overall Study||16
262922|NCT00433004|636450|P1|COMPLETED|Overall Study||22
262923|NCT00433004|636449|P2|STARTED|Overall Study||23
262924|NCT00433004|636450|P1|STARTED|Overall Study||27
262925|NCT00432991|636462|P2|NOT COMPLETED|Overall Study||12
262926|NCT00432991|636463|P1|NOT COMPLETED|Overall Study||7
262927|NCT00432991|636462|P2|COMPLETED|Overall Study||19
262928|NCT00432991|636463|P1|COMPLETED|Overall Study||15
262929|NCT00432991|636462|P2|STARTED|Overall Study||31
262930|NCT00432991|636463|P1|STARTED|Overall Study||22
262931|NCT00432965|636475|P2|NOT COMPLETED|Overall Study||86
262932|NCT00432965|636476|P1|NOT COMPLETED|Overall Study||94
262933|NCT00432965|636475|P2|COMPLETED|Overall Study||80
262934|NCT00432965|636476|P1|COMPLETED|Overall Study||75
262935|NCT00432965|636475|P2|STARTED|Overall Study||166
262936|NCT00432965|636476|P1|STARTED|Overall Study||169
262937|NCT00432835|636484|P2|NOT COMPLETED|Overall Study||7
262938|NCT00432835|636485|P1|NOT COMPLETED|Overall Study||6
262939|NCT00432835|636484|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
262940|NCT00432835|636485|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
262941|NCT00432835|636484|P2|Completed 2nd Intervention|Overall Study||23
262942|NCT00432835|636485|P1|Completed 2nd Intervention|Overall Study||22
262943|NCT00432835|636484|P2|Completed 1st Intervention|Overall Study||23
262944|NCT00432835|636485|P1|Completed 1st Intervention|Overall Study||22
262945|NCT00432835|636484|P2|STARTED|Overall Study||30
262946|NCT00432835|636485|P1|STARTED|Overall Study||28
262947|NCT00432809|636498|P3|NOT COMPLETED|2 Year Sub-study||1
262948|NCT00432809|636499|P2|NOT COMPLETED|2 Year Sub-study||2
262949|NCT00432809|636500|P1|NOT COMPLETED|2 Year Sub-study||3
262950|NCT00432809|636498|P3|COMPLETED|2 Year Sub-study||19
262951|NCT00432809|636499|P2|COMPLETED|2 Year Sub-study||18
262952|NCT00432809|636500|P1|COMPLETED|2 Year Sub-study||17
262953|NCT00432809|636498|P3|STARTED|2 Year Sub-study||20
262954|NCT00432809|636499|P2|STARTED|2 Year Sub-study||20
262955|NCT00432809|636500|P1|STARTED|2 Year Sub-study||20
262956|NCT00432809|636498|P3|NOT COMPLETED|1 Year Follow-up||1
262957|NCT00432809|636499|P2|NOT COMPLETED|1 Year Follow-up||0
262958|NCT00432809|636500|P1|NOT COMPLETED|1 Year Follow-up||9
262959|NCT00432809|636498|P3|COMPLETED|1 Year Follow-up||49
262960|NCT00432809|636499|P2|COMPLETED|1 Year Follow-up||50
262961|NCT00432809|636500|P1|COMPLETED|1 Year Follow-up||41
262962|NCT00432809|636498|P3|STARTED|1 Year Follow-up||50
262963|NCT00432809|636499|P2|STARTED|1 Year Follow-up||50
262964|NCT00432809|636500|P1|STARTED|1 Year Follow-up||50
262965|NCT00432744|636573|P2|NOT COMPLETED|Months 7 - 12||1
262966|NCT00432744|636574|P1|NOT COMPLETED|Months 7 - 12||1
262967|NCT00432744|636573|P2|COMPLETED|Months 7 - 12||7
262968|NCT00432744|636574|P1|COMPLETED|Months 7 - 12||6
262969|NCT00432744|636573|P2|STARTED|Months 7 - 12||8
262970|NCT00432744|636574|P1|STARTED|Months 7 - 12||7
262971|NCT00432744|636573|P2|NOT COMPLETED|Months 0-6||4
262972|NCT00432744|636574|P1|NOT COMPLETED|Months 0-6||5
262973|NCT00432744|636573|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
262974|NCT00432744|636574|P1|COMPLETED|Months 0-6||7
262975|NCT00432744|636573|P2|STARTED|Months 0-6||12
262976|NCT00432744|636574|P1|STARTED|Months 0-6||12
262977|NCT00432666|636586|P2|NOT COMPLETED|Open-Label Extension Period||0
262978|NCT00432666|636587|P1|NOT COMPLETED|Open-Label Extension Period||25
262979|NCT00432666|636586|P2|COMPLETED|Open-Label Extension Period||0
262980|NCT00432666|636587|P1|COMPLETED|Open-Label Extension Period||120
262981|NCT00432666|636586|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
262982|NCT00432666|636587|P1|STARTED|Open-Label Extension Period||145
262983|NCT00432666|636586|P2|NOT COMPLETED|Main Period||1
262984|NCT00432666|636587|P1|NOT COMPLETED|Main Period||2
262985|NCT00432666|636586|P2|COMPLETED|Main Period||74
262986|NCT00432666|636587|P1|COMPLETED|Main Period||71
262987|NCT00432666|636586|P2|STARTED|Main Period||75
262988|NCT00432666|636587|P1|STARTED|Main Period||73
262989|NCT00432601|636751|P2|NOT COMPLETED|Time 2 to Time 3||22
262990|NCT00432601|636752|P1|NOT COMPLETED|Time 2 to Time 3||19
262991|NCT00432601|636751|P2|COMPLETED|Time 2 to Time 3||122
262992|NCT00432601|636752|P1|COMPLETED|Time 2 to Time 3||122
262993|NCT00432601|636751|P2|STARTED|Time 2 to Time 3||144
262994|NCT00432601|636752|P1|STARTED|Time 2 to Time 3||141
262995|NCT00432601|636751|P2|NOT COMPLETED|Time 1 to Time 2||368
262996|NCT00432601|636752|P1|NOT COMPLETED|Time 1 to Time 2||369
262997|NCT00432601|636751|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
262998|NCT00432601|636752|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
262999|NCT00432601|636751|P2|STARTED|Time 1 to Time 2||512
263000|NCT00432601|636752|P1|STARTED|Time 1 to Time 2||510
263001|NCT00432562|636760|P2|NOT COMPLETED|Overall Study||0
263002|NCT00432562|636761|P1|NOT COMPLETED|Overall Study||3
263003|NCT00432562|636760|P2|COMPLETED|Overall Study||15
263004|NCT00432562|636761|P1|COMPLETED|Overall Study||13
263005|NCT00432562|636760|P2|STARTED|Overall Study||15
263006|NCT00432562|636761|P1|STARTED|Overall Study||16
263007|NCT00432458|636787|P2|NOT COMPLETED|Overall Study||1
263008|NCT00432458|636788|P1|NOT COMPLETED|Overall Study||5
263009|NCT00432458|636787|P2|COMPLETED|Overall Study||32
263010|NCT00432458|636788|P1|COMPLETED|Overall Study||30
263011|NCT00432458|636787|P2|STARTED|Overall Study||33
263012|NCT00432458|636788|P1|STARTED|Overall Study||35
263013|NCT00432445|636806|P1|NOT COMPLETED|Overall Study||0
263014|NCT00432445|636806|P1|COMPLETED|Overall Study||2
263015|NCT00432445|636806|P1|STARTED|Overall Study||2
263016|NCT00432380|636813|P3|NOT COMPLETED|Overall Study||1
263017|NCT00432380|636814|P2|NOT COMPLETED|Overall Study||4
263018|NCT00432380|636815|P1|NOT COMPLETED|Overall Study||4
263019|NCT00432380|636813|P3|COMPLETED|Overall Study||74
263020|NCT00432380|636814|P2|COMPLETED|Overall Study||146
263021|NCT00432380|636815|P1|COMPLETED|Overall Study||146
263022|NCT00432380|636813|P3|STARTED|Overall Study||75
263023|NCT00432380|636814|P2|STARTED|Overall Study||150
263024|NCT00432380|636815|P1|STARTED|Overall Study||150
263025|NCT00432341|636841|P2|NOT COMPLETED|Overall Study||0
263026|NCT00432341|636842|P1|NOT COMPLETED|Overall Study||0
263027|NCT00432341|636841|P2|COMPLETED|Overall Study||30
263028|NCT00432341|636842|P1|COMPLETED|Overall Study||24
263029|NCT00432341|636841|P2|STARTED|Overall Study||30
263030|NCT00432341|636842|P1|STARTED|Overall Study||24
263031|NCT00432276|636868|P2|NOT COMPLETED|Overall Study||156
263032|NCT00432276|636869|P1|NOT COMPLETED|Overall Study||121
263033|NCT00432276|636868|P2|COMPLETED|Overall Study||243
263034|NCT00432276|636869|P1|COMPLETED|Overall Study||283
263035|NCT00432276|636868|P2|Per Protocol Set|Overall Study||306
263036|NCT00432276|636869|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
263037|NCT00432276|636868|P2|STARTED|Overall Study||399
263038|NCT00432276|636869|P1|STARTED|Overall Study||404
263039|NCT00432237|636959|P4|NOT COMPLETED|Overall Study||124
263040|NCT00432237|636960|P3|NOT COMPLETED|Overall Study||109
263041|NCT00432237|636961|P2|NOT COMPLETED|Overall Study||101
263042|NCT00432237|636962|P1|NOT COMPLETED|Overall Study||67
263043|NCT00432237|636959|P4|COMPLETED|Overall Study||366
263044|NCT00432237|636960|P3|COMPLETED|Overall Study||375
263045|NCT00432237|636961|P2|COMPLETED|Overall Study||384
263046|NCT00432237|636962|P1|COMPLETED|Overall Study||177
263047|NCT00432237|636959|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
263048|NCT00432237|636960|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
263049|NCT00432237|636961|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
263050|NCT00432237|636962|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
263051|NCT00432237|636959|P4|Completed--With Data|Overall Study||365
263052|NCT00432237|636960|P3|Completed--With Data|Overall Study||370
263053|NCT00432237|636961|P2|Completed--With Data|Overall Study||381
263054|NCT00432237|636962|P1|Completed--With Data|Overall Study||176
263055|NCT00432237|636959|P4|STARTED|Overall Study||490
263056|NCT00432237|636960|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
263057|NCT00432237|636961|P2|STARTED|Overall Study||485
263058|NCT00432237|636962|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
263059|NCT00432159|637005|P5|NOT COMPLETED|Overall Study||10
263060|NCT00432159|637006|P4|NOT COMPLETED|Overall Study||5
263061|NCT00432159|637007|P3|NOT COMPLETED|Overall Study||4
263062|NCT00432159|637008|P2|NOT COMPLETED|Overall Study||30
263063|NCT00432159|637009|P1|NOT COMPLETED|Overall Study||22
263064|NCT00432159|637005|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
263065|NCT00432159|637006|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
263066|NCT00432159|637007|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
263067|NCT00432159|637008|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
263068|NCT00432159|637009|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
263069|NCT00432159|637005|P5|STARTED|Overall Study||89
263070|NCT00432159|637006|P4|STARTED|Overall Study||20
263071|NCT00432159|637007|P3|STARTED|Overall Study||39
263072|NCT00432159|637008|P2|STARTED|Overall Study||167
263073|NCT00432159|637009|P1|STARTED|Overall Study||185
263074|NCT00432042|637116|P3|NOT COMPLETED|Overall Study||2
263075|NCT00432042|637117|P2|NOT COMPLETED|Overall Study||1
263076|NCT00432042|637118|P1|NOT COMPLETED|Overall Study||7
263077|NCT00432042|637116|P3|COMPLETED|Overall Study||239
263078|NCT00432042|637117|P2|COMPLETED|Overall Study||234
263079|NCT00432042|637118|P1|COMPLETED|Overall Study||472
263080|NCT00432042|637116|P3|Vaccinated|Overall Study||240
263081|NCT00432042|637117|P2|Vaccinated|Overall Study||235
263082|NCT00432042|637118|P1|Vaccinated|Overall Study||477
263083|NCT00432042|637116|P3|STARTED|Overall Study|Number randomized.|241
263084|NCT00432042|637117|P2|STARTED|Overall Study|Number randomized.|235
263085|NCT00432042|637118|P1|STARTED|Overall Study|Number randomized.|479
263086|NCT00431964|637131|P2|NOT COMPLETED|Overall Study||8
263087|NCT00431964|637132|P1|NOT COMPLETED|Overall Study||6
263088|NCT00431964|637131|P2|COMPLETED|Overall Study||124
263089|NCT00431964|637132|P1|COMPLETED|Overall Study||125
263090|NCT00431964|637131|P2|Withdrew From Study|Overall Study||5
263091|NCT00431964|637132|P1|Withdrew From Study|Overall Study||6
263092|NCT00431964|637131|P2|Did Not Receive Drug|Overall Study||3
263093|NCT00431964|637132|P1|Did Not Receive Drug|Overall Study||0
263094|NCT00431964|637131|P2|Randomized/Received Drug|Overall Study||129
263095|NCT00431964|637132|P1|Randomized/Received Drug|Overall Study||131
263096|NCT00431964|637131|P2|STARTED|Overall Study||132
263097|NCT00431964|637132|P1|STARTED|Overall Study||131
263098|NCT00431951|637142|P4|NOT COMPLETED|Overall Study||2
263099|NCT00431951|637143|P3|NOT COMPLETED|Overall Study||2
263100|NCT00431951|637144|P2|NOT COMPLETED|Overall Study||2
263101|NCT00431951|637145|P1|NOT COMPLETED|Overall Study||1
263102|NCT00431951|637142|P4|COMPLETED|Overall Study||4
263103|NCT00431951|637143|P3|COMPLETED|Overall Study||6
263104|NCT00431951|637144|P2|COMPLETED|Overall Study||6
263105|NCT00431951|637145|P1|COMPLETED|Overall Study||7
263106|NCT00431951|637142|P4|STARTED|Overall Study||6
263107|NCT00431951|637143|P3|STARTED|Overall Study||8
263108|NCT00431951|637144|P2|STARTED|Overall Study||8
263109|NCT00431951|637145|P1|STARTED|Overall Study||8
263110|NCT00431847|637207|P5|NOT COMPLETED|Overall Study||1
263111|NCT00431847|637208|P4|NOT COMPLETED|Overall Study||14
263112|NCT00431847|637209|P3|NOT COMPLETED|Overall Study||4
263113|NCT00431847|637210|P2|NOT COMPLETED|Overall Study||3
263114|NCT00431847|637211|P1|NOT COMPLETED|Overall Study||6
263115|NCT00431847|637207|P5|COMPLETED|Overall Study||0
263116|NCT00431847|637208|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
263117|NCT00431847|637209|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
263118|NCT00431847|637210|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
263119|NCT00431847|637211|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
263120|NCT00431847|637207|P5|STARTED|Overall Study||1
263121|NCT00431847|637208|P4|STARTED|Overall Study||184
263122|NCT00431847|637209|P3|STARTED|Overall Study||24
263123|NCT00431847|637210|P2|STARTED|Overall Study||45
263124|NCT00431847|637211|P1|STARTED|Overall Study||132
263125|NCT00431834|637285|P1|NOT COMPLETED|Overall Study||13
263126|NCT00431834|637285|P1|COMPLETED|Overall Study||62
263127|NCT00431834|637285|P1|STARTED|Overall Study||75
263128|NCT00431626|637294|P2|NOT COMPLETED|Overall Study||0
263129|NCT00431626|637295|P1|NOT COMPLETED|Overall Study||0
263130|NCT00431626|637294|P2|COMPLETED|Overall Study||0
263131|NCT00431626|637295|P1|COMPLETED|Overall Study||4
263132|NCT00431626|637294|P2|STARTED|Overall Study||0
263133|NCT00431626|637295|P1|STARTED|Overall Study||4
263134|NCT00431496|637301|P1|NOT COMPLETED|Overall Study||11
263135|NCT00431496|637301|P1|COMPLETED|Overall Study||60
263136|NCT00431496|637301|P1|STARTED|Overall Study||71
263137|NCT00431444|637312|P2|NOT COMPLETED|Overall Study||7
263138|NCT00431444|637313|P1|NOT COMPLETED|Overall Study||5
263139|NCT00431444|637312|P2|COMPLETED|Overall Study||46
263140|NCT00431444|637313|P1|COMPLETED|Overall Study||51
263141|NCT00431444|637312|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
263142|NCT00431444|637313|P1|STARTED|Overall Study||56
263143|NCT00431184|637339|P2|NOT COMPLETED|Second Intervention (Day 2)||0
263144|NCT00431184|637340|P1|NOT COMPLETED|Second Intervention (Day 2)||0
263145|NCT00431184|637339|P2|COMPLETED|Second Intervention (Day 2)||9
263146|NCT00431184|637340|P1|COMPLETED|Second Intervention (Day 2)||10
263147|NCT00431184|637339|P2|STARTED|Second Intervention (Day 2)||9
263148|NCT00431184|637340|P1|STARTED|Second Intervention (Day 2)||10
263149|NCT00431184|637339|P2|NOT COMPLETED|1st Intervention (Day 1)||0
263150|NCT00431184|637340|P1|NOT COMPLETED|1st Intervention (Day 1)||0
263151|NCT00431184|637339|P2|COMPLETED|1st Intervention (Day 1)||9
263152|NCT00431184|637340|P1|COMPLETED|1st Intervention (Day 1)||10
263153|NCT00431184|637339|P2|STARTED|1st Intervention (Day 1)||9
263154|NCT00431184|637340|P1|STARTED|1st Intervention (Day 1)||10
263155|NCT00431132|637348|P1|NOT COMPLETED|Overall Study||44
263156|NCT00431132|637348|P1|COMPLETED|Overall Study||292
263157|NCT00431132|637348|P1|STARTED|Overall Study||336
263158|NCT00431067|637353|P1|NOT COMPLETED|Overall Study||41
263159|NCT00431067|637353|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
263160|NCT00431067|637353|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
263161|NCT00431041|637363|P2|NOT COMPLETED|Overall Study||24
263162|NCT00431041|637364|P1|NOT COMPLETED|Overall Study||16
263163|NCT00431041|637363|P2|COMPLETED|Overall Study||40
263164|NCT00431041|637364|P1|COMPLETED|Overall Study||52
263165|NCT00431041|637363|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
263166|NCT00431041|637364|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
263167|NCT00430950|637378|P2|NOT COMPLETED|Overall Study||13
263168|NCT00430950|637379|P1|NOT COMPLETED|Overall Study||13
263169|NCT00430950|637378|P2|COMPLETED|Overall Study||495
263170|NCT00430950|637379|P1|COMPLETED|Overall Study||489
263171|NCT00430950|637378|P2|STARTED|Overall Study||508
263172|NCT00430950|637379|P1|STARTED|Overall Study||502
263173|NCT00430937|637393|P2|NOT COMPLETED|Overall Study||28
263174|NCT00430937|637394|P1|NOT COMPLETED|Overall Study||27
263175|NCT00430937|637393|P2|COMPLETED|Overall Study||64
263176|NCT00430937|637394|P1|COMPLETED|Overall Study||70
263177|NCT00430937|637393|P2|STARTED|Overall Study||92
263178|NCT00430937|637394|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
263179|NCT00430781|637405|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
263180|NCT00430781|637406|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
263181|NCT00430781|637407|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
263182|NCT00430781|637405|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
263183|NCT00430781|637406|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
263184|NCT00430781|637407|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
263185|NCT00430781|637405|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
263186|NCT00430781|637406|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
263187|NCT00430781|637407|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
263188|NCT00430781|637405|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
263189|NCT00430781|637406|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
263190|NCT00430781|637407|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
263191|NCT00430781|637405|P3|COMPLETED|Final Analysis; 31 July 2008||26
263192|NCT00430781|637406|P2|COMPLETED|Final Analysis; 31 July 2008||39
263193|NCT00430781|637407|P1|COMPLETED|Final Analysis; 31 July 2008||0
263194|NCT00430781|637405|P3|Ongoing|Final Analysis; 31 July 2008||32
263195|NCT00430781|637406|P2|Ongoing|Final Analysis; 31 July 2008||29
263196|NCT00430781|637407|P1|Ongoing|Final Analysis; 31 July 2008||0
263197|NCT00430781|637405|P3|STARTED|Final Analysis; 31 July 2008||74
263198|NCT00430781|637406|P2|STARTED|Final Analysis; 31 July 2008||78
263199|NCT00430781|637407|P1|STARTED|Final Analysis; 31 July 2008||0
263200|NCT00430781|637405|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
263201|NCT00430781|637406|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
263202|NCT00430781|637407|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
263203|NCT00430781|637405|P3|COMPLETED|Interim Analysis; 11 February 2008||0
263204|NCT00430781|637406|P2|COMPLETED|Interim Analysis; 11 February 2008||0
263205|NCT00430781|637407|P1|COMPLETED|Interim Analysis; 11 February 2008||0
263206|NCT00430781|637405|P3|Ongoing|Interim Analysis; 11 February 2008||25
263207|NCT00430781|637406|P2|Ongoing|Interim Analysis; 11 February 2008||20
263208|NCT00430781|637407|P1|Ongoing|Interim Analysis; 11 February 2008||23
263209|NCT00430781|637405|P3|STARTED|Interim Analysis; 11 February 2008||60
263210|NCT00430781|637406|P2|STARTED|Interim Analysis; 11 February 2008||58
263211|NCT00430781|637407|P1|STARTED|Interim Analysis; 11 February 2008||59
263212|NCT00430768|637433|P3|NOT COMPLETED|Overall Study||0
263213|NCT00430768|637434|P2|NOT COMPLETED|Overall Study||0
263214|NCT00430768|637435|P1|NOT COMPLETED|Overall Study||0
263215|NCT00430768|637433|P3|COMPLETED|Overall Study||3
263216|NCT00430768|637434|P2|COMPLETED|Overall Study||3
263217|NCT00430768|637435|P1|COMPLETED|Overall Study||3
263218|NCT00430768|637433|P3|STARTED|Overall Study||3
263219|NCT00430768|637434|P2|STARTED|Overall Study||3
263220|NCT00430768|637435|P1|STARTED|Overall Study||3
263221|NCT00430755|637449|P1|NOT COMPLETED|Overall Study||53
263222|NCT00430755|637449|P1|COMPLETED|Overall Study||45
263223|NCT00430755|637449|P1|STARTED|Overall Study||98
263224|NCT00430716|637456|P3|NOT COMPLETED|Open Label Phase||7
263225|NCT00430716|637457|P2|NOT COMPLETED|Open Label Phase||7
263226|NCT00430716|637458|P1|NOT COMPLETED|Open Label Phase||9
263227|NCT00430716|637456|P3|COMPLETED|Open Label Phase||32
263228|NCT00430716|637457|P2|COMPLETED|Open Label Phase||31
263229|NCT00430716|637458|P1|COMPLETED|Open Label Phase||27
263230|NCT00430716|637456|P3|STARTED|Open Label Phase||39
263231|NCT00430716|637457|P2|STARTED|Open Label Phase||38
263232|NCT00430716|637458|P1|STARTED|Open Label Phase||36
263233|NCT00430716|637456|P3|NOT COMPLETED|Double Blind Phase||6
263234|NCT00430716|637457|P2|NOT COMPLETED|Double Blind Phase||5
263235|NCT00430716|637458|P1|NOT COMPLETED|Double Blind Phase||6
263236|NCT00430716|637456|P3|COMPLETED|Double Blind Phase||39
263237|NCT00430716|637457|P2|COMPLETED|Double Blind Phase||38
263238|NCT00430716|637458|P1|COMPLETED|Double Blind Phase||36
263239|NCT00430716|637456|P3|Treated|Double Blind Phase||45
263240|NCT00430716|637457|P2|Treated|Double Blind Phase||43
263241|NCT00430716|637458|P1|Treated|Double Blind Phase||41
263242|NCT00430716|637456|P3|STARTED|Double Blind Phase||45
263243|NCT00430716|637457|P2|STARTED|Double Blind Phase||43
263244|NCT00430716|637458|P1|STARTED|Double Blind Phase||42
263245|NCT00430677|637490|P3|NOT COMPLETED|Long-term Extension Period||63
263246|NCT00430677|637491|P2|NOT COMPLETED|Long-term Extension Period||58
263247|NCT00430677|637492|P1|NOT COMPLETED|Long-term Extension Period||60
263248|NCT00430677|637490|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
263249|NCT00430677|637491|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
263250|NCT00430677|637492|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
263251|NCT00430677|637490|P3|STARTED|Long-term Extension Period||74
263252|NCT00430677|637491|P2|STARTED|Long-term Extension Period||67
263253|NCT00430677|637492|P1|STARTED|Long-term Extension Period||70
263254|NCT00430677|637490|P3|NOT COMPLETED|Short-term Period||22
263255|NCT00430677|637491|P2|NOT COMPLETED|Short-term Period||25
263256|NCT00430677|637492|P1|NOT COMPLETED|Short-term Period||23
263257|NCT00430677|637490|P3|COMPLETED|Short-term Period|Completed the short-term period|78
263258|NCT00430677|637491|P2|COMPLETED|Short-term Period|Completed the short-term period|74
263259|NCT00430677|637492|P1|COMPLETED|Short-term Period|Completed the short-term period|76
263260|NCT00430677|637490|P3|STARTED|Short-term Period||100
263261|NCT00430677|637491|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
263262|NCT00430677|637492|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
263263|NCT00430638|637615|P2|NOT COMPLETED|Overall Study||48
263264|NCT00430638|637616|P1|NOT COMPLETED|Overall Study||78
263265|NCT00430638|637615|P2|COMPLETED|Overall Study||92
263266|NCT00430638|637616|P1|COMPLETED|Overall Study||60
263267|NCT00430638|637615|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
263268|NCT00430638|637616|P1|STARTED|Overall Study||138
263269|NCT00430625|637634|P2|NOT COMPLETED|Overall Study||0
263270|NCT00430625|637635|P1|NOT COMPLETED|Overall Study||0
263271|NCT00430625|637634|P2|COMPLETED|Overall Study||12
263272|NCT00430625|637635|P1|COMPLETED|Overall Study||13
263273|NCT00430625|637634|P2|STARTED|Overall Study||12
263274|NCT00430625|637635|P1|STARTED|Overall Study||13
263275|NCT00430573|637651|P1|NOT COMPLETED|Overall Study||5
263276|NCT00430573|637651|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
263277|NCT00430573|637651|P1|STARTED|Overall Study||10
263278|NCT00430508|637660|P4|NOT COMPLETED|Overall Study||5
263279|NCT00430508|637661|P3|NOT COMPLETED|Overall Study||13
263280|NCT00430508|637662|P2|NOT COMPLETED|Overall Study||6
263281|NCT00430508|637663|P1|NOT COMPLETED|Overall Study||3
263282|NCT00430508|637660|P4|COMPLETED|Overall Study||269
263283|NCT00430508|637661|P3|COMPLETED|Overall Study||266
263284|NCT00430508|637662|P2|COMPLETED|Overall Study||272
263285|NCT00430508|637663|P1|COMPLETED|Overall Study||137
263286|NCT00430508|637660|P4|STARTED|Overall Study||274
263287|NCT00430508|637661|P3|STARTED|Overall Study||279
263288|NCT00430508|637662|P2|STARTED|Overall Study||278
263289|NCT00430508|637663|P1|STARTED|Overall Study||140
263290|NCT00430495|637701|P4|NOT COMPLETED|Overall Study||4
263291|NCT00430495|637702|P3|NOT COMPLETED|Overall Study||13
263292|NCT00430495|637703|P2|NOT COMPLETED|Overall Study||7
263293|NCT00430495|637704|P1|NOT COMPLETED|Overall Study||14
263294|NCT00430495|637701|P4|COMPLETED|Overall Study||60
263295|NCT00430495|637702|P3|COMPLETED|Overall Study||49
263296|NCT00430495|637703|P2|COMPLETED|Overall Study||59
263297|NCT00430495|637704|P1|COMPLETED|Overall Study||50
263298|NCT00430495|637701|P4|Treated|Overall Study||64
263299|NCT00430495|637702|P3|Treated|Overall Study||62
263300|NCT00430495|637703|P2|Treated|Overall Study||66
263301|NCT00430495|637704|P1|Treated|Overall Study||62
263302|NCT00430495|637701|P4|STARTED|Overall Study||64
263303|NCT00430495|637702|P3|STARTED|Overall Study||62
263304|NCT00430495|637703|P2|STARTED|Overall Study||66
263305|NCT00430495|637704|P1|STARTED|Overall Study||64
263306|NCT00430352|637742|P1|NOT COMPLETED|Overall Study||138
263307|NCT00430352|637742|P1|COMPLETED|Overall Study||407
263308|NCT00430352|637742|P1|STARTED|Overall Study||545
263309|NCT00430300|637760|P4|NOT COMPLETED|Overall Study||2
263310|NCT00430300|637761|P3|NOT COMPLETED|Overall Study||6
263311|NCT00430300|637762|P2|NOT COMPLETED|Overall Study||2
263312|NCT00430300|637763|P1|NOT COMPLETED|Overall Study||2
263313|NCT00430300|637760|P4|COMPLETED|Overall Study||15
263314|NCT00430300|637761|P3|COMPLETED|Overall Study||29
263315|NCT00430300|637762|P2|COMPLETED|Overall Study||16
263316|NCT00430300|637763|P1|COMPLETED|Overall Study||15
263317|NCT00430300|637760|P4|STARTED|Overall Study||17
263318|NCT00430300|637761|P3|STARTED|Overall Study||35
263319|NCT00430300|637762|P2|STARTED|Overall Study||18
263320|NCT00430300|637763|P1|STARTED|Overall Study||17
263321|NCT00430248|637868|P3|NOT COMPLETED|Overall Study||135
263322|NCT00430248|637869|P2|NOT COMPLETED|Overall Study||158
263323|NCT00430248|637870|P1|NOT COMPLETED|Overall Study||125
263324|NCT00430248|637868|P3|COMPLETED|Overall Study||621
263325|NCT00430248|637869|P2|COMPLETED|Overall Study||598
263326|NCT00430248|637870|P1|COMPLETED|Overall Study||632
263327|NCT00430248|637868|P3|STARTED|Overall Study||756
263328|NCT00430248|637869|P2|STARTED|Overall Study||756
263329|NCT00430248|637870|P1|STARTED|Overall Study||757
263330|NCT00430092|637929|P3|NOT COMPLETED|Overall Study||57
263331|NCT00430092|637930|P2|NOT COMPLETED|Overall Study||4
263332|NCT00430092|637931|P1|NOT COMPLETED|Overall Study||6
263333|NCT00430092|637929|P3|COMPLETED|Overall Study||56
263334|NCT00430092|637930|P2|COMPLETED|Overall Study||48
263335|NCT00430092|637931|P1|COMPLETED|Overall Study||48
263336|NCT00430092|637929|P3|STARTED|Overall Study||113
263337|NCT00430092|637930|P2|STARTED|Overall Study||52
263338|NCT00430092|637931|P1|STARTED|Overall Study||54
263339|NCT00430027|637936|P1|NOT COMPLETED|Overall Study||8
263340|NCT00430027|637936|P1|COMPLETED|Overall Study||0
263341|NCT00430027|637936|P1|STARTED|Overall Study||8
263342|NCT00429949|637940|P1|NOT COMPLETED|Overall Study||0
263343|NCT00429949|637940|P1|COMPLETED|Overall Study||21
263344|NCT00429949|637940|P1|STARTED|Overall Study||21
263345|NCT00429923|637953|P3|NOT COMPLETED|Overall Study||39
263346|NCT00429923|637954|P2|NOT COMPLETED|Overall Study||4
263347|NCT00429923|637955|P1|NOT COMPLETED|Overall Study||5
263348|NCT00429923|637953|P3|COMPLETED|Overall Study||68
263349|NCT00429923|637954|P2|COMPLETED|Overall Study||51
263350|NCT00429923|637955|P1|COMPLETED|Overall Study||52
263351|NCT00429923|637953|P3|STARTED|Overall Study||107
263352|NCT00429923|637954|P2|STARTED|Overall Study||55
263353|NCT00429923|637955|P1|STARTED|Overall Study||57
263354|NCT00429793|637960|P1|NOT COMPLETED|Overall Study||6
263355|NCT00429793|637960|P1|COMPLETED|Overall Study||54
263356|NCT00429793|637960|P1|STARTED|Overall Study||60
263357|NCT00429702|637976|P2|NOT COMPLETED|Overall Study||0
263358|NCT00429702|637977|P1|NOT COMPLETED|Overall Study||0
263359|NCT00429702|637976|P2|COMPLETED|Overall Study||4
263360|NCT00429702|637977|P1|COMPLETED|Overall Study||3
263361|NCT00429702|637976|P2|STARTED|Overall Study||4
263362|NCT00429702|637977|P1|STARTED|Overall Study||3
263363|NCT00429663|637987|P2|NOT COMPLETED|Overall Study||39
263364|NCT00429663|637988|P1|NOT COMPLETED|Overall Study||36
263365|NCT00429663|637987|P2|COMPLETED|Overall Study||41
263366|NCT00429663|637988|P1|COMPLETED|Overall Study||40
263367|NCT00429663|637987|P2|STARTED|Overall Study||80
263368|NCT00429663|637988|P1|STARTED|Overall Study||76
263369|NCT00429572|638002|P1|NOT COMPLETED|Overall Study||1
263370|NCT00429572|638002|P1|COMPLETED|Overall Study||18
263371|NCT00429572|638002|P1|STARTED|Overall Study||19
263372|NCT00429507|638010|P1|NOT COMPLETED|Overall Study||0
263373|NCT00429507|638010|P1|COMPLETED|Overall Study||12
263374|NCT00429507|638010|P1|STARTED|Overall Study||12
263375|NCT00429494|638014|P1|NOT COMPLETED|Overall Study||15
263376|NCT00429494|638014|P1|COMPLETED|Overall Study||44
263377|NCT00429494|638014|P1|STARTED|Overall Study||59
263378|NCT00429416|638018|P1|NOT COMPLETED|Overall Study||1
263379|NCT00429416|638018|P1|COMPLETED|Overall Study||13
263380|NCT00429416|638018|P1|STARTED|Overall Study||14
263381|NCT00429403|638028|P2|NOT COMPLETED|Overall Study||0
263382|NCT00429403|638029|P1|NOT COMPLETED|Overall Study||0
263383|NCT00429403|638028|P2|COMPLETED|Overall Study||0
263384|NCT00429403|638029|P1|COMPLETED|Overall Study||1
263385|NCT00429403|638028|P2|STARTED|Overall Study||0
263386|NCT00429403|638029|P1|STARTED|Overall Study||1
263387|NCT00429364|638037|P2|NOT COMPLETED|Overall Study||33
263388|NCT00429364|638038|P1|NOT COMPLETED|Overall Study||32
263389|NCT00429364|638037|P2|COMPLETED|Overall Study||272
263390|NCT00429364|638038|P1|COMPLETED|Overall Study||271
263391|NCT00429364|638037|P2|STARTED|Overall Study||305
263392|NCT00429364|638038|P1|STARTED|Overall Study||303
263393|NCT00429299|638097|P3|NOT COMPLETED|Overall Study||4
263394|NCT00429299|638098|P2|NOT COMPLETED|Overall Study||7
263395|NCT00429299|638099|P1|NOT COMPLETED|Overall Study||4
263396|NCT00429299|638097|P3|COMPLETED|Overall Study||42
263397|NCT00429299|638098|P2|COMPLETED|Overall Study||32
263398|NCT00429299|638099|P1|COMPLETED|Overall Study||32
263399|NCT00429299|638097|P3|STARTED|Overall Study||46
263400|NCT00429299|638098|P2|STARTED|Overall Study||39
263401|NCT00429299|638099|P1|STARTED|Overall Study||36
263402|NCT00429273|638131|P3|NOT COMPLETED|Overall Study||9
263403|NCT00429273|638132|P2|NOT COMPLETED|Overall Study||8
263404|NCT00429273|638133|P1|NOT COMPLETED|Overall Study||8
263405|NCT00429273|638131|P3|COMPLETED|Overall Study||61
263406|NCT00429273|638132|P2|COMPLETED|Overall Study||61
263407|NCT00429273|638133|P1|COMPLETED|Overall Study||60
263408|NCT00429273|638131|P3|STARTED|Overall Study||70
263409|NCT00429273|638132|P2|STARTED|Overall Study||69
263410|NCT00429273|638133|P1|STARTED|Overall Study||68
263411|NCT00429182|638141|P1|NOT COMPLETED|Overall Study||7
263412|NCT00429182|638141|P1|COMPLETED|Overall Study||25
263413|NCT00429182|638141|P1|STARTED|Overall Study||32
263414|NCT00429169|638148|P2|NOT COMPLETED|Overall Study||2
263415|NCT00429169|638149|P1|NOT COMPLETED|Overall Study||2
263416|NCT00429169|638148|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
263417|NCT00429169|638149|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
263418|NCT00429169|638148|P2|STARTED|Overall Study||40
263419|NCT00429169|638149|P1|STARTED|Overall Study||38
263420|NCT00429143|638159|P1|NOT COMPLETED|Overall Study||0
263421|NCT00429143|638159|P1|COMPLETED|Overall Study||27
263422|NCT00429143|638159|P1|STARTED|Overall Study||27
263423|NCT00429104|638167|P1|NOT COMPLETED|Overall Study||1
263424|NCT00429104|638167|P1|COMPLETED|Overall Study||17
263425|NCT00429104|638167|P1|STARTED|Overall Study||18
263426|NCT00429026|638172|P1|NOT COMPLETED|Overall Study||40
263427|NCT00429026|638172|P1|COMPLETED|Overall Study||0
263428|NCT00429026|638172|P1|STARTED|Overall Study||40
263429|NCT00428974|638180|P4|NOT COMPLETED|Overall Study||3
263430|NCT00428974|638181|P3|NOT COMPLETED|Overall Study||1
263431|NCT00428974|638182|P2|NOT COMPLETED|Overall Study||0
263432|NCT00428974|638183|P1|NOT COMPLETED|Overall Study||8
263433|NCT00428974|638180|P4|COMPLETED|Overall Study||16
263434|NCT00428974|638181|P3|COMPLETED|Overall Study||14
263435|NCT00428974|638182|P2|COMPLETED|Overall Study||17
263436|NCT00428974|638183|P1|COMPLETED|Overall Study||17
263437|NCT00428974|638180|P4|STARTED|Overall Study||19
263438|NCT00428974|638181|P3|STARTED|Overall Study||15
263439|NCT00428974|638182|P2|STARTED|Overall Study||17
263440|NCT00428974|638183|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
263441|NCT00428948|638199|P2|NOT COMPLETED|Overall Study||67
263442|NCT00428948|638200|P1|NOT COMPLETED|Overall Study||221
263443|NCT00428948|638199|P2|COMPLETED|Overall Study||417
263444|NCT00428948|638200|P1|COMPLETED|Overall Study||740
263445|NCT00428948|638199|P2|Received Treatment|Overall Study||483
263446|NCT00428948|638200|P1|Received Treatment|Overall Study||961
263447|NCT00428948|638199|P2|STARTED|Overall Study||484
263448|NCT00428948|638200|P1|STARTED|Overall Study||961
263449|NCT00428922|638218|P1|NOT COMPLETED|Overall Study||0
263450|NCT00428922|638218|P1|COMPLETED|Overall Study||26
263451|NCT00428922|638218|P1|STARTED|Overall Study||26
263452|NCT00428844|638228|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
263453|NCT00428844|638229|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
263454|NCT00428844|638230|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
263455|NCT00428844|638228|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
263456|NCT00428844|638229|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
263457|NCT00428844|638230|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
263458|NCT00428844|638228|P3|STARTED|Completed Test of Cure (TOC) Visit||19
263459|NCT00428844|638229|P2|STARTED|Completed Test of Cure (TOC) Visit||18
263460|NCT00428844|638230|P1|STARTED|Completed Test of Cure (TOC) Visit||23
263461|NCT00428844|638228|P3|NOT COMPLETED|Completed Study Drug Treatment||7
263462|NCT00428844|638229|P2|NOT COMPLETED|Completed Study Drug Treatment||6
263463|NCT00428844|638230|P1|NOT COMPLETED|Completed Study Drug Treatment||2
263464|NCT00428844|638228|P3|COMPLETED|Completed Study Drug Treatment||19
263465|NCT00428844|638229|P2|COMPLETED|Completed Study Drug Treatment||18
263466|NCT00428844|638230|P1|COMPLETED|Completed Study Drug Treatment||23
263467|NCT00428844|638228|P3|Received First Dose|Completed Study Drug Treatment||25
263468|NCT00428844|638229|P2|Received First Dose|Completed Study Drug Treatment||24
263469|NCT00428844|638230|P1|Received First Dose|Completed Study Drug Treatment||25
263470|NCT00428844|638228|P3|STARTED|Completed Study Drug Treatment||26
263471|NCT00428844|638229|P2|STARTED|Completed Study Drug Treatment||24
263472|NCT00428844|638230|P1|STARTED|Completed Study Drug Treatment||25
263473|NCT00428792|638253|P2|NOT COMPLETED|Overall Study||4
263474|NCT00428792|638254|P1|NOT COMPLETED|Overall Study||1
263475|NCT00428792|638253|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
263476|NCT00428792|638254|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
263477|NCT00428792|638253|P2|STARTED|Overall Study||70
263478|NCT00428792|638254|P1|STARTED|Overall Study||80
263479|NCT00428610|638281|P3|NOT COMPLETED|Overall Study||32
263480|NCT00428610|638282|P2|NOT COMPLETED|Overall Study||18
263481|NCT00428610|638283|P1|NOT COMPLETED|Overall Study||53
263482|NCT00428610|638281|P3|COMPLETED|Overall Study||0
263483|NCT00428610|638282|P2|COMPLETED|Overall Study||0
263484|NCT00428610|638283|P1|COMPLETED|Overall Study||0
263485|NCT00428610|638281|P3|Received at Least One Dose of Study Drug|Overall Study||32
263486|NCT00428610|638282|P2|Received at Least One Dose of Study Drug|Overall Study||18
263487|NCT00428610|638283|P1|Received at Least One Dose of Study Drug|Overall Study||53
263488|NCT00428610|638281|P3|STARTED|Overall Study||32
263489|NCT00428610|638282|P2|STARTED|Overall Study||18
263490|NCT00428610|638283|P1|STARTED|Overall Study||53
263491|NCT00428597|638317|P2|NOT COMPLETED|Overall Study||85
263492|NCT00428597|638318|P1|NOT COMPLETED|Overall Study||86
263493|NCT00428597|638317|P2|COMPLETED|Overall Study||0
263494|NCT00428597|638318|P1|COMPLETED|Overall Study||0
263495|NCT00428597|638317|P2|Received Treatment|Overall Study||82
263496|NCT00428597|638318|P1|Received Treatment|Overall Study||83
263497|NCT00428597|638317|P2|STARTED|Overall Study||85
263498|NCT00428597|638318|P1|STARTED|Overall Study||86
263499|NCT00428584|638360|P2|NOT COMPLETED|Extension Phase||29
263500|NCT00428584|638361|P1|NOT COMPLETED|Extension Phase||21
263501|NCT00428584|638360|P2|COMPLETED|Extension Phase||34
263502|NCT00428584|638361|P1|COMPLETED|Extension Phase||35
263503|NCT00428584|638360|P2|STARTED|Extension Phase||63
263504|NCT00428584|638361|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
263505|NCT00428584|638360|P2|NOT COMPLETED|Comparative Phase||1
263506|NCT00428584|638361|P1|NOT COMPLETED|Comparative Phase||9
263507|NCT00428584|638360|P2|COMPLETED|Comparative Phase||63
263508|NCT00428584|638361|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
263509|NCT00428584|638360|P2|STARTED|Comparative Phase||64
263510|NCT00428584|638361|P1|STARTED|Comparative Phase||65
263511|NCT00428441|638385|P1|NOT COMPLETED|Overall Study||1
263512|NCT00428441|638385|P1|COMPLETED|Overall Study||74
263513|NCT00428441|638385|P1|STARTED|Overall Study||75
263514|NCT00428389|638391|P2|NOT COMPLETED|Extension Phase||26
263515|NCT00428389|638392|P1|NOT COMPLETED|Extension Phase||32
263516|NCT00428389|638391|P2|COMPLETED|Extension Phase||91
263517|NCT00428389|638392|P1|COMPLETED|Extension Phase||85
263518|NCT00428389|638391|P2|STARTED|Extension Phase||117
263519|NCT00428389|638392|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
263520|NCT00428389|638391|P2|NOT COMPLETED|Core Phase||11
263521|NCT00428389|638392|P1|NOT COMPLETED|Core Phase||11
263522|NCT00428389|638391|P2|COMPLETED|Core Phase||120
263523|NCT00428389|638392|P1|COMPLETED|Core Phase||120
263524|NCT00428389|638391|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
263525|NCT00428389|638392|P1|Intent-to-treat Population|Core Phase||131
263526|NCT00428389|638391|P2|STARTED|Core Phase||131
263527|NCT00428389|638392|P1|STARTED|Core Phase||131
263528|NCT00428298|638412|P2|NOT COMPLETED|Overall Study||11
263529|NCT00428298|638413|P1|NOT COMPLETED|Overall Study||14
263530|NCT00428298|638412|P2|COMPLETED|Overall Study||19
263531|NCT00428298|638413|P1|COMPLETED|Overall Study||16
263532|NCT00428298|638412|P2|Second RBANS at Study Exit|Overall Study||3
263533|NCT00428298|638413|P1|Second RBANS at Study Exit|Overall Study||3
263534|NCT00428298|638412|P2|STARTED|Overall Study||30
263535|NCT00428298|638413|P1|STARTED|Overall Study||30
263536|NCT00428246|638426|P3|NOT COMPLETED|Overall Study||1
263537|NCT00428246|638427|P2|NOT COMPLETED|Overall Study||0
263538|NCT00428246|638428|P1|NOT COMPLETED|Overall Study||1
263539|NCT00428246|638426|P3|COMPLETED|Overall Study||7
263540|NCT00428246|638427|P2|COMPLETED|Overall Study||8
263541|NCT00428246|638428|P1|COMPLETED|Overall Study||7
263542|NCT00428246|638426|P3|STARTED|Overall Study||8
263543|NCT00428246|638427|P2|STARTED|Overall Study||8
263544|NCT00428246|638428|P1|STARTED|Overall Study||8
263545|NCT00428220|638436|P1|NOT COMPLETED|Overall Study||223
263546|NCT00428220|638436|P1|COMPLETED|Overall Study||0
263547|NCT00428220|638436|P1|STARTED|Overall Study||223
263548|NCT00428207|638452|P2|NOT COMPLETED|Overall Study||0
263549|NCT00428207|638453|P1|NOT COMPLETED|Overall Study||0
263550|NCT00428207|638452|P2|COMPLETED|Overall Study||2
263551|NCT00428207|638453|P1|COMPLETED|Overall Study||2
263552|NCT00428207|638452|P2|STARTED|Overall Study||2
263553|NCT00428207|638453|P1|STARTED|Overall Study||2
263554|NCT00428116|638461|P2|NOT COMPLETED|Overall Study||0
263555|NCT00428116|638462|P1|NOT COMPLETED|Overall Study||3
263556|NCT00428116|638461|P2|COMPLETED|Overall Study||21
263557|NCT00428116|638462|P1|COMPLETED|Overall Study||18
263558|NCT00428116|638461|P2|STARTED|Overall Study||21
263559|NCT00428116|638462|P1|STARTED|Overall Study||21
263560|NCT00428090|638474|P4|NOT COMPLETED|Overall Study||28
263561|NCT00428090|638475|P3|NOT COMPLETED|Overall Study||38
263562|NCT00428090|638476|P2|NOT COMPLETED|Overall Study||31
263563|NCT00428090|638477|P1|NOT COMPLETED|Overall Study||34
263564|NCT00428090|638474|P4|COMPLETED|Overall Study||55
263565|NCT00428090|638475|P3|COMPLETED|Overall Study||127
263566|NCT00428090|638476|P2|COMPLETED|Overall Study||135
263567|NCT00428090|638477|P1|COMPLETED|Overall Study||131
263568|NCT00428090|638474|P4|STARTED|Overall Study||83
263569|NCT00428090|638475|P3|STARTED|Overall Study||165
263570|NCT00428090|638476|P2|STARTED|Overall Study||166
263571|NCT00428090|638477|P1|STARTED|Overall Study||165
263572|NCT00428077|638591|P1|NOT COMPLETED|Overall Study||0
263573|NCT00428077|638591|P1|COMPLETED|Overall Study||4
263574|NCT00428077|638591|P1|STARTED|Overall Study||4
263575|NCT00427999|638595|P1|NOT COMPLETED|Overall Study||32
263576|NCT00427999|638595|P1|COMPLETED|Overall Study||33
263577|NCT00427999|638595|P1|Extension Follow-up|Overall Study||19
263578|NCT00427999|638595|P1|Intent to Treat (ITT)|Overall Study||61
263579|NCT00427999|638595|P1|STARTED|Overall Study||65
263580|NCT00427973|638604|P1|NOT COMPLETED|Overall Study||0
263581|NCT00427973|638604|P1|COMPLETED|Overall Study||17
263582|NCT00427973|638604|P1|STARTED|Overall Study||17
263583|NCT00427960|638613|P2|NOT COMPLETED|Overall Study||4
263584|NCT00427960|638614|P1|NOT COMPLETED|Overall Study||2
263585|NCT00427960|638613|P2|COMPLETED|Overall Study||21
263586|NCT00427960|638614|P1|COMPLETED|Overall Study||28
263587|NCT00427960|638613|P2|STARTED|Overall Study||25
263588|NCT00427960|638614|P1|STARTED|Overall Study||30
263589|NCT00427934|638652|P4|NOT COMPLETED|Overall Study||15
263590|NCT00427934|638653|P3|NOT COMPLETED|Overall Study||23
263591|NCT00427934|638654|P2|NOT COMPLETED|Overall Study||0
263592|NCT00427934|638655|P1|NOT COMPLETED|Overall Study||1
263593|NCT00427934|638652|P4|COMPLETED|Overall Study||19
263594|NCT00427934|638653|P3|COMPLETED|Overall Study||55
263595|NCT00427934|638654|P2|COMPLETED|Overall Study||8
263596|NCT00427934|638655|P1|COMPLETED|Overall Study||7
263597|NCT00427934|638652|P4|Treated|Overall Study||33
263598|NCT00427934|638653|P3|Treated|Overall Study||77
263599|NCT00427934|638654|P2|Treated|Overall Study||8
263600|NCT00427934|638655|P1|Treated|Overall Study||8
263601|NCT00427934|638652|P4|STARTED|Overall Study||34
263602|NCT00427934|638653|P3|STARTED|Overall Study||78
263603|NCT00427934|638654|P2|STARTED|Overall Study||8
263604|NCT00427934|638655|P1|STARTED|Overall Study||8
263605|NCT00427921|638723|P1|NOT COMPLETED|Overall Study||50
263606|NCT00427921|638723|P1|COMPLETED|Overall Study||254
263607|NCT00427921|638723|P1|STARTED|Overall Study||304
263608|NCT00427895|638746|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
263609|NCT00427895|638747|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
263610|NCT00427895|638748|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
263611|NCT00427895|638749|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
263612|NCT00427895|638750|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
263613|NCT00427895|638751|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
263614|NCT00427895|638752|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
263615|NCT00427895|638753|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
263616|NCT00427895|638746|P8|COMPLETED|Vax 2/Year 3 to 4||212
263617|NCT00427895|638747|P7|COMPLETED|Vax 2/Year 3 to 4||189
263618|NCT00427895|638748|P6|COMPLETED|Vax 2/Year 3 to 4||108
263619|NCT00427895|638749|P5|COMPLETED|Vax 2/Year 3 to 4||107
263620|NCT00427895|638750|P4|COMPLETED|Vax 2/Year 3 to 4||0
263621|NCT00427895|638751|P3|COMPLETED|Vax 2/Year 3 to 4||0
263622|NCT00427895|638752|P2|COMPLETED|Vax 2/Year 3 to 4||0
263623|NCT00427895|638753|P1|COMPLETED|Vax 2/Year 3 to 4||0
263624|NCT00427895|638746|P8|STARTED|Vax 2/Year 3 to 4||214
263625|NCT00427895|638747|P7|STARTED|Vax 2/Year 3 to 4||189
263626|NCT00427895|638748|P6|STARTED|Vax 2/Year 3 to 4||108
263627|NCT00427895|638749|P5|STARTED|Vax 2/Year 3 to 4||108
263628|NCT00427895|638750|P4|STARTED|Vax 2/Year 3 to 4||0
263629|NCT00427895|638751|P3|STARTED|Vax 2/Year 3 to 4||0
263630|NCT00427895|638752|P2|STARTED|Vax 2/Year 3 to 4||0
263631|NCT00427895|638753|P1|STARTED|Vax 2/Year 3 to 4||0
263632|NCT00427895|638746|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263633|NCT00427895|638747|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263634|NCT00427895|638748|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263635|NCT00427895|638749|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263636|NCT00427895|638750|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
263637|NCT00427895|638751|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
263638|NCT00427895|638752|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
263639|NCT00427895|638753|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
263640|NCT00427895|638746|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263641|NCT00427895|638747|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263642|NCT00427895|638748|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263643|NCT00427895|638749|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263644|NCT00427895|638750|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
263645|NCT00427895|638751|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
263646|NCT00427895|638752|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
263647|NCT00427895|638753|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
263648|NCT00427895|638746|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
263649|NCT00427895|638747|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
263650|NCT00427895|638748|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
263651|NCT00427895|638749|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
263652|NCT00427895|638750|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
263653|NCT00427895|638751|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
263654|NCT00427895|638752|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
263655|NCT00427895|638753|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
263656|NCT00427895|638746|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
263657|NCT00427895|638747|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
263658|NCT00427895|638748|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
263659|NCT00427895|638749|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
263660|NCT00427895|638750|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
263661|NCT00427895|638751|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
263662|NCT00427895|638752|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
263663|NCT00427895|638753|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
263664|NCT00427895|638746|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
263665|NCT00427895|638747|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
263666|NCT00427895|638748|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
263667|NCT00427895|638749|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
263668|NCT00427895|638750|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
263669|NCT00427895|638751|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
263670|NCT00427895|638752|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
263671|NCT00427895|638753|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
263672|NCT00427895|638746|P8|STARTED|Vax 1/Year 1 Follow-up||0
263673|NCT00427895|638747|P7|STARTED|Vax 1/Year 1 Follow-up||0
263674|NCT00427895|638748|P6|STARTED|Vax 1/Year 1 Follow-up||0
263675|NCT00427895|638749|P5|STARTED|Vax 1/Year 1 Follow-up||0
263676|NCT00427895|638750|P4|STARTED|Vax 1/Year 1 Follow-up||502
263677|NCT00427895|638751|P3|STARTED|Vax 1/Year 1 Follow-up||392
263678|NCT00427895|638752|P2|STARTED|Vax 1/Year 1 Follow-up||411
263679|NCT00427895|638753|P1|STARTED|Vax 1/Year 1 Follow-up||411
263680|NCT00427895|638746|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
263681|NCT00427895|638747|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
263682|NCT00427895|638748|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
263683|NCT00427895|638749|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
263684|NCT00427895|638750|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
263685|NCT00427895|638751|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
263686|NCT00427895|638752|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
263687|NCT00427895|638753|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
263688|NCT00427895|638746|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
263689|NCT00427895|638747|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
263690|NCT00427895|638748|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
263691|NCT00427895|638749|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
263692|NCT00427895|638750|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
263693|NCT00427895|638751|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
263694|NCT00427895|638752|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
263695|NCT00427895|638753|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
263696|NCT00427895|638746|P8|STARTED|Between 6-Month Follow-up - Year 1||0
263697|NCT00427895|638747|P7|STARTED|Between 6-Month Follow-up - Year 1||0
263698|NCT00427895|638748|P6|STARTED|Between 6-Month Follow-up - Year 1||0
263699|NCT00427895|638749|P5|STARTED|Between 6-Month Follow-up - Year 1||0
263700|NCT00427895|638750|P4|STARTED|Between 6-Month Follow-up - Year 1||854
263701|NCT00427895|638751|P3|STARTED|Between 6-Month Follow-up - Year 1||392
263702|NCT00427895|638752|P2|STARTED|Between 6-Month Follow-up - Year 1||411
263703|NCT00427895|638753|P1|STARTED|Between 6-Month Follow-up - Year 1||411
263704|NCT00427895|638746|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263705|NCT00427895|638747|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263706|NCT00427895|638748|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263707|NCT00427895|638749|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263708|NCT00427895|638750|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
263709|NCT00427895|638751|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
263710|NCT00427895|638752|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
263711|NCT00427895|638753|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
263712|NCT00427895|638746|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263713|NCT00427895|638747|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263714|NCT00427895|638748|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263715|NCT00427895|638749|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
263716|NCT00427895|638750|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
263717|NCT00427895|638751|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
263718|NCT00427895|638752|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
263719|NCT00427895|638753|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
263720|NCT00427895|638746|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
263721|NCT00427895|638747|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
263722|NCT00427895|638748|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
263723|NCT00427895|638749|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
263724|NCT00427895|638750|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
263725|NCT00427895|638751|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
263726|NCT00427895|638752|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
263727|NCT00427895|638753|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
263728|NCT00427895|638746|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
263729|NCT00427895|638747|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
263730|NCT00427895|638748|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
263731|NCT00427895|638749|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
263732|NCT00427895|638750|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
263733|NCT00427895|638751|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
263734|NCT00427895|638752|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
263735|NCT00427895|638753|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
263736|NCT00427804|638810|P2|NOT COMPLETED|Overall Study||0
263737|NCT00427804|638811|P1|NOT COMPLETED|Overall Study||0
263738|NCT00427804|638810|P2|COMPLETED|Overall Study||5
263739|NCT00427804|638811|P1|COMPLETED|Overall Study||4
263740|NCT00427804|638810|P2|STARTED|Overall Study||5
263741|NCT00427804|638811|P1|STARTED|Overall Study||4
263742|NCT00427791|638819|P2|NOT COMPLETED|Overall Study||0
263743|NCT00427791|638820|P1|NOT COMPLETED|Overall Study||0
263744|NCT00427791|638819|P2|COMPLETED|Overall Study||13
263745|NCT00427791|638820|P1|COMPLETED|Overall Study||10
263746|NCT00427791|638819|P2|STARTED|Overall Study||13
263747|NCT00427791|638820|P1|STARTED|Overall Study||10
263748|NCT00427778|638828|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
263749|NCT00427778|638829|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
263750|NCT00427778|638828|P2|COMPLETED|Second Intervention (4 Weeks)||14
263751|NCT00427778|638829|P1|COMPLETED|Second Intervention (4 Weeks)||10
263752|NCT00427778|638828|P2|STARTED|Second Intervention (4 Weeks)||14
263753|NCT00427778|638829|P1|STARTED|Second Intervention (4 Weeks)||10
263754|NCT00427778|638828|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
263755|NCT00427778|638829|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
263756|NCT00427778|638828|P2|COMPLETED|Wash Out (2 Weeks)||14
263757|NCT00427778|638829|P1|COMPLETED|Wash Out (2 Weeks)||10
263758|NCT00427778|638828|P2|STARTED|Wash Out (2 Weeks)||14
263759|NCT00427778|638829|P1|STARTED|Wash Out (2 Weeks)||10
263760|NCT00427778|638828|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
263761|NCT00427778|638829|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
263762|NCT00427778|638828|P2|COMPLETED|First Intervention (4 Weeks)||14
263763|NCT00427778|638829|P1|COMPLETED|First Intervention (4 Weeks)||10
263764|NCT00427778|638828|P2|STARTED|First Intervention (4 Weeks)||15
263765|NCT00427778|638829|P1|STARTED|First Intervention (4 Weeks)||14
263766|NCT00427765|638848|P1|NOT COMPLETED|Overall Study||0
263767|NCT00427765|638848|P1|COMPLETED|Overall Study||164
263768|NCT00427765|638848|P1|STARTED|Overall Study||164
263769|NCT00427700|638854|P2|NOT COMPLETED|Overall Study||11
263770|NCT00427700|638855|P1|NOT COMPLETED|Overall Study||3
263771|NCT00427700|638854|P2|COMPLETED|Overall Study||31
263772|NCT00427700|638855|P1|COMPLETED|Overall Study||37
263773|NCT00427700|638854|P2|STARTED|Overall Study||42
263774|NCT00427700|638855|P1|STARTED|Overall Study||40
263775|NCT00427661|638863|P1|NOT COMPLETED|Overall Study||0
263776|NCT00427661|638863|P1|COMPLETED|Overall Study||8
263777|NCT00427661|638863|P1|STARTED|Overall Study||8
263778|NCT00427635|638871|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
263779|NCT00427635|638872|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
263780|NCT00427635|638871|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
263781|NCT00427635|638872|P1|COMPLETED|Study Completion to Safety Follow-up||25
263782|NCT00427635|638871|P2|STARTED|Study Completion to Safety Follow-up||26
263783|NCT00427635|638872|P1|STARTED|Study Completion to Safety Follow-up||25
263784|NCT00427635|638871|P2|NOT COMPLETED|Treatment Phase||0
263785|NCT00427635|638872|P1|NOT COMPLETED|Treatment Phase||1
263786|NCT00427635|638871|P2|COMPLETED|Treatment Phase|ITT population|26
263787|NCT00427635|638872|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
263788|NCT00427635|638871|P2|STARTED|Treatment Phase|Randomised|26
263789|NCT00427635|638872|P1|STARTED|Treatment Phase|Randomised|26
263790|NCT00427557|638900|P1|NOT COMPLETED|Overall Study||0
263791|NCT00427557|638900|P1|COMPLETED|Overall Study||30
263792|NCT00427557|638900|P1|STARTED|Overall Study||30
263793|NCT00427349|638904|P1|NOT COMPLETED|Overall Study||46
263794|NCT00427349|638904|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
263795|NCT00427349|638904|P1|Eligible and Treated|Overall Study||44
263796|NCT00427349|638904|P1|Treated|Overall Study||45
263797|NCT00427349|638904|P1|Eligible|Overall Study||45
263798|NCT00427349|638904|P1|STARTED|Overall Study||46
263799|NCT00427336|638910|P1|NOT COMPLETED|Overall Study||0
263800|NCT00427336|638910|P1|COMPLETED|Overall Study||9
263801|NCT00427336|638910|P1|STARTED|Overall Study||9
263802|NCT00427037|638916|P2|NOT COMPLETED|Overall Study||7
263803|NCT00427037|638917|P1|NOT COMPLETED|Overall Study||7
263804|NCT00427037|638916|P2|COMPLETED|Overall Study||10
263805|NCT00427037|638917|P1|COMPLETED|Overall Study||10
263806|NCT00427037|638916|P2|STARTED|Overall Study||17
263807|NCT00427037|638917|P1|STARTED|Overall Study||17
263808|NCT00427011|638925|P1|NOT COMPLETED|Overall Study||25
263809|NCT00427011|638925|P1|COMPLETED|Overall Study||0
263810|NCT00427011|638925|P1|STARTED|Overall Study||25
263811|NCT00426855|638936|P1|NOT COMPLETED|Overall Study||0
263812|NCT00426855|638936|P1|COMPLETED|Overall Study||12
263813|NCT00426855|638936|P1|STARTED|Overall Study||12
263814|NCT00426842|638940|P1|NOT COMPLETED|Overall Study||1
263815|NCT00426842|638940|P1|COMPLETED|Overall Study||10
263816|NCT00426842|638940|P1|STARTED|Overall Study||11
263817|NCT00426764|638946|P1|NOT COMPLETED|Overall Study||98
263818|NCT00426764|638946|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6 (data cutoff of October 31 2010).|33
263819|NCT00426764|638946|P1|Received 6 or More Treatment Cycles|Overall Study||36
263820|NCT00426764|638946|P1|Received 4 or More Treatment Cycles|Overall Study||50
263821|NCT00426764|638946|P1|Histopathologically-Confirmed Population|Overall Study|Central histologic confirmation of peripheral T-cell lymphoma (PTCL).|130
263822|NCT00426764|638946|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
263823|NCT00426751|638962|P2|NOT COMPLETED|Overall Study||20
263824|NCT00426751|638963|P1|NOT COMPLETED|Overall Study||22
263825|NCT00426751|638962|P2|COMPLETED|Overall Study||183
263826|NCT00426751|638963|P1|COMPLETED|Overall Study||204
263827|NCT00426751|638962|P2|STARTED|Overall Study||203
263828|NCT00426751|638963|P1|STARTED|Overall Study||226
263829|NCT00426660|639007|P1|NOT COMPLETED|Overall Study||131
263830|NCT00426660|639007|P1|COMPLETED|Overall Study||916
263831|NCT00426660|639007|P1|Safety Analysis Set|Overall Study||1032
263832|NCT00426660|639007|P1|Treated|Overall Study||1032
263833|NCT00426660|639007|P1|STARTED|Overall Study||1047
263834|NCT00426556|639038|P4|NOT COMPLETED|Phase II - Extension Phase||23
263835|NCT00426556|639039|P3|NOT COMPLETED|Phase II - Extension Phase||0
263836|NCT00426556|639040|P2|NOT COMPLETED|Phase II - Extension Phase||0
263837|NCT00426556|639041|P1|NOT COMPLETED|Phase II - Extension Phase||0
263838|NCT00426556|639038|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
263839|NCT00426556|639039|P3|COMPLETED|Phase II - Extension Phase||0
263840|NCT00426556|639040|P2|COMPLETED|Phase II - Extension Phase||0
263841|NCT00426556|639041|P1|COMPLETED|Phase II - Extension Phase||0
263842|NCT00426556|639038|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
263843|NCT00426556|639039|P3|STARTED|Phase II - Extension Phase||0
263844|NCT00426556|639040|P2|STARTED|Phase II - Extension Phase||0
263845|NCT00426556|639041|P1|STARTED|Phase II - Extension Phase||0
263846|NCT00426556|639038|P4|NOT COMPLETED|Phase II - Core Phase||27
263847|NCT00426556|639039|P3|NOT COMPLETED|Phase II - Core Phase||0
263848|NCT00426556|639040|P2|NOT COMPLETED|Phase II - Core Phase||0
263849|NCT00426556|639041|P1|NOT COMPLETED|Phase II - Core Phase||0
263850|NCT00426556|639038|P4|COMPLETED|Phase II - Core Phase||28
263851|NCT00426556|639039|P3|COMPLETED|Phase II - Core Phase||0
263852|NCT00426556|639040|P2|COMPLETED|Phase II - Core Phase||0
263853|NCT00426556|639041|P1|COMPLETED|Phase II - Core Phase||0
263854|NCT00426556|639038|P4|STARTED|Phase II - Core Phase||55
263855|NCT00426556|639039|P3|STARTED|Phase II - Core Phase||0
263856|NCT00426556|639040|P2|STARTED|Phase II - Core Phase||0
263857|NCT00426556|639041|P1|STARTED|Phase II - Core Phase||0
263858|NCT00426556|639038|P4|NOT COMPLETED|Phase I - Extension Phase||0
263859|NCT00426556|639039|P3|NOT COMPLETED|Phase I - Extension Phase||7
263860|NCT00426556|639040|P2|NOT COMPLETED|Phase I - Extension Phase||6
263861|NCT00426556|639041|P1|NOT COMPLETED|Phase I - Extension Phase||5
263862|NCT00426556|639038|P4|COMPLETED|Phase I - Extension Phase||0
263863|NCT00426556|639039|P3|COMPLETED|Phase I - Extension Phase||0
263864|NCT00426556|639040|P2|COMPLETED|Phase I - Extension Phase||1
263865|NCT00426556|639041|P1|COMPLETED|Phase I - Extension Phase||0
263866|NCT00426556|639038|P4|STARTED|Phase I - Extension Phase||0
263867|NCT00426556|639039|P3|STARTED|Phase I - Extension Phase||7
263868|NCT00426556|639040|P2|STARTED|Phase I - Extension Phase||7
263869|NCT00426556|639041|P1|STARTED|Phase I - Extension Phase||5
263870|NCT00426556|639038|P4|NOT COMPLETED|Phase I - Core Phase||0
263871|NCT00426556|639039|P3|NOT COMPLETED|Phase I - Core Phase||3
263872|NCT00426556|639040|P2|NOT COMPLETED|Phase I - Core Phase||10
263873|NCT00426556|639041|P1|NOT COMPLETED|Phase I - Core Phase||1
263874|NCT00426556|639038|P4|COMPLETED|Phase I - Core Phase||0
263875|NCT00426556|639039|P3|COMPLETED|Phase I - Core Phase||7
263876|NCT00426556|639040|P2|COMPLETED|Phase I - Core Phase||7
263877|NCT00426556|639041|P1|COMPLETED|Phase I - Core Phase||5
263878|NCT00426556|639038|P4|STARTED|Phase I - Core Phase||0
263879|NCT00426556|639039|P3|STARTED|Phase I - Core Phase||10
263880|NCT00426556|639040|P2|STARTED|Phase I - Core Phase||17
263881|NCT00426556|639041|P1|STARTED|Phase I - Core Phase||6
263882|NCT00426361|639066|P3|NOT COMPLETED|Overall Study||5
263883|NCT00426361|639067|P2|NOT COMPLETED|Overall Study||5
263884|NCT00426361|639068|P1|NOT COMPLETED|Overall Study||4
263885|NCT00426361|639066|P3|COMPLETED|Overall Study||243
263886|NCT00426361|639067|P2|COMPLETED|Overall Study||250
263887|NCT00426361|639068|P1|COMPLETED|Overall Study||244
263888|NCT00426361|639066|P3|STARTED|Overall Study||248
263889|NCT00426361|639067|P2|STARTED|Overall Study||255
263890|NCT00426361|639068|P1|STARTED|Overall Study||248
263891|NCT00426283|639120|P2|NOT COMPLETED|Overall Study||1
263892|NCT00426283|639121|P1|NOT COMPLETED|Overall Study||5
263893|NCT00426283|639120|P2|COMPLETED|Overall Study||13
263894|NCT00426283|639121|P1|COMPLETED|Overall Study||23
263895|NCT00426283|639120|P2|STARTED|Overall Study||14
263896|NCT00426283|639121|P1|STARTED|Overall Study||28
263897|NCT00426270|639127|P1|NOT COMPLETED|Overall Study||6
263898|NCT00426270|639127|P1|COMPLETED|Overall Study||110
263899|NCT00426270|639127|P1|STARTED|Overall Study||116
263900|NCT00426231|639137|P2|NOT COMPLETED|Overall Study||12
263901|NCT00426231|639138|P1|NOT COMPLETED|Overall Study||9
263902|NCT00426231|639137|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
263903|NCT00426231|639138|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
263904|NCT00426231|639137|P2|STARTED|Overall Study||37
263905|NCT00426231|639138|P1|STARTED|Overall Study||36
263906|NCT00426153|639148|P2|NOT COMPLETED|Overall Study||0
263907|NCT00426153|639149|P1|NOT COMPLETED|Overall Study||0
263908|NCT00426153|639148|P2|COMPLETED|Overall Study||14
263909|NCT00426153|639149|P1|COMPLETED|Overall Study||28
263910|NCT00426153|639148|P2|STARTED|Overall Study||14
263911|NCT00426153|639149|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
263912|NCT00426127|639161|P1|NOT COMPLETED|Overall Study||2
263913|NCT00426127|639161|P1|COMPLETED|Overall Study||0
263914|NCT00426127|639161|P1|STARTED|Overall Study||2
263915|NCT00425945|639169|P2|NOT COMPLETED|Overall Study||5
263916|NCT00425945|639170|P1|NOT COMPLETED|Overall Study||4
263917|NCT00425945|639169|P2|COMPLETED|Overall Study||61
263918|NCT00425945|639170|P1|COMPLETED|Overall Study||60
263919|NCT00425945|639169|P2|STARTED|Overall Study||66
263920|NCT00425945|639170|P1|STARTED|Overall Study||64
263921|NCT00425854|639208|P2|NOT COMPLETED|Overall Study||21
263922|NCT00425854|639209|P1|NOT COMPLETED|Overall Study||29
263923|NCT00425854|639208|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
263924|NCT00425854|639209|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
263925|NCT00425854|639208|P2|STARTED|Overall Study|Treated|21
263926|NCT00425854|639209|P1|STARTED|Overall Study|Treated|29
263927|NCT00425802|639230|P1|NOT COMPLETED|Overall Study||0
263928|NCT00425802|639230|P1|COMPLETED|Overall Study||61
263929|NCT00425802|639230|P1|STARTED|Overall Study||61
263930|NCT00425750|639242|P1|NOT COMPLETED|Overall Study||25
263931|NCT00425750|639242|P1|COMPLETED|Overall Study||0
263932|NCT00425750|639242|P1|STARTED|Overall Study||25
263933|NCT00425698|639250|P2|NOT COMPLETED|Overall Study||2
263934|NCT00425698|639251|P1|NOT COMPLETED|Overall Study||3
263935|NCT00425698|639250|P2|COMPLETED|Overall Study||42
263936|NCT00425698|639251|P1|COMPLETED|Overall Study||41
263937|NCT00425698|639250|P2|STARTED|Overall Study||44
263938|NCT00425698|639251|P1|STARTED|Overall Study||44
263939|NCT00425672|639257|P1|NOT COMPLETED|Overall Study||1
263940|NCT00425672|639257|P1|COMPLETED|Overall Study||14
263941|NCT00425672|639257|P1|STARTED|Overall Study||15
263942|NCT00425607|639266|P1|NOT COMPLETED|Overall Study||2
263943|NCT00425607|639266|P1|COMPLETED|Overall Study||27
263944|NCT00425607|639266|P1|Received Treatment|Overall Study||28
263945|NCT00425607|639266|P1|STARTED|Overall Study||29
263946|NCT00425503|639270|P1|NOT COMPLETED|Overall Study||3
263947|NCT00425503|639270|P1|COMPLETED|Overall Study||37
263948|NCT00425503|639270|P1|STARTED|Overall Study||40
263949|NCT00425438|639276|P2|NOT COMPLETED|Overall Study||27
263950|NCT00425438|639277|P1|NOT COMPLETED|Overall Study||25
263951|NCT00425438|639276|P2|COMPLETED|Overall Study||0
263952|NCT00425438|639277|P1|COMPLETED|Overall Study||0
263953|NCT00425438|639276|P2|STARTED|Overall Study||27
263954|NCT00425438|639277|P1|STARTED|Overall Study||25
263955|NCT00425386|639293|P1|NOT COMPLETED|Overall Study||3
263956|NCT00425386|639293|P1|COMPLETED|Overall Study||43
263957|NCT00425386|639293|P1|STARTED|Overall Study||46
263958|NCT00425373|639311|P9|NOT COMPLETED|Overall Study||18
263959|NCT00425373|639312|P8|NOT COMPLETED|Overall Study||10
263960|NCT00425373|639313|P7|NOT COMPLETED|Overall Study||7
263961|NCT00425373|639314|P6|NOT COMPLETED|Overall Study||9
263962|NCT00425373|639315|P5|NOT COMPLETED|Overall Study||10
263963|NCT00425373|639316|P4|NOT COMPLETED|Overall Study||2
263964|NCT00425373|639317|P3|NOT COMPLETED|Overall Study||3
263965|NCT00425373|639318|P2|NOT COMPLETED|Overall Study||3
263966|NCT00425373|639319|P1|NOT COMPLETED|Overall Study||5
263967|NCT00425373|639311|P9|COMPLETED|Overall Study||148
263968|NCT00425373|639312|P8|COMPLETED|Overall Study||151
263969|NCT00425373|639313|P7|COMPLETED|Overall Study||154
263970|NCT00425373|639314|P6|COMPLETED|Overall Study||154
263971|NCT00425373|639315|P5|COMPLETED|Overall Study||159
263972|NCT00425373|639316|P4|COMPLETED|Overall Study||160
263973|NCT00425373|639317|P3|COMPLETED|Overall Study||157
263974|NCT00425373|639318|P2|COMPLETED|Overall Study||164
263975|NCT00425373|639319|P1|COMPLETED|Overall Study||154
263976|NCT00425373|639311|P9|STARTED|Overall Study||166
263977|NCT00425373|639312|P8|STARTED|Overall Study||161
263978|NCT00425373|639313|P7|STARTED|Overall Study||161
263979|NCT00425373|639314|P6|STARTED|Overall Study||163
263980|NCT00425373|639315|P5|STARTED|Overall Study||169
263981|NCT00425373|639316|P4|STARTED|Overall Study||162
263982|NCT00425373|639317|P3|STARTED|Overall Study||160
263983|NCT00425373|639318|P2|STARTED|Overall Study||167
263984|NCT00425373|639319|P1|STARTED|Overall Study||159
263985|NCT00425308|639377|P2|NOT COMPLETED|Overall Study||1
263986|NCT00425308|639378|P1|NOT COMPLETED|Overall Study||4
263987|NCT00425308|639377|P2|COMPLETED|Overall Study||14
263988|NCT00425308|639378|P1|COMPLETED|Overall Study||11
263989|NCT00425308|639377|P2|STARTED|Overall Study||15
263990|NCT00425308|639378|P1|STARTED|Overall Study||15
263991|NCT00425269|639408|P2|NOT COMPLETED|Overall Study||20
263992|NCT00425269|639409|P1|NOT COMPLETED|Overall Study||19
263993|NCT00425269|639408|P2|COMPLETED|Overall Study||77
263994|NCT00425269|639409|P1|COMPLETED|Overall Study||82
263995|NCT00425269|639408|P2|STARTED|Overall Study||97
263996|NCT00425269|639409|P1|STARTED|Overall Study||101
263997|NCT00425113|639487|P2|NOT COMPLETED|Overall Study||2
263998|NCT00425113|639488|P1|NOT COMPLETED|Overall Study||2
263999|NCT00425113|639487|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
264000|NCT00425113|639488|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
264001|NCT00425113|639487|P2|Exposed to Study Drug|Overall Study||17
264002|NCT00425113|639488|P1|Exposed to Study Drug|Overall Study||16
264003|NCT00425113|639487|P2|STARTED|Overall Study||18
264004|NCT00425113|639488|P1|STARTED|Overall Study||17
264005|NCT00425100|639496|P1|NOT COMPLETED|Overall Study||53
264006|NCT00425100|639496|P1|COMPLETED|Overall Study||463
264007|NCT00425100|639496|P1|STARTED|Overall Study||516
264008|NCT00425061|639540|P7|NOT COMPLETED|Overall Study||19
264009|NCT00425061|639541|P6|NOT COMPLETED|Overall Study||4
264010|NCT00425061|639542|P5|NOT COMPLETED|Overall Study||26
264011|NCT00425061|639543|P4|NOT COMPLETED|Overall Study||2
264012|NCT00425061|639544|P3|NOT COMPLETED|Overall Study||0
264013|NCT00425061|639545|P2|NOT COMPLETED|Overall Study||2
264014|NCT00425061|639546|P1|NOT COMPLETED|Overall Study||2
264015|NCT00425061|639540|P7|COMPLETED|Overall Study||26
264016|NCT00425061|639541|P6|COMPLETED|Overall Study||0
264017|NCT00425061|639542|P5|COMPLETED|Overall Study||19
264018|NCT00425061|639543|P4|COMPLETED|Overall Study||14
264019|NCT00425061|639544|P3|COMPLETED|Overall Study||16
264020|NCT00425061|639545|P2|COMPLETED|Overall Study||15
264021|NCT00425061|639546|P1|COMPLETED|Overall Study||14
264022|NCT00425061|639540|P7|STARTED|Overall Study||45
264023|NCT00425061|639541|P6|STARTED|Overall Study||4
264024|NCT00425061|639542|P5|STARTED|Overall Study||45
264025|NCT00425061|639543|P4|STARTED|Overall Study||16
264026|NCT00425061|639544|P3|STARTED|Overall Study||16
264027|NCT00425061|639545|P2|STARTED|Overall Study||17
264028|NCT00425061|639546|P1|STARTED|Overall Study||16
264029|NCT00424827|639662|P1|NOT COMPLETED|Overall Study||1
264030|NCT00424827|639662|P1|COMPLETED|Overall Study||10
264031|NCT00424827|639662|P1|STARTED|Overall Study||11
264032|NCT00424775|639670|P2|NOT COMPLETED|Overall Study||0
264033|NCT00424775|639671|P1|NOT COMPLETED|Overall Study||3
264034|NCT00424775|639670|P2|COMPLETED|Overall Study||0
264035|NCT00424775|639671|P1|COMPLETED|Overall Study||0
264036|NCT00424775|639670|P2|STARTED|Overall Study||0
264037|NCT00424775|639671|P1|STARTED|Overall Study||3
264038|NCT00424762|639681|P2|NOT COMPLETED|Overall Study||22
264039|NCT00424762|639682|P1|NOT COMPLETED|Overall Study||20
264040|NCT00424762|639681|P2|COMPLETED|Overall Study||54
264041|NCT00424762|639682|P1|COMPLETED|Overall Study||54
264042|NCT00424762|639681|P2|STARTED|Overall Study||76
264043|NCT00424762|639682|P1|STARTED|Overall Study||74
264044|NCT00424749|639692|P1|NOT COMPLETED|Overall Study||1
264045|NCT00424749|639692|P1|COMPLETED|Overall Study||3
264046|NCT00424749|639692|P1|STARTED|Overall Study||4
264047|NCT00424645|639699|P2|NOT COMPLETED|Overall Study||0
264048|NCT00424645|639700|P1|NOT COMPLETED|Overall Study||1
264049|NCT00424645|639699|P2|COMPLETED|Overall Study||0
264050|NCT00424645|639700|P1|COMPLETED|Overall Study||2
264051|NCT00424645|639699|P2|STARTED|Overall Study||0
264052|NCT00424645|639700|P1|STARTED|Overall Study||3
264053|NCT00424632|639708|P10|NOT COMPLETED|Overall Study||6
264054|NCT00424632|639709|P9|NOT COMPLETED|Overall Study||16
264055|NCT00424632|639710|P8|NOT COMPLETED|Overall Study||3
264056|NCT00424632|639711|P7|NOT COMPLETED|Overall Study||7
264057|NCT00424632|639712|P6|NOT COMPLETED|Overall Study||15
264058|NCT00424632|639713|P5|NOT COMPLETED|Overall Study||3
264059|NCT00424632|639714|P4|NOT COMPLETED|Overall Study||4
264060|NCT00424632|639715|P3|NOT COMPLETED|Overall Study||1
264061|NCT00424632|639716|P2|NOT COMPLETED|Overall Study||1
264062|NCT00424632|639717|P1|NOT COMPLETED|Overall Study||1
264063|NCT00424632|639708|P10|COMPLETED|Overall Study||0
264064|NCT00424632|639709|P9|COMPLETED|Overall Study||0
264065|NCT00424632|639710|P8|COMPLETED|Overall Study||0
264066|NCT00424632|639711|P7|COMPLETED|Overall Study||0
264067|NCT00424632|639712|P6|COMPLETED|Overall Study||0
264068|NCT00424632|639713|P5|COMPLETED|Overall Study||0
264069|NCT00424632|639714|P4|COMPLETED|Overall Study||0
264070|NCT00424632|639715|P3|COMPLETED|Overall Study||0
264071|NCT00424632|639716|P2|COMPLETED|Overall Study||0
264072|NCT00424632|639717|P1|COMPLETED|Overall Study||0
264073|NCT00424632|639708|P10|STARTED|Overall Study||6
264074|NCT00424632|639709|P9|STARTED|Overall Study||16
264075|NCT00424632|639710|P8|STARTED|Overall Study||3
264076|NCT00424632|639711|P7|STARTED|Overall Study||7
264077|NCT00424632|639712|P6|STARTED|Overall Study||15
264078|NCT00424632|639713|P5|STARTED|Overall Study||3
264079|NCT00424632|639714|P4|STARTED|Overall Study||4
264080|NCT00424632|639715|P3|STARTED|Overall Study||1
264081|NCT00424632|639716|P2|STARTED|Overall Study||1
264082|NCT00424632|639717|P1|STARTED|Overall Study||1
264083|NCT00424619|639851|P3|NOT COMPLETED|3 Month||0
264084|NCT00424619|639852|P2|NOT COMPLETED|3 Month||0
264085|NCT00424619|639853|P1|NOT COMPLETED|3 Month||0
264086|NCT00424619|639851|P3|COMPLETED|3 Month||17
264087|NCT00424619|639852|P2|COMPLETED|3 Month||18
264088|NCT00424619|639853|P1|COMPLETED|3 Month||12
264089|NCT00424619|639851|P3|STARTED|3 Month||17
264090|NCT00424619|639852|P2|STARTED|3 Month||18
264091|NCT00424619|639853|P1|STARTED|3 Month||12
264092|NCT00424619|639851|P3|NOT COMPLETED|4 Week||0
264093|NCT00424619|639852|P2|NOT COMPLETED|4 Week||0
264094|NCT00424619|639853|P1|NOT COMPLETED|4 Week||0
264095|NCT00424619|639851|P3|COMPLETED|4 Week||17
264096|NCT00424619|639852|P2|COMPLETED|4 Week||17
264097|NCT00424619|639853|P1|COMPLETED|4 Week||18
264098|NCT00424619|639851|P3|STARTED|4 Week||17
264099|NCT00424619|639852|P2|STARTED|4 Week||17
264100|NCT00424619|639853|P1|STARTED|4 Week||18
264101|NCT00424619|639851|P3|NOT COMPLETED|Baseline||1
264102|NCT00424619|639852|P2|NOT COMPLETED|Baseline||0
264103|NCT00424619|639853|P1|NOT COMPLETED|Baseline||0
264104|NCT00424619|639851|P3|COMPLETED|Baseline||20
264105|NCT00424619|639852|P2|COMPLETED|Baseline||22
264106|NCT00424619|639853|P1|COMPLETED|Baseline||22
264107|NCT00424619|639851|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
264108|NCT00424619|639852|P2|STARTED|Baseline||22
264109|NCT00424619|639853|P1|STARTED|Baseline||22
264110|NCT00424593|639887|P2|NOT COMPLETED|Dose-Blind Extension Period||0
264111|NCT00424593|639888|P1|NOT COMPLETED|Dose-Blind Extension Period||64
264112|NCT00424593|639887|P2|COMPLETED|Dose-Blind Extension Period||0
264113|NCT00424593|639888|P1|COMPLETED|Dose-Blind Extension Period||117
264114|NCT00424593|639887|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
264115|NCT00424593|639888|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
264116|NCT00424593|639887|P2|NOT COMPLETED|Acute Double-Blind Period||23
264117|NCT00424593|639888|P1|NOT COMPLETED|Acute Double-Blind Period||31
264118|NCT00424593|639887|P2|COMPLETED|Acute Double-Blind Period||98
264119|NCT00424593|639888|P1|COMPLETED|Acute Double-Blind Period||84
264120|NCT00424593|639887|P2|STARTED|Acute Double-Blind Period||121
264121|NCT00424593|639888|P1|STARTED|Acute Double-Blind Period||115
264122|NCT00424554|639934|P2|NOT COMPLETED|Overall Study||0
264123|NCT00424554|639935|P1|NOT COMPLETED|Overall Study||0
264124|NCT00424554|639934|P2|COMPLETED|Overall Study||6
264125|NCT00424554|639935|P1|COMPLETED|Overall Study||34
264126|NCT00424554|639934|P2|STARTED|Overall Study||6
264127|NCT00424554|639935|P1|STARTED|Overall Study||34
264128|NCT00424528|639952|P3|NOT COMPLETED|Overall Study||4
264129|NCT00424528|639953|P2|NOT COMPLETED|Overall Study||4
264130|NCT00424528|639954|P1|NOT COMPLETED|Overall Study||5
264131|NCT00424528|639952|P3|COMPLETED|Overall Study||74
264132|NCT00424528|639953|P2|COMPLETED|Overall Study||76
264133|NCT00424528|639954|P1|COMPLETED|Overall Study||71
264134|NCT00424528|639952|P3|STARTED|Overall Study||78
264135|NCT00424528|639953|P2|STARTED|Overall Study||80
264136|NCT00424528|639954|P1|STARTED|Overall Study||76
264137|NCT00424515|640009|P2|NOT COMPLETED|Overall Study||13
264138|NCT00424515|640010|P1|NOT COMPLETED|Overall Study||11
264139|NCT00424515|640009|P2|COMPLETED|Overall Study||0
264140|NCT00424515|640010|P1|COMPLETED|Overall Study||0
264141|NCT00424515|640009|P2|STARTED|Overall Study||13
264142|NCT00424515|640010|P1|STARTED|Overall Study||11
264143|NCT00424502|640020|P1|NOT COMPLETED|Overall Study||0
264144|NCT00424502|640020|P1|COMPLETED|Overall Study||20
264145|NCT00424502|640020|P1|STARTED|Overall Study||20
264146|NCT00424476|640032|P3|NOT COMPLETED|Overall Study||49
264147|NCT00424476|640033|P2|NOT COMPLETED|Overall Study||48
264148|NCT00424476|640034|P1|NOT COMPLETED|Overall Study||61
264149|NCT00424476|640032|P3|COMPLETED|Overall Study||241
264150|NCT00424476|640033|P2|COMPLETED|Overall Study||240
264151|NCT00424476|640034|P1|COMPLETED|Overall Study||226
264152|NCT00424476|640032|P3|STARTED|Overall Study||290
264153|NCT00424476|640033|P2|STARTED|Overall Study||288
264154|NCT00424476|640034|P1|STARTED|Overall Study||287
264155|NCT00424398|640060|P3|NOT COMPLETED|Overall Study||0
264156|NCT00424398|640061|P2|NOT COMPLETED|Overall Study||1
264157|NCT00424398|640062|P1|NOT COMPLETED|Overall Study||3
264158|NCT00424398|640060|P3|COMPLETED|Overall Study||36
264159|NCT00424398|640061|P2|COMPLETED|Overall Study||35
264160|NCT00424398|640062|P1|COMPLETED|Overall Study||32
264161|NCT00424398|640060|P3|STARTED|Overall Study||36
264162|NCT00424398|640061|P2|STARTED|Overall Study||36
264163|NCT00424398|640062|P1|STARTED|Overall Study||35
264164|NCT00424385|640106|P1|NOT COMPLETED|Cohort 1||1
264165|NCT00424385|640106|P1|COMPLETED|Cohort 1||4
264166|NCT00424385|640106|P1|STARTED|Cohort 1||5
264167|NCT00424385|640106|P1|NOT COMPLETED|Cohort 0||6
264168|NCT00424385|640106|P1|COMPLETED|Cohort 0||6
264169|NCT00424385|640106|P1|STARTED|Cohort 0||12
264170|NCT00424372|640113|P1|NOT COMPLETED|Overall Study||31
264171|NCT00424372|640113|P1|COMPLETED|Overall Study||95
264172|NCT00424372|640113|P1|STARTED|Overall Study||126
264173|NCT00424346|640125|P4|NOT COMPLETED|Extension Phase||55
264174|NCT00424346|640126|P3|NOT COMPLETED|Extension Phase||55
264175|NCT00424346|640127|P2|NOT COMPLETED|Extension Phase||102
264176|NCT00424346|640128|P1|NOT COMPLETED|Extension Phase||0
264177|NCT00424346|640125|P4|COMPLETED|Extension Phase||3
264178|NCT00424346|640126|P3|COMPLETED|Extension Phase||4
264179|NCT00424346|640127|P2|COMPLETED|Extension Phase||8
264180|NCT00424346|640128|P1|COMPLETED|Extension Phase||0
264181|NCT00424346|640125|P4|STARTED|Extension Phase||58
264182|NCT00424346|640126|P3|STARTED|Extension Phase||59
264183|NCT00424346|640127|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
264184|NCT00424346|640128|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
264185|NCT00424346|640125|P4|NOT COMPLETED|Core Study||7
264186|NCT00424346|640126|P3|NOT COMPLETED|Core Study||4
264187|NCT00424346|640127|P2|NOT COMPLETED|Core Study||8
264188|NCT00424346|640128|P1|NOT COMPLETED|Core Study||9
264189|NCT00424346|640125|P4|COMPLETED|Core Study||63
264190|NCT00424346|640126|P3|COMPLETED|Core Study||65
264191|NCT00424346|640127|P2|COMPLETED|Core Study||56
264192|NCT00424346|640128|P1|COMPLETED|Core Study||62
264193|NCT00424346|640125|P4|STARTED|Core Study||70
264194|NCT00424346|640126|P3|STARTED|Core Study||69
264195|NCT00424346|640127|P2|STARTED|Core Study||64
264196|NCT00424346|640128|P1|STARTED|Core Study||71
264197|NCT00424294|640243|P2|NOT COMPLETED|Overall Study||15
264198|NCT00424294|640244|P1|NOT COMPLETED|Overall Study||8
264199|NCT00424294|640243|P2|COMPLETED|Overall Study||19
264200|NCT00424294|640244|P1|COMPLETED|Overall Study||28
264201|NCT00424294|640243|P2|Treated|Overall Study||34
264202|NCT00424294|640244|P1|Treated|Overall Study||35
264203|NCT00424294|640243|P2|STARTED|Overall Study||34
264204|NCT00424294|640244|P1|STARTED|Overall Study||36
264205|NCT00424268|640294|P2|NOT COMPLETED|Overall Study||39
264206|NCT00424268|640295|P1|NOT COMPLETED|Overall Study||62
264207|NCT00424268|640294|P2|COMPLETED|Overall Study||333
264208|NCT00424268|640295|P1|COMPLETED|Overall Study||309
264209|NCT00424268|640294|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
264210|NCT00424268|640295|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
264211|NCT00424255|640311|P2|NOT COMPLETED|Overall Study||346
264212|NCT00424255|640312|P1|NOT COMPLETED|Overall Study||342
264213|NCT00424255|640311|P2|COMPLETED|Overall Study||0
264214|NCT00424255|640312|P1|COMPLETED|Overall Study||0
264215|NCT00424255|640311|P2|STARTED|Overall Study||346
264216|NCT00424255|640312|P1|STARTED|Overall Study||342
264217|NCT00424190|640360|P2|NOT COMPLETED|Overall Study||30
264218|NCT00424190|640361|P1|NOT COMPLETED|Overall Study||22
264219|NCT00424190|640360|P2|COMPLETED|Overall Study||317
264220|NCT00424190|640361|P1|COMPLETED|Overall Study||329
264221|NCT00424190|640360|P2|STARTED|Overall Study||347
264222|NCT00424190|640361|P1|STARTED|Overall Study||351
264223|NCT00424177|640367|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
264224|NCT00424177|640367|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
264225|NCT00424177|640367|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
264226|NCT00424177|640367|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
264227|NCT00424177|640367|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
264228|NCT00424177|640367|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
264229|NCT00424177|640367|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
264230|NCT00424177|640367|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
264231|NCT00424177|640367|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
264232|NCT00424047|640396|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
264233|NCT00424047|640397|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
264234|NCT00424047|640396|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
264235|NCT00424047|640397|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
264236|NCT00424047|640396|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
264237|NCT00424047|640397|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
264238|NCT00424047|640396|P2|NOT COMPLETED|On Study at Time of Unblinding||167
264239|NCT00424047|640397|P1|NOT COMPLETED|On Study at Time of Unblinding||155
264240|NCT00424047|640396|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
264241|NCT00424047|640397|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
264242|NCT00424047|640396|P2|STARTED|On Study at Time of Unblinding||175
264243|NCT00424047|640397|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
264244|NCT00424047|640396|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
264245|NCT00424047|640397|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
264246|NCT00424047|640396|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
264247|NCT00424047|640397|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
264248|NCT00424047|640396|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
264249|NCT00424047|640397|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
264250|NCT00424047|640396|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
264251|NCT00424047|640397|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
264252|NCT00424047|640396|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
264253|NCT00424047|640397|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
264254|NCT00424021|640429|P4|NOT COMPLETED|AMB-220-E Study Period||10
264255|NCT00424021|640430|P3|NOT COMPLETED|AMB-220-E Study Period||5
264256|NCT00424021|640431|P2|NOT COMPLETED|AMB-220-E Study Period||2
264257|NCT00424021|640432|P1|NOT COMPLETED|AMB-220-E Study Period||1
264258|NCT00424021|640429|P4|COMPLETED|AMB-220-E Study Period||16
264259|NCT00424021|640430|P3|COMPLETED|AMB-220-E Study Period||14
264260|NCT00424021|640431|P2|COMPLETED|AMB-220-E Study Period||5
264261|NCT00424021|640432|P1|COMPLETED|AMB-220-E Study Period||1
264262|NCT00424021|640429|P4|STARTED|AMB-220-E Study Period||26
264263|NCT00424021|640430|P3|STARTED|AMB-220-E Study Period||19
264264|NCT00424021|640431|P2|STARTED|AMB-220-E Study Period||7
264265|NCT00424021|640432|P1|STARTED|AMB-220-E Study Period||2
264266|NCT00424021|640429|P4|NOT COMPLETED|NCT00046319 Study Period||1
264267|NCT00424021|640430|P3|NOT COMPLETED|NCT00046319 Study Period||1
264268|NCT00424021|640431|P2|NOT COMPLETED|NCT00046319 Study Period||3
264269|NCT00424021|640432|P1|NOT COMPLETED|NCT00046319 Study Period||1
264270|NCT00424021|640429|P4|COMPLETED|NCT00046319 Study Period||12
264271|NCT00424021|640430|P3|COMPLETED|NCT00046319 Study Period||15
264272|NCT00424021|640431|P2|COMPLETED|NCT00046319 Study Period||16
264273|NCT00424021|640432|P1|COMPLETED|NCT00046319 Study Period||15
264274|NCT00424021|640429|P4|STARTED|NCT00046319 Study Period||13
264275|NCT00424021|640430|P3|STARTED|NCT00046319 Study Period||16
264276|NCT00424021|640431|P2|STARTED|NCT00046319 Study Period||19
264277|NCT00424021|640432|P1|STARTED|NCT00046319 Study Period||16
264278|NCT00424008|640475|P2|NOT COMPLETED|Overall Study||335
264279|NCT00424008|640476|P1|NOT COMPLETED|Overall Study||349
264280|NCT00424008|640475|P2|COMPLETED|Overall Study||16
264281|NCT00424008|640476|P1|COMPLETED|Overall Study||22
264282|NCT00424008|640475|P2|STARTED|Overall Study||351
264283|NCT00424008|640476|P1|STARTED|Overall Study||371
264284|NCT00423943|640491|P2|NOT COMPLETED|Overall Study||1
264285|NCT00423943|640492|P1|NOT COMPLETED|Overall Study||3
264286|NCT00423943|640491|P2|COMPLETED|Overall Study||13
264287|NCT00423943|640492|P1|COMPLETED|Overall Study||16
264288|NCT00423943|640491|P2|STARTED|Overall Study||14
264289|NCT00423943|640492|P1|STARTED|Overall Study||19
264290|NCT00423930|640506|P1|NOT COMPLETED|Overall Study||2
264291|NCT00423930|640506|P1|COMPLETED|Overall Study||42
264292|NCT00423930|640506|P1|STARTED|Overall Study||44
264293|NCT00423917|640511|P1|NOT COMPLETED|Overall Study||3
264294|NCT00423917|640511|P1|COMPLETED|Overall Study||33
264295|NCT00423917|640511|P1|STARTED|Overall Study||36
264296|NCT00423891|640524|P3|NOT COMPLETED|Post-Dosing Follow Up||2
264297|NCT00423891|640525|P2|NOT COMPLETED|Post-Dosing Follow Up||3
264298|NCT00423891|640526|P1|NOT COMPLETED|Post-Dosing Follow Up||2
264299|NCT00423891|640524|P3|COMPLETED|Post-Dosing Follow Up||3
264300|NCT00423891|640525|P2|COMPLETED|Post-Dosing Follow Up||15
264301|NCT00423891|640526|P1|COMPLETED|Post-Dosing Follow Up||20
264302|NCT00423891|640524|P3|STARTED|Post-Dosing Follow Up||5
264303|NCT00423891|640525|P2|STARTED|Post-Dosing Follow Up||18
264304|NCT00423891|640526|P1|STARTED|Post-Dosing Follow Up||22
264305|NCT00423891|640524|P3|NOT COMPLETED|Treatment||0
264306|NCT00423891|640525|P2|NOT COMPLETED|Treatment||0
264307|NCT00423891|640526|P1|NOT COMPLETED|Treatment||2
264308|NCT00423891|640524|P3|COMPLETED|Treatment||5
264309|NCT00423891|640525|P2|COMPLETED|Treatment||19
264310|NCT00423891|640526|P1|COMPLETED|Treatment||22
264311|NCT00423891|640524|P3|STARTED|Treatment||5
264312|NCT00423891|640525|P2|STARTED|Treatment||19
264313|NCT00423891|640526|P1|STARTED|Treatment||24
264314|NCT00423891|640524|P3|NOT COMPLETED|Enrolled||3
264315|NCT00423891|640525|P2|NOT COMPLETED|Enrolled||2
264316|NCT00423891|640526|P1|NOT COMPLETED|Enrolled||11
264317|NCT00423891|640524|P3|COMPLETED|Enrolled||5
264318|NCT00423891|640525|P2|COMPLETED|Enrolled||19
264319|NCT00423891|640526|P1|COMPLETED|Enrolled||24
264320|NCT00423891|640524|P3|STARTED|Enrolled||8
264321|NCT00423891|640525|P2|STARTED|Enrolled||21
264322|NCT00423891|640526|P1|STARTED|Enrolled||35
264323|NCT00423878|640595|P2|NOT COMPLETED|Overall Study||8
264324|NCT00423878|640596|P1|NOT COMPLETED|Overall Study||20
264325|NCT00423878|640595|P2|COMPLETED|Overall Study||98
264326|NCT00423878|640596|P1|COMPLETED|Overall Study||89
264327|NCT00423878|640595|P2|STARTED|Overall Study||106
264328|NCT00423878|640596|P1|STARTED|Overall Study||109
264329|NCT00423852|640604|P1|NOT COMPLETED|Overall Study||3
264330|NCT00423852|640604|P1|COMPLETED|Overall Study||23
264331|NCT00423852|640604|P1|STARTED|Overall Study||26
264332|NCT00423813|640612|P3|NOT COMPLETED|Overall Study||74
264333|NCT00423813|640613|P2|NOT COMPLETED|Overall Study||66
264334|NCT00423813|640614|P1|NOT COMPLETED|Overall Study||57
264335|NCT00423813|640612|P3|COMPLETED|Overall Study||116
264336|NCT00423813|640613|P2|COMPLETED|Overall Study||129
264337|NCT00423813|640614|P1|COMPLETED|Overall Study||131
264338|NCT00423813|640612|P3|Treated|Overall Study||189
264339|NCT00423813|640613|P2|Treated|Overall Study||194
264340|NCT00423813|640614|P1|Treated|Overall Study||188
264341|NCT00423813|640612|P3|STARTED|Overall Study||190
264342|NCT00423813|640613|P2|STARTED|Overall Study||195
264343|NCT00423813|640614|P1|STARTED|Overall Study||188
264344|NCT00423800|640624|P2|NOT COMPLETED|Overall Study||1
264345|NCT00423800|640625|P1|NOT COMPLETED|Overall Study||0
264346|NCT00423800|640624|P2|COMPLETED|Overall Study||1
264347|NCT00423800|640625|P1|COMPLETED|Overall Study||3
264348|NCT00423800|640624|P2|STARTED|Overall Study||2
264349|NCT00423800|640625|P1|STARTED|Overall Study||3
264350|NCT00423735|640637|P3|NOT COMPLETED|Overall Study||0
264351|NCT00423735|640638|P2|NOT COMPLETED|Overall Study||6
264352|NCT00423735|640639|P1|NOT COMPLETED|Overall Study||8
264353|NCT00423735|640637|P3|COMPLETED|Overall Study||0
264354|NCT00423735|640638|P2|COMPLETED|Overall Study||29
264355|NCT00423735|640639|P1|COMPLETED|Overall Study||21
264356|NCT00423735|640637|P3|STARTED|Overall Study||0
264357|NCT00423735|640638|P2|STARTED|Overall Study||35
264358|NCT00423735|640639|P1|STARTED|Overall Study||29
264359|NCT00423722|640662|P2|NOT COMPLETED|Overall Study||13
264360|NCT00423722|640663|P1|NOT COMPLETED|Overall Study||14
264361|NCT00423722|640662|P2|COMPLETED|Overall Study||53
264362|NCT00423722|640663|P1|COMPLETED|Overall Study||49
264363|NCT00423722|640662|P2|STARTED|Overall Study||66
264364|NCT00423722|640663|P1|STARTED|Overall Study||63
264365|NCT00423683|640685|P2|NOT COMPLETED|Overall Study||0
264366|NCT00423683|640686|P1|NOT COMPLETED|Overall Study||1
264367|NCT00423683|640685|P2|COMPLETED|Overall Study||33
264368|NCT00423683|640686|P1|COMPLETED|Overall Study||30
264369|NCT00423683|640685|P2|STARTED|Overall Study||33
264370|NCT00423683|640686|P1|STARTED|Overall Study||31
264371|NCT00423670|640705|P8|NOT COMPLETED|Follow-up Period||3
264372|NCT00423670|640706|P7|NOT COMPLETED|Follow-up Period||9
264373|NCT00423670|640707|P6|NOT COMPLETED|Follow-up Period||0
264374|NCT00423670|640708|P5|NOT COMPLETED|Follow-up Period||2
264375|NCT00423670|640709|P4|NOT COMPLETED|Follow-up Period||5
264376|NCT00423670|640710|P3|NOT COMPLETED|Follow-up Period||11
264377|NCT00423670|640711|P2|NOT COMPLETED|Follow-up Period||16
264378|NCT00423670|640712|P1|NOT COMPLETED|Follow-up Period||3
264379|NCT00423670|640705|P8|COMPLETED|Follow-up Period||32
264380|NCT00423670|640706|P7|COMPLETED|Follow-up Period||41
264381|NCT00423670|640707|P6|COMPLETED|Follow-up Period||14
264382|NCT00423670|640708|P5|COMPLETED|Follow-up Period||89
264383|NCT00423670|640709|P4|COMPLETED|Follow-up Period||91
264384|NCT00423670|640710|P3|COMPLETED|Follow-up Period||85
264385|NCT00423670|640711|P2|COMPLETED|Follow-up Period||84
264386|NCT00423670|640712|P1|COMPLETED|Follow-up Period||94
264387|NCT00423670|640705|P8|STARTED|Follow-up Period||35
264388|NCT00423670|640706|P7|STARTED|Follow-up Period||50
264389|NCT00423670|640707|P6|STARTED|Follow-up Period||14
264390|NCT00423670|640708|P5|STARTED|Follow-up Period||91
264391|NCT00423670|640709|P4|STARTED|Follow-up Period||96
264392|NCT00423670|640710|P3|STARTED|Follow-up Period||96
264393|NCT00423670|640711|P2|STARTED|Follow-up Period||100
264394|NCT00423670|640712|P1|STARTED|Follow-up Period||97
264395|NCT00423670|640705|P8|NOT COMPLETED|Treatment Period||21
264396|NCT00423670|640706|P7|NOT COMPLETED|Treatment Period||31
264397|NCT00423670|640707|P6|NOT COMPLETED|Treatment Period||8
264398|NCT00423670|640708|P5|NOT COMPLETED|Treatment Period||27
264399|NCT00423670|640709|P4|NOT COMPLETED|Treatment Period||40
264400|NCT00423670|640710|P3|NOT COMPLETED|Treatment Period||27
264401|NCT00423670|640711|P2|NOT COMPLETED|Treatment Period||30
264402|NCT00423670|640712|P1|NOT COMPLETED|Treatment Period||52
264403|NCT00423670|640705|P8|COMPLETED|Treatment Period||15
264404|NCT00423670|640706|P7|COMPLETED|Treatment Period||28
264405|NCT00423670|640707|P6|COMPLETED|Treatment Period||8
264406|NCT00423670|640708|P5|COMPLETED|Treatment Period||76
264407|NCT00423670|640709|P4|COMPLETED|Treatment Period||63
264408|NCT00423670|640710|P3|COMPLETED|Treatment Period||76
264409|NCT00423670|640711|P2|COMPLETED|Treatment Period||77
264410|NCT00423670|640712|P1|COMPLETED|Treatment Period||52
264411|NCT00423670|640705|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
264412|NCT00423670|640706|P7|STARTED|Treatment Period||59
264413|NCT00423670|640707|P6|STARTED|Treatment Period||16
264414|NCT00423670|640708|P5|STARTED|Treatment Period||103
264415|NCT00423670|640709|P4|STARTED|Treatment Period||103
264416|NCT00423670|640710|P3|STARTED|Treatment Period||103
264417|NCT00423670|640711|P2|STARTED|Treatment Period||107
264418|NCT00423670|640712|P1|STARTED|Treatment Period||104
264419|NCT00423657|640770|P2|NOT COMPLETED|Overall Study||25
264420|NCT00423657|640771|P1|NOT COMPLETED|Overall Study||26
264421|NCT00423657|640770|P2|COMPLETED|Overall Study||313
264422|NCT00423657|640771|P1|COMPLETED|Overall Study||316
264423|NCT00423657|640770|P2|STARTED|Overall Study||338
264424|NCT00423657|640771|P1|STARTED|Overall Study||342
264425|NCT00423605|640777|P1|NOT COMPLETED|Overall Study||241
264426|NCT00423605|640777|P1|COMPLETED|Overall Study||319
264427|NCT00423605|640777|P1|STARTED|Overall Study||560
264428|NCT00423592|640781|P1|NOT COMPLETED|Overall Study||7
264429|NCT00423592|640781|P1|COMPLETED|Overall Study|Completed study|29
264430|NCT00423592|640781|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
264431|NCT00423592|640781|P1|STARTED|Overall Study|Enrolled|36
264432|NCT00423579|640802|P2|NOT COMPLETED|Overall Study||4
264433|NCT00423579|640803|P1|NOT COMPLETED|Overall Study||4
264434|NCT00423579|640802|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
264435|NCT00423579|640803|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
264436|NCT00423579|640802|P2|STARTED|Overall Study||60
264437|NCT00423579|640803|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
264438|NCT00423488|640811|P2|NOT COMPLETED|Overall Study||1
264439|NCT00423488|640812|P1|NOT COMPLETED|Overall Study||5
264440|NCT00423488|640811|P2|COMPLETED|Overall Study||50
264441|NCT00423488|640812|P1|COMPLETED|Overall Study||37
264442|NCT00423488|640811|P2|STARTED|Overall Study||51
264443|NCT00423488|640812|P1|STARTED|Overall Study||42
264444|NCT00423449|640818|P5|NOT COMPLETED|Overall Study||7
264445|NCT00423449|640819|P4|NOT COMPLETED|Overall Study||22
264446|NCT00423449|640820|P3|NOT COMPLETED|Overall Study||15
264447|NCT00423449|640821|P2|NOT COMPLETED|Overall Study||4
264448|NCT00423449|640822|P1|NOT COMPLETED|Overall Study||3
264449|NCT00423449|640818|P5|COMPLETED|Overall Study||0
264450|NCT00423449|640819|P4|COMPLETED|Overall Study||5
264451|NCT00423449|640820|P3|COMPLETED|Overall Study||2
264452|NCT00423449|640821|P2|COMPLETED|Overall Study||2
264453|NCT00423449|640822|P1|COMPLETED|Overall Study||1
264454|NCT00423449|640818|P5|STARTED|Overall Study||7
264455|NCT00423449|640819|P4|STARTED|Overall Study||27
264456|NCT00423449|640820|P3|STARTED|Overall Study||17
264457|NCT00423449|640821|P2|STARTED|Overall Study||6
264458|NCT00423449|640822|P1|STARTED|Overall Study||4
264459|NCT00423436|640847|P2|NOT COMPLETED|Overall Study||0
264460|NCT00423436|640848|P1|NOT COMPLETED|Overall Study||0
264461|NCT00423436|640847|P2|COMPLETED|Overall Study||33
264462|NCT00423436|640848|P1|COMPLETED|Overall Study||35
264463|NCT00423436|640847|P2|STARTED|Overall Study||33
264464|NCT00423436|640848|P1|STARTED|Overall Study||35
264465|NCT00423358|640856|P2|NOT COMPLETED|Overall Study||0
264466|NCT00423358|640857|P1|NOT COMPLETED|Overall Study||0
264467|NCT00423358|640856|P2|COMPLETED|Overall Study||11
264468|NCT00423358|640857|P1|COMPLETED|Overall Study||11
264469|NCT00423358|640856|P2|STARTED|Overall Study||11
264470|NCT00423358|640857|P1|STARTED|Overall Study||11
264471|NCT00423332|640869|P2|NOT COMPLETED|Overall Study||7
264472|NCT00423332|640870|P1|NOT COMPLETED|Overall Study||9
264473|NCT00423332|640869|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
264474|NCT00423332|640870|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
264475|NCT00423332|640869|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
264476|NCT00423332|640870|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
264477|NCT00423332|640869|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
264478|NCT00423332|640870|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
264479|NCT00423332|640869|P2|STARTED|Overall Study|Number randomised|18
264480|NCT00423332|640870|P1|STARTED|Overall Study|Randomised|53
264481|NCT00423319|640889|P2|NOT COMPLETED|Overall Study||252
264482|NCT00423319|640890|P1|NOT COMPLETED|Overall Study||224
264483|NCT00423319|640889|P2|COMPLETED|Overall Study||2447
264484|NCT00423319|640890|P1|COMPLETED|Overall Study||2484
264485|NCT00423319|640889|P2|Participants Who Received Treatment|Overall Study||2659
264486|NCT00423319|640890|P1|Participants Who Received Treatment|Overall Study||2673
264487|NCT00423319|640889|P2|STARTED|Overall Study|Randomized|2699
264488|NCT00423319|640890|P1|STARTED|Overall Study|Randomized|2708
264489|NCT00423293|640922|P1|NOT COMPLETED|Overall Study||11
264490|NCT00423293|640922|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
264491|NCT00423293|640922|P1|STARTED|Overall Study||63
264492|NCT00423267|640928|P2|NOT COMPLETED|Period B||0
264493|NCT00423267|640929|P1|NOT COMPLETED|Period B||0
264494|NCT00423267|640928|P2|COMPLETED|Period B||0
264495|NCT00423267|640929|P1|COMPLETED|Period B||12
264496|NCT00423267|640928|P2|STARTED|Period B||0
264497|NCT00423267|640929|P1|STARTED|Period B||12
264498|NCT00423267|640928|P2|NOT COMPLETED|Period A||1
264499|NCT00423267|640929|P1|NOT COMPLETED|Period A||2
264500|NCT00423267|640928|P2|COMPLETED|Period A||6
264501|NCT00423267|640929|P1|COMPLETED|Period A||7
264502|NCT00423267|640928|P2|STARTED|Period A||7
264503|NCT00423267|640929|P1|STARTED|Period A||9
264504|NCT00423189|640949|P3|NOT COMPLETED|Overall Study||0
264505|NCT00423189|640950|P2|NOT COMPLETED|Overall Study||1
264506|NCT00423189|640951|P1|NOT COMPLETED|Overall Study||0
264507|NCT00423189|640949|P3|COMPLETED|Overall Study||2
264508|NCT00423189|640950|P2|COMPLETED|Overall Study||2
264509|NCT00423189|640951|P1|COMPLETED|Overall Study||2
264510|NCT00423189|640949|P3|STARTED|Overall Study||2
264511|NCT00423189|640950|P2|STARTED|Overall Study||3
264512|NCT00423189|640951|P1|STARTED|Overall Study||2
264513|NCT00423176|640973|P2|NOT COMPLETED|Overall Study||29
264514|NCT00423176|640974|P1|NOT COMPLETED|Overall Study||16
264515|NCT00423176|640973|P2|COMPLETED|Overall Study||94
264516|NCT00423176|640974|P1|COMPLETED|Overall Study||98
264517|NCT00423176|640973|P2|STARTED|Overall Study||123
264518|NCT00423176|640974|P1|STARTED|Overall Study||114
264519|NCT00423150|640982|P1|NOT COMPLETED|Overall Study||86
264520|NCT00423150|640982|P1|COMPLETED|Overall Study||0
264521|NCT00423150|640982|P1|STARTED|Overall Study||86
264522|NCT00423098|640988|P2|NOT COMPLETED|Overall Study||4
264523|NCT00423098|640989|P1|NOT COMPLETED|Overall Study||3
264524|NCT00423098|640988|P2|COMPLETED|Overall Study||35
264525|NCT00423098|640989|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
264526|NCT00423098|640988|P2|STARTED|Overall Study||39
264527|NCT00423098|640989|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
264528|NCT00423085|641016|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
264529|NCT00423085|641017|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
264530|NCT00423085|641018|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
264531|NCT00423085|641019|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
264532|NCT00423085|641016|P4|COMPLETED|52-Week Open-Label Extension Phase||474
264533|NCT00423085|641017|P3|COMPLETED|52-Week Open-Label Extension Phase||0
264534|NCT00423085|641018|P2|COMPLETED|52-Week Open-Label Extension Phase||0
264535|NCT00423085|641019|P1|COMPLETED|52-Week Open-Label Extension Phase||0
264536|NCT00423085|641016|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
264537|NCT00423085|641017|P3|STARTED|52-Week Open-Label Extension Phase||0
264538|NCT00423085|641018|P2|STARTED|52-Week Open-Label Extension Phase||0
264539|NCT00423085|641019|P1|STARTED|52-Week Open-Label Extension Phase||0
264540|NCT00423085|641016|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
264541|NCT00423085|641017|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
264542|NCT00423085|641018|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
264543|NCT00423085|641019|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
264544|NCT00423085|641016|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
264545|NCT00423085|641017|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
264546|NCT00423085|641018|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
264547|NCT00423085|641019|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
264548|NCT00423085|641016|P4|STARTED|24-Week Double-Blind Treatment Phase||0
264549|NCT00423085|641017|P3|STARTED|24-Week Double-Blind Treatment Phase||287
264550|NCT00423085|641018|P2|STARTED|24-Week Double-Blind Treatment Phase||284
264551|NCT00423085|641019|P1|STARTED|24-Week Double-Blind Treatment Phase||288
264552|NCT00423046|641048|P2|NOT COMPLETED|Overall Study||345
264553|NCT00423046|641049|P1|NOT COMPLETED|Overall Study||340
264554|NCT00423046|641048|P2|COMPLETED|Overall Study|Completed until Month 60|208
264555|NCT00423046|641049|P1|COMPLETED|Overall Study|Completed until Month 60|213
264556|NCT00423046|641048|P2|STARTED|Overall Study||553
264557|NCT00423046|641049|P1|STARTED|Overall Study||553
264558|NCT00422942|641115|P1|NOT COMPLETED|Overall Study||3
264559|NCT00422942|641115|P1|COMPLETED|Overall Study||0
264560|NCT00422942|641115|P1|STARTED|Overall Study||3
264561|NCT00422903|641134|P2|NOT COMPLETED|Overall Study||5
264562|NCT00422903|641135|P1|NOT COMPLETED|Overall Study||4
264563|NCT00422903|641134|P2|COMPLETED|Overall Study||38
264564|NCT00422903|641135|P1|COMPLETED|Overall Study||45
264565|NCT00422903|641134|P2|STARTED|Overall Study||43
264566|NCT00422903|641135|P1|STARTED|Overall Study||49
264567|NCT00422812|641163|P4|NOT COMPLETED|Overall Study||2
264568|NCT00422812|641164|P3|NOT COMPLETED|Overall Study||2
264569|NCT00422812|641165|P2|NOT COMPLETED|Overall Study||1
264570|NCT00422812|641166|P1|NOT COMPLETED|Overall Study||0
264571|NCT00422812|641163|P4|COMPLETED|Overall Study||103
264572|NCT00422812|641164|P3|COMPLETED|Overall Study||91
264573|NCT00422812|641165|P2|COMPLETED|Overall Study||103
264574|NCT00422812|641166|P1|COMPLETED|Overall Study||98
264575|NCT00422812|641163|P4|STARTED|Overall Study||105
264576|NCT00422812|641164|P3|STARTED|Overall Study||93
264577|NCT00422812|641165|P2|STARTED|Overall Study||104
264578|NCT00422812|641166|P1|STARTED|Overall Study||98
264579|NCT00422799|641184|P1|NOT COMPLETED|Overall Study||13
264580|NCT00422799|641184|P1|COMPLETED|Overall Study||50
264581|NCT00422799|641184|P1|STARTED|Overall Study||63
264582|NCT00422734|641193|P2|NOT COMPLETED|Overall Study||21
264583|NCT00422734|641194|P1|NOT COMPLETED|Overall Study||14
264584|NCT00422734|641193|P2|COMPLETED|Overall Study||243
264585|NCT00422734|641194|P1|COMPLETED|Overall Study||64
264586|NCT00422734|641193|P2|STARTED|Overall Study||264
264587|NCT00422734|641194|P1|STARTED|Overall Study||78
264588|NCT00422695|641228|P2|NOT COMPLETED|Overall Study||0
264589|NCT00422695|641229|P1|NOT COMPLETED|Overall Study||0
264590|NCT00422695|641228|P2|COMPLETED|Overall Study||38
264591|NCT00422695|641229|P1|COMPLETED|Overall Study||105
264592|NCT00422695|641228|P2|STARTED|Overall Study||38
264593|NCT00422695|641229|P1|STARTED|Overall Study||105
264594|NCT00422669|641240|P3|NOT COMPLETED|Overall Study||7
264595|NCT00422669|641241|P2|NOT COMPLETED|Overall Study||100
264596|NCT00422669|641242|P1|NOT COMPLETED|Overall Study||98
264597|NCT00422669|641240|P3|COMPLETED|Overall Study||0
264779|NCT00422097|641593|P3|COMPLETED|Dose Level 3||3
264598|NCT00422669|641241|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
264599|NCT00422669|641242|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
264600|NCT00422669|641240|P3|STARTED|Overall Study||7
264601|NCT00422669|641241|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
264602|NCT00422669|641242|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
264603|NCT00422656|641263|P1|NOT COMPLETED|Overall Study||0
264604|NCT00422656|641263|P1|COMPLETED|Overall Study||37
264605|NCT00422656|641263|P1|STARTED|Overall Study||37
264606|NCT00422513|641272|P2|NOT COMPLETED|Overall Study||106
264607|NCT00422513|641273|P1|NOT COMPLETED|Overall Study||107
264608|NCT00422513|641272|P2|COMPLETED|Overall Study||24
264609|NCT00422513|641273|P1|COMPLETED|Overall Study||23
264610|NCT00422513|641272|P2|STARTED|Overall Study||130
264611|NCT00422513|641273|P1|STARTED|Overall Study||130
264612|NCT00422448|641285|P1|NOT COMPLETED|Overall Study||0
264613|NCT00422448|641285|P1|COMPLETED|Overall Study||43
264614|NCT00422448|641285|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
264615|NCT00422422|641290|P1|NOT COMPLETED|Overall Study||10
264616|NCT00422422|641290|P1|COMPLETED|Overall Study||90
264617|NCT00422422|641290|P1|STARTED|Overall Study||100
264618|NCT00422383|641307|P5|NOT COMPLETED|Overall Study||3
264619|NCT00422383|641308|P4|NOT COMPLETED|Overall Study||2
264620|NCT00422383|641309|P3|NOT COMPLETED|Overall Study||4
264621|NCT00422383|641310|P2|NOT COMPLETED|Overall Study||14
264622|NCT00422383|641311|P1|NOT COMPLETED|Overall Study||15
264623|NCT00422383|641307|P5|COMPLETED|Overall Study||22
264624|NCT00422383|641308|P4|COMPLETED|Overall Study||4
264625|NCT00422383|641309|P3|COMPLETED|Overall Study||89
264626|NCT00422383|641310|P2|COMPLETED|Overall Study||106
264627|NCT00422383|641311|P1|COMPLETED|Overall Study||119
264628|NCT00422383|641307|P5|STARTED|Overall Study||25
264629|NCT00422383|641308|P4|STARTED|Overall Study||6
264630|NCT00422383|641309|P3|STARTED|Overall Study||93
264631|NCT00422383|641310|P2|STARTED|Overall Study||120
264632|NCT00422383|641311|P1|STARTED|Overall Study||134
264633|NCT00422292|641454|P4|NOT COMPLETED|Overall Study||24
264634|NCT00422292|641455|P3|NOT COMPLETED|Overall Study||22
264635|NCT00422292|641456|P2|NOT COMPLETED|Overall Study||66
264636|NCT00422292|641457|P1|NOT COMPLETED|Overall Study||18
264637|NCT00422292|641454|P4|COMPLETED|Overall Study||452
264638|NCT00422292|641455|P3|COMPLETED|Overall Study||224
264639|NCT00422292|641456|P2|COMPLETED|Overall Study||598
264640|NCT00422292|641457|P1|COMPLETED|Overall Study||239
264641|NCT00422292|641454|P4|STARTED|Overall Study||476
264642|NCT00422292|641455|P3|STARTED|Overall Study||246
264643|NCT00422292|641456|P2|STARTED|Overall Study||664
264644|NCT00422292|641457|P1|STARTED|Overall Study||257
264645|NCT00422279|641485|P2|NOT COMPLETED|Overall Study||0
264646|NCT00422279|641486|P1|NOT COMPLETED|Overall Study||0
264647|NCT00422279|641485|P2|COMPLETED|Overall Study||2
264648|NCT00422279|641486|P1|COMPLETED|Overall Study||2
264649|NCT00422279|641485|P2|24 Month After Loading Period|Overall Study||2
264650|NCT00422279|641486|P1|24 Month After Loading Period|Overall Study||2
264651|NCT00422279|641485|P2|STARTED|Overall Study||2
264652|NCT00422279|641486|P1|STARTED|Overall Study||2
264653|NCT00422227|641496|P2|NOT COMPLETED|Overall Study||15
264654|NCT00422227|641497|P1|NOT COMPLETED|Overall Study||4
264655|NCT00422227|641496|P2|COMPLETED|Overall Study||88
264656|NCT00422227|641497|P1|COMPLETED|Overall Study||193
264657|NCT00422227|641496|P2|STARTED|Overall Study||103
264658|NCT00422227|641497|P1|STARTED|Overall Study||197
264659|NCT00422201|641521|P1|NOT COMPLETED|Overall Study||11
264660|NCT00422201|641521|P1|COMPLETED|Overall Study||7
264661|NCT00422201|641521|P1|STARTED|Overall Study||18
264662|NCT00422162|641527|P2|NOT COMPLETED|Overall Study||30
264663|NCT00422162|641528|P1|NOT COMPLETED|Overall Study||24
264664|NCT00422162|641527|P2|COMPLETED|Overall Study||142
264665|NCT00422162|641528|P1|COMPLETED|Overall Study||143
264666|NCT00422162|641527|P2|Received Treatment|Overall Study||171
264667|NCT00422162|641528|P1|Received Treatment|Overall Study||167
264668|NCT00422162|641527|P2|STARTED|Overall Study||172
264669|NCT00422162|641528|P1|STARTED|Overall Study||167
264670|NCT00422097|641588|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264671|NCT00422097|641589|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264672|NCT00422097|641590|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264673|NCT00422097|641591|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264674|NCT00422097|641592|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264675|NCT00422097|641593|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264676|NCT00422097|641594|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264677|NCT00422097|641595|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
264678|NCT00422097|641588|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
264679|NCT00422097|641589|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
264680|NCT00422097|641590|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
264681|NCT00422097|641591|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
264682|NCT00422097|641592|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
264683|NCT00422097|641593|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
264780|NCT00422097|641594|P2|COMPLETED|Dose Level 3||0
264684|NCT00422097|641594|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
264685|NCT00422097|641595|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
264686|NCT00422097|641588|P8|STARTED|Ixabepilone With Famotidine or Food||7
264687|NCT00422097|641589|P7|STARTED|Ixabepilone With Famotidine or Food||8
264688|NCT00422097|641590|P6|STARTED|Ixabepilone With Famotidine or Food||0
264689|NCT00422097|641591|P5|STARTED|Ixabepilone With Famotidine or Food||0
264690|NCT00422097|641592|P4|STARTED|Ixabepilone With Famotidine or Food||0
264691|NCT00422097|641593|P3|STARTED|Ixabepilone With Famotidine or Food||0
264692|NCT00422097|641594|P2|STARTED|Ixabepilone With Famotidine or Food||0
264693|NCT00422097|641595|P1|STARTED|Ixabepilone With Famotidine or Food||0
264694|NCT00422097|641588|P8|NOT COMPLETED|Dose Level 6||0
264695|NCT00422097|641589|P7|NOT COMPLETED|Dose Level 6||0
264696|NCT00422097|641590|P6|NOT COMPLETED|Dose Level 6||0
264697|NCT00422097|641591|P5|NOT COMPLETED|Dose Level 6||0
264698|NCT00422097|641592|P4|NOT COMPLETED|Dose Level 6||0
264699|NCT00422097|641593|P3|NOT COMPLETED|Dose Level 6||0
264700|NCT00422097|641594|P2|NOT COMPLETED|Dose Level 6||0
264701|NCT00422097|641595|P1|NOT COMPLETED|Dose Level 6||0
264702|NCT00422097|641588|P8|COMPLETED|Dose Level 6||0
264703|NCT00422097|641589|P7|COMPLETED|Dose Level 6||0
264704|NCT00422097|641590|P6|COMPLETED|Dose Level 6||6
264705|NCT00422097|641591|P5|COMPLETED|Dose Level 6||0
264706|NCT00422097|641592|P4|COMPLETED|Dose Level 6||0
264707|NCT00422097|641593|P3|COMPLETED|Dose Level 6||0
264708|NCT00422097|641594|P2|COMPLETED|Dose Level 6||0
264709|NCT00422097|641595|P1|COMPLETED|Dose Level 6||0
264710|NCT00422097|641588|P8|STARTED|Dose Level 6||0
264711|NCT00422097|641589|P7|STARTED|Dose Level 6||0
264712|NCT00422097|641590|P6|STARTED|Dose Level 6||6
264713|NCT00422097|641591|P5|STARTED|Dose Level 6||0
264714|NCT00422097|641592|P4|STARTED|Dose Level 6||0
264715|NCT00422097|641593|P3|STARTED|Dose Level 6||0
264716|NCT00422097|641594|P2|STARTED|Dose Level 6||0
264717|NCT00422097|641595|P1|STARTED|Dose Level 6||0
264718|NCT00422097|641588|P8|NOT COMPLETED|Dose Level 5||0
264719|NCT00422097|641589|P7|NOT COMPLETED|Dose Level 5||0
264720|NCT00422097|641590|P6|NOT COMPLETED|Dose Level 5||0
264721|NCT00422097|641591|P5|NOT COMPLETED|Dose Level 5||0
264722|NCT00422097|641592|P4|NOT COMPLETED|Dose Level 5||0
264723|NCT00422097|641593|P3|NOT COMPLETED|Dose Level 5||0
264724|NCT00422097|641594|P2|NOT COMPLETED|Dose Level 5||0
264725|NCT00422097|641595|P1|NOT COMPLETED|Dose Level 5||0
264726|NCT00422097|641588|P8|COMPLETED|Dose Level 5||0
264727|NCT00422097|641589|P7|COMPLETED|Dose Level 5||0
264728|NCT00422097|641590|P6|COMPLETED|Dose Level 5||0
264729|NCT00422097|641591|P5|COMPLETED|Dose Level 5||23
264730|NCT00422097|641592|P4|COMPLETED|Dose Level 5||0
264731|NCT00422097|641593|P3|COMPLETED|Dose Level 5||0
264732|NCT00422097|641594|P2|COMPLETED|Dose Level 5||0
264733|NCT00422097|641595|P1|COMPLETED|Dose Level 5||0
264734|NCT00422097|641588|P8|STARTED|Dose Level 5||0
264735|NCT00422097|641589|P7|STARTED|Dose Level 5||0
264736|NCT00422097|641590|P6|STARTED|Dose Level 5||0
264737|NCT00422097|641591|P5|STARTED|Dose Level 5||23
264738|NCT00422097|641592|P4|STARTED|Dose Level 5||0
264739|NCT00422097|641593|P3|STARTED|Dose Level 5||0
264740|NCT00422097|641594|P2|STARTED|Dose Level 5||0
264741|NCT00422097|641595|P1|STARTED|Dose Level 5||0
264742|NCT00422097|641588|P8|NOT COMPLETED|Dose Level 4||0
264743|NCT00422097|641589|P7|NOT COMPLETED|Dose Level 4||0
264744|NCT00422097|641590|P6|NOT COMPLETED|Dose Level 4||0
264745|NCT00422097|641591|P5|NOT COMPLETED|Dose Level 4||0
264746|NCT00422097|641592|P4|NOT COMPLETED|Dose Level 4||0
264747|NCT00422097|641593|P3|NOT COMPLETED|Dose Level 4||0
264748|NCT00422097|641594|P2|NOT COMPLETED|Dose Level 4||0
264749|NCT00422097|641595|P1|NOT COMPLETED|Dose Level 4||0
264750|NCT00422097|641588|P8|COMPLETED|Dose Level 4||0
264751|NCT00422097|641589|P7|COMPLETED|Dose Level 4||0
264752|NCT00422097|641590|P6|COMPLETED|Dose Level 4||0
264753|NCT00422097|641591|P5|COMPLETED|Dose Level 4||0
264754|NCT00422097|641592|P4|COMPLETED|Dose Level 4||3
264755|NCT00422097|641593|P3|COMPLETED|Dose Level 4||0
264756|NCT00422097|641594|P2|COMPLETED|Dose Level 4||0
264757|NCT00422097|641595|P1|COMPLETED|Dose Level 4||0
264758|NCT00422097|641588|P8|STARTED|Dose Level 4||0
264759|NCT00422097|641589|P7|STARTED|Dose Level 4||0
264760|NCT00422097|641590|P6|STARTED|Dose Level 4||0
264761|NCT00422097|641591|P5|STARTED|Dose Level 4||0
264762|NCT00422097|641592|P4|STARTED|Dose Level 4||3
264763|NCT00422097|641593|P3|STARTED|Dose Level 4||0
264764|NCT00422097|641594|P2|STARTED|Dose Level 4||0
264765|NCT00422097|641595|P1|STARTED|Dose Level 4||0
264766|NCT00422097|641588|P8|NOT COMPLETED|Dose Level 3||0
264767|NCT00422097|641589|P7|NOT COMPLETED|Dose Level 3||0
264768|NCT00422097|641590|P6|NOT COMPLETED|Dose Level 3||0
264769|NCT00422097|641591|P5|NOT COMPLETED|Dose Level 3||0
264770|NCT00422097|641592|P4|NOT COMPLETED|Dose Level 3||0
264771|NCT00422097|641593|P3|NOT COMPLETED|Dose Level 3||0
264772|NCT00422097|641594|P2|NOT COMPLETED|Dose Level 3||0
264773|NCT00422097|641595|P1|NOT COMPLETED|Dose Level 3||0
264774|NCT00422097|641588|P8|COMPLETED|Dose Level 3||0
264775|NCT00422097|641589|P7|COMPLETED|Dose Level 3||0
264776|NCT00422097|641590|P6|COMPLETED|Dose Level 3||0
264777|NCT00422097|641591|P5|COMPLETED|Dose Level 3||0
264778|NCT00422097|641592|P4|COMPLETED|Dose Level 3||0
264781|NCT00422097|641595|P1|COMPLETED|Dose Level 3||0
264782|NCT00422097|641588|P8|STARTED|Dose Level 3||0
264783|NCT00422097|641589|P7|STARTED|Dose Level 3||0
264784|NCT00422097|641590|P6|STARTED|Dose Level 3||0
264785|NCT00422097|641591|P5|STARTED|Dose Level 3||0
264786|NCT00422097|641592|P4|STARTED|Dose Level 3||0
264787|NCT00422097|641593|P3|STARTED|Dose Level 3||3
264788|NCT00422097|641594|P2|STARTED|Dose Level 3||0
264789|NCT00422097|641595|P1|STARTED|Dose Level 3||0
264790|NCT00422097|641588|P8|NOT COMPLETED|Dose Level 2||0
264791|NCT00422097|641589|P7|NOT COMPLETED|Dose Level 2||0
264792|NCT00422097|641590|P6|NOT COMPLETED|Dose Level 2||0
264793|NCT00422097|641591|P5|NOT COMPLETED|Dose Level 2||0
264794|NCT00422097|641592|P4|NOT COMPLETED|Dose Level 2||0
264795|NCT00422097|641593|P3|NOT COMPLETED|Dose Level 2||0
264796|NCT00422097|641594|P2|NOT COMPLETED|Dose Level 2||1
264797|NCT00422097|641595|P1|NOT COMPLETED|Dose Level 2||0
264798|NCT00422097|641588|P8|COMPLETED|Dose Level 2||0
264799|NCT00422097|641589|P7|COMPLETED|Dose Level 2||0
264800|NCT00422097|641590|P6|COMPLETED|Dose Level 2||0
264801|NCT00422097|641591|P5|COMPLETED|Dose Level 2||0
264802|NCT00422097|641592|P4|COMPLETED|Dose Level 2||0
264803|NCT00422097|641593|P3|COMPLETED|Dose Level 2||0
264804|NCT00422097|641594|P2|COMPLETED|Dose Level 2||5
264805|NCT00422097|641595|P1|COMPLETED|Dose Level 2||0
264806|NCT00422097|641588|P8|STARTED|Dose Level 2||0
264807|NCT00422097|641589|P7|STARTED|Dose Level 2||0
264808|NCT00422097|641590|P6|STARTED|Dose Level 2||0
264809|NCT00422097|641591|P5|STARTED|Dose Level 2||0
264810|NCT00422097|641592|P4|STARTED|Dose Level 2||0
264811|NCT00422097|641593|P3|STARTED|Dose Level 2||0
264812|NCT00422097|641594|P2|STARTED|Dose Level 2||6
264813|NCT00422097|641595|P1|STARTED|Dose Level 2||0
264814|NCT00422097|641588|P8|NOT COMPLETED|Dose Level 1||0
264815|NCT00422097|641589|P7|NOT COMPLETED|Dose Level 1||0
264816|NCT00422097|641590|P6|NOT COMPLETED|Dose Level 1||0
264817|NCT00422097|641591|P5|NOT COMPLETED|Dose Level 1||0
264818|NCT00422097|641592|P4|NOT COMPLETED|Dose Level 1||0
264819|NCT00422097|641593|P3|NOT COMPLETED|Dose Level 1||0
264820|NCT00422097|641594|P2|NOT COMPLETED|Dose Level 1||0
264821|NCT00422097|641595|P1|NOT COMPLETED|Dose Level 1||0
264822|NCT00422097|641588|P8|COMPLETED|Dose Level 1||0
264823|NCT00422097|641589|P7|COMPLETED|Dose Level 1||0
264824|NCT00422097|641590|P6|COMPLETED|Dose Level 1||0
264825|NCT00422097|641591|P5|COMPLETED|Dose Level 1||0
264826|NCT00422097|641592|P4|COMPLETED|Dose Level 1||0
264827|NCT00422097|641593|P3|COMPLETED|Dose Level 1||0
264828|NCT00422097|641594|P2|COMPLETED|Dose Level 1||0
264829|NCT00422097|641595|P1|COMPLETED|Dose Level 1||3
264830|NCT00422097|641588|P8|STARTED|Dose Level 1||0
264831|NCT00422097|641589|P7|STARTED|Dose Level 1||0
264832|NCT00422097|641590|P6|STARTED|Dose Level 1||0
264833|NCT00422097|641591|P5|STARTED|Dose Level 1||0
264834|NCT00422097|641592|P4|STARTED|Dose Level 1||0
264835|NCT00422097|641593|P3|STARTED|Dose Level 1||0
264836|NCT00422097|641594|P2|STARTED|Dose Level 1||0
264837|NCT00422097|641595|P1|STARTED|Dose Level 1||3
264838|NCT00422058|641660|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
264839|NCT00422058|641661|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
264840|NCT00422058|641662|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
264841|NCT00422058|641663|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
264842|NCT00422058|641664|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
264843|NCT00422058|641665|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
264844|NCT00422058|641660|P6|COMPLETED|Open-Label Extension, Week 20-104||45
264845|NCT00422058|641661|P5|COMPLETED|Open-Label Extension, Week 20-104||47
264846|NCT00422058|641662|P4|COMPLETED|Open-Label Extension, Week 20-104||45
264847|NCT00422058|641663|P3|COMPLETED|Open-Label Extension, Week 20-104||38
264848|NCT00422058|641664|P2|COMPLETED|Open-Label Extension, Week 20-104||46
264849|NCT00422058|641665|P1|COMPLETED|Open-Label Extension, Week 20-104||47
264850|NCT00422058|641660|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
264851|NCT00422058|641661|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
264852|NCT00422058|641662|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
264853|NCT00422058|641663|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
264854|NCT00422058|641664|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
264855|NCT00422058|641665|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
264856|NCT00422058|641660|P6|STARTED|Open-Label Extension, Week 20-104||79
264857|NCT00422058|641661|P5|STARTED|Open-Label Extension, Week 20-104||82
264858|NCT00422058|641662|P4|STARTED|Open-Label Extension, Week 20-104||73
264859|NCT00422058|641663|P3|STARTED|Open-Label Extension, Week 20-104||74
264860|NCT00422058|641664|P2|STARTED|Open-Label Extension, Week 20-104||85
264861|NCT00422058|641665|P1|STARTED|Open-Label Extension, Week 20-104||79
264862|NCT00422058|641660|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
264863|NCT00422058|641661|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
264864|NCT00422058|641662|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
264865|NCT00422058|641663|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
264866|NCT00422058|641664|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
264867|NCT00422058|641665|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
264868|NCT00422058|641660|P6|COMPLETED|Double-Blind, Week 0-20||79
264869|NCT00422058|641661|P5|COMPLETED|Double-Blind, Week 0-20||82
264870|NCT00422058|641662|P4|COMPLETED|Double-Blind, Week 0-20||73
264871|NCT00422058|641663|P3|COMPLETED|Double-Blind, Week 0-20||74
264872|NCT00422058|641664|P2|COMPLETED|Double-Blind, Week 0-20||85
264873|NCT00422058|641665|P1|COMPLETED|Double-Blind, Week 0-20||79
264874|NCT00422058|641660|P6|STARTED|Double-Blind, Week 0-20||95
264875|NCT00422058|641661|P5|STARTED|Double-Blind, Week 0-20||93
264876|NCT00422058|641662|P4|STARTED|Double-Blind, Week 0-20||93
264877|NCT00422058|641663|P3|STARTED|Double-Blind, Week 0-20||90
264878|NCT00422058|641664|P2|STARTED|Double-Blind, Week 0-20||95
264879|NCT00422058|641665|P1|STARTED|Double-Blind, Week 0-20||98
264880|NCT00422032|641795|P2|NOT COMPLETED|Overall Study||0
264881|NCT00422032|641796|P1|NOT COMPLETED|Overall Study||0
264882|NCT00422032|641795|P2|COMPLETED|Overall Study||21
264883|NCT00422032|641796|P1|COMPLETED|Overall Study||37
264884|NCT00422032|641795|P2|STARTED|Overall Study||21
264885|NCT00422032|641796|P1|STARTED|Overall Study||37
264886|NCT00421993|641806|P4|NOT COMPLETED|Overall Study||57
264887|NCT00421993|641807|P3|NOT COMPLETED|Overall Study||52
264888|NCT00421993|641808|P2|NOT COMPLETED|Overall Study||49
264889|NCT00421993|641809|P1|NOT COMPLETED|Overall Study||53
264890|NCT00421993|641806|P4|COMPLETED|Overall Study||361
264891|NCT00421993|641807|P3|COMPLETED|Overall Study||363
264892|NCT00421993|641808|P2|COMPLETED|Overall Study||369
264893|NCT00421993|641809|P1|COMPLETED|Overall Study||366
264894|NCT00421993|641806|P4|STARTED|Overall Study||418
264895|NCT00421993|641807|P3|STARTED|Overall Study||415
264896|NCT00421993|641808|P2|STARTED|Overall Study||418
264897|NCT00421993|641809|P1|STARTED|Overall Study||419
264898|NCT00421954|641839|P1|NOT COMPLETED|Overall Study||0
264899|NCT00421954|641839|P1|COMPLETED|Overall Study||0
264900|NCT00421954|641839|P1|STARTED|Overall Study||0
264901|NCT00421928|641846|P3|NOT COMPLETED|Overall Study||134
264902|NCT00421928|641847|P2|NOT COMPLETED|Overall Study||224
264903|NCT00421928|641848|P1|NOT COMPLETED|Overall Study||163
264904|NCT00421928|641846|P3|COMPLETED|Overall Study||203
264905|NCT00421928|641847|P2|COMPLETED|Overall Study||118
264906|NCT00421928|641848|P1|COMPLETED|Overall Study||181
264907|NCT00421928|641846|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
264908|NCT00421928|641847|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
264909|NCT00421928|641848|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
264910|NCT00421889|641883|P9|NOT COMPLETED|Overall Study||11
264911|NCT00421889|641884|P8|NOT COMPLETED|Overall Study||2
264912|NCT00421889|641885|P7|NOT COMPLETED|Overall Study||4
264913|NCT00421889|641886|P6|NOT COMPLETED|Overall Study||35
264914|NCT00421889|641887|P5|NOT COMPLETED|Overall Study||6
264915|NCT00421889|641888|P4|NOT COMPLETED|Overall Study||4
264916|NCT00421889|641889|P3|NOT COMPLETED|Overall Study||3
264917|NCT00421889|641890|P2|NOT COMPLETED|Overall Study||5
264918|NCT00421889|641891|P1|NOT COMPLETED|Overall Study||5
264919|NCT00421889|641883|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
264920|NCT00421889|641884|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
264921|NCT00421889|641885|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
264922|NCT00421889|641886|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
264923|NCT00421889|641887|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
264924|NCT00421889|641888|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
264925|NCT00421889|641889|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
264926|NCT00421889|641890|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
264927|NCT00421889|641891|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
264928|NCT00421889|641883|P9|STARTED|Overall Study||15
264929|NCT00421889|641884|P8|STARTED|Overall Study||3
264930|NCT00421889|641885|P7|STARTED|Overall Study||4
264931|NCT00421889|641886|P6|STARTED|Overall Study||35
264932|NCT00421889|641887|P5|STARTED|Overall Study||6
264933|NCT00421889|641888|P4|STARTED|Overall Study||4
264934|NCT00421889|641889|P3|STARTED|Overall Study||3
264935|NCT00421889|641890|P2|STARTED|Overall Study||5
264936|NCT00421889|641891|P1|STARTED|Overall Study||5
264937|NCT00421733|641936|P3|NOT COMPLETED|Overall Study||20
264938|NCT00421733|641937|P2|NOT COMPLETED|Overall Study||26
264939|NCT00421733|641938|P1|NOT COMPLETED|Overall Study||15
264940|NCT00421733|641936|P3|COMPLETED|Overall Study||73
264941|NCT00421733|641937|P2|COMPLETED|Overall Study||69
264942|NCT00421733|641938|P1|COMPLETED|Overall Study||78
264943|NCT00421733|641936|P3|STARTED|Overall Study||93
264944|NCT00421733|641937|P2|STARTED|Overall Study||95
264945|NCT00421733|641938|P1|STARTED|Overall Study||93
264946|NCT00421707|641958|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
264947|NCT00421707|641959|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
264948|NCT00421707|641958|P2|COMPLETED|Period 3:Treatment Period 2||49
264949|NCT00421707|641959|P1|COMPLETED|Period 3:Treatment Period 2||53
264950|NCT00421707|641958|P2|STARTED|Period 3:Treatment Period 2||52
264951|NCT00421707|641959|P1|STARTED|Period 3:Treatment Period 2||55
264952|NCT00421707|641958|P2|NOT COMPLETED|Period 2: Washout||4
264953|NCT00421707|641959|P1|NOT COMPLETED|Period 2: Washout||1
264954|NCT00421707|641958|P2|COMPLETED|Period 2: Washout||52
264955|NCT00421707|641959|P1|COMPLETED|Period 2: Washout||55
264956|NCT00421707|641958|P2|STARTED|Period 2: Washout||56
264957|NCT00421707|641959|P1|STARTED|Period 2: Washout||56
264958|NCT00421707|641958|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
264959|NCT00421707|641959|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
264960|NCT00421707|641958|P2|COMPLETED|Period 1: Treatment Period 1||56
264961|NCT00421707|641959|P1|COMPLETED|Period 1: Treatment Period 1||56
264962|NCT00421707|641958|P2|STARTED|Period 1: Treatment Period 1||65
264963|NCT00421707|641959|P1|STARTED|Period 1: Treatment Period 1||67
264964|NCT00421603|642001|P2|NOT COMPLETED|Overall Study||12
264965|NCT00421603|642002|P1|NOT COMPLETED|Overall Study||11
264966|NCT00421603|642001|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
264967|NCT00421603|642002|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
264968|NCT00421603|642001|P2|STARTED|Overall Study||42
264969|NCT00421603|642002|P1|STARTED|Overall Study||39
264970|NCT00421408|642010|P2|NOT COMPLETED|Overall Study||45
264971|NCT00421408|642011|P1|NOT COMPLETED|Overall Study||42
264972|NCT00421408|642010|P2|COMPLETED|Overall Study||61
264973|NCT00421408|642011|P1|COMPLETED|Overall Study||60
264974|NCT00421408|642010|P2|STARTED|Overall Study||106
264975|NCT00421408|642011|P1|STARTED|Overall Study||102
264976|NCT00421343|642029|P1|NOT COMPLETED|Overall Study||6
264977|NCT00421343|642029|P1|COMPLETED|Overall Study||23
264978|NCT00421343|642029|P1|STARTED|Overall Study||29
264979|NCT00421174|642035|P2|NOT COMPLETED|Overall Study||1
264980|NCT00421174|642036|P1|NOT COMPLETED|Overall Study||2
264981|NCT00421174|642035|P2|COMPLETED|Overall Study||18
264982|NCT00421174|642036|P1|COMPLETED|Overall Study||16
264983|NCT00421174|642035|P2|STARTED|Overall Study||19
264984|NCT00421174|642036|P1|STARTED|Overall Study||18
264985|NCT00420992|642066|P2|NOT COMPLETED|Maintenance Phase||75
264986|NCT00420992|642067|P1|NOT COMPLETED|Maintenance Phase||61
264987|NCT00420992|642066|P2|COMPLETED|Maintenance Phase||98
264988|NCT00420992|642067|P1|COMPLETED|Maintenance Phase||110
264989|NCT00420992|642066|P2|STARTED|Maintenance Phase||173
264990|NCT00420992|642067|P1|STARTED|Maintenance Phase||171
264991|NCT00420992|642066|P2|NOT COMPLETED|Titration Phase||0
264992|NCT00420992|642067|P1|NOT COMPLETED|Titration Phase||203
264993|NCT00420992|642066|P2|COMPLETED|Titration Phase||0
264994|NCT00420992|642067|P1|COMPLETED|Titration Phase||344
264995|NCT00420992|642066|P2|STARTED|Titration Phase||0
264996|NCT00420992|642067|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
264997|NCT00420927|642081|P7|NOT COMPLETED|Period 2||53
264998|NCT00420927|642082|P6|NOT COMPLETED|Period 2||15
264999|NCT00420927|642083|P5|NOT COMPLETED|Period 2||43
265000|NCT00420927|642084|P4|NOT COMPLETED|Period 2||10
265001|NCT00420927|642085|P3|NOT COMPLETED|Period 2||13
265002|NCT00420927|642086|P2|NOT COMPLETED|Period 2||0
265003|NCT00420927|642087|P1|NOT COMPLETED|Period 2||0
265004|NCT00420927|642081|P7|COMPLETED|Period 2||295
265005|NCT00420927|642082|P6|COMPLETED|Period 2||97
265006|NCT00420927|642083|P5|COMPLETED|Period 2||216
265007|NCT00420927|642084|P4|COMPLETED|Period 2||95
265008|NCT00420927|642085|P3|COMPLETED|Period 2||89
265009|NCT00420927|642086|P2|COMPLETED|Period 2||0
265010|NCT00420927|642087|P1|COMPLETED|Period 2||0
265011|NCT00420927|642081|P7|STARTED|Period 2||348
265012|NCT00420927|642082|P6|STARTED|Period 2||112
265013|NCT00420927|642083|P5|STARTED|Period 2||259
265014|NCT00420927|642084|P4|STARTED|Period 2||105
265015|NCT00420927|642085|P3|STARTED|Period 2||102
265016|NCT00420927|642086|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
265017|NCT00420927|642087|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
265018|NCT00420927|642081|P7|NOT COMPLETED|Period 1||0
265019|NCT00420927|642082|P6|NOT COMPLETED|Period 1||0
265020|NCT00420927|642083|P5|NOT COMPLETED|Period 1||0
265021|NCT00420927|642084|P4|NOT COMPLETED|Period 1||0
265022|NCT00420927|642085|P3|NOT COMPLETED|Period 1||0
265023|NCT00420927|642086|P2|NOT COMPLETED|Period 1||57
265024|NCT00420927|642087|P1|NOT COMPLETED|Period 1||49
265025|NCT00420927|642081|P7|COMPLETED|Period 1||0
265026|NCT00420927|642082|P6|COMPLETED|Period 1||0
265027|NCT00420927|642083|P5|COMPLETED|Period 1||0
265028|NCT00420927|642084|P4|COMPLETED|Period 1||0
265029|NCT00420927|642085|P3|COMPLETED|Period 1||0
265030|NCT00420927|642086|P2|COMPLETED|Period 1||460
265031|NCT00420927|642087|P1|COMPLETED|Period 1||466
265032|NCT00420927|642081|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
265033|NCT00420927|642082|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
265034|NCT00420927|642083|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
265035|NCT00420927|642084|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
265036|NCT00420927|642085|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
265037|NCT00420927|642086|P2|STARTED|Period 1||517
265038|NCT00420927|642087|P1|STARTED|Period 1||515
265039|NCT00420849|642191|P1|NOT COMPLETED|Overall Study||331
265040|NCT00420849|642191|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
265041|NCT00420849|642191|P1|STARTED|Overall Study||587
265042|NCT00420784|642260|P4|NOT COMPLETED|Overall Study||78
265043|NCT00420784|642261|P3|NOT COMPLETED|Overall Study||53
265044|NCT00420784|642262|P2|NOT COMPLETED|Overall Study||58
265045|NCT00420784|642263|P1|NOT COMPLETED|Overall Study||29
265046|NCT00420784|642260|P4|COMPLETED|Overall Study||36
265047|NCT00420784|642261|P3|COMPLETED|Overall Study||58
265048|NCT00420784|642262|P2|COMPLETED|Overall Study||55
265049|NCT00420784|642263|P1|COMPLETED|Overall Study||86
265050|NCT00420784|642260|P4|STARTED|Overall Study||114
265051|NCT00420784|642261|P3|STARTED|Overall Study||111
265052|NCT00420784|642262|P2|STARTED|Overall Study||113
265053|NCT00420784|642263|P1|STARTED|Overall Study||115
265054|NCT00420745|642292|P2|NOT COMPLETED|Overall Study||6
265055|NCT00420745|642293|P1|NOT COMPLETED|Overall Study||15
265056|NCT00420745|642292|P2|COMPLETED|Overall Study||333
265057|NCT00420745|642293|P1|COMPLETED|Overall Study||655
265058|NCT00420745|642292|P2|STARTED|Overall Study||339
265059|NCT00420745|642293|P1|STARTED|Overall Study||670
265060|NCT00420641|642312|P3|NOT COMPLETED|Overall Study||44
265061|NCT00420641|642313|P2|NOT COMPLETED|Overall Study||72
265062|NCT00420641|642314|P1|NOT COMPLETED|Overall Study||45
265063|NCT00420641|642312|P3|COMPLETED|Overall Study||128
265064|NCT00420641|642313|P2|COMPLETED|Overall Study||100
265065|NCT00420641|642314|P1|COMPLETED|Overall Study||115
265066|NCT00420641|642312|P3|STARTED|Overall Study||172
265067|NCT00420641|642313|P2|STARTED|Overall Study||172
265068|NCT00420641|642314|P1|STARTED|Overall Study||160
265069|NCT00420628|642390|P2|NOT COMPLETED|Overall Study||4
265070|NCT00420628|642391|P1|NOT COMPLETED|Overall Study||9
265071|NCT00420628|642390|P2|COMPLETED|Overall Study||32
265072|NCT00420628|642391|P1|COMPLETED|Overall Study||63
265073|NCT00420628|642390|P2|STARTED|Overall Study||36
265074|NCT00420628|642391|P1|STARTED|Overall Study||72
265075|NCT00420511|642407|P2|NOT COMPLETED|Overall Study||1
265076|NCT00420511|642408|P1|NOT COMPLETED|Overall Study||2
265077|NCT00420511|642407|P2|COMPLETED|Overall Study||10
265078|NCT00420511|642408|P1|COMPLETED|Overall Study||8
265079|NCT00420511|642407|P2|STARTED|Overall Study||11
265080|NCT00420511|642408|P1|STARTED|Overall Study||10
265081|NCT00420459|642418|P1|NOT COMPLETED|Overall Study||0
265082|NCT00420459|642418|P1|COMPLETED|Overall Study||12
265083|NCT00420459|642418|P1|STARTED|Overall Study||12
265084|NCT00420420|642429|P2|NOT COMPLETED|Overall Study||4
265085|NCT00420420|642430|P1|NOT COMPLETED|Overall Study||8
265086|NCT00420420|642429|P2|COMPLETED|Overall Study||67
265087|NCT00420420|642430|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
265088|NCT00420420|642429|P2|STARTED|Overall Study|Number of patients randomized.|71
265089|NCT00420420|642430|P1|STARTED|Overall Study|Number of patients randomized.|73
265090|NCT00420407|642448|P2|NOT COMPLETED|Overall Study||6
265091|NCT00420407|642449|P1|NOT COMPLETED|Overall Study||4
265092|NCT00420407|642448|P2|COMPLETED|Overall Study||34
265093|NCT00420407|642449|P1|COMPLETED|Overall Study||37
265094|NCT00420407|642448|P2|STARTED|Overall Study||40
265095|NCT00420407|642449|P1|STARTED|Overall Study||41
265096|NCT00420342|642458|P3|NOT COMPLETED|Overall Study||1
265097|NCT00420342|642459|P2|NOT COMPLETED|Overall Study||2
265098|NCT00420342|642460|P1|NOT COMPLETED|Overall Study||1
265099|NCT00420342|642458|P3|COMPLETED|Overall Study||28
265100|NCT00420342|642459|P2|COMPLETED|Overall Study||31
265101|NCT00420342|642460|P1|COMPLETED|Overall Study||29
265102|NCT00420342|642458|P3|Received Treatment|Overall Study||29
265103|NCT00420342|642459|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
265104|NCT00420342|642460|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
265105|NCT00420342|642458|P3|STARTED|Overall Study||29
265106|NCT00420342|642459|P2|STARTED|Overall Study||33
265107|NCT00420342|642460|P1|STARTED|Overall Study||30
265108|NCT00420316|642503|P2|NOT COMPLETED|Overall Study||9
265109|NCT00420316|642504|P1|NOT COMPLETED|Overall Study||12
265110|NCT00420316|642503|P2|COMPLETED|Overall Study||522
265111|NCT00420316|642504|P1|COMPLETED|Overall Study||1070
265112|NCT00420316|642503|P2|STARTED|Overall Study||531
265113|NCT00420316|642504|P1|STARTED|Overall Study||1082
265114|NCT00420303|642528|P2|NOT COMPLETED|Overall Study||4
265115|NCT00420303|642529|P1|NOT COMPLETED|Overall Study||1
265116|NCT00420303|642528|P2|COMPLETED|Overall Study||8
265117|NCT00420303|642529|P1|COMPLETED|Overall Study||11
265118|NCT00420303|642528|P2|STARTED|Overall Study||12
265119|NCT00420303|642529|P1|STARTED|Overall Study||12
265120|NCT00420290|642541|P2|NOT COMPLETED|Overall Study||4
265121|NCT00420290|642542|P1|NOT COMPLETED|Overall Study||4
265122|NCT00420290|642541|P2|COMPLETED|Overall Study||7
265123|NCT00420290|642542|P1|COMPLETED|Overall Study||7
265124|NCT00420290|642541|P2|STARTED|Overall Study||11
265125|NCT00420290|642542|P1|STARTED|Overall Study||11
265126|NCT00420238|642558|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
265127|NCT00420238|642559|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
265128|NCT00420238|642558|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
265129|NCT00420238|642559|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
265130|NCT00420238|642558|P2|STARTED|12 Week Open-Label Treatment Period 2||39
265131|NCT00420238|642559|P1|STARTED|12 Week Open-Label Treatment Period 2||38
265132|NCT00420238|642558|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
265133|NCT00420238|642559|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
265134|NCT00420238|642558|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
265135|NCT00420238|642559|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
265136|NCT00420238|642558|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
265137|NCT00420238|642559|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
265138|NCT00420212|642698|P3|NOT COMPLETED|Overall Study||96
265139|NCT00420212|642699|P2|NOT COMPLETED|Overall Study||95
265140|NCT00420212|642700|P1|NOT COMPLETED|Overall Study||91
265141|NCT00420212|642698|P3|COMPLETED|Overall Study||320
265142|NCT00420212|642699|P2|COMPLETED|Overall Study||315
265143|NCT00420212|642700|P1|COMPLETED|Overall Study||317
265144|NCT00420212|642698|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
265145|NCT00420212|642699|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
265146|NCT00420212|642700|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
265147|NCT00420199|642726|P2|NOT COMPLETED|Overall Study||0
265148|NCT00420199|642727|P1|NOT COMPLETED|Overall Study||1
265149|NCT00420199|642726|P2|COMPLETED|Overall Study||23
265150|NCT00420199|642727|P1|COMPLETED|Overall Study||26
265151|NCT00420199|642726|P2|STARTED|Overall Study||23
265152|NCT00420199|642727|P1|STARTED|Overall Study||27
265153|NCT00420147|642782|P2|NOT COMPLETED|Overall Study||0
265154|NCT00420147|642783|P1|NOT COMPLETED|Overall Study||0
265155|NCT00420147|642782|P2|COMPLETED|Overall Study||19
265156|NCT00420147|642783|P1|COMPLETED|Overall Study||19
265157|NCT00420147|642782|P2|STARTED|Overall Study||19
265158|NCT00420147|642783|P1|STARTED|Overall Study||19
265159|NCT00420095|642793|P2|NOT COMPLETED|Overall Study||1
265160|NCT00420095|642794|P1|NOT COMPLETED|Overall Study||3
265161|NCT00420095|642793|P2|COMPLETED|Overall Study||59
265162|NCT00420095|642794|P1|COMPLETED|Overall Study||54
265163|NCT00420095|642793|P2|STARTED|Overall Study||60
265164|NCT00420095|642794|P1|STARTED|Overall Study||57
265165|NCT00420056|642812|P1|NOT COMPLETED|Overall Study||17
265166|NCT00420056|642812|P1|COMPLETED|Overall Study||0
265167|NCT00420056|642812|P1|STARTED|Overall Study||17
265168|NCT00420017|642836|P2|NOT COMPLETED|Overall Study||0
265169|NCT00420017|642837|P1|NOT COMPLETED|Overall Study||2
265170|NCT00420017|642836|P2|COMPLETED|Overall Study||40
265171|NCT00420017|642837|P1|COMPLETED|Overall Study|40 completed analysis|38
265172|NCT00420017|642836|P2|STARTED|Overall Study||40
265173|NCT00420017|642837|P1|STARTED|Overall Study||40
265174|NCT00420004|642852|P3|NOT COMPLETED|Overall Study||32
265175|NCT00420004|642853|P2|NOT COMPLETED|Overall Study||71
265176|NCT00420004|642854|P1|NOT COMPLETED|Overall Study||129
265177|NCT00420004|642852|P3|COMPLETED|Overall Study||30
265178|NCT00420004|642853|P2|COMPLETED|Overall Study||67
265179|NCT00420004|642854|P1|COMPLETED|Overall Study||140
265180|NCT00420004|642852|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
265181|NCT00420004|642853|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
265182|NCT00420004|642854|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
265183|NCT00420004|642852|P3|STARTED|Overall Study||62
265184|NCT00420004|642853|P2|STARTED|Overall Study||138
265185|NCT00420004|642854|P1|STARTED|Overall Study||269
265186|NCT00419952|642919|P2|NOT COMPLETED|Overall Study||125
265187|NCT00419952|642920|P1|NOT COMPLETED|Overall Study||149
265188|NCT00419952|642919|P2|COMPLETED|Overall Study||240
265189|NCT00419952|642920|P1|COMPLETED|Overall Study||228
265190|NCT00419952|642919|P2|STARTED|Overall Study||365
265191|NCT00419952|642920|P1|STARTED|Overall Study||377
265192|NCT00419926|642954|P2|NOT COMPLETED|Overall Study||10
265193|NCT00419926|642955|P1|NOT COMPLETED|Overall Study||14
265194|NCT00419926|642954|P2|COMPLETED|Overall Study||148
265195|NCT00419926|642955|P1|COMPLETED|Overall Study||141
265196|NCT00419926|642954|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
265197|NCT00419926|642955|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
265198|NCT00419770|642971|P2|NOT COMPLETED|Overall Study||1
265199|NCT00419770|642972|P1|NOT COMPLETED|Overall Study||5
265200|NCT00419770|642971|P2|COMPLETED|Overall Study||8
265201|NCT00419770|642972|P1|COMPLETED|Overall Study||6
265202|NCT00419770|642971|P2|STARTED|Overall Study||9
265203|NCT00419770|642972|P1|STARTED|Overall Study||11
265204|NCT00419757|642980|P2|NOT COMPLETED|Overall Study||21
265205|NCT00419757|642981|P1|NOT COMPLETED|Overall Study||18
265206|NCT00419757|642980|P2|COMPLETED|Overall Study|Randomized patients|102
265207|NCT00419757|642981|P1|COMPLETED|Overall Study|Randomized patients|109
265208|NCT00419757|642980|P2|STARTED|Overall Study|Randomized patients|123
265209|NCT00419757|642981|P1|STARTED|Overall Study|Randomized patients|127
265210|NCT00419744|643020|P3|NOT COMPLETED|Overall Study||133
265211|NCT00419744|643021|P2|NOT COMPLETED|Overall Study||118
265212|NCT00419744|643022|P1|NOT COMPLETED|Overall Study||117
265213|NCT00419744|643020|P3|COMPLETED|Overall Study||271
265214|NCT00419744|643021|P2|COMPLETED|Overall Study||290
265215|NCT00419744|643022|P1|COMPLETED|Overall Study||290
265216|NCT00419744|643020|P3|STARTED|Overall Study||404
265217|NCT00419744|643021|P2|STARTED|Overall Study||408
265218|NCT00419744|643022|P1|STARTED|Overall Study||407
265219|NCT00419445|643054|P3|NOT COMPLETED|Overall Study||1
265220|NCT00419445|643055|P2|NOT COMPLETED|Overall Study||2
265221|NCT00419445|643056|P1|NOT COMPLETED|Overall Study||1
265222|NCT00419445|643054|P3|COMPLETED|Overall Study||7
265223|NCT00419445|643055|P2|COMPLETED|Overall Study||14
265224|NCT00419445|643056|P1|COMPLETED|Overall Study||7
265225|NCT00419445|643054|P3|STARTED|Overall Study||8
265226|NCT00419445|643055|P2|STARTED|Overall Study||16
265227|NCT00419445|643056|P1|STARTED|Overall Study||8
265228|NCT00419393|643064|P1|NOT COMPLETED|Overall Study||24
265229|NCT00419393|643064|P1|COMPLETED|Overall Study||166
265230|NCT00419393|643064|P1|STARTED|Overall Study|One subject did not receive medication|190
265231|NCT00419380|643074|P2|NOT COMPLETED|Overall Study||10
265232|NCT00419380|643075|P1|NOT COMPLETED|Overall Study||1
265233|NCT00419380|643074|P2|COMPLETED|Overall Study||12
265234|NCT00419380|643075|P1|COMPLETED|Overall Study||18
265235|NCT00419380|643074|P2|STARTED|Overall Study||22
265236|NCT00419380|643075|P1|STARTED|Overall Study||19
265237|NCT00419341|643083|P1|NOT COMPLETED|Efficacy Period||10
265238|NCT00419341|643083|P1|COMPLETED|Efficacy Period||28
265239|NCT00419341|643083|P1|STARTED|Efficacy Period||38
265240|NCT00419341|643083|P1|NOT COMPLETED|Wash in/Wash Out Period||11
265241|NCT00419341|643083|P1|COMPLETED|Wash in/Wash Out Period||38
265242|NCT00419341|643083|P1|STARTED|Wash in/Wash Out Period||49
265243|NCT00419315|643106|P2|NOT COMPLETED|Overall Study||0
265244|NCT00419315|643107|P1|NOT COMPLETED|Overall Study||0
265245|NCT00419315|643106|P2|COMPLETED|Overall Study||78
265246|NCT00419315|643107|P1|COMPLETED|Overall Study||85
265247|NCT00419315|643106|P2|STARTED|Overall Study||78
265248|NCT00419315|643107|P1|STARTED|Overall Study||85
265249|NCT00419263|643118|P3|NOT COMPLETED|Overall Study||3
265250|NCT00419263|643119|P2|NOT COMPLETED|Overall Study||2
265251|NCT00419263|643120|P1|NOT COMPLETED|Overall Study||3
265252|NCT00419263|643118|P3|COMPLETED|Overall Study||112
265253|NCT00419263|643119|P2|COMPLETED|Overall Study||112
265254|NCT00419263|643120|P1|COMPLETED|Overall Study||112
265255|NCT00419263|643118|P3|STARTED|Overall Study||115
265256|NCT00419263|643119|P2|STARTED|Overall Study||114
265257|NCT00419263|643120|P1|STARTED|Overall Study||115
265258|NCT00419159|643149|P2|NOT COMPLETED|Overall Study||100
265259|NCT00419159|643150|P1|NOT COMPLETED|Overall Study||99
265260|NCT00419159|643149|P2|COMPLETED|Overall Study||0
265261|NCT00419159|643150|P1|COMPLETED|Overall Study||0
265262|NCT00419159|643149|P2|STARTED|Overall Study||100
265263|NCT00419159|643150|P1|STARTED|Overall Study|Full Analysis Set|99
265264|NCT00419120|643164|P1|NOT COMPLETED|Long Term Follow up Period||10
265265|NCT00419120|643164|P1|COMPLETED|Long Term Follow up Period||0
265266|NCT00419120|643164|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
265267|NCT00419120|643164|P1|NOT COMPLETED|Primary Study Period||0
265268|NCT00419120|643164|P1|COMPLETED|Primary Study Period||10
265269|NCT00419120|643164|P1|STARTED|Primary Study Period||10
265270|NCT00419094|643171|P2|NOT COMPLETED|Overall Study||30
265271|NCT00419094|643172|P1|NOT COMPLETED|Overall Study||7
265272|NCT00419094|643171|P2|COMPLETED|Overall Study||141
265273|NCT00419094|643172|P1|COMPLETED|Overall Study||50
265274|NCT00419094|643171|P2|STARTED|Overall Study||171
265275|NCT00419094|643172|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
265276|NCT00419003|643186|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
265277|NCT00419003|643187|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
265278|NCT00419003|643186|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
265279|NCT00419003|643187|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
265280|NCT00419003|643186|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
265281|NCT00419003|643187|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
265282|NCT00419003|643186|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
265283|NCT00419003|643187|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
265284|NCT00419003|643186|P2|COMPLETED|Phase I, Ketamine Infusion||7
265285|NCT00419003|643187|P1|COMPLETED|Phase I, Ketamine Infusion||7
265286|NCT00419003|643186|P2|STARTED|Phase I, Ketamine Infusion||13
265287|NCT00419003|643187|P1|STARTED|Phase I, Ketamine Infusion||13
265288|NCT00418977|643198|P2|NOT COMPLETED|Overall Study||3
265289|NCT00418977|643199|P1|NOT COMPLETED|Overall Study||3
265290|NCT00418977|643198|P2|COMPLETED|Overall Study||13
265291|NCT00418977|643199|P1|COMPLETED|Overall Study||40
265292|NCT00418977|643198|P2|STARTED|Overall Study||16
265293|NCT00418977|643199|P1|STARTED|Overall Study||43
265294|NCT00418964|643216|P3|NOT COMPLETED|Overall Study||6
265295|NCT00418964|643217|P2|NOT COMPLETED|Overall Study||3
265296|NCT00418964|643218|P1|NOT COMPLETED|Overall Study||1
265297|NCT00418964|643216|P3|COMPLETED|Overall Study||14
265298|NCT00418964|643217|P2|COMPLETED|Overall Study||17
265299|NCT00418964|643218|P1|COMPLETED|Overall Study||21
265300|NCT00418964|643216|P3|STARTED|Overall Study||20
265301|NCT00418964|643217|P2|STARTED|Overall Study||20
265302|NCT00418964|643218|P1|STARTED|Overall Study||22
265303|NCT00418951|643229|P3|NOT COMPLETED|Overall Study||0
265304|NCT00418951|643230|P2|NOT COMPLETED|Overall Study||0
265305|NCT00418951|643231|P1|NOT COMPLETED|Overall Study||0
265306|NCT00418951|643229|P3|COMPLETED|Overall Study||40
265307|NCT00418951|643230|P2|COMPLETED|Overall Study||33
265308|NCT00418951|643231|P1|COMPLETED|Overall Study||39
265309|NCT00418951|643229|P3|STARTED|Overall Study||40
265310|NCT00418951|643230|P2|STARTED|Overall Study||33
265311|NCT00418951|643231|P1|STARTED|Overall Study||39
265312|NCT00418938|643241|P2|NOT COMPLETED|Overall Study||23
265313|NCT00418938|643242|P1|NOT COMPLETED|Overall Study||24
265314|NCT00418938|643241|P2|COMPLETED|Overall Study||108
265315|NCT00418938|643242|P1|COMPLETED|Overall Study||109
265316|NCT00418938|643241|P2|STARTED|Overall Study||131
265317|NCT00418938|643242|P1|STARTED|Overall Study||133
265318|NCT00418886|643262|P2|NOT COMPLETED|Overall Study||255
265319|NCT00418886|643263|P1|NOT COMPLETED|Overall Study||226
265320|NCT00418886|643262|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
265321|NCT00418886|643263|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
265322|NCT00418886|643262|P2|STARTED|Overall Study|randomised patients|278
265323|NCT00418886|643263|P1|STARTED|Overall Study|randomised patients|256
265324|NCT00418834|643289|P2|NOT COMPLETED|Overall Study||20
265325|NCT00418834|643290|P1|NOT COMPLETED|Overall Study||23
265326|NCT00418834|643289|P2|COMPLETED|Overall Study||507
265327|NCT00418834|643290|P1|COMPLETED|Overall Study||503
265328|NCT00418834|643289|P2|STARTED|Overall Study||527
265329|NCT00418834|643290|P1|STARTED|Overall Study||526
265330|NCT00418717|643350|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
265331|NCT00418717|643350|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
265332|NCT00418717|643350|P1|STARTED|Treatment Period B - Weeks 5-12||41
265333|NCT00418717|643350|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
265334|NCT00418717|643350|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
265335|NCT00418717|643350|P1|STARTED|Treatment Period A - Weeks 1-4||42
265336|NCT00418691|643358|P3|NOT COMPLETED|Overall Study||5
265337|NCT00418691|643359|P2|NOT COMPLETED|Overall Study||2
265338|NCT00418691|643360|P1|NOT COMPLETED|Overall Study||2
265339|NCT00418691|643358|P3|COMPLETED|Overall Study||5
265340|NCT00418691|643359|P2|COMPLETED|Overall Study||10
265341|NCT00418691|643360|P1|COMPLETED|Overall Study||9
265342|NCT00418691|643358|P3|STARTED|Overall Study||10
265343|NCT00418691|643359|P2|STARTED|Overall Study||12
265344|NCT00418691|643360|P1|STARTED|Overall Study||11
265345|NCT00418665|643371|P3|NOT COMPLETED|Treatment Extension||2
265346|NCT00418665|643372|P2|NOT COMPLETED|Treatment Extension||4
265347|NCT00418665|643373|P1|NOT COMPLETED|Treatment Extension||6
265348|NCT00418665|643371|P3|COMPLETED|Treatment Extension||7
265349|NCT00418665|643372|P2|COMPLETED|Treatment Extension||4
265350|NCT00418665|643373|P1|COMPLETED|Treatment Extension||1
265351|NCT00418665|643371|P3|STARTED|Treatment Extension||9
265352|NCT00418665|643372|P2|STARTED|Treatment Extension||8
265353|NCT00418665|643373|P1|STARTED|Treatment Extension||7
265354|NCT00418665|643371|P3|NOT COMPLETED|Treatment Period||4
265355|NCT00418665|643372|P2|NOT COMPLETED|Treatment Period||6
265356|NCT00418665|643373|P1|NOT COMPLETED|Treatment Period||5
265357|NCT00418665|643371|P3|COMPLETED|Treatment Period||9
265358|NCT00418665|643372|P2|COMPLETED|Treatment Period||8
265359|NCT00418665|643373|P1|COMPLETED|Treatment Period||7
265360|NCT00418665|643371|P3|Received Study Medication|Treatment Period||13
265361|NCT00418665|643372|P2|Received Study Medication|Treatment Period||13
265362|NCT00418665|643373|P1|Received Study Medication|Treatment Period||11
265363|NCT00418665|643371|P3|STARTED|Treatment Period||13
265364|NCT00418665|643372|P2|STARTED|Treatment Period||14
265365|NCT00418665|643373|P1|STARTED|Treatment Period||12
265366|NCT00418574|643392|P2|NOT COMPLETED|Overall Study||23
265367|NCT00418574|643393|P1|NOT COMPLETED|Overall Study||48
265368|NCT00418574|643392|P2|COMPLETED|Overall Study||272
265369|NCT00418574|643393|P1|COMPLETED|Overall Study||545
265370|NCT00418574|643392|P2|TREATED|Overall Study||294
265371|NCT00418574|643393|P1|TREATED|Overall Study||592
265372|NCT00418574|643392|P2|STARTED|Overall Study||295
265373|NCT00418574|643393|P1|STARTED|Overall Study||593
265374|NCT00418561|643407|P3|NOT COMPLETED|Overall Study||0
265375|NCT00418561|643408|P2|NOT COMPLETED|Overall Study||1
265376|NCT00418561|643409|P1|NOT COMPLETED|Overall Study||0
265377|NCT00418561|643407|P3|COMPLETED|Overall Study||4
265378|NCT00418561|643408|P2|COMPLETED|Overall Study||4
265379|NCT00418561|643409|P1|COMPLETED|Overall Study||4
265380|NCT00418561|643407|P3|STARTED|Overall Study||4
265381|NCT00418561|643408|P2|STARTED|Overall Study||5
265382|NCT00418561|643409|P1|STARTED|Overall Study||4
265383|NCT00418522|643479|P2|NOT COMPLETED|Overall Study||42
265384|NCT00418522|643480|P1|NOT COMPLETED|Overall Study||83
265385|NCT00418522|643479|P2|COMPLETED|Overall Study||152
265386|NCT00418522|643480|P1|COMPLETED|Overall Study||136
265387|NCT00418522|643479|P2|Received Treatment|Overall Study||190
265388|NCT00418522|643480|P1|Received Treatment|Overall Study||212
265389|NCT00418522|643479|P2|STARTED|Overall Study||194
265390|NCT00418522|643480|P1|STARTED|Overall Study||219
265391|NCT00418379|643527|P3|NOT COMPLETED|Year 5||3
265392|NCT00418379|643528|P2|NOT COMPLETED|Year 5||5
265393|NCT00418379|643529|P1|NOT COMPLETED|Year 5||2
265394|NCT00418379|643527|P3|COMPLETED|Year 5||131
265395|NCT00418379|643528|P2|COMPLETED|Year 5||115
265396|NCT00418379|643529|P1|COMPLETED|Year 5||126
265397|NCT00418379|643527|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
265398|NCT00418379|643528|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
265399|NCT00418379|643529|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
265400|NCT00418379|643527|P3|NOT COMPLETED|Year 4||2
265401|NCT00418379|643528|P2|NOT COMPLETED|Year 4||5
265402|NCT00418379|643529|P1|NOT COMPLETED|Year 4||3
265403|NCT00418379|643527|P3|COMPLETED|Year 4||154
265404|NCT00418379|643528|P2|COMPLETED|Year 4||136
265405|NCT00418379|643529|P1|COMPLETED|Year 4||142
265406|NCT00418379|643527|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
265407|NCT00418379|643528|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
265408|NCT00418379|643529|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
265409|NCT00418379|643527|P3|NOT COMPLETED|Year 3||3
265410|NCT00418379|643528|P2|NOT COMPLETED|Year 3||2
265411|NCT00418379|643529|P1|NOT COMPLETED|Year 3||3
265412|NCT00418379|643527|P3|COMPLETED|Year 3||163
265413|NCT00418379|643528|P2|COMPLETED|Year 3||146
265414|NCT00418379|643529|P1|COMPLETED|Year 3||148
265415|NCT00418379|643527|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
265416|NCT00418379|643528|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
265417|NCT00418379|643529|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
265418|NCT00418379|643527|P3|NOT COMPLETED|Year 2||10
265419|NCT00418379|643528|P2|NOT COMPLETED|Year 2||4
265420|NCT00418379|643529|P1|NOT COMPLETED|Year 2||8
265421|NCT00418379|643527|P3|COMPLETED|Year 2||172
265422|NCT00418379|643528|P2|COMPLETED|Year 2||155
265423|NCT00418379|643529|P1|COMPLETED|Year 2||159
265424|NCT00418379|643527|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
265425|NCT00418379|643528|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
265426|NCT00418379|643529|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
265427|NCT00418379|643527|P3|NOT COMPLETED|Year 1||15
265428|NCT00418379|643528|P2|NOT COMPLETED|Year 1||28
265429|NCT00418379|643529|P1|NOT COMPLETED|Year 1||18
265430|NCT00418379|643527|P3|COMPLETED|Year 1||204
265431|NCT00418379|643528|P2|COMPLETED|Year 1||179
265432|NCT00418379|643529|P1|COMPLETED|Year 1||189
265433|NCT00418379|643527|P3|STARTED|Year 1||219
265434|NCT00418379|643528|P2|STARTED|Year 1||207
265435|NCT00418379|643529|P1|STARTED|Year 1||207
265436|NCT00418314|643539|P2|NOT COMPLETED|Overall Study||2
265437|NCT00418314|643540|P1|NOT COMPLETED|Overall Study||1
265438|NCT00418314|643539|P2|COMPLETED|Overall Study||828
265439|NCT00418314|643540|P1|COMPLETED|Overall Study||816
265440|NCT00418314|643539|P2|STARTED|Overall Study||830
265441|NCT00418314|643540|P1|STARTED|Overall Study||817
265442|NCT00418262|643550|P1|NOT COMPLETED|Visits 8 Thru 10||5
265443|NCT00418262|643550|P1|COMPLETED|Visits 8 Thru 10||11
265444|NCT00418262|643550|P1|STARTED|Visits 8 Thru 10||16
265445|NCT00418262|643550|P1|NOT COMPLETED|Visits 5 Thru 8||9
265446|NCT00418262|643550|P1|COMPLETED|Visits 5 Thru 8||16
265447|NCT00418262|643550|P1|STARTED|Visits 5 Thru 8||25
265448|NCT00418262|643550|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
265449|NCT00418262|643550|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
265450|NCT00418262|643550|P1|STARTED|Visits 1 (Baseline) Thru 5||27
265451|NCT00418184|643570|P2|NOT COMPLETED|Open-label Phase||5
265452|NCT00418184|643571|P1|NOT COMPLETED|Open-label Phase||5
265453|NCT00418184|643570|P2|COMPLETED|Open-label Phase|5 dropped out|43
265454|NCT00418184|643571|P1|COMPLETED|Open-label Phase|5 dropped out|97
265455|NCT00418184|643570|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
265456|NCT00418184|643571|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
265457|NCT00418184|643570|P2|NOT COMPLETED|Double-blind Phase||11
265458|NCT00418184|643571|P1|NOT COMPLETED|Double-blind Phase||27
265459|NCT00418184|643570|P2|COMPLETED|Double-blind Phase||52
265460|NCT00418184|643571|P1|COMPLETED|Double-blind Phase||110
265461|NCT00418184|643570|P2|STARTED|Double-blind Phase||63
265462|NCT00418184|643571|P1|STARTED|Double-blind Phase||137
265463|NCT00418145|643579|P1|NOT COMPLETED|Overall Study||6
265464|NCT00418145|643579|P1|COMPLETED|Overall Study||10
265465|NCT00418145|643579|P1|STARTED|Overall Study||16
265466|NCT00418093|643591|P1|NOT COMPLETED|Overall Study||0
265467|NCT00418093|643591|P1|COMPLETED|Overall Study||19
265468|NCT00418093|643591|P1|Completed Study|Overall Study||19
265469|NCT00418093|643591|P1|STARTED|Overall Study||19
265470|NCT00418028|643600|P2|NOT COMPLETED|Overall Study||1
265471|NCT00418028|643601|P1|NOT COMPLETED|Overall Study||2
265472|NCT00418028|643600|P2|COMPLETED|Overall Study||97
265473|NCT00418028|643601|P1|COMPLETED|Overall Study||95
265474|NCT00418028|643600|P2|STARTED|Overall Study||98
265475|NCT00418028|643601|P1|STARTED|Overall Study||97
265476|NCT00418015|643623|P4|NOT COMPLETED|Overall Study||0
265477|NCT00418015|643624|P3|NOT COMPLETED|Overall Study||0
265478|NCT00418015|643625|P2|NOT COMPLETED|Overall Study||0
265479|NCT00418015|643626|P1|NOT COMPLETED|Overall Study||0
265480|NCT00418015|643623|P4|COMPLETED|Overall Study||25
265481|NCT00418015|643624|P3|COMPLETED|Overall Study||78
265482|NCT00418015|643625|P2|COMPLETED|Overall Study||46
265483|NCT00418015|643626|P1|COMPLETED|Overall Study||144
265484|NCT00418015|643623|P4|STARTED|Overall Study||25
265485|NCT00418015|643624|P3|STARTED|Overall Study||78
265486|NCT00418015|643625|P2|STARTED|Overall Study||46
265487|NCT00418015|643626|P1|STARTED|Overall Study||144
265488|NCT00417989|643654|P2|NOT COMPLETED|Overall Study||22
265489|NCT00417989|643655|P1|NOT COMPLETED|Overall Study||20
265490|NCT00417989|643654|P2|COMPLETED|Overall Study||219
265491|NCT00417989|643655|P1|COMPLETED|Overall Study||224
265492|NCT00417989|643654|P2|STARTED|Overall Study||241
265493|NCT00417989|643655|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
265494|NCT00417976|643677|P1|NOT COMPLETED|Overall Study||3
265495|NCT00417976|643677|P1|COMPLETED|Overall Study||39
265496|NCT00417976|643677|P1|STARTED|Overall Study||42
265497|NCT00417963|643682|P1|NOT COMPLETED|Overall Study||41
265498|NCT00417963|643682|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
265499|NCT00417963|643682|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
265500|NCT00417885|643699|P1|NOT COMPLETED|Overall Study||6
265501|NCT00417885|643699|P1|COMPLETED|Overall Study||0
265502|NCT00417885|643699|P1|STARTED|Overall Study||6
265503|NCT00417612|643710|P2|NOT COMPLETED|Overall Study||3
265504|NCT00417612|643711|P1|NOT COMPLETED|Overall Study||3
265505|NCT00417612|643710|P2|COMPLETED|Overall Study||8
265506|NCT00417612|643711|P1|COMPLETED|Overall Study||19
265507|NCT00417612|643710|P2|STARTED|Overall Study||11
265508|NCT00417612|643711|P1|STARTED|Overall Study||22
265509|NCT00417482|643737|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
265510|NCT00417482|643738|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
265511|NCT00417482|643739|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
265512|NCT00417482|643737|P3|COMPLETED|Phase B 2nd 16 Weeks||10
265513|NCT00417482|643738|P2|COMPLETED|Phase B 2nd 16 Weeks||14
265514|NCT00417482|643739|P1|COMPLETED|Phase B 2nd 16 Weeks||10
265515|NCT00417482|643737|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
265516|NCT00417482|643738|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
265517|NCT00417482|643739|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
265518|NCT00417482|643737|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
265519|NCT00417482|643738|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
265520|NCT00417482|643739|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
265521|NCT00417482|643737|P3|COMPLETED|Phase B 1st 16 Weeks||13
265522|NCT00417482|643738|P2|COMPLETED|Phase B 1st 16 Weeks||27
265523|NCT00417482|643739|P1|COMPLETED|Phase B 1st 16 Weeks||13
265524|NCT00417482|643737|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
265525|NCT00417482|643738|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
265526|NCT00417482|643739|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
265527|NCT00417417|643765|P2|NOT COMPLETED|Overall Study||0
265528|NCT00417417|643766|P1|NOT COMPLETED|Overall Study||0
265529|NCT00417417|643765|P2|COMPLETED|Overall Study||6
265530|NCT00417417|643766|P1|COMPLETED|Overall Study||4
265531|NCT00417417|643765|P2|STARTED|Overall Study||6
265532|NCT00417417|643766|P1|STARTED|Overall Study||4
265533|NCT00417274|643774|P1|NOT COMPLETED|Overall Study||0
265534|NCT00417274|643774|P1|COMPLETED|Overall Study||31
265535|NCT00417274|643774|P1|STARTED|Overall Study||31
265536|NCT00417248|643778|P1|NOT COMPLETED|Overall Study||8
265537|NCT00417248|643778|P1|COMPLETED|Overall Study||0
265538|NCT00417248|643778|P1|STARTED|Overall Study||8
265539|NCT00417170|643785|P2|NOT COMPLETED|Overall Study||3
265540|NCT00417170|643786|P1|NOT COMPLETED|Overall Study||2
265541|NCT00417170|643785|P2|COMPLETED|Overall Study||22
265542|NCT00417170|643786|P1|COMPLETED|Overall Study||21
265543|NCT00417170|643785|P2|Pharmacodynamics Population|Overall Study||23
265544|NCT00417170|643786|P1|Pharmacodynamics Population|Overall Study||21
265545|NCT00417170|643785|P2|STARTED|Overall Study||25
265546|NCT00417170|643786|P1|STARTED|Overall Study|"Started indicates Safety population."|23
265547|NCT00417079|643802|P2|NOT COMPLETED|Overall Study||273
265548|NCT00417079|643803|P1|NOT COMPLETED|Overall Study||331
265549|NCT00417079|643802|P2|COMPLETED|Overall Study|Randomized patients|105
265550|NCT00417079|643803|P1|COMPLETED|Overall Study|Randomized patients|46
265551|NCT00417079|643802|P2|STARTED|Overall Study|Randomized patients|378
265552|NCT00417079|643803|P1|STARTED|Overall Study|Randomized patients|377
265553|NCT00417027|643826|P3|NOT COMPLETED|Overall Study||5
265554|NCT00417027|643827|P2|NOT COMPLETED|Overall Study||5
265555|NCT00417027|643828|P1|NOT COMPLETED|Overall Study||0
265556|NCT00417027|643826|P3|COMPLETED|Overall Study||54
265557|NCT00417027|643827|P2|COMPLETED|Overall Study||60
265558|NCT00417027|643828|P1|COMPLETED|Overall Study||66
265559|NCT00417027|643826|P3|STARTED|Overall Study||59
265560|NCT00417027|643827|P2|STARTED|Overall Study||65
265561|NCT00417027|643828|P1|STARTED|Overall Study||66
265562|NCT00416884|643854|P1|NOT COMPLETED|Overall Study||1
265563|NCT00416884|643854|P1|COMPLETED|Overall Study||0
265564|NCT00416884|643854|P1|STARTED|Overall Study||1
265565|NCT00416793|643858|P1|NOT COMPLETED|Overall Study||0
265566|NCT00416793|643858|P1|COMPLETED|Overall Study||9
265567|NCT00416793|643858|P1|STARTED|Overall Study||9
265568|NCT00416715|643862|P1|NOT COMPLETED|Overall Study||15
265569|NCT00416715|643862|P1|COMPLETED|Overall Study||85
265570|NCT00416715|643862|P1|STARTED|Overall Study||100
265571|NCT00416624|643873|P4|NOT COMPLETED|Overall Study||17
265572|NCT00416624|643874|P3|NOT COMPLETED|Overall Study||18
265573|NCT00416624|643875|P2|NOT COMPLETED|Overall Study||27
265574|NCT00416624|643876|P1|NOT COMPLETED|Overall Study||22
265575|NCT00416624|643873|P4|COMPLETED|Overall Study||40
265576|NCT00416624|643874|P3|COMPLETED|Overall Study||40
265577|NCT00416624|643875|P2|COMPLETED|Overall Study||33
265578|NCT00416624|643876|P1|COMPLETED|Overall Study||39
265579|NCT00416624|643873|P4|STARTED|Overall Study||57
265580|NCT00416624|643874|P3|STARTED|Overall Study||58
265581|NCT00416624|643875|P2|STARTED|Overall Study||60
265582|NCT00416624|643876|P1|STARTED|Overall Study||61
265583|NCT00416598|643930|P1|NOT COMPLETED|Decitabine Maintenance||72
265584|NCT00416598|643930|P1|COMPLETED|Decitabine Maintenance||62
265585|NCT00416598|643930|P1|STARTED|Decitabine Maintenance||134
265586|NCT00416598|643930|P1|NOT COMPLETED|Induction & Intensification||412
265587|NCT00416598|643930|P1|COMPLETED|Induction & Intensification||134
265588|NCT00416598|643930|P1|STARTED|Induction & Intensification||546
265589|NCT00416572|643938|P3|NOT COMPLETED|Overall Study||8
265590|NCT00416572|643939|P2|NOT COMPLETED|Overall Study||7
265591|NCT00416572|643940|P1|NOT COMPLETED|Overall Study||13
265592|NCT00416572|643938|P3|COMPLETED|Overall Study||76
265593|NCT00416572|643939|P2|COMPLETED|Overall Study||78
265594|NCT00416572|643940|P1|COMPLETED|Overall Study||70
265595|NCT00416572|643938|P3|STARTED|Overall Study||84
265596|NCT00416572|643939|P2|STARTED|Overall Study||85
265597|NCT00416572|643940|P1|STARTED|Overall Study||83
265598|NCT00416520|643956|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
265599|NCT00416520|643957|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
265600|NCT00416520|643958|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
265601|NCT00416520|643959|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
265602|NCT00416520|643956|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
265603|NCT00416520|643957|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
265604|NCT00416520|643958|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
265605|NCT00416520|643959|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
265606|NCT00416520|643956|P4|STARTED|Placebo-controlled Withdrawal Period||54
265607|NCT00416520|643957|P3|STARTED|Placebo-controlled Withdrawal Period||50
265608|NCT00416520|643958|P2|STARTED|Placebo-controlled Withdrawal Period||0
265609|NCT00416520|643959|P1|STARTED|Placebo-controlled Withdrawal Period||0
265610|NCT00416520|643956|P4|NOT COMPLETED|Open-label Period||0
265611|NCT00416520|643957|P3|NOT COMPLETED|Open-label Period||0
265612|NCT00416520|643958|P2|NOT COMPLETED|Open-label Period||32
265613|NCT00416520|643959|P1|NOT COMPLETED|Open-label Period||60
265614|NCT00416520|643956|P4|COMPLETED|Open-label Period||0
265615|NCT00416520|643957|P3|COMPLETED|Open-label Period||0
265616|NCT00416520|643958|P2|COMPLETED|Open-label Period||139
265617|NCT00416520|643959|P1|COMPLETED|Open-label Period||105
265618|NCT00416520|643956|P4|STARTED|Open-label Period||0
265619|NCT00416520|643957|P3|STARTED|Open-label Period||0
265620|NCT00416520|643958|P2|STARTED|Open-label Period||171
265621|NCT00416520|643959|P1|STARTED|Open-label Period||165
265622|NCT00416494|643971|P2|NOT COMPLETED|Overall Study||0
265623|NCT00416494|643972|P1|NOT COMPLETED|Overall Study||0
265624|NCT00416494|643971|P2|COMPLETED|Overall Study||31
265625|NCT00416494|643972|P1|COMPLETED|Overall Study||19
265626|NCT00416494|643971|P2|STARTED|Overall Study||31
265627|NCT00416494|643972|P1|STARTED|Overall Study||19
265628|NCT00416455|643988|P2|NOT COMPLETED|Overall Study||8
265629|NCT00416455|643989|P1|NOT COMPLETED|Overall Study||16
265630|NCT00416455|643988|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
265631|NCT00416455|643989|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
265632|NCT00416455|643988|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
265633|NCT00416455|643989|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
265634|NCT00416195|644003|P2|NOT COMPLETED|Overall Study||4
265635|NCT00416195|644004|P1|NOT COMPLETED|Overall Study||2
265636|NCT00416195|644003|P2|COMPLETED|Overall Study||34
265637|NCT00416195|644004|P1|COMPLETED|Overall Study||8
265638|NCT00416195|644003|P2|STARTED|Overall Study||38
265639|NCT00416195|644004|P1|STARTED|Overall Study||10
265640|NCT00416182|644014|P2|NOT COMPLETED|Overall Study||2
265641|NCT00416182|644015|P1|NOT COMPLETED|Overall Study||3
265642|NCT00416182|644014|P2|COMPLETED|Overall Study||6
265643|NCT00416182|644015|P1|COMPLETED|Overall Study||5
265644|NCT00416182|644014|P2|STARTED|Overall Study||8
265645|NCT00416182|644015|P1|STARTED|Overall Study||8
265646|NCT00416078|644029|P2|NOT COMPLETED|Overall Study||8
265647|NCT00416078|644030|P1|NOT COMPLETED|Overall Study||11
265648|NCT00416078|644029|P2|COMPLETED|Overall Study||16
265649|NCT00416078|644030|P1|COMPLETED|Overall Study||18
265650|NCT00416078|644029|P2|STARTED|Overall Study||24
265651|NCT00416078|644030|P1|STARTED|Overall Study||29
265652|NCT00415909|644046|P1|NOT COMPLETED|Overall Study||3
265653|NCT00415909|644046|P1|COMPLETED|Overall Study||0
265654|NCT00415909|644046|P1|STARTED|Overall Study||3
265655|NCT00415870|644052|P2|NOT COMPLETED|Overall Study||7
265656|NCT00415870|644053|P1|NOT COMPLETED|Overall Study||6
265657|NCT00415870|644052|P2|COMPLETED|Overall Study||26
265658|NCT00415870|644053|P1|COMPLETED|Overall Study||26
265659|NCT00415870|644052|P2|STARTED|Overall Study||33
265660|NCT00415870|644053|P1|STARTED|Overall Study||32
265661|NCT00415857|644061|P2|NOT COMPLETED|Overall Study||0
265662|NCT00415857|644062|P1|NOT COMPLETED|Overall Study||0
265663|NCT00415857|644061|P2|COMPLETED|Overall Study||3
265664|NCT00415857|644062|P1|COMPLETED|Overall Study||2
265665|NCT00415857|644061|P2|STARTED|Overall Study||3
265666|NCT00415857|644062|P1|STARTED|Overall Study||2
265667|NCT00415623|644072|P2|NOT COMPLETED|Overall Study||5
265668|NCT00415623|644073|P1|NOT COMPLETED|Overall Study||5
265669|NCT00415623|644072|P2|COMPLETED|Overall Study||146
265670|NCT00415623|644073|P1|COMPLETED|Overall Study||149
265671|NCT00415623|644072|P2|STARTED|Overall Study||151
265672|NCT00415623|644073|P1|STARTED|Overall Study||154
265673|NCT00415610|644100|P3|NOT COMPLETED|Overall Study||5
265674|NCT00415610|644101|P2|NOT COMPLETED|Overall Study||2
265675|NCT00415610|644102|P1|NOT COMPLETED|Overall Study||3
265676|NCT00415610|644100|P3|COMPLETED|Overall Study||17
265677|NCT00415610|644101|P2|COMPLETED|Overall Study||18
265678|NCT00415610|644102|P1|COMPLETED|Overall Study||15
265679|NCT00415610|644100|P3|STARTED|Overall Study||22
265680|NCT00415610|644101|P2|STARTED|Overall Study||20
265681|NCT00415610|644102|P1|STARTED|Overall Study||18
265682|NCT00415597|644122|P1|NOT COMPLETED|Treatment||305
265683|NCT00415597|644122|P1|COMPLETED|Treatment||160
265684|NCT00415597|644122|P1|STARTED|Treatment||465
265685|NCT00415597|644122|P1|NOT COMPLETED|Enrollment||2
265686|NCT00415597|644122|P1|COMPLETED|Enrollment||465
265687|NCT00415597|644122|P1|STARTED|Enrollment||467
265688|NCT00415532|644130|P2|NOT COMPLETED|Safety Follow Up Period||12
265689|NCT00415532|644131|P1|NOT COMPLETED|Safety Follow Up Period||9
265690|NCT00415532|644130|P2|COMPLETED|Safety Follow Up Period||18
265691|NCT00415532|644131|P1|COMPLETED|Safety Follow Up Period||34
265692|NCT00415532|644130|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
265693|NCT00415532|644131|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
265694|NCT00415532|644130|P2|NOT COMPLETED|Treatment Period||15
265695|NCT00415532|644131|P1|NOT COMPLETED|Treatment Period||17
265696|NCT00415532|644130|P2|COMPLETED|Treatment Period||142
265697|NCT00415532|644131|P1|COMPLETED|Treatment Period||60
265698|NCT00415532|644130|P2|Switched to Romiplostim Group|Treatment Period||0
265699|NCT00415532|644131|P1|Switched to Romiplostim Group|Treatment Period||2
265700|NCT00415532|644130|P2|Received Treatment|Treatment Period||154
265701|NCT00415532|644131|P1|Received Treatment|Treatment Period||75
265702|NCT00415532|644130|P2|STARTED|Treatment Period||157
265703|NCT00415532|644131|P1|STARTED|Treatment Period||77
265704|NCT00415519|644153|P2|NOT COMPLETED|Overall Study||0
265705|NCT00415519|644154|P1|NOT COMPLETED|Overall Study||4
265706|NCT00415519|644153|P2|COMPLETED|Overall Study||12
265707|NCT00415519|644154|P1|COMPLETED|Overall Study||9
265708|NCT00415519|644153|P2|STARTED|Overall Study||12
265709|NCT00415519|644154|P1|STARTED|Overall Study||13
265710|NCT00415506|644174|P2|NOT COMPLETED|Overall Study||1
265711|NCT00415506|644175|P1|NOT COMPLETED|Overall Study||3
265712|NCT00415506|644174|P2|COMPLETED|Overall Study||9
265713|NCT00415506|644175|P1|COMPLETED|Overall Study||9
265714|NCT00415506|644174|P2|STARTED|Overall Study||10
265715|NCT00415506|644175|P1|STARTED|Overall Study||12
265716|NCT00415493|644185|P2|NOT COMPLETED|Overall Study||0
265717|NCT00415493|644186|P1|NOT COMPLETED|Overall Study||0
265718|NCT00415493|644185|P2|COMPLETED|Overall Study||12
265719|NCT00415493|644186|P1|COMPLETED|Overall Study||12
265720|NCT00415493|644185|P2|STARTED|Overall Study||12
265721|NCT00415493|644186|P1|STARTED|Overall Study||12
265722|NCT00415194|644194|P2|NOT COMPLETED|Overall Study||342
265723|NCT00415194|644195|P1|NOT COMPLETED|Overall Study||328
265724|NCT00415194|644194|P2|COMPLETED|Overall Study||55
265725|NCT00415194|644195|P1|COMPLETED|Overall Study||70
265726|NCT00415194|644194|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
265727|NCT00415194|644195|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
265728|NCT00415194|644194|P2|STARTED|Overall Study||397
265729|NCT00415194|644195|P1|STARTED|Overall Study||398
265730|NCT00415168|644211|P1|NOT COMPLETED|Overall Study||52
265731|NCT00415168|644211|P1|COMPLETED|Overall Study||1
265732|NCT00415168|644211|P1|Completed Treatment|Overall Study||15
265733|NCT00415168|644211|P1|STARTED|Overall Study||53
265734|NCT00415051|644221|P1|NOT COMPLETED|Overall Study||1
265735|NCT00415051|644221|P1|COMPLETED|Overall Study||19
265736|NCT00415051|644221|P1|STARTED|Overall Study||20
265737|NCT00414973|644232|P4|NOT COMPLETED|Overall Study||0
265738|NCT00414973|644233|P3|NOT COMPLETED|Overall Study||3
265739|NCT00414973|644234|P2|NOT COMPLETED|Overall Study||10
265740|NCT00414973|644235|P1|NOT COMPLETED|Overall Study||28
265741|NCT00414973|644232|P4|COMPLETED|Overall Study||11
265742|NCT00414973|644233|P3|COMPLETED|Overall Study||21
265743|NCT00414973|644234|P2|COMPLETED|Overall Study||99
265744|NCT00414973|644235|P1|COMPLETED|Overall Study||190
265745|NCT00414973|644232|P4|STARTED|Overall Study||11
265746|NCT00414973|644233|P3|STARTED|Overall Study||24
265747|NCT00414973|644234|P2|STARTED|Overall Study||109
265748|NCT00414973|644235|P1|STARTED|Overall Study||218
265749|NCT00414908|644255|P2|NOT COMPLETED|Overall Study||1
265750|NCT00414908|644256|P1|NOT COMPLETED|Overall Study||1
265751|NCT00414908|644255|P2|COMPLETED|Overall Study||28
265752|NCT00414908|644256|P1|COMPLETED|Overall Study||24
265753|NCT00414908|644255|P2|STARTED|Overall Study||29
265754|NCT00414908|644256|P1|STARTED|Overall Study||25
265755|NCT00414817|644280|P2|NOT COMPLETED|Overall Study||3016
265756|NCT00414817|644281|P1|NOT COMPLETED|Overall Study||3130
265757|NCT00414817|644280|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
265758|NCT00414817|644281|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
265759|NCT00414817|644280|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
265760|NCT00414817|644281|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
265761|NCT00414817|644280|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
265762|NCT00414817|644281|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
265763|NCT00414817|644280|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
265764|NCT00414817|644281|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
265765|NCT00414817|644280|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
265766|NCT00414817|644281|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
265767|NCT00414817|644280|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
265768|NCT00414817|644281|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
265769|NCT00414817|644280|P2|STARTED|Overall Study||7031
265770|NCT00414817|644281|P1|STARTED|Overall Study||7033
265771|NCT00414726|644293|P2|NOT COMPLETED|Overall Study||1
265772|NCT00414726|644294|P1|NOT COMPLETED|Overall Study||0
265773|NCT00414726|644293|P2|COMPLETED|Overall Study||41
265774|NCT00414726|644294|P1|COMPLETED|Overall Study||43
265775|NCT00414726|644293|P2|STARTED|Overall Study||42
265776|NCT00414726|644294|P1|STARTED|Overall Study||43
265777|NCT00414700|644304|P2|NOT COMPLETED|Overall Study||3
265778|NCT00414700|644305|P1|NOT COMPLETED|Overall Study||6
265779|NCT00414700|644304|P2|COMPLETED|Overall Study||58
265780|NCT00414700|644305|P1|COMPLETED|Overall Study||51
265781|NCT00414700|644304|P2|STARTED|Overall Study||61
265782|NCT00414700|644305|P1|STARTED|Overall Study||57
265783|NCT00414661|644329|P4|NOT COMPLETED|Overall Study||3
265784|NCT00414661|644330|P3|NOT COMPLETED|Overall Study||2
265785|NCT00414661|644331|P2|NOT COMPLETED|Overall Study||14
265786|NCT00414661|644332|P1|NOT COMPLETED|Overall Study||14
265787|NCT00414661|644329|P4|COMPLETED|Overall Study||0
265788|NCT00414661|644330|P3|COMPLETED|Overall Study||20
265789|NCT00414661|644331|P2|COMPLETED|Overall Study||75
265790|NCT00414661|644332|P1|COMPLETED|Overall Study||34
265791|NCT00414661|644329|P4|STARTED|Overall Study||3
265792|NCT00414661|644330|P3|STARTED|Overall Study||22
265793|NCT00414661|644331|P2|STARTED|Overall Study||89
265794|NCT00414661|644332|P1|STARTED|Overall Study||48
265795|NCT00414635|644356|P2|NOT COMPLETED|Overall Study||2
265796|NCT00414635|644357|P1|NOT COMPLETED|Overall Study||5
265797|NCT00414635|644356|P2|COMPLETED|Overall Study||28
265798|NCT00414635|644357|P1|COMPLETED|Overall Study||25
265799|NCT00414635|644356|P2|STARTED|Overall Study||30
265800|NCT00414635|644357|P1|STARTED|Overall Study||30
265801|NCT00414609|644377|P3|NOT COMPLETED|Extension Study||57
265802|NCT00414609|644378|P2|NOT COMPLETED|Extension Study||0
265803|NCT00414609|644379|P1|NOT COMPLETED|Extension Study||0
265804|NCT00414609|644377|P3|COMPLETED|Extension Study||365
265805|NCT00414609|644378|P2|COMPLETED|Extension Study||0
265806|NCT00414609|644379|P1|COMPLETED|Extension Study||0
265807|NCT00414609|644377|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
265808|NCT00414609|644378|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
265809|NCT00414609|644379|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
265810|NCT00414609|644377|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
265811|NCT00414609|644378|P2|STARTED|Extension Study||0
265812|NCT00414609|644379|P1|STARTED|Extension Study||0
265813|NCT00414609|644377|P3|NOT COMPLETED|Core Study||0
265814|NCT00414609|644378|P2|NOT COMPLETED|Core Study||45
265815|NCT00414609|644379|P1|NOT COMPLETED|Core Study||34
265816|NCT00414609|644377|P3|COMPLETED|Core Study||0
265817|NCT00414609|644378|P2|COMPLETED|Core Study||378
265818|NCT00414609|644379|P1|COMPLETED|Core Study||363
265819|NCT00414609|644377|P3|Echocardiogram Evaluable Set|Core Study||0
265820|NCT00414609|644378|P2|Echocardiogram Evaluable Set|Core Study||343
265821|NCT00414609|644379|P1|Echocardiogram Evaluable Set|Core Study||330
265822|NCT00414609|644377|P3|Received Study Drug|Core Study||0
265823|NCT00414609|644378|P2|Received Study Drug|Core Study||422
265824|NCT00414609|644379|P1|Received Study Drug|Core Study||397
265825|NCT00414609|644377|P3|STARTED|Core Study||0
265826|NCT00414609|644378|P2|STARTED|Core Study||423
265827|NCT00414609|644379|P1|STARTED|Core Study||397
265828|NCT00414596|644402|P1|NOT COMPLETED|Overall Study||2
265829|NCT00414596|644402|P1|COMPLETED|Overall Study|April 2007|18
265830|NCT00414596|644402|P1|STARTED|Overall Study|December 2006|20
265831|NCT00414544|644411|P1|NOT COMPLETED|Overall Study||14
265832|NCT00414544|644411|P1|COMPLETED|Overall Study||131
265833|NCT00414544|644411|P1|STARTED|Overall Study||145
265834|NCT00414518|644419|P2|NOT COMPLETED|Overall Study||0
265835|NCT00414518|644420|P1|NOT COMPLETED|Overall Study||0
265836|NCT00414518|644419|P2|COMPLETED|Overall Study||9
265837|NCT00414518|644420|P1|COMPLETED|Overall Study||7
265838|NCT00414518|644419|P2|STARTED|Overall Study||9
265839|NCT00414518|644420|P1|STARTED|Overall Study||7
265840|NCT00414466|644434|P4|NOT COMPLETED|Overall Study||1
265841|NCT00414466|644435|P3|NOT COMPLETED|Overall Study||1
265842|NCT00414466|644436|P2|NOT COMPLETED|Overall Study||0
265843|NCT00414466|644437|P1|NOT COMPLETED|Overall Study||2
265844|NCT00414466|644434|P4|COMPLETED|Overall Study||42
265845|NCT00414466|644435|P3|COMPLETED|Overall Study||40
265846|NCT00414466|644436|P2|COMPLETED|Overall Study||42
265847|NCT00414466|644437|P1|COMPLETED|Overall Study||42
265848|NCT00414466|644434|P4|STARTED|Overall Study||43
265849|NCT00414466|644435|P3|STARTED|Overall Study||41
265850|NCT00414466|644436|P2|STARTED|Overall Study||42
265851|NCT00414466|644437|P1|STARTED|Overall Study||44
265852|NCT00414453|644455|P1|NOT COMPLETED|Overall Study||16
265853|NCT00414453|644455|P1|COMPLETED|Overall Study||3
265854|NCT00414453|644455|P1|STARTED|Overall Study||19
265855|NCT00414440|644503|P2|NOT COMPLETED|Extension Period||140
265856|NCT00414440|644504|P1|NOT COMPLETED|Extension Period||150
265857|NCT00414440|644503|P2|COMPLETED|Extension Period|Extension|77
265858|NCT00414440|644504|P1|COMPLETED|Extension Period|Extension|64
265859|NCT00414440|644503|P2|STARTED|Extension Period|Extension|217
265860|NCT00414440|644504|P1|STARTED|Extension Period|Extension|214
265861|NCT00414440|644503|P2|NOT COMPLETED|Core Period||32
265862|NCT00414440|644504|P1|NOT COMPLETED|Core Period||70
265863|NCT00414440|644503|P2|COMPLETED|Core Period|Core period|185
265864|NCT00414440|644504|P1|COMPLETED|Core Period|Core period|144
265865|NCT00414440|644503|P2|STARTED|Core Period|Core period|217
265866|NCT00414440|644504|P1|STARTED|Core Period|Core period|214
265867|NCT00414388|644518|P1|NOT COMPLETED|Overall Study||1
265868|NCT00414388|644518|P1|COMPLETED|Overall Study||21
265869|NCT00414388|644518|P1|STARTED|Overall Study||22
265870|NCT00414310|644526|P2|NOT COMPLETED|Overall Study||0
265871|NCT00414310|644527|P1|NOT COMPLETED|Overall Study||1
265872|NCT00414310|644526|P2|COMPLETED|Overall Study||79
265873|NCT00414310|644527|P1|COMPLETED|Overall Study||70
265874|NCT00414310|644526|P2|STARTED|Overall Study||79
265875|NCT00414310|644527|P1|STARTED|Overall Study||71
265876|NCT00414206|644536|P3|NOT COMPLETED|Overall Study||55
265877|NCT00414206|644537|P2|NOT COMPLETED|Overall Study||56
265878|NCT00414206|644538|P1|NOT COMPLETED|Overall Study||58
265879|NCT00414206|644536|P3|COMPLETED|Overall Study||59
265880|NCT00414206|644537|P2|COMPLETED|Overall Study||58
265881|NCT00414206|644538|P1|COMPLETED|Overall Study||57
265882|NCT00414206|644536|P3|STARTED|Overall Study||114
265883|NCT00414206|644537|P2|STARTED|Overall Study||114
265884|NCT00414206|644538|P1|STARTED|Overall Study||115
265885|NCT00414167|644548|P2|NOT COMPLETED|Overall Study||3
265886|NCT00414167|644549|P1|NOT COMPLETED|Overall Study||4
265887|NCT00414167|644548|P2|COMPLETED|Overall Study||27
265888|NCT00414167|644549|P1|COMPLETED|Overall Study||27
265889|NCT00414167|644548|P2|STARTED|Overall Study||30
265890|NCT00414167|644549|P1|STARTED|Overall Study||31
265891|NCT00414050|644561|P4|NOT COMPLETED|Overall Study||8
265892|NCT00414050|644562|P3|NOT COMPLETED|Overall Study||6
265893|NCT00414050|644563|P2|NOT COMPLETED|Overall Study||8
265894|NCT00414050|644564|P1|NOT COMPLETED|Overall Study||9
265895|NCT00414050|644561|P4|COMPLETED|Overall Study||423
265896|NCT00414050|644562|P3|COMPLETED|Overall Study||423
265897|NCT00414050|644563|P2|COMPLETED|Overall Study||419
265898|NCT00414050|644564|P1|COMPLETED|Overall Study||422
265899|NCT00414050|644561|P4|Received Vaccination 3|Overall Study||424
265900|NCT00414050|644562|P3|Received Vaccination 3|Overall Study||425
265901|NCT00414050|644563|P2|Received Vaccination 3|Overall Study||419
265902|NCT00414050|644564|P1|Received Vaccination 3|Overall Study||424
265903|NCT00414050|644561|P4|Received Vaccination 2|Overall Study||425
265904|NCT00414050|644562|P3|Received Vaccination 2|Overall Study||425
265905|NCT00414050|644563|P2|Received Vaccination 2|Overall Study||421
265906|NCT00414050|644564|P1|Received Vaccination 2|Overall Study||425
265907|NCT00414050|644561|P4|Received Vaccination 1|Overall Study||431
265908|NCT00414050|644562|P3|Received Vaccination 1|Overall Study||429
265909|NCT00414050|644563|P2|Received Vaccination 1|Overall Study||426
265910|NCT00414050|644564|P1|Received Vaccination 1|Overall Study||431
265911|NCT00414050|644561|P4|STARTED|Overall Study||431
265912|NCT00414050|644562|P3|STARTED|Overall Study||429
265913|NCT00414050|644563|P2|STARTED|Overall Study||427
265914|NCT00414050|644564|P1|STARTED|Overall Study||431
265915|NCT00414011|644578|P1|NOT COMPLETED|Overall Study||5
265916|NCT00414011|644578|P1|COMPLETED|Overall Study||35
265917|NCT00414011|644578|P1|STARTED|Overall Study||40
265918|NCT00413972|644587|P4|NOT COMPLETED|Overall Study||3
265919|NCT00413972|644588|P3|NOT COMPLETED|Overall Study||10
265920|NCT00413972|644589|P2|NOT COMPLETED|Overall Study||8
265921|NCT00413972|644590|P1|NOT COMPLETED|Overall Study||7
265922|NCT00413972|644587|P4|COMPLETED|Overall Study||95
265923|NCT00413972|644588|P3|COMPLETED|Overall Study||88
265924|NCT00413972|644589|P2|COMPLETED|Overall Study||90
265925|NCT00413972|644590|P1|COMPLETED|Overall Study||91
265926|NCT00413972|644587|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
265927|NCT00413972|644588|P3|STARTED|Overall Study||98
265928|NCT00413972|644589|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
265929|NCT00413972|644590|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
265930|NCT00413959|644600|P1|NOT COMPLETED|Overall Study||1
265931|NCT00413959|644600|P1|COMPLETED|Overall Study||11
265932|NCT00413959|644600|P1|STARTED|Overall Study||12
265933|NCT00413920|644607|P2|NOT COMPLETED|Overall Study||28
265934|NCT00413920|644608|P1|NOT COMPLETED|Overall Study||28
265935|NCT00413920|644607|P2|COMPLETED|Overall Study||82
265936|NCT00413920|644608|P1|COMPLETED|Overall Study||84
265937|NCT00413920|644607|P2|STARTED|Overall Study||110
265938|NCT00413920|644608|P1|STARTED|Overall Study||112
265939|NCT00413894|644623|P1|NOT COMPLETED|Overall Study||80
265940|NCT00413894|644623|P1|COMPLETED|Overall Study||344
265941|NCT00413894|644623|P1|STARTED|Overall Study||424
265942|NCT00413777|644640|P2|NOT COMPLETED|Extension Period||0
265943|NCT00413777|644641|P1|NOT COMPLETED|Extension Period||0
265944|NCT00413777|644640|P2|COMPLETED|Extension Period||18
265945|NCT00413777|644641|P1|COMPLETED|Extension Period||17
265946|NCT00413777|644640|P2|STARTED|Extension Period||18
265947|NCT00413777|644641|P1|STARTED|Extension Period||17
265948|NCT00413777|644640|P2|NOT COMPLETED|Fixed-dose Period||3
265949|NCT00413777|644641|P1|NOT COMPLETED|Fixed-dose Period||4
265950|NCT00413777|644640|P2|COMPLETED|Fixed-dose Period||21
265951|NCT00413777|644641|P1|COMPLETED|Fixed-dose Period||18
265952|NCT00413777|644640|P2|STARTED|Fixed-dose Period||24
265953|NCT00413777|644641|P1|STARTED|Fixed-dose Period||22
265954|NCT00413699|644689|P2|NOT COMPLETED|Overall Study||1705
265955|NCT00413699|644690|P1|NOT COMPLETED|Overall Study||639
265956|NCT00413699|644689|P2|COMPLETED|Overall Study||1653
265957|NCT00413699|644690|P1|COMPLETED|Overall Study||484
265958|NCT00413699|644689|P2|STARTED|Overall Study||3358
265959|NCT00413699|644690|P1|STARTED|Overall Study||1123
265960|NCT00413660|644764|P11|NOT COMPLETED|Post Week 12||1
265961|NCT00413660|644765|P10|NOT COMPLETED|Post Week 12||1
265962|NCT00413660|644766|P9|NOT COMPLETED|Post Week 12||0
265963|NCT00413660|644767|P8|NOT COMPLETED|Post Week 12||0
265964|NCT00413660|644768|P7|NOT COMPLETED|Post Week 12||3
265965|NCT00413660|644769|P6|NOT COMPLETED|Post Week 12||3
265966|NCT00413660|644770|P5|NOT COMPLETED|Post Week 12||6
265967|NCT00413660|644771|P4|NOT COMPLETED|Post Week 12||1
265968|NCT00413660|644772|P3|NOT COMPLETED|Post Week 12||8
265969|NCT00413660|644773|P2|NOT COMPLETED|Post Week 12||4
265970|NCT00413660|644774|P1|NOT COMPLETED|Post Week 12||3
265971|NCT00413660|644764|P11|COMPLETED|Post Week 12||17
265972|NCT00413660|644765|P10|COMPLETED|Post Week 12||12
265973|NCT00413660|644766|P9|COMPLETED|Post Week 12||13
265974|NCT00413660|644767|P8|COMPLETED|Post Week 12||21
265975|NCT00413660|644768|P7|COMPLETED|Post Week 12||37
265976|NCT00413660|644769|P6|COMPLETED|Post Week 12||54
265977|NCT00413660|644770|P5|COMPLETED|Post Week 12||60
265978|NCT00413660|644771|P4|COMPLETED|Post Week 12||66
265979|NCT00413660|644772|P3|COMPLETED|Post Week 12||56
265980|NCT00413660|644773|P2|COMPLETED|Post Week 12||44
265981|NCT00413660|644774|P1|COMPLETED|Post Week 12||40
265982|NCT00413660|644764|P11|STARTED|Post Week 12||18
265983|NCT00413660|644765|P10|STARTED|Post Week 12||13
265984|NCT00413660|644766|P9|STARTED|Post Week 12||13
265985|NCT00413660|644767|P8|STARTED|Post Week 12||21
265986|NCT00413660|644768|P7|STARTED|Post Week 12||40
265987|NCT00413660|644769|P6|STARTED|Post Week 12||57
265988|NCT00413660|644770|P5|STARTED|Post Week 12||66
265989|NCT00413660|644771|P4|STARTED|Post Week 12||67
265990|NCT00413660|644772|P3|STARTED|Post Week 12||64
265991|NCT00413660|644773|P2|STARTED|Post Week 12||48
265992|NCT00413660|644774|P1|STARTED|Post Week 12||43
265993|NCT00413660|644764|P11|NOT COMPLETED|Up To Week 12||0
265994|NCT00413660|644765|P10|NOT COMPLETED|Up To Week 12||0
265995|NCT00413660|644766|P9|NOT COMPLETED|Up To Week 12||0
265996|NCT00413660|644767|P8|NOT COMPLETED|Up To Week 12||0
265997|NCT00413660|644768|P7|NOT COMPLETED|Up To Week 12||11
265998|NCT00413660|644769|P6|NOT COMPLETED|Up To Week 12||10
265999|NCT00413660|644770|P5|NOT COMPLETED|Up To Week 12||9
266000|NCT00413660|644771|P4|NOT COMPLETED|Up To Week 12||8
266001|NCT00413660|644772|P3|NOT COMPLETED|Up To Week 12||7
266002|NCT00413660|644773|P2|NOT COMPLETED|Up To Week 12||7
266003|NCT00413660|644774|P1|NOT COMPLETED|Up To Week 12||7
266004|NCT00413660|644764|P11|COMPLETED|Up To Week 12||0
266005|NCT00413660|644765|P10|COMPLETED|Up To Week 12||0
266006|NCT00413660|644766|P9|COMPLETED|Up To Week 12||0
266007|NCT00413660|644767|P8|COMPLETED|Up To Week 12||0
266008|NCT00413660|644768|P7|COMPLETED|Up To Week 12||58
266009|NCT00413660|644769|P6|COMPLETED|Up To Week 12||70
266010|NCT00413660|644770|P5|COMPLETED|Up To Week 12||66
266011|NCT00413660|644771|P4|COMPLETED|Up To Week 12||67
266012|NCT00413660|644772|P3|COMPLETED|Up To Week 12||64
266013|NCT00413660|644773|P2|COMPLETED|Up To Week 12||61
266014|NCT00413660|644774|P1|COMPLETED|Up To Week 12||64
266015|NCT00413660|644764|P11|Treated|Up To Week 12||0
266016|NCT00413660|644765|P10|Treated|Up To Week 12||0
266017|NCT00413660|644766|P9|Treated|Up To Week 12||0
266018|NCT00413660|644767|P8|Treated|Up To Week 12||0
266019|NCT00413660|644768|P7|Treated|Up To Week 12||69
266020|NCT00413660|644769|P6|Treated|Up To Week 12||80
266021|NCT00413660|644770|P5|Treated|Up To Week 12||75
266022|NCT00413660|644771|P4|Treated|Up To Week 12||74
266023|NCT00413660|644772|P3|Treated|Up To Week 12||71
266024|NCT00413660|644773|P2|Treated|Up To Week 12||68
266025|NCT00413660|644774|P1|Treated|Up To Week 12||70
266026|NCT00413660|644764|P11|STARTED|Up To Week 12||0
266027|NCT00413660|644765|P10|STARTED|Up To Week 12||0
266028|NCT00413660|644766|P9|STARTED|Up To Week 12||0
266029|NCT00413660|644767|P8|STARTED|Up To Week 12||0
266030|NCT00413660|644768|P7|STARTED|Up To Week 12||69
266031|NCT00413660|644769|P6|STARTED|Up To Week 12||80
266032|NCT00413660|644770|P5|STARTED|Up To Week 12||75
266033|NCT00413660|644771|P4|STARTED|Up To Week 12||75
266034|NCT00413660|644772|P3|STARTED|Up To Week 12||71
266035|NCT00413660|644773|P2|STARTED|Up To Week 12||68
266036|NCT00413660|644774|P1|STARTED|Up To Week 12||71
266037|NCT00413634|645122|P2|NOT COMPLETED|Overall Study||0
266038|NCT00413634|645123|P1|NOT COMPLETED|Overall Study||0
266039|NCT00413634|645122|P2|COMPLETED|Overall Study||12
266040|NCT00413634|645123|P1|COMPLETED|Overall Study||12
266041|NCT00413634|645122|P2|STARTED|Overall Study||12
266042|NCT00413634|645123|P1|STARTED|Overall Study||12
266043|NCT00413582|645161|P2|NOT COMPLETED|Overall Study||0
266044|NCT00413582|645162|P1|NOT COMPLETED|Overall Study||0
266045|NCT00413582|645161|P2|COMPLETED|Overall Study|all enrolled completed|55
266046|NCT00413582|645162|P1|COMPLETED|Overall Study|all enrolled completed|55
266047|NCT00413582|645161|P2|Completion of Study|Overall Study|all enrolled completed|55
266048|NCT00413582|645162|P1|Completion of Study|Overall Study|all enrolled completed|55
266049|NCT00413582|645161|P2|STARTED|Overall Study|all enrolled completed|55
266050|NCT00413582|645162|P1|STARTED|Overall Study|all enrolled completed|55
266051|NCT00413478|645170|P1|NOT COMPLETED|Overall Study||0
266052|NCT00413478|645170|P1|COMPLETED|Overall Study||9
266053|NCT00413478|645170|P1|STARTED|Overall Study||9
266054|NCT00413413|645177|P3|NOT COMPLETED|Double-Blind||18
266055|NCT00413413|645178|P2|NOT COMPLETED|Double-Blind||14
266056|NCT00413413|645179|P1|NOT COMPLETED|Double-Blind||15
266057|NCT00413413|645177|P3|COMPLETED|Double-Blind||285
266058|NCT00413413|645178|P2|COMPLETED|Double-Blind||293
266059|NCT00413413|645179|P1|COMPLETED|Double-Blind||293
266060|NCT00413413|645177|P3|STARTED|Double-Blind||303
266061|NCT00413413|645178|P2|STARTED|Double-Blind||307
266062|NCT00413413|645179|P1|STARTED|Double-Blind||308
266063|NCT00413413|645177|P3|NOT COMPLETED|Single-Blind||0
266064|NCT00413413|645178|P2|NOT COMPLETED|Single-Blind||216
266065|NCT00413413|645179|P1|NOT COMPLETED|Single-Blind||0
266066|NCT00413413|645177|P3|COMPLETED|Single-Blind||0
266067|NCT00413413|645178|P2|COMPLETED|Single-Blind||918
266068|NCT00413413|645179|P1|COMPLETED|Single-Blind||0
266069|NCT00413413|645177|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
266070|NCT00413413|645178|P2|STARTED|Single-Blind||1134
266071|NCT00413413|645179|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
266072|NCT00413400|645201|P2|NOT COMPLETED|Overall Study||4
266073|NCT00413400|645202|P1|NOT COMPLETED|Overall Study||2
266074|NCT00413400|645201|P2|COMPLETED|Overall Study||12
266075|NCT00413400|645202|P1|COMPLETED|Overall Study||22
266076|NCT00413400|645201|P2|3 Month Visit|Overall Study||12
266077|NCT00413400|645202|P1|3 Month Visit|Overall Study||22
266078|NCT00413400|645201|P2|STARTED|Overall Study||16
266079|NCT00413400|645202|P1|STARTED|Overall Study||24
266080|NCT00413374|645230|P1|NOT COMPLETED|Overall Study||6
266081|NCT00413374|645230|P1|COMPLETED|Overall Study||34
266082|NCT00413374|645230|P1|STARTED|Overall Study||40
266083|NCT00413335|645237|P2|NOT COMPLETED|Overall Study||0
266084|NCT00413335|645238|P1|NOT COMPLETED|Overall Study||0
266085|NCT00413335|645237|P2|COMPLETED|Overall Study||9
266086|NCT00413335|645238|P1|COMPLETED|Overall Study||12
266087|NCT00413335|645237|P2|STARTED|Overall Study||9
266088|NCT00413335|645238|P1|STARTED|Overall Study||12
266089|NCT00413283|645256|P4|NOT COMPLETED|Overall Study||4
266090|NCT00413283|645257|P3|NOT COMPLETED|Overall Study||2
266091|NCT00413283|645258|P2|NOT COMPLETED|Overall Study||3
266092|NCT00413283|645259|P1|NOT COMPLETED|Overall Study||1
266093|NCT00413283|645256|P4|COMPLETED|Overall Study||13
266094|NCT00413283|645257|P3|COMPLETED|Overall Study||16
266095|NCT00413283|645258|P2|COMPLETED|Overall Study||13
266096|NCT00413283|645259|P1|COMPLETED|Overall Study||11
266097|NCT00413283|645256|P4|Received Study Drug|Overall Study||16
266098|NCT00413283|645257|P3|Received Study Drug|Overall Study||18
266099|NCT00413283|645258|P2|Received Study Drug|Overall Study||16
266100|NCT00413283|645259|P1|Received Study Drug|Overall Study||12
266101|NCT00413283|645256|P4|STARTED|Overall Study||17
266102|NCT00413283|645257|P3|STARTED|Overall Study||18
266103|NCT00413283|645258|P2|STARTED|Overall Study||16
266104|NCT00413283|645259|P1|STARTED|Overall Study||12
266105|NCT00413244|645291|P2|NOT COMPLETED|Overall Study||1
266106|NCT00413244|645292|P1|NOT COMPLETED|Overall Study||10
266107|NCT00413244|645291|P2|COMPLETED|Overall Study||19
266108|NCT00413244|645292|P1|COMPLETED|Overall Study||21
266109|NCT00413244|645291|P2|STARTED|Overall Study||20
266110|NCT00413244|645292|P1|STARTED|Overall Study||31
266111|NCT00413231|645320|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
266112|NCT00413231|645320|P1|COMPLETED|365-day to 60-month Post Treatment||93
266113|NCT00413231|645320|P1|STARTED|365-day to 60-month Post Treatment||139
266114|NCT00413231|645320|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
266115|NCT00413231|645320|P1|COMPLETED|30-day to 365-day Post Treatment||139
266116|NCT00413231|645320|P1|STARTED|30-day to 365-day Post Treatment||152
266117|NCT00413231|645320|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
266118|NCT00413231|645320|P1|COMPLETED|0 to 30-day Post Treatment||152
266119|NCT00413231|645320|P1|STARTED|0 to 30-day Post Treatment||160
266120|NCT00413218|645352|P2|NOT COMPLETED|Overall Study||96
266121|NCT00413218|645353|P1|NOT COMPLETED|Overall Study||103
266122|NCT00413218|645352|P2|COMPLETED|Overall Study||131
266123|NCT00413218|645353|P1|COMPLETED|Overall Study||120
266124|NCT00413218|645352|P2|Intent to Treat Population (ITT)|Overall Study||219
266125|NCT00413218|645353|P1|Intent to Treat Population (ITT)|Overall Study||221
266126|NCT00413218|645352|P2|STARTED|Overall Study||227
266127|NCT00413218|645353|P1|STARTED|Overall Study||223
266128|NCT00413192|645379|P4|NOT COMPLETED|Overall Study||32
266129|NCT00413192|645380|P3|NOT COMPLETED|Overall Study||19
266130|NCT00413192|645381|P2|NOT COMPLETED|Overall Study||40
266131|NCT00413192|645382|P1|NOT COMPLETED|Overall Study||37
266132|NCT00413192|645379|P4|COMPLETED|Overall Study||0
266133|NCT00413192|645380|P3|COMPLETED|Overall Study||0
266134|NCT00413192|645381|P2|COMPLETED|Overall Study||0
266135|NCT00413192|645382|P1|COMPLETED|Overall Study||0
266136|NCT00413192|645379|P4|STARTED|Overall Study||32
266137|NCT00413192|645380|P3|STARTED|Overall Study||19
266138|NCT00413192|645381|P2|STARTED|Overall Study||40
266139|NCT00413192|645382|P1|STARTED|Overall Study||37
266140|NCT00413153|645422|P2|NOT COMPLETED|Overall Study||1
266141|NCT00413153|645423|P1|NOT COMPLETED|Overall Study||2
266142|NCT00413153|645422|P2|COMPLETED|Overall Study||7
266143|NCT00413153|645423|P1|COMPLETED|Overall Study||5
266144|NCT00413153|645422|P2|STARTED|Overall Study||8
266145|NCT00413153|645423|P1|STARTED|Overall Study||7
266146|NCT00413062|645447|P2|NOT COMPLETED|Overall Study||210
266147|NCT00413062|645448|P1|NOT COMPLETED|Overall Study||678
266148|NCT00413062|645447|P2|COMPLETED|Overall Study||344
266149|NCT00413062|645448|P1|COMPLETED|Overall Study||988
266150|NCT00413062|645447|P2|STARTED|Overall Study||554
266151|NCT00413062|645448|P1|STARTED|Overall Study||1666
266152|NCT00413049|645474|P2|NOT COMPLETED|Overall Study||18
266153|NCT00413049|645475|P1|NOT COMPLETED|Overall Study||24
266154|NCT00413049|645474|P2|COMPLETED|Overall Study||331
266155|NCT00413049|645475|P1|COMPLETED|Overall Study||325
266156|NCT00413049|645474|P2|STARTED|Overall Study||349
266157|NCT00413049|645475|P1|STARTED|Overall Study||349
266158|NCT00413036|645491|P1|NOT COMPLETED|Overall Study||217
266159|NCT00413036|645491|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
266160|NCT00413036|645491|P1|STARTED|Overall Study||217
266161|NCT00413010|645501|P2|NOT COMPLETED|Overall Study||63
266162|NCT00413010|645502|P1|NOT COMPLETED|Overall Study||72
266163|NCT00413010|645501|P2|COMPLETED|Overall Study||113
266164|NCT00413010|645502|P1|COMPLETED|Overall Study||108
266165|NCT00413010|645501|P2|STARTED|Overall Study||176
266166|NCT00413010|645502|P1|STARTED|Overall Study||180
266167|NCT00412984|645524|P2|NOT COMPLETED|Overall Study||2493
266168|NCT00412984|645525|P1|NOT COMPLETED|Overall Study||2310
266169|NCT00412984|645524|P2|COMPLETED|Overall Study||6588
266170|NCT00412984|645525|P1|COMPLETED|Overall Study||6810
266171|NCT00412984|645524|P2|STARTED|Overall Study|Randomized participants|9081
266172|NCT00412984|645525|P1|STARTED|Overall Study|Randomized participants|9120
266173|NCT00412971|645569|P2|NOT COMPLETED|Overall Study||10
266174|NCT00412971|645570|P1|NOT COMPLETED|Overall Study||30
266175|NCT00412971|645569|P2|COMPLETED|Overall Study||108
266176|NCT00412971|645570|P1|COMPLETED|Overall Study||85
266177|NCT00412971|645569|P2|STARTED|Overall Study||118
266178|NCT00412971|645570|P1|STARTED|Overall Study||115
266179|NCT00412958|645583|P4|NOT COMPLETED|Overall Study||1
266180|NCT00412958|645584|P3|NOT COMPLETED|Overall Study||0
266181|NCT00412958|645585|P2|NOT COMPLETED|Overall Study||4
266182|NCT00412958|645586|P1|NOT COMPLETED|Overall Study||3
266183|NCT00412958|645583|P4|COMPLETED|Overall Study||30
266184|NCT00412958|645584|P3|COMPLETED|Overall Study||32
266185|NCT00412958|645585|P2|COMPLETED|Overall Study||29
266186|NCT00412958|645586|P1|COMPLETED|Overall Study||26
266187|NCT00412958|645583|P4|STARTED|Overall Study||31
266188|NCT00412958|645584|P3|STARTED|Overall Study||32
266189|NCT00412958|645585|P2|STARTED|Overall Study||33
266190|NCT00412958|645586|P1|STARTED|Overall Study||29
266191|NCT00412932|645596|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
266192|NCT00412932|645596|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
266193|NCT00412932|645596|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
266194|NCT00412932|645596|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
266195|NCT00412932|645596|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
266196|NCT00412932|645596|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
266197|NCT00412932|645596|P1|NOT COMPLETED|Olmesartan 40 mg||8
266198|NCT00412932|645596|P1|COMPLETED|Olmesartan 40 mg||161
266199|NCT00412932|645596|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
266200|NCT00412932|645596|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
266201|NCT00412932|645596|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
266202|NCT00412932|645596|P1|STARTED|Olmesartan (Olm) 20 mg||178
266203|NCT00412893|645607|P2|NOT COMPLETED|Overall Study||144
266204|NCT00412893|645608|P1|NOT COMPLETED|Overall Study||145
266205|NCT00412893|645607|P2|COMPLETED|Overall Study|Defined as completed treatment|120
266206|NCT00412893|645608|P1|COMPLETED|Overall Study|Defined as completed treatment|118
266207|NCT00412893|645607|P2|Received Treatment|Overall Study||258
266208|NCT00412893|645608|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
266209|NCT00412893|645607|P2|STARTED|Overall Study||264
266210|NCT00412893|645608|P1|STARTED|Overall Study||263
266211|NCT00412867|645634|P1|NOT COMPLETED|Overall Study||0
266212|NCT00412867|645634|P1|COMPLETED|Overall Study||58
266213|NCT00412867|645634|P1|STARTED|Overall Study||58
266214|NCT00412854|645646|P2|NOT COMPLETED|Overall Study||16
266215|NCT00412854|645647|P1|NOT COMPLETED|Overall Study||14
266216|NCT00412854|645646|P2|COMPLETED|Overall Study||314
266217|NCT00412854|645647|P1|COMPLETED|Overall Study||316
266218|NCT00412854|645646|P2|STARTED|Overall Study||330
266219|NCT00412854|645647|P1|STARTED|Overall Study||330
266220|NCT00412841|645675|P2|NOT COMPLETED|Overall Study||5
266221|NCT00412841|645676|P1|NOT COMPLETED|Overall Study||10
266222|NCT00412841|645675|P2|COMPLETED|Overall Study||16
266223|NCT00412841|645676|P1|COMPLETED|Overall Study||12
266224|NCT00412841|645675|P2|STARTED|Overall Study||21
266225|NCT00412841|645676|P1|STARTED|Overall Study||22
266226|NCT00412750|645687|P3|NOT COMPLETED|Overall Study||23
266227|NCT00412750|645688|P2|NOT COMPLETED|Overall Study||21
266228|NCT00412750|645689|P1|NOT COMPLETED|Overall Study||31
266229|NCT00412750|645687|P3|COMPLETED|Overall Study||31
266230|NCT00412750|645688|P2|COMPLETED|Overall Study||34
266231|NCT00412750|645689|P1|COMPLETED|Overall Study||19
266232|NCT00412750|645687|P3|STARTED|Overall Study||54
266233|NCT00412750|645688|P2|STARTED|Overall Study||55
266234|NCT00412750|645689|P1|STARTED|Overall Study||50
266235|NCT00412737|645714|P2|NOT COMPLETED|Overall Study||6
266236|NCT00412737|645715|P1|NOT COMPLETED|Overall Study||16
266237|NCT00412737|645714|P2|COMPLETED|Overall Study||232
266238|NCT00412737|645715|P1|COMPLETED|Overall Study||221
266239|NCT00412737|645714|P2|STARTED|Overall Study||238
266240|NCT00412737|645715|P1|STARTED|Overall Study||237
266241|NCT00412607|645733|P1|NOT COMPLETED|Overall Study||104
266242|NCT00412607|645733|P1|COMPLETED|Overall Study||145
266243|NCT00412607|645733|P1|Started Study Catheter|Overall Study||233
266244|NCT00412607|645733|P1|STARTED|Overall Study||249
266245|NCT00412542|645746|P2|NOT COMPLETED|Overall Study||3
266246|NCT00412542|645747|P1|NOT COMPLETED|Overall Study||0
266247|NCT00412542|645746|P2|COMPLETED|Overall Study||42
266248|NCT00412542|645747|P1|COMPLETED|Overall Study||33
266249|NCT00412542|645746|P2|STARTED|Overall Study||45
266250|NCT00412542|645747|P1|STARTED|Overall Study||33
266251|NCT00412529|645753|P2|NOT COMPLETED|Overall Study||0
266252|NCT00412529|645754|P1|NOT COMPLETED|Overall Study||0
266253|NCT00412529|645753|P2|COMPLETED|Overall Study||21
266254|NCT00412529|645754|P1|COMPLETED|Overall Study||23
266255|NCT00412529|645753|P2|STARTED|Overall Study||21
266256|NCT00412529|645754|P1|STARTED|Overall Study||23
266257|NCT00412516|645777|P3|NOT COMPLETED|Overall Study||0
266258|NCT00412516|645778|P2|NOT COMPLETED|Overall Study||0
266259|NCT00412516|645779|P1|NOT COMPLETED|Overall Study||0
266260|NCT00412516|645777|P3|COMPLETED|Overall Study||214
266261|NCT00412516|645778|P2|COMPLETED|Overall Study||212
266262|NCT00412516|645779|P1|COMPLETED|Overall Study||93
266263|NCT00412516|645777|P3|STARTED|Overall Study||214
266264|NCT00412516|645778|P2|STARTED|Overall Study||212
266265|NCT00412516|645779|P1|STARTED|Overall Study||93
266266|NCT00412464|645796|P1|NOT COMPLETED|Overall Study||0
266267|NCT00412464|645796|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
266268|NCT00412464|645796|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
266269|NCT00412451|645808|P4|NOT COMPLETED|Overall Study||2
266270|NCT00412451|645809|P3|NOT COMPLETED|Overall Study||1
266271|NCT00412451|645810|P2|NOT COMPLETED|Overall Study||0
266272|NCT00412451|645811|P1|NOT COMPLETED|Overall Study||0
266273|NCT00412451|645808|P4|COMPLETED|Overall Study||11
266274|NCT00412451|645809|P3|COMPLETED|Overall Study||14
266275|NCT00412451|645810|P2|COMPLETED|Overall Study||15
266276|NCT00412451|645811|P1|COMPLETED|Overall Study||8
266277|NCT00412451|645808|P4|STARTED|Overall Study||13
266278|NCT00412451|645809|P3|STARTED|Overall Study||15
266279|NCT00412451|645810|P2|STARTED|Overall Study||15
266280|NCT00412451|645811|P1|STARTED|Overall Study||8
266281|NCT00412425|645823|P2|NOT COMPLETED|Overall Study||0
266282|NCT00412425|645824|P1|NOT COMPLETED|Overall Study||0
266283|NCT00412425|645823|P2|COMPLETED|Overall Study||15
266284|NCT00412425|645824|P1|COMPLETED|Overall Study||15
266285|NCT00412425|645823|P2|STARTED|Overall Study||15
266286|NCT00412425|645824|P1|STARTED|Overall Study||15
266287|NCT00412373|645832|P2|NOT COMPLETED|Overall Study||77
266288|NCT00412373|645833|P1|NOT COMPLETED|Overall Study||41
266289|NCT00412373|645832|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
266290|NCT00412373|645833|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
266291|NCT00412373|645832|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
266292|NCT00412373|645833|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
266293|NCT00412360|645875|P2|NOT COMPLETED|Overall Study||3
266294|NCT00412360|645876|P1|NOT COMPLETED|Overall Study||1
266295|NCT00412360|645875|P2|COMPLETED|Overall Study||108
266296|NCT00412360|645876|P1|COMPLETED|Overall Study||112
266297|NCT00412360|645875|P2|STARTED|Overall Study||111
266298|NCT00412360|645876|P1|STARTED|Overall Study||113
266299|NCT00412243|645900|P1|NOT COMPLETED|Overall Study||0
266300|NCT00412243|645900|P1|COMPLETED|Overall Study||50
266301|NCT00412243|645900|P1|STARTED|Overall Study||50
266302|NCT00412217|645906|P2|NOT COMPLETED|Overall Study||48
266303|NCT00412217|645907|P1|NOT COMPLETED|Overall Study||46
266304|NCT00412217|645906|P2|COMPLETED|Overall Study||0
266305|NCT00412217|645907|P1|COMPLETED|Overall Study||0
266306|NCT00412217|645906|P2|STARTED|Overall Study||48
266307|NCT00412217|645907|P1|STARTED|Overall Study||46
266308|NCT00412113|645921|P2|NOT COMPLETED|Overall Study||15
266309|NCT00412113|645922|P1|NOT COMPLETED|Overall Study||12
266310|NCT00412113|645921|P2|COMPLETED|Overall Study|15-April-2008|107
266311|NCT00412113|645922|P1|COMPLETED|Overall Study|15-April-2008|111
266312|NCT00412113|645921|P2|Received Treatment|Overall Study||122
266313|NCT00412113|645922|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
266314|NCT00412113|645921|P2|STARTED|Overall Study|15-January-2007|122
266315|NCT00412113|645922|P1|STARTED|Overall Study|15-January-2007|123
266316|NCT00412087|645976|P2|NOT COMPLETED|Overall Study||65
266317|NCT00412087|645977|P1|NOT COMPLETED|Overall Study||62
266318|NCT00412087|645976|P2|COMPLETED|Overall Study||66
266319|NCT00412087|645977|P1|COMPLETED|Overall Study||72
266320|NCT00412087|645976|P2|STARTED|Overall Study||131
266321|NCT00412087|645977|P1|STARTED|Overall Study||134
266322|NCT00412074|645988|P3|NOT COMPLETED|Overall Study||67
266323|NCT00412074|645989|P2|NOT COMPLETED|Overall Study||22
266324|NCT00412074|645990|P1|NOT COMPLETED|Overall Study||77
266325|NCT00412074|645988|P3|COMPLETED|Overall Study||128
266326|NCT00412074|645989|P2|COMPLETED|Overall Study||44
266327|NCT00412074|645990|P1|COMPLETED|Overall Study||122
266328|NCT00412074|645988|P3|STARTED|Overall Study||195
266329|NCT00412074|645989|P2|STARTED|Overall Study||66
266330|NCT00412074|645990|P1|STARTED|Overall Study||199
266331|NCT00412061|646006|P2|NOT COMPLETED|Open Label Phase||170
266332|NCT00412061|646007|P1|NOT COMPLETED|Open Label Phase||0
266333|NCT00412061|646006|P2|COMPLETED|Open Label Phase||0
266334|NCT00412061|646007|P1|COMPLETED|Open Label Phase||0
266335|NCT00412061|646006|P2|STARTED|Open Label Phase||170
266336|NCT00412061|646007|P1|STARTED|Open Label Phase||0
266337|NCT00412061|646006|P2|NOT COMPLETED|Double Blind Phase||213
266338|NCT00412061|646007|P1|NOT COMPLETED|Double Blind Phase||216
266339|NCT00412061|646006|P2|COMPLETED|Double Blind Phase||0
266340|NCT00412061|646007|P1|COMPLETED|Double Blind Phase||0
266341|NCT00412061|646006|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
266342|NCT00412061|646007|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
266343|NCT00412061|646006|P2|STARTED|Double Blind Phase||213
266344|NCT00412061|646007|P1|STARTED|Double Blind Phase||216
266345|NCT00411788|646025|P1|NOT COMPLETED|Overall Study||2
266346|NCT00411788|646025|P1|COMPLETED|Overall Study||9
266347|NCT00411788|646025|P1|STARTED|Overall Study||11
266348|NCT00411762|646034|P1|NOT COMPLETED|Overall Study||5
266349|NCT00411762|646034|P1|COMPLETED|Overall Study||20
266350|NCT00411762|646034|P1|STARTED|Overall Study||25
266351|NCT00411749|646041|P2|NOT COMPLETED|Overall Study||0
266352|NCT00411749|646042|P1|NOT COMPLETED|Overall Study||0
266353|NCT00411749|646041|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
266354|NCT00411749|646042|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
266355|NCT00411749|646041|P2|Vaccinated|Overall Study||25
266356|NCT00411749|646042|P1|Vaccinated|Overall Study||82
266357|NCT00411749|646041|P2|STARTED|Overall Study||25
266358|NCT00411749|646042|P1|STARTED|Overall Study||82
266359|NCT00411671|646058|P1|NOT COMPLETED|Overall Study||20
266360|NCT00411671|646058|P1|COMPLETED|Overall Study||85
266361|NCT00411671|646058|P1|STARTED|Overall Study||105
266362|NCT00411645|646066|P2|NOT COMPLETED|Overall Study||164
266363|NCT00411645|646067|P1|NOT COMPLETED|Overall Study||81
266364|NCT00411645|646066|P2|COMPLETED|Overall Study||290
266365|NCT00411645|646067|P1|COMPLETED|Overall Study||146
266366|NCT00411645|646066|P2|STARTED|Overall Study||454
266367|NCT00411645|646067|P1|STARTED|Overall Study||227
266368|NCT00411619|646091|P1|NOT COMPLETED|Overall Study||6
266369|NCT00411619|646091|P1|COMPLETED|Overall Study||22
266370|NCT00411619|646091|P1|STARTED|Overall Study||28
266371|NCT00411554|646098|P2|NOT COMPLETED|Overall Study||9
266372|NCT00411554|646099|P1|NOT COMPLETED|Overall Study||8
266373|NCT00411554|646098|P2|COMPLETED|Overall Study||147
266374|NCT00411554|646099|P1|COMPLETED|Overall Study||155
266375|NCT00411554|646098|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
266376|NCT00411554|646099|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
266377|NCT00411463|646111|P2|NOT COMPLETED|Overall Study||3
266378|NCT00411463|646112|P1|NOT COMPLETED|Overall Study||3
266379|NCT00411463|646111|P2|COMPLETED|Overall Study||8
266380|NCT00411463|646112|P1|COMPLETED|Overall Study||11
266381|NCT00411463|646111|P2|STARTED|Overall Study||11
266382|NCT00411463|646112|P1|STARTED|Overall Study||14
266383|NCT00411450|646125|P1|NOT COMPLETED|Overall Study||3
266384|NCT00411450|646125|P1|COMPLETED|Overall Study|Ended second-line treatment|113
266385|NCT00411450|646125|P1|Received Treatment|Overall Study||115
266386|NCT00411450|646125|P1|STARTED|Overall Study||116
266387|NCT00411411|646153|P2|NOT COMPLETED|Overall Study||0
266388|NCT00411411|646154|P1|NOT COMPLETED|Overall Study||0
266389|NCT00411411|646153|P2|COMPLETED|Overall Study||25
266390|NCT00411411|646154|P1|COMPLETED|Overall Study||24
266391|NCT00411411|646153|P2|STARTED|Overall Study||25
266392|NCT00411411|646154|P1|STARTED|Overall Study||24
266393|NCT00411398|646162|P1|NOT COMPLETED|Overall Study||5
266394|NCT00411398|646162|P1|COMPLETED|Overall Study||10
266395|NCT00411398|646162|P1|STARTED|Overall Study||15
266396|NCT00411216|646168|P2|NOT COMPLETED|Overall Study||2
266397|NCT00411216|646169|P1|NOT COMPLETED|Overall Study||0
266398|NCT00411216|646168|P2|COMPLETED|Overall Study||8
266399|NCT00411216|646169|P1|COMPLETED|Overall Study||13
266400|NCT00411216|646168|P2|STARTED|Overall Study||10
266401|NCT00411216|646169|P1|STARTED|Overall Study||13
266402|NCT00411151|646175|P1|NOT COMPLETED|Overall Study||47
266403|NCT00411151|646175|P1|COMPLETED|Overall Study||5
266404|NCT00411151|646175|P1|STARTED|Overall Study||52
266405|NCT00411086|646185|P1|NOT COMPLETED|Overall Study||0
266406|NCT00411086|646185|P1|COMPLETED|Overall Study||52
266407|NCT00411086|646185|P1|STARTED|Overall Study||52
266408|NCT00410904|646193|P2|NOT COMPLETED|Overall Study||0
266409|NCT00410904|646194|P1|NOT COMPLETED|Overall Study||0
266410|NCT00410904|646193|P2|COMPLETED|Overall Study||20
266411|NCT00410904|646194|P1|COMPLETED|Overall Study||40
266412|NCT00410904|646193|P2|STARTED|Overall Study||20
266413|NCT00410904|646194|P1|STARTED|Overall Study||40
266414|NCT00410891|646202|P1|NOT COMPLETED|Overall Study||0
266415|NCT00410891|646202|P1|COMPLETED|Overall Study||129
266416|NCT00410891|646202|P1|STARTED|Overall Study||129
266417|NCT00410826|646208|P2|NOT COMPLETED|Overall Study||4
266418|NCT00410826|646209|P1|NOT COMPLETED|Overall Study||9
266419|NCT00410826|646208|P2|COMPLETED|Overall Study||95
266420|NCT00410826|646209|P1|COMPLETED|Overall Study||96
266421|NCT00410826|646208|P2|STARTED|Overall Study||99
266422|NCT00410826|646209|P1|STARTED|Overall Study||105
266423|NCT00410813|646219|P2|NOT COMPLETED|Overall Study||42
266424|NCT00410813|646220|P1|NOT COMPLETED|Overall Study||43
266425|NCT00410813|646219|P2|COMPLETED|Overall Study||0
266426|NCT00410813|646220|P1|COMPLETED|Overall Study|Patients treated until progression.|0
266427|NCT00410813|646219|P2|Eligible|Overall Study||38
266428|NCT00410813|646220|P1|Eligible|Overall Study||41
266429|NCT00410813|646219|P2|STARTED|Overall Study||42
266430|NCT00410813|646220|P1|STARTED|Overall Study||43
266431|NCT00410761|646257|P2|NOT COMPLETED|Overall Study||72
266432|NCT00410761|646258|P1|NOT COMPLETED|Overall Study||120
266433|NCT00410761|646257|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
266434|NCT00410761|646258|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
266435|NCT00410761|646257|P2|STARTED|Overall Study|randomised patients|100
266436|NCT00410761|646258|P1|STARTED|Overall Study|randomised patients|231
266437|NCT00410605|646278|P1|NOT COMPLETED|Overall Study||25
266438|NCT00410605|646278|P1|COMPLETED|Overall Study||14
266439|NCT00410605|646278|P1|STARTED|Overall Study||39
266440|NCT00410514|646290|P3|NOT COMPLETED|Overall Study||7
266441|NCT00410514|646291|P2|NOT COMPLETED|Overall Study||3
266442|NCT00410514|646292|P1|NOT COMPLETED|Overall Study||2
266443|NCT00410514|646290|P3|COMPLETED|Overall Study||58
266444|NCT00410514|646291|P2|COMPLETED|Overall Study||67
266445|NCT00410514|646292|P1|COMPLETED|Overall Study||63
266446|NCT00410514|646290|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
266447|NCT00410514|646291|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
266448|NCT00410514|646292|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
266449|NCT00410514|646290|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
266450|NCT00410514|646291|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
266451|NCT00410514|646292|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
266452|NCT00410514|646290|P3|STARTED|Overall Study||65
266453|NCT00410514|646291|P2|STARTED|Overall Study||70
266454|NCT00410514|646292|P1|STARTED|Overall Study||65
266455|NCT00410488|646353|P2|NOT COMPLETED|Overall Study||0
266456|NCT00410488|646354|P1|NOT COMPLETED|Overall Study||0
266457|NCT00410488|646353|P2|COMPLETED|Overall Study||34
266458|NCT00410488|646354|P1|COMPLETED|Overall Study||16
266459|NCT00410488|646353|P2|STARTED|Overall Study||34
266460|NCT00410488|646354|P1|STARTED|Overall Study||16
266461|NCT00410423|646359|P4|NOT COMPLETED|Phase 2||0
266462|NCT00410423|646360|P3|NOT COMPLETED|Phase 2||0
266463|NCT00410423|646361|P2|NOT COMPLETED|Phase 2||0
266464|NCT00410423|646362|P1|NOT COMPLETED|Phase 2||0
266465|NCT00410423|646359|P4|COMPLETED|Phase 2||44
266466|NCT00410423|646360|P3|COMPLETED|Phase 2||0
266467|NCT00410423|646361|P2|COMPLETED|Phase 2||0
266468|NCT00410423|646362|P1|COMPLETED|Phase 2||0
266469|NCT00410423|646359|P4|STARTED|Phase 2||44
266470|NCT00410423|646360|P3|STARTED|Phase 2||0
266471|NCT00410423|646361|P2|STARTED|Phase 2||0
266472|NCT00410423|646362|P1|STARTED|Phase 2||0
266473|NCT00410423|646359|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
266474|NCT00410423|646360|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
266475|NCT00410423|646361|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
266476|NCT00410423|646362|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
266477|NCT00410423|646359|P4|COMPLETED|Phase 1 - Dose Level 3||0
266478|NCT00410423|646360|P3|COMPLETED|Phase 1 - Dose Level 3||3
266479|NCT00410423|646361|P2|COMPLETED|Phase 1 - Dose Level 3||0
266480|NCT00410423|646362|P1|COMPLETED|Phase 1 - Dose Level 3||0
266481|NCT00410423|646359|P4|STARTED|Phase 1 - Dose Level 3||0
266482|NCT00410423|646360|P3|STARTED|Phase 1 - Dose Level 3||3
266483|NCT00410423|646361|P2|STARTED|Phase 1 - Dose Level 3||0
266484|NCT00410423|646362|P1|STARTED|Phase 1 - Dose Level 3||0
266485|NCT00410423|646359|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
266486|NCT00410423|646360|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
266487|NCT00410423|646361|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
266488|NCT00410423|646362|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
266489|NCT00410423|646359|P4|COMPLETED|Phase 1 - Dose Level 2||0
266490|NCT00410423|646360|P3|COMPLETED|Phase 1 - Dose Level 2||0
266491|NCT00410423|646361|P2|COMPLETED|Phase 1 - Dose Level 2||5
266492|NCT00410423|646362|P1|COMPLETED|Phase 1 - Dose Level 2||0
266493|NCT00410423|646359|P4|STARTED|Phase 1 - Dose Level 2||0
266494|NCT00410423|646360|P3|STARTED|Phase 1 - Dose Level 2||0
266495|NCT00410423|646361|P2|STARTED|Phase 1 - Dose Level 2||5
266496|NCT00410423|646362|P1|STARTED|Phase 1 - Dose Level 2||0
266497|NCT00410423|646359|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
266498|NCT00410423|646360|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
266499|NCT00410423|646361|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
266500|NCT00410423|646362|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
266501|NCT00410423|646359|P4|COMPLETED|Phase 1 - Dose Level 1||0
266502|NCT00410423|646360|P3|COMPLETED|Phase 1 - Dose Level 1||0
266503|NCT00410423|646361|P2|COMPLETED|Phase 1 - Dose Level 1||0
266504|NCT00410423|646362|P1|COMPLETED|Phase 1 - Dose Level 1||3
266505|NCT00410423|646359|P4|STARTED|Phase 1 - Dose Level 1||0
266506|NCT00410423|646360|P3|STARTED|Phase 1 - Dose Level 1||0
266507|NCT00410423|646361|P2|STARTED|Phase 1 - Dose Level 1||0
266508|NCT00410423|646362|P1|STARTED|Phase 1 - Dose Level 1||3
266509|NCT00410410|646375|P9|NOT COMPLETED|Open-Label Period (OL)||349
266510|NCT00410410|646376|P8|NOT COMPLETED|Open-Label Period (OL)||0
266511|NCT00410410|646377|P7|NOT COMPLETED|Open-Label Period (OL)||0
266512|NCT00410410|646378|P6|NOT COMPLETED|Open-Label Period (OL)||0
266513|NCT00410410|646379|P5|NOT COMPLETED|Open-Label Period (OL)||0
266514|NCT00410410|646380|P4|NOT COMPLETED|Open-Label Period (OL)||0
266515|NCT00410410|646381|P3|NOT COMPLETED|Open-Label Period (OL)||0
266516|NCT00410410|646382|P2|NOT COMPLETED|Open-Label Period (OL)||0
266517|NCT00410410|646383|P1|NOT COMPLETED|Open-Label Period (OL)||0
266518|NCT00410410|646375|P9|COMPLETED|Open-Label Period (OL)||0
266519|NCT00410410|646376|P8|COMPLETED|Open-Label Period (OL)||0
266520|NCT00410410|646377|P7|COMPLETED|Open-Label Period (OL)||0
266521|NCT00410410|646378|P6|COMPLETED|Open-Label Period (OL)||0
266522|NCT00410410|646379|P5|COMPLETED|Open-Label Period (OL)||0
266523|NCT00410410|646380|P4|COMPLETED|Open-Label Period (OL)||0
266524|NCT00410410|646381|P3|COMPLETED|Open-Label Period (OL)||0
266525|NCT00410410|646382|P2|COMPLETED|Open-Label Period (OL)||0
266526|NCT00410410|646383|P1|COMPLETED|Open-Label Period (OL)||0
266527|NCT00410410|646375|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
266528|NCT00410410|646376|P8|STARTED|Open-Label Period (OL)||0
266529|NCT00410410|646377|P7|STARTED|Open-Label Period (OL)||0
266530|NCT00410410|646378|P6|STARTED|Open-Label Period (OL)||0
266531|NCT00410410|646379|P5|STARTED|Open-Label Period (OL)||0
266532|NCT00410410|646380|P4|STARTED|Open-Label Period (OL)||0
266533|NCT00410410|646381|P3|STARTED|Open-Label Period (OL)||0
266534|NCT00410410|646382|P2|STARTED|Open-Label Period (OL)||0
266535|NCT00410410|646383|P1|STARTED|Open-Label Period (OL)||0
266536|NCT00410410|646375|P9|NOT COMPLETED|Maintenance Period (MP)||0
266537|NCT00410410|646376|P8|NOT COMPLETED|Maintenance Period (MP)||55
266538|NCT00410410|646377|P7|NOT COMPLETED|Maintenance Period (MP)||50
266539|NCT00410410|646378|P6|NOT COMPLETED|Maintenance Period (MP)||0
266540|NCT00410410|646379|P5|NOT COMPLETED|Maintenance Period (MP)||0
266541|NCT00410410|646380|P4|NOT COMPLETED|Maintenance Period (MP)||0
266542|NCT00410410|646381|P3|NOT COMPLETED|Maintenance Period (MP)||0
266543|NCT00410410|646382|P2|NOT COMPLETED|Maintenance Period (MP)||0
266544|NCT00410410|646383|P1|NOT COMPLETED|Maintenance Period (MP)||0
266545|NCT00410410|646375|P9|COMPLETED|Maintenance Period (MP)||0
266546|NCT00410410|646376|P8|COMPLETED|Maintenance Period (MP)||11
266547|NCT00410410|646377|P7|COMPLETED|Maintenance Period (MP)||15
266548|NCT00410410|646378|P6|COMPLETED|Maintenance Period (MP)||0
266549|NCT00410410|646379|P5|COMPLETED|Maintenance Period (MP)||0
266550|NCT00410410|646380|P4|COMPLETED|Maintenance Period (MP)||0
266551|NCT00410410|646381|P3|COMPLETED|Maintenance Period (MP)||0
266552|NCT00410410|646382|P2|COMPLETED|Maintenance Period (MP)||0
266553|NCT00410410|646383|P1|COMPLETED|Maintenance Period (MP)||0
266554|NCT00410410|646375|P9|STARTED|Maintenance Period (MP)||0
266555|NCT00410410|646376|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
266556|NCT00410410|646377|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
266557|NCT00410410|646378|P6|STARTED|Maintenance Period (MP)||0
266558|NCT00410410|646379|P5|STARTED|Maintenance Period (MP)||0
266559|NCT00410410|646380|P4|STARTED|Maintenance Period (MP)||0
266560|NCT00410410|646381|P3|STARTED|Maintenance Period (MP)||0
266561|NCT00410410|646382|P2|STARTED|Maintenance Period (MP)||0
266562|NCT00410410|646383|P1|STARTED|Maintenance Period (MP)||0
266563|NCT00410410|646375|P9|NOT COMPLETED|Induction Period (IP)||0
266564|NCT00410410|646376|P8|NOT COMPLETED|Induction Period (IP)||0
266565|NCT00410410|646377|P7|NOT COMPLETED|Induction Period (IP)||0
266566|NCT00410410|646378|P6|NOT COMPLETED|Induction Period (IP)||29
266567|NCT00410410|646379|P5|NOT COMPLETED|Induction Period (IP)||32
266568|NCT00410410|646380|P4|NOT COMPLETED|Induction Period (IP)||20
266569|NCT00410410|646381|P3|NOT COMPLETED|Induction Period (IP)||17
266570|NCT00410410|646382|P2|NOT COMPLETED|Induction Period (IP)||35
266571|NCT00410410|646383|P1|NOT COMPLETED|Induction Period (IP)||35
266572|NCT00410410|646375|P9|COMPLETED|Induction Period (IP)||0
266573|NCT00410410|646376|P8|COMPLETED|Induction Period (IP)||0
266574|NCT00410410|646377|P7|COMPLETED|Induction Period (IP)||0
266575|NCT00410410|646378|P6|COMPLETED|Induction Period (IP)||21
266576|NCT00410410|646379|P5|COMPLETED|Induction Period (IP)||19
266577|NCT00410410|646380|P4|COMPLETED|Induction Period (IP)||120
266578|NCT00410410|646381|P3|COMPLETED|Induction Period (IP)||53
266579|NCT00410410|646382|P2|COMPLETED|Induction Period (IP)||104
266580|NCT00410410|646383|P1|COMPLETED|Induction Period (IP)||106
266581|NCT00410410|646375|P9|STARTED|Induction Period (IP)||0
266582|NCT00410410|646376|P8|STARTED|Induction Period (IP)||0
266583|NCT00410410|646377|P7|STARTED|Induction Period (IP)||0
266584|NCT00410410|646378|P6|STARTED|Induction Period (IP)||50
266585|NCT00410410|646379|P5|STARTED|Induction Period (IP)||51
266586|NCT00410410|646380|P4|STARTED|Induction Period (IP)||140
266587|NCT00410410|646381|P3|STARTED|Induction Period (IP)||70
266588|NCT00410410|646382|P2|STARTED|Induction Period (IP)||139
266589|NCT00410410|646383|P1|STARTED|Induction Period (IP)||141
266590|NCT00410384|646544|P3|NOT COMPLETED|Overall Study||82
266591|NCT00410384|646545|P2|NOT COMPLETED|Overall Study||72
266592|NCT00410384|646546|P1|NOT COMPLETED|Overall Study||89
266593|NCT00410384|646544|P3|COMPLETED|Overall Study||191
266594|NCT00410384|646545|P2|COMPLETED|Overall Study||199
266595|NCT00410384|646546|P1|COMPLETED|Overall Study||186
266596|NCT00410384|646544|P3|STARTED|Overall Study||273
266597|NCT00410384|646545|P2|STARTED|Overall Study||271
266598|NCT00410384|646546|P1|STARTED|Overall Study||275
266599|NCT00410280|646574|P2|NOT COMPLETED|Overall Study||0
266600|NCT00410280|646575|P1|NOT COMPLETED|Overall Study||0
266601|NCT00410280|646574|P2|COMPLETED|Overall Study||13
266602|NCT00410280|646575|P1|COMPLETED|Overall Study||14
266603|NCT00410280|646574|P2|STARTED|Overall Study||13
266604|NCT00410280|646575|P1|STARTED|Overall Study||14
266605|NCT00410202|646619|P3|NOT COMPLETED|Off-treatment Follow up||12
266606|NCT00410202|646620|P2|NOT COMPLETED|Off-treatment Follow up||8
266607|NCT00410202|646621|P1|NOT COMPLETED|Off-treatment Follow up||14
266608|NCT00410202|646619|P3|COMPLETED|Off-treatment Follow up||2
266609|NCT00410202|646620|P2|COMPLETED|Off-treatment Follow up||0
266610|NCT00410202|646621|P1|COMPLETED|Off-treatment Follow up||1
266611|NCT00410202|646619|P3|STARTED|Off-treatment Follow up||14
266612|NCT00410202|646620|P2|STARTED|Off-treatment Follow up||8
266613|NCT00410202|646621|P1|STARTED|Off-treatment Follow up||15
266614|NCT00410202|646619|P3|NOT COMPLETED|On-Treatment||71
266615|NCT00410202|646620|P2|NOT COMPLETED|On-Treatment||79
266616|NCT00410202|646621|P1|NOT COMPLETED|On-Treatment||75
266617|NCT00410202|646619|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
266618|NCT00410202|646620|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
266619|NCT00410202|646621|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
266620|NCT00410202|646619|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
266621|NCT00410202|646620|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
266622|NCT00410202|646621|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
266623|NCT00410202|646619|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
266624|NCT00410202|646620|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
266625|NCT00410202|646621|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
266626|NCT00410202|646619|P3|STARTED|On-Treatment||137
266627|NCT00410202|646620|P2|STARTED|On-Treatment||140
266628|NCT00410202|646621|P1|STARTED|On-Treatment||138
266629|NCT00410189|646701|P1|NOT COMPLETED|Overall Study||0
266630|NCT00410189|646701|P1|COMPLETED|Overall Study||54
266631|NCT00410189|646701|P1|STARTED|Overall Study||54
266632|NCT00410163|646708|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
266633|NCT00410163|646709|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
266634|NCT00410163|646708|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
266635|NCT00410163|646709|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
266636|NCT00410163|646708|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
266637|NCT00410163|646709|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
266638|NCT00410163|646708|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
266639|NCT00410163|646709|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
266640|NCT00410163|646708|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
266641|NCT00410163|646709|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
266642|NCT00410163|646708|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
266643|NCT00410163|646709|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
266644|NCT00410150|646753|P2|NOT COMPLETED|Overall Study||3
266645|NCT00410150|646754|P1|NOT COMPLETED|Overall Study||2
266646|NCT00410150|646753|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
266647|NCT00410150|646754|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
266648|NCT00410150|646753|P2|STARTED|Overall Study||20
266649|NCT00410150|646754|P1|STARTED|Overall Study||22
266650|NCT00410124|646762|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
266651|NCT00410124|646763|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
266652|NCT00410124|646762|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
266653|NCT00410124|646763|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
266654|NCT00410124|646762|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
266655|NCT00410124|646763|P1|STARTED|Extension Phase - Open Label (45 Months)||67
266656|NCT00410124|646762|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
266657|NCT00410124|646763|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
266658|NCT00410124|646762|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
266659|NCT00410124|646763|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
266660|NCT00410124|646762|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
266661|NCT00410124|646763|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
266662|NCT00410124|646762|P2|Ongoing|Core Phase Double Blind (15 Months)||4
266663|NCT00410124|646763|P1|Ongoing|Core Phase Double Blind (15 Months)||13
266664|NCT00410124|646762|P2|STARTED|Core Phase Double Blind (15 Months)||139
266665|NCT00410124|646763|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
266666|NCT00410072|646794|P2|NOT COMPLETED|After Week 48 to Week 96||11
266667|NCT00410072|646795|P1|NOT COMPLETED|After Week 48 to Week 96||6
266668|NCT00410072|646794|P2|COMPLETED|After Week 48 to Week 96||174
266669|NCT00410072|646795|P1|COMPLETED|After Week 48 to Week 96||170
266670|NCT00410072|646794|P2|STARTED|After Week 48 to Week 96||185
266671|NCT00410072|646795|P1|STARTED|After Week 48 to Week 96||176
266672|NCT00410072|646794|P2|NOT COMPLETED|Day 1 to Week 48||12
266673|NCT00410072|646795|P1|NOT COMPLETED|Day 1 to Week 48||6
266674|NCT00410072|646794|P2|COMPLETED|Day 1 to Week 48||185
266675|NCT00410072|646795|P1|COMPLETED|Day 1 to Week 48||176
266676|NCT00410072|646794|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
266677|NCT00410072|646795|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
266678|NCT00410059|646831|P1|NOT COMPLETED|Overall Study||0
266679|NCT00410059|646831|P1|COMPLETED|Overall Study||59
266680|NCT00410059|646831|P1|STARTED|Overall Study||59
266681|NCT00410046|646835|P1|NOT COMPLETED|Overall Study||5
266682|NCT00410046|646835|P1|COMPLETED|Overall Study||79
266683|NCT00410046|646835|P1|STARTED|Overall Study||84
266684|NCT00409838|646866|P2|NOT COMPLETED|Long-term Extension Period||0
266685|NCT00409838|646867|P1|NOT COMPLETED|Long-term Extension Period||18
266686|NCT00409838|646866|P2|COMPLETED|Long-term Extension Period||0
266687|NCT00409838|646867|P1|COMPLETED|Long-term Extension Period||87
266688|NCT00409838|646866|P2|STARTED|Long-term Extension Period||0
266689|NCT00409838|646867|P1|STARTED|Long-term Extension Period||105
266690|NCT00409838|646866|P2|NOT COMPLETED|Short-term Period||5
266691|NCT00409838|646867|P1|NOT COMPLETED|Short-term Period||3
266692|NCT00409838|646866|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
266693|NCT00409838|646867|P1|COMPLETED|Short-term Period||53
266694|NCT00409838|646866|P2|Treated (Baseline) Population|Short-term Period||57
266695|NCT00409838|646867|P1|Treated (Baseline) Population|Short-term Period||55
266696|NCT00409838|646866|P2|STARTED|Short-term Period|Randomized|57
266697|NCT00409838|646867|P1|STARTED|Short-term Period|Randomized|56
266698|NCT00409825|646928|P1|NOT COMPLETED|Overall Study||0
266699|NCT00409825|646928|P1|COMPLETED|Overall Study||61
266700|NCT00409825|646928|P1|STARTED|Overall Study||61
266701|NCT00409786|646932|P1|NOT COMPLETED|Overall Study||3
266702|NCT00409786|646932|P1|COMPLETED|Overall Study||47
266703|NCT00409786|646932|P1|STARTED|Overall Study||50
266704|NCT00409773|646941|P5|NOT COMPLETED|Overall Study||10
266705|NCT00409773|646942|P4|NOT COMPLETED|Overall Study||12
266706|NCT00409773|646943|P3|NOT COMPLETED|Overall Study||9
266707|NCT00409773|646944|P2|NOT COMPLETED|Overall Study||7
266708|NCT00409773|646945|P1|NOT COMPLETED|Overall Study||9
266709|NCT00409773|646941|P5|COMPLETED|Overall Study||218
266710|NCT00409773|646942|P4|COMPLETED|Overall Study||216
266711|NCT00409773|646943|P3|COMPLETED|Overall Study||220
266712|NCT00409773|646944|P2|COMPLETED|Overall Study||222
266713|NCT00409773|646945|P1|COMPLETED|Overall Study||220
266714|NCT00409773|646941|P5|STARTED|Overall Study||228
266715|NCT00409773|646942|P4|STARTED|Overall Study||228
266716|NCT00409773|646943|P3|STARTED|Overall Study||229
266717|NCT00409773|646944|P2|STARTED|Overall Study||229
266718|NCT00409773|646945|P1|STARTED|Overall Study||229
266719|NCT00409747|647027|P1|NOT COMPLETED|Overall Study||1
266720|NCT00409747|647027|P1|COMPLETED|Overall Study||10
266721|NCT00409747|647027|P1|STARTED|Overall Study||11
266722|NCT00409708|647034|P2|NOT COMPLETED|Washout||10
266723|NCT00409708|647035|P1|NOT COMPLETED|Washout||21
266724|NCT00409708|647034|P2|COMPLETED|Washout||29
266725|NCT00409708|647035|P1|COMPLETED|Washout||17
266726|NCT00409708|647034|P2|STARTED|Washout||39
266727|NCT00409708|647035|P1|STARTED|Washout||38
266728|NCT00409708|647034|P2|NOT COMPLETED|Treatment||17
266729|NCT00409708|647035|P1|NOT COMPLETED|Treatment||15
266730|NCT00409708|647034|P2|COMPLETED|Treatment||39
266731|NCT00409708|647035|P1|COMPLETED|Treatment||38
266732|NCT00409708|647034|P2|STARTED|Treatment||56
266733|NCT00409708|647035|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
266734|NCT00409682|647056|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
266735|NCT00409682|647057|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
266736|NCT00409682|647058|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
266737|NCT00409682|647056|P3|COMPLETED|EOW Double-blind Maintenance Period||66
266738|NCT00409682|647057|P2|COMPLETED|EOW Double-blind Maintenance Period||58
266739|NCT00409682|647058|P1|COMPLETED|EOW Double-blind Maintenance Period||0
266740|NCT00409682|647056|P3|STARTED|EOW Double-blind Maintenance Period||93
266741|NCT00409682|647057|P2|STARTED|EOW Double-blind Maintenance Period||95
266742|NCT00409682|647058|P1|STARTED|EOW Double-blind Maintenance Period||0
266743|NCT00409682|647056|P3|NOT COMPLETED|Open-label Induction Period||0
266744|NCT00409682|647057|P2|NOT COMPLETED|Open-label Induction Period||0
266745|NCT00409682|647058|P1|NOT COMPLETED|Open-label Induction Period||4
266746|NCT00409682|647056|P3|COMPLETED|Open-label Induction Period||0
266747|NCT00409682|647057|P2|COMPLETED|Open-label Induction Period||0
266748|NCT00409682|647058|P1|COMPLETED|Open-label Induction Period||188
266749|NCT00409682|647056|P3|STARTED|Open-label Induction Period||0
266750|NCT00409682|647057|P2|STARTED|Open-label Induction Period||0
266751|NCT00409682|647058|P1|STARTED|Open-label Induction Period||192
266752|NCT00409617|647075|P1|NOT COMPLETED|Overall Study||160
266753|NCT00409617|647075|P1|COMPLETED|Overall Study||785
266754|NCT00409617|647075|P1|STARTED|Overall Study||945
266755|NCT00409578|647091|P4|NOT COMPLETED|Overall Study||67
266756|NCT00409578|647092|P3|NOT COMPLETED|Overall Study||54
266757|NCT00409578|647093|P2|NOT COMPLETED|Overall Study||70
266758|NCT00409578|647094|P1|NOT COMPLETED|Overall Study||52
266759|NCT00409578|647091|P4|COMPLETED|Overall Study||214
266760|NCT00409578|647092|P3|COMPLETED|Overall Study||215
266761|NCT00409578|647093|P2|COMPLETED|Overall Study||201
266762|NCT00409578|647094|P1|COMPLETED|Overall Study||228
266763|NCT00409578|647091|P4|STARTED|Overall Study||281
266764|NCT00409578|647092|P3|STARTED|Overall Study||269
266765|NCT00409578|647093|P2|STARTED|Overall Study||271
266766|NCT00409578|647094|P1|STARTED|Overall Study||280
266767|NCT00409565|647116|P1|NOT COMPLETED|Overall Study||1
266768|NCT00409565|647116|P1|COMPLETED|Overall Study||45
266769|NCT00409565|647116|P1|Overall Response Rate|Overall Study||7
266770|NCT00409565|647116|P1|STARTED|Overall Study||46
266771|NCT00409539|647129|P5|NOT COMPLETED|Overall Study||25
266772|NCT00409539|647130|P4|NOT COMPLETED|Overall Study||12
266773|NCT00409539|647131|P3|NOT COMPLETED|Overall Study||14
266774|NCT00409539|647132|P2|NOT COMPLETED|Overall Study||11
266775|NCT00409539|647133|P1|NOT COMPLETED|Overall Study||11
266776|NCT00409539|647129|P5|COMPLETED|Overall Study||85
266777|NCT00409539|647130|P4|COMPLETED|Overall Study||97
266778|NCT00409539|647131|P3|COMPLETED|Overall Study||95
266779|NCT00409539|647132|P2|COMPLETED|Overall Study||100
266780|NCT00409539|647133|P1|COMPLETED|Overall Study||100
266781|NCT00409539|647129|P5|STARTED|Overall Study||110
266782|NCT00409539|647130|P4|STARTED|Overall Study||109
266783|NCT00409539|647131|P3|STARTED|Overall Study||109
266784|NCT00409539|647132|P2|STARTED|Overall Study||111
266785|NCT00409539|647133|P1|STARTED|Overall Study||111
266786|NCT00409409|647152|P2|NOT COMPLETED|Overall Study||4
266787|NCT00409409|647153|P1|NOT COMPLETED|Overall Study||8
266788|NCT00409409|647152|P2|COMPLETED|Overall Study||135
266789|NCT00409409|647153|P1|COMPLETED|Overall Study||131
266790|NCT00409409|647152|P2|STARTED|Overall Study||139
266791|NCT00409409|647153|P1|STARTED|Overall Study||139
266792|NCT00409344|647161|P2|NOT COMPLETED|Overall Study||0
266793|NCT00409344|647162|P1|NOT COMPLETED|Overall Study||0
266794|NCT00409344|647161|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
266795|NCT00409344|647162|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
266796|NCT00409344|647161|P2|STARTED|Overall Study|No participants enrolled|0
266797|NCT00409344|647162|P1|STARTED|Overall Study|No participants enrolled|0
266798|NCT00409331|647180|P1|NOT COMPLETED|Overall Study||1
266799|NCT00409331|647180|P1|COMPLETED|Overall Study||0
266800|NCT00409331|647180|P1|STARTED|Overall Study||1
266801|NCT00409292|647184|P1|NOT COMPLETED|Overall Study||0
266802|NCT00409292|647184|P1|COMPLETED|Overall Study||33
266803|NCT00409292|647184|P1|STARTED|Overall Study||33
266804|NCT00409240|647193|P2|NOT COMPLETED|Overall Study||1
266805|NCT00409240|647194|P1|NOT COMPLETED|Overall Study||3
266806|NCT00409240|647193|P2|COMPLETED|Overall Study||49
266807|NCT00409240|647194|P1|COMPLETED|Overall Study||50
266808|NCT00409240|647193|P2|STARTED|Overall Study||50
266809|NCT00409240|647194|P1|STARTED|Overall Study||53
266810|NCT00409188|647202|P2|NOT COMPLETED|Overall Study||175
266811|NCT00409188|647203|P1|NOT COMPLETED|Overall Study||383
266812|NCT00409188|647202|P2|COMPLETED|Overall Study||332
266813|NCT00409188|647203|P1|COMPLETED|Overall Study||623
266814|NCT00409188|647202|P2|STARTED|Overall Study||507
266815|NCT00409188|647203|P1|STARTED|Overall Study||1006
266816|NCT00409175|647219|P2|NOT COMPLETED|Overall Study||19
266817|NCT00409175|647220|P1|NOT COMPLETED|Overall Study||18
266818|NCT00409175|647219|P2|COMPLETED|Overall Study||44
266819|NCT00409175|647220|P1|COMPLETED|Overall Study||47
266820|NCT00409175|647219|P2|STARTED|Overall Study||63
266821|NCT00409175|647220|P1|STARTED|Overall Study||65
266822|NCT00409006|647246|P2|NOT COMPLETED|Overall Study||12
266823|NCT00409006|647247|P1|NOT COMPLETED|Overall Study||20
266824|NCT00409006|647246|P2|COMPLETED|Overall Study||19
266825|NCT00409006|647247|P1|COMPLETED|Overall Study||19
266826|NCT00409006|647246|P2|STARTED|Overall Study||31
266827|NCT00409006|647247|P1|STARTED|Overall Study||39
266828|NCT00408993|647263|P2|NOT COMPLETED|Overall Study||17
266829|NCT00408993|647264|P1|NOT COMPLETED|Overall Study||19
266830|NCT00408993|647263|P2|COMPLETED|Overall Study||92
266831|NCT00408993|647264|P1|COMPLETED|Overall Study||87
266832|NCT00408993|647263|P2|STARTED|Overall Study||109
266833|NCT00408993|647264|P1|STARTED|Overall Study||106
266834|NCT00408928|647296|P1|NOT COMPLETED|Overall Study||3
266835|NCT00408928|647296|P1|COMPLETED|Overall Study||8
266836|NCT00408928|647296|P1|STARTED|Overall Study||11
266837|NCT00408902|647301|P1|NOT COMPLETED|Overall Study||10
266838|NCT00408902|647301|P1|COMPLETED|Overall Study||0
266839|NCT00408902|647301|P1|STARTED|Overall Study||10
266840|NCT00408876|647311|P4|NOT COMPLETED|Overall Study||35
266841|NCT00408876|647312|P3|NOT COMPLETED|Overall Study||50
266842|NCT00408876|647313|P2|NOT COMPLETED|Overall Study||36
266843|NCT00408876|647314|P1|NOT COMPLETED|Overall Study||16
266844|NCT00408876|647311|P4|COMPLETED|Overall Study||82
266845|NCT00408876|647312|P3|COMPLETED|Overall Study||62
266846|NCT00408876|647313|P2|COMPLETED|Overall Study||80
266847|NCT00408876|647314|P1|COMPLETED|Overall Study||43
266848|NCT00408876|647311|P4|STARTED|Overall Study||117
266849|NCT00408876|647312|P3|STARTED|Overall Study||112
266850|NCT00408876|647313|P2|STARTED|Overall Study||116
266851|NCT00408876|647314|P1|STARTED|Overall Study||59
266852|NCT00408694|647564|P1|NOT COMPLETED|Overall Study||2
266853|NCT00408694|647564|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
266854|NCT00408694|647564|P1|STARTED|Overall Study||46
266855|NCT00408681|647576|P1|NOT COMPLETED|Overall Study||9
266856|NCT00408681|647576|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
266857|NCT00408681|647576|P1|STARTED|Overall Study||20
266858|NCT00408629|647595|P2|NOT COMPLETED|Overall Study||125
266859|NCT00408629|647596|P1|NOT COMPLETED|Overall Study||97
266860|NCT00408629|647595|P2|COMPLETED|Overall Study||135
266861|NCT00408629|647596|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
266862|NCT00408629|647595|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
266863|NCT00408629|647596|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
266864|NCT00408603|647638|P3|NOT COMPLETED|Overall Study||40
266865|NCT00408603|647639|P2|NOT COMPLETED|Overall Study||2
266866|NCT00408603|647640|P1|NOT COMPLETED|Overall Study||4
266867|NCT00408603|647638|P3|COMPLETED|Overall Study||35
266868|NCT00408603|647639|P2|COMPLETED|Overall Study||37
266869|NCT00408603|647640|P1|COMPLETED|Overall Study||65
266870|NCT00408603|647638|P3|STARTED|Overall Study||75
266871|NCT00408603|647639|P2|STARTED|Overall Study||39
266872|NCT00408603|647640|P1|STARTED|Overall Study||69
266873|NCT00408590|647656|P9|NOT COMPLETED|Overall Study||0
266874|NCT00408590|647657|P8|NOT COMPLETED|Overall Study||0
266875|NCT00408590|647658|P7|NOT COMPLETED|Overall Study||0
266876|NCT00408590|647659|P6|NOT COMPLETED|Overall Study||0
266877|NCT00408590|647660|P5|NOT COMPLETED|Overall Study||0
266878|NCT00408590|647661|P4|NOT COMPLETED|Overall Study||0
266879|NCT00408590|647662|P3|NOT COMPLETED|Overall Study||0
266880|NCT00408590|647663|P2|NOT COMPLETED|Overall Study||0
266881|NCT00408590|647664|P1|NOT COMPLETED|Overall Study||0
266882|NCT00408590|647656|P9|COMPLETED|Overall Study||13
266883|NCT00408590|647657|P8|COMPLETED|Overall Study||3
266884|NCT00408590|647658|P7|COMPLETED|Overall Study||3
266885|NCT00408590|647659|P6|COMPLETED|Overall Study||3
266886|NCT00408590|647660|P5|COMPLETED|Overall Study||3
266887|NCT00408590|647661|P4|COMPLETED|Overall Study||3
266888|NCT00408590|647662|P3|COMPLETED|Overall Study||3
266889|NCT00408590|647663|P2|COMPLETED|Overall Study||3
266890|NCT00408590|647664|P1|COMPLETED|Overall Study||3
266891|NCT00408590|647656|P9|STARTED|Overall Study||13
266892|NCT00408590|647657|P8|STARTED|Overall Study||3
266893|NCT00408590|647658|P7|STARTED|Overall Study||3
266894|NCT00408590|647659|P6|STARTED|Overall Study||3
266895|NCT00408590|647660|P5|STARTED|Overall Study||3
266896|NCT00408590|647661|P4|STARTED|Overall Study||3
266897|NCT00408590|647662|P3|STARTED|Overall Study||3
266898|NCT00408590|647663|P2|STARTED|Overall Study||3
266899|NCT00408590|647664|P1|STARTED|Overall Study||3
266900|NCT00408499|647683|P5|NOT COMPLETED|Phase II- MTD Expansion||20
266901|NCT00408499|647684|P4|NOT COMPLETED|Phase II- MTD Expansion||0
266902|NCT00408499|647685|P3|NOT COMPLETED|Phase II- MTD Expansion||0
266903|NCT00408499|647686|P2|NOT COMPLETED|Phase II- MTD Expansion||0
266904|NCT00408499|647687|P1|NOT COMPLETED|Phase II- MTD Expansion||0
266905|NCT00408499|647683|P5|COMPLETED|Phase II- MTD Expansion||24
266906|NCT00408499|647684|P4|COMPLETED|Phase II- MTD Expansion||0
266907|NCT00408499|647685|P3|COMPLETED|Phase II- MTD Expansion||0
266908|NCT00408499|647686|P2|COMPLETED|Phase II- MTD Expansion||0
266909|NCT00408499|647687|P1|COMPLETED|Phase II- MTD Expansion||0
266910|NCT00408499|647683|P5|STARTED|Phase II- MTD Expansion||44
266911|NCT00408499|647684|P4|STARTED|Phase II- MTD Expansion||0
266912|NCT00408499|647685|P3|STARTED|Phase II- MTD Expansion||0
266913|NCT00408499|647686|P2|STARTED|Phase II- MTD Expansion||0
266914|NCT00408499|647687|P1|STARTED|Phase II- MTD Expansion||0
266915|NCT00408499|647683|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
266916|NCT00408499|647684|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
266917|NCT00408499|647685|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
266918|NCT00408499|647686|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
266919|NCT00408499|647687|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
266920|NCT00408499|647683|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
266921|NCT00408499|647684|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
266922|NCT00408499|647685|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
266923|NCT00408499|647686|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
266924|NCT00408499|647687|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
266925|NCT00408499|647683|P5|STARTED|Phase 1: Dose Levels 1-4||0
266926|NCT00408499|647684|P4|STARTED|Phase 1: Dose Levels 1-4||6
266927|NCT00408499|647685|P3|STARTED|Phase 1: Dose Levels 1-4||3
266928|NCT00408499|647686|P2|STARTED|Phase 1: Dose Levels 1-4||7
266929|NCT00408499|647687|P1|STARTED|Phase 1: Dose Levels 1-4||4
266930|NCT00408460|647696|P1|NOT COMPLETED|Overall Study||0
266931|NCT00408460|647696|P1|COMPLETED|Overall Study||34
266932|NCT00408460|647696|P1|STARTED|Overall Study||34
266933|NCT00408421|647704|P3|NOT COMPLETED|Treatment Re-Randomization||5
266934|NCT00408421|647705|P2|NOT COMPLETED|Treatment Re-Randomization||7
266935|NCT00408421|647706|P1|NOT COMPLETED|Treatment Re-Randomization||7
266936|NCT00408421|647704|P3|COMPLETED|Treatment Re-Randomization||38
266937|NCT00408421|647705|P2|COMPLETED|Treatment Re-Randomization||39
266938|NCT00408421|647706|P1|COMPLETED|Treatment Re-Randomization||96
266939|NCT00408421|647704|P3|STARTED|Treatment Re-Randomization||43
266940|NCT00408421|647705|P2|STARTED|Treatment Re-Randomization||46
266941|NCT00408421|647706|P1|STARTED|Treatment Re-Randomization||103
266942|NCT00408421|647704|P3|NOT COMPLETED|Treatment Initial Randomization||0
266943|NCT00408421|647705|P2|NOT COMPLETED|Treatment Initial Randomization||22
266944|NCT00408421|647706|P1|NOT COMPLETED|Treatment Initial Randomization||17
266945|NCT00408421|647704|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
266946|NCT00408421|647705|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
266947|NCT00408421|647706|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
266948|NCT00408421|647704|P3|STARTED|Treatment Initial Randomization||0
266949|NCT00408421|647705|P2|STARTED|Treatment Initial Randomization||111
266950|NCT00408421|647706|P1|STARTED|Treatment Initial Randomization||120
266951|NCT00408408|647786|P6|NOT COMPLETED|Overall Study||3
266952|NCT00408408|647787|P5|NOT COMPLETED|Overall Study||5
266953|NCT00408408|647788|P4|NOT COMPLETED|Overall Study||7
266954|NCT00408408|647789|P3|NOT COMPLETED|Overall Study||0
266955|NCT00408408|647790|P2|NOT COMPLETED|Overall Study||3
266956|NCT00408408|647791|P1|NOT COMPLETED|Overall Study||2
266957|NCT00408408|647786|P6|COMPLETED|Overall Study||201
266958|NCT00408408|647787|P5|COMPLETED|Overall Study||192
266959|NCT00408408|647788|P4|COMPLETED|Overall Study||194
266960|NCT00408408|647789|P3|COMPLETED|Overall Study||204
266961|NCT00408408|647790|P2|COMPLETED|Overall Study||196
266962|NCT00408408|647791|P1|COMPLETED|Overall Study||199
266963|NCT00408408|647786|P6|STARTED|Overall Study||204
266964|NCT00408408|647787|P5|STARTED|Overall Study||197
266965|NCT00408408|647788|P4|STARTED|Overall Study||201
266966|NCT00408408|647789|P3|STARTED|Overall Study||204
266967|NCT00408408|647790|P2|STARTED|Overall Study||199
266968|NCT00408408|647791|P1|STARTED|Overall Study||201
266969|NCT00408317|647853|P2|NOT COMPLETED|Second Intervention Period||2
266970|NCT00408317|647854|P1|NOT COMPLETED|Second Intervention Period||2
266971|NCT00408317|647853|P2|COMPLETED|Second Intervention Period||14
266972|NCT00408317|647854|P1|COMPLETED|Second Intervention Period||12
266973|NCT00408317|647853|P2|STARTED|Second Intervention Period||16
266974|NCT00408317|647854|P1|STARTED|Second Intervention Period||14
266975|NCT00408317|647853|P2|NOT COMPLETED|First Intervention Period||1
266976|NCT00408317|647854|P1|NOT COMPLETED|First Intervention Period||0
266977|NCT00408317|647853|P2|COMPLETED|First Intervention Period||16
266978|NCT00408317|647854|P1|COMPLETED|First Intervention Period||14
266979|NCT00408317|647853|P2|STARTED|First Intervention Period||17
266980|NCT00408317|647854|P1|STARTED|First Intervention Period||14
266981|NCT00408200|647868|P2|NOT COMPLETED|Overall Study||0
266982|NCT00408200|647869|P1|NOT COMPLETED|Overall Study||0
266983|NCT00408200|647868|P2|COMPLETED|Overall Study||53
266984|NCT00408200|647869|P1|COMPLETED|Overall Study||57
266985|NCT00408200|647868|P2|STARTED|Overall Study||53
266986|NCT00408200|647869|P1|STARTED|Overall Study||57
266987|NCT00408070|647877|P1|NOT COMPLETED|Overall Study||0
266988|NCT00408070|647877|P1|COMPLETED|Overall Study||5
266989|NCT00408070|647877|P1|STARTED|Overall Study||5
266990|NCT00407966|647885|P1|NOT COMPLETED|Overall Study||0
266991|NCT00407966|647885|P1|COMPLETED|Overall Study||45
266992|NCT00407966|647885|P1|CR|Overall Study||30
266993|NCT00407966|647885|P1|STARTED|Overall Study||45
266994|NCT00407888|647889|P1|NOT COMPLETED|Overall Study||0
266995|NCT00407888|647889|P1|COMPLETED|Overall Study||60
266996|NCT00407888|647889|P1|STARTED|Overall Study||60
266997|NCT00407797|647897|P1|NOT COMPLETED|Overall Study||18
266998|NCT00407797|647897|P1|COMPLETED|Overall Study||118
266999|NCT00407797|647897|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
267000|NCT00407797|647897|P1|STARTED|Overall Study||136
267001|NCT00407758|647912|P1|NOT COMPLETED|Overall Study||1
267002|NCT00407758|647912|P1|COMPLETED|Overall Study||27
267003|NCT00407758|647912|P1|STARTED|Overall Study||28
267004|NCT00407745|647925|P2|NOT COMPLETED|Overall Study||17
267005|NCT00407745|647926|P1|NOT COMPLETED|Overall Study||19
267006|NCT00407745|647925|P2|COMPLETED|Overall Study||91
267007|NCT00407745|647926|P1|COMPLETED|Overall Study||93
267008|NCT00407745|647925|P2|Treated|Overall Study||107
267009|NCT00407745|647926|P1|Treated|Overall Study||112
267010|NCT00407745|647925|P2|STARTED|Overall Study||108
267011|NCT00407745|647926|P1|STARTED|Overall Study||112
267012|NCT00407654|647998|P1|NOT COMPLETED|Overall Study||0
267013|NCT00407654|647998|P1|COMPLETED|Overall Study||75
267014|NCT00407654|647998|P1|STARTED|Overall Study||75
267015|NCT00407563|648010|P1|NOT COMPLETED|Overall Study||1
267016|NCT00407563|648010|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
267017|NCT00407563|648010|P1|STARTED|Overall Study||48
267018|NCT00407550|648020|P2|NOT COMPLETED|Overall Study||4
267019|NCT00407550|648021|P1|NOT COMPLETED|Overall Study||3
267020|NCT00407550|648020|P2|COMPLETED|Overall Study||5
267021|NCT00407550|648021|P1|COMPLETED|Overall Study||7
267022|NCT00407550|648020|P2|STARTED|Overall Study||9
267023|NCT00407550|648021|P1|STARTED|Overall Study||10
267024|NCT00407537|648029|P2|NOT COMPLETED|Overall Study||44
267025|NCT00407537|648030|P1|NOT COMPLETED|Overall Study||93
267026|NCT00407537|648029|P2|COMPLETED|Overall Study||638
267027|NCT00407537|648030|P1|COMPLETED|Overall Study||686
267028|NCT00407537|648029|P2|Eligible for Efficacy Analysis|Overall Study||657
267029|NCT00407537|648030|P1|Eligible for Efficacy Analysis|Overall Study||760
267030|NCT00407537|648029|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
267031|NCT00407537|648030|P1|STARTED|Overall Study||779
267032|NCT00407511|648078|P1|NOT COMPLETED|Overall Study||22
267033|NCT00407511|648078|P1|COMPLETED|Overall Study||99
267034|NCT00407511|648078|P1|STARTED|Overall Study||121
267035|NCT00407485|648092|P1|NOT COMPLETED|Overall Study||0
267036|NCT00407485|648092|P1|COMPLETED|Overall Study||22
267037|NCT00407485|648092|P1|STARTED|Overall Study||22
267038|NCT00407381|648100|P3|NOT COMPLETED|Overall Study||2
267039|NCT00407381|648101|P2|NOT COMPLETED|Overall Study||4
267040|NCT00407381|648102|P1|NOT COMPLETED|Overall Study||3
267041|NCT00407381|648100|P3|COMPLETED|Overall Study||40
267042|NCT00407381|648101|P2|COMPLETED|Overall Study||38
267043|NCT00407381|648102|P1|COMPLETED|Overall Study||39
267044|NCT00407381|648100|P3|STARTED|Overall Study||42
267045|NCT00407381|648101|P2|STARTED|Overall Study||42
267046|NCT00407381|648102|P1|STARTED|Overall Study||42
267047|NCT00407355|648112|P2|NOT COMPLETED|Overall Study||11
267048|NCT00407355|648113|P1|NOT COMPLETED|Overall Study||10
267049|NCT00407355|648112|P2|COMPLETED|Overall Study||9
267050|NCT00407355|648113|P1|COMPLETED|Overall Study||10
267051|NCT00407355|648112|P2|STARTED|Overall Study||20
267052|NCT00407355|648113|P1|STARTED|Overall Study||20
267053|NCT00407030|648124|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
267054|NCT00407030|648125|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
267055|NCT00407030|648126|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
267056|NCT00407030|648124|P3|COMPLETED|Extension Period - up to 68 Weeks||0
267057|NCT00407030|648125|P2|COMPLETED|Extension Period - up to 68 Weeks||74
267058|NCT00407030|648126|P1|COMPLETED|Extension Period - up to 68 Weeks||84
267059|NCT00407030|648124|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
267060|NCT00407030|648125|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
267061|NCT00407030|648126|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
267062|NCT00407030|648124|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
267063|NCT00407030|648125|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
267064|NCT00407030|648126|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
267065|NCT00407030|648124|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
267066|NCT00407030|648125|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
267067|NCT00407030|648126|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
267068|NCT00407030|648124|P3|STARTED|Main Period - 8 to 20 Weeks||74
267069|NCT00407030|648125|P2|STARTED|Main Period - 8 to 20 Weeks||78
267070|NCT00407030|648126|P1|STARTED|Main Period - 8 to 20 Weeks||81
267071|NCT00406848|648154|P2|NOT COMPLETED|Overall Study||54
267072|NCT00406848|648155|P1|NOT COMPLETED|Overall Study||93
267073|NCT00406848|648154|P2|COMPLETED|Overall Study||67
267074|NCT00406848|648155|P1|COMPLETED|Overall Study||156
267075|NCT00406848|648154|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
267076|NCT00406848|648155|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
267077|NCT00406783|648219|P2|NOT COMPLETED|Overall Study||15
267078|NCT00406783|648220|P1|NOT COMPLETED|Overall Study||14
267079|NCT00406783|648219|P2|COMPLETED|Overall Study||256
267080|NCT00406783|648220|P1|COMPLETED|Overall Study||262
267081|NCT00406783|648219|P2|STARTED|Overall Study||271
267082|NCT00406783|648220|P1|STARTED|Overall Study||276
267083|NCT00406718|648235|P3|NOT COMPLETED|Overall Study||8
267084|NCT00406718|648236|P2|NOT COMPLETED|Overall Study||14
267085|NCT00406718|648237|P1|NOT COMPLETED|Overall Study||4
267086|NCT00406718|648235|P3|COMPLETED|Overall Study||39
267087|NCT00406718|648236|P2|COMPLETED|Overall Study||34
267088|NCT00406718|648237|P1|COMPLETED|Overall Study||43
267089|NCT00406718|648235|P3|STARTED|Overall Study||47
267090|NCT00406718|648236|P2|STARTED|Overall Study||48
267091|NCT00406718|648237|P1|STARTED|Overall Study||47
267092|NCT00406692|648251|P1|NOT COMPLETED|Overall Study||7
267093|NCT00406692|648251|P1|COMPLETED|Overall Study||9
267094|NCT00406692|648251|P1|STARTED|Overall Study||16
267095|NCT00406653|648261|P7|NOT COMPLETED|Open-Label Period||324
267096|NCT00406653|648262|P6|NOT COMPLETED|Open-Label Period||0
267097|NCT00406653|648263|P5|NOT COMPLETED|Open-Label Period||0
267098|NCT00406653|648264|P4|NOT COMPLETED|Open-Label Period||0
267099|NCT00406653|648265|P3|NOT COMPLETED|Open-Label Period||0
267100|NCT00406653|648266|P2|NOT COMPLETED|Open-Label Period||0
267101|NCT00406653|648267|P1|NOT COMPLETED|Open-Label Period||0
267102|NCT00406653|648261|P7|COMPLETED|Open-Label Period||0
267103|NCT00406653|648262|P6|COMPLETED|Open-Label Period||0
267104|NCT00406653|648263|P5|COMPLETED|Open-Label Period||0
267105|NCT00406653|648264|P4|COMPLETED|Open-Label Period||0
267106|NCT00406653|648265|P3|COMPLETED|Open-Label Period||0
267107|NCT00406653|648266|P2|COMPLETED|Open-Label Period||0
267108|NCT00406653|648267|P1|COMPLETED|Open-Label Period||0
267109|NCT00406653|648261|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
267110|NCT00406653|648262|P6|STARTED|Open-Label Period||0
267111|NCT00406653|648263|P5|STARTED|Open-Label Period||0
267112|NCT00406653|648264|P4|STARTED|Open-Label Period||0
267113|NCT00406653|648265|P3|STARTED|Open-Label Period||0
267114|NCT00406653|648266|P2|STARTED|Open-Label Period||0
267115|NCT00406653|648267|P1|STARTED|Open-Label Period||0
267116|NCT00406653|648261|P7|NOT COMPLETED|Maintenance Period||0
267117|NCT00406653|648262|P6|NOT COMPLETED|Maintenance Period||36
267118|NCT00406653|648263|P5|NOT COMPLETED|Maintenance Period||30
267119|NCT00406653|648264|P4|NOT COMPLETED|Maintenance Period||0
267120|NCT00406653|648265|P3|NOT COMPLETED|Maintenance Period||0
267121|NCT00406653|648266|P2|NOT COMPLETED|Maintenance Period||0
267122|NCT00406653|648267|P1|NOT COMPLETED|Maintenance Period||0
267123|NCT00406653|648261|P7|COMPLETED|Maintenance Period||0
267124|NCT00406653|648262|P6|COMPLETED|Maintenance Period||10
267125|NCT00406653|648263|P5|COMPLETED|Maintenance Period||14
267126|NCT00406653|648264|P4|COMPLETED|Maintenance Period||0
267127|NCT00406653|648265|P3|COMPLETED|Maintenance Period||0
267128|NCT00406653|648266|P2|COMPLETED|Maintenance Period||0
267129|NCT00406653|648267|P1|COMPLETED|Maintenance Period||0
267130|NCT00406653|648261|P7|STARTED|Maintenance Period||0
267131|NCT00406653|648262|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
267132|NCT00406653|648263|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
267133|NCT00406653|648264|P4|STARTED|Maintenance Period||0
267134|NCT00406653|648265|P3|STARTED|Maintenance Period||0
267135|NCT00406653|648266|P2|STARTED|Maintenance Period||0
267136|NCT00406653|648267|P1|STARTED|Maintenance Period||0
267137|NCT00406653|648261|P7|NOT COMPLETED|Induction Period||0
267138|NCT00406653|648262|P6|NOT COMPLETED|Induction Period||0
267139|NCT00406653|648263|P5|NOT COMPLETED|Induction Period||0
267140|NCT00406653|648264|P4|NOT COMPLETED|Induction Period||26
267141|NCT00406653|648265|P3|NOT COMPLETED|Induction Period||18
267142|NCT00406653|648266|P2|NOT COMPLETED|Induction Period||34
267143|NCT00406653|648267|P1|NOT COMPLETED|Induction Period||15
267144|NCT00406653|648261|P7|COMPLETED|Induction Period||0
267145|NCT00406653|648262|P6|COMPLETED|Induction Period||0
267146|NCT00406653|648263|P5|COMPLETED|Induction Period||0
267147|NCT00406653|648264|P4|COMPLETED|Induction Period||102
267148|NCT00406653|648265|P3|COMPLETED|Induction Period||112
267149|NCT00406653|648266|P2|COMPLETED|Induction Period||94
267150|NCT00406653|648267|P1|COMPLETED|Induction Period||50
267151|NCT00406653|648261|P7|STARTED|Induction Period||0
267152|NCT00406653|648262|P6|STARTED|Induction Period||0
267153|NCT00406653|648263|P5|STARTED|Induction Period||0
267154|NCT00406653|648264|P4|STARTED|Induction Period||128
267155|NCT00406653|648265|P3|STARTED|Induction Period||130
267156|NCT00406653|648266|P2|STARTED|Induction Period||128
267157|NCT00406653|648267|P1|STARTED|Induction Period||65
267158|NCT00406640|648348|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
267159|NCT00406640|648349|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
267160|NCT00406640|648348|P2|COMPLETED|OL Extension Phase for Non-Responders||36
267161|NCT00406640|648349|P1|COMPLETED|OL Extension Phase for Non-Responders||47
267162|NCT00406640|648348|P2|STARTED|OL Extension Phase for Non-Responders||60
267163|NCT00406640|648349|P1|STARTED|OL Extension Phase for Non-Responders||69
267164|NCT00406640|648348|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
267165|NCT00406640|648349|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
267166|NCT00406640|648348|P2|COMPLETED|DB Continuation Phase for Responders||151
267167|NCT00406640|648349|P1|COMPLETED|DB Continuation Phase for Responders||139
267168|NCT00406640|648348|P2|STARTED|DB Continuation Phase for Responders||188
267169|NCT00406640|648349|P1|STARTED|DB Continuation Phase for Responders||172
267170|NCT00406640|648348|P2|NOT COMPLETED|Acute Phase||43
267171|NCT00406640|648349|P1|NOT COMPLETED|Acute Phase||51
267172|NCT00406640|648348|P2|COMPLETED|Acute Phase||256
267173|NCT00406640|648349|P1|COMPLETED|Acute Phase||245
267174|NCT00406640|648348|P2|STARTED|Acute Phase||299
267175|NCT00406640|648349|P1|STARTED|Acute Phase||296
267176|NCT00406393|648381|P2|NOT COMPLETED|Overall Study||1
267177|NCT00406393|648382|P1|NOT COMPLETED|Overall Study||2
267178|NCT00406393|648381|P2|COMPLETED|Overall Study||152
267179|NCT00406393|648382|P1|COMPLETED|Overall Study||149
267180|NCT00406393|648381|P2|STARTED|Overall Study||153
267181|NCT00406393|648382|P1|STARTED|Overall Study||151
267182|NCT00406367|648412|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
267183|NCT00406367|648413|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
267184|NCT00406367|648412|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
267185|NCT00406367|648413|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
267186|NCT00406367|648412|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
267187|NCT00406367|648413|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
267188|NCT00406367|648412|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
267189|NCT00406367|648413|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
267190|NCT00406367|648412|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
267191|NCT00406367|648413|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
267192|NCT00406367|648412|P2|STARTED|Main Period - 6 to 20 Weeks||34
267193|NCT00406367|648413|P1|STARTED|Main Period - 6 to 20 Weeks||75
267194|NCT00406354|648428|P3|NOT COMPLETED|All Randomized and Treated Patients||22
267195|NCT00406354|648429|P2|NOT COMPLETED|All Randomized and Treated Patients||13
267196|NCT00406354|648430|P1|NOT COMPLETED|All Randomized and Treated Patients||16
267197|NCT00406354|648428|P3|COMPLETED|All Randomized and Treated Patients||37
267198|NCT00406354|648429|P2|COMPLETED|All Randomized and Treated Patients||48
267199|NCT00406354|648430|P1|COMPLETED|All Randomized and Treated Patients||44
267200|NCT00406354|648428|P3|STARTED|All Randomized and Treated Patients||59
267201|NCT00406354|648429|P2|STARTED|All Randomized and Treated Patients||61
267202|NCT00406354|648430|P1|STARTED|All Randomized and Treated Patients||60
267203|NCT00406354|648428|P3|NOT COMPLETED|All Randomized Patients||1
267204|NCT00406354|648429|P2|NOT COMPLETED|All Randomized Patients||0
267205|NCT00406354|648430|P1|NOT COMPLETED|All Randomized Patients||0
267206|NCT00406354|648428|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
267207|NCT00406354|648429|P2|COMPLETED|All Randomized Patients||61
267208|NCT00406354|648430|P1|COMPLETED|All Randomized Patients||60
267209|NCT00406354|648428|P3|STARTED|All Randomized Patients||60
267210|NCT00406354|648429|P2|STARTED|All Randomized Patients||61
267211|NCT00406354|648430|P1|STARTED|All Randomized Patients||60
267212|NCT00406315|648501|P1|NOT COMPLETED|Overall Study||141
267213|NCT00406315|648501|P1|COMPLETED|Overall Study||100
267214|NCT00406315|648501|P1|STARTED|Overall Study|Started = Treated|241
267215|NCT00406276|648519|P1|NOT COMPLETED|Overall Study||4
267216|NCT00406276|648519|P1|COMPLETED|Overall Study||24
267217|NCT00406276|648519|P1|STARTED|Overall Study||28
267218|NCT00406133|648528|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
267219|NCT00406133|648529|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
267220|NCT00406133|648530|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
267221|NCT00406133|648531|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
267222|NCT00406133|648528|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
267223|NCT00406133|648529|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
267224|NCT00406133|648530|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
267225|NCT00406133|648531|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
267226|NCT00406133|648528|P4|STARTED|Phase 2 (Second 26 Week Period)||60
267227|NCT00406133|648529|P3|STARTED|Phase 2 (Second 26 Week Period)||67
267228|NCT00406133|648530|P2|STARTED|Phase 2 (Second 26 Week Period)||155
267229|NCT00406133|648531|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
267230|NCT00406133|648528|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
267231|NCT00406133|648529|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
267232|NCT00406133|648530|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
267233|NCT00406133|648531|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
267234|NCT00406133|648528|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
267235|NCT00406133|648529|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
267236|NCT00406133|648530|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
267237|NCT00406133|648531|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
267238|NCT00406133|648528|P4|STARTED|Phase 1 (First 26 Week Period)||62
267239|NCT00406133|648529|P3|STARTED|Phase 1 (First 26 Week Period)||67
267240|NCT00406133|648530|P2|STARTED|Phase 1 (First 26 Week Period)||157
267241|NCT00406133|648531|P1|STARTED|Phase 1 (First 26 Week Period)||165
267242|NCT00406107|648595|P2|NOT COMPLETED|Overall Study||1
267243|NCT00406107|648596|P1|NOT COMPLETED|Overall Study||1
267244|NCT00406107|648595|P2|COMPLETED|Overall Study||4
267245|NCT00406107|648596|P1|COMPLETED|Overall Study||14
267246|NCT00406107|648595|P2|STARTED|Overall Study||5
267247|NCT00406107|648596|P1|STARTED|Overall Study||15
267248|NCT00406029|648611|P5|NOT COMPLETED|Overall Study||8
267249|NCT00406029|648612|P4|NOT COMPLETED|Overall Study||17
267250|NCT00406029|648613|P3|NOT COMPLETED|Overall Study||10
267251|NCT00406029|648614|P2|NOT COMPLETED|Overall Study||8
267252|NCT00406029|648615|P1|NOT COMPLETED|Overall Study||16
267253|NCT00406029|648611|P5|COMPLETED|Overall Study||41
267254|NCT00406029|648612|P4|COMPLETED|Overall Study||40
267255|NCT00406029|648613|P3|COMPLETED|Overall Study||39
267256|NCT00406029|648614|P2|COMPLETED|Overall Study||41
267257|NCT00406029|648615|P1|COMPLETED|Overall Study||33
267258|NCT00406029|648611|P5|Treated|Overall Study||47
267259|NCT00406029|648612|P4|Treated|Overall Study||54
267260|NCT00406029|648613|P3|Treated|Overall Study||47
267261|NCT00406029|648614|P2|Treated|Overall Study||49
267262|NCT00406029|648615|P1|Treated|Overall Study||49
267263|NCT00406029|648611|P5|STARTED|Overall Study||49
267264|NCT00406029|648612|P4|STARTED|Overall Study||57
267265|NCT00406029|648613|P3|STARTED|Overall Study||49
267266|NCT00406029|648614|P2|STARTED|Overall Study||49
267267|NCT00406029|648615|P1|STARTED|Overall Study||49
267268|NCT00405964|648719|P2|NOT COMPLETED|Overall Study||95
267269|NCT00405964|648720|P1|NOT COMPLETED|Overall Study||59
267270|NCT00405964|648719|P2|COMPLETED|Overall Study||261
267271|NCT00405964|648720|P1|COMPLETED|Overall Study||301
267272|NCT00405964|648719|P2|STARTED|Overall Study||356
267273|NCT00405964|648720|P1|STARTED|Overall Study||360
267274|NCT00405938|648732|P2|NOT COMPLETED|Overall Study||0
267275|NCT00405938|648733|P1|NOT COMPLETED|Overall Study||0
267276|NCT00405938|648732|P2|COMPLETED|Overall Study||41
267277|NCT00405938|648733|P1|COMPLETED|Overall Study||38
267278|NCT00405938|648732|P2|STARTED|Overall Study||41
267279|NCT00405938|648733|P1|STARTED|Overall Study||38
267280|NCT00405912|648742|P3|NOT COMPLETED|Overall Study||16
267281|NCT00405912|648743|P2|NOT COMPLETED|Overall Study||19
267282|NCT00405912|648744|P1|NOT COMPLETED|Overall Study||16
267283|NCT00405912|648742|P3|COMPLETED|Overall Study||23
267284|NCT00405912|648743|P2|COMPLETED|Overall Study||21
267285|NCT00405912|648744|P1|COMPLETED|Overall Study||23
267286|NCT00405912|648742|P3|STARTED|Overall Study||39
267287|NCT00405912|648743|P2|STARTED|Overall Study||40
267288|NCT00405912|648744|P1|STARTED|Overall Study||39
267289|NCT00405821|648757|P2|NOT COMPLETED|Overall Study||22
267290|NCT00405821|648758|P1|NOT COMPLETED|Overall Study||22
267291|NCT00405821|648757|P2|COMPLETED|Overall Study||198
267292|NCT00405821|648758|P1|COMPLETED|Overall Study||198
267293|NCT00405821|648757|P2|STARTED|Overall Study||220
267294|NCT00405821|648758|P1|STARTED|Overall Study||220
267295|NCT00405756|648771|P3|NOT COMPLETED|Follow-up||88
267296|NCT00405756|648772|P2|NOT COMPLETED|Follow-up||90
267297|NCT00405756|648773|P1|NOT COMPLETED|Follow-up||75
267298|NCT00405756|648771|P3|COMPLETED|Follow-up||0
267299|NCT00405756|648772|P2|COMPLETED|Follow-up||0
267300|NCT00405756|648773|P1|COMPLETED|Follow-up||0
267301|NCT00405756|648771|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
267302|NCT00405756|648772|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
267303|NCT00405756|648773|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
267304|NCT00405756|648771|P3|NOT COMPLETED|Open-label Extension||72
267305|NCT00405756|648772|P2|NOT COMPLETED|Open-label Extension||47
267306|NCT00405756|648773|P1|NOT COMPLETED|Open-label Extension||19
267307|NCT00405756|648771|P3|COMPLETED|Open-label Extension||0
267308|NCT00405756|648772|P2|COMPLETED|Open-label Extension||0
267309|NCT00405756|648773|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
267310|NCT00405756|648771|P3|STARTED|Open-label Extension||72
267311|NCT00405756|648772|P2|STARTED|Open-label Extension||47
267312|NCT00405756|648773|P1|STARTED|Open-label Extension||19
267313|NCT00405756|648771|P3|NOT COMPLETED|Double-blind Treatment||154
267314|NCT00405756|648772|P2|NOT COMPLETED|Double-blind Treatment||153
267315|NCT00405756|648773|P1|NOT COMPLETED|Double-blind Treatment||152
267316|NCT00405756|648771|P3|COMPLETED|Double-blind Treatment||0
267317|NCT00405756|648772|P2|COMPLETED|Double-blind Treatment||0
267318|NCT00405756|648773|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
267319|NCT00405756|648771|P3|Safety Population|Double-blind Treatment||153
267320|NCT00405756|648772|P2|Safety Population|Double-blind Treatment||152
267321|NCT00405756|648773|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
267322|NCT00405756|648771|P3|STARTED|Double-blind Treatment||154
267323|NCT00405756|648772|P2|STARTED|Double-blind Treatment||153
267324|NCT00405756|648773|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
267325|NCT00405704|648863|P2|NOT COMPLETED|Overall Study||46
267326|NCT00405704|648864|P1|NOT COMPLETED|Overall Study||41
267327|NCT00405704|648863|P2|COMPLETED|Overall Study||259
267328|NCT00405704|648864|P1|COMPLETED|Overall Study||261
267329|NCT00405704|648863|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
267330|NCT00405704|648864|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
267331|NCT00405704|648863|P2|Recurrent UTI With E. Coli|Overall Study||57
267332|NCT00405704|648864|P1|Recurrent UTI With E. Coli|Overall Study||30
267333|NCT00405704|648863|P2|Outcome Stool Assessed|Overall Study||210
267334|NCT00405704|648864|P1|Outcome Stool Assessed|Overall Study||203
267335|NCT00405704|648863|P2|Completed Assessments for New Scarring|Overall Study||227
267336|NCT00405704|648864|P1|Completed Assessments for New Scarring|Overall Study||220
267337|NCT00405704|648863|P2|Completed Outcome Renal Scan|Overall Study||235
267338|NCT00405704|648864|P1|Completed Outcome Renal Scan|Overall Study||227
267339|NCT00405704|648863|P2|STARTED|Overall Study||305
267340|NCT00405704|648864|P1|STARTED|Overall Study||302
267341|NCT00405652|648884|P1|NOT COMPLETED|Overall Study||4
267342|NCT00405652|648884|P1|COMPLETED|Overall Study||30
267343|NCT00405652|648884|P1|STARTED|Overall Study||34
267344|NCT00405639|648891|P2|NOT COMPLETED|Overall Study||0
267345|NCT00405639|648892|P1|NOT COMPLETED|Overall Study||3
267346|NCT00405639|648891|P2|COMPLETED|Overall Study||12
267347|NCT00405639|648892|P1|COMPLETED|Overall Study||22
267348|NCT00405639|648891|P2|STARTED|Overall Study||12
267349|NCT00405639|648892|P1|STARTED|Overall Study||25
267350|NCT00405587|648908|P4|NOT COMPLETED|Overall Study||20
267351|NCT00405587|648909|P3|NOT COMPLETED|Overall Study||22
267352|NCT00405587|648910|P2|NOT COMPLETED|Overall Study||28
267353|NCT00405587|648911|P1|NOT COMPLETED|Overall Study||26
267354|NCT00405587|648908|P4|COMPLETED|Overall Study||1
267355|NCT00405587|648909|P3|COMPLETED|Overall Study||10
267356|NCT00405587|648910|P2|COMPLETED|Overall Study||2
267357|NCT00405587|648911|P1|COMPLETED|Overall Study||0
267358|NCT00405587|648908|P4|STARTED|Overall Study||21
267359|NCT00405587|648909|P3|STARTED|Overall Study||32
267360|NCT00405587|648910|P2|STARTED|Overall Study||30
267361|NCT00405587|648911|P1|STARTED|Overall Study||26
267362|NCT00405548|649029|P2|NOT COMPLETED|Overall Study||1
267363|NCT00405548|649030|P1|NOT COMPLETED|Overall Study||4
267364|NCT00405548|649029|P2|COMPLETED|Overall Study||12
267365|NCT00405548|649030|P1|COMPLETED|Overall Study||24
267366|NCT00405548|649029|P2|STARTED|Overall Study||13
267367|NCT00405548|649030|P1|STARTED|Overall Study||28
267368|NCT00405509|649044|P2|NOT COMPLETED|Overall Study||0
267369|NCT00405509|649045|P1|NOT COMPLETED|Overall Study||0
267370|NCT00405509|649044|P2|COMPLETED|Overall Study||22
267371|NCT00405509|649045|P1|COMPLETED|Overall Study||11
267372|NCT00405509|649044|P2|STARTED|Overall Study||22
267373|NCT00405509|649045|P1|STARTED|Overall Study||11
267374|NCT00405288|649061|P2|NOT COMPLETED|Overall Study||0
267375|NCT00405288|649062|P1|NOT COMPLETED|Overall Study||0
267376|NCT00405288|649061|P2|COMPLETED|Overall Study||204
267377|NCT00405288|649062|P1|COMPLETED|Overall Study||204
267378|NCT00405288|649061|P2|STARTED|Overall Study||204
267379|NCT00405288|649062|P1|STARTED|Overall Study||204
267380|NCT00405275|649092|P2|NOT COMPLETED|Overall Study||19
267381|NCT00405275|649093|P1|NOT COMPLETED|Overall Study||23
267382|NCT00405275|649092|P2|COMPLETED|Overall Study||156
267383|NCT00405275|649093|P1|COMPLETED|Overall Study||155
267384|NCT00405275|649092|P2|24 Week (Switch)|Overall Study||44
267385|NCT00405275|649093|P1|24 Week (Switch)|Overall Study||44
267386|NCT00405275|649092|P2|24 Week (no Switch)|Overall Study||121
267387|NCT00405275|649093|P1|24 Week (no Switch)|Overall Study||119
267388|NCT00405275|649092|P2|24 Weeks (Total)|Overall Study||165
267389|NCT00405275|649093|P1|24 Weeks (Total)|Overall Study||163
267390|NCT00405275|649092|P2|STARTED|Overall Study||175
267391|NCT00405275|649093|P1|STARTED|Overall Study||178
267392|NCT00405067|649102|P3|NOT COMPLETED|Overall Study||5
267393|NCT00405067|649103|P2|NOT COMPLETED|Overall Study||9
267394|NCT00405067|649104|P1|NOT COMPLETED|Overall Study||4
267395|NCT00405067|649102|P3|COMPLETED|Overall Study||24
267396|NCT00405067|649103|P2|COMPLETED|Overall Study||19
267397|NCT00405067|649104|P1|COMPLETED|Overall Study||24
267398|NCT00405067|649102|P3|STARTED|Overall Study||29
267399|NCT00405067|649103|P2|STARTED|Overall Study||28
267400|NCT00405067|649104|P1|STARTED|Overall Study||28
267401|NCT00404924|649141|P2|NOT COMPLETED|Overall Study||306
267402|NCT00404924|649142|P1|NOT COMPLETED|Overall Study||603
267403|NCT00404924|649141|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
267404|NCT00404924|649142|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
267405|NCT00404924|649141|P2|STARTED|Overall Study|randomised patients|307
267406|NCT00404924|649142|P1|STARTED|Overall Study|randomised patients|617
267407|NCT00404820|649160|P2|NOT COMPLETED|Overall Study||24
267408|NCT00404820|649161|P1|NOT COMPLETED|Overall Study||19
267409|NCT00404820|649160|P2|COMPLETED|Overall Study||172
267410|NCT00404820|649161|P1|COMPLETED|Overall Study||389
267411|NCT00404820|649160|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
267412|NCT00404820|649161|P1|Started Treatment|Overall Study||408
267413|NCT00404820|649160|P2|STARTED|Overall Study||196
267414|NCT00404820|649161|P1|STARTED|Overall Study||408
267415|NCT00404768|649183|P4|NOT COMPLETED|Part C||14
267416|NCT00404768|649184|P3|NOT COMPLETED|Part C||8
267417|NCT00404768|649185|P2|NOT COMPLETED|Part C||0
267418|NCT00404768|649186|P1|NOT COMPLETED|Part C||0
267419|NCT00404768|649183|P4|COMPLETED|Part C||20
267420|NCT00404768|649184|P3|COMPLETED|Part C||22
267421|NCT00404768|649185|P2|COMPLETED|Part C||0
267422|NCT00404768|649186|P1|COMPLETED|Part C||0
267423|NCT00404768|649183|P4|STARTED|Part C||34
267424|NCT00404768|649184|P3|STARTED|Part C||30
267425|NCT00404768|649185|P2|STARTED|Part C||0
267426|NCT00404768|649186|P1|STARTED|Part C||0
267427|NCT00404768|649183|P4|NOT COMPLETED|Part A and B||0
267428|NCT00404768|649184|P3|NOT COMPLETED|Part A and B||0
267429|NCT00404768|649185|P2|NOT COMPLETED|Part A and B||1
267430|NCT00404768|649186|P1|NOT COMPLETED|Part A and B||1
267431|NCT00404768|649183|P4|COMPLETED|Part A and B||0
267432|NCT00404768|649184|P3|COMPLETED|Part A and B||0
267433|NCT00404768|649185|P2|COMPLETED|Part A and B||8
267434|NCT00404768|649186|P1|COMPLETED|Part A and B||19
267435|NCT00404768|649183|P4|STARTED|Part A and B||0
267436|NCT00404768|649184|P3|STARTED|Part A and B||0
267437|NCT00404768|649185|P2|STARTED|Part A and B||9
267438|NCT00404768|649186|P1|STARTED|Part A and B||20
267439|NCT00404755|649247|P1|NOT COMPLETED|Phase III (Imipramine)||0
267440|NCT00404755|649247|P1|COMPLETED|Phase III (Imipramine)||3
267441|NCT00404755|649247|P1|STARTED|Phase III (Imipramine)||3
267442|NCT00404755|649247|P1|NOT COMPLETED|Phase II (Escitalopram)||2
267443|NCT00404755|649247|P1|COMPLETED|Phase II (Escitalopram)||9
267444|NCT00404755|649247|P1|STARTED|Phase II (Escitalopram)||11
267445|NCT00404755|649247|P1|NOT COMPLETED|Phase I (Bupropion)||4
267446|NCT00404755|649247|P1|COMPLETED|Phase I (Bupropion)||13
267447|NCT00404755|649247|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
267448|NCT00404651|649262|P4|NOT COMPLETED|Overall Study||21
267449|NCT00404651|649263|P3|NOT COMPLETED|Overall Study||45
267450|NCT00404651|649264|P2|NOT COMPLETED|Overall Study||28
267451|NCT00404651|649265|P1|NOT COMPLETED|Overall Study||39
267452|NCT00404651|649262|P4|COMPLETED|Overall Study||146
267453|NCT00404651|649263|P3|COMPLETED|Overall Study||294
267454|NCT00404651|649264|P2|COMPLETED|Overall Study||315
267455|NCT00404651|649265|P1|COMPLETED|Overall Study||301
267456|NCT00404651|649262|P4|STARTED|Overall Study||167
267457|NCT00404651|649263|P3|STARTED|Overall Study||339
267458|NCT00404651|649264|P2|STARTED|Overall Study||343
267459|NCT00404651|649265|P1|STARTED|Overall Study||340
267460|NCT00404547|649293|P2|NOT COMPLETED|Overall Study||25
267461|NCT00404547|649294|P1|NOT COMPLETED|Overall Study||90
267462|NCT00404547|649293|P2|COMPLETED|Overall Study||334
267463|NCT00404547|649294|P1|COMPLETED|Overall Study||672
267464|NCT00404547|649293|P2|STARTED|Overall Study||359
267465|NCT00404547|649294|P1|STARTED|Overall Study||762
267466|NCT00404495|649304|P2|NOT COMPLETED|Overall Study||11
267467|NCT00404495|649305|P1|NOT COMPLETED|Overall Study||44
267468|NCT00404495|649304|P2|COMPLETED|Overall Study||6
267469|NCT00404495|649305|P1|COMPLETED|Overall Study||22
267470|NCT00404495|649304|P2|STARTED|Overall Study||17
267471|NCT00404495|649305|P1|STARTED|Overall Study||66
267472|NCT00404352|649324|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
267473|NCT00404352|649325|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
267474|NCT00404352|649326|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
267475|NCT00404352|649327|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
267476|NCT00404352|649328|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
267477|NCT00404352|649329|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
267478|NCT00404352|649330|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
267479|NCT00404352|649331|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
267480|NCT00404352|649332|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
267481|NCT00404352|649324|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
267482|NCT00404352|649325|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
267483|NCT00404352|649326|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
267484|NCT00404352|649327|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
267485|NCT00404352|649328|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
267486|NCT00404352|649329|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
267487|NCT00404352|649330|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
267488|NCT00404352|649331|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
267489|NCT00404352|649332|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
267490|NCT00404352|649324|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
267491|NCT00404352|649325|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
267492|NCT00404352|649326|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
267493|NCT00404352|649327|P6|STARTED|Open Label Extension (up to 36 Months)||0
267494|NCT00404352|649328|P5|STARTED|Open Label Extension (up to 36 Months)||0
267495|NCT00404352|649329|P4|STARTED|Open Label Extension (up to 36 Months)||0
267496|NCT00404352|649330|P3|STARTED|Open Label Extension (up to 36 Months)||0
267497|NCT00404352|649331|P2|STARTED|Open Label Extension (up to 36 Months)||0
267498|NCT00404352|649332|P1|STARTED|Open Label Extension (up to 36 Months)||0
267499|NCT00404352|649324|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
267500|NCT00404352|649325|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
267501|NCT00404352|649326|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
267502|NCT00404352|649327|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
267503|NCT00404352|649328|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
267504|NCT00404352|649329|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
267505|NCT00404352|649330|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
267506|NCT00404352|649331|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
267507|NCT00404352|649332|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
267508|NCT00404352|649324|P9|COMPLETED|Open Label (up to 24 Month)||0
267509|NCT00404352|649325|P8|COMPLETED|Open Label (up to 24 Month)||0
267510|NCT00404352|649326|P7|COMPLETED|Open Label (up to 24 Month)||0
267511|NCT00404352|649327|P6|COMPLETED|Open Label (up to 24 Month)||52
267512|NCT00404352|649328|P5|COMPLETED|Open Label (up to 24 Month)||28
267513|NCT00404352|649329|P4|COMPLETED|Open Label (up to 24 Month)||28
267514|NCT00404352|649330|P3|COMPLETED|Open Label (up to 24 Month)||0
267515|NCT00404352|649331|P2|COMPLETED|Open Label (up to 24 Month)||0
267516|NCT00404352|649332|P1|COMPLETED|Open Label (up to 24 Month)||0
267517|NCT00404352|649324|P9|STARTED|Open Label (up to 24 Month)||0
267518|NCT00404352|649325|P8|STARTED|Open Label (up to 24 Month)||0
267519|NCT00404352|649326|P7|STARTED|Open Label (up to 24 Month)||0
267520|NCT00404352|649327|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
267521|NCT00404352|649328|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
267522|NCT00404352|649329|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
267523|NCT00404352|649330|P3|STARTED|Open Label (up to 24 Month)||0
267524|NCT00404352|649331|P2|STARTED|Open Label (up to 24 Month)||0
267525|NCT00404352|649332|P1|STARTED|Open Label (up to 24 Month)||0
267526|NCT00404352|649324|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
267527|NCT00404352|649325|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
267528|NCT00404352|649326|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
267529|NCT00404352|649327|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
267530|NCT00404352|649328|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
267531|NCT00404352|649329|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
267532|NCT00404352|649330|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
267533|NCT00404352|649331|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
267534|NCT00404352|649332|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
267535|NCT00404352|649324|P9|COMPLETED|Double Blind (up to 24 Month)||0
267536|NCT00404352|649325|P8|COMPLETED|Double Blind (up to 24 Month)||0
267537|NCT00404352|649326|P7|COMPLETED|Double Blind (up to 24 Month)||0
267538|NCT00404352|649327|P6|COMPLETED|Double Blind (up to 24 Month)||0
267539|NCT00404352|649328|P5|COMPLETED|Double Blind (up to 24 Month)||0
267540|NCT00404352|649329|P4|COMPLETED|Double Blind (up to 24 Month)||0
267541|NCT00404352|649330|P3|COMPLETED|Double Blind (up to 24 Month)||92
267542|NCT00404352|649331|P2|COMPLETED|Double Blind (up to 24 Month)||128
267543|NCT00404352|649332|P1|COMPLETED|Double Blind (up to 24 Month)||119
267544|NCT00404352|649324|P9|Treated|Double Blind (up to 24 Month)||0
267545|NCT00404352|649325|P8|Treated|Double Blind (up to 24 Month)||0
267546|NCT00404352|649326|P7|Treated|Double Blind (up to 24 Month)||0
267547|NCT00404352|649327|P6|Treated|Double Blind (up to 24 Month)||0
267548|NCT00404352|649328|P5|Treated|Double Blind (up to 24 Month)||0
267549|NCT00404352|649329|P4|Treated|Double Blind (up to 24 Month)||0
267550|NCT00404352|649330|P3|Treated|Double Blind (up to 24 Month)||171
267551|NCT00404352|649331|P2|Treated|Double Blind (up to 24 Month)||173
267552|NCT00404352|649332|P1|Treated|Double Blind (up to 24 Month)||171
267553|NCT00404352|649324|P9|STARTED|Double Blind (up to 24 Month)||0
267554|NCT00404352|649325|P8|STARTED|Double Blind (up to 24 Month)||0
267555|NCT00404352|649326|P7|STARTED|Double Blind (up to 24 Month)||0
267556|NCT00404352|649327|P6|STARTED|Double Blind (up to 24 Month)||0
267557|NCT00404352|649328|P5|STARTED|Double Blind (up to 24 Month)||0
267558|NCT00404352|649329|P4|STARTED|Double Blind (up to 24 Month)||0
267559|NCT00404352|649330|P3|STARTED|Double Blind (up to 24 Month)||171
267560|NCT00404352|649331|P2|STARTED|Double Blind (up to 24 Month)||175
267561|NCT00404352|649332|P1|STARTED|Double Blind (up to 24 Month)||171
267562|NCT00404248|649367|P9|NOT COMPLETED|Overall Study||0
267563|NCT00404248|649368|P8|NOT COMPLETED|Overall Study||0
267564|NCT00404248|649369|P7|NOT COMPLETED|Overall Study||0
267565|NCT00404248|649370|P6|NOT COMPLETED|Overall Study||0
267566|NCT00404248|649371|P5|NOT COMPLETED|Overall Study||0
267567|NCT00404248|649372|P4|NOT COMPLETED|Overall Study||0
267568|NCT00404248|649373|P3|NOT COMPLETED|Overall Study||0
267569|NCT00404248|649374|P2|NOT COMPLETED|Overall Study||1
267570|NCT00404248|649375|P1|NOT COMPLETED|Overall Study||0
267571|NCT00404248|649367|P9|COMPLETED|Overall Study||3
267572|NCT00404248|649368|P8|COMPLETED|Overall Study||6
267573|NCT00404248|649369|P7|COMPLETED|Overall Study||6
267574|NCT00404248|649370|P6|COMPLETED|Overall Study||3
267575|NCT00404248|649371|P5|COMPLETED|Overall Study||3
267576|NCT00404248|649372|P4|COMPLETED|Overall Study||2
267577|NCT00404248|649373|P3|COMPLETED|Overall Study||5
267578|NCT00404248|649374|P2|COMPLETED|Overall Study||3
267579|NCT00404248|649375|P1|COMPLETED|Overall Study||3
267580|NCT00404248|649367|P9|STARTED|Overall Study||3
267581|NCT00404248|649368|P8|STARTED|Overall Study||6
267582|NCT00404248|649369|P7|STARTED|Overall Study||6
267583|NCT00404248|649370|P6|STARTED|Overall Study||3
267584|NCT00404248|649371|P5|STARTED|Overall Study||3
267585|NCT00404248|649372|P4|STARTED|Overall Study||2
267586|NCT00404248|649373|P3|STARTED|Overall Study||5
267587|NCT00404248|649374|P2|STARTED|Overall Study||4
267588|NCT00404248|649375|P1|STARTED|Overall Study||3
267589|NCT00404092|649410|P4|NOT COMPLETED|Overall Study||0
267590|NCT00404092|649411|P3|NOT COMPLETED|Overall Study||1
267591|NCT00404092|649412|P2|NOT COMPLETED|Overall Study||0
267592|NCT00404092|649413|P1|NOT COMPLETED|Overall Study||1
267593|NCT00404092|649410|P4|COMPLETED|Overall Study||20
267594|NCT00404092|649411|P3|COMPLETED|Overall Study||8
267595|NCT00404092|649412|P2|COMPLETED|Overall Study||8
267596|NCT00404092|649413|P1|COMPLETED|Overall Study||8
267597|NCT00404092|649410|P4|STARTED|Overall Study||20
267598|NCT00404092|649411|P3|STARTED|Overall Study||9
267599|NCT00404092|649412|P2|STARTED|Overall Study||8
267600|NCT00404092|649413|P1|STARTED|Overall Study||9
267601|NCT00404079|649429|P2|NOT COMPLETED|Overall Study||20
267602|NCT00404079|649430|P1|NOT COMPLETED|Overall Study||22
267603|NCT00404079|649429|P2|COMPLETED|Overall Study||105
267604|NCT00404079|649430|P1|COMPLETED|Overall Study||103
267605|NCT00404079|649429|P2|STARTED|Overall Study||125
267606|NCT00404079|649430|P1|STARTED|Overall Study||125
267607|NCT00404066|649436|P1|NOT COMPLETED|Overall Study||3
267608|NCT00404066|649436|P1|COMPLETED|Overall Study||18
267609|NCT00404066|649436|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
267610|NCT00403845|649441|P4|NOT COMPLETED|Treatment Period 4||0
267611|NCT00403845|649442|P3|NOT COMPLETED|Treatment Period 4||0
267612|NCT00403845|649443|P2|NOT COMPLETED|Treatment Period 4||0
267613|NCT00403845|649444|P1|NOT COMPLETED|Treatment Period 4||0
267614|NCT00403845|649441|P4|COMPLETED|Treatment Period 4||11
267615|NCT00403845|649442|P3|COMPLETED|Treatment Period 4||11
267616|NCT00403845|649443|P2|COMPLETED|Treatment Period 4||13
267617|NCT00403845|649444|P1|COMPLETED|Treatment Period 4||10
267618|NCT00403845|649441|P4|STARTED|Treatment Period 4||11
267619|NCT00403845|649442|P3|STARTED|Treatment Period 4||11
267620|NCT00403845|649443|P2|STARTED|Treatment Period 4||13
267621|NCT00403845|649444|P1|STARTED|Treatment Period 4||10
267622|NCT00403845|649441|P4|NOT COMPLETED|Treatment Period 3||2
267623|NCT00403845|649442|P3|NOT COMPLETED|Treatment Period 3||0
267624|NCT00403845|649443|P2|NOT COMPLETED|Treatment Period 3||0
267625|NCT00403845|649444|P1|NOT COMPLETED|Treatment Period 3||0
267626|NCT00403845|649441|P4|COMPLETED|Treatment Period 3||11
267627|NCT00403845|649442|P3|COMPLETED|Treatment Period 3||11
267628|NCT00403845|649443|P2|COMPLETED|Treatment Period 3||13
267629|NCT00403845|649444|P1|COMPLETED|Treatment Period 3||10
267630|NCT00403845|649441|P4|STARTED|Treatment Period 3||13
267631|NCT00403845|649442|P3|STARTED|Treatment Period 3||11
267632|NCT00403845|649443|P2|STARTED|Treatment Period 3||13
267633|NCT00403845|649444|P1|STARTED|Treatment Period 3||10
267634|NCT00403845|649441|P4|NOT COMPLETED|Treatment Period 2||0
267635|NCT00403845|649442|P3|NOT COMPLETED|Treatment Period 2||0
267636|NCT00403845|649443|P2|NOT COMPLETED|Treatment Period 2||0
267637|NCT00403845|649444|P1|NOT COMPLETED|Treatment Period 2||1
267638|NCT00403845|649441|P4|COMPLETED|Treatment Period 2||13
267639|NCT00403845|649442|P3|COMPLETED|Treatment Period 2||11
267640|NCT00403845|649443|P2|COMPLETED|Treatment Period 2||13
267641|NCT00403845|649444|P1|COMPLETED|Treatment Period 2||10
267642|NCT00403845|649441|P4|STARTED|Treatment Period 2||13
267643|NCT00403845|649442|P3|STARTED|Treatment Period 2||11
267644|NCT00403845|649443|P2|STARTED|Treatment Period 2||13
267645|NCT00403845|649444|P1|STARTED|Treatment Period 2||11
267646|NCT00403845|649441|P4|NOT COMPLETED|Treatment Period 1||1
267647|NCT00403845|649442|P3|NOT COMPLETED|Treatment Period 1||0
267648|NCT00403845|649443|P2|NOT COMPLETED|Treatment Period 1||0
267649|NCT00403845|649444|P1|NOT COMPLETED|Treatment Period 1||1
267650|NCT00403845|649441|P4|COMPLETED|Treatment Period 1||13
267651|NCT00403845|649442|P3|COMPLETED|Treatment Period 1||11
267652|NCT00403845|649443|P2|COMPLETED|Treatment Period 1||13
267653|NCT00403845|649444|P1|COMPLETED|Treatment Period 1||11
267654|NCT00403845|649441|P4|STARTED|Treatment Period 1||14
267655|NCT00403845|649442|P3|STARTED|Treatment Period 1||11
267656|NCT00403845|649443|P2|STARTED|Treatment Period 1||13
267657|NCT00403845|649444|P1|STARTED|Treatment Period 1||12
267658|NCT00403767|649468|P2|NOT COMPLETED|Overall Study||2468
267659|NCT00403767|649469|P1|NOT COMPLETED|Overall Study||2520
267660|NCT00403767|649468|P2|COMPLETED|Overall Study||4657
267661|NCT00403767|649469|P1|COMPLETED|Overall Study||4591
267662|NCT00403767|649468|P2|STARTED|Overall Study||7125
267663|NCT00403767|649469|P1|STARTED|Overall Study||7111
267664|NCT00403754|649493|P4|NOT COMPLETED|Open Label: Salmeterol||0
267665|NCT00403754|649494|P3|NOT COMPLETED|Open Label: Salmeterol||0
267666|NCT00403754|649495|P2|NOT COMPLETED|Open Label: Salmeterol||0
267667|NCT00403754|649496|P1|NOT COMPLETED|Open Label: Salmeterol||0
267668|NCT00403754|649493|P4|COMPLETED|Open Label: Salmeterol||11
267669|NCT00403754|649494|P3|COMPLETED|Open Label: Salmeterol||8
267670|NCT00403754|649495|P2|COMPLETED|Open Label: Salmeterol||9
267671|NCT00403754|649496|P1|COMPLETED|Open Label: Salmeterol||11
267672|NCT00403754|649493|P4|STARTED|Open Label: Salmeterol||11
267673|NCT00403754|649494|P3|STARTED|Open Label: Salmeterol||8
267674|NCT00403754|649495|P2|STARTED|Open Label: Salmeterol||9
267675|NCT00403754|649496|P1|STARTED|Open Label: Salmeterol||11
267676|NCT00403754|649493|P4|NOT COMPLETED|Core Treatment Period 4||0
267677|NCT00403754|649494|P3|NOT COMPLETED|Core Treatment Period 4||0
267678|NCT00403754|649495|P2|NOT COMPLETED|Core Treatment Period 4||0
267679|NCT00403754|649496|P1|NOT COMPLETED|Core Treatment Period 4||0
267680|NCT00403754|649493|P4|COMPLETED|Core Treatment Period 4||11
267681|NCT00403754|649494|P3|COMPLETED|Core Treatment Period 4||8
267682|NCT00403754|649495|P2|COMPLETED|Core Treatment Period 4||9
267683|NCT00403754|649496|P1|COMPLETED|Core Treatment Period 4||11
267684|NCT00403754|649493|P4|STARTED|Core Treatment Period 4||11
267685|NCT00403754|649494|P3|STARTED|Core Treatment Period 4||8
267686|NCT00403754|649495|P2|STARTED|Core Treatment Period 4||9
267687|NCT00403754|649496|P1|STARTED|Core Treatment Period 4||11
267688|NCT00403754|649493|P4|NOT COMPLETED|Core Treatment Period 3||0
267689|NCT00403754|649494|P3|NOT COMPLETED|Core Treatment Period 3||0
267690|NCT00403754|649495|P2|NOT COMPLETED|Core Treatment Period 3||0
267691|NCT00403754|649496|P1|NOT COMPLETED|Core Treatment Period 3||0
267692|NCT00403754|649493|P4|COMPLETED|Core Treatment Period 3||11
267693|NCT00403754|649494|P3|COMPLETED|Core Treatment Period 3||8
267694|NCT00403754|649495|P2|COMPLETED|Core Treatment Period 3||9
267695|NCT00403754|649496|P1|COMPLETED|Core Treatment Period 3||11
267696|NCT00403754|649493|P4|STARTED|Core Treatment Period 3||11
267697|NCT00403754|649494|P3|STARTED|Core Treatment Period 3||8
267698|NCT00403754|649495|P2|STARTED|Core Treatment Period 3||9
267699|NCT00403754|649496|P1|STARTED|Core Treatment Period 3||11
267700|NCT00403754|649493|P4|NOT COMPLETED|Core Treatment Period 2||0
267701|NCT00403754|649494|P3|NOT COMPLETED|Core Treatment Period 2||1
267702|NCT00403754|649495|P2|NOT COMPLETED|Core Treatment Period 2||0
267703|NCT00403754|649496|P1|NOT COMPLETED|Core Treatment Period 2||0
267704|NCT00403754|649493|P4|COMPLETED|Core Treatment Period 2||11
267705|NCT00403754|649494|P3|COMPLETED|Core Treatment Period 2||8
267706|NCT00403754|649495|P2|COMPLETED|Core Treatment Period 2||9
267707|NCT00403754|649496|P1|COMPLETED|Core Treatment Period 2||11
267708|NCT00403754|649493|P4|STARTED|Core Treatment Period 2||11
267709|NCT00403754|649494|P3|STARTED|Core Treatment Period 2||9
267710|NCT00403754|649495|P2|STARTED|Core Treatment Period 2||9
267711|NCT00403754|649496|P1|STARTED|Core Treatment Period 2||11
267712|NCT00403754|649493|P4|NOT COMPLETED|Core Treatment Period 1||0
267713|NCT00403754|649494|P3|NOT COMPLETED|Core Treatment Period 1||0
267714|NCT00403754|649495|P2|NOT COMPLETED|Core Treatment Period 1||1
267715|NCT00403754|649496|P1|NOT COMPLETED|Core Treatment Period 1||0
267716|NCT00403754|649493|P4|COMPLETED|Core Treatment Period 1||11
267717|NCT00403754|649494|P3|COMPLETED|Core Treatment Period 1||9
267718|NCT00403754|649495|P2|COMPLETED|Core Treatment Period 1||9
267719|NCT00403754|649496|P1|COMPLETED|Core Treatment Period 1||11
267720|NCT00403754|649493|P4|STARTED|Core Treatment Period 1||11
267721|NCT00403754|649494|P3|STARTED|Core Treatment Period 1||9
267722|NCT00403754|649495|P2|STARTED|Core Treatment Period 1||10
267723|NCT00403754|649496|P1|STARTED|Core Treatment Period 1||11
267724|NCT00403585|649523|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
267725|NCT00403585|649523|P1|COMPLETED|Open-Label Phase; Extension Study||74
267726|NCT00403585|649523|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
267727|NCT00403585|649523|P1|NOT COMPLETED|Initial Treatment Phase||2
267728|NCT00403585|649523|P1|COMPLETED|Initial Treatment Phase||102
267729|NCT00403585|649523|P1|STARTED|Initial Treatment Phase||104
267730|NCT00403546|649534|P3|NOT COMPLETED|Randomized Trial||16
267731|NCT00403546|649535|P2|NOT COMPLETED|Randomized Trial||17
267732|NCT00403546|649536|P1|NOT COMPLETED|Randomized Trial||0
267733|NCT00403546|649534|P3|COMPLETED|Randomized Trial||21
267734|NCT00403546|649535|P2|COMPLETED|Randomized Trial||21
267735|NCT00403546|649536|P1|COMPLETED|Randomized Trial||0
267736|NCT00403546|649534|P3|STARTED|Randomized Trial||37
267737|NCT00403546|649535|P2|STARTED|Randomized Trial||38
267738|NCT00403546|649536|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
267739|NCT00403546|649534|P3|NOT COMPLETED|Screening Phase||0
267740|NCT00403546|649535|P2|NOT COMPLETED|Screening Phase||0
267741|NCT00403546|649536|P1|NOT COMPLETED|Screening Phase||28
267742|NCT00403546|649534|P3|COMPLETED|Screening Phase||0
267743|NCT00403546|649535|P2|COMPLETED|Screening Phase||0
267744|NCT00403546|649536|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
267745|NCT00403546|649534|P3|STARTED|Screening Phase||0
267746|NCT00403546|649535|P2|STARTED|Screening Phase||0
267747|NCT00403546|649536|P1|STARTED|Screening Phase||103
267748|NCT00403546|649534|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
267749|NCT00403546|649535|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
267750|NCT00403546|649536|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
267751|NCT00403546|649534|P3|COMPLETED|Signed Informed Consent/Open-Label||0
267752|NCT00403546|649535|P2|COMPLETED|Signed Informed Consent/Open-Label||0
267753|NCT00403546|649536|P1|COMPLETED|Signed Informed Consent/Open-Label||103
267754|NCT00403546|649534|P3|STARTED|Signed Informed Consent/Open-Label||0
267755|NCT00403546|649535|P2|STARTED|Signed Informed Consent/Open-Label||0
267756|NCT00403546|649536|P1|STARTED|Signed Informed Consent/Open-Label||131
267757|NCT00403481|649576|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
267758|NCT00403481|649576|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
267759|NCT00403481|649576|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
267760|NCT00403481|649576|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
267761|NCT00403481|649576|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
267853|NCT00402688|649960|P3|NOT COMPLETED|Overall Study||15
267854|NCT00402688|649961|P2|NOT COMPLETED|Overall Study||16
267762|NCT00403481|649576|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
267763|NCT00403481|649576|P1|NOT COMPLETED|Olm 40 mg||5
267764|NCT00403481|649576|P1|COMPLETED|Olm 40 mg||177
267765|NCT00403481|649576|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
267766|NCT00403481|649576|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
267767|NCT00403481|649576|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
267768|NCT00403481|649576|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
267769|NCT00403455|649591|P1|NOT COMPLETED|Overall Study||1
267770|NCT00403455|649591|P1|COMPLETED|Overall Study||37
267771|NCT00403455|649591|P1|STARTED|Overall Study||38
267772|NCT00403403|649597|P2|NOT COMPLETED|Overall Study||0
267773|NCT00403403|649598|P1|NOT COMPLETED|Overall Study||0
267774|NCT00403403|649597|P2|COMPLETED|Overall Study||52
267775|NCT00403403|649598|P1|COMPLETED|Overall Study||50
267776|NCT00403403|649597|P2|Safety-Evaluable Patients|Overall Study||51
267777|NCT00403403|649598|P1|Safety-Evaluable Patients|Overall Study||47
267778|NCT00403403|649597|P2|STARTED|Overall Study||52
267779|NCT00403403|649598|P1|STARTED|Overall Study||50
267780|NCT00403390|649614|P2|NOT COMPLETED|Overall Study||0
267781|NCT00403390|649615|P1|NOT COMPLETED|Overall Study||3
267782|NCT00403390|649614|P2|COMPLETED|Overall Study||18
267783|NCT00403390|649615|P1|COMPLETED|Overall Study||13
267784|NCT00403390|649614|P2|STARTED|Overall Study||18
267785|NCT00403390|649615|P1|STARTED|Overall Study||16
267786|NCT00403273|649623|P2|NOT COMPLETED|Overall Study||4
267787|NCT00403273|649624|P1|NOT COMPLETED|Overall Study||3
267788|NCT00403273|649623|P2|COMPLETED|Overall Study||25
267789|NCT00403273|649624|P1|COMPLETED|Overall Study||22
267790|NCT00403273|649623|P2|STARTED|Overall Study||29
267791|NCT00403273|649624|P1|STARTED|Overall Study||25
267792|NCT00403234|649666|P4|NOT COMPLETED|Overall Study||0
267793|NCT00403234|649667|P3|NOT COMPLETED|Overall Study||1
267794|NCT00403234|649668|P2|NOT COMPLETED|Overall Study||1
267795|NCT00403234|649669|P1|NOT COMPLETED|Overall Study||1
267796|NCT00403234|649666|P4|COMPLETED|Overall Study||2
267797|NCT00403234|649667|P3|COMPLETED|Overall Study||2
267798|NCT00403234|649668|P2|COMPLETED|Overall Study||2
267799|NCT00403234|649669|P1|COMPLETED|Overall Study||1
267800|NCT00403234|649666|P4|STARTED|Overall Study||2
267801|NCT00403234|649667|P3|STARTED|Overall Study||3
267802|NCT00403234|649668|P2|STARTED|Overall Study||3
267803|NCT00403234|649669|P1|STARTED|Overall Study||2
267804|NCT00403130|649679|P1|NOT COMPLETED|Overall Study||5
267805|NCT00403130|649679|P1|COMPLETED|Overall Study||26
267806|NCT00403130|649679|P1|STARTED|Overall Study||31
267807|NCT00403117|649686|P1|NOT COMPLETED|Overall Study||20
267808|NCT00403117|649686|P1|COMPLETED|Overall Study||29
267809|NCT00403117|649686|P1|STARTED|Overall Study||49
267810|NCT00402987|649732|P4|NOT COMPLETED|Overall Study||0
267811|NCT00402987|649733|P3|NOT COMPLETED|Overall Study||1
267812|NCT00402987|649734|P2|NOT COMPLETED|Overall Study||0
267813|NCT00402987|649735|P1|NOT COMPLETED|Overall Study||0
267814|NCT00402987|649732|P4|COMPLETED|Overall Study||89
267815|NCT00402987|649733|P3|COMPLETED|Overall Study||44
267816|NCT00402987|649734|P2|COMPLETED|Overall Study||45
267817|NCT00402987|649735|P1|COMPLETED|Overall Study||90
267818|NCT00402987|649732|P4|STARTED|Overall Study||89
267819|NCT00402987|649733|P3|STARTED|Overall Study||45
267820|NCT00402987|649734|P2|STARTED|Overall Study||45
267821|NCT00402987|649735|P1|STARTED|Overall Study||90
267822|NCT00402896|649897|P1|NOT COMPLETED|Overall Study||0
267823|NCT00402896|649897|P1|COMPLETED|Overall Study||20
267824|NCT00402896|649897|P1|STARTED|Overall Study||20
267825|NCT00402883|649901|P1|NOT COMPLETED|Maintenance Therapy||0
267826|NCT00402883|649901|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
267827|NCT00402883|649901|P1|STARTED|Maintenance Therapy||5
267828|NCT00402883|649901|P1|NOT COMPLETED|Consolidation Therapy||0
267829|NCT00402883|649901|P1|COMPLETED|Consolidation Therapy||5
267830|NCT00402883|649901|P1|STARTED|Consolidation Therapy||5
267831|NCT00402883|649901|P1|NOT COMPLETED|Induction Therapy||0
267832|NCT00402883|649901|P1|COMPLETED|Induction Therapy||5
267833|NCT00402883|649901|P1|STARTED|Induction Therapy||5
267834|NCT00402740|649905|P1|NOT COMPLETED|Overall Study||80
267835|NCT00402740|649905|P1|COMPLETED|Overall Study||242
267836|NCT00402740|649905|P1|STARTED|Overall Study||322
267837|NCT00402727|649917|P2|NOT COMPLETED|Overall Study||34
267838|NCT00402727|649918|P1|NOT COMPLETED|Overall Study||42
267839|NCT00402727|649917|P2|COMPLETED|Overall Study||347
267840|NCT00402727|649918|P1|COMPLETED|Overall Study||390
267841|NCT00402727|649917|P2|Achieving Test Of Cure (TOC)|Overall Study||347
267842|NCT00402727|649918|P1|Achieving Test Of Cure (TOC)|Overall Study||390
267843|NCT00402727|649917|P2|Achieving End Of Treatment (EOT)|Overall Study||355
267844|NCT00402727|649918|P1|Achieving End Of Treatment (EOT)|Overall Study||408
267845|NCT00402727|649917|P2|STARTED|Overall Study||381
267846|NCT00402727|649918|P1|STARTED|Overall Study||432
267847|NCT00402714|649948|P2|NOT COMPLETED|Overall Study||0
267848|NCT00402714|649949|P1|NOT COMPLETED|Overall Study||0
267849|NCT00402714|649948|P2|COMPLETED|Overall Study||11
267850|NCT00402714|649949|P1|COMPLETED|Overall Study||3
267851|NCT00402714|649948|P2|STARTED|Overall Study||11
267852|NCT00402714|649949|P1|STARTED|Overall Study||3
267855|NCT00402688|649962|P1|NOT COMPLETED|Overall Study||21
267856|NCT00402688|649960|P3|COMPLETED|Overall Study||65
267857|NCT00402688|649961|P2|COMPLETED|Overall Study||65
267858|NCT00402688|649962|P1|COMPLETED|Overall Study||60
267859|NCT00402688|649960|P3|STARTED|Overall Study||80
267860|NCT00402688|649961|P2|STARTED|Overall Study||81
267861|NCT00402688|649962|P1|STARTED|Overall Study||81
267862|NCT00402649|649985|P1|NOT COMPLETED|Overall Study||2
267863|NCT00402649|649985|P1|COMPLETED|Overall Study||33
267864|NCT00402649|649985|P1|STARTED|Overall Study||35
267865|NCT00402597|650000|P5|NOT COMPLETED|Overall Study||124
267866|NCT00402597|650001|P4|NOT COMPLETED|Overall Study||74
267867|NCT00402597|650002|P3|NOT COMPLETED|Overall Study||212
267868|NCT00402597|650003|P2|NOT COMPLETED|Overall Study||46
267869|NCT00402597|650004|P1|NOT COMPLETED|Overall Study||191
267870|NCT00402597|650000|P5|COMPLETED|Overall Study||479
267871|NCT00402597|650001|P4|COMPLETED|Overall Study||279
267872|NCT00402597|650002|P3|COMPLETED|Overall Study||834
267873|NCT00402597|650003|P2|COMPLETED|Overall Study||261
267874|NCT00402597|650004|P1|COMPLETED|Overall Study||962
267875|NCT00402597|650000|P5|STARTED|Overall Study||603
267876|NCT00402597|650001|P4|STARTED|Overall Study||353
267877|NCT00402597|650002|P3|STARTED|Overall Study||1046
267878|NCT00402597|650003|P2|STARTED|Overall Study||307
267879|NCT00402597|650004|P1|STARTED|Overall Study||1153
267880|NCT00402363|650045|P4|NOT COMPLETED|Overall Study||10
267881|NCT00402363|650046|P3|NOT COMPLETED|Overall Study||6
267882|NCT00402363|650047|P2|NOT COMPLETED|Overall Study||30
267883|NCT00402363|650048|P1|NOT COMPLETED|Overall Study||33
267884|NCT00402363|650045|P4|COMPLETED|Overall Study||45
267885|NCT00402363|650046|P3|COMPLETED|Overall Study||60
267886|NCT00402363|650047|P2|COMPLETED|Overall Study||246
267887|NCT00402363|650048|P1|COMPLETED|Overall Study||233
267888|NCT00402363|650045|P4|STARTED|Overall Study||55
267889|NCT00402363|650046|P3|STARTED|Overall Study||66
267890|NCT00402363|650047|P2|STARTED|Overall Study||276
267891|NCT00402363|650048|P1|STARTED|Overall Study||266
267892|NCT00402337|650111|P5|NOT COMPLETED|Overall Study||8
267893|NCT00402337|650112|P4|NOT COMPLETED|Overall Study||12
267894|NCT00402337|650113|P3|NOT COMPLETED|Overall Study||4
267895|NCT00402337|650114|P2|NOT COMPLETED|Overall Study||6
267896|NCT00402337|650115|P1|NOT COMPLETED|Overall Study||5
267897|NCT00402337|650111|P5|COMPLETED|Overall Study||61
267898|NCT00402337|650112|P4|COMPLETED|Overall Study||51
267899|NCT00402337|650113|P3|COMPLETED|Overall Study||58
267900|NCT00402337|650114|P2|COMPLETED|Overall Study||51
267901|NCT00402337|650115|P1|COMPLETED|Overall Study||54
267902|NCT00402337|650111|P5|STARTED|Overall Study||69
267903|NCT00402337|650112|P4|STARTED|Overall Study||63
267904|NCT00402337|650113|P3|STARTED|Overall Study||62
267905|NCT00402337|650114|P2|STARTED|Overall Study||57
267906|NCT00402337|650115|P1|STARTED|Overall Study||59
267907|NCT00402324|650154|P2|NOT COMPLETED|Overall Study||41
267908|NCT00402324|650155|P1|NOT COMPLETED|Overall Study||43
267909|NCT00402324|650154|P2|COMPLETED|Overall Study||60
267910|NCT00402324|650155|P1|COMPLETED|Overall Study||58
267911|NCT00402324|650154|P2|STARTED|Overall Study||101
267912|NCT00402324|650155|P1|STARTED|Overall Study||101
267913|NCT00402285|650188|P3|NOT COMPLETED|Overall Study||2
267914|NCT00402285|650189|P2|NOT COMPLETED|Overall Study||6
267915|NCT00402285|650190|P1|NOT COMPLETED|Overall Study||7
267916|NCT00402285|650188|P3|COMPLETED|Overall Study||26
267917|NCT00402285|650189|P2|COMPLETED|Overall Study||21
267918|NCT00402285|650190|P1|COMPLETED|Overall Study||22
267919|NCT00402285|650188|P3|STARTED|Overall Study||28
267920|NCT00402285|650189|P2|STARTED|Overall Study||27
267921|NCT00402285|650190|P1|STARTED|Overall Study||29
267922|NCT00402246|650198|P2|NOT COMPLETED|Overall Study||234
267923|NCT00402246|650199|P1|NOT COMPLETED|Overall Study||220
267924|NCT00402246|650198|P2|COMPLETED|Overall Study||749
267925|NCT00402246|650199|P1|COMPLETED|Overall Study||794
267926|NCT00402246|650198|P2|STARTED|Overall Study||983
267927|NCT00402246|650199|P1|STARTED|Overall Study||1014
267928|NCT00402233|650233|P4|NOT COMPLETED|Overall Study||11
267929|NCT00402233|650234|P3|NOT COMPLETED|Overall Study||11
267930|NCT00402233|650235|P2|NOT COMPLETED|Overall Study||10
267931|NCT00402233|650236|P1|NOT COMPLETED|Overall Study||5
267932|NCT00402233|650233|P4|COMPLETED|Overall Study||62
267933|NCT00402233|650234|P3|COMPLETED|Overall Study||70
267934|NCT00402233|650235|P2|COMPLETED|Overall Study||70
267935|NCT00402233|650236|P1|COMPLETED|Overall Study||72
267936|NCT00402233|650233|P4|STARTED|Overall Study||73
267937|NCT00402233|650234|P3|STARTED|Overall Study||81
267938|NCT00402233|650235|P2|STARTED|Overall Study||80
267939|NCT00402233|650236|P1|STARTED|Overall Study||77
267940|NCT00402194|650260|P2|NOT COMPLETED|Overall Study||0
267941|NCT00402194|650261|P1|NOT COMPLETED|Overall Study||0
267942|NCT00402194|650260|P2|COMPLETED|Overall Study||8
267943|NCT00402194|650261|P1|COMPLETED|Overall Study||9
267944|NCT00402194|650260|P2|STARTED|Overall Study||8
267945|NCT00402194|650261|P1|STARTED|Overall Study||9
267946|NCT00402168|650271|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
267947|NCT00402168|650272|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
267948|NCT00402168|650271|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
267949|NCT00402168|650272|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
267950|NCT00402168|650271|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
267951|NCT00402168|650272|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
267952|NCT00402168|650271|P2|NOT COMPLETED|Long Term (LT)||17
267953|NCT00402168|650272|P1|NOT COMPLETED|Long Term (LT)||11
267954|NCT00402168|650271|P2|COMPLETED|Long Term (LT)||64
267955|NCT00402168|650272|P1|COMPLETED|Long Term (LT)||70
267956|NCT00402168|650271|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
267957|NCT00402168|650272|P1|STARTED|Long Term (LT)||81
267958|NCT00402168|650271|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
267959|NCT00402168|650272|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
267960|NCT00402168|650271|P2|COMPLETED|Treatment (up to 12 Months)||86
267961|NCT00402168|650272|P1|COMPLETED|Treatment (up to 12 Months)||81
267962|NCT00402168|650271|P2|STARTED|Treatment (up to 12 Months)||88
267963|NCT00402168|650272|P1|STARTED|Treatment (up to 12 Months)||83
267964|NCT00402168|650271|P2|NOT COMPLETED|Randomized||1
267965|NCT00402168|650272|P1|NOT COMPLETED|Randomized||1
267966|NCT00402168|650271|P2|COMPLETED|Randomized||88
267967|NCT00402168|650272|P1|COMPLETED|Randomized||83
267968|NCT00402168|650271|P2|STARTED|Randomized||89
267969|NCT00402168|650272|P1|STARTED|Randomized||84
267970|NCT00402103|650329|P2|NOT COMPLETED|Overall Study||13
267971|NCT00402103|650330|P1|NOT COMPLETED|Overall Study||91
267972|NCT00402103|650329|P2|COMPLETED|Overall Study||73
267973|NCT00402103|650330|P1|COMPLETED|Overall Study||379
267974|NCT00402103|650329|P2|STARTED|Overall Study||86
267975|NCT00402103|650330|P1|STARTED|Overall Study||470
267976|NCT00402051|650346|P2|NOT COMPLETED|Overall Study||35
267977|NCT00402051|650347|P1|NOT COMPLETED|Overall Study||38
267978|NCT00402051|650346|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
267979|NCT00402051|650347|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
267980|NCT00402051|650346|P2|Received Treatment|Overall Study||65
267981|NCT00402051|650347|P1|Received Treatment|Overall Study||65
267982|NCT00402051|650346|P2|STARTED|Overall Study||67
267983|NCT00402051|650347|P1|STARTED|Overall Study||66
267984|NCT00402025|650364|P3|NOT COMPLETED|Overall Study||10
267985|NCT00402025|650365|P2|NOT COMPLETED|Overall Study||3
267986|NCT00402025|650366|P1|NOT COMPLETED|Overall Study||2
267987|NCT00402025|650364|P3|COMPLETED|Overall Study||0
267988|NCT00402025|650365|P2|COMPLETED|Overall Study||1
267989|NCT00402025|650366|P1|COMPLETED|Overall Study||1
267990|NCT00402025|650364|P3|STARTED|Overall Study||10
267991|NCT00402025|650365|P2|STARTED|Overall Study||4
267992|NCT00402025|650366|P1|STARTED|Overall Study||3
267993|NCT00401973|650392|P3|NOT COMPLETED|Overall Study||23
267994|NCT00401973|650393|P2|NOT COMPLETED|Overall Study||26
267995|NCT00401973|650394|P1|NOT COMPLETED|Overall Study||11
267996|NCT00401973|650392|P3|COMPLETED|Overall Study||50
267997|NCT00401973|650393|P2|COMPLETED|Overall Study||50
267998|NCT00401973|650394|P1|COMPLETED|Overall Study||39
267999|NCT00401973|650392|P3|STARTED|Overall Study||73
268000|NCT00401973|650393|P2|STARTED|Overall Study||76
268001|NCT00401973|650394|P1|STARTED|Overall Study||50
268002|NCT00401960|650433|P2|NOT COMPLETED|Overall Study||0
268003|NCT00401960|650434|P1|NOT COMPLETED|Overall Study||5
268004|NCT00401960|650433|P2|COMPLETED|Overall Study||1
268005|NCT00401960|650434|P1|COMPLETED|Overall Study||0
268006|NCT00401960|650433|P2|STARTED|Overall Study||1
268007|NCT00401960|650434|P1|STARTED|Overall Study||5
268008|NCT00401882|650444|P2|NOT COMPLETED|Overall Study||0
268009|NCT00401882|650445|P1|NOT COMPLETED|Overall Study||0
268010|NCT00401882|650444|P2|COMPLETED|Overall Study||5
268011|NCT00401882|650445|P1|COMPLETED|Overall Study||2
268012|NCT00401882|650444|P2|STARTED|Overall Study||5
268013|NCT00401882|650445|P1|STARTED|Overall Study||2
268014|NCT00401843|650464|P3|NOT COMPLETED|Overall Study||142
268015|NCT00401843|650465|P2|NOT COMPLETED|Overall Study||144
268016|NCT00401843|650466|P1|NOT COMPLETED|Overall Study||21
268017|NCT00401843|650464|P3|COMPLETED|Overall Study||0
268018|NCT00401843|650465|P2|COMPLETED|Overall Study||0
268019|NCT00401843|650466|P1|COMPLETED|Overall Study||0
268020|NCT00401843|650464|P3|Treated|Overall Study||139
268021|NCT00401843|650465|P2|Treated|Overall Study||142
268022|NCT00401843|650466|P1|Treated|Overall Study||21
268023|NCT00401843|650464|P3|STARTED|Overall Study||142
268024|NCT00401843|650465|P2|STARTED|Overall Study||144
268025|NCT00401843|650466|P1|STARTED|Overall Study||21
268026|NCT00401830|650484|P2|NOT COMPLETED|Overall Study||32
268027|NCT00401830|650485|P1|NOT COMPLETED|Overall Study||31
268028|NCT00401830|650484|P2|COMPLETED|Overall Study||46
268029|NCT00401830|650485|P1|COMPLETED|Overall Study||50
268030|NCT00401830|650484|P2|STARTED|Overall Study||78
268031|NCT00401830|650485|P1|STARTED|Overall Study||81
268032|NCT00401817|650517|P1|NOT COMPLETED|Overall Study||0
268033|NCT00401817|650517|P1|COMPLETED|Overall Study||11
268034|NCT00401817|650517|P1|STARTED|Overall Study||11
268035|NCT00401778|650527|P3|NOT COMPLETED|Overall Study||1
268036|NCT00401778|650528|P2|NOT COMPLETED|Overall Study||1
268037|NCT00401778|650529|P1|NOT COMPLETED|Overall Study||1
268038|NCT00401778|650527|P3|COMPLETED|Overall Study||10
268039|NCT00401778|650528|P2|COMPLETED|Overall Study||11
268040|NCT00401778|650529|P1|COMPLETED|Overall Study||9
268041|NCT00401778|650527|P3|STARTED|Overall Study||11
268042|NCT00401778|650528|P2|STARTED|Overall Study||12
268043|NCT00401778|650529|P1|STARTED|Overall Study||10
268044|NCT00401752|650543|P2|NOT COMPLETED|Overall Study||18
268045|NCT00401752|650544|P1|NOT COMPLETED|Overall Study||10
268046|NCT00401752|650543|P2|COMPLETED|Overall Study||94
268047|NCT00401752|650544|P1|COMPLETED|Overall Study||97
268048|NCT00401752|650543|P2|Patients Included in Per-Protocol Popula|Overall Study||99
268049|NCT00401752|650544|P1|Patients Included in Per-Protocol Popula|Overall Study||100
268050|NCT00401752|650543|P2|Patients Included in Safety Population|Overall Study||110
268051|NCT00401752|650544|P1|Patients Included in Safety Population|Overall Study||107
268052|NCT00401752|650543|P2|Patients Included in ITT Population|Overall Study||111
268053|NCT00401752|650544|P1|Patients Included in ITT Population|Overall Study||106
268054|NCT00401752|650543|P2|Number of Patients Received Treatment|Overall Study||111
268055|NCT00401752|650544|P1|Number of Patients Received Treatment|Overall Study||107
268056|NCT00401752|650543|P2|STARTED|Overall Study||112
268057|NCT00401752|650544|P1|STARTED|Overall Study||107
268058|NCT00401726|650562|P2|NOT COMPLETED|Overall Study||112
268059|NCT00401726|650563|P1|NOT COMPLETED|Overall Study||97
268060|NCT00401726|650562|P2|COMPLETED|Overall Study||156
268061|NCT00401726|650563|P1|COMPLETED|Overall Study||172
268062|NCT00401726|650562|P2|STARTED|Overall Study||268
268063|NCT00401726|650563|P1|STARTED|Overall Study||269
268064|NCT00401622|650585|P2|NOT COMPLETED|Overall Study||43
268065|NCT00401622|650586|P1|NOT COMPLETED|Overall Study||34
268066|NCT00401622|650585|P2|COMPLETED|Overall Study||117
268067|NCT00401622|650586|P1|COMPLETED|Overall Study||126
268068|NCT00401622|650585|P2|STARTED|Overall Study||160
268069|NCT00401622|650586|P1|STARTED|Overall Study||160
268070|NCT00401544|650598|P4|NOT COMPLETED|Overall Study||16
268071|NCT00401544|650599|P3|NOT COMPLETED|Overall Study||12
268072|NCT00401544|650600|P2|NOT COMPLETED|Overall Study||18
268073|NCT00401544|650601|P1|NOT COMPLETED|Overall Study||18
268074|NCT00401544|650598|P4|COMPLETED|Overall Study||44
268075|NCT00401544|650599|P3|COMPLETED|Overall Study||48
268076|NCT00401544|650600|P2|COMPLETED|Overall Study||44
268077|NCT00401544|650601|P1|COMPLETED|Overall Study||38
268078|NCT00401544|650598|P4|STARTED|Overall Study|Randomized and treated|60
268079|NCT00401544|650599|P3|STARTED|Overall Study|Randomized and treated|60
268080|NCT00401544|650600|P2|STARTED|Overall Study|Randomized and treated|62
268081|NCT00401544|650601|P1|STARTED|Overall Study|Randomized and treated|56
268082|NCT00401531|650641|P2|NOT COMPLETED|Overall Study||10
268083|NCT00401531|650642|P1|NOT COMPLETED|Overall Study||9
268084|NCT00401531|650641|P2|COMPLETED|Overall Study||196
268085|NCT00401531|650642|P1|COMPLETED|Overall Study||197
268086|NCT00401531|650641|P2|STARTED|Overall Study||206
268087|NCT00401531|650642|P1|STARTED|Overall Study||206
268088|NCT00401414|650661|P3|NOT COMPLETED|Overall Study||0
268089|NCT00401414|650662|P2|NOT COMPLETED|Overall Study||0
268090|NCT00401414|650663|P1|NOT COMPLETED|Overall Study||0
268091|NCT00401414|650661|P3|COMPLETED|Overall Study||79
268092|NCT00401414|650662|P2|COMPLETED|Overall Study||147
268093|NCT00401414|650663|P1|COMPLETED|Overall Study||118
268094|NCT00401414|650661|P3|STARTED|Overall Study||79
268095|NCT00401414|650662|P2|STARTED|Overall Study||147
268096|NCT00401414|650663|P1|STARTED|Overall Study||118
268097|NCT00401401|650687|P4|NOT COMPLETED|Overall Study||3
268098|NCT00401401|650688|P3|NOT COMPLETED|Overall Study||1
268099|NCT00401401|650689|P2|NOT COMPLETED|Overall Study||0
268100|NCT00401401|650690|P1|NOT COMPLETED|Overall Study||0
268101|NCT00401401|650687|P4|COMPLETED|Overall Study||9
268102|NCT00401401|650688|P3|COMPLETED|Overall Study||5
268103|NCT00401401|650689|P2|COMPLETED|Overall Study||6
268104|NCT00401401|650690|P1|COMPLETED|Overall Study||6
268105|NCT00401401|650687|P4|STARTED|Overall Study||12
268106|NCT00401401|650688|P3|STARTED|Overall Study||6
268107|NCT00401401|650689|P2|STARTED|Overall Study||6
268108|NCT00401401|650690|P1|STARTED|Overall Study||6
268109|NCT00401258|650712|P1|NOT COMPLETED|Overall Study||7
268110|NCT00401258|650712|P1|COMPLETED|Overall Study||8
268111|NCT00401258|650712|P1|STARTED|Overall Study||15
268112|NCT00401245|650727|P8|NOT COMPLETED|Double Blind Tapering Phase||7
268113|NCT00401245|650728|P7|NOT COMPLETED|Double Blind Tapering Phase||7
268114|NCT00401245|650729|P6|NOT COMPLETED|Double Blind Tapering Phase||4
268115|NCT00401245|650730|P5|NOT COMPLETED|Double Blind Tapering Phase||4
268116|NCT00401245|650731|P4|NOT COMPLETED|Double Blind Tapering Phase||0
268117|NCT00401245|650732|P3|NOT COMPLETED|Double Blind Tapering Phase||0
268118|NCT00401245|650733|P2|NOT COMPLETED|Double Blind Tapering Phase||0
268119|NCT00401245|650734|P1|NOT COMPLETED|Double Blind Tapering Phase||0
268120|NCT00401245|650727|P8|COMPLETED|Double Blind Tapering Phase||95
268121|NCT00401245|650728|P7|COMPLETED|Double Blind Tapering Phase||80
268122|NCT00401245|650729|P6|COMPLETED|Double Blind Tapering Phase||90
268123|NCT00401245|650730|P5|COMPLETED|Double Blind Tapering Phase||97
268124|NCT00401245|650731|P4|COMPLETED|Double Blind Tapering Phase||0
268125|NCT00401245|650732|P3|COMPLETED|Double Blind Tapering Phase||0
268126|NCT00401245|650733|P2|COMPLETED|Double Blind Tapering Phase||0
268127|NCT00401245|650734|P1|COMPLETED|Double Blind Tapering Phase||0
268128|NCT00401245|650727|P8|STARTED|Double Blind Tapering Phase||102
268129|NCT00401245|650728|P7|STARTED|Double Blind Tapering Phase||87
268130|NCT00401245|650729|P6|STARTED|Double Blind Tapering Phase||94
268131|NCT00401245|650730|P5|STARTED|Double Blind Tapering Phase||101
268132|NCT00401245|650731|P4|STARTED|Double Blind Tapering Phase||0
268133|NCT00401245|650732|P3|STARTED|Double Blind Tapering Phase||0
268134|NCT00401245|650733|P2|STARTED|Double Blind Tapering Phase||0
268135|NCT00401245|650734|P1|STARTED|Double Blind Tapering Phase||0
268136|NCT00401245|650727|P8|NOT COMPLETED|Open Label Phase||0
268137|NCT00401245|650728|P7|NOT COMPLETED|Open Label Phase||0
268138|NCT00401245|650729|P6|NOT COMPLETED|Open Label Phase||0
268139|NCT00401245|650730|P5|NOT COMPLETED|Open Label Phase||0
268140|NCT00401245|650731|P4|NOT COMPLETED|Open Label Phase||21
268141|NCT00401245|650732|P3|NOT COMPLETED|Open Label Phase||23
268142|NCT00401245|650733|P2|NOT COMPLETED|Open Label Phase||35
268143|NCT00401245|650734|P1|NOT COMPLETED|Open Label Phase||21
268144|NCT00401245|650727|P8|COMPLETED|Open Label Phase||0
268145|NCT00401245|650728|P7|COMPLETED|Open Label Phase||0
268146|NCT00401245|650729|P6|COMPLETED|Open Label Phase||0
268147|NCT00401245|650730|P5|COMPLETED|Open Label Phase||0
268148|NCT00401245|650731|P4|COMPLETED|Open Label Phase||84
268149|NCT00401245|650732|P3|COMPLETED|Open Label Phase||95
268150|NCT00401245|650733|P2|COMPLETED|Open Label Phase||81
268151|NCT00401245|650734|P1|COMPLETED|Open Label Phase||101
268152|NCT00401245|650727|P8|STARTED|Open Label Phase||0
268153|NCT00401245|650728|P7|STARTED|Open Label Phase||0
268154|NCT00401245|650729|P6|STARTED|Open Label Phase||0
268155|NCT00401245|650730|P5|STARTED|Open Label Phase||0
268156|NCT00401245|650731|P4|STARTED|Open Label Phase||105
268157|NCT00401245|650732|P3|STARTED|Open Label Phase||118
268158|NCT00401245|650733|P2|STARTED|Open Label Phase||116
268159|NCT00401245|650734|P1|STARTED|Open Label Phase||122
268160|NCT00401245|650727|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
268161|NCT00401245|650728|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
268162|NCT00401245|650729|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
268163|NCT00401245|650730|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
268164|NCT00401245|650731|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
268165|NCT00401245|650732|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
268166|NCT00401245|650733|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
268167|NCT00401245|650734|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
268168|NCT00401245|650727|P8|COMPLETED|Between Titration and Open Label Phase||0
268169|NCT00401245|650728|P7|COMPLETED|Between Titration and Open Label Phase||0
268170|NCT00401245|650729|P6|COMPLETED|Between Titration and Open Label Phase||0
268171|NCT00401245|650730|P5|COMPLETED|Between Titration and Open Label Phase||0
268172|NCT00401245|650731|P4|COMPLETED|Between Titration and Open Label Phase||105
268173|NCT00401245|650732|P3|COMPLETED|Between Titration and Open Label Phase||118
268174|NCT00401245|650733|P2|COMPLETED|Between Titration and Open Label Phase||116
268175|NCT00401245|650734|P1|COMPLETED|Between Titration and Open Label Phase||122
268176|NCT00401245|650727|P8|STARTED|Between Titration and Open Label Phase||0
268177|NCT00401245|650728|P7|STARTED|Between Titration and Open Label Phase||0
268178|NCT00401245|650729|P6|STARTED|Between Titration and Open Label Phase||0
268179|NCT00401245|650730|P5|STARTED|Between Titration and Open Label Phase||0
268180|NCT00401245|650731|P4|STARTED|Between Titration and Open Label Phase||107
268181|NCT00401245|650732|P3|STARTED|Between Titration and Open Label Phase||118
268182|NCT00401245|650733|P2|STARTED|Between Titration and Open Label Phase||118
268183|NCT00401245|650734|P1|STARTED|Between Titration and Open Label Phase||122
268184|NCT00401245|650727|P8|NOT COMPLETED|Double Blind Titration Phase||0
268185|NCT00401245|650728|P7|NOT COMPLETED|Double Blind Titration Phase||0
268186|NCT00401245|650729|P6|NOT COMPLETED|Double Blind Titration Phase||0
268187|NCT00401245|650730|P5|NOT COMPLETED|Double Blind Titration Phase||0
268188|NCT00401245|650731|P4|NOT COMPLETED|Double Blind Titration Phase||15
268189|NCT00401245|650732|P3|NOT COMPLETED|Double Blind Titration Phase||6
268190|NCT00401245|650733|P2|NOT COMPLETED|Double Blind Titration Phase||3
268191|NCT00401245|650734|P1|NOT COMPLETED|Double Blind Titration Phase||4
268192|NCT00401245|650727|P8|COMPLETED|Double Blind Titration Phase||0
268193|NCT00401245|650728|P7|COMPLETED|Double Blind Titration Phase||0
268194|NCT00401245|650729|P6|COMPLETED|Double Blind Titration Phase||0
268195|NCT00401245|650730|P5|COMPLETED|Double Blind Titration Phase||0
268196|NCT00401245|650731|P4|COMPLETED|Double Blind Titration Phase||107
268197|NCT00401245|650732|P3|COMPLETED|Double Blind Titration Phase||118
268198|NCT00401245|650733|P2|COMPLETED|Double Blind Titration Phase||118
268199|NCT00401245|650734|P1|COMPLETED|Double Blind Titration Phase||122
268200|NCT00401245|650727|P8|STARTED|Double Blind Titration Phase||0
268201|NCT00401245|650728|P7|STARTED|Double Blind Titration Phase||0
268202|NCT00401245|650729|P6|STARTED|Double Blind Titration Phase||0
268203|NCT00401245|650730|P5|STARTED|Double Blind Titration Phase||0
268204|NCT00401245|650731|P4|STARTED|Double Blind Titration Phase||122
268205|NCT00401245|650732|P3|STARTED|Double Blind Titration Phase||124
268206|NCT00401245|650733|P2|STARTED|Double Blind Titration Phase||121
268207|NCT00401245|650734|P1|STARTED|Double Blind Titration Phase||126
268208|NCT00401193|650802|P3|NOT COMPLETED|Overall Study||6
268209|NCT00401193|650803|P2|NOT COMPLETED|Overall Study||11
268210|NCT00401193|650804|P1|NOT COMPLETED|Overall Study||15
268211|NCT00401193|650802|P3|COMPLETED|Overall Study||63
268212|NCT00401193|650803|P2|COMPLETED|Overall Study||106
268213|NCT00401193|650804|P1|COMPLETED|Overall Study||103
268214|NCT00401193|650802|P3|Modified Intent to Treat Population|Overall Study||67
268215|NCT00401193|650803|P2|Modified Intent to Treat Population|Overall Study||115
268216|NCT00401193|650804|P1|Modified Intent to Treat Population|Overall Study||112
268217|NCT00401193|650802|P3|Intent to Treat Population|Overall Study||67
268218|NCT00401193|650803|P2|Intent to Treat Population|Overall Study||115
268219|NCT00401193|650804|P1|Intent to Treat Population|Overall Study||115
268220|NCT00401193|650802|P3|STARTED|Overall Study||69
268221|NCT00401193|650803|P2|STARTED|Overall Study||117
268222|NCT00401193|650804|P1|STARTED|Overall Study||118
268223|NCT00401102|650818|P1|NOT COMPLETED|Overall Study||7
268224|NCT00401102|650818|P1|COMPLETED|Overall Study||5
268225|NCT00401102|650818|P1|STARTED|Overall Study||12
268226|NCT00400946|650827|P5|NOT COMPLETED|Overall Study||38
268227|NCT00400946|650828|P4|NOT COMPLETED|Overall Study||47
268228|NCT00400946|650829|P3|NOT COMPLETED|Overall Study||2
268229|NCT00400946|650830|P2|NOT COMPLETED|Overall Study||11
268230|NCT00400946|650831|P1|NOT COMPLETED|Overall Study||14
268231|NCT00400946|650827|P5|COMPLETED|Overall Study||206
268232|NCT00400946|650828|P4|COMPLETED|Overall Study||4
268233|NCT00400946|650829|P3|COMPLETED|Overall Study||40
268234|NCT00400946|650830|P2|COMPLETED|Overall Study||221
268235|NCT00400946|650831|P1|COMPLETED|Overall Study||217
268236|NCT00400946|650827|P5|Eligible and Treated|Overall Study||243
268237|NCT00400946|650828|P4|Eligible and Treated|Overall Study||46
268238|NCT00400946|650829|P3|Eligible and Treated|Overall Study||42
268239|NCT00400946|650830|P2|Eligible and Treated|Overall Study||232
268240|NCT00400946|650831|P1|Eligible and Treated|Overall Study||231
268241|NCT00400946|650827|P5|Evaluable for Day 32 MRD|Overall Study||168
268242|NCT00400946|650828|P4|Evaluable for Day 32 MRD|Overall Study||12
268243|NCT00400946|650829|P3|Evaluable for Day 32 MRD|Overall Study||33
268244|NCT00400946|650830|P2|Evaluable for Day 32 MRD|Overall Study||167
268245|NCT00400946|650831|P1|Evaluable for Day 32 MRD|Overall Study||166
268246|NCT00400946|650827|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
268247|NCT00400946|650828|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
268248|NCT00400946|650829|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
268249|NCT00400946|650830|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
268250|NCT00400946|650831|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
268251|NCT00400946|650827|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
268252|NCT00400946|650828|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
268253|NCT00400946|650829|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
268254|NCT00400946|650830|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
268255|NCT00400946|650831|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
268256|NCT00400946|650827|P5|STARTED|Overall Study||244
268257|NCT00400946|650828|P4|STARTED|Overall Study||51
268258|NCT00400946|650829|P3|STARTED|Overall Study||42
268259|NCT00400946|650830|P2|STARTED|Overall Study||232
268260|NCT00400946|650831|P1|STARTED|Overall Study||231
268261|NCT00400881|650859|P2|NOT COMPLETED|Overall Study||0
268262|NCT00400881|650860|P1|NOT COMPLETED|Overall Study||0
268263|NCT00400881|650859|P2|COMPLETED|Overall Study||60
268264|NCT00400881|650860|P1|COMPLETED|Overall Study||62
268265|NCT00400881|650859|P2|STARTED|Overall Study||60
268266|NCT00400881|650860|P1|STARTED|Overall Study||62
268267|NCT00400829|650868|P1|NOT COMPLETED|Overall Study||0
268268|NCT00400829|650868|P1|COMPLETED|Overall Study||66
268269|NCT00400829|650868|P1|STARTED|Overall Study||66
268270|NCT00400803|650874|P1|NOT COMPLETED|Overall Study||0
268271|NCT00400803|650874|P1|COMPLETED|Overall Study||35
268272|NCT00400803|650874|P1|STARTED|Overall Study||35
268273|NCT00400764|650890|P5|NOT COMPLETED|Phase II||11
268274|NCT00400764|650891|P4|NOT COMPLETED|Phase II||26
268275|NCT00400764|650892|P3|NOT COMPLETED|Phase II||23
268276|NCT00400764|650893|P2|NOT COMPLETED|Phase II||0
268277|NCT00400764|650894|P1|NOT COMPLETED|Phase II||0
268278|NCT00400764|650890|P5|COMPLETED|Phase II||0
268279|NCT00400764|650891|P4|COMPLETED|Phase II||0
268280|NCT00400764|650892|P3|COMPLETED|Phase II||0
268281|NCT00400764|650893|P2|COMPLETED|Phase II||0
268282|NCT00400764|650894|P1|COMPLETED|Phase II||0
268283|NCT00400764|650890|P5|Treated|Phase II||11
268284|NCT00400764|650891|P4|Treated|Phase II||26
268285|NCT00400764|650892|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
268286|NCT00400764|650893|P2|Treated|Phase II||0
268287|NCT00400764|650894|P1|Treated|Phase II||0
268288|NCT00400764|650890|P5|STARTED|Phase II||11
268289|NCT00400764|650891|P4|STARTED|Phase II||26
268290|NCT00400764|650892|P3|STARTED|Phase II||23
268291|NCT00400764|650893|P2|STARTED|Phase II||0
268292|NCT00400764|650894|P1|STARTED|Phase II||0
268293|NCT00400764|650890|P5|NOT COMPLETED|Phase Ib||0
268294|NCT00400764|650891|P4|NOT COMPLETED|Phase Ib||0
268295|NCT00400764|650892|P3|NOT COMPLETED|Phase Ib||0
268296|NCT00400764|650893|P2|NOT COMPLETED|Phase Ib||4
268297|NCT00400764|650894|P1|NOT COMPLETED|Phase Ib||6
268298|NCT00400764|650890|P5|COMPLETED|Phase Ib||0
268299|NCT00400764|650891|P4|COMPLETED|Phase Ib||0
268300|NCT00400764|650892|P3|COMPLETED|Phase Ib||0
268301|NCT00400764|650893|P2|COMPLETED|Phase Ib||2
268302|NCT00400764|650894|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
268303|NCT00400764|650890|P5|Treated|Phase Ib||0
268304|NCT00400764|650891|P4|Treated|Phase Ib||0
268305|NCT00400764|650892|P3|Treated|Phase Ib||0
268306|NCT00400764|650893|P2|Treated|Phase Ib||6
268307|NCT00400764|650894|P1|Treated|Phase Ib||6
268308|NCT00400764|650890|P5|STARTED|Phase Ib||0
268309|NCT00400764|650891|P4|STARTED|Phase Ib||0
268310|NCT00400764|650892|P3|STARTED|Phase Ib||0
268311|NCT00400764|650893|P2|STARTED|Phase Ib||6
268312|NCT00400764|650894|P1|STARTED|Phase Ib||6
268313|NCT00400712|650947|P2|NOT COMPLETED|Overall Study||16
268314|NCT00400712|650948|P1|NOT COMPLETED|Overall Study||17
268315|NCT00400712|650947|P2|COMPLETED|Overall Study||35
268316|NCT00400712|650948|P1|COMPLETED|Overall Study||35
268317|NCT00400712|650947|P2|STARTED|Overall Study||51
268318|NCT00400712|650948|P1|STARTED|Overall Study||52
268319|NCT00400686|650966|P1|NOT COMPLETED|Overall Study||0
268320|NCT00400686|650966|P1|COMPLETED|Overall Study||31
268321|NCT00400686|650966|P1|STARTED|Overall Study||31
268322|NCT00400634|650974|P2|NOT COMPLETED|Overall Study||1
268323|NCT00400634|650975|P1|NOT COMPLETED|Overall Study||4
268324|NCT00400634|650974|P2|COMPLETED|Overall Study||19
268325|NCT00400634|650975|P1|COMPLETED|Overall Study||34
268326|NCT00400634|650974|P2|STARTED|Overall Study||20
268327|NCT00400634|650975|P1|STARTED|Overall Study||38
268328|NCT00400569|650983|P1|NOT COMPLETED|Overall Study||1
268329|NCT00400569|650983|P1|COMPLETED|Overall Study||47
268330|NCT00400569|650983|P1|STARTED|Overall Study||48
268331|NCT00400400|650996|P2|NOT COMPLETED|Overall Study||15
268332|NCT00400400|650997|P1|NOT COMPLETED|Overall Study||14
268333|NCT00400400|650996|P2|COMPLETED|Overall Study||185
268334|NCT00400400|650997|P1|COMPLETED|Overall Study||186
268335|NCT00400400|650996|P2|Intent-to-Treat Population|Overall Study||197
268336|NCT00400400|650997|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
268337|NCT00400400|650996|P2|STARTED|Overall Study||200
268338|NCT00400400|650997|P1|STARTED|Overall Study||200
268339|NCT00400205|651015|P1|NOT COMPLETED|Overall Study||5
268340|NCT00400205|651015|P1|COMPLETED|Overall Study||9
268341|NCT00400205|651015|P1|STARTED|Overall Study||14
268342|NCT00400179|651022|P2|NOT COMPLETED|Overall Study||18
268343|NCT00400179|651023|P1|NOT COMPLETED|Overall Study||6
268344|NCT00400179|651022|P2|COMPLETED|Overall Study||508
268345|NCT00400179|651023|P1|COMPLETED|Overall Study|Received Treatment|521
268346|NCT00400179|651022|P2|STARTED|Overall Study||526
268347|NCT00400179|651023|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
268348|NCT00400153|651040|P3|NOT COMPLETED|Overall Study||61
268349|NCT00400153|651041|P2|NOT COMPLETED|Overall Study||55
268350|NCT00400153|651042|P1|NOT COMPLETED|Overall Study||48
268351|NCT00400153|651040|P3|COMPLETED|Overall Study||422
268352|NCT00400153|651041|P2|COMPLETED|Overall Study||436
268353|NCT00400153|651042|P1|COMPLETED|Overall Study||438
268354|NCT00400153|651040|P3|STARTED|Overall Study||483
268355|NCT00400153|651041|P2|STARTED|Overall Study||491
268356|NCT00400153|651042|P1|STARTED|Overall Study||486
268357|NCT00399893|651289|P2|NOT COMPLETED|Overall Study||0
268358|NCT00399893|651290|P1|NOT COMPLETED|Overall Study||1
268359|NCT00399893|651289|P2|COMPLETED|Overall Study||3
268360|NCT00399893|651290|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
268361|NCT00399893|651289|P2|STARTED|Overall Study||3
268362|NCT00399893|651290|P1|STARTED|Overall Study||2
268363|NCT00399880|651318|P2|NOT COMPLETED|Overall Study||0
268364|NCT00399880|651319|P1|NOT COMPLETED|Overall Study||0
268365|NCT00399880|651318|P2|COMPLETED|Overall Study||65
268366|NCT00399880|651319|P1|COMPLETED|Overall Study||65
268367|NCT00399880|651318|P2|STARTED|Overall Study||65
268368|NCT00399880|651319|P1|STARTED|Overall Study||65
268369|NCT00399802|651329|P2|NOT COMPLETED|Overall Study||3
268370|NCT00399802|651330|P1|NOT COMPLETED|Overall Study||0
268371|NCT00399802|651329|P2|COMPLETED|Overall Study||26
268372|NCT00399802|651330|P1|COMPLETED|Overall Study||14
268373|NCT00399802|651329|P2|STARTED|Overall Study||29
268374|NCT00399802|651330|P1|STARTED|Overall Study||14
268375|NCT00399763|651344|P2|NOT COMPLETED|Overall Study||3
268376|NCT00399763|651345|P1|NOT COMPLETED|Overall Study||2
268377|NCT00399763|651344|P2|COMPLETED|Overall Study||32
268378|NCT00399763|651345|P1|COMPLETED|Overall Study||33
268379|NCT00399763|651344|P2|STARTED|Overall Study||35
268380|NCT00399763|651345|P1|STARTED|Overall Study||35
268381|NCT00399568|651357|P2|NOT COMPLETED|Overall Study||9
268382|NCT00399568|651358|P1|NOT COMPLETED|Overall Study||12
268383|NCT00399568|651357|P2|COMPLETED|Overall Study||156
268384|NCT00399568|651358|P1|COMPLETED|Overall Study||154
268385|NCT00399568|651357|P2|STARTED|Overall Study||165
268386|NCT00399568|651358|P1|STARTED|Overall Study||166
268387|NCT00399542|651372|P2|NOT COMPLETED|Overall Study||43
268388|NCT00399542|651373|P1|NOT COMPLETED|Overall Study||84
268389|NCT00399542|651372|P2|COMPLETED|Overall Study||151
268390|NCT00399542|651373|P1|COMPLETED|Overall Study||303
268391|NCT00399542|651372|P2|STARTED|Overall Study||194
268392|NCT00399542|651373|P1|STARTED|Overall Study||387
268393|NCT00399516|651435|P1|NOT COMPLETED|Overall Study||2
268394|NCT00399516|651435|P1|COMPLETED|Overall Study||19
268395|NCT00399516|651435|P1|STARTED|Overall Study||21
268396|NCT00399360|651443|P4|NOT COMPLETED|Overall Study||6
268397|NCT00399360|651444|P3|NOT COMPLETED|Overall Study||3
268398|NCT00399360|651445|P2|NOT COMPLETED|Overall Study||3
268399|NCT00399360|651446|P1|NOT COMPLETED|Overall Study||2
268400|NCT00399360|651443|P4|COMPLETED|Overall Study||9
268401|NCT00399360|651444|P3|COMPLETED|Overall Study||10
268402|NCT00399360|651445|P2|COMPLETED|Overall Study||8
268403|NCT00399360|651446|P1|COMPLETED|Overall Study||9
268404|NCT00399360|651443|P4|STARTED|Overall Study||15
268405|NCT00399360|651444|P3|STARTED|Overall Study||13
268406|NCT00399360|651445|P2|STARTED|Overall Study||11
268407|NCT00399360|651446|P1|STARTED|Overall Study||11
268408|NCT00399308|651495|P3|NOT COMPLETED|Overall Study||1
268409|NCT00399308|651496|P2|NOT COMPLETED|Overall Study||0
268410|NCT00399308|651497|P1|NOT COMPLETED|Overall Study||0
268411|NCT00399308|651495|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
268412|NCT00399308|651496|P2|COMPLETED|Overall Study||15
268413|NCT00399308|651497|P1|COMPLETED|Overall Study||13
268414|NCT00399308|651495|P3|STARTED|Overall Study||12
268415|NCT00399308|651496|P2|STARTED|Overall Study||15
268416|NCT00399308|651497|P1|STARTED|Overall Study||13
268417|NCT00399035|651517|P3|NOT COMPLETED|Overall Study||252
268418|NCT00399035|651518|P2|NOT COMPLETED|Overall Study||158
268419|NCT00399035|651519|P1|NOT COMPLETED|Overall Study||313
268420|NCT00399035|651517|P3|COMPLETED|Overall Study||106
268421|NCT00399035|651518|P2|COMPLETED|Overall Study||58
268422|NCT00399035|651519|P1|COMPLETED|Overall Study||189
268423|NCT00399035|651517|P3|STARTED|Overall Study||358
268424|NCT00399035|651518|P2|STARTED|Overall Study||216
268425|NCT00399035|651519|P1|STARTED|Overall Study||502
268426|NCT00398983|651540|P2|NOT COMPLETED|Overall Study||0
268427|NCT00398983|651541|P1|NOT COMPLETED|Overall Study||0
268428|NCT00398983|651540|P2|COMPLETED|Overall Study||25
268429|NCT00398983|651541|P1|COMPLETED|Overall Study||20
268430|NCT00398983|651540|P2|STARTED|Overall Study||25
268431|NCT00398983|651541|P1|STARTED|Overall Study||20
268432|NCT00398918|651547|P1|NOT COMPLETED|Overall Study||0
268433|NCT00398918|651547|P1|COMPLETED|Overall Study||10
268434|NCT00398918|651547|P1|STARTED|Overall Study||10
268435|NCT00398866|651555|P3|NOT COMPLETED|Overall Study||8
268436|NCT00398866|651556|P2|NOT COMPLETED|Overall Study||8
268437|NCT00398866|651557|P1|NOT COMPLETED|Overall Study||14
268438|NCT00398866|651555|P3|COMPLETED|Overall Study||58
268439|NCT00398866|651556|P2|COMPLETED|Overall Study||60
268440|NCT00398866|651557|P1|COMPLETED|Overall Study||52
268441|NCT00398866|651555|P3|STARTED|Overall Study||66
268442|NCT00398866|651556|P2|STARTED|Overall Study||68
268443|NCT00398866|651557|P1|STARTED|Overall Study||66
268444|NCT00398632|651568|P1|NOT COMPLETED|Overall Study||2
268445|NCT00398632|651568|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
268446|NCT00398632|651568|P1|STARTED|Overall Study||6
268447|NCT00398567|651576|P3|NOT COMPLETED|Overall Study||34
268448|NCT00398567|651577|P2|NOT COMPLETED|Overall Study||4
268449|NCT00398567|651578|P1|NOT COMPLETED|Overall Study||4
268450|NCT00398567|651576|P3|COMPLETED|Overall Study||3
268451|NCT00398567|651577|P2|COMPLETED|Overall Study||0
268452|NCT00398567|651578|P1|COMPLETED|Overall Study||0
268453|NCT00398567|651576|P3|STARTED|Overall Study||37
268454|NCT00398567|651577|P2|STARTED|Overall Study||4
268455|NCT00398567|651578|P1|STARTED|Overall Study||4
268456|NCT00398476|651590|P2|NOT COMPLETED|Treatment Period 2||0
268457|NCT00398476|651591|P1|NOT COMPLETED|Treatment Period 2||0
268458|NCT00398476|651590|P2|COMPLETED|Treatment Period 2||64
268459|NCT00398476|651591|P1|COMPLETED|Treatment Period 2||63
268460|NCT00398476|651590|P2|STARTED|Treatment Period 2||64
268461|NCT00398476|651591|P1|STARTED|Treatment Period 2||63
268462|NCT00398476|651590|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
268463|NCT00398476|651591|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
268464|NCT00398476|651590|P2|COMPLETED|Washout Period (20 Minutes)||64
268465|NCT00398476|651591|P1|COMPLETED|Washout Period (20 Minutes)||63
268466|NCT00398476|651590|P2|STARTED|Washout Period (20 Minutes)||64
268467|NCT00398476|651591|P1|STARTED|Washout Period (20 Minutes)||63
268468|NCT00398476|651590|P2|NOT COMPLETED|Treatment Period 1||0
268469|NCT00398476|651591|P1|NOT COMPLETED|Treatment Period 1||0
268470|NCT00398476|651590|P2|COMPLETED|Treatment Period 1||64
268471|NCT00398476|651591|P1|COMPLETED|Treatment Period 1||63
268472|NCT00398476|651590|P2|STARTED|Treatment Period 1||64
268473|NCT00398476|651591|P1|STARTED|Treatment Period 1||63
268474|NCT00398411|651632|P2|NOT COMPLETED|Overall Study||1
268475|NCT00398411|651633|P1|NOT COMPLETED|Overall Study||0
268476|NCT00398411|651632|P2|COMPLETED|Overall Study||31
268477|NCT00398411|651633|P1|COMPLETED|Overall Study||34
268478|NCT00398411|651632|P2|STARTED|Overall Study||32
268479|NCT00398411|651633|P1|STARTED|Overall Study||34
268480|NCT00398398|651649|P1|NOT COMPLETED|Overall Study||0
268481|NCT00398398|651649|P1|COMPLETED|Overall Study||44
268482|NCT00398398|651649|P1|STARTED|Overall Study||44
268483|NCT00398320|651656|P1|NOT COMPLETED|Overall Study||6
268484|NCT00398320|651656|P1|COMPLETED|Overall Study||34
268485|NCT00398320|651656|P1|STARTED|Overall Study||40
268486|NCT00398216|651669|P5|NOT COMPLETED|Overall Study||15
268487|NCT00398216|651670|P4|NOT COMPLETED|Overall Study||22
268488|NCT00398216|651671|P3|NOT COMPLETED|Overall Study||21
268489|NCT00398216|651672|P2|NOT COMPLETED|Overall Study||19
268490|NCT00398216|651673|P1|NOT COMPLETED|Overall Study||11
268491|NCT00398216|651669|P5|COMPLETED|Overall Study||157
268492|NCT00398216|651670|P4|COMPLETED|Overall Study||155
268493|NCT00398216|651671|P3|COMPLETED|Overall Study||164
268494|NCT00398216|651672|P2|COMPLETED|Overall Study||151
268495|NCT00398216|651673|P1|COMPLETED|Overall Study||181
268496|NCT00398216|651669|P5|STARTED|Overall Study||172
268497|NCT00398216|651670|P4|STARTED|Overall Study||177
268498|NCT00398216|651671|P3|STARTED|Overall Study||185
268499|NCT00398216|651672|P2|STARTED|Overall Study||170
268500|NCT00398216|651673|P1|STARTED|Overall Study||192
268501|NCT00398138|651700|P1|NOT COMPLETED|Overall Study||2
268502|NCT00398138|651700|P1|COMPLETED|Overall Study||10
268503|NCT00398138|651700|P1|STARTED|Overall Study||12
268504|NCT00398112|651705|P1|NOT COMPLETED|Overall Study||18
268505|NCT00398112|651705|P1|COMPLETED|Overall Study||0
268506|NCT00398112|651705|P1|STARTED|Overall Study||18
268507|NCT00398086|651716|P3|NOT COMPLETED|Overall Study||2
268508|NCT00398086|651717|P2|NOT COMPLETED|Overall Study||23
268509|NCT00398086|651718|P1|NOT COMPLETED|Overall Study||9
268510|NCT00398086|651716|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
268511|NCT00398086|651717|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
268512|NCT00398086|651718|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
268513|NCT00398086|651716|P3|Phase 1, Dose Escalation Population|Overall Study||3
268514|NCT00398086|651717|P2|Phase 1, Dose Escalation Population|Overall Study||7
268515|NCT00398086|651718|P1|Phase 1, Dose Escalation Population|Overall Study||20
268516|NCT00398086|651716|P3|STARTED|Overall Study||3
268517|NCT00398086|651717|P2|STARTED|Overall Study||44
268518|NCT00398086|651718|P1|STARTED|Overall Study||20
268519|NCT00398073|651752|P2|NOT COMPLETED|Overall Study||0
268520|NCT00398073|651753|P1|NOT COMPLETED|Overall Study||1
268521|NCT00398073|651752|P2|COMPLETED|Overall Study||17
268522|NCT00398073|651753|P1|COMPLETED|Overall Study||17
268523|NCT00398073|651752|P2|STARTED|Overall Study||17
268524|NCT00398073|651753|P1|STARTED|Overall Study||18
268525|NCT00398047|651763|P1|NOT COMPLETED|Overall Study||3
268526|NCT00398047|651763|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
268527|NCT00398047|651763|P1|STARTED|Overall Study||3
268528|NCT00397982|651773|P1|NOT COMPLETED|Overall Study||4
268529|NCT00397982|651773|P1|COMPLETED|Overall Study||13
268530|NCT00397982|651773|P1|STARTED|Overall Study||17
268531|NCT00397930|651784|P2|NOT COMPLETED|Overall Study||51
268532|NCT00397930|651785|P1|NOT COMPLETED|Overall Study||38
268533|NCT00397930|651784|P2|COMPLETED|Overall Study||153
268534|NCT00397930|651785|P1|COMPLETED|Overall Study||168
268535|NCT00397930|651784|P2|STARTED|Overall Study||204
268536|NCT00397930|651785|P1|STARTED|Overall Study||206
268537|NCT00397904|651791|P1|NOT COMPLETED|Overall Study||0
268538|NCT00397904|651791|P1|COMPLETED|Overall Study||16
268539|NCT00397904|651791|P1|STARTED|Overall Study||16
268540|NCT00397891|651800|P5|NOT COMPLETED|Overall Study||1
268541|NCT00397891|651801|P4|NOT COMPLETED|Overall Study||0
268542|NCT00397891|651802|P3|NOT COMPLETED|Overall Study||0
268543|NCT00397891|651803|P2|NOT COMPLETED|Overall Study||0
268544|NCT00397891|651804|P1|NOT COMPLETED|Overall Study||1
268545|NCT00397891|651800|P5|COMPLETED|Overall Study||7
268546|NCT00397891|651801|P4|COMPLETED|Overall Study||6
268547|NCT00397891|651802|P3|COMPLETED|Overall Study||6
268548|NCT00397891|651803|P2|COMPLETED|Overall Study||6
268549|NCT00397891|651804|P1|COMPLETED|Overall Study||5
268550|NCT00397891|651800|P5|STARTED|Overall Study||8
268551|NCT00397891|651801|P4|STARTED|Overall Study||6
268552|NCT00397891|651802|P3|STARTED|Overall Study||6
268553|NCT00397891|651803|P2|STARTED|Overall Study||6
268554|NCT00397891|651804|P1|STARTED|Overall Study||6
268555|NCT00397878|651902|P1|NOT COMPLETED|Overall Study||0
268556|NCT00397878|651902|P1|COMPLETED|Overall Study||10
268557|NCT00397878|651902|P1|STARTED|Overall Study||10
268558|NCT00397839|651908|P2|NOT COMPLETED|Overall Study||18
268559|NCT00397839|651909|P1|NOT COMPLETED|Overall Study||7
268560|NCT00397839|651908|P2|COMPLETED|Overall Study||69
268561|NCT00397839|651909|P1|COMPLETED|Overall Study||41
268562|NCT00397839|651908|P2|STARTED|Overall Study||87
268563|NCT00397839|651909|P1|STARTED|Overall Study||48
268564|NCT00397631|651925|P2|NOT COMPLETED|Overall Study||44
268565|NCT00397631|651926|P1|NOT COMPLETED|Overall Study||30
268566|NCT00397631|651925|P2|COMPLETED|Overall Study||215
268567|NCT00397631|651926|P1|COMPLETED|Overall Study||231
268568|NCT00397631|651925|P2|STARTED|Overall Study||259
268569|NCT00397631|651926|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
268570|NCT00397540|651938|P2|NOT COMPLETED|Overall Study||0
268571|NCT00397540|651939|P1|NOT COMPLETED|Overall Study||1
268572|NCT00397540|651938|P2|COMPLETED|Overall Study||85
268573|NCT00397540|651939|P1|COMPLETED|Overall Study||59
268574|NCT00397540|651938|P2|STARTED|Overall Study||85
268575|NCT00397540|651939|P1|STARTED|Overall Study||60
268576|NCT00397514|651945|P1|NOT COMPLETED|Overall Study||9
268577|NCT00397514|651945|P1|COMPLETED|Overall Study||25
268578|NCT00397514|651945|P1|STARTED|Overall Study||34
268579|NCT00397488|651955|P1|NOT COMPLETED|Overall Study||7
268580|NCT00397488|651955|P1|COMPLETED|Overall Study||71
268581|NCT00397488|651955|P1|STARTED|Overall Study||78
268582|NCT00397462|651962|P3|NOT COMPLETED|Overall Study||0
268583|NCT00397462|651963|P2|NOT COMPLETED|Overall Study||0
268584|NCT00397462|651964|P1|NOT COMPLETED|Overall Study||0
268585|NCT00397462|651962|P3|COMPLETED|Overall Study||15
268586|NCT00397462|651963|P2|COMPLETED|Overall Study||13
268587|NCT00397462|651964|P1|COMPLETED|Overall Study||16
268588|NCT00397462|651962|P3|STARTED|Overall Study||15
268589|NCT00397462|651963|P2|STARTED|Overall Study||13
268590|NCT00397462|651964|P1|STARTED|Overall Study||16
268591|NCT00397254|651975|P2|NOT COMPLETED|Overall Study||2
268592|NCT00397254|651976|P1|NOT COMPLETED|Overall Study||2
268593|NCT00397254|651975|P2|COMPLETED|Overall Study||74
268594|NCT00397254|651976|P1|COMPLETED|Overall Study||77
268595|NCT00397254|651975|P2|STARTED|Overall Study||76
268596|NCT00397254|651976|P1|STARTED|Overall Study||79
268597|NCT00397215|651998|P4|NOT COMPLETED|Month 24 (Day 720)||0
268598|NCT00397215|651999|P3|NOT COMPLETED|Month 24 (Day 720)||0
268599|NCT00397215|652000|P2|NOT COMPLETED|Month 24 (Day 720)||0
268600|NCT00397215|652001|P1|NOT COMPLETED|Month 24 (Day 720)||0
268601|NCT00397215|651998|P4|COMPLETED|Month 24 (Day 720)||36
268602|NCT00397215|651999|P3|COMPLETED|Month 24 (Day 720)||117
268603|NCT00397215|652000|P2|COMPLETED|Month 24 (Day 720)||45
268604|NCT00397215|652001|P1|COMPLETED|Month 24 (Day 720)||122
268605|NCT00397215|651998|P4|STARTED|Month 24 (Day 720)||36
268606|NCT00397215|651999|P3|STARTED|Month 24 (Day 720)||117
268607|NCT00397215|652000|P2|STARTED|Month 24 (Day 720)||45
268608|NCT00397215|652001|P1|STARTED|Month 24 (Day 720)||122
268609|NCT00397215|651998|P4|NOT COMPLETED|Month 12 (Day 360)||0
268610|NCT00397215|651999|P3|NOT COMPLETED|Month 12 (Day 360)||0
268611|NCT00397215|652000|P2|NOT COMPLETED|Month 12 (Day 360)||0
268612|NCT00397215|652001|P1|NOT COMPLETED|Month 12 (Day 360)||0
268613|NCT00397215|651998|P4|COMPLETED|Month 12 (Day 360)||42
268614|NCT00397215|651999|P3|COMPLETED|Month 12 (Day 360)||125
268615|NCT00397215|652000|P2|COMPLETED|Month 12 (Day 360)||48
268616|NCT00397215|652001|P1|COMPLETED|Month 12 (Day 360)||130
268617|NCT00397215|651998|P4|STARTED|Month 12 (Day 360)||42
268618|NCT00397215|651999|P3|STARTED|Month 12 (Day 360)||125
268619|NCT00397215|652000|P2|STARTED|Month 12 (Day 360)||48
268620|NCT00397215|652001|P1|STARTED|Month 12 (Day 360)||130
268621|NCT00397215|651998|P4|NOT COMPLETED|Month 6 (Day 180)||0
268622|NCT00397215|651999|P3|NOT COMPLETED|Month 6 (Day 180)||5
268623|NCT00397215|652000|P2|NOT COMPLETED|Month 6 (Day 180)||3
268624|NCT00397215|652001|P1|NOT COMPLETED|Month 6 (Day 180)||2
268625|NCT00397215|651998|P4|COMPLETED|Month 6 (Day 180)||51
268626|NCT00397215|651999|P3|COMPLETED|Month 6 (Day 180)||153
268627|NCT00397215|652000|P2|COMPLETED|Month 6 (Day 180)||55
268628|NCT00397215|652001|P1|COMPLETED|Month 6 (Day 180)||162
268629|NCT00397215|651998|P4|STARTED|Month 6 (Day 180)||51
268630|NCT00397215|651999|P3|STARTED|Month 6 (Day 180)||158
268631|NCT00397215|652000|P2|STARTED|Month 6 (Day 180)||58
268632|NCT00397215|652001|P1|STARTED|Month 6 (Day 180)||164
268633|NCT00397215|651998|P4|NOT COMPLETED|Month 0 (Day 0)||4
268634|NCT00397215|651999|P3|NOT COMPLETED|Month 0 (Day 0)||6
268635|NCT00397215|652000|P2|NOT COMPLETED|Month 0 (Day 0)||5
268636|NCT00397215|652001|P1|NOT COMPLETED|Month 0 (Day 0)||7
268637|NCT00397215|651998|P4|COMPLETED|Month 0 (Day 0)||48
268638|NCT00397215|651999|P3|COMPLETED|Month 0 (Day 0)||153
268639|NCT00397215|652000|P2|COMPLETED|Month 0 (Day 0)||56
268640|NCT00397215|652001|P1|COMPLETED|Month 0 (Day 0)||158
268641|NCT00397215|651998|P4|STARTED|Month 0 (Day 0)||52
268642|NCT00397215|651999|P3|STARTED|Month 0 (Day 0)||159
268643|NCT00397215|652000|P2|STARTED|Month 0 (Day 0)||61
268644|NCT00397215|652001|P1|STARTED|Month 0 (Day 0)||165
268645|NCT00397189|652137|P2|NOT COMPLETED|Extension Period||43
268646|NCT00397189|652138|P1|NOT COMPLETED|Extension Period||113
268647|NCT00397189|652137|P2|COMPLETED|Extension Period||134
268648|NCT00397189|652138|P1|COMPLETED|Extension Period||421
268649|NCT00397189|652137|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
268650|NCT00397189|652138|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
268651|NCT00397189|652137|P2|NOT COMPLETED|3 Weeks Period||22
268652|NCT00397189|652138|P1|NOT COMPLETED|3 Weeks Period||21
268653|NCT00397189|652137|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
268654|NCT00397189|652138|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
268655|NCT00397189|652137|P2|STARTED|3 Weeks Period||395
268656|NCT00397189|652138|P1|STARTED|3 Weeks Period||394
268657|NCT00397150|652148|P2|NOT COMPLETED|Overall Study||145
268658|NCT00397150|652149|P1|NOT COMPLETED|Overall Study||135
268659|NCT00397150|652148|P2|COMPLETED|Overall Study||1111
268660|NCT00397150|652149|P1|COMPLETED|Overall Study||1188
268661|NCT00397150|652148|P2|STARTED|Overall Study||1256
268662|NCT00397150|652149|P1|STARTED|Overall Study||1323
268663|NCT00397046|652165|P4|NOT COMPLETED|Overall Study||5
268664|NCT00397046|652166|P3|NOT COMPLETED|Overall Study||10
268665|NCT00397046|652167|P2|NOT COMPLETED|Overall Study||3
268666|NCT00397046|652168|P1|NOT COMPLETED|Overall Study||3
268667|NCT00397046|652165|P4|COMPLETED|Overall Study||0
268668|NCT00397046|652166|P3|COMPLETED|Overall Study||0
268669|NCT00397046|652167|P2|COMPLETED|Overall Study||0
268670|NCT00397046|652168|P1|COMPLETED|Overall Study||0
268671|NCT00397046|652165|P4|STARTED|Overall Study||5
268672|NCT00397046|652166|P3|STARTED|Overall Study||10
268673|NCT00397046|652167|P2|STARTED|Overall Study||3
268674|NCT00397046|652168|P1|STARTED|Overall Study||3
268675|NCT00397033|652189|P3|NOT COMPLETED|Overall Study||23
268676|NCT00397033|652190|P2|NOT COMPLETED|Overall Study||37
268677|NCT00397033|652191|P1|NOT COMPLETED|Overall Study||44
268678|NCT00397033|652189|P3|COMPLETED|Overall Study||77
268679|NCT00397033|652190|P2|COMPLETED|Overall Study||72
268680|NCT00397033|652191|P1|COMPLETED|Overall Study||63
268681|NCT00397033|652189|P3|ITT Population|Overall Study||98
268682|NCT00397033|652190|P2|ITT Population|Overall Study||105
268683|NCT00397033|652191|P1|ITT Population|Overall Study||107
268684|NCT00397033|652189|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
268685|NCT00397033|652190|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
268686|NCT00397033|652191|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
268687|NCT00397033|652189|P3|STARTED|Overall Study||100
268688|NCT00397033|652190|P2|STARTED|Overall Study||109
268689|NCT00397033|652191|P1|STARTED|Overall Study||107
268690|NCT00396981|652252|P2|NOT COMPLETED|Overall Study||9
268691|NCT00396981|652253|P1|NOT COMPLETED|Overall Study||15
268692|NCT00396981|652252|P2|COMPLETED|Overall Study||306
268693|NCT00396981|652253|P1|COMPLETED|Overall Study||296
268694|NCT00396981|652252|P2|STARTED|Overall Study||315
268695|NCT00396981|652253|P1|STARTED|Overall Study||311
268696|NCT00396877|652273|P2|NOT COMPLETED|Overall Study||8
268697|NCT00396877|652274|P1|NOT COMPLETED|Overall Study||6
268698|NCT00396877|652273|P2|COMPLETED|Overall Study|Completed follow-up|459
268699|NCT00396877|652274|P1|COMPLETED|Overall Study|Completed follow-up|433
268700|NCT00396877|652273|P2|Completed Treatment|Overall Study||352
268701|NCT00396877|652274|P1|Completed Treatment|Overall Study||356
268702|NCT00396877|652273|P2|Treated|Overall Study||464
268703|NCT00396877|652274|P1|Treated|Overall Study||436
268704|NCT00396877|652273|P2|STARTED|Overall Study|Randomized|467
268705|NCT00396877|652274|P1|STARTED|Overall Study|Randomized|439
268706|NCT00396812|652284|P1|NOT COMPLETED|Overall Study||1
268707|NCT00396812|652284|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
268708|NCT00396812|652284|P1|STARTED|Overall Study||4
268709|NCT00396656|652296|P2|NOT COMPLETED|Second Treatment Period||1
268710|NCT00396656|652297|P1|NOT COMPLETED|Second Treatment Period||0
268711|NCT00396656|652296|P2|COMPLETED|Second Treatment Period||12
268712|NCT00396656|652297|P1|COMPLETED|Second Treatment Period||15
268713|NCT00396656|652296|P2|STARTED|Second Treatment Period||13
268714|NCT00396656|652297|P1|STARTED|Second Treatment Period||15
268715|NCT00396656|652296|P2|NOT COMPLETED|First Treatment Period||2
268716|NCT00396656|652297|P1|NOT COMPLETED|First Treatment Period||0
268717|NCT00396656|652296|P2|COMPLETED|First Treatment Period||13
268718|NCT00396656|652297|P1|COMPLETED|First Treatment Period||15
268719|NCT00396656|652296|P2|STARTED|First Treatment Period||15
268720|NCT00396656|652297|P1|STARTED|First Treatment Period||15
268721|NCT00396630|652315|P2|NOT COMPLETED|Overall Study||5
268722|NCT00396630|652316|P1|NOT COMPLETED|Overall Study||5
268723|NCT00396630|652315|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
268724|NCT00396630|652316|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
268725|NCT00396630|652315|P2|STARTED|Overall Study||100
268726|NCT00396630|652316|P1|STARTED|Overall Study||100
268727|NCT00396591|652336|P1|NOT COMPLETED|Overall Study||16
268728|NCT00396591|652336|P1|COMPLETED|Overall Study||0
268729|NCT00396591|652336|P1|STARTED|Overall Study||16
268730|NCT00396565|652349|P3|NOT COMPLETED|Overall Study||17
268731|NCT00396565|652350|P2|NOT COMPLETED|Overall Study||91
268732|NCT00396565|652351|P1|NOT COMPLETED|Overall Study||48
268733|NCT00396565|652349|P3|COMPLETED|Overall Study||30
268734|NCT00396565|652350|P2|COMPLETED|Overall Study||47
268735|NCT00396565|652351|P1|COMPLETED|Overall Study||88
268736|NCT00396565|652349|P3|STARTED|Overall Study||47
268737|NCT00396565|652350|P2|STARTED|Overall Study||138
268738|NCT00396565|652351|P1|STARTED|Overall Study||136
268739|NCT00396409|652376|P2|NOT COMPLETED|Period 2 - 2008||2
268740|NCT00396409|652377|P1|NOT COMPLETED|Period 2 - 2008||7
268741|NCT00396409|652376|P2|COMPLETED|Period 2 - 2008||53
268742|NCT00396409|652377|P1|COMPLETED|Period 2 - 2008||52
268743|NCT00396409|652376|P2|STARTED|Period 2 - 2008||55
268744|NCT00396409|652377|P1|STARTED|Period 2 - 2008||59
268745|NCT00396409|652376|P2|NOT COMPLETED|Between Period 1 and Period 2||2
268746|NCT00396409|652377|P1|NOT COMPLETED|Between Period 1 and Period 2||3
268747|NCT00396409|652376|P2|COMPLETED|Between Period 1 and Period 2||55
268748|NCT00396409|652377|P1|COMPLETED|Between Period 1 and Period 2||59
268749|NCT00396409|652376|P2|STARTED|Between Period 1 and Period 2||57
268750|NCT00396409|652377|P1|STARTED|Between Period 1 and Period 2||62
268751|NCT00396409|652376|P2|NOT COMPLETED|Period 1 - 2007||6
268752|NCT00396409|652377|P1|NOT COMPLETED|Period 1 - 2007||3
268753|NCT00396409|652376|P2|COMPLETED|Period 1 - 2007||57
268754|NCT00396409|652377|P1|COMPLETED|Period 1 - 2007||62
268755|NCT00396409|652376|P2|STARTED|Period 1 - 2007||63
268756|NCT00396409|652377|P1|STARTED|Period 1 - 2007||65
268757|NCT00396383|652407|P1|NOT COMPLETED|Overall Study||3
268758|NCT00396383|652407|P1|COMPLETED|Overall Study||6
268759|NCT00396383|652407|P1|STARTED|Overall Study||9
268760|NCT00396331|652420|P1|NOT COMPLETED|Overall Study||32
268761|NCT00396331|652420|P1|COMPLETED|Overall Study||68
268762|NCT00396331|652420|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
268763|NCT00396331|652420|P1|Number of Participants Treated|Overall Study||100
268764|NCT00396331|652420|P1|STARTED|Overall Study||100
268765|NCT00396318|652473|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
268766|NCT00396318|652473|P1|COMPLETED|7-Day Post-Treatment Contact||240
268767|NCT00396318|652473|P1|STARTED|7-Day Post-Treatment Contact||241
268768|NCT00396318|652473|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
268769|NCT00396318|652473|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
268770|NCT00396318|652473|P1|STARTED|48- to 96-Hour Follow-Up Period||246
268771|NCT00396318|652473|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
268772|NCT00396318|652473|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
268773|NCT00396318|652473|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
268774|NCT00396292|652486|P2|NOT COMPLETED|Overall Study||16
268775|NCT00396292|652487|P1|NOT COMPLETED|Overall Study||9
268776|NCT00396292|652486|P2|COMPLETED|Overall Study||162
268777|NCT00396292|652487|P1|COMPLETED|Overall Study||165
268778|NCT00396292|652486|P2|STARTED|Overall Study||178
268779|NCT00396292|652487|P1|STARTED|Overall Study||174
268780|NCT00396279|652493|P1|NOT COMPLETED|Overall Study||30
268781|NCT00396279|652493|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
268782|NCT00396279|652493|P1|STARTED|Overall Study||37
268783|NCT00396266|652504|P2|NOT COMPLETED|Overall Study||0
268784|NCT00396266|652505|P1|NOT COMPLETED|Overall Study||0
268785|NCT00396266|652504|P2|COMPLETED|Overall Study||14
268786|NCT00396266|652505|P1|COMPLETED|Overall Study||8
268787|NCT00396266|652504|P2|STARTED|Overall Study||14
268788|NCT00396266|652505|P1|STARTED|Overall Study||8
268789|NCT00396253|652526|P1|NOT COMPLETED|Overall Study||13
268790|NCT00396253|652526|P1|COMPLETED|Overall Study||210
268791|NCT00396253|652526|P1|STARTED|Overall Study||223
268792|NCT00396201|652538|P1|NOT COMPLETED|Follow-up Period||0
268793|NCT00396201|652538|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
268794|NCT00396201|652538|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
268795|NCT00396201|652538|P1|NOT COMPLETED|Treatment Period||0
268796|NCT00396201|652538|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
268797|NCT00396201|652538|P1|STARTED|Treatment Period||22
268798|NCT00396162|652557|P2|NOT COMPLETED|Overall Study||3
268799|NCT00396162|652558|P1|NOT COMPLETED|Overall Study||2
268800|NCT00396162|652557|P2|COMPLETED|Overall Study||35
268801|NCT00396162|652558|P1|COMPLETED|Overall Study||37
268802|NCT00396162|652557|P2|STARTED|Overall Study||38
268803|NCT00396162|652558|P1|STARTED|Overall Study||39
268804|NCT00396136|652570|P1|NOT COMPLETED|Overall Study||125
268805|NCT00396136|652570|P1|COMPLETED|Overall Study||96
268806|NCT00396136|652570|P1|STARTED|Overall Study||221
268807|NCT00396097|652577|P2|NOT COMPLETED|Overall Study||46
268808|NCT00396097|652578|P1|NOT COMPLETED|Overall Study||26
268809|NCT00396097|652577|P2|COMPLETED|Overall Study||156
268810|NCT00396097|652578|P1|COMPLETED|Overall Study||88
268811|NCT00396097|652577|P2|STARTED|Overall Study||202
268812|NCT00396097|652578|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
268813|NCT00396084|652606|P6|NOT COMPLETED|Overall Study||2
268814|NCT00396084|652607|P5|NOT COMPLETED|Overall Study||1
268815|NCT00396084|652608|P4|NOT COMPLETED|Overall Study||1
268816|NCT00396084|652609|P3|NOT COMPLETED|Overall Study||0
268817|NCT00396084|652610|P2|NOT COMPLETED|Overall Study||0
268818|NCT00396084|652611|P1|NOT COMPLETED|Overall Study||0
268819|NCT00396084|652606|P6|COMPLETED|Overall Study||18
268820|NCT00396084|652607|P5|COMPLETED|Overall Study||9
268821|NCT00396084|652608|P4|COMPLETED|Overall Study||9
268822|NCT00396084|652609|P3|COMPLETED|Overall Study||10
268823|NCT00396084|652610|P2|COMPLETED|Overall Study||10
268824|NCT00396084|652611|P1|COMPLETED|Overall Study||10
268825|NCT00396084|652606|P6|STARTED|Overall Study||20
268826|NCT00396084|652607|P5|STARTED|Overall Study||10
268827|NCT00396084|652608|P4|STARTED|Overall Study||10
268828|NCT00396084|652609|P3|STARTED|Overall Study||10
268829|NCT00396084|652610|P2|STARTED|Overall Study||10
268830|NCT00396084|652611|P1|STARTED|Overall Study||10
268831|NCT00396032|652686|P2|NOT COMPLETED|Overall Study||5
268832|NCT00396032|652687|P1|NOT COMPLETED|Overall Study||4
268833|NCT00396032|652686|P2|COMPLETED|Overall Study||71
268834|NCT00396032|652687|P1|COMPLETED|Overall Study||70
268835|NCT00396032|652686|P2|STARTED|Overall Study||76
268836|NCT00396032|652687|P1|STARTED|Overall Study||74
268837|NCT00396019|652704|P3|NOT COMPLETED|Overall Study||1
268838|NCT00396019|652705|P2|NOT COMPLETED|Overall Study||3
268839|NCT00396019|652706|P1|NOT COMPLETED|Overall Study||0
268840|NCT00396019|652704|P3|COMPLETED|Overall Study||29
268841|NCT00396019|652705|P2|COMPLETED|Overall Study||26
268842|NCT00396019|652706|P1|COMPLETED|Overall Study||27
268843|NCT00396019|652704|P3|STARTED|Overall Study||30
268844|NCT00396019|652705|P2|STARTED|Overall Study||29
268845|NCT00396019|652706|P1|STARTED|Overall Study||27
268846|NCT00396006|652716|P1|NOT COMPLETED|Overall Study||0
268847|NCT00396006|652716|P1|COMPLETED|Overall Study||13
268848|NCT00396006|652716|P1|STARTED|Overall Study||13
268849|NCT00395993|652733|P2|NOT COMPLETED|Overall Study||19
268850|NCT00395993|652734|P1|NOT COMPLETED|Overall Study||35
268851|NCT00395993|652733|P2|COMPLETED|Overall Study||212
268852|NCT00395993|652734|P1|COMPLETED|Overall Study||211
268853|NCT00395993|652733|P2|STARTED|Overall Study||231
268854|NCT00395993|652734|P1|STARTED|Overall Study||246
268855|NCT00395967|652740|P1|NOT COMPLETED|Follow-up Period||2
268856|NCT00395967|652740|P1|COMPLETED|Follow-up Period||3
268857|NCT00395967|652740|P1|STARTED|Follow-up Period|Participants who had transplants.|5
268858|NCT00395967|652740|P1|NOT COMPLETED|Treatment Period||1
268859|NCT00395967|652740|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
268860|NCT00395967|652740|P1|STARTED|Treatment Period||5
268861|NCT00395876|652751|P2|NOT COMPLETED|Overall Study||0
268862|NCT00395876|652752|P1|NOT COMPLETED|Overall Study||3
268863|NCT00395876|652751|P2|COMPLETED|Overall Study||50
268864|NCT00395876|652752|P1|COMPLETED|Overall Study||47
268865|NCT00395876|652751|P2|STARTED|Overall Study||50
268866|NCT00395876|652752|P1|STARTED|Overall Study||50
268867|NCT00395863|652780|P2|NOT COMPLETED|Overall Study||3
268868|NCT00395863|652781|P1|NOT COMPLETED|Overall Study||2
268869|NCT00395863|652780|P2|COMPLETED|Overall Study||20
268870|NCT00395863|652781|P1|COMPLETED|Overall Study||21
268871|NCT00395863|652780|P2|STARTED|Overall Study||23
268872|NCT00395863|652781|P1|STARTED|Overall Study||23
268873|NCT00395850|652816|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
268874|NCT00395850|652817|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
268875|NCT00395850|652818|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
268876|NCT00395850|652819|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
268877|NCT00395850|652816|P4|COMPLETED|Disulfiram/Placebo Treatment||8
268878|NCT00395850|652817|P3|COMPLETED|Disulfiram/Placebo Treatment||5
268879|NCT00395850|652818|P2|COMPLETED|Disulfiram/Placebo Treatment||9
268880|NCT00395850|652819|P1|COMPLETED|Disulfiram/Placebo Treatment||11
268881|NCT00395850|652816|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
268882|NCT00395850|652817|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
268883|NCT00395850|652818|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
268884|NCT00395850|652819|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
268885|NCT00395850|652816|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
268886|NCT00395850|652817|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
268887|NCT00395850|652818|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
268888|NCT00395850|652819|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
268889|NCT00395850|652816|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
268890|NCT00395850|652817|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
268891|NCT00395850|652818|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
268892|NCT00395850|652819|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
268893|NCT00395850|652816|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
268894|NCT00395850|652817|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
268895|NCT00395850|652818|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
268896|NCT00395850|652819|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
268897|NCT00395850|652816|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
268898|NCT00395850|652817|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
268899|NCT00395850|652818|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
268900|NCT00395850|652819|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
268901|NCT00395850|652816|P4|COMPLETED|Pre-randomization Baseline/Induction||0
268902|NCT00395850|652817|P3|COMPLETED|Pre-randomization Baseline/Induction||0
268903|NCT00395850|652818|P2|COMPLETED|Pre-randomization Baseline/Induction||0
268904|NCT00395850|652819|P1|COMPLETED|Pre-randomization Baseline/Induction||107
268905|NCT00395850|652816|P4|STARTED|Pre-randomization Baseline/Induction||0
268906|NCT00395850|652817|P3|STARTED|Pre-randomization Baseline/Induction||0
268907|NCT00395850|652818|P2|STARTED|Pre-randomization Baseline/Induction||0
268908|NCT00395850|652819|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
268909|NCT00395746|652836|P3|NOT COMPLETED|Overall Study||22
268910|NCT00395746|652837|P2|NOT COMPLETED|Overall Study||4
268911|NCT00395746|652838|P1|NOT COMPLETED|Overall Study||10
268912|NCT00395746|652836|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
268913|NCT00395746|652837|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
268914|NCT00395746|652838|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
268915|NCT00395746|652836|P3|STARTED|Overall Study|Exposed to study drug|88
268916|NCT00395746|652837|P2|STARTED|Overall Study|Exposed to study drug|88
268917|NCT00395746|652838|P1|STARTED|Overall Study|Exposed to study drug|88
268918|NCT00395733|652884|P2|NOT COMPLETED|Period 2||5
268919|NCT00395733|652885|P1|NOT COMPLETED|Period 2||2
268920|NCT00395733|652884|P2|COMPLETED|Period 2||37
268921|NCT00395733|652885|P1|COMPLETED|Period 2||39
268922|NCT00395733|652884|P2|STARTED|Period 2||42
268923|NCT00395733|652885|P1|STARTED|Period 2||41
268924|NCT00395733|652884|P2|NOT COMPLETED|Period 1||0
268925|NCT00395733|652885|P1|NOT COMPLETED|Period 1||0
268926|NCT00395733|652884|P2|COMPLETED|Period 1||42
268927|NCT00395733|652885|P1|COMPLETED|Period 1||41
268928|NCT00395733|652884|P2|STARTED|Period 1||42
268929|NCT00395733|652885|P1|STARTED|Period 1||41
268930|NCT00395694|652909|P2|NOT COMPLETED|Continuation Phase||13
268931|NCT00395694|652910|P1|NOT COMPLETED|Continuation Phase||15
268932|NCT00395694|652909|P2|COMPLETED|Continuation Phase||35
268933|NCT00395694|652910|P1|COMPLETED|Continuation Phase||34
269022|NCT00395304|653232|P1|STARTED|Treatment Period 3||30
268934|NCT00395694|652909|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
268935|NCT00395694|652910|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
268936|NCT00395694|652909|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
268937|NCT00395694|652910|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
268938|NCT00395694|652909|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
268939|NCT00395694|652910|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
268940|NCT00395694|652909|P2|STARTED|Escalation Phase + Maintenance Phase||51
268941|NCT00395694|652910|P1|STARTED|Escalation Phase + Maintenance Phase||51
268942|NCT00395642|652941|P1|NOT COMPLETED|Overall Study||13
268943|NCT00395642|652941|P1|COMPLETED|Overall Study||53
268944|NCT00395642|652941|P1|STARTED|Overall Study||66
268945|NCT00395629|652948|P3|NOT COMPLETED|Extension Study||3
268946|NCT00395629|652949|P2|NOT COMPLETED|Extension Study||0
268947|NCT00395629|652950|P1|NOT COMPLETED|Extension Study||0
268948|NCT00395629|652948|P3|COMPLETED|Extension Study||8
268949|NCT00395629|652949|P2|COMPLETED|Extension Study||6
268950|NCT00395629|652950|P1|COMPLETED|Extension Study||9
268951|NCT00395629|652948|P3|STARTED|Extension Study||11
268952|NCT00395629|652949|P2|STARTED|Extension Study||6
268953|NCT00395629|652950|P1|STARTED|Extension Study||9
268954|NCT00395629|652948|P3|NOT COMPLETED|Core Study||7
268955|NCT00395629|652949|P2|NOT COMPLETED|Core Study||4
268956|NCT00395629|652950|P1|NOT COMPLETED|Core Study||1
268957|NCT00395629|652948|P3|COMPLETED|Core Study||16
268958|NCT00395629|652949|P2|COMPLETED|Core Study||11
268959|NCT00395629|652950|P1|COMPLETED|Core Study||10
268960|NCT00395629|652948|P3|STARTED|Core Study||23
268961|NCT00395629|652949|P2|STARTED|Core Study||15
268962|NCT00395629|652950|P1|STARTED|Core Study||11
268963|NCT00395512|652968|P4|NOT COMPLETED|Overall Study||38
268964|NCT00395512|652969|P3|NOT COMPLETED|Overall Study||28
268965|NCT00395512|652970|P2|NOT COMPLETED|Overall Study||37
268966|NCT00395512|652971|P1|NOT COMPLETED|Overall Study||38
268967|NCT00395512|652968|P4|COMPLETED|Overall Study||126
268968|NCT00395512|652969|P3|COMPLETED|Overall Study||136
268969|NCT00395512|652970|P2|COMPLETED|Overall Study||126
268970|NCT00395512|652971|P1|COMPLETED|Overall Study||126
268971|NCT00395512|652968|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
268972|NCT00395512|652969|P3|Safety Set|Overall Study||164
268973|NCT00395512|652970|P2|Safety Set|Overall Study||163
268974|NCT00395512|652971|P1|Safety Set|Overall Study||164
268975|NCT00395512|652968|P4|STARTED|Overall Study||164
268976|NCT00395512|652969|P3|STARTED|Overall Study||164
268977|NCT00395512|652970|P2|STARTED|Overall Study||163
268978|NCT00395512|652971|P1|STARTED|Overall Study||164
268979|NCT00395486|653143|P2|NOT COMPLETED|Overall Study||5
268980|NCT00395486|653144|P1|NOT COMPLETED|Overall Study||6
268981|NCT00395486|653143|P2|COMPLETED|Overall Study|Completed subjects|121
268982|NCT00395486|653144|P1|COMPLETED|Overall Study|Completed subjects|126
268983|NCT00395486|653143|P2|STARTED|Overall Study|Randomized subjects|126
268984|NCT00395486|653144|P1|STARTED|Overall Study|Randomized subjects|132
268985|NCT00395460|653174|P2|NOT COMPLETED|Overall Study||0
268986|NCT00395460|653175|P1|NOT COMPLETED|Overall Study||1
268987|NCT00395460|653174|P2|COMPLETED|Overall Study||75
268988|NCT00395460|653175|P1|COMPLETED|Overall Study||71
268989|NCT00395460|653174|P2|Received Treatment|Overall Study||75
268990|NCT00395460|653175|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
268991|NCT00395460|653174|P2|STARTED|Overall Study||75
268992|NCT00395460|653175|P1|STARTED|Overall Study||72
268993|NCT00395447|653199|P2|NOT COMPLETED|Overall Study||111
268994|NCT00395447|653200|P1|NOT COMPLETED|Overall Study||121
268995|NCT00395447|653199|P2|COMPLETED|Overall Study||602
268996|NCT00395447|653200|P1|COMPLETED|Overall Study||910
268997|NCT00395447|653199|P2|STARTED|Overall Study||713
268998|NCT00395447|653200|P1|STARTED|Overall Study||1031
268999|NCT00395343|653208|P2|NOT COMPLETED|Overall Study||36
269000|NCT00395343|653209|P1|NOT COMPLETED|Overall Study||41
269001|NCT00395343|653208|P2|COMPLETED|Overall Study||283
269002|NCT00395343|653209|P1|COMPLETED|Overall Study||281
269003|NCT00395343|653208|P2|STARTED|Overall Study||319
269004|NCT00395343|653209|P1|STARTED|Overall Study||322
269005|NCT00395304|653227|P6|NOT COMPLETED|Treatment Period 3||1
269006|NCT00395304|653228|P5|NOT COMPLETED|Treatment Period 3||0
269007|NCT00395304|653229|P4|NOT COMPLETED|Treatment Period 3||2
269008|NCT00395304|653230|P3|NOT COMPLETED|Treatment Period 3||0
269009|NCT00395304|653231|P2|NOT COMPLETED|Treatment Period 3||2
269010|NCT00395304|653232|P1|NOT COMPLETED|Treatment Period 3||1
269011|NCT00395304|653227|P6|COMPLETED|Treatment Period 3||27
269012|NCT00395304|653228|P5|COMPLETED|Treatment Period 3||27
269013|NCT00395304|653229|P4|COMPLETED|Treatment Period 3||25
269014|NCT00395304|653230|P3|COMPLETED|Treatment Period 3||29
269015|NCT00395304|653231|P2|COMPLETED|Treatment Period 3||20
269016|NCT00395304|653232|P1|COMPLETED|Treatment Period 3||29
269017|NCT00395304|653227|P6|STARTED|Treatment Period 3||28
269018|NCT00395304|653228|P5|STARTED|Treatment Period 3||27
269019|NCT00395304|653229|P4|STARTED|Treatment Period 3||27
269020|NCT00395304|653230|P3|STARTED|Treatment Period 3||29
269021|NCT00395304|653231|P2|STARTED|Treatment Period 3||22
269023|NCT00395304|653227|P6|NOT COMPLETED|Treatment Period 2||2
269024|NCT00395304|653228|P5|NOT COMPLETED|Treatment Period 2||0
269025|NCT00395304|653229|P4|NOT COMPLETED|Treatment Period 2||1
269026|NCT00395304|653230|P3|NOT COMPLETED|Treatment Period 2||1
269027|NCT00395304|653231|P2|NOT COMPLETED|Treatment Period 2||4
269028|NCT00395304|653232|P1|NOT COMPLETED|Treatment Period 2||0
269029|NCT00395304|653227|P6|COMPLETED|Treatment Period 2||28
269030|NCT00395304|653228|P5|COMPLETED|Treatment Period 2||27
269031|NCT00395304|653229|P4|COMPLETED|Treatment Period 2||27
269032|NCT00395304|653230|P3|COMPLETED|Treatment Period 2||29
269033|NCT00395304|653231|P2|COMPLETED|Treatment Period 2||22
269034|NCT00395304|653232|P1|COMPLETED|Treatment Period 2||30
269035|NCT00395304|653227|P6|STARTED|Treatment Period 2||30
269036|NCT00395304|653228|P5|STARTED|Treatment Period 2||27
269037|NCT00395304|653229|P4|STARTED|Treatment Period 2||28
269038|NCT00395304|653230|P3|STARTED|Treatment Period 2||30
269039|NCT00395304|653231|P2|STARTED|Treatment Period 2||26
269040|NCT00395304|653232|P1|STARTED|Treatment Period 2||30
269041|NCT00395304|653227|P6|NOT COMPLETED|Treatment Period 1||2
269042|NCT00395304|653228|P5|NOT COMPLETED|Treatment Period 1||1
269043|NCT00395304|653229|P4|NOT COMPLETED|Treatment Period 1||3
269044|NCT00395304|653230|P3|NOT COMPLETED|Treatment Period 1||0
269045|NCT00395304|653231|P2|NOT COMPLETED|Treatment Period 1||4
269046|NCT00395304|653232|P1|NOT COMPLETED|Treatment Period 1||1
269047|NCT00395304|653227|P6|COMPLETED|Treatment Period 1||30
269048|NCT00395304|653228|P5|COMPLETED|Treatment Period 1||27
269049|NCT00395304|653229|P4|COMPLETED|Treatment Period 1||28
269050|NCT00395304|653230|P3|COMPLETED|Treatment Period 1||30
269051|NCT00395304|653231|P2|COMPLETED|Treatment Period 1||26
269052|NCT00395304|653232|P1|COMPLETED|Treatment Period 1||30
269053|NCT00395304|653227|P6|STARTED|Treatment Period 1||32
269054|NCT00395304|653228|P5|STARTED|Treatment Period 1||28
269055|NCT00395304|653229|P4|STARTED|Treatment Period 1||31
269056|NCT00395304|653230|P3|STARTED|Treatment Period 1||30
269057|NCT00395304|653231|P2|STARTED|Treatment Period 1||30
269058|NCT00395304|653232|P1|STARTED|Treatment Period 1||31
269059|NCT00395291|653275|P2|NOT COMPLETED|Second Intervention||0
269060|NCT00395291|653276|P1|NOT COMPLETED|Second Intervention||0
269061|NCT00395291|653275|P2|COMPLETED|Second Intervention||9
269062|NCT00395291|653276|P1|COMPLETED|Second Intervention||13
269063|NCT00395291|653275|P2|STARTED|Second Intervention||9
269064|NCT00395291|653276|P1|STARTED|Second Intervention||13
269065|NCT00395291|653275|P2|NOT COMPLETED|Washout Period for 30 Days||0
269066|NCT00395291|653276|P1|NOT COMPLETED|Washout Period for 30 Days||2
269067|NCT00395291|653275|P2|COMPLETED|Washout Period for 30 Days||9
269068|NCT00395291|653276|P1|COMPLETED|Washout Period for 30 Days||13
269069|NCT00395291|653275|P2|STARTED|Washout Period for 30 Days||9
269070|NCT00395291|653276|P1|STARTED|Washout Period for 30 Days||15
269071|NCT00395291|653275|P2|NOT COMPLETED|First Intervention||0
269072|NCT00395291|653276|P1|NOT COMPLETED|First Intervention||2
269073|NCT00395291|653275|P2|COMPLETED|First Intervention||9
269074|NCT00395291|653276|P1|COMPLETED|First Intervention||15
269075|NCT00395291|653275|P2|STARTED|First Intervention||9
269076|NCT00395291|653276|P1|STARTED|First Intervention||17
269077|NCT00395226|653308|P2|NOT COMPLETED|Overall Study||5
269078|NCT00395226|653309|P1|NOT COMPLETED|Overall Study||4
269079|NCT00395226|653308|P2|COMPLETED|Overall Study||22
269080|NCT00395226|653309|P1|COMPLETED|Overall Study||22
269081|NCT00395226|653308|P2|STARTED|Overall Study||27
269082|NCT00395226|653309|P1|STARTED|Overall Study||26
269083|NCT00395161|653317|P2|NOT COMPLETED|Overall Study||0
269084|NCT00395161|653318|P1|NOT COMPLETED|Overall Study||0
269085|NCT00395161|653317|P2|COMPLETED|Overall Study||144
269086|NCT00395161|653318|P1|COMPLETED|Overall Study||149
269087|NCT00395161|653317|P2|STARTED|Overall Study||144
269088|NCT00395161|653318|P1|STARTED|Overall Study||149
269089|NCT00395135|653334|P5|NOT COMPLETED|Year 2||190
269090|NCT00395135|653335|P4|NOT COMPLETED|Year 2||88
269091|NCT00395135|653336|P3|NOT COMPLETED|Year 2||147
269092|NCT00395135|653337|P2|NOT COMPLETED|Year 2||0
269093|NCT00395135|653338|P1|NOT COMPLETED|Year 2||0
269094|NCT00395135|653334|P5|COMPLETED|Year 2||507
269095|NCT00395135|653335|P4|COMPLETED|Year 2||195
269096|NCT00395135|653336|P3|COMPLETED|Year 2||426
269097|NCT00395135|653337|P2|COMPLETED|Year 2||0
269098|NCT00395135|653338|P1|COMPLETED|Year 2||0
269099|NCT00395135|653334|P5|STARTED|Year 2||697
269100|NCT00395135|653335|P4|STARTED|Year 2||283
269101|NCT00395135|653336|P3|STARTED|Year 2||573
269102|NCT00395135|653337|P2|STARTED|Year 2||0
269103|NCT00395135|653338|P1|STARTED|Year 2||0
269104|NCT00395135|653334|P5|NOT COMPLETED|Year 1||0
269105|NCT00395135|653335|P4|NOT COMPLETED|Year 1||0
269106|NCT00395135|653336|P3|NOT COMPLETED|Year 1||0
269107|NCT00395135|653337|P2|NOT COMPLETED|Year 1||871
269108|NCT00395135|653338|P1|NOT COMPLETED|Year 1||712
269109|NCT00395135|653334|P5|COMPLETED|Year 1||0
269110|NCT00395135|653335|P4|COMPLETED|Year 1||0
269111|NCT00395135|653336|P3|COMPLETED|Year 1||0
269112|NCT00395135|653337|P2|COMPLETED|Year 1||716
269113|NCT00395135|653338|P1|COMPLETED|Year 1||883
269114|NCT00395135|653334|P5|STARTED|Year 1||0
269115|NCT00395135|653335|P4|STARTED|Year 1||0
269116|NCT00395135|653336|P3|STARTED|Year 1||0
269117|NCT00395135|653337|P2|STARTED|Year 1||1587
269118|NCT00395135|653338|P1|STARTED|Year 1||1595
269119|NCT00395083|653356|P2|NOT COMPLETED|Overall Study||8
269120|NCT00395083|653357|P1|NOT COMPLETED|Overall Study||10
269121|NCT00395083|653356|P2|COMPLETED|Overall Study||201
269122|NCT00395083|653357|P1|COMPLETED|Overall Study||207
269123|NCT00395083|653356|P2|STARTED|Overall Study||209
269124|NCT00395083|653357|P1|STARTED|Overall Study||217
269125|NCT00395057|653373|P4|NOT COMPLETED|Overall Study||33
269126|NCT00395057|653374|P3|NOT COMPLETED|Overall Study||33
269127|NCT00395057|653375|P2|NOT COMPLETED|Overall Study||34
269128|NCT00395057|653376|P1|NOT COMPLETED|Overall Study||32
269129|NCT00395057|653373|P4|COMPLETED|Overall Study||1
269130|NCT00395057|653374|P3|COMPLETED|Overall Study||2
269131|NCT00395057|653375|P2|COMPLETED|Overall Study||1
269132|NCT00395057|653376|P1|COMPLETED|Overall Study||2
269133|NCT00395057|653373|P4|STARTED|Overall Study||34
269134|NCT00395057|653374|P3|STARTED|Overall Study||35
269135|NCT00395057|653375|P2|STARTED|Overall Study||35
269136|NCT00395057|653376|P1|STARTED|Overall Study||34
269137|NCT00395044|653404|P2|NOT COMPLETED|Overall Study||14
269138|NCT00395044|653405|P1|NOT COMPLETED|Overall Study||18
269139|NCT00395044|653404|P2|COMPLETED|Overall Study||11
269140|NCT00395044|653405|P1|COMPLETED|Overall Study||7
269141|NCT00395044|653404|P2|STARTED|Overall Study||25
269142|NCT00395044|653405|P1|STARTED|Overall Study||25
269143|NCT00395018|653423|P1|NOT COMPLETED|Off-Treatment Follow-up||4
269144|NCT00395018|653423|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
269145|NCT00395018|653423|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
269146|NCT00395018|653423|P1|NOT COMPLETED|On-Treatment||10
269147|NCT00395018|653423|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
269148|NCT00395018|653423|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
269149|NCT00395018|653423|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
269150|NCT00395018|653423|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
269151|NCT00394953|653444|P2|NOT COMPLETED|Second Treatment Period||74
269152|NCT00394953|653445|P1|NOT COMPLETED|Second Treatment Period||29
269153|NCT00394953|653444|P2|COMPLETED|Second Treatment Period||148
269154|NCT00394953|653445|P1|COMPLETED|Second Treatment Period||187
269155|NCT00394953|653444|P2|STARTED|Second Treatment Period||222
269156|NCT00394953|653445|P1|STARTED|Second Treatment Period||216
269157|NCT00394953|653444|P2|NOT COMPLETED|First Treatment Period||22
269158|NCT00394953|653445|P1|NOT COMPLETED|First Treatment Period||29
269159|NCT00394953|653444|P2|COMPLETED|First Treatment Period||222
269160|NCT00394953|653445|P1|COMPLETED|First Treatment Period||216
269161|NCT00394953|653444|P2|STARTED|First Treatment Period||244
269162|NCT00394953|653445|P1|STARTED|First Treatment Period||245
269163|NCT00394914|653463|P3|NOT COMPLETED|Treatment Period||6
269164|NCT00394914|653464|P2|NOT COMPLETED|Treatment Period||10
269165|NCT00394914|653465|P1|NOT COMPLETED|Treatment Period||0
269166|NCT00394914|653463|P3|COMPLETED|Treatment Period||151
269167|NCT00394914|653464|P2|COMPLETED|Treatment Period||144
269168|NCT00394914|653465|P1|COMPLETED|Treatment Period||0
269169|NCT00394914|653463|P3|STARTED|Treatment Period||157
269170|NCT00394914|653464|P2|STARTED|Treatment Period||154
269171|NCT00394914|653465|P1|STARTED|Treatment Period||0
269172|NCT00394914|653463|P3|NOT COMPLETED|Pre-exposure Period||0
269173|NCT00394914|653464|P2|NOT COMPLETED|Pre-exposure Period||0
269174|NCT00394914|653465|P1|NOT COMPLETED|Pre-exposure Period||0
269175|NCT00394914|653463|P3|COMPLETED|Pre-exposure Period||0
269176|NCT00394914|653464|P2|COMPLETED|Pre-exposure Period||0
269177|NCT00394914|653465|P1|COMPLETED|Pre-exposure Period||311
269178|NCT00394914|653463|P3|STARTED|Pre-exposure Period||0
269179|NCT00394914|653464|P2|STARTED|Pre-exposure Period||0
269180|NCT00394914|653465|P1|STARTED|Pre-exposure Period||311
269181|NCT00394914|653463|P3|NOT COMPLETED|Screening Period||0
269182|NCT00394914|653464|P2|NOT COMPLETED|Screening Period||0
269183|NCT00394914|653465|P1|NOT COMPLETED|Screening Period||0
269184|NCT00394914|653463|P3|COMPLETED|Screening Period||0
269185|NCT00394914|653464|P2|COMPLETED|Screening Period||0
269186|NCT00394914|653465|P1|COMPLETED|Screening Period||311
269187|NCT00394914|653463|P3|STARTED|Screening Period||0
269188|NCT00394914|653464|P2|STARTED|Screening Period||0
269189|NCT00394914|653465|P1|STARTED|Screening Period||311
269190|NCT00394901|653493|P4|NOT COMPLETED|Double-blind Phase||27
269191|NCT00394901|653494|P3|NOT COMPLETED|Double-blind Phase||18
269192|NCT00394901|653495|P2|NOT COMPLETED|Double-blind Phase||14
269193|NCT00394901|653496|P1|NOT COMPLETED|Double-blind Phase||15
269194|NCT00394901|653493|P4|COMPLETED|Double-blind Phase||70
269195|NCT00394901|653494|P3|COMPLETED|Double-blind Phase||71
269196|NCT00394901|653495|P2|COMPLETED|Double-blind Phase||73
269197|NCT00394901|653496|P1|COMPLETED|Double-blind Phase||83
269198|NCT00394901|653493|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
269199|NCT00394901|653494|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
269200|NCT00394901|653495|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
269201|NCT00394901|653496|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
269202|NCT00394901|653493|P4|NOT COMPLETED|Baseline Phase||0
269203|NCT00394901|653494|P3|NOT COMPLETED|Baseline Phase||1
269204|NCT00394901|653495|P2|NOT COMPLETED|Baseline Phase||0
269205|NCT00394901|653496|P1|NOT COMPLETED|Baseline Phase||0
269206|NCT00394901|653493|P4|COMPLETED|Baseline Phase||97
269207|NCT00394901|653494|P3|COMPLETED|Baseline Phase||89
269208|NCT00394901|653495|P2|COMPLETED|Baseline Phase||87
269209|NCT00394901|653496|P1|COMPLETED|Baseline Phase||98
269210|NCT00394901|653493|P4|STARTED|Baseline Phase|Subjects randomized|97
269211|NCT00394901|653494|P3|STARTED|Baseline Phase|Subjects randomized|90
269212|NCT00394901|653495|P2|STARTED|Baseline Phase|Subjects randomized|87
269213|NCT00394901|653496|P1|STARTED|Baseline Phase|Subjects randomized|98
269214|NCT00394888|653724|P3|NOT COMPLETED|Overall Study||0
269215|NCT00394888|653725|P2|NOT COMPLETED|Overall Study||0
269216|NCT00394888|653726|P1|NOT COMPLETED|Overall Study||0
269217|NCT00394888|653724|P3|COMPLETED|Overall Study||201
269218|NCT00394888|653725|P2|COMPLETED|Overall Study||48
269219|NCT00394888|653726|P1|COMPLETED|Overall Study||108
269220|NCT00394888|653724|P3|STARTED|Overall Study||201
269221|NCT00394888|653725|P2|STARTED|Overall Study||48
269222|NCT00394888|653726|P1|STARTED|Overall Study||108
269223|NCT00394836|653739|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
269224|NCT00394836|653740|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
269225|NCT00394836|653739|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
269226|NCT00394836|653740|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
269227|NCT00394836|653739|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
269228|NCT00394836|653740|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
269229|NCT00394836|653739|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
269230|NCT00394836|653740|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
269231|NCT00394836|653739|P2|COMPLETED|Teatment or Follow-up Phase||8
269232|NCT00394836|653740|P1|COMPLETED|Teatment or Follow-up Phase||2
269233|NCT00394836|653739|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
269234|NCT00394836|653740|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
269235|NCT00394836|653739|P2|STARTED|Teatment or Follow-up Phase||86
269236|NCT00394836|653740|P1|STARTED|Teatment or Follow-up Phase||30
269237|NCT00394771|653786|P4|NOT COMPLETED|Overall Study||39
269238|NCT00394771|653787|P3|NOT COMPLETED|Overall Study||47
269239|NCT00394771|653788|P2|NOT COMPLETED|Overall Study||34
269240|NCT00394771|653789|P1|NOT COMPLETED|Overall Study||41
269241|NCT00394771|653786|P4|COMPLETED|Overall Study||109
269242|NCT00394771|653787|P3|COMPLETED|Overall Study||96
269243|NCT00394771|653788|P2|COMPLETED|Overall Study||102
269244|NCT00394771|653789|P1|COMPLETED|Overall Study||99
269245|NCT00394771|653786|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
269246|NCT00394771|653787|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
269247|NCT00394771|653788|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
269248|NCT00394771|653789|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
269249|NCT00394771|653786|P4|STARTED|Overall Study|Safety population of treated participants|148
269250|NCT00394771|653787|P3|STARTED|Overall Study|Safety population of treated participants|143
269251|NCT00394771|653788|P2|STARTED|Overall Study|Safety population of treated participants|136
269252|NCT00394771|653789|P1|STARTED|Overall Study|Safety population of treated participants|140
269253|NCT00394706|653859|P8|NOT COMPLETED|Overall Study||0
269254|NCT00394706|653860|P7|NOT COMPLETED|Overall Study||3
269255|NCT00394706|653861|P6|NOT COMPLETED|Overall Study||7
269256|NCT00394706|653862|P5|NOT COMPLETED|Overall Study||2
269257|NCT00394706|653863|P4|NOT COMPLETED|Overall Study||1
269258|NCT00394706|653864|P3|NOT COMPLETED|Overall Study||9
269259|NCT00394706|653865|P2|NOT COMPLETED|Overall Study||2
269260|NCT00394706|653866|P1|NOT COMPLETED|Overall Study||4
269261|NCT00394706|653859|P8|COMPLETED|Overall Study||851
269262|NCT00394706|653860|P7|COMPLETED|Overall Study||926
269263|NCT00394706|653861|P6|COMPLETED|Overall Study||1377
269264|NCT00394706|653862|P5|COMPLETED|Overall Study||1634
269265|NCT00394706|653863|P4|COMPLETED|Overall Study||1632
269266|NCT00394706|653864|P3|COMPLETED|Overall Study||1615
269267|NCT00394706|653865|P2|COMPLETED|Overall Study||1860
269268|NCT00394706|653866|P1|COMPLETED|Overall Study||1815
269269|NCT00394706|653859|P8|STARTED|Overall Study||851
269270|NCT00394706|653860|P7|STARTED|Overall Study||929
269271|NCT00394706|653861|P6|STARTED|Overall Study||1384
269272|NCT00394706|653862|P5|STARTED|Overall Study||1636
269273|NCT00394706|653863|P4|STARTED|Overall Study||1633
269274|NCT00394706|653864|P3|STARTED|Overall Study||1624
269275|NCT00394706|653865|P2|STARTED|Overall Study||1862
269276|NCT00394706|653866|P1|STARTED|Overall Study||1819
269277|NCT00394654|653886|P2|NOT COMPLETED|Overall Study||0
269278|NCT00394654|653887|P1|NOT COMPLETED|Overall Study||2
269279|NCT00394654|653886|P2|COMPLETED|Overall Study||15
269280|NCT00394654|653887|P1|COMPLETED|Overall Study||13
269281|NCT00394654|653886|P2|STARTED|Overall Study||15
269282|NCT00394654|653887|P1|STARTED|Overall Study||15
269283|NCT00394589|653952|P3|NOT COMPLETED|Overall Study||7
269284|NCT00394589|653953|P2|NOT COMPLETED|Overall Study||3
269285|NCT00394589|653954|P1|NOT COMPLETED|Overall Study||8
269286|NCT00394589|653952|P3|COMPLETED|Overall Study||11
269287|NCT00394589|653953|P2|COMPLETED|Overall Study||8
269288|NCT00394589|653954|P1|COMPLETED|Overall Study||6
269289|NCT00394589|653952|P3|STARTED|Overall Study||18
269290|NCT00394589|653953|P2|STARTED|Overall Study||11
269291|NCT00394589|653954|P1|STARTED|Overall Study||14
269292|NCT00394524|653964|P2|NOT COMPLETED|Overall Study||10
269293|NCT00394524|653965|P1|NOT COMPLETED|Overall Study||11
269294|NCT00394524|653964|P2|COMPLETED|Overall Study||68
269295|NCT00394524|653965|P1|COMPLETED|Overall Study||68
269296|NCT00394524|653964|P2|STARTED|Overall Study||78
269297|NCT00394524|653965|P1|STARTED|Overall Study||79
269298|NCT00394472|653977|P2|NOT COMPLETED|Overall Study||11
269299|NCT00394472|653978|P1|NOT COMPLETED|Overall Study||9
269300|NCT00394472|653977|P2|COMPLETED|Overall Study||111
269301|NCT00394472|653978|P1|COMPLETED|Overall Study||113
269302|NCT00394472|653977|P2|STARTED|Overall Study||122
269303|NCT00394472|653978|P1|STARTED|Overall Study||122
269304|NCT00394433|653986|P1|NOT COMPLETED|Overall Study||3
269305|NCT00394433|653986|P1|COMPLETED|Overall Study||35
269306|NCT00394433|653986|P1|Evaluable and Treated|Overall Study||35
269307|NCT00394433|653986|P1|STARTED|Overall Study||38
269308|NCT00394355|653997|P4|NOT COMPLETED|Overall Study||31
269309|NCT00394355|653998|P3|NOT COMPLETED|Overall Study||38
269310|NCT00394355|653999|P2|NOT COMPLETED|Overall Study||34
269311|NCT00394355|654000|P1|NOT COMPLETED|Overall Study||35
269312|NCT00394355|653997|P4|COMPLETED|Overall Study||111
269313|NCT00394355|653998|P3|COMPLETED|Overall Study||109
269314|NCT00394355|653999|P2|COMPLETED|Overall Study||103
269315|NCT00394355|654000|P1|COMPLETED|Overall Study||105
269316|NCT00394355|653997|P4|STARTED|Overall Study||142
269317|NCT00394355|653998|P3|STARTED|Overall Study||147
269318|NCT00394355|653999|P2|STARTED|Overall Study||137
269319|NCT00394355|654000|P1|STARTED|Overall Study||140
269320|NCT00394329|654026|P4|NOT COMPLETED|Overall Study||24
269321|NCT00394329|654027|P3|NOT COMPLETED|Overall Study||13
269322|NCT00394329|654028|P2|NOT COMPLETED|Overall Study||9
269323|NCT00394329|654029|P1|NOT COMPLETED|Overall Study||8
269324|NCT00394329|654026|P4|COMPLETED|Overall Study||50
269325|NCT00394329|654027|P3|COMPLETED|Overall Study||58
269326|NCT00394329|654028|P2|COMPLETED|Overall Study||63
269327|NCT00394329|654029|P1|COMPLETED|Overall Study||63
269328|NCT00394329|654026|P4|STARTED|Overall Study||74
269329|NCT00394329|654027|P3|STARTED|Overall Study||71
269330|NCT00394329|654028|P2|STARTED|Overall Study||72
269331|NCT00394329|654029|P1|STARTED|Overall Study||71
269332|NCT00394277|654079|P4|NOT COMPLETED|Overall Study||125
269333|NCT00394277|654080|P3|NOT COMPLETED|Overall Study||120
269334|NCT00394277|654081|P2|NOT COMPLETED|Overall Study||60
269335|NCT00394277|654082|P1|NOT COMPLETED|Overall Study||58
269336|NCT00394277|654079|P4|COMPLETED|Overall Study||266
269337|NCT00394277|654080|P3|COMPLETED|Overall Study||273
269338|NCT00394277|654081|P2|COMPLETED|Overall Study||136
269339|NCT00394277|654082|P1|COMPLETED|Overall Study||137
269340|NCT00394277|654079|P4|STARTED|Overall Study||391
269341|NCT00394277|654080|P3|STARTED|Overall Study||393
269342|NCT00394277|654081|P2|STARTED|Overall Study||196
269343|NCT00394277|654082|P1|STARTED|Overall Study||195
269344|NCT00394251|654106|P2|NOT COMPLETED|Overall Study||38
269345|NCT00394251|654107|P1|NOT COMPLETED|Overall Study||37
269346|NCT00394251|654106|P2|COMPLETED|Overall Study||61
269347|NCT00394251|654107|P1|COMPLETED|Overall Study||61
269348|NCT00394251|654106|P2|At Least One Dose of Taxane|Overall Study||93
269349|NCT00394251|654107|P1|At Least One Dose of Taxane|Overall Study||93
269350|NCT00394251|654106|P2|STARTED|Overall Study||99
269351|NCT00394251|654107|P1|STARTED|Overall Study||98
269352|NCT00394212|654135|P2|NOT COMPLETED|Overall Study||1
269353|NCT00394212|654136|P1|NOT COMPLETED|Overall Study||7
269354|NCT00394212|654135|P2|COMPLETED|Overall Study||26
269355|NCT00394212|654136|P1|COMPLETED|Overall Study||43
269356|NCT00394212|654135|P2|6 Month Follow-up|Overall Study||26
269357|NCT00394212|654136|P1|6 Month Follow-up|Overall Study||43
269358|NCT00394212|654135|P2|3 Month Follow-up|Overall Study||26
269359|NCT00394212|654136|P1|3 Month Follow-up|Overall Study||45
269360|NCT00394212|654135|P2|6 Week Follow-up|Overall Study||26
269361|NCT00394212|654136|P1|6 Week Follow-up|Overall Study||45
269362|NCT00394212|654135|P2|STARTED|Overall Study||27
269363|NCT00394212|654136|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
269364|NCT00394095|654150|P2|NOT COMPLETED|Overall Study||0
269365|NCT00394095|654151|P1|NOT COMPLETED|Overall Study||1
269366|NCT00394095|654150|P2|COMPLETED|Overall Study||14
269367|NCT00394095|654151|P1|COMPLETED|Overall Study||16
269368|NCT00394095|654150|P2|Screened|Overall Study||14
269369|NCT00394095|654151|P1|Screened|Overall Study||17
269370|NCT00394095|654150|P2|STARTED|Overall Study||14
269371|NCT00394095|654151|P1|STARTED|Overall Study||17
269372|NCT00394082|654159|P1|NOT COMPLETED|Overall Study||26
269373|NCT00394082|654159|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
269374|NCT00394082|654159|P1|At Least One Response Assessment|Overall Study||43
269375|NCT00394082|654159|P1|STARTED|Overall Study||50
269376|NCT00393978|654170|P2|NOT COMPLETED|Overall Study||20
269377|NCT00393978|654171|P1|NOT COMPLETED|Overall Study||16
269378|NCT00393978|654170|P2|COMPLETED|Overall Study||18
269379|NCT00393978|654171|P1|COMPLETED|Overall Study||21
269380|NCT00393978|654170|P2|STARTED|Overall Study||38
269381|NCT00393978|654171|P1|STARTED|Overall Study||37
269382|NCT00393939|654181|P2|NOT COMPLETED|Overall Study||297
269383|NCT00393939|654182|P1|NOT COMPLETED|Overall Study||296
269384|NCT00393939|654181|P2|COMPLETED|Overall Study||0
269385|NCT00393939|654182|P1|COMPLETED|Overall Study||0
269386|NCT00393939|654181|P2|Treated|Overall Study||293
269387|NCT00393939|654182|P1|Treated|Overall Study||295
269388|NCT00393939|654181|P2|STARTED|Overall Study||297
269389|NCT00393939|654182|P1|STARTED|Overall Study||296
269390|NCT00393913|654200|P1|NOT COMPLETED|CPAP Withdrawal||0
269391|NCT00393913|654200|P1|COMPLETED|CPAP Withdrawal||42
269392|NCT00393913|654200|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
269393|NCT00393913|654200|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
269394|NCT00393913|654200|P1|NOT COMPLETED|CPAP||7
269395|NCT00393913|654200|P1|COMPLETED|CPAP||93
269396|NCT00393913|654200|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
269397|NCT00393913|654200|P1|NOT COMPLETED|Initial Assessment||37
269398|NCT00393913|654200|P1|COMPLETED|Initial Assessment||107
269399|NCT00393913|654200|P1|STARTED|Initial Assessment||144
269400|NCT00393887|654208|P2|NOT COMPLETED|Overall Study||9
269401|NCT00393887|654209|P1|NOT COMPLETED|Overall Study||16
269402|NCT00393887|654208|P2|COMPLETED|Overall Study||41
269403|NCT00393887|654209|P1|COMPLETED|Overall Study||34
269404|NCT00393887|654208|P2|1 Year|Overall Study||50
269405|NCT00393887|654209|P1|1 Year|Overall Study||45
269406|NCT00393887|654208|P2|STARTED|Overall Study||50
269407|NCT00393887|654209|P1|STARTED|Overall Study||50
269408|NCT00393874|654218|P3|NOT COMPLETED|Overall Study||2
269409|NCT00393874|654219|P2|NOT COMPLETED|Overall Study||4
269410|NCT00393874|654220|P1|NOT COMPLETED|Overall Study||3
269411|NCT00393874|654218|P3|COMPLETED|Overall Study||13
269412|NCT00393874|654219|P2|COMPLETED|Overall Study||13
269413|NCT00393874|654220|P1|COMPLETED|Overall Study||15
269414|NCT00393874|654218|P3|STARTED|Overall Study||15
269415|NCT00393874|654219|P2|STARTED|Overall Study||17
269416|NCT00393874|654220|P1|STARTED|Overall Study||18
269417|NCT00393861|654237|P1|NOT COMPLETED|Overall Study||26
269418|NCT00393861|654237|P1|COMPLETED|Overall Study||3
269419|NCT00393861|654237|P1|STARTED|Overall Study||29
269420|NCT00393848|654248|P4|NOT COMPLETED|Overall Study||1
269421|NCT00393848|654249|P3|NOT COMPLETED|Overall Study||2
269422|NCT00393848|654250|P2|NOT COMPLETED|Overall Study||0
269423|NCT00393848|654251|P1|NOT COMPLETED|Overall Study||0
269424|NCT00393848|654248|P4|COMPLETED|Overall Study||8
269425|NCT00393848|654249|P3|COMPLETED|Overall Study||4
269426|NCT00393848|654250|P2|COMPLETED|Overall Study||9
269427|NCT00393848|654251|P1|COMPLETED|Overall Study||16
269428|NCT00393848|654248|P4|STARTED|Overall Study||9
269429|NCT00393848|654249|P3|STARTED|Overall Study||6
269430|NCT00393848|654250|P2|STARTED|Overall Study||9
269431|NCT00393848|654251|P1|STARTED|Overall Study||16
269432|NCT00393796|654265|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
269433|NCT00393796|654266|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
269434|NCT00393796|654265|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
269435|NCT00393796|654266|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
269436|NCT00393796|654265|P2|STARTED|Open Label Period - Placebo to SUTENT||16
269437|NCT00393796|654266|P1|STARTED|Open Label Period - Placebo to SUTENT||0
269438|NCT00393796|654265|P2|NOT COMPLETED|Double Blind Period||0
269439|NCT00393796|654266|P1|NOT COMPLETED|Double Blind Period||0
269440|NCT00393796|654265|P2|COMPLETED|Double Blind Period||28
269441|NCT00393796|654266|P1|COMPLETED|Double Blind Period||26
269442|NCT00393796|654265|P2|STARTED|Double Blind Period||28
269443|NCT00393796|654266|P1|STARTED|Double Blind Period||26
269444|NCT00393718|654274|P2|NOT COMPLETED|Overall Study||22
269445|NCT00393718|654275|P1|NOT COMPLETED|Overall Study||43
269446|NCT00393718|654274|P2|COMPLETED|Overall Study||110
269447|NCT00393718|654275|P1|COMPLETED|Overall Study||225
269448|NCT00393718|654274|P2|STARTED|Overall Study||132
269449|NCT00393718|654275|P1|STARTED|Overall Study||268
269450|NCT00393705|654307|P2|NOT COMPLETED|Overall Study||23
269451|NCT00393705|654308|P1|NOT COMPLETED|Overall Study||23
269452|NCT00393705|654307|P2|COMPLETED|Overall Study||128
269453|NCT00393705|654308|P1|COMPLETED|Overall Study||128
269454|NCT00393705|654307|P2|Received at Least One Dose of Study Drug|Overall Study||139
269455|NCT00393705|654308|P1|Received at Least One Dose of Study Drug|Overall Study||139
269456|NCT00393705|654307|P2|STARTED|Overall Study||151
269457|NCT00393705|654308|P1|STARTED|Overall Study||151
269458|NCT00393523|654337|P5|NOT COMPLETED|Overall Study||1
269459|NCT00393523|654338|P4|NOT COMPLETED|Overall Study||6
269460|NCT00393523|654339|P3|NOT COMPLETED|Overall Study||4
269461|NCT00393523|654340|P2|NOT COMPLETED|Overall Study||9
269462|NCT00393523|654341|P1|NOT COMPLETED|Overall Study||12
269463|NCT00393523|654337|P5|COMPLETED|Overall Study||19
269464|NCT00393523|654338|P4|COMPLETED|Overall Study||348
269465|NCT00393523|654339|P3|COMPLETED|Overall Study||349
269466|NCT00393523|654340|P2|COMPLETED|Overall Study||366
269467|NCT00393523|654341|P1|COMPLETED|Overall Study||364
269468|NCT00393523|654337|P5|Vaccination Visit 1|Overall Study||20
269469|NCT00393523|654338|P4|Vaccination Visit 1|Overall Study||352
269470|NCT00393523|654339|P3|Vaccination Visit 1|Overall Study||349
269471|NCT00393523|654340|P2|Vaccination Visit 1|Overall Study||375
269472|NCT00393523|654341|P1|Vaccination Visit 1|Overall Study||374
269473|NCT00393523|654337|P5|STARTED|Overall Study||20
269474|NCT00393523|654338|P4|STARTED|Overall Study||354
269475|NCT00393523|654339|P3|STARTED|Overall Study||353
269476|NCT00393523|654340|P2|STARTED|Overall Study||375
269477|NCT00393523|654341|P1|STARTED|Overall Study||376
269478|NCT00393510|654358|P2|NOT COMPLETED|Overall Study||9
269479|NCT00393510|654359|P1|NOT COMPLETED|Overall Study||3
269480|NCT00393510|654358|P2|COMPLETED|Overall Study||31
269481|NCT00393510|654359|P1|COMPLETED|Overall Study||37
269482|NCT00393510|654358|P2|STARTED|Overall Study||40
269483|NCT00393510|654359|P1|STARTED|Overall Study||40
269484|NCT00393484|654371|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
269485|NCT00393484|654372|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
269486|NCT00393484|654371|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
269487|NCT00393484|654372|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
269488|NCT00393484|654371|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
269489|NCT00393484|654372|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
269490|NCT00393484|654371|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
269491|NCT00393484|654372|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
269492|NCT00393484|654371|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
269493|NCT00393484|654372|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
269494|NCT00393484|654371|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
269495|NCT00393484|654372|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
269496|NCT00393484|654371|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
269497|NCT00393484|654372|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
269498|NCT00393484|654371|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
269499|NCT00393484|654372|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
269500|NCT00393484|654371|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
269501|NCT00393484|654372|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
269502|NCT00393458|654408|P4|NOT COMPLETED|Overall Study||137
269503|NCT00393458|654409|P3|NOT COMPLETED|Overall Study||112
269504|NCT00393458|654410|P2|NOT COMPLETED|Overall Study||102
269505|NCT00393458|654411|P1|NOT COMPLETED|Overall Study||99
269506|NCT00393458|654408|P4|COMPLETED|Overall Study||295
269507|NCT00393458|654409|P3|COMPLETED|Overall Study||323
269508|NCT00393458|654410|P2|COMPLETED|Overall Study||326
269509|NCT00393458|654411|P1|COMPLETED|Overall Study||338
269510|NCT00393458|654408|P4|Exposed to Study Medication or Placebo|Overall Study||432
269511|NCT00393458|654409|P3|Exposed to Study Medication or Placebo|Overall Study||434
269512|NCT00393458|654410|P2|Exposed to Study Medication or Placebo|Overall Study||425
269513|NCT00393458|654411|P1|Exposed to Study Medication or Placebo|Overall Study||437
269514|NCT00393458|654408|P4|STARTED|Overall Study||432
269515|NCT00393458|654409|P3|STARTED|Overall Study||435
269516|NCT00393458|654410|P2|STARTED|Overall Study||428
269517|NCT00393458|654411|P1|STARTED|Overall Study||437
269518|NCT00393380|654425|P1|NOT COMPLETED|Overall Study||0
269519|NCT00393380|654425|P1|COMPLETED|Overall Study||13
269520|NCT00393380|654425|P1|STARTED|Overall Study||13
269521|NCT00393367|654438|P2|NOT COMPLETED|Overall Study||7
269522|NCT00393367|654439|P1|NOT COMPLETED|Overall Study||2
269523|NCT00393367|654438|P2|COMPLETED|Overall Study||81
269524|NCT00393367|654439|P1|COMPLETED|Overall Study||89
269525|NCT00393367|654438|P2|STARTED|Overall Study||88
269526|NCT00393367|654439|P1|STARTED|Overall Study||91
269527|NCT00393094|654467|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
269528|NCT00393094|654467|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
269529|NCT00393094|654467|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
269530|NCT00393094|654467|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
269531|NCT00393094|654467|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
269532|NCT00393094|654467|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
269533|NCT00393068|654474|P1|NOT COMPLETED|Overall Study||18
269534|NCT00393068|654474|P1|COMPLETED|Overall Study||44
269535|NCT00393068|654474|P1|STARTED|Overall Study||62
269536|NCT00393042|654478|P2|NOT COMPLETED|Second Intervetion||8
269537|NCT00393042|654479|P1|NOT COMPLETED|Second Intervetion||2
269538|NCT00393042|654478|P2|COMPLETED|Second Intervetion||19
269539|NCT00393042|654479|P1|COMPLETED|Second Intervetion||24
269540|NCT00393042|654478|P2|Completed 25/30 mg Dosage|Second Intervetion||20
269541|NCT00393042|654479|P1|Completed 25/30 mg Dosage|Second Intervetion||24
269542|NCT00393042|654478|P2|Completed the 20mg Dosage|Second Intervetion||21
269543|NCT00393042|654479|P1|Completed the 20mg Dosage|Second Intervetion||24
269544|NCT00393042|654478|P2|Completed 10 mg Dosage|Second Intervetion||24
269545|NCT00393042|654479|P1|Completed 10 mg Dosage|Second Intervetion||26
269546|NCT00393042|654478|P2|Completed Placebo Dosage|Second Intervetion||21
269547|NCT00393042|654479|P1|Completed Placebo Dosage|Second Intervetion||25
269548|NCT00393042|654478|P2|STARTED|Second Intervetion||27
269549|NCT00393042|654479|P1|STARTED|Second Intervetion||26
269550|NCT00393042|654478|P2|NOT COMPLETED|First Intervention||6
269551|NCT00393042|654479|P1|NOT COMPLETED|First Intervention||5
269552|NCT00393042|654478|P2|COMPLETED|First Intervention||27
269553|NCT00393042|654479|P1|COMPLETED|First Intervention||26
269554|NCT00393042|654478|P2|Completed 25/30mg Dosage|First Intervention||27
269555|NCT00393042|654479|P1|Completed 25/30mg Dosage|First Intervention||27
269556|NCT00393042|654478|P2|Completed 20 mg Dosage|First Intervention||28
269557|NCT00393042|654479|P1|Completed 20 mg Dosage|First Intervention||26
269558|NCT00393042|654478|P2|Completed 10mg Dosage|First Intervention||29
269559|NCT00393042|654479|P1|Completed 10mg Dosage|First Intervention||29
269560|NCT00393042|654478|P2|Completed the Placebo Dosage|First Intervention||29
269561|NCT00393042|654479|P1|Completed the Placebo Dosage|First Intervention||27
269562|NCT00393042|654478|P2|STARTED|First Intervention||33
269563|NCT00393042|654479|P1|STARTED|First Intervention||31
269564|NCT00393029|654551|P2|NOT COMPLETED|Overall Study||1
269565|NCT00393029|654552|P1|NOT COMPLETED|Overall Study||0
269566|NCT00393029|654551|P2|COMPLETED|Overall Study||9
269567|NCT00393029|654552|P1|COMPLETED|Overall Study||2
269568|NCT00393029|654551|P2|STARTED|Overall Study||10
269569|NCT00393029|654552|P1|STARTED|Overall Study||2
269570|NCT00392951|654561|P1|NOT COMPLETED|Overall Study||0
269571|NCT00392951|654561|P1|COMPLETED|Overall Study||30
269572|NCT00392951|654561|P1|STARTED|Overall Study||30
269573|NCT00392925|654573|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
269574|NCT00392925|654574|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
269575|NCT00392925|654575|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
269576|NCT00392925|654576|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
269577|NCT00392925|654573|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
269578|NCT00392925|654574|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
269579|NCT00392925|654575|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
269580|NCT00392925|654576|P1|COMPLETED|Randomization to Treatment Group Period||0
269581|NCT00392925|654573|P4|STARTED|Randomization to Treatment Group Period||56
269582|NCT00392925|654574|P3|STARTED|Randomization to Treatment Group Period||56
269583|NCT00392925|654575|P2|STARTED|Randomization to Treatment Group Period||27
269584|NCT00392925|654576|P1|STARTED|Randomization to Treatment Group Period||0
269585|NCT00392925|654573|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
269586|NCT00392925|654574|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
269587|NCT00392925|654575|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
269588|NCT00392925|654576|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
269589|NCT00392925|654573|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
269590|NCT00392925|654574|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
269591|NCT00392925|654575|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
269592|NCT00392925|654576|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
269593|NCT00392925|654573|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
269594|NCT00392925|654574|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
269595|NCT00392925|654575|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
269596|NCT00392925|654576|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
269597|NCT00392860|654664|P3|NOT COMPLETED|Overall Study||0
269598|NCT00392860|654665|P2|NOT COMPLETED|Overall Study||0
269599|NCT00392860|654666|P1|NOT COMPLETED|Overall Study||0
269600|NCT00392860|654664|P3|COMPLETED|Overall Study||1
269601|NCT00392860|654665|P2|COMPLETED|Overall Study||0
269602|NCT00392860|654666|P1|COMPLETED|Overall Study||3
269603|NCT00392860|654664|P3|STARTED|Overall Study||1
269604|NCT00392860|654665|P2|STARTED|Overall Study||0
269605|NCT00392860|654666|P1|STARTED|Overall Study||3
269606|NCT00392834|654674|P2|NOT COMPLETED|Overall Study||0
269607|NCT00392834|654675|P1|NOT COMPLETED|Overall Study||0
269608|NCT00392834|654674|P2|COMPLETED|Overall Study||32
269609|NCT00392834|654675|P1|COMPLETED|Overall Study||2
269610|NCT00392834|654674|P2|STARTED|Overall Study||32
269611|NCT00392834|654675|P1|STARTED|Overall Study||2
269612|NCT00392821|654681|P1|NOT COMPLETED|Overall Study||19
269613|NCT00392821|654681|P1|COMPLETED|Overall Study||59
269614|NCT00392821|654681|P1|STARTED|Overall Study||78
269615|NCT00392808|654690|P4|NOT COMPLETED|Overall Study||4
269616|NCT00392808|654691|P3|NOT COMPLETED|Overall Study||2
269617|NCT00392808|654692|P2|NOT COMPLETED|Overall Study||3
269618|NCT00392808|654693|P1|NOT COMPLETED|Overall Study||6
269619|NCT00392808|654690|P4|COMPLETED|Overall Study||100
269620|NCT00392808|654691|P3|COMPLETED|Overall Study||107
269621|NCT00392808|654692|P2|COMPLETED|Overall Study||86
269622|NCT00392808|654693|P1|COMPLETED|Overall Study||81
269623|NCT00392808|654690|P4|STARTED|Overall Study||104
269624|NCT00392808|654691|P3|STARTED|Overall Study||109
269625|NCT00392808|654692|P2|STARTED|Overall Study||89
269626|NCT00392808|654693|P1|STARTED|Overall Study||87
269627|NCT00392782|654707|P1|NOT COMPLETED|Overall Study||0
269628|NCT00392782|654707|P1|COMPLETED|Overall Study||24
269629|NCT00392782|654707|P1|STARTED|Overall Study||24
269630|NCT00392769|654717|P1|NOT COMPLETED|Overall Study||10
269631|NCT00392769|654717|P1|COMPLETED|Overall Study||23
269632|NCT00392769|654717|P1|STARTED|Overall Study||33
269633|NCT00392704|654721|P1|NOT COMPLETED|Combined Modality Therapy||5
269634|NCT00392704|654721|P1|COMPLETED|Combined Modality Therapy||49
269635|NCT00392704|654721|P1|STARTED|Combined Modality Therapy||54
269636|NCT00392704|654721|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
269637|NCT00392704|654721|P1|COMPLETED|Neoadjuvant Chemotherapy||54
269638|NCT00392704|654721|P1|STARTED|Neoadjuvant Chemotherapy||60
269639|NCT00392678|654730|P4|NOT COMPLETED|Overall Study||1
269640|NCT00392678|654731|P3|NOT COMPLETED|Overall Study||2
269641|NCT00392678|654732|P2|NOT COMPLETED|Overall Study||1
269642|NCT00392678|654733|P1|NOT COMPLETED|Overall Study||0
269643|NCT00392678|654730|P4|COMPLETED|Overall Study||26
269644|NCT00392678|654731|P3|COMPLETED|Overall Study||25
269645|NCT00392678|654732|P2|COMPLETED|Overall Study||26
269646|NCT00392678|654733|P1|COMPLETED|Overall Study||27
269647|NCT00392678|654730|P4|STARTED|Overall Study||27
269648|NCT00392678|654731|P3|STARTED|Overall Study||27
269649|NCT00392678|654732|P2|STARTED|Overall Study||27
269650|NCT00392678|654733|P1|STARTED|Overall Study||27
269651|NCT00392665|654769|P2|NOT COMPLETED|Overall Study||15
269652|NCT00392665|654770|P1|NOT COMPLETED|Overall Study||17
269653|NCT00392665|654769|P2|COMPLETED|Overall Study||3
269654|NCT00392665|654770|P1|COMPLETED|Overall Study||1
269655|NCT00392665|654769|P2|STARTED|Overall Study||18
269656|NCT00392665|654770|P1|STARTED|Overall Study||18
269657|NCT00392496|654782|P1|NOT COMPLETED|Overall Study||0
269658|NCT00392496|654782|P1|COMPLETED|Overall Study||19
269659|NCT00392496|654782|P1|STARTED|Overall Study||19
269660|NCT00392444|654786|P1|NOT COMPLETED|Overall Study||0
269661|NCT00392444|654786|P1|COMPLETED|Overall Study||39
269662|NCT00392444|654786|P1|STARTED|Overall Study||39
269663|NCT00392392|654790|P1|NOT COMPLETED|Overall Study||20
269664|NCT00392392|654790|P1|COMPLETED|Overall Study||9
269665|NCT00392392|654790|P1|STARTED|Overall Study||29
269666|NCT00392379|654796|P2|NOT COMPLETED|Overall Study||38
269667|NCT00392379|654797|P1|NOT COMPLETED|Overall Study||22
269668|NCT00392379|654796|P2|COMPLETED|Overall Study|Medication period|96
269669|NCT00392379|654797|P1|COMPLETED|Overall Study|Medication period|114
269670|NCT00392379|654796|P2|STARTED|Overall Study|Medication period|134
269671|NCT00392379|654797|P1|STARTED|Overall Study|Medication period|136
269672|NCT00392288|654810|P3|NOT COMPLETED|Overall Study||17
269673|NCT00392288|654811|P2|NOT COMPLETED|Overall Study||22
269674|NCT00392288|654812|P1|NOT COMPLETED|Overall Study||32
269675|NCT00392288|654810|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
269676|NCT00392288|654811|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
269677|NCT00392288|654812|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
269678|NCT00392288|654810|P3|Treatment Period|Overall Study||175
269679|NCT00392288|654811|P2|Treatment Period|Overall Study||174
269680|NCT00392288|654812|P1|Treatment Period|Overall Study||172
269681|NCT00392288|654810|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
269682|NCT00392288|654811|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
269683|NCT00392288|654812|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
269684|NCT00392236|654828|P2|NOT COMPLETED|Overall Study||6
269685|NCT00392236|654829|P1|NOT COMPLETED|Overall Study||12
269686|NCT00392236|654828|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
269687|NCT00392236|654829|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
269688|NCT00392236|654828|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
269689|NCT00392236|654829|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
269690|NCT00392223|654837|P2|NOT COMPLETED|Overall Study||13
269691|NCT00392223|654838|P1|NOT COMPLETED|Overall Study||9
269692|NCT00392223|654837|P2|COMPLETED|Overall Study||47
269693|NCT00392223|654838|P1|COMPLETED|Overall Study||49
269694|NCT00392223|654837|P2|STARTED|Overall Study||60
269695|NCT00392223|654838|P1|STARTED|Overall Study||58
269696|NCT00392210|654856|P2|NOT COMPLETED|Second Voiding Trial||0
269697|NCT00392210|654857|P1|NOT COMPLETED|Second Voiding Trial||0
269698|NCT00392210|654856|P2|COMPLETED|Second Voiding Trial||31
269699|NCT00392210|654857|P1|COMPLETED|Second Voiding Trial||34
269700|NCT00392210|654856|P2|STARTED|Second Voiding Trial||31
269701|NCT00392210|654857|P1|STARTED|Second Voiding Trial||34
269702|NCT00392210|654856|P2|NOT COMPLETED|First Voiding Trial||2
269703|NCT00392210|654857|P1|NOT COMPLETED|First Voiding Trial||2
269704|NCT00392210|654856|P2|COMPLETED|First Voiding Trial||31
269705|NCT00392210|654857|P1|COMPLETED|First Voiding Trial||34
269706|NCT00392210|654856|P2|STARTED|First Voiding Trial||33
269707|NCT00392210|654857|P1|STARTED|First Voiding Trial||36
269708|NCT00392197|654865|P2|NOT COMPLETED|Overall Study||30
269709|NCT00392197|654866|P1|NOT COMPLETED|Overall Study||21
269710|NCT00392197|654865|P2|COMPLETED|Overall Study||33
269711|NCT00392197|654866|P1|COMPLETED|Overall Study||27
269712|NCT00392197|654865|P2|STARTED|Overall Study||63
269713|NCT00392197|654866|P1|STARTED|Overall Study||48
269714|NCT00392171|654874|P1|NOT COMPLETED|Overall Study||105
269715|NCT00392171|654874|P1|COMPLETED|Overall Study||15
269716|NCT00392171|654874|P1|STARTED|Overall Study||120
269717|NCT00391989|654878|P1|NOT COMPLETED|Overall Study||2
269718|NCT00391989|654878|P1|COMPLETED|Overall Study||53
269719|NCT00391989|654878|P1|STARTED|Overall Study||55
269720|NCT00391976|654885|P3|NOT COMPLETED|Overall Study||35
269721|NCT00391976|654886|P2|NOT COMPLETED|Overall Study||25
269722|NCT00391976|654887|P1|NOT COMPLETED|Overall Study||27
269723|NCT00391976|654885|P3|COMPLETED|Overall Study||0
269724|NCT00391976|654886|P2|COMPLETED|Overall Study||18
269725|NCT00391976|654887|P1|COMPLETED|Overall Study||18
269726|NCT00391976|654885|P3|Safety Population|Overall Study||35
269727|NCT00391976|654886|P2|Safety Population|Overall Study||43
269728|NCT00391976|654887|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
269729|NCT00391976|654885|P3|Randomized|Overall Study||0
269730|NCT00391976|654886|P2|Randomized|Overall Study||43
269731|NCT00391976|654887|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
269732|NCT00391976|654885|P3|STARTED|Overall Study||35
269733|NCT00391976|654886|P2|STARTED|Overall Study||43
269734|NCT00391976|654887|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
269735|NCT00391898|654911|P2|NOT COMPLETED|Overall Study||10
269736|NCT00391898|654912|P1|NOT COMPLETED|Overall Study||11
269737|NCT00391898|654911|P2|COMPLETED|Overall Study||39
269738|NCT00391898|654912|P1|COMPLETED|Overall Study||35
269739|NCT00391898|654911|P2|STARTED|Overall Study||49
269740|NCT00391898|654912|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
269741|NCT00391872|654932|P2|NOT COMPLETED|Overall Study||255
269742|NCT00391872|654933|P1|NOT COMPLETED|Overall Study||307
269743|NCT00391872|654932|P2|COMPLETED|Overall Study||9036
269744|NCT00391872|654933|P1|COMPLETED|Overall Study||9026
269745|NCT00391872|654932|P2|STARTED|Overall Study||9291
269746|NCT00391872|654933|P1|STARTED|Overall Study||9333
269747|NCT00391846|654971|P2|NOT COMPLETED|Overall Study||7
269748|NCT00391846|654972|P1|NOT COMPLETED|Overall Study||8
269749|NCT00391846|654971|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
269750|NCT00391846|654972|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
269751|NCT00391846|654971|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
269752|NCT00391846|654972|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
269753|NCT00391807|654992|P1|NOT COMPLETED|Overall Study||715
269754|NCT00391807|654992|P1|COMPLETED|Overall Study||968
269755|NCT00391807|654992|P1|STARTED|Overall Study||1683
269756|NCT00391768|655019|P7|NOT COMPLETED|Overall Study||4
269757|NCT00391768|655020|P6|NOT COMPLETED|Overall Study||3
269758|NCT00391768|655021|P5|NOT COMPLETED|Overall Study||2
269759|NCT00391768|655022|P4|NOT COMPLETED|Overall Study||1
269760|NCT00391768|655023|P3|NOT COMPLETED|Overall Study||1
269761|NCT00391768|655024|P2|NOT COMPLETED|Overall Study||0
269762|NCT00391768|655025|P1|NOT COMPLETED|Overall Study||0
269763|NCT00391768|655019|P7|COMPLETED|Overall Study||19
269764|NCT00391768|655020|P6|COMPLETED|Overall Study||7
269765|NCT00391768|655021|P5|COMPLETED|Overall Study||22
269766|NCT00391768|655022|P4|COMPLETED|Overall Study||7
269767|NCT00391768|655023|P3|COMPLETED|Overall Study||6
269768|NCT00391768|655024|P2|COMPLETED|Overall Study||3
269769|NCT00391768|655025|P1|COMPLETED|Overall Study||12
269770|NCT00391768|655019|P7|STARTED|Overall Study||23
269771|NCT00391768|655020|P6|STARTED|Overall Study||10
269772|NCT00391768|655021|P5|STARTED|Overall Study||24
269773|NCT00391768|655022|P4|STARTED|Overall Study||8
269774|NCT00391768|655023|P3|STARTED|Overall Study||7
269775|NCT00391768|655024|P2|STARTED|Overall Study||3
269776|NCT00391768|655025|P1|STARTED|Overall Study||12
269777|NCT00391716|655093|P3|NOT COMPLETED|Overall Study||19
269778|NCT00391716|655094|P2|NOT COMPLETED|Overall Study||19
269779|NCT00391716|655095|P1|NOT COMPLETED|Overall Study||27
269780|NCT00391716|655093|P3|COMPLETED|Overall Study||30
269781|NCT00391716|655094|P2|COMPLETED|Overall Study||28
269782|NCT00391716|655095|P1|COMPLETED|Overall Study||27
269783|NCT00391716|655093|P3|STARTED|Overall Study||49
269784|NCT00391716|655094|P2|STARTED|Overall Study||47
269785|NCT00391716|655095|P1|STARTED|Overall Study||54
269786|NCT00391625|655112|P1|NOT COMPLETED|Month 84||0
269787|NCT00391625|655112|P1|COMPLETED|Month 84||8
269788|NCT00391625|655112|P1|STARTED|Month 84||8
269789|NCT00391625|655112|P1|NOT COMPLETED|Month 50||1
269790|NCT00391625|655112|P1|COMPLETED|Month 50||8
269791|NCT00391625|655112|P1|STARTED|Month 50||9
269792|NCT00391625|655112|P1|NOT COMPLETED|Month 14||1
269793|NCT00391625|655112|P1|COMPLETED|Month 14||9
269794|NCT00391625|655112|P1|STARTED|Month 14||10
269795|NCT00391625|655112|P1|NOT COMPLETED|Baseline||0
269796|NCT00391625|655112|P1|COMPLETED|Baseline||10
269797|NCT00391625|655112|P1|STARTED|Baseline||10
269798|NCT00391599|655154|P2|NOT COMPLETED|Overall Study||0
269799|NCT00391599|655155|P1|NOT COMPLETED|Overall Study||0
269800|NCT00391599|655154|P2|COMPLETED|Overall Study||65
269801|NCT00391599|655155|P1|COMPLETED|Overall Study||65
269802|NCT00391599|655154|P2|STARTED|Overall Study||65
269803|NCT00391599|655155|P1|STARTED|Overall Study||65
269804|NCT00391586|655165|P1|NOT COMPLETED|Overall Study||24
269805|NCT00391586|655165|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
269806|NCT00391586|655165|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
269807|NCT00391586|655165|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
269808|NCT00391586|655165|P1|STARTED|Overall Study||45
269809|NCT00391469|655174|P2|NOT COMPLETED|Overall Study||0
269810|NCT00391469|655175|P1|NOT COMPLETED|Overall Study||0
269811|NCT00391469|655174|P2|COMPLETED|Overall Study||671
269812|NCT00391469|655175|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
269813|NCT00391469|655174|P2|STARTED|Overall Study||671
269814|NCT00391469|655175|P1|STARTED|Overall Study||688
269815|NCT00391443|655189|P2|NOT COMPLETED|Overall Study||0
269816|NCT00391443|655190|P1|NOT COMPLETED|Overall Study||0
269817|NCT00391443|655189|P2|COMPLETED|Overall Study||407
269818|NCT00391443|655190|P1|COMPLETED|Overall Study||209
269819|NCT00391443|655189|P2|STARTED|Overall Study||407
269820|NCT00391443|655190|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
269821|NCT00391391|655202|P4|NOT COMPLETED|Overall Study||19
269822|NCT00391391|655203|P3|NOT COMPLETED|Overall Study||23
269823|NCT00391391|655204|P2|NOT COMPLETED|Overall Study||10
269824|NCT00391391|655205|P1|NOT COMPLETED|Overall Study||9
269825|NCT00391391|655202|P4|COMPLETED|Overall Study||145
269826|NCT00391391|655203|P3|COMPLETED|Overall Study||138
269827|NCT00391391|655204|P2|COMPLETED|Overall Study||87
269828|NCT00391391|655205|P1|COMPLETED|Overall Study||89
269829|NCT00391391|655202|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
269830|NCT00391391|655203|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
269831|NCT00391391|655204|P2|STARTED|Overall Study||97
269832|NCT00391391|655205|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
269833|NCT00391365|655237|P2|NOT COMPLETED|Overall Study||19
269834|NCT00391365|655238|P1|NOT COMPLETED|Overall Study||25
269835|NCT00391365|655237|P2|COMPLETED|Overall Study||151
269836|NCT00391365|655238|P1|COMPLETED|Overall Study||78
269837|NCT00391365|655237|P2|STARTED|Overall Study||170
269838|NCT00391365|655238|P1|STARTED|Overall Study||103
269839|NCT00391274|655250|P2|NOT COMPLETED|Overall Study||57
269840|NCT00391274|655251|P1|NOT COMPLETED|Overall Study||61
269841|NCT00391274|655250|P2|COMPLETED|Overall Study||47
269842|NCT00391274|655251|P1|COMPLETED|Overall Study||46
269843|NCT00391274|655250|P2|Received at Least One Dose of Study Drug|Overall Study||102
269844|NCT00391274|655251|P1|Received at Least One Dose of Study Drug|Overall Study||106
269845|NCT00391274|655250|P2|STARTED|Overall Study||104
269846|NCT00391274|655251|P1|STARTED|Overall Study||107
269847|NCT00391222|655270|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
269848|NCT00391222|655271|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
269849|NCT00391222|655272|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
269850|NCT00391222|655273|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
269851|NCT00391222|655270|P4|COMPLETED|Period III (Double-Blind Treatment)||0
269852|NCT00391222|655271|P3|COMPLETED|Period III (Double-Blind Treatment)||108
269853|NCT00391222|655272|P2|COMPLETED|Period III (Double-Blind Treatment)||113
269854|NCT00391222|655273|P1|COMPLETED|Period III (Double-Blind Treatment)||104
269855|NCT00391222|655270|P4|STARTED|Period III (Double-Blind Treatment)||0
269856|NCT00391222|655271|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
269857|NCT00391222|655272|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
269858|NCT00391222|655273|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
269859|NCT00391222|655270|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
269860|NCT00391222|655271|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
269861|NCT00391222|655272|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
269862|NCT00391222|655273|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
269863|NCT00391222|655270|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
269864|NCT00391222|655271|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
269865|NCT00391222|655272|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
269866|NCT00391222|655273|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
269867|NCT00391222|655270|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
269868|NCT00391222|655271|P3|STARTED|Period II (Open-label Risperidone LAI)||0
269869|NCT00391222|655272|P2|STARTED|Period II (Open-label Risperidone LAI)||0
269870|NCT00391222|655273|P1|STARTED|Period II (Open-label Risperidone LAI)||0
269871|NCT00391092|655299|P2|NOT COMPLETED|Overall Study||216
269872|NCT00391092|655300|P1|NOT COMPLETED|Overall Study||208
269873|NCT00391092|655299|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
269874|NCT00391092|655300|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
269875|NCT00391092|655299|P2|Received Treatment|Overall Study||215
269876|NCT00391092|655300|P1|Received Treatment|Overall Study||206
269877|NCT00391092|655299|P2|STARTED|Overall Study||216
269878|NCT00391092|655300|P1|STARTED|Overall Study||208
269879|NCT00391079|655320|P2|NOT COMPLETED|Overall Study||16
269880|NCT00391079|655321|P1|NOT COMPLETED|Overall Study||26
269881|NCT00391079|655320|P2|COMPLETED|Overall Study||156
269882|NCT00391079|655321|P1|COMPLETED|Overall Study||141
269883|NCT00391079|655320|P2|STARTED|Overall Study||172
269884|NCT00391079|655321|P1|STARTED|Overall Study||167
269885|NCT00391053|655343|P4|NOT COMPLETED|Overall Study||10
269886|NCT00391053|655344|P3|NOT COMPLETED|Overall Study||2
269887|NCT00391053|655345|P2|NOT COMPLETED|Overall Study||1
269888|NCT00391053|655346|P1|NOT COMPLETED|Overall Study||9
269889|NCT00391053|655343|P4|COMPLETED|Overall Study||1252
269890|NCT00391053|655344|P3|COMPLETED|Overall Study||868
269891|NCT00391053|655345|P2|COMPLETED|Overall Study||847
269892|NCT00391053|655346|P1|COMPLETED|Overall Study||848
269893|NCT00391053|655343|P4|STARTED|Overall Study||1262
269894|NCT00391053|655344|P3|STARTED|Overall Study||870
269895|NCT00391053|655345|P2|STARTED|Overall Study||848
269896|NCT00391053|655346|P1|STARTED|Overall Study||857
269897|NCT00391027|655370|P2|NOT COMPLETED|Overall Study||12
269898|NCT00391027|655371|P1|NOT COMPLETED|Overall Study||25
269899|NCT00391027|655370|P2|COMPLETED|Overall Study||110
269900|NCT00391027|655371|P1|COMPLETED|Overall Study||110
269901|NCT00391027|655370|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
269902|NCT00391027|655371|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
269903|NCT00390884|655411|P2|NOT COMPLETED|Overall Study||2
269904|NCT00390884|655412|P1|NOT COMPLETED|Overall Study||2
269905|NCT00390884|655411|P2|COMPLETED|Overall Study||55
269906|NCT00390884|655412|P1|COMPLETED|Overall Study||114
269907|NCT00390884|655411|P2|STARTED|Overall Study||57
269908|NCT00390884|655412|P1|STARTED|Overall Study||116
269909|NCT00390858|655424|P2|NOT COMPLETED|Overall Study||7
269910|NCT00390858|655425|P1|NOT COMPLETED|Overall Study||9
269911|NCT00390858|655424|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
269912|NCT00390858|655425|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
269913|NCT00390858|655424|P2|Completed Core & Entered Extension Study|Overall Study||20
269914|NCT00390858|655425|P1|Completed Core & Entered Extension Study|Overall Study||19
269915|NCT00390858|655424|P2|STARTED|Overall Study|20 Participants started the Core Study|20
269916|NCT00390858|655425|P1|STARTED|Overall Study|20 participants started the Core Study|20
269917|NCT00390806|655439|P2|NOT COMPLETED|Overall Study||32
269918|NCT00390806|655440|P1|NOT COMPLETED|Overall Study||30
269919|NCT00390806|655439|P2|COMPLETED|Overall Study||204
269920|NCT00390806|655440|P1|COMPLETED|Overall Study||206
269921|NCT00390806|655439|P2|Ongoing|Overall Study||2
269922|NCT00390806|655440|P1|Ongoing|Overall Study||4
269923|NCT00390806|655439|P2|STARTED|Overall Study||236
269924|NCT00390806|655440|P1|STARTED|Overall Study||236
269925|NCT00390780|655508|P2|NOT COMPLETED|Overall Study||27
269926|NCT00390780|655509|P1|NOT COMPLETED|Overall Study||23
269927|NCT00390780|655508|P2|COMPLETED|Overall Study||260
269928|NCT00390780|655509|P1|COMPLETED|Overall Study||268
269929|NCT00390780|655508|P2|Treatment|Overall Study||287
269930|NCT00390780|655509|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
269931|NCT00390780|655508|P2|STARTED|Overall Study||287
269932|NCT00390780|655509|P1|STARTED|Overall Study||291
269933|NCT00390689|655542|P3|NOT COMPLETED|Overall Study||3
269934|NCT00390689|655543|P2|NOT COMPLETED|Overall Study||5
269935|NCT00390689|655544|P1|NOT COMPLETED|Overall Study||5
269936|NCT00390689|655542|P3|COMPLETED|Overall Study||50
269937|NCT00390689|655543|P2|COMPLETED|Overall Study||48
269938|NCT00390689|655544|P1|COMPLETED|Overall Study||43
269939|NCT00390689|655542|P3|STARTED|Overall Study||53
269940|NCT00390689|655543|P2|STARTED|Overall Study||53
269941|NCT00390689|655544|P1|STARTED|Overall Study||48
269942|NCT00390611|655604|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
269943|NCT00390611|655605|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
269944|NCT00390611|655604|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
269945|NCT00390611|655605|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
269946|NCT00390611|655604|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
269947|NCT00390611|655605|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
269948|NCT00390611|655604|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
269949|NCT00390611|655605|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
269950|NCT00390611|655604|P2|COMPLETED|6 Cycles of Study Treatment||37
269951|NCT00390611|655605|P1|COMPLETED|6 Cycles of Study Treatment||34
269952|NCT00390611|655604|P2|STARTED|6 Cycles of Study Treatment||42
269953|NCT00390611|655605|P1|STARTED|6 Cycles of Study Treatment||43
269954|NCT00390572|655619|P2|NOT COMPLETED|Overall Study||5
269955|NCT00390572|655620|P1|NOT COMPLETED|Overall Study||8
269956|NCT00390572|655619|P2|COMPLETED|Overall Study||64
269957|NCT00390572|655620|P1|COMPLETED|Overall Study||60
269958|NCT00390572|655619|P2|STARTED|Overall Study||69
269959|NCT00390572|655620|P1|STARTED|Overall Study||68
269960|NCT00390559|655634|P1|NOT COMPLETED|Overall Study||44
269961|NCT00390559|655634|P1|COMPLETED|Overall Study||80
269962|NCT00390559|655634|P1|ActiveP/PlaceboC|Overall Study||90
269963|NCT00390559|655634|P1|PlaceboP/PlaceboC|Overall Study||93
269964|NCT00390559|655634|P1|ActiveP/ActiveC|Overall Study||87
269965|NCT00390559|655634|P1|Received PlaceboP/Active C|Overall Study||93
269966|NCT00390559|655634|P1|STARTED|Overall Study||124
269967|NCT00390546|655646|P2|NOT COMPLETED|Overall Study||5
269968|NCT00390546|655647|P1|NOT COMPLETED|Overall Study||6
269969|NCT00390546|655646|P2|COMPLETED|Overall Study||34
269970|NCT00390546|655647|P1|COMPLETED|Overall Study||27
269971|NCT00390546|655646|P2|STARTED|Overall Study||39
269972|NCT00390546|655647|P1|STARTED|Overall Study||33
269973|NCT00390468|655657|P1|NOT COMPLETED|Overall Study||3
269974|NCT00390468|655657|P1|COMPLETED|Overall Study||15
269975|NCT00390468|655657|P1|STARTED|Overall Study||18
269976|NCT00390455|655663|P2|NOT COMPLETED|Overall Study||23
269977|NCT00390455|655664|P1|NOT COMPLETED|Overall Study||32
269978|NCT00390455|655663|P2|COMPLETED|Overall Study||124
269979|NCT00390455|655664|P1|COMPLETED|Overall Study||116
269980|NCT00390455|655663|P2|STARTED|Overall Study||147
269981|NCT00390455|655664|P1|STARTED|Overall Study||148
269982|NCT00390429|655685|P4|NOT COMPLETED|Overall Study||0
269983|NCT00390429|655686|P3|NOT COMPLETED|Overall Study||0
269984|NCT00390429|655687|P2|NOT COMPLETED|Overall Study||0
269985|NCT00390429|655688|P1|NOT COMPLETED|Overall Study||0
269986|NCT00390429|655685|P4|COMPLETED|Overall Study||39
269987|NCT00390429|655686|P3|COMPLETED|Overall Study||25
269988|NCT00390429|655687|P2|COMPLETED|Overall Study||12
269989|NCT00390429|655688|P1|COMPLETED|Overall Study||5
269990|NCT00390429|655685|P4|STARTED|Overall Study||39
269991|NCT00390429|655686|P3|STARTED|Overall Study||25
269992|NCT00390429|655687|P2|STARTED|Overall Study||12
269993|NCT00390429|655688|P1|STARTED|Overall Study||5
269994|NCT00390416|655704|P1|NOT COMPLETED|Overall Study||4
269995|NCT00390416|655704|P1|COMPLETED|Overall Study||44
269996|NCT00390416|655704|P1|STARTED|Overall Study||48
269997|NCT00390364|655710|P1|NOT COMPLETED|Overall Study||0
269998|NCT00390364|655710|P1|COMPLETED|Overall Study||1
269999|NCT00390364|655710|P1|STARTED|Overall Study||1
270000|NCT00390234|655714|P1|NOT COMPLETED|Overall Study||0
270001|NCT00390234|655714|P1|COMPLETED|Overall Study||63
270002|NCT00390234|655714|P1|STARTED|Overall Study||63
270003|NCT00390221|655725|P3|NOT COMPLETED|Overall Study||15
270004|NCT00390221|655726|P2|NOT COMPLETED|Overall Study||20
270005|NCT00390221|655727|P1|NOT COMPLETED|Overall Study||18
270006|NCT00390221|655725|P3|COMPLETED|Overall Study||194
270007|NCT00390221|655726|P2|COMPLETED|Overall Study||188
270008|NCT00390221|655727|P1|COMPLETED|Overall Study||186
270009|NCT00390221|655725|P3|STARTED|Overall Study||209
270010|NCT00390221|655726|P2|STARTED|Overall Study||208
270011|NCT00390221|655727|P1|STARTED|Overall Study||204
270012|NCT00390182|655748|P1|NOT COMPLETED|Overall Study||5
270013|NCT00390182|655748|P1|COMPLETED|Overall Study||33
270014|NCT00390182|655748|P1|STARTED|Overall Study||38
270015|NCT00390013|655757|P4|NOT COMPLETED|Phase 2 Second Treatment||0
270016|NCT00390013|655758|P3|NOT COMPLETED|Phase 2 Second Treatment||0
270017|NCT00390013|655759|P2|NOT COMPLETED|Phase 2 Second Treatment||0
270018|NCT00390013|655760|P1|NOT COMPLETED|Phase 2 Second Treatment||0
270019|NCT00390013|655757|P4|COMPLETED|Phase 2 Second Treatment||0
270020|NCT00390013|655758|P3|COMPLETED|Phase 2 Second Treatment||0
270021|NCT00390013|655759|P2|COMPLETED|Phase 2 Second Treatment||1
270022|NCT00390013|655760|P1|COMPLETED|Phase 2 Second Treatment||2
270023|NCT00390013|655757|P4|STARTED|Phase 2 Second Treatment||0
270024|NCT00390013|655758|P3|STARTED|Phase 2 Second Treatment||0
270025|NCT00390013|655759|P2|STARTED|Phase 2 Second Treatment||1
270026|NCT00390013|655760|P1|STARTED|Phase 2 Second Treatment||2
270027|NCT00390013|655757|P4|NOT COMPLETED|Phase 2 First Treatment||0
270028|NCT00390013|655758|P3|NOT COMPLETED|Phase 2 First Treatment||0
270029|NCT00390013|655759|P2|NOT COMPLETED|Phase 2 First Treatment||1
270030|NCT00390013|655760|P1|NOT COMPLETED|Phase 2 First Treatment||1
270031|NCT00390013|655757|P4|COMPLETED|Phase 2 First Treatment||0
270032|NCT00390013|655758|P3|COMPLETED|Phase 2 First Treatment||0
270033|NCT00390013|655759|P2|COMPLETED|Phase 2 First Treatment||1
270034|NCT00390013|655760|P1|COMPLETED|Phase 2 First Treatment||2
270035|NCT00390013|655757|P4|STARTED|Phase 2 First Treatment||0
270036|NCT00390013|655758|P3|STARTED|Phase 2 First Treatment||0
270037|NCT00390013|655759|P2|STARTED|Phase 2 First Treatment||2
270038|NCT00390013|655760|P1|STARTED|Phase 2 First Treatment||3
270039|NCT00390013|655757|P4|NOT COMPLETED|Phase 1||1
270040|NCT00390013|655758|P3|NOT COMPLETED|Phase 1||0
270041|NCT00390013|655759|P2|NOT COMPLETED|Phase 1||0
270042|NCT00390013|655760|P1|NOT COMPLETED|Phase 1||0
270043|NCT00390013|655757|P4|COMPLETED|Phase 1||1
270044|NCT00390013|655758|P3|COMPLETED|Phase 1||2
270045|NCT00390013|655759|P2|COMPLETED|Phase 1||0
270046|NCT00390013|655760|P1|COMPLETED|Phase 1||0
270047|NCT00390013|655757|P4|STARTED|Phase 1||2
270048|NCT00390013|655758|P3|STARTED|Phase 1||2
270049|NCT00390013|655759|P2|STARTED|Phase 1||0
270050|NCT00390013|655760|P1|STARTED|Phase 1||0
270051|NCT00389974|655766|P1|NOT COMPLETED|Overall Study||0
270052|NCT00389974|655766|P1|COMPLETED|Overall Study||19
270053|NCT00389974|655766|P1|STARTED|Overall Study||19
270054|NCT00389857|655772|P2|NOT COMPLETED|Overall Study||0
270055|NCT00389857|655773|P1|NOT COMPLETED|Overall Study||0
270056|NCT00389857|655772|P2|COMPLETED|Overall Study||17
270057|NCT00389857|655773|P1|COMPLETED|Overall Study||14
270058|NCT00389857|655772|P2|STARTED|Overall Study||17
270059|NCT00389857|655773|P1|STARTED|Overall Study||14
270060|NCT00389831|655785|P2|NOT COMPLETED|Overall Study||7
270061|NCT00389831|655786|P1|NOT COMPLETED|Overall Study||0
270062|NCT00389831|655785|P2|COMPLETED|Overall Study||27
270063|NCT00389831|655786|P1|COMPLETED|Overall Study||10
270064|NCT00389831|655785|P2|STARTED|Overall Study||34
270065|NCT00389831|655786|P1|STARTED|Overall Study||10
270066|NCT00389818|655812|P1|NOT COMPLETED|Overall Study||3
270067|NCT00389818|655812|P1|COMPLETED|Overall Study||40
270068|NCT00389818|655812|P1|STARTED|Overall Study||43
270069|NCT00389805|655818|P2|NOT COMPLETED|Phase II||0
270070|NCT00389805|655819|P1|NOT COMPLETED|Phase II||0
270071|NCT00389805|655818|P2|COMPLETED|Phase II||0
270072|NCT00389805|655819|P1|COMPLETED|Phase II||0
270073|NCT00389805|655818|P2|STARTED|Phase II|The Phase II study was not conducted.|0
270074|NCT00389805|655819|P1|STARTED|Phase II|The Phase II study was not conducted.|0
270075|NCT00389805|655818|P2|NOT COMPLETED|Phase I||0
270076|NCT00389805|655819|P1|NOT COMPLETED|Phase I||0
270077|NCT00389805|655818|P2|COMPLETED|Phase I||12
270078|NCT00389805|655819|P1|COMPLETED|Phase I||15
270079|NCT00389805|655818|P2|STARTED|Phase I||12
270080|NCT00389805|655819|P1|STARTED|Phase I||15
270081|NCT00389597|655849|P4|NOT COMPLETED|Overall Study||6
270082|NCT00389597|655850|P3|NOT COMPLETED|Overall Study||4
270083|NCT00389597|655851|P2|NOT COMPLETED|Overall Study||6
270084|NCT00389597|655852|P1|NOT COMPLETED|Overall Study||8
270085|NCT00389597|655849|P4|COMPLETED|Overall Study||99
270086|NCT00389597|655850|P3|COMPLETED|Overall Study||221
270087|NCT00389597|655851|P2|COMPLETED|Overall Study||75
270088|NCT00389597|655852|P1|COMPLETED|Overall Study||156
270089|NCT00389597|655849|P4|24 mo|Overall Study||99
270090|NCT00389597|655850|P3|24 mo|Overall Study||221
270091|NCT00389597|655851|P2|24 mo|Overall Study||75
270092|NCT00389597|655852|P1|24 mo|Overall Study||156
270093|NCT00389597|655849|P4|STARTED|Overall Study||105
270094|NCT00389597|655850|P3|STARTED|Overall Study||225
270095|NCT00389597|655851|P2|STARTED|Overall Study||81
270096|NCT00389597|655852|P1|STARTED|Overall Study||164
270097|NCT00389532|655864|P2|NOT COMPLETED|Overall Study||0
270098|NCT00389532|655865|P1|NOT COMPLETED|Overall Study||0
270099|NCT00389532|655864|P2|COMPLETED|Overall Study||56
270100|NCT00389532|655865|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
270101|NCT00389532|655864|P2|STARTED|Overall Study||56
270102|NCT00389532|655865|P1|STARTED|Overall Study||60
270103|NCT00389519|655877|P4|NOT COMPLETED|Treated||4
270104|NCT00389519|655878|P3|NOT COMPLETED|Treated||0
270105|NCT00389519|655879|P2|NOT COMPLETED|Treated||1
270106|NCT00389519|655880|P1|NOT COMPLETED|Treated||2
270107|NCT00389519|655877|P4|COMPLETED|Treated||76
270108|NCT00389519|655878|P3|COMPLETED|Treated||40
270109|NCT00389519|655879|P2|COMPLETED|Treated||40
270110|NCT00389519|655880|P1|COMPLETED|Treated||79
270111|NCT00389519|655877|P4|STARTED|Treated||80
270112|NCT00389519|655878|P3|STARTED|Treated||40
270113|NCT00389519|655879|P2|STARTED|Treated||41
270114|NCT00389519|655880|P1|STARTED|Treated||81
270115|NCT00389519|655877|P4|NOT COMPLETED|Randomized||0
270116|NCT00389519|655878|P3|NOT COMPLETED|Randomized||0
270117|NCT00389519|655879|P2|NOT COMPLETED|Randomized||0
270118|NCT00389519|655880|P1|NOT COMPLETED|Randomized||2
270119|NCT00389519|655877|P4|COMPLETED|Randomized||80
270120|NCT00389519|655878|P3|COMPLETED|Randomized||40
270121|NCT00389519|655879|P2|COMPLETED|Randomized||41
270122|NCT00389519|655880|P1|COMPLETED|Randomized||81
270123|NCT00389519|655877|P4|STARTED|Randomized||80
270124|NCT00389519|655878|P3|STARTED|Randomized||40
270125|NCT00389519|655879|P2|STARTED|Randomized||41
270126|NCT00389519|655880|P1|STARTED|Randomized||83
270127|NCT00389519|655877|P4|NOT COMPLETED|Placebo Run-In||0
270128|NCT00389519|655878|P3|NOT COMPLETED|Placebo Run-In||0
270129|NCT00389519|655879|P2|NOT COMPLETED|Placebo Run-In||0
270130|NCT00389519|655880|P1|NOT COMPLETED|Placebo Run-In||178
270131|NCT00389519|655877|P4|COMPLETED|Placebo Run-In||0
270132|NCT00389519|655878|P3|COMPLETED|Placebo Run-In||0
270133|NCT00389519|655879|P2|COMPLETED|Placebo Run-In||0
270134|NCT00389519|655880|P1|COMPLETED|Placebo Run-In||244
270135|NCT00389519|655877|P4|STARTED|Placebo Run-In||0
270136|NCT00389519|655878|P3|STARTED|Placebo Run-In||0
270137|NCT00389519|655879|P2|STARTED|Placebo Run-In||0
270138|NCT00389519|655880|P1|STARTED|Placebo Run-In||422
270139|NCT00389493|655909|P3|NOT COMPLETED|Overall Study||3
270140|NCT00389493|655910|P2|NOT COMPLETED|Overall Study||8
270141|NCT00389493|655911|P1|NOT COMPLETED|Overall Study||3
270142|NCT00389493|655909|P3|COMPLETED|Overall Study||17
270143|NCT00389493|655910|P2|COMPLETED|Overall Study||32
270144|NCT00389493|655911|P1|COMPLETED|Overall Study||37
270145|NCT00389493|655909|P3|STARTED|Overall Study||20
270146|NCT00389493|655910|P2|STARTED|Overall Study||40
270147|NCT00389493|655911|P1|STARTED|Overall Study||40
270148|NCT00389467|655935|P4|NOT COMPLETED|Overall Study||0
270149|NCT00389467|655936|P3|NOT COMPLETED|Overall Study||0
270150|NCT00389467|655937|P2|NOT COMPLETED|Overall Study||0
270151|NCT00389467|655938|P1|NOT COMPLETED|Overall Study||0
270152|NCT00389467|655935|P4|COMPLETED|Overall Study||20
270153|NCT00389467|655936|P3|COMPLETED|Overall Study||30
270154|NCT00389467|655937|P2|COMPLETED|Overall Study||34
270155|NCT00389467|655938|P1|COMPLETED|Overall Study||34
270156|NCT00389467|655935|P4|STARTED|Overall Study||20
270157|NCT00389467|655936|P3|STARTED|Overall Study||30
270158|NCT00389467|655937|P2|STARTED|Overall Study||34
270159|NCT00389467|655938|P1|STARTED|Overall Study||34
270160|NCT00389441|655957|P1|NOT COMPLETED|Overall Study||52
270161|NCT00389441|655957|P1|COMPLETED|Overall Study||0
270162|NCT00389441|655957|P1|STARTED|Overall Study||52
270163|NCT00389324|655966|P1|NOT COMPLETED|Subcutaneous Phase||7
270164|NCT00389324|655966|P1|COMPLETED|Subcutaneous Phase||25
270165|NCT00389324|655966|P1|STARTED|Subcutaneous Phase||32
270166|NCT00389324|655966|P1|NOT COMPLETED|Intravenous Phase||0
270167|NCT00389324|655966|P1|COMPLETED|Intravenous Phase||32
270168|NCT00389324|655966|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
270169|NCT00389324|655966|P1|NOT COMPLETED|Run-In Phase||3
270170|NCT00389324|655966|P1|COMPLETED|Run-In Phase||18
270171|NCT00389324|655966|P1|STARTED|Run-In Phase||21
270172|NCT00389207|655976|P3|NOT COMPLETED|Overall Study||41
270173|NCT00389207|655977|P2|NOT COMPLETED|Overall Study||72
270174|NCT00389207|655978|P1|NOT COMPLETED|Overall Study||63
270175|NCT00389207|655976|P3|COMPLETED|Overall Study||152
270176|NCT00389207|655977|P2|COMPLETED|Overall Study||116
270177|NCT00389207|655978|P1|COMPLETED|Overall Study||125
270178|NCT00389207|655976|P3|STARTED|Overall Study||193
270179|NCT00389207|655977|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
270180|NCT00389207|655978|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
270181|NCT00389168|656082|P2|NOT COMPLETED|Overall Study||5
270182|NCT00389168|656083|P1|NOT COMPLETED|Overall Study||9
270183|NCT00389168|656082|P2|COMPLETED|Overall Study||53
270184|NCT00389168|656083|P1|COMPLETED|Overall Study||47
270185|NCT00389168|656082|P2|STARTED|Overall Study||58
270186|NCT00389168|656083|P1|STARTED|Overall Study||56
270187|NCT00389064|656101|P2|NOT COMPLETED|Overall Study||59
270188|NCT00389064|656102|P1|NOT COMPLETED|Overall Study||45
270189|NCT00389064|656101|P2|COMPLETED|Overall Study||168
270190|NCT00389064|656102|P1|COMPLETED|Overall Study||178
270191|NCT00389064|656101|P2|STARTED|Overall Study||227
270192|NCT00389064|656102|P1|STARTED|Overall Study||223
270193|NCT00388973|656130|P2|NOT COMPLETED|Overall Study||58
270194|NCT00388973|656131|P1|NOT COMPLETED|Overall Study||56
270195|NCT00388973|656130|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
270196|NCT00388973|656131|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
270197|NCT00388973|656130|P2|Completed Study|Overall Study||114
270198|NCT00388973|656131|P1|Completed Study|Overall Study||110
270199|NCT00388973|656130|P2|STARTED|Overall Study|Randomized|172
270200|NCT00388973|656131|P1|STARTED|Overall Study|Randomized|166
270201|NCT00388947|656151|P1|NOT COMPLETED|Overall Study||47
270202|NCT00388947|656151|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
270203|NCT00388947|656151|P1|STARTED|Overall Study||1590
270204|NCT00388804|656158|P2|NOT COMPLETED|Overall Study||0
270205|NCT00388804|656159|P1|NOT COMPLETED|Overall Study||0
270206|NCT00388804|656158|P2|COMPLETED|Overall Study||21
270207|NCT00388804|656159|P1|COMPLETED|Overall Study||17
270208|NCT00388804|656158|P2|STARTED|Overall Study||21
270209|NCT00388804|656159|P1|STARTED|Overall Study||17
270210|NCT00388726|656167|P2|NOT COMPLETED|Overall Study||244
270211|NCT00388726|656168|P1|NOT COMPLETED|Overall Study||484
270212|NCT00388726|656167|P2|COMPLETED|Overall Study||10
270213|NCT00388726|656168|P1|COMPLETED|Overall Study||24
270214|NCT00388726|656167|P2|STARTED|Overall Study||254
270215|NCT00388726|656168|P1|STARTED|Overall Study||508
270216|NCT00388583|656182|P2|NOT COMPLETED|Overall Study||4
270217|NCT00388583|656183|P1|NOT COMPLETED|Overall Study||6
270218|NCT00388583|656182|P2|COMPLETED|Overall Study||406
270219|NCT00388583|656183|P1|COMPLETED|Overall Study||401
270220|NCT00388583|656182|P2|STARTED|Overall Study||410
270221|NCT00388583|656183|P1|STARTED|Overall Study||407
270222|NCT00388505|656197|P2|NOT COMPLETED|Overall Study||38
270223|NCT00388505|656198|P1|NOT COMPLETED|Overall Study||83
270224|NCT00388505|656197|P2|COMPLETED|Overall Study||171
270225|NCT00388505|656198|P1|COMPLETED|Overall Study||225
270226|NCT00388505|656197|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
270227|NCT00388505|656198|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
270228|NCT00388453|656223|P3|NOT COMPLETED|Overall Study||0
270229|NCT00388453|656224|P2|NOT COMPLETED|Overall Study||0
270230|NCT00388453|656225|P1|NOT COMPLETED|Overall Study||0
270231|NCT00388453|656223|P3|COMPLETED|Overall Study||10
270232|NCT00388453|656224|P2|COMPLETED|Overall Study||17
270233|NCT00388453|656225|P1|COMPLETED|Overall Study||20
270234|NCT00388453|656223|P3|STARTED|Overall Study||10
270235|NCT00388453|656224|P2|STARTED|Overall Study||17
270236|NCT00388453|656225|P1|STARTED|Overall Study||20
270237|NCT00388414|656244|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
270238|NCT00388414|656245|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
270239|NCT00388414|656244|P2|COMPLETED|Second Intervention (8 Weeks)||7
270240|NCT00388414|656245|P1|COMPLETED|Second Intervention (8 Weeks)||7
270241|NCT00388414|656244|P2|STARTED|Second Intervention (8 Weeks)||7
270242|NCT00388414|656245|P1|STARTED|Second Intervention (8 Weeks)||7
270243|NCT00388414|656244|P2|NOT COMPLETED|Washout (1 Week)||0
270244|NCT00388414|656245|P1|NOT COMPLETED|Washout (1 Week)||0
270245|NCT00388414|656244|P2|COMPLETED|Washout (1 Week)||7
270246|NCT00388414|656245|P1|COMPLETED|Washout (1 Week)||7
270247|NCT00388414|656244|P2|STARTED|Washout (1 Week)||7
270248|NCT00388414|656245|P1|STARTED|Washout (1 Week)||7
270249|NCT00388414|656244|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
270250|NCT00388414|656245|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
270251|NCT00388414|656244|P2|COMPLETED|First Intervention (8 Weeks)||7
270252|NCT00388414|656245|P1|COMPLETED|First Intervention (8 Weeks)||7
270253|NCT00388414|656244|P2|STARTED|First Intervention (8 Weeks)||7
270254|NCT00388414|656245|P1|STARTED|First Intervention (8 Weeks)||7
270255|NCT00388362|656253|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
270256|NCT00388362|656253|P1|COMPLETED|Remained on Study Median of 514 Days||21
270257|NCT00388362|656253|P1|STARTED|Remained on Study Median of 514 Days||23
270258|NCT00388362|656253|P1|NOT COMPLETED|Enrolled||13
270259|NCT00388362|656253|P1|COMPLETED|Enrolled||23
270260|NCT00388362|656253|P1|STARTED|Enrolled||36
270261|NCT00388349|656258|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
270262|NCT00388349|656259|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
270263|NCT00388349|656258|P2|COMPLETED|Phase 2 Dose Expansion||0
270264|NCT00388349|656259|P1|COMPLETED|Phase 2 Dose Expansion||139
270265|NCT00388349|656258|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
270266|NCT00388349|656259|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
270267|NCT00388349|656258|P2|NOT COMPLETED|Phase I Dose Escalation||3
270268|NCT00388349|656259|P1|NOT COMPLETED|Phase I Dose Escalation||0
270269|NCT00388349|656258|P2|COMPLETED|Phase I Dose Escalation||1
270270|NCT00388349|656259|P1|COMPLETED|Phase I Dose Escalation||3
270271|NCT00388349|656258|P2|STARTED|Phase I Dose Escalation||4
270272|NCT00388349|656259|P1|STARTED|Phase I Dose Escalation||3
270273|NCT00388154|656268|P1|NOT COMPLETED|Overall Study||1
270274|NCT00388154|656268|P1|COMPLETED|Overall Study||20
270275|NCT00388154|656268|P1|STARTED|Overall Study||21
270276|NCT00388037|656273|P1|NOT COMPLETED|Overall Study||1
270277|NCT00388037|656273|P1|COMPLETED|Overall Study||30
270278|NCT00388037|656273|P1|STARTED|Overall Study||31
270279|NCT00387959|656277|P1|NOT COMPLETED|Overall Study||1
270280|NCT00387959|656277|P1|COMPLETED|Overall Study||16
270281|NCT00387959|656277|P1|STARTED|Overall Study||17
270282|NCT00387894|656281|P1|NOT COMPLETED|Overall Study||1
270283|NCT00387894|656281|P1|COMPLETED|Overall Study||5
270284|NCT00387894|656281|P1|STARTED|Overall Study||6
270285|NCT00387881|656288|P2|NOT COMPLETED|Overall Study||102
270286|NCT00387881|656289|P1|NOT COMPLETED|Overall Study||89
270287|NCT00387881|656288|P2|COMPLETED|Overall Study||243
270288|NCT00387881|656289|P1|COMPLETED|Overall Study||245
270289|NCT00387881|656288|P2|STARTED|Overall Study||345
270290|NCT00387881|656289|P1|STARTED|Overall Study||334
270291|NCT00387829|656313|P2|NOT COMPLETED|Intent-to-treat Population||30
270292|NCT00387829|656314|P1|NOT COMPLETED|Intent-to-treat Population||38
270293|NCT00387829|656313|P2|COMPLETED|Intent-to-treat Population||136
270294|NCT00387829|656314|P1|COMPLETED|Intent-to-treat Population||139
270295|NCT00387829|656313|P2|STARTED|Intent-to-treat Population||166
270296|NCT00387829|656314|P1|STARTED|Intent-to-treat Population||177
270297|NCT00387829|656313|P2|NOT COMPLETED|Safety Population||33
270298|NCT00387829|656314|P1|NOT COMPLETED|Safety Population||39
270299|NCT00387829|656313|P2|COMPLETED|Safety Population||136
270300|NCT00387829|656314|P1|COMPLETED|Safety Population||139
270301|NCT00387829|656313|P2|STARTED|Safety Population||169
270302|NCT00387829|656314|P1|STARTED|Safety Population||178
270303|NCT00387790|656322|P1|NOT COMPLETED|Overall Study||14
270304|NCT00387790|656322|P1|COMPLETED|Overall Study||50
270305|NCT00387790|656322|P1|STARTED|Overall Study||64
270306|NCT00387764|656328|P1|NOT COMPLETED|Overall Study||31
270307|NCT00387764|656328|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
270308|NCT00387764|656328|P1|STARTED|Overall Study||80
270309|NCT00387751|656346|P1|NOT COMPLETED|Overall Study||0
270310|NCT00387751|656346|P1|COMPLETED|Overall Study||14
270311|NCT00387751|656346|P1|STARTED|Overall Study||14
270312|NCT00387725|656356|P4|NOT COMPLETED|Overall Study||2
270313|NCT00387725|656357|P3|NOT COMPLETED|Overall Study||2
270314|NCT00387725|656358|P2|NOT COMPLETED|Overall Study||1
270315|NCT00387725|656359|P1|NOT COMPLETED|Overall Study||1
270316|NCT00387725|656356|P4|COMPLETED|Overall Study||43
270317|NCT00387725|656357|P3|COMPLETED|Overall Study||43
270318|NCT00387725|656358|P2|COMPLETED|Overall Study||15
270319|NCT00387725|656359|P1|COMPLETED|Overall Study||20
270320|NCT00387725|656356|P4|STARTED|Overall Study||45
270321|NCT00387725|656357|P3|STARTED|Overall Study||45
270322|NCT00387725|656358|P2|STARTED|Overall Study||16
270323|NCT00387725|656359|P1|STARTED|Overall Study||21
270324|NCT00387712|656379|P2|NOT COMPLETED|Overall Study||36
270325|NCT00387712|656380|P1|NOT COMPLETED|Overall Study||29
270326|NCT00387712|656379|P2|COMPLETED|Overall Study||16
270327|NCT00387712|656380|P1|COMPLETED|Overall Study||18
270328|NCT00387712|656379|P2|STARTED|Overall Study||52
270329|NCT00387712|656380|P1|STARTED|Overall Study||47
270330|NCT00387673|656390|P3|NOT COMPLETED|Overall Study||0
270331|NCT00387673|656391|P2|NOT COMPLETED|Overall Study||0
270332|NCT00387673|656392|P1|NOT COMPLETED|Overall Study||0
270333|NCT00387673|656390|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
270334|NCT00387673|656391|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
270335|NCT00387673|656392|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
270336|NCT00387673|656390|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
270337|NCT00387673|656391|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
270338|NCT00387673|656392|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
270339|NCT00387660|656400|P2|NOT COMPLETED|Overall Study||0
270340|NCT00387660|656401|P1|NOT COMPLETED|Overall Study||0
270341|NCT00387660|656400|P2|COMPLETED|Overall Study||40
270342|NCT00387660|656401|P1|COMPLETED|Overall Study||40
270343|NCT00387660|656400|P2|STARTED|Overall Study||40
270344|NCT00387660|656401|P1|STARTED|Overall Study||40
270345|NCT00387647|656411|P1|NOT COMPLETED|Overall Study||18
270346|NCT00387647|656411|P1|COMPLETED|Overall Study||6
270347|NCT00387647|656411|P1|STARTED|Overall Study||24
270348|NCT00387621|656420|P2|NOT COMPLETED|Second Intervention||0
270349|NCT00387621|656421|P1|NOT COMPLETED|Second Intervention||0
270350|NCT00387621|656420|P2|COMPLETED|Second Intervention||29
270351|NCT00387621|656421|P1|COMPLETED|Second Intervention||29
270352|NCT00387621|656420|P2|STARTED|Second Intervention||29
270353|NCT00387621|656421|P1|STARTED|Second Intervention||29
270354|NCT00387621|656420|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
270355|NCT00387621|656421|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
270356|NCT00387621|656420|P2|COMPLETED|Washout Period of 2 Weeks||29
270357|NCT00387621|656421|P1|COMPLETED|Washout Period of 2 Weeks||29
270358|NCT00387621|656420|P2|STARTED|Washout Period of 2 Weeks||29
270359|NCT00387621|656421|P1|STARTED|Washout Period of 2 Weeks||29
270360|NCT00387621|656420|P2|NOT COMPLETED|First Intervention||0
270361|NCT00387621|656421|P1|NOT COMPLETED|First Intervention||0
270362|NCT00387621|656420|P2|COMPLETED|First Intervention||29
270363|NCT00387621|656421|P1|COMPLETED|First Intervention||29
270364|NCT00387621|656420|P2|STARTED|First Intervention||29
270365|NCT00387621|656421|P1|STARTED|First Intervention||29
270366|NCT00387426|656451|P1|NOT COMPLETED|Overall Study||14
270367|NCT00387426|656451|P1|COMPLETED|Overall Study||0
270368|NCT00387426|656451|P1|STARTED|Overall Study||14
270369|NCT00387348|656458|P3|NOT COMPLETED|Overall Study||4
270370|NCT00387348|656459|P2|NOT COMPLETED|Overall Study||3
270371|NCT00387348|656460|P1|NOT COMPLETED|Overall Study||3
270372|NCT00387348|656458|P3|COMPLETED|Overall Study||7
270373|NCT00387348|656459|P2|COMPLETED|Overall Study||2
270374|NCT00387348|656460|P1|COMPLETED|Overall Study||5
270375|NCT00387348|656458|P3|STARTED|Overall Study||11
270376|NCT00387348|656459|P2|STARTED|Overall Study||5
270377|NCT00387348|656460|P1|STARTED|Overall Study||8
270378|NCT00387335|656476|P2|NOT COMPLETED|Overall Study||0
270379|NCT00387335|656477|P1|NOT COMPLETED|Overall Study||0
270380|NCT00387335|656476|P2|COMPLETED|Overall Study||7
270381|NCT00387335|656477|P1|COMPLETED|Overall Study||15
270382|NCT00387335|656476|P2|STARTED|Overall Study||7
270383|NCT00387335|656477|P1|STARTED|Overall Study||15
270384|NCT00387153|656489|P1|NOT COMPLETED|Overall Study||8
270385|NCT00387153|656489|P1|COMPLETED|Overall Study||0
270386|NCT00387153|656489|P1|STARTED|Overall Study||8
270387|NCT00387127|656495|P2|NOT COMPLETED|Overall Study||34
270388|NCT00387127|656496|P1|NOT COMPLETED|Overall Study||33
270389|NCT00387127|656495|P2|COMPLETED|Overall Study||0
270390|NCT00387127|656496|P1|COMPLETED|Overall Study||0
270391|NCT00387127|656495|P2|STARTED|Overall Study||34
270392|NCT00387127|656496|P1|STARTED|Overall Study||33
270393|NCT00387088|656538|P2|NOT COMPLETED|Overall Study||373
270394|NCT00387088|656539|P1|NOT COMPLETED|Overall Study||318
270395|NCT00387088|656538|P2|COMPLETED|Overall Study||1629
270396|NCT00387088|656539|P1|COMPLETED|Overall Study||1671
270397|NCT00387088|656538|P2|STARTED|Overall Study||2002
270398|NCT00387088|656539|P1|STARTED|Overall Study||1989
270399|NCT00387036|656583|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
270400|NCT00387036|656584|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
270401|NCT00387036|656583|P2|COMPLETED|2-Week Crossover Second Intervention||6
270402|NCT00387036|656584|P1|COMPLETED|2-Week Crossover Second Intervention||6
270403|NCT00387036|656583|P2|STARTED|2-Week Crossover Second Intervention||6
270404|NCT00387036|656584|P1|STARTED|2-Week Crossover Second Intervention||6
270405|NCT00387036|656583|P2|NOT COMPLETED|2-Week Placebo Washout||0
270406|NCT00387036|656584|P1|NOT COMPLETED|2-Week Placebo Washout||0
270407|NCT00387036|656583|P2|COMPLETED|2-Week Placebo Washout||6
270408|NCT00387036|656584|P1|COMPLETED|2-Week Placebo Washout||6
270409|NCT00387036|656583|P2|STARTED|2-Week Placebo Washout||6
270410|NCT00387036|656584|P1|STARTED|2-Week Placebo Washout||6
270411|NCT00387036|656583|P2|NOT COMPLETED|2-Week First Intervention||0
270412|NCT00387036|656584|P1|NOT COMPLETED|2-Week First Intervention||0
270413|NCT00387036|656583|P2|COMPLETED|2-Week First Intervention||6
270414|NCT00387036|656584|P1|COMPLETED|2-Week First Intervention||6
270415|NCT00387036|656583|P2|STARTED|2-Week First Intervention||6
270416|NCT00387036|656584|P1|STARTED|2-Week First Intervention||6
270417|NCT00387023|656592|P1|NOT COMPLETED|Overall Study||0
270418|NCT00387023|656592|P1|COMPLETED|Overall Study||12
270419|NCT00387023|656592|P1|STARTED|Overall Study||12
270420|NCT00387010|656596|P1|NOT COMPLETED|Treatment Period||11
270421|NCT00387010|656596|P1|COMPLETED|Treatment Period||169
270422|NCT00387010|656596|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
270423|NCT00387010|656596|P1|STARTED|Treatment Period||180
270424|NCT00387010|656596|P1|NOT COMPLETED|Dose Titration Period||38
270425|NCT00387010|656596|P1|COMPLETED|Dose Titration Period||180
270426|NCT00387010|656596|P1|STARTED|Dose Titration Period||218
270427|NCT00386880|656617|P2|NOT COMPLETED|Overall Study||0
270428|NCT00386880|656618|P1|NOT COMPLETED|Overall Study||0
270429|NCT00386880|656617|P2|COMPLETED|Overall Study||8
270430|NCT00386880|656618|P1|COMPLETED|Overall Study||30
270431|NCT00386880|656617|P2|STARTED|Overall Study||8
270432|NCT00386880|656618|P1|STARTED|Overall Study||30
270433|NCT00386776|656623|P1|NOT COMPLETED|Overall Study||8
270434|NCT00386776|656623|P1|COMPLETED|Overall Study||32
270435|NCT00386776|656623|P1|STARTED|Overall Study||40
270436|NCT00386607|656633|P2|NOT COMPLETED|Extension||17
270437|NCT00386607|656634|P1|NOT COMPLETED|Extension||0
270438|NCT00386607|656633|P2|COMPLETED|Extension||145
270439|NCT00386607|656634|P1|COMPLETED|Extension||0
270440|NCT00386607|656633|P2|STARTED|Extension||162
270441|NCT00386607|656634|P1|STARTED|Extension||0
270442|NCT00386607|656633|P2|NOT COMPLETED|Core||0
270443|NCT00386607|656634|P1|NOT COMPLETED|Core||115
270444|NCT00386607|656633|P2|COMPLETED|Core||0
270445|NCT00386607|656634|P1|COMPLETED|Core||486
270446|NCT00386607|656633|P2|STARTED|Core||0
270447|NCT00386607|656634|P1|STARTED|Core||601
270448|NCT00386477|656652|P2|NOT COMPLETED|Overall Study||0
270449|NCT00386477|656653|P1|NOT COMPLETED|Overall Study||0
270450|NCT00386477|656652|P2|COMPLETED|Overall Study||145
270451|NCT00386477|656653|P1|COMPLETED|Overall Study||155
270452|NCT00386477|656652|P2|STARTED|Overall Study||145
270453|NCT00386477|656653|P1|STARTED|Overall Study||155
270454|NCT00386425|656662|P3|NOT COMPLETED|Overall Study||0
270455|NCT00386425|656663|P2|NOT COMPLETED|Overall Study||1
270456|NCT00386425|656664|P1|NOT COMPLETED|Overall Study||3
270457|NCT00386425|656662|P3|COMPLETED|Overall Study||53
270458|NCT00386425|656663|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
270459|NCT00386425|656664|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
270460|NCT00386425|656662|P3|Received Study Drug|Overall Study||53
270461|NCT00386425|656663|P2|Received Study Drug|Overall Study||206
270462|NCT00386425|656664|P1|Received Study Drug|Overall Study||227
270463|NCT00386425|656662|P3|STARTED|Overall Study||53
270464|NCT00386425|656663|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
270465|NCT00386425|656664|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
270466|NCT00386360|656690|P2|NOT COMPLETED|Overall Study||17
270467|NCT00386360|656691|P1|NOT COMPLETED|Overall Study||9
270468|NCT00386360|656690|P2|COMPLETED|Overall Study||95
270469|NCT00386360|656691|P1|COMPLETED|Overall Study||40
270470|NCT00386360|656690|P2|Primary Efficacy|Overall Study||77
270471|NCT00386360|656691|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
270472|NCT00386360|656690|P2|Intent to Treat Population (ITT)|Overall Study||110
270473|NCT00386360|656691|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
270474|NCT00386360|656690|P2|STARTED|Overall Study||112
270475|NCT00386360|656691|P1|STARTED|Overall Study||49
270476|NCT00386334|656725|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
270477|NCT00386334|656726|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
270478|NCT00386334|656725|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
270479|NCT00386334|656726|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
270480|NCT00386334|656725|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
270481|NCT00386334|656726|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
270482|NCT00386334|656725|P2|NOT COMPLETED|Double Blind Period||47
270483|NCT00386334|656726|P1|NOT COMPLETED|Double Blind Period||46
270484|NCT00386334|656725|P2|COMPLETED|Double Blind Period||147
270485|NCT00386334|656726|P1|COMPLETED|Double Blind Period||148
270486|NCT00386334|656725|P2|STARTED|Double Blind Period||194
270487|NCT00386334|656726|P1|STARTED|Double Blind Period||194
270488|NCT00386308|656870|P2|NOT COMPLETED|Overall Study||19
270489|NCT00386308|656871|P1|NOT COMPLETED|Overall Study||29
270490|NCT00386308|656870|P2|COMPLETED|Overall Study||54
270491|NCT00386308|656871|P1|COMPLETED|Overall Study||94
270492|NCT00386308|656870|P2|Modified Intent to Treat Population|Overall Study||72
270493|NCT00386308|656871|P1|Modified Intent to Treat Population|Overall Study||115
270494|NCT00386308|656870|P2|Intent to Treat Population|Overall Study||72
270495|NCT00386308|656871|P1|Intent to Treat Population|Overall Study||117
270496|NCT00386308|656870|P2|STARTED|Overall Study||73
270497|NCT00386308|656871|P1|STARTED|Overall Study||123
270498|NCT00386256|656887|P4|NOT COMPLETED|Overall Study||0
270499|NCT00386256|656888|P3|NOT COMPLETED|Overall Study||0
270500|NCT00386256|656889|P2|NOT COMPLETED|Overall Study||0
270501|NCT00386256|656890|P1|NOT COMPLETED|Overall Study||0
270502|NCT00386256|656887|P4|COMPLETED|Overall Study||3
270503|NCT00386256|656888|P3|COMPLETED|Overall Study||4
270504|NCT00386256|656889|P2|COMPLETED|Overall Study||15
270505|NCT00386256|656890|P1|COMPLETED|Overall Study||16
270506|NCT00386256|656887|P4|STARTED|Overall Study||3
270507|NCT00386256|656888|P3|STARTED|Overall Study||4
270508|NCT00386256|656889|P2|STARTED|Overall Study||15
270509|NCT00386256|656890|P1|STARTED|Overall Study||16
270510|NCT00386243|656906|P2|NOT COMPLETED|Overall Study||13
270511|NCT00386243|656907|P1|NOT COMPLETED|Overall Study||7
270512|NCT00386243|656906|P2|COMPLETED|Overall Study||108
270513|NCT00386243|656907|P1|COMPLETED|Overall Study||114
270514|NCT00386243|656906|P2|STARTED|Overall Study||121
270515|NCT00386243|656907|P1|STARTED|Overall Study||121
270516|NCT00386152|656918|P3|NOT COMPLETED|Overall Study||33
270517|NCT00386152|656919|P2|NOT COMPLETED|Overall Study||40
270518|NCT00386152|656920|P1|NOT COMPLETED|Overall Study||44
270519|NCT00386152|656918|P3|COMPLETED|Overall Study||42
270520|NCT00386152|656919|P2|COMPLETED|Overall Study||37
270521|NCT00386152|656920|P1|COMPLETED|Overall Study||31
270522|NCT00386152|656918|P3|STARTED|Overall Study|number of subjects treated|75
270523|NCT00386152|656919|P2|STARTED|Overall Study|number of subjects treated|77
270524|NCT00386152|656920|P1|STARTED|Overall Study|number of subjects treated|75
270525|NCT00386100|656939|P2|NOT COMPLETED|Overall Study||131
270526|NCT00386100|656940|P1|NOT COMPLETED|Overall Study||154
270527|NCT00386100|656939|P2|COMPLETED|Overall Study||217
270528|NCT00386100|656940|P1|COMPLETED|Overall Study||186
270529|NCT00386100|656939|P2|STARTED|Overall Study||348
270530|NCT00386100|656940|P1|STARTED|Overall Study||340
270531|NCT00386022|657004|P2|NOT COMPLETED|Plus Estrogen||1
270532|NCT00386022|657005|P1|NOT COMPLETED|Plus Estrogen||2
270533|NCT00386022|657004|P2|COMPLETED|Plus Estrogen||8
270534|NCT00386022|657005|P1|COMPLETED|Plus Estrogen||8
270535|NCT00386022|657004|P2|All Doses GnRH|Plus Estrogen||8
270536|NCT00386022|657005|P1|All Doses GnRH|Plus Estrogen||8
270537|NCT00386022|657004|P2|Estrogen Patch|Plus Estrogen||9
270538|NCT00386022|657005|P1|Estrogen Patch|Plus Estrogen||8
270539|NCT00386022|657004|P2|STARTED|Plus Estrogen||9
270540|NCT00386022|657005|P1|STARTED|Plus Estrogen||10
270541|NCT00386022|657004|P2|NOT COMPLETED|Baseline||0
270542|NCT00386022|657005|P1|NOT COMPLETED|Baseline||0
270543|NCT00386022|657004|P2|COMPLETED|Baseline||9
270544|NCT00386022|657005|P1|COMPLETED|Baseline||10
270545|NCT00386022|657004|P2|All Doses of GnRH|Baseline||9
270546|NCT00386022|657005|P1|All Doses of GnRH|Baseline||10
270547|NCT00386022|657004|P2|STARTED|Baseline||9
270548|NCT00386022|657005|P1|STARTED|Baseline||10
270549|NCT00386009|657015|P2|NOT COMPLETED|Overall Study||10
270550|NCT00386009|657016|P1|NOT COMPLETED|Overall Study||9
270551|NCT00386009|657015|P2|COMPLETED|Overall Study||89
270552|NCT00386009|657016|P1|COMPLETED|Overall Study||92
270553|NCT00386009|657015|P2|STARTED|Overall Study||99
270554|NCT00386009|657016|P1|STARTED|Overall Study||101
270555|NCT00385996|657054|P1|NOT COMPLETED|Overall Study||0
270556|NCT00385996|657054|P1|COMPLETED|Overall Study||22
270557|NCT00385996|657054|P1|STARTED|Overall Study||22
270558|NCT00385944|657061|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
270559|NCT00385944|657062|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
270560|NCT00385944|657063|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
270561|NCT00385944|657061|P3|COMPLETED|2nd Maintenance Dose Period||0
270562|NCT00385944|657062|P2|COMPLETED|2nd Maintenance Dose Period||19
270563|NCT00385944|657063|P1|COMPLETED|2nd Maintenance Dose Period||22
270564|NCT00385944|657061|P3|STARTED|2nd Maintenance Dose Period||0
270565|NCT00385944|657062|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
270566|NCT00385944|657063|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
270567|NCT00385944|657061|P3|NOT COMPLETED|1st Maintenance Dose Period||0
270568|NCT00385944|657062|P2|NOT COMPLETED|1st Maintenance Dose Period||1
270569|NCT00385944|657063|P1|NOT COMPLETED|1st Maintenance Dose Period||4
270570|NCT00385944|657061|P3|COMPLETED|1st Maintenance Dose Period||0
270571|NCT00385944|657062|P2|COMPLETED|1st Maintenance Dose Period||24
270572|NCT00385944|657063|P1|COMPLETED|1st Maintenance Dose Period||25
270573|NCT00385944|657061|P3|STARTED|1st Maintenance Dose Period||0
270574|NCT00385944|657062|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
270575|NCT00385944|657063|P1|STARTED|1st Maintenance Dose Period||29
270576|NCT00385944|657061|P3|NOT COMPLETED|Loading Dose||0
270577|NCT00385944|657062|P2|NOT COMPLETED|Loading Dose||0
270578|NCT00385944|657063|P1|NOT COMPLETED|Loading Dose||0
270579|NCT00385944|657061|P3|COMPLETED|Loading Dose||56
270580|NCT00385944|657062|P2|COMPLETED|Loading Dose||0
270581|NCT00385944|657063|P1|COMPLETED|Loading Dose||0
270582|NCT00385944|657061|P3|STARTED|Loading Dose||56
270583|NCT00385944|657062|P2|STARTED|Loading Dose||0
270584|NCT00385944|657063|P1|STARTED|Loading Dose||0
270585|NCT00385918|657106|P3|NOT COMPLETED|Intervention Phase After Randomization||0
270586|NCT00385918|657107|P2|NOT COMPLETED|Intervention Phase After Randomization||0
270587|NCT00385918|657108|P1|NOT COMPLETED|Intervention Phase After Randomization||3
270588|NCT00385918|657106|P3|COMPLETED|Intervention Phase After Randomization||0
270589|NCT00385918|657107|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
270590|NCT00385918|657108|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
270591|NCT00385918|657106|P3|STARTED|Intervention Phase After Randomization||0
270592|NCT00385918|657107|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
270593|NCT00385918|657108|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
270594|NCT00385918|657106|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
270595|NCT00385918|657107|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
270596|NCT00385918|657108|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
270597|NCT00385918|657106|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
270598|NCT00385918|657107|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
270599|NCT00385918|657108|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
270600|NCT00385918|657106|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
270601|NCT00385918|657107|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
270602|NCT00385918|657108|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
270685|NCT00385723|657260|P2|COMPLETED|Overall Study||45
270603|NCT00385918|657106|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
270604|NCT00385918|657107|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
270605|NCT00385918|657108|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
270606|NCT00385918|657106|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
270607|NCT00385918|657107|P2|STARTED|Feasibility & Baseline Measurement Phase||0
270608|NCT00385918|657108|P1|STARTED|Feasibility & Baseline Measurement Phase||0
270609|NCT00385840|657132|P2|NOT COMPLETED|Overall Study||14
270610|NCT00385840|657133|P1|NOT COMPLETED|Overall Study||4
270611|NCT00385840|657132|P2|COMPLETED|Overall Study||531
270612|NCT00385840|657133|P1|COMPLETED|Overall Study||129
270613|NCT00385840|657132|P2|STARTED|Overall Study||545
270614|NCT00385840|657133|P1|STARTED|Overall Study||133
270615|NCT00385827|657156|P3|NOT COMPLETED|Part 2||48
270616|NCT00385827|657157|P2|NOT COMPLETED|Part 2||33
270617|NCT00385827|657158|P1|NOT COMPLETED|Part 2||0
270618|NCT00385827|657156|P3|COMPLETED|Part 2||0
270619|NCT00385827|657157|P2|COMPLETED|Part 2||16
270620|NCT00385827|657158|P1|COMPLETED|Part 2||0
270621|NCT00385827|657156|P3|Treated|Part 2||46
270622|NCT00385827|657157|P2|Treated|Part 2||47
270623|NCT00385827|657158|P1|Treated|Part 2||0
270624|NCT00385827|657156|P3|STARTED|Part 2||48
270625|NCT00385827|657157|P2|STARTED|Part 2||49
270626|NCT00385827|657158|P1|STARTED|Part 2||0
270627|NCT00385827|657156|P3|NOT COMPLETED|Part 1||0
270628|NCT00385827|657157|P2|NOT COMPLETED|Part 1||0
270629|NCT00385827|657158|P1|NOT COMPLETED|Part 1||9
270630|NCT00385827|657156|P3|COMPLETED|Part 1||0
270631|NCT00385827|657157|P2|COMPLETED|Part 1||0
270632|NCT00385827|657158|P1|COMPLETED|Part 1||0
270633|NCT00385827|657156|P3|Treated|Part 1||0
270634|NCT00385827|657157|P2|Treated|Part 1||0
270635|NCT00385827|657158|P1|Treated|Part 1||9
270636|NCT00385827|657156|P3|STARTED|Part 1||0
270637|NCT00385827|657157|P2|STARTED|Part 1||0
270638|NCT00385827|657158|P1|STARTED|Part 1||9
270639|NCT00385801|657180|P2|NOT COMPLETED|Overall Study||8
270640|NCT00385801|657181|P1|NOT COMPLETED|Overall Study||9
270641|NCT00385801|657180|P2|COMPLETED|Overall Study||8
270642|NCT00385801|657181|P1|COMPLETED|Overall Study||6
270643|NCT00385801|657180|P2|STARTED|Overall Study||16
270644|NCT00385801|657181|P1|STARTED|Overall Study||15
270645|NCT00385788|657195|P2|NOT COMPLETED|Overall Study||0
270646|NCT00385788|657196|P1|NOT COMPLETED|Overall Study||0
270647|NCT00385788|657195|P2|COMPLETED|Overall Study||40
270648|NCT00385788|657196|P1|COMPLETED|Overall Study||12
270649|NCT00385788|657195|P2|STARTED|Overall Study||40
270650|NCT00385788|657196|P1|STARTED|Overall Study||12
270651|NCT00385762|657202|P1|NOT COMPLETED|Overall Study||2
270652|NCT00385762|657202|P1|COMPLETED|Overall Study||33
270653|NCT00385762|657202|P1|STARTED|Overall Study||35
270654|NCT00385736|657212|P3|NOT COMPLETED|Safety Analysis Set||80
270655|NCT00385736|657213|P2|NOT COMPLETED|Safety Analysis Set||44
270656|NCT00385736|657214|P1|NOT COMPLETED|Safety Analysis Set||70
270657|NCT00385736|657212|P3|COMPLETED|Safety Analysis Set||143
270658|NCT00385736|657213|P2|COMPLETED|Safety Analysis Set||86
270659|NCT00385736|657214|P1|COMPLETED|Safety Analysis Set||153
270660|NCT00385736|657212|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
270661|NCT00385736|657213|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
270662|NCT00385736|657214|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
270663|NCT00385736|657212|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
270664|NCT00385736|657213|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
270665|NCT00385736|657214|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
270666|NCT00385736|657212|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
270667|NCT00385736|657213|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
270668|NCT00385736|657214|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
270669|NCT00385736|657212|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
270670|NCT00385736|657213|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
270671|NCT00385736|657214|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
270672|NCT00385736|657212|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
270673|NCT00385736|657213|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
270674|NCT00385736|657214|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
270675|NCT00385736|657212|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
270676|NCT00385736|657213|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
270677|NCT00385736|657214|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
270678|NCT00385736|657212|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
270679|NCT00385736|657213|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
270680|NCT00385736|657214|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
270681|NCT00385723|657259|P3|NOT COMPLETED|Overall Study||2
270682|NCT00385723|657260|P2|NOT COMPLETED|Overall Study||1
270683|NCT00385723|657261|P1|NOT COMPLETED|Overall Study||2
270684|NCT00385723|657259|P3|COMPLETED|Overall Study||44
270686|NCT00385723|657261|P1|COMPLETED|Overall Study||44
270687|NCT00385723|657259|P3|STARTED|Overall Study||46
270688|NCT00385723|657260|P2|STARTED|Overall Study||46
270689|NCT00385723|657261|P1|STARTED|Overall Study||46
270690|NCT00385684|657275|P2|NOT COMPLETED|PHASE B||0
270691|NCT00385684|657276|P1|NOT COMPLETED|PHASE B||0
270692|NCT00385684|657275|P2|COMPLETED|PHASE B||3
270693|NCT00385684|657276|P1|COMPLETED|PHASE B||5
270694|NCT00385684|657275|P2|STARTED|PHASE B||3
270695|NCT00385684|657276|P1|STARTED|PHASE B||5
270696|NCT00385684|657275|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
270697|NCT00385684|657276|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
270698|NCT00385684|657275|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
270699|NCT00385684|657276|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
270700|NCT00385684|657275|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
270701|NCT00385684|657276|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
270702|NCT00385684|657275|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
270703|NCT00385684|657276|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
270704|NCT00385684|657275|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
270705|NCT00385684|657276|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
270706|NCT00385684|657275|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
270707|NCT00385684|657276|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
270708|NCT00385671|657285|P3|NOT COMPLETED|Overall Study||36
270709|NCT00385671|657286|P2|NOT COMPLETED|Overall Study||51
270710|NCT00385671|657287|P1|NOT COMPLETED|Overall Study||38
270711|NCT00385671|657285|P3|COMPLETED|Overall Study||99
270712|NCT00385671|657286|P2|COMPLETED|Overall Study||87
270713|NCT00385671|657287|P1|COMPLETED|Overall Study||96
270714|NCT00385671|657285|P3|STARTED|Overall Study||135
270715|NCT00385671|657286|P2|STARTED|Overall Study||138
270716|NCT00385671|657287|P1|STARTED|Overall Study||134
270717|NCT00385593|657443|P2|NOT COMPLETED|Overall Study||37
270718|NCT00385593|657444|P1|NOT COMPLETED|Overall Study||58
270719|NCT00385593|657443|P2|COMPLETED|Overall Study||289
270720|NCT00385593|657444|P1|COMPLETED|Overall Study||270
270721|NCT00385593|657443|P2|STARTED|Overall Study||326
270722|NCT00385593|657444|P1|STARTED|Overall Study||328
270723|NCT00385580|657462|P2|NOT COMPLETED|Overall Study||0
270724|NCT00385580|657463|P1|NOT COMPLETED|Overall Study||0
270725|NCT00385580|657462|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
270726|NCT00385580|657463|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
270727|NCT00385580|657462|P2|STARTED|Overall Study|Number of participants treated.|47
270728|NCT00385580|657463|P1|STARTED|Overall Study|Number of participants treated.|48
270729|NCT00385541|657554|P2|NOT COMPLETED|Overall Study||1
270730|NCT00385541|657555|P1|NOT COMPLETED|Overall Study||0
270731|NCT00385541|657554|P2|COMPLETED|Overall Study||24
270732|NCT00385541|657555|P1|COMPLETED|Overall Study||25
270733|NCT00385541|657554|P2|STARTED|Overall Study||25
270734|NCT00385541|657555|P1|STARTED|Overall Study||25
270735|NCT00385515|657571|P2|NOT COMPLETED|Overall Study||3
270736|NCT00385515|657572|P1|NOT COMPLETED|Overall Study||4
270737|NCT00385515|657571|P2|COMPLETED|Overall Study||21
270738|NCT00385515|657572|P1|COMPLETED|Overall Study||53
270739|NCT00385515|657571|P2|STARTED|Overall Study||24
270740|NCT00385515|657572|P1|STARTED|Overall Study||57
270741|NCT00385268|657580|P2|NOT COMPLETED|Overall Study||8
270742|NCT00385268|657581|P1|NOT COMPLETED|Overall Study||16
270743|NCT00385268|657580|P2|COMPLETED|Overall Study||18
270744|NCT00385268|657581|P1|COMPLETED|Overall Study||18
270745|NCT00385268|657580|P2|STARTED|Overall Study||26
270746|NCT00385268|657581|P1|STARTED|Overall Study||34
270747|NCT00385216|657587|P2|NOT COMPLETED|Second Intervention||0
270748|NCT00385216|657588|P1|NOT COMPLETED|Second Intervention||0
270749|NCT00385216|657587|P2|COMPLETED|Second Intervention||9
270750|NCT00385216|657588|P1|COMPLETED|Second Intervention||11
270751|NCT00385216|657587|P2|STARTED|Second Intervention||9
270752|NCT00385216|657588|P1|STARTED|Second Intervention||11
270753|NCT00385216|657587|P2|NOT COMPLETED|First Intervention||0
270754|NCT00385216|657588|P1|NOT COMPLETED|First Intervention||0
270755|NCT00385216|657587|P2|COMPLETED|First Intervention||9
270756|NCT00385216|657588|P1|COMPLETED|First Intervention||11
270757|NCT00385216|657587|P2|STARTED|First Intervention||9
270758|NCT00385216|657588|P1|STARTED|First Intervention||11
270759|NCT00385203|657602|P2|NOT COMPLETED|Overall Study||7
270760|NCT00385203|657603|P1|NOT COMPLETED|Overall Study||26
270761|NCT00385203|657602|P2|COMPLETED|Overall Study||3
270762|NCT00385203|657603|P1|COMPLETED|Overall Study||0
270763|NCT00385203|657602|P2|STARTED|Overall Study||10
270764|NCT00385203|657603|P1|STARTED|Overall Study||26
270765|NCT00385138|657623|P2|NOT COMPLETED|Overall Study||28
270766|NCT00385138|657624|P1|NOT COMPLETED|Overall Study||30
270767|NCT00385138|657623|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
270768|NCT00385138|657624|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
270769|NCT00385138|657623|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
270770|NCT00385138|657624|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
270771|NCT00385138|657623|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
270772|NCT00385138|657624|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
270773|NCT00385138|657623|P2|Intent-to-treat (ITT)|Overall Study||2669
270774|NCT00385138|657624|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
270775|NCT00385138|657623|P2|STARTED|Overall Study||2669
270776|NCT00385138|657624|P1|STARTED|Overall Study||2695
270777|NCT00385008|657670|P2|NOT COMPLETED|Overall Study||0
270778|NCT00385008|657671|P1|NOT COMPLETED|Overall Study||0
270779|NCT00385008|657670|P2|COMPLETED|Overall Study||10
270780|NCT00385008|657671|P1|COMPLETED|Overall Study||10
270781|NCT00385008|657670|P2|In Presence of Migraine|Overall Study||5
270782|NCT00385008|657671|P1|In Presence of Migraine|Overall Study||5
270783|NCT00385008|657670|P2|In Absence of Migraine|Overall Study||10
270784|NCT00385008|657671|P1|In Absence of Migraine|Overall Study||10
270785|NCT00385008|657670|P2|STARTED|Overall Study||10
270786|NCT00385008|657671|P1|STARTED|Overall Study||10
270787|NCT00384956|657691|P1|NOT COMPLETED|Overall Study||3
270788|NCT00384956|657691|P1|COMPLETED|Overall Study||22
270789|NCT00384956|657691|P1|STARTED|Overall Study||25
270790|NCT00384930|657708|P5|NOT COMPLETED|Overall Study||47
270791|NCT00384930|657709|P4|NOT COMPLETED|Overall Study||41
270792|NCT00384930|657710|P3|NOT COMPLETED|Overall Study||30
270793|NCT00384930|657711|P2|NOT COMPLETED|Overall Study||27
270794|NCT00384930|657712|P1|NOT COMPLETED|Overall Study||27
270795|NCT00384930|657708|P5|COMPLETED|Overall Study||162
270796|NCT00384930|657709|P4|COMPLETED|Overall Study||175
270797|NCT00384930|657710|P3|COMPLETED|Overall Study||182
270798|NCT00384930|657711|P2|COMPLETED|Overall Study||182
270799|NCT00384930|657712|P1|COMPLETED|Overall Study||185
270800|NCT00384930|657708|P5|Received Double-Blind Study Drug|Overall Study||209
270801|NCT00384930|657709|P4|Received Double-Blind Study Drug|Overall Study||216
270802|NCT00384930|657710|P3|Received Double-Blind Study Drug|Overall Study||212
270803|NCT00384930|657711|P2|Received Double-Blind Study Drug|Overall Study||208
270804|NCT00384930|657712|P1|Received Double-Blind Study Drug|Overall Study||211
270805|NCT00384930|657708|P5|STARTED|Overall Study||209
270806|NCT00384930|657709|P4|STARTED|Overall Study||216
270807|NCT00384930|657710|P3|STARTED|Overall Study||212
270808|NCT00384930|657711|P2|STARTED|Overall Study||209
270809|NCT00384930|657712|P1|STARTED|Overall Study||212
270810|NCT00384865|657770|P4|NOT COMPLETED|Overall Study||0
270811|NCT00384865|657771|P3|NOT COMPLETED|Overall Study||0
270812|NCT00384865|657772|P2|NOT COMPLETED|Overall Study||0
270813|NCT00384865|657773|P1|NOT COMPLETED|Overall Study||0
270814|NCT00384865|657770|P4|COMPLETED|Overall Study||16
270815|NCT00384865|657771|P3|COMPLETED|Overall Study||16
270816|NCT00384865|657772|P2|COMPLETED|Overall Study||16
270817|NCT00384865|657773|P1|COMPLETED|Overall Study||16
270818|NCT00384865|657770|P4|Completed Six Month Assessment|Overall Study||11
270819|NCT00384865|657771|P3|Completed Six Month Assessment|Overall Study||15
270820|NCT00384865|657772|P2|Completed Six Month Assessment|Overall Study||12
270821|NCT00384865|657773|P1|Completed Six Month Assessment|Overall Study||11
270822|NCT00384865|657770|P4|STARTED|Overall Study||16
270823|NCT00384865|657771|P3|STARTED|Overall Study||16
270824|NCT00384865|657772|P2|STARTED|Overall Study||16
270825|NCT00384865|657773|P1|STARTED|Overall Study||16
270826|NCT00384813|657793|P2|NOT COMPLETED|Overall Study||0
270827|NCT00384813|657794|P1|NOT COMPLETED|Overall Study||2
270828|NCT00384813|657793|P2|COMPLETED|Overall Study||20
270829|NCT00384813|657794|P1|COMPLETED|Overall Study||21
270830|NCT00384813|657793|P2|STARTED|Overall Study||20
270831|NCT00384813|657794|P1|STARTED|Overall Study||23
270832|NCT00384748|657802|P2|NOT COMPLETED|Overall Study||0
270833|NCT00384748|657803|P1|NOT COMPLETED|Overall Study||0
270834|NCT00384748|657802|P2|COMPLETED|Overall Study||23
270835|NCT00384748|657803|P1|COMPLETED|Overall Study||25
270836|NCT00384748|657802|P2|STARTED|Overall Study||23
270837|NCT00384748|657803|P1|STARTED|Overall Study||25
270838|NCT00384670|657809|P1|NOT COMPLETED|Overall Study||0
270839|NCT00384670|657809|P1|COMPLETED|Overall Study||7
270840|NCT00384670|657809|P1|STARTED|Overall Study||7
270841|NCT00384397|657822|P3|NOT COMPLETED|Overall Study||33
270842|NCT00384397|657823|P2|NOT COMPLETED|Overall Study||46
270843|NCT00384397|657824|P1|NOT COMPLETED|Overall Study||32
270844|NCT00384397|657822|P3|COMPLETED|Overall Study||385
270845|NCT00384397|657823|P2|COMPLETED|Overall Study||247
270846|NCT00384397|657824|P1|COMPLETED|Overall Study||375
270847|NCT00384397|657822|P3|STARTED|Overall Study||418
270848|NCT00384397|657823|P2|STARTED|Overall Study||293
270849|NCT00384397|657824|P1|STARTED|Overall Study||407
270850|NCT00384332|657843|P2|NOT COMPLETED|Overall Study||0
270851|NCT00384332|657844|P1|NOT COMPLETED|Overall Study||4
270852|NCT00384332|657843|P2|COMPLETED|Overall Study||10
270853|NCT00384332|657844|P1|COMPLETED|Overall Study||9
270854|NCT00384332|657843|P2|STARTED|Overall Study||10
270855|NCT00384332|657844|P1|STARTED|Overall Study||13
270856|NCT00384293|657854|P3|NOT COMPLETED|Post-randomization Period||219
270857|NCT00384293|657855|P2|NOT COMPLETED|Post-randomization Period||214
270858|NCT00384293|657856|P1|NOT COMPLETED|Post-randomization Period||0
270859|NCT00384293|657854|P3|COMPLETED|Post-randomization Period||0
270860|NCT00384293|657855|P2|COMPLETED|Post-randomization Period||0
270861|NCT00384293|657856|P1|COMPLETED|Post-randomization Period||0
270862|NCT00384293|657854|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
270863|NCT00384293|657855|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
270864|NCT00384293|657856|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
270865|NCT00384293|657854|P3|STARTED|Post-randomization Period||219
270866|NCT00384293|657855|P2|STARTED|Post-randomization Period||214
270867|NCT00384293|657856|P1|STARTED|Post-randomization Period||0
270868|NCT00384293|657854|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
270869|NCT00384293|657855|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
270870|NCT00384293|657856|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
270871|NCT00384293|657854|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
270872|NCT00384293|657855|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
270873|NCT00384293|657856|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
270874|NCT00384293|657854|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
270875|NCT00384293|657855|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
270876|NCT00384293|657856|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
270877|NCT00384293|657854|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
270878|NCT00384293|657855|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
270879|NCT00384293|657856|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
270880|NCT00384293|657854|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
270881|NCT00384293|657855|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
270882|NCT00384293|657856|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
270883|NCT00384241|657869|P2|NOT COMPLETED|Overall Study||0
270884|NCT00384241|657870|P1|NOT COMPLETED|Overall Study||0
270885|NCT00384241|657869|P2|COMPLETED|Overall Study||599
270886|NCT00384241|657870|P1|COMPLETED|Overall Study||500
270887|NCT00384241|657869|P2|STARTED|Overall Study||599
270888|NCT00384241|657870|P1|STARTED|Overall Study||500
270889|NCT00384189|657880|P4|NOT COMPLETED|Overall Study||40
270890|NCT00384189|657881|P3|NOT COMPLETED|Overall Study||58
270891|NCT00384189|657882|P2|NOT COMPLETED|Overall Study||57
270892|NCT00384189|657883|P1|NOT COMPLETED|Overall Study||50
270893|NCT00384189|657880|P4|COMPLETED|Overall Study||110
270894|NCT00384189|657881|P3|COMPLETED|Overall Study||255
270895|NCT00384189|657882|P2|COMPLETED|Overall Study||255
270896|NCT00384189|657883|P1|COMPLETED|Overall Study||255
270897|NCT00384189|657880|P4|Actual Treatment Received|Overall Study||146
270898|NCT00384189|657881|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
270899|NCT00384189|657882|P2|Actual Treatment Received|Overall Study||312
270900|NCT00384189|657883|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
270901|NCT00384189|657880|P4|Randomized, Not Treated|Overall Study||4
270902|NCT00384189|657881|P3|Randomized, Not Treated|Overall Study||2
270903|NCT00384189|657882|P2|Randomized, Not Treated|Overall Study||0
270904|NCT00384189|657883|P1|Randomized, Not Treated|Overall Study||1
270905|NCT00384189|657880|P4|STARTED|Overall Study||150
270906|NCT00384189|657881|P3|STARTED|Overall Study||313
270907|NCT00384189|657882|P2|STARTED|Overall Study||312
270908|NCT00384189|657883|P1|STARTED|Overall Study||305
270909|NCT00384176|657944|P3|NOT COMPLETED|Overall Study||132
270910|NCT00384176|657945|P2|NOT COMPLETED|Overall Study||319
270911|NCT00384176|657946|P1|NOT COMPLETED|Overall Study||312
270912|NCT00384176|657944|P3|COMPLETED|Overall Study||60
270913|NCT00384176|657945|P2|COMPLETED|Overall Study||394
270914|NCT00384176|657946|P1|COMPLETED|Overall Study||397
270915|NCT00384176|657944|P3|STARTED|Overall Study||192
270916|NCT00384176|657945|P2|STARTED|Overall Study||713
270917|NCT00384176|657946|P1|STARTED|Overall Study||709
270918|NCT00384085|657972|P3|NOT COMPLETED|Overall Study||56
270919|NCT00384085|657973|P2|NOT COMPLETED|Overall Study||46
270920|NCT00384085|657974|P1|NOT COMPLETED|Overall Study||39
270921|NCT00384085|657972|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
270922|NCT00384085|657973|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
270923|NCT00384085|657974|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
270924|NCT00384085|657972|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
270925|NCT00384085|657973|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
270926|NCT00384085|657974|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
270927|NCT00384085|657972|P3|Treated (Safety Population)|Overall Study||194
270928|NCT00384085|657973|P2|Treated (Safety Population)|Overall Study||194
270929|NCT00384085|657974|P1|Treated (Safety Population)|Overall Study||194
270930|NCT00384085|657972|P3|Intent-To-Treat (ITT)|Overall Study||197
270931|NCT00384085|657973|P2|Intent-To-Treat (ITT)|Overall Study||196
270932|NCT00384085|657974|P1|Intent-To-Treat (ITT)|Overall Study||195
270933|NCT00384085|657972|P3|STARTED|Overall Study|Randomized|197
270934|NCT00384085|657973|P2|STARTED|Overall Study|Randomized|196
270935|NCT00384085|657974|P1|STARTED|Overall Study|Randomized|195
270936|NCT00384059|658000|P2|NOT COMPLETED|Toddler Dose||2
270937|NCT00384059|658001|P1|NOT COMPLETED|Toddler Dose||1
270938|NCT00384059|658000|P2|COMPLETED|Toddler Dose||120
270939|NCT00384059|658001|P1|COMPLETED|Toddler Dose||130
270940|NCT00384059|658000|P2|STARTED|Toddler Dose||122
270941|NCT00384059|658001|P1|STARTED|Toddler Dose||131
270942|NCT00384059|658000|P2|NOT COMPLETED|After Infant Series||10
270943|NCT00384059|658001|P1|NOT COMPLETED|After Infant Series||4
270944|NCT00384059|658000|P2|COMPLETED|After Infant Series||122
270945|NCT00384059|658001|P1|COMPLETED|After Infant Series||131
270946|NCT00384059|658000|P2|STARTED|After Infant Series||132
270947|NCT00384059|658001|P1|STARTED|After Infant Series||135
270948|NCT00384059|658000|P2|NOT COMPLETED|Infant Series||13
270949|NCT00384059|658001|P1|NOT COMPLETED|Infant Series||6
270950|NCT00384059|658000|P2|COMPLETED|Infant Series||132
270951|NCT00384059|658001|P1|COMPLETED|Infant Series||135
270952|NCT00384059|658000|P2|Vaccinated Dose 2|Infant Series||135
270953|NCT00384059|658001|P1|Vaccinated Dose 2|Infant Series||136
270954|NCT00384059|658000|P2|Vaccinated Dose 1|Infant Series||139
270955|NCT00384059|658001|P1|Vaccinated Dose 1|Infant Series||139
270956|NCT00384059|658000|P2|STARTED|Infant Series||145
270957|NCT00384059|658001|P1|STARTED|Infant Series||141
270958|NCT00384033|658051|P4|NOT COMPLETED|Overall Study||40
270959|NCT00384033|658052|P3|NOT COMPLETED|Overall Study||43
270960|NCT00384033|658053|P2|NOT COMPLETED|Overall Study||35
270961|NCT00384033|658054|P1|NOT COMPLETED|Overall Study||41
270962|NCT00384033|658051|P4|COMPLETED|Overall Study||119
270963|NCT00384033|658052|P3|COMPLETED|Overall Study||117
270964|NCT00384033|658053|P2|COMPLETED|Overall Study||120
270965|NCT00384033|658054|P1|COMPLETED|Overall Study||123
270966|NCT00384033|658051|P4|Treated|Overall Study||157
270967|NCT00384033|658052|P3|Treated|Overall Study||150
270968|NCT00384033|658053|P2|Treated|Overall Study||148
270969|NCT00384033|658054|P1|Treated|Overall Study||161
270970|NCT00384033|658051|P4|STARTED|Overall Study||159
270971|NCT00384033|658052|P3|STARTED|Overall Study||160
270972|NCT00384033|658053|P2|STARTED|Overall Study||155
270973|NCT00384033|658054|P1|STARTED|Overall Study||164
270974|NCT00383942|658098|P2|NOT COMPLETED|Overall Study||0
270975|NCT00383942|658099|P1|NOT COMPLETED|Overall Study||0
270976|NCT00383942|658098|P2|COMPLETED|Overall Study||40
270977|NCT00383942|658099|P1|COMPLETED|Overall Study||40
270978|NCT00383942|658098|P2|STARTED|Overall Study||40
270979|NCT00383942|658099|P1|STARTED|Overall Study||40
270980|NCT00383786|658107|P2|NOT COMPLETED|Overall Study||12
270981|NCT00383786|658108|P1|NOT COMPLETED|Overall Study||4
270982|NCT00383786|658107|P2|COMPLETED|Overall Study||13
270983|NCT00383786|658108|P1|COMPLETED|Overall Study||18
270984|NCT00383786|658107|P2|STARTED|Overall Study||25
270985|NCT00383786|658108|P1|STARTED|Overall Study||22
270986|NCT00383760|658114|P1|NOT COMPLETED|Overall Study||0
270987|NCT00383760|658114|P1|COMPLETED|Overall Study||15
270988|NCT00383760|658114|P1|STARTED|Overall Study||15
270989|NCT00383747|658130|P4|NOT COMPLETED|Visit 2||0
270990|NCT00383747|658131|P3|NOT COMPLETED|Visit 2||0
270991|NCT00383747|658132|P2|NOT COMPLETED|Visit 2||0
270992|NCT00383747|658133|P1|NOT COMPLETED|Visit 2||0
270993|NCT00383747|658130|P4|COMPLETED|Visit 2||16
270994|NCT00383747|658131|P3|COMPLETED|Visit 2||16
270995|NCT00383747|658132|P2|COMPLETED|Visit 2||14
270996|NCT00383747|658133|P1|COMPLETED|Visit 2||14
270997|NCT00383747|658130|P4|STARTED|Visit 2||16
270998|NCT00383747|658131|P3|STARTED|Visit 2||16
270999|NCT00383747|658132|P2|STARTED|Visit 2||14
271000|NCT00383747|658133|P1|STARTED|Visit 2||14
271001|NCT00383747|658130|P4|NOT COMPLETED|Visit 1||0
271002|NCT00383747|658131|P3|NOT COMPLETED|Visit 1||0
271003|NCT00383747|658132|P2|NOT COMPLETED|Visit 1||0
271004|NCT00383747|658133|P1|NOT COMPLETED|Visit 1||0
271005|NCT00383747|658130|P4|COMPLETED|Visit 1||16
271006|NCT00383747|658131|P3|COMPLETED|Visit 1||16
271007|NCT00383747|658132|P2|COMPLETED|Visit 1||14
271008|NCT00383747|658133|P1|COMPLETED|Visit 1||14
271009|NCT00383747|658130|P4|STARTED|Visit 1||16
271010|NCT00383747|658131|P3|STARTED|Visit 1||16
271011|NCT00383747|658132|P2|STARTED|Visit 1||14
271012|NCT00383747|658133|P1|STARTED|Visit 1||14
271013|NCT00383721|658158|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
271014|NCT00383721|658159|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
271015|NCT00383721|658160|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
271016|NCT00383721|658161|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
271017|NCT00383721|658162|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
271018|NCT00383721|658158|P5|COMPLETED|26-Week Treatment Safety Extension||8
271019|NCT00383721|658159|P4|COMPLETED|26-Week Treatment Safety Extension||131
271020|NCT00383721|658160|P3|COMPLETED|26-Week Treatment Safety Extension||126
271021|NCT00383721|658161|P2|COMPLETED|26-Week Treatment Safety Extension||136
271022|NCT00383721|658162|P1|COMPLETED|26-Week Treatment Safety Extension||126
271023|NCT00383721|658158|P5|STARTED|26-Week Treatment Safety Extension||8
271024|NCT00383721|658159|P4|STARTED|26-Week Treatment Safety Extension||148
271025|NCT00383721|658160|P3|STARTED|26-Week Treatment Safety Extension||149
271026|NCT00383721|658161|P2|STARTED|26-Week Treatment Safety Extension||153
271027|NCT00383721|658162|P1|STARTED|26-Week Treatment Safety Extension||145
271028|NCT00383721|658158|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
271029|NCT00383721|658159|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
271030|NCT00383721|658160|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
271031|NCT00383721|658161|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
271032|NCT00383721|658162|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
271033|NCT00383721|658158|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
271034|NCT00383721|658159|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
271035|NCT00383721|658160|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
271036|NCT00383721|658161|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
271037|NCT00383721|658162|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
271038|NCT00383721|658158|P5|STARTED|26-Week Double-Blind Treatment Period||236
271039|NCT00383721|658159|P4|STARTED|26-Week Double-Blind Treatment Period||243
271040|NCT00383721|658160|P3|STARTED|26-Week Double-Blind Treatment Period||253
271041|NCT00383721|658161|P2|STARTED|26-Week Double-Blind Treatment Period||239
271042|NCT00383721|658162|P1|STARTED|26-Week Double-Blind Treatment Period||225
271043|NCT00383643|658202|P3|NOT COMPLETED|Overall Study||1
271044|NCT00383643|658203|P2|NOT COMPLETED|Overall Study||1
271045|NCT00383643|658204|P1|NOT COMPLETED|Overall Study||1
271046|NCT00383643|658202|P3|COMPLETED|Overall Study||13
271047|NCT00383643|658203|P2|COMPLETED|Overall Study||15
271048|NCT00383643|658204|P1|COMPLETED|Overall Study||17
271049|NCT00383643|658202|P3|STARTED|Overall Study||14
271050|NCT00383643|658203|P2|STARTED|Overall Study||16
271051|NCT00383643|658204|P1|STARTED|Overall Study||18
271052|NCT00383565|658224|P1|NOT COMPLETED|Overall Study||0
271053|NCT00383565|658224|P1|COMPLETED|Overall Study||9
271054|NCT00383565|658224|P1|STARTED|Overall Study||9
271055|NCT00383552|658234|P4|NOT COMPLETED|Overall Study||72
271056|NCT00383552|658235|P3|NOT COMPLETED|Overall Study||61
271057|NCT00383552|658236|P2|NOT COMPLETED|Overall Study||41
271058|NCT00383552|658237|P1|NOT COMPLETED|Overall Study||36
271059|NCT00383552|658234|P4|COMPLETED|Overall Study||116
271060|NCT00383552|658235|P3|COMPLETED|Overall Study||127
271061|NCT00383552|658236|P2|COMPLETED|Overall Study||147
271062|NCT00383552|658237|P1|COMPLETED|Overall Study||146
271063|NCT00383552|658234|P4|STARTED|Overall Study||188
271064|NCT00383552|658235|P3|STARTED|Overall Study||188
271065|NCT00383552|658236|P2|STARTED|Overall Study||188
271066|NCT00383552|658237|P1|STARTED|Overall Study||182
271067|NCT00383500|658279|P3|NOT COMPLETED|Overall Study||2
271068|NCT00383500|658280|P2|NOT COMPLETED|Overall Study||3
271069|NCT00383500|658281|P1|NOT COMPLETED|Overall Study||8
271070|NCT00383500|658279|P3|COMPLETED|Overall Study||22
271071|NCT00383500|658280|P2|COMPLETED|Overall Study||21
271072|NCT00383500|658281|P1|COMPLETED|Overall Study||19
271073|NCT00383500|658279|P3|STARTED|Overall Study||24
271074|NCT00383500|658280|P2|STARTED|Overall Study||24
271075|NCT00383500|658281|P1|STARTED|Overall Study||27
271076|NCT00383435|658297|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
271077|NCT00383435|658298|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
271078|NCT00383435|658299|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
271079|NCT00383435|658300|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
271080|NCT00383435|658301|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
271081|NCT00383435|658297|P5|COMPLETED|26-Week Treatment Safety Extension||10
271082|NCT00383435|658298|P4|COMPLETED|26-Week Treatment Safety Extension||116
271083|NCT00383435|658299|P3|COMPLETED|26-Week Treatment Safety Extension||108
271084|NCT00383435|658300|P2|COMPLETED|26-Week Treatment Safety Extension||121
271085|NCT00383435|658301|P1|COMPLETED|26-Week Treatment Safety Extension||117
271086|NCT00383435|658297|P5|STARTED|26-Week Treatment Safety Extension||13
271087|NCT00383435|658298|P4|STARTED|26-Week Treatment Safety Extension||131
271088|NCT00383435|658299|P3|STARTED|26-Week Treatment Safety Extension||124
271089|NCT00383435|658300|P2|STARTED|26-Week Treatment Safety Extension||130
271090|NCT00383435|658301|P1|STARTED|26-Week Treatment Safety Extension||131
271091|NCT00383435|658297|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
271092|NCT00383435|658298|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
271093|NCT00383435|658299|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
271094|NCT00383435|658300|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
271095|NCT00383435|658301|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
271096|NCT00383435|658297|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
271097|NCT00383435|658298|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
271098|NCT00383435|658299|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
271099|NCT00383435|658300|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
271100|NCT00383435|658301|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
271101|NCT00383435|658297|P5|STARTED|26-Week Double-Blind Treatment Period||212
271102|NCT00383435|658298|P4|STARTED|26-Week Double-Blind Treatment Period||209
271103|NCT00383435|658299|P3|STARTED|26-Week Double-Blind Treatment Period||210
271104|NCT00383435|658300|P2|STARTED|26-Week Double-Blind Treatment Period||207
271105|NCT00383435|658301|P1|STARTED|26-Week Double-Blind Treatment Period||217
271106|NCT00383331|658340|P2|NOT COMPLETED|Overall Study||1
271107|NCT00383331|658341|P1|NOT COMPLETED|Overall Study||0
271108|NCT00383331|658340|P2|COMPLETED|Overall Study||8
271109|NCT00383331|658341|P1|COMPLETED|Overall Study||10
271110|NCT00383331|658340|P2|STARTED|Overall Study||9
271111|NCT00383331|658341|P1|STARTED|Overall Study||10
271112|NCT00383266|658357|P1|NOT COMPLETED|Overall Study||0
271113|NCT00383266|658357|P1|COMPLETED|Overall Study||9
271114|NCT00383266|658357|P1|STARTED|Overall Study||9
271115|NCT00383240|658370|P4|NOT COMPLETED|Overall Study||77
271116|NCT00383240|658371|P3|NOT COMPLETED|Overall Study||85
271117|NCT00383240|658372|P2|NOT COMPLETED|Overall Study||33
271118|NCT00383240|658373|P1|NOT COMPLETED|Overall Study||35
271119|NCT00383240|658370|P4|COMPLETED|Overall Study||119
271120|NCT00383240|658371|P3|COMPLETED|Overall Study||117
271121|NCT00383240|658372|P2|COMPLETED|Overall Study||159
271122|NCT00383240|658373|P1|COMPLETED|Overall Study||156
271123|NCT00383240|658370|P4|STARTED|Overall Study||196
271124|NCT00383240|658371|P3|STARTED|Overall Study||202
271125|NCT00383240|658372|P2|STARTED|Overall Study||192
271126|NCT00383240|658373|P1|STARTED|Overall Study||191
271127|NCT00383162|658404|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
271128|NCT00383162|658405|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
271129|NCT00383162|658404|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
271130|NCT00383162|658405|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
271131|NCT00383162|658404|P2|STARTED|Migraine Attack 2 (Period 2)||73
271132|NCT00383162|658405|P1|STARTED|Migraine Attack 2 (Period 2)||67
271133|NCT00383162|658404|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
271134|NCT00383162|658405|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
271135|NCT00383162|658404|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
271136|NCT00383162|658405|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
271137|NCT00383162|658404|P2|STARTED|Migraine Attack 1 (Period 1)||86
271138|NCT00383162|658405|P1|STARTED|Migraine Attack 1 (Period 1)||87
271139|NCT00383149|658447|P1|NOT COMPLETED|Overall Study||54
271140|NCT00383149|658447|P1|COMPLETED|Overall Study||0
271141|NCT00383149|658447|P1|STARTED|Overall Study||54
271142|NCT00383123|658466|P2|NOT COMPLETED|Overall Study||86
271143|NCT00383123|658467|P1|NOT COMPLETED|Overall Study||111
271144|NCT00383123|658466|P2|COMPLETED|Overall Study||1124
271145|NCT00383123|658467|P1|COMPLETED|Overall Study||2004
271146|NCT00383123|658466|P2|STARTED|Overall Study||1210
271147|NCT00383123|658467|P1|STARTED|Overall Study||2115
271148|NCT00383110|658489|P2|NOT COMPLETED|Overall Study||0
271149|NCT00383110|658490|P1|NOT COMPLETED|Overall Study||0
271150|NCT00383110|658489|P2|COMPLETED|Overall Study||150
271151|NCT00383110|658490|P1|COMPLETED|Overall Study||150
271152|NCT00383110|658489|P2|STARTED|Overall Study||150
271153|NCT00383110|658490|P1|STARTED|Overall Study||150
271154|NCT00383084|658508|P2|NOT COMPLETED|Overall Study||10
271155|NCT00383084|658509|P1|NOT COMPLETED|Overall Study||12
271156|NCT00383084|658508|P2|COMPLETED|Overall Study||28
271157|NCT00383084|658509|P1|COMPLETED|Overall Study||34
271158|NCT00383084|658508|P2|STARTED|Overall Study||38
271159|NCT00383084|658509|P1|STARTED|Overall Study||46
271160|NCT00383071|658525|P4|NOT COMPLETED|Overall Study||3
271161|NCT00383071|658526|P3|NOT COMPLETED|Overall Study||7
271162|NCT00383071|658527|P2|NOT COMPLETED|Overall Study||4
271163|NCT00383071|658528|P1|NOT COMPLETED|Overall Study||0
271164|NCT00383071|658525|P4|COMPLETED|Overall Study||22
271165|NCT00383071|658526|P3|COMPLETED|Overall Study||44
271166|NCT00383071|658527|P2|COMPLETED|Overall Study||21
271167|NCT00383071|658528|P1|COMPLETED|Overall Study||25
271168|NCT00383071|658525|P4|STARTED|Overall Study||25
271169|NCT00383071|658526|P3|STARTED|Overall Study||51
271170|NCT00383071|658527|P2|STARTED|Overall Study||25
271171|NCT00383071|658528|P1|STARTED|Overall Study||25
271172|NCT00383019|658540|P2|NOT COMPLETED|Overall Study||2
271173|NCT00383019|658541|P1|NOT COMPLETED|Overall Study||5
271174|NCT00383019|658540|P2|COMPLETED|Overall Study||143
271175|NCT00383019|658541|P1|COMPLETED|Overall Study||139
271176|NCT00383019|658540|P2|STARTED|Overall Study||145
271177|NCT00383019|658541|P1|STARTED|Overall Study||144
271178|NCT00382993|658563|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
271179|NCT00382993|658564|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
271180|NCT00382993|658563|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
271181|NCT00382993|658564|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
271182|NCT00382993|658563|P2|STARTED|Migraine Attack 2 (Period 2)||67
271183|NCT00382993|658564|P1|STARTED|Migraine Attack 2 (Period 2)||70
271184|NCT00382993|658563|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
271185|NCT00382993|658564|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
271186|NCT00382993|658563|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
271187|NCT00382993|658564|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
271188|NCT00382993|658563|P2|STARTED|Migraine Attack 1 (Period 1)||85
271189|NCT00382993|658564|P1|STARTED|Migraine Attack 1 (Period 1)||84
271190|NCT00382967|658608|P2|NOT COMPLETED|Overall Study||1
271191|NCT00382967|658609|P1|NOT COMPLETED|Overall Study||1
271192|NCT00382967|658608|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
271193|NCT00382967|658609|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
271194|NCT00382967|658608|P2|STARTED|Overall Study||138
271195|NCT00382967|658609|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
271196|NCT00382928|658619|P2|NOT COMPLETED|Overall Study||0
271197|NCT00382928|658620|P1|NOT COMPLETED|Overall Study||0
271198|NCT00382928|658619|P2|COMPLETED|Overall Study||95
271199|NCT00382928|658620|P1|COMPLETED|Overall Study||97
271200|NCT00382928|658619|P2|STARTED|Overall Study||95
271201|NCT00382928|658620|P1|STARTED|Overall Study||97
271202|NCT00382863|658634|P2|NOT COMPLETED|Overall Study||36
271203|NCT00382863|658635|P1|NOT COMPLETED|Overall Study||15
271204|NCT00382863|658634|P2|COMPLETED|Overall Study||78
271205|NCT00382863|658635|P1|COMPLETED|Overall Study||81
271206|NCT00382863|658634|P2|STARTED|Overall Study||114
271207|NCT00382863|658635|P1|STARTED|Overall Study||96
271208|NCT00382785|658691|P2|NOT COMPLETED|Overall Study||0
271209|NCT00382785|658692|P1|NOT COMPLETED|Overall Study||0
271210|NCT00382785|658691|P2|COMPLETED|Overall Study||26
271211|NCT00382785|658692|P1|COMPLETED|Overall Study||25
271212|NCT00382785|658691|P2|STARTED|Overall Study||26
271213|NCT00382785|658692|P1|STARTED|Overall Study||25
271214|NCT00382733|658702|P5|NOT COMPLETED|Overall Study||0
271215|NCT00382733|658703|P4|NOT COMPLETED|Overall Study||0
271216|NCT00382733|658704|P3|NOT COMPLETED|Overall Study||0
271217|NCT00382733|658705|P2|NOT COMPLETED|Overall Study||1
271218|NCT00382733|658706|P1|NOT COMPLETED|Overall Study||0
271219|NCT00382733|658702|P5|COMPLETED|Overall Study||2
271220|NCT00382733|658703|P4|COMPLETED|Overall Study||14
271221|NCT00382733|658704|P3|COMPLETED|Overall Study||3
271222|NCT00382733|658705|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
271223|NCT00382733|658706|P1|COMPLETED|Overall Study||3
271224|NCT00382733|658702|P5|STARTED|Overall Study||2
271225|NCT00382733|658703|P4|STARTED|Overall Study||14
271226|NCT00382733|658704|P3|STARTED|Overall Study||3
271227|NCT00382733|658705|P2|STARTED|Overall Study||4
271228|NCT00382733|658706|P1|STARTED|Overall Study||3
271229|NCT00382720|658727|P3|NOT COMPLETED|Overall Study||86
271230|NCT00382720|658728|P2|NOT COMPLETED|Overall Study||89
271231|NCT00382720|658729|P1|NOT COMPLETED|Overall Study||79
271232|NCT00382720|658727|P3|COMPLETED|Overall Study||0
271233|NCT00382720|658728|P2|COMPLETED|Overall Study||0
271234|NCT00382720|658729|P1|COMPLETED|Overall Study||0
271235|NCT00382720|658727|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
271236|NCT00382720|658728|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
271237|NCT00382720|658729|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
271238|NCT00382720|658727|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
271239|NCT00382720|658728|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
271240|NCT00382720|658729|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
271241|NCT00382720|658727|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
271242|NCT00382720|658728|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
271243|NCT00382720|658729|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
271244|NCT00382720|658727|P3|STARTED|Overall Study||86
271245|NCT00382720|658728|P2|STARTED|Overall Study||89
271246|NCT00382720|658729|P1|STARTED|Overall Study||79
271247|NCT00382590|658745|P2|NOT COMPLETED|Overall Study||0
271248|NCT00382590|658746|P1|NOT COMPLETED|Overall Study||0
271249|NCT00382590|658745|P2|COMPLETED|Overall Study||6
271250|NCT00382590|658746|P1|COMPLETED|Overall Study||4
271251|NCT00382590|658745|P2|STARTED|Overall Study||6
271252|NCT00382590|658746|P1|STARTED|Overall Study||4
271253|NCT00382408|658754|P2|NOT COMPLETED|Overall Study||54
271254|NCT00382408|658755|P1|NOT COMPLETED|Overall Study||144
271255|NCT00382408|658754|P2|COMPLETED|Overall Study||955
271256|NCT00382408|658755|P1|COMPLETED|Overall Study||2887
271257|NCT00382408|658754|P2|STARTED|Overall Study||1009
271258|NCT00382408|658755|P1|STARTED|Overall Study||3031
271259|NCT00382291|658782|P3|NOT COMPLETED|Overall Study||8
271260|NCT00382291|658783|P2|NOT COMPLETED|Overall Study||7
271261|NCT00382291|658784|P1|NOT COMPLETED|Overall Study||4
271262|NCT00382291|658782|P3|COMPLETED|Overall Study||13
271263|NCT00382291|658783|P2|COMPLETED|Overall Study||10
271264|NCT00382291|658784|P1|COMPLETED|Overall Study||14
271265|NCT00382291|658782|P3|STARTED|Overall Study||21
271266|NCT00382291|658783|P2|STARTED|Overall Study||17
271267|NCT00382291|658784|P1|STARTED|Overall Study||18
271268|NCT00382174|658797|P3|NOT COMPLETED|Overall Study||21
271269|NCT00382174|658798|P2|NOT COMPLETED|Overall Study||17
271270|NCT00382174|658799|P1|NOT COMPLETED|Overall Study||4
271271|NCT00382174|658797|P3|COMPLETED|Overall Study||51
271272|NCT00382174|658798|P2|COMPLETED|Overall Study||37
271273|NCT00382174|658799|P1|COMPLETED|Overall Study||14
271274|NCT00382174|658797|P3|STARTED|Overall Study||72
271275|NCT00382174|658798|P2|STARTED|Overall Study||54
271276|NCT00382174|658799|P1|STARTED|Overall Study||18
271277|NCT00382148|658812|P2|NOT COMPLETED|Overall Study||0
271278|NCT00382148|658813|P1|NOT COMPLETED|Overall Study||1
271279|NCT00382148|658812|P2|COMPLETED|Overall Study||7
271280|NCT00382148|658813|P1|COMPLETED|Overall Study||3
271281|NCT00382148|658812|P2|STARTED|Overall Study||7
271282|NCT00382148|658813|P1|STARTED|Overall Study||4
271283|NCT00382109|658827|P2|NOT COMPLETED|Overall Study||4
271284|NCT00382109|658828|P1|NOT COMPLETED|Overall Study||12
271285|NCT00382109|658827|P2|COMPLETED|Overall Study||66
271286|NCT00382109|658828|P1|COMPLETED|Overall Study||64
271287|NCT00382109|658827|P2|STARTED|Overall Study||70
271288|NCT00382109|658828|P1|STARTED|Overall Study||76
271289|NCT00382031|658850|P2|NOT COMPLETED|Overall Study||0
271290|NCT00382031|658851|P1|NOT COMPLETED|Overall Study||0
271291|NCT00382031|658850|P2|COMPLETED|Overall Study||95
271292|NCT00382031|658851|P1|COMPLETED|Overall Study||191
271293|NCT00382031|658850|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
271294|NCT00382031|658851|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
271295|NCT00382018|658867|P4|NOT COMPLETED|Overall Study||59
271296|NCT00382018|658868|P3|NOT COMPLETED|Overall Study||64
271297|NCT00382018|658869|P2|NOT COMPLETED|Overall Study||165
271298|NCT00382018|658870|P1|NOT COMPLETED|Overall Study||0
271299|NCT00382018|658867|P4|COMPLETED|Overall Study||0
271300|NCT00382018|658868|P3|COMPLETED|Overall Study||0
271301|NCT00382018|658869|P2|COMPLETED|Overall Study||0
271302|NCT00382018|658870|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
271303|NCT00382018|658867|P4|STARTED|Overall Study||59
271304|NCT00382018|658868|P3|STARTED|Overall Study||64
271305|NCT00382018|658869|P2|STARTED|Overall Study||165
271306|NCT00382018|658870|P1|STARTED|Overall Study||276
271307|NCT00381940|658888|P1|NOT COMPLETED|Overall Study||5
271308|NCT00381940|658888|P1|COMPLETED|Overall Study||21
271309|NCT00381940|658888|P1|STARTED|Overall Study||26
271310|NCT00381888|658892|P1|NOT COMPLETED|Overall Study||17
271311|NCT00381888|658892|P1|COMPLETED|Overall Study||27
271312|NCT00381888|658892|P1|STARTED|Overall Study||44
271313|NCT00381862|658897|P1|NOT COMPLETED|Overall Study||10
271314|NCT00381862|658897|P1|COMPLETED|Overall Study||44
271315|NCT00381862|658897|P1|STARTED|Overall Study||54
271316|NCT00381849|658903|P2|NOT COMPLETED|Open-label||0
271317|NCT00381849|658904|P1|NOT COMPLETED|Open-label||0
271318|NCT00381849|658903|P2|COMPLETED|Open-label||9
271319|NCT00381849|658904|P1|COMPLETED|Open-label||10
271320|NCT00381849|658903|P2|STARTED|Open-label||9
271321|NCT00381849|658904|P1|STARTED|Open-label||10
271322|NCT00381849|658903|P2|NOT COMPLETED|Second Intervention||0
271323|NCT00381849|658904|P1|NOT COMPLETED|Second Intervention||0
271324|NCT00381849|658903|P2|COMPLETED|Second Intervention||9
271325|NCT00381849|658904|P1|COMPLETED|Second Intervention||10
271326|NCT00381849|658903|P2|STARTED|Second Intervention||9
271327|NCT00381849|658904|P1|STARTED|Second Intervention||10
271328|NCT00381849|658903|P2|NOT COMPLETED|Wash Out||1
271329|NCT00381849|658904|P1|NOT COMPLETED|Wash Out||0
271330|NCT00381849|658903|P2|COMPLETED|Wash Out||9
271331|NCT00381849|658904|P1|COMPLETED|Wash Out||10
271332|NCT00381849|658903|P2|STARTED|Wash Out||10
271333|NCT00381849|658904|P1|STARTED|Wash Out||10
271334|NCT00381849|658903|P2|NOT COMPLETED|First Intervention||0
271335|NCT00381849|658904|P1|NOT COMPLETED|First Intervention||0
271336|NCT00381849|658903|P2|COMPLETED|First Intervention||10
271337|NCT00381849|658904|P1|COMPLETED|First Intervention||10
271338|NCT00381849|658903|P2|STARTED|First Intervention||10
271339|NCT00381849|658904|P1|STARTED|First Intervention||10
271340|NCT00381810|658922|P1|NOT COMPLETED|B Cell Follow-up||7
271341|NCT00381810|658922|P1|COMPLETED|B Cell Follow-up||0
271342|NCT00381810|658922|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
271343|NCT00381810|658922|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
271344|NCT00381810|658922|P1|COMPLETED|Treatment and Safety Follow-up||16
271345|NCT00381810|658922|P1|STARTED|Treatment and Safety Follow-up||31
271346|NCT00381797|658931|P5|NOT COMPLETED|Overall Study||2
271347|NCT00381797|658932|P4|NOT COMPLETED|Overall Study||1
271348|NCT00381797|658933|P3|NOT COMPLETED|Overall Study||0
271349|NCT00381797|658934|P2|NOT COMPLETED|Overall Study||1
271350|NCT00381797|658935|P1|NOT COMPLETED|Overall Study||1
271351|NCT00381797|658931|P5|COMPLETED|Overall Study||35
271352|NCT00381797|658932|P4|COMPLETED|Overall Study||14
271353|NCT00381797|658933|P3|COMPLETED|Overall Study||10
271354|NCT00381797|658934|P2|COMPLETED|Overall Study||16
271355|NCT00381797|658935|P1|COMPLETED|Overall Study||17
271356|NCT00381797|658931|P5|STARTED|Overall Study||37
271357|NCT00381797|658932|P4|STARTED|Overall Study||15
271358|NCT00381797|658933|P3|STARTED|Overall Study||10
271359|NCT00381797|658934|P2|STARTED|Overall Study||17
271360|NCT00381797|658935|P1|STARTED|Overall Study||18
271361|NCT00381706|659010|P3|NOT COMPLETED|Overall Study||1
271362|NCT00381706|659011|P2|NOT COMPLETED|Overall Study||2
271363|NCT00381706|659012|P1|NOT COMPLETED|Overall Study||7
271364|NCT00381706|659010|P3|COMPLETED|Overall Study||79
271365|NCT00381706|659011|P2|COMPLETED|Overall Study||81
271366|NCT00381706|659012|P1|COMPLETED|Overall Study||75
271367|NCT00381706|659010|P3|STARTED|Overall Study||80
271368|NCT00381706|659011|P2|STARTED|Overall Study||83
271369|NCT00381706|659012|P1|STARTED|Overall Study||82
271370|NCT00381693|659035|P1|NOT COMPLETED|Overall Study||8
271371|NCT00381693|659035|P1|COMPLETED|Overall Study||2
271372|NCT00381693|659035|P1|STARTED|Overall Study||10
271373|NCT00381680|659044|P2|NOT COMPLETED|Overall Study||50
271374|NCT00381680|659045|P1|NOT COMPLETED|Overall Study||125
271375|NCT00381680|659044|P2|COMPLETED|Overall Study||19
271376|NCT00381680|659045|P1|COMPLETED|Overall Study||81
271377|NCT00381680|659044|P2|STARTED|Overall Study||69
271378|NCT00381680|659045|P1|STARTED|Overall Study||206
271379|NCT00381641|659062|P2|NOT COMPLETED|Overall Study||2
271380|NCT00381641|659063|P1|NOT COMPLETED|Overall Study||0
271381|NCT00381641|659062|P2|COMPLETED|Overall Study||23
271382|NCT00381641|659063|P1|COMPLETED|Overall Study||38
271383|NCT00381641|659062|P2|STARTED|Overall Study||25
271384|NCT00381641|659063|P1|STARTED|Overall Study||38
271385|NCT00381628|659079|P4|NOT COMPLETED|Overall Study||0
271386|NCT00381628|659080|P3|NOT COMPLETED|Overall Study||0
271387|NCT00381628|659081|P2|NOT COMPLETED|Overall Study||0
271388|NCT00381628|659082|P1|NOT COMPLETED|Overall Study||0
271389|NCT00381628|659079|P4|COMPLETED|Overall Study||14
271390|NCT00381628|659080|P3|COMPLETED|Overall Study||0
271391|NCT00381628|659081|P2|COMPLETED|Overall Study||27
271392|NCT00381628|659082|P1|COMPLETED|Overall Study||18
271393|NCT00381628|659079|P4|STARTED|Overall Study||14
271394|NCT00381628|659080|P3|STARTED|Overall Study||0
271395|NCT00381628|659081|P2|STARTED|Overall Study||27
271396|NCT00381628|659082|P1|STARTED|Overall Study||18
271397|NCT00381615|659096|P4|NOT COMPLETED|Overall Study||2
271398|NCT00381615|659097|P3|NOT COMPLETED|Overall Study||1
271399|NCT00381615|659098|P2|NOT COMPLETED|Overall Study||5
271400|NCT00381615|659099|P1|NOT COMPLETED|Overall Study||4
271401|NCT00381615|659096|P4|COMPLETED|Overall Study||22
271402|NCT00381615|659097|P3|COMPLETED|Overall Study||24
271403|NCT00381615|659098|P2|COMPLETED|Overall Study||45
271404|NCT00381615|659099|P1|COMPLETED|Overall Study||44
271405|NCT00381615|659096|P4|STARTED|Overall Study||24
271406|NCT00381615|659097|P3|STARTED|Overall Study||25
271407|NCT00381615|659098|P2|STARTED|Overall Study||50
271408|NCT00381615|659099|P1|STARTED|Overall Study||48
271409|NCT00381563|659151|P2|NOT COMPLETED|Overall Study||6
271410|NCT00381563|659152|P1|NOT COMPLETED|Overall Study||7
271411|NCT00381563|659151|P2|COMPLETED|Overall Study||33
271412|NCT00381563|659152|P1|COMPLETED|Overall Study||34
271413|NCT00381563|659151|P2|STARTED|Overall Study||39
271414|NCT00381563|659152|P1|STARTED|Overall Study||41
271415|NCT00381550|659159|P1|NOT COMPLETED|Overall Study||0
271416|NCT00381550|659159|P1|COMPLETED|Overall Study||35
271417|NCT00381550|659159|P1|STARTED|Overall Study||35
271418|NCT00381485|659167|P4|NOT COMPLETED|Double-Blind Treatment Period||33
271419|NCT00381485|659168|P3|NOT COMPLETED|Double-Blind Treatment Period||25
271420|NCT00381485|659169|P2|NOT COMPLETED|Double-Blind Treatment Period||27
271421|NCT00381485|659170|P1|NOT COMPLETED|Double-Blind Treatment Period||0
271422|NCT00381485|659167|P4|COMPLETED|Double-Blind Treatment Period||207
271423|NCT00381485|659168|P3|COMPLETED|Double-Blind Treatment Period||208
271424|NCT00381485|659169|P2|COMPLETED|Double-Blind Treatment Period||228
271425|NCT00381485|659170|P1|COMPLETED|Double-Blind Treatment Period||0
271426|NCT00381485|659167|P4|STARTED|Double-Blind Treatment Period||240
271427|NCT00381485|659168|P3|STARTED|Double-Blind Treatment Period||233
271428|NCT00381485|659169|P2|STARTED|Double-Blind Treatment Period||255
271429|NCT00381485|659170|P1|STARTED|Double-Blind Treatment Period||0
271430|NCT00381485|659167|P4|NOT COMPLETED|Open-Label Run-In Period||0
271431|NCT00381485|659168|P3|NOT COMPLETED|Open-Label Run-In Period||0
271432|NCT00381485|659169|P2|NOT COMPLETED|Open-Label Run-In Period||0
271433|NCT00381485|659170|P1|NOT COMPLETED|Open-Label Run-In Period||106
271434|NCT00381485|659167|P4|COMPLETED|Open-Label Run-In Period||0
271435|NCT00381485|659168|P3|COMPLETED|Open-Label Run-In Period||0
271436|NCT00381485|659169|P2|COMPLETED|Open-Label Run-In Period||0
271437|NCT00381485|659170|P1|COMPLETED|Open-Label Run-In Period||728
271438|NCT00381485|659167|P4|STARTED|Open-Label Run-In Period||0
271439|NCT00381485|659168|P3|STARTED|Open-Label Run-In Period||0
271440|NCT00381485|659169|P2|STARTED|Open-Label Run-In Period||0
271441|NCT00381485|659170|P1|STARTED|Open-Label Run-In Period||834
271442|NCT00381381|659188|P1|NOT COMPLETED|Overall Study||64
271443|NCT00381381|659188|P1|COMPLETED|Overall Study||135
271444|NCT00381381|659188|P1|STARTED|Overall Study||199
271445|NCT00381303|659197|P2|NOT COMPLETED|Overall Study||33
271446|NCT00381303|659198|P1|NOT COMPLETED|Overall Study||94
271447|NCT00381303|659197|P2|COMPLETED|Overall Study||109
271448|NCT00381303|659198|P1|COMPLETED|Overall Study||193
271449|NCT00381303|659197|P2|STARTED|Overall Study||142
271450|NCT00381303|659198|P1|STARTED|Overall Study||287
271451|NCT00381238|659258|P1|NOT COMPLETED|Overall Study||12
271452|NCT00381238|659258|P1|COMPLETED|Overall Study||21
271453|NCT00381238|659258|P1|STARTED|Overall Study||33
271454|NCT00381095|659274|P2|NOT COMPLETED|Overall Study||21
271455|NCT00381095|659275|P1|NOT COMPLETED|Overall Study||13
271456|NCT00381095|659274|P2|COMPLETED|Overall Study||59
271457|NCT00381095|659275|P1|COMPLETED|Overall Study||59
271458|NCT00381095|659274|P2|STARTED|Overall Study||80
271459|NCT00381095|659275|P1|STARTED|Overall Study||72
271460|NCT00381043|659307|P2|NOT COMPLETED|Overall Study||8
271461|NCT00381043|659308|P1|NOT COMPLETED|Overall Study||12
271462|NCT00381043|659307|P2|COMPLETED|Overall Study||41
271463|NCT00381043|659308|P1|COMPLETED|Overall Study||39
271464|NCT00381043|659307|P2|STARTED|Overall Study||49
271465|NCT00381043|659308|P1|STARTED|Overall Study||51
271466|NCT00381004|659326|P1|NOT COMPLETED|Overall Study||0
271467|NCT00381004|659326|P1|COMPLETED|Overall Study||60
271468|NCT00381004|659326|P1|STARTED|Overall Study||60
271469|NCT00380978|659334|P2|NOT COMPLETED|Overall Study||10
271470|NCT00380978|659335|P1|NOT COMPLETED|Overall Study||2
271471|NCT00380978|659334|P2|COMPLETED|Overall Study||400
271472|NCT00380978|659335|P1|COMPLETED|Overall Study||406
271473|NCT00380978|659334|P2|STARTED|Overall Study||410
271474|NCT00380978|659335|P1|STARTED|Overall Study||408
271475|NCT00380874|659357|P2|NOT COMPLETED|Overall Study||10
271476|NCT00380874|659358|P1|NOT COMPLETED|Overall Study||13
271477|NCT00380874|659357|P2|COMPLETED|Overall Study||19
271478|NCT00380874|659358|P1|COMPLETED|Overall Study||19
271479|NCT00380874|659357|P2|STARTED|Overall Study||29
271480|NCT00380874|659358|P1|STARTED|Overall Study||32
271481|NCT00380861|659376|P2|NOT COMPLETED|Overall Study||17
271482|NCT00380861|659377|P1|NOT COMPLETED|Overall Study||18
271483|NCT00380861|659376|P2|COMPLETED|Overall Study||74
271484|NCT00380861|659377|P1|COMPLETED|Overall Study||75
271485|NCT00380861|659376|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
271486|NCT00380861|659377|P1|STARTED|Overall Study||93
271487|NCT00380718|659383|P1|NOT COMPLETED|Overall Study||18
271488|NCT00380718|659383|P1|COMPLETED|Overall Study||15
271489|NCT00380718|659383|P1|Received Escalated Dose in Cycle 2|Overall Study||25
271490|NCT00380718|659383|P1|Received at Least One Dose of Study Drug|Overall Study||33
271491|NCT00380718|659383|P1|STARTED|Overall Study||33
271492|NCT00380692|659395|P2|NOT COMPLETED|Study Period III - Open Label||12
271493|NCT00380692|659396|P1|NOT COMPLETED|Study Period III - Open Label||6
271494|NCT00380692|659395|P2|COMPLETED|Study Period III - Open Label||34
271495|NCT00380692|659396|P1|COMPLETED|Study Period III - Open Label||36
271496|NCT00380692|659395|P2|STARTED|Study Period III - Open Label||46
271497|NCT00380692|659396|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
271498|NCT00380692|659395|P2|NOT COMPLETED|Study Period II - Double Blind||3
271499|NCT00380692|659396|P1|NOT COMPLETED|Study Period II - Double Blind||5
271500|NCT00380692|659395|P2|COMPLETED|Study Period II - Double Blind||46
271501|NCT00380692|659396|P1|COMPLETED|Study Period II - Double Blind||43
271502|NCT00380692|659395|P2|STARTED|Study Period II - Double Blind||49
271503|NCT00380692|659396|P1|STARTED|Study Period II - Double Blind||48
271504|NCT00380588|659444|P2|NOT COMPLETED|Overall Study||40
271505|NCT00380588|659445|P1|NOT COMPLETED|Overall Study||39
271506|NCT00380588|659444|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
271507|NCT00380588|659445|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
271508|NCT00380588|659444|P2|Received at Least One Dose of Study Drug|Overall Study||42
271509|NCT00380588|659445|P1|Received at Least One Dose of Study Drug|Overall Study||41
271510|NCT00380588|659444|P2|STARTED|Overall Study||42
271511|NCT00380588|659445|P1|STARTED|Overall Study||42
271512|NCT00380367|659457|P1|NOT COMPLETED|Overall Study||2
271513|NCT00380367|659457|P1|COMPLETED|Overall Study||108
271514|NCT00380367|659457|P1|STARTED|Overall Study||110
271515|NCT00380250|659464|P2|NOT COMPLETED|Overall Study||55
271516|NCT00380250|659465|P1|NOT COMPLETED|Overall Study||99
271517|NCT00380250|659464|P2|COMPLETED|Overall Study||139
271518|NCT00380250|659465|P1|COMPLETED|Overall Study||297
271519|NCT00380250|659464|P2|STARTED|Overall Study||194
271520|NCT00380250|659465|P1|STARTED|Overall Study||396
271521|NCT00380081|659533|P6|NOT COMPLETED|Overall Study||1
271522|NCT00380081|659534|P5|NOT COMPLETED|Overall Study||1
271523|NCT00380081|659535|P4|NOT COMPLETED|Overall Study||0
271524|NCT00380081|659536|P3|NOT COMPLETED|Overall Study||0
271525|NCT00380081|659537|P2|NOT COMPLETED|Overall Study||0
271526|NCT00380081|659538|P1|NOT COMPLETED|Overall Study||0
271527|NCT00380081|659533|P6|COMPLETED|Overall Study||13
271528|NCT00380081|659534|P5|COMPLETED|Overall Study||12
271529|NCT00380081|659535|P4|COMPLETED|Overall Study||15
271530|NCT00380081|659536|P3|COMPLETED|Overall Study||13
271531|NCT00380081|659537|P2|COMPLETED|Overall Study||13
271532|NCT00380081|659538|P1|COMPLETED|Overall Study||14
271533|NCT00380081|659533|P6|STARTED|Overall Study||14
271534|NCT00380081|659534|P5|STARTED|Overall Study||13
271535|NCT00380081|659535|P4|STARTED|Overall Study||15
271536|NCT00380081|659536|P3|STARTED|Overall Study||13
271537|NCT00380081|659537|P2|STARTED|Overall Study||13
271538|NCT00380081|659538|P1|STARTED|Overall Study||14
271539|NCT00380068|659588|P1|NOT COMPLETED|Overall Study||69
271540|NCT00380068|659588|P1|COMPLETED|Overall Study||155
271541|NCT00380068|659588|P1|STARTED|Overall Study||224
271542|NCT00380029|659608|P1|NOT COMPLETED|Overall Study||0
271543|NCT00380029|659608|P1|COMPLETED|Overall Study||20
271544|NCT00380029|659608|P1|STARTED|Overall Study||20
271545|NCT00379912|659620|P2|NOT COMPLETED|Overall Study||0
271546|NCT00379912|659621|P1|NOT COMPLETED|Overall Study||1
271547|NCT00379912|659620|P2|COMPLETED|Overall Study||8
271548|NCT00379912|659621|P1|COMPLETED|Overall Study||6
271549|NCT00379912|659620|P2|STARTED|Overall Study||8
271550|NCT00379912|659621|P1|STARTED|Overall Study||7
271551|NCT00379899|659643|P2|NOT COMPLETED|Overall Study||40
271552|NCT00379899|659644|P1|NOT COMPLETED|Overall Study||40
271553|NCT00379899|659643|P2|COMPLETED|Overall Study||140
271554|NCT00379899|659644|P1|COMPLETED|Overall Study||140
271555|NCT00379899|659643|P2|STARTED|Overall Study||180
271556|NCT00379899|659644|P1|STARTED|Overall Study||180
271557|NCT00379834|659672|P1|NOT COMPLETED|Overall Study||2
271558|NCT00379834|659672|P1|COMPLETED|Overall Study||8
271559|NCT00379834|659672|P1|STARTED|Overall Study||10
271560|NCT00379821|659680|P4|NOT COMPLETED|Overall Study||79
271561|NCT00379821|659681|P3|NOT COMPLETED|Overall Study||67
271562|NCT00379821|659682|P2|NOT COMPLETED|Overall Study||89
271563|NCT00379821|659683|P1|NOT COMPLETED|Overall Study||73
271564|NCT00379821|659680|P4|COMPLETED|Overall Study||81
271565|NCT00379821|659681|P3|COMPLETED|Overall Study||93
271566|NCT00379821|659682|P2|COMPLETED|Overall Study||71
271567|NCT00379821|659683|P1|COMPLETED|Overall Study||87
271568|NCT00379821|659680|P4|STARTED|Overall Study||160
271569|NCT00379821|659681|P3|STARTED|Overall Study||160
271570|NCT00379821|659682|P2|STARTED|Overall Study||160
271571|NCT00379821|659683|P1|STARTED|Overall Study||160
271572|NCT00379808|659824|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
271573|NCT00379808|659825|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
271574|NCT00379808|659824|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
271575|NCT00379808|659825|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
271576|NCT00379808|659824|P2|STARTED|Intervention Period 2 (4 Weeks)||11
271577|NCT00379808|659825|P1|STARTED|Intervention Period 2 (4 Weeks)||11
271578|NCT00379808|659824|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
271579|NCT00379808|659825|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
271580|NCT00379808|659824|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
271581|NCT00379808|659825|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
271582|NCT00379808|659824|P2|STARTED|Intervention Period 1 (4 Weeks)||11
271583|NCT00379808|659825|P1|STARTED|Intervention Period 1 (4 Weeks)||11
271584|NCT00379795|659846|P5|NOT COMPLETED|Overall Study||49
271585|NCT00379795|659847|P4|NOT COMPLETED|Overall Study||68
271586|NCT00379795|659848|P3|NOT COMPLETED|Overall Study||93
271587|NCT00379795|659849|P2|NOT COMPLETED|Overall Study||51
271588|NCT00379795|659850|P1|NOT COMPLETED|Overall Study||476
271589|NCT00379795|659846|P5|COMPLETED|Overall Study||14
271590|NCT00379795|659847|P4|COMPLETED|Overall Study||6
271591|NCT00379795|659848|P3|COMPLETED|Overall Study||23
271592|NCT00379795|659849|P2|COMPLETED|Overall Study||23
271593|NCT00379795|659850|P1|COMPLETED|Overall Study||50
271594|NCT00379795|659846|P5|Received Ranibizumab in Extension Study|Overall Study||0
271595|NCT00379795|659847|P4|Received Ranibizumab in Extension Study|Overall Study||55
271596|NCT00379795|659848|P3|Received Ranibizumab in Extension Study|Overall Study||113
271597|NCT00379795|659849|P2|Received Ranibizumab in Extension Study|Overall Study||41
271598|NCT00379795|659850|P1|Received Ranibizumab in Extension Study|Overall Study||377
271599|NCT00379795|659846|P5|STARTED|Overall Study||63
271600|NCT00379795|659847|P4|STARTED|Overall Study||74
271601|NCT00379795|659848|P3|STARTED|Overall Study||116
271602|NCT00379795|659849|P2|STARTED|Overall Study||74
271603|NCT00379795|659850|P1|STARTED|Overall Study||526
271604|NCT00379769|659880|P6|NOT COMPLETED|Observational Follow-up||148
271605|NCT00379769|659881|P5|NOT COMPLETED|Observational Follow-up||149
271606|NCT00379769|659882|P4|NOT COMPLETED|Observational Follow-up||0
271607|NCT00379769|659883|P3|NOT COMPLETED|Observational Follow-up||0
271608|NCT00379769|659884|P2|NOT COMPLETED|Observational Follow-up||0
271609|NCT00379769|659885|P1|NOT COMPLETED|Observational Follow-up||0
271610|NCT00379769|659880|P6|COMPLETED|Observational Follow-up||1102
271611|NCT00379769|659881|P5|COMPLETED|Observational Follow-up||1131
271612|NCT00379769|659882|P4|COMPLETED|Observational Follow-up||0
271613|NCT00379769|659883|P3|COMPLETED|Observational Follow-up||0
271614|NCT00379769|659884|P2|COMPLETED|Observational Follow-up||0
271615|NCT00379769|659885|P1|COMPLETED|Observational Follow-up||0
271616|NCT00379769|659880|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
271617|NCT00379769|659881|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
271618|NCT00379769|659882|P4|STARTED|Observational Follow-up||0
271619|NCT00379769|659883|P3|STARTED|Observational Follow-up||0
271620|NCT00379769|659884|P2|STARTED|Observational Follow-up||0
271621|NCT00379769|659885|P1|STARTED|Observational Follow-up||0
271622|NCT00379769|659880|P6|NOT COMPLETED|Main Study||0
271623|NCT00379769|659881|P5|NOT COMPLETED|Main Study||0
271624|NCT00379769|659882|P4|NOT COMPLETED|Main Study||230
271625|NCT00379769|659883|P3|NOT COMPLETED|Main Study||207
271626|NCT00379769|659884|P2|NOT COMPLETED|Main Study||199
271627|NCT00379769|659885|P1|NOT COMPLETED|Main Study||178
271628|NCT00379769|659880|P6|COMPLETED|Main Study||0
271629|NCT00379769|659881|P5|COMPLETED|Main Study||0
271630|NCT00379769|659882|P4|COMPLETED|Main Study||892
271631|NCT00379769|659883|P3|COMPLETED|Main Study||896
271632|NCT00379769|659884|P2|COMPLETED|Main Study||906
271633|NCT00379769|659885|P1|COMPLETED|Main Study||939
271634|NCT00379769|659880|P6|STARTED|Main Study||0
271635|NCT00379769|659881|P5|STARTED|Main Study||0
271636|NCT00379769|659882|P4|STARTED|Main Study||1122
271637|NCT00379769|659883|P3|STARTED|Main Study||1103
271638|NCT00379769|659884|P2|STARTED|Main Study||1105
271639|NCT00379769|659885|P1|STARTED|Main Study||1117
271640|NCT00379639|660044|P5|NOT COMPLETED|Overall Study||6
271641|NCT00379639|660045|P4|NOT COMPLETED|Overall Study||6
271642|NCT00379639|660046|P3|NOT COMPLETED|Overall Study||9
271643|NCT00379639|660047|P2|NOT COMPLETED|Overall Study||5
271644|NCT00379639|660048|P1|NOT COMPLETED|Overall Study||3
271645|NCT00379639|660044|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
271646|NCT00379639|660045|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
271647|NCT00379639|660046|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
271648|NCT00379639|660047|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
271649|NCT00379639|660048|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
271650|NCT00379639|660044|P5|Completed 6 Cycles of Therapy|Overall Study||0
271651|NCT00379639|660045|P4|Completed 6 Cycles of Therapy|Overall Study||0
271652|NCT00379639|660046|P3|Completed 6 Cycles of Therapy|Overall Study||1
271653|NCT00379639|660047|P2|Completed 6 Cycles of Therapy|Overall Study||2
271654|NCT00379639|660048|P1|Completed 6 Cycles of Therapy|Overall Study||4
271738|NCT00379080|660228|P2|COMPLETED|Overall Study||15
271655|NCT00379639|660044|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
271656|NCT00379639|660045|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
271657|NCT00379639|660046|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
271658|NCT00379639|660047|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
271659|NCT00379639|660048|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
271660|NCT00379639|660044|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
271661|NCT00379639|660045|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
271662|NCT00379639|660046|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
271663|NCT00379639|660047|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
271664|NCT00379639|660048|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
271665|NCT00379587|660070|P1|NOT COMPLETED|Overall Study||2
271666|NCT00379587|660070|P1|COMPLETED|Overall Study||63
271667|NCT00379587|660070|P1|STARTED|Overall Study||65
271668|NCT00379574|660077|P1|NOT COMPLETED|Overall Study||0
271669|NCT00379574|660077|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
271670|NCT00379574|660077|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
271671|NCT00379353|660084|P2|NOT COMPLETED|Overall Study||6
271672|NCT00379353|660085|P1|NOT COMPLETED|Overall Study||11
271673|NCT00379353|660084|P2|COMPLETED|Overall Study||9
271674|NCT00379353|660085|P1|COMPLETED|Overall Study||5
271675|NCT00379353|660084|P2|STARTED|Overall Study||15
271676|NCT00379353|660085|P1|STARTED|Overall Study||16
271677|NCT00379340|660120|P5|NOT COMPLETED|Overall Study||14
271678|NCT00379340|660121|P4|NOT COMPLETED|Overall Study||13
271679|NCT00379340|660122|P3|NOT COMPLETED|Overall Study||2
271680|NCT00379340|660123|P2|NOT COMPLETED|Overall Study||3
271681|NCT00379340|660124|P1|NOT COMPLETED|Overall Study||13
271682|NCT00379340|660120|P5|COMPLETED|Overall Study||9
271683|NCT00379340|660121|P4|COMPLETED|Overall Study||37
271684|NCT00379340|660122|P3|COMPLETED|Overall Study||50
271685|NCT00379340|660123|P2|COMPLETED|Overall Study||132
271686|NCT00379340|660124|P1|COMPLETED|Overall Study||107
271687|NCT00379340|660120|P5|STARTED|Overall Study||23
271688|NCT00379340|660121|P4|STARTED|Overall Study||50
271689|NCT00379340|660122|P3|STARTED|Overall Study||52
271690|NCT00379340|660123|P2|STARTED|Overall Study||135
271691|NCT00379340|660124|P1|STARTED|Overall Study||120
271692|NCT00379288|660141|P4|NOT COMPLETED|Overall Study||8
271693|NCT00379288|660142|P3|NOT COMPLETED|Overall Study||10
271694|NCT00379288|660143|P2|NOT COMPLETED|Overall Study||22
271695|NCT00379288|660144|P1|NOT COMPLETED|Overall Study||19
271696|NCT00379288|660141|P4|COMPLETED|Overall Study||57
271697|NCT00379288|660142|P3|COMPLETED|Overall Study||58
271698|NCT00379288|660143|P2|COMPLETED|Overall Study||108
271699|NCT00379288|660144|P1|COMPLETED|Overall Study||122
271700|NCT00379288|660141|P4|STARTED|Overall Study||65
271701|NCT00379288|660142|P3|STARTED|Overall Study||68
271702|NCT00379288|660143|P2|STARTED|Overall Study||130
271703|NCT00379288|660144|P1|STARTED|Overall Study||141
271704|NCT00379236|660156|P3|NOT COMPLETED|Open-label Extension||55
271705|NCT00379236|660157|P2|NOT COMPLETED|Open-label Extension||0
271706|NCT00379236|660158|P1|NOT COMPLETED|Open-label Extension||0
271707|NCT00379236|660156|P3|COMPLETED|Open-label Extension||378
271708|NCT00379236|660157|P2|COMPLETED|Open-label Extension||0
271709|NCT00379236|660158|P1|COMPLETED|Open-label Extension||0
271710|NCT00379236|660156|P3|STARTED|Open-label Extension||433
271711|NCT00379236|660157|P2|STARTED|Open-label Extension||0
271712|NCT00379236|660158|P1|STARTED|Open-label Extension||0
271713|NCT00379236|660156|P3|NOT COMPLETED|Double-blind||0
271714|NCT00379236|660157|P2|NOT COMPLETED|Double-blind||36
271715|NCT00379236|660158|P1|NOT COMPLETED|Double-blind||36
271716|NCT00379236|660156|P3|COMPLETED|Double-blind||0
271717|NCT00379236|660157|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
271718|NCT00379236|660158|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
271719|NCT00379236|660156|P3|STARTED|Double-blind||0
271720|NCT00379236|660157|P2|STARTED|Double-blind||295
271721|NCT00379236|660158|P1|STARTED|Double-blind||293
271722|NCT00379210|660203|P2|NOT COMPLETED|Overall Study||7
271723|NCT00379210|660204|P1|NOT COMPLETED|Overall Study||10
271724|NCT00379210|660203|P2|COMPLETED|Overall Study||23
271725|NCT00379210|660204|P1|COMPLETED|Overall Study||20
271726|NCT00379210|660203|P2|STARTED|Overall Study||30
271727|NCT00379210|660204|P1|STARTED|Overall Study||30
271728|NCT00379197|660210|P1|NOT COMPLETED|Overall Study||5
271729|NCT00379197|660210|P1|COMPLETED|Overall Study||8
271730|NCT00379197|660210|P1|STARTED|Overall Study||13
271731|NCT00379145|660215|P1|NOT COMPLETED|Overall Study||0
271732|NCT00379145|660215|P1|COMPLETED|Overall Study||20
271733|NCT00379145|660215|P1|STARTED|Overall Study||20
271734|NCT00379080|660227|P3|NOT COMPLETED|Overall Study||0
271735|NCT00379080|660228|P2|NOT COMPLETED|Overall Study||4
271736|NCT00379080|660229|P1|NOT COMPLETED|Overall Study||0
271737|NCT00379080|660227|P3|COMPLETED|Overall Study||31
271739|NCT00379080|660229|P1|COMPLETED|Overall Study||6
271740|NCT00379080|660227|P3|STARTED|Overall Study||31
271741|NCT00379080|660228|P2|STARTED|Overall Study||19
271742|NCT00379080|660229|P1|STARTED|Overall Study||6
271743|NCT00378898|660274|P2|NOT COMPLETED|Overall Study||6
271744|NCT00378898|660275|P1|NOT COMPLETED|Overall Study||11
271745|NCT00378898|660274|P2|COMPLETED|Overall Study||11
271746|NCT00378898|660275|P1|COMPLETED|Overall Study||11
271747|NCT00378898|660274|P2|STARTED|Overall Study||17
271748|NCT00378898|660275|P1|STARTED|Overall Study||22
271749|NCT00378703|660287|P4|NOT COMPLETED|Overall Study||91
271750|NCT00378703|660288|P3|NOT COMPLETED|Overall Study||90
271751|NCT00378703|660289|P2|NOT COMPLETED|Overall Study||91
271752|NCT00378703|660290|P1|NOT COMPLETED|Overall Study||89
271753|NCT00378703|660287|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
271754|NCT00378703|660288|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
271755|NCT00378703|660289|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
271756|NCT00378703|660290|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
271757|NCT00378703|660287|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
271758|NCT00378703|660288|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
271759|NCT00378703|660289|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
271760|NCT00378703|660290|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
271761|NCT00378703|660287|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
271762|NCT00378703|660288|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
271763|NCT00378703|660289|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
271764|NCT00378703|660290|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
271765|NCT00378703|660287|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
271766|NCT00378703|660288|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
271767|NCT00378703|660289|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
271768|NCT00378703|660290|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
271769|NCT00378599|660312|P1|NOT COMPLETED|Overall Study||52
271770|NCT00378599|660312|P1|COMPLETED|Overall Study||73
271771|NCT00378599|660312|P1|STARTED|Overall Study||125
271772|NCT00378573|660316|P1|NOT COMPLETED|Follow-up||14
271773|NCT00378573|660316|P1|COMPLETED|Follow-up||3
271774|NCT00378573|660316|P1|STARTED|Follow-up||17
271775|NCT00378573|660316|P1|NOT COMPLETED|Treatment Period||17
271776|NCT00378573|660316|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
271777|NCT00378573|660316|P1|STARTED|Treatment Period||17
271778|NCT00378560|660324|P2|NOT COMPLETED|Overall Study||58
271779|NCT00378560|660325|P1|NOT COMPLETED|Overall Study||56
271780|NCT00378560|660324|P2|COMPLETED|Overall Study||454
271781|NCT00378560|660325|P1|COMPLETED|Overall Study||453
271782|NCT00378560|660324|P2|Vaccinated|Overall Study||512
271783|NCT00378560|660325|P1|Vaccinated|Overall Study||509
271784|NCT00378560|660324|P2|STARTED|Overall Study||512
271785|NCT00378560|660325|P1|STARTED|Overall Study||509
271786|NCT00378534|660339|P1|NOT COMPLETED|Overall Study||60
271787|NCT00378534|660339|P1|COMPLETED|Overall Study|Transplantation Recipients|55
271788|NCT00378534|660339|P1|STARTED|Overall Study||115
271789|NCT00378508|660345|P2|NOT COMPLETED|Overall Study||3
271790|NCT00378508|660346|P1|NOT COMPLETED|Overall Study||2
271791|NCT00378508|660345|P2|COMPLETED|Overall Study||31
271792|NCT00378508|660346|P1|COMPLETED|Overall Study||27
271793|NCT00378508|660345|P2|Received Intervention/Placebo|Overall Study||31
271794|NCT00378508|660346|P1|Received Intervention/Placebo|Overall Study||28
271795|NCT00378508|660345|P2|Randomized|Overall Study||34
271796|NCT00378508|660346|P1|Randomized|Overall Study||29
271797|NCT00378508|660345|P2|STARTED|Overall Study||34
271798|NCT00378508|660346|P1|STARTED|Overall Study||29
271799|NCT00378378|660365|P3|NOT COMPLETED|Overall Study||2
271800|NCT00378378|660366|P2|NOT COMPLETED|Overall Study||1
271801|NCT00378378|660367|P1|NOT COMPLETED|Overall Study||0
271802|NCT00378378|660365|P3|COMPLETED|Overall Study||24
271803|NCT00378378|660366|P2|COMPLETED|Overall Study||49
271804|NCT00378378|660367|P1|COMPLETED|Overall Study||51
271805|NCT00378378|660365|P3|STARTED|Overall Study||26
271806|NCT00378378|660366|P2|STARTED|Overall Study||50
271807|NCT00378378|660367|P1|STARTED|Overall Study||51
271808|NCT00378352|660380|P6|NOT COMPLETED|Efficacy Phase||7
271809|NCT00378352|660381|P5|NOT COMPLETED|Efficacy Phase||11
271810|NCT00378352|660382|P4|NOT COMPLETED|Efficacy Phase||0
271811|NCT00378352|660383|P3|NOT COMPLETED|Efficacy Phase||0
271812|NCT00378352|660384|P2|NOT COMPLETED|Efficacy Phase||0
271813|NCT00378352|660385|P1|NOT COMPLETED|Efficacy Phase||0
271814|NCT00378352|660380|P6|COMPLETED|Efficacy Phase||59
271815|NCT00378352|660381|P5|COMPLETED|Efficacy Phase||54
271816|NCT00378352|660382|P4|COMPLETED|Efficacy Phase||0
271817|NCT00378352|660383|P3|COMPLETED|Efficacy Phase||0
271818|NCT00378352|660384|P2|COMPLETED|Efficacy Phase||0
271819|NCT00378352|660385|P1|COMPLETED|Efficacy Phase||0
271820|NCT00378352|660380|P6|Safety Analysis|Efficacy Phase||64
271901|NCT00378352|660383|P3|STARTED|Dose Escalation 15,000 Units||0
271821|NCT00378352|660381|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
271822|NCT00378352|660382|P4|Safety Analysis|Efficacy Phase||0
271823|NCT00378352|660383|P3|Safety Analysis|Efficacy Phase||0
271824|NCT00378352|660384|P2|Safety Analysis|Efficacy Phase||0
271825|NCT00378352|660385|P1|Safety Analysis|Efficacy Phase||0
271826|NCT00378352|660380|P6|STARTED|Efficacy Phase||66
271827|NCT00378352|660381|P5|STARTED|Efficacy Phase||65
271828|NCT00378352|660382|P4|STARTED|Efficacy Phase||0
271829|NCT00378352|660383|P3|STARTED|Efficacy Phase||0
271830|NCT00378352|660384|P2|STARTED|Efficacy Phase||0
271831|NCT00378352|660385|P1|STARTED|Efficacy Phase||0
271832|NCT00378352|660380|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
271833|NCT00378352|660381|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
271834|NCT00378352|660382|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
271835|NCT00378352|660383|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
271836|NCT00378352|660384|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
271837|NCT00378352|660385|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
271838|NCT00378352|660380|P6|COMPLETED|Dose Escalation 60,000 Units||0
271839|NCT00378352|660381|P5|COMPLETED|Dose Escalation 60,000 Units||0
271840|NCT00378352|660382|P4|COMPLETED|Dose Escalation 60,000 Units||10
271841|NCT00378352|660383|P3|COMPLETED|Dose Escalation 60,000 Units||17
271842|NCT00378352|660384|P2|COMPLETED|Dose Escalation 60,000 Units||0
271843|NCT00378352|660385|P1|COMPLETED|Dose Escalation 60,000 Units||0
271844|NCT00378352|660380|P6|Safety Analysis|Dose Escalation 60,000 Units||0
271845|NCT00378352|660381|P5|Safety Analysis|Dose Escalation 60,000 Units||0
271846|NCT00378352|660382|P4|Safety Analysis|Dose Escalation 60,000 Units||11
271847|NCT00378352|660383|P3|Safety Analysis|Dose Escalation 60,000 Units||19
271848|NCT00378352|660384|P2|Safety Analysis|Dose Escalation 60,000 Units||0
271849|NCT00378352|660385|P1|Safety Analysis|Dose Escalation 60,000 Units||0
271850|NCT00378352|660380|P6|STARTED|Dose Escalation 60,000 Units||0
271851|NCT00378352|660381|P5|STARTED|Dose Escalation 60,000 Units||0
271852|NCT00378352|660382|P4|STARTED|Dose Escalation 60,000 Units||11
271853|NCT00378352|660383|P3|STARTED|Dose Escalation 60,000 Units||20
271854|NCT00378352|660384|P2|STARTED|Dose Escalation 60,000 Units||0
271855|NCT00378352|660385|P1|STARTED|Dose Escalation 60,000 Units||0
271856|NCT00378352|660380|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
271857|NCT00378352|660381|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
271858|NCT00378352|660382|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
271859|NCT00378352|660383|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
271860|NCT00378352|660384|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
271861|NCT00378352|660385|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
271862|NCT00378352|660380|P6|COMPLETED|Dose Escalation 30,000 Units||0
271863|NCT00378352|660381|P5|COMPLETED|Dose Escalation 30,000 Units||0
271864|NCT00378352|660382|P4|COMPLETED|Dose Escalation 30,000 Units||9
271865|NCT00378352|660383|P3|COMPLETED|Dose Escalation 30,000 Units||0
271866|NCT00378352|660384|P2|COMPLETED|Dose Escalation 30,000 Units||16
271867|NCT00378352|660385|P1|COMPLETED|Dose Escalation 30,000 Units||0
271868|NCT00378352|660380|P6|Safety Analysis|Dose Escalation 30,000 Units||0
271869|NCT00378352|660381|P5|Safety Analysis|Dose Escalation 30,000 Units||0
271870|NCT00378352|660382|P4|Safety Analysis|Dose Escalation 30,000 Units||11
271871|NCT00378352|660383|P3|Safety Analysis|Dose Escalation 30,000 Units||0
271872|NCT00378352|660384|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
271873|NCT00378352|660385|P1|Safety Analysis|Dose Escalation 30,000 Units||0
271874|NCT00378352|660380|P6|STARTED|Dose Escalation 30,000 Units||0
271875|NCT00378352|660381|P5|STARTED|Dose Escalation 30,000 Units||0
271876|NCT00378352|660382|P4|STARTED|Dose Escalation 30,000 Units||11
271877|NCT00378352|660383|P3|STARTED|Dose Escalation 30,000 Units||0
271878|NCT00378352|660384|P2|STARTED|Dose Escalation 30,000 Units||19
271879|NCT00378352|660385|P1|STARTED|Dose Escalation 30,000 Units||0
271880|NCT00378352|660380|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
271881|NCT00378352|660381|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
271882|NCT00378352|660382|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
271883|NCT00378352|660383|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
271884|NCT00378352|660384|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
271885|NCT00378352|660385|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
271886|NCT00378352|660380|P6|COMPLETED|Dose Escalation 15,000 Units||0
271887|NCT00378352|660381|P5|COMPLETED|Dose Escalation 15,000 Units||0
271888|NCT00378352|660382|P4|COMPLETED|Dose Escalation 15,000 Units||10
271889|NCT00378352|660383|P3|COMPLETED|Dose Escalation 15,000 Units||0
271890|NCT00378352|660384|P2|COMPLETED|Dose Escalation 15,000 Units||0
271891|NCT00378352|660385|P1|COMPLETED|Dose Escalation 15,000 Units||15
271892|NCT00378352|660380|P6|Safety Analysis|Dose Escalation 15,000 Units||0
271893|NCT00378352|660381|P5|Safety Analysis|Dose Escalation 15,000 Units||0
271894|NCT00378352|660382|P4|Safety Analysis|Dose Escalation 15,000 Units||11
271895|NCT00378352|660383|P3|Safety Analysis|Dose Escalation 15,000 Units||0
271896|NCT00378352|660384|P2|Safety Analysis|Dose Escalation 15,000 Units||0
271897|NCT00378352|660385|P1|Safety Analysis|Dose Escalation 15,000 Units||19
271898|NCT00378352|660380|P6|STARTED|Dose Escalation 15,000 Units||0
271899|NCT00378352|660381|P5|STARTED|Dose Escalation 15,000 Units||0
271900|NCT00378352|660382|P4|STARTED|Dose Escalation 15,000 Units||11
271902|NCT00378352|660384|P2|STARTED|Dose Escalation 15,000 Units||0
271903|NCT00378352|660385|P1|STARTED|Dose Escalation 15,000 Units||20
271904|NCT00378326|660407|P1|NOT COMPLETED|Overall Study||0
271905|NCT00378326|660407|P1|COMPLETED|Overall Study||26
271906|NCT00378326|660407|P1|STARTED|Overall Study||26
271907|NCT00378209|660413|P1|NOT COMPLETED|Overall Study||22
271908|NCT00378209|660413|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
271909|NCT00378209|660413|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
271910|NCT00378105|660423|P2|NOT COMPLETED|Overall Study||30
271911|NCT00378105|660424|P1|NOT COMPLETED|Overall Study||20
271912|NCT00378105|660423|P2|COMPLETED|Overall Study||5
271913|NCT00378105|660424|P1|COMPLETED|Overall Study||11
271914|NCT00378105|660423|P2|STARTED|Overall Study||35
271915|NCT00378105|660424|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
271916|NCT00378079|660436|P3|NOT COMPLETED|Overall Study||0
271917|NCT00378079|660437|P2|NOT COMPLETED|Overall Study||1
271918|NCT00378079|660438|P1|NOT COMPLETED|Overall Study||6
271919|NCT00378079|660436|P3|COMPLETED|Overall Study||71
271920|NCT00378079|660437|P2|COMPLETED|Overall Study||69
271921|NCT00378079|660438|P1|COMPLETED|Overall Study||64
271922|NCT00378079|660436|P3|STARTED|Overall Study||71
271923|NCT00378079|660437|P2|STARTED|Overall Study||70
271924|NCT00378079|660438|P1|STARTED|Overall Study||70
271925|NCT00378014|660460|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
271926|NCT00378014|660461|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
271927|NCT00378014|660460|P2|COMPLETED|Extension (Month 12 to Month 59)||26
271928|NCT00378014|660461|P1|COMPLETED|Extension (Month 12 to Month 59)||27
271929|NCT00378014|660460|P2|STARTED|Extension (Month 12 to Month 59)||40
271930|NCT00378014|660461|P1|STARTED|Extension (Month 12 to Month 59)||41
271931|NCT00378014|660460|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
271932|NCT00378014|660461|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
271933|NCT00378014|660460|P2|COMPLETED|Core (Randomization to Month 11)||90
271934|NCT00378014|660461|P1|COMPLETED|Core (Randomization to Month 11)||87
271935|NCT00378014|660460|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
271936|NCT00378014|660461|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
271937|NCT00378014|660460|P2|STARTED|Core (Randomization to Month 11)||102
271938|NCT00378014|660461|P1|STARTED|Core (Randomization to Month 11)||101
271939|NCT00377962|660487|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
271940|NCT00377962|660488|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
271941|NCT00377962|660487|P2|COMPLETED|Extension Study: 12-24 Months||123
271942|NCT00377962|660488|P1|COMPLETED|Extension Study: 12-24 Months||98
271943|NCT00377962|660487|P2|STARTED|Extension Study: 12-24 Months||127
271944|NCT00377962|660488|P1|STARTED|Extension Study: 12-24 Months||108
271945|NCT00377962|660487|P2|NOT COMPLETED|Core Study: 0-12 Months||9
271946|NCT00377962|660488|P1|NOT COMPLETED|Core Study: 0-12 Months||28
271947|NCT00377962|660487|P2|COMPLETED|Core Study: 0-12 Months||133
271948|NCT00377962|660488|P1|COMPLETED|Core Study: 0-12 Months||112
271949|NCT00377962|660487|P2|STARTED|Core Study: 0-12 Months||142
271950|NCT00377962|660488|P1|STARTED|Core Study: 0-12 Months||140
271951|NCT00377858|660524|P2|NOT COMPLETED|Overall Study||27
271952|NCT00377858|660525|P1|NOT COMPLETED|Overall Study||31
271953|NCT00377858|660524|P2|COMPLETED|Overall Study||215
271954|NCT00377858|660525|P1|COMPLETED|Overall Study||211
271955|NCT00377858|660524|P2|Had at Least One Post-Baseline Value|Overall Study||240
271956|NCT00377858|660525|P1|Had at Least One Post-Baseline Value|Overall Study||239
271957|NCT00377858|660524|P2|STARTED|Overall Study||242
271958|NCT00377858|660525|P1|STARTED|Overall Study||242
271959|NCT00377832|660555|P2|NOT COMPLETED|Overall Study||0
271960|NCT00377832|660556|P1|NOT COMPLETED|Overall Study||0
271961|NCT00377832|660555|P2|COMPLETED|Overall Study||6
271962|NCT00377832|660556|P1|COMPLETED|Overall Study||7
271963|NCT00377832|660555|P2|STARTED|Overall Study||6
271964|NCT00377832|660556|P1|STARTED|Overall Study||7
271965|NCT00377819|660578|P2|NOT COMPLETED|Overall Study||10
271966|NCT00377819|660579|P1|NOT COMPLETED|Overall Study||13
271967|NCT00377819|660578|P2|COMPLETED|Overall Study||243
271968|NCT00377819|660579|P1|COMPLETED|Overall Study||238
271969|NCT00377819|660578|P2|Received Study Medication|Overall Study||253
271970|NCT00377819|660579|P1|Received Study Medication|Overall Study||249
271971|NCT00377819|660578|P2|STARTED|Overall Study||253
271972|NCT00377819|660579|P1|STARTED|Overall Study||251
271973|NCT00377741|660591|P2|NOT COMPLETED|Overall Study||0
271974|NCT00377741|660592|P1|NOT COMPLETED|Overall Study||0
271975|NCT00377741|660591|P2|COMPLETED|Overall Study||15
271976|NCT00377741|660592|P1|COMPLETED|Overall Study||16
271977|NCT00377741|660591|P2|STARTED|Overall Study||15
271978|NCT00377741|660592|P1|STARTED|Overall Study||16
271979|NCT00377676|660608|P2|NOT COMPLETED|Overall Study||322
271980|NCT00377676|660609|P1|NOT COMPLETED|Overall Study||961
271981|NCT00377676|660608|P2|COMPLETED|Overall Study||694
271982|NCT00377676|660609|P1|COMPLETED|Overall Study||1093
271983|NCT00377676|660608|P2|STARTED|Overall Study||1016
271984|NCT00377676|660609|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
271985|NCT00377637|660625|P4|NOT COMPLETED|Maintenance Phase||57
271986|NCT00377637|660626|P3|NOT COMPLETED|Maintenance Phase||43
271987|NCT00377637|660627|P2|NOT COMPLETED|Maintenance Phase||0
271988|NCT00377637|660628|P1|NOT COMPLETED|Maintenance Phase||0
271989|NCT00377637|660625|P4|COMPLETED|Maintenance Phase||54
271990|NCT00377637|660626|P3|COMPLETED|Maintenance Phase||73
271991|NCT00377637|660627|P2|COMPLETED|Maintenance Phase||0
271992|NCT00377637|660628|P1|COMPLETED|Maintenance Phase||0
271993|NCT00377637|660625|P4|STARTED|Maintenance Phase||111
271994|NCT00377637|660626|P3|STARTED|Maintenance Phase||116
271995|NCT00377637|660627|P2|STARTED|Maintenance Phase||0
271996|NCT00377637|660628|P1|STARTED|Maintenance Phase||0
271997|NCT00377637|660625|P4|NOT COMPLETED|Induction Phase||0
271998|NCT00377637|660626|P3|NOT COMPLETED|Induction Phase||0
271999|NCT00377637|660627|P2|NOT COMPLETED|Induction Phase||35
272000|NCT00377637|660628|P1|NOT COMPLETED|Induction Phase||29
272001|NCT00377637|660625|P4|COMPLETED|Induction Phase||0
272002|NCT00377637|660626|P3|COMPLETED|Induction Phase||0
272003|NCT00377637|660627|P2|COMPLETED|Induction Phase||150
272004|NCT00377637|660628|P1|COMPLETED|Induction Phase||156
272005|NCT00377637|660625|P4|Safety Population|Induction Phase||0
272006|NCT00377637|660626|P3|Safety Population|Induction Phase||0
272007|NCT00377637|660627|P2|Safety Population|Induction Phase||184
272008|NCT00377637|660628|P1|Safety Population|Induction Phase||180
272009|NCT00377637|660625|P4|STARTED|Induction Phase||0
272010|NCT00377637|660626|P3|STARTED|Induction Phase||0
272011|NCT00377637|660627|P2|STARTED|Induction Phase|Intent-To-Treat|185
272012|NCT00377637|660628|P1|STARTED|Induction Phase|Intent-To-Treat|185
272013|NCT00377572|660664|P2|NOT COMPLETED|Overall Study||54
272014|NCT00377572|660665|P1|NOT COMPLETED|Overall Study||53
272015|NCT00377572|660664|P2|COMPLETED|Overall Study||157
272016|NCT00377572|660665|P1|COMPLETED|Overall Study||155
272017|NCT00377572|660664|P2|STARTED|Overall Study||211
272018|NCT00377572|660665|P1|STARTED|Overall Study||208
272019|NCT00377520|660703|P1|NOT COMPLETED|Overall Study||1
272020|NCT00377520|660703|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
272021|NCT00377520|660703|P1|STARTED|Overall Study||27
272022|NCT00377455|660708|P1|NOT COMPLETED|Overall Study||1
272023|NCT00377455|660708|P1|COMPLETED|Overall Study||4
272024|NCT00377455|660708|P1|STARTED|Overall Study||5
272025|NCT00377429|660716|P1|NOT COMPLETED|Overall Study||15
272026|NCT00377429|660716|P1|COMPLETED|Overall Study|Completed main study|32
272027|NCT00377429|660716|P1|STARTED|Overall Study|Treated|47
272028|NCT00377403|660727|P2|NOT COMPLETED|Overall Study||7
272029|NCT00377403|660728|P1|NOT COMPLETED|Overall Study||4
272030|NCT00377403|660727|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
272031|NCT00377403|660728|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
272032|NCT00377403|660727|P2|Day 28 Assessment|Overall Study||77
272033|NCT00377403|660728|P1|Day 28 Assessment|Overall Study||82
272034|NCT00377403|660727|P2|Day 10 Assessment|Overall Study||71
272035|NCT00377403|660728|P1|Day 10 Assessment|Overall Study||81
272036|NCT00377403|660727|P2|Day 7 Assessment|Overall Study||75
272037|NCT00377403|660728|P1|Day 7 Assessment|Overall Study||80
272038|NCT00377403|660727|P2|Day -3 Assessment|Overall Study||74
272039|NCT00377403|660728|P1|Day -3 Assessment|Overall Study||81
272040|NCT00377403|660727|P2|STARTED|Overall Study||81
272041|NCT00377403|660728|P1|STARTED|Overall Study||85
272042|NCT00377364|660736|P2|NOT COMPLETED|Overall Study||0
272043|NCT00377364|660737|P1|NOT COMPLETED|Overall Study||2
272044|NCT00377364|660736|P2|COMPLETED|Overall Study||14
272045|NCT00377364|660737|P1|COMPLETED|Overall Study||14
272046|NCT00377364|660736|P2|STARTED|Overall Study||14
272047|NCT00377364|660737|P1|STARTED|Overall Study||16
272048|NCT00377312|660763|P2|NOT COMPLETED|Overall Study||1
272049|NCT00377312|660764|P1|NOT COMPLETED|Overall Study||1
272050|NCT00377312|660763|P2|COMPLETED|Overall Study||4
272051|NCT00377312|660764|P1|COMPLETED|Overall Study||5
272052|NCT00377312|660763|P2|STARTED|Overall Study||5
272053|NCT00377312|660764|P1|STARTED|Overall Study||6
272054|NCT00377299|660796|P2|NOT COMPLETED|Overall Study||24
272055|NCT00377299|660797|P1|NOT COMPLETED|Overall Study||19
272056|NCT00377299|660796|P2|COMPLETED|Overall Study||4
272057|NCT00377299|660797|P1|COMPLETED|Overall Study||13
272058|NCT00377299|660796|P2|STARTED|Overall Study||28
272059|NCT00377299|660797|P1|STARTED|Overall Study||32
272060|NCT00377260|660813|P2|NOT COMPLETED|Overall Study||5
272061|NCT00377260|660814|P1|NOT COMPLETED|Overall Study||2
272062|NCT00377260|660813|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
272063|NCT00377260|660814|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
272064|NCT00377260|660813|P2|STARTED|Overall Study||147
272065|NCT00377260|660814|P1|STARTED|Overall Study||144
272066|NCT00377234|660868|P2|NOT COMPLETED|Overall Study||31
272067|NCT00377234|660869|P1|NOT COMPLETED|Overall Study||34
272068|NCT00377234|660868|P2|COMPLETED|Overall Study||145
272069|NCT00377234|660869|P1|COMPLETED|Overall Study||146
272070|NCT00377234|660868|P2|Safety Analysis Set: Risedronate|Overall Study||174
272071|NCT00377234|660869|P1|Safety Analysis Set: Risedronate|Overall Study||153
272072|NCT00377234|660868|P2|Safety Analysis Set: Ibandronate|Overall Study||150
272073|NCT00377234|660869|P1|Safety Analysis Set: Ibandronate|Overall Study||177
272074|NCT00377234|660868|P2|Safety Analysis Set: Period 2|Overall Study||150
272075|NCT00377234|660869|P1|Safety Analysis Set: Period 2|Overall Study||153
272076|NCT00377234|660868|P2|Safety Analysis Set: Period 1|Overall Study||174
272077|NCT00377234|660869|P1|Safety Analysis Set: Period 1|Overall Study||177
272078|NCT00377234|660868|P2|Received Treatment|Overall Study||174
272079|NCT00377234|660869|P1|Received Treatment|Overall Study||177
272080|NCT00377234|660868|P2|Did Not Receive Study Treatment|Overall Study||2
272081|NCT00377234|660869|P1|Did Not Receive Study Treatment|Overall Study||3
272082|NCT00377234|660868|P2|Randomized|Overall Study||176
272083|NCT00377234|660869|P1|Randomized|Overall Study||180
272084|NCT00377234|660868|P2|STARTED|Overall Study||176
272085|NCT00377234|660869|P1|STARTED|Overall Study||180
272086|NCT00377156|660887|P2|NOT COMPLETED|Overall Study||54
272087|NCT00377156|660888|P1|NOT COMPLETED|Overall Study||48
272088|NCT00377156|660887|P2|COMPLETED|Overall Study||48
272089|NCT00377156|660888|P1|COMPLETED|Overall Study||63
272090|NCT00377156|660887|P2|STARTED|Overall Study||102
272091|NCT00377156|660888|P1|STARTED|Overall Study||111
272092|NCT00376961|660902|P2|NOT COMPLETED|Maintenance||23
272093|NCT00376961|660903|P1|NOT COMPLETED|Maintenance||0
272094|NCT00376961|660902|P2|COMPLETED|Maintenance||27
272095|NCT00376961|660903|P1|COMPLETED|Maintenance||0
272096|NCT00376961|660902|P2|Eligible|Maintenance||47
272097|NCT00376961|660903|P1|Eligible|Maintenance||0
272098|NCT00376961|660902|P2|STARTED|Maintenance||50
272099|NCT00376961|660903|P1|STARTED|Maintenance||0
272100|NCT00376961|660902|P2|NOT COMPLETED|Initial Registration||0
272101|NCT00376961|660903|P1|NOT COMPLETED|Initial Registration||7
272102|NCT00376961|660902|P2|COMPLETED|Initial Registration||0
272103|NCT00376961|660903|P1|COMPLETED|Initial Registration||61
272104|NCT00376961|660902|P2|Eligible|Initial Registration||0
272105|NCT00376961|660903|P1|Eligible|Initial Registration||65
272106|NCT00376961|660902|P2|STARTED|Initial Registration||0
272107|NCT00376961|660903|P1|STARTED|Initial Registration||68
272108|NCT00376948|660912|P1|NOT COMPLETED|Overall Study||0
272109|NCT00376948|660912|P1|COMPLETED|Overall Study||20
272110|NCT00376948|660912|P1|STARTED|Overall Study||20
272111|NCT00376935|660921|P4|NOT COMPLETED|Overall Study||0
272112|NCT00376935|660922|P3|NOT COMPLETED|Overall Study||0
272113|NCT00376935|660923|P2|NOT COMPLETED|Overall Study||0
272114|NCT00376935|660924|P1|NOT COMPLETED|Overall Study||0
272115|NCT00376935|660921|P4|COMPLETED|Overall Study||24
272116|NCT00376935|660922|P3|COMPLETED|Overall Study||25
272117|NCT00376935|660923|P2|COMPLETED|Overall Study||25
272118|NCT00376935|660924|P1|COMPLETED|Overall Study||25
272119|NCT00376935|660921|P4|STARTED|Overall Study||24
272120|NCT00376935|660922|P3|STARTED|Overall Study||25
272121|NCT00376935|660923|P2|STARTED|Overall Study||25
272122|NCT00376935|660924|P1|STARTED|Overall Study||25
272123|NCT00376805|660962|P1|NOT COMPLETED|Overall Study||0
272124|NCT00376805|660962|P1|COMPLETED|Overall Study||6
272125|NCT00376805|660962|P1|STARTED|Overall Study||6
272126|NCT00376688|660969|P1|NOT COMPLETED|Overall Study||4
272127|NCT00376688|660969|P1|COMPLETED|Overall Study||27
272128|NCT00376688|660969|P1|STARTED|Overall Study||31
272129|NCT00376675|660975|P2|NOT COMPLETED|Overall Study||14
272130|NCT00376675|660976|P1|NOT COMPLETED|Overall Study||20
272131|NCT00376675|660975|P2|COMPLETED|Overall Study||56
272132|NCT00376675|660976|P1|COMPLETED|Overall Study||49
272133|NCT00376675|660975|P2|STARTED|Overall Study||70
272134|NCT00376675|660976|P1|STARTED|Overall Study||69
272135|NCT00376597|661000|P2|NOT COMPLETED|Overall Study||3
272136|NCT00376597|661001|P1|NOT COMPLETED|Overall Study||11
272137|NCT00376597|661000|P2|COMPLETED|Overall Study||312
272138|NCT00376597|661001|P1|COMPLETED|Overall Study||242
272139|NCT00376597|661000|P2|STARTED|Overall Study||315
272140|NCT00376597|661001|P1|STARTED|Overall Study||253
272141|NCT00376558|661015|P2|NOT COMPLETED|Overall Study||0
272142|NCT00376558|661016|P1|NOT COMPLETED|Overall Study||0
272143|NCT00376558|661015|P2|COMPLETED|Overall Study||25
272144|NCT00376558|661016|P1|COMPLETED|Overall Study||25
272145|NCT00376558|661015|P2|STARTED|Overall Study||25
272146|NCT00376558|661016|P1|STARTED|Overall Study||25
272147|NCT00376532|661025|P2|NOT COMPLETED|Overall Study||6
272148|NCT00376532|661026|P1|NOT COMPLETED|Overall Study||6
272149|NCT00376532|661025|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
272150|NCT00376532|661026|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
272151|NCT00376532|661025|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
272152|NCT00376532|661026|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
272153|NCT00376506|661036|P2|NOT COMPLETED|Overall Study||2
272154|NCT00376506|661037|P1|NOT COMPLETED|Overall Study||0
272155|NCT00376506|661036|P2|COMPLETED|Overall Study||4
272156|NCT00376506|661037|P1|COMPLETED|Overall Study||4
272157|NCT00376506|661036|P2|STARTED|Overall Study||6
272158|NCT00376506|661037|P1|STARTED|Overall Study||4
272159|NCT00376363|661055|P2|NOT COMPLETED|Overall Study||46
272160|NCT00376363|661056|P1|NOT COMPLETED|Overall Study||56
272161|NCT00376363|661055|P2|COMPLETED|Overall Study||87
272162|NCT00376363|661056|P1|COMPLETED|Overall Study||87
272163|NCT00376363|661055|P2|STARTED|Overall Study||133
272164|NCT00376363|661056|P1|STARTED|Overall Study||143
272165|NCT00376259|661068|P2|NOT COMPLETED|Overall Study||21
272166|NCT00376259|661069|P1|NOT COMPLETED|Overall Study||22
272167|NCT00376259|661068|P2|COMPLETED|Overall Study||0
272168|NCT00376259|661069|P1|COMPLETED|Overall Study||0
272169|NCT00376259|661068|P2|Received Study Drug|Overall Study||21
272170|NCT00376259|661069|P1|Received Study Drug|Overall Study||21
272171|NCT00376259|661068|P2|STARTED|Overall Study||21
272172|NCT00376259|661069|P1|STARTED|Overall Study||22
272173|NCT00376220|661083|P2|NOT COMPLETED|Overall Study||12
272174|NCT00376220|661084|P1|NOT COMPLETED|Overall Study||10
272175|NCT00376220|661083|P2|COMPLETED|Overall Study||35
272176|NCT00376220|661084|P1|COMPLETED|Overall Study||37
272177|NCT00376220|661083|P2|STARTED|Overall Study||47
272178|NCT00376220|661084|P1|STARTED|Overall Study||47
272179|NCT00376168|661092|P2|NOT COMPLETED|Overall Study||1
272180|NCT00376168|661093|P1|NOT COMPLETED|Overall Study||2
272181|NCT00376168|661092|P2|COMPLETED|Overall Study||15
272182|NCT00376168|661093|P1|COMPLETED|Overall Study||14
272183|NCT00376168|661092|P2|STARTED|Overall Study|One patient randomized but not treated|16
272184|NCT00376168|661093|P1|STARTED|Overall Study||16
272185|NCT00375999|661107|P1|NOT COMPLETED|Overall Study||2
272186|NCT00375999|661107|P1|COMPLETED|Overall Study||32
272187|NCT00375999|661107|P1|STARTED|Overall Study||34
272188|NCT00375973|661113|P2|NOT COMPLETED|Overall Study||2
272189|NCT00375973|661114|P1|NOT COMPLETED|Overall Study||10
272190|NCT00375973|661113|P2|COMPLETED|Overall Study||28
272191|NCT00375973|661114|P1|COMPLETED|Overall Study||20
272192|NCT00375973|661113|P2|STARTED|Overall Study||30
272193|NCT00375973|661114|P1|STARTED|Overall Study||30
272194|NCT00375934|661134|P2|NOT COMPLETED|Overall Study||6
272195|NCT00375934|661135|P1|NOT COMPLETED|Overall Study||3
272196|NCT00375934|661134|P2|COMPLETED|Overall Study||95
272197|NCT00375934|661135|P1|COMPLETED|Overall Study||96
272198|NCT00375934|661134|P2|STARTED|Overall Study||101
272199|NCT00375934|661135|P1|STARTED|Overall Study||99
272200|NCT00375752|661163|P2|NOT COMPLETED|Overall Study||15
272201|NCT00375752|661164|P1|NOT COMPLETED|Overall Study||12
272202|NCT00375752|661163|P2|COMPLETED|Overall Study||74
272203|NCT00375752|661164|P1|COMPLETED|Overall Study||67
272204|NCT00375752|661163|P2|STARTED|Overall Study||89
272205|NCT00375752|661164|P1|STARTED|Overall Study||79
272206|NCT00375713|661180|P2|NOT COMPLETED|Overall Study||23
272207|NCT00375713|661181|P1|NOT COMPLETED|Overall Study||20
272208|NCT00375713|661180|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
272209|NCT00375713|661181|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
272210|NCT00375713|661180|P2|STARTED|Overall Study|Randomized population (N=234).|234
272211|NCT00375713|661181|P1|STARTED|Overall Study|Randomized population (N=232).|232
272212|NCT00375674|661195|P2|NOT COMPLETED|Overall Study||115
272213|NCT00375674|661196|P1|NOT COMPLETED|Overall Study||123
272214|NCT00375674|661195|P2|COMPLETED|Overall Study||191
272215|NCT00375674|661196|P1|COMPLETED|Overall Study||186
272216|NCT00375674|661195|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
272217|NCT00375674|661196|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
272218|NCT00375674|661195|P2|Intent-to-Treat Population|Overall Study||306
272219|NCT00375674|661196|P1|Intent-to-Treat Population|Overall Study||309
272220|NCT00375674|661195|P2|STARTED|Overall Study||306
272221|NCT00375674|661196|P1|STARTED|Overall Study||309
272222|NCT00375609|661225|P3|NOT COMPLETED|Overall Study||1
272223|NCT00375609|661226|P2|NOT COMPLETED|Overall Study||7
272224|NCT00375609|661227|P1|NOT COMPLETED|Overall Study||4
272225|NCT00375609|661225|P3|COMPLETED|Overall Study||42
272226|NCT00375609|661226|P2|COMPLETED|Overall Study||77
272227|NCT00375609|661227|P1|COMPLETED|Overall Study||84
272228|NCT00375609|661225|P3|STARTED|Overall Study||43
272229|NCT00375609|661226|P2|STARTED|Overall Study||84
272230|NCT00375609|661227|P1|STARTED|Overall Study||88
272231|NCT00375518|661243|P2|NOT COMPLETED|Overall Study||17
272232|NCT00375518|661244|P1|NOT COMPLETED|Overall Study||8
272233|NCT00375518|661243|P2|COMPLETED|Overall Study||65
272234|NCT00375518|661244|P1|COMPLETED|Overall Study||72
272235|NCT00375518|661243|P2|STARTED|Overall Study||82
272236|NCT00375518|661244|P1|STARTED|Overall Study||80
272237|NCT00375505|661252|P2|NOT COMPLETED|Overall Study||2
272238|NCT00375505|661253|P1|NOT COMPLETED|Overall Study||1
272239|NCT00375505|661252|P2|COMPLETED|Overall Study||32
272240|NCT00375505|661253|P1|COMPLETED|Overall Study||35
272241|NCT00375505|661252|P2|STARTED|Overall Study||34
272242|NCT00375505|661253|P1|STARTED|Overall Study||36
272243|NCT00375492|661297|P2|NOT COMPLETED|Overall Study||26
272244|NCT00375492|661298|P1|NOT COMPLETED|Overall Study||26
272245|NCT00375492|661297|P2|COMPLETED|Overall Study||72
272246|NCT00375492|661298|P1|COMPLETED|Overall Study||70
272247|NCT00375492|661297|P2|STARTED|Overall Study||98
272248|NCT00375492|661298|P1|STARTED|Overall Study||96
272249|NCT00375427|661328|P2|NOT COMPLETED|Overall Study||74
272250|NCT00375427|661329|P1|NOT COMPLETED|Overall Study||60
272251|NCT00375427|661328|P2|COMPLETED|Overall Study||142
272252|NCT00375427|661329|P1|COMPLETED|Overall Study||149
272253|NCT00375427|661328|P2|STARTED|Overall Study||216
272254|NCT00375427|661329|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
272255|NCT00375219|661354|P3|NOT COMPLETED|Overall Study||21
272256|NCT00375219|661355|P2|NOT COMPLETED|Overall Study||20
272257|NCT00375219|661356|P1|NOT COMPLETED|Overall Study||59
272258|NCT00375219|661354|P3|COMPLETED|Overall Study||0
272259|NCT00375219|661355|P2|COMPLETED|Overall Study||0
272260|NCT00375219|661356|P1|COMPLETED|Overall Study||3
272261|NCT00375219|661354|P3|STARTED|Overall Study||21
272262|NCT00375219|661355|P2|STARTED|Overall Study||20
272263|NCT00375219|661356|P1|STARTED|Overall Study||62
272264|NCT00374907|661424|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
272265|NCT00374907|661425|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
272266|NCT00374907|661424|P2|COMPLETED|116-Week Short-term + Long-term Period||2
272267|NCT00374907|661425|P1|COMPLETED|116-Week Short-term + Long-term Period||7
272268|NCT00374907|661424|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
272269|NCT00374907|661425|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
272270|NCT00374907|661424|P2|STARTED|116-Week Short-term + Long-term Period||16
272271|NCT00374907|661425|P1|STARTED|116-Week Short-term + Long-term Period||20
272272|NCT00374907|661424|P2|NOT COMPLETED|12-Week Short-term Period||1
272273|NCT00374907|661425|P1|NOT COMPLETED|12-Week Short-term Period||3
272274|NCT00374907|661424|P2|COMPLETED|12-Week Short-term Period||15
272275|NCT00374907|661425|P1|COMPLETED|12-Week Short-term Period||17
272276|NCT00374907|661424|P2|STARTED|12-Week Short-term Period||16
272277|NCT00374907|661425|P1|STARTED|12-Week Short-term Period||20
272278|NCT00374868|661437|P1|NOT COMPLETED|Overall Study||36
272279|NCT00374868|661437|P1|COMPLETED|Overall Study||2
272280|NCT00374868|661437|P1|STARTED|Overall Study||38
272281|NCT00374842|661451|P3|NOT COMPLETED|Overall Study||0
272282|NCT00374842|661452|P2|NOT COMPLETED|Overall Study||0
272283|NCT00374842|661453|P1|NOT COMPLETED|Overall Study||0
272284|NCT00374842|661451|P3|COMPLETED|Overall Study||100
272285|NCT00374842|661452|P2|COMPLETED|Overall Study||100
272286|NCT00374842|661453|P1|COMPLETED|Overall Study||100
272287|NCT00374842|661451|P3|STARTED|Overall Study||100
272288|NCT00374842|661452|P2|STARTED|Overall Study||100
272289|NCT00374842|661453|P1|STARTED|Overall Study||100
272290|NCT00374803|661484|P2|NOT COMPLETED|Overall Study||0
272291|NCT00374803|661485|P1|NOT COMPLETED|Overall Study||0
272292|NCT00374803|661484|P2|COMPLETED|Overall Study||23
272293|NCT00374803|661485|P1|COMPLETED|Overall Study||22
272294|NCT00374803|661484|P2|STARTED|Overall Study||23
272295|NCT00374803|661485|P1|STARTED|Overall Study||22
272296|NCT00374556|661501|P2|NOT COMPLETED|Overall Study||1
272297|NCT00374556|661502|P1|NOT COMPLETED|Overall Study||1
272298|NCT00374556|661501|P2|COMPLETED|Overall Study||15
272299|NCT00374556|661502|P1|COMPLETED|Overall Study||13
272300|NCT00374556|661501|P2|STARTED|Overall Study||16
272301|NCT00374556|661502|P1|STARTED|Overall Study||14
272302|NCT00374543|661554|P2|NOT COMPLETED|Overall Study||0
272303|NCT00374543|661555|P1|NOT COMPLETED|Overall Study||0
272304|NCT00374543|661554|P2|COMPLETED|Overall Study||1
272305|NCT00374543|661555|P1|COMPLETED|Overall Study||2
272306|NCT00374543|661554|P2|STARTED|Overall Study||1
272307|NCT00374543|661555|P1|STARTED|Overall Study||2
272308|NCT00374452|661563|P2|NOT COMPLETED|Overall Study||5
272309|NCT00374452|661564|P1|NOT COMPLETED|Overall Study||5
272310|NCT00374452|661563|P2|COMPLETED|Overall Study||43
272311|NCT00374452|661564|P1|COMPLETED|Overall Study||29
272312|NCT00374452|661563|P2|Intervention Started|Overall Study||46
272313|NCT00374452|661564|P1|Intervention Started|Overall Study||30
272314|NCT00374452|661563|P2|STARTED|Overall Study||48
272315|NCT00374452|661564|P1|STARTED|Overall Study||34
272316|NCT00374335|661570|P1|NOT COMPLETED|Overall Study||0
272317|NCT00374335|661570|P1|COMPLETED|Overall Study||261
272318|NCT00374335|661570|P1|STARTED|Overall Study||261
272319|NCT00374322|661577|P2|NOT COMPLETED|Overall Study||1304
272320|NCT00374322|661578|P1|NOT COMPLETED|Overall Study||1257
272321|NCT00374322|661577|P2|COMPLETED|Overall Study||278
272322|NCT00374322|661578|P1|COMPLETED|Overall Study||322
272323|NCT00374322|661577|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
272324|NCT00374322|661578|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
272325|NCT00374322|661577|P2|STARTED|Overall Study||1582
272326|NCT00374322|661578|P1|STARTED|Overall Study||1579
272327|NCT00374244|661616|P2|NOT COMPLETED|Overall Study||0
272328|NCT00374244|661617|P1|NOT COMPLETED|Overall Study||0
272329|NCT00374244|661616|P2|COMPLETED|Overall Study||14
272330|NCT00374244|661617|P1|COMPLETED|Overall Study||14
272331|NCT00374244|661616|P2|STARTED|Overall Study||14
272332|NCT00374244|661617|P1|STARTED|Overall Study||14
272333|NCT00374231|661663|P1|NOT COMPLETED|Overall Study||0
272334|NCT00374231|661663|P1|COMPLETED|Overall Study||40
272335|NCT00374231|661663|P1|STARTED|Overall Study||40
272336|NCT00374140|661669|P1|NOT COMPLETED|Overall Study||2
272337|NCT00374140|661669|P1|COMPLETED|Overall Study||38
272338|NCT00374140|661669|P1|STARTED|Overall Study||40
272339|NCT00374127|661676|P1|NOT COMPLETED|Overall Study||11
272340|NCT00374127|661676|P1|COMPLETED|Overall Study||24
272341|NCT00374127|661676|P1|STARTED|Overall Study||35
272342|NCT00374088|661712|P2|NOT COMPLETED|Overall Study||1
272343|NCT00374088|661713|P1|NOT COMPLETED|Overall Study||1
272344|NCT00374088|661712|P2|COMPLETED|Overall Study||10
272345|NCT00374088|661713|P1|COMPLETED|Overall Study||9
272346|NCT00374088|661712|P2|STARTED|Overall Study||11
272347|NCT00374088|661713|P1|STARTED|Overall Study||10
272348|NCT00373958|661725|P2|NOT COMPLETED|Toddler Dose||38
272349|NCT00373958|661726|P1|NOT COMPLETED|Toddler Dose||30
272350|NCT00373958|661725|P2|COMPLETED|Toddler Dose||252
272351|NCT00373958|661726|P1|COMPLETED|Toddler Dose||264
272352|NCT00373958|661725|P2|Vaccinated Toddler Dose|Toddler Dose||265
272353|NCT00373958|661726|P1|Vaccinated Toddler Dose|Toddler Dose||272
272354|NCT00373958|661725|P2|Withdrawn After Infant Series|Toddler Dose||25
272355|NCT00373958|661726|P1|Withdrawn After Infant Series|Toddler Dose||22
272356|NCT00373958|661725|P2|STARTED|Toddler Dose||290
272357|NCT00373958|661726|P1|STARTED|Toddler Dose||294
272358|NCT00373958|661725|P2|NOT COMPLETED|Infant Series||42
272359|NCT00373958|661726|P1|NOT COMPLETED|Infant Series||40
272360|NCT00373958|661725|P2|COMPLETED|Infant Series||290
272361|NCT00373958|661726|P1|COMPLETED|Infant Series||294
272362|NCT00373958|661725|P2|Vaccinated Dose 3|Infant Series||300
272363|NCT00373958|661726|P1|Vaccinated Dose 3|Infant Series||298
272364|NCT00373958|661725|P2|Vaccinated Dose 2|Infant Series||305
272365|NCT00373958|661726|P1|Vaccinated Dose 2|Infant Series||309
272366|NCT00373958|661725|P2|Vaccinated Dose 1|Infant Series||331
272367|NCT00373958|661726|P1|Vaccinated Dose 1|Infant Series||332
272368|NCT00373958|661725|P2|STARTED|Infant Series||332
272369|NCT00373958|661726|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
272370|NCT00373880|661774|P1|NOT COMPLETED|Overall Study||18
272371|NCT00373880|661774|P1|COMPLETED|Overall Study||8
272372|NCT00373880|661774|P1|STARTED|Overall Study||26
272373|NCT00373698|661804|P2|NOT COMPLETED|Overall Study||0
272374|NCT00373698|661805|P1|NOT COMPLETED|Overall Study||11
272375|NCT00373698|661804|P2|COMPLETED|Overall Study||99
272376|NCT00373698|661805|P1|COMPLETED|Overall Study||85
272377|NCT00373698|661804|P2|STARTED|Overall Study||99
272378|NCT00373698|661805|P1|STARTED|Overall Study||96
272379|NCT00373685|661819|P2|NOT COMPLETED|Overall Study||1421
272380|NCT00373685|661820|P1|NOT COMPLETED|Overall Study||1439
272381|NCT00373685|661819|P2|COMPLETED|Overall Study||2611
272382|NCT00373685|661820|P1|COMPLETED|Overall Study||2596
272383|NCT00373685|661819|P2|Treated|Overall Study||3955
272384|NCT00373685|661820|P1|Treated|Overall Study||3984
272385|NCT00373685|661819|P2|STARTED|Overall Study||4032
272386|NCT00373685|661820|P1|STARTED|Overall Study||4035
272387|NCT00373529|661854|P1|NOT COMPLETED|Overall Study||108
272388|NCT00373529|661854|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
272389|NCT00373529|661854|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
272390|NCT00373529|661854|P1|STARTED|Overall Study||116
272391|NCT00373490|661866|P2|NOT COMPLETED|Overall Study||6
272392|NCT00373490|661867|P1|NOT COMPLETED|Overall Study||9
272393|NCT00373490|661866|P2|COMPLETED|Overall Study||0
272394|NCT00373490|661867|P1|COMPLETED|Overall Study||1
272395|NCT00373490|661866|P2|STARTED|Overall Study||6
272396|NCT00373490|661867|P1|STARTED|Overall Study||10
272397|NCT00373425|661890|P5|NOT COMPLETED|Overall Study||72
272398|NCT00373425|661891|P4|NOT COMPLETED|Overall Study||11
272399|NCT00373425|661892|P3|NOT COMPLETED|Overall Study||134
272400|NCT00373425|661893|P2|NOT COMPLETED|Overall Study||153
272401|NCT00373425|661894|P1|NOT COMPLETED|Overall Study||370
272402|NCT00373425|661890|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
272403|NCT00373425|661891|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
272404|NCT00373425|661892|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
272405|NCT00373425|661893|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
272406|NCT00373425|661894|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
272407|NCT00373425|661890|P5|Received Treatment|Overall Study||132
272408|NCT00373425|661891|P4|Received Treatment|Overall Study||7
272409|NCT00373425|661892|P3|Received Treatment|Overall Study||134
272410|NCT00373425|661893|P2|Received Treatment|Overall Study||342
272411|NCT00373425|661894|P1|Received Treatment|Overall Study||612
272412|NCT00373425|661890|P5|STARTED|Overall Study||132
272413|NCT00373425|661891|P4|STARTED|Overall Study||11
272414|NCT00373425|661892|P3|STARTED|Overall Study||134
272415|NCT00373425|661893|P2|STARTED|Overall Study||350
272416|NCT00373425|661894|P1|STARTED|Overall Study||623
272417|NCT00373386|661919|P1|NOT COMPLETED|Overall Study||0
272418|NCT00373386|661919|P1|COMPLETED|Overall Study||9
272419|NCT00373386|661919|P1|STARTED|Overall Study||9
272420|NCT00373360|661929|P1|NOT COMPLETED|Overall Study||0
272421|NCT00373360|661929|P1|COMPLETED|Overall Study||10
272422|NCT00373360|661929|P1|STARTED|Overall Study||10
272423|NCT00373334|661960|P3|NOT COMPLETED|Overall Study||13
272424|NCT00373334|661961|P2|NOT COMPLETED|Overall Study||18
272425|NCT00373334|661962|P1|NOT COMPLETED|Overall Study||10
272426|NCT00373334|661960|P3|COMPLETED|Overall Study||32
272427|NCT00373334|661961|P2|COMPLETED|Overall Study||32
272428|NCT00373334|661962|P1|COMPLETED|Overall Study||33
272429|NCT00373334|661960|P3|STARTED|Overall Study||45
272430|NCT00373334|661961|P2|STARTED|Overall Study||50
272431|NCT00373334|661962|P1|STARTED|Overall Study||43
272432|NCT00373295|661976|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
272433|NCT00373295|661977|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
272434|NCT00373295|661978|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
272435|NCT00373295|661979|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
272436|NCT00373295|661980|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
272437|NCT00373295|661981|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
272438|NCT00373295|661976|P6|COMPLETED|Intervention 3 (8 Days)||2
272439|NCT00373295|661977|P5|COMPLETED|Intervention 3 (8 Days)||2
272440|NCT00373295|661978|P4|COMPLETED|Intervention 3 (8 Days)||2
272441|NCT00373295|661979|P3|COMPLETED|Intervention 3 (8 Days)||1
272442|NCT00373295|661980|P2|COMPLETED|Intervention 3 (8 Days)||1
272443|NCT00373295|661981|P1|COMPLETED|Intervention 3 (8 Days)||2
272444|NCT00373295|661976|P6|STARTED|Intervention 3 (8 Days)||2
272445|NCT00373295|661977|P5|STARTED|Intervention 3 (8 Days)||2
272446|NCT00373295|661978|P4|STARTED|Intervention 3 (8 Days)||2
272447|NCT00373295|661979|P3|STARTED|Intervention 3 (8 Days)||1
272448|NCT00373295|661980|P2|STARTED|Intervention 3 (8 Days)||1
272449|NCT00373295|661981|P1|STARTED|Intervention 3 (8 Days)||2
272450|NCT00373295|661976|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
272451|NCT00373295|661977|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
272452|NCT00373295|661978|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
272453|NCT00373295|661979|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
272454|NCT00373295|661980|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
272455|NCT00373295|661981|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
272456|NCT00373295|661976|P6|COMPLETED|Intervention 2 (8 Days)||2
272457|NCT00373295|661977|P5|COMPLETED|Intervention 2 (8 Days)||2
272458|NCT00373295|661978|P4|COMPLETED|Intervention 2 (8 Days)||2
272459|NCT00373295|661979|P3|COMPLETED|Intervention 2 (8 Days)||1
272460|NCT00373295|661980|P2|COMPLETED|Intervention 2 (8 Days)||1
272461|NCT00373295|661981|P1|COMPLETED|Intervention 2 (8 Days)||2
272462|NCT00373295|661976|P6|STARTED|Intervention 2 (8 Days)||2
272463|NCT00373295|661977|P5|STARTED|Intervention 2 (8 Days)||2
272464|NCT00373295|661978|P4|STARTED|Intervention 2 (8 Days)||2
272465|NCT00373295|661979|P3|STARTED|Intervention 2 (8 Days)||1
272466|NCT00373295|661980|P2|STARTED|Intervention 2 (8 Days)||1
272467|NCT00373295|661981|P1|STARTED|Intervention 2 (8 Days)||2
272468|NCT00373295|661976|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
272469|NCT00373295|661977|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
272470|NCT00373295|661978|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
272471|NCT00373295|661979|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
272472|NCT00373295|661980|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
272473|NCT00373295|661981|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
272474|NCT00373295|661976|P6|COMPLETED|Intervention 1 (8 Days)||2
272475|NCT00373295|661977|P5|COMPLETED|Intervention 1 (8 Days)||2
272476|NCT00373295|661978|P4|COMPLETED|Intervention 1 (8 Days)||2
272477|NCT00373295|661979|P3|COMPLETED|Intervention 1 (8 Days)||1
272478|NCT00373295|661980|P2|COMPLETED|Intervention 1 (8 Days)||1
272479|NCT00373295|661981|P1|COMPLETED|Intervention 1 (8 Days)||2
272480|NCT00373295|661976|P6|STARTED|Intervention 1 (8 Days)||2
272481|NCT00373295|661977|P5|STARTED|Intervention 1 (8 Days)||3
272482|NCT00373295|661978|P4|STARTED|Intervention 1 (8 Days)||2
272483|NCT00373295|661979|P3|STARTED|Intervention 1 (8 Days)||1
272484|NCT00373295|661980|P2|STARTED|Intervention 1 (8 Days)||3
272485|NCT00373295|661981|P1|STARTED|Intervention 1 (8 Days)||2
272486|NCT00373269|661991|P2|NOT COMPLETED|Overall Study||0
272487|NCT00373269|661992|P1|NOT COMPLETED|Overall Study||0
272488|NCT00373269|661991|P2|COMPLETED|Overall Study||10
272489|NCT00373269|661992|P1|COMPLETED|Overall Study||11
272490|NCT00373269|661991|P2|STARTED|Overall Study||10
272491|NCT00373269|661992|P1|STARTED|Overall Study||11
272492|NCT00373256|662002|P2|NOT COMPLETED|Overall Study||247
272493|NCT00373256|662003|P1|NOT COMPLETED|Overall Study||241
272494|NCT00373256|662002|P2|COMPLETED|Overall Study||0
272495|NCT00373256|662003|P1|COMPLETED|Overall Study||0
272496|NCT00373256|662002|P2|Treated|Overall Study||236
272497|NCT00373256|662003|P1|Treated|Overall Study||235
272498|NCT00373256|662002|P2|STARTED|Overall Study||247
272499|NCT00373256|662003|P1|STARTED|Overall Study||241
272500|NCT00373113|662029|P2|NOT COMPLETED|Overall Study||244
272501|NCT00373113|662030|P1|NOT COMPLETED|Overall Study||238
272502|NCT00373113|662029|P2|COMPLETED|Overall Study||0
272503|NCT00373113|662030|P1|COMPLETED|Overall Study||0
272504|NCT00373113|662029|P2|Received Treatment|Overall Study||240
272505|NCT00373113|662030|P1|Received Treatment|Overall Study||238
272506|NCT00373113|662029|P2|STARTED|Overall Study||244
272507|NCT00373113|662030|P1|STARTED|Overall Study||238
272508|NCT00372996|662052|P4|NOT COMPLETED|Overall Study||20
272509|NCT00372996|662053|P3|NOT COMPLETED|Overall Study||28
272510|NCT00372996|662054|P2|NOT COMPLETED|Overall Study||14
272511|NCT00372996|662055|P1|NOT COMPLETED|Overall Study||37
272512|NCT00372996|662052|P4|COMPLETED|Overall Study||23
272513|NCT00372996|662053|P3|COMPLETED|Overall Study||33
272514|NCT00372996|662054|P2|COMPLETED|Overall Study||22
272515|NCT00372996|662055|P1|COMPLETED|Overall Study||42
272516|NCT00372996|662052|P4|STARTED|Overall Study||43
272517|NCT00372996|662053|P3|STARTED|Overall Study||61
272518|NCT00372996|662054|P2|STARTED|Overall Study||36
272519|NCT00372996|662055|P1|STARTED|Overall Study||79
272520|NCT00372970|662081|P2|NOT COMPLETED|Overall Study||0
272521|NCT00372970|662082|P1|NOT COMPLETED|Overall Study||0
272522|NCT00372970|662081|P2|COMPLETED|Overall Study||16
272523|NCT00372970|662082|P1|COMPLETED|Overall Study||16
272524|NCT00372970|662081|P2|STARTED|Overall Study||16
272525|NCT00372970|662082|P1|STARTED|Overall Study||16
272526|NCT00372957|662091|P3|NOT COMPLETED|Overall Study||0
272527|NCT00372957|662092|P2|NOT COMPLETED|Overall Study||0
272528|NCT00372957|662093|P1|NOT COMPLETED|Overall Study||0
272529|NCT00372957|662091|P3|COMPLETED|Overall Study||10
272530|NCT00372957|662092|P2|COMPLETED|Overall Study||10
272531|NCT00372957|662093|P1|COMPLETED|Overall Study||10
272532|NCT00372957|662091|P3|STARTED|Overall Study||10
272533|NCT00372957|662092|P2|STARTED|Overall Study||10
272534|NCT00372957|662093|P1|STARTED|Overall Study||10
272535|NCT00372775|662140|P1|NOT COMPLETED|Overall Study||63
272536|NCT00372775|662140|P1|COMPLETED|Overall Study||3
272537|NCT00372775|662140|P1|Received Treatment|Overall Study||64
272538|NCT00372775|662140|P1|STARTED|Overall Study||66
272539|NCT00372697|662162|P2|NOT COMPLETED|Overall Study||1
272540|NCT00372697|662163|P1|NOT COMPLETED|Overall Study||1
272541|NCT00372697|662162|P2|COMPLETED|Overall Study||11
272542|NCT00372697|662163|P1|COMPLETED|Overall Study||15
272543|NCT00372697|662162|P2|STARTED|Overall Study||12
272544|NCT00372697|662163|P1|STARTED|Overall Study||16
272545|NCT00372619|662188|P7|NOT COMPLETED|Overall Study||0
272546|NCT00372619|662189|P6|NOT COMPLETED|Overall Study||3
272547|NCT00372619|662190|P5|NOT COMPLETED|Overall Study||0
272548|NCT00372619|662191|P4|NOT COMPLETED|Overall Study||0
272549|NCT00372619|662192|P3|NOT COMPLETED|Overall Study||0
272550|NCT00372619|662193|P2|NOT COMPLETED|Overall Study||0
272551|NCT00372619|662194|P1|NOT COMPLETED|Overall Study||0
272552|NCT00372619|662188|P7|COMPLETED|Overall Study||2
272553|NCT00372619|662189|P6|COMPLETED|Overall Study||39
272554|NCT00372619|662190|P5|COMPLETED|Overall Study||7
272555|NCT00372619|662191|P4|COMPLETED|Overall Study||10
272556|NCT00372619|662192|P3|COMPLETED|Overall Study||3
272557|NCT00372619|662193|P2|COMPLETED|Overall Study||2
272558|NCT00372619|662194|P1|COMPLETED|Overall Study||8
272559|NCT00372619|662188|P7|STARTED|Overall Study||2
272560|NCT00372619|662189|P6|STARTED|Overall Study||42
272561|NCT00372619|662190|P5|STARTED|Overall Study||7
272562|NCT00372619|662191|P4|STARTED|Overall Study||10
272563|NCT00372619|662192|P3|STARTED|Overall Study||3
272564|NCT00372619|662193|P2|STARTED|Overall Study||2
272565|NCT00372619|662194|P1|STARTED|Overall Study||8
272566|NCT00372593|662227|P3|NOT COMPLETED|Overall Study||4
272567|NCT00372593|662228|P2|NOT COMPLETED|Overall Study||198
272568|NCT00372593|662229|P1|NOT COMPLETED|Overall Study||204
272569|NCT00372593|662227|P3|COMPLETED|Overall Study||3
272570|NCT00372593|662228|P2|COMPLETED|Overall Study||334
272571|NCT00372593|662229|P1|COMPLETED|Overall Study||327
272572|NCT00372593|662227|P3|STARTED|Overall Study||7
272573|NCT00372593|662228|P2|STARTED|Overall Study||532
272574|NCT00372593|662229|P1|STARTED|Overall Study||531
272575|NCT00372567|662258|P3|NOT COMPLETED|Phase 3 Study||12
272576|NCT00372567|662259|P2|NOT COMPLETED|Phase 3 Study||26
272577|NCT00372567|662260|P1|NOT COMPLETED|Phase 3 Study||31
272578|NCT00372567|662258|P3|COMPLETED|Phase 3 Study||0
272579|NCT00372567|662259|P2|COMPLETED|Phase 3 Study||0
272580|NCT00372567|662260|P1|COMPLETED|Phase 3 Study||0
272581|NCT00372567|662258|P3|Received Treatment|Phase 3 Study||12
272582|NCT00372567|662259|P2|Received Treatment|Phase 3 Study||25
272583|NCT00372567|662260|P1|Received Treatment|Phase 3 Study||31
272584|NCT00372567|662258|P3|STARTED|Phase 3 Study||12
272585|NCT00372567|662259|P2|STARTED|Phase 3 Study||26
272586|NCT00372567|662260|P1|STARTED|Phase 3 Study||31
272587|NCT00372567|662258|P3|NOT COMPLETED|Phase 1 Sub-study||0
272588|NCT00372567|662259|P2|NOT COMPLETED|Phase 1 Sub-study||0
272589|NCT00372567|662260|P1|NOT COMPLETED|Phase 1 Sub-study||0
272590|NCT00372567|662258|P3|COMPLETED|Phase 1 Sub-study||12
272591|NCT00372567|662259|P2|COMPLETED|Phase 1 Sub-study||0
272592|NCT00372567|662260|P1|COMPLETED|Phase 1 Sub-study||0
272593|NCT00372567|662258|P3|STARTED|Phase 1 Sub-study||12
272594|NCT00372567|662259|P2|STARTED|Phase 1 Sub-study||0
272595|NCT00372567|662260|P1|STARTED|Phase 1 Sub-study||0
272596|NCT00372528|662288|P1|NOT COMPLETED|Overall Study||21
272597|NCT00372528|662288|P1|COMPLETED|Overall Study||0
272598|NCT00372528|662288|P1|STARTED|Overall Study||21
272599|NCT00372489|662293|P1|NOT COMPLETED|Overall Study||79
272600|NCT00372489|662293|P1|COMPLETED|Overall Study||2
272601|NCT00372489|662293|P1|STARTED|Overall Study||81
272602|NCT00372424|662297|P1|NOT COMPLETED|Overall Study||26
272603|NCT00372424|662297|P1|COMPLETED|Overall Study||0
272604|NCT00372424|662297|P1|Treated|Overall Study||25
272605|NCT00372424|662297|P1|STARTED|Overall Study||26
272606|NCT00372411|662311|P3|NOT COMPLETED|Overall Study||3
272607|NCT00372411|662312|P2|NOT COMPLETED|Overall Study||8
272608|NCT00372411|662313|P1|NOT COMPLETED|Overall Study||5
272609|NCT00372411|662311|P3|COMPLETED|Overall Study||25
272610|NCT00372411|662312|P2|COMPLETED|Overall Study||42
272611|NCT00372411|662313|P1|COMPLETED|Overall Study||44
272612|NCT00372411|662311|P3|STARTED|Overall Study||28
272613|NCT00372411|662312|P2|STARTED|Overall Study||50
272614|NCT00372411|662313|P1|STARTED|Overall Study||49
272615|NCT00372385|662337|P4|NOT COMPLETED|Overall Study||8
272616|NCT00372385|662338|P3|NOT COMPLETED|Overall Study||10
272617|NCT00372385|662339|P2|NOT COMPLETED|Overall Study||20
272618|NCT00372385|662340|P1|NOT COMPLETED|Overall Study||33
272619|NCT00372385|662337|P4|COMPLETED|Overall Study||70
272620|NCT00372385|662338|P3|COMPLETED|Overall Study||72
272621|NCT00372385|662339|P2|COMPLETED|Overall Study||61
272622|NCT00372385|662340|P1|COMPLETED|Overall Study||49
272623|NCT00372385|662337|P4|STARTED|Overall Study||78
272624|NCT00372385|662338|P3|STARTED|Overall Study||82
272625|NCT00372385|662339|P2|STARTED|Overall Study||81
272626|NCT00372385|662340|P1|STARTED|Overall Study||82
272627|NCT00372190|662369|P2|NOT COMPLETED|Overall Study||1
272628|NCT00372190|662370|P1|NOT COMPLETED|Overall Study||3
272629|NCT00372190|662369|P2|COMPLETED|Overall Study||96
272630|NCT00372190|662370|P1|COMPLETED|Overall Study||90
272631|NCT00372190|662369|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
272632|NCT00372190|662370|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
272633|NCT00372112|662386|P4|NOT COMPLETED|Overall Study||4
272634|NCT00372112|662387|P3|NOT COMPLETED|Overall Study||4
272635|NCT00372112|662388|P2|NOT COMPLETED|Overall Study||1
272636|NCT00372112|662389|P1|NOT COMPLETED|Overall Study||1
272637|NCT00372112|662386|P4|COMPLETED|Overall Study||14
272638|NCT00372112|662387|P3|COMPLETED|Overall Study||13
272639|NCT00372112|662388|P2|COMPLETED|Overall Study||15
272640|NCT00372112|662389|P1|COMPLETED|Overall Study||16
272641|NCT00372112|662386|P4|STARTED|Overall Study||18
272642|NCT00372112|662387|P3|STARTED|Overall Study||17
272643|NCT00372112|662388|P2|STARTED|Overall Study||16
272644|NCT00372112|662389|P1|STARTED|Overall Study||17
272645|NCT00372060|662520|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
272646|NCT00372060|662521|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
272647|NCT00372060|662520|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
272648|NCT00372060|662521|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
272649|NCT00372060|662520|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
272650|NCT00372060|662521|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
272651|NCT00372060|662520|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
272652|NCT00372060|662521|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
272653|NCT00372060|662520|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
272654|NCT00372060|662521|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
272655|NCT00372060|662520|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
272656|NCT00372060|662521|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
272657|NCT00371865|662536|P2|NOT COMPLETED|Overall Study||14
272658|NCT00371865|662537|P1|NOT COMPLETED|Overall Study||15
272659|NCT00371865|662536|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
272660|NCT00371865|662537|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
272661|NCT00371865|662536|P2|STARTED|Overall Study||57
272662|NCT00371865|662537|P1|STARTED|Overall Study||57
272663|NCT00371839|662554|P3|NOT COMPLETED|Overall Study||2
272664|NCT00371839|662555|P2|NOT COMPLETED|Overall Study||7
272665|NCT00371839|662556|P1|NOT COMPLETED|Overall Study||17
272666|NCT00371839|662554|P3|COMPLETED|Overall Study||7
272667|NCT00371839|662555|P2|COMPLETED|Overall Study||13
272668|NCT00371839|662556|P1|COMPLETED|Overall Study||32
272669|NCT00371839|662554|P3|STARTED|Overall Study||9
272670|NCT00371839|662555|P2|STARTED|Overall Study||20
272671|NCT00371839|662556|P1|STARTED|Overall Study||49
272672|NCT00371826|662565|P3|NOT COMPLETED|Extension Phase (24 Months)||2
272673|NCT00371826|662566|P2|NOT COMPLETED|Extension Phase (24 Months)||10
272674|NCT00371826|662567|P1|NOT COMPLETED|Extension Phase (24 Months)||5
272675|NCT00371826|662565|P3|COMPLETED|Extension Phase (24 Months)||3
272676|NCT00371826|662566|P2|COMPLETED|Extension Phase (24 Months)||29
272677|NCT00371826|662567|P1|COMPLETED|Extension Phase (24 Months)||18
272678|NCT00371826|662565|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
272679|NCT00371826|662566|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
272680|NCT00371826|662567|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
272681|NCT00371826|662565|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
272682|NCT00371826|662566|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
272683|NCT00371826|662567|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
272684|NCT00371826|662565|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
272685|NCT00371826|662566|P2|STARTED|Extension Phase (24 Months)||39
272686|NCT00371826|662567|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
272687|NCT00371826|662565|P3|NOT COMPLETED|Core Phase (12 Months)||24
272688|NCT00371826|662566|P2|NOT COMPLETED|Core Phase (12 Months)||8
272689|NCT00371826|662567|P1|NOT COMPLETED|Core Phase (12 Months)||24
272690|NCT00371826|662565|P3|COMPLETED|Core Phase (12 Months)||6
272691|NCT00371826|662566|P2|COMPLETED|Core Phase (12 Months)||39
272692|NCT00371826|662567|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
272693|NCT00371826|662565|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
272694|NCT00371826|662566|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
272695|NCT00371826|662567|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
272696|NCT00371826|662565|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
272697|NCT00371826|662566|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
272698|NCT00371826|662567|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
272699|NCT00371826|662565|P3|STARTED|Core Phase (12 Months)||30
272700|NCT00371826|662566|P2|STARTED|Core Phase (12 Months)||47
272701|NCT00371826|662567|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
272702|NCT00371787|662691|P2|NOT COMPLETED|Overall Study||1
272703|NCT00371787|662692|P1|NOT COMPLETED|Overall Study||3
272704|NCT00371787|662691|P2|COMPLETED|Overall Study||11
272705|NCT00371787|662692|P1|COMPLETED|Overall Study||23
272706|NCT00371787|662691|P2|STARTED|Overall Study||12
272707|NCT00371787|662692|P1|STARTED|Overall Study||26
272708|NCT00371761|662706|P2|NOT COMPLETED|Overall Study||10
272709|NCT00371761|662707|P1|NOT COMPLETED|Overall Study||8
272710|NCT00371761|662706|P2|COMPLETED|Overall Study||2
272711|NCT00371761|662707|P1|COMPLETED|Overall Study||5
272712|NCT00371761|662706|P2|STARTED|Overall Study||12
272713|NCT00371761|662707|P1|STARTED|Overall Study||13
272714|NCT00371683|662715|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
272715|NCT00371683|662716|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
272716|NCT00371683|662715|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
272717|NCT00371683|662716|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
272718|NCT00371683|662715|P2|STARTED|Follow-Up Period - Randomized Patients||1533
272719|NCT00371683|662716|P1|STARTED|Follow-Up Period - Randomized Patients||1553
272720|NCT00371683|662715|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
272721|NCT00371683|662716|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
272722|NCT00371683|662715|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
272723|NCT00371683|662716|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
272724|NCT00371683|662715|P2|STARTED|DB Treatment Period-Randomized Patients||1596
272725|NCT00371683|662716|P1|STARTED|DB Treatment Period-Randomized Patients||1599
272726|NCT00371644|662770|P2|NOT COMPLETED|Overall Study||13
272727|NCT00371644|662771|P1|NOT COMPLETED|Overall Study||28
272728|NCT00371644|662770|P2|COMPLETED|Overall Study||44
272729|NCT00371644|662771|P1|COMPLETED|Overall Study||44
272730|NCT00371644|662770|P2|STARTED|Overall Study||57
272731|NCT00371644|662771|P1|STARTED|Overall Study||72
272732|NCT00371631|662777|P1|NOT COMPLETED|Overall Study||0
272733|NCT00371631|662777|P1|COMPLETED|Overall Study||13
272734|NCT00371631|662777|P1|STARTED|Overall Study||13
272735|NCT00371566|662784|P2|NOT COMPLETED|Follow Up Phase||7
272736|NCT00371566|662785|P1|NOT COMPLETED|Follow Up Phase||3
272737|NCT00371566|662784|P2|COMPLETED|Follow Up Phase||58
272738|NCT00371566|662785|P1|COMPLETED|Follow Up Phase||28
272739|NCT00371566|662784|P2|STARTED|Follow Up Phase||65
272740|NCT00371566|662785|P1|STARTED|Follow Up Phase||31
272741|NCT00371566|662784|P2|NOT COMPLETED|Chemoradiation Phase||3
272742|NCT00371566|662785|P1|NOT COMPLETED|Chemoradiation Phase||5
272743|NCT00371566|662784|P2|COMPLETED|Chemoradiation Phase||65
272744|NCT00371566|662785|P1|COMPLETED|Chemoradiation Phase||31
272745|NCT00371566|662784|P2|STARTED|Chemoradiation Phase||68
272746|NCT00371566|662785|P1|STARTED|Chemoradiation Phase||36
272747|NCT00371566|662784|P2|NOT COMPLETED|Treatment Phase||3
272748|NCT00371566|662785|P1|NOT COMPLETED|Treatment Phase||0
272749|NCT00371566|662784|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
272750|NCT00371566|662785|P1|COMPLETED|Treatment Phase||36
272751|NCT00371566|662784|P2|STARTED|Treatment Phase||71
272752|NCT00371566|662785|P1|STARTED|Treatment Phase||36
272753|NCT00371540|662857|P2|NOT COMPLETED|Overall Study||9
272754|NCT00371540|662858|P1|NOT COMPLETED|Overall Study||10
272755|NCT00371540|662857|P2|COMPLETED|Overall Study||87
272756|NCT00371540|662858|P1|COMPLETED|Overall Study||102
272757|NCT00371540|662857|P2|STARTED|Overall Study||96
272758|NCT00371540|662858|P1|STARTED|Overall Study||112
272759|NCT00371462|662870|P2|NOT COMPLETED|Overall Study||8
272760|NCT00371462|662871|P1|NOT COMPLETED|Overall Study||8
272761|NCT00371462|662870|P2|COMPLETED|Overall Study||27
272762|NCT00371462|662871|P1|COMPLETED|Overall Study||27
272763|NCT00371462|662870|P2|STARTED|Overall Study||35
272764|NCT00371462|662871|P1|STARTED|Overall Study||35
272765|NCT00371449|662877|P1|NOT COMPLETED|Overall Study||0
272766|NCT00371449|662877|P1|COMPLETED|Overall Study||120
272767|NCT00371449|662877|P1|STARTED|Overall Study||120
272768|NCT00371436|662888|P2|NOT COMPLETED|Overall Study||21
272769|NCT00371436|662889|P1|NOT COMPLETED|Overall Study||34
272770|NCT00371436|662888|P2|COMPLETED|Overall Study||68
272771|NCT00371436|662889|P1|COMPLETED|Overall Study||58
272772|NCT00371436|662888|P2|STARTED|Overall Study||89
272773|NCT00371436|662889|P1|STARTED|Overall Study||92
272774|NCT00371397|662895|P12|NOT COMPLETED|Session 3||0
272775|NCT00371397|662896|P11|NOT COMPLETED|Session 3||0
272776|NCT00371397|662897|P10|NOT COMPLETED|Session 3||0
272777|NCT00371397|662898|P9|NOT COMPLETED|Session 3||0
272778|NCT00371397|662899|P8|NOT COMPLETED|Session 3||0
272779|NCT00371397|662900|P7|NOT COMPLETED|Session 3||0
272780|NCT00371397|662901|P6|NOT COMPLETED|Session 3||0
272781|NCT00371397|662902|P5|NOT COMPLETED|Session 3||0
272782|NCT00371397|662903|P4|NOT COMPLETED|Session 3||0
272783|NCT00371397|662904|P3|NOT COMPLETED|Session 3||0
272784|NCT00371397|662905|P2|NOT COMPLETED|Session 3||0
272785|NCT00371397|662906|P1|NOT COMPLETED|Session 3||0
272786|NCT00371397|662895|P12|COMPLETED|Session 3||2
272787|NCT00371397|662896|P11|COMPLETED|Session 3||4
272788|NCT00371397|662897|P10|COMPLETED|Session 3||5
272789|NCT00371397|662898|P9|COMPLETED|Session 3||6
272790|NCT00371397|662899|P8|COMPLETED|Session 3||4
272791|NCT00371397|662900|P7|COMPLETED|Session 3||4
272792|NCT00371397|662901|P6|COMPLETED|Session 3||4
272793|NCT00371397|662902|P5|COMPLETED|Session 3||3
272794|NCT00371397|662903|P4|COMPLETED|Session 3||2
272795|NCT00371397|662904|P3|COMPLETED|Session 3||5
272796|NCT00371397|662905|P2|COMPLETED|Session 3||7
272797|NCT00371397|662906|P1|COMPLETED|Session 3||4
272798|NCT00371397|662895|P12|STARTED|Session 3||2
272799|NCT00371397|662896|P11|STARTED|Session 3||4
272800|NCT00371397|662897|P10|STARTED|Session 3||5
272801|NCT00371397|662898|P9|STARTED|Session 3||6
272802|NCT00371397|662899|P8|STARTED|Session 3||4
272803|NCT00371397|662900|P7|STARTED|Session 3||4
272804|NCT00371397|662901|P6|STARTED|Session 3||4
272805|NCT00371397|662902|P5|STARTED|Session 3||3
272806|NCT00371397|662903|P4|STARTED|Session 3||2
272807|NCT00371397|662904|P3|STARTED|Session 3||5
272808|NCT00371397|662905|P2|STARTED|Session 3||7
272809|NCT00371397|662906|P1|STARTED|Session 3||4
272810|NCT00371397|662895|P12|NOT COMPLETED|Session 2||0
272811|NCT00371397|662896|P11|NOT COMPLETED|Session 2||0
272812|NCT00371397|662897|P10|NOT COMPLETED|Session 2||0
272813|NCT00371397|662898|P9|NOT COMPLETED|Session 2||0
272814|NCT00371397|662899|P8|NOT COMPLETED|Session 2||0
272815|NCT00371397|662900|P7|NOT COMPLETED|Session 2||0
272816|NCT00371397|662901|P6|NOT COMPLETED|Session 2||0
272817|NCT00371397|662902|P5|NOT COMPLETED|Session 2||0
272818|NCT00371397|662903|P4|NOT COMPLETED|Session 2||0
272819|NCT00371397|662904|P3|NOT COMPLETED|Session 2||0
272820|NCT00371397|662905|P2|NOT COMPLETED|Session 2||0
272821|NCT00371397|662906|P1|NOT COMPLETED|Session 2||0
272822|NCT00371397|662895|P12|COMPLETED|Session 2||2
272823|NCT00371397|662896|P11|COMPLETED|Session 2||4
272824|NCT00371397|662897|P10|COMPLETED|Session 2||5
272825|NCT00371397|662898|P9|COMPLETED|Session 2||6
272826|NCT00371397|662899|P8|COMPLETED|Session 2||4
272827|NCT00371397|662900|P7|COMPLETED|Session 2||4
272828|NCT00371397|662901|P6|COMPLETED|Session 2||4
272829|NCT00371397|662902|P5|COMPLETED|Session 2||3
272830|NCT00371397|662903|P4|COMPLETED|Session 2||2
272831|NCT00371397|662904|P3|COMPLETED|Session 2||5
272832|NCT00371397|662905|P2|COMPLETED|Session 2||7
272833|NCT00371397|662906|P1|COMPLETED|Session 2||4
272834|NCT00371397|662895|P12|STARTED|Session 2||2
272835|NCT00371397|662896|P11|STARTED|Session 2||4
272836|NCT00371397|662897|P10|STARTED|Session 2||5
272837|NCT00371397|662898|P9|STARTED|Session 2||6
272838|NCT00371397|662899|P8|STARTED|Session 2||4
272839|NCT00371397|662900|P7|STARTED|Session 2||4
272840|NCT00371397|662901|P6|STARTED|Session 2||4
272841|NCT00371397|662902|P5|STARTED|Session 2||3
272842|NCT00371397|662903|P4|STARTED|Session 2||2
272843|NCT00371397|662904|P3|STARTED|Session 2||5
272844|NCT00371397|662905|P2|STARTED|Session 2||7
272845|NCT00371397|662906|P1|STARTED|Session 2||4
272846|NCT00371397|662895|P12|NOT COMPLETED|Session 1||0
272847|NCT00371397|662896|P11|NOT COMPLETED|Session 1||0
272848|NCT00371397|662897|P10|NOT COMPLETED|Session 1||0
272849|NCT00371397|662898|P9|NOT COMPLETED|Session 1||0
272850|NCT00371397|662899|P8|NOT COMPLETED|Session 1||1
272851|NCT00371397|662900|P7|NOT COMPLETED|Session 1||0
272852|NCT00371397|662901|P6|NOT COMPLETED|Session 1||0
272853|NCT00371397|662902|P5|NOT COMPLETED|Session 1||0
272854|NCT00371397|662903|P4|NOT COMPLETED|Session 1||0
272855|NCT00371397|662904|P3|NOT COMPLETED|Session 1||0
272856|NCT00371397|662905|P2|NOT COMPLETED|Session 1||0
272857|NCT00371397|662906|P1|NOT COMPLETED|Session 1||1
272858|NCT00371397|662895|P12|COMPLETED|Session 1||2
272859|NCT00371397|662896|P11|COMPLETED|Session 1||4
272860|NCT00371397|662897|P10|COMPLETED|Session 1||5
272861|NCT00371397|662898|P9|COMPLETED|Session 1||6
272862|NCT00371397|662899|P8|COMPLETED|Session 1||4
272863|NCT00371397|662900|P7|COMPLETED|Session 1||4
272864|NCT00371397|662901|P6|COMPLETED|Session 1||4
272865|NCT00371397|662902|P5|COMPLETED|Session 1||3
272866|NCT00371397|662903|P4|COMPLETED|Session 1||2
272867|NCT00371397|662904|P3|COMPLETED|Session 1||5
272868|NCT00371397|662905|P2|COMPLETED|Session 1||7
272869|NCT00371397|662906|P1|COMPLETED|Session 1||4
272870|NCT00371397|662895|P12|STARTED|Session 1||2
272871|NCT00371397|662896|P11|STARTED|Session 1||4
272872|NCT00371397|662897|P10|STARTED|Session 1||5
272873|NCT00371397|662898|P9|STARTED|Session 1||6
272874|NCT00371397|662899|P8|STARTED|Session 1||5
272875|NCT00371397|662900|P7|STARTED|Session 1||4
272876|NCT00371397|662901|P6|STARTED|Session 1||4
272877|NCT00371397|662902|P5|STARTED|Session 1||3
272878|NCT00371397|662903|P4|STARTED|Session 1||2
272879|NCT00371397|662904|P3|STARTED|Session 1||5
272880|NCT00371397|662905|P2|STARTED|Session 1||7
272881|NCT00371397|662906|P1|STARTED|Session 1||5
272882|NCT00371345|662914|P2|NOT COMPLETED|Overall Study||46
272883|NCT00371345|662915|P1|NOT COMPLETED|Overall Study||24
272884|NCT00371345|662914|P2|COMPLETED|Overall Study||0
272885|NCT00371345|662915|P1|COMPLETED|Overall Study||0
272886|NCT00371345|662914|P2|STARTED|Overall Study||46
272887|NCT00371345|662915|P1|STARTED|Overall Study||24
272888|NCT00371293|662975|P3|NOT COMPLETED|Overall Study||16
272889|NCT00371293|662976|P2|NOT COMPLETED|Overall Study||19
272890|NCT00371293|662977|P1|NOT COMPLETED|Overall Study||10
272891|NCT00371293|662975|P3|COMPLETED|Overall Study||46
272892|NCT00371293|662976|P2|COMPLETED|Overall Study||42
272893|NCT00371293|662977|P1|COMPLETED|Overall Study||48
272894|NCT00371293|662975|P3|STARTED|Overall Study||62
272895|NCT00371293|662976|P2|STARTED|Overall Study||61
272896|NCT00371293|662977|P1|STARTED|Overall Study||58
272897|NCT00371267|662999|P2|NOT COMPLETED|Overall Study||18
272898|NCT00371267|663000|P1|NOT COMPLETED|Overall Study||9
272899|NCT00371267|662999|P2|COMPLETED|Overall Study||32
272900|NCT00371267|663000|P1|COMPLETED|Overall Study||39
272901|NCT00371267|662999|P2|STARTED|Overall Study||50
272902|NCT00371267|663000|P1|STARTED|Overall Study||48
272903|NCT00371254|663016|P2|NOT COMPLETED|Overall Study||21
272904|NCT00371254|663017|P1|NOT COMPLETED|Overall Study||23
272905|NCT00371254|663016|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
272906|NCT00371254|663017|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
272907|NCT00371254|663016|P2|STARTED|Overall Study|Number of participants treated|21
272908|NCT00371254|663017|P1|STARTED|Overall Study|Number of participants treated|23
272909|NCT00371176|663069|P2|NOT COMPLETED|Overall Study||8
272910|NCT00371176|663070|P1|NOT COMPLETED|Overall Study||5
272911|NCT00371176|663069|P2|COMPLETED|Overall Study||5
272912|NCT00371176|663070|P1|COMPLETED|Overall Study||8
272913|NCT00371176|663069|P2|Completed Treatment|Overall Study||9
272914|NCT00371176|663070|P1|Completed Treatment|Overall Study||10
272915|NCT00371176|663069|P2|STARTED|Overall Study||13
272916|NCT00371176|663070|P1|STARTED|Overall Study||13
272917|NCT00371150|663100|P2|NOT COMPLETED|Overall Study||2
272918|NCT00371150|663101|P1|NOT COMPLETED|Overall Study||3
272919|NCT00371150|663100|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
272920|NCT00371150|663101|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
272921|NCT00371150|663100|P2|Discontinued at or After Week 48 Visit|Overall Study||1
272922|NCT00371150|663101|P1|Discontinued at or After Week 48 Visit|Overall Study||2
272923|NCT00371150|663100|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
272924|NCT00371150|663101|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
272925|NCT00371150|663100|P2|STARTED|Overall Study||6
272926|NCT00371150|663101|P1|STARTED|Overall Study||40
272927|NCT00371137|663136|P3|NOT COMPLETED|Overall Study||79
272928|NCT00371137|663137|P2|NOT COMPLETED|Overall Study||63
272929|NCT00371137|663138|P1|NOT COMPLETED|Overall Study||72
272930|NCT00371137|663136|P3|COMPLETED|Overall Study||104
272931|NCT00371137|663137|P2|COMPLETED|Overall Study||119
272932|NCT00371137|663138|P1|COMPLETED|Overall Study||111
272933|NCT00371137|663136|P3|Treated|Overall Study||182
272934|NCT00371137|663137|P2|Treated|Overall Study||182
272935|NCT00371137|663138|P1|Treated|Overall Study||183
272936|NCT00371137|663136|P3|STARTED|Overall Study||183
272937|NCT00371137|663137|P2|STARTED|Overall Study||182
272938|NCT00371137|663138|P1|STARTED|Overall Study||183
272939|NCT00370994|663148|P2|NOT COMPLETED|Overall Study||0
272940|NCT00370994|663149|P1|NOT COMPLETED|Overall Study||0
272941|NCT00370994|663148|P2|COMPLETED|Overall Study||60
272942|NCT00370994|663149|P1|COMPLETED|Overall Study||60
272943|NCT00370994|663148|P2|STARTED|Overall Study||60
272944|NCT00370994|663149|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
272945|NCT00370838|663159|P2|NOT COMPLETED|Taper||0
272946|NCT00370838|663160|P1|NOT COMPLETED|Taper||0
272947|NCT00370838|663159|P2|COMPLETED|Taper||3
272948|NCT00370838|663160|P1|COMPLETED|Taper||7
272949|NCT00370838|663159|P2|STARTED|Taper||3
272950|NCT00370838|663160|P1|STARTED|Taper||7
272951|NCT00370838|663159|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
272952|NCT00370838|663160|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
272953|NCT00370838|663159|P2|COMPLETED|Period 2 (Days 65-107)||3
272954|NCT00370838|663160|P1|COMPLETED|Period 2 (Days 65-107)||7
272955|NCT00370838|663159|P2|STARTED|Period 2 (Days 65-107)||3
272956|NCT00370838|663160|P1|STARTED|Period 2 (Days 65-107)||7
272957|NCT00370838|663159|P2|NOT COMPLETED|Washout (Days 51-64)||0
272958|NCT00370838|663160|P1|NOT COMPLETED|Washout (Days 51-64)||0
272959|NCT00370838|663159|P2|COMPLETED|Washout (Days 51-64)||3
272960|NCT00370838|663160|P1|COMPLETED|Washout (Days 51-64)||7
272961|NCT00370838|663159|P2|STARTED|Washout (Days 51-64)||3
272962|NCT00370838|663160|P1|STARTED|Washout (Days 51-64)||7
272963|NCT00370838|663159|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
272964|NCT00370838|663160|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
272965|NCT00370838|663159|P2|COMPLETED|Period 1 (Days 8-50)||3
272966|NCT00370838|663160|P1|COMPLETED|Period 1 (Days 8-50)||7
272967|NCT00370838|663159|P2|STARTED|Period 1 (Days 8-50)||3
272968|NCT00370838|663160|P1|STARTED|Period 1 (Days 8-50)||7
272969|NCT00370682|663181|P3|NOT COMPLETED|Overall Study||1
272970|NCT00370682|663182|P2|NOT COMPLETED|Overall Study||3
272971|NCT00370682|663183|P1|NOT COMPLETED|Overall Study||0
272972|NCT00370682|663181|P3|COMPLETED|Overall Study||39
272973|NCT00370682|663182|P2|COMPLETED|Overall Study||37
272974|NCT00370682|663183|P1|COMPLETED|Overall Study||40
272975|NCT00370682|663181|P3|STARTED|Overall Study||40
272976|NCT00370682|663182|P2|STARTED|Overall Study||40
272977|NCT00370682|663183|P1|STARTED|Overall Study||40
272978|NCT00370552|663225|P3|NOT COMPLETED|Overall Study||32
272979|NCT00370552|663226|P2|NOT COMPLETED|Overall Study||45
272980|NCT00370552|663227|P1|NOT COMPLETED|Overall Study||46
272981|NCT00370552|663225|P3|COMPLETED|Overall Study||0
272982|NCT00370552|663226|P2|COMPLETED|Overall Study||0
272983|NCT00370552|663227|P1|COMPLETED|Overall Study||0
272984|NCT00370552|663225|P3|STARTED|Overall Study|Randomized|32
272985|NCT00370552|663226|P2|STARTED|Overall Study|Randomized|45
272986|NCT00370552|663227|P1|STARTED|Overall Study|Randomized|46
272987|NCT00370331|663267|P2|NOT COMPLETED|Overall Study||23
272988|NCT00370331|663268|P1|NOT COMPLETED|Overall Study||7
272989|NCT00370331|663267|P2|COMPLETED|Overall Study||112
272990|NCT00370331|663268|P1|COMPLETED|Overall Study||55
272991|NCT00370331|663267|P2|STARTED|Overall Study||135
272992|NCT00370331|663268|P1|STARTED|Overall Study||62
272993|NCT00370292|663294|P1|NOT COMPLETED|Overall Study||13
272994|NCT00370292|663294|P1|COMPLETED|Overall Study||6
272995|NCT00370292|663294|P1|STARTED|Overall Study||19
272996|NCT00370149|663307|P2|NOT COMPLETED|Overall Study||19
272997|NCT00370149|663308|P1|NOT COMPLETED|Overall Study||19
272998|NCT00370149|663307|P2|COMPLETED|Overall Study||142
272999|NCT00370149|663308|P1|COMPLETED|Overall Study||146
273000|NCT00370149|663307|P2|STARTED|Overall Study||161
273001|NCT00370149|663308|P1|STARTED|Overall Study||165
273002|NCT00370071|663318|P1|NOT COMPLETED|Overall Study||2
273003|NCT00370071|663318|P1|COMPLETED|Overall Study||37
273004|NCT00370071|663318|P1|STARTED|Overall Study||39
273005|NCT00370032|663335|P2|NOT COMPLETED|Follow-up Period||0
273006|NCT00370032|663336|P1|NOT COMPLETED|Follow-up Period||1
273007|NCT00370032|663335|P2|COMPLETED|Follow-up Period||22
273008|NCT00370032|663336|P1|COMPLETED|Follow-up Period||22
273009|NCT00370032|663335|P2|STARTED|Follow-up Period||22
273010|NCT00370032|663336|P1|STARTED|Follow-up Period||23
273011|NCT00370032|663335|P2|NOT COMPLETED|Treatment Period 2||0
273012|NCT00370032|663336|P1|NOT COMPLETED|Treatment Period 2||0
273013|NCT00370032|663335|P2|COMPLETED|Treatment Period 2||22
273014|NCT00370032|663336|P1|COMPLETED|Treatment Period 2||23
273015|NCT00370032|663335|P2|STARTED|Treatment Period 2||22
273016|NCT00370032|663336|P1|STARTED|Treatment Period 2||23
273017|NCT00370032|663335|P2|NOT COMPLETED|Washout Period||2
273018|NCT00370032|663336|P1|NOT COMPLETED|Washout Period||1
273019|NCT00370032|663335|P2|COMPLETED|Washout Period||22
273020|NCT00370032|663336|P1|COMPLETED|Washout Period||23
273021|NCT00370032|663335|P2|STARTED|Washout Period||24
273022|NCT00370032|663336|P1|STARTED|Washout Period||24
273023|NCT00370032|663335|P2|NOT COMPLETED|Treatment Period 1||1
273024|NCT00370032|663336|P1|NOT COMPLETED|Treatment Period 1||0
273025|NCT00370032|663335|P2|COMPLETED|Treatment Period 1||24
273026|NCT00370032|663336|P1|COMPLETED|Treatment Period 1||24
273027|NCT00370032|663335|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
273028|NCT00370032|663336|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
273029|NCT00369967|663356|P2|NOT COMPLETED|Overall Study||12
273030|NCT00369967|663357|P1|NOT COMPLETED|Overall Study||23
273031|NCT00369967|663356|P2|COMPLETED|Overall Study||5
273032|NCT00369967|663357|P1|COMPLETED|Overall Study||8
273033|NCT00369967|663356|P2|STARTED|Overall Study||17
273034|NCT00369967|663357|P1|STARTED|Overall Study||31
273035|NCT00369941|663375|P2|NOT COMPLETED|Overall Study||100
273036|NCT00369941|663376|P1|NOT COMPLETED|Overall Study||72
273037|NCT00369941|663375|P2|COMPLETED|Overall Study||184
273038|NCT00369941|663376|P1|COMPLETED|Overall Study||210
273039|NCT00369941|663375|P2|Treated|Overall Study||282
273040|NCT00369941|663376|P1|Treated|Overall Study||281
273041|NCT00369941|663375|P2|STARTED|Overall Study||284
273042|NCT00369941|663376|P1|STARTED|Overall Study||282
273043|NCT00369928|663529|P3|NOT COMPLETED|Overall Study||20
273044|NCT00369928|663530|P2|NOT COMPLETED|Overall Study||16
273045|NCT00369928|663531|P1|NOT COMPLETED|Overall Study||8
273046|NCT00369928|663529|P3|COMPLETED|Overall Study||66
273047|NCT00369928|663530|P2|COMPLETED|Overall Study||69
273048|NCT00369928|663531|P1|COMPLETED|Overall Study||77
273049|NCT00369928|663529|P3|STARTED|Overall Study||86
273050|NCT00369928|663530|P2|STARTED|Overall Study||85
273051|NCT00369928|663531|P1|STARTED|Overall Study||85
273052|NCT00369915|663541|P2|NOT COMPLETED|Overall Study||3
273053|NCT00369915|663542|P1|NOT COMPLETED|Overall Study||6
273054|NCT00369915|663541|P2|COMPLETED|Overall Study||4
273055|NCT00369915|663542|P1|COMPLETED|Overall Study||4
273056|NCT00369915|663541|P2|STARTED|Overall Study||7
273057|NCT00369915|663542|P1|STARTED|Overall Study||10
273058|NCT00369824|663556|P6|NOT COMPLETED|Overall Study||11
273059|NCT00369824|663557|P5|NOT COMPLETED|Overall Study||18
273060|NCT00369824|663558|P4|NOT COMPLETED|Overall Study||15
273061|NCT00369824|663559|P3|NOT COMPLETED|Overall Study||12
273062|NCT00369824|663560|P2|NOT COMPLETED|Overall Study||19
273063|NCT00369824|663561|P1|NOT COMPLETED|Overall Study||15
273064|NCT00369824|663556|P6|COMPLETED|Overall Study||204
273065|NCT00369824|663557|P5|COMPLETED|Overall Study||196
273066|NCT00369824|663558|P4|COMPLETED|Overall Study||199
273067|NCT00369824|663559|P3|COMPLETED|Overall Study||202
273068|NCT00369824|663560|P2|COMPLETED|Overall Study||195
273069|NCT00369824|663561|P1|COMPLETED|Overall Study||197
273070|NCT00369824|663556|P6|STARTED|Overall Study||215
273071|NCT00369824|663557|P5|STARTED|Overall Study||214
273072|NCT00369824|663558|P4|STARTED|Overall Study||214
273073|NCT00369824|663559|P3|STARTED|Overall Study||214
273074|NCT00369824|663560|P2|STARTED|Overall Study||214
273075|NCT00369824|663561|P1|STARTED|Overall Study||212
273076|NCT00369785|663661|P2|NOT COMPLETED|Overall Study||25
273077|NCT00369785|663662|P1|NOT COMPLETED|Overall Study||27
273078|NCT00369785|663661|P2|COMPLETED|Overall Study||74
273079|NCT00369785|663662|P1|COMPLETED|Overall Study||72
273080|NCT00369785|663661|P2|STARTED|Overall Study||99
273081|NCT00369785|663662|P1|STARTED|Overall Study||99
273082|NCT00369746|663672|P2|NOT COMPLETED|Overall Study||0
273083|NCT00369746|663673|P1|NOT COMPLETED|Overall Study||0
273084|NCT00369746|663672|P2|COMPLETED|Overall Study||536
273085|NCT00369746|663673|P1|COMPLETED|Overall Study||138
273086|NCT00369746|663672|P2|STARTED|Overall Study||536
273087|NCT00369746|663673|P1|STARTED|Overall Study||138
273088|NCT00369681|663683|P1|NOT COMPLETED|Overall Study||1
273089|NCT00369681|663683|P1|COMPLETED|Overall Study||49
273090|NCT00369681|663683|P1|STARTED|Overall Study||50
273091|NCT00369668|663692|P3|NOT COMPLETED|Overall Study||7
273092|NCT00369668|663693|P2|NOT COMPLETED|Overall Study||5
273093|NCT00369668|663694|P1|NOT COMPLETED|Overall Study||4
273094|NCT00369668|663692|P3|COMPLETED|Overall Study||3
273095|NCT00369668|663693|P2|COMPLETED|Overall Study||5
273096|NCT00369668|663694|P1|COMPLETED|Overall Study||6
273097|NCT00369668|663692|P3|STARTED|Overall Study||10
273098|NCT00369668|663693|P2|STARTED|Overall Study||10
273099|NCT00369668|663694|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
273100|NCT00369655|663708|P1|NOT COMPLETED|Overall Study||2
273101|NCT00369655|663708|P1|COMPLETED|Overall Study||19
273102|NCT00369655|663708|P1|STARTED|Overall Study||21
273103|NCT00369590|663719|P2|NOT COMPLETED|Overall Study||0
273104|NCT00369590|663720|P1|NOT COMPLETED|Overall Study||0
273105|NCT00369590|663719|P2|COMPLETED|Overall Study||42
273106|NCT00369590|663720|P1|COMPLETED|Overall Study||16
273107|NCT00369590|663719|P2|STARTED|Overall Study||42
273108|NCT00369590|663720|P1|STARTED|Overall Study||16
273109|NCT00369577|663738|P3|NOT COMPLETED|Overall Study||1
273110|NCT00369577|663739|P2|NOT COMPLETED|Overall Study||0
273111|NCT00369577|663740|P1|NOT COMPLETED|Overall Study||0
273112|NCT00369577|663738|P3|COMPLETED|Overall Study||40
273113|NCT00369577|663739|P2|COMPLETED|Overall Study||45
273114|NCT00369577|663740|P1|COMPLETED|Overall Study||43
273115|NCT00369577|663738|P3|STARTED|Overall Study||41
273116|NCT00369577|663739|P2|STARTED|Overall Study||45
273117|NCT00369577|663740|P1|STARTED|Overall Study||43
273118|NCT00369564|663759|P2|NOT COMPLETED|Overall Study||23
273119|NCT00369564|663760|P1|NOT COMPLETED|Overall Study||43
273120|NCT00369564|663759|P2|COMPLETED|Overall Study||100
273121|NCT00369564|663760|P1|COMPLETED|Overall Study||84
273122|NCT00369564|663759|P2|STARTED|Overall Study||123
273123|NCT00369564|663760|P1|STARTED|Overall Study||127
273124|NCT00369512|663766|P1|NOT COMPLETED|Overall Study||0
273125|NCT00369512|663766|P1|COMPLETED|Overall Study||15
273126|NCT00369512|663766|P1|STARTED|Overall Study||15
273127|NCT00369486|663777|P5|NOT COMPLETED|34-Week Visit||3
273128|NCT00369486|663778|P4|NOT COMPLETED|34-Week Visit||3
273129|NCT00369486|663779|P3|NOT COMPLETED|34-Week Visit||1
273130|NCT00369486|663780|P2|NOT COMPLETED|34-Week Visit||1
273131|NCT00369486|663781|P1|NOT COMPLETED|34-Week Visit||0
273132|NCT00369486|663777|P5|COMPLETED|34-Week Visit|Number of eyes|22
273133|NCT00369486|663778|P4|COMPLETED|34-Week Visit|Number of eyes|19
273134|NCT00369486|663779|P3|COMPLETED|34-Week Visit|Number of eyes|22
273135|NCT00369486|663780|P2|COMPLETED|34-Week Visit|Number of eyes|20
273136|NCT00369486|663781|P1|COMPLETED|34-Week Visit|Number of eyes|38
273137|NCT00369486|663777|P5|STARTED|34-Week Visit|Number of eyes that|25
273138|NCT00369486|663778|P4|STARTED|34-Week Visit|Number of eyes|22
273139|NCT00369486|663779|P3|STARTED|34-Week Visit|Number of eyes|23
273140|NCT00369486|663780|P2|STARTED|34-Week Visit|Number of eyes|21
273141|NCT00369486|663781|P1|STARTED|34-Week Visit|Number of eyes|38
273142|NCT00369486|663777|P5|NOT COMPLETED|17-Week Visit||1
273143|NCT00369486|663778|P4|NOT COMPLETED|17-Week Visit||1
273144|NCT00369486|663779|P3|NOT COMPLETED|17-Week Visit||1
273145|NCT00369486|663780|P2|NOT COMPLETED|17-Week Visit||0
273146|NCT00369486|663781|P1|NOT COMPLETED|17-Week Visit||0
273147|NCT00369486|663777|P5|COMPLETED|17-Week Visit|Number of eyes|24
273148|NCT00369486|663778|P4|COMPLETED|17-Week Visit|Number of eyes|21
273149|NCT00369486|663779|P3|COMPLETED|17-Week Visit|Number of eyes|22
273150|NCT00369486|663780|P2|COMPLETED|17-Week Visit|Number of eyes|21
273151|NCT00369486|663781|P1|COMPLETED|17-Week Visit|Number of eyes|38
273152|NCT00369486|663777|P5|STARTED|17-Week Visit|Number of eyes|25
273153|NCT00369486|663778|P4|STARTED|17-Week Visit|Number of eyes|22
273154|NCT00369486|663779|P3|STARTED|17-Week Visit|Number of eyes|23
273155|NCT00369486|663780|P2|STARTED|17-Week Visit|Number of eyes|21
273156|NCT00369486|663781|P1|STARTED|17-Week Visit|Number of eyes|38
273157|NCT00369486|663777|P5|NOT COMPLETED|8-Week Visit||1
273158|NCT00369486|663778|P4|NOT COMPLETED|8-Week Visit||1
273159|NCT00369486|663779|P3|NOT COMPLETED|8-Week Visit||0
273160|NCT00369486|663780|P2|NOT COMPLETED|8-Week Visit||1
273161|NCT00369486|663781|P1|NOT COMPLETED|8-Week Visit||0
273162|NCT00369486|663777|P5|COMPLETED|8-Week Visit|Number of eyes|24
273163|NCT00369486|663778|P4|COMPLETED|8-Week Visit|Number of eyes|21
273164|NCT00369486|663779|P3|COMPLETED|8-Week Visit|Number of eyes|22
273165|NCT00369486|663780|P2|COMPLETED|8-Week Visit|Number of eyes|20
273166|NCT00369486|663781|P1|COMPLETED|8-Week Visit|Number of eyes|38
273167|NCT00369486|663777|P5|STARTED|8-Week Visit|Number of eyes|25
273168|NCT00369486|663778|P4|STARTED|8-Week Visit|Number of eyes|22
273169|NCT00369486|663779|P3|STARTED|8-Week Visit|Number of eyes|22
273170|NCT00369486|663780|P2|STARTED|8-Week Visit|Number of eyes|21
273171|NCT00369486|663781|P1|STARTED|8-Week Visit|Number of eyes|38
273172|NCT00369486|663777|P5|NOT COMPLETED|4-Week Visit||1
273173|NCT00369486|663778|P4|NOT COMPLETED|4-Week Visit||2
273174|NCT00369486|663779|P3|NOT COMPLETED|4-Week Visit||1
273175|NCT00369486|663780|P2|NOT COMPLETED|4-Week Visit||2
273176|NCT00369486|663781|P1|NOT COMPLETED|4-Week Visit||2
273177|NCT00369486|663777|P5|COMPLETED|4-Week Visit|Number of eyes|24
273178|NCT00369486|663778|P4|COMPLETED|4-Week Visit|Number of eyes|20
273179|NCT00369486|663779|P3|COMPLETED|4-Week Visit|Number of eyes|22
273180|NCT00369486|663780|P2|COMPLETED|4-Week Visit|Number of eyes;|19
273181|NCT00369486|663781|P1|COMPLETED|4-Week Visit|Number of eyes|36
273182|NCT00369486|663777|P5|STARTED|4-Week Visit|Number of eyes|25
273183|NCT00369486|663778|P4|STARTED|4-Week Visit|Number of eyes|22
273184|NCT00369486|663779|P3|STARTED|4-Week Visit|Number of eyes|23
273185|NCT00369486|663780|P2|STARTED|4-Week Visit|Number of eyes|21
273186|NCT00369486|663781|P1|STARTED|4-Week Visit|Number of eyes|38
273187|NCT00369382|663820|P2|NOT COMPLETED|Overall Study||3
273188|NCT00369382|663821|P1|NOT COMPLETED|Overall Study||10
273189|NCT00369382|663820|P2|COMPLETED|Overall Study||54
273190|NCT00369382|663821|P1|COMPLETED|Overall Study||49
273191|NCT00369382|663820|P2|Completed Assigned Treatment Regimen|Overall Study||33
273192|NCT00369382|663821|P1|Completed Assigned Treatment Regimen|Overall Study||48
273193|NCT00369382|663820|P2|Received Treatment|Overall Study||57
273194|NCT00369382|663821|P1|Received Treatment|Overall Study||57
273195|NCT00369382|663820|P2|STARTED|Overall Study||57
273196|NCT00369382|663821|P1|STARTED|Overall Study||59
273197|NCT00369343|663854|P2|NOT COMPLETED|Open-label Phase||30
273198|NCT00369343|663855|P1|NOT COMPLETED|Open-label Phase||57
273199|NCT00369343|663854|P2|COMPLETED|Open-label Phase||79
273200|NCT00369343|663855|P1|COMPLETED|Open-label Phase||155
273201|NCT00369343|663854|P2|STARTED|Open-label Phase||109
273202|NCT00369343|663855|P1|STARTED|Open-label Phase||212
273203|NCT00369343|663854|P2|NOT COMPLETED|Double-blind Phase||16
273204|NCT00369343|663855|P1|NOT COMPLETED|Double-blind Phase||44
273205|NCT00369343|663854|P2|COMPLETED|Double-blind Phase||109
273206|NCT00369343|663855|P1|COMPLETED|Double-blind Phase||212
273207|NCT00369343|663854|P2|STARTED|Double-blind Phase||125
273208|NCT00369343|663855|P1|STARTED|Double-blind Phase||256
273209|NCT00369317|663888|P1|NOT COMPLETED|Overall Study||20
273210|NCT00369317|663888|P1|COMPLETED|Overall Study||185
273211|NCT00369317|663888|P1|STARTED|Overall Study||205
273212|NCT00369278|663904|P2|NOT COMPLETED|Overall Study||21
273213|NCT00369278|663905|P1|NOT COMPLETED|Overall Study||24
273214|NCT00369278|663904|P2|COMPLETED|Overall Study||44
273215|NCT00369278|663905|P1|COMPLETED|Overall Study||39
273216|NCT00369278|663904|P2|STARTED|Overall Study||65
273217|NCT00369278|663905|P1|STARTED|Overall Study||63
273218|NCT00369265|663921|P2|NOT COMPLETED|Overall Study||7
273219|NCT00369265|663922|P1|NOT COMPLETED|Overall Study||4
273220|NCT00369265|663921|P2|COMPLETED|Overall Study||0
273221|NCT00369265|663922|P1|COMPLETED|Overall Study||0
273222|NCT00369265|663921|P2|STARTED|Overall Study||7
273223|NCT00369265|663922|P1|STARTED|Overall Study||4
273224|NCT00369226|663930|P2|NOT COMPLETED|Phase II (45 Days)||0
273225|NCT00369226|663931|P1|NOT COMPLETED|Phase II (45 Days)||0
273226|NCT00369226|663930|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
273227|NCT00369226|663931|P1|COMPLETED|Phase II (45 Days)||0
273228|NCT00369226|663930|P2|STARTED|Phase II (45 Days)||32
273229|NCT00369226|663931|P1|STARTED|Phase II (45 Days)||0
273230|NCT00369226|663930|P2|NOT COMPLETED|Phase I (45 Days)||0
273231|NCT00369226|663931|P1|NOT COMPLETED|Phase I (45 Days)||0
273232|NCT00369226|663930|P2|COMPLETED|Phase I (45 Days)||0
273233|NCT00369226|663931|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
273234|NCT00369226|663930|P2|STARTED|Phase I (45 Days)||0
273235|NCT00369226|663931|P1|STARTED|Phase I (45 Days)||13
273236|NCT00369161|663943|P2|NOT COMPLETED|Overall Study||24
273237|NCT00369161|663944|P1|NOT COMPLETED|Overall Study||27
273238|NCT00369161|663943|P2|COMPLETED|Overall Study||95
273239|NCT00369161|663944|P1|COMPLETED|Overall Study||82
273240|NCT00369161|663943|P2|Intention to Treat (ITT)|Overall Study||117
273241|NCT00369161|663944|P1|Intention to Treat (ITT)|Overall Study||107
273242|NCT00369161|663943|P2|STARTED|Overall Study||119
273243|NCT00369161|663944|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
273244|NCT00369122|663954|P1|NOT COMPLETED|Overall Study||11
273245|NCT00369122|663954|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
273246|NCT00369122|663954|P1|STARTED|Overall Study||60
273247|NCT00368992|663961|P1|NOT COMPLETED|Overall Study||110
273248|NCT00368992|663961|P1|COMPLETED|Overall Study||0
273249|NCT00368992|663961|P1|STARTED|Overall Study||110
273250|NCT00368979|663970|P2|NOT COMPLETED|Overall Study||30
273251|NCT00368979|663971|P1|NOT COMPLETED|Overall Study||25
273252|NCT00368979|663970|P2|COMPLETED|Overall Study||163
273253|NCT00368979|663971|P1|COMPLETED|Overall Study||160
273254|NCT00368979|663970|P2|STARTED|Overall Study||193
273255|NCT00368979|663971|P1|STARTED|Overall Study||185
273256|NCT00368966|663987|P2|NOT COMPLETED|Toddler Dose||3
273257|NCT00368966|663988|P1|NOT COMPLETED|Toddler Dose||1
273258|NCT00368966|663987|P2|COMPLETED|Toddler Dose||286
273259|NCT00368966|663988|P1|COMPLETED|Toddler Dose||292
273260|NCT00368966|663987|P2|STARTED|Toddler Dose||289
273261|NCT00368966|663988|P1|STARTED|Toddler Dose||293
273262|NCT00368966|663987|P2|NOT COMPLETED|After Infant||5
273263|NCT00368966|663988|P1|NOT COMPLETED|After Infant||6
273264|NCT00368966|663987|P2|COMPLETED|After Infant||289
273265|NCT00368966|663988|P1|COMPLETED|After Infant||293
273266|NCT00368966|663987|P2|STARTED|After Infant||294
273267|NCT00368966|663988|P1|STARTED|After Infant||299
273268|NCT00368966|663987|P2|NOT COMPLETED|Infant Series||10
273269|NCT00368966|663988|P1|NOT COMPLETED|Infant Series||16
273270|NCT00368966|663987|P2|COMPLETED|Infant Series||294
273271|NCT00368966|663988|P1|COMPLETED|Infant Series||299
273272|NCT00368966|663987|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
273273|NCT00368966|663988|P1|Vaccinated Dose 3|Infant Series||301
273274|NCT00368966|663987|P2|Vaccinated Dose 2|Infant Series||298
273275|NCT00368966|663988|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
273276|NCT00368966|663987|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
273277|NCT00368966|663988|P1|Vaccinated Dose 1|Infant Series||314
273278|NCT00368966|663987|P2|STARTED|Infant Series||304
273279|NCT00368966|663988|P1|STARTED|Infant Series||315
273280|NCT00368940|664044|P2|NOT COMPLETED|Completed 12-wk Treatment||5
273281|NCT00368940|664045|P1|NOT COMPLETED|Completed 12-wk Treatment||6
273282|NCT00368940|664044|P2|COMPLETED|Completed 12-wk Treatment||32
273283|NCT00368940|664045|P1|COMPLETED|Completed 12-wk Treatment||31
273284|NCT00368940|664044|P2|STARTED|Completed 12-wk Treatment||37
273285|NCT00368940|664045|P1|STARTED|Completed 12-wk Treatment||37
273286|NCT00368940|664044|P2|NOT COMPLETED|Intention-to-Treat||0
273287|NCT00368940|664045|P1|NOT COMPLETED|Intention-to-Treat||0
273288|NCT00368940|664044|P2|COMPLETED|Intention-to-Treat||37
273289|NCT00368940|664045|P1|COMPLETED|Intention-to-Treat||37
273290|NCT00368940|664044|P2|STARTED|Intention-to-Treat||37
273291|NCT00368940|664045|P1|STARTED|Intention-to-Treat||37
273292|NCT00368927|664059|P2|NOT COMPLETED|Overall Study||3
273293|NCT00368927|664060|P1|NOT COMPLETED|Overall Study||5
273294|NCT00368927|664059|P2|COMPLETED|Overall Study||27
273295|NCT00368927|664060|P1|COMPLETED|Overall Study||26
273296|NCT00368927|664059|P2|STARTED|Overall Study||30
273297|NCT00368927|664060|P1|STARTED|Overall Study||31
273298|NCT00368875|664068|P2|NOT COMPLETED|Overall Study||48
273299|NCT00368875|664069|P1|NOT COMPLETED|Overall Study||6
273300|NCT00368875|664068|P2|COMPLETED|Overall Study||0
273301|NCT00368875|664069|P1|COMPLETED|Overall Study||0
273302|NCT00368875|664068|P2|STARTED|Overall Study||48
273303|NCT00368875|664069|P1|STARTED|Overall Study||6
273304|NCT00368849|664077|P2|NOT COMPLETED|Overall Study||2
273305|NCT00368849|664078|P1|NOT COMPLETED|Overall Study||0
273306|NCT00368849|664077|P2|COMPLETED|Overall Study||8
273307|NCT00368849|664078|P1|COMPLETED|Overall Study||10
273308|NCT00368849|664077|P2|STARTED|Overall Study||10
273309|NCT00368849|664078|P1|STARTED|Overall Study||10
273310|NCT00368745|664094|P2|NOT COMPLETED|Double-blind Treatment Period||31
273311|NCT00368745|664095|P1|NOT COMPLETED|Double-blind Treatment Period||26
273312|NCT00368745|664094|P2|COMPLETED|Double-blind Treatment Period||19
273313|NCT00368745|664095|P1|COMPLETED|Double-blind Treatment Period||30
273314|NCT00368745|664094|P2|STARTED|Double-blind Treatment Period||50
273315|NCT00368745|664095|P1|STARTED|Double-blind Treatment Period||56
273316|NCT00368745|664094|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
273317|NCT00368745|664095|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
273318|NCT00368745|664094|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
273319|NCT00368745|664095|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
273320|NCT00368745|664094|P2|STARTED|Randomized to Double-blind Treatment||51
273321|NCT00368745|664095|P1|STARTED|Randomized to Double-blind Treatment||57
273322|NCT00368641|664127|P2|NOT COMPLETED|Overall Study||6
273323|NCT00368641|664128|P1|NOT COMPLETED|Overall Study||6
273324|NCT00368641|664127|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
273325|NCT00368641|664128|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
273326|NCT00368641|664127|P2|STARTED|Overall Study||6
273327|NCT00368641|664128|P1|STARTED|Overall Study||6
273328|NCT00368550|664136|P2|NOT COMPLETED|Overall Study||23
273329|NCT00368550|664137|P1|NOT COMPLETED|Overall Study||28
273330|NCT00368550|664136|P2|COMPLETED|Overall Study||48
273331|NCT00368550|664137|P1|COMPLETED|Overall Study||35
273332|NCT00368550|664136|P2|STARTED|Overall Study||71
273333|NCT00368550|664137|P1|STARTED|Overall Study||63
273334|NCT00368537|664149|P2|NOT COMPLETED|Baseline Participants||24
273335|NCT00368537|664150|P1|NOT COMPLETED|Baseline Participants||24
273336|NCT00368537|664149|P2|COMPLETED|Baseline Participants||239
273337|NCT00368537|664150|P1|COMPLETED|Baseline Participants||244
273338|NCT00368537|664149|P2|STARTED|Baseline Participants||263
273339|NCT00368537|664150|P1|STARTED|Baseline Participants||268
273340|NCT00368537|664149|P2|NOT COMPLETED|Randomization||6
273341|NCT00368537|664150|P1|NOT COMPLETED|Randomization||13
273342|NCT00368537|664149|P2|COMPLETED|Randomization||263
273343|NCT00368537|664150|P1|COMPLETED|Randomization||268
273344|NCT00368537|664149|P2|STARTED|Randomization||269
273345|NCT00368537|664150|P1|STARTED|Randomization||281
273346|NCT00368472|664164|P1|NOT COMPLETED|Overall Study||105
273347|NCT00368472|664164|P1|COMPLETED|Overall Study||33
273348|NCT00368472|664164|P1|STARTED|Overall Study||138
273349|NCT00368459|664172|P2|NOT COMPLETED|Overall Study||1
273350|NCT00368459|664173|P1|NOT COMPLETED|Overall Study||2
273351|NCT00368459|664172|P2|COMPLETED|Overall Study||20
273352|NCT00368459|664173|P1|COMPLETED|Overall Study||19
273353|NCT00368459|664172|P2|STARTED|Overall Study||21
273354|NCT00368459|664173|P1|STARTED|Overall Study||21
273355|NCT00368316|664199|P2|NOT COMPLETED|Overall Study||46
273356|NCT00368316|664200|P1|NOT COMPLETED|Overall Study||42
273357|NCT00368316|664199|P2|COMPLETED|Overall Study||1319
273358|NCT00368316|664200|P1|COMPLETED|Overall Study||1392
273359|NCT00368316|664199|P2|STARTED|Overall Study||1365
273360|NCT00368316|664200|P1|STARTED|Overall Study||1434
273361|NCT00368290|664212|P2|NOT COMPLETED|Overall Study||10
273362|NCT00368290|664213|P1|NOT COMPLETED|Overall Study||13
273363|NCT00368290|664212|P2|COMPLETED|Overall Study||37
273364|NCT00368290|664213|P1|COMPLETED|Overall Study||34
273365|NCT00368290|664212|P2|STARTED|Overall Study||47
273366|NCT00368290|664213|P1|STARTED|Overall Study||47
273367|NCT00368277|664223|P2|NOT COMPLETED|Overall Study||108
273368|NCT00368277|664224|P1|NOT COMPLETED|Overall Study||113
273369|NCT00368277|664223|P2|COMPLETED|Overall Study||336
273370|NCT00368277|664224|P1|COMPLETED|Overall Study||344
273371|NCT00368277|664223|P2|STARTED|Overall Study||444
273372|NCT00368277|664224|P1|STARTED|Overall Study||457
273373|NCT00368251|664239|P3|NOT COMPLETED|Overall Study||1
273374|NCT00368251|664240|P2|NOT COMPLETED|Overall Study||0
273375|NCT00368251|664241|P1|NOT COMPLETED|Overall Study||1
273376|NCT00368251|664239|P3|COMPLETED|Overall Study||17
273377|NCT00368251|664240|P2|COMPLETED|Overall Study||20
273378|NCT00368251|664241|P1|COMPLETED|Overall Study||17
273379|NCT00368251|664239|P3|STARTED|Overall Study||18
273380|NCT00368251|664240|P2|STARTED|Overall Study||20
273381|NCT00368251|664241|P1|STARTED|Overall Study||18
273382|NCT00368108|664264|P3|NOT COMPLETED|Overall Study||68
273383|NCT00368108|664265|P2|NOT COMPLETED|Overall Study||53
273384|NCT00368108|664266|P1|NOT COMPLETED|Overall Study||64
273385|NCT00368108|664264|P3|COMPLETED|Overall Study||182
273386|NCT00368108|664265|P2|COMPLETED|Overall Study||198
273387|NCT00368108|664266|P1|COMPLETED|Overall Study||187
273388|NCT00368108|664264|P3|STARTED|Overall Study||250
273389|NCT00368108|664265|P2|STARTED|Overall Study||251
273390|NCT00368108|664266|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
273391|NCT00368069|664285|P2|NOT COMPLETED|Overall Study||7
273392|NCT00368069|664286|P1|NOT COMPLETED|Overall Study||8
273393|NCT00368069|664285|P2|COMPLETED|Overall Study||72
273394|NCT00368069|664286|P1|COMPLETED|Overall Study||71
273395|NCT00368069|664285|P2|STARTED|Overall Study||79
273396|NCT00368069|664286|P1|STARTED|Overall Study||79
273397|NCT00367991|664304|P2|NOT COMPLETED|Overall Study||2
273398|NCT00367991|664305|P1|NOT COMPLETED|Overall Study||2
273399|NCT00367991|664304|P2|COMPLETED|Overall Study||13
273400|NCT00367991|664305|P1|COMPLETED|Overall Study||27
273401|NCT00367991|664304|P2|STARTED|Overall Study||15
273402|NCT00367991|664305|P1|STARTED|Overall Study||29
273403|NCT00367835|664323|P2|NOT COMPLETED|Overall Study||31
273404|NCT00367835|664324|P1|NOT COMPLETED|Overall Study||29
273405|NCT00367835|664323|P2|COMPLETED|Overall Study||48
273406|NCT00367835|664324|P1|COMPLETED|Overall Study||109
273407|NCT00367835|664323|P2|STARTED|Overall Study||79
273408|NCT00367835|664324|P1|STARTED|Overall Study||138
273409|NCT00367770|664350|P1|NOT COMPLETED|Overall Study||2
273410|NCT00367770|664350|P1|COMPLETED|Overall Study||35
273411|NCT00367770|664350|P1|STARTED|Overall Study||37
273412|NCT00367744|664358|P2|NOT COMPLETED|Overall Study||5
273413|NCT00367744|664359|P1|NOT COMPLETED|Overall Study||4
273414|NCT00367744|664358|P2|COMPLETED|Overall Study||32
273415|NCT00367744|664359|P1|COMPLETED|Overall Study||30
273416|NCT00367744|664358|P2|STARTED|Overall Study||37
273417|NCT00367744|664359|P1|STARTED|Overall Study||34
273418|NCT00367679|664367|P1|NOT COMPLETED|Overall Study||0
273419|NCT00367679|664367|P1|COMPLETED|Overall Study||35
273420|NCT00367679|664367|P1|STARTED|Overall Study||35
273421|NCT00367640|664388|P4|NOT COMPLETED|Overall Study||10
273422|NCT00367640|664389|P3|NOT COMPLETED|Overall Study||19
273423|NCT00367640|664390|P2|NOT COMPLETED|Overall Study||22
273424|NCT00367640|664391|P1|NOT COMPLETED|Overall Study||18
273425|NCT00367640|664388|P4|COMPLETED|Overall Study||146
273426|NCT00367640|664389|P3|COMPLETED|Overall Study||141
273427|NCT00367640|664390|P2|COMPLETED|Overall Study||133
273428|NCT00367640|664391|P1|COMPLETED|Overall Study||139
273429|NCT00367640|664388|P4|STARTED|Overall Study||156
273430|NCT00367640|664389|P3|STARTED|Overall Study||160
273431|NCT00367640|664390|P2|STARTED|Overall Study||155
273432|NCT00367640|664391|P1|STARTED|Overall Study||157
273433|NCT00367601|664401|P1|NOT COMPLETED|Overall Study||0
273434|NCT00367601|664401|P1|COMPLETED|Overall Study||25
273435|NCT00367601|664401|P1|STARTED|Overall Study||25
273436|NCT00367484|664407|P1|NOT COMPLETED|Overall Study||17
273520|NCT00366678|664594|P1|NOT COMPLETED|Toddler Dose||5
273437|NCT00367484|664407|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
273438|NCT00367484|664407|P1|STARTED|Overall Study||460
273439|NCT00367432|664411|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
273440|NCT00367432|664412|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
273441|NCT00367432|664411|P2|COMPLETED|Second Period (up to 54 Months)||69
273442|NCT00367432|664412|P1|COMPLETED|Second Period (up to 54 Months)||188
273443|NCT00367432|664411|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
273444|NCT00367432|664412|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
273445|NCT00367432|664411|P2|NOT COMPLETED|First Period (16 Weeks)||0
273446|NCT00367432|664412|P1|NOT COMPLETED|First Period (16 Weeks)||38
273447|NCT00367432|664411|P2|COMPLETED|First Period (16 Weeks)||0
273448|NCT00367432|664412|P1|COMPLETED|First Period (16 Weeks)||275
273449|NCT00367432|664411|P2|STARTED|First Period (16 Weeks)||0
273450|NCT00367432|664412|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
273451|NCT00367380|664427|P3|NOT COMPLETED|Overall Study||0
273452|NCT00367380|664428|P2|NOT COMPLETED|Overall Study||0
273453|NCT00367380|664429|P1|NOT COMPLETED|Overall Study||0
273454|NCT00367380|664427|P3|COMPLETED|Overall Study||6
273455|NCT00367380|664428|P2|COMPLETED|Overall Study||6
273456|NCT00367380|664429|P1|COMPLETED|Overall Study||6
273457|NCT00367380|664427|P3|STARTED|Overall Study||6
273458|NCT00367380|664428|P2|STARTED|Overall Study||6
273459|NCT00367380|664429|P1|STARTED|Overall Study||6
273460|NCT00367341|664439|P2|NOT COMPLETED|Overall Study||0
273461|NCT00367341|664440|P1|NOT COMPLETED|Overall Study||2
273462|NCT00367341|664439|P2|COMPLETED|Overall Study||40
273463|NCT00367341|664440|P1|COMPLETED|Overall Study||40
273464|NCT00367341|664439|P2|STARTED|Overall Study||40
273465|NCT00367341|664440|P1|STARTED|Overall Study||42
273466|NCT00367237|664450|P2|NOT COMPLETED|Overall Study||11
273467|NCT00367237|664451|P1|NOT COMPLETED|Overall Study||10
273468|NCT00367237|664450|P2|COMPLETED|Overall Study||47
273469|NCT00367237|664451|P1|COMPLETED|Overall Study||47
273470|NCT00367237|664450|P2|STARTED|Overall Study|Number of subjects randomized|58
273471|NCT00367237|664451|P1|STARTED|Overall Study|Number of subjects randomized|57
273472|NCT00367133|664460|P3|NOT COMPLETED|3 Years||18
273473|NCT00367133|664461|P2|NOT COMPLETED|3 Years||23
273474|NCT00367133|664462|P1|NOT COMPLETED|3 Years||28
273475|NCT00367133|664460|P3|COMPLETED|3 Years||98
273476|NCT00367133|664461|P2|COMPLETED|3 Years||93
273477|NCT00367133|664462|P1|COMPLETED|3 Years||115
273478|NCT00367133|664460|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
273479|NCT00367133|664461|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
273480|NCT00367133|664462|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
273481|NCT00367133|664460|P3|NOT COMPLETED|2 Years||49
273482|NCT00367133|664461|P2|NOT COMPLETED|2 Years||36
273483|NCT00367133|664462|P1|NOT COMPLETED|2 Years||58
273484|NCT00367133|664460|P3|COMPLETED|2 Years||205
273485|NCT00367133|664461|P2|COMPLETED|2 Years||220
273486|NCT00367133|664462|P1|COMPLETED|2 Years||272
273487|NCT00367133|664460|P3|STARTED|2 Years|Number of Eyes|254
273488|NCT00367133|664461|P2|STARTED|2 Years|Number of Eyes|256
273489|NCT00367133|664462|P1|STARTED|2 Years|Number of Eyes|330
273490|NCT00367055|664514|P2|NOT COMPLETED|Overall Study||11
273491|NCT00367055|664515|P1|NOT COMPLETED|Overall Study||11
273492|NCT00367055|664514|P2|COMPLETED|Overall Study||30
273493|NCT00367055|664515|P1|COMPLETED|Overall Study||32
273494|NCT00367055|664514|P2|STARTED|Overall Study||41
273495|NCT00367055|664515|P1|STARTED|Overall Study||43
273496|NCT00366899|664531|P2|NOT COMPLETED|Toddler Dose||1
273497|NCT00366899|664532|P1|NOT COMPLETED|Toddler Dose||2
273498|NCT00366899|664531|P2|COMPLETED|Toddler Dose||281
273499|NCT00366899|664532|P1|COMPLETED|Toddler Dose||285
273500|NCT00366899|664531|P2|STARTED|Toddler Dose||282
273501|NCT00366899|664532|P1|STARTED|Toddler Dose||287
273502|NCT00366899|664531|P2|NOT COMPLETED|After Infant Series||9
273503|NCT00366899|664532|P1|NOT COMPLETED|After Infant Series||7
273504|NCT00366899|664531|P2|COMPLETED|After Infant Series||282
273505|NCT00366899|664532|P1|COMPLETED|After Infant Series||287
273506|NCT00366899|664531|P2|STARTED|After Infant Series||291
273507|NCT00366899|664532|P1|STARTED|After Infant Series||294
273508|NCT00366899|664531|P2|NOT COMPLETED|Infant Series||12
273509|NCT00366899|664532|P1|NOT COMPLETED|Infant Series||9
273510|NCT00366899|664531|P2|COMPLETED|Infant Series||291
273511|NCT00366899|664532|P1|COMPLETED|Infant Series||294
273512|NCT00366899|664531|P2|Vaccinated Dose 2|Infant Series||293
273513|NCT00366899|664532|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
273514|NCT00366899|664531|P2|Vaccinated Dose 1|Infant Series||302
273515|NCT00366899|664532|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
273516|NCT00366899|664531|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
273517|NCT00366899|664532|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
273518|NCT00366678|664592|P3|NOT COMPLETED|Toddler Dose||0
273519|NCT00366678|664593|P2|NOT COMPLETED|Toddler Dose||1
273521|NCT00366678|664592|P3|COMPLETED|Toddler Dose||137
273522|NCT00366678|664593|P2|COMPLETED|Toddler Dose||151
273523|NCT00366678|664594|P1|COMPLETED|Toddler Dose||268
273524|NCT00366678|664592|P3|STARTED|Toddler Dose||137
273525|NCT00366678|664593|P2|STARTED|Toddler Dose||152
273526|NCT00366678|664594|P1|STARTED|Toddler Dose||273
273527|NCT00366678|664592|P3|NOT COMPLETED|After Infant||0
273528|NCT00366678|664593|P2|NOT COMPLETED|After Infant||10
273529|NCT00366678|664594|P1|NOT COMPLETED|After Infant||17
273530|NCT00366678|664592|P3|COMPLETED|After Infant||0
273531|NCT00366678|664593|P2|COMPLETED|After Infant||289
273532|NCT00366678|664594|P1|COMPLETED|After Infant||273
273533|NCT00366678|664592|P3|STARTED|After Infant||0
273534|NCT00366678|664593|P2|STARTED|After Infant||299
273535|NCT00366678|664594|P1|STARTED|After Infant||290
273536|NCT00366678|664592|P3|NOT COMPLETED|Infant Series||0
273537|NCT00366678|664593|P2|NOT COMPLETED|Infant Series||10
273538|NCT00366678|664594|P1|NOT COMPLETED|Infant Series||14
273539|NCT00366678|664592|P3|COMPLETED|Infant Series||0
273540|NCT00366678|664593|P2|COMPLETED|Infant Series||299
273541|NCT00366678|664594|P1|COMPLETED|Infant Series||290
273542|NCT00366678|664592|P3|Vaccinated Dose 3|Infant Series||0
273543|NCT00366678|664593|P2|Vaccinated Dose 3|Infant Series||302
273544|NCT00366678|664594|P1|Vaccinated Dose 3|Infant Series||291
273545|NCT00366678|664592|P3|Vaccinated Dose 2|Infant Series||0
273546|NCT00366678|664593|P2|Vaccinated Dose 2|Infant Series||304
273547|NCT00366678|664594|P1|Vaccinated Dose 2|Infant Series||295
273548|NCT00366678|664592|P3|Vaccinated Dose 1|Infant Series||0
273549|NCT00366678|664593|P2|Vaccinated Dose 1|Infant Series||309
273550|NCT00366678|664594|P1|Vaccinated Dose 1|Infant Series||302
273551|NCT00366678|664592|P3|STARTED|Infant Series||0
273552|NCT00366678|664593|P2|STARTED|Infant Series||309
273553|NCT00366678|664594|P1|STARTED|Infant Series||304
273554|NCT00366626|664661|P2|NOT COMPLETED|Overall Study||0
273555|NCT00366626|664662|P1|NOT COMPLETED|Overall Study||0
273556|NCT00366626|664661|P2|COMPLETED|Overall Study||45
273557|NCT00366626|664662|P1|COMPLETED|Overall Study||38
273558|NCT00366626|664661|P2|STARTED|Overall Study||45
273559|NCT00366626|664662|P1|STARTED|Overall Study||38
273560|NCT00366548|664676|P2|NOT COMPLETED|Toddler Dose||0
273561|NCT00366548|664677|P1|NOT COMPLETED|Toddler Dose||0
273562|NCT00366548|664676|P2|COMPLETED|Toddler Dose||244
273563|NCT00366548|664677|P1|COMPLETED|Toddler Dose||240
273564|NCT00366548|664676|P2|STARTED|Toddler Dose||244
273565|NCT00366548|664677|P1|STARTED|Toddler Dose||240
273566|NCT00366548|664676|P2|NOT COMPLETED|After Infant Series||1
273567|NCT00366548|664677|P1|NOT COMPLETED|After Infant Series||6
273568|NCT00366548|664676|P2|COMPLETED|After Infant Series||244
273569|NCT00366548|664677|P1|COMPLETED|After Infant Series||240
273570|NCT00366548|664676|P2|STARTED|After Infant Series||245
273571|NCT00366548|664677|P1|STARTED|After Infant Series||246
273572|NCT00366548|664676|P2|NOT COMPLETED|Infant Series||5
273573|NCT00366548|664677|P1|NOT COMPLETED|Infant Series||4
273574|NCT00366548|664676|P2|COMPLETED|Infant Series||245
273575|NCT00366548|664677|P1|COMPLETED|Infant Series||246
273576|NCT00366548|664676|P2|Vaccinated Dose 3|Infant Series||247
273577|NCT00366548|664677|P1|Vaccinated Dose 3|Infant Series||246
273578|NCT00366548|664676|P2|Vaccinated Dose 2|Infant Series||249
273579|NCT00366548|664677|P1|Vaccinated Dose 2|Infant Series||246
273580|NCT00366548|664676|P2|Vaccinated Dose 1|Infant Series||250
273581|NCT00366548|664677|P1|Vaccinated Dose 1|Infant Series||250
273582|NCT00366548|664676|P2|STARTED|Infant Series||250
273583|NCT00366548|664677|P1|STARTED|Infant Series||250
273584|NCT00366457|664711|P1|NOT COMPLETED|Overall Study||2
273585|NCT00366457|664711|P1|COMPLETED|Overall Study||30
273586|NCT00366457|664711|P1|STARTED|Overall Study||32
273587|NCT00366444|664720|P2|NOT COMPLETED|Overall Study||2
273588|NCT00366444|664721|P1|NOT COMPLETED|Overall Study||1
273589|NCT00366444|664720|P2|COMPLETED|Overall Study||97
273590|NCT00366444|664721|P1|COMPLETED|Overall Study||101
273591|NCT00366444|664720|P2|STARTED|Overall Study||99
273592|NCT00366444|664721|P1|STARTED|Overall Study||102
273593|NCT00366340|664749|P2|NOT COMPLETED|Toddler Dose||1
273594|NCT00366340|664750|P1|NOT COMPLETED|Toddler Dose||1
273595|NCT00366340|664749|P2|COMPLETED|Toddler Dose||286
273596|NCT00366340|664750|P1|COMPLETED|Toddler Dose||289
273597|NCT00366340|664749|P2|STARTED|Toddler Dose||287
273598|NCT00366340|664750|P1|STARTED|Toddler Dose||290
273599|NCT00366340|664749|P2|NOT COMPLETED|After the Infant Series||6
273600|NCT00366340|664750|P1|NOT COMPLETED|After the Infant Series||3
273601|NCT00366340|664749|P2|COMPLETED|After the Infant Series||287
273602|NCT00366340|664750|P1|COMPLETED|After the Infant Series||290
273603|NCT00366340|664749|P2|STARTED|After the Infant Series||293
273604|NCT00366340|664750|P1|STARTED|After the Infant Series||293
273605|NCT00366340|664749|P2|NOT COMPLETED|Infant Series||10
273606|NCT00366340|664750|P1|NOT COMPLETED|Infant Series||8
273607|NCT00366340|664749|P2|COMPLETED|Infant Series||293
273608|NCT00366340|664750|P1|COMPLETED|Infant Series||293
273609|NCT00366340|664749|P2|Vaccinated Dose 3|Infant Series||293
273610|NCT00366340|664750|P1|Vaccinated Dose 3|Infant Series||294
273611|NCT00366340|664749|P2|Vaccinated Dose 2|Infant Series||297
273612|NCT00366340|664750|P1|Vaccinated Dose 2|Infant Series||296
273613|NCT00366340|664749|P2|Vaccinated Dose 1|Infant Series||303
273614|NCT00366340|664750|P1|Vaccinated Dose 1|Infant Series||300
273615|NCT00366340|664749|P2|STARTED|Infant Series||303
273616|NCT00366340|664750|P1|STARTED|Infant Series||301
273617|NCT00366301|664808|P4|NOT COMPLETED|Overall Study||8
273618|NCT00366301|664809|P3|NOT COMPLETED|Overall Study||4
273619|NCT00366301|664810|P2|NOT COMPLETED|Overall Study||6
273620|NCT00366301|664811|P1|NOT COMPLETED|Overall Study||8
273621|NCT00366301|664808|P4|COMPLETED|Overall Study||116
273622|NCT00366301|664809|P3|COMPLETED|Overall Study||122
273623|NCT00366301|664810|P2|COMPLETED|Overall Study||120
273624|NCT00366301|664811|P1|COMPLETED|Overall Study||116
273625|NCT00366301|664808|P4|Either 6W or 14W CRP Obtained|Overall Study||119
273626|NCT00366301|664809|P3|Either 6W or 14W CRP Obtained|Overall Study||124
273627|NCT00366301|664810|P2|Either 6W or 14W CRP Obtained|Overall Study||124
273628|NCT00366301|664811|P1|Either 6W or 14W CRP Obtained|Overall Study||120
273629|NCT00366301|664808|P4|STARTED|Overall Study||124
273630|NCT00366301|664809|P3|STARTED|Overall Study||126
273631|NCT00366301|664810|P2|STARTED|Overall Study||126
273632|NCT00366301|664811|P1|STARTED|Overall Study||124
273633|NCT00366275|664821|P1|NOT COMPLETED|Overall Study||6
273634|NCT00366275|664821|P1|COMPLETED|Overall Study||58
273635|NCT00366275|664821|P1|STARTED|Overall Study||64
273636|NCT00366249|664827|P2|NOT COMPLETED|Overall Study||78
273637|NCT00366249|664828|P1|NOT COMPLETED|Overall Study||131
273638|NCT00366249|664827|P2|COMPLETED|Overall Study||430
273639|NCT00366249|664828|P1|COMPLETED|Overall Study||422
273640|NCT00366249|664827|P2|STARTED|Overall Study||508
273641|NCT00366249|664828|P1|STARTED|Overall Study||553
273642|NCT00366106|664842|P1|NOT COMPLETED|Overall Study||0
273643|NCT00366106|664842|P1|COMPLETED|Overall Study||32
273644|NCT00366106|664842|P1|STARTED|Overall Study||32
273645|NCT00366028|664851|P2|NOT COMPLETED|Overall Study||0
273646|NCT00366028|664852|P1|NOT COMPLETED|Overall Study||0
273647|NCT00366028|664851|P2|COMPLETED|Overall Study||735
273648|NCT00366028|664852|P1|COMPLETED|Overall Study||889
273649|NCT00366028|664851|P2|STARTED|Overall Study||735
273650|NCT00366028|664852|P1|STARTED|Overall Study||889
273651|NCT00365976|664862|P2|NOT COMPLETED|Overall Study||5
273652|NCT00365976|664863|P1|NOT COMPLETED|Overall Study||1
273653|NCT00365976|664862|P2|COMPLETED|Overall Study||20
273654|NCT00365976|664863|P1|COMPLETED|Overall Study||32
273655|NCT00365976|664862|P2|STARTED|Overall Study||25
273656|NCT00365976|664863|P1|STARTED|Overall Study||33
273657|NCT00365872|664894|P3|NOT COMPLETED|Overall Study||0
273658|NCT00365872|664895|P2|NOT COMPLETED|Overall Study||0
273659|NCT00365872|664896|P1|NOT COMPLETED|Overall Study||0
273660|NCT00365872|664894|P3|COMPLETED|Overall Study||6
273661|NCT00365872|664895|P2|COMPLETED|Overall Study||6
273662|NCT00365872|664896|P1|COMPLETED|Overall Study||5
273663|NCT00365872|664894|P3|STARTED|Overall Study||6
273664|NCT00365872|664895|P2|STARTED|Overall Study||6
273665|NCT00365872|664896|P1|STARTED|Overall Study||5
273666|NCT00365859|664909|P4|NOT COMPLETED|Overall Study||131
273667|NCT00365859|664910|P3|NOT COMPLETED|Overall Study||67
273668|NCT00365859|664911|P2|NOT COMPLETED|Overall Study||33
273669|NCT00365859|664912|P1|NOT COMPLETED|Overall Study||31
273670|NCT00365859|664909|P4|COMPLETED|Overall Study||199
273671|NCT00365859|664910|P3|COMPLETED|Overall Study||107
273672|NCT00365859|664911|P2|COMPLETED|Overall Study||37
273673|NCT00365859|664912|P1|COMPLETED|Overall Study||55
273674|NCT00365859|664909|P4|Efficacy Population|Overall Study||322
273675|NCT00365859|664910|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
273676|NCT00365859|664911|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
273677|NCT00365859|664912|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
273678|NCT00365859|664909|P4|Safety Population|Overall Study||330
273679|NCT00365859|664910|P3|Safety Population|Overall Study||174
273680|NCT00365859|664911|P2|Safety Population|Overall Study||70
273681|NCT00365859|664912|P1|Safety Population|Overall Study||86
273682|NCT00365859|664909|P4|STARTED|Overall Study||330
273683|NCT00365859|664910|P3|STARTED|Overall Study||174
273684|NCT00365859|664911|P2|STARTED|Overall Study||70
273685|NCT00365859|664912|P1|STARTED|Overall Study||86
273686|NCT00365846|665001|P1|NOT COMPLETED|Overall Study||1
273687|NCT00365846|665001|P1|COMPLETED|Overall Study||28
273688|NCT00365846|665001|P1|STARTED|Overall Study||29
273689|NCT00365768|665012|P2|NOT COMPLETED|Overall Study||0
273690|NCT00365768|665013|P1|NOT COMPLETED|Overall Study||0
273691|NCT00365768|665012|P2|COMPLETED|Overall Study||25
273692|NCT00365768|665013|P1|COMPLETED|Overall Study||24
273693|NCT00365768|665012|P2|STARTED|Overall Study||25
273694|NCT00365768|665013|P1|STARTED|Overall Study||24
273695|NCT00365716|665026|P7|NOT COMPLETED|Extension 2||10
273696|NCT00365716|665027|P6|NOT COMPLETED|Extension 2||0
273697|NCT00365716|665028|P5|NOT COMPLETED|Extension 2||0
273698|NCT00365716|665029|P4|NOT COMPLETED|Extension 2||0
273699|NCT00365716|665030|P3|NOT COMPLETED|Extension 2||0
273700|NCT00365716|665031|P2|NOT COMPLETED|Extension 2||0
273701|NCT00365716|665032|P1|NOT COMPLETED|Extension 2||0
273702|NCT00365716|665026|P7|COMPLETED|Extension 2||7
273703|NCT00365716|665027|P6|COMPLETED|Extension 2||0
273704|NCT00365716|665028|P5|COMPLETED|Extension 2||0
273705|NCT00365716|665029|P4|COMPLETED|Extension 2||0
273706|NCT00365716|665030|P3|COMPLETED|Extension 2||0
273707|NCT00365716|665031|P2|COMPLETED|Extension 2||0
273708|NCT00365716|665032|P1|COMPLETED|Extension 2||0
273709|NCT00365716|665026|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
273710|NCT00365716|665027|P6|STARTED|Extension 2||0
273711|NCT00365716|665028|P5|STARTED|Extension 2||0
273712|NCT00365716|665029|P4|STARTED|Extension 2||0
273713|NCT00365716|665030|P3|STARTED|Extension 2||0
273714|NCT00365716|665031|P2|STARTED|Extension 2||0
273715|NCT00365716|665032|P1|STARTED|Extension 2||0
273716|NCT00365716|665026|P7|NOT COMPLETED|Extension 1||0
273717|NCT00365716|665027|P6|NOT COMPLETED|Extension 1||22
273718|NCT00365716|665028|P5|NOT COMPLETED|Extension 1||0
273719|NCT00365716|665029|P4|NOT COMPLETED|Extension 1||0
273720|NCT00365716|665030|P3|NOT COMPLETED|Extension 1||0
273721|NCT00365716|665031|P2|NOT COMPLETED|Extension 1||0
273722|NCT00365716|665032|P1|NOT COMPLETED|Extension 1||0
273723|NCT00365716|665026|P7|COMPLETED|Extension 1||0
273724|NCT00365716|665027|P6|COMPLETED|Extension 1||219
273725|NCT00365716|665028|P5|COMPLETED|Extension 1||0
273726|NCT00365716|665029|P4|COMPLETED|Extension 1||0
273727|NCT00365716|665030|P3|COMPLETED|Extension 1||0
273728|NCT00365716|665031|P2|COMPLETED|Extension 1||0
273729|NCT00365716|665032|P1|COMPLETED|Extension 1||0
273730|NCT00365716|665026|P7|STARTED|Extension 1||0
273731|NCT00365716|665027|P6|STARTED|Extension 1||241
273732|NCT00365716|665028|P5|STARTED|Extension 1||0
273733|NCT00365716|665029|P4|STARTED|Extension 1||0
273734|NCT00365716|665030|P3|STARTED|Extension 1||0
273735|NCT00365716|665031|P2|STARTED|Extension 1||0
273736|NCT00365716|665032|P1|STARTED|Extension 1||0
273737|NCT00365716|665026|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
273738|NCT00365716|665027|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
273739|NCT00365716|665028|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
273740|NCT00365716|665029|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
273741|NCT00365716|665030|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
273742|NCT00365716|665031|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
273743|NCT00365716|665032|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
273744|NCT00365716|665026|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
273745|NCT00365716|665027|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
273746|NCT00365716|665028|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
273747|NCT00365716|665029|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
273748|NCT00365716|665030|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
273749|NCT00365716|665031|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
273750|NCT00365716|665032|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
273751|NCT00365716|665026|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
273752|NCT00365716|665027|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
273753|NCT00365716|665028|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
273754|NCT00365716|665029|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
273755|NCT00365716|665030|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
273756|NCT00365716|665031|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
273757|NCT00365716|665032|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
273758|NCT00365716|665026|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
273759|NCT00365716|665027|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
273760|NCT00365716|665028|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
273761|NCT00365716|665029|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
273762|NCT00365716|665030|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
273763|NCT00365716|665031|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
273764|NCT00365716|665032|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
273765|NCT00365716|665026|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
273766|NCT00365716|665027|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
273767|NCT00365716|665028|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
273768|NCT00365716|665029|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
273769|NCT00365716|665030|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
273770|NCT00365716|665031|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
273771|NCT00365716|665032|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
273772|NCT00365716|665026|P7|STARTED|Base Study (Day 1 to Month 7)||0
273773|NCT00365716|665027|P6|STARTED|Base Study (Day 1 to Month 7)||0
273774|NCT00365716|665028|P5|STARTED|Base Study (Day 1 to Month 7)||146
273775|NCT00365716|665029|P4|STARTED|Base Study (Day 1 to Month 7)||146
273776|NCT00365716|665030|P3|STARTED|Base Study (Day 1 to Month 7)||292
273777|NCT00365716|665031|P2|STARTED|Base Study (Day 1 to Month 7)||284
273778|NCT00365716|665032|P1|STARTED|Base Study (Day 1 to Month 7)||290
273779|NCT00365599|665047|P1|NOT COMPLETED|Overall Study||0
273780|NCT00365599|665047|P1|COMPLETED|Overall Study||43
273781|NCT00365599|665047|P1|STARTED|Overall Study||43
273782|NCT00365547|665053|P1|NOT COMPLETED|Overall Study||3
273783|NCT00365547|665053|P1|COMPLETED|Overall Study||43
273784|NCT00365547|665053|P1|STARTED|Overall Study||46
273785|NCT00365508|665063|P2|NOT COMPLETED|Overall Study||154
273786|NCT00365508|665064|P1|NOT COMPLETED|Overall Study||139
273787|NCT00365508|665063|P2|COMPLETED|Overall Study||167
273788|NCT00365508|665064|P1|COMPLETED|Overall Study||182
273789|NCT00365508|665063|P2|STARTED|Overall Study||321
273790|NCT00365508|665064|P1|STARTED|Overall Study||321
273791|NCT00365456|665072|P2|NOT COMPLETED|Trial Period III (12 Months)||5
273792|NCT00365456|665073|P1|NOT COMPLETED|Trial Period III (12 Months)||18
273793|NCT00365456|665072|P2|COMPLETED|Trial Period III (12 Months)||127
273794|NCT00365456|665073|P1|COMPLETED|Trial Period III (12 Months)||118
273795|NCT00365456|665072|P2|STARTED|Trial Period III (12 Months)||132
273796|NCT00365456|665073|P1|STARTED|Trial Period III (12 Months)||136
273797|NCT00365456|665072|P2|NOT COMPLETED|Trial Period II (12 Months)||14
273798|NCT00365456|665073|P1|NOT COMPLETED|Trial Period II (12 Months)||0
273799|NCT00365456|665072|P2|COMPLETED|Trial Period II (12 Months)||268
273800|NCT00365456|665073|P1|COMPLETED|Trial Period II (12 Months)||0
273801|NCT00365456|665072|P2|STARTED|Trial Period II (12 Months)||282
273802|NCT00365456|665073|P1|STARTED|Trial Period II (12 Months)||0
273803|NCT00365456|665072|P2|NOT COMPLETED|Trial Period I (12 Months)||0
273804|NCT00365456|665073|P1|NOT COMPLETED|Trial Period I (12 Months)||125
273805|NCT00365456|665072|P2|COMPLETED|Trial Period I (12 Months)||0
273806|NCT00365456|665073|P1|COMPLETED|Trial Period I (12 Months)||282
273807|NCT00365456|665072|P2|STARTED|Trial Period I (12 Months)||0
273808|NCT00365456|665073|P1|STARTED|Trial Period I (12 Months)||407
273809|NCT00365417|665079|P1|NOT COMPLETED|Overall Study||0
273810|NCT00365417|665079|P1|COMPLETED|Overall Study||45
273811|NCT00365417|665079|P1|STARTED|Overall Study||45
273812|NCT00365391|665085|P1|NOT COMPLETED|Overall Study||0
273813|NCT00365391|665085|P1|COMPLETED|Overall Study||27
273814|NCT00365391|665085|P1|STARTED|Overall Study||27
273815|NCT00365378|665095|P3|NOT COMPLETED|Extension||197
273816|NCT00365378|665096|P2|NOT COMPLETED|Extension||0
273817|NCT00365378|665097|P1|NOT COMPLETED|Extension||0
273818|NCT00365378|665095|P3|COMPLETED|Extension||203
273819|NCT00365378|665096|P2|COMPLETED|Extension||0
273820|NCT00365378|665097|P1|COMPLETED|Extension||0
273821|NCT00365378|665095|P3|STARTED|Extension||400
273822|NCT00365378|665096|P2|STARTED|Extension||0
273823|NCT00365378|665097|P1|STARTED|Extension||0
273824|NCT00365378|665095|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
273825|NCT00365378|665096|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
273826|NCT00365378|665097|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
273827|NCT00365378|665095|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
273828|NCT00365378|665096|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
273829|NCT00365378|665097|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
273830|NCT00365378|665095|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
273831|NCT00365378|665096|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
273832|NCT00365378|665097|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
273833|NCT00365378|665095|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
273834|NCT00365378|665096|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
273835|NCT00365378|665097|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
273836|NCT00365378|665095|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
273837|NCT00365378|665096|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
273838|NCT00365378|665097|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
273839|NCT00365378|665095|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
273840|NCT00365378|665096|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
273841|NCT00365378|665097|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
273842|NCT00365378|665095|P3|STARTED|Vaccination (Day 1 to Month 7)||0
273843|NCT00365378|665096|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
273844|NCT00365378|665097|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
273845|NCT00365365|665111|P3|NOT COMPLETED|Overall Study||15
273846|NCT00365365|665112|P2|NOT COMPLETED|Overall Study||36
273847|NCT00365365|665113|P1|NOT COMPLETED|Overall Study||34
273848|NCT00365365|665111|P3|COMPLETED|Overall Study||44
273849|NCT00365365|665112|P2|COMPLETED|Overall Study||41
273850|NCT00365365|665113|P1|COMPLETED|Overall Study||44
273851|NCT00365365|665111|P3|COMPLETED TREATMENT|Overall Study||45
273852|NCT00365365|665112|P2|COMPLETED TREATMENT|Overall Study||36
273853|NCT00365365|665113|P1|COMPLETED TREATMENT|Overall Study||38
273854|NCT00365365|665111|P3|TREATED (SAFETY POPULATION)|Overall Study||59
273855|NCT00365365|665112|P2|TREATED (SAFETY POPULATION)|Overall Study||75
273856|NCT00365365|665113|P1|TREATED (SAFETY POPULATION)|Overall Study||78
273857|NCT00365365|665111|P3|STARTED|Overall Study||59
273858|NCT00365365|665112|P2|STARTED|Overall Study||77
273859|NCT00365365|665113|P1|STARTED|Overall Study||78
273860|NCT00365352|665130|P3|NOT COMPLETED|Overall Study||15
273861|NCT00365352|665131|P2|NOT COMPLETED|Overall Study||11
273862|NCT00365352|665132|P1|NOT COMPLETED|Overall Study||20
273863|NCT00365352|665130|P3|COMPLETED|Overall Study||98
273864|NCT00365352|665131|P2|COMPLETED|Overall Study||104
273865|NCT00365352|665132|P1|COMPLETED|Overall Study||77
273866|NCT00365352|665130|P3|Modified Intent-to-Treat Population|Overall Study||111
273867|NCT00365352|665131|P2|Modified Intent-to-Treat Population|Overall Study||114
273868|NCT00365352|665132|P1|Modified Intent-to-Treat Population|Overall Study||96
273869|NCT00365352|665130|P3|Safety Population|Overall Study||111
273870|NCT00365352|665131|P2|Safety Population|Overall Study||115
273871|NCT00365352|665132|P1|Safety Population|Overall Study||96
273872|NCT00365352|665130|P3|STARTED|Overall Study||113
273873|NCT00365352|665131|P2|STARTED|Overall Study||115
273874|NCT00365352|665132|P1|STARTED|Overall Study||97
273875|NCT00365300|665216|P2|NOT COMPLETED|Double-blind Phase||9
273876|NCT00365300|665217|P1|NOT COMPLETED|Double-blind Phase||11
273877|NCT00365300|665216|P2|COMPLETED|Double-blind Phase||45
273878|NCT00365300|665217|P1|COMPLETED|Double-blind Phase||43
273879|NCT00365300|665216|P2|STARTED|Double-blind Phase||54
273880|NCT00365300|665217|P1|STARTED|Double-blind Phase||54
273881|NCT00365300|665216|P2|NOT COMPLETED|Open-label Phase||0
273882|NCT00365300|665217|P1|NOT COMPLETED|Open-label Phase||22
273883|NCT00365300|665216|P2|COMPLETED|Open-label Phase||0
273884|NCT00365300|665217|P1|COMPLETED|Open-label Phase||107
273885|NCT00365300|665216|P2|STARTED|Open-label Phase||0
273886|NCT00365300|665217|P1|STARTED|Open-label Phase||129
273887|NCT00365274|665226|P1|NOT COMPLETED|Overall Study||0
273888|NCT00365274|665226|P1|COMPLETED|Overall Study||6
273889|NCT00365274|665226|P1|STARTED|Overall Study||6
273890|NCT00365261|665232|P2|NOT COMPLETED|Overall Study||3
273891|NCT00365261|665233|P1|NOT COMPLETED|Overall Study||3
273892|NCT00365261|665232|P2|COMPLETED|Overall Study||19
273893|NCT00365261|665233|P1|COMPLETED|Overall Study||20
273894|NCT00365261|665232|P2|STARTED|Overall Study||22
273895|NCT00365261|665233|P1|STARTED|Overall Study||23
273896|NCT00365209|665243|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
273897|NCT00365209|665243|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
273898|NCT00365209|665243|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
273899|NCT00365209|665243|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
273900|NCT00365209|665243|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
273901|NCT00365209|665243|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
273902|NCT00365144|665272|P1|NOT COMPLETED|Overall Study||0
273903|NCT00365144|665272|P1|COMPLETED|Overall Study||36
273904|NCT00365144|665272|P1|STARTED|Overall Study||36
273905|NCT00365105|665282|P2|NOT COMPLETED|Overall Study||4
273906|NCT00365105|665283|P1|NOT COMPLETED|Overall Study||6
273907|NCT00365105|665282|P2|COMPLETED|Overall Study||128
273908|NCT00365105|665283|P1|COMPLETED|Overall Study||123
273909|NCT00365105|665282|P2|STARTED|Overall Study||132
273910|NCT00365105|665283|P1|STARTED|Overall Study||129
273911|NCT00365053|665289|P1|NOT COMPLETED|Overall Study||0
273912|NCT00365053|665289|P1|COMPLETED|Overall Study||13
273913|NCT00365053|665289|P1|STARTED|Overall Study||13
273914|NCT00364949|665300|P2|NOT COMPLETED|Overall Study||0
273915|NCT00364949|665301|P1|NOT COMPLETED|Overall Study||0
273916|NCT00364949|665300|P2|COMPLETED|Overall Study||39
273917|NCT00364949|665301|P1|COMPLETED|Overall Study||31
273918|NCT00364949|665300|P2|STARTED|Overall Study||39
273919|NCT00364949|665301|P1|STARTED|Overall Study||31
273920|NCT00364923|665319|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
273921|NCT00364923|665319|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
273922|NCT00364923|665319|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
273923|NCT00364923|665319|P1|NOT COMPLETED|Treatment With Pralatrexate||4
273924|NCT00364923|665319|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
273925|NCT00364923|665319|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
273926|NCT00364858|665328|P2|NOT COMPLETED|Overall Study||22
273927|NCT00364858|665329|P1|NOT COMPLETED|Overall Study||7
273928|NCT00364858|665328|P2|COMPLETED|Overall Study||40
273929|NCT00364858|665329|P1|COMPLETED|Overall Study||26
273930|NCT00364858|665328|P2|STARTED|Overall Study||62
273931|NCT00364858|665329|P1|STARTED|Overall Study||33
273932|NCT00364845|665344|P2|NOT COMPLETED|Overall Study||11
273933|NCT00364845|665345|P1|NOT COMPLETED|Overall Study||11
273934|NCT00364845|665344|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
273935|NCT00364845|665345|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
273936|NCT00364845|665344|P2|STARTED|Overall Study||23
273937|NCT00364845|665345|P1|STARTED|Overall Study||28
273938|NCT00364832|665366|P12|NOT COMPLETED|Extension Year 2||3
273939|NCT00364832|665367|P11|NOT COMPLETED|Extension Year 2||5
273940|NCT00364832|665368|P10|NOT COMPLETED|Extension Year 2||5
273941|NCT00364832|665369|P9|NOT COMPLETED|Extension Year 2||0
273942|NCT00364832|665370|P8|NOT COMPLETED|Extension Year 2||0
273943|NCT00364832|665371|P7|NOT COMPLETED|Extension Year 2||0
273944|NCT00364832|665372|P6|NOT COMPLETED|Extension Year 2||0
273945|NCT00364832|665373|P5|NOT COMPLETED|Extension Year 2||0
273946|NCT00364832|665374|P4|NOT COMPLETED|Extension Year 2||0
273947|NCT00364832|665375|P3|NOT COMPLETED|Extension Year 2||0
273948|NCT00364832|665376|P2|NOT COMPLETED|Extension Year 2||0
273949|NCT00364832|665377|P1|NOT COMPLETED|Extension Year 2||0
273950|NCT00364832|665366|P12|COMPLETED|Extension Year 2||11
273951|NCT00364832|665367|P11|COMPLETED|Extension Year 2||9
273952|NCT00364832|665368|P10|COMPLETED|Extension Year 2||9
273953|NCT00364832|665369|P9|COMPLETED|Extension Year 2||0
273954|NCT00364832|665370|P8|COMPLETED|Extension Year 2||0
273955|NCT00364832|665371|P7|COMPLETED|Extension Year 2||0
273956|NCT00364832|665372|P6|COMPLETED|Extension Year 2||0
273957|NCT00364832|665373|P5|COMPLETED|Extension Year 2||0
273958|NCT00364832|665374|P4|COMPLETED|Extension Year 2||0
273959|NCT00364832|665375|P3|COMPLETED|Extension Year 2||0
273960|NCT00364832|665376|P2|COMPLETED|Extension Year 2||0
273961|NCT00364832|665377|P1|COMPLETED|Extension Year 2||0
273962|NCT00364832|665366|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
273963|NCT00364832|665367|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
273964|NCT00364832|665368|P10|STARTED|Extension Year 2||14
273965|NCT00364832|665369|P9|STARTED|Extension Year 2||0
273966|NCT00364832|665370|P8|STARTED|Extension Year 2||0
273967|NCT00364832|665371|P7|STARTED|Extension Year 2||0
273968|NCT00364832|665372|P6|STARTED|Extension Year 2||0
273969|NCT00364832|665373|P5|STARTED|Extension Year 2||0
273970|NCT00364832|665374|P4|STARTED|Extension Year 2||0
273971|NCT00364832|665375|P3|STARTED|Extension Year 2||0
273972|NCT00364832|665376|P2|STARTED|Extension Year 2||0
273973|NCT00364832|665377|P1|STARTED|Extension Year 2||0
273974|NCT00364832|665366|P12|NOT COMPLETED|Extension Year 1||10
273975|NCT00364832|665367|P11|NOT COMPLETED|Extension Year 1||2
273976|NCT00364832|665368|P10|NOT COMPLETED|Extension Year 1||4
273977|NCT00364832|665369|P9|NOT COMPLETED|Extension Year 1||0
273978|NCT00364832|665370|P8|NOT COMPLETED|Extension Year 1||0
273979|NCT00364832|665371|P7|NOT COMPLETED|Extension Year 1||0
273980|NCT00364832|665372|P6|NOT COMPLETED|Extension Year 1||0
273981|NCT00364832|665373|P5|NOT COMPLETED|Extension Year 1||0
273982|NCT00364832|665374|P4|NOT COMPLETED|Extension Year 1||0
273983|NCT00364832|665375|P3|NOT COMPLETED|Extension Year 1||0
273984|NCT00364832|665376|P2|NOT COMPLETED|Extension Year 1||0
273985|NCT00364832|665377|P1|NOT COMPLETED|Extension Year 1||0
273986|NCT00364832|665366|P12|COMPLETED|Extension Year 1||17
273987|NCT00364832|665367|P11|COMPLETED|Extension Year 1||15
273988|NCT00364832|665368|P10|COMPLETED|Extension Year 1||14
273989|NCT00364832|665369|P9|COMPLETED|Extension Year 1||0
273990|NCT00364832|665370|P8|COMPLETED|Extension Year 1||0
273991|NCT00364832|665371|P7|COMPLETED|Extension Year 1||0
273992|NCT00364832|665372|P6|COMPLETED|Extension Year 1||0
273993|NCT00364832|665373|P5|COMPLETED|Extension Year 1||0
273994|NCT00364832|665374|P4|COMPLETED|Extension Year 1||0
273995|NCT00364832|665375|P3|COMPLETED|Extension Year 1||0
273996|NCT00364832|665376|P2|COMPLETED|Extension Year 1||0
273997|NCT00364832|665377|P1|COMPLETED|Extension Year 1||0
273998|NCT00364832|665366|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
273999|NCT00364832|665367|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
274000|NCT00364832|665368|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
274001|NCT00364832|665369|P9|STARTED|Extension Year 1||0
274002|NCT00364832|665370|P8|STARTED|Extension Year 1||0
274003|NCT00364832|665371|P7|STARTED|Extension Year 1||0
274004|NCT00364832|665372|P6|STARTED|Extension Year 1||0
274005|NCT00364832|665373|P5|STARTED|Extension Year 1||0
274006|NCT00364832|665374|P4|STARTED|Extension Year 1||0
274007|NCT00364832|665375|P3|STARTED|Extension Year 1||0
274008|NCT00364832|665376|P2|STARTED|Extension Year 1||0
274009|NCT00364832|665377|P1|STARTED|Extension Year 1||0
274010|NCT00364832|665366|P12|NOT COMPLETED|Core Period||0
274011|NCT00364832|665367|P11|NOT COMPLETED|Core Period||0
274012|NCT00364832|665368|P10|NOT COMPLETED|Core Period||0
274013|NCT00364832|665369|P9|NOT COMPLETED|Core Period||0
274014|NCT00364832|665370|P8|NOT COMPLETED|Core Period||1
274015|NCT00364832|665371|P7|NOT COMPLETED|Core Period||4
274016|NCT00364832|665372|P6|NOT COMPLETED|Core Period||0
274017|NCT00364832|665373|P5|NOT COMPLETED|Core Period||0
274018|NCT00364832|665374|P4|NOT COMPLETED|Core Period||1
274019|NCT00364832|665375|P3|NOT COMPLETED|Core Period||1
274020|NCT00364832|665376|P2|NOT COMPLETED|Core Period||2
274021|NCT00364832|665377|P1|NOT COMPLETED|Core Period||2
274022|NCT00364832|665366|P12|COMPLETED|Core Period||0
274023|NCT00364832|665367|P11|COMPLETED|Core Period||0
274024|NCT00364832|665368|P10|COMPLETED|Core Period||0
274025|NCT00364832|665369|P9|COMPLETED|Core Period||16
274026|NCT00364832|665370|P8|COMPLETED|Core Period||14
274027|NCT00364832|665371|P7|COMPLETED|Core Period||12
274028|NCT00364832|665372|P6|COMPLETED|Core Period||12
274029|NCT00364832|665373|P5|COMPLETED|Core Period||16
274030|NCT00364832|665374|P4|COMPLETED|Core Period||15
274031|NCT00364832|665375|P3|COMPLETED|Core Period||14
274032|NCT00364832|665376|P2|COMPLETED|Core Period||13
274033|NCT00364832|665377|P1|COMPLETED|Core Period||14
274034|NCT00364832|665366|P12|STARTED|Core Period||0
274035|NCT00364832|665367|P11|STARTED|Core Period||0
274036|NCT00364832|665368|P10|STARTED|Core Period||0
274037|NCT00364832|665369|P9|STARTED|Core Period||16
274038|NCT00364832|665370|P8|STARTED|Core Period||15
274039|NCT00364832|665371|P7|STARTED|Core Period||16
274040|NCT00364832|665372|P6|STARTED|Core Period||12
274041|NCT00364832|665373|P5|STARTED|Core Period||16
274042|NCT00364832|665374|P4|STARTED|Core Period||16
274043|NCT00364832|665375|P3|STARTED|Core Period||15
274044|NCT00364832|665376|P2|STARTED|Core Period||15
274045|NCT00364832|665377|P1|STARTED|Core Period||16
274046|NCT00364819|665430|P1|NOT COMPLETED|Overall Study||0
274047|NCT00364819|665430|P1|COMPLETED|Overall Study||6
274048|NCT00364819|665430|P1|STARTED|Overall Study||6
274049|NCT00364793|665442|P4|NOT COMPLETED|Overall Study||3
274050|NCT00364793|665443|P3|NOT COMPLETED|Overall Study||4
274051|NCT00364793|665444|P2|NOT COMPLETED|Overall Study||5
274052|NCT00364793|665445|P1|NOT COMPLETED|Overall Study||8
274053|NCT00364793|665442|P4|COMPLETED|Overall Study||5
274054|NCT00364793|665443|P3|COMPLETED|Overall Study||0
274055|NCT00364793|665444|P2|COMPLETED|Overall Study||5
274056|NCT00364793|665445|P1|COMPLETED|Overall Study||7
274057|NCT00364793|665442|P4|STARTED|Overall Study||8
274058|NCT00364793|665443|P3|STARTED|Overall Study||4
274059|NCT00364793|665444|P2|STARTED|Overall Study||10
274060|NCT00364793|665445|P1|STARTED|Overall Study||15
274061|NCT00364611|665581|P2|NOT COMPLETED|Overall Study||21
274062|NCT00364611|665582|P1|NOT COMPLETED|Overall Study||51
274063|NCT00364611|665581|P2|COMPLETED|Overall Study||0
274064|NCT00364611|665582|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
274065|NCT00364611|665581|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
274066|NCT00364611|665582|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
274067|NCT00364611|665581|P2|STARTED|Overall Study||21
274068|NCT00364611|665582|P1|STARTED|Overall Study||52
274069|NCT00364533|665605|P5|NOT COMPLETED|Overall Study||51
274070|NCT00364533|665606|P4|NOT COMPLETED|Overall Study||31
274071|NCT00364533|665607|P3|NOT COMPLETED|Overall Study||45
274072|NCT00364533|665608|P2|NOT COMPLETED|Overall Study||40
274073|NCT00364533|665609|P1|NOT COMPLETED|Overall Study||42
274074|NCT00364533|665605|P5|COMPLETED|Overall Study||24
274075|NCT00364533|665606|P4|COMPLETED|Overall Study||36
274076|NCT00364533|665607|P3|COMPLETED|Overall Study||30
274077|NCT00364533|665608|P2|COMPLETED|Overall Study||31
274078|NCT00364533|665609|P1|COMPLETED|Overall Study||35
274079|NCT00364533|665605|P5|STARTED|Overall Study||75
274080|NCT00364533|665606|P4|STARTED|Overall Study||67
274081|NCT00364533|665607|P3|STARTED|Overall Study||75
274082|NCT00364533|665608|P2|STARTED|Overall Study||71
274083|NCT00364533|665609|P1|STARTED|Overall Study||77
274084|NCT00364377|665633|P2|NOT COMPLETED|Overall Study||0
274085|NCT00364377|665634|P1|NOT COMPLETED|Overall Study||0
274086|NCT00364377|665633|P2|COMPLETED|Overall Study||11
274087|NCT00364377|665634|P1|COMPLETED|Overall Study||11
274088|NCT00364377|665633|P2|STARTED|Overall Study||11
274089|NCT00364377|665634|P1|STARTED|Overall Study||11
274090|NCT00364351|665642|P2|NOT COMPLETED|Overall Study||583
274091|NCT00364351|665643|P1|NOT COMPLETED|Overall Study||592
274092|NCT00364351|665642|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
274093|NCT00364351|665643|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
274094|NCT00364351|665642|P2|STARTED|Overall Study|randomised patients|617
274095|NCT00364351|665643|P1|STARTED|Overall Study|randomised patients|623
274096|NCT00364286|665661|P1|NOT COMPLETED|Overall Study||3
274097|NCT00364286|665661|P1|COMPLETED|Overall Study||14
274098|NCT00364286|665661|P1|STARTED|Overall Study||17
274099|NCT00364182|665668|P3|NOT COMPLETED|Fourth Intervention||0
274100|NCT00364182|665669|P2|NOT COMPLETED|Fourth Intervention||0
274101|NCT00364182|665670|P1|NOT COMPLETED|Fourth Intervention||0
274102|NCT00364182|665668|P3|COMPLETED|Fourth Intervention||22
274103|NCT00364182|665669|P2|COMPLETED|Fourth Intervention||19
274104|NCT00364182|665670|P1|COMPLETED|Fourth Intervention||0
274105|NCT00364182|665668|P3|STARTED|Fourth Intervention||22
274106|NCT00364182|665669|P2|STARTED|Fourth Intervention||19
274107|NCT00364182|665670|P1|STARTED|Fourth Intervention||0
274108|NCT00364182|665668|P3|NOT COMPLETED|Third Intervention||1
274109|NCT00364182|665669|P2|NOT COMPLETED|Third Intervention||1
274110|NCT00364182|665670|P1|NOT COMPLETED|Third Intervention||0
274111|NCT00364182|665668|P3|COMPLETED|Third Intervention||22
274112|NCT00364182|665669|P2|COMPLETED|Third Intervention||19
274113|NCT00364182|665670|P1|COMPLETED|Third Intervention||0
274114|NCT00364182|665668|P3|STARTED|Third Intervention||23
274115|NCT00364182|665669|P2|STARTED|Third Intervention||20
274116|NCT00364182|665670|P1|STARTED|Third Intervention||0
274117|NCT00364182|665668|P3|NOT COMPLETED|Second Intervention||2
274118|NCT00364182|665669|P2|NOT COMPLETED|Second Intervention||2
274119|NCT00364182|665670|P1|NOT COMPLETED|Second Intervention||0
274120|NCT00364182|665668|P3|COMPLETED|Second Intervention||23
274121|NCT00364182|665669|P2|COMPLETED|Second Intervention||20
274122|NCT00364182|665670|P1|COMPLETED|Second Intervention||0
274123|NCT00364182|665668|P3|Randomized|Second Intervention||25
274124|NCT00364182|665669|P2|Randomized|Second Intervention||22
274125|NCT00364182|665670|P1|Randomized|Second Intervention||0
274126|NCT00364182|665668|P3|STARTED|Second Intervention||25
274127|NCT00364182|665669|P2|STARTED|Second Intervention||22
274128|NCT00364182|665670|P1|STARTED|Second Intervention||0
274129|NCT00364182|665668|P3|NOT COMPLETED|First Intervention||0
274130|NCT00364182|665669|P2|NOT COMPLETED|First Intervention||0
274131|NCT00364182|665670|P1|NOT COMPLETED|First Intervention||3
274132|NCT00364182|665668|P3|COMPLETED|First Intervention||25
274133|NCT00364182|665669|P2|COMPLETED|First Intervention||22
274134|NCT00364182|665670|P1|COMPLETED|First Intervention||0
274135|NCT00364182|665668|P3|STARTED|First Intervention||25
274136|NCT00364182|665669|P2|STARTED|First Intervention||22
274137|NCT00364182|665670|P1|STARTED|First Intervention||3
274138|NCT00364156|665704|P2|NOT COMPLETED|Overall Study||81
274139|NCT00364156|665705|P1|NOT COMPLETED|Overall Study||79
274140|NCT00364156|665704|P2|COMPLETED|Overall Study||205
274141|NCT00364156|665705|P1|COMPLETED|Overall Study||203
274142|NCT00364156|665704|P2|STARTED|Overall Study||286
274143|NCT00364156|665705|P1|STARTED|Overall Study||282
274144|NCT00364130|665713|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
274145|NCT00364130|665714|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
274146|NCT00364130|665713|P2|COMPLETED|Post Intervention Follow-up Period||50
274147|NCT00364130|665714|P1|COMPLETED|Post Intervention Follow-up Period||55
274148|NCT00364130|665713|P2|STARTED|Post Intervention Follow-up Period||61
274149|NCT00364130|665714|P1|STARTED|Post Intervention Follow-up Period||60
274150|NCT00364130|665713|P2|NOT COMPLETED|Intervention Period||8
274151|NCT00364130|665714|P1|NOT COMPLETED|Intervention Period||9
274152|NCT00364130|665713|P2|COMPLETED|Intervention Period||61
274153|NCT00364130|665714|P1|COMPLETED|Intervention Period||60
274154|NCT00364130|665713|P2|STARTED|Intervention Period||69
274155|NCT00364130|665714|P1|STARTED|Intervention Period||69
274156|NCT00364013|665736|P2|NOT COMPLETED|Overall Study||95
274157|NCT00364013|665737|P1|NOT COMPLETED|Overall Study||101
274158|NCT00364013|665736|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
274159|NCT00364013|665737|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
274160|NCT00364013|665736|P2|Received Study Drug|Overall Study||583
274161|NCT00364013|665737|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
274162|NCT00364013|665736|P2|STARTED|Overall Study||590
274163|NCT00364013|665737|P1|STARTED|Overall Study||593
274164|NCT00363896|665765|P2|NOT COMPLETED|Overall Study||47
274165|NCT00363896|665766|P1|NOT COMPLETED|Overall Study||89
274166|NCT00363896|665765|P2|COMPLETED|Overall Study||169
274167|NCT00363896|665766|P1|COMPLETED|Overall Study||538
274168|NCT00363896|665765|P2|STARTED|Overall Study||216
274169|NCT00363896|665766|P1|STARTED|Overall Study||627
274170|NCT00363883|665778|P1|NOT COMPLETED|Overall Study||0
274171|NCT00363883|665778|P1|COMPLETED|Overall Study||14
274172|NCT00363883|665778|P1|STARTED|Overall Study||14
274173|NCT00363805|665787|P3|NOT COMPLETED|Overall Study||3
274174|NCT00363805|665788|P2|NOT COMPLETED|Overall Study||6
274175|NCT00363805|665789|P1|NOT COMPLETED|Overall Study||4
274176|NCT00363805|665787|P3|COMPLETED|Overall Study||70
274177|NCT00363805|665788|P2|COMPLETED|Overall Study||57
274178|NCT00363805|665789|P1|COMPLETED|Overall Study||38
274179|NCT00363805|665787|P3|STARTED|Overall Study||73
274180|NCT00363805|665788|P2|STARTED|Overall Study||63
274181|NCT00363805|665789|P1|STARTED|Overall Study||42
274182|NCT00363779|665800|P1|NOT COMPLETED|Overall Study||0
274183|NCT00363779|665800|P1|COMPLETED|Overall Study||5
274184|NCT00363779|665800|P1|STARTED|Overall Study||5
274185|NCT00363675|665805|P1|NOT COMPLETED|Overall Study||0
274186|NCT00363675|665805|P1|COMPLETED|Overall Study||3
274187|NCT00363675|665805|P1|Completed Testing|Overall Study||3
274188|NCT00363675|665805|P1|STARTED|Overall Study||3
274189|NCT00363545|665814|P2|NOT COMPLETED|Overall Study||57
274190|NCT00363545|665815|P1|NOT COMPLETED|Overall Study||44
274191|NCT00363545|665814|P2|COMPLETED|Overall Study||581
274192|NCT00363545|665815|P1|COMPLETED|Overall Study||592
274193|NCT00363545|665814|P2|STARTED|Overall Study||638
274194|NCT00363545|665815|P1|STARTED|Overall Study||636
274195|NCT00363480|665833|P1|NOT COMPLETED|Overall Study||17
274196|NCT00363480|665833|P1|COMPLETED|Overall Study||204
274197|NCT00363480|665833|P1|STARTED|Overall Study||221
274198|NCT00363467|665853|P1|NOT COMPLETED|Overall Study||1
274199|NCT00363467|665853|P1|COMPLETED|Overall Study||2
274200|NCT00363467|665853|P1|STARTED|Overall Study||3
274201|NCT00363415|665863|P2|NOT COMPLETED|Overall Study||249
274202|NCT00363415|665864|P1|NOT COMPLETED|Overall Study||361
274203|NCT00363415|665863|P2|COMPLETED|Overall Study||206
274204|NCT00363415|665864|P1|COMPLETED|Overall Study||92
274205|NCT00363415|665863|P2|Received at Least One Dose of Study Drug|Overall Study||447
274206|NCT00363415|665864|P1|Received at Least One Dose of Study Drug|Overall Study||433
274207|NCT00363415|665863|P2|STARTED|Overall Study||455
274208|NCT00363415|665864|P1|STARTED|Overall Study||453
274209|NCT00363311|665882|P2|NOT COMPLETED|Overall Study||45
274210|NCT00363311|665883|P1|NOT COMPLETED|Overall Study||76
274211|NCT00363311|665882|P2|COMPLETED|Overall Study||102
274212|NCT00363311|665883|P1|COMPLETED|Overall Study||79
274213|NCT00363311|665882|P2|STARTED|Overall Study||147
274214|NCT00363311|665883|P1|STARTED|Overall Study||155
274215|NCT00363298|665949|P2|NOT COMPLETED|4-week Study Continuation Phase||0
274216|NCT00363298|665950|P1|NOT COMPLETED|4-week Study Continuation Phase||1
274217|NCT00363298|665949|P2|COMPLETED|4-week Study Continuation Phase||7
274218|NCT00363298|665950|P1|COMPLETED|4-week Study Continuation Phase||5
274219|NCT00363298|665949|P2|STARTED|4-week Study Continuation Phase||7
274220|NCT00363298|665950|P1|STARTED|4-week Study Continuation Phase||6
274221|NCT00363298|665949|P2|NOT COMPLETED|First Study Week||5
274222|NCT00363298|665950|P1|NOT COMPLETED|First Study Week||6
274223|NCT00363298|665949|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
274224|NCT00363298|665950|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
274225|NCT00363298|665949|P2|STARTED|First Study Week||12
274226|NCT00363298|665950|P1|STARTED|First Study Week||12
274227|NCT00363246|665958|P1|NOT COMPLETED|Overall Study||97
274228|NCT00363246|665958|P1|COMPLETED|Overall Study||669
274229|NCT00363246|665958|P1|STARTED|Overall Study||766
274230|NCT00363168|665965|P2|NOT COMPLETED|Overall Study||0
274231|NCT00363168|665966|P1|NOT COMPLETED|Overall Study||0
274232|NCT00363168|665965|P2|COMPLETED|Overall Study||2
274233|NCT00363168|665966|P1|COMPLETED|Overall Study||5
274234|NCT00363168|665965|P2|STARTED|Overall Study||2
274235|NCT00363168|665966|P1|STARTED|Overall Study||5
274236|NCT00363142|665976|P2|NOT COMPLETED|Overall Study||3
274237|NCT00363142|665977|P1|NOT COMPLETED|Overall Study||7
274238|NCT00363142|665976|P2|COMPLETED|Overall Study||66
274239|NCT00363142|665977|P1|COMPLETED|Overall Study||133
274240|NCT00363142|665976|P2|STARTED|Overall Study||69
274241|NCT00363142|665977|P1|STARTED|Overall Study||140
274242|NCT00363129|666006|P2|NOT COMPLETED|Overall Study||33
274243|NCT00363129|666007|P1|NOT COMPLETED|Overall Study||29
274244|NCT00363129|666006|P2|COMPLETED|Overall Study||60
274245|NCT00363129|666007|P1|COMPLETED|Overall Study||67
274246|NCT00363129|666006|P2|STARTED|Overall Study||93
274247|NCT00363129|666007|P1|STARTED|Overall Study||96
274248|NCT00363077|666023|P2|NOT COMPLETED|Overall Study||0
274249|NCT00363077|666024|P1|NOT COMPLETED|Overall Study||0
274250|NCT00363077|666023|P2|COMPLETED|Overall Study||75
274251|NCT00363077|666024|P1|COMPLETED|Overall Study||75
274252|NCT00363077|666023|P2|STARTED|Overall Study||75
274253|NCT00363077|666024|P1|STARTED|Overall Study||75
274254|NCT00363051|666050|P2|NOT COMPLETED|Overall Study||22
274255|NCT00363051|666051|P1|NOT COMPLETED|Overall Study||38
274256|NCT00363051|666050|P2|COMPLETED|Overall Study||23
274257|NCT00363051|666051|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
274258|NCT00363051|666050|P2|STARTED|Overall Study||45
274259|NCT00363051|666051|P1|STARTED|Overall Study||115
274260|NCT00363038|666068|P1|NOT COMPLETED|Overall Study||0
274261|NCT00363038|666068|P1|COMPLETED|Overall Study||16
274262|NCT00363038|666068|P1|STARTED|Overall Study||16
274263|NCT00362882|666074|P2|NOT COMPLETED|Overall Study||0
274264|NCT00362882|666075|P1|NOT COMPLETED|Overall Study||0
274265|NCT00362882|666074|P2|COMPLETED|Overall Study||41
274266|NCT00362882|666075|P1|COMPLETED|Overall Study||40
274267|NCT00362882|666074|P2|STARTED|Overall Study||41
274268|NCT00362882|666075|P1|STARTED|Overall Study||40
274269|NCT00362817|666087|P1|NOT COMPLETED|Overall Study||0
274270|NCT00362817|666087|P1|COMPLETED|Overall Study||17
274271|NCT00362817|666087|P1|STARTED|Overall Study||17
274272|NCT00362648|666100|P4|NOT COMPLETED|Overall Study||11
274273|NCT00362648|666101|P3|NOT COMPLETED|Overall Study||9
274274|NCT00362648|666102|P2|NOT COMPLETED|Overall Study||134
274275|NCT00362648|666103|P1|NOT COMPLETED|Overall Study||126
274276|NCT00362648|666100|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
274277|NCT00362648|666101|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
274278|NCT00362648|666102|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
274279|NCT00362648|666103|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
274280|NCT00362648|666100|P4|Vaccinated at Visit 3|Overall Study||1007
274281|NCT00362648|666101|P3|Vaccinated at Visit 3|Overall Study||1009
274282|NCT00362648|666102|P2|Vaccinated at Visit 3|Overall Study||2612
274283|NCT00362648|666103|P1|Vaccinated at Visit 3|Overall Study||2613
274284|NCT00362648|666100|P4|Vaccinated at Visit 2|Overall Study||1009
274285|NCT00362648|666101|P3|Vaccinated at Visit 2|Overall Study||1013
274286|NCT00362648|666102|P2|Vaccinated at Visit 2|Overall Study||2666
274287|NCT00362648|666103|P1|Vaccinated at Visit 2|Overall Study||2657
274288|NCT00362648|666100|P4|Vaccinated at Visit 1|Overall Study||1018
274289|NCT00362648|666101|P3|Vaccinated at Visit 1|Overall Study||1018
274290|NCT00362648|666102|P2|Vaccinated at Visit 1|Overall Study||2735
274291|NCT00362648|666103|P1|Vaccinated at Visit 1|Overall Study||2733
274292|NCT00362648|666100|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
274293|NCT00362648|666101|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
274294|NCT00362648|666102|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
274295|NCT00362648|666103|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
274296|NCT00362609|666121|P2|NOT COMPLETED|Overall Study||2
274297|NCT00362609|666122|P1|NOT COMPLETED|Overall Study||0
274298|NCT00362609|666121|P2|COMPLETED|Overall Study||38
274299|NCT00362609|666122|P1|COMPLETED|Overall Study||19
274300|NCT00362609|666121|P2|STARTED|Overall Study||40
274301|NCT00362609|666122|P1|STARTED|Overall Study||19
274302|NCT00362466|666136|P2|NOT COMPLETED|Overall Study||0
274303|NCT00362466|666137|P1|NOT COMPLETED|Overall Study||0
274304|NCT00362466|666136|P2|COMPLETED|Overall Study||1
274305|NCT00362466|666137|P1|COMPLETED|Overall Study||2
274306|NCT00362466|666136|P2|STARTED|Overall Study||1
274307|NCT00362466|666137|P1|STARTED|Overall Study||2
274308|NCT00362453|666159|P2|NOT COMPLETED|Overall Study||0
274309|NCT00362453|666160|P1|NOT COMPLETED|Overall Study||0
274310|NCT00362453|666159|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
274311|NCT00362453|666160|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
274312|NCT00362453|666159|P2|STARTED|Overall Study||20
274313|NCT00362453|666160|P1|STARTED|Overall Study||20
274314|NCT00362440|666192|P2|NOT COMPLETED|Overall Study||1
274315|NCT00362440|666193|P1|NOT COMPLETED|Overall Study||2
274316|NCT00362440|666192|P2|COMPLETED|Overall Study||3
274317|NCT00362440|666193|P1|COMPLETED|Overall Study||3
274318|NCT00362440|666192|P2|STARTED|Overall Study||4
274319|NCT00362440|666193|P1|STARTED|Overall Study||5
274320|NCT00362414|666203|P1|NOT COMPLETED|Overall Study||3
274321|NCT00362414|666203|P1|COMPLETED|Overall Study||12
274322|NCT00362414|666203|P1|STARTED|Overall Study||15
274323|NCT00362401|666223|P3|NOT COMPLETED|Overall Study||0
274324|NCT00362401|666224|P2|NOT COMPLETED|Overall Study||0
274325|NCT00362401|666225|P1|NOT COMPLETED|Overall Study||0
274326|NCT00362401|666223|P3|COMPLETED|Overall Study||40
274327|NCT00362401|666224|P2|COMPLETED|Overall Study||29
274328|NCT00362401|666225|P1|COMPLETED|Overall Study||15
274329|NCT00362401|666223|P3|STARTED|Overall Study||40
274330|NCT00362401|666224|P2|STARTED|Overall Study||29
274331|NCT00362401|666225|P1|STARTED|Overall Study||15
274332|NCT00362375|666232|P2|NOT COMPLETED|Overall Study||35
274333|NCT00362375|666233|P1|NOT COMPLETED|Overall Study||40
274334|NCT00362375|666232|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
274335|NCT00362375|666233|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
274336|NCT00362375|666232|P2|STARTED|Overall Study|Number eligible and randomized|152
274337|NCT00362375|666233|P1|STARTED|Overall Study|Number eligible and randomized|161
274338|NCT00362336|666250|P3|NOT COMPLETED|Overall Study||3
274339|NCT00362336|666251|P2|NOT COMPLETED|Overall Study||7
274340|NCT00362336|666252|P1|NOT COMPLETED|Overall Study||10
274341|NCT00362336|666250|P3|COMPLETED|Overall Study||134
274342|NCT00362336|666251|P2|COMPLETED|Overall Study||235
274343|NCT00362336|666252|P1|COMPLETED|Overall Study||233
274344|NCT00362336|666250|P3|STARTED|Overall Study||137
274345|NCT00362336|666251|P2|STARTED|Overall Study||242
274346|NCT00362336|666252|P1|STARTED|Overall Study||243
274347|NCT00362297|666280|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
274348|NCT00362297|666281|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
274349|NCT00362297|666280|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
274350|NCT00362297|666281|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
274351|NCT00362297|666280|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
274352|NCT00362297|666281|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
274353|NCT00362297|666280|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
274354|NCT00362297|666281|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
274355|NCT00362297|666280|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
274356|NCT00362297|666281|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
274357|NCT00362297|666280|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
274358|NCT00362297|666281|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
274359|NCT00362232|666289|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
274360|NCT00362232|666290|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
274361|NCT00362232|666289|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
274362|NCT00362232|666290|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
274363|NCT00362232|666289|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
274364|NCT00362232|666290|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
274365|NCT00362232|666289|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
274366|NCT00362232|666290|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
274367|NCT00362232|666289|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
274368|NCT00362232|666290|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
274369|NCT00362232|666289|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
274370|NCT00362232|666290|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
274371|NCT00362232|666289|P2|STARTED|Treatment (12 +/- 2 Days)||1564
274372|NCT00362232|666290|P1|STARTED|Treatment (12 +/- 2 Days)||1584
274373|NCT00362180|666335|P9|NOT COMPLETED|20 Week Safety Follow-up||0
274374|NCT00362180|666336|P8|NOT COMPLETED|20 Week Safety Follow-up||0
274375|NCT00362180|666337|P7|NOT COMPLETED|20 Week Safety Follow-up||0
274376|NCT00362180|666338|P6|NOT COMPLETED|20 Week Safety Follow-up||0
274377|NCT00362180|666339|P5|NOT COMPLETED|20 Week Safety Follow-up||0
274378|NCT00362180|666340|P4|NOT COMPLETED|20 Week Safety Follow-up||0
274379|NCT00362180|666341|P3|NOT COMPLETED|20 Week Safety Follow-up||0
274380|NCT00362180|666342|P2|NOT COMPLETED|20 Week Safety Follow-up||0
274381|NCT00362180|666343|P1|NOT COMPLETED|20 Week Safety Follow-up||0
274382|NCT00362180|666335|P9|COMPLETED|20 Week Safety Follow-up||1
274383|NCT00362180|666336|P8|COMPLETED|20 Week Safety Follow-up||3
274384|NCT00362180|666337|P7|COMPLETED|20 Week Safety Follow-up||0
274385|NCT00362180|666338|P6|COMPLETED|20 Week Safety Follow-up||9
274386|NCT00362180|666339|P5|COMPLETED|20 Week Safety Follow-up||11
274387|NCT00362180|666340|P4|COMPLETED|20 Week Safety Follow-up||0
274388|NCT00362180|666341|P3|COMPLETED|20 Week Safety Follow-up||1
274389|NCT00362180|666342|P2|COMPLETED|20 Week Safety Follow-up||2
274390|NCT00362180|666343|P1|COMPLETED|20 Week Safety Follow-up||3
274391|NCT00362180|666335|P9|STARTED|20 Week Safety Follow-up||1
274392|NCT00362180|666336|P8|STARTED|20 Week Safety Follow-up||3
274393|NCT00362180|666337|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
274394|NCT00362180|666338|P6|STARTED|20 Week Safety Follow-up||9
274395|NCT00362180|666339|P5|STARTED|20 Week Safety Follow-up||11
274396|NCT00362180|666340|P4|STARTED|20 Week Safety Follow-up||0
274397|NCT00362180|666341|P3|STARTED|20 Week Safety Follow-up||1
274398|NCT00362180|666342|P2|STARTED|20 Week Safety Follow-up||2
274399|NCT00362180|666343|P1|STARTED|20 Week Safety Follow-up||3
274400|NCT00362180|666335|P9|NOT COMPLETED|Treated Period||0
274401|NCT00362180|666336|P8|NOT COMPLETED|Treated Period||1
274402|NCT00362180|666337|P7|NOT COMPLETED|Treated Period||0
274403|NCT00362180|666338|P6|NOT COMPLETED|Treated Period||1
274404|NCT00362180|666339|P5|NOT COMPLETED|Treated Period||0
274405|NCT00362180|666340|P4|NOT COMPLETED|Treated Period||0
274406|NCT00362180|666341|P3|NOT COMPLETED|Treated Period||0
274407|NCT00362180|666342|P2|NOT COMPLETED|Treated Period||0
274408|NCT00362180|666343|P1|NOT COMPLETED|Treated Period||1
274409|NCT00362180|666335|P9|COMPLETED|Treated Period||1
274410|NCT00362180|666336|P8|COMPLETED|Treated Period||2
274411|NCT00362180|666337|P7|COMPLETED|Treated Period||6
274412|NCT00362180|666338|P6|COMPLETED|Treated Period||9
274413|NCT00362180|666339|P5|COMPLETED|Treated Period||11
274414|NCT00362180|666340|P4|COMPLETED|Treated Period||0
274415|NCT00362180|666341|P3|COMPLETED|Treated Period||1
274416|NCT00362180|666342|P2|COMPLETED|Treated Period||2
274417|NCT00362180|666343|P1|COMPLETED|Treated Period||3
274418|NCT00362180|666335|P9|STARTED|Treated Period||1
274419|NCT00362180|666336|P8|STARTED|Treated Period||3
274420|NCT00362180|666337|P7|STARTED|Treated Period||6
274421|NCT00362180|666338|P6|STARTED|Treated Period||10
274422|NCT00362180|666339|P5|STARTED|Treated Period||11
274423|NCT00362180|666340|P4|STARTED|Treated Period||0
274424|NCT00362180|666341|P3|STARTED|Treated Period||1
274425|NCT00362180|666342|P2|STARTED|Treated Period||2
274426|NCT00362180|666343|P1|STARTED|Treated Period||4
274427|NCT00362128|666404|P1|NOT COMPLETED|Overall Study||0
274428|NCT00362128|666404|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
274429|NCT00362128|666404|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
274430|NCT00362115|666415|P7|NOT COMPLETED|Overall Study||12
274431|NCT00362115|666416|P6|NOT COMPLETED|Overall Study||7
274432|NCT00362115|666417|P5|NOT COMPLETED|Overall Study||7
274433|NCT00362115|666418|P4|NOT COMPLETED|Overall Study||4
274434|NCT00362115|666419|P3|NOT COMPLETED|Overall Study||7
274435|NCT00362115|666420|P2|NOT COMPLETED|Overall Study||6
274436|NCT00362115|666421|P1|NOT COMPLETED|Overall Study||2
274437|NCT00362115|666415|P7|COMPLETED|Overall Study||52
274438|NCT00362115|666416|P6|COMPLETED|Overall Study||57
274439|NCT00362115|666417|P5|COMPLETED|Overall Study||57
274440|NCT00362115|666418|P4|COMPLETED|Overall Study||59
274441|NCT00362115|666419|P3|COMPLETED|Overall Study||57
274442|NCT00362115|666420|P2|COMPLETED|Overall Study||59
274443|NCT00362115|666421|P1|COMPLETED|Overall Study||63
274444|NCT00362115|666415|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
274445|NCT00362115|666416|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
274446|NCT00362115|666417|P5|STARTED|Overall Study||64
274447|NCT00362115|666418|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
274448|NCT00362115|666419|P3|STARTED|Overall Study||64
274449|NCT00362115|666420|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
274450|NCT00362115|666421|P1|STARTED|Overall Study||65
274451|NCT00361972|666572|P2|NOT COMPLETED|Overall Study||0
274452|NCT00361972|666573|P1|NOT COMPLETED|Overall Study||0
274453|NCT00361972|666572|P2|COMPLETED|Overall Study||9
274454|NCT00361972|666573|P1|COMPLETED|Overall Study||8
274455|NCT00361972|666572|P2|STARTED|Overall Study||9
274456|NCT00361972|666573|P1|STARTED|Overall Study||8
274457|NCT00361712|666583|P2|NOT COMPLETED|Overall Study||0
274458|NCT00361712|666584|P1|NOT COMPLETED|Overall Study||0
274459|NCT00361712|666583|P2|COMPLETED|Overall Study||21
274460|NCT00361712|666584|P1|COMPLETED|Overall Study||20
274461|NCT00361712|666583|P2|STARTED|Overall Study||21
274462|NCT00361712|666584|P1|STARTED|Overall Study||20
274463|NCT00361634|666594|P1|NOT COMPLETED|Overall Study||2
274464|NCT00361634|666594|P1|COMPLETED|Overall Study||12
274465|NCT00361634|666594|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
274466|NCT00361634|666594|P1|STARTED|Overall Study||14
274467|NCT00361595|666612|P1|NOT COMPLETED|Overall Study||0
274468|NCT00361595|666612|P1|COMPLETED|Overall Study||35
274469|NCT00361595|666612|P1|STARTED|Overall Study||35
274470|NCT00361569|666623|P4|NOT COMPLETED|Overall Study||21
274471|NCT00361569|666624|P3|NOT COMPLETED|Overall Study||18
274472|NCT00361569|666625|P2|NOT COMPLETED|Overall Study||11
274473|NCT00361569|666626|P1|NOT COMPLETED|Overall Study||12
274474|NCT00361569|666623|P4|COMPLETED|Overall Study||135
274475|NCT00361569|666624|P3|COMPLETED|Overall Study||137
274476|NCT00361569|666625|P2|COMPLETED|Overall Study||150
274477|NCT00361569|666626|P1|COMPLETED|Overall Study||138
274478|NCT00361569|666623|P4|STARTED|Overall Study||156
274479|NCT00361569|666624|P3|STARTED|Overall Study||155
274480|NCT00361569|666625|P2|STARTED|Overall Study||161
274481|NCT00361569|666626|P1|STARTED|Overall Study||150
274482|NCT00361504|666650|P2|NOT COMPLETED|Overall Study||145
274483|NCT00361504|666651|P1|NOT COMPLETED|Overall Study||481
274484|NCT00361504|666650|P2|COMPLETED|Overall Study||78
274485|NCT00361504|666651|P1|COMPLETED|Overall Study||413
274486|NCT00361504|666650|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
274487|NCT00361504|666651|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
274488|NCT00361439|666661|P2|NOT COMPLETED|Overall Study||0
274489|NCT00361439|666662|P1|NOT COMPLETED|Overall Study||0
274490|NCT00361439|666661|P2|COMPLETED|Overall Study||9
274491|NCT00361439|666662|P1|COMPLETED|Overall Study||8
274492|NCT00361439|666661|P2|STARTED|Overall Study||9
274493|NCT00361439|666662|P1|STARTED|Overall Study||8
274494|NCT00361374|666677|P3|NOT COMPLETED|Overall Study||12
274495|NCT00361374|666678|P2|NOT COMPLETED|Overall Study||15
274496|NCT00361374|666679|P1|NOT COMPLETED|Overall Study||15
274497|NCT00361374|666677|P3|COMPLETED|Overall Study||53
274498|NCT00361374|666678|P2|COMPLETED|Overall Study||50
274499|NCT00361374|666679|P1|COMPLETED|Overall Study||51
274500|NCT00361374|666677|P3|STARTED|Overall Study||65
274501|NCT00361374|666678|P2|STARTED|Overall Study||65
274502|NCT00361374|666679|P1|STARTED|Overall Study||66
274503|NCT00361335|666692|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
274504|NCT00361335|666693|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
274505|NCT00361335|666694|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
274506|NCT00361335|666695|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
274507|NCT00361335|666696|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
274508|NCT00361335|666697|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
274509|NCT00361335|666698|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
274510|NCT00361335|666692|P7|COMPLETED|SC Period: Week E0 to Week E24||164
274511|NCT00361335|666693|P6|COMPLETED|SC Period: Week E0 to Week E24||23
274512|NCT00361335|666694|P5|COMPLETED|SC Period: Week E0 to Week E24||3
274513|NCT00361335|666695|P4|COMPLETED|SC Period: Week E0 to Week E24||59
274514|NCT00361335|666696|P3|COMPLETED|SC Period: Week E0 to Week E24||99
274515|NCT00361335|666697|P2|COMPLETED|SC Period: Week E0 to Week E24||56
274516|NCT00361335|666698|P1|COMPLETED|SC Period: Week E0 to Week E24||80
274517|NCT00361335|666692|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
274518|NCT00361335|666693|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
274519|NCT00361335|666694|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
274520|NCT00361335|666695|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
274521|NCT00361335|666696|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
274522|NCT00361335|666697|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
274523|NCT00361335|666698|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
274524|NCT00361335|666692|P7|NOT COMPLETED|IV Period: Baseline to E0||0
274525|NCT00361335|666693|P6|NOT COMPLETED|IV Period: Baseline to E0||0
274526|NCT00361335|666694|P5|NOT COMPLETED|IV Period: Baseline to E0||24
274527|NCT00361335|666695|P4|NOT COMPLETED|IV Period: Baseline to E0||27
274528|NCT00361335|666696|P3|NOT COMPLETED|IV Period: Baseline to E0||21
274529|NCT00361335|666697|P2|NOT COMPLETED|IV Period: Baseline to E0||29
274530|NCT00361335|666698|P1|NOT COMPLETED|IV Period: Baseline to E0||20
274531|NCT00361335|666692|P7|COMPLETED|IV Period: Baseline to E0||0
274532|NCT00361335|666693|P6|COMPLETED|IV Period: Baseline to E0||0
274533|NCT00361335|666694|P5|COMPLETED|IV Period: Baseline to E0||105
274534|NCT00361335|666695|P4|COMPLETED|IV Period: Baseline to E0||102
274535|NCT00361335|666696|P3|COMPLETED|IV Period: Baseline to E0||107
274536|NCT00361335|666697|P2|COMPLETED|IV Period: Baseline to E0||99
274537|NCT00361335|666698|P1|COMPLETED|IV Period: Baseline to E0||109
274538|NCT00361335|666692|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
274539|NCT00361335|666693|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
274540|NCT00361335|666694|P5|STARTED|IV Period: Baseline to E0||129
274541|NCT00361335|666695|P4|STARTED|IV Period: Baseline to E0||129
274542|NCT00361335|666696|P3|STARTED|IV Period: Baseline to E0||128
274543|NCT00361335|666697|P2|STARTED|IV Period: Baseline to E0||128
274544|NCT00361335|666698|P1|STARTED|IV Period: Baseline to E0||129
274545|NCT00361283|666742|P1|NOT COMPLETED|Overall Study||27
274546|NCT00361283|666742|P1|COMPLETED|Overall Study||81
274547|NCT00361283|666742|P1|STARTED|Overall Study||108
274548|NCT00361270|666750|P4|NOT COMPLETED|Overall Study||13
274549|NCT00361270|666751|P3|NOT COMPLETED|Overall Study||10
274550|NCT00361270|666752|P2|NOT COMPLETED|Overall Study||14
274551|NCT00361270|666753|P1|NOT COMPLETED|Overall Study||24
274552|NCT00361270|666750|P4|COMPLETED|Overall Study||25
274553|NCT00361270|666751|P3|COMPLETED|Overall Study||25
274554|NCT00361270|666752|P2|COMPLETED|Overall Study||25
274555|NCT00361270|666753|P1|COMPLETED|Overall Study||25
274556|NCT00361270|666750|P4|STARTED|Overall Study||38
274557|NCT00361270|666751|P3|STARTED|Overall Study||35
274558|NCT00361270|666752|P2|STARTED|Overall Study||39
274559|NCT00361270|666753|P1|STARTED|Overall Study||49
274560|NCT00361257|666773|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
274561|NCT00361257|666774|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
274562|NCT00361257|666773|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
274563|NCT00361257|666774|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
274564|NCT00361257|666773|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
274565|NCT00361257|666774|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
274566|NCT00361257|666773|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
274567|NCT00361257|666774|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
274568|NCT00361257|666773|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
274569|NCT00361257|666774|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
274570|NCT00361257|666773|P2|STARTED|Step 1: Minocycline vs. Placebo||55
274571|NCT00361257|666774|P1|STARTED|Step 1: Minocycline vs. Placebo||52
274572|NCT00361231|666826|P1|NOT COMPLETED|Overall Study||34
274573|NCT00361231|666826|P1|COMPLETED|Overall Study||1
274574|NCT00361231|666826|P1|STARTED|Overall Study||35
274575|NCT00361218|666831|P1|NOT COMPLETED|Overall Study||23
274576|NCT00361218|666831|P1|COMPLETED|Overall Study||30
274577|NCT00361218|666831|P1|Completed Baseline Assessment|Overall Study||47
274578|NCT00361218|666831|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
274579|NCT00361140|666839|P3|NOT COMPLETED|Overall Study||0
274580|NCT00361140|666840|P2|NOT COMPLETED|Overall Study||0
274581|NCT00361140|666841|P1|NOT COMPLETED|Overall Study||0
274582|NCT00361140|666839|P3|COMPLETED|Overall Study||3
274583|NCT00361140|666840|P2|COMPLETED|Overall Study||29
274584|NCT00361140|666841|P1|COMPLETED|Overall Study||40
274585|NCT00361140|666839|P3|STARTED|Overall Study||3
274586|NCT00361140|666840|P2|STARTED|Overall Study||29
274587|NCT00361140|666841|P1|STARTED|Overall Study||40
274588|NCT00360971|666854|P2|NOT COMPLETED|Overall Study||0
274589|NCT00360971|666855|P1|NOT COMPLETED|Overall Study||0
274590|NCT00360971|666854|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
274591|NCT00360971|666855|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
274592|NCT00360971|666854|P2|STARTED|Overall Study||11
274593|NCT00360971|666855|P1|STARTED|Overall Study||10
274594|NCT00360828|666871|P1|NOT COMPLETED|Overall Study||1
274595|NCT00360828|666871|P1|COMPLETED|Overall Study||9
274596|NCT00360828|666871|P1|STARTED|Overall Study||10
274597|NCT00360724|666881|P2|NOT COMPLETED|Overall Study||4
274598|NCT00360724|666882|P1|NOT COMPLETED|Overall Study||4
274599|NCT00360724|666881|P2|COMPLETED|Overall Study||28
274600|NCT00360724|666882|P1|COMPLETED|Overall Study||29
274601|NCT00360724|666881|P2|STARTED|Overall Study||32
274602|NCT00360724|666882|P1|STARTED|Overall Study||33
274603|NCT00360698|666910|P2|NOT COMPLETED|Treatment Period||1
274604|NCT00360698|666911|P1|NOT COMPLETED|Treatment Period||1
274605|NCT00360698|666910|P2|COMPLETED|Treatment Period||56
274606|NCT00360698|666911|P1|COMPLETED|Treatment Period||48
274607|NCT00360698|666910|P2|STARTED|Treatment Period||57
274608|NCT00360698|666911|P1|STARTED|Treatment Period||49
274609|NCT00360698|666910|P2|NOT COMPLETED|Run-In||10
274610|NCT00360698|666911|P1|NOT COMPLETED|Run-In||0
274611|NCT00360698|666910|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
274612|NCT00360698|666911|P1|COMPLETED|Run-In||0
274613|NCT00360698|666910|P2|STARTED|Run-In||135
274614|NCT00360698|666911|P1|STARTED|Run-In||0
274615|NCT00360685|666939|P2|NOT COMPLETED|Overall Study||0
274616|NCT00360685|666940|P1|NOT COMPLETED|Overall Study||0
274617|NCT00360685|666939|P2|COMPLETED|Overall Study||42
274618|NCT00360685|666940|P1|COMPLETED|Overall Study||47
274619|NCT00360685|666939|P2|STARTED|Overall Study||42
274620|NCT00360685|666940|P1|STARTED|Overall Study||47
274621|NCT00360672|666950|P1|NOT COMPLETED|Overall Study||0
274622|NCT00360672|666950|P1|COMPLETED|Overall Study||27
274623|NCT00360672|666950|P1|STARTED|Overall Study||27
274624|NCT00360568|666956|P2|NOT COMPLETED|Overall Study||5
274625|NCT00360568|666957|P1|NOT COMPLETED|Overall Study||2
274626|NCT00360568|666956|P2|COMPLETED|Overall Study||24
274627|NCT00360568|666957|P1|COMPLETED|Overall Study||31
274628|NCT00360568|666956|P2|STARTED|Overall Study||29
274629|NCT00360568|666957|P1|STARTED|Overall Study||33
274630|NCT00360555|667068|P4|NOT COMPLETED|Overall Study||112
274631|NCT00360555|667069|P3|NOT COMPLETED|Overall Study||145
274632|NCT00360555|667070|P2|NOT COMPLETED|Overall Study||134
274633|NCT00360555|667071|P1|NOT COMPLETED|Overall Study||122
274634|NCT00360555|667068|P4|COMPLETED|Overall Study||287
274635|NCT00360555|667069|P3|COMPLETED|Overall Study||251
274636|NCT00360555|667070|P2|COMPLETED|Overall Study||259
274637|NCT00360555|667071|P1|COMPLETED|Overall Study||274
274638|NCT00360555|667068|P4|STARTED|Overall Study||399
274639|NCT00360555|667069|P3|STARTED|Overall Study||396
274640|NCT00360555|667070|P2|STARTED|Overall Study||393
274641|NCT00360555|667071|P1|STARTED|Overall Study||396
274642|NCT00360529|667088|P3|NOT COMPLETED|Overall Study||91
274643|NCT00360529|667089|P2|NOT COMPLETED|Overall Study||65
274644|NCT00360529|667090|P1|NOT COMPLETED|Overall Study||61
274645|NCT00360529|667088|P3|COMPLETED|Overall Study||199
274646|NCT00360529|667089|P2|COMPLETED|Overall Study||230
274647|NCT00360529|667090|P1|COMPLETED|Overall Study||234
274648|NCT00360529|667088|P3|STARTED|Overall Study||290
274649|NCT00360529|667089|P2|STARTED|Overall Study||295
274650|NCT00360529|667090|P1|STARTED|Overall Study||295
274651|NCT00360490|667118|P2|NOT COMPLETED|Overall Study||11
274652|NCT00360490|667119|P1|NOT COMPLETED|Overall Study||9
274653|NCT00360490|667118|P2|COMPLETED|Overall Study||72
274654|NCT00360490|667119|P1|COMPLETED|Overall Study||73
274655|NCT00360490|667118|P2|STARTED|Overall Study||83
274656|NCT00360490|667119|P1|STARTED|Overall Study||82
274657|NCT00360412|667154|P2|NOT COMPLETED|Overall Study||662
274658|NCT00360412|667155|P1|NOT COMPLETED|Overall Study||333
274659|NCT00360412|667154|P2|COMPLETED|Overall Study||2
274660|NCT00360412|667155|P1|COMPLETED|Overall Study||0
274661|NCT00360412|667154|P2|STARTED|Overall Study||664
274662|NCT00360412|667155|P1|STARTED|Overall Study||333
274663|NCT00360399|667170|P3|NOT COMPLETED|Overall Study||46
274664|NCT00360399|667171|P2|NOT COMPLETED|Overall Study||36
274665|NCT00360399|667172|P1|NOT COMPLETED|Overall Study||28
274666|NCT00360399|667170|P3|COMPLETED|Overall Study||69
274667|NCT00360399|667171|P2|COMPLETED|Overall Study||79
274668|NCT00360399|667172|P1|COMPLETED|Overall Study||86
274669|NCT00360399|667170|P3|Had Post-randomization Assessment|Overall Study||105
274670|NCT00360399|667171|P2|Had Post-randomization Assessment|Overall Study||106
274671|NCT00360399|667172|P1|Had Post-randomization Assessment|Overall Study||105
274672|NCT00360399|667170|P3|STARTED|Overall Study||115
274673|NCT00360399|667171|P2|STARTED|Overall Study||115
274674|NCT00360399|667172|P1|STARTED|Overall Study||114
274675|NCT00360360|667195|P1|NOT COMPLETED|Overall Study||6
274676|NCT00360360|667195|P1|COMPLETED|Overall Study||54
274677|NCT00360360|667195|P1|STARTED|Overall Study||60
274678|NCT00360334|667202|P2|NOT COMPLETED|Overall Study||13
274679|NCT00360334|667203|P1|NOT COMPLETED|Overall Study||19
274680|NCT00360334|667202|P2|COMPLETED|Overall Study||104
274681|NCT00360334|667203|P1|COMPLETED|Overall Study||99
274682|NCT00360334|667202|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
274683|NCT00360334|667203|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
274684|NCT00360334|667202|P2|STARTED|Overall Study||117
274685|NCT00360334|667203|P1|STARTED|Overall Study||118
274686|NCT00360308|667266|P3|NOT COMPLETED|Overall Study||88
274687|NCT00360308|667267|P2|NOT COMPLETED|Overall Study||79
274688|NCT00360308|667268|P1|NOT COMPLETED|Overall Study||76
274689|NCT00360308|667266|P3|COMPLETED|Overall Study||154
274690|NCT00360308|667267|P2|COMPLETED|Overall Study||155
274691|NCT00360308|667268|P1|COMPLETED|Overall Study||171
274692|NCT00360308|667266|P3|STARTED|Overall Study||242
274693|NCT00360308|667267|P2|STARTED|Overall Study||234
274694|NCT00360308|667268|P1|STARTED|Overall Study||247
274695|NCT00360282|667285|P4|NOT COMPLETED|Second Intervention||0
274696|NCT00360282|667286|P3|NOT COMPLETED|Second Intervention||0
274697|NCT00360282|667287|P2|NOT COMPLETED|Second Intervention||1
274698|NCT00360282|667288|P1|NOT COMPLETED|Second Intervention||0
274699|NCT00360282|667285|P4|COMPLETED|Second Intervention||6
274700|NCT00360282|667286|P3|COMPLETED|Second Intervention||6
274701|NCT00360282|667287|P2|COMPLETED|Second Intervention||7
274702|NCT00360282|667288|P1|COMPLETED|Second Intervention||6
274703|NCT00360282|667285|P4|STARTED|Second Intervention||6
274704|NCT00360282|667286|P3|STARTED|Second Intervention||6
274705|NCT00360282|667287|P2|STARTED|Second Intervention||8
274706|NCT00360282|667288|P1|STARTED|Second Intervention||6
274707|NCT00360282|667285|P4|NOT COMPLETED|Washout 1-3 Weeks||0
274708|NCT00360282|667286|P3|NOT COMPLETED|Washout 1-3 Weeks||1
274709|NCT00360282|667287|P2|NOT COMPLETED|Washout 1-3 Weeks||0
274710|NCT00360282|667288|P1|NOT COMPLETED|Washout 1-3 Weeks||0
274711|NCT00360282|667285|P4|COMPLETED|Washout 1-3 Weeks||6
274712|NCT00360282|667286|P3|COMPLETED|Washout 1-3 Weeks||6
274713|NCT00360282|667287|P2|COMPLETED|Washout 1-3 Weeks||8
274714|NCT00360282|667288|P1|COMPLETED|Washout 1-3 Weeks||6
274715|NCT00360282|667285|P4|STARTED|Washout 1-3 Weeks||6
274716|NCT00360282|667286|P3|STARTED|Washout 1-3 Weeks||7
274717|NCT00360282|667287|P2|STARTED|Washout 1-3 Weeks||8
274718|NCT00360282|667288|P1|STARTED|Washout 1-3 Weeks||6
274719|NCT00360282|667285|P4|NOT COMPLETED|First Intervention||0
274720|NCT00360282|667286|P3|NOT COMPLETED|First Intervention||0
274721|NCT00360282|667287|P2|NOT COMPLETED|First Intervention||0
274722|NCT00360282|667288|P1|NOT COMPLETED|First Intervention||0
274723|NCT00360282|667285|P4|COMPLETED|First Intervention||6
274724|NCT00360282|667286|P3|COMPLETED|First Intervention||7
274725|NCT00360282|667287|P2|COMPLETED|First Intervention||8
274726|NCT00360282|667288|P1|COMPLETED|First Intervention||6
274727|NCT00360282|667285|P4|STARTED|First Intervention||6
274728|NCT00360282|667286|P3|STARTED|First Intervention||7
274729|NCT00360282|667287|P2|STARTED|First Intervention||8
274730|NCT00360282|667288|P1|STARTED|First Intervention||6
274731|NCT00360269|667300|P2|NOT COMPLETED|Overall Study||12
274732|NCT00360269|667301|P1|NOT COMPLETED|Overall Study||10
274733|NCT00360269|667300|P2|COMPLETED|Overall Study||7
274734|NCT00360269|667301|P1|COMPLETED|Overall Study||9
274735|NCT00360269|667300|P2|STARTED|Overall Study||19
274736|NCT00360269|667301|P1|STARTED|Overall Study||19
274737|NCT00360243|667319|P4|NOT COMPLETED|Overall Study||125
274738|NCT00360243|667320|P3|NOT COMPLETED|Overall Study||156
274739|NCT00360243|667321|P2|NOT COMPLETED|Overall Study||120
274740|NCT00360243|667322|P1|NOT COMPLETED|Overall Study||102
274741|NCT00360243|667319|P4|COMPLETED|Overall Study||224
274742|NCT00360243|667320|P3|COMPLETED|Overall Study||180
274743|NCT00360243|667321|P2|COMPLETED|Overall Study||243
274744|NCT00360243|667322|P1|COMPLETED|Overall Study||235
274745|NCT00360243|667319|P4|STARTED|Overall Study||349
274746|NCT00360243|667320|P3|STARTED|Overall Study||336
274747|NCT00360243|667321|P2|STARTED|Overall Study||363
274748|NCT00360243|667322|P1|STARTED|Overall Study||337
274749|NCT00360230|667343|P7|NOT COMPLETED|Overall Study||2
274750|NCT00360230|667344|P6|NOT COMPLETED|Overall Study||4
274751|NCT00360230|667345|P5|NOT COMPLETED|Overall Study||5
274752|NCT00360230|667346|P4|NOT COMPLETED|Overall Study||2
274753|NCT00360230|667347|P3|NOT COMPLETED|Overall Study||3
274754|NCT00360230|667348|P2|NOT COMPLETED|Overall Study||3
274755|NCT00360230|667349|P1|NOT COMPLETED|Overall Study||6
274756|NCT00360230|667343|P7|COMPLETED|Overall Study||43
274757|NCT00360230|667344|P6|COMPLETED|Overall Study||86
274758|NCT00360230|667345|P5|COMPLETED|Overall Study||85
274759|NCT00360230|667346|P4|COMPLETED|Overall Study||88
274760|NCT00360230|667347|P3|COMPLETED|Overall Study||42
274761|NCT00360230|667348|P2|COMPLETED|Overall Study||87
274762|NCT00360230|667349|P1|COMPLETED|Overall Study||84
274763|NCT00360230|667343|P7|STARTED|Overall Study||45
274764|NCT00360230|667344|P6|STARTED|Overall Study||90
274765|NCT00360230|667345|P5|STARTED|Overall Study||90
274766|NCT00360230|667346|P4|STARTED|Overall Study||90
274767|NCT00360230|667347|P3|STARTED|Overall Study||45
274768|NCT00360230|667348|P2|STARTED|Overall Study||90
274769|NCT00360230|667349|P1|STARTED|Overall Study||90
274770|NCT00360126|667400|P1|NOT COMPLETED|Overall Study||0
274771|NCT00360126|667400|P1|COMPLETED|Overall Study||11
274772|NCT00360126|667400|P1|STARTED|Overall Study||11
274773|NCT00360009|667407|P3|NOT COMPLETED|Overall Study||3
274774|NCT00360009|667408|P2|NOT COMPLETED|Overall Study||4
274775|NCT00360009|667409|P1|NOT COMPLETED|Overall Study||0
274776|NCT00360009|667407|P3|COMPLETED|Overall Study||23
274777|NCT00360009|667408|P2|COMPLETED|Overall Study||22
274778|NCT00360009|667409|P1|COMPLETED|Overall Study||10
274779|NCT00360009|667407|P3|STARTED|Overall Study||26
274780|NCT00360009|667408|P2|STARTED|Overall Study||26
274781|NCT00360009|667409|P1|STARTED|Overall Study||10
274782|NCT00359983|667450|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
274783|NCT00359983|667451|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
274784|NCT00359983|667452|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
274785|NCT00359983|667450|P3|COMPLETED|Year 5 Persistence Follow-up||42
274786|NCT00359983|667451|P2|COMPLETED|Year 5 Persistence Follow-up||44
274787|NCT00359983|667452|P1|COMPLETED|Year 5 Persistence Follow-up||95
274788|NCT00359983|667450|P3|STARTED|Year 5 Persistence Follow-up||42
274789|NCT00359983|667451|P2|STARTED|Year 5 Persistence Follow-up||44
274790|NCT00359983|667452|P1|STARTED|Year 5 Persistence Follow-up||95
274791|NCT00359983|667450|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
274792|NCT00359983|667451|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
274793|NCT00359983|667452|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
274794|NCT00359983|667450|P3|COMPLETED|Year 3 Persistence Follow-up||51
274795|NCT00359983|667451|P2|COMPLETED|Year 3 Persistence Follow-up||47
274796|NCT00359983|667452|P1|COMPLETED|Year 3 Persistence Follow-up||103
274797|NCT00359983|667450|P3|STARTED|Year 3 Persistence Follow-up||51
274798|NCT00359983|667451|P2|STARTED|Year 3 Persistence Follow-up||47
274799|NCT00359983|667452|P1|STARTED|Year 3 Persistence Follow-up||103
274800|NCT00359983|667450|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
274801|NCT00359983|667451|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
274802|NCT00359983|667452|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
274803|NCT00359983|667450|P3|COMPLETED|Year 1 Persistence Follow-up||62
274804|NCT00359983|667451|P2|COMPLETED|Year 1 Persistence Follow-up||70
274805|NCT00359983|667452|P1|COMPLETED|Year 1 Persistence Follow-up||138
274806|NCT00359983|667450|P3|STARTED|Year 1 Persistence Follow-up||62
274807|NCT00359983|667451|P2|STARTED|Year 1 Persistence Follow-up||70
274808|NCT00359983|667452|P1|STARTED|Year 1 Persistence Follow-up||138
274809|NCT00359944|667487|P3|NOT COMPLETED|Overall Study||19
274810|NCT00359944|667488|P2|NOT COMPLETED|Overall Study||19
274811|NCT00359944|667489|P1|NOT COMPLETED|Overall Study||16
274812|NCT00359944|667487|P3|COMPLETED|Overall Study||38
274813|NCT00359944|667488|P2|COMPLETED|Overall Study||28
274814|NCT00359944|667489|P1|COMPLETED|Overall Study||34
274815|NCT00359944|667487|P3|STARTED|Overall Study||57
274816|NCT00359944|667488|P2|STARTED|Overall Study||47
274817|NCT00359944|667489|P1|STARTED|Overall Study||50
274818|NCT00359801|667505|P2|NOT COMPLETED|Overall Study||220
274819|NCT00359801|667506|P1|NOT COMPLETED|Overall Study||305
274820|NCT00359801|667505|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
274821|NCT00359801|667506|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
274822|NCT00359801|667505|P2|STARTED|Overall Study||989
274823|NCT00359801|667506|P1|STARTED|Overall Study||987
274824|NCT00359788|667540|P2|NOT COMPLETED|Overall Study||17
274825|NCT00359788|667541|P1|NOT COMPLETED|Overall Study||23
274826|NCT00359788|667540|P2|COMPLETED|Overall Study||159
274827|NCT00359788|667541|P1|COMPLETED|Overall Study||150
274828|NCT00359788|667540|P2|STARTED|Overall Study||176
274829|NCT00359788|667541|P1|STARTED|Overall Study||173
274830|NCT00359762|667775|P5|NOT COMPLETED|Period I||0
274831|NCT00359762|667776|P4|NOT COMPLETED|Period I||0
274832|NCT00359762|667777|P3|NOT COMPLETED|Period I||0
274833|NCT00359762|667778|P2|NOT COMPLETED|Period I||0
274834|NCT00359762|667779|P1|NOT COMPLETED|Period I||0
274835|NCT00359762|667775|P5|COMPLETED|Period I||0
274836|NCT00359762|667776|P4|COMPLETED|Period I||0
274837|NCT00359762|667777|P3|COMPLETED|Period I||0
274838|NCT00359762|667778|P2|COMPLETED|Period I||0
274839|NCT00359762|667779|P1|COMPLETED|Period I||0
274840|NCT00359762|667775|P5|STARTED|Period I||0
274841|NCT00359762|667776|P4|STARTED|Period I||0
274842|NCT00359762|667777|P3|STARTED|Period I||0
274843|NCT00359762|667778|P2|STARTED|Period I||0
274844|NCT00359762|667779|P1|STARTED|Period I||0
274845|NCT00359762|667775|P5|NOT COMPLETED|Period III||0
274846|NCT00359762|667776|P4|NOT COMPLETED|Period III||65
274847|NCT00359762|667777|P3|NOT COMPLETED|Period III||30
274848|NCT00359762|667778|P2|NOT COMPLETED|Period III||29
274849|NCT00359762|667779|P1|NOT COMPLETED|Period III||0
274850|NCT00359762|667775|P5|COMPLETED|Period III||0
274851|NCT00359762|667776|P4|COMPLETED|Period III||101
274852|NCT00359762|667777|P3|COMPLETED|Period III||47
274853|NCT00359762|667778|P2|COMPLETED|Period III||48
274854|NCT00359762|667779|P1|COMPLETED|Period III||0
274855|NCT00359762|667775|P5|Extension ITT Efficacy Population|Period III||0
274856|NCT00359762|667776|P4|Extension ITT Efficacy Population|Period III||164
274857|NCT00359762|667777|P3|Extension ITT Efficacy Population|Period III||75
274858|NCT00359762|667778|P2|Extension ITT Efficacy Population|Period III||73
274859|NCT00359762|667779|P1|Extension ITT Efficacy Population|Period III||0
274860|NCT00359762|667775|P5|Extension ITT Safety Population|Period III||0
274861|NCT00359762|667776|P4|Extension ITT Safety Population|Period III||166
274862|NCT00359762|667777|P3|Extension ITT Safety Population|Period III||76
274863|NCT00359762|667778|P2|Extension ITT Safety Population|Period III||74
274864|NCT00359762|667779|P1|Extension ITT Safety Population|Period III||0
274865|NCT00359762|667775|P5|STARTED|Period III||0
274866|NCT00359762|667776|P4|STARTED|Period III||166
274867|NCT00359762|667777|P3|STARTED|Period III||77
274868|NCT00359762|667778|P2|STARTED|Period III||77
274869|NCT00359762|667779|P1|STARTED|Period III||0
274870|NCT00359762|667775|P5|NOT COMPLETED|Period II||174
274871|NCT00359762|667776|P4|NOT COMPLETED|Period II||0
274872|NCT00359762|667777|P3|NOT COMPLETED|Period II||0
274873|NCT00359762|667778|P2|NOT COMPLETED|Period II||0
274874|NCT00359762|667779|P1|NOT COMPLETED|Period II||128
274875|NCT00359762|667775|P5|COMPLETED|Period II||341
274876|NCT00359762|667776|P4|COMPLETED|Period II||0
274877|NCT00359762|667777|P3|COMPLETED|Period II||0
274878|NCT00359762|667778|P2|COMPLETED|Period II||0
274879|NCT00359762|667779|P1|COMPLETED|Period II||386
274880|NCT00359762|667775|P5|Without Treatment Failure|Period II||138
274881|NCT00359762|667776|P4|Without Treatment Failure|Period II||0
274882|NCT00359762|667777|P3|Without Treatment Failure|Period II||0
274883|NCT00359762|667778|P2|Without Treatment Failure|Period II||0
274884|NCT00359762|667779|P1|Without Treatment Failure|Period II||124
274885|NCT00359762|667775|P5|Met Primary Endpoint|Period II||203
274886|NCT00359762|667776|P4|Met Primary Endpoint|Period II||0
274887|NCT00359762|667777|P3|Met Primary Endpoint|Period II||0
274888|NCT00359762|667778|P2|Met Primary Endpoint|Period II||0
274889|NCT00359762|667779|P1|Met Primary Endpoint|Period II||262
274890|NCT00359762|667775|P5|ITT Efficacy Population|Period II||490
274891|NCT00359762|667776|P4|ITT Efficacy Population|Period II||0
274892|NCT00359762|667777|P3|ITT Efficacy Population|Period II||0
274893|NCT00359762|667778|P2|ITT Efficacy Population|Period II||0
274894|NCT00359762|667779|P1|ITT Efficacy Population|Period II||487
274895|NCT00359762|667775|P5|Intent to Treat (ITT) Safety Population|Period II||511
274896|NCT00359762|667776|P4|Intent to Treat (ITT) Safety Population|Period II||0
274897|NCT00359762|667777|P3|Intent to Treat (ITT) Safety Population|Period II||0
274898|NCT00359762|667778|P2|Intent to Treat (ITT) Safety Population|Period II||0
274899|NCT00359762|667779|P1|Intent to Treat (ITT) Safety Population|Period II||508
274900|NCT00359762|667775|P5|STARTED|Period II||515
274901|NCT00359762|667776|P4|STARTED|Period II||0
274902|NCT00359762|667777|P3|STARTED|Period II||0
274903|NCT00359762|667778|P2|STARTED|Period II||0
274904|NCT00359762|667779|P1|STARTED|Period II||514
274905|NCT00359736|667842|P2|NOT COMPLETED|Overall Study||0
274906|NCT00359736|667843|P1|NOT COMPLETED|Overall Study||0
274907|NCT00359736|667842|P2|COMPLETED|Overall Study||15
274908|NCT00359736|667843|P1|COMPLETED|Overall Study||14
274909|NCT00359736|667842|P2|STARTED|Overall Study||15
274910|NCT00359736|667843|P1|STARTED|Overall Study||14
274911|NCT00359632|667853|P2|NOT COMPLETED|Overall Study||0
274912|NCT00359632|667854|P1|NOT COMPLETED|Overall Study||4
274913|NCT00359632|667853|P2|COMPLETED|Overall Study||9
274914|NCT00359632|667854|P1|COMPLETED|Overall Study||20
274915|NCT00359632|667853|P2|STARTED|Overall Study||9
274916|NCT00359632|667854|P1|STARTED|Overall Study||24
274917|NCT00359619|667868|P7|NOT COMPLETED|Overall Study||4
274918|NCT00359619|667869|P6|NOT COMPLETED|Overall Study||5
274919|NCT00359619|667870|P5|NOT COMPLETED|Overall Study||3
274920|NCT00359619|667871|P4|NOT COMPLETED|Overall Study||3
274921|NCT00359619|667872|P3|NOT COMPLETED|Overall Study||7
274922|NCT00359619|667873|P2|NOT COMPLETED|Overall Study||5
274923|NCT00359619|667874|P1|NOT COMPLETED|Overall Study||8
274924|NCT00359619|667868|P7|COMPLETED|Overall Study||46
274925|NCT00359619|667869|P6|COMPLETED|Overall Study||45
274926|NCT00359619|667870|P5|COMPLETED|Overall Study||45
274927|NCT00359619|667871|P4|COMPLETED|Overall Study||45
274928|NCT00359619|667872|P3|COMPLETED|Overall Study||42
274929|NCT00359619|667873|P2|COMPLETED|Overall Study||45
274930|NCT00359619|667874|P1|COMPLETED|Overall Study||80
274931|NCT00359619|667868|P7|STARTED|Overall Study||50
274932|NCT00359619|667869|P6|STARTED|Overall Study||50
274933|NCT00359619|667870|P5|STARTED|Overall Study||48
274934|NCT00359619|667871|P4|STARTED|Overall Study||48
274935|NCT00359619|667872|P3|STARTED|Overall Study||49
274936|NCT00359619|667873|P2|STARTED|Overall Study||50
274937|NCT00359619|667874|P1|STARTED|Overall Study||88
274938|NCT00359424|668004|P2|NOT COMPLETED|Overall Study||67
274939|NCT00359424|668005|P1|NOT COMPLETED|Overall Study||130
274940|NCT00359424|668004|P2|COMPLETED|Overall Study||155
274941|NCT00359424|668005|P1|COMPLETED|Overall Study||304
274942|NCT00359424|668004|P2|270 Day Follow up|Overall Study||159
274943|NCT00359424|668005|P1|270 Day Follow up|Overall Study||313
274944|NCT00359424|668004|P2|180 Day Follow up|Overall Study||167
274945|NCT00359424|668005|P1|180 Day Follow up|Overall Study||325
274946|NCT00359424|668004|P2|90 Day Follow up|Overall Study||172
274947|NCT00359424|668005|P1|90 Day Follow up|Overall Study||343
274948|NCT00359424|668004|P2|STARTED|Overall Study||222
274949|NCT00359424|668005|P1|STARTED|Overall Study||434
274950|NCT00359281|668044|P9|NOT COMPLETED|Overall Study||0
274951|NCT00359281|668045|P8|NOT COMPLETED|Overall Study||0
274952|NCT00359281|668046|P7|NOT COMPLETED|Overall Study||2
274953|NCT00359281|668047|P6|NOT COMPLETED|Overall Study||0
274954|NCT00359281|668048|P5|NOT COMPLETED|Overall Study||0
274955|NCT00359281|668049|P4|NOT COMPLETED|Overall Study||0
274956|NCT00359281|668050|P3|NOT COMPLETED|Overall Study||0
274957|NCT00359281|668051|P2|NOT COMPLETED|Overall Study||0
274958|NCT00359281|668052|P1|NOT COMPLETED|Overall Study||1
274959|NCT00359281|668044|P9|COMPLETED|Overall Study||20
274960|NCT00359281|668045|P8|COMPLETED|Overall Study||15
274961|NCT00359281|668046|P7|COMPLETED|Overall Study||16
274962|NCT00359281|668047|P6|COMPLETED|Overall Study||15
274963|NCT00359281|668048|P5|COMPLETED|Overall Study||10
274964|NCT00359281|668049|P4|COMPLETED|Overall Study||10
274965|NCT00359281|668050|P3|COMPLETED|Overall Study||10
274966|NCT00359281|668051|P2|COMPLETED|Overall Study||15
274967|NCT00359281|668052|P1|COMPLETED|Overall Study||15
274968|NCT00359281|668044|P9|STARTED|Overall Study||20
274969|NCT00359281|668045|P8|STARTED|Overall Study||15
274970|NCT00359281|668046|P7|STARTED|Overall Study||18
274971|NCT00359281|668047|P6|STARTED|Overall Study||15
274972|NCT00359281|668048|P5|STARTED|Overall Study||10
274973|NCT00359281|668049|P4|STARTED|Overall Study||10
274974|NCT00359281|668050|P3|STARTED|Overall Study||10
274975|NCT00359281|668051|P2|STARTED|Overall Study||15
274976|NCT00359281|668052|P1|STARTED|Overall Study||16
274977|NCT00359216|668084|P2|NOT COMPLETED|Overall Study||1
274978|NCT00359216|668085|P1|NOT COMPLETED|Overall Study||0
274979|NCT00359216|668084|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
274980|NCT00359216|668085|P1|COMPLETED|Overall Study||20
274981|NCT00359216|668084|P2|STARTED|Overall Study||10
274982|NCT00359216|668085|P1|STARTED|Overall Study||20
274983|NCT00359203|668093|P2|NOT COMPLETED|Overall Study||0
274984|NCT00359203|668094|P1|NOT COMPLETED|Overall Study||0
274985|NCT00359203|668093|P2|COMPLETED|Overall Study||38
274986|NCT00359203|668094|P1|COMPLETED|Overall Study||39
274987|NCT00359203|668093|P2|STARTED|Overall Study||38
274988|NCT00359203|668094|P1|STARTED|Overall Study||39
274989|NCT00359138|668103|P3|NOT COMPLETED|Overall Study||0
274990|NCT00359138|668104|P2|NOT COMPLETED|Overall Study||0
274991|NCT00359138|668105|P1|NOT COMPLETED|Overall Study||0
274992|NCT00359138|668103|P3|COMPLETED|Overall Study||12
274993|NCT00359138|668104|P2|COMPLETED|Overall Study||12
274994|NCT00359138|668105|P1|COMPLETED|Overall Study||12
274995|NCT00359138|668103|P3|STARTED|Overall Study||12
274996|NCT00359138|668104|P2|STARTED|Overall Study||12
274997|NCT00359138|668105|P1|STARTED|Overall Study||12
274998|NCT00359073|668115|P2|NOT COMPLETED|Overall Study||2
274999|NCT00359073|668116|P1|NOT COMPLETED|Overall Study||4
275000|NCT00359073|668115|P2|COMPLETED|Overall Study||11
275001|NCT00359073|668116|P1|COMPLETED|Overall Study||8
275002|NCT00359073|668115|P2|STARTED|Overall Study||13
275003|NCT00359073|668116|P1|STARTED|Overall Study||12
275004|NCT00359021|668128|P2|NOT COMPLETED|Overall Study||52
275005|NCT00359021|668129|P1|NOT COMPLETED|Overall Study||81
275006|NCT00359021|668128|P2|COMPLETED|Overall Study||195
275007|NCT00359021|668129|P1|COMPLETED|Overall Study||175
275008|NCT00359021|668128|P2|STARTED|Overall Study||247
275009|NCT00359021|668129|P1|STARTED|Overall Study||256
275010|NCT00358956|668141|P1|NOT COMPLETED|Overall Study||8
275011|NCT00358956|668141|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
275012|NCT00358956|668141|P1|STARTED|Overall Study||19
275013|NCT00358917|668153|P2|NOT COMPLETED|Overall Study||69
275014|NCT00358917|668154|P1|NOT COMPLETED|Overall Study||66
275015|NCT00358917|668153|P2|COMPLETED|Overall Study||230
275016|NCT00358917|668154|P1|COMPLETED|Overall Study||234
275017|NCT00358917|668153|P2|STARTED|Overall Study||299
275018|NCT00358917|668154|P1|STARTED|Overall Study||300
275019|NCT00358826|668172|P8|NOT COMPLETED|MDCT Substudy||0
275020|NCT00358826|668173|P7|NOT COMPLETED|MDCT Substudy||0
275021|NCT00358826|668174|P6|NOT COMPLETED|MDCT Substudy||2
275022|NCT00358826|668175|P5|NOT COMPLETED|MDCT Substudy||1
275023|NCT00358826|668176|P4|NOT COMPLETED|MDCT Substudy||0
275024|NCT00358826|668177|P3|NOT COMPLETED|MDCT Substudy||0
275025|NCT00358826|668178|P2|NOT COMPLETED|MDCT Substudy||0
275026|NCT00358826|668179|P1|NOT COMPLETED|MDCT Substudy||0
275027|NCT00358826|668172|P8|COMPLETED|MDCT Substudy||27
275028|NCT00358826|668173|P7|COMPLETED|MDCT Substudy||19
275029|NCT00358826|668174|P6|COMPLETED|MDCT Substudy||20
275030|NCT00358826|668175|P5|COMPLETED|MDCT Substudy||24
275031|NCT00358826|668176|P4|COMPLETED|MDCT Substudy||0
275032|NCT00358826|668177|P3|COMPLETED|MDCT Substudy||0
275033|NCT00358826|668178|P2|COMPLETED|MDCT Substudy||0
275034|NCT00358826|668179|P1|COMPLETED|MDCT Substudy||0
275035|NCT00358826|668172|P8|STARTED|MDCT Substudy||27
275036|NCT00358826|668173|P7|STARTED|MDCT Substudy||19
275037|NCT00358826|668174|P6|STARTED|MDCT Substudy||22
275038|NCT00358826|668175|P5|STARTED|MDCT Substudy||25
275039|NCT00358826|668176|P4|STARTED|MDCT Substudy||0
275040|NCT00358826|668177|P3|STARTED|MDCT Substudy||0
275041|NCT00358826|668178|P2|STARTED|MDCT Substudy||0
275042|NCT00358826|668179|P1|STARTED|MDCT Substudy||0
275043|NCT00358826|668172|P8|NOT COMPLETED|Core Study||0
275044|NCT00358826|668173|P7|NOT COMPLETED|Core Study||0
275045|NCT00358826|668174|P6|NOT COMPLETED|Core Study||0
275046|NCT00358826|668175|P5|NOT COMPLETED|Core Study||0
275047|NCT00358826|668176|P4|NOT COMPLETED|Core Study||2
275048|NCT00358826|668177|P3|NOT COMPLETED|Core Study||2
275049|NCT00358826|668178|P2|NOT COMPLETED|Core Study||5
275050|NCT00358826|668179|P1|NOT COMPLETED|Core Study||3
275051|NCT00358826|668172|P8|COMPLETED|Core Study||0
275052|NCT00358826|668173|P7|COMPLETED|Core Study||0
275053|NCT00358826|668174|P6|COMPLETED|Core Study||0
275054|NCT00358826|668175|P5|COMPLETED|Core Study||0
275055|NCT00358826|668176|P4|COMPLETED|Core Study||50
275056|NCT00358826|668177|P3|COMPLETED|Core Study||42
275057|NCT00358826|668178|P2|COMPLETED|Core Study||41
275058|NCT00358826|668179|P1|COMPLETED|Core Study||46
275059|NCT00358826|668172|P8|STARTED|Core Study||0
275060|NCT00358826|668173|P7|STARTED|Core Study||0
275061|NCT00358826|668174|P6|STARTED|Core Study||0
275062|NCT00358826|668175|P5|STARTED|Core Study||0
275063|NCT00358826|668176|P4|STARTED|Core Study||52
275064|NCT00358826|668177|P3|STARTED|Core Study||44
275065|NCT00358826|668178|P2|STARTED|Core Study||46
275066|NCT00358826|668179|P1|STARTED|Core Study||49
275067|NCT00358735|668215|P2|NOT COMPLETED|Overall Study||17
275068|NCT00358735|668216|P1|NOT COMPLETED|Overall Study||8
275069|NCT00358735|668215|P2|COMPLETED|Overall Study|Efficacy|190
275070|NCT00358735|668216|P1|COMPLETED|Overall Study|Efficacy|196
275071|NCT00358735|668215|P2|Not Completed Safety|Overall Study||13
275072|NCT00358735|668216|P1|Not Completed Safety|Overall Study||6
275073|NCT00358735|668215|P2|Completed Safety|Overall Study||194
275074|NCT00358735|668216|P1|Completed Safety|Overall Study||198
275075|NCT00358735|668215|P2|STARTED|Overall Study||207
275076|NCT00358735|668216|P1|STARTED|Overall Study||204
275077|NCT00358670|668246|P2|NOT COMPLETED|Overall Study||219
275078|NCT00358670|668247|P1|NOT COMPLETED|Overall Study||222
275079|NCT00358670|668246|P2|COMPLETED|Overall Study||0
275080|NCT00358670|668247|P1|COMPLETED|Overall Study||0
275081|NCT00358670|668246|P2|STARTED|Overall Study||219
275082|NCT00358670|668247|P1|STARTED|Overall Study||222
275083|NCT00358644|668261|P1|NOT COMPLETED|Overall Study||50
275084|NCT00358644|668261|P1|COMPLETED|Overall Study||5
275085|NCT00358644|668261|P1|STARTED|Overall Study||55
275086|NCT00358579|668267|P2|NOT COMPLETED|Overall Study||0
275087|NCT00358579|668268|P1|NOT COMPLETED|Overall Study||0
275088|NCT00358579|668267|P2|COMPLETED|Overall Study||374
275089|NCT00358579|668268|P1|COMPLETED|Overall Study||353
275090|NCT00358579|668267|P2|STARTED|Overall Study||374
275091|NCT00358579|668268|P1|STARTED|Overall Study||353
275092|NCT00358527|668284|P2|NOT COMPLETED|Overall Study||3
275093|NCT00358527|668285|P1|NOT COMPLETED|Overall Study||13
275094|NCT00358527|668284|P2|COMPLETED|Overall Study||131
275095|NCT00358527|668285|P1|COMPLETED|Overall Study||254
275096|NCT00358527|668284|P2|STARTED|Overall Study||134
275097|NCT00358527|668285|P1|STARTED|Overall Study||267
275098|NCT00358501|668295|P2|NOT COMPLETED|Overall Study||0
275099|NCT00358501|668296|P1|NOT COMPLETED|Overall Study||0
275100|NCT00358501|668295|P2|COMPLETED|Overall Study||32
275101|NCT00358501|668296|P1|COMPLETED|Overall Study||102
275102|NCT00358501|668295|P2|STARTED|Overall Study||32
275103|NCT00358501|668296|P1|STARTED|Overall Study||102
275104|NCT00358462|668311|P2|NOT COMPLETED|Overall Study||64
275105|NCT00358462|668312|P1|NOT COMPLETED|Overall Study||59
275106|NCT00358462|668311|P2|COMPLETED|Overall Study||238
275107|NCT00358462|668312|P1|COMPLETED|Overall Study||245
275108|NCT00358462|668311|P2|STARTED|Overall Study||302
275109|NCT00358462|668312|P1|STARTED|Overall Study||304
275110|NCT00358449|668323|P3|NOT COMPLETED|Overall Study||2
275111|NCT00358449|668324|P2|NOT COMPLETED|Overall Study||1
275112|NCT00358449|668325|P1|NOT COMPLETED|Overall Study||4
275113|NCT00358449|668323|P3|COMPLETED|Overall Study||18
275114|NCT00358449|668324|P2|COMPLETED|Overall Study||19
275115|NCT00358449|668325|P1|COMPLETED|Overall Study||15
275116|NCT00358449|668323|P3|STARTED|Overall Study||20
275117|NCT00358449|668324|P2|STARTED|Overall Study||20
275118|NCT00358449|668325|P1|STARTED|Overall Study||19
275119|NCT00358436|668428|P2|NOT COMPLETED|Overall Study||86
275120|NCT00358436|668429|P1|NOT COMPLETED|Overall Study||154
275121|NCT00358436|668428|P2|COMPLETED|Overall Study||118
275122|NCT00358436|668429|P1|COMPLETED|Overall Study||446
275123|NCT00358436|668428|P2|STARTED|Overall Study||204
275124|NCT00358436|668429|P1|STARTED|Overall Study||600
275125|NCT00358332|668445|P4|NOT COMPLETED|Overall Study||0
275126|NCT00358332|668446|P3|NOT COMPLETED|Overall Study||1
275127|NCT00358332|668447|P2|NOT COMPLETED|Overall Study||3
275128|NCT00358332|668448|P1|NOT COMPLETED|Overall Study||0
275129|NCT00358332|668445|P4|COMPLETED|Overall Study||25
275130|NCT00358332|668446|P3|COMPLETED|Overall Study||29
275131|NCT00358332|668447|P2|COMPLETED|Overall Study||27
275132|NCT00358332|668448|P1|COMPLETED|Overall Study||15
275133|NCT00358332|668445|P4|STARTED|Overall Study||25
275134|NCT00358332|668446|P3|STARTED|Overall Study||30
275135|NCT00358332|668447|P2|STARTED|Overall Study||30
275136|NCT00358332|668448|P1|STARTED|Overall Study||15
275137|NCT00358215|668500|P2|NOT COMPLETED|Overall Study||652
275138|NCT00358215|668501|P1|NOT COMPLETED|Overall Study||679
275139|NCT00358215|668500|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
275140|NCT00358215|668501|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
275141|NCT00358215|668500|P2|Received Investigational Product|Overall Study||1133
275142|NCT00358215|668501|P1|Received Investigational Product|Overall Study||1140
275143|NCT00358215|668500|P2|STARTED|Overall Study||1136
275144|NCT00358215|668501|P1|STARTED|Overall Study||1142
275145|NCT00358150|668515|P1|NOT COMPLETED|Overall Study||7
275146|NCT00358150|668515|P1|COMPLETED|Overall Study||19
275147|NCT00358150|668515|P1|STARTED|Overall Study||26
275148|NCT00358007|668537|P1|NOT COMPLETED|Overall Study||2
275149|NCT00358007|668537|P1|COMPLETED|Overall Study||28
275150|NCT00358007|668537|P1|STARTED|Overall Study||30
275151|NCT00357994|668544|P2|NOT COMPLETED|Overall Study||3
275152|NCT00357994|668545|P1|NOT COMPLETED|Overall Study||2
275153|NCT00357994|668544|P2|COMPLETED|Overall Study||31
275154|NCT00357994|668545|P1|COMPLETED|Overall Study||35
275155|NCT00357994|668544|P2|STARTED|Overall Study||34
275156|NCT00357994|668545|P1|STARTED|Overall Study||37
275157|NCT00357968|668599|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
275158|NCT00357968|668600|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
275159|NCT00357968|668599|P2|COMPLETED|Crossover Maintenance Dose Phase||55
275160|NCT00357968|668600|P1|COMPLETED|Crossover Maintenance Dose Phase||54
275161|NCT00357968|668599|P2|STARTED|Crossover Maintenance Dose Phase||55
275162|NCT00357968|668600|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
275163|NCT00357968|668599|P2|NOT COMPLETED|First Maintenance Dose Phase||44
275164|NCT00357968|668600|P1|NOT COMPLETED|First Maintenance Dose Phase||48
275165|NCT00357968|668599|P2|COMPLETED|First Maintenance Dose Phase||55
275166|NCT00357968|668600|P1|COMPLETED|First Maintenance Dose Phase||54
275167|NCT00357968|668599|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
275168|NCT00357968|668600|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
275169|NCT00357968|668599|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
275170|NCT00357968|668600|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
275171|NCT00357968|668599|P2|Received Loading Dose|First Maintenance Dose Phase||99
275172|NCT00357968|668600|P1|Received Loading Dose|First Maintenance Dose Phase||102
275173|NCT00357968|668599|P2|STARTED|First Maintenance Dose Phase||99
275174|NCT00357968|668600|P1|STARTED|First Maintenance Dose Phase||102
275175|NCT00357955|668644|P2|NOT COMPLETED|Overall Study||3
275176|NCT00357955|668645|P1|NOT COMPLETED|Overall Study||6
275177|NCT00357955|668644|P2|COMPLETED|Overall Study||51
275178|NCT00357955|668645|P1|COMPLETED|Overall Study||58
275179|NCT00357955|668644|P2|STARTED|Overall Study||54
275180|NCT00357955|668645|P1|STARTED|Overall Study||64
275181|NCT00357903|668653|P2|NOT COMPLETED|Overall Study||43
275182|NCT00357903|668654|P1|NOT COMPLETED|Overall Study||363
275183|NCT00357903|668653|P2|COMPLETED|Overall Study||15
275184|NCT00357903|668654|P1|COMPLETED|Overall Study||218
275185|NCT00357903|668653|P2|STARTED|Overall Study||58
275186|NCT00357903|668654|P1|STARTED|Overall Study||581
275187|NCT00357877|668694|P2|NOT COMPLETED|Overall Study||30
275188|NCT00357877|668695|P1|NOT COMPLETED|Overall Study||26
275189|NCT00357877|668694|P2|COMPLETED|Overall Study||460
275190|NCT00357877|668695|P1|COMPLETED|Overall Study||467
275191|NCT00357877|668694|P2|STARTED|Overall Study||490
275192|NCT00357877|668695|P1|STARTED|Overall Study||493
275193|NCT00357760|668709|P2|NOT COMPLETED|Overall Study||35
275194|NCT00357760|668710|P1|NOT COMPLETED|Overall Study||59
275195|NCT00357760|668709|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
275196|NCT00357760|668710|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
275197|NCT00357760|668709|P2|Patients Who Undergo Dose Escalation|Overall Study||16
275198|NCT00357760|668710|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
275199|NCT00357760|668709|P2|Eligible and Treated Patients|Overall Study||32
275200|NCT00357760|668710|P1|Eligible and Treated Patients|Overall Study||57
275201|NCT00357760|668709|P2|Patients Who Started Treatment|Overall Study||34
275202|NCT00357760|668710|P1|Patients Who Started Treatment|Overall Study||57
275203|NCT00357760|668709|P2|STARTED|Overall Study||35
275204|NCT00357760|668710|P1|STARTED|Overall Study||59
275205|NCT00357734|668720|P1|NOT COMPLETED|Overall Study||4
275206|NCT00357734|668720|P1|COMPLETED|Overall Study||10
275207|NCT00357734|668720|P1|Patient Received 500 mg of ZD1839|Overall Study||1
275208|NCT00357734|668720|P1|Patients Received 250 mg of ZD1839|Overall Study||13
275209|NCT00357734|668720|P1|STARTED|Overall Study||14
275210|NCT00357656|668731|P2|NOT COMPLETED|Overall Study||3
275211|NCT00357656|668732|P1|NOT COMPLETED|Overall Study||0
275212|NCT00357656|668731|P2|COMPLETED|Overall Study||29
275213|NCT00357656|668732|P1|COMPLETED|Overall Study||31
275214|NCT00357656|668731|P2|STARTED|Overall Study||32
275215|NCT00357656|668732|P1|STARTED|Overall Study||31
275216|NCT00357552|668783|P1|NOT COMPLETED|Weeks 24 to 104||5
275217|NCT00357552|668783|P1|COMPLETED|Weeks 24 to 104||117
275218|NCT00357552|668783|P1|STARTED|Weeks 24 to 104||122
275219|NCT00357552|668783|P1|NOT COMPLETED|Weeks 0 to 24||1
275220|NCT00357552|668783|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
275221|NCT00357552|668783|P1|STARTED|Weeks 0 to 24||123
275222|NCT00357552|668783|P1|NOT COMPLETED|Screening||84
275223|NCT00357552|668783|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
275224|NCT00357552|668783|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
275225|NCT00357500|668798|P1|NOT COMPLETED|Overall Study||77
275226|NCT00357500|668798|P1|COMPLETED|Overall Study||24
275227|NCT00357500|668798|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
275228|NCT00357500|668798|P1|STARTED|Overall Study||101
275229|NCT00357396|668807|P2|NOT COMPLETED|Overall Study||0
275230|NCT00357396|668808|P1|NOT COMPLETED|Overall Study||1
275231|NCT00357396|668807|P2|COMPLETED|Overall Study||4
275232|NCT00357396|668808|P1|COMPLETED|Overall Study||5
275233|NCT00357396|668807|P2|STARTED|Overall Study||4
275234|NCT00357396|668808|P1|STARTED|Overall Study||6
275235|NCT00357370|668816|P3|NOT COMPLETED|Cohort 2||2
275236|NCT00357370|668817|P2|NOT COMPLETED|Cohort 2||7
275237|NCT00357370|668818|P1|NOT COMPLETED|Cohort 2||2
275238|NCT00357370|668816|P3|COMPLETED|Cohort 2||22
275239|NCT00357370|668817|P2|COMPLETED|Cohort 2||16
275240|NCT00357370|668818|P1|COMPLETED|Cohort 2||22
275241|NCT00357370|668816|P3|STARTED|Cohort 2||24
275242|NCT00357370|668817|P2|STARTED|Cohort 2||23
275243|NCT00357370|668818|P1|STARTED|Cohort 2||24
275244|NCT00357370|668816|P3|NOT COMPLETED|Cohort 1||0
275245|NCT00357370|668817|P2|NOT COMPLETED|Cohort 1||0
275246|NCT00357370|668818|P1|NOT COMPLETED|Cohort 1||0
275247|NCT00357370|668816|P3|COMPLETED|Cohort 1||0
275248|NCT00357370|668817|P2|COMPLETED|Cohort 1||0
275249|NCT00357370|668818|P1|COMPLETED|Cohort 1||4
275250|NCT00357370|668816|P3|STARTED|Cohort 1||0
275251|NCT00357370|668817|P2|STARTED|Cohort 1||0
275252|NCT00357370|668818|P1|STARTED|Cohort 1||4
275253|NCT00357331|668843|P2|NOT COMPLETED|Overall Study||0
275254|NCT00357331|668844|P1|NOT COMPLETED|Overall Study||0
275255|NCT00357331|668843|P2|COMPLETED|Overall Study||41
275256|NCT00357331|668844|P1|COMPLETED|Overall Study||42
275257|NCT00357331|668843|P2|STARTED|Overall Study||41
275258|NCT00357331|668844|P1|STARTED|Overall Study||42
275259|NCT00357162|668854|P1|NOT COMPLETED|Overall Study||0
275260|NCT00357162|668854|P1|COMPLETED|Overall Study||21
275261|NCT00357162|668854|P1|STARTED|Overall Study||21
275262|NCT00357110|668864|P2|NOT COMPLETED|Overall Study||5
275263|NCT00357110|668865|P1|NOT COMPLETED|Overall Study||5
275264|NCT00357110|668864|P2|COMPLETED|Overall Study||2
275265|NCT00357110|668865|P1|COMPLETED|Overall Study||1
275266|NCT00357110|668864|P2|STARTED|Overall Study||7
275267|NCT00357110|668865|P1|STARTED|Overall Study||6
275268|NCT00357097|668873|P2|NOT COMPLETED|Overall Study||29
275269|NCT00357097|668874|P1|NOT COMPLETED|Overall Study||54
275270|NCT00357097|668873|P2|COMPLETED|Overall Study||38
275271|NCT00357097|668874|P1|COMPLETED|Overall Study||145
275272|NCT00357097|668873|P2|STARTED|Overall Study||67
275273|NCT00357097|668874|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
275274|NCT00357032|668918|P1|NOT COMPLETED|Overall Study||0
275275|NCT00357032|668918|P1|COMPLETED|Overall Study||12
275276|NCT00357032|668918|P1|STARTED|Overall Study||12
275277|NCT00357006|668928|P3|NOT COMPLETED|Overall Study||3
275278|NCT00357006|668929|P2|NOT COMPLETED|Overall Study||5
275279|NCT00357006|668930|P1|NOT COMPLETED|Overall Study||2
275280|NCT00357006|668928|P3|COMPLETED|Overall Study||59
275281|NCT00357006|668929|P2|COMPLETED|Overall Study||51
275282|NCT00357006|668930|P1|COMPLETED|Overall Study||60
275283|NCT00357006|668928|P3|STARTED|Overall Study||62
275284|NCT00357006|668929|P2|STARTED|Overall Study||56
275285|NCT00357006|668930|P1|STARTED|Overall Study||62
275286|NCT00356915|668941|P3|NOT COMPLETED|Overall Study||42
275287|NCT00356915|668942|P2|NOT COMPLETED|Overall Study||94
275288|NCT00356915|668943|P1|NOT COMPLETED|Overall Study||76
275289|NCT00356915|668941|P3|COMPLETED|Overall Study||156
275290|NCT00356915|668942|P2|COMPLETED|Overall Study||496
275291|NCT00356915|668943|P1|COMPLETED|Overall Study||517
275292|NCT00356915|668941|P3|STARTED|Overall Study||198
275293|NCT00356915|668942|P2|STARTED|Overall Study||590
275294|NCT00356915|668943|P1|STARTED|Overall Study||593
275295|NCT00356889|668960|P1|NOT COMPLETED|Overall Study||3
275296|NCT00356889|668960|P1|COMPLETED|Overall Study||53
275297|NCT00356889|668960|P1|STARTED|Overall Study||56
275298|NCT00356863|668969|P2|NOT COMPLETED|Overall Study||75
275299|NCT00356863|668970|P1|NOT COMPLETED|Overall Study||92
275300|NCT00356863|668969|P2|COMPLETED|Overall Study||445
275301|NCT00356863|668970|P1|COMPLETED|Overall Study||412
275302|NCT00356863|668969|P2|STARTED|Overall Study||520
275303|NCT00356863|668970|P1|STARTED|Overall Study||504
275304|NCT00356811|668996|P1|NOT COMPLETED|Overall Study||49
275305|NCT00356811|668996|P1|COMPLETED|Overall Study||8
275306|NCT00356811|668996|P1|STARTED|Overall Study||57
275307|NCT00356603|669011|P2|NOT COMPLETED|Overall Study||3
275308|NCT00356603|669012|P1|NOT COMPLETED|Overall Study||6
275309|NCT00356603|669011|P2|COMPLETED|Overall Study||33
275310|NCT00356603|669012|P1|COMPLETED|Overall Study||33
275311|NCT00356603|669011|P2|STARTED|Overall Study||36
275312|NCT00356603|669012|P1|STARTED|Overall Study||39
275313|NCT00356590|669026|P1|NOT COMPLETED|Overall Study||274
275314|NCT00356590|669026|P1|COMPLETED|Overall Study||194
275315|NCT00356590|669026|P1|STARTED|Overall Study||468
275316|NCT00356525|669062|P4|NOT COMPLETED|Overall Study||9
275317|NCT00356525|669063|P3|NOT COMPLETED|Overall Study||7
275318|NCT00356525|669064|P2|NOT COMPLETED|Overall Study||11
275319|NCT00356525|669065|P1|NOT COMPLETED|Overall Study||14
275320|NCT00356525|669062|P4|COMPLETED|Overall Study||0
275321|NCT00356525|669063|P3|COMPLETED|Overall Study||0
275322|NCT00356525|669064|P2|COMPLETED|Overall Study||0
275323|NCT00356525|669065|P1|COMPLETED|Overall Study||0
275324|NCT00356525|669062|P4|STARTED|Overall Study||9
275325|NCT00356525|669063|P3|STARTED|Overall Study||7
275326|NCT00356525|669064|P2|STARTED|Overall Study||11
275327|NCT00356525|669065|P1|STARTED|Overall Study||14
275328|NCT00356434|669093|P2|NOT COMPLETED|Overall Study||0
275329|NCT00356434|669094|P1|NOT COMPLETED|Overall Study||0
275330|NCT00356434|669093|P2|COMPLETED|Overall Study||7
275331|NCT00356434|669094|P1|COMPLETED|Overall Study||4
275332|NCT00356434|669093|P2|STARTED|Overall Study||7
275333|NCT00356434|669094|P1|STARTED|Overall Study||4
275334|NCT00356421|669106|P2|NOT COMPLETED|Overall Study||17
275335|NCT00356421|669107|P1|NOT COMPLETED|Overall Study||32
275336|NCT00356421|669106|P2|COMPLETED|Overall Study||3
275337|NCT00356421|669107|P1|COMPLETED|Overall Study||6
275338|NCT00356421|669106|P2|STARTED|Overall Study||20
275339|NCT00356421|669107|P1|STARTED|Overall Study||38
275340|NCT00356408|669147|P1|NOT COMPLETED|Overall Study||60
275341|NCT00356408|669147|P1|COMPLETED|Overall Study||43
275342|NCT00356408|669147|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
275343|NCT00356304|669164|P2|NOT COMPLETED|Overall Study||4
275344|NCT00356304|669165|P1|NOT COMPLETED|Overall Study||2
275345|NCT00356304|669164|P2|COMPLETED|Overall Study||20
275346|NCT00356304|669165|P1|COMPLETED|Overall Study||24
275347|NCT00356304|669164|P2|STARTED|Overall Study||24
275348|NCT00356304|669165|P1|STARTED|Overall Study||26
275349|NCT00356278|669176|P3|NOT COMPLETED|Overall Study||19
275350|NCT00356278|669177|P2|NOT COMPLETED|Overall Study||15
275351|NCT00356278|669178|P1|NOT COMPLETED|Overall Study||25
275352|NCT00356278|669176|P3|COMPLETED|Overall Study||34
275353|NCT00356278|669177|P2|COMPLETED|Overall Study||35
275354|NCT00356278|669178|P1|COMPLETED|Overall Study||28
275355|NCT00356278|669176|P3|STARTED|Overall Study||53
275356|NCT00356278|669177|P2|STARTED|Overall Study||50
275357|NCT00356278|669178|P1|STARTED|Overall Study||53
275358|NCT00356265|669216|P3|NOT COMPLETED|Overall Study||1
275359|NCT00356265|669217|P2|NOT COMPLETED|Overall Study||0
275360|NCT00356265|669218|P1|NOT COMPLETED|Overall Study||0
275361|NCT00356265|669216|P3|COMPLETED|Overall Study||5
275362|NCT00356265|669217|P2|COMPLETED|Overall Study||2
275363|NCT00356265|669218|P1|COMPLETED|Overall Study||7
275364|NCT00356265|669216|P3|STARTED|Overall Study||6
275365|NCT00356265|669217|P2|STARTED|Overall Study||2
275366|NCT00356265|669218|P1|STARTED|Overall Study||7
275367|NCT00356200|669230|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
275368|NCT00356200|669231|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
275369|NCT00356200|669230|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
275370|NCT00356200|669231|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
275371|NCT00356200|669230|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
275372|NCT00356200|669231|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
275373|NCT00356200|669230|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
275374|NCT00356200|669231|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
275375|NCT00356200|669230|P2|COMPLETED|Cohort 1: 10 ug/ml||0
275376|NCT00356200|669231|P1|COMPLETED|Cohort 1: 10 ug/ml||4
275377|NCT00356200|669230|P2|STARTED|Cohort 1: 10 ug/ml||0
275378|NCT00356200|669231|P1|STARTED|Cohort 1: 10 ug/ml||5
275379|NCT00356187|669245|P2|NOT COMPLETED|Overall Study||0
275380|NCT00356187|669246|P1|NOT COMPLETED|Overall Study||0
275381|NCT00356187|669245|P2|COMPLETED|Overall Study||0
275382|NCT00356187|669246|P1|COMPLETED|Overall Study||0
275383|NCT00356187|669245|P2|STARTED|Overall Study||0
275384|NCT00356187|669246|P1|STARTED|Overall Study||0
275385|NCT00356148|669260|P2|NOT COMPLETED|Overall Study||1
275386|NCT00356148|669261|P1|NOT COMPLETED|Overall Study||2
275387|NCT00356148|669260|P2|COMPLETED|Overall Study||182
275388|NCT00356148|669261|P1|COMPLETED|Overall Study||187
275389|NCT00356148|669260|P2|STARTED|Overall Study||183
275390|NCT00356148|669261|P1|STARTED|Overall Study||189
275391|NCT00356135|669272|P3|NOT COMPLETED|Overall Study||5
275392|NCT00356135|669273|P2|NOT COMPLETED|Overall Study||2
275393|NCT00356135|669274|P1|NOT COMPLETED|Overall Study||4
275394|NCT00356135|669272|P3|COMPLETED|Overall Study||39
275395|NCT00356135|669273|P2|COMPLETED|Overall Study||46
275396|NCT00356135|669274|P1|COMPLETED|Overall Study||43
275397|NCT00356135|669272|P3|STARTED|Overall Study||44
275398|NCT00356135|669273|P2|STARTED|Overall Study||48
275399|NCT00356135|669274|P1|STARTED|Overall Study||47
275400|NCT00356122|669296|P1|NOT COMPLETED|FOLLOW-UP||41
275401|NCT00356122|669296|P1|COMPLETED|FOLLOW-UP||12
275402|NCT00356122|669296|P1|STARTED|FOLLOW-UP||53
275403|NCT00356122|669296|P1|NOT COMPLETED|TREATMENT||45
275404|NCT00356122|669296|P1|COMPLETED|TREATMENT||8
275405|NCT00356122|669296|P1|STARTED|TREATMENT||53
275406|NCT00356057|669307|P3|NOT COMPLETED|Overall Study||12
275407|NCT00356057|669308|P2|NOT COMPLETED|Overall Study||14
275408|NCT00356057|669309|P1|NOT COMPLETED|Overall Study||13
275409|NCT00356057|669307|P3|COMPLETED|Overall Study||22
275410|NCT00356057|669308|P2|COMPLETED|Overall Study||47
275411|NCT00356057|669309|P1|COMPLETED|Overall Study||45
275412|NCT00356057|669307|P3|IMPLANTED|Overall Study||25
275413|NCT00356057|669308|P2|IMPLANTED|Overall Study||52
275414|NCT00356057|669309|P1|IMPLANTED|Overall Study||49
275415|NCT00356057|669307|P3|STARTED|Overall Study||34
275416|NCT00356057|669308|P2|STARTED|Overall Study||61
275417|NCT00356057|669309|P1|STARTED|Overall Study||58
275418|NCT00356031|669347|P1|NOT COMPLETED|Overall Study||0
275419|NCT00356031|669347|P1|COMPLETED|Overall Study||20
275420|NCT00356031|669347|P1|STARTED|Overall Study||20
275421|NCT00355914|669358|P2|NOT COMPLETED|Overall Study||0
275422|NCT00355914|669359|P1|NOT COMPLETED|Overall Study||0
275423|NCT00355914|669358|P2|COMPLETED|Overall Study||60
275424|NCT00355914|669359|P1|COMPLETED|Overall Study||60
275425|NCT00355914|669358|P2|STARTED|Overall Study||60
275426|NCT00355914|669359|P1|STARTED|Overall Study||60
275427|NCT00355797|669370|P3|NOT COMPLETED|Overall Study||142
275428|NCT00355797|669371|P2|NOT COMPLETED|Overall Study||148
275429|NCT00355797|669372|P1|NOT COMPLETED|Overall Study||240
275430|NCT00355797|669370|P3|COMPLETED|Overall Study||239
275431|NCT00355797|669371|P2|COMPLETED|Overall Study||221
275432|NCT00355797|669372|P1|COMPLETED|Overall Study||501
275433|NCT00355797|669370|P3|STARTED|Overall Study||381
275434|NCT00355797|669371|P2|STARTED|Overall Study||369
275435|NCT00355797|669372|P1|STARTED|Overall Study||741
275436|NCT00355784|669404|P3|NOT COMPLETED|Overall Study||2
275437|NCT00355784|669405|P2|NOT COMPLETED|Overall Study||0
275438|NCT00355784|669406|P1|NOT COMPLETED|Overall Study||0
275439|NCT00355784|669404|P3|COMPLETED|Overall Study||5
275440|NCT00355784|669405|P2|COMPLETED|Overall Study||8
275441|NCT00355784|669406|P1|COMPLETED|Overall Study||9
275442|NCT00355784|669404|P3|STARTED|Overall Study||7
275443|NCT00355784|669405|P2|STARTED|Overall Study||8
275444|NCT00355784|669406|P1|STARTED|Overall Study||9
275445|NCT00355706|669440|P2|NOT COMPLETED|Overall Study||0
275446|NCT00355706|669441|P1|NOT COMPLETED|Overall Study||0
275447|NCT00355706|669440|P2|COMPLETED|Overall Study||50
275448|NCT00355706|669441|P1|COMPLETED|Overall Study||50
275449|NCT00355706|669440|P2|STARTED|Overall Study||50
275450|NCT00355706|669441|P1|STARTED|Overall Study||50
275451|NCT00355615|669455|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
275452|NCT00355615|669456|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
275453|NCT00355615|669457|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
275454|NCT00355615|669458|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
275455|NCT00355615|669459|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
275456|NCT00355615|669455|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
275457|NCT00355615|669456|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
275458|NCT00355615|669457|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
275459|NCT00355615|669458|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
275460|NCT00355615|669459|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
275461|NCT00355615|669455|P5|STARTED|40-week Rosuvastatin Open Label Period||173
275462|NCT00355615|669456|P4|STARTED|40-week Rosuvastatin Open Label Period||0
275463|NCT00355615|669457|P3|STARTED|40-week Rosuvastatin Open Label Period||0
275464|NCT00355615|669458|P2|STARTED|40-week Rosuvastatin Open Label Period||0
275465|NCT00355615|669459|P1|STARTED|40-week Rosuvastatin Open Label Period||0
275466|NCT00355615|669455|P5|NOT COMPLETED|Randomized Double Blind Period||0
275467|NCT00355615|669456|P4|NOT COMPLETED|Randomized Double Blind Period||1
275468|NCT00355615|669457|P3|NOT COMPLETED|Randomized Double Blind Period||1
275469|NCT00355615|669458|P2|NOT COMPLETED|Randomized Double Blind Period||0
275470|NCT00355615|669459|P1|NOT COMPLETED|Randomized Double Blind Period||1
275471|NCT00355615|669455|P5|COMPLETED|Randomized Double Blind Period||0
275472|NCT00355615|669456|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
275473|NCT00355615|669457|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
275474|NCT00355615|669458|P2|COMPLETED|Randomized Double Blind Period||44
275475|NCT00355615|669459|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
275476|NCT00355615|669455|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
275477|NCT00355615|669456|P4|STARTED|Randomized Double Blind Period||46
275478|NCT00355615|669457|P3|STARTED|Randomized Double Blind Period||45
275479|NCT00355615|669458|P2|STARTED|Randomized Double Blind Period||44
275480|NCT00355615|669459|P1|STARTED|Randomized Double Blind Period||42
275481|NCT00355472|669518|P1|NOT COMPLETED|Overall Study||1
275482|NCT00355472|669518|P1|COMPLETED|Overall Study||15
275483|NCT00355472|669518|P1|STARTED|Overall Study||16
275484|NCT00355394|669545|P2|NOT COMPLETED|Overall Study||0
275485|NCT00355394|669546|P1|NOT COMPLETED|Overall Study||0
275486|NCT00355394|669545|P2|COMPLETED|Overall Study||16
275487|NCT00355394|669546|P1|COMPLETED|Overall Study||15
275488|NCT00355394|669545|P2|STARTED|Overall Study||16
275489|NCT00355394|669546|P1|STARTED|Overall Study||15
275490|NCT00355368|669564|P2|NOT COMPLETED|Overall Study||9
275491|NCT00355368|669565|P1|NOT COMPLETED|Overall Study||10
275492|NCT00355368|669564|P2|COMPLETED|Overall Study||201
275493|NCT00355368|669565|P1|COMPLETED|Overall Study||200
275494|NCT00355368|669564|P2|STARTED|Overall Study||210
275495|NCT00355368|669565|P1|STARTED|Overall Study||210
275496|NCT00355342|669579|P2|NOT COMPLETED|Overall Study||36
275497|NCT00355342|669580|P1|NOT COMPLETED|Overall Study||39
275498|NCT00355342|669579|P2|COMPLETED|Overall Study||56
275499|NCT00355342|669580|P1|COMPLETED|Overall Study||55
275500|NCT00355342|669579|P2|STARTED|Overall Study||92
275501|NCT00355342|669580|P1|STARTED|Overall Study||94
275502|NCT00355199|669590|P2|NOT COMPLETED|Overall Study||4
275503|NCT00355199|669591|P1|NOT COMPLETED|Overall Study||7
275504|NCT00355199|669590|P2|COMPLETED|Overall Study||122
275505|NCT00355199|669591|P1|COMPLETED|Overall Study||113
275506|NCT00355199|669590|P2|STARTED|Overall Study||126
275507|NCT00355199|669591|P1|STARTED|Overall Study||120
275508|NCT00355147|669607|P2|NOT COMPLETED|Overall Study||20
275509|NCT00355147|669608|P1|NOT COMPLETED|Overall Study||18
275510|NCT00355147|669607|P2|COMPLETED|Overall Study||67
275511|NCT00355147|669608|P1|COMPLETED|Overall Study||69
275512|NCT00355147|669607|P2|STARTED|Overall Study||87
275513|NCT00355147|669608|P1|STARTED|Overall Study||87
275514|NCT00355134|669627|P5|NOT COMPLETED|Extension Phase||19
275515|NCT00355134|669628|P4|NOT COMPLETED|Extension Phase||16
275516|NCT00355134|669629|P3|NOT COMPLETED|Extension Phase||0
275517|NCT00355134|669630|P2|NOT COMPLETED|Extension Phase||37
275518|NCT00355134|669631|P1|NOT COMPLETED|Extension Phase||31
275519|NCT00355134|669627|P5|COMPLETED|Extension Phase||88
275520|NCT00355134|669628|P4|COMPLETED|Extension Phase||89
275521|NCT00355134|669629|P3|COMPLETED|Extension Phase||0
275522|NCT00355134|669630|P2|COMPLETED|Extension Phase||180
275523|NCT00355134|669631|P1|COMPLETED|Extension Phase||172
275524|NCT00355134|669627|P5|STARTED|Extension Phase||107
275525|NCT00355134|669628|P4|STARTED|Extension Phase||105
275526|NCT00355134|669629|P3|STARTED|Extension Phase||0
275527|NCT00355134|669630|P2|STARTED|Extension Phase||217
275528|NCT00355134|669631|P1|STARTED|Extension Phase||203
275529|NCT00355134|669627|P5|NOT COMPLETED|Core Phase||0
275530|NCT00355134|669628|P4|NOT COMPLETED|Core Phase||0
275531|NCT00355134|669629|P3|NOT COMPLETED|Core Phase||100
275532|NCT00355134|669630|P2|NOT COMPLETED|Core Phase||86
275533|NCT00355134|669631|P1|NOT COMPLETED|Core Phase||119
275534|NCT00355134|669627|P5|COMPLETED|Core Phase||0
275535|NCT00355134|669628|P4|COMPLETED|Core Phase||0
275536|NCT00355134|669629|P3|COMPLETED|Core Phase||255
275537|NCT00355134|669630|P2|COMPLETED|Core Phase||272
275538|NCT00355134|669631|P1|COMPLETED|Core Phase||251
275539|NCT00355134|669627|P5|STARTED|Core Phase||0
275540|NCT00355134|669628|P4|STARTED|Core Phase||0
275541|NCT00355134|669629|P3|STARTED|Core Phase||355
275542|NCT00355134|669630|P2|STARTED|Core Phase||358
275543|NCT00355134|669631|P1|STARTED|Core Phase||370
275544|NCT00355121|669674|P3|NOT COMPLETED|Overall Study||5
275545|NCT00355121|669675|P2|NOT COMPLETED|Overall Study||29
275546|NCT00355121|669676|P1|NOT COMPLETED|Overall Study||21
275547|NCT00355121|669674|P3|COMPLETED|Overall Study||170
275548|NCT00355121|669675|P2|COMPLETED|Overall Study||324
275549|NCT00355121|669676|P1|COMPLETED|Overall Study||332
275550|NCT00355121|669674|P3|STARTED|Overall Study||175
275551|NCT00355121|669675|P2|STARTED|Overall Study||353
275552|NCT00355121|669676|P1|STARTED|Overall Study||353
275553|NCT00355082|669707|P3|NOT COMPLETED|Continuation Phase||3
275554|NCT00355082|669708|P2|NOT COMPLETED|Continuation Phase||0
275555|NCT00355082|669709|P1|NOT COMPLETED|Continuation Phase||24
275556|NCT00355082|669707|P3|COMPLETED|Continuation Phase||8
275557|NCT00355082|669708|P2|COMPLETED|Continuation Phase||0
275558|NCT00355082|669709|P1|COMPLETED|Continuation Phase||160
275559|NCT00355082|669707|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
275560|NCT00355082|669708|P2|STARTED|Continuation Phase||0
275561|NCT00355082|669709|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
275562|NCT00355082|669707|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
275563|NCT00355082|669708|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
275564|NCT00355082|669709|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
275565|NCT00355082|669707|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
275566|NCT00355082|669708|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
275567|NCT00355082|669709|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
275568|NCT00355082|669707|P3|STARTED|Double-Blind (DB) Treatment Phase||0
275569|NCT00355082|669708|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
275570|NCT00355082|669709|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
275571|NCT00355030|669731|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
275572|NCT00355030|669732|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
275573|NCT00355030|669731|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
275574|NCT00355030|669732|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
275575|NCT00355030|669731|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
275576|NCT00355030|669732|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
275577|NCT00355030|669731|P2|NOT COMPLETED|Study Period 1 Treatment||44
275578|NCT00355030|669732|P1|NOT COMPLETED|Study Period 1 Treatment||45
275579|NCT00355030|669731|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
275580|NCT00355030|669732|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
275581|NCT00355030|669731|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
275582|NCT00355030|669732|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
275583|NCT00355030|669731|P2|STARTED|Study Period 1 Treatment||45
275584|NCT00355030|669732|P1|STARTED|Study Period 1 Treatment||46
275585|NCT00354978|669754|P1|NOT COMPLETED|Overall Study||0
275586|NCT00354978|669754|P1|COMPLETED|Overall Study||43
275587|NCT00354978|669754|P1|STARTED|Overall Study||43
275588|NCT00354913|669758|P1|NOT COMPLETED|Overall Study||0
275589|NCT00354913|669758|P1|COMPLETED|Overall Study||21
275590|NCT00354913|669758|P1|STARTED|Overall Study||21
275591|NCT00354887|669765|P1|NOT COMPLETED|Overall Study||1
275592|NCT00354887|669765|P1|COMPLETED|Overall Study||29
275593|NCT00354887|669765|P1|STARTED|Overall Study||30
275594|NCT00354835|669771|P2|NOT COMPLETED|Overall Study||61
275595|NCT00354835|669772|P1|NOT COMPLETED|Overall Study||52
275596|NCT00354835|669771|P2|COMPLETED|Overall Study||181
275597|NCT00354835|669772|P1|COMPLETED|Overall Study||187
275598|NCT00354835|669771|P2|STARTED|Overall Study||242
275599|NCT00354835|669772|P1|STARTED|Overall Study||239
275600|NCT00354770|669804|P2|NOT COMPLETED|Overall Study||3
275601|NCT00354770|669805|P1|NOT COMPLETED|Overall Study||3
275602|NCT00354770|669804|P2|COMPLETED|Overall Study||22
275603|NCT00354770|669805|P1|COMPLETED|Overall Study||22
275604|NCT00354770|669804|P2|STARTED|Overall Study||25
275605|NCT00354770|669805|P1|STARTED|Overall Study||25
275606|NCT00354744|669811|P1|NOT COMPLETED|Overall Study||42
275607|NCT00354744|669811|P1|COMPLETED|Overall Study||67
275608|NCT00354744|669811|P1|STARTED|Overall Study||109
275609|NCT00354679|669816|P1|NOT COMPLETED|Overall Study||1
275610|NCT00354679|669816|P1|COMPLETED|Overall Study||33
275611|NCT00354679|669816|P1|STARTED|Overall Study||34
275612|NCT00354640|669820|P1|NOT COMPLETED|Overall Study||0
275613|NCT00354640|669820|P1|COMPLETED|Overall Study||11
275614|NCT00354640|669820|P1|STARTED|Overall Study||11
275615|NCT00354614|669825|P1|NOT COMPLETED|Overall Study||28
275616|NCT00354614|669825|P1|COMPLETED|Overall Study||53
275617|NCT00354614|669825|P1|STARTED|Overall Study||81
275618|NCT00354601|669829|P1|NOT COMPLETED|Overall Study||2
275619|NCT00354601|669829|P1|COMPLETED|Overall Study||0
275620|NCT00354601|669829|P1|STARTED|Overall Study||2
275621|NCT00354484|669838|P2|NOT COMPLETED|Overall Study||3
275622|NCT00354484|669839|P1|NOT COMPLETED|Overall Study||4
275623|NCT00354484|669838|P2|COMPLETED|Overall Study||144
275624|NCT00354484|669839|P1|COMPLETED|Overall Study||138
275625|NCT00354484|669838|P2|STARTED|Overall Study||147
275626|NCT00354484|669839|P1|STARTED|Overall Study||142
275627|NCT00354432|669849|P4|NOT COMPLETED|Overall Study||10
275628|NCT00354432|669850|P3|NOT COMPLETED|Overall Study||10
275629|NCT00354432|669851|P2|NOT COMPLETED|Overall Study||8
275630|NCT00354432|669852|P1|NOT COMPLETED|Overall Study||6
275631|NCT00354432|669849|P4|COMPLETED|Overall Study||20
275632|NCT00354432|669850|P3|COMPLETED|Overall Study||20
275633|NCT00354432|669851|P2|COMPLETED|Overall Study||22
275634|NCT00354432|669852|P1|COMPLETED|Overall Study||24
275635|NCT00354432|669849|P4|STARTED|Overall Study||30
275636|NCT00354432|669850|P3|STARTED|Overall Study||30
275637|NCT00354432|669851|P2|STARTED|Overall Study||30
275638|NCT00354432|669852|P1|STARTED|Overall Study||30
275639|NCT00354341|669868|P2|NOT COMPLETED|Overall Study||7
275640|NCT00354341|669869|P1|NOT COMPLETED|Overall Study||3
275641|NCT00354341|669868|P2|COMPLETED|Overall Study||75
275642|NCT00354341|669869|P1|COMPLETED|Overall Study||85
275643|NCT00354341|669868|P2|STARTED|Overall Study||82
275644|NCT00354341|669869|P1|STARTED|Overall Study||88
275645|NCT00354172|669885|P1|NOT COMPLETED|Overall Study||1
275646|NCT00354172|669885|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
275647|NCT00354172|669885|P1|STARTED|Overall Study||16
275648|NCT00354159|669905|P2|NOT COMPLETED|Long-term Follow-up||176
275649|NCT00354159|669906|P1|NOT COMPLETED|Long-term Follow-up||180
275650|NCT00354159|669905|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
275651|NCT00354159|669906|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
275652|NCT00354159|669905|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
275653|NCT00354159|669906|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
275654|NCT00354159|669905|P2|NOT COMPLETED|Randomized Study Period||22
275655|NCT00354159|669906|P1|NOT COMPLETED|Randomized Study Period||22
275656|NCT00354159|669905|P2|COMPLETED|Randomized Study Period||176
275657|NCT00354159|669906|P1|COMPLETED|Randomized Study Period||180
275658|NCT00354159|669905|P2|STARTED|Randomized Study Period||198
275659|NCT00354159|669906|P1|STARTED|Randomized Study Period||202
275660|NCT00354107|669949|P1|NOT COMPLETED|Overall Study||5
275661|NCT00354107|669949|P1|COMPLETED|Overall Study||0
275662|NCT00354107|669949|P1|STARTED|Overall Study||5
275663|NCT00354029|669959|P2|NOT COMPLETED|Overall Study||2
275664|NCT00354029|669960|P1|NOT COMPLETED|Overall Study||4
275665|NCT00354029|669959|P2|COMPLETED|Overall Study||38
275666|NCT00354029|669960|P1|COMPLETED|Overall Study||39
275667|NCT00354029|669959|P2|STARTED|Overall Study||40
275668|NCT00354029|669960|P1|STARTED|Overall Study||43
275669|NCT00353977|669966|P1|NOT COMPLETED|Overall Study||0
275670|NCT00353977|669966|P1|COMPLETED|Overall Study||38
275671|NCT00353977|669966|P1|STARTED|Overall Study||38
275672|NCT00353873|669972|P2|NOT COMPLETED|Overall Study||3
275673|NCT00353873|669973|P1|NOT COMPLETED|Overall Study||6
275674|NCT00353873|669972|P2|COMPLETED|Overall Study||147
275675|NCT00353873|669973|P1|COMPLETED|Overall Study||147
275676|NCT00353873|669972|P2|STARTED|Overall Study||150
275677|NCT00353873|669973|P1|STARTED|Overall Study||153
275678|NCT00353834|669987|P2|NOT COMPLETED|Overall Study||0
275679|NCT00353834|669988|P1|NOT COMPLETED|Overall Study||0
275680|NCT00353834|669987|P2|COMPLETED|Overall Study||27
275681|NCT00353834|669988|P1|COMPLETED|Overall Study||26
275682|NCT00353834|669987|P2|STARTED|Overall Study||27
275683|NCT00353834|669988|P1|STARTED|Overall Study||26
275684|NCT00353795|669996|P1|NOT COMPLETED|Overall Study||0
275685|NCT00353795|669996|P1|COMPLETED|Overall Study||179
275686|NCT00353795|669996|P1|STARTED|Overall Study||179
275687|NCT00353704|670002|P2|NOT COMPLETED|Overall Study||1
275688|NCT00353704|670003|P1|NOT COMPLETED|Overall Study||3
275689|NCT00353704|670002|P2|COMPLETED|Overall Study||24
275690|NCT00353704|670003|P1|COMPLETED|Overall Study||22
275691|NCT00353704|670002|P2|STARTED|Overall Study||25
275692|NCT00353704|670003|P1|STARTED|Overall Study||25
275693|NCT00353652|670017|P6|NOT COMPLETED|Overall Study||5
275694|NCT00353652|670018|P5|NOT COMPLETED|Overall Study||5
275695|NCT00353652|670019|P4|NOT COMPLETED|Overall Study||0
275696|NCT00353652|670020|P3|NOT COMPLETED|Overall Study||0
275697|NCT00353652|670021|P2|NOT COMPLETED|Overall Study||0
275698|NCT00353652|670022|P1|NOT COMPLETED|Overall Study||0
275699|NCT00353652|670017|P6|COMPLETED|Overall Study||18
275700|NCT00353652|670018|P5|COMPLETED|Overall Study||18
275701|NCT00353652|670019|P4|COMPLETED|Overall Study||7
275702|NCT00353652|670020|P3|COMPLETED|Overall Study||17
275703|NCT00353652|670021|P2|COMPLETED|Overall Study||17
275704|NCT00353652|670022|P1|COMPLETED|Overall Study||17
275705|NCT00353652|670017|P6|STARTED|Overall Study||23
275706|NCT00353652|670018|P5|STARTED|Overall Study||23
275707|NCT00353652|670019|P4|STARTED|Overall Study||7
275708|NCT00353652|670020|P3|STARTED|Overall Study||17
275709|NCT00353652|670021|P2|STARTED|Overall Study||17
275710|NCT00353652|670022|P1|STARTED|Overall Study||17
275711|NCT00353496|670038|P2|NOT COMPLETED|Overall Study||17
275712|NCT00353496|670039|P1|NOT COMPLETED|Overall Study||16
275713|NCT00353496|670038|P2|COMPLETED|Overall Study||86
275714|NCT00353496|670039|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
275715|NCT00353496|670038|P2|STARTED|Overall Study||103
275716|NCT00353496|670039|P1|STARTED|Overall Study||101
275717|NCT00353431|670056|P2|NOT COMPLETED|Overall Study||0
275718|NCT00353431|670057|P1|NOT COMPLETED|Overall Study||0
275719|NCT00353431|670056|P2|COMPLETED|Overall Study||67
275720|NCT00353431|670057|P1|COMPLETED|Overall Study||63
275721|NCT00353431|670056|P2|STARTED|Overall Study||67
275722|NCT00353431|670057|P1|STARTED|Overall Study||63
275723|NCT00353418|670073|P2|NOT COMPLETED|Overall Study||158
275724|NCT00353418|670074|P1|NOT COMPLETED|Overall Study||83
275725|NCT00353418|670073|P2|COMPLETED|Overall Study||119
275726|NCT00353418|670074|P1|COMPLETED|Overall Study||55
275727|NCT00353418|670073|P2|STARTED|Overall Study||277
275728|NCT00353418|670074|P1|STARTED|Overall Study||138
275729|NCT00353366|670092|P1|NOT COMPLETED|Overall Study||143
275730|NCT00353366|670092|P1|COMPLETED|Overall Study||1289
275731|NCT00353366|670092|P1|STARTED|Overall Study||1432
275732|NCT00353301|670099|P1|NOT COMPLETED|Overall Study||0
275733|NCT00353301|670099|P1|COMPLETED|Overall Study||25
275734|NCT00353301|670099|P1|STARTED|Overall Study||25
275735|NCT00353275|670106|P2|NOT COMPLETED|Overall Study||0
275736|NCT00353275|670107|P1|NOT COMPLETED|Overall Study||0
275737|NCT00353275|670106|P2|COMPLETED|Overall Study||3
275738|NCT00353275|670107|P1|COMPLETED|Overall Study||2
275739|NCT00353275|670106|P2|STARTED|Overall Study||3
275740|NCT00353275|670107|P1|STARTED|Overall Study||2
275741|NCT00353262|670113|P1|NOT COMPLETED|Overall Study||29
275742|NCT00353262|670113|P1|COMPLETED|Overall Study||7
275743|NCT00353262|670113|P1|STARTED|Overall Study||36
275744|NCT00353119|670132|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
275745|NCT00353119|670133|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
275746|NCT00353119|670132|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
275747|NCT00353119|670133|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
275748|NCT00353119|670132|P2|STARTED|Second Intervention Week 12 to Week 28||10
275749|NCT00353119|670133|P1|STARTED|Second Intervention Week 12 to Week 28||5
275750|NCT00353119|670132|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
275751|NCT00353119|670133|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
275752|NCT00353119|670132|P2|COMPLETED|First Intervention Day 0 to Week 12||10
275753|NCT00353119|670133|P1|COMPLETED|First Intervention Day 0 to Week 12||5
275754|NCT00353119|670132|P2|STARTED|First Intervention Day 0 to Week 12||10
275755|NCT00353119|670133|P1|STARTED|First Intervention Day 0 to Week 12||5
275756|NCT00352911|670145|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
275757|NCT00352911|670146|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
275758|NCT00352911|670145|P2|COMPLETED|300mg Twice Daily (14 Days)||3
275759|NCT00352911|670146|P1|COMPLETED|300mg Twice Daily (14 Days)||15
275760|NCT00352911|670145|P2|STARTED|300mg Twice Daily (14 Days)||3
275761|NCT00352911|670146|P1|STARTED|300mg Twice Daily (14 Days)||16
275762|NCT00352911|670145|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
275763|NCT00352911|670146|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
275764|NCT00352911|670145|P2|COMPLETED|150mg Twice Daily (14 Days)||3
275765|NCT00352911|670146|P1|COMPLETED|150mg Twice Daily (14 Days)||16
275766|NCT00352911|670145|P2|STARTED|150mg Twice Daily (14 Days)||3
275767|NCT00352911|670146|P1|STARTED|150mg Twice Daily (14 Days)||16
275768|NCT00352885|670154|P2|NOT COMPLETED|Overall Study||8
275769|NCT00352885|670155|P1|NOT COMPLETED|Overall Study||5
275770|NCT00352885|670154|P2|COMPLETED|Overall Study||3
275771|NCT00352885|670155|P1|COMPLETED|Overall Study||4
275772|NCT00352885|670154|P2|STARTED|Overall Study||11
275773|NCT00352885|670155|P1|STARTED|Overall Study||9
275774|NCT00352846|670163|P2|NOT COMPLETED|Overall Study||13
275775|NCT00352846|670164|P1|NOT COMPLETED|Overall Study||8
275776|NCT00352846|670163|P2|COMPLETED|Overall Study||24
275777|NCT00352846|670164|P1|COMPLETED|Overall Study||29
275778|NCT00352846|670163|P2|STARTED|Overall Study||37
275779|NCT00352846|670164|P1|STARTED|Overall Study||37
275780|NCT00352781|670170|P1|NOT COMPLETED|Overall Study||883
275781|NCT00352781|670170|P1|COMPLETED|Overall Study||884
275782|NCT00352781|670170|P1|STARTED|Overall Study||1767
275783|NCT00352755|670175|P1|NOT COMPLETED|Overall Study||2
275784|NCT00352755|670175|P1|COMPLETED|Overall Study||16
275785|NCT00352755|670175|P1|STARTED|Overall Study||18
275786|NCT00352690|670185|P2|NOT COMPLETED|Overall Study||0
275787|NCT00352690|670186|P1|NOT COMPLETED|Overall Study||2
275788|NCT00352690|670185|P2|COMPLETED|Overall Study||0
275789|NCT00352690|670186|P1|COMPLETED|Overall Study||8
275790|NCT00352690|670185|P2|STARTED|Overall Study||0
275791|NCT00352690|670186|P1|STARTED|Overall Study||10
275792|NCT00352664|670206|P2|NOT COMPLETED|Overall Study||0
275793|NCT00352664|670207|P1|NOT COMPLETED|Overall Study||7
275794|NCT00352664|670206|P2|COMPLETED|Overall Study||0
275795|NCT00352664|670207|P1|COMPLETED|Overall Study||20
275796|NCT00352664|670206|P2|STARTED|Overall Study||0
275797|NCT00352664|670207|P1|STARTED|Overall Study||27
275798|NCT00352612|670215|P2|NOT COMPLETED|Overall Study||0
275799|NCT00352612|670216|P1|NOT COMPLETED|Overall Study||0
275800|NCT00352612|670215|P2|COMPLETED|Overall Study||100
275801|NCT00352612|670216|P1|COMPLETED|Overall Study||100
275802|NCT00352612|670215|P2|STARTED|Overall Study||100
275803|NCT00352612|670216|P1|STARTED|Overall Study||100
275804|NCT00352534|670224|P7|NOT COMPLETED|Final Risk Group Assignment||39
275805|NCT00352534|670225|P6|NOT COMPLETED|Final Risk Group Assignment||45
275806|NCT00352534|670226|P5|NOT COMPLETED|Final Risk Group Assignment||1
275807|NCT00352534|670227|P4|NOT COMPLETED|Final Risk Group Assignment||3
275808|NCT00352534|670228|P3|NOT COMPLETED|Final Risk Group Assignment||3
275809|NCT00352534|670229|P2|NOT COMPLETED|Final Risk Group Assignment||0
275810|NCT00352534|670230|P1|NOT COMPLETED|Final Risk Group Assignment||0
275811|NCT00352534|670224|P7|COMPLETED|Final Risk Group Assignment||1
275812|NCT00352534|670225|P6|COMPLETED|Final Risk Group Assignment||503
275813|NCT00352534|670226|P5|COMPLETED|Final Risk Group Assignment||31
275814|NCT00352534|670227|P4|COMPLETED|Final Risk Group Assignment||49
275815|NCT00352534|670228|P3|COMPLETED|Final Risk Group Assignment||116
275816|NCT00352534|670229|P2|COMPLETED|Final Risk Group Assignment||0
275817|NCT00352534|670230|P1|COMPLETED|Final Risk Group Assignment||0
275818|NCT00352534|670224|P7|STARTED|Final Risk Group Assignment||40
275819|NCT00352534|670225|P6|STARTED|Final Risk Group Assignment||548
275820|NCT00352534|670226|P5|STARTED|Final Risk Group Assignment||32
275821|NCT00352534|670227|P4|STARTED|Final Risk Group Assignment||52
275822|NCT00352534|670228|P3|STARTED|Final Risk Group Assignment||119
275823|NCT00352534|670229|P2|STARTED|Final Risk Group Assignment||0
275824|NCT00352534|670230|P1|STARTED|Final Risk Group Assignment||0
275825|NCT00352534|670224|P7|NOT COMPLETED|Initial Staging||0
275826|NCT00352534|670225|P6|NOT COMPLETED|Initial Staging||0
275827|NCT00352534|670226|P5|NOT COMPLETED|Initial Staging||0
275828|NCT00352534|670227|P4|NOT COMPLETED|Initial Staging||0
275829|NCT00352534|670228|P3|NOT COMPLETED|Initial Staging||0
275830|NCT00352534|670229|P2|NOT COMPLETED|Initial Staging||9
275831|NCT00352534|670230|P1|NOT COMPLETED|Initial Staging||8
275832|NCT00352534|670224|P7|COMPLETED|Initial Staging||0
275833|NCT00352534|670225|P6|COMPLETED|Initial Staging||0
275834|NCT00352534|670226|P5|COMPLETED|Initial Staging||0
275835|NCT00352534|670227|P4|COMPLETED|Initial Staging||0
275836|NCT00352534|670228|P3|COMPLETED|Initial Staging||0
275837|NCT00352534|670229|P2|COMPLETED|Initial Staging||588
275838|NCT00352534|670230|P1|COMPLETED|Initial Staging||203
275839|NCT00352534|670224|P7|STARTED|Initial Staging||0
275840|NCT00352534|670225|P6|STARTED|Initial Staging||0
275841|NCT00352534|670226|P5|STARTED|Initial Staging||0
275842|NCT00352534|670227|P4|STARTED|Initial Staging||0
275843|NCT00352534|670228|P3|STARTED|Initial Staging||0
275844|NCT00352534|670229|P2|STARTED|Initial Staging||597
275845|NCT00352534|670230|P1|STARTED|Initial Staging||211
275846|NCT00352417|670247|P2|NOT COMPLETED|Overall Study||5
275847|NCT00352417|670248|P1|NOT COMPLETED|Overall Study||5
275848|NCT00352417|670247|P2|COMPLETED|Overall Study||21
275849|NCT00352417|670248|P1|COMPLETED|Overall Study||19
275850|NCT00352417|670247|P2|STARTED|Overall Study||26
275851|NCT00352417|670248|P1|STARTED|Overall Study||24
275852|NCT00352365|670262|P1|NOT COMPLETED|Maintenance Therapy||12
275853|NCT00352365|670262|P1|COMPLETED|Maintenance Therapy||0
275854|NCT00352365|670262|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
275855|NCT00352365|670262|P1|STARTED|Maintenance Therapy||12
275856|NCT00352365|670262|P1|NOT COMPLETED|Induction Therapy||27
275857|NCT00352365|670262|P1|COMPLETED|Induction Therapy||14
275858|NCT00352365|670262|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
275859|NCT00352365|670262|P1|Eligible|Induction Therapy||38
275860|NCT00352365|670262|P1|STARTED|Induction Therapy||41
275861|NCT00352118|670272|P1|NOT COMPLETED|Overall Study||4
275862|NCT00352118|670272|P1|COMPLETED|Overall Study||0
275863|NCT00352118|670272|P1|STARTED|Overall Study||4
275864|NCT00352105|670282|P1|NOT COMPLETED|Overall Study||40
275865|NCT00352105|670282|P1|COMPLETED|Overall Study||20
275866|NCT00352105|670282|P1|STARTED|Overall Study||60
275867|NCT00352053|670293|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
275868|NCT00352053|670294|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
275869|NCT00352053|670293|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
275870|NCT00352053|670294|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
275871|NCT00352053|670293|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
275872|NCT00352053|670294|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
275873|NCT00352053|670293|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
275874|NCT00352053|670294|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
275875|NCT00352053|670293|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
275876|NCT00352053|670294|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
275877|NCT00352053|670293|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
275878|NCT00352053|670294|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
275879|NCT00352053|670293|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
275880|NCT00352053|670294|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
275881|NCT00352053|670293|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
275882|NCT00352053|670294|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
275883|NCT00352053|670293|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
275884|NCT00352053|670294|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
275885|NCT00352053|670293|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
275886|NCT00352053|670294|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
275887|NCT00352053|670293|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
275888|NCT00352053|670294|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
275889|NCT00352053|670293|P2|STARTED|Double-Blind Phase (Through Week 48)||42
275890|NCT00352053|670294|P1|STARTED|Double-Blind Phase (Through Week 48)||45
275891|NCT00352027|670461|P1|NOT COMPLETED|Overall Study||3
275892|NCT00352027|670461|P1|COMPLETED|Overall Study||77
275893|NCT00352027|670461|P1|STARTED|Overall Study||80
275894|NCT00351936|670730|P1|NOT COMPLETED|Overall Study||0
275895|NCT00351936|670730|P1|COMPLETED|Overall Study||15
275896|NCT00351936|670730|P1|STARTED|Overall Study||15
275897|NCT00351819|670749|P2|NOT COMPLETED|Overall Study||12
275898|NCT00351819|670750|P1|NOT COMPLETED|Overall Study||7
275899|NCT00351819|670749|P2|COMPLETED|Overall Study||29
275900|NCT00351819|670750|P1|COMPLETED|Overall Study||36
275901|NCT00351819|670749|P2|STARTED|Overall Study||41
275902|NCT00351819|670750|P1|STARTED|Overall Study||43
275903|NCT00351741|670800|P2|NOT COMPLETED|Overall Study||0
275904|NCT00351741|670801|P1|NOT COMPLETED|Overall Study||0
275905|NCT00351741|670800|P2|COMPLETED|Overall Study||31
275906|NCT00351741|670801|P1|COMPLETED|Overall Study||31
275907|NCT00351741|670800|P2|STARTED|Overall Study||31
275908|NCT00351741|670801|P1|STARTED|Overall Study||31
275909|NCT00351533|670821|P2|NOT COMPLETED|Overall Study||5
275910|NCT00351533|670822|P1|NOT COMPLETED|Overall Study||2
275911|NCT00351533|670821|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
275912|NCT00351533|670822|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
275913|NCT00351533|670821|P2|STARTED|Overall Study||49
275914|NCT00351533|670822|P1|STARTED|Overall Study||41
275915|NCT00351468|670882|P1|NOT COMPLETED|Overall Study||167
275916|NCT00351468|670882|P1|COMPLETED|Overall Study||135
275917|NCT00351468|670882|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
275918|NCT00351468|670882|P1|Subjects From TRA108057 Repeat|Overall Study||43
275919|NCT00351468|670882|P1|Subjects From TRA102537 Raise|Overall Study||146
275920|NCT00351468|670882|P1|Subjects From TRA100773B|Overall Study||61
275921|NCT00351468|670882|P1|Subjects From TRA100773A|Overall Study||51
275922|NCT00351468|670882|P1|STARTED|Overall Study||302
275923|NCT00351416|670899|P2|NOT COMPLETED|Overall Study||0
275924|NCT00351416|670900|P1|NOT COMPLETED|Overall Study||0
275925|NCT00351416|670899|P2|COMPLETED|Overall Study||9
275926|NCT00351416|670900|P1|COMPLETED|Overall Study||6
275927|NCT00351416|670899|P2|STARTED|Overall Study||9
275928|NCT00351416|670900|P1|STARTED|Overall Study||6
275929|NCT00351377|670906|P1|NOT COMPLETED|Overall Study||7
275930|NCT00351377|670906|P1|COMPLETED|Overall Study||104
275931|NCT00351377|670906|P1|STARTED|Overall Study||111
275932|NCT00351351|670920|P2|NOT COMPLETED|Overall Study||4
275933|NCT00351351|670921|P1|NOT COMPLETED|Overall Study||9
275934|NCT00351351|670920|P2|COMPLETED|Overall Study||32
275935|NCT00351351|670921|P1|COMPLETED|Overall Study||25
275936|NCT00351351|670920|P2|STARTED|Overall Study||36
275937|NCT00351351|670921|P1|STARTED|Overall Study||34
275938|NCT00351299|670929|P2|NOT COMPLETED|Overall Study||0
275939|NCT00351299|670930|P1|NOT COMPLETED|Overall Study||0
275940|NCT00351299|670929|P2|COMPLETED|Overall Study||28
275941|NCT00351299|670930|P1|COMPLETED|Overall Study||25
275942|NCT00351299|670929|P2|STARTED|Overall Study||28
275943|NCT00351299|670930|P1|STARTED|Overall Study||25
275944|NCT00351273|670947|P3|NOT COMPLETED|Overall Study||5
275945|NCT00351273|670948|P2|NOT COMPLETED|Overall Study||2
275946|NCT00351273|670949|P1|NOT COMPLETED|Overall Study||1
275947|NCT00351273|670947|P3|COMPLETED|Overall Study||10
275948|NCT00351273|670948|P2|COMPLETED|Overall Study||10
275949|NCT00351273|670949|P1|COMPLETED|Overall Study||14
275950|NCT00351273|670947|P3|STARTED|Overall Study||15
275951|NCT00351273|670948|P2|STARTED|Overall Study||12
275952|NCT00351273|670949|P1|STARTED|Overall Study||15
275953|NCT00351039|670957|P1|NOT COMPLETED|Overall Study||0
275954|NCT00351039|670957|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
275955|NCT00351039|670957|P1|STARTED|Overall Study||8
275956|NCT00351000|670966|P1|NOT COMPLETED|Overall Study||3
275957|NCT00351000|670966|P1|COMPLETED|Overall Study||21
275958|NCT00351000|670966|P1|STARTED|Overall Study||24
275959|NCT00350870|670977|P4|NOT COMPLETED|Overall Study||15
275960|NCT00350870|670978|P3|NOT COMPLETED|Overall Study||16
275961|NCT00350870|670979|P2|NOT COMPLETED|Overall Study||17
275962|NCT00350870|670980|P1|NOT COMPLETED|Overall Study||22
275963|NCT00350870|670977|P4|COMPLETED|Overall Study||7
275964|NCT00350870|670978|P3|COMPLETED|Overall Study||6
275965|NCT00350870|670979|P2|COMPLETED|Overall Study||11
275966|NCT00350870|670980|P1|COMPLETED|Overall Study||5
275967|NCT00350870|670977|P4|Had at Least 1 Day of Med|Overall Study||19
275968|NCT00350870|670978|P3|Had at Least 1 Day of Med|Overall Study||18
275969|NCT00350870|670979|P2|Had at Least 1 Day of Med|Overall Study||24
275970|NCT00350870|670980|P1|Had at Least 1 Day of Med|Overall Study||19
275971|NCT00350870|670977|P4|STARTED|Overall Study||22
275972|NCT00350870|670978|P3|STARTED|Overall Study||22
275973|NCT00350870|670979|P2|STARTED|Overall Study||28
275974|NCT00350870|670980|P1|STARTED|Overall Study||27
275975|NCT00350844|670994|P1|NOT COMPLETED|Overall Study||1
275976|NCT00350844|670994|P1|COMPLETED|Overall Study||5
275977|NCT00350844|670994|P1|STARTED|Overall Study||6
275978|NCT00350792|670998|P1|NOT COMPLETED|Overall Study||33
275979|NCT00350792|670998|P1|COMPLETED|Overall Study||29
275980|NCT00350792|670998|P1|STARTED|Overall Study||62
275981|NCT00350779|671008|P2|NOT COMPLETED|Overall Study||21
275982|NCT00350779|671009|P1|NOT COMPLETED|Overall Study||22
275983|NCT00350779|671008|P2|COMPLETED|Overall Study||71
275984|NCT00350779|671009|P1|COMPLETED|Overall Study||148
275985|NCT00350779|671008|P2|STARTED|Overall Study||92
275986|NCT00350779|671009|P1|STARTED|Overall Study||170
275987|NCT00350727|671030|P3|NOT COMPLETED|Phase II||22
275988|NCT00350727|671031|P2|NOT COMPLETED|Phase II||19
275989|NCT00350727|671032|P1|NOT COMPLETED|Phase II||0
275990|NCT00350727|671030|P3|COMPLETED|Phase II||0
275991|NCT00350727|671031|P2|COMPLETED|Phase II||0
275992|NCT00350727|671032|P1|COMPLETED|Phase II||0
275993|NCT00350727|671030|P3|STARTED|Phase II||22
275994|NCT00350727|671031|P2|STARTED|Phase II||19
275995|NCT00350727|671032|P1|STARTED|Phase II||0
275996|NCT00350727|671030|P3|NOT COMPLETED|Phase I: Dose Escalation||0
275997|NCT00350727|671031|P2|NOT COMPLETED|Phase I: Dose Escalation||0
275998|NCT00350727|671032|P1|NOT COMPLETED|Phase I: Dose Escalation||34
275999|NCT00350727|671030|P3|COMPLETED|Phase I: Dose Escalation||0
276000|NCT00350727|671031|P2|COMPLETED|Phase I: Dose Escalation||0
276001|NCT00350727|671032|P1|COMPLETED|Phase I: Dose Escalation||0
276002|NCT00350727|671030|P3|STARTED|Phase I: Dose Escalation||0
276003|NCT00350727|671031|P2|STARTED|Phase I: Dose Escalation||0
276004|NCT00350727|671032|P1|STARTED|Phase I: Dose Escalation||34
276005|NCT00350636|671176|P2|NOT COMPLETED|Overall Study||45
276006|NCT00350636|671177|P1|NOT COMPLETED|Overall Study||43
276007|NCT00350636|671176|P2|COMPLETED|Overall Study||355
276008|NCT00350636|671177|P1|COMPLETED|Overall Study||346
276009|NCT00350636|671176|P2|STARTED|Overall Study||400
276010|NCT00350636|671177|P1|STARTED|Overall Study||389
276011|NCT00350623|671196|P3|NOT COMPLETED|Overall Study||6
276012|NCT00350623|671197|P2|NOT COMPLETED|Overall Study||4
276013|NCT00350623|671198|P1|NOT COMPLETED|Overall Study||8
276014|NCT00350623|671196|P3|COMPLETED|Overall Study||62
276015|NCT00350623|671197|P2|COMPLETED|Overall Study||67
276016|NCT00350623|671198|P1|COMPLETED|Overall Study||63
276017|NCT00350623|671196|P3|STARTED|Overall Study||68
276018|NCT00350623|671197|P2|STARTED|Overall Study||71
276019|NCT00350623|671198|P1|STARTED|Overall Study||71
276020|NCT00350545|671206|P1|NOT COMPLETED|Overall Study||2
276021|NCT00350545|671206|P1|COMPLETED|Overall Study||35
276022|NCT00350545|671206|P1|STARTED|Overall Study||37
276023|NCT00350532|671216|P2|NOT COMPLETED|Overall Study||0
276024|NCT00350532|671217|P1|NOT COMPLETED|Overall Study||0
276025|NCT00350532|671216|P2|COMPLETED|Overall Study||19
276026|NCT00350532|671217|P1|COMPLETED|Overall Study||24
276027|NCT00350532|671216|P2|STARTED|Overall Study||19
276028|NCT00350532|671217|P1|STARTED|Overall Study||24
276029|NCT00350519|671225|P2|NOT COMPLETED|Overall Study||6
276030|NCT00350519|671226|P1|NOT COMPLETED|Overall Study||4
276031|NCT00350519|671225|P2|COMPLETED|Overall Study||13
276032|NCT00350519|671226|P1|COMPLETED|Overall Study||14
276033|NCT00350519|671225|P2|STARTED|Overall Study||19
276034|NCT00350519|671226|P1|STARTED|Overall Study||18
276035|NCT00350402|671240|P2|NOT COMPLETED|Overall Study||1
276036|NCT00350402|671241|P1|NOT COMPLETED|Overall Study||1
276037|NCT00350402|671240|P2|COMPLETED|Overall Study||20
276038|NCT00350402|671241|P1|COMPLETED|Overall Study||20
276039|NCT00350402|671240|P2|STARTED|Overall Study||21
276040|NCT00350402|671241|P1|STARTED|Overall Study||21
276041|NCT00350363|671253|P1|NOT COMPLETED|Overall Study||0
276042|NCT00350363|671253|P1|COMPLETED|Overall Study||60
276043|NCT00350363|671253|P1|STARTED|Overall Study||60
276044|NCT00350272|671259|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
276045|NCT00350272|671260|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
276046|NCT00350272|671259|P2|COMPLETED|Open-Label 84 Week Treatment||27
276047|NCT00350272|671260|P1|COMPLETED|Open-Label 84 Week Treatment||21
276048|NCT00350272|671259|P2|STARTED|Open-Label 84 Week Treatment||35
276049|NCT00350272|671260|P1|STARTED|Open-Label 84 Week Treatment||30
276050|NCT00350272|671259|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
276051|NCT00350272|671260|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
276052|NCT00350272|671259|P2|COMPLETED|Blinded 12 Week Treatment||35
276053|NCT00350272|671260|P1|COMPLETED|Blinded 12 Week Treatment||30
276054|NCT00350272|671259|P2|STARTED|Blinded 12 Week Treatment||37
276055|NCT00350272|671260|P1|STARTED|Blinded 12 Week Treatment||39
276056|NCT00350220|671270|P2|NOT COMPLETED|Overall Study||0
276057|NCT00350220|671271|P1|NOT COMPLETED|Overall Study||0
276058|NCT00350220|671270|P2|COMPLETED|Overall Study||30
276059|NCT00350220|671271|P1|COMPLETED|Overall Study||30
276060|NCT00350220|671270|P2|STARTED|Overall Study||30
276061|NCT00350220|671271|P1|STARTED|Overall Study||30
276062|NCT00350207|671282|P3|NOT COMPLETED|Overall Study||7
276063|NCT00350207|671283|P2|NOT COMPLETED|Overall Study||6
276064|NCT00350207|671284|P1|NOT COMPLETED|Overall Study||8
276065|NCT00350207|671282|P3|COMPLETED|Overall Study||119
276066|NCT00350207|671283|P2|COMPLETED|Overall Study||128
276067|NCT00350207|671284|P1|COMPLETED|Overall Study||120
276068|NCT00350207|671282|P3|STARTED|Overall Study||126
276069|NCT00350207|671283|P2|STARTED|Overall Study||134
276070|NCT00350207|671284|P1|STARTED|Overall Study||128
276071|NCT00350142|671478|P1|NOT COMPLETED|Overall Study||0
276072|NCT00350142|671478|P1|COMPLETED|Overall Study||20
276073|NCT00350142|671478|P1|STARTED|Overall Study||20
276074|NCT00350025|671485|P2|NOT COMPLETED|Overall Study||2
276075|NCT00350025|671486|P1|NOT COMPLETED|Overall Study||0
276076|NCT00350025|671485|P2|COMPLETED|Overall Study||28
276077|NCT00350025|671486|P1|COMPLETED|Overall Study||11
276078|NCT00350025|671485|P2|STARTED|Overall Study||30
276079|NCT00350025|671486|P1|STARTED|Overall Study||11
276080|NCT00349921|671498|P4|NOT COMPLETED|Second Spinal Injection||0
276081|NCT00349921|671499|P3|NOT COMPLETED|Second Spinal Injection||0
276082|NCT00349921|671500|P2|NOT COMPLETED|Second Spinal Injection||0
276083|NCT00349921|671501|P1|NOT COMPLETED|Second Spinal Injection||0
276084|NCT00349921|671498|P4|COMPLETED|Second Spinal Injection||1
276085|NCT00349921|671499|P3|COMPLETED|Second Spinal Injection||0
276086|NCT00349921|671500|P2|COMPLETED|Second Spinal Injection||10
276087|NCT00349921|671501|P1|COMPLETED|Second Spinal Injection||9
276088|NCT00349921|671498|P4|STARTED|Second Spinal Injection||1
276089|NCT00349921|671499|P3|STARTED|Second Spinal Injection||0
276090|NCT00349921|671500|P2|STARTED|Second Spinal Injection||10
276091|NCT00349921|671501|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
276092|NCT00349921|671498|P4|NOT COMPLETED|First Spinal Injection||0
276093|NCT00349921|671499|P3|NOT COMPLETED|First Spinal Injection||1
276094|NCT00349921|671500|P2|NOT COMPLETED|First Spinal Injection||0
276095|NCT00349921|671501|P1|NOT COMPLETED|First Spinal Injection||1
276096|NCT00349921|671498|P4|COMPLETED|First Spinal Injection||1
276097|NCT00349921|671499|P3|COMPLETED|First Spinal Injection||0
276098|NCT00349921|671500|P2|COMPLETED|First Spinal Injection||10
276099|NCT00349921|671501|P1|COMPLETED|First Spinal Injection||9
276100|NCT00349921|671498|P4|STARTED|First Spinal Injection||1
276101|NCT00349921|671499|P3|STARTED|First Spinal Injection||1
276102|NCT00349921|671500|P2|STARTED|First Spinal Injection||10
276103|NCT00349921|671501|P1|STARTED|First Spinal Injection||10
276104|NCT00349908|671512|P2|NOT COMPLETED|Overall Study||4
276105|NCT00349908|671513|P1|NOT COMPLETED|Overall Study||0
276106|NCT00349908|671512|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
276107|NCT00349908|671513|P1|COMPLETED|Overall Study||10
276108|NCT00349908|671512|P2|STARTED|Overall Study||10
276109|NCT00349908|671513|P1|STARTED|Overall Study||10
276110|NCT00349778|671531|P1|NOT COMPLETED|Overall Study||0
276111|NCT00349778|671531|P1|COMPLETED|Overall Study||102
276112|NCT00349778|671531|P1|STARTED|Overall Study||102
276113|NCT00349752|671539|P2|NOT COMPLETED|Overall Study||64
276114|NCT00349752|671540|P1|NOT COMPLETED|Overall Study||59
276115|NCT00349752|671539|P2|COMPLETED|Overall Study||23
276116|NCT00349752|671540|P1|COMPLETED|Overall Study||28
276117|NCT00349752|671539|P2|STARTED|Overall Study||87
276118|NCT00349752|671540|P1|STARTED|Overall Study||87
276119|NCT00349713|671569|P3|NOT COMPLETED|Overall Study||0
276120|NCT00349713|671570|P2|NOT COMPLETED|Overall Study||0
276121|NCT00349713|671571|P1|NOT COMPLETED|Overall Study||0
276122|NCT00349713|671569|P3|COMPLETED|Overall Study||20
276123|NCT00349713|671570|P2|COMPLETED|Overall Study||20
276124|NCT00349713|671571|P1|COMPLETED|Overall Study||20
276125|NCT00349713|671569|P3|STARTED|Overall Study||20
276126|NCT00349713|671570|P2|STARTED|Overall Study||20
276127|NCT00349713|671571|P1|STARTED|Overall Study||20
276128|NCT00349622|671593|P2|NOT COMPLETED|Overall Study||96
276129|NCT00349622|671594|P1|NOT COMPLETED|Overall Study||178
276130|NCT00349622|671593|P2|COMPLETED|Overall Study||77
276131|NCT00349622|671594|P1|COMPLETED|Overall Study||162
276132|NCT00349622|671593|P2|STARTED|Overall Study||173
276133|NCT00349622|671594|P1|STARTED|Overall Study||340
276134|NCT00349466|671612|P2|NOT COMPLETED|Overall Study||3
276135|NCT00349466|671613|P1|NOT COMPLETED|Overall Study||9
276136|NCT00349466|671612|P2|COMPLETED|Overall Study||35
276137|NCT00349466|671613|P1|COMPLETED|Overall Study||33
276138|NCT00349466|671612|P2|STARTED|Overall Study||38
276139|NCT00349466|671613|P1|STARTED|Overall Study||42
276140|NCT00349388|671621|P2|NOT COMPLETED|Overall Study||0
276141|NCT00349388|671622|P1|NOT COMPLETED|Overall Study||0
276142|NCT00349388|671621|P2|COMPLETED|Overall Study||1
276143|NCT00349388|671622|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
276144|NCT00349388|671621|P2|STARTED|Overall Study||1
276145|NCT00349388|671622|P1|STARTED|Overall Study|no patients enrolled|0
276146|NCT00349349|671631|P3|NOT COMPLETED|Overall Study||6
276147|NCT00349349|671632|P2|NOT COMPLETED|Overall Study||62
276148|NCT00349349|671633|P1|NOT COMPLETED|Overall Study||53
276149|NCT00349349|671631|P3|COMPLETED|Overall Study||10
276150|NCT00349349|671632|P2|COMPLETED|Overall Study||50
276151|NCT00349349|671633|P1|COMPLETED|Overall Study||42
276152|NCT00349349|671631|P3|STARTED|Overall Study||16
276153|NCT00349349|671632|P2|STARTED|Overall Study||112
276154|NCT00349349|671633|P1|STARTED|Overall Study||95
276155|NCT00349336|671699|P2|NOT COMPLETED|Overall Study||14
276156|NCT00349336|671700|P1|NOT COMPLETED|Overall Study||13
276157|NCT00349336|671699|P2|COMPLETED|Overall Study||18
276158|NCT00349336|671700|P1|COMPLETED|Overall Study||19
276159|NCT00349336|671699|P2|STARTED|Overall Study||32
276160|NCT00349336|671700|P1|STARTED|Overall Study||32
276161|NCT00348933|671722|P1|NOT COMPLETED|Overall Study||25
276162|NCT00348933|671722|P1|COMPLETED|Overall Study||65
276163|NCT00348933|671722|P1|STARTED|Overall Study||90
276164|NCT00348881|671730|P2|NOT COMPLETED|Overall Study||12
276165|NCT00348881|671731|P1|NOT COMPLETED|Overall Study||17
276166|NCT00348881|671730|P2|COMPLETED|Overall Study||697
276167|NCT00348881|671731|P1|COMPLETED|Overall Study||1407
276168|NCT00348881|671730|P2|STARTED|Overall Study||709
276169|NCT00348881|671731|P1|STARTED|Overall Study||1424
276170|NCT00348816|671743|P1|NOT COMPLETED|Overall Study||1
276171|NCT00348816|671743|P1|COMPLETED|Overall Study||19
276172|NCT00348816|671743|P1|STARTED|Overall Study||20
276173|NCT00348790|671750|P1|NOT COMPLETED|Completed Treatment||25
276174|NCT00348790|671750|P1|COMPLETED|Completed Treatment||0
276175|NCT00348790|671750|P1|STARTED|Completed Treatment||25
276176|NCT00348790|671750|P1|NOT COMPLETED|Began Treatment||0
276177|NCT00348790|671750|P1|COMPLETED|Began Treatment||25
276178|NCT00348790|671750|P1|STARTED|Began Treatment||25
276179|NCT00348686|671755|P1|NOT COMPLETED|Overall Study||66
276180|NCT00348686|671755|P1|COMPLETED|Overall Study||249
276181|NCT00348686|671755|P1|STARTED|Overall Study||315
276182|NCT00348673|671772|P9|NOT COMPLETED|Stage 2||0
276183|NCT00348673|671773|P8|NOT COMPLETED|Stage 2||0
276184|NCT00348673|671774|P7|NOT COMPLETED|Stage 2||0
276185|NCT00348673|671775|P6|NOT COMPLETED|Stage 2||0
276186|NCT00348673|671776|P5|NOT COMPLETED|Stage 2||0
276187|NCT00348673|671777|P4|NOT COMPLETED|Stage 2||0
276188|NCT00348673|671778|P3|NOT COMPLETED|Stage 2||0
276189|NCT00348673|671779|P2|NOT COMPLETED|Stage 2||0
276190|NCT00348673|671780|P1|NOT COMPLETED|Stage 2||0
276191|NCT00348673|671772|P9|COMPLETED|Stage 2||2
276192|NCT00348673|671773|P8|COMPLETED|Stage 2||6
276193|NCT00348673|671774|P7|COMPLETED|Stage 2||6
276194|NCT00348673|671775|P6|COMPLETED|Stage 2||6
276195|NCT00348673|671776|P5|COMPLETED|Stage 2||0
276196|NCT00348673|671777|P4|COMPLETED|Stage 2||0
276197|NCT00348673|671778|P3|COMPLETED|Stage 2||0
276198|NCT00348673|671779|P2|COMPLETED|Stage 2||0
276199|NCT00348673|671780|P1|COMPLETED|Stage 2||0
276200|NCT00348673|671772|P9|STARTED|Stage 2||2
276201|NCT00348673|671773|P8|STARTED|Stage 2||6
276202|NCT00348673|671774|P7|STARTED|Stage 2||6
276203|NCT00348673|671775|P6|STARTED|Stage 2||6
276204|NCT00348673|671776|P5|STARTED|Stage 2||0
276205|NCT00348673|671777|P4|STARTED|Stage 2||0
276206|NCT00348673|671778|P3|STARTED|Stage 2||0
276207|NCT00348673|671779|P2|STARTED|Stage 2||0
276208|NCT00348673|671780|P1|STARTED|Stage 2||0
276209|NCT00348673|671772|P9|NOT COMPLETED|Stage 1||0
276210|NCT00348673|671773|P8|NOT COMPLETED|Stage 1||0
276211|NCT00348673|671774|P7|NOT COMPLETED|Stage 1||0
276212|NCT00348673|671775|P6|NOT COMPLETED|Stage 1||0
276213|NCT00348673|671776|P5|NOT COMPLETED|Stage 1||0
276214|NCT00348673|671777|P4|NOT COMPLETED|Stage 1||0
276215|NCT00348673|671778|P3|NOT COMPLETED|Stage 1||1
276216|NCT00348673|671779|P2|NOT COMPLETED|Stage 1||0
276217|NCT00348673|671780|P1|NOT COMPLETED|Stage 1||0
276218|NCT00348673|671772|P9|COMPLETED|Stage 1||0
276219|NCT00348673|671773|P8|COMPLETED|Stage 1||0
276220|NCT00348673|671774|P7|COMPLETED|Stage 1||0
276221|NCT00348673|671775|P6|COMPLETED|Stage 1||0
276222|NCT00348673|671776|P5|COMPLETED|Stage 1||4
276223|NCT00348673|671777|P4|COMPLETED|Stage 1||6
276224|NCT00348673|671778|P3|COMPLETED|Stage 1||6
276225|NCT00348673|671779|P2|COMPLETED|Stage 1||6
276226|NCT00348673|671780|P1|COMPLETED|Stage 1||6
276227|NCT00348673|671772|P9|Treated|Stage 1||0
276228|NCT00348673|671773|P8|Treated|Stage 1||0
276229|NCT00348673|671774|P7|Treated|Stage 1||0
276230|NCT00348673|671775|P6|Treated|Stage 1||0
276231|NCT00348673|671776|P5|Treated|Stage 1||4
276232|NCT00348673|671777|P4|Treated|Stage 1||6
276233|NCT00348673|671778|P3|Treated|Stage 1||6
276234|NCT00348673|671779|P2|Treated|Stage 1||6
276235|NCT00348673|671780|P1|Treated|Stage 1||6
276236|NCT00348673|671772|P9|STARTED|Stage 1||0
276237|NCT00348673|671773|P8|STARTED|Stage 1||0
276238|NCT00348673|671774|P7|STARTED|Stage 1||0
276239|NCT00348673|671775|P6|STARTED|Stage 1||0
276240|NCT00348673|671776|P5|STARTED|Stage 1||4
276241|NCT00348673|671777|P4|STARTED|Stage 1||6
276242|NCT00348673|671778|P3|STARTED|Stage 1||7
276243|NCT00348673|671779|P2|STARTED|Stage 1||6
276244|NCT00348673|671780|P1|STARTED|Stage 1||6
276245|NCT00348556|671827|P1|NOT COMPLETED|Overall Study||1
276246|NCT00348556|671827|P1|COMPLETED|Overall Study||3
276247|NCT00348556|671827|P1|STARTED|Overall Study||4
276248|NCT00348374|671834|P2|NOT COMPLETED|Overall Study||32
276249|NCT00348374|671835|P1|NOT COMPLETED|Overall Study||19
276250|NCT00348374|671834|P2|COMPLETED|Overall Study||71
276251|NCT00348374|671835|P1|COMPLETED|Overall Study||69
276252|NCT00348374|671834|P2|Received Study Treatment|Overall Study||96
276253|NCT00348374|671835|P1|Received Study Treatment|Overall Study||88
276254|NCT00348374|671834|P2|STARTED|Overall Study||103
276255|NCT00348374|671835|P1|STARTED|Overall Study||88
276256|NCT00348348|671882|P2|NOT COMPLETED|Overall Study||27
276257|NCT00348348|671883|P1|NOT COMPLETED|Overall Study||25
276258|NCT00348348|671882|P2|COMPLETED|Overall Study||555
276259|NCT00348348|671883|P1|COMPLETED|Overall Study||554
276260|NCT00348348|671882|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
276261|NCT00348348|671883|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
276262|NCT00348309|671898|P3|NOT COMPLETED|Overall Study||143
276263|NCT00348309|671899|P2|NOT COMPLETED|Overall Study||98
276264|NCT00348309|671900|P1|NOT COMPLETED|Overall Study||134
276265|NCT00348309|671898|P3|COMPLETED|Overall Study||346
276266|NCT00348309|671899|P2|COMPLETED|Overall Study||396
276267|NCT00348309|671900|P1|COMPLETED|Overall Study||362
276268|NCT00348309|671898|P3|STARTED|Overall Study||489
276269|NCT00348309|671899|P2|STARTED|Overall Study||494
276270|NCT00348309|671900|P1|STARTED|Overall Study||496
276271|NCT00348283|671973|P2|NOT COMPLETED|Open Label||34
276272|NCT00348283|671974|P1|NOT COMPLETED|Open Label||0
276273|NCT00348283|671973|P2|COMPLETED|Open Label||66
276274|NCT00348283|671974|P1|COMPLETED|Open Label||0
276275|NCT00348283|671973|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
276276|NCT00348283|671974|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
276277|NCT00348283|671973|P2|NOT COMPLETED|Double Blind||10
276278|NCT00348283|671974|P1|NOT COMPLETED|Double Blind||5
276279|NCT00348283|671973|P2|COMPLETED|Double Blind||54
276280|NCT00348283|671974|P1|COMPLETED|Double Blind||60
276281|NCT00348283|671973|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
276282|NCT00348283|671974|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
276283|NCT00348283|671973|P2|NOT COMPLETED|Induction||6
276284|NCT00348283|671974|P1|NOT COMPLETED|Induction||0
276285|NCT00348283|671973|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
276286|NCT00348283|671974|P1|COMPLETED|Induction||0
276287|NCT00348283|671973|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
276288|NCT00348283|671974|P1|STARTED|Induction||0
276289|NCT00348140|671993|P3|NOT COMPLETED|Overall Study||163
276290|NCT00348140|671994|P2|NOT COMPLETED|Overall Study||139
276291|NCT00348140|671995|P1|NOT COMPLETED|Overall Study||126
276292|NCT00348140|671993|P3|COMPLETED|Overall Study||328
276293|NCT00348140|671994|P2|COMPLETED|Overall Study||351
276294|NCT00348140|671995|P1|COMPLETED|Overall Study||361
276295|NCT00348140|671993|P3|STARTED|Overall Study||491
276296|NCT00348140|671994|P2|STARTED|Overall Study||490
276297|NCT00348140|671995|P1|STARTED|Overall Study||487
276298|NCT00347958|672093|P1|NOT COMPLETED|Overall Study||4
276299|NCT00347958|672093|P1|COMPLETED|Overall Study||540
276300|NCT00347958|672093|P1|STARTED|Overall Study||544
276301|NCT00347932|672102|P2|NOT COMPLETED|Overall Study||52
276302|NCT00347932|672103|P1|NOT COMPLETED|Overall Study||31
276303|NCT00347932|672102|P2|COMPLETED|Overall Study||430
276304|NCT00347932|672103|P1|COMPLETED|Overall Study||444
276305|NCT00347932|672102|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
276306|NCT00347932|672103|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
276307|NCT00347919|672118|P3|NOT COMPLETED|Overall Study||38
276308|NCT00347919|672119|P2|NOT COMPLETED|Overall Study||76
276309|NCT00347919|672120|P1|NOT COMPLETED|Overall Study||71
276310|NCT00347919|672118|P3|COMPLETED|Overall Study||2
276311|NCT00347919|672119|P2|COMPLETED|Overall Study||0
276312|NCT00347919|672120|P1|COMPLETED|Overall Study||2
276313|NCT00347919|672118|P3|STARTED|Overall Study|Safety Population|40
276314|NCT00347919|672119|P2|STARTED|Overall Study|Safety Population|76
276315|NCT00347919|672120|P1|STARTED|Overall Study|Safety Population|73
276316|NCT00347776|672143|P3|NOT COMPLETED|12 Month Follow-up||19
276317|NCT00347776|672144|P2|NOT COMPLETED|12 Month Follow-up||16
276318|NCT00347776|672145|P1|NOT COMPLETED|12 Month Follow-up||23
276319|NCT00347776|672143|P3|COMPLETED|12 Month Follow-up||436
276320|NCT00347776|672144|P2|COMPLETED|12 Month Follow-up||446
276321|NCT00347776|672145|P1|COMPLETED|12 Month Follow-up||425
276322|NCT00347776|672143|P3|STARTED|12 Month Follow-up||455
276323|NCT00347776|672144|P2|STARTED|12 Month Follow-up||462
276324|NCT00347776|672145|P1|STARTED|12 Month Follow-up||448
276325|NCT00347776|672143|P3|NOT COMPLETED|6 Month Follow-up||18
276326|NCT00347776|672144|P2|NOT COMPLETED|6 Month Follow-up||13
276327|NCT00347776|672145|P1|NOT COMPLETED|6 Month Follow-up||22
276328|NCT00347776|672143|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
276329|NCT00347776|672144|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
276330|NCT00347776|672145|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
276331|NCT00347776|672143|P3|STARTED|6 Month Follow-up||473
276332|NCT00347776|672144|P2|STARTED|6 Month Follow-up||475
276333|NCT00347776|672145|P1|STARTED|6 Month Follow-up||470
276334|NCT00347776|672143|P3|NOT COMPLETED|1.5 Month Follow-up||12
276335|NCT00347776|672144|P2|NOT COMPLETED|1.5 Month Follow-up||8
276336|NCT00347776|672145|P1|NOT COMPLETED|1.5 Month Follow-up||14
276337|NCT00347776|672143|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
276338|NCT00347776|672144|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
276339|NCT00347776|672145|P1|COMPLETED|1.5 Month Follow-up||470
276340|NCT00347776|672143|P3|STARTED|1.5 Month Follow-up||485
276341|NCT00347776|672144|P2|STARTED|1.5 Month Follow-up||483
276342|NCT00347776|672145|P1|STARTED|1.5 Month Follow-up||484
276343|NCT00347438|672157|P1|NOT COMPLETED|Overall Study||2
276344|NCT00347438|672157|P1|COMPLETED|Overall Study||16
276345|NCT00347438|672157|P1|STARTED|Overall Study||18
276346|NCT00347360|672179|P15|NOT COMPLETED|Overall Study||4
276347|NCT00347360|672180|P14|NOT COMPLETED|Overall Study||8
276348|NCT00347360|672181|P13|NOT COMPLETED|Overall Study||10
276349|NCT00347360|672182|P12|NOT COMPLETED|Overall Study||6
276350|NCT00347360|672183|P11|NOT COMPLETED|Overall Study||5
276351|NCT00347360|672184|P10|NOT COMPLETED|Overall Study||9
276352|NCT00347360|672185|P9|NOT COMPLETED|Overall Study||6
276353|NCT00347360|672186|P8|NOT COMPLETED|Overall Study||3
276354|NCT00347360|672187|P7|NOT COMPLETED|Overall Study||7
276355|NCT00347360|672188|P6|NOT COMPLETED|Overall Study||8
276356|NCT00347360|672189|P5|NOT COMPLETED|Overall Study||5
276357|NCT00347360|672190|P4|NOT COMPLETED|Overall Study||13
276358|NCT00347360|672191|P3|NOT COMPLETED|Overall Study||6
276359|NCT00347360|672192|P2|NOT COMPLETED|Overall Study||8
276360|NCT00347360|672193|P1|NOT COMPLETED|Overall Study||5
276361|NCT00347360|672179|P15|COMPLETED|Overall Study||39
276362|NCT00347360|672180|P14|COMPLETED|Overall Study||36
276363|NCT00347360|672181|P13|COMPLETED|Overall Study||34
276364|NCT00347360|672182|P12|COMPLETED|Overall Study||37
276365|NCT00347360|672183|P11|COMPLETED|Overall Study||39
276366|NCT00347360|672184|P10|COMPLETED|Overall Study||35
276367|NCT00347360|672185|P9|COMPLETED|Overall Study||38
276368|NCT00347360|672186|P8|COMPLETED|Overall Study||40
276369|NCT00347360|672187|P7|COMPLETED|Overall Study||37
276370|NCT00347360|672188|P6|COMPLETED|Overall Study||36
276371|NCT00347360|672189|P5|COMPLETED|Overall Study||39
276372|NCT00347360|672190|P4|COMPLETED|Overall Study||30
276373|NCT00347360|672191|P3|COMPLETED|Overall Study||37
276374|NCT00347360|672192|P2|COMPLETED|Overall Study||35
276375|NCT00347360|672193|P1|COMPLETED|Overall Study||39
276376|NCT00347360|672179|P15|STARTED|Overall Study||43
276377|NCT00347360|672180|P14|STARTED|Overall Study||44
276378|NCT00347360|672181|P13|STARTED|Overall Study||44
276379|NCT00347360|672182|P12|STARTED|Overall Study||43
276380|NCT00347360|672183|P11|STARTED|Overall Study||44
276381|NCT00347360|672184|P10|STARTED|Overall Study||44
276382|NCT00347360|672185|P9|STARTED|Overall Study||44
276383|NCT00347360|672186|P8|STARTED|Overall Study||43
276384|NCT00347360|672187|P7|STARTED|Overall Study||44
276385|NCT00347360|672188|P6|STARTED|Overall Study||44
276386|NCT00347360|672189|P5|STARTED|Overall Study||44
276387|NCT00347360|672190|P4|STARTED|Overall Study||43
276388|NCT00347360|672191|P3|STARTED|Overall Study||43
276389|NCT00347360|672192|P2|STARTED|Overall Study||43
276390|NCT00347360|672193|P1|STARTED|Overall Study||44
276391|NCT00347308|672375|P1|NOT COMPLETED|Overall Study||0
276392|NCT00347308|672375|P1|COMPLETED|Overall Study||40
276393|NCT00347308|672375|P1|STARTED|Overall Study||40
276394|NCT00347269|672381|P2|NOT COMPLETED|Overall Study||106
276395|NCT00347269|672382|P1|NOT COMPLETED|Overall Study||94
276396|NCT00347269|672381|P2|COMPLETED|Overall Study||395
276397|NCT00347269|672382|P1|COMPLETED|Overall Study||409
276398|NCT00347269|672381|P2|STARTED|Overall Study||501
276399|NCT00347269|672382|P1|STARTED|Overall Study||503
276400|NCT00347022|672390|P2|NOT COMPLETED|Overall Study||5
276401|NCT00347022|672391|P1|NOT COMPLETED|Overall Study||12
276402|NCT00347022|672390|P2|COMPLETED|Overall Study||66
276403|NCT00347022|672391|P1|COMPLETED|Overall Study||62
276404|NCT00347022|672390|P2|STARTED|Overall Study||71
276405|NCT00347022|672391|P1|STARTED|Overall Study||74
276406|NCT00347009|672397|P1|NOT COMPLETED|Overall Study||27
276407|NCT00347009|672397|P1|COMPLETED|Overall Study||128
276408|NCT00347009|672397|P1|STARTED|Overall Study||155
276409|NCT00346905|672414|P1|NOT COMPLETED|Overall Study||4
276410|NCT00346905|672414|P1|COMPLETED|Overall Study||12
276411|NCT00346905|672414|P1|STARTED|Overall Study||16
276412|NCT00346775|672418|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
276413|NCT00346775|672419|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
276414|NCT00346775|672418|P2|COMPLETED|Period 3: Intervention Period 2||45
276415|NCT00346775|672419|P1|COMPLETED|Period 3: Intervention Period 2||44
276416|NCT00346775|672418|P2|STARTED|Period 3: Intervention Period 2||45
276417|NCT00346775|672419|P1|STARTED|Period 3: Intervention Period 2||44
276418|NCT00346775|672418|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
276419|NCT00346775|672419|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
276420|NCT00346775|672418|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
276421|NCT00346775|672419|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
276422|NCT00346775|672418|P2|STARTED|Period 2: Washout Period (7 Days)||45
276423|NCT00346775|672419|P1|STARTED|Period 2: Washout Period (7 Days)||44
276424|NCT00346775|672418|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
276425|NCT00346775|672419|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
276426|NCT00346775|672418|P2|COMPLETED|Period 1: Intervention Period 1||45
276427|NCT00346775|672419|P1|COMPLETED|Period 1: Intervention Period 1||44
276428|NCT00346775|672418|P2|STARTED|Period 1: Intervention Period 1||48
276429|NCT00346775|672419|P1|STARTED|Period 1: Intervention Period 1||49
276430|NCT00346697|672431|P2|NOT COMPLETED|Overall Study||1
276431|NCT00346697|672432|P1|NOT COMPLETED|Overall Study||0
276432|NCT00346697|672431|P2|COMPLETED|Overall Study||23
276433|NCT00346697|672432|P1|COMPLETED|Overall Study||24
276434|NCT00346697|672431|P2|STARTED|Overall Study||24
276435|NCT00346697|672432|P1|STARTED|Overall Study||24
276436|NCT00346632|672468|P10|NOT COMPLETED|Overall Study||3
276437|NCT00346632|672469|P9|NOT COMPLETED|Overall Study||4
276438|NCT00346632|672470|P8|NOT COMPLETED|Overall Study||4
276439|NCT00346632|672471|P7|NOT COMPLETED|Overall Study||5
276440|NCT00346632|672472|P6|NOT COMPLETED|Overall Study||2
276441|NCT00346632|672473|P5|NOT COMPLETED|Overall Study||4
276442|NCT00346632|672474|P4|NOT COMPLETED|Overall Study||3
276443|NCT00346632|672475|P3|NOT COMPLETED|Overall Study||6
276444|NCT00346632|672476|P2|NOT COMPLETED|Overall Study||3
276445|NCT00346632|672477|P1|NOT COMPLETED|Overall Study||3
276446|NCT00346632|672468|P10|COMPLETED|Overall Study||0
276447|NCT00346632|672469|P9|COMPLETED|Overall Study||0
276448|NCT00346632|672470|P8|COMPLETED|Overall Study||0
276449|NCT00346632|672471|P7|COMPLETED|Overall Study||0
276450|NCT00346632|672472|P6|COMPLETED|Overall Study||0
276451|NCT00346632|672473|P5|COMPLETED|Overall Study||0
276452|NCT00346632|672474|P4|COMPLETED|Overall Study||0
276453|NCT00346632|672475|P3|COMPLETED|Overall Study||0
276454|NCT00346632|672476|P2|COMPLETED|Overall Study||0
276455|NCT00346632|672477|P1|COMPLETED|Overall Study||0
276456|NCT00346632|672468|P10|STARTED|Overall Study||3
276457|NCT00346632|672469|P9|STARTED|Overall Study||4
276458|NCT00346632|672470|P8|STARTED|Overall Study||4
276459|NCT00346632|672471|P7|STARTED|Overall Study||5
276460|NCT00346632|672472|P6|STARTED|Overall Study||2
276461|NCT00346632|672473|P5|STARTED|Overall Study||4
276462|NCT00346632|672474|P4|STARTED|Overall Study||3
276463|NCT00346632|672475|P3|STARTED|Overall Study||6
276464|NCT00346632|672476|P2|STARTED|Overall Study||3
276465|NCT00346632|672477|P1|STARTED|Overall Study||3
276466|NCT00346476|672620|P1|NOT COMPLETED|Overall Study||0
276467|NCT00346476|672620|P1|COMPLETED|Overall Study||1250
276468|NCT00346476|672620|P1|STARTED|Overall Study||1250
276469|NCT00346398|672627|P2|NOT COMPLETED|Overall Study||2
276470|NCT00346398|672628|P1|NOT COMPLETED|Overall Study||3
276471|NCT00346398|672627|P2|COMPLETED|Overall Study||24
276472|NCT00346398|672628|P1|COMPLETED|Overall Study||22
276473|NCT00346398|672627|P2|STARTED|Overall Study||26
276474|NCT00346398|672628|P1|STARTED|Overall Study||25
276475|NCT00346333|672640|P2|NOT COMPLETED|Overall Study||8
276476|NCT00346333|672641|P1|NOT COMPLETED|Overall Study||5
276477|NCT00346333|672640|P2|COMPLETED|Overall Study||111
276478|NCT00346333|672641|P1|COMPLETED|Overall Study||116
276479|NCT00346333|672640|P2|STARTED|Overall Study||119
276480|NCT00346333|672641|P1|STARTED|Overall Study||121
276481|NCT00346268|672657|P2|NOT COMPLETED|Overall Study||3
276482|NCT00346268|672658|P1|NOT COMPLETED|Overall Study||2
276483|NCT00346268|672657|P2|COMPLETED|Overall Study||50
276484|NCT00346268|672658|P1|COMPLETED|Overall Study||50
276485|NCT00346268|672657|P2|STARTED|Overall Study||53
276486|NCT00346268|672658|P1|STARTED|Overall Study||52
276487|NCT00346216|672693|P3|NOT COMPLETED|Overall Study||2348
276488|NCT00346216|672694|P2|NOT COMPLETED|Overall Study||2460
276489|NCT00346216|672695|P1|NOT COMPLETED|Overall Study||2408
276490|NCT00346216|672693|P3|COMPLETED|Overall Study||5621
276491|NCT00346216|672694|P2|COMPLETED|Overall Study||5580
276492|NCT00346216|672695|P1|COMPLETED|Overall Study||5664
276493|NCT00346216|672693|P3|STARTED|Overall Study||7969
276494|NCT00346216|672694|P2|STARTED|Overall Study||8040
276495|NCT00346216|672695|P1|STARTED|Overall Study||8072
276496|NCT00346164|672716|P4|NOT COMPLETED|Overall Study||106
276497|NCT00346164|672717|P3|NOT COMPLETED|Overall Study||26
276498|NCT00346164|672718|P2|NOT COMPLETED|Overall Study||7
276499|NCT00346164|672719|P1|NOT COMPLETED|Overall Study||17
276500|NCT00346164|672716|P4|COMPLETED|Overall Study||117
276501|NCT00346164|672717|P3|COMPLETED|Overall Study||96
276502|NCT00346164|672718|P2|COMPLETED|Overall Study||14
276503|NCT00346164|672719|P1|COMPLETED|Overall Study||205
276504|NCT00346164|672716|P4|STARTED|Overall Study||223
276505|NCT00346164|672717|P3|STARTED|Overall Study||122
276506|NCT00346164|672718|P2|STARTED|Overall Study||21
276507|NCT00346164|672719|P1|STARTED|Overall Study||222
276508|NCT00346151|672754|P1|NOT COMPLETED|Overall Study||3
276509|NCT00346151|672754|P1|COMPLETED|Overall Study||2
276510|NCT00346151|672754|P1|STARTED|Overall Study||5
276511|NCT00346034|672772|P1|NOT COMPLETED|Overall Study||57
276512|NCT00346034|672772|P1|COMPLETED|Overall Study||300
276513|NCT00346034|672772|P1|STARTED|Overall Study||357
276514|NCT00345969|672779|P2|NOT COMPLETED|Overall Study||2
276515|NCT00345969|672780|P1|NOT COMPLETED|Overall Study||1
276516|NCT00345969|672779|P2|COMPLETED|Overall Study||11
276517|NCT00345969|672780|P1|COMPLETED|Overall Study||11
276518|NCT00345969|672779|P2|STARTED|Overall Study||13
276519|NCT00345969|672780|P1|STARTED|Overall Study||12
276520|NCT00345878|672812|P2|NOT COMPLETED|Overall Study||1
276521|NCT00345878|672813|P1|NOT COMPLETED|Overall Study||4
276522|NCT00345878|672812|P2|COMPLETED|Overall Study||135
276523|NCT00345878|672813|P1|COMPLETED|Overall Study||131
276524|NCT00345878|672812|P2|STARTED|Overall Study||136
276525|NCT00345878|672813|P1|STARTED|Overall Study||135
276526|NCT00345839|672831|P2|NOT COMPLETED|Overall Study||159
276527|NCT00345839|672832|P1|NOT COMPLETED|Overall Study||149
276528|NCT00345839|672831|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
276529|NCT00345839|672832|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
276530|NCT00345839|672831|P2|STARTED|Overall Study|Randomized to placebo|1935
276531|NCT00345839|672832|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
276532|NCT00345683|672858|P2|NOT COMPLETED|Overall Study||9
276533|NCT00345683|672859|P1|NOT COMPLETED|Overall Study||25
276534|NCT00345683|672858|P2|COMPLETED|Overall Study||1001
276535|NCT00345683|672859|P1|COMPLETED|Overall Study||2985
276536|NCT00345683|672858|P2|STARTED|Overall Study||1010
276537|NCT00345683|672859|P1|STARTED|Overall Study||3010
276538|NCT00345631|672882|P3|NOT COMPLETED|Overall Study||6
276539|NCT00345631|672883|P2|NOT COMPLETED|Overall Study||8
276540|NCT00345631|672884|P1|NOT COMPLETED|Overall Study||4
276541|NCT00345631|672882|P3|COMPLETED|Overall Study||128
276542|NCT00345631|672883|P2|COMPLETED|Overall Study||259
276543|NCT00345631|672884|P1|COMPLETED|Overall Study||83
276544|NCT00345631|672882|P3|STARTED|Overall Study||134
276545|NCT00345631|672883|P2|STARTED|Overall Study||267
276546|NCT00345631|672884|P1|STARTED|Overall Study||87
276547|NCT00345605|672916|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
276548|NCT00345605|672917|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
276549|NCT00345605|672916|P2|COMPLETED|Arm 2, Opposite Treatment||6
276550|NCT00345605|672917|P1|COMPLETED|Arm 2, Opposite Treatment||5
276551|NCT00345605|672916|P2|STARTED|Arm 2, Opposite Treatment||6
276552|NCT00345605|672917|P1|STARTED|Arm 2, Opposite Treatment||6
276553|NCT00345605|672916|P2|NOT COMPLETED|Crossover Wash-out||0
276554|NCT00345605|672917|P1|NOT COMPLETED|Crossover Wash-out||0
276555|NCT00345605|672916|P2|COMPLETED|Crossover Wash-out||6
276556|NCT00345605|672917|P1|COMPLETED|Crossover Wash-out||6
276557|NCT00345605|672916|P2|STARTED|Crossover Wash-out||6
276558|NCT00345605|672917|P1|STARTED|Crossover Wash-out||6
276559|NCT00345605|672916|P2|NOT COMPLETED|Interval||0
276560|NCT00345605|672917|P1|NOT COMPLETED|Interval||0
276561|NCT00345605|672916|P2|COMPLETED|Interval||6
276562|NCT00345605|672917|P1|COMPLETED|Interval||6
276563|NCT00345605|672916|P2|STARTED|Interval||6
276564|NCT00345605|672917|P1|STARTED|Interval||6
276565|NCT00345605|672916|P2|NOT COMPLETED|Arm 1||1
276566|NCT00345605|672917|P1|NOT COMPLETED|Arm 1||0
276567|NCT00345605|672916|P2|COMPLETED|Arm 1||5
276568|NCT00345605|672917|P1|COMPLETED|Arm 1||6
276569|NCT00345605|672916|P2|STARTED|Arm 1||6
276570|NCT00345605|672917|P1|STARTED|Arm 1||6
276571|NCT00345605|672916|P2|NOT COMPLETED|Initial Washout||0
276572|NCT00345605|672917|P1|NOT COMPLETED|Initial Washout||0
276573|NCT00345605|672916|P2|COMPLETED|Initial Washout||6
276574|NCT00345605|672917|P1|COMPLETED|Initial Washout||6
276575|NCT00345605|672916|P2|STARTED|Initial Washout||6
276576|NCT00345605|672917|P1|STARTED|Initial Washout||6
276577|NCT00345592|672937|P2|NOT COMPLETED|Overall Study||24
276578|NCT00345592|672938|P1|NOT COMPLETED|Overall Study||25
276579|NCT00345592|672937|P2|COMPLETED|Overall Study||173
276580|NCT00345592|672938|P1|COMPLETED|Overall Study||174
276581|NCT00345592|672937|P2|STARTED|Overall Study||197
276582|NCT00345592|672938|P1|STARTED|Overall Study||199
276583|NCT00345579|672946|P2|NOT COMPLETED|Overall Study||65
276584|NCT00345579|672947|P1|NOT COMPLETED|Overall Study||164
276585|NCT00345579|672946|P2|COMPLETED|Overall Study||1048
276586|NCT00345579|672947|P1|COMPLETED|Overall Study||3114
276587|NCT00345579|672946|P2|STARTED|Overall Study||1113
276588|NCT00345579|672947|P1|STARTED|Overall Study||3278
276589|NCT00345540|672967|P1|NOT COMPLETED|Overall Study||1
276590|NCT00345540|672967|P1|COMPLETED|Overall Study||15
276591|NCT00345540|672967|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
276592|NCT00345397|672973|P1|NOT COMPLETED|Overall Study||1
276593|NCT00345397|672973|P1|COMPLETED|Overall Study||6
276594|NCT00345397|672973|P1|STARTED|Overall Study||7
276595|NCT00345384|672980|P2|NOT COMPLETED|Overall Study||0
276596|NCT00345384|672981|P1|NOT COMPLETED|Overall Study||0
276597|NCT00345384|672980|P2|COMPLETED|Overall Study||19
276598|NCT00345384|672981|P1|COMPLETED|Overall Study||19
276599|NCT00345384|672980|P2|STARTED|Overall Study||19
276600|NCT00345384|672981|P1|STARTED|Overall Study||19
276601|NCT00345371|672991|P2|NOT COMPLETED|Overall Study||33
276602|NCT00345371|672992|P1|NOT COMPLETED|Overall Study||30
276603|NCT00345371|672991|P2|COMPLETED|Overall Study||38
276604|NCT00345371|672992|P1|COMPLETED|Overall Study||39
276605|NCT00345371|672991|P2|STARTED|Overall Study||71
276606|NCT00345371|672992|P1|STARTED|Overall Study||69
276607|NCT00345332|673002|P2|NOT COMPLETED|Overall Study||0
276608|NCT00345332|673003|P1|NOT COMPLETED|Overall Study||0
276609|NCT00345332|673002|P2|COMPLETED|Overall Study||20
276610|NCT00345332|673003|P1|COMPLETED|Overall Study||11
276611|NCT00345332|673002|P2|STARTED|Overall Study||20
276612|NCT00345332|673003|P1|STARTED|Overall Study||11
276613|NCT00345293|673011|P2|NOT COMPLETED|Overall Study||0
276614|NCT00345293|673012|P1|NOT COMPLETED|Overall Study||2
276615|NCT00345293|673011|P2|COMPLETED|Overall Study||3
276616|NCT00345293|673012|P1|COMPLETED|Overall Study||8
276617|NCT00345293|673011|P2|STARTED|Overall Study||3
276618|NCT00345293|673012|P1|STARTED|Overall Study||10
276619|NCT00345254|673021|P2|NOT COMPLETED|Overall Study||0
276620|NCT00345254|673022|P1|NOT COMPLETED|Overall Study||0
276621|NCT00345254|673021|P2|COMPLETED|Overall Study||30
276622|NCT00345254|673022|P1|COMPLETED|Overall Study||30
276623|NCT00345254|673021|P2|STARTED|Overall Study||30
276624|NCT00345254|673022|P1|STARTED|Overall Study||30
276625|NCT00345176|673032|P4|NOT COMPLETED|Overall Study||10
276626|NCT00345176|673033|P3|NOT COMPLETED|Overall Study||6
276627|NCT00345176|673034|P2|NOT COMPLETED|Overall Study||6
276628|NCT00345176|673035|P1|NOT COMPLETED|Overall Study||5
276629|NCT00345176|673032|P4|COMPLETED|Overall Study||1069
276630|NCT00345176|673033|P3|COMPLETED|Overall Study||1062
276631|NCT00345176|673034|P2|COMPLETED|Overall Study||1038
276632|NCT00345176|673035|P1|COMPLETED|Overall Study||1007
276633|NCT00345176|673032|P4|STARTED|Overall Study||1079
276634|NCT00345176|673033|P3|STARTED|Overall Study||1068
276635|NCT00345176|673034|P2|STARTED|Overall Study||1044
276636|NCT00345176|673035|P1|STARTED|Overall Study||1012
276637|NCT00345046|673058|P3|NOT COMPLETED|Overall Study||2
276638|NCT00345046|673059|P2|NOT COMPLETED|Overall Study||1
276639|NCT00345046|673060|P1|NOT COMPLETED|Overall Study||1
276640|NCT00345046|673058|P3|COMPLETED|Overall Study||14
276641|NCT00345046|673059|P2|COMPLETED|Overall Study||21
276642|NCT00345046|673060|P1|COMPLETED|Overall Study||17
276643|NCT00345046|673058|P3|STARTED|Overall Study||16
276644|NCT00345046|673059|P2|STARTED|Overall Study||22
276645|NCT00345046|673060|P1|STARTED|Overall Study||18
276646|NCT00345033|673070|P2|NOT COMPLETED|Overall Study||4
276647|NCT00345033|673071|P1|NOT COMPLETED|Overall Study||4
276648|NCT00345033|673070|P2|COMPLETED|Overall Study||14
276649|NCT00345033|673071|P1|COMPLETED|Overall Study||16
276650|NCT00345033|673070|P2|STARTED|Overall Study||18
276651|NCT00345033|673071|P1|STARTED|Overall Study||20
276652|NCT00344968|673090|P3|NOT COMPLETED|Overall Study||116
276653|NCT00344968|673091|P2|NOT COMPLETED|Overall Study||102
276654|NCT00344968|673092|P1|NOT COMPLETED|Overall Study||59
276655|NCT00344968|673090|P3|COMPLETED|Overall Study||279
276656|NCT00344968|673091|P2|COMPLETED|Overall Study||274
276657|NCT00344968|673092|P1|COMPLETED|Overall Study||126
276658|NCT00344968|673090|P3|STARTED|Overall Study||395
276659|NCT00344968|673091|P2|STARTED|Overall Study||376
276660|NCT00344968|673092|P1|STARTED|Overall Study||185
276661|NCT00344773|673103|P1|NOT COMPLETED|Overall Study||21
276662|NCT00344773|673103|P1|COMPLETED|Overall Study||25
276663|NCT00344773|673103|P1|STARTED|Overall Study||46
276664|NCT00344682|673111|P2|NOT COMPLETED|Overall Study||1
276665|NCT00344682|673112|P1|NOT COMPLETED|Overall Study||4
276666|NCT00344682|673111|P2|COMPLETED|Overall Study||14
276667|NCT00344682|673112|P1|COMPLETED|Overall Study||12
276668|NCT00344682|673111|P2|STARTED|Overall Study||15
276669|NCT00344682|673112|P1|STARTED|Overall Study||16
276670|NCT00344500|673126|P3|NOT COMPLETED|Overall Study||2
276671|NCT00344500|673127|P2|NOT COMPLETED|Overall Study||35
276672|NCT00344500|673128|P1|NOT COMPLETED|Overall Study||23
276673|NCT00344500|673126|P3|COMPLETED|Overall Study||12
276674|NCT00344500|673127|P2|COMPLETED|Overall Study||25
276675|NCT00344500|673128|P1|COMPLETED|Overall Study||25
276676|NCT00344500|673126|P3|STARTED|Overall Study||14
276677|NCT00344500|673127|P2|STARTED|Overall Study||60
276678|NCT00344500|673128|P1|STARTED|Overall Study||48
276679|NCT00344487|673139|P1|NOT COMPLETED|Overall Study||1
276680|NCT00344487|673139|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
276681|NCT00344487|673139|P1|STARTED|Overall Study||3
276682|NCT00344461|673143|P1|NOT COMPLETED|Overall Study||21
276683|NCT00344461|673143|P1|COMPLETED|Overall Study||33
276684|NCT00344461|673143|P1|STARTED|Overall Study||54
276685|NCT00344448|673154|P2|NOT COMPLETED|Open Label||1
276686|NCT00344448|673155|P1|NOT COMPLETED|Open Label||2
276687|NCT00344448|673154|P2|COMPLETED|Open Label||2
276688|NCT00344448|673155|P1|COMPLETED|Open Label||2
276689|NCT00344448|673154|P2|STARTED|Open Label||3
276690|NCT00344448|673155|P1|STARTED|Open Label||4
276691|NCT00344448|673154|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
276692|NCT00344448|673155|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
276693|NCT00344448|673154|P2|COMPLETED|Double Blind, Placebo Controlled||3
276694|NCT00344448|673155|P1|COMPLETED|Double Blind, Placebo Controlled||4
276695|NCT00344448|673154|P2|STARTED|Double Blind, Placebo Controlled||3
276696|NCT00344448|673155|P1|STARTED|Double Blind, Placebo Controlled||6
276697|NCT00344448|673154|P2|NOT COMPLETED|Screening||1
276698|NCT00344448|673155|P1|NOT COMPLETED|Screening||0
276699|NCT00344448|673154|P2|COMPLETED|Screening||3
276700|NCT00344448|673155|P1|COMPLETED|Screening||6
276701|NCT00344448|673154|P2|STARTED|Screening||4
276702|NCT00344448|673155|P1|STARTED|Screening|No randomization during the screening phase|6
276703|NCT00344370|673163|P2|NOT COMPLETED|Overall Study||3
276704|NCT00344370|673164|P1|NOT COMPLETED|Overall Study||15
276705|NCT00344370|673163|P2|COMPLETED|Overall Study||68
276706|NCT00344370|673164|P1|COMPLETED|Overall Study||128
276707|NCT00344370|673163|P2|STARTED|Overall Study||71
276708|NCT00344370|673164|P1|STARTED|Overall Study||143
276709|NCT00344305|673174|P2|NOT COMPLETED|Overall Study||1
276710|NCT00344305|673175|P1|NOT COMPLETED|Overall Study||2
276711|NCT00344305|673174|P2|COMPLETED|Overall Study||99
276712|NCT00344305|673175|P1|COMPLETED|Overall Study||98
276713|NCT00344305|673174|P2|STARTED|Overall Study||100
276714|NCT00344305|673175|P1|STARTED|Overall Study||100
276715|NCT00344175|673212|P2|NOT COMPLETED|Overall Study||10
276716|NCT00344175|673213|P1|NOT COMPLETED|Overall Study||12
276717|NCT00344175|673212|P2|COMPLETED|Overall Study||47
276718|NCT00344175|673213|P1|COMPLETED|Overall Study||109
276719|NCT00344175|673212|P2|STARTED|Overall Study||57
276720|NCT00344175|673213|P1|STARTED|Overall Study||121
276721|NCT00344032|673225|P2|NOT COMPLETED|Overall Study||10
276722|NCT00344032|673226|P1|NOT COMPLETED|Overall Study||14
276723|NCT00344032|673225|P2|COMPLETED|Overall Study||168
276724|NCT00344032|673226|P1|COMPLETED|Overall Study||162
276725|NCT00344032|673225|P2|STARTED|Overall Study||178
276726|NCT00344032|673226|P1|STARTED|Overall Study||176
276727|NCT00344019|673245|P3|NOT COMPLETED|Overall Study||74
276728|NCT00344019|673246|P2|NOT COMPLETED|Overall Study||0
276729|NCT00344019|673247|P1|NOT COMPLETED|Overall Study||0
276730|NCT00344019|673245|P3|COMPLETED|Overall Study||0
276731|NCT00344019|673246|P2|COMPLETED|Overall Study||11
276732|NCT00344019|673247|P1|COMPLETED|Overall Study||12
276733|NCT00344019|673245|P3|STARTED|Overall Study||74
276734|NCT00344019|673246|P2|STARTED|Overall Study||11
276735|NCT00344019|673247|P1|STARTED|Overall Study||12
276736|NCT00343915|673265|P2|NOT COMPLETED|Month 66 Follow-up||0
276737|NCT00343915|673266|P1|NOT COMPLETED|Month 66 Follow-up||0
276738|NCT00343915|673265|P2|COMPLETED|Month 66 Follow-up||76
276739|NCT00343915|673266|P1|COMPLETED|Month 66 Follow-up||158
276740|NCT00343915|673265|P2|STARTED|Month 66 Follow-up||76
276741|NCT00343915|673266|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
276742|NCT00343915|673265|P2|NOT COMPLETED|Month 54 Follow-up||0
276743|NCT00343915|673266|P1|NOT COMPLETED|Month 54 Follow-up||0
276744|NCT00343915|673265|P2|COMPLETED|Month 54 Follow-up||79
276745|NCT00343915|673266|P1|COMPLETED|Month 54 Follow-up||166
276746|NCT00343915|673265|P2|STARTED|Month 54 Follow-up||79
276747|NCT00343915|673266|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
276748|NCT00343915|673265|P2|NOT COMPLETED|Month 42 Follow-up||0
276749|NCT00343915|673266|P1|NOT COMPLETED|Month 42 Follow-up||0
276750|NCT00343915|673265|P2|COMPLETED|Month 42 Follow-up||84
276751|NCT00343915|673266|P1|COMPLETED|Month 42 Follow-up||174
276752|NCT00343915|673265|P2|STARTED|Month 42 Follow-up||84
276753|NCT00343915|673266|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
276754|NCT00343915|673265|P2|NOT COMPLETED|Month 30 Follow-up||0
276755|NCT00343915|673266|P1|NOT COMPLETED|Month 30 Follow-up||0
276756|NCT00343915|673265|P2|COMPLETED|Month 30 Follow-up||88
276757|NCT00343915|673266|P1|COMPLETED|Month 30 Follow-up||179
276758|NCT00343915|673265|P2|STARTED|Month 30 Follow-up||88
276759|NCT00343915|673266|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
276760|NCT00343915|673265|P2|NOT COMPLETED|Primary Study||3
276761|NCT00343915|673266|P1|NOT COMPLETED|Primary Study||4
276762|NCT00343915|673265|P2|COMPLETED|Primary Study||123
276763|NCT00343915|673266|P1|COMPLETED|Primary Study||254
276764|NCT00343915|673265|P2|STARTED|Primary Study||126
276765|NCT00343915|673266|P1|STARTED|Primary Study||258
276766|NCT00343889|673292|P2|NOT COMPLETED|Overall Study||1
276767|NCT00343889|673293|P1|NOT COMPLETED|Overall Study||3
276768|NCT00343889|673292|P2|COMPLETED|Overall Study||188
276769|NCT00343889|673293|P1|COMPLETED|Overall Study||187
276770|NCT00343889|673292|P2|STARTED|Overall Study||189
276771|NCT00343889|673293|P1|STARTED|Overall Study||190
276772|NCT00343863|673311|P2|NOT COMPLETED|Overall Study||0
276773|NCT00343863|673312|P1|NOT COMPLETED|Overall Study||0
276774|NCT00343863|673311|P2|COMPLETED|Overall Study||34
276775|NCT00343863|673312|P1|COMPLETED|Overall Study||7
276776|NCT00343863|673311|P2|STARTED|Overall Study||34
276777|NCT00343863|673312|P1|STARTED|Overall Study||7
276778|NCT00343785|673334|P1|NOT COMPLETED|Overall Study||0
276779|NCT00343785|673334|P1|COMPLETED|Overall Study||21
276780|NCT00343785|673334|P1|STARTED|Overall Study||21
276781|NCT00343564|673351|P11|NOT COMPLETED|Overall Study||0
276782|NCT00343564|673352|P10|NOT COMPLETED|Overall Study||0
276783|NCT00343564|673353|P9|NOT COMPLETED|Overall Study||0
276784|NCT00343564|673354|P8|NOT COMPLETED|Overall Study||0
276785|NCT00343564|673355|P7|NOT COMPLETED|Overall Study||0
276786|NCT00343564|673356|P6|NOT COMPLETED|Overall Study||0
276787|NCT00343564|673357|P5|NOT COMPLETED|Overall Study||0
276788|NCT00343564|673358|P4|NOT COMPLETED|Overall Study||0
276789|NCT00343564|673359|P3|NOT COMPLETED|Overall Study||0
276790|NCT00343564|673360|P2|NOT COMPLETED|Overall Study||0
276791|NCT00343564|673361|P1|NOT COMPLETED|Overall Study||0
276792|NCT00343564|673351|P11|COMPLETED|Overall Study||8
276793|NCT00343564|673352|P10|COMPLETED|Overall Study||8
276794|NCT00343564|673353|P9|COMPLETED|Overall Study||3
276795|NCT00343564|673354|P8|COMPLETED|Overall Study||3
276796|NCT00343564|673355|P7|COMPLETED|Overall Study||4
276797|NCT00343564|673356|P6|COMPLETED|Overall Study||9
276798|NCT00343564|673357|P5|COMPLETED|Overall Study||10
276799|NCT00343564|673358|P4|COMPLETED|Overall Study||7
276800|NCT00343564|673359|P3|COMPLETED|Overall Study||3
276801|NCT00343564|673360|P2|COMPLETED|Overall Study||7
276802|NCT00343564|673361|P1|COMPLETED|Overall Study||6
276803|NCT00343564|673351|P11|STARTED|Overall Study||8
276804|NCT00343564|673352|P10|STARTED|Overall Study||8
276805|NCT00343564|673353|P9|STARTED|Overall Study||3
276806|NCT00343564|673354|P8|STARTED|Overall Study||3
276807|NCT00343564|673355|P7|STARTED|Overall Study||4
276808|NCT00343564|673356|P6|STARTED|Overall Study||9
276809|NCT00343564|673357|P5|STARTED|Overall Study||10
276810|NCT00343564|673358|P4|STARTED|Overall Study||7
276811|NCT00343564|673359|P3|STARTED|Overall Study||3
276812|NCT00343564|673360|P2|STARTED|Overall Study||7
276813|NCT00343564|673361|P1|STARTED|Overall Study||6
276814|NCT00343512|673376|P1|NOT COMPLETED|Overall Study||2
276815|NCT00343512|673376|P1|COMPLETED|Overall Study||32
276816|NCT00343512|673376|P1|STARTED|Overall Study||34
276817|NCT00343460|673388|P3|NOT COMPLETED|Cycle 2 - 4||0
276818|NCT00343460|673389|P2|NOT COMPLETED|Cycle 2 - 4||50
276819|NCT00343460|673390|P1|NOT COMPLETED|Cycle 2 - 4||56
276820|NCT00343460|673388|P3|COMPLETED|Cycle 2 - 4||0
276821|NCT00343460|673389|P2|COMPLETED|Cycle 2 - 4||515
276822|NCT00343460|673390|P1|COMPLETED|Cycle 2 - 4||528
276823|NCT00343460|673388|P3|STARTED|Cycle 2 - 4||0
276824|NCT00343460|673389|P2|STARTED|Cycle 2 - 4||565
276825|NCT00343460|673390|P1|STARTED|Cycle 2 - 4||584
276826|NCT00343460|673388|P3|NOT COMPLETED|Cycle 1||18
276827|NCT00343460|673389|P2|NOT COMPLETED|Cycle 1||22
276828|NCT00343460|673390|P1|NOT COMPLETED|Cycle 1||22
276829|NCT00343460|673388|P3|COMPLETED|Cycle 1||454
276830|NCT00343460|673389|P2|COMPLETED|Cycle 1||459
276831|NCT00343460|673390|P1|COMPLETED|Cycle 1||453
276832|NCT00343460|673388|P3|STARTED|Cycle 1||472
276833|NCT00343460|673389|P2|STARTED|Cycle 1||481
276834|NCT00343460|673390|P1|STARTED|Cycle 1||475
276835|NCT00343382|673464|P3|NOT COMPLETED|Overall Study||17
276836|NCT00343382|673465|P2|NOT COMPLETED|Overall Study||14
276837|NCT00343382|673466|P1|NOT COMPLETED|Overall Study||4
276838|NCT00343382|673464|P3|COMPLETED|Overall Study||49
276839|NCT00343382|673465|P2|COMPLETED|Overall Study||51
276840|NCT00343382|673466|P1|COMPLETED|Overall Study||60
276841|NCT00343382|673464|P3|STARTED|Overall Study||66
276842|NCT00343382|673465|P2|STARTED|Overall Study||65
276843|NCT00343382|673466|P1|STARTED|Overall Study||64
276844|NCT00343291|673485|P2|NOT COMPLETED|Overall Study||56
276845|NCT00343291|673486|P1|NOT COMPLETED|Overall Study||57
276846|NCT00343291|673485|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
276847|NCT00343291|673486|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
276848|NCT00343291|673485|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
276849|NCT00343291|673486|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
276850|NCT00343291|673485|P2|STARTED|Overall Study||61
276851|NCT00343291|673486|P1|STARTED|Overall Study||60
276852|NCT00343252|673502|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
276853|NCT00343252|673503|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
276854|NCT00343252|673502|P2|COMPLETED|18 Months (All Treated Participants)||269
276855|NCT00343252|673503|P1|COMPLETED|18 Months (All Treated Participants)||259
276856|NCT00343252|673502|P2|STARTED|18 Months (All Treated Participants)||350
276857|NCT00343252|673503|P1|STARTED|18 Months (All Treated Participants)||360
276858|NCT00343252|673502|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
276859|NCT00343252|673503|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
276860|NCT00343252|673502|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
276861|NCT00343252|673503|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
276862|NCT00343252|673502|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
276863|NCT00343252|673503|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
276864|NCT00343252|673502|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
276865|NCT00343252|673503|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
276866|NCT00343252|673502|P2|COMPLETED|6 Months (All Treated Participants)||306
276867|NCT00343252|673503|P1|COMPLETED|6 Months (All Treated Participants)||304
276868|NCT00343252|673502|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
276869|NCT00343252|673503|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
276870|NCT00343252|673502|P2|NOT COMPLETED|All Randomized Participants||82
276871|NCT00343252|673503|P1|NOT COMPLETED|All Randomized Participants||102
276872|NCT00343252|673502|P2|COMPLETED|All Randomized Participants||269
276873|NCT00343252|673503|P1|COMPLETED|All Randomized Participants||259
276874|NCT00343252|673502|P2|STARTED|All Randomized Participants||351
276875|NCT00343252|673503|P1|STARTED|All Randomized Participants||361
276876|NCT00343083|673549|P1|NOT COMPLETED|Overall Study||21
276877|NCT00343083|673549|P1|COMPLETED|Overall Study||22
276878|NCT00343083|673549|P1|STARTED|Overall Study||43
276879|NCT00343044|673558|P1|NOT COMPLETED|Overall Study||0
276880|NCT00343044|673558|P1|COMPLETED|Overall Study||40
276881|NCT00343044|673558|P1|STARTED|Overall Study||40
276882|NCT00342628|673568|P3|NOT COMPLETED|Overall Study||19
276883|NCT00342628|673569|P2|NOT COMPLETED|Overall Study||21
276884|NCT00342628|673570|P1|NOT COMPLETED|Overall Study||20
276885|NCT00342628|673568|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
276886|NCT00342628|673569|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
276887|NCT00342628|673570|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
276888|NCT00342628|673568|P3|STARTED|Overall Study||100
276889|NCT00342628|673569|P2|STARTED|Overall Study||101
276890|NCT00342628|673570|P1|STARTED|Overall Study||100
276891|NCT00342563|673591|P4|NOT COMPLETED|Overall Study||6
276892|NCT00342563|673592|P3|NOT COMPLETED|Overall Study||14
276893|NCT00342563|673593|P2|NOT COMPLETED|Overall Study||8
276894|NCT00342563|673594|P1|NOT COMPLETED|Overall Study||6
276895|NCT00342563|673591|P4|COMPLETED|Overall Study||22
276896|NCT00342563|673592|P3|COMPLETED|Overall Study||26
276897|NCT00342563|673593|P2|COMPLETED|Overall Study||19
276898|NCT00342563|673594|P1|COMPLETED|Overall Study||35
276899|NCT00342563|673591|P4|STARTED|Overall Study||28
276900|NCT00342563|673592|P3|STARTED|Overall Study||40
276901|NCT00342563|673593|P2|STARTED|Overall Study||27
276902|NCT00342563|673594|P1|STARTED|Overall Study||41
276903|NCT00342355|673614|P4|NOT COMPLETED|Overall Study||0
276904|NCT00342355|673615|P3|NOT COMPLETED|Overall Study||0
276905|NCT00342355|673616|P2|NOT COMPLETED|Overall Study||0
276906|NCT00342355|673617|P1|NOT COMPLETED|Overall Study||0
276907|NCT00342355|673614|P4|COMPLETED|Overall Study||443
276908|NCT00342355|673615|P3|COMPLETED|Overall Study||444
276909|NCT00342355|673616|P2|COMPLETED|Overall Study||440
276910|NCT00342355|673617|P1|COMPLETED|Overall Study||444
276911|NCT00342355|673614|P4|STARTED|Overall Study||443
276912|NCT00342355|673615|P3|STARTED|Overall Study||444
276913|NCT00342355|673616|P2|STARTED|Overall Study||440
276914|NCT00342355|673617|P1|STARTED|Overall Study||444
276915|NCT00340834|673636|P5|NOT COMPLETED|Extension Phase of Study||44
276916|NCT00340834|673637|P4|NOT COMPLETED|Extension Phase of Study||53
276917|NCT00340834|673638|P3|NOT COMPLETED|Extension Phase of Study||0
276918|NCT00340834|673639|P2|NOT COMPLETED|Extension Phase of Study||76
276919|NCT00340834|673640|P1|NOT COMPLETED|Extension Phase of Study||85
276920|NCT00340834|673636|P5|COMPLETED|Extension Phase of Study||123
276921|NCT00340834|673637|P4|COMPLETED|Extension Phase of Study||123
276922|NCT00340834|673638|P3|COMPLETED|Extension Phase of Study||0
276923|NCT00340834|673639|P2|COMPLETED|Extension Phase of Study||281
276924|NCT00340834|673640|P1|COMPLETED|Extension Phase of Study||245
276925|NCT00340834|673636|P5|Received Study Drug|Extension Phase of Study||167
276926|NCT00340834|673637|P4|Received Study Drug|Extension Phase of Study||174
276927|NCT00340834|673638|P3|Received Study Drug|Extension Phase of Study||0
276928|NCT00340834|673639|P2|Received Study Drug|Extension Phase of Study||356
276929|NCT00340834|673640|P1|Received Study Drug|Extension Phase of Study||330
276930|NCT00340834|673636|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
276931|NCT00340834|673637|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
276932|NCT00340834|673638|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
276933|NCT00340834|673639|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
276934|NCT00340834|673640|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
276935|NCT00340834|673636|P5|NOT COMPLETED|Core Phase of Study||0
276936|NCT00340834|673637|P4|NOT COMPLETED|Core Phase of Study||0
276937|NCT00340834|673638|P3|NOT COMPLETED|Core Phase of Study||49
276938|NCT00340834|673639|P2|NOT COMPLETED|Core Phase of Study||33
276939|NCT00340834|673640|P1|NOT COMPLETED|Core Phase of Study||57
276940|NCT00340834|673636|P5|COMPLETED|Core Phase of Study||0
276941|NCT00340834|673637|P4|COMPLETED|Core Phase of Study||0
276942|NCT00340834|673638|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
276943|NCT00340834|673639|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
276944|NCT00340834|673640|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
276945|NCT00340834|673636|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
276946|NCT00340834|673637|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
276947|NCT00340834|673638|P3|STARTED|Core Phase of Study||435
276948|NCT00340834|673639|P2|STARTED|Core Phase of Study||431
276949|NCT00340834|673640|P1|STARTED|Core Phase of Study||426
276950|NCT00340704|673674|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
276951|NCT00340704|673675|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
276952|NCT00340704|673676|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
276953|NCT00340704|673677|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
276954|NCT00340704|673678|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
276955|NCT00340704|673679|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
276956|NCT00340704|673680|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
276957|NCT00340704|673681|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
276958|NCT00340704|673682|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
276959|NCT00340704|673674|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
276960|NCT00340704|673675|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
276961|NCT00340704|673676|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
276962|NCT00340704|673677|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
276963|NCT00340704|673678|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
276964|NCT00340704|673679|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
276965|NCT00340704|673680|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
276966|NCT00340704|673681|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
276967|NCT00340704|673682|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
276968|NCT00340704|673674|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
276969|NCT00340704|673675|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
276970|NCT00340704|673676|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
276971|NCT00340704|673677|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
276972|NCT00340704|673678|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
276973|NCT00340704|673679|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
276974|NCT00340704|673680|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
276975|NCT00340704|673681|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
276976|NCT00340704|673682|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
276977|NCT00340704|673674|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
276978|NCT00340704|673675|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
276979|NCT00340704|673676|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
276980|NCT00340704|673677|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
276981|NCT00340704|673678|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
276982|NCT00340704|673679|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
276983|NCT00340704|673680|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
276984|NCT00340704|673681|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
276985|NCT00340704|673682|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
276986|NCT00340704|673674|P9|NOT COMPLETED|PK Study||0
276987|NCT00340704|673675|P8|NOT COMPLETED|PK Study||0
276988|NCT00340704|673676|P7|NOT COMPLETED|PK Study||0
276989|NCT00340704|673677|P6|NOT COMPLETED|PK Study||0
276990|NCT00340704|673678|P5|NOT COMPLETED|PK Study||0
276991|NCT00340704|673679|P4|NOT COMPLETED|PK Study||0
276992|NCT00340704|673680|P3|NOT COMPLETED|PK Study||1
276993|NCT00340704|673681|P2|NOT COMPLETED|PK Study||1
276994|NCT00340704|673682|P1|NOT COMPLETED|PK Study||0
276995|NCT00340704|673674|P9|COMPLETED|PK Study||0
276996|NCT00340704|673675|P8|COMPLETED|PK Study||0
276997|NCT00340704|673676|P7|COMPLETED|PK Study||0
276998|NCT00340704|673677|P6|COMPLETED|PK Study||0
276999|NCT00340704|673678|P5|COMPLETED|PK Study||0
277000|NCT00340704|673679|P4|COMPLETED|PK Study||0
277001|NCT00340704|673680|P3|COMPLETED|PK Study||10
277002|NCT00340704|673681|P2|COMPLETED|PK Study||9
277003|NCT00340704|673682|P1|COMPLETED|PK Study||10
277004|NCT00340704|673674|P9|STARTED|PK Study||0
277005|NCT00340704|673675|P8|STARTED|PK Study||0
277006|NCT00340704|673676|P7|STARTED|PK Study||0
277007|NCT00340704|673677|P6|STARTED|PK Study||0
277008|NCT00340704|673678|P5|STARTED|PK Study||0
277009|NCT00340704|673679|P4|STARTED|PK Study||0
277010|NCT00340704|673680|P3|STARTED|PK Study||11
277011|NCT00340704|673681|P2|STARTED|PK Study||10
277012|NCT00340704|673682|P1|STARTED|PK Study||10
277013|NCT00340678|673788|P4|NOT COMPLETED|Overall Study||0
277014|NCT00340678|673789|P3|NOT COMPLETED|Overall Study||0
277015|NCT00340678|673790|P2|NOT COMPLETED|Overall Study||0
277016|NCT00340678|673791|P1|NOT COMPLETED|Overall Study||1
277017|NCT00340678|673788|P4|COMPLETED|Overall Study||39
277018|NCT00340678|673789|P3|COMPLETED|Overall Study||39
277019|NCT00340678|673790|P2|COMPLETED|Overall Study||46
277020|NCT00340678|673791|P1|COMPLETED|Overall Study||45
277021|NCT00340678|673788|P4|STARTED|Overall Study||39
277022|NCT00340678|673789|P3|STARTED|Overall Study||39
277023|NCT00340678|673790|P2|STARTED|Overall Study||46
277024|NCT00340678|673791|P1|STARTED|Overall Study||46
277025|NCT00340379|673805|P2|NOT COMPLETED|Overall Study||9
277026|NCT00340379|673806|P1|NOT COMPLETED|Overall Study||8
277027|NCT00340379|673805|P2|COMPLETED|Overall Study||28
277028|NCT00340379|673806|P1|COMPLETED|Overall Study||27
277029|NCT00340379|673805|P2|STARTED|Overall Study||37
277030|NCT00340379|673806|P1|STARTED|Overall Study||35
277031|NCT00339833|673818|P2|NOT COMPLETED|Overall Study||8
277032|NCT00339833|673819|P1|NOT COMPLETED|Overall Study||6
277033|NCT00339833|673818|P2|COMPLETED|Overall Study||18
277034|NCT00339833|673819|P1|COMPLETED|Overall Study||22
277035|NCT00339833|673818|P2|STARTED|Overall Study||26
277036|NCT00339833|673819|P1|STARTED|Overall Study||28
277037|NCT00339183|673829|P2|NOT COMPLETED|Overall Study||105
277038|NCT00339183|673830|P1|NOT COMPLETED|Overall Study||121
277039|NCT00339183|673829|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
277040|NCT00339183|673830|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
277041|NCT00339183|673829|P2|Received Study Drug|Overall Study||593
277042|NCT00339183|673830|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
277043|NCT00339183|673829|P2|STARTED|Overall Study||595
277044|NCT00339183|673830|P1|STARTED|Overall Study||591
277045|NCT00339144|673859|P3|NOT COMPLETED|Overall Study||4
277046|NCT00339144|673860|P2|NOT COMPLETED|Overall Study||3
277047|NCT00339144|673861|P1|NOT COMPLETED|Overall Study||9
277048|NCT00339144|673859|P3|COMPLETED|Overall Study||0
277049|NCT00339144|673860|P2|COMPLETED|Overall Study||0
277050|NCT00339144|673861|P1|COMPLETED|Overall Study||0
277051|NCT00339144|673859|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
277052|NCT00339144|673860|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
277053|NCT00339144|673861|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
277054|NCT00339079|673947|P4|NOT COMPLETED|Overall Study||24
277055|NCT00339079|673948|P3|NOT COMPLETED|Overall Study||18
277056|NCT00339079|673949|P2|NOT COMPLETED|Overall Study||23
277057|NCT00339079|673950|P1|NOT COMPLETED|Overall Study||33
277058|NCT00339079|673947|P4|COMPLETED|Overall Study||29
277059|NCT00339079|673948|P3|COMPLETED|Overall Study||27
277060|NCT00339079|673949|P2|COMPLETED|Overall Study||21
277061|NCT00339079|673950|P1|COMPLETED|Overall Study||20
277062|NCT00339079|673947|P4|STARTED|Overall Study||53
277063|NCT00339079|673948|P3|STARTED|Overall Study||45
277064|NCT00339079|673949|P2|STARTED|Overall Study||44
277065|NCT00339079|673950|P1|STARTED|Overall Study||53
277066|NCT00339040|673966|P2|NOT COMPLETED|Stage II||2
277067|NCT00339040|673967|P1|NOT COMPLETED|Stage II||10
277068|NCT00339040|673966|P2|COMPLETED|Stage II||27
277069|NCT00339040|673967|P1|COMPLETED|Stage II||84
277070|NCT00339040|673966|P2|Vaccination 6 at Week 120|Stage II||27
277071|NCT00339040|673967|P1|Vaccination 6 at Week 120|Stage II||0
277072|NCT00339040|673966|P2|Vaccination 5 at Week 104|Stage II||28
277073|NCT00339040|673967|P1|Vaccination 5 at Week 104|Stage II||0
277074|NCT00339040|673966|P2|Vaccination 4 at Week 96|Stage II||29
277075|NCT00339040|673967|P1|Vaccination 4 at Week 96|Stage II||84
277076|NCT00339040|673966|P2|STARTED|Stage II||29
277077|NCT00339040|673967|P1|STARTED|Stage II||94
277078|NCT00339040|673966|P2|NOT COMPLETED|Stage I||1
277079|NCT00339040|673967|P1|NOT COMPLETED|Stage I||2
277080|NCT00339040|673966|P2|COMPLETED|Stage I||29
277081|NCT00339040|673967|P1|COMPLETED|Stage I||94
277082|NCT00339040|673966|P2|Vaccination 3 at Week 24|Stage I||30
277083|NCT00339040|673967|P1|Vaccination 3 at Week 24|Stage I||94
277084|NCT00339040|673966|P2|Vaccination 2 at Week 8|Stage I||30
277085|NCT00339040|673967|P1|Vaccination 2 at Week 8|Stage I||95
277086|NCT00339040|673966|P2|Vaccination 1 at Week 0|Stage I||30
277087|NCT00339040|673967|P1|Vaccination 1 at Week 0|Stage I||96
277088|NCT00339040|673966|P2|STARTED|Stage I||30
277089|NCT00339040|673967|P1|STARTED|Stage I||96
277090|NCT00338988|673985|P1|NOT COMPLETED|Overall Study||1
277091|NCT00338988|673985|P1|COMPLETED|Overall Study||43
277092|NCT00338988|673985|P1|STARTED|Overall Study||44
277093|NCT00338962|673994|P4|NOT COMPLETED|Overall Study||3
277094|NCT00338962|673995|P3|NOT COMPLETED|Overall Study||6
277095|NCT00338962|673996|P2|NOT COMPLETED|Overall Study||4
277096|NCT00338962|673997|P1|NOT COMPLETED|Overall Study||8
277097|NCT00338962|673994|P4|COMPLETED|Overall Study||21
277098|NCT00338962|673995|P3|COMPLETED|Overall Study||16
277099|NCT00338962|673996|P2|COMPLETED|Overall Study||16
277100|NCT00338962|673997|P1|COMPLETED|Overall Study||14
277101|NCT00338962|673994|P4|STARTED|Overall Study||24
277102|NCT00338962|673995|P3|STARTED|Overall Study||22
277103|NCT00338962|673996|P2|STARTED|Overall Study||20
277104|NCT00338962|673997|P1|STARTED|Overall Study||22
277105|NCT00338884|674019|P1|NOT COMPLETED|Overall Study||78
277106|NCT00338884|674019|P1|COMPLETED|Overall Study||42
277107|NCT00338884|674019|P1|Received Treatment|Overall Study||119
277108|NCT00338884|674019|P1|STARTED|Overall Study||120
277109|NCT00338806|674053|P2|NOT COMPLETED|Follow-up||3
277110|NCT00338806|674054|P1|NOT COMPLETED|Follow-up||1
277111|NCT00338806|674053|P2|COMPLETED|Follow-up||1
277112|NCT00338806|674054|P1|COMPLETED|Follow-up||1
277113|NCT00338806|674053|P2|STARTED|Follow-up||4
277114|NCT00338806|674054|P1|STARTED|Follow-up||2
277115|NCT00338806|674053|P2|NOT COMPLETED|Acute Phase||1
277116|NCT00338806|674054|P1|NOT COMPLETED|Acute Phase||0
277117|NCT00338806|674053|P2|COMPLETED|Acute Phase||4
277118|NCT00338806|674054|P1|COMPLETED|Acute Phase||2
277119|NCT00338806|674053|P2|STARTED|Acute Phase||5
277120|NCT00338806|674054|P1|STARTED|Acute Phase||2
277121|NCT00338741|674116|P2|NOT COMPLETED|Overall Study||0
277122|NCT00338741|674117|P1|NOT COMPLETED|Overall Study||2
277123|NCT00338741|674116|P2|COMPLETED|Overall Study||2
277124|NCT00338741|674117|P1|COMPLETED|Overall Study||32
277125|NCT00338741|674116|P2|STARTED|Overall Study||2
277126|NCT00338741|674117|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
277127|NCT00338598|674127|P2|NOT COMPLETED|Overall Study||2
277128|NCT00338598|674128|P1|NOT COMPLETED|Overall Study||0
277129|NCT00338598|674127|P2|COMPLETED|Overall Study||8
277130|NCT00338598|674128|P1|COMPLETED|Overall Study||10
277131|NCT00338598|674127|P2|STARTED|Overall Study||10
277132|NCT00338598|674128|P1|STARTED|Overall Study||10
277133|NCT00338455|674148|P2|NOT COMPLETED|Overall Study||1
277134|NCT00338455|674149|P1|NOT COMPLETED|Overall Study||3
277135|NCT00338455|674148|P2|COMPLETED|Overall Study||6
277136|NCT00338455|674149|P1|COMPLETED|Overall Study||6
277137|NCT00338455|674148|P2|Administered Study Drug|Overall Study||7
277138|NCT00338455|674149|P1|Administered Study Drug|Overall Study||8
277139|NCT00338455|674148|P2|STARTED|Overall Study||7
277140|NCT00338455|674149|P1|STARTED|Overall Study||9
277141|NCT00338286|674163|P2|NOT COMPLETED|Overall Study||213
277142|NCT00338286|674164|P1|NOT COMPLETED|Overall Study||233
277143|NCT00338286|674163|P2|COMPLETED|Overall Study||837
277144|NCT00338286|674164|P1|COMPLETED|Overall Study||815
277145|NCT00338286|674163|P2|STARTED|Overall Study||1050
277146|NCT00338286|674164|P1|STARTED|Overall Study||1048
277147|NCT00338104|674181|P3|NOT COMPLETED|Overall Study||3
277148|NCT00338104|674182|P2|NOT COMPLETED|Overall Study||1
277149|NCT00338104|674183|P1|NOT COMPLETED|Overall Study||2
277150|NCT00338104|674181|P3|COMPLETED|Overall Study||22
277151|NCT00338104|674182|P2|COMPLETED|Overall Study||24
277152|NCT00338104|674183|P1|COMPLETED|Overall Study||23
277153|NCT00338104|674181|P3|STARTED|Overall Study||25
277154|NCT00338104|674182|P2|STARTED|Overall Study||25
277155|NCT00338104|674183|P1|STARTED|Overall Study||25
277156|NCT00338039|674194|P1|NOT COMPLETED|Overall Study||0
277157|NCT00338039|674194|P1|COMPLETED|Overall Study||69
277158|NCT00338039|674194|P1|STARTED|Overall Study||69
277159|NCT00337987|674199|P1|NOT COMPLETED|Overall Study||0
277160|NCT00337987|674199|P1|COMPLETED|Overall Study||49
277161|NCT00337987|674199|P1|STARTED|Overall Study||49
277162|NCT00337935|674206|P2|NOT COMPLETED|Overall Study||27
277163|NCT00337935|674207|P1|NOT COMPLETED|Overall Study||10
277164|NCT00337935|674206|P2|COMPLETED|Overall Study||91
277165|NCT00337935|674207|P1|COMPLETED|Overall Study||29
277166|NCT00337935|674206|P2|STARTED|Overall Study||118
277167|NCT00337935|674207|P1|STARTED|Overall Study||39
277168|NCT00337818|674220|P3|NOT COMPLETED|Overall Study||107
277169|NCT00337818|674221|P2|NOT COMPLETED|Overall Study||91
277170|NCT00337818|674222|P1|NOT COMPLETED|Overall Study||289
277171|NCT00337818|674220|P3|COMPLETED|Overall Study||51
277172|NCT00337818|674221|P2|COMPLETED|Overall Study||63
277173|NCT00337818|674222|P1|COMPLETED|Overall Study||169
277174|NCT00337818|674220|P3|STARTED|Overall Study||158
277175|NCT00337818|674221|P2|STARTED|Overall Study||154
277176|NCT00337818|674222|P1|STARTED|Overall Study||458
277177|NCT00337779|674244|P2|NOT COMPLETED|Overall Study||79
277178|NCT00337779|674245|P1|NOT COMPLETED|Overall Study||52
277179|NCT00337779|674244|P2|COMPLETED|Overall Study||490
277180|NCT00337779|674245|P1|COMPLETED|Overall Study||534
277181|NCT00337779|674244|P2|STARTED|Overall Study||569
277182|NCT00337779|674245|P1|STARTED|Overall Study||586
277183|NCT00337727|674257|P2|NOT COMPLETED|Overall Study||12
277184|NCT00337727|674258|P1|NOT COMPLETED|Overall Study||18
277185|NCT00337727|674257|P2|COMPLETED|Overall Study||406
277186|NCT00337727|674258|P1|COMPLETED|Overall Study||412
277187|NCT00337727|674257|P2|STARTED|Overall Study||418
277188|NCT00337727|674258|P1|STARTED|Overall Study||430
277189|NCT00337675|674269|P3|NOT COMPLETED|Overall Study||99
277190|NCT00337675|674270|P2|NOT COMPLETED|Overall Study||103
277191|NCT00337675|674271|P1|NOT COMPLETED|Overall Study||97
277192|NCT00337675|674269|P3|COMPLETED|Overall Study||492
277193|NCT00337675|674270|P2|COMPLETED|Overall Study||488
277194|NCT00337675|674271|P1|COMPLETED|Overall Study||492
277195|NCT00337675|674269|P3|STARTED|Overall Study||591
277196|NCT00337675|674270|P2|STARTED|Overall Study||591
277197|NCT00337675|674271|P1|STARTED|Overall Study||589
277198|NCT00337662|674288|P4|NOT COMPLETED|Study Period III||0
277199|NCT00337662|674289|P3|NOT COMPLETED|Study Period III||44
277200|NCT00337662|674290|P2|NOT COMPLETED|Study Period III||58
277201|NCT00337662|674291|P1|NOT COMPLETED|Study Period III||60
277202|NCT00337662|674288|P4|COMPLETED|Study Period III||0
277203|NCT00337662|674289|P3|COMPLETED|Study Period III||100
277204|NCT00337662|674290|P2|COMPLETED|Study Period III||134
277205|NCT00337662|674291|P1|COMPLETED|Study Period III||126
277206|NCT00337662|674288|P4|STARTED|Study Period III||0
277207|NCT00337662|674289|P3|STARTED|Study Period III||144
277208|NCT00337662|674290|P2|STARTED|Study Period III||192
277209|NCT00337662|674291|P1|STARTED|Study Period III||186
277210|NCT00337662|674288|P4|NOT COMPLETED|Study Period II||106
277211|NCT00337662|674289|P3|NOT COMPLETED|Study Period II||0
277212|NCT00337662|674290|P2|NOT COMPLETED|Study Period II||0
277213|NCT00337662|674291|P1|NOT COMPLETED|Study Period II||0
277214|NCT00337662|674288|P4|COMPLETED|Study Period II||522
277215|NCT00337662|674289|P3|COMPLETED|Study Period II||0
277216|NCT00337662|674290|P2|COMPLETED|Study Period II||0
277217|NCT00337662|674291|P1|COMPLETED|Study Period II||0
277218|NCT00337662|674288|P4|STARTED|Study Period II||628
277219|NCT00337662|674289|P3|STARTED|Study Period II||0
277220|NCT00337662|674290|P2|STARTED|Study Period II||0
277221|NCT00337662|674291|P1|STARTED|Study Period II||0
277222|NCT00337610|674345|P2|NOT COMPLETED|Overall Study||14
277223|NCT00337610|674346|P1|NOT COMPLETED|Overall Study||17
277224|NCT00337610|674345|P2|COMPLETED|Overall Study||80
277225|NCT00337610|674346|P1|COMPLETED|Overall Study||79
277226|NCT00337610|674345|P2|Completed Week 18|Overall Study||82
277227|NCT00337610|674346|P1|Completed Week 18|Overall Study||89
277228|NCT00337610|674345|P2|STARTED|Overall Study||94
277229|NCT00337610|674346|P1|STARTED|Overall Study||96
277230|NCT00337571|674362|P4|NOT COMPLETED|Overall Study||7
277231|NCT00337571|674363|P3|NOT COMPLETED|Overall Study||10
277232|NCT00337571|674364|P2|NOT COMPLETED|Overall Study||9
277233|NCT00337571|674365|P1|NOT COMPLETED|Overall Study||14
277234|NCT00337571|674362|P4|COMPLETED|Overall Study||47
277235|NCT00337571|674363|P3|COMPLETED|Overall Study||49
277236|NCT00337571|674364|P2|COMPLETED|Overall Study||44
277237|NCT00337571|674365|P1|COMPLETED|Overall Study||38
277238|NCT00337571|674362|P4|STARTED|Overall Study||54
277239|NCT00337571|674363|P3|STARTED|Overall Study||59
277240|NCT00337571|674364|P2|STARTED|Overall Study||53
277241|NCT00337571|674365|P1|STARTED|Overall Study||52
277242|NCT00337467|674403|P1|NOT COMPLETED|Overall Study||10
277243|NCT00337467|674403|P1|COMPLETED|Overall Study||51
277244|NCT00337467|674403|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
277245|NCT00337467|674403|P1|STARTED|Overall Study||61
277246|NCT00337428|674422|P2|NOT COMPLETED|Overall Study||3
277247|NCT00337428|674423|P1|NOT COMPLETED|Overall Study||4
277248|NCT00337428|674422|P2|COMPLETED|Overall Study||421
277249|NCT00337428|674423|P1|COMPLETED|Overall Study||415
277250|NCT00337428|674422|P2|STARTED|Overall Study||424
277251|NCT00337428|674423|P1|STARTED|Overall Study||419
277252|NCT00337350|674463|P2|NOT COMPLETED|Overall Study||1
277253|NCT00337350|674464|P1|NOT COMPLETED|Overall Study||1
277254|NCT00337350|674463|P2|COMPLETED|Overall Study||10
277255|NCT00337350|674464|P1|COMPLETED|Overall Study||8
277256|NCT00337350|674463|P2|STARTED|Overall Study||11
277257|NCT00337350|674464|P1|STARTED|Overall Study||9
277258|NCT00337285|674474|P1|NOT COMPLETED|Overall Study||158
277259|NCT00337285|674474|P1|COMPLETED|Overall Study||191
277260|NCT00337285|674474|P1|STARTED|Overall Study||349
277261|NCT00337272|674482|P2|NOT COMPLETED|Withdrawal Period||1
277262|NCT00337272|674483|P1|NOT COMPLETED|Withdrawal Period||0
277263|NCT00337272|674482|P2|COMPLETED|Withdrawal Period||6
277264|NCT00337272|674483|P1|COMPLETED|Withdrawal Period||6
277265|NCT00337272|674482|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
277266|NCT00337272|674483|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
277267|NCT00337272|674482|P2|NOT COMPLETED|Treatment Period||2
277268|NCT00337272|674483|P1|NOT COMPLETED|Treatment Period||1
277269|NCT00337272|674482|P2|COMPLETED|Treatment Period||7
277270|NCT00337272|674483|P1|COMPLETED|Treatment Period||6
277271|NCT00337272|674482|P2|Randomization|Treatment Period||9
277272|NCT00337272|674483|P1|Randomization|Treatment Period||7
277273|NCT00337272|674482|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
277274|NCT00337272|674483|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
277275|NCT00337272|674482|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
277276|NCT00337272|674483|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
277277|NCT00337272|674482|P2|COMPLETED|Screening Period (Pre-randomization)||0
277278|NCT00337272|674483|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
277279|NCT00337272|674482|P2|STARTED|Screening Period (Pre-randomization)||0
277280|NCT00337272|674483|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
277281|NCT00337207|674503|P1|NOT COMPLETED|Overall Study||3
277282|NCT00337207|674503|P1|COMPLETED|Overall Study||52
277283|NCT00337207|674503|P1|STARTED|Overall Study||55
277284|NCT00337194|674509|P2|NOT COMPLETED|Overall Study||4
277285|NCT00337194|674510|P1|NOT COMPLETED|Overall Study||12
277286|NCT00337194|674509|P2|COMPLETED|Overall Study||3
277287|NCT00337194|674510|P1|COMPLETED|Overall Study||11
277288|NCT00337194|674509|P2|STARTED|Overall Study||7
277289|NCT00337194|674510|P1|STARTED|Overall Study||23
277290|NCT00337168|674525|P1|NOT COMPLETED|Overall Study||8
277291|NCT00337168|674525|P1|COMPLETED|Overall Study||29
277292|NCT00337168|674525|P1|Eligible and Treated|Overall Study||36
277293|NCT00337168|674525|P1|Eligible|Overall Study||37
277294|NCT00337168|674525|P1|STARTED|Overall Study||37
277295|NCT00337129|674532|P1|NOT COMPLETED|Overall Study||40
277296|NCT00337129|674532|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
277297|NCT00337129|674532|P1|STARTED|Overall Study||40
277298|NCT00337103|674541|P2|NOT COMPLETED|Overall Study||543
277299|NCT00337103|674542|P1|NOT COMPLETED|Overall Study||549
277300|NCT00337103|674541|P2|COMPLETED|Overall Study||5
277301|NCT00337103|674542|P1|COMPLETED|Overall Study||5
277302|NCT00337103|674541|P2|STARTED|Overall Study||548
277303|NCT00337103|674542|P1|STARTED|Overall Study||554
277304|NCT00337077|674553|P3|NOT COMPLETED|Overall Study||25
277305|NCT00337077|674554|P2|NOT COMPLETED|Overall Study||53
277306|NCT00337077|674555|P1|NOT COMPLETED|Overall Study||43
277307|NCT00337077|674553|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
277308|NCT00337077|674554|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
277309|NCT00337077|674555|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
277310|NCT00337077|674553|P3|Patients With Measurable Disease|Overall Study||13
277311|NCT00337077|674554|P2|Patients With Measurable Disease|Overall Study||38
277312|NCT00337077|674555|P1|Patients With Measurable Disease|Overall Study||26
277313|NCT00337077|674553|P3|Eligible and Treated|Overall Study||24
277314|NCT00337077|674554|P2|Eligible and Treated|Overall Study||51
277315|NCT00337077|674555|P1|Eligible and Treated|Overall Study||41
277316|NCT00337077|674553|P3|Toxicity Assessed|Overall Study||25
277317|NCT00337077|674554|P2|Toxicity Assessed|Overall Study||51
277318|NCT00337077|674555|P1|Toxicity Assessed|Overall Study||42
277319|NCT00337077|674553|P3|Treated|Overall Study||25
277320|NCT00337077|674554|P2|Treated|Overall Study||52
277321|NCT00337077|674555|P1|Treated|Overall Study||42
277322|NCT00337077|674553|P3|STARTED|Overall Study||25
277323|NCT00337077|674554|P2|STARTED|Overall Study||53
277324|NCT00337077|674555|P1|STARTED|Overall Study||43
277325|NCT00336973|674564|P1|NOT COMPLETED|Overall Study||33
277326|NCT00336973|674564|P1|COMPLETED|Overall Study||33
277327|NCT00336973|674564|P1|STARTED|Overall Study||66
277328|NCT00336895|674570|P1|NOT COMPLETED|Overall Study||4
277329|NCT00336895|674570|P1|COMPLETED|Overall Study||26
277330|NCT00336895|674570|P1|STARTED|Overall Study||30
277331|NCT00336856|674576|P1|NOT COMPLETED|Overall Study||4
277332|NCT00336856|674576|P1|COMPLETED|Overall Study||31
277333|NCT00336856|674576|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
277334|NCT00336817|674584|P2|NOT COMPLETED|Overall Study||2
277335|NCT00336817|674585|P1|NOT COMPLETED|Overall Study||1
277336|NCT00336817|674584|P2|COMPLETED|Overall Study||13
277337|NCT00336817|674585|P1|COMPLETED|Overall Study||14
277338|NCT00336817|674584|P2|STARTED|Overall Study||15
277339|NCT00336817|674585|P1|STARTED|Overall Study||15
277340|NCT00336700|674615|P1|NOT COMPLETED|Overall Study||0
277341|NCT00336700|674615|P1|COMPLETED|Overall Study||25
277342|NCT00336700|674615|P1|STARTED|Overall Study||25
277343|NCT00336583|674624|P1|NOT COMPLETED|Overall Study||2
277344|NCT00336583|674624|P1|COMPLETED|Overall Study||25
277345|NCT00336583|674624|P1|STARTED|Overall Study||27
277346|NCT00336544|674631|P2|NOT COMPLETED|Overall Study||22
277347|NCT00336544|674632|P1|NOT COMPLETED|Overall Study||19
277348|NCT00336544|674631|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
277349|NCT00336544|674632|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
277350|NCT00336544|674631|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
277351|NCT00336544|674632|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
277352|NCT00336505|674646|P2|NOT COMPLETED|Overall Study||27
277353|NCT00336505|674647|P1|NOT COMPLETED|Overall Study||37
277354|NCT00336505|674646|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
277355|NCT00336505|674647|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
277356|NCT00336505|674646|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
277357|NCT00336505|674647|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
277358|NCT00336492|674662|P3|NOT COMPLETED|Overall Study||11
277359|NCT00336492|674663|P2|NOT COMPLETED|Overall Study||4
277360|NCT00336492|674664|P1|NOT COMPLETED|Overall Study||15
277361|NCT00336492|674662|P3|COMPLETED|Overall Study||12
277362|NCT00336492|674663|P2|COMPLETED|Overall Study||18
277363|NCT00336492|674664|P1|COMPLETED|Overall Study||0
277364|NCT00336492|674662|P3|STARTED|Overall Study||23
277365|NCT00336492|674663|P2|STARTED|Overall Study||22
277366|NCT00336492|674664|P1|STARTED|Overall Study||15
277367|NCT00336479|674676|P4|NOT COMPLETED|Overall Study||4
277368|NCT00336479|674677|P3|NOT COMPLETED|Overall Study||26
277369|NCT00336479|674678|P2|NOT COMPLETED|Overall Study||25
277370|NCT00336479|674679|P1|NOT COMPLETED|Overall Study||37
277371|NCT00336479|674676|P4|COMPLETED|Overall Study||13
277372|NCT00336479|674677|P3|COMPLETED|Overall Study||53
277373|NCT00336479|674678|P2|COMPLETED|Overall Study||54
277374|NCT00336479|674679|P1|COMPLETED|Overall Study||38
277375|NCT00336479|674676|P4|STARTED|Overall Study||17
277376|NCT00336479|674677|P3|STARTED|Overall Study||79
277377|NCT00336479|674678|P2|STARTED|Overall Study||79
277378|NCT00336479|674679|P1|STARTED|Overall Study||75
277379|NCT00336323|674707|P5|NOT COMPLETED|Overall Study||3
277380|NCT00336323|674708|P4|NOT COMPLETED|Overall Study||0
277381|NCT00336323|674709|P3|NOT COMPLETED|Overall Study||1
277382|NCT00336323|674710|P2|NOT COMPLETED|Overall Study||1
277383|NCT00336323|674711|P1|NOT COMPLETED|Overall Study||0
277384|NCT00336323|674707|P5|COMPLETED|Overall Study||19
277385|NCT00336323|674708|P4|COMPLETED|Overall Study||22
277386|NCT00336323|674709|P3|COMPLETED|Overall Study||23
277387|NCT00336323|674710|P2|COMPLETED|Overall Study||21
277388|NCT00336323|674711|P1|COMPLETED|Overall Study||19
277389|NCT00336323|674707|P5|24 Week Visit|Overall Study||19
277390|NCT00336323|674708|P4|24 Week Visit|Overall Study||22
277391|NCT00336323|674709|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
277392|NCT00336323|674710|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
277393|NCT00336323|674711|P1|24 Week Visit|Overall Study||18
277394|NCT00336323|674707|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
277395|NCT00336323|674708|P4|18 Week Visit|Overall Study||21
277396|NCT00336323|674709|P3|18 Week Visit|Overall Study||23
277397|NCT00336323|674710|P2|18 Week Visit|Overall Study||22
277398|NCT00336323|674711|P1|18 Week Visit|Overall Study||19
277399|NCT00336323|674707|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
277400|NCT00336323|674708|P4|12 Week Visit|Overall Study||22
277401|NCT00336323|674709|P3|12 Week Visit|Overall Study||24
277402|NCT00336323|674710|P2|12 Week Visit|Overall Study||21
277403|NCT00336323|674711|P1|12 Week Visit|Overall Study||19
277404|NCT00336323|674707|P5|9 Week Visit|Overall Study||19
277405|NCT00336323|674708|P4|9 Week Visit|Overall Study||21
277406|NCT00336323|674709|P3|9 Week Visit|Overall Study||23
277407|NCT00336323|674710|P2|9 Week Visit|Overall Study||21
277408|NCT00336323|674711|P1|9 Week Visit|Overall Study||18
277409|NCT00336323|674707|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
277410|NCT00336323|674708|P4|6 Week Visit|Overall Study||22
277411|NCT00336323|674709|P3|6 Week Visit|Overall Study||24
277412|NCT00336323|674710|P2|6 Week Visit|Overall Study||22
277413|NCT00336323|674711|P1|6 Week Visit|Overall Study||18
277414|NCT00336323|674707|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
277415|NCT00336323|674708|P4|3 Week Visit|Overall Study||22
277416|NCT00336323|674709|P3|3 Week Visit|Overall Study||24
277417|NCT00336323|674710|P2|3 Week Visit|Overall Study||21
277418|NCT00336323|674711|P1|3 Week Visit|Overall Study||18
277419|NCT00336323|674707|P5|STARTED|Overall Study||22
277420|NCT00336323|674708|P4|STARTED|Overall Study||22
277421|NCT00336323|674709|P3|STARTED|Overall Study||24
277422|NCT00336323|674710|P2|STARTED|Overall Study||22
277423|NCT00336323|674711|P1|STARTED|Overall Study||19
277424|NCT00336284|674768|P2|NOT COMPLETED|Overall Study||151
277425|NCT00336284|674769|P1|NOT COMPLETED|Overall Study||236
277426|NCT00336284|674768|P2|COMPLETED|Overall Study||322
277427|NCT00336284|674769|P1|COMPLETED|Overall Study||741
277428|NCT00336284|674768|P2|STARTED|Overall Study||473
277429|NCT00336284|674769|P1|STARTED|Overall Study||977
277430|NCT00336232|674781|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
277431|NCT00336232|674781|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
277432|NCT00336232|674781|P1|STARTED|High Vitamin K (500mcg Daily)||42
277433|NCT00336232|674781|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
277434|NCT00336232|674781|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
277435|NCT00336232|674781|P1|STARTED|Low Vitamin K (10mcg Daily)||42
277436|NCT00336232|674781|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
277437|NCT00336232|674781|P1|COMPLETED|Baseline (200mcg Daily)||42
277438|NCT00336232|674781|P1|STARTED|Baseline (200mcg Daily)||59
277439|NCT00335972|674787|P2|NOT COMPLETED|Overall Study||3
277440|NCT00335972|674788|P1|NOT COMPLETED|Overall Study||0
277441|NCT00335972|674787|P2|COMPLETED|Overall Study||68
277442|NCT00335972|674788|P1|COMPLETED|Overall Study||71
277443|NCT00335972|674787|P2|STARTED|Overall Study||71
277444|NCT00335972|674788|P1|STARTED|Overall Study||71
277445|NCT00335959|674798|P1|NOT COMPLETED|Overall Study||3
277446|NCT00335959|674798|P1|COMPLETED|Overall Study||4
277447|NCT00335959|674798|P1|Eligible and Began Protocol Therapy|Overall Study||6
277448|NCT00335959|674798|P1|Eligible|Overall Study||6
277449|NCT00335959|674798|P1|STARTED|Overall Study||7
277450|NCT00335829|674803|P1|NOT COMPLETED|Overall Study||3
277451|NCT00335829|674803|P1|COMPLETED|Overall Study||23
277452|NCT00335829|674803|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
277453|NCT00335829|674803|P1|Received Bevacizumab|Overall Study||26
277454|NCT00335829|674803|P1|STARTED|Overall Study||26
277455|NCT00335777|674817|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
277456|NCT00335777|674817|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
277457|NCT00335777|674817|P1|STARTED|Treated 2 Headaches Per Protocol||35
277458|NCT00335777|674817|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
277459|NCT00335777|674817|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
277460|NCT00335777|674817|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
277461|NCT00335738|674824|P2|NOT COMPLETED|Overall Study||4
277462|NCT00335738|674825|P1|NOT COMPLETED|Overall Study||11
277463|NCT00335738|674824|P2|COMPLETED|Overall Study||219
277464|NCT00335738|674825|P1|COMPLETED|Overall Study||97
277465|NCT00335738|674824|P2|STARTED|Overall Study||223
277466|NCT00335738|674825|P1|STARTED|Overall Study||108
277467|NCT00335725|674842|P2|NOT COMPLETED|Overall Study||5
277468|NCT00335725|674843|P1|NOT COMPLETED|Overall Study||4
277469|NCT00335725|674842|P2|COMPLETED|Overall Study||71
277470|NCT00335725|674843|P1|COMPLETED|Overall Study||71
277471|NCT00335725|674842|P2|STARTED|Overall Study||76
277472|NCT00335725|674843|P1|STARTED|Overall Study||75
277473|NCT00335556|674857|P6|NOT COMPLETED|Overall Study||1
277474|NCT00335556|674858|P5|NOT COMPLETED|Overall Study||1
277475|NCT00335556|674859|P4|NOT COMPLETED|Overall Study||5
277476|NCT00335556|674860|P3|NOT COMPLETED|Overall Study||5
277477|NCT00335556|674861|P2|NOT COMPLETED|Overall Study||34
277478|NCT00335556|674862|P1|NOT COMPLETED|Overall Study||2
277479|NCT00335556|674857|P6|COMPLETED|Overall Study||29
277480|NCT00335556|674858|P5|COMPLETED|Overall Study||77
277481|NCT00335556|674859|P4|COMPLETED|Overall Study||5
277482|NCT00335556|674860|P3|COMPLETED|Overall Study||2
277483|NCT00335556|674861|P2|COMPLETED|Overall Study||64
277484|NCT00335556|674862|P1|COMPLETED|Overall Study||66
277485|NCT00335556|674857|P6|STARTED|Overall Study||30
277486|NCT00335556|674858|P5|STARTED|Overall Study||78
277487|NCT00335556|674859|P4|STARTED|Overall Study||10
277488|NCT00335556|674860|P3|STARTED|Overall Study||7
277489|NCT00335556|674861|P2|STARTED|Overall Study||98
277490|NCT00335556|674862|P1|STARTED|Overall Study||68
277491|NCT00335517|674883|P1|NOT COMPLETED|Overall Study||2
277492|NCT00335517|674883|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
277493|NCT00335517|674883|P1|STARTED|Overall Study||100
277494|NCT00335504|674891|P4|NOT COMPLETED|Overall Study||0
277495|NCT00335504|674892|P3|NOT COMPLETED|Overall Study||0
277496|NCT00335504|674893|P2|NOT COMPLETED|Overall Study||0
277497|NCT00335504|674894|P1|NOT COMPLETED|Overall Study||0
277498|NCT00335504|674891|P4|COMPLETED|Overall Study||22
277499|NCT00335504|674892|P3|COMPLETED|Overall Study||20
277500|NCT00335504|674893|P2|COMPLETED|Overall Study||21
277501|NCT00335504|674894|P1|COMPLETED|Overall Study||22
277502|NCT00335504|674891|P4|STARTED|Overall Study||22
277503|NCT00335504|674892|P3|STARTED|Overall Study||20
277504|NCT00335504|674893|P2|STARTED|Overall Study||21
277505|NCT00335504|674894|P1|STARTED|Overall Study||22
277506|NCT00335478|674916|P1|NOT COMPLETED|Overall Study||24
277507|NCT00335478|674916|P1|COMPLETED|Overall Study||30
277508|NCT00335478|674916|P1|STARTED|Overall Study||54
277509|NCT00335452|674924|P4|NOT COMPLETED|Overall Study||131
277510|NCT00335452|674925|P3|NOT COMPLETED|Overall Study||159
277511|NCT00335452|674926|P2|NOT COMPLETED|Overall Study||147
277512|NCT00335452|674927|P1|NOT COMPLETED|Overall Study||158
277513|NCT00335452|674924|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
277514|NCT00335452|674925|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
277515|NCT00335452|674926|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
277516|NCT00335452|674927|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
277517|NCT00335452|674924|P4|TREATED WITH ASA|Overall Study||6247
277518|NCT00335452|674925|P3|TREATED WITH ASA|Overall Study||6261
277519|NCT00335452|674926|P2|TREATED WITH ASA|Overall Study||6251
277520|NCT00335452|674927|P1|TREATED WITH ASA|Overall Study||6302
277521|NCT00335452|674924|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
277522|NCT00335452|674925|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
277523|NCT00335452|674926|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
277524|NCT00335452|674927|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
277525|NCT00335452|674924|P4|STARTED|Overall Study|Randomized|6253
277526|NCT00335452|674925|P3|STARTED|Overall Study|Randomized|6267
277527|NCT00335452|674926|P2|STARTED|Overall Study|Randomized|6254
277528|NCT00335452|674927|P1|STARTED|Overall Study|Randomized|6312
277529|NCT00335322|674952|P3|NOT COMPLETED|Overall Study||2
277530|NCT00335322|674953|P2|NOT COMPLETED|Overall Study||2
277531|NCT00335322|674954|P1|NOT COMPLETED|Overall Study||1
277532|NCT00335322|674952|P3|COMPLETED|Overall Study||103
277533|NCT00335322|674953|P2|COMPLETED|Overall Study||105
277534|NCT00335322|674954|P1|COMPLETED|Overall Study||114
277535|NCT00335322|674952|P3|STARTED|Overall Study||105
277536|NCT00335322|674953|P2|STARTED|Overall Study||107
277537|NCT00335322|674954|P1|STARTED|Overall Study||115
277538|NCT00335283|674964|P2|NOT COMPLETED|Overall Study||5
277539|NCT00335283|674965|P1|NOT COMPLETED|Overall Study||6
277540|NCT00335283|674964|P2|COMPLETED|Overall Study||34
277541|NCT00335283|674965|P1|COMPLETED|Overall Study||30
277542|NCT00335283|674964|P2|STARTED|Overall Study||39
277543|NCT00335283|674965|P1|STARTED|Overall Study||36
277544|NCT00335257|674980|P3|NOT COMPLETED|Overall Study||0
277545|NCT00335257|674981|P2|NOT COMPLETED|Overall Study||0
277546|NCT00335257|674982|P1|NOT COMPLETED|Overall Study||0
277639|NCT00333879|675207|P1|NOT COMPLETED|Overall Study||0
277547|NCT00335257|674980|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
277548|NCT00335257|674981|P2|COMPLETED|Overall Study||9377
277549|NCT00335257|674982|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
277550|NCT00335257|674980|P3|STARTED|Overall Study||60190
277551|NCT00335257|674981|P2|STARTED|Overall Study||9377
277552|NCT00335257|674982|P1|STARTED|Overall Study||15542
277553|NCT00335153|674999|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
277554|NCT00335153|674999|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
277555|NCT00335153|674999|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
277556|NCT00335153|674999|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
277557|NCT00335153|674999|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
277558|NCT00335153|674999|P1|STARTED|Nasojejunal (NJ) Test Period||354
277559|NCT00335140|675036|P1|NOT COMPLETED|Overall Study||1
277560|NCT00335140|675036|P1|COMPLETED|Overall Study||25
277561|NCT00335140|675036|P1|Treated|Overall Study||25
277562|NCT00335140|675036|P1|Eligible|Overall Study||25
277563|NCT00335140|675036|P1|STARTED|Overall Study||26
277564|NCT00334958|675042|P2|NOT COMPLETED|Overall Study||24
277565|NCT00334958|675043|P1|NOT COMPLETED|Overall Study||37
277566|NCT00334958|675042|P2|COMPLETED|Overall Study||156
277567|NCT00334958|675043|P1|COMPLETED|Overall Study||139
277568|NCT00334958|675042|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
277569|NCT00334958|675043|P1|STARTED|Overall Study||176
277570|NCT00334893|675057|P2|NOT COMPLETED|Overall Study||0
277571|NCT00334893|675058|P1|NOT COMPLETED|Overall Study||1
277572|NCT00334893|675057|P2|COMPLETED|Overall Study||37
277573|NCT00334893|675058|P1|COMPLETED|Overall Study||36
277574|NCT00334893|675057|P2|STARTED|Overall Study||37
277575|NCT00334893|675058|P1|STARTED|Overall Study||37
277576|NCT00334815|675068|P2|NOT COMPLETED|Overall Study||10
277577|NCT00334815|675069|P1|NOT COMPLETED|Overall Study||7
277578|NCT00334815|675068|P2|COMPLETED|Overall Study||3
277579|NCT00334815|675069|P1|COMPLETED|Overall Study||9
277580|NCT00334815|675068|P2|STARTED|Overall Study||13
277581|NCT00334815|675069|P1|STARTED|Overall Study||16
277582|NCT00334802|675083|P2|NOT COMPLETED|Overall Study||40
277583|NCT00334802|675084|P1|NOT COMPLETED|Overall Study||6
277584|NCT00334802|675083|P2|COMPLETED|Overall Study||16
277585|NCT00334802|675084|P1|COMPLETED|Overall Study||0
277586|NCT00334802|675083|P2|STARTED|Overall Study||56
277587|NCT00334802|675084|P1|STARTED|Overall Study||6
277588|NCT00334633|675104|P3|NOT COMPLETED|Overall Study||82
277589|NCT00334633|675105|P2|NOT COMPLETED|Overall Study||82
277590|NCT00334633|675106|P1|NOT COMPLETED|Overall Study||80
277591|NCT00334633|675104|P3|COMPLETED|Overall Study||114
277592|NCT00334633|675105|P2|COMPLETED|Overall Study||118
277593|NCT00334633|675106|P1|COMPLETED|Overall Study||117
277594|NCT00334633|675104|P3|STARTED|Overall Study||196
277595|NCT00334633|675105|P2|STARTED|Overall Study||200
277596|NCT00334633|675106|P1|STARTED|Overall Study||197
277597|NCT00334542|675117|P1|NOT COMPLETED|Overall Study||5
277598|NCT00334542|675117|P1|COMPLETED|Overall Study||45
277599|NCT00334542|675117|P1|STARTED|Overall Study||50
277600|NCT00334295|675122|P1|NOT COMPLETED|Overall Study||5
277601|NCT00334295|675122|P1|COMPLETED|Overall Study||30
277602|NCT00334295|675122|P1|STARTED|Overall Study||35
277603|NCT00334282|675132|P2|NOT COMPLETED|Overall Study||108
277604|NCT00334282|675133|P1|NOT COMPLETED|Overall Study||222
277605|NCT00334282|675132|P2|COMPLETED|Overall Study||37
277606|NCT00334282|675133|P1|COMPLETED|Overall Study||68
277607|NCT00334282|675132|P2|STARTED|Overall Study||145
277608|NCT00334282|675133|P1|STARTED|Overall Study||290
277609|NCT00334204|675156|P1|NOT COMPLETED|Overall Study||2
277610|NCT00334204|675156|P1|COMPLETED|Overall Study||56
277611|NCT00334204|675156|P1|STARTED|Overall Study||58
277612|NCT00334113|675164|P2|NOT COMPLETED|Overall Study||3
277613|NCT00334113|675165|P1|NOT COMPLETED|Overall Study||2
277614|NCT00334113|675164|P2|COMPLETED|Overall Study||31
277615|NCT00334113|675165|P1|COMPLETED|Overall Study||30
277616|NCT00334113|675164|P2|STARTED|Overall Study||34
277617|NCT00334113|675165|P1|STARTED|Overall Study||32
277618|NCT00334074|675171|P1|NOT COMPLETED|Overall Study||0
277619|NCT00334074|675171|P1|COMPLETED|Overall Study||30
277620|NCT00334074|675171|P1|STARTED|Overall Study||30
277621|NCT00334061|675176|P1|NOT COMPLETED|Overall Study||0
277622|NCT00334061|675176|P1|COMPLETED|Overall Study|November 2007|125
277623|NCT00334061|675176|P1|STARTED|Overall Study|June 2006|125
277624|NCT00333983|675188|P3|NOT COMPLETED|Overall Study||2
277625|NCT00333983|675189|P2|NOT COMPLETED|Overall Study||5
277626|NCT00333983|675190|P1|NOT COMPLETED|Overall Study||3
277627|NCT00333983|675188|P3|COMPLETED|Overall Study||19
277628|NCT00333983|675189|P2|COMPLETED|Overall Study||16
277629|NCT00333983|675190|P1|COMPLETED|Overall Study||17
277630|NCT00333983|675188|P3|STARTED|Overall Study||21
277631|NCT00333983|675189|P2|STARTED|Overall Study||21
277632|NCT00333983|675190|P1|STARTED|Overall Study||20
277633|NCT00333970|675200|P2|NOT COMPLETED|Overall Study||7
277634|NCT00333970|675201|P1|NOT COMPLETED|Overall Study||13
277635|NCT00333970|675200|P2|COMPLETED|Overall Study||18
277636|NCT00333970|675201|P1|COMPLETED|Overall Study||37
277637|NCT00333970|675200|P2|STARTED|Overall Study||25
277638|NCT00333970|675201|P1|STARTED|Overall Study||50
277640|NCT00333879|675207|P1|COMPLETED|Overall Study||4
277641|NCT00333879|675207|P1|STARTED|Overall Study||4
277642|NCT00333866|675216|P4|NOT COMPLETED|Overall Study||66
277643|NCT00333866|675217|P3|NOT COMPLETED|Overall Study||51
277644|NCT00333866|675218|P2|NOT COMPLETED|Overall Study||64
277645|NCT00333866|675219|P1|NOT COMPLETED|Overall Study||48
277646|NCT00333866|675216|P4|COMPLETED|Overall Study||121
277647|NCT00333866|675217|P3|COMPLETED|Overall Study||133
277648|NCT00333866|675218|P2|COMPLETED|Overall Study||123
277649|NCT00333866|675219|P1|COMPLETED|Overall Study||141
277650|NCT00333866|675216|P4|TREATED|Overall Study||186
277651|NCT00333866|675217|P3|TREATED|Overall Study||182
277652|NCT00333866|675218|P2|TREATED|Overall Study||184
277653|NCT00333866|675219|P1|TREATED|Overall Study||184
277654|NCT00333866|675216|P4|STARTED|Overall Study||187
277655|NCT00333866|675217|P3|STARTED|Overall Study||184
277656|NCT00333866|675218|P2|STARTED|Overall Study||187
277657|NCT00333866|675219|P1|STARTED|Overall Study||189
277658|NCT00333840|675279|P4|NOT COMPLETED|Second-line Treatment Period||188
277659|NCT00333840|675280|P3|NOT COMPLETED|Second-line Treatment Period||14
277660|NCT00333840|675281|P2|NOT COMPLETED|Second-line Treatment Period||0
277661|NCT00333840|675282|P1|NOT COMPLETED|Second-line Treatment Period||0
277662|NCT00333840|675279|P4|COMPLETED|Second-line Treatment Period||175
277663|NCT00333840|675280|P3|COMPLETED|Second-line Treatment Period||0
277664|NCT00333840|675281|P2|COMPLETED|Second-line Treatment Period||0
277665|NCT00333840|675282|P1|COMPLETED|Second-line Treatment Period||0
277666|NCT00333840|675279|P4|STARTED|Second-line Treatment Period||363
277667|NCT00333840|675280|P3|STARTED|Second-line Treatment Period||14
277668|NCT00333840|675281|P2|STARTED|Second-line Treatment Period||0
277669|NCT00333840|675282|P1|STARTED|Second-line Treatment Period||0
277670|NCT00333840|675279|P4|NOT COMPLETED|First-line Treatment Period||0
277671|NCT00333840|675280|P3|NOT COMPLETED|First-line Treatment Period||0
277672|NCT00333840|675281|P2|NOT COMPLETED|First-line Treatment Period||546
277673|NCT00333840|675282|P1|NOT COMPLETED|First-line Treatment Period||286
277674|NCT00333840|675279|P4|COMPLETED|First-line Treatment Period||0
277675|NCT00333840|675280|P3|COMPLETED|First-line Treatment Period||0
277676|NCT00333840|675281|P2|COMPLETED|First-line Treatment Period||7
277677|NCT00333840|675282|P1|COMPLETED|First-line Treatment Period||267
277678|NCT00333840|675279|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
277679|NCT00333840|675280|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
277680|NCT00333840|675281|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
277681|NCT00333840|675282|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
277682|NCT00333840|675279|P4|STARTED|First-line Treatment Period||0
277683|NCT00333840|675280|P3|STARTED|First-line Treatment Period||0
277684|NCT00333840|675281|P2|STARTED|First-line Treatment Period||553
277685|NCT00333840|675282|P1|STARTED|First-line Treatment Period||553
277686|NCT00333814|675310|P3|NOT COMPLETED|Overall Study||5
277687|NCT00333814|675311|P2|NOT COMPLETED|Overall Study||4
277688|NCT00333814|675312|P1|NOT COMPLETED|Overall Study||3
277689|NCT00333814|675310|P3|COMPLETED|Overall Study||71
277690|NCT00333814|675311|P2|COMPLETED|Overall Study||73
277691|NCT00333814|675312|P1|COMPLETED|Overall Study||73
277692|NCT00333814|675310|P3|STARTED|Overall Study||76
277693|NCT00333814|675311|P2|STARTED|Overall Study||77
277694|NCT00333814|675312|P1|STARTED|Overall Study||76
277695|NCT00333801|675328|P2|NOT COMPLETED|Overall Study||6
277696|NCT00333801|675329|P1|NOT COMPLETED|Overall Study||8
277697|NCT00333801|675328|P2|COMPLETED|Overall Study||36
277698|NCT00333801|675329|P1|COMPLETED|Overall Study||35
277699|NCT00333801|675328|P2|STARTED|Overall Study||42
277700|NCT00333801|675329|P1|STARTED|Overall Study||43
277701|NCT00333788|675347|P1|NOT COMPLETED|Overall Study||162
277702|NCT00333788|675347|P1|COMPLETED|Overall Study||71
277703|NCT00333788|675347|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
277704|NCT00333775|675377|P3|NOT COMPLETED|Overall Study||247
277705|NCT00333775|675378|P2|NOT COMPLETED|Overall Study||248
277706|NCT00333775|675379|P1|NOT COMPLETED|Overall Study||241
277707|NCT00333775|675377|P3|COMPLETED|Overall Study||0
277708|NCT00333775|675378|P2|COMPLETED|Overall Study||0
277709|NCT00333775|675379|P1|COMPLETED|Overall Study||0
277710|NCT00333775|675377|P3|Received Treatment|Overall Study||245
277711|NCT00333775|675378|P2|Received Treatment|Overall Study||247
277712|NCT00333775|675379|P1|Received Treatment|Overall Study||238
277713|NCT00333775|675377|P3|STARTED|Overall Study||247
277714|NCT00333775|675378|P2|STARTED|Overall Study||248
277715|NCT00333775|675379|P1|STARTED|Overall Study||241
277716|NCT00333762|675399|P1|NOT COMPLETED|Overall Study||4
277717|NCT00333762|675399|P1|COMPLETED|Overall Study||0
277718|NCT00333762|675399|P1|STARTED|Overall Study||4
277719|NCT00333710|675406|P3|NOT COMPLETED|Overall Study||1
277720|NCT00333710|675407|P2|NOT COMPLETED|Overall Study||4
277721|NCT00333710|675408|P1|NOT COMPLETED|Overall Study||11
277722|NCT00333710|675406|P3|COMPLETED|Overall Study||15
277723|NCT00333710|675407|P2|COMPLETED|Overall Study||14
277724|NCT00333710|675408|P1|COMPLETED|Overall Study||8
277725|NCT00333710|675406|P3|STARTED|Overall Study||16
277726|NCT00333710|675407|P2|STARTED|Overall Study||18
277727|NCT00333710|675408|P1|STARTED|Overall Study||19
277728|NCT00333619|675418|P2|NOT COMPLETED|Overall Study||10
277729|NCT00333619|675419|P1|NOT COMPLETED|Overall Study||21
277730|NCT00333619|675418|P2|COMPLETED|Overall Study||99
277731|NCT00333619|675419|P1|COMPLETED|Overall Study||89
277732|NCT00333619|675418|P2|3-month Follow-up|Overall Study||105
277733|NCT00333619|675419|P1|3-month Follow-up|Overall Study||101
277734|NCT00333619|675418|P2|Post-treatment|Overall Study||109
277735|NCT00333619|675419|P1|Post-treatment|Overall Study||109
277736|NCT00333619|675418|P2|STARTED|Overall Study||109
277737|NCT00333619|675419|P1|STARTED|Overall Study||110
277738|NCT00333437|675427|P1|NOT COMPLETED|Overall Study||0
277739|NCT00333437|675427|P1|COMPLETED|Overall Study||7
277740|NCT00333437|675427|P1|STARTED|Overall Study||7
277741|NCT00333359|675437|P2|NOT COMPLETED|Overall Study||122
277742|NCT00333359|675438|P1|NOT COMPLETED|Overall Study||73
277743|NCT00333359|675437|P2|COMPLETED|Overall Study||260
277744|NCT00333359|675438|P1|COMPLETED|Overall Study||126
277745|NCT00333359|675437|P2|STARTED|Overall Study||382
277746|NCT00333359|675438|P1|STARTED|Overall Study||199
277747|NCT00333229|675481|P2|NOT COMPLETED|Overall Study||1
277748|NCT00333229|675482|P1|NOT COMPLETED|Overall Study||0
277749|NCT00333229|675481|P2|COMPLETED|Overall Study||4
277750|NCT00333229|675482|P1|COMPLETED|Overall Study||6
277751|NCT00333229|675481|P2|STARTED|Overall Study||5
277752|NCT00333229|675482|P1|STARTED|Overall Study||6
277753|NCT00333138|675499|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
277754|NCT00333138|675500|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
277755|NCT00333138|675501|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
277756|NCT00333138|675499|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
277757|NCT00333138|675500|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
277758|NCT00333138|675501|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
277759|NCT00333138|675499|P3|STARTED|Extension Study (Month6 to End of Study)||80
277760|NCT00333138|675500|P2|STARTED|Extension Study (Month6 to End of Study)||87
277761|NCT00333138|675501|P1|STARTED|Extension Study (Month6 to End of Study)||83
277762|NCT00333138|675499|P3|NOT COMPLETED|Core Study (6 Months)||12
277763|NCT00333138|675500|P2|NOT COMPLETED|Core Study (6 Months)||6
277764|NCT00333138|675501|P1|NOT COMPLETED|Core Study (6 Months)||7
277765|NCT00333138|675499|P3|COMPLETED|Core Study (6 Months)||82
277766|NCT00333138|675500|P2|COMPLETED|Core Study (6 Months)||88
277767|NCT00333138|675501|P1|COMPLETED|Core Study (6 Months)||86
277768|NCT00333138|675499|P3|STARTED|Core Study (6 Months)||94
277769|NCT00333138|675500|P2|STARTED|Core Study (6 Months)||94
277770|NCT00333138|675501|P1|STARTED|Core Study (6 Months)||93
277771|NCT00332839|675540|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
277772|NCT00332839|675541|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
277773|NCT00332839|675540|P2|COMPLETED|Follow-up (Months 12 - 60)||31
277774|NCT00332839|675541|P1|COMPLETED|Follow-up (Months 12 - 60)||29
277775|NCT00332839|675540|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
277776|NCT00332839|675541|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
277777|NCT00332839|675540|P2|NOT COMPLETED|Core (Months 0 - 12)||18
277778|NCT00332839|675541|P1|NOT COMPLETED|Core (Months 0 - 12)||10
277779|NCT00332839|675540|P2|COMPLETED|Core (Months 0 - 12)||28
277780|NCT00332839|675541|P1|COMPLETED|Core (Months 0 - 12)||37
277781|NCT00332839|675540|P2|Safety Set|Core (Months 0 - 12)||46
277782|NCT00332839|675541|P1|Safety Set|Core (Months 0 - 12)||47
277783|NCT00332839|675540|P2|STARTED|Core (Months 0 - 12)||46
277784|NCT00332839|675541|P1|STARTED|Core (Months 0 - 12)||47
277785|NCT00332722|675561|P2|NOT COMPLETED|Overall Study||0
277786|NCT00332722|675562|P1|NOT COMPLETED|Overall Study||0
277787|NCT00332722|675561|P2|COMPLETED|Overall Study||60
277788|NCT00332722|675562|P1|COMPLETED|Overall Study||60
277789|NCT00332722|675561|P2|STARTED|Overall Study||60
277790|NCT00332722|675562|P1|STARTED|Overall Study||60
277791|NCT00332709|675572|P2|NOT COMPLETED|Overall Study||20
277792|NCT00332709|675573|P1|NOT COMPLETED|Overall Study||16
277793|NCT00332709|675572|P2|COMPLETED|Overall Study||21
277794|NCT00332709|675573|P1|COMPLETED|Overall Study||24
277795|NCT00332709|675572|P2|STARTED|Overall Study||41
277796|NCT00332709|675573|P1|STARTED|Overall Study||40
277797|NCT00332696|675597|P2|NOT COMPLETED|Overall Study||30
277798|NCT00332696|675598|P1|NOT COMPLETED|Overall Study||30
277799|NCT00332696|675597|P2|COMPLETED|Overall Study||2
277800|NCT00332696|675598|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
277801|NCT00332696|675597|P2|Completed Day 14 Visit|Overall Study||15
277802|NCT00332696|675598|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
277803|NCT00332696|675597|P2|STARTED|Overall Study||32
277804|NCT00332696|675598|P1|STARTED|Overall Study||32
277805|NCT00332644|675630|P6|NOT COMPLETED|Overall Study||15
277806|NCT00332644|675631|P5|NOT COMPLETED|Overall Study||12
277807|NCT00332644|675632|P4|NOT COMPLETED|Overall Study||20
277808|NCT00332644|675633|P3|NOT COMPLETED|Overall Study||9
277809|NCT00332644|675634|P2|NOT COMPLETED|Overall Study||22
277810|NCT00332644|675635|P1|NOT COMPLETED|Overall Study||12
277811|NCT00332644|675630|P6|COMPLETED|Overall Study||174
277812|NCT00332644|675631|P5|COMPLETED|Overall Study||250
277813|NCT00332644|675632|P4|COMPLETED|Overall Study||244
277814|NCT00332644|675633|P3|COMPLETED|Overall Study||258
277815|NCT00332644|675634|P2|COMPLETED|Overall Study||238
277816|NCT00332644|675635|P1|COMPLETED|Overall Study||250
277817|NCT00332644|675630|P6|STARTED|Overall Study||189
277818|NCT00332644|675631|P5|STARTED|Overall Study||262
277819|NCT00332644|675632|P4|STARTED|Overall Study||264
277820|NCT00332644|675633|P3|STARTED|Overall Study||267
277821|NCT00332644|675634|P2|STARTED|Overall Study||260
277822|NCT00332644|675635|P1|STARTED|Overall Study||262
277823|NCT00332605|675652|P3|NOT COMPLETED|Overall Study||8
277824|NCT00332605|675653|P2|NOT COMPLETED|Overall Study||2
277825|NCT00332605|675654|P1|NOT COMPLETED|Overall Study||2
277826|NCT00332605|675652|P3|COMPLETED|Overall Study||9
277827|NCT00332605|675653|P2|COMPLETED|Overall Study||12
277828|NCT00332605|675654|P1|COMPLETED|Overall Study||12
277829|NCT00332605|675652|P3|STARTED|Overall Study||17
277830|NCT00332605|675653|P2|STARTED|Overall Study||14
277831|NCT00332605|675654|P1|STARTED|Overall Study||14
277832|NCT00332579|675664|P2|NOT COMPLETED|Overall Study||1
277833|NCT00332579|675665|P1|NOT COMPLETED|Overall Study||1
277834|NCT00332579|675664|P2|COMPLETED|Overall Study||12
277835|NCT00332579|675665|P1|COMPLETED|Overall Study||11
277836|NCT00332579|675664|P2|STARTED|Overall Study||13
277837|NCT00332579|675665|P1|STARTED|Overall Study||12
277838|NCT00332488|675674|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
277839|NCT00332488|675675|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
277840|NCT00332488|675676|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
277841|NCT00332488|675674|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
277842|NCT00332488|675675|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
277843|NCT00332488|675676|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
277844|NCT00332488|675674|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
277845|NCT00332488|675675|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
277846|NCT00332488|675676|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
277847|NCT00332488|675674|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
277848|NCT00332488|675675|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
277849|NCT00332488|675676|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
277850|NCT00332488|675674|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
277851|NCT00332488|675675|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
277852|NCT00332488|675676|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
277853|NCT00332488|675674|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
277854|NCT00332488|675675|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
277855|NCT00332488|675676|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
277856|NCT00332462|675688|P1|NOT COMPLETED|Overall Study||16
277857|NCT00332462|675688|P1|COMPLETED|Overall Study||18
277858|NCT00332462|675688|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
277859|NCT00332462|675688|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
277860|NCT00332462|675688|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
277861|NCT00332332|675695|P1|NOT COMPLETED|Overall Study||68
277862|NCT00332332|675695|P1|COMPLETED|Overall Study||178
277863|NCT00332332|675695|P1|Received Study Medication|Overall Study||230
277864|NCT00332332|675695|P1|STARTED|Overall Study||246
277865|NCT00332241|675704|P2|NOT COMPLETED|Overall Study||8
277866|NCT00332241|675705|P1|NOT COMPLETED|Overall Study||15
277867|NCT00332241|675704|P2|COMPLETED|Overall Study||39
277868|NCT00332241|675705|P1|COMPLETED|Overall Study||36
277869|NCT00332241|675704|P2|STARTED|Overall Study||47
277870|NCT00332241|675705|P1|STARTED|Overall Study||51
277871|NCT00332189|675725|P1|NOT COMPLETED|Overall Study||21
277872|NCT00332189|675725|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
277873|NCT00332189|675725|P1|STARTED|Overall Study||111
277874|NCT00332163|675732|P2|NOT COMPLETED|Overall Study||0
277875|NCT00332163|675733|P1|NOT COMPLETED|Overall Study||0
277876|NCT00332163|675732|P2|COMPLETED|Overall Study||47
277877|NCT00332163|675733|P1|COMPLETED|Overall Study||48
277878|NCT00332163|675732|P2|Received Treatment|Overall Study||47
277879|NCT00332163|675733|P1|Received Treatment|Overall Study||48
277880|NCT00332163|675732|P2|STARTED|Overall Study||47
277881|NCT00332163|675733|P1|STARTED|Overall Study||48
277882|NCT00331864|675767|P2|NOT COMPLETED|Overall Study||4
277883|NCT00331864|675768|P1|NOT COMPLETED|Overall Study||58
277884|NCT00331864|675767|P2|COMPLETED|Overall Study||14
277885|NCT00331864|675768|P1|COMPLETED|Overall Study||455
277886|NCT00331864|675767|P2|STARTED|Overall Study||18
277887|NCT00331864|675768|P1|STARTED|Overall Study||513
277888|NCT00331799|675787|P1|NOT COMPLETED|Overall Study||3
277889|NCT00331799|675787|P1|COMPLETED|Overall Study||15
277890|NCT00331799|675787|P1|STARTED|Overall Study||18
277891|NCT00331773|675793|P2|NOT COMPLETED|Overall Study||7
277892|NCT00331773|675794|P1|NOT COMPLETED|Overall Study||16
277893|NCT00331773|675793|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
277894|NCT00331773|675794|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
277895|NCT00331773|675793|P2|STARTED|Overall Study||557
277896|NCT00331773|675794|P1|STARTED|Overall Study||558
277897|NCT00331760|675822|P2|NOT COMPLETED|Overall Study||8
277898|NCT00331760|675823|P1|NOT COMPLETED|Overall Study||15
277899|NCT00331760|675822|P2|COMPLETED|Overall Study||40
277900|NCT00331760|675823|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
277901|NCT00331760|675822|P2|STARTED|Overall Study||48
277902|NCT00331760|675823|P1|STARTED|Overall Study||58
277903|NCT00331682|675829|P1|NOT COMPLETED|Overall Study||1
277904|NCT00331682|675829|P1|COMPLETED|Overall Study||9
277905|NCT00331682|675829|P1|STARTED|Overall Study||10
277906|NCT00331552|675837|P2|NOT COMPLETED|Period 3: Phase II||0
277907|NCT00331552|675838|P1|NOT COMPLETED|Period 3: Phase II||2
277908|NCT00331552|675837|P2|COMPLETED|Period 3: Phase II||0
277909|NCT00331552|675838|P1|COMPLETED|Period 3: Phase II||22
277910|NCT00331552|675837|P2|STARTED|Period 3: Phase II||0
277911|NCT00331552|675838|P1|STARTED|Period 3: Phase II||24
277912|NCT00331552|675837|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
277913|NCT00331552|675838|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
277914|NCT00331552|675837|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
277915|NCT00331552|675838|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
277916|NCT00331552|675837|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
277917|NCT00331552|675838|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
277918|NCT00331552|675837|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
277919|NCT00331552|675838|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
277920|NCT00331552|675837|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
277921|NCT00331552|675838|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
277922|NCT00331552|675837|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
277923|NCT00331552|675838|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
277924|NCT00331422|675852|P1|NOT COMPLETED|Overall Study||5
277925|NCT00331422|675852|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
277926|NCT00331422|675852|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
277927|NCT00331409|675861|P1|NOT COMPLETED|Overall Study||4
277928|NCT00331409|675861|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
277929|NCT00331409|675861|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
277930|NCT00331344|675869|P9|NOT COMPLETED|Phase II||4
277931|NCT00331344|675870|P8|NOT COMPLETED|Phase II||0
277932|NCT00331344|675871|P7|NOT COMPLETED|Phase II||0
277933|NCT00331344|675872|P6|NOT COMPLETED|Phase II||0
277934|NCT00331344|675873|P5|NOT COMPLETED|Phase II||0
277935|NCT00331344|675874|P4|NOT COMPLETED|Phase II||0
277936|NCT00331344|675875|P3|NOT COMPLETED|Phase II||0
277937|NCT00331344|675876|P2|NOT COMPLETED|Phase II||0
277938|NCT00331344|675877|P1|NOT COMPLETED|Phase II||0
277939|NCT00331344|675869|P9|COMPLETED|Phase II||48
277940|NCT00331344|675870|P8|COMPLETED|Phase II||6
277941|NCT00331344|675871|P7|COMPLETED|Phase II||0
277942|NCT00331344|675872|P6|COMPLETED|Phase II||0
277943|NCT00331344|675873|P5|COMPLETED|Phase II||0
277944|NCT00331344|675874|P4|COMPLETED|Phase II||0
277945|NCT00331344|675875|P3|COMPLETED|Phase II||0
277946|NCT00331344|675876|P2|COMPLETED|Phase II||0
277947|NCT00331344|675877|P1|COMPLETED|Phase II||0
277948|NCT00331344|675869|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
277949|NCT00331344|675870|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
277950|NCT00331344|675871|P7|STARTED|Phase II||0
277951|NCT00331344|675872|P6|STARTED|Phase II||0
277952|NCT00331344|675873|P5|STARTED|Phase II||0
277953|NCT00331344|675874|P4|STARTED|Phase II||0
277954|NCT00331344|675875|P3|STARTED|Phase II||0
277955|NCT00331344|675876|P2|STARTED|Phase II||0
277956|NCT00331344|675877|P1|STARTED|Phase II||0
277957|NCT00331344|675869|P9|NOT COMPLETED|Phase I||0
277958|NCT00331344|675870|P8|NOT COMPLETED|Phase I||1
277959|NCT00331344|675871|P7|NOT COMPLETED|Phase I||0
277960|NCT00331344|675872|P6|NOT COMPLETED|Phase I||2
277961|NCT00331344|675873|P5|NOT COMPLETED|Phase I||2
277962|NCT00331344|675874|P4|NOT COMPLETED|Phase I||1
277963|NCT00331344|675875|P3|NOT COMPLETED|Phase I||0
277964|NCT00331344|675876|P2|NOT COMPLETED|Phase I||0
277965|NCT00331344|675877|P1|NOT COMPLETED|Phase I||0
277966|NCT00331344|675869|P9|COMPLETED|Phase I||0
277967|NCT00331344|675870|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
277968|NCT00331344|675871|P7|COMPLETED|Phase I||4
277969|NCT00331344|675872|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
277970|NCT00331344|675873|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
277971|NCT00331344|675874|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
277972|NCT00331344|675875|P3|COMPLETED|Phase I||3
277973|NCT00331344|675876|P2|COMPLETED|Phase I||3
277974|NCT00331344|675877|P1|COMPLETED|Phase I||3
277975|NCT00331344|675869|P9|STARTED|Phase I||0
277976|NCT00331344|675870|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
277977|NCT00331344|675871|P7|STARTED|Phase I||4
277978|NCT00331344|675872|P6|STARTED|Phase I||5
277979|NCT00331344|675873|P5|STARTED|Phase I||6
277980|NCT00331344|675874|P4|STARTED|Phase I||6
277981|NCT00331344|675875|P3|STARTED|Phase I||3
277982|NCT00331344|675876|P2|STARTED|Phase I||3
277983|NCT00331344|675877|P1|STARTED|Phase I||3
277984|NCT00331006|675891|P1|NOT COMPLETED|Follow-Up Phase II||3
277985|NCT00331006|675891|P1|COMPLETED|Follow-Up Phase II||11
277986|NCT00331006|675891|P1|STARTED|Follow-Up Phase II||14
277987|NCT00331006|675891|P1|NOT COMPLETED|Follow-Up Phase I||1
277988|NCT00331006|675891|P1|COMPLETED|Follow-Up Phase I||14
277989|NCT00331006|675891|P1|STARTED|Follow-Up Phase I||15
277990|NCT00331006|675891|P1|NOT COMPLETED|Treatment Phase||1
277991|NCT00331006|675891|P1|COMPLETED|Treatment Phase||15
277992|NCT00331006|675891|P1|STARTED|Treatment Phase||16
277993|NCT00331006|675891|P1|NOT COMPLETED|Screening Phase||7
277994|NCT00331006|675891|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
277995|NCT00331006|675891|P1|STARTED|Screening Phase||23
277996|NCT00330967|675904|P2|NOT COMPLETED|Overall Study||14
277997|NCT00330967|675905|P1|NOT COMPLETED|Overall Study||0
277998|NCT00330967|675904|P2|COMPLETED|Overall Study||11
277999|NCT00330967|675905|P1|COMPLETED|Overall Study||0
278000|NCT00330967|675904|P2|STARTED|Overall Study||25
278001|NCT00330967|675905|P1|STARTED|Overall Study||0
278002|NCT00330928|675916|P1|NOT COMPLETED|Overall Study||17
278003|NCT00330928|675916|P1|COMPLETED|Overall Study||89
278004|NCT00330928|675916|P1|1 Year Phone Contact|Overall Study||89
278005|NCT00330928|675916|P1|7 Day Phone Contact|Overall Study||99
278006|NCT00330928|675916|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
278007|NCT00330915|675921|P1|NOT COMPLETED|Overall Study||0
278008|NCT00330915|675921|P1|COMPLETED|Overall Study||37
278009|NCT00330915|675921|P1|STARTED|Overall Study||37
278010|NCT00330876|675928|P2|NOT COMPLETED|Overall Study||13
278011|NCT00330876|675929|P1|NOT COMPLETED|Overall Study||71
278012|NCT00330876|675928|P2|COMPLETED|Overall Study||77
278013|NCT00330876|675929|P1|COMPLETED|Overall Study||378
278014|NCT00330876|675928|P2|STARTED|Overall Study||90
278015|NCT00330876|675929|P1|STARTED|Overall Study||449
278016|NCT00330759|675939|P2|NOT COMPLETED|Overall Study||706
278017|NCT00330759|675940|P1|NOT COMPLETED|Overall Study||712
278018|NCT00330759|675939|P2|COMPLETED|Overall Study||180
278019|NCT00330759|675940|P1|COMPLETED|Overall Study||178
278020|NCT00330759|675939|P2|Received Investigational Product|Overall Study||878
278021|NCT00330759|675940|P1|Received Investigational Product|Overall Study||878
278022|NCT00330759|675939|P2|STARTED|Overall Study||886
278023|NCT00330759|675940|P1|STARTED|Overall Study||890
278024|NCT00330733|675952|P2|NOT COMPLETED|Overall Study||5
278025|NCT00330733|675953|P1|NOT COMPLETED|Overall Study||7
278026|NCT00330733|675952|P2|COMPLETED|Overall Study||29
278027|NCT00330733|675953|P1|COMPLETED|Overall Study||30
278028|NCT00330733|675952|P2|Received Study Medication|Overall Study||34
278029|NCT00330733|675953|P1|Received Study Medication|Overall Study||36
278030|NCT00330733|675952|P2|STARTED|Overall Study||34
278031|NCT00330733|675953|P1|STARTED|Overall Study||37
278032|NCT00330681|675961|P2|NOT COMPLETED|Overall Study||14
278033|NCT00330681|675962|P1|NOT COMPLETED|Overall Study||9
278034|NCT00330681|675961|P2|COMPLETED|Overall Study||90
278035|NCT00330681|675962|P1|COMPLETED|Overall Study||93
278036|NCT00330681|675961|P2|STARTED|Overall Study||104
278037|NCT00330681|675962|P1|STARTED|Overall Study||102
278038|NCT00330668|675984|P1|NOT COMPLETED|Overall Study||114
278039|NCT00330668|675984|P1|COMPLETED|Overall Study||0
278040|NCT00330668|675984|P1|STARTED|Overall Study||114
278041|NCT00330616|675991|P1|NOT COMPLETED|Overall Study||21
278042|NCT00330616|675991|P1|COMPLETED|Overall Study||14
278043|NCT00330616|675991|P1|STARTED|Overall Study||35
278044|NCT00330564|676010|P1|NOT COMPLETED|Overall Study||0
278045|NCT00330564|676010|P1|COMPLETED|Overall Study||15
278046|NCT00330564|676010|P1|STARTED|Overall Study||15
278047|NCT00330460|676017|P2|NOT COMPLETED|Overall Study||33
278048|NCT00330460|676018|P1|NOT COMPLETED|Overall Study||42
278049|NCT00330460|676017|P2|COMPLETED|Overall Study||561
278050|NCT00330460|676018|P1|COMPLETED|Overall Study||553
278051|NCT00330460|676017|P2|STARTED|Overall Study||594
278052|NCT00330460|676018|P1|STARTED|Overall Study||595
278053|NCT00330421|676032|P2|NOT COMPLETED|Overall Study||0
278054|NCT00330421|676033|P1|NOT COMPLETED|Overall Study||0
278055|NCT00330421|676032|P2|COMPLETED|Overall Study||0
278056|NCT00330421|676033|P1|COMPLETED|Overall Study||15
278057|NCT00330421|676032|P2|STARTED|Overall Study||0
278058|NCT00330421|676033|P1|STARTED|Overall Study||15
278059|NCT00330382|676039|P2|NOT COMPLETED|Overall Study||17
278060|NCT00330382|676040|P1|NOT COMPLETED|Overall Study||24
278061|NCT00330382|676039|P2|COMPLETED|Overall Study||48
278062|NCT00330382|676040|P1|COMPLETED|Overall Study||43
278063|NCT00330382|676039|P2|STARTED|Overall Study||65
278064|NCT00330382|676040|P1|STARTED|Overall Study||67
278065|NCT00330343|676061|P1|NOT COMPLETED|Overall Study||5
278066|NCT00330343|676061|P1|COMPLETED|Overall Study||59
278067|NCT00330343|676061|P1|STARTED|Overall Study||64
278068|NCT00330174|676067|P2|NOT COMPLETED|Overall Study||19
278069|NCT00330174|676068|P1|NOT COMPLETED|Overall Study||22
278070|NCT00330174|676067|P2|COMPLETED|Overall Study||26
278071|NCT00330174|676068|P1|COMPLETED|Overall Study||23
278072|NCT00330174|676067|P2|STARTED|Overall Study||45
278073|NCT00330174|676068|P1|STARTED|Overall Study||45
278074|NCT00330161|676080|P1|NOT COMPLETED|Overall Study||0
278075|NCT00330161|676080|P1|COMPLETED|Overall Study||29
278076|NCT00330161|676080|P1|STARTED|Overall Study||29
278077|NCT00329901|676092|P3|NOT COMPLETED|Overall Study||4
278078|NCT00329901|676093|P2|NOT COMPLETED|Overall Study||5
278079|NCT00329901|676094|P1|NOT COMPLETED|Overall Study||9
278080|NCT00329901|676092|P3|COMPLETED|Overall Study||353
278081|NCT00329901|676093|P2|COMPLETED|Overall Study||349
278082|NCT00329901|676094|P1|COMPLETED|Overall Study||352
278083|NCT00329901|676092|P3|STARTED|Overall Study||357
278084|NCT00329901|676093|P2|STARTED|Overall Study||354
278085|NCT00329901|676094|P1|STARTED|Overall Study||361
278086|NCT00329849|676124|P2|NOT COMPLETED|Overall Study||4
278087|NCT00329849|676125|P1|NOT COMPLETED|Overall Study||6
278088|NCT00329849|676124|P2|COMPLETED|Overall Study||546
278089|NCT00329849|676125|P1|COMPLETED|Overall Study||944
278090|NCT00329849|676124|P2|STARTED|Overall Study||550
278091|NCT00329849|676125|P1|STARTED|Overall Study||950
278092|NCT00329836|676145|P1|NOT COMPLETED|Overall Study||0
278093|NCT00329836|676145|P1|COMPLETED|Overall Study||41
278094|NCT00329836|676145|P1|STARTED|Overall Study||41
278095|NCT00329797|676151|P2|NOT COMPLETED|Overall Study||6
278096|NCT00329797|676152|P1|NOT COMPLETED|Overall Study||7
278097|NCT00329797|676151|P2|COMPLETED|Overall Study||46
278098|NCT00329797|676152|P1|COMPLETED|Overall Study||50
278099|NCT00329797|676151|P2|STARTED|Overall Study||52
278100|NCT00329797|676152|P1|STARTED|Overall Study||57
278101|NCT00329784|676168|P4|NOT COMPLETED|Overall Study||0
278102|NCT00329784|676169|P3|NOT COMPLETED|Overall Study||0
278103|NCT00329784|676170|P2|NOT COMPLETED|Overall Study||5
278104|NCT00329784|676171|P1|NOT COMPLETED|Overall Study||5
278105|NCT00329784|676168|P4|COMPLETED|Overall Study||47
278106|NCT00329784|676169|P3|COMPLETED|Overall Study||51
278107|NCT00329784|676170|P2|COMPLETED|Overall Study||267
278108|NCT00329784|676171|P1|COMPLETED|Overall Study||265
278109|NCT00329784|676168|P4|STARTED|Overall Study||47
278110|NCT00329784|676169|P3|STARTED|Overall Study||51
278111|NCT00329784|676170|P2|STARTED|Overall Study||272
278112|NCT00329784|676171|P1|STARTED|Overall Study||270
278113|NCT00329771|676193|P1|NOT COMPLETED|Overall Study||3
278114|NCT00329771|676193|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
278115|NCT00329771|676193|P1|STARTED|Overall Study||28
278116|NCT00329745|676199|P2|NOT COMPLETED|Overall Study||102
278117|NCT00329745|676200|P1|NOT COMPLETED|Overall Study||87
278118|NCT00329745|676199|P2|COMPLETED|Overall Study||4226
278119|NCT00329745|676200|P1|COMPLETED|Overall Study||4272
278120|NCT00329745|676199|P2|STARTED|Overall Study||4328
278121|NCT00329745|676200|P1|STARTED|Overall Study||4359
278122|NCT00329732|676210|P2|NOT COMPLETED|Overall Study||0
278123|NCT00329732|676211|P1|NOT COMPLETED|Overall Study||0
278124|NCT00329732|676210|P2|COMPLETED|Overall Study||0
278125|NCT00329732|676211|P1|COMPLETED|Overall Study||2
278126|NCT00329732|676210|P2|STARTED|Overall Study||0
278127|NCT00329732|676211|P1|STARTED|Overall Study||2
278128|NCT00329719|676220|P4|NOT COMPLETED|Overall Study||1
278129|NCT00329719|676221|P3|NOT COMPLETED|Overall Study||0
278130|NCT00329719|676222|P2|NOT COMPLETED|Overall Study||0
278131|NCT00329719|676223|P1|NOT COMPLETED|Overall Study||0
278132|NCT00329719|676220|P4|COMPLETED|Overall Study||44
278133|NCT00329719|676221|P3|COMPLETED|Overall Study||9
278134|NCT00329719|676222|P2|COMPLETED|Overall Study||49
278135|NCT00329719|676223|P1|COMPLETED|Overall Study||12
278136|NCT00329719|676220|P4|STARTED|Overall Study||45
278137|NCT00329719|676221|P3|STARTED|Overall Study||9
278138|NCT00329719|676222|P2|STARTED|Overall Study||49
278139|NCT00329719|676223|P1|STARTED|Overall Study||12
278140|NCT00329641|676245|P1|NOT COMPLETED|Overall Study||6
278141|NCT00329641|676245|P1|COMPLETED|Overall Study||19
278142|NCT00329641|676245|P1|Eligible and Received Treatment|Overall Study||24
278143|NCT00329641|676245|P1|Eligible|Overall Study||25
278144|NCT00329641|676245|P1|STARTED|Overall Study||25
278145|NCT00329602|676254|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
278146|NCT00329602|676255|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
278147|NCT00329602|676256|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
278148|NCT00329602|676254|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
278149|NCT00329602|676255|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
278150|NCT00329602|676256|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
278151|NCT00329602|676254|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
278152|NCT00329602|676255|P2|STARTED|40-Week Open-Label Treatment Phase||0
278153|NCT00329602|676256|P1|STARTED|40-Week Open-Label Treatment Phase||0
278154|NCT00329602|676254|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
278155|NCT00329602|676255|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
278156|NCT00329602|676256|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
278157|NCT00329602|676254|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
278158|NCT00329602|676255|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
278159|NCT00329602|676256|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
278160|NCT00329602|676254|P3|STARTED|26-Week Double-Blind Treatment Phase||0
278161|NCT00329602|676255|P2|STARTED|26-Week Double-Blind Treatment Phase||197
278162|NCT00329602|676256|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
278163|NCT00329550|676294|P3|NOT COMPLETED|Overall Study||4
278164|NCT00329550|676295|P2|NOT COMPLETED|Overall Study||4
278165|NCT00329550|676296|P1|NOT COMPLETED|Overall Study||4
278166|NCT00329550|676294|P3|COMPLETED|Overall Study||12
278167|NCT00329550|676295|P2|COMPLETED|Overall Study||11
278168|NCT00329550|676296|P1|COMPLETED|Overall Study||5
278169|NCT00329550|676294|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
278170|NCT00329550|676295|P2|STARTED|Overall Study||15
278171|NCT00329550|676296|P1|STARTED|Overall Study||9
278172|NCT00329524|676543|P1|NOT COMPLETED|Overall Study||0
278173|NCT00329524|676543|P1|COMPLETED|Overall Study||5
278174|NCT00329524|676543|P1|STARTED|Overall Study||5
278175|NCT00329433|676551|P2|NOT COMPLETED|Overall Study||0
278176|NCT00329433|676552|P1|NOT COMPLETED|Overall Study||0
278177|NCT00329433|676551|P2|COMPLETED|Overall Study||59
278178|NCT00329433|676552|P1|COMPLETED|Overall Study||61
278179|NCT00329433|676551|P2|STARTED|Overall Study||59
278180|NCT00329433|676552|P1|STARTED|Overall Study||61
278181|NCT00329420|676561|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
278182|NCT00329420|676562|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
278183|NCT00329420|676563|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
278184|NCT00329420|676561|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
278185|NCT00329420|676562|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
278186|NCT00329420|676563|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
278187|NCT00329420|676561|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
278188|NCT00329420|676562|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
278189|NCT00329420|676563|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
278190|NCT00329420|676561|P3|NOT COMPLETED|Re-induction Phase||8
278191|NCT00329420|676562|P2|NOT COMPLETED|Re-induction Phase||6
278192|NCT00329420|676563|P1|NOT COMPLETED|Re-induction Phase||6
278193|NCT00329420|676561|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
278194|NCT00329420|676562|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
278195|NCT00329420|676563|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
278196|NCT00329420|676561|P3|STARTED|Re-induction Phase||15
278197|NCT00329420|676562|P2|STARTED|Re-induction Phase||13
278198|NCT00329420|676563|P1|STARTED|Re-induction Phase||18
278199|NCT00329407|676942|P1|NOT COMPLETED|Overall Study||1
278200|NCT00329407|676942|P1|COMPLETED|Overall Study||9
278201|NCT00329407|676942|P1|STARTED|Overall Study||10
278202|NCT00329238|676949|P2|NOT COMPLETED|Overall Study||281
278203|NCT00329238|676950|P1|NOT COMPLETED|Overall Study||276
278204|NCT00329238|676949|P2|COMPLETED|Overall Study||1145
278205|NCT00329238|676950|P1|COMPLETED|Overall Study||1154
278206|NCT00329238|676949|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
278207|NCT00329238|676950|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
278208|NCT00329160|676986|P1|NOT COMPLETED|Overall Study||88
278209|NCT00329160|676986|P1|COMPLETED|Overall Study||126
278210|NCT00329160|676986|P1|Treatment Period|Overall Study||214
278211|NCT00329160|676986|P1|Observation Period|Overall Study||214
278212|NCT00329160|676986|P1|STARTED|Overall Study||214
278213|NCT00329108|676995|P2|NOT COMPLETED|Overall Study||12
278214|NCT00329108|676996|P1|NOT COMPLETED|Overall Study||10
278215|NCT00329108|676995|P2|COMPLETED|Overall Study||2
278216|NCT00329108|676996|P1|COMPLETED|Overall Study||5
278217|NCT00329108|676995|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
278218|NCT00329108|676996|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
278219|NCT00329030|677004|P2|NOT COMPLETED|Overall Study||6
278220|NCT00329030|677005|P1|NOT COMPLETED|Overall Study||8
278221|NCT00329030|677004|P2|COMPLETED|Overall Study||107
278222|NCT00329030|677005|P1|COMPLETED|Overall Study||103
278223|NCT00329030|677004|P2|STARTED|Overall Study||113
278224|NCT00329030|677005|P1|STARTED|Overall Study||111
278225|NCT00328926|677036|P3|NOT COMPLETED|Overall Study||2
278226|NCT00328926|677037|P2|NOT COMPLETED|Overall Study||3
278227|NCT00328926|677038|P1|NOT COMPLETED|Overall Study||2
278228|NCT00328926|677036|P3|COMPLETED|Overall Study||1
278229|NCT00328926|677037|P2|COMPLETED|Overall Study||0
278230|NCT00328926|677038|P1|COMPLETED|Overall Study||3
278231|NCT00328926|677036|P3|STARTED|Overall Study||3
278232|NCT00328926|677037|P2|STARTED|Overall Study||3
278233|NCT00328926|677038|P1|STARTED|Overall Study||5
278234|NCT00328861|677054|P2|NOT COMPLETED|Overall Study||0
278235|NCT00328861|677055|P1|NOT COMPLETED|Overall Study||0
278236|NCT00328861|677054|P2|COMPLETED|Overall Study||1
278237|NCT00328861|677055|P1|COMPLETED|Overall Study||7
278238|NCT00328861|677054|P2|STARTED|Overall Study||1
278239|NCT00328861|677055|P1|STARTED|Overall Study||7
278240|NCT00328783|677063|P1|NOT COMPLETED|Overall Study||26
278241|NCT00328783|677063|P1|COMPLETED|Overall Study||86
278242|NCT00328783|677063|P1|STARTED|Overall Study||112
278243|NCT00328770|677071|P1|NOT COMPLETED|Overall Study||0
278244|NCT00328770|677071|P1|COMPLETED|Overall Study||70
278245|NCT00328770|677071|P1|STARTED|Overall Study||70
278246|NCT00328627|677089|P12|NOT COMPLETED|Overall Study||16
278247|NCT00328627|677090|P11|NOT COMPLETED|Overall Study||18
278248|NCT00328627|677091|P10|NOT COMPLETED|Overall Study||32
278249|NCT00328627|677092|P9|NOT COMPLETED|Overall Study||17
278250|NCT00328627|677093|P8|NOT COMPLETED|Overall Study||14
278251|NCT00328627|677094|P7|NOT COMPLETED|Overall Study||35
278252|NCT00328627|677095|P6|NOT COMPLETED|Overall Study||20
278253|NCT00328627|677096|P5|NOT COMPLETED|Overall Study||15
278254|NCT00328627|677097|P4|NOT COMPLETED|Overall Study||37
278255|NCT00328627|677098|P3|NOT COMPLETED|Overall Study||28
278256|NCT00328627|677099|P2|NOT COMPLETED|Overall Study||31
278257|NCT00328627|677100|P1|NOT COMPLETED|Overall Study||59
278258|NCT00328627|677089|P12|COMPLETED|Overall Study||114
278259|NCT00328627|677090|P11|COMPLETED|Overall Study||112
278260|NCT00328627|677091|P10|COMPLETED|Overall Study||97
278261|NCT00328627|677092|P9|COMPLETED|Overall Study||113
278262|NCT00328627|677093|P8|COMPLETED|Overall Study||116
278263|NCT00328627|677094|P7|COMPLETED|Overall Study||94
278264|NCT00328627|677095|P6|COMPLETED|Overall Study||110
278265|NCT00328627|677096|P5|COMPLETED|Overall Study||115
278266|NCT00328627|677097|P4|COMPLETED|Overall Study||93
278267|NCT00328627|677098|P3|COMPLETED|Overall Study||101
278268|NCT00328627|677099|P2|COMPLETED|Overall Study||97
278269|NCT00328627|677100|P1|COMPLETED|Overall Study||70
278270|NCT00328627|677089|P12|Safety Set|Overall Study||130
278271|NCT00328627|677090|P11|Safety Set|Overall Study||130
278272|NCT00328627|677091|P10|Safety Set|Overall Study||129
278273|NCT00328627|677092|P9|Safety Set|Overall Study||130
278274|NCT00328627|677093|P8|Safety Set|Overall Study||130
278275|NCT00328627|677094|P7|Safety Set|Overall Study||129
278276|NCT00328627|677095|P6|Safety Set|Overall Study||130
278277|NCT00328627|677096|P5|Safety Set|Overall Study||130
278278|NCT00328627|677097|P4|Safety Set|Overall Study||129
278279|NCT00328627|677098|P3|Safety Set|Overall Study||129
278280|NCT00328627|677099|P2|Safety Set|Overall Study||128
278281|NCT00328627|677100|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
278282|NCT00328627|677089|P12|STARTED|Overall Study||130
278283|NCT00328627|677090|P11|STARTED|Overall Study||130
278284|NCT00328627|677091|P10|STARTED|Overall Study||129
278285|NCT00328627|677092|P9|STARTED|Overall Study||130
278286|NCT00328627|677093|P8|STARTED|Overall Study||130
278287|NCT00328627|677094|P7|STARTED|Overall Study||129
278288|NCT00328627|677095|P6|STARTED|Overall Study||130
278289|NCT00328627|677096|P5|STARTED|Overall Study||130
278290|NCT00328627|677097|P4|STARTED|Overall Study||130
278291|NCT00328627|677098|P3|STARTED|Overall Study||129
278292|NCT00328627|677099|P2|STARTED|Overall Study||128
278293|NCT00328627|677100|P1|STARTED|Overall Study||129
278294|NCT00328614|678623|P6|NOT COMPLETED|Overall Study||1
278295|NCT00328614|678624|P5|NOT COMPLETED|Overall Study||1
278296|NCT00328614|678625|P4|NOT COMPLETED|Overall Study||1
278297|NCT00328614|678626|P3|NOT COMPLETED|Overall Study||0
278298|NCT00328614|678627|P2|NOT COMPLETED|Overall Study||0
278299|NCT00328614|678628|P1|NOT COMPLETED|Overall Study||0
278300|NCT00328614|678623|P6|COMPLETED|Overall Study||5
278301|NCT00328614|678624|P5|COMPLETED|Overall Study||5
278302|NCT00328614|678625|P4|COMPLETED|Overall Study||5
278303|NCT00328614|678626|P3|COMPLETED|Overall Study||6
278304|NCT00328614|678627|P2|COMPLETED|Overall Study||4
278305|NCT00328614|678628|P1|COMPLETED|Overall Study||4
278306|NCT00328614|678623|P6|STARTED|Overall Study||6
278307|NCT00328614|678624|P5|STARTED|Overall Study||6
278308|NCT00328614|678625|P4|STARTED|Overall Study||6
278309|NCT00328614|678626|P3|STARTED|Overall Study||6
278310|NCT00328614|678627|P2|STARTED|Overall Study||4
278311|NCT00328614|678628|P1|STARTED|Overall Study||4
278312|NCT00328562|678637|P1|NOT COMPLETED|Overall Study||1
278313|NCT00328562|678637|P1|COMPLETED|Overall Study||12
278314|NCT00328562|678637|P1|STARTED|Overall Study||13
278315|NCT00328510|678646|P2|NOT COMPLETED|Overall Study||4
278316|NCT00328510|678647|P1|NOT COMPLETED|Overall Study||10
278317|NCT00328510|678646|P2|COMPLETED|Overall Study||37
278318|NCT00328510|678647|P1|COMPLETED|Overall Study||32
278319|NCT00328510|678646|P2|STARTED|Overall Study||41
278320|NCT00328510|678647|P1|STARTED|Overall Study||42
278321|NCT00328263|678655|P2|NOT COMPLETED|Overall Study||4
278322|NCT00328263|678656|P1|NOT COMPLETED|Overall Study||3
278323|NCT00328263|678655|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
278324|NCT00328263|678656|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
278325|NCT00328263|678655|P2|STARTED|Overall Study||221
278326|NCT00328263|678656|P1|STARTED|Overall Study||216
278327|NCT00328198|678662|P1|NOT COMPLETED|Follow-up||35
278328|NCT00328198|678662|P1|COMPLETED|Follow-up||43
278329|NCT00328198|678662|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
278330|NCT00328198|678662|P1|NOT COMPLETED|Treatment||38
278331|NCT00328198|678662|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
278332|NCT00328198|678662|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
278333|NCT00328172|678677|P5|NOT COMPLETED|Overall Study||5
278334|NCT00328172|678678|P4|NOT COMPLETED|Overall Study||13
278335|NCT00328172|678679|P3|NOT COMPLETED|Overall Study||10
278336|NCT00328172|678680|P2|NOT COMPLETED|Overall Study||14
278337|NCT00328172|678681|P1|NOT COMPLETED|Overall Study||22
278338|NCT00328172|678677|P5|COMPLETED|Overall Study||60
278339|NCT00328172|678678|P4|COMPLETED|Overall Study||42
278340|NCT00328172|678679|P3|COMPLETED|Overall Study||47
278341|NCT00328172|678680|P2|COMPLETED|Overall Study||44
278342|NCT00328172|678681|P1|COMPLETED|Overall Study||45
278343|NCT00328172|678677|P5|STARTED|Overall Study||65
278344|NCT00328172|678678|P4|STARTED|Overall Study||55
278345|NCT00328172|678679|P3|STARTED|Overall Study||57
278346|NCT00328172|678680|P2|STARTED|Overall Study||58
278347|NCT00328172|678681|P1|STARTED|Overall Study||67
278348|NCT00328094|678705|P2|NOT COMPLETED|Overall Study||3
278349|NCT00328094|678706|P1|NOT COMPLETED|Overall Study||3
278350|NCT00328094|678705|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
278351|NCT00328094|678706|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
278352|NCT00328094|678705|P2|STARTED|Overall Study||125
278353|NCT00328094|678706|P1|STARTED|Overall Study||117
278354|NCT00328042|678716|P2|NOT COMPLETED|Overall Study||2
278355|NCT00328042|678717|P1|NOT COMPLETED|Overall Study||0
278356|NCT00328042|678716|P2|COMPLETED|Overall Study||63
278357|NCT00328042|678717|P1|COMPLETED|Overall Study||69
278358|NCT00328042|678716|P2|STARTED|Overall Study||65
278359|NCT00328042|678717|P1|STARTED|Overall Study||69
278360|NCT00328016|678727|P2|NOT COMPLETED|Overall Study||0
278361|NCT00328016|678728|P1|NOT COMPLETED|Overall Study||0
278362|NCT00328016|678727|P2|COMPLETED|Overall Study||21
278363|NCT00328016|678728|P1|COMPLETED|Overall Study||23
278364|NCT00328016|678727|P2|STARTED|Overall Study||21
278365|NCT00328016|678728|P1|STARTED|Overall Study||23
278366|NCT00327717|678740|P2|NOT COMPLETED|Overall Study||14
278367|NCT00327717|678741|P1|NOT COMPLETED|Overall Study||9
278368|NCT00327717|678740|P2|COMPLETED|Overall Study||106
278369|NCT00327717|678741|P1|COMPLETED|Overall Study||111
278370|NCT00327717|678740|P2|STARTED|Overall Study||120
278371|NCT00327717|678741|P1|STARTED|Overall Study||120
278372|NCT00327470|678767|P2|NOT COMPLETED|Overall Study||63
278373|NCT00327470|678768|P1|NOT COMPLETED|Overall Study||29
278374|NCT00327470|678767|P2|COMPLETED|Overall Study||118
278375|NCT00327470|678768|P1|COMPLETED|Overall Study||78
278376|NCT00327470|678767|P2|Treated|Overall Study||179
278377|NCT00327470|678768|P1|Treated|Overall Study||107
278378|NCT00327470|678767|P2|STARTED|Overall Study||181
278379|NCT00327470|678768|P1|STARTED|Overall Study||107
278380|NCT00327444|678788|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
278381|NCT00327444|678789|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
278382|NCT00327444|678788|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
278383|NCT00327444|678789|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
278384|NCT00327444|678788|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
278385|NCT00327444|678789|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
278386|NCT00327444|678788|P2|STARTED|Open Label Treatment (OL) Period||10
278387|NCT00327444|678789|P1|STARTED|Open Label Treatment (OL) Period||11
278388|NCT00327444|678788|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
278389|NCT00327444|678789|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
278390|NCT00327444|678788|P2|COMPLETED|Double Blind Treatment (DB) Period||0
278391|NCT00327444|678789|P1|COMPLETED|Double Blind Treatment (DB) Period||0
278392|NCT00327444|678788|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
278393|NCT00327444|678789|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
278394|NCT00327444|678788|P2|STARTED|Double Blind Treatment (DB) Period||29
278395|NCT00327444|678789|P1|STARTED|Double Blind Treatment (DB) Period||26
278396|NCT00327392|678801|P1|NOT COMPLETED|Overall Study||0
278397|NCT00327392|678801|P1|COMPLETED|Overall Study||123
278398|NCT00327392|678801|P1|STARTED|Overall Study||123
278399|NCT00327340|678807|P2|NOT COMPLETED|Overall Study||30
278400|NCT00327340|678808|P1|NOT COMPLETED|Overall Study||15
278401|NCT00327340|678807|P2|COMPLETED|Overall Study||16
278402|NCT00327340|678808|P1|COMPLETED|Overall Study||8
278403|NCT00327340|678807|P2|STARTED|Overall Study||46
278404|NCT00327340|678808|P1|STARTED|Overall Study||23
278405|NCT00327171|678822|P2|NOT COMPLETED|Overall Study||109
278406|NCT00327171|678823|P1|NOT COMPLETED|Overall Study||108
278407|NCT00327171|678822|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
278408|NCT00327171|678823|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
278409|NCT00327171|678822|P2|STARTED|Overall Study||109
278410|NCT00327171|678823|P1|STARTED|Overall Study||109
278411|NCT00327015|678855|P4|NOT COMPLETED|Overall Study||109
278412|NCT00327015|678856|P3|NOT COMPLETED|Overall Study||126
278413|NCT00327015|678857|P2|NOT COMPLETED|Overall Study||92
278414|NCT00327015|678858|P1|NOT COMPLETED|Overall Study||91
278415|NCT00327015|678855|P4|COMPLETED|Overall Study||219
278416|NCT00327015|678856|P3|COMPLETED|Overall Study||209
278417|NCT00327015|678857|P2|COMPLETED|Overall Study||231
278418|NCT00327015|678858|P1|COMPLETED|Overall Study||229
278419|NCT00327015|678855|P4|Completed Study Without Being Rescued|Overall Study||144
278420|NCT00327015|678856|P3|Completed Study Without Being Rescued|Overall Study||113
278421|NCT00327015|678857|P2|Completed Study Without Being Rescued|Overall Study||177
278422|NCT00327015|678858|P1|Completed Study Without Being Rescued|Overall Study||179
278423|NCT00327015|678855|P4|STARTED|Overall Study||328
278424|NCT00327015|678856|P3|STARTED|Overall Study||335
278425|NCT00327015|678857|P2|STARTED|Overall Study||323
278426|NCT00327015|678858|P1|STARTED|Overall Study||320
278427|NCT00326963|678900|P1|NOT COMPLETED|Overall Study||33
278428|NCT00326963|678900|P1|COMPLETED|Overall Study||107
278429|NCT00326963|678900|P1|STARTED|Overall Study||140
278430|NCT00326950|678920|P1|NOT COMPLETED|Overall Study||1
278431|NCT00326950|678920|P1|COMPLETED|Overall Study||14
278432|NCT00326950|678920|P1|STARTED|Overall Study||15
278433|NCT00326924|678927|P2|NOT COMPLETED|Overall Study||1
278434|NCT00326924|678928|P1|NOT COMPLETED|Overall Study||1
278435|NCT00326924|678927|P2|COMPLETED|Overall Study||188
278436|NCT00326924|678928|P1|COMPLETED|Overall Study||187
278437|NCT00326924|678927|P2|STARTED|Overall Study||189
278438|NCT00326924|678928|P1|STARTED|Overall Study||188
278439|NCT00326911|678942|P2|NOT COMPLETED|Overall Study||2
278440|NCT00326911|678943|P1|NOT COMPLETED|Overall Study||1
278441|NCT00326911|678942|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
278442|NCT00326911|678943|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
278443|NCT00326911|678942|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
278444|NCT00326911|678943|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
278445|NCT00326898|678996|P3|NOT COMPLETED|Overall Study||203
278446|NCT00326898|678997|P2|NOT COMPLETED|Overall Study||343
278447|NCT00326898|678998|P1|NOT COMPLETED|Overall Study||351
278448|NCT00326898|678996|P3|COMPLETED|Overall Study||444
278449|NCT00326898|678997|P2|COMPLETED|Overall Study||306
278450|NCT00326898|678998|P1|COMPLETED|Overall Study||296
278451|NCT00326898|678996|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
278452|NCT00326898|678997|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
278453|NCT00326898|678998|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
278454|NCT00326898|678996|P3|Patients With Clear Cell Histology|Overall Study||540
278455|NCT00326898|678997|P2|Patients With Clear Cell Histology|Overall Study||540
278456|NCT00326898|678998|P1|Patients With Clear Cell Histology|Overall Study||542
278457|NCT00326898|678996|P3|Patients With Toxicity Data|Overall Study||626
278458|NCT00326898|678997|P2|Patients With Toxicity Data|Overall Study||628
278459|NCT00326898|678998|P1|Patients With Toxicity Data|Overall Study||625
278460|NCT00326898|678996|P3|STARTED|Overall Study||647
278461|NCT00326898|678997|P2|STARTED|Overall Study||649
278462|NCT00326898|678998|P1|STARTED|Overall Study||647
278463|NCT00326885|679015|P1|NOT COMPLETED|Overall Study||7
278464|NCT00326885|679015|P1|COMPLETED|Overall Study||25
278465|NCT00326885|679015|P1|STARTED|Overall Study||32
278466|NCT00326872|679024|P1|NOT COMPLETED|Overall Study||0
278467|NCT00326872|679024|P1|COMPLETED|Overall Study||26
278468|NCT00326872|679024|P1|STARTED|Overall Study||26
278469|NCT00326781|679035|P2|NOT COMPLETED|Overall Study||32
278470|NCT00326781|679036|P1|NOT COMPLETED|Overall Study||42
278471|NCT00326781|679035|P2|COMPLETED|Overall Study||298
278472|NCT00326781|679036|P1|COMPLETED|Overall Study||302
278473|NCT00326781|679035|P2|STARTED|Overall Study||330
278474|NCT00326781|679036|P1|STARTED|Overall Study||344
278475|NCT00326716|679046|P4|NOT COMPLETED|Infants||0
278476|NCT00326716|679047|P3|NOT COMPLETED|Infants||0
278477|NCT00326716|679048|P2|NOT COMPLETED|Infants||0
278478|NCT00326716|679049|P1|NOT COMPLETED|Infants||0
278479|NCT00326716|679046|P4|COMPLETED|Infants||20
278480|NCT00326716|679047|P3|COMPLETED|Infants||20
278481|NCT00326716|679048|P2|COMPLETED|Infants||0
278482|NCT00326716|679049|P1|COMPLETED|Infants||0
278483|NCT00326716|679046|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
278484|NCT00326716|679047|P3|STARTED|Infants|All infants were followed.|20
278485|NCT00326716|679048|P2|STARTED|Infants||0
278486|NCT00326716|679049|P1|STARTED|Infants||0
278487|NCT00326716|679046|P4|NOT COMPLETED|Pre-Natal Mothers||0
278488|NCT00326716|679047|P3|NOT COMPLETED|Pre-Natal Mothers||0
278489|NCT00326716|679048|P2|NOT COMPLETED|Pre-Natal Mothers||2
278490|NCT00326716|679049|P1|NOT COMPLETED|Pre-Natal Mothers||1
278491|NCT00326716|679046|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
278492|NCT00326716|679047|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
278493|NCT00326716|679048|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
278494|NCT00326716|679049|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
278495|NCT00326716|679046|P4|STARTED|Pre-Natal Mothers||0
278496|NCT00326716|679047|P3|STARTED|Pre-Natal Mothers||0
278497|NCT00326716|679048|P2|STARTED|Pre-Natal Mothers||21
278498|NCT00326716|679049|P1|STARTED|Pre-Natal Mothers||20
278499|NCT00326612|679121|P2|NOT COMPLETED|Overall Study||137
278500|NCT00326612|679122|P1|NOT COMPLETED|Overall Study||129
278501|NCT00326612|679121|P2|COMPLETED|Overall Study||42
278502|NCT00326612|679122|P1|COMPLETED|Overall Study||50
278503|NCT00326612|679121|P2|STARTED|Overall Study||179
278504|NCT00326612|679122|P1|STARTED|Overall Study||179
278505|NCT00326599|679144|P4|NOT COMPLETED|Overall Study||19
278506|NCT00326599|679145|P3|NOT COMPLETED|Overall Study||53
278507|NCT00326599|679146|P2|NOT COMPLETED|Overall Study||1
278508|NCT00326599|679147|P1|NOT COMPLETED|Overall Study||6
278509|NCT00326599|679144|P4|COMPLETED|Overall Study||10
278510|NCT00326599|679145|P3|COMPLETED|Overall Study||5
278511|NCT00326599|679146|P2|COMPLETED|Overall Study||2
278512|NCT00326599|679147|P1|COMPLETED|Overall Study||0
278513|NCT00326599|679144|P4|STARTED|Overall Study||29
278514|NCT00326599|679145|P3|STARTED|Overall Study||58
278515|NCT00326599|679146|P2|STARTED|Overall Study||3
278516|NCT00326599|679147|P1|STARTED|Overall Study||6
278517|NCT00326495|679166|P1|NOT COMPLETED|Overall Study||5
278518|NCT00326495|679166|P1|COMPLETED|Overall Study||46
278519|NCT00326495|679166|P1|STARTED|Overall Study||51
278520|NCT00326417|679173|P4|NOT COMPLETED|Overall Study||3
278521|NCT00326417|679174|P3|NOT COMPLETED|Overall Study||1
278522|NCT00326417|679175|P2|NOT COMPLETED|Overall Study||0
278523|NCT00326417|679176|P1|NOT COMPLETED|Overall Study||14
278524|NCT00326417|679173|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
278525|NCT00326417|679174|P3|COMPLETED|Overall Study||38
278526|NCT00326417|679175|P2|COMPLETED|Overall Study||41
278527|NCT00326417|679176|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
278528|NCT00326417|679173|P4|Phase II|Overall Study||0
278529|NCT00326417|679174|P3|Phase II|Overall Study||33
278530|NCT00326417|679175|P2|Phase II|Overall Study||35
278531|NCT00326417|679176|P1|Phase II|Overall Study||8
278532|NCT00326417|679173|P4|Phase I|Overall Study||3
278533|NCT00326417|679174|P3|Phase I|Overall Study||6
278534|NCT00326417|679175|P2|Phase I|Overall Study||6
278535|NCT00326417|679176|P1|Phase I|Overall Study||6
278536|NCT00326417|679173|P4|STARTED|Overall Study||3
278537|NCT00326417|679174|P3|STARTED|Overall Study||39
278538|NCT00326417|679175|P2|STARTED|Overall Study||41
278539|NCT00326417|679176|P1|STARTED|Overall Study||14
278540|NCT00326196|679194|P2|NOT COMPLETED|Overall Study||0
278541|NCT00326196|679195|P1|NOT COMPLETED|Overall Study||0
278542|NCT00326196|679194|P2|COMPLETED|Overall Study||97
278543|NCT00326196|679195|P1|COMPLETED|Overall Study||101
278544|NCT00326196|679194|P2|STARTED|Overall Study||97
278545|NCT00326196|679195|P1|STARTED|Overall Study||101
278546|NCT00326183|679203|P2|NOT COMPLETED|Overall Study||83
278547|NCT00326183|679204|P1|NOT COMPLETED|Overall Study||200
278548|NCT00326183|679203|P2|COMPLETED|Overall Study||264
278549|NCT00326183|679204|P1|COMPLETED|Overall Study||1253
278550|NCT00326183|679203|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
278551|NCT00326183|679204|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
278552|NCT00326183|679203|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
278553|NCT00326183|679204|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
278554|NCT00326183|679203|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
278555|NCT00326183|679204|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
278556|NCT00326183|679203|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
278557|NCT00326183|679204|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
278558|NCT00326183|679203|P2|STARTED|Overall Study||347
278559|NCT00326183|679204|P1|STARTED|Overall Study||1453
278560|NCT00326170|679230|P1|NOT COMPLETED|Overall Study||0
278561|NCT00326170|679230|P1|COMPLETED|Overall Study||34
278562|NCT00326170|679230|P1|STARTED|Overall Study||34
278563|NCT00326118|679236|P2|NOT COMPLETED|Year 5 Follow up||0
278564|NCT00326118|679237|P1|NOT COMPLETED|Year 5 Follow up||0
278565|NCT00326118|679236|P2|COMPLETED|Year 5 Follow up||78
278566|NCT00326118|679237|P1|COMPLETED|Year 5 Follow up||217
278567|NCT00326118|679236|P2|STARTED|Year 5 Follow up||78
278568|NCT00326118|679237|P1|STARTED|Year 5 Follow up||217
278569|NCT00326118|679236|P2|NOT COMPLETED|Year 4 Follow-up||0
278570|NCT00326118|679237|P1|NOT COMPLETED|Year 4 Follow-up||0
278571|NCT00326118|679236|P2|COMPLETED|Year 4 Follow-up||80
278572|NCT00326118|679237|P1|COMPLETED|Year 4 Follow-up||228
278573|NCT00326118|679236|P2|STARTED|Year 4 Follow-up||80
278574|NCT00326118|679237|P1|STARTED|Year 4 Follow-up||228
278575|NCT00326118|679236|P2|NOT COMPLETED|Year 3 Follow-up||0
278576|NCT00326118|679237|P1|NOT COMPLETED|Year 3 Follow-up||0
278577|NCT00326118|679236|P2|COMPLETED|Year 3 Follow-up||89
278578|NCT00326118|679237|P1|COMPLETED|Year 3 Follow-up||256
278579|NCT00326118|679236|P2|STARTED|Year 3 Follow-up||89
278580|NCT00326118|679237|P1|STARTED|Year 3 Follow-up||256
278581|NCT00326118|679236|P2|NOT COMPLETED|Year 2 Follow-up||0
278582|NCT00326118|679237|P1|NOT COMPLETED|Year 2 Follow-up||0
278583|NCT00326118|679236|P2|COMPLETED|Year 2 Follow-up||92
278584|NCT00326118|679237|P1|COMPLETED|Year 2 Follow-up||270
278585|NCT00326118|679236|P2|STARTED|Year 2 Follow-up||92
278586|NCT00326118|679237|P1|STARTED|Year 2 Follow-up||270
278587|NCT00326118|679236|P2|NOT COMPLETED|Year 1 Follow-up||0
278588|NCT00326118|679237|P1|NOT COMPLETED|Year 1 Follow-up||0
278589|NCT00326118|679236|P2|COMPLETED|Year 1 Follow-up||100
278590|NCT00326118|679237|P1|COMPLETED|Year 1 Follow-up||295
278591|NCT00326118|679236|P2|STARTED|Year 1 Follow-up||100
278592|NCT00326118|679237|P1|STARTED|Year 1 Follow-up||295
278593|NCT00326118|679236|P2|NOT COMPLETED|Active Phase||1
278594|NCT00326118|679237|P1|NOT COMPLETED|Active Phase||4
278595|NCT00326118|679236|P2|COMPLETED|Active Phase||108
278596|NCT00326118|679237|P1|COMPLETED|Active Phase||320
278597|NCT00326118|679236|P2|STARTED|Active Phase||109
278598|NCT00326118|679237|P1|STARTED|Active Phase||324
278599|NCT00326001|679273|P2|NOT COMPLETED|Overall Study||8
278600|NCT00326001|679274|P1|NOT COMPLETED|Overall Study||7
278601|NCT00326001|679273|P2|COMPLETED|Overall Study||219
278602|NCT00326001|679274|P1|COMPLETED|Overall Study||229
278603|NCT00326001|679273|P2|STARTED|Overall Study||227
278604|NCT00326001|679274|P1|STARTED|Overall Study||236
278605|NCT00325897|679288|P2|NOT COMPLETED|Overall Study||13
278606|NCT00325897|679289|P1|NOT COMPLETED|Overall Study||12
278607|NCT00325897|679288|P2|COMPLETED|Overall Study||559
278608|NCT00325897|679289|P1|COMPLETED|Overall Study||558
278609|NCT00325897|679288|P2|STARTED|Overall Study||572
278610|NCT00325897|679289|P1|STARTED|Overall Study||570
278611|NCT00325819|679309|P2|NOT COMPLETED|Overall Study||13
278612|NCT00325819|679310|P1|NOT COMPLETED|Overall Study||9
278613|NCT00325819|679309|P2|COMPLETED|Overall Study||176
278614|NCT00325819|679310|P1|COMPLETED|Overall Study||176
278615|NCT00325819|679309|P2|STARTED|Overall Study||189
278616|NCT00325819|679310|P1|STARTED|Overall Study||185
278617|NCT00325780|679330|P1|NOT COMPLETED|Overall Study||155
278618|NCT00325780|679330|P1|COMPLETED|Overall Study||1200
278619|NCT00325780|679330|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
278620|NCT00325780|679330|P1|STARTED|Overall Study||1355
278621|NCT00325754|679337|P2|NOT COMPLETED|Overall Study||1
278622|NCT00325754|679338|P1|NOT COMPLETED|Overall Study||4
278623|NCT00325754|679337|P2|COMPLETED|Overall Study||10
278624|NCT00325754|679338|P1|COMPLETED|Overall Study||7
278625|NCT00325754|679337|P2|STARTED|Overall Study||11
278626|NCT00325754|679338|P1|STARTED|Overall Study||11
278627|NCT00325598|679354|P2|NOT COMPLETED|Overall Study||0
278628|NCT00325598|679355|P1|NOT COMPLETED|Overall Study||0
278629|NCT00325598|679354|P2|COMPLETED|Overall Study||50
278630|NCT00325598|679355|P1|COMPLETED|Overall Study||50
278631|NCT00325598|679354|P2|STARTED|Overall Study||50
278632|NCT00325598|679355|P1|STARTED|Overall Study||50
278633|NCT00325468|679370|P5|NOT COMPLETED|Overall Study||8
278634|NCT00325468|679371|P4|NOT COMPLETED|Overall Study||34
278635|NCT00325468|679372|P3|NOT COMPLETED|Overall Study||4
278636|NCT00325468|679373|P2|NOT COMPLETED|Overall Study||5
278637|NCT00325468|679374|P1|NOT COMPLETED|Overall Study||11
278638|NCT00325468|679370|P5|COMPLETED|Overall Study||14
278639|NCT00325468|679371|P4|COMPLETED|Overall Study||90
278640|NCT00325468|679372|P3|COMPLETED|Overall Study||10
278641|NCT00325468|679373|P2|COMPLETED|Overall Study||12
278642|NCT00325468|679374|P1|COMPLETED|Overall Study||12
278643|NCT00325468|679370|P5|STARTED|Overall Study||22
278644|NCT00325468|679371|P4|STARTED|Overall Study||124
278645|NCT00325468|679372|P3|STARTED|Overall Study||14
278646|NCT00325468|679373|P2|STARTED|Overall Study||17
278647|NCT00325468|679374|P1|STARTED|Overall Study||23
278648|NCT00325442|679409|P2|NOT COMPLETED|Overall Study||21
278649|NCT00325442|679410|P1|NOT COMPLETED|Overall Study||9
278650|NCT00325442|679409|P2|COMPLETED|Overall Study||153
278651|NCT00325442|679410|P1|COMPLETED|Overall Study||167
278652|NCT00325442|679409|P2|STARTED|Overall Study||174
278653|NCT00325442|679410|P1|STARTED|Overall Study||176
278654|NCT00325416|679457|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
278655|NCT00325416|679458|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
278656|NCT00325416|679457|P2|COMPLETED|Phase II: Treatment at MTD||40
278657|NCT00325416|679458|P1|COMPLETED|Phase II: Treatment at MTD||78
278658|NCT00325416|679457|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
278659|NCT00325416|679458|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
278660|NCT00325416|679457|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
278661|NCT00325416|679458|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
278662|NCT00325416|679457|P2|STARTED|Phase II: Treatment at MTD||42
278663|NCT00325416|679458|P1|STARTED|Phase II: Treatment at MTD||78
278664|NCT00325416|679457|P2|NOT COMPLETED|Phase I: Dose Escalation||16
278665|NCT00325416|679458|P1|NOT COMPLETED|Phase I: Dose Escalation||22
278666|NCT00325416|679457|P2|COMPLETED|Phase I: Dose Escalation||44
278667|NCT00325416|679458|P1|COMPLETED|Phase I: Dose Escalation||48
278668|NCT00325416|679457|P2|STARTED|Phase I: Dose Escalation||60
278669|NCT00325416|679458|P1|STARTED|Phase I: Dose Escalation||70
278670|NCT00325403|679472|P2|NOT COMPLETED|Overall Study||51
278671|NCT00325403|679473|P1|NOT COMPLETED|Overall Study||18
278672|NCT00325403|679472|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
278673|NCT00325403|679473|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
278674|NCT00325403|679472|P2|STARTED|Overall Study||233
278675|NCT00325403|679473|P1|STARTED|Overall Study||116
278676|NCT00325234|679511|P2|NOT COMPLETED|Overall Study||66
278677|NCT00325234|679512|P1|NOT COMPLETED|Overall Study||69
278678|NCT00325234|679511|P2|COMPLETED|Overall Study||0
278679|NCT00325234|679512|P1|COMPLETED|Overall Study||0
278680|NCT00325234|679511|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
278681|NCT00325234|679512|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
278682|NCT00325234|679511|P2|STARTED|Overall Study||66
278683|NCT00325234|679512|P1|STARTED|Overall Study||69
278684|NCT00325195|679531|P3|NOT COMPLETED|Received Intervention: ITT Population||4
278685|NCT00325195|679532|P2|NOT COMPLETED|Received Intervention: ITT Population||25
278686|NCT00325195|679533|P1|NOT COMPLETED|Received Intervention: ITT Population||26
278687|NCT00325195|679531|P3|COMPLETED|Received Intervention: ITT Population||39
278688|NCT00325195|679532|P2|COMPLETED|Received Intervention: ITT Population||59
278689|NCT00325195|679533|P1|COMPLETED|Received Intervention: ITT Population||59
278690|NCT00325195|679531|P3|STARTED|Received Intervention: ITT Population||43
278691|NCT00325195|679532|P2|STARTED|Received Intervention: ITT Population||84
278692|NCT00325195|679533|P1|STARTED|Received Intervention: ITT Population||85
278693|NCT00325195|679531|P3|NOT COMPLETED|Randomized||3
278694|NCT00325195|679532|P2|NOT COMPLETED|Randomized||5
278695|NCT00325195|679533|P1|NOT COMPLETED|Randomized||5
278696|NCT00325195|679531|P3|COMPLETED|Randomized||43
278697|NCT00325195|679532|P2|COMPLETED|Randomized||84
278698|NCT00325195|679533|P1|COMPLETED|Randomized||85
278699|NCT00325195|679531|P3|STARTED|Randomized||46
278700|NCT00325195|679532|P2|STARTED|Randomized||89
278701|NCT00325195|679533|P1|STARTED|Randomized||90
278702|NCT00325156|679556|P1|NOT COMPLETED|Overall Study||112
278703|NCT00325156|679556|P1|COMPLETED|Overall Study||2478
278704|NCT00325156|679556|P1|STARTED|Overall Study||2590
278705|NCT00325143|679563|P1|NOT COMPLETED|Overall Study||26
278706|NCT00325143|679563|P1|COMPLETED|Overall Study||676
278707|NCT00325143|679563|P1|STARTED|Overall Study||702
278708|NCT00325130|679572|P2|NOT COMPLETED|Overall Study||30
278709|NCT00325130|679573|P1|NOT COMPLETED|Overall Study||19
278710|NCT00325130|679572|P2|COMPLETED|Overall Study||494
278711|NCT00325130|679573|P1|COMPLETED|Overall Study||499
278712|NCT00325130|679572|P2|STARTED|Overall Study||524
278713|NCT00325130|679573|P1|STARTED|Overall Study||518
278714|NCT00325078|679616|P3|NOT COMPLETED|Overall Study||2
278715|NCT00325078|679617|P2|NOT COMPLETED|Overall Study||5
278716|NCT00325078|679618|P1|NOT COMPLETED|Overall Study||5
278717|NCT00325078|679616|P3|COMPLETED|Overall Study||23
278718|NCT00325078|679617|P2|COMPLETED|Overall Study||2
278719|NCT00325078|679618|P1|COMPLETED|Overall Study||3
278720|NCT00325078|679616|P3|STARTED|Overall Study||25
278721|NCT00325078|679617|P2|STARTED|Overall Study||7
278722|NCT00325078|679618|P1|STARTED|Overall Study||8
278723|NCT00325039|679630|P2|NOT COMPLETED|Overall Study||14
278724|NCT00325039|679631|P1|NOT COMPLETED|Overall Study||18
278725|NCT00325039|679630|P2|COMPLETED|Overall Study||285
278726|NCT00325039|679631|P1|COMPLETED|Overall Study||280
278727|NCT00325039|679630|P2|STARTED|Overall Study||299
278728|NCT00325039|679631|P1|STARTED|Overall Study||298
278729|NCT00324987|679647|P2|NOT COMPLETED|Overall Study||6
278730|NCT00324987|679648|P1|NOT COMPLETED|Overall Study||6
278731|NCT00324987|679647|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
278732|NCT00324987|679648|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
278733|NCT00324987|679647|P2|STARTED|Overall Study||6
278734|NCT00324987|679648|P1|STARTED|Overall Study||6
278735|NCT00324961|679662|P1|NOT COMPLETED|Overall Study||43
278736|NCT00324961|679662|P1|COMPLETED|Overall Study||490
278737|NCT00324961|679662|P1|STARTED|Overall Study||533
278738|NCT00324896|679677|P2|NOT COMPLETED|Overall Study||8
278739|NCT00324896|679678|P1|NOT COMPLETED|Overall Study||3
278740|NCT00324896|679677|P2|COMPLETED|Overall Study||7
278741|NCT00324896|679678|P1|COMPLETED|Overall Study||12
278742|NCT00324896|679677|P2|STARTED|Overall Study||15
278743|NCT00324896|679678|P1|STARTED|Overall Study||15
278744|NCT00324870|679686|P1|NOT COMPLETED|Overall Study||0
278745|NCT00324870|679686|P1|COMPLETED|Overall Study||37
278746|NCT00324870|679686|P1|STARTED|Overall Study||37
278747|NCT00324857|679694|P4|NOT COMPLETED|Overall Study||5
278748|NCT00324857|679695|P3|NOT COMPLETED|Overall Study||7
278749|NCT00324857|679696|P2|NOT COMPLETED|Overall Study||6
278750|NCT00324857|679697|P1|NOT COMPLETED|Overall Study||6
278751|NCT00324857|679694|P4|COMPLETED|Overall Study||158
278752|NCT00324857|679695|P3|COMPLETED|Overall Study||158
278753|NCT00324857|679696|P2|COMPLETED|Overall Study||162
278754|NCT00324857|679697|P1|COMPLETED|Overall Study||161
278755|NCT00324857|679694|P4|STARTED|Overall Study||163
278756|NCT00324857|679695|P3|STARTED|Overall Study||165
278757|NCT00324857|679696|P2|STARTED|Overall Study||168
278758|NCT00324857|679697|P1|STARTED|Overall Study||167
278759|NCT00324805|679709|P2|NOT COMPLETED|Overall Study||483
278760|NCT00324805|679710|P1|NOT COMPLETED|Overall Study||150
278761|NCT00324805|679709|P2|COMPLETED|Overall Study||269
278762|NCT00324805|679710|P1|COMPLETED|Overall Study||599
278763|NCT00324805|679709|P2|Started Assigned Therapy|Overall Study||735
278764|NCT00324805|679710|P1|Started Assigned Therapy|Overall Study||737
278765|NCT00324805|679709|P2|STARTED|Overall Study||752
278766|NCT00324805|679710|P1|STARTED|Overall Study||749
278767|NCT00324740|679722|P3|NOT COMPLETED|Overall Study||1
278768|NCT00324740|679723|P2|NOT COMPLETED|Overall Study||0
278769|NCT00324740|679724|P1|NOT COMPLETED|Overall Study||1
278770|NCT00324740|679722|P3|COMPLETED|Overall Study||3
278771|NCT00324740|679723|P2|COMPLETED|Overall Study||3
278772|NCT00324740|679724|P1|COMPLETED|Overall Study||6
278773|NCT00324740|679722|P3|STARTED|Overall Study||4
278774|NCT00324740|679723|P2|STARTED|Overall Study||3
278775|NCT00324740|679724|P1|STARTED|Overall Study||7
278776|NCT00324701|679733|P2|NOT COMPLETED|Overall Study||17
278777|NCT00324701|679734|P1|NOT COMPLETED|Overall Study||20
278778|NCT00324701|679733|P2|COMPLETED|Overall Study||104
278779|NCT00324701|679734|P1|COMPLETED|Overall Study||100
278780|NCT00324701|679733|P2|Week 8 Assessment|Overall Study||107
278781|NCT00324701|679734|P1|Week 8 Assessment|Overall Study||108
278782|NCT00324701|679733|P2|STARTED|Overall Study||121
278783|NCT00324701|679734|P1|STARTED|Overall Study||120
278784|NCT00324675|679744|P2|NOT COMPLETED|Overall Study||0
278785|NCT00324675|679745|P1|NOT COMPLETED|Overall Study||1
278786|NCT00324675|679744|P2|COMPLETED|Overall Study||14
278787|NCT00324675|679745|P1|COMPLETED|Overall Study||13
278788|NCT00324675|679744|P2|STARTED|Overall Study||14
278789|NCT00324675|679745|P1|STARTED|Overall Study||14
278790|NCT00324649|679753|P2|NOT COMPLETED|Overall Study||5
278791|NCT00324649|679754|P1|NOT COMPLETED|Overall Study||2
278792|NCT00324649|679753|P2|COMPLETED|Overall Study||36
278793|NCT00324649|679754|P1|COMPLETED|Overall Study||37
278794|NCT00324649|679753|P2|STARTED|Overall Study||41
278795|NCT00324649|679754|P1|STARTED|Overall Study||39
278796|NCT00324415|679794|P1|NOT COMPLETED|Overall Study||0
278797|NCT00324415|679794|P1|COMPLETED|Overall Study||45
278798|NCT00324415|679794|P1|STARTED|Overall Study||45
278799|NCT00324350|679809|P2|NOT COMPLETED|Overall Study||0
278800|NCT00324350|679810|P1|NOT COMPLETED|Overall Study||0
278801|NCT00324350|679809|P2|COMPLETED|Overall Study||3632
278802|NCT00324350|679810|P1|COMPLETED|Overall Study||3655
278803|NCT00324350|679809|P2|Falls Follow-Up|Overall Study||3418
278804|NCT00324350|679810|P1|Falls Follow-Up|Overall Study||3364
278805|NCT00324350|679809|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
278806|NCT00324350|679810|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
278807|NCT00324350|679809|P2|STARTED|Overall Study||3632
278808|NCT00324350|679810|P1|STARTED|Overall Study||3655
278809|NCT00324272|679824|P4|NOT COMPLETED|Overall Study||0
278810|NCT00324272|679825|P3|NOT COMPLETED|Overall Study||0
278811|NCT00324272|679826|P2|NOT COMPLETED|Overall Study||0
278812|NCT00324272|679827|P1|NOT COMPLETED|Overall Study||0
278813|NCT00324272|679824|P4|COMPLETED|Overall Study||18
278814|NCT00324272|679825|P3|COMPLETED|Overall Study||18
278815|NCT00324272|679826|P2|COMPLETED|Overall Study||20
278816|NCT00324272|679827|P1|COMPLETED|Overall Study||18
278817|NCT00324272|679824|P4|STARTED|Overall Study||18
278818|NCT00324272|679825|P3|STARTED|Overall Study||18
278819|NCT00324272|679826|P2|STARTED|Overall Study||20
278820|NCT00324272|679827|P1|STARTED|Overall Study||18
278821|NCT00324259|679863|P2|NOT COMPLETED|Overall Study||0
278822|NCT00324259|679864|P1|NOT COMPLETED|Overall Study||0
278823|NCT00324259|679863|P2|COMPLETED|Overall Study||32
278824|NCT00324259|679864|P1|COMPLETED|Overall Study||34
278825|NCT00324259|679863|P2|STARTED|Overall Study||32
278826|NCT00324259|679864|P1|STARTED|Overall Study||34
278827|NCT00324233|679885|P2|NOT COMPLETED|Second Period||7
278828|NCT00324233|679886|P1|NOT COMPLETED|Second Period||5
278829|NCT00324233|679885|P2|COMPLETED|Second Period||11
278830|NCT00324233|679886|P1|COMPLETED|Second Period||12
278831|NCT00324233|679885|P2|STARTED|Second Period||18
278832|NCT00324233|679886|P1|STARTED|Second Period||17
278833|NCT00324233|679885|P2|NOT COMPLETED|First Period||0
278834|NCT00324233|679886|P1|NOT COMPLETED|First Period||1
278835|NCT00324233|679885|P2|COMPLETED|First Period||18
278836|NCT00324233|679886|P1|COMPLETED|First Period||17
278837|NCT00324233|679885|P2|STARTED|First Period||18
278838|NCT00324233|679886|P1|STARTED|First Period||18
278839|NCT00324168|679894|P2|NOT COMPLETED|Overall Study||30
278840|NCT00324168|679895|P1|NOT COMPLETED|Overall Study||28
278841|NCT00324168|679894|P2|COMPLETED|Overall Study||220
278842|NCT00324168|679895|P1|COMPLETED|Overall Study||222
278843|NCT00324168|679894|P2|STARTED|Overall Study||250
278844|NCT00324168|679895|P1|STARTED|Overall Study||250
278845|NCT00324155|679923|P2|NOT COMPLETED|Follow-up Phase||6
278846|NCT00324155|679924|P1|NOT COMPLETED|Follow-up Phase||11
278847|NCT00324155|679923|P2|COMPLETED|Follow-up Phase||245
278848|NCT00324155|679924|P1|COMPLETED|Follow-up Phase||236
278849|NCT00324155|679923|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
278850|NCT00324155|679924|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
278851|NCT00324155|679923|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
278852|NCT00324155|679924|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
278853|NCT00324155|679923|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
278854|NCT00324155|679924|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
278855|NCT00324155|679923|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
278856|NCT00324155|679924|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
278857|NCT00324155|679923|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
278858|NCT00324155|679924|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
278859|NCT00324155|679923|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
278860|NCT00324155|679924|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
278861|NCT00324155|679923|P2|STARTED|Received Treatment in Induction Phase||251
278862|NCT00324155|679924|P1|STARTED|Received Treatment in Induction Phase||247
278863|NCT00324155|679923|P2|NOT COMPLETED|Enrolled and Randomized||1
278864|NCT00324155|679924|P1|NOT COMPLETED|Enrolled and Randomized||3
278865|NCT00324155|679923|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
278866|NCT00324155|679924|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
278867|NCT00324155|679923|P2|STARTED|Enrolled and Randomized||252
278868|NCT00324155|679924|P1|STARTED|Enrolled and Randomized||250
278869|NCT00324116|679954|P1|NOT COMPLETED|Overall Study||32
278870|NCT00324116|679954|P1|COMPLETED|Overall Study||49
278871|NCT00324116|679954|P1|STARTED|Overall Study|subjects received treatment|81
278872|NCT00324038|679966|P2|NOT COMPLETED|Overall Study||51
278873|NCT00324038|679967|P1|NOT COMPLETED|Overall Study||49
278874|NCT00324038|679966|P2|COMPLETED|Overall Study||58
278875|NCT00324038|679967|P1|COMPLETED|Overall Study||61
278876|NCT00324038|679966|P2|STARTED|Overall Study||109
278877|NCT00324038|679967|P1|STARTED|Overall Study||110
278878|NCT00323882|679978|P5|NOT COMPLETED|Overall Study||32
278879|NCT00323882|679979|P4|NOT COMPLETED|Overall Study||7
278880|NCT00323882|679980|P3|NOT COMPLETED|Overall Study||13
278881|NCT00323882|679981|P2|NOT COMPLETED|Overall Study||6
278882|NCT00323882|679982|P1|NOT COMPLETED|Overall Study||8
278883|NCT00323882|679978|P5|COMPLETED|Overall Study||2
278884|NCT00323882|679979|P4|COMPLETED|Overall Study||0
278885|NCT00323882|679980|P3|COMPLETED|Overall Study||3
278886|NCT00323882|679981|P2|COMPLETED|Overall Study||0
278887|NCT00323882|679982|P1|COMPLETED|Overall Study||0
278888|NCT00323882|679978|P5|STARTED|Overall Study||34
278889|NCT00323882|679979|P4|STARTED|Overall Study||7
278890|NCT00323882|679980|P3|STARTED|Overall Study||16
278891|NCT00323882|679981|P2|STARTED|Overall Study||6
278892|NCT00323882|679982|P1|STARTED|Overall Study||8
278893|NCT00323869|680053|P1|NOT COMPLETED|Overall Study||1
278894|NCT00323869|680053|P1|COMPLETED|Overall Study||47
278895|NCT00323869|680053|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
278896|NCT00323869|680053|P1|STARTED|Overall Study|Enrollment|48
278897|NCT00323739|680065|P1|NOT COMPLETED|Overall Study||0
278898|NCT00323739|680065|P1|COMPLETED|Overall Study||80
278899|NCT00323739|680065|P1|STARTED|Overall Study||80
278900|NCT00323635|680072|P2|NOT COMPLETED|Overall Study||0
278901|NCT00323635|680073|P1|NOT COMPLETED|Overall Study||0
278902|NCT00323635|680072|P2|COMPLETED|Overall Study||9
278903|NCT00323635|680073|P1|COMPLETED|Overall Study||10
278904|NCT00323635|680072|P2|STARTED|Overall Study||9
278905|NCT00323635|680073|P1|STARTED|Overall Study||10
278906|NCT00323622|680109|P8|NOT COMPLETED|Overall Study||15
278907|NCT00323622|680110|P7|NOT COMPLETED|Overall Study||5
278908|NCT00323622|680111|P6|NOT COMPLETED|Overall Study||74
278909|NCT00323622|680112|P5|NOT COMPLETED|Overall Study||39
278910|NCT00323622|680113|P4|NOT COMPLETED|Overall Study||12
278911|NCT00323622|680114|P3|NOT COMPLETED|Overall Study||4
278912|NCT00323622|680115|P2|NOT COMPLETED|Overall Study||92
278913|NCT00323622|680116|P1|NOT COMPLETED|Overall Study||31
278914|NCT00323622|680109|P8|COMPLETED|Overall Study||125
278915|NCT00323622|680110|P7|COMPLETED|Overall Study||38
278916|NCT00323622|680111|P6|COMPLETED|Overall Study||454
278917|NCT00323622|680112|P5|COMPLETED|Overall Study||120
278918|NCT00323622|680113|P4|COMPLETED|Overall Study||122
278919|NCT00323622|680114|P3|COMPLETED|Overall Study||38
278920|NCT00323622|680115|P2|COMPLETED|Overall Study||423
278921|NCT00323622|680116|P1|COMPLETED|Overall Study||145
278922|NCT00323622|680109|P8|STARTED|Overall Study||140
278923|NCT00323622|680110|P7|STARTED|Overall Study||43
278924|NCT00323622|680111|P6|STARTED|Overall Study||528
278925|NCT00323622|680112|P5|STARTED|Overall Study||159
278926|NCT00323622|680113|P4|STARTED|Overall Study||134
278927|NCT00323622|680114|P3|STARTED|Overall Study||42
278928|NCT00323622|680115|P2|STARTED|Overall Study||515
278929|NCT00323622|680116|P1|STARTED|Overall Study||176
278930|NCT00323609|680158|P4|NOT COMPLETED|Overall Study||15
278931|NCT00323609|680159|P3|NOT COMPLETED|Overall Study||8
278932|NCT00323609|680160|P2|NOT COMPLETED|Overall Study||99
278933|NCT00323609|680161|P1|NOT COMPLETED|Overall Study||91
278934|NCT00323609|680158|P4|COMPLETED|Overall Study||0
278935|NCT00323609|680159|P3|COMPLETED|Overall Study||0
278936|NCT00323609|680160|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
278937|NCT00323609|680161|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
278938|NCT00323609|680158|P4|STARTED|Overall Study||15
278939|NCT00323609|680159|P3|STARTED|Overall Study||8
278940|NCT00323609|680160|P2|STARTED|Overall Study||190
278941|NCT00323609|680161|P1|STARTED|Overall Study||191
278942|NCT00323557|680197|P2|NOT COMPLETED|Overall Study||0
278943|NCT00323557|680198|P1|NOT COMPLETED|Overall Study||1
278944|NCT00323557|680197|P2|COMPLETED|Overall Study||7
278945|NCT00323557|680198|P1|COMPLETED|Overall Study||24
278946|NCT00323557|680197|P2|STARTED|Overall Study||7
278947|NCT00323557|680198|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
278948|NCT00323492|680207|P3|NOT COMPLETED|Study Phase 2||1
278949|NCT00323492|680208|P2|NOT COMPLETED|Study Phase 2||1
278950|NCT00323492|680209|P1|NOT COMPLETED|Study Phase 2||4
278951|NCT00323492|680207|P3|COMPLETED|Study Phase 2||24
278952|NCT00323492|680208|P2|COMPLETED|Study Phase 2||17
278953|NCT00323492|680209|P1|COMPLETED|Study Phase 2||40
278954|NCT00323492|680207|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
278955|NCT00323492|680208|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
278956|NCT00323492|680209|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
278957|NCT00323492|680207|P3|NOT COMPLETED|Study Phase 1||0
278958|NCT00323492|680208|P2|NOT COMPLETED|Study Phase 1||0
278959|NCT00323492|680209|P1|NOT COMPLETED|Study Phase 1||2
278960|NCT00323492|680207|P3|COMPLETED|Study Phase 1||0
278961|NCT00323492|680208|P2|COMPLETED|Study Phase 1||45
278962|NCT00323492|680209|P1|COMPLETED|Study Phase 1||45
279049|NCT00323063|680376|P2|STARTED|Overall Study||23
278963|NCT00323492|680207|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
278964|NCT00323492|680208|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
278965|NCT00323492|680209|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
278966|NCT00323492|680207|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
278967|NCT00323492|680208|P2|STARTED|Study Phase 1||45
278968|NCT00323492|680209|P1|STARTED|Study Phase 1||47
278969|NCT00323479|680240|P1|NOT COMPLETED|Overall Study||8
278970|NCT00323479|680240|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
278971|NCT00323479|680240|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
278972|NCT00323479|680240|P1|STARTED|Overall Study||114
278973|NCT00323427|680251|P2|NOT COMPLETED|Overall Study||23
278974|NCT00323427|680252|P1|NOT COMPLETED|Overall Study||31
278975|NCT00323427|680251|P2|COMPLETED|Overall Study||43
278976|NCT00323427|680252|P1|COMPLETED|Overall Study||38
278977|NCT00323427|680251|P2|STARTED|Overall Study||66
278978|NCT00323427|680252|P1|STARTED|Overall Study||69
278979|NCT00323414|680264|P2|NOT COMPLETED|Overall Study||1
278980|NCT00323414|680265|P1|NOT COMPLETED|Overall Study||0
278981|NCT00323414|680264|P2|COMPLETED|Overall Study||18
278982|NCT00323414|680265|P1|COMPLETED|Overall Study||18
278983|NCT00323414|680264|P2|STARTED|Overall Study||19
278984|NCT00323414|680265|P1|STARTED|Overall Study||18
278985|NCT00323362|680281|P1|NOT COMPLETED|Overall Study||0
278986|NCT00323362|680281|P1|COMPLETED|Overall Study||17
278987|NCT00323362|680281|P1|STARTED|Overall Study||17
278988|NCT00323310|680287|P1|NOT COMPLETED|Overall Study||3
278989|NCT00323310|680287|P1|COMPLETED|Overall Study||89
278990|NCT00323310|680287|P1|STARTED|Overall Study||92
278991|NCT00323297|680302|P2|NOT COMPLETED|Part B (Open-label)||12
278992|NCT00323297|680303|P1|NOT COMPLETED|Part B (Open-label)||9
278993|NCT00323297|680302|P2|COMPLETED|Part B (Open-label)||31
278994|NCT00323297|680303|P1|COMPLETED|Part B (Open-label)||39
278995|NCT00323297|680302|P2|STARTED|Part B (Open-label)||43
278996|NCT00323297|680303|P1|STARTED|Part B (Open-label)||48
278997|NCT00323297|680302|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
278998|NCT00323297|680303|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
278999|NCT00323297|680302|P2|COMPLETED|Part A (Double Blind Randomized)||43
279000|NCT00323297|680303|P1|COMPLETED|Part A (Double Blind Randomized)||48
279001|NCT00323297|680302|P2|STARTED|Part A (Double Blind Randomized)||50
279002|NCT00323297|680303|P1|STARTED|Part A (Double Blind Randomized)||53
279003|NCT00323284|680321|P2|NOT COMPLETED|24 Months Follow-up||22
279004|NCT00323284|680322|P1|NOT COMPLETED|24 Months Follow-up||18
279005|NCT00323284|680321|P2|COMPLETED|24 Months Follow-up||101
279006|NCT00323284|680322|P1|COMPLETED|24 Months Follow-up||98
279007|NCT00323284|680321|P2|STARTED|24 Months Follow-up||123
279008|NCT00323284|680322|P1|STARTED|24 Months Follow-up||116
279009|NCT00323284|680321|P2|NOT COMPLETED|12 Months Follow-up||9
279010|NCT00323284|680322|P1|NOT COMPLETED|12 Months Follow-up||5
279011|NCT00323284|680321|P2|COMPLETED|12 Months Follow-up||114
279012|NCT00323284|680322|P1|COMPLETED|12 Months Follow-up||111
279013|NCT00323284|680321|P2|STARTED|12 Months Follow-up||123
279014|NCT00323284|680322|P1|STARTED|12 Months Follow-up||116
279015|NCT00323271|680332|P2|NOT COMPLETED|Overall Study||3
279016|NCT00323271|680333|P1|NOT COMPLETED|Overall Study||2
279017|NCT00323271|680332|P2|COMPLETED|Overall Study||9
279018|NCT00323271|680333|P1|COMPLETED|Overall Study||11
279019|NCT00323271|680332|P2|STARTED|Overall Study||12
279020|NCT00323271|680333|P1|STARTED|Overall Study||13
279021|NCT00323258|680343|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
279022|NCT00323258|680344|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
279023|NCT00323258|680343|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
279024|NCT00323258|680344|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
279025|NCT00323258|680343|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
279026|NCT00323258|680344|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
279027|NCT00323258|680343|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
279028|NCT00323258|680344|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
279029|NCT00323258|680343|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
279030|NCT00323258|680344|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
279031|NCT00323258|680343|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
279032|NCT00323258|680344|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
279033|NCT00323193|680360|P2|NOT COMPLETED|Overall Study||15
279034|NCT00323193|680361|P1|NOT COMPLETED|Overall Study||23
279035|NCT00323193|680360|P2|COMPLETED|Overall Study||41
279036|NCT00323193|680361|P1|COMPLETED|Overall Study||30
279037|NCT00323193|680360|P2|STARTED|Overall Study||56
279038|NCT00323193|680361|P1|STARTED|Overall Study||53
279039|NCT00323115|680369|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
279040|NCT00323115|680369|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
279041|NCT00323115|680369|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
279042|NCT00323115|680369|P1|NOT COMPLETED|Vaccine Administration||1
279043|NCT00323115|680369|P1|COMPLETED|Vaccine Administration||10
279044|NCT00323115|680369|P1|STARTED|Vaccine Administration||11
279045|NCT00323063|680376|P2|NOT COMPLETED|Overall Study||0
279046|NCT00323063|680377|P1|NOT COMPLETED|Overall Study||2
279047|NCT00323063|680376|P2|COMPLETED|Overall Study||23
279048|NCT00323063|680377|P1|COMPLETED|Overall Study||24
279050|NCT00323063|680377|P1|STARTED|Overall Study||26
279051|NCT00323037|680389|P2|NOT COMPLETED|Overall Study||27
279052|NCT00323037|680390|P1|NOT COMPLETED|Overall Study||33
279053|NCT00323037|680389|P2|COMPLETED|Overall Study||126
279054|NCT00323037|680390|P1|COMPLETED|Overall Study||132
279055|NCT00323037|680389|P2|STARTED|Overall Study|Number randomized|153
279056|NCT00323037|680390|P1|STARTED|Overall Study|Number randomized|165
279057|NCT00322881|680394|P1|NOT COMPLETED|Overall Study||5
279058|NCT00322881|680394|P1|COMPLETED|Overall Study||7
279059|NCT00322881|680394|P1|STARTED|Overall Study||12
279060|NCT00322868|680398|P1|NOT COMPLETED|Overall Study||1
279061|NCT00322868|680398|P1|COMPLETED|Overall Study||20
279062|NCT00322868|680398|P1|STARTED|Overall Study||21
279063|NCT00322855|680417|P1|NOT COMPLETED|Overall Study||0
279064|NCT00322855|680417|P1|COMPLETED|Overall Study||1
279065|NCT00322855|680417|P1|STARTED|Overall Study||1
279066|NCT00322842|680423|P2|NOT COMPLETED|Overall Study||2
279067|NCT00322842|680424|P1|NOT COMPLETED|Overall Study||2
279068|NCT00322842|680423|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
279069|NCT00322842|680424|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
279070|NCT00322842|680423|P2|STARTED|Overall Study||31
279071|NCT00322842|680424|P1|STARTED|Overall Study||4
279072|NCT00322777|680451|P2|NOT COMPLETED|Overall Study||0
279073|NCT00322777|680452|P1|NOT COMPLETED|Overall Study||0
279074|NCT00322777|680451|P2|COMPLETED|Overall Study||45
279075|NCT00322777|680452|P1|COMPLETED|Overall Study||39
279076|NCT00322777|680451|P2|Data Collection at Week 24|Overall Study||45
279077|NCT00322777|680452|P1|Data Collection at Week 24|Overall Study||39
279078|NCT00322777|680451|P2|Data Collection at Week 16|Overall Study||45
279079|NCT00322777|680452|P1|Data Collection at Week 16|Overall Study||39
279080|NCT00322777|680451|P2|Data Collection at Week 8|Overall Study||45
279081|NCT00322777|680452|P1|Data Collection at Week 8|Overall Study||39
279082|NCT00322777|680451|P2|"Data Collection at BASELINE|"|Overall Study||45
279083|NCT00322777|680452|P1|"Data Collection at BASELINE|"|Overall Study||39
279084|NCT00322777|680451|P2|STARTED|Overall Study||45
279085|NCT00322777|680452|P1|STARTED|Overall Study||39
279086|NCT00322712|680462|P1|NOT COMPLETED|Overall Study||1
279087|NCT00322712|680462|P1|COMPLETED|Overall Study||11
279088|NCT00322712|680462|P1|STARTED|Overall Study||12
279089|NCT00322621|680466|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
279090|NCT00322621|680467|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
279091|NCT00322621|680468|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
279092|NCT00322621|680466|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
279093|NCT00322621|680467|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
279094|NCT00322621|680468|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
279095|NCT00322621|680466|P3|STARTED|Period III - Maintenance / Rescue Phase||69
279096|NCT00322621|680467|P2|STARTED|Period III - Maintenance / Rescue Phase||115
279097|NCT00322621|680468|P1|STARTED|Period III - Maintenance / Rescue Phase||0
279098|NCT00322621|680466|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
279099|NCT00322621|680467|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
279100|NCT00322621|680468|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
279101|NCT00322621|680466|P3|COMPLETED|Period II - Acute Therapy Phase||0
279102|NCT00322621|680467|P2|COMPLETED|Period II - Acute Therapy Phase||0
279103|NCT00322621|680468|P1|COMPLETED|Period II - Acute Therapy Phase||184
279104|NCT00322621|680466|P3|STARTED|Period II - Acute Therapy Phase||0
279105|NCT00322621|680467|P2|STARTED|Period II - Acute Therapy Phase||0
279106|NCT00322621|680468|P1|STARTED|Period II - Acute Therapy Phase||216
279107|NCT00322556|680520|P1|NOT COMPLETED|Overall Study||12
279108|NCT00322556|680520|P1|COMPLETED|Overall Study||43
279109|NCT00322556|680520|P1|STARTED|Overall Study||55
279110|NCT00322491|680536|P2|NOT COMPLETED|Overall Study||2
279111|NCT00322491|680537|P1|NOT COMPLETED|Overall Study||2
279112|NCT00322491|680536|P2|COMPLETED|Overall Study||24
279113|NCT00322491|680537|P1|COMPLETED|Overall Study||21
279114|NCT00322491|680536|P2|STARTED|Overall Study||26
279115|NCT00322491|680537|P1|STARTED|Overall Study||23
279116|NCT00322465|680563|P4|NOT COMPLETED|Overall Study||26
279117|NCT00322465|680564|P3|NOT COMPLETED|Overall Study||26
279118|NCT00322465|680565|P2|NOT COMPLETED|Overall Study||24
279119|NCT00322465|680566|P1|NOT COMPLETED|Overall Study||20
279120|NCT00322465|680563|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
279121|NCT00322465|680564|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
279122|NCT00322465|680565|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
279123|NCT00322465|680566|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
279124|NCT00322465|680563|P4|STARTED|Overall Study|Randomized|79
279125|NCT00322465|680564|P3|STARTED|Overall Study|Randomized|77
279126|NCT00322465|680565|P2|STARTED|Overall Study|Randomized|73
279127|NCT00322465|680566|P1|STARTED|Overall Study|Randomized|76
279128|NCT00322452|680627|P2|NOT COMPLETED|Overall Study||276
279129|NCT00322452|680628|P1|NOT COMPLETED|Overall Study||247
279130|NCT00322452|680627|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
279131|NCT00322452|680628|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
279132|NCT00322452|680627|P2|STARTED|Overall Study|Number of patients randomized|608
279133|NCT00322452|680628|P1|STARTED|Overall Study|Number of patients randomized|609
279134|NCT00322439|680664|P1|NOT COMPLETED|Overall Study||1056
279135|NCT00322439|680664|P1|COMPLETED|Overall Study||1455
279136|NCT00322439|680664|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
279137|NCT00322439|680664|P1|STARTED|Overall Study||2511
279138|NCT00322387|680679|P2|NOT COMPLETED|Follow-up Period||3
279139|NCT00322387|680680|P1|NOT COMPLETED|Follow-up Period||2
279140|NCT00322387|680679|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
279141|NCT00322387|680680|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
279142|NCT00322387|680679|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
279143|NCT00322387|680680|P1|STARTED|Follow-up Period|Participants who had transplants|14
279144|NCT00322387|680679|P2|NOT COMPLETED|Treatment Period||1
279145|NCT00322387|680680|P1|NOT COMPLETED|Treatment Period||0
279146|NCT00322387|680679|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
279147|NCT00322387|680680|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
279148|NCT00322387|680679|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
279149|NCT00322387|680680|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
279150|NCT00322374|680714|P4|NOT COMPLETED|Second Escalation||0
279151|NCT00322374|680715|P3|NOT COMPLETED|Second Escalation||6
279152|NCT00322374|680716|P2|NOT COMPLETED|Second Escalation||0
279153|NCT00322374|680717|P1|NOT COMPLETED|Second Escalation||0
279154|NCT00322374|680714|P4|COMPLETED|Second Escalation||0
279155|NCT00322374|680715|P3|COMPLETED|Second Escalation||0
279156|NCT00322374|680716|P2|COMPLETED|Second Escalation||0
279157|NCT00322374|680717|P1|COMPLETED|Second Escalation||0
279158|NCT00322374|680714|P4|STARTED|Second Escalation||0
279159|NCT00322374|680715|P3|STARTED|Second Escalation||6
279160|NCT00322374|680716|P2|STARTED|Second Escalation||0
279161|NCT00322374|680717|P1|STARTED|Second Escalation||0
279162|NCT00322374|680714|P4|NOT COMPLETED|First Escalation||0
279163|NCT00322374|680715|P3|NOT COMPLETED|First Escalation||0
279164|NCT00322374|680716|P2|NOT COMPLETED|First Escalation||30
279165|NCT00322374|680717|P1|NOT COMPLETED|First Escalation||0
279166|NCT00322374|680714|P4|COMPLETED|First Escalation||0
279167|NCT00322374|680715|P3|COMPLETED|First Escalation||0
279168|NCT00322374|680716|P2|COMPLETED|First Escalation||0
279169|NCT00322374|680717|P1|COMPLETED|First Escalation||0
279170|NCT00322374|680714|P4|STARTED|First Escalation||0
279171|NCT00322374|680715|P3|STARTED|First Escalation||0
279172|NCT00322374|680716|P2|STARTED|First Escalation||30
279173|NCT00322374|680717|P1|STARTED|First Escalation||0
279174|NCT00322374|680714|P4|NOT COMPLETED|Starting Dose||0
279175|NCT00322374|680715|P3|NOT COMPLETED|Starting Dose||0
279176|NCT00322374|680716|P2|NOT COMPLETED|Starting Dose||0
279177|NCT00322374|680717|P1|NOT COMPLETED|Starting Dose||6
279178|NCT00322374|680714|P4|COMPLETED|Starting Dose||0
279179|NCT00322374|680715|P3|COMPLETED|Starting Dose||0
279180|NCT00322374|680716|P2|COMPLETED|Starting Dose||0
279181|NCT00322374|680717|P1|COMPLETED|Starting Dose||0
279182|NCT00322374|680714|P4|STARTED|Starting Dose||0
279183|NCT00322374|680715|P3|STARTED|Starting Dose||0
279184|NCT00322374|680716|P2|STARTED|Starting Dose||0
279185|NCT00322374|680717|P1|STARTED|Starting Dose||6
279186|NCT00322374|680714|P4|NOT COMPLETED|Enrollment||0
279187|NCT00322374|680715|P3|NOT COMPLETED|Enrollment||0
279188|NCT00322374|680716|P2|NOT COMPLETED|Enrollment||0
279189|NCT00322374|680717|P1|NOT COMPLETED|Enrollment||0
279190|NCT00322374|680714|P4|COMPLETED|Enrollment||42
279191|NCT00322374|680715|P3|COMPLETED|Enrollment||0
279192|NCT00322374|680716|P2|COMPLETED|Enrollment||0
279193|NCT00322374|680717|P1|COMPLETED|Enrollment||0
279194|NCT00322374|680714|P4|STARTED|Enrollment||42
279195|NCT00322374|680715|P3|STARTED|Enrollment||0
279196|NCT00322374|680716|P2|STARTED|Enrollment||0
279197|NCT00322374|680717|P1|STARTED|Enrollment||0
279198|NCT00322348|680767|P2|NOT COMPLETED|Overall Study||33
279199|NCT00322348|680768|P1|NOT COMPLETED|Overall Study||37
279200|NCT00322348|680767|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
279201|NCT00322348|680768|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
279202|NCT00322348|680767|P2|Received Study Treatment|Overall Study||48
279203|NCT00322348|680768|P1|Received Study Treatment|Overall Study||50
279204|NCT00322348|680767|P2|STARTED|Overall Study||49
279205|NCT00322348|680768|P1|STARTED|Overall Study||49
279206|NCT00322335|680787|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
279207|NCT00322335|680788|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
279208|NCT00322335|680789|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
279209|NCT00322335|680787|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
279210|NCT00322335|680788|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
279211|NCT00322335|680789|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
279212|NCT00322335|680787|P3|STARTED|Subjects 66 Months After Booster Dose||53
279213|NCT00322335|680788|P2|STARTED|Subjects 66 Months After Booster Dose||104
279214|NCT00322335|680789|P1|STARTED|Subjects 66 Months After Booster Dose||48
279215|NCT00322335|680787|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
279216|NCT00322335|680788|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
279217|NCT00322335|680789|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
279218|NCT00322335|680787|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
279219|NCT00322335|680788|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
279220|NCT00322335|680789|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
279221|NCT00322335|680787|P3|STARTED|Subjects 54 Months After Booster Dose||56
279222|NCT00322335|680788|P2|STARTED|Subjects 54 Months After Booster Dose||108
279223|NCT00322335|680789|P1|STARTED|Subjects 54 Months After Booster Dose||50
279224|NCT00322335|680787|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
279225|NCT00322335|680788|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
279226|NCT00322335|680789|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
279227|NCT00322335|680787|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
279228|NCT00322335|680788|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
279229|NCT00322335|680789|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
279230|NCT00322335|680787|P3|STARTED|Subjects 42 Months After Booster Dose||56
279231|NCT00322335|680788|P2|STARTED|Subjects 42 Months After Booster Dose||113
279232|NCT00322335|680789|P1|STARTED|Subjects 42 Months After Booster Dose||51
279233|NCT00322335|680787|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
279234|NCT00322335|680788|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
279235|NCT00322335|680789|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
279236|NCT00322335|680787|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
279237|NCT00322335|680788|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
279238|NCT00322335|680789|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
279239|NCT00322335|680787|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
279240|NCT00322335|680788|P2|STARTED|Subjects 30 Months After Booster Dose||119
279241|NCT00322335|680789|P1|STARTED|Subjects 30 Months After Booster Dose||54
279242|NCT00322335|680787|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
279243|NCT00322335|680788|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
279244|NCT00322335|680789|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
279245|NCT00322335|680787|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
279246|NCT00322335|680788|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
279247|NCT00322335|680789|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
279248|NCT00322335|680787|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
279249|NCT00322335|680788|P2|STARTED|Subjects 18 Months After Booster Dose||123
279250|NCT00322335|680789|P1|STARTED|Subjects 18 Months After Booster Dose||58
279251|NCT00322309|680829|P2|NOT COMPLETED|Overall Study||4
279252|NCT00322309|680830|P1|NOT COMPLETED|Overall Study||2
279253|NCT00322309|680829|P2|COMPLETED|Overall Study||9
279254|NCT00322309|680830|P1|COMPLETED|Overall Study||9
279255|NCT00322309|680829|P2|STARTED|Overall Study||13
279256|NCT00322309|680830|P1|STARTED|Overall Study||11
279257|NCT00322231|680846|P2|NOT COMPLETED|Period 2||0
279258|NCT00322231|680847|P1|NOT COMPLETED|Period 2||0
279259|NCT00322231|680846|P2|COMPLETED|Period 2||49
279260|NCT00322231|680847|P1|COMPLETED|Period 2||51
279261|NCT00322231|680846|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
279262|NCT00322231|680847|P1|STARTED|Period 2||51
279263|NCT00322231|680846|P2|NOT COMPLETED|Period 1||0
279264|NCT00322231|680847|P1|NOT COMPLETED|Period 1||0
279265|NCT00322231|680846|P2|COMPLETED|Period 1||50
279266|NCT00322231|680847|P1|COMPLETED|Period 1||51
279267|NCT00322231|680846|P2|STARTED|Period 1||50
279268|NCT00322231|680847|P1|STARTED|Period 1||51
279269|NCT00322153|680859|P2|NOT COMPLETED|Overall Study||69
279270|NCT00322153|680860|P1|NOT COMPLETED|Overall Study||63
279271|NCT00322153|680859|P2|COMPLETED|Overall Study||273
279272|NCT00322153|680860|P1|COMPLETED|Overall Study||272
279273|NCT00322153|680859|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
279274|NCT00322153|680860|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
279275|NCT00322153|680859|P2|STARTED|Overall Study|Randomized to Memantine ER|342
279276|NCT00322153|680860|P1|STARTED|Overall Study|Randomized to placebo|335
279277|NCT00322101|680872|P2|NOT COMPLETED|Overall Study||0
279278|NCT00322101|680873|P1|NOT COMPLETED|Overall Study||0
279279|NCT00322101|680872|P2|COMPLETED|Overall Study||11
279280|NCT00322101|680873|P1|COMPLETED|Overall Study||14
279281|NCT00322101|680872|P2|STARTED|Overall Study||11
279282|NCT00322101|680873|P1|STARTED|Overall Study||14
279283|NCT00322049|680893|P4|NOT COMPLETED|Overall Study||1
279284|NCT00322049|680894|P3|NOT COMPLETED|Overall Study||0
279285|NCT00322049|680895|P2|NOT COMPLETED|Overall Study||1
279286|NCT00322049|680896|P1|NOT COMPLETED|Overall Study||0
279287|NCT00322049|680893|P4|COMPLETED|Overall Study||16
279288|NCT00322049|680894|P3|COMPLETED|Overall Study||20
279289|NCT00322049|680895|P2|COMPLETED|Overall Study||9
279290|NCT00322049|680896|P1|COMPLETED|Overall Study||4
279291|NCT00322049|680893|P4|STARTED|Overall Study||17
279292|NCT00322049|680894|P3|STARTED|Overall Study||20
279293|NCT00322049|680895|P2|STARTED|Overall Study||10
279294|NCT00322049|680896|P1|STARTED|Overall Study||4
279295|NCT00321984|680929|P3|NOT COMPLETED|Overall Study||26
279296|NCT00321984|680930|P2|NOT COMPLETED|Overall Study||21
279297|NCT00321984|680931|P1|NOT COMPLETED|Overall Study||27
279298|NCT00321984|680929|P3|COMPLETED|Overall Study||289
279299|NCT00321984|680930|P2|COMPLETED|Overall Study||294
279300|NCT00321984|680931|P1|COMPLETED|Overall Study||290
279301|NCT00321984|680929|P3|STARTED|Overall Study||315
279302|NCT00321984|680930|P2|STARTED|Overall Study||315
279303|NCT00321984|680931|P1|STARTED|Overall Study||317
279304|NCT00321971|680950|P2|NOT COMPLETED|Overall Study||11
279305|NCT00321971|680951|P1|NOT COMPLETED|Overall Study||8
279306|NCT00321971|680950|P2|COMPLETED|Overall Study||26
279307|NCT00321971|680951|P1|COMPLETED|Overall Study||28
279308|NCT00321971|680950|P2|STARTED|Overall Study||37
279309|NCT00321971|680951|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
279310|NCT00321932|680959|P2|NOT COMPLETED|Overall Study||21
279311|NCT00321932|680960|P1|NOT COMPLETED|Overall Study||10
279312|NCT00321932|680959|P2|COMPLETED|Overall Study||11
279313|NCT00321932|680960|P1|COMPLETED|Overall Study||19
279314|NCT00321932|680959|P2|STARTED|Overall Study||32
279315|NCT00321932|680960|P1|STARTED|Overall Study||29
279316|NCT00321919|680984|P2|NOT COMPLETED|Overall Study||52
279317|NCT00321919|680985|P1|NOT COMPLETED|Overall Study||75
279318|NCT00321919|680984|P2|COMPLETED|Overall Study||250
279319|NCT00321919|680985|P1|COMPLETED|Overall Study||226
279320|NCT00321919|680984|P2|STARTED|Overall Study||302
279321|NCT00321919|680985|P1|STARTED|Overall Study||301
279322|NCT00321906|681027|P2|NOT COMPLETED|Overall Study||56
279323|NCT00321906|681028|P1|NOT COMPLETED|Overall Study||46
279324|NCT00321906|681027|P2|COMPLETED|Overall Study||31
279325|NCT00321906|681028|P1|COMPLETED|Overall Study||48
279326|NCT00321906|681027|P2|STARTED|Overall Study||87
279327|NCT00321906|681028|P1|STARTED|Overall Study||94
279328|NCT00321893|681050|P2|NOT COMPLETED|Overall Study||14
279329|NCT00321893|681051|P1|NOT COMPLETED|Overall Study||24
279330|NCT00321893|681050|P2|COMPLETED|Overall Study||87
279331|NCT00321893|681051|P1|COMPLETED|Overall Study||77
279332|NCT00321893|681050|P2|STARTED|Overall Study||101
279333|NCT00321893|681051|P1|STARTED|Overall Study||101
279334|NCT00321854|681065|P2|NOT COMPLETED|Overall Study||82
279335|NCT00321854|681066|P1|NOT COMPLETED|Overall Study||63
279336|NCT00321854|681065|P2|COMPLETED|Overall Study||192
279337|NCT00321854|681066|P1|COMPLETED|Overall Study||198
279338|NCT00321854|681065|P2|STARTED|Overall Study||274
279339|NCT00321854|681066|P1|STARTED|Overall Study||261
279340|NCT00321828|681184|P1|NOT COMPLETED|Overall Study||4
279341|NCT00321828|681184|P1|COMPLETED|Overall Study||86
279342|NCT00321828|681184|P1|STARTED|Overall Study||90
279343|NCT00321789|681190|P2|NOT COMPLETED|Overall Study||16
279344|NCT00321789|681191|P1|NOT COMPLETED|Overall Study||15
279345|NCT00321789|681190|P2|COMPLETED|Overall Study||112
279346|NCT00321789|681191|P1|COMPLETED|Overall Study||112
279347|NCT00321789|681190|P2|STARTED|Overall Study||128
279348|NCT00321789|681191|P1|STARTED|Overall Study||127
279349|NCT00321763|681223|P4|NOT COMPLETED|Overall Study||5
279350|NCT00321763|681224|P3|NOT COMPLETED|Overall Study||6
279351|NCT00321763|681225|P2|NOT COMPLETED|Overall Study||2
279352|NCT00321763|681226|P1|NOT COMPLETED|Overall Study||6
279353|NCT00321763|681223|P4|COMPLETED|Overall Study||565
279354|NCT00321763|681224|P3|COMPLETED|Overall Study||848
279355|NCT00321763|681225|P2|COMPLETED|Overall Study||848
279356|NCT00321763|681226|P1|COMPLETED|Overall Study||844
279357|NCT00321763|681223|P4|STARTED|Overall Study||570
279358|NCT00321763|681224|P3|STARTED|Overall Study||854
279359|NCT00321763|681225|P2|STARTED|Overall Study||850
279360|NCT00321763|681226|P1|STARTED|Overall Study||850
279361|NCT00321737|681286|P3|NOT COMPLETED|Overall Study||54
279362|NCT00321737|681287|P2|NOT COMPLETED|Overall Study||48
279363|NCT00321737|681288|P1|NOT COMPLETED|Overall Study||122
279364|NCT00321737|681286|P3|COMPLETED|Overall Study||104
279365|NCT00321737|681287|P2|COMPLETED|Overall Study||92
279366|NCT00321737|681288|P1|COMPLETED|Overall Study||25
279367|NCT00321737|681286|P3|STARTED|Overall Study||158
279368|NCT00321737|681287|P2|STARTED|Overall Study||140
279369|NCT00321737|681288|P1|STARTED|Overall Study||147
279370|NCT00321711|681316|P5|NOT COMPLETED|Part B||5
279371|NCT00321711|681317|P4|NOT COMPLETED|Part B||6
279372|NCT00321711|681318|P3|NOT COMPLETED|Part B||0
279373|NCT00321711|681319|P2|NOT COMPLETED|Part B||0
279374|NCT00321711|681320|P1|NOT COMPLETED|Part B||0
279375|NCT00321711|681316|P5|COMPLETED|Part B||10
279376|NCT00321711|681317|P4|COMPLETED|Part B||8
279377|NCT00321711|681318|P3|COMPLETED|Part B||0
279378|NCT00321711|681319|P2|COMPLETED|Part B||0
279379|NCT00321711|681320|P1|COMPLETED|Part B||0
279380|NCT00321711|681316|P5|STARTED|Part B||15
279381|NCT00321711|681317|P4|STARTED|Part B||14
279382|NCT00321711|681318|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
279383|NCT00321711|681319|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
279384|NCT00321711|681320|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
279385|NCT00321711|681316|P5|NOT COMPLETED|Part A||0
279386|NCT00321711|681317|P4|NOT COMPLETED|Part A||0
279387|NCT00321711|681318|P3|NOT COMPLETED|Part A||11
279388|NCT00321711|681319|P2|NOT COMPLETED|Part A||10
279389|NCT00321711|681320|P1|NOT COMPLETED|Part A||5
279390|NCT00321711|681316|P5|COMPLETED|Part A||0
279391|NCT00321711|681317|P4|COMPLETED|Part A||0
279654|NCT00320398|681812|P2|COMPLETED|Overall Study||52
279392|NCT00321711|681318|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
279393|NCT00321711|681319|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
279394|NCT00321711|681320|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
279395|NCT00321711|681316|P5|STARTED|Part A||0
279396|NCT00321711|681317|P4|STARTED|Part A||0
279397|NCT00321711|681318|P3|STARTED|Part A||14
279398|NCT00321711|681319|P2|STARTED|Part A||13
279399|NCT00321711|681320|P1|STARTED|Part A||13
279400|NCT00321698|681352|P5|NOT COMPLETED|Phase II, MTD Dose||0
279401|NCT00321698|681353|P4|NOT COMPLETED|Phase II, MTD Dose||0
279402|NCT00321698|681354|P3|NOT COMPLETED|Phase II, MTD Dose||0
279403|NCT00321698|681355|P2|NOT COMPLETED|Phase II, MTD Dose||0
279404|NCT00321698|681356|P1|NOT COMPLETED|Phase II, MTD Dose||0
279405|NCT00321698|681352|P5|COMPLETED|Phase II, MTD Dose||13
279406|NCT00321698|681353|P4|COMPLETED|Phase II, MTD Dose||0
279407|NCT00321698|681354|P3|COMPLETED|Phase II, MTD Dose||0
279408|NCT00321698|681355|P2|COMPLETED|Phase II, MTD Dose||0
279409|NCT00321698|681356|P1|COMPLETED|Phase II, MTD Dose||0
279410|NCT00321698|681352|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
279411|NCT00321698|681353|P4|STARTED|Phase II, MTD Dose||0
279412|NCT00321698|681354|P3|STARTED|Phase II, MTD Dose||0
279413|NCT00321698|681355|P2|STARTED|Phase II, MTD Dose||0
279414|NCT00321698|681356|P1|STARTED|Phase II, MTD Dose||0
279415|NCT00321698|681352|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
279416|NCT00321698|681353|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
279417|NCT00321698|681354|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
279418|NCT00321698|681355|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
279419|NCT00321698|681356|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
279420|NCT00321698|681352|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
279421|NCT00321698|681353|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
279422|NCT00321698|681354|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
279423|NCT00321698|681355|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
279424|NCT00321698|681356|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
279425|NCT00321698|681352|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
279426|NCT00321698|681353|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
279427|NCT00321698|681354|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
279428|NCT00321698|681355|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
279429|NCT00321698|681356|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
279430|NCT00321685|681370|P1|NOT COMPLETED|Overall Study||39
279431|NCT00321685|681370|P1|COMPLETED|Overall Study||18
279432|NCT00321685|681370|P1|Eligible and Treated|Overall Study||53
279433|NCT00321685|681370|P1|Started Protocol Therapy|Overall Study||55
279434|NCT00321685|681370|P1|Eligible|Overall Study||55
279435|NCT00321685|681370|P1|STARTED|Overall Study||57
279436|NCT00321672|681382|P4|NOT COMPLETED|Overall Study||2
279437|NCT00321672|681383|P3|NOT COMPLETED|Overall Study||11
279438|NCT00321672|681384|P2|NOT COMPLETED|Overall Study||8
279439|NCT00321672|681385|P1|NOT COMPLETED|Overall Study||12
279440|NCT00321672|681382|P4|COMPLETED|Overall Study||71
279441|NCT00321672|681383|P3|COMPLETED|Overall Study||156
279442|NCT00321672|681384|P2|COMPLETED|Overall Study||81
279443|NCT00321672|681385|P1|COMPLETED|Overall Study||153
279444|NCT00321672|681382|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
279445|NCT00321672|681383|P3|STARTED|Overall Study||167
279446|NCT00321672|681384|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
279447|NCT00321672|681385|P1|STARTED|Overall Study||165
279448|NCT00321646|681411|P1|NOT COMPLETED|Prostatectomy||0
279449|NCT00321646|681411|P1|COMPLETED|Prostatectomy||37
279450|NCT00321646|681411|P1|STARTED|Prostatectomy||37
279451|NCT00321646|681411|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
279452|NCT00321646|681411|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
279453|NCT00321646|681411|P1|STARTED|Neoadjuvant Chemotherapy||42
279454|NCT00321620|681418|P2|NOT COMPLETED|Overall Study||722
279455|NCT00321620|681419|P1|NOT COMPLETED|Overall Study||743
279456|NCT00321620|681418|P2|COMPLETED|Overall Study||228
279457|NCT00321620|681419|P1|COMPLETED|Overall Study||208
279458|NCT00321620|681418|P2|Received Investigational Product|Overall Study||942
279459|NCT00321620|681419|P1|Received Investigational Product|Overall Study||946
279460|NCT00321620|681418|P2|STARTED|Overall Study||950
279461|NCT00321620|681419|P1|STARTED|Overall Study||951
279462|NCT00321594|681431|P5|NOT COMPLETED|Phase II, MTD Dose||0
279463|NCT00321594|681432|P4|NOT COMPLETED|Phase II, MTD Dose||0
279464|NCT00321594|681433|P3|NOT COMPLETED|Phase II, MTD Dose||0
279465|NCT00321594|681434|P2|NOT COMPLETED|Phase II, MTD Dose||0
279466|NCT00321594|681435|P1|NOT COMPLETED|Phase II, MTD Dose||0
279467|NCT00321594|681431|P5|COMPLETED|Phase II, MTD Dose||36
279468|NCT00321594|681432|P4|COMPLETED|Phase II, MTD Dose||6
279469|NCT00321594|681433|P3|COMPLETED|Phase II, MTD Dose||0
279470|NCT00321594|681434|P2|COMPLETED|Phase II, MTD Dose||0
279471|NCT00321594|681435|P1|COMPLETED|Phase II, MTD Dose||0
279472|NCT00321594|681431|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
279473|NCT00321594|681432|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
279474|NCT00321594|681433|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
279475|NCT00321594|681434|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
279476|NCT00321594|681435|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
279477|NCT00321594|681431|P5|NOT COMPLETED|Phase I, Level 1-4||0
279478|NCT00321594|681432|P4|NOT COMPLETED|Phase I, Level 1-4||0
279479|NCT00321594|681433|P3|NOT COMPLETED|Phase I, Level 1-4||0
279480|NCT00321594|681434|P2|NOT COMPLETED|Phase I, Level 1-4||0
279481|NCT00321594|681435|P1|NOT COMPLETED|Phase I, Level 1-4||0
279482|NCT00321594|681431|P5|COMPLETED|Phase I, Level 1-4||0
279483|NCT00321594|681432|P4|COMPLETED|Phase I, Level 1-4||6
279484|NCT00321594|681433|P3|COMPLETED|Phase I, Level 1-4||6
279485|NCT00321594|681434|P2|COMPLETED|Phase I, Level 1-4||3
279486|NCT00321594|681435|P1|COMPLETED|Phase I, Level 1-4||3
279487|NCT00321594|681431|P5|STARTED|Phase I, Level 1-4||0
279488|NCT00321594|681432|P4|STARTED|Phase I, Level 1-4||6
279489|NCT00321594|681433|P3|STARTED|Phase I, Level 1-4||6
279490|NCT00321594|681434|P2|STARTED|Phase I, Level 1-4||3
279491|NCT00321594|681435|P1|STARTED|Phase I, Level 1-4||3
279492|NCT00321464|681449|P2|NOT COMPLETED|Overall Study||558
279493|NCT00321464|681450|P1|NOT COMPLETED|Overall Study||559
279494|NCT00321464|681449|P2|COMPLETED|Overall Study||468
279495|NCT00321464|681450|P1|COMPLETED|Overall Study||461
279496|NCT00321464|681449|P2|Received Investigational Product|Overall Study||1019
279497|NCT00321464|681450|P1|Received Investigational Product|Overall Study||1014
279498|NCT00321464|681449|P2|STARTED|Overall Study||1026
279499|NCT00321464|681450|P1|STARTED|Overall Study||1020
279500|NCT00321373|681463|P3|NOT COMPLETED|Overall Study||3
279501|NCT00321373|681464|P2|NOT COMPLETED|Overall Study||0
279502|NCT00321373|681465|P1|NOT COMPLETED|Overall Study||2
279503|NCT00321373|681463|P3|COMPLETED|Overall Study||404
279504|NCT00321373|681464|P2|COMPLETED|Overall Study||406
279505|NCT00321373|681465|P1|COMPLETED|Overall Study||405
279506|NCT00321373|681463|P3|STARTED|Overall Study||407
279507|NCT00321373|681464|P2|STARTED|Overall Study||406
279508|NCT00321373|681465|P1|STARTED|Overall Study||407
279509|NCT00321321|681488|P1|NOT COMPLETED|Overall Study||0
279510|NCT00321321|681488|P1|COMPLETED|Overall Study||12
279511|NCT00321321|681488|P1|STARTED|Overall Study||12
279512|NCT00321269|681494|P2|NOT COMPLETED|Overall Study||6
279513|NCT00321269|681495|P1|NOT COMPLETED|Overall Study||8
279514|NCT00321269|681494|P2|COMPLETED|Overall Study||68
279515|NCT00321269|681495|P1|COMPLETED|Overall Study||66
279516|NCT00321269|681494|P2|STARTED|Overall Study||74
279517|NCT00321269|681495|P1|STARTED|Overall Study||74
279518|NCT00320801|681505|P4|NOT COMPLETED|Extension Phase||48
279519|NCT00320801|681506|P3|NOT COMPLETED|Extension Phase||0
279520|NCT00320801|681507|P2|NOT COMPLETED|Extension Phase||0
279521|NCT00320801|681508|P1|NOT COMPLETED|Extension Phase||0
279522|NCT00320801|681505|P4|COMPLETED|Extension Phase||7
279523|NCT00320801|681506|P3|COMPLETED|Extension Phase||0
279524|NCT00320801|681507|P2|COMPLETED|Extension Phase||0
279525|NCT00320801|681508|P1|COMPLETED|Extension Phase||0
279526|NCT00320801|681505|P4|STARTED|Extension Phase||55
279527|NCT00320801|681506|P3|STARTED|Extension Phase||0
279528|NCT00320801|681507|P2|STARTED|Extension Phase||0
279529|NCT00320801|681508|P1|STARTED|Extension Phase||0
279530|NCT00320801|681505|P4|NOT COMPLETED|Double-blind Phase||0
279531|NCT00320801|681506|P3|NOT COMPLETED|Double-blind Phase||14
279532|NCT00320801|681507|P2|NOT COMPLETED|Double-blind Phase||11
279533|NCT00320801|681508|P1|NOT COMPLETED|Double-blind Phase||0
279534|NCT00320801|681505|P4|COMPLETED|Double-blind Phase||0
279535|NCT00320801|681506|P3|COMPLETED|Double-blind Phase||35
279536|NCT00320801|681507|P2|COMPLETED|Double-blind Phase||36
279537|NCT00320801|681508|P1|COMPLETED|Double-blind Phase||0
279538|NCT00320801|681505|P4|STARTED|Double-blind Phase||0
279539|NCT00320801|681506|P3|STARTED|Double-blind Phase||49
279540|NCT00320801|681507|P2|STARTED|Double-blind Phase||47
279541|NCT00320801|681508|P1|STARTED|Double-blind Phase||0
279542|NCT00320801|681505|P4|NOT COMPLETED|Open-label Run-in Period||0
279543|NCT00320801|681506|P3|NOT COMPLETED|Open-label Run-in Period||0
279544|NCT00320801|681507|P2|NOT COMPLETED|Open-label Run-in Period||0
279545|NCT00320801|681508|P1|NOT COMPLETED|Open-label Run-in Period||92
279546|NCT00320801|681505|P4|COMPLETED|Open-label Run-in Period||0
279547|NCT00320801|681506|P3|COMPLETED|Open-label Run-in Period||0
279548|NCT00320801|681507|P2|COMPLETED|Open-label Run-in Period||0
279549|NCT00320801|681508|P1|COMPLETED|Open-label Run-in Period||96
279550|NCT00320801|681505|P4|STARTED|Open-label Run-in Period||0
279551|NCT00320801|681506|P3|STARTED|Open-label Run-in Period||0
279552|NCT00320801|681507|P2|STARTED|Open-label Run-in Period||0
279553|NCT00320801|681508|P1|STARTED|Open-label Run-in Period||188
279554|NCT00320788|681523|P5|NOT COMPLETED|Overall Study||5
279555|NCT00320788|681524|P4|NOT COMPLETED|Overall Study||5
279556|NCT00320788|681525|P3|NOT COMPLETED|Overall Study||3
279557|NCT00320788|681526|P2|NOT COMPLETED|Overall Study||6
279558|NCT00320788|681527|P1|NOT COMPLETED|Overall Study||6
279559|NCT00320788|681523|P5|COMPLETED|Overall Study||26
279560|NCT00320788|681524|P4|COMPLETED|Overall Study||27
279561|NCT00320788|681525|P3|COMPLETED|Overall Study||29
279562|NCT00320788|681526|P2|COMPLETED|Overall Study||26
279563|NCT00320788|681527|P1|COMPLETED|Overall Study||26
279564|NCT00320788|681523|P5|Participants Received Treatment (SAF)|Overall Study||31
279565|NCT00320788|681524|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
279566|NCT00320788|681525|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
279567|NCT00320788|681526|P2|Participants Received Treatment (SAF)|Overall Study||32
279568|NCT00320788|681527|P1|Participants Received Treatment (SAF)|Overall Study||32
279569|NCT00320788|681523|P5|STARTED|Overall Study||31
279570|NCT00320788|681524|P4|STARTED|Overall Study|Participants Randomized|32
279571|NCT00320788|681525|P3|STARTED|Overall Study||32
279572|NCT00320788|681526|P2|STARTED|Overall Study||32
279573|NCT00320788|681527|P1|STARTED|Overall Study||32
279574|NCT00320749|681570|P3|NOT COMPLETED|Overall Study||9
279575|NCT00320749|681571|P2|NOT COMPLETED|Overall Study||2
279576|NCT00320749|681572|P1|NOT COMPLETED|Overall Study||0
279577|NCT00320749|681570|P3|COMPLETED|Overall Study||1
279578|NCT00320749|681571|P2|COMPLETED|Overall Study||6
279579|NCT00320749|681572|P1|COMPLETED|Overall Study||3
279580|NCT00320749|681570|P3|STARTED|Overall Study||10
279581|NCT00320749|681571|P2|STARTED|Overall Study||8
279582|NCT00320749|681572|P1|STARTED|Overall Study||3
279583|NCT00320710|681581|P3|NOT COMPLETED|Overall Study||5
279584|NCT00320710|681582|P2|NOT COMPLETED|Overall Study||76
279585|NCT00320710|681583|P1|NOT COMPLETED|Overall Study||94
279586|NCT00320710|681581|P3|COMPLETED|Overall Study||8
279587|NCT00320710|681582|P2|COMPLETED|Overall Study||127
279588|NCT00320710|681583|P1|COMPLETED|Overall Study||106
279589|NCT00320710|681581|P3|Treated (Safety Set)|Overall Study||13
279590|NCT00320710|681582|P2|Treated (Safety Set)|Overall Study||202
279591|NCT00320710|681583|P1|Treated (Safety Set)|Overall Study||198
279592|NCT00320710|681581|P3|STARTED|Overall Study||13
279593|NCT00320710|681582|P2|STARTED|Overall Study||203
279594|NCT00320710|681583|P1|STARTED|Overall Study||200
279595|NCT00320671|681606|P2|NOT COMPLETED|Overall Study||38
279596|NCT00320671|681607|P1|NOT COMPLETED|Overall Study||33
279597|NCT00320671|681606|P2|COMPLETED|Overall Study||58
279598|NCT00320671|681607|P1|COMPLETED|Overall Study||69
279599|NCT00320671|681606|P2|STARTED|Overall Study||96
279600|NCT00320671|681607|P1|STARTED|Overall Study||102
279601|NCT00320606|681613|P1|NOT COMPLETED|Overall Study||14
279602|NCT00320606|681613|P1|COMPLETED|Overall Study|2 discontinued early, 12 ongoing in study|6
279603|NCT00320606|681613|P1|STARTED|Overall Study||20
279604|NCT00320593|681619|P2|NOT COMPLETED|Overall Study||1
279605|NCT00320593|681620|P1|NOT COMPLETED|Overall Study||7
279606|NCT00320593|681619|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
279607|NCT00320593|681620|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
279608|NCT00320593|681619|P2|STARTED|Overall Study||59
279609|NCT00320593|681620|P1|STARTED|Overall Study||59
279610|NCT00320541|681644|P2|NOT COMPLETED|Overall Study||57
279611|NCT00320541|681645|P1|NOT COMPLETED|Overall Study||50
279612|NCT00320541|681644|P2|COMPLETED|Overall Study||36
279613|NCT00320541|681645|P1|COMPLETED|Overall Study||44
279614|NCT00320541|681644|P2|STARTED|Overall Study||93
279615|NCT00320541|681645|P1|STARTED|Overall Study||94
279616|NCT00320528|681672|P3|NOT COMPLETED|Study Period III||106
279617|NCT00320528|681673|P2|NOT COMPLETED|Study Period III||31
279618|NCT00320528|681674|P1|NOT COMPLETED|Study Period III||87
279619|NCT00320528|681672|P3|COMPLETED|Study Period III||2
279620|NCT00320528|681673|P2|COMPLETED|Study Period III||0
279621|NCT00320528|681674|P1|COMPLETED|Study Period III||0
279622|NCT00320528|681672|P3|STARTED|Study Period III||108
279623|NCT00320528|681673|P2|STARTED|Study Period III||31
279624|NCT00320528|681674|P1|STARTED|Study Period III||87
279625|NCT00320528|681672|P3|NOT COMPLETED|Study Period II||22
279626|NCT00320528|681673|P2|NOT COMPLETED|Study Period II||10
279627|NCT00320528|681674|P1|NOT COMPLETED|Study Period II||11
279628|NCT00320528|681672|P3|COMPLETED|Study Period II||108
279629|NCT00320528|681673|P2|COMPLETED|Study Period II||31
279630|NCT00320528|681674|P1|COMPLETED|Study Period II||87
279631|NCT00320528|681672|P3|Received at Least One Dose of Study Drug|Study Period II||128
279632|NCT00320528|681673|P2|Received at Least One Dose of Study Drug|Study Period II||38
279633|NCT00320528|681674|P1|Received at Least One Dose of Study Drug|Study Period II||97
279634|NCT00320528|681672|P3|STARTED|Study Period II||130
279635|NCT00320528|681673|P2|STARTED|Study Period II||41
279636|NCT00320528|681674|P1|STARTED|Study Period II||98
279637|NCT00320515|681709|P1|NOT COMPLETED|Overall Study||49
279638|NCT00320515|681709|P1|COMPLETED|Overall Study||20
279639|NCT00320515|681709|P1|STARTED|Overall Study||69
279640|NCT00320489|681718|P2|NOT COMPLETED|Overall Study||136
279641|NCT00320489|681719|P1|NOT COMPLETED|Overall Study||145
279642|NCT00320489|681718|P2|COMPLETED|Overall Study||124
279643|NCT00320489|681719|P1|COMPLETED|Overall Study||119
279644|NCT00320489|681718|P2|STARTED|Overall Study||260
279645|NCT00320489|681719|P1|STARTED|Overall Study||264
279646|NCT00320424|681775|P1|NOT COMPLETED|Overall Study||6
279647|NCT00320424|681775|P1|COMPLETED|Overall Study||42
279648|NCT00320424|681775|P1|STARTED|Overall Study||48
279649|NCT00320411|681789|P1|NOT COMPLETED|Overall Study||4
279650|NCT00320411|681789|P1|COMPLETED|Overall Study||58
279651|NCT00320411|681789|P1|STARTED|Overall Study||62
279652|NCT00320398|681812|P2|NOT COMPLETED|Overall Study||4
279653|NCT00320398|681813|P1|NOT COMPLETED|Overall Study||2
279655|NCT00320398|681813|P1|COMPLETED|Overall Study||56
279656|NCT00320398|681812|P2|STARTED|Overall Study||56
279657|NCT00320398|681813|P1|STARTED|Overall Study||58
279658|NCT00320385|681841|P2|NOT COMPLETED|Overall Study||22
279659|NCT00320385|681842|P1|NOT COMPLETED|Overall Study||18
279660|NCT00320385|681841|P2|COMPLETED|Overall Study||126
279661|NCT00320385|681842|P1|COMPLETED|Overall Study||130
279662|NCT00320385|681841|P2|STARTED|Overall Study||148
279663|NCT00320385|681842|P1|STARTED|Overall Study||148
279664|NCT00320372|681865|P2|NOT COMPLETED|Overall Study||163
279665|NCT00320372|681866|P1|NOT COMPLETED|Overall Study||195
279666|NCT00320372|681865|P2|COMPLETED|Overall Study||138
279667|NCT00320372|681866|P1|COMPLETED|Overall Study||299
279668|NCT00320372|681865|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
279669|NCT00320372|681866|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
279670|NCT00320372|681865|P2|VNS Therapy D-23 Original|Overall Study||0
279671|NCT00320372|681866|P1|VNS Therapy D-23 Original|Overall Study||335
279672|NCT00320372|681865|P2|STARTED|Overall Study||301
279673|NCT00320372|681866|P1|STARTED|Overall Study||494
279674|NCT00320281|681893|P2|NOT COMPLETED|Overall Study||0
279675|NCT00320281|681894|P1|NOT COMPLETED|Overall Study||0
279676|NCT00320281|681893|P2|COMPLETED|Overall Study||9
279677|NCT00320281|681894|P1|COMPLETED|Overall Study||10
279678|NCT00320281|681893|P2|STARTED|Overall Study||9
279679|NCT00320281|681894|P1|STARTED|Overall Study||10
279680|NCT00320255|681906|P6|NOT COMPLETED|Overall Study||0
279681|NCT00320255|681907|P5|NOT COMPLETED|Overall Study||0
279682|NCT00320255|681908|P4|NOT COMPLETED|Overall Study||8
279683|NCT00320255|681909|P3|NOT COMPLETED|Overall Study||6
279684|NCT00320255|681910|P2|NOT COMPLETED|Overall Study||7
279685|NCT00320255|681911|P1|NOT COMPLETED|Overall Study||11
279686|NCT00320255|681906|P6|COMPLETED|Overall Study||3
279687|NCT00320255|681907|P5|COMPLETED|Overall Study||2
279688|NCT00320255|681908|P4|COMPLETED|Overall Study||25
279689|NCT00320255|681909|P3|COMPLETED|Overall Study||24
279690|NCT00320255|681910|P2|COMPLETED|Overall Study||25
279691|NCT00320255|681911|P1|COMPLETED|Overall Study||19
279692|NCT00320255|681906|P6|Received Treatment|Overall Study||3
279693|NCT00320255|681907|P5|Received Treatment|Overall Study||2
279694|NCT00320255|681908|P4|Received Treatment|Overall Study||32
279695|NCT00320255|681909|P3|Received Treatment|Overall Study||29
279696|NCT00320255|681910|P2|Received Treatment|Overall Study||32
279697|NCT00320255|681911|P1|Received Treatment|Overall Study||29
279698|NCT00320255|681906|P6|STARTED|Overall Study||3
279699|NCT00320255|681907|P5|STARTED|Overall Study||2
279700|NCT00320255|681908|P4|STARTED|Overall Study||33
279701|NCT00320255|681909|P3|STARTED|Overall Study||30
279702|NCT00320255|681910|P2|STARTED|Overall Study||32
279703|NCT00320255|681911|P1|STARTED|Overall Study||30
279704|NCT00320242|681991|P2|NOT COMPLETED|Overall Study||4
279705|NCT00320242|681992|P1|NOT COMPLETED|Overall Study||2
279706|NCT00320242|681991|P2|COMPLETED|Overall Study||12
279707|NCT00320242|681992|P1|COMPLETED|Overall Study||14
279708|NCT00320242|681991|P2|STARTED|Overall Study||16
279709|NCT00320242|681992|P1|STARTED|Overall Study||16
279710|NCT00320216|682004|P5|NOT COMPLETED|Overall Study||6
279711|NCT00320216|682005|P4|NOT COMPLETED|Overall Study||3
279712|NCT00320216|682006|P3|NOT COMPLETED|Overall Study||6
279713|NCT00320216|682007|P2|NOT COMPLETED|Overall Study||10
279714|NCT00320216|682008|P1|NOT COMPLETED|Overall Study||16
279715|NCT00320216|682004|P5|COMPLETED|Overall Study||58
279716|NCT00320216|682005|P4|COMPLETED|Overall Study||61
279717|NCT00320216|682006|P3|COMPLETED|Overall Study||58
279718|NCT00320216|682007|P2|COMPLETED|Overall Study||54
279719|NCT00320216|682008|P1|COMPLETED|Overall Study||48
279720|NCT00320216|682004|P5|STARTED|Overall Study||64
279721|NCT00320216|682005|P4|STARTED|Overall Study||64
279722|NCT00320216|682006|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
279723|NCT00320216|682007|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
279724|NCT00320216|682008|P1|STARTED|Overall Study||64
279725|NCT00320190|682042|P2|NOT COMPLETED|Long-term (12-month) Extension||2
279726|NCT00320190|682043|P1|NOT COMPLETED|Long-term (12-month) Extension||9
279727|NCT00320190|682042|P2|COMPLETED|Long-term (12-month) Extension||1
279728|NCT00320190|682043|P1|COMPLETED|Long-term (12-month) Extension||2
279729|NCT00320190|682042|P2|STARTED|Long-term (12-month) Extension||3
279730|NCT00320190|682043|P1|STARTED|Long-term (12-month) Extension||11
279731|NCT00320190|682042|P2|NOT COMPLETED|First 12 Months||10
279732|NCT00320190|682043|P1|NOT COMPLETED|First 12 Months||8
279733|NCT00320190|682042|P2|COMPLETED|First 12 Months||3
279734|NCT00320190|682043|P1|COMPLETED|First 12 Months||11
279735|NCT00320190|682042|P2|STARTED|First 12 Months||13
279736|NCT00320190|682043|P1|STARTED|First 12 Months||19
279737|NCT00320112|682063|P2|NOT COMPLETED|Overall Study||5
279738|NCT00320112|682064|P1|NOT COMPLETED|Overall Study||8
279739|NCT00320112|682063|P2|COMPLETED|Overall Study||114
279740|NCT00320112|682064|P1|COMPLETED|Overall Study||117
279741|NCT00320112|682063|P2|STARTED|Overall Study||119
279742|NCT00320112|682064|P1|STARTED|Overall Study||125
279743|NCT00319982|682078|P2|NOT COMPLETED|Overall Study||0
279744|NCT00319982|682079|P1|NOT COMPLETED|Overall Study||1
279745|NCT00319982|682078|P2|COMPLETED|Overall Study||20
279746|NCT00319982|682079|P1|COMPLETED|Overall Study||18
279747|NCT00319982|682078|P2|STARTED|Overall Study||20
279748|NCT00319982|682079|P1|STARTED|Overall Study||19
279749|NCT00319839|682097|P1|NOT COMPLETED|Overall Study||6
279750|NCT00319839|682097|P1|COMPLETED|Overall Study||1
279751|NCT00319839|682097|P1|STARTED|Overall Study||7
279752|NCT00319748|682103|P1|NOT COMPLETED|Overall Study||0
279753|NCT00319748|682103|P1|COMPLETED|Overall Study||13
279754|NCT00319748|682103|P1|STARTED|Overall Study||13
279755|NCT00319735|682113|P1|NOT COMPLETED|Overall Study||2
279756|NCT00319735|682113|P1|COMPLETED|Overall Study||39
279757|NCT00319735|682113|P1|STARTED|Overall Study||41
279758|NCT00319696|682126|P1|NOT COMPLETED|Overall Study||60
279759|NCT00319696|682126|P1|COMPLETED|Overall Study||56
279760|NCT00319696|682126|P1|STARTED|Overall Study||116
279761|NCT00319644|682152|P2|NOT COMPLETED|Overall Study||0
279762|NCT00319644|682153|P1|NOT COMPLETED|Overall Study||0
279763|NCT00319644|682152|P2|COMPLETED|Overall Study||16
279764|NCT00319644|682153|P1|COMPLETED|Overall Study||21
279765|NCT00319644|682152|P2|STARTED|Overall Study||16
279766|NCT00319644|682153|P1|STARTED|Overall Study||21
279767|NCT00319592|682163|P2|NOT COMPLETED|Overall Study||1
279768|NCT00319592|682164|P1|NOT COMPLETED|Overall Study||1
279769|NCT00319592|682163|P2|COMPLETED|Overall Study||29
279770|NCT00319592|682164|P1|COMPLETED|Overall Study||29
279771|NCT00319592|682163|P2|STARTED|Overall Study||30
279772|NCT00319592|682164|P1|STARTED|Overall Study||30
279773|NCT00319553|682180|P2|NOT COMPLETED|Overall Study||4
279774|NCT00319553|682181|P1|NOT COMPLETED|Overall Study||4
279775|NCT00319553|682180|P2|COMPLETED|Overall Study||317
279776|NCT00319553|682181|P1|COMPLETED|Overall Study||319
279777|NCT00319553|682180|P2|STARTED|Overall Study||321
279778|NCT00319553|682181|P1|STARTED|Overall Study||323
279779|NCT00319501|682195|P2|NOT COMPLETED|Open-label Extension Period||0
279780|NCT00319501|682196|P1|NOT COMPLETED|Open-label Extension Period||51
279781|NCT00319501|682195|P2|COMPLETED|Open-label Extension Period||0
279782|NCT00319501|682196|P1|COMPLETED|Open-label Extension Period||0
279783|NCT00319501|682195|P2|Received Treatment|Open-label Extension Period||0
279784|NCT00319501|682196|P1|Received Treatment|Open-label Extension Period||33
279785|NCT00319501|682195|P2|STARTED|Open-label Extension Period||0
279786|NCT00319501|682196|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
279787|NCT00319501|682195|P2|NOT COMPLETED|Open-label Period||0
279788|NCT00319501|682196|P1|NOT COMPLETED|Open-label Period||116
279789|NCT00319501|682195|P2|COMPLETED|Open-label Period||0
279790|NCT00319501|682196|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
279791|NCT00319501|682195|P2|Received Treatment|Open-label Period||0
279792|NCT00319501|682196|P1|Received Treatment|Open-label Period||128
279793|NCT00319501|682195|P2|STARTED|Open-label Period||0
279794|NCT00319501|682196|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
279795|NCT00319501|682195|P2|NOT COMPLETED|Double-blind Period||32
279796|NCT00319501|682196|P1|NOT COMPLETED|Double-blind Period||43
279797|NCT00319501|682195|P2|COMPLETED|Double-blind Period||78
279798|NCT00319501|682196|P1|COMPLETED|Double-blind Period||81
279799|NCT00319501|682195|P2|Received Treatment|Double-blind Period||81
279800|NCT00319501|682196|P1|Received Treatment|Double-blind Period||82
279801|NCT00319501|682195|P2|STARTED|Double-blind Period|Randomized participants|110
279802|NCT00319501|682196|P1|STARTED|Double-blind Period|Randomized participants|124
279803|NCT00319449|682222|P2|NOT COMPLETED|Overall Study||0
279804|NCT00319449|682223|P1|NOT COMPLETED|Overall Study||2
279805|NCT00319449|682222|P2|COMPLETED|Overall Study||12
279806|NCT00319449|682223|P1|COMPLETED|Overall Study||8
279807|NCT00319449|682222|P2|STARTED|Overall Study||12
279808|NCT00319449|682223|P1|STARTED|Overall Study||10
279809|NCT00319436|682235|P2|NOT COMPLETED|Overall Study||7
279810|NCT00319436|682236|P1|NOT COMPLETED|Overall Study||6
279811|NCT00319436|682235|P2|COMPLETED|Overall Study||17
279812|NCT00319436|682236|P1|COMPLETED|Overall Study||17
279813|NCT00319436|682235|P2|STARTED|Overall Study||24
279814|NCT00319436|682236|P1|STARTED|Overall Study||23
279815|NCT00319254|682254|P1|NOT COMPLETED|Overall Study||54
279816|NCT00319254|682254|P1|COMPLETED|Overall Study||21
279817|NCT00319254|682254|P1|Treated|Overall Study||73
279818|NCT00319254|682254|P1|STARTED|Overall Study||75
279819|NCT00319111|682267|P1|NOT COMPLETED|Overall Study||47
279820|NCT00319111|682267|P1|COMPLETED|Overall Study||104
279821|NCT00319111|682267|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
279822|NCT00319098|682281|P2|NOT COMPLETED|Overall Study||32
279823|NCT00319098|682282|P1|NOT COMPLETED|Overall Study||135
279824|NCT00319098|682281|P2|COMPLETED|Overall Study||1237
279825|NCT00319098|682282|P1|COMPLETED|Overall Study||3667
279826|NCT00319098|682281|P2|STARTED|Overall Study||1269
279827|NCT00319098|682282|P1|STARTED|Overall Study||3802
279828|NCT00319046|682340|P1|NOT COMPLETED|Overall Study||8
279829|NCT00319046|682340|P1|COMPLETED|Overall Study||34
279830|NCT00319046|682340|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
279831|NCT00319020|682349|P2|NOT COMPLETED|Overall Study||13
279832|NCT00319020|682350|P1|NOT COMPLETED|Overall Study||7
279833|NCT00319020|682349|P2|COMPLETED|Overall Study||8
279834|NCT00319020|682350|P1|COMPLETED|Overall Study||8
279835|NCT00319020|682349|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
279836|NCT00319020|682350|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
279837|NCT00319020|682349|P2|STARTED|Overall Study||21
279838|NCT00319020|682350|P1|STARTED|Overall Study||15
279839|NCT00318929|682379|P1|NOT COMPLETED|Overall Study||0
279840|NCT00318929|682379|P1|COMPLETED|Overall Study||14
279841|NCT00318929|682379|P1|STARTED|Overall Study||14
279842|NCT00318812|682388|P2|NOT COMPLETED|Overall Study||0
279843|NCT00318812|682389|P1|NOT COMPLETED|Overall Study||0
279844|NCT00318812|682388|P2|COMPLETED|Overall Study||22
279845|NCT00318812|682389|P1|COMPLETED|Overall Study||18
279846|NCT00318812|682388|P2|STARTED|Overall Study||22
279847|NCT00318812|682389|P1|STARTED|Overall Study||18
279848|NCT00318708|682401|P2|NOT COMPLETED|Overall Study||5
279849|NCT00318708|682402|P1|NOT COMPLETED|Overall Study||8
279850|NCT00318708|682401|P2|COMPLETED|Overall Study||40
279851|NCT00318708|682402|P1|COMPLETED|Overall Study||39
279852|NCT00318708|682401|P2|8-week Milestone|Overall Study||42
279853|NCT00318708|682402|P1|8-week Milestone|Overall Study||42
279854|NCT00318708|682401|P2|STARTED|Overall Study||45
279855|NCT00318708|682402|P1|STARTED|Overall Study||47
279856|NCT00318656|682422|P2|NOT COMPLETED|Overall Study||2
279857|NCT00318656|682423|P1|NOT COMPLETED|Overall Study||0
279858|NCT00318656|682422|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
279859|NCT00318656|682423|P1|COMPLETED|Overall Study||12
279860|NCT00318656|682422|P2|STARTED|Overall Study||11
279861|NCT00318656|682423|P1|STARTED|Overall Study||12
279862|NCT00318591|682461|P2|NOT COMPLETED|Overall Study||45
279863|NCT00318591|682462|P1|NOT COMPLETED|Overall Study||60
279864|NCT00318591|682461|P2|COMPLETED|Overall Study||69
279865|NCT00318591|682462|P1|COMPLETED|Overall Study||45
279866|NCT00318591|682461|P2|STARTED|Overall Study||114
279867|NCT00318591|682462|P1|STARTED|Overall Study||105
279868|NCT00318565|682480|P1|NOT COMPLETED|Overall Study||24
279869|NCT00318565|682480|P1|COMPLETED|Overall Study||267
279870|NCT00318565|682480|P1|STARTED|Overall Study||291
279871|NCT00318474|682487|P2|NOT COMPLETED|Overall Study||17
279872|NCT00318474|682488|P1|NOT COMPLETED|Overall Study||18
279873|NCT00318474|682487|P2|COMPLETED|Overall Study||10
279874|NCT00318474|682488|P1|COMPLETED|Overall Study||7
279875|NCT00318474|682487|P2|STARTED|Overall Study||27
279876|NCT00318474|682488|P1|STARTED|Overall Study||25
279877|NCT00318461|682499|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
279878|NCT00318461|682500|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
279879|NCT00318461|682501|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
279880|NCT00318461|682502|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
279881|NCT00318461|682503|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
279882|NCT00318461|682499|P5|COMPLETED|Open-Label Extension, 18 Months||113
279883|NCT00318461|682500|P4|COMPLETED|Open-Label Extension, 18 Months||31
279884|NCT00318461|682501|P3|COMPLETED|Open-Label Extension, 18 Months||118
279885|NCT00318461|682502|P2|COMPLETED|Open-Label Extension, 18 Months||137
279886|NCT00318461|682503|P1|COMPLETED|Open-Label Extension, 18 Months||130
279887|NCT00318461|682499|P5|STARTED|Open-Label Extension, 18 Months||210
279888|NCT00318461|682500|P4|STARTED|Open-Label Extension, 18 Months||74
279889|NCT00318461|682501|P3|STARTED|Open-Label Extension, 18 Months||191
279890|NCT00318461|682502|P2|STARTED|Open-Label Extension, 18 Months||197
279891|NCT00318461|682503|P1|STARTED|Open-Label Extension, 18 Months||208
279892|NCT00318461|682499|P5|NOT COMPLETED|Double-Blind, 6 Months||34
279893|NCT00318461|682500|P4|NOT COMPLETED|Double-Blind, 6 Months||48
279894|NCT00318461|682501|P3|NOT COMPLETED|Double-Blind, 6 Months||51
279895|NCT00318461|682502|P2|NOT COMPLETED|Double-Blind, 6 Months||44
279896|NCT00318461|682503|P1|NOT COMPLETED|Double-Blind, 6 Months||34
279897|NCT00318461|682499|P5|COMPLETED|Double-Blind, 6 Months||210
279898|NCT00318461|682500|P4|COMPLETED|Double-Blind, 6 Months||74
279899|NCT00318461|682501|P3|COMPLETED|Double-Blind, 6 Months||191
279900|NCT00318461|682502|P2|COMPLETED|Double-Blind, 6 Months||197
279901|NCT00318461|682503|P1|COMPLETED|Double-Blind, 6 Months||208
279902|NCT00318461|682499|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
279903|NCT00318461|682500|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
279904|NCT00318461|682501|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
279905|NCT00318461|682502|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
279906|NCT00318461|682503|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
279907|NCT00318461|682499|P5|STARTED|Double-Blind, 6 Months|Randomised|244
279908|NCT00318461|682500|P4|STARTED|Double-Blind, 6 Months|Randomised|122
279909|NCT00318461|682501|P3|STARTED|Double-Blind, 6 Months|Randomised|242
279910|NCT00318461|682502|P2|STARTED|Double-Blind, 6 Months|Randomised|241
279911|NCT00318461|682503|P1|STARTED|Double-Blind, 6 Months|Randomised|242
279912|NCT00318409|682582|P2|NOT COMPLETED|Overall Study||1
279913|NCT00318409|682583|P1|NOT COMPLETED|Overall Study||2
279914|NCT00318409|682582|P2|COMPLETED|Overall Study||9
279915|NCT00318409|682583|P1|COMPLETED|Overall Study||18
279916|NCT00318409|682582|P2|STARTED|Overall Study||10
279917|NCT00318409|682583|P1|STARTED|Overall Study||20
279918|NCT00318370|682602|P3|NOT COMPLETED|Period 3||33
279919|NCT00318370|682603|P2|NOT COMPLETED|Period 3||0
279920|NCT00318370|682604|P1|NOT COMPLETED|Period 3||0
279921|NCT00318370|682602|P3|COMPLETED|Period 3||3
279922|NCT00318370|682603|P2|COMPLETED|Period 3||0
279923|NCT00318370|682604|P1|COMPLETED|Period 3||0
279924|NCT00318370|682602|P3|STARTED|Period 3||36
279925|NCT00318370|682603|P2|STARTED|Period 3||0
279926|NCT00318370|682604|P1|STARTED|Period 3||0
279927|NCT00318370|682602|P3|NOT COMPLETED|Period 2||0
279928|NCT00318370|682603|P2|NOT COMPLETED|Period 2||11
279929|NCT00318370|682604|P1|NOT COMPLETED|Period 2||0
279930|NCT00318370|682602|P3|COMPLETED|Period 2||0
279931|NCT00318370|682603|P2|COMPLETED|Period 2||36
279932|NCT00318370|682604|P1|COMPLETED|Period 2||0
279933|NCT00318370|682602|P3|STARTED|Period 2||0
279934|NCT00318370|682603|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
279935|NCT00318370|682604|P1|STARTED|Period 2||0
279936|NCT00318370|682602|P3|NOT COMPLETED|Period 1||0
279937|NCT00318370|682603|P2|NOT COMPLETED|Period 1||0
279938|NCT00318370|682604|P1|NOT COMPLETED|Period 1||7
279939|NCT00318370|682602|P3|COMPLETED|Period 1||0
279940|NCT00318370|682603|P2|COMPLETED|Period 1||0
279941|NCT00318370|682604|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
279942|NCT00318370|682602|P3|STARTED|Period 1||0
279943|NCT00318370|682603|P2|STARTED|Period 1||0
279944|NCT00318370|682604|P1|STARTED|Period 1||28
279945|NCT00318292|682616|P2|NOT COMPLETED|Overall Study||0
279946|NCT00318292|682617|P1|NOT COMPLETED|Overall Study||0
279947|NCT00318292|682616|P2|COMPLETED|Overall Study||45
279948|NCT00318292|682617|P1|COMPLETED|Overall Study||45
279949|NCT00318292|682616|P2|STARTED|Overall Study||45
279950|NCT00318292|682617|P1|STARTED|Overall Study||45
279951|NCT00318136|682623|P1|NOT COMPLETED|Overall Study||45
279952|NCT00318136|682623|P1|COMPLETED|Overall Study||2
279953|NCT00318136|682623|P1|STARTED|Overall Study||47
279954|NCT00317941|682632|P3|NOT COMPLETED|Overall Study||8
279955|NCT00317941|682633|P2|NOT COMPLETED|Overall Study||5
279956|NCT00317941|682634|P1|NOT COMPLETED|Overall Study||7
279957|NCT00317941|682632|P3|COMPLETED|Overall Study||60
279958|NCT00317941|682633|P2|COMPLETED|Overall Study||74
279959|NCT00317941|682634|P1|COMPLETED|Overall Study||66
279960|NCT00317941|682632|P3|Fulfilled Requirements PP Population|Overall Study||63
279961|NCT00317941|682633|P2|Fulfilled Requirements PP Population|Overall Study||76
279962|NCT00317941|682634|P1|Fulfilled Requirements PP Population|Overall Study||66
279963|NCT00317941|682632|P3|Fulfilled Requirement Safety Population|Overall Study||65
279964|NCT00317941|682633|P2|Fulfilled Requirement Safety Population|Overall Study||77
279965|NCT00317941|682634|P1|Fulfilled Requirement Safety Population|Overall Study||73
279966|NCT00317941|682632|P3|Participants Received Treatment|Overall Study||68
279967|NCT00317941|682633|P2|Participants Received Treatment|Overall Study||79
279968|NCT00317941|682634|P1|Participants Received Treatment|Overall Study||73
279969|NCT00317941|682632|P3|STARTED|Overall Study||68
279970|NCT00317941|682633|P2|STARTED|Overall Study||79
279971|NCT00317941|682634|P1|STARTED|Overall Study||73
279972|NCT00317720|682675|P2|NOT COMPLETED|Overall Study||0
279973|NCT00317720|682676|P1|NOT COMPLETED|Overall Study||0
279974|NCT00317720|682675|P2|COMPLETED|Overall Study||7
279975|NCT00317720|682676|P1|COMPLETED|Overall Study||40
279976|NCT00317720|682675|P2|STARTED|Overall Study||7
279977|NCT00317720|682676|P1|STARTED|Overall Study||40
279978|NCT00317642|682683|P2|NOT COMPLETED|Overall Study||135
279979|NCT00317642|682684|P1|NOT COMPLETED|Overall Study||122
279980|NCT00317642|682683|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
279981|NCT00317642|682684|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
279982|NCT00317642|682683|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
279983|NCT00317642|682684|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
279984|NCT00317642|682683|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
279985|NCT00317642|682684|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
279986|NCT00317642|682683|P2|STARTED|Overall Study||163
279987|NCT00317642|682684|P1|STARTED|Overall Study||163
279988|NCT00317473|682763|P6|NOT COMPLETED|Overall Study||3
279989|NCT00317473|682764|P5|NOT COMPLETED|Overall Study||8
279990|NCT00317473|682765|P4|NOT COMPLETED|Overall Study||2
279991|NCT00317473|682766|P3|NOT COMPLETED|Overall Study||3
279992|NCT00317473|682767|P2|NOT COMPLETED|Overall Study||3
279993|NCT00317473|682768|P1|NOT COMPLETED|Overall Study||4
279994|NCT00317473|682763|P6|COMPLETED|Overall Study||12
279995|NCT00317473|682764|P5|COMPLETED|Overall Study||22
279996|NCT00317473|682765|P4|COMPLETED|Overall Study||13
279997|NCT00317473|682766|P3|COMPLETED|Overall Study||27
279998|NCT00317473|682767|P2|COMPLETED|Overall Study||12
279999|NCT00317473|682768|P1|COMPLETED|Overall Study||26
280000|NCT00317473|682763|P6|STARTED|Overall Study||15
280001|NCT00317473|682764|P5|STARTED|Overall Study||30
280002|NCT00317473|682765|P4|STARTED|Overall Study||15
280003|NCT00317473|682766|P3|STARTED|Overall Study||30
280004|NCT00317473|682767|P2|STARTED|Overall Study||15
280005|NCT00317473|682768|P1|STARTED|Overall Study||30
280006|NCT00317239|682794|P2|NOT COMPLETED|Overall Study||19
280007|NCT00317239|682795|P1|NOT COMPLETED|Overall Study||13
280008|NCT00317239|682794|P2|COMPLETED|Overall Study||84
280009|NCT00317239|682795|P1|COMPLETED|Overall Study||134
280010|NCT00317239|682794|P2|STARTED|Overall Study||103
280011|NCT00317239|682795|P1|STARTED|Overall Study||147
280012|NCT00317226|682801|P1|NOT COMPLETED|Overall Study||23
280013|NCT00317226|682801|P1|COMPLETED|Overall Study||104
280014|NCT00317226|682801|P1|STARTED|Overall Study||127
280015|NCT00317109|682807|P2|NOT COMPLETED|Overall Study||0
280016|NCT00317109|682808|P1|NOT COMPLETED|Overall Study||3
280017|NCT00317109|682807|P2|COMPLETED|Overall Study||84
280018|NCT00317109|682808|P1|COMPLETED|Overall Study||81
280019|NCT00317109|682807|P2|STARTED|Overall Study||84
280020|NCT00317109|682808|P1|STARTED|Overall Study||84
280021|NCT00317044|682845|P3|NOT COMPLETED|Overall Study||45
280022|NCT00317044|682846|P2|NOT COMPLETED|Overall Study||40
280023|NCT00317044|682847|P1|NOT COMPLETED|Overall Study||48
280024|NCT00317044|682845|P3|COMPLETED|Overall Study||283
280025|NCT00317044|682846|P2|COMPLETED|Overall Study||273
280026|NCT00317044|682847|P1|COMPLETED|Overall Study||272
280027|NCT00317044|682845|P3|STARTED|Overall Study||328
280028|NCT00317044|682846|P2|STARTED|Overall Study||313
280029|NCT00317044|682847|P1|STARTED|Overall Study||320
280030|NCT00316914|682893|P2|NOT COMPLETED|Overall Study||36
280031|NCT00316914|682894|P1|NOT COMPLETED|Overall Study||33
280032|NCT00316914|682893|P2|COMPLETED|Overall Study||16
280033|NCT00316914|682894|P1|COMPLETED|Overall Study||17
280034|NCT00316914|682893|P2|STARTED|Overall Study||52
280035|NCT00316914|682894|P1|STARTED|Overall Study||50
280036|NCT00316888|682924|P2|NOT COMPLETED|Overall Study||8
280037|NCT00316888|682925|P1|NOT COMPLETED|Overall Study||6
280038|NCT00316888|682924|P2|COMPLETED|Overall Study||27
280039|NCT00316888|682925|P1|COMPLETED|Overall Study||22
280040|NCT00316888|682924|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
280041|NCT00316888|682925|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
280042|NCT00316888|682924|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
280043|NCT00316888|682925|P1|Started Induction Chemotherapy|Overall Study||28
280044|NCT00316888|682924|P2|Treated|Overall Study||34
280045|NCT00316888|682925|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
280046|NCT00316888|682924|P2|Eligible|Overall Study||35
280047|NCT00316888|682925|P1|Eligible|Overall Study||28
280048|NCT00316888|682924|P2|STARTED|Overall Study||35
280049|NCT00316888|682925|P1|STARTED|Overall Study||28
280050|NCT00316862|682939|P1|NOT COMPLETED|Overall Study||0
280051|NCT00316862|682939|P1|COMPLETED|Overall Study||82
280052|NCT00316862|682939|P1|STARTED|Overall Study||82
280053|NCT00316719|682947|P2|NOT COMPLETED|Overall Study||6
280054|NCT00316719|682948|P1|NOT COMPLETED|Overall Study||2
280055|NCT00316719|682947|P2|COMPLETED|Overall Study||47
280056|NCT00316719|682948|P1|COMPLETED|Overall Study||50
280057|NCT00316719|682947|P2|STARTED|Overall Study||53
280058|NCT00316719|682948|P1|STARTED|Overall Study||52
280059|NCT00316706|682974|P2|NOT COMPLETED|Overall Study||48
280060|NCT00316706|682975|P1|NOT COMPLETED|Overall Study||38
280061|NCT00316706|682974|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
280062|NCT00316706|682975|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
280063|NCT00316706|682974|P2|STARTED|Overall Study||619
280064|NCT00316706|682975|P1|STARTED|Overall Study||626
280065|NCT00316693|682991|P2|NOT COMPLETED|Overall Study||85
280066|NCT00316693|682992|P1|NOT COMPLETED|Overall Study||77
280067|NCT00316693|682991|P2|COMPLETED|Overall Study||436
280068|NCT00316693|682992|P1|COMPLETED|Overall Study||442
280069|NCT00316693|682991|P2|STARTED|Overall Study||521
280070|NCT00316693|682992|P1|STARTED|Overall Study||519
280071|NCT00316355|683034|P2|NOT COMPLETED|Overall Study||7
280072|NCT00316355|683035|P1|NOT COMPLETED|Overall Study||5
280073|NCT00316355|683034|P2|COMPLETED|Overall Study||12
280074|NCT00316355|683035|P1|COMPLETED|Overall Study||10
280075|NCT00316355|683034|P2|Started Treatment|Overall Study||18
280076|NCT00316355|683035|P1|Started Treatment|Overall Study||12
280077|NCT00316355|683034|P2|STARTED|Overall Study||19
280078|NCT00316355|683035|P1|STARTED|Overall Study||15
280079|NCT00316303|683045|P2|NOT COMPLETED|Overall Study||16
280080|NCT00316303|683046|P1|NOT COMPLETED|Overall Study||11
280081|NCT00316303|683045|P2|COMPLETED|Overall Study||102
280082|NCT00316303|683046|P1|COMPLETED|Overall Study||107
280083|NCT00316303|683045|P2|STARTED|Overall Study||118
280084|NCT00316303|683046|P1|STARTED|Overall Study||118
280085|NCT00316277|683062|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
280086|NCT00316277|683063|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
280087|NCT00316277|683062|P2|COMPLETED|Phase 2 (24 Weeks)||161
280088|NCT00316277|683063|P1|COMPLETED|Phase 2 (24 Weeks)||161
280089|NCT00316277|683062|P2|STARTED|Phase 2 (24 Weeks)||180
280090|NCT00316277|683063|P1|STARTED|Phase 2 (24 Weeks)||180
280091|NCT00316277|683062|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
280092|NCT00316277|683063|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
280093|NCT00316277|683062|P2|COMPLETED|Phase 1 (12 Weeks)||24
280094|NCT00316277|683063|P1|COMPLETED|Phase 1 (12 Weeks)||19
280095|NCT00316277|683062|P2|STARTED|Phase 1 (12 Weeks)||324
280096|NCT00316277|683063|P1|STARTED|Phase 1 (12 Weeks)||329
280097|NCT00316264|683084|P3|NOT COMPLETED|Overall Study||6
280098|NCT00316264|683085|P2|NOT COMPLETED|Overall Study||7
280099|NCT00316264|683086|P1|NOT COMPLETED|Overall Study||6
280100|NCT00316264|683084|P3|COMPLETED|Overall Study||87
280101|NCT00316264|683085|P2|COMPLETED|Overall Study||77
280102|NCT00316264|683086|P1|COMPLETED|Overall Study||77
280103|NCT00316264|683084|P3|STARTED|Overall Study||93
280104|NCT00316264|683085|P2|STARTED|Overall Study||84
280105|NCT00316264|683086|P1|STARTED|Overall Study||83
280106|NCT00316225|683154|P1|NOT COMPLETED|Overall Study||25
280107|NCT00316225|683154|P1|COMPLETED|Overall Study||6
280108|NCT00316225|683154|P1|STARTED|Overall Study||31
280109|NCT00316199|683163|P1|NOT COMPLETED|Overall Study||12
280110|NCT00316199|683163|P1|COMPLETED|Overall Study||48
280111|NCT00316199|683163|P1|STARTED|Overall Study||60
280112|NCT00316186|683171|P1|NOT COMPLETED|Overall Study||12
280113|NCT00316186|683171|P1|COMPLETED|Overall Study||21
280114|NCT00316186|683171|P1|STARTED|Overall Study||33
280115|NCT00316173|683185|P2|NOT COMPLETED|Treatment Phase||42
280116|NCT00316173|683186|P1|NOT COMPLETED|Treatment Phase||0
280117|NCT00316173|683185|P2|COMPLETED|Treatment Phase||13
280118|NCT00316173|683186|P1|COMPLETED|Treatment Phase||0
280119|NCT00316173|683185|P2|STARTED|Treatment Phase||55
280120|NCT00316173|683186|P1|STARTED|Treatment Phase||0
280121|NCT00316173|683185|P2|NOT COMPLETED|Run-in Phase||0
280122|NCT00316173|683186|P1|NOT COMPLETED|Run-in Phase||7
280123|NCT00316173|683185|P2|COMPLETED|Run-in Phase||0
280124|NCT00316173|683186|P1|COMPLETED|Run-in Phase||15
280125|NCT00316173|683185|P2|STARTED|Run-in Phase||0
280126|NCT00316173|683186|P1|STARTED|Run-in Phase||22
280127|NCT00316121|683199|P2|NOT COMPLETED|Overall Study||9
280128|NCT00316121|683200|P1|NOT COMPLETED|Overall Study||22
280129|NCT00316121|683199|P2|COMPLETED|Overall Study||37
280130|NCT00316121|683200|P1|COMPLETED|Overall Study||70
280131|NCT00316121|683199|P2|STARTED|Overall Study||46
280132|NCT00316121|683200|P1|STARTED|Overall Study||92
280133|NCT00316082|683211|P5|NOT COMPLETED|Overall Study||26
280134|NCT00316082|683212|P4|NOT COMPLETED|Overall Study||26
280135|NCT00316082|683213|P3|NOT COMPLETED|Overall Study||27
280136|NCT00316082|683214|P2|NOT COMPLETED|Overall Study||22
280137|NCT00316082|683215|P1|NOT COMPLETED|Overall Study||33
280138|NCT00316082|683211|P5|COMPLETED|Overall Study||48
280139|NCT00316082|683212|P4|COMPLETED|Overall Study||46
280140|NCT00316082|683213|P3|COMPLETED|Overall Study||44
280141|NCT00316082|683214|P2|COMPLETED|Overall Study||52
280142|NCT00316082|683215|P1|COMPLETED|Overall Study||41
280143|NCT00316082|683211|P5|Completed Study Without Being Rescued|Overall Study||31
280144|NCT00316082|683212|P4|Completed Study Without Being Rescued|Overall Study||27
280145|NCT00316082|683213|P3|Completed Study Without Being Rescued|Overall Study||29
280146|NCT00316082|683214|P2|Completed Study Without Being Rescued|Overall Study||35
280147|NCT00316082|683215|P1|Completed Study Without Being Rescued|Overall Study||25
280148|NCT00316082|683211|P5|STARTED|Overall Study||74
280149|NCT00316082|683212|P4|STARTED|Overall Study||72
280150|NCT00316082|683213|P3|STARTED|Overall Study||71
280151|NCT00316082|683214|P2|STARTED|Overall Study||74
280152|NCT00316082|683215|P1|STARTED|Overall Study||74
280153|NCT00316017|683246|P3|NOT COMPLETED|Overall Study||19
280154|NCT00316017|683247|P2|NOT COMPLETED|Overall Study||13
280155|NCT00316017|683248|P1|NOT COMPLETED|Overall Study||11
280156|NCT00316017|683246|P3|COMPLETED|Overall Study||376
280157|NCT00316017|683247|P2|COMPLETED|Overall Study||256
280158|NCT00316017|683248|P1|COMPLETED|Overall Study||220
280159|NCT00316017|683246|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
280160|NCT00316017|683247|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
280161|NCT00316017|683248|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
280162|NCT00316004|683322|P3|NOT COMPLETED|Overall Study||21
280163|NCT00316004|683323|P2|NOT COMPLETED|Overall Study||14
280164|NCT00316004|683324|P1|NOT COMPLETED|Overall Study||14
280165|NCT00316004|683322|P3|COMPLETED|Overall Study||582
280166|NCT00316004|683323|P2|COMPLETED|Overall Study||341
280167|NCT00316004|683324|P1|COMPLETED|Overall Study||359
280168|NCT00316004|683322|P3|STARTED|Overall Study||603
280169|NCT00316004|683323|P2|STARTED|Overall Study||355
280170|NCT00316004|683324|P1|STARTED|Overall Study||373
280171|NCT00315939|683379|P2|NOT COMPLETED|Admission 3 (3 Months)||2
280172|NCT00315939|683380|P1|NOT COMPLETED|Admission 3 (3 Months)||4
280173|NCT00315939|683379|P2|COMPLETED|Admission 3 (3 Months)||49
280174|NCT00315939|683380|P1|COMPLETED|Admission 3 (3 Months)||48
280175|NCT00315939|683379|P2|STARTED|Admission 3 (3 Months)||51
280176|NCT00315939|683380|P1|STARTED|Admission 3 (3 Months)||52
280177|NCT00315939|683379|P2|NOT COMPLETED|Admission 2 (3 Months)||4
280178|NCT00315939|683380|P1|NOT COMPLETED|Admission 2 (3 Months)||4
280179|NCT00315939|683379|P2|COMPLETED|Admission 2 (3 Months)||51
280180|NCT00315939|683380|P1|COMPLETED|Admission 2 (3 Months)||52
280181|NCT00315939|683379|P2|STARTED|Admission 2 (3 Months)||55
280182|NCT00315939|683380|P1|STARTED|Admission 2 (3 Months)||56
280183|NCT00315939|683379|P2|NOT COMPLETED|Admission 1 (3 Months)||6
280184|NCT00315939|683380|P1|NOT COMPLETED|Admission 1 (3 Months)||3
280185|NCT00315939|683379|P2|COMPLETED|Admission 1 (3 Months)||55
280186|NCT00315939|683380|P1|COMPLETED|Admission 1 (3 Months)||56
280187|NCT00315939|683379|P2|STARTED|Admission 1 (3 Months)||61
280188|NCT00315939|683380|P1|STARTED|Admission 1 (3 Months)||59
280189|NCT00315822|683388|P2|NOT COMPLETED|Overall Study||0
280190|NCT00315822|683389|P1|NOT COMPLETED|Overall Study||0
280191|NCT00315822|683388|P2|COMPLETED|Overall Study||202
280192|NCT00315822|683389|P1|COMPLETED|Overall Study||198
280193|NCT00315822|683388|P2|STARTED|Overall Study||202
280194|NCT00315822|683389|P1|STARTED|Overall Study||198
280195|NCT00315731|683395|P1|NOT COMPLETED|Overall Study||6
280196|NCT00315731|683395|P1|COMPLETED|Overall Study||9
280197|NCT00315731|683395|P1|STARTED|Overall Study||15
280198|NCT00315705|683423|P1|NOT COMPLETED|Phase 2||25
280199|NCT00315705|683423|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
280200|NCT00315705|683423|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
280201|NCT00315705|683423|P1|NOT COMPLETED|Phase 1||25
280202|NCT00315705|683423|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
280203|NCT00315705|683423|P1|STARTED|Phase 1||25
280204|NCT00315627|683460|P1|NOT COMPLETED|Overall Study||0
280205|NCT00315627|683460|P1|COMPLETED|Overall Study||3
280206|NCT00315627|683460|P1|STARTED|Overall Study||3
280207|NCT00315614|683468|P1|NOT COMPLETED|Overall Study||0
280208|NCT00315614|683468|P1|COMPLETED|Overall Study||3
280209|NCT00315614|683468|P1|STARTED|Overall Study||3
280210|NCT00315588|683475|P1|NOT COMPLETED|Overall Study||0
280211|NCT00315588|683475|P1|COMPLETED|Overall Study||7
280212|NCT00315588|683475|P1|STARTED|Overall Study||7
280213|NCT00315458|683484|P4|NOT COMPLETED|Overall Study||29
280214|NCT00315458|683485|P3|NOT COMPLETED|Overall Study||52
280215|NCT00315458|683486|P2|NOT COMPLETED|Overall Study||12
280216|NCT00315458|683487|P1|NOT COMPLETED|Overall Study||3
280217|NCT00315458|683484|P4|COMPLETED|Overall Study||10
280218|NCT00315458|683485|P3|COMPLETED|Overall Study||107
280219|NCT00315458|683486|P2|COMPLETED|Overall Study||44
280220|NCT00315458|683487|P1|COMPLETED|Overall Study||48
280221|NCT00315458|683484|P4|STARTED|Overall Study||39
280222|NCT00315458|683485|P3|STARTED|Overall Study||159
280223|NCT00315458|683486|P2|STARTED|Overall Study||56
280224|NCT00315458|683487|P1|STARTED|Overall Study||51
280225|NCT00315445|683500|P3|NOT COMPLETED|Overall Study||24
280226|NCT00315445|683501|P2|NOT COMPLETED|Overall Study||16
280227|NCT00315445|683502|P1|NOT COMPLETED|Overall Study||27
280228|NCT00315445|683500|P3|COMPLETED|Overall Study||22
280229|NCT00315445|683501|P2|COMPLETED|Overall Study||27
280230|NCT00315445|683502|P1|COMPLETED|Overall Study||18
280231|NCT00315445|683500|P3|STARTED|Overall Study||46
280232|NCT00315445|683501|P2|STARTED|Overall Study||43
280233|NCT00315445|683502|P1|STARTED|Overall Study||45
280234|NCT00315341|683575|P2|NOT COMPLETED|Overall Study||138
280235|NCT00315341|683576|P1|NOT COMPLETED|Overall Study||400
280236|NCT00315341|683575|P2|COMPLETED|Overall Study||391
280237|NCT00315341|683576|P1|COMPLETED|Overall Study||340
280238|NCT00315341|683575|P2|STARTED|Overall Study||529
280239|NCT00315341|683576|P1|STARTED|Overall Study||740
280240|NCT00315328|683586|P4|NOT COMPLETED|Overall Study||2
280241|NCT00315328|683587|P3|NOT COMPLETED|Overall Study||5
280242|NCT00315328|683588|P2|NOT COMPLETED|Overall Study||7
280243|NCT00315328|683589|P1|NOT COMPLETED|Overall Study||14
280244|NCT00315328|683586|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
280245|NCT00315328|683587|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
280246|NCT00315328|683588|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
280247|NCT00315328|683589|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
280248|NCT00315328|683586|P4|5 Week Visit|Overall Study||19
280249|NCT00315328|683587|P3|5 Week Visit|Overall Study||17
280250|NCT00315328|683588|P2|5 Week Visit|Overall Study||89
280251|NCT00315328|683589|P1|5 Week Visit|Overall Study||91
280252|NCT00315328|683586|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
280253|NCT00315328|683587|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
280254|NCT00315328|683588|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
280255|NCT00315328|683589|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
280256|NCT00315302|683659|P4|NOT COMPLETED|Overall Study||3
280257|NCT00315302|683660|P3|NOT COMPLETED|Overall Study||2
280258|NCT00315302|683661|P2|NOT COMPLETED|Overall Study||2
280259|NCT00315302|683662|P1|NOT COMPLETED|Overall Study||6
280260|NCT00315302|683659|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
280261|NCT00315302|683660|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
280262|NCT00315302|683661|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
280263|NCT00315302|683662|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
280264|NCT00315302|683659|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
280265|NCT00315302|683660|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
280266|NCT00315302|683661|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
280267|NCT00315302|683662|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
280268|NCT00315302|683659|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
280269|NCT00315302|683660|P3|18 Week Primary Outcome Visit|Overall Study||24
280270|NCT00315302|683661|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
280271|NCT00315302|683662|P1|18 Week Primary Outcome Visit|Overall Study||84
280272|NCT00315302|683659|P4|10 Week Visit|Overall Study||29
280273|NCT00315302|683660|P3|10 Week Visit|Overall Study||24
280274|NCT00315302|683661|P2|10 Week Visit|Overall Study||85
280275|NCT00315302|683662|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
280276|NCT00315302|683659|P4|5 Week Visit|Overall Study||30
280277|NCT00315302|683660|P3|5 Week Visit|Overall Study||26
280278|NCT00315302|683661|P2|5 Week Visit|Overall Study||86
280279|NCT00315302|683662|P1|5 Week Visit|Overall Study||85
280280|NCT00315302|683659|P4|STARTED|Overall Study||34
280281|NCT00315302|683660|P3|STARTED|Overall Study||26
280282|NCT00315302|683661|P2|STARTED|Overall Study||90
280283|NCT00315302|683662|P1|STARTED|Overall Study||90
280284|NCT00315146|683708|P4|NOT COMPLETED|Overall Study||0
280285|NCT00315146|683709|P3|NOT COMPLETED|Overall Study||2
280286|NCT00315146|683710|P2|NOT COMPLETED|Overall Study||3
280287|NCT00315146|683711|P1|NOT COMPLETED|Overall Study||2
280288|NCT00315146|683708|P4|COMPLETED|Overall Study||22
280289|NCT00315146|683709|P3|COMPLETED|Overall Study||20
280290|NCT00315146|683710|P2|COMPLETED|Overall Study||19
280291|NCT00315146|683711|P1|COMPLETED|Overall Study||20
280292|NCT00315146|683708|P4|STARTED|Overall Study||22
280293|NCT00315146|683709|P3|STARTED|Overall Study||22
280294|NCT00315146|683710|P2|STARTED|Overall Study||22
280295|NCT00315146|683711|P1|STARTED|Overall Study||22
280296|NCT00315120|683729|P4|NOT COMPLETED|Overall Study||0
280297|NCT00315120|683730|P3|NOT COMPLETED|Overall Study||0
280298|NCT00315120|683731|P2|NOT COMPLETED|Overall Study||0
280299|NCT00315120|683732|P1|NOT COMPLETED|Overall Study||0
280300|NCT00315120|683729|P4|COMPLETED|Overall Study||107
280301|NCT00315120|683730|P3|COMPLETED|Overall Study||115
280302|NCT00315120|683731|P2|COMPLETED|Overall Study||118
280303|NCT00315120|683732|P1|COMPLETED|Overall Study||115
280304|NCT00315120|683729|P4|STARTED|Overall Study||107
280305|NCT00315120|683730|P3|STARTED|Overall Study||115
280306|NCT00315120|683731|P2|STARTED|Overall Study||118
280307|NCT00315120|683732|P1|STARTED|Overall Study||115
280308|NCT00315055|683792|P2|NOT COMPLETED|Overall Study||5
280309|NCT00315055|683793|P1|NOT COMPLETED|Overall Study||3
280310|NCT00315055|683792|P2|COMPLETED|Overall Study||150
280311|NCT00315055|683793|P1|COMPLETED|Overall Study||152
280312|NCT00315055|683792|P2|STARTED|Overall Study||155
280313|NCT00315055|683793|P1|STARTED|Overall Study||155
280314|NCT00314951|683811|P2|NOT COMPLETED|Follow-up||34
280315|NCT00314951|683812|P1|NOT COMPLETED|Follow-up||44
280316|NCT00314951|683811|P2|COMPLETED|Follow-up||255
280317|NCT00314951|683812|P1|COMPLETED|Follow-up||263
280318|NCT00314951|683811|P2|STARTED|Follow-up||289
280319|NCT00314951|683812|P1|STARTED|Follow-up||307
280320|NCT00314951|683811|P2|NOT COMPLETED|Treatment||11
280321|NCT00314951|683812|P1|NOT COMPLETED|Treatment||16
280322|NCT00314951|683811|P2|COMPLETED|Treatment||289
280323|NCT00314951|683812|P1|COMPLETED|Treatment||307
280324|NCT00314951|683811|P2|STARTED|Treatment||300
280325|NCT00314951|683812|P1|STARTED|Treatment||323
280326|NCT00314951|683811|P2|NOT COMPLETED|Enrollment||6
280327|NCT00314951|683812|P1|NOT COMPLETED|Enrollment||0
280328|NCT00314951|683811|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
280329|NCT00314951|683812|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
280330|NCT00314951|683811|P2|STARTED|Enrollment||306
280331|NCT00314951|683812|P1|STARTED|Enrollment||323
280332|NCT00314808|683822|P1|NOT COMPLETED|Overall Study||8
280333|NCT00314808|683822|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
280334|NCT00314808|683822|P1|STARTED|Overall Study||33
280335|NCT00314574|683832|P2|NOT COMPLETED|Overall Study||83
280336|NCT00314574|683833|P1|NOT COMPLETED|Overall Study||94
280337|NCT00314574|683832|P2|COMPLETED|Overall Study||344
280338|NCT00314574|683833|P1|COMPLETED|Overall Study||329
280339|NCT00314574|683832|P2|Safety Population|Overall Study||428
280340|NCT00314574|683833|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
280341|NCT00314574|683832|P2|Received at Least One Dose of Study Drug|Overall Study||427
280342|NCT00314574|683833|P1|Received at Least One Dose of Study Drug|Overall Study||421
280343|NCT00314574|683832|P2|STARTED|Overall Study||427
280344|NCT00314574|683833|P1|STARTED|Overall Study||423
280345|NCT00314366|683849|P2|NOT COMPLETED|Overall Study||0
280346|NCT00314366|683850|P1|NOT COMPLETED|Overall Study||1
280347|NCT00314366|683849|P2|COMPLETED|Overall Study||10
280348|NCT00314366|683850|P1|COMPLETED|Overall Study||10
280349|NCT00314366|683849|P2|STARTED|Overall Study||10
280350|NCT00314366|683850|P1|STARTED|Overall Study||11
280351|NCT00314353|683880|P2|NOT COMPLETED|Follow-up||0
280352|NCT00314353|683881|P1|NOT COMPLETED|Follow-up||0
280353|NCT00314353|683880|P2|COMPLETED|Follow-up||0
280354|NCT00314353|683881|P1|COMPLETED|Follow-up||3
280355|NCT00314353|683880|P2|STARTED|Follow-up||0
280356|NCT00314353|683881|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
280357|NCT00314353|683880|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
280358|NCT00314353|683881|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
280359|NCT00314353|683880|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
280360|NCT00314353|683881|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
280361|NCT00314353|683880|P2|STARTED|Protocol Therapy (8 Cycles)||3
280362|NCT00314353|683881|P1|STARTED|Protocol Therapy (8 Cycles)||4
280363|NCT00314340|683895|P1|NOT COMPLETED|Overall Study||1
280364|NCT00314340|683895|P1|COMPLETED|Overall Study||11
280365|NCT00314340|683895|P1|Placebo|Overall Study||12
280366|NCT00314340|683895|P1|Hydrocodone Plus APAP|Overall Study||12
280367|NCT00314340|683895|P1|ER Morphine|Overall Study||11
280368|NCT00314340|683895|P1|STARTED|Overall Study||12
280369|NCT00314327|683901|P1|NOT COMPLETED|Overall Study||1
280370|NCT00314327|683901|P1|COMPLETED|Overall Study||0
280371|NCT00314327|683901|P1|STARTED|Overall Study||1
280372|NCT00314262|683906|P1|NOT COMPLETED|Overall Study||5
280373|NCT00314262|683906|P1|COMPLETED|Overall Study||7
280374|NCT00314262|683906|P1|STARTED|Overall Study||12
280375|NCT00314249|683914|P2|NOT COMPLETED|Overall Study||163
280376|NCT00314249|683915|P1|NOT COMPLETED|Overall Study||152
280377|NCT00314249|683914|P2|COMPLETED|Overall Study||353
280378|NCT00314249|683915|P1|COMPLETED|Overall Study||357
280379|NCT00314249|683914|P2|STARTED|Overall Study||516
280380|NCT00314249|683915|P1|STARTED|Overall Study||509
280381|NCT00314236|683933|P2|NOT COMPLETED|Overall Study||2
280382|NCT00314236|683934|P1|NOT COMPLETED|Overall Study||0
280383|NCT00314236|683933|P2|COMPLETED|Overall Study||37
280384|NCT00314236|683934|P1|COMPLETED|Overall Study||41
280385|NCT00314236|683933|P2|STARTED|Overall Study||39
280386|NCT00314236|683934|P1|STARTED|Overall Study||41
280387|NCT00314145|683948|P2|NOT COMPLETED|Overall Study||29
280388|NCT00314145|683949|P1|NOT COMPLETED|Overall Study||21
280389|NCT00314145|683948|P2|COMPLETED|Overall Study||381
280390|NCT00314145|683949|P1|COMPLETED|Overall Study||389
280391|NCT00314145|683948|P2|STARTED|Overall Study||410
280392|NCT00314145|683949|P1|STARTED|Overall Study||410
280393|NCT00314132|683963|P2|NOT COMPLETED|Overall Study||18
280394|NCT00314132|683964|P1|NOT COMPLETED|Overall Study||8
280395|NCT00314132|683963|P2|COMPLETED|Overall Study||1583
280396|NCT00314132|683964|P1|COMPLETED|Overall Study||395
280397|NCT00314132|683963|P2|STARTED|Overall Study||1601
280398|NCT00314132|683964|P1|STARTED|Overall Study||403
280399|NCT00314106|683974|P2|NOT COMPLETED|Overall Study||0
280400|NCT00314106|683975|P1|NOT COMPLETED|Overall Study||0
280401|NCT00314106|683974|P2|COMPLETED|Overall Study||8
280402|NCT00314106|683975|P1|COMPLETED|Overall Study||18
280403|NCT00314106|683974|P2|STARTED|Overall Study||8
280404|NCT00314106|683975|P1|STARTED|Overall Study||18
280405|NCT00313911|683985|P2|NOT COMPLETED|Overall Study||41
280406|NCT00313911|683986|P1|NOT COMPLETED|Overall Study||94
280407|NCT00313911|683985|P2|COMPLETED|Overall Study||670
280408|NCT00313911|683986|P1|COMPLETED|Overall Study||1328
280409|NCT00313911|683985|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
280410|NCT00313911|683986|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
280411|NCT00313846|684000|P2|NOT COMPLETED|Overall Study||11
280412|NCT00313846|684001|P1|NOT COMPLETED|Overall Study||5
280413|NCT00313846|684000|P2|COMPLETED|Overall Study||153
280414|NCT00313846|684001|P1|COMPLETED|Overall Study||157
280415|NCT00313846|684000|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
280416|NCT00313846|684001|P1|STARTED|Overall Study||162
280417|NCT00313820|684012|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
280418|NCT00313820|684013|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
280419|NCT00313820|684012|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
280420|NCT00313820|684013|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
280421|NCT00313820|684012|P2|STARTED|Pregabalin or Placebo Treatment Period||109
280422|NCT00313820|684013|P1|STARTED|Pregabalin or Placebo Treatment Period||110
280423|NCT00313820|684012|P2|NOT COMPLETED|Assigned to Treatment||0
280424|NCT00313820|684013|P1|NOT COMPLETED|Assigned to Treatment||1
280425|NCT00313820|684012|P2|COMPLETED|Assigned to Treatment||109
280426|NCT00313820|684013|P1|COMPLETED|Assigned to Treatment||110
280427|NCT00313820|684012|P2|STARTED|Assigned to Treatment||109
280428|NCT00313820|684013|P1|STARTED|Assigned to Treatment||111
280429|NCT00313781|684051|P3|NOT COMPLETED|After Crossover||27
280430|NCT00313781|684052|P2|NOT COMPLETED|After Crossover||0
280431|NCT00313781|684053|P1|NOT COMPLETED|After Crossover||0
280432|NCT00313781|684051|P3|COMPLETED|After Crossover||10
280433|NCT00313781|684052|P2|COMPLETED|After Crossover||0
280434|NCT00313781|684053|P1|COMPLETED|After Crossover||0
280435|NCT00313781|684051|P3|STARTED|After Crossover||37
280436|NCT00313781|684052|P2|STARTED|After Crossover||0
280437|NCT00313781|684053|P1|STARTED|After Crossover||0
280438|NCT00313781|684051|P3|NOT COMPLETED|Before Crossover||0
280439|NCT00313781|684052|P2|NOT COMPLETED|Before Crossover||79
280440|NCT00313781|684053|P1|NOT COMPLETED|Before Crossover||75
280441|NCT00313781|684051|P3|COMPLETED|Before Crossover||0
280442|NCT00313781|684052|P2|COMPLETED|Before Crossover||23
280443|NCT00313781|684053|P1|COMPLETED|Before Crossover||27
280444|NCT00313781|684051|P3|Treated|Before Crossover||0
280445|NCT00313781|684052|P2|Treated|Before Crossover||102
280446|NCT00313781|684053|P1|Treated|Before Crossover||97
280447|NCT00313781|684051|P3|STARTED|Before Crossover||0
280448|NCT00313781|684052|P2|STARTED|Before Crossover||102
280449|NCT00313781|684053|P1|STARTED|Before Crossover||102
280450|NCT00313716|684093|P6|NOT COMPLETED|Overall Study||13
280451|NCT00313716|684094|P5|NOT COMPLETED|Overall Study||6
280452|NCT00313716|684095|P4|NOT COMPLETED|Overall Study||4
280453|NCT00313716|684096|P3|NOT COMPLETED|Overall Study||12
280454|NCT00313716|684097|P2|NOT COMPLETED|Overall Study||8
280455|NCT00313716|684098|P1|NOT COMPLETED|Overall Study||5
280456|NCT00313716|684093|P6|COMPLETED|Overall Study||35
280457|NCT00313716|684094|P5|COMPLETED|Overall Study||27
280458|NCT00313716|684095|P4|COMPLETED|Overall Study||16
280459|NCT00313716|684096|P3|COMPLETED|Overall Study||38
280460|NCT00313716|684097|P2|COMPLETED|Overall Study||23
280461|NCT00313716|684098|P1|COMPLETED|Overall Study||13
280462|NCT00313716|684093|P6|STARTED|Overall Study||48
280463|NCT00313716|684094|P5|STARTED|Overall Study||33
280464|NCT00313716|684095|P4|STARTED|Overall Study||20
280465|NCT00313716|684096|P3|STARTED|Overall Study||50
280466|NCT00313716|684097|P2|STARTED|Overall Study||31
280467|NCT00313716|684098|P1|STARTED|Overall Study||18
280468|NCT00313703|684125|P4|NOT COMPLETED|Overall Study||12
280469|NCT00313703|684126|P3|NOT COMPLETED|Overall Study||5
280470|NCT00313703|684127|P2|NOT COMPLETED|Overall Study||2
280471|NCT00313703|684128|P1|NOT COMPLETED|Overall Study||11
280472|NCT00313703|684125|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
280473|NCT00313703|684126|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
280474|NCT00313703|684127|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
280475|NCT00313703|684128|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
280476|NCT00313703|684125|P4|STARTED|Overall Study||12
280477|NCT00313703|684126|P3|STARTED|Overall Study||77
280478|NCT00313703|684127|P2|STARTED|Overall Study||34
280479|NCT00313703|684128|P1|STARTED|Overall Study||186
280480|NCT00313612|684144|P2|NOT COMPLETED|Overall Study||1
280481|NCT00313612|684145|P1|NOT COMPLETED|Overall Study||0
280482|NCT00313612|684144|P2|COMPLETED|Overall Study||19
280483|NCT00313612|684145|P1|COMPLETED|Overall Study||19
280484|NCT00313612|684144|P2|STARTED|Overall Study||20
280485|NCT00313612|684145|P1|STARTED|Overall Study||19
280486|NCT00313586|684157|P4|NOT COMPLETED|Overall Study||23
280487|NCT00313586|684158|P3|NOT COMPLETED|Overall Study||24
280488|NCT00313586|684159|P2|NOT COMPLETED|Overall Study||70
280489|NCT00313586|684160|P1|NOT COMPLETED|Overall Study||70
280490|NCT00313586|684157|P4|COMPLETED|Overall Study||0
280491|NCT00313586|684158|P3|COMPLETED|Overall Study||0
280492|NCT00313586|684159|P2|COMPLETED|Overall Study||5
280493|NCT00313586|684160|P1|COMPLETED|Overall Study||5
280494|NCT00313586|684157|P4|Treated|Overall Study||23
280495|NCT00313586|684158|P3|Treated|Overall Study||24
280496|NCT00313586|684159|P2|Treated|Overall Study||75
280497|NCT00313586|684160|P1|Treated|Overall Study||74
280498|NCT00313586|684157|P4|STARTED|Overall Study||23
280499|NCT00313586|684158|P3|STARTED|Overall Study||24
280500|NCT00313586|684159|P2|STARTED|Overall Study||75
280501|NCT00313586|684160|P1|STARTED|Overall Study||75
280502|NCT00313443|684168|P1|NOT COMPLETED|Overall Study||0
280503|NCT00313443|684168|P1|COMPLETED|Overall Study||30
280504|NCT00313443|684168|P1|STARTED|Overall Study||30
280505|NCT00313313|684179|P3|NOT COMPLETED|Overall Study||82
280506|NCT00313313|684180|P2|NOT COMPLETED|Overall Study||66
280507|NCT00313313|684181|P1|NOT COMPLETED|Overall Study||63
280508|NCT00313313|684179|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
280509|NCT00313313|684180|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
280510|NCT00313313|684181|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
280511|NCT00313313|684179|P3|STARTED|Overall Study||267
280512|NCT00313313|684180|P2|STARTED|Overall Study||253
280513|NCT00313313|684181|P1|STARTED|Overall Study||248
280514|NCT00313300|684203|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
280515|NCT00313300|684204|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
280516|NCT00313300|684205|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
280517|NCT00313300|684206|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
280518|NCT00313300|684207|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
280519|NCT00313300|684203|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
280520|NCT00313300|684204|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
280521|NCT00313300|684205|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
280522|NCT00313300|684206|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
280523|NCT00313300|684207|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
280524|NCT00313300|684203|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
280525|NCT00313300|684204|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
280526|NCT00313300|684205|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
280527|NCT00313300|684206|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
280528|NCT00313300|684207|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
280529|NCT00313300|684203|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
280530|NCT00313300|684204|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
280531|NCT00313300|684205|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
280532|NCT00313300|684206|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
280533|NCT00313300|684207|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
280534|NCT00313300|684203|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
280535|NCT00313300|684204|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
280536|NCT00313300|684205|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
280537|NCT00313300|684206|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
280538|NCT00313300|684207|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
280539|NCT00313300|684203|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
280540|NCT00313300|684204|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
280541|NCT00313300|684205|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
280542|NCT00313300|684206|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
280543|NCT00313300|684207|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
280544|NCT00313300|684203|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
280545|NCT00313300|684204|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
280546|NCT00313300|684205|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
280547|NCT00313300|684206|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
280548|NCT00313300|684207|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
280549|NCT00313300|684203|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
280550|NCT00313300|684204|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
280551|NCT00313300|684205|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
280552|NCT00313300|684206|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
280553|NCT00313300|684207|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
280554|NCT00313300|684203|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
280555|NCT00313300|684204|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
280556|NCT00313300|684205|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
280557|NCT00313300|684206|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
280558|NCT00313300|684207|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
280559|NCT00313300|684203|P5|STARTED|Randomized in Phase B (26 Weeks)||221
280560|NCT00313300|684204|P4|STARTED|Randomized in Phase B (26 Weeks)||248
280561|NCT00313300|684205|P3|STARTED|Randomized in Phase B (26 Weeks)||134
280562|NCT00313300|684206|P2|STARTED|Randomized in Phase B (26 Weeks)||138
280563|NCT00313300|684207|P1|STARTED|Randomized in Phase B (26 Weeks)||427
280564|NCT00313300|684203|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
280565|NCT00313300|684204|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
280566|NCT00313300|684205|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
280567|NCT00313300|684206|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
280568|NCT00313300|684207|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
280569|NCT00313300|684203|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
280570|NCT00313300|684204|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
280571|NCT00313300|684205|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
280572|NCT00313300|684206|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
280573|NCT00313300|684207|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
280574|NCT00313300|684203|P5|STARTED|Randomized in Phase A (26 Weeks)||0
280575|NCT00313300|684204|P4|STARTED|Randomized in Phase A (26 Weeks)||0
280576|NCT00313300|684205|P3|STARTED|Randomized in Phase A (26 Weeks)||184
280577|NCT00313300|684206|P2|STARTED|Randomized in Phase A (26 Weeks)||179
280578|NCT00313300|684207|P1|STARTED|Randomized in Phase A (26 Weeks)||184
280579|NCT00313209|684259|P2|NOT COMPLETED|Overall Study||82
280580|NCT00313209|684260|P1|NOT COMPLETED|Overall Study||107
280581|NCT00313209|684259|P2|COMPLETED|Overall Study||385
280582|NCT00313209|684260|P1|COMPLETED|Overall Study||359
280583|NCT00313209|684259|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
280584|NCT00313209|684260|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
280585|NCT00313170|684277|P3|NOT COMPLETED|Overall Study||32
280586|NCT00313170|684278|P2|NOT COMPLETED|Overall Study||34
280587|NCT00313170|684279|P1|NOT COMPLETED|Overall Study||36
280588|NCT00313170|684277|P3|COMPLETED|Overall Study||14
280589|NCT00313170|684278|P2|COMPLETED|Overall Study||16
280590|NCT00313170|684279|P1|COMPLETED|Overall Study||11
280591|NCT00313170|684277|P3|STARTED|Overall Study||46
280592|NCT00313170|684278|P2|STARTED|Overall Study||50
280593|NCT00313170|684279|P1|STARTED|Overall Study||47
280594|NCT00313144|684295|P1|NOT COMPLETED|Overall Study||110
280595|NCT00313144|684295|P1|COMPLETED|Overall Study||17
280596|NCT00313144|684295|P1|STARTED|Overall Study||127
280597|NCT00313014|684382|P3|NOT COMPLETED|Overall Study||61
280598|NCT00313014|684383|P2|NOT COMPLETED|Overall Study||73
280599|NCT00313014|684384|P1|NOT COMPLETED|Overall Study||93
280600|NCT00313014|684382|P3|COMPLETED|Overall Study||159
280601|NCT00313014|684383|P2|COMPLETED|Overall Study||146
280602|NCT00313014|684384|P1|COMPLETED|Overall Study||128
280603|NCT00313014|684382|P3|STARTED|Overall Study||220
280604|NCT00313014|684383|P2|STARTED|Overall Study||219
280605|NCT00313014|684384|P1|STARTED|Overall Study||221
280606|NCT00312923|684404|P2|NOT COMPLETED|Overall Study||6
280607|NCT00312923|684405|P1|NOT COMPLETED|Overall Study||9
280608|NCT00312923|684404|P2|COMPLETED|Overall Study||20
280609|NCT00312923|684405|P1|COMPLETED|Overall Study||19
280610|NCT00312923|684404|P2|STARTED|Overall Study||26
280611|NCT00312923|684405|P1|STARTED|Overall Study||28
280612|NCT00312897|684415|P2|NOT COMPLETED|Overall Study||6
280613|NCT00312897|684416|P1|NOT COMPLETED|Overall Study||6
280614|NCT00312897|684415|P2|COMPLETED|Overall Study||18
280615|NCT00312897|684416|P1|COMPLETED|Overall Study||21
280616|NCT00312897|684415|P2|STARTED|Overall Study||24
280617|NCT00312897|684416|P1|STARTED|Overall Study||27
280618|NCT00312884|684426|P2|NOT COMPLETED|Overall Study||12
280619|NCT00312884|684427|P1|NOT COMPLETED|Overall Study||17
280620|NCT00312884|684426|P2|COMPLETED|Overall Study||79
280621|NCT00312884|684427|P1|COMPLETED|Overall Study||74
280622|NCT00312884|684426|P2|STARTED|Overall Study||91
280623|NCT00312884|684427|P1|STARTED|Overall Study||91
280624|NCT00312858|684441|P2|NOT COMPLETED|Overall Study||93
280625|NCT00312858|684442|P1|NOT COMPLETED|Overall Study||68
280626|NCT00312858|684441|P2|COMPLETED|Overall Study||230
280627|NCT00312858|684442|P1|COMPLETED|Overall Study||262
280628|NCT00312858|684441|P2|Visit 4|Overall Study||240
280629|NCT00312858|684442|P1|Visit 4|Overall Study||262
280630|NCT00312858|684441|P2|Visit 3|Overall Study||261
280631|NCT00312858|684442|P1|Visit 3|Overall Study||273
280632|NCT00312858|684441|P2|Visit 2|Overall Study||294
280633|NCT00312858|684442|P1|Visit 2|Overall Study||305
280634|NCT00312858|684441|P2|Visit 1|Overall Study||323
280635|NCT00312858|684442|P1|Visit 1|Overall Study||330
280636|NCT00312858|684441|P2|STARTED|Overall Study||323
280637|NCT00312858|684442|P1|STARTED|Overall Study||330
280638|NCT00312845|684496|P2|NOT COMPLETED|Overall Study||95
280639|NCT00312845|684497|P1|NOT COMPLETED|Overall Study||99
280640|NCT00312845|684496|P2|COMPLETED|Overall Study||245
280641|NCT00312845|684497|P1|COMPLETED|Overall Study||237
280642|NCT00312845|684496|P2|STARTED|Overall Study||340
280643|NCT00312845|684497|P1|STARTED|Overall Study||336
280644|NCT00312728|684505|P1|NOT COMPLETED|Overall Study||110
280645|NCT00312728|684505|P1|COMPLETED|Overall Study||5
280646|NCT00312728|684505|P1|STARTED|Overall Study||115
280647|NCT00312572|684516|P2|NOT COMPLETED|Overall Study||21
280648|NCT00312572|684517|P1|NOT COMPLETED|Overall Study||16
280649|NCT00312572|684516|P2|COMPLETED|Overall Study||82
280650|NCT00312572|684517|P1|COMPLETED|Overall Study||85
280651|NCT00312572|684516|P2|STARTED|Overall Study||103
280652|NCT00312572|684517|P1|STARTED|Overall Study||101
280653|NCT00312494|684528|P3|NOT COMPLETED|Overall Study||43
280654|NCT00312494|684529|P2|NOT COMPLETED|Overall Study||58
280655|NCT00312494|684530|P1|NOT COMPLETED|Overall Study||71
280656|NCT00312494|684528|P3|COMPLETED|Overall Study||179
280657|NCT00312494|684529|P2|COMPLETED|Overall Study||168
280658|NCT00312494|684530|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
280659|NCT00312494|684528|P3|Received Study Treatment|Overall Study||217
280660|NCT00312494|684529|P2|Received Study Treatment|Overall Study||216
280661|NCT00312494|684530|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
280662|NCT00312494|684528|P3|STARTED|Overall Study||222
280663|NCT00312494|684529|P2|STARTED|Overall Study||226
280664|NCT00312494|684530|P1|STARTED|Overall Study||232
280665|NCT00312377|684564|P2|NOT COMPLETED|Overall Study||668
280666|NCT00312377|684565|P1|NOT COMPLETED|Overall Study||644
280667|NCT00312377|684564|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
280668|NCT00312377|684565|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
280669|NCT00312377|684564|P2|STARTED|Overall Study|randomised patients|697
280670|NCT00312377|684565|P1|STARTED|Overall Study|randomised patients|694
280671|NCT00312338|684589|P2|NOT COMPLETED|Overall Study||3
280672|NCT00312338|684590|P1|NOT COMPLETED|Overall Study||22
280673|NCT00312338|684589|P2|COMPLETED|Overall Study||54
280674|NCT00312338|684590|P1|COMPLETED|Overall Study||83
280675|NCT00312338|684589|P2|STARTED|Overall Study||57
280676|NCT00312338|684590|P1|STARTED|Overall Study||105
280677|NCT00312221|684603|P4|NOT COMPLETED|Double-blind Phase||70
280678|NCT00312221|684604|P3|NOT COMPLETED|Double-blind Phase||72
280679|NCT00312221|684605|P2|NOT COMPLETED|Double-blind Phase||59
280680|NCT00312221|684606|P1|NOT COMPLETED|Double-blind Phase||0
280681|NCT00312221|684603|P4|COMPLETED|Double-blind Phase||63
280682|NCT00312221|684604|P3|COMPLETED|Double-blind Phase||77
280683|NCT00312221|684605|P2|COMPLETED|Double-blind Phase||77
280684|NCT00312221|684606|P1|COMPLETED|Double-blind Phase||0
280685|NCT00312221|684603|P4|STARTED|Double-blind Phase||133
280686|NCT00312221|684604|P3|STARTED|Double-blind Phase||149
280687|NCT00312221|684605|P2|STARTED|Double-blind Phase||136
280688|NCT00312221|684606|P1|STARTED|Double-blind Phase||0
280689|NCT00312221|684603|P4|NOT COMPLETED|Open-label Run-in Period||0
280690|NCT00312221|684604|P3|NOT COMPLETED|Open-label Run-in Period||0
280691|NCT00312221|684605|P2|NOT COMPLETED|Open-label Run-in Period||0
280692|NCT00312221|684606|P1|NOT COMPLETED|Open-label Run-in Period||234
280693|NCT00312221|684603|P4|COMPLETED|Open-label Run-in Period||0
280694|NCT00312221|684604|P3|COMPLETED|Open-label Run-in Period||0
280695|NCT00312221|684605|P2|COMPLETED|Open-label Run-in Period||0
280696|NCT00312221|684606|P1|COMPLETED|Open-label Run-in Period||418
280697|NCT00312221|684603|P4|STARTED|Open-label Run-in Period||0
280698|NCT00312221|684604|P3|STARTED|Open-label Run-in Period||0
280699|NCT00312221|684605|P2|STARTED|Open-label Run-in Period||0
280700|NCT00312221|684606|P1|STARTED|Open-label Run-in Period||652
280701|NCT00312208|684626|P2|NOT COMPLETED|Overall Study||123
280702|NCT00312208|684627|P1|NOT COMPLETED|Overall Study||172
280703|NCT00312208|684626|P2|COMPLETED|Overall Study||1526
280704|NCT00312208|684627|P1|COMPLETED|Overall Study||1477
280705|NCT00312208|684626|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
280706|NCT00312208|684627|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
280707|NCT00312195|684637|P2|NOT COMPLETED|Overall Study||6
280708|NCT00312195|684638|P1|NOT COMPLETED|Overall Study||6
280709|NCT00312195|684637|P2|COMPLETED|Overall Study||123
280710|NCT00312195|684638|P1|COMPLETED|Overall Study||132
280711|NCT00312195|684637|P2|STARTED|Overall Study||129
280712|NCT00312195|684638|P1|STARTED|Overall Study||138
280713|NCT00311766|684654|P2|NOT COMPLETED|Overall Study||5
280714|NCT00311766|684655|P1|NOT COMPLETED|Overall Study||0
280715|NCT00311766|684654|P2|COMPLETED|Overall Study||17
280716|NCT00311766|684655|P1|COMPLETED|Overall Study||8
280717|NCT00311766|684654|P2|STARTED|Overall Study||22
280718|NCT00311766|684655|P1|STARTED|Overall Study||8
280719|NCT00311584|684665|P2|NOT COMPLETED|Overall Study||23
280720|NCT00311584|684666|P1|NOT COMPLETED|Overall Study||20
280721|NCT00311584|684665|P2|COMPLETED|Overall Study||7
280722|NCT00311584|684666|P1|COMPLETED|Overall Study||9
280723|NCT00311584|684665|P2|STARTED|Overall Study||30
280724|NCT00311584|684666|P1|STARTED|Overall Study||29
280725|NCT00311402|684674|P2|NOT COMPLETED|Overall Study||177
280726|NCT00311402|684675|P1|NOT COMPLETED|Overall Study||210
280727|NCT00311402|684674|P2|COMPLETED|Overall Study||462
280728|NCT00311402|684675|P1|COMPLETED|Overall Study||445
280729|NCT00311402|684674|P2|STARTED|Overall Study||639
280730|NCT00311402|684675|P1|STARTED|Overall Study||655
280731|NCT00311376|684702|P3|NOT COMPLETED|Treatment Cycle 2||0
280732|NCT00311376|684703|P2|NOT COMPLETED|Treatment Cycle 2||13
280733|NCT00311376|684704|P1|NOT COMPLETED|Treatment Cycle 2||9
280734|NCT00311376|684702|P3|COMPLETED|Treatment Cycle 2||0
280735|NCT00311376|684703|P2|COMPLETED|Treatment Cycle 2||112
280736|NCT00311376|684704|P1|COMPLETED|Treatment Cycle 2||106
280737|NCT00311376|684702|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
280738|NCT00311376|684703|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
280739|NCT00311376|684704|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
280740|NCT00311376|684702|P3|NOT COMPLETED|Treatment Cycle 1||17
280741|NCT00311376|684703|P2|NOT COMPLETED|Treatment Cycle 1||17
280742|NCT00311376|684704|P1|NOT COMPLETED|Treatment Cycle 1||27
280743|NCT00311376|684702|P3|COMPLETED|Treatment Cycle 1||132
280744|NCT00311376|684703|P2|COMPLETED|Treatment Cycle 1||118
280745|NCT00311376|684704|P1|COMPLETED|Treatment Cycle 1||105
280746|NCT00311376|684702|P3|STARTED|Treatment Cycle 1||149
280747|NCT00311376|684703|P2|STARTED|Treatment Cycle 1||135
280748|NCT00311376|684704|P1|STARTED|Treatment Cycle 1||132
280749|NCT00311363|684724|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
280750|NCT00311363|684725|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
280751|NCT00311363|684726|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
280752|NCT00311363|684724|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
280753|NCT00311363|684725|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
280754|NCT00311363|684726|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
280755|NCT00311363|684724|P3|STARTED|12-Week Double-Blind Treatment Period||96
280756|NCT00311363|684725|P2|STARTED|12-Week Double-Blind Treatment Period||98
280757|NCT00311363|684726|P1|STARTED|12-Week Double-Blind Treatment Period||0
280758|NCT00311363|684724|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
280759|NCT00311363|684725|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
280760|NCT00311363|684726|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
280761|NCT00311363|684724|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
280762|NCT00311363|684725|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
280763|NCT00311363|684726|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
280764|NCT00311363|684724|P3|STARTED|24-Week Single-Blind Treatment Period||0
280765|NCT00311363|684725|P2|STARTED|24-Week Single-Blind Treatment Period||0
280766|NCT00311363|684726|P1|STARTED|24-Week Single-Blind Treatment Period||327
280767|NCT00311311|684786|P2|NOT COMPLETED|Overall Study||9
280768|NCT00311311|684787|P1|NOT COMPLETED|Overall Study||8
280769|NCT00311311|684786|P2|COMPLETED|Overall Study||26
280770|NCT00311311|684787|P1|COMPLETED|Overall Study||29
280771|NCT00311311|684786|P2|STARTED|Overall Study||35
280772|NCT00311311|684787|P1|STARTED|Overall Study||37
280773|NCT00311181|684837|P1|NOT COMPLETED|Overall Study||96
280774|NCT00311181|684837|P1|COMPLETED|Overall Study||121
280775|NCT00311181|684837|P1|STARTED|Overall Study||217
280776|NCT00311155|684843|P1|NOT COMPLETED|Overall Study||93
280777|NCT00311155|684843|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
280778|NCT00311155|684843|P1|STARTED|Overall Study||694
280779|NCT00310856|684855|P3|NOT COMPLETED|Overall Study||8
280780|NCT00310856|684856|P2|NOT COMPLETED|Overall Study||5
280781|NCT00310856|684857|P1|NOT COMPLETED|Overall Study||5
280782|NCT00310856|684855|P3|COMPLETED|Overall Study||42
280783|NCT00310856|684856|P2|COMPLETED|Overall Study||56
280784|NCT00310856|684857|P1|COMPLETED|Overall Study||59
280785|NCT00310856|684855|P3|STARTED|Overall Study||50
280786|NCT00310856|684856|P2|STARTED|Overall Study||61
280787|NCT00310856|684857|P1|STARTED|Overall Study||64
280788|NCT00310817|684881|P4|NOT COMPLETED|Overall Study||8
280789|NCT00310817|684882|P3|NOT COMPLETED|Overall Study||8
280790|NCT00310817|684883|P2|NOT COMPLETED|Overall Study||8
280791|NCT00310817|684884|P1|NOT COMPLETED|Overall Study||11
280792|NCT00310817|684881|P4|COMPLETED|Overall Study||74
280793|NCT00310817|684882|P3|COMPLETED|Overall Study||120
280794|NCT00310817|684883|P2|COMPLETED|Overall Study||198
280795|NCT00310817|684884|P1|COMPLETED|Overall Study||196
280796|NCT00310817|684881|P4|STARTED|Overall Study||82
280797|NCT00310817|684882|P3|STARTED|Overall Study||128
280798|NCT00310817|684883|P2|STARTED|Overall Study||206
280799|NCT00310817|684884|P1|STARTED|Overall Study||207
280800|NCT00310804|684972|P2|NOT COMPLETED|Overall Study||0
280801|NCT00310804|684973|P1|NOT COMPLETED|Overall Study||5
280802|NCT00310804|684972|P2|COMPLETED|Overall Study||171
280803|NCT00310804|684973|P1|COMPLETED|Overall Study||1024
280804|NCT00310804|684972|P2|STARTED|Overall Study||171
280805|NCT00310804|684973|P1|STARTED|Overall Study||1029
280806|NCT00310791|685008|P2|NOT COMPLETED|Overall Study||10
280807|NCT00310791|685009|P1|NOT COMPLETED|Overall Study||10
280808|NCT00310791|685008|P2|COMPLETED|Overall Study||30
280809|NCT00310791|685009|P1|COMPLETED|Overall Study||30
280810|NCT00310791|685008|P2|STARTED|Overall Study||40
280811|NCT00310791|685009|P1|STARTED|Overall Study||40
280812|NCT00310466|685017|P2|NOT COMPLETED|Overall Study||12
280813|NCT00310466|685018|P1|NOT COMPLETED|Overall Study||18
280814|NCT00310466|685017|P2|COMPLETED|Overall Study||101
280815|NCT00310466|685018|P1|COMPLETED|Overall Study||95
280816|NCT00310466|685017|P2|STARTED|Overall Study||113
280817|NCT00310466|685018|P1|STARTED|Overall Study||113
280818|NCT00310440|685032|P2|NOT COMPLETED|Overall Study||13
280819|NCT00310440|685033|P1|NOT COMPLETED|Overall Study||26
280820|NCT00310440|685032|P2|COMPLETED|Overall Study||141
280821|NCT00310440|685033|P1|COMPLETED|Overall Study||139
280822|NCT00310440|685032|P2|STARTED|Overall Study||154
280823|NCT00310440|685033|P1|STARTED|Overall Study||165
280824|NCT00310427|685059|P2|NOT COMPLETED|Overall Study||1
280825|NCT00310427|685060|P1|NOT COMPLETED|Overall Study||2
280826|NCT00310427|685059|P2|COMPLETED|Overall Study||25
280827|NCT00310427|685060|P1|COMPLETED|Overall Study||25
280828|NCT00310427|685059|P2|STARTED|Overall Study||26
280829|NCT00310427|685060|P1|STARTED|Overall Study||27
280830|NCT00310401|685082|P2|NOT COMPLETED|Overall Study||0
280831|NCT00310401|685083|P1|NOT COMPLETED|Overall Study||0
280832|NCT00310401|685082|P2|COMPLETED|Overall Study||246
280833|NCT00310401|685083|P1|COMPLETED|Overall Study||260
280834|NCT00310401|685082|P2|STARTED|Overall Study||246
280835|NCT00310401|685083|P1|STARTED|Overall Study||260
280836|NCT00310375|685099|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
280837|NCT00310375|685100|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
280838|NCT00310375|685101|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
280839|NCT00310375|685099|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
280840|NCT00310375|685100|P2|COMPLETED|Safety Follow-up Continuation Phase||0
280841|NCT00310375|685101|P1|COMPLETED|Safety Follow-up Continuation Phase||0
280842|NCT00310375|685099|P3|STARTED|Safety Follow-up Continuation Phase||19
280843|NCT00310375|685100|P2|STARTED|Safety Follow-up Continuation Phase||0
280844|NCT00310375|685101|P1|STARTED|Safety Follow-up Continuation Phase||0
280845|NCT00310375|685099|P3|NOT COMPLETED|Primary Reporting Phase||0
280846|NCT00310375|685100|P2|NOT COMPLETED|Primary Reporting Phase||68
280847|NCT00310375|685101|P1|NOT COMPLETED|Primary Reporting Phase||91
280848|NCT00310375|685099|P3|COMPLETED|Primary Reporting Phase||0
280849|NCT00310375|685100|P2|COMPLETED|Primary Reporting Phase||11
280850|NCT00310375|685101|P1|COMPLETED|Primary Reporting Phase||11
280851|NCT00310375|685099|P3|STARTED|Primary Reporting Phase||0
280852|NCT00310375|685100|P2|STARTED|Primary Reporting Phase||79
280853|NCT00310375|685101|P1|STARTED|Primary Reporting Phase||102
280854|NCT00310362|685146|P3|NOT COMPLETED|Overall Study||0
280855|NCT00310362|685147|P2|NOT COMPLETED|Overall Study||0
280856|NCT00310362|685148|P1|NOT COMPLETED|Overall Study||0
280857|NCT00310362|685146|P3|COMPLETED|Overall Study||1206
280858|NCT00310362|685147|P2|COMPLETED|Overall Study||1205
280859|NCT00310362|685148|P1|COMPLETED|Overall Study||1199
280860|NCT00310362|685146|P3|STARTED|Overall Study||1206
280861|NCT00310362|685147|P2|STARTED|Overall Study||1205
280862|NCT00310362|685148|P1|STARTED|Overall Study||1199
280863|NCT00310310|685158|P2|NOT COMPLETED|Overall Study||20
280864|NCT00310310|685159|P1|NOT COMPLETED|Overall Study||30
280865|NCT00310310|685158|P2|COMPLETED|Overall Study||100
280866|NCT00310310|685159|P1|COMPLETED|Overall Study||90
280867|NCT00310310|685158|P2|STARTED|Overall Study||120
280868|NCT00310310|685159|P1|STARTED|Overall Study||120
280869|NCT00310076|685183|P1|NOT COMPLETED|Overall Study||3
280870|NCT00310076|685183|P1|COMPLETED|Overall Study||26
280871|NCT00310076|685183|P1|STARTED|Overall Study||29
280872|NCT00309985|685189|P2|NOT COMPLETED|Overall Study||1
280873|NCT00309985|685190|P1|NOT COMPLETED|Overall Study||62
280874|NCT00309985|685189|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
280875|NCT00309985|685190|P1|COMPLETED|Overall Study||335
280876|NCT00309985|685189|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
280877|NCT00309985|685190|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
280878|NCT00309985|685189|P2|Toxicity Analysis|Overall Study||392
280879|NCT00309985|685190|P1|Toxicity Analysis|Overall Study||390
280880|NCT00309985|685189|P2|STARTED|Overall Study||393
280881|NCT00309985|685190|P1|STARTED|Overall Study||397
280882|NCT00309946|685206|P1|NOT COMPLETED|Overall Study||1
280883|NCT00309946|685206|P1|COMPLETED|Overall Study||50
280884|NCT00309946|685206|P1|STARTED|Overall Study||51
280885|NCT00309907|685212|P1|NOT COMPLETED|Overall Study||20
280886|NCT00309907|685212|P1|COMPLETED|Overall Study||19
280887|NCT00309907|685212|P1|STARTED|Overall Study||39
280888|NCT00309777|685225|P4|NOT COMPLETED|Overall Study||4
280889|NCT00309777|685226|P3|NOT COMPLETED|Overall Study||19
280890|NCT00309777|685227|P2|NOT COMPLETED|Overall Study||9
280891|NCT00309777|685228|P1|NOT COMPLETED|Overall Study||23
280892|NCT00309777|685225|P4|COMPLETED|Overall Study||107
280893|NCT00309777|685226|P3|COMPLETED|Overall Study||304
280894|NCT00309777|685227|P2|COMPLETED|Overall Study||99
280895|NCT00309777|685228|P1|COMPLETED|Overall Study||292
280896|NCT00309777|685225|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
280897|NCT00309777|685226|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
280898|NCT00309777|685227|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
280899|NCT00309777|685228|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
280900|NCT00309777|685225|P4|STARTED|Overall Study||111
280901|NCT00309777|685226|P3|STARTED|Overall Study||323
280902|NCT00309777|685227|P2|STARTED|Overall Study||108
280903|NCT00309777|685228|P1|STARTED|Overall Study||315
280904|NCT00309751|685244|P2|NOT COMPLETED|Overall Study||15
280905|NCT00309751|685245|P1|NOT COMPLETED|Overall Study||31
280906|NCT00309751|685244|P2|COMPLETED|Overall Study||124
280907|NCT00309751|685245|P1|COMPLETED|Overall Study||248
280908|NCT00309751|685244|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
280909|NCT00309751|685245|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
280910|NCT00309751|685244|P2|STARTED|Overall Study||139
280911|NCT00309751|685245|P1|STARTED|Overall Study||279
280912|NCT00309738|685255|P2|NOT COMPLETED|Overall Study||12
280913|NCT00309738|685256|P1|NOT COMPLETED|Overall Study||13
280914|NCT00309738|685255|P2|COMPLETED|Overall Study||107
280915|NCT00309738|685256|P1|COMPLETED|Overall Study||223
280916|NCT00309738|685255|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
280917|NCT00309738|685256|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
280918|NCT00309738|685255|P2|STARTED|Overall Study||119
280919|NCT00309738|685256|P1|STARTED|Overall Study||236
280920|NCT00309608|685269|P5|NOT COMPLETED|Overall Study||4
280921|NCT00309608|685270|P4|NOT COMPLETED|Overall Study||6
280922|NCT00309608|685271|P3|NOT COMPLETED|Overall Study||10
280923|NCT00309608|685272|P2|NOT COMPLETED|Overall Study||13
280924|NCT00309608|685273|P1|NOT COMPLETED|Overall Study||14
280925|NCT00309608|685269|P5|COMPLETED|Overall Study||61
280926|NCT00309608|685270|P4|COMPLETED|Overall Study||60
280927|NCT00309608|685271|P3|COMPLETED|Overall Study||56
280928|NCT00309608|685272|P2|COMPLETED|Overall Study||52
280929|NCT00309608|685273|P1|COMPLETED|Overall Study||57
280930|NCT00309608|685269|P5|STARTED|Overall Study||65
280931|NCT00309608|685270|P4|STARTED|Overall Study||66
280932|NCT00309608|685271|P3|STARTED|Overall Study||66
280933|NCT00309608|685272|P2|STARTED|Overall Study||65
280934|NCT00309608|685273|P1|STARTED|Overall Study||71
280935|NCT00309465|685300|P6|NOT COMPLETED|Overall Study||0
280936|NCT00309465|685301|P5|NOT COMPLETED|Overall Study||0
280937|NCT00309465|685302|P4|NOT COMPLETED|Overall Study||1
280938|NCT00309465|685303|P3|NOT COMPLETED|Overall Study||0
280939|NCT00309465|685304|P2|NOT COMPLETED|Overall Study||0
280940|NCT00309465|685305|P1|NOT COMPLETED|Overall Study||0
280941|NCT00309465|685300|P6|COMPLETED|Overall Study||76
280942|NCT00309465|685301|P5|COMPLETED|Overall Study||76
280943|NCT00309465|685302|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
280944|NCT00309465|685303|P3|COMPLETED|Overall Study||58
280945|NCT00309465|685304|P2|COMPLETED|Overall Study||58
280946|NCT00309465|685305|P1|COMPLETED|Overall Study||58
280947|NCT00309465|685300|P6|STARTED|Overall Study||76
280948|NCT00309465|685301|P5|STARTED|Overall Study||76
280949|NCT00309465|685302|P4|STARTED|Overall Study||76
280950|NCT00309465|685303|P3|STARTED|Overall Study||58
280951|NCT00309465|685304|P2|STARTED|Overall Study||58
280952|NCT00309465|685305|P1|STARTED|Overall Study||58
280953|NCT00309452|685321|P2|NOT COMPLETED|Overall Study||0
280954|NCT00309452|685322|P1|NOT COMPLETED|Overall Study||3
280955|NCT00309452|685321|P2|COMPLETED|Overall Study||60
280956|NCT00309452|685322|P1|COMPLETED|Overall Study||57
280957|NCT00309452|685321|P2|STARTED|Overall Study||60
280958|NCT00309452|685322|P1|STARTED|Overall Study||60
280959|NCT00309387|685350|P2|NOT COMPLETED|Overall Study||159
280960|NCT00309387|685351|P1|NOT COMPLETED|Overall Study||142
280961|NCT00309387|685350|P2|COMPLETED|Overall Study||351
280962|NCT00309387|685351|P1|COMPLETED|Overall Study||368
280963|NCT00309387|685350|P2|STARTED|Overall Study||510
280964|NCT00309387|685351|P1|STARTED|Overall Study||510
280965|NCT00309244|685369|P2|NOT COMPLETED|Overall Study||97
280966|NCT00309244|685370|P1|NOT COMPLETED|Overall Study||118
280967|NCT00309244|685369|P2|COMPLETED|Overall Study||246
280968|NCT00309244|685370|P1|COMPLETED|Overall Study||216
280969|NCT00309244|685369|P2|STARTED|Overall Study||343
280970|NCT00309244|685370|P1|STARTED|Overall Study||334
280971|NCT00308997|685392|P2|NOT COMPLETED|Overall Study||1
280972|NCT00308997|685393|P1|NOT COMPLETED|Overall Study||1
280973|NCT00308997|685392|P2|COMPLETED|Overall Study||28
280974|NCT00308997|685393|P1|COMPLETED|Overall Study||55
280975|NCT00308997|685392|P2|STARTED|Overall Study||29
280976|NCT00308997|685393|P1|STARTED|Overall Study||56
280977|NCT00308737|685412|P3|NOT COMPLETED|Overall Study||37
280978|NCT00308737|685413|P2|NOT COMPLETED|Overall Study||289
280979|NCT00308737|685414|P1|NOT COMPLETED|Overall Study||463
280980|NCT00308737|685412|P3|COMPLETED|Overall Study||127
280981|NCT00308737|685413|P2|COMPLETED|Overall Study||662
280982|NCT00308737|685414|P1|COMPLETED|Overall Study||475
280983|NCT00308737|685412|P3|STARTED|Overall Study||164
280984|NCT00308737|685413|P2|STARTED|Overall Study||951
280985|NCT00308737|685414|P1|STARTED|Overall Study||938
280986|NCT00308711|685454|P3|NOT COMPLETED|Overall Study||5
280987|NCT00308711|685455|P2|NOT COMPLETED|Overall Study||4
280988|NCT00308711|685456|P1|NOT COMPLETED|Overall Study||2
280989|NCT00308711|685454|P3|COMPLETED|Overall Study||431
280990|NCT00308711|685455|P2|COMPLETED|Overall Study||440
280991|NCT00308711|685456|P1|COMPLETED|Overall Study||426
280992|NCT00308711|685454|P3|STARTED|Overall Study||436
280993|NCT00308711|685455|P2|STARTED|Overall Study||444
280994|NCT00308711|685456|P1|STARTED|Overall Study||428
280995|NCT00308620|685491|P3|NOT COMPLETED|Overall Study||1
280996|NCT00308620|685492|P2|NOT COMPLETED|Overall Study||1
280997|NCT00308620|685493|P1|NOT COMPLETED|Overall Study||1
280998|NCT00308620|685491|P3|COMPLETED|Overall Study||5
280999|NCT00308620|685492|P2|COMPLETED|Overall Study||3
281000|NCT00308620|685493|P1|COMPLETED|Overall Study||2
281001|NCT00308620|685491|P3|STARTED|Overall Study||6
281002|NCT00308620|685492|P2|STARTED|Overall Study||4
281003|NCT00308620|685493|P1|STARTED|Overall Study||3
281004|NCT00308581|685502|P3|NOT COMPLETED|Randomized Maintenance Phase||0
281005|NCT00308581|685503|P2|NOT COMPLETED|Randomized Maintenance Phase||103
281006|NCT00308581|685504|P1|NOT COMPLETED|Randomized Maintenance Phase||105
281007|NCT00308581|685502|P3|COMPLETED|Randomized Maintenance Phase||0
281008|NCT00308581|685503|P2|COMPLETED|Randomized Maintenance Phase||83
281009|NCT00308581|685504|P1|COMPLETED|Randomized Maintenance Phase||82
281010|NCT00308581|685502|P3|STARTED|Randomized Maintenance Phase||0
281011|NCT00308581|685503|P2|STARTED|Randomized Maintenance Phase||186
281012|NCT00308581|685504|P1|STARTED|Randomized Maintenance Phase||187
281013|NCT00308581|685502|P3|NOT COMPLETED|Induction Phase||166
281014|NCT00308581|685503|P2|NOT COMPLETED|Induction Phase||0
281015|NCT00308581|685504|P1|NOT COMPLETED|Induction Phase||0
281016|NCT00308581|685502|P3|COMPLETED|Induction Phase||373
281017|NCT00308581|685503|P2|COMPLETED|Induction Phase|Not applicable in this period|0
281018|NCT00308581|685504|P1|COMPLETED|Induction Phase|Not applicable in this period|0
281019|NCT00308581|685502|P3|STARTED|Induction Phase||539
281020|NCT00308581|685503|P2|STARTED|Induction Phase|Not applicable in this period|0
281021|NCT00308581|685504|P1|STARTED|Induction Phase|Not applicable in this period|0
281022|NCT00308555|685630|P2|NOT COMPLETED|Overall Study||0
281023|NCT00308555|685631|P1|NOT COMPLETED|Overall Study||3
281024|NCT00308555|685630|P2|COMPLETED|Overall Study||11
281025|NCT00308555|685631|P1|COMPLETED|Overall Study||10
281026|NCT00308555|685630|P2|STARTED|Overall Study||11
281027|NCT00308555|685631|P1|STARTED|Overall Study||13
281028|NCT00308516|685639|P2|NOT COMPLETED|Overall Study||21
281029|NCT00308516|685640|P1|NOT COMPLETED|Overall Study||29
281030|NCT00308516|685639|P2|COMPLETED|Overall Study||10
281031|NCT00308516|685640|P1|COMPLETED|Overall Study||6
281032|NCT00308516|685639|P2|STARTED|Overall Study||31
281033|NCT00308516|685640|P1|STARTED|Overall Study||35
281034|NCT00308308|685648|P2|NOT COMPLETED|Overall Study||68
281035|NCT00308308|685649|P1|NOT COMPLETED|Overall Study||103
281036|NCT00308308|685648|P2|COMPLETED|Overall Study||220
281037|NCT00308308|685649|P1|COMPLETED|Overall Study||198
281038|NCT00308308|685648|P2|STARTED|Overall Study||288
281039|NCT00308308|685649|P1|STARTED|Overall Study||301
281040|NCT00308230|685672|P3|NOT COMPLETED|Overall Study||0
281041|NCT00308230|685673|P2|NOT COMPLETED|Overall Study||0
281042|NCT00308230|685674|P1|NOT COMPLETED|Overall Study||0
281043|NCT00308230|685672|P3|COMPLETED|Overall Study||20
281044|NCT00308230|685673|P2|COMPLETED|Overall Study||8
281045|NCT00308230|685674|P1|COMPLETED|Overall Study||6
281046|NCT00308230|685672|P3|STARTED|Overall Study||20
281047|NCT00308230|685673|P2|STARTED|Overall Study||8
281048|NCT00308230|685674|P1|STARTED|Overall Study||6
281049|NCT00308139|685684|P2|NOT COMPLETED|Overall Study||87
281050|NCT00308139|685685|P1|NOT COMPLETED|Overall Study||94
281051|NCT00308139|685684|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
281052|NCT00308139|685685|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
281053|NCT00308139|685684|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
281054|NCT00308139|685685|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
281055|NCT00308139|685684|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
281056|NCT00308139|685685|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
281057|NCT00308139|685684|P2|Pharmacokinetics Population|Overall Study||0
281058|NCT00308139|685685|P1|Pharmacokinetics Population|Overall Study||129
281059|NCT00308139|685684|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
281060|NCT00308139|685685|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
281061|NCT00308139|685684|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
281062|NCT00308139|685685|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
281063|NCT00308139|685684|P2|STARTED|Overall Study||151
281064|NCT00308139|685685|P1|STARTED|Overall Study||152
281065|NCT00308113|685759|P4|NOT COMPLETED|Overall Study||1
281066|NCT00308113|685760|P3|NOT COMPLETED|Overall Study||0
281067|NCT00308113|685761|P2|NOT COMPLETED|Overall Study||0
281068|NCT00308113|685762|P1|NOT COMPLETED|Overall Study||0
281069|NCT00308113|685759|P4|COMPLETED|Overall Study||1
281070|NCT00308113|685760|P3|COMPLETED|Overall Study||1
281071|NCT00308113|685761|P2|COMPLETED|Overall Study||0
281072|NCT00308113|685762|P1|COMPLETED|Overall Study||0
281073|NCT00308113|685759|P4|STARTED|Overall Study||2
281074|NCT00308113|685760|P3|STARTED|Overall Study||1
281075|NCT00308113|685761|P2|STARTED|Overall Study||0
281076|NCT00308113|685762|P1|STARTED|Overall Study||0
281077|NCT00308087|685782|P2|NOT COMPLETED|Overall Study||37
281078|NCT00308087|685783|P1|NOT COMPLETED|Overall Study||36
281079|NCT00308087|685782|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
281080|NCT00308087|685783|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
281081|NCT00308087|685782|P2|STARTED|Overall Study||38
281082|NCT00308087|685783|P1|STARTED|Overall Study||37
281083|NCT00308074|685799|P1|NOT COMPLETED|Overall Study||1
281084|NCT00308074|685799|P1|COMPLETED|Overall Study||13
281085|NCT00308074|685799|P1|STARTED|Overall Study||14
281086|NCT00308061|685808|P2|NOT COMPLETED|Overall Study||0
281087|NCT00308061|685809|P1|NOT COMPLETED|Overall Study||0
281088|NCT00308061|685808|P2|COMPLETED|Overall Study||20
281089|NCT00308061|685809|P1|COMPLETED|Overall Study||20
281090|NCT00308061|685808|P2|STARTED|Overall Study||20
281091|NCT00308061|685809|P1|STARTED|Overall Study||20
281092|NCT00307931|685816|P1|NOT COMPLETED|Overall Study||1
281093|NCT00307931|685816|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
281094|NCT00307931|685816|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
281095|NCT00307801|685833|P2|NOT COMPLETED|Overall Study||17
281096|NCT00307801|685834|P1|NOT COMPLETED|Overall Study||32
281097|NCT00307801|685833|P2|COMPLETED|Overall Study||65
281098|NCT00307801|685834|P1|COMPLETED|Overall Study||117
281099|NCT00307801|685833|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
281100|NCT00307801|685834|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
281101|NCT00307801|685833|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
281102|NCT00307801|685834|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
281103|NCT00307801|685833|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
281104|NCT00307801|685834|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
281105|NCT00307801|685833|P2|Subjects Received Treatment|Overall Study||81
281106|NCT00307801|685834|P1|Subjects Received Treatment|Overall Study||145
281107|NCT00307801|685833|P2|STARTED|Overall Study||82
281108|NCT00307801|685834|P1|STARTED|Overall Study||149
281109|NCT00307736|685946|P4|NOT COMPLETED|Overall Study||3
281110|NCT00307736|685947|P3|NOT COMPLETED|Overall Study||3
281111|NCT00307736|685948|P2|NOT COMPLETED|Overall Study||0
281112|NCT00307736|685949|P1|NOT COMPLETED|Overall Study||0
281113|NCT00307736|685946|P4|COMPLETED|Overall Study||20
281114|NCT00307736|685947|P3|COMPLETED|Overall Study||0
281115|NCT00307736|685948|P2|COMPLETED|Overall Study||3
281116|NCT00307736|685949|P1|COMPLETED|Overall Study||3
281117|NCT00307736|685946|P4|STARTED|Overall Study||23
281118|NCT00307736|685947|P3|STARTED|Overall Study||3
281119|NCT00307736|685948|P2|STARTED|Overall Study||3
281120|NCT00307736|685949|P1|STARTED|Overall Study||3
281121|NCT00307684|685960|P3|NOT COMPLETED|Double Blind Phase||0
281122|NCT00307684|685961|P2|NOT COMPLETED|Double Blind Phase||5
281123|NCT00307684|685962|P1|NOT COMPLETED|Double Blind Phase||2
281124|NCT00307684|685960|P3|COMPLETED|Double Blind Phase||0
281125|NCT00307684|685961|P2|COMPLETED|Double Blind Phase||17
281126|NCT00307684|685962|P1|COMPLETED|Double Blind Phase||21
281127|NCT00307684|685960|P3|STARTED|Double Blind Phase||0
281128|NCT00307684|685961|P2|STARTED|Double Blind Phase||22
281129|NCT00307684|685962|P1|STARTED|Double Blind Phase||23
281130|NCT00307684|685960|P3|NOT COMPLETED|Open Label Phase||56
281131|NCT00307684|685961|P2|NOT COMPLETED|Open Label Phase||0
281132|NCT00307684|685962|P1|NOT COMPLETED|Open Label Phase||0
281133|NCT00307684|685960|P3|COMPLETED|Open Label Phase||99
281134|NCT00307684|685961|P2|COMPLETED|Open Label Phase||0
281135|NCT00307684|685962|P1|COMPLETED|Open Label Phase||0
281136|NCT00307684|685960|P3|STARTED|Open Label Phase|1 screening failure|155
281137|NCT00307684|685961|P2|STARTED|Open Label Phase||0
281138|NCT00307684|685962|P1|STARTED|Open Label Phase||0
281139|NCT00307489|685990|P2|NOT COMPLETED|Week 48 Through Week 168||6
281140|NCT00307489|685991|P1|NOT COMPLETED|Week 48 Through Week 168||6
281141|NCT00307489|685990|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
281142|NCT00307489|685991|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
281143|NCT00307489|685990|P2|STARTED|Week 48 Through Week 168||50
281144|NCT00307489|685991|P1|STARTED|Week 48 Through Week 168||52
281145|NCT00307489|685990|P2|NOT COMPLETED|Baseline Through Week 48||2
281146|NCT00307489|685991|P1|NOT COMPLETED|Baseline Through Week 48||1
281147|NCT00307489|685990|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
281148|NCT00307489|685991|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
281149|NCT00307489|685990|P2|STARTED|Baseline Through Week 48||52
281150|NCT00307489|685991|P1|STARTED|Baseline Through Week 48||53
281151|NCT00307437|686036|P7|NOT COMPLETED|After Controlled Period||113
281152|NCT00307437|686037|P6|NOT COMPLETED|After Controlled Period||122
281153|NCT00307437|686038|P5|NOT COMPLETED|After Controlled Period||55
281154|NCT00307437|686039|P4|NOT COMPLETED|After Controlled Period||58
281155|NCT00307437|686040|P3|NOT COMPLETED|After Controlled Period||0
281156|NCT00307437|686041|P2|NOT COMPLETED|After Controlled Period||0
281157|NCT00307437|686042|P1|NOT COMPLETED|After Controlled Period||0
281158|NCT00307437|686036|P7|COMPLETED|After Controlled Period||289
281159|NCT00307437|686037|P6|COMPLETED|After Controlled Period||281
281160|NCT00307437|686038|P5|COMPLETED|After Controlled Period||140
281161|NCT00307437|686039|P4|COMPLETED|After Controlled Period||139
281162|NCT00307437|686040|P3|COMPLETED|After Controlled Period||0
281163|NCT00307437|686041|P2|COMPLETED|After Controlled Period||0
281164|NCT00307437|686042|P1|COMPLETED|After Controlled Period||0
281165|NCT00307437|686036|P7|STARTED|After Controlled Period||402
281166|NCT00307437|686037|P6|STARTED|After Controlled Period||403
281167|NCT00307437|686038|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
281168|NCT00307437|686039|P4|STARTED|After Controlled Period||197
281169|NCT00307437|686040|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
281170|NCT00307437|686041|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
281171|NCT00307437|686042|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
281172|NCT00307437|686036|P7|NOT COMPLETED|Controlled Period||0
281173|NCT00307437|686037|P6|NOT COMPLETED|Controlled Period||0
281174|NCT00307437|686038|P5|NOT COMPLETED|Controlled Period||0
281175|NCT00307437|686039|P4|NOT COMPLETED|Controlled Period||0
281176|NCT00307437|686040|P3|NOT COMPLETED|Controlled Period||9
281177|NCT00307437|686041|P2|NOT COMPLETED|Controlled Period||6
281178|NCT00307437|686042|P1|NOT COMPLETED|Controlled Period||16
281179|NCT00307437|686036|P7|COMPLETED|Controlled Period||0
281180|NCT00307437|686037|P6|COMPLETED|Controlled Period||0
281181|NCT00307437|686038|P5|COMPLETED|Controlled Period||0
281182|NCT00307437|686039|P4|COMPLETED|Controlled Period||0
281183|NCT00307437|686040|P3|COMPLETED|Controlled Period||402
281184|NCT00307437|686041|P2|COMPLETED|Controlled Period||403
281185|NCT00307437|686042|P1|COMPLETED|Controlled Period||394
281186|NCT00307437|686036|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
281187|NCT00307437|686037|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
281188|NCT00307437|686038|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
281189|NCT00307437|686039|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
281190|NCT00307437|686040|P3|STARTED|Controlled Period||411
281191|NCT00307437|686041|P2|STARTED|Controlled Period||409
281192|NCT00307437|686042|P1|STARTED|Controlled Period||410
281193|NCT00307333|686068|P2|NOT COMPLETED|Overall Study||3
281194|NCT00307333|686069|P1|NOT COMPLETED|Overall Study||11
281195|NCT00307333|686068|P2|COMPLETED|Overall Study||1489
281196|NCT00307333|686069|P1|COMPLETED|Overall Study||1500
281197|NCT00307333|686068|P2|STARTED|Overall Study||1492
281198|NCT00307333|686069|P1|STARTED|Overall Study||1511
281199|NCT00307294|686081|P1|NOT COMPLETED|Overall Study||1
281200|NCT00307294|686081|P1|COMPLETED|Overall Study||39
281201|NCT00307294|686081|P1|STARTED|Overall Study||40
281202|NCT00307164|686090|P2|NOT COMPLETED|Overall Study||14
281203|NCT00307164|686091|P1|NOT COMPLETED|Overall Study||15
281204|NCT00307164|686090|P2|COMPLETED|Overall Study||68
281205|NCT00307164|686091|P1|COMPLETED|Overall Study||68
281206|NCT00307164|686090|P2|STARTED|Overall Study||82
281207|NCT00307164|686091|P1|STARTED|Overall Study||83
281208|NCT00307151|686131|P4|NOT COMPLETED|Overall Study||11
281209|NCT00307151|686132|P3|NOT COMPLETED|Overall Study||20
281210|NCT00307151|686133|P2|NOT COMPLETED|Overall Study||7
281211|NCT00307151|686134|P1|NOT COMPLETED|Overall Study||11
281212|NCT00307151|686131|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
281213|NCT00307151|686132|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
281214|NCT00307151|686133|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
281215|NCT00307151|686134|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
281216|NCT00307151|686131|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
281217|NCT00307151|686132|P3|STARTED|Overall Study||147
281218|NCT00307151|686133|P2|STARTED|Overall Study||82
281219|NCT00307151|686134|P1|STARTED|Overall Study||82
281220|NCT00307125|686178|P3|NOT COMPLETED|Pilot Phase||1
281221|NCT00307125|686179|P2|NOT COMPLETED|Pilot Phase||2
281222|NCT00307125|686180|P1|NOT COMPLETED|Pilot Phase||0
281223|NCT00307125|686178|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
281224|NCT00307125|686179|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
281225|NCT00307125|686180|P1|COMPLETED|Pilot Phase||0
281226|NCT00307125|686178|P3|STARTED|Pilot Phase||7
281227|NCT00307125|686179|P2|STARTED|Pilot Phase||15
281228|NCT00307125|686180|P1|STARTED|Pilot Phase||0
281229|NCT00307125|686178|P3|NOT COMPLETED|Screening Phase||0
281230|NCT00307125|686179|P2|NOT COMPLETED|Screening Phase||0
281231|NCT00307125|686180|P1|NOT COMPLETED|Screening Phase||454
281232|NCT00307125|686178|P3|COMPLETED|Screening Phase||0
281233|NCT00307125|686179|P2|COMPLETED|Screening Phase||0
281234|NCT00307125|686180|P1|COMPLETED|Screening Phase||303
281235|NCT00307125|686178|P3|STARTED|Screening Phase||0
281236|NCT00307125|686179|P2|STARTED|Screening Phase||0
281237|NCT00307125|686180|P1|STARTED|Screening Phase||757
281238|NCT00307086|686202|P1|NOT COMPLETED|Overall Study||5
281239|NCT00307086|686202|P1|COMPLETED|Overall Study||25
281240|NCT00307086|686202|P1|STARTED|Overall Study||30
281241|NCT00307047|686208|P2|NOT COMPLETED|Overall Study||49
281242|NCT00307047|686209|P1|NOT COMPLETED|Overall Study||69
281243|NCT00307047|686208|P2|COMPLETED|Overall Study||1180
281244|NCT00307047|686209|P1|COMPLETED|Overall Study||2389
281245|NCT00307047|686208|P2|STARTED|Overall Study||1229
281246|NCT00307047|686209|P1|STARTED|Overall Study||2458
281247|NCT00307034|686347|P2|NOT COMPLETED|Overall Study||7
281248|NCT00307034|686348|P1|NOT COMPLETED|Overall Study||2
281249|NCT00307034|686347|P2|COMPLETED|Overall Study||169
281250|NCT00307034|686348|P1|COMPLETED|Overall Study||173
281251|NCT00307034|686347|P2|STARTED|Overall Study||176
281252|NCT00307034|686348|P1|STARTED|Overall Study||175
281253|NCT00306917|686388|P2|NOT COMPLETED|Overall Study||109
281254|NCT00306917|686389|P1|NOT COMPLETED|Overall Study||108
281255|NCT00306917|686388|P2|COMPLETED|Overall Study||15
281256|NCT00306917|686389|P1|COMPLETED|Overall Study||13
281257|NCT00306917|686388|P2|60 Month Follow up|Overall Study||15
281258|NCT00306917|686389|P1|60 Month Follow up|Overall Study||13
281259|NCT00306917|686388|P2|48 Month Follow up|Overall Study||22
281260|NCT00306917|686389|P1|48 Month Follow up|Overall Study||29
281261|NCT00306917|686388|P2|36 Month Follow up|Overall Study||42
281262|NCT00306917|686389|P1|36 Month Follow up|Overall Study||56
281263|NCT00306917|686388|P2|24 Month Follow up|Overall Study||71
281264|NCT00306917|686389|P1|24 Month Follow up|Overall Study||60
281265|NCT00306917|686388|P2|12 Month Follow|Overall Study||94
281266|NCT00306917|686389|P1|12 Month Follow|Overall Study||86
281267|NCT00306917|686388|P2|Postoperative to 6 Month Follow up|Overall Study||100
281268|NCT00306917|686389|P1|Postoperative to 6 Month Follow up|Overall Study||93
281269|NCT00306917|686388|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
281270|NCT00306917|686389|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
281271|NCT00306891|686399|P4|NOT COMPLETED|Part B||17
281272|NCT00306891|686400|P3|NOT COMPLETED|Part B||11
281273|NCT00306891|686401|P2|NOT COMPLETED|Part B||0
281274|NCT00306891|686402|P1|NOT COMPLETED|Part B||0
281275|NCT00306891|686399|P4|COMPLETED|Part B||14
281276|NCT00306891|686400|P3|COMPLETED|Part B||5
281277|NCT00306891|686401|P2|COMPLETED|Part B||0
281278|NCT00306891|686402|P1|COMPLETED|Part B||0
281279|NCT00306891|686399|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
281280|NCT00306891|686400|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
281281|NCT00306891|686401|P2|STARTED|Part B||0
281282|NCT00306891|686402|P1|STARTED|Part B||0
281283|NCT00306891|686399|P4|NOT COMPLETED|Part A||0
281284|NCT00306891|686400|P3|NOT COMPLETED|Part A||0
281285|NCT00306891|686401|P2|NOT COMPLETED|Part A||6
281286|NCT00306891|686402|P1|NOT COMPLETED|Part A||5
281287|NCT00306891|686399|P4|COMPLETED|Part A||0
281288|NCT00306891|686400|P3|COMPLETED|Part A||0
281289|NCT00306891|686401|P2|COMPLETED|Part A||16
281290|NCT00306891|686402|P1|COMPLETED|Part A||18
281291|NCT00306891|686399|P4|STARTED|Part A||0
281292|NCT00306891|686400|P3|STARTED|Part A||0
281293|NCT00306891|686401|P2|STARTED|Part A||22
281294|NCT00306891|686402|P1|STARTED|Part A||23
281295|NCT00306852|686425|P2|NOT COMPLETED|Overall Study||38
281296|NCT00306852|686426|P1|NOT COMPLETED|Overall Study||29
281297|NCT00306852|686425|P2|COMPLETED|Overall Study||69
281298|NCT00306852|686426|P1|COMPLETED|Overall Study||76
281299|NCT00306852|686425|P2|STARTED|Overall Study||107
281300|NCT00306852|686426|P1|STARTED|Overall Study||105
281301|NCT00306787|686444|P2|NOT COMPLETED|Overall Study||241
281302|NCT00306787|686445|P1|NOT COMPLETED|Overall Study||234
281303|NCT00306787|686444|P2|COMPLETED|Overall Study||359
281304|NCT00306787|686445|P1|COMPLETED|Overall Study||345
281305|NCT00306787|686444|P2|Intent to Treat (ITT) Population|Overall Study||381
281306|NCT00306787|686445|P1|Intent to Treat (ITT) Population|Overall Study||370
281307|NCT00306787|686444|P2|Received Study Drug (Safety Population)|Overall Study||385
281308|NCT00306787|686445|P1|Received Study Drug (Safety Population)|Overall Study||371
281309|NCT00306787|686444|P2|STARTED|Overall Study||600
281310|NCT00306787|686445|P1|STARTED|Overall Study||579
281311|NCT00306670|686463|P2|NOT COMPLETED|Overall Study||2
281312|NCT00306670|686464|P1|NOT COMPLETED|Overall Study||0
281313|NCT00306670|686463|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
281314|NCT00306670|686464|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
281397|NCT00306189|686772|P3|STARTED|Overall Study||56
281315|NCT00306670|686463|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
281316|NCT00306670|686464|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
281317|NCT00306592|686470|P2|NOT COMPLETED|Overall Study||58
281318|NCT00306592|686471|P1|NOT COMPLETED|Overall Study||31
281319|NCT00306592|686470|P2|COMPLETED|Overall Study||632
281320|NCT00306592|686471|P1|COMPLETED|Overall Study||373
281321|NCT00306592|686470|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
281322|NCT00306592|686471|P1|Entered 101-MS-321 Extension Study|Overall Study||22
281323|NCT00306592|686470|P2|Completed at 48 Weeks|Overall Study||632
281324|NCT00306592|686471|P1|Completed at 48 Weeks|Overall Study||81
281325|NCT00306592|686470|P2|Completed Between 24 and 48 Weeks|Overall Study||0
281326|NCT00306592|686471|P1|Completed Between 24 and 48 Weeks|Overall Study||85
281327|NCT00306592|686470|P2|Completed at 24 Weeks|Overall Study||0
281328|NCT00306592|686471|P1|Completed at 24 Weeks|Overall Study||207
281329|NCT00306592|686470|P2|STARTED|Overall Study||690
281330|NCT00306592|686471|P1|STARTED|Overall Study||404
281331|NCT00306527|686481|P4|NOT COMPLETED|Overall Study||6
281332|NCT00306527|686482|P3|NOT COMPLETED|Overall Study||5
281333|NCT00306527|686483|P2|NOT COMPLETED|Overall Study||7
281334|NCT00306527|686484|P1|NOT COMPLETED|Overall Study||6
281335|NCT00306527|686481|P4|COMPLETED|Overall Study||590
281336|NCT00306527|686482|P3|COMPLETED|Overall Study|Additional death has been reported post study. Please refer to outcome measure-2.|567
281337|NCT00306527|686483|P2|COMPLETED|Overall Study||527
281338|NCT00306527|686484|P1|COMPLETED|Overall Study||527
281339|NCT00306527|686481|P4|STARTED|Overall Study||596
281340|NCT00306527|686482|P3|STARTED|Overall Study||572
281341|NCT00306527|686483|P2|STARTED|Overall Study||534
281342|NCT00306527|686484|P1|STARTED|Overall Study||533
281343|NCT00306488|686538|P2|NOT COMPLETED|Overall Study||1
281344|NCT00306488|686539|P1|NOT COMPLETED|Overall Study||1
281345|NCT00306488|686538|P2|COMPLETED|Overall Study||10
281346|NCT00306488|686539|P1|COMPLETED|Overall Study||10
281347|NCT00306488|686538|P2|STARTED|Overall Study||11
281348|NCT00306488|686539|P1|STARTED|Overall Study||11
281349|NCT00306384|686553|P3|NOT COMPLETED|Overall Study||277
281350|NCT00306384|686554|P2|NOT COMPLETED|Overall Study||508
281351|NCT00306384|686555|P1|NOT COMPLETED|Overall Study||542
281352|NCT00306384|686553|P3|COMPLETED|Overall Study||251
281353|NCT00306384|686554|P2|COMPLETED|Overall Study||891
281354|NCT00306384|686555|P1|COMPLETED|Overall Study||854
281355|NCT00306384|686553|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
281356|NCT00306384|686554|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
281357|NCT00306384|686555|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
281358|NCT00306384|686553|P3|STARTED|Overall Study||528
281359|NCT00306384|686554|P2|STARTED|Overall Study||1399
281360|NCT00306384|686555|P1|STARTED|Overall Study||1396
281361|NCT00306293|686587|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
281362|NCT00306293|686588|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
281363|NCT00306293|686587|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
281364|NCT00306293|686588|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
281365|NCT00306293|686587|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
281366|NCT00306293|686588|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
281367|NCT00306293|686587|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
281368|NCT00306293|686588|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
281369|NCT00306293|686587|P2|COMPLETED|Washout (Day 61 to Day 66)||27
281370|NCT00306293|686588|P1|COMPLETED|Washout (Day 61 to Day 66)||27
281371|NCT00306293|686587|P2|STARTED|Washout (Day 61 to Day 66)||27
281372|NCT00306293|686588|P1|STARTED|Washout (Day 61 to Day 66)||27
281373|NCT00306293|686587|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
281374|NCT00306293|686588|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
281375|NCT00306293|686587|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
281376|NCT00306293|686588|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
281377|NCT00306293|686587|P2|STARTED|Period 1 (Day 1 to Day 60)||35
281378|NCT00306293|686588|P1|STARTED|Period 1 (Day 1 to Day 60)||35
281379|NCT00306202|686609|P3|NOT COMPLETED|Overall Study||0
281380|NCT00306202|686610|P2|NOT COMPLETED|Overall Study||1
281381|NCT00306202|686611|P1|NOT COMPLETED|Overall Study||6
281382|NCT00306202|686609|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
281383|NCT00306202|686610|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
281384|NCT00306202|686611|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
281385|NCT00306202|686609|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
281386|NCT00306202|686610|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
281387|NCT00306202|686611|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
281388|NCT00306189|686771|P4|NOT COMPLETED|Overall Study||5
281389|NCT00306189|686772|P3|NOT COMPLETED|Overall Study||11
281390|NCT00306189|686773|P2|NOT COMPLETED|Overall Study||6
281391|NCT00306189|686774|P1|NOT COMPLETED|Overall Study||9
281392|NCT00306189|686771|P4|COMPLETED|Overall Study||52
281393|NCT00306189|686772|P3|COMPLETED|Overall Study||45
281394|NCT00306189|686773|P2|COMPLETED|Overall Study||50
281395|NCT00306189|686774|P1|COMPLETED|Overall Study||48
281396|NCT00306189|686771|P4|STARTED|Overall Study||57
281398|NCT00306189|686773|P2|STARTED|Overall Study||56
281399|NCT00306189|686774|P1|STARTED|Overall Study||57
281400|NCT00306163|686786|P2|NOT COMPLETED|Overall Study||0
281401|NCT00306163|686787|P1|NOT COMPLETED|Overall Study||0
281402|NCT00306163|686786|P2|COMPLETED|Overall Study||18
281403|NCT00306163|686787|P1|COMPLETED|Overall Study||19
281404|NCT00306163|686786|P2|STARTED|Overall Study||18
281405|NCT00306163|686787|P1|STARTED|Overall Study||19
281406|NCT00305942|686793|P1|NOT COMPLETED|Overall Study||38
281407|NCT00305942|686793|P1|COMPLETED|Overall Study||23
281408|NCT00305942|686793|P1|STARTED|Overall Study||61
281409|NCT00305877|686801|P2|NOT COMPLETED|Overall Study||34
281410|NCT00305877|686802|P1|NOT COMPLETED|Overall Study||24
281411|NCT00305877|686801|P2|COMPLETED|Overall Study||34
281412|NCT00305877|686802|P1|COMPLETED|Overall Study||45
281413|NCT00305877|686801|P2|Included in Efficacy Analysis|Overall Study||62
281414|NCT00305877|686802|P1|Included in Efficacy Analysis|Overall Study||65
281415|NCT00305877|686801|P2|Eligible|Overall Study||66
281416|NCT00305877|686802|P1|Eligible|Overall Study||66
281417|NCT00305877|686801|P2|Treated|Overall Study||63
281418|NCT00305877|686802|P1|Treated|Overall Study||67
281419|NCT00305877|686801|P2|STARTED|Overall Study||68
281420|NCT00305877|686802|P1|STARTED|Overall Study||69
281421|NCT00305864|686816|P4|NOT COMPLETED|Overall Study||13
281422|NCT00305864|686817|P3|NOT COMPLETED|Overall Study||1
281423|NCT00305864|686818|P2|NOT COMPLETED|Overall Study||1
281424|NCT00305864|686819|P1|NOT COMPLETED|Overall Study||0
281425|NCT00305864|686816|P4|COMPLETED|Overall Study||81
281426|NCT00305864|686817|P3|COMPLETED|Overall Study||6
281427|NCT00305864|686818|P2|COMPLETED|Overall Study||9
281428|NCT00305864|686819|P1|COMPLETED|Overall Study||7
281429|NCT00305864|686816|P4|STARTED|Overall Study||94
281430|NCT00305864|686817|P3|STARTED|Overall Study||7
281431|NCT00305864|686818|P2|STARTED|Overall Study||10
281432|NCT00305864|686819|P1|STARTED|Overall Study||7
281433|NCT00305773|686832|P2|NOT COMPLETED|Overall Study||18
281434|NCT00305773|686833|P1|NOT COMPLETED|Overall Study||14
281435|NCT00305773|686832|P2|COMPLETED|Overall Study||4
281436|NCT00305773|686833|P1|COMPLETED|Overall Study||1
281437|NCT00305773|686832|P2|STARTED|Overall Study||22
281438|NCT00305773|686833|P1|STARTED|Overall Study||15
281439|NCT00305760|686847|P1|NOT COMPLETED|Overall Study||47
281440|NCT00305760|686847|P1|COMPLETED|Overall Study||13
281441|NCT00305760|686847|P1|STARTED|Overall Study||60
281442|NCT00305643|686853|P2|NOT COMPLETED|Overall Study||0
281443|NCT00305643|686854|P1|NOT COMPLETED|Overall Study||0
281444|NCT00305643|686853|P2|COMPLETED|Overall Study||5
281445|NCT00305643|686854|P1|COMPLETED|Overall Study||6
281446|NCT00305643|686853|P2|STARTED|Overall Study||5
281447|NCT00305643|686854|P1|STARTED|Overall Study||6
281448|NCT00305604|686864|P2|NOT COMPLETED|Overall Study||47
281449|NCT00305604|686865|P1|NOT COMPLETED|Overall Study||32
281450|NCT00305604|686864|P2|COMPLETED|Overall Study||57
281451|NCT00305604|686865|P1|COMPLETED|Overall Study||70
281452|NCT00305604|686864|P2|STARTED|Overall Study||104
281453|NCT00305604|686865|P1|STARTED|Overall Study||102
281454|NCT00305578|686879|P2|NOT COMPLETED|Overall Study||2
281455|NCT00305578|686880|P1|NOT COMPLETED|Overall Study||3
281456|NCT00305578|686879|P2|COMPLETED|Overall Study||12
281457|NCT00305578|686880|P1|COMPLETED|Overall Study||12
281458|NCT00305578|686879|P2|STARTED|Overall Study||14
281459|NCT00305578|686880|P1|STARTED|Overall Study||15
281460|NCT00305565|686889|P3|NOT COMPLETED|Overall Study (ITT Population)||5
281461|NCT00305565|686890|P2|NOT COMPLETED|Overall Study (ITT Population)||11
281462|NCT00305565|686891|P1|NOT COMPLETED|Overall Study (ITT Population)||13
281463|NCT00305565|686889|P3|COMPLETED|Overall Study (ITT Population)||102
281464|NCT00305565|686890|P2|COMPLETED|Overall Study (ITT Population)||90
281465|NCT00305565|686891|P1|COMPLETED|Overall Study (ITT Population)||89
281466|NCT00305565|686889|P3|STARTED|Overall Study (ITT Population)||107
281467|NCT00305565|686890|P2|STARTED|Overall Study (ITT Population)||101
281468|NCT00305565|686891|P1|STARTED|Overall Study (ITT Population)||102
281469|NCT00305565|686889|P3|NOT COMPLETED|Overall Study (Safety Population)||7
281470|NCT00305565|686890|P2|NOT COMPLETED|Overall Study (Safety Population)||12
281471|NCT00305565|686891|P1|NOT COMPLETED|Overall Study (Safety Population)||14
281472|NCT00305565|686889|P3|COMPLETED|Overall Study (Safety Population)||106
281473|NCT00305565|686890|P2|COMPLETED|Overall Study (Safety Population)||95
281474|NCT00305565|686891|P1|COMPLETED|Overall Study (Safety Population)||97
281475|NCT00305565|686889|P3|STARTED|Overall Study (Safety Population)||113
281476|NCT00305565|686890|P2|STARTED|Overall Study (Safety Population)||107
281477|NCT00305565|686891|P1|STARTED|Overall Study (Safety Population)||111
281478|NCT00305448|687009|P3|NOT COMPLETED|Overall Study||33
281479|NCT00305448|687010|P2|NOT COMPLETED|Overall Study||34
281480|NCT00305448|687011|P1|NOT COMPLETED|Overall Study||31
281481|NCT00305448|687009|P3|COMPLETED|Overall Study||14
281482|NCT00305448|687010|P2|COMPLETED|Overall Study||17
281483|NCT00305448|687011|P1|COMPLETED|Overall Study||14
281484|NCT00305448|687009|P3|STARTED|Overall Study||47
281485|NCT00305448|687010|P2|STARTED|Overall Study||51
281486|NCT00305448|687011|P1|STARTED|Overall Study||45
281487|NCT00305344|687027|P1|NOT COMPLETED|Overall Study||0
281488|NCT00305344|687027|P1|COMPLETED|Overall Study||23
281489|NCT00305344|687027|P1|STARTED|Overall Study||23
281490|NCT00305253|687033|P2|NOT COMPLETED|Overall Study||1
281491|NCT00305253|687034|P1|NOT COMPLETED|Overall Study||0
281492|NCT00305253|687033|P2|COMPLETED|Overall Study||558
281493|NCT00305253|687034|P1|COMPLETED|Overall Study||432
281494|NCT00305253|687033|P2|STARTED|Overall Study||559
281495|NCT00305253|687034|P1|STARTED|Overall Study||432
281496|NCT00305227|687046|P2|NOT COMPLETED|Overall Study||6
281497|NCT00305227|687047|P1|NOT COMPLETED|Overall Study||7
281498|NCT00305227|687046|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
281499|NCT00305227|687047|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
281500|NCT00305227|687046|P2|STARTED|Overall Study||50
281501|NCT00305227|687047|P1|STARTED|Overall Study||50
281502|NCT00305162|687055|P2|NOT COMPLETED|1 Year Follow-up Period||65
281503|NCT00305162|687056|P1|NOT COMPLETED|1 Year Follow-up Period||55
281504|NCT00305162|687055|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
281505|NCT00305162|687056|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
281506|NCT00305162|687055|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
281507|NCT00305162|687056|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
281508|NCT00305162|687055|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
281509|NCT00305162|687056|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
281510|NCT00305162|687055|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
281511|NCT00305162|687056|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
281512|NCT00305162|687055|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
281513|NCT00305162|687056|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
281514|NCT00305162|687055|P2|STARTED|1 Year Follow-up Period||4447
281515|NCT00305162|687056|P1|STARTED|1 Year Follow-up Period||4435
281516|NCT00305162|687055|P2|NOT COMPLETED|30-day Follow-up Period||63
281517|NCT00305162|687056|P1|NOT COMPLETED|30-day Follow-up Period||62
281518|NCT00305162|687055|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
281519|NCT00305162|687056|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
281520|NCT00305162|687055|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
281521|NCT00305162|687056|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
281522|NCT00305162|687055|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
281523|NCT00305162|687056|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
281524|NCT00305162|687055|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
281525|NCT00305162|687056|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
281526|NCT00305162|687055|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
281527|NCT00305162|687056|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
281528|NCT00305162|687055|P2|STARTED|30-day Follow-up Period||4447
281529|NCT00305162|687056|P1|STARTED|30-day Follow-up Period||4435
281530|NCT00305162|687055|P2|NOT COMPLETED|48 Hour Follow-up Period||16
281531|NCT00305162|687056|P1|NOT COMPLETED|48 Hour Follow-up Period||20
281532|NCT00305162|687055|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
281533|NCT00305162|687056|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
281534|NCT00305162|687055|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
281535|NCT00305162|687056|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
281536|NCT00305162|687055|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
281537|NCT00305162|687056|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
281538|NCT00305162|687055|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
281539|NCT00305162|687056|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
281540|NCT00305162|687055|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
281541|NCT00305162|687056|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
281542|NCT00305162|687055|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
281543|NCT00305162|687056|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
281544|NCT00305162|687055|P2|STARTED|48 Hour Follow-up Period||4447
281545|NCT00305162|687056|P1|STARTED|48 Hour Follow-up Period||4435
281546|NCT00304954|687098|P4|NOT COMPLETED|Overall Study||0
281547|NCT00304954|687099|P3|NOT COMPLETED|Overall Study||1
281548|NCT00304954|687100|P2|NOT COMPLETED|Overall Study||0
281549|NCT00304954|687101|P1|NOT COMPLETED|Overall Study||1
281550|NCT00304954|687098|P4|COMPLETED|Overall Study||3
281551|NCT00304954|687099|P3|COMPLETED|Overall Study||2
281552|NCT00304954|687100|P2|COMPLETED|Overall Study||3
281553|NCT00304954|687101|P1|COMPLETED|Overall Study||3
281554|NCT00304954|687098|P4|STARTED|Overall Study||3
281555|NCT00304954|687099|P3|STARTED|Overall Study||3
281556|NCT00304954|687100|P2|STARTED|Overall Study||3
281557|NCT00304954|687101|P1|STARTED|Overall Study||4
281558|NCT00304915|687121|P2|NOT COMPLETED|Overall Study||16
281559|NCT00304915|687122|P1|NOT COMPLETED|Overall Study||18
281560|NCT00304915|687121|P2|COMPLETED|Overall Study||110
281561|NCT00304915|687122|P1|COMPLETED|Overall Study||105
281562|NCT00304915|687121|P2|STARTED|Overall Study||126
281563|NCT00304915|687122|P1|STARTED|Overall Study||123
281564|NCT00304746|687130|P2|NOT COMPLETED|Overall Study||0
281565|NCT00304746|687131|P1|NOT COMPLETED|Overall Study||0
281566|NCT00304746|687130|P2|COMPLETED|Overall Study||50
281567|NCT00304746|687131|P1|COMPLETED|Overall Study||50
281568|NCT00304746|687130|P2|STARTED|Overall Study||50
281569|NCT00304746|687131|P1|STARTED|Overall Study||50
281570|NCT00304707|687141|P2|NOT COMPLETED|Overall Study||6
281571|NCT00304707|687142|P1|NOT COMPLETED|Overall Study||7
281572|NCT00304707|687141|P2|COMPLETED|Overall Study||64
281573|NCT00304707|687142|P1|COMPLETED|Overall Study||66
281574|NCT00304707|687141|P2|STARTED|Overall Study||70
281575|NCT00304707|687142|P1|STARTED|Overall Study||73
281576|NCT00304356|687148|P1|NOT COMPLETED|Nitazoxanide||5
281577|NCT00304356|687148|P1|COMPLETED|Nitazoxanide||22
281578|NCT00304356|687148|P1|STARTED|Nitazoxanide||27
281579|NCT00304356|687148|P1|NOT COMPLETED|Nitazoxanide||5
281580|NCT00304356|687148|P1|COMPLETED|Nitazoxanide||22
281581|NCT00304356|687148|P1|STARTED|Nitazoxanide||27
281582|NCT00304278|687152|P1|NOT COMPLETED|Overall Study||2
281583|NCT00304278|687152|P1|COMPLETED|Overall Study||19
281584|NCT00304278|687152|P1|STARTED|Overall Study||21
281585|NCT00304265|687159|P2|NOT COMPLETED|Overall Study||0
281586|NCT00304265|687160|P1|NOT COMPLETED|Overall Study||0
281587|NCT00304265|687159|P2|COMPLETED|Overall Study||98
281588|NCT00304265|687160|P1|COMPLETED|Overall Study||117
281589|NCT00304265|687159|P2|STARTED|Overall Study||98
281590|NCT00304265|687160|P1|STARTED|Overall Study||117
281591|NCT00304187|687168|P2|NOT COMPLETED|Overall Study||1
281592|NCT00304187|687169|P1|NOT COMPLETED|Overall Study||2
281593|NCT00304187|687168|P2|COMPLETED|Overall Study||13
281594|NCT00304187|687169|P1|COMPLETED|Overall Study||13
281595|NCT00304187|687168|P2|STARTED|Overall Study||14
281596|NCT00304187|687169|P1|STARTED|Overall Study||15
281597|NCT00304161|687177|P2|NOT COMPLETED|Overall Study||6
281598|NCT00304161|687178|P1|NOT COMPLETED|Overall Study||6
281599|NCT00304161|687177|P2|COMPLETED|Overall Study||21
281600|NCT00304161|687178|P1|COMPLETED|Overall Study||22
281601|NCT00304161|687177|P2|STARTED|Overall Study||27
281602|NCT00304161|687178|P1|STARTED|Overall Study||28
281603|NCT00304096|687188|P2|NOT COMPLETED|Overall Study||0
281604|NCT00304096|687189|P1|NOT COMPLETED|Overall Study||0
281605|NCT00304096|687188|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
281606|NCT00304096|687189|P1|COMPLETED|Overall Study||6
281607|NCT00304096|687188|P2|STARTED|Overall Study||5
281608|NCT00304096|687189|P1|STARTED|Overall Study||6
281609|NCT00304083|687199|P2|NOT COMPLETED|Overall Study||8
281610|NCT00304083|687200|P1|NOT COMPLETED|Overall Study||22
281611|NCT00304083|687199|P2|COMPLETED|Overall Study||6
281612|NCT00304083|687200|P1|COMPLETED|Overall Study||12
281613|NCT00304083|687199|P2|Completed 4 Cycles|Overall Study||7
281614|NCT00304083|687200|P1|Completed 4 Cycles|Overall Study||22
281615|NCT00304083|687199|P2|STARTED|Overall Study||14
281616|NCT00304083|687200|P1|STARTED|Overall Study||34
281617|NCT00304070|687208|P3|NOT COMPLETED|Overall Study||12
281618|NCT00304070|687209|P2|NOT COMPLETED|Overall Study||7
281619|NCT00304070|687210|P1|NOT COMPLETED|Overall Study||3
281620|NCT00304070|687208|P3|COMPLETED|Overall Study||27
281621|NCT00304070|687209|P2|COMPLETED|Overall Study||8
281622|NCT00304070|687210|P1|COMPLETED|Overall Study||21
281623|NCT00304070|687208|P3|STARTED|Overall Study||39
281624|NCT00304070|687209|P2|STARTED|Overall Study||15
281625|NCT00304070|687210|P1|STARTED|Overall Study||24
281626|NCT00304031|687225|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
281627|NCT00304031|687226|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
281628|NCT00304031|687227|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
281629|NCT00304031|687225|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
281630|NCT00304031|687226|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
281631|NCT00304031|687227|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
281632|NCT00304031|687225|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
281633|NCT00304031|687226|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
281634|NCT00304031|687227|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
281635|NCT00304031|687225|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
281636|NCT00304031|687226|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
281637|NCT00304031|687227|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
281638|NCT00304031|687225|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
281639|NCT00304031|687226|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
281640|NCT00304031|687227|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
281641|NCT00304031|687225|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
281642|NCT00304031|687226|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
281643|NCT00304031|687227|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
281644|NCT00304031|687225|P3|NOT COMPLETED|Registration||0
281645|NCT00304031|687226|P2|NOT COMPLETED|Registration||0
281646|NCT00304031|687227|P1|NOT COMPLETED|Registration||48
281647|NCT00304031|687225|P3|COMPLETED|Registration||0
281648|NCT00304031|687226|P2|COMPLETED|Registration||0
281649|NCT00304031|687227|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
281650|NCT00304031|687225|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
281651|NCT00304031|687226|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
281652|NCT00304031|687227|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
281653|NCT00303979|687237|P3|NOT COMPLETED|Single Time Point (18 Month)||0
281654|NCT00303979|687238|P2|NOT COMPLETED|Single Time Point (18 Month)||0
281655|NCT00303979|687239|P1|NOT COMPLETED|Single Time Point (18 Month)||0
281656|NCT00303979|687237|P3|COMPLETED|Single Time Point (18 Month)||9641
281657|NCT00303979|687238|P2|COMPLETED|Single Time Point (18 Month)||0
281658|NCT00303979|687239|P1|COMPLETED|Single Time Point (18 Month)||0
281659|NCT00303979|687237|P3|STARTED|Single Time Point (18 Month)||9641
281660|NCT00303979|687238|P2|STARTED|Single Time Point (18 Month)||0
281661|NCT00303979|687239|P1|STARTED|Single Time Point (18 Month)||0
281662|NCT00303979|687237|P3|NOT COMPLETED|Single Time Point (6 Month)||0
281663|NCT00303979|687238|P2|NOT COMPLETED|Single Time Point (6 Month)||0
281664|NCT00303979|687239|P1|NOT COMPLETED|Single Time Point (6 Month)||0
281665|NCT00303979|687237|P3|COMPLETED|Single Time Point (6 Month)||0
281666|NCT00303979|687238|P2|COMPLETED|Single Time Point (6 Month)||9992
281667|NCT00303979|687239|P1|COMPLETED|Single Time Point (6 Month)||0
281668|NCT00303979|687237|P3|STARTED|Single Time Point (6 Month)||0
281669|NCT00303979|687238|P2|STARTED|Single Time Point (6 Month)||9992
281670|NCT00303979|687239|P1|STARTED|Single Time Point (6 Month)||0
281671|NCT00303979|687237|P3|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
281672|NCT00303979|687238|P2|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
281673|NCT00303979|687239|P1|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||7572
281674|NCT00303979|687237|P3|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
281675|NCT00303979|687238|P2|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
281676|NCT00303979|687239|P1|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)|at 24 Month|7605
281677|NCT00303979|687237|P3|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
281678|NCT00303979|687238|P2|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
281679|NCT00303979|687239|P1|STARTED|Longitudinal (Baseline, 12 and 24 Month)|at Baseline|15177
281680|NCT00303966|687249|P1|NOT COMPLETED|Overall Study||0
281681|NCT00303966|687249|P1|COMPLETED|Overall Study||5
281682|NCT00303966|687249|P1|STARTED|Overall Study||5
281683|NCT00303953|687258|P1|NOT COMPLETED|Overall Study||19
281684|NCT00303953|687258|P1|COMPLETED|Overall Study||3
281685|NCT00303953|687258|P1|Eligible and Treated|Overall Study||20
281686|NCT00303953|687258|P1|Eligible|Overall Study||21
281687|NCT00303953|687258|P1|STARTED|Overall Study||22
281688|NCT00303901|687264|P1|NOT COMPLETED|Overall Study||0
281689|NCT00303901|687264|P1|COMPLETED|Overall Study||40
281690|NCT00303901|687264|P1|STARTED|Overall Study||40
281691|NCT00303862|687269|P1|NOT COMPLETED|Overall Study||0
281692|NCT00303862|687269|P1|COMPLETED|Overall Study||10
281693|NCT00303862|687269|P1|STARTED|Overall Study||10
281694|NCT00303823|687278|P2|NOT COMPLETED|Overall Study||10
281695|NCT00303823|687279|P1|NOT COMPLETED|Overall Study||15
281696|NCT00303823|687278|P2|COMPLETED|Overall Study||38
281697|NCT00303823|687279|P1|COMPLETED|Overall Study||35
281698|NCT00303823|687278|P2|STARTED|Overall Study||48
281699|NCT00303823|687279|P1|STARTED|Overall Study||50
281700|NCT00303667|687293|P2|NOT COMPLETED|Overall Study||4
281701|NCT00303667|687294|P1|NOT COMPLETED|Overall Study||0
281702|NCT00303667|687293|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
281703|NCT00303667|687294|P1|COMPLETED|Overall Study||8
281704|NCT00303667|687293|P2|STARTED|Overall Study||39
281705|NCT00303667|687294|P1|STARTED|Overall Study||8
281706|NCT00303628|687318|P2|NOT COMPLETED|Overall Study||73
281707|NCT00303628|687319|P1|NOT COMPLETED|Overall Study||50
281708|NCT00303628|687318|P2|COMPLETED|Overall Study||106
281709|NCT00303628|687319|P1|COMPLETED|Overall Study||126
281710|NCT00303628|687318|P2|Treated|Overall Study||174
281711|NCT00303628|687319|P1|Treated|Overall Study||173
281712|NCT00303628|687318|P2|Eligible|Overall Study||177
281713|NCT00303628|687319|P1|Eligible|Overall Study||171
281714|NCT00303628|687318|P2|STARTED|Overall Study||179
281715|NCT00303628|687319|P1|STARTED|Overall Study||176
281716|NCT00303602|687337|P2|NOT COMPLETED|Overall Study||15
281717|NCT00303602|687338|P1|NOT COMPLETED|Overall Study||19
281718|NCT00303602|687337|P2|COMPLETED|Overall Study||50
281719|NCT00303602|687338|P1|COMPLETED|Overall Study||65
281720|NCT00303602|687337|P2|STARTED|Overall Study||65
281721|NCT00303602|687338|P1|STARTED|Overall Study||84
281722|NCT00303511|687378|P1|NOT COMPLETED|Overall Study||0
281723|NCT00303511|687378|P1|COMPLETED|Overall Study||10
281724|NCT00303511|687378|P1|STARTED|Overall Study||10
281725|NCT00303485|687384|P2|NOT COMPLETED|Overall Study||2
281726|NCT00303485|687385|P1|NOT COMPLETED|Overall Study||1
281727|NCT00303485|687384|P2|COMPLETED|Overall Study||15
281728|NCT00303485|687385|P1|COMPLETED|Overall Study||48
281729|NCT00303485|687384|P2|STARTED|Overall Study||17
281730|NCT00303485|687385|P1|STARTED|Overall Study||49
281731|NCT00303472|687416|P7|NOT COMPLETED|Treatment Extension (Optional)||0
281732|NCT00303472|687417|P6|NOT COMPLETED|Treatment Extension (Optional)||1
281733|NCT00303472|687418|P5|NOT COMPLETED|Treatment Extension (Optional)||4
281734|NCT00303472|687419|P4|NOT COMPLETED|Treatment Extension (Optional)||8
281735|NCT00303472|687420|P3|NOT COMPLETED|Treatment Extension (Optional)||9
281736|NCT00303472|687421|P2|NOT COMPLETED|Treatment Extension (Optional)||6
281737|NCT00303472|687422|P1|NOT COMPLETED|Treatment Extension (Optional)||5
281738|NCT00303472|687416|P7|COMPLETED|Treatment Extension (Optional)||1
281739|NCT00303472|687417|P6|COMPLETED|Treatment Extension (Optional)||4
281740|NCT00303472|687418|P5|COMPLETED|Treatment Extension (Optional)||1
281741|NCT00303472|687419|P4|COMPLETED|Treatment Extension (Optional)||5
281742|NCT00303472|687420|P3|COMPLETED|Treatment Extension (Optional)||2
281743|NCT00303472|687421|P2|COMPLETED|Treatment Extension (Optional)||5
281744|NCT00303472|687422|P1|COMPLETED|Treatment Extension (Optional)||1
281745|NCT00303472|687416|P7|STARTED|Treatment Extension (Optional)||1
281746|NCT00303472|687417|P6|STARTED|Treatment Extension (Optional)||5
281747|NCT00303472|687418|P5|STARTED|Treatment Extension (Optional)||5
281748|NCT00303472|687419|P4|STARTED|Treatment Extension (Optional)||13
281749|NCT00303472|687420|P3|STARTED|Treatment Extension (Optional)||11
281750|NCT00303472|687421|P2|STARTED|Treatment Extension (Optional)||11
281751|NCT00303472|687422|P1|STARTED|Treatment Extension (Optional)||6
281752|NCT00303472|687416|P7|NOT COMPLETED|Treatment Period||2
281753|NCT00303472|687417|P6|NOT COMPLETED|Treatment Period||1
281754|NCT00303472|687418|P5|NOT COMPLETED|Treatment Period||3
281755|NCT00303472|687419|P4|NOT COMPLETED|Treatment Period||2
281756|NCT00303472|687420|P3|NOT COMPLETED|Treatment Period||0
281757|NCT00303472|687421|P2|NOT COMPLETED|Treatment Period||0
281758|NCT00303472|687422|P1|NOT COMPLETED|Treatment Period||0
281759|NCT00303472|687416|P7|COMPLETED|Treatment Period||3
281760|NCT00303472|687417|P6|COMPLETED|Treatment Period||11
281761|NCT00303472|687418|P5|COMPLETED|Treatment Period||8
281762|NCT00303472|687419|P4|COMPLETED|Treatment Period||14
281763|NCT00303472|687420|P3|COMPLETED|Treatment Period||11
281764|NCT00303472|687421|P2|COMPLETED|Treatment Period||11
281765|NCT00303472|687422|P1|COMPLETED|Treatment Period||6
281766|NCT00303472|687416|P7|STARTED|Treatment Period||5
281767|NCT00303472|687417|P6|STARTED|Treatment Period||12
281768|NCT00303472|687418|P5|STARTED|Treatment Period||11
281769|NCT00303472|687419|P4|STARTED|Treatment Period||16
281770|NCT00303472|687420|P3|STARTED|Treatment Period||11
281771|NCT00303472|687421|P2|STARTED|Treatment Period||11
281772|NCT00303472|687422|P1|STARTED|Treatment Period||6
281773|NCT00303459|687482|P2|NOT COMPLETED|Overall Study||89
281774|NCT00303459|687483|P1|NOT COMPLETED|Overall Study||83
281775|NCT00303459|687482|P2|COMPLETED|Overall Study||86
281776|NCT00303459|687483|P1|COMPLETED|Overall Study||76
281777|NCT00303459|687482|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
281778|NCT00303459|687483|P1|STARTED|Overall Study||159
281779|NCT00303446|687509|P2|NOT COMPLETED|Overall Study||4
281780|NCT00303446|687510|P1|NOT COMPLETED|Overall Study||2
281781|NCT00303446|687509|P2|COMPLETED|Overall Study||21
281782|NCT00303446|687510|P1|COMPLETED|Overall Study||23
281783|NCT00303446|687509|P2|STARTED|Overall Study||25
281784|NCT00303446|687510|P1|STARTED|Overall Study||25
281785|NCT00303329|687546|P2|NOT COMPLETED|Overall Study||62
281786|NCT00303329|687547|P1|NOT COMPLETED|Overall Study||35
281787|NCT00303329|687546|P2|COMPLETED|Overall Study||37
281788|NCT00303329|687547|P1|COMPLETED|Overall Study||50
281789|NCT00303329|687546|P2|STARTED|Overall Study||99
281790|NCT00303329|687547|P1|STARTED|Overall Study||85
281791|NCT00303316|687561|P2|NOT COMPLETED|Overall Study||3
281792|NCT00303316|687562|P1|NOT COMPLETED|Overall Study||2
281793|NCT00303316|687561|P2|COMPLETED|Overall Study||223
281794|NCT00303316|687562|P1|COMPLETED|Overall Study||230
281795|NCT00303316|687561|P2|STARTED|Overall Study||226
281796|NCT00303316|687562|P1|STARTED|Overall Study||232
281797|NCT00303186|687574|P1|NOT COMPLETED|Overall Study||52
281798|NCT00303186|687574|P1|COMPLETED|Overall Study||55
281799|NCT00303186|687574|P1|STARTED|Overall Study||107
281800|NCT00303108|687608|P3|NOT COMPLETED|Overall Study||16
281801|NCT00303108|687609|P2|NOT COMPLETED|Overall Study||9
281802|NCT00303108|687610|P1|NOT COMPLETED|Overall Study||12
281803|NCT00303108|687608|P3|COMPLETED|Overall Study||31
281804|NCT00303108|687609|P2|COMPLETED|Overall Study||37
281805|NCT00303108|687610|P1|COMPLETED|Overall Study||31
281806|NCT00303108|687608|P3|STARTED|Overall Study||47
281807|NCT00303108|687609|P2|STARTED|Overall Study||46
281808|NCT00303108|687610|P1|STARTED|Overall Study||43
281809|NCT00303069|687630|P4|NOT COMPLETED|Overall Study||2
281810|NCT00303069|687631|P3|NOT COMPLETED|Overall Study||1
281811|NCT00303069|687632|P2|NOT COMPLETED|Overall Study||0
281812|NCT00303069|687633|P1|NOT COMPLETED|Overall Study||2
281813|NCT00303069|687630|P4|COMPLETED|Overall Study||29
281814|NCT00303069|687631|P3|COMPLETED|Overall Study||33
281815|NCT00303069|687632|P2|COMPLETED|Overall Study||28
281816|NCT00303069|687633|P1|COMPLETED|Overall Study||29
281817|NCT00303069|687630|P4|STARTED|Overall Study||31
281818|NCT00303069|687631|P3|STARTED|Overall Study||34
281819|NCT00303069|687632|P2|STARTED|Overall Study||28
281820|NCT00303069|687633|P1|STARTED|Overall Study||31
281821|NCT00302952|687653|P2|NOT COMPLETED|Overall Study||5
281822|NCT00302952|687654|P1|NOT COMPLETED|Overall Study||3
281823|NCT00302952|687653|P2|COMPLETED|Overall Study||25
281824|NCT00302952|687654|P1|COMPLETED|Overall Study||31
281825|NCT00302952|687653|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
281826|NCT00302952|687654|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
281827|NCT00302952|687653|P2|Started Intent-to-Treat (ITT)|Overall Study||30
281828|NCT00302952|687654|P1|Started Intent-to-Treat (ITT)|Overall Study||34
281829|NCT00302952|687653|P2|STARTED|Overall Study||30
281830|NCT00302952|687654|P1|STARTED|Overall Study||34
281831|NCT00302848|687691|P3|NOT COMPLETED|Overall Study||579
281832|NCT00302848|687692|P2|NOT COMPLETED|Overall Study||419
281833|NCT00302848|687693|P1|NOT COMPLETED|Overall Study||401
281834|NCT00302848|687691|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
281835|NCT00302848|687692|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
281836|NCT00302848|687693|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
281837|NCT00302848|687691|P3|STARTED|Overall Study||26341
281838|NCT00302848|687692|P2|STARTED|Overall Study||15428
281839|NCT00302848|687693|P1|STARTED|Overall Study||16534
281840|NCT00302731|687704|P4|NOT COMPLETED|Overall Study||0
281841|NCT00302731|687705|P3|NOT COMPLETED|Overall Study||3
281842|NCT00302731|687706|P2|NOT COMPLETED|Overall Study||5
281843|NCT00302731|687707|P1|NOT COMPLETED|Overall Study||4
281844|NCT00302731|687704|P4|COMPLETED|Overall Study||4
281845|NCT00302731|687705|P3|COMPLETED|Overall Study||2
281846|NCT00302731|687706|P2|COMPLETED|Overall Study||1
281847|NCT00302731|687707|P1|COMPLETED|Overall Study||2
281848|NCT00302731|687704|P4|STARTED|Overall Study||4
281849|NCT00302731|687705|P3|STARTED|Overall Study||5
281850|NCT00302731|687706|P2|STARTED|Overall Study||6
281851|NCT00302731|687707|P1|STARTED|Overall Study||6
281852|NCT00302718|687733|P4|NOT COMPLETED|Overall Study||2
281853|NCT00302718|687734|P3|NOT COMPLETED|Overall Study||2
281854|NCT00302718|687735|P2|NOT COMPLETED|Overall Study||1
281855|NCT00302718|687736|P1|NOT COMPLETED|Overall Study||1
281856|NCT00302718|687733|P4|COMPLETED|Overall Study||19
281857|NCT00302718|687734|P3|COMPLETED|Overall Study||19
281858|NCT00302718|687735|P2|COMPLETED|Overall Study||20
281859|NCT00302718|687736|P1|COMPLETED|Overall Study||19
281860|NCT00302718|687733|P4|STARTED|Overall Study||21
281861|NCT00302718|687734|P3|STARTED|Overall Study||21
281862|NCT00302718|687735|P2|STARTED|Overall Study||21
281863|NCT00302718|687736|P1|STARTED|Overall Study||20
281864|NCT00302458|687768|P1|NOT COMPLETED|Overall Study||3
281865|NCT00302458|687768|P1|COMPLETED|Overall Study||26
281866|NCT00302458|687768|P1|STARTED|Overall Study||29
281867|NCT00302328|687779|P3|NOT COMPLETED|Overall Study||0
281868|NCT00302328|687780|P2|NOT COMPLETED|Overall Study||1
281869|NCT00302328|687781|P1|NOT COMPLETED|Overall Study||0
281870|NCT00302328|687779|P3|COMPLETED|Overall Study||18
281871|NCT00302328|687780|P2|COMPLETED|Overall Study|developed cancer during the study|34
281872|NCT00302328|687781|P1|COMPLETED|Overall Study||25
281873|NCT00302328|687779|P3|STARTED|Overall Study||18
281874|NCT00302328|687780|P2|STARTED|Overall Study||35
281875|NCT00302328|687781|P1|STARTED|Overall Study||25
281876|NCT00302211|687798|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
281877|NCT00302211|687799|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
281878|NCT00302211|687800|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
281879|NCT00302211|687801|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
281880|NCT00302211|687802|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
281881|NCT00302211|687798|P5|COMPLETED|Open Label-Patients From Double-Blind||24
281882|NCT00302211|687799|P4|COMPLETED|Open Label-Patients From Double-Blind||18
281883|NCT00302211|687800|P3|COMPLETED|Open Label-Patients From Double-Blind||0
281884|NCT00302211|687801|P2|COMPLETED|Open Label-Patients From Double-Blind||0
281885|NCT00302211|687802|P1|COMPLETED|Open Label-Patients From Double-Blind||0
281886|NCT00302211|687798|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
281887|NCT00302211|687799|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
281888|NCT00302211|687800|P3|STARTED|Open Label-Patients From Double-Blind||0
281889|NCT00302211|687801|P2|STARTED|Open Label-Patients From Double-Blind||0
281890|NCT00302211|687802|P1|STARTED|Open Label-Patients From Double-Blind||0
281891|NCT00302211|687798|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
281892|NCT00302211|687799|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
281893|NCT00302211|687800|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
281894|NCT00302211|687801|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
281895|NCT00302211|687802|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
281896|NCT00302211|687798|P5|COMPLETED|Double Blind Period (New Patients)||0
281897|NCT00302211|687799|P4|COMPLETED|Double Blind Period (New Patients)||0
281898|NCT00302211|687800|P3|COMPLETED|Double Blind Period (New Patients)||10
281899|NCT00302211|687801|P2|COMPLETED|Double Blind Period (New Patients)||25
281900|NCT00302211|687802|P1|COMPLETED|Double Blind Period (New Patients)||23
281901|NCT00302211|687798|P5|STARTED|Double Blind Period (New Patients)||0
281902|NCT00302211|687799|P4|STARTED|Double Blind Period (New Patients)||0
281903|NCT00302211|687800|P3|STARTED|Double Blind Period (New Patients)|placebo plus sildenafil with or without bosentan|14
281904|NCT00302211|687801|P2|STARTED|Double Blind Period (New Patients)|iloprost 4x/day plus sildenafil with or without bosentan|27
281905|NCT00302211|687802|P1|STARTED|Double Blind Period (New Patients)|iloprost 6x/day plus sildenafil with or without bosentan|26
281906|NCT00302159|687814|P1|NOT COMPLETED|Overall Study||2
281907|NCT00302159|687814|P1|COMPLETED|Overall Study||41
281908|NCT00302159|687814|P1|STARTED|Overall Study||43
281909|NCT00302133|687825|P2|NOT COMPLETED|Overall Study||4
281910|NCT00302133|687826|P1|NOT COMPLETED|Overall Study||4
281911|NCT00302133|687825|P2|COMPLETED|Overall Study||5
281912|NCT00302133|687826|P1|COMPLETED|Overall Study||5
281913|NCT00302133|687825|P2|STARTED|Overall Study||9
281914|NCT00302133|687826|P1|STARTED|Overall Study||9
281915|NCT00302107|687836|P2|NOT COMPLETED|Overall Study||9
281916|NCT00302107|687837|P1|NOT COMPLETED|Overall Study||8
281917|NCT00302107|687836|P2|COMPLETED|Overall Study||30
281918|NCT00302107|687837|P1|COMPLETED|Overall Study||31
281919|NCT00302107|687836|P2|STARTED|Overall Study||39
281920|NCT00302107|687837|P1|STARTED|Overall Study||39
281921|NCT00302081|687846|P3|NOT COMPLETED|Overall Study||52
281922|NCT00302081|687847|P2|NOT COMPLETED|Overall Study||43
281923|NCT00302081|687848|P1|NOT COMPLETED|Overall Study||56
281924|NCT00302081|687846|P3|COMPLETED|Overall Study||178
281925|NCT00302081|687847|P2|COMPLETED|Overall Study||186
281926|NCT00302081|687848|P1|COMPLETED|Overall Study||181
281927|NCT00302081|687846|P3|STARTED|Overall Study||230
281928|NCT00302081|687847|P2|STARTED|Overall Study||229
281929|NCT00302081|687848|P1|STARTED|Overall Study||237
281930|NCT00302068|687859|P3|NOT COMPLETED|Overall Study||1
281931|NCT00302068|687860|P2|NOT COMPLETED|Overall Study||4
281932|NCT00302068|687861|P1|NOT COMPLETED|Overall Study||1
281933|NCT00302068|687859|P3|COMPLETED|Overall Study||23
281934|NCT00302068|687860|P2|COMPLETED|Overall Study||36
281935|NCT00302068|687861|P1|COMPLETED|Overall Study||36
281936|NCT00302068|687859|P3|STARTED|Overall Study||24
281937|NCT00302068|687860|P2|STARTED|Overall Study||40
281938|NCT00302068|687861|P1|STARTED|Overall Study||37
281939|NCT00302055|687889|P2|NOT COMPLETED|Overall Study||13
281940|NCT00302055|687890|P1|NOT COMPLETED|Overall Study||9
281941|NCT00302055|687889|P2|COMPLETED|Overall Study||36
281942|NCT00302055|687890|P1|COMPLETED|Overall Study||14
281943|NCT00302055|687889|P2|STARTED|Overall Study||49
281944|NCT00302055|687890|P1|STARTED|Overall Study||23
281945|NCT00302042|687898|P2|NOT COMPLETED|Overall Study||8
281946|NCT00302042|687899|P1|NOT COMPLETED|Overall Study||7
281947|NCT00302042|687898|P2|COMPLETED|Overall Study||38
281948|NCT00302042|687899|P1|COMPLETED|Overall Study||39
281949|NCT00302042|687898|P2|STARTED|Overall Study||46
281950|NCT00302042|687899|P1|STARTED|Overall Study||46
281951|NCT00302003|687905|P1|NOT COMPLETED|Overall Study||80
281952|NCT00302003|687905|P1|COMPLETED|Overall Study||207
281953|NCT00302003|687905|P1|STARTED|Overall Study||287
281954|NCT00301964|687912|P1|NOT COMPLETED|Overall Study||4
281955|NCT00301964|687912|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
281956|NCT00301964|687912|P1|STARTED|Overall Study||56
281957|NCT00301873|687927|P1|NOT COMPLETED|Overall Study||0
281958|NCT00301873|687927|P1|COMPLETED|Overall Study||59
281959|NCT00301873|687927|P1|STARTED|Overall Study||59
281960|NCT00301834|687933|P1|NOT COMPLETED|Overall Study||1
281961|NCT00301834|687933|P1|COMPLETED|Overall Study||34
281962|NCT00301834|687933|P1|STARTED|Overall Study||35
281963|NCT00301821|687942|P1|NOT COMPLETED|Overall Study||26
281964|NCT00301821|687942|P1|COMPLETED|Overall Study||81
281965|NCT00301821|687942|P1|STARTED|Overall Study||107
281966|NCT00301808|687949|P1|NOT COMPLETED|Overall Study||12
281967|NCT00301808|687949|P1|COMPLETED|Overall Study||17
281968|NCT00301808|687949|P1|STARTED|Overall Study||29
281969|NCT00301756|687956|P1|NOT COMPLETED|Overall Study||0
281970|NCT00301756|687956|P1|COMPLETED|Overall Study||32
281971|NCT00301756|687956|P1|STARTED|Overall Study||32
281972|NCT00301418|687965|P1|NOT COMPLETED|Overall Study||0
281973|NCT00301418|687965|P1|COMPLETED|Overall Study||11
281974|NCT00301418|687965|P1|STARTED|Overall Study||11
281975|NCT00301366|687971|P1|NOT COMPLETED|Overall Study||1
281976|NCT00301366|687971|P1|COMPLETED|Overall Study||37
281977|NCT00301366|687971|P1|STARTED|Overall Study||38
281978|NCT00301262|687977|P2|NOT COMPLETED|Open Label Phase (OL)||2
281979|NCT00301262|687978|P1|NOT COMPLETED|Open Label Phase (OL)||4
281980|NCT00301262|687977|P2|COMPLETED|Open Label Phase (OL)||67
281981|NCT00301262|687978|P1|COMPLETED|Open Label Phase (OL)||79
281982|NCT00301262|687977|P2|STARTED|Open Label Phase (OL)||69
281983|NCT00301262|687978|P1|STARTED|Open Label Phase (OL)||83
281984|NCT00301262|687977|P2|NOT COMPLETED|Double Blind Phase (DB)||13
281985|NCT00301262|687978|P1|NOT COMPLETED|Double Blind Phase (DB)||10
281986|NCT00301262|687977|P2|COMPLETED|Double Blind Phase (DB)||69
281987|NCT00301262|687978|P1|COMPLETED|Double Blind Phase (DB)||84
281988|NCT00301262|687977|P2|STARTED|Double Blind Phase (DB)||82
281989|NCT00301262|687978|P1|STARTED|Double Blind Phase (DB)||94
281990|NCT00301080|688136|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281991|NCT00301080|688137|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281992|NCT00301080|688138|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281993|NCT00301080|688139|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281994|NCT00301080|688140|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281995|NCT00301080|688136|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281996|NCT00301080|688137|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281997|NCT00301080|688138|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281998|NCT00301080|688139|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
281999|NCT00301080|688140|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
282000|NCT00301080|688136|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
282001|NCT00301080|688137|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
282002|NCT00301080|688138|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
282003|NCT00301080|688139|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
282004|NCT00301080|688140|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
282005|NCT00301080|688136|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
282006|NCT00301080|688137|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
282007|NCT00301080|688138|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
282008|NCT00301080|688139|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
282009|NCT00301080|688140|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
282010|NCT00301080|688136|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
282011|NCT00301080|688137|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
282012|NCT00301080|688138|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
282013|NCT00301080|688139|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
282014|NCT00301080|688140|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
282015|NCT00301080|688136|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
282016|NCT00301080|688137|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
282017|NCT00301080|688138|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
282018|NCT00301080|688139|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
282019|NCT00301080|688140|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
282020|NCT00301080|688136|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
282021|NCT00301080|688137|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
282022|NCT00301080|688138|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
282023|NCT00301080|688139|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
282024|NCT00301080|688140|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
282025|NCT00301080|688136|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
282026|NCT00301080|688137|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
282027|NCT00301080|688138|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
282028|NCT00301080|688139|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
282029|NCT00301080|688140|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
282030|NCT00301028|688169|P1|NOT COMPLETED|Overall Study||0
282031|NCT00301028|688169|P1|COMPLETED|Overall Study||47
282032|NCT00301028|688169|P1|STARTED|Overall Study||47
282033|NCT00300885|688175|P2|NOT COMPLETED|Follow-up||195
282034|NCT00300885|688176|P1|NOT COMPLETED|Follow-up||178
282035|NCT00300885|688175|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
282036|NCT00300885|688176|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
282037|NCT00300885|688175|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
282038|NCT00300885|688176|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
282039|NCT00300885|688175|P2|NOT COMPLETED|Treatment||374
282040|NCT00300885|688176|P1|NOT COMPLETED|Treatment||373
282041|NCT00300885|688175|P2|COMPLETED|Treatment||88
282042|NCT00300885|688176|P1|COMPLETED|Treatment||91
282043|NCT00300885|688175|P2|Received Treatment|Treatment||459
282044|NCT00300885|688176|P1|Received Treatment|Treatment||463
282045|NCT00300885|688175|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
282046|NCT00300885|688176|P1|STARTED|Treatment||464
282047|NCT00300781|688194|P2|NOT COMPLETED|Overall Study||62
282048|NCT00300781|688195|P1|NOT COMPLETED|Overall Study||63
282049|NCT00300781|688194|P2|COMPLETED|Overall Study||8
282050|NCT00300781|688195|P1|COMPLETED|Overall Study||3
282051|NCT00300781|688194|P2|STARTED|Overall Study||70
282052|NCT00300781|688195|P1|STARTED|Overall Study||66
282053|NCT00300755|688210|P3|NOT COMPLETED|Overall Study||2
282054|NCT00300755|688211|P2|NOT COMPLETED|Overall Study||4
282055|NCT00300755|688212|P1|NOT COMPLETED|Overall Study||1
282056|NCT00300755|688210|P3|COMPLETED|Overall Study||19
282057|NCT00300755|688211|P2|COMPLETED|Overall Study||17
282058|NCT00300755|688212|P1|COMPLETED|Overall Study||17
282059|NCT00300755|688210|P3|STARTED|Overall Study||21
282060|NCT00300755|688211|P2|STARTED|Overall Study||21
282061|NCT00300755|688212|P1|STARTED|Overall Study||18
282062|NCT00300742|688229|P1|NOT COMPLETED|Overall Study||2
282063|NCT00300742|688229|P1|COMPLETED|Overall Study||3
282064|NCT00300742|688229|P1|STARTED|Overall Study||5
282065|NCT00300677|688237|P1|NOT COMPLETED|Overall Study||0
282066|NCT00300677|688237|P1|COMPLETED|Overall Study||12
282067|NCT00300677|688237|P1|STARTED|Overall Study||12
282068|NCT00300495|688246|P2|NOT COMPLETED|Overall Study||1
282069|NCT00300495|688247|P1|NOT COMPLETED|Overall Study||4
282070|NCT00300495|688246|P2|COMPLETED|Overall Study||8
282071|NCT00300495|688247|P1|COMPLETED|Overall Study||6
282072|NCT00300495|688246|P2|STARTED|Overall Study||9
282073|NCT00300495|688247|P1|STARTED|Overall Study||10
282074|NCT00300482|688261|P6|NOT COMPLETED|Overall Study||16
282075|NCT00300482|688262|P5|NOT COMPLETED|Overall Study||23
282076|NCT00300482|688263|P4|NOT COMPLETED|Overall Study||24
282077|NCT00300482|688264|P3|NOT COMPLETED|Overall Study||51
282078|NCT00300482|688265|P2|NOT COMPLETED|Overall Study||41
282079|NCT00300482|688266|P1|NOT COMPLETED|Overall Study||41
282080|NCT00300482|688261|P6|COMPLETED|Overall Study||115
282081|NCT00300482|688262|P5|COMPLETED|Overall Study||243
282082|NCT00300482|688263|P4|COMPLETED|Overall Study||237
282083|NCT00300482|688264|P3|COMPLETED|Overall Study||208
282084|NCT00300482|688265|P2|COMPLETED|Overall Study||220
282085|NCT00300482|688266|P1|COMPLETED|Overall Study||220
282086|NCT00300482|688261|P6|STARTED|Overall Study||131
282087|NCT00300482|688262|P5|STARTED|Overall Study||266
282088|NCT00300482|688263|P4|STARTED|Overall Study||261
282089|NCT00300482|688264|P3|STARTED|Overall Study||259
282090|NCT00300482|688265|P2|STARTED|Overall Study||261
282091|NCT00300482|688266|P1|STARTED|Overall Study|"For all arms, started means treated."|261
282092|NCT00300469|688328|P6|NOT COMPLETED|Overall Study||9
282093|NCT00300469|688329|P5|NOT COMPLETED|Overall Study||14
282094|NCT00300469|688330|P4|NOT COMPLETED|Overall Study||9
282095|NCT00300469|688331|P3|NOT COMPLETED|Overall Study||17
282096|NCT00300469|688332|P2|NOT COMPLETED|Overall Study||21
282097|NCT00300469|688333|P1|NOT COMPLETED|Overall Study||21
282098|NCT00300469|688328|P6|COMPLETED|Overall Study||46
282099|NCT00300469|688329|P5|COMPLETED|Overall Study||95
282100|NCT00300469|688330|P4|COMPLETED|Overall Study||104
282101|NCT00300469|688331|P3|COMPLETED|Overall Study||95
282102|NCT00300469|688332|P2|COMPLETED|Overall Study||89
282103|NCT00300469|688333|P1|COMPLETED|Overall Study||89
282104|NCT00300469|688328|P6|STARTED|Overall Study||55
282105|NCT00300469|688329|P5|STARTED|Overall Study||109
282106|NCT00300469|688330|P4|STARTED|Overall Study||113
282107|NCT00300469|688331|P3|STARTED|Overall Study||112
282108|NCT00300469|688332|P2|STARTED|Overall Study||110
282109|NCT00300469|688333|P1|STARTED|Overall Study|"For all arms, started means treated."|110
282110|NCT00300456|688395|P6|NOT COMPLETED|Overall Study||11
282111|NCT00300456|688396|P5|NOT COMPLETED|Overall Study||17
282112|NCT00300456|688397|P4|NOT COMPLETED|Overall Study||14
282113|NCT00300456|688398|P3|NOT COMPLETED|Overall Study||21
282114|NCT00300456|688399|P2|NOT COMPLETED|Overall Study||16
282115|NCT00300456|688400|P1|NOT COMPLETED|Overall Study||16
282116|NCT00300456|688395|P6|COMPLETED|Overall Study||48
282117|NCT00300456|688396|P5|COMPLETED|Overall Study||99
282118|NCT00300456|688397|P4|COMPLETED|Overall Study||105
282119|NCT00300456|688398|P3|COMPLETED|Overall Study||98
282120|NCT00300456|688399|P2|COMPLETED|Overall Study||102
282121|NCT00300456|688400|P1|COMPLETED|Overall Study||103
282122|NCT00300456|688395|P6|STARTED|Overall Study||59
282123|NCT00300456|688396|P5|STARTED|Overall Study||116
282124|NCT00300456|688397|P4|STARTED|Overall Study||119
282125|NCT00300456|688398|P3|STARTED|Overall Study||119
282126|NCT00300456|688399|P2|STARTED|Overall Study||118
282127|NCT00300456|688400|P1|STARTED|Overall Study|"For all arms, started means treated."|119
282128|NCT00300430|688459|P3|NOT COMPLETED|Overall Study||151
282129|NCT00300430|688460|P2|NOT COMPLETED|Overall Study||169
282130|NCT00300430|688461|P1|NOT COMPLETED|Overall Study||367
282131|NCT00300430|688459|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
282132|NCT00300430|688460|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
282133|NCT00300430|688461|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
282134|NCT00300430|688459|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
282135|NCT00300430|688460|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
282136|NCT00300430|688461|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
282137|NCT00300391|688495|P2|NOT COMPLETED|Overall Study||0
282138|NCT00300391|688496|P1|NOT COMPLETED|Overall Study||0
282139|NCT00300391|688495|P2|COMPLETED|Overall Study||14
282140|NCT00300391|688496|P1|COMPLETED|Overall Study||16
282141|NCT00300391|688495|P2|STARTED|Overall Study||14
282142|NCT00300391|688496|P1|STARTED|Overall Study||16
282143|NCT00300365|688514|P2|NOT COMPLETED|Overall Study||2
282144|NCT00300365|688515|P1|NOT COMPLETED|Overall Study||4
282145|NCT00300365|688514|P2|COMPLETED|Overall Study||38
282146|NCT00300365|688515|P1|COMPLETED|Overall Study||34
282147|NCT00300365|688514|P2|STARTED|Overall Study||40
282148|NCT00300365|688515|P1|STARTED|Overall Study||38
282149|NCT00300274|688524|P3|NOT COMPLETED|Overall Study||45
282150|NCT00300274|688525|P2|NOT COMPLETED|Overall Study||27
282151|NCT00300274|688526|P1|NOT COMPLETED|Overall Study||46
282152|NCT00300274|688524|P3|COMPLETED|Overall Study||226
282153|NCT00300274|688525|P2|COMPLETED|Overall Study||141
282154|NCT00300274|688526|P1|COMPLETED|Overall Study||236
282155|NCT00300274|688524|P3|Completed 12 Month|Overall Study||248
282156|NCT00300274|688525|P2|Completed 12 Month|Overall Study||149
282157|NCT00300274|688526|P1|Completed 12 Month|Overall Study||250
282158|NCT00300274|688524|P3|STARTED|Overall Study||271
282159|NCT00300274|688525|P2|STARTED|Overall Study||168
282160|NCT00300274|688526|P1|STARTED|Overall Study||282
282161|NCT00300235|688566|P5|NOT COMPLETED|Overall Study||0
282162|NCT00300235|688567|P4|NOT COMPLETED|Overall Study||0
282163|NCT00300235|688568|P3|NOT COMPLETED|Overall Study||0
282164|NCT00300235|688569|P2|NOT COMPLETED|Overall Study||0
282165|NCT00300235|688570|P1|NOT COMPLETED|Overall Study||0
282166|NCT00300235|688566|P5|COMPLETED|Overall Study||251
282167|NCT00300235|688567|P4|COMPLETED|Overall Study||362
282168|NCT00300235|688568|P3|COMPLETED|Overall Study||398
282169|NCT00300235|688569|P2|COMPLETED|Overall Study||240
282170|NCT00300235|688570|P1|COMPLETED|Overall Study||208
282171|NCT00300235|688566|P5|STARTED|Overall Study||251
282172|NCT00300235|688567|P4|STARTED|Overall Study||362
282173|NCT00300235|688568|P3|STARTED|Overall Study||398
282174|NCT00300235|688569|P2|STARTED|Overall Study||240
282175|NCT00300235|688570|P1|STARTED|Overall Study||208
282176|NCT00299975|688585|P3|NOT COMPLETED|Overall Study||8
282177|NCT00299975|688586|P2|NOT COMPLETED|Overall Study||1
282178|NCT00299975|688587|P1|NOT COMPLETED|Overall Study||3
282179|NCT00299975|688585|P3|COMPLETED|Overall Study||25
282180|NCT00299975|688586|P2|COMPLETED|Overall Study||31
282181|NCT00299975|688587|P1|COMPLETED|Overall Study||29
282182|NCT00299975|688585|P3|Received Allocated Intervention|Overall Study||32
282183|NCT00299975|688586|P2|Received Allocated Intervention|Overall Study||32
282184|NCT00299975|688587|P1|Received Allocated Intervention|Overall Study||32
282185|NCT00299975|688585|P3|STARTED|Overall Study||33
282186|NCT00299975|688586|P2|STARTED|Overall Study||32
282187|NCT00299975|688587|P1|STARTED|Overall Study||32
282188|NCT00299741|688637|P1|NOT COMPLETED|Overall Study||0
282189|NCT00299741|688637|P1|COMPLETED|Overall Study||36
282190|NCT00299741|688637|P1|STARTED|Overall Study||36
282191|NCT00299702|688644|P2|NOT COMPLETED|Overall Study||50
282192|NCT00299702|688645|P1|NOT COMPLETED|Overall Study||53
282193|NCT00299702|688644|P2|COMPLETED|Overall Study||126
282194|NCT00299702|688645|P1|COMPLETED|Overall Study||126
282195|NCT00299702|688644|P2|STARTED|Overall Study||176
282196|NCT00299702|688645|P1|STARTED|Overall Study||179
282197|NCT00299689|688653|P1|NOT COMPLETED|Overall Study||0
282198|NCT00299689|688653|P1|COMPLETED|Overall Study||69
282199|NCT00299689|688653|P1|STARTED|Overall Study||69
282200|NCT00299546|688660|P3|NOT COMPLETED|Overall Study||86
282201|NCT00299546|688661|P2|NOT COMPLETED|Overall Study||92
282202|NCT00299546|688662|P1|NOT COMPLETED|Overall Study||100
282203|NCT00299546|688660|P3|COMPLETED|Overall Study||67
282204|NCT00299546|688661|P2|COMPLETED|Overall Study||61
282205|NCT00299546|688662|P1|COMPLETED|Overall Study||55
282206|NCT00299546|688660|P3|STARTED|Overall Study||153
282207|NCT00299546|688661|P2|STARTED|Overall Study||153
282208|NCT00299546|688662|P1|STARTED|Overall Study||155
282209|NCT00299494|688693|P6|NOT COMPLETED|Overall Study||26
282210|NCT00299494|688694|P5|NOT COMPLETED|Overall Study||27
282211|NCT00299494|688695|P4|NOT COMPLETED|Overall Study||10
282212|NCT00299494|688696|P3|NOT COMPLETED|Overall Study||4
282213|NCT00299494|688697|P2|NOT COMPLETED|Overall Study||1
282214|NCT00299494|688698|P1|NOT COMPLETED|Overall Study||3
282215|NCT00299494|688693|P6|COMPLETED|Overall Study||4
282216|NCT00299494|688694|P5|COMPLETED|Overall Study||13
282217|NCT00299494|688695|P4|COMPLETED|Overall Study||24
282218|NCT00299494|688696|P3|COMPLETED|Overall Study||3
282219|NCT00299494|688697|P2|COMPLETED|Overall Study||2
282220|NCT00299494|688698|P1|COMPLETED|Overall Study||2
282221|NCT00299494|688693|P6|STARTED|Overall Study||30
282222|NCT00299494|688694|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
282223|NCT00299494|688695|P4|STARTED|Overall Study||34
282224|NCT00299494|688696|P3|STARTED|Overall Study||7
282225|NCT00299494|688697|P2|STARTED|Overall Study||3
282226|NCT00299494|688698|P1|STARTED|Overall Study||5
282227|NCT00299416|688801|P1|NOT COMPLETED|Overall Study||0
282228|NCT00299416|688801|P1|COMPLETED|Overall Study||30
282229|NCT00299416|688801|P1|STARTED|Overall Study||30
282230|NCT00299221|688809|P2|NOT COMPLETED|Overall Study||0
282231|NCT00299221|688810|P1|NOT COMPLETED|Overall Study||0
282232|NCT00299221|688809|P2|COMPLETED|Overall Study||71
282233|NCT00299221|688810|P1|COMPLETED|Overall Study||79
282234|NCT00299221|688809|P2|STARTED|Overall Study||71
282235|NCT00299221|688810|P1|STARTED|Overall Study||79
282236|NCT00299156|688827|P3|NOT COMPLETED|Period 2 (Randomized)||0
282237|NCT00299156|688828|P2|NOT COMPLETED|Period 2 (Randomized)||1
282238|NCT00299156|688829|P1|NOT COMPLETED|Period 2 (Randomized)||0
282239|NCT00299156|688827|P3|COMPLETED|Period 2 (Randomized)||16
282240|NCT00299156|688828|P2|COMPLETED|Period 2 (Randomized)||16
282241|NCT00299156|688829|P1|COMPLETED|Period 2 (Randomized)||0
282242|NCT00299156|688827|P3|STARTED|Period 2 (Randomized)||16
282243|NCT00299156|688828|P2|STARTED|Period 2 (Randomized)||17
282244|NCT00299156|688829|P1|STARTED|Period 2 (Randomized)||0
282245|NCT00299156|688827|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
282246|NCT00299156|688828|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
282247|NCT00299156|688829|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
282248|NCT00299156|688827|P3|COMPLETED|Period 1 (Non-Randomized)||0
282249|NCT00299156|688828|P2|COMPLETED|Period 1 (Non-Randomized)||0
282250|NCT00299156|688829|P1|COMPLETED|Period 1 (Non-Randomized)||32
282251|NCT00299156|688827|P3|STARTED|Period 1 (Non-Randomized)||0
282252|NCT00299156|688828|P2|STARTED|Period 1 (Non-Randomized)||0
282253|NCT00299156|688829|P1|STARTED|Period 1 (Non-Randomized)||32
282254|NCT00299130|688840|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
282255|NCT00299130|688841|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
282256|NCT00299130|688842|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
282257|NCT00299130|688840|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
282258|NCT00299130|688841|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
282259|NCT00299130|688842|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
282260|NCT00299130|688840|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
282261|NCT00299130|688841|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
282262|NCT00299130|688842|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
282263|NCT00299130|688840|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
282264|NCT00299130|688841|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
282265|NCT00299130|688842|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
282266|NCT00299130|688840|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
282267|NCT00299130|688841|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
282268|NCT00299130|688842|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
282269|NCT00299130|688840|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
282270|NCT00299130|688841|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
282271|NCT00299130|688842|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
282272|NCT00299130|688840|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
282273|NCT00299130|688841|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
282274|NCT00299130|688842|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
282275|NCT00299130|688840|P3|COMPLETED|Treatment Period (up to 5 Years)||121
282276|NCT00299130|688841|P2|COMPLETED|Treatment Period (up to 5 Years)||125
282277|NCT00299130|688842|P1|COMPLETED|Treatment Period (up to 5 Years)||119
282278|NCT00299130|688840|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
282279|NCT00299130|688841|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
282280|NCT00299130|688842|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
282281|NCT00299130|688840|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
282282|NCT00299130|688841|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
282283|NCT00299130|688842|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
282284|NCT00299130|688840|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
282285|NCT00299130|688841|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
282286|NCT00299130|688842|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
282287|NCT00299130|688840|P3|Treated|Treatment Period (up to 5 Years)||170
282288|NCT00299130|688841|P2|Treated|Treatment Period (up to 5 Years)||167
282289|NCT00299130|688842|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
282290|NCT00299130|688840|P3|STARTED|Treatment Period (up to 5 Years)||171
282291|NCT00299130|688841|P2|STARTED|Treatment Period (up to 5 Years)||168
282292|NCT00299130|688842|P1|STARTED|Treatment Period (up to 5 Years)||172
282293|NCT00299104|688947|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
282294|NCT00299104|688948|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
282295|NCT00299104|688949|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
282296|NCT00299104|688947|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
282297|NCT00299104|688948|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
282298|NCT00299104|688949|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
282299|NCT00299104|688947|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
282300|NCT00299104|688948|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
282301|NCT00299104|688949|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
282302|NCT00299104|688947|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
282303|NCT00299104|688948|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
282304|NCT00299104|688949|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
282305|NCT00299104|688947|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
282306|NCT00299104|688948|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
282307|NCT00299104|688949|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
282308|NCT00299104|688947|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
282309|NCT00299104|688948|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
282310|NCT00299104|688949|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
282311|NCT00299104|688947|P3|NOT COMPLETED|Treatment Period||172
282312|NCT00299104|688948|P2|NOT COMPLETED|Treatment Period||175
282313|NCT00299104|688949|P1|NOT COMPLETED|Treatment Period||189
282314|NCT00299104|688947|P3|COMPLETED|Treatment Period||80
282315|NCT00299104|688948|P2|COMPLETED|Treatment Period||77
282316|NCT00299104|688949|P1|COMPLETED|Treatment Period|Completed Week 152|62
282317|NCT00299104|688947|P3|Completed Week 104|Treatment Period||216
282318|NCT00299104|688948|P2|Completed Week 104|Treatment Period||213
282319|NCT00299104|688949|P1|Completed Week 104|Treatment Period||178
282320|NCT00299104|688947|P3|Completed Week 52|Treatment Period||232
282321|NCT00299104|688948|P2|Completed Week 52|Treatment Period||227
282322|NCT00299104|688949|P1|Completed Week 52|Treatment Period||213
282323|NCT00299104|688947|P3|Completed Week 24|Treatment Period||241
282324|NCT00299104|688948|P2|Completed Week 24|Treatment Period||240
282325|NCT00299104|688949|P1|Completed Week 24|Treatment Period||227
282326|NCT00299104|688947|P3|Safety/ITT: Received Study Drug|Treatment Period||250
282327|NCT00299104|688948|P2|Safety/ITT: Received Study Drug|Treatment Period||249
282328|NCT00299104|688949|P1|Safety/ITT: Received Study Drug|Treatment Period||249
282329|NCT00299104|688947|P3|STARTED|Treatment Period||252
282330|NCT00299104|688948|P2|STARTED|Treatment Period||252
282331|NCT00299104|688949|P1|STARTED|Treatment Period||251
282332|NCT00299000|689046|P2|NOT COMPLETED|Overall Study||0
282333|NCT00299000|689047|P1|NOT COMPLETED|Overall Study||0
282334|NCT00299000|689046|P2|COMPLETED|Overall Study||2
282335|NCT00299000|689047|P1|COMPLETED|Overall Study||2
282336|NCT00299000|689046|P2|STARTED|Overall Study||2
282337|NCT00299000|689047|P1|STARTED|Overall Study||2
282338|NCT00298766|689059|P1|NOT COMPLETED|Overall Study||46
282339|NCT00298766|689059|P1|COMPLETED|Overall Study||24
282340|NCT00298766|689059|P1|STARTED|Overall Study||70
282341|NCT00298740|689068|P1|NOT COMPLETED|Overall Study||9
282342|NCT00298740|689068|P1|COMPLETED|Overall Study||3
282343|NCT00298740|689068|P1|STARTED|Overall Study||12
282344|NCT00298610|689072|P1|NOT COMPLETED|Overall Study||0
282345|NCT00298610|689072|P1|COMPLETED|Overall Study||30
282346|NCT00298610|689072|P1|STARTED|Overall Study||30
282347|NCT00298558|689086|P4|NOT COMPLETED|10th Annual (A10)||163
282348|NCT00298558|689087|P3|NOT COMPLETED|10th Annual (A10)||171
282349|NCT00298558|689088|P2|NOT COMPLETED|10th Annual (A10)||153
282350|NCT00298558|689089|P1|NOT COMPLETED|10th Annual (A10)||172
282351|NCT00298558|689086|P4|COMPLETED|10th Annual (A10)||285
282352|NCT00298558|689087|P3|COMPLETED|10th Annual (A10)||319
282353|NCT00298558|689088|P2|COMPLETED|10th Annual (A10)||316
282354|NCT00298558|689089|P1|COMPLETED|10th Annual (A10)||300
282355|NCT00298558|689086|P4|STARTED|10th Annual (A10)||448
282356|NCT00298558|689087|P3|STARTED|10th Annual (A10)||490
282357|NCT00298558|689088|P2|STARTED|10th Annual (A10)||469
282358|NCT00298558|689089|P1|STARTED|10th Annual (A10)||472
282359|NCT00298558|689086|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
282360|NCT00298558|689087|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
282361|NCT00298558|689088|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
282362|NCT00298558|689089|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
282363|NCT00298558|689086|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
282364|NCT00298558|689087|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
282365|NCT00298558|689088|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
282366|NCT00298558|689089|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
282367|NCT00298558|689086|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
282368|NCT00298558|689087|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
282369|NCT00298558|689088|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
282370|NCT00298558|689089|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
282371|NCT00298558|689086|P4|NOT COMPLETED|3rd Annual Booster||0
282372|NCT00298558|689087|P3|NOT COMPLETED|3rd Annual Booster||140
282373|NCT00298558|689088|P2|NOT COMPLETED|3rd Annual Booster||128
282374|NCT00298558|689089|P1|NOT COMPLETED|3rd Annual Booster||122
282375|NCT00298558|689086|P4|COMPLETED|3rd Annual Booster||0
282376|NCT00298558|689087|P3|COMPLETED|3rd Annual Booster||230
282377|NCT00298558|689088|P2|COMPLETED|3rd Annual Booster||243
282378|NCT00298558|689089|P1|COMPLETED|3rd Annual Booster||250
282379|NCT00298558|689086|P4|STARTED|3rd Annual Booster||0
282380|NCT00298558|689087|P3|STARTED|3rd Annual Booster||370
282381|NCT00298558|689088|P2|STARTED|3rd Annual Booster||371
282382|NCT00298558|689089|P1|STARTED|3rd Annual Booster||372
282383|NCT00298558|689086|P4|NOT COMPLETED|2nd Annual (A2)||32
282384|NCT00298558|689087|P3|NOT COMPLETED|2nd Annual (A2)||27
282385|NCT00298558|689088|P2|NOT COMPLETED|2nd Annual (A2)||11
282386|NCT00298558|689089|P1|NOT COMPLETED|2nd Annual (A2)||22
282387|NCT00298558|689086|P4|COMPLETED|2nd Annual (A2)||552
282388|NCT00298558|689087|P3|COMPLETED|2nd Annual (A2)||574
282389|NCT00298558|689088|P2|COMPLETED|2nd Annual (A2)||555
282390|NCT00298558|689089|P1|COMPLETED|2nd Annual (A2)||563
282391|NCT00298558|689086|P4|STARTED|2nd Annual (A2)||584
282392|NCT00298558|689087|P3|STARTED|2nd Annual (A2)||601
282393|NCT00298558|689088|P2|STARTED|2nd Annual (A2)||566
282394|NCT00298558|689089|P1|STARTED|2nd Annual (A2)||585
282395|NCT00298558|689086|P4|NOT COMPLETED|1st Annual (A1)||55
282396|NCT00298558|689087|P3|NOT COMPLETED|1st Annual (A1)||52
282397|NCT00298558|689088|P2|NOT COMPLETED|1st Annual (A1)||63
282398|NCT00298558|689089|P1|NOT COMPLETED|1st Annual (A1)||55
282399|NCT00298558|689086|P4|COMPLETED|1st Annual (A1)||584
282400|NCT00298558|689087|P3|COMPLETED|1st Annual (A1)||601
282401|NCT00298558|689088|P2|COMPLETED|1st Annual (A1)||566
282402|NCT00298558|689089|P1|COMPLETED|1st Annual (A1)||585
282403|NCT00298558|689086|P4|STARTED|1st Annual (A1)||639
282404|NCT00298558|689087|P3|STARTED|1st Annual (A1)||653
282405|NCT00298558|689088|P2|STARTED|1st Annual (A1)||629
282406|NCT00298558|689089|P1|STARTED|1st Annual (A1)||640
282407|NCT00298558|689086|P4|NOT COMPLETED|Booster||0
282408|NCT00298558|689087|P3|NOT COMPLETED|Booster||75
282409|NCT00298558|689088|P2|NOT COMPLETED|Booster||70
282410|NCT00298558|689089|P1|NOT COMPLETED|Booster||89
282411|NCT00298558|689086|P4|COMPLETED|Booster||0
282412|NCT00298558|689087|P3|COMPLETED|Booster||295
282413|NCT00298558|689088|P2|COMPLETED|Booster||301
282414|NCT00298558|689089|P1|COMPLETED|Booster||283
282415|NCT00298558|689086|P4|STARTED|Booster||0
282416|NCT00298558|689087|P3|STARTED|Booster||370
282417|NCT00298558|689088|P2|STARTED|Booster||371
282418|NCT00298558|689089|P1|STARTED|Booster||372
282419|NCT00298558|689086|P4|NOT COMPLETED|Immediate Post Test||65
282420|NCT00298558|689087|P3|NOT COMPLETED|Immediate Post Test||59
282421|NCT00298558|689088|P2|NOT COMPLETED|Immediate Post Test||76
282422|NCT00298558|689089|P1|NOT COMPLETED|Immediate Post Test||71
282423|NCT00298558|689086|P4|COMPLETED|Immediate Post Test||639
282424|NCT00298558|689087|P3|COMPLETED|Immediate Post Test||653
282425|NCT00298558|689088|P2|COMPLETED|Immediate Post Test||629
282426|NCT00298558|689089|P1|COMPLETED|Immediate Post Test||640
282427|NCT00298558|689086|P4|STARTED|Immediate Post Test||704
282428|NCT00298558|689087|P3|STARTED|Immediate Post Test||712
282429|NCT00298558|689088|P2|STARTED|Immediate Post Test||705
282430|NCT00298558|689089|P1|STARTED|Immediate Post Test||711
282431|NCT00298558|689086|P4|NOT COMPLETED|Intervention||419
282432|NCT00298558|689087|P3|NOT COMPLETED|Intervention||75
282433|NCT00298558|689088|P2|NOT COMPLETED|Intervention||78
282434|NCT00298558|689089|P1|NOT COMPLETED|Intervention||91
282435|NCT00298558|689086|P4|COMPLETED|Intervention||285
282436|NCT00298558|689087|P3|COMPLETED|Intervention||637
282437|NCT00298558|689088|P2|COMPLETED|Intervention||627
282438|NCT00298558|689089|P1|COMPLETED|Intervention||620
282439|NCT00298558|689086|P4|STARTED|Intervention||704
282440|NCT00298558|689087|P3|STARTED|Intervention||712
282441|NCT00298558|689088|P2|STARTED|Intervention||705
282442|NCT00298558|689089|P1|STARTED|Intervention||711
282443|NCT00298558|689086|P4|NOT COMPLETED|Baseline||0
282444|NCT00298558|689087|P3|NOT COMPLETED|Baseline||0
282445|NCT00298558|689088|P2|NOT COMPLETED|Baseline||0
282446|NCT00298558|689089|P1|NOT COMPLETED|Baseline||0
282447|NCT00298558|689086|P4|COMPLETED|Baseline||704
282448|NCT00298558|689087|P3|COMPLETED|Baseline||712
282449|NCT00298558|689088|P2|COMPLETED|Baseline||705
282450|NCT00298558|689089|P1|COMPLETED|Baseline||711
282451|NCT00298558|689086|P4|STARTED|Baseline||704
282452|NCT00298558|689087|P3|STARTED|Baseline||712
282453|NCT00298558|689088|P2|STARTED|Baseline||705
282454|NCT00298558|689089|P1|STARTED|Baseline||711
282455|NCT00298363|689122|P3|NOT COMPLETED|Overall Study||6
282456|NCT00298363|689123|P2|NOT COMPLETED|Overall Study||8
282457|NCT00298363|689124|P1|NOT COMPLETED|Overall Study||17
282458|NCT00298363|689122|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
282459|NCT00298363|689123|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
282460|NCT00298363|689124|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
282461|NCT00298363|689122|P3|STARTED|Overall Study||22
282462|NCT00298363|689123|P2|STARTED|Overall Study||45
282463|NCT00298363|689124|P1|STARTED|Overall Study||45
282464|NCT00298272|689282|P2|NOT COMPLETED|Safety Follow-up Phase||4
282465|NCT00298272|689283|P1|NOT COMPLETED|Safety Follow-up Phase||4
282466|NCT00298272|689282|P2|COMPLETED|Safety Follow-up Phase||13
282467|NCT00298272|689283|P1|COMPLETED|Safety Follow-up Phase||18
282468|NCT00298272|689282|P2|STARTED|Safety Follow-up Phase||17
282469|NCT00298272|689283|P1|STARTED|Safety Follow-up Phase||22
282470|NCT00298272|689282|P2|NOT COMPLETED|Open Label Retreatment Phase||4
282471|NCT00298272|689283|P1|NOT COMPLETED|Open Label Retreatment Phase||9
282472|NCT00298272|689282|P2|COMPLETED|Open Label Retreatment Phase||12
282473|NCT00298272|689283|P1|COMPLETED|Open Label Retreatment Phase||13
282474|NCT00298272|689282|P2|Completed to Week 56|Open Label Retreatment Phase||12
282475|NCT00298272|689283|P1|Completed to Week 56|Open Label Retreatment Phase||13
282476|NCT00298272|689282|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
282477|NCT00298272|689283|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
282478|NCT00298272|689282|P2|STARTED|Open Label Retreatment Phase||16
282479|NCT00298272|689283|P1|STARTED|Open Label Retreatment Phase||22
282480|NCT00298272|689282|P2|NOT COMPLETED|Double-blind Phase||0
282481|NCT00298272|689283|P1|NOT COMPLETED|Double-blind Phase||8
282482|NCT00298272|689282|P2|COMPLETED|Double-blind Phase||18
282483|NCT00298272|689283|P1|COMPLETED|Double-blind Phase||28
282484|NCT00298272|689282|P2|Completed to Week 56|Double-blind Phase||3
282485|NCT00298272|689283|P1|Completed to Week 56|Double-blind Phase||8
282486|NCT00298272|689282|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
282487|NCT00298272|689283|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
282488|NCT00298272|689282|P2|Safety Population|Double-blind Phase||18
282489|NCT00298272|689283|P1|Safety Population|Double-blind Phase|received treatment|33
282490|NCT00298272|689282|P2|STARTED|Double-blind Phase||18
282491|NCT00298272|689283|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
282492|NCT00298233|689306|P4|NOT COMPLETED|Overall Study||0
282493|NCT00298233|689307|P3|NOT COMPLETED|Overall Study||0
282494|NCT00298233|689308|P2|NOT COMPLETED|Overall Study||0
282495|NCT00298233|689309|P1|NOT COMPLETED|Overall Study||0
282496|NCT00298233|689306|P4|COMPLETED|Overall Study||124
282497|NCT00298233|689307|P3|COMPLETED|Overall Study||122
282498|NCT00298233|689308|P2|COMPLETED|Overall Study||41
282499|NCT00298233|689309|P1|COMPLETED|Overall Study||39
282500|NCT00298233|689306|P4|STARTED|Overall Study||124
282501|NCT00298233|689307|P3|STARTED|Overall Study||122
282502|NCT00298233|689308|P2|STARTED|Overall Study||41
282503|NCT00298233|689309|P1|STARTED|Overall Study||39
282504|NCT00298155|689328|P3|NOT COMPLETED|Overall Study||0
282505|NCT00298155|689329|P2|NOT COMPLETED|Overall Study||0
282506|NCT00298155|689330|P1|NOT COMPLETED|Overall Study||0
282507|NCT00298155|689328|P3|COMPLETED|Overall Study||13
282508|NCT00298155|689329|P2|COMPLETED|Overall Study||10
282509|NCT00298155|689330|P1|COMPLETED|Overall Study||12
282510|NCT00298155|689328|P3|STARTED|Overall Study||13
282511|NCT00298155|689329|P2|STARTED|Overall Study||10
282512|NCT00298155|689330|P1|STARTED|Overall Study||12
282513|NCT00298090|689341|P1|NOT COMPLETED|Overall Study||18
282514|NCT00298090|689341|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
282515|NCT00298090|689341|P1|STARTED|Overall Study||47
282516|NCT00297830|689348|P3|NOT COMPLETED|12 Month Visit||0
282517|NCT00297830|689349|P2|NOT COMPLETED|12 Month Visit||6
282518|NCT00297830|689350|P1|NOT COMPLETED|12 Month Visit||1
282519|NCT00297830|689348|P3|COMPLETED|12 Month Visit||24
282520|NCT00297830|689349|P2|COMPLETED|12 Month Visit||35
282521|NCT00297830|689350|P1|COMPLETED|12 Month Visit||37
282522|NCT00297830|689348|P3|STARTED|12 Month Visit||24
282523|NCT00297830|689349|P2|STARTED|12 Month Visit||41
282524|NCT00297830|689350|P1|STARTED|12 Month Visit||38
282525|NCT00297830|689348|P3|NOT COMPLETED|6 Month Visit||3
282526|NCT00297830|689349|P2|NOT COMPLETED|6 Month Visit||2
282527|NCT00297830|689350|P1|NOT COMPLETED|6 Month Visit||3
282528|NCT00297830|689348|P3|COMPLETED|6 Month Visit||24
282529|NCT00297830|689349|P2|COMPLETED|6 Month Visit||41
282530|NCT00297830|689350|P1|COMPLETED|6 Month Visit||38
282531|NCT00297830|689348|P3|STARTED|6 Month Visit||27
282532|NCT00297830|689349|P2|STARTED|6 Month Visit||43
282533|NCT00297830|689350|P1|STARTED|6 Month Visit||41
282534|NCT00297830|689348|P3|NOT COMPLETED|Baseline||0
282535|NCT00297830|689349|P2|NOT COMPLETED|Baseline||0
282536|NCT00297830|689350|P1|NOT COMPLETED|Baseline||0
282537|NCT00297830|689348|P3|COMPLETED|Baseline||27
282538|NCT00297830|689349|P2|COMPLETED|Baseline||43
282539|NCT00297830|689350|P1|COMPLETED|Baseline||41
282540|NCT00297830|689348|P3|STARTED|Baseline||27
282541|NCT00297830|689349|P2|STARTED|Baseline||43
282542|NCT00297830|689350|P1|STARTED|Baseline||41
282543|NCT00297778|689369|P2|NOT COMPLETED|Overall Study||20
282544|NCT00297778|689370|P1|NOT COMPLETED|Overall Study||19
282545|NCT00297778|689369|P2|COMPLETED|Overall Study||124
282546|NCT00297778|689370|P1|COMPLETED|Overall Study||133
282547|NCT00297778|689369|P2|STARTED|Overall Study||144
282548|NCT00297778|689370|P1|STARTED|Overall Study||152
282549|NCT00297648|689404|P1|NOT COMPLETED|Overall Study||36
282550|NCT00297648|689404|P1|COMPLETED|Overall Study||53
282551|NCT00297648|689404|P1|STARTED|Overall Study||89
282552|NCT00297596|689443|P1|NOT COMPLETED|Overall Study||0
282553|NCT00297596|689443|P1|COMPLETED|Overall Study||25
282554|NCT00297596|689443|P1|STARTED|Overall Study||25
282555|NCT00297492|689450|P3|NOT COMPLETED|6 Month Follow-up||27
282556|NCT00297492|689451|P2|NOT COMPLETED|6 Month Follow-up||49
282557|NCT00297492|689452|P1|NOT COMPLETED|6 Month Follow-up||63
282558|NCT00297492|689450|P3|COMPLETED|6 Month Follow-up||118
282559|NCT00297492|689451|P2|COMPLETED|6 Month Follow-up||237
282560|NCT00297492|689452|P1|COMPLETED|6 Month Follow-up||227
282561|NCT00297492|689450|P3|STARTED|6 Month Follow-up||145
282562|NCT00297492|689451|P2|STARTED|6 Month Follow-up||286
282563|NCT00297492|689452|P1|STARTED|6 Month Follow-up||290
282564|NCT00297492|689450|P3|NOT COMPLETED|Set Quit Date||5
282565|NCT00297492|689451|P2|NOT COMPLETED|Set Quit Date||13
282566|NCT00297492|689452|P1|NOT COMPLETED|Set Quit Date||7
282567|NCT00297492|689450|P3|COMPLETED|Set Quit Date||145
282568|NCT00297492|689451|P2|COMPLETED|Set Quit Date||286
282569|NCT00297492|689452|P1|COMPLETED|Set Quit Date||290
282570|NCT00297492|689450|P3|STARTED|Set Quit Date||150
282571|NCT00297492|689451|P2|STARTED|Set Quit Date||299
282572|NCT00297492|689452|P1|STARTED|Set Quit Date||297
282573|NCT00297427|689462|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
282574|NCT00297427|689463|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
282575|NCT00297427|689462|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
282576|NCT00297427|689463|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
282577|NCT00297427|689462|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
282578|NCT00297427|689463|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
282579|NCT00297427|689462|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
282580|NCT00297427|689463|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
282653|NCT00296816|689608|P1|NOT COMPLETED|Overall Study||74
282581|NCT00297427|689462|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
282582|NCT00297427|689463|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
282583|NCT00297427|689462|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
282584|NCT00297427|689463|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
282585|NCT00297427|689462|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
282586|NCT00297427|689463|P1|STARTED|Phase 2: Optional Crossover for Sham||54
282587|NCT00297427|689462|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
282588|NCT00297427|689463|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
282589|NCT00297427|689462|P2|COMPLETED|Phase 1: Initial Intervention||54
282590|NCT00297427|689463|P1|COMPLETED|Phase 1: Initial Intervention||56
282591|NCT00297427|689462|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
282592|NCT00297427|689463|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
282593|NCT00297258|689504|P1|NOT COMPLETED|Overall Study||142
282594|NCT00297258|689504|P1|COMPLETED|Overall Study||0
282595|NCT00297258|689504|P1|STARTED|Overall Study||142
282596|NCT00297232|689523|P1|NOT COMPLETED|Overall Study||605
282597|NCT00297232|689523|P1|COMPLETED|Overall Study||489
282598|NCT00297232|689523|P1|STARTED|Overall Study||1094
282599|NCT00297167|689529|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
282600|NCT00297167|689530|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
282601|NCT00297167|689531|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
282602|NCT00297167|689529|P3|COMPLETED|Open-label Dose Normalization Period 2||31
282603|NCT00297167|689530|P2|COMPLETED|Open-label Dose Normalization Period 2||0
282604|NCT00297167|689531|P1|COMPLETED|Open-label Dose Normalization Period 2||0
282605|NCT00297167|689529|P3|STARTED|Open-label Dose Normalization Period 2||31
282606|NCT00297167|689530|P2|STARTED|Open-label Dose Normalization Period 2||0
282607|NCT00297167|689531|P1|STARTED|Open-label Dose Normalization Period 2||0
282608|NCT00297167|689529|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
282609|NCT00297167|689530|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
282610|NCT00297167|689531|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
282611|NCT00297167|689529|P3|COMPLETED|Second Double-blind Intervention Period||0
282612|NCT00297167|689530|P2|COMPLETED|Second Double-blind Intervention Period||15
282613|NCT00297167|689531|P1|COMPLETED|Second Double-blind Intervention Period||16
282614|NCT00297167|689529|P3|STARTED|Second Double-blind Intervention Period||0
282615|NCT00297167|689530|P2|STARTED|Second Double-blind Intervention Period||15
282616|NCT00297167|689531|P1|STARTED|Second Double-blind Intervention Period||17
282617|NCT00297167|689529|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
282618|NCT00297167|689530|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
282619|NCT00297167|689531|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
282620|NCT00297167|689529|P3|COMPLETED|Open-label Dose Normalization Period 1||32
282621|NCT00297167|689530|P2|COMPLETED|Open-label Dose Normalization Period 1||0
282622|NCT00297167|689531|P1|COMPLETED|Open-label Dose Normalization Period 1||0
282623|NCT00297167|689529|P3|STARTED|Open-label Dose Normalization Period 1||33
282624|NCT00297167|689530|P2|STARTED|Open-label Dose Normalization Period 1||0
282625|NCT00297167|689531|P1|STARTED|Open-label Dose Normalization Period 1||0
282626|NCT00297167|689529|P3|NOT COMPLETED|First Double-blind Intervention Period||0
282627|NCT00297167|689530|P2|NOT COMPLETED|First Double-blind Intervention Period||0
282628|NCT00297167|689531|P1|NOT COMPLETED|First Double-blind Intervention Period||0
282629|NCT00297167|689529|P3|COMPLETED|First Double-blind Intervention Period||0
282630|NCT00297167|689530|P2|COMPLETED|First Double-blind Intervention Period||16
282631|NCT00297167|689531|P1|COMPLETED|First Double-blind Intervention Period||17
282632|NCT00297167|689529|P3|STARTED|First Double-blind Intervention Period||0
282633|NCT00297167|689530|P2|STARTED|First Double-blind Intervention Period||16
282634|NCT00297167|689531|P1|STARTED|First Double-blind Intervention Period||17
282635|NCT00297115|689557|P2|NOT COMPLETED|Overall Study||246
282636|NCT00297115|689558|P1|NOT COMPLETED|Overall Study||245
282637|NCT00297115|689557|P2|COMPLETED|Overall Study||550
282638|NCT00297115|689558|P1|COMPLETED|Overall Study||527
282639|NCT00297115|689557|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
282640|NCT00297115|689558|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
282641|NCT00297102|689576|P2|NOT COMPLETED|Overall Study||233
282642|NCT00297102|689577|P1|NOT COMPLETED|Overall Study||263
282643|NCT00297102|689576|P2|COMPLETED|Overall Study||525
282644|NCT00297102|689577|P1|COMPLETED|Overall Study||502
282645|NCT00297102|689576|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
282646|NCT00297102|689577|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
282647|NCT00297037|689595|P2|NOT COMPLETED|Overall Study||0
282648|NCT00297037|689596|P1|NOT COMPLETED|Overall Study||2
282649|NCT00297037|689595|P2|COMPLETED|Overall Study||11
282650|NCT00297037|689596|P1|COMPLETED|Overall Study||8
282651|NCT00297037|689595|P2|STARTED|Overall Study||11
282652|NCT00297037|689596|P1|STARTED|Overall Study||10
282654|NCT00296816|689608|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
282655|NCT00296816|689608|P1|STARTED|Overall Study||132
282656|NCT00296647|689625|P5|NOT COMPLETED|Overall Study||20
282657|NCT00296647|689626|P4|NOT COMPLETED|Overall Study||17
282658|NCT00296647|689627|P3|NOT COMPLETED|Overall Study||34
282659|NCT00296647|689628|P2|NOT COMPLETED|Overall Study||28
282660|NCT00296647|689629|P1|NOT COMPLETED|Overall Study||32
282661|NCT00296647|689625|P5|COMPLETED|Overall Study||248
282662|NCT00296647|689626|P4|COMPLETED|Overall Study||262
282663|NCT00296647|689627|P3|COMPLETED|Overall Study||222
282664|NCT00296647|689628|P2|COMPLETED|Overall Study||233
282665|NCT00296647|689629|P1|COMPLETED|Overall Study||250
282666|NCT00296647|689625|P5|STARTED|Overall Study||268
282667|NCT00296647|689626|P4|STARTED|Overall Study||279
282668|NCT00296647|689627|P3|STARTED|Overall Study||256
282669|NCT00296647|689628|P2|STARTED|Overall Study||261
282670|NCT00296647|689629|P1|STARTED|Overall Study||282
282671|NCT00296517|689643|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
282672|NCT00296517|689644|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
282673|NCT00296517|689643|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
282674|NCT00296517|689644|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
282675|NCT00296517|689643|P2|STARTED|Dose Level 3 - Weeks 3-12||161
282676|NCT00296517|689644|P1|STARTED|Dose Level 3 - Weeks 3-12||157
282677|NCT00296517|689643|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
282678|NCT00296517|689644|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
282679|NCT00296517|689643|P2|COMPLETED|Dose Level 2 - Week 2||161
282680|NCT00296517|689644|P1|COMPLETED|Dose Level 2 - Week 2||157
282681|NCT00296517|689643|P2|STARTED|Dose Level 2 - Week 2||166
282682|NCT00296517|689644|P1|STARTED|Dose Level 2 - Week 2||159
282683|NCT00296517|689643|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
282684|NCT00296517|689644|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
282685|NCT00296517|689643|P2|COMPLETED|Dose Level 1 - Week 1||166
282686|NCT00296517|689644|P1|COMPLETED|Dose Level 1 - Week 1||159
282687|NCT00296517|689643|P2|STARTED|Dose Level 1 - Week 1||166
282688|NCT00296517|689644|P1|STARTED|Dose Level 1 - Week 1||159
282689|NCT00296504|689680|P9|NOT COMPLETED|Final Analysis||21
282690|NCT00296504|689681|P8|NOT COMPLETED|Final Analysis||0
282691|NCT00296504|689682|P7|NOT COMPLETED|Final Analysis||0
282692|NCT00296504|689683|P6|NOT COMPLETED|Final Analysis||0
282693|NCT00296504|689684|P5|NOT COMPLETED|Final Analysis||0
282694|NCT00296504|689685|P4|NOT COMPLETED|Final Analysis||0
282695|NCT00296504|689686|P3|NOT COMPLETED|Final Analysis||0
282696|NCT00296504|689687|P2|NOT COMPLETED|Final Analysis||0
282697|NCT00296504|689688|P1|NOT COMPLETED|Final Analysis||0
282698|NCT00296504|689680|P9|COMPLETED|Final Analysis||90
282699|NCT00296504|689681|P8|COMPLETED|Final Analysis||0
282700|NCT00296504|689682|P7|COMPLETED|Final Analysis||0
282701|NCT00296504|689683|P6|COMPLETED|Final Analysis||0
282702|NCT00296504|689684|P5|COMPLETED|Final Analysis||0
282703|NCT00296504|689685|P4|COMPLETED|Final Analysis||0
282704|NCT00296504|689686|P3|COMPLETED|Final Analysis||0
282705|NCT00296504|689687|P2|COMPLETED|Final Analysis||0
282706|NCT00296504|689688|P1|COMPLETED|Final Analysis||0
282707|NCT00296504|689680|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
282708|NCT00296504|689681|P8|STARTED|Final Analysis||0
282709|NCT00296504|689682|P7|STARTED|Final Analysis||0
282710|NCT00296504|689683|P6|STARTED|Final Analysis||0
282711|NCT00296504|689684|P5|STARTED|Final Analysis||0
282712|NCT00296504|689685|P4|STARTED|Final Analysis||0
282713|NCT00296504|689686|P3|STARTED|Final Analysis||0
282714|NCT00296504|689687|P2|STARTED|Final Analysis||0
282715|NCT00296504|689688|P1|STARTED|Final Analysis||0
282716|NCT00296504|689680|P9|NOT COMPLETED|Interim Analysis||0
282717|NCT00296504|689681|P8|NOT COMPLETED|Interim Analysis||49
282718|NCT00296504|689682|P7|NOT COMPLETED|Interim Analysis||74
282719|NCT00296504|689683|P6|NOT COMPLETED|Interim Analysis||37
282720|NCT00296504|689684|P5|NOT COMPLETED|Interim Analysis||37
282721|NCT00296504|689685|P4|NOT COMPLETED|Interim Analysis||43
282722|NCT00296504|689686|P3|NOT COMPLETED|Interim Analysis||105
282723|NCT00296504|689687|P2|NOT COMPLETED|Interim Analysis||18
282724|NCT00296504|689688|P1|NOT COMPLETED|Interim Analysis||76
282725|NCT00296504|689680|P9|COMPLETED|Interim Analysis||0
282726|NCT00296504|689681|P8|COMPLETED|Interim Analysis||37
282727|NCT00296504|689682|P7|COMPLETED|Interim Analysis||30
282728|NCT00296504|689683|P6|COMPLETED|Interim Analysis||41
282729|NCT00296504|689684|P5|COMPLETED|Interim Analysis||36
282730|NCT00296504|689685|P4|COMPLETED|Interim Analysis||11
282731|NCT00296504|689686|P3|COMPLETED|Interim Analysis||116
282732|NCT00296504|689687|P2|COMPLETED|Interim Analysis||0
282733|NCT00296504|689688|P1|COMPLETED|Interim Analysis||43
282734|NCT00296504|689680|P9|Ongoing|Interim Analysis||0
282735|NCT00296504|689681|P8|Ongoing|Interim Analysis||1
282736|NCT00296504|689682|P7|Ongoing|Interim Analysis||30
282737|NCT00296504|689683|P6|Ongoing|Interim Analysis||0
282738|NCT00296504|689684|P5|Ongoing|Interim Analysis||0
282739|NCT00296504|689685|P4|Ongoing|Interim Analysis||22
282740|NCT00296504|689686|P3|Ongoing|Interim Analysis||16
282741|NCT00296504|689687|P2|Ongoing|Interim Analysis||12
282742|NCT00296504|689688|P1|Ongoing|Interim Analysis||32
282743|NCT00296504|689680|P9|STARTED|Interim Analysis||0
282744|NCT00296504|689681|P8|STARTED|Interim Analysis||86
282745|NCT00296504|689682|P7|STARTED|Interim Analysis||104
282746|NCT00296504|689683|P6|STARTED|Interim Analysis||78
282747|NCT00296504|689684|P5|STARTED|Interim Analysis||73
282748|NCT00296504|689685|P4|STARTED|Interim Analysis||54
282749|NCT00296504|689686|P3|STARTED|Interim Analysis||221
282750|NCT00296504|689687|P2|STARTED|Interim Analysis||18
282751|NCT00296504|689688|P1|STARTED|Interim Analysis||119
282752|NCT00296491|689781|P4|NOT COMPLETED|Overall Study||43
282753|NCT00296491|689782|P3|NOT COMPLETED|Overall Study||43
282754|NCT00296491|689783|P2|NOT COMPLETED|Overall Study||53
282755|NCT00296491|689784|P1|NOT COMPLETED|Overall Study||42
282756|NCT00296491|689781|P4|COMPLETED|Overall Study||138
282757|NCT00296491|689782|P3|COMPLETED|Overall Study||137
282758|NCT00296491|689783|P2|COMPLETED|Overall Study||129
282759|NCT00296491|689784|P1|COMPLETED|Overall Study||140
282760|NCT00296491|689781|P4|STARTED|Overall Study||181
282761|NCT00296491|689782|P3|STARTED|Overall Study||180
282762|NCT00296491|689783|P2|STARTED|Overall Study||182
282763|NCT00296491|689784|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
282764|NCT00296400|689813|P3|NOT COMPLETED|Overall Study||13
282765|NCT00296400|689814|P2|NOT COMPLETED|Overall Study||18
282766|NCT00296400|689815|P1|NOT COMPLETED|Overall Study||17
282767|NCT00296400|689813|P3|COMPLETED|Overall Study||67
282768|NCT00296400|689814|P2|COMPLETED|Overall Study||69
282769|NCT00296400|689815|P1|COMPLETED|Overall Study||53
282770|NCT00296400|689813|P3|STARTED|Overall Study||80
282771|NCT00296400|689814|P2|STARTED|Overall Study||87
282772|NCT00296400|689815|P1|STARTED|Overall Study||70
282773|NCT00296374|690039|P3|NOT COMPLETED|Overall Study||29
282774|NCT00296374|690040|P2|NOT COMPLETED|Overall Study||23
282775|NCT00296374|690041|P1|NOT COMPLETED|Overall Study||25
282776|NCT00296374|690039|P3|COMPLETED|Overall Study||82
282777|NCT00296374|690040|P2|COMPLETED|Overall Study||101
282778|NCT00296374|690041|P1|COMPLETED|Overall Study||93
282779|NCT00296374|690039|P3|STARTED|Overall Study||111
282780|NCT00296374|690040|P2|STARTED|Overall Study||124
282781|NCT00296374|690041|P1|STARTED|Overall Study||118
282782|NCT00296335|690264|P2|NOT COMPLETED|Overall Study||122
282783|NCT00296335|690265|P1|NOT COMPLETED|Overall Study||30
282784|NCT00296335|690264|P2|COMPLETED|Overall Study||309
282785|NCT00296335|690265|P1|COMPLETED|Overall Study||394
282786|NCT00296335|690264|P2|STARTED|Overall Study||431
282787|NCT00296335|690265|P1|STARTED|Overall Study||424
282788|NCT00296322|690277|P2|NOT COMPLETED|Overall Study||79
282789|NCT00296322|690278|P1|NOT COMPLETED|Overall Study||21
282790|NCT00296322|690277|P2|COMPLETED|Overall Study||184
282791|NCT00296322|690278|P1|COMPLETED|Overall Study||237
282792|NCT00296322|690277|P2|STARTED|Overall Study||263
282793|NCT00296322|690278|P1|STARTED|Overall Study||258
282794|NCT00296296|690290|P2|NOT COMPLETED|Overall Study||13
282795|NCT00296296|690291|P1|NOT COMPLETED|Overall Study||2
282796|NCT00296296|690290|P2|COMPLETED|Overall Study||5
282797|NCT00296296|690291|P1|COMPLETED|Overall Study||9
282798|NCT00296296|690290|P2|STARTED|Overall Study||18
282799|NCT00296296|690291|P1|STARTED|Overall Study||11
282800|NCT00296244|690305|P2|NOT COMPLETED|Overall Study||1
282801|NCT00296244|690306|P1|NOT COMPLETED|Overall Study||0
282802|NCT00296244|690305|P2|COMPLETED|Overall Study||19
282803|NCT00296244|690306|P1|COMPLETED|Overall Study||20
282804|NCT00296244|690305|P2|STARTED|Overall Study||20
282805|NCT00296244|690306|P1|STARTED|Overall Study||20
282806|NCT00296231|690322|P1|NOT COMPLETED|Overall Study||0
282807|NCT00296231|690322|P1|COMPLETED|Overall Study||14
282808|NCT00296231|690322|P1|STARTED|Overall Study||14
282809|NCT00296192|690332|P5|NOT COMPLETED|Overall Study||0
282810|NCT00296192|690333|P4|NOT COMPLETED|Overall Study||0
282811|NCT00296192|690334|P3|NOT COMPLETED|Overall Study||0
282812|NCT00296192|690335|P2|NOT COMPLETED|Overall Study||0
282813|NCT00296192|690336|P1|NOT COMPLETED|Overall Study||0
282814|NCT00296192|690332|P5|COMPLETED|Overall Study||16
282815|NCT00296192|690333|P4|COMPLETED|Overall Study||17
282816|NCT00296192|690334|P3|COMPLETED|Overall Study||16
282817|NCT00296192|690335|P2|COMPLETED|Overall Study||16
282818|NCT00296192|690336|P1|COMPLETED|Overall Study||17
282819|NCT00296192|690332|P5|STARTED|Overall Study||16
282820|NCT00296192|690333|P4|STARTED|Overall Study||17
282821|NCT00296192|690334|P3|STARTED|Overall Study||16
282822|NCT00296192|690335|P2|STARTED|Overall Study||16
282823|NCT00296192|690336|P1|STARTED|Overall Study||17
282824|NCT00296036|690370|P6|NOT COMPLETED|Overall Study||4
282825|NCT00296036|690371|P5|NOT COMPLETED|Overall Study||2
282826|NCT00296036|690372|P4|NOT COMPLETED|Overall Study||1
282827|NCT00296036|690373|P3|NOT COMPLETED|Overall Study||2
282828|NCT00296036|690374|P2|NOT COMPLETED|Overall Study||0
282829|NCT00296036|690375|P1|NOT COMPLETED|Overall Study||1
282830|NCT00296036|690370|P6|COMPLETED|Overall Study||28
282831|NCT00296036|690371|P5|COMPLETED|Overall Study||31
282832|NCT00296036|690372|P4|COMPLETED|Overall Study||16
282833|NCT00296036|690373|P3|COMPLETED|Overall Study||16
282834|NCT00296036|690374|P2|COMPLETED|Overall Study||18
282835|NCT00296036|690375|P1|COMPLETED|Overall Study||18
282836|NCT00296036|690370|P6|STARTED|Overall Study||32
282837|NCT00296036|690371|P5|STARTED|Overall Study||33
282838|NCT00296036|690372|P4|STARTED|Overall Study||17
282839|NCT00296036|690373|P3|STARTED|Overall Study||18
282840|NCT00296036|690374|P2|STARTED|Overall Study||18
282841|NCT00296036|690375|P1|STARTED|Overall Study||19
282842|NCT00295880|690401|P1|NOT COMPLETED|Overall Study||2
282843|NCT00295880|690401|P1|COMPLETED|Overall Study||10
282844|NCT00295880|690401|P1|STARTED|Overall Study||12
282845|NCT00295854|690415|P3|NOT COMPLETED|Overall Study||15
282846|NCT00295854|690416|P2|NOT COMPLETED|Overall Study||21
282847|NCT00295854|690417|P1|NOT COMPLETED|Overall Study||18
282848|NCT00295854|690415|P3|COMPLETED|Overall Study||87
282849|NCT00295854|690416|P2|COMPLETED|Overall Study||87
282850|NCT00295854|690417|P1|COMPLETED|Overall Study||77
282851|NCT00295854|690415|P3|ITT Population (N=296)|Overall Study||99
282852|NCT00295854|690416|P2|ITT Population (N=296)|Overall Study||105
282853|NCT00295854|690417|P1|ITT Population (N=296)|Overall Study||92
282854|NCT00295854|690415|P3|Safety Population (N=304)|Overall Study||101
282855|NCT00295854|690416|P2|Safety Population (N=304)|Overall Study||108
282856|NCT00295854|690417|P1|Safety Population (N=304)|Overall Study||95
282857|NCT00295854|690415|P3|STARTED|Overall Study||102
282858|NCT00295854|690416|P2|STARTED|Overall Study||108
282859|NCT00295854|690417|P1|STARTED|Overall Study||95
282860|NCT00295750|690431|P3|NOT COMPLETED|Overall Study||32
282861|NCT00295750|690432|P2|NOT COMPLETED|Overall Study||41
282862|NCT00295750|690433|P1|NOT COMPLETED|Overall Study||43
282863|NCT00295750|690431|P3|COMPLETED|Overall Study||172
282864|NCT00295750|690432|P2|COMPLETED|Overall Study||169
282865|NCT00295750|690433|P1|COMPLETED|Overall Study||163
282866|NCT00295750|690431|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
282867|NCT00295750|690432|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
282868|NCT00295750|690433|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
282869|NCT00295750|690431|P3|STARTED|Overall Study|randomized|204
282870|NCT00295750|690432|P2|STARTED|Overall Study|randomized|210
282871|NCT00295750|690433|P1|STARTED|Overall Study|randomized|206
282872|NCT00295633|690468|P3|NOT COMPLETED|Overall Study||76
282873|NCT00295633|690469|P2|NOT COMPLETED|Overall Study||67
282874|NCT00295633|690470|P1|NOT COMPLETED|Overall Study||62
282875|NCT00295633|690468|P3|COMPLETED|Overall Study||108
282876|NCT00295633|690469|P2|COMPLETED|Overall Study||119
282877|NCT00295633|690470|P1|COMPLETED|Overall Study||133
282878|NCT00295633|690468|P3|Completed Study Without Being Rescued|Overall Study||51
282879|NCT00295633|690469|P2|Completed Study Without Being Rescued|Overall Study||82
282880|NCT00295633|690470|P1|Completed Study Without Being Rescued|Overall Study||88
282881|NCT00295633|690468|P3|STARTED|Overall Study||184
282882|NCT00295633|690469|P2|STARTED|Overall Study||186
282883|NCT00295633|690470|P1|STARTED|Overall Study||195
282884|NCT00295503|690487|P1|NOT COMPLETED|Overall Study||0
282885|NCT00295503|690487|P1|COMPLETED|Overall Study||53
282886|NCT00295503|690487|P1|STARTED|Overall Study||53
282887|NCT00295490|690497|P4|NOT COMPLETED|Overall Study||5
282888|NCT00295490|690498|P3|NOT COMPLETED|Overall Study||4
282889|NCT00295490|690499|P2|NOT COMPLETED|Overall Study||4
282890|NCT00295490|690500|P1|NOT COMPLETED|Overall Study||1
282891|NCT00295490|690497|P4|COMPLETED|Overall Study||12
282892|NCT00295490|690498|P3|COMPLETED|Overall Study||12
282893|NCT00295490|690499|P2|COMPLETED|Overall Study||15
282894|NCT00295490|690500|P1|COMPLETED|Overall Study||14
282895|NCT00295490|690497|P4|STARTED|Overall Study||17
282896|NCT00295490|690498|P3|STARTED|Overall Study||16
282897|NCT00295490|690499|P2|STARTED|Overall Study||19
282898|NCT00295490|690500|P1|STARTED|Overall Study||15
282899|NCT00295061|690540|P2|NOT COMPLETED|Overall Study||0
282900|NCT00295061|690541|P1|NOT COMPLETED|Overall Study||0
282901|NCT00295061|690540|P2|COMPLETED|Overall Study||12
282902|NCT00295061|690541|P1|COMPLETED|Overall Study||12
282903|NCT00295061|690540|P2|STARTED|Overall Study||12
282904|NCT00295061|690541|P1|STARTED|Overall Study||12
282905|NCT00295009|690553|P6|NOT COMPLETED|Overall Study||269
282906|NCT00295009|690554|P5|NOT COMPLETED|Overall Study||58
282907|NCT00295009|690555|P4|NOT COMPLETED|Overall Study||25
282908|NCT00295009|690556|P3|NOT COMPLETED|Overall Study||12
282909|NCT00295009|690557|P2|NOT COMPLETED|Overall Study||49
282910|NCT00295009|690558|P1|NOT COMPLETED|Overall Study||41
282911|NCT00295009|690553|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
282912|NCT00295009|690554|P5|COMPLETED|Overall Study|Completed 60 month visit|116
282913|NCT00295009|690555|P4|COMPLETED|Overall Study|Completed 60 month visit|57
282914|NCT00295009|690556|P3|COMPLETED|Overall Study|Completed 60 month visit|39
282915|NCT00295009|690557|P2|COMPLETED|Overall Study|Completed 60 month visit|134
282916|NCT00295009|690558|P1|COMPLETED|Overall Study|Completed 60 month visit|52
282917|NCT00295009|690553|P6|Completed 24 Month Analysis|Overall Study||198
282918|NCT00295009|690554|P5|Completed 24 Month Analysis|Overall Study||133
282919|NCT00295009|690555|P4|Completed 24 Month Analysis|Overall Study||60
282920|NCT00295009|690556|P3|Completed 24 Month Analysis|Overall Study||45
282921|NCT00295009|690557|P2|Completed 24 Month Analysis|Overall Study||148
282922|NCT00295009|690558|P1|Completed 24 Month Analysis|Overall Study||71
282923|NCT00295009|690553|P6|Treated|Overall Study||259
282924|NCT00295009|690554|P5|Treated|Overall Study||165
282925|NCT00295009|690555|P4|Treated|Overall Study||72
282926|NCT00295009|690556|P3|Treated|Overall Study||50
282927|NCT00295009|690557|P2|Treated|Overall Study||162
282928|NCT00295009|690558|P1|Treated|Overall Study||80
282929|NCT00295009|690553|P6|STARTED|Overall Study||269
282930|NCT00295009|690554|P5|STARTED|Overall Study||174
282931|NCT00295009|690555|P4|STARTED|Overall Study||82
282932|NCT00295009|690556|P3|STARTED|Overall Study||51
282933|NCT00295009|690557|P2|STARTED|Overall Study||183
282934|NCT00295009|690558|P1|STARTED|Overall Study||93
282935|NCT00294762|690580|P2|NOT COMPLETED|Overall Study||3
282936|NCT00294762|690581|P1|NOT COMPLETED|Overall Study||3
282937|NCT00294762|690580|P2|COMPLETED|Overall Study||68
282938|NCT00294762|690581|P1|COMPLETED|Overall Study||69
282939|NCT00294762|690580|P2|STARTED|Overall Study||71
282940|NCT00294762|690581|P1|STARTED|Overall Study||72
282941|NCT00294723|690600|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
282942|NCT00294723|690601|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
282943|NCT00294723|690602|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
282944|NCT00294723|690600|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
282945|NCT00294723|690601|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
282946|NCT00294723|690602|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
282947|NCT00294723|690600|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
282948|NCT00294723|690601|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
282949|NCT00294723|690602|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
282950|NCT00294723|690600|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
282951|NCT00294723|690601|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
282952|NCT00294723|690602|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
282953|NCT00294723|690600|P3|COMPLETED|Open-Label Extension 52 Weeks||97
282954|NCT00294723|690601|P2|COMPLETED|Open-Label Extension 52 Weeks||110
282955|NCT00294723|690602|P1|COMPLETED|Open-Label Extension 52 Weeks||114
282956|NCT00294723|690600|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
282957|NCT00294723|690601|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
282958|NCT00294723|690602|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
282959|NCT00294723|690600|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
282960|NCT00294723|690601|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
282961|NCT00294723|690602|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
282962|NCT00294723|690600|P3|COMPLETED|Double-Blind Period 52 Weeks||152
282963|NCT00294723|690601|P2|COMPLETED|Double-Blind Period 52 Weeks||162
282964|NCT00294723|690602|P1|COMPLETED|Double-Blind Period 52 Weeks||173
282965|NCT00294723|690600|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
282966|NCT00294723|690601|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
282967|NCT00294723|690602|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
282968|NCT00294723|690600|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
282969|NCT00294723|690601|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
282970|NCT00294723|690602|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
282971|NCT00294684|690663|P2|NOT COMPLETED|Overall Study||8
282972|NCT00294684|690664|P1|NOT COMPLETED|Overall Study||5
282973|NCT00294684|690663|P2|COMPLETED|Overall Study||62
282974|NCT00294684|690664|P1|COMPLETED|Overall Study||65
282975|NCT00294684|690663|P2|STARTED|Overall Study||70
282976|NCT00294684|690664|P1|STARTED|Overall Study||70
282977|NCT00294671|690704|P2|NOT COMPLETED|Overall Study||40
282978|NCT00294671|690705|P1|NOT COMPLETED|Overall Study||27
282979|NCT00294671|690704|P2|COMPLETED|Overall Study||26
282980|NCT00294671|690705|P1|COMPLETED|Overall Study||37
282981|NCT00294671|690704|P2|STARTED|Overall Study||66
282982|NCT00294671|690705|P1|STARTED|Overall Study||64
282983|NCT00294658|690721|P2|NOT COMPLETED|Overall Study||9
282984|NCT00294658|690722|P1|NOT COMPLETED|Overall Study||6
282985|NCT00294658|690721|P2|COMPLETED|Overall Study||51
282986|NCT00294658|690722|P1|COMPLETED|Overall Study||60
282987|NCT00294658|690721|P2|STARTED|Overall Study||60
282988|NCT00294658|690722|P1|STARTED|Overall Study||66
282989|NCT00294645|690786|P2|NOT COMPLETED|Overall Study||92
282990|NCT00294645|690787|P1|NOT COMPLETED|Overall Study||48
282991|NCT00294645|690786|P2|COMPLETED|Overall Study||510
282992|NCT00294645|690787|P1|COMPLETED|Overall Study||247
282993|NCT00294645|690786|P2|STARTED|Overall Study||602
282994|NCT00294645|690787|P1|STARTED|Overall Study||295
282995|NCT00294554|690821|P2|NOT COMPLETED|Overall Study||2
282996|NCT00294554|690822|P1|NOT COMPLETED|Overall Study||0
282997|NCT00294554|690821|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
282998|NCT00294554|690822|P1|COMPLETED|Overall Study||10
282999|NCT00294554|690821|P2|STARTED|Overall Study||10
283000|NCT00294554|690822|P1|STARTED|Overall Study||10
283001|NCT00294515|690832|P2|NOT COMPLETED|Overall Study||28
283002|NCT00294515|690833|P1|NOT COMPLETED|Overall Study||34
283003|NCT00294515|690832|P2|COMPLETED|Overall Study||132
283004|NCT00294515|690833|P1|COMPLETED|Overall Study||132
283005|NCT00294515|690832|P2|STARTED|Overall Study|Randomized|160
283006|NCT00294515|690833|P1|STARTED|Overall Study|Randomized|166
283007|NCT00294398|690849|P2|NOT COMPLETED|Overall Study||26
283008|NCT00294398|690850|P1|NOT COMPLETED|Overall Study||21
283009|NCT00294398|690849|P2|COMPLETED|Overall Study||48
283010|NCT00294398|690850|P1|COMPLETED|Overall Study||57
283011|NCT00294398|690849|P2|STARTED|Overall Study||74
283012|NCT00294398|690850|P1|STARTED|Overall Study||78
283013|NCT00294060|690858|P1|NOT COMPLETED|Overall Study||1173
283014|NCT00294060|690858|P1|COMPLETED|Overall Study||840
283015|NCT00294060|690858|P1|STARTED|Overall Study||2013
283016|NCT00294047|690866|P2|NOT COMPLETED|Month 84||989
283017|NCT00294047|690867|P1|NOT COMPLETED|Month 84||973
283018|NCT00294047|690866|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
283019|NCT00294047|690867|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
283020|NCT00294047|690866|P2|STARTED|Month 84||2870
283021|NCT00294047|690867|P1|STARTED|Month 84||2877
283022|NCT00294047|690866|P2|NOT COMPLETED|Month 48||433
283023|NCT00294047|690867|P1|NOT COMPLETED|Month 48||425
283024|NCT00294047|690866|P2|COMPLETED|Month 48||2438
283025|NCT00294047|690867|P1|COMPLETED|Month 48||2456
283026|NCT00294047|690866|P2|Participated up to Month 48|Month 48||2281
283027|NCT00294047|690867|P1|Participated up to Month 48|Month 48||2305
283028|NCT00294047|690866|P2|STARTED|Month 48||2871
283029|NCT00294047|690867|P1|STARTED|Month 48||2881
283030|NCT00293813|690972|P3|NOT COMPLETED|Overall Study||8
283031|NCT00293813|690973|P2|NOT COMPLETED|Overall Study||9
283032|NCT00293813|690974|P1|NOT COMPLETED|Overall Study||13
283033|NCT00293813|690972|P3|COMPLETED|Overall Study||74
283034|NCT00293813|690973|P2|COMPLETED|Overall Study||74
283035|NCT00293813|690974|P1|COMPLETED|Overall Study||69
283036|NCT00293813|690972|P3|STARTED|Overall Study||82
283037|NCT00293813|690973|P2|STARTED|Overall Study||83
283038|NCT00293813|690974|P1|STARTED|Overall Study||82
283039|NCT00293722|690985|P1|NOT COMPLETED|Overall Study||427
283040|NCT00293722|690985|P1|COMPLETED|Overall Study||864
283041|NCT00293722|690985|P1|STARTED|Overall Study||1291
283042|NCT00293709|690999|P1|NOT COMPLETED|Overall Study||47
283043|NCT00293709|690999|P1|COMPLETED|Overall Study||102
283044|NCT00293709|690999|P1|STARTED|Overall Study||149
283045|NCT00293579|691013|P1|NOT COMPLETED|Overall Study||1
283046|NCT00293579|691013|P1|COMPLETED|Overall Study||4
283047|NCT00293579|691013|P1|STARTED|Overall Study||5
283048|NCT00293540|691022|P2|NOT COMPLETED|Overall Study||8
283049|NCT00293540|691023|P1|NOT COMPLETED|Overall Study||7
283050|NCT00293540|691022|P2|COMPLETED|Overall Study||119
283051|NCT00293540|691023|P1|COMPLETED|Overall Study||115
283052|NCT00293540|691022|P2|STARTED|Overall Study||127
283053|NCT00293540|691023|P1|STARTED|Overall Study||122
283054|NCT00293462|691032|P3|NOT COMPLETED|Overall Study||10
283055|NCT00293462|691033|P2|NOT COMPLETED|Overall Study||8
283056|NCT00293462|691034|P1|NOT COMPLETED|Overall Study||7
283057|NCT00293462|691032|P3|COMPLETED|Overall Study||21
283058|NCT00293462|691033|P2|COMPLETED|Overall Study||21
283059|NCT00293462|691034|P1|COMPLETED|Overall Study||24
283060|NCT00293462|691032|P3|STARTED|Overall Study||31
283061|NCT00293462|691033|P2|STARTED|Overall Study||29
283062|NCT00293462|691034|P1|STARTED|Overall Study||31
283063|NCT00293384|691053|P1|NOT COMPLETED|Overall Study||5
283064|NCT00293384|691053|P1|COMPLETED|Overall Study||35
283065|NCT00293384|691053|P1|STARTED|Overall Study||40
283066|NCT00293293|691062|P2|NOT COMPLETED|Overall Study||2
283067|NCT00293293|691063|P1|NOT COMPLETED|Overall Study||2
283068|NCT00293293|691062|P2|COMPLETED|Overall Study||21
283069|NCT00293293|691063|P1|COMPLETED|Overall Study||18
283070|NCT00293293|691062|P2|STARTED|Overall Study||23
283071|NCT00293293|691063|P1|STARTED|Overall Study||20
283072|NCT00293267|691091|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
283073|NCT00293267|691092|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
283074|NCT00293267|691091|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
283075|NCT00293267|691092|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
283076|NCT00293267|691091|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
283077|NCT00293267|691092|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
283078|NCT00293267|691091|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
283079|NCT00293267|691092|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
283080|NCT00293267|691091|P2|COMPLETED|Extension - Open-Label Week 157-240||26
283081|NCT00293267|691092|P1|COMPLETED|Extension - Open-Label Week 157-240||111
283082|NCT00293267|691091|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
283083|NCT00293267|691092|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
283084|NCT00293267|691091|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
283085|NCT00293267|691092|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
283086|NCT00293267|691091|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
283087|NCT00293267|691092|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
283088|NCT00293267|691091|P2|STARTED|Extension - Double-Blind Week 49-156||50
283089|NCT00293267|691092|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
283090|NCT00293267|691091|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
283091|NCT00293267|691092|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
283092|NCT00293267|691091|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
283093|NCT00293267|691092|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
283094|NCT00293267|691091|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
283170|NCT00292370|691374|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
283095|NCT00293267|691092|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
283096|NCT00293267|691091|P2|Treated|Primary Study - Double-Blind Week 0-48||118
283097|NCT00293267|691092|P1|Treated|Primary Study - Double-Blind Week 0-48||232
283098|NCT00293267|691091|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
283099|NCT00293267|691092|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
283100|NCT00293254|691132|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
283101|NCT00293254|691133|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
283102|NCT00293254|691132|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
283103|NCT00293254|691133|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
283104|NCT00293254|691132|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
283105|NCT00293254|691133|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
283106|NCT00293254|691132|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
283107|NCT00293254|691133|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
283108|NCT00293254|691132|P2|COMPLETED|Extension - Open-Label Week 157-240||18
283109|NCT00293254|691133|P1|COMPLETED|Extension - Open-Label Week 157-240||110
283110|NCT00293254|691132|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
283111|NCT00293254|691133|P1|STARTED|Extension - Open-Label Week 157-240||120
283112|NCT00293254|691132|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
283113|NCT00293254|691133|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
283114|NCT00293254|691132|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
283115|NCT00293254|691133|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
283116|NCT00293254|691132|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
283117|NCT00293254|691133|P1|STARTED|Extension - Double-Blind Week 49-156||177
283118|NCT00293254|691132|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
283119|NCT00293254|691133|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
283120|NCT00293254|691132|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
283121|NCT00293254|691133|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
283122|NCT00293254|691132|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
283123|NCT00293254|691133|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
283124|NCT00293254|691132|P2|Treated|Primary Study - Double-Blind Week 0-48||119
283125|NCT00293254|691133|P1|Treated|Primary Study - Double-Blind Week 0-48||230
283126|NCT00293254|691132|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
283127|NCT00293254|691133|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
283128|NCT00293241|691173|P2|NOT COMPLETED|Overall Study||41
283129|NCT00293241|691174|P1|NOT COMPLETED|Overall Study||36
283130|NCT00293241|691173|P2|COMPLETED|Overall Study||265
283131|NCT00293241|691174|P1|COMPLETED|Overall Study||263
283132|NCT00293241|691173|P2|STARTED|Overall Study||306
283133|NCT00293241|691174|P1|STARTED|Overall Study||299
283134|NCT00293059|691218|P2|NOT COMPLETED|Overall Study||19
283135|NCT00293059|691219|P1|NOT COMPLETED|Overall Study||35
283136|NCT00293059|691218|P2|COMPLETED|Overall Study||51
283137|NCT00293059|691219|P1|COMPLETED|Overall Study||85
283138|NCT00293059|691218|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
283139|NCT00293059|691219|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
283140|NCT00293059|691218|P2|Cycle 3/Treatment Day 84|Overall Study||55
283141|NCT00293059|691219|P1|Cycle 3/Treatment Day 84|Overall Study||100
283142|NCT00293059|691218|P2|Cycle 1/Treatment Day 28|Overall Study||64
283143|NCT00293059|691219|P1|Cycle 1/Treatment Day 28|Overall Study||115
283144|NCT00293059|691218|P2|Subjects Received Treatment|Overall Study||66
283145|NCT00293059|691219|P1|Subjects Received Treatment|Overall Study||119
283146|NCT00293059|691218|P2|STARTED|Overall Study||70
283147|NCT00293059|691219|P1|STARTED|Overall Study||120
283148|NCT00293020|691331|P1|NOT COMPLETED|Overall Study||162
283149|NCT00293020|691331|P1|COMPLETED|Overall Study||82
283150|NCT00293020|691331|P1|STARTED|Overall Study||244
283151|NCT00292981|691335|P1|NOT COMPLETED|Overall Study||39
283152|NCT00292981|691335|P1|COMPLETED|Overall Study||18
283153|NCT00292981|691335|P1|STARTED|Overall Study||57
283154|NCT00292591|691345|P3|NOT COMPLETED|Overall Study||58
283155|NCT00292591|691346|P2|NOT COMPLETED|Overall Study||56
283156|NCT00292591|691347|P1|NOT COMPLETED|Overall Study||64
283157|NCT00292591|691345|P3|COMPLETED|Overall Study||110
283158|NCT00292591|691346|P2|COMPLETED|Overall Study||111
283159|NCT00292591|691347|P1|COMPLETED|Overall Study||102
283160|NCT00292591|691345|P3|STARTED|Overall Study||168
283161|NCT00292591|691346|P2|STARTED|Overall Study||167
283162|NCT00292591|691347|P1|STARTED|Overall Study||166
283163|NCT00292461|691357|P2|NOT COMPLETED|Overall Study||6
283164|NCT00292461|691358|P1|NOT COMPLETED|Overall Study||10
283165|NCT00292461|691357|P2|COMPLETED|Overall Study||24
283166|NCT00292461|691358|P1|COMPLETED|Overall Study||24
283167|NCT00292461|691357|P2|STARTED|Overall Study||30
283168|NCT00292461|691358|P1|STARTED|Overall Study||34
283169|NCT00292370|691373|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
283258|NCT00291876|691559|P1|STARTED|Month 210||124
283171|NCT00292370|691375|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
283172|NCT00292370|691373|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
283173|NCT00292370|691374|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
283174|NCT00292370|691375|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
283175|NCT00292370|691373|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
283176|NCT00292370|691374|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
283177|NCT00292370|691375|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
283178|NCT00292370|691373|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
283179|NCT00292370|691374|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
283180|NCT00292370|691375|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
283181|NCT00292370|691373|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
283182|NCT00292370|691374|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
283183|NCT00292370|691375|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
283184|NCT00292370|691373|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
283185|NCT00292370|691374|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
283186|NCT00292370|691375|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
283187|NCT00292318|691384|P2|NOT COMPLETED|Overall Study||1
283188|NCT00292318|691385|P1|NOT COMPLETED|Overall Study||2
283189|NCT00292318|691384|P2|COMPLETED|Overall Study||2
283190|NCT00292318|691385|P1|COMPLETED|Overall Study||2
283191|NCT00292318|691384|P2|STARTED|Overall Study||3
283192|NCT00292318|691385|P1|STARTED|Overall Study||4
283193|NCT00292227|691395|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
283194|NCT00292227|691396|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
283195|NCT00292227|691397|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
283196|NCT00292227|691395|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
283197|NCT00292227|691396|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
283198|NCT00292227|691397|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
283199|NCT00292227|691395|P3|STARTED|Cross-over Period 2 (Day 39)||30
283200|NCT00292227|691396|P2|STARTED|Cross-over Period 2 (Day 39)||31
283201|NCT00292227|691397|P1|STARTED|Cross-over Period 2 (Day 39)||65
283202|NCT00292227|691395|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
283203|NCT00292227|691396|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
283204|NCT00292227|691397|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
283205|NCT00292227|691395|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
283206|NCT00292227|691396|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
283207|NCT00292227|691397|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
283208|NCT00292227|691395|P3|STARTED|Cross-over Period 1 (Day 32)||30
283209|NCT00292227|691396|P2|STARTED|Cross-over Period 1 (Day 32)||31
283210|NCT00292227|691397|P1|STARTED|Cross-over Period 1 (Day 32)||65
283211|NCT00292227|691395|P3|NOT COMPLETED|Patch Period||3
283212|NCT00292227|691396|P2|NOT COMPLETED|Patch Period||0
283213|NCT00292227|691397|P1|NOT COMPLETED|Patch Period||1
283214|NCT00292227|691395|P3|COMPLETED|Patch Period||30
283215|NCT00292227|691396|P2|COMPLETED|Patch Period||31
283216|NCT00292227|691397|P1|COMPLETED|Patch Period||65
283217|NCT00292227|691395|P3|STARTED|Patch Period||33
283218|NCT00292227|691396|P2|STARTED|Patch Period||31
283219|NCT00292227|691397|P1|STARTED|Patch Period||66
283220|NCT00292188|691479|P3|NOT COMPLETED|Double-Blind||29
283221|NCT00292188|691480|P2|NOT COMPLETED|Double-Blind||31
283222|NCT00292188|691481|P1|NOT COMPLETED|Double-Blind||0
283223|NCT00292188|691479|P3|COMPLETED|Double-Blind||98
283224|NCT00292188|691480|P2|COMPLETED|Double-Blind||96
283225|NCT00292188|691481|P1|COMPLETED|Double-Blind||0
283226|NCT00292188|691479|P3|STARTED|Double-Blind||127
283227|NCT00292188|691480|P2|STARTED|Double-Blind||127
283228|NCT00292188|691481|P1|STARTED|Double-Blind||0
283229|NCT00292188|691479|P3|NOT COMPLETED|Single-Blind||0
283230|NCT00292188|691480|P2|NOT COMPLETED|Single-Blind||0
283231|NCT00292188|691481|P1|NOT COMPLETED|Single-Blind||114
283232|NCT00292188|691479|P3|COMPLETED|Single-Blind||0
283233|NCT00292188|691480|P2|COMPLETED|Single-Blind||0
283234|NCT00292188|691481|P1|COMPLETED|Single-Blind||254
283235|NCT00292188|691479|P3|Received Treatment|Single-Blind||0
283236|NCT00292188|691480|P2|Received Treatment|Single-Blind||0
283237|NCT00292188|691481|P1|Received Treatment|Single-Blind||367
283238|NCT00292188|691479|P3|STARTED|Single-Blind||0
283239|NCT00292188|691480|P2|STARTED|Single-Blind||0
283240|NCT00292188|691481|P1|STARTED|Single-Blind||368
283241|NCT00292162|691542|P2|NOT COMPLETED|Overall Study||2
283242|NCT00292162|691543|P1|NOT COMPLETED|Overall Study||1
283243|NCT00292162|691542|P2|COMPLETED|Overall Study||20
283244|NCT00292162|691543|P1|COMPLETED|Overall Study||18
283245|NCT00292162|691542|P2|STARTED|Overall Study||22
283246|NCT00292162|691543|P1|STARTED|Overall Study||19
283247|NCT00291876|691559|P1|NOT COMPLETED|Month 246||0
283248|NCT00291876|691559|P1|COMPLETED|Month 246||116
283249|NCT00291876|691559|P1|STARTED|Month 246||116
283250|NCT00291876|691559|P1|NOT COMPLETED|Month 234||0
283251|NCT00291876|691559|P1|COMPLETED|Month 234||110
283252|NCT00291876|691559|P1|STARTED|Month 234||110
283253|NCT00291876|691559|P1|NOT COMPLETED|Month 222||0
283254|NCT00291876|691559|P1|COMPLETED|Month 222||114
283255|NCT00291876|691559|P1|STARTED|Month 222||114
283256|NCT00291876|691559|P1|NOT COMPLETED|Month 210||0
283257|NCT00291876|691559|P1|COMPLETED|Month 210||124
283259|NCT00291876|691559|P1|NOT COMPLETED|Month 198||0
283260|NCT00291876|691559|P1|COMPLETED|Month 198||135
283261|NCT00291876|691559|P1|STARTED|Month 198||135
283262|NCT00291876|691559|P1|NOT COMPLETED|Month 186||0
283263|NCT00291876|691559|P1|COMPLETED|Month 186||129
283264|NCT00291876|691559|P1|STARTED|Month 186||129
283265|NCT00291876|691559|P1|NOT COMPLETED|Month 174||0
283266|NCT00291876|691559|P1|COMPLETED|Month 174||127
283267|NCT00291876|691559|P1|STARTED|Month 174||127
283268|NCT00291876|691559|P1|NOT COMPLETED|Month 162||0
283269|NCT00291876|691559|P1|COMPLETED|Month 162||127
283270|NCT00291876|691559|P1|STARTED|Month 162||127
283271|NCT00291876|691559|P1|NOT COMPLETED|Month 150||0
283272|NCT00291876|691559|P1|COMPLETED|Month 150||117
283273|NCT00291876|691559|P1|STARTED|Month 150||117
283274|NCT00291876|691559|P1|NOT COMPLETED|Month 138||0
283275|NCT00291876|691559|P1|COMPLETED|Month 138||107
283276|NCT00291876|691559|P1|STARTED|Month 138||107
283277|NCT00291694|691573|P2|NOT COMPLETED|Overall Study||5
283278|NCT00291694|691574|P1|NOT COMPLETED|Overall Study||3
283279|NCT00291694|691573|P2|COMPLETED|Overall Study||43
283280|NCT00291694|691574|P1|COMPLETED|Overall Study||21
283281|NCT00291694|691573|P2|STARTED|Overall Study||48
283282|NCT00291694|691574|P1|STARTED|Overall Study||24
283283|NCT00291655|691588|P1|NOT COMPLETED|Overall Study||15
283284|NCT00291655|691588|P1|COMPLETED|Overall Study||115
283285|NCT00291655|691588|P1|STARTED|Overall Study||130
283286|NCT00291577|691593|P1|NOT COMPLETED|Overall Study||21
283287|NCT00291577|691593|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
283288|NCT00291577|691593|P1|STARTED|Overall Study||22
283289|NCT00291551|691612|P1|NOT COMPLETED|Overall Study||13
283290|NCT00291551|691612|P1|COMPLETED|Overall Study||26
283291|NCT00291551|691612|P1|STARTED|Overall Study||39
283292|NCT00291343|691629|P2|NOT COMPLETED|Overall Study||0
283293|NCT00291343|691630|P1|NOT COMPLETED|Overall Study||0
283294|NCT00291343|691629|P2|COMPLETED|Overall Study||93
283295|NCT00291343|691630|P1|COMPLETED|Overall Study||203
283296|NCT00291343|691629|P2|STARTED|Overall Study||93
283297|NCT00291343|691630|P1|STARTED|Overall Study||203
283298|NCT00291330|691660|P2|NOT COMPLETED|Overall Study||97
283299|NCT00291330|691661|P1|NOT COMPLETED|Overall Study||101
283300|NCT00291330|691660|P2|COMPLETED|Overall Study|Completed planned observation time|1169
283301|NCT00291330|691661|P1|COMPLETED|Overall Study|Completed planned observation time|1172
283302|NCT00291330|691660|P2|STARTED|Overall Study|Started Treatment|1266
283303|NCT00291330|691661|P1|STARTED|Overall Study|Started Treatment|1273
283304|NCT00291317|691683|P1|NOT COMPLETED|Overall Study||0
283305|NCT00291317|691683|P1|COMPLETED|Overall Study||6
283306|NCT00291317|691683|P1|STARTED|Overall Study||6
283307|NCT00291226|691690|P2|NOT COMPLETED|Overall Study||1
283308|NCT00291226|691691|P1|NOT COMPLETED|Overall Study||1
283309|NCT00291226|691690|P2|COMPLETED|Overall Study||3
283310|NCT00291226|691691|P1|COMPLETED|Overall Study||3
283311|NCT00291226|691690|P2|STARTED|Overall Study||4
283312|NCT00291226|691691|P1|STARTED|Overall Study||4
283313|NCT00291187|691703|P4|NOT COMPLETED|Overall Study||0
283314|NCT00291187|691704|P3|NOT COMPLETED|Overall Study||1
283315|NCT00291187|691705|P2|NOT COMPLETED|Overall Study||0
283316|NCT00291187|691706|P1|NOT COMPLETED|Overall Study||0
283317|NCT00291187|691703|P4|COMPLETED|Overall Study||106
283318|NCT00291187|691704|P3|COMPLETED|Overall Study||102
283319|NCT00291187|691705|P2|COMPLETED|Overall Study||100
283320|NCT00291187|691706|P1|COMPLETED|Overall Study||103
283321|NCT00291187|691703|P4|STARTED|Overall Study||106
283322|NCT00291187|691704|P3|STARTED|Overall Study||103
283323|NCT00291187|691705|P2|STARTED|Overall Study||100
283324|NCT00291187|691706|P1|STARTED|Overall Study||103
283325|NCT00291161|691732|P4|NOT COMPLETED|Overall Study||65
283326|NCT00291161|691733|P3|NOT COMPLETED|Overall Study||93
283327|NCT00291161|691734|P2|NOT COMPLETED|Overall Study||58
283328|NCT00291161|691735|P1|NOT COMPLETED|Overall Study||81
283329|NCT00291161|691732|P4|COMPLETED|Overall Study||122
283330|NCT00291161|691733|P3|COMPLETED|Overall Study||206
283331|NCT00291161|691734|P2|COMPLETED|Overall Study||134
283332|NCT00291161|691735|P1|COMPLETED|Overall Study||235
283333|NCT00291161|691732|P4|STARTED|Overall Study||187
283334|NCT00291161|691733|P3|STARTED|Overall Study||299
283335|NCT00291161|691734|P2|STARTED|Overall Study||192
283336|NCT00291161|691735|P1|STARTED|Overall Study||316
283337|NCT00291135|691743|P1|NOT COMPLETED|Overall Study||0
283338|NCT00291135|691743|P1|COMPLETED|Overall Study||42
283339|NCT00291135|691743|P1|STARTED|Overall Study||42
283340|NCT00291018|691750|P3|NOT COMPLETED|Overall Study||43
283341|NCT00291018|691751|P2|NOT COMPLETED|Overall Study||42
283342|NCT00291018|691752|P1|NOT COMPLETED|Overall Study||25
283343|NCT00291018|691750|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
283344|NCT00291018|691751|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
283345|NCT00291018|691752|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
283346|NCT00291018|691750|P3|Evaluated at 24 Months|Overall Study||105
283347|NCT00291018|691751|P2|Evaluated at 24 Months|Overall Study||92
283348|NCT00291018|691752|P1|Evaluated at 24 Months|Overall Study||99
283349|NCT00291018|691750|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
283350|NCT00291018|691751|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
283351|NCT00291018|691752|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
283352|NCT00290888|691792|P2|NOT COMPLETED|Overall Study||1
283353|NCT00290888|691793|P1|NOT COMPLETED|Overall Study||3
283354|NCT00290888|691792|P2|COMPLETED|Overall Study||44
283355|NCT00290888|691793|P1|COMPLETED|Overall Study||38
283356|NCT00290888|691792|P2|STARTED|Overall Study||45
283357|NCT00290888|691793|P1|STARTED|Overall Study||41
283358|NCT00290810|691801|P1|NOT COMPLETED|Overall Study||0
283359|NCT00290810|691801|P1|COMPLETED|Overall Study||12
283360|NCT00290810|691801|P1|STARTED|Overall Study||12
283361|NCT00290771|691810|P2|NOT COMPLETED|Overall Study||97
283362|NCT00290771|691811|P1|NOT COMPLETED|Overall Study||127
283363|NCT00290771|691810|P2|COMPLETED|Overall Study||3
283364|NCT00290771|691811|P1|COMPLETED|Overall Study||4
283365|NCT00290771|691810|P2|STARTED|Overall Study||100
283366|NCT00290771|691811|P1|STARTED|Overall Study||131
283367|NCT00290758|691835|P2|NOT COMPLETED|Post Intervention rFNA||5
283368|NCT00290758|691836|P1|NOT COMPLETED|Post Intervention rFNA||6
283369|NCT00290758|691835|P2|COMPLETED|Post Intervention rFNA||49
283370|NCT00290758|691836|P1|COMPLETED|Post Intervention rFNA||49
283371|NCT00290758|691835|P2|STARTED|Post Intervention rFNA||54
283372|NCT00290758|691836|P1|STARTED|Post Intervention rFNA||55
283373|NCT00290758|691835|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
283374|NCT00290758|691836|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
283375|NCT00290758|691835|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
283376|NCT00290758|691836|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
283377|NCT00290758|691835|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
283378|NCT00290758|691836|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
283379|NCT00290758|691835|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
283380|NCT00290758|691836|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
283381|NCT00290758|691835|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
283382|NCT00290758|691836|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
283383|NCT00290758|691835|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
283384|NCT00290758|691836|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
283385|NCT00290758|691835|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
283386|NCT00290758|691836|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
283387|NCT00290732|691858|P5|NOT COMPLETED|Overall Study||0
283388|NCT00290732|691859|P4|NOT COMPLETED|Overall Study||0
283389|NCT00290732|691860|P3|NOT COMPLETED|Overall Study||1
283390|NCT00290732|691861|P2|NOT COMPLETED|Overall Study||1
283391|NCT00290732|691862|P1|NOT COMPLETED|Overall Study||0
283392|NCT00290732|691858|P5|COMPLETED|Overall Study||3
283393|NCT00290732|691859|P4|COMPLETED|Overall Study||6
283394|NCT00290732|691860|P3|COMPLETED|Overall Study||3
283395|NCT00290732|691861|P2|COMPLETED|Overall Study||3
283396|NCT00290732|691862|P1|COMPLETED|Overall Study||3
283397|NCT00290732|691858|P5|STARTED|Overall Study||3
283398|NCT00290732|691859|P4|STARTED|Overall Study||6
283399|NCT00290732|691860|P3|STARTED|Overall Study||4
283400|NCT00290732|691861|P2|STARTED|Overall Study||4
283401|NCT00290732|691862|P1|STARTED|Overall Study||3
283402|NCT00290693|691880|P1|NOT COMPLETED|Overall Study||2
283403|NCT00290693|691880|P1|COMPLETED|Overall Study||43
283404|NCT00290693|691880|P1|STARTED|Overall Study||45
283405|NCT00290654|691888|P1|NOT COMPLETED|Overall Study||0
283406|NCT00290654|691888|P1|COMPLETED|Overall Study||41
283407|NCT00290654|691888|P1|STARTED|Overall Study||41
283408|NCT00290615|691899|P1|NOT COMPLETED|Overall Study||0
283409|NCT00290615|691899|P1|COMPLETED|Overall Study||30
283410|NCT00290615|691899|P1|STARTED|Overall Study||30
283411|NCT00290537|691906|P2|NOT COMPLETED|Overall Study||0
283412|NCT00290537|691907|P1|NOT COMPLETED|Overall Study||0
283413|NCT00290537|691906|P2|COMPLETED|Overall Study||0
283414|NCT00290537|691907|P1|COMPLETED|Overall Study||4
283415|NCT00290537|691906|P2|STARTED|Overall Study||0
283416|NCT00290537|691907|P1|STARTED|Overall Study||4
283417|NCT00290472|691915|P3|NOT COMPLETED|Overall Study||0
283418|NCT00290472|691916|P2|NOT COMPLETED|Overall Study||0
283419|NCT00290472|691917|P1|NOT COMPLETED|Overall Study||0
283420|NCT00290472|691915|P3|COMPLETED|Overall Study||18
283421|NCT00290472|691916|P2|COMPLETED|Overall Study||39
283422|NCT00290472|691917|P1|COMPLETED|Overall Study||32
283423|NCT00290472|691915|P3|STARTED|Overall Study||18
283424|NCT00290472|691916|P2|STARTED|Overall Study||39
283425|NCT00290472|691917|P1|STARTED|Overall Study||32
283426|NCT00290407|691929|P1|NOT COMPLETED|Overall Study||2
283427|NCT00290407|691929|P1|COMPLETED|Overall Study||0
283428|NCT00290407|691929|P1|STARTED|Overall Study||2
283429|NCT00290329|691937|P3|NOT COMPLETED|Overall Study||0
283430|NCT00290329|691938|P2|NOT COMPLETED|Overall Study||0
283431|NCT00290329|691939|P1|NOT COMPLETED|Overall Study||0
283432|NCT00290329|691937|P3|COMPLETED|Overall Study||61
283433|NCT00290329|691938|P2|COMPLETED|Overall Study||86
283434|NCT00290329|691939|P1|COMPLETED|Overall Study||102
283435|NCT00290329|691937|P3|STARTED|Overall Study||61
283436|NCT00290329|691938|P2|STARTED|Overall Study||86
283437|NCT00290329|691939|P1|STARTED|Overall Study||102
283438|NCT00290290|691961|P2|NOT COMPLETED|Overall Study||18
283439|NCT00290290|691962|P1|NOT COMPLETED|Overall Study||18
283440|NCT00290290|691961|P2|COMPLETED|Overall Study||391
283441|NCT00290290|691962|P1|COMPLETED|Overall Study||422
283442|NCT00290290|691961|P2|STARTED|Overall Study||409
283443|NCT00290290|691962|P1|STARTED|Overall Study||440
283444|NCT00290251|691968|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
283445|NCT00290251|691969|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
283446|NCT00290251|691970|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
283447|NCT00290251|691968|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
283448|NCT00290251|691969|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
283449|NCT00290251|691970|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
283450|NCT00290251|691968|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
283451|NCT00290251|691969|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
283452|NCT00290251|691970|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
283453|NCT00290251|691968|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
283454|NCT00290251|691969|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
283455|NCT00290251|691970|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
283456|NCT00290251|691968|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
283457|NCT00290251|691969|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
283458|NCT00290251|691970|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
283459|NCT00290251|691968|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
283460|NCT00290251|691969|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
283461|NCT00290251|691970|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
283462|NCT00290251|691968|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
283463|NCT00290251|691969|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
283464|NCT00290251|691970|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
283465|NCT00290251|691968|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
283466|NCT00290251|691969|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
283467|NCT00290251|691970|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
283468|NCT00290251|691968|P3|STARTED|Treatment 1 (Months 1 - 3)||14
283469|NCT00290251|691969|P2|STARTED|Treatment 1 (Months 1 - 3)||14
283470|NCT00290251|691970|P1|STARTED|Treatment 1 (Months 1 - 3)||14
283471|NCT00290238|691982|P2|NOT COMPLETED|Overall Study||41
283472|NCT00290238|691983|P1|NOT COMPLETED|Overall Study||42
283473|NCT00290238|691982|P2|COMPLETED|Overall Study||24
283474|NCT00290238|691983|P1|COMPLETED|Overall Study||15
283475|NCT00290238|691982|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
283476|NCT00290238|691983|P1|STARTED|Overall Study||57
283477|NCT00290199|691993|P2|NOT COMPLETED|Overall Study||0
283478|NCT00290199|691994|P1|NOT COMPLETED|Overall Study||0
283479|NCT00290199|691993|P2|COMPLETED|Overall Study||82
283480|NCT00290199|691994|P1|COMPLETED|Overall Study||87
283481|NCT00290199|691993|P2|STARTED|Overall Study||82
283482|NCT00290199|691994|P1|STARTED|Overall Study||87
283483|NCT00290186|692008|P2|NOT COMPLETED|Overall Study||5
283484|NCT00290186|692009|P1|NOT COMPLETED|Overall Study||5
283485|NCT00290186|692008|P2|COMPLETED|Overall Study||19
283486|NCT00290186|692009|P1|COMPLETED|Overall Study||20
283487|NCT00290186|692008|P2|Completed 6-month Followup Assessments|Overall Study||19
283488|NCT00290186|692009|P1|Completed 6-month Followup Assessments|Overall Study||20
283489|NCT00290186|692008|P2|Completed 3-month Followup Assessments|Overall Study||21
283490|NCT00290186|692009|P1|Completed 3-month Followup Assessments|Overall Study||20
283491|NCT00290186|692008|P2|Completed Post-treatment Assessments|Overall Study||22
283492|NCT00290186|692009|P1|Completed Post-treatment Assessments|Overall Study||24
283493|NCT00290186|692008|P2|Completed 8 Weeks of Treatment|Overall Study||22
283494|NCT00290186|692009|P1|Completed 8 Weeks of Treatment|Overall Study||24
283495|NCT00290186|692008|P2|Completed Baseline Assessments|Overall Study||24
283496|NCT00290186|692009|P1|Completed Baseline Assessments|Overall Study||25
283497|NCT00290186|692008|P2|STARTED|Overall Study||24
283498|NCT00290186|692009|P1|STARTED|Overall Study||25
283499|NCT00290147|692049|P2|NOT COMPLETED|Overall Study||0
283500|NCT00290147|692050|P1|NOT COMPLETED|Overall Study||0
283501|NCT00290147|692049|P2|COMPLETED|Overall Study||12
283502|NCT00290147|692050|P1|COMPLETED|Overall Study||10
283503|NCT00290147|692049|P2|STARTED|Overall Study||12
283504|NCT00290147|692050|P1|STARTED|Overall Study||10
283505|NCT00289991|692060|P2|NOT COMPLETED|Overall Study||80
283506|NCT00289991|692061|P1|NOT COMPLETED|Overall Study||58
283507|NCT00289991|692060|P2|COMPLETED|Overall Study||175
283508|NCT00289991|692061|P1|COMPLETED|Overall Study||176
283509|NCT00289991|692060|P2|STARTED|Overall Study||255
283510|NCT00289991|692061|P1|STARTED|Overall Study||234
283511|NCT00289978|692086|P3|NOT COMPLETED|Overall Study||86
283512|NCT00289978|692087|P2|NOT COMPLETED|Overall Study||56
283513|NCT00289978|692088|P1|NOT COMPLETED|Overall Study||97
283514|NCT00289978|692086|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
283515|NCT00289978|692087|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
283516|NCT00289978|692088|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
283517|NCT00289978|692086|P3|STARTED|Overall Study||418
283518|NCT00289978|692087|P2|STARTED|Overall Study||425
283519|NCT00289978|692088|P1|STARTED|Overall Study||429
283520|NCT00289913|692107|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
283521|NCT00289913|692108|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
283522|NCT00289913|692109|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
283523|NCT00289913|692110|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
283524|NCT00289913|692111|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
283525|NCT00289913|692107|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
283526|NCT00289913|692108|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
283527|NCT00289913|692109|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
283528|NCT00289913|692110|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
283529|NCT00289913|692111|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
283530|NCT00289913|692107|P5|STARTED|Visit 4 (Stage I and Stage II)||597
283531|NCT00289913|692108|P4|STARTED|Visit 4 (Stage I and Stage II)||131
283532|NCT00289913|692109|P3|STARTED|Visit 4 (Stage I and Stage II)||138
283533|NCT00289913|692110|P2|STARTED|Visit 4 (Stage I and Stage II)||106
283534|NCT00289913|692111|P1|STARTED|Visit 4 (Stage I and Stage II)||122
283535|NCT00289913|692107|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
283536|NCT00289913|692108|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
283537|NCT00289913|692109|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
283538|NCT00289913|692110|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
283539|NCT00289913|692111|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
283540|NCT00289913|692107|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
283541|NCT00289913|692108|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
283542|NCT00289913|692109|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
283543|NCT00289913|692110|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
283544|NCT00289913|692111|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
283545|NCT00289913|692107|P5|STARTED|Visit 3 (Stage I and Stage II)||605
283546|NCT00289913|692108|P4|STARTED|Visit 3 (Stage I and Stage II)||135
283547|NCT00289913|692109|P3|STARTED|Visit 3 (Stage I and Stage II)||140
283548|NCT00289913|692110|P2|STARTED|Visit 3 (Stage I and Stage II)||114
283549|NCT00289913|692111|P1|STARTED|Visit 3 (Stage I and Stage II)||131
283550|NCT00289913|692107|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
283551|NCT00289913|692108|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
283552|NCT00289913|692109|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
283553|NCT00289913|692110|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
283554|NCT00289913|692111|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
283555|NCT00289913|692107|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
283556|NCT00289913|692108|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
283557|NCT00289913|692109|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
283558|NCT00289913|692110|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
283559|NCT00289913|692111|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
283560|NCT00289913|692107|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
283561|NCT00289913|692108|P4|STARTED|Visit 2 (Stage I and Stage II)||141
283562|NCT00289913|692109|P3|STARTED|Visit 2 (Stage I and Stage II)||150
283563|NCT00289913|692110|P2|STARTED|Visit 2 (Stage I and Stage II)||135
283564|NCT00289913|692111|P1|STARTED|Visit 2 (Stage I and Stage II)||146
283565|NCT00289913|692107|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
283566|NCT00289913|692108|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
283567|NCT00289913|692109|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
283568|NCT00289913|692110|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
283569|NCT00289913|692111|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
283570|NCT00289913|692107|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
283571|NCT00289913|692108|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
283572|NCT00289913|692109|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
283573|NCT00289913|692110|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
283574|NCT00289913|692111|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
283575|NCT00289913|692107|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
283576|NCT00289913|692108|P4|STARTED|Visit 1 (Stage I and Stage II)||152
283577|NCT00289913|692109|P3|STARTED|Visit 1 (Stage I and Stage II)||159
283578|NCT00289913|692110|P2|STARTED|Visit 1 (Stage I and Stage II)||151
283579|NCT00289913|692111|P1|STARTED|Visit 1 (Stage I and Stage II)||155
283580|NCT00289900|692142|P6|NOT COMPLETED|Overall Study||61
283581|NCT00289900|692143|P5|NOT COMPLETED|Overall Study||45
283582|NCT00289900|692144|P4|NOT COMPLETED|Overall Study||59
283583|NCT00289900|692145|P3|NOT COMPLETED|Overall Study||33
283584|NCT00289900|692146|P2|NOT COMPLETED|Overall Study||120
283585|NCT00289900|692147|P1|NOT COMPLETED|Overall Study||68
283586|NCT00289900|692142|P6|COMPLETED|Overall Study||372
283587|NCT00289900|692143|P5|COMPLETED|Overall Study||392
283588|NCT00289900|692144|P4|COMPLETED|Overall Study||380
283589|NCT00289900|692145|P3|COMPLETED|Overall Study||265
283590|NCT00289900|692146|P2|COMPLETED|Overall Study||316
283591|NCT00289900|692147|P1|COMPLETED|Overall Study||229
283592|NCT00289900|692142|P6|Treated|Overall Study||433
283593|NCT00289900|692143|P5|Treated|Overall Study||437
283594|NCT00289900|692144|P4|Treated|Overall Study||439
283595|NCT00289900|692145|P3|Treated|Overall Study||298
283596|NCT00289900|692146|P2|Treated|Overall Study||435
283597|NCT00289900|692147|P1|Treated|Overall Study||297
283598|NCT00289900|692142|P6|STARTED|Overall Study||433
283599|NCT00289900|692143|P5|STARTED|Overall Study||437
283600|NCT00289900|692144|P4|STARTED|Overall Study||439
283601|NCT00289900|692145|P3|STARTED|Overall Study||298
283602|NCT00289900|692146|P2|STARTED|Overall Study||436
283603|NCT00289900|692147|P1|STARTED|Overall Study||297
283604|NCT00289887|692251|P2|NOT COMPLETED|Overall Study||29
283605|NCT00289887|692252|P1|NOT COMPLETED|Overall Study||22
283606|NCT00289887|692251|P2|COMPLETED|Overall Study||105
283607|NCT00289887|692252|P1|COMPLETED|Overall Study||105
283608|NCT00289887|692251|P2|STARTED|Overall Study||134
283609|NCT00289887|692252|P1|STARTED|Overall Study||127
283610|NCT00289874|692270|P2|NOT COMPLETED|Overall Study||8
283611|NCT00289874|692271|P1|NOT COMPLETED|Overall Study||6
283612|NCT00289874|692270|P2|COMPLETED|Overall Study||210
283613|NCT00289874|692271|P1|COMPLETED|Overall Study||197
283614|NCT00289874|692270|P2|STARTED|Overall Study||218
283615|NCT00289874|692271|P1|STARTED|Overall Study||203
283616|NCT00289848|692281|P2|NOT COMPLETED|Overall Study||45
283617|NCT00289848|692282|P1|NOT COMPLETED|Overall Study||46
283618|NCT00289848|692281|P2|COMPLETED|Overall Study||133
283619|NCT00289848|692282|P1|COMPLETED|Overall Study||306
283620|NCT00289848|692281|P2|STARTED|Overall Study||178
283621|NCT00289848|692282|P1|STARTED|Overall Study||352
283622|NCT00289783|692294|P2|NOT COMPLETED|Fourth Dose Phase||24
283623|NCT00289783|692295|P1|NOT COMPLETED|Fourth Dose Phase||87
283624|NCT00289783|692294|P2|COMPLETED|Fourth Dose Phase||899
283625|NCT00289783|692295|P1|COMPLETED|Fourth Dose Phase||2682
283626|NCT00289783|692294|P2|STARTED|Fourth Dose Phase||923
283627|NCT00289783|692295|P1|STARTED|Fourth Dose Phase||2769
283628|NCT00289783|692294|P2|NOT COMPLETED|Primary Phase||83
283629|NCT00289783|692295|P1|NOT COMPLETED|Primary Phase||248
283630|NCT00289783|692294|P2|COMPLETED|Primary Phase||961
283631|NCT00289783|692295|P1|COMPLETED|Primary Phase||2888
283632|NCT00289783|692294|P2|STARTED|Primary Phase||1044
283633|NCT00289783|692295|P1|STARTED|Primary Phase||3136
283634|NCT00289770|692473|P1|NOT COMPLETED|Year 15||1
283635|NCT00289770|692473|P1|COMPLETED|Year 15||49
283636|NCT00289770|692473|P1|STARTED|Year 15||50
283637|NCT00289770|692473|P1|NOT COMPLETED|Year 14||0
283638|NCT00289770|692473|P1|COMPLETED|Year 14||43
283639|NCT00289770|692473|P1|STARTED|Year 14||43
283640|NCT00289770|692473|P1|NOT COMPLETED|Year 13||0
283641|NCT00289770|692473|P1|COMPLETED|Year 13||37
283642|NCT00289770|692473|P1|STARTED|Year 13||37
283643|NCT00289770|692473|P1|NOT COMPLETED|Year 12||0
283644|NCT00289770|692473|P1|COMPLETED|Year 12||40
283645|NCT00289770|692473|P1|STARTED|Year 12||40
283646|NCT00289770|692473|P1|NOT COMPLETED|Year 11||0
283647|NCT00289770|692473|P1|COMPLETED|Year 11||37
283648|NCT00289770|692473|P1|STARTED|Year 11||37
283649|NCT00289757|692485|P1|NOT COMPLETED|Overall Study||0
283650|NCT00289757|692485|P1|COMPLETED|Overall Study||78
283651|NCT00289757|692485|P1|STARTED|Overall Study||78
283652|NCT00289744|692496|P3|NOT COMPLETED|Additional Dose Phase||0
283653|NCT00289744|692497|P2|NOT COMPLETED|Additional Dose Phase||0
283654|NCT00289744|692498|P1|NOT COMPLETED|Additional Dose Phase||0
283655|NCT00289744|692496|P3|COMPLETED|Additional Dose Phase||6
283656|NCT00289744|692497|P2|COMPLETED|Additional Dose Phase||19
283657|NCT00289744|692498|P1|COMPLETED|Additional Dose Phase||0
283658|NCT00289744|692496|P3|STARTED|Additional Dose Phase||6
283659|NCT00289744|692497|P2|STARTED|Additional Dose Phase||19
283660|NCT00289744|692498|P1|STARTED|Additional Dose Phase||0
283661|NCT00289744|692496|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
283662|NCT00289744|692497|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
283663|NCT00289744|692498|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
283664|NCT00289744|692496|P3|COMPLETED|Year 10 Long-term Follow-up||0
283665|NCT00289744|692497|P2|COMPLETED|Year 10 Long-term Follow-up||0
283666|NCT00289744|692498|P1|COMPLETED|Year 10 Long-term Follow-up||171
283667|NCT00289744|692496|P3|STARTED|Year 10 Long-term Follow-up||0
283668|NCT00289744|692497|P2|STARTED|Year 10 Long-term Follow-up||0
283669|NCT00289744|692498|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
283670|NCT00289744|692496|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
283671|NCT00289744|692497|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
283672|NCT00289744|692498|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
283673|NCT00289744|692496|P3|COMPLETED|Year 9 Long-term Follow-up||0
283674|NCT00289744|692497|P2|COMPLETED|Year 9 Long-term Follow-up||0
283675|NCT00289744|692498|P1|COMPLETED|Year 9 Long-term Follow-up||173
283676|NCT00289744|692496|P3|STARTED|Year 9 Long-term Follow-up||0
283677|NCT00289744|692497|P2|STARTED|Year 9 Long-term Follow-up||0
283678|NCT00289744|692498|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
283679|NCT00289744|692496|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
283680|NCT00289744|692497|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
283681|NCT00289744|692498|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
283682|NCT00289744|692496|P3|COMPLETED|Year 8 Long-term Follow-up||0
283683|NCT00289744|692497|P2|COMPLETED|Year 8 Long-term Follow-up||0
283684|NCT00289744|692498|P1|COMPLETED|Year 8 Long-term Follow-up||174
283685|NCT00289744|692496|P3|STARTED|Year 8 Long-term Follow-up||0
283686|NCT00289744|692497|P2|STARTED|Year 8 Long-term Follow-up||0
283687|NCT00289744|692498|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
283688|NCT00289744|692496|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
283689|NCT00289744|692497|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
283690|NCT00289744|692498|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
283691|NCT00289744|692496|P3|COMPLETED|Year 7 Long-term Follow-up||0
283692|NCT00289744|692497|P2|COMPLETED|Year 7 Long-term Follow-up||0
283693|NCT00289744|692498|P1|COMPLETED|Year 7 Long-term Follow-up||175
283694|NCT00289744|692496|P3|STARTED|Year 7 Long-term Follow-up||0
283695|NCT00289744|692497|P2|STARTED|Year 7 Long-term Follow-up||0
283696|NCT00289744|692498|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
283697|NCT00289744|692496|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
283698|NCT00289744|692497|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
283699|NCT00289744|692498|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
283700|NCT00289744|692496|P3|COMPLETED|Year 6 Long-term Follow-up||0
283701|NCT00289744|692497|P2|COMPLETED|Year 6 Long-term Follow-up||0
283702|NCT00289744|692498|P1|COMPLETED|Year 6 Long-term Follow-up||178
283703|NCT00289744|692496|P3|STARTED|Year 6 Long-term Follow-up||0
283704|NCT00289744|692497|P2|STARTED|Year 6 Long-term Follow-up||0
283705|NCT00289744|692498|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
283706|NCT00289718|692516|P1|NOT COMPLETED|Overall Study||0
283707|NCT00289718|692516|P1|COMPLETED|Overall Study||51
283708|NCT00289718|692516|P1|STARTED|Overall Study||51
283709|NCT00289536|692531|P3|NOT COMPLETED|Period 3||1
283710|NCT00289536|692532|P2|NOT COMPLETED|Period 3||0
283711|NCT00289536|692533|P1|NOT COMPLETED|Period 3||0
283712|NCT00289536|692531|P3|COMPLETED|Period 3||9
283713|NCT00289536|692532|P2|COMPLETED|Period 3||9
283714|NCT00289536|692533|P1|COMPLETED|Period 3||7
283715|NCT00289536|692531|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
283716|NCT00289536|692532|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
283717|NCT00289536|692533|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
283718|NCT00289536|692531|P3|NOT COMPLETED|Period 2||0
283719|NCT00289536|692532|P2|NOT COMPLETED|Period 2||0
283720|NCT00289536|692533|P1|NOT COMPLETED|Period 2||0
283721|NCT00289536|692531|P3|COMPLETED|Period 2||7
283722|NCT00289536|692532|P2|COMPLETED|Period 2||9
283723|NCT00289536|692533|P1|COMPLETED|Period 2||10
283724|NCT00289536|692531|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
283725|NCT00289536|692532|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
283726|NCT00289536|692533|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
283727|NCT00289536|692531|P3|NOT COMPLETED|Period 1||0
283728|NCT00289536|692532|P2|NOT COMPLETED|Period 1||0
283729|NCT00289536|692533|P1|NOT COMPLETED|Period 1||0
283730|NCT00289536|692531|P3|COMPLETED|Period 1||9
283731|NCT00289536|692532|P2|COMPLETED|Period 1||8
283732|NCT00289536|692533|P1|COMPLETED|Period 1||9
283733|NCT00289536|692531|P3|STARTED|Period 1||9
283734|NCT00289536|692532|P2|STARTED|Period 1||8
283735|NCT00289536|692533|P1|STARTED|Period 1||9
283736|NCT00289471|692572|P1|NOT COMPLETED|Overall Study||0
283737|NCT00289471|692572|P1|COMPLETED|Overall Study||630
283738|NCT00289471|692572|P1|STARTED|Overall Study||630
283739|NCT00289458|692579|P3|NOT COMPLETED|Overall Study||6
283740|NCT00289458|692580|P2|NOT COMPLETED|Overall Study||6
283741|NCT00289458|692581|P1|NOT COMPLETED|Overall Study||6
283742|NCT00289458|692579|P3|COMPLETED|Overall Study||22
283743|NCT00289458|692580|P2|COMPLETED|Overall Study||20
283744|NCT00289458|692581|P1|COMPLETED|Overall Study||19
283745|NCT00289458|692579|P3|STARTED|Overall Study||28
283746|NCT00289458|692580|P2|STARTED|Overall Study||26
283747|NCT00289458|692581|P1|STARTED|Overall Study||25
283748|NCT00289341|692606|P2|NOT COMPLETED|Overall Study||0
283749|NCT00289341|692607|P1|NOT COMPLETED|Overall Study||0
283750|NCT00289341|692606|P2|COMPLETED|Overall Study||12
283751|NCT00289341|692607|P1|COMPLETED|Overall Study||12
283752|NCT00289341|692606|P2|STARTED|Overall Study||12
283753|NCT00289341|692607|P1|STARTED|Overall Study||12
283754|NCT00289289|692620|P3|NOT COMPLETED|Overall Study||49
283755|NCT00289289|692621|P2|NOT COMPLETED|Overall Study||10
283756|NCT00289289|692622|P1|NOT COMPLETED|Overall Study||19
283757|NCT00289289|692620|P3|COMPLETED|Overall Study||95
283758|NCT00289289|692621|P2|COMPLETED|Overall Study||114
283759|NCT00289289|692622|P1|COMPLETED|Overall Study||113
283760|NCT00289289|692620|P3|STARTED|Overall Study||144
283761|NCT00289289|692621|P2|STARTED|Overall Study||124
283762|NCT00289289|692622|P1|STARTED|Overall Study||132
283763|NCT00289276|692637|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
283764|NCT00289276|692638|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
283765|NCT00289276|692637|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
283766|NCT00289276|692638|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
283767|NCT00289276|692637|P2|STARTED|Second Part of FAST Study (Expansion)||109
283768|NCT00289276|692638|P1|STARTED|Second Part of FAST Study (Expansion)||0
283769|NCT00289276|692637|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
283770|NCT00289276|692638|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
283771|NCT00289276|692637|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
283772|NCT00289276|692638|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
283773|NCT00289276|692637|P2|STARTED|First Part of FAST Study (Pivotal)||0
283774|NCT00289276|692638|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
283775|NCT00289211|692653|P3|NOT COMPLETED|Overall Study||10
283776|NCT00289211|692654|P2|NOT COMPLETED|Overall Study||1
283777|NCT00289211|692655|P1|NOT COMPLETED|Overall Study||0
283778|NCT00289211|692653|P3|COMPLETED|Overall Study||2
283779|NCT00289211|692654|P2|COMPLETED|Overall Study||34
283780|NCT00289211|692655|P1|COMPLETED|Overall Study||36
283781|NCT00289211|692653|P3|STARTED|Overall Study||12
283782|NCT00289211|692654|P2|STARTED|Overall Study||35
283783|NCT00289211|692655|P1|STARTED|Overall Study||36
283784|NCT00289198|692673|P2|NOT COMPLETED|Overall Study||30
283785|NCT00289198|692674|P1|NOT COMPLETED|Overall Study||31
283786|NCT00289198|692673|P2|COMPLETED|Overall Study||121
283787|NCT00289198|692674|P1|COMPLETED|Overall Study||120
283788|NCT00289198|692673|P2|STARTED|Overall Study||151
283789|NCT00289198|692674|P1|STARTED|Overall Study||151
283790|NCT00289185|692724|P2|NOT COMPLETED|Overall Study||26
283791|NCT00289185|692725|P1|NOT COMPLETED|Overall Study||28
283792|NCT00289185|692724|P2|COMPLETED|Overall Study||144
283793|NCT00289185|692725|P1|COMPLETED|Overall Study||142
283794|NCT00289185|692724|P2|STARTED|Overall Study||170
283795|NCT00289185|692725|P1|STARTED|Overall Study||170
283796|NCT00289133|692772|P2|NOT COMPLETED|Overall Study||298
283797|NCT00289133|692773|P1|NOT COMPLETED|Overall Study||272
283798|NCT00289133|692772|P2|COMPLETED|Overall Study||179
283799|NCT00289133|692773|P1|COMPLETED|Overall Study||189
283800|NCT00289133|692772|P2|STARTED|Overall Study||477
283801|NCT00289133|692773|P1|STARTED|Overall Study||461
283802|NCT00289120|692795|P1|NOT COMPLETED|Overall Study||0
283803|NCT00289120|692795|P1|COMPLETED|Overall Study||13
283804|NCT00289120|692795|P1|STARTED|Overall Study||13
283805|NCT00289107|692813|P2|NOT COMPLETED|Overall Study||44
283806|NCT00289107|692814|P1|NOT COMPLETED|Overall Study||53
283807|NCT00289107|692813|P2|COMPLETED|Overall Study||28
283808|NCT00289107|692814|P1|COMPLETED|Overall Study||24
283809|NCT00289107|692813|P2|STARTED|Overall Study||72
283810|NCT00289107|692814|P1|STARTED|Overall Study||77
283811|NCT00289094|692822|P2|NOT COMPLETED|Overall Study||47
283812|NCT00289094|692823|P1|NOT COMPLETED|Overall Study||47
283813|NCT00289094|692822|P2|COMPLETED|Overall Study||2
283814|NCT00289094|692823|P1|COMPLETED|Overall Study||3
283815|NCT00289094|692822|P2|STARTED|Overall Study||49
283816|NCT00289094|692823|P1|STARTED|Overall Study||50
283817|NCT00289016|692829|P1|NOT COMPLETED|Overall Study||37
283818|NCT00289016|692829|P1|COMPLETED|Overall Study||13
283819|NCT00289016|692829|P1|STARTED|Overall Study||50
283820|NCT00288912|692841|P3|NOT COMPLETED|Overall Study||28
283821|NCT00288912|692842|P2|NOT COMPLETED|Overall Study||17
283822|NCT00288912|692843|P1|NOT COMPLETED|Overall Study||17
283823|NCT00288912|692841|P3|COMPLETED|Overall Study||146
283824|NCT00288912|692842|P2|COMPLETED|Overall Study||157
283825|NCT00288912|692843|P1|COMPLETED|Overall Study||158
283826|NCT00288912|692841|P3|STARTED|Overall Study||174
283827|NCT00288912|692842|P2|STARTED|Overall Study||174
283828|NCT00288912|692843|P1|STARTED|Overall Study||175
283829|NCT00288886|692862|P2|NOT COMPLETED|Overall Study||11
283830|NCT00288886|692863|P1|NOT COMPLETED|Overall Study||11
283831|NCT00288886|692862|P2|COMPLETED|Overall Study||81
283832|NCT00288886|692863|P1|COMPLETED|Overall Study||80
283833|NCT00288886|692862|P2|12-month Follow Up|Overall Study||81
283834|NCT00288886|692863|P1|12-month Follow Up|Overall Study||80
283835|NCT00288886|692862|P2|6-month Follow Up|Overall Study||84
283836|NCT00288886|692863|P1|6-month Follow Up|Overall Study||85
283837|NCT00288886|692862|P2|3-month Follow Up|Overall Study||85
283838|NCT00288886|692863|P1|3-month Follow Up|Overall Study||82
283839|NCT00288886|692862|P2|STARTED|Overall Study||92
283840|NCT00288886|692863|P1|STARTED|Overall Study||91
283841|NCT00288860|692883|P2|NOT COMPLETED|Overall Study||97
283842|NCT00288860|692884|P1|NOT COMPLETED|Overall Study||102
283843|NCT00288860|692883|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
283844|NCT00288860|692884|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
283845|NCT00288860|692883|P2|Completed 12 Month fu Survey|Overall Study||281
283846|NCT00288860|692884|P1|Completed 12 Month fu Survey|Overall Study||257
283847|NCT00288860|692883|P2|Completed 4 Month fu Survey|Overall Study||299
283848|NCT00288860|692884|P1|Completed 4 Month fu Survey|Overall Study||275
283849|NCT00288860|692883|P2|Completed Intake Survey|Overall Study||417
283850|NCT00288860|692884|P1|Completed Intake Survey|Overall Study||408
283851|NCT00288860|692883|P2|STARTED|Overall Study||425
283852|NCT00288860|692884|P1|STARTED|Overall Study||412
283853|NCT00288704|692897|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
283854|NCT00288704|692898|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
283855|NCT00288704|692899|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
283856|NCT00288704|692897|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
283857|NCT00288704|692898|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
283858|NCT00288704|692899|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
283859|NCT00288704|692897|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
283860|NCT00288704|692898|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
283861|NCT00288704|692899|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
283862|NCT00288704|692897|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
283863|NCT00288704|692898|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
283864|NCT00288704|692899|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
283865|NCT00288704|692897|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
283866|NCT00288704|692898|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
283867|NCT00288704|692899|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
283868|NCT00288704|692897|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
283869|NCT00288704|692898|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
283870|NCT00288704|692899|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
283871|NCT00288704|692897|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
283872|NCT00288704|692898|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
283873|NCT00288704|692899|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
283874|NCT00288704|692897|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
283875|NCT00288704|692898|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
283876|NCT00288704|692899|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
283877|NCT00288704|692897|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
283878|NCT00288704|692898|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
283879|NCT00288704|692899|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
283880|NCT00288639|692926|P1|NOT COMPLETED|Overall Study||12
283881|NCT00288639|692926|P1|COMPLETED|Overall Study||86
283882|NCT00288639|692926|P1|STARTED|Overall Study||98
283883|NCT00288626|692943|P1|NOT COMPLETED|Overall Study||7
283884|NCT00288626|692943|P1|COMPLETED|Overall Study||17
283885|NCT00288626|692943|P1|STARTED|Overall Study||24
283886|NCT00288600|692968|P2|NOT COMPLETED|Overall Study||0
283887|NCT00288600|692969|P1|NOT COMPLETED|Overall Study||0
283888|NCT00288600|692968|P2|COMPLETED|Overall Study||46
283889|NCT00288600|692969|P1|COMPLETED|Overall Study||46
283890|NCT00288600|692968|P2|STARTED|Overall Study||46
283891|NCT00288600|692969|P1|STARTED|Overall Study||46
283892|NCT00288587|692977|P2|NOT COMPLETED|Overall Study||10
283893|NCT00288587|692978|P1|NOT COMPLETED|Overall Study||5
283894|NCT00288587|692977|P2|COMPLETED|Overall Study||7
283895|NCT00288587|692978|P1|COMPLETED|Overall Study||14
283896|NCT00288587|692977|P2|STARTED|Overall Study||17
283897|NCT00288587|692978|P1|STARTED|Overall Study||19
283898|NCT00288574|692994|P2|NOT COMPLETED|Overall Study||0
283899|NCT00288574|692995|P1|NOT COMPLETED|Overall Study||0
283900|NCT00288574|692994|P2|COMPLETED|Overall Study||44
283901|NCT00288574|692995|P1|COMPLETED|Overall Study||49
283902|NCT00288574|692994|P2|STARTED|Overall Study||44
283903|NCT00288574|692995|P1|STARTED|Overall Study||49
283904|NCT00288509|693021|P1|NOT COMPLETED|Treatment Cycle 4||8
283905|NCT00288509|693021|P1|COMPLETED|Treatment Cycle 4||80
283906|NCT00288509|693021|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
283907|NCT00288509|693021|P1|NOT COMPLETED|Treatment Cycle 3||5
283908|NCT00288509|693021|P1|COMPLETED|Treatment Cycle 3||91
283909|NCT00288509|693021|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
283910|NCT00288509|693021|P1|NOT COMPLETED|Treatment Cycle 2||3
283911|NCT00288509|693021|P1|COMPLETED|Treatment Cycle 2||97
283912|NCT00288509|693021|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
283913|NCT00288509|693021|P1|NOT COMPLETED|Treatment Cycle 1||6
283914|NCT00288509|693021|P1|COMPLETED|Treatment Cycle 1||102
283915|NCT00288509|693021|P1|STARTED|Treatment Cycle 1||108
283916|NCT00288080|693030|P2|NOT COMPLETED|Overall Study||23
283917|NCT00288080|693031|P1|NOT COMPLETED|Overall Study||26
283918|NCT00288080|693030|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
283919|NCT00288080|693031|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
283920|NCT00288080|693030|P2|STARTED|Overall Study||305
283921|NCT00288080|693031|P1|STARTED|Overall Study||307
283922|NCT00288067|693047|P1|NOT COMPLETED|Overall Study||0
283923|NCT00288067|693047|P1|COMPLETED|Overall Study||32
283924|NCT00288067|693047|P1|STARTED|Overall Study||32
283925|NCT00288054|693053|P1|NOT COMPLETED|Overall Study||24
283926|NCT00288054|693053|P1|COMPLETED|Overall Study||0
283927|NCT00288054|693053|P1|STARTED|Overall Study||24
283928|NCT00287872|693061|P1|NOT COMPLETED|Overall Study||0
283929|NCT00287872|693061|P1|COMPLETED|Overall Study||30
283930|NCT00287872|693061|P1|STARTED|Overall Study||30
283931|NCT00287729|693071|P2|NOT COMPLETED|Overall Study||31
283932|NCT00287729|693072|P1|NOT COMPLETED|Overall Study||34
283933|NCT00287729|693071|P2|COMPLETED|Overall Study||142
283934|NCT00287729|693072|P1|COMPLETED|Overall Study||137
283935|NCT00287729|693071|P2|STARTED|Overall Study||173
283936|NCT00287729|693072|P1|STARTED|Overall Study||171
283937|NCT00287716|693095|P3|NOT COMPLETED|Overall Study||31
283938|NCT00287716|693096|P2|NOT COMPLETED|Overall Study||17
283939|NCT00287716|693097|P1|NOT COMPLETED|Overall Study||38
283940|NCT00287716|693095|P3|COMPLETED|Overall Study||143
283941|NCT00287716|693096|P2|COMPLETED|Overall Study||70
283942|NCT00287716|693097|P1|COMPLETED|Overall Study||136
283943|NCT00287716|693095|P3|STARTED|Overall Study||174
283944|NCT00287716|693096|P2|STARTED|Overall Study||87
283945|NCT00287716|693097|P1|STARTED|Overall Study||174
283946|NCT00287586|693128|P2|NOT COMPLETED|Overall Study||52
283947|NCT00287586|693129|P1|NOT COMPLETED|Overall Study||45
283948|NCT00287586|693128|P2|COMPLETED|Overall Study||100
283949|NCT00287586|693129|P1|COMPLETED|Overall Study||111
283950|NCT00287586|693128|P2|Intent-to-treat: Received Study Drug|Overall Study||151
283951|NCT00287586|693129|P1|Intent-to-treat: Received Study Drug|Overall Study||155
283952|NCT00287586|693128|P2|STARTED|Overall Study||152
283953|NCT00287586|693129|P1|STARTED|Overall Study||156
283954|NCT00287365|693165|P1|NOT COMPLETED|Overall Study||13
283955|NCT00287365|693165|P1|COMPLETED|Overall Study||12
283956|NCT00287365|693165|P1|STARTED|Overall Study||25
283957|NCT00287339|693176|P2|NOT COMPLETED|Overall Study||0
283958|NCT00287339|693177|P1|NOT COMPLETED|Overall Study||0
283959|NCT00287339|693176|P2|COMPLETED|Overall Study||18
283960|NCT00287339|693177|P1|COMPLETED|Overall Study||22
283961|NCT00287339|693176|P2|STARTED|Overall Study||18
283962|NCT00287339|693177|P1|STARTED|Overall Study||22
283963|NCT00287222|693183|P1|NOT COMPLETED|Overall Study||0
283964|NCT00287222|693183|P1|COMPLETED|Overall Study||21
283965|NCT00287222|693183|P1|STARTED|Overall Study||21
283966|NCT00287118|693187|P1|NOT COMPLETED|Overall Study||52
283967|NCT00287118|693187|P1|COMPLETED|Overall Study||137
283968|NCT00287118|693187|P1|STARTED|Overall Study||189
283969|NCT00287079|693193|P2|NOT COMPLETED|Overall Study||1
283970|NCT00287079|693194|P1|NOT COMPLETED|Overall Study||22
283971|NCT00287079|693193|P2|COMPLETED|Overall Study||2
283972|NCT00287079|693194|P1|COMPLETED|Overall Study||10
283973|NCT00287079|693193|P2|STARTED|Overall Study||3
283974|NCT00287079|693194|P1|STARTED|Overall Study||32
283975|NCT00287053|693206|P2|NOT COMPLETED|Overall Study||1
283976|NCT00287053|693207|P1|NOT COMPLETED|Overall Study||4
283977|NCT00287053|693206|P2|COMPLETED|Overall Study||26
283978|NCT00287053|693207|P1|COMPLETED|Overall Study||26
283979|NCT00287053|693206|P2|STARTED|Overall Study||27
283980|NCT00287053|693207|P1|STARTED|Overall Study||30
283981|NCT00286949|693213|P1|NOT COMPLETED|Overall Study||0
283982|NCT00286949|693213|P1|COMPLETED|Overall Study||12
283983|NCT00286949|693213|P1|STARTED|Overall Study||12
283984|NCT00286754|693222|P3|NOT COMPLETED|Overall Study||10
283985|NCT00286754|693223|P2|NOT COMPLETED|Overall Study||18
283986|NCT00286754|693224|P1|NOT COMPLETED|Overall Study||20
283987|NCT00286754|693222|P3|COMPLETED|Overall Study||170
283988|NCT00286754|693223|P2|COMPLETED|Overall Study||159
283989|NCT00286754|693224|P1|COMPLETED|Overall Study||156
283990|NCT00286754|693222|P3|STARTED|Overall Study||180
283991|NCT00286754|693223|P2|STARTED|Overall Study||177
283992|NCT00286754|693224|P1|STARTED|Overall Study||176
283993|NCT00286741|693258|P2|NOT COMPLETED|Overall Study||17
283994|NCT00286741|693259|P1|NOT COMPLETED|Overall Study||11
283995|NCT00286741|693258|P2|COMPLETED|Overall Study||89
283996|NCT00286741|693259|P1|COMPLETED|Overall Study||122
283997|NCT00286741|693258|P2|STARTED|Overall Study||106
283998|NCT00286741|693259|P1|STARTED|Overall Study||133
283999|NCT00286728|693269|P2|NOT COMPLETED|Overall Study||29
284000|NCT00286728|693270|P1|NOT COMPLETED|Overall Study||36
284001|NCT00286728|693269|P2|COMPLETED|Overall Study||116
284002|NCT00286728|693270|P1|COMPLETED|Overall Study||106
284003|NCT00286728|693269|P2|STARTED|Overall Study||145
284004|NCT00286728|693270|P1|STARTED|Overall Study||142
284005|NCT00286494|693279|P3|NOT COMPLETED|Overall Study||39
284006|NCT00286494|693280|P2|NOT COMPLETED|Overall Study||44
284007|NCT00286494|693281|P1|NOT COMPLETED|Overall Study||26
284008|NCT00286494|693279|P3|COMPLETED|Overall Study||160
284009|NCT00286494|693280|P2|COMPLETED|Overall Study||153
284010|NCT00286494|693281|P1|COMPLETED|Overall Study||71
284011|NCT00286494|693279|P3|STARTED|Overall Study||199
284012|NCT00286494|693280|P2|STARTED|Overall Study||197
284013|NCT00286494|693281|P1|STARTED|Overall Study||97
284014|NCT00286468|693442|P3|NOT COMPLETED|Overall Study||50
284015|NCT00286468|693443|P2|NOT COMPLETED|Overall Study||50
284016|NCT00286468|693444|P1|NOT COMPLETED|Overall Study||37
284017|NCT00286468|693442|P3|COMPLETED|Overall Study||148
284018|NCT00286468|693443|P2|COMPLETED|Overall Study||153
284019|NCT00286468|693444|P1|COMPLETED|Overall Study||62
284020|NCT00286468|693442|P3|STARTED|Overall Study||198
284021|NCT00286468|693443|P2|STARTED|Overall Study||203
284022|NCT00286468|693444|P1|STARTED|Overall Study||99
284023|NCT00286455|693605|P3|NOT COMPLETED|Overall Study||24
284024|NCT00286455|693606|P2|NOT COMPLETED|Overall Study||28
284025|NCT00286455|693607|P1|NOT COMPLETED|Overall Study||25
284026|NCT00286455|693605|P3|COMPLETED|Overall Study||107
284027|NCT00286455|693606|P2|COMPLETED|Overall Study||105
284028|NCT00286455|693607|P1|COMPLETED|Overall Study||40
284029|NCT00286455|693605|P3|STARTED|Overall Study||131
284030|NCT00286455|693606|P2|STARTED|Overall Study||133
284031|NCT00286455|693607|P1|STARTED|Overall Study||65
284032|NCT00286442|693786|P3|NOT COMPLETED|Overall Study||32
284033|NCT00286442|693787|P2|NOT COMPLETED|Overall Study||45
284034|NCT00286442|693788|P1|NOT COMPLETED|Overall Study||37
284035|NCT00286442|693786|P3|COMPLETED|Overall Study||72
284036|NCT00286442|693787|P2|COMPLETED|Overall Study||165
284037|NCT00286442|693788|P1|COMPLETED|Overall Study||176
284038|NCT00286442|693786|P3|STARTED|Overall Study||104
284039|NCT00286442|693787|P2|STARTED|Overall Study||210
284040|NCT00286442|693788|P1|STARTED|Overall Study||213
284041|NCT00286429|693949|P3|NOT COMPLETED|Overall Study||52
284042|NCT00286429|693950|P2|NOT COMPLETED|Overall Study||48
284043|NCT00286429|693951|P1|NOT COMPLETED|Overall Study||75
284044|NCT00286429|693949|P3|COMPLETED|Overall Study||77
284045|NCT00286429|693950|P2|COMPLETED|Overall Study||83
284046|NCT00286429|693951|P1|COMPLETED|Overall Study||55
284047|NCT00286429|693949|P3|STARTED|Overall Study||129
284048|NCT00286429|693950|P2|STARTED|Overall Study||131
284049|NCT00286429|693951|P1|STARTED|Overall Study||130
284050|NCT00286325|694055|P1|NOT COMPLETED|Overall Study||0
284051|NCT00286325|694055|P1|COMPLETED|Overall Study||8
284052|NCT00286325|694055|P1|STARTED|Overall Study||8
284053|NCT00286221|694067|P4|NOT COMPLETED|Overall Study||6
284054|NCT00286221|694068|P3|NOT COMPLETED|Overall Study||9
284055|NCT00286221|694069|P2|NOT COMPLETED|Overall Study||5
284056|NCT00286221|694070|P1|NOT COMPLETED|Overall Study||10
284057|NCT00286221|694067|P4|COMPLETED|Overall Study||34
284058|NCT00286221|694068|P3|COMPLETED|Overall Study||31
284059|NCT00286221|694069|P2|COMPLETED|Overall Study||35
284060|NCT00286221|694070|P1|COMPLETED|Overall Study||29
284061|NCT00286221|694067|P4|STARTED|Overall Study||40
284062|NCT00286221|694068|P3|STARTED|Overall Study||40
284063|NCT00286221|694069|P2|STARTED|Overall Study||40
284064|NCT00286221|694070|P1|STARTED|Overall Study||39
284065|NCT00286182|694086|P2|NOT COMPLETED|Overall Study||3
284066|NCT00286182|694087|P1|NOT COMPLETED|Overall Study||5
284067|NCT00286182|694086|P2|COMPLETED|Overall Study||25
284068|NCT00286182|694087|P1|COMPLETED|Overall Study||23
284069|NCT00286182|694086|P2|STARTED|Overall Study||28
284070|NCT00286182|694087|P1|STARTED|Overall Study||28
284071|NCT00286156|694096|P3|NOT COMPLETED|Overall Study||1
284072|NCT00286156|694097|P2|NOT COMPLETED|Overall Study||1
284073|NCT00286156|694098|P1|NOT COMPLETED|Overall Study||2
284074|NCT00286156|694096|P3|COMPLETED|Overall Study||9
284075|NCT00286156|694097|P2|COMPLETED|Overall Study||9
284076|NCT00286156|694098|P1|COMPLETED|Overall Study||8
284077|NCT00286156|694096|P3|STARTED|Overall Study||10
284078|NCT00286156|694097|P2|STARTED|Overall Study||10
284079|NCT00286156|694098|P1|STARTED|Overall Study||10
284080|NCT00286091|694111|P2|NOT COMPLETED|Open-label Treatment Phase||71
284081|NCT00286091|694112|P1|NOT COMPLETED|Open-label Treatment Phase||77
284082|NCT00286091|694111|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
284083|NCT00286091|694112|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
284084|NCT00286091|694111|P2|Received Treatment|Open-label Treatment Phase||101
284085|NCT00286091|694112|P1|Received Treatment|Open-label Treatment Phase||109
284086|NCT00286091|694111|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
284087|NCT00286091|694112|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
284088|NCT00286091|694111|P2|NOT COMPLETED|Double-blind Treatment Phase||593
284089|NCT00286091|694112|P1|NOT COMPLETED|Double-blind Treatment Phase||584
284090|NCT00286091|694111|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
284091|NCT00286091|694112|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
284092|NCT00286091|694111|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
284093|NCT00286091|694112|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
284094|NCT00286091|694111|P2|Received Treatment|Double-blind Treatment Phase||716
284095|NCT00286091|694112|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
284096|NCT00286091|694111|P2|STARTED|Double-blind Treatment Phase||716
284097|NCT00286091|694112|P1|STARTED|Double-blind Treatment Phase||716
284098|NCT00286078|694126|P2|NOT COMPLETED|Overall Study||34
284099|NCT00286078|694127|P1|NOT COMPLETED|Overall Study||32
284100|NCT00286078|694126|P2|COMPLETED|Overall Study||34
284101|NCT00286078|694127|P1|COMPLETED|Overall Study||40
284102|NCT00286078|694126|P2|12 Weeks|Overall Study||62
284103|NCT00286078|694127|P1|12 Weeks|Overall Study||63
284104|NCT00286078|694126|P2|STARTED|Overall Study||68
284105|NCT00286078|694127|P1|STARTED|Overall Study||72
284106|NCT00285857|694135|P1|NOT COMPLETED|Overall Study||4
284107|NCT00285857|694135|P1|COMPLETED|Overall Study||26
284108|NCT00285857|694135|P1|STARTED|Overall Study||30
284109|NCT00285818|694148|P2|NOT COMPLETED|Overall Study||2
284110|NCT00285818|694149|P1|NOT COMPLETED|Overall Study||4
284111|NCT00285818|694148|P2|COMPLETED|Overall Study||3
284112|NCT00285818|694149|P1|COMPLETED|Overall Study||2
284113|NCT00285818|694148|P2|STARTED|Overall Study||5
284114|NCT00285818|694149|P1|STARTED|Overall Study||6
284115|NCT00285779|694157|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
284116|NCT00285779|694158|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
284117|NCT00285779|694157|P2|COMPLETED|Follow-up Period (wk 24-32)||10
284118|NCT00285779|694158|P1|COMPLETED|Follow-up Period (wk 24-32)||8
284119|NCT00285779|694157|P2|STARTED|Follow-up Period (wk 24-32)||10
284120|NCT00285779|694158|P1|STARTED|Follow-up Period (wk 24-32)||9
284121|NCT00285779|694157|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
284122|NCT00285779|694158|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
284123|NCT00285779|694157|P2|COMPLETED|Open Label Period (wk 12-24)||10
284124|NCT00285779|694158|P1|COMPLETED|Open Label Period (wk 12-24)||9
284125|NCT00285779|694157|P2|STARTED|Open Label Period (wk 12-24)||12
284126|NCT00285779|694158|P1|STARTED|Open Label Period (wk 12-24)||11
284127|NCT00285779|694157|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
284128|NCT00285779|694158|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
284129|NCT00285779|694157|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
284130|NCT00285779|694158|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
284131|NCT00285779|694157|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
284132|NCT00285779|694158|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
284133|NCT00285649|694194|P3|NOT COMPLETED|Overall Study||6
284134|NCT00285649|694195|P2|NOT COMPLETED|Overall Study||6
284135|NCT00285649|694196|P1|NOT COMPLETED|Overall Study||9
284136|NCT00285649|694194|P3|COMPLETED|Overall Study||42
284137|NCT00285649|694195|P2|COMPLETED|Overall Study||66
284138|NCT00285649|694196|P1|COMPLETED|Overall Study||63
284139|NCT00285649|694194|P3|STARTED|Overall Study||48
284140|NCT00285649|694195|P2|STARTED|Overall Study||72
284141|NCT00285649|694196|P1|STARTED|Overall Study||72
284142|NCT00285584|694206|P2|NOT COMPLETED|Month 9||3
284143|NCT00285584|694207|P1|NOT COMPLETED|Month 9||1
284144|NCT00285584|694206|P2|COMPLETED|Month 9||14
284145|NCT00285584|694207|P1|COMPLETED|Month 9||15
284146|NCT00285584|694206|P2|STARTED|Month 9||17
284147|NCT00285584|694207|P1|STARTED|Month 9||16
284148|NCT00285584|694206|P2|NOT COMPLETED|Month 6||1
284149|NCT00285584|694207|P1|NOT COMPLETED|Month 6||0
284150|NCT00285584|694206|P2|COMPLETED|Month 6||17
284151|NCT00285584|694207|P1|COMPLETED|Month 6||16
284152|NCT00285584|694206|P2|STARTED|Month 6||18
284153|NCT00285584|694207|P1|STARTED|Month 6||16
284154|NCT00285584|694206|P2|NOT COMPLETED|Month 3||3
284155|NCT00285584|694207|P1|NOT COMPLETED|Month 3||4
284156|NCT00285584|694206|P2|COMPLETED|Month 3||18
284157|NCT00285584|694207|P1|COMPLETED|Month 3||16
284158|NCT00285584|694206|P2|STARTED|Month 3||21
284159|NCT00285584|694207|P1|STARTED|Month 3||20
284160|NCT00285584|694206|P2|NOT COMPLETED|Enrollment (Month 0)||0
284161|NCT00285584|694207|P1|NOT COMPLETED|Enrollment (Month 0)||0
284162|NCT00285584|694206|P2|COMPLETED|Enrollment (Month 0)||21
284163|NCT00285584|694207|P1|COMPLETED|Enrollment (Month 0)||20
284164|NCT00285584|694206|P2|STARTED|Enrollment (Month 0)||21
284165|NCT00285584|694207|P1|STARTED|Enrollment (Month 0)||20
284166|NCT00285467|694221|P2|NOT COMPLETED|Overall Study||0
284167|NCT00285467|694222|P1|NOT COMPLETED|Overall Study||0
284168|NCT00285467|694221|P2|COMPLETED|Overall Study||22
284169|NCT00285467|694222|P1|COMPLETED|Overall Study||25
284170|NCT00285467|694221|P2|STARTED|Overall Study||22
284171|NCT00285467|694222|P1|STARTED|Overall Study||25
284172|NCT00285246|694230|P1|NOT COMPLETED|Overall Study||48
284173|NCT00285246|694230|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
284174|NCT00285246|694230|P1|STARTED|Overall Study||838
284175|NCT00285207|694239|P2|NOT COMPLETED|Overall Study||6
284176|NCT00285207|694240|P1|NOT COMPLETED|Overall Study||9
284177|NCT00285207|694239|P2|COMPLETED|Overall Study||71
284178|NCT00285207|694240|P1|COMPLETED|Overall Study||61
284179|NCT00285207|694239|P2|Treated|Overall Study||75
284180|NCT00285207|694240|P1|Treated|Overall Study||63
284181|NCT00285207|694239|P2|STARTED|Overall Study||77
284182|NCT00285207|694240|P1|STARTED|Overall Study||70
284183|NCT00285012|694248|P2|NOT COMPLETED|Received Study Tx||94
284184|NCT00285012|694249|P1|NOT COMPLETED|Received Study Tx||72
284185|NCT00285012|694248|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
284186|NCT00285012|694249|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
284187|NCT00285012|694248|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
284188|NCT00285012|694249|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
284189|NCT00285012|694248|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
284190|NCT00285012|694249|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
284191|NCT00285012|694248|P2|STARTED|Received Study Tx||251
284192|NCT00285012|694249|P1|STARTED|Received Study Tx||248
284193|NCT00285012|694248|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
284194|NCT00285012|694249|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
284195|NCT00285012|694248|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
284196|NCT00285012|694249|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
284197|NCT00285012|694248|P2|STARTED|Assigned to Study Treatment (Tx)||254
284198|NCT00285012|694249|P1|STARTED|Assigned to Study Treatment (Tx)||250
284199|NCT00284934|694275|P2|NOT COMPLETED|Overall Study||3
284200|NCT00284934|694276|P1|NOT COMPLETED|Overall Study||4
284201|NCT00284934|694275|P2|COMPLETED|Overall Study||43
284202|NCT00284934|694276|P1|COMPLETED|Overall Study||44
284203|NCT00284934|694275|P2|Intent-to-treat Population (ITT)|Overall Study||45
284204|NCT00284934|694276|P1|Intent-to-treat Population (ITT)|Overall Study||47
284205|NCT00284934|694275|P2|STARTED|Overall Study||46
284206|NCT00284934|694276|P1|STARTED|Overall Study||48
284207|NCT00284856|694291|P3|NOT COMPLETED|Overall Study||60
284208|NCT00284856|694292|P2|NOT COMPLETED|Overall Study||50
284209|NCT00284856|694293|P1|NOT COMPLETED|Overall Study||51
284210|NCT00284856|694291|P3|COMPLETED|Overall Study||276
284211|NCT00284856|694292|P2|COMPLETED|Overall Study||286
284212|NCT00284856|694293|P1|COMPLETED|Overall Study||296
284213|NCT00284856|694291|P3|STARTED|Overall Study||336
284214|NCT00284856|694292|P2|STARTED|Overall Study||336
284215|NCT00284856|694293|P1|STARTED|Overall Study||347
284216|NCT00284739|694309|P2|NOT COMPLETED|Overall Study||0
284217|NCT00284739|694310|P1|NOT COMPLETED|Overall Study||0
284218|NCT00284739|694309|P2|COMPLETED|Overall Study||9
284219|NCT00284739|694310|P1|COMPLETED|Overall Study||11
284220|NCT00284739|694309|P2|STARTED|Overall Study||9
284221|NCT00284739|694310|P1|STARTED|Overall Study||11
284222|NCT00284557|694322|P2|NOT COMPLETED|Overall Study||13
284223|NCT00284557|694323|P1|NOT COMPLETED|Overall Study||9
284224|NCT00284557|694322|P2|COMPLETED|Overall Study||50
284225|NCT00284557|694323|P1|COMPLETED|Overall Study||58
284226|NCT00284557|694322|P2|STARTED|Overall Study||63
284227|NCT00284557|694323|P1|STARTED|Overall Study||67
284228|NCT00284518|694335|P4|NOT COMPLETED|Overall Study||33
284229|NCT00284518|694336|P3|NOT COMPLETED|Overall Study||28
284230|NCT00284518|694337|P2|NOT COMPLETED|Overall Study||28
284231|NCT00284518|694338|P1|NOT COMPLETED|Overall Study||26
284232|NCT00284518|694335|P4|COMPLETED|Overall Study||61
284233|NCT00284518|694336|P3|COMPLETED|Overall Study||67
284234|NCT00284518|694337|P2|COMPLETED|Overall Study||66
284235|NCT00284518|694338|P1|COMPLETED|Overall Study||71
284236|NCT00284518|694335|P4|STARTED|Overall Study||94
284237|NCT00284518|694336|P3|STARTED|Overall Study||95
284238|NCT00284518|694337|P2|STARTED|Overall Study||94
284239|NCT00284518|694338|P1|STARTED|Overall Study||97
284240|NCT00284180|694378|P2|NOT COMPLETED|Overall Study||4
284241|NCT00284180|694379|P1|NOT COMPLETED|Overall Study||0
284242|NCT00284180|694378|P2|COMPLETED|Overall Study||17
284243|NCT00284180|694379|P1|COMPLETED|Overall Study||11
284244|NCT00284180|694378|P2|STARTED|Overall Study||21
284245|NCT00284180|694379|P1|STARTED|Overall Study||11
284246|NCT00284154|694385|P1|NOT COMPLETED|Overall Study||42
284247|NCT00284154|694385|P1|COMPLETED|Overall Study||9
284248|NCT00284154|694385|P1|STARTED|Overall Study||51
284249|NCT00284141|694392|P1|NOT COMPLETED|Overall Study||98
284250|NCT00284141|694392|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
284251|NCT00284141|694392|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
284252|NCT00284141|694392|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
284253|NCT00284141|694392|P1|STARTED|Overall Study||98
284254|NCT00284089|694415|P4|NOT COMPLETED|Extension Phase||12
284255|NCT00284089|694416|P3|NOT COMPLETED|Extension Phase||6
284256|NCT00284089|694417|P2|NOT COMPLETED|Extension Phase||0
284257|NCT00284089|694418|P1|NOT COMPLETED|Extension Phase||2
284258|NCT00284089|694415|P4|COMPLETED|Extension Phase||21
284259|NCT00284089|694416|P3|COMPLETED|Extension Phase||22
284260|NCT00284089|694417|P2|COMPLETED|Extension Phase||6
284261|NCT00284089|694418|P1|COMPLETED|Extension Phase||1
284262|NCT00284089|694415|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
284263|NCT00284089|694416|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
284264|NCT00284089|694417|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
284265|NCT00284089|694418|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
284266|NCT00284089|694415|P4|NOT COMPLETED|Multiple Dose Phase||4
284267|NCT00284089|694416|P3|NOT COMPLETED|Multiple Dose Phase||4
284268|NCT00284089|694417|P2|NOT COMPLETED|Multiple Dose Phase||0
284269|NCT00284089|694418|P1|NOT COMPLETED|Multiple Dose Phase||1
284270|NCT00284089|694415|P4|COMPLETED|Multiple Dose Phase||37
284271|NCT00284089|694416|P3|COMPLETED|Multiple Dose Phase||31
284272|NCT00284089|694417|P2|COMPLETED|Multiple Dose Phase||6
284273|NCT00284089|694418|P1|COMPLETED|Multiple Dose Phase||4
284274|NCT00284089|694415|P4|STARTED|Multiple Dose Phase||41
284275|NCT00284089|694416|P3|STARTED|Multiple Dose Phase||35
284276|NCT00284089|694417|P2|STARTED|Multiple Dose Phase||6
284277|NCT00284089|694418|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
284278|NCT00284089|694415|P4|NOT COMPLETED|Single Dose Phase||0
284279|NCT00284089|694416|P3|NOT COMPLETED|Single Dose Phase||0
284280|NCT00284089|694417|P2|NOT COMPLETED|Single Dose Phase||0
284281|NCT00284089|694418|P1|NOT COMPLETED|Single Dose Phase||0
284282|NCT00284089|694415|P4|COMPLETED|Single Dose Phase||0
284283|NCT00284089|694416|P3|COMPLETED|Single Dose Phase||0
284284|NCT00284089|694417|P2|COMPLETED|Single Dose Phase||6
284285|NCT00284089|694418|P1|COMPLETED|Single Dose Phase||6
284286|NCT00284089|694415|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
284287|NCT00284089|694416|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
284288|NCT00284089|694417|P2|STARTED|Single Dose Phase||6
284289|NCT00284089|694418|P1|STARTED|Single Dose Phase||6
284290|NCT00284050|694447|P3|NOT COMPLETED|Overall Study||9
284291|NCT00284050|694448|P2|NOT COMPLETED|Overall Study||5
284292|NCT00284050|694449|P1|NOT COMPLETED|Overall Study||5
284293|NCT00284050|694447|P3|COMPLETED|Overall Study||40
284294|NCT00284050|694448|P2|COMPLETED|Overall Study||46
284295|NCT00284050|694449|P1|COMPLETED|Overall Study||46
284296|NCT00284050|694447|P3|STARTED|Overall Study||49
284297|NCT00284050|694448|P2|STARTED|Overall Study||51
284298|NCT00284050|694449|P1|STARTED|Overall Study||51
284299|NCT00283868|694465|P2|NOT COMPLETED|Overall Study||8
284300|NCT00283868|694466|P1|NOT COMPLETED|Overall Study||7
284301|NCT00283868|694465|P2|COMPLETED|Overall Study||103
284302|NCT00283868|694466|P1|COMPLETED|Overall Study||104
284303|NCT00283868|694465|P2|STARTED|Overall Study||111
284304|NCT00283868|694466|P1|STARTED|Overall Study||111
284305|NCT00283842|694483|P5|NOT COMPLETED|Overall Study||15
284306|NCT00283842|694484|P4|NOT COMPLETED|Overall Study||27
284307|NCT00283842|694485|P3|NOT COMPLETED|Overall Study||31
284308|NCT00283842|694486|P2|NOT COMPLETED|Overall Study||18
284309|NCT00283842|694487|P1|NOT COMPLETED|Overall Study||12
284310|NCT00283842|694483|P5|COMPLETED|Overall Study||75
284311|NCT00283842|694484|P4|COMPLETED|Overall Study||42
284312|NCT00283842|694485|P3|COMPLETED|Overall Study||68
284313|NCT00283842|694486|P2|COMPLETED|Overall Study||69
284314|NCT00283842|694487|P1|COMPLETED|Overall Study||51
284315|NCT00283842|694483|P5|STARTED|Overall Study||90
284316|NCT00283842|694484|P4|STARTED|Overall Study||69
284317|NCT00283842|694485|P3|STARTED|Overall Study||99
284318|NCT00283842|694486|P2|STARTED|Overall Study||87
284319|NCT00283842|694487|P1|STARTED|Overall Study||63
284320|NCT00283816|694506|P2|NOT COMPLETED|Overall Study||2
284321|NCT00283816|694507|P1|NOT COMPLETED|Overall Study||2
284322|NCT00283816|694506|P2|COMPLETED|Overall Study||16
284323|NCT00283816|694507|P1|COMPLETED|Overall Study||16
284324|NCT00283816|694506|P2|STARTED|Overall Study||18
284325|NCT00283816|694507|P1|STARTED|Overall Study||18
284326|NCT00283803|694519|P1|NOT COMPLETED|Overall Study||13
284327|NCT00283803|694519|P1|COMPLETED|Overall Study||19
284328|NCT00283803|694519|P1|STARTED|Overall Study||32
284329|NCT00283712|694527|P2|NOT COMPLETED|Overall Study||1
284330|NCT00283712|694528|P1|NOT COMPLETED|Overall Study||0
284331|NCT00283712|694527|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
284332|NCT00283712|694528|P1|COMPLETED|Overall Study||10
284333|NCT00283712|694527|P2|Per-Protocol Sample|Overall Study||7
284334|NCT00283712|694528|P1|Per-Protocol Sample|Overall Study||6
284335|NCT00283712|694527|P2|Safety Sample|Overall Study||10
284336|NCT00283712|694528|P1|Safety Sample|Overall Study||10
284337|NCT00283712|694527|P2|Intent-to-treat Sample|Overall Study||10
284338|NCT00283712|694528|P1|Intent-to-treat Sample|Overall Study||10
284339|NCT00283712|694527|P2|STARTED|Overall Study||10
284340|NCT00283712|694528|P1|STARTED|Overall Study||10
284341|NCT00283686|694566|P4|NOT COMPLETED|Overall Study||32
284342|NCT00283686|694567|P3|NOT COMPLETED|Overall Study||33
284343|NCT00283686|694568|P2|NOT COMPLETED|Overall Study||41
284344|NCT00283686|694569|P1|NOT COMPLETED|Overall Study||29
284345|NCT00283686|694566|P4|COMPLETED|Overall Study||109
284346|NCT00283686|694567|P3|COMPLETED|Overall Study||111
284347|NCT00283686|694568|P2|COMPLETED|Overall Study||92
284348|NCT00283686|694569|P1|COMPLETED|Overall Study||111
284349|NCT00283686|694566|P4|STARTED|Overall Study||141
284350|NCT00283686|694567|P3|STARTED|Overall Study||144
284351|NCT00283686|694568|P2|STARTED|Overall Study||133
284352|NCT00283686|694569|P1|STARTED|Overall Study||140
284353|NCT00283595|694613|P2|NOT COMPLETED|Overall Study||2
284354|NCT00283595|694614|P1|NOT COMPLETED|Overall Study||1
284355|NCT00283595|694613|P2|COMPLETED|Overall Study||9
284356|NCT00283595|694614|P1|COMPLETED|Overall Study||9
284357|NCT00283595|694613|P2|STARTED|Overall Study||11
284358|NCT00283595|694614|P1|STARTED|Overall Study||10
284359|NCT00283504|694624|P2|NOT COMPLETED|Overall Study||0
284360|NCT00283504|694625|P1|NOT COMPLETED|Overall Study||0
284361|NCT00283504|694624|P2|COMPLETED|Overall Study||6
284362|NCT00283504|694625|P1|COMPLETED|Overall Study||7
284363|NCT00283504|694624|P2|STARTED|Overall Study||6
284364|NCT00283504|694625|P1|STARTED|Overall Study||7
284365|NCT00283439|694639|P4|NOT COMPLETED|Overall Study||9
284366|NCT00283439|694640|P3|NOT COMPLETED|Overall Study||11
284367|NCT00283439|694641|P2|NOT COMPLETED|Overall Study||11
284368|NCT00283439|694642|P1|NOT COMPLETED|Overall Study||8
284369|NCT00283439|694639|P4|COMPLETED|Overall Study||0
284370|NCT00283439|694640|P3|COMPLETED|Overall Study||0
284371|NCT00283439|694641|P2|COMPLETED|Overall Study||0
284372|NCT00283439|694642|P1|COMPLETED|Overall Study||0
284373|NCT00283439|694639|P4|STARTED|Overall Study||9
284374|NCT00283439|694640|P3|STARTED|Overall Study||11
284375|NCT00283439|694641|P2|STARTED|Overall Study||11
284376|NCT00283439|694642|P1|STARTED|Overall Study||8
284377|NCT00283400|694668|P4|NOT COMPLETED|Overall Study||0
284378|NCT00283400|694669|P3|NOT COMPLETED|Overall Study||1
284379|NCT00283400|694670|P2|NOT COMPLETED|Overall Study||1
284380|NCT00283400|694671|P1|NOT COMPLETED|Overall Study||2
284381|NCT00283400|694668|P4|COMPLETED|Overall Study||0
284382|NCT00283400|694669|P3|COMPLETED|Overall Study||6
284383|NCT00283400|694670|P2|COMPLETED|Overall Study||19
284384|NCT00283400|694671|P1|COMPLETED|Overall Study||18
284385|NCT00283400|694668|P4|STARTED|Overall Study||0
284386|NCT00283400|694669|P3|STARTED|Overall Study||7
284387|NCT00283400|694670|P2|STARTED|Overall Study||20
284388|NCT00283400|694671|P1|STARTED|Overall Study||20
284389|NCT00283387|694689|P2|NOT COMPLETED|Second Intervention||0
284390|NCT00283387|694690|P1|NOT COMPLETED|Second Intervention||0
284391|NCT00283387|694689|P2|COMPLETED|Second Intervention||5
284392|NCT00283387|694690|P1|COMPLETED|Second Intervention||5
284393|NCT00283387|694689|P2|STARTED|Second Intervention||5
284394|NCT00283387|694690|P1|STARTED|Second Intervention||5
284395|NCT00283387|694689|P2|NOT COMPLETED|Washout Period of 2 Months||0
284396|NCT00283387|694690|P1|NOT COMPLETED|Washout Period of 2 Months||0
284397|NCT00283387|694689|P2|COMPLETED|Washout Period of 2 Months||5
284398|NCT00283387|694690|P1|COMPLETED|Washout Period of 2 Months||5
284399|NCT00283387|694689|P2|STARTED|Washout Period of 2 Months||5
284400|NCT00283387|694690|P1|STARTED|Washout Period of 2 Months||5
284401|NCT00283387|694689|P2|NOT COMPLETED|First Intervention||2
284402|NCT00283387|694690|P1|NOT COMPLETED|First Intervention||1
284403|NCT00283387|694689|P2|COMPLETED|First Intervention||5
284404|NCT00283387|694690|P1|COMPLETED|First Intervention||5
284405|NCT00283387|694689|P2|STARTED|First Intervention||7
284406|NCT00283387|694690|P1|STARTED|First Intervention||6
284407|NCT00283296|694696|P1|NOT COMPLETED|Overall Study||5
284408|NCT00283296|694696|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
284409|NCT00283296|694696|P1|STARTED|Overall Study||14
284410|NCT00283244|694705|P3|NOT COMPLETED|Overall Study||51
284411|NCT00283244|694706|P2|NOT COMPLETED|Overall Study||51
284412|NCT00283244|694707|P1|NOT COMPLETED|Overall Study||18
284413|NCT00283244|694705|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
284414|NCT00283244|694706|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
284415|NCT00283244|694707|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
284416|NCT00283244|694705|P3|STARTED|Overall Study||51
284417|NCT00283244|694706|P2|STARTED|Overall Study||51
284418|NCT00283244|694707|P1|STARTED|Overall Study||44
284419|NCT00283075|694727|P2|NOT COMPLETED|Overall Study||0
284420|NCT00283075|694728|P1|NOT COMPLETED|Overall Study||0
284421|NCT00283075|694727|P2|COMPLETED|Overall Study||6
284422|NCT00283075|694728|P1|COMPLETED|Overall Study||25
284423|NCT00283075|694727|P2|STARTED|Overall Study||6
284424|NCT00283075|694728|P1|STARTED|Overall Study||25
284425|NCT00283062|694743|P4|NOT COMPLETED|Overall Study||49
284426|NCT00283062|694744|P3|NOT COMPLETED|Overall Study||41
284427|NCT00283062|694745|P2|NOT COMPLETED|Overall Study||7
284428|NCT00283062|694746|P1|NOT COMPLETED|Overall Study||12
284429|NCT00283062|694743|P4|COMPLETED|Overall Study||13
284430|NCT00283062|694744|P3|COMPLETED|Overall Study||15
284431|NCT00283062|694745|P2|COMPLETED|Overall Study||48
284432|NCT00283062|694746|P1|COMPLETED|Overall Study||43
284433|NCT00283062|694743|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
284434|NCT00283062|694744|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
284435|NCT00283062|694745|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
284436|NCT00283062|694746|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
284437|NCT00283062|694743|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
284438|NCT00283062|694744|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
284439|NCT00283062|694745|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
284440|NCT00283062|694746|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
284441|NCT00283062|694743|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
284442|NCT00283062|694744|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
284443|NCT00283062|694745|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
284444|NCT00283062|694746|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
284445|NCT00283062|694743|P4|STARTED|Overall Study||62
284446|NCT00283062|694744|P3|STARTED|Overall Study||56
284447|NCT00283062|694745|P2|STARTED|Overall Study||55
284448|NCT00283062|694746|P1|STARTED|Overall Study||55
284449|NCT00283049|694779|P3|NOT COMPLETED|Overall Study||54
284450|NCT00283049|694780|P2|NOT COMPLETED|Overall Study||45
284451|NCT00283049|694781|P1|NOT COMPLETED|Overall Study||58
284452|NCT00283049|694779|P3|COMPLETED|Overall Study||76
284453|NCT00283049|694780|P2|COMPLETED|Overall Study||83
284454|NCT00283049|694781|P1|COMPLETED|Overall Study||70
284455|NCT00283049|694779|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
284456|NCT00283049|694780|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
284457|NCT00283049|694781|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
284458|NCT00282984|694809|P2|NOT COMPLETED|Overall Study||61
284459|NCT00282984|694810|P1|NOT COMPLETED|Overall Study||51
284460|NCT00282984|694809|P2|COMPLETED|Overall Study||289
284461|NCT00282984|694810|P1|COMPLETED|Overall Study||302
284462|NCT00282984|694809|P2|STARTED|Overall Study||350
284463|NCT00282984|694810|P1|STARTED|Overall Study||353
284464|NCT00282971|694836|P2|NOT COMPLETED|Overall Study||22
284465|NCT00282971|694837|P1|NOT COMPLETED|Overall Study||34
284466|NCT00282971|694836|P2|COMPLETED|Overall Study||149
284467|NCT00282971|694837|P1|COMPLETED|Overall Study||146
284468|NCT00282971|694836|P2|STARTED|Overall Study||171
284469|NCT00282971|694837|P1|STARTED|Overall Study||180
284470|NCT00282919|694847|P1|NOT COMPLETED|Overall Study||7
284471|NCT00282919|694847|P1|COMPLETED|Overall Study||103
284472|NCT00282919|694847|P1|STARTED|Overall Study||110
284473|NCT00282867|694862|P3|NOT COMPLETED|Overall Study||0
284474|NCT00282867|694863|P2|NOT COMPLETED|Overall Study||1
284475|NCT00282867|694864|P1|NOT COMPLETED|Overall Study||1
284476|NCT00282867|694862|P3|COMPLETED|Overall Study||25
284477|NCT00282867|694863|P2|COMPLETED|Overall Study||24
284478|NCT00282867|694864|P1|COMPLETED|Overall Study||23
284479|NCT00282867|694862|P3|STARTED|Overall Study||25
284480|NCT00282867|694863|P2|STARTED|Overall Study||25
284481|NCT00282867|694864|P1|STARTED|Overall Study||24
284482|NCT00282828|694881|P3|NOT COMPLETED|Overall Study||9
284483|NCT00282828|694882|P2|NOT COMPLETED|Overall Study||12
284484|NCT00282828|694883|P1|NOT COMPLETED|Overall Study||6
284485|NCT00282828|694881|P3|COMPLETED|Overall Study||50
284486|NCT00282828|694882|P2|COMPLETED|Overall Study||47
284487|NCT00282828|694883|P1|COMPLETED|Overall Study||57
284488|NCT00282828|694881|P3|STARTED|Overall Study||59
284489|NCT00282828|694882|P2|STARTED|Overall Study||59
284490|NCT00282828|694883|P1|STARTED|Overall Study||63
284491|NCT00282815|694896|P2|NOT COMPLETED|Overall Study||6
284492|NCT00282815|694897|P1|NOT COMPLETED|Overall Study||7
284493|NCT00282815|694896|P2|COMPLETED|Overall Study||11
284494|NCT00282815|694897|P1|COMPLETED|Overall Study||8
284495|NCT00282815|694896|P2|STARTED|Overall Study||17
284496|NCT00282815|694897|P1|STARTED|Overall Study||15
284497|NCT00282672|694910|P4|NOT COMPLETED|5 Year: Follow up||5
284498|NCT00282672|694911|P3|NOT COMPLETED|5 Year: Follow up||0
284499|NCT00282672|694912|P2|NOT COMPLETED|5 Year: Follow up||5
284500|NCT00282672|694913|P1|NOT COMPLETED|5 Year: Follow up||1
284501|NCT00282672|694910|P4|COMPLETED|5 Year: Follow up||20
284502|NCT00282672|694911|P3|COMPLETED|5 Year: Follow up||12
284503|NCT00282672|694912|P2|COMPLETED|5 Year: Follow up||27
284504|NCT00282672|694913|P1|COMPLETED|5 Year: Follow up||14
284505|NCT00282672|694910|P4|STARTED|5 Year: Follow up|11 withdrew|25
284506|NCT00282672|694911|P3|STARTED|5 Year: Follow up|3 withdrew|12
284507|NCT00282672|694912|P2|STARTED|5 Year: Follow up|7 withdrew|32
284508|NCT00282672|694913|P1|STARTED|5 Year: Follow up|1 withdrew|15
284509|NCT00282672|694910|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
284510|NCT00282672|694911|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
284511|NCT00282672|694912|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
284512|NCT00282672|694913|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
284513|NCT00282672|694910|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
284514|NCT00282672|694911|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
284515|NCT00282672|694912|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
284516|NCT00282672|694913|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
284517|NCT00282672|694910|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
284518|NCT00282672|694911|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
284519|NCT00282672|694912|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
284520|NCT00282672|694913|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
284521|NCT00282672|694910|P4|NOT COMPLETED|1 Year||4
284522|NCT00282672|694911|P3|NOT COMPLETED|1 Year||1
284523|NCT00282672|694912|P2|NOT COMPLETED|1 Year||2
284524|NCT00282672|694913|P1|NOT COMPLETED|1 Year||3
284525|NCT00282672|694910|P4|COMPLETED|1 Year||38
284526|NCT00282672|694911|P3|COMPLETED|1 Year||20
284527|NCT00282672|694912|P2|COMPLETED|1 Year||40
284528|NCT00282672|694913|P1|COMPLETED|1 Year||19
284529|NCT00282672|694910|P4|STARTED|1 Year||42
284530|NCT00282672|694911|P3|STARTED|1 Year||21
284531|NCT00282672|694912|P2|STARTED|1 Year||42
284532|NCT00282672|694913|P1|STARTED|1 Year||22
284533|NCT00282568|694961|P1|NOT COMPLETED|Extended Treatment Period||24
284534|NCT00282568|694961|P1|COMPLETED|Extended Treatment Period||42
284535|NCT00282568|694961|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
284536|NCT00282568|694961|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
284537|NCT00282568|694961|P1|COMPLETED|Pharmacokinetic Treatment Period||67
284538|NCT00282568|694961|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
284539|NCT00282568|694961|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
284540|NCT00282568|694961|P1|STARTED|Pharmacokinetic Treatment Period||70
284541|NCT00282464|694987|P2|NOT COMPLETED|Overall Study||62
284542|NCT00282464|694988|P1|NOT COMPLETED|Overall Study||73
284543|NCT00282464|694987|P2|COMPLETED|Overall Study||134
284544|NCT00282464|694988|P1|COMPLETED|Overall Study||112
284545|NCT00282464|694987|P2|STARTED|Overall Study||196
284546|NCT00282464|694988|P1|STARTED|Overall Study||185
284547|NCT00282438|695038|P2|NOT COMPLETED|Overall Study||1
284548|NCT00282438|695039|P1|NOT COMPLETED|Overall Study||1
284549|NCT00282438|695038|P2|COMPLETED|Overall Study||0
284550|NCT00282438|695039|P1|COMPLETED|Overall Study||0
284551|NCT00282438|695038|P2|STARTED|Overall Study||1
284552|NCT00282438|695039|P1|STARTED|Overall Study||1
284553|NCT00282347|695047|P2|NOT COMPLETED|B Cell Follow-up Period||0
284554|NCT00282347|695048|P1|NOT COMPLETED|B Cell Follow-up Period||5
284555|NCT00282347|695047|P2|COMPLETED|B Cell Follow-up Period||4
284556|NCT00282347|695048|P1|COMPLETED|B Cell Follow-up Period||15
284557|NCT00282347|695047|P2|STARTED|B Cell Follow-up Period||4
284558|NCT00282347|695048|P1|STARTED|B Cell Follow-up Period||20
284559|NCT00282347|695047|P2|NOT COMPLETED|Safety Follow-up Period||6
284560|NCT00282347|695048|P1|NOT COMPLETED|Safety Follow-up Period||3
284561|NCT00282347|695047|P2|COMPLETED|Safety Follow-up Period||57
284562|NCT00282347|695048|P1|COMPLETED|Safety Follow-up Period||64
284563|NCT00282347|695047|P2|STARTED|Safety Follow-up Period||63
284564|NCT00282347|695048|P1|STARTED|Safety Follow-up Period||67
284565|NCT00282347|695047|P2|NOT COMPLETED|Treatment Period||9
284566|NCT00282347|695048|P1|NOT COMPLETED|Treatment Period||5
284567|NCT00282347|695047|P2|COMPLETED|Treatment Period||63
284568|NCT00282347|695048|P1|COMPLETED|Treatment Period||67
284569|NCT00282347|695047|P2|STARTED|Treatment Period||72
284570|NCT00282347|695048|P1|STARTED|Treatment Period||72
284571|NCT00282334|695074|P2|NOT COMPLETED|Overall Study||5
284572|NCT00282334|695075|P1|NOT COMPLETED|Overall Study||8
284573|NCT00282334|695074|P2|COMPLETED|Overall Study||118
284574|NCT00282334|695075|P1|COMPLETED|Overall Study||105
284575|NCT00282334|695074|P2|STARTED|Overall Study||123
284576|NCT00282334|695075|P1|STARTED|Overall Study||113
284577|NCT00282308|695083|P3|NOT COMPLETED|Safety Follow-up Period||19
284578|NCT00282308|695084|P2|NOT COMPLETED|Safety Follow-up Period||0
284579|NCT00282308|695085|P1|NOT COMPLETED|Safety Follow-up Period||0
284580|NCT00282308|695083|P3|COMPLETED|Safety Follow-up Period||81
284581|NCT00282308|695084|P2|COMPLETED|Safety Follow-up Period||0
284582|NCT00282308|695085|P1|COMPLETED|Safety Follow-up Period||0
284583|NCT00282308|695083|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
284584|NCT00282308|695084|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
284585|NCT00282308|695085|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
284586|NCT00282308|695083|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
284587|NCT00282308|695084|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
284588|NCT00282308|695085|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
284589|NCT00282308|695083|P3|COMPLETED|Optional Extension Re-treatment Period||72
284590|NCT00282308|695084|P2|COMPLETED|Optional Extension Re-treatment Period||0
284591|NCT00282308|695085|P1|COMPLETED|Optional Extension Re-treatment Period||0
284592|NCT00282308|695083|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
284593|NCT00282308|695084|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
284594|NCT00282308|695085|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
284595|NCT00282308|695083|P3|NOT COMPLETED|Treatment Period||0
284596|NCT00282308|695084|P2|NOT COMPLETED|Treatment Period||6
284597|NCT00282308|695085|P1|NOT COMPLETED|Treatment Period||4
284598|NCT00282308|695083|P3|COMPLETED|Treatment Period||0
284599|NCT00282308|695084|P2|COMPLETED|Treatment Period||28
284600|NCT00282308|695085|P1|COMPLETED|Treatment Period||65
284601|NCT00282308|695083|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
284602|NCT00282308|695084|P2|STARTED|Treatment Period||34
284603|NCT00282308|695085|P1|STARTED|Treatment Period||69
284604|NCT00282295|695115|P3|NOT COMPLETED|Overall Study||8
284605|NCT00282295|695116|P2|NOT COMPLETED|Overall Study||17
284606|NCT00282295|695117|P1|NOT COMPLETED|Overall Study||3
284607|NCT00282295|695115|P3|COMPLETED|Overall Study||441
284608|NCT00282295|695116|P2|COMPLETED|Overall Study||429
284609|NCT00282295|695117|P1|COMPLETED|Overall Study||443
284610|NCT00282295|695115|P3|STARTED|Overall Study||449
284611|NCT00282295|695116|P2|STARTED|Overall Study||446
284612|NCT00282295|695117|P1|STARTED|Overall Study||446
284613|NCT00282282|695166|P1|NOT COMPLETED|Overall Study||0
284614|NCT00282282|695166|P1|COMPLETED|Overall Study||29
284615|NCT00282282|695166|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
284616|NCT00282256|695172|P1|NOT COMPLETED|Extension Treatment Period||2
284617|NCT00282256|695172|P1|COMPLETED|Extension Treatment Period||16
284618|NCT00282256|695172|P1|STARTED|Extension Treatment Period||18
284619|NCT00282256|695172|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
284620|NCT00282256|695172|P1|COMPLETED|Pharmacokinetic Treatment Period||18
284621|NCT00282256|695172|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
284622|NCT00282256|695172|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
284623|NCT00282256|695172|P1|STARTED|Pharmacokinetic Treatment Period||19
284624|NCT00282243|695193|P1|NOT COMPLETED|Extension Treatment Period||22
284625|NCT00282243|695193|P1|COMPLETED|Extension Treatment Period||43
284626|NCT00282243|695193|P1|STARTED|Extension Treatment Period||65
284627|NCT00282243|695193|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
284628|NCT00282243|695193|P1|COMPLETED|Pharmacokinetic Treatment Period||65
284629|NCT00282243|695193|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
284630|NCT00282243|695193|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
284631|NCT00282243|695193|P1|STARTED|Pharmacokinetic Treatment Period||70
284632|NCT00282152|695219|P2|NOT COMPLETED|Overall Study||0
284633|NCT00282152|695220|P1|NOT COMPLETED|Overall Study||1
284634|NCT00282152|695219|P2|COMPLETED|Overall Study||15
284635|NCT00282152|695220|P1|COMPLETED|Overall Study||14
284636|NCT00282152|695219|P2|STARTED|Overall Study||15
284637|NCT00282152|695220|P1|STARTED|Overall Study||15
284638|NCT00282113|695241|P3|NOT COMPLETED|Overall Study||0
284639|NCT00282113|695242|P2|NOT COMPLETED|Overall Study||0
284640|NCT00282113|695243|P1|NOT COMPLETED|Overall Study||1
284641|NCT00282113|695241|P3|COMPLETED|Overall Study||29
284642|NCT00282113|695242|P2|COMPLETED|Overall Study||30
284643|NCT00282113|695243|P1|COMPLETED|Overall Study||30
284644|NCT00282113|695241|P3|STARTED|Overall Study||29
284645|NCT00282113|695242|P2|STARTED|Overall Study||30
284646|NCT00282113|695243|P1|STARTED|Overall Study||31
284647|NCT00282087|695257|P1|NOT COMPLETED|Overall Study||1
284648|NCT00282087|695257|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
284649|NCT00282087|695257|P1|STARTED|Overall Study||47
284650|NCT00282048|695270|P1|NOT COMPLETED|Overall Study||62
284651|NCT00282048|695270|P1|COMPLETED|Overall Study||0
284652|NCT00282048|695270|P1|STARTED|Overall Study||62
284653|NCT00281957|695284|P2|NOT COMPLETED|Overall Study||42
284654|NCT00281957|695285|P1|NOT COMPLETED|Overall Study||67
284655|NCT00281957|695284|P2|COMPLETED|Overall Study||0
284656|NCT00281957|695285|P1|COMPLETED|Overall Study||0
284657|NCT00281957|695284|P2|Eligible and Received Treatment|Overall Study||39
284658|NCT00281957|695285|P1|Eligible and Received Treatment|Overall Study||63
284659|NCT00281957|695284|P2|Eligible|Overall Study||40
284660|NCT00281957|695285|P1|Eligible|Overall Study||66
284661|NCT00281957|695284|P2|STARTED|Overall Study||42
284662|NCT00281957|695285|P1|STARTED|Overall Study||67
284663|NCT00281918|695299|P2|NOT COMPLETED|Overall Study||108
284664|NCT00281918|695300|P1|NOT COMPLETED|Overall Study||142
284665|NCT00281918|695299|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
284666|NCT00281918|695300|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
284667|NCT00281918|695299|P2|Safety Population; Received Study Drug|Overall Study||402
284668|NCT00281918|695300|P1|Safety Population; Received Study Drug|Overall Study||398
284669|NCT00281918|695299|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
284670|NCT00281918|695300|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
284671|NCT00281879|695334|P8|NOT COMPLETED|Overall Study||1
284672|NCT00281879|695335|P7|NOT COMPLETED|Overall Study||0
284673|NCT00281879|695336|P6|NOT COMPLETED|Overall Study||9
284674|NCT00281879|695337|P5|NOT COMPLETED|Overall Study||6
284675|NCT00281879|695338|P4|NOT COMPLETED|Overall Study||0
284676|NCT00281879|695339|P3|NOT COMPLETED|Overall Study||20
284677|NCT00281879|695340|P2|NOT COMPLETED|Overall Study||36
284678|NCT00281879|695341|P1|NOT COMPLETED|Overall Study||128
284679|NCT00281879|695334|P8|COMPLETED|Overall Study||0
284680|NCT00281879|695335|P7|COMPLETED|Overall Study||0
284681|NCT00281879|695336|P6|COMPLETED|Overall Study||0
284682|NCT00281879|695337|P5|COMPLETED|Overall Study||0
284683|NCT00281879|695338|P4|COMPLETED|Overall Study||0
284684|NCT00281879|695339|P3|COMPLETED|Overall Study||0
284685|NCT00281879|695340|P2|COMPLETED|Overall Study||0
284686|NCT00281879|695341|P1|COMPLETED|Overall Study||0
284687|NCT00281879|695334|P8|STARTED|Overall Study||1
284688|NCT00281879|695335|P7|STARTED|Overall Study||0
284689|NCT00281879|695336|P6|STARTED|Overall Study||9
284690|NCT00281879|695337|P5|STARTED|Overall Study||6
284691|NCT00281879|695338|P4|STARTED|Overall Study||0
284692|NCT00281879|695339|P3|STARTED|Overall Study||20
284693|NCT00281879|695340|P2|STARTED|Overall Study||36
284694|NCT00281879|695341|P1|STARTED|Overall Study||128
284695|NCT00281840|695359|P1|NOT COMPLETED|Overall Study||25
284696|NCT00281840|695359|P1|COMPLETED|Overall Study||5
284697|NCT00281840|695359|P1|STARTED|Overall Study||30
284698|NCT00281827|695364|P1|NOT COMPLETED|Overall Study||0
284699|NCT00281827|695364|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
284700|NCT00281827|695364|P1|STARTED|Overall Study||22
284701|NCT00281697|695375|P2|NOT COMPLETED|Overall Study||197
284702|NCT00281697|695376|P1|NOT COMPLETED|Overall Study||401
284703|NCT00281697|695375|P2|COMPLETED|Overall Study||28
284704|NCT00281697|695376|P1|COMPLETED|Overall Study||58
284705|NCT00281697|695375|P2|STARTED|Overall Study||225
284706|NCT00281697|695376|P1|STARTED|Overall Study||459
284707|NCT00281658|695394|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
284708|NCT00281658|695395|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
284709|NCT00281658|695396|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
284710|NCT00281658|695394|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
284711|NCT00281658|695395|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
284712|NCT00281658|695396|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
284713|NCT00281658|695394|P3|STARTED|Open-label Monotherapy Extension Phase||149
284714|NCT00281658|695395|P2|STARTED|Open-label Monotherapy Extension Phase||0
284715|NCT00281658|695396|P1|STARTED|Open-label Monotherapy Extension Phase||0
284716|NCT00281658|695394|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
284717|NCT00281658|695395|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
284718|NCT00281658|695396|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
284719|NCT00281658|695394|P3|COMPLETED|Double-blind, Randomized Phase||0
284720|NCT00281658|695395|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
284721|NCT00281658|695396|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
284722|NCT00281658|695394|P3|STARTED|Double-blind, Randomized Phase||0
284723|NCT00281658|695395|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
284724|NCT00281658|695396|P1|STARTED|Double-blind, Randomized Phase||222
284725|NCT00281632|695413|P1|NOT COMPLETED|Overall Study||36
284726|NCT00281632|695413|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
284727|NCT00281632|695413|P1|STARTED|Overall Study||36
284728|NCT00281580|695455|P16|NOT COMPLETED|Overall Study||13
284729|NCT00281580|695456|P15|NOT COMPLETED|Overall Study||7
284730|NCT00281580|695457|P14|NOT COMPLETED|Overall Study||7
284731|NCT00281580|695458|P13|NOT COMPLETED|Overall Study||13
284732|NCT00281580|695459|P12|NOT COMPLETED|Overall Study||10
284733|NCT00281580|695460|P11|NOT COMPLETED|Overall Study||4
284734|NCT00281580|695461|P10|NOT COMPLETED|Overall Study||12
284735|NCT00281580|695462|P9|NOT COMPLETED|Overall Study||8
284736|NCT00281580|695463|P8|NOT COMPLETED|Overall Study||1
284737|NCT00281580|695464|P7|NOT COMPLETED|Overall Study||5
284738|NCT00281580|695465|P6|NOT COMPLETED|Overall Study||3
284739|NCT00281580|695466|P5|NOT COMPLETED|Overall Study||4
284740|NCT00281580|695467|P4|NOT COMPLETED|Overall Study||17
284741|NCT00281580|695468|P3|NOT COMPLETED|Overall Study||5
284742|NCT00281580|695469|P2|NOT COMPLETED|Overall Study||1
284743|NCT00281580|695470|P1|NOT COMPLETED|Overall Study||7
284744|NCT00281580|695455|P16|COMPLETED|Overall Study||116
284745|NCT00281580|695456|P15|COMPLETED|Overall Study||133
284746|NCT00281580|695457|P14|COMPLETED|Overall Study||43
284747|NCT00281580|695458|P13|COMPLETED|Overall Study||129
284748|NCT00281580|695459|P12|COMPLETED|Overall Study||136
284749|NCT00281580|695460|P11|COMPLETED|Overall Study||44
284750|NCT00281580|695461|P10|COMPLETED|Overall Study||117
284751|NCT00281580|695462|P9|COMPLETED|Overall Study||135
284752|NCT00281580|695463|P8|COMPLETED|Overall Study||46
284753|NCT00281580|695464|P7|COMPLETED|Overall Study||39
284754|NCT00281580|695465|P6|COMPLETED|Overall Study||43
284755|NCT00281580|695466|P5|COMPLETED|Overall Study||40
284756|NCT00281580|695467|P4|COMPLETED|Overall Study||118
284757|NCT00281580|695468|P3|COMPLETED|Overall Study||125
284758|NCT00281580|695469|P2|COMPLETED|Overall Study||41
284759|NCT00281580|695470|P1|COMPLETED|Overall Study||39
284760|NCT00281580|695455|P16|STARTED|Overall Study||129
284761|NCT00281580|695456|P15|STARTED|Overall Study||140
284762|NCT00281580|695457|P14|STARTED|Overall Study||50
284763|NCT00281580|695458|P13|STARTED|Overall Study||142
284764|NCT00281580|695459|P12|STARTED|Overall Study||146
284765|NCT00281580|695460|P11|STARTED|Overall Study||48
284766|NCT00281580|695461|P10|STARTED|Overall Study||129
284767|NCT00281580|695462|P9|STARTED|Overall Study||143
284768|NCT00281580|695463|P8|STARTED|Overall Study||47
284769|NCT00281580|695464|P7|STARTED|Overall Study||44
284770|NCT00281580|695465|P6|STARTED|Overall Study||46
284771|NCT00281580|695466|P5|STARTED|Overall Study||44
284772|NCT00281580|695467|P4|STARTED|Overall Study||135
284773|NCT00281580|695468|P3|STARTED|Overall Study||130
284774|NCT00281580|695469|P2|STARTED|Overall Study||42
284775|NCT00281580|695470|P1|STARTED|Overall Study||46
284776|NCT00281528|695817|P3|NOT COMPLETED|Overall Study||79
284777|NCT00281528|695818|P2|NOT COMPLETED|Overall Study||54
284778|NCT00281528|695819|P1|NOT COMPLETED|Overall Study||75
284779|NCT00281528|695817|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
284780|NCT00281528|695818|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
284781|NCT00281528|695819|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
284782|NCT00281528|695817|P3|STARTED|Overall Study||79
284783|NCT00281528|695818|P2|STARTED|Overall Study||54
284784|NCT00281528|695819|P1|STARTED|Overall Study||75
284785|NCT00281463|695863|P1|NOT COMPLETED|Overall Study||0
284786|NCT00281463|695863|P1|COMPLETED|Overall Study||45
284787|NCT00281463|695863|P1|STARTED|Overall Study||45
284788|NCT00281320|695870|P2|NOT COMPLETED|Overall Study||21
284789|NCT00281320|695871|P1|NOT COMPLETED|Overall Study||25
284790|NCT00281320|695870|P2|COMPLETED|Overall Study||40
284791|NCT00281320|695871|P1|COMPLETED|Overall Study||36
284792|NCT00281320|695870|P2|STARTED|Overall Study||61
284793|NCT00281320|695871|P1|STARTED|Overall Study||61
284794|NCT00281099|695893|P2|NOT COMPLETED|Overall Study||222
284795|NCT00281099|695894|P1|NOT COMPLETED|Overall Study||205
284796|NCT00281099|695893|P2|COMPLETED|Overall Study||296
284797|NCT00281099|695894|P1|COMPLETED|Overall Study||308
284798|NCT00281099|695893|P2|STARTED|Overall Study||518
284799|NCT00281099|695894|P1|STARTED|Overall Study||513
284800|NCT00281021|695935|P1|NOT COMPLETED|Overall Study||2
284801|NCT00281021|695935|P1|COMPLETED|Overall Study||24
284802|NCT00281021|695935|P1|STARTED|Overall Study||26
284803|NCT00280917|695943|P4|NOT COMPLETED|Overall Study||2
284804|NCT00280917|695944|P3|NOT COMPLETED|Overall Study||6
284805|NCT00280917|695945|P2|NOT COMPLETED|Overall Study||6
284806|NCT00280917|695946|P1|NOT COMPLETED|Overall Study||2
284807|NCT00280917|695943|P4|COMPLETED|Overall Study||61
284808|NCT00280917|695944|P3|COMPLETED|Overall Study||57
284809|NCT00280917|695945|P2|COMPLETED|Overall Study||57
284810|NCT00280917|695946|P1|COMPLETED|Overall Study||63
284811|NCT00280917|695943|P4|STARTED|Overall Study||63
284812|NCT00280917|695944|P3|STARTED|Overall Study||63
284813|NCT00280917|695945|P2|STARTED|Overall Study||63
284814|NCT00280917|695946|P1|STARTED|Overall Study||65
284815|NCT00280904|695956|P1|NOT COMPLETED|Overall Study||0
284816|NCT00280904|695956|P1|COMPLETED|Overall Study||433
284817|NCT00280904|695956|P1|STARTED|Overall Study||433
284818|NCT00280826|695961|P1|NOT COMPLETED|Overall Study||0
284819|NCT00280826|695961|P1|COMPLETED|Overall Study||6
284820|NCT00280826|695961|P1|STARTED|Overall Study||6
284821|NCT00280748|695969|P1|NOT COMPLETED|Overall Study||4
284822|NCT00280748|695969|P1|COMPLETED|Overall Study||6
284823|NCT00280748|695969|P1|STARTED|Overall Study||10
284824|NCT00280735|695979|P1|NOT COMPLETED|Overall Study||18
284825|NCT00280735|695979|P1|COMPLETED|Overall Study||57
284826|NCT00280735|695979|P1|Received Adequate Exposure|Overall Study||57
284827|NCT00280735|695979|P1|Received Treatment|Overall Study||72
284828|NCT00280735|695979|P1|STARTED|Overall Study||75
284829|NCT00280683|695991|P2|NOT COMPLETED|Overall Study||3
284830|NCT00280683|695992|P1|NOT COMPLETED|Overall Study||2
284831|NCT00280683|695991|P2|COMPLETED|Overall Study||7
284832|NCT00280683|695992|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
284833|NCT00280683|695991|P2|STARTED|Overall Study||10
284834|NCT00280683|695992|P1|STARTED|Overall Study||10
284835|NCT00280566|696002|P3|NOT COMPLETED|Period 2 Double Blind||57
284836|NCT00280566|696003|P2|NOT COMPLETED|Period 2 Double Blind||43
284837|NCT00280566|696004|P1|NOT COMPLETED|Period 2 Double Blind||0
284838|NCT00280566|696002|P3|COMPLETED|Period 2 Double Blind||54
284839|NCT00280566|696003|P2|COMPLETED|Period 2 Double Blind||84
284840|NCT00280566|696004|P1|COMPLETED|Period 2 Double Blind||0
284841|NCT00280566|696002|P3|STARTED|Period 2 Double Blind||111
284842|NCT00280566|696003|P2|STARTED|Period 2 Double Blind||127
284843|NCT00280566|696004|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
284844|NCT00280566|696002|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
284845|NCT00280566|696003|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
284846|NCT00280566|696004|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
284847|NCT00280566|696002|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
284848|NCT00280566|696003|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
284849|NCT00280566|696004|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
284850|NCT00280566|696002|P3|STARTED|Period 1 Open Label Ziprasidone||0
284851|NCT00280566|696003|P2|STARTED|Period 1 Open Label Ziprasidone||0
284852|NCT00280566|696004|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
284853|NCT00280397|696029|P1|NOT COMPLETED|Overall Study||1
284854|NCT00280397|696029|P1|COMPLETED|Overall Study||26
284855|NCT00280397|696029|P1|STARTED|Overall Study||27
284856|NCT00280384|696044|P8|NOT COMPLETED|Overall Study||0
284857|NCT00280384|696045|P7|NOT COMPLETED|Overall Study||0
284858|NCT00280384|696046|P6|NOT COMPLETED|Overall Study||0
284859|NCT00280384|696047|P5|NOT COMPLETED|Overall Study||0
284860|NCT00280384|696048|P4|NOT COMPLETED|Overall Study||0
284861|NCT00280384|696049|P3|NOT COMPLETED|Overall Study||0
284862|NCT00280384|696050|P2|NOT COMPLETED|Overall Study||0
284863|NCT00280384|696051|P1|NOT COMPLETED|Overall Study||0
284864|NCT00280384|696044|P8|COMPLETED|Overall Study||6
284865|NCT00280384|696045|P7|COMPLETED|Overall Study||6
284866|NCT00280384|696046|P6|COMPLETED|Overall Study||6
284867|NCT00280384|696047|P5|COMPLETED|Overall Study||6
284868|NCT00280384|696048|P4|COMPLETED|Overall Study||6
284869|NCT00280384|696049|P3|COMPLETED|Overall Study||6
284870|NCT00280384|696050|P2|COMPLETED|Overall Study||6
284871|NCT00280384|696051|P1|COMPLETED|Overall Study||6
284872|NCT00280384|696044|P8|STARTED|Overall Study||6
284873|NCT00280384|696045|P7|STARTED|Overall Study||6
284874|NCT00280384|696046|P6|STARTED|Overall Study||6
284875|NCT00280384|696047|P5|STARTED|Overall Study||6
284876|NCT00280384|696048|P4|STARTED|Overall Study||6
284877|NCT00280384|696049|P3|STARTED|Overall Study||6
284878|NCT00280384|696050|P2|STARTED|Overall Study||6
284879|NCT00280384|696051|P1|STARTED|Overall Study||6
284880|NCT00280293|696095|P2|NOT COMPLETED|Overall Study||23
284881|NCT00280293|696096|P1|NOT COMPLETED|Overall Study||26
284882|NCT00280293|696095|P2|COMPLETED|Overall Study||34
284883|NCT00280293|696096|P1|COMPLETED|Overall Study||29
284884|NCT00280293|696095|P2|STARTED|Overall Study||57
284885|NCT00280293|696096|P1|STARTED|Overall Study||55
284886|NCT00280241|696108|P1|NOT COMPLETED|Overall Study||10
284887|NCT00280241|696108|P1|COMPLETED|Overall Study||55
284888|NCT00280241|696108|P1|STARTED|Overall Study||65
284889|NCT00280150|696119|P4|NOT COMPLETED|Overall Study||10
284890|NCT00280150|696120|P3|NOT COMPLETED|Overall Study||5
284891|NCT00280150|696121|P2|NOT COMPLETED|Overall Study||1
284892|NCT00280150|696122|P1|NOT COMPLETED|Overall Study||3
284893|NCT00280150|696119|P4|COMPLETED|Overall Study||20
284894|NCT00280150|696120|P3|COMPLETED|Overall Study||1
284895|NCT00280150|696121|P2|COMPLETED|Overall Study||4
284896|NCT00280150|696122|P1|COMPLETED|Overall Study||2
284897|NCT00280150|696119|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
284898|NCT00280150|696120|P3|Consolidation Therapy|Overall Study||3
284899|NCT00280150|696121|P2|Consolidation Therapy|Overall Study||5
284900|NCT00280150|696122|P1|Consolidation Therapy|Overall Study||2
284901|NCT00280150|696119|P4|Cohort Induction|Overall Study||30
284902|NCT00280150|696120|P3|Cohort Induction|Overall Study||6
284903|NCT00280150|696121|P2|Cohort Induction|Overall Study||5
284904|NCT00280150|696122|P1|Cohort Induction|Overall Study||5
284905|NCT00280150|696119|P4|STARTED|Overall Study||30
284906|NCT00280150|696120|P3|STARTED|Overall Study||6
284907|NCT00280150|696121|P2|STARTED|Overall Study||5
284908|NCT00280150|696122|P1|STARTED|Overall Study||5
284909|NCT00280059|696137|P2|NOT COMPLETED|Extension Phase||38
284910|NCT00280059|696138|P1|NOT COMPLETED|Extension Phase||49
284911|NCT00280059|696137|P2|COMPLETED|Extension Phase||177
284912|NCT00280059|696138|P1|COMPLETED|Extension Phase||145
284913|NCT00280059|696137|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
284914|NCT00280059|696138|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
284915|NCT00280059|696137|P2|NOT COMPLETED|Efficacy Assessment Phase||80
284916|NCT00280059|696138|P1|NOT COMPLETED|Efficacy Assessment Phase||94
284917|NCT00280059|696137|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
284918|NCT00280059|696138|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
284919|NCT00280059|696137|P2|STARTED|Efficacy Assessment Phase||330
284920|NCT00280059|696138|P1|STARTED|Efficacy Assessment Phase||330
284921|NCT00279955|696187|P3|NOT COMPLETED|Overall Study||0
284922|NCT00279955|696188|P2|NOT COMPLETED|Overall Study||0
284923|NCT00279955|696189|P1|NOT COMPLETED|Overall Study||0
284924|NCT00279955|696187|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
284925|NCT00279955|696188|P2|COMPLETED|Overall Study||486
284926|NCT00279955|696189|P1|COMPLETED|Overall Study||157
284927|NCT00279955|696187|P3|STARTED|Overall Study||358
284928|NCT00279955|696188|P2|STARTED|Overall Study||486
284929|NCT00279955|696189|P1|STARTED|Overall Study||157
284930|NCT00279916|696202|P2|NOT COMPLETED|Overall Study||5
284931|NCT00279916|696203|P1|NOT COMPLETED|Overall Study||7
284932|NCT00279916|696202|P2|COMPLETED|Overall Study||41
284933|NCT00279916|696203|P1|COMPLETED|Overall Study||38
284934|NCT00279916|696202|P2|STARTED|Overall Study||46
284935|NCT00279916|696203|P1|STARTED|Overall Study||45
284936|NCT00279708|696225|P2|NOT COMPLETED|Overall Study||4
284937|NCT00279708|696226|P1|NOT COMPLETED|Overall Study||3
284938|NCT00279708|696225|P2|COMPLETED|Overall Study||24
284939|NCT00279708|696226|P1|COMPLETED|Overall Study||24
284940|NCT00279708|696225|P2|STARTED|Overall Study||28
284941|NCT00279708|696226|P1|STARTED|Overall Study|"Started meaning randomized"|27
284942|NCT00279591|696234|P2|NOT COMPLETED|Overall Study||0
284943|NCT00279591|696235|P1|NOT COMPLETED|Overall Study||0
284944|NCT00279591|696234|P2|COMPLETED|Overall Study||46
284945|NCT00279591|696235|P1|COMPLETED|Overall Study||48
284946|NCT00279591|696234|P2|STARTED|Overall Study||46
284947|NCT00279591|696235|P1|STARTED|Overall Study||48
284948|NCT00279500|696249|P1|NOT COMPLETED|Overall Study||0
284949|NCT00279500|696249|P1|COMPLETED|Overall Study|6 patients treated|6
284950|NCT00279500|696249|P1|STARTED|Overall Study|6 patients treated|6
284951|NCT00279305|696255|P2|NOT COMPLETED|Overall Study||1
284952|NCT00279305|696256|P1|NOT COMPLETED|Overall Study||8
284953|NCT00279305|696255|P2|COMPLETED|Overall Study||29
284954|NCT00279305|696256|P1|COMPLETED|Overall Study||49
284955|NCT00279305|696255|P2|STARTED|Overall Study||30
284956|NCT00279305|696256|P1|STARTED|Overall Study||57
284957|NCT00279214|696264|P2|NOT COMPLETED|Overall Study||2
284958|NCT00279214|696265|P1|NOT COMPLETED|Overall Study||3
284959|NCT00279214|696264|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
284960|NCT00279214|696265|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
284961|NCT00279214|696264|P2|STARTED|Overall Study||21
284962|NCT00279214|696265|P1|STARTED|Overall Study||22
284963|NCT00279201|696295|P6|NOT COMPLETED|Intensification Addendum||37
284964|NCT00279201|696296|P5|NOT COMPLETED|Intensification Addendum||29
284965|NCT00279201|696297|P4|NOT COMPLETED|Intensification Addendum||28
284966|NCT00279201|696298|P3|NOT COMPLETED|Intensification Addendum||23
284967|NCT00279201|696299|P2|NOT COMPLETED|Intensification Addendum||0
284968|NCT00279201|696300|P1|NOT COMPLETED|Intensification Addendum||0
284969|NCT00279201|696295|P6|COMPLETED|Intensification Addendum||162
284970|NCT00279201|696296|P5|COMPLETED|Intensification Addendum||142
284971|NCT00279201|696297|P4|COMPLETED|Intensification Addendum||172
284972|NCT00279201|696298|P3|COMPLETED|Intensification Addendum||151
284973|NCT00279201|696299|P2|COMPLETED|Intensification Addendum||0
284974|NCT00279201|696300|P1|COMPLETED|Intensification Addendum||0
284975|NCT00279201|696295|P6|STARTED|Intensification Addendum||199
284976|NCT00279201|696296|P5|STARTED|Intensification Addendum||171
284977|NCT00279201|696297|P4|STARTED|Intensification Addendum||200
284978|NCT00279201|696298|P3|STARTED|Intensification Addendum||174
284979|NCT00279201|696299|P2|STARTED|Intensification Addendum||0
284980|NCT00279201|696300|P1|STARTED|Intensification Addendum||0
284981|NCT00279201|696295|P6|NOT COMPLETED|Maintenance||0
284982|NCT00279201|696296|P5|NOT COMPLETED|Maintenance||0
284983|NCT00279201|696297|P4|NOT COMPLETED|Maintenance||0
284984|NCT00279201|696298|P3|NOT COMPLETED|Maintenance||0
284985|NCT00279201|696299|P2|NOT COMPLETED|Maintenance||234
284986|NCT00279201|696300|P1|NOT COMPLETED|Maintenance||231
284987|NCT00279201|696295|P6|COMPLETED|Maintenance||0
284988|NCT00279201|696296|P5|COMPLETED|Maintenance||0
284989|NCT00279201|696297|P4|COMPLETED|Maintenance||0
284990|NCT00279201|696298|P3|COMPLETED|Maintenance||0
284991|NCT00279201|696299|P2|COMPLETED|Maintenance||239
284992|NCT00279201|696300|P1|COMPLETED|Maintenance||188
284993|NCT00279201|696295|P6|STARTED|Maintenance||0
284994|NCT00279201|696296|P5|STARTED|Maintenance||0
284995|NCT00279201|696297|P4|STARTED|Maintenance||0
284996|NCT00279201|696298|P3|STARTED|Maintenance||0
284997|NCT00279201|696299|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
284998|NCT00279201|696300|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
284999|NCT00279201|696295|P6|NOT COMPLETED|Initiation||0
285000|NCT00279201|696296|P5|NOT COMPLETED|Initiation||0
285001|NCT00279201|696297|P4|NOT COMPLETED|Initiation||0
285002|NCT00279201|696298|P3|NOT COMPLETED|Initiation||0
285003|NCT00279201|696299|P2|NOT COMPLETED|Initiation||145
285004|NCT00279201|696300|P1|NOT COMPLETED|Initiation||128
285005|NCT00279201|696295|P6|COMPLETED|Initiation||0
285006|NCT00279201|696296|P5|COMPLETED|Initiation||0
285007|NCT00279201|696297|P4|COMPLETED|Initiation||0
285008|NCT00279201|696298|P3|COMPLETED|Initiation||0
285009|NCT00279201|696299|P2|COMPLETED|Initiation||900
285010|NCT00279201|696300|P1|COMPLETED|Initiation||918
285011|NCT00279201|696295|P6|STARTED|Initiation||0
285012|NCT00279201|696296|P5|STARTED|Initiation||0
285013|NCT00279201|696297|P4|STARTED|Initiation||0
285014|NCT00279201|696298|P3|STARTED|Initiation||0
285015|NCT00279201|696299|P2|STARTED|Initiation||1045
285016|NCT00279201|696300|P1|STARTED|Initiation||1046
285017|NCT00278993|696444|P1|NOT COMPLETED|Overall Study||107
285018|NCT00278993|696444|P1|COMPLETED|Overall Study||1
285019|NCT00278993|696444|P1|STARTED|Overall Study||108
285020|NCT00278954|696452|P1|NOT COMPLETED|Overall Study||5
285021|NCT00278954|696452|P1|COMPLETED|Overall Study||45
285022|NCT00278954|696452|P1|STARTED|Overall Study||50
285023|NCT00278915|696460|P1|NOT COMPLETED|Overall Study||1
285024|NCT00278915|696460|P1|COMPLETED|Overall Study||29
285025|NCT00278915|696460|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
285026|NCT00278889|696496|P3|NOT COMPLETED|Overall Study||20
285027|NCT00278889|696497|P2|NOT COMPLETED|Overall Study||27
285028|NCT00278889|696498|P1|NOT COMPLETED|Overall Study||25
285029|NCT00278889|696496|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
285030|NCT00278889|696497|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
285031|NCT00278889|696498|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
285032|NCT00278889|696496|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
285033|NCT00278889|696497|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
285034|NCT00278889|696498|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
285035|NCT00278889|696496|P3|STARTED|Overall Study|Randomised|68
285036|NCT00278889|696497|P2|STARTED|Overall Study|Randomised|74
285037|NCT00278889|696498|P1|STARTED|Overall Study|Randomised|73
285038|NCT00278876|696524|P1|NOT COMPLETED|Overall Study||9
285039|NCT00278876|696524|P1|COMPLETED|Overall Study||38
285040|NCT00278876|696524|P1|STARTED|Overall Study||47
285041|NCT00278863|696532|P2|NOT COMPLETED|Overall Study||2
285042|NCT00278863|696533|P1|NOT COMPLETED|Overall Study||5
285043|NCT00278863|696532|P2|COMPLETED|Overall Study||45
285044|NCT00278863|696533|P1|COMPLETED|Overall Study||44
285045|NCT00278863|696532|P2|STARTED|Overall Study||47
285046|NCT00278863|696533|P1|STARTED|Overall Study||49
285047|NCT00278655|696541|P1|NOT COMPLETED|Overall Study||0
285048|NCT00278655|696541|P1|COMPLETED|Overall Study||21
285049|NCT00278655|696541|P1|STARTED|Overall Study||21
285050|NCT00278525|696548|P2|NOT COMPLETED|Overall Study||0
285051|NCT00278525|696549|P1|NOT COMPLETED|Overall Study||0
285052|NCT00278525|696548|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
285053|NCT00278525|696549|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
285054|NCT00278525|696548|P2|STARTED|Overall Study||10
285055|NCT00278525|696549|P1|STARTED|Overall Study||9
285056|NCT00278473|696559|P2|NOT COMPLETED|Overall Study||3
285057|NCT00278473|696560|P1|NOT COMPLETED|Overall Study||4
285058|NCT00278473|696559|P2|COMPLETED|Overall Study||40
285059|NCT00278473|696560|P1|COMPLETED|Overall Study||41
285060|NCT00278473|696559|P2|STARTED|Overall Study||43
285061|NCT00278473|696560|P1|STARTED|Overall Study||45
285062|NCT00278395|696576|P1|NOT COMPLETED|Overall Study||3
285063|NCT00278395|696576|P1|COMPLETED|Overall Study||11
285064|NCT00278395|696576|P1|STARTED|Overall Study||14
285065|NCT00278343|696583|P1|NOT COMPLETED|Overall Study||0
285066|NCT00278343|696583|P1|COMPLETED|Overall Study||74
285067|NCT00278343|696583|P1|STARTED|Overall Study||74
285068|NCT00277524|696590|P4|NOT COMPLETED|Overall Study||0
285069|NCT00277524|696591|P3|NOT COMPLETED|Overall Study||0
285070|NCT00277524|696592|P2|NOT COMPLETED|Overall Study||0
285071|NCT00277524|696593|P1|NOT COMPLETED|Overall Study||0
285072|NCT00277524|696590|P4|COMPLETED|Overall Study||850
285073|NCT00277524|696591|P3|COMPLETED|Overall Study||1088
285074|NCT00277524|696592|P2|COMPLETED|Overall Study||324
285075|NCT00277524|696593|P1|COMPLETED|Overall Study||621
285076|NCT00277524|696590|P4|STARTED|Overall Study||850
285077|NCT00277524|696591|P3|STARTED|Overall Study||1088
285078|NCT00277524|696592|P2|STARTED|Overall Study||324
285079|NCT00277524|696593|P1|STARTED|Overall Study||621
285080|NCT00277446|696611|P1|NOT COMPLETED|Overall Study||0
285081|NCT00277446|696611|P1|COMPLETED|Overall Study||13
285082|NCT00277446|696611|P1|STARTED|Overall Study||13
285083|NCT00277394|696619|P2|NOT COMPLETED|Overall Study||24
285084|NCT00277394|696620|P1|NOT COMPLETED|Overall Study||37
285085|NCT00277394|696619|P2|COMPLETED|Overall Study||246
285086|NCT00277394|696620|P1|COMPLETED|Overall Study||232
285087|NCT00277394|696619|P2|STARTED|Overall Study||270
285088|NCT00277394|696620|P1|STARTED|Overall Study||269
285089|NCT00277355|696632|P2|NOT COMPLETED|Overall Study||5
285090|NCT00277355|696633|P1|NOT COMPLETED|Overall Study||14
285091|NCT00277355|696632|P2|COMPLETED|Overall Study||22
285092|NCT00277355|696633|P1|COMPLETED|Overall Study||73
285093|NCT00277355|696632|P2|STARTED|Overall Study||27
285094|NCT00277355|696633|P1|STARTED|Overall Study||87
285095|NCT00277212|696641|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
285096|NCT00277212|696642|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
285097|NCT00277212|696643|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
285098|NCT00277212|696641|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
285099|NCT00277212|696642|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
285100|NCT00277212|696643|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
285101|NCT00277212|696641|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
285102|NCT00277212|696642|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
285103|NCT00277212|696643|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
285104|NCT00277212|696641|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
285105|NCT00277212|696642|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
285106|NCT00277212|696643|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
285107|NCT00277212|696641|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
285108|NCT00277212|696642|P2|STARTED|Phase 2 - Double-Blind Treatment||173
285109|NCT00277212|696643|P1|STARTED|Phase 2 - Double-Blind Treatment||0
285110|NCT00277212|696641|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
285111|NCT00277212|696642|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
285112|NCT00277212|696643|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
285113|NCT00277212|696641|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
285114|NCT00277212|696642|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
285115|NCT00277212|696643|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
285116|NCT00277212|696641|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
285117|NCT00277212|696642|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
285118|NCT00277212|696643|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
285119|NCT00277212|696641|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
285120|NCT00277212|696642|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
285121|NCT00277212|696643|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
285122|NCT00277212|696641|P3|STARTED|Phase 1 - Single-Blind Treatment||0
285123|NCT00277212|696642|P2|STARTED|Phase 1 - Single-Blind Treatment||0
285124|NCT00277212|696643|P1|STARTED|Phase 1 - Single-Blind Treatment||787
285125|NCT00277095|696681|P1|NOT COMPLETED|Overall Study||21
285126|NCT00277095|696681|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
285127|NCT00277095|696681|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
285128|NCT00276861|696685|P1|NOT COMPLETED|Overall Study||0
285129|NCT00276861|696685|P1|COMPLETED|Overall Study||10
285130|NCT00276861|696685|P1|STARTED|Overall Study||10
285131|NCT00276614|696690|P1|NOT COMPLETED|Overall Study||3
285132|NCT00276614|696690|P1|COMPLETED|Overall Study||1
285133|NCT00276614|696690|P1|STARTED|Overall Study||4
285134|NCT00276549|696694|P1|NOT COMPLETED|Overall Study||0
285135|NCT00276549|696694|P1|COMPLETED|Overall Study||35
285136|NCT00276549|696694|P1|STARTED|Overall Study||35
285137|NCT00276484|696701|P2|NOT COMPLETED|Overall Study||13
285138|NCT00276484|696702|P1|NOT COMPLETED|Overall Study||9
285139|NCT00276484|696701|P2|COMPLETED|Overall Study||278
285140|NCT00276484|696702|P1|COMPLETED|Overall Study||279
285141|NCT00276484|696701|P2|STARTED|Overall Study||291
285142|NCT00276484|696702|P1|STARTED|Overall Study||288
285143|NCT00276458|696734|P2|NOT COMPLETED|Overall Study||7
285144|NCT00276458|696735|P1|NOT COMPLETED|Overall Study||6
285145|NCT00276458|696734|P2|COMPLETED|Overall Study||91
285146|NCT00276458|696735|P1|COMPLETED|Overall Study||92
285147|NCT00276458|696734|P2|STARTED|Overall Study||98
285148|NCT00276458|696735|P1|STARTED|Overall Study||98
285149|NCT00276419|696769|P2|NOT COMPLETED|Second Intervention||0
285150|NCT00276419|696770|P1|NOT COMPLETED|Second Intervention||0
285151|NCT00276419|696769|P2|COMPLETED|Second Intervention||8
285152|NCT00276419|696770|P1|COMPLETED|Second Intervention||7
285153|NCT00276419|696769|P2|STARTED|Second Intervention||8
285154|NCT00276419|696770|P1|STARTED|Second Intervention||7
285155|NCT00276419|696769|P2|NOT COMPLETED|Wash-out Phase||0
285156|NCT00276419|696770|P1|NOT COMPLETED|Wash-out Phase||0
285157|NCT00276419|696769|P2|COMPLETED|Wash-out Phase||8
285158|NCT00276419|696770|P1|COMPLETED|Wash-out Phase||7
285159|NCT00276419|696769|P2|STARTED|Wash-out Phase||8
285160|NCT00276419|696770|P1|STARTED|Wash-out Phase||7
285161|NCT00276419|696769|P2|NOT COMPLETED|First Intervention||2
285162|NCT00276419|696770|P1|NOT COMPLETED|First Intervention||1
285163|NCT00276419|696769|P2|COMPLETED|First Intervention||8
285164|NCT00276419|696770|P1|COMPLETED|First Intervention||7
285165|NCT00276419|696769|P2|STARTED|First Intervention||10
285166|NCT00276419|696770|P1|STARTED|First Intervention||8
285167|NCT00276406|696782|P2|NOT COMPLETED|Overall Study||0
285168|NCT00276406|696783|P1|NOT COMPLETED|Overall Study||0
285169|NCT00276406|696782|P2|COMPLETED|Overall Study||14
285170|NCT00276406|696783|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
285171|NCT00276406|696782|P2|STARTED|Overall Study||14
285172|NCT00276406|696783|P1|STARTED|Overall Study||16
285173|NCT00276380|696813|P2|NOT COMPLETED|Overall Study||14
285174|NCT00276380|696814|P1|NOT COMPLETED|Overall Study||14
285175|NCT00276380|696813|P2|COMPLETED|Overall Study||88
285176|NCT00276380|696814|P1|COMPLETED|Overall Study||88
285177|NCT00276380|696813|P2|STARTED|Overall Study||102
285178|NCT00276380|696814|P1|STARTED|Overall Study||102
285179|NCT00276250|696835|P3|NOT COMPLETED|Overall Study||0
285180|NCT00276250|696836|P2|NOT COMPLETED|Overall Study||0
285181|NCT00276250|696837|P1|NOT COMPLETED|Overall Study||0
285182|NCT00276250|696835|P3|COMPLETED|Overall Study||0
285183|NCT00276250|696836|P2|COMPLETED|Overall Study||1
285184|NCT00276250|696837|P1|COMPLETED|Overall Study||4
285185|NCT00276250|696835|P3|STARTED|Overall Study||0
285186|NCT00276250|696836|P2|STARTED|Overall Study||1
285187|NCT00276250|696837|P1|STARTED|Overall Study||4
285188|NCT00276159|696869|P1|NOT COMPLETED|Overall Study||6
285189|NCT00276159|696869|P1|COMPLETED|Overall Study||0
285190|NCT00276159|696869|P1|STARTED|Overall Study||6
285191|NCT00276094|696879|P3|NOT COMPLETED|Overall Study||38
285192|NCT00276094|696880|P2|NOT COMPLETED|Overall Study||42
285193|NCT00276094|696881|P1|NOT COMPLETED|Overall Study||57
285194|NCT00276094|696879|P3|COMPLETED|Overall Study||230
285195|NCT00276094|696880|P2|COMPLETED|Overall Study||234
285196|NCT00276094|696881|P1|COMPLETED|Overall Study||225
285197|NCT00276094|696879|P3|STARTED|Overall Study||268
285198|NCT00276094|696880|P2|STARTED|Overall Study||276
285199|NCT00276094|696881|P1|STARTED|Overall Study||282
285200|NCT00276016|696934|P6|NOT COMPLETED|Intervention 3||0
285201|NCT00276016|696935|P5|NOT COMPLETED|Intervention 3||0
285202|NCT00276016|696936|P4|NOT COMPLETED|Intervention 3||0
285203|NCT00276016|696937|P3|NOT COMPLETED|Intervention 3||0
285204|NCT00276016|696938|P2|NOT COMPLETED|Intervention 3||0
285205|NCT00276016|696939|P1|NOT COMPLETED|Intervention 3||0
285206|NCT00276016|696934|P6|COMPLETED|Intervention 3||6
285207|NCT00276016|696935|P5|COMPLETED|Intervention 3||6
285208|NCT00276016|696936|P4|COMPLETED|Intervention 3||6
285209|NCT00276016|696937|P3|COMPLETED|Intervention 3||7
285210|NCT00276016|696938|P2|COMPLETED|Intervention 3||6
285211|NCT00276016|696939|P1|COMPLETED|Intervention 3||7
285212|NCT00276016|696934|P6|STARTED|Intervention 3||6
285213|NCT00276016|696935|P5|STARTED|Intervention 3||6
285214|NCT00276016|696936|P4|STARTED|Intervention 3||6
285215|NCT00276016|696937|P3|STARTED|Intervention 3||7
285216|NCT00276016|696938|P2|STARTED|Intervention 3||6
285217|NCT00276016|696939|P1|STARTED|Intervention 3||7
285218|NCT00276016|696934|P6|NOT COMPLETED|Wash Out 2||0
285219|NCT00276016|696935|P5|NOT COMPLETED|Wash Out 2||0
285220|NCT00276016|696936|P4|NOT COMPLETED|Wash Out 2||0
285221|NCT00276016|696937|P3|NOT COMPLETED|Wash Out 2||0
285222|NCT00276016|696938|P2|NOT COMPLETED|Wash Out 2||0
285223|NCT00276016|696939|P1|NOT COMPLETED|Wash Out 2||0
285224|NCT00276016|696934|P6|COMPLETED|Wash Out 2||6
285225|NCT00276016|696935|P5|COMPLETED|Wash Out 2||6
285226|NCT00276016|696936|P4|COMPLETED|Wash Out 2||6
285227|NCT00276016|696937|P3|COMPLETED|Wash Out 2||7
285228|NCT00276016|696938|P2|COMPLETED|Wash Out 2||6
285229|NCT00276016|696939|P1|COMPLETED|Wash Out 2||7
285230|NCT00276016|696934|P6|STARTED|Wash Out 2||6
285231|NCT00276016|696935|P5|STARTED|Wash Out 2||6
285232|NCT00276016|696936|P4|STARTED|Wash Out 2||6
285233|NCT00276016|696937|P3|STARTED|Wash Out 2||7
285234|NCT00276016|696938|P2|STARTED|Wash Out 2||6
285235|NCT00276016|696939|P1|STARTED|Wash Out 2||7
285236|NCT00276016|696934|P6|NOT COMPLETED|Intervention 2||0
285237|NCT00276016|696935|P5|NOT COMPLETED|Intervention 2||0
285238|NCT00276016|696936|P4|NOT COMPLETED|Intervention 2||0
285239|NCT00276016|696937|P3|NOT COMPLETED|Intervention 2||0
285240|NCT00276016|696938|P2|NOT COMPLETED|Intervention 2||0
285241|NCT00276016|696939|P1|NOT COMPLETED|Intervention 2||0
285242|NCT00276016|696934|P6|COMPLETED|Intervention 2||6
285243|NCT00276016|696935|P5|COMPLETED|Intervention 2||6
285244|NCT00276016|696936|P4|COMPLETED|Intervention 2||6
285245|NCT00276016|696937|P3|COMPLETED|Intervention 2||7
285246|NCT00276016|696938|P2|COMPLETED|Intervention 2||6
285247|NCT00276016|696939|P1|COMPLETED|Intervention 2||7
285248|NCT00276016|696934|P6|STARTED|Intervention 2||6
285249|NCT00276016|696935|P5|STARTED|Intervention 2||6
285250|NCT00276016|696936|P4|STARTED|Intervention 2||6
285251|NCT00276016|696937|P3|STARTED|Intervention 2||7
285252|NCT00276016|696938|P2|STARTED|Intervention 2||6
285253|NCT00276016|696939|P1|STARTED|Intervention 2||7
285254|NCT00276016|696934|P6|NOT COMPLETED|Wash Out 1||0
285255|NCT00276016|696935|P5|NOT COMPLETED|Wash Out 1||0
285256|NCT00276016|696936|P4|NOT COMPLETED|Wash Out 1||0
285257|NCT00276016|696937|P3|NOT COMPLETED|Wash Out 1||0
285258|NCT00276016|696938|P2|NOT COMPLETED|Wash Out 1||0
285259|NCT00276016|696939|P1|NOT COMPLETED|Wash Out 1||0
285260|NCT00276016|696934|P6|COMPLETED|Wash Out 1||6
285261|NCT00276016|696935|P5|COMPLETED|Wash Out 1||6
285262|NCT00276016|696936|P4|COMPLETED|Wash Out 1||6
285263|NCT00276016|696937|P3|COMPLETED|Wash Out 1||7
285264|NCT00276016|696938|P2|COMPLETED|Wash Out 1||6
285265|NCT00276016|696939|P1|COMPLETED|Wash Out 1||7
285266|NCT00276016|696934|P6|STARTED|Wash Out 1||6
285267|NCT00276016|696935|P5|STARTED|Wash Out 1||6
285268|NCT00276016|696936|P4|STARTED|Wash Out 1||6
285269|NCT00276016|696937|P3|STARTED|Wash Out 1||7
285270|NCT00276016|696938|P2|STARTED|Wash Out 1||6
285271|NCT00276016|696939|P1|STARTED|Wash Out 1||7
285272|NCT00276016|696934|P6|NOT COMPLETED|Intervention 1||0
285273|NCT00276016|696935|P5|NOT COMPLETED|Intervention 1||0
285274|NCT00276016|696936|P4|NOT COMPLETED|Intervention 1||0
285275|NCT00276016|696937|P3|NOT COMPLETED|Intervention 1||0
285276|NCT00276016|696938|P2|NOT COMPLETED|Intervention 1||1
285277|NCT00276016|696939|P1|NOT COMPLETED|Intervention 1||0
285278|NCT00276016|696934|P6|COMPLETED|Intervention 1||6
285279|NCT00276016|696935|P5|COMPLETED|Intervention 1||6
285280|NCT00276016|696936|P4|COMPLETED|Intervention 1||6
285281|NCT00276016|696937|P3|COMPLETED|Intervention 1||7
285282|NCT00276016|696938|P2|COMPLETED|Intervention 1||6
285283|NCT00276016|696939|P1|COMPLETED|Intervention 1||7
285284|NCT00276016|696934|P6|STARTED|Intervention 1||6
285285|NCT00276016|696935|P5|STARTED|Intervention 1||6
285286|NCT00276016|696936|P4|STARTED|Intervention 1||6
285287|NCT00276016|696937|P3|STARTED|Intervention 1||7
285288|NCT00276016|696938|P2|STARTED|Intervention 1||7
285289|NCT00276016|696939|P1|STARTED|Intervention 1||7
285290|NCT00275834|696951|P3|NOT COMPLETED|Overall Study||1
285291|NCT00275834|696952|P2|NOT COMPLETED|Overall Study||3
285292|NCT00275834|696953|P1|NOT COMPLETED|Overall Study||3
285293|NCT00275834|696951|P3|COMPLETED|Overall Study||74
285294|NCT00275834|696952|P2|COMPLETED|Overall Study||73
285295|NCT00275834|696953|P1|COMPLETED|Overall Study||71
285296|NCT00275834|696951|P3|Completed Study While on Study Drug|Overall Study||62
285297|NCT00275834|696952|P2|Completed Study While on Study Drug|Overall Study||51
285298|NCT00275834|696953|P1|Completed Study While on Study Drug|Overall Study||54
285299|NCT00275834|696951|P3|STARTED|Overall Study||75
285300|NCT00275834|696952|P2|STARTED|Overall Study||76
285301|NCT00275834|696953|P1|STARTED|Overall Study||74
285302|NCT00275821|696985|P3|NOT COMPLETED|Overall Study||12
285303|NCT00275821|696986|P2|NOT COMPLETED|Overall Study||23
285304|NCT00275821|696987|P1|NOT COMPLETED|Overall Study||14
285305|NCT00275821|696985|P3|COMPLETED|Overall Study||103
285306|NCT00275821|696986|P2|COMPLETED|Overall Study||95
285307|NCT00275821|696987|P1|COMPLETED|Overall Study||106
285308|NCT00275821|696985|P3|STARTED|Overall Study||115
285309|NCT00275821|696986|P2|STARTED|Overall Study||118
285310|NCT00275821|696987|P1|STARTED|Overall Study||120
285311|NCT00275561|697006|P2|NOT COMPLETED|Overall Study||6
285312|NCT00275561|697007|P1|NOT COMPLETED|Overall Study||2
285313|NCT00275561|697006|P2|COMPLETED|Overall Study||15
285314|NCT00275561|697007|P1|COMPLETED|Overall Study||19
285315|NCT00275561|697006|P2|STARTED|Overall Study||21
285316|NCT00275561|697007|P1|STARTED|Overall Study||21
285317|NCT00275509|697019|P2|NOT COMPLETED|Overall Study||1
285318|NCT00275509|697020|P1|NOT COMPLETED|Overall Study||0
285319|NCT00275509|697019|P2|COMPLETED|Overall Study||25
285320|NCT00275509|697020|P1|COMPLETED|Overall Study||30
285321|NCT00275509|697019|P2|STARTED|Overall Study||26
285322|NCT00275509|697020|P1|STARTED|Overall Study||30
285323|NCT00275392|697032|P2|NOT COMPLETED|Overall Study||2
285324|NCT00275392|697033|P1|NOT COMPLETED|Overall Study||0
285325|NCT00275392|697032|P2|COMPLETED|Overall Study||17
285326|NCT00275392|697033|P1|COMPLETED|Overall Study||20
285327|NCT00275392|697032|P2|STARTED|Overall Study||19
285328|NCT00275392|697033|P1|STARTED|Overall Study||20
285329|NCT00275340|697043|P2|NOT COMPLETED|Overall Study||4
285330|NCT00275340|697044|P1|NOT COMPLETED|Overall Study||2
285331|NCT00275340|697043|P2|COMPLETED|Overall Study||45
285332|NCT00275340|697044|P1|COMPLETED|Overall Study||50
285333|NCT00275340|697043|P2|STARTED|Overall Study||49
285334|NCT00275340|697044|P1|STARTED|Overall Study||52
285335|NCT00275301|697048|P1|NOT COMPLETED|Overall Study||5
285336|NCT00275301|697048|P1|COMPLETED|Overall Study||14
285337|NCT00275301|697048|P1|STARTED|Overall Study||19
285338|NCT00275275|697055|P3|NOT COMPLETED|Overall Study||6
285339|NCT00275275|697056|P2|NOT COMPLETED|Overall Study||2
285340|NCT00275275|697057|P1|NOT COMPLETED|Overall Study||6
285341|NCT00275275|697055|P3|COMPLETED|Overall Study||15
285342|NCT00275275|697056|P2|COMPLETED|Overall Study||18
285343|NCT00275275|697057|P1|COMPLETED|Overall Study||14
285344|NCT00275275|697055|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
285345|NCT00275275|697056|P2|STARTED|Overall Study||20
285346|NCT00275275|697057|P1|STARTED|Overall Study||20
285347|NCT00275262|697067|P2|NOT COMPLETED|Overall Study||9
285348|NCT00275262|697068|P1|NOT COMPLETED|Overall Study||6
285349|NCT00275262|697067|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
285350|NCT00275262|697068|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
285351|NCT00275262|697067|P2|STARTED|Overall Study||13
285352|NCT00275262|697068|P1|STARTED|Overall Study||12
285353|NCT00275028|697082|P1|NOT COMPLETED|Overall Study||47
285354|NCT00275028|697082|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
285355|NCT00275028|697082|P1|STARTED|Overall Study||47
285356|NCT00275002|697089|P2|NOT COMPLETED|Overall Study||16
285357|NCT00275002|697090|P1|NOT COMPLETED|Overall Study||22
285358|NCT00275002|697089|P2|COMPLETED|Overall Study||0
285359|NCT00275002|697090|P1|COMPLETED|Overall Study||3
285360|NCT00275002|697089|P2|STARTED|Overall Study||16
285361|NCT00275002|697090|P1|STARTED|Overall Study||25
285362|NCT00274937|697098|P1|NOT COMPLETED|Overall Study||20
285363|NCT00274937|697098|P1|COMPLETED|Overall Study||91
285364|NCT00274937|697098|P1|STARTED|Overall Study||111
285365|NCT00274924|697108|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
285366|NCT00274924|697109|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
285367|NCT00274924|697110|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
285368|NCT00274924|697108|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
285369|NCT00274924|697109|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
285370|NCT00274924|697110|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
285371|NCT00274924|697108|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
285372|NCT00274924|697109|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
285373|NCT00274924|697110|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
285374|NCT00274924|697108|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
285375|NCT00274924|697109|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
285376|NCT00274924|697110|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
285377|NCT00274924|697108|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
285378|NCT00274924|697109|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
285379|NCT00274924|697110|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
285380|NCT00274924|697108|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
285381|NCT00274924|697109|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
285382|NCT00274924|697110|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
285383|NCT00274924|697108|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
285384|NCT00274924|697109|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
285385|NCT00274924|697110|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
285386|NCT00274924|697108|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
285387|NCT00274924|697109|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
285388|NCT00274924|697110|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
285389|NCT00274924|697108|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
285390|NCT00274924|697109|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
285391|NCT00274924|697110|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
285392|NCT00274846|697119|P1|NOT COMPLETED|Overall Study||1
285393|NCT00274846|697119|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
285394|NCT00274846|697119|P1|STARTED|Overall Study||21
285395|NCT00274781|697127|P1|NOT COMPLETED|Overall Study||0
285396|NCT00274781|697127|P1|COMPLETED|Overall Study||30
285397|NCT00274781|697127|P1|STARTED|Overall Study||30
285398|NCT00274768|697133|P1|NOT COMPLETED|Overall Study||0
285399|NCT00274768|697133|P1|COMPLETED|Overall Study||26
285400|NCT00274768|697133|P1|STARTED|Overall Study||26
285401|NCT00274742|697143|P6|NOT COMPLETED|Overall Study||3
285402|NCT00274742|697144|P5|NOT COMPLETED|Overall Study||16
285403|NCT00274742|697145|P4|NOT COMPLETED|Overall Study||5
285404|NCT00274742|697146|P3|NOT COMPLETED|Overall Study||2
285405|NCT00274742|697147|P2|NOT COMPLETED|Overall Study||8
285406|NCT00274742|697148|P1|NOT COMPLETED|Overall Study||0
285407|NCT00274742|697143|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
285408|NCT00274742|697144|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
285409|NCT00274742|697145|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
285410|NCT00274742|697146|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
285411|NCT00274742|697147|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
285412|NCT00274742|697148|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
285413|NCT00274742|697143|P6|STARTED|Overall Study||4
285414|NCT00274742|697144|P5|STARTED|Overall Study||32
285415|NCT00274742|697145|P4|STARTED|Overall Study||9
285416|NCT00274742|697146|P3|STARTED|Overall Study||6
285417|NCT00274742|697147|P2|STARTED|Overall Study||13
285418|NCT00274742|697148|P1|STARTED|Overall Study||12
285419|NCT00274716|697186|P6|NOT COMPLETED|Phase B||1
285420|NCT00274716|697187|P5|NOT COMPLETED|Phase B||0
285421|NCT00274716|697188|P4|NOT COMPLETED|Phase B||1
285422|NCT00274716|697189|P3|NOT COMPLETED|Phase B||3
285423|NCT00274716|697190|P2|NOT COMPLETED|Phase B||4
285424|NCT00274716|697191|P1|NOT COMPLETED|Phase B||1
285425|NCT00274716|697186|P6|COMPLETED|Phase B||14
285426|NCT00274716|697187|P5|COMPLETED|Phase B||16
285427|NCT00274716|697188|P4|COMPLETED|Phase B||41
285428|NCT00274716|697189|P3|COMPLETED|Phase B||41
285429|NCT00274716|697190|P2|COMPLETED|Phase B||40
285430|NCT00274716|697191|P1|COMPLETED|Phase B||42
285431|NCT00274716|697186|P6|STARTED|Phase B||15
285432|NCT00274716|697187|P5|STARTED|Phase B||16
285433|NCT00274716|697188|P4|STARTED|Phase B||42
285434|NCT00274716|697189|P3|STARTED|Phase B||44
285435|NCT00274716|697190|P2|STARTED|Phase B||44
285436|NCT00274716|697191|P1|STARTED|Phase B||43
285437|NCT00274716|697186|P6|NOT COMPLETED|Phase A||4
285438|NCT00274716|697187|P5|NOT COMPLETED|Phase A||3
285439|NCT00274716|697188|P4|NOT COMPLETED|Phase A||9
285440|NCT00274716|697189|P3|NOT COMPLETED|Phase A||8
285441|NCT00274716|697190|P2|NOT COMPLETED|Phase A||10
285442|NCT00274716|697191|P1|NOT COMPLETED|Phase A||11
285443|NCT00274716|697186|P6|COMPLETED|Phase A||15
285444|NCT00274716|697187|P5|COMPLETED|Phase A||16
285445|NCT00274716|697188|P4|COMPLETED|Phase A||42
285446|NCT00274716|697189|P3|COMPLETED|Phase A||44
285447|NCT00274716|697190|P2|COMPLETED|Phase A||44
285448|NCT00274716|697191|P1|COMPLETED|Phase A||43
285449|NCT00274716|697186|P6|STARTED|Phase A||19
285450|NCT00274716|697187|P5|STARTED|Phase A||19
285451|NCT00274716|697188|P4|STARTED|Phase A||51
285452|NCT00274716|697189|P3|STARTED|Phase A||52
285453|NCT00274716|697190|P2|STARTED|Phase A||54
285454|NCT00274716|697191|P1|STARTED|Phase A||54
285455|NCT00274651|697253|P2|NOT COMPLETED|Overall Study||20
285456|NCT00274651|697254|P1|NOT COMPLETED|Overall Study||28
285457|NCT00274651|697253|P2|COMPLETED|Overall Study||4
285458|NCT00274651|697254|P1|COMPLETED|Overall Study||1
285459|NCT00274651|697253|P2|STARTED|Overall Study||24
285460|NCT00274651|697254|P1|STARTED|Overall Study||29
285461|NCT00274625|697269|P2|NOT COMPLETED|Overall Study||62
285462|NCT00274625|697270|P1|NOT COMPLETED|Overall Study||60
285463|NCT00274625|697269|P2|COMPLETED|Overall Study||141
285464|NCT00274625|697270|P1|COMPLETED|Overall Study||139
285465|NCT00274625|697269|P2|STARTED|Overall Study||203
285466|NCT00274625|697270|P1|STARTED|Overall Study||199
285467|NCT00274469|697278|P2|NOT COMPLETED|Overall Study||50
285468|NCT00274469|697279|P1|NOT COMPLETED|Overall Study||38
285469|NCT00274469|697278|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|53
285470|NCT00274469|697279|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|64
285471|NCT00274469|697278|P2|STARTED|Overall Study|Number of patients randomized|103
285472|NCT00274469|697279|P1|STARTED|Overall Study|Number of patients randomized|102
285473|NCT00274456|697297|P4|NOT COMPLETED|Overall Study||45
285474|NCT00274456|697298|P3|NOT COMPLETED|Overall Study||35
285475|NCT00274456|697299|P2|NOT COMPLETED|Overall Study||27
285476|NCT00274456|697300|P1|NOT COMPLETED|Overall Study||37
285477|NCT00274456|697297|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
285478|NCT00274456|697298|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
285479|NCT00274456|697299|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
285480|NCT00274456|697300|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
285481|NCT00274456|697297|P4|At Least One Response Assessment|Overall Study||70
285482|NCT00274456|697298|P3|At Least One Response Assessment|Overall Study||73
285483|NCT00274456|697299|P2|At Least One Response Assessment|Overall Study||76
285484|NCT00274456|697300|P1|At Least One Response Assessment|Overall Study||73
285485|NCT00274456|697297|P4|STARTED|Overall Study||74
285486|NCT00274456|697298|P3|STARTED|Overall Study||74
285487|NCT00274456|697299|P2|STARTED|Overall Study||76
285488|NCT00274456|697300|P1|STARTED|Overall Study||76
285489|NCT00274287|697342|P1|NOT COMPLETED|Overall Study||2
285490|NCT00274287|697342|P1|COMPLETED|Overall Study||13
285491|NCT00274287|697342|P1|STARTED|Overall Study||15
285492|NCT00274261|697348|P2|NOT COMPLETED|Overall Study||337
285493|NCT00274261|697349|P1|NOT COMPLETED|Overall Study||489
285494|NCT00274261|697348|P2|COMPLETED|Overall Study||296
285495|NCT00274261|697349|P1|COMPLETED|Overall Study||443
285496|NCT00274261|697348|P2|STARTED|Overall Study||633
285497|NCT00274261|697349|P1|STARTED|Overall Study||932
285498|NCT00273910|697363|P6|NOT COMPLETED|Overall Study||0
285499|NCT00273910|697364|P5|NOT COMPLETED|Overall Study||0
285500|NCT00273910|697365|P4|NOT COMPLETED|Overall Study||0
285501|NCT00273910|697366|P3|NOT COMPLETED|Overall Study||0
285502|NCT00273910|697367|P2|NOT COMPLETED|Overall Study||0
285503|NCT00273910|697368|P1|NOT COMPLETED|Overall Study||0
285504|NCT00273910|697363|P6|COMPLETED|Overall Study||14
285505|NCT00273910|697364|P5|COMPLETED|Overall Study||15
285506|NCT00273910|697365|P4|COMPLETED|Overall Study||19
285507|NCT00273910|697366|P3|COMPLETED|Overall Study||18
285508|NCT00273910|697367|P2|COMPLETED|Overall Study||19
285509|NCT00273910|697368|P1|COMPLETED|Overall Study||19
285510|NCT00273910|697363|P6|STARTED|Overall Study||14
285511|NCT00273910|697364|P5|STARTED|Overall Study||15
285512|NCT00273910|697365|P4|STARTED|Overall Study||19
285513|NCT00273910|697366|P3|STARTED|Overall Study||18
285514|NCT00273910|697367|P2|STARTED|Overall Study||19
285515|NCT00273910|697368|P1|STARTED|Overall Study||19
285516|NCT00273858|697388|P1|NOT COMPLETED|Overall Study||537
285517|NCT00273858|697388|P1|COMPLETED|Overall Study||343
285518|NCT00273858|697388|P1|STARTED|Overall Study||880
285519|NCT00273793|697403|P6|NOT COMPLETED|Overall Study||0
285520|NCT00273793|697404|P5|NOT COMPLETED|Overall Study||0
285521|NCT00273793|697405|P4|NOT COMPLETED|Overall Study||0
285522|NCT00273793|697406|P3|NOT COMPLETED|Overall Study||0
285523|NCT00273793|697407|P2|NOT COMPLETED|Overall Study||0
285524|NCT00273793|697408|P1|NOT COMPLETED|Overall Study||0
285525|NCT00273793|697403|P6|COMPLETED|Overall Study||29
285526|NCT00273793|697404|P5|COMPLETED|Overall Study||58
285527|NCT00273793|697405|P4|COMPLETED|Overall Study||60
285528|NCT00273793|697406|P3|COMPLETED|Overall Study||18
285529|NCT00273793|697407|P2|COMPLETED|Overall Study||38
285530|NCT00273793|697408|P1|COMPLETED|Overall Study||36
285531|NCT00273793|697403|P6|STARTED|Overall Study||29
285532|NCT00273793|697404|P5|STARTED|Overall Study||58
285533|NCT00273793|697405|P4|STARTED|Overall Study||60
285534|NCT00273793|697406|P3|STARTED|Overall Study||18
285535|NCT00273793|697407|P2|STARTED|Overall Study||38
285536|NCT00273793|697408|P1|STARTED|Overall Study||36
285537|NCT00273754|697430|P2|NOT COMPLETED|Overall Study||0
285538|NCT00273754|697431|P1|NOT COMPLETED|Overall Study||0
285539|NCT00273754|697430|P2|COMPLETED|Overall Study||36
285540|NCT00273754|697431|P1|COMPLETED|Overall Study||36
285541|NCT00273754|697430|P2|STARTED|Overall Study||36
285542|NCT00273754|697431|P1|STARTED|Overall Study||36
285543|NCT00273182|697447|P1|NOT COMPLETED|Overall Study||985
285544|NCT00273182|697447|P1|COMPLETED|Overall Study||1014
285545|NCT00273182|697447|P1|STARTED|Overall Study||1999
285546|NCT00273052|697457|P2|NOT COMPLETED|Overall Study||88
285547|NCT00273052|697458|P1|NOT COMPLETED|Overall Study||69
285548|NCT00273052|697457|P2|COMPLETED|Overall Study||190
285549|NCT00273052|697458|P1|COMPLETED|Overall Study||221
285550|NCT00273052|697457|P2|STARTED|Overall Study||278
285551|NCT00273052|697458|P1|STARTED|Overall Study||290
285552|NCT00272987|697493|P3|NOT COMPLETED|Overall Study||19
285553|NCT00272987|697494|P2|NOT COMPLETED|Overall Study||14
285554|NCT00272987|697495|P1|NOT COMPLETED|Overall Study||21
285555|NCT00272987|697493|P3|COMPLETED|Overall Study||1
285556|NCT00272987|697494|P2|COMPLETED|Overall Study||0
285557|NCT00272987|697495|P1|COMPLETED|Overall Study||8
285558|NCT00272987|697493|P3|Ongoing|Overall Study||15
285559|NCT00272987|697494|P2|Ongoing|Overall Study||14
285560|NCT00272987|697495|P1|Ongoing|Overall Study||20
285561|NCT00272987|697493|P3|STARTED|Overall Study||20
285562|NCT00272987|697494|P2|STARTED|Overall Study||14
285563|NCT00272987|697495|P1|STARTED|Overall Study||29
285564|NCT00272961|697559|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
285565|NCT00272961|697560|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
285566|NCT00272961|697561|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
285567|NCT00272961|697562|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
285568|NCT00272961|697563|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
285569|NCT00272961|697559|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
285570|NCT00272961|697560|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
285571|NCT00272961|697561|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
285572|NCT00272961|697562|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
285573|NCT00272961|697563|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
285574|NCT00272961|697559|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
285575|NCT00272961|697560|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
285576|NCT00272961|697561|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
285577|NCT00272961|697562|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
285578|NCT00272961|697563|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
285579|NCT00272961|697559|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285580|NCT00272961|697560|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285581|NCT00272961|697561|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285582|NCT00272961|697562|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285583|NCT00272961|697563|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
285584|NCT00272961|697559|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285585|NCT00272961|697560|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285586|NCT00272961|697561|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285587|NCT00272961|697562|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
285588|NCT00272961|697563|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
285589|NCT00272961|697559|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
285590|NCT00272961|697560|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
285591|NCT00272961|697561|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
285592|NCT00272961|697562|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
285593|NCT00272961|697563|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
285594|NCT00272844|697620|P1|NOT COMPLETED|Overall Study||5
285595|NCT00272844|697620|P1|COMPLETED|Overall Study||18
285596|NCT00272844|697620|P1|STARTED|Overall Study||23
285597|NCT00272792|697628|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
285598|NCT00272792|697629|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
285599|NCT00272792|697628|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
285600|NCT00272792|697629|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
285601|NCT00272792|697628|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
285602|NCT00272792|697629|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
285603|NCT00272792|697628|P2|NOT COMPLETED|Part 1: Responsiveness||0
285604|NCT00272792|697629|P1|NOT COMPLETED|Part 1: Responsiveness||1
285605|NCT00272792|697628|P2|COMPLETED|Part 1: Responsiveness||0
285606|NCT00272792|697629|P1|COMPLETED|Part 1: Responsiveness||89
285607|NCT00272792|697628|P2|STARTED|Part 1: Responsiveness||0
285608|NCT00272792|697629|P1|STARTED|Part 1: Responsiveness||90
285609|NCT00272779|697639|P2|NOT COMPLETED|Baseline Through Week 96||136
285610|NCT00272779|697640|P1|NOT COMPLETED|Baseline Through Week 96||139
285611|NCT00272779|697639|P2|COMPLETED|Baseline Through Week 96||307
285612|NCT00272779|697640|P1|COMPLETED|Baseline Through Week 96||301
285613|NCT00272779|697639|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
285614|NCT00272779|697640|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
285615|NCT00272779|697639|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
285616|NCT00272779|697640|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
285617|NCT00272779|697639|P2|NOT COMPLETED|Baseline Through Week 48||443
285618|NCT00272779|697640|P1|NOT COMPLETED|Baseline Through Week 48||440
285619|NCT00272779|697639|P2|COMPLETED|Baseline Through Week 48||0
285620|NCT00272779|697640|P1|COMPLETED|Baseline Through Week 48||0
285621|NCT00272779|697639|P2|STILL ON TREATMENT|Baseline Through Week 48||368
285622|NCT00272779|697640|P1|STILL ON TREATMENT|Baseline Through Week 48||385
285623|NCT00272779|697639|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
285624|NCT00272779|697640|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
285625|NCT00272779|697639|P2|Discontinued Before Week 48|Baseline Through Week 48||58
285626|NCT00272779|697640|P1|Discontinued Before Week 48|Baseline Through Week 48||39
285627|NCT00272779|697639|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
285628|NCT00272779|697640|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
285629|NCT00272779|697639|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
285630|NCT00272779|697640|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
285631|NCT00272779|697639|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
285632|NCT00272779|697640|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
285633|NCT00272337|697824|P5|NOT COMPLETED|Overall Study||0
285634|NCT00272337|697825|P4|NOT COMPLETED|Overall Study||0
285635|NCT00272337|697826|P3|NOT COMPLETED|Overall Study||0
285636|NCT00272337|697827|P2|NOT COMPLETED|Overall Study||0
285637|NCT00272337|697828|P1|NOT COMPLETED|Overall Study||0
285638|NCT00272337|697824|P5|COMPLETED|Overall Study||8
285639|NCT00272337|697825|P4|COMPLETED|Overall Study||7
285640|NCT00272337|697826|P3|COMPLETED|Overall Study||7
285641|NCT00272337|697827|P2|COMPLETED|Overall Study||7
285642|NCT00272337|697828|P1|COMPLETED|Overall Study||8
285643|NCT00272337|697824|P5|STARTED|Overall Study||8
285644|NCT00272337|697825|P4|STARTED|Overall Study||7
285645|NCT00272337|697826|P3|STARTED|Overall Study||7
285646|NCT00272337|697827|P2|STARTED|Overall Study||7
285647|NCT00272337|697828|P1|STARTED|Overall Study||8
285648|NCT00272311|697845|P5|NOT COMPLETED|Overall Study||0
285649|NCT00272311|697846|P4|NOT COMPLETED|Overall Study||0
285650|NCT00272311|697847|P3|NOT COMPLETED|Overall Study||0
285651|NCT00272311|697848|P2|NOT COMPLETED|Overall Study||0
285652|NCT00272311|697849|P1|NOT COMPLETED|Overall Study||0
285653|NCT00272311|697845|P5|COMPLETED|Overall Study||14
285654|NCT00272311|697846|P4|COMPLETED|Overall Study||14
285655|NCT00272311|697847|P3|COMPLETED|Overall Study||14
285656|NCT00272311|697848|P2|COMPLETED|Overall Study||14
285657|NCT00272311|697849|P1|COMPLETED|Overall Study||14
285658|NCT00272311|697845|P5|STARTED|Overall Study||14
285659|NCT00272311|697846|P4|STARTED|Overall Study||14
285660|NCT00272311|697847|P3|STARTED|Overall Study||14
285661|NCT00272311|697848|P2|STARTED|Overall Study||14
285662|NCT00272311|697849|P1|STARTED|Overall Study||14
285663|NCT00272168|697863|P2|NOT COMPLETED|Overall Study||10
285664|NCT00272168|697864|P1|NOT COMPLETED|Overall Study||10
285665|NCT00272168|697863|P2|COMPLETED|Overall Study||31
285666|NCT00272168|697864|P1|COMPLETED|Overall Study||37
285667|NCT00272168|697863|P2|STARTED|Overall Study||41
285668|NCT00272168|697864|P1|STARTED|Overall Study||47
285669|NCT00272038|697880|P1|NOT COMPLETED|Overall Study||7
285670|NCT00272038|697880|P1|COMPLETED|Overall Study||22
285671|NCT00272038|697880|P1|STARTED|Overall Study||29
285672|NCT00271947|697885|P1|NOT COMPLETED|Overall Study||1
285673|NCT00271947|697885|P1|COMPLETED|Overall Study||0
285674|NCT00271947|697885|P1|STARTED|Overall Study||1
285675|NCT00271856|697891|P2|NOT COMPLETED|Overall Study||18
285676|NCT00271856|697892|P1|NOT COMPLETED|Overall Study||11
285677|NCT00271856|697891|P2|COMPLETED|Overall Study||70
285678|NCT00271856|697892|P1|COMPLETED|Overall Study||78
285679|NCT00271856|697891|P2|STARTED|Overall Study||88
285680|NCT00271856|697892|P1|STARTED|Overall Study||89
285681|NCT00271817|697911|P3|NOT COMPLETED|Part 2||84
285682|NCT00271817|697912|P2|NOT COMPLETED|Part 2||32
285683|NCT00271817|697913|P1|NOT COMPLETED|Part 2||0
285684|NCT00271817|697911|P3|COMPLETED|Part 2||401
285685|NCT00271817|697912|P2|COMPLETED|Part 2||234
285686|NCT00271817|697913|P1|COMPLETED|Part 2||0
285687|NCT00271817|697911|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
285688|NCT00271817|697912|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
285689|NCT00271817|697913|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
285690|NCT00271817|697911|P3|NOT COMPLETED|Part 1||285
285691|NCT00271817|697912|P2|NOT COMPLETED|Part 1||59
285692|NCT00271817|697913|P1|NOT COMPLETED|Part 1||106
285693|NCT00271817|697911|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
285694|NCT00271817|697912|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
285695|NCT00271817|697913|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
285696|NCT00271817|697911|P3|STARTED|Part 1||676
285697|NCT00271817|697912|P2|STARTED|Part 1||272
285698|NCT00271817|697913|P1|STARTED|Part 1||272
285699|NCT00271739|697942|P2|NOT COMPLETED|Overall Study||105
285700|NCT00271739|697943|P1|NOT COMPLETED|Overall Study||115
285701|NCT00271739|697942|P2|COMPLETED|Overall Study||716
285702|NCT00271739|697943|P1|COMPLETED|Overall Study||729
285703|NCT00271739|697942|P2|STARTED|Overall Study||821
285704|NCT00271739|697943|P1|STARTED|Overall Study||844
285705|NCT00271609|697955|P2|NOT COMPLETED|Overall Study||3
285706|NCT00271609|697956|P1|NOT COMPLETED|Overall Study||13
285707|NCT00271609|697955|P2|COMPLETED|Overall Study||29
285708|NCT00271609|697956|P1|COMPLETED|Overall Study||43
285709|NCT00271609|697955|P2|STARTED|Overall Study||32
285710|NCT00271609|697956|P1|STARTED|Overall Study||56
285711|NCT00271596|697966|P2|NOT COMPLETED|Overall Study||1
285712|NCT00271596|697967|P1|NOT COMPLETED|Overall Study||1
285713|NCT00271596|697966|P2|COMPLETED|Overall Study||15
285714|NCT00271596|697967|P1|COMPLETED|Overall Study||16
285715|NCT00271596|697966|P2|STARTED|Overall Study||16
285716|NCT00271596|697967|P1|STARTED|Overall Study||17
285717|NCT00271570|697993|P2|NOT COMPLETED|Overall Study||0
285718|NCT00271570|697994|P1|NOT COMPLETED|Overall Study||0
285719|NCT00271570|697993|P2|COMPLETED|Overall Study||12
285720|NCT00271570|697994|P1|COMPLETED|Overall Study||12
285721|NCT00271570|697993|P2|STARTED|Overall Study||12
285722|NCT00271570|697994|P1|STARTED|Overall Study||12
285723|NCT00271544|698002|P1|NOT COMPLETED|Overall Study||20
285724|NCT00271544|698002|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
285725|NCT00271544|698002|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
285726|NCT00271544|698002|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
285727|NCT00271544|698002|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
285728|NCT00271375|698026|P3|NOT COMPLETED|Overall Study||0
285729|NCT00271375|698027|P2|NOT COMPLETED|Overall Study||0
285730|NCT00271375|698028|P1|NOT COMPLETED|Overall Study||0
285731|NCT00271375|698026|P3|COMPLETED|Overall Study||57
285732|NCT00271375|698027|P2|COMPLETED|Overall Study||83
285733|NCT00271375|698028|P1|COMPLETED|Overall Study||114
285734|NCT00271375|698026|P3|STARTED|Overall Study||57
285735|NCT00271375|698027|P2|STARTED|Overall Study||83
285736|NCT00271375|698028|P1|STARTED|Overall Study||114
285737|NCT00271219|698066|P2|NOT COMPLETED|Overall Study||28
285738|NCT00271219|698067|P1|NOT COMPLETED|Overall Study||16
285739|NCT00271219|698066|P2|COMPLETED|Overall Study||58
285740|NCT00271219|698067|P1|COMPLETED|Overall Study||73
285741|NCT00271219|698066|P2|STARTED|Overall Study||86
285742|NCT00271219|698067|P1|STARTED|Overall Study||89
285743|NCT00271154|698093|P2|NOT COMPLETED|Overall Study||0
285744|NCT00271154|698094|P1|NOT COMPLETED|Overall Study||0
285745|NCT00271154|698093|P2|COMPLETED|Overall Study||419
285746|NCT00271154|698094|P1|COMPLETED|Overall Study||191
285747|NCT00271154|698093|P2|STARTED|Overall Study||419
285748|NCT00271154|698094|P1|STARTED|Overall Study||191
285749|NCT00271024|698107|P4|NOT COMPLETED|Overall Study||24
285750|NCT00271024|698108|P3|NOT COMPLETED|Overall Study||23
285751|NCT00271024|698109|P2|NOT COMPLETED|Overall Study||26
285752|NCT00271024|698110|P1|NOT COMPLETED|Overall Study||22
285753|NCT00271024|698107|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
285754|NCT00271024|698108|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
285755|NCT00271024|698109|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
285756|NCT00271024|698110|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
285757|NCT00271024|698107|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
285758|NCT00271024|698108|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
285759|NCT00271024|698109|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
285760|NCT00271024|698110|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
285761|NCT00271024|698107|P4|STARTED|Overall Study||88
285762|NCT00271024|698108|P3|STARTED|Overall Study||88
285763|NCT00271024|698109|P2|STARTED|Overall Study||77
285764|NCT00271024|698110|P1|STARTED|Overall Study||80
285765|NCT00271011|698152|P1|NOT COMPLETED|Overall Study||0
285766|NCT00271011|698152|P1|COMPLETED|Overall Study||13
285767|NCT00271011|698152|P1|STARTED|Overall Study||13
285768|NCT00270998|698160|P3|NOT COMPLETED|12 Month Follow-up||21
285769|NCT00270998|698161|P2|NOT COMPLETED|12 Month Follow-up||25
285770|NCT00270998|698162|P1|NOT COMPLETED|12 Month Follow-up||14
285771|NCT00270998|698160|P3|COMPLETED|12 Month Follow-up||111
285772|NCT00270998|698161|P2|COMPLETED|12 Month Follow-up||99
285773|NCT00270998|698162|P1|COMPLETED|12 Month Follow-up||96
285774|NCT00270998|698160|P3|STARTED|12 Month Follow-up||132
285775|NCT00270998|698161|P2|STARTED|12 Month Follow-up||124
285776|NCT00270998|698162|P1|STARTED|12 Month Follow-up||110
285777|NCT00270998|698160|P3|NOT COMPLETED|3 Month Follow-up||18
285778|NCT00270998|698161|P2|NOT COMPLETED|3 Month Follow-up||22
285779|NCT00270998|698162|P1|NOT COMPLETED|3 Month Follow-up||39
285780|NCT00270998|698160|P3|COMPLETED|3 Month Follow-up||132
285781|NCT00270998|698161|P2|COMPLETED|3 Month Follow-up||124
285782|NCT00270998|698162|P1|COMPLETED|3 Month Follow-up||110
285783|NCT00270998|698160|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
285784|NCT00270998|698161|P2|STARTED|3 Month Follow-up||146
285785|NCT00270998|698162|P1|STARTED|3 Month Follow-up||149
285786|NCT00270894|698191|P1|NOT COMPLETED|Overall Study||2
285787|NCT00270894|698191|P1|COMPLETED|Overall Study||28
285788|NCT00270894|698191|P1|STARTED|Overall Study||30
285789|NCT00270855|698203|P2|NOT COMPLETED|Overall Study||8
285790|NCT00270855|698204|P1|NOT COMPLETED|Overall Study||8
285791|NCT00270855|698203|P2|COMPLETED|Overall Study||6
285792|NCT00270855|698204|P1|COMPLETED|Overall Study||7
285793|NCT00270855|698203|P2|STARTED|Overall Study||14
285794|NCT00270855|698204|P1|STARTED|Overall Study||15
285795|NCT00270842|698263|P3|NOT COMPLETED|Overall Study||16
285796|NCT00270842|698264|P2|NOT COMPLETED|Overall Study||16
285797|NCT00270842|698265|P1|NOT COMPLETED|Overall Study||15
285798|NCT00270842|698263|P3|COMPLETED|Overall Study||18
285799|NCT00270842|698264|P2|COMPLETED|Overall Study||18
285800|NCT00270842|698265|P1|COMPLETED|Overall Study||18
285801|NCT00270842|698263|P3|STARTED|Overall Study||34
285802|NCT00270842|698264|P2|STARTED|Overall Study||34
285803|NCT00270842|698265|P1|STARTED|Overall Study||33
285804|NCT00270790|698276|P1|NOT COMPLETED|Overall Study||5
285805|NCT00270790|698276|P1|COMPLETED|Overall Study||16
285806|NCT00270790|698276|P1|STARTED|Overall Study||21
285807|NCT00270634|698285|P4|NOT COMPLETED|Overall Study||5
285808|NCT00270634|698286|P3|NOT COMPLETED|Overall Study||22
285809|NCT00270634|698287|P2|NOT COMPLETED|Overall Study||13
285810|NCT00270634|698288|P1|NOT COMPLETED|Overall Study||17
285811|NCT00270634|698285|P4|COMPLETED|Overall Study||81
285812|NCT00270634|698286|P3|COMPLETED|Overall Study||62
285813|NCT00270634|698287|P2|COMPLETED|Overall Study||64
285814|NCT00270634|698288|P1|COMPLETED|Overall Study||70
285815|NCT00270634|698285|P4|STARTED|Overall Study||86
285816|NCT00270634|698286|P3|STARTED|Overall Study||84
285817|NCT00270634|698287|P2|STARTED|Overall Study||77
285818|NCT00270634|698288|P1|STARTED|Overall Study||87
285819|NCT00270296|698325|P3|NOT COMPLETED|Overall Study||61
285820|NCT00270296|698326|P2|NOT COMPLETED|Overall Study||90
285821|NCT00270296|698327|P1|NOT COMPLETED|Overall Study||99
285822|NCT00270296|698325|P3|COMPLETED|Overall Study||109
285823|NCT00270296|698326|P2|COMPLETED|Overall Study||185
285824|NCT00270296|698327|P1|COMPLETED|Overall Study||186
285825|NCT00270296|698325|P3|STARTED|Overall Study||170
285826|NCT00270296|698326|P2|STARTED|Overall Study||275
285827|NCT00270296|698327|P1|STARTED|Overall Study||285
285828|NCT00270257|698340|P2|NOT COMPLETED|Overall Study||424
285829|NCT00270257|698341|P1|NOT COMPLETED|Overall Study||412
285830|NCT00270257|698340|P2|COMPLETED|Overall Study||204
285831|NCT00270257|698341|P1|COMPLETED|Overall Study||211
285832|NCT00270257|698340|P2|Visit 104|Overall Study||204
285833|NCT00270257|698341|P1|Visit 104|Overall Study||211
285834|NCT00270257|698340|P2|Week 78|Overall Study||285
285835|NCT00270257|698341|P1|Week 78|Overall Study||283
285836|NCT00270257|698340|P2|Week 52|Overall Study||340
285837|NCT00270257|698341|P1|Week 52|Overall Study||362
285838|NCT00270257|698340|P2|Week 26|Overall Study||440
285839|NCT00270257|698341|P1|Week 26|Overall Study||460
285840|NCT00270257|698340|P2|Week 8|Overall Study||443
285841|NCT00270257|698341|P1|Week 8|Overall Study||510
285842|NCT00270257|698340|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
285843|NCT00270257|698341|P1|STARTED|Overall Study||623
285844|NCT00270231|698359|P2|NOT COMPLETED|Second Intervention||1
285845|NCT00270231|698360|P1|NOT COMPLETED|Second Intervention||0
285846|NCT00270231|698359|P2|COMPLETED|Second Intervention||30
285847|NCT00270231|698360|P1|COMPLETED|Second Intervention||30
285848|NCT00270231|698359|P2|STARTED|Second Intervention||31
285849|NCT00270231|698360|P1|STARTED|Second Intervention||30
285850|NCT00270231|698359|P2|NOT COMPLETED|Washout Period||0
285851|NCT00270231|698360|P1|NOT COMPLETED|Washout Period||1
285852|NCT00270231|698359|P2|COMPLETED|Washout Period||31
285853|NCT00270231|698360|P1|COMPLETED|Washout Period||30
285854|NCT00270231|698359|P2|STARTED|Washout Period||31
285855|NCT00270231|698360|P1|STARTED|Washout Period||31
285856|NCT00270231|698359|P2|NOT COMPLETED|First Intervention||1
285857|NCT00270231|698360|P1|NOT COMPLETED|First Intervention||1
285858|NCT00270231|698359|P2|COMPLETED|First Intervention||31
285859|NCT00270231|698360|P1|COMPLETED|First Intervention||31
285860|NCT00270231|698359|P2|STARTED|First Intervention||32
285861|NCT00270231|698360|P1|STARTED|First Intervention||32
285862|NCT00270205|698370|P4|NOT COMPLETED|Overall Study||1
285863|NCT00270205|698371|P3|NOT COMPLETED|Overall Study||0
285864|NCT00270205|698372|P2|NOT COMPLETED|Overall Study||0
285865|NCT00270205|698373|P1|NOT COMPLETED|Overall Study||1
285866|NCT00270205|698370|P4|COMPLETED|Overall Study||6
285867|NCT00270205|698371|P3|COMPLETED|Overall Study||6
285868|NCT00270205|698372|P2|COMPLETED|Overall Study||6
285869|NCT00270205|698373|P1|COMPLETED|Overall Study||5
285870|NCT00270205|698370|P4|STARTED|Overall Study||7
285871|NCT00270205|698371|P3|STARTED|Overall Study||6
285872|NCT00270205|698372|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
285873|NCT00270205|698373|P1|STARTED|Overall Study||6
285874|NCT00269919|698491|P1|NOT COMPLETED|Overall Study||27
285875|NCT00269919|698491|P1|COMPLETED|Overall Study||13
285876|NCT00269919|698491|P1|Treated|Overall Study||39
285877|NCT00269919|698491|P1|STARTED|Overall Study||40
285878|NCT00269633|698510|P2|NOT COMPLETED|Overall Study||0
285879|NCT00269633|698511|P1|NOT COMPLETED|Overall Study||1
285880|NCT00269633|698510|P2|COMPLETED|Overall Study||5
285881|NCT00269633|698511|P1|COMPLETED|Overall Study||3
285882|NCT00269633|698510|P2|STARTED|Overall Study||5
285883|NCT00269633|698511|P1|STARTED|Overall Study||4
285884|NCT00269477|698521|P4|NOT COMPLETED|Overall Study||0
285885|NCT00269477|698522|P3|NOT COMPLETED|Overall Study||1
285886|NCT00269477|698523|P2|NOT COMPLETED|Overall Study||6
285887|NCT00269477|698524|P1|NOT COMPLETED|Overall Study||5
285888|NCT00269477|698521|P4|COMPLETED|Overall Study||60
285889|NCT00269477|698522|P3|COMPLETED|Overall Study||57
285890|NCT00269477|698523|P2|COMPLETED|Overall Study||12
285891|NCT00269477|698524|P1|COMPLETED|Overall Study||4
285892|NCT00269477|698521|P4|STARTED|Overall Study||60
285893|NCT00269477|698522|P3|STARTED|Overall Study||58
285894|NCT00269477|698523|P2|STARTED|Overall Study||18
285895|NCT00269477|698524|P1|STARTED|Overall Study||9
285896|NCT00269152|698540|P2|NOT COMPLETED|Overall Study||10
285897|NCT00269152|698541|P1|NOT COMPLETED|Overall Study||18
285898|NCT00269152|698540|P2|COMPLETED|Overall Study||49
285899|NCT00269152|698541|P1|COMPLETED|Overall Study||45
285900|NCT00269152|698540|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
285901|NCT00269152|698541|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
285902|NCT00269113|698557|P2|NOT COMPLETED|Overall Study||37
285903|NCT00269113|698558|P1|NOT COMPLETED|Overall Study||74
285904|NCT00269113|698557|P2|COMPLETED|Overall Study||146
285905|NCT00269113|698558|P1|COMPLETED|Overall Study||103
285906|NCT00269113|698557|P2|STARTED|Overall Study||183
285907|NCT00269113|698558|P1|STARTED|Overall Study||177
285908|NCT00268996|698578|P2|NOT COMPLETED|Overall Study||20
285909|NCT00268996|698579|P1|NOT COMPLETED|Overall Study||21
285910|NCT00268996|698578|P2|COMPLETED|Overall Study||152
285911|NCT00268996|698579|P1|COMPLETED|Overall Study||130
285912|NCT00268996|698578|P2|STARTED|Overall Study||172
285913|NCT00268996|698579|P1|STARTED|Overall Study||151
285914|NCT00268983|698623|P2|NOT COMPLETED|Overall Study||0
285915|NCT00268983|698624|P1|NOT COMPLETED|Overall Study||3
285916|NCT00268983|698623|P2|COMPLETED|Overall Study||8
285917|NCT00268983|698624|P1|COMPLETED|Overall Study||3
285918|NCT00268983|698623|P2|STARTED|Overall Study||8
285919|NCT00268983|698624|P1|STARTED|Overall Study||6
285920|NCT00268905|698667|P3|NOT COMPLETED|Overall Study||12
285921|NCT00268905|698668|P2|NOT COMPLETED|Overall Study||9
285922|NCT00268905|698669|P1|NOT COMPLETED|Overall Study||43
285923|NCT00268905|698667|P3|COMPLETED|Overall Study||0
285924|NCT00268905|698668|P2|COMPLETED|Overall Study||0
285925|NCT00268905|698669|P1|COMPLETED|Overall Study||0
285926|NCT00268905|698667|P3|STARTED|Overall Study||12
285927|NCT00268905|698668|P2|STARTED|Overall Study||9
285928|NCT00268905|698669|P1|STARTED|Overall Study||43
285929|NCT00268892|698686|P3|NOT COMPLETED|Overall Study||39
285930|NCT00268892|698687|P2|NOT COMPLETED|Overall Study||42
285931|NCT00268892|698688|P1|NOT COMPLETED|Overall Study||39
285932|NCT00268892|698686|P3|COMPLETED|Overall Study||54
285933|NCT00268892|698687|P2|COMPLETED|Overall Study||53
285934|NCT00268892|698688|P1|COMPLETED|Overall Study||51
285935|NCT00268892|698686|P3|Switched to Higher Dose|Overall Study||76
285936|NCT00268892|698687|P2|Switched to Higher Dose|Overall Study||68
285937|NCT00268892|698688|P1|Switched to Higher Dose|Overall Study||59
285938|NCT00268892|698686|P3|STARTED|Overall Study||93
285939|NCT00268892|698687|P2|STARTED|Overall Study||95
285940|NCT00268892|698688|P1|STARTED|Overall Study||90
285941|NCT00268762|698699|P1|NOT COMPLETED|Overall Study||0
285942|NCT00268762|698699|P1|COMPLETED|Overall Study||65
285943|NCT00268762|698699|P1|STARTED|Overall Study||65
285944|NCT00268463|698707|P2|NOT COMPLETED|Overall Study||12
285945|NCT00268463|698708|P1|NOT COMPLETED|Overall Study||10
285946|NCT00268463|698707|P2|COMPLETED|Overall Study||0
285947|NCT00268463|698708|P1|COMPLETED|Overall Study||0
285948|NCT00268463|698707|P2|STARTED|Overall Study||12
285949|NCT00268463|698708|P1|STARTED|Overall Study||10
285950|NCT00268437|698714|P1|NOT COMPLETED|Overall Study||1
285951|NCT00268437|698714|P1|COMPLETED|Overall Study||26
285952|NCT00268437|698714|P1|STARTED|Overall Study||27
285953|NCT00268346|698721|P2|NOT COMPLETED|Overall Study||3
285954|NCT00268346|698722|P1|NOT COMPLETED|Overall Study||0
285955|NCT00268346|698721|P2|COMPLETED|Overall Study||37
285956|NCT00268346|698722|P1|COMPLETED|Overall Study||18
285957|NCT00268346|698721|P2|Started Treatment|Overall Study||40
285958|NCT00268346|698722|P1|Started Treatment|Overall Study||18
285959|NCT00268346|698721|P2|STARTED|Overall Study||40
285960|NCT00268346|698722|P1|STARTED|Overall Study||18
285961|NCT00268242|698728|P1|NOT COMPLETED|Overall Study||1
285962|NCT00268242|698728|P1|COMPLETED|Overall Study||23
285963|NCT00268242|698728|P1|STARTED|Overall Study||24
285964|NCT00268203|698737|P1|NOT COMPLETED|Overall Study||647
285965|NCT00268203|698737|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
285966|NCT00268203|698737|P1|Completed 2 Years of Follow-up|Overall Study||62
285967|NCT00268203|698737|P1|STARTED|Overall Study||765
285968|NCT00267969|698751|P7|NOT COMPLETED|After Controlled Period||72
285969|NCT00267969|698752|P6|NOT COMPLETED|After Controlled Period||82
285970|NCT00267969|698753|P5|NOT COMPLETED|After Controlled Period||35
285971|NCT00267969|698754|P4|NOT COMPLETED|After Controlled Period||36
285972|NCT00267969|698755|P3|NOT COMPLETED|After Controlled Period||0
285973|NCT00267969|698756|P2|NOT COMPLETED|After Controlled Period||0
285974|NCT00267969|698757|P1|NOT COMPLETED|After Controlled Period||0
285975|NCT00267969|698751|P7|COMPLETED|After Controlled Period||173
285976|NCT00267969|698752|P6|COMPLETED|After Controlled Period||172
285977|NCT00267969|698753|P5|COMPLETED|After Controlled Period||85
285978|NCT00267969|698754|P4|COMPLETED|After Controlled Period||87
285979|NCT00267969|698755|P3|COMPLETED|After Controlled Period||0
285980|NCT00267969|698756|P2|COMPLETED|After Controlled Period||0
285981|NCT00267969|698757|P1|COMPLETED|After Controlled Period||0
285982|NCT00267969|698751|P7|STARTED|After Controlled Period||245
285983|NCT00267969|698752|P6|STARTED|After Controlled Period||254
285984|NCT00267969|698753|P5|STARTED|After Controlled Period||120
285985|NCT00267969|698754|P4|STARTED|After Controlled Period||123
285986|NCT00267969|698755|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
285987|NCT00267969|698756|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
285988|NCT00267969|698757|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
285989|NCT00267969|698751|P7|NOT COMPLETED|Controlled Period||0
285990|NCT00267969|698752|P6|NOT COMPLETED|Controlled Period||0
285991|NCT00267969|698753|P5|NOT COMPLETED|Controlled Period||0
285992|NCT00267969|698754|P4|NOT COMPLETED|Controlled Period||0
285993|NCT00267969|698755|P3|NOT COMPLETED|Controlled Period||11
285994|NCT00267969|698756|P2|NOT COMPLETED|Controlled Period||1
285995|NCT00267969|698757|P1|NOT COMPLETED|Controlled Period||12
285996|NCT00267969|698751|P7|COMPLETED|Controlled Period||0
285997|NCT00267969|698752|P6|COMPLETED|Controlled Period||0
285998|NCT00267969|698753|P5|COMPLETED|Controlled Period||0
285999|NCT00267969|698754|P4|COMPLETED|Controlled Period||0
286000|NCT00267969|698755|P3|COMPLETED|Controlled Period||245
286001|NCT00267969|698756|P2|COMPLETED|Controlled Period||254
286002|NCT00267969|698757|P1|COMPLETED|Controlled Period||243
286003|NCT00267969|698751|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
286004|NCT00267969|698752|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
286005|NCT00267969|698753|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
286006|NCT00267969|698754|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
286007|NCT00267969|698755|P3|STARTED|Controlled Period|Number of patients randomized|256
286008|NCT00267969|698756|P2|STARTED|Controlled Period|Number of patients randomized|255
286009|NCT00267969|698757|P1|STARTED|Controlled Period|Number of patients randomized|255
286010|NCT00267956|698783|P4|NOT COMPLETED|After Controlled Period||2
286011|NCT00267956|698784|P3|NOT COMPLETED|After Controlled Period||5
286012|NCT00267956|698785|P2|NOT COMPLETED|After Controlled Period||0
286013|NCT00267956|698786|P1|NOT COMPLETED|After Controlled Period||0
286014|NCT00267956|698783|P4|COMPLETED|After Controlled Period||70
286015|NCT00267956|698784|P3|COMPLETED|After Controlled Period||52
286016|NCT00267956|698785|P2|COMPLETED|After Controlled Period||0
286017|NCT00267956|698786|P1|COMPLETED|After Controlled Period||0
286018|NCT00267956|698783|P4|STARTED|After Controlled Period||72
286019|NCT00267956|698784|P3|STARTED|After Controlled Period||57
286020|NCT00267956|698785|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
286021|NCT00267956|698786|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
286022|NCT00267956|698783|P4|NOT COMPLETED|Controlled Period||0
286023|NCT00267956|698784|P3|NOT COMPLETED|Controlled Period||0
286024|NCT00267956|698785|P2|NOT COMPLETED|Controlled Period||4
286025|NCT00267956|698786|P1|NOT COMPLETED|Controlled Period||13
286026|NCT00267956|698783|P4|COMPLETED|Controlled Period||0
286027|NCT00267956|698784|P3|COMPLETED|Controlled Period||0
286028|NCT00267956|698785|P2|COMPLETED|Controlled Period||72
286029|NCT00267956|698786|P1|COMPLETED|Controlled Period||57
286030|NCT00267956|698783|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
286031|NCT00267956|698784|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
286032|NCT00267956|698785|P2|STARTED|Controlled Period||76
286033|NCT00267956|698786|P1|STARTED|Controlled Period||70
286034|NCT00267774|698806|P2|NOT COMPLETED|Overall Study||0
286035|NCT00267774|698807|P1|NOT COMPLETED|Overall Study||0
286036|NCT00267774|698806|P2|COMPLETED|Overall Study||496
286037|NCT00267774|698807|P1|COMPLETED|Overall Study||509
286038|NCT00267774|698806|P2|STARTED|Overall Study||496
286039|NCT00267774|698807|P1|STARTED|Overall Study||509
286040|NCT00267748|698818|P3|NOT COMPLETED|Randomized Period||132
286041|NCT00267748|698819|P2|NOT COMPLETED|Randomized Period||127
286042|NCT00267748|698820|P1|NOT COMPLETED|Randomized Period||0
286043|NCT00267748|698818|P3|COMPLETED|Randomized Period||14
286044|NCT00267748|698819|P2|COMPLETED|Randomized Period||19
286045|NCT00267748|698820|P1|COMPLETED|Randomized Period||0
286046|NCT00267748|698818|P3|Treated|Randomized Period||143
286047|NCT00267748|698819|P2|Treated|Randomized Period||146
286048|NCT00267748|698820|P1|Treated|Randomized Period||0
286049|NCT00267748|698818|P3|STARTED|Randomized Period||146
286050|NCT00267748|698819|P2|STARTED|Randomized Period||146
286051|NCT00267748|698820|P1|STARTED|Randomized Period||0
286052|NCT00267748|698818|P3|NOT COMPLETED|Non-randomized Period||0
286053|NCT00267748|698819|P2|NOT COMPLETED|Non-randomized Period||0
286054|NCT00267748|698820|P1|NOT COMPLETED|Non-randomized Period||23
286055|NCT00267748|698818|P3|COMPLETED|Non-randomized Period||0
286056|NCT00267748|698819|P2|COMPLETED|Non-randomized Period||0
286057|NCT00267748|698820|P1|COMPLETED|Non-randomized Period||2
286058|NCT00267748|698818|P3|STARTED|Non-randomized Period||0
286059|NCT00267748|698819|P2|STARTED|Non-randomized Period||0
286060|NCT00267748|698820|P1|STARTED|Non-randomized Period||25
286061|NCT00267696|698837|P1|NOT COMPLETED|Overall Study||0
286062|NCT00267696|698837|P1|COMPLETED|Overall Study||45
286063|NCT00267696|698837|P1|STARTED|Overall Study||45
286064|NCT00267670|698844|P2|NOT COMPLETED|Overall Study||0
286065|NCT00267670|698845|P1|NOT COMPLETED|Overall Study||4
286066|NCT00267670|698844|P2|COMPLETED|Overall Study||7
286067|NCT00267670|698845|P1|COMPLETED|Overall Study||15
286068|NCT00267670|698844|P2|STARTED|Overall Study||7
286069|NCT00267670|698845|P1|STARTED|Overall Study||19
286070|NCT00267644|698859|P2|NOT COMPLETED|Overall Study||0
286071|NCT00267644|698860|P1|NOT COMPLETED|Overall Study||0
286072|NCT00267644|698859|P2|COMPLETED|Overall Study||63
286073|NCT00267644|698860|P1|COMPLETED|Overall Study||13
286074|NCT00267644|698859|P2|STARTED|Overall Study||63
286075|NCT00267644|698860|P1|STARTED|Overall Study||13
286076|NCT00267631|698870|P2|NOT COMPLETED|Overall Study||0
286077|NCT00267631|698871|P1|NOT COMPLETED|Overall Study||0
286078|NCT00267631|698870|P2|COMPLETED|Overall Study||3031
286079|NCT00267631|698871|P1|COMPLETED|Overall Study||2361
286080|NCT00267631|698870|P2|STARTED|Overall Study||3031
286081|NCT00267631|698871|P1|STARTED|Overall Study||2361
286082|NCT00267488|698877|P1|NOT COMPLETED|Overall Study||11
286083|NCT00267488|698877|P1|COMPLETED|Overall Study||26
286084|NCT00267488|698877|P1|STARTED|Overall Study||37
286085|NCT00267293|698889|P3|NOT COMPLETED|Overall Study||0
286086|NCT00267293|698890|P2|NOT COMPLETED|Overall Study||0
286087|NCT00267293|698891|P1|NOT COMPLETED|Overall Study||0
286088|NCT00267293|698889|P3|COMPLETED|Overall Study||20
286089|NCT00267293|698890|P2|COMPLETED|Overall Study||20
286090|NCT00267293|698891|P1|COMPLETED|Overall Study||20
286091|NCT00267293|698889|P3|STARTED|Overall Study||20
286092|NCT00267293|698890|P2|STARTED|Overall Study||20
286093|NCT00267293|698891|P1|STARTED|Overall Study||20
286094|NCT00267202|698901|P2|NOT COMPLETED|Overall Study||34
286095|NCT00267202|698902|P1|NOT COMPLETED|Overall Study||53
286096|NCT00267202|698901|P2|COMPLETED|Overall Study||105
286097|NCT00267202|698902|P1|COMPLETED|Overall Study||83
286098|NCT00267202|698901|P2|STARTED|Overall Study||139
286099|NCT00267202|698902|P1|STARTED|Overall Study||136
286100|NCT00267189|698923|P2|NOT COMPLETED|Overall Study||1
286101|NCT00267189|698924|P1|NOT COMPLETED|Overall Study||5
286102|NCT00267189|698923|P2|COMPLETED|Overall Study||72
286103|NCT00267189|698924|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
286104|NCT00267189|698923|P2|Completed Study Medication|Overall Study||72
286105|NCT00267189|698924|P1|Completed Study Medication|Overall Study||54
286106|NCT00267189|698923|P2|STARTED|Overall Study||73
286107|NCT00267189|698924|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
286108|NCT00267150|698934|P1|NOT COMPLETED|Overall Study||1
286109|NCT00267150|698934|P1|COMPLETED|Overall Study||30
286110|NCT00267150|698934|P1|STARTED|Overall Study||31
286111|NCT00267111|698941|P2|NOT COMPLETED|Overall Study||0
286112|NCT00267111|698942|P1|NOT COMPLETED|Overall Study||0
286113|NCT00267111|698941|P2|COMPLETED|Overall Study||55
286114|NCT00267111|698942|P1|COMPLETED|Overall Study||55
286115|NCT00267111|698941|P2|STARTED|Overall Study||55
286116|NCT00267111|698942|P1|STARTED|Overall Study||55
286117|NCT00267098|698958|P8|NOT COMPLETED|Overall Study||15
286118|NCT00267098|698959|P7|NOT COMPLETED|Overall Study||46
286119|NCT00267098|698960|P6|NOT COMPLETED|Overall Study||40
286120|NCT00267098|698961|P5|NOT COMPLETED|Overall Study||37
286121|NCT00267098|698962|P4|NOT COMPLETED|Overall Study||106
286122|NCT00267098|698963|P3|NOT COMPLETED|Overall Study||94
286123|NCT00267098|698964|P2|NOT COMPLETED|Overall Study||51
286124|NCT00267098|698965|P1|NOT COMPLETED|Overall Study||109
286125|NCT00267098|698958|P8|COMPLETED|Overall Study||5
286126|NCT00267098|698959|P7|COMPLETED|Overall Study||55
286127|NCT00267098|698960|P6|COMPLETED|Overall Study||66
286128|NCT00267098|698961|P5|COMPLETED|Overall Study||10
286129|NCT00267098|698962|P4|COMPLETED|Overall Study||135
286130|NCT00267098|698963|P3|COMPLETED|Overall Study||149
286131|NCT00267098|698964|P2|COMPLETED|Overall Study||0
286132|NCT00267098|698965|P1|COMPLETED|Overall Study||0
286133|NCT00267098|698958|P8|STARTED|Overall Study||20
286134|NCT00267098|698959|P7|STARTED|Overall Study||101
286135|NCT00267098|698960|P6|STARTED|Overall Study||106
286136|NCT00267098|698961|P5|STARTED|Overall Study||47
286137|NCT00267098|698962|P4|STARTED|Overall Study||241
286138|NCT00267098|698963|P3|STARTED|Overall Study||243
286139|NCT00267098|698964|P2|STARTED|Overall Study||51
286140|NCT00267098|698965|P1|STARTED|Overall Study||109
286141|NCT00267085|699098|P1|NOT COMPLETED|Overall Study||0
286142|NCT00267085|699098|P1|COMPLETED|Overall Study||10
286143|NCT00267085|699098|P1|STARTED|Overall Study||10
286144|NCT00267059|699102|P1|NOT COMPLETED|Overall Study||0
286145|NCT00267059|699102|P1|COMPLETED|Overall Study||44
286146|NCT00267059|699102|P1|STARTED|Overall Study||44
286147|NCT00267046|699108|P2|NOT COMPLETED|Overall Study||11
286148|NCT00267046|699109|P1|NOT COMPLETED|Overall Study||12
286149|NCT00267046|699108|P2|COMPLETED|Overall Study||5
286150|NCT00267046|699109|P1|COMPLETED|Overall Study||20
286151|NCT00267046|699108|P2|STARTED|Overall Study||16
286152|NCT00267046|699109|P1|STARTED|Overall Study||32
286153|NCT00267007|699119|P2|NOT COMPLETED|Overall Study||1
286154|NCT00267007|699120|P1|NOT COMPLETED|Overall Study||8
286155|NCT00267007|699119|P2|COMPLETED|Overall Study||10
286156|NCT00267007|699120|P1|COMPLETED|Overall Study||11
286157|NCT00267007|699119|P2|STARTED|Overall Study||11
286158|NCT00267007|699120|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
286159|NCT00266877|699131|P3|NOT COMPLETED|Overall Study||28
286160|NCT00266877|699132|P2|NOT COMPLETED|Overall Study||48
286161|NCT00266877|699133|P1|NOT COMPLETED|Overall Study||91
286162|NCT00266877|699131|P3|COMPLETED|Overall Study||0
286163|NCT00266877|699132|P2|COMPLETED|Overall Study||0
286164|NCT00266877|699133|P1|COMPLETED|Overall Study||0
286165|NCT00266877|699131|P3|STARTED|Overall Study||28
286166|NCT00266877|699132|P2|STARTED|Overall Study||48
286167|NCT00266877|699133|P1|STARTED|Overall Study||91
286168|NCT00266864|699152|P2|NOT COMPLETED|Overall Study||2
286169|NCT00266864|699153|P1|NOT COMPLETED|Overall Study||5
286170|NCT00266864|699152|P2|COMPLETED|Overall Study||11
286171|NCT00266864|699153|P1|COMPLETED|Overall Study||13
286172|NCT00266864|699152|P2|STARTED|Overall Study||13
286173|NCT00266864|699153|P1|STARTED|Overall Study||18
286174|NCT00266825|699162|P2|NOT COMPLETED|Completed Follow-Up||24
286175|NCT00266825|699163|P1|NOT COMPLETED|Completed Follow-Up||25
286176|NCT00266825|699162|P2|COMPLETED|Completed Follow-Up||154
286177|NCT00266825|699163|P1|COMPLETED|Completed Follow-Up||147
286178|NCT00266825|699162|P2|STARTED|Completed Follow-Up||178
286179|NCT00266825|699163|P1|STARTED|Completed Follow-Up||172
286180|NCT00266825|699162|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
286181|NCT00266825|699163|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
286182|NCT00266825|699162|P2|COMPLETED|Enrolled and Allocated Intervention||178
286183|NCT00266825|699163|P1|COMPLETED|Enrolled and Allocated Intervention||172
286184|NCT00266825|699162|P2|STARTED|Enrolled and Allocated Intervention||178
286185|NCT00266825|699163|P1|STARTED|Enrolled and Allocated Intervention||172
286186|NCT00266812|699189|P2|NOT COMPLETED|Overall Study||11
286187|NCT00266812|699190|P1|NOT COMPLETED|Overall Study||21
286188|NCT00266812|699189|P2|COMPLETED|Overall Study||2
286189|NCT00266812|699190|P1|COMPLETED|Overall Study||1
286190|NCT00266812|699189|P2|STARTED|Overall Study||13
286191|NCT00266812|699190|P1|STARTED|Overall Study||22
286192|NCT00266799|699198|P2|NOT COMPLETED|Overall Study||34
286193|NCT00266799|699199|P1|NOT COMPLETED|Overall Study||36
286194|NCT00266799|699198|P2|COMPLETED|Overall Study||68
286195|NCT00266799|699199|P1|COMPLETED|Overall Study||62
286196|NCT00266799|699198|P2|STARTED|Overall Study||102
286197|NCT00266799|699199|P1|STARTED|Overall Study||98
286198|NCT00266695|699213|P1|NOT COMPLETED|Overall Study||29
286199|NCT00266695|699213|P1|COMPLETED|Overall Study||174
286200|NCT00266695|699213|P1|STARTED|Overall Study||203
286201|NCT00266656|699225|P2|NOT COMPLETED|Overall Study||13
286202|NCT00266656|699226|P1|NOT COMPLETED|Overall Study||14
286203|NCT00266656|699225|P2|COMPLETED|Overall Study||20
286204|NCT00266656|699226|P1|COMPLETED|Overall Study||22
286205|NCT00266656|699225|P2|STARTED|Overall Study||33
286206|NCT00266656|699226|P1|STARTED|Overall Study||36
286207|NCT00266630|699250|P2|NOT COMPLETED|Overall Study||28
286208|NCT00266630|699251|P1|NOT COMPLETED|Overall Study||42
286209|NCT00266630|699250|P2|COMPLETED|Overall Study||11
286210|NCT00266630|699251|P1|COMPLETED|Overall Study||58
286211|NCT00266630|699250|P2|STARTED|Overall Study||39
286212|NCT00266630|699251|P1|STARTED|Overall Study||100
286213|NCT00266409|699293|P4|NOT COMPLETED|Overall Study||22
286214|NCT00266409|699294|P3|NOT COMPLETED|Overall Study||17
286215|NCT00266409|699295|P2|NOT COMPLETED|Overall Study||46
286216|NCT00266409|699296|P1|NOT COMPLETED|Overall Study||45
286217|NCT00266409|699293|P4|COMPLETED|Overall Study||49
286218|NCT00266409|699294|P3|COMPLETED|Overall Study||55
286219|NCT00266409|699295|P2|COMPLETED|Overall Study||92
286220|NCT00266409|699296|P1|COMPLETED|Overall Study||92
286221|NCT00266409|699293|P4|STARTED|Overall Study||71
286222|NCT00266409|699294|P3|STARTED|Overall Study||72
286223|NCT00266409|699295|P2|STARTED|Overall Study||138
286224|NCT00266409|699296|P1|STARTED|Overall Study||137
286225|NCT00266279|699578|P1|NOT COMPLETED|Overall Study||2
286226|NCT00266279|699578|P1|COMPLETED|Overall Study||15
286227|NCT00266279|699578|P1|STARTED|Overall Study||17
286228|NCT00266227|699584|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
286229|NCT00266227|699585|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
286230|NCT00266227|699586|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
286231|NCT00266227|699584|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
286232|NCT00266227|699585|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
286233|NCT00266227|699586|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
286234|NCT00266227|699584|P3|STARTED|Retreatment: Week 48 to Week 72||0
286235|NCT00266227|699585|P2|STARTED|Retreatment: Week 48 to Week 72||134
286236|NCT00266227|699586|P1|STARTED|Retreatment: Week 48 to Week 72||291
286237|NCT00266227|699584|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
286238|NCT00266227|699585|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
286239|NCT00266227|699586|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
286240|NCT00266227|699584|P3|COMPLETED|Retreatment: Up to Week 48||0
286241|NCT00266227|699585|P2|COMPLETED|Retreatment: Up to Week 48||134
286242|NCT00266227|699586|P1|COMPLETED|Retreatment: Up to Week 48||291
286243|NCT00266227|699584|P3|STARTED|Retreatment: Up to Week 48||0
286244|NCT00266227|699585|P2|STARTED|Retreatment: Up to Week 48||157
286245|NCT00266227|699586|P1|STARTED|Retreatment: Up to Week 48||318
286246|NCT00266227|699584|P3|NOT COMPLETED|Initial Treatment||77
286247|NCT00266227|699585|P2|NOT COMPLETED|Initial Treatment||0
286248|NCT00266227|699586|P1|NOT COMPLETED|Initial Treatment||0
286249|NCT00266227|699584|P3|COMPLETED|Initial Treatment||482
286250|NCT00266227|699585|P2|COMPLETED|Initial Treatment||0
286251|NCT00266227|699586|P1|COMPLETED|Initial Treatment||0
286252|NCT00266227|699584|P3|STARTED|Initial Treatment||559
286253|NCT00266227|699585|P2|STARTED|Initial Treatment||0
286254|NCT00266227|699586|P1|STARTED|Initial Treatment||0
286255|NCT00266110|699631|P1|NOT COMPLETED|Overall Study||7
286256|NCT00266110|699631|P1|COMPLETED|Overall Study||10
286257|NCT00266110|699631|P1|STARTED|Overall Study||17
286258|NCT00266032|699638|P3|NOT COMPLETED|Open-label Safety Extension||25
286259|NCT00266032|699639|P2|NOT COMPLETED|Open-label Safety Extension||14
286260|NCT00266032|699640|P1|NOT COMPLETED|Open-label Safety Extension||41
286261|NCT00266032|699638|P3|COMPLETED|Open-label Safety Extension||140
286262|NCT00266032|699639|P2|COMPLETED|Open-label Safety Extension||115
286263|NCT00266032|699640|P1|COMPLETED|Open-label Safety Extension||448
286264|NCT00266032|699638|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
286265|NCT00266032|699639|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
286266|NCT00266032|699640|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
286267|NCT00266032|699638|P3|NOT COMPLETED|Treatment||47
286268|NCT00266032|699639|P2|NOT COMPLETED|Treatment||64
286269|NCT00266032|699640|P1|NOT COMPLETED|Treatment||111
286270|NCT00266032|699638|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
286271|NCT00266032|699639|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
286272|NCT00266032|699640|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
286273|NCT00266032|699638|P3|Patients Treated and in FAS|Treatment|FAS|216
286274|NCT00266032|699639|P2|Patients Treated and in FAS|Treatment|FAS|209
286275|NCT00266032|699640|P1|Patients Treated and in FAS|Treatment|FAS|642
286276|NCT00266032|699638|P3|Patients Treated|Treatment||229
286277|NCT00266032|699639|P2|Patients Treated|Treatment||221
286278|NCT00266032|699640|P1|Patients Treated|Treatment||684
286279|NCT00266032|699638|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
286280|NCT00266032|699639|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
286281|NCT00266032|699640|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
286282|NCT00265941|699670|P2|NOT COMPLETED|Overall Study||26
286283|NCT00265941|699671|P1|NOT COMPLETED|Overall Study||23
286284|NCT00265941|699670|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
286285|NCT00265941|699671|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
286286|NCT00265941|699670|P2|STARTED|Overall Study||470
286287|NCT00265941|699671|P1|STARTED|Overall Study||470
286288|NCT00265889|699703|P1|NOT COMPLETED|Overall Study||5
286289|NCT00265889|699703|P1|COMPLETED|Overall Study||37
286290|NCT00265889|699703|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
286291|NCT00265889|699703|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
286292|NCT00265889|699703|P1|STARTED|Overall Study||42
286293|NCT00265850|699712|P3|NOT COMPLETED|Overall Study||0
286294|NCT00265850|699713|P2|NOT COMPLETED|Overall Study||0
286295|NCT00265850|699714|P1|NOT COMPLETED|Overall Study||0
286296|NCT00265850|699712|P3|COMPLETED|Overall Study||533
286297|NCT00265850|699713|P2|COMPLETED|Overall Study||902
286298|NCT00265850|699714|P1|COMPLETED|Overall Study||899
286299|NCT00265850|699712|P3|STARTED|Overall Study||533
286300|NCT00265850|699713|P2|STARTED|Overall Study||902
286301|NCT00265850|699714|P1|STARTED|Overall Study||899
286302|NCT00265798|699724|P1|NOT COMPLETED|Overall Study||0
286303|NCT00265798|699724|P1|COMPLETED|Overall Study||38
286304|NCT00265798|699724|P1|STARTED|Overall Study||38
286305|NCT00265785|699730|P1|NOT COMPLETED|Overall Study||27
286306|NCT00265785|699730|P1|COMPLETED|Overall Study||0
286307|NCT00265785|699730|P1|Eligible and Began Protocol Treatment|Overall Study||24
286308|NCT00265785|699730|P1|Eligible|Overall Study||26
286309|NCT00265785|699730|P1|STARTED|Overall Study||27
286310|NCT00265759|699743|P4|NOT COMPLETED|Overall Study||9
286311|NCT00265759|699744|P3|NOT COMPLETED|Overall Study||2
286312|NCT00265759|699745|P2|NOT COMPLETED|Overall Study||1
286313|NCT00265759|699746|P1|NOT COMPLETED|Overall Study||0
286314|NCT00265759|699743|P4|COMPLETED|Overall Study||236
286315|NCT00265759|699744|P3|COMPLETED|Overall Study||123
286316|NCT00265759|699745|P2|COMPLETED|Overall Study||127
286317|NCT00265759|699746|P1|COMPLETED|Overall Study||124
286318|NCT00265759|699743|P4|STARTED|Overall Study||245
286319|NCT00265759|699744|P3|STARTED|Overall Study||125
286320|NCT00265759|699745|P2|STARTED|Overall Study||128
286321|NCT00265759|699746|P1|STARTED|Overall Study||124
286322|NCT00265616|699777|P2|NOT COMPLETED|Overall Study||0
286323|NCT00265616|699778|P1|NOT COMPLETED|Overall Study||0
286324|NCT00265616|699777|P2|COMPLETED|Overall Study||9
286325|NCT00265616|699778|P1|COMPLETED|Overall Study||14
286326|NCT00265616|699777|P2|STARTED|Overall Study||9
286327|NCT00265616|699778|P1|STARTED|Overall Study||14
286328|NCT00265512|699796|P2|NOT COMPLETED|Overall Study||95
286329|NCT00265512|699797|P1|NOT COMPLETED|Overall Study||45
286330|NCT00265512|699796|P2|COMPLETED|Overall Study||359
286331|NCT00265512|699797|P1|COMPLETED|Overall Study||168
286332|NCT00265512|699796|P2|STARTED|Overall Study||454
286333|NCT00265512|699797|P1|STARTED|Overall Study||213
286334|NCT00265473|699803|P1|NOT COMPLETED|Overall Study||0
286335|NCT00265473|699803|P1|COMPLETED|Overall Study||5
286336|NCT00265473|699803|P1|STARTED|Overall Study||5
286337|NCT00265395|699813|P2|NOT COMPLETED|Overall Study||17
286338|NCT00265395|699814|P1|NOT COMPLETED|Overall Study||8
286339|NCT00265395|699813|P2|COMPLETED|Overall Study||56
286340|NCT00265395|699814|P1|COMPLETED|Overall Study||78
286341|NCT00265395|699813|P2|STARTED|Overall Study||73
286342|NCT00265395|699814|P1|STARTED|Overall Study||86
286343|NCT00265382|699819|P1|NOT COMPLETED|Overall Study||145
286344|NCT00265382|699819|P1|COMPLETED|Overall Study||76
286345|NCT00265382|699819|P1|STARTED|Overall Study||221
286346|NCT00265343|699839|P2|NOT COMPLETED|Overall Study||19
286347|NCT00265343|699840|P1|NOT COMPLETED|Overall Study||21
286348|NCT00265343|699839|P2|COMPLETED|Overall Study||153
286349|NCT00265343|699840|P1|COMPLETED|Overall Study||113
286350|NCT00265343|699839|P2|STARTED|Overall Study||172
286351|NCT00265343|699840|P1|STARTED|Overall Study||134
286352|NCT00265330|699848|P1|NOT COMPLETED|Overall Study||95
286353|NCT00265330|699848|P1|COMPLETED|Overall Study||67
286354|NCT00265330|699848|P1|STARTED|Overall Study||162
286355|NCT00265317|699874|P4|NOT COMPLETED|Phase 2||65
286356|NCT00265317|699875|P3|NOT COMPLETED|Phase 2||64
286357|NCT00265317|699876|P2|NOT COMPLETED|Phase 2||0
286358|NCT00265317|699877|P1|NOT COMPLETED|Phase 2||0
286359|NCT00265317|699874|P4|COMPLETED|Phase 2||2
286360|NCT00265317|699875|P3|COMPLETED|Phase 2||1
286361|NCT00265317|699876|P2|COMPLETED|Phase 2||0
286362|NCT00265317|699877|P1|COMPLETED|Phase 2||0
286363|NCT00265317|699874|P4|STARTED|Phase 2||67
286364|NCT00265317|699875|P3|STARTED|Phase 2||65
286365|NCT00265317|699876|P2|STARTED|Phase 2||0
286366|NCT00265317|699877|P1|STARTED|Phase 2||0
286367|NCT00265317|699874|P4|NOT COMPLETED|Lead-In||0
286368|NCT00265317|699875|P3|NOT COMPLETED|Lead-In||0
286369|NCT00265317|699876|P2|NOT COMPLETED|Lead-In||17
286370|NCT00265317|699877|P1|NOT COMPLETED|Lead-In||12
286371|NCT00265317|699874|P4|COMPLETED|Lead-In||0
286372|NCT00265317|699875|P3|COMPLETED|Lead-In||0
286373|NCT00265317|699876|P2|COMPLETED|Lead-In||0
286374|NCT00265317|699877|P1|COMPLETED|Lead-In||1
286375|NCT00265317|699874|P4|STARTED|Lead-In||0
286376|NCT00265317|699875|P3|STARTED|Lead-In||0
286377|NCT00265317|699876|P2|STARTED|Lead-In||17
286378|NCT00265317|699877|P1|STARTED|Lead-In||13
286379|NCT00265239|699992|P2|NOT COMPLETED|Overall Study||1
286380|NCT00265239|699993|P1|NOT COMPLETED|Overall Study||2
286381|NCT00265239|699992|P2|COMPLETED|Overall Study||51
286382|NCT00265239|699993|P1|COMPLETED|Overall Study||50
286383|NCT00265239|699992|P2|STARTED|Overall Study||52
286384|NCT00265239|699993|P1|STARTED|Overall Study||52
286385|NCT00265200|700005|P1|NOT COMPLETED|Overall Study||4
286386|NCT00265200|700005|P1|COMPLETED|Overall Study||24
286387|NCT00265200|700005|P1|STARTED|Overall Study||28
286388|NCT00265122|700015|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
286389|NCT00265122|700016|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
286390|NCT00265122|700017|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
286391|NCT00265122|700018|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
286392|NCT00265122|700019|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
286393|NCT00265122|700020|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
286394|NCT00265122|700015|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
286395|NCT00265122|700016|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
286396|NCT00265122|700017|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
286397|NCT00265122|700018|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
286398|NCT00265122|700019|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
286399|NCT00265122|700020|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
286400|NCT00265122|700015|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
286401|NCT00265122|700016|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
286402|NCT00265122|700017|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
286403|NCT00265122|700018|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
286404|NCT00265122|700019|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
286405|NCT00265122|700020|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
286406|NCT00265122|700015|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
286407|NCT00265122|700016|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
286408|NCT00265122|700017|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
286409|NCT00265122|700018|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
286410|NCT00265122|700019|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
286411|NCT00265122|700020|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
286412|NCT00265122|700015|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
286413|NCT00265122|700016|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
286414|NCT00265122|700017|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
286415|NCT00265122|700018|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
286416|NCT00265122|700019|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
286417|NCT00265122|700020|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
286418|NCT00265122|700015|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
286419|NCT00265122|700016|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
286420|NCT00265122|700017|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
286421|NCT00265122|700018|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
286422|NCT00265122|700019|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
286423|NCT00265122|700020|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
286424|NCT00265109|700042|P1|NOT COMPLETED|Overall Study||6
286425|NCT00265109|700042|P1|COMPLETED|Overall Study||11
286426|NCT00265109|700042|P1|STARTED|Overall Study||17
286427|NCT00265096|700049|P3|NOT COMPLETED|Overall Study||39
286428|NCT00265096|700050|P2|NOT COMPLETED|Overall Study||51
286429|NCT00265096|700051|P1|NOT COMPLETED|Overall Study||36
286430|NCT00265096|700049|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
286431|NCT00265096|700050|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
286432|NCT00265096|700051|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
286433|NCT00265096|700049|P3|STARTED|Overall Study||146
286434|NCT00265096|700050|P2|STARTED|Overall Study||146
286435|NCT00265096|700051|P1|STARTED|Overall Study||113
286436|NCT00265083|700083|P3|NOT COMPLETED|Overall Study||42
286437|NCT00265083|700084|P2|NOT COMPLETED|Overall Study||42
286438|NCT00265083|700085|P1|NOT COMPLETED|Overall Study||17
286439|NCT00265083|700083|P3|COMPLETED|Overall Study||98
286440|NCT00265083|700084|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
286441|NCT00265083|700085|P1|COMPLETED|Overall Study||61
286442|NCT00265083|700083|P3|STARTED|Overall Study||140
286443|NCT00265083|700084|P2|STARTED|Overall Study|One patient did not receive study agent.|138
286444|NCT00265083|700085|P1|STARTED|Overall Study||78
286445|NCT00264875|700106|P1|NOT COMPLETED|Overall Study||30
286446|NCT00264875|700106|P1|COMPLETED|Overall Study||190
286447|NCT00264875|700106|P1|STARTED|Overall Study||220
286448|NCT00264849|700112|P2|NOT COMPLETED|Overall Study||25
286449|NCT00264849|700113|P1|NOT COMPLETED|Overall Study||22
286450|NCT00264849|700112|P2|COMPLETED|Overall Study||106
286451|NCT00264849|700113|P1|COMPLETED|Overall Study||253
286452|NCT00264849|700112|P2|STARTED|Overall Study||131
286453|NCT00264849|700113|P1|STARTED|Overall Study||275
286454|NCT00264810|700149|P2|NOT COMPLETED|Open Label Evaluation Period||6
286455|NCT00264810|700150|P1|NOT COMPLETED|Open Label Evaluation Period||6
286456|NCT00264810|700149|P2|COMPLETED|Open Label Evaluation Period||86
286457|NCT00264810|700150|P1|COMPLETED|Open Label Evaluation Period||89
286458|NCT00264810|700149|P2|1-year Post-implant|Open Label Evaluation Period||90
286459|NCT00264810|700150|P1|1-year Post-implant|Open Label Evaluation Period||92
286460|NCT00264810|700149|P2|STARTED|Open Label Evaluation Period||92
286461|NCT00264810|700150|P1|STARTED|Open Label Evaluation Period||95
286462|NCT00264810|700149|P2|NOT COMPLETED|Blinded Evaluation Period||1
286463|NCT00264810|700150|P1|NOT COMPLETED|Blinded Evaluation Period||1
286464|NCT00264810|700149|P2|COMPLETED|Blinded Evaluation Period||92
286465|NCT00264810|700150|P1|COMPLETED|Blinded Evaluation Period||95
286466|NCT00264810|700149|P2|STARTED|Blinded Evaluation Period||93
286467|NCT00264810|700150|P1|STARTED|Blinded Evaluation Period||96
286468|NCT00264810|700149|P2|NOT COMPLETED|Stimulation Optimization Period||1
286469|NCT00264810|700150|P1|NOT COMPLETED|Stimulation Optimization Period||1
286470|NCT00264810|700149|P2|COMPLETED|Stimulation Optimization Period||93
286471|NCT00264810|700150|P1|COMPLETED|Stimulation Optimization Period||96
286472|NCT00264810|700149|P2|STARTED|Stimulation Optimization Period||94
286473|NCT00264810|700150|P1|STARTED|Stimulation Optimization Period||97
286474|NCT00264810|700149|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
286475|NCT00264810|700150|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
286476|NCT00264810|700149|P2|COMPLETED|Post-Operative Stabilization Period||94
286477|NCT00264810|700150|P1|COMPLETED|Post-Operative Stabilization Period||97
286478|NCT00264810|700149|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
286479|NCT00264810|700150|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
286480|NCT00264810|700149|P2|NOT COMPLETED|Baseline||26
286481|NCT00264810|700150|P1|NOT COMPLETED|Baseline||23
286482|NCT00264810|700149|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
286483|NCT00264810|700150|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
286484|NCT00264810|700149|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
286573|NCT00264147|700351|P2|NOT COMPLETED|Treatment II Period||0
286485|NCT00264810|700150|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
286486|NCT00264797|700160|P2|NOT COMPLETED|Overall Study||43
286487|NCT00264797|700161|P1|NOT COMPLETED|Overall Study||33
286488|NCT00264797|700160|P2|COMPLETED|Overall Study||109
286489|NCT00264797|700161|P1|COMPLETED|Overall Study||118
286490|NCT00264797|700160|P2|STARTED|Overall Study||152
286491|NCT00264797|700161|P1|STARTED|Overall Study||151
286492|NCT00264641|700175|P2|NOT COMPLETED|Overall Study||0
286493|NCT00264641|700176|P1|NOT COMPLETED|Overall Study||0
286494|NCT00264641|700175|P2|COMPLETED|Overall Study||10
286495|NCT00264641|700176|P1|COMPLETED|Overall Study||10
286496|NCT00264641|700175|P2|Initiation of the Study|Overall Study||10
286497|NCT00264641|700176|P1|Initiation of the Study|Overall Study||10
286498|NCT00264641|700175|P2|STARTED|Overall Study||10
286499|NCT00264641|700176|P1|STARTED|Overall Study||10
286500|NCT00264576|700183|P2|NOT COMPLETED|Overall Study||1
286501|NCT00264576|700184|P1|NOT COMPLETED|Overall Study||1
286502|NCT00264576|700183|P2|COMPLETED|Overall Study||304
286503|NCT00264576|700184|P1|COMPLETED|Overall Study||307
286504|NCT00264576|700183|P2|STARTED|Overall Study||305
286505|NCT00264576|700184|P1|STARTED|Overall Study||308
286506|NCT00264550|700208|P4|NOT COMPLETED|Overall Study||30
286507|NCT00264550|700209|P3|NOT COMPLETED|Overall Study||17
286508|NCT00264550|700210|P2|NOT COMPLETED|Overall Study||41
286509|NCT00264550|700211|P1|NOT COMPLETED|Overall Study||43
286510|NCT00264550|700208|P4|COMPLETED|Overall Study||59
286511|NCT00264550|700209|P3|COMPLETED|Overall Study||72
286512|NCT00264550|700210|P2|COMPLETED|Overall Study||92
286513|NCT00264550|700211|P1|COMPLETED|Overall Study||90
286514|NCT00264550|700208|P4|STARTED|Overall Study||89
286515|NCT00264550|700209|P3|STARTED|Overall Study||89
286516|NCT00264550|700210|P2|STARTED|Overall Study||133
286517|NCT00264550|700211|P1|STARTED|Overall Study||133
286518|NCT00264537|700250|P4|NOT COMPLETED|Overall Study||60
286519|NCT00264537|700251|P3|NOT COMPLETED|Overall Study||50
286520|NCT00264537|700252|P2|NOT COMPLETED|Overall Study||58
286521|NCT00264537|700253|P1|NOT COMPLETED|Overall Study||50
286522|NCT00264537|700250|P4|COMPLETED|Overall Study||99
286523|NCT00264537|700251|P3|COMPLETED|Overall Study||109
286524|NCT00264537|700252|P2|COMPLETED|Overall Study||101
286525|NCT00264537|700253|P1|COMPLETED|Overall Study||110
286526|NCT00264537|700250|P4|STARTED|Overall Study||159
286527|NCT00264537|700251|P3|STARTED|Overall Study||159
286528|NCT00264537|700252|P2|STARTED|Overall Study||159
286529|NCT00264537|700253|P1|STARTED|Overall Study||160
286530|NCT00264498|700285|P2|NOT COMPLETED|Crossover Treatment||9
286531|NCT00264498|700286|P1|NOT COMPLETED|Crossover Treatment||6
286532|NCT00264498|700285|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
286533|NCT00264498|700286|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
286534|NCT00264498|700285|P2|STARTED|Crossover Treatment||9
286535|NCT00264498|700286|P1|STARTED|Crossover Treatment||6
286536|NCT00264498|700285|P2|NOT COMPLETED|Randomized Treatment||18
286537|NCT00264498|700286|P1|NOT COMPLETED|Randomized Treatment||17
286538|NCT00264498|700285|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
286539|NCT00264498|700286|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
286540|NCT00264498|700285|P2|STARTED|Randomized Treatment||18
286541|NCT00264498|700286|P1|STARTED|Randomized Treatment||17
286542|NCT00264381|700294|P2|NOT COMPLETED|Overall Study||0
286543|NCT00264381|700295|P1|NOT COMPLETED|Overall Study||0
286544|NCT00264381|700294|P2|COMPLETED|Overall Study||37
286545|NCT00264381|700295|P1|COMPLETED|Overall Study||35
286546|NCT00264381|700294|P2|STARTED|Overall Study||37
286547|NCT00264381|700295|P1|STARTED|Overall Study||35
286548|NCT00264303|700309|P2|NOT COMPLETED|Overall Study||29
286549|NCT00264303|700310|P1|NOT COMPLETED|Overall Study||25
286550|NCT00264303|700309|P2|COMPLETED|Overall Study||419
286551|NCT00264303|700310|P1|COMPLETED|Overall Study||413
286552|NCT00264303|700309|P2|STARTED|Overall Study||448
286553|NCT00264303|700310|P1|STARTED|Overall Study||438
286554|NCT00264290|700328|P2|NOT COMPLETED|Observation (4 Weeks)||0
286555|NCT00264290|700329|P1|NOT COMPLETED|Observation (4 Weeks)||0
286556|NCT00264290|700328|P2|COMPLETED|Observation (4 Weeks)||14
286557|NCT00264290|700329|P1|COMPLETED|Observation (4 Weeks)||15
286558|NCT00264290|700328|P2|STARTED|Observation (4 Weeks)||14
286559|NCT00264290|700329|P1|STARTED|Observation (4 Weeks)||15
286560|NCT00264290|700328|P2|NOT COMPLETED|Intervention (8 Weeks)||0
286561|NCT00264290|700329|P1|NOT COMPLETED|Intervention (8 Weeks)||1
286562|NCT00264290|700328|P2|COMPLETED|Intervention (8 Weeks)||14
286563|NCT00264290|700329|P1|COMPLETED|Intervention (8 Weeks)||15
286564|NCT00264290|700328|P2|STARTED|Intervention (8 Weeks)||14
286565|NCT00264290|700329|P1|STARTED|Intervention (8 Weeks)||16
286566|NCT00264238|700335|P1|NOT COMPLETED|Overall Study||1
286567|NCT00264238|700335|P1|COMPLETED|Overall Study||14
286568|NCT00264238|700335|P1|STARTED|Overall Study||15
286569|NCT00264147|700347|P6|NOT COMPLETED|Treatment II Period||33
286570|NCT00264147|700348|P5|NOT COMPLETED|Treatment II Period||33
286571|NCT00264147|700349|P4|NOT COMPLETED|Treatment II Period||0
286572|NCT00264147|700350|P3|NOT COMPLETED|Treatment II Period||0
286574|NCT00264147|700352|P1|NOT COMPLETED|Treatment II Period||0
286575|NCT00264147|700347|P6|COMPLETED|Treatment II Period||116
286576|NCT00264147|700348|P5|COMPLETED|Treatment II Period||147
286577|NCT00264147|700349|P4|COMPLETED|Treatment II Period||0
286578|NCT00264147|700350|P3|COMPLETED|Treatment II Period||0
286579|NCT00264147|700351|P2|COMPLETED|Treatment II Period||0
286580|NCT00264147|700352|P1|COMPLETED|Treatment II Period||0
286581|NCT00264147|700347|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
286582|NCT00264147|700348|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
286583|NCT00264147|700349|P4|STARTED|Treatment II Period||0
286584|NCT00264147|700350|P3|STARTED|Treatment II Period||0
286585|NCT00264147|700351|P2|STARTED|Treatment II Period||0
286586|NCT00264147|700352|P1|STARTED|Treatment II Period||0
286587|NCT00264147|700347|P6|NOT COMPLETED|Treatment I Period||0
286588|NCT00264147|700348|P5|NOT COMPLETED|Treatment I Period||56
286589|NCT00264147|700349|P4|NOT COMPLETED|Treatment I Period||72
286590|NCT00264147|700350|P3|NOT COMPLETED|Treatment I Period||77
286591|NCT00264147|700351|P2|NOT COMPLETED|Treatment I Period||83
286592|NCT00264147|700352|P1|NOT COMPLETED|Treatment I Period||98
286593|NCT00264147|700347|P6|COMPLETED|Treatment I Period||0
286594|NCT00264147|700348|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
286595|NCT00264147|700349|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
286596|NCT00264147|700350|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
286597|NCT00264147|700351|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
286598|NCT00264147|700352|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
286599|NCT00264147|700347|P6|STARTED|Treatment I Period||0
286600|NCT00264147|700348|P5|STARTED|Treatment I Period||155
286601|NCT00264147|700349|P4|STARTED|Treatment I Period||140
286602|NCT00264147|700350|P3|STARTED|Treatment I Period||151
286603|NCT00264147|700351|P2|STARTED|Treatment I Period||154
286604|NCT00264147|700352|P1|STARTED|Treatment I Period||161
286605|NCT00264004|700395|P4|NOT COMPLETED|Overall Study||15
286606|NCT00264004|700396|P3|NOT COMPLETED|Overall Study||14
286607|NCT00264004|700397|P2|NOT COMPLETED|Overall Study||11
286608|NCT00264004|700398|P1|NOT COMPLETED|Overall Study||17
286609|NCT00264004|700395|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
286610|NCT00264004|700396|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
286611|NCT00264004|700397|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
286612|NCT00264004|700398|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
286613|NCT00264004|700395|P4|STARTED|Overall Study|Randomised|34
286614|NCT00264004|700396|P3|STARTED|Overall Study|Randomised|30
286615|NCT00264004|700397|P2|STARTED|Overall Study|Randomised|32
286616|NCT00264004|700398|P1|STARTED|Overall Study|Randomised|30
286617|NCT00263887|700426|P2|NOT COMPLETED|Overall Study||7
286618|NCT00263887|700427|P1|NOT COMPLETED|Overall Study||3
286619|NCT00263887|700426|P2|COMPLETED|Overall Study||32
286620|NCT00263887|700427|P1|COMPLETED|Overall Study||35
286621|NCT00263887|700426|P2|STARTED|Overall Study||39
286622|NCT00263887|700427|P1|STARTED|Overall Study||38
286623|NCT00263757|700435|P2|NOT COMPLETED|Overall Study||8
286624|NCT00263757|700436|P1|NOT COMPLETED|Overall Study||8
286625|NCT00263757|700435|P2|COMPLETED|Overall Study||5
286626|NCT00263757|700436|P1|COMPLETED|Overall Study||4
286627|NCT00263757|700435|P2|STARTED|Overall Study||13
286628|NCT00263757|700436|P1|STARTED|Overall Study||12
286629|NCT00263666|700448|P2|NOT COMPLETED|Overall Study||11
286630|NCT00263666|700449|P1|NOT COMPLETED|Overall Study||7
286631|NCT00263666|700448|P2|COMPLETED|Overall Study||39
286632|NCT00263666|700449|P1|COMPLETED|Overall Study||43
286633|NCT00263666|700448|P2|STARTED|Overall Study||50
286634|NCT00263666|700449|P1|STARTED|Overall Study||50
286635|NCT00263328|700503|P3|NOT COMPLETED|Overall Study||7
286636|NCT00263328|700504|P2|NOT COMPLETED|Overall Study||2
286637|NCT00263328|700505|P1|NOT COMPLETED|Overall Study||8
286638|NCT00263328|700503|P3|COMPLETED|Overall Study||6
286639|NCT00263328|700504|P2|COMPLETED|Overall Study||12
286640|NCT00263328|700505|P1|COMPLETED|Overall Study||10
286641|NCT00263328|700503|P3|STARTED|Overall Study||13
286642|NCT00263328|700504|P2|STARTED|Overall Study||14
286643|NCT00263328|700505|P1|STARTED|Overall Study||18
286644|NCT00263211|700663|P2|NOT COMPLETED|Overall Study||1
286645|NCT00263211|700664|P1|NOT COMPLETED|Overall Study||5
286646|NCT00263211|700663|P2|COMPLETED|Overall Study||23
286647|NCT00263211|700664|P1|COMPLETED|Overall Study||19
286648|NCT00263211|700663|P2|STARTED|Overall Study||24
286649|NCT00263211|700664|P1|STARTED|Overall Study||24
286650|NCT00262964|700682|P4|NOT COMPLETED|Overall Study||0
286651|NCT00262964|700683|P3|NOT COMPLETED|Overall Study||0
286652|NCT00262964|700684|P2|NOT COMPLETED|Overall Study||0
286653|NCT00262964|700685|P1|NOT COMPLETED|Overall Study||0
286654|NCT00262964|700682|P4|COMPLETED|Overall Study||12
286655|NCT00262964|700683|P3|COMPLETED|Overall Study||17
286656|NCT00262964|700684|P2|COMPLETED|Overall Study||11
286657|NCT00262964|700685|P1|COMPLETED|Overall Study||11
286658|NCT00262964|700682|P4|STARTED|Overall Study||12
286659|NCT00262964|700683|P3|STARTED|Overall Study||17
286660|NCT00262964|700684|P2|STARTED|Overall Study||11
286661|NCT00262964|700685|P1|STARTED|Overall Study||11
286662|NCT00262951|700715|P1|NOT COMPLETED|Overall Study||16
286663|NCT00262951|700715|P1|COMPLETED|Overall Study||7
286664|NCT00262951|700715|P1|STARTED|Overall Study||23
286665|NCT00262925|700720|P1|NOT COMPLETED|Overall Study||11
286666|NCT00262925|700720|P1|COMPLETED|Overall Study||1
286667|NCT00262925|700720|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
286668|NCT00262873|700726|P1|NOT COMPLETED|Overall Study||8
286669|NCT00262873|700726|P1|COMPLETED|Overall Study||0
286670|NCT00262873|700726|P1|STARTED|Overall Study||8
286671|NCT00262860|700737|P1|NOT COMPLETED|Overall Study||2
286672|NCT00262860|700737|P1|COMPLETED|Overall Study||16
286673|NCT00262860|700737|P1|STARTED|Overall Study||18
286674|NCT00262847|700746|P3|NOT COMPLETED|Overall Study||396
286675|NCT00262847|700747|P2|NOT COMPLETED|Overall Study||513
286676|NCT00262847|700748|P1|NOT COMPLETED|Overall Study||518
286677|NCT00262847|700746|P3|COMPLETED|Overall Study||227
286678|NCT00262847|700747|P2|COMPLETED|Overall Study||112
286679|NCT00262847|700748|P1|COMPLETED|Overall Study||107
286680|NCT00262847|700746|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
286681|NCT00262847|700747|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
286682|NCT00262847|700748|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
286683|NCT00262834|700767|P2|NOT COMPLETED|Overall Study||4
286684|NCT00262834|700768|P1|NOT COMPLETED|Overall Study||1
286685|NCT00262834|700767|P2|COMPLETED|Overall Study||25
286686|NCT00262834|700768|P1|COMPLETED|Overall Study||24
286687|NCT00262834|700767|P2|STARTED|Overall Study||29
286688|NCT00262834|700768|P1|STARTED|Overall Study||25
286689|NCT00262821|700781|P2|NOT COMPLETED|Overall Study||19
286690|NCT00262821|700782|P1|NOT COMPLETED|Overall Study||4
286691|NCT00262821|700781|P2|COMPLETED|Overall Study||185
286692|NCT00262821|700782|P1|COMPLETED|Overall Study||194
286693|NCT00262821|700781|P2|STARTED|Overall Study||204
286694|NCT00262821|700782|P1|STARTED|Overall Study||198
286695|NCT00262743|700794|P2|NOT COMPLETED|Overall Study||12
286696|NCT00262743|700795|P1|NOT COMPLETED|Overall Study||0
286697|NCT00262743|700794|P2|COMPLETED|Overall Study||30
286698|NCT00262743|700795|P1|COMPLETED|Overall Study||27
286699|NCT00262743|700794|P2|STARTED|Overall Study||42
286700|NCT00262743|700795|P1|STARTED|Overall Study||27
286701|NCT00262730|700802|P1|NOT COMPLETED|Overall Study||0
286702|NCT00262730|700802|P1|COMPLETED|Overall Study||97
286703|NCT00262730|700802|P1|STARTED|Overall Study||97
286704|NCT00262639|700810|P4|NOT COMPLETED|Overall Study||0
286705|NCT00262639|700811|P3|NOT COMPLETED|Overall Study||0
286706|NCT00262639|700812|P2|NOT COMPLETED|Overall Study||0
286707|NCT00262639|700813|P1|NOT COMPLETED|Overall Study||0
286708|NCT00262639|700810|P4|COMPLETED|Overall Study||7
286709|NCT00262639|700811|P3|COMPLETED|Overall Study||9
286710|NCT00262639|700812|P2|COMPLETED|Overall Study||26
286711|NCT00262639|700813|P1|COMPLETED|Overall Study||18
286712|NCT00262639|700810|P4|STARTED|Overall Study||7
286713|NCT00262639|700811|P3|STARTED|Overall Study||9
286714|NCT00262639|700812|P2|STARTED|Overall Study||26
286715|NCT00262639|700813|P1|STARTED|Overall Study||18
286716|NCT00262600|700830|P3|NOT COMPLETED|Overall Study||266
286717|NCT00262600|700831|P2|NOT COMPLETED|Overall Study||252
286718|NCT00262600|700832|P1|NOT COMPLETED|Overall Study||235
286719|NCT00262600|700830|P3|COMPLETED|Overall Study||5756
286720|NCT00262600|700831|P2|COMPLETED|Overall Study||5824
286721|NCT00262600|700832|P1|COMPLETED|Overall Study||5780
286722|NCT00262600|700830|P3|STARTED|Overall Study||6022
286723|NCT00262600|700831|P2|STARTED|Overall Study||6076
286724|NCT00262600|700832|P1|STARTED|Overall Study||6015
286725|NCT00262522|700859|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
286726|NCT00262522|700860|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
286727|NCT00262522|700861|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
286728|NCT00262522|700862|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
286729|NCT00262522|700859|P4|COMPLETED|Study Start Through 96 Weeks||0
286730|NCT00262522|700860|P3|COMPLETED|Study Start Through 96 Weeks||254
286731|NCT00262522|700861|P2|COMPLETED|Study Start Through 96 Weeks||0
286732|NCT00262522|700862|P1|COMPLETED|Study Start Through 96 Weeks||256
286733|NCT00262522|700859|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
286734|NCT00262522|700860|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
286735|NCT00262522|700861|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
286736|NCT00262522|700862|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
286737|NCT00262522|700859|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
286738|NCT00262522|700860|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
286739|NCT00262522|700861|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
286740|NCT00262522|700862|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
286741|NCT00262522|700859|P4|COMPLETED|Study Start Through 48 Weeks||0
286742|NCT00262522|700860|P3|COMPLETED|Study Start Through 48 Weeks||276
286743|NCT00262522|700861|P2|COMPLETED|Study Start Through 48 Weeks||0
286744|NCT00262522|700862|P1|COMPLETED|Study Start Through 48 Weeks||284
286822|NCT00262080|700959|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
286745|NCT00262522|700859|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
286746|NCT00262522|700860|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
286747|NCT00262522|700861|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
286748|NCT00262522|700862|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
286749|NCT00262522|700859|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
286750|NCT00262522|700860|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
286751|NCT00262522|700861|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
286752|NCT00262522|700862|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
286753|NCT00262522|700859|P4|COMPLETED|Study Start Through 8 Weeks||160
286754|NCT00262522|700860|P3|COMPLETED|Study Start Through 8 Weeks||155
286755|NCT00262522|700861|P2|COMPLETED|Study Start Through 8 Weeks||161
286756|NCT00262522|700862|P1|COMPLETED|Study Start Through 8 Weeks||163
286757|NCT00262522|700859|P4|STARTED|Study Start Through 8 Weeks||165
286758|NCT00262522|700860|P3|STARTED|Study Start Through 8 Weeks||166
286759|NCT00262522|700861|P2|STARTED|Study Start Through 8 Weeks||166
286760|NCT00262522|700862|P1|STARTED|Study Start Through 8 Weeks||167
286761|NCT00262509|700884|P2|NOT COMPLETED|Overall Study||0
286762|NCT00262509|700885|P1|NOT COMPLETED|Overall Study||0
286763|NCT00262509|700884|P2|COMPLETED|Overall Study||9
286764|NCT00262509|700885|P1|COMPLETED|Overall Study||8
286765|NCT00262509|700884|P2|STARTED|Overall Study||9
286766|NCT00262509|700885|P1|STARTED|Overall Study||8
286767|NCT00262314|700891|P1|NOT COMPLETED|Overall Study||337
286768|NCT00262314|700891|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
286769|NCT00262314|700891|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
286770|NCT00262301|700909|P3|NOT COMPLETED|Open-label Phase||0
286771|NCT00262301|700910|P2|NOT COMPLETED|Open-label Phase||0
286772|NCT00262301|700911|P1|NOT COMPLETED|Open-label Phase||0
286773|NCT00262301|700909|P3|COMPLETED|Open-label Phase||57
286774|NCT00262301|700910|P2|COMPLETED|Open-label Phase||0
286775|NCT00262301|700911|P1|COMPLETED|Open-label Phase||0
286776|NCT00262301|700909|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
286777|NCT00262301|700910|P2|STARTED|Open-label Phase||0
286778|NCT00262301|700911|P1|STARTED|Open-label Phase||0
286779|NCT00262301|700909|P3|NOT COMPLETED|Double-blind Phase||0
286780|NCT00262301|700910|P2|NOT COMPLETED|Double-blind Phase||1
286781|NCT00262301|700911|P1|NOT COMPLETED|Double-blind Phase||1
286782|NCT00262301|700909|P3|COMPLETED|Double-blind Phase||0
286783|NCT00262301|700910|P2|COMPLETED|Double-blind Phase||15
286784|NCT00262301|700911|P1|COMPLETED|Double-blind Phase||15
286785|NCT00262301|700909|P3|STARTED|Double-blind Phase||0
286786|NCT00262301|700910|P2|STARTED|Double-blind Phase||16
286787|NCT00262301|700911|P1|STARTED|Double-blind Phase||16
286788|NCT00262223|700924|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
286789|NCT00262223|700925|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
286790|NCT00262223|700924|P2|COMPLETED|12-month Post-treatment Follow-up||22
286791|NCT00262223|700925|P1|COMPLETED|12-month Post-treatment Follow-up||21
286792|NCT00262223|700924|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
286793|NCT00262223|700925|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
286794|NCT00262223|700924|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
286795|NCT00262223|700925|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
286796|NCT00262223|700924|P2|COMPLETED|6-month Post-treatment Follow-up||28
286797|NCT00262223|700925|P1|COMPLETED|6-month Post-treatment Follow-up||22
286798|NCT00262223|700924|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
286799|NCT00262223|700925|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
286800|NCT00262223|700924|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
286801|NCT00262223|700925|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
286802|NCT00262223|700924|P2|COMPLETED|1-week Post-treatment Follow-up||25
286803|NCT00262223|700925|P1|COMPLETED|1-week Post-treatment Follow-up||24
286804|NCT00262223|700924|P2|STARTED|1-week Post-treatment Follow-up||29
286805|NCT00262223|700925|P1|STARTED|1-week Post-treatment Follow-up||28
286806|NCT00262223|700924|P2|NOT COMPLETED|Treatment Phase||8
286807|NCT00262223|700925|P1|NOT COMPLETED|Treatment Phase||4
286808|NCT00262223|700924|P2|COMPLETED|Treatment Phase||29
286809|NCT00262223|700925|P1|COMPLETED|Treatment Phase||28
286810|NCT00262223|700924|P2|STARTED|Treatment Phase||37
286811|NCT00262223|700925|P1|STARTED|Treatment Phase||32
286812|NCT00262119|700936|P3|NOT COMPLETED|Overall Study||58
286813|NCT00262119|700937|P2|NOT COMPLETED|Overall Study||70
286814|NCT00262119|700938|P1|NOT COMPLETED|Overall Study||58
286815|NCT00262119|700936|P3|COMPLETED|Overall Study||325
286816|NCT00262119|700937|P2|COMPLETED|Overall Study||328
286817|NCT00262119|700938|P1|COMPLETED|Overall Study||327
286818|NCT00262119|700936|P3|STARTED|Overall Study||383
286819|NCT00262119|700937|P2|STARTED|Overall Study||398
286820|NCT00262119|700938|P1|STARTED|Overall Study||385
286821|NCT00262080|700958|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
286823|NCT00262080|700960|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
286824|NCT00262080|700958|P3|COMPLETED|Repeat Dose Treatment Period||14
286825|NCT00262080|700959|P2|COMPLETED|Repeat Dose Treatment Period||25
286826|NCT00262080|700960|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
286827|NCT00262080|700958|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
286828|NCT00262080|700959|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
286829|NCT00262080|700960|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
286830|NCT00262080|700958|P3|NOT COMPLETED|Double Blind Treatment Period||0
286831|NCT00262080|700959|P2|NOT COMPLETED|Double Blind Treatment Period||0
286832|NCT00262080|700960|P1|NOT COMPLETED|Double Blind Treatment Period||1
286833|NCT00262080|700958|P3|COMPLETED|Double Blind Treatment Period||0
286834|NCT00262080|700959|P2|COMPLETED|Double Blind Treatment Period||36
286835|NCT00262080|700960|P1|COMPLETED|Double Blind Treatment Period||35
286836|NCT00262080|700958|P3|STARTED|Double Blind Treatment Period||0
286837|NCT00262080|700959|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
286838|NCT00262080|700960|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
286839|NCT00262067|700980|P4|NOT COMPLETED|Overall Study||113
286840|NCT00262067|700981|P3|NOT COMPLETED|Overall Study||216
286841|NCT00262067|700982|P2|NOT COMPLETED|Overall Study||100
286842|NCT00262067|700983|P1|NOT COMPLETED|Overall Study||219
286843|NCT00262067|700980|P4|COMPLETED|Overall Study||93
286844|NCT00262067|700981|P3|COMPLETED|Overall Study||193
286845|NCT00262067|700982|P2|COMPLETED|Overall Study||107
286846|NCT00262067|700983|P1|COMPLETED|Overall Study||196
286847|NCT00262067|700980|P4|STARTED|Overall Study||206
286848|NCT00262067|700981|P3|STARTED|Overall Study||409
286849|NCT00262067|700982|P2|STARTED|Overall Study||207
286850|NCT00262067|700983|P1|STARTED|Overall Study||415
286851|NCT00262041|701017|P3|NOT COMPLETED|Overall Study||6
286852|NCT00262041|701018|P2|NOT COMPLETED|Overall Study||4
286853|NCT00262041|701019|P1|NOT COMPLETED|Overall Study||2
286854|NCT00262041|701017|P3|COMPLETED|Overall Study||203
286855|NCT00262041|701018|P2|COMPLETED|Overall Study||147
286856|NCT00262041|701019|P1|COMPLETED|Overall Study||162
286857|NCT00262041|701017|P3|STARTED|Overall Study||209
286858|NCT00262041|701018|P2|STARTED|Overall Study||151
286859|NCT00262041|701019|P1|STARTED|Overall Study||164
286860|NCT00262028|701048|P9|NOT COMPLETED|Overall Study||19
286861|NCT00262028|701049|P8|NOT COMPLETED|Overall Study||18
286862|NCT00262028|701050|P7|NOT COMPLETED|Overall Study||12
286863|NCT00262028|701051|P6|NOT COMPLETED|Overall Study||13
286864|NCT00262028|701052|P5|NOT COMPLETED|Overall Study||12
286865|NCT00262028|701053|P4|NOT COMPLETED|Overall Study||23
286866|NCT00262028|701054|P3|NOT COMPLETED|Overall Study||20
286867|NCT00262028|701055|P2|NOT COMPLETED|Overall Study||27
286868|NCT00262028|701056|P1|NOT COMPLETED|Overall Study||24
286869|NCT00262028|701048|P9|COMPLETED|Overall Study||81
286870|NCT00262028|701049|P8|COMPLETED|Overall Study||55
286871|NCT00262028|701050|P7|COMPLETED|Overall Study||59
286872|NCT00262028|701051|P6|COMPLETED|Overall Study||60
286873|NCT00262028|701052|P5|COMPLETED|Overall Study||62
286874|NCT00262028|701053|P4|COMPLETED|Overall Study||134
286875|NCT00262028|701054|P3|COMPLETED|Overall Study||137
286876|NCT00262028|701055|P2|COMPLETED|Overall Study||126
286877|NCT00262028|701056|P1|COMPLETED|Overall Study||128
286878|NCT00262028|701048|P9|STARTED|Overall Study||100
286879|NCT00262028|701049|P8|STARTED|Overall Study||73
286880|NCT00262028|701050|P7|STARTED|Overall Study||71
286881|NCT00262028|701051|P6|STARTED|Overall Study||73
286882|NCT00262028|701052|P5|STARTED|Overall Study||74
286883|NCT00262028|701053|P4|STARTED|Overall Study||157
286884|NCT00262028|701054|P3|STARTED|Overall Study||157
286885|NCT00262028|701055|P2|STARTED|Overall Study||153
286886|NCT00262028|701056|P1|STARTED|Overall Study||152
286887|NCT00262002|701118|P7|NOT COMPLETED|Overall Study||6
286888|NCT00262002|701119|P6|NOT COMPLETED|Overall Study||7
286889|NCT00262002|701120|P5|NOT COMPLETED|Overall Study||7
286890|NCT00262002|701121|P4|NOT COMPLETED|Overall Study||5
286891|NCT00262002|701122|P3|NOT COMPLETED|Overall Study||0
286892|NCT00262002|701123|P2|NOT COMPLETED|Overall Study||6
286893|NCT00262002|701124|P1|NOT COMPLETED|Overall Study||11
286894|NCT00262002|701118|P7|COMPLETED|Overall Study||84
286895|NCT00262002|701119|P6|COMPLETED|Overall Study||83
286896|NCT00262002|701120|P5|COMPLETED|Overall Study||91
286897|NCT00262002|701121|P4|COMPLETED|Overall Study||93
286898|NCT00262002|701122|P3|COMPLETED|Overall Study||45
286899|NCT00262002|701123|P2|COMPLETED|Overall Study||84
286900|NCT00262002|701124|P1|COMPLETED|Overall Study||79
286901|NCT00262002|701118|P7|STARTED|Overall Study||90
286902|NCT00262002|701119|P6|STARTED|Overall Study||90
286903|NCT00262002|701120|P5|STARTED|Overall Study||98
286904|NCT00262002|701121|P4|STARTED|Overall Study||98
286905|NCT00262002|701122|P3|STARTED|Overall Study||45
286906|NCT00262002|701123|P2|STARTED|Overall Study||90
286907|NCT00262002|701124|P1|STARTED|Overall Study||90
286908|NCT00261950|701217|P1|NOT COMPLETED|Overall Study||26
286909|NCT00261950|701217|P1|COMPLETED|Overall Study||84
286910|NCT00261950|701217|P1|STARTED|Overall Study||110
286911|NCT00261846|701242|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
286912|NCT00261846|701243|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
286913|NCT00261846|701244|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
286914|NCT00261846|701245|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
286915|NCT00261846|701246|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
286916|NCT00261846|701247|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
286917|NCT00261846|701248|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
286918|NCT00261846|701249|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
286919|NCT00261846|701250|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
286920|NCT00261846|701251|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
286921|NCT00261846|701252|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
286922|NCT00261846|701253|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
286923|NCT00261846|701242|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
286924|NCT00261846|701243|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
286925|NCT00261846|701244|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
286926|NCT00261846|701245|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
286927|NCT00261846|701246|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
286928|NCT00261846|701247|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
286929|NCT00261846|701248|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
286930|NCT00261846|701249|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
286931|NCT00261846|701250|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
286932|NCT00261846|701251|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
286933|NCT00261846|701252|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
286934|NCT00261846|701253|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
286935|NCT00261846|701242|P12|STARTED|Period 2: Part 2 (Efficacy)||24
286936|NCT00261846|701243|P11|STARTED|Period 2: Part 2 (Efficacy)||64
286937|NCT00261846|701244|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
286938|NCT00261846|701245|P9|STARTED|Period 2: Part 2 (Efficacy)||26
286939|NCT00261846|701246|P8|STARTED|Period 2: Part 2 (Efficacy)||50
286940|NCT00261846|701247|P7|STARTED|Period 2: Part 2 (Efficacy)||38
286941|NCT00261846|701248|P6|STARTED|Period 2: Part 2 (Efficacy)||5
286942|NCT00261846|701249|P5|STARTED|Period 2: Part 2 (Efficacy)||89
286943|NCT00261846|701250|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
286944|NCT00261846|701251|P3|STARTED|Period 2: Part 2 (Efficacy)||0
286945|NCT00261846|701252|P2|STARTED|Period 2: Part 2 (Efficacy)||0
286946|NCT00261846|701253|P1|STARTED|Period 2: Part 2 (Efficacy)||0
286947|NCT00261846|701242|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286948|NCT00261846|701243|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286949|NCT00261846|701244|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286950|NCT00261846|701245|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286951|NCT00261846|701246|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286952|NCT00261846|701247|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286953|NCT00261846|701248|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286954|NCT00261846|701249|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286955|NCT00261846|701250|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286956|NCT00261846|701251|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
286957|NCT00261846|701252|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
286958|NCT00261846|701253|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
286959|NCT00261846|701242|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286960|NCT00261846|701243|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286961|NCT00261846|701244|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286962|NCT00261846|701245|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286963|NCT00261846|701246|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286964|NCT00261846|701247|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286965|NCT00261846|701248|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286966|NCT00261846|701249|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286967|NCT00261846|701250|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286968|NCT00261846|701251|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286969|NCT00261846|701252|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286970|NCT00261846|701253|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
286971|NCT00261846|701242|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
286972|NCT00261846|701243|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
286973|NCT00261846|701244|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
286974|NCT00261846|701245|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
286975|NCT00261846|701246|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
286976|NCT00261846|701247|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
286977|NCT00261846|701248|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
286978|NCT00261846|701249|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
286979|NCT00261846|701250|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
286980|NCT00261846|701251|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
286981|NCT00261846|701252|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
286982|NCT00261846|701253|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
286983|NCT00261833|701512|P2|NOT COMPLETED|Overall Study||18
286984|NCT00261833|701513|P1|NOT COMPLETED|Overall Study||9
286985|NCT00261833|701512|P2|COMPLETED|Overall Study||69
286986|NCT00261833|701513|P1|COMPLETED|Overall Study||84
286987|NCT00261833|701512|P2|STARTED|Overall Study||87
286988|NCT00261833|701513|P1|STARTED|Overall Study||93
286989|NCT00261716|701547|P2|NOT COMPLETED|Overall Study||10
286990|NCT00261716|701548|P1|NOT COMPLETED|Overall Study||6
286991|NCT00261716|701547|P2|COMPLETED|Overall Study||11
286992|NCT00261716|701548|P1|COMPLETED|Overall Study||11
286993|NCT00261716|701547|P2|STARTED|Overall Study||21
286994|NCT00261716|701548|P1|STARTED|Overall Study||17
286995|NCT00261495|701568|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
286996|NCT00261495|701569|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
286997|NCT00261495|701568|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
286998|NCT00261495|701569|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
286999|NCT00261495|701568|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
287000|NCT00261495|701569|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
287001|NCT00261495|701568|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
287002|NCT00261495|701569|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
287003|NCT00261495|701568|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
287004|NCT00261495|701569|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
287005|NCT00261495|701568|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
287006|NCT00261495|701569|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
287007|NCT00261495|701568|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
287008|NCT00261495|701569|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
287009|NCT00261495|701568|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
287010|NCT00261495|701569|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
287011|NCT00261495|701568|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
287012|NCT00261495|701569|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
287013|NCT00261443|701733|P3|NOT COMPLETED|4: Extension Phase||2
287014|NCT00261443|701734|P2|NOT COMPLETED|4: Extension Phase||3
287015|NCT00261443|701735|P1|NOT COMPLETED|4: Extension Phase||0
287016|NCT00261443|701733|P3|COMPLETED|4: Extension Phase||21
287017|NCT00261443|701734|P2|COMPLETED|4: Extension Phase||16
287018|NCT00261443|701735|P1|COMPLETED|4: Extension Phase||0
287019|NCT00261443|701733|P3|STARTED|4: Extension Phase||23
287020|NCT00261443|701734|P2|STARTED|4: Extension Phase||19
287021|NCT00261443|701735|P1|STARTED|4: Extension Phase||0
287022|NCT00261443|701733|P3|NOT COMPLETED|3: Assessment of Relapse||65
287023|NCT00261443|701734|P2|NOT COMPLETED|3: Assessment of Relapse||80
287024|NCT00261443|701735|P1|NOT COMPLETED|3: Assessment of Relapse||0
287025|NCT00261443|701733|P3|COMPLETED|3: Assessment of Relapse||103
287026|NCT00261443|701734|P2|COMPLETED|3: Assessment of Relapse||89
287027|NCT00261443|701735|P1|COMPLETED|3: Assessment of Relapse||0
287028|NCT00261443|701733|P3|STARTED|3: Assessment of Relapse||168
287029|NCT00261443|701734|P2|STARTED|3: Assessment of Relapse||169
287030|NCT00261443|701735|P1|STARTED|3: Assessment of Relapse||0
287031|NCT00261443|701733|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
287032|NCT00261443|701734|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
287033|NCT00261443|701735|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
287034|NCT00261443|701733|P3|COMPLETED|2: Stability & Maintenance of Stability||0
287035|NCT00261443|701734|P2|COMPLETED|2: Stability & Maintenance of Stability||0
287036|NCT00261443|701735|P1|COMPLETED|2: Stability & Maintenance of Stability||346
287037|NCT00261443|701733|P3|STARTED|2: Stability & Maintenance of Stability||0
287038|NCT00261443|701734|P2|STARTED|2: Stability & Maintenance of Stability||0
287039|NCT00261443|701735|P1|STARTED|2: Stability & Maintenance of Stability||686
287040|NCT00261443|701733|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
287041|NCT00261443|701734|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
287042|NCT00261443|701735|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
287043|NCT00261443|701733|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
287044|NCT00261443|701734|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
287045|NCT00261443|701735|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
287046|NCT00261443|701733|P3|STARTED|1: Confirmation of Partial Nonresponse||0
287047|NCT00261443|701734|P2|STARTED|1: Confirmation of Partial Nonresponse||0
287048|NCT00261443|701735|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
287049|NCT00260962|701992|P2|NOT COMPLETED|Overall Study||2
287050|NCT00260962|701993|P1|NOT COMPLETED|Overall Study||4
287051|NCT00260962|701992|P2|COMPLETED|Overall Study||14
287052|NCT00260962|701993|P1|COMPLETED|Overall Study||14
287053|NCT00260962|701992|P2|STARTED|Overall Study||16
287054|NCT00260962|701993|P1|STARTED|Overall Study||18
287055|NCT00260832|702003|P2|NOT COMPLETED|Overall Study||211
287056|NCT00260832|702004|P1|NOT COMPLETED|Overall Study||228
287057|NCT00260832|702003|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
287058|NCT00260832|702004|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
287059|NCT00260832|702003|P2|STARTED|Overall Study||242
287060|NCT00260832|702004|P1|STARTED|Overall Study||243
287061|NCT00260689|702013|P3|NOT COMPLETED|Overall Study||15
287062|NCT00260689|702014|P2|NOT COMPLETED|Overall Study||49
287063|NCT00260689|702015|P1|NOT COMPLETED|Overall Study||41
287064|NCT00260689|702013|P3|COMPLETED|Overall Study||1
287065|NCT00260689|702014|P2|COMPLETED|Overall Study||11
287066|NCT00260689|702015|P1|COMPLETED|Overall Study||19
287067|NCT00260689|702013|P3|STARTED|Overall Study||16
287068|NCT00260689|702014|P2|STARTED|Overall Study||60
287069|NCT00260689|702015|P1|STARTED|Overall Study||60
287070|NCT00260533|702031|P2|NOT COMPLETED|Overall Study||3
287071|NCT00260533|702032|P1|NOT COMPLETED|Overall Study||3
287072|NCT00260533|702031|P2|COMPLETED|Overall Study||10
287073|NCT00260533|702032|P1|COMPLETED|Overall Study||11
287074|NCT00260533|702031|P2|STARTED|Overall Study||13
287075|NCT00260533|702032|P1|STARTED|Overall Study||14
287076|NCT00260429|702040|P2|NOT COMPLETED|Overall Study||0
287077|NCT00260429|702041|P1|NOT COMPLETED|Overall Study||2
287078|NCT00260429|702040|P2|COMPLETED|Overall Study||12
287079|NCT00260429|702041|P1|COMPLETED|Overall Study||21
287080|NCT00260429|702040|P2|STARTED|Overall Study||12
287081|NCT00260429|702041|P1|STARTED|Overall Study||23
287082|NCT00260208|702049|P2|NOT COMPLETED|Overall Study||34
287083|NCT00260208|702050|P1|NOT COMPLETED|Overall Study||47
287084|NCT00260208|702049|P2|COMPLETED|Overall Study||138
287085|NCT00260208|702050|P1|COMPLETED|Overall Study||137
287086|NCT00260208|702049|P2|Modified ITT|Overall Study||96
287087|NCT00260208|702050|P1|Modified ITT|Overall Study||101
287088|NCT00260208|702049|P2|Intent to Treat (ITT) Population|Overall Study||169
287089|NCT00260208|702050|P1|Intent to Treat (ITT) Population|Overall Study||182
287090|NCT00260208|702049|P2|STARTED|Overall Study||172
287091|NCT00260208|702050|P1|STARTED|Overall Study|"Started indicates safety population."|184
287092|NCT00260195|702080|P2|NOT COMPLETED|Overall Study||0
287093|NCT00260195|702081|P1|NOT COMPLETED|Overall Study||0
287094|NCT00260195|702080|P2|COMPLETED|Overall Study||37
287095|NCT00260195|702081|P1|COMPLETED|Overall Study||39
287096|NCT00260195|702080|P2|STARTED|Overall Study||37
287097|NCT00260195|702081|P1|STARTED|Overall Study||39
287098|NCT00260065|702093|P1|NOT COMPLETED|Overall Study||93
287099|NCT00260065|702093|P1|COMPLETED|Overall Study||6
287100|NCT00260065|702093|P1|STARTED|Overall Study||99
287101|NCT00259857|702100|P2|NOT COMPLETED|24 Months Treatment||3
287102|NCT00259857|702101|P1|NOT COMPLETED|24 Months Treatment||0
287103|NCT00259857|702100|P2|COMPLETED|24 Months Treatment||6
287104|NCT00259857|702101|P1|COMPLETED|24 Months Treatment||10
287105|NCT00259857|702100|P2|STARTED|24 Months Treatment||9
287106|NCT00259857|702101|P1|STARTED|24 Months Treatment||10
287107|NCT00259857|702100|P2|NOT COMPLETED|12 Months Treatment||2
287108|NCT00259857|702101|P1|NOT COMPLETED|12 Months Treatment||1
287109|NCT00259857|702100|P2|COMPLETED|12 Months Treatment||9
287110|NCT00259857|702101|P1|COMPLETED|12 Months Treatment||10
287111|NCT00259857|702100|P2|STARTED|12 Months Treatment||11
287112|NCT00259857|702101|P1|STARTED|12 Months Treatment||11
287113|NCT00259740|702119|P2|NOT COMPLETED|Overall Study||53
287114|NCT00259740|702120|P1|NOT COMPLETED|Overall Study||43
287115|NCT00259740|702119|P2|COMPLETED|Overall Study||0
287116|NCT00259740|702120|P1|COMPLETED|Overall Study||0
287117|NCT00259740|702119|P2|Received Study Medication|Overall Study||53
287118|NCT00259740|702120|P1|Received Study Medication|Overall Study||42
287119|NCT00259740|702119|P2|STARTED|Overall Study||53
287120|NCT00259740|702120|P1|STARTED|Overall Study||43
287121|NCT00259649|702130|P1|NOT COMPLETED|Overall Study||10
287122|NCT00259649|702130|P1|COMPLETED|Overall Study||61
287123|NCT00259649|702130|P1|STARTED|Overall Study||71
287124|NCT00259610|702138|P4|NOT COMPLETED|Overall Study||43
287125|NCT00259610|702139|P3|NOT COMPLETED|Overall Study||73
287126|NCT00259610|702140|P2|NOT COMPLETED|Overall Study||46
287127|NCT00259610|702141|P1|NOT COMPLETED|Overall Study||76
287128|NCT00259610|702138|P4|COMPLETED|Overall Study||81
287129|NCT00259610|702139|P3|COMPLETED|Overall Study||182
287130|NCT00259610|702140|P2|COMPLETED|Overall Study||86
287131|NCT00259610|702141|P1|COMPLETED|Overall Study||168
287132|NCT00259610|702138|P4|STARTED|Overall Study||124
287133|NCT00259610|702139|P3|STARTED|Overall Study||255
287134|NCT00259610|702140|P2|STARTED|Overall Study||132
287135|NCT00259610|702141|P1|STARTED|Overall Study||244
287136|NCT00259298|702155|P1|NOT COMPLETED|Overall Study||3
287137|NCT00259298|702155|P1|COMPLETED|Overall Study||9
287138|NCT00259298|702155|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
287139|NCT00259298|702155|P1|STARTED|Overall Study||12
287140|NCT00259285|702163|P1|NOT COMPLETED|Overall Study||0
287141|NCT00259285|702163|P1|COMPLETED|Overall Study||10
287142|NCT00259285|702163|P1|STARTED|Overall Study||10
287143|NCT00259272|702173|P4|NOT COMPLETED|Overall Study||21
287144|NCT00259272|702174|P3|NOT COMPLETED|Overall Study||5
287145|NCT00259272|702175|P2|NOT COMPLETED|Overall Study||7
287146|NCT00259272|702176|P1|NOT COMPLETED|Overall Study||15
287147|NCT00259272|702173|P4|COMPLETED|Overall Study||27
287148|NCT00259272|702174|P3|COMPLETED|Overall Study||21
287149|NCT00259272|702175|P2|COMPLETED|Overall Study||24
287150|NCT00259272|702176|P1|COMPLETED|Overall Study||21
287151|NCT00259272|702173|P4|STARTED|Overall Study||48
287152|NCT00259272|702174|P3|STARTED|Overall Study||26
287153|NCT00259272|702175|P2|STARTED|Overall Study||31
287154|NCT00259272|702176|P1|STARTED|Overall Study||36
287155|NCT00259090|702254|P3|NOT COMPLETED|Overall Study||0
287156|NCT00259090|702255|P2|NOT COMPLETED|Overall Study||0
287157|NCT00259090|702256|P1|NOT COMPLETED|Overall Study||0
287158|NCT00259090|702254|P3|COMPLETED|Overall Study||37
287159|NCT00259090|702255|P2|COMPLETED|Overall Study||31
287160|NCT00259090|702256|P1|COMPLETED|Overall Study||35
287161|NCT00259090|702254|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
287162|NCT00259090|702255|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
287250|NCT00258206|702484|P1|COMPLETED|Overall Study||21
287163|NCT00259090|702256|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
287164|NCT00259012|702272|P2|NOT COMPLETED|Overall Study||4
287165|NCT00259012|702273|P1|NOT COMPLETED|Overall Study||2
287166|NCT00259012|702272|P2|COMPLETED|Overall Study||30
287167|NCT00259012|702273|P1|COMPLETED|Overall Study||31
287168|NCT00259012|702272|P2|STARTED|Overall Study||34
287169|NCT00259012|702273|P1|STARTED|Overall Study||33
287170|NCT00258908|702305|P1|NOT COMPLETED|Overall Study||0
287171|NCT00258908|702305|P1|COMPLETED|Overall Study||112
287172|NCT00258908|702305|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
287173|NCT00258895|702313|P2|NOT COMPLETED|Overall Study||3
287174|NCT00258895|702314|P1|NOT COMPLETED|Overall Study||10
287175|NCT00258895|702313|P2|COMPLETED|Overall Study||159
287176|NCT00258895|702314|P1|COMPLETED|Overall Study||477
287177|NCT00258895|702313|P2|STARTED|Overall Study||162
287178|NCT00258895|702314|P1|STARTED|Overall Study||487
287179|NCT00258882|702330|P2|NOT COMPLETED|Pregnancy Surveillance||0
287180|NCT00258882|702331|P1|NOT COMPLETED|Pregnancy Surveillance||0
287181|NCT00258882|702330|P2|COMPLETED|Pregnancy Surveillance||675
287182|NCT00258882|702331|P1|COMPLETED|Pregnancy Surveillance||225
287183|NCT00258882|702330|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
287184|NCT00258882|702331|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
287185|NCT00258882|702330|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
287186|NCT00258882|702331|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
287187|NCT00258882|702330|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
287188|NCT00258882|702331|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
287189|NCT00258882|702330|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
287190|NCT00258882|702331|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
287191|NCT00258882|702330|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
287192|NCT00258882|702331|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
287193|NCT00258882|702330|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
287194|NCT00258882|702331|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
287195|NCT00258882|702330|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
287196|NCT00258882|702331|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
287197|NCT00258856|702350|P4|NOT COMPLETED|Overall Study||1
287198|NCT00258856|702351|P3|NOT COMPLETED|Overall Study||2
287199|NCT00258856|702352|P2|NOT COMPLETED|Overall Study||0
287200|NCT00258856|702353|P1|NOT COMPLETED|Overall Study||3
287201|NCT00258856|702350|P4|COMPLETED|Overall Study||58
287202|NCT00258856|702351|P3|COMPLETED|Overall Study||56
287203|NCT00258856|702352|P2|COMPLETED|Overall Study||58
287204|NCT00258856|702353|P1|COMPLETED|Overall Study||56
287205|NCT00258856|702350|P4|STARTED|Overall Study||59
287206|NCT00258856|702351|P3|STARTED|Overall Study||58
287207|NCT00258856|702352|P2|STARTED|Overall Study||58
287208|NCT00258856|702353|P1|STARTED|Overall Study||59
287209|NCT00258830|702365|P2|NOT COMPLETED|Overall Study||0
287210|NCT00258830|702366|P1|NOT COMPLETED|Overall Study||0
287211|NCT00258830|702365|P2|COMPLETED|Overall Study||60
287212|NCT00258830|702366|P1|COMPLETED|Overall Study||60
287213|NCT00258830|702365|P2|STARTED|Overall Study||60
287214|NCT00258830|702366|P1|STARTED|Overall Study||60
287215|NCT00258817|702380|P2|NOT COMPLETED|Overall Study||0
287216|NCT00258817|702381|P1|NOT COMPLETED|Overall Study||0
287217|NCT00258817|702380|P2|COMPLETED|Overall Study||15
287218|NCT00258817|702381|P1|COMPLETED|Overall Study||15
287219|NCT00258817|702380|P2|STARTED|Overall Study||15
287220|NCT00258817|702381|P1|STARTED|Overall Study||15
287221|NCT00258674|702394|P3|NOT COMPLETED|Overall Study||34
287222|NCT00258674|702395|P2|NOT COMPLETED|Overall Study||53
287223|NCT00258674|702396|P1|NOT COMPLETED|Overall Study||32
287224|NCT00258674|702394|P3|COMPLETED|Overall Study||568
287225|NCT00258674|702395|P2|COMPLETED|Overall Study||758
287226|NCT00258674|702396|P1|COMPLETED|Overall Study||565
287227|NCT00258674|702394|P3|STARTED|Overall Study||602
287228|NCT00258674|702395|P2|STARTED|Overall Study||811
287229|NCT00258674|702396|P1|STARTED|Overall Study||597
287230|NCT00258440|702455|P3|NOT COMPLETED|Overall Study||1
287231|NCT00258440|702456|P2|NOT COMPLETED|Overall Study||0
287232|NCT00258440|702457|P1|NOT COMPLETED|Overall Study||0
287233|NCT00258440|702455|P3|COMPLETED|Overall Study||5
287234|NCT00258440|702456|P2|COMPLETED|Overall Study||0
287235|NCT00258440|702457|P1|COMPLETED|Overall Study||1
287236|NCT00258440|702455|P3|STARTED|Overall Study||6
287237|NCT00258440|702456|P2|STARTED|Overall Study||0
287238|NCT00258440|702457|P1|STARTED|Overall Study||1
287239|NCT00258362|702468|P1|NOT COMPLETED|Overall Study||0
287240|NCT00258362|702468|P1|COMPLETED|Overall Study||41
287241|NCT00258362|702468|P1|STARTED|Overall Study||41
287242|NCT00258349|702473|P1|NOT COMPLETED|Overall Study||0
287243|NCT00258349|702473|P1|COMPLETED|Overall Study||16
287244|NCT00258349|702473|P1|HER2-positive by Central Review|Overall Study||10
287245|NCT00258349|702473|P1|STARTED|Overall Study||16
287246|NCT00258310|702480|P1|NOT COMPLETED|Overall Study||0
287247|NCT00258310|702480|P1|COMPLETED|Overall Study||35
287248|NCT00258310|702480|P1|STARTED|Overall Study||35
287249|NCT00258206|702484|P1|NOT COMPLETED|Overall Study||0
287251|NCT00258206|702484|P1|STARTED|Overall Study||21
287252|NCT00258154|702490|P2|NOT COMPLETED|Overall Study||7
287253|NCT00258154|702491|P1|NOT COMPLETED|Overall Study||9
287254|NCT00258154|702490|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
287255|NCT00258154|702491|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
287256|NCT00258154|702490|P2|Vaccinated at Visit 3|Overall Study||197
287257|NCT00258154|702491|P1|Vaccinated at Visit 3|Overall Study||195
287258|NCT00258154|702490|P2|Vaccinated at Visit 2|Overall Study||198
287259|NCT00258154|702491|P1|Vaccinated at Visit 2|Overall Study||198
287260|NCT00258154|702490|P2|Vaccinated at Visit 1|Overall Study||202
287261|NCT00258154|702491|P1|Vaccinated at Visit 1|Overall Study||201
287262|NCT00258154|702490|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
287263|NCT00258154|702491|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
287264|NCT00258011|702559|P1|NOT COMPLETED|Overall Study||0
287265|NCT00258011|702559|P1|COMPLETED|Overall Study||3
287266|NCT00258011|702559|P1|STARTED|Overall Study||3
287267|NCT00257933|702566|P2|NOT COMPLETED|Overall Study||0
287268|NCT00257933|702567|P1|NOT COMPLETED|Overall Study||0
287269|NCT00257933|702566|P2|COMPLETED|Overall Study||78
287270|NCT00257933|702567|P1|COMPLETED|Overall Study||74
287271|NCT00257933|702566|P2|STARTED|Overall Study||78
287272|NCT00257933|702567|P1|STARTED|Overall Study||74
287273|NCT00257920|702575|P2|NOT COMPLETED|Period: Second Intervention||1
287274|NCT00257920|702576|P1|NOT COMPLETED|Period: Second Intervention||2
287275|NCT00257920|702575|P2|COMPLETED|Period: Second Intervention||18
287276|NCT00257920|702576|P1|COMPLETED|Period: Second Intervention||19
287277|NCT00257920|702575|P2|STARTED|Period: Second Intervention||19
287278|NCT00257920|702576|P1|STARTED|Period: Second Intervention||21
287279|NCT00257920|702575|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
287280|NCT00257920|702576|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
287281|NCT00257920|702575|P2|COMPLETED|Period: Washout Period of Two Weeks||19
287282|NCT00257920|702576|P1|COMPLETED|Period: Washout Period of Two Weeks||21
287283|NCT00257920|702575|P2|STARTED|Period: Washout Period of Two Weeks||20
287284|NCT00257920|702576|P1|STARTED|Period: Washout Period of Two Weeks||21
287285|NCT00257920|702575|P2|NOT COMPLETED|Period: First Intervention||0
287286|NCT00257920|702576|P1|NOT COMPLETED|Period: First Intervention||0
287287|NCT00257920|702575|P2|COMPLETED|Period: First Intervention||20
287288|NCT00257920|702576|P1|COMPLETED|Period: First Intervention||21
287289|NCT00257920|702575|P2|STARTED|Period: First Intervention||20
287290|NCT00257920|702576|P1|STARTED|Period: First Intervention||21
287291|NCT00257894|702586|P2|NOT COMPLETED|Overall Study||5
287292|NCT00257894|702587|P1|NOT COMPLETED|Overall Study||4
287293|NCT00257894|702586|P2|COMPLETED|Overall Study||15
287294|NCT00257894|702587|P1|COMPLETED|Overall Study||17
287295|NCT00257894|702586|P2|STARTED|Overall Study||20
287296|NCT00257894|702587|P1|STARTED|Overall Study||21
287297|NCT00257686|702605|P6|NOT COMPLETED|Overall Study||9
287298|NCT00257686|702606|P5|NOT COMPLETED|Overall Study||22
287299|NCT00257686|702607|P4|NOT COMPLETED|Overall Study||11
287300|NCT00257686|702608|P3|NOT COMPLETED|Overall Study||18
287301|NCT00257686|702609|P2|NOT COMPLETED|Overall Study||19
287302|NCT00257686|702610|P1|NOT COMPLETED|Overall Study||21
287303|NCT00257686|702605|P6|COMPLETED|Overall Study||95
287304|NCT00257686|702606|P5|COMPLETED|Overall Study||194
287305|NCT00257686|702607|P4|COMPLETED|Overall Study||88
287306|NCT00257686|702608|P3|COMPLETED|Overall Study||208
287307|NCT00257686|702609|P2|COMPLETED|Overall Study||89
287308|NCT00257686|702610|P1|COMPLETED|Overall Study||188
287309|NCT00257686|702605|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
287310|NCT00257686|702606|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
287311|NCT00257686|702607|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
287312|NCT00257686|702608|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
287313|NCT00257686|702609|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
287314|NCT00257686|702610|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
287315|NCT00257686|702605|P6|STARTED|Overall Study||104
287316|NCT00257686|702606|P5|STARTED|Overall Study||216
287317|NCT00257686|702607|P4|STARTED|Overall Study||99
287318|NCT00257686|702608|P3|STARTED|Overall Study||226
287319|NCT00257686|702609|P2|STARTED|Overall Study||108
287320|NCT00257686|702610|P1|STARTED|Overall Study||209
287321|NCT00257660|702632|P2|NOT COMPLETED|Overall Study||23
287322|NCT00257660|702633|P1|NOT COMPLETED|Overall Study||10
287323|NCT00257660|702632|P2|COMPLETED|Overall Study||38
287324|NCT00257660|702633|P1|COMPLETED|Overall Study||45
287325|NCT00257660|702632|P2|STARTED|Overall Study||61
287326|NCT00257660|702633|P1|STARTED|Overall Study||55
287327|NCT00257608|702663|P3|NOT COMPLETED|Post Chemotherapy Phase||244
287328|NCT00257608|702664|P2|NOT COMPLETED|Post Chemotherapy Phase||264
287329|NCT00257608|702665|P1|NOT COMPLETED|Post Chemotherapy Phase||0
287330|NCT00257608|702663|P3|COMPLETED|Post Chemotherapy Phase||126
287331|NCT00257608|702664|P2|COMPLETED|Post Chemotherapy Phase||109
287332|NCT00257608|702665|P1|COMPLETED|Post Chemotherapy Phase||0
287333|NCT00257608|702663|P3|STARTED|Post Chemotherapy Phase||370
287334|NCT00257608|702664|P2|STARTED|Post Chemotherapy Phase||373
287335|NCT00257608|702665|P1|STARTED|Post Chemotherapy Phase||0
287336|NCT00257608|702663|P3|NOT COMPLETED|Chemotherapy Phase||0
287337|NCT00257608|702664|P2|NOT COMPLETED|Chemotherapy Phase||0
287338|NCT00257608|702665|P1|NOT COMPLETED|Chemotherapy Phase||376
287339|NCT00257608|702663|P3|COMPLETED|Chemotherapy Phase||0
287340|NCT00257608|702664|P2|COMPLETED|Chemotherapy Phase||0
287341|NCT00257608|702665|P1|COMPLETED|Chemotherapy Phase||769
287342|NCT00257608|702663|P3|STARTED|Chemotherapy Phase||0
287343|NCT00257608|702664|P2|STARTED|Chemotherapy Phase||0
287344|NCT00257608|702665|P1|STARTED|Chemotherapy Phase||1145
287345|NCT00257556|702691|P2|NOT COMPLETED|Overall Study||10
287346|NCT00257556|702692|P1|NOT COMPLETED|Overall Study||14
287347|NCT00257556|702691|P2|COMPLETED|Overall Study||32
287348|NCT00257556|702692|P1|COMPLETED|Overall Study||24
287349|NCT00257556|702691|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
287350|NCT00257556|702692|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
287351|NCT00257556|702691|P2|STARTED|Overall Study||42
287352|NCT00257556|702692|P1|STARTED|Overall Study||38
287353|NCT00257322|702718|P1|NOT COMPLETED|Overall Study||4
287354|NCT00257322|702718|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
287355|NCT00257322|702718|P1|STARTED|Overall Study|20 subjects accrued.|20
287356|NCT00257309|702725|P2|NOT COMPLETED|Overall Study||2
287357|NCT00257309|702726|P1|NOT COMPLETED|Overall Study||2
287358|NCT00257309|702725|P2|COMPLETED|Overall Study||130
287359|NCT00257309|702726|P1|COMPLETED|Overall Study||132
287360|NCT00257309|702725|P2|STARTED|Overall Study||132
287361|NCT00257309|702726|P1|STARTED|Overall Study||134
287362|NCT00257192|702736|P2|NOT COMPLETED|Overall Study||39
287363|NCT00257192|702737|P1|NOT COMPLETED|Overall Study||58
287364|NCT00257192|702736|P2|COMPLETED|Overall Study||52
287365|NCT00257192|702737|P1|COMPLETED|Overall Study||135
287366|NCT00257192|702736|P2|Received Study Treatment|Overall Study||90
287367|NCT00257192|702737|P1|Received Study Treatment|Overall Study||193
287368|NCT00257192|702736|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
287369|NCT00257192|702737|P1|STARTED|Overall Study||193
287370|NCT00257166|702781|P2|NOT COMPLETED|Overall Study||37
287371|NCT00257166|702782|P1|NOT COMPLETED|Overall Study||53
287372|NCT00257166|702781|P2|COMPLETED|Overall Study||51
287373|NCT00257166|702782|P1|COMPLETED|Overall Study||97
287374|NCT00257166|702781|P2|Treated|Overall Study||88
287375|NCT00257166|702782|P1|Treated|Overall Study||149
287376|NCT00257166|702781|P2|STARTED|Overall Study||88
287377|NCT00257166|702782|P1|STARTED|Overall Study||150
287378|NCT00257010|702794|P1|NOT COMPLETED|Overall Study||128
287379|NCT00257010|702794|P1|COMPLETED|Overall Study||319
287380|NCT00257010|702794|P1|STARTED|Overall Study||447
287381|NCT00256997|702805|P2|NOT COMPLETED|Overall Study||55
287382|NCT00256997|702806|P1|NOT COMPLETED|Overall Study||48
287383|NCT00256997|702805|P2|COMPLETED|Overall Study||31
287384|NCT00256997|702806|P1|COMPLETED|Overall Study||33
287385|NCT00256997|702805|P2|Treated|Overall Study||86
287386|NCT00256997|702806|P1|Treated|Overall Study||79
287387|NCT00256997|702805|P2|STARTED|Overall Study||86
287388|NCT00256997|702806|P1|STARTED|Overall Study||81
287389|NCT00256984|702830|P1|NOT COMPLETED|Overall Study||16
287390|NCT00256984|702830|P1|COMPLETED|Overall Study||59
287391|NCT00256984|702830|P1|STARTED|Overall Study||75
287392|NCT00256867|702848|P8|NOT COMPLETED|Overall Study||11
287393|NCT00256867|702849|P7|NOT COMPLETED|Overall Study||5
287394|NCT00256867|702850|P6|NOT COMPLETED|Overall Study||6
287395|NCT00256867|702851|P5|NOT COMPLETED|Overall Study||7
287396|NCT00256867|702852|P4|NOT COMPLETED|Overall Study||6
287397|NCT00256867|702853|P3|NOT COMPLETED|Overall Study||5
287398|NCT00256867|702854|P2|NOT COMPLETED|Overall Study||5
287399|NCT00256867|702855|P1|NOT COMPLETED|Overall Study||2
287400|NCT00256867|702848|P8|COMPLETED|Overall Study||36
287401|NCT00256867|702849|P7|COMPLETED|Overall Study||41
287402|NCT00256867|702850|P6|COMPLETED|Overall Study||40
287403|NCT00256867|702851|P5|COMPLETED|Overall Study||41
287404|NCT00256867|702852|P4|COMPLETED|Overall Study||40
287405|NCT00256867|702853|P3|COMPLETED|Overall Study||40
287406|NCT00256867|702854|P2|COMPLETED|Overall Study||39
287407|NCT00256867|702855|P1|COMPLETED|Overall Study||45
287408|NCT00256867|702848|P8|STARTED|Overall Study||47
287409|NCT00256867|702849|P7|STARTED|Overall Study||46
287410|NCT00256867|702850|P6|STARTED|Overall Study||46
287411|NCT00256867|702851|P5|STARTED|Overall Study||48
287412|NCT00256867|702852|P4|STARTED|Overall Study||46
287413|NCT00256867|702853|P3|STARTED|Overall Study||45
287414|NCT00256867|702854|P2|STARTED|Overall Study||44
287415|NCT00256867|702855|P1|STARTED|Overall Study||47
287416|NCT00256750|702942|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
287417|NCT00256750|702943|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
287418|NCT00256750|702944|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
287419|NCT00256750|702942|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
287420|NCT00256750|702943|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
287421|NCT00256750|702944|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
287422|NCT00256750|702942|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
287508|NCT00255970|703176|P1|Final Visit Week 24|Overall Study||21
287423|NCT00256750|702943|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
287424|NCT00256750|702944|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
287425|NCT00256750|702942|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
287426|NCT00256750|702943|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
287427|NCT00256750|702944|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
287428|NCT00256750|702942|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
287429|NCT00256750|702943|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
287430|NCT00256750|702944|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
287431|NCT00256750|702942|P3|STARTED|Post-Transplant Treated (36 Months)||164
287432|NCT00256750|702943|P2|STARTED|Post-Transplant Treated (36 Months)||176
287433|NCT00256750|702944|P1|STARTED|Post-Transplant Treated (36 Months)||153
287434|NCT00256750|702942|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
287435|NCT00256750|702943|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
287436|NCT00256750|702944|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
287437|NCT00256750|702942|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
287438|NCT00256750|702943|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
287439|NCT00256750|702944|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
287440|NCT00256750|702942|P3|STARTED|Post-Transplant Treated (24 Months)||173
287441|NCT00256750|702943|P2|STARTED|Post-Transplant Treated (24 Months)||183
287442|NCT00256750|702944|P1|STARTED|Post-Transplant Treated (24 Months)||174
287443|NCT00256750|702942|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
287444|NCT00256750|702943|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
287445|NCT00256750|702944|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
287446|NCT00256750|702942|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
287447|NCT00256750|702943|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
287448|NCT00256750|702944|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
287449|NCT00256750|702942|P3|STARTED|Post-Transplant Treated (12 Months)||219
287450|NCT00256750|702943|P2|STARTED|Post-Transplant Treated (12 Months)||226
287451|NCT00256750|702944|P1|STARTED|Post-Transplant Treated (12 Months)||215
287452|NCT00256750|702942|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
287453|NCT00256750|702943|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
287454|NCT00256750|702944|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
287455|NCT00256750|702942|P3|COMPLETED|Transplanted Pre-Treatment||219
287456|NCT00256750|702943|P2|COMPLETED|Transplanted Pre-Treatment||226
287457|NCT00256750|702944|P1|COMPLETED|Transplanted Pre-Treatment||215
287458|NCT00256750|702942|P3|STARTED|Transplanted Pre-Treatment||219
287459|NCT00256750|702943|P2|STARTED|Transplanted Pre-Treatment||226
287460|NCT00256750|702944|P1|STARTED|Transplanted Pre-Treatment||221
287461|NCT00256724|703080|P2|NOT COMPLETED|Overall Study||8
287462|NCT00256724|703081|P1|NOT COMPLETED|Overall Study||5
287463|NCT00256724|703080|P2|COMPLETED|Overall Study||16
287464|NCT00256724|703081|P1|COMPLETED|Overall Study||18
287465|NCT00256724|703080|P2|STARTED|Overall Study||24
287466|NCT00256724|703081|P1|STARTED|Overall Study||23
287467|NCT00256698|703091|P2|NOT COMPLETED|Overall Study||172
287468|NCT00256698|703092|P1|NOT COMPLETED|Overall Study||167
287469|NCT00256698|703091|P2|COMPLETED|Overall Study||84
287470|NCT00256698|703092|P1|COMPLETED|Overall Study||91
287471|NCT00256698|703091|P2|STARTED|Overall Study||256
287472|NCT00256698|703092|P1|STARTED|Overall Study||258
287473|NCT00256308|703110|P1|NOT COMPLETED|Overall Study||2
287474|NCT00256308|703110|P1|COMPLETED|Overall Study||4
287475|NCT00256308|703110|P1|STARTED|Overall Study||6
287476|NCT00256295|703118|P1|NOT COMPLETED|Overall Study||4
287477|NCT00256295|703118|P1|COMPLETED|Overall Study||3
287478|NCT00256295|703118|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
287479|NCT00256282|703124|P1|NOT COMPLETED|Overall Study||16
287480|NCT00256282|703124|P1|COMPLETED|Overall Study||36
287481|NCT00256282|703124|P1|STARTED|Overall Study||52
287482|NCT00256243|703129|P1|NOT COMPLETED|Overall Study||10
287483|NCT00256243|703129|P1|COMPLETED|Overall Study||38
287484|NCT00256243|703129|P1|STARTED|Overall Study||48
287485|NCT00256204|703138|P4|NOT COMPLETED|Overall Study||49
287486|NCT00256204|703139|P3|NOT COMPLETED|Overall Study||54
287487|NCT00256204|703140|P2|NOT COMPLETED|Overall Study||50
287488|NCT00256204|703141|P1|NOT COMPLETED|Overall Study||67
287489|NCT00256204|703138|P4|COMPLETED|Overall Study||244
287490|NCT00256204|703139|P3|COMPLETED|Overall Study||241
287491|NCT00256204|703140|P2|COMPLETED|Overall Study||238
287492|NCT00256204|703141|P1|COMPLETED|Overall Study||231
287493|NCT00256204|703138|P4|STARTED|Overall Study||293
287494|NCT00256204|703139|P3|STARTED|Overall Study||295
287495|NCT00256204|703140|P2|STARTED|Overall Study||288
287496|NCT00256204|703141|P1|STARTED|Overall Study||298
287497|NCT00256126|703156|P2|NOT COMPLETED|Overall Study||2
287498|NCT00256126|703157|P1|NOT COMPLETED|Overall Study||2
287499|NCT00256126|703156|P2|COMPLETED|Overall Study||167
287500|NCT00256126|703157|P1|COMPLETED|Overall Study||147
287501|NCT00256126|703156|P2|STARTED|Overall Study||169
287502|NCT00256126|703157|P1|STARTED|Overall Study||149
287503|NCT00255970|703175|P2|NOT COMPLETED|Overall Study||0
287504|NCT00255970|703176|P1|NOT COMPLETED|Overall Study||0
287505|NCT00255970|703175|P2|COMPLETED|Overall Study||19
287506|NCT00255970|703176|P1|COMPLETED|Overall Study||21
287507|NCT00255970|703175|P2|Final Visit Week 24|Overall Study||19
287509|NCT00255970|703175|P2|Screening Visit|Overall Study||19
287510|NCT00255970|703176|P1|Screening Visit|Overall Study||21
287511|NCT00255970|703175|P2|STARTED|Overall Study||19
287512|NCT00255970|703176|P1|STARTED|Overall Study||21
287513|NCT00255840|703196|P2|NOT COMPLETED|Overall Study||70
287514|NCT00255840|703197|P1|NOT COMPLETED|Overall Study||63
287515|NCT00255840|703196|P2|COMPLETED|Overall Study||334
287516|NCT00255840|703197|P1|COMPLETED|Overall Study||345
287517|NCT00255840|703196|P2|STARTED|Overall Study||404
287518|NCT00255840|703197|P1|STARTED|Overall Study||408
287519|NCT00255723|703205|P2|NOT COMPLETED|Overall Study||2
287520|NCT00255723|703206|P1|NOT COMPLETED|Overall Study||2
287521|NCT00255723|703205|P2|COMPLETED|Overall Study||39
287522|NCT00255723|703206|P1|COMPLETED|Overall Study||54
287523|NCT00255723|703205|P2|STARTED|Overall Study||41
287524|NCT00255723|703206|P1|STARTED|Overall Study||56
287525|NCT00255684|703212|P1|NOT COMPLETED|Overall Study||0
287526|NCT00255684|703212|P1|COMPLETED|Overall Study||16
287527|NCT00255684|703212|P1|STARTED|Overall Study||16
287528|NCT00255190|703219|P2|NOT COMPLETED|Overall Study||157
287529|NCT00255190|703220|P1|NOT COMPLETED|Overall Study||50
287530|NCT00255190|703219|P2|COMPLETED|Overall Study||281
287531|NCT00255190|703220|P1|COMPLETED|Overall Study||103
287532|NCT00255190|703219|P2|STARTED|Overall Study||438
287533|NCT00255190|703220|P1|STARTED|Overall Study||153
287534|NCT00255177|703288|P4|NOT COMPLETED|Overall Study||2
287535|NCT00255177|703289|P3|NOT COMPLETED|Overall Study||1
287536|NCT00255177|703290|P2|NOT COMPLETED|Overall Study||1
287537|NCT00255177|703291|P1|NOT COMPLETED|Overall Study||2
287538|NCT00255177|703288|P4|COMPLETED|Overall Study||4
287539|NCT00255177|703289|P3|COMPLETED|Overall Study||12
287540|NCT00255177|703290|P2|COMPLETED|Overall Study||13
287541|NCT00255177|703291|P1|COMPLETED|Overall Study||9
287542|NCT00255177|703288|P4|STARTED|Overall Study||6
287543|NCT00255177|703289|P3|STARTED|Overall Study||13
287544|NCT00255177|703290|P2|STARTED|Overall Study||14
287545|NCT00255177|703291|P1|STARTED|Overall Study||11
287546|NCT00255164|703304|P3|NOT COMPLETED|Overall Study||49
287547|NCT00255164|703305|P2|NOT COMPLETED|Overall Study||49
287548|NCT00255164|703306|P1|NOT COMPLETED|Overall Study||123
287549|NCT00255164|703304|P3|COMPLETED|Overall Study||103
287550|NCT00255164|703305|P2|COMPLETED|Overall Study||110
287551|NCT00255164|703306|P1|COMPLETED|Overall Study||17
287552|NCT00255164|703304|P3|STARTED|Overall Study||152
287553|NCT00255164|703305|P2|STARTED|Overall Study||159
287554|NCT00255164|703306|P1|STARTED|Overall Study||140
287555|NCT00255151|703332|P3|NOT COMPLETED|Overall Study||49
287556|NCT00255151|703333|P2|NOT COMPLETED|Overall Study||49
287557|NCT00255151|703334|P1|NOT COMPLETED|Overall Study||123
287558|NCT00255151|703332|P3|COMPLETED|Overall Study||103
287559|NCT00255151|703333|P2|COMPLETED|Overall Study||110
287560|NCT00255151|703334|P1|COMPLETED|Overall Study||17
287561|NCT00255151|703332|P3|STARTED|Overall Study||152
287562|NCT00255151|703333|P2|STARTED|Overall Study||159
287563|NCT00255151|703334|P1|STARTED|Overall Study||140
287564|NCT00255125|703359|P2|NOT COMPLETED|Overall Study||0
287565|NCT00255125|703360|P1|NOT COMPLETED|Overall Study||0
287566|NCT00255125|703359|P2|COMPLETED|Overall Study||42
287567|NCT00255125|703360|P1|COMPLETED|Overall Study||44
287568|NCT00255125|703359|P2|STARTED|Overall Study||42
287569|NCT00255125|703360|P1|STARTED|Overall Study||44
287570|NCT00255086|703368|P2|NOT COMPLETED|Overall Study||2
287571|NCT00255086|703369|P1|NOT COMPLETED|Overall Study||2
287572|NCT00255086|703368|P2|COMPLETED|Overall Study||6
287573|NCT00255086|703369|P1|COMPLETED|Overall Study||7
287574|NCT00255086|703368|P2|STARTED|Overall Study||8
287575|NCT00255086|703369|P1|STARTED|Overall Study||9
287576|NCT00255047|703381|P4|NOT COMPLETED|Overall Study||46
287577|NCT00255047|703382|P3|NOT COMPLETED|Overall Study||50
287578|NCT00255047|703383|P2|NOT COMPLETED|Overall Study||48
287579|NCT00255047|703384|P1|NOT COMPLETED|Overall Study||48
287580|NCT00255047|703381|P4|COMPLETED|Overall Study||502
287581|NCT00255047|703382|P3|COMPLETED|Overall Study||496
287582|NCT00255047|703383|P2|COMPLETED|Overall Study||487
287583|NCT00255047|703384|P1|COMPLETED|Overall Study||490
287584|NCT00255047|703381|P4|STARTED|Overall Study||548
287585|NCT00255047|703382|P3|STARTED|Overall Study||546
287586|NCT00255047|703383|P2|STARTED|Overall Study||535
287587|NCT00255047|703384|P1|STARTED|Overall Study||538
287588|NCT00255034|703408|P2|NOT COMPLETED|Overall Study||38
287589|NCT00255034|703409|P1|NOT COMPLETED|Overall Study||15
287590|NCT00255034|703408|P2|COMPLETED|Overall Study||26
287591|NCT00255034|703409|P1|COMPLETED|Overall Study||64
287592|NCT00255034|703408|P2|STARTED|Overall Study||64
287593|NCT00255034|703409|P1|STARTED|Overall Study||79
287594|NCT00255008|703419|P4|NOT COMPLETED|Overall Study||22
287595|NCT00255008|703420|P3|NOT COMPLETED|Overall Study||16
287596|NCT00255008|703421|P2|NOT COMPLETED|Overall Study||9
287597|NCT00255008|703422|P1|NOT COMPLETED|Overall Study||32
287598|NCT00255008|703419|P4|COMPLETED|Overall Study||12
287599|NCT00255008|703420|P3|COMPLETED|Overall Study||17
287600|NCT00255008|703421|P2|COMPLETED|Overall Study||0
287601|NCT00255008|703422|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
287602|NCT00255008|703419|P4|STARTED|Overall Study||34
287603|NCT00255008|703420|P3|STARTED|Overall Study||33
287604|NCT00255008|703421|P2|STARTED|Overall Study||9
287605|NCT00255008|703422|P1|STARTED|Overall Study||45
287606|NCT00254995|703434|P2|NOT COMPLETED|Overall Study||0
287607|NCT00254995|703435|P1|NOT COMPLETED|Overall Study||0
287608|NCT00254995|703434|P2|COMPLETED|Overall Study||31065
287609|NCT00254995|703435|P1|COMPLETED|Overall Study||31561
287610|NCT00254995|703434|P2|STARTED|Overall Study||31065
287611|NCT00254995|703435|P1|STARTED|Overall Study||31561
287612|NCT00254982|703458|P2|NOT COMPLETED|Overall Study||31
287613|NCT00254982|703459|P1|NOT COMPLETED|Overall Study||36
287614|NCT00254982|703458|P2|COMPLETED|Overall Study||265
287615|NCT00254982|703459|P1|COMPLETED|Overall Study||261
287616|NCT00254982|703458|P2|STARTED|Overall Study||296
287617|NCT00254982|703459|P1|STARTED|Overall Study||297
287618|NCT00254592|703465|P1|NOT COMPLETED|Overall Study||2
287619|NCT00254592|703465|P1|COMPLETED|Overall Study||41
287620|NCT00254592|703465|P1|STARTED|Overall Study||43
287621|NCT00254566|703471|P2|NOT COMPLETED|Overall Study||26
287622|NCT00254566|703472|P1|NOT COMPLETED|Overall Study||31
287623|NCT00254566|703471|P2|COMPLETED|Overall Study||172
287624|NCT00254566|703472|P1|COMPLETED|Overall Study||167
287625|NCT00254566|703471|P2|STARTED|Overall Study||198
287626|NCT00254566|703472|P1|STARTED|Overall Study||198
287627|NCT00254540|703496|P2|NOT COMPLETED|Overall Study||22
287628|NCT00254540|703497|P1|NOT COMPLETED|Overall Study||19
287629|NCT00254540|703496|P2|COMPLETED|Overall Study||4
287630|NCT00254540|703497|P1|COMPLETED|Overall Study||6
287631|NCT00254540|703496|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
287632|NCT00254540|703497|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
287633|NCT00254501|703526|P2|NOT COMPLETED|Overall Study||1
287634|NCT00254501|703527|P1|NOT COMPLETED|Overall Study||1
287635|NCT00254501|703526|P2|COMPLETED|Overall Study||36
287636|NCT00254501|703527|P1|COMPLETED|Overall Study||31
287637|NCT00254501|703526|P2|STARTED|Overall Study||37
287638|NCT00254501|703527|P1|STARTED|Overall Study||32
287639|NCT00254462|703541|P2|NOT COMPLETED|Overall Study||10
287640|NCT00254462|703542|P1|NOT COMPLETED|Overall Study||8
287641|NCT00254462|703541|P2|COMPLETED|Overall Study||39
287642|NCT00254462|703542|P1|COMPLETED|Overall Study||36
287643|NCT00254462|703541|P2|STARTED|Overall Study||49
287644|NCT00254462|703542|P1|STARTED|Overall Study||44
287645|NCT00254293|703556|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
287646|NCT00254293|703557|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
287647|NCT00254293|703558|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
287648|NCT00254293|703559|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
287649|NCT00254293|703560|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
287650|NCT00254293|703561|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
287651|NCT00254293|703562|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
287652|NCT00254293|703556|P7|COMPLETED|LTE Open Label Fixed Dosing||35
287653|NCT00254293|703557|P6|COMPLETED|LTE Open Label Fixed Dosing||0
287654|NCT00254293|703558|P5|COMPLETED|LTE Open Label Fixed Dosing||0
287655|NCT00254293|703559|P4|COMPLETED|LTE Open Label Fixed Dosing||0
287656|NCT00254293|703560|P3|COMPLETED|LTE Open Label Fixed Dosing||0
287657|NCT00254293|703561|P2|COMPLETED|LTE Open Label Fixed Dosing||0
287658|NCT00254293|703562|P1|COMPLETED|LTE Open Label Fixed Dosing||0
287659|NCT00254293|703556|P7|STARTED|LTE Open Label Fixed Dosing||48
287660|NCT00254293|703557|P6|STARTED|LTE Open Label Fixed Dosing||0
287661|NCT00254293|703558|P5|STARTED|LTE Open Label Fixed Dosing||0
287662|NCT00254293|703559|P4|STARTED|LTE Open Label Fixed Dosing||0
287663|NCT00254293|703560|P3|STARTED|LTE Open Label Fixed Dosing||0
287664|NCT00254293|703561|P2|STARTED|LTE Open Label Fixed Dosing||0
287665|NCT00254293|703562|P1|STARTED|LTE Open Label Fixed Dosing||0
287666|NCT00254293|703556|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
287667|NCT00254293|703557|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
287668|NCT00254293|703558|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
287669|NCT00254293|703559|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
287670|NCT00254293|703560|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
287671|NCT00254293|703561|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
287672|NCT00254293|703562|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
287673|NCT00254293|703556|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
287674|NCT00254293|703557|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
287675|NCT00254293|703558|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
287676|NCT00254293|703559|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
287677|NCT00254293|703560|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
287678|NCT00254293|703561|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
287679|NCT00254293|703562|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
287680|NCT00254293|703556|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
287681|NCT00254293|703557|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
287682|NCT00254293|703558|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
287683|NCT00254293|703559|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
287684|NCT00254293|703560|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
287685|NCT00254293|703561|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
287686|NCT00254293|703562|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
287687|NCT00254293|703556|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
287688|NCT00254293|703557|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
287689|NCT00254293|703558|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
287690|NCT00254293|703559|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
287691|NCT00254293|703560|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
287692|NCT00254293|703561|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
287693|NCT00254293|703562|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
287694|NCT00254293|703556|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
287695|NCT00254293|703557|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
287696|NCT00254293|703558|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
287697|NCT00254293|703559|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
287698|NCT00254293|703560|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
287699|NCT00254293|703561|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
287700|NCT00254293|703562|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
287701|NCT00254293|703556|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
287702|NCT00254293|703557|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
287703|NCT00254293|703558|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
287704|NCT00254293|703559|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
287705|NCT00254293|703560|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
287706|NCT00254293|703561|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
287707|NCT00254293|703562|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
287708|NCT00254163|703645|P2|NOT COMPLETED|Overall Study||46
287709|NCT00254163|703646|P1|NOT COMPLETED|Overall Study||45
287710|NCT00254163|703645|P2|COMPLETED|Overall Study||46
287711|NCT00254163|703646|P1|COMPLETED|Overall Study||47
287712|NCT00254163|703645|P2|STARTED|Overall Study||92
287713|NCT00254163|703646|P1|STARTED|Overall Study||92
287714|NCT00254072|703670|P2|NOT COMPLETED|Overall Study||0
287715|NCT00254072|703671|P1|NOT COMPLETED|Overall Study||0
287716|NCT00254072|703670|P2|COMPLETED|Overall Study||175
287717|NCT00254072|703671|P1|COMPLETED|Overall Study||180
287718|NCT00254072|703670|P2|STARTED|Overall Study||175
287719|NCT00254072|703671|P1|STARTED|Overall Study||180
287720|NCT00253981|703679|P2|NOT COMPLETED|Overall Study||0
287721|NCT00253981|703680|P1|NOT COMPLETED|Overall Study||0
287722|NCT00253981|703679|P2|COMPLETED|Overall Study||14
287723|NCT00253981|703680|P1|COMPLETED|Overall Study||16
287724|NCT00253981|703679|P2|STARTED|Overall Study||14
287725|NCT00253981|703680|P1|STARTED|Overall Study||16
287726|NCT00253890|703688|P2|NOT COMPLETED|Overall Study||7
287727|NCT00253890|703689|P1|NOT COMPLETED|Overall Study||7
287728|NCT00253890|703688|P2|COMPLETED|Overall Study||61
287729|NCT00253890|703689|P1|COMPLETED|Overall Study||62
287730|NCT00253890|703688|P2|STARTED|Overall Study||68
287731|NCT00253890|703689|P1|STARTED|Overall Study||69
287732|NCT00253747|703697|P2|NOT COMPLETED|Overall Study||27
287733|NCT00253747|703698|P1|NOT COMPLETED|Overall Study||24
287734|NCT00253747|703697|P2|COMPLETED|Overall Study||101
287735|NCT00253747|703698|P1|COMPLETED|Overall Study||103
287736|NCT00253747|703697|P2|STARTED|Overall Study||128
287737|NCT00253747|703698|P1|STARTED|Overall Study||127
287738|NCT00253708|703719|P3|NOT COMPLETED|Overall Study||1
287739|NCT00253708|703720|P2|NOT COMPLETED|Overall Study||0
287740|NCT00253708|703721|P1|NOT COMPLETED|Overall Study||0
287741|NCT00253708|703719|P3|COMPLETED|Overall Study||8
287742|NCT00253708|703720|P2|COMPLETED|Overall Study||10
287743|NCT00253708|703721|P1|COMPLETED|Overall Study||20
287744|NCT00253708|703719|P3|STARTED|Overall Study||9
287745|NCT00253708|703720|P2|STARTED|Overall Study||10
287746|NCT00253708|703721|P1|STARTED|Overall Study||20
287747|NCT00253643|703751|P4|NOT COMPLETED|Overall Study||3
287748|NCT00253643|703752|P3|NOT COMPLETED|Overall Study||1
287749|NCT00253643|703753|P2|NOT COMPLETED|Overall Study||0
287750|NCT00253643|703754|P1|NOT COMPLETED|Overall Study||0
287751|NCT00253643|703751|P4|COMPLETED|Overall Study||28
287752|NCT00253643|703752|P3|COMPLETED|Overall Study||28
287753|NCT00253643|703753|P2|COMPLETED|Overall Study||15
287754|NCT00253643|703754|P1|COMPLETED|Overall Study||14
287755|NCT00253643|703751|P4|STARTED|Overall Study||31
287756|NCT00253643|703752|P3|STARTED|Overall Study||29
287757|NCT00253643|703753|P2|STARTED|Overall Study||15
287758|NCT00253643|703754|P1|STARTED|Overall Study||14
287759|NCT00253630|703768|P1|NOT COMPLETED|Overall Study||2
287760|NCT00253630|703768|P1|COMPLETED|Overall Study||35
287761|NCT00253630|703768|P1|STARTED|Overall Study||37
287762|NCT00253513|703777|P1|NOT COMPLETED|Overall Study||0
287763|NCT00253513|703777|P1|COMPLETED|Overall Study||60
287764|NCT00253513|703777|P1|STARTED|Overall Study||60
287765|NCT00253448|703784|P1|NOT COMPLETED|Overall Study||1
287766|NCT00253448|703784|P1|COMPLETED|Overall Study||34
287767|NCT00253448|703784|P1|STARTED|Overall Study||35
287768|NCT00253435|703790|P2|NOT COMPLETED|Overall Study||0
287769|NCT00253435|703791|P1|NOT COMPLETED|Overall Study||0
287770|NCT00253435|703790|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
287771|NCT00253435|703791|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
287772|NCT00253435|703790|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
287773|NCT00253435|703791|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
287774|NCT00253435|703790|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
287775|NCT00253435|703791|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
287776|NCT00253435|703790|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
287777|NCT00253435|703791|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
287778|NCT00253435|703790|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
287779|NCT00253435|703791|P1|STARTED|Overall Study|Total number is 42|42
287780|NCT00253370|703803|P1|NOT COMPLETED|Overall Study||43
287781|NCT00253370|703803|P1|COMPLETED|Overall Study||1
287782|NCT00253370|703803|P1|STARTED|Overall Study||44
287783|NCT00253019|703812|P3|NOT COMPLETED|Overall Study||18
287784|NCT00253019|703813|P2|NOT COMPLETED|Overall Study||31
287785|NCT00253019|703814|P1|NOT COMPLETED|Overall Study||29
287786|NCT00253019|703812|P3|COMPLETED|Overall Study||83
287787|NCT00253019|703813|P2|COMPLETED|Overall Study||78
287788|NCT00253019|703814|P1|COMPLETED|Overall Study||82
287789|NCT00253019|703812|P3|STARTED|Overall Study||101
287790|NCT00253019|703813|P2|STARTED|Overall Study||109
287791|NCT00253019|703814|P1|STARTED|Overall Study||111
287792|NCT00252967|703824|P2|NOT COMPLETED|Overall Study||0
287793|NCT00252967|703825|P1|NOT COMPLETED|Overall Study||0
287794|NCT00252967|703824|P2|COMPLETED|Overall Study||33
287795|NCT00252967|703825|P1|COMPLETED|Overall Study||31
287796|NCT00252967|703824|P2|STARTED|Overall Study||33
287797|NCT00252967|703825|P1|STARTED|Overall Study||31
287798|NCT00252733|703849|P2|NOT COMPLETED|Overall Study||92
287799|NCT00252733|703850|P1|NOT COMPLETED|Overall Study||106
287800|NCT00252733|703849|P2|COMPLETED|Overall Study||618
287801|NCT00252733|703850|P1|COMPLETED|Overall Study||605
287802|NCT00252733|703849|P2|STARTED|Overall Study||710
287803|NCT00252733|703850|P1|STARTED|Overall Study||711
287804|NCT00252720|703860|P2|NOT COMPLETED|Overall Study||165
287805|NCT00252720|703861|P1|NOT COMPLETED|Overall Study||132
287806|NCT00252720|703860|P2|COMPLETED|Overall Study||789
287807|NCT00252720|703861|P1|COMPLETED|Overall Study||819
287808|NCT00252720|703860|P2|STARTED|Overall Study||954
287809|NCT00252720|703861|P1|STARTED|Overall Study||951
287810|NCT00252694|703875|P2|NOT COMPLETED|Overall Study||154
287811|NCT00252694|703876|P1|NOT COMPLETED|Overall Study||144
287812|NCT00252694|703875|P2|COMPLETED|Overall Study||800
287813|NCT00252694|703876|P1|COMPLETED|Overall Study||807
287814|NCT00252694|703875|P2|STARTED|Overall Study||954
287815|NCT00252694|703876|P1|STARTED|Overall Study||951
287816|NCT00252629|703891|P3|NOT COMPLETED|Overall Study||0
287817|NCT00252629|703892|P2|NOT COMPLETED|Overall Study||0
287818|NCT00252629|703893|P1|NOT COMPLETED|Overall Study||1
287819|NCT00252629|703891|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
287820|NCT00252629|703892|P2|COMPLETED|Overall Study||9
287821|NCT00252629|703893|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
287822|NCT00252629|703891|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
287823|NCT00252629|703892|P2|STARTED|Overall Study||9
287824|NCT00252629|703893|P1|STARTED|Overall Study||9
287825|NCT00252590|703909|P3|NOT COMPLETED|Overall Study||3
287826|NCT00252590|703910|P2|NOT COMPLETED|Overall Study||2
287827|NCT00252590|703911|P1|NOT COMPLETED|Overall Study||2
287828|NCT00252590|703909|P3|COMPLETED|Overall Study||31
287829|NCT00252590|703910|P2|COMPLETED|Overall Study||28
287830|NCT00252590|703911|P1|COMPLETED|Overall Study||33
287831|NCT00252590|703909|P3|STARTED|Overall Study||34
287832|NCT00252590|703910|P2|STARTED|Overall Study||30
287833|NCT00252590|703911|P1|STARTED|Overall Study||35
287834|NCT00252564|703924|P2|NOT COMPLETED|Overall Study||44
287835|NCT00252564|703925|P1|NOT COMPLETED|Overall Study||39
287836|NCT00252564|703924|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
287837|NCT00252564|703925|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
287838|NCT00252564|703924|P2|STARTED|Overall Study|From randomization|123
287839|NCT00252564|703925|P1|STARTED|Overall Study|From randomization|124
287840|NCT00252538|703937|P2|NOT COMPLETED|Overall Study||0
287841|NCT00252538|703938|P1|NOT COMPLETED|Overall Study||0
287842|NCT00252538|703937|P2|COMPLETED|Overall Study||114
287843|NCT00252538|703938|P1|COMPLETED|Overall Study||19
287844|NCT00252538|703937|P2|STARTED|Overall Study||114
287845|NCT00252538|703938|P1|STARTED|Overall Study||19
287846|NCT00252512|703945|P2|NOT COMPLETED|12 Month Follow up||1
287847|NCT00252512|703946|P1|NOT COMPLETED|12 Month Follow up||9
287848|NCT00252512|703945|P2|COMPLETED|12 Month Follow up||121
287849|NCT00252512|703946|P1|COMPLETED|12 Month Follow up||123
287850|NCT00252512|703945|P2|STARTED|12 Month Follow up||122
287851|NCT00252512|703946|P1|STARTED|12 Month Follow up||132
287852|NCT00252512|703945|P2|NOT COMPLETED|Six Month Follow up||12
287853|NCT00252512|703946|P1|NOT COMPLETED|Six Month Follow up||4
287854|NCT00252512|703945|P2|COMPLETED|Six Month Follow up||122
287855|NCT00252512|703946|P1|COMPLETED|Six Month Follow up||132
287856|NCT00252512|703945|P2|STARTED|Six Month Follow up||134
287857|NCT00252512|703946|P1|STARTED|Six Month Follow up||136
287858|NCT00252512|703945|P2|NOT COMPLETED|Intervention||31
287859|NCT00252512|703946|P1|NOT COMPLETED|Intervention||29
287860|NCT00252512|703945|P2|COMPLETED|Intervention||134
287861|NCT00252512|703946|P1|COMPLETED|Intervention||136
287862|NCT00252512|703945|P2|STARTED|Intervention||165
287863|NCT00252512|703946|P1|STARTED|Intervention||165
287864|NCT00252499|703955|P3|NOT COMPLETED|Overall Study||0
287865|NCT00252499|703956|P2|NOT COMPLETED|Overall Study||0
287866|NCT00252499|703957|P1|NOT COMPLETED|Overall Study||1
287867|NCT00252499|703955|P3|COMPLETED|Overall Study||6
287868|NCT00252499|703956|P2|COMPLETED|Overall Study||2
287869|NCT00252499|703957|P1|COMPLETED|Overall Study||4
287870|NCT00252499|703955|P3|STARTED|Overall Study||6
287871|NCT00252499|703956|P2|STARTED|Overall Study||2
287872|NCT00252499|703957|P1|STARTED|Overall Study||5
287873|NCT00252382|703980|P1|NOT COMPLETED|Overall Study||26
287874|NCT00252382|703980|P1|COMPLETED|Overall Study||5
287875|NCT00252382|703980|P1|STARTED|Overall Study||31
287876|NCT00252239|703989|P4|NOT COMPLETED|Overall Study||1
287877|NCT00252239|703990|P3|NOT COMPLETED|Overall Study||2
287878|NCT00252239|703991|P2|NOT COMPLETED|Overall Study||0
287879|NCT00252239|703992|P1|NOT COMPLETED|Overall Study||1
287880|NCT00252239|703989|P4|COMPLETED|Overall Study||30
287881|NCT00252239|703990|P3|COMPLETED|Overall Study||17
287882|NCT00252239|703991|P2|COMPLETED|Overall Study||31
287883|NCT00252239|703992|P1|COMPLETED|Overall Study||30
287884|NCT00252239|703989|P4|STARTED|Overall Study||31
287885|NCT00252239|703990|P3|STARTED|Overall Study||19
287886|NCT00252239|703991|P2|STARTED|Overall Study||31
287887|NCT00252239|703992|P1|STARTED|Overall Study||31
287888|NCT00252187|704004|P2|NOT COMPLETED|Overall Study||1
287889|NCT00252187|704005|P1|NOT COMPLETED|Overall Study||4
287890|NCT00252187|704004|P2|COMPLETED|Overall Study||20
287891|NCT00252187|704005|P1|COMPLETED|Overall Study||20
287892|NCT00252187|704004|P2|STARTED|Overall Study||21
287893|NCT00252187|704005|P1|STARTED|Overall Study||24
287894|NCT00252174|704028|P3|NOT COMPLETED|Overall Study||0
287895|NCT00252174|704029|P2|NOT COMPLETED|Overall Study||1
287896|NCT00252174|704030|P1|NOT COMPLETED|Overall Study||0
287897|NCT00252174|704028|P3|COMPLETED|Overall Study||0
287898|NCT00252174|704029|P2|COMPLETED|Overall Study||1
287899|NCT00252174|704030|P1|COMPLETED|Overall Study||0
287900|NCT00252174|704028|P3|STARTED|Overall Study|No subjects entered Stage 2|0
287901|NCT00252174|704029|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
287902|NCT00252174|704030|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
287903|NCT00252057|704070|P2|NOT COMPLETED|Overall Study||8
287904|NCT00252057|704071|P1|NOT COMPLETED|Overall Study||3
287905|NCT00252057|704070|P2|COMPLETED|Overall Study||368
287906|NCT00252057|704071|P1|COMPLETED|Overall Study||370
287907|NCT00252057|704070|P2|STARTED|Overall Study||376
287908|NCT00252057|704071|P1|STARTED|Overall Study||373
287909|NCT00251979|704079|P2|NOT COMPLETED|Overall Study||40
287910|NCT00251979|704080|P1|NOT COMPLETED|Overall Study||38
287911|NCT00251979|704079|P2|COMPLETED|Overall Study||349
287912|NCT00251979|704080|P1|COMPLETED|Overall Study||337
287913|NCT00251979|704079|P2|STARTED|Overall Study|ITT population|389
287914|NCT00251979|704080|P1|STARTED|Overall Study|ITT population|375
287915|NCT00251927|704112|P2|NOT COMPLETED|Overall Study||74
287916|NCT00251927|704113|P1|NOT COMPLETED|Overall Study||108
287917|NCT00251927|704112|P2|COMPLETED|Overall Study|Completed 5 year visit|192
287918|NCT00251927|704113|P1|COMPLETED|Overall Study|Completed 5 year visit|180
287919|NCT00251927|704112|P2|STARTED|Overall Study|Randomised|266
287920|NCT00251927|704113|P1|STARTED|Overall Study|Randomised|288
287921|NCT00251862|704143|P3|NOT COMPLETED|Overall Study||0
287922|NCT00251862|704144|P2|NOT COMPLETED|Overall Study||0
287923|NCT00251862|704145|P1|NOT COMPLETED|Overall Study||0
287924|NCT00251862|704143|P3|COMPLETED|Overall Study||276
287925|NCT00251862|704144|P2|COMPLETED|Overall Study||269
287926|NCT00251862|704145|P1|COMPLETED|Overall Study||280
287927|NCT00251862|704143|P3|STARTED|Overall Study||276
287928|NCT00251862|704144|P2|STARTED|Overall Study||269
287929|NCT00251862|704145|P1|STARTED|Overall Study||280
287930|NCT00251758|704165|P3|NOT COMPLETED|Overall Study||27
287931|NCT00251758|704166|P2|NOT COMPLETED|Overall Study||27
287932|NCT00251758|704167|P1|NOT COMPLETED|Overall Study||28
287933|NCT00251758|704165|P3|COMPLETED|Overall Study||277
287934|NCT00251758|704166|P2|COMPLETED|Overall Study||285
287935|NCT00251758|704167|P1|COMPLETED|Overall Study||264
287936|NCT00251758|704165|P3|STARTED|Overall Study||304
287937|NCT00251758|704166|P2|STARTED|Overall Study||312
287938|NCT00251758|704167|P1|STARTED|Overall Study||292
287939|NCT00251745|704187|P3|NOT COMPLETED|Overall Study||27
287940|NCT00251745|704188|P2|NOT COMPLETED|Overall Study||27
287941|NCT00251745|704189|P1|NOT COMPLETED|Overall Study||28
287942|NCT00251745|704187|P3|COMPLETED|Overall Study||277
287943|NCT00251745|704188|P2|COMPLETED|Overall Study||285
287944|NCT00251745|704189|P1|COMPLETED|Overall Study||264
287945|NCT00251745|704187|P3|STARTED|Overall Study||304
287946|NCT00251745|704188|P2|STARTED|Overall Study||312
287947|NCT00251745|704189|P1|STARTED|Overall Study||292
287948|NCT00251719|704209|P3|NOT COMPLETED|Overall Study||30
287949|NCT00251719|704210|P2|NOT COMPLETED|Overall Study||45
287950|NCT00251719|704211|P1|NOT COMPLETED|Overall Study||53
287951|NCT00251719|704209|P3|COMPLETED|Overall Study||643
287952|NCT00251719|704210|P2|COMPLETED|Overall Study||642
287953|NCT00251719|704211|P1|COMPLETED|Overall Study||641
287954|NCT00251719|704209|P3|STARTED|Overall Study||673
287955|NCT00251719|704210|P2|STARTED|Overall Study||687
287956|NCT00251719|704211|P1|STARTED|Overall Study||694
287957|NCT00251693|704237|P3|NOT COMPLETED|Overall Study||46
287958|NCT00251693|704238|P2|NOT COMPLETED|Overall Study||44
287959|NCT00251693|704239|P1|NOT COMPLETED|Overall Study||51
287960|NCT00251693|704237|P3|COMPLETED|Overall Study||644
287961|NCT00251693|704238|P2|COMPLETED|Overall Study||624
287962|NCT00251693|704239|P1|COMPLETED|Overall Study||629
287963|NCT00251693|704237|P3|STARTED|Overall Study||690
287964|NCT00251693|704238|P2|STARTED|Overall Study||668
287965|NCT00251693|704239|P1|STARTED|Overall Study||680
287966|NCT00251641|704264|P2|NOT COMPLETED|Overall Study||88
287967|NCT00251641|704265|P1|NOT COMPLETED|Overall Study||112
287968|NCT00251641|704264|P2|COMPLETED|Overall Study||127
287969|NCT00251641|704265|P1|COMPLETED|Overall Study||541
287970|NCT00251641|704264|P2|STARTED|Overall Study||215
287971|NCT00251641|704265|P1|STARTED|Overall Study||653
287972|NCT00251589|704283|P4|NOT COMPLETED|Overall Study||2
287973|NCT00251589|704284|P3|NOT COMPLETED|Overall Study||2
287974|NCT00251589|704285|P2|NOT COMPLETED|Overall Study||3
287975|NCT00251589|704286|P1|NOT COMPLETED|Overall Study||15
287976|NCT00251589|704283|P4|COMPLETED|Overall Study||0
287977|NCT00251589|704284|P3|COMPLETED|Overall Study||0
287978|NCT00251589|704285|P2|COMPLETED|Overall Study||0
287979|NCT00251589|704286|P1|COMPLETED|Overall Study||1
287980|NCT00251589|704283|P4|STARTED|Overall Study||2
287981|NCT00251589|704284|P3|STARTED|Overall Study||2
287982|NCT00251589|704285|P2|STARTED|Overall Study||3
287983|NCT00251589|704286|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
287984|NCT00251316|704323|P2|NOT COMPLETED|Overall Study||3
287985|NCT00251316|704324|P1|NOT COMPLETED|Overall Study||2
287986|NCT00251316|704323|P2|COMPLETED|Overall Study||14
287987|NCT00251316|704324|P1|COMPLETED|Overall Study||15
287988|NCT00251316|704323|P2|STARTED|Overall Study||17
287989|NCT00251316|704324|P1|STARTED|Overall Study||17
287990|NCT00251303|704332|P2|NOT COMPLETED|Overall Study||1
287991|NCT00251303|704333|P1|NOT COMPLETED|Overall Study||8
287992|NCT00251303|704332|P2|COMPLETED|Overall Study||29
287993|NCT00251303|704333|P1|COMPLETED|Overall Study||22
287994|NCT00251303|704332|P2|STARTED|Overall Study||30
287995|NCT00251303|704333|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
287996|NCT00251238|704343|P2|NOT COMPLETED|Overall Study||0
287997|NCT00251238|704344|P1|NOT COMPLETED|Overall Study||0
287998|NCT00251238|704343|P2|COMPLETED|Overall Study||20
287999|NCT00251238|704344|P1|COMPLETED|Overall Study||21
288000|NCT00251238|704343|P2|STARTED|Overall Study||20
288001|NCT00251238|704344|P1|STARTED|Overall Study||21
288002|NCT00251225|704354|P1|NOT COMPLETED|Overall Study||0
288003|NCT00251225|704354|P1|COMPLETED|Overall Study||49
288004|NCT00251225|704354|P1|STARTED|Overall Study||49
288005|NCT00251004|704363|P3|NOT COMPLETED|Overall Study||31
288006|NCT00251004|704364|P2|NOT COMPLETED|Overall Study||41
288007|NCT00251004|704365|P1|NOT COMPLETED|Overall Study||45
288008|NCT00251004|704363|P3|COMPLETED|Overall Study||246
288009|NCT00251004|704364|P2|COMPLETED|Overall Study||238
288010|NCT00251004|704365|P1|COMPLETED|Overall Study||232
288011|NCT00251004|704363|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
288012|NCT00251004|704364|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
288013|NCT00251004|704365|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
288014|NCT00251004|704363|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
288015|NCT00251004|704364|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
288016|NCT00251004|704365|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
288017|NCT00251004|704363|P3|STARTED|Overall Study||277
288018|NCT00251004|704364|P2|STARTED|Overall Study||279
288019|NCT00251004|704365|P1|STARTED|Overall Study||277
288020|NCT00250926|704382|P1|NOT COMPLETED|Overall Study||0
288021|NCT00250926|704382|P1|COMPLETED|Overall Study||23
288022|NCT00250926|704382|P1|STARTED|Overall Study||23
288023|NCT00250835|704389|P1|NOT COMPLETED|Overall Study||1
288024|NCT00250835|704389|P1|COMPLETED|Overall Study||37
288025|NCT00250835|704389|P1|STARTED|Overall Study||38
288026|NCT00250718|704398|P1|NOT COMPLETED|Overall Study||3
288027|NCT00250718|704398|P1|COMPLETED|Overall Study||14
288028|NCT00250718|704398|P1|Received Treatment|Overall Study||16
288029|NCT00250718|704398|P1|STARTED|Overall Study||17
288030|NCT00250705|704403|P1|NOT COMPLETED|Overall Study||2
288031|NCT00250705|704403|P1|COMPLETED|Overall Study||10
288032|NCT00250705|704403|P1|STARTED|Overall Study||12
288033|NCT00250679|704414|P3|NOT COMPLETED|Overall Study||44
288034|NCT00250679|704415|P2|NOT COMPLETED|Overall Study||49
288035|NCT00250679|704416|P1|NOT COMPLETED|Overall Study||39
288036|NCT00250679|704414|P3|COMPLETED|Overall Study||103
288037|NCT00250679|704415|P2|COMPLETED|Overall Study||100
288038|NCT00250679|704416|P1|COMPLETED|Overall Study||108
288039|NCT00250679|704414|P3|STARTED|Overall Study||147
288040|NCT00250679|704415|P2|STARTED|Overall Study||149
288041|NCT00250679|704416|P1|STARTED|Overall Study||147
288042|NCT00250588|704517|P3|NOT COMPLETED|Overall Study||13
288043|NCT00250588|704518|P2|NOT COMPLETED|Overall Study||19
288044|NCT00250588|704519|P1|NOT COMPLETED|Overall Study||9
288045|NCT00250588|704517|P3|COMPLETED|Overall Study||74
288046|NCT00250588|704518|P2|COMPLETED|Overall Study||65
288047|NCT00250588|704519|P1|COMPLETED|Overall Study||72
288048|NCT00250588|704517|P3|STARTED|Overall Study||87
288049|NCT00250588|704518|P2|STARTED|Overall Study||84
288050|NCT00250588|704519|P1|STARTED|Overall Study||81
288051|NCT00250497|704535|P2|NOT COMPLETED|Overall Study||15
288052|NCT00250497|704536|P1|NOT COMPLETED|Overall Study||5
288053|NCT00250497|704535|P2|COMPLETED|Overall Study||159
288054|NCT00250497|704536|P1|COMPLETED|Overall Study||177
288055|NCT00250497|704535|P2|STARTED|Overall Study||174
288056|NCT00250497|704536|P1|STARTED|Overall Study||182
288057|NCT00250484|704554|P2|NOT COMPLETED|Overall Study||0
288058|NCT00250484|704555|P1|NOT COMPLETED|Overall Study||0
288059|NCT00250484|704554|P2|COMPLETED|Overall Study||8
288060|NCT00250484|704555|P1|COMPLETED|Overall Study||9
288061|NCT00250484|704554|P2|STARTED|Overall Study||8
288062|NCT00250484|704555|P1|STARTED|Overall Study||9
288063|NCT00250458|704567|P2|NOT COMPLETED|Overall Study||17
288064|NCT00250458|704568|P1|NOT COMPLETED|Overall Study||32
288065|NCT00250458|704567|P2|COMPLETED|Overall Study||97
288066|NCT00250458|704568|P1|COMPLETED|Overall Study||200
288067|NCT00250458|704567|P2|STARTED|Overall Study||114
288068|NCT00250458|704568|P1|STARTED|Overall Study||232
288069|NCT00250432|704578|P2|NOT COMPLETED|Overall Study||47
288070|NCT00250432|704579|P1|NOT COMPLETED|Overall Study||45
288071|NCT00250432|704578|P2|COMPLETED|Overall Study||53
288072|NCT00250432|704579|P1|COMPLETED|Overall Study||59
288073|NCT00250432|704578|P2|STARTED|Overall Study||100
288074|NCT00250432|704579|P1|STARTED|Overall Study||104
288075|NCT00250276|704591|P4|NOT COMPLETED|Overall Study||19
288076|NCT00250276|704592|P3|NOT COMPLETED|Overall Study||19
288077|NCT00250276|704593|P2|NOT COMPLETED|Overall Study||21
288078|NCT00250276|704594|P1|NOT COMPLETED|Overall Study||17
288079|NCT00250276|704591|P4|COMPLETED|Overall Study||181
288080|NCT00250276|704592|P3|COMPLETED|Overall Study||182
288081|NCT00250276|704593|P2|COMPLETED|Overall Study||177
288082|NCT00250276|704594|P1|COMPLETED|Overall Study||182
288083|NCT00250276|704591|P4|STARTED|Overall Study||200
288084|NCT00250276|704592|P3|STARTED|Overall Study||201
288085|NCT00250276|704593|P2|STARTED|Overall Study||198
288086|NCT00250276|704594|P1|STARTED|Overall Study||199
288087|NCT00249873|704674|P2|NOT COMPLETED|Overall Study||1254
288088|NCT00249873|704675|P1|NOT COMPLETED|Overall Study||1330
288089|NCT00249873|704674|P2|COMPLETED|Overall Study|started and completed study drug|2528
288090|NCT00249873|704675|P1|COMPLETED|Overall Study|started and completed study drug|2442
288091|NCT00249873|704674|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
288092|NCT00249873|704675|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
288093|NCT00249834|704695|P8|NOT COMPLETED|Overall Study||0
288094|NCT00249834|704696|P7|NOT COMPLETED|Overall Study||1
288095|NCT00249834|704697|P6|NOT COMPLETED|Overall Study||2
288096|NCT00249834|704698|P5|NOT COMPLETED|Overall Study||5
288097|NCT00249834|704699|P4|NOT COMPLETED|Overall Study||8
288098|NCT00249834|704700|P3|NOT COMPLETED|Overall Study||14
288099|NCT00249834|704701|P2|NOT COMPLETED|Overall Study||19
288100|NCT00249834|704702|P1|NOT COMPLETED|Overall Study||1
288101|NCT00249834|704695|P8|COMPLETED|Overall Study||2
288102|NCT00249834|704696|P7|COMPLETED|Overall Study||1
288103|NCT00249834|704697|P6|COMPLETED|Overall Study||8
288104|NCT00249834|704698|P5|COMPLETED|Overall Study||19
288105|NCT00249834|704699|P4|COMPLETED|Overall Study||26
288106|NCT00249834|704700|P3|COMPLETED|Overall Study||31
288107|NCT00249834|704701|P2|COMPLETED|Overall Study||29
288108|NCT00249834|704702|P1|COMPLETED|Overall Study||0
288109|NCT00249834|704695|P8|STARTED|Overall Study||2
288110|NCT00249834|704696|P7|STARTED|Overall Study||2
288111|NCT00249834|704697|P6|STARTED|Overall Study||10
288112|NCT00249834|704698|P5|STARTED|Overall Study||24
288113|NCT00249834|704699|P4|STARTED|Overall Study||34
288114|NCT00249834|704700|P3|STARTED|Overall Study||45
288115|NCT00249834|704701|P2|STARTED|Overall Study||48
288116|NCT00249834|704702|P1|STARTED|Overall Study||1
288117|NCT00249821|704751|P2|NOT COMPLETED|Overall Study||1
288118|NCT00249821|704752|P1|NOT COMPLETED|Overall Study||0
288119|NCT00249821|704751|P2|COMPLETED|Overall Study||11
288120|NCT00249821|704752|P1|COMPLETED|Overall Study||10
288121|NCT00249821|704751|P2|STARTED|Overall Study||12
288122|NCT00249821|704752|P1|STARTED|Overall Study||10
288123|NCT00249808|704772|P1|NOT COMPLETED|Overall Study||182
288124|NCT00249808|704772|P1|COMPLETED|Overall Study||1084
288125|NCT00249808|704772|P1|STARTED|Overall Study||1266
288126|NCT00249795|704780|P2|NOT COMPLETED|Overall Study||1390
288127|NCT00249795|704781|P1|NOT COMPLETED|Overall Study||1394
288128|NCT00249795|704780|P2|COMPLETED|Overall Study|started and completed study drug|3108
288129|NCT00249795|704781|P1|COMPLETED|Overall Study|started and completed study drug|3124
288130|NCT00249795|704780|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
288131|NCT00249795|704781|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
288132|NCT00249613|704801|P2|NOT COMPLETED|12 Month Follow-up||15
288133|NCT00249613|704802|P1|NOT COMPLETED|12 Month Follow-up||17
288134|NCT00249613|704801|P2|COMPLETED|12 Month Follow-up||124
288135|NCT00249613|704802|P1|COMPLETED|12 Month Follow-up||135
288136|NCT00249613|704801|P2|STARTED|12 Month Follow-up||139
288137|NCT00249613|704802|P1|STARTED|12 Month Follow-up||152
288138|NCT00249613|704801|P2|NOT COMPLETED|Baseline||0
288139|NCT00249613|704802|P1|NOT COMPLETED|Baseline||0
288140|NCT00249613|704801|P2|COMPLETED|Baseline||139
288141|NCT00249613|704802|P1|COMPLETED|Baseline||152
288142|NCT00249613|704801|P2|STARTED|Baseline||139
288143|NCT00249613|704802|P1|STARTED|Baseline||152
288144|NCT00249496|704813|P2|NOT COMPLETED|Overall Study||1
288145|NCT00249496|704814|P1|NOT COMPLETED|Overall Study||0
288146|NCT00249496|704813|P2|COMPLETED|Overall Study||26
288147|NCT00249496|704814|P1|COMPLETED|Overall Study||24
288148|NCT00249496|704813|P2|STARTED|Overall Study||27
288149|NCT00249496|704814|P1|STARTED|Overall Study||24
288150|NCT00249470|704830|P2|NOT COMPLETED|Overall Study||0
288151|NCT00249470|704831|P1|NOT COMPLETED|Overall Study||0
288152|NCT00249470|704830|P2|COMPLETED|Overall Study||28
288153|NCT00249470|704831|P1|COMPLETED|Overall Study||28
288154|NCT00249470|704830|P2|STARTED|Overall Study||28
288155|NCT00249470|704831|P1|STARTED|Overall Study||28
288156|NCT00249444|704843|P2|NOT COMPLETED|Overall Study||15
288157|NCT00249444|704844|P1|NOT COMPLETED|Overall Study||12
288158|NCT00249444|704843|P2|COMPLETED|Overall Study||29
288159|NCT00249444|704844|P1|COMPLETED|Overall Study||30
288160|NCT00249444|704843|P2|STARTED|Overall Study||44
288161|NCT00249444|704844|P1|STARTED|Overall Study||42
288162|NCT00249379|704854|P2|NOT COMPLETED|Overall Study||8
288163|NCT00249379|704855|P1|NOT COMPLETED|Overall Study||8
288164|NCT00249379|704854|P2|COMPLETED|Overall Study||4
288165|NCT00249379|704855|P1|COMPLETED|Overall Study||6
288166|NCT00249379|704854|P2|STARTED|Overall Study||12
288167|NCT00249379|704855|P1|STARTED|Overall Study||14
288168|NCT00249288|704869|P2|NOT COMPLETED|Overall Study||5
288169|NCT00249288|704870|P1|NOT COMPLETED|Overall Study||5
288170|NCT00249288|704869|P2|COMPLETED|Overall Study||14
288171|NCT00249288|704870|P1|COMPLETED|Overall Study||14
288172|NCT00249288|704869|P2|Initiated Treatment|Overall Study||15
288173|NCT00249288|704870|P1|Initiated Treatment|Overall Study||17
288174|NCT00249288|704869|P2|STARTED|Overall Study||19
288175|NCT00249288|704870|P1|STARTED|Overall Study||19
288176|NCT00249249|704905|P4|NOT COMPLETED|Overall Study||3
288177|NCT00249249|704906|P3|NOT COMPLETED|Overall Study||15
288178|NCT00249249|704907|P2|NOT COMPLETED|Overall Study||5
288179|NCT00249249|704908|P1|NOT COMPLETED|Overall Study||20
288180|NCT00249249|704905|P4|COMPLETED|Overall Study||100
288181|NCT00249249|704906|P3|COMPLETED|Overall Study||288
288182|NCT00249249|704907|P2|COMPLETED|Overall Study||98
288183|NCT00249249|704908|P1|COMPLETED|Overall Study||301
288184|NCT00249249|704905|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
288185|NCT00249249|704906|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
288186|NCT00249249|704907|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
288187|NCT00249249|704908|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
288188|NCT00249249|704905|P4|STARTED|Overall Study||103
288189|NCT00249249|704906|P3|STARTED|Overall Study||303
288190|NCT00249249|704907|P2|STARTED|Overall Study||103
288191|NCT00249249|704908|P1|STARTED|Overall Study||321
288192|NCT00249002|704962|P1|NOT COMPLETED|Overall Study||7
288193|NCT00249002|704962|P1|COMPLETED|Overall Study||2
288194|NCT00249002|704962|P1|STARTED|Overall Study||9
288195|NCT00248807|704980|P2|NOT COMPLETED|Overall Study||0
288196|NCT00248807|704981|P1|NOT COMPLETED|Overall Study||0
288197|NCT00248807|704980|P2|COMPLETED|Overall Study||11
288198|NCT00248807|704981|P1|COMPLETED|Overall Study||19
288199|NCT00248807|704980|P2|STARTED|Overall Study||11
288200|NCT00248807|704981|P1|STARTED|Overall Study||19
288201|NCT00248794|704998|P3|NOT COMPLETED|Overall Study||3
288202|NCT00248794|704999|P2|NOT COMPLETED|Overall Study||8
288203|NCT00248794|705000|P1|NOT COMPLETED|Overall Study||6
288204|NCT00248794|704998|P3|COMPLETED|Overall Study||7
288205|NCT00248794|704999|P2|COMPLETED|Overall Study||16
288206|NCT00248794|705000|P1|COMPLETED|Overall Study||19
288207|NCT00248794|704998|P3|STARTED|Overall Study||10
288208|NCT00248794|704999|P2|STARTED|Overall Study||24
288209|NCT00248794|705000|P1|STARTED|Overall Study||25
288210|NCT00248781|705022|P2|NOT COMPLETED|Overall Study||4
288211|NCT00248781|705023|P1|NOT COMPLETED|Overall Study||10
288212|NCT00248781|705022|P2|COMPLETED|Overall Study||47
288213|NCT00248781|705023|P1|COMPLETED|Overall Study||42
288214|NCT00248781|705022|P2|STARTED|Overall Study||51
288215|NCT00248781|705023|P1|STARTED|Overall Study||52
288216|NCT00248651|705050|P3|NOT COMPLETED|Overall Study||32
288217|NCT00248651|705051|P2|NOT COMPLETED|Overall Study||40
288218|NCT00248651|705052|P1|NOT COMPLETED|Overall Study||28
288219|NCT00248651|705050|P3|COMPLETED|Overall Study||65
288220|NCT00248651|705051|P2|COMPLETED|Overall Study||58
288221|NCT00248651|705052|P1|COMPLETED|Overall Study||69
288222|NCT00248651|705050|P3|Completed 12 Weeks of Treatment|Overall Study||75
288223|NCT00248651|705051|P2|Completed 12 Weeks of Treatment|Overall Study||66
288224|NCT00248651|705052|P1|Completed 12 Weeks of Treatment|Overall Study||78
288225|NCT00248651|705050|P3|STARTED|Overall Study||97
288226|NCT00248651|705051|P2|STARTED|Overall Study||98
288227|NCT00248651|705052|P1|STARTED|Overall Study||97
288228|NCT00248638|705071|P2|NOT COMPLETED|Overall Study||0
288229|NCT00248638|705072|P1|NOT COMPLETED|Overall Study||0
288230|NCT00248638|705071|P2|COMPLETED|Overall Study||75
288231|NCT00248638|705072|P1|COMPLETED|Overall Study||75
288232|NCT00248638|705071|P2|STARTED|Overall Study||75
288233|NCT00248638|705072|P1|STARTED|Overall Study||75
288234|NCT00248625|705088|P2|NOT COMPLETED|Overall Study||2
288235|NCT00248625|705089|P1|NOT COMPLETED|Overall Study||0
288236|NCT00248625|705088|P2|COMPLETED|Overall Study||90
288237|NCT00248625|705089|P1|COMPLETED|Overall Study||92
288238|NCT00248625|705088|P2|STARTED|Overall Study||92
288239|NCT00248625|705089|P1|STARTED|Overall Study||92
288240|NCT00248612|705113|P4|NOT COMPLETED|Overall Study||0
288241|NCT00248612|705114|P3|NOT COMPLETED|Overall Study||0
288242|NCT00248612|705115|P2|NOT COMPLETED|Overall Study||0
288243|NCT00248612|705116|P1|NOT COMPLETED|Overall Study||0
288244|NCT00248612|705113|P4|COMPLETED|Overall Study||22
288245|NCT00248612|705114|P3|COMPLETED|Overall Study||14
288246|NCT00248612|705115|P2|COMPLETED|Overall Study||21
288247|NCT00248612|705116|P1|COMPLETED|Overall Study||24
288248|NCT00248612|705113|P4|STARTED|Overall Study||22
288249|NCT00248612|705114|P3|STARTED|Overall Study||14
288250|NCT00248612|705115|P2|STARTED|Overall Study||21
288251|NCT00248612|705116|P1|STARTED|Overall Study||24
288252|NCT00248560|705158|P1|NOT COMPLETED|Overall Study||0
288253|NCT00248560|705158|P1|COMPLETED|Overall Study||36
288254|NCT00248560|705158|P1|STARTED|Overall Study||36
288255|NCT00248547|705164|P2|NOT COMPLETED|Overall Study||0
288256|NCT00248547|705165|P1|NOT COMPLETED|Overall Study||0
288257|NCT00248547|705164|P2|COMPLETED|Overall Study||20
288258|NCT00248547|705165|P1|COMPLETED|Overall Study||20
288259|NCT00248547|705164|P2|STARTED|Overall Study||20
288260|NCT00248547|705165|P1|STARTED|Overall Study||20
288261|NCT00248495|705171|P1|NOT COMPLETED|Overall Study||1
288262|NCT00248495|705171|P1|COMPLETED|Overall Study||37
288263|NCT00248495|705171|P1|STARTED|Overall Study||38
288264|NCT00248287|705182|P2|NOT COMPLETED|Overall Study||19
288265|NCT00248287|705183|P1|NOT COMPLETED|Overall Study||24
288266|NCT00248287|705182|P2|COMPLETED|Overall Study||60
288267|NCT00248287|705183|P1|COMPLETED|Overall Study||51
288268|NCT00248287|705182|P2|STARTED|Overall Study||79
288269|NCT00248287|705183|P1|STARTED|Overall Study||75
288270|NCT00248170|705197|P2|NOT COMPLETED|Overall Study||808
288271|NCT00248170|705198|P1|NOT COMPLETED|Overall Study||761
288272|NCT00248170|705197|P2|COMPLETED|Overall Study||1286
288273|NCT00248170|705198|P1|COMPLETED|Overall Study||1317
288274|NCT00248170|705197|P2|Safety Set|Overall Study||2062
288275|NCT00248170|705198|P1|Safety Set|Overall Study||2049
288276|NCT00248170|705197|P2|Intent-to-treat (ITT)|Overall Study||2075
288277|NCT00248170|705198|P1|Intent-to-treat (ITT)|Overall Study||2061
288278|NCT00248170|705197|P2|STARTED|Overall Study||2094
288279|NCT00248170|705198|P1|STARTED|Overall Study||2078
288280|NCT00247962|705220|P2|NOT COMPLETED|Overall Study||19
288281|NCT00247962|705221|P1|NOT COMPLETED|Overall Study||26
288282|NCT00247962|705220|P2|COMPLETED|Overall Study||168
288283|NCT00247962|705221|P1|COMPLETED|Overall Study||353
288284|NCT00247962|705220|P2|STARTED|Overall Study||187
288285|NCT00247962|705221|P1|STARTED|Overall Study||379
288286|NCT00247676|705229|P1|NOT COMPLETED|Overall Study||36
288287|NCT00247676|705229|P1|COMPLETED|Overall Study||1
288288|NCT00247676|705229|P1|STARTED|Overall Study||37
288289|NCT00247624|705259|P2|NOT COMPLETED|Overall Study||4
288290|NCT00247624|705260|P1|NOT COMPLETED|Overall Study||5
288291|NCT00247624|705259|P2|COMPLETED|Overall Study||26
288292|NCT00247624|705260|P1|COMPLETED|Overall Study||25
288293|NCT00247624|705259|P2|STARTED|Overall Study||30
288294|NCT00247624|705260|P1|STARTED|Overall Study||30
288295|NCT00247611|705274|P2|NOT COMPLETED|On Protocol Sample||125
288296|NCT00247611|705275|P1|NOT COMPLETED|On Protocol Sample||111
288297|NCT00247611|705274|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
288298|NCT00247611|705275|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
288299|NCT00247611|705274|P2|STARTED|On Protocol Sample|ITT sample participants|277
288300|NCT00247611|705275|P1|STARTED|On Protocol Sample|ITT sample participants|287
288301|NCT00247611|705274|P2|NOT COMPLETED|Intention to Treat Sample||13
288302|NCT00247611|705275|P1|NOT COMPLETED|Intention to Treat Sample||17
288303|NCT00247611|705274|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
288304|NCT00247611|705275|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
288305|NCT00247611|705274|P2|STARTED|Intention to Treat Sample|Participants randomized|290
288306|NCT00247611|705275|P1|STARTED|Intention to Treat Sample|Participants randomized|304
288307|NCT00247611|705274|P2|NOT COMPLETED|Baselined||13
288308|NCT00247611|705275|P1|NOT COMPLETED|Baselined||17
288309|NCT00247611|705274|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
288310|NCT00247611|705275|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
288311|NCT00247611|705274|P2|STARTED|Baselined|Participants randomized|290
288312|NCT00247611|705275|P1|STARTED|Baselined|Participants randomized|304
288313|NCT00247416|705293|P2|NOT COMPLETED|Overall Study||2
288314|NCT00247416|705294|P1|NOT COMPLETED|Overall Study||1
288315|NCT00247416|705293|P2|COMPLETED|Overall Study||31
288316|NCT00247416|705294|P1|COMPLETED|Overall Study||25
288317|NCT00247416|705293|P2|STARTED|Overall Study||33
288318|NCT00247416|705294|P1|STARTED|Overall Study||26
288319|NCT00247377|705308|P2|NOT COMPLETED|Overall Study||0
288320|NCT00247377|705309|P1|NOT COMPLETED|Overall Study||0
288321|NCT00247377|705308|P2|COMPLETED|Overall Study||86
288322|NCT00247377|705309|P1|COMPLETED|Overall Study||111
288323|NCT00247377|705308|P2|STARTED|Overall Study||86
288324|NCT00247377|705309|P1|STARTED|Overall Study||111
288325|NCT00247273|705335|P2|NOT COMPLETED|Overall Study||137
288326|NCT00247273|705336|P1|NOT COMPLETED|Overall Study||146
288327|NCT00247273|705335|P2|COMPLETED|Overall Study||513
288328|NCT00247273|705336|P1|COMPLETED|Overall Study||498
288329|NCT00247273|705335|P2|Intent to Treat Population|Overall Study||650
288330|NCT00247273|705336|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
288331|NCT00247273|705335|P2|STARTED|Overall Study||650
288332|NCT00247273|705336|P1|STARTED|Overall Study||644
288333|NCT00246805|705382|P2|NOT COMPLETED|Phase 2||0
288334|NCT00246805|705383|P1|NOT COMPLETED|Phase 2||0
288335|NCT00246805|705382|P2|COMPLETED|Phase 2||33
288336|NCT00246805|705383|P1|COMPLETED|Phase 2||33
288337|NCT00246805|705382|P2|STARTED|Phase 2||33
288338|NCT00246805|705383|P1|STARTED|Phase 2||33
288339|NCT00246805|705382|P2|NOT COMPLETED|Phase 1||0
288340|NCT00246805|705383|P1|NOT COMPLETED|Phase 1||1
288341|NCT00246805|705382|P2|COMPLETED|Phase 1||33
288342|NCT00246805|705383|P1|COMPLETED|Phase 1||33
288343|NCT00246805|705382|P2|STARTED|Phase 1||33
288344|NCT00246805|705383|P1|STARTED|Phase 1||34
288345|NCT00246753|705389|P1|NOT COMPLETED|Overall Study||8
288346|NCT00246753|705389|P1|COMPLETED|Overall Study||21
288347|NCT00246753|705389|P1|STARTED|Overall Study||29
288348|NCT00246740|705397|P2|NOT COMPLETED|Experimental Phase||0
288349|NCT00246740|705398|P1|NOT COMPLETED|Experimental Phase||0
288350|NCT00246740|705397|P2|COMPLETED|Experimental Phase||20
288351|NCT00246740|705398|P1|COMPLETED|Experimental Phase||22
288352|NCT00246740|705397|P2|STARTED|Experimental Phase||20
288353|NCT00246740|705398|P1|STARTED|Experimental Phase||22
288354|NCT00246740|705397|P2|NOT COMPLETED|Initial Enrollment||8
288355|NCT00246740|705398|P1|NOT COMPLETED|Initial Enrollment||6
288356|NCT00246740|705397|P2|COMPLETED|Initial Enrollment||20
288357|NCT00246740|705398|P1|COMPLETED|Initial Enrollment||22
288358|NCT00246740|705397|P2|STARTED|Initial Enrollment||28
288359|NCT00246740|705398|P1|STARTED|Initial Enrollment||28
288360|NCT00246571|705422|P2|NOT COMPLETED|Overall Study||104
288361|NCT00246571|705423|P1|NOT COMPLETED|Overall Study||113
288362|NCT00246571|705422|P2|COMPLETED|Overall Study||0
288363|NCT00246571|705423|P1|COMPLETED|Overall Study||0
288364|NCT00246571|705422|P2|Randomized But Not Treated|Overall Study||1
288365|NCT00246571|705423|P1|Randomized But Not Treated|Overall Study||3
288366|NCT00246571|705422|P2|STARTED|Overall Study||104
288367|NCT00246571|705423|P1|STARTED|Overall Study||113
288368|NCT00246519|705463|P2|NOT COMPLETED|Overall Study||64
288369|NCT00246519|705464|P1|NOT COMPLETED|Overall Study||56
288370|NCT00246519|705463|P2|COMPLETED|Overall Study||382
288371|NCT00246519|705464|P1|COMPLETED|Overall Study||386
288372|NCT00246519|705463|P2|STARTED|Overall Study||446
288373|NCT00246519|705464|P1|STARTED|Overall Study||442
288374|NCT00246376|705475|P5|NOT COMPLETED|Overall Study||17
288375|NCT00246376|705476|P4|NOT COMPLETED|Overall Study||26
288376|NCT00246376|705477|P3|NOT COMPLETED|Overall Study||16
288377|NCT00246376|705478|P2|NOT COMPLETED|Overall Study||19
288378|NCT00246376|705479|P1|NOT COMPLETED|Overall Study||15
288379|NCT00246376|705475|P5|COMPLETED|Overall Study||28
288380|NCT00246376|705476|P4|COMPLETED|Overall Study||21
288381|NCT00246376|705477|P3|COMPLETED|Overall Study||29
288382|NCT00246376|705478|P2|COMPLETED|Overall Study||24
288383|NCT00246376|705479|P1|COMPLETED|Overall Study||26
288384|NCT00246376|705475|P5|After Dietary run-in at Two Weeks|Overall Study||42
288385|NCT00246376|705476|P4|After Dietary run-in at Two Weeks|Overall Study||40
288386|NCT00246376|705477|P3|After Dietary run-in at Two Weeks|Overall Study||41
288387|NCT00246376|705478|P2|After Dietary run-in at Two Weeks|Overall Study||38
288388|NCT00246376|705479|P1|After Dietary run-in at Two Weeks|Overall Study||30
288389|NCT00246376|705475|P5|STARTED|Overall Study||45
288390|NCT00246376|705476|P4|STARTED|Overall Study||47
288391|NCT00246376|705477|P3|STARTED|Overall Study||45
288392|NCT00246376|705478|P2|STARTED|Overall Study||43
288393|NCT00246376|705479|P1|STARTED|Overall Study||41
288394|NCT00246337|705530|P9|NOT COMPLETED|Overall Study||11
288395|NCT00246337|705531|P8|NOT COMPLETED|Overall Study||13
288396|NCT00246337|705532|P7|NOT COMPLETED|Overall Study||9
288397|NCT00246337|705533|P6|NOT COMPLETED|Overall Study||15
288398|NCT00246337|705534|P5|NOT COMPLETED|Overall Study||4
288399|NCT00246337|705535|P4|NOT COMPLETED|Overall Study||1
288400|NCT00246337|705536|P3|NOT COMPLETED|Overall Study||3
288401|NCT00246337|705537|P2|NOT COMPLETED|Overall Study||2
288402|NCT00246337|705538|P1|NOT COMPLETED|Overall Study||32
288403|NCT00246337|705530|P9|COMPLETED|Overall Study||34
288404|NCT00246337|705531|P8|COMPLETED|Overall Study||40
288405|NCT00246337|705532|P7|COMPLETED|Overall Study||45
288406|NCT00246337|705533|P6|COMPLETED|Overall Study||39
288407|NCT00246337|705534|P5|COMPLETED|Overall Study||12
288408|NCT00246337|705535|P4|COMPLETED|Overall Study||16
288409|NCT00246337|705536|P3|COMPLETED|Overall Study||15
288410|NCT00246337|705537|P2|COMPLETED|Overall Study||14
288411|NCT00246337|705538|P1|COMPLETED|Overall Study||115
288412|NCT00246337|705530|P9|Completed Period (Both Doses)|Overall Study||15
288413|NCT00246337|705531|P8|Completed Period (Both Doses)|Overall Study||13
288414|NCT00246337|705532|P7|Completed Period (Both Doses)|Overall Study||16
288415|NCT00246337|705533|P6|Completed Period (Both Doses)|Overall Study||10
288416|NCT00246337|705534|P5|Completed Period (Both Doses)|Overall Study||4
288417|NCT00246337|705535|P4|Completed Period (Both Doses)|Overall Study||11
288418|NCT00246337|705536|P3|Completed Period (Both Doses)|Overall Study||6
288419|NCT00246337|705537|P2|Completed Period (Both Doses)|Overall Study||10
288420|NCT00246337|705538|P1|Completed Period (Both Doses)|Overall Study||69
288421|NCT00246337|705530|P9|Completed Period (Initial Dose)|Overall Study||19
288422|NCT00246337|705531|P8|Completed Period (Initial Dose)|Overall Study||27
288423|NCT00246337|705532|P7|Completed Period (Initial Dose)|Overall Study||29
288424|NCT00246337|705533|P6|Completed Period (Initial Dose)|Overall Study||29
288425|NCT00246337|705534|P5|Completed Period (Initial Dose)|Overall Study||8
288426|NCT00246337|705535|P4|Completed Period (Initial Dose)|Overall Study||5
288427|NCT00246337|705536|P3|Completed Period (Initial Dose)|Overall Study||9
288428|NCT00246337|705537|P2|Completed Period (Initial Dose)|Overall Study||4
288429|NCT00246337|705538|P1|Completed Period (Initial Dose)|Overall Study||46
288430|NCT00246337|705530|P9|STARTED|Overall Study||45
288431|NCT00246337|705531|P8|STARTED|Overall Study||53
288432|NCT00246337|705532|P7|STARTED|Overall Study||54
288433|NCT00246337|705533|P6|STARTED|Overall Study||54
288434|NCT00246337|705534|P5|STARTED|Overall Study||16
288435|NCT00246337|705535|P4|STARTED|Overall Study||17
288436|NCT00246337|705536|P3|STARTED|Overall Study||18
288437|NCT00246337|705537|P2|STARTED|Overall Study||16
288438|NCT00246337|705538|P1|STARTED|Overall Study||147
288439|NCT00246324|705585|P1|NOT COMPLETED|Overall Study||1
288440|NCT00246324|705585|P1|COMPLETED|Overall Study||15
288441|NCT00246324|705585|P1|STARTED|Overall Study||16
288442|NCT00246259|705592|P2|NOT COMPLETED|Overall Study||26
288443|NCT00246259|705593|P1|NOT COMPLETED|Overall Study||28
288444|NCT00246259|705592|P2|COMPLETED|Overall Study||15
288445|NCT00246259|705593|P1|COMPLETED|Overall Study||16
288446|NCT00246259|705592|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
288447|NCT00246259|705593|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
288448|NCT00246259|705592|P2|STARTED|Overall Study||41
288449|NCT00246259|705593|P1|STARTED|Overall Study||44
288450|NCT00246090|705627|P1|NOT COMPLETED|Overall Study||295
288451|NCT00246090|705627|P1|COMPLETED|Overall Study||3
288452|NCT00246090|705627|P1|STARTED|Overall Study||298
288453|NCT00246025|705636|P4|NOT COMPLETED|Overall Study||13
288454|NCT00246025|705637|P3|NOT COMPLETED|Overall Study||10
288455|NCT00246025|705638|P2|NOT COMPLETED|Overall Study||9
288456|NCT00246025|705639|P1|NOT COMPLETED|Overall Study||10
288457|NCT00246025|705636|P4|COMPLETED|Overall Study||116
288458|NCT00246025|705637|P3|COMPLETED|Overall Study||116
288459|NCT00246025|705638|P2|COMPLETED|Overall Study||124
288460|NCT00246025|705639|P1|COMPLETED|Overall Study||114
288461|NCT00246025|705636|P4|STARTED|Overall Study||129
288462|NCT00246025|705637|P3|STARTED|Overall Study||126
288463|NCT00246025|705638|P2|STARTED|Overall Study||133
288464|NCT00246025|705639|P1|STARTED|Overall Study||124
288465|NCT00246012|705698|P9|NOT COMPLETED|Overall Study||28
288466|NCT00246012|705699|P8|NOT COMPLETED|Overall Study||28
288467|NCT00246012|705700|P7|NOT COMPLETED|Overall Study||31
288468|NCT00246012|705701|P6|NOT COMPLETED|Overall Study||28
288469|NCT00246012|705702|P5|NOT COMPLETED|Overall Study||3
288470|NCT00246012|705703|P4|NOT COMPLETED|Overall Study||3
288471|NCT00246012|705704|P3|NOT COMPLETED|Overall Study||2
288472|NCT00246012|705705|P2|NOT COMPLETED|Overall Study||1
288473|NCT00246012|705706|P1|NOT COMPLETED|Overall Study||3
288474|NCT00246012|705698|P9|COMPLETED|Overall Study||4
288475|NCT00246012|705699|P8|COMPLETED|Overall Study||5
288476|NCT00246012|705700|P7|COMPLETED|Overall Study||1
288477|NCT00246012|705701|P6|COMPLETED|Overall Study||4
288478|NCT00246012|705702|P5|COMPLETED|Overall Study||0
288479|NCT00246012|705703|P4|COMPLETED|Overall Study||0
288480|NCT00246012|705704|P3|COMPLETED|Overall Study||1
288481|NCT00246012|705705|P2|COMPLETED|Overall Study||2
288482|NCT00246012|705706|P1|COMPLETED|Overall Study||0
288483|NCT00246012|705698|P9|Treated|Overall Study||32
288484|NCT00246012|705699|P8|Treated|Overall Study||33
288485|NCT00246012|705700|P7|Treated|Overall Study||31
288486|NCT00246012|705701|P6|Treated|Overall Study||31
288487|NCT00246012|705702|P5|Treated|Overall Study||3
288488|NCT00246012|705703|P4|Treated|Overall Study||3
288489|NCT00246012|705704|P3|Treated|Overall Study||3
288490|NCT00246012|705705|P2|Treated|Overall Study||3
288491|NCT00246012|705706|P1|Treated|Overall Study||3
288492|NCT00246012|705698|P9|STARTED|Overall Study||32
288493|NCT00246012|705699|P8|STARTED|Overall Study||33
288494|NCT00246012|705700|P7|STARTED|Overall Study||32
288495|NCT00246012|705701|P6|STARTED|Overall Study||32
288496|NCT00246012|705702|P5|STARTED|Overall Study||3
288497|NCT00246012|705703|P4|STARTED|Overall Study||3
288498|NCT00246012|705704|P3|STARTED|Overall Study||3
288499|NCT00246012|705705|P2|STARTED|Overall Study||3
288500|NCT00246012|705706|P1|STARTED|Overall Study||3
288501|NCT00245960|705801|P2|NOT COMPLETED|Overall Study||28
288502|NCT00245960|705802|P1|NOT COMPLETED|Overall Study||29
288503|NCT00245960|705801|P2|COMPLETED|Overall Study||345
288504|NCT00245960|705802|P1|COMPLETED|Overall Study||350
288505|NCT00245960|705801|P2|STARTED|Overall Study||373
288506|NCT00245960|705802|P1|STARTED|Overall Study||379
288507|NCT00245856|705810|P2|NOT COMPLETED|Period Two||1
288508|NCT00245856|705811|P1|NOT COMPLETED|Period Two||0
288509|NCT00245856|705810|P2|COMPLETED|Period Two||38
288510|NCT00245856|705811|P1|COMPLETED|Period Two||0
288511|NCT00245856|705810|P2|STARTED|Period Two||39
288512|NCT00245856|705811|P1|STARTED|Period Two||0
288513|NCT00245856|705810|P2|NOT COMPLETED|Period One||0
288514|NCT00245856|705811|P1|NOT COMPLETED|Period One||0
288515|NCT00245856|705810|P2|COMPLETED|Period One||0
288516|NCT00245856|705811|P1|COMPLETED|Period One||28
288517|NCT00245856|705810|P2|STARTED|Period One||0
288518|NCT00245856|705811|P1|STARTED|Period One||28
288519|NCT00245635|705820|P2|NOT COMPLETED|Overall Study||0
288520|NCT00245635|705821|P1|NOT COMPLETED|Overall Study||0
288521|NCT00245635|705820|P2|COMPLETED|Overall Study||18
288522|NCT00245635|705821|P1|COMPLETED|Overall Study||25
288523|NCT00245635|705820|P2|STARTED|Overall Study||18
288524|NCT00245635|705821|P1|STARTED|Overall Study||25
288525|NCT00245570|705827|P6|NOT COMPLETED|Treatment Period IV||0
288526|NCT00245570|705828|P5|NOT COMPLETED|Treatment Period IV||0
288527|NCT00245570|705829|P4|NOT COMPLETED|Treatment Period IV||0
288528|NCT00245570|705830|P3|NOT COMPLETED|Treatment Period IV||0
288529|NCT00245570|705831|P2|NOT COMPLETED|Treatment Period IV||0
288530|NCT00245570|705832|P1|NOT COMPLETED|Treatment Period IV||0
288531|NCT00245570|705827|P6|COMPLETED|Treatment Period IV||8
288532|NCT00245570|705828|P5|COMPLETED|Treatment Period IV||8
288533|NCT00245570|705829|P4|COMPLETED|Treatment Period IV||8
288534|NCT00245570|705830|P3|COMPLETED|Treatment Period IV||8
288535|NCT00245570|705831|P2|COMPLETED|Treatment Period IV||7
288536|NCT00245570|705832|P1|COMPLETED|Treatment Period IV||7
288537|NCT00245570|705827|P6|STARTED|Treatment Period IV||8
288538|NCT00245570|705828|P5|STARTED|Treatment Period IV||8
288539|NCT00245570|705829|P4|STARTED|Treatment Period IV||8
288540|NCT00245570|705830|P3|STARTED|Treatment Period IV||8
288541|NCT00245570|705831|P2|STARTED|Treatment Period IV||7
288542|NCT00245570|705832|P1|STARTED|Treatment Period IV||7
288543|NCT00245570|705827|P6|NOT COMPLETED|Washout Between Periods III and IV||0
288544|NCT00245570|705828|P5|NOT COMPLETED|Washout Between Periods III and IV||0
288545|NCT00245570|705829|P4|NOT COMPLETED|Washout Between Periods III and IV||0
288546|NCT00245570|705830|P3|NOT COMPLETED|Washout Between Periods III and IV||0
288547|NCT00245570|705831|P2|NOT COMPLETED|Washout Between Periods III and IV||1
288548|NCT00245570|705832|P1|NOT COMPLETED|Washout Between Periods III and IV||0
288549|NCT00245570|705827|P6|COMPLETED|Washout Between Periods III and IV||8
288550|NCT00245570|705828|P5|COMPLETED|Washout Between Periods III and IV||8
288551|NCT00245570|705829|P4|COMPLETED|Washout Between Periods III and IV||8
288552|NCT00245570|705830|P3|COMPLETED|Washout Between Periods III and IV||8
288553|NCT00245570|705831|P2|COMPLETED|Washout Between Periods III and IV||7
288554|NCT00245570|705832|P1|COMPLETED|Washout Between Periods III and IV||7
288555|NCT00245570|705827|P6|STARTED|Washout Between Periods III and IV||8
288556|NCT00245570|705828|P5|STARTED|Washout Between Periods III and IV||8
288557|NCT00245570|705829|P4|STARTED|Washout Between Periods III and IV||8
288558|NCT00245570|705830|P3|STARTED|Washout Between Periods III and IV||8
288559|NCT00245570|705831|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
288560|NCT00245570|705832|P1|STARTED|Washout Between Periods III and IV||7
288561|NCT00245570|705827|P6|NOT COMPLETED|Treatment Period III||0
288562|NCT00245570|705828|P5|NOT COMPLETED|Treatment Period III||0
288563|NCT00245570|705829|P4|NOT COMPLETED|Treatment Period III||0
288564|NCT00245570|705830|P3|NOT COMPLETED|Treatment Period III||0
288565|NCT00245570|705831|P2|NOT COMPLETED|Treatment Period III||0
288566|NCT00245570|705832|P1|NOT COMPLETED|Treatment Period III||0
288567|NCT00245570|705827|P6|COMPLETED|Treatment Period III||8
288568|NCT00245570|705828|P5|COMPLETED|Treatment Period III||8
288569|NCT00245570|705829|P4|COMPLETED|Treatment Period III||8
288570|NCT00245570|705830|P3|COMPLETED|Treatment Period III||8
288571|NCT00245570|705831|P2|COMPLETED|Treatment Period III||8
288572|NCT00245570|705832|P1|COMPLETED|Treatment Period III||7
288573|NCT00245570|705827|P6|STARTED|Treatment Period III||8
288574|NCT00245570|705828|P5|STARTED|Treatment Period III||8
288575|NCT00245570|705829|P4|STARTED|Treatment Period III||8
288576|NCT00245570|705830|P3|STARTED|Treatment Period III||8
288577|NCT00245570|705831|P2|STARTED|Treatment Period III||8
288578|NCT00245570|705832|P1|STARTED|Treatment Period III||7
288579|NCT00245570|705827|P6|NOT COMPLETED|Washout Between Periods II and III||0
288580|NCT00245570|705828|P5|NOT COMPLETED|Washout Between Periods II and III||0
288581|NCT00245570|705829|P4|NOT COMPLETED|Washout Between Periods II and III||0
288582|NCT00245570|705830|P3|NOT COMPLETED|Washout Between Periods II and III||0
288583|NCT00245570|705831|P2|NOT COMPLETED|Washout Between Periods II and III||0
288584|NCT00245570|705832|P1|NOT COMPLETED|Washout Between Periods II and III||0
288585|NCT00245570|705827|P6|COMPLETED|Washout Between Periods II and III||8
288586|NCT00245570|705828|P5|COMPLETED|Washout Between Periods II and III||8
288587|NCT00245570|705829|P4|COMPLETED|Washout Between Periods II and III||8
288588|NCT00245570|705830|P3|COMPLETED|Washout Between Periods II and III||8
288589|NCT00245570|705831|P2|COMPLETED|Washout Between Periods II and III||8
288590|NCT00245570|705832|P1|COMPLETED|Washout Between Periods II and III||7
288591|NCT00245570|705827|P6|STARTED|Washout Between Periods II and III||8
288592|NCT00245570|705828|P5|STARTED|Washout Between Periods II and III||8
288593|NCT00245570|705829|P4|STARTED|Washout Between Periods II and III||8
288594|NCT00245570|705830|P3|STARTED|Washout Between Periods II and III||8
288595|NCT00245570|705831|P2|STARTED|Washout Between Periods II and III||8
288596|NCT00245570|705832|P1|STARTED|Washout Between Periods II and III||7
288597|NCT00245570|705827|P6|NOT COMPLETED|Treatment Period II||0
288598|NCT00245570|705828|P5|NOT COMPLETED|Treatment Period II||0
288599|NCT00245570|705829|P4|NOT COMPLETED|Treatment Period II||0
288600|NCT00245570|705830|P3|NOT COMPLETED|Treatment Period II||0
288601|NCT00245570|705831|P2|NOT COMPLETED|Treatment Period II||0
288602|NCT00245570|705832|P1|NOT COMPLETED|Treatment Period II||0
288603|NCT00245570|705827|P6|COMPLETED|Treatment Period II||8
288604|NCT00245570|705828|P5|COMPLETED|Treatment Period II||8
288605|NCT00245570|705829|P4|COMPLETED|Treatment Period II||8
288606|NCT00245570|705830|P3|COMPLETED|Treatment Period II||8
288607|NCT00245570|705831|P2|COMPLETED|Treatment Period II||8
288608|NCT00245570|705832|P1|COMPLETED|Treatment Period II||7
288609|NCT00245570|705827|P6|STARTED|Treatment Period II||8
288610|NCT00245570|705828|P5|STARTED|Treatment Period II||8
288611|NCT00245570|705829|P4|STARTED|Treatment Period II||8
288612|NCT00245570|705830|P3|STARTED|Treatment Period II||8
288613|NCT00245570|705831|P2|STARTED|Treatment Period II||8
288614|NCT00245570|705832|P1|STARTED|Treatment Period II||7
288615|NCT00245557|705878|P2|NOT COMPLETED|Overall Study||16
288616|NCT00245557|705879|P1|NOT COMPLETED|Overall Study||6
288617|NCT00245557|705878|P2|COMPLETED|Overall Study||10
288618|NCT00245557|705879|P1|COMPLETED|Overall Study||11
288619|NCT00245557|705878|P2|STARTED|Overall Study||26
288620|NCT00245557|705879|P1|STARTED|Overall Study||17
288621|NCT00245518|705892|P2|NOT COMPLETED|Overall Study||0
288622|NCT00245518|705893|P1|NOT COMPLETED|Overall Study||0
288623|NCT00245518|705892|P2|COMPLETED|Overall Study||16
288624|NCT00245518|705893|P1|COMPLETED|Overall Study||17
288625|NCT00245518|705892|P2|STARTED|Overall Study||16
288626|NCT00245518|705893|P1|STARTED|Overall Study||17
288627|NCT00245466|705966|P3|NOT COMPLETED|Overall Study||37
288628|NCT00245466|705967|P2|NOT COMPLETED|Overall Study||44
288629|NCT00245466|705968|P1|NOT COMPLETED|Overall Study||36
288630|NCT00245466|705966|P3|COMPLETED|Overall Study||3
288631|NCT00245466|705967|P2|COMPLETED|Overall Study||2
288632|NCT00245466|705968|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
288633|NCT00245466|705966|P3|Started FE200486 CS02A|Overall Study||26
288634|NCT00245466|705967|P2|Started FE200486 CS02A|Overall Study||30
288635|NCT00245466|705968|P1|Started FE200486 CS02A|Overall Study||32
288636|NCT00245466|705966|P3|STARTED|Overall Study||40
288637|NCT00245466|705967|P2|STARTED|Overall Study||46
288638|NCT00245466|705968|P1|STARTED|Overall Study||43
288639|NCT00245219|705985|P3|NOT COMPLETED|Overall Study||2
288640|NCT00245219|705986|P2|NOT COMPLETED|Overall Study||6
288641|NCT00245219|705987|P1|NOT COMPLETED|Overall Study||6
288642|NCT00245219|705985|P3|COMPLETED|Overall Study||58
288643|NCT00245219|705986|P2|COMPLETED|Overall Study||88
288644|NCT00245219|705987|P1|COMPLETED|Overall Study||85
288645|NCT00245219|705985|P3|STARTED|Overall Study||60
288646|NCT00245219|705986|P2|STARTED|Overall Study||94
288647|NCT00245219|705987|P1|STARTED|Overall Study||91
288648|NCT00245128|706001|P1|NOT COMPLETED|Overall Study||10
288649|NCT00245128|706001|P1|COMPLETED|Overall Study||0
288650|NCT00245128|706001|P1|STARTED|Overall Study||10
288651|NCT00245102|706011|P6|NOT COMPLETED|Overall Study||4
288652|NCT00245102|706012|P5|NOT COMPLETED|Overall Study||0
288653|NCT00245102|706013|P4|NOT COMPLETED|Overall Study||3
288654|NCT00245102|706014|P3|NOT COMPLETED|Overall Study||7
288655|NCT00245102|706015|P2|NOT COMPLETED|Overall Study||4
288656|NCT00245102|706016|P1|NOT COMPLETED|Overall Study||7
288657|NCT00245102|706011|P6|COMPLETED|Overall Study||19
288658|NCT00245102|706012|P5|COMPLETED|Overall Study||5
288659|NCT00245102|706013|P4|COMPLETED|Overall Study||10
288660|NCT00245102|706014|P3|COMPLETED|Overall Study||39
288661|NCT00245102|706015|P2|COMPLETED|Overall Study||12
288662|NCT00245102|706016|P1|COMPLETED|Overall Study||37
288663|NCT00245102|706011|P6|STARTED|Overall Study||23
288664|NCT00245102|706012|P5|STARTED|Overall Study||5
288665|NCT00245102|706013|P4|STARTED|Overall Study||13
288666|NCT00245102|706014|P3|STARTED|Overall Study||46
288667|NCT00245102|706015|P2|STARTED|Overall Study||16
288668|NCT00245102|706016|P1|STARTED|Overall Study||44
288669|NCT00245063|706032|P2|NOT COMPLETED|Overall Study||5
288670|NCT00245063|706033|P1|NOT COMPLETED|Overall Study||7
288671|NCT00245063|706032|P2|COMPLETED|Overall Study||8
288672|NCT00245063|706033|P1|COMPLETED|Overall Study||5
288673|NCT00245063|706032|P2|STARTED|Overall Study||13
288674|NCT00245063|706033|P1|STARTED|Overall Study||12
288675|NCT00245050|706041|P2|NOT COMPLETED|Overall Study||2
288676|NCT00245050|706042|P1|NOT COMPLETED|Overall Study||3
288677|NCT00245050|706041|P2|COMPLETED|Overall Study||14
288678|NCT00245050|706042|P1|COMPLETED|Overall Study||15
288679|NCT00245050|706041|P2|STARTED|Overall Study||16
288680|NCT00245050|706042|P1|STARTED|Overall Study||18
288681|NCT00245037|706050|P1|NOT COMPLETED|Overall Study||17
288682|NCT00245037|706050|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
288683|NCT00245037|706050|P1|STARTED|Overall Study||147
288684|NCT00245011|706060|P1|NOT COMPLETED|Overall Study||1
288685|NCT00245011|706060|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
288686|NCT00245011|706060|P1|STARTED|Overall Study||11
288687|NCT00244985|706064|P1|NOT COMPLETED|Overall Study||0
288688|NCT00244985|706064|P1|COMPLETED|Overall Study||42
288689|NCT00244985|706064|P1|STARTED|Overall Study||42
288690|NCT00244933|706072|P1|NOT COMPLETED|Overall Study||2
288691|NCT00244933|706072|P1|COMPLETED|Overall Study||17
288692|NCT00244933|706072|P1|STARTED|Overall Study||19
288693|NCT00244881|706076|P1|NOT COMPLETED|Overall Study||3
288694|NCT00244881|706076|P1|COMPLETED|Overall Study||23
288695|NCT00244881|706076|P1|STARTED|Overall Study||26
288696|NCT00244855|706084|P2|NOT COMPLETED|Overall Study||1
288697|NCT00244855|706085|P1|NOT COMPLETED|Overall Study||0
288698|NCT00244855|706084|P2|COMPLETED|Overall Study||24
288699|NCT00244855|706085|P1|COMPLETED|Overall Study||7
288700|NCT00244855|706084|P2|STARTED|Overall Study||25
288701|NCT00244855|706085|P1|STARTED|Overall Study||7
288702|NCT00244764|706093|P1|NOT COMPLETED|Overall Study||96
288703|NCT00244764|706093|P1|COMPLETED|Overall Study||129
288704|NCT00244764|706093|P1|STARTED|Overall Study||225
288705|NCT00244751|706103|P3|NOT COMPLETED|Overall Study||10
288706|NCT00244751|706104|P2|NOT COMPLETED|Overall Study||15
288707|NCT00244751|706105|P1|NOT COMPLETED|Overall Study||16
288708|NCT00244751|706103|P3|COMPLETED|Overall Study||78
288709|NCT00244751|706104|P2|COMPLETED|Overall Study||74
288710|NCT00244751|706105|P1|COMPLETED|Overall Study||72
288711|NCT00244751|706103|P3|STARTED|Overall Study||88
288712|NCT00244751|706104|P2|STARTED|Overall Study||89
288713|NCT00244751|706105|P1|STARTED|Overall Study||88
288714|NCT00244725|706206|P4|NOT COMPLETED|Overall Study||21
288715|NCT00244725|706207|P3|NOT COMPLETED|Overall Study||24
288716|NCT00244725|706208|P2|NOT COMPLETED|Overall Study||19
288717|NCT00244725|706209|P1|NOT COMPLETED|Overall Study||23
288718|NCT00244725|706206|P4|COMPLETED|Overall Study||216
288719|NCT00244725|706207|P3|COMPLETED|Overall Study||215
288720|NCT00244725|706208|P2|COMPLETED|Overall Study||226
288721|NCT00244725|706209|P1|COMPLETED|Overall Study||214
288722|NCT00244725|706206|P4|STARTED|Overall Study||237
288723|NCT00244725|706207|P3|STARTED|Overall Study||239
288724|NCT00244725|706208|P2|STARTED|Overall Study||245
288725|NCT00244725|706209|P1|STARTED|Overall Study||237
288726|NCT00244712|706265|P2|NOT COMPLETED|Overall Study||124
288727|NCT00244712|706266|P1|NOT COMPLETED|Overall Study||109
288728|NCT00244712|706265|P2|COMPLETED|Overall Study||221
288729|NCT00244712|706266|P1|COMPLETED|Overall Study||234
288730|NCT00244712|706265|P2|STARTED|Overall Study||345
288731|NCT00244712|706266|P1|STARTED|Overall Study||343
288732|NCT00244621|706301|P3|NOT COMPLETED|Open-label Treatment Period||2
288733|NCT00244621|706302|P2|NOT COMPLETED|Open-label Treatment Period||1
288734|NCT00244621|706303|P1|NOT COMPLETED|Open-label Treatment Period||1
288735|NCT00244621|706301|P3|COMPLETED|Open-label Treatment Period||28
288736|NCT00244621|706302|P2|COMPLETED|Open-label Treatment Period||28
288737|NCT00244621|706303|P1|COMPLETED|Open-label Treatment Period||25
288738|NCT00244621|706301|P3|STARTED|Open-label Treatment Period||30
288739|NCT00244621|706302|P2|STARTED|Open-label Treatment Period||29
288740|NCT00244621|706303|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
288741|NCT00244621|706301|P3|NOT COMPLETED|Double-blind Treatment Period||2
288742|NCT00244621|706302|P2|NOT COMPLETED|Double-blind Treatment Period||3
288743|NCT00244621|706303|P1|NOT COMPLETED|Double-blind Treatment Period||2
288744|NCT00244621|706301|P3|COMPLETED|Double-blind Treatment Period||30
288745|NCT00244621|706302|P2|COMPLETED|Double-blind Treatment Period||29
288746|NCT00244621|706303|P1|COMPLETED|Double-blind Treatment Period||27
288747|NCT00244621|706301|P3|STARTED|Double-blind Treatment Period||32
288748|NCT00244621|706302|P2|STARTED|Double-blind Treatment Period||32
288749|NCT00244621|706303|P1|STARTED|Double-blind Treatment Period||29
288750|NCT00244374|706320|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
288751|NCT00244374|706321|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
288752|NCT00244374|706322|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
288753|NCT00244374|706323|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
288754|NCT00244374|706324|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
288755|NCT00244374|706320|P5|COMPLETED|Vaccine Adherence Cohort||41
288756|NCT00244374|706321|P4|COMPLETED|Vaccine Adherence Cohort||36
288757|NCT00244374|706322|P3|COMPLETED|Vaccine Adherence Cohort||43
288758|NCT00244374|706323|P2|COMPLETED|Vaccine Adherence Cohort||47
288759|NCT00244374|706324|P1|COMPLETED|Vaccine Adherence Cohort||0
288760|NCT00244374|706320|P5|STARTED|Vaccine Adherence Cohort||41
288761|NCT00244374|706321|P4|STARTED|Vaccine Adherence Cohort||36
288762|NCT00244374|706322|P3|STARTED|Vaccine Adherence Cohort||43
288763|NCT00244374|706323|P2|STARTED|Vaccine Adherence Cohort||47
288764|NCT00244374|706324|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
288765|NCT00244374|706320|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288766|NCT00244374|706321|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288767|NCT00244374|706322|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288768|NCT00244374|706323|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288769|NCT00244374|706324|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
288770|NCT00244374|706320|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288771|NCT00244374|706321|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288772|NCT00244374|706322|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288773|NCT00244374|706323|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
288774|NCT00244374|706324|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
288775|NCT00244374|706320|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
288776|NCT00244374|706321|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
288777|NCT00244374|706322|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
288778|NCT00244374|706323|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
288779|NCT00244374|706324|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
288780|NCT00244374|706320|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
288781|NCT00244374|706321|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
288782|NCT00244374|706322|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
288783|NCT00244374|706323|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
288784|NCT00244374|706324|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
288785|NCT00244374|706320|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
288786|NCT00244374|706321|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
288787|NCT00244374|706322|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
288788|NCT00244374|706323|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
288789|NCT00244374|706324|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
288790|NCT00244374|706320|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
288791|NCT00244374|706321|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
288792|NCT00244374|706322|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
288793|NCT00244374|706323|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
288794|NCT00244374|706324|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
288795|NCT00244374|706320|P5|STARTED|Pre-Randomization Cross-sectional Study||0
288796|NCT00244374|706321|P4|STARTED|Pre-Randomization Cross-sectional Study||0
288797|NCT00244374|706322|P3|STARTED|Pre-Randomization Cross-sectional Study||0
288798|NCT00244374|706323|P2|STARTED|Pre-Randomization Cross-sectional Study||0
288799|NCT00244374|706324|P1|STARTED|Pre-Randomization Cross-sectional Study||546
288800|NCT00244140|706342|P2|NOT COMPLETED|Overall Study||0
288801|NCT00244140|706343|P1|NOT COMPLETED|Overall Study||0
288802|NCT00244140|706342|P2|COMPLETED|Overall Study||22
288803|NCT00244140|706343|P1|COMPLETED|Overall Study||412
288804|NCT00244140|706342|P2|STARTED|Overall Study||22
288805|NCT00244140|706343|P1|STARTED|Overall Study||412
288806|NCT00244101|706358|P3|NOT COMPLETED|Overall Study||0
288807|NCT00244101|706359|P2|NOT COMPLETED|Overall Study||0
288808|NCT00244101|706360|P1|NOT COMPLETED|Overall Study||0
288809|NCT00244101|706358|P3|COMPLETED|Overall Study||216
288810|NCT00244101|706359|P2|COMPLETED|Overall Study||223
288811|NCT00244101|706360|P1|COMPLETED|Overall Study||209
288812|NCT00244101|706358|P3|STARTED|Overall Study||216
288813|NCT00244101|706359|P2|STARTED|Overall Study||223
288814|NCT00244101|706360|P1|STARTED|Overall Study||209
288815|NCT00244010|706370|P2|NOT COMPLETED|Overall Study||0
288816|NCT00244010|706371|P1|NOT COMPLETED|Overall Study||0
288817|NCT00244010|706370|P2|COMPLETED|Overall Study||2
288818|NCT00244010|706371|P1|COMPLETED|Overall Study||2
288819|NCT00244010|706370|P2|STARTED|Overall Study||2
288820|NCT00244010|706371|P1|STARTED|Overall Study||2
288821|NCT00243932|706380|P3|NOT COMPLETED|Stage 2: Efficacy||0
288822|NCT00243932|706381|P2|NOT COMPLETED|Stage 2: Efficacy||0
288823|NCT00243932|706382|P1|NOT COMPLETED|Stage 2: Efficacy||0
288824|NCT00243932|706380|P3|COMPLETED|Stage 2: Efficacy||0
288825|NCT00243932|706381|P2|COMPLETED|Stage 2: Efficacy||40
288826|NCT00243932|706382|P1|COMPLETED|Stage 2: Efficacy||40
288827|NCT00243932|706380|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
288828|NCT00243932|706381|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
288829|NCT00243932|706382|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
288830|NCT00243932|706380|P3|NOT COMPLETED|Stage 1: Dose Selection||0
288831|NCT00243932|706381|P2|NOT COMPLETED|Stage 1: Dose Selection||0
288832|NCT00243932|706382|P1|NOT COMPLETED|Stage 1: Dose Selection||2
288833|NCT00243932|706380|P3|COMPLETED|Stage 1: Dose Selection||35
288834|NCT00243932|706381|P2|COMPLETED|Stage 1: Dose Selection||35
288835|NCT00243932|706382|P1|COMPLETED|Stage 1: Dose Selection||33
288836|NCT00243932|706380|P3|STARTED|Stage 1: Dose Selection||35
288837|NCT00243932|706381|P2|STARTED|Stage 1: Dose Selection||35
288838|NCT00243932|706382|P1|STARTED|Stage 1: Dose Selection||35
288839|NCT00243919|706393|P3|NOT COMPLETED|Overall Study||11
288840|NCT00243919|706394|P2|NOT COMPLETED|Overall Study||18
288841|NCT00243919|706395|P1|NOT COMPLETED|Overall Study||17
288842|NCT00243919|706393|P3|COMPLETED|Overall Study||115
288843|NCT00243919|706394|P2|COMPLETED|Overall Study||125
288844|NCT00243919|706395|P1|COMPLETED|Overall Study||122
288845|NCT00243919|706393|P3|STARTED|Overall Study||126
288846|NCT00243919|706394|P2|STARTED|Overall Study||143
288847|NCT00243919|706395|P1|STARTED|Overall Study||139
288848|NCT00243659|706438|P2|NOT COMPLETED|Overall Study||3
288849|NCT00243659|706439|P1|NOT COMPLETED|Overall Study||2
288850|NCT00243659|706438|P2|COMPLETED|Overall Study||5
288851|NCT00243659|706439|P1|COMPLETED|Overall Study||20
288852|NCT00243659|706438|P2|STARTED|Overall Study||8
288853|NCT00243659|706439|P1|STARTED|Overall Study||22
288854|NCT00243503|706447|P1|NOT COMPLETED|Overall Study||58
288855|NCT00243503|706447|P1|COMPLETED|Overall Study||2
288856|NCT00243503|706447|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
288857|NCT00243412|706464|P2|NOT COMPLETED|Overall Study||11
288858|NCT00243412|706465|P1|NOT COMPLETED|Overall Study||10
288859|NCT00243412|706464|P2|COMPLETED|Overall Study|Completed Week 104|10
288860|NCT00243412|706465|P1|COMPLETED|Overall Study|Completed Week 104|11
288861|NCT00243412|706464|P2|Safety Evaluable|Overall Study||20
288862|NCT00243412|706465|P1|Safety Evaluable|Overall Study||21
288863|NCT00243412|706464|P2|STARTED|Overall Study|Intent to treat|21
288864|NCT00243412|706465|P1|STARTED|Overall Study|Intent to treat|21
288865|NCT00243386|706491|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
288866|NCT00243386|706492|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
288867|NCT00243386|706493|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
288868|NCT00243386|706491|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
288869|NCT00243386|706492|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
288870|NCT00243386|706493|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
288871|NCT00243386|706491|P3|STARTED|PK-Driven or Standard Prophylaxis||32
288872|NCT00243386|706492|P2|STARTED|PK-Driven or Standard Prophylaxis||34
288873|NCT00243386|706493|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
288874|NCT00243386|706491|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
288875|NCT00243386|706492|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
288876|NCT00243386|706493|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
288877|NCT00243386|706491|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
288878|NCT00243386|706492|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
288879|NCT00243386|706493|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
288880|NCT00243386|706491|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
288881|NCT00243386|706492|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
288882|NCT00243386|706493|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
288883|NCT00243386|706491|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
288884|NCT00243386|706492|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
288885|NCT00243386|706493|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
288886|NCT00243386|706491|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
288887|NCT00243386|706492|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
288888|NCT00243386|706493|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
288889|NCT00243386|706491|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
288890|NCT00243386|706492|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
288891|NCT00243386|706493|P1|STARTED|On-Demand Regimen (Study Part 1)||73
288892|NCT00243347|706558|P1|NOT COMPLETED|Overall Study||19
288893|NCT00243347|706558|P1|COMPLETED|Overall Study|Completed study|0
288894|NCT00243347|706558|P1|STARTED|Overall Study|Treated|19
288895|NCT00243269|706567|P4|NOT COMPLETED|Overall Study||4
288896|NCT00243269|706568|P3|NOT COMPLETED|Overall Study||1
288897|NCT00243269|706569|P2|NOT COMPLETED|Overall Study||1
288898|NCT00243269|706570|P1|NOT COMPLETED|Overall Study||3
288899|NCT00243269|706567|P4|COMPLETED|Overall Study||25
288900|NCT00243269|706568|P3|COMPLETED|Overall Study||11
288901|NCT00243269|706569|P2|COMPLETED|Overall Study||10
288902|NCT00243269|706570|P1|COMPLETED|Overall Study||28
288903|NCT00243269|706567|P4|STARTED|Overall Study||29
288904|NCT00243269|706568|P3|STARTED|Overall Study||12
288905|NCT00243269|706569|P2|STARTED|Overall Study||11
288906|NCT00243269|706570|P1|STARTED|Overall Study||31
288907|NCT00243243|706586|P2|NOT COMPLETED|Overall Study||0
288908|NCT00243243|706587|P1|NOT COMPLETED|Overall Study||0
288909|NCT00243243|706586|P2|COMPLETED|Overall Study||10
288910|NCT00243243|706587|P1|COMPLETED|Overall Study||10
288911|NCT00243243|706586|P2|STARTED|Overall Study||10
288912|NCT00243243|706587|P1|STARTED|Overall Study||10
288913|NCT00243191|706593|P1|NOT COMPLETED|Overall Study||0
288914|NCT00243191|706593|P1|COMPLETED|Overall Study||18
288915|NCT00243191|706593|P1|STARTED|Overall Study||18
288916|NCT00243074|706597|P1|NOT COMPLETED|Overall Study||54
288917|NCT00243074|706597|P1|COMPLETED|Overall Study||0
288918|NCT00243074|706597|P1|STARTED|Overall Study||54
288919|NCT00243061|706607|P1|NOT COMPLETED|Overall Study||0
288920|NCT00243061|706607|P1|COMPLETED|Overall Study||24
288921|NCT00243061|706607|P1|STARTED|Overall Study||24
288922|NCT00243022|706618|P2|NOT COMPLETED|Overall Study||1
288923|NCT00243022|706619|P1|NOT COMPLETED|Overall Study||2
288924|NCT00243022|706618|P2|COMPLETED|Overall Study||4
288925|NCT00243022|706619|P1|COMPLETED|Overall Study||5
288926|NCT00243022|706618|P2|STARTED|Overall Study||5
288927|NCT00243022|706619|P1|STARTED|Overall Study||7
288928|NCT00242710|706641|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
288929|NCT00242710|706642|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
288930|NCT00242710|706643|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
288931|NCT00242710|706644|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
288932|NCT00242710|706641|P4|COMPLETED|Study Extension (up to Year 2)||84
288933|NCT00242710|706642|P3|COMPLETED|Study Extension (up to Year 2)||69
288934|NCT00242710|706643|P2|COMPLETED|Study Extension (up to Year 2)||148
288935|NCT00242710|706644|P1|COMPLETED|Study Extension (up to Year 2)||141
288936|NCT00242710|706641|P4|STARTED|Study Extension (up to Year 2)||94
288937|NCT00242710|706642|P3|STARTED|Study Extension (up to Year 2)||84
288938|NCT00242710|706643|P2|STARTED|Study Extension (up to Year 2)||177
288939|NCT00242710|706644|P1|STARTED|Study Extension (up to Year 2)||168
288940|NCT00242710|706641|P4|NOT COMPLETED|Period Between Core Study and Extension||49
288941|NCT00242710|706642|P3|NOT COMPLETED|Period Between Core Study and Extension||48
288942|NCT00242710|706643|P2|NOT COMPLETED|Period Between Core Study and Extension||112
288943|NCT00242710|706644|P1|NOT COMPLETED|Period Between Core Study and Extension||119
288944|NCT00242710|706641|P4|COMPLETED|Period Between Core Study and Extension||94
288945|NCT00242710|706642|P3|COMPLETED|Period Between Core Study and Extension||84
288946|NCT00242710|706643|P2|COMPLETED|Period Between Core Study and Extension||177
288947|NCT00242710|706644|P1|COMPLETED|Period Between Core Study and Extension||168
288948|NCT00242710|706641|P4|STARTED|Period Between Core Study and Extension||143
288949|NCT00242710|706642|P3|STARTED|Period Between Core Study and Extension||132
288950|NCT00242710|706643|P2|STARTED|Period Between Core Study and Extension||289
288951|NCT00242710|706644|P1|STARTED|Period Between Core Study and Extension||287
288952|NCT00242710|706641|P4|NOT COMPLETED|Core Study (up to Year 1)||31
288953|NCT00242710|706642|P3|NOT COMPLETED|Core Study (up to Year 1)||51
288954|NCT00242710|706643|P2|NOT COMPLETED|Core Study (up to Year 1)||64
288955|NCT00242710|706644|P1|NOT COMPLETED|Core Study (up to Year 1)||86
288956|NCT00242710|706641|P4|COMPLETED|Core Study (up to Year 1)||143
288957|NCT00242710|706642|P3|COMPLETED|Core Study (up to Year 1)||132
288958|NCT00242710|706643|P2|COMPLETED|Core Study (up to Year 1)||289
288959|NCT00242710|706644|P1|COMPLETED|Core Study (up to Year 1)||287
288960|NCT00242710|706641|P4|Treated|Core Study (up to Year 1)||172
288961|NCT00242710|706642|P3|Treated|Core Study (up to Year 1)||179
288962|NCT00242710|706643|P2|Treated|Core Study (up to Year 1)||349
288963|NCT00242710|706644|P1|Treated|Core Study (up to Year 1)||361
288964|NCT00242710|706641|P4|STARTED|Core Study (up to Year 1)||174
288965|NCT00242710|706642|P3|STARTED|Core Study (up to Year 1)||183
288966|NCT00242710|706643|P2|STARTED|Core Study (up to Year 1)||353
288967|NCT00242710|706644|P1|STARTED|Core Study (up to Year 1)||373
288968|NCT00242684|706694|P1|NOT COMPLETED|Overall Study||0
288969|NCT00242684|706694|P1|COMPLETED|Overall Study||446
288970|NCT00242684|706694|P1|STARTED|Overall Study||446
288971|NCT00242658|706701|P2|NOT COMPLETED|Overall Study||19
288972|NCT00242658|706702|P1|NOT COMPLETED|Overall Study||22
288973|NCT00242658|706701|P2|COMPLETED|Overall Study||188
288974|NCT00242658|706702|P1|COMPLETED|Overall Study||165
288975|NCT00242658|706701|P2|STARTED|Overall Study||207
288976|NCT00242658|706702|P1|STARTED|Overall Study||187
288977|NCT00242632|706712|P2|NOT COMPLETED|Overall Study||0
288978|NCT00242632|706713|P1|NOT COMPLETED|Overall Study||0
288979|NCT00242632|706712|P2|COMPLETED|Overall Study||11
288980|NCT00242632|706713|P1|COMPLETED|Overall Study||11
288981|NCT00242632|706712|P2|STARTED|Overall Study||11
288982|NCT00242632|706713|P1|STARTED|Overall Study||11
288983|NCT00242619|706721|P2|NOT COMPLETED|Overall Study||0
288984|NCT00242619|706722|P1|NOT COMPLETED|Overall Study||0
288985|NCT00242619|706721|P2|COMPLETED|Overall Study||4
288986|NCT00242619|706722|P1|COMPLETED|Overall Study||8
288987|NCT00242619|706721|P2|STARTED|Overall Study||4
288988|NCT00242619|706722|P1|STARTED|Overall Study||8
288989|NCT00242580|706733|P3|NOT COMPLETED|Overall Study||14
288990|NCT00242580|706734|P2|NOT COMPLETED|Overall Study||12
288991|NCT00242580|706735|P1|NOT COMPLETED|Overall Study||10
288992|NCT00242580|706733|P3|COMPLETED|Overall Study||24
288993|NCT00242580|706734|P2|COMPLETED|Overall Study||29
288994|NCT00242580|706735|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
288995|NCT00242580|706733|P3|STARTED|Overall Study||38
288996|NCT00242580|706734|P2|STARTED|Overall Study||41
288997|NCT00242580|706735|P1|STARTED|Overall Study||32
288998|NCT00242567|706760|P2|NOT COMPLETED|Overall Study||140
288999|NCT00242567|706761|P1|NOT COMPLETED|Overall Study||166
289000|NCT00242567|706760|P2|COMPLETED|Overall Study||123
289001|NCT00242567|706761|P1|COMPLETED|Overall Study||93
289002|NCT00242567|706760|P2|Never Received Study Drug|Overall Study||191
289003|NCT00242567|706761|P1|Never Received Study Drug|Overall Study||0
289004|NCT00242567|706760|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
289005|NCT00242567|706761|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
289006|NCT00242567|706760|P2|STARTED|Overall Study||263
289007|NCT00242567|706761|P1|STARTED|Overall Study||259
289008|NCT00242502|706777|P1|NOT COMPLETED|Overall Study||0
289009|NCT00242502|706777|P1|COMPLETED|Overall Study||59
289010|NCT00242502|706777|P1|STARTED|Overall Study||59
289011|NCT00242385|706781|P2|NOT COMPLETED|Period 2||0
289012|NCT00242385|706782|P1|NOT COMPLETED|Period 2||0
289013|NCT00242385|706781|P2|COMPLETED|Period 2||11
289014|NCT00242385|706782|P1|COMPLETED|Period 2||14
289015|NCT00242385|706781|P2|STARTED|Period 2||11
289016|NCT00242385|706782|P1|STARTED|Period 2||14
289017|NCT00242385|706781|P2|NOT COMPLETED|Period 1||0
289018|NCT00242385|706782|P1|NOT COMPLETED|Period 1||0
289019|NCT00242385|706781|P2|COMPLETED|Period 1||11
289020|NCT00242385|706782|P1|COMPLETED|Period 1||14
289021|NCT00242385|706781|P2|STARTED|Period 1||11
289022|NCT00242385|706782|P1|STARTED|Period 1||14
289023|NCT00242216|706808|P2|NOT COMPLETED|Overall Study||22
289024|NCT00242216|706809|P1|NOT COMPLETED|Overall Study||18
289025|NCT00242216|706808|P2|COMPLETED|Overall Study||15
289026|NCT00242216|706809|P1|COMPLETED|Overall Study||21
289027|NCT00242216|706808|P2|STARTED|Overall Study||37
289028|NCT00242216|706809|P1|STARTED|Overall Study||39
289029|NCT00241969|706819|P2|NOT COMPLETED|Overall Study||0
289030|NCT00241969|706820|P1|NOT COMPLETED|Overall Study||0
289031|NCT00241969|706819|P2|COMPLETED|Overall Study||42
289032|NCT00241969|706820|P1|COMPLETED|Overall Study||36
289033|NCT00241969|706819|P2|STARTED|Overall Study||42
289034|NCT00241969|706820|P1|STARTED|Overall Study||36
289035|NCT00241904|706832|P2|NOT COMPLETED|Overall Study||24
289036|NCT00241904|706833|P1|NOT COMPLETED|Overall Study||34
289037|NCT00241904|706832|P2|COMPLETED|Overall Study||240
289038|NCT00241904|706833|P1|COMPLETED|Overall Study||227
289039|NCT00241904|706832|P2|STARTED|Overall Study||264
289040|NCT00241904|706833|P1|STARTED|Overall Study||261
289041|NCT00241839|706847|P2|NOT COMPLETED|Overall Study||18
289042|NCT00241839|706848|P1|NOT COMPLETED|Overall Study||19
289043|NCT00241839|706847|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
289044|NCT00241839|706848|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
289045|NCT00241839|706847|P2|STARTED|Overall Study||71
289046|NCT00241839|706848|P1|STARTED|Overall Study||71
289047|NCT00241644|706864|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
289048|NCT00241644|706865|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
289049|NCT00241644|706866|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
289050|NCT00241644|706867|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
289051|NCT00241644|706864|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
289052|NCT00241644|706865|P3|COMPLETED|Second Efficacy Period (Year 2)||682
289053|NCT00241644|706866|P2|COMPLETED|Second Efficacy Period (Year 2)||697
289054|NCT00241644|706867|P1|COMPLETED|Second Efficacy Period (Year 2)||710
289055|NCT00241644|706864|P4|STARTED|Second Efficacy Period (Year 2)||1525
289056|NCT00241644|706865|P3|STARTED|Second Efficacy Period (Year 2)||746
289057|NCT00241644|706866|P2|STARTED|Second Efficacy Period (Year 2)||754
289058|NCT00241644|706867|P1|STARTED|Second Efficacy Period (Year 2)||771
289059|NCT00241644|706864|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
289060|NCT00241644|706865|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
289061|NCT00241644|706866|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
289062|NCT00241644|706867|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
289063|NCT00241644|706864|P4|COMPLETED|First Efficacy Period (Year 1)||2803
289064|NCT00241644|706865|P3|COMPLETED|First Efficacy Period (Year 1)||1392
289065|NCT00241644|706866|P2|COMPLETED|First Efficacy Period (Year 1)||1383
289066|NCT00241644|706867|P1|COMPLETED|First Efficacy Period (Year 1)||1420
289067|NCT00241644|706864|P4|STARTED|First Efficacy Period (Year 1)||3298
289068|NCT00241644|706865|P3|STARTED|First Efficacy Period (Year 1)||1641
289069|NCT00241644|706866|P2|STARTED|First Efficacy Period (Year 1)||1651
289070|NCT00241644|706867|P1|STARTED|First Efficacy Period (Year 1)||1647
289071|NCT00241358|706952|P3|NOT COMPLETED|Overall Study||1
289072|NCT00241358|706953|P2|NOT COMPLETED|Overall Study||1
289073|NCT00241358|706954|P1|NOT COMPLETED|Overall Study||0
289074|NCT00241358|706952|P3|COMPLETED|Overall Study||20
289075|NCT00241358|706953|P2|COMPLETED|Overall Study||45
289076|NCT00241358|706954|P1|COMPLETED|Overall Study||25
289077|NCT00241358|706952|P3|STARTED|Overall Study||21
289078|NCT00241358|706953|P2|STARTED|Overall Study||46
289079|NCT00241358|706954|P1|STARTED|Overall Study||25
289080|NCT00241280|706987|P2|NOT COMPLETED|Overall Study||68
289081|NCT00241280|706988|P1|NOT COMPLETED|Overall Study||48
289082|NCT00241280|706987|P2|COMPLETED|Overall Study||186
289083|NCT00241280|706988|P1|COMPLETED|Overall Study||199
289084|NCT00241280|706987|P2|STARTED|Overall Study||254
289085|NCT00241280|706988|P1|STARTED|Overall Study||247
289086|NCT00241176|706996|P1|NOT COMPLETED|Overall Study||0
289087|NCT00241176|706996|P1|COMPLETED|Overall Study||11
289088|NCT00241176|706996|P1|STARTED|Overall Study||11
289089|NCT00240994|707003|P1|NOT COMPLETED|Overall Study||3
289090|NCT00240994|707003|P1|COMPLETED|Overall Study||32
289091|NCT00240994|707003|P1|STARTED|Overall Study||35
289092|NCT00240981|707009|P2|NOT COMPLETED|Overall Study||33
289093|NCT00240981|707010|P1|NOT COMPLETED|Overall Study||38
289094|NCT00240981|707009|P2|COMPLETED|Overall Study||70
289095|NCT00240981|707010|P1|COMPLETED|Overall Study||68
289096|NCT00240981|707009|P2|Intent to Treat Sample|Overall Study||83
289097|NCT00240981|707010|P1|Intent to Treat Sample|Overall Study||82
289098|NCT00240981|707009|P2|STARTED|Overall Study||103
289099|NCT00240981|707010|P1|STARTED|Overall Study||106
289100|NCT00240539|707038|P4|NOT COMPLETED|Overall Study||0
289101|NCT00240539|707039|P3|NOT COMPLETED|Overall Study||0
289102|NCT00240539|707040|P2|NOT COMPLETED|Overall Study||0
289103|NCT00240539|707041|P1|NOT COMPLETED|Overall Study||0
289104|NCT00240539|707038|P4|COMPLETED|Overall Study||1
289105|NCT00240539|707039|P3|COMPLETED|Overall Study||31
289106|NCT00240539|707040|P2|COMPLETED|Overall Study||2
289107|NCT00240539|707041|P1|COMPLETED|Overall Study||2
289108|NCT00240539|707038|P4|STARTED|Overall Study||1
289109|NCT00240539|707039|P3|STARTED|Overall Study||31
289110|NCT00240539|707040|P2|STARTED|Overall Study||2
289111|NCT00240539|707041|P1|STARTED|Overall Study||2
289112|NCT00240526|707063|P4|NOT COMPLETED|Year 20||0
289113|NCT00240526|707064|P3|NOT COMPLETED|Year 20||0
289114|NCT00240526|707065|P2|NOT COMPLETED|Year 20||0
289115|NCT00240526|707066|P1|NOT COMPLETED|Year 20||0
289116|NCT00240526|707063|P4|COMPLETED|Year 20||20
289117|NCT00240526|707064|P3|COMPLETED|Year 20||13
289118|NCT00240526|707065|P2|COMPLETED|Year 20||17
289119|NCT00240526|707066|P1|COMPLETED|Year 20||19
289120|NCT00240526|707063|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
289121|NCT00240526|707064|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
289122|NCT00240526|707065|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
289123|NCT00240526|707066|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
289124|NCT00240526|707063|P4|NOT COMPLETED|Year 19||0
289125|NCT00240526|707064|P3|NOT COMPLETED|Year 19||0
289126|NCT00240526|707065|P2|NOT COMPLETED|Year 19||0
289127|NCT00240526|707066|P1|NOT COMPLETED|Year 19||0
289128|NCT00240526|707063|P4|COMPLETED|Year 19||18
289129|NCT00240526|707064|P3|COMPLETED|Year 19||12
289130|NCT00240526|707065|P2|COMPLETED|Year 19||16
289131|NCT00240526|707066|P1|COMPLETED|Year 19||17
289132|NCT00240526|707063|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
289133|NCT00240526|707064|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
289134|NCT00240526|707065|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
289135|NCT00240526|707066|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
289136|NCT00240526|707063|P4|NOT COMPLETED|Year 18||0
289137|NCT00240526|707064|P3|NOT COMPLETED|Year 18||0
289138|NCT00240526|707065|P2|NOT COMPLETED|Year 18||0
289139|NCT00240526|707066|P1|NOT COMPLETED|Year 18||0
289140|NCT00240526|707063|P4|COMPLETED|Year 18||20
289141|NCT00240526|707064|P3|COMPLETED|Year 18||14
289142|NCT00240526|707065|P2|COMPLETED|Year 18||17
289143|NCT00240526|707066|P1|COMPLETED|Year 18||16
289144|NCT00240526|707063|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
289145|NCT00240526|707064|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
289146|NCT00240526|707065|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
289147|NCT00240526|707066|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
289148|NCT00240526|707063|P4|NOT COMPLETED|Year 17||0
289149|NCT00240526|707064|P3|NOT COMPLETED|Year 17||0
289150|NCT00240526|707065|P2|NOT COMPLETED|Year 17||0
289151|NCT00240526|707066|P1|NOT COMPLETED|Year 17||0
289152|NCT00240526|707063|P4|COMPLETED|Year 17||20
289153|NCT00240526|707064|P3|COMPLETED|Year 17||13
289154|NCT00240526|707065|P2|COMPLETED|Year 17||17
289155|NCT00240526|707066|P1|COMPLETED|Year 17||19
289156|NCT00240526|707063|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
289157|NCT00240526|707064|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
289158|NCT00240526|707065|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
289159|NCT00240526|707066|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
289160|NCT00240526|707063|P4|NOT COMPLETED|Year 16||0
289161|NCT00240526|707064|P3|NOT COMPLETED|Year 16||0
289162|NCT00240526|707065|P2|NOT COMPLETED|Year 16||0
289163|NCT00240526|707066|P1|NOT COMPLETED|Year 16||0
289164|NCT00240526|707063|P4|COMPLETED|Year 16||22
289165|NCT00240526|707064|P3|COMPLETED|Year 16||16
289166|NCT00240526|707065|P2|COMPLETED|Year 16||19
289167|NCT00240526|707066|P1|COMPLETED|Year 16||17
289168|NCT00240526|707063|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
289169|NCT00240526|707064|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
289170|NCT00240526|707065|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
289171|NCT00240526|707066|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
289172|NCT00240526|707063|P4|NOT COMPLETED|Year 15||0
289173|NCT00240526|707064|P3|NOT COMPLETED|Year 15||0
289174|NCT00240526|707065|P2|NOT COMPLETED|Year 15||0
289175|NCT00240526|707066|P1|NOT COMPLETED|Year 15||0
289176|NCT00240526|707063|P4|COMPLETED|Year 15||21
289177|NCT00240526|707064|P3|COMPLETED|Year 15||14
289178|NCT00240526|707065|P2|COMPLETED|Year 15||19
289179|NCT00240526|707066|P1|COMPLETED|Year 15||19
289180|NCT00240526|707063|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
289181|NCT00240526|707064|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
289182|NCT00240526|707065|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
289183|NCT00240526|707066|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
289184|NCT00240500|707102|P6|NOT COMPLETED|Overall Study||1
289185|NCT00240500|707103|P5|NOT COMPLETED|Overall Study||3
289186|NCT00240500|707104|P4|NOT COMPLETED|Overall Study||4
289187|NCT00240500|707105|P3|NOT COMPLETED|Overall Study||3
289188|NCT00240500|707106|P2|NOT COMPLETED|Overall Study||3
289189|NCT00240500|707107|P1|NOT COMPLETED|Overall Study||1
289190|NCT00240500|707102|P6|COMPLETED|Overall Study||2
289191|NCT00240500|707103|P5|COMPLETED|Overall Study||26
289192|NCT00240500|707104|P4|COMPLETED|Overall Study||19
289193|NCT00240500|707105|P3|COMPLETED|Overall Study||14
289194|NCT00240500|707106|P2|COMPLETED|Overall Study||17
289195|NCT00240500|707107|P1|COMPLETED|Overall Study||16
289196|NCT00240500|707102|P6|STARTED|Overall Study||3
289197|NCT00240500|707103|P5|STARTED|Overall Study||29
289198|NCT00240500|707104|P4|STARTED|Overall Study||23
289199|NCT00240500|707105|P3|STARTED|Overall Study||17
289200|NCT00240500|707106|P2|STARTED|Overall Study||20
289201|NCT00240500|707107|P1|STARTED|Overall Study||17
289202|NCT00240487|707129|P2|NOT COMPLETED|Overall Study||0
289203|NCT00240487|707130|P1|NOT COMPLETED|Overall Study||0
289204|NCT00240487|707129|P2|COMPLETED|Overall Study||28
289205|NCT00240487|707130|P1|COMPLETED|Overall Study||24
289206|NCT00240487|707129|P2|STARTED|Overall Study||28
289207|NCT00240487|707130|P1|STARTED|Overall Study||24
289208|NCT00240331|707138|P2|NOT COMPLETED|Overall Study||134
289209|NCT00240331|707139|P1|NOT COMPLETED|Overall Study||126
289210|NCT00240331|707138|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
289211|NCT00240331|707139|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
289212|NCT00240331|707138|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
289213|NCT00240331|707139|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
289214|NCT00240227|707157|P1|NOT COMPLETED|Overall Study||0
289215|NCT00240227|707157|P1|COMPLETED|Overall Study||8
289216|NCT00240227|707157|P1|STARTED|Overall Study||8
289217|NCT00240162|707163|P1|NOT COMPLETED|Overall Study||0
289218|NCT00240162|707163|P1|COMPLETED|Overall Study||21
289219|NCT00240162|707163|P1|STARTED|Overall Study||21
289220|NCT00240110|707172|P2|NOT COMPLETED|Overall Study||7
289221|NCT00240110|707173|P1|NOT COMPLETED|Overall Study||6
289222|NCT00240110|707172|P2|COMPLETED|Overall Study||6
289223|NCT00240110|707173|P1|COMPLETED|Overall Study||7
289224|NCT00240110|707172|P2|STARTED|Overall Study||13
289225|NCT00240110|707173|P1|STARTED|Overall Study||13
289226|NCT00240097|707181|P1|NOT COMPLETED|Part II||23
289227|NCT00240097|707181|P1|COMPLETED|Part II||3
289228|NCT00240097|707181|P1|STARTED|Part II||26
289229|NCT00240097|707181|P1|NOT COMPLETED|Part I||4
289230|NCT00240097|707181|P1|COMPLETED|Part I||26
289231|NCT00240097|707181|P1|STARTED|Part I||30
289232|NCT00240071|707191|P1|NOT COMPLETED|Overall Study||3
289233|NCT00240071|707191|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
289234|NCT00240071|707191|P1|STARTED|Overall Study||30
289235|NCT00239928|707196|P1|NOT COMPLETED|Overall Study||10
289236|NCT00239928|707196|P1|COMPLETED|Overall Study||51
289237|NCT00239928|707196|P1|STARTED|Overall Study||61
289238|NCT00239837|707208|P2|NOT COMPLETED|Overall Study||7
289239|NCT00239837|707209|P1|NOT COMPLETED|Overall Study||3
289240|NCT00239837|707208|P2|COMPLETED|Overall Study|3-year follow-up|45
289241|NCT00239837|707209|P1|COMPLETED|Overall Study|3-year follow-up|45
289242|NCT00239837|707208|P2|6 Months|Overall Study||50
289243|NCT00239837|707209|P1|6 Months|Overall Study||48
289244|NCT00239837|707208|P2|STARTED|Overall Study||52
289245|NCT00239837|707209|P1|STARTED|Overall Study||48
289246|NCT00239733|707229|P1|NOT COMPLETED|Overall Study||0
289247|NCT00239733|707229|P1|COMPLETED|Overall Study||6
289248|NCT00239733|707229|P1|STARTED|Overall Study||6
289249|NCT00239720|707236|P2|NOT COMPLETED|Overall Study||1
289250|NCT00239720|707237|P1|NOT COMPLETED|Overall Study||1
289251|NCT00239720|707236|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
289252|NCT00239720|707237|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
289253|NCT00239720|707236|P2|STARTED|Overall Study||1
289254|NCT00239720|707237|P1|STARTED|Overall Study||3
289255|NCT00239681|707245|P2|NOT COMPLETED|Overall Study||715
289256|NCT00239681|707246|P1|NOT COMPLETED|Overall Study||693
289257|NCT00239681|707245|P2|COMPLETED|Overall Study||8186
289258|NCT00239681|707246|P1|COMPLETED|Overall Study||8208
289259|NCT00239681|707245|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
289260|NCT00239681|707246|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
289261|NCT00239681|707245|P2|STARTED|Overall Study||8901
289262|NCT00239681|707246|P1|STARTED|Overall Study||8901
289263|NCT00239642|707265|P3|NOT COMPLETED|Overall Study||2
289264|NCT00239642|707266|P2|NOT COMPLETED|Overall Study||0
289265|NCT00239642|707267|P1|NOT COMPLETED|Overall Study||2
289266|NCT00239642|707265|P3|COMPLETED|Overall Study||47
289267|NCT00239642|707266|P2|COMPLETED|Overall Study||47
289268|NCT00239642|707267|P1|COMPLETED|Overall Study||47
289269|NCT00239642|707265|P3|STARTED|Overall Study||49
289270|NCT00239642|707266|P2|STARTED|Overall Study||47
289271|NCT00239642|707267|P1|STARTED|Overall Study||49
289272|NCT00239356|707301|P2|NOT COMPLETED|Overall Study||9
289273|NCT00239356|707302|P1|NOT COMPLETED|Overall Study||39
289274|NCT00239356|707301|P2|COMPLETED|Overall Study||11
289275|NCT00239356|707302|P1|COMPLETED|Overall Study||58
289276|NCT00239356|707301|P2|STARTED|Overall Study||20
289277|NCT00239356|707302|P1|STARTED|Overall Study||97
289278|NCT00239226|707324|P4|NOT COMPLETED|Overall Study||3
289279|NCT00239226|707325|P3|NOT COMPLETED|Overall Study||1
289280|NCT00239226|707326|P2|NOT COMPLETED|Overall Study||0
289281|NCT00239226|707327|P1|NOT COMPLETED|Overall Study||1
289282|NCT00239226|707324|P4|COMPLETED|Overall Study||14
289283|NCT00239226|707325|P3|COMPLETED|Overall Study||36
289284|NCT00239226|707326|P2|COMPLETED|Overall Study||18
289285|NCT00239226|707327|P1|COMPLETED|Overall Study||29
289286|NCT00239226|707324|P4|STARTED|Overall Study||17
289287|NCT00239226|707325|P3|STARTED|Overall Study||37
289288|NCT00239226|707326|P2|STARTED|Overall Study||18
289289|NCT00239226|707327|P1|STARTED|Overall Study||30
289290|NCT00239005|707339|P2|NOT COMPLETED|Overall Study||12
289291|NCT00239005|707340|P1|NOT COMPLETED|Overall Study||12
289292|NCT00239005|707339|P2|COMPLETED|Overall Study||53
289293|NCT00239005|707340|P1|COMPLETED|Overall Study||57
289294|NCT00239005|707339|P2|Intention-to-treat Population (ITT)|Overall Study||61
289295|NCT00239005|707340|P1|Intention-to-treat Population (ITT)|Overall Study||68
289296|NCT00239005|707339|P2|STARTED|Overall Study||65
289297|NCT00239005|707340|P1|STARTED|Overall Study||69
289298|NCT00238615|707350|P1|NOT COMPLETED|Overall Study||0
289299|NCT00238615|707350|P1|COMPLETED|Overall Study||13
289300|NCT00238615|707350|P1|STARTED|Overall Study||13
289301|NCT00238433|707356|P1|NOT COMPLETED|Overall Study||3
289302|NCT00238433|707356|P1|COMPLETED|Overall Study||34
289303|NCT00238433|707356|P1|STARTED|Overall Study||37
289304|NCT00238420|707363|P2|NOT COMPLETED|Overall Study||1
289305|NCT00238420|707364|P1|NOT COMPLETED|Overall Study||1
289306|NCT00238420|707363|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
289307|NCT00238420|707364|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
289308|NCT00238420|707363|P2|STARTED|Overall Study||48
289309|NCT00238420|707364|P1|STARTED|Overall Study||22
289310|NCT00238355|707374|P1|NOT COMPLETED|Overall Study||3
289311|NCT00238355|707374|P1|COMPLETED|Overall Study||10
289312|NCT00238355|707374|P1|STARTED|Overall Study||13
289313|NCT00238303|707381|P3|NOT COMPLETED|Overall Study||9
289314|NCT00238303|707382|P2|NOT COMPLETED|Overall Study||2
289315|NCT00238303|707383|P1|NOT COMPLETED|Overall Study||15
289316|NCT00238303|707381|P3|COMPLETED|Overall Study||11
289317|NCT00238303|707382|P2|COMPLETED|Overall Study||13
289318|NCT00238303|707383|P1|COMPLETED|Overall Study||53
289319|NCT00238303|707381|P3|STARTED|Overall Study||20
289320|NCT00238303|707382|P2|STARTED|Overall Study||15
289321|NCT00238303|707383|P1|STARTED|Overall Study||68
289322|NCT00238264|707400|P1|NOT COMPLETED|Overall Study||36
289323|NCT00238264|707400|P1|COMPLETED|Overall Study||56
289324|NCT00238264|707400|P1|STARTED|Overall Study||92
289325|NCT00238238|707413|P3|NOT COMPLETED|Overall Study||0
289326|NCT00238238|707414|P2|NOT COMPLETED|Overall Study||3
289327|NCT00238238|707415|P1|NOT COMPLETED|Overall Study||0
289328|NCT00238238|707413|P3|COMPLETED|Overall Study||46
289329|NCT00238238|707414|P2|COMPLETED|Overall Study||45
289330|NCT00238238|707415|P1|COMPLETED|Overall Study||3
289331|NCT00238238|707413|P3|STARTED|Overall Study||46
289332|NCT00238238|707414|P2|STARTED|Overall Study||48
289333|NCT00238238|707415|P1|STARTED|Overall Study||3
289334|NCT00238121|707428|P2|NOT COMPLETED|Overall Study||2
289335|NCT00238121|707429|P1|NOT COMPLETED|Overall Study||3
289336|NCT00238121|707428|P2|COMPLETED|Overall Study||14
289337|NCT00238121|707429|P1|COMPLETED|Overall Study||37
289338|NCT00238121|707428|P2|STARTED|Overall Study||16
289339|NCT00238121|707429|P1|STARTED|Overall Study||40
289340|NCT00238108|707442|P2|NOT COMPLETED|Overall Study||0
289341|NCT00238108|707443|P1|NOT COMPLETED|Overall Study||0
289342|NCT00238108|707442|P2|COMPLETED|Overall Study||8
289343|NCT00238108|707443|P1|COMPLETED|Overall Study||8
289344|NCT00238108|707442|P2|STARTED|Overall Study||8
289345|NCT00238108|707443|P1|STARTED|Overall Study||8
289346|NCT00237809|707455|P4|NOT COMPLETED|Overall Study||9
289347|NCT00237809|707456|P3|NOT COMPLETED|Overall Study||9
289348|NCT00237809|707457|P2|NOT COMPLETED|Overall Study||10
289349|NCT00237809|707458|P1|NOT COMPLETED|Overall Study||11
289350|NCT00237809|707455|P4|COMPLETED|Overall Study||17
289351|NCT00237809|707456|P3|COMPLETED|Overall Study||15
289352|NCT00237809|707457|P2|COMPLETED|Overall Study||17
289353|NCT00237809|707458|P1|COMPLETED|Overall Study||16
289354|NCT00237809|707455|P4|STARTED|Overall Study||26
289355|NCT00237809|707456|P3|STARTED|Overall Study||24
289356|NCT00237809|707457|P2|STARTED|Overall Study||27
289357|NCT00237809|707458|P1|STARTED|Overall Study||27
289358|NCT00237796|707494|P2|NOT COMPLETED|Overall Study||5
289359|NCT00237796|707495|P1|NOT COMPLETED|Overall Study||10
289360|NCT00237796|707494|P2|COMPLETED|Overall Study||33
289361|NCT00237796|707495|P1|COMPLETED|Overall Study||31
289362|NCT00237796|707494|P2|STARTED|Overall Study||38
289363|NCT00237796|707495|P1|STARTED|Overall Study||41
289364|NCT00237770|707515|P2|NOT COMPLETED|Overall Study||0
289365|NCT00237770|707516|P1|NOT COMPLETED|Overall Study||0
289366|NCT00237770|707515|P2|COMPLETED|Overall Study||7
289367|NCT00237770|707516|P1|COMPLETED|Overall Study||9
289368|NCT00237770|707515|P2|STARTED|Overall Study||7
289369|NCT00237770|707516|P1|STARTED|Overall Study||9
289370|NCT00237744|707529|P3|NOT COMPLETED|Overall Study||0
289371|NCT00237744|707530|P2|NOT COMPLETED|Overall Study||1
289372|NCT00237744|707531|P1|NOT COMPLETED|Overall Study||3
289373|NCT00237744|707529|P3|COMPLETED|Overall Study||18
289374|NCT00237744|707530|P2|COMPLETED|Overall Study||10
289375|NCT00237744|707531|P1|COMPLETED|Overall Study||8
289376|NCT00237744|707529|P3|STARTED|Overall Study||18
289377|NCT00237744|707530|P2|STARTED|Overall Study||11
289378|NCT00237744|707531|P1|STARTED|Overall Study||11
289379|NCT00237718|707544|P2|NOT COMPLETED|Overall Study||41
289380|NCT00237718|707545|P1|NOT COMPLETED|Overall Study||46
289381|NCT00237718|707544|P2|COMPLETED|Overall Study||124
289382|NCT00237718|707545|P1|COMPLETED|Overall Study||114
289383|NCT00237718|707544|P2|STARTED|Overall Study||165
289384|NCT00237718|707545|P1|STARTED|Overall Study||160
289385|NCT00237692|707557|P4|NOT COMPLETED|Overall Study||19
289386|NCT00237692|707558|P3|NOT COMPLETED|Overall Study||22
289387|NCT00237692|707559|P2|NOT COMPLETED|Overall Study||14
289388|NCT00237692|707560|P1|NOT COMPLETED|Overall Study||18
289389|NCT00237692|707557|P4|COMPLETED|Overall Study||128
289390|NCT00237692|707558|P3|COMPLETED|Overall Study||127
289391|NCT00237692|707559|P2|COMPLETED|Overall Study||134
289392|NCT00237692|707560|P1|COMPLETED|Overall Study||129
289393|NCT00237692|707557|P4|18 Month f/u|Overall Study||122
289394|NCT00237692|707558|P3|18 Month f/u|Overall Study||126
289395|NCT00237692|707559|P2|18 Month f/u|Overall Study||131
289396|NCT00237692|707560|P1|18 Month f/u|Overall Study||124
289397|NCT00237692|707557|P4|12 Month f/u|Overall Study||127
289398|NCT00237692|707558|P3|12 Month f/u|Overall Study||132
289399|NCT00237692|707559|P2|12 Month f/u|Overall Study||127
289400|NCT00237692|707560|P1|12 Month f/u|Overall Study||137
289401|NCT00237692|707557|P4|6 Month f/u|Overall Study||134
289402|NCT00237692|707558|P3|6 Month f/u|Overall Study||135
289403|NCT00237692|707559|P2|6 Month f/u|Overall Study||134
289404|NCT00237692|707560|P1|6 Month f/u|Overall Study||132
289405|NCT00237692|707557|P4|STARTED|Overall Study||147
289406|NCT00237692|707558|P3|STARTED|Overall Study||149
289407|NCT00237692|707559|P2|STARTED|Overall Study||148
289408|NCT00237692|707560|P1|STARTED|Overall Study||147
289409|NCT00237666|707590|P1|NOT COMPLETED|Overall Study||6
289410|NCT00237666|707590|P1|COMPLETED|Overall Study||24
289411|NCT00237666|707590|P1|STARTED|Overall Study||30
289412|NCT00237458|707600|P1|NOT COMPLETED|Overall Study||3
289413|NCT00237458|707600|P1|COMPLETED|Overall Study||4
289414|NCT00237458|707600|P1|STARTED|Overall Study||7
289415|NCT00237185|707618|P2|NOT COMPLETED|Extension||19
289416|NCT00237185|707619|P1|NOT COMPLETED|Extension||16
289417|NCT00237185|707618|P2|COMPLETED|Extension||13
289418|NCT00237185|707619|P1|COMPLETED|Extension||8
289419|NCT00237185|707618|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
289420|NCT00237185|707619|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
289421|NCT00237185|707618|P2|NOT COMPLETED|Core||37
289422|NCT00237185|707619|P1|NOT COMPLETED|Core||44
289423|NCT00237185|707618|P2|COMPLETED|Core||37
289424|NCT00237185|707619|P1|COMPLETED|Core||30
289425|NCT00237185|707618|P2|Treated Participants|Core||74
289426|NCT00237185|707619|P1|Treated Participants|Core||73
289427|NCT00237185|707618|P2|STARTED|Core||74
289428|NCT00237185|707619|P1|STARTED|Core||74
289429|NCT00237042|707650|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
289430|NCT00237042|707651|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
289431|NCT00237042|707652|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
289432|NCT00237042|707650|P3|COMPLETED|Long Term (12 Month) Follow up||48
289433|NCT00237042|707651|P2|COMPLETED|Long Term (12 Month) Follow up||46
289434|NCT00237042|707652|P1|COMPLETED|Long Term (12 Month) Follow up||48
289435|NCT00237042|707650|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
289436|NCT00237042|707651|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
289437|NCT00237042|707652|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
289438|NCT00237042|707650|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
289439|NCT00237042|707651|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
289440|NCT00237042|707652|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
289441|NCT00237042|707650|P3|COMPLETED|Short Term (6 Month) Follow up||46
289442|NCT00237042|707651|P2|COMPLETED|Short Term (6 Month) Follow up||47
289443|NCT00237042|707652|P1|COMPLETED|Short Term (6 Month) Follow up||50
289444|NCT00237042|707650|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
289445|NCT00237042|707651|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
289446|NCT00237042|707652|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
289447|NCT00237042|707650|P3|NOT COMPLETED|Treatment||38
289448|NCT00237042|707651|P2|NOT COMPLETED|Treatment||7
289449|NCT00237042|707652|P1|NOT COMPLETED|Treatment||6
289450|NCT00237042|707650|P3|COMPLETED|Treatment||36
289451|NCT00237042|707651|P2|COMPLETED|Treatment||50
289452|NCT00237042|707652|P1|COMPLETED|Treatment||54
289453|NCT00237042|707650|P3|STARTED|Treatment||74
289454|NCT00237042|707651|P2|STARTED|Treatment||57
289455|NCT00237042|707652|P1|STARTED|Treatment||60
289456|NCT00236977|707671|P2|NOT COMPLETED|Overall Study||19
289457|NCT00236977|707672|P1|NOT COMPLETED|Overall Study||21
289458|NCT00236977|707671|P2|COMPLETED|Overall Study||72
289459|NCT00236977|707672|P1|COMPLETED|Overall Study||70
289460|NCT00236977|707671|P2|STARTED|Overall Study||91
289461|NCT00236977|707672|P1|STARTED|Overall Study||91
289462|NCT00236951|707694|P4|NOT COMPLETED|Overall Study||31
289463|NCT00236951|707695|P3|NOT COMPLETED|Overall Study||19
289464|NCT00236951|707696|P2|NOT COMPLETED|Overall Study||31
289465|NCT00236951|707697|P1|NOT COMPLETED|Overall Study||26
289466|NCT00236951|707694|P4|COMPLETED|Overall Study||17
289467|NCT00236951|707695|P3|COMPLETED|Overall Study||21
289468|NCT00236951|707696|P2|COMPLETED|Overall Study||46
289469|NCT00236951|707697|P1|COMPLETED|Overall Study||33
289470|NCT00236951|707694|P4|STARTED|Overall Study||48
289471|NCT00236951|707695|P3|STARTED|Overall Study||40
289472|NCT00236951|707696|P2|STARTED|Overall Study||77
289473|NCT00236951|707697|P1|STARTED|Overall Study||59
289474|NCT00236938|707709|P2|NOT COMPLETED|Overall Study||20
289475|NCT00236938|707710|P1|NOT COMPLETED|Overall Study||13
289476|NCT00236938|707709|P2|COMPLETED|Overall Study||26
289477|NCT00236938|707710|P1|COMPLETED|Overall Study||62
289478|NCT00236938|707709|P2|STARTED|Overall Study||46
289479|NCT00236938|707710|P1|STARTED|Overall Study||75
289480|NCT00236899|707726|P4|NOT COMPLETED|Overall Study||40
289481|NCT00236899|707727|P3|NOT COMPLETED|Overall Study||44
289482|NCT00236899|707728|P2|NOT COMPLETED|Overall Study||40
289483|NCT00236899|707729|P1|NOT COMPLETED|Overall Study||42
289484|NCT00236899|707726|P4|COMPLETED|Overall Study||19
289485|NCT00236899|707727|P3|COMPLETED|Overall Study||14
289486|NCT00236899|707728|P2|COMPLETED|Overall Study||24
289487|NCT00236899|707729|P1|COMPLETED|Overall Study||18
289488|NCT00236899|707726|P4|STARTED|Overall Study||59
289489|NCT00236899|707727|P3|STARTED|Overall Study||58
289490|NCT00236899|707728|P2|STARTED|Overall Study||64
289491|NCT00236899|707729|P1|STARTED|Overall Study||60
289492|NCT00236197|707761|P2|NOT COMPLETED|Overall Study||14
289493|NCT00236197|707762|P1|NOT COMPLETED|Overall Study||5
289494|NCT00236197|707761|P2|COMPLETED|Overall Study||293
289495|NCT00236197|707762|P1|COMPLETED|Overall Study||307
289496|NCT00236197|707761|P2|STARTED|Overall Study||307
289497|NCT00236197|707762|P1|STARTED|Overall Study||312
289498|NCT00236184|707770|P2|NOT COMPLETED|Overall Study||11
289499|NCT00236184|707771|P1|NOT COMPLETED|Overall Study||18
289500|NCT00236184|707770|P2|COMPLETED|Overall Study||308
289501|NCT00236184|707771|P1|COMPLETED|Overall Study||292
289502|NCT00236184|707770|P2|STARTED|Overall Study||319
289503|NCT00236184|707771|P1|STARTED|Overall Study||310
289504|NCT00236080|707782|P5|NOT COMPLETED|Overall Study||1
289505|NCT00236080|707783|P4|NOT COMPLETED|Overall Study||2
289506|NCT00236080|707784|P3|NOT COMPLETED|Overall Study||5
289507|NCT00236080|707785|P2|NOT COMPLETED|Overall Study||1
289508|NCT00236080|707786|P1|NOT COMPLETED|Overall Study||2
289509|NCT00236080|707782|P5|COMPLETED|Overall Study||26
289510|NCT00236080|707783|P4|COMPLETED|Overall Study||23
289511|NCT00236080|707784|P3|COMPLETED|Overall Study||22
289512|NCT00236080|707785|P2|COMPLETED|Overall Study||27
289513|NCT00236080|707786|P1|COMPLETED|Overall Study||27
289514|NCT00236080|707782|P5|STARTED|Overall Study||27
289515|NCT00236080|707783|P4|STARTED|Overall Study||25
289516|NCT00236080|707784|P3|STARTED|Overall Study||27
289517|NCT00236080|707785|P2|STARTED|Overall Study||28
289518|NCT00236080|707786|P1|STARTED|Overall Study||29
289519|NCT00235989|707807|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
289520|NCT00235989|707808|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
289521|NCT00235989|707809|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
289522|NCT00235989|707810|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
289523|NCT00235989|707811|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
289524|NCT00235989|707812|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
289525|NCT00235989|707807|P6|COMPLETED|Extension Treatment Period (ET)||0
289526|NCT00235989|707808|P5|COMPLETED|Extension Treatment Period (ET)||0
289527|NCT00235989|707809|P4|COMPLETED|Extension Treatment Period (ET)||14
289528|NCT00235989|707810|P3|COMPLETED|Extension Treatment Period (ET)||14
289529|NCT00235989|707811|P2|COMPLETED|Extension Treatment Period (ET)||2
289530|NCT00235989|707812|P1|COMPLETED|Extension Treatment Period (ET)||8
289531|NCT00235989|707807|P6|STARTED|Extension Treatment Period (ET)||0
289532|NCT00235989|707808|P5|STARTED|Extension Treatment Period (ET)||0
289533|NCT00235989|707809|P4|STARTED|Extension Treatment Period (ET)||20
289534|NCT00235989|707810|P3|STARTED|Extension Treatment Period (ET)||19
289535|NCT00235989|707811|P2|STARTED|Extension Treatment Period (ET)||6
289536|NCT00235989|707812|P1|STARTED|Extension Treatment Period (ET)||16
289537|NCT00235989|707807|P6|NOT COMPLETED|Core Treatment Period (CT)||2
289538|NCT00235989|707808|P5|NOT COMPLETED|Core Treatment Period (CT)||0
289539|NCT00235989|707809|P4|NOT COMPLETED|Core Treatment Period (CT)||0
289540|NCT00235989|707810|P3|NOT COMPLETED|Core Treatment Period (CT)||0
289541|NCT00235989|707811|P2|NOT COMPLETED|Core Treatment Period (CT)||0
289542|NCT00235989|707812|P1|NOT COMPLETED|Core Treatment Period (CT)||0
289543|NCT00235989|707807|P6|COMPLETED|Core Treatment Period (CT)||25
289544|NCT00235989|707808|P5|COMPLETED|Core Treatment Period (CT)||36
289545|NCT00235989|707809|P4|COMPLETED|Core Treatment Period (CT)||0
289546|NCT00235989|707810|P3|COMPLETED|Core Treatment Period (CT)||0
289547|NCT00235989|707811|P2|COMPLETED|Core Treatment Period (CT)||0
289548|NCT00235989|707812|P1|COMPLETED|Core Treatment Period (CT)||0
289549|NCT00235989|707807|P6|STARTED|Core Treatment Period (CT)||27
289550|NCT00235989|707808|P5|STARTED|Core Treatment Period (CT)||36
289551|NCT00235989|707809|P4|STARTED|Core Treatment Period (CT)||0
289552|NCT00235989|707810|P3|STARTED|Core Treatment Period (CT)||0
289553|NCT00235989|707811|P2|STARTED|Core Treatment Period (CT)||0
289554|NCT00235989|707812|P1|STARTED|Core Treatment Period (CT)||0
289555|NCT00235872|707826|P1|NOT COMPLETED|Overall Study||147
289556|NCT00235872|707826|P1|COMPLETED|Overall Study||162
289557|NCT00235872|707826|P1|STARTED|Overall Study||309
289558|NCT00235833|707841|P1|NOT COMPLETED|Overall Study||16
289559|NCT00235833|707841|P1|COMPLETED|Overall Study||9
289560|NCT00235833|707841|P1|STARTED|Overall Study||25
289561|NCT00235755|707857|P3|NOT COMPLETED|12-Week Maintenance Phase||31
289562|NCT00235755|707858|P2|NOT COMPLETED|12-Week Maintenance Phase||27
289563|NCT00235755|707859|P1|NOT COMPLETED|12-Week Maintenance Phase||16
289564|NCT00235755|707857|P3|COMPLETED|12-Week Maintenance Phase||122
289565|NCT00235755|707858|P2|COMPLETED|12-Week Maintenance Phase||135
289566|NCT00235755|707859|P1|COMPLETED|12-Week Maintenance Phase||152
289567|NCT00235755|707857|P3|STARTED|12-Week Maintenance Phase||153
289568|NCT00235755|707858|P2|STARTED|12-Week Maintenance Phase||162
289569|NCT00235755|707859|P1|STARTED|12-Week Maintenance Phase||168
289570|NCT00235755|707857|P3|NOT COMPLETED|4-Week Titration Phase||26
289571|NCT00235755|707858|P2|NOT COMPLETED|4-Week Titration Phase||19
289572|NCT00235755|707859|P1|NOT COMPLETED|4-Week Titration Phase||11
289573|NCT00235755|707857|P3|COMPLETED|4-Week Titration Phase||153
289574|NCT00235755|707858|P2|COMPLETED|4-Week Titration Phase||162
289575|NCT00235755|707859|P1|COMPLETED|4-Week Titration Phase||168
289576|NCT00235755|707857|P3|STARTED|4-Week Titration Phase||179
289577|NCT00235755|707858|P2|STARTED|4-Week Titration Phase||181
289578|NCT00235755|707859|P1|STARTED|4-Week Titration Phase||179
289579|NCT00235716|707937|P4|NOT COMPLETED|Overall Study||62
289580|NCT00235716|707938|P3|NOT COMPLETED|Overall Study||65
289581|NCT00235716|707939|P2|NOT COMPLETED|Overall Study||67
289582|NCT00235716|707940|P1|NOT COMPLETED|Overall Study||62
289583|NCT00235716|707937|P4|COMPLETED|Overall Study||90
289584|NCT00235716|707938|P3|COMPLETED|Overall Study||89
289585|NCT00235716|707939|P2|COMPLETED|Overall Study||88
289586|NCT00235716|707940|P1|COMPLETED|Overall Study||90
289587|NCT00235716|707937|P4|STARTED|Overall Study||152
289588|NCT00235716|707938|P3|STARTED|Overall Study||154
289589|NCT00235716|707939|P2|STARTED|Overall Study||155
289590|NCT00235716|707940|P1|STARTED|Overall Study||152
289591|NCT00235573|707974|P1|NOT COMPLETED|Overall Study||0
289592|NCT00235573|707974|P1|COMPLETED|Overall Study||21
289593|NCT00235573|707974|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
289594|NCT00235456|707980|P2|NOT COMPLETED|Overall Study||7
289595|NCT00235456|707981|P1|NOT COMPLETED|Overall Study||2
289596|NCT00235456|707980|P2|COMPLETED|Overall Study||143
289597|NCT00235456|707981|P1|COMPLETED|Overall Study||148
289598|NCT00235456|707980|P2|STARTED|Overall Study||150
289599|NCT00235456|707981|P1|STARTED|Overall Study||150
289600|NCT00235443|708003|P6|NOT COMPLETED|Overall Study||45
289601|NCT00235443|708004|P5|NOT COMPLETED|Overall Study||30
289602|NCT00235443|708005|P4|NOT COMPLETED|Overall Study||97
289603|NCT00235443|708006|P3|NOT COMPLETED|Overall Study||62
289604|NCT00235443|708007|P2|NOT COMPLETED|Overall Study||38
289605|NCT00235443|708008|P1|NOT COMPLETED|Overall Study||8
289606|NCT00235443|708003|P6|COMPLETED|Overall Study||9
289607|NCT00235443|708004|P5|COMPLETED|Overall Study||9
289608|NCT00235443|708005|P4|COMPLETED|Overall Study||108
289609|NCT00235443|708006|P3|COMPLETED|Overall Study||23
289610|NCT00235443|708007|P2|COMPLETED|Overall Study||19
289611|NCT00235443|708008|P1|COMPLETED|Overall Study||3
289612|NCT00235443|708003|P6|STARTED|Overall Study||54
289613|NCT00235443|708004|P5|STARTED|Overall Study||39
289614|NCT00235443|708005|P4|STARTED|Overall Study||205
289615|NCT00235443|708006|P3|STARTED|Overall Study||85
289616|NCT00235443|708007|P2|STARTED|Overall Study||57
289617|NCT00235443|708008|P1|STARTED|Overall Study||11
289618|NCT00235391|708149|P6|NOT COMPLETED|Overall Study||4
289619|NCT00235391|708150|P5|NOT COMPLETED|Overall Study||12
289620|NCT00235391|708151|P4|NOT COMPLETED|Overall Study||220
289621|NCT00235391|708152|P3|NOT COMPLETED|Overall Study||24
289622|NCT00235391|708153|P2|NOT COMPLETED|Overall Study||18
289623|NCT00235391|708154|P1|NOT COMPLETED|Overall Study||12
289624|NCT00235391|708149|P6|COMPLETED|Overall Study||3
289625|NCT00235391|708150|P5|COMPLETED|Overall Study||31
289626|NCT00235391|708151|P4|COMPLETED|Overall Study||944
289627|NCT00235391|708152|P3|COMPLETED|Overall Study||148
289628|NCT00235391|708153|P2|COMPLETED|Overall Study||182
289629|NCT00235391|708154|P1|COMPLETED|Overall Study||85
289630|NCT00235391|708149|P6|Deferasirox Treatment|Overall Study||7
289631|NCT00235391|708150|P5|Deferasirox Treatment|Overall Study||43
289632|NCT00235391|708151|P4|Deferasirox Treatment|Overall Study||1164
289633|NCT00235391|708152|P3|Deferasirox Treatment|Overall Study||172
289634|NCT00235391|708153|P2|Deferasirox Treatment|Overall Study||200
289635|NCT00235391|708154|P1|Deferasirox Treatment|Overall Study||97
289636|NCT00235391|708149|P6|STARTED|Overall Study||7
289637|NCT00235391|708150|P5|STARTED|Overall Study||43
289638|NCT00235391|708151|P4|STARTED|Overall Study||1164
289639|NCT00235391|708152|P3|STARTED|Overall Study||172
289640|NCT00235391|708153|P2|STARTED|Overall Study||200
289641|NCT00235391|708154|P1|STARTED|Overall Study||97
289642|NCT00235326|708171|P2|NOT COMPLETED|Overall Study||1400
289643|NCT00235326|708172|P1|NOT COMPLETED|Overall Study||746
289644|NCT00235326|708171|P2|COMPLETED|Overall Study||1586
289645|NCT00235326|708172|P1|COMPLETED|Overall Study||829
289646|NCT00235326|708171|P2|STARTED|Overall Study||2986
289647|NCT00235326|708172|P1|STARTED|Overall Study||1575
289648|NCT00234884|708176|P1|NOT COMPLETED|Overall Study||1630
289649|NCT00234884|708176|P1|COMPLETED|Overall Study||1805
289650|NCT00234884|708176|P1|STARTED|Overall Study||3435
289651|NCT00234832|708186|P2|NOT COMPLETED|Overall Study||996
289652|NCT00234832|708187|P1|NOT COMPLETED|Overall Study||1016
289653|NCT00234832|708186|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
289654|NCT00234832|708187|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
289655|NCT00234832|708186|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
289656|NCT00234832|708187|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
289657|NCT00234494|708212|P1|NOT COMPLETED|Overall Study||2
289658|NCT00234494|708212|P1|COMPLETED|Overall Study||43
289659|NCT00234494|708212|P1|STARTED|Overall Study||45
289660|NCT00234286|708219|P1|NOT COMPLETED|Overall Study||0
289661|NCT00234286|708219|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
289662|NCT00234286|708219|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
289663|NCT00234104|708258|P4|NOT COMPLETED|Overall Study||8
289664|NCT00234104|708259|P3|NOT COMPLETED|Overall Study||5
289665|NCT00234104|708260|P2|NOT COMPLETED|Overall Study||1
289666|NCT00234104|708261|P1|NOT COMPLETED|Overall Study||4
289667|NCT00234104|708258|P4|COMPLETED|Overall Study||21
289668|NCT00234104|708259|P3|COMPLETED|Overall Study||29
289669|NCT00234104|708260|P2|COMPLETED|Overall Study||28
289670|NCT00234104|708261|P1|COMPLETED|Overall Study||26
289671|NCT00234104|708258|P4|STARTED|Overall Study||29
289672|NCT00234104|708259|P3|STARTED|Overall Study||34
289673|NCT00234104|708260|P2|STARTED|Overall Study||29
289674|NCT00234104|708261|P1|STARTED|Overall Study||30
289675|NCT00234078|708275|P4|NOT COMPLETED|Overall Study||4
289676|NCT00234078|708276|P3|NOT COMPLETED|Overall Study||10
289677|NCT00234078|708277|P2|NOT COMPLETED|Overall Study||9
289678|NCT00234078|708278|P1|NOT COMPLETED|Overall Study||6
289679|NCT00234078|708275|P4|COMPLETED|Overall Study||68
289680|NCT00234078|708276|P3|COMPLETED|Overall Study||64
289681|NCT00234078|708277|P2|COMPLETED|Overall Study||63
289682|NCT00234078|708278|P1|COMPLETED|Overall Study||66
289683|NCT00234078|708275|P4|STARTED|Overall Study||72
289684|NCT00234078|708276|P3|STARTED|Overall Study||74
289685|NCT00234078|708277|P2|STARTED|Overall Study||72
289686|NCT00234078|708278|P1|STARTED|Overall Study||72
289687|NCT00234065|708302|P2|NOT COMPLETED|Overall Study||356
289688|NCT00234065|708303|P1|NOT COMPLETED|Overall Study||475
289689|NCT00234065|708302|P2|COMPLETED|Overall Study||1004
289690|NCT00234065|708303|P1|COMPLETED|Overall Study||881
289691|NCT00234065|708302|P2|STARTED|Overall Study||1360
289692|NCT00234065|708303|P1|STARTED|Overall Study||1356
289693|NCT00234039|708319|P1|NOT COMPLETED|Overall Study||50
289694|NCT00234039|708319|P1|COMPLETED|Overall Study||8
289695|NCT00234039|708319|P1|Eligible and Began Protocol Therapy|Overall Study||47
289696|NCT00234039|708319|P1|Eligible|Overall Study||49
289697|NCT00234039|708319|P1|STARTED|Overall Study||58
289698|NCT00233987|708326|P1|NOT COMPLETED|Overall Study||15
289699|NCT00233987|708326|P1|COMPLETED|Overall Study||83
289700|NCT00233987|708326|P1|Eligible and Treated|Overall Study||92
289701|NCT00233987|708326|P1|Eligible|Overall Study||94
289702|NCT00233987|708326|P1|STARTED|Overall Study||98
289703|NCT00233948|708335|P6|NOT COMPLETED|Overall Study||0
289704|NCT00233948|708336|P5|NOT COMPLETED|Overall Study||0
289705|NCT00233948|708337|P4|NOT COMPLETED|Overall Study||0
289706|NCT00233948|708338|P3|NOT COMPLETED|Overall Study||0
289707|NCT00233948|708339|P2|NOT COMPLETED|Overall Study||0
289708|NCT00233948|708340|P1|NOT COMPLETED|Overall Study||1
289709|NCT00233948|708335|P6|COMPLETED|Overall Study||12
289710|NCT00233948|708336|P5|COMPLETED|Overall Study||4
289711|NCT00233948|708337|P4|COMPLETED|Overall Study||3
289712|NCT00233948|708338|P3|COMPLETED|Overall Study||3
289713|NCT00233948|708339|P2|COMPLETED|Overall Study||3
289714|NCT00233948|708340|P1|COMPLETED|Overall Study||3
289715|NCT00233948|708335|P6|STARTED|Overall Study||12
289716|NCT00233948|708336|P5|STARTED|Overall Study||4
289717|NCT00233948|708337|P4|STARTED|Overall Study||3
289718|NCT00233948|708338|P3|STARTED|Overall Study||3
289719|NCT00233948|708339|P2|STARTED|Overall Study||3
289720|NCT00233948|708340|P1|STARTED|Overall Study||4
289721|NCT00233519|708357|P2|NOT COMPLETED|Overall Study||1
289722|NCT00233519|708358|P1|NOT COMPLETED|Overall Study||1
289723|NCT00233519|708357|P2|COMPLETED|Overall Study||9
289724|NCT00233519|708358|P1|COMPLETED|Overall Study||6
289725|NCT00233519|708357|P2|STARTED|Overall Study||10
289726|NCT00233519|708358|P1|STARTED|Overall Study||7
289727|NCT00233454|708364|P1|NOT COMPLETED|Overall Study||6
289728|NCT00233454|708364|P1|COMPLETED|Overall Study||20
289729|NCT00233454|708364|P1|2 Months (for Response Rate)|Overall Study||26
289730|NCT00233454|708364|P1|STARTED|Overall Study||26
289731|NCT00233402|708371|P2|NOT COMPLETED|Overall Study||124
289732|NCT00233402|708372|P1|NOT COMPLETED|Overall Study||104
289733|NCT00233402|708371|P2|COMPLETED|Overall Study||271
289734|NCT00233402|708372|P1|COMPLETED|Overall Study||280
289735|NCT00233402|708371|P2|STARTED|Overall Study||395
289736|NCT00233402|708372|P1|STARTED|Overall Study||384
289737|NCT00233324|708387|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
289738|NCT00233324|708388|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
289739|NCT00233324|708389|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
289740|NCT00233324|708390|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
289741|NCT00233324|708387|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
289742|NCT00233324|708388|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
289743|NCT00233324|708389|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
289744|NCT00233324|708390|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
289745|NCT00233324|708387|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
289746|NCT00233324|708388|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
289747|NCT00233324|708389|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
289748|NCT00233324|708390|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
289749|NCT00233324|708387|P4|NOT COMPLETED|Main Study||47
289750|NCT00233324|708388|P3|NOT COMPLETED|Main Study||62
289751|NCT00233324|708389|P2|NOT COMPLETED|Main Study||60
289752|NCT00233324|708390|P1|NOT COMPLETED|Main Study||68
289753|NCT00233324|708387|P4|COMPLETED|Main Study||280
289754|NCT00233324|708388|P3|COMPLETED|Main Study||274
289755|NCT00233324|708389|P2|COMPLETED|Main Study||275
289756|NCT00233324|708390|P1|COMPLETED|Main Study||250
289757|NCT00233324|708387|P4|STARTED|Main Study||327
289758|NCT00233324|708388|P3|STARTED|Main Study||336
289759|NCT00233324|708389|P2|STARTED|Main Study||335
289760|NCT00233324|708390|P1|STARTED|Main Study||318
289761|NCT00233103|708406|P2|NOT COMPLETED|Overall Study||6
289762|NCT00233103|708407|P1|NOT COMPLETED|Overall Study||5
289763|NCT00233103|708406|P2|COMPLETED|Overall Study||19
289764|NCT00233103|708407|P1|COMPLETED|Overall Study||22
289765|NCT00233103|708406|P2|STARTED|Overall Study||25
289766|NCT00233103|708407|P1|STARTED|Overall Study||27
289767|NCT00233090|708421|P2|NOT COMPLETED|Overall Study||0
289768|NCT00233090|708422|P1|NOT COMPLETED|Overall Study||0
289769|NCT00233090|708421|P2|COMPLETED|Overall Study||9
289770|NCT00233090|708422|P1|COMPLETED|Overall Study||12
289771|NCT00233090|708421|P2|STARTED|Overall Study||9
289772|NCT00233090|708422|P1|STARTED|Overall Study||12
289773|NCT00233064|708444|P2|NOT COMPLETED|Overall Study||12
289774|NCT00233064|708445|P1|NOT COMPLETED|Overall Study||14
289775|NCT00233064|708444|P2|COMPLETED|Overall Study||190
289776|NCT00233064|708445|P1|COMPLETED|Overall Study||197
289777|NCT00233064|708444|P2|STARTED|Overall Study||202
289778|NCT00233064|708445|P1|STARTED|Overall Study||211
289779|NCT00232739|708452|P1|NOT COMPLETED|Overall Study||9
289780|NCT00232739|708452|P1|COMPLETED|Overall Study||91
289781|NCT00232739|708452|P1|STARTED|Overall Study||100
289782|NCT00232596|708471|P2|NOT COMPLETED|12-Week Maintenance Phase||28
289783|NCT00232596|708472|P1|NOT COMPLETED|12-Week Maintenance Phase||12
289784|NCT00232596|708471|P2|COMPLETED|12-Week Maintenance Phase||97
289785|NCT00232596|708472|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
289786|NCT00232596|708471|P2|STARTED|12-Week Maintenance Phase||125
289787|NCT00232596|708472|P1|STARTED|12-Week Maintenance Phase||138
289788|NCT00232596|708471|P2|NOT COMPLETED|6-Week Titration Phase||29
289789|NCT00232596|708472|P1|NOT COMPLETED|6-Week Titration Phase||14
289790|NCT00232596|708471|P2|COMPLETED|6-Week Titration Phase||125
289791|NCT00232596|708472|P1|COMPLETED|6-Week Titration Phase||138
289792|NCT00232596|708471|P2|STARTED|6-Week Titration Phase||154
289793|NCT00232596|708472|P1|STARTED|6-Week Titration Phase||152
289794|NCT00232583|708524|P2|NOT COMPLETED|Overall Study||13
289795|NCT00232583|708525|P1|NOT COMPLETED|Overall Study||10
289796|NCT00232583|708524|P2|COMPLETED|Overall Study||16
289797|NCT00232583|708525|P1|COMPLETED|Overall Study||19
289798|NCT00232583|708524|P2|STARTED|Overall Study||29
289799|NCT00232583|708525|P1|STARTED|Overall Study||29
289800|NCT00232557|708563|P2|NOT COMPLETED|Overall Study||5
289801|NCT00232557|708564|P1|NOT COMPLETED|Overall Study||3
289802|NCT00232557|708563|P2|COMPLETED|Overall Study||60
289803|NCT00232557|708564|P1|COMPLETED|Overall Study||68
289804|NCT00232557|708563|P2|STARTED|Overall Study||65
289805|NCT00232557|708564|P1|STARTED|Overall Study||71
289806|NCT00232544|708574|P2|NOT COMPLETED|Overall Study||15
289807|NCT00232544|708575|P1|NOT COMPLETED|Overall Study||20
289808|NCT00232544|708574|P2|COMPLETED|Overall Study||111
289809|NCT00232544|708575|P1|COMPLETED|Overall Study||104
289810|NCT00232544|708574|P2|STARTED|Overall Study||126
289811|NCT00232544|708575|P1|STARTED|Overall Study||124
289812|NCT00232505|708585|P2|NOT COMPLETED|Overall Study||11
289813|NCT00232505|708586|P1|NOT COMPLETED|Overall Study||5
289814|NCT00232505|708585|P2|COMPLETED|Overall Study||60
289815|NCT00232505|708586|P1|COMPLETED|Overall Study||26
289816|NCT00232505|708585|P2|Off Protocol|Overall Study||0
289817|NCT00232505|708586|P1|Off Protocol|Overall Study||5
289818|NCT00232505|708585|P2|Early Progressors|Overall Study||5
289819|NCT00232505|708586|P1|Early Progressors|Overall Study||2
289820|NCT00232505|708585|P2|Not Evaluable|Overall Study||6
289821|NCT00232505|708586|P1|Not Evaluable|Overall Study||0
289822|NCT00232505|708585|P2|STARTED|Overall Study||71
289823|NCT00232505|708586|P1|STARTED|Overall Study||31
289824|NCT00232479|708599|P1|NOT COMPLETED|Overall Study||0
289825|NCT00232479|708599|P1|COMPLETED|Overall Study||44
289826|NCT00232479|708599|P1|STARTED|Overall Study||44
289827|NCT00232180|708606|P3|NOT COMPLETED|Open Label Phase||148
289828|NCT00232180|708607|P2|NOT COMPLETED|Open Label Phase||0
289829|NCT00232180|708608|P1|NOT COMPLETED|Open Label Phase||0
289830|NCT00232180|708606|P3|COMPLETED|Open Label Phase||1098
289831|NCT00232180|708607|P2|COMPLETED|Open Label Phase||0
289832|NCT00232180|708608|P1|COMPLETED|Open Label Phase||0
289833|NCT00232180|708606|P3|Treated|Open Label Phase||1245
289834|NCT00232180|708607|P2|Treated|Open Label Phase||0
289835|NCT00232180|708608|P1|Treated|Open Label Phase||0
289836|NCT00232180|708606|P3|STARTED|Open Label Phase||1246
289837|NCT00232180|708607|P2|STARTED|Open Label Phase||0
289838|NCT00232180|708608|P1|STARTED|Open Label Phase||0
289839|NCT00232180|708606|P3|NOT COMPLETED|Double-blind (DB) Phase||0
289840|NCT00232180|708607|P2|NOT COMPLETED|Double-blind (DB) Phase||605
289841|NCT00232180|708608|P1|NOT COMPLETED|Double-blind (DB) Phase||541
289842|NCT00232180|708606|P3|COMPLETED|Double-blind (DB) Phase||0
289843|NCT00232180|708607|P2|COMPLETED|Double-blind (DB) Phase||771
289844|NCT00232180|708608|P1|COMPLETED|Double-blind (DB) Phase||826
289845|NCT00232180|708606|P3|Treated|Double-blind (DB) Phase||0
289846|NCT00232180|708607|P2|Treated|Double-blind (DB) Phase||1372
289847|NCT00232180|708608|P1|Treated|Double-blind (DB) Phase||1364
289848|NCT00232180|708606|P3|STARTED|Double-blind (DB) Phase||0
289849|NCT00232180|708607|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
289850|NCT00232180|708608|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
289851|NCT00232141|708653|P2|NOT COMPLETED|Overall Study||26
289852|NCT00232141|708654|P1|NOT COMPLETED|Overall Study||31
289853|NCT00232141|708653|P2|COMPLETED|Overall Study||125
289854|NCT00232141|708654|P1|COMPLETED|Overall Study||120
289855|NCT00232141|708653|P2|STARTED|Overall Study||151
289856|NCT00232141|708654|P1|STARTED|Overall Study||151
289857|NCT00231894|708724|P2|NOT COMPLETED|Overall Study||1
289858|NCT00231894|708725|P1|NOT COMPLETED|Overall Study||1
289859|NCT00231894|708724|P2|COMPLETED|Overall Study||24
289860|NCT00231894|708725|P1|COMPLETED|Overall Study||30
289861|NCT00231894|708724|P2|STARTED|Overall Study||25
289862|NCT00231894|708725|P1|STARTED|Overall Study||31
289863|NCT00231816|708749|P2|NOT COMPLETED|Overall Study||12
289864|NCT00231816|708750|P1|NOT COMPLETED|Overall Study||16
289865|NCT00231816|708749|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
289866|NCT00231816|708750|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
289867|NCT00231816|708749|P2|Vaccinated at Visit 2|Overall Study||371
289868|NCT00231816|708750|P1|Vaccinated at Visit 2|Overall Study||369
289869|NCT00231816|708749|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
289870|NCT00231816|708750|P1|Vaccinated at Visit 1|Overall Study||382
289871|NCT00231816|708749|P2|STARTED|Overall Study||381
289872|NCT00231816|708750|P1|STARTED|Overall Study||382
289873|NCT00231777|708765|P2|NOT COMPLETED|Overall Study||2
289874|NCT00231777|708766|P1|NOT COMPLETED|Overall Study||6
289875|NCT00231777|708765|P2|COMPLETED|Overall Study||44
289876|NCT00231777|708766|P1|COMPLETED|Overall Study||164
289877|NCT00231777|708765|P2|STARTED|Overall Study||46
289878|NCT00231777|708766|P1|STARTED|Overall Study||170
289879|NCT00231478|708780|P2|NOT COMPLETED|Overall Study||6
289880|NCT00231478|708781|P1|NOT COMPLETED|Overall Study||8
289881|NCT00231478|708780|P2|COMPLETED|Overall Study||78
289882|NCT00231478|708781|P1|COMPLETED|Overall Study||79
289883|NCT00231478|708780|P2|STARTED|Overall Study||84
289884|NCT00231478|708781|P1|STARTED|Overall Study||87
289885|NCT00231465|708793|P1|NOT COMPLETED|Overall Study||2
289886|NCT00231465|708793|P1|COMPLETED|Overall Study||42
289887|NCT00231465|708793|P1|STARTED|Overall Study||44
289888|NCT00231309|708799|P1|NOT COMPLETED|Overall Study||0
289889|NCT00231309|708799|P1|COMPLETED|Overall Study||10
289890|NCT00231309|708799|P1|STARTED|Overall Study||10
289891|NCT00231283|708804|P1|NOT COMPLETED|Overall Study||5
289892|NCT00231283|708804|P1|COMPLETED|Overall Study||95
289893|NCT00231283|708804|P1|STARTED|Overall Study||100
289894|NCT00231179|708813|P2|NOT COMPLETED|Overall Study||24
289895|NCT00231179|708814|P1|NOT COMPLETED|Overall Study||24
289896|NCT00231179|708813|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
289897|NCT00231179|708814|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
289898|NCT00231179|708813|P2|STARTED|Overall Study||150
289899|NCT00231179|708814|P1|STARTED|Overall Study||152
289900|NCT00231153|708830|P2|NOT COMPLETED|Overall Study||188
289901|NCT00231153|708831|P1|NOT COMPLETED|Overall Study||217
289902|NCT00231153|708830|P2|COMPLETED|Overall Study||720
289903|NCT00231153|708831|P1|COMPLETED|Overall Study||690
289904|NCT00231153|708830|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
289905|NCT00231153|708831|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
289906|NCT00231114|708841|P2|NOT COMPLETED|Post-Treatment Period||1
289907|NCT00231114|708842|P1|NOT COMPLETED|Post-Treatment Period||8
289908|NCT00231114|708841|P2|COMPLETED|Post-Treatment Period||97
289909|NCT00231114|708842|P1|COMPLETED|Post-Treatment Period||181
289910|NCT00231114|708841|P2|STARTED|Post-Treatment Period||98
289911|NCT00231114|708842|P1|STARTED|Post-Treatment Period||189
289912|NCT00231114|708841|P2|NOT COMPLETED|Treatment Period||0
289913|NCT00231114|708842|P1|NOT COMPLETED|Treatment Period||1
289914|NCT00231114|708841|P2|COMPLETED|Treatment Period||98
289915|NCT00231114|708842|P1|COMPLETED|Treatment Period||189
289916|NCT00231114|708841|P2|STARTED|Treatment Period||98
289917|NCT00231114|708842|P1|STARTED|Treatment Period||190
289918|NCT00231114|708841|P2|NOT COMPLETED|Randomized||3
289919|NCT00231114|708842|P1|NOT COMPLETED|Randomized||6
289920|NCT00231114|708841|P2|COMPLETED|Randomized||98
289921|NCT00231114|708842|P1|COMPLETED|Randomized||190
289922|NCT00231114|708841|P2|STARTED|Randomized||101
289923|NCT00231114|708842|P1|STARTED|Randomized||196
289924|NCT00231062|708878|P1|NOT COMPLETED|Overall Study||6
289925|NCT00231062|708878|P1|COMPLETED|Overall Study||109
289926|NCT00231062|708878|P1|STARTED|Overall Study||115
289927|NCT00230971|708886|P2|NOT COMPLETED|Baseline Participants||19
289928|NCT00230971|708887|P1|NOT COMPLETED|Baseline Participants||22
289929|NCT00230971|708886|P2|COMPLETED|Baseline Participants||216
289930|NCT00230971|708887|P1|COMPLETED|Baseline Participants||210
289931|NCT00230971|708886|P2|STARTED|Baseline Participants||235
289932|NCT00230971|708887|P1|STARTED|Baseline Participants||232
289933|NCT00230971|708886|P2|NOT COMPLETED|Randomization||3
289934|NCT00230971|708887|P1|NOT COMPLETED|Randomization||3
289935|NCT00230971|708886|P2|COMPLETED|Randomization||235
289936|NCT00230971|708887|P1|COMPLETED|Randomization||232
289937|NCT00230971|708886|P2|STARTED|Randomization||238
289938|NCT00230971|708887|P1|STARTED|Randomization||235
289939|NCT00230802|708901|P2|NOT COMPLETED|Overall Study||0
289940|NCT00230802|708902|P1|NOT COMPLETED|Overall Study||0
289941|NCT00230802|708901|P2|COMPLETED|Overall Study||23
289942|NCT00230802|708902|P1|COMPLETED|Overall Study||25
289943|NCT00230802|708901|P2|STARTED|Overall Study||23
289944|NCT00230802|708902|P1|STARTED|Overall Study||25
289945|NCT00230737|708915|P3|NOT COMPLETED|Overall Study||0
289946|NCT00230737|708916|P2|NOT COMPLETED|Overall Study||0
289947|NCT00230737|708917|P1|NOT COMPLETED|Overall Study||0
289948|NCT00230737|708915|P3|COMPLETED|Overall Study||8
289949|NCT00230737|708916|P2|COMPLETED|Overall Study||10
289950|NCT00230737|708917|P1|COMPLETED|Overall Study||9
289951|NCT00230737|708915|P3|STARTED|Overall Study||8
289952|NCT00230737|708916|P2|STARTED|Overall Study||10
289953|NCT00230737|708917|P1|STARTED|Overall Study||9
289954|NCT00230282|708925|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
289955|NCT00230282|708925|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
289956|NCT00230282|708925|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
289957|NCT00230282|708925|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
289958|NCT00230282|708925|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
289959|NCT00230282|708925|P1|STARTED|Fludarabine + Cyclophosphamide||25
289960|NCT00230178|708933|P3|NOT COMPLETED|Overall Study||7
289961|NCT00230178|708934|P2|NOT COMPLETED|Overall Study||7
289962|NCT00230178|708935|P1|NOT COMPLETED|Overall Study||4
289963|NCT00230178|708933|P3|COMPLETED|Overall Study||86
289964|NCT00230178|708934|P2|COMPLETED|Overall Study||86
289965|NCT00230178|708935|P1|COMPLETED|Overall Study||90
289966|NCT00230178|708933|P3|Treated|Overall Study||91
289967|NCT00230178|708934|P2|Treated|Overall Study||92
289968|NCT00230178|708935|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
289969|NCT00230178|708933|P3|STARTED|Overall Study||93
289970|NCT00230178|708934|P2|STARTED|Overall Study||93
289971|NCT00230178|708935|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
289972|NCT00230126|708951|P2|NOT COMPLETED|Overall Study||1
289973|NCT00230126|708952|P1|NOT COMPLETED|Overall Study||2
289974|NCT00230126|708951|P2|COMPLETED|Overall Study||27
289975|NCT00230126|708952|P1|COMPLETED|Overall Study||28
289976|NCT00230126|708951|P2|STARTED|Overall Study||28
289977|NCT00230126|708952|P1|STARTED|Overall Study||30
289978|NCT00230100|708964|P2|NOT COMPLETED|Overall Study||0
289979|NCT00230100|708965|P1|NOT COMPLETED|Overall Study||0
289980|NCT00230100|708964|P2|COMPLETED|Overall Study||17
289981|NCT00230100|708965|P1|COMPLETED|Overall Study||29
289982|NCT00230100|708964|P2|STARTED|Overall Study||17
289983|NCT00230100|708965|P1|STARTED|Overall Study||29
289984|NCT00230048|708987|P2|NOT COMPLETED|Overall Study||18
289985|NCT00230048|708988|P1|NOT COMPLETED|Overall Study||13
289986|NCT00230048|708987|P2|COMPLETED|Overall Study||37
289987|NCT00230048|708988|P1|COMPLETED|Overall Study||39
289988|NCT00230048|708987|P2|Completed Intervention/Control Session|Overall Study||55
289989|NCT00230048|708988|P1|Completed Intervention/Control Session|Overall Study||52
289990|NCT00230048|708987|P2|STARTED|Overall Study||55
289991|NCT00230048|708988|P1|STARTED|Overall Study||52
289992|NCT00230022|708998|P2|NOT COMPLETED|Overall Study||0
289993|NCT00230022|708999|P1|NOT COMPLETED|Overall Study||0
289994|NCT00230022|708998|P2|COMPLETED|Overall Study||15
289995|NCT00230022|708999|P1|COMPLETED|Overall Study||15
289996|NCT00230022|708998|P2|STARTED|Overall Study||15
289997|NCT00230022|708999|P1|STARTED|Overall Study||15
289998|NCT00230009|709007|P2|NOT COMPLETED|Follow-up||26
289999|NCT00230009|709008|P1|NOT COMPLETED|Follow-up||31
290000|NCT00230009|709007|P2|COMPLETED|Follow-up||24
290001|NCT00230009|709008|P1|COMPLETED|Follow-up||19
290002|NCT00230009|709007|P2|STARTED|Follow-up||50
290003|NCT00230009|709008|P1|STARTED|Follow-up||50
290004|NCT00230009|709007|P2|NOT COMPLETED|Single Session Intervention/Control||0
290005|NCT00230009|709008|P1|NOT COMPLETED|Single Session Intervention/Control||0
290006|NCT00230009|709007|P2|COMPLETED|Single Session Intervention/Control||50
290007|NCT00230009|709008|P1|COMPLETED|Single Session Intervention/Control||50
290008|NCT00230009|709007|P2|STARTED|Single Session Intervention/Control||50
290009|NCT00230009|709008|P1|STARTED|Single Session Intervention/Control||50
290010|NCT00229970|709025|P3|NOT COMPLETED|Overall Study||0
290011|NCT00229970|709026|P2|NOT COMPLETED|Overall Study||0
290012|NCT00229970|709027|P1|NOT COMPLETED|Overall Study||0
290013|NCT00229970|709025|P3|COMPLETED|Overall Study||75
290014|NCT00229970|709026|P2|COMPLETED|Overall Study||72
290015|NCT00229970|709027|P1|COMPLETED|Overall Study||78
290016|NCT00229970|709025|P3|STARTED|Overall Study||75
290017|NCT00229970|709026|P2|STARTED|Overall Study||72
290018|NCT00229970|709027|P1|STARTED|Overall Study||78
290019|NCT00229957|709037|P2|NOT COMPLETED|Overall Study||12
290020|NCT00229957|709038|P1|NOT COMPLETED|Overall Study||20
290021|NCT00229957|709037|P2|COMPLETED|Overall Study||139
290022|NCT00229957|709038|P1|COMPLETED|Overall Study||132
290023|NCT00229957|709037|P2|STARTED|Overall Study||151
290024|NCT00229957|709038|P1|STARTED|Overall Study||152
290025|NCT00229931|709046|P2|NOT COMPLETED|Overall Study||2
290026|NCT00229931|709047|P1|NOT COMPLETED|Overall Study||4
290027|NCT00229931|709046|P2|COMPLETED|Overall Study||3
290028|NCT00229931|709047|P1|COMPLETED|Overall Study||2
290029|NCT00229931|709046|P2|STARTED|Overall Study||5
290030|NCT00229931|709047|P1|STARTED|Overall Study||6
290031|NCT00229723|709062|P7|NOT COMPLETED|Maintenance Phase||10
290032|NCT00229723|709063|P6|NOT COMPLETED|Maintenance Phase||19
290033|NCT00229723|709064|P5|NOT COMPLETED|Maintenance Phase||15
290034|NCT00229723|709065|P4|NOT COMPLETED|Maintenance Phase||17
290035|NCT00229723|709066|P3|NOT COMPLETED|Maintenance Phase||9
290036|NCT00229723|709067|P2|NOT COMPLETED|Maintenance Phase||14
290037|NCT00229723|709068|P1|NOT COMPLETED|Maintenance Phase||25
290038|NCT00229723|709062|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
290039|NCT00229723|709063|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
290040|NCT00229723|709064|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
290041|NCT00229723|709065|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
290042|NCT00229723|709066|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
290043|NCT00229723|709067|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
290044|NCT00229723|709068|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
290045|NCT00229723|709062|P7|STARTED|Maintenance Phase||19
290046|NCT00229723|709063|P6|STARTED|Maintenance Phase||31
290047|NCT00229723|709064|P5|STARTED|Maintenance Phase||22
290048|NCT00229723|709065|P4|STARTED|Maintenance Phase||26
290049|NCT00229723|709066|P3|STARTED|Maintenance Phase||25
290050|NCT00229723|709067|P2|STARTED|Maintenance Phase||19
290051|NCT00229723|709068|P1|STARTED|Maintenance Phase||50
290052|NCT00229723|709062|P7|NOT COMPLETED|Concomitant Phase||3
290053|NCT00229723|709063|P6|NOT COMPLETED|Concomitant Phase||3
290054|NCT00229723|709064|P5|NOT COMPLETED|Concomitant Phase||2
290055|NCT00229723|709065|P4|NOT COMPLETED|Concomitant Phase||5
290056|NCT00229723|709066|P3|NOT COMPLETED|Concomitant Phase||6
290057|NCT00229723|709067|P2|NOT COMPLETED|Concomitant Phase||5
290058|NCT00229723|709068|P1|NOT COMPLETED|Concomitant Phase||10
290059|NCT00229723|709062|P7|COMPLETED|Concomitant Phase||19
290060|NCT00229723|709063|P6|COMPLETED|Concomitant Phase||31
290061|NCT00229723|709064|P5|COMPLETED|Concomitant Phase||22
290062|NCT00229723|709065|P4|COMPLETED|Concomitant Phase||26
290063|NCT00229723|709066|P3|COMPLETED|Concomitant Phase||25
290064|NCT00229723|709067|P2|COMPLETED|Concomitant Phase||19
290065|NCT00229723|709068|P1|COMPLETED|Concomitant Phase||50
290066|NCT00229723|709062|P7|STARTED|Concomitant Phase|Received randomized treatment|22
290067|NCT00229723|709063|P6|STARTED|Concomitant Phase|Received randomized treatment|34
290068|NCT00229723|709064|P5|STARTED|Concomitant Phase|Received randomized treatment|24
290069|NCT00229723|709065|P4|STARTED|Concomitant Phase|Received randomized treatment|31
290070|NCT00229723|709066|P3|STARTED|Concomitant Phase|Received randomized treatment|31
290071|NCT00229723|709067|P2|STARTED|Concomitant Phase|Received randomized treatment|24
290072|NCT00229723|709068|P1|STARTED|Concomitant Phase|Received randomized treatment|60
290073|NCT00229658|709121|P2|NOT COMPLETED|Overall Study||167
290074|NCT00229658|709122|P1|NOT COMPLETED|Overall Study||225
290075|NCT00229658|709121|P2|COMPLETED|Overall Study||364
290076|NCT00229658|709122|P1|COMPLETED|Overall Study||541
290077|NCT00229658|709121|P2|STARTED|Overall Study||531
290078|NCT00229658|709122|P1|STARTED|Overall Study||766
290079|NCT00229619|709150|P1|NOT COMPLETED|Overall Study||0
290080|NCT00229619|709150|P1|COMPLETED|Overall Study||11
290081|NCT00229619|709150|P1|STARTED|Overall Study||11
290082|NCT00229203|709156|P2|NOT COMPLETED|Overall Study||19
290083|NCT00229203|709157|P1|NOT COMPLETED|Overall Study||32
290084|NCT00229203|709156|P2|COMPLETED|Overall Study||0
290085|NCT00229203|709157|P1|COMPLETED|Overall Study||0
290086|NCT00229203|709156|P2|STARTED|Overall Study||19
290087|NCT00229203|709157|P1|STARTED|Overall Study||32
290088|NCT00228943|709169|P1|NOT COMPLETED|Week 2||1
290089|NCT00228943|709169|P1|COMPLETED|Week 2||27
290090|NCT00228943|709169|P1|STARTED|Week 2||28
290091|NCT00228943|709169|P1|NOT COMPLETED|Week 1||0
290092|NCT00228943|709169|P1|COMPLETED|Week 1||28
290093|NCT00228943|709169|P1|STARTED|Week 1||28
290094|NCT00228917|709181|P4|NOT COMPLETED|Overall Study||0
290095|NCT00228917|709182|P3|NOT COMPLETED|Overall Study||0
290096|NCT00228917|709183|P2|NOT COMPLETED|Overall Study||3
290097|NCT00228917|709184|P1|NOT COMPLETED|Overall Study||1
290098|NCT00228917|709181|P4|COMPLETED|Overall Study||107
290099|NCT00228917|709182|P3|COMPLETED|Overall Study||213
290100|NCT00228917|709183|P2|COMPLETED|Overall Study||320
290101|NCT00228917|709184|P1|COMPLETED|Overall Study||646
290102|NCT00228917|709181|P4|STARTED|Overall Study||107
290103|NCT00228917|709182|P3|STARTED|Overall Study||213
290104|NCT00228917|709183|P2|STARTED|Overall Study||323
290105|NCT00228917|709184|P1|STARTED|Overall Study||647
290106|NCT00228813|709210|P1|NOT COMPLETED|Overall Study||4
290107|NCT00228813|709210|P1|COMPLETED|Overall Study||4
290108|NCT00228813|709210|P1|STARTED|Overall Study||8
290109|NCT00228566|709216|P1|NOT COMPLETED|Overall Study||71
290110|NCT00228566|709216|P1|COMPLETED|Overall Study||176
290111|NCT00228566|709216|P1|STARTED|Overall Study||247
290112|NCT00228553|709220|P1|NOT COMPLETED|Overall Study||430
290113|NCT00228553|709220|P1|COMPLETED|Overall Study||313
290114|NCT00228553|709220|P1|STARTED|Overall Study||743
290115|NCT00228384|709226|P2|NOT COMPLETED|Overall Study||29
290116|NCT00228384|709227|P1|NOT COMPLETED|Overall Study||29
290117|NCT00228384|709226|P2|COMPLETED|Overall Study||47
290118|NCT00228384|709227|P1|COMPLETED|Overall Study||43
290119|NCT00228384|709226|P2|Three Year Follow-up (Final)|Overall Study||47
290120|NCT00228384|709227|P1|Three Year Follow-up (Final)|Overall Study||43
290121|NCT00228384|709226|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
290122|NCT00228384|709227|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
290123|NCT00228384|709226|P2|Baseline|Overall Study||76
290124|NCT00228384|709227|P1|Baseline|Overall Study||72
290125|NCT00228384|709226|P2|STARTED|Overall Study||76
290126|NCT00228384|709227|P1|STARTED|Overall Study||72
290127|NCT00227994|709267|P2|NOT COMPLETED|Overall Study||7
290128|NCT00227994|709268|P1|NOT COMPLETED|Overall Study||7
290129|NCT00227994|709267|P2|COMPLETED|Overall Study||13
290130|NCT00227994|709268|P1|COMPLETED|Overall Study||13
290131|NCT00227994|709267|P2|STARTED|Overall Study||20
290132|NCT00227994|709268|P1|STARTED|Overall Study||20
290133|NCT00227903|709278|P2|NOT COMPLETED|Overall Study||10
290134|NCT00227903|709279|P1|NOT COMPLETED|Overall Study||5
290135|NCT00227903|709278|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
290136|NCT00227903|709279|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
290137|NCT00227903|709278|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
290138|NCT00227903|709279|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
290139|NCT00227903|709278|P2|STARTED|Overall Study||92
290140|NCT00227903|709279|P1|STARTED|Overall Study||91
290141|NCT00227760|709339|P1|NOT COMPLETED|Overall Study||0
290142|NCT00227760|709339|P1|COMPLETED|Overall Study||44
290143|NCT00227760|709339|P1|STARTED|Overall Study||44
290144|NCT00227721|709345|P1|NOT COMPLETED|Overall Study||1
290145|NCT00227721|709345|P1|COMPLETED|Overall Study||29
290146|NCT00227721|709345|P1|STARTED|Overall Study||30
290147|NCT00227591|709349|P1|NOT COMPLETED|Overall Study||1
290148|NCT00227591|709349|P1|COMPLETED|Overall Study||47
290149|NCT00227591|709349|P1|Began Treatment|Overall Study||47
290150|NCT00227591|709349|P1|STARTED|Overall Study|48 pts registered to the study|48
290151|NCT00227539|709353|P1|NOT COMPLETED|Overall Study||1
290152|NCT00227539|709353|P1|COMPLETED|Overall Study||24
290153|NCT00227539|709353|P1|STARTED|Overall Study||25
290154|NCT00227370|709361|P2|NOT COMPLETED|Overall Study||24
290155|NCT00227370|709362|P1|NOT COMPLETED|Overall Study||21
290156|NCT00227370|709361|P2|COMPLETED|Overall Study||46
290157|NCT00227370|709362|P1|COMPLETED|Overall Study||45
290158|NCT00227370|709361|P2|STARTED|Overall Study|Treatment Group|70
290159|NCT00227370|709362|P1|STARTED|Overall Study|Placebo Group|66
290160|NCT00227344|709382|P2|NOT COMPLETED|Overall Study||5
290161|NCT00227344|709383|P1|NOT COMPLETED|Overall Study||12
290162|NCT00227344|709382|P2|COMPLETED|Overall Study||37
290163|NCT00227344|709383|P1|COMPLETED|Overall Study||75
290164|NCT00227344|709382|P2|STARTED|Overall Study||42
290165|NCT00227344|709383|P1|STARTED|Overall Study||87
290166|NCT00227305|709403|P1|NOT COMPLETED|Overall Study||144
290167|NCT00227305|709403|P1|COMPLETED|Overall Study|Completed 26 weeks|237
290168|NCT00227305|709403|P1|Drug Received|Overall Study|safety population|380
290169|NCT00227305|709403|P1|STARTED|Overall Study|enrolled|381
290170|NCT00227266|709420|P3|NOT COMPLETED|Overall Study||4
290171|NCT00227266|709421|P2|NOT COMPLETED|Overall Study||0
290172|NCT00227266|709422|P1|NOT COMPLETED|Overall Study||1
290173|NCT00227266|709420|P3|COMPLETED|Overall Study||29
290174|NCT00227266|709421|P2|COMPLETED|Overall Study||30
290175|NCT00227266|709422|P1|COMPLETED|Overall Study||30
290176|NCT00227266|709420|P3|STARTED|Overall Study||33
290177|NCT00227266|709421|P2|STARTED|Overall Study||30
290178|NCT00227266|709422|P1|STARTED|Overall Study||31
290179|NCT00227019|709442|P1|NOT COMPLETED|Overall Study||0
290180|NCT00227019|709442|P1|COMPLETED|Overall Study||16
290181|NCT00227019|709442|P1|STARTED|Overall Study||16
290182|NCT00226941|709452|P4|NOT COMPLETED|Overall Study||2
290183|NCT00226941|709453|P3|NOT COMPLETED|Overall Study||0
290184|NCT00226941|709454|P2|NOT COMPLETED|Overall Study||0
290185|NCT00226941|709455|P1|NOT COMPLETED|Overall Study||0
290186|NCT00226941|709452|P4|COMPLETED|Overall Study||5
290187|NCT00226941|709453|P3|COMPLETED|Overall Study||4
290188|NCT00226941|709454|P2|COMPLETED|Overall Study||6
290189|NCT00226941|709455|P1|COMPLETED|Overall Study||6
290190|NCT00226941|709452|P4|STARTED|Overall Study||7
290191|NCT00226941|709453|P3|STARTED|Overall Study||4
290192|NCT00226941|709454|P2|STARTED|Overall Study||6
290193|NCT00226941|709455|P1|STARTED|Overall Study||6
290194|NCT00226811|709489|P1|NOT COMPLETED|Overall Study||76
290195|NCT00226811|709489|P1|COMPLETED|Overall Study||2
290196|NCT00226811|709489|P1|STARTED|Overall Study||78
290197|NCT00226655|709499|P1|NOT COMPLETED|Overall Study||79
290198|NCT00226655|709499|P1|COMPLETED|Overall Study||33
290199|NCT00226655|709499|P1|STARTED|Overall Study||112
290200|NCT00226590|709503|P1|NOT COMPLETED|Overall Study||0
290201|NCT00226590|709503|P1|COMPLETED|Overall Study||39
290202|NCT00226590|709503|P1|STARTED|Overall Study||39
290203|NCT00226577|709510|P1|NOT COMPLETED|Overall Study||0
290204|NCT00226577|709510|P1|COMPLETED|Overall Study||52
290205|NCT00226577|709510|P1|STARTED|Overall Study||52
290206|NCT00226239|709518|P1|NOT COMPLETED|Maintenance Cetuximab||14
290207|NCT00226239|709518|P1|COMPLETED|Maintenance Cetuximab||17
290208|NCT00226239|709518|P1|STARTED|Maintenance Cetuximab||31
290209|NCT00226239|709518|P1|NOT COMPLETED|XPE, Definitive Therapy||4
290210|NCT00226239|709518|P1|COMPLETED|XPE, Definitive Therapy||33
290211|NCT00226239|709518|P1|STARTED|XPE, Definitive Therapy||37
290212|NCT00226239|709518|P1|NOT COMPLETED|TPE, Induction Therapy||2
290213|NCT00226239|709518|P1|COMPLETED|TPE, Induction Therapy||37
290214|NCT00226239|709518|P1|STARTED|TPE, Induction Therapy||39
290215|NCT00225784|709527|P1|NOT COMPLETED|Overall Study||4
290216|NCT00225784|709527|P1|COMPLETED|Overall Study||33
290217|NCT00225784|709527|P1|STARTED|Overall Study||37
290218|NCT00225732|709540|P2|NOT COMPLETED|Overall Study||0
290219|NCT00225732|709541|P1|NOT COMPLETED|Overall Study||0
290220|NCT00225732|709540|P2|COMPLETED|Overall Study||166
290221|NCT00225732|709541|P1|COMPLETED|Overall Study||153
290222|NCT00225732|709540|P2|STARTED|Overall Study||166
290223|NCT00225732|709541|P1|STARTED|Overall Study||153
290224|NCT00225498|709547|P1|NOT COMPLETED|Overall Study||0
290225|NCT00225498|709547|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
290226|NCT00225498|709547|P1|STARTED|Overall Study||10
290227|NCT00225420|709551|P3|NOT COMPLETED|Overall Study||0
290228|NCT00225420|709552|P2|NOT COMPLETED|Overall Study||0
290229|NCT00225420|709553|P1|NOT COMPLETED|Overall Study||0
290230|NCT00225420|709551|P3|COMPLETED|Overall Study||3
290231|NCT00225420|709552|P2|COMPLETED|Overall Study||6
290232|NCT00225420|709553|P1|COMPLETED|Overall Study||9
290233|NCT00225420|709551|P3|STARTED|Overall Study||3
290234|NCT00225420|709552|P2|STARTED|Overall Study||6
290235|NCT00225420|709553|P1|STARTED|Overall Study||9
290236|NCT00225277|709562|P2|NOT COMPLETED|Overall Study||95
290237|NCT00225277|709563|P1|NOT COMPLETED|Overall Study||97
290238|NCT00225277|709562|P2|COMPLETED|Overall Study||178
290239|NCT00225277|709563|P1|COMPLETED|Overall Study||177
290240|NCT00225277|709562|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
290241|NCT00225277|709563|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
290242|NCT00225251|709581|P2|NOT COMPLETED|Overall Study||1
290243|NCT00225251|709582|P1|NOT COMPLETED|Overall Study||1
290244|NCT00225251|709581|P2|COMPLETED|Overall Study||6
290245|NCT00225251|709582|P1|COMPLETED|Overall Study||10
290246|NCT00225251|709581|P2|STARTED|Overall Study||7
290247|NCT00225251|709582|P1|STARTED|Overall Study||11
290248|NCT00225212|709596|P1|NOT COMPLETED|Overall Study||6
290249|NCT00225212|709596|P1|COMPLETED|Overall Study||29
290250|NCT00225212|709596|P1|STARTED|Overall Study||35
290251|NCT00225147|709605|P4|NOT COMPLETED|Open-label Phase||10
290252|NCT00225147|709606|P3|NOT COMPLETED|Open-label Phase||0
290253|NCT00225147|709607|P2|NOT COMPLETED|Open-label Phase||0
290254|NCT00225147|709608|P1|NOT COMPLETED|Open-label Phase||0
290255|NCT00225147|709605|P4|COMPLETED|Open-label Phase||52
290256|NCT00225147|709606|P3|COMPLETED|Open-label Phase||0
290257|NCT00225147|709607|P2|COMPLETED|Open-label Phase||0
290258|NCT00225147|709608|P1|COMPLETED|Open-label Phase||0
290259|NCT00225147|709605|P4|STARTED|Open-label Phase||62
290260|NCT00225147|709606|P3|STARTED|Open-label Phase||0
290261|NCT00225147|709607|P2|STARTED|Open-label Phase||0
290262|NCT00225147|709608|P1|STARTED|Open-label Phase||0
290263|NCT00225147|709605|P4|NOT COMPLETED|Double-blind Phase||0
290264|NCT00225147|709606|P3|NOT COMPLETED|Double-blind Phase||0
290265|NCT00225147|709607|P2|NOT COMPLETED|Double-blind Phase||0
290266|NCT00225147|709608|P1|NOT COMPLETED|Double-blind Phase||0
290267|NCT00225147|709605|P4|COMPLETED|Double-blind Phase||0
290268|NCT00225147|709606|P3|COMPLETED|Double-blind Phase||13
290269|NCT00225147|709607|P2|COMPLETED|Double-blind Phase||12
290270|NCT00225147|709608|P1|COMPLETED|Double-blind Phase||13
290271|NCT00225147|709605|P4|STARTED|Double-blind Phase||0
290272|NCT00225147|709606|P3|STARTED|Double-blind Phase||13
290273|NCT00225147|709607|P2|STARTED|Double-blind Phase||12
290274|NCT00225147|709608|P1|STARTED|Double-blind Phase||13
290275|NCT00225017|709624|P2|NOT COMPLETED|Overall Study||1
290276|NCT00225017|709625|P1|NOT COMPLETED|Overall Study||0
290277|NCT00225017|709624|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
290278|NCT00225017|709625|P1|COMPLETED|Overall Study||26
290279|NCT00225017|709624|P2|STARTED|Overall Study||24
290280|NCT00225017|709625|P1|STARTED|Overall Study||26
290281|NCT00224952|709638|P3|NOT COMPLETED|Overall Study||0
290282|NCT00224952|709639|P2|NOT COMPLETED|Overall Study||0
290283|NCT00224952|709640|P1|NOT COMPLETED|Overall Study||0
290284|NCT00224952|709638|P3|COMPLETED|Overall Study||134
290285|NCT00224952|709639|P2|COMPLETED|Overall Study||87
290286|NCT00224952|709640|P1|COMPLETED|Overall Study||53
290287|NCT00224952|709638|P3|STARTED|Overall Study||134
290288|NCT00224952|709639|P2|STARTED|Overall Study||87
290289|NCT00224952|709640|P1|STARTED|Overall Study||53
290290|NCT00224874|709655|P4|NOT COMPLETED|Overall Study||0
290291|NCT00224874|709656|P3|NOT COMPLETED|Overall Study||1
290292|NCT00224874|709657|P2|NOT COMPLETED|Overall Study||0
290293|NCT00224874|709658|P1|NOT COMPLETED|Overall Study||0
290294|NCT00224874|709655|P4|COMPLETED|Overall Study||42
290295|NCT00224874|709656|P3|COMPLETED|Overall Study||46
290296|NCT00224874|709657|P2|COMPLETED|Overall Study||45
290297|NCT00224874|709658|P1|COMPLETED|Overall Study||46
290298|NCT00224874|709655|P4|STARTED|Overall Study||42
290299|NCT00224874|709656|P3|STARTED|Overall Study||47
290300|NCT00224874|709657|P2|STARTED|Overall Study||45
290301|NCT00224874|709658|P1|STARTED|Overall Study||46
290302|NCT00224770|709703|P3|NOT COMPLETED|Overall Study||0
290303|NCT00224770|709704|P2|NOT COMPLETED|Overall Study||2
290304|NCT00224770|709705|P1|NOT COMPLETED|Overall Study||4
290305|NCT00224770|709703|P3|COMPLETED|Overall Study||14
290306|NCT00224770|709704|P2|COMPLETED|Overall Study||52
290307|NCT00224770|709705|P1|COMPLETED|Overall Study||38
290308|NCT00224770|709703|P3|STARTED|Overall Study||14
290309|NCT00224770|709704|P2|STARTED|Overall Study||54
290310|NCT00224770|709705|P1|STARTED|Overall Study||42
290311|NCT00224484|709740|P3|NOT COMPLETED|Overall Study||62
290312|NCT00224484|709741|P2|NOT COMPLETED|Overall Study||65
290313|NCT00224484|709742|P1|NOT COMPLETED|Overall Study||146
290314|NCT00224484|709740|P3|COMPLETED|Overall Study||1425
290315|NCT00224484|709741|P2|COMPLETED|Overall Study||1426
290316|NCT00224484|709742|P1|COMPLETED|Overall Study||2831
290317|NCT00224484|709740|P3|STARTED|Overall Study||1487
290318|NCT00224484|709741|P2|STARTED|Overall Study||1491
290319|NCT00224484|709742|P1|STARTED|Overall Study||2977
290320|NCT00224289|709801|P1|NOT COMPLETED|Overall Study||0
290321|NCT00224289|709801|P1|COMPLETED|Overall Study||17
290322|NCT00224289|709801|P1|STARTED|Overall Study||17
290323|NCT00224133|709806|P1|NOT COMPLETED|Overall Study||226
290324|NCT00224133|709806|P1|COMPLETED|Overall Study||435
290325|NCT00224133|709806|P1|STARTED|Overall Study||661
290326|NCT00224120|709812|P2|NOT COMPLETED|Overall Study||24
290327|NCT00224120|709813|P1|NOT COMPLETED|Overall Study||22
290328|NCT00224120|709812|P2|COMPLETED|Overall Study||205
290329|NCT00224120|709813|P1|COMPLETED|Overall Study||211
290330|NCT00224120|709812|P2|STARTED|Overall Study||229
290331|NCT00224120|709813|P1|STARTED|Overall Study||233
290332|NCT00224107|709823|P2|NOT COMPLETED|Overall Study||14
290333|NCT00224107|709824|P1|NOT COMPLETED|Overall Study||31
290334|NCT00224107|709823|P2|COMPLETED|Overall Study||214
290335|NCT00224107|709824|P1|COMPLETED|Overall Study||202
290336|NCT00224107|709823|P2|STARTED|Overall Study||228
290337|NCT00224107|709824|P1|STARTED|Overall Study||233
290338|NCT00224055|709834|P2|NOT COMPLETED|Overall Study||14
290339|NCT00224055|709835|P1|NOT COMPLETED|Overall Study||15
290340|NCT00224055|709834|P2|COMPLETED|Overall Study||31
290341|NCT00224055|709835|P1|COMPLETED|Overall Study||29
290342|NCT00224055|709834|P2|STARTED|Overall Study||45
290343|NCT00224055|709835|P1|STARTED|Overall Study||44
290344|NCT00224042|709845|P2|NOT COMPLETED|Overall Study||6
290345|NCT00224042|709846|P1|NOT COMPLETED|Overall Study||6
290346|NCT00224042|709845|P2|COMPLETED|Overall Study||20
290347|NCT00224042|709846|P1|COMPLETED|Overall Study||20
290348|NCT00224042|709845|P2|STARTED|Overall Study||26
290349|NCT00224042|709846|P1|STARTED|Overall Study||26
290350|NCT00224029|709858|P1|NOT COMPLETED|Overall Study||6
290351|NCT00224029|709858|P1|COMPLETED|Overall Study||18
290352|NCT00224029|709858|P1|STARTED|Overall Study||24
290353|NCT00224016|709864|P2|NOT COMPLETED|Follow-Up Period||0
290354|NCT00224016|709865|P1|NOT COMPLETED|Follow-Up Period||0
290355|NCT00224016|709864|P2|COMPLETED|Follow-Up Period||0
290356|NCT00224016|709865|P1|COMPLETED|Follow-Up Period||35
290357|NCT00224016|709864|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
290358|NCT00224016|709865|P1|STARTED|Follow-Up Period||35
290359|NCT00224016|709864|P2|NOT COMPLETED|Maintenance Period||1
290360|NCT00224016|709865|P1|NOT COMPLETED|Maintenance Period||2
290361|NCT00224016|709864|P2|COMPLETED|Maintenance Period||14
290362|NCT00224016|709865|P1|COMPLETED|Maintenance Period||36
290363|NCT00224016|709864|P2|STARTED|Maintenance Period||15
290364|NCT00224016|709865|P1|STARTED|Maintenance Period||38
290365|NCT00224016|709864|P2|NOT COMPLETED|Titration Period||1
290366|NCT00224016|709865|P1|NOT COMPLETED|Titration Period||1
290367|NCT00224016|709864|P2|COMPLETED|Titration Period||15
290368|NCT00224016|709865|P1|COMPLETED|Titration Period||38
290369|NCT00224016|709864|P2|STARTED|Titration Period||16
290370|NCT00224016|709865|P1|STARTED|Titration Period||39
290371|NCT00224003|709873|P1|NOT COMPLETED|Overall Study||7
290372|NCT00224003|709873|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
290373|NCT00224003|709873|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
290374|NCT00223977|709880|P3|NOT COMPLETED|Overall Study||3
290375|NCT00223977|709881|P2|NOT COMPLETED|Overall Study||11
290376|NCT00223977|709882|P1|NOT COMPLETED|Overall Study||9
290377|NCT00223977|709880|P3|COMPLETED|Overall Study||39
290378|NCT00223977|709881|P2|COMPLETED|Overall Study||47
290379|NCT00223977|709882|P1|COMPLETED|Overall Study||37
290380|NCT00223977|709880|P3|STARTED|Overall Study||42
290381|NCT00223977|709881|P2|STARTED|Overall Study||58
290382|NCT00223977|709882|P1|STARTED|Overall Study||46
290383|NCT00223821|709904|P2|NOT COMPLETED|Overall Study||10
290384|NCT00223821|709905|P1|NOT COMPLETED|Overall Study||4
290385|NCT00223821|709904|P2|COMPLETED|Overall Study||22
290386|NCT00223821|709905|P1|COMPLETED|Overall Study||28
290387|NCT00223821|709904|P2|Completed 6-month Follow-up|Overall Study||25
290388|NCT00223821|709905|P1|Completed 6-month Follow-up|Overall Study||28
290389|NCT00223821|709904|P2|Completed Post-treatment Assessment|Overall Study||27
290390|NCT00223821|709905|P1|Completed Post-treatment Assessment|Overall Study||31
290391|NCT00223821|709904|P2|Completed Therapy|Overall Study||28
290392|NCT00223821|709905|P1|Completed Therapy|Overall Study||31
290393|NCT00223821|709904|P2|STARTED|Overall Study||32
290394|NCT00223821|709905|P1|STARTED|Overall Study||32
290395|NCT00223808|709916|P3|NOT COMPLETED|Overall Study||5
290396|NCT00223808|709917|P2|NOT COMPLETED|Overall Study||5
290397|NCT00223808|709918|P1|NOT COMPLETED|Overall Study||3
290398|NCT00223808|709916|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
290399|NCT00223808|709917|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
290400|NCT00223808|709918|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
290401|NCT00223808|709916|P3|STARTED|Overall Study||23
290402|NCT00223808|709917|P2|STARTED|Overall Study||22
290403|NCT00223808|709918|P1|STARTED|Overall Study||22
290404|NCT00223795|709935|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
290405|NCT00223795|709936|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
290406|NCT00223795|709935|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
290407|NCT00223795|709936|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
290408|NCT00223795|709935|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
290409|NCT00223795|709936|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
290410|NCT00223795|709935|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
290411|NCT00223795|709936|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
290412|NCT00223795|709935|P2|COMPLETED|First Intervention - Eight Weeks||18
290413|NCT00223795|709936|P1|COMPLETED|First Intervention - Eight Weeks||19
290414|NCT00223795|709935|P2|STARTED|First Intervention - Eight Weeks||27
290415|NCT00223795|709936|P1|STARTED|First Intervention - Eight Weeks||26
290416|NCT00223704|709946|P3|NOT COMPLETED|Overall Study||0
290417|NCT00223704|709947|P2|NOT COMPLETED|Overall Study||0
290418|NCT00223704|709948|P1|NOT COMPLETED|Overall Study||0
290419|NCT00223704|709946|P3|COMPLETED|Overall Study||40
290420|NCT00223704|709947|P2|COMPLETED|Overall Study||37
290421|NCT00223704|709948|P1|COMPLETED|Overall Study||38
290422|NCT00223704|709946|P3|STARTED|Overall Study||40
290423|NCT00223704|709947|P2|STARTED|Overall Study||37
290424|NCT00223704|709948|P1|STARTED|Overall Study||38
290425|NCT00223678|709970|P2|NOT COMPLETED|Overall Study||0
290426|NCT00223678|709971|P1|NOT COMPLETED|Overall Study||0
290427|NCT00223678|709970|P2|COMPLETED|Overall Study||7
290428|NCT00223678|709971|P1|COMPLETED|Overall Study||13
290429|NCT00223678|709970|P2|STARTED|Overall Study||7
290430|NCT00223678|709971|P1|STARTED|Overall Study||13
290431|NCT00223665|709977|P1|NOT COMPLETED|Overall Study||0
290432|NCT00223665|709977|P1|COMPLETED|Overall Study||102
290433|NCT00223665|709977|P1|STARTED|Overall Study||102
290434|NCT00223652|709997|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
290435|NCT00223652|709998|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
290436|NCT00223652|709997|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
290437|NCT00223652|709998|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
290438|NCT00223652|709997|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
290439|NCT00223652|709998|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
290440|NCT00223652|709997|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
290441|NCT00223652|709998|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
290442|NCT00223652|709997|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
290443|NCT00223652|709998|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
290444|NCT00223652|709997|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
290445|NCT00223652|709998|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
290446|NCT00223652|709997|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
290447|NCT00223652|709998|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
290448|NCT00223652|709997|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
290449|NCT00223652|709998|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
290450|NCT00223652|709997|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
290451|NCT00223652|709998|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
290452|NCT00223496|710014|P1|NOT COMPLETED|Overall Study||22
290453|NCT00223496|710014|P1|COMPLETED|Overall Study||10
290454|NCT00223496|710014|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
290455|NCT00223236|710020|P2|NOT COMPLETED|Overall Study||14
290456|NCT00223236|710021|P1|NOT COMPLETED|Overall Study||7
290457|NCT00223236|710020|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
290458|NCT00223236|710021|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
290459|NCT00223236|710020|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
290460|NCT00223236|710021|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
290461|NCT00222729|710033|P1|NOT COMPLETED|Overall Study||3
290462|NCT00222729|710033|P1|COMPLETED|Overall Study||37
290463|NCT00222729|710033|P1|STARTED|Overall Study||40
290464|NCT00222105|710040|P1|NOT COMPLETED|Overall Study||14
290465|NCT00222105|710040|P1|COMPLETED|Overall Study||11
290466|NCT00222105|710040|P1|STARTED|Overall Study||25
290467|NCT00221299|710048|P4|NOT COMPLETED|Overall Study||1
290468|NCT00221299|710049|P3|NOT COMPLETED|Overall Study||0
290469|NCT00221299|710050|P2|NOT COMPLETED|Overall Study||2
290470|NCT00221299|710051|P1|NOT COMPLETED|Overall Study||1
290471|NCT00221299|710048|P4|COMPLETED|Overall Study||10
290472|NCT00221299|710049|P3|COMPLETED|Overall Study||14
290473|NCT00221299|710050|P2|COMPLETED|Overall Study||11
290474|NCT00221299|710051|P1|COMPLETED|Overall Study||10
290475|NCT00221299|710048|P4|STARTED|Overall Study||11
290476|NCT00221299|710049|P3|STARTED|Overall Study||14
290477|NCT00221299|710050|P2|STARTED|Overall Study||13
290478|NCT00221299|710051|P1|STARTED|Overall Study||11
290479|NCT00221195|710061|P2|NOT COMPLETED|Overall Study||3
290480|NCT00221195|710062|P1|NOT COMPLETED|Overall Study||5
290481|NCT00221195|710061|P2|COMPLETED|Overall Study||14
290482|NCT00221195|710062|P1|COMPLETED|Overall Study||12
290483|NCT00221195|710061|P2|STARTED|Overall Study||17
290484|NCT00221195|710062|P1|STARTED|Overall Study||17
290485|NCT00221117|710071|P2|NOT COMPLETED|Overall Study||0
290486|NCT00221117|710072|P1|NOT COMPLETED|Overall Study||0
290487|NCT00221117|710071|P2|COMPLETED|Overall Study||9
290488|NCT00221117|710072|P1|COMPLETED|Overall Study||12
290489|NCT00221117|710071|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
290490|NCT00221117|710072|P1|STARTED|Overall Study||12
290491|NCT00221104|710082|P2|NOT COMPLETED|Overall Study||76
290492|NCT00221104|710083|P1|NOT COMPLETED|Overall Study||83
290493|NCT00221104|710082|P2|COMPLETED|Overall Study||709
290494|NCT00221104|710083|P1|COMPLETED|Overall Study||710
290495|NCT00221104|710082|P2|STARTED|Overall Study||785
290496|NCT00221104|710083|P1|STARTED|Overall Study||793
290497|NCT00220961|710099|P2|NOT COMPLETED|Overall Study||90
290498|NCT00220961|710100|P1|NOT COMPLETED|Overall Study||71
290499|NCT00220961|710099|P2|COMPLETED|Overall Study||213
290500|NCT00220961|710100|P1|COMPLETED|Overall Study||228
290501|NCT00220961|710099|P2|STARTED|Overall Study||303
290502|NCT00220961|710100|P1|STARTED|Overall Study||299
290503|NCT00220805|710116|P2|NOT COMPLETED|Overall Study||11
290504|NCT00220805|710117|P1|NOT COMPLETED|Overall Study||8
290505|NCT00220805|710116|P2|COMPLETED|Overall Study||16
290506|NCT00220805|710117|P1|COMPLETED|Overall Study||22
290507|NCT00220805|710116|P2|STARTED|Overall Study||27
290508|NCT00220805|710117|P1|STARTED|Overall Study||30
290509|NCT00220779|710138|P3|NOT COMPLETED|Overall Study||4
290510|NCT00220779|710139|P2|NOT COMPLETED|Overall Study||4
290511|NCT00220779|710140|P1|NOT COMPLETED|Overall Study||7
290512|NCT00220779|710138|P3|COMPLETED|Overall Study||37
290513|NCT00220779|710139|P2|COMPLETED|Overall Study||38
290514|NCT00220779|710140|P1|COMPLETED|Overall Study||38
290515|NCT00220779|710138|P3|STARTED|Overall Study||41
290516|NCT00220779|710139|P2|STARTED|Overall Study||42
290517|NCT00220779|710140|P1|STARTED|Overall Study||45
290518|NCT00220740|710150|P2|NOT COMPLETED|Withdrawal Period||15
290519|NCT00220740|710151|P1|NOT COMPLETED|Withdrawal Period||6
290520|NCT00220740|710150|P2|COMPLETED|Withdrawal Period||16
290521|NCT00220740|710151|P1|COMPLETED|Withdrawal Period||37
290522|NCT00220740|710150|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
290523|NCT00220740|710151|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
290524|NCT00220740|710150|P2|NOT COMPLETED|Rescue Treatment||18
290525|NCT00220740|710151|P1|NOT COMPLETED|Rescue Treatment||19
290526|NCT00220740|710150|P2|COMPLETED|Rescue Treatment||5
290527|NCT00220740|710151|P1|COMPLETED|Rescue Treatment||26
290528|NCT00220740|710150|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
290529|NCT00220740|710151|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
290530|NCT00220740|710150|P2|NOT COMPLETED|Efficacy Period||46
290531|NCT00220740|710151|P1|NOT COMPLETED|Efficacy Period||26
290532|NCT00220740|710150|P2|COMPLETED|Efficacy Period||12
290533|NCT00220740|710151|P1|COMPLETED|Efficacy Period||33
290534|NCT00220740|710150|P2|STARTED|Efficacy Period||58
290535|NCT00220740|710151|P1|STARTED|Efficacy Period||59
290536|NCT00220727|710165|P2|NOT COMPLETED|Second Infusion (Week <6)||0
290537|NCT00220727|710166|P1|NOT COMPLETED|Second Infusion (Week <6)||1
290538|NCT00220727|710165|P2|COMPLETED|Second Infusion (Week <6)||4
290539|NCT00220727|710166|P1|COMPLETED|Second Infusion (Week <6)||3
290540|NCT00220727|710165|P2|STARTED|Second Infusion (Week <6)||4
290541|NCT00220727|710166|P1|STARTED|Second Infusion (Week <6)||4
290542|NCT00220727|710165|P2|NOT COMPLETED|First Infusion (Week 0)||0
290543|NCT00220727|710166|P1|NOT COMPLETED|First Infusion (Week 0)||0
290544|NCT00220727|710165|P2|COMPLETED|First Infusion (Week 0)||4
290545|NCT00220727|710166|P1|COMPLETED|First Infusion (Week 0)||4
290546|NCT00220727|710165|P2|STARTED|First Infusion (Week 0)||4
290547|NCT00220727|710166|P1|STARTED|First Infusion (Week 0)||4
290548|NCT00220701|710182|P2|NOT COMPLETED|Overall Study||4
290549|NCT00220701|710183|P1|NOT COMPLETED|Overall Study||5
290550|NCT00220701|710182|P2|COMPLETED|Overall Study||13
290551|NCT00220701|710183|P1|COMPLETED|Overall Study||12
290552|NCT00220701|710182|P2|STARTED|Overall Study||17
290553|NCT00220701|710183|P1|STARTED|Overall Study||17
290554|NCT00220636|710199|P1|NOT COMPLETED|Overall Study||4
290555|NCT00220636|710199|P1|COMPLETED|Overall Study||11
290556|NCT00220636|710199|P1|STARTED|Overall Study||15
290557|NCT00219557|710209|P3|NOT COMPLETED|Phase 2||33
290558|NCT00219557|710210|P2|NOT COMPLETED|Phase 2||69
290559|NCT00219557|710211|P1|NOT COMPLETED|Phase 2||0
290560|NCT00219557|710209|P3|COMPLETED|Phase 2||1
290561|NCT00219557|710210|P2|COMPLETED|Phase 2||0
290562|NCT00219557|710211|P1|COMPLETED|Phase 2||0
290563|NCT00219557|710209|P3|Treated|Phase 2||31
290564|NCT00219557|710210|P2|Treated|Phase 2||68
290565|NCT00219557|710211|P1|Treated|Phase 2||0
290566|NCT00219557|710209|P3|STARTED|Phase 2||34
290567|NCT00219557|710210|P2|STARTED|Phase 2||69
290568|NCT00219557|710211|P1|STARTED|Phase 2||0
290569|NCT00219557|710209|P3|NOT COMPLETED|Phase 1||0
290570|NCT00219557|710210|P2|NOT COMPLETED|Phase 1||0
290571|NCT00219557|710211|P1|NOT COMPLETED|Phase 1||7
290572|NCT00219557|710209|P3|COMPLETED|Phase 1||0
290573|NCT00219557|710210|P2|COMPLETED|Phase 1||0
290574|NCT00219557|710211|P1|COMPLETED|Phase 1||1
290575|NCT00219557|710209|P3|STARTED|Phase 1||0
290576|NCT00219557|710210|P2|STARTED|Phase 1||0
290577|NCT00219557|710211|P1|STARTED|Phase 1||8
290578|NCT00219544|710239|P2|NOT COMPLETED|Double Blind Treatment Period||0
290579|NCT00219544|710240|P1|NOT COMPLETED|Double Blind Treatment Period||0
290580|NCT00219544|710239|P2|COMPLETED|Double Blind Treatment Period||77
290581|NCT00219544|710240|P1|COMPLETED|Double Blind Treatment Period||80
290582|NCT00219544|710239|P2|STARTED|Double Blind Treatment Period||77
290583|NCT00219544|710240|P1|STARTED|Double Blind Treatment Period||80
290584|NCT00219544|710239|P2|NOT COMPLETED|Single Blind Treatment Period||0
290585|NCT00219544|710240|P1|NOT COMPLETED|Single Blind Treatment Period||22
290586|NCT00219544|710239|P2|COMPLETED|Single Blind Treatment Period||0
290587|NCT00219544|710240|P1|COMPLETED|Single Blind Treatment Period||234
290588|NCT00219544|710239|P2|STARTED|Single Blind Treatment Period||0
290589|NCT00219544|710240|P1|STARTED|Single Blind Treatment Period||256
290590|NCT00219349|710278|P1|NOT COMPLETED|Escitalopram Phase||3
290591|NCT00219349|710278|P1|COMPLETED|Escitalopram Phase||4
290592|NCT00219349|710278|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
290593|NCT00219349|710278|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
290594|NCT00219349|710278|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
290595|NCT00219349|710278|P1|STARTED|Cognitive Behavioral Therapy Phase||25
290596|NCT00219284|710291|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
290597|NCT00219284|710292|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
290598|NCT00219284|710291|P2|COMPLETED|Extension Phase - 8 Weeks||99
290599|NCT00219284|710292|P1|COMPLETED|Extension Phase - 8 Weeks||112
290600|NCT00219284|710291|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
290601|NCT00219284|710292|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
290602|NCT00219284|710291|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
290603|NCT00219284|710292|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
290604|NCT00219284|710291|P2|COMPLETED|Treatment Phase - 16 Weeks||128
290605|NCT00219284|710292|P1|COMPLETED|Treatment Phase - 16 Weeks||136
290606|NCT00219284|710291|P2|STARTED|Treatment Phase - 16 Weeks||179
290607|NCT00219284|710292|P1|STARTED|Treatment Phase - 16 Weeks||180
290608|NCT00219141|710317|P3|NOT COMPLETED|Overall Study||12
290609|NCT00219141|710318|P2|NOT COMPLETED|Overall Study||21
290610|NCT00219141|710319|P1|NOT COMPLETED|Overall Study||14
290611|NCT00219141|710317|P3|COMPLETED|Overall Study||142
290612|NCT00219141|710318|P2|COMPLETED|Overall Study||131
290613|NCT00219141|710319|P1|COMPLETED|Overall Study||140
290614|NCT00219141|710317|P3|STARTED|Overall Study||154
290615|NCT00219141|710318|P2|STARTED|Overall Study||152
290616|NCT00219141|710319|P1|STARTED|Overall Study||154
290617|NCT00218634|710365|P2|NOT COMPLETED|Overall Study||15
290618|NCT00218634|710366|P1|NOT COMPLETED|Overall Study||8
290619|NCT00218634|710365|P2|COMPLETED|Overall Study||30
290620|NCT00218634|710366|P1|COMPLETED|Overall Study||36
290621|NCT00218634|710365|P2|STARTED|Overall Study||45
290622|NCT00218634|710366|P1|STARTED|Overall Study||44
290623|NCT00218543|710386|P1|NOT COMPLETED|Overall Study||15
290624|NCT00218543|710386|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
290625|NCT00218543|710386|P1|STARTED|Overall Study||20
290626|NCT00218465|710393|P2|NOT COMPLETED|Overall Study||18
290627|NCT00218465|710394|P1|NOT COMPLETED|Overall Study||17
290628|NCT00218465|710393|P2|COMPLETED|Overall Study||30
290629|NCT00218465|710394|P1|COMPLETED|Overall Study||33
290630|NCT00218465|710393|P2|STARTED|Overall Study||48
290631|NCT00218465|710394|P1|STARTED|Overall Study||50
290632|NCT00218439|710406|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
290633|NCT00218439|710407|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
290634|NCT00218439|710406|P2|COMPLETED|Second Intervention (4 Weeks)||30
290635|NCT00218439|710407|P1|COMPLETED|Second Intervention (4 Weeks)||33
290636|NCT00218439|710406|P2|STARTED|Second Intervention (4 Weeks)||35
290637|NCT00218439|710407|P1|STARTED|Second Intervention (4 Weeks)||40
290638|NCT00218439|710406|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
290639|NCT00218439|710407|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
290640|NCT00218439|710406|P2|COMPLETED|First Intervention (4 Weeks)||35
290641|NCT00218439|710407|P1|COMPLETED|First Intervention (4 Weeks)||40
290642|NCT00218439|710406|P2|STARTED|First Intervention (4 Weeks)||47
290643|NCT00218439|710407|P1|STARTED|First Intervention (4 Weeks)||58
290644|NCT00218335|710425|P4|NOT COMPLETED|Overall Study||36
290645|NCT00218335|710426|P3|NOT COMPLETED|Overall Study||54
290646|NCT00218335|710427|P2|NOT COMPLETED|Overall Study||3
290647|NCT00218335|710428|P1|NOT COMPLETED|Overall Study||6
290648|NCT00218335|710425|P4|COMPLETED|Overall Study||388
290649|NCT00218335|710426|P3|COMPLETED|Overall Study||319
290650|NCT00218335|710427|P2|COMPLETED|Overall Study||110
290651|NCT00218335|710428|P1|COMPLETED|Overall Study||108
290652|NCT00218335|710425|P4|18 Month Follow-up|Overall Study||368
290653|NCT00218335|710426|P3|18 Month Follow-up|Overall Study||296
290654|NCT00218335|710427|P2|18 Month Follow-up|Overall Study||108
290655|NCT00218335|710428|P1|18 Month Follow-up|Overall Study||101
290656|NCT00218335|710425|P4|12 Month Follow-up|Overall Study||303
290657|NCT00218335|710426|P3|12 Month Follow-up|Overall Study||244
290658|NCT00218335|710427|P2|12 Month Follow-up|Overall Study||102
290659|NCT00218335|710428|P1|12 Month Follow-up|Overall Study||95
290660|NCT00218335|710425|P4|6 Month Follow-up|Overall Study||301
290661|NCT00218335|710426|P3|6 Month Follow-up|Overall Study||219
290662|NCT00218335|710427|P2|6 Month Follow-up|Overall Study||99
290663|NCT00218335|710428|P1|6 Month Follow-up|Overall Study||103
290664|NCT00218335|710425|P4|STARTED|Overall Study||424
290665|NCT00218335|710426|P3|STARTED|Overall Study||373
290666|NCT00218335|710427|P2|STARTED|Overall Study||113
290667|NCT00218335|710428|P1|STARTED|Overall Study||114
290668|NCT00218296|710492|P2|NOT COMPLETED|Overall Study||121
290669|NCT00218296|710493|P1|NOT COMPLETED|Overall Study||111
290670|NCT00218296|710492|P2|COMPLETED|Overall Study||48
290671|NCT00218296|710493|P1|COMPLETED|Overall Study||52
290672|NCT00218296|710492|P2|Attended Visti|Overall Study||102
290673|NCT00218296|710493|P1|Attended Visti|Overall Study||97
290674|NCT00218296|710492|P2|STARTED|Overall Study||169
290675|NCT00218296|710493|P1|STARTED|Overall Study||163
290676|NCT00218062|710513|P4|NOT COMPLETED|Overall Study||13
290677|NCT00218062|710514|P3|NOT COMPLETED|Overall Study||12
290678|NCT00218062|710515|P2|NOT COMPLETED|Overall Study||16
290679|NCT00218062|710516|P1|NOT COMPLETED|Overall Study||15
290680|NCT00218062|710513|P4|COMPLETED|Overall Study||3
290681|NCT00218062|710514|P3|COMPLETED|Overall Study||3
290682|NCT00218062|710515|P2|COMPLETED|Overall Study||4
290683|NCT00218062|710516|P1|COMPLETED|Overall Study||7
290684|NCT00218062|710513|P4|Received First Dose of Study Medication|Overall Study||12
290685|NCT00218062|710514|P3|Received First Dose of Study Medication|Overall Study||10
290686|NCT00218062|710515|P2|Received First Dose of Study Medication|Overall Study||11
290687|NCT00218062|710516|P1|Received First Dose of Study Medication|Overall Study||16
290688|NCT00218062|710513|P4|STARTED|Overall Study||16
290689|NCT00218062|710514|P3|STARTED|Overall Study||15
290690|NCT00218062|710515|P2|STARTED|Overall Study||20
290691|NCT00218062|710516|P1|STARTED|Overall Study||22
290692|NCT00218023|710546|P4|NOT COMPLETED|Overall Study||7
290693|NCT00218023|710547|P3|NOT COMPLETED|Overall Study||10
290694|NCT00218023|710548|P2|NOT COMPLETED|Overall Study||15
290695|NCT00218023|710549|P1|NOT COMPLETED|Overall Study||13
290696|NCT00218023|710546|P4|COMPLETED|Overall Study||11
290697|NCT00218023|710547|P3|COMPLETED|Overall Study||6
290698|NCT00218023|710548|P2|COMPLETED|Overall Study||10
290699|NCT00218023|710549|P1|COMPLETED|Overall Study||9
290700|NCT00218023|710546|P4|Received Drug or Placebo in Phase II|Overall Study||18
290701|NCT00218023|710547|P3|Received Drug or Placebo in Phase II|Overall Study||15
290702|NCT00218023|710548|P2|Received Drug or Placebo in Phase II|Overall Study||24
290703|NCT00218023|710549|P1|Received Drug or Placebo in Phase II|Overall Study||18
290704|NCT00218023|710546|P4|STARTED|Overall Study||18
290705|NCT00218023|710547|P3|STARTED|Overall Study||16
290706|NCT00218023|710548|P2|STARTED|Overall Study||25
290707|NCT00218023|710549|P1|STARTED|Overall Study||22
290708|NCT00217971|710565|P2|NOT COMPLETED|Overall Study||33
290709|NCT00217971|710566|P1|NOT COMPLETED|Overall Study||24
290710|NCT00217971|710565|P2|COMPLETED|Overall Study||44
290711|NCT00217971|710566|P1|COMPLETED|Overall Study||55
290712|NCT00217971|710565|P2|STARTED|Overall Study||77
290713|NCT00217971|710566|P1|STARTED|Overall Study||79
290714|NCT00217724|710572|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
290715|NCT00217724|710573|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
290716|NCT00217724|710572|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
290717|NCT00217724|710573|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
290718|NCT00217724|710572|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
290719|NCT00217724|710573|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
290720|NCT00217724|710572|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
290721|NCT00217724|710573|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
290722|NCT00217724|710572|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
290723|NCT00217724|710573|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
290724|NCT00217724|710572|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
290725|NCT00217724|710573|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
290726|NCT00217672|710581|P2|NOT COMPLETED|Follow-up||0
290727|NCT00217672|710582|P1|NOT COMPLETED|Follow-up||5
290728|NCT00217672|710581|P2|COMPLETED|Follow-up||0
290729|NCT00217672|710582|P1|COMPLETED|Follow-up||69
290730|NCT00217672|710581|P2|STARTED|Follow-up||0
290731|NCT00217672|710582|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
290732|NCT00217672|710581|P2|NOT COMPLETED|Treatment||7
290733|NCT00217672|710582|P1|NOT COMPLETED|Treatment||67
290734|NCT00217672|710581|P2|COMPLETED|Treatment||0
290735|NCT00217672|710582|P1|COMPLETED|Treatment||0
290736|NCT00217672|710581|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
290737|NCT00217672|710582|P1|STARTED|Treatment||67
290738|NCT00217672|710581|P2|NOT COMPLETED|Allocation||0
290739|NCT00217672|710582|P1|NOT COMPLETED|Allocation||2
290740|NCT00217672|710581|P2|COMPLETED|Allocation||7
290741|NCT00217672|710582|P1|COMPLETED|Allocation||67
290742|NCT00217672|710581|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
290743|NCT00217672|710582|P1|STARTED|Allocation||69
290744|NCT00217620|710588|P1|NOT COMPLETED|Overall Study||51
290745|NCT00217620|710588|P1|COMPLETED|Overall Study||0
290746|NCT00217620|710588|P1|Eligible and Began Protocol Therapy|Overall Study||37
290747|NCT00217620|710588|P1|Eligible|Overall Study||38
290748|NCT00217620|710588|P1|STARTED|Overall Study||51
290749|NCT00217581|710599|P1|NOT COMPLETED|Overall Study||1
290750|NCT00217581|710599|P1|COMPLETED|Overall Study||38
290751|NCT00217581|710599|P1|STARTED|Overall Study||39
290752|NCT00217490|710611|P4|NOT COMPLETED|Overall Study||23
290753|NCT00217490|710612|P3|NOT COMPLETED|Overall Study||24
290754|NCT00217490|710613|P2|NOT COMPLETED|Overall Study||25
290755|NCT00217490|710614|P1|NOT COMPLETED|Overall Study||17
290756|NCT00217490|710611|P4|COMPLETED|Overall Study||130
290757|NCT00217490|710612|P3|COMPLETED|Overall Study||131
290758|NCT00217490|710613|P2|COMPLETED|Overall Study||128
290759|NCT00217490|710614|P1|COMPLETED|Overall Study||137
290760|NCT00217490|710611|P4|STARTED|Overall Study||153
290761|NCT00217490|710612|P3|STARTED|Overall Study||155
290762|NCT00217490|710613|P2|STARTED|Overall Study||153
290763|NCT00217490|710614|P1|STARTED|Overall Study||154
290764|NCT00217464|710628|P1|NOT COMPLETED|Overall Study||17
290765|NCT00217464|710628|P1|COMPLETED|Overall Study||0
290766|NCT00217464|710628|P1|STARTED|Overall Study||17
290767|NCT00217438|710635|P2|NOT COMPLETED|Overall Study||1
290768|NCT00217438|710636|P1|NOT COMPLETED|Overall Study||0
290769|NCT00217438|710635|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
290770|NCT00217438|710636|P1|COMPLETED|Overall Study||66
290771|NCT00217438|710635|P2|STARTED|Overall Study||64
290772|NCT00217438|710636|P1|STARTED|Overall Study||66
290773|NCT00217425|710644|P1|NOT COMPLETED|Overall Study||37
290774|NCT00217425|710644|P1|COMPLETED|Overall Study||9
290775|NCT00217425|710644|P1|Eligible and Treated|Overall Study||39
290776|NCT00217425|710644|P1|Treated|Overall Study||44
290777|NCT00217425|710644|P1|STARTED|Overall Study||46
290778|NCT00217399|710650|P1|NOT COMPLETED|Overall Study||0
290779|NCT00217399|710650|P1|COMPLETED|Overall Study||35
290780|NCT00217399|710650|P1|STARTED|Overall Study||35
290781|NCT00217087|710658|P2|NOT COMPLETED|Overall Study||20
290782|NCT00217087|710659|P1|NOT COMPLETED|Overall Study||11
290783|NCT00217087|710658|P2|COMPLETED|Overall Study||17
290784|NCT00217087|710659|P1|COMPLETED|Overall Study||25
290785|NCT00217087|710658|P2|STARTED|Overall Study||37
290786|NCT00217087|710659|P1|STARTED|Overall Study||36
290787|NCT00217022|710673|P2|NOT COMPLETED|Overall Study||1
290788|NCT00217022|710674|P1|NOT COMPLETED|Overall Study||1
290789|NCT00217022|710673|P2|COMPLETED|Overall Study||3
290790|NCT00217022|710674|P1|COMPLETED|Overall Study||11
290791|NCT00217022|710673|P2|STARTED|Overall Study||4
290792|NCT00217022|710674|P1|STARTED|Overall Study||12
290793|NCT00216736|710684|P2|NOT COMPLETED|Overall Study||1
290794|NCT00216736|710685|P1|NOT COMPLETED|Overall Study||1
290795|NCT00216736|710684|P2|COMPLETED|Overall Study||30
290796|NCT00216736|710685|P1|COMPLETED|Overall Study||31
290797|NCT00216736|710684|P2|STARTED|Overall Study||31
290798|NCT00216736|710685|P1|STARTED|Overall Study||32
290799|NCT00216671|710699|P2|NOT COMPLETED|Overall Study||50
290800|NCT00216671|710700|P1|NOT COMPLETED|Overall Study||35
290801|NCT00216671|710699|P2|COMPLETED|Overall Study||60
290802|NCT00216671|710700|P1|COMPLETED|Overall Study||75
290803|NCT00216671|710699|P2|STARTED|Overall Study||110
290804|NCT00216671|710700|P1|STARTED|Overall Study||110
290805|NCT00216476|710718|P3|NOT COMPLETED|Overall Study||17
290806|NCT00216476|710719|P2|NOT COMPLETED|Overall Study||107
290807|NCT00216476|710720|P1|NOT COMPLETED|Overall Study||105
290808|NCT00216476|710718|P3|COMPLETED|Overall Study||28
290809|NCT00216476|710719|P2|COMPLETED|Overall Study||230
290810|NCT00216476|710720|P1|COMPLETED|Overall Study||224
290811|NCT00216476|710718|P3|STARTED|Overall Study||45
290812|NCT00216476|710719|P2|STARTED|Overall Study||337
290813|NCT00216476|710720|P1|STARTED|Overall Study||329
290814|NCT00216320|710740|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
290815|NCT00216320|710741|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
290816|NCT00216320|710742|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
290817|NCT00216320|710740|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
290818|NCT00216320|710741|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
290819|NCT00216320|710742|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
290820|NCT00216320|710740|P3|STARTED|Phase 2 (Weeks 6 -12)||25
290821|NCT00216320|710741|P2|STARTED|Phase 2 (Weeks 6 -12)||35
290822|NCT00216320|710742|P1|STARTED|Phase 2 (Weeks 6 -12)||43
290823|NCT00216320|710740|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
290824|NCT00216320|710741|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
290825|NCT00216320|710742|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
290826|NCT00216320|710740|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
290827|NCT00216320|710741|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
290828|NCT00216320|710742|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
290829|NCT00216320|710740|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
290830|NCT00216320|710741|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
290831|NCT00216320|710742|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
290832|NCT00216203|710757|P1|NOT COMPLETED|Overall Study||2
290833|NCT00216203|710757|P1|COMPLETED|Overall Study||34
290834|NCT00216203|710757|P1|STARTED|Overall Study||36
290835|NCT00216125|710765|P3|NOT COMPLETED|Randomization Phase||8
290836|NCT00216125|710766|P2|NOT COMPLETED|Randomization Phase||11
290837|NCT00216125|710767|P1|NOT COMPLETED|Randomization Phase||0
290838|NCT00216125|710765|P3|COMPLETED|Randomization Phase||74
290839|NCT00216125|710766|P2|COMPLETED|Randomization Phase||73
290840|NCT00216125|710767|P1|COMPLETED|Randomization Phase||0
290841|NCT00216125|710765|P3|DSMB Cohort for Futility|Randomization Phase||74
290842|NCT00216125|710766|P2|DSMB Cohort for Futility|Randomization Phase||73
290843|NCT00216125|710767|P1|DSMB Cohort for Futility|Randomization Phase||0
290844|NCT00216125|710765|P3|STARTED|Randomization Phase||82
290845|NCT00216125|710766|P2|STARTED|Randomization Phase||84
290846|NCT00216125|710767|P1|STARTED|Randomization Phase||0
290847|NCT00216125|710765|P3|NOT COMPLETED|Pre-Randomization Phase||0
290848|NCT00216125|710766|P2|NOT COMPLETED|Pre-Randomization Phase||0
290849|NCT00216125|710767|P1|NOT COMPLETED|Pre-Randomization Phase||77
290850|NCT00216125|710765|P3|COMPLETED|Pre-Randomization Phase||0
290851|NCT00216125|710766|P2|COMPLETED|Pre-Randomization Phase||0
290852|NCT00216125|710767|P1|COMPLETED|Pre-Randomization Phase||166
290853|NCT00216125|710765|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
290854|NCT00216125|710766|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
290855|NCT00216125|710767|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
290856|NCT00216125|710765|P3|STARTED|Pre-Randomization Phase||0
290857|NCT00216125|710766|P2|STARTED|Pre-Randomization Phase||0
290858|NCT00216125|710767|P1|STARTED|Pre-Randomization Phase||243
290859|NCT00216099|710776|P1|NOT COMPLETED|Overall Study||1
290860|NCT00216099|710776|P1|COMPLETED|Overall Study||48
290861|NCT00216099|710776|P1|Response Analysis|Overall Study||48
290862|NCT00216099|710776|P1|Toxicity Analysis|Overall Study||49
290863|NCT00216099|710776|P1|STARTED|Overall Study||49
290864|NCT00216086|710787|P1|NOT COMPLETED|Overall Study||4
290865|NCT00216086|710787|P1|COMPLETED|Overall Study||18
290866|NCT00216086|710787|P1|STARTED|Overall Study||22
290867|NCT00216060|710796|P2|NOT COMPLETED|Overall Study||0
290868|NCT00216060|710797|P1|NOT COMPLETED|Overall Study||0
290869|NCT00216060|710796|P2|COMPLETED|Overall Study||31
290870|NCT00216060|710797|P1|COMPLETED|Overall Study||32
290871|NCT00216060|710796|P2|STARTED|Overall Study||31
290872|NCT00216060|710797|P1|STARTED|Overall Study||32
290873|NCT00215943|710819|P2|NOT COMPLETED|Overall Study||14
290874|NCT00215943|710820|P1|NOT COMPLETED|Overall Study||9
290875|NCT00215943|710819|P2|COMPLETED|Overall Study||23
290876|NCT00215943|710820|P1|COMPLETED|Overall Study||27
290877|NCT00215943|710819|P2|STARTED|Overall Study||37
290878|NCT00215943|710820|P1|STARTED|Overall Study||36
290879|NCT00215930|710832|P1|NOT COMPLETED|Overall Study||0
290880|NCT00215930|710832|P1|COMPLETED|Overall Study||53
290881|NCT00215930|710832|P1|STARTED|Overall Study||53
290882|NCT00215787|710838|P1|NOT COMPLETED|Overall Study||0
290883|NCT00215787|710838|P1|COMPLETED|Overall Study||20
290884|NCT00215787|710838|P1|STARTED|Overall Study||20
290885|NCT00215683|710845|P3|NOT COMPLETED|Overall Study||32
290886|NCT00215683|710846|P2|NOT COMPLETED|Overall Study||26
290887|NCT00215683|710847|P1|NOT COMPLETED|Overall Study||29
290888|NCT00215683|710845|P3|COMPLETED|Overall Study||12
290889|NCT00215683|710846|P2|COMPLETED|Overall Study||22
290890|NCT00215683|710847|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
290891|NCT00215683|710845|P3|Switched to 160 mg|Overall Study||36
290892|NCT00215683|710846|P2|Switched to 160 mg|Overall Study||41
290893|NCT00215683|710847|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
290894|NCT00215683|710845|P3|STARTED|Overall Study||44
290895|NCT00215683|710846|P2|STARTED|Overall Study||48
290896|NCT00215683|710847|P1|STARTED|Overall Study|Safety analysis set|45
290897|NCT00215657|710866|P8|NOT COMPLETED|Overall Study||16
290898|NCT00215657|710867|P7|NOT COMPLETED|Overall Study||23
290899|NCT00215657|710868|P6|NOT COMPLETED|Overall Study||20
290900|NCT00215657|710869|P5|NOT COMPLETED|Overall Study||23
290901|NCT00215657|710870|P4|NOT COMPLETED|Overall Study||18
290902|NCT00215657|710871|P3|NOT COMPLETED|Overall Study||11
290903|NCT00215657|710872|P2|NOT COMPLETED|Overall Study||11
290904|NCT00215657|710873|P1|NOT COMPLETED|Overall Study||22
290905|NCT00215657|710866|P8|COMPLETED|Overall Study||11
290906|NCT00215657|710867|P7|COMPLETED|Overall Study||4
290907|NCT00215657|710868|P6|COMPLETED|Overall Study||4
290908|NCT00215657|710869|P5|COMPLETED|Overall Study||4
290909|NCT00215657|710870|P4|COMPLETED|Overall Study||6
290910|NCT00215657|710871|P3|COMPLETED|Overall Study||2
290911|NCT00215657|710872|P2|COMPLETED|Overall Study||1
290912|NCT00215657|710873|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
290913|NCT00215657|710866|P8|Started FE200486 CS07A|Overall Study||23
290914|NCT00215657|710867|P7|Started FE200486 CS07A|Overall Study||14
290915|NCT00215657|710868|P6|Started FE200486 CS07A|Overall Study||20
290916|NCT00215657|710869|P5|Started FE200486 CS07A|Overall Study||17
290917|NCT00215657|710870|P4|Started FE200486 CS07A|Overall Study||24
290918|NCT00215657|710871|P3|Started FE200486 CS07A|Overall Study||7
290919|NCT00215657|710872|P2|Started FE200486 CS07A|Overall Study||6
290920|NCT00215657|710873|P1|Started FE200486 CS07A|Overall Study||20
290921|NCT00215657|710866|P8|Intention-to-treat Population|Overall Study||27
290922|NCT00215657|710867|P7|Intention-to-treat Population|Overall Study||24
290923|NCT00215657|710868|P6|Intention-to-treat Population|Overall Study||24
290924|NCT00215657|710869|P5|Intention-to-treat Population|Overall Study||24
290925|NCT00215657|710870|P4|Intention-to-treat Population|Overall Study||24
290926|NCT00215657|710871|P3|Intention-to-treat Population|Overall Study||12
290927|NCT00215657|710872|P2|Intention-to-treat Population|Overall Study||12
290928|NCT00215657|710873|P1|Intention-to-treat Population|Overall Study||25
290929|NCT00215657|710866|P8|STARTED|Overall Study||27
290930|NCT00215657|710867|P7|STARTED|Overall Study||27
290931|NCT00215657|710868|P6|STARTED|Overall Study||24
290932|NCT00215657|710869|P5|STARTED|Overall Study||27
290933|NCT00215657|710870|P4|STARTED|Overall Study||24
290934|NCT00215657|710871|P3|STARTED|Overall Study||13
290935|NCT00215657|710872|P2|STARTED|Overall Study||12
290936|NCT00215657|710873|P1|STARTED|Overall Study||26
290937|NCT00215553|710906|P7|NOT COMPLETED|Overall Study||0
290938|NCT00215553|710907|P6|NOT COMPLETED|Overall Study||6
290939|NCT00215553|710908|P5|NOT COMPLETED|Overall Study||2
290940|NCT00215553|710909|P4|NOT COMPLETED|Overall Study||1
290941|NCT00215553|710910|P3|NOT COMPLETED|Overall Study||2
290942|NCT00215553|710911|P2|NOT COMPLETED|Overall Study||1
290943|NCT00215553|710912|P1|NOT COMPLETED|Overall Study||0
290944|NCT00215553|710906|P7|COMPLETED|Overall Study||36
290945|NCT00215553|710907|P6|COMPLETED|Overall Study|6 Subjects discontinued due to AE|32
290946|NCT00215553|710908|P5|COMPLETED|Overall Study|2 Subjects discontinued due to AE|26
290947|NCT00215553|710909|P4|COMPLETED|Overall Study|1 Subject discontinued due to AE|4
290948|NCT00215553|710910|P3|COMPLETED|Overall Study|2 Subjects discontinued due to AE|4
290949|NCT00215553|710911|P2|COMPLETED|Overall Study|1 Subject discontinued due to AE|5
290950|NCT00215553|710912|P1|COMPLETED|Overall Study||5
290951|NCT00215553|710906|P7|STARTED|Overall Study||36
290952|NCT00215553|710907|P6|STARTED|Overall Study||38
290953|NCT00215553|710908|P5|STARTED|Overall Study||28
290954|NCT00215553|710909|P4|STARTED|Overall Study||5
290955|NCT00215553|710910|P3|STARTED|Overall Study||6
290956|NCT00215553|710911|P2|STARTED|Overall Study||6
290957|NCT00215553|710912|P1|STARTED|Overall Study||5
290958|NCT00215540|710945|P3|NOT COMPLETED|Overall Study||0
290959|NCT00215540|710946|P2|NOT COMPLETED|Overall Study||0
290960|NCT00215540|710947|P1|NOT COMPLETED|Overall Study||1
290961|NCT00215540|710945|P3|COMPLETED|Overall Study||44
290962|NCT00215540|710946|P2|COMPLETED|Overall Study||47
290963|NCT00215540|710947|P1|COMPLETED|Overall Study||44
290964|NCT00215540|710945|P3|STARTED|Overall Study||44
290965|NCT00215540|710946|P2|STARTED|Overall Study||47
290966|NCT00215540|710947|P1|STARTED|Overall Study||45
290967|NCT00215150|710982|P1|NOT COMPLETED|Randomization Phase Placebo||1
290968|NCT00215150|710982|P1|COMPLETED|Randomization Phase Placebo||10
290969|NCT00215150|710982|P1|STARTED|Randomization Phase Placebo||11
290970|NCT00215150|710982|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
290971|NCT00215150|710982|P1|COMPLETED|Randomization Phase Ziprasidone||7
290972|NCT00215150|710982|P1|STARTED|Randomization Phase Ziprasidone||10
290973|NCT00215150|710982|P1|NOT COMPLETED|Open Label Phase||30
290974|NCT00215150|710982|P1|COMPLETED|Open Label Phase||21
290975|NCT00215150|710982|P1|STARTED|Open Label Phase|Number of subjects consented|51
290976|NCT00215137|710990|P3|NOT COMPLETED|Randomization Period||0
290977|NCT00215137|710991|P2|NOT COMPLETED|Randomization Period||2
290978|NCT00215137|710992|P1|NOT COMPLETED|Randomization Period||0
290979|NCT00215137|710990|P3|COMPLETED|Randomization Period||5
290980|NCT00215137|710991|P2|COMPLETED|Randomization Period||5
290981|NCT00215137|710992|P1|COMPLETED|Randomization Period||0
290982|NCT00215137|710990|P3|STARTED|Randomization Period||5
290983|NCT00215137|710991|P2|STARTED|Randomization Period||7
290984|NCT00215137|710992|P1|STARTED|Randomization Period||0
290985|NCT00215137|710990|P3|NOT COMPLETED|Open Label Escitalopram||0
290986|NCT00215137|710991|P2|NOT COMPLETED|Open Label Escitalopram||0
290987|NCT00215137|710992|P1|NOT COMPLETED|Open Label Escitalopram||1
290988|NCT00215137|710990|P3|COMPLETED|Open Label Escitalopram||0
290989|NCT00215137|710991|P2|COMPLETED|Open Label Escitalopram||0
290990|NCT00215137|710992|P1|COMPLETED|Open Label Escitalopram||13
290991|NCT00215137|710990|P3|STARTED|Open Label Escitalopram||0
290992|NCT00215137|710991|P2|STARTED|Open Label Escitalopram||0
290993|NCT00215137|710992|P1|STARTED|Open Label Escitalopram||14
290994|NCT00214903|711004|P4|NOT COMPLETED|Overall Study||0
290995|NCT00214903|711005|P3|NOT COMPLETED|Overall Study||0
290996|NCT00214903|711006|P2|NOT COMPLETED|Overall Study||0
290997|NCT00214903|711007|P1|NOT COMPLETED|Overall Study||0
290998|NCT00214903|711004|P4|COMPLETED|Overall Study||3057
290999|NCT00214903|711005|P3|COMPLETED|Overall Study||4113
291000|NCT00214903|711006|P2|COMPLETED|Overall Study||13384
291001|NCT00214903|711007|P1|COMPLETED|Overall Study||10043
291002|NCT00214903|711004|P4|STARTED|Overall Study||3057
291003|NCT00214903|711005|P3|STARTED|Overall Study||4113
291004|NCT00214903|711006|P2|STARTED|Overall Study||13384
291005|NCT00214903|711007|P1|STARTED|Overall Study||10043
291006|NCT00214786|711021|P1|NOT COMPLETED|Overall Study||3
291007|NCT00214786|711021|P1|COMPLETED|Overall Study||1
291008|NCT00214786|711021|P1|STARTED|Overall Study||4
291009|NCT00214539|711036|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
291010|NCT00214539|711037|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
291011|NCT00214539|711036|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
291012|NCT00214539|711037|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
291013|NCT00214539|711036|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
291014|NCT00214539|711037|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
291015|NCT00214539|711036|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
291016|NCT00214539|711037|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
291017|NCT00214539|711036|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
291018|NCT00214539|711037|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
291019|NCT00214539|711036|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
291020|NCT00214539|711037|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
291021|NCT00214539|711036|P2|NOT COMPLETED|Treatment Period||0
291022|NCT00214539|711037|P1|NOT COMPLETED|Treatment Period||0
291023|NCT00214539|711036|P2|COMPLETED|Treatment Period||17
291024|NCT00214539|711037|P1|COMPLETED|Treatment Period||15
291025|NCT00214539|711036|P2|STARTED|Treatment Period||17
291026|NCT00214539|711037|P1|STARTED|Treatment Period||15
291027|NCT00214539|711036|P2|NOT COMPLETED|Randomized||0
291028|NCT00214539|711037|P1|NOT COMPLETED|Randomized||2
291029|NCT00214539|711036|P2|COMPLETED|Randomized||17
291030|NCT00214539|711037|P1|COMPLETED|Randomized||15
291031|NCT00214539|711036|P2|STARTED|Randomized||17
291032|NCT00214539|711037|P1|STARTED|Randomized||17
291033|NCT00214526|711063|P2|NOT COMPLETED|Post-Treatment Period||0
291034|NCT00214526|711064|P1|NOT COMPLETED|Post-Treatment Period||1
291035|NCT00214526|711063|P2|COMPLETED|Post-Treatment Period||49
291036|NCT00214526|711064|P1|COMPLETED|Post-Treatment Period||52
291037|NCT00214526|711063|P2|STARTED|Post-Treatment Period||49
291038|NCT00214526|711064|P1|STARTED|Post-Treatment Period||53
291039|NCT00214526|711063|P2|NOT COMPLETED|Treatment Period||5
291040|NCT00214526|711064|P1|NOT COMPLETED|Treatment Period||2
291041|NCT00214526|711063|P2|COMPLETED|Treatment Period||49
291042|NCT00214526|711064|P1|COMPLETED|Treatment Period||53
291043|NCT00214526|711063|P2|STARTED|Treatment Period||54
291044|NCT00214526|711064|P1|STARTED|Treatment Period||55
291045|NCT00214526|711063|P2|NOT COMPLETED|Randomized||2
291046|NCT00214526|711064|P1|NOT COMPLETED|Randomized||1
291047|NCT00214526|711063|P2|COMPLETED|Randomized||54
291048|NCT00214526|711064|P1|COMPLETED|Randomized||55
291049|NCT00214526|711063|P2|STARTED|Randomized||56
291050|NCT00214526|711064|P1|STARTED|Randomized||56
291051|NCT00214487|711092|P2|NOT COMPLETED|Overall Study||3
291052|NCT00214487|711093|P1|NOT COMPLETED|Overall Study||5
291053|NCT00214487|711092|P2|COMPLETED|Overall Study||40
291054|NCT00214487|711093|P1|COMPLETED|Overall Study||38
291055|NCT00214487|711092|P2|STARTED|Overall Study||43
291056|NCT00214487|711093|P1|STARTED|Overall Study||43
291057|NCT00214461|711103|P4|NOT COMPLETED|Overall Study||1
291058|NCT00214461|711104|P3|NOT COMPLETED|Overall Study||2
291059|NCT00214461|711105|P2|NOT COMPLETED|Overall Study||0
291060|NCT00214461|711106|P1|NOT COMPLETED|Overall Study||0
291061|NCT00214461|711103|P4|COMPLETED|Overall Study||11
291062|NCT00214461|711104|P3|COMPLETED|Overall Study||10
291063|NCT00214461|711105|P2|COMPLETED|Overall Study||12
291064|NCT00214461|711106|P1|COMPLETED|Overall Study||12
291065|NCT00214461|711103|P4|STARTED|Overall Study||12
291066|NCT00214461|711104|P3|STARTED|Overall Study||12
291067|NCT00214461|711105|P2|STARTED|Overall Study||12
291068|NCT00214461|711106|P1|STARTED|Overall Study||12
291069|NCT00214383|711122|P2|NOT COMPLETED|Overall Study||26
291070|NCT00214383|711123|P1|NOT COMPLETED|Overall Study||16
291071|NCT00214383|711122|P2|COMPLETED|Overall Study||127
291072|NCT00214383|711123|P1|COMPLETED|Overall Study||132
291073|NCT00214383|711122|P2|STARTED|Overall Study||153
291074|NCT00214383|711123|P1|STARTED|Overall Study||148
291075|NCT00214201|711135|P2|NOT COMPLETED|Overall Study||2
291076|NCT00214201|711136|P1|NOT COMPLETED|Overall Study||2
291077|NCT00214201|711135|P2|COMPLETED|Overall Study||18
291078|NCT00214201|711136|P1|COMPLETED|Overall Study||18
291079|NCT00214201|711135|P2|STARTED|Overall Study||20
291080|NCT00214201|711136|P1|STARTED|Overall Study||20
291081|NCT00214136|711146|P1|NOT COMPLETED|Overall Study||5
291082|NCT00214136|711146|P1|COMPLETED|Overall Study||25
291083|NCT00214136|711146|P1|STARTED|Overall Study||30
291084|NCT00214019|711151|P1|NOT COMPLETED|Overall Study||30
291085|NCT00214019|711151|P1|COMPLETED|Overall Study||6
291086|NCT00214019|711151|P1|Fluticason/Salmeterol Arm|Overall Study||6
291087|NCT00214019|711151|P1|Fluticasone/Placebo Arm|Overall Study||6
291088|NCT00214019|711151|P1|Placebo/Salmeterol Arm|Overall Study||6
291089|NCT00214019|711151|P1|Placebo/Placebo Arm|Overall Study||6
291090|NCT00214019|711151|P1|STARTED|Overall Study||36
291091|NCT00213980|711160|P2|NOT COMPLETED|Overall Study||7
291092|NCT00213980|711161|P1|NOT COMPLETED|Overall Study||6
291093|NCT00213980|711160|P2|COMPLETED|Overall Study||29
291094|NCT00213980|711161|P1|COMPLETED|Overall Study||26
291095|NCT00213980|711160|P2|STARTED|Overall Study||36
291096|NCT00213980|711161|P1|STARTED|Overall Study||32
291097|NCT00213135|711176|P3|NOT COMPLETED|Overall Study||57
291098|NCT00213135|711177|P2|NOT COMPLETED|Overall Study||35
291099|NCT00213135|711178|P1|NOT COMPLETED|Overall Study||50
291100|NCT00213135|711176|P3|COMPLETED|Overall Study||380
291101|NCT00213135|711177|P2|COMPLETED|Overall Study||398
291102|NCT00213135|711178|P1|COMPLETED|Overall Study||406
291103|NCT00213135|711176|P3|STARTED|Overall Study||437
291104|NCT00213135|711177|P2|STARTED|Overall Study||433
291105|NCT00213135|711178|P1|STARTED|Overall Study||456
291106|NCT00212758|711195|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
291107|NCT00212758|711196|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
291108|NCT00212758|711195|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
291109|NCT00212758|711196|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
291110|NCT00212758|711195|P2|STARTED|Standard Therapy of GH (12 Months)||9
291111|NCT00212758|711196|P1|STARTED|Standard Therapy of GH (12 Months)||8
291112|NCT00212758|711195|P2|NOT COMPLETED|Second Intervention (7 Days)||0
291113|NCT00212758|711196|P1|NOT COMPLETED|Second Intervention (7 Days)||0
291114|NCT00212758|711195|P2|COMPLETED|Second Intervention (7 Days)||9
291115|NCT00212758|711196|P1|COMPLETED|Second Intervention (7 Days)||8
291116|NCT00212758|711195|P2|STARTED|Second Intervention (7 Days)||9
291117|NCT00212758|711196|P1|STARTED|Second Intervention (7 Days)||8
291118|NCT00212758|711195|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
291119|NCT00212758|711196|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
291120|NCT00212758|711195|P2|COMPLETED|Wash Out Period (2 Weeks)||9
291121|NCT00212758|711196|P1|COMPLETED|Wash Out Period (2 Weeks)||8
291122|NCT00212758|711195|P2|STARTED|Wash Out Period (2 Weeks)||9
291123|NCT00212758|711196|P1|STARTED|Wash Out Period (2 Weeks)||8
291124|NCT00212758|711195|P2|NOT COMPLETED|First Intervention (7 Days)||0
291125|NCT00212758|711196|P1|NOT COMPLETED|First Intervention (7 Days)||0
291126|NCT00212758|711195|P2|COMPLETED|First Intervention (7 Days)||9
291127|NCT00212758|711196|P1|COMPLETED|First Intervention (7 Days)||8
291128|NCT00212758|711195|P2|STARTED|First Intervention (7 Days)||9
291129|NCT00212758|711196|P1|STARTED|First Intervention (7 Days)||8
291130|NCT00212355|711202|P1|NOT COMPLETED|Overall Study||3
291131|NCT00212355|711202|P1|COMPLETED|Overall Study||34
291132|NCT00212355|711202|P1|STARTED|Overall Study||37
291133|NCT00212264|711209|P3|NOT COMPLETED|Overall Study||4
291134|NCT00212264|711210|P2|NOT COMPLETED|Overall Study||16
291135|NCT00212264|711211|P1|NOT COMPLETED|Overall Study||12
291136|NCT00212264|711209|P3|COMPLETED|Overall Study||64
291137|NCT00212264|711210|P2|COMPLETED|Overall Study||54
291138|NCT00212264|711211|P1|COMPLETED|Overall Study||58
291139|NCT00212264|711209|P3|STARTED|Overall Study||68
291140|NCT00212264|711210|P2|STARTED|Overall Study||70
291141|NCT00212264|711211|P1|STARTED|Overall Study||70
291142|NCT00212134|711223|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
291143|NCT00212134|711224|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
291144|NCT00212134|711223|P2|COMPLETED|Phase 3 (Age 10 Years)||35
291145|NCT00212134|711224|P1|COMPLETED|Phase 3 (Age 10 Years)||36
291146|NCT00212134|711223|P2|STARTED|Phase 3 (Age 10 Years)||56
291147|NCT00212134|711224|P1|STARTED|Phase 3 (Age 10 Years)||57
291148|NCT00212134|711223|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
291149|NCT00212134|711224|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
291150|NCT00212134|711223|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
291151|NCT00212134|711224|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
291152|NCT00212134|711223|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
291153|NCT00212134|711224|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
291154|NCT00212134|711223|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
291155|NCT00212134|711224|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
291156|NCT00212134|711223|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
291157|NCT00212134|711224|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
291158|NCT00212134|711223|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
291159|NCT00212134|711224|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
291160|NCT00212134|711223|P2|STARTED|Phase 1 (to Age 1 Year)||57
291161|NCT00212134|711224|P1|STARTED|Phase 1 (to Age 1 Year)||57
291162|NCT00211887|711245|P3|NOT COMPLETED|Overall Study||36
291163|NCT00211887|711246|P2|NOT COMPLETED|Overall Study||56
291164|NCT00211887|711247|P1|NOT COMPLETED|Overall Study||102
291165|NCT00211887|711245|P3|COMPLETED|Overall Study||223
291166|NCT00211887|711246|P2|COMPLETED|Overall Study||194
291167|NCT00211887|711247|P1|COMPLETED|Overall Study||397
291168|NCT00211887|711245|P3|STARTED|Overall Study||259
291169|NCT00211887|711246|P2|STARTED|Overall Study||250
291170|NCT00211887|711247|P1|STARTED|Overall Study||499
291171|NCT00211809|711264|P1|NOT COMPLETED|Overall Study||6
291172|NCT00211809|711264|P1|COMPLETED|Overall Study||11
291173|NCT00211809|711264|P1|STARTED|Overall Study||17
291174|NCT00211692|711280|P2|NOT COMPLETED|Overall Study||0
291175|NCT00211692|711281|P1|NOT COMPLETED|Overall Study||0
291176|NCT00211692|711280|P2|COMPLETED|Overall Study||31
291177|NCT00211692|711281|P1|COMPLETED|Overall Study||33
291178|NCT00211692|711280|P2|STARTED|Overall Study||31
291179|NCT00211692|711281|P1|STARTED|Overall Study||33
291180|NCT00211536|711291|P2|NOT COMPLETED|Overall Study||7
291181|NCT00211536|711292|P1|NOT COMPLETED|Overall Study||4
291182|NCT00211536|711291|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
291183|NCT00211536|711292|P1|COMPLETED|Overall Study||49
291184|NCT00211536|711291|P2|As Treated Data Analysis Set|Overall Study||48
291185|NCT00211536|711292|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
291186|NCT00211536|711291|P2|STARTED|Overall Study||54
291187|NCT00211536|711292|P1|STARTED|Overall Study||53
291188|NCT00211510|711308|P2|NOT COMPLETED|Overall Study||2
291189|NCT00211510|711309|P1|NOT COMPLETED|Overall Study||6
291190|NCT00211510|711308|P2|COMPLETED|Overall Study||72
291191|NCT00211510|711309|P1|COMPLETED|Overall Study||66
291192|NCT00211510|711308|P2|STARTED|Overall Study||74
291193|NCT00211510|711309|P1|STARTED|Overall Study||72
291194|NCT00211237|711327|P3|NOT COMPLETED|12 Months||6
291195|NCT00211237|711328|P2|NOT COMPLETED|12 Months||2
291196|NCT00211237|711329|P1|NOT COMPLETED|12 Months||9
291197|NCT00211237|711327|P3|COMPLETED|12 Months||28
291198|NCT00211237|711328|P2|COMPLETED|12 Months||6
291199|NCT00211237|711329|P1|COMPLETED|12 Months||40
291200|NCT00211237|711327|P3|STARTED|12 Months||34
291201|NCT00211237|711328|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
291202|NCT00211237|711329|P1|STARTED|12 Months||49
291203|NCT00211237|711327|P3|NOT COMPLETED|6 Months||3
291204|NCT00211237|711328|P2|NOT COMPLETED|6 Months||2
291205|NCT00211237|711329|P1|NOT COMPLETED|6 Months||8
291206|NCT00211237|711327|P3|COMPLETED|6 Months||33
291207|NCT00211237|711328|P2|COMPLETED|6 Months||9
291208|NCT00211237|711329|P1|COMPLETED|6 Months||49
291209|NCT00211237|711327|P3|STARTED|6 Months||36
291210|NCT00211237|711328|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
291211|NCT00211237|711329|P1|STARTED|6 Months||57
291212|NCT00211237|711327|P3|NOT COMPLETED|3 Months||1
291213|NCT00211237|711328|P2|NOT COMPLETED|3 Months||4
291214|NCT00211237|711329|P1|NOT COMPLETED|3 Months||8
291215|NCT00211237|711327|P3|COMPLETED|3 Months||33
291216|NCT00211237|711328|P2|COMPLETED|3 Months||14
291217|NCT00211237|711329|P1|COMPLETED|3 Months||57
291218|NCT00211237|711327|P3|STARTED|3 Months||34
291219|NCT00211237|711328|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
291220|NCT00211237|711329|P1|STARTED|3 Months||65
291221|NCT00211237|711327|P3|NOT COMPLETED|1 Month||0
291222|NCT00211237|711328|P2|NOT COMPLETED|1 Month||9
291223|NCT00211237|711329|P1|NOT COMPLETED|1 Month||3
291224|NCT00211237|711327|P3|COMPLETED|1 Month||0
291225|NCT00211237|711328|P2|COMPLETED|1 Month||52
291226|NCT00211237|711329|P1|COMPLETED|1 Month||65
291227|NCT00211237|711327|P3|STARTED|1 Month||0
291228|NCT00211237|711328|P2|STARTED|1 Month||61
291229|NCT00211237|711329|P1|STARTED|1 Month||68
291230|NCT00211237|711327|P3|NOT COMPLETED|Baseline||0
291231|NCT00211237|711328|P2|NOT COMPLETED|Baseline||3
291232|NCT00211237|711329|P1|NOT COMPLETED|Baseline||2
291233|NCT00211237|711327|P3|COMPLETED|Baseline||0
291234|NCT00211237|711328|P2|COMPLETED|Baseline||61
291235|NCT00211237|711329|P1|COMPLETED|Baseline||68
291236|NCT00211237|711327|P3|STARTED|Baseline||0
291237|NCT00211237|711328|P2|STARTED|Baseline||64
291238|NCT00211237|711329|P1|STARTED|Baseline||70
291239|NCT00211172|711421|P2|NOT COMPLETED|Overall Study||32
291240|NCT00211172|711422|P1|NOT COMPLETED|Overall Study||39
291241|NCT00211172|711421|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
291242|NCT00211172|711422|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
291243|NCT00211172|711421|P2|STARTED|Overall Study||458
291244|NCT00211172|711422|P1|STARTED|Overall Study||449
291245|NCT00211081|711428|P1|NOT COMPLETED|Overall Study||2
291246|NCT00211081|711428|P1|COMPLETED|Overall Study||10
291247|NCT00211081|711428|P1|STARTED|Overall Study||12
291248|NCT00210639|711440|P2|NOT COMPLETED|Overall Study||42
291249|NCT00210639|711441|P1|NOT COMPLETED|Overall Study||63
291250|NCT00210639|711440|P2|COMPLETED|Overall Study||41
291251|NCT00210639|711441|P1|COMPLETED|Overall Study||61
291252|NCT00210639|711440|P2|STARTED|Overall Study||83
291253|NCT00210639|711441|P1|STARTED|Overall Study||124
291254|NCT00210626|711449|P2|NOT COMPLETED|Overall Study||45
291255|NCT00210626|711450|P1|NOT COMPLETED|Overall Study||48
291256|NCT00210626|711449|P2|COMPLETED|Overall Study||50
291257|NCT00210626|711450|P1|COMPLETED|Overall Study||49
291258|NCT00210626|711449|P2|STARTED|Overall Study||95
291259|NCT00210626|711450|P1|STARTED|Overall Study||97
291260|NCT00210470|711458|P1|NOT COMPLETED|Overall Study||1
291261|NCT00210470|711458|P1|COMPLETED|Overall Study||26
291262|NCT00210470|711458|P1|STARTED|Overall Study||27
291263|NCT00209560|711464|P2|NOT COMPLETED|Overall Study||0
291264|NCT00209560|711465|P1|NOT COMPLETED|Overall Study||1
291265|NCT00209560|711464|P2|COMPLETED|Overall Study||42
291266|NCT00209560|711465|P1|COMPLETED|Overall Study||120
291267|NCT00209560|711464|P2|STARTED|Overall Study||42
291268|NCT00209560|711465|P1|STARTED|Overall Study||121
291269|NCT00209417|711475|P2|NOT COMPLETED|Overall Study||0
291270|NCT00209417|711476|P1|NOT COMPLETED|Overall Study||0
291271|NCT00209417|711475|P2|COMPLETED|Overall Study||327
291272|NCT00209417|711476|P1|COMPLETED|Overall Study||321
291273|NCT00209417|711475|P2|STARTED|Overall Study||327
291274|NCT00209417|711476|P1|STARTED|Overall Study||321
291275|NCT00209339|711484|P1|NOT COMPLETED|At 5 Years Follow-up||8
291276|NCT00209339|711484|P1|COMPLETED|At 5 Years Follow-up||15
291277|NCT00209339|711484|P1|STARTED|At 5 Years Follow-up||23
291278|NCT00209339|711484|P1|NOT COMPLETED|At 4 Years Follow-up||5
291279|NCT00209339|711484|P1|COMPLETED|At 4 Years Follow-up||23
291280|NCT00209339|711484|P1|STARTED|At 4 Years Follow-up||28
291281|NCT00209339|711484|P1|NOT COMPLETED|At 3 Years Follow-up||1
291282|NCT00209339|711484|P1|COMPLETED|At 3 Years Follow-up||28
291283|NCT00209339|711484|P1|STARTED|At 3 Years Follow-up||29
291284|NCT00209339|711484|P1|NOT COMPLETED|At 24 Months Follow-up||11
291285|NCT00209339|711484|P1|COMPLETED|At 24 Months Follow-up||29
291286|NCT00209339|711484|P1|STARTED|At 24 Months Follow-up||40
291287|NCT00209339|711484|P1|NOT COMPLETED|At 12 Months Follow-up||15
291288|NCT00209339|711484|P1|COMPLETED|At 12 Months Follow-up||40
291289|NCT00209339|711484|P1|STARTED|At 12 Months Follow-up||55
291290|NCT00209274|711568|P2|NOT COMPLETED|Overall Study||47
291291|NCT00209274|711569|P1|NOT COMPLETED|Overall Study||71
291292|NCT00209274|711568|P2|COMPLETED|Overall Study||48
291293|NCT00209274|711569|P1|COMPLETED|Overall Study||113
291294|NCT00209274|711568|P2|STARTED|Overall Study||95
291295|NCT00209274|711569|P1|STARTED|Overall Study||184
291296|NCT00209170|711889|P2|NOT COMPLETED|Overall Study||3
291297|NCT00209170|711890|P1|NOT COMPLETED|Overall Study||2
291298|NCT00209170|711889|P2|COMPLETED|Overall Study||4
291299|NCT00209170|711890|P1|COMPLETED|Overall Study||5
291300|NCT00209170|711889|P2|STARTED|Overall Study||7
291301|NCT00209170|711890|P1|STARTED|Overall Study||7
291302|NCT00209131|711898|P2|NOT COMPLETED|Overall Study||11
291303|NCT00209131|711899|P1|NOT COMPLETED|Overall Study||15
291304|NCT00209131|711898|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
291305|NCT00209131|711899|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
291306|NCT00209131|711898|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
291307|NCT00209131|711899|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
291308|NCT00209092|711909|P2|NOT COMPLETED|Overall Study||2
291309|NCT00209092|711910|P1|NOT COMPLETED|Overall Study||8
291310|NCT00209092|711909|P2|COMPLETED|Overall Study||24
291311|NCT00209092|711910|P1|COMPLETED|Overall Study||17
291312|NCT00209092|711909|P2|STARTED|Overall Study||26
291313|NCT00209092|711910|P1|STARTED|Overall Study||25
291314|NCT00209027|711920|P2|NOT COMPLETED|Overall Study||0
291315|NCT00209027|711921|P1|NOT COMPLETED|Overall Study||10
291316|NCT00209027|711920|P2|COMPLETED|Overall Study||10
291317|NCT00209027|711921|P1|COMPLETED|Overall Study||0
291318|NCT00209027|711920|P2|STARTED|Overall Study||10
291319|NCT00209027|711921|P1|STARTED|Overall Study||10
291320|NCT00208975|711927|P1|NOT COMPLETED|Overall Study||0
291321|NCT00208975|711927|P1|COMPLETED|Overall Study||15
291322|NCT00208975|711927|P1|STARTED|Overall Study||15
291323|NCT00208949|711934|P2|NOT COMPLETED|Overall Study||0
291324|NCT00208949|711935|P1|NOT COMPLETED|Overall Study||0
291325|NCT00208949|711934|P2|COMPLETED|Overall Study||25
291326|NCT00208949|711935|P1|COMPLETED|Overall Study||25
291327|NCT00208949|711934|P2|STARTED|Overall Study||25
291328|NCT00208949|711935|P1|STARTED|Overall Study||25
291329|NCT00208767|711945|P2|NOT COMPLETED|Overall Study||7
291330|NCT00208767|711946|P1|NOT COMPLETED|Overall Study||27
291331|NCT00208767|711945|P2|COMPLETED|Overall Study||33
291332|NCT00208767|711946|P1|COMPLETED|Overall Study||53
291333|NCT00208767|711945|P2|STARTED|Overall Study||40
291334|NCT00208767|711946|P1|STARTED|Overall Study||80
291335|NCT00208507|711954|P2|NOT COMPLETED|Overall Study||8
291336|NCT00208507|711955|P1|NOT COMPLETED|Overall Study||14
291337|NCT00208507|711954|P2|COMPLETED|Overall Study||79
291338|NCT00208507|711955|P1|COMPLETED|Overall Study||163
291339|NCT00208507|711954|P2|STARTED|Overall Study||87
291340|NCT00208507|711955|P1|STARTED|Overall Study||177
291341|NCT00208494|711963|P2|NOT COMPLETED|Overall Study||34
291342|NCT00208494|711964|P1|NOT COMPLETED|Overall Study||30
291343|NCT00208494|711963|P2|COMPLETED|Overall Study||162
291344|NCT00208494|711964|P1|COMPLETED|Overall Study||164
291345|NCT00208494|711963|P2|STARTED|Overall Study||196
291346|NCT00208494|711964|P1|STARTED|Overall Study||194
291347|NCT00208325|711974|P4|NOT COMPLETED|Overall Study||14
291348|NCT00208325|711975|P3|NOT COMPLETED|Overall Study||14
291349|NCT00208325|711976|P2|NOT COMPLETED|Overall Study||54
291350|NCT00208325|711977|P1|NOT COMPLETED|Overall Study||51
291351|NCT00208325|711974|P4|COMPLETED|Overall Study||147
291352|NCT00208325|711975|P3|COMPLETED|Overall Study||156
291353|NCT00208325|711976|P2|COMPLETED|Overall Study||142
291354|NCT00208325|711977|P1|COMPLETED|Overall Study||142
291355|NCT00208325|711974|P4|STARTED|Overall Study||161
291356|NCT00208325|711975|P3|STARTED|Overall Study||170
291357|NCT00208325|711976|P2|STARTED|Overall Study||196
291358|NCT00208325|711977|P1|STARTED|Overall Study||193
291359|NCT00208091|712085|P1|NOT COMPLETED|Overall Study||0
291360|NCT00208091|712085|P1|COMPLETED|Overall Study||16
291361|NCT00208091|712085|P1|STARTED|Overall Study||16
291362|NCT00208026|712093|P1|NOT COMPLETED|Overall Study||0
291363|NCT00208026|712093|P1|COMPLETED|Overall Study||3
291364|NCT00208026|712093|P1|STARTED|Overall Study||3
291365|NCT00207883|712099|P2|NOT COMPLETED|Overall Study||0
291366|NCT00207883|712100|P1|NOT COMPLETED|Overall Study||0
291367|NCT00207883|712099|P2|COMPLETED|Overall Study||119
291368|NCT00207883|712100|P1|COMPLETED|Overall Study||93
291369|NCT00207883|712099|P2|STARTED|Overall Study||119
291370|NCT00207883|712100|P1|STARTED|Overall Study||93
291371|NCT00207740|712112|P4|NOT COMPLETED|Overall Study||43
291372|NCT00207740|712113|P3|NOT COMPLETED|Overall Study||40
291373|NCT00207740|712114|P2|NOT COMPLETED|Overall Study||41
291374|NCT00207740|712115|P1|NOT COMPLETED|Overall Study||29
291375|NCT00207740|712112|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
291376|NCT00207740|712113|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
291377|NCT00207740|712114|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
291378|NCT00207740|712115|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
291379|NCT00207740|712112|P4|STARTED|Overall Study||78
291380|NCT00207740|712113|P3|STARTED|Overall Study||76
291381|NCT00207740|712114|P2|STARTED|Overall Study||77
291382|NCT00207740|712115|P1|STARTED|Overall Study||78
291383|NCT00207727|712161|P5|NOT COMPLETED|Overall Study||34
291384|NCT00207727|712162|P4|NOT COMPLETED|Overall Study||37
291385|NCT00207727|712163|P3|NOT COMPLETED|Overall Study||41
291386|NCT00207727|712164|P2|NOT COMPLETED|Overall Study||42
291387|NCT00207727|712165|P1|NOT COMPLETED|Overall Study||38
291388|NCT00207727|712161|P5|COMPLETED|Overall Study||16
291389|NCT00207727|712162|P4|COMPLETED|Overall Study||13
291390|NCT00207727|712163|P3|COMPLETED|Overall Study||9
291391|NCT00207727|712164|P2|COMPLETED|Overall Study||8
291392|NCT00207727|712165|P1|COMPLETED|Overall Study||11
291393|NCT00207727|712161|P5|STARTED|Overall Study||50
291394|NCT00207727|712162|P4|STARTED|Overall Study||50
291395|NCT00207727|712163|P3|STARTED|Overall Study||50
291396|NCT00207727|712164|P2|STARTED|Overall Study||50
291397|NCT00207727|712165|P1|STARTED|Overall Study||49
291398|NCT00207714|712192|P5|NOT COMPLETED|Overall Study||5
291399|NCT00207714|712193|P4|NOT COMPLETED|Overall Study||8
291400|NCT00207714|712194|P3|NOT COMPLETED|Overall Study||10
291401|NCT00207714|712195|P2|NOT COMPLETED|Overall Study||7
291402|NCT00207714|712196|P1|NOT COMPLETED|Overall Study||14
291403|NCT00207714|712192|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
291404|NCT00207714|712193|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
291405|NCT00207714|712194|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
291406|NCT00207714|712195|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
291407|NCT00207714|712196|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
291408|NCT00207714|712192|P5|STARTED|Overall Study||34
291409|NCT00207714|712193|P4|STARTED|Overall Study||34
291410|NCT00207714|712194|P3|STARTED|Overall Study||34
291411|NCT00207714|712195|P2|STARTED|Overall Study||35
291412|NCT00207714|712196|P1|STARTED|Overall Study||35
291413|NCT00207142|712218|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
291414|NCT00207142|712219|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
291415|NCT00207142|712220|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
291416|NCT00207142|712221|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
291417|NCT00207142|712218|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
291418|NCT00207142|712219|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
291419|NCT00207142|712220|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
291420|NCT00207142|712221|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
291421|NCT00207142|712218|P4|STARTED|Maintenance Phase/Rescue Phase||50
291422|NCT00207142|712219|P3|STARTED|Maintenance Phase/Rescue Phase||85
291423|NCT00207142|712220|P2|STARTED|Maintenance Phase/Rescue Phase||87
291424|NCT00207142|712221|P1|STARTED|Maintenance Phase/Rescue Phase||0
291425|NCT00207142|712218|P4|NOT COMPLETED|Induction Phase||0
291426|NCT00207142|712219|P3|NOT COMPLETED|Induction Phase||0
291427|NCT00207142|712220|P2|NOT COMPLETED|Induction Phase||0
291428|NCT00207142|712221|P1|NOT COMPLETED|Induction Phase||30
291429|NCT00207142|712218|P4|COMPLETED|Induction Phase||0
291430|NCT00207142|712219|P3|COMPLETED|Induction Phase||0
291431|NCT00207142|712220|P2|COMPLETED|Induction Phase||0
291432|NCT00207142|712221|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
291433|NCT00207142|712218|P4|STARTED|Induction Phase||0
291434|NCT00207142|712219|P3|STARTED|Induction Phase||0
291435|NCT00207142|712220|P2|STARTED|Induction Phase||0
291436|NCT00207142|712221|P1|STARTED|Induction Phase||252
291437|NCT00207090|712258|P1|NOT COMPLETED|Overall Study||7
291438|NCT00207090|712258|P1|COMPLETED|Overall Study||8
291439|NCT00207090|712258|P1|STARTED|Overall Study|Number of participants treated|15
291440|NCT00206726|712287|P1|NOT COMPLETED|Overall Study||51
291441|NCT00206726|712287|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
291442|NCT00206726|712287|P1|4 Cycles Completed|Overall Study|per protocol population|41
291443|NCT00206726|712287|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
291444|NCT00206726|712287|P1|STARTED|Overall Study||60
291445|NCT00206518|712298|P2|NOT COMPLETED|Overall Study||6
291446|NCT00206518|712299|P1|NOT COMPLETED|Overall Study||10
291447|NCT00206518|712298|P2|COMPLETED|Overall Study||78
291448|NCT00206518|712299|P1|COMPLETED|Overall Study||73
291449|NCT00206518|712298|P2|STARTED|Overall Study||84
291450|NCT00206518|712299|P1|STARTED|Overall Study||83
291451|NCT00206440|712311|P2|NOT COMPLETED|Overall Study||4
291452|NCT00206440|712312|P1|NOT COMPLETED|Overall Study||5
291453|NCT00206440|712311|P2|COMPLETED|Overall Study||18
291454|NCT00206440|712312|P1|COMPLETED|Overall Study||16
291455|NCT00206440|712311|P2|STARTED|Overall Study||22
291456|NCT00206440|712312|P1|STARTED|Overall Study||21
291457|NCT00206427|712318|P1|NOT COMPLETED|Overall Study||2
291458|NCT00206427|712318|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
291459|NCT00206427|712318|P1|STARTED|Overall Study|Received First Dose|49
291460|NCT00206336|712322|P1|NOT COMPLETED|Overall Study||0
291461|NCT00206336|712322|P1|COMPLETED|Overall Study||20
291462|NCT00206336|712322|P1|STARTED|Overall Study||20
291463|NCT00206323|712328|P2|NOT COMPLETED|Overall Study||3
291464|NCT00206323|712329|P1|NOT COMPLETED|Overall Study||6
291465|NCT00206323|712328|P2|COMPLETED|Overall Study||12
291466|NCT00206323|712329|P1|COMPLETED|Overall Study||8
291467|NCT00206323|712328|P2|STARTED|Overall Study||15
291468|NCT00206323|712329|P1|STARTED|Overall Study||14
291469|NCT00206102|712337|P2|NOT COMPLETED|Overall Study||315
291470|NCT00206102|712338|P1|NOT COMPLETED|Overall Study||408
291471|NCT00206102|712337|P2|COMPLETED|Overall Study||187
291472|NCT00206102|712338|P1|COMPLETED|Overall Study||188
291473|NCT00206102|712337|P2|STARTED|Overall Study||502
291474|NCT00206102|712338|P1|STARTED|Overall Study||596
291475|NCT00206076|712374|P2|NOT COMPLETED|Overall Study||1
291476|NCT00206076|712375|P1|NOT COMPLETED|Overall Study||3
291477|NCT00206076|712374|P2|COMPLETED|Overall Study||9
291478|NCT00206076|712375|P1|COMPLETED|Overall Study||6
291479|NCT00206076|712374|P2|STARTED|Overall Study||10
291480|NCT00206076|712375|P1|STARTED|Overall Study||9
291481|NCT00205881|712385|P1|NOT COMPLETED|Overall Study||16
291482|NCT00205881|712385|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
291483|NCT00205881|712385|P1|STARTED|Overall Study||32
291484|NCT00205855|712390|P1|NOT COMPLETED|Overall Study||21
291485|NCT00205855|712390|P1|COMPLETED|Overall Study||44
291486|NCT00205855|712390|P1|STARTED|Overall Study||65
291487|NCT00205803|712396|P2|NOT COMPLETED|Toddler Dose||3
291488|NCT00205803|712397|P1|NOT COMPLETED|Toddler Dose||2
291489|NCT00205803|712396|P2|COMPLETED|Toddler Dose||100
291490|NCT00205803|712397|P1|COMPLETED|Toddler Dose||84
291491|NCT00205803|712396|P2|STARTED|Toddler Dose||103
291492|NCT00205803|712397|P1|STARTED|Toddler Dose||86
291493|NCT00205803|712396|P2|NOT COMPLETED|After Infant Series||13
291494|NCT00205803|712397|P1|NOT COMPLETED|After Infant Series||18
291495|NCT00205803|712396|P2|COMPLETED|After Infant Series||103
291496|NCT00205803|712397|P1|COMPLETED|After Infant Series||86
291497|NCT00205803|712396|P2|STARTED|After Infant Series||116
291498|NCT00205803|712397|P1|STARTED|After Infant Series||104
291499|NCT00205803|712396|P2|NOT COMPLETED|Infant Series||11
291500|NCT00205803|712397|P1|NOT COMPLETED|Infant Series||18
291501|NCT00205803|712396|P2|COMPLETED|Infant Series||116
291502|NCT00205803|712397|P1|COMPLETED|Infant Series||104
291503|NCT00205803|712396|P2|Vaccinated Dose 3|Infant Series||118
291504|NCT00205803|712397|P1|Vaccinated Dose 3|Infant Series||110
291505|NCT00205803|712396|P2|Vaccinated Dose 2|Infant Series||122
291506|NCT00205803|712397|P1|Vaccinated Dose 2|Infant Series||115
291507|NCT00205803|712396|P2|Vaccinated Dose 1|Infant Series||126
291508|NCT00205803|712397|P1|Vaccinated Dose 1|Infant Series||121
291509|NCT00205803|712396|P2|STARTED|Infant Series||127
291510|NCT00205803|712397|P1|STARTED|Infant Series||122
291511|NCT00205777|712453|P6|NOT COMPLETED|Study Extension II||282
291512|NCT00205777|712454|P5|NOT COMPLETED|Study Extension II||0
291513|NCT00205777|712455|P4|NOT COMPLETED|Study Extension II||149
291514|NCT00205777|712456|P3|NOT COMPLETED|Study Extension II||0
291515|NCT00205777|712457|P2|NOT COMPLETED|Study Extension II||0
291516|NCT00205777|712458|P1|NOT COMPLETED|Study Extension II||0
291517|NCT00205777|712453|P6|COMPLETED|Study Extension II||860
291518|NCT00205777|712454|P5|COMPLETED|Study Extension II||0
291519|NCT00205777|712455|P4|COMPLETED|Study Extension II||441
291520|NCT00205777|712456|P3|COMPLETED|Study Extension II||0
291521|NCT00205777|712457|P2|COMPLETED|Study Extension II||0
291522|NCT00205777|712458|P1|COMPLETED|Study Extension II||0
291523|NCT00205777|712453|P6|TREATED|Study Extension II||1011
291524|NCT00205777|712454|P5|TREATED|Study Extension II||0
291525|NCT00205777|712455|P4|TREATED|Study Extension II||519
291526|NCT00205777|712456|P3|TREATED|Study Extension II||0
291527|NCT00205777|712457|P2|TREATED|Study Extension II||0
291528|NCT00205777|712458|P1|TREATED|Study Extension II||0
291529|NCT00205777|712453|P6|STARTED|Study Extension II||1142
291530|NCT00205777|712454|P5|STARTED|Study Extension II||0
291531|NCT00205777|712455|P4|STARTED|Study Extension II||590
291532|NCT00205777|712456|P3|STARTED|Study Extension II||0
291533|NCT00205777|712457|P2|STARTED|Study Extension II||0
291534|NCT00205777|712458|P1|STARTED|Study Extension II||0
291535|NCT00205777|712453|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
291536|NCT00205777|712454|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
291537|NCT00205777|712455|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
291538|NCT00205777|712456|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
291539|NCT00205777|712457|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
291540|NCT00205777|712458|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
291541|NCT00205777|712453|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
291542|NCT00205777|712454|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
291543|NCT00205777|712455|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
291544|NCT00205777|712456|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
291545|NCT00205777|712457|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
291546|NCT00205777|712458|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
291547|NCT00205777|712453|P6|STARTED|Completed SE I, Entered Extension SE II||0
291548|NCT00205777|712454|P5|STARTED|Completed SE I, Entered Extension SE II||840
291549|NCT00205777|712455|P4|STARTED|Completed SE I, Entered Extension SE II||830
291550|NCT00205777|712456|P3|STARTED|Completed SE I, Entered Extension SE II||0
291551|NCT00205777|712457|P2|STARTED|Completed SE I, Entered Extension SE II||0
291552|NCT00205777|712458|P1|STARTED|Completed SE I, Entered Extension SE II||833
291553|NCT00205777|712453|P6|NOT COMPLETED|Study Extension I||0
291554|NCT00205777|712454|P5|NOT COMPLETED|Study Extension I||201
291555|NCT00205777|712455|P4|NOT COMPLETED|Study Extension I||228
291556|NCT00205777|712456|P3|NOT COMPLETED|Study Extension I||1070
291557|NCT00205777|712457|P2|NOT COMPLETED|Study Extension I||0
291558|NCT00205777|712458|P1|NOT COMPLETED|Study Extension I||214
291559|NCT00205777|712453|P6|COMPLETED|Study Extension I||0
291560|NCT00205777|712454|P5|COMPLETED|Study Extension I||840
291561|NCT00205777|712455|P4|COMPLETED|Study Extension I||830
291562|NCT00205777|712456|P3|COMPLETED|Study Extension I||0
291563|NCT00205777|712457|P2|COMPLETED|Study Extension I||0
291564|NCT00205777|712458|P1|COMPLETED|Study Extension I||833
291565|NCT00205777|712453|P6|STARTED|Study Extension I||0
291566|NCT00205777|712454|P5|STARTED|Study Extension I||1041
291567|NCT00205777|712455|P4|STARTED|Study Extension I||1058
291568|NCT00205777|712456|P3|STARTED|Study Extension I||1070
291569|NCT00205777|712457|P2|STARTED|Study Extension I||0
291570|NCT00205777|712458|P1|STARTED|Study Extension I||1047
291571|NCT00205777|712453|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
291572|NCT00205777|712454|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
291573|NCT00205777|712455|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
291574|NCT00205777|712456|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
291575|NCT00205777|712457|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
291576|NCT00205777|712458|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
291577|NCT00205777|712453|P6|COMPLETED|Completed Core Study, Entered SE I||0
291578|NCT00205777|712454|P5|COMPLETED|Completed Core Study, Entered SE I||0
291579|NCT00205777|712455|P4|COMPLETED|Completed Core Study, Entered SE I||1058
291580|NCT00205777|712456|P3|COMPLETED|Completed Core Study, Entered SE I||1070
291581|NCT00205777|712457|P2|COMPLETED|Completed Core Study, Entered SE I||1041
291582|NCT00205777|712458|P1|COMPLETED|Completed Core Study, Entered SE I||1047
291583|NCT00205777|712453|P6|STARTED|Completed Core Study, Entered SE I||0
291584|NCT00205777|712454|P5|STARTED|Completed Core Study, Entered SE I||0
291585|NCT00205777|712455|P4|STARTED|Completed Core Study, Entered SE I||1282
291586|NCT00205777|712456|P3|STARTED|Completed Core Study, Entered SE I||1277
291587|NCT00205777|712457|P2|STARTED|Completed Core Study, Entered SE I||1245
291588|NCT00205777|712458|P1|STARTED|Completed Core Study, Entered SE I||1279
291589|NCT00205777|712453|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
291590|NCT00205777|712454|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
291591|NCT00205777|712455|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
291592|NCT00205777|712456|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
291593|NCT00205777|712457|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
291594|NCT00205777|712458|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
291595|NCT00205777|712453|P6|COMPLETED|Core Study (Up to 3 Years)||0
291596|NCT00205777|712454|P5|COMPLETED|Core Study (Up to 3 Years)||0
291597|NCT00205777|712455|P4|COMPLETED|Core Study (Up to 3 Years)||1282
291598|NCT00205777|712456|P3|COMPLETED|Core Study (Up to 3 Years)||1277
291599|NCT00205777|712457|P2|COMPLETED|Core Study (Up to 3 Years)||1245
291600|NCT00205777|712458|P1|COMPLETED|Core Study (Up to 3 Years)||1279
291601|NCT00205777|712453|P6|TREATED|Core Study (Up to 3 Years)||0
291602|NCT00205777|712454|P5|TREATED|Core Study (Up to 3 Years)||0
291603|NCT00205777|712455|P4|TREATED|Core Study (Up to 3 Years)||1885
291604|NCT00205777|712456|P3|TREATED|Core Study (Up to 3 Years)||1849
291605|NCT00205777|712457|P2|TREATED|Core Study (Up to 3 Years)||1872
291606|NCT00205777|712458|P1|TREATED|Core Study (Up to 3 Years)||1886
291607|NCT00205777|712453|P6|STARTED|Core Study (Up to 3 Years)||0
291608|NCT00205777|712454|P5|STARTED|Core Study (Up to 3 Years)||0
291609|NCT00205777|712455|P4|STARTED|Core Study (Up to 3 Years)||1914
291610|NCT00205777|712456|P3|STARTED|Core Study (Up to 3 Years)||1884
291611|NCT00205777|712457|P2|STARTED|Core Study (Up to 3 Years)||1904
291612|NCT00205777|712458|P1|STARTED|Core Study (Up to 3 Years)||1907
291613|NCT00205712|712667|P2|NOT COMPLETED|Overall Study||1
291614|NCT00205712|712668|P1|NOT COMPLETED|Overall Study||0
291615|NCT00205712|712667|P2|COMPLETED|Overall Study||19
291616|NCT00205712|712668|P1|COMPLETED|Overall Study||20
291617|NCT00205712|712667|P2|STARTED|Overall Study||20
291618|NCT00205712|712668|P1|STARTED|Overall Study||20
291619|NCT00205504|712680|P2|NOT COMPLETED|Overall Study||0
291620|NCT00205504|712681|P1|NOT COMPLETED|Overall Study||7
291621|NCT00205504|712680|P2|COMPLETED|Overall Study||15
291622|NCT00205504|712681|P1|COMPLETED|Overall Study||14
291623|NCT00205504|712680|P2|STARTED|Overall Study||15
291624|NCT00205504|712681|P1|STARTED|Overall Study||21
291625|NCT00205374|712707|P2|NOT COMPLETED|Overall Study||0
291626|NCT00205374|712708|P1|NOT COMPLETED|Overall Study||0
291627|NCT00205374|712707|P2|COMPLETED|Overall Study||9
291628|NCT00205374|712708|P1|COMPLETED|Overall Study||10
291629|NCT00205374|712707|P2|STARTED|Overall Study||9
291630|NCT00205374|712708|P1|STARTED|Overall Study||10
291631|NCT00205348|712716|P1|NOT COMPLETED|Overall Study||30
291632|NCT00205348|712716|P1|COMPLETED|Overall Study||116
291633|NCT00205348|712716|P1|STARTED|Overall Study||146
291634|NCT00205049|712722|P2|NOT COMPLETED|Overall Study||0
291635|NCT00205049|712723|P1|NOT COMPLETED|Overall Study||0
291636|NCT00205049|712722|P2|COMPLETED|Overall Study||0
291637|NCT00205049|712723|P1|COMPLETED|Overall Study||0
291638|NCT00205049|712722|P2|STARTED|Overall Study||0
291639|NCT00205049|712723|P1|STARTED|Overall Study||0
291640|NCT00204932|712731|P2|NOT COMPLETED|Overall Study||6
291641|NCT00204932|712732|P1|NOT COMPLETED|Overall Study||2
291642|NCT00204932|712731|P2|COMPLETED|Overall Study||18
291643|NCT00204932|712732|P1|COMPLETED|Overall Study||22
291644|NCT00204932|712731|P2|STARTED|Overall Study||24
291645|NCT00204932|712732|P1|STARTED|Overall Study||24
291646|NCT00204373|712738|P1|NOT COMPLETED|Overall Study||0
291647|NCT00204373|712738|P1|COMPLETED|Overall Study||72
291648|NCT00204373|712738|P1|STARTED|Overall Study||72
291649|NCT00203996|712749|P10|NOT COMPLETED|Overall Study||1
291650|NCT00203996|712750|P9|NOT COMPLETED|Overall Study||0
291651|NCT00203996|712751|P8|NOT COMPLETED|Overall Study||2
291652|NCT00203996|712752|P7|NOT COMPLETED|Overall Study||0
291653|NCT00203996|712753|P6|NOT COMPLETED|Overall Study||0
291654|NCT00203996|712754|P5|NOT COMPLETED|Overall Study||1
291655|NCT00203996|712755|P4|NOT COMPLETED|Overall Study||10
291656|NCT00203996|712756|P3|NOT COMPLETED|Overall Study||0
291657|NCT00203996|712757|P2|NOT COMPLETED|Overall Study||0
291658|NCT00203996|712758|P1|NOT COMPLETED|Overall Study||0
291659|NCT00203996|712749|P10|COMPLETED|Overall Study||2
291660|NCT00203996|712750|P9|COMPLETED|Overall Study||2
291661|NCT00203996|712751|P8|COMPLETED|Overall Study||2
291662|NCT00203996|712752|P7|COMPLETED|Overall Study||2
291663|NCT00203996|712753|P6|COMPLETED|Overall Study||3
291664|NCT00203996|712754|P5|COMPLETED|Overall Study||3
291665|NCT00203996|712755|P4|COMPLETED|Overall Study||9
291666|NCT00203996|712756|P3|COMPLETED|Overall Study||0
291667|NCT00203996|712757|P2|COMPLETED|Overall Study||0
291668|NCT00203996|712758|P1|COMPLETED|Overall Study||0
291669|NCT00203996|712749|P10|Aim 3 Only: Third Intervention|Overall Study||2
291670|NCT00203996|712750|P9|Aim 3 Only: Third Intervention|Overall Study||2
291671|NCT00203996|712751|P8|Aim 3 Only: Third Intervention|Overall Study||2
291672|NCT00203996|712752|P7|Aim 3 Only: Third Intervention|Overall Study||2
291673|NCT00203996|712753|P6|Aim 3 Only: Third Intervention|Overall Study||3
291674|NCT00203996|712754|P5|Aim 3 Only: Third Intervention|Overall Study||0
291675|NCT00203996|712755|P4|Aim 3 Only: Third Intervention|Overall Study||0
291676|NCT00203996|712756|P3|Aim 3 Only: Third Intervention|Overall Study||0
291677|NCT00203996|712757|P2|Aim 3 Only: Third Intervention|Overall Study||0
291678|NCT00203996|712758|P1|Aim 3 Only: Third Intervention|Overall Study||0
291679|NCT00203996|712749|P10|Aim 3 Only: Second Washout|Overall Study||2
291680|NCT00203996|712750|P9|Aim 3 Only: Second Washout|Overall Study||2
291681|NCT00203996|712751|P8|Aim 3 Only: Second Washout|Overall Study||2
291682|NCT00203996|712752|P7|Aim 3 Only: Second Washout|Overall Study||2
291683|NCT00203996|712753|P6|Aim 3 Only: Second Washout|Overall Study||3
291684|NCT00203996|712754|P5|Aim 3 Only: Second Washout|Overall Study||0
291685|NCT00203996|712755|P4|Aim 3 Only: Second Washout|Overall Study||0
291686|NCT00203996|712756|P3|Aim 3 Only: Second Washout|Overall Study||0
291687|NCT00203996|712757|P2|Aim 3 Only: Second Washout|Overall Study||0
291688|NCT00203996|712758|P1|Aim 3 Only: Second Washout|Overall Study||0
291689|NCT00203996|712749|P10|Aim 3 Only: Second Intervention|Overall Study||2
291690|NCT00203996|712750|P9|Aim 3 Only: Second Intervention|Overall Study||2
291691|NCT00203996|712751|P8|Aim 3 Only: Second Intervention|Overall Study||2
291692|NCT00203996|712752|P7|Aim 3 Only: Second Intervention|Overall Study||2
291693|NCT00203996|712753|P6|Aim 3 Only: Second Intervention|Overall Study||3
291694|NCT00203996|712754|P5|Aim 3 Only: Second Intervention|Overall Study||0
291695|NCT00203996|712755|P4|Aim 3 Only: Second Intervention|Overall Study||0
291696|NCT00203996|712756|P3|Aim 3 Only: Second Intervention|Overall Study||0
291697|NCT00203996|712757|P2|Aim 3 Only: Second Intervention|Overall Study||0
291698|NCT00203996|712758|P1|Aim 3 Only: Second Intervention|Overall Study||0
291699|NCT00203996|712749|P10|Aim 3 Only: Washout|Overall Study||2
291700|NCT00203996|712750|P9|Aim 3 Only: Washout|Overall Study||2
291701|NCT00203996|712751|P8|Aim 3 Only: Washout|Overall Study||2
291702|NCT00203996|712752|P7|Aim 3 Only: Washout|Overall Study||2
291703|NCT00203996|712753|P6|Aim 3 Only: Washout|Overall Study||3
291704|NCT00203996|712754|P5|Aim 3 Only: Washout|Overall Study||0
291705|NCT00203996|712755|P4|Aim 3 Only: Washout|Overall Study||0
291706|NCT00203996|712756|P3|Aim 3 Only: Washout|Overall Study||0
291707|NCT00203996|712757|P2|Aim 3 Only: Washout|Overall Study||0
291708|NCT00203996|712758|P1|Aim 3 Only: Washout|Overall Study||0
291709|NCT00203996|712749|P10|Aim 3 Only: First Intervention|Overall Study||3
291710|NCT00203996|712750|P9|Aim 3 Only: First Intervention|Overall Study||2
291711|NCT00203996|712751|P8|Aim 3 Only: First Intervention|Overall Study||4
291712|NCT00203996|712752|P7|Aim 3 Only: First Intervention|Overall Study||2
291713|NCT00203996|712753|P6|Aim 3 Only: First Intervention|Overall Study||3
291714|NCT00203996|712754|P5|Aim 3 Only: First Intervention|Overall Study||0
291715|NCT00203996|712755|P4|Aim 3 Only: First Intervention|Overall Study||0
291716|NCT00203996|712756|P3|Aim 3 Only: First Intervention|Overall Study||0
291717|NCT00203996|712757|P2|Aim 3 Only: First Intervention|Overall Study||0
291718|NCT00203996|712758|P1|Aim 3 Only: First Intervention|Overall Study||0
291719|NCT00203996|712749|P10|STARTED|Overall Study||3
291720|NCT00203996|712750|P9|STARTED|Overall Study||2
291721|NCT00203996|712751|P8|STARTED|Overall Study||4
291722|NCT00203996|712752|P7|STARTED|Overall Study||2
291723|NCT00203996|712753|P6|STARTED|Overall Study||3
291724|NCT00203996|712754|P5|STARTED|Overall Study||4
291725|NCT00203996|712755|P4|STARTED|Overall Study||19
291726|NCT00203996|712756|P3|STARTED|Overall Study||0
291727|NCT00203996|712757|P2|STARTED|Overall Study||0
291728|NCT00203996|712758|P1|STARTED|Overall Study||0
291729|NCT00203931|712807|P2|NOT COMPLETED|Overall Study||5
291730|NCT00203931|712808|P1|NOT COMPLETED|Overall Study||7
291731|NCT00203931|712807|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
291732|NCT00203931|712808|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
291733|NCT00203931|712807|P2|STARTED|Overall Study||28
291734|NCT00203931|712808|P1|STARTED|Overall Study||27
291735|NCT00203892|712825|P3|NOT COMPLETED|Overall Study||0
291736|NCT00203892|712826|P2|NOT COMPLETED|Overall Study||2
291737|NCT00203892|712827|P1|NOT COMPLETED|Overall Study||2
291738|NCT00203892|712825|P3|COMPLETED|Overall Study||6
291739|NCT00203892|712826|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
291740|NCT00203892|712827|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
291741|NCT00203892|712825|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
291742|NCT00203892|712826|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
291743|NCT00203892|712827|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
291744|NCT00203892|712825|P3|STARTED|Overall Study||6
291745|NCT00203892|712826|P2|STARTED|Overall Study||10
291746|NCT00203892|712827|P1|STARTED|Overall Study||7
291747|NCT00203502|712838|P1|NOT COMPLETED|Overall Study||1
291748|NCT00203502|712838|P1|COMPLETED|Overall Study||39
291749|NCT00203502|712838|P1|STARTED|Overall Study||40
291750|NCT00203476|712849|P3|NOT COMPLETED|Overall Study||0
291751|NCT00203476|712850|P2|NOT COMPLETED|Overall Study||1
291752|NCT00203476|712851|P1|NOT COMPLETED|Overall Study||1
291753|NCT00203476|712849|P3|COMPLETED|Overall Study||10
291754|NCT00203476|712850|P2|COMPLETED|Overall Study||9
291755|NCT00203476|712851|P1|COMPLETED|Overall Study||9
291756|NCT00203476|712849|P3|STARTED|Overall Study||10
291757|NCT00203476|712850|P2|STARTED|Overall Study||10
291758|NCT00203476|712851|P1|STARTED|Overall Study||10
291759|NCT00203424|712868|P1|NOT COMPLETED|Follow-up Period||6
291760|NCT00203424|712868|P1|COMPLETED|Follow-up Period||10
291761|NCT00203424|712868|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
291762|NCT00203424|712868|P1|NOT COMPLETED|Treatment Period||11
291763|NCT00203424|712868|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
291764|NCT00203424|712868|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
291765|NCT00203411|712875|P1|NOT COMPLETED|Follow-up||4
291766|NCT00203411|712875|P1|COMPLETED|Follow-up||41
291767|NCT00203411|712875|P1|STARTED|Follow-up||45
291768|NCT00203411|712875|P1|NOT COMPLETED|Treatment Period||0
291769|NCT00203411|712875|P1|COMPLETED|Treatment Period||45
291770|NCT00203411|712875|P1|STARTED|Treatment Period||45
291771|NCT00203307|712884|P2|NOT COMPLETED|Second Intervention||0
291772|NCT00203307|712885|P1|NOT COMPLETED|Second Intervention||0
291773|NCT00203307|712884|P2|COMPLETED|Second Intervention||0
291774|NCT00203307|712885|P1|COMPLETED|Second Intervention||1
291775|NCT00203307|712884|P2|STARTED|Second Intervention||0
291776|NCT00203307|712885|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
291777|NCT00203307|712884|P2|NOT COMPLETED|First Intervention||0
291778|NCT00203307|712885|P1|NOT COMPLETED|First Intervention||2
291779|NCT00203307|712884|P2|COMPLETED|First Intervention||0
291780|NCT00203307|712885|P1|COMPLETED|First Intervention||1
291781|NCT00203307|712884|P2|STARTED|First Intervention||0
291782|NCT00203307|712885|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
291783|NCT00203294|712893|P2|NOT COMPLETED|Overall Study||13
291784|NCT00203294|712894|P1|NOT COMPLETED|Overall Study||8
291785|NCT00203294|712893|P2|COMPLETED|Overall Study||10
291786|NCT00203294|712894|P1|COMPLETED|Overall Study||14
291787|NCT00203294|712893|P2|STARTED|Overall Study||23
291788|NCT00203294|712894|P1|STARTED|Overall Study||22
291789|NCT00203268|712900|P1|NOT COMPLETED|Late Treatment||0
291790|NCT00203268|712900|P1|COMPLETED|Late Treatment||9
291791|NCT00203268|712900|P1|STARTED|Late Treatment||9
291792|NCT00203268|712900|P1|NOT COMPLETED|Early Treatment||4
291793|NCT00203268|712900|P1|COMPLETED|Early Treatment||9
291794|NCT00203268|712900|P1|STARTED|Early Treatment||13
291795|NCT00203242|712906|P1|NOT COMPLETED|Overall Study||1
291796|NCT00203242|712906|P1|COMPLETED|Overall Study||14
291797|NCT00203242|712906|P1|STARTED|Overall Study||15
291798|NCT00203229|712912|P2|NOT COMPLETED|Overall Study||3
291799|NCT00203229|712913|P1|NOT COMPLETED|Overall Study||3
291800|NCT00203229|712912|P2|COMPLETED|Overall Study||7
291801|NCT00203229|712913|P1|COMPLETED|Overall Study||7
291802|NCT00203229|712912|P2|STARTED|Overall Study||10
291803|NCT00203229|712913|P1|STARTED|Overall Study||10
291804|NCT00203216|712919|P1|NOT COMPLETED|Overall Study||4
291805|NCT00203216|712919|P1|COMPLETED|Overall Study||27
291806|NCT00203216|712919|P1|STARTED|Overall Study||31
291807|NCT00203203|712925|P2|NOT COMPLETED|Overall Study||0
291808|NCT00203203|712926|P1|NOT COMPLETED|Overall Study||1
291809|NCT00203203|712925|P2|COMPLETED|Overall Study||20
291810|NCT00203203|712926|P1|COMPLETED|Overall Study||9
291811|NCT00203203|712925|P2|STARTED|Overall Study||20
291812|NCT00203203|712926|P1|STARTED|Overall Study||10
291813|NCT00203047|712958|P2|NOT COMPLETED|Overall Study||203
291814|NCT00203047|712959|P1|NOT COMPLETED|Overall Study||191
291815|NCT00203047|712958|P2|COMPLETED|Overall Study||7
291816|NCT00203047|712959|P1|COMPLETED|Overall Study||13
291817|NCT00203047|712958|P2|In Database as of January 29, 2009|Overall Study||209
291818|NCT00203047|712959|P1|In Database as of January 29, 2009|Overall Study||199
291819|NCT00203047|712958|P2|STARTED|Overall Study||210
291820|NCT00203047|712959|P1|STARTED|Overall Study||204
291821|NCT00202878|712973|P2|NOT COMPLETED|Overall Study||2217
291822|NCT00202878|712974|P1|NOT COMPLETED|Overall Study||2199
291823|NCT00202878|712973|P2|COMPLETED|Overall Study||6860
291824|NCT00202878|712974|P1|COMPLETED|Overall Study||6868
291825|NCT00202878|712973|P2|STARTED|Overall Study||9077
291826|NCT00202878|712974|P1|STARTED|Overall Study||9067
291827|NCT00202839|712988|P2|NOT COMPLETED|Overall Study||10
291828|NCT00202839|712989|P1|NOT COMPLETED|Overall Study||24
291829|NCT00202839|712988|P2|COMPLETED|Overall Study||72
291830|NCT00202839|712989|P1|COMPLETED|Overall Study||54
291831|NCT00202839|712988|P2|STARTED|Overall Study||82
291832|NCT00202839|712989|P1|STARTED|Overall Study||78
291833|NCT00202722|712997|P1|NOT COMPLETED|Overall Study||0
291834|NCT00202722|712997|P1|COMPLETED|Overall Study||41
291835|NCT00202722|712997|P1|STARTED|Overall Study||41
291836|NCT00202644|713004|P2|NOT COMPLETED|Overall Study||27
291837|NCT00202644|713005|P1|NOT COMPLETED|Overall Study||35
291838|NCT00202644|713004|P2|COMPLETED|Overall Study||43
291839|NCT00202644|713005|P1|COMPLETED|Overall Study||41
291840|NCT00202644|713004|P2|STARTED|Overall Study||70
291841|NCT00202644|713005|P1|STARTED|Overall Study|One participant not randomized but treated.|76
291842|NCT00202449|713032|P3|NOT COMPLETED|Overall Study||12
291843|NCT00202449|713033|P2|NOT COMPLETED|Overall Study||11
291844|NCT00202449|713034|P1|NOT COMPLETED|Overall Study||11
291845|NCT00202449|713032|P3|COMPLETED|Overall Study||9
291846|NCT00202449|713033|P2|COMPLETED|Overall Study||9
291847|NCT00202449|713034|P1|COMPLETED|Overall Study||7
291848|NCT00202449|713032|P3|STARTED|Overall Study||21
291849|NCT00202449|713033|P2|STARTED|Overall Study||20
291850|NCT00202449|713034|P1|STARTED|Overall Study||18
291851|NCT00201877|713048|P1|NOT COMPLETED|Overall Study||0
291852|NCT00201877|713048|P1|COMPLETED|Overall Study||25
291853|NCT00201877|713048|P1|STARTED|Overall Study||25
291854|NCT00201864|713055|P1|NOT COMPLETED|Overall Study||0
291855|NCT00201864|713055|P1|COMPLETED|Overall Study||40
291856|NCT00201864|713055|P1|STARTED|Overall Study||40
291857|NCT00201851|713066|P3|NOT COMPLETED|Overall Study||1
291858|NCT00201851|713067|P2|NOT COMPLETED|Overall Study||2
291859|NCT00201851|713068|P1|NOT COMPLETED|Overall Study||8
291860|NCT00201851|713066|P3|COMPLETED|Overall Study||230
291861|NCT00201851|713067|P2|COMPLETED|Overall Study||255
291862|NCT00201851|713068|P1|COMPLETED|Overall Study||244
291863|NCT00201851|713066|P3|STARTED|Overall Study||231
291864|NCT00201851|713067|P2|STARTED|Overall Study||257
291865|NCT00201851|713068|P1|STARTED|Overall Study||252
291866|NCT00201838|713078|P2|NOT COMPLETED|Overall Study||0
291867|NCT00201838|713079|P1|NOT COMPLETED|Overall Study||0
291868|NCT00201838|713078|P2|COMPLETED|Overall Study||8
291869|NCT00201838|713079|P1|COMPLETED|Overall Study||30
291870|NCT00201838|713078|P2|Treatment Cohort|Overall Study||8
291871|NCT00201838|713079|P1|Treatment Cohort|Overall Study||30
291872|NCT00201838|713078|P2|STARTED|Overall Study||8
291873|NCT00201838|713079|P1|STARTED|Overall Study||30
291874|NCT00201825|713093|P1|NOT COMPLETED|Overall Study||0
291875|NCT00201825|713093|P1|COMPLETED|Overall Study||29
291876|NCT00201825|713093|P1|STARTED|Overall Study||29
291877|NCT00201773|713100|P1|NOT COMPLETED|Overall Study||6
291878|NCT00201773|713100|P1|COMPLETED|Overall Study||16
291879|NCT00201773|713100|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
291880|NCT00201773|713100|P1|Received All Exemestane Therapy|Overall Study||5
291881|NCT00201773|713100|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
291882|NCT00201773|713100|P1|STARTED|Overall Study||22
291883|NCT00201760|713109|P2|NOT COMPLETED|Overall Study||0
291884|NCT00201760|713110|P1|NOT COMPLETED|Overall Study||0
291885|NCT00201760|713109|P2|COMPLETED|Overall Study||5
291886|NCT00201760|713110|P1|COMPLETED|Overall Study||5
291887|NCT00201760|713109|P2|STARTED|Overall Study||5
291888|NCT00201760|713110|P1|STARTED|Overall Study||5
291889|NCT00201734|713122|P2|NOT COMPLETED|Overall Study||0
291890|NCT00201734|713123|P1|NOT COMPLETED|Overall Study||3
291891|NCT00201734|713122|P2|COMPLETED|Overall Study||25
291892|NCT00201734|713123|P1|COMPLETED|Overall Study||29
291893|NCT00201734|713122|P2|Patients Not Evaluable|Overall Study||0
291894|NCT00201734|713123|P1|Patients Not Evaluable|Overall Study||3
291895|NCT00201734|713122|P2|STARTED|Overall Study||25
291896|NCT00201734|713123|P1|STARTED|Overall Study||32
291897|NCT00201643|713140|P2|NOT COMPLETED|Overall Study||4
291898|NCT00201643|713141|P1|NOT COMPLETED|Overall Study||5
291899|NCT00201643|713140|P2|COMPLETED|Overall Study||210
291900|NCT00201643|713141|P1|COMPLETED|Overall Study||218
291901|NCT00201643|713140|P2|STARTED|Overall Study||214
291902|NCT00201643|713141|P1|STARTED|Overall Study||223
291903|NCT00201448|713165|P2|NOT COMPLETED|Overall Study||0
291904|NCT00201448|713166|P1|NOT COMPLETED|Overall Study||0
291905|NCT00201448|713165|P2|COMPLETED|Overall Study||40
291906|NCT00201448|713166|P1|COMPLETED|Overall Study||42
291907|NCT00201448|713165|P2|STARTED|Overall Study||40
291908|NCT00201448|713166|P1|STARTED|Overall Study||42
291909|NCT00201409|713176|P2|NOT COMPLETED|Overall Study||1
291910|NCT00201409|713177|P1|NOT COMPLETED|Overall Study||1
291911|NCT00201409|713176|P2|COMPLETED|Overall Study||66
291912|NCT00201409|713177|P1|COMPLETED|Overall Study||64
291913|NCT00201409|713176|P2|STARTED|Overall Study||67
291914|NCT00201409|713177|P1|STARTED|Overall Study||65
291915|NCT00201240|713187|P1|NOT COMPLETED|Overall Study||3
291916|NCT00201240|713187|P1|COMPLETED|Overall Study||44
291917|NCT00201240|713187|P1|STARTED|Overall Study||47
291918|NCT00201201|713205|P2|NOT COMPLETED|Overall Study||7
291919|NCT00201201|713206|P1|NOT COMPLETED|Overall Study||5
291920|NCT00201201|713205|P2|COMPLETED|Overall Study||66
291921|NCT00201201|713206|P1|COMPLETED|Overall Study||82
291922|NCT00201201|713205|P2|STARTED|Overall Study||73
291923|NCT00201201|713206|P1|STARTED|Overall Study||87
291924|NCT00201123|713225|P3|NOT COMPLETED|Overall Study||9
291925|NCT00201123|713226|P2|NOT COMPLETED|Overall Study||4
291926|NCT00201123|713227|P1|NOT COMPLETED|Overall Study||6
291927|NCT00201123|713225|P3|COMPLETED|Overall Study||23
291928|NCT00201123|713226|P2|COMPLETED|Overall Study||28
291929|NCT00201123|713227|P1|COMPLETED|Overall Study||26
291930|NCT00201123|713225|P3|Did Not Meet Continuation Criteria|Overall Study||5
291931|NCT00201123|713226|P2|Did Not Meet Continuation Criteria|Overall Study||0
291932|NCT00201123|713227|P1|Did Not Meet Continuation Criteria|Overall Study||2
291933|NCT00201123|713225|P3|STARTED|Overall Study||32
291934|NCT00201123|713226|P2|STARTED|Overall Study||32
291935|NCT00201123|713227|P1|STARTED|Overall Study||32
291936|NCT00201006|713244|P3|NOT COMPLETED|Overall Study||4
291937|NCT00201006|713245|P2|NOT COMPLETED|Overall Study||2
291938|NCT00201006|713246|P1|NOT COMPLETED|Overall Study||8
291939|NCT00201006|713244|P3|COMPLETED|Overall Study||75
291940|NCT00201006|713245|P2|COMPLETED|Overall Study||70
291941|NCT00201006|713246|P1|COMPLETED|Overall Study||75
291942|NCT00201006|713244|P3|STARTED|Overall Study||79
291943|NCT00201006|713245|P2|STARTED|Overall Study||72
291944|NCT00201006|713246|P1|STARTED|Overall Study||83
291945|NCT00200967|713256|P2|NOT COMPLETED|Run-out Period||0
291946|NCT00200967|713257|P1|NOT COMPLETED|Run-out Period||1
291947|NCT00200967|713256|P2|COMPLETED|Run-out Period||41
291948|NCT00200967|713257|P1|COMPLETED|Run-out Period||34
291949|NCT00200967|713256|P2|STARTED|Run-out Period||41
291950|NCT00200967|713257|P1|STARTED|Run-out Period||35
291951|NCT00200967|713256|P2|NOT COMPLETED|Second Treatment Period||2
291952|NCT00200967|713257|P1|NOT COMPLETED|Second Treatment Period||1
291953|NCT00200967|713256|P2|COMPLETED|Second Treatment Period||41
291954|NCT00200967|713257|P1|COMPLETED|Second Treatment Period||35
291955|NCT00200967|713256|P2|STARTED|Second Treatment Period||43
291956|NCT00200967|713257|P1|STARTED|Second Treatment Period||36
291957|NCT00200967|713256|P2|NOT COMPLETED|Wash-out Period||1
291958|NCT00200967|713257|P1|NOT COMPLETED|Wash-out Period||0
291959|NCT00200967|713256|P2|COMPLETED|Wash-out Period||43
291960|NCT00200967|713257|P1|COMPLETED|Wash-out Period||36
291961|NCT00200967|713256|P2|STARTED|Wash-out Period||44
291962|NCT00200967|713257|P1|STARTED|Wash-out Period||36
291963|NCT00200967|713256|P2|NOT COMPLETED|First Treatment Period||1
291964|NCT00200967|713257|P1|NOT COMPLETED|First Treatment Period||6
291965|NCT00200967|713256|P2|COMPLETED|First Treatment Period||44
291966|NCT00200967|713257|P1|COMPLETED|First Treatment Period||36
291967|NCT00200967|713256|P2|First Treatment Period|First Treatment Period||45
291968|NCT00200967|713257|P1|First Treatment Period|First Treatment Period||42
291969|NCT00200967|713256|P2|STARTED|First Treatment Period||45
291970|NCT00200967|713257|P1|STARTED|First Treatment Period||42
291971|NCT00200785|713287|P2|NOT COMPLETED|Second Intervention||0
291972|NCT00200785|713288|P1|NOT COMPLETED|Second Intervention||0
291973|NCT00200785|713287|P2|COMPLETED|Second Intervention||6
291974|NCT00200785|713288|P1|COMPLETED|Second Intervention||9
291975|NCT00200785|713287|P2|STARTED|Second Intervention||6
291976|NCT00200785|713288|P1|STARTED|Second Intervention||9
291977|NCT00200785|713287|P2|NOT COMPLETED|Washout Period of 1 Week||0
291978|NCT00200785|713288|P1|NOT COMPLETED|Washout Period of 1 Week||0
291979|NCT00200785|713287|P2|COMPLETED|Washout Period of 1 Week||6
291980|NCT00200785|713288|P1|COMPLETED|Washout Period of 1 Week||9
291981|NCT00200785|713287|P2|STARTED|Washout Period of 1 Week||6
291982|NCT00200785|713288|P1|STARTED|Washout Period of 1 Week||9
291983|NCT00200785|713287|P2|NOT COMPLETED|First Intervention||0
291984|NCT00200785|713288|P1|NOT COMPLETED|First Intervention||0
291985|NCT00200785|713287|P2|COMPLETED|First Intervention||6
291986|NCT00200785|713288|P1|COMPLETED|First Intervention||9
291987|NCT00200785|713287|P2|STARTED|First Intervention||6
291988|NCT00200785|713288|P1|STARTED|First Intervention||9
291989|NCT00200356|713298|P2|NOT COMPLETED|Overall Study||7
291990|NCT00200356|713299|P1|NOT COMPLETED|Overall Study||8
291991|NCT00200356|713298|P2|COMPLETED|Overall Study||195
291992|NCT00200356|713299|P1|COMPLETED|Overall Study||191
291993|NCT00200356|713298|P2|Safety Analysis Set|Overall Study||198
291994|NCT00200356|713299|P1|Safety Analysis Set|Overall Study||194
291995|NCT00200356|713298|P2|STARTED|Overall Study||202
291996|NCT00200356|713299|P1|STARTED|Overall Study||199
291997|NCT00200343|713326|P3|NOT COMPLETED|Overall Study||13
291998|NCT00200343|713327|P2|NOT COMPLETED|Overall Study||8
291999|NCT00200343|713328|P1|NOT COMPLETED|Overall Study||16
292000|NCT00200343|713326|P3|COMPLETED|Overall Study||184
292001|NCT00200343|713327|P2|COMPLETED|Overall Study||192
292002|NCT00200343|713328|P1|COMPLETED|Overall Study||183
292003|NCT00200343|713326|P3|STARTED|Overall Study||197
292004|NCT00200343|713327|P2|STARTED|Overall Study||200
292005|NCT00200343|713328|P1|STARTED|Overall Study||199
292006|NCT00200161|713353|P2|NOT COMPLETED|Overall Study||0
292007|NCT00200161|713354|P1|NOT COMPLETED|Overall Study||0
292008|NCT00200161|713353|P2|COMPLETED|Overall Study||42
292009|NCT00200161|713354|P1|COMPLETED|Overall Study||43
292010|NCT00200161|713353|P2|STARTED|Overall Study||42
292011|NCT00200161|713354|P1|STARTED|Overall Study||43
292012|NCT00200057|713366|P1|NOT COMPLETED|Overall Study||9
292013|NCT00200057|713366|P1|COMPLETED|Overall Study||111
292014|NCT00200057|713366|P1|12 Month Follow-up|Overall Study||111
292015|NCT00200057|713366|P1|6 Month Follow-up|Overall Study||114
292016|NCT00200057|713366|P1|3 Month Follow-up|Overall Study||116
292017|NCT00200057|713366|P1|1 Month Follow-up|Overall Study||117
292018|NCT00200057|713366|P1|STARTED|Overall Study||120
292019|NCT00199914|713378|P2|NOT COMPLETED|Overall Study||6
292020|NCT00199914|713379|P1|NOT COMPLETED|Overall Study||3
292021|NCT00199914|713378|P2|COMPLETED|Overall Study||54
292022|NCT00199914|713379|P1|COMPLETED|Overall Study||50
292023|NCT00199914|713378|P2|STARTED|Overall Study||60
292024|NCT00199914|713379|P1|STARTED|Overall Study||53
292025|NCT00199381|713385|P1|NOT COMPLETED|Overall Study||504
292026|NCT00199381|713385|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
292027|NCT00199381|713385|P1|STARTED|Overall Study||504
292028|NCT00198822|713392|P3|NOT COMPLETED|Overall Study||21
292029|NCT00198822|713393|P2|NOT COMPLETED|Overall Study||20
292030|NCT00198822|713394|P1|NOT COMPLETED|Overall Study||14
292031|NCT00198822|713392|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
292032|NCT00198822|713393|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
292033|NCT00198822|713394|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
292034|NCT00198822|713392|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
292035|NCT00198822|713393|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
292036|NCT00198822|713394|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
292037|NCT00198133|713413|P2|NOT COMPLETED|Overall Study||8
292038|NCT00198133|713414|P1|NOT COMPLETED|Overall Study||5
292039|NCT00198133|713413|P2|COMPLETED|Overall Study||3
292040|NCT00198133|713414|P1|COMPLETED|Overall Study||11
292041|NCT00198133|713413|P2|STARTED|Overall Study||11
292042|NCT00198133|713414|P1|STARTED|Overall Study||16
292043|NCT00198081|713426|P2|NOT COMPLETED|Overall Study||0
292044|NCT00198081|713427|P1|NOT COMPLETED|Overall Study||1
292045|NCT00198081|713426|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
292046|NCT00198081|713427|P1|COMPLETED|Overall Study||4
292047|NCT00198081|713426|P2|STARTED|Overall Study|No enrollment on this arm.|0
292048|NCT00198081|713427|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
292049|NCT00198042|713453|P1|NOT COMPLETED|Overall Study||0
292050|NCT00198042|713453|P1|COMPLETED|Overall Study||18
292051|NCT00198042|713453|P1|STARTED|Overall Study||18
292052|NCT00198029|713457|P1|NOT COMPLETED|Overall Study||4
292053|NCT00198029|713457|P1|COMPLETED|Overall Study||28
292054|NCT00198029|713457|P1|STARTED|Overall Study||32
292055|NCT00197496|713464|P2|NOT COMPLETED|Follow-up||1
292056|NCT00197496|713465|P1|NOT COMPLETED|Follow-up||2
292057|NCT00197496|713464|P2|COMPLETED|Follow-up||4
292058|NCT00197496|713465|P1|COMPLETED|Follow-up||10
292059|NCT00197496|713464|P2|STARTED|Follow-up||5
292060|NCT00197496|713465|P1|STARTED|Follow-up||12
292061|NCT00197496|713464|P2|NOT COMPLETED|Baseline to Discharge||2
292062|NCT00197496|713465|P1|NOT COMPLETED|Baseline to Discharge||2
292063|NCT00197496|713464|P2|COMPLETED|Baseline to Discharge||5
292064|NCT00197496|713465|P1|COMPLETED|Baseline to Discharge||12
292065|NCT00197496|713464|P2|STARTED|Baseline to Discharge||7
292066|NCT00197496|713465|P1|STARTED|Baseline to Discharge||14
292067|NCT00197392|713480|P2|NOT COMPLETED|Overall Study||86
292068|NCT00197392|713481|P1|NOT COMPLETED|Overall Study||88
292069|NCT00197392|713480|P2|COMPLETED|Overall Study||134
292070|NCT00197392|713481|P1|COMPLETED|Overall Study||126
292071|NCT00197392|713480|P2|Per Protocol|Overall Study||134
292072|NCT00197392|713481|P1|Per Protocol|Overall Study||126
292073|NCT00197392|713480|P2|Evaluable|Overall Study||181
292074|NCT00197392|713481|P1|Evaluable|Overall Study||176
292075|NCT00197392|713480|P2|Modified Intent to Treat|Overall Study||210
292076|NCT00197392|713481|P1|Modified Intent to Treat|Overall Study||209
292077|NCT00197392|713480|P2|Safety Population|Overall Study||220
292078|NCT00197392|713481|P1|Safety Population|Overall Study||214
292079|NCT00197392|713480|P2|STARTED|Overall Study||220
292080|NCT00197392|713481|P1|STARTED|Overall Study||214
292081|NCT00197236|713513|P3|NOT COMPLETED|Overall Study||23
292082|NCT00197236|713514|P2|NOT COMPLETED|Overall Study||17
292083|NCT00197236|713515|P1|NOT COMPLETED|Overall Study||14
292084|NCT00197236|713513|P3|COMPLETED|Overall Study||109
292085|NCT00197236|713514|P2|COMPLETED|Overall Study||110
292086|NCT00197236|713515|P1|COMPLETED|Overall Study||121
292087|NCT00197236|713513|P3|STARTED|Overall Study||132
292088|NCT00197236|713514|P2|STARTED|Overall Study||127
292089|NCT00197236|713515|P1|STARTED|Overall Study||135
292090|NCT00197184|713564|P2|NOT COMPLETED|Overall Study||0
292091|NCT00197184|713565|P1|NOT COMPLETED|Overall Study||0
292092|NCT00197184|713564|P2|COMPLETED|Overall Study||137
292093|NCT00197184|713565|P1|COMPLETED|Overall Study||139
292094|NCT00197184|713564|P2|STARTED|Overall Study||137
292095|NCT00197184|713565|P1|STARTED|Overall Study||139
292096|NCT00197119|713589|P2|NOT COMPLETED|Year 10||0
292097|NCT00197119|713590|P1|NOT COMPLETED|Year 10||0
292098|NCT00197119|713589|P2|COMPLETED|Year 10||108
292099|NCT00197119|713590|P1|COMPLETED|Year 10||120
292100|NCT00197119|713589|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
292101|NCT00197119|713590|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
292102|NCT00197119|713589|P2|NOT COMPLETED|Year 9||0
292103|NCT00197119|713590|P1|NOT COMPLETED|Year 9||0
292104|NCT00197119|713589|P2|COMPLETED|Year 9||114
292105|NCT00197119|713590|P1|COMPLETED|Year 9||121
292106|NCT00197119|713589|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
292107|NCT00197119|713590|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
292108|NCT00197119|713589|P2|NOT COMPLETED|Year 8||0
292109|NCT00197119|713590|P1|NOT COMPLETED|Year 8||0
292110|NCT00197119|713589|P2|COMPLETED|Year 8||115
292111|NCT00197119|713590|P1|COMPLETED|Year 8||122
292112|NCT00197119|713589|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
292113|NCT00197119|713590|P1|STARTED|Year 8||122
292114|NCT00197119|713589|P2|NOT COMPLETED|Year 7||0
292115|NCT00197119|713590|P1|NOT COMPLETED|Year 7||0
292116|NCT00197119|713589|P2|COMPLETED|Year 7||114
292117|NCT00197119|713590|P1|COMPLETED|Year 7||122
292118|NCT00197119|713589|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
292119|NCT00197119|713590|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
292120|NCT00197119|713589|P2|NOT COMPLETED|Year 6||0
292121|NCT00197119|713590|P1|NOT COMPLETED|Year 6||0
292122|NCT00197119|713589|P2|COMPLETED|Year 6||118
292123|NCT00197119|713590|P1|COMPLETED|Year 6||126
292124|NCT00197119|713589|P2|STARTED|Year 6||118
292125|NCT00197119|713590|P1|STARTED|Year 6||126
292126|NCT00197106|713602|P3|NOT COMPLETED|Overall Treatment Period||6
292127|NCT00197106|713603|P2|NOT COMPLETED|Overall Treatment Period||1
292128|NCT00197106|713604|P1|NOT COMPLETED|Overall Treatment Period||0
292129|NCT00197106|713602|P3|COMPLETED|Overall Treatment Period||74
292130|NCT00197106|713603|P2|COMPLETED|Overall Treatment Period||77
292131|NCT00197106|713604|P1|COMPLETED|Overall Treatment Period||0
292132|NCT00197106|713602|P3|STARTED|Overall Treatment Period||80
292133|NCT00197106|713603|P2|STARTED|Overall Treatment Period||78
292134|NCT00197106|713604|P1|STARTED|Overall Treatment Period||0
292135|NCT00197106|713602|P3|NOT COMPLETED|4-Week Run-In Period||0
292136|NCT00197106|713603|P2|NOT COMPLETED|4-Week Run-In Period||0
292137|NCT00197106|713604|P1|NOT COMPLETED|4-Week Run-In Period||99
292138|NCT00197106|713602|P3|COMPLETED|4-Week Run-In Period||0
292139|NCT00197106|713603|P2|COMPLETED|4-Week Run-In Period||0
292140|NCT00197106|713604|P1|COMPLETED|4-Week Run-In Period||158
292141|NCT00197106|713602|P3|STARTED|4-Week Run-In Period||0
292142|NCT00197106|713603|P2|STARTED|4-Week Run-In Period||0
292143|NCT00197106|713604|P1|STARTED|4-Week Run-In Period||257
292144|NCT00197028|713640|P2|NOT COMPLETED|Overall Study||21
292145|NCT00197028|713641|P1|NOT COMPLETED|Overall Study||16
292146|NCT00197028|713640|P2|COMPLETED|Overall Study||86
292147|NCT00197028|713641|P1|COMPLETED|Overall Study||91
292148|NCT00197028|713640|P2|STARTED|Overall Study||107
292149|NCT00197028|713641|P1|STARTED|Overall Study||107
292150|NCT00197015|713684|P3|NOT COMPLETED|Overall Study||77
292151|NCT00197015|713685|P2|NOT COMPLETED|Overall Study||89
292152|NCT00197015|713686|P1|NOT COMPLETED|Overall Study||50
292153|NCT00197015|713684|P3|COMPLETED|Overall Study||385
292154|NCT00197015|713685|P2|COMPLETED|Overall Study||366
292155|NCT00197015|713686|P1|COMPLETED|Overall Study||274
292156|NCT00197015|713684|P3|STARTED|Overall Study||462
292157|NCT00197015|713685|P2|STARTED|Overall Study||455
292158|NCT00197015|713686|P1|STARTED|Overall Study||324
292159|NCT00197002|713745|P3|NOT COMPLETED|Overall Study||17
292160|NCT00197002|713746|P2|NOT COMPLETED|Overall Study||18
292161|NCT00197002|713747|P1|NOT COMPLETED|Overall Study||22
292162|NCT00197002|713745|P3|COMPLETED|Overall Study||132
292163|NCT00197002|713746|P2|COMPLETED|Overall Study||119
292164|NCT00197002|713747|P1|COMPLETED|Overall Study||125
292165|NCT00197002|713745|P3|STARTED|Overall Study||149
292166|NCT00197002|713746|P2|STARTED|Overall Study||137
292167|NCT00197002|713747|P1|STARTED|Overall Study||147
292168|NCT00196976|713798|P14|NOT COMPLETED|Booster Study||0
292169|NCT00196976|713799|P13|NOT COMPLETED|Booster Study||0
292170|NCT00196976|713800|P12|NOT COMPLETED|Booster Study||2
292171|NCT00196976|713801|P11|NOT COMPLETED|Booster Study||2
292172|NCT00196976|713802|P10|NOT COMPLETED|Booster Study||0
292173|NCT00196976|713803|P9|NOT COMPLETED|Booster Study||0
292174|NCT00196976|713804|P8|NOT COMPLETED|Booster Study||0
292175|NCT00196976|713805|P7|NOT COMPLETED|Booster Study||0
292176|NCT00196976|713806|P6|NOT COMPLETED|Booster Study||0
292177|NCT00196976|713807|P5|NOT COMPLETED|Booster Study||0
292178|NCT00196976|713808|P4|NOT COMPLETED|Booster Study||0
292179|NCT00196976|713809|P3|NOT COMPLETED|Booster Study||0
292180|NCT00196976|713810|P2|NOT COMPLETED|Booster Study||0
292181|NCT00196976|713811|P1|NOT COMPLETED|Booster Study||0
292182|NCT00196976|713798|P14|COMPLETED|Booster Study||43
292183|NCT00196976|713799|P13|COMPLETED|Booster Study||45
292184|NCT00196976|713800|P12|COMPLETED|Booster Study||30
292185|NCT00196976|713801|P11|COMPLETED|Booster Study||31
292186|NCT00196976|713802|P10|COMPLETED|Booster Study||0
292187|NCT00196976|713803|P9|COMPLETED|Booster Study||0
292188|NCT00196976|713804|P8|COMPLETED|Booster Study||0
292189|NCT00196976|713805|P7|COMPLETED|Booster Study||0
292190|NCT00196976|713806|P6|COMPLETED|Booster Study||0
292191|NCT00196976|713807|P5|COMPLETED|Booster Study||0
292192|NCT00196976|713808|P4|COMPLETED|Booster Study||0
292193|NCT00196976|713809|P3|COMPLETED|Booster Study||0
292194|NCT00196976|713810|P2|COMPLETED|Booster Study||0
292195|NCT00196976|713811|P1|COMPLETED|Booster Study||0
292196|NCT00196976|713798|P14|STARTED|Booster Study||43
292197|NCT00196976|713799|P13|STARTED|Booster Study||45
292198|NCT00196976|713800|P12|STARTED|Booster Study||32
292199|NCT00196976|713801|P11|STARTED|Booster Study||33
292200|NCT00196976|713802|P10|STARTED|Booster Study||0
292201|NCT00196976|713803|P9|STARTED|Booster Study||0
292202|NCT00196976|713804|P8|STARTED|Booster Study||0
292203|NCT00196976|713805|P7|STARTED|Booster Study||0
292204|NCT00196976|713806|P6|STARTED|Booster Study||0
292205|NCT00196976|713807|P5|STARTED|Booster Study||0
292206|NCT00196976|713808|P4|STARTED|Booster Study||0
292207|NCT00196976|713809|P3|STARTED|Booster Study||0
292208|NCT00196976|713810|P2|STARTED|Booster Study||0
292209|NCT00196976|713811|P1|STARTED|Booster Study||0
292210|NCT00196976|713798|P14|NOT COMPLETED|Primary Study||0
292211|NCT00196976|713799|P13|NOT COMPLETED|Primary Study||0
292212|NCT00196976|713800|P12|NOT COMPLETED|Primary Study||0
292213|NCT00196976|713801|P11|NOT COMPLETED|Primary Study||0
292214|NCT00196976|713802|P10|NOT COMPLETED|Primary Study||1
292215|NCT00196976|713803|P9|NOT COMPLETED|Primary Study||0
292216|NCT00196976|713804|P8|NOT COMPLETED|Primary Study||3
292217|NCT00196976|713805|P7|NOT COMPLETED|Primary Study||0
292218|NCT00196976|713806|P6|NOT COMPLETED|Primary Study||2
292219|NCT00196976|713807|P5|NOT COMPLETED|Primary Study||3
292220|NCT00196976|713808|P4|NOT COMPLETED|Primary Study||1
292221|NCT00196976|713809|P3|NOT COMPLETED|Primary Study||4
292222|NCT00196976|713810|P2|NOT COMPLETED|Primary Study||1
292223|NCT00196976|713811|P1|NOT COMPLETED|Primary Study||1
292224|NCT00196976|713798|P14|COMPLETED|Primary Study||0
292225|NCT00196976|713799|P13|COMPLETED|Primary Study||0
292226|NCT00196976|713800|P12|COMPLETED|Primary Study||0
292227|NCT00196976|713801|P11|COMPLETED|Primary Study||0
292228|NCT00196976|713802|P10|COMPLETED|Primary Study||51
292229|NCT00196976|713803|P9|COMPLETED|Primary Study||52
292230|NCT00196976|713804|P8|COMPLETED|Primary Study||49
292231|NCT00196976|713805|P7|COMPLETED|Primary Study||50
292232|NCT00196976|713806|P6|COMPLETED|Primary Study||52
292233|NCT00196976|713807|P5|COMPLETED|Primary Study||37
292234|NCT00196976|713808|P4|COMPLETED|Primary Study||39
292235|NCT00196976|713809|P3|COMPLETED|Primary Study||37
292236|NCT00196976|713810|P2|COMPLETED|Primary Study||40
292237|NCT00196976|713811|P1|COMPLETED|Primary Study||38
292238|NCT00196976|713798|P14|STARTED|Primary Study||0
292239|NCT00196976|713799|P13|STARTED|Primary Study||0
292240|NCT00196976|713800|P12|STARTED|Primary Study||0
292241|NCT00196976|713801|P11|STARTED|Primary Study||0
292242|NCT00196976|713802|P10|STARTED|Primary Study||52
292243|NCT00196976|713803|P9|STARTED|Primary Study||52
292244|NCT00196976|713804|P8|STARTED|Primary Study||52
292245|NCT00196976|713805|P7|STARTED|Primary Study||50
292246|NCT00196976|713806|P6|STARTED|Primary Study||54
292247|NCT00196976|713807|P5|STARTED|Primary Study||40
292248|NCT00196976|713808|P4|STARTED|Primary Study||40
292249|NCT00196976|713809|P3|STARTED|Primary Study||41
292250|NCT00196976|713810|P2|STARTED|Primary Study||41
292251|NCT00196976|713811|P1|STARTED|Primary Study||39
292252|NCT00196937|714007|P3|NOT COMPLETED|Overall Study||7
292253|NCT00196937|714008|P2|NOT COMPLETED|Overall Study||5
292254|NCT00196937|714009|P1|NOT COMPLETED|Overall Study||9
292255|NCT00196937|714007|P3|COMPLETED|Overall Study||204
292256|NCT00196937|714008|P2|COMPLETED|Overall Study||221
292257|NCT00196937|714009|P1|COMPLETED|Overall Study||220
292258|NCT00196937|714007|P3|STARTED|Overall Study||211
292259|NCT00196937|714008|P2|STARTED|Overall Study||226
292260|NCT00196937|714009|P1|STARTED|Overall Study||229
292261|NCT00196716|714047|P1|NOT COMPLETED|0.3 mg/kg Period||0
292262|NCT00196716|714047|P1|COMPLETED|0.3 mg/kg Period||21
292263|NCT00196716|714047|P1|STARTED|0.3 mg/kg Period||21
292264|NCT00196716|714047|P1|NOT COMPLETED|1.0 mg/kg Period||0
292265|NCT00196716|714047|P1|COMPLETED|1.0 mg/kg Period||21
292266|NCT00196716|714047|P1|STARTED|1.0 mg/kg Period||21
292267|NCT00196326|714057|P1|NOT COMPLETED|Overall Study||986
292268|NCT00196326|714057|P1|COMPLETED|Overall Study||1249
292269|NCT00196326|714057|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
292270|NCT00196326|714057|P1|Safety Population|Overall Study|Treated participants|2185
292271|NCT00196326|714057|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
292272|NCT00196313|714065|P2|NOT COMPLETED|Overall Study||8
292273|NCT00196313|714066|P1|NOT COMPLETED|Overall Study||11
292274|NCT00196313|714065|P2|COMPLETED|Overall Study||40
292275|NCT00196313|714066|P1|COMPLETED|Overall Study||36
292276|NCT00196313|714065|P2|STARTED|Overall Study||48
292277|NCT00196313|714066|P1|STARTED|Overall Study||47
292278|NCT00196196|714080|P1|NOT COMPLETED|Overall Study||7
292279|NCT00196196|714080|P1|COMPLETED|Overall Study||267
292280|NCT00196196|714080|P1|STARTED|Overall Study||274
292281|NCT00196105|714088|P3|NOT COMPLETED|Overall Study||7
292282|NCT00196105|714089|P2|NOT COMPLETED|Overall Study||5
292283|NCT00196105|714090|P1|NOT COMPLETED|Overall Study||4
292284|NCT00196105|714088|P3|COMPLETED|Overall Study||82
292285|NCT00196105|714089|P2|COMPLETED|Overall Study||83
292286|NCT00196105|714090|P1|COMPLETED|Overall Study||60
292287|NCT00196105|714088|P3|STARTED|Overall Study||89
292288|NCT00196105|714089|P2|STARTED|Overall Study||88
292289|NCT00196105|714090|P1|STARTED|Overall Study||64
292290|NCT00195819|714110|P2|NOT COMPLETED|Open-label||20
292291|NCT00195819|714111|P1|NOT COMPLETED|Open-label||0
292292|NCT00195819|714110|P2|COMPLETED|Open-label||62
292293|NCT00195819|714111|P1|COMPLETED|Open-label||0
292294|NCT00195819|714110|P2|STARTED|Open-label||82
292295|NCT00195819|714111|P1|STARTED|Open-label||0
292296|NCT00195819|714110|P2|NOT COMPLETED|Double-Blind||0
292297|NCT00195819|714111|P1|NOT COMPLETED|Double-Blind||2
292298|NCT00195819|714110|P2|COMPLETED|Double-Blind||38
292299|NCT00195819|714111|P1|COMPLETED|Double-Blind||42
292300|NCT00195819|714110|P2|STARTED|Double-Blind||38
292301|NCT00195819|714111|P1|STARTED|Double-Blind||44
292302|NCT00195715|714161|P1|NOT COMPLETED|Overall Study||377
292303|NCT00195715|714161|P1|COMPLETED|Overall Study||400
292304|NCT00195715|714161|P1|STARTED|Overall Study||777
292305|NCT00195702|714192|P6|NOT COMPLETED|Open-label Extension Phase||78
292306|NCT00195702|714193|P5|NOT COMPLETED|Open-label Extension Phase||78
292307|NCT00195702|714194|P4|NOT COMPLETED|Open-label Extension Phase||99
292308|NCT00195702|714195|P3|NOT COMPLETED|Open-label Extension Phase||0
292309|NCT00195702|714196|P2|NOT COMPLETED|Open-label Extension Phase||0
292310|NCT00195702|714197|P1|NOT COMPLETED|Open-label Extension Phase||0
292311|NCT00195702|714192|P6|COMPLETED|Open-label Extension Phase||56
292312|NCT00195702|714193|P5|COMPLETED|Open-label Extension Phase||80
292313|NCT00195702|714194|P4|COMPLETED|Open-label Extension Phase||66
292314|NCT00195702|714195|P3|COMPLETED|Open-label Extension Phase||0
292315|NCT00195702|714196|P2|COMPLETED|Open-label Extension Phase||0
292316|NCT00195702|714197|P1|COMPLETED|Open-label Extension Phase||0
292317|NCT00195702|714192|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
292318|NCT00195702|714193|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
292319|NCT00195702|714194|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
292320|NCT00195702|714195|P3|STARTED|Open-label Extension Phase||0
292321|NCT00195702|714196|P2|STARTED|Open-label Extension Phase||0
292322|NCT00195702|714197|P1|STARTED|Open-label Extension Phase||0
292323|NCT00195702|714192|P6|NOT COMPLETED|Double-blind Phase||0
292324|NCT00195702|714193|P5|NOT COMPLETED|Double-blind Phase||0
292325|NCT00195702|714194|P4|NOT COMPLETED|Double-blind Phase||0
292326|NCT00195702|714195|P3|NOT COMPLETED|Double-blind Phase||60
292327|NCT00195702|714196|P2|NOT COMPLETED|Double-blind Phase||48
292328|NCT00195702|714197|P1|NOT COMPLETED|Double-blind Phase||44
292329|NCT00195702|714192|P6|COMPLETED|Double-blind Phase||0
292330|NCT00195702|714193|P5|COMPLETED|Double-blind Phase||0
292331|NCT00195702|714194|P4|COMPLETED|Double-blind Phase||0
292332|NCT00195702|714195|P3|COMPLETED|Double-blind Phase||140
292333|NCT00195702|714196|P2|COMPLETED|Double-blind Phase||159
292334|NCT00195702|714197|P1|COMPLETED|Double-blind Phase||168
292335|NCT00195702|714192|P6|STARTED|Double-blind Phase||0
292336|NCT00195702|714193|P5|STARTED|Double-blind Phase||0
292337|NCT00195702|714194|P4|STARTED|Double-blind Phase||0
292338|NCT00195702|714195|P3|STARTED|Double-blind Phase||200
292339|NCT00195702|714196|P2|STARTED|Double-blind Phase||207
292340|NCT00195702|714197|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
292341|NCT00195676|714261|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
292342|NCT00195676|714261|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
292343|NCT00195676|714261|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
292344|NCT00195676|714261|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
292345|NCT00195676|714261|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
292346|NCT00195676|714261|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
292347|NCT00195676|714261|P1|NOT COMPLETED|Period O - Open-label Treatment||606
292348|NCT00195676|714261|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
292349|NCT00195676|714261|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
292350|NCT00195663|714275|P3|NOT COMPLETED|Open-Label Extension Period||97
292351|NCT00195663|714276|P2|NOT COMPLETED|Open-Label Extension Period||74
292352|NCT00195663|714277|P1|NOT COMPLETED|Open-Label Extension Period||76
292353|NCT00195663|714275|P3|COMPLETED|Open-Label Extension Period||86
292354|NCT00195663|714276|P2|COMPLETED|Open-Label Extension Period||85
292355|NCT00195663|714277|P1|COMPLETED|Open-Label Extension Period||79
292356|NCT00195663|714275|P3|STARTED|Open-Label Extension Period||183
292357|NCT00195663|714276|P2|STARTED|Open-Label Extension Period||159
292358|NCT00195663|714277|P1|STARTED|Open-Label Extension Period||155
292359|NCT00195663|714275|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
292360|NCT00195663|714276|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
292361|NCT00195663|714277|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
292362|NCT00195663|714275|P3|COMPLETED|2-year Double-blind Treatment Period||196
292363|NCT00195663|714276|P2|COMPLETED|2-year Double-blind Treatment Period||166
292364|NCT00195663|714277|P1|COMPLETED|2-year Double-blind Treatment Period||164
292365|NCT00195663|714275|P3|STARTED|2-year Double-blind Treatment Period||268
292366|NCT00195663|714276|P2|STARTED|2-year Double-blind Treatment Period||274
292367|NCT00195663|714277|P1|STARTED|2-year Double-blind Treatment Period||257
292368|NCT00195650|714371|P1|NOT COMPLETED|Overall Study||525
292369|NCT00195650|714371|P1|COMPLETED|Overall Study||321
292370|NCT00195650|714371|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
292371|NCT00195507|714387|P2|NOT COMPLETED|Overall Study||118
292372|NCT00195507|714388|P1|NOT COMPLETED|Overall Study||99
292373|NCT00195507|714387|P2|COMPLETED|Overall Study||245
292374|NCT00195507|714388|P1|COMPLETED|Overall Study||258
292375|NCT00195507|714387|P2|STARTED|Overall Study||363
292376|NCT00195507|714388|P1|STARTED|Overall Study||357
292377|NCT00195494|714402|P6|NOT COMPLETED|Year 2||0
292378|NCT00195494|714403|P5|NOT COMPLETED|Year 2||0
292379|NCT00195494|714404|P4|NOT COMPLETED|Year 2||23
292380|NCT00195494|714405|P3|NOT COMPLETED|Year 2||18
292381|NCT00195494|714406|P2|NOT COMPLETED|Year 2||16
292382|NCT00195494|714407|P1|NOT COMPLETED|Year 2||7
292383|NCT00195494|714402|P6|COMPLETED|Year 2||0
292384|NCT00195494|714403|P5|COMPLETED|Year 2||0
292385|NCT00195494|714404|P4|COMPLETED|Year 2||76
292386|NCT00195494|714405|P3|COMPLETED|Year 2||93
292387|NCT00195494|714406|P2|COMPLETED|Year 2||74
292388|NCT00195494|714407|P1|COMPLETED|Year 2||104
292389|NCT00195494|714402|P6|STARTED|Year 2||0
292390|NCT00195494|714403|P5|STARTED|Year 2||0
292391|NCT00195494|714404|P4|STARTED|Year 2||99
292392|NCT00195494|714405|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
292393|NCT00195494|714406|P2|STARTED|Year 2||90
292394|NCT00195494|714407|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
292395|NCT00195494|714402|P6|NOT COMPLETED|Year 1||53
292396|NCT00195494|714403|P5|NOT COMPLETED|Year 1||79
292397|NCT00195494|714404|P4|NOT COMPLETED|Year 1||0
292398|NCT00195494|714405|P3|NOT COMPLETED|Year 1||0
292399|NCT00195494|714406|P2|NOT COMPLETED|Year 1||0
292400|NCT00195494|714407|P1|NOT COMPLETED|Year 1||0
292401|NCT00195494|714402|P6|COMPLETED|Year 1||221
292402|NCT00195494|714403|P5|COMPLETED|Year 1||189
292403|NCT00195494|714404|P4|COMPLETED|Year 1||0
292404|NCT00195494|714405|P3|COMPLETED|Year 1||0
292405|NCT00195494|714406|P2|COMPLETED|Year 1||0
292406|NCT00195494|714407|P1|COMPLETED|Year 1||0
292407|NCT00195494|714402|P6|STARTED|Year 1||274
292408|NCT00195494|714403|P5|STARTED|Year 1||268
292409|NCT00195494|714404|P4|STARTED|Year 1||0
292410|NCT00195494|714405|P3|STARTED|Year 1||0
292411|NCT00195494|714406|P2|STARTED|Year 1||0
292412|NCT00195494|714407|P1|STARTED|Year 1||0
292413|NCT00195442|714425|P1|NOT COMPLETED|Overall Study||136
292414|NCT00195442|714425|P1|COMPLETED|Overall Study||152
292415|NCT00195442|714425|P1|STARTED|Overall Study||288
292416|NCT00195429|714444|P2|NOT COMPLETED|Overall Study||5
292417|NCT00195429|714445|P1|NOT COMPLETED|Overall Study||5
292418|NCT00195429|714444|P2|COMPLETED|Overall Study||18
292419|NCT00195429|714445|P1|COMPLETED|Overall Study||19
292420|NCT00195429|714444|P2|STARTED|Overall Study||23
292421|NCT00195429|714445|P1|STARTED|Overall Study||24
292422|NCT00195403|714453|P1|NOT COMPLETED|Overall Study||0
292423|NCT00195403|714453|P1|COMPLETED|Overall Study||1014
292424|NCT00195403|714453|P1|STARTED|Overall Study||1014
292425|NCT00195351|714461|P2|NOT COMPLETED|Overall Study||16
292426|NCT00195351|714462|P1|NOT COMPLETED|Overall Study||21
292427|NCT00195351|714461|P2|COMPLETED|Overall Study||215
292428|NCT00195351|714462|P1|COMPLETED|Overall Study||215
292429|NCT00195351|714461|P2|STARTED|Overall Study||231
292430|NCT00195351|714462|P1|STARTED|Overall Study||236
292431|NCT00195338|714472|P1|NOT COMPLETED|Overall Study||12
292432|NCT00195338|714472|P1|COMPLETED|Overall Study||13
292433|NCT00195338|714472|P1|STARTED|Overall Study||25
292434|NCT00195273|714482|P2|NOT COMPLETED|Overall Study||14
292435|NCT00195273|714483|P1|NOT COMPLETED|Overall Study||21
292436|NCT00195273|714482|P2|COMPLETED|Overall Study||16
292437|NCT00195273|714483|P1|COMPLETED|Overall Study||10
292438|NCT00195273|714482|P2|STARTED|Overall Study||30
292439|NCT00195273|714483|P1|STARTED|Overall Study||31
292440|NCT00195260|714497|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
292441|NCT00195260|714498|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
292442|NCT00195260|714499|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
292443|NCT00195260|714500|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292444|NCT00195260|714501|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292445|NCT00195260|714502|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292446|NCT00195260|714503|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292447|NCT00195260|714504|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292448|NCT00195260|714505|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292449|NCT00195260|714506|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292450|NCT00195260|714507|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292451|NCT00195260|714497|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
292452|NCT00195260|714498|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292453|NCT00195260|714499|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
292454|NCT00195260|714500|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292455|NCT00195260|714501|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292456|NCT00195260|714502|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292457|NCT00195260|714503|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292458|NCT00195260|714504|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292459|NCT00195260|714505|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292460|NCT00195260|714506|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292461|NCT00195260|714507|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292462|NCT00195260|714497|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
292463|NCT00195260|714498|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
292464|NCT00195260|714499|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
292465|NCT00195260|714500|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292466|NCT00195260|714501|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292467|NCT00195260|714502|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292468|NCT00195260|714503|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292469|NCT00195260|714504|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292470|NCT00195260|714505|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292471|NCT00195260|714506|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292472|NCT00195260|714507|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
292473|NCT00195260|714497|P11|NOT COMPLETED|Part 1: Dose Escalation||0
292474|NCT00195260|714498|P10|NOT COMPLETED|Part 1: Dose Escalation||0
292475|NCT00195260|714499|P9|NOT COMPLETED|Part 1: Dose Escalation||0
292476|NCT00195260|714500|P8|NOT COMPLETED|Part 1: Dose Escalation||6
292477|NCT00195260|714501|P7|NOT COMPLETED|Part 1: Dose Escalation||10
292478|NCT00195260|714502|P6|NOT COMPLETED|Part 1: Dose Escalation||7
292479|NCT00195260|714503|P5|NOT COMPLETED|Part 1: Dose Escalation||7
292480|NCT00195260|714504|P4|NOT COMPLETED|Part 1: Dose Escalation||7
292481|NCT00195260|714505|P3|NOT COMPLETED|Part 1: Dose Escalation||6
292482|NCT00195260|714506|P2|NOT COMPLETED|Part 1: Dose Escalation||4
292483|NCT00195260|714507|P1|NOT COMPLETED|Part 1: Dose Escalation||4
292484|NCT00195260|714497|P11|COMPLETED|Part 1: Dose Escalation||0
292485|NCT00195260|714498|P10|COMPLETED|Part 1: Dose Escalation||0
292486|NCT00195260|714499|P9|COMPLETED|Part 1: Dose Escalation||0
292487|NCT00195260|714500|P8|COMPLETED|Part 1: Dose Escalation||0
292488|NCT00195260|714501|P7|COMPLETED|Part 1: Dose Escalation||0
292489|NCT00195260|714502|P6|COMPLETED|Part 1: Dose Escalation||0
292490|NCT00195260|714503|P5|COMPLETED|Part 1: Dose Escalation||0
292491|NCT00195260|714504|P4|COMPLETED|Part 1: Dose Escalation||0
292492|NCT00195260|714505|P3|COMPLETED|Part 1: Dose Escalation||0
292493|NCT00195260|714506|P2|COMPLETED|Part 1: Dose Escalation||0
292494|NCT00195260|714507|P1|COMPLETED|Part 1: Dose Escalation||0
292495|NCT00195260|714497|P11|STARTED|Part 1: Dose Escalation||0
292496|NCT00195260|714498|P10|STARTED|Part 1: Dose Escalation||0
292497|NCT00195260|714499|P9|STARTED|Part 1: Dose Escalation||0
292498|NCT00195260|714500|P8|STARTED|Part 1: Dose Escalation||6
292499|NCT00195260|714501|P7|STARTED|Part 1: Dose Escalation||10
292500|NCT00195260|714502|P6|STARTED|Part 1: Dose Escalation||7
292501|NCT00195260|714503|P5|STARTED|Part 1: Dose Escalation||7
292502|NCT00195260|714504|P4|STARTED|Part 1: Dose Escalation||7
292503|NCT00195260|714505|P3|STARTED|Part 1: Dose Escalation||6
292504|NCT00195260|714506|P2|STARTED|Part 1: Dose Escalation||4
292505|NCT00195260|714507|P1|STARTED|Part 1: Dose Escalation||4
292506|NCT00195039|714653|P1|NOT COMPLETED|Overall Study||0
292507|NCT00195039|714653|P1|COMPLETED|Overall Study||47
292508|NCT00195039|714653|P1|STARTED|Overall Study||47
292509|NCT00195013|714666|P2|NOT COMPLETED|Overall Study||1
292510|NCT00195013|714667|P1|NOT COMPLETED|Overall Study||2
292511|NCT00195013|714666|P2|COMPLETED|Overall Study||15
292512|NCT00195013|714667|P1|COMPLETED|Overall Study||12
292513|NCT00195013|714666|P2|STARTED|Overall Study||16
292514|NCT00195013|714667|P1|STARTED|Overall Study||14
292515|NCT00194896|714677|P4|NOT COMPLETED|Overall Study||12
292516|NCT00194896|714678|P3|NOT COMPLETED|Overall Study||6
292517|NCT00194896|714679|P2|NOT COMPLETED|Overall Study||5
292518|NCT00194896|714680|P1|NOT COMPLETED|Overall Study||11
292519|NCT00194896|714677|P4|COMPLETED|Overall Study||9
292520|NCT00194896|714678|P3|COMPLETED|Overall Study||7
292521|NCT00194896|714679|P2|COMPLETED|Overall Study||10
292522|NCT00194896|714680|P1|COMPLETED|Overall Study||4
292523|NCT00194896|714677|P4|STARTED|Overall Study||21
292524|NCT00194896|714678|P3|STARTED|Overall Study||13
292525|NCT00194896|714679|P2|STARTED|Overall Study||15
292526|NCT00194896|714680|P1|STARTED|Overall Study||15
292527|NCT00194792|714694|P1|NOT COMPLETED|Overall Study||1
292528|NCT00194792|714694|P1|COMPLETED|Overall Study||27
292529|NCT00194792|714694|P1|STARTED|Overall Study||28
292530|NCT00194779|714704|P1|NOT COMPLETED|Overall Study||0
292531|NCT00194779|714704|P1|COMPLETED|Overall Study||50
292532|NCT00194779|714704|P1|STARTED|Overall Study||50
292533|NCT00194675|714718|P2|NOT COMPLETED|Overall Study||2
292534|NCT00194675|714719|P1|NOT COMPLETED|Overall Study||5
292535|NCT00194675|714718|P2|COMPLETED|Overall Study||24
292536|NCT00194675|714719|P1|COMPLETED|Overall Study||22
292537|NCT00194675|714718|P2|STARTED|Overall Study||26
292538|NCT00194675|714719|P1|STARTED|Overall Study||27
292539|NCT00194610|714737|P2|NOT COMPLETED|Overall Study||0
292540|NCT00194610|714738|P1|NOT COMPLETED|Overall Study||0
292541|NCT00194610|714737|P2|COMPLETED|Overall Study||9
292542|NCT00194610|714738|P1|COMPLETED|Overall Study||11
292543|NCT00194610|714737|P2|STARTED|Overall Study||9
292544|NCT00194610|714738|P1|STARTED|Overall Study||11
292545|NCT00194532|714746|P2|NOT COMPLETED|Overall Study||0
292546|NCT00194532|714747|P1|NOT COMPLETED|Overall Study||0
292547|NCT00194532|714746|P2|COMPLETED|Overall Study||150
292548|NCT00194532|714747|P1|COMPLETED|Overall Study||150
292549|NCT00194532|714746|P2|STARTED|Overall Study||150
292550|NCT00194532|714747|P1|STARTED|Overall Study||150
292551|NCT00194129|714757|P2|NOT COMPLETED|Overall Study||13
292552|NCT00194129|714758|P1|NOT COMPLETED|Overall Study||10
292553|NCT00194129|714757|P2|COMPLETED|Overall Study||3
292554|NCT00194129|714758|P1|COMPLETED|Overall Study||5
292555|NCT00194129|714757|P2|STARTED|Overall Study||16
292556|NCT00194129|714758|P1|STARTED|Overall Study||15
292557|NCT00194077|714773|P2|NOT COMPLETED|Overall Study||30
292558|NCT00194077|714774|P1|NOT COMPLETED|Overall Study||24
292559|NCT00194077|714773|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
292560|NCT00194077|714774|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
292561|NCT00194077|714773|P2|STARTED|Overall Study||30
292562|NCT00194077|714774|P1|STARTED|Overall Study||30
292563|NCT00194025|714780|P1|NOT COMPLETED|Overall Study||5
292564|NCT00194025|714780|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
292565|NCT00194025|714780|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
292566|NCT00194012|714795|P2|NOT COMPLETED|Open Label Extension (OLE)||6
292567|NCT00194012|714796|P1|NOT COMPLETED|Open Label Extension (OLE)||5
292568|NCT00194012|714795|P2|COMPLETED|Open Label Extension (OLE)||15
292569|NCT00194012|714796|P1|COMPLETED|Open Label Extension (OLE)||17
292570|NCT00194012|714795|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
292571|NCT00194012|714796|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
292572|NCT00194012|714795|P2|NOT COMPLETED|Randomized Phase||25
292573|NCT00194012|714796|P1|NOT COMPLETED|Randomized Phase||16
292574|NCT00194012|714795|P2|COMPLETED|Randomized Phase||6
292575|NCT00194012|714796|P1|COMPLETED|Randomized Phase||15
292576|NCT00194012|714795|P2|Received More Than One Dose|Randomized Phase||29
292577|NCT00194012|714796|P1|Received More Than One Dose|Randomized Phase||30
292578|NCT00194012|714795|P2|STARTED|Randomized Phase||31
292579|NCT00194012|714796|P1|STARTED|Randomized Phase||31
292580|NCT00193609|714832|P1|NOT COMPLETED|Overall Study||4
292581|NCT00193609|714832|P1|COMPLETED|Overall Study||44
292582|NCT00193609|714832|P1|STARTED|Overall Study||48
292583|NCT00193596|714839|P2|NOT COMPLETED|Overall Study||66
292584|NCT00193596|714840|P1|NOT COMPLETED|Overall Study||56
292585|NCT00193596|714839|P2|COMPLETED|Overall Study||39
292586|NCT00193596|714840|P1|COMPLETED|Overall Study||37
292587|NCT00193596|714839|P2|STARTED|Overall Study||105
292588|NCT00193596|714840|P1|STARTED|Overall Study||93
292589|NCT00193492|714850|P2|NOT COMPLETED|Overall Study||15
292590|NCT00193492|714851|P1|NOT COMPLETED|Overall Study||17
292591|NCT00193492|714850|P2|COMPLETED|Overall Study||14
292592|NCT00193492|714851|P1|COMPLETED|Overall Study||14
292593|NCT00193492|714850|P2|STARTED|Overall Study||29
292594|NCT00193492|714851|P1|STARTED|Overall Study||31
292595|NCT00193479|714859|P1|NOT COMPLETED|Maintenance Rituximab||0
292596|NCT00193479|714859|P1|COMPLETED|Maintenance Rituximab||44
292597|NCT00193479|714859|P1|STARTED|Maintenance Rituximab||44
292598|NCT00193479|714859|P1|NOT COMPLETED|Induction Chemotherapy||3
292599|NCT00193479|714859|P1|COMPLETED|Induction Chemotherapy||48
292600|NCT00193479|714859|P1|STARTED|Induction Chemotherapy||51
292601|NCT00193453|714863|P1|NOT COMPLETED|Overall Study||48
292602|NCT00193453|714863|P1|COMPLETED|Overall Study||21
292603|NCT00193453|714863|P1|STARTED|Overall Study||69
292604|NCT00193427|714869|P1|NOT COMPLETED|Overall Study||49
292605|NCT00193427|714869|P1|COMPLETED|Overall Study||26
292606|NCT00193427|714869|P1|STARTED|Overall Study||75
292607|NCT00193414|714876|P1|NOT COMPLETED|Overall Study||58
292608|NCT00193414|714876|P1|COMPLETED|Overall Study||14
292609|NCT00193414|714876|P1|STARTED|Overall Study||72
292610|NCT00193375|714882|P1|NOT COMPLETED|Overall Study||19
292611|NCT00193375|714882|P1|COMPLETED|Overall Study||41
292612|NCT00193375|714882|P1|STARTED|Overall Study||60
292613|NCT00193258|714888|P1|NOT COMPLETED|Overall Study||0
292614|NCT00193258|714888|P1|COMPLETED|Overall Study||94
292615|NCT00193258|714888|P1|STARTED|Overall Study||94
292616|NCT00193219|714894|P1|NOT COMPLETED|Overall Study||30
292617|NCT00193219|714894|P1|COMPLETED|Overall Study||6
292618|NCT00193219|714894|P1|STARTED|Overall Study||36
292619|NCT00193206|714900|P1|NOT COMPLETED|Postoperative Therapy||14
292620|NCT00193206|714900|P1|COMPLETED|Postoperative Therapy||102
292621|NCT00193206|714900|P1|STARTED|Postoperative Therapy||116
292622|NCT00193206|714900|P1|NOT COMPLETED|Surgery||0
292623|NCT00193206|714900|P1|COMPLETED|Surgery||116
292624|NCT00193206|714900|P1|STARTED|Surgery||116
292625|NCT00193206|714900|P1|NOT COMPLETED|Preoperative Therapy||7
292626|NCT00193206|714900|P1|COMPLETED|Preoperative Therapy||116
292627|NCT00193206|714900|P1|STARTED|Preoperative Therapy||123
292628|NCT00193180|714904|P1|NOT COMPLETED|Overall Study||10
292629|NCT00193180|714904|P1|COMPLETED|Overall Study||27
292630|NCT00193180|714904|P1|STARTED|Overall Study||37
292631|NCT00193128|714912|P2|NOT COMPLETED|Overall Study||10
292632|NCT00193128|714913|P1|NOT COMPLETED|Overall Study||0
292633|NCT00193128|714912|P2|COMPLETED|Overall Study||39
292634|NCT00193128|714913|P1|COMPLETED|Overall Study||10
292635|NCT00193128|714912|P2|STARTED|Overall Study||49
292636|NCT00193128|714913|P1|STARTED|Overall Study||10
292637|NCT00193063|714919|P1|NOT COMPLETED|Overall Study||4
292638|NCT00193063|714919|P1|COMPLETED|Overall Study||37
292639|NCT00193063|714919|P1|STARTED|Overall Study||41
292640|NCT00193050|714925|P1|NOT COMPLETED|Adjuvant||10
292641|NCT00193050|714925|P1|COMPLETED|Adjuvant||77
292642|NCT00193050|714925|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
292643|NCT00193050|714925|P1|NOT COMPLETED|Surgery||0
292644|NCT00193050|714925|P1|COMPLETED|Surgery||103
292645|NCT00193050|714925|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
292646|NCT00193050|714925|P1|NOT COMPLETED|Neoadjuvant Treatment||9
292647|NCT00193050|714925|P1|COMPLETED|Neoadjuvant Treatment||101
292648|NCT00193050|714925|P1|STARTED|Neoadjuvant Treatment||110
292649|NCT00193037|714931|P2|NOT COMPLETED|Crossover Treatment||0
292650|NCT00193037|714932|P1|NOT COMPLETED|Crossover Treatment||0
292651|NCT00193037|714931|P2|COMPLETED|Crossover Treatment||24
292652|NCT00193037|714932|P1|COMPLETED|Crossover Treatment||32
292653|NCT00193037|714931|P2|STARTED|Crossover Treatment||24
292654|NCT00193037|714932|P1|STARTED|Crossover Treatment||32
292655|NCT00193037|714931|P2|NOT COMPLETED|Randomized Treatment||28
292656|NCT00193037|714932|P1|NOT COMPLETED|Randomized Treatment||18
292657|NCT00193037|714931|P2|COMPLETED|Randomized Treatment||24
292658|NCT00193037|714932|P1|COMPLETED|Randomized Treatment||32
292659|NCT00193037|714931|P2|STARTED|Randomized Treatment||52
292660|NCT00193037|714932|P1|STARTED|Randomized Treatment||50
292661|NCT00192647|714942|P2|NOT COMPLETED|Overall Study||146
292662|NCT00192647|714943|P1|NOT COMPLETED|Overall Study||128
292663|NCT00192647|714942|P2|COMPLETED|Overall Study||302
292664|NCT00192647|714943|P1|COMPLETED|Overall Study||320
292665|NCT00192647|714942|P2|Treated|Overall Study||438
292666|NCT00192647|714943|P1|Treated|Overall Study||433
292667|NCT00192647|714942|P2|STARTED|Overall Study||448
292668|NCT00192647|714943|P1|STARTED|Overall Study||448
292669|NCT00192296|714963|P4|NOT COMPLETED|Overall Study||0
292670|NCT00192296|714964|P3|NOT COMPLETED|Overall Study||0
292671|NCT00192296|714965|P2|NOT COMPLETED|Overall Study||1
292672|NCT00192296|714966|P1|NOT COMPLETED|Overall Study||0
292673|NCT00192296|714963|P4|COMPLETED|Overall Study||6
292674|NCT00192296|714964|P3|COMPLETED|Overall Study||6
292675|NCT00192296|714965|P2|COMPLETED|Overall Study||5
292676|NCT00192296|714966|P1|COMPLETED|Overall Study||6
292677|NCT00192296|714963|P4|STARTED|Overall Study||6
292678|NCT00192296|714964|P3|STARTED|Overall Study||6
292679|NCT00192296|714965|P2|STARTED|Overall Study||6
292680|NCT00192296|714966|P1|STARTED|Overall Study||6
292681|NCT00192075|715022|P2|NOT COMPLETED|Overall Study||19
292682|NCT00192075|715023|P1|NOT COMPLETED|Overall Study||39
292683|NCT00192075|715022|P2|COMPLETED|Overall Study||23
292684|NCT00192075|715023|P1|COMPLETED|Overall Study||3
292685|NCT00192075|715022|P2|STARTED|Overall Study||42
292686|NCT00192075|715023|P1|STARTED|Overall Study||42
292687|NCT00192036|715048|P1|NOT COMPLETED|Overall Study||21
292688|NCT00192036|715048|P1|COMPLETED|Overall Study||28
292689|NCT00192036|715048|P1|STARTED|Overall Study||49
292690|NCT00192023|715058|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
292691|NCT00192023|715059|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
292692|NCT00192023|715058|P2|COMPLETED|Period IV - Optional Open-Label||0
292693|NCT00192023|715059|P1|COMPLETED|Period IV - Optional Open-Label||49
292694|NCT00192023|715058|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
292695|NCT00192023|715059|P1|STARTED|Period IV - Optional Open-Label||124
292696|NCT00192023|715058|P2|NOT COMPLETED|Period III - Double-Blind||0
292697|NCT00192023|715059|P1|NOT COMPLETED|Period III - Double-Blind||7
292698|NCT00192023|715058|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
292699|NCT00192023|715059|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
292700|NCT00192023|715058|P2|STARTED|Period III - Double-Blind||32
292701|NCT00192023|715059|P1|STARTED|Period III - Double-Blind||107
292702|NCT00191984|715081|P1|NOT COMPLETED|Overall Study||39
292703|NCT00191984|715081|P1|COMPLETED|Overall Study||7
292704|NCT00191984|715081|P1|STARTED|Overall Study||46
292705|NCT00191945|715091|P2|NOT COMPLETED|Open-Label Treatment Extension||0
292706|NCT00191945|715092|P1|NOT COMPLETED|Open-Label Treatment Extension||0
292707|NCT00191945|715091|P2|COMPLETED|Open-Label Treatment Extension||48
292708|NCT00191945|715092|P1|COMPLETED|Open-Label Treatment Extension||94
292709|NCT00191945|715091|P2|STARTED|Open-Label Treatment Extension||48
292710|NCT00191945|715092|P1|STARTED|Open-Label Treatment Extension||94
292711|NCT00191945|715091|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
292712|NCT00191945|715092|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
292713|NCT00191945|715091|P2|COMPLETED|Double-Blind Acute Treatment||48
292714|NCT00191945|715092|P1|COMPLETED|Double-Blind Acute Treatment||94
292715|NCT00191945|715091|P2|STARTED|Double-Blind Acute Treatment||51
292716|NCT00191945|715092|P1|STARTED|Double-Blind Acute Treatment||100
292717|NCT00191906|715128|P4|NOT COMPLETED|Study Period III||0
292718|NCT00191906|715129|P3|NOT COMPLETED|Study Period III||0
292719|NCT00191906|715130|P2|NOT COMPLETED|Study Period III||4
292720|NCT00191906|715131|P1|NOT COMPLETED|Study Period III||5
292721|NCT00191906|715128|P4|COMPLETED|Study Period III||0
292722|NCT00191906|715129|P3|COMPLETED|Study Period III||0
292723|NCT00191906|715130|P2|COMPLETED|Study Period III||7
292724|NCT00191906|715131|P1|COMPLETED|Study Period III||9
292725|NCT00191906|715128|P4|STARTED|Study Period III||0
292726|NCT00191906|715129|P3|STARTED|Study Period III||0
292727|NCT00191906|715130|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
292728|NCT00191906|715131|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
292729|NCT00191906|715128|P4|NOT COMPLETED|Study Period II||0
292730|NCT00191906|715129|P3|NOT COMPLETED|Study Period II||1
292731|NCT00191906|715130|P2|NOT COMPLETED|Study Period II||5
292732|NCT00191906|715131|P1|NOT COMPLETED|Study Period II||0
292733|NCT00191906|715128|P4|COMPLETED|Study Period II||18
292734|NCT00191906|715129|P3|COMPLETED|Study Period II||26
292735|NCT00191906|715130|P2|COMPLETED|Study Period II||32
292736|NCT00191906|715131|P1|COMPLETED|Study Period II||39
292737|NCT00191906|715128|P4|STARTED|Study Period II||18
292738|NCT00191906|715129|P3|STARTED|Study Period II||27
292739|NCT00191906|715130|P2|STARTED|Study Period II||37
292740|NCT00191906|715131|P1|STARTED|Study Period II||39
292741|NCT00191854|715174|P3|NOT COMPLETED|Overall Study||39
292742|NCT00191854|715175|P2|NOT COMPLETED|Overall Study||30
292743|NCT00191854|715176|P1|NOT COMPLETED|Overall Study||37
292744|NCT00191854|715174|P3|COMPLETED|Overall Study||12
292745|NCT00191854|715175|P2|COMPLETED|Overall Study||17
292746|NCT00191854|715176|P1|COMPLETED|Overall Study||12
292747|NCT00191854|715174|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
292748|NCT00191854|715175|P2|Received at Least One Dose of Study Drug|Overall Study||47
292749|NCT00191854|715176|P1|Received at Least One Dose of Study Drug|Overall Study||49
292750|NCT00191854|715174|P3|STARTED|Overall Study||51
292751|NCT00191854|715175|P2|STARTED|Overall Study||47
292752|NCT00191854|715176|P1|STARTED|Overall Study||49
292753|NCT00191815|715196|P1|NOT COMPLETED|Overall Study||40
292754|NCT00191815|715196|P1|COMPLETED|Overall Study||30
292755|NCT00191815|715196|P1|Treated|Overall Study||67
292756|NCT00191815|715196|P1|STARTED|Overall Study||70
292757|NCT00191789|715208|P1|NOT COMPLETED|Overall Study||25
292758|NCT00191789|715208|P1|COMPLETED|Overall Study||40
292759|NCT00191789|715208|P1|STARTED|Overall Study||65
292760|NCT00191724|715225|P5|NOT COMPLETED|Overall Study||3
292761|NCT00191724|715226|P4|NOT COMPLETED|Overall Study||3
292762|NCT00191724|715227|P3|NOT COMPLETED|Overall Study||1
292763|NCT00191724|715228|P2|NOT COMPLETED|Overall Study||1
292764|NCT00191724|715229|P1|NOT COMPLETED|Overall Study||1
292765|NCT00191724|715225|P5|COMPLETED|Overall Study||12
292766|NCT00191724|715226|P4|COMPLETED|Overall Study||5
292767|NCT00191724|715227|P3|COMPLETED|Overall Study||8
292768|NCT00191724|715228|P2|COMPLETED|Overall Study||8
292769|NCT00191724|715229|P1|COMPLETED|Overall Study||5
292770|NCT00191724|715225|P5|STARTED|Overall Study||15
292771|NCT00191724|715226|P4|STARTED|Overall Study||8
292772|NCT00191724|715227|P3|STARTED|Overall Study||9
292773|NCT00191724|715228|P2|STARTED|Overall Study||9
292774|NCT00191724|715229|P1|STARTED|Overall Study||6
292775|NCT00191646|715258|P2|NOT COMPLETED|Overall Study||153
292776|NCT00191646|715259|P1|NOT COMPLETED|Overall Study||171
292777|NCT00191646|715258|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
292778|NCT00191646|715259|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
292779|NCT00191646|715258|P2|Received Crossover Therapy|Overall Study||78
292780|NCT00191646|715259|P1|Received Crossover Therapy|Overall Study||77
292781|NCT00191646|715258|P2|Received Consolidation Therapy|Overall Study||183
292782|NCT00191646|715259|P1|Received Consolidation Therapy|Overall Study||169
292783|NCT00191646|715258|P2|Received Induction Therapy|Overall Study||409
292784|NCT00191646|715259|P1|Received Induction Therapy|Overall Study||411
292785|NCT00191646|715258|P2|STARTED|Overall Study||414
292786|NCT00191646|715259|P1|STARTED|Overall Study||417
292787|NCT00191477|715279|P2|NOT COMPLETED|Overall Study||129
292788|NCT00191477|715280|P1|NOT COMPLETED|Overall Study||138
292789|NCT00191477|715279|P2|COMPLETED|Overall Study||47
292790|NCT00191477|715280|P1|COMPLETED|Overall Study||41
292791|NCT00191477|715279|P2|Received Study Drug|Overall Study||162
292792|NCT00191477|715280|P1|Received Study Drug|Overall Study||166
292793|NCT00191477|715279|P2|STARTED|Overall Study||176
292794|NCT00191477|715280|P1|STARTED|Overall Study||179
292795|NCT00191451|715299|P3|NOT COMPLETED|Overall Study||14
292796|NCT00191451|715300|P2|NOT COMPLETED|Overall Study||14
292797|NCT00191451|715301|P1|NOT COMPLETED|Overall Study||7
292798|NCT00191451|715299|P3|COMPLETED|Overall Study||35
292799|NCT00191451|715300|P2|COMPLETED|Overall Study||37
292800|NCT00191451|715301|P1|COMPLETED|Overall Study||43
292801|NCT00191451|715299|P3|Received at Least One Dose of Study Drug|Overall Study||47
292802|NCT00191451|715300|P2|Received at Least One Dose of Study Drug|Overall Study||48
292803|NCT00191451|715301|P1|Received at Least One Dose of Study Drug|Overall Study||50
292804|NCT00191451|715299|P3|STARTED|Overall Study||49
292805|NCT00191451|715300|P2|STARTED|Overall Study||51
292806|NCT00191451|715301|P1|STARTED|Overall Study||50
292807|NCT00191386|715321|P1|NOT COMPLETED|Overall Study||160
292808|NCT00191386|715321|P1|COMPLETED|Overall Study||68
292809|NCT00191386|715321|P1|3 Years|Overall Study||65
292810|NCT00191386|715321|P1|2 Years|Overall Study||105
292811|NCT00191386|715321|P1|12 Months|Overall Study||149
292812|NCT00191386|715321|P1|6 Months|Overall Study||183
292813|NCT00191386|715321|P1|STARTED|Overall Study||228
292814|NCT00191334|715328|P1|NOT COMPLETED|Overall Study||17
292815|NCT00191334|715328|P1|COMPLETED|Overall Study||33
292816|NCT00191334|715328|P1|STARTED|Overall Study||50
292817|NCT00191308|715336|P1|NOT COMPLETED|Overall Study||1
292818|NCT00191308|715336|P1|COMPLETED|Overall Study||29
292819|NCT00191308|715336|P1|STARTED|Overall Study||30
292820|NCT00191282|715346|P2|NOT COMPLETED|Overall Study||212
292821|NCT00191282|715347|P1|NOT COMPLETED|Overall Study||220
292822|NCT00191282|715346|P2|COMPLETED|Overall Study||346
292823|NCT00191282|715347|P1|COMPLETED|Overall Study||338
292824|NCT00191282|715346|P2|STARTED|Overall Study||558
292825|NCT00191282|715347|P1|STARTED|Overall Study||558
292826|NCT00191269|715407|P2|NOT COMPLETED|Overall Study||58
292827|NCT00191269|715408|P1|NOT COMPLETED|Overall Study||6
292828|NCT00191269|715407|P2|COMPLETED|Overall Study||4
292829|NCT00191269|715408|P1|COMPLETED|Overall Study||0
292830|NCT00191269|715407|P2|STARTED|Overall Study||62
292831|NCT00191269|715408|P1|STARTED|Overall Study||6
292832|NCT00191191|715424|P2|NOT COMPLETED|Overall Study||112
292833|NCT00191191|715425|P1|NOT COMPLETED|Overall Study||114
292834|NCT00191191|715424|P2|COMPLETED|Overall Study||0
292835|NCT00191191|715425|P1|COMPLETED|Overall Study||0
292836|NCT00191191|715424|P2|Full Analysis Set Population|Overall Study||108
292837|NCT00191191|715425|P1|Full Analysis Set Population|Overall Study||108
292838|NCT00191191|715424|P2|Safety Analysis Population|Overall Study||111
292839|NCT00191191|715425|P1|Safety Analysis Population|Overall Study||114
292840|NCT00191191|715424|P2|STARTED|Overall Study||112
292841|NCT00191191|715425|P1|STARTED|Overall Study||114
292842|NCT00191165|715441|P2|NOT COMPLETED|Overall Study||2
292843|NCT00191165|715442|P1|NOT COMPLETED|Overall Study||2
292844|NCT00191165|715441|P2|COMPLETED|Overall Study||11
292845|NCT00191165|715442|P1|COMPLETED|Overall Study||12
292846|NCT00191165|715441|P2|STARTED|Overall Study||13
292847|NCT00191165|715442|P1|STARTED|Overall Study||14
292848|NCT00191152|715454|P2|NOT COMPLETED|Crossover Treatment||28
292849|NCT00191152|715455|P1|NOT COMPLETED|Crossover Treatment||27
292850|NCT00191152|715454|P2|COMPLETED|Crossover Treatment||53
292851|NCT00191152|715455|P1|COMPLETED|Crossover Treatment||50
292852|NCT00191152|715454|P2|Received Treatment|Crossover Treatment||80
292853|NCT00191152|715455|P1|Received Treatment|Crossover Treatment||76
292854|NCT00191152|715454|P2|STARTED|Crossover Treatment||81
292855|NCT00191152|715455|P1|STARTED|Crossover Treatment||77
292856|NCT00191152|715454|P2|NOT COMPLETED|Initial Treatment||153
292857|NCT00191152|715455|P1|NOT COMPLETED|Initial Treatment||141
292858|NCT00191152|715454|P2|COMPLETED|Initial Treatment||83
292859|NCT00191152|715455|P1|COMPLETED|Initial Treatment||98
292860|NCT00191152|715454|P2|Received Initial Treatment|Initial Treatment||227
292861|NCT00191152|715455|P1|Received Initial Treatment|Initial Treatment||236
292862|NCT00191152|715454|P2|STARTED|Initial Treatment||236
292863|NCT00191152|715455|P1|STARTED|Initial Treatment||239
292864|NCT00191139|715487|P2|NOT COMPLETED|Overall Study||12
292865|NCT00191139|715488|P1|NOT COMPLETED|Overall Study||5
292866|NCT00191139|715487|P2|COMPLETED|Overall Study||20
292867|NCT00191139|715488|P1|COMPLETED|Overall Study||27
292868|NCT00191139|715487|P2|STARTED|Overall Study||32
292869|NCT00191139|715488|P1|STARTED|Overall Study||32
292870|NCT00191113|715504|P2|NOT COMPLETED|Addendum 3||0
292871|NCT00191113|715505|P1|NOT COMPLETED|Addendum 3||0
292872|NCT00191113|715504|P2|COMPLETED|Addendum 3||37
292873|NCT00191113|715505|P1|COMPLETED|Addendum 3||20
292874|NCT00191113|715504|P2|STARTED|Addendum 3||37
292875|NCT00191113|715505|P1|STARTED|Addendum 3||20
292876|NCT00191113|715504|P2|NOT COMPLETED|Addendum 2||17
292877|NCT00191113|715505|P1|NOT COMPLETED|Addendum 2||10
292878|NCT00191113|715504|P2|COMPLETED|Addendum 2||31
292879|NCT00191113|715505|P1|COMPLETED|Addendum 2||18
292880|NCT00191113|715504|P2|STARTED|Addendum 2||48
292881|NCT00191113|715505|P1|STARTED|Addendum 2||28
292882|NCT00191113|715504|P2|NOT COMPLETED|Addendum 1||0
292883|NCT00191113|715505|P1|NOT COMPLETED|Addendum 1||0
292884|NCT00191113|715504|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
292885|NCT00191113|715505|P1|COMPLETED|Addendum 1||2
292886|NCT00191113|715504|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
292887|NCT00191113|715505|P1|STARTED|Addendum 1||2
292888|NCT00191113|715504|P2|NOT COMPLETED|Core Study||15
292889|NCT00191113|715505|P1|NOT COMPLETED|Core Study||35
292890|NCT00191113|715504|P2|COMPLETED|Core Study||61
292891|NCT00191113|715505|P1|COMPLETED|Core Study||43
292892|NCT00191113|715504|P2|STARTED|Core Study||76
292893|NCT00191113|715505|P1|STARTED|Core Study||78
292894|NCT00191100|715547|P2|NOT COMPLETED|Overall Study||12
292895|NCT00191100|715548|P1|NOT COMPLETED|Overall Study||42
292896|NCT00191100|715547|P2|COMPLETED|Overall Study||244
292897|NCT00191100|715548|P1|COMPLETED|Overall Study||217
292898|NCT00191100|715547|P2|STARTED|Overall Study||256
292899|NCT00191100|715548|P1|STARTED|Overall Study||259
292900|NCT00190983|715564|P1|NOT COMPLETED|Overall Study||2
292901|NCT00190983|715564|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
292902|NCT00190983|715564|P1|STARTED|Overall Study||29
292903|NCT00190775|715573|P2|NOT COMPLETED|Overall Study||100
292904|NCT00190775|715574|P1|NOT COMPLETED|Overall Study||149
292905|NCT00190775|715573|P2|COMPLETED|Overall Study||134
292906|NCT00190775|715574|P1|COMPLETED|Overall Study||119
292907|NCT00190775|715573|P2|Received Study Drug|Overall Study||234
292908|NCT00190775|715574|P1|Received Study Drug|Overall Study||266
292909|NCT00190775|715573|P2|STARTED|Overall Study||234
292910|NCT00190775|715574|P1|STARTED|Overall Study||268
292911|NCT00190749|715645|P2|NOT COMPLETED|Overall Study||31
292912|NCT00190749|715646|P1|NOT COMPLETED|Overall Study||26
292913|NCT00190749|715645|P2|COMPLETED|Overall Study||31
292914|NCT00190749|715646|P1|COMPLETED|Overall Study||42
292915|NCT00190749|715645|P2|STARTED|Overall Study||62
292916|NCT00190749|715646|P1|STARTED|Overall Study||68
292917|NCT00190684|715710|P1|NOT COMPLETED|Overall Study||1489
292918|NCT00190684|715710|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
292919|NCT00190684|715710|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
292920|NCT00190684|715710|P1|STARTED|Overall Study||1553
292921|NCT00190671|715731|P2|NOT COMPLETED|Overall Study||42
292922|NCT00190671|715732|P1|NOT COMPLETED|Overall Study||27
292923|NCT00190671|715731|P2|COMPLETED|Overall Study||19
292924|NCT00190671|715732|P1|COMPLETED|Overall Study||15
292925|NCT00190671|715731|P2|STARTED|Overall Study||61
292926|NCT00190671|715732|P1|STARTED|Overall Study||42
292927|NCT00189540|715752|P2|NOT COMPLETED|Overall Study||1
292928|NCT00189540|715753|P1|NOT COMPLETED|Overall Study||7
292929|NCT00189540|715752|P2|COMPLETED|Overall Study||5
292930|NCT00189540|715753|P1|COMPLETED|Overall Study||14
292931|NCT00189540|715752|P2|STARTED|Overall Study||6
292932|NCT00189540|715753|P1|STARTED|Overall Study||21
292933|NCT00189488|715771|P2|NOT COMPLETED|Overall Study||22
292934|NCT00189488|715772|P1|NOT COMPLETED|Overall Study||15
292935|NCT00189488|715771|P2|COMPLETED|Overall Study||55
292936|NCT00189488|715772|P1|COMPLETED|Overall Study||63
292937|NCT00189488|715771|P2|Received Palifermin/Placebo|Overall Study||76
292938|NCT00189488|715772|P1|Received Palifermin/Placebo|Overall Study||75
292939|NCT00189488|715771|P2|STARTED|Overall Study||77
292940|NCT00189488|715772|P1|STARTED|Overall Study||78
292941|NCT00189475|715794|P2|NOT COMPLETED|Overall Study||0
292942|NCT00189475|715795|P1|NOT COMPLETED|Overall Study||0
292943|NCT00189475|715794|P2|COMPLETED|Overall Study||42
292944|NCT00189475|715795|P1|COMPLETED|Overall Study||42
292945|NCT00189475|715794|P2|STARTED|Overall Study||42
292946|NCT00189475|715795|P1|STARTED|Overall Study||42
292947|NCT00189462|715803|P2|NOT COMPLETED|Overall Study||21
292948|NCT00189462|715804|P1|NOT COMPLETED|Overall Study||23
292949|NCT00189462|715803|P2|COMPLETED|Overall Study||28
292950|NCT00189462|715804|P1|COMPLETED|Overall Study||27
292951|NCT00189462|715803|P2|STARTED|Overall Study||49
292952|NCT00189462|715804|P1|STARTED|Overall Study||50
292953|NCT00189436|715812|P2|NOT COMPLETED|Overall Study||5
292954|NCT00189436|715813|P1|NOT COMPLETED|Overall Study||8
292955|NCT00189436|715812|P2|COMPLETED|Overall Study||25
292956|NCT00189436|715813|P1|COMPLETED|Overall Study||23
292957|NCT00189436|715812|P2|STARTED|Overall Study||30
292958|NCT00189436|715813|P1|STARTED|Overall Study||31
292959|NCT00189423|715821|P2|NOT COMPLETED|Overall Study||766
292960|NCT00189423|715822|P1|NOT COMPLETED|Overall Study||765
292961|NCT00189423|715821|P2|COMPLETED|Overall Study||74
292962|NCT00189423|715822|P1|COMPLETED|Overall Study||48
292963|NCT00189423|715821|P2|STARTED|Overall Study||840
292964|NCT00189423|715822|P1|STARTED|Overall Study||813
292965|NCT00189306|715844|P1|NOT COMPLETED|Long-Term Follow-up||38
292966|NCT00189306|715844|P1|COMPLETED|Long-Term Follow-up||119
292967|NCT00189306|715844|P1|STARTED|Long-Term Follow-up||157
292968|NCT00189306|715844|P1|NOT COMPLETED|Posttreatment Period||12
292969|NCT00189306|715844|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
292970|NCT00189306|715844|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
292971|NCT00189306|715844|P1|NOT COMPLETED|Treatment Period||5
292972|NCT00189306|715844|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
292973|NCT00189306|715844|P1|STARTED|Treatment Period||169
292974|NCT00189202|715849|P1|NOT COMPLETED|Overall Study||5
292975|NCT00189202|715849|P1|COMPLETED|Overall Study||44
292976|NCT00189202|715849|P1|STARTED|Overall Study||49
292977|NCT00189137|715860|P2|NOT COMPLETED|Overall Study||0
292978|NCT00189137|715861|P1|NOT COMPLETED|Overall Study||0
292979|NCT00189137|715860|P2|COMPLETED|Overall Study||43
292980|NCT00189137|715861|P1|COMPLETED|Overall Study||37
292981|NCT00189137|715860|P2|STARTED|Overall Study||43
292982|NCT00189137|715861|P1|STARTED|Overall Study||37
292983|NCT00189098|715871|P2|NOT COMPLETED|Overall Study||6
292984|NCT00189098|715872|P1|NOT COMPLETED|Overall Study||5
292985|NCT00189098|715871|P2|COMPLETED|Overall Study||44
292986|NCT00189098|715872|P1|COMPLETED|Overall Study||46
292987|NCT00189098|715871|P2|STARTED|Overall Study||50
292988|NCT00189098|715872|P1|STARTED|Overall Study||51
292989|NCT00187889|715890|P2|NOT COMPLETED|Overall Study||4
292990|NCT00187889|715891|P1|NOT COMPLETED|Overall Study||6
292991|NCT00187889|715890|P2|COMPLETED|Overall Study||22
292992|NCT00187889|715891|P1|COMPLETED|Overall Study||19
292993|NCT00187889|715890|P2|STARTED|Overall Study||26
292994|NCT00187889|715891|P1|STARTED|Overall Study||25
292995|NCT00187876|715901|P2|NOT COMPLETED|Overall Study||0
292996|NCT00187876|715902|P1|NOT COMPLETED|Overall Study||0
292997|NCT00187876|715901|P2|COMPLETED|Overall Study||43
292998|NCT00187876|715902|P1|COMPLETED|Overall Study||24
292999|NCT00187876|715901|P2|STARTED|Overall Study||43
293000|NCT00187876|715902|P1|STARTED|Overall Study||24
293001|NCT00187720|715910|P2|NOT COMPLETED|Overall Study||0
293002|NCT00187720|715911|P1|NOT COMPLETED|Overall Study||0
293003|NCT00187720|715910|P2|COMPLETED|Overall Study||14
293004|NCT00187720|715911|P1|COMPLETED|Overall Study||9
293005|NCT00187720|715910|P2|STARTED|Overall Study||14
293006|NCT00187720|715911|P1|STARTED|Overall Study||9
293007|NCT00187681|715919|P2|NOT COMPLETED|Overall Study||0
293008|NCT00187681|715920|P1|NOT COMPLETED|Overall Study||0
293009|NCT00187681|715919|P2|COMPLETED|Overall Study||8
293010|NCT00187681|715920|P1|COMPLETED|Overall Study||12
293011|NCT00187681|715919|P2|STARTED|Overall Study||8
293012|NCT00187681|715920|P1|STARTED|Overall Study||12
293013|NCT00187655|715928|P1|NOT COMPLETED|Overall Study||0
293014|NCT00187655|715928|P1|COMPLETED|Overall Study||24
293015|NCT00187655|715928|P1|STARTED|Overall Study||24
293016|NCT00187486|715933|P1|NOT COMPLETED|Overall Study||1
293017|NCT00187486|715933|P1|COMPLETED|Overall Study||65
293018|NCT00187486|715933|P1|STARTED|Overall Study||66
293019|NCT00187226|715944|P6|NOT COMPLETED|Overall Study||0
293020|NCT00187226|715945|P5|NOT COMPLETED|Overall Study||0
293021|NCT00187226|715946|P4|NOT COMPLETED|Overall Study||0
293022|NCT00187226|715947|P3|NOT COMPLETED|Overall Study||0
293023|NCT00187226|715948|P2|NOT COMPLETED|Overall Study||0
293024|NCT00187226|715949|P1|NOT COMPLETED|Overall Study||0
293025|NCT00187226|715944|P6|COMPLETED|Overall Study||1
293026|NCT00187226|715945|P5|COMPLETED|Overall Study||34
293027|NCT00187226|715946|P4|COMPLETED|Overall Study||2
293028|NCT00187226|715947|P3|COMPLETED|Overall Study||28
293029|NCT00187226|715948|P2|COMPLETED|Overall Study||49
293030|NCT00187226|715949|P1|COMPLETED|Overall Study||88
293031|NCT00187226|715944|P6|STARTED|Overall Study||1
293032|NCT00187226|715945|P5|STARTED|Overall Study||34
293033|NCT00187226|715946|P4|STARTED|Overall Study||2
293034|NCT00187226|715947|P3|STARTED|Overall Study||28
293035|NCT00187226|715948|P2|STARTED|Overall Study||49
293036|NCT00187226|715949|P1|STARTED|Overall Study||88
293037|NCT00187200|715965|P2|NOT COMPLETED|Overall Study||18
293038|NCT00187200|715966|P1|NOT COMPLETED|Overall Study||18
293039|NCT00187200|715965|P2|COMPLETED|Overall Study||26
293040|NCT00187200|715966|P1|COMPLETED|Overall Study||31
293041|NCT00187200|715965|P2|STARTED|Overall Study||44
293042|NCT00187200|715966|P1|STARTED|Overall Study||49
293043|NCT00187135|715984|P6|NOT COMPLETED|Visit Three||6
293044|NCT00187135|715985|P5|NOT COMPLETED|Visit Three||8
293045|NCT00187135|715986|P4|NOT COMPLETED|Visit Three||9
293046|NCT00187135|715987|P3|NOT COMPLETED|Visit Three||9
293047|NCT00187135|715988|P2|NOT COMPLETED|Visit Three||7
293048|NCT00187135|715989|P1|NOT COMPLETED|Visit Three||7
293049|NCT00187135|715984|P6|COMPLETED|Visit Three||12
293050|NCT00187135|715985|P5|COMPLETED|Visit Three||11
293051|NCT00187135|715986|P4|COMPLETED|Visit Three||9
293052|NCT00187135|715987|P3|COMPLETED|Visit Three||14
293053|NCT00187135|715988|P2|COMPLETED|Visit Three||17
293054|NCT00187135|715989|P1|COMPLETED|Visit Three||14
293055|NCT00187135|715984|P6|STARTED|Visit Three||18
293056|NCT00187135|715985|P5|STARTED|Visit Three||19
293057|NCT00187135|715986|P4|STARTED|Visit Three||18
293058|NCT00187135|715987|P3|STARTED|Visit Three||23
293059|NCT00187135|715988|P2|STARTED|Visit Three||24
293060|NCT00187135|715989|P1|STARTED|Visit Three||21
293061|NCT00187135|715984|P6|NOT COMPLETED|Visit Two||8
293062|NCT00187135|715985|P5|NOT COMPLETED|Visit Two||6
293063|NCT00187135|715986|P4|NOT COMPLETED|Visit Two||8
293064|NCT00187135|715987|P3|NOT COMPLETED|Visit Two||2
293065|NCT00187135|715988|P2|NOT COMPLETED|Visit Two||3
293066|NCT00187135|715989|P1|NOT COMPLETED|Visit Two||5
293067|NCT00187135|715984|P6|COMPLETED|Visit Two||18
293068|NCT00187135|715985|P5|COMPLETED|Visit Two||19
293069|NCT00187135|715986|P4|COMPLETED|Visit Two||18
293070|NCT00187135|715987|P3|COMPLETED|Visit Two||23
293071|NCT00187135|715988|P2|COMPLETED|Visit Two||24
293072|NCT00187135|715989|P1|COMPLETED|Visit Two||21
293073|NCT00187135|715984|P6|STARTED|Visit Two||26
293074|NCT00187135|715985|P5|STARTED|Visit Two||25
293075|NCT00187135|715986|P4|STARTED|Visit Two||26
293076|NCT00187135|715987|P3|STARTED|Visit Two||25
293077|NCT00187135|715988|P2|STARTED|Visit Two||27
293078|NCT00187135|715989|P1|STARTED|Visit Two||26
293079|NCT00187135|715984|P6|NOT COMPLETED|Visit One||2
293080|NCT00187135|715985|P5|NOT COMPLETED|Visit One||0
293081|NCT00187135|715986|P4|NOT COMPLETED|Visit One||0
293082|NCT00187135|715987|P3|NOT COMPLETED|Visit One||0
293083|NCT00187135|715988|P2|NOT COMPLETED|Visit One||1
293084|NCT00187135|715989|P1|NOT COMPLETED|Visit One||4
293085|NCT00187135|715984|P6|COMPLETED|Visit One||26
293086|NCT00187135|715985|P5|COMPLETED|Visit One||25
293087|NCT00187135|715986|P4|COMPLETED|Visit One||26
293088|NCT00187135|715987|P3|COMPLETED|Visit One||25
293089|NCT00187135|715988|P2|COMPLETED|Visit One||27
293090|NCT00187135|715989|P1|COMPLETED|Visit One||26
293091|NCT00187135|715984|P6|STARTED|Visit One||28
293092|NCT00187135|715985|P5|STARTED|Visit One||25
293093|NCT00187135|715986|P4|STARTED|Visit One||26
293094|NCT00187135|715987|P3|STARTED|Visit One||25
293095|NCT00187135|715988|P2|STARTED|Visit One||28
293096|NCT00187135|715989|P1|STARTED|Visit One||30
293097|NCT00187096|716012|P3|NOT COMPLETED|Overall Study||1
293098|NCT00187096|716013|P2|NOT COMPLETED|Overall Study||0
293099|NCT00187096|716014|P1|NOT COMPLETED|Overall Study||0
293100|NCT00187096|716012|P3|COMPLETED|Overall Study||11
293101|NCT00187096|716013|P2|COMPLETED|Overall Study||3
293102|NCT00187096|716014|P1|COMPLETED|Overall Study||10
293103|NCT00187096|716012|P3|STARTED|Overall Study||12
293104|NCT00187096|716013|P2|STARTED|Overall Study||3
293105|NCT00187096|716014|P1|STARTED|Overall Study||10
293106|NCT00186901|716052|P3|NOT COMPLETED|Overall Study||149
293107|NCT00186901|716053|P2|NOT COMPLETED|Overall Study||45
293108|NCT00186901|716054|P1|NOT COMPLETED|Overall Study||49
293109|NCT00186901|716052|P3|COMPLETED|Overall Study||0
293110|NCT00186901|716053|P2|COMPLETED|Overall Study||96
293111|NCT00186901|716054|P1|COMPLETED|Overall Study||85
293112|NCT00186901|716052|P3|24 Month Follow-up|Overall Study||0
293113|NCT00186901|716053|P2|24 Month Follow-up|Overall Study||107
293114|NCT00186901|716054|P1|24 Month Follow-up|Overall Study||106
293115|NCT00186901|716052|P3|12 Month Follow-up|Overall Study||0
293116|NCT00186901|716053|P2|12 Month Follow-up|Overall Study||122
293117|NCT00186901|716054|P1|12 Month Follow-up|Overall Study||117
293118|NCT00186901|716052|P3|Baseline|Overall Study||0
293119|NCT00186901|716053|P2|Baseline|Overall Study||141
293120|NCT00186901|716054|P1|Baseline|Overall Study||134
293121|NCT00186901|716052|P3|STARTED|Overall Study||149
293122|NCT00186901|716053|P2|STARTED|Overall Study||141
293123|NCT00186901|716054|P1|STARTED|Overall Study||134
293124|NCT00186888|716094|P3|NOT COMPLETED|Overall Study||0
293125|NCT00186888|716095|P2|NOT COMPLETED|Overall Study||3
293126|NCT00186888|716096|P1|NOT COMPLETED|Overall Study||4
293127|NCT00186888|716094|P3|COMPLETED|Overall Study||55
293128|NCT00186888|716095|P2|COMPLETED|Overall Study||24
293129|NCT00186888|716096|P1|COMPLETED|Overall Study||19
293130|NCT00186888|716094|P3|Window Therapy|Overall Study||0
293131|NCT00186888|716095|P2|Window Therapy|Overall Study||27
293132|NCT00186888|716096|P1|Window Therapy|Overall Study||0
293133|NCT00186888|716094|P3|STARTED|Overall Study||55
293134|NCT00186888|716095|P2|STARTED|Overall Study||27
293135|NCT00186888|716096|P1|STARTED|Overall Study||23
293136|NCT00186875|716173|P2|NOT COMPLETED|Overall Study||0
293137|NCT00186875|716174|P1|NOT COMPLETED|Overall Study||0
293138|NCT00186875|716173|P2|COMPLETED|Overall Study||14
293139|NCT00186875|716174|P1|COMPLETED|Overall Study||26
293140|NCT00186875|716173|P2|STARTED|Overall Study||14
293141|NCT00186875|716174|P1|STARTED|Overall Study||26
293142|NCT00186628|716188|P1|NOT COMPLETED|Overall Study||3
293143|NCT00186628|716188|P1|COMPLETED|Overall Study||33
293144|NCT00186628|716188|P1|STARTED|Overall Study||36
293145|NCT00186537|716199|P3|NOT COMPLETED|Overall Study||3
293146|NCT00186537|716200|P2|NOT COMPLETED|Overall Study||0
293147|NCT00186537|716201|P1|NOT COMPLETED|Overall Study||7
293148|NCT00186537|716199|P3|COMPLETED|Overall Study||13
293149|NCT00186537|716200|P2|COMPLETED|Overall Study||12
293150|NCT00186537|716201|P1|COMPLETED|Overall Study||12
293151|NCT00186537|716199|P3|STARTED|Overall Study||16
293152|NCT00186537|716200|P2|STARTED|Overall Study||12
293153|NCT00186537|716201|P1|STARTED|Overall Study||19
293154|NCT00186485|716215|P1|NOT COMPLETED|Overall Study||3
293155|NCT00186485|716215|P1|COMPLETED|Overall Study||25
293156|NCT00186485|716215|P1|STARTED|Overall Study||28
293157|NCT00186446|716221|P1|NOT COMPLETED|Overall Study||9
293158|NCT00186446|716221|P1|COMPLETED|Overall Study||11
293159|NCT00186446|716221|P1|STARTED|Overall Study||20
293160|NCT00186186|716227|P1|NOT COMPLETED|Overall Study||8
293161|NCT00186186|716227|P1|COMPLETED|Overall Study||20
293162|NCT00186186|716227|P1|STARTED|Overall Study||28
293163|NCT00186121|716232|P1|NOT COMPLETED|Overall Study||3
293164|NCT00186121|716232|P1|COMPLETED|Overall Study||32
293165|NCT00186121|716232|P1|STARTED|Overall Study||35
293166|NCT00186069|716244|P2|NOT COMPLETED|Overall Study||0
293167|NCT00186069|716245|P1|NOT COMPLETED|Overall Study||0
293168|NCT00186069|716244|P2|COMPLETED|Overall Study||15
293169|NCT00186069|716245|P1|COMPLETED|Overall Study||15
293170|NCT00186069|716244|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
293171|NCT00186069|716245|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
293172|NCT00186056|716257|P2|NOT COMPLETED|Overall Study||1
293173|NCT00186056|716258|P1|NOT COMPLETED|Overall Study||2
293174|NCT00186056|716257|P2|COMPLETED|Overall Study||16
293175|NCT00186056|716258|P1|COMPLETED|Overall Study||12
293176|NCT00186056|716257|P2|STARTED|Overall Study||17
293177|NCT00186056|716258|P1|STARTED|Overall Study||14
293178|NCT00186043|716266|P2|NOT COMPLETED|Overall Study||13
293179|NCT00186043|716267|P1|NOT COMPLETED|Overall Study||15
293180|NCT00186043|716266|P2|COMPLETED|Overall Study||12
293181|NCT00186043|716267|P1|COMPLETED|Overall Study||15
293182|NCT00186043|716266|P2|STARTED|Overall Study||25
293183|NCT00186043|716267|P1|STARTED|Overall Study||30
293184|NCT00186017|716279|P2|NOT COMPLETED|Overall Study||3
293185|NCT00186017|716280|P1|NOT COMPLETED|Overall Study||2
293186|NCT00186017|716279|P2|COMPLETED|Overall Study||22
293187|NCT00186017|716280|P1|COMPLETED|Overall Study||23
293188|NCT00186017|716279|P2|STARTED|Overall Study||25
293189|NCT00186017|716280|P1|STARTED|Overall Study||25
293190|NCT00185965|716294|P2|NOT COMPLETED|Overall Study||1
293191|NCT00185965|716295|P1|NOT COMPLETED|Overall Study||0
293192|NCT00185965|716294|P2|COMPLETED|Overall Study||14
293193|NCT00185965|716295|P1|COMPLETED|Overall Study||15
293194|NCT00185965|716294|P2|STARTED|Overall Study||15
293195|NCT00185965|716295|P1|STARTED|Overall Study||15
293196|NCT00185731|716301|P1|NOT COMPLETED|Overall Study||2
293197|NCT00185731|716301|P1|COMPLETED|Overall Study||23
293198|NCT00185731|716301|P1|STARTED|Overall Study||25
293199|NCT00185692|716307|P1|NOT COMPLETED|Overall Study||16
293200|NCT00185692|716307|P1|COMPLETED|Overall Study||0
293201|NCT00185692|716307|P1|STARTED|Overall Study||16
293202|NCT00185679|716312|P1|NOT COMPLETED|Overall Study||0
293203|NCT00185679|716312|P1|COMPLETED|Overall Study||13
293204|NCT00185679|716312|P1|STARTED|Overall Study||13
293205|NCT00185640|716318|P1|NOT COMPLETED|Overall Study||145
293206|NCT00185640|716318|P1|COMPLETED|Overall Study||158
293207|NCT00185640|716318|P1|90 Days Post-transplant|Overall Study||161
293208|NCT00185640|716318|P1|Transplanted|Overall Study||296
293209|NCT00185640|716318|P1|STARTED|Overall Study||303
293210|NCT00185614|716327|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
293211|NCT00185614|716327|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
293212|NCT00185614|716327|P1|STARTED|Allogenic HCT (Allo-HCT)||59
293213|NCT00185614|716327|P1|NOT COMPLETED|Inter-treatment Period||4
293214|NCT00185614|716327|P1|COMPLETED|Inter-treatment Period||59
293215|NCT00185614|716327|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
293216|NCT00185614|716327|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
293217|NCT00185614|716327|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
293218|NCT00185614|716327|P1|STARTED|Autologous HCT (Auto-HCT)||63
293219|NCT00185588|716339|P4|NOT COMPLETED|Overall Study||4
293220|NCT00185588|716340|P3|NOT COMPLETED|Overall Study||6
293221|NCT00185588|716341|P2|NOT COMPLETED|Overall Study||2
293222|NCT00185588|716342|P1|NOT COMPLETED|Overall Study||3
293223|NCT00185588|716339|P4|COMPLETED|Overall Study||13
293224|NCT00185588|716340|P3|COMPLETED|Overall Study||0
293225|NCT00185588|716341|P2|COMPLETED|Overall Study||2
293226|NCT00185588|716342|P1|COMPLETED|Overall Study||3
293227|NCT00185588|716339|P4|STARTED|Overall Study||17
293228|NCT00185588|716340|P3|STARTED|Overall Study||6
293229|NCT00185588|716341|P2|STARTED|Overall Study||4
293230|NCT00185588|716342|P1|STARTED|Overall Study||6
293231|NCT00185458|716356|P1|NOT COMPLETED|HRT Phase||27
293232|NCT00185458|716356|P1|COMPLETED|HRT Phase||141
293233|NCT00185458|716356|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
293234|NCT00185458|716356|P1|NOT COMPLETED|Contraception Phase||58
293235|NCT00185458|716356|P1|COMPLETED|Contraception Phase||336
293236|NCT00185458|716356|P1|STARTED|Contraception Phase||394
293237|NCT00185380|716419|P3|NOT COMPLETED|Overall Study||74
293238|NCT00185380|716420|P2|NOT COMPLETED|Overall Study||72
293239|NCT00185380|716421|P1|NOT COMPLETED|Overall Study||66
293240|NCT00185380|716419|P3|COMPLETED|Overall Study||182
293241|NCT00185380|716420|P2|COMPLETED|Overall Study||174
293242|NCT00185380|716421|P1|COMPLETED|Overall Study||174
293243|NCT00185380|716419|P3|Subjects Received Treatment|Overall Study||254
293244|NCT00185380|716420|P2|Subjects Received Treatment|Overall Study||245
293245|NCT00185380|716421|P1|Subjects Received Treatment|Overall Study||239
293246|NCT00185380|716419|P3|STARTED|Overall Study||256
293247|NCT00185380|716420|P2|STARTED|Overall Study||246
293248|NCT00185380|716421|P1|STARTED|Overall Study||240
293249|NCT00185211|716449|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
293250|NCT00185211|716450|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
293251|NCT00185211|716449|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
293252|NCT00185211|716450|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
293253|NCT00185211|716449|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
293254|NCT00185211|716450|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
293255|NCT00185211|716449|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
293256|NCT00185211|716450|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
293257|NCT00185211|716449|P2|COMPLETED|Placebo-controlled Study (92012)||166
293258|NCT00185211|716450|P1|COMPLETED|Placebo-controlled Study (92012)||271
293259|NCT00185211|716449|P2|STARTED|Placebo-controlled Study (92012)||176
293260|NCT00185211|716450|P1|STARTED|Placebo-controlled Study (92012)||292
293261|NCT00184717|716478|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
293262|NCT00184717|716479|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
293263|NCT00184717|716480|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
293264|NCT00184717|716481|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
293265|NCT00184717|716482|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
293266|NCT00184717|716478|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
293267|NCT00184717|716479|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
293268|NCT00184717|716480|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
293269|NCT00184717|716481|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
293270|NCT00184717|716482|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
293271|NCT00184717|716478|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
293272|NCT00184717|716479|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
293273|NCT00184717|716480|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
293274|NCT00184717|716481|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
293275|NCT00184717|716482|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
293276|NCT00184717|716478|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
293277|NCT00184717|716479|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
293278|NCT00184717|716480|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
293279|NCT00184717|716481|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
293280|NCT00184717|716482|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
293281|NCT00184717|716478|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
293282|NCT00184717|716479|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
293283|NCT00184717|716480|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
293284|NCT00184717|716481|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
293285|NCT00184717|716482|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
293286|NCT00184717|716478|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
293287|NCT00184717|716479|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
293288|NCT00184717|716480|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
293289|NCT00184717|716481|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
293290|NCT00184717|716482|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
293291|NCT00184717|716478|P5|STARTED|Main Period (GHLIQUID-1516)||0
293292|NCT00184717|716479|P4|STARTED|Main Period (GHLIQUID-1516)||0
293293|NCT00184717|716480|P3|STARTED|Main Period (GHLIQUID-1516)||21
293294|NCT00184717|716481|P2|STARTED|Main Period (GHLIQUID-1516)||38
293295|NCT00184717|716482|P1|STARTED|Main Period (GHLIQUID-1516)||39
293296|NCT00184600|716523|P3|NOT COMPLETED|Overall Study||34
293297|NCT00184600|716524|P2|NOT COMPLETED|Overall Study||51
293298|NCT00184600|716525|P1|NOT COMPLETED|Overall Study||45
293299|NCT00184600|716523|P3|COMPLETED|Overall Study||201
293300|NCT00184600|716524|P2|COMPLETED|Overall Study||188
293301|NCT00184600|716525|P1|COMPLETED|Overall Study||189
293302|NCT00184600|716523|P3|STARTED|Overall Study||235
293303|NCT00184600|716524|P2|STARTED|Overall Study||239
293304|NCT00184600|716525|P1|STARTED|Overall Study||234
293305|NCT00184548|716579|P4|NOT COMPLETED|Overall Study||7
293306|NCT00184548|716580|P3|NOT COMPLETED|Overall Study||3
293307|NCT00184548|716581|P2|NOT COMPLETED|Overall Study||13
293308|NCT00184548|716582|P1|NOT COMPLETED|Overall Study||8
293309|NCT00184548|716579|P4|COMPLETED|Overall Study||38
293310|NCT00184548|716580|P3|COMPLETED|Overall Study||44
293311|NCT00184548|716581|P2|COMPLETED|Overall Study||242
293312|NCT00184548|716582|P1|COMPLETED|Overall Study||218
293313|NCT00184548|716579|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
293314|NCT00184548|716580|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
293315|NCT00184548|716581|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
293316|NCT00184548|716582|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
293317|NCT00184548|716579|P4|STARTED|Overall Study||45
293318|NCT00184548|716580|P3|STARTED|Overall Study||47
293319|NCT00184548|716581|P2|STARTED|Overall Study||255
293320|NCT00184548|716582|P1|STARTED|Overall Study||226
293321|NCT00184093|716616|P1|NOT COMPLETED|Overall Study||9
293322|NCT00184093|716616|P1|COMPLETED|Overall Study||26
293323|NCT00184093|716616|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
293324|NCT00184054|716621|P1|NOT COMPLETED|Overall Study||1
293325|NCT00184054|716621|P1|COMPLETED|Overall Study||10
293326|NCT00184054|716621|P1|STARTED|Overall Study||11
293327|NCT00184028|716626|P1|NOT COMPLETED|Overall Study||10
293328|NCT00184028|716626|P1|COMPLETED|Overall Study||2
293329|NCT00184028|716626|P1|STARTED|Overall Study||12
293330|NCT00184002|716631|P1|NOT COMPLETED|Overall Study||17
293331|NCT00184002|716631|P1|COMPLETED|Overall Study||51
293332|NCT00184002|716631|P1|STARTED|Overall Study||68
293333|NCT00183963|716640|P4|NOT COMPLETED|Overall Study||1
293334|NCT00183963|716641|P3|NOT COMPLETED|Overall Study||1
293335|NCT00183963|716642|P2|NOT COMPLETED|Overall Study||1
293336|NCT00183963|716643|P1|NOT COMPLETED|Overall Study||1
293337|NCT00183963|716640|P4|COMPLETED|Overall Study||0
293338|NCT00183963|716641|P3|COMPLETED|Overall Study||0
293339|NCT00183963|716642|P2|COMPLETED|Overall Study||0
293340|NCT00183963|716643|P1|COMPLETED|Overall Study||0
293341|NCT00183963|716640|P4|STARTED|Overall Study||1
293342|NCT00183963|716641|P3|STARTED|Overall Study||1
293343|NCT00183963|716642|P2|STARTED|Overall Study||1
293344|NCT00183963|716643|P1|STARTED|Overall Study||1
293345|NCT00183872|716657|P1|NOT COMPLETED|Overall Study||16
293346|NCT00183872|716657|P1|COMPLETED|Overall Study||24
293347|NCT00183872|716657|P1|STARTED|Overall Study||40
293348|NCT00183794|716662|P1|NOT COMPLETED|Overall Study||0
293349|NCT00183794|716662|P1|COMPLETED|Overall Study||20
293350|NCT00183794|716662|P1|STARTED|Overall Study||20
293351|NCT00183729|716669|P2|NOT COMPLETED|Overall Study||5
293352|NCT00183729|716670|P1|NOT COMPLETED|Overall Study||3
293353|NCT00183729|716669|P2|COMPLETED|Overall Study||13
293354|NCT00183729|716670|P1|COMPLETED|Overall Study||14
293355|NCT00183729|716669|P2|STARTED|Overall Study||18
293356|NCT00183729|716670|P1|STARTED|Overall Study||17
293357|NCT00183677|716680|P1|NOT COMPLETED|Overall Study||44
293358|NCT00183677|716680|P1|COMPLETED|Overall Study||53
293359|NCT00183677|716680|P1|STARTED|Overall Study||97
293360|NCT00183625|716686|P4|NOT COMPLETED|Overall Study||14
293361|NCT00183625|716687|P3|NOT COMPLETED|Overall Study||19
293362|NCT00183625|716688|P2|NOT COMPLETED|Overall Study||18
293363|NCT00183625|716689|P1|NOT COMPLETED|Overall Study||18
293364|NCT00183625|716686|P4|COMPLETED|Overall Study||10
293365|NCT00183625|716687|P3|COMPLETED|Overall Study||9
293366|NCT00183625|716688|P2|COMPLETED|Overall Study||10
293367|NCT00183625|716689|P1|COMPLETED|Overall Study||9
293368|NCT00183625|716686|P4|Obtained Employment|Overall Study||14
293369|NCT00183625|716687|P3|Obtained Employment|Overall Study||14
293370|NCT00183625|716688|P2|Obtained Employment|Overall Study||18
293371|NCT00183625|716689|P1|Obtained Employment|Overall Study||21
293372|NCT00183625|716686|P4|STARTED|Overall Study||24
293373|NCT00183625|716687|P3|STARTED|Overall Study||28
293374|NCT00183625|716688|P2|STARTED|Overall Study||28
293375|NCT00183625|716689|P1|STARTED|Overall Study||27
293376|NCT00183469|716699|P2|NOT COMPLETED|Overall Study||29
293377|NCT00183469|716700|P1|NOT COMPLETED|Overall Study||28
293378|NCT00183469|716699|P2|COMPLETED|Overall Study||16
293379|NCT00183469|716700|P1|COMPLETED|Overall Study||13
293380|NCT00183469|716699|P2|STARTED|Overall Study||45
293381|NCT00183469|716700|P1|STARTED|Overall Study||41
293382|NCT00183456|716710|P4|NOT COMPLETED|Overall Study||28
293383|NCT00183456|716711|P3|NOT COMPLETED|Overall Study||16
293384|NCT00183456|716712|P2|NOT COMPLETED|Overall Study||1
293385|NCT00183456|716713|P1|NOT COMPLETED|Overall Study||3
293386|NCT00183456|716710|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
293387|NCT00183456|716711|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
293388|NCT00183456|716712|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
293389|NCT00183456|716713|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
293390|NCT00183456|716710|P4|18 Month Follow-up|Overall Study||207
293391|NCT00183456|716711|P3|18 Month Follow-up|Overall Study||303
293392|NCT00183456|716712|P2|18 Month Follow-up|Overall Study||81
293393|NCT00183456|716713|P1|18 Month Follow-up|Overall Study||80
293394|NCT00183456|716710|P4|12 Month Follow-up|Overall Study||186
293395|NCT00183456|716711|P3|12 Month Follow-up|Overall Study||267
293396|NCT00183456|716712|P2|12 Month Follow-up|Overall Study||74
293397|NCT00183456|716713|P1|12 Month Follow-up|Overall Study||76
293398|NCT00183456|716710|P4|6 Month Follow-up|Overall Study||175
293399|NCT00183456|716711|P3|6 Month Follow-up|Overall Study||278
293400|NCT00183456|716712|P2|6 Month Follow-up|Overall Study||77
293401|NCT00183456|716713|P1|6 Month Follow-up|Overall Study||74
293402|NCT00183456|716710|P4|STARTED|Overall Study||248
293403|NCT00183456|716711|P3|STARTED|Overall Study||329
293404|NCT00183456|716712|P2|STARTED|Overall Study||84
293405|NCT00183456|716713|P1|STARTED|Overall Study||85
293406|NCT00183430|716761|P2|NOT COMPLETED|Overall Study||0
293407|NCT00183430|716762|P1|NOT COMPLETED|Overall Study||6
293408|NCT00183430|716761|P2|COMPLETED|Overall Study||11
293409|NCT00183430|716762|P1|COMPLETED|Overall Study||3
293410|NCT00183430|716761|P2|STARTED|Overall Study||11
293411|NCT00183430|716762|P1|STARTED|Overall Study||9
293412|NCT00183339|716774|P2|NOT COMPLETED|Overall Study||4
293413|NCT00183339|716775|P1|NOT COMPLETED|Overall Study||6
293414|NCT00183339|716774|P2|COMPLETED|Overall Study||4
293415|NCT00183339|716775|P1|COMPLETED|Overall Study||4
293416|NCT00183339|716774|P2|STARTED|Overall Study||8
293417|NCT00183339|716775|P1|STARTED|Overall Study||10
293418|NCT00183274|716787|P6|NOT COMPLETED|Phase 3: Double-Blind||4
293419|NCT00183274|716788|P5|NOT COMPLETED|Phase 3: Double-Blind||20
293420|NCT00183274|716789|P4|NOT COMPLETED|Phase 3: Double-Blind||2
293421|NCT00183274|716790|P3|NOT COMPLETED|Phase 3: Double-Blind||0
293422|NCT00183274|716791|P2|NOT COMPLETED|Phase 3: Double-Blind||0
293423|NCT00183274|716792|P1|NOT COMPLETED|Phase 3: Double-Blind||0
293424|NCT00183274|716787|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
293425|NCT00183274|716788|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
293426|NCT00183274|716789|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
293427|NCT00183274|716790|P3|COMPLETED|Phase 3: Double-Blind||0
293428|NCT00183274|716791|P2|COMPLETED|Phase 3: Double-Blind||0
293429|NCT00183274|716792|P1|COMPLETED|Phase 3: Double-Blind||0
293430|NCT00183274|716787|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
293431|NCT00183274|716788|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
293432|NCT00183274|716789|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
293433|NCT00183274|716790|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
293434|NCT00183274|716791|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
293435|NCT00183274|716792|P1|STARTED|Phase 3: Double-Blind||0
293436|NCT00183274|716787|P6|NOT COMPLETED|Phase 2: Double-Blind||0
293437|NCT00183274|716788|P5|NOT COMPLETED|Phase 2: Double-Blind||0
293438|NCT00183274|716789|P4|NOT COMPLETED|Phase 2: Double-Blind||0
293439|NCT00183274|716790|P3|NOT COMPLETED|Phase 2: Double-Blind||43
293440|NCT00183274|716791|P2|NOT COMPLETED|Phase 2: Double-Blind||26
293441|NCT00183274|716792|P1|NOT COMPLETED|Phase 2: Double-Blind||0
293442|NCT00183274|716787|P6|COMPLETED|Phase 2: Double-Blind||0
293443|NCT00183274|716788|P5|COMPLETED|Phase 2: Double-Blind||0
293444|NCT00183274|716789|P4|COMPLETED|Phase 2: Double-Blind||0
293445|NCT00183274|716790|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
293446|NCT00183274|716791|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
293447|NCT00183274|716792|P1|COMPLETED|Phase 2: Double-Blind||0
293448|NCT00183274|716787|P6|STARTED|Phase 2: Double-Blind||0
293449|NCT00183274|716788|P5|STARTED|Phase 2: Double-Blind||0
293450|NCT00183274|716789|P4|STARTED|Phase 2: Double-Blind||0
293451|NCT00183274|716790|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
293452|NCT00183274|716791|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
293453|NCT00183274|716792|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
293454|NCT00183274|716787|P6|NOT COMPLETED|Phase 1: Open-Label||0
293455|NCT00183274|716788|P5|NOT COMPLETED|Phase 1: Open-Label||0
293456|NCT00183274|716789|P4|NOT COMPLETED|Phase 1: Open-Label||0
293457|NCT00183274|716790|P3|NOT COMPLETED|Phase 1: Open-Label||0
293458|NCT00183274|716791|P2|NOT COMPLETED|Phase 1: Open-Label||0
293459|NCT00183274|716792|P1|NOT COMPLETED|Phase 1: Open-Label||110
293460|NCT00183274|716787|P6|COMPLETED|Phase 1: Open-Label||0
293461|NCT00183274|716788|P5|COMPLETED|Phase 1: Open-Label||0
293462|NCT00183274|716789|P4|COMPLETED|Phase 1: Open-Label||0
293463|NCT00183274|716790|P3|COMPLETED|Phase 1: Open-Label||0
293464|NCT00183274|716791|P2|COMPLETED|Phase 1: Open-Label||0
293465|NCT00183274|716792|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
293466|NCT00183274|716787|P6|STARTED|Phase 1: Open-Label||0
293467|NCT00183274|716788|P5|STARTED|Phase 1: Open-Label||0
293468|NCT00183274|716789|P4|STARTED|Phase 1: Open-Label||0
293469|NCT00183274|716790|P3|STARTED|Phase 1: Open-Label||0
293470|NCT00183274|716791|P2|STARTED|Phase 1: Open-Label||0
293471|NCT00183274|716792|P1|STARTED|Phase 1: Open-Label||268
293472|NCT00183248|716809|P2|NOT COMPLETED|Overall Study||1
293473|NCT00183248|716810|P1|NOT COMPLETED|Overall Study||1
293474|NCT00183248|716809|P2|COMPLETED|Overall Study||4
293475|NCT00183248|716810|P1|COMPLETED|Overall Study||3
293476|NCT00183248|716809|P2|STARTED|Overall Study||5
293477|NCT00183248|716810|P1|STARTED|Overall Study||4
293478|NCT00183196|716831|P3|NOT COMPLETED|Overall Study||18
293479|NCT00183196|716832|P2|NOT COMPLETED|Overall Study||15
293480|NCT00183196|716833|P1|NOT COMPLETED|Overall Study||20
293481|NCT00183196|716831|P3|COMPLETED|Overall Study||32
293482|NCT00183196|716832|P2|COMPLETED|Overall Study||35
293483|NCT00183196|716833|P1|COMPLETED|Overall Study||30
293484|NCT00183196|716831|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
293485|NCT00183196|716832|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
293486|NCT00183196|716833|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
293487|NCT00183092|716843|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
293488|NCT00183092|716844|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
293489|NCT00183092|716845|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
293490|NCT00183092|716846|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
293491|NCT00183092|716843|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
293492|NCT00183092|716844|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
293493|NCT00183092|716845|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
293494|NCT00183092|716846|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
293495|NCT00183092|716843|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
293496|NCT00183092|716844|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
293497|NCT00183092|716845|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
293498|NCT00183092|716846|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
293499|NCT00183092|716843|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
293500|NCT00183092|716844|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
293501|NCT00183092|716845|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
293502|NCT00183092|716846|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
293503|NCT00183092|716843|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
293504|NCT00183092|716844|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
293505|NCT00183092|716845|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
293506|NCT00183092|716846|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
293507|NCT00183092|716843|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
293508|NCT00183092|716844|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
293509|NCT00183092|716845|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
293510|NCT00183092|716846|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
293511|NCT00183092|716843|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
293512|NCT00183092|716844|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
293513|NCT00183092|716845|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
293514|NCT00183092|716846|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
293515|NCT00183092|716843|P4|STARTED|Double-blind (Baseline - Month 2)||0
293516|NCT00183092|716844|P3|STARTED|Double-blind (Baseline - Month 2)||0
293517|NCT00183092|716845|P2|STARTED|Double-blind (Baseline - Month 2)||28
293518|NCT00183092|716846|P1|STARTED|Double-blind (Baseline - Month 2)||23
293519|NCT00182793|716867|P1|NOT COMPLETED|Overall Study||0
293520|NCT00182793|716867|P1|COMPLETED|Overall Study||32
293521|NCT00182793|716867|P1|STARTED|Overall Study||32
293522|NCT00182767|716872|P5|NOT COMPLETED|Overall Study||0
293523|NCT00182767|716873|P4|NOT COMPLETED|Overall Study||0
293524|NCT00182767|716874|P3|NOT COMPLETED|Overall Study||0
293525|NCT00182767|716875|P2|NOT COMPLETED|Overall Study||0
293526|NCT00182767|716876|P1|NOT COMPLETED|Overall Study||0
293527|NCT00182767|716872|P5|COMPLETED|Overall Study||24
293528|NCT00182767|716873|P4|COMPLETED|Overall Study||3
293529|NCT00182767|716874|P3|COMPLETED|Overall Study||6
293530|NCT00182767|716875|P2|COMPLETED|Overall Study||6
293531|NCT00182767|716876|P1|COMPLETED|Overall Study||6
293532|NCT00182767|716872|P5|STARTED|Overall Study||24
293533|NCT00182767|716873|P4|STARTED|Overall Study||3
293534|NCT00182767|716874|P3|STARTED|Overall Study||6
293535|NCT00182767|716875|P2|STARTED|Overall Study||6
293536|NCT00182767|716876|P1|STARTED|Overall Study||6
293537|NCT00182754|716893|P2|NOT COMPLETED|Overall Study||0
293538|NCT00182754|716894|P1|NOT COMPLETED|Overall Study||0
293539|NCT00182754|716893|P2|COMPLETED|Overall Study||17
293540|NCT00182754|716894|P1|COMPLETED|Overall Study||16
293541|NCT00182754|716893|P2|STARTED|Overall Study||17
293542|NCT00182754|716894|P1|STARTED|Overall Study||16
293543|NCT00182728|716904|P1|NOT COMPLETED|Overall Study||0
293544|NCT00182728|716904|P1|COMPLETED|Overall Study||71
293545|NCT00182728|716904|P1|STARTED|Overall Study||71
293546|NCT00182689|716916|P2|NOT COMPLETED|Overall Study||49
293547|NCT00182689|716917|P1|NOT COMPLETED|Overall Study||40
293548|NCT00182689|716916|P2|COMPLETED|Overall Study||0
293549|NCT00182689|716917|P1|COMPLETED|Overall Study||0
293550|NCT00182689|716916|P2|Eligible and Began Protocol Therapy|Overall Study||45
293551|NCT00182689|716917|P1|Eligible and Began Protocol Therapy|Overall Study||38
293552|NCT00182689|716916|P2|Eligible|Overall Study||45
293553|NCT00182689|716917|P1|Eligible|Overall Study||39
293554|NCT00182689|716916|P2|STARTED|Overall Study||49
293555|NCT00182689|716917|P1|STARTED|Overall Study||40
293556|NCT00182637|716927|P1|NOT COMPLETED|Overall Study||3
293557|NCT00182637|716927|P1|COMPLETED|Overall Study|off study date|2
293558|NCT00182637|716927|P1|STARTED|Overall Study|active/on treatment date|5
293559|NCT00182091|716937|P4|NOT COMPLETED|Overall Study||0
293560|NCT00182091|716938|P3|NOT COMPLETED|Overall Study||0
293561|NCT00182091|716939|P2|NOT COMPLETED|Overall Study||0
293562|NCT00182091|716940|P1|NOT COMPLETED|Overall Study||1
293563|NCT00182091|716937|P4|COMPLETED|Overall Study||20
293564|NCT00182091|716938|P3|COMPLETED|Overall Study||25
293565|NCT00182091|716939|P2|COMPLETED|Overall Study||15
293566|NCT00182091|716940|P1|COMPLETED|Overall Study||14
293567|NCT00182091|716937|P4|STARTED|Overall Study||20
293568|NCT00182091|716938|P3|STARTED|Overall Study||25
293569|NCT00182091|716939|P2|STARTED|Overall Study||15
293570|NCT00182091|716940|P1|STARTED|Overall Study||15
293571|NCT00182078|716956|P2|NOT COMPLETED|Overall Study||0
293572|NCT00182078|716957|P1|NOT COMPLETED|Overall Study||1
293573|NCT00182078|716956|P2|COMPLETED|Overall Study||17
293574|NCT00182078|716957|P1|COMPLETED|Overall Study||8
293575|NCT00182078|716956|P2|STARTED|Overall Study||17
293576|NCT00182078|716957|P1|STARTED|Overall Study||9
293577|NCT00182000|716969|P2|NOT COMPLETED|Overall Study||2
293578|NCT00182000|716970|P1|NOT COMPLETED|Overall Study||5
293579|NCT00182000|716969|P2|COMPLETED|Overall Study||13
293580|NCT00182000|716970|P1|COMPLETED|Overall Study||9
293581|NCT00182000|716969|P2|STARTED|Overall Study||15
293582|NCT00182000|716970|P1|STARTED|Overall Study||14
293583|NCT00181883|716976|P1|NOT COMPLETED|Overall Study||10
293584|NCT00181883|716976|P1|COMPLETED|Overall Study||20
293585|NCT00181883|716976|P1|STARTED|Overall Study||30
293586|NCT00181844|716980|P1|NOT COMPLETED|Exposed to Study Medication||17
293587|NCT00181844|716980|P1|COMPLETED|Exposed to Study Medication||22
293588|NCT00181844|716980|P1|STARTED|Exposed to Study Medication||39
293589|NCT00181844|716980|P1|NOT COMPLETED|Signed Consent||12
293590|NCT00181844|716980|P1|COMPLETED|Signed Consent||39
293591|NCT00181844|716980|P1|STARTED|Signed Consent||51
293592|NCT00181766|716984|P1|NOT COMPLETED|Overall Study||12
293593|NCT00181766|716984|P1|COMPLETED|Overall Study|Completed the trial.|33
293594|NCT00181766|716984|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
293595|NCT00181714|716989|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
293596|NCT00181714|716989|P1|COMPLETED|Began Treatment With OROS-MPH||30
293597|NCT00181714|716989|P1|STARTED|Began Treatment With OROS-MPH||154
293598|NCT00181714|716989|P1|NOT COMPLETED|Signed Consent/Enrolled||49
293599|NCT00181714|716989|P1|COMPLETED|Signed Consent/Enrolled||154
293600|NCT00181714|716989|P1|STARTED|Signed Consent/Enrolled||203
293601|NCT00181623|716993|P1|NOT COMPLETED|Overall Study||1
293602|NCT00181623|716993|P1|COMPLETED|Overall Study||5
293603|NCT00181623|716993|P1|STARTED|Overall Study||6
293604|NCT00181610|717001|P3|NOT COMPLETED|Overall Study||0
293605|NCT00181610|717002|P2|NOT COMPLETED|Overall Study||1
293606|NCT00181610|717003|P1|NOT COMPLETED|Overall Study||0
293607|NCT00181610|717001|P3|COMPLETED|Overall Study||3
293608|NCT00181610|717002|P2|COMPLETED|Overall Study||3
293609|NCT00181610|717003|P1|COMPLETED|Overall Study||4
293610|NCT00181610|717001|P3|STARTED|Overall Study||3
293611|NCT00181610|717002|P2|STARTED|Overall Study||4
293612|NCT00181610|717003|P1|STARTED|Overall Study||4
293613|NCT00181155|717014|P2|NOT COMPLETED|Overall Study||0
293614|NCT00181155|717015|P1|NOT COMPLETED|Overall Study||2
293615|NCT00181155|717014|P2|COMPLETED|Overall Study||3
293616|NCT00181155|717015|P1|COMPLETED|Overall Study||13
293617|NCT00181155|717014|P2|STARTED|Overall Study||3
293618|NCT00181155|717015|P1|STARTED|Overall Study||15
293619|NCT00180687|717027|P4|NOT COMPLETED|Overall Study||0
293620|NCT00180687|717028|P3|NOT COMPLETED|Overall Study||0
293621|NCT00180687|717029|P2|NOT COMPLETED|Overall Study||0
293622|NCT00180687|717030|P1|NOT COMPLETED|Overall Study||0
293623|NCT00180687|717027|P4|COMPLETED|Overall Study||20
293624|NCT00180687|717028|P3|COMPLETED|Overall Study||20
293625|NCT00180687|717029|P2|COMPLETED|Overall Study||20
293626|NCT00180687|717030|P1|COMPLETED|Overall Study||20
293627|NCT00180687|717027|P4|STARTED|Overall Study||20
293628|NCT00180687|717028|P3|STARTED|Overall Study||20
293629|NCT00180687|717029|P2|STARTED|Overall Study||20
293630|NCT00180687|717030|P1|STARTED|Overall Study||20
293631|NCT00180479|717054|P2|NOT COMPLETED|Overall Study||13
293632|NCT00180479|717055|P1|NOT COMPLETED|Overall Study||16
293633|NCT00180479|717054|P2|COMPLETED|Overall Study||320
293634|NCT00180479|717055|P1|COMPLETED|Overall Study||653
293722|NCT00178919|717315|P2|STARTED|Overall Study||93
293635|NCT00180479|717054|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
293636|NCT00180479|717055|P1|STARTED|Overall Study||669
293637|NCT00180323|717147|P1|NOT COMPLETED|Overall Study||0
293638|NCT00180323|717147|P1|COMPLETED|Overall Study||43
293639|NCT00180323|717147|P1|STARTED|Overall Study||43
293640|NCT00180271|717156|P2|NOT COMPLETED|Overall Study||0
293641|NCT00180271|717157|P1|NOT COMPLETED|Overall Study||0
293642|NCT00180271|717156|P2|COMPLETED|Overall Study||731
293643|NCT00180271|717157|P1|COMPLETED|Overall Study||1089
293644|NCT00180271|717156|P2|STARTED|Overall Study||731
293645|NCT00180271|717157|P1|STARTED|Overall Study||1089
293646|NCT00179959|717165|P2|NOT COMPLETED|Overall Study||3
293647|NCT00179959|717166|P1|NOT COMPLETED|Overall Study||6
293648|NCT00179959|717165|P2|COMPLETED|Overall Study||13
293649|NCT00179959|717166|P1|COMPLETED|Overall Study||9
293650|NCT00179959|717165|P2|STARTED|Overall Study||16
293651|NCT00179959|717166|P1|STARTED|Overall Study||15
293652|NCT00179673|717172|P1|NOT COMPLETED|Overall Study||43
293653|NCT00179673|717172|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
293654|NCT00179673|717172|P1|Received Study Drug|Overall Study||43
293655|NCT00179673|717172|P1|STARTED|Overall Study||43
293656|NCT00179660|717180|P1|NOT COMPLETED|Overall Study||50
293657|NCT00179660|717180|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
293658|NCT00179660|717180|P1|Completed 12 Cycles of Treatment|Overall Study||12
293659|NCT00179660|717180|P1|Received Study Drug|Overall Study||49
293660|NCT00179660|717180|P1|STARTED|Overall Study||50
293661|NCT00179647|717189|P1|NOT COMPLETED|Overall Study||1913
293662|NCT00179647|717189|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
293663|NCT00179647|717189|P1|STARTED|Overall Study||1913
293664|NCT00179621|717196|P4|NOT COMPLETED|Open-Label Period||43
293665|NCT00179621|717197|P3|NOT COMPLETED|Open-Label Period||28
293666|NCT00179621|717198|P2|NOT COMPLETED|Open-Label Period||28
293667|NCT00179621|717199|P1|NOT COMPLETED|Open-Label Period||0
293668|NCT00179621|717196|P4|COMPLETED|Open-Label Period||13
293669|NCT00179621|717197|P3|COMPLETED|Open-Label Period||19
293670|NCT00179621|717198|P2|COMPLETED|Open-Label Period||14
293671|NCT00179621|717199|P1|COMPLETED|Open-Label Period||0
293672|NCT00179621|717196|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
293673|NCT00179621|717197|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
293674|NCT00179621|717198|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
293675|NCT00179621|717199|P1|STARTED|Open-Label Period||0
293676|NCT00179621|717196|P4|NOT COMPLETED|Double-Blind Period||0
293677|NCT00179621|717197|P3|NOT COMPLETED|Double-Blind Period||30
293678|NCT00179621|717198|P2|NOT COMPLETED|Double-Blind Period||46
293679|NCT00179621|717199|P1|NOT COMPLETED|Double-Blind Period||64
293680|NCT00179621|717196|P4|COMPLETED|Double-Blind Period||0
293681|NCT00179621|717197|P3|COMPLETED|Double-Blind Period||39
293682|NCT00179621|717198|P2|COMPLETED|Double-Blind Period||23
293683|NCT00179621|717199|P1|COMPLETED|Double-Blind Period||3
293684|NCT00179621|717196|P4|STARTED|Double-Blind Period||0
293685|NCT00179621|717197|P3|STARTED|Double-Blind Period||69
293686|NCT00179621|717198|P2|STARTED|Double-Blind Period||69
293687|NCT00179621|717199|P1|STARTED|Double-Blind Period||67
293688|NCT00179517|717252|P2|NOT COMPLETED|Overall Study||1
293689|NCT00179517|717253|P1|NOT COMPLETED|Overall Study||2
293690|NCT00179517|717252|P2|COMPLETED|Overall Study||19
293691|NCT00179517|717253|P1|COMPLETED|Overall Study||18
293692|NCT00179517|717252|P2|STARTED|Overall Study||20
293693|NCT00179517|717253|P1|STARTED|Overall Study||20
293694|NCT00179478|717277|P2|NOT COMPLETED|Overall Study||15
293695|NCT00179478|717278|P1|NOT COMPLETED|Overall Study||13
293696|NCT00179478|717277|P2|COMPLETED|Overall Study||59
293697|NCT00179478|717278|P1|COMPLETED|Overall Study||68
293698|NCT00179478|717277|P2|STARTED|Overall Study||74
293699|NCT00179478|717278|P1|STARTED|Overall Study||81
293700|NCT00179413|717291|P2|NOT COMPLETED|Overall Study||115
293701|NCT00179413|717292|P1|NOT COMPLETED|Overall Study||125
293702|NCT00179413|717291|P2|COMPLETED|Overall Study||152
293703|NCT00179413|717292|P1|COMPLETED|Overall Study||157
293704|NCT00179413|717291|P2|STARTED|Overall Study||267
293705|NCT00179413|717292|P1|STARTED|Overall Study||282
293706|NCT00179309|717304|P2|NOT COMPLETED|Crossover||0
293707|NCT00179309|717305|P1|NOT COMPLETED|Crossover||0
293708|NCT00179309|717304|P2|COMPLETED|Crossover||3
293709|NCT00179309|717305|P1|COMPLETED|Crossover||0
293710|NCT00179309|717304|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
293711|NCT00179309|717305|P1|STARTED|Crossover||0
293712|NCT00179309|717304|P2|NOT COMPLETED|Treatment||5
293713|NCT00179309|717305|P1|NOT COMPLETED|Treatment||4
293714|NCT00179309|717304|P2|COMPLETED|Treatment||18
293715|NCT00179309|717305|P1|COMPLETED|Treatment||21
293716|NCT00179309|717304|P2|STARTED|Treatment||23
293717|NCT00179309|717305|P1|STARTED|Treatment||25
293718|NCT00178919|717315|P2|NOT COMPLETED|Overall Study||25
293719|NCT00178919|717316|P1|NOT COMPLETED|Overall Study||0
293720|NCT00178919|717315|P2|COMPLETED|Overall Study||68
293721|NCT00178919|717316|P1|COMPLETED|Overall Study||19
293723|NCT00178919|717316|P1|STARTED|Overall Study||19
293724|NCT00178841|717324|P1|NOT COMPLETED|Overall Study||0
293725|NCT00178841|717324|P1|COMPLETED|Overall Study||4
293726|NCT00178841|717324|P1|STARTED|Overall Study||4
293727|NCT00178711|717332|P2|NOT COMPLETED|Overall Study||0
293728|NCT00178711|717333|P1|NOT COMPLETED|Overall Study||0
293729|NCT00178711|717332|P2|COMPLETED|Overall Study||45
293730|NCT00178711|717333|P1|COMPLETED|Overall Study||52
293731|NCT00178711|717332|P2|STARTED|Overall Study||45
293732|NCT00178711|717333|P1|STARTED|Overall Study||52
293733|NCT00178685|717344|P3|NOT COMPLETED|Overall Study||196
293734|NCT00178685|717345|P2|NOT COMPLETED|Overall Study||204
293735|NCT00178685|717346|P1|NOT COMPLETED|Overall Study||111
293736|NCT00178685|717344|P3|COMPLETED|Overall Study||128
293737|NCT00178685|717345|P2|COMPLETED|Overall Study||120
293738|NCT00178685|717346|P1|COMPLETED|Overall Study||61
293739|NCT00178685|717344|P3|STARTED|Overall Study||324
293740|NCT00178685|717345|P2|STARTED|Overall Study||324
293741|NCT00178685|717346|P1|STARTED|Overall Study||172
293742|NCT00178633|717357|P1|NOT COMPLETED|Overall Study||6
293743|NCT00178633|717357|P1|COMPLETED|Overall Study||37
293744|NCT00178633|717357|P1|STARTED|Overall Study||43
293745|NCT00178503|717365|P1|NOT COMPLETED|MPH Trial: High Dose||0
293746|NCT00178503|717365|P1|COMPLETED|MPH Trial: High Dose||24
293747|NCT00178503|717365|P1|STARTED|MPH Trial: High Dose||24
293748|NCT00178503|717365|P1|NOT COMPLETED|MPH Trial: Med Dose||0
293749|NCT00178503|717365|P1|COMPLETED|MPH Trial: Med Dose||24
293750|NCT00178503|717365|P1|STARTED|MPH Trial: Med Dose||24
293751|NCT00178503|717365|P1|NOT COMPLETED|MPH Trial: Low Dose||0
293752|NCT00178503|717365|P1|COMPLETED|MPH Trial: Low Dose||24
293753|NCT00178503|717365|P1|STARTED|MPH Trial: Low Dose||24
293754|NCT00178503|717365|P1|NOT COMPLETED|MPH Trial: Placebo||0
293755|NCT00178503|717365|P1|COMPLETED|MPH Trial: Placebo||24
293756|NCT00178503|717365|P1|STARTED|MPH Trial: Placebo||24
293757|NCT00178477|717383|P1|NOT COMPLETED|Overall Study||5
293758|NCT00178477|717383|P1|COMPLETED|Overall Study||5
293759|NCT00178477|717383|P1|STARTED|Overall Study||10
293760|NCT00178464|717387|P1|NOT COMPLETED|Overall Study||2
293761|NCT00178464|717387|P1|COMPLETED|Overall Study||9
293762|NCT00178464|717387|P1|STARTED|Overall Study||11
293763|NCT00178256|717392|P4|NOT COMPLETED|Overall Study||2
293764|NCT00178256|717393|P3|NOT COMPLETED|Overall Study||0
293765|NCT00178256|717394|P2|NOT COMPLETED|Overall Study||1
293766|NCT00178256|717395|P1|NOT COMPLETED|Overall Study||4
293767|NCT00178256|717392|P4|COMPLETED|Overall Study||16
293768|NCT00178256|717393|P3|COMPLETED|Overall Study||6
293769|NCT00178256|717394|P2|COMPLETED|Overall Study||6
293770|NCT00178256|717395|P1|COMPLETED|Overall Study||6
293771|NCT00178256|717392|P4|STARTED|Overall Study||18
293772|NCT00178256|717393|P3|STARTED|Overall Study||6
293773|NCT00178256|717394|P2|STARTED|Overall Study||7
293774|NCT00178256|717395|P1|STARTED|Overall Study||10
293775|NCT00178191|717405|P3|NOT COMPLETED|Overall Study||0
293776|NCT00178191|717406|P2|NOT COMPLETED|Overall Study||0
293777|NCT00178191|717407|P1|NOT COMPLETED|Overall Study||0
293778|NCT00178191|717405|P3|COMPLETED|Overall Study||7
293779|NCT00178191|717406|P2|COMPLETED|Overall Study||10
293780|NCT00178191|717407|P1|COMPLETED|Overall Study||11
293781|NCT00178191|717405|P3|STARTED|Overall Study||7
293782|NCT00178191|717406|P2|STARTED|Overall Study||10
293783|NCT00178191|717407|P1|STARTED|Overall Study||11
293784|NCT00178178|717419|P4|NOT COMPLETED|Overall Study||0
293785|NCT00178178|717420|P3|NOT COMPLETED|Overall Study||0
293786|NCT00178178|717421|P2|NOT COMPLETED|Overall Study||0
293787|NCT00178178|717422|P1|NOT COMPLETED|Overall Study||0
293788|NCT00178178|717419|P4|COMPLETED|Overall Study||24
293789|NCT00178178|717420|P3|COMPLETED|Overall Study||24
293790|NCT00178178|717421|P2|COMPLETED|Overall Study||24
293791|NCT00178178|717422|P1|COMPLETED|Overall Study||24
293792|NCT00178178|717419|P4|STARTED|Overall Study||24
293793|NCT00178178|717420|P3|STARTED|Overall Study||24
293794|NCT00178178|717421|P2|STARTED|Overall Study||24
293795|NCT00178178|717422|P1|STARTED|Overall Study||24
293796|NCT00178126|717434|P2|NOT COMPLETED|Overall Study||27
293797|NCT00178126|717435|P1|NOT COMPLETED|Overall Study||25
293798|NCT00178126|717434|P2|COMPLETED|Overall Study||86
293799|NCT00178126|717435|P1|COMPLETED|Overall Study||94
293800|NCT00178126|717434|P2|STARTED|Overall Study||113
293801|NCT00178126|717435|P1|STARTED|Overall Study||119
293802|NCT00177970|717443|P2|NOT COMPLETED|Overall Study||0
293803|NCT00177970|717444|P1|NOT COMPLETED|Overall Study||0
293804|NCT00177970|717443|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
293805|NCT00177970|717444|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
293806|NCT00177970|717443|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
293807|NCT00177970|717444|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
293808|NCT00177866|717466|P2|NOT COMPLETED|Overall Study||0
293809|NCT00177866|717467|P1|NOT COMPLETED|Overall Study||0
293810|NCT00177866|717466|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
293811|NCT00177866|717467|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
293812|NCT00177866|717466|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
293813|NCT00177866|717467|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
293814|NCT00177671|717477|P2|NOT COMPLETED|Overall Study||14
293815|NCT00177671|717478|P1|NOT COMPLETED|Overall Study||25
293816|NCT00177671|717477|P2|COMPLETED|Overall Study||49
293817|NCT00177671|717478|P1|COMPLETED|Overall Study||42
293818|NCT00177671|717477|P2|Month 24|Overall Study||49
293819|NCT00177671|717478|P1|Month 24|Overall Study||42
293820|NCT00177671|717477|P2|Month 12|Overall Study||57
293821|NCT00177671|717478|P1|Month 12|Overall Study||45
293822|NCT00177671|717477|P2|STARTED|Overall Study||63
293823|NCT00177671|717478|P1|STARTED|Overall Study||67
293824|NCT00177307|717490|P1|NOT COMPLETED|Overall Study||1
293825|NCT00177307|717490|P1|COMPLETED|Overall Study||39
293826|NCT00177307|717490|P1|STARTED|Overall Study||40
293827|NCT00177294|717499|P2|NOT COMPLETED|Overall Study||5
293828|NCT00177294|717500|P1|NOT COMPLETED|Overall Study||7
293829|NCT00177294|717499|P2|COMPLETED|Overall Study||59
293830|NCT00177294|717500|P1|COMPLETED|Overall Study||53
293831|NCT00177294|717499|P2|STARTED|Overall Study||64
293832|NCT00177294|717500|P1|STARTED|Overall Study||60
293833|NCT00177255|717506|P1|NOT COMPLETED|Overall Study||0
293834|NCT00177255|717506|P1|COMPLETED|Overall Study||39
293835|NCT00177255|717506|P1|STARTED|Overall Study||39
293836|NCT00177216|717514|P3|NOT COMPLETED|Overall Study||1
293837|NCT00177216|717515|P2|NOT COMPLETED|Overall Study||3
293838|NCT00177216|717516|P1|NOT COMPLETED|Overall Study||6
293839|NCT00177216|717514|P3|COMPLETED|Overall Study||19
293840|NCT00177216|717515|P2|COMPLETED|Overall Study||20
293841|NCT00177216|717516|P1|COMPLETED|Overall Study||20
293842|NCT00177216|717514|P3|STARTED|Overall Study||20
293843|NCT00177216|717515|P2|STARTED|Overall Study||23
293844|NCT00177216|717516|P1|STARTED|Overall Study||26
293845|NCT00177164|717532|P2|NOT COMPLETED|Overall Study||16
293846|NCT00177164|717533|P1|NOT COMPLETED|Overall Study||9
293847|NCT00177164|717532|P2|COMPLETED|Overall Study||9
293848|NCT00177164|717533|P1|COMPLETED|Overall Study||14
293849|NCT00177164|717532|P2|STARTED|Overall Study||25
293850|NCT00177164|717533|P1|STARTED|Overall Study||23
293851|NCT00176917|717545|P1|NOT COMPLETED|Overall Study||0
293852|NCT00176917|717545|P1|COMPLETED|Overall Study||41
293853|NCT00176917|717545|P1|STARTED|Overall Study||41
293854|NCT00176904|717552|P1|NOT COMPLETED|Overall Study||0
293855|NCT00176904|717552|P1|COMPLETED|Overall Study||135
293856|NCT00176904|717552|P1|STARTED|Overall Study||135
293857|NCT00176878|717560|P1|NOT COMPLETED|Overall Study||0
293858|NCT00176878|717560|P1|COMPLETED|Overall Study||10
293859|NCT00176878|717560|P1|STARTED|Overall Study||10
293860|NCT00176865|717572|P3|NOT COMPLETED|Overall Study||0
293861|NCT00176865|717573|P2|NOT COMPLETED|Overall Study||0
293862|NCT00176865|717574|P1|NOT COMPLETED|Overall Study||0
293863|NCT00176865|717572|P3|COMPLETED|Overall Study||6
293864|NCT00176865|717573|P2|COMPLETED|Overall Study||10
293865|NCT00176865|717574|P1|COMPLETED|Overall Study||3
293866|NCT00176865|717572|P3|STARTED|Overall Study||6
293867|NCT00176865|717573|P2|STARTED|Overall Study||10
293868|NCT00176865|717574|P1|STARTED|Overall Study||3
293869|NCT00176852|717612|P3|NOT COMPLETED|Overall Study||0
293870|NCT00176852|717613|P2|NOT COMPLETED|Overall Study||0
293871|NCT00176852|717614|P1|NOT COMPLETED|Overall Study||0
293872|NCT00176852|717612|P3|COMPLETED|Overall Study||14
293873|NCT00176852|717613|P2|COMPLETED|Overall Study||5
293874|NCT00176852|717614|P1|COMPLETED|Overall Study||3
293875|NCT00176852|717612|P3|STARTED|Overall Study||14
293876|NCT00176852|717613|P2|STARTED|Overall Study||5
293877|NCT00176852|717614|P1|STARTED|Overall Study||3
293878|NCT00176839|717673|P1|NOT COMPLETED|Overall Study||0
293879|NCT00176839|717673|P1|COMPLETED|Overall Study||11
293880|NCT00176839|717673|P1|STARTED|Overall Study||11
293881|NCT00176826|717682|P1|NOT COMPLETED|Overall Study||0
293882|NCT00176826|717682|P1|COMPLETED|Overall Study||22
293883|NCT00176826|717682|P1|STARTED|Overall Study||22
293884|NCT00176800|717692|P1|NOT COMPLETED|Overall Study||0
293885|NCT00176800|717692|P1|COMPLETED|Overall Study||69
293886|NCT00176800|717692|P1|STARTED|Overall Study||69
293887|NCT00176644|717698|P1|NOT COMPLETED|Overall Study||1
293888|NCT00176644|717698|P1|COMPLETED|Overall Study||22
293889|NCT00176644|717698|P1|STARTED|Overall Study||23
293890|NCT00176631|717706|P1|NOT COMPLETED|Overall Study||0
293891|NCT00176631|717706|P1|COMPLETED|Overall Study||10
293892|NCT00176631|717706|P1|STARTED|Overall Study||10
293893|NCT00176605|717711|P1|NOT COMPLETED|Overall Study||2
293894|NCT00176605|717711|P1|COMPLETED|Overall Study||13
293895|NCT00176605|717711|P1|STARTED|Overall Study||15
293896|NCT00176501|717716|P1|NOT COMPLETED|Overall Study||0
293897|NCT00176501|717716|P1|COMPLETED|Overall Study||3
293898|NCT00176501|717716|P1|STARTED|Overall Study||3
293899|NCT00176488|717722|P1|NOT COMPLETED|Overall Study||1
293900|NCT00176488|717722|P1|COMPLETED|Overall Study||30
293901|NCT00176488|717722|P1|STARTED|Overall Study||31
293902|NCT00176462|717730|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
293903|NCT00176462|717731|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
293904|NCT00176462|717730|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
293905|NCT00176462|717731|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
293906|NCT00176462|717730|P2|STARTED|Continuation -up to 30mos Post Remission||26
293907|NCT00176462|717731|P1|STARTED|Continuation -up to 30mos Post Remission||19
293908|NCT00176462|717730|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
293909|NCT00176462|717731|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
293910|NCT00176462|717730|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
293911|NCT00176462|717731|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
293912|NCT00176462|717730|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
293913|NCT00176462|717731|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
293914|NCT00176462|717730|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
293915|NCT00176462|717731|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
293916|NCT00176462|717730|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
293917|NCT00176462|717731|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
293918|NCT00176462|717730|P2|STARTED|Delayed Intensification (8 Weeks)||29
293919|NCT00176462|717731|P1|STARTED|Delayed Intensification (8 Weeks)||20
293920|NCT00176462|717730|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
293921|NCT00176462|717731|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
293922|NCT00176462|717730|P2|COMPLETED|Consolidation (12 Weeks)||29
293923|NCT00176462|717731|P1|COMPLETED|Consolidation (12 Weeks)||20
293924|NCT00176462|717730|P2|STARTED|Consolidation (12 Weeks)||34
293925|NCT00176462|717731|P1|STARTED|Consolidation (12 Weeks)||20
293926|NCT00176462|717730|P2|NOT COMPLETED|Induction (4 Weeks)||5
293927|NCT00176462|717731|P1|NOT COMPLETED|Induction (4 Weeks)||1
293928|NCT00176462|717730|P2|COMPLETED|Induction (4 Weeks)||34
293929|NCT00176462|717731|P1|COMPLETED|Induction (4 Weeks)||20
293930|NCT00176462|717730|P2|STARTED|Induction (4 Weeks)||39
293931|NCT00176462|717731|P1|STARTED|Induction (4 Weeks)||21
293932|NCT00176436|717740|P2|NOT COMPLETED|Overall Study||5
293933|NCT00176436|717741|P1|NOT COMPLETED|Overall Study||6
293934|NCT00176436|717740|P2|COMPLETED|Overall Study||12
293935|NCT00176436|717741|P1|COMPLETED|Overall Study||14
293936|NCT00176436|717740|P2|STARTED|Overall Study||17
293937|NCT00176436|717741|P1|STARTED|Overall Study||20
293938|NCT00176306|717747|P1|NOT COMPLETED|Overall Study||0
293939|NCT00176306|717747|P1|COMPLETED|Overall Study||15
293940|NCT00176306|717747|P1|STARTED|Overall Study||15
293941|NCT00176254|717751|P1|NOT COMPLETED|Overall Study||1
293942|NCT00176254|717751|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
293943|NCT00176254|717751|P1|STARTED|Overall Study||40
293944|NCT00176228|717759|P1|NOT COMPLETED|Overall Study||2
293945|NCT00176228|717759|P1|COMPLETED|Overall Study|Study ended|46
293946|NCT00176228|717759|P1|STARTED|Overall Study|When study began|48
293947|NCT00176202|717766|P2|NOT COMPLETED|Overall Study||16
293948|NCT00176202|717767|P1|NOT COMPLETED|Overall Study||5
293949|NCT00176202|717766|P2|COMPLETED|Overall Study||17
293950|NCT00176202|717767|P1|COMPLETED|Overall Study||27
293951|NCT00176202|717766|P2|STARTED|Overall Study||33
293952|NCT00176202|717767|P1|STARTED|Overall Study||32
293953|NCT00175877|717779|P1|NOT COMPLETED|Overall Study||349
293954|NCT00175877|717779|P1|COMPLETED|Overall Study||497
293955|NCT00175877|717779|P1|STARTED|Overall Study||846
293956|NCT00175019|717813|P3|NOT COMPLETED|Overall Study||57
293957|NCT00175019|717814|P2|NOT COMPLETED|Overall Study||171
293958|NCT00175019|717815|P1|NOT COMPLETED|Overall Study||194
293959|NCT00175019|717813|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
293960|NCT00175019|717814|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
293961|NCT00175019|717815|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
293962|NCT00175019|717813|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
293963|NCT00175019|717814|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
293964|NCT00175019|717815|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
293965|NCT00175006|717859|P1|NOT COMPLETED|Overall Study||0
293966|NCT00175006|717859|P1|COMPLETED|Overall Study||13
293967|NCT00175006|717859|P1|STARTED|Overall Study||13
293968|NCT00174967|717868|P4|NOT COMPLETED|Overall Study||2
293969|NCT00174967|717869|P3|NOT COMPLETED|Overall Study||2
293970|NCT00174967|717870|P2|NOT COMPLETED|Overall Study||3
293971|NCT00174967|717871|P1|NOT COMPLETED|Overall Study||1
293972|NCT00174967|717868|P4|COMPLETED|Overall Study||36
293973|NCT00174967|717869|P3|COMPLETED|Overall Study||36
293974|NCT00174967|717870|P2|COMPLETED|Overall Study||37
293975|NCT00174967|717871|P1|COMPLETED|Overall Study||36
293976|NCT00174967|717868|P4|STARTED|Overall Study||38
293977|NCT00174967|717869|P3|STARTED|Overall Study||38
293978|NCT00174967|717870|P2|STARTED|Overall Study||40
293979|NCT00174967|717871|P1|STARTED|Overall Study||37
293980|NCT00174954|717917|P1|NOT COMPLETED|Overall Study||4
293981|NCT00174954|717917|P1|COMPLETED|Overall Study||28
293982|NCT00174954|717917|P1|STARTED|Overall Study||32
293983|NCT00174941|717925|P4|NOT COMPLETED|Overall Study||58
293984|NCT00174941|717926|P3|NOT COMPLETED|Overall Study||18
293985|NCT00174941|717927|P2|NOT COMPLETED|Overall Study||38
293986|NCT00174941|717928|P1|NOT COMPLETED|Overall Study||2
293987|NCT00174941|717925|P4|COMPLETED|Overall Study||58
293988|NCT00174941|717926|P3|COMPLETED|Overall Study||11
293989|NCT00174941|717927|P2|COMPLETED|Overall Study||41
293990|NCT00174941|717928|P1|COMPLETED|Overall Study||6
293991|NCT00174941|717925|P4|STARTED|Overall Study||116
293992|NCT00174941|717926|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
293993|NCT00174941|717927|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
293994|NCT00174941|717928|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
293995|NCT00174915|718003|P5|NOT COMPLETED|Overall Study||33
293996|NCT00174915|718004|P4|NOT COMPLETED|Overall Study||57
293997|NCT00174915|718005|P3|NOT COMPLETED|Overall Study||48
293998|NCT00174915|718006|P2|NOT COMPLETED|Overall Study||69
293999|NCT00174915|718007|P1|NOT COMPLETED|Overall Study||93
294000|NCT00174915|718003|P5|COMPLETED|Overall Study||101
294001|NCT00174915|718004|P4|COMPLETED|Overall Study||211
294002|NCT00174915|718005|P3|COMPLETED|Overall Study||86
294003|NCT00174915|718006|P2|COMPLETED|Overall Study||200
294004|NCT00174915|718007|P1|COMPLETED|Overall Study||174
294005|NCT00174915|718003|P5|STARTED|Overall Study||134
294006|NCT00174915|718004|P4|STARTED|Overall Study||268
294007|NCT00174915|718005|P3|STARTED|Overall Study||134
294008|NCT00174915|718006|P2|STARTED|Overall Study||269
294009|NCT00174915|718007|P1|STARTED|Overall Study||267
294010|NCT00174785|718066|P2|NOT COMPLETED|Overall Study||716
294011|NCT00174785|718067|P1|NOT COMPLETED|Overall Study||696
294012|NCT00174785|718066|P2|COMPLETED|Overall Study|completed study drug|1611
294013|NCT00174785|718067|P1|COMPLETED|Overall Study|completed study drug|1605
294014|NCT00174785|718066|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
294015|NCT00174785|718067|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
294016|NCT00174460|718083|P2|NOT COMPLETED|Overall Study||1
294017|NCT00174460|718084|P1|NOT COMPLETED|Overall Study||0
294018|NCT00174460|718083|P2|COMPLETED|Overall Study||14
294019|NCT00174460|718084|P1|COMPLETED|Overall Study||18
294020|NCT00174460|718083|P2|Received Study Treatment|Overall Study||14
294021|NCT00174460|718084|P1|Received Study Treatment|Overall Study||18
294022|NCT00174460|718083|P2|STARTED|Overall Study||15
294023|NCT00174460|718084|P1|STARTED|Overall Study||18
294024|NCT00174447|718130|P1|NOT COMPLETED|Overall Study||38
294025|NCT00174447|718130|P1|COMPLETED|Overall Study||5
294026|NCT00174447|718130|P1|STARTED|Overall Study||43
294027|NCT00174382|718139|P1|NOT COMPLETED|Overall Study||33
294028|NCT00174382|718139|P1|COMPLETED|Overall Study||116
294029|NCT00174382|718139|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
294030|NCT00174291|718158|P2|NOT COMPLETED|Overall Study||6
294031|NCT00174291|718159|P1|NOT COMPLETED|Overall Study||5
294032|NCT00174291|718158|P2|COMPLETED|Overall Study||4
294033|NCT00174291|718159|P1|COMPLETED|Overall Study||6
294034|NCT00174291|718158|P2|STARTED|Overall Study||10
294035|NCT00174291|718159|P1|STARTED|Overall Study||11
294036|NCT00174265|718189|P2|NOT COMPLETED|Overall Study||21
294037|NCT00174265|718190|P1|NOT COMPLETED|Overall Study||29
294038|NCT00174265|718189|P2|COMPLETED|Overall Study||89
294039|NCT00174265|718190|P1|COMPLETED|Overall Study||57
294040|NCT00174265|718189|P2|STARTED|Overall Study||110
294041|NCT00174265|718190|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
294042|NCT00174252|718198|P1|NOT COMPLETED|Overall Study||2
294043|NCT00174252|718198|P1|COMPLETED|Overall Study||55
294044|NCT00174252|718198|P1|STARTED|Overall Study||57
294045|NCT00174187|718233|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
294046|NCT00174187|718234|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
294047|NCT00174187|718235|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
294048|NCT00174187|718233|P3|COMPLETED|Period 2 (After 3 Years)||13
294049|NCT00174187|718234|P2|COMPLETED|Period 2 (After 3 Years)||0
294050|NCT00174187|718235|P1|COMPLETED|Period 2 (After 3 Years)||0
294051|NCT00174187|718233|P3|STARTED|Period 2 (After 3 Years)||21
294052|NCT00174187|718234|P2|STARTED|Period 2 (After 3 Years)||0
294053|NCT00174187|718235|P1|STARTED|Period 2 (After 3 Years)||0
294054|NCT00174187|718233|P3|NOT COMPLETED|Between Period 1 and Period 2||5
294055|NCT00174187|718234|P2|NOT COMPLETED|Between Period 1 and Period 2||0
294056|NCT00174187|718235|P1|NOT COMPLETED|Between Period 1 and Period 2||0
294057|NCT00174187|718233|P3|COMPLETED|Between Period 1 and Period 2||21
294058|NCT00174187|718234|P2|COMPLETED|Between Period 1 and Period 2||0
294059|NCT00174187|718235|P1|COMPLETED|Between Period 1 and Period 2||0
294060|NCT00174187|718233|P3|Consented|Between Period 1 and Period 2||24
294061|NCT00174187|718234|P2|Consented|Between Period 1 and Period 2||0
294062|NCT00174187|718235|P1|Consented|Between Period 1 and Period 2||0
294063|NCT00174187|718233|P3|STARTED|Between Period 1 and Period 2||26
294064|NCT00174187|718234|P2|STARTED|Between Period 1 and Period 2||0
294065|NCT00174187|718235|P1|STARTED|Between Period 1 and Period 2||0
294066|NCT00174187|718233|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
294067|NCT00174187|718234|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
294068|NCT00174187|718235|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
294069|NCT00174187|718233|P3|COMPLETED|Period 1 (up to 3 Years)||0
294070|NCT00174187|718234|P2|COMPLETED|Period 1 (up to 3 Years)||11
294071|NCT00174187|718235|P1|COMPLETED|Period 1 (up to 3 Years)||15
294072|NCT00174187|718233|P3|STARTED|Period 1 (up to 3 Years)||0
294073|NCT00174187|718234|P2|STARTED|Period 1 (up to 3 Years)||15
294074|NCT00174187|718235|P1|STARTED|Period 1 (up to 3 Years)||15
294075|NCT00172185|718300|P4|NOT COMPLETED|Overall Study||4
294076|NCT00172185|718301|P3|NOT COMPLETED|Overall Study||5
294077|NCT00172185|718302|P2|NOT COMPLETED|Overall Study||2
294078|NCT00172185|718303|P1|NOT COMPLETED|Overall Study||0
294079|NCT00172185|718300|P4|COMPLETED|Overall Study||23
294080|NCT00172185|718301|P3|COMPLETED|Overall Study||20
294081|NCT00172185|718302|P2|COMPLETED|Overall Study||5
294082|NCT00172185|718303|P1|COMPLETED|Overall Study||6
294083|NCT00172185|718300|P4|STARTED|Overall Study||27
294084|NCT00172185|718301|P3|STARTED|Overall Study||25
294085|NCT00172185|718302|P2|STARTED|Overall Study||7
294086|NCT00172185|718303|P1|STARTED|Overall Study||6
294087|NCT00172042|718319|P2|NOT COMPLETED|Overall Study||125
294088|NCT00172042|718320|P1|NOT COMPLETED|Overall Study||158
294089|NCT00172042|718319|P2|COMPLETED|Overall Study||86
294090|NCT00172042|718320|P1|COMPLETED|Overall Study||68
294091|NCT00172042|718319|P2|STARTED|Overall Study||211
294092|NCT00172042|718320|P1|STARTED|Overall Study||226
294093|NCT00171925|718342|P2|NOT COMPLETED|Overall Study||31
294094|NCT00171925|718343|P1|NOT COMPLETED|Overall Study||30
294095|NCT00171925|718342|P2|COMPLETED|Overall Study||40
294096|NCT00171925|718343|P1|COMPLETED|Overall Study||42
294097|NCT00171925|718342|P2|STARTED|Overall Study||71
294098|NCT00171925|718343|P1|STARTED|Overall Study||72
294099|NCT00171873|718355|P2|NOT COMPLETED|Overall Study||3
294100|NCT00171873|718356|P1|NOT COMPLETED|Overall Study||9
294101|NCT00171873|718355|P2|COMPLETED|Overall Study||40
294102|NCT00171873|718356|P1|COMPLETED|Overall Study||33
294103|NCT00171873|718355|P2|STARTED|Overall Study||43
294104|NCT00171873|718356|P1|STARTED|Overall Study||42
294105|NCT00171834|718369|P7|NOT COMPLETED|Overall Study||4
294106|NCT00171834|718370|P6|NOT COMPLETED|Overall Study||35
294107|NCT00171834|718371|P5|NOT COMPLETED|Overall Study||8
294108|NCT00171834|718372|P4|NOT COMPLETED|Overall Study||12
294109|NCT00171834|718373|P3|NOT COMPLETED|Overall Study||12
294110|NCT00171834|718374|P2|NOT COMPLETED|Overall Study||12
294111|NCT00171834|718375|P1|NOT COMPLETED|Overall Study||6
294112|NCT00171834|718369|P7|COMPLETED|Overall Study||0
294113|NCT00171834|718370|P6|COMPLETED|Overall Study||0
294114|NCT00171834|718371|P5|COMPLETED|Overall Study||0
294115|NCT00171834|718372|P4|COMPLETED|Overall Study||0
294116|NCT00171834|718373|P3|COMPLETED|Overall Study||0
294117|NCT00171834|718374|P2|COMPLETED|Overall Study||0
294118|NCT00171834|718375|P1|COMPLETED|Overall Study||0
294119|NCT00171834|718369|P7|Completed 6 Cycles of Treatment|Overall Study||0
294120|NCT00171834|718370|P6|Completed 6 Cycles of Treatment|Overall Study||1
294121|NCT00171834|718371|P5|Completed 6 Cycles of Treatment|Overall Study||2
294122|NCT00171834|718372|P4|Completed 6 Cycles of Treatment|Overall Study||0
294123|NCT00171834|718373|P3|Completed 6 Cycles of Treatment|Overall Study||1
294124|NCT00171834|718374|P2|Completed 6 Cycles of Treatment|Overall Study||0
294125|NCT00171834|718375|P1|Completed 6 Cycles of Treatment|Overall Study||0
294126|NCT00171834|718369|P7|STARTED|Overall Study||4
294127|NCT00171834|718370|P6|STARTED|Overall Study||35
294128|NCT00171834|718371|P5|STARTED|Overall Study||8
294129|NCT00171834|718372|P4|STARTED|Overall Study||12
294130|NCT00171834|718373|P3|STARTED|Overall Study||12
294131|NCT00171834|718374|P2|STARTED|Overall Study||12
294132|NCT00171834|718375|P1|STARTED|Overall Study||6
294133|NCT00171704|718415|P2|NOT COMPLETED|Overall Study||49
294134|NCT00171704|718416|P1|NOT COMPLETED|Overall Study||44
294135|NCT00171704|718415|P2|COMPLETED|Overall Study||81
294136|NCT00171704|718416|P1|COMPLETED|Overall Study||89
294137|NCT00171704|718415|P2|STARTED|Overall Study||130
294138|NCT00171704|718416|P1|STARTED|Overall Study||133
294139|NCT00171340|718438|P2|NOT COMPLETED|Overall Study||135
294140|NCT00171340|718439|P1|NOT COMPLETED|Overall Study||124
294141|NCT00171340|718438|P2|COMPLETED|Overall Study||398
294142|NCT00171340|718439|P1|COMPLETED|Overall Study||408
294143|NCT00171340|718438|P2|STARTED|Overall Study||533
294144|NCT00171340|718439|P1|STARTED|Overall Study||532
294145|NCT00171314|718455|P2|NOT COMPLETED|Overall Study||78
294146|NCT00171314|718456|P1|NOT COMPLETED|Overall Study||91
294147|NCT00171314|718455|P2|COMPLETED|Overall Study||186
294148|NCT00171314|718456|P1|COMPLETED|Overall Study||172
294149|NCT00171314|718455|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
294150|NCT00171314|718456|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
294151|NCT00171314|718455|P2|STARTED|Overall Study||264
294152|NCT00171314|718456|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
294153|NCT00171301|718472|P2|NOT COMPLETED|Overall Study||9
294154|NCT00171301|718473|P1|NOT COMPLETED|Overall Study||8
294155|NCT00171301|718472|P2|COMPLETED|Overall Study||62
294156|NCT00171301|718473|P1|COMPLETED|Overall Study||154
294157|NCT00171301|718472|P2|Received Deferasirox|Overall Study||69
294158|NCT00171301|718473|P1|Received Deferasirox|Overall Study||162
294159|NCT00171301|718472|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
294160|NCT00171301|718473|P1|STARTED|Overall Study||162
294161|NCT00171210|718486|P2|NOT COMPLETED|Overall Study||115
294162|NCT00171210|718487|P1|NOT COMPLETED|Overall Study||69
294163|NCT00171210|718486|P2|COMPLETED|Overall Study||181
294164|NCT00171210|718487|P1|COMPLETED|Overall Study||190
294165|NCT00171210|718486|P2|STARTED EXTENSION STUDY|Overall Study||247
294166|NCT00171210|718487|P1|STARTED EXTENSION STUDY|Overall Study||259
294167|NCT00171210|718486|P2|STARTED|Overall Study||296
294168|NCT00171210|718487|P1|STARTED|Overall Study||259
294169|NCT00171054|718517|P2|NOT COMPLETED|Overall Study||12
294170|NCT00171054|718518|P1|NOT COMPLETED|Overall Study||10
294171|NCT00171054|718517|P2|COMPLETED|Overall Study||50
294172|NCT00171054|718518|P1|COMPLETED|Overall Study||53
294173|NCT00171054|718517|P2|STARTED|Overall Study||62
294174|NCT00171054|718518|P1|STARTED|Overall Study||63
294175|NCT00170950|718550|P2|NOT COMPLETED|Overall Study||910
294176|NCT00170950|718551|P1|NOT COMPLETED|Overall Study||885
294177|NCT00170950|718550|P2|COMPLETED|Overall Study||4852
294178|NCT00170950|718551|P1|COMPLETED|Overall Study||4859
294179|NCT00170950|718550|P2|STARTED|Overall Study||5762
294180|NCT00170950|718551|P1|STARTED|Overall Study||5744
294181|NCT00170846|718564|P3|NOT COMPLETED|Overall Study||13
294182|NCT00170846|718565|P2|NOT COMPLETED|Overall Study||19
294183|NCT00170846|718566|P1|NOT COMPLETED|Overall Study||11
294184|NCT00170846|718564|P3|COMPLETED|Overall Study||131
294185|NCT00170846|718565|P2|COMPLETED|Overall Study||108
294186|NCT00170846|718566|P1|COMPLETED|Overall Study||112
294187|NCT00170846|718564|P3|STARTED|Overall Study||144
294188|NCT00170846|718565|P2|STARTED|Overall Study||127
294189|NCT00170846|718566|P1|STARTED|Overall Study||123
294190|NCT00170625|718580|P1|NOT COMPLETED|Overall Study||0
294191|NCT00170625|718580|P1|COMPLETED|Overall Study||26
294192|NCT00170625|718580|P1|STARTED|Overall Study||26
294193|NCT00170157|718585|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
294194|NCT00170157|718586|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
294195|NCT00170157|718585|P2|COMPLETED|Treatment Period 2 Crossover||41
294196|NCT00170157|718586|P1|COMPLETED|Treatment Period 2 Crossover||0
294197|NCT00170157|718585|P2|STARTED|Treatment Period 2 Crossover||41
294198|NCT00170157|718586|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
294199|NCT00170157|718585|P2|NOT COMPLETED|Washout Period of 14 Days||17
294200|NCT00170157|718586|P1|NOT COMPLETED|Washout Period of 14 Days||0
294201|NCT00170157|718585|P2|COMPLETED|Washout Period of 14 Days||41
294202|NCT00170157|718586|P1|COMPLETED|Washout Period of 14 Days||0
294203|NCT00170157|718585|P2|STARTED|Washout Period of 14 Days||58
294204|NCT00170157|718586|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
294205|NCT00170157|718585|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
294206|NCT00170157|718586|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
294207|NCT00170157|718585|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
294208|NCT00170157|718586|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
294209|NCT00170157|718585|P2|STARTED|Treatment Period 1 Initial Randomization||58
294210|NCT00170157|718586|P1|STARTED|Treatment Period 1 Initial Randomization||54
294211|NCT00169442|718598|P6|NOT COMPLETED|Overall Study||2
294212|NCT00169442|718599|P5|NOT COMPLETED|Overall Study||1
294213|NCT00169442|718600|P4|NOT COMPLETED|Overall Study||0
294214|NCT00169442|718601|P3|NOT COMPLETED|Overall Study||1
294215|NCT00169442|718602|P2|NOT COMPLETED|Overall Study||1
294216|NCT00169442|718603|P1|NOT COMPLETED|Overall Study||0
294217|NCT00169442|718598|P6|COMPLETED|Overall Study||41
294218|NCT00169442|718599|P5|COMPLETED|Overall Study||41
294219|NCT00169442|718600|P4|COMPLETED|Overall Study||250
294220|NCT00169442|718601|P3|COMPLETED|Overall Study||166
294221|NCT00169442|718602|P2|COMPLETED|Overall Study||123
294222|NCT00169442|718603|P1|COMPLETED|Overall Study||119
294223|NCT00169442|718598|P6|STARTED|Overall Study||43
294224|NCT00169442|718599|P5|STARTED|Overall Study||42
294225|NCT00169442|718600|P4|STARTED|Overall Study||250
294226|NCT00169442|718601|P3|STARTED|Overall Study||167
294227|NCT00169442|718602|P2|STARTED|Overall Study||124
294228|NCT00169442|718603|P1|STARTED|Overall Study||119
294229|NCT00168844|718713|P3|NOT COMPLETED|Overall Study||91
294230|NCT00168844|718714|P2|NOT COMPLETED|Overall Study||55
294231|NCT00168844|718715|P1|NOT COMPLETED|Overall Study||55
294232|NCT00168844|718713|P3|COMPLETED|Overall Study||228
294233|NCT00168844|718714|P2|COMPLETED|Overall Study||277
294234|NCT00168844|718715|P1|COMPLETED|Overall Study||277
294235|NCT00168844|718713|P3|STARTED|Overall Study||319
294236|NCT00168844|718714|P2|STARTED|Overall Study||332
294237|NCT00168844|718715|P1|STARTED|Overall Study||332
294238|NCT00168831|718897|P3|NOT COMPLETED|Overall Study||114
294239|NCT00168831|718898|P2|NOT COMPLETED|Overall Study||81
294240|NCT00168831|718899|P1|NOT COMPLETED|Overall Study||60
294241|NCT00168831|718897|P3|COMPLETED|Overall Study||220
294242|NCT00168831|718898|P2|COMPLETED|Overall Study||254
294243|NCT00168831|718899|P1|COMPLETED|Overall Study||278
294244|NCT00168831|718897|P3|STARTED|Overall Study||334
294245|NCT00168831|718898|P2|STARTED|Overall Study||335
294246|NCT00168831|718899|P1|STARTED|Overall Study||338
294247|NCT00168818|719081|P3|NOT COMPLETED|Treatment||133
294248|NCT00168818|719082|P2|NOT COMPLETED|Treatment||151
294249|NCT00168818|719083|P1|NOT COMPLETED|Treatment||133
294250|NCT00168818|719081|P3|COMPLETED|Treatment||1021
294251|NCT00168818|719082|P2|COMPLETED|Treatment||1012
294252|NCT00168818|719083|P1|COMPLETED|Treatment||1013
294253|NCT00168818|719081|P3|STARTED|Treatment||1154
294254|NCT00168818|719082|P2|STARTED|Treatment||1163
294255|NCT00168818|719083|P1|STARTED|Treatment||1146
294256|NCT00168818|719081|P3|NOT COMPLETED|Overall Study||124
294257|NCT00168818|719082|P2|NOT COMPLETED|Overall Study||109
294258|NCT00168818|719083|P1|NOT COMPLETED|Overall Study||117
294259|NCT00168818|719081|P3|COMPLETED|Overall Study||1030
294260|NCT00168818|719082|P2|COMPLETED|Overall Study||1054
294261|NCT00168818|719083|P1|COMPLETED|Overall Study||1029
294262|NCT00168818|719081|P3|STARTED|Overall Study||1154
294263|NCT00168818|719082|P2|STARTED|Overall Study||1163
294264|NCT00168818|719083|P1|STARTED|Overall Study||1146
294265|NCT00168805|719127|P3|NOT COMPLETED|Treatment||62
294266|NCT00168805|719128|P2|NOT COMPLETED|Treatment||56
294267|NCT00168805|719129|P1|NOT COMPLETED|Treatment||49
294268|NCT00168805|719127|P3|COMPLETED|Treatment||632
294269|NCT00168805|719128|P2|COMPLETED|Treatment||647
294270|NCT00168805|719129|P1|COMPLETED|Treatment||630
294271|NCT00168805|719127|P3|STARTED|Treatment||694
294272|NCT00168805|719128|P2|STARTED|Treatment||703
294273|NCT00168805|719129|P1|STARTED|Treatment||679
294274|NCT00168805|719127|P3|NOT COMPLETED|Overall Study||78
294275|NCT00168805|719128|P2|NOT COMPLETED|Overall Study||78
294276|NCT00168805|719129|P1|NOT COMPLETED|Overall Study||71
294277|NCT00168805|719127|P3|COMPLETED|Overall Study||616
294278|NCT00168805|719128|P2|COMPLETED|Overall Study||625
294279|NCT00168805|719129|P1|COMPLETED|Overall Study||608
294280|NCT00168805|719127|P3|STARTED|Overall Study||694
294281|NCT00168805|719128|P2|STARTED|Overall Study||703
294282|NCT00168805|719129|P1|STARTED|Overall Study||679
294283|NCT00168454|719176|P6|NOT COMPLETED|Overall Study||6
294284|NCT00168454|719177|P5|NOT COMPLETED|Overall Study||6
294285|NCT00168454|719178|P4|NOT COMPLETED|Overall Study||9
294286|NCT00168454|719179|P3|NOT COMPLETED|Overall Study||6
294287|NCT00168454|719180|P2|NOT COMPLETED|Overall Study||7
294288|NCT00168454|719181|P1|NOT COMPLETED|Overall Study||7
294289|NCT00168454|719176|P6|COMPLETED|Overall Study||50
294290|NCT00168454|719177|P5|COMPLETED|Overall Study||47
294291|NCT00168454|719178|P4|COMPLETED|Overall Study||40
294292|NCT00168454|719179|P3|COMPLETED|Overall Study||48
294293|NCT00168454|719180|P2|COMPLETED|Overall Study||50
294294|NCT00168454|719181|P1|COMPLETED|Overall Study||37
294295|NCT00168454|719176|P6|STARTED|Overall Study||56
294296|NCT00168454|719177|P5|STARTED|Overall Study||53
294297|NCT00168454|719178|P4|STARTED|Overall Study||49
294298|NCT00168454|719179|P3|STARTED|Overall Study||54
294299|NCT00168454|719180|P2|STARTED|Overall Study||57
294300|NCT00168454|719181|P1|STARTED|Overall Study||44
294301|NCT00168428|719227|P2|NOT COMPLETED|Open-Label Phase (OL)||68
294302|NCT00168428|719228|P1|NOT COMPLETED|Open-Label Phase (OL)||44
294303|NCT00168428|719227|P2|COMPLETED|Open-Label Phase (OL)||261
294304|NCT00168428|719228|P1|COMPLETED|Open-Label Phase (OL)||261
294305|NCT00168428|719227|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
294306|NCT00168428|719228|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
294307|NCT00168428|719227|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
294308|NCT00168428|719228|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
294309|NCT00168428|719227|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
294310|NCT00168428|719228|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
294311|NCT00168428|719227|P2|STARTED|Double-Blind Phase (DB)||358
294312|NCT00168428|719228|P1|STARTED|Double-Blind Phase (DB)||347
294313|NCT00168389|719247|P3|NOT COMPLETED|Overall Study||95
294314|NCT00168389|719248|P2|NOT COMPLETED|Overall Study||48
294315|NCT00168389|719249|P1|NOT COMPLETED|Overall Study||56
294316|NCT00168389|719247|P3|COMPLETED|Overall Study||70
294317|NCT00168389|719248|P2|COMPLETED|Overall Study||118
294318|NCT00168389|719249|P1|COMPLETED|Overall Study||107
294319|NCT00168389|719247|P3|STARTED|Overall Study||165
294320|NCT00168389|719248|P2|STARTED|Overall Study||166
294321|NCT00168389|719249|P1|STARTED|Overall Study||163
294322|NCT00168337|719278|P3|NOT COMPLETED|Overall Study||103
294323|NCT00168337|719279|P2|NOT COMPLETED|Overall Study||69
294324|NCT00168337|719280|P1|NOT COMPLETED|Overall Study||70
294325|NCT00168337|719278|P3|COMPLETED|Overall Study||82
294326|NCT00168337|719279|P2|COMPLETED|Overall Study||112
294327|NCT00168337|719280|P1|COMPLETED|Overall Study||118
294328|NCT00168337|719278|P3|STARTED|Overall Study||185
294329|NCT00168337|719279|P2|STARTED|Overall Study||181
294330|NCT00168337|719280|P1|STARTED|Overall Study||188
294331|NCT00168324|719309|P3|NOT COMPLETED|Open-Label Period||6
294332|NCT00168324|719310|P2|NOT COMPLETED|Open-Label Period||8
294333|NCT00168324|719311|P1|NOT COMPLETED|Open-Label Period||4
294334|NCT00168324|719309|P3|COMPLETED|Open-Label Period||152
294335|NCT00168324|719310|P2|COMPLETED|Open-Label Period||147
294336|NCT00168324|719311|P1|COMPLETED|Open-Label Period||160
294337|NCT00168324|719309|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
294338|NCT00168324|719310|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
294339|NCT00168324|719311|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
294340|NCT00168324|719309|P3|NOT COMPLETED|Double-Blind Period||13
294341|NCT00168324|719310|P2|NOT COMPLETED|Double-Blind Period||7
294342|NCT00168324|719311|P1|NOT COMPLETED|Double-Blind Period||12
294343|NCT00168324|719309|P3|COMPLETED|Double-Blind Period||189
294344|NCT00168324|719310|P2|COMPLETED|Double-Blind Period||189
294345|NCT00168324|719311|P1|COMPLETED|Double-Blind Period||189
294346|NCT00168324|719309|P3|STARTED|Double-Blind Period||202
294347|NCT00168324|719310|P2|STARTED|Double-Blind Period||196
294348|NCT00168324|719311|P1|STARTED|Double-Blind Period||201
294349|NCT00168311|719333|P2|NOT COMPLETED|Overall Study||2
294350|NCT00168311|719334|P1|NOT COMPLETED|Overall Study||0
294351|NCT00168311|719333|P2|COMPLETED|Overall Study||8
294352|NCT00168311|719334|P1|COMPLETED|Overall Study||12
294353|NCT00168311|719333|P2|STARTED|Overall Study||10
294354|NCT00168311|719334|P1|STARTED|Overall Study||12
294355|NCT00168298|719343|P3|NOT COMPLETED|Open-Label Period||8
294356|NCT00168298|719344|P2|NOT COMPLETED|Open-Label Period||5
294357|NCT00168298|719345|P1|NOT COMPLETED|Open-Label Period||7
294358|NCT00168298|719343|P3|COMPLETED|Open-Label Period||160
294359|NCT00168298|719344|P2|COMPLETED|Open-Label Period||168
294360|NCT00168298|719345|P1|COMPLETED|Open-Label Period||172
294361|NCT00168298|719343|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
294362|NCT00168298|719344|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
294363|NCT00168298|719345|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
294364|NCT00168298|719343|P3|NOT COMPLETED|Double-Blind Period||15
294365|NCT00168298|719344|P2|NOT COMPLETED|Double-Blind Period||12
294366|NCT00168298|719345|P1|NOT COMPLETED|Double-Blind Period||12
294367|NCT00168298|719343|P3|COMPLETED|Double-Blind Period||209
294368|NCT00168298|719344|P2|COMPLETED|Double-Blind Period||206
294369|NCT00168298|719345|P1|COMPLETED|Double-Blind Period||214
294370|NCT00168298|719343|P3|STARTED|Double-Blind Period||224
294371|NCT00168298|719344|P2|STARTED|Double-Blind Period||218
294372|NCT00168298|719345|P1|STARTED|Double-Blind Period||226
294373|NCT00168103|719365|P4|NOT COMPLETED|Overall Study||0
294374|NCT00168103|719366|P3|NOT COMPLETED|Overall Study||1
294375|NCT00168103|719367|P2|NOT COMPLETED|Overall Study||5
294376|NCT00168103|719368|P1|NOT COMPLETED|Overall Study||2
294377|NCT00168103|719365|P4|COMPLETED|Overall Study||1
294378|NCT00168103|719366|P3|COMPLETED|Overall Study||41
294379|NCT00168103|719367|P2|COMPLETED|Overall Study||38
294380|NCT00168103|719368|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
294381|NCT00168103|719365|P4|STARTED|Overall Study||1
294382|NCT00168103|719366|P3|STARTED|Overall Study||42
294383|NCT00168103|719367|P2|STARTED|Overall Study||43
294384|NCT00168103|719368|P1|STARTED|Overall Study||40
294385|NCT00168064|719390|P2|NOT COMPLETED|Overall Study||44
294386|NCT00168064|719391|P1|NOT COMPLETED|Overall Study||49
294387|NCT00168064|719390|P2|COMPLETED|Overall Study||86
294388|NCT00168064|719391|P1|COMPLETED|Overall Study||81
294389|NCT00168064|719390|P2|STARTED|Overall Study|127 participants received AP formulation|130
294390|NCT00168064|719391|P1|STARTED|Overall Study|128 participants received PG formulation|130
294391|NCT00168038|719399|P1|NOT COMPLETED|Overall Study||2
294392|NCT00168038|719399|P1|COMPLETED|Overall Study||55
294393|NCT00168038|719399|P1|STARTED|Overall Study||57
294394|NCT00167778|719411|P1|NOT COMPLETED|Overall Study||1
294395|NCT00167778|719411|P1|COMPLETED|Overall Study||10
294396|NCT00167778|719411|P1|STARTED|Overall Study||11
294397|NCT00167544|719462|P2|NOT COMPLETED|Overall Study||0
294398|NCT00167544|719463|P1|NOT COMPLETED|Overall Study||1
294399|NCT00167544|719462|P2|COMPLETED|Overall Study||33
294400|NCT00167544|719463|P1|COMPLETED|Overall Study||30
294401|NCT00167544|719462|P2|STARTED|Overall Study||33
294402|NCT00167544|719463|P1|STARTED|Overall Study||31
294403|NCT00167414|719477|P1|NOT COMPLETED|Overall Study||10
294404|NCT00167414|719477|P1|COMPLETED|Overall Study||39
294405|NCT00167414|719477|P1|STARTED|Overall Study||49
294406|NCT00167388|719489|P4|NOT COMPLETED|Overall Study||0
294407|NCT00167388|719490|P3|NOT COMPLETED|Overall Study||0
294408|NCT00167388|719491|P2|NOT COMPLETED|Overall Study||0
294409|NCT00167388|719492|P1|NOT COMPLETED|Overall Study||0
294410|NCT00167388|719489|P4|COMPLETED|Overall Study||6
294411|NCT00167388|719490|P3|COMPLETED|Overall Study||6
294412|NCT00167388|719491|P2|COMPLETED|Overall Study||5
294413|NCT00167388|719492|P1|COMPLETED|Overall Study||5
294414|NCT00167388|719489|P4|Completed Doppler Study|Overall Study||6
294415|NCT00167388|719490|P3|Completed Doppler Study|Overall Study||6
294416|NCT00167388|719491|P2|Completed Doppler Study|Overall Study||5
294417|NCT00167388|719492|P1|Completed Doppler Study|Overall Study||5
294418|NCT00167388|719489|P4|STARTED|Overall Study||6
294419|NCT00167388|719490|P3|STARTED|Overall Study||6
294420|NCT00167388|719491|P2|STARTED|Overall Study||5
294421|NCT00167388|719492|P1|STARTED|Overall Study||5
294422|NCT00167310|719502|P2|NOT COMPLETED|Overall Study||10
294423|NCT00167310|719503|P1|NOT COMPLETED|Overall Study||8
294424|NCT00167310|719502|P2|COMPLETED|Overall Study||18
294425|NCT00167310|719503|P1|COMPLETED|Overall Study||21
294426|NCT00167310|719502|P2|STARTED|Overall Study||28
294427|NCT00167310|719503|P1|STARTED|Overall Study||29
294428|NCT00167245|719513|P2|NOT COMPLETED|Overall Study||41
294429|NCT00167245|719514|P1|NOT COMPLETED|Overall Study||29
294430|NCT00167245|719513|P2|COMPLETED|Overall Study||46
294431|NCT00167245|719514|P1|COMPLETED|Overall Study||54
294432|NCT00167245|719513|P2|STARTED|Overall Study||87
294433|NCT00167245|719514|P1|STARTED|Overall Study||83
294434|NCT00167206|719522|P1|NOT COMPLETED|Overall Study||0
294435|NCT00167206|719522|P1|COMPLETED|Overall Study||16
294436|NCT00167206|719522|P1|STARTED|Overall Study||16
294437|NCT00167180|719536|P2|NOT COMPLETED|Overall Study||0
294438|NCT00167180|719537|P1|NOT COMPLETED|Overall Study||0
294439|NCT00167180|719536|P2|COMPLETED|Overall Study||57
294440|NCT00167180|719537|P1|COMPLETED|Overall Study||0
294441|NCT00167180|719536|P2|STARTED|Overall Study||57
294442|NCT00167180|719537|P1|STARTED|Overall Study||0
294443|NCT00167102|719553|P2|NOT COMPLETED|Overall Study||0
294444|NCT00167102|719554|P1|NOT COMPLETED|Overall Study||0
294445|NCT00167102|719553|P2|COMPLETED|Overall Study||22
294446|NCT00167102|719554|P1|COMPLETED|Overall Study||23
294447|NCT00167102|719553|P2|STARTED|Overall Study||22
294448|NCT00167102|719554|P1|STARTED|Overall Study||23
294449|NCT00166712|719564|P2|NOT COMPLETED|Overall Study||5
294450|NCT00166712|719565|P1|NOT COMPLETED|Overall Study||2
294451|NCT00166712|719564|P2|COMPLETED|Overall Study|Completed study participation.|11
294452|NCT00166712|719565|P1|COMPLETED|Overall Study|Completed study participation.|22
294453|NCT00166712|719564|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
294454|NCT00166712|719565|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
294455|NCT00166712|719564|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
294456|NCT00166712|719565|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
294457|NCT00166712|719564|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
294458|NCT00166712|719565|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
294459|NCT00166712|719564|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
294460|NCT00166712|719565|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
294461|NCT00166712|719564|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
294462|NCT00166712|719565|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
294463|NCT00166517|719582|P2|NOT COMPLETED|Overall Study||2
294464|NCT00166517|719583|P1|NOT COMPLETED|Overall Study||5
294465|NCT00166517|719582|P2|COMPLETED|Overall Study||61
294466|NCT00166517|719583|P1|COMPLETED|Overall Study||110
294467|NCT00166517|719582|P2|Vaccinated at Visit 3|Overall Study||61
294468|NCT00166517|719583|P1|Vaccinated at Visit 3|Overall Study||110
294469|NCT00166517|719582|P2|Vaccinated at Visit 2|Overall Study||61
294470|NCT00166517|719583|P1|Vaccinated at Visit 2|Overall Study||112
294471|NCT00166517|719582|P2|Vaccinated at Visit 1|Overall Study||63
294472|NCT00166517|719583|P1|Vaccinated at Visit 1|Overall Study||115
294473|NCT00166517|719582|P2|STARTED|Overall Study||63
294474|NCT00166517|719583|P1|STARTED|Overall Study||115
294475|NCT00166504|719593|P2|NOT COMPLETED|Overall Study||4
294476|NCT00166504|719594|P1|NOT COMPLETED|Overall Study||5
294477|NCT00166504|719593|P2|COMPLETED|Overall Study||91
294478|NCT00166504|719594|P1|COMPLETED|Overall Study||103
294479|NCT00166504|719593|P2|STARTED|Overall Study||95
294480|NCT00166504|719594|P1|STARTED|Overall Study||108
294481|NCT00166361|719602|P2|NOT COMPLETED|Overall Study||0
294482|NCT00166361|719603|P1|NOT COMPLETED|Overall Study||0
294483|NCT00166361|719602|P2|COMPLETED|Overall Study||10
294484|NCT00166361|719603|P1|COMPLETED|Overall Study||14
294485|NCT00166361|719602|P2|STARTED|Overall Study||10
294486|NCT00166361|719603|P1|STARTED|Overall Study||14
294487|NCT00166296|719611|P2|NOT COMPLETED|Overall Study||9
294488|NCT00166296|719612|P1|NOT COMPLETED|Overall Study||7
294489|NCT00166296|719611|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
294490|NCT00166296|719612|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
294491|NCT00166296|719611|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
294492|NCT00166296|719612|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
294493|NCT00166296|719611|P2|STARTED|Overall Study|Randomized patients|66
294494|NCT00166296|719612|P1|STARTED|Overall Study|Randomized patients|67
294495|NCT00166205|719624|P1|NOT COMPLETED|Overall Study||48
294496|NCT00166205|719624|P1|COMPLETED|Overall Study||228
294497|NCT00166205|719624|P1|Intervention - SAGB Surgery|Overall Study||276
294498|NCT00166205|719624|P1|STARTED|Overall Study||276
294499|NCT00166166|719640|P2|NOT COMPLETED|Overall Study||0
294500|NCT00166166|719641|P1|NOT COMPLETED|Overall Study||0
294501|NCT00166166|719640|P2|COMPLETED|Overall Study||71
294502|NCT00166166|719641|P1|COMPLETED|Overall Study||103
294503|NCT00166166|719640|P2|STARTED|Overall Study||71
294504|NCT00166166|719641|P1|STARTED|Overall Study||103
294505|NCT00166114|719664|P2|NOT COMPLETED|Overall Study||6
294506|NCT00166114|719665|P1|NOT COMPLETED|Overall Study||14
294507|NCT00166114|719664|P2|COMPLETED|Overall Study||13
294508|NCT00166114|719665|P1|COMPLETED|Overall Study||7
294509|NCT00166114|719664|P2|STARTED|Overall Study||19
294510|NCT00166114|719665|P1|STARTED|Overall Study||21
294511|NCT00166036|719673|P2|NOT COMPLETED|Overall Study||0
294512|NCT00166036|719674|P1|NOT COMPLETED|Overall Study||0
294513|NCT00166036|719673|P2|COMPLETED|Overall Study||19
294514|NCT00166036|719674|P1|COMPLETED|Overall Study||17
294515|NCT00166036|719673|P2|STARTED|Overall Study||19
294516|NCT00166036|719674|P1|STARTED|Overall Study||17
294517|NCT00165984|719682|P1|NOT COMPLETED|Overall Study||15
294518|NCT00165984|719682|P1|COMPLETED|Overall Study||150
294519|NCT00165984|719682|P1|STARTED|Overall Study||165
294520|NCT00165958|719691|P2|NOT COMPLETED|Overall Study||2
294521|NCT00165958|719692|P1|NOT COMPLETED|Overall Study||1
294522|NCT00165958|719691|P2|COMPLETED|Overall Study||19
294523|NCT00165958|719692|P1|COMPLETED|Overall Study||18
294524|NCT00165958|719691|P2|STARTED|Overall Study||21
294525|NCT00165958|719692|P1|STARTED|Overall Study||19
294526|NCT00165841|719700|P2|NOT COMPLETED|Overall Study||62
294527|NCT00165841|719701|P1|NOT COMPLETED|Overall Study||30
294528|NCT00165841|719700|P2|COMPLETED|Overall Study||35
294529|NCT00165841|719701|P1|COMPLETED|Overall Study||73
294530|NCT00165841|719700|P2|STARTED|Overall Study||97
294531|NCT00165841|719701|P1|STARTED|Overall Study||103
294532|NCT00165789|719711|P4|NOT COMPLETED|Overall Study||14
294533|NCT00165789|719712|P3|NOT COMPLETED|Overall Study||1
294534|NCT00165789|719713|P2|NOT COMPLETED|Overall Study||4
294535|NCT00165789|719714|P1|NOT COMPLETED|Overall Study||0
294536|NCT00165789|719711|P4|COMPLETED|Overall Study||21
294537|NCT00165789|719712|P3|COMPLETED|Overall Study||11
294538|NCT00165789|719713|P2|COMPLETED|Overall Study||16
294539|NCT00165789|719714|P1|COMPLETED|Overall Study||8
294540|NCT00165789|719711|P4|STARTED|Overall Study||35
294541|NCT00165789|719712|P3|STARTED|Overall Study||12
294542|NCT00165789|719713|P2|STARTED|Overall Study||20
294543|NCT00165789|719714|P1|STARTED|Overall Study||8
294544|NCT00165776|719768|P4|NOT COMPLETED|Overall Study||2
294545|NCT00165776|719769|P3|NOT COMPLETED|Overall Study||2
294546|NCT00165776|719770|P2|NOT COMPLETED|Overall Study||1
294547|NCT00165776|719771|P1|NOT COMPLETED|Overall Study||4
294548|NCT00165776|719768|P4|COMPLETED|Overall Study||29
294549|NCT00165776|719769|P3|COMPLETED|Overall Study||31
294550|NCT00165776|719770|P2|COMPLETED|Overall Study||33
294551|NCT00165776|719771|P1|COMPLETED|Overall Study||31
294552|NCT00165776|719768|P4|STARTED|Overall Study||31
294553|NCT00165776|719769|P3|STARTED|Overall Study||33
294554|NCT00165776|719770|P2|STARTED|Overall Study||34
294555|NCT00165776|719771|P1|STARTED|Overall Study||35
294556|NCT00165698|719807|P2|NOT COMPLETED|Overall Study||15
294557|NCT00165698|719808|P1|NOT COMPLETED|Overall Study||8
294558|NCT00165698|719807|P2|COMPLETED|Overall Study||105
294559|NCT00165698|719808|P1|COMPLETED|Overall Study||112
294560|NCT00165698|719807|P2|STARTED|Overall Study||120
294561|NCT00165698|719808|P1|STARTED|Overall Study||120
294562|NCT00165672|719834|P2|NOT COMPLETED|Overall Study||1
294563|NCT00165672|719835|P1|NOT COMPLETED|Overall Study||0
294564|NCT00165672|719834|P2|COMPLETED|Overall Study||12
294565|NCT00165672|719835|P1|COMPLETED|Overall Study||13
294566|NCT00165672|719834|P2|STARTED|Overall Study||13
294567|NCT00165672|719835|P1|STARTED|Overall Study||13
294568|NCT00165646|719844|P3|NOT COMPLETED|Overall Study||4
294569|NCT00165646|719845|P2|NOT COMPLETED|Overall Study||5
294570|NCT00165646|719846|P1|NOT COMPLETED|Overall Study||5
294571|NCT00165646|719844|P3|COMPLETED|Overall Study||98
294572|NCT00165646|719845|P2|COMPLETED|Overall Study||88
294573|NCT00165646|719846|P1|COMPLETED|Overall Study||88
294574|NCT00165646|719844|P3|STARTED|Overall Study||102
294575|NCT00165646|719845|P2|STARTED|Overall Study||93
294576|NCT00165646|719846|P1|STARTED|Overall Study||93
294577|NCT00165503|719854|P1|NOT COMPLETED|Overall Study||16
294578|NCT00165503|719854|P1|COMPLETED|Overall Study||0
294579|NCT00165503|719854|P1|STARTED|Overall Study||16
294580|NCT00163657|719861|P3|NOT COMPLETED|Overall Study||37
294581|NCT00163657|719862|P2|NOT COMPLETED|Overall Study||23
294582|NCT00163657|719863|P1|NOT COMPLETED|Overall Study||20
294583|NCT00163657|719861|P3|COMPLETED|Overall Study||116
294584|NCT00163657|719862|P2|COMPLETED|Overall Study||56
294585|NCT00163657|719863|P1|COMPLETED|Overall Study||60
294586|NCT00163657|719861|P3|STARTED|Overall Study||153
294587|NCT00163657|719862|P2|STARTED|Overall Study||79
294588|NCT00163657|719863|P1|STARTED|Overall Study||80
294589|NCT00163293|719877|P3|NOT COMPLETED|Overall Study||19
294590|NCT00163293|719878|P2|NOT COMPLETED|Overall Study||7
294591|NCT00163293|719879|P1|NOT COMPLETED|Overall Study||13
294592|NCT00163293|719877|P3|COMPLETED|Overall Study||66
294593|NCT00163293|719878|P2|COMPLETED|Overall Study||69
294594|NCT00163293|719879|P1|COMPLETED|Overall Study||66
294595|NCT00163293|719877|P3|STARTED|Overall Study||85
294596|NCT00163293|719878|P2|STARTED|Overall Study||76
294597|NCT00163293|719879|P1|STARTED|Overall Study||79
294598|NCT00163215|719953|P1|NOT COMPLETED|Overall Study||15
294599|NCT00163215|719953|P1|COMPLETED|Overall Study||31
294600|NCT00163215|719953|P1|STARTED|Overall Study||46
294601|NCT00163189|719973|P1|NOT COMPLETED|Overall Study||63
294602|NCT00163189|719973|P1|COMPLETED|Overall Study||35
294603|NCT00163189|719973|P1|STARTED|Overall Study||98
294604|NCT00163020|719997|P2|NOT COMPLETED|Overall Study||2
294605|NCT00163020|719998|P1|NOT COMPLETED|Overall Study||0
294606|NCT00163020|719997|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
294607|NCT00163020|719998|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
294608|NCT00163020|719997|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
294609|NCT00163020|719998|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
294610|NCT00162981|720038|P2|NOT COMPLETED|Overall Study||6
294611|NCT00162981|720039|P1|NOT COMPLETED|Overall Study||4
294612|NCT00162981|720038|P2|COMPLETED|Overall Study||30
294613|NCT00162981|720039|P1|COMPLETED|Overall Study||28
294614|NCT00162981|720038|P2|STARTED|Overall Study||36
294615|NCT00162981|720039|P1|STARTED|Overall Study||32
294616|NCT00162942|720055|P2|NOT COMPLETED|Overall Study||52
294617|NCT00162942|720056|P1|NOT COMPLETED|Overall Study||106
294618|NCT00162942|720055|P2|COMPLETED|Overall Study||26
294619|NCT00162942|720056|P1|COMPLETED|Overall Study||51
294620|NCT00162942|720055|P2|Week 12|Overall Study||61
294621|NCT00162942|720056|P1|Week 12|Overall Study||127
294622|NCT00162942|720055|P2|STARTED|Overall Study||78
294623|NCT00162942|720056|P1|STARTED|Overall Study||157
294624|NCT00162773|720104|P1|NOT COMPLETED|Overall Study||22
294625|NCT00162773|720104|P1|COMPLETED|Overall Study||7
294626|NCT00162773|720104|P1|STARTED|Overall Study||29
294627|NCT00162370|720108|P1|NOT COMPLETED|Efficacy Population||51
294628|NCT00162370|720108|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
294629|NCT00162370|720108|P1|STARTED|Efficacy Population||366
294630|NCT00162370|720108|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
294631|NCT00162370|720108|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
294632|NCT00162370|720108|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
294633|NCT00162266|720116|P4|NOT COMPLETED|Open-Label Period||137
294634|NCT00162266|720117|P3|NOT COMPLETED|Open-Label Period||0
294635|NCT00162266|720118|P2|NOT COMPLETED|Open-Label Period||0
294636|NCT00162266|720119|P1|NOT COMPLETED|Open-Label Period||0
294637|NCT00162266|720116|P4|COMPLETED|Open-Label Period||82
294638|NCT00162266|720117|P3|COMPLETED|Open-Label Period||0
294639|NCT00162266|720118|P2|COMPLETED|Open-Label Period||0
294640|NCT00162266|720119|P1|COMPLETED|Open-Label Period||0
294641|NCT00162266|720116|P4|STARTED|Open-Label Period||219
294642|NCT00162266|720117|P3|STARTED|Open-Label Period||0
294643|NCT00162266|720118|P2|STARTED|Open-Label Period||0
294644|NCT00162266|720119|P1|STARTED|Open-Label Period||0
294645|NCT00162266|720116|P4|NOT COMPLETED|Double-Blind Period||0
294646|NCT00162266|720117|P3|NOT COMPLETED|Double-Blind Period||48
294647|NCT00162266|720118|P2|NOT COMPLETED|Double-Blind Period||31
294648|NCT00162266|720119|P1|NOT COMPLETED|Double-Blind Period||25
294649|NCT00162266|720116|P4|COMPLETED|Double-Blind Period||0
294650|NCT00162266|720117|P3|COMPLETED|Double-Blind Period||71
294651|NCT00162266|720118|P2|COMPLETED|Double-Blind Period||74
294652|NCT00162266|720119|P1|COMPLETED|Double-Blind Period||90
294653|NCT00162266|720116|P4|Completed Day 1 to Day 181|Double-Blind Period||0
294654|NCT00162266|720117|P3|Completed Day 1 to Day 181|Double-Blind Period||78
294655|NCT00162266|720118|P2|Completed Day 1 to Day 181|Double-Blind Period||80
294656|NCT00162266|720119|P1|Completed Day 1 to Day 181|Double-Blind Period||98
294657|NCT00162266|720116|P4|STARTED|Double-Blind Period||0
294658|NCT00162266|720117|P3|STARTED|Double-Blind Period||119
294659|NCT00162266|720118|P2|STARTED|Double-Blind Period||105
294660|NCT00162266|720119|P1|STARTED|Double-Blind Period||115
294661|NCT00162136|720320|P1|NOT COMPLETED|Overall Study||35
294662|NCT00162136|720320|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
294663|NCT00162136|720320|P1|STARTED|Overall Study||35
294664|NCT00162123|720352|P8|NOT COMPLETED|Overall Study||58
294665|NCT00162123|720353|P7|NOT COMPLETED|Overall Study||4
294666|NCT00162123|720354|P6|NOT COMPLETED|Overall Study||9
294667|NCT00162123|720355|P5|NOT COMPLETED|Overall Study||31
294668|NCT00162123|720356|P4|NOT COMPLETED|Overall Study||8
294669|NCT00162123|720357|P3|NOT COMPLETED|Overall Study||21
294670|NCT00162123|720358|P2|NOT COMPLETED|Overall Study||29
294671|NCT00162123|720359|P1|NOT COMPLETED|Overall Study||44
294672|NCT00162123|720352|P8|COMPLETED|Overall Study|Still on treatment|0
294673|NCT00162123|720353|P7|COMPLETED|Overall Study|Still on treatment|0
294674|NCT00162123|720354|P6|COMPLETED|Overall Study|Still on treatment|4
294675|NCT00162123|720355|P5|COMPLETED|Overall Study|Still on treatment|14
294676|NCT00162123|720356|P4|COMPLETED|Overall Study|Still on treatment|3
294677|NCT00162123|720357|P3|COMPLETED|Overall Study|Still on treatment|3
294678|NCT00162123|720358|P2|COMPLETED|Overall Study|Still on treatment|5
294679|NCT00162123|720359|P1|COMPLETED|Overall Study|Still on treatment|9
294680|NCT00162123|720352|P8|Received Treatment|Overall Study||0
294681|NCT00162123|720353|P7|Received Treatment|Overall Study||4
294682|NCT00162123|720354|P6|Received Treatment|Overall Study||12
294683|NCT00162123|720355|P5|Received Treatment|Overall Study||33
294684|NCT00162123|720356|P4|Received Treatment|Overall Study||11
294685|NCT00162123|720357|P3|Received Treatment|Overall Study||24
294686|NCT00162123|720358|P2|Received Treatment|Overall Study||34
294687|NCT00162123|720359|P1|Received Treatment|Overall Study||53
294688|NCT00162123|720352|P8|STARTED|Overall Study|Enrolled|58
294689|NCT00162123|720353|P7|STARTED|Overall Study|Enrolled|4
294690|NCT00162123|720354|P6|STARTED|Overall Study|Enrolled|13
294691|NCT00162123|720355|P5|STARTED|Overall Study|Enrolled|45
294692|NCT00162123|720356|P4|STARTED|Overall Study|Enrolled|11
294693|NCT00162123|720357|P3|STARTED|Overall Study|Enrolled|24
294694|NCT00162123|720358|P2|STARTED|Overall Study|Enrolled|34
294695|NCT00162123|720359|P1|STARTED|Overall Study|Enrolled|53
294696|NCT00162097|720392|P4|NOT COMPLETED|Overall Study||1
294697|NCT00162097|720393|P3|NOT COMPLETED|Overall Study||0
294698|NCT00162097|720394|P2|NOT COMPLETED|Overall Study||0
294699|NCT00162097|720395|P1|NOT COMPLETED|Overall Study||0
294700|NCT00162097|720392|P4|COMPLETED|Overall Study||6
294701|NCT00162097|720393|P3|COMPLETED|Overall Study||1
294702|NCT00162097|720394|P2|COMPLETED|Overall Study||2
294703|NCT00162097|720395|P1|COMPLETED|Overall Study||6
294791|NCT00160251|720605|P5|COMPLETED|Prior to Amendment 2||21
294704|NCT00162097|720392|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
294705|NCT00162097|720393|P3|STARTED|Overall Study|Treated on Day 1|1
294706|NCT00162097|720394|P2|STARTED|Overall Study|Treated on Day 1|2
294707|NCT00162097|720395|P1|STARTED|Overall Study|Treated on Day 1|6
294708|NCT00162032|720457|P2|NOT COMPLETED|Overall Study||2
294709|NCT00162032|720458|P1|NOT COMPLETED|Overall Study||5
294710|NCT00162032|720457|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
294711|NCT00162032|720458|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
294712|NCT00162032|720457|P2|STARTED|Overall Study||116
294713|NCT00162032|720458|P1|STARTED|Overall Study||329
294714|NCT00161616|720468|P2|NOT COMPLETED|Overall Study||19
294715|NCT00161616|720469|P1|NOT COMPLETED|Overall Study||26
294716|NCT00161616|720468|P2|COMPLETED|Overall Study||119
294717|NCT00161616|720469|P1|COMPLETED|Overall Study||113
294718|NCT00161616|720468|P2|STARTED|Overall Study||138
294719|NCT00161616|720469|P1|STARTED|Overall Study||139
294720|NCT00161473|720479|P2|NOT COMPLETED|Overall Study||6
294721|NCT00161473|720480|P1|NOT COMPLETED|Overall Study||5
294722|NCT00161473|720479|P2|COMPLETED|Overall Study||6
294723|NCT00161473|720480|P1|COMPLETED|Overall Study||7
294724|NCT00161473|720479|P2|STARTED|Overall Study||12
294725|NCT00161473|720480|P1|STARTED|Overall Study||12
294726|NCT00161382|720494|P2|NOT COMPLETED|Overall Study||289
294727|NCT00161382|720495|P1|NOT COMPLETED|Overall Study||249
294728|NCT00161382|720494|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
294729|NCT00161382|720495|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
294730|NCT00161382|720494|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
294731|NCT00161382|720495|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
294732|NCT00161213|720501|P1|NOT COMPLETED|Overall Study||2
294733|NCT00161213|720501|P1|COMPLETED|Overall Study||42
294734|NCT00161213|720501|P1|STARTED|Overall Study||44
294735|NCT00160706|720508|P1|NOT COMPLETED|Overall Study||286
294736|NCT00160706|720508|P1|COMPLETED|Overall Study||24
294737|NCT00160706|720508|P1|STARTED|Overall Study||310
294738|NCT00160693|720520|P1|NOT COMPLETED|Overall Study||235
294739|NCT00160693|720520|P1|COMPLETED|Overall Study||167
294740|NCT00160693|720520|P1|STARTED|Overall Study||402
294741|NCT00160641|720537|P1|NOT COMPLETED|Overall Study||221
294742|NCT00160641|720537|P1|COMPLETED|Overall Study||346
294743|NCT00160641|720537|P1|STARTED|Overall Study||567
294744|NCT00160563|720571|P3|NOT COMPLETED|Overall Study||90
294745|NCT00160563|720572|P2|NOT COMPLETED|Overall Study||45
294746|NCT00160563|720573|P1|NOT COMPLETED|Overall Study||51
294747|NCT00160563|720571|P3|COMPLETED|Overall Study||11
294748|NCT00160563|720572|P2|COMPLETED|Overall Study||2
294749|NCT00160563|720573|P1|COMPLETED|Overall Study||8
294750|NCT00160563|720571|P3|STARTED|Overall Study||101
294751|NCT00160563|720572|P2|STARTED|Overall Study||47
294752|NCT00160563|720573|P1|STARTED|Overall Study||59
294753|NCT00160524|720585|P1|NOT COMPLETED|Overall Study||478
294754|NCT00160524|720585|P1|COMPLETED|Overall Study||117
294755|NCT00160524|720585|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
294756|NCT00160251|720602|P8|NOT COMPLETED|Post-amendment 2||55
294757|NCT00160251|720603|P7|NOT COMPLETED|Post-amendment 2||0
294758|NCT00160251|720604|P6|NOT COMPLETED|Post-amendment 2||0
294759|NCT00160251|720605|P5|NOT COMPLETED|Post-amendment 2||0
294760|NCT00160251|720606|P4|NOT COMPLETED|Post-amendment 2||0
294761|NCT00160251|720607|P3|NOT COMPLETED|Post-amendment 2||0
294762|NCT00160251|720608|P2|NOT COMPLETED|Post-amendment 2||0
294763|NCT00160251|720609|P1|NOT COMPLETED|Post-amendment 2||0
294764|NCT00160251|720602|P8|COMPLETED|Post-amendment 2||88
294765|NCT00160251|720603|P7|COMPLETED|Post-amendment 2||0
294766|NCT00160251|720604|P6|COMPLETED|Post-amendment 2||0
294767|NCT00160251|720605|P5|COMPLETED|Post-amendment 2||0
294768|NCT00160251|720606|P4|COMPLETED|Post-amendment 2||0
294769|NCT00160251|720607|P3|COMPLETED|Post-amendment 2||0
294770|NCT00160251|720608|P2|COMPLETED|Post-amendment 2||0
294771|NCT00160251|720609|P1|COMPLETED|Post-amendment 2||0
294772|NCT00160251|720602|P8|STARTED|Post-amendment 2||143
294773|NCT00160251|720603|P7|STARTED|Post-amendment 2||0
294774|NCT00160251|720604|P6|STARTED|Post-amendment 2||0
294775|NCT00160251|720605|P5|STARTED|Post-amendment 2||0
294776|NCT00160251|720606|P4|STARTED|Post-amendment 2||0
294777|NCT00160251|720607|P3|STARTED|Post-amendment 2||0
294778|NCT00160251|720608|P2|STARTED|Post-amendment 2||0
294779|NCT00160251|720609|P1|STARTED|Post-amendment 2||0
294780|NCT00160251|720602|P8|NOT COMPLETED|Prior to Amendment 2||0
294781|NCT00160251|720603|P7|NOT COMPLETED|Prior to Amendment 2||4
294782|NCT00160251|720604|P6|NOT COMPLETED|Prior to Amendment 2||83
294783|NCT00160251|720605|P5|NOT COMPLETED|Prior to Amendment 2||28
294784|NCT00160251|720606|P4|NOT COMPLETED|Prior to Amendment 2||40
294785|NCT00160251|720607|P3|NOT COMPLETED|Prior to Amendment 2||44
294786|NCT00160251|720608|P2|NOT COMPLETED|Prior to Amendment 2||6
294787|NCT00160251|720609|P1|NOT COMPLETED|Prior to Amendment 2||9
294788|NCT00160251|720602|P8|COMPLETED|Prior to Amendment 2||0
294789|NCT00160251|720603|P7|COMPLETED|Prior to Amendment 2||61
294790|NCT00160251|720604|P6|COMPLETED|Prior to Amendment 2||14
294792|NCT00160251|720606|P4|COMPLETED|Prior to Amendment 2||9
294793|NCT00160251|720607|P3|COMPLETED|Prior to Amendment 2||4
294794|NCT00160251|720608|P2|COMPLETED|Prior to Amendment 2||28
294795|NCT00160251|720609|P1|COMPLETED|Prior to Amendment 2||6
294796|NCT00160251|720602|P8|STARTED|Prior to Amendment 2||0
294797|NCT00160251|720603|P7|STARTED|Prior to Amendment 2||65
294798|NCT00160251|720604|P6|STARTED|Prior to Amendment 2||97
294799|NCT00160251|720605|P5|STARTED|Prior to Amendment 2||49
294800|NCT00160251|720606|P4|STARTED|Prior to Amendment 2||49
294801|NCT00160251|720607|P3|STARTED|Prior to Amendment 2||48
294802|NCT00160251|720608|P2|STARTED|Prior to Amendment 2||34
294803|NCT00160251|720609|P1|STARTED|Prior to Amendment 2||15
294804|NCT00160199|720685|P2|NOT COMPLETED|Overall Study||37
294805|NCT00160199|720686|P1|NOT COMPLETED|Overall Study||24
294806|NCT00160199|720685|P2|COMPLETED|Overall Study||81
294807|NCT00160199|720686|P1|COMPLETED|Overall Study||98
294808|NCT00160199|720685|P2|STARTED|Overall Study||118
294809|NCT00160199|720686|P1|STARTED|Overall Study||122
294810|NCT00159965|720706|P2|NOT COMPLETED|Overall Study||5
294811|NCT00159965|720707|P1|NOT COMPLETED|Overall Study||7
294812|NCT00159965|720706|P2|COMPLETED|Overall Study||14
294813|NCT00159965|720707|P1|COMPLETED|Overall Study||12
294814|NCT00159965|720706|P2|STARTED|Overall Study||19
294815|NCT00159965|720707|P1|STARTED|Overall Study||19
294816|NCT00159913|720743|P4|NOT COMPLETED|Overall Study||2
294817|NCT00159913|720744|P3|NOT COMPLETED|Overall Study||2
294818|NCT00159913|720745|P2|NOT COMPLETED|Overall Study||0
294819|NCT00159913|720746|P1|NOT COMPLETED|Overall Study||2
294820|NCT00159913|720743|P4|COMPLETED|Overall Study||58
294821|NCT00159913|720744|P3|COMPLETED|Overall Study||75
294822|NCT00159913|720745|P2|COMPLETED|Overall Study||55
294823|NCT00159913|720746|P1|COMPLETED|Overall Study||40
294824|NCT00159913|720743|P4|STARTED|Overall Study||60
294825|NCT00159913|720744|P3|STARTED|Overall Study||77
294826|NCT00159913|720745|P2|STARTED|Overall Study||55
294827|NCT00159913|720746|P1|STARTED|Overall Study||42
294828|NCT00159874|720820|P7|NOT COMPLETED|Overall Study||5
294829|NCT00159874|720821|P6|NOT COMPLETED|Overall Study||12
294830|NCT00159874|720822|P5|NOT COMPLETED|Overall Study||8
294831|NCT00159874|720823|P4|NOT COMPLETED|Overall Study||6
294832|NCT00159874|720824|P3|NOT COMPLETED|Overall Study||43
294833|NCT00159874|720825|P2|NOT COMPLETED|Overall Study||30
294834|NCT00159874|720826|P1|NOT COMPLETED|Overall Study||20
294835|NCT00159874|720820|P7|COMPLETED|Overall Study||0
294836|NCT00159874|720821|P6|COMPLETED|Overall Study||11
294837|NCT00159874|720822|P5|COMPLETED|Overall Study||11
294838|NCT00159874|720823|P4|COMPLETED|Overall Study||7
294839|NCT00159874|720824|P3|COMPLETED|Overall Study||34
294840|NCT00159874|720825|P2|COMPLETED|Overall Study||25
294841|NCT00159874|720826|P1|COMPLETED|Overall Study||22
294842|NCT00159874|720820|P7|Treated|Overall Study||5
294843|NCT00159874|720821|P6|Treated|Overall Study||23
294844|NCT00159874|720822|P5|Treated|Overall Study||19
294845|NCT00159874|720823|P4|Treated|Overall Study||13
294846|NCT00159874|720824|P3|Treated|Overall Study||77
294847|NCT00159874|720825|P2|Treated|Overall Study||55
294848|NCT00159874|720826|P1|Treated|Overall Study||42
294849|NCT00159874|720820|P7|STARTED|Overall Study||5
294850|NCT00159874|720821|P6|STARTED|Overall Study||23
294851|NCT00159874|720822|P5|STARTED|Overall Study||19
294852|NCT00159874|720823|P4|STARTED|Overall Study||13
294853|NCT00159874|720824|P3|STARTED|Overall Study||77
294854|NCT00159874|720825|P2|STARTED|Overall Study||55
294855|NCT00159874|720826|P1|STARTED|Overall Study||42
294856|NCT00159861|720996|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
294857|NCT00159861|720997|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
294858|NCT00159861|720996|P2|COMPLETED|Extension Study - up to 3 Years||56
294859|NCT00159861|720997|P1|COMPLETED|Extension Study - up to 3 Years||53
294860|NCT00159861|720996|P2|Treated|Extension Study - up to 3 Years||127
294861|NCT00159861|720997|P1|Treated|Extension Study - up to 3 Years||115
294862|NCT00159861|720996|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
294863|NCT00159861|720997|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
294864|NCT00159861|720996|P2|NOT COMPLETED|Core Study - 16 Weeks||12
294865|NCT00159861|720997|P1|NOT COMPLETED|Core Study - 16 Weeks||25
294866|NCT00159861|720996|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
294867|NCT00159861|720997|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
294868|NCT00159861|720996|P2|Treated|Core Study - 16 Weeks||134
294869|NCT00159861|720997|P1|Treated|Core Study - 16 Weeks||131
294870|NCT00159861|720996|P2|STARTED|Core Study - 16 Weeks||134
294871|NCT00159861|720997|P1|STARTED|Core Study - 16 Weeks||133
294872|NCT00159822|721018|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
294873|NCT00159822|721018|P1|COMPLETED|Post-treatment Follow-up Period||23
294874|NCT00159822|721018|P1|STARTED|Post-treatment Follow-up Period||26
294875|NCT00159822|721018|P1|NOT COMPLETED|Voriconazole Treatment Period||22
294876|NCT00159822|721018|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
294877|NCT00159822|721018|P1|STARTED|Voriconazole Treatment Period||48
294878|NCT00159783|721036|P3|NOT COMPLETED|Overall Study||39
294879|NCT00159783|721037|P2|NOT COMPLETED|Overall Study||27
294880|NCT00159783|721038|P1|NOT COMPLETED|Overall Study||19
294881|NCT00159783|721036|P3|COMPLETED|Overall Study||68
294882|NCT00159783|721037|P2|COMPLETED|Overall Study||52
294883|NCT00159783|721038|P1|COMPLETED|Overall Study||13
294884|NCT00159783|721036|P3|STARTED|Overall Study||107
294885|NCT00159783|721037|P2|STARTED|Overall Study||79
294886|NCT00159783|721038|P1|STARTED|Overall Study||32
294887|NCT00159432|721068|P1|NOT COMPLETED|Overall Study||10
294888|NCT00159432|721068|P1|COMPLETED|Overall Study||53
294889|NCT00159432|721068|P1|STARTED|Overall Study||63
294890|NCT00159419|721075|P2|NOT COMPLETED|Overall Study||0
294891|NCT00159419|721076|P1|NOT COMPLETED|Overall Study||0
294892|NCT00159419|721075|P2|COMPLETED|Overall Study||9
294893|NCT00159419|721076|P1|COMPLETED|Overall Study||9
294894|NCT00159419|721075|P2|STARTED|Overall Study||9
294895|NCT00159419|721076|P1|STARTED|Overall Study||9
294896|NCT00158925|721082|P1|NOT COMPLETED|Overall Study||12
294897|NCT00158925|721082|P1|COMPLETED|Overall Study||84
294898|NCT00158925|721082|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
294899|NCT00158756|721095|P5|NOT COMPLETED|Overall Study||3
294900|NCT00158756|721096|P4|NOT COMPLETED|Overall Study||1
294901|NCT00158756|721097|P3|NOT COMPLETED|Overall Study||8
294902|NCT00158756|721098|P2|NOT COMPLETED|Overall Study||0
294903|NCT00158756|721099|P1|NOT COMPLETED|Overall Study||5
294904|NCT00158756|721095|P5|COMPLETED|Overall Study||96
294905|NCT00158756|721096|P4|COMPLETED|Overall Study||22
294906|NCT00158756|721097|P3|COMPLETED|Overall Study||73
294907|NCT00158756|721098|P2|COMPLETED|Overall Study||25
294908|NCT00158756|721099|P1|COMPLETED|Overall Study||75
294909|NCT00158756|721095|P5|STARTED|Overall Study||99
294910|NCT00158756|721096|P4|STARTED|Overall Study||23
294911|NCT00158756|721097|P3|STARTED|Overall Study||81
294912|NCT00158756|721098|P2|STARTED|Overall Study||25
294913|NCT00158756|721099|P1|STARTED|Overall Study||80
294914|NCT00158743|721196|P2|NOT COMPLETED|Overall Study||7
294915|NCT00158743|721197|P1|NOT COMPLETED|Overall Study||9
294916|NCT00158743|721196|P2|COMPLETED|Overall Study||20
294917|NCT00158743|721197|P1|COMPLETED|Overall Study||15
294918|NCT00158743|721196|P2|STARTED|Overall Study||27
294919|NCT00158743|721197|P1|STARTED|Overall Study||24
294920|NCT00158600|721205|P2|NOT COMPLETED|Overall Study||4
294921|NCT00158600|721206|P1|NOT COMPLETED|Overall Study||5
294922|NCT00158600|721205|P2|COMPLETED|Overall Study||26
294923|NCT00158600|721206|P1|COMPLETED|Overall Study||55
294924|NCT00158600|721205|P2|STARTED|Overall Study||30
294925|NCT00158600|721206|P1|STARTED|Overall Study||60
294926|NCT00158379|721224|P1|NOT COMPLETED|Overall Study||0
294927|NCT00158379|721224|P1|COMPLETED|Overall Study||105
294928|NCT00158379|721224|P1|STARTED|Overall Study||105
294929|NCT00158262|721231|P2|NOT COMPLETED|Overall Study||1
294930|NCT00158262|721232|P1|NOT COMPLETED|Overall Study||1
294931|NCT00158262|721231|P2|COMPLETED|Overall Study||21
294932|NCT00158262|721232|P1|COMPLETED|Overall Study||20
294933|NCT00158262|721231|P2|STARTED|Overall Study||22
294934|NCT00158262|721232|P1|STARTED|Overall Study||21
294935|NCT00158249|721244|P2|NOT COMPLETED|Overall Study||0
294936|NCT00158249|721245|P1|NOT COMPLETED|Overall Study||2
294937|NCT00158249|721244|P2|COMPLETED|Overall Study||10
294938|NCT00158249|721245|P1|COMPLETED|Overall Study||9
294939|NCT00158249|721244|P2|STARTED|Overall Study||10
294940|NCT00158249|721245|P1|STARTED|Overall Study||11
294941|NCT00158223|721255|P2|NOT COMPLETED|Overall Study||3
294942|NCT00158223|721256|P1|NOT COMPLETED|Overall Study||5
294943|NCT00158223|721255|P2|COMPLETED|Overall Study||22
294944|NCT00158223|721256|P1|COMPLETED|Overall Study||23
294945|NCT00158223|721255|P2|STARTED|Overall Study||25
294946|NCT00158223|721256|P1|STARTED|Overall Study||28
294947|NCT00158197|721270|P4|NOT COMPLETED|Overall Study||0
294948|NCT00158197|721271|P3|NOT COMPLETED|Overall Study||0
294949|NCT00158197|721272|P2|NOT COMPLETED|Overall Study||0
294950|NCT00158197|721273|P1|NOT COMPLETED|Overall Study||0
294951|NCT00158197|721270|P4|COMPLETED|Overall Study||29
294952|NCT00158197|721271|P3|COMPLETED|Overall Study||28
294953|NCT00158197|721272|P2|COMPLETED|Overall Study||30
294954|NCT00158197|721273|P1|COMPLETED|Overall Study||32
294955|NCT00158197|721270|P4|STARTED|Overall Study||29
294956|NCT00158197|721271|P3|STARTED|Overall Study||28
294957|NCT00158197|721272|P2|STARTED|Overall Study||30
294958|NCT00158197|721273|P1|STARTED|Overall Study||32
294959|NCT00158184|721293|P2|NOT COMPLETED|Overall Study||2
294960|NCT00158184|721294|P1|NOT COMPLETED|Overall Study||6
294961|NCT00158184|721293|P2|COMPLETED|Overall Study||9
294962|NCT00158184|721294|P1|COMPLETED|Overall Study||10
294963|NCT00158184|721293|P2|STARTED|Overall Study||11
294964|NCT00158184|721294|P1|STARTED|Overall Study||16
294965|NCT00158054|721304|P2|NOT COMPLETED|Overall Study||3
294966|NCT00158054|721305|P1|NOT COMPLETED|Overall Study||10
294967|NCT00158054|721304|P2|COMPLETED|Overall Study||74
294968|NCT00158054|721305|P1|COMPLETED|Overall Study||70
294969|NCT00158054|721304|P2|STARTED|Overall Study||77
294970|NCT00158054|721305|P1|STARTED|Overall Study||80
294971|NCT00157950|721319|P2|NOT COMPLETED|Overall Study||0
294972|NCT00157950|721320|P1|NOT COMPLETED|Overall Study||1
294973|NCT00157950|721319|P2|COMPLETED|Overall Study||59
294974|NCT00157950|721320|P1|COMPLETED|Overall Study||116
294975|NCT00157950|721319|P2|Vaccinated at Dose 3|Overall Study||59
294976|NCT00157950|721320|P1|Vaccinated at Dose 3|Overall Study||116
294977|NCT00157950|721319|P2|Vaccinated at Dose 2|Overall Study||59
294978|NCT00157950|721320|P1|Vaccinated at Dose 2|Overall Study||117
294979|NCT00157950|721319|P2|Vaccinated at Dose 1|Overall Study||59
294980|NCT00157950|721320|P1|Vaccinated at Dose 1|Overall Study||117
294981|NCT00157950|721319|P2|STARTED|Overall Study||59
294982|NCT00157950|721320|P1|STARTED|Overall Study||117
294983|NCT00157820|721337|P3|NOT COMPLETED|2nd 8 Months||14
294984|NCT00157820|721338|P2|NOT COMPLETED|2nd 8 Months||13
294985|NCT00157820|721339|P1|NOT COMPLETED|2nd 8 Months||5
294986|NCT00157820|721337|P3|COMPLETED|2nd 8 Months||94
294987|NCT00157820|721338|P2|COMPLETED|2nd 8 Months||88
294988|NCT00157820|721339|P1|COMPLETED|2nd 8 Months||98
294989|NCT00157820|721337|P3|STARTED|2nd 8 Months||108
294990|NCT00157820|721338|P2|STARTED|2nd 8 Months||101
294991|NCT00157820|721339|P1|STARTED|2nd 8 Months||103
294992|NCT00157820|721337|P3|NOT COMPLETED|1 Month Wash Out Period||0
294993|NCT00157820|721338|P2|NOT COMPLETED|1 Month Wash Out Period||0
294994|NCT00157820|721339|P1|NOT COMPLETED|1 Month Wash Out Period||0
294995|NCT00157820|721337|P3|COMPLETED|1 Month Wash Out Period||108
294996|NCT00157820|721338|P2|COMPLETED|1 Month Wash Out Period||101
294997|NCT00157820|721339|P1|COMPLETED|1 Month Wash Out Period||103
294998|NCT00157820|721337|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
294999|NCT00157820|721338|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
295000|NCT00157820|721339|P1|STARTED|1 Month Wash Out Period||103
295001|NCT00157820|721337|P3|NOT COMPLETED|1st 8 Month||6
295002|NCT00157820|721338|P2|NOT COMPLETED|1st 8 Month||12
295003|NCT00157820|721339|P1|NOT COMPLETED|1st 8 Month||8
295004|NCT00157820|721337|P3|COMPLETED|1st 8 Month||106
295005|NCT00157820|721338|P2|COMPLETED|1st 8 Month||99
295006|NCT00157820|721339|P1|COMPLETED|1st 8 Month||103
295007|NCT00157820|721337|P3|STARTED|1st 8 Month||112
295008|NCT00157820|721338|P2|STARTED|1st 8 Month||111
295009|NCT00157820|721339|P1|STARTED|1st 8 Month||111
295010|NCT00157820|721337|P3|NOT COMPLETED|Randomized||8
295011|NCT00157820|721338|P2|NOT COMPLETED|Randomized||5
295012|NCT00157820|721339|P1|NOT COMPLETED|Randomized||7
295013|NCT00157820|721337|P3|COMPLETED|Randomized||112
295014|NCT00157820|721338|P2|COMPLETED|Randomized||111
295015|NCT00157820|721339|P1|COMPLETED|Randomized||111
295016|NCT00157820|721337|P3|STARTED|Randomized||120
295017|NCT00157820|721338|P2|STARTED|Randomized||116
295018|NCT00157820|721339|P1|STARTED|Randomized||118
295019|NCT00157755|721352|P6|NOT COMPLETED|Overall Study||5
295020|NCT00157755|721353|P5|NOT COMPLETED|Overall Study||2
295021|NCT00157755|721354|P4|NOT COMPLETED|Overall Study||4
295022|NCT00157755|721355|P3|NOT COMPLETED|Overall Study||7
295023|NCT00157755|721356|P2|NOT COMPLETED|Overall Study||4
295024|NCT00157755|721357|P1|NOT COMPLETED|Overall Study||2
295025|NCT00157755|721352|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
295026|NCT00157755|721353|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
295027|NCT00157755|721354|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
295028|NCT00157755|721355|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
295029|NCT00157755|721356|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
295030|NCT00157755|721357|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
295031|NCT00157755|721352|P6|STARTED|Overall Study||5
295032|NCT00157755|721353|P5|STARTED|Overall Study||12
295033|NCT00157755|721354|P4|STARTED|Overall Study||15
295034|NCT00157755|721355|P3|STARTED|Overall Study||10
295035|NCT00157755|721356|P2|STARTED|Overall Study||19
295036|NCT00157755|721357|P1|STARTED|Overall Study||26
295037|NCT00157573|721379|P2|NOT COMPLETED|Overall Study||0
295038|NCT00157573|721380|P1|NOT COMPLETED|Overall Study||0
295039|NCT00157573|721379|P2|COMPLETED|Overall Study||37
295040|NCT00157573|721380|P1|COMPLETED|Overall Study||35
295041|NCT00157573|721379|P2|STARTED|Overall Study||37
295042|NCT00157573|721380|P1|STARTED|Overall Study||35
295043|NCT00157248|721393|P4|NOT COMPLETED|Overall Study||47
295044|NCT00157248|721394|P3|NOT COMPLETED|Overall Study||21
295045|NCT00157248|721395|P2|NOT COMPLETED|Overall Study||37
295046|NCT00157248|721396|P1|NOT COMPLETED|Overall Study||48
295047|NCT00157248|721393|P4|COMPLETED|Overall Study||77
295048|NCT00157248|721394|P3|COMPLETED|Overall Study||29
295049|NCT00157248|721395|P2|COMPLETED|Overall Study||52
295050|NCT00157248|721396|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
295051|NCT00157248|721393|P4|STARTED|Overall Study||124
295052|NCT00157248|721394|P3|STARTED|Overall Study||50
295053|NCT00157248|721395|P2|STARTED|Overall Study||89
295054|NCT00157248|721396|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
295055|NCT00157209|721502|P2|NOT COMPLETED|Overall Study||0
295056|NCT00157209|721503|P1|NOT COMPLETED|Overall Study||10
295057|NCT00157209|721502|P2|COMPLETED|Overall Study||83
295058|NCT00157209|721503|P1|COMPLETED|Overall Study||78
295059|NCT00157209|721502|P2|STARTED|Overall Study||83
295060|NCT00157209|721503|P1|STARTED|Overall Study||88
295061|NCT00157196|721517|P1|NOT COMPLETED|Overall Study||9
295062|NCT00157196|721517|P1|COMPLETED|Overall Study||13
295063|NCT00157196|721517|P1|STARTED|Overall Study||22
295064|NCT00157157|721523|P1|NOT COMPLETED|Overall Study||11
295065|NCT00157157|721523|P1|COMPLETED|Overall Study||44
295066|NCT00157157|721523|P1|STARTED|Overall Study||55
295067|NCT00157014|721550|P4|NOT COMPLETED|Overall Study||1
295068|NCT00157014|721551|P3|NOT COMPLETED|Overall Study||1
295069|NCT00157014|721552|P2|NOT COMPLETED|Overall Study||5
295070|NCT00157014|721553|P1|NOT COMPLETED|Overall Study||7
295071|NCT00157014|721550|P4|COMPLETED|Overall Study||5
295072|NCT00157014|721551|P3|COMPLETED|Overall Study||4
295073|NCT00157014|721552|P2|COMPLETED|Overall Study||41
295074|NCT00157014|721553|P1|COMPLETED|Overall Study||45
295075|NCT00157014|721550|P4|STARTED|Overall Study||6
295076|NCT00157014|721551|P3|STARTED|Overall Study||5
295077|NCT00157014|721552|P2|STARTED|Overall Study||46
295078|NCT00157014|721553|P1|STARTED|Overall Study||52
295079|NCT00156936|721633|P2|NOT COMPLETED|Overall Study||11
295080|NCT00156936|721634|P1|NOT COMPLETED|Overall Study||72
295081|NCT00156936|721633|P2|COMPLETED|Overall Study||5
295082|NCT00156936|721634|P1|COMPLETED|Overall Study||20
295083|NCT00156936|721633|P2|STARTED|Overall Study||16
295084|NCT00156936|721634|P1|STARTED|Overall Study||92
295085|NCT00156923|721642|P2|NOT COMPLETED|Overall Study||32
295086|NCT00156923|721643|P1|NOT COMPLETED|Overall Study||34
295087|NCT00156923|721642|P2|COMPLETED|Overall Study||20
295088|NCT00156923|721643|P1|COMPLETED|Overall Study||22
295089|NCT00156923|721642|P2|STARTED|Overall Study||52
295090|NCT00156923|721643|P1|STARTED|Overall Study||56
295091|NCT00156910|721651|P2|NOT COMPLETED|Open-Label Phase (OL)||55
295092|NCT00156910|721652|P1|NOT COMPLETED|Open-Label Phase (OL)||33
295093|NCT00156910|721651|P2|COMPLETED|Open-Label Phase (OL)||231
295094|NCT00156910|721652|P1|COMPLETED|Open-Label Phase (OL)||252
295095|NCT00156910|721651|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
295096|NCT00156910|721652|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
295097|NCT00156910|721651|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
295098|NCT00156910|721652|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
295099|NCT00156910|721651|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
295100|NCT00156910|721652|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
295101|NCT00156910|721651|P2|STARTED|Double-Blind Phase (DB)||338
295102|NCT00156910|721652|P1|STARTED|Double-Blind Phase (DB)||341
295103|NCT00156819|721669|P3|NOT COMPLETED|Overall Study||3
295104|NCT00156819|721670|P2|NOT COMPLETED|Overall Study||1
295105|NCT00156819|721671|P1|NOT COMPLETED|Overall Study||1
295106|NCT00156819|721669|P3|COMPLETED|Overall Study||162
295107|NCT00156819|721670|P2|COMPLETED|Overall Study||165
295108|NCT00156819|721671|P1|COMPLETED|Overall Study||168
295109|NCT00156819|721669|P3|STARTED|Overall Study||165
295110|NCT00156819|721670|P2|STARTED|Overall Study||166
295111|NCT00156819|721671|P1|STARTED|Overall Study||169
295112|NCT00156715|721679|P1|NOT COMPLETED|Overall Study||7
295113|NCT00156715|721679|P1|COMPLETED|Overall Study||16
295114|NCT00156715|721679|P1|STARTED|Overall Study||23
295115|NCT00156533|721688|P4|NOT COMPLETED|Overall Study||2
295116|NCT00156533|721689|P3|NOT COMPLETED|Overall Study||2
295117|NCT00156533|721690|P2|NOT COMPLETED|Overall Study||2
295118|NCT00156533|721691|P1|NOT COMPLETED|Overall Study||2
295119|NCT00156533|721688|P4|COMPLETED|Overall Study||3
295120|NCT00156533|721689|P3|COMPLETED|Overall Study||3
295121|NCT00156533|721690|P2|COMPLETED|Overall Study||3
295122|NCT00156533|721691|P1|COMPLETED|Overall Study||3
295123|NCT00156533|721688|P4|STARTED|Overall Study||5
295124|NCT00156533|721689|P3|STARTED|Overall Study||5
295125|NCT00156533|721690|P2|STARTED|Overall Study||5
295126|NCT00156533|721691|P1|STARTED|Overall Study||5
295127|NCT00156390|721707|P2|NOT COMPLETED|Overall Study||8
295128|NCT00156390|721708|P1|NOT COMPLETED|Overall Study||14
295129|NCT00156390|721707|P2|COMPLETED|Overall Study||69
295130|NCT00156390|721708|P1|COMPLETED|Overall Study||96
295131|NCT00156390|721707|P2|STARTED|Overall Study||77
295132|NCT00156390|721708|P1|STARTED|Overall Study||110
295133|NCT00156247|721716|P1|NOT COMPLETED|Overall Study||4
295134|NCT00156247|721716|P1|COMPLETED|Overall Study||5
295135|NCT00156247|721716|P1|STARTED|Overall Study||9
295136|NCT00156065|721725|P3|NOT COMPLETED|Overall Study||27
295137|NCT00156065|721726|P2|NOT COMPLETED|Overall Study||63
295138|NCT00156065|721727|P1|NOT COMPLETED|Overall Study||31
295139|NCT00156065|721725|P3|COMPLETED|Overall Study||16
295140|NCT00156065|721726|P2|COMPLETED|Overall Study||30
295141|NCT00156065|721727|P1|COMPLETED|Overall Study||20
295142|NCT00156065|721725|P3|STARTED|Overall Study||43
295143|NCT00156065|721726|P2|STARTED|Overall Study||93
295144|NCT00156065|721727|P1|STARTED|Overall Study||51
295145|NCT00156013|721738|P1|NOT COMPLETED|Overall Study||2
295146|NCT00156013|721738|P1|COMPLETED|Overall Study||31
295147|NCT00156013|721738|P1|STARTED|Overall Study||33
295148|NCT00154466|721747|P3|NOT COMPLETED|Overall Study||0
295149|NCT00154466|721748|P2|NOT COMPLETED|Overall Study||0
295150|NCT00154466|721749|P1|NOT COMPLETED|Overall Study||0
295151|NCT00154466|721747|P3|COMPLETED|Overall Study||19
295152|NCT00154466|721748|P2|COMPLETED|Overall Study||19
295153|NCT00154466|721749|P1|COMPLETED|Overall Study||20
295154|NCT00154466|721747|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
295155|NCT00154466|721748|P2|STARTED|Overall Study||19
295156|NCT00154466|721749|P1|STARTED|Overall Study||20
295157|NCT00154375|721761|P2|NOT COMPLETED|Overall Study||106
295158|NCT00154375|721762|P1|NOT COMPLETED|Overall Study||113
295159|NCT00154375|721761|P2|COMPLETED|Overall Study||14
295160|NCT00154375|721762|P1|COMPLETED|Overall Study||7
295161|NCT00154375|721761|P2|Not Exposed to Study Treatment|Overall Study||2
295162|NCT00154375|721762|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
295163|NCT00154375|721761|P2|Discontinued Study Treatment|Overall Study||104
295164|NCT00154375|721762|P1|Discontinued Study Treatment|Overall Study||111
295165|NCT00154375|721761|P2|STARTED|Overall Study||120
295166|NCT00154375|721762|P1|STARTED|Overall Study||120
295167|NCT00154310|721773|P2|NOT COMPLETED|Overall Study||28
295168|NCT00154310|721774|P1|NOT COMPLETED|Overall Study||37
295169|NCT00154310|721773|P2|COMPLETED|Overall Study||117
295170|NCT00154310|721774|P1|COMPLETED|Overall Study||118
295171|NCT00154310|721773|P2|STARTED|Overall Study||145
295172|NCT00154310|721774|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
295173|NCT00154297|721790|P2|NOT COMPLETED|Overall Study||7
295174|NCT00154297|721791|P1|NOT COMPLETED|Overall Study||8
295175|NCT00154297|721790|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
295176|NCT00154297|721791|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
295177|NCT00154297|721790|P2|STARTED|Overall Study|Randomized population.|74
295178|NCT00154297|721791|P1|STARTED|Overall Study|Randomized population.|65
295179|NCT00154284|721809|P2|NOT COMPLETED|Overall Study||13
295180|NCT00154284|721810|P1|NOT COMPLETED|Overall Study||7
295181|NCT00154284|721809|P2|COMPLETED|Overall Study||42
295182|NCT00154284|721810|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
295183|NCT00154284|721809|P2|Intent to Treat (ITT) Population|Overall Study||53
295184|NCT00154284|721810|P1|Intent to Treat (ITT) Population|Overall Study||57
295185|NCT00154284|721809|P2|STARTED|Overall Study||55
295186|NCT00154284|721810|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
295187|NCT00154102|721824|P2|NOT COMPLETED|Overall Study||2
295188|NCT00154102|721825|P1|NOT COMPLETED|Overall Study||7
295189|NCT00154102|721824|P2|COMPLETED|Overall Study||597
295190|NCT00154102|721825|P1|COMPLETED|Overall Study||592
295191|NCT00154102|721824|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
295192|NCT00154102|721825|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
295193|NCT00154063|721861|P2|NOT COMPLETED|Overall Study||22
295194|NCT00154063|721862|P1|NOT COMPLETED|Overall Study||12
295195|NCT00154063|721861|P2|COMPLETED|Overall Study||80
295196|NCT00154063|721862|P1|COMPLETED|Overall Study||92
295197|NCT00154063|721861|P2|STARTED|Overall Study||102
295198|NCT00154063|721862|P1|STARTED|Overall Study||104
295199|NCT00153985|721918|P1|NOT COMPLETED|Overall Study||0
295200|NCT00153985|721918|P1|COMPLETED|Overall Study||2
295201|NCT00153985|721918|P1|STARTED|Overall Study||2
295202|NCT00153920|721924|P1|NOT COMPLETED|Overall Study||30
295203|NCT00153920|721924|P1|COMPLETED|Overall Study||36
295204|NCT00153920|721924|P1|Eligible and Treated|Overall Study||64
295205|NCT00153920|721924|P1|STARTED|Overall Study||66
295206|NCT00153816|721939|P6|NOT COMPLETED|Overall Study||27
295207|NCT00153816|721940|P5|NOT COMPLETED|Overall Study||17
295208|NCT00153816|721941|P4|NOT COMPLETED|Overall Study||31
295209|NCT00153816|721942|P3|NOT COMPLETED|Overall Study||32
295210|NCT00153816|721943|P2|NOT COMPLETED|Overall Study||32
295211|NCT00153816|721944|P1|NOT COMPLETED|Overall Study||32
295212|NCT00153816|721939|P6|COMPLETED|Overall Study||262
295213|NCT00153816|721940|P5|COMPLETED|Overall Study||278
295214|NCT00153816|721941|P4|COMPLETED|Overall Study||390
295215|NCT00153816|721942|P3|COMPLETED|Overall Study||388
295216|NCT00153816|721943|P2|COMPLETED|Overall Study||387
295217|NCT00153816|721944|P1|COMPLETED|Overall Study||383
295218|NCT00153816|721939|P6|STARTED|Overall Study||289
295219|NCT00153816|721940|P5|STARTED|Overall Study||295
295220|NCT00153816|721941|P4|STARTED|Overall Study||421
295221|NCT00153816|721942|P3|STARTED|Overall Study||420
295222|NCT00153816|721943|P2|STARTED|Overall Study||419
295223|NCT00153816|721944|P1|STARTED|Overall Study||415
295224|NCT00153179|721966|P4|NOT COMPLETED|Study Visit Day 2||0
295225|NCT00153179|721967|P3|NOT COMPLETED|Study Visit Day 2||0
295226|NCT00153179|721968|P2|NOT COMPLETED|Study Visit Day 2||0
295227|NCT00153179|721969|P1|NOT COMPLETED|Study Visit Day 2||0
295228|NCT00153179|721966|P4|COMPLETED|Study Visit Day 2||7
295229|NCT00153179|721967|P3|COMPLETED|Study Visit Day 2||11
295230|NCT00153179|721968|P2|COMPLETED|Study Visit Day 2||8
295231|NCT00153179|721969|P1|COMPLETED|Study Visit Day 2||9
295232|NCT00153179|721966|P4|STARTED|Study Visit Day 2||7
295233|NCT00153179|721967|P3|STARTED|Study Visit Day 2||11
295234|NCT00153179|721968|P2|STARTED|Study Visit Day 2||8
295235|NCT00153179|721969|P1|STARTED|Study Visit Day 2||9
295236|NCT00153179|721966|P4|NOT COMPLETED|Study Visit Day 1||0
295237|NCT00153179|721967|P3|NOT COMPLETED|Study Visit Day 1||0
295238|NCT00153179|721968|P2|NOT COMPLETED|Study Visit Day 1||0
295239|NCT00153179|721969|P1|NOT COMPLETED|Study Visit Day 1||0
295240|NCT00153179|721966|P4|COMPLETED|Study Visit Day 1||9
295241|NCT00153179|721967|P3|COMPLETED|Study Visit Day 1||13
295242|NCT00153179|721968|P2|COMPLETED|Study Visit Day 1||8
295243|NCT00153179|721969|P1|COMPLETED|Study Visit Day 1||10
295244|NCT00153179|721966|P4|STARTED|Study Visit Day 1||9
295245|NCT00153179|721967|P3|STARTED|Study Visit Day 1||13
295246|NCT00153179|721968|P2|STARTED|Study Visit Day 1||8
295247|NCT00153179|721969|P1|STARTED|Study Visit Day 1||10
295248|NCT00153166|721980|P3|NOT COMPLETED|Overall Study||0
295249|NCT00153166|721981|P2|NOT COMPLETED|Overall Study||0
295250|NCT00153166|721982|P1|NOT COMPLETED|Overall Study||0
295251|NCT00153166|721980|P3|COMPLETED|Overall Study||28
295252|NCT00153166|721981|P2|COMPLETED|Overall Study||37
295253|NCT00153166|721982|P1|COMPLETED|Overall Study||11
295254|NCT00153166|721980|P3|Received Placebo and Placebo|Overall Study||7
295255|NCT00153166|721981|P2|Received Placebo and Placebo|Overall Study||9
295256|NCT00153166|721982|P1|Received Placebo and Placebo|Overall Study||3
295257|NCT00153166|721980|P3|Received Placebo and Pioglitazone|Overall Study||7
295258|NCT00153166|721981|P2|Received Placebo and Pioglitazone|Overall Study||10
295259|NCT00153166|721982|P1|Received Placebo and Pioglitazone|Overall Study||3
295260|NCT00153166|721980|P3|Received Atorvastatin and Placebo|Overall Study||7
295261|NCT00153166|721981|P2|Received Atorvastatin and Placebo|Overall Study||9
295262|NCT00153166|721982|P1|Received Atorvastatin and Placebo|Overall Study||2
295263|NCT00153166|721980|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
295264|NCT00153166|721981|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
295265|NCT00153166|721982|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
295266|NCT00153166|721980|P3|STARTED|Overall Study||28
295267|NCT00153166|721981|P2|STARTED|Overall Study||37
295268|NCT00153166|721982|P1|STARTED|Overall Study||11
295269|NCT00153101|721999|P5|NOT COMPLETED|Overall Study||10
295270|NCT00153101|722000|P4|NOT COMPLETED|Overall Study||8
295271|NCT00153101|722001|P3|NOT COMPLETED|Overall Study||15
295272|NCT00153101|722002|P2|NOT COMPLETED|Overall Study||18
295273|NCT00153101|722003|P1|NOT COMPLETED|Overall Study||17
295274|NCT00153101|721999|P5|COMPLETED|Overall Study||2962
295275|NCT00153101|722000|P4|COMPLETED|Overall Study||2946
295276|NCT00153101|722001|P3|COMPLETED|Overall Study||8561
295277|NCT00153101|722002|P2|COMPLETED|Overall Study||8524
295278|NCT00153101|722003|P1|COMPLETED|Overall Study||8485
295279|NCT00153101|721999|P5|STARTED|Overall Study||2972
295280|NCT00153101|722000|P4|STARTED|Overall Study||2954
295281|NCT00153101|722001|P3|STARTED|Overall Study||8576
295282|NCT00153101|722002|P2|STARTED|Overall Study||8542
295283|NCT00153101|722003|P1|STARTED|Overall Study||8502
295284|NCT00153062|722111|P4|NOT COMPLETED|Overall Study||411
295285|NCT00153062|722112|P3|NOT COMPLETED|Overall Study||415
295286|NCT00153062|722113|P2|NOT COMPLETED|Overall Study||406
295287|NCT00153062|722114|P1|NOT COMPLETED|Overall Study||387
295288|NCT00153062|722111|P4|COMPLETED|Overall Study||4680
295289|NCT00153062|722112|P3|COMPLETED|Overall Study||4645
295290|NCT00153062|722113|P2|COMPLETED|Overall Study||4689
295291|NCT00153062|722114|P1|COMPLETED|Overall Study||4699
295292|NCT00153062|722111|P4|STARTED|Overall Study||5091
295293|NCT00153062|722112|P3|STARTED|Overall Study||5060
295294|NCT00153062|722113|P2|STARTED|Overall Study||5095
295295|NCT00153062|722114|P1|STARTED|Overall Study||5086
295296|NCT00152971|722133|P3|NOT COMPLETED|Treatment||80
295297|NCT00152971|722134|P2|NOT COMPLETED|Treatment||63
295298|NCT00152971|722135|P1|NOT COMPLETED|Treatment||71
295299|NCT00152971|722133|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
295300|NCT00152971|722134|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
295301|NCT00152971|722135|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
295302|NCT00152971|722133|P3|STARTED|Treatment||868
295303|NCT00152971|722134|P2|STARTED|Treatment||871
295304|NCT00152971|722135|P1|STARTED|Treatment||857
295305|NCT00152971|722133|P3|NOT COMPLETED|Overall Study||49
295306|NCT00152971|722134|P2|NOT COMPLETED|Overall Study||48
295307|NCT00152971|722135|P1|NOT COMPLETED|Overall Study||51
295308|NCT00152971|722133|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
295309|NCT00152971|722134|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
295310|NCT00152971|722135|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
295311|NCT00152971|722133|P3|STARTED|Overall Study||868
295312|NCT00152971|722134|P2|STARTED|Overall Study||871
295313|NCT00152971|722135|P1|STARTED|Overall Study||857
295314|NCT00152763|722171|P4|NOT COMPLETED|Overall Study||14
295315|NCT00152763|722172|P3|NOT COMPLETED|Overall Study||4
295316|NCT00152763|722173|P2|NOT COMPLETED|Overall Study||5
295317|NCT00152763|722174|P1|NOT COMPLETED|Overall Study||10
295318|NCT00152763|722171|P4|COMPLETED|Overall Study||63
295319|NCT00152763|722172|P3|COMPLETED|Overall Study||16
295320|NCT00152763|722173|P2|COMPLETED|Overall Study||14
295321|NCT00152763|722174|P1|COMPLETED|Overall Study||67
295322|NCT00152763|722171|P4|STARTED|Overall Study||77
295323|NCT00152763|722172|P3|STARTED|Overall Study||20
295324|NCT00152763|722173|P2|STARTED|Overall Study||19
295325|NCT00152763|722174|P1|STARTED|Overall Study||77
295326|NCT00152516|722290|P1|NOT COMPLETED|Overall Study||75
295327|NCT00152516|722290|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
295328|NCT00152516|722290|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
295329|NCT00152009|722318|P4|NOT COMPLETED|Overall Study||33
295330|NCT00152009|722319|P3|NOT COMPLETED|Overall Study||37
295331|NCT00152009|722320|P2|NOT COMPLETED|Overall Study||31
295332|NCT00152009|722321|P1|NOT COMPLETED|Overall Study||29
295333|NCT00152009|722318|P4|COMPLETED|Overall Study||53
295334|NCT00152009|722319|P3|COMPLETED|Overall Study||49
295335|NCT00152009|722320|P2|COMPLETED|Overall Study||55
295336|NCT00152009|722321|P1|COMPLETED|Overall Study||58
295337|NCT00152009|722318|P4|STARTED|Overall Study||86
295338|NCT00152009|722319|P3|STARTED|Overall Study||86
295339|NCT00152009|722320|P2|STARTED|Overall Study||86
295340|NCT00152009|722321|P1|STARTED|Overall Study||87
295341|NCT00151996|722353|P2|NOT COMPLETED|Overall Study||7
295342|NCT00151996|722354|P1|NOT COMPLETED|Overall Study||5
295343|NCT00151996|722353|P2|COMPLETED|Overall Study||26
295344|NCT00151996|722354|P1|COMPLETED|Overall Study||37
295345|NCT00151996|722353|P2|STARTED|Overall Study||33
295346|NCT00151996|722354|P1|STARTED|Overall Study||42
295347|NCT00151892|722370|P2|NOT COMPLETED|Overall Study||83
295348|NCT00151892|722371|P1|NOT COMPLETED|Overall Study||76
295349|NCT00151892|722370|P2|COMPLETED|Overall Study||330
295350|NCT00151892|722371|P1|COMPLETED|Overall Study||340
295351|NCT00151892|722370|P2|STARTED|Overall Study||413
295352|NCT00151892|722371|P1|STARTED|Overall Study||416
295353|NCT00151814|722388|P3|NOT COMPLETED|Overall Study||0
295354|NCT00151814|722389|P2|NOT COMPLETED|Overall Study||0
295355|NCT00151814|722390|P1|NOT COMPLETED|Overall Study||0
295356|NCT00151814|722388|P3|COMPLETED|Overall Study||10
295357|NCT00151814|722389|P2|COMPLETED|Overall Study||10
295358|NCT00151814|722390|P1|COMPLETED|Overall Study||4
295359|NCT00151814|722388|P3|STARTED|Overall Study||10
295360|NCT00151814|722389|P2|STARTED|Overall Study||10
295361|NCT00151814|722390|P1|STARTED|Overall Study||4
295362|NCT00151775|722416|P12|NOT COMPLETED|Period 4: Open Label||0
295363|NCT00151775|722417|P11|NOT COMPLETED|Period 4: Open Label||0
295364|NCT00151775|722418|P10|NOT COMPLETED|Period 4: Open Label||21
295365|NCT00151775|722419|P9|NOT COMPLETED|Period 4: Open Label||0
295366|NCT00151775|722420|P8|NOT COMPLETED|Period 4: Open Label||0
295367|NCT00151775|722421|P7|NOT COMPLETED|Period 4: Open Label||0
295368|NCT00151775|722422|P6|NOT COMPLETED|Period 4: Open Label||0
295369|NCT00151775|722423|P5|NOT COMPLETED|Period 4: Open Label||30
295370|NCT00151775|722424|P4|NOT COMPLETED|Period 4: Open Label||0
295371|NCT00151775|722425|P3|NOT COMPLETED|Period 4: Open Label||0
295372|NCT00151775|722426|P2|NOT COMPLETED|Period 4: Open Label||0
295373|NCT00151775|722427|P1|NOT COMPLETED|Period 4: Open Label||0
295374|NCT00151775|722416|P12|COMPLETED|Period 4: Open Label||0
295375|NCT00151775|722417|P11|COMPLETED|Period 4: Open Label||57
295376|NCT00151775|722418|P10|COMPLETED|Period 4: Open Label||83
295377|NCT00151775|722419|P9|COMPLETED|Period 4: Open Label||0
295378|NCT00151775|722420|P8|COMPLETED|Period 4: Open Label||0
295379|NCT00151775|722421|P7|COMPLETED|Period 4: Open Label||0
295380|NCT00151775|722422|P6|COMPLETED|Period 4: Open Label||0
295381|NCT00151775|722423|P5|COMPLETED|Period 4: Open Label||149
295382|NCT00151775|722424|P4|COMPLETED|Period 4: Open Label||0
295383|NCT00151775|722425|P3|COMPLETED|Period 4: Open Label||0
295384|NCT00151775|722426|P2|COMPLETED|Period 4: Open Label||0
295385|NCT00151775|722427|P1|COMPLETED|Period 4: Open Label||0
295386|NCT00151775|722416|P12|STARTED|Period 4: Open Label||0
295387|NCT00151775|722417|P11|STARTED|Period 4: Open Label||57
295388|NCT00151775|722418|P10|STARTED|Period 4: Open Label||104
295389|NCT00151775|722419|P9|STARTED|Period 4: Open Label||0
295390|NCT00151775|722420|P8|STARTED|Period 4: Open Label||0
295391|NCT00151775|722421|P7|STARTED|Period 4: Open Label||0
295392|NCT00151775|722422|P6|STARTED|Period 4: Open Label||0
295393|NCT00151775|722423|P5|STARTED|Period 4: Open Label||179
295394|NCT00151775|722424|P4|STARTED|Period 4: Open Label||0
295395|NCT00151775|722425|P3|STARTED|Period 4: Open Label||0
295396|NCT00151775|722426|P2|STARTED|Period 4: Open Label||0
295397|NCT00151775|722427|P1|STARTED|Period 4: Open Label||0
295398|NCT00151775|722416|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
295399|NCT00151775|722417|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
295400|NCT00151775|722418|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
295401|NCT00151775|722419|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
295402|NCT00151775|722420|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
295403|NCT00151775|722421|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
295404|NCT00151775|722422|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
295405|NCT00151775|722423|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
295406|NCT00151775|722424|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
295407|NCT00151775|722425|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
295408|NCT00151775|722426|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
295409|NCT00151775|722427|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
295410|NCT00151775|722416|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
295411|NCT00151775|722417|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
295412|NCT00151775|722418|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
295413|NCT00151775|722419|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
295414|NCT00151775|722420|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
295415|NCT00151775|722421|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
295416|NCT00151775|722422|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
295417|NCT00151775|722423|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
295418|NCT00151775|722424|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
295419|NCT00151775|722425|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
295420|NCT00151775|722426|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
295421|NCT00151775|722427|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
295422|NCT00151775|722416|P12|STARTED|Period 3: Double-blind, Withdrawal||29
295423|NCT00151775|722417|P11|STARTED|Period 3: Double-blind, Withdrawal||29
295424|NCT00151775|722418|P10|STARTED|Period 3: Double-blind, Withdrawal||0
295425|NCT00151775|722419|P9|STARTED|Period 3: Double-blind, Withdrawal||26
295426|NCT00151775|722420|P8|STARTED|Period 3: Double-blind, Withdrawal||28
295427|NCT00151775|722421|P7|STARTED|Period 3: Double-blind, Withdrawal||27
295428|NCT00151775|722422|P6|STARTED|Period 3: Double-blind, Withdrawal||26
295429|NCT00151775|722423|P5|STARTED|Period 3: Double-blind, Withdrawal||0
295430|NCT00151775|722424|P4|STARTED|Period 3: Double-blind, Withdrawal||44
295431|NCT00151775|722425|P3|STARTED|Period 3: Double-blind, Withdrawal||45
295432|NCT00151775|722426|P2|STARTED|Period 3: Double-blind, Withdrawal||45
295433|NCT00151775|722427|P1|STARTED|Period 3: Double-blind, Withdrawal||48
295434|NCT00151775|722416|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
295435|NCT00151775|722417|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
295436|NCT00151775|722418|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
295437|NCT00151775|722419|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
295438|NCT00151775|722420|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
295439|NCT00151775|722421|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
295440|NCT00151775|722422|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
295441|NCT00151775|722423|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
295442|NCT00151775|722424|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
295443|NCT00151775|722425|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
295444|NCT00151775|722426|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
295445|NCT00151775|722427|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
295446|NCT00151775|722416|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
295447|NCT00151775|722417|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
295448|NCT00151775|722418|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
295449|NCT00151775|722419|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
295450|NCT00151775|722420|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
295451|NCT00151775|722421|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
295452|NCT00151775|722422|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
295453|NCT00151775|722423|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
295454|NCT00151775|722424|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
295455|NCT00151775|722425|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
295456|NCT00151775|722426|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
295457|NCT00151775|722427|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
295458|NCT00151775|722416|P12|STARTED|Period 2 - Double-Blind Dose Response||0
295459|NCT00151775|722417|P11|STARTED|Period 2 - Double-Blind Dose Response||60
295460|NCT00151775|722418|P10|STARTED|Period 2 - Double-Blind Dose Response||0
295461|NCT00151775|722419|P9|STARTED|Period 2 - Double-Blind Dose Response||0
295462|NCT00151775|722420|P8|STARTED|Period 2 - Double-Blind Dose Response||0
295463|NCT00151775|722421|P7|STARTED|Period 2 - Double-Blind Dose Response||56
295464|NCT00151775|722422|P6|STARTED|Period 2 - Double-Blind Dose Response||56
295465|NCT00151775|722423|P5|STARTED|Period 2 - Double-Blind Dose Response||0
295466|NCT00151775|722424|P4|STARTED|Period 2 - Double-Blind Dose Response||0
295467|NCT00151775|722425|P3|STARTED|Period 2 - Double-Blind Dose Response||0
295468|NCT00151775|722426|P2|STARTED|Period 2 - Double-Blind Dose Response||95
295469|NCT00151775|722427|P1|STARTED|Period 2 - Double-Blind Dose Response||95
295470|NCT00151476|722471|P2|NOT COMPLETED|FAP Analyzed Subjects||3
295471|NCT00151476|722472|P1|NOT COMPLETED|FAP Analyzed Subjects||0
295472|NCT00151476|722471|P2|COMPLETED|FAP Analyzed Subjects||51
295473|NCT00151476|722472|P1|COMPLETED|FAP Analyzed Subjects||13
295474|NCT00151476|722471|P2|STARTED|FAP Analyzed Subjects||54
295475|NCT00151476|722472|P1|STARTED|FAP Analyzed Subjects||13
295476|NCT00151476|722471|P2|NOT COMPLETED|FAP Identified Subjects||1
295477|NCT00151476|722472|P1|NOT COMPLETED|FAP Identified Subjects||0
295478|NCT00151476|722471|P2|COMPLETED|FAP Identified Subjects||54
295479|NCT00151476|722472|P1|COMPLETED|FAP Identified Subjects||13
295480|NCT00151476|722471|P2|STARTED|FAP Identified Subjects||55
295481|NCT00151476|722472|P1|STARTED|FAP Identified Subjects||13
295482|NCT00151411|722529|P2|NOT COMPLETED|Overall Study||43
295483|NCT00151411|722530|P1|NOT COMPLETED|Overall Study||33
295484|NCT00151411|722529|P2|COMPLETED|Overall Study||16
295485|NCT00151411|722530|P1|COMPLETED|Overall Study||22
295486|NCT00151411|722529|P2|STARTED|Overall Study||59
295487|NCT00151411|722530|P1|STARTED|Overall Study||55
295488|NCT00151372|722542|P2|NOT COMPLETED|Overall Study||29
295489|NCT00151372|722543|P1|NOT COMPLETED|Overall Study||29
295490|NCT00151372|722542|P2|COMPLETED|Overall Study||45
295491|NCT00151372|722543|P1|COMPLETED|Overall Study||38
295492|NCT00151372|722542|P2|STARTED|Overall Study||74
295493|NCT00151372|722543|P1|STARTED|Overall Study||67
295494|NCT00151320|722553|P1|NOT COMPLETED|Overall Study||0
295495|NCT00151320|722553|P1|COMPLETED|Overall Study||76
295496|NCT00151320|722553|P1|STARTED|Overall Study||76
295497|NCT00151281|722558|P1|NOT COMPLETED|Overall Study||3
295498|NCT00151281|722558|P1|COMPLETED|Overall Study||22
295499|NCT00151281|722558|P1|STARTED|Overall Study||25
295500|NCT00150969|722567|P2|NOT COMPLETED|24-48 Month Extension||100
295501|NCT00150969|722568|P1|NOT COMPLETED|24-48 Month Extension||88
295502|NCT00150969|722567|P2|COMPLETED|24-48 Month Extension||40
295503|NCT00150969|722568|P1|COMPLETED|24-48 Month Extension||33
295504|NCT00150969|722567|P2|STARTED|24-48 Month Extension||140
295505|NCT00150969|722568|P1|STARTED|24-48 Month Extension||121
295506|NCT00150969|722567|P2|NOT COMPLETED|24 Month Main Study||21
295507|NCT00150969|722568|P1|NOT COMPLETED|24 Month Main Study||19
295508|NCT00150969|722567|P2|COMPLETED|24 Month Main Study||202
295509|NCT00150969|722568|P1|COMPLETED|24 Month Main Study||198
295510|NCT00150969|722567|P2|STARTED|24 Month Main Study||223
295511|NCT00150969|722568|P1|STARTED|24 Month Main Study||217
295512|NCT00150618|722605|P5|NOT COMPLETED|Overall Study||25
295513|NCT00150618|722606|P4|NOT COMPLETED|Overall Study||26
295514|NCT00150618|722607|P3|NOT COMPLETED|Overall Study||27
295515|NCT00150618|722608|P2|NOT COMPLETED|Overall Study||18
295516|NCT00150618|722609|P1|NOT COMPLETED|Overall Study||17
295517|NCT00150618|722605|P5|COMPLETED|Overall Study||41
295518|NCT00150618|722606|P4|COMPLETED|Overall Study||40
295519|NCT00150618|722607|P3|COMPLETED|Overall Study||38
295520|NCT00150618|722608|P2|COMPLETED|Overall Study||47
295521|NCT00150618|722609|P1|COMPLETED|Overall Study||45
295522|NCT00150618|722605|P5|STARTED|Overall Study||66
295523|NCT00150618|722606|P4|STARTED|Overall Study||66
295524|NCT00150618|722607|P3|STARTED|Overall Study||65
295525|NCT00150618|722608|P2|STARTED|Overall Study||65
295526|NCT00150618|722609|P1|STARTED|Overall Study||62
295527|NCT00150592|722643|P2|NOT COMPLETED|Overall Study||3
295528|NCT00150592|722644|P1|NOT COMPLETED|Overall Study||7
295529|NCT00150592|722643|P2|COMPLETED|Overall Study||54
295530|NCT00150592|722644|P1|COMPLETED|Overall Study||114
295531|NCT00150592|722643|P2|STARTED|Overall Study||57
295532|NCT00150592|722644|P1|STARTED|Overall Study||121
295533|NCT00150462|722675|P11|NOT COMPLETED|Overall Study||3
295534|NCT00150462|722676|P10|NOT COMPLETED|Overall Study||6
295535|NCT00150462|722677|P9|NOT COMPLETED|Overall Study||6
295536|NCT00150462|722678|P8|NOT COMPLETED|Overall Study||8
295537|NCT00150462|722679|P7|NOT COMPLETED|Overall Study||3
295538|NCT00150462|722680|P6|NOT COMPLETED|Overall Study||4
295539|NCT00150462|722681|P5|NOT COMPLETED|Overall Study||3
295540|NCT00150462|722682|P4|NOT COMPLETED|Overall Study||3
295541|NCT00150462|722683|P3|NOT COMPLETED|Overall Study||4
295542|NCT00150462|722684|P2|NOT COMPLETED|Overall Study||3
295543|NCT00150462|722685|P1|NOT COMPLETED|Overall Study||3
295544|NCT00150462|722675|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
295545|NCT00150462|722676|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
295546|NCT00150462|722677|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295547|NCT00150462|722678|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295548|NCT00150462|722679|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295549|NCT00150462|722680|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295550|NCT00150462|722681|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295551|NCT00150462|722682|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295552|NCT00150462|722683|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295553|NCT00150462|722684|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295554|NCT00150462|722685|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
295555|NCT00150462|722675|P11|STARTED|Overall Study||4
295556|NCT00150462|722676|P10|STARTED|Overall Study||7
295557|NCT00150462|722677|P9|STARTED|Overall Study||6
295558|NCT00150462|722678|P8|STARTED|Overall Study||8
295559|NCT00150462|722679|P7|STARTED|Overall Study||3
295560|NCT00150462|722680|P6|STARTED|Overall Study||4
295561|NCT00150462|722681|P5|STARTED|Overall Study||3
295562|NCT00150462|722682|P4|STARTED|Overall Study||3
295563|NCT00150462|722683|P3|STARTED|Overall Study||4
295564|NCT00150462|722684|P2|STARTED|Overall Study||3
295565|NCT00150462|722685|P1|STARTED|Overall Study||3
295566|NCT00150345|722795|P2|NOT COMPLETED|Overall Study||32
295567|NCT00150345|722796|P1|NOT COMPLETED|Overall Study||34
295568|NCT00150345|722795|P2|COMPLETED|Overall Study||34
295569|NCT00150345|722796|P1|COMPLETED|Overall Study||47
295570|NCT00150345|722795|P2|STARTED|Overall Study||66
295571|NCT00150345|722796|P1|STARTED|Overall Study||81
295572|NCT00150176|722860|P2|NOT COMPLETED|Overall Study||120
295573|NCT00150176|722861|P1|NOT COMPLETED|Overall Study||59
295574|NCT00150176|722860|P2|COMPLETED|Overall Study||72
295575|NCT00150176|722861|P1|COMPLETED|Overall Study||135
295576|NCT00150176|722860|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
295577|NCT00150176|722861|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
295578|NCT00149994|722872|P2|NOT COMPLETED|Overall Study||1
295579|NCT00149994|722873|P1|NOT COMPLETED|Overall Study||1
295580|NCT00149994|722872|P2|COMPLETED|Overall Study||85
295581|NCT00149994|722873|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
295582|NCT00149994|722872|P2|STARTED|Overall Study||86
295583|NCT00149994|722873|P1|STARTED|Overall Study|"Started indicates Safety population."|85
295584|NCT00149890|722881|P2|NOT COMPLETED|Overall Study||18
295585|NCT00149890|722882|P1|NOT COMPLETED|Overall Study||13
295586|NCT00149890|722881|P2|COMPLETED|Overall Study||20
295587|NCT00149890|722882|P1|COMPLETED|Overall Study||26
295588|NCT00149890|722881|P2|STARTED|Overall Study||38
295589|NCT00149890|722882|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
295590|NCT00149825|722902|P2|NOT COMPLETED|Overall Study||3
295591|NCT00149825|722903|P1|NOT COMPLETED|Overall Study||5
295592|NCT00149825|722902|P2|COMPLETED|Overall Study||12
295593|NCT00149825|722903|P1|COMPLETED|Overall Study||10
295594|NCT00149825|722902|P2|STARTED|Overall Study||15
295595|NCT00149825|722903|P1|STARTED|Overall Study||15
295596|NCT00149799|722913|P3|NOT COMPLETED|Discontinuation (Phase II)||9
295597|NCT00149799|722914|P2|NOT COMPLETED|Discontinuation (Phase II)||3
295598|NCT00149799|722915|P1|NOT COMPLETED|Discontinuation (Phase II)||0
295599|NCT00149799|722913|P3|COMPLETED|Discontinuation (Phase II)||21
295600|NCT00149799|722914|P2|COMPLETED|Discontinuation (Phase II)||25
295601|NCT00149799|722915|P1|COMPLETED|Discontinuation (Phase II)||0
295602|NCT00149799|722913|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
295603|NCT00149799|722914|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
295604|NCT00149799|722915|P1|STARTED|Discontinuation (Phase II)||0
295605|NCT00149799|722913|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
295606|NCT00149799|722914|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
295607|NCT00149799|722915|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
295608|NCT00149799|722913|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
295609|NCT00149799|722914|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
295610|NCT00149799|722915|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
295611|NCT00149799|722913|P3|STARTED|Open Label Escitalopram (Phase I)||0
295612|NCT00149799|722914|P2|STARTED|Open Label Escitalopram (Phase I)||0
295613|NCT00149799|722915|P1|STARTED|Open Label Escitalopram (Phase I)||100
295614|NCT00149747|722931|P2|NOT COMPLETED|Overall Study||3
295615|NCT00149747|722932|P1|NOT COMPLETED|Overall Study||4
295616|NCT00149747|722931|P2|COMPLETED|Overall Study||27
295617|NCT00149747|722932|P1|COMPLETED|Overall Study||32
295618|NCT00149747|722931|P2|STARTED|Overall Study||30
295619|NCT00149747|722932|P1|STARTED|Overall Study||36
295620|NCT00149669|722944|P2|NOT COMPLETED|Overall Study||5
295621|NCT00149669|722945|P1|NOT COMPLETED|Overall Study||3
295622|NCT00149669|722944|P2|COMPLETED|Overall Study||30
295623|NCT00149669|722945|P1|COMPLETED|Overall Study||29
295624|NCT00149669|722944|P2|STARTED|Overall Study||35
295625|NCT00149669|722945|P1|STARTED|Overall Study||32
295626|NCT00149643|722965|P2|NOT COMPLETED|Overall Study||36
295627|NCT00149643|722966|P1|NOT COMPLETED|Overall Study||34
295628|NCT00149643|722965|P2|COMPLETED|Overall Study||0
295629|NCT00149643|722966|P1|COMPLETED|Overall Study||0
295630|NCT00149643|722965|P2|STARTED|Overall Study||36
295631|NCT00149643|722966|P1|STARTED|Overall Study||34
295632|NCT00149630|722978|P2|NOT COMPLETED|Overall Study||5
295633|NCT00149630|722979|P1|NOT COMPLETED|Overall Study||8
295634|NCT00149630|722978|P2|COMPLETED|Overall Study||35
295635|NCT00149630|722979|P1|COMPLETED|Overall Study||26
295636|NCT00149630|722978|P2|STARTED|Overall Study||40
295637|NCT00149630|722979|P1|STARTED|Overall Study||34
295638|NCT00149396|722989|P1|NOT COMPLETED|Overall Study||23
295639|NCT00149396|722989|P1|COMPLETED|Overall Study||9
295640|NCT00149396|722989|P1|Completed NV1020 and Chemotherapy|Overall Study||9
295641|NCT00149396|722989|P1|Completed NV1020 Therapy|Overall Study||29
295642|NCT00149396|722989|P1|STARTED|Overall Study||32
295643|NCT00149227|723032|P2|NOT COMPLETED|Overall Study||0
295644|NCT00149227|723033|P1|NOT COMPLETED|Overall Study||0
295645|NCT00149227|723032|P2|COMPLETED|Overall Study||1514
295646|NCT00149227|723033|P1|COMPLETED|Overall Study||1517
295647|NCT00149227|723032|P2|STARTED|Overall Study||1514
295648|NCT00149227|723033|P1|STARTED|Overall Study||1517
295649|NCT00149214|723059|P2|NOT COMPLETED|Overall Study||17
295650|NCT00149214|723060|P1|NOT COMPLETED|Overall Study||26
295651|NCT00149214|723059|P2|COMPLETED|Overall Study||105
295652|NCT00149214|723060|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
295653|NCT00149214|723059|P2|STARTED|Overall Study||122
295654|NCT00149214|723060|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
295655|NCT00148954|723076|P2|NOT COMPLETED|Overall Study||300
295656|NCT00148954|723077|P1|NOT COMPLETED|Overall Study||307
295657|NCT00148954|723076|P2|COMPLETED|Overall Study||677
295658|NCT00148954|723077|P1|COMPLETED|Overall Study||678
295659|NCT00148954|723076|P2|STARTED|Overall Study||977
295660|NCT00148954|723077|P1|STARTED|Overall Study||985
295661|NCT00148798|723085|P2|NOT COMPLETED|Overall Study||0
295662|NCT00148798|723086|P1|NOT COMPLETED|Overall Study||0
295663|NCT00148798|723085|P2|COMPLETED|Overall Study||568
295664|NCT00148798|723086|P1|COMPLETED|Overall Study||557
295665|NCT00148798|723085|P2|STARTED|Overall Study|ITT Population|568
295666|NCT00148798|723086|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
295667|NCT00148759|723108|P2|NOT COMPLETED|Overall Study||1
295668|NCT00148759|723109|P1|NOT COMPLETED|Overall Study||2
295669|NCT00148759|723108|P2|COMPLETED|Overall Study||11
295670|NCT00148759|723109|P1|COMPLETED|Overall Study||9
295671|NCT00148759|723108|P2|24-hr PK Sampling|Overall Study||11
295672|NCT00148759|723109|P1|24-hr PK Sampling|Overall Study||9
295673|NCT00148759|723108|P2|STARTED|Overall Study||12
295674|NCT00148759|723109|P1|STARTED|Overall Study||11
295675|NCT00148733|723119|P2|NOT COMPLETED|Overall Study||15
295676|NCT00148733|723120|P1|NOT COMPLETED|Overall Study||14
295677|NCT00148733|723119|P2|COMPLETED|Overall Study||1299
295678|NCT00148733|723120|P1|COMPLETED|Overall Study||1300
295679|NCT00148733|723119|P2|STARTED|Overall Study||1314
295680|NCT00148733|723120|P1|STARTED|Overall Study||1314
295681|NCT00148668|723128|P2|NOT COMPLETED|Overall Study||0
295682|NCT00148668|723129|P1|NOT COMPLETED|Overall Study||0
295683|NCT00148668|723128|P2|COMPLETED|Overall Study||40
295684|NCT00148668|723129|P1|COMPLETED|Overall Study||41
295685|NCT00148668|723128|P2|STARTED|Overall Study||40
295686|NCT00148668|723129|P1|STARTED|Overall Study||41
295687|NCT00148317|723135|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
295688|NCT00148317|723135|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
295689|NCT00148317|723135|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
295690|NCT00148317|723135|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
295691|NCT00148317|723135|P1|COMPLETED|Consolidation (VEL + DEX)||38
295692|NCT00148317|723135|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
295693|NCT00148317|723135|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
295694|NCT00148317|723135|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
295695|NCT00148317|723135|P1|STARTED|Consolidation (VEL + DEX)||38
295696|NCT00148122|723142|P1|NOT COMPLETED|Overall Study||2
295697|NCT00148122|723142|P1|COMPLETED|Overall Study||38
295698|NCT00148122|723142|P1|STARTED|Overall Study||40
295699|NCT00148109|723150|P2|NOT COMPLETED|Overall Study||20
295700|NCT00148109|723151|P1|NOT COMPLETED|Overall Study||12
295701|NCT00148109|723150|P2|COMPLETED|Overall Study||1
295702|NCT00148109|723151|P1|COMPLETED|Overall Study||3
295703|NCT00148109|723150|P2|STARTED|Overall Study||21
295704|NCT00148109|723151|P1|STARTED|Overall Study||15
295705|NCT00147966|723161|P1|NOT COMPLETED|Overall Study||0
295706|NCT00147966|723161|P1|COMPLETED|Overall Study||24
295707|NCT00147966|723161|P1|STARTED|Overall Study||24
295708|NCT00147823|723167|P2|NOT COMPLETED|Overall Study||15
295709|NCT00147823|723168|P1|NOT COMPLETED|Overall Study||13
295710|NCT00147823|723167|P2|COMPLETED|Overall Study||16
295711|NCT00147823|723168|P1|COMPLETED|Overall Study||19
295712|NCT00147823|723167|P2|Month 24 Visit|Overall Study||18
295713|NCT00147823|723168|P1|Month 24 Visit|Overall Study||21
295714|NCT00147823|723167|P2|Month 18 Visit|Overall Study||20
295715|NCT00147823|723168|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
295716|NCT00147823|723167|P2|Month 12 CT Scan|Overall Study||25
295717|NCT00147823|723168|P1|Month 12 CT Scan|Overall Study||20
295718|NCT00147823|723167|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
295719|NCT00147823|723168|P1|Month 12 Visit|Overall Study||21
295720|NCT00147823|723167|P2|Month 6 Visit|Overall Study||21
295721|NCT00147823|723168|P1|Month 6 Visit|Overall Study||25
295722|NCT00147823|723167|P2|Month 3 Visit|Overall Study||24
295723|NCT00147823|723168|P1|Month 3 Visit|Overall Study||25
295724|NCT00147823|723167|P2|Week 6 Visit|Overall Study||28
295725|NCT00147823|723168|P1|Week 6 Visit|Overall Study||26
295726|NCT00147823|723167|P2|STARTED|Overall Study||31
295727|NCT00147823|723168|P1|STARTED|Overall Study||32
295728|NCT00147745|723199|P3|NOT COMPLETED|Overall Study||0
295729|NCT00147745|723200|P2|NOT COMPLETED|Overall Study||0
295730|NCT00147745|723201|P1|NOT COMPLETED|Overall Study||1
295731|NCT00147745|723199|P3|COMPLETED|Overall Study||6
295732|NCT00147745|723200|P2|COMPLETED|Overall Study||14
295733|NCT00147745|723201|P1|COMPLETED|Overall Study||15
295734|NCT00147745|723199|P3|STARTED|Overall Study||6
295735|NCT00147745|723200|P2|STARTED|Overall Study||14
295736|NCT00147745|723201|P1|STARTED|Overall Study||16
295737|NCT00147537|723223|P11|NOT COMPLETED|Phase 2||52
295738|NCT00147537|723224|P10|NOT COMPLETED|Phase 2||161
295739|NCT00147537|723225|P9|NOT COMPLETED|Phase 2||0
295740|NCT00147537|723226|P8|NOT COMPLETED|Phase 2||0
295741|NCT00147537|723227|P7|NOT COMPLETED|Phase 2||0
295742|NCT00147537|723228|P6|NOT COMPLETED|Phase 2||0
295743|NCT00147537|723229|P5|NOT COMPLETED|Phase 2||0
295744|NCT00147537|723230|P4|NOT COMPLETED|Phase 2||0
295745|NCT00147537|723231|P3|NOT COMPLETED|Phase 2||0
295746|NCT00147537|723232|P2|NOT COMPLETED|Phase 2||0
295747|NCT00147537|723233|P1|NOT COMPLETED|Phase 2||0
295748|NCT00147537|723223|P11|COMPLETED|Phase 2||3
295749|NCT00147537|723224|P10|COMPLETED|Phase 2||5
295750|NCT00147537|723225|P9|COMPLETED|Phase 2||0
295751|NCT00147537|723226|P8|COMPLETED|Phase 2||0
295752|NCT00147537|723227|P7|COMPLETED|Phase 2||0
295753|NCT00147537|723228|P6|COMPLETED|Phase 2||0
295754|NCT00147537|723229|P5|COMPLETED|Phase 2||0
295755|NCT00147537|723230|P4|COMPLETED|Phase 2||0
295756|NCT00147537|723231|P3|COMPLETED|Phase 2||0
295757|NCT00147537|723232|P2|COMPLETED|Phase 2||0
295758|NCT00147537|723233|P1|COMPLETED|Phase 2||0
295759|NCT00147537|723223|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
295760|NCT00147537|723224|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
295761|NCT00147537|723225|P9|STARTED|Phase 2||0
295762|NCT00147537|723226|P8|STARTED|Phase 2||0
295763|NCT00147537|723227|P7|STARTED|Phase 2||0
295764|NCT00147537|723228|P6|STARTED|Phase 2||0
295765|NCT00147537|723229|P5|STARTED|Phase 2||0
295766|NCT00147537|723230|P4|STARTED|Phase 2||0
295767|NCT00147537|723231|P3|STARTED|Phase 2||0
295768|NCT00147537|723232|P2|STARTED|Phase 2||0
295769|NCT00147537|723233|P1|STARTED|Phase 2||0
295770|NCT00147537|723223|P11|NOT COMPLETED|Phase 1b||0
295771|NCT00147537|723224|P10|NOT COMPLETED|Phase 1b||0
295772|NCT00147537|723225|P9|NOT COMPLETED|Phase 1b||17
295773|NCT00147537|723226|P8|NOT COMPLETED|Phase 1b||7
295774|NCT00147537|723227|P7|NOT COMPLETED|Phase 1b||18
295775|NCT00147537|723228|P6|NOT COMPLETED|Phase 1b||3
295776|NCT00147537|723229|P5|NOT COMPLETED|Phase 1b||3
295777|NCT00147537|723230|P4|NOT COMPLETED|Phase 1b||2
295778|NCT00147537|723231|P3|NOT COMPLETED|Phase 1b||4
295779|NCT00147537|723232|P2|NOT COMPLETED|Phase 1b||2
295780|NCT00147537|723233|P1|NOT COMPLETED|Phase 1b||2
295781|NCT00147537|723223|P11|COMPLETED|Phase 1b||0
295782|NCT00147537|723224|P10|COMPLETED|Phase 1b||0
295783|NCT00147537|723225|P9|COMPLETED|Phase 1b||1
295784|NCT00147537|723226|P8|COMPLETED|Phase 1b||0
295785|NCT00147537|723227|P7|COMPLETED|Phase 1b||0
295786|NCT00147537|723228|P6|COMPLETED|Phase 1b||0
295787|NCT00147537|723229|P5|COMPLETED|Phase 1b||0
295788|NCT00147537|723230|P4|COMPLETED|Phase 1b||1
295789|NCT00147537|723231|P3|COMPLETED|Phase 1b||0
295790|NCT00147537|723232|P2|COMPLETED|Phase 1b||0
295791|NCT00147537|723233|P1|COMPLETED|Phase 1b||1
295792|NCT00147537|723223|P11|STARTED|Phase 1b||0
295793|NCT00147537|723224|P10|STARTED|Phase 1b||0
295794|NCT00147537|723225|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
295795|NCT00147537|723226|P8|STARTED|Phase 1b||7
295796|NCT00147537|723227|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
295797|NCT00147537|723228|P6|STARTED|Phase 1b||3
295798|NCT00147537|723229|P5|STARTED|Phase 1b||3
295799|NCT00147537|723230|P4|STARTED|Phase 1b||3
295800|NCT00147537|723231|P3|STARTED|Phase 1b||4
295801|NCT00147537|723232|P2|STARTED|Phase 1b||2
295802|NCT00147537|723233|P1|STARTED|Phase 1b||3
295803|NCT00147498|723416|P4|NOT COMPLETED|Overall Study||17
295804|NCT00147498|723417|P3|NOT COMPLETED|Overall Study||17
295805|NCT00147498|723418|P2|NOT COMPLETED|Overall Study||9
295806|NCT00147498|723419|P1|NOT COMPLETED|Overall Study||3
295807|NCT00147498|723416|P4|COMPLETED|Overall Study||48
295808|NCT00147498|723417|P3|COMPLETED|Overall Study||52
295809|NCT00147498|723418|P2|COMPLETED|Overall Study||60
295810|NCT00147498|723419|P1|COMPLETED|Overall Study||58
295811|NCT00147498|723416|P4|STARTED|Overall Study||65
295812|NCT00147498|723417|P3|STARTED|Overall Study||69
295813|NCT00147498|723418|P2|STARTED|Overall Study||69
295814|NCT00147498|723419|P1|STARTED|Overall Study||61
295815|NCT00147446|723515|P2|NOT COMPLETED|Overall Study||0
295816|NCT00147446|723516|P1|NOT COMPLETED|Overall Study||0
295817|NCT00147446|723515|P2|COMPLETED|Overall Study||61
295818|NCT00147446|723516|P1|COMPLETED|Overall Study||60
295819|NCT00147446|723515|P2|STARTED|Overall Study||61
295820|NCT00147446|723516|P1|STARTED|Overall Study||60
295821|NCT00147316|723524|P1|NOT COMPLETED|Overall Study||0
295822|NCT00147316|723524|P1|COMPLETED|Overall Study||103
295823|NCT00147316|723524|P1|STARTED|Overall Study||103
295824|NCT00147290|723531|P2|NOT COMPLETED|Overall Study||0
295825|NCT00147290|723532|P1|NOT COMPLETED|Overall Study||0
295826|NCT00147290|723531|P2|COMPLETED|Overall Study||260
295827|NCT00147290|723532|P1|COMPLETED|Overall Study||266
295828|NCT00147290|723531|P2|STARTED|Overall Study||260
295829|NCT00147290|723532|P1|STARTED|Overall Study||266
295830|NCT00147277|723538|P2|NOT COMPLETED|Overall Study||0
295831|NCT00147277|723539|P1|NOT COMPLETED|Overall Study||0
295832|NCT00147277|723538|P2|COMPLETED|Overall Study||450
295833|NCT00147277|723539|P1|COMPLETED|Overall Study||475
295834|NCT00147277|723538|P2|STARTED|Overall Study||450
295835|NCT00147277|723539|P1|STARTED|Overall Study||475
295836|NCT00147238|723543|P1|NOT COMPLETED|Overall Study||8
295837|NCT00147238|723543|P1|COMPLETED|Overall Study||2
295838|NCT00147238|723543|P1|STARTED|Overall Study||10
295839|NCT00147225|723553|P6|NOT COMPLETED|Overall Study||2
295840|NCT00147225|723554|P5|NOT COMPLETED|Overall Study||1
295841|NCT00147225|723555|P4|NOT COMPLETED|Overall Study||1
295842|NCT00147225|723556|P3|NOT COMPLETED|Overall Study||2
295843|NCT00147225|723557|P2|NOT COMPLETED|Overall Study||0
295844|NCT00147225|723558|P1|NOT COMPLETED|Overall Study||1
295845|NCT00147225|723553|P6|COMPLETED|Overall Study||10
295846|NCT00147225|723554|P5|COMPLETED|Overall Study||10
295847|NCT00147225|723555|P4|COMPLETED|Overall Study||10
295848|NCT00147225|723556|P3|COMPLETED|Overall Study||6
295849|NCT00147225|723557|P2|COMPLETED|Overall Study||6
295850|NCT00147225|723558|P1|COMPLETED|Overall Study||6
295851|NCT00147225|723553|P6|STARTED|Overall Study||12
295852|NCT00147225|723554|P5|STARTED|Overall Study||11
295853|NCT00147225|723555|P4|STARTED|Overall Study||11
295854|NCT00147225|723556|P3|STARTED|Overall Study||8
295855|NCT00147225|723557|P2|STARTED|Overall Study||6
295856|NCT00147225|723558|P1|STARTED|Overall Study||7
295857|NCT00147212|723578|P1|NOT COMPLETED|Overall Study||0
295858|NCT00147212|723578|P1|COMPLETED|Overall Study||50
295859|NCT00147212|723578|P1|STARTED|Overall Study||50
295860|NCT00147199|723584|P2|NOT COMPLETED|Overall Study||10
295861|NCT00147199|723585|P1|NOT COMPLETED|Overall Study||13
295862|NCT00147199|723584|P2|COMPLETED|Overall Study||110
295863|NCT00147199|723585|P1|COMPLETED|Overall Study||102
295864|NCT00147199|723584|P2|STARTED|Overall Study||120
295865|NCT00147199|723585|P1|STARTED|Overall Study||115
295866|NCT00147030|723609|P2|NOT COMPLETED|Overall Study||0
295867|NCT00147030|723610|P1|NOT COMPLETED|Overall Study||0
295868|NCT00147030|723609|P2|COMPLETED|Overall Study||162
295869|NCT00147030|723610|P1|COMPLETED|Overall Study||163
295870|NCT00147030|723609|P2|STARTED|Overall Study||162
295871|NCT00147030|723610|P1|STARTED|Overall Study||163
295872|NCT00146848|723661|P3|NOT COMPLETED|Post-randomization||39
295873|NCT00146848|723662|P2|NOT COMPLETED|Post-randomization||47
295874|NCT00146848|723663|P1|NOT COMPLETED|Post-randomization||38
295875|NCT00146848|723661|P3|COMPLETED|Post-randomization||431
295876|NCT00146848|723662|P2|COMPLETED|Post-randomization||441
295877|NCT00146848|723663|P1|COMPLETED|Post-randomization||437
295878|NCT00146848|723661|P3|STARTED|Post-randomization||470
295879|NCT00146848|723662|P2|STARTED|Post-randomization||488
295880|NCT00146848|723663|P1|STARTED|Post-randomization||475
295881|NCT00146848|723661|P3|NOT COMPLETED|Pre-randomization||0
295882|NCT00146848|723662|P2|NOT COMPLETED|Pre-randomization||0
295883|NCT00146848|723663|P1|NOT COMPLETED|Pre-randomization||309
295884|NCT00146848|723661|P3|COMPLETED|Pre-randomization||0
295885|NCT00146848|723662|P2|COMPLETED|Pre-randomization||0
295886|NCT00146848|723663|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
295887|NCT00146848|723661|P3|STARTED|Pre-randomization||0
295888|NCT00146848|723662|P2|STARTED|Pre-randomization||0
295889|NCT00146848|723663|P1|STARTED|Pre-randomization|Registered|1742
295890|NCT00146770|723679|P2|NOT COMPLETED|Overall Study||0
295891|NCT00146770|723680|P1|NOT COMPLETED|Overall Study||5
295892|NCT00146770|723679|P2|COMPLETED|Overall Study||22
295893|NCT00146770|723680|P1|COMPLETED|Overall Study||18
295894|NCT00146770|723679|P2|STARTED|Overall Study||22
295895|NCT00146770|723680|P1|STARTED|Overall Study||23
295896|NCT00146757|723698|P2|NOT COMPLETED|Overall Study||0
295897|NCT00146757|723699|P1|NOT COMPLETED|Overall Study||2
295898|NCT00146757|723698|P2|COMPLETED|Overall Study||4
295899|NCT00146757|723699|P1|COMPLETED|Overall Study||14
295900|NCT00146757|723698|P2|STARTED|Overall Study||4
295901|NCT00146757|723699|P1|STARTED|Overall Study||16
295902|NCT00146640|723718|P2|NOT COMPLETED|Overall Study||14
295903|NCT00146640|723719|P1|NOT COMPLETED|Overall Study||23
295904|NCT00146640|723718|P2|COMPLETED|Overall Study||130
295905|NCT00146640|723719|P1|COMPLETED|Overall Study||121
295906|NCT00146640|723718|P2|STARTED|Overall Study||144
295907|NCT00146640|723719|P1|STARTED|Overall Study||144
295908|NCT00146328|723742|P3|NOT COMPLETED|Overall Study||291
295909|NCT00146328|723743|P2|NOT COMPLETED|Overall Study||154
295910|NCT00146328|723744|P1|NOT COMPLETED|Overall Study||141
295911|NCT00146328|723742|P3|COMPLETED|Overall Study||158
295912|NCT00146328|723743|P2|COMPLETED|Overall Study||101
295913|NCT00146328|723744|P1|COMPLETED|Overall Study||150
295914|NCT00146328|723742|P3|STARTED|Overall Study||449
295915|NCT00146328|723743|P2|STARTED|Overall Study||255
295916|NCT00146328|723744|P1|STARTED|Overall Study||291
295917|NCT00146172|723835|P8|NOT COMPLETED|Overall Study||40
295918|NCT00146172|723836|P7|NOT COMPLETED|Overall Study||6
295919|NCT00146172|723837|P6|NOT COMPLETED|Overall Study||7
295920|NCT00146172|723838|P5|NOT COMPLETED|Overall Study||3
295921|NCT00146172|723839|P4|NOT COMPLETED|Overall Study||6
295922|NCT00146172|723840|P3|NOT COMPLETED|Overall Study||4
295923|NCT00146172|723841|P2|NOT COMPLETED|Overall Study||4
295924|NCT00146172|723842|P1|NOT COMPLETED|Overall Study||3
295925|NCT00146172|723835|P8|COMPLETED|Overall Study||0
295926|NCT00146172|723836|P7|COMPLETED|Overall Study||0
295927|NCT00146172|723837|P6|COMPLETED|Overall Study||0
295928|NCT00146172|723838|P5|COMPLETED|Overall Study||0
295929|NCT00146172|723839|P4|COMPLETED|Overall Study||0
295930|NCT00146172|723840|P3|COMPLETED|Overall Study||0
295931|NCT00146172|723841|P2|COMPLETED|Overall Study||0
295932|NCT00146172|723842|P1|COMPLETED|Overall Study||0
295933|NCT00146172|723835|P8|Received Drug|Overall Study||39
295934|NCT00146172|723836|P7|Received Drug|Overall Study||6
295935|NCT00146172|723837|P6|Received Drug|Overall Study||7
295936|NCT00146172|723838|P5|Received Drug|Overall Study||3
295937|NCT00146172|723839|P4|Received Drug|Overall Study||6
295938|NCT00146172|723840|P3|Received Drug|Overall Study||4
295939|NCT00146172|723841|P2|Received Drug|Overall Study||4
295940|NCT00146172|723842|P1|Received Drug|Overall Study||3
295941|NCT00146172|723835|P8|STARTED|Overall Study||40
295942|NCT00146172|723836|P7|STARTED|Overall Study||6
295943|NCT00146172|723837|P6|STARTED|Overall Study||7
295944|NCT00146172|723838|P5|STARTED|Overall Study||3
295945|NCT00146172|723839|P4|STARTED|Overall Study||6
295946|NCT00146172|723840|P3|STARTED|Overall Study||4
295947|NCT00146172|723841|P2|STARTED|Overall Study||4
295948|NCT00146172|723842|P1|STARTED|Overall Study||3
295949|NCT00145795|723876|P2|NOT COMPLETED|Overall Study||0
295950|NCT00145795|723877|P1|NOT COMPLETED|Overall Study||1
295951|NCT00145795|723876|P2|COMPLETED|Overall Study||10
295952|NCT00145795|723877|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
295953|NCT00145795|723876|P2|STARTED|Overall Study||10
295954|NCT00145795|723877|P1|STARTED|Overall Study||10
295955|NCT00145704|723903|P2|NOT COMPLETED|Overall Study||3
295956|NCT00145704|723904|P1|NOT COMPLETED|Overall Study||3
295957|NCT00145704|723903|P2|COMPLETED|Overall Study||0
295958|NCT00145704|723904|P1|COMPLETED|Overall Study||0
295959|NCT00145704|723903|P2|STARTED|Overall Study||3
295960|NCT00145704|723904|P1|STARTED|Overall Study||3
295961|NCT00145626|723912|P1|NOT COMPLETED|Overall Study||5
295962|NCT00145626|723912|P1|COMPLETED|Overall Study||14
295963|NCT00145626|723912|P1|STARTED|Overall Study||19
295964|NCT00145600|723958|P4|NOT COMPLETED|Overall Study||16
295965|NCT00145600|723959|P3|NOT COMPLETED|Overall Study||5
295966|NCT00145600|723960|P2|NOT COMPLETED|Overall Study||10
295967|NCT00145600|723961|P1|NOT COMPLETED|Overall Study||8
295968|NCT00145600|723958|P4|COMPLETED|Overall Study||130
295969|NCT00145600|723959|P3|COMPLETED|Overall Study||8
295970|NCT00145600|723960|P2|COMPLETED|Overall Study||36
295971|NCT00145600|723961|P1|COMPLETED|Overall Study||83
295972|NCT00145600|723958|P4|STARTED|Overall Study||146
295973|NCT00145600|723959|P3|STARTED|Overall Study||13
295974|NCT00145600|723960|P2|STARTED|Overall Study||46
295975|NCT00145600|723961|P1|STARTED|Overall Study||91
295976|NCT00145587|724075|P2|NOT COMPLETED|Overall Study||0
295977|NCT00145587|724076|P1|NOT COMPLETED|Overall Study||0
295978|NCT00145587|724075|P2|COMPLETED|Overall Study||1
295979|NCT00145587|724076|P1|COMPLETED|Overall Study||5
295980|NCT00145587|724075|P2|STARTED|Overall Study||1
295981|NCT00145587|724076|P1|STARTED|Overall Study||5
295982|NCT00145574|724085|P3|NOT COMPLETED|Open Label Long-term Extension||11
295983|NCT00145574|724086|P2|NOT COMPLETED|Open Label Long-term Extension||0
295984|NCT00145574|724087|P1|NOT COMPLETED|Open Label Long-term Extension||0
295985|NCT00145574|724085|P3|COMPLETED|Open Label Long-term Extension||173
295986|NCT00145574|724086|P2|COMPLETED|Open Label Long-term Extension||0
295987|NCT00145574|724087|P1|COMPLETED|Open Label Long-term Extension||0
295988|NCT00145574|724085|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
295989|NCT00145574|724086|P2|STARTED|Open Label Long-term Extension||0
295990|NCT00145574|724087|P1|STARTED|Open Label Long-term Extension||0
295991|NCT00145574|724085|P3|NOT COMPLETED|Double Blind||2
295992|NCT00145574|724086|P2|NOT COMPLETED|Double Blind||5
295993|NCT00145574|724087|P1|NOT COMPLETED|Double Blind||1
295994|NCT00145574|724085|P3|COMPLETED|Double Blind||62
295995|NCT00145574|724086|P2|COMPLETED|Double Blind||60
295996|NCT00145574|724087|P1|COMPLETED|Double Blind||64
295997|NCT00145574|724085|P3|STARTED|Double Blind||64
295998|NCT00145574|724086|P2|STARTED|Double Blind||65
295999|NCT00145574|724087|P1|STARTED|Double Blind||65
296000|NCT00145509|724144|P2|NOT COMPLETED|Overall Study||21
296001|NCT00145509|724145|P1|NOT COMPLETED|Overall Study||22
296002|NCT00145509|724144|P2|COMPLETED|Overall Study||15
296003|NCT00145509|724145|P1|COMPLETED|Overall Study||19
296004|NCT00145509|724144|P2|STARTED|Overall Study||36
296005|NCT00145509|724145|P1|STARTED|Overall Study||41
296006|NCT00145496|724159|P2|NOT COMPLETED|Overall Study||81
296007|NCT00145496|724160|P1|NOT COMPLETED|Overall Study||123
296008|NCT00145496|724159|P2|COMPLETED|Overall Study||143
296009|NCT00145496|724160|P1|COMPLETED|Overall Study||121
296010|NCT00145496|724159|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
296011|NCT00145496|724160|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
296012|NCT00145418|724170|P1|NOT COMPLETED|Overall Study||0
296013|NCT00145418|724170|P1|COMPLETED|Overall Study||15
296014|NCT00145418|724170|P1|STARTED|Overall Study||15
296015|NCT00145327|724180|P3|NOT COMPLETED|Overall Study||248
296016|NCT00145327|724181|P2|NOT COMPLETED|Overall Study||124
296017|NCT00145327|724182|P1|NOT COMPLETED|Overall Study||142
296018|NCT00145327|724180|P3|COMPLETED|Overall Study||975
296019|NCT00145327|724181|P2|COMPLETED|Overall Study||493
296020|NCT00145327|724182|P1|COMPLETED|Overall Study||474
296021|NCT00145327|724180|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
296022|NCT00145327|724181|P2|STARTED|Overall Study||617
296023|NCT00145327|724182|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
296024|NCT00145249|724238|P3|NOT COMPLETED|Overall Study||17
296025|NCT00145249|724239|P2|NOT COMPLETED|Overall Study||15
296026|NCT00145249|724240|P1|NOT COMPLETED|Overall Study||11
296027|NCT00145249|724238|P3|COMPLETED|Overall Study||31
296028|NCT00145249|724239|P2|COMPLETED|Overall Study||33
296029|NCT00145249|724240|P1|COMPLETED|Overall Study||36
296030|NCT00145249|724238|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
296031|NCT00145249|724239|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
296032|NCT00145249|724240|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
296033|NCT00145119|724281|P1|NOT COMPLETED|Overall Study||45
296034|NCT00145119|724281|P1|COMPLETED|Overall Study||267
296035|NCT00145119|724281|P1|STARTED|Overall Study||312
296036|NCT00145041|724285|P1|NOT COMPLETED|Overall Study||0
296037|NCT00145041|724285|P1|COMPLETED|Overall Study||7
296038|NCT00145041|724285|P1|STARTED|Overall Study||7
296039|NCT00144963|724291|P1|NOT COMPLETED|Overall Study||0
296040|NCT00144963|724291|P1|COMPLETED|Overall Study||36
296041|NCT00144963|724291|P1|STARTED|Overall Study||36
296042|NCT00144781|724299|P4|NOT COMPLETED|Overall Study||0
296043|NCT00144781|724300|P3|NOT COMPLETED|Overall Study||0
296044|NCT00144781|724301|P2|NOT COMPLETED|Overall Study||2
296045|NCT00144781|724302|P1|NOT COMPLETED|Overall Study||0
296046|NCT00144781|724299|P4|COMPLETED|Overall Study||9
296047|NCT00144781|724300|P3|COMPLETED|Overall Study||8
296048|NCT00144781|724301|P2|COMPLETED|Overall Study||7
296049|NCT00144781|724302|P1|COMPLETED|Overall Study||8
296050|NCT00144781|724299|P4|STARTED|Overall Study||9
296051|NCT00144781|724300|P3|STARTED|Overall Study||8
296052|NCT00144781|724301|P2|STARTED|Overall Study||9
296053|NCT00144781|724302|P1|STARTED|Overall Study||8
296054|NCT00144391|724322|P2|NOT COMPLETED|Overall Study||0
296055|NCT00144391|724323|P1|NOT COMPLETED|Overall Study||0
296056|NCT00144391|724322|P2|COMPLETED|Overall Study||9
296057|NCT00144391|724323|P1|COMPLETED|Overall Study||11
296058|NCT00144391|724322|P2|STARTED|Overall Study||9
296059|NCT00144391|724323|P1|STARTED|Overall Study||11
296060|NCT00144339|724331|P2|NOT COMPLETED|Overall Study||1099
296061|NCT00144339|724332|P1|NOT COMPLETED|Overall Study||1358
296062|NCT00144339|724331|P2|COMPLETED|Overall Study||1887
296063|NCT00144339|724332|P1|COMPLETED|Overall Study||1648
296064|NCT00144339|724331|P2|STARTED|Overall Study||2986
296065|NCT00144339|724332|P1|STARTED|Overall Study||3006
296066|NCT00144300|724540|P2|NOT COMPLETED|Overall Study||28
296067|NCT00144300|724541|P1|NOT COMPLETED|Overall Study||29
296068|NCT00144300|724540|P2|COMPLETED|Overall Study||97
296069|NCT00144300|724541|P1|COMPLETED|Overall Study||92
296070|NCT00144300|724540|P2|STARTED|Overall Study||125
296071|NCT00144300|724541|P1|STARTED|Overall Study||121
296072|NCT00144170|724589|P2|NOT COMPLETED|Overall Study||396
296073|NCT00144170|724590|P1|NOT COMPLETED|Overall Study||352
296074|NCT00144170|724589|P2|COMPLETED|Overall Study||32
296075|NCT00144170|724590|P1|COMPLETED|Overall Study||86
296076|NCT00144170|724589|P2|STARTED|Overall Study||428
296077|NCT00144170|724590|P1|STARTED|Overall Study||438
296078|NCT00144027|724780|P2|NOT COMPLETED|Overall Study||11
296079|NCT00144027|724781|P1|NOT COMPLETED|Overall Study||3
296080|NCT00144027|724780|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
296081|NCT00144027|724781|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
296082|NCT00144027|724780|P2|Completed 6 Month Assessment|Overall Study||24
296083|NCT00144027|724781|P1|Completed 6 Month Assessment|Overall Study||37
296084|NCT00144027|724780|P2|Completed Baseline Assessment|Overall Study||29
296085|NCT00144027|724781|P1|Completed Baseline Assessment|Overall Study||39
296086|NCT00144027|724780|P2|STARTED|Overall Study|participants who consented|36
296087|NCT00144027|724781|P1|STARTED|Overall Study|participants who consented|39
296088|NCT00143845|724787|P1|NOT COMPLETED|Overall Study||0
296089|NCT00143845|724787|P1|COMPLETED|Overall Study||54
296090|NCT00143845|724787|P1|STARTED|Overall Study||54
296091|NCT00143819|724795|P2|NOT COMPLETED|Overall Study||3
296092|NCT00143819|724796|P1|NOT COMPLETED|Overall Study||2
296093|NCT00143819|724795|P2|COMPLETED|Overall Study||5
296094|NCT00143819|724796|P1|COMPLETED|Overall Study||3
296095|NCT00143819|724795|P2|STARTED|Overall Study||8
296096|NCT00143819|724796|P1|STARTED|Overall Study||5
296097|NCT00143598|724811|P2|NOT COMPLETED|Overall Study||94
296098|NCT00143598|724812|P1|NOT COMPLETED|Overall Study||92
296099|NCT00143598|724811|P2|COMPLETED|Overall Study||302
296100|NCT00143598|724812|P1|COMPLETED|Overall Study||318
296101|NCT00143598|724811|P2|STARTED|Overall Study||396
296102|NCT00143598|724812|P1|STARTED|Overall Study||410
296103|NCT00143507|724826|P2|NOT COMPLETED|Overall Study||652
296104|NCT00143507|724827|P1|NOT COMPLETED|Overall Study||687
296105|NCT00143507|724826|P2|COMPLETED|Overall Study||4786
296106|NCT00143507|724827|P1|COMPLETED|Overall Study||4792
296107|NCT00143507|724826|P2|STARTED|Overall Study||5438
296108|NCT00143507|724827|P1|STARTED|Overall Study||5479
296109|NCT00143455|724861|P4|NOT COMPLETED|Cohort 2||93
296110|NCT00143455|724862|P3|NOT COMPLETED|Cohort 2||106
296111|NCT00143455|724863|P2|NOT COMPLETED|Cohort 2||0
296112|NCT00143455|724864|P1|NOT COMPLETED|Cohort 2||0
296113|NCT00143455|724861|P4|COMPLETED|Cohort 2||111
296114|NCT00143455|724862|P3|COMPLETED|Cohort 2||97
296115|NCT00143455|724863|P2|COMPLETED|Cohort 2||0
296116|NCT00143455|724864|P1|COMPLETED|Cohort 2||0
296117|NCT00143455|724861|P4|Received Treatment|Cohort 2||203
296118|NCT00143455|724862|P3|Received Treatment|Cohort 2||202
296119|NCT00143455|724863|P2|Received Treatment|Cohort 2||0
296120|NCT00143455|724864|P1|Received Treatment|Cohort 2||0
296121|NCT00143455|724861|P4|STARTED|Cohort 2||204
296122|NCT00143455|724862|P3|STARTED|Cohort 2||203
296123|NCT00143455|724863|P2|STARTED|Cohort 2||0
296124|NCT00143455|724864|P1|STARTED|Cohort 2||0
296125|NCT00143455|724861|P4|NOT COMPLETED|Cohort 1||0
296126|NCT00143455|724862|P3|NOT COMPLETED|Cohort 1||0
296127|NCT00143455|724863|P2|NOT COMPLETED|Cohort 1||17
296128|NCT00143455|724864|P1|NOT COMPLETED|Cohort 1||14
296129|NCT00143455|724861|P4|COMPLETED|Cohort 1||0
296130|NCT00143455|724862|P3|COMPLETED|Cohort 1||0
296131|NCT00143455|724863|P2|COMPLETED|Cohort 1||22
296132|NCT00143455|724864|P1|COMPLETED|Cohort 1||25
296133|NCT00143455|724861|P4|Received Treatment|Cohort 1||0
296134|NCT00143455|724862|P3|Received Treatment|Cohort 1||0
296135|NCT00143455|724863|P2|Received Treatment|Cohort 1||38
296136|NCT00143455|724864|P1|Received Treatment|Cohort 1||39
296137|NCT00143455|724861|P4|STARTED|Cohort 1||0
296138|NCT00143455|724862|P3|STARTED|Cohort 1||0
296139|NCT00143455|724863|P2|STARTED|Cohort 1||39
296140|NCT00143455|724864|P1|STARTED|Cohort 1||39
296141|NCT00143403|724898|P2|NOT COMPLETED|Overall Study||46
296142|NCT00143403|724899|P1|NOT COMPLETED|Overall Study||35
296143|NCT00143403|724898|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
296144|NCT00143403|724899|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
296145|NCT00143403|724898|P2|Treated|Overall Study||153
296146|NCT00143403|724899|P1|Treated|Overall Study||153
296147|NCT00143403|724898|P2|STARTED|Overall Study||161
296148|NCT00143403|724899|P1|STARTED|Overall Study||160
296149|NCT00143390|724909|P2|NOT COMPLETED|Overall Study||149
296150|NCT00143390|724910|P1|NOT COMPLETED|Overall Study||149
296151|NCT00143390|724909|P2|COMPLETED|Overall Study||0
296152|NCT00143390|724910|P1|COMPLETED|Overall Study||0
296153|NCT00143390|724909|P2|STARTED|Overall Study||149
296154|NCT00143390|724910|P1|STARTED|Overall Study||149
296155|NCT00143312|724926|P1|NOT COMPLETED|Overall Study||16
296156|NCT00143312|724926|P1|COMPLETED|Overall Study||29
296157|NCT00143312|724926|P1|STARTED|Overall Study||45
296158|NCT00143247|724936|P1|NOT COMPLETED|Overall Study||156
296159|NCT00143247|724936|P1|COMPLETED|Overall Study||17
296160|NCT00143247|724936|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
296161|NCT00142935|724953|P3|NOT COMPLETED|Overall Study||7
296162|NCT00142935|724954|P2|NOT COMPLETED|Overall Study||8
296163|NCT00142935|724955|P1|NOT COMPLETED|Overall Study||3
296164|NCT00142935|724953|P3|COMPLETED|Overall Study||23
296165|NCT00142935|724954|P2|COMPLETED|Overall Study||20
296166|NCT00142935|724955|P1|COMPLETED|Overall Study||26
296167|NCT00142935|724953|P3|STARTED|Overall Study||30
296168|NCT00142935|724954|P2|STARTED|Overall Study||28
296169|NCT00142935|724955|P1|STARTED|Overall Study||29
296170|NCT00142909|724980|P2|NOT COMPLETED|Medications Begin||3
296171|NCT00142909|724981|P1|NOT COMPLETED|Medications Begin||9
296172|NCT00142909|724980|P2|COMPLETED|Medications Begin||31
296173|NCT00142909|724981|P1|COMPLETED|Medications Begin||26
296174|NCT00142909|724980|P2|STARTED|Medications Begin||34
296175|NCT00142909|724981|P1|STARTED|Medications Begin||35
296176|NCT00142909|724980|P2|NOT COMPLETED|Randomization||10
296177|NCT00142909|724981|P1|NOT COMPLETED|Randomization||7
296178|NCT00142909|724980|P2|COMPLETED|Randomization||34
296179|NCT00142909|724981|P1|COMPLETED|Randomization||35
296180|NCT00142909|724980|P2|STARTED|Randomization||44
296181|NCT00142909|724981|P1|STARTED|Randomization||42
296182|NCT00142818|725001|P4|NOT COMPLETED|Overall Study||22
296183|NCT00142818|725002|P3|NOT COMPLETED|Overall Study||13
296184|NCT00142818|725003|P2|NOT COMPLETED|Overall Study||21
296185|NCT00142818|725004|P1|NOT COMPLETED|Overall Study||17
296186|NCT00142818|725001|P4|COMPLETED|Overall Study||20
296187|NCT00142818|725002|P3|COMPLETED|Overall Study||24
296188|NCT00142818|725003|P2|COMPLETED|Overall Study||19
296189|NCT00142818|725004|P1|COMPLETED|Overall Study||28
296190|NCT00142818|725001|P4|STARTED|Overall Study||42
296191|NCT00142818|725002|P3|STARTED|Overall Study||37
296192|NCT00142818|725003|P2|STARTED|Overall Study||40
296193|NCT00142818|725004|P1|STARTED|Overall Study||45
296194|NCT00142792|725017|P3|NOT COMPLETED|Overall Study||12
296195|NCT00142792|725018|P2|NOT COMPLETED|Overall Study||15
296196|NCT00142792|725019|P1|NOT COMPLETED|Overall Study||12
296197|NCT00142792|725017|P3|COMPLETED|Overall Study||30
296198|NCT00142792|725018|P2|COMPLETED|Overall Study||26
296199|NCT00142792|725019|P1|COMPLETED|Overall Study||27
296200|NCT00142792|725017|P3|Completed Intervention|Overall Study||37
296201|NCT00142792|725018|P2|Completed Intervention|Overall Study||37
296202|NCT00142792|725019|P1|Completed Intervention|Overall Study||35
296203|NCT00142792|725017|P3|STARTED|Overall Study||42
296204|NCT00142792|725018|P2|STARTED|Overall Study||41
296205|NCT00142792|725019|P1|STARTED|Overall Study||39
296206|NCT00142597|725032|P2|NOT COMPLETED|Overall Study||1
296207|NCT00142597|725033|P1|NOT COMPLETED|Overall Study||3
296208|NCT00142597|725032|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
296209|NCT00142597|725033|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
296210|NCT00142597|725032|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
296211|NCT00142597|725033|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
296212|NCT00142506|725041|P2|NOT COMPLETED|Overall Study||29
296213|NCT00142506|725042|P1|NOT COMPLETED|Overall Study||72
296214|NCT00142506|725041|P2|COMPLETED|Overall Study||77
296215|NCT00142506|725042|P1|COMPLETED|Overall Study||112
296216|NCT00142506|725041|P2|STARTED|Overall Study||106
296217|NCT00142506|725042|P1|STARTED|Overall Study||184
296218|NCT00142415|725054|P6|NOT COMPLETED|Overall Study||2
296219|NCT00142415|725055|P5|NOT COMPLETED|Overall Study||1
296220|NCT00142415|725056|P4|NOT COMPLETED|Overall Study||0
296221|NCT00142415|725057|P3|NOT COMPLETED|Overall Study||0
296222|NCT00142415|725058|P2|NOT COMPLETED|Overall Study||0
296223|NCT00142415|725059|P1|NOT COMPLETED|Overall Study||0
296224|NCT00142415|725054|P6|COMPLETED|Overall Study||6
296225|NCT00142415|725055|P5|COMPLETED|Overall Study||2
296226|NCT00142415|725056|P4|COMPLETED|Overall Study||3
296227|NCT00142415|725057|P3|COMPLETED|Overall Study||6
296228|NCT00142415|725058|P2|COMPLETED|Overall Study||3
296229|NCT00142415|725059|P1|COMPLETED|Overall Study||3
296230|NCT00142415|725054|P6|STARTED|Overall Study||8
296231|NCT00142415|725055|P5|STARTED|Overall Study||3
296232|NCT00142415|725056|P4|STARTED|Overall Study||3
296233|NCT00142415|725057|P3|STARTED|Overall Study||6
296234|NCT00142415|725058|P2|STARTED|Overall Study||3
296235|NCT00142415|725059|P1|STARTED|Overall Study||3
296236|NCT00142298|725097|P10|NOT COMPLETED|Overall Study||0
296237|NCT00142298|725098|P9|NOT COMPLETED|Overall Study||5
296238|NCT00142298|725099|P8|NOT COMPLETED|Overall Study||8
296239|NCT00142298|725100|P7|NOT COMPLETED|Overall Study||8
296240|NCT00142298|725101|P6|NOT COMPLETED|Overall Study||16
296241|NCT00142298|725102|P5|NOT COMPLETED|Overall Study||10
296242|NCT00142298|725103|P4|NOT COMPLETED|Overall Study||85
296243|NCT00142298|725104|P3|NOT COMPLETED|Overall Study||33
296244|NCT00142298|725105|P2|NOT COMPLETED|Overall Study||176
296245|NCT00142298|725106|P1|NOT COMPLETED|Overall Study||160
296246|NCT00142298|725097|P10|COMPLETED|Overall Study||13
296247|NCT00142298|725098|P9|COMPLETED|Overall Study||52
296248|NCT00142298|725099|P8|COMPLETED|Overall Study||58
296249|NCT00142298|725100|P7|COMPLETED|Overall Study||15
296250|NCT00142298|725101|P6|COMPLETED|Overall Study||10
296251|NCT00142298|725102|P5|COMPLETED|Overall Study||46
296252|NCT00142298|725103|P4|COMPLETED|Overall Study||121
296253|NCT00142298|725104|P3|COMPLETED|Overall Study||90
296254|NCT00142298|725105|P2|COMPLETED|Overall Study||456
296255|NCT00142298|725106|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
296256|NCT00142298|725097|P10|Per Protocol Population|Overall Study||13
296257|NCT00142298|725098|P9|Per Protocol Population|Overall Study||56
296258|NCT00142298|725099|P8|Per Protocol Population|Overall Study||64
296259|NCT00142298|725100|P7|Per Protocol Population|Overall Study||19
296260|NCT00142298|725101|P6|Per Protocol Population|Overall Study||25
296261|NCT00142298|725102|P5|Per Protocol Population|Overall Study||50
296262|NCT00142298|725103|P4|Per Protocol Population|Overall Study||202
296263|NCT00142298|725104|P3|Per Protocol Population|Overall Study||120
296264|NCT00142298|725105|P2|Per Protocol Population|Overall Study||606
296265|NCT00142298|725106|P1|Per Protocol Population|Overall Study||635
296266|NCT00142298|725097|P10|Safety Population|Overall Study||13
296267|NCT00142298|725098|P9|Safety Population|Overall Study||57
296268|NCT00142298|725099|P8|Safety Population|Overall Study||66
296269|NCT00142298|725100|P7|Safety Population|Overall Study||23
296270|NCT00142298|725101|P6|Safety Population|Overall Study||26
296271|NCT00142298|725102|P5|Safety Population|Overall Study||50
296272|NCT00142298|725103|P4|Safety Population|Overall Study||206
296273|NCT00142298|725104|P3|Safety Population|Overall Study||122
296274|NCT00142298|725105|P2|Safety Population|Overall Study||626
296275|NCT00142298|725106|P1|Safety Population|Overall Study||655
296276|NCT00142298|725097|P10|STARTED|Overall Study||13
296277|NCT00142298|725098|P9|STARTED|Overall Study||57
296278|NCT00142298|725099|P8|STARTED|Overall Study||66
296279|NCT00142298|725100|P7|STARTED|Overall Study||23
296280|NCT00142298|725101|P6|STARTED|Overall Study||26
296281|NCT00142298|725102|P5|STARTED|Overall Study||56
296282|NCT00142298|725103|P4|STARTED|Overall Study||206
296283|NCT00142298|725104|P3|STARTED|Overall Study||123
296284|NCT00142298|725105|P2|STARTED|Overall Study||632
296285|NCT00142298|725106|P1|STARTED|Overall Study||667
296286|NCT00142168|725128|P1|NOT COMPLETED|Overall Study||0
296287|NCT00142168|725128|P1|COMPLETED|Overall Study||16
296288|NCT00142168|725128|P1|STARTED|Overall Study||16
296289|NCT00142116|725135|P1|NOT COMPLETED|Overall Study||0
296290|NCT00142116|725135|P1|COMPLETED|Overall Study||25
296291|NCT00142116|725135|P1|STARTED|Overall Study||25
296292|NCT00141921|725140|P1|NOT COMPLETED|Overall Study||141
296293|NCT00141921|725140|P1|COMPLETED|Overall Study||41
296294|NCT00141921|725140|P1|Received Treatment|Overall Study||181
296295|NCT00141921|725140|P1|STARTED|Overall Study||182
296296|NCT00141817|725166|P4|NOT COMPLETED|Overall Study||0
296297|NCT00141817|725167|P3|NOT COMPLETED|Overall Study||1
296298|NCT00141817|725168|P2|NOT COMPLETED|Overall Study||0
296299|NCT00141817|725169|P1|NOT COMPLETED|Overall Study||1
296300|NCT00141817|725166|P4|COMPLETED|Overall Study||13
296301|NCT00141817|725167|P3|COMPLETED|Overall Study||10
296302|NCT00141817|725168|P2|COMPLETED|Overall Study||10
296303|NCT00141817|725169|P1|COMPLETED|Overall Study||6
296304|NCT00141817|725166|P4|STARTED|Overall Study||13
296305|NCT00141817|725167|P3|STARTED|Overall Study||11
296306|NCT00141817|725168|P2|STARTED|Overall Study||10
296307|NCT00141817|725169|P1|STARTED|Overall Study||7
296308|NCT00141778|725210|P3|NOT COMPLETED|Started Study Medication||4
296309|NCT00141778|725211|P2|NOT COMPLETED|Started Study Medication||7
296310|NCT00141778|725212|P1|NOT COMPLETED|Started Study Medication||2
296311|NCT00141778|725210|P3|COMPLETED|Started Study Medication||143
296312|NCT00141778|725211|P2|COMPLETED|Started Study Medication||144
296313|NCT00141778|725212|P1|COMPLETED|Started Study Medication||145
296314|NCT00141778|725210|P3|STARTED|Started Study Medication||147
296315|NCT00141778|725211|P2|STARTED|Started Study Medication||151
296316|NCT00141778|725212|P1|STARTED|Started Study Medication||147
296317|NCT00141778|725210|P3|NOT COMPLETED|Randomization Prior to Study Med||6
296318|NCT00141778|725211|P2|NOT COMPLETED|Randomization Prior to Study Med||2
296319|NCT00141778|725212|P1|NOT COMPLETED|Randomization Prior to Study Med||5
296320|NCT00141778|725210|P3|COMPLETED|Randomization Prior to Study Med||147
296321|NCT00141778|725211|P2|COMPLETED|Randomization Prior to Study Med||151
296322|NCT00141778|725212|P1|COMPLETED|Randomization Prior to Study Med||147
296323|NCT00141778|725210|P3|STARTED|Randomization Prior to Study Med||153
296324|NCT00141778|725211|P2|STARTED|Randomization Prior to Study Med||153
296325|NCT00141778|725212|P1|STARTED|Randomization Prior to Study Med||152
296326|NCT00141765|725250|P1|NOT COMPLETED|Overall Study||0
296327|NCT00141765|725250|P1|COMPLETED|Overall Study||25
296328|NCT00141765|725250|P1|STARTED|Overall Study||25
296329|NCT00141739|725254|P1|NOT COMPLETED|Overall Study||0
296330|NCT00141739|725254|P1|COMPLETED|Overall Study||100
296331|NCT00141739|725254|P1|STARTED|Overall Study|Number of evaluable patients|100
296332|NCT00141726|725265|P1|NOT COMPLETED|Overall Study||3
296333|NCT00141726|725265|P1|COMPLETED|Overall Study||31
296334|NCT00141726|725265|P1|STARTED|Overall Study||34
296335|NCT00141518|725273|P3|NOT COMPLETED|Overall Study||6
296336|NCT00141518|725274|P2|NOT COMPLETED|Overall Study||6
296337|NCT00141518|725275|P1|NOT COMPLETED|Overall Study||16
296338|NCT00141518|725273|P3|COMPLETED|Overall Study||12
296339|NCT00141518|725274|P2|COMPLETED|Overall Study||16
296340|NCT00141518|725275|P1|COMPLETED|Overall Study||21
296341|NCT00141518|725273|P3|Full Analysis Sample|Overall Study||18
296342|NCT00141518|725274|P2|Full Analysis Sample|Overall Study||22
296343|NCT00141518|725275|P1|Full Analysis Sample|Overall Study||27
296344|NCT00141518|725273|P3|Safety Sample|Overall Study||18
296345|NCT00141518|725274|P2|Safety Sample|Overall Study||22
296346|NCT00141518|725275|P1|Safety Sample|Overall Study||36
296347|NCT00141518|725273|P3|STARTED|Overall Study||18
296348|NCT00141518|725274|P2|STARTED|Overall Study||22
296349|NCT00141518|725275|P1|STARTED|Overall Study||37
296350|NCT00141453|725464|P2|NOT COMPLETED|Overall Study||5
296351|NCT00141453|725465|P1|NOT COMPLETED|Overall Study||6
296352|NCT00141453|725464|P2|COMPLETED|Overall Study||284
296353|NCT00141453|725465|P1|COMPLETED|Overall Study||282
296354|NCT00141453|725464|P2|STARTED|Overall Study||289
296355|NCT00141453|725465|P1|STARTED|Overall Study||288
296356|NCT00141297|725479|P10|NOT COMPLETED|Overall Study||6
296357|NCT00141297|725480|P9|NOT COMPLETED|Overall Study||20
296358|NCT00141297|725481|P8|NOT COMPLETED|Overall Study||4
296359|NCT00141297|725482|P7|NOT COMPLETED|Overall Study||3
296360|NCT00141297|725483|P6|NOT COMPLETED|Overall Study||3
296361|NCT00141297|725484|P5|NOT COMPLETED|Overall Study||22
296362|NCT00141297|725485|P4|NOT COMPLETED|Overall Study||3
296363|NCT00141297|725486|P3|NOT COMPLETED|Overall Study||7
296364|NCT00141297|725487|P2|NOT COMPLETED|Overall Study||3
296365|NCT00141297|725488|P1|NOT COMPLETED|Overall Study||3
296366|NCT00141297|725479|P10|COMPLETED|Overall Study||0
296367|NCT00141297|725480|P9|COMPLETED|Overall Study||0
296368|NCT00141297|725481|P8|COMPLETED|Overall Study||0
296369|NCT00141297|725482|P7|COMPLETED|Overall Study||0
296370|NCT00141297|725483|P6|COMPLETED|Overall Study||0
296371|NCT00141297|725484|P5|COMPLETED|Overall Study||0
296372|NCT00141297|725485|P4|COMPLETED|Overall Study||0
296373|NCT00141297|725486|P3|COMPLETED|Overall Study||0
296374|NCT00141297|725487|P2|COMPLETED|Overall Study||0
296375|NCT00141297|725488|P1|COMPLETED|Overall Study||0
296376|NCT00141297|725479|P10|STARTED|Overall Study||6
296377|NCT00141297|725480|P9|STARTED|Overall Study||20
296378|NCT00141297|725481|P8|STARTED|Overall Study||4
296379|NCT00141297|725482|P7|STARTED|Overall Study||3
296380|NCT00141297|725483|P6|STARTED|Overall Study||3
296381|NCT00141297|725484|P5|STARTED|Overall Study||22
296382|NCT00141297|725485|P4|STARTED|Overall Study||3
296383|NCT00141297|725486|P3|STARTED|Overall Study||7
296384|NCT00141297|725487|P2|STARTED|Overall Study||3
296385|NCT00141297|725488|P1|STARTED|Overall Study||3
296386|NCT00141271|725766|P3|NOT COMPLETED|Overall Study||57
296387|NCT00141271|725767|P2|NOT COMPLETED|Overall Study||63
296388|NCT00141271|725768|P1|NOT COMPLETED|Overall Study||80
296389|NCT00141271|725766|P3|COMPLETED|Overall Study||111
296390|NCT00141271|725767|P2|COMPLETED|Overall Study||102
296391|NCT00141271|725768|P1|COMPLETED|Overall Study||91
296392|NCT00141271|725766|P3|STARTED|Overall Study||168
296393|NCT00141271|725767|P2|STARTED|Overall Study||165
296394|NCT00141271|725768|P1|STARTED|Overall Study||171
296395|NCT00141219|725889|P2|NOT COMPLETED|Overall Study||16
296396|NCT00141219|725890|P1|NOT COMPLETED|Overall Study||24
296397|NCT00141219|725889|P2|COMPLETED|Overall Study||62
296398|NCT00141219|725890|P1|COMPLETED|Overall Study||138
296399|NCT00141219|725889|P2|STARTED|Overall Study||78
296400|NCT00141219|725890|P1|STARTED|Overall Study||162
296401|NCT00141115|725940|P1|NOT COMPLETED|Overall Study||1
296402|NCT00141115|725940|P1|COMPLETED|Overall Study||2
296403|NCT00141115|725940|P1|STARTED|Overall Study||3
296404|NCT00141102|725946|P2|NOT COMPLETED|Overall Study||625
296405|NCT00141102|725947|P1|NOT COMPLETED|Overall Study||508
296406|NCT00141102|725946|P2|COMPLETED|Overall Study||1621
296407|NCT00141102|725947|P1|COMPLETED|Overall Study||1730
296408|NCT00141102|725946|P2|Received Treatment|Overall Study||2237
296409|NCT00141102|725947|P1|Received Treatment|Overall Study||2223
296410|NCT00141102|725946|P2|STARTED|Overall Study||2246
296411|NCT00141102|725947|P1|STARTED|Overall Study||2238
296412|NCT00141037|725987|P2|NOT COMPLETED|Overall Study||18
296413|NCT00141037|725988|P1|NOT COMPLETED|Overall Study||10
296414|NCT00141037|725987|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
296415|NCT00141037|725988|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
296416|NCT00141037|725987|P2|STARTED|Overall Study||70
296417|NCT00141037|725988|P1|STARTED|Overall Study||60
296418|NCT00140842|725998|P2|NOT COMPLETED|Overall Study||0
296419|NCT00140842|725999|P1|NOT COMPLETED|Overall Study||0
296420|NCT00140842|725998|P2|COMPLETED|Overall Study||15
296421|NCT00140842|725999|P1|COMPLETED|Overall Study||15
296422|NCT00140842|725998|P2|STARTED|Overall Study||15
296423|NCT00140842|725999|P1|STARTED|Overall Study||15
296424|NCT00140621|726007|P1|NOT COMPLETED|Overall Study||0
296425|NCT00140621|726007|P1|COMPLETED|Overall Study||6
296426|NCT00140621|726007|P1|STARTED|Overall Study||6
296427|NCT00140556|726017|P1|NOT COMPLETED|Chemoradiotherapy Period||0
296428|NCT00140556|726017|P1|COMPLETED|Chemoradiotherapy Period||28
296429|NCT00140556|726017|P1|STARTED|Chemoradiotherapy Period||28
296430|NCT00140556|726017|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
296431|NCT00140556|726017|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
296432|NCT00140556|726017|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
296433|NCT00140426|726023|P2|NOT COMPLETED|Overall Study||3
296434|NCT00140426|726024|P1|NOT COMPLETED|Overall Study||0
296435|NCT00140426|726023|P2|COMPLETED|Overall Study||16
296436|NCT00140426|726024|P1|COMPLETED|Overall Study||22
296437|NCT00140426|726023|P2|STARTED|Overall Study||19
296438|NCT00140426|726024|P1|STARTED|Overall Study||22
296439|NCT00140413|726057|P2|NOT COMPLETED|Overall Study||0
296440|NCT00140413|726058|P1|NOT COMPLETED|Overall Study||3
296441|NCT00140413|726057|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
296442|NCT00140413|726058|P1|COMPLETED|Overall Study||10
296443|NCT00140413|726057|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
296444|NCT00140413|726058|P1|Received at Least One Dose of GH|Overall Study||13
296445|NCT00140413|726057|P2|STARTED|Overall Study||7
296446|NCT00140413|726058|P1|STARTED|Overall Study||13
296447|NCT00140244|726065|P2|NOT COMPLETED|Intervention 2||2
296448|NCT00140244|726066|P1|NOT COMPLETED|Intervention 2||0
296449|NCT00140244|726065|P2|COMPLETED|Intervention 2||2
296450|NCT00140244|726066|P1|COMPLETED|Intervention 2||3
296451|NCT00140244|726065|P2|STARTED|Intervention 2||4
296452|NCT00140244|726066|P1|STARTED|Intervention 2||3
296453|NCT00140244|726065|P2|NOT COMPLETED|Washout||0
296454|NCT00140244|726066|P1|NOT COMPLETED|Washout||0
296455|NCT00140244|726065|P2|COMPLETED|Washout||4
296456|NCT00140244|726066|P1|COMPLETED|Washout||3
296457|NCT00140244|726065|P2|STARTED|Washout||4
296458|NCT00140244|726066|P1|STARTED|Washout||3
296459|NCT00140244|726065|P2|NOT COMPLETED|Intervention 1||0
296460|NCT00140244|726066|P1|NOT COMPLETED|Intervention 1||0
296461|NCT00140244|726065|P2|COMPLETED|Intervention 1||4
296462|NCT00140244|726066|P1|COMPLETED|Intervention 1||3
296463|NCT00140244|726065|P2|STARTED|Intervention 1||4
296464|NCT00140244|726066|P1|STARTED|Intervention 1||3
296465|NCT00140231|726098|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
296466|NCT00140231|726099|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
296467|NCT00140231|726098|P2|COMPLETED|Fasting State With Leptin and Crossover||6
296468|NCT00140231|726099|P1|COMPLETED|Fasting State With Leptin and Crossover||7
296469|NCT00140231|726098|P2|STARTED|Fasting State With Leptin and Crossover||6
296470|NCT00140231|726099|P1|STARTED|Fasting State With Leptin and Crossover||7
296471|NCT00140231|726098|P2|NOT COMPLETED|Washout 8 Weeks||0
296472|NCT00140231|726099|P1|NOT COMPLETED|Washout 8 Weeks||0
296473|NCT00140231|726098|P2|COMPLETED|Washout 8 Weeks||6
296474|NCT00140231|726099|P1|COMPLETED|Washout 8 Weeks||7
296475|NCT00140231|726098|P2|STARTED|Washout 8 Weeks||6
296476|NCT00140231|726099|P1|STARTED|Washout 8 Weeks||7
296477|NCT00140231|726098|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
296478|NCT00140231|726099|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
296479|NCT00140231|726098|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
296480|NCT00140231|726099|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
296481|NCT00140231|726098|P2|STARTED|First Fasting State 3 Days With Placebo||6
296482|NCT00140231|726099|P1|STARTED|First Fasting State 3 Days With Placebo||7
296483|NCT00140231|726098|P2|NOT COMPLETED|Washout 8weeks||0
296484|NCT00140231|726099|P1|NOT COMPLETED|Washout 8weeks||0
296485|NCT00140231|726098|P2|COMPLETED|Washout 8weeks||6
296486|NCT00140231|726099|P1|COMPLETED|Washout 8weeks||7
296487|NCT00140231|726098|P2|STARTED|Washout 8weeks||6
296488|NCT00140231|726099|P1|STARTED|Washout 8weeks||7
296489|NCT00140231|726098|P2|NOT COMPLETED|Fed State 1 Day- day5||0
296490|NCT00140231|726099|P1|NOT COMPLETED|Fed State 1 Day- day5||0
296491|NCT00140231|726098|P2|COMPLETED|Fed State 1 Day- day5||6
296492|NCT00140231|726099|P1|COMPLETED|Fed State 1 Day- day5||7
296493|NCT00140231|726098|P2|STARTED|Fed State 1 Day- day5||6
296494|NCT00140231|726099|P1|STARTED|Fed State 1 Day- day5||7
296495|NCT00140140|726118|P3|NOT COMPLETED|Overall Study||2
296496|NCT00140140|726119|P2|NOT COMPLETED|Overall Study||2
296497|NCT00140140|726120|P1|NOT COMPLETED|Overall Study||2
296498|NCT00140140|726118|P3|COMPLETED|Overall Study|Progressive disease|4
296499|NCT00140140|726119|P2|COMPLETED|Overall Study|Progressive disease|4
296500|NCT00140140|726120|P1|COMPLETED|Overall Study|Progressive disease|2
296501|NCT00140140|726118|P3|STARTED|Overall Study||6
296502|NCT00140140|726119|P2|STARTED|Overall Study||6
296503|NCT00140140|726120|P1|STARTED|Overall Study||4
296504|NCT00139997|726159|P2|NOT COMPLETED|Overall Study||2
296505|NCT00139997|726160|P1|NOT COMPLETED|Overall Study||1
296506|NCT00139997|726159|P2|COMPLETED|Overall Study||9
296507|NCT00139997|726160|P1|COMPLETED|Overall Study||14
296508|NCT00139997|726159|P2|STARTED|Overall Study||11
296509|NCT00139997|726160|P1|STARTED|Overall Study||15
296510|NCT00139776|726170|P4|NOT COMPLETED|Period III||106
296511|NCT00139776|726171|P3|NOT COMPLETED|Period III||76
296512|NCT00139776|726172|P2|NOT COMPLETED|Period III||0
296513|NCT00139776|726173|P1|NOT COMPLETED|Period III||0
296514|NCT00139776|726170|P4|COMPLETED|Period III||321
296515|NCT00139776|726171|P3|COMPLETED|Period III||355
296516|NCT00139776|726172|P2|COMPLETED|Period III||0
296517|NCT00139776|726173|P1|COMPLETED|Period III||0
296518|NCT00139776|726170|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
296519|NCT00139776|726171|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
296520|NCT00139776|726172|P2|STARTED|Period III||0
296521|NCT00139776|726173|P1|STARTED|Period III||0
296522|NCT00139776|726170|P4|NOT COMPLETED|Period II||0
296523|NCT00139776|726171|P3|NOT COMPLETED|Period II||0
296524|NCT00139776|726172|P2|NOT COMPLETED|Period II||322
296525|NCT00139776|726173|P1|NOT COMPLETED|Period II||0
296526|NCT00139776|726170|P4|COMPLETED|Period II||0
296527|NCT00139776|726171|P3|COMPLETED|Period II||0
296528|NCT00139776|726172|P2|COMPLETED|Period II||875
296529|NCT00139776|726173|P1|COMPLETED|Period II||0
296530|NCT00139776|726170|P4|STARTED|Period II||0
296531|NCT00139776|726171|P3|STARTED|Period II||0
296532|NCT00139776|726172|P2|STARTED|Period II||1197
296533|NCT00139776|726173|P1|STARTED|Period II||0
296534|NCT00139776|726170|P4|NOT COMPLETED|Period I||0
296535|NCT00139776|726171|P3|NOT COMPLETED|Period I||0
296536|NCT00139776|726172|P2|NOT COMPLETED|Period I||0
296537|NCT00139776|726173|P1|NOT COMPLETED|Period I||575
296538|NCT00139776|726170|P4|COMPLETED|Period I||0
296539|NCT00139776|726171|P3|COMPLETED|Period I||0
296540|NCT00139776|726172|P2|COMPLETED|Period I||0
296541|NCT00139776|726173|P1|COMPLETED|Period I||1197
296542|NCT00139776|726170|P4|STARTED|Period I||0
296543|NCT00139776|726171|P3|STARTED|Period I||0
296544|NCT00139776|726172|P2|STARTED|Period I||0
296545|NCT00139776|726173|P1|STARTED|Period I||1772
296546|NCT00139737|726208|P1|NOT COMPLETED|Overall Study||341
296547|NCT00139737|726208|P1|COMPLETED|Overall Study||3
296548|NCT00139737|726208|P1|Received Treatment|Overall Study||331
296549|NCT00139737|726208|P1|STARTED|Overall Study||344
296550|NCT00139659|726214|P2|NOT COMPLETED|Overall Study||18
296551|NCT00139659|726215|P1|NOT COMPLETED|Overall Study||40
296552|NCT00139659|726214|P2|COMPLETED|Overall Study||123
296553|NCT00139659|726215|P1|COMPLETED|Overall Study||106
296554|NCT00139659|726214|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
296555|NCT00139659|726215|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
296556|NCT00139477|726293|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
296557|NCT00139477|726294|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
296558|NCT00139477|726293|P2|COMPLETED|Second Intervention -6Months to 12Months||18
296559|NCT00139477|726294|P1|COMPLETED|Second Intervention -6Months to 12Months||14
296560|NCT00139477|726293|P2|STARTED|Second Intervention -6Months to 12Months||23
296561|NCT00139477|726294|P1|STARTED|Second Intervention -6Months to 12Months||19
296562|NCT00139477|726293|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
296563|NCT00139477|726294|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
296564|NCT00139477|726293|P2|COMPLETED|First Intervention -Baseline to 6Months||23
296565|NCT00139477|726294|P1|COMPLETED|First Intervention -Baseline to 6Months||19
296566|NCT00139477|726293|P2|STARTED|First Intervention -Baseline to 6Months||35
296567|NCT00139477|726294|P1|STARTED|First Intervention -Baseline to 6Months||31
296568|NCT00138671|726316|P2|NOT COMPLETED|Overall Study||16
296569|NCT00138671|726317|P1|NOT COMPLETED|Overall Study||13
296570|NCT00138671|726316|P2|COMPLETED|Overall Study||30
296571|NCT00138671|726317|P1|COMPLETED|Overall Study||46
296572|NCT00138671|726316|P2|STARTED|Overall Study||46
296573|NCT00138671|726317|P1|STARTED|Overall Study||59
296574|NCT00138658|726367|P1|NOT COMPLETED|Overall Study||61
296575|NCT00138658|726367|P1|COMPLETED|Overall Study||20
296576|NCT00138658|726367|P1|STARTED|Overall Study||81
296577|NCT00138645|726379|P2|NOT COMPLETED|Overall Study||7
296578|NCT00138645|726380|P1|NOT COMPLETED|Overall Study||6
296579|NCT00138645|726379|P2|COMPLETED|Overall Study||23
296580|NCT00138645|726380|P1|COMPLETED|Overall Study||24
296581|NCT00138645|726379|P2|STARTED|Overall Study||30
296582|NCT00138645|726380|P1|STARTED|Overall Study||30
296583|NCT00138424|726390|P4|NOT COMPLETED|Overall Study||0
296584|NCT00138424|726391|P3|NOT COMPLETED|Overall Study||0
296585|NCT00138424|726392|P2|NOT COMPLETED|Overall Study||1
296586|NCT00138424|726393|P1|NOT COMPLETED|Overall Study||0
296587|NCT00138424|726390|P4|COMPLETED|Overall Study||3
296588|NCT00138424|726391|P3|COMPLETED|Overall Study||5
296589|NCT00138424|726392|P2|COMPLETED|Overall Study||4
296590|NCT00138424|726393|P1|COMPLETED|Overall Study||9
296591|NCT00138424|726390|P4|STARTED|Overall Study||3
296592|NCT00138424|726391|P3|STARTED|Overall Study||5
296593|NCT00138424|726392|P2|STARTED|Overall Study||5
296594|NCT00138424|726393|P1|STARTED|Overall Study||9
296595|NCT00138294|726459|P1|NOT COMPLETED|Overall Study||0
296596|NCT00138294|726459|P1|COMPLETED|Overall Study||29255
296597|NCT00138294|726459|P1|STARTED|Overall Study||29255
296598|NCT00138203|726469|P1|NOT COMPLETED|Overall Study||0
296599|NCT00138203|726469|P1|COMPLETED|Overall Study||16
296600|NCT00138203|726469|P1|STARTED|Overall Study||16
296601|NCT00138151|726476|P1|NOT COMPLETED|Overall Study||4
296602|NCT00138151|726476|P1|COMPLETED|Overall Study||29
296603|NCT00138151|726476|P1|STARTED|Overall Study||33
296604|NCT00138125|726482|P1|NOT COMPLETED|Overall Study||0
296605|NCT00138125|726482|P1|COMPLETED|Overall Study||2
296606|NCT00138125|726482|P1|STARTED|Overall Study||2
296607|NCT00138073|726486|P1|NOT COMPLETED|Overall Study||55
296608|NCT00138073|726486|P1|COMPLETED|Overall Study||0
296609|NCT00138073|726486|P1|Pre-intervention Testing|Overall Study||55
296610|NCT00138073|726486|P1|STARTED|Overall Study||55
296611|NCT00138034|726493|P2|NOT COMPLETED|Overall Study||3
296612|NCT00138034|726494|P1|NOT COMPLETED|Overall Study||3
296613|NCT00138034|726493|P2|COMPLETED|Overall Study||20
296614|NCT00138034|726494|P1|COMPLETED|Overall Study||23
296615|NCT00138034|726493|P2|STARTED|Overall Study||23
296616|NCT00138034|726494|P1|STARTED|Overall Study||26
296617|NCT00137969|726504|P2|NOT COMPLETED|Overall Study||21
296618|NCT00137969|726505|P1|NOT COMPLETED|Overall Study||67
296619|NCT00137969|726504|P2|COMPLETED|Overall Study||67
296620|NCT00137969|726505|P1|COMPLETED|Overall Study||107
296621|NCT00137969|726504|P2|Received Study Drug|Overall Study||88
296622|NCT00137969|726505|P1|Received Study Drug|Overall Study||169
296623|NCT00137969|726504|P2|STARTED|Overall Study||88
296624|NCT00137969|726505|P1|STARTED|Overall Study||174
296625|NCT00137631|726527|P2|NOT COMPLETED|Overall Study||41
296626|NCT00137631|726528|P1|NOT COMPLETED|Overall Study||37
296627|NCT00137631|726527|P2|COMPLETED|Overall Study||133
296628|NCT00137631|726528|P1|COMPLETED|Overall Study||127
296629|NCT00137631|726527|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
296630|NCT00137631|726528|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
296631|NCT00137631|726527|P2|Complete 3-month Follow-up|Overall Study||125
296632|NCT00137631|726528|P1|Complete 3-month Follow-up|Overall Study||120
296633|NCT00137631|726527|P2|STARTED|Overall Study||174
296634|NCT00137631|726528|P1|STARTED|Overall Study||164
296635|NCT00137449|726544|P2|NOT COMPLETED|Overall Study||18
296636|NCT00137449|726545|P1|NOT COMPLETED|Overall Study||16
296637|NCT00137449|726544|P2|COMPLETED|Overall Study||12
296638|NCT00137449|726545|P1|COMPLETED|Overall Study||14
296639|NCT00137449|726544|P2|STARTED|Overall Study||30
296640|NCT00137449|726545|P1|STARTED|Overall Study||30
296641|NCT00137436|726582|P1|NOT COMPLETED|Overall Study||43
296642|NCT00137436|726582|P1|COMPLETED|Overall Study||12
296643|NCT00137436|726582|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
296644|NCT00137423|726601|P2|NOT COMPLETED|Overall Study||44
296645|NCT00137423|726602|P1|NOT COMPLETED|Overall Study||39
296646|NCT00137423|726601|P2|COMPLETED|Overall Study||9
296647|NCT00137423|726602|P1|COMPLETED|Overall Study||15
296648|NCT00137423|726601|P2|STARTED|Overall Study||53
296649|NCT00137423|726602|P1|STARTED|Overall Study||54
296650|NCT00137280|726624|P2|NOT COMPLETED|Overall Study||55
296651|NCT00137280|726625|P1|NOT COMPLETED|Overall Study||84
296652|NCT00137280|726624|P2|COMPLETED|Overall Study||357
296653|NCT00137280|726625|P1|COMPLETED|Overall Study||305
296654|NCT00137280|726624|P2|STARTED|Overall Study||412
296655|NCT00137280|726625|P1|STARTED|Overall Study||389
296656|NCT00137267|726639|P2|NOT COMPLETED|Overall Study||21
296657|NCT00137267|726640|P1|NOT COMPLETED|Overall Study||15
296658|NCT00137267|726639|P2|COMPLETED|Overall Study||26
296659|NCT00137267|726640|P1|COMPLETED|Overall Study||40
296660|NCT00137267|726639|P2|STARTED|Overall Study||47
296661|NCT00137267|726640|P1|STARTED|Overall Study||55
296662|NCT00137111|726652|P4|NOT COMPLETED|Total Therapy||0
296663|NCT00137111|726653|P3|NOT COMPLETED|Total Therapy||0
296664|NCT00137111|726654|P2|NOT COMPLETED|Total Therapy||0
296665|NCT00137111|726655|P1|NOT COMPLETED|Total Therapy||40
296666|NCT00137111|726652|P4|COMPLETED|Total Therapy||0
296667|NCT00137111|726653|P3|COMPLETED|Total Therapy||0
296668|NCT00137111|726654|P2|COMPLETED|Total Therapy||0
296669|NCT00137111|726655|P1|COMPLETED|Total Therapy||458
296670|NCT00137111|726652|P4|STARTED|Total Therapy||0
296671|NCT00137111|726653|P3|STARTED|Total Therapy||0
296672|NCT00137111|726654|P2|STARTED|Total Therapy||0
296673|NCT00137111|726655|P1|STARTED|Total Therapy||498
296674|NCT00137111|726652|P4|NOT COMPLETED|Window Therapy||0
296675|NCT00137111|726653|P3|NOT COMPLETED|Window Therapy||0
296676|NCT00137111|726654|P2|NOT COMPLETED|Window Therapy||0
296677|NCT00137111|726655|P1|NOT COMPLETED|Window Therapy||0
296678|NCT00137111|726652|P4|COMPLETED|Window Therapy||142
296679|NCT00137111|726653|P3|COMPLETED|Window Therapy||180
296680|NCT00137111|726654|P2|COMPLETED|Window Therapy||176
296681|NCT00137111|726655|P1|COMPLETED|Window Therapy||0
296682|NCT00137111|726652|P4|STARTED|Window Therapy||142
296683|NCT00137111|726653|P3|STARTED|Window Therapy||180
296684|NCT00137111|726654|P2|STARTED|Window Therapy||176
296685|NCT00137111|726655|P1|STARTED|Window Therapy||0
296686|NCT00137046|726669|P2|NOT COMPLETED|Overall Study||93
296687|NCT00137046|726670|P1|NOT COMPLETED|Overall Study||99
296688|NCT00137046|726669|P2|COMPLETED|Overall Study||198
296775|NCT00135694|726897|P2|STARTED|Overall Study||77
296689|NCT00137046|726670|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
296690|NCT00137046|726669|P2|Received Study Treatment|Overall Study||290
296691|NCT00137046|726670|P1|Received Study Treatment|Overall Study||290
296692|NCT00137046|726669|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
296693|NCT00137046|726670|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
296694|NCT00136955|726718|P1|NOT COMPLETED|Overall Study||23
296695|NCT00136955|726718|P1|COMPLETED|Overall Study||18
296696|NCT00136955|726718|P1|STARTED|Overall Study||41
296697|NCT00136916|726727|P2|NOT COMPLETED|Overall Study||104
296698|NCT00136916|726728|P1|NOT COMPLETED|Overall Study||125
296699|NCT00136916|726727|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
296700|NCT00136916|726728|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
296701|NCT00136916|726727|P2|Received Treatment|Overall Study||311
296702|NCT00136916|726728|P1|Received Treatment|Overall Study||316
296703|NCT00136916|726727|P2|STARTED|Overall Study||316
296704|NCT00136916|726728|P1|STARTED|Overall Study||319
296705|NCT00136838|726782|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
296706|NCT00136838|726783|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
296707|NCT00136838|726782|P2|COMPLETED|Second Intervention ( 5 Days)||6
296708|NCT00136838|726783|P1|COMPLETED|Second Intervention ( 5 Days)||6
296709|NCT00136838|726782|P2|STARTED|Second Intervention ( 5 Days)||6
296710|NCT00136838|726783|P1|STARTED|Second Intervention ( 5 Days)||6
296711|NCT00136838|726782|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
296712|NCT00136838|726783|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
296713|NCT00136838|726782|P2|COMPLETED|First Intervention ( 5 Days)||6
296714|NCT00136838|726783|P1|COMPLETED|First Intervention ( 5 Days)||6
296715|NCT00136838|726782|P2|STARTED|First Intervention ( 5 Days)||6
296716|NCT00136838|726783|P1|STARTED|First Intervention ( 5 Days)||6
296717|NCT00136812|726793|P2|NOT COMPLETED|Overall Study||0
296718|NCT00136812|726794|P1|NOT COMPLETED|Overall Study||0
296719|NCT00136812|726793|P2|COMPLETED|Overall Study||113
296720|NCT00136812|726794|P1|COMPLETED|Overall Study||111
296721|NCT00136812|726793|P2|STARTED|Overall Study||113
296722|NCT00136812|726794|P1|STARTED|Overall Study||111
296723|NCT00136760|726804|P4|NOT COMPLETED|Overall Study||0
296724|NCT00136760|726805|P3|NOT COMPLETED|Overall Study||0
296725|NCT00136760|726806|P2|NOT COMPLETED|Overall Study||0
296726|NCT00136760|726807|P1|NOT COMPLETED|Overall Study||0
296727|NCT00136760|726804|P4|COMPLETED|Overall Study||13
296728|NCT00136760|726805|P3|COMPLETED|Overall Study||11
296729|NCT00136760|726806|P2|COMPLETED|Overall Study||16
296730|NCT00136760|726807|P1|COMPLETED|Overall Study||12
296731|NCT00136760|726804|P4|STARTED|Overall Study||13
296732|NCT00136760|726805|P3|STARTED|Overall Study||11
296733|NCT00136760|726806|P2|STARTED|Overall Study||16
296734|NCT00136760|726807|P1|STARTED|Overall Study||12
296735|NCT00136695|726823|P2|NOT COMPLETED|Overall Study||8
296736|NCT00136695|726824|P1|NOT COMPLETED|Overall Study||11
296737|NCT00136695|726823|P2|COMPLETED|Overall Study||35
296738|NCT00136695|726824|P1|COMPLETED|Overall Study||34
296739|NCT00136695|726823|P2|STARTED|Overall Study||43
296740|NCT00136695|726824|P1|STARTED|Overall Study||45
296741|NCT00136357|726832|P2|NOT COMPLETED|Overall Study||2
296742|NCT00136357|726833|P1|NOT COMPLETED|Overall Study||3
296743|NCT00136357|726832|P2|COMPLETED|Overall Study||39
296744|NCT00136357|726833|P1|COMPLETED|Overall Study||38
296745|NCT00136357|726832|P2|STARTED|Overall Study||41
296746|NCT00136357|726833|P1|STARTED|Overall Study||41
296747|NCT00136318|726841|P2|NOT COMPLETED|Overall Study||7
296748|NCT00136318|726842|P1|NOT COMPLETED|Overall Study||7
296749|NCT00136318|726841|P2|COMPLETED|Overall Study||84
296750|NCT00136318|726842|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
296751|NCT00136318|726841|P2|STARTED|Overall Study|Took first dose of study medication|91
296752|NCT00136318|726842|P1|STARTED|Overall Study|Took first dose of study medication|90
296753|NCT00136084|726858|P2|NOT COMPLETED|Overall Study||42
296754|NCT00136084|726859|P1|NOT COMPLETED|Overall Study||48
296755|NCT00136084|726858|P2|COMPLETED|Overall Study||72
296756|NCT00136084|726859|P1|COMPLETED|Overall Study||61
296757|NCT00136084|726858|P2|STARTED|Overall Study||114
296758|NCT00136084|726859|P1|STARTED|Overall Study||109
296759|NCT00135798|726875|P3|NOT COMPLETED|Overall Study||0
296760|NCT00135798|726876|P2|NOT COMPLETED|Overall Study||0
296761|NCT00135798|726877|P1|NOT COMPLETED|Overall Study||0
296762|NCT00135798|726875|P3|COMPLETED|Overall Study||32
296763|NCT00135798|726876|P2|COMPLETED|Overall Study||31
296764|NCT00135798|726877|P1|COMPLETED|Overall Study||16
296765|NCT00135798|726875|P3|STARTED|Overall Study||32
296766|NCT00135798|726876|P2|STARTED|Overall Study||31
296767|NCT00135798|726877|P1|STARTED|Overall Study||16
296768|NCT00135694|726896|P3|NOT COMPLETED|Overall Study||7
296769|NCT00135694|726897|P2|NOT COMPLETED|Overall Study||21
296770|NCT00135694|726898|P1|NOT COMPLETED|Overall Study||180
296771|NCT00135694|726896|P3|COMPLETED|Overall Study||11
296772|NCT00135694|726897|P2|COMPLETED|Overall Study||56
296773|NCT00135694|726898|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
296774|NCT00135694|726896|P3|STARTED|Overall Study||18
296776|NCT00135694|726898|P1|STARTED|Overall Study||180
296777|NCT00135356|726918|P2|NOT COMPLETED|Overall Study||9
296778|NCT00135356|726919|P1|NOT COMPLETED|Overall Study||17
296779|NCT00135356|726918|P2|COMPLETED|Overall Study||60
296780|NCT00135356|726919|P1|COMPLETED|Overall Study||114
296781|NCT00135356|726918|P2|Discontinued on or After Week 96 Visit|Overall Study||0
296782|NCT00135356|726919|P1|Discontinued on or After Week 96 Visit|Overall Study||1
296783|NCT00135356|726918|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
296784|NCT00135356|726919|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
296785|NCT00135356|726918|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
296786|NCT00135356|726919|P1|STARTED|Overall Study|Number randomized and treated|131
296787|NCT00135330|726962|P3|NOT COMPLETED|Overall Study||11
296788|NCT00135330|726963|P2|NOT COMPLETED|Overall Study||13
296789|NCT00135330|726964|P1|NOT COMPLETED|Overall Study||12
296790|NCT00135330|726962|P3|COMPLETED|Overall Study||34
296791|NCT00135330|726963|P2|COMPLETED|Overall Study||34
296792|NCT00135330|726964|P1|COMPLETED|Overall Study||33
296793|NCT00135330|726962|P3|STARTED|Overall Study||45
296794|NCT00135330|726963|P2|STARTED|Overall Study||47
296795|NCT00135330|726964|P1|STARTED|Overall Study||45
296796|NCT00135200|727056|P1|NOT COMPLETED|Overall Study||0
296797|NCT00135200|727056|P1|COMPLETED|Overall Study||16
296798|NCT00135200|727056|P1|STARTED|Overall Study||16
296799|NCT00134901|727063|P2|NOT COMPLETED|Overall Study||15
296800|NCT00134901|727064|P1|NOT COMPLETED|Overall Study||17
296801|NCT00134901|727063|P2|COMPLETED|Overall Study||27
296802|NCT00134901|727064|P1|COMPLETED|Overall Study||22
296803|NCT00134901|727063|P2|STARTED|Overall Study||42
296804|NCT00134901|727064|P1|STARTED|Overall Study||39
296805|NCT00134784|727076|P4|NOT COMPLETED|Overall Study||1
296806|NCT00134784|727077|P3|NOT COMPLETED|Overall Study||2
296807|NCT00134784|727078|P2|NOT COMPLETED|Overall Study||2
296808|NCT00134784|727079|P1|NOT COMPLETED|Overall Study||2
296809|NCT00134784|727076|P4|COMPLETED|Overall Study||37
296810|NCT00134784|727077|P3|COMPLETED|Overall Study||35
296811|NCT00134784|727078|P2|COMPLETED|Overall Study||36
296812|NCT00134784|727079|P1|COMPLETED|Overall Study||27
296813|NCT00134784|727076|P4|STARTED|Overall Study||38
296814|NCT00134784|727077|P3|STARTED|Overall Study||37
296815|NCT00134784|727078|P2|STARTED|Overall Study||38
296816|NCT00134784|727079|P1|STARTED|Overall Study||29
296817|NCT00134719|727089|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
296818|NCT00134719|727090|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
296819|NCT00134719|727091|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
296820|NCT00134719|727089|P3|COMPLETED|Fourth Dose Vaccination Phase||203
296821|NCT00134719|727090|P2|COMPLETED|Fourth Dose Vaccination Phase||203
296822|NCT00134719|727091|P1|COMPLETED|Fourth Dose Vaccination Phase||623
296823|NCT00134719|727089|P3|STARTED|Fourth Dose Vaccination Phase||204
296824|NCT00134719|727090|P2|STARTED|Fourth Dose Vaccination Phase||206
296825|NCT00134719|727091|P1|STARTED|Fourth Dose Vaccination Phase||625
296826|NCT00134719|727089|P3|NOT COMPLETED|Primary Vaccination Phase||5
296827|NCT00134719|727090|P2|NOT COMPLETED|Primary Vaccination Phase||6
296828|NCT00134719|727091|P1|NOT COMPLETED|Primary Vaccination Phase||14
296829|NCT00134719|727089|P3|COMPLETED|Primary Vaccination Phase||216
296830|NCT00134719|727090|P2|COMPLETED|Primary Vaccination Phase||215
296831|NCT00134719|727091|P1|COMPLETED|Primary Vaccination Phase||647
296832|NCT00134719|727089|P3|STARTED|Primary Vaccination Phase||221
296833|NCT00134719|727090|P2|STARTED|Primary Vaccination Phase||221
296834|NCT00134719|727091|P1|STARTED|Primary Vaccination Phase||661
296835|NCT00134563|727222|P3|NOT COMPLETED|Overall Study||96
296836|NCT00134563|727223|P2|NOT COMPLETED|Overall Study||92
296837|NCT00134563|727224|P1|NOT COMPLETED|Overall Study||104
296838|NCT00134563|727222|P3|COMPLETED|Overall Study|completed treatment period|263
296839|NCT00134563|727223|P2|COMPLETED|Overall Study|completed treatment period|274
296840|NCT00134563|727224|P1|COMPLETED|Overall Study|completed treatment period|259
296841|NCT00134563|727222|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
296842|NCT00134563|727223|P2|Treated|Overall Study||365
296843|NCT00134563|727224|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
296844|NCT00134563|727222|P3|STARTED|Overall Study|Randomized|359
296845|NCT00134563|727223|P2|STARTED|Overall Study|Randomized|366
296846|NCT00134563|727224|P1|STARTED|Overall Study|Randomized|363
296847|NCT00134381|727247|P6|NOT COMPLETED|Overall Study||2
296848|NCT00134381|727248|P5|NOT COMPLETED|Overall Study||0
296849|NCT00134381|727249|P4|NOT COMPLETED|Overall Study||0
296850|NCT00134381|727250|P3|NOT COMPLETED|Overall Study||0
296851|NCT00134381|727251|P2|NOT COMPLETED|Overall Study||0
296852|NCT00134381|727252|P1|NOT COMPLETED|Overall Study||0
296853|NCT00134381|727247|P6|COMPLETED|Overall Study||29
296854|NCT00134381|727248|P5|COMPLETED|Overall Study||31
296855|NCT00134381|727249|P4|COMPLETED|Overall Study||2
296856|NCT00134381|727250|P3|COMPLETED|Overall Study||1
296857|NCT00134381|727251|P2|COMPLETED|Overall Study||2
296858|NCT00134381|727252|P1|COMPLETED|Overall Study||1
296859|NCT00134381|727247|P6|STARTED|Overall Study||31
296860|NCT00134381|727248|P5|STARTED|Overall Study||31
296861|NCT00134381|727249|P4|STARTED|Overall Study||2
296862|NCT00134381|727250|P3|STARTED|Overall Study||1
296863|NCT00134381|727251|P2|STARTED|Overall Study||2
296864|NCT00134381|727252|P1|STARTED|Overall Study||1
296865|NCT00134056|727287|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
296866|NCT00134056|727288|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
296867|NCT00134056|727287|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
296868|NCT00134056|727288|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
296869|NCT00134056|727287|P2|STARTED|Eligible for Protocol Assigned Treatment||500
296870|NCT00134056|727288|P1|STARTED|Eligible for Protocol Assigned Treatment||496
296871|NCT00134056|727287|P2|NOT COMPLETED|Randomization||20
296872|NCT00134056|727288|P1|NOT COMPLETED|Randomization||22
296873|NCT00134056|727287|P2|COMPLETED|Randomization||500
296874|NCT00134056|727288|P1|COMPLETED|Randomization||496
296875|NCT00134056|727287|P2|STARTED|Randomization||520
296876|NCT00134056|727288|P1|STARTED|Randomization||518
296877|NCT00134043|727310|P2|NOT COMPLETED|Overall Study||0
296878|NCT00134043|727311|P1|NOT COMPLETED|Overall Study||0
296879|NCT00134043|727310|P2|COMPLETED|Overall Study||3
296880|NCT00134043|727311|P1|COMPLETED|Overall Study||16
296881|NCT00134043|727310|P2|STARTED|Overall Study||3
296882|NCT00134043|727311|P1|STARTED|Overall Study||16
296883|NCT00134004|727316|P1|NOT COMPLETED|Overall Study||0
296884|NCT00134004|727316|P1|COMPLETED|Overall Study||210
296885|NCT00134004|727316|P1|STARTED|Overall Study||210
296886|NCT00133978|727328|P4|NOT COMPLETED|Overall Study||2
296887|NCT00133978|727329|P3|NOT COMPLETED|Overall Study||0
296888|NCT00133978|727330|P2|NOT COMPLETED|Overall Study||1
296889|NCT00133978|727331|P1|NOT COMPLETED|Overall Study||2
296890|NCT00133978|727328|P4|COMPLETED|Overall Study||300
296891|NCT00133978|727329|P3|COMPLETED|Overall Study||310
296892|NCT00133978|727330|P2|COMPLETED|Overall Study||307
296893|NCT00133978|727331|P1|COMPLETED|Overall Study||301
296894|NCT00133978|727328|P4|STARTED|Overall Study||302
296895|NCT00133978|727329|P3|STARTED|Overall Study||310
296896|NCT00133978|727330|P2|STARTED|Overall Study||308
296897|NCT00133978|727331|P1|STARTED|Overall Study||303
296898|NCT00133952|727355|P2|NOT COMPLETED|Overall Study||28
296899|NCT00133952|727356|P1|NOT COMPLETED|Overall Study||42
296900|NCT00133952|727355|P2|COMPLETED|Overall Study||124
296901|NCT00133952|727356|P1|COMPLETED|Overall Study||115
296902|NCT00133952|727355|P2|Received at Least One Dose of Study Drug|Overall Study||149
296903|NCT00133952|727356|P1|Received at Least One Dose of Study Drug|Overall Study||153
296904|NCT00133952|727355|P2|STARTED|Overall Study||152
296905|NCT00133952|727356|P1|STARTED|Overall Study||157
296906|NCT00133809|727378|P1|NOT COMPLETED|Overall Study||0
296907|NCT00133809|727378|P1|COMPLETED|Overall Study||8
296908|NCT00133809|727378|P1|STARTED|Overall Study||8
296909|NCT00133705|727387|P2|NOT COMPLETED|Overall Study||3
296910|NCT00133705|727388|P1|NOT COMPLETED|Overall Study||2
296911|NCT00133705|727387|P2|COMPLETED|Overall Study||17
296912|NCT00133705|727388|P1|COMPLETED|Overall Study||20
296913|NCT00133705|727387|P2|STARTED|Overall Study||20
296914|NCT00133705|727388|P1|STARTED|Overall Study||22
296915|NCT00133575|727401|P7|NOT COMPLETED|Overall Study||3
296916|NCT00133575|727402|P6|NOT COMPLETED|Overall Study||1
296917|NCT00133575|727403|P5|NOT COMPLETED|Overall Study||4
296918|NCT00133575|727404|P4|NOT COMPLETED|Overall Study||1
296919|NCT00133575|727405|P3|NOT COMPLETED|Overall Study||2
296920|NCT00133575|727406|P2|NOT COMPLETED|Overall Study||0
296921|NCT00133575|727407|P1|NOT COMPLETED|Overall Study||0
296922|NCT00133575|727401|P7|COMPLETED|Overall Study||9
296923|NCT00133575|727402|P6|COMPLETED|Overall Study||9
296924|NCT00133575|727403|P5|COMPLETED|Overall Study||6
296925|NCT00133575|727404|P4|COMPLETED|Overall Study||9
296926|NCT00133575|727405|P3|COMPLETED|Overall Study||8
296927|NCT00133575|727406|P2|COMPLETED|Overall Study||10
296928|NCT00133575|727407|P1|COMPLETED|Overall Study||10
296929|NCT00133575|727401|P7|STARTED|Overall Study||12
296930|NCT00133575|727402|P6|STARTED|Overall Study||10
296931|NCT00133575|727403|P5|STARTED|Overall Study||10
296932|NCT00133575|727404|P4|STARTED|Overall Study||10
296933|NCT00133575|727405|P3|STARTED|Overall Study||10
296934|NCT00133575|727406|P2|STARTED|Overall Study||10
296935|NCT00133575|727407|P1|STARTED|Overall Study||10
296936|NCT00132873|727514|P1|NOT COMPLETED|Overall Study||9
296937|NCT00132873|727514|P1|COMPLETED|Overall Study||50
296938|NCT00132873|727514|P1|STARTED|Overall Study||59
296939|NCT00132808|727522|P3|NOT COMPLETED|Stratum II||9
296940|NCT00132808|727523|P2|NOT COMPLETED|Stratum II||15
296941|NCT00132808|727524|P1|NOT COMPLETED|Stratum II||8
296942|NCT00132808|727522|P3|COMPLETED|Stratum II||116
296943|NCT00132808|727523|P2|COMPLETED|Stratum II||96
296944|NCT00132808|727524|P1|COMPLETED|Stratum II||113
296945|NCT00132808|727522|P3|STARTED|Stratum II||125
296946|NCT00132808|727523|P2|STARTED|Stratum II||111
296947|NCT00132808|727524|P1|STARTED|Stratum II||121
296948|NCT00132808|727522|P3|NOT COMPLETED|Stratum I||5
296949|NCT00132808|727523|P2|NOT COMPLETED|Stratum I||12
296950|NCT00132808|727524|P1|NOT COMPLETED|Stratum I||9
296951|NCT00132808|727522|P3|COMPLETED|Stratum I||72
296952|NCT00132808|727523|P2|COMPLETED|Stratum I||58
296953|NCT00132808|727524|P1|COMPLETED|Stratum I||68
296954|NCT00132808|727522|P3|STARTED|Stratum I||77
296955|NCT00132808|727523|P2|STARTED|Stratum I||70
296956|NCT00132808|727524|P1|STARTED|Stratum I||77
296957|NCT00132769|727549|P2|NOT COMPLETED|Overall Study||11
296958|NCT00132769|727550|P1|NOT COMPLETED|Overall Study||11
296959|NCT00132769|727549|P2|COMPLETED|Overall Study||42
296960|NCT00132769|727550|P1|COMPLETED|Overall Study||42
296961|NCT00132769|727549|P2|STARTED|Overall Study||53
296962|NCT00132769|727550|P1|STARTED|Overall Study||53
296963|NCT00132730|727576|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
296964|NCT00132730|727577|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
296965|NCT00132730|727578|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
296966|NCT00132730|727579|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
296967|NCT00132730|727580|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
296968|NCT00132730|727581|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
296969|NCT00132730|727576|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
296970|NCT00132730|727577|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
296971|NCT00132730|727578|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
296972|NCT00132730|727579|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
296973|NCT00132730|727580|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
296974|NCT00132730|727581|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
296975|NCT00132730|727576|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
296976|NCT00132730|727577|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
296977|NCT00132730|727578|P4|STARTED|Period V - Open-label Extension (EXT2)||0
296978|NCT00132730|727579|P3|STARTED|Period V - Open-label Extension (EXT2)||0
296979|NCT00132730|727580|P2|STARTED|Period V - Open-label Extension (EXT2)||0
296980|NCT00132730|727581|P1|STARTED|Period V - Open-label Extension (EXT2)||0
296981|NCT00132730|727576|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
296982|NCT00132730|727577|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
296983|NCT00132730|727578|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
296984|NCT00132730|727579|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
296985|NCT00132730|727580|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
296986|NCT00132730|727581|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
296987|NCT00132730|727576|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
296988|NCT00132730|727577|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
296989|NCT00132730|727578|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
296990|NCT00132730|727579|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
296991|NCT00132730|727580|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
296992|NCT00132730|727581|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
296993|NCT00132730|727576|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
296994|NCT00132730|727577|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
296995|NCT00132730|727578|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
296996|NCT00132730|727579|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
296997|NCT00132730|727580|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
296998|NCT00132730|727581|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
296999|NCT00132730|727576|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
297000|NCT00132730|727577|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
297001|NCT00132730|727578|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
297002|NCT00132730|727579|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
297003|NCT00132730|727580|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
297004|NCT00132730|727581|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
297005|NCT00132730|727576|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
297006|NCT00132730|727577|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
297007|NCT00132730|727578|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
297008|NCT00132730|727579|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
297009|NCT00132730|727580|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
297010|NCT00132730|727581|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
297011|NCT00132730|727576|P6|STARTED|Period III - Blinded Extension (EXT1)||0
297012|NCT00132730|727577|P5|STARTED|Period III - Blinded Extension (EXT1)||0
297013|NCT00132730|727578|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
297014|NCT00132730|727579|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
297015|NCT00132730|727580|P2|STARTED|Period III - Blinded Extension (EXT1)||0
297016|NCT00132730|727581|P1|STARTED|Period III - Blinded Extension (EXT1)||0
297017|NCT00132730|727576|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
297018|NCT00132730|727577|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
297019|NCT00132730|727578|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
297020|NCT00132730|727579|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
297021|NCT00132730|727580|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
297022|NCT00132730|727581|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
297023|NCT00132730|727576|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
297024|NCT00132730|727577|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
297025|NCT00132730|727578|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
297026|NCT00132730|727579|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
297027|NCT00132730|727580|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
297028|NCT00132730|727581|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
297029|NCT00132730|727576|P6|STARTED|Period II - 12-week Treatment (Base)||0
297189|NCT00131664|727806|P2|STARTED|First Period (First 6 Months)||135
297030|NCT00132730|727577|P5|STARTED|Period II - 12-week Treatment (Base)||0
297031|NCT00132730|727578|P4|STARTED|Period II - 12-week Treatment (Base)||153
297032|NCT00132730|727579|P3|STARTED|Period II - 12-week Treatment (Base)||153
297033|NCT00132730|727580|P2|STARTED|Period II - 12-week Treatment (Base)||148
297034|NCT00132730|727581|P1|STARTED|Period II - 12-week Treatment (Base)||150
297035|NCT00132730|727576|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
297036|NCT00132730|727577|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
297037|NCT00132730|727578|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
297038|NCT00132730|727579|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
297039|NCT00132730|727580|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
297040|NCT00132730|727581|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
297041|NCT00132730|727576|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
297042|NCT00132730|727577|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
297043|NCT00132730|727578|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
297044|NCT00132730|727579|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
297045|NCT00132730|727580|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
297046|NCT00132730|727581|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
297047|NCT00132730|727576|P6|STARTED|Period I - Placebo Run-in (Base)||0
297048|NCT00132730|727577|P5|STARTED|Period I - Placebo Run-in (Base)||0
297049|NCT00132730|727578|P4|STARTED|Period I - Placebo Run-in (Base)||153
297050|NCT00132730|727579|P3|STARTED|Period I - Placebo Run-in (Base)||153
297051|NCT00132730|727580|P2|STARTED|Period I - Placebo Run-in (Base)||148
297052|NCT00132730|727581|P1|STARTED|Period I - Placebo Run-in (Base)||150
297053|NCT00132691|727625|P2|NOT COMPLETED|Overall Study||12
297054|NCT00132691|727626|P1|NOT COMPLETED|Overall Study||11
297055|NCT00132691|727625|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
297056|NCT00132691|727626|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
297057|NCT00132691|727625|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
297058|NCT00132691|727626|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
297059|NCT00132678|727666|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
297060|NCT00132678|727667|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
297061|NCT00132678|727668|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
297062|NCT00132678|727666|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
297063|NCT00132678|727667|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
297064|NCT00132678|727668|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
297065|NCT00132678|727666|P3|STARTED|Period IV (Double-Blind Treatment)||0
297066|NCT00132678|727667|P2|STARTED|Period IV (Double-Blind Treatment)||149
297067|NCT00132678|727668|P1|STARTED|Period IV (Double-Blind Treatment)||154
297068|NCT00132678|727666|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
297069|NCT00132678|727667|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
297070|NCT00132678|727668|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
297071|NCT00132678|727666|P3|COMPLETED|Period III (Open-Label Stabilization)||0
297072|NCT00132678|727667|P2|COMPLETED|Period III (Open-Label Stabilization)||0
297073|NCT00132678|727668|P1|COMPLETED|Period III (Open-Label Stabilization)||303
297074|NCT00132678|727666|P3|STARTED|Period III (Open-Label Stabilization)||0
297075|NCT00132678|727667|P2|STARTED|Period III (Open-Label Stabilization)||0
297076|NCT00132678|727668|P1|STARTED|Period III (Open-Label Stabilization)||501
297077|NCT00132678|727666|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
297078|NCT00132678|727667|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
297079|NCT00132678|727668|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
297080|NCT00132678|727666|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
297081|NCT00132678|727667|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
297082|NCT00132678|727668|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
297083|NCT00132678|727666|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
297084|NCT00132678|727667|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
297085|NCT00132678|727668|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
297086|NCT00132496|727682|P2|NOT COMPLETED|Overall Study||2
297087|NCT00132496|727683|P1|NOT COMPLETED|Overall Study||2
297088|NCT00132496|727682|P2|COMPLETED|Overall Study||55
297089|NCT00132496|727683|P1|COMPLETED|Overall Study||52
297090|NCT00132496|727682|P2|STARTED|Overall Study||57
297091|NCT00132496|727683|P1|STARTED|Overall Study||54
297092|NCT00132314|727691|P2|NOT COMPLETED|Overall Study||72
297093|NCT00132314|727692|P1|NOT COMPLETED|Overall Study||73
297094|NCT00132314|727691|P2|COMPLETED|Overall Study||120
297095|NCT00132314|727692|P1|COMPLETED|Overall Study||117
297096|NCT00132314|727691|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
297097|NCT00132314|727692|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
297098|NCT00132314|727691|P2|Received Treatment|Overall Study||185
297099|NCT00132314|727692|P1|Received Treatment|Overall Study||188
297100|NCT00132314|727691|P2|STARTED|Overall Study||192
297101|NCT00132314|727692|P1|STARTED|Overall Study||190
297102|NCT00132132|727702|P2|NOT COMPLETED|Overall Study||2
297103|NCT00132132|727703|P1|NOT COMPLETED|Overall Study||7
297104|NCT00132132|727702|P2|COMPLETED|Overall Study||13
297105|NCT00132132|727703|P1|COMPLETED|Overall Study||8
297106|NCT00132132|727702|P2|STARTED|Overall Study||15
297107|NCT00132132|727703|P1|STARTED|Overall Study||15
297108|NCT00132028|727711|P1|NOT COMPLETED|Overall Study||27
297109|NCT00132028|727711|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
297110|NCT00132028|727711|P1|Eligible and Began Protocol Therapy|Overall Study||25
297111|NCT00132028|727711|P1|Eligible|Overall Study||25
297112|NCT00132028|727711|P1|STARTED|Overall Study||27
297113|NCT00132002|727717|P1|NOT COMPLETED|Overall Study||0
297114|NCT00132002|727717|P1|COMPLETED|Overall Study||14
297115|NCT00132002|727717|P1|STARTED|Overall Study||14
297116|NCT00131937|727723|P1|NOT COMPLETED|Overall Study||14
297117|NCT00131937|727723|P1|COMPLETED|Overall Study||0
297118|NCT00131937|727723|P1|STARTED|Overall Study||14
297119|NCT00131911|727731|P2|NOT COMPLETED|Overall Study||0
297120|NCT00131911|727732|P1|NOT COMPLETED|Overall Study||1
297121|NCT00131911|727731|P2|COMPLETED|Overall Study||42
297122|NCT00131911|727732|P1|COMPLETED|Overall Study||50
297123|NCT00131911|727731|P2|STARTED|Overall Study||42
297124|NCT00131911|727732|P1|STARTED|Overall Study||51
297125|NCT00131885|727749|P4|NOT COMPLETED|Time 2: Second Intervention||0
297126|NCT00131885|727750|P3|NOT COMPLETED|Time 2: Second Intervention||0
297127|NCT00131885|727751|P2|NOT COMPLETED|Time 2: Second Intervention||0
297128|NCT00131885|727752|P1|NOT COMPLETED|Time 2: Second Intervention||0
297129|NCT00131885|727749|P4|COMPLETED|Time 2: Second Intervention||9
297130|NCT00131885|727750|P3|COMPLETED|Time 2: Second Intervention||9
297131|NCT00131885|727751|P2|COMPLETED|Time 2: Second Intervention||9
297132|NCT00131885|727752|P1|COMPLETED|Time 2: Second Intervention||9
297133|NCT00131885|727749|P4|STARTED|Time 2: Second Intervention||9
297134|NCT00131885|727750|P3|STARTED|Time 2: Second Intervention||9
297135|NCT00131885|727751|P2|STARTED|Time 2: Second Intervention||9
297136|NCT00131885|727752|P1|STARTED|Time 2: Second Intervention||9
297137|NCT00131885|727749|P4|NOT COMPLETED|Time 1: First Intervention||0
297138|NCT00131885|727750|P3|NOT COMPLETED|Time 1: First Intervention||0
297139|NCT00131885|727751|P2|NOT COMPLETED|Time 1: First Intervention||0
297140|NCT00131885|727752|P1|NOT COMPLETED|Time 1: First Intervention||0
297141|NCT00131885|727749|P4|COMPLETED|Time 1: First Intervention||9
297142|NCT00131885|727750|P3|COMPLETED|Time 1: First Intervention||9
297143|NCT00131885|727751|P2|COMPLETED|Time 1: First Intervention||9
297144|NCT00131885|727752|P1|COMPLETED|Time 1: First Intervention||9
297145|NCT00131885|727749|P4|STARTED|Time 1: First Intervention||9
297146|NCT00131885|727750|P3|STARTED|Time 1: First Intervention||9
297147|NCT00131885|727751|P2|STARTED|Time 1: First Intervention||9
297148|NCT00131885|727752|P1|STARTED|Time 1: First Intervention||9
297149|NCT00131677|727784|P2|NOT COMPLETED|Overall Study||39
297150|NCT00131677|727785|P1|NOT COMPLETED|Overall Study||30
297151|NCT00131677|727784|P2|COMPLETED|Overall Study||160
297152|NCT00131677|727785|P1|COMPLETED|Overall Study||171
297153|NCT00131677|727784|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
297154|NCT00131677|727785|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
297155|NCT00131664|727802|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
297156|NCT00131664|727803|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
297157|NCT00131664|727804|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
297158|NCT00131664|727805|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
297159|NCT00131664|727806|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
297160|NCT00131664|727807|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
297161|NCT00131664|727802|P6|COMPLETED|Second Period (Additional Drug Added)||22
297162|NCT00131664|727803|P5|COMPLETED|Second Period (Additional Drug Added)||15
297163|NCT00131664|727804|P4|COMPLETED|Second Period (Additional Drug Added)||19
297164|NCT00131664|727805|P3|COMPLETED|Second Period (Additional Drug Added)||76
297165|NCT00131664|727806|P2|COMPLETED|Second Period (Additional Drug Added)||97
297166|NCT00131664|727807|P1|COMPLETED|Second Period (Additional Drug Added)||81
297167|NCT00131664|727802|P6|STARTED|Second Period (Additional Drug Added)||25
297168|NCT00131664|727803|P5|STARTED|Second Period (Additional Drug Added)||16
297169|NCT00131664|727804|P4|STARTED|Second Period (Additional Drug Added)||21
297170|NCT00131664|727805|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
297171|NCT00131664|727806|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
297172|NCT00131664|727807|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
297173|NCT00131664|727802|P6|NOT COMPLETED|First Period (First 6 Months)||0
297174|NCT00131664|727803|P5|NOT COMPLETED|First Period (First 6 Months)||0
297175|NCT00131664|727804|P4|NOT COMPLETED|First Period (First 6 Months)||0
297176|NCT00131664|727805|P3|NOT COMPLETED|First Period (First 6 Months)||16
297177|NCT00131664|727806|P2|NOT COMPLETED|First Period (First 6 Months)||18
297178|NCT00131664|727807|P1|NOT COMPLETED|First Period (First 6 Months)||25
297179|NCT00131664|727802|P6|COMPLETED|First Period (First 6 Months)||0
297180|NCT00131664|727803|P5|COMPLETED|First Period (First 6 Months)||0
297181|NCT00131664|727804|P4|COMPLETED|First Period (First 6 Months)||0
297182|NCT00131664|727805|P3|COMPLETED|First Period (First 6 Months)||104
297183|NCT00131664|727806|P2|COMPLETED|First Period (First 6 Months)||117
297184|NCT00131664|727807|P1|COMPLETED|First Period (First 6 Months)||111
297185|NCT00131664|727802|P6|STARTED|First Period (First 6 Months)||0
297186|NCT00131664|727803|P5|STARTED|First Period (First 6 Months)||0
297187|NCT00131664|727804|P4|STARTED|First Period (First 6 Months)||0
297188|NCT00131664|727805|P3|STARTED|First Period (First 6 Months)||120
297190|NCT00131664|727807|P1|STARTED|First Period (First 6 Months)||136
297191|NCT00131573|727868|P2|NOT COMPLETED|Overall Study||26
297192|NCT00131573|727869|P1|NOT COMPLETED|Overall Study||33
297193|NCT00131573|727868|P2|COMPLETED|Overall Study||13
297194|NCT00131573|727869|P1|COMPLETED|Overall Study||13
297195|NCT00131573|727868|P2|STARTED|Overall Study||39
297196|NCT00131573|727869|P1|STARTED|Overall Study||46
297197|NCT00131508|727879|P2|NOT COMPLETED|Overall Study||8
297198|NCT00131508|727880|P1|NOT COMPLETED|Overall Study||3
297199|NCT00131508|727879|P2|COMPLETED|Overall Study||5
297200|NCT00131508|727880|P1|COMPLETED|Overall Study||9
297201|NCT00131508|727879|P2|STARTED|Overall Study||13
297202|NCT00131508|727880|P1|STARTED|Overall Study||12
297203|NCT00131456|727904|P2|NOT COMPLETED|Overall Study||20
297204|NCT00131456|727905|P1|NOT COMPLETED|Overall Study||19
297205|NCT00131456|727904|P2|COMPLETED|Overall Study||31
297206|NCT00131456|727905|P1|COMPLETED|Overall Study||33
297207|NCT00131456|727904|P2|STARTED|Overall Study||51
297208|NCT00131456|727905|P1|STARTED|Overall Study||52
297209|NCT00131378|727915|P4|NOT COMPLETED|Overall Study||9
297210|NCT00131378|727916|P3|NOT COMPLETED|Overall Study||10
297211|NCT00131378|727917|P2|NOT COMPLETED|Overall Study||18
297212|NCT00131378|727918|P1|NOT COMPLETED|Overall Study||11
297213|NCT00131378|727915|P4|COMPLETED|Overall Study||21
297214|NCT00131378|727916|P3|COMPLETED|Overall Study||22
297215|NCT00131378|727917|P2|COMPLETED|Overall Study||22
297216|NCT00131378|727918|P1|COMPLETED|Overall Study||29
297217|NCT00131378|727915|P4|STARTED|Overall Study||30
297218|NCT00131378|727916|P3|STARTED|Overall Study||32
297219|NCT00131378|727917|P2|STARTED|Overall Study||40
297220|NCT00131378|727918|P1|STARTED|Overall Study||40
297221|NCT00131352|727942|P2|NOT COMPLETED|Repeat Treatment Period||0
297222|NCT00131352|727943|P1|NOT COMPLETED|Repeat Treatment Period||2
297223|NCT00131352|727942|P2|COMPLETED|Repeat Treatment Period||0
297224|NCT00131352|727943|P1|COMPLETED|Repeat Treatment Period||158
297225|NCT00131352|727942|P2|STARTED|Repeat Treatment Period||0
297226|NCT00131352|727943|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
297227|NCT00131352|727942|P2|NOT COMPLETED|Initial Treatment Period||12
297228|NCT00131352|727943|P1|NOT COMPLETED|Initial Treatment Period||9
297229|NCT00131352|727942|P2|COMPLETED|Initial Treatment Period||118
297230|NCT00131352|727943|P1|COMPLETED|Initial Treatment Period||114
297231|NCT00131352|727942|P2|Intent to Treat Population|Initial Treatment Period||129
297232|NCT00131352|727943|P1|Intent to Treat Population|Initial Treatment Period||124
297233|NCT00131352|727942|P2|STARTED|Initial Treatment Period|Safety population|130
297234|NCT00131352|727943|P1|STARTED|Initial Treatment Period|Safety population|123
297235|NCT00131248|727965|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
297236|NCT00131248|727966|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
297237|NCT00131248|727965|P2|COMPLETED|Intervention 3 (4-day Course)||9
297238|NCT00131248|727966|P1|COMPLETED|Intervention 3 (4-day Course)||8
297239|NCT00131248|727965|P2|STARTED|Intervention 3 (4-day Course)||9
297240|NCT00131248|727966|P1|STARTED|Intervention 3 (4-day Course)||8
297241|NCT00131248|727965|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
297242|NCT00131248|727966|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
297243|NCT00131248|727965|P2|COMPLETED|Washout 2 (24 Hours)||9
297244|NCT00131248|727966|P1|COMPLETED|Washout 2 (24 Hours)||8
297245|NCT00131248|727965|P2|STARTED|Washout 2 (24 Hours)||9
297246|NCT00131248|727966|P1|STARTED|Washout 2 (24 Hours)||8
297247|NCT00131248|727965|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
297248|NCT00131248|727966|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
297249|NCT00131248|727965|P2|COMPLETED|Intervention 2 (7-day Course)||9
297250|NCT00131248|727966|P1|COMPLETED|Intervention 2 (7-day Course)||8
297251|NCT00131248|727965|P2|STARTED|Intervention 2 (7-day Course)||9
297252|NCT00131248|727966|P1|STARTED|Intervention 2 (7-day Course)||8
297253|NCT00131248|727965|P2|NOT COMPLETED|Washout (24 Hour)||0
297254|NCT00131248|727966|P1|NOT COMPLETED|Washout (24 Hour)||0
297255|NCT00131248|727965|P2|COMPLETED|Washout (24 Hour)||9
297256|NCT00131248|727966|P1|COMPLETED|Washout (24 Hour)||8
297257|NCT00131248|727965|P2|STARTED|Washout (24 Hour)||9
297258|NCT00131248|727966|P1|STARTED|Washout (24 Hour)||8
297259|NCT00131248|727965|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
297260|NCT00131248|727966|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
297261|NCT00131248|727965|P2|COMPLETED|Intervention 1 (3-day Course)||9
297262|NCT00131248|727966|P1|COMPLETED|Intervention 1 (3-day Course)||8
297263|NCT00131248|727965|P2|STARTED|Intervention 1 (3-day Course)||9
297264|NCT00131248|727966|P1|STARTED|Intervention 1 (3-day Course)||9
297265|NCT00130923|727974|P2|NOT COMPLETED|Overall Study||14
297266|NCT00130923|727975|P1|NOT COMPLETED|Overall Study||13
297267|NCT00130923|727974|P2|COMPLETED|Overall Study||32
297268|NCT00130923|727975|P1|COMPLETED|Overall Study||36
297269|NCT00130923|727974|P2|STARTED|Overall Study||46
297270|NCT00130923|727975|P1|STARTED|Overall Study||49
297271|NCT00130832|727983|P2|NOT COMPLETED|Overall Study||17
297272|NCT00130832|727984|P1|NOT COMPLETED|Overall Study||16
297273|NCT00130832|727983|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
297274|NCT00130832|727984|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
297275|NCT00130832|727983|P2|STARTED|Overall Study||363
297276|NCT00130832|727984|P1|STARTED|Overall Study||372
297277|NCT00130793|727996|P2|NOT COMPLETED|Overall Study||4
297278|NCT00130793|727997|P1|NOT COMPLETED|Overall Study||3
297279|NCT00130793|727996|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
297280|NCT00130793|727997|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
297281|NCT00130793|727996|P2|Vaccinated|Overall Study||185
297282|NCT00130793|727997|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
297283|NCT00130793|727996|P2|STARTED|Overall Study||185
297284|NCT00130793|727997|P1|STARTED|Overall Study||183
297285|NCT00130780|728009|P2|NOT COMPLETED|Overall Study||0
297286|NCT00130780|728010|P1|NOT COMPLETED|Overall Study||0
297287|NCT00130780|728009|P2|COMPLETED|Overall Study||20
297288|NCT00130780|728010|P1|COMPLETED|Overall Study||51
297289|NCT00130780|728009|P2|STARTED|Overall Study||20
297290|NCT00130780|728010|P1|STARTED|Overall Study||51
297291|NCT00130728|728018|P2|NOT COMPLETED|Overall Study||213
297292|NCT00130728|728019|P1|NOT COMPLETED|Overall Study||211
297293|NCT00130728|728018|P2|COMPLETED|Overall Study||104
297294|NCT00130728|728019|P1|COMPLETED|Overall Study||108
297295|NCT00130728|728018|P2|Received Study Drug (Safety Population)|Overall Study||313
297296|NCT00130728|728019|P1|Received Study Drug (Safety Population)|Overall Study||313
297297|NCT00130728|728018|P2|STARTED|Overall Study||317
297298|NCT00130728|728019|P1|STARTED|Overall Study||319
297299|NCT00130689|728031|P1|NOT COMPLETED|Overall Study||43
297300|NCT00130689|728031|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
297301|NCT00130689|728031|P1|Treated|Overall Study||35
297302|NCT00130689|728031|P1|Eligible|Overall Study||37
297303|NCT00130689|728031|P1|STARTED|Overall Study||43
297304|NCT00130637|728035|P1|NOT COMPLETED|Overall Study||3
297305|NCT00130637|728035|P1|COMPLETED|Overall Study||3
297306|NCT00130637|728035|P1|STARTED|Overall Study||6
297307|NCT00130520|728040|P1|NOT COMPLETED|Overall Study||39
297308|NCT00130520|728040|P1|COMPLETED|Overall Study||1
297309|NCT00130520|728040|P1|Completion of at Least One Cycle|Overall Study||39
297310|NCT00130520|728040|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
297311|NCT00130286|728050|P4|NOT COMPLETED|Overall Study||2
297312|NCT00130286|728051|P3|NOT COMPLETED|Overall Study||4
297313|NCT00130286|728052|P2|NOT COMPLETED|Overall Study||3
297314|NCT00130286|728053|P1|NOT COMPLETED|Overall Study||0
297315|NCT00130286|728050|P4|COMPLETED|Overall Study||17
297316|NCT00130286|728051|P3|COMPLETED|Overall Study||13
297317|NCT00130286|728052|P2|COMPLETED|Overall Study||16
297318|NCT00130286|728053|P1|COMPLETED|Overall Study||22
297319|NCT00130286|728050|P4|STARTED|Overall Study||19
297320|NCT00130286|728051|P3|STARTED|Overall Study||17
297321|NCT00130286|728052|P2|STARTED|Overall Study||19
297322|NCT00130286|728053|P1|STARTED|Overall Study||22
297323|NCT00130247|728073|P2|NOT COMPLETED|Overall Study||4
297324|NCT00130247|728074|P1|NOT COMPLETED|Overall Study||2
297325|NCT00130247|728073|P2|COMPLETED|Overall Study||194
297326|NCT00130247|728074|P1|COMPLETED|Overall Study||194
297327|NCT00130247|728073|P2|STARTED|Overall Study||198
297328|NCT00130247|728074|P1|STARTED|Overall Study||196
297329|NCT00130208|728092|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
297330|NCT00130208|728093|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
297331|NCT00130208|728092|P2|COMPLETED|Washout Period (8 Weeks)||490
297332|NCT00130208|728093|P1|COMPLETED|Washout Period (8 Weeks)||494
297333|NCT00130208|728092|P2|STARTED|Washout Period (8 Weeks)||502
297334|NCT00130208|728093|P1|STARTED|Washout Period (8 Weeks)||500
297335|NCT00130208|728092|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
297336|NCT00130208|728093|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
297337|NCT00130208|728092|P2|COMPLETED|Maintenance Period (26 Weeks)||502
297338|NCT00130208|728093|P1|COMPLETED|Maintenance Period (26 Weeks)||500
297339|NCT00130208|728092|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
297340|NCT00130208|728093|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
297341|NCT00130208|728092|P2|STARTED|Maintenance Period (26 Weeks)||532
297342|NCT00130208|728093|P1|STARTED|Maintenance Period (26 Weeks)||524
297343|NCT00130117|728105|P2|NOT COMPLETED|Overall Study||3
297344|NCT00130117|728106|P1|NOT COMPLETED|Overall Study||4
297345|NCT00130117|728105|P2|COMPLETED|Overall Study||6
297346|NCT00130117|728106|P1|COMPLETED|Overall Study||7
297347|NCT00130117|728105|P2|STARTED|Overall Study||9
297348|NCT00130117|728106|P1|STARTED|Overall Study||11
297349|NCT00130039|728129|P2|NOT COMPLETED|Overall Study||18
297350|NCT00130039|728130|P1|NOT COMPLETED|Overall Study||30
297351|NCT00130039|728129|P2|COMPLETED|Overall Study|full analysis set|207
297352|NCT00130039|728130|P1|COMPLETED|Overall Study|full analysis set|202
297353|NCT00130039|728129|P2|STARTED|Overall Study||225
297354|NCT00130039|728130|P1|STARTED|Overall Study||232
297355|NCT00129974|728146|P1|NOT COMPLETED|Overall Study||1
297356|NCT00129974|728146|P1|COMPLETED|Overall Study||0
297357|NCT00129974|728146|P1|STARTED|Overall Study||1
297358|NCT00129961|728153|P2|NOT COMPLETED|Overall Study||23
297359|NCT00129961|728154|P1|NOT COMPLETED|Overall Study||19
297360|NCT00129961|728153|P2|COMPLETED|Overall Study||24
297361|NCT00129961|728154|P1|COMPLETED|Overall Study||20
297362|NCT00129961|728153|P2|STARTED|Overall Study||47
297363|NCT00129961|728154|P1|STARTED|Overall Study||39
297364|NCT00129766|728190|P2|NOT COMPLETED|Overall Study||59
297365|NCT00129766|728191|P1|NOT COMPLETED|Overall Study||60
297366|NCT00129766|728190|P2|COMPLETED|Overall Study||3270
297367|NCT00129766|728191|P1|COMPLETED|Overall Study||3246
297368|NCT00129766|728190|P2|STARTED|Overall Study||3329
297369|NCT00129766|728191|P1|STARTED|Overall Study||3306
297370|NCT00129727|728229|P1|NOT COMPLETED|Overall Study||5
297371|NCT00129727|728229|P1|COMPLETED|Overall Study||57
297372|NCT00129727|728229|P1|STARTED|Overall Study||62
297373|NCT00129623|728237|P2|NOT COMPLETED|Overall Study||12
297374|NCT00129623|728238|P1|NOT COMPLETED|Overall Study||10
297375|NCT00129623|728237|P2|COMPLETED|Overall Study||65
297376|NCT00129623|728238|P1|COMPLETED|Overall Study||73
297377|NCT00129623|728237|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
297378|NCT00129623|728238|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
297379|NCT00129623|728237|P2|STARTED|Overall Study||77
297380|NCT00129623|728238|P1|STARTED|Overall Study||83
297381|NCT00129545|728263|P3|NOT COMPLETED|Overall Study||111
297382|NCT00129545|728264|P2|NOT COMPLETED|Overall Study||164
297383|NCT00129545|728265|P1|NOT COMPLETED|Overall Study||26
297384|NCT00129545|728263|P3|COMPLETED|Overall Study||133
297385|NCT00129545|728264|P2|COMPLETED|Overall Study||299
297386|NCT00129545|728265|P1|COMPLETED|Overall Study||67
297387|NCT00129545|728263|P3|STARTED|Overall Study||244
297388|NCT00129545|728264|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
297389|NCT00129545|728265|P1|STARTED|Overall Study||93
297390|NCT00129480|728277|P2|NOT COMPLETED|Overall Study||0
297391|NCT00129480|728278|P1|NOT COMPLETED|Overall Study||0
297392|NCT00129480|728277|P2|COMPLETED|Overall Study||214
297393|NCT00129480|728278|P1|COMPLETED|Overall Study||187
297394|NCT00129480|728277|P2|STARTED|Overall Study||214
297395|NCT00129480|728278|P1|STARTED|Overall Study||187
297396|NCT00129467|728286|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
297397|NCT00129467|728287|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
297398|NCT00129467|728286|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
297399|NCT00129467|728287|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
297400|NCT00129467|728286|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
297401|NCT00129467|728287|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
297402|NCT00129467|728286|P2|NOT COMPLETED|Received Intervention||4
297403|NCT00129467|728287|P1|NOT COMPLETED|Received Intervention||6
297404|NCT00129467|728286|P2|COMPLETED|Received Intervention||13
297405|NCT00129467|728287|P1|COMPLETED|Received Intervention||9
297406|NCT00129467|728286|P2|STARTED|Received Intervention||17
297407|NCT00129467|728287|P1|STARTED|Received Intervention||15
297408|NCT00129441|728295|P2|NOT COMPLETED|Overall Study||0
297409|NCT00129441|728296|P1|NOT COMPLETED|Overall Study||0
297410|NCT00129441|728295|P2|COMPLETED|Overall Study||6
297411|NCT00129441|728296|P1|COMPLETED|Overall Study||9
297412|NCT00129441|728295|P2|Year 1, Visit 8|Overall Study||6
297413|NCT00129441|728296|P1|Year 1, Visit 8|Overall Study||9
297414|NCT00129441|728295|P2|Week 26, Visit 7|Overall Study||6
297415|NCT00129441|728296|P1|Week 26, Visit 7|Overall Study||9
297416|NCT00129441|728295|P2|Week 5, Visit 6|Overall Study||6
297417|NCT00129441|728296|P1|Week 5, Visit 6|Overall Study||9
297418|NCT00129441|728295|P2|Week 4, Visit 5|Overall Study||6
297419|NCT00129441|728296|P1|Week 4, Visit 5|Overall Study||9
297420|NCT00129441|728295|P2|Week 3, Visit 4|Overall Study||6
297421|NCT00129441|728296|P1|Week 3, Visit 4|Overall Study||9
297422|NCT00129441|728295|P2|Week 2, Visit 3|Overall Study||6
297423|NCT00129441|728296|P1|Week 2, Visit 3|Overall Study||9
297424|NCT00129441|728295|P2|Week 1, Visit 2|Overall Study||6
297425|NCT00129441|728296|P1|Week 1, Visit 2|Overall Study||9
297426|NCT00129441|728295|P2|Baseline, Visit 1|Overall Study||6
297427|NCT00129441|728296|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
297428|NCT00129441|728295|P2|STARTED|Overall Study||6
297429|NCT00129441|728296|P1|STARTED|Overall Study||9
297430|NCT00129402|728318|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
297431|NCT00129402|728319|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297432|NCT00129402|728320|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297433|NCT00129402|728321|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297434|NCT00129402|728322|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297435|NCT00129402|728323|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297436|NCT00129402|728324|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297437|NCT00129402|728318|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
297438|NCT00129402|728319|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297439|NCT00129402|728320|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297440|NCT00129402|728321|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297441|NCT00129402|728322|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297442|NCT00129402|728323|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297443|NCT00129402|728324|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
297444|NCT00129402|728318|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
297445|NCT00129402|728319|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
297446|NCT00129402|728320|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
297447|NCT00129402|728321|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
297448|NCT00129402|728322|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
297449|NCT00129402|728323|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
297450|NCT00129402|728324|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
297451|NCT00129402|728318|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297452|NCT00129402|728319|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
297453|NCT00129402|728320|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297454|NCT00129402|728321|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297455|NCT00129402|728322|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
297456|NCT00129402|728323|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297457|NCT00129402|728324|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297458|NCT00129402|728318|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297459|NCT00129402|728319|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
297460|NCT00129402|728320|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297461|NCT00129402|728321|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297462|NCT00129402|728322|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
297463|NCT00129402|728323|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297464|NCT00129402|728324|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
297465|NCT00129402|728318|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
297466|NCT00129402|728319|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
297467|NCT00129402|728320|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
297468|NCT00129402|728321|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
297469|NCT00129402|728322|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
297470|NCT00129402|728323|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
297471|NCT00129402|728324|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
297472|NCT00129402|728318|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
297473|NCT00129402|728319|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
297474|NCT00129402|728320|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
297475|NCT00129402|728321|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
297476|NCT00129402|728322|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
297477|NCT00129402|728323|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
297478|NCT00129402|728324|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
297479|NCT00129402|728318|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
297480|NCT00129402|728319|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
297481|NCT00129402|728320|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
297482|NCT00129402|728321|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
297483|NCT00129402|728322|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
297484|NCT00129402|728323|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
297485|NCT00129402|728324|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
297486|NCT00129402|728318|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
297487|NCT00129402|728319|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
297488|NCT00129402|728320|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
297489|NCT00129402|728321|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
297490|NCT00129402|728322|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
297491|NCT00129402|728323|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
297492|NCT00129402|728324|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
297493|NCT00129311|728343|P2|NOT COMPLETED|Overall Study||19
297494|NCT00129311|728344|P1|NOT COMPLETED|Overall Study||12
297495|NCT00129311|728343|P2|COMPLETED|Overall Study||31
297496|NCT00129311|728344|P1|COMPLETED|Overall Study||39
297497|NCT00129311|728343|P2|STARTED|Overall Study||50
297498|NCT00129311|728344|P1|STARTED|Overall Study||51
297499|NCT00129285|728355|P3|NOT COMPLETED|Overall Study||38
297500|NCT00129285|728356|P2|NOT COMPLETED|Overall Study||27
297501|NCT00129285|728357|P1|NOT COMPLETED|Overall Study||25
297502|NCT00129285|728355|P3|COMPLETED|Overall Study||37
297503|NCT00129285|728356|P2|COMPLETED|Overall Study||43
297504|NCT00129285|728357|P1|COMPLETED|Overall Study||40
297505|NCT00129285|728355|P3|STARTED|Overall Study||75
297506|NCT00129285|728356|P2|STARTED|Overall Study||70
297507|NCT00129285|728357|P1|STARTED|Overall Study||65
297508|NCT00129272|728373|P2|NOT COMPLETED|Overall Study||22
297509|NCT00129272|728374|P1|NOT COMPLETED|Overall Study||17
297510|NCT00129272|728373|P2|COMPLETED|Overall Study||51
297511|NCT00129272|728374|P1|COMPLETED|Overall Study||54
297512|NCT00129272|728373|P2|STARTED|Overall Study||73
297513|NCT00129272|728374|P1|STARTED|Overall Study||71
297514|NCT00129259|728384|P2|NOT COMPLETED|Overall Study||3
297515|NCT00129259|728385|P1|NOT COMPLETED|Overall Study||3
297516|NCT00129259|728384|P2|COMPLETED|Overall Study||22
297517|NCT00129259|728385|P1|COMPLETED|Overall Study||49
297518|NCT00129259|728384|P2|Received All or Part of Cycle 2|Overall Study||0
297519|NCT00129259|728385|P1|Received All or Part of Cycle 2|Overall Study||40
297520|NCT00129259|728384|P2|Received All or Part of Cycle 1|Overall Study||0
297521|NCT00129259|728385|P1|Received All or Part of Cycle 1|Overall Study||52
297522|NCT00129259|728384|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
297523|NCT00129259|728385|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
297524|NCT00129246|728397|P2|NOT COMPLETED|Overall Study||0
297525|NCT00129246|728398|P1|NOT COMPLETED|Overall Study||0
297526|NCT00129246|728397|P2|COMPLETED|Overall Study||20
297527|NCT00129246|728398|P1|COMPLETED|Overall Study||20
297528|NCT00129246|728397|P2|STARTED|Overall Study||20
297529|NCT00129246|728398|P1|STARTED|Overall Study||20
297530|NCT00129220|728413|P3|NOT COMPLETED|Study Period III||10
297531|NCT00129220|728414|P2|NOT COMPLETED|Study Period III||1
297532|NCT00129220|728415|P1|NOT COMPLETED|Study Period III||13
297533|NCT00129220|728413|P3|COMPLETED|Study Period III||42
297534|NCT00129220|728414|P2|COMPLETED|Study Period III||7
297535|NCT00129220|728415|P1|COMPLETED|Study Period III||59
297536|NCT00129220|728413|P3|STARTED|Study Period III||52
297537|NCT00129220|728414|P2|STARTED|Study Period III||8
297538|NCT00129220|728415|P1|STARTED|Study Period III||72
297539|NCT00129220|728413|P3|NOT COMPLETED|Study Period II||47
297540|NCT00129220|728414|P2|NOT COMPLETED|Study Period II||12
297541|NCT00129220|728415|P1|NOT COMPLETED|Study Period II||33
297542|NCT00129220|728413|P3|COMPLETED|Study Period II||52
297543|NCT00129220|728414|P2|COMPLETED|Study Period II||8
297544|NCT00129220|728415|P1|COMPLETED|Study Period II||72
297545|NCT00129220|728413|P3|Received at Least One Dose of Study Drug|Study Period II||97
297546|NCT00129220|728414|P2|Received at Least One Dose of Study Drug|Study Period II||20
297547|NCT00129220|728415|P1|Received at Least One Dose of Study Drug|Study Period II||104
297548|NCT00129220|728413|P3|STARTED|Study Period II||99
297549|NCT00129220|728414|P2|STARTED|Study Period II||20
297550|NCT00129220|728415|P1|STARTED|Study Period II||105
297551|NCT00129129|728455|P5|NOT COMPLETED|Fourth Dose Phase||6
297552|NCT00129129|728456|P4|NOT COMPLETED|Fourth Dose Phase||4
297553|NCT00129129|728457|P3|NOT COMPLETED|Fourth Dose Phase||0
297554|NCT00129129|728458|P2|NOT COMPLETED|Fourth Dose Phase||0
297555|NCT00129129|728459|P1|NOT COMPLETED|Fourth Dose Phase||4
297556|NCT00129129|728455|P5|COMPLETED|Fourth Dose Phase||124
297557|NCT00129129|728456|P4|COMPLETED|Fourth Dose Phase||128
297558|NCT00129129|728457|P3|COMPLETED|Fourth Dose Phase||0
297559|NCT00129129|728458|P2|COMPLETED|Fourth Dose Phase||0
297560|NCT00129129|728459|P1|COMPLETED|Fourth Dose Phase||232
297561|NCT00129129|728455|P5|STARTED|Fourth Dose Phase||130
297562|NCT00129129|728456|P4|STARTED|Fourth Dose Phase||132
297563|NCT00129129|728457|P3|STARTED|Fourth Dose Phase||0
297564|NCT00129129|728458|P2|STARTED|Fourth Dose Phase||0
297565|NCT00129129|728459|P1|STARTED|Fourth Dose Phase||236
297566|NCT00129129|728455|P5|NOT COMPLETED|Primary Phase||0
297567|NCT00129129|728456|P4|NOT COMPLETED|Primary Phase||0
297568|NCT00129129|728457|P3|NOT COMPLETED|Primary Phase||0
297569|NCT00129129|728458|P2|NOT COMPLETED|Primary Phase||25
297570|NCT00129129|728459|P1|NOT COMPLETED|Primary Phase||25
297571|NCT00129129|728455|P5|COMPLETED|Primary Phase||0
297572|NCT00129129|728456|P4|COMPLETED|Primary Phase||0
297573|NCT00129129|728457|P3|COMPLETED|Primary Phase||150
297574|NCT00129129|728458|P2|COMPLETED|Primary Phase||294
297575|NCT00129129|728459|P1|COMPLETED|Primary Phase||262
297576|NCT00129129|728455|P5|STARTED|Primary Phase||0
297577|NCT00129129|728456|P4|STARTED|Primary Phase||0
297578|NCT00129129|728457|P3|STARTED|Primary Phase||150
297579|NCT00129129|728458|P2|STARTED|Primary Phase||319
297580|NCT00129129|728459|P1|STARTED|Primary Phase||287
297581|NCT00129116|728666|P5|NOT COMPLETED|Booster Phase||1
297582|NCT00129116|728667|P4|NOT COMPLETED|Booster Phase||0
297583|NCT00129116|728668|P3|NOT COMPLETED|Booster Phase||0
297584|NCT00129116|728669|P2|NOT COMPLETED|Booster Phase||0
297585|NCT00129116|728670|P1|NOT COMPLETED|Booster Phase||2
297586|NCT00129116|728666|P5|COMPLETED|Booster Phase||43
297587|NCT00129116|728667|P4|COMPLETED|Booster Phase||44
297588|NCT00129116|728668|P3|COMPLETED|Booster Phase||44
297589|NCT00129116|728669|P2|COMPLETED|Booster Phase||42
297590|NCT00129116|728670|P1|COMPLETED|Booster Phase||45
297591|NCT00129116|728666|P5|STARTED|Booster Phase||44
297592|NCT00129116|728667|P4|STARTED|Booster Phase||44
297593|NCT00129116|728668|P3|STARTED|Booster Phase||44
297594|NCT00129116|728669|P2|STARTED|Booster Phase||42
297595|NCT00129116|728670|P1|STARTED|Booster Phase||47
297596|NCT00129116|728666|P5|NOT COMPLETED|Primary Phase||1
297597|NCT00129116|728667|P4|NOT COMPLETED|Primary Phase||1
297598|NCT00129116|728668|P3|NOT COMPLETED|Primary Phase||1
297599|NCT00129116|728669|P2|NOT COMPLETED|Primary Phase||4
297600|NCT00129116|728670|P1|NOT COMPLETED|Primary Phase||2
297601|NCT00129116|728666|P5|COMPLETED|Primary Phase||76
297602|NCT00129116|728667|P4|COMPLETED|Primary Phase||77
297603|NCT00129116|728668|P3|COMPLETED|Primary Phase||77
297604|NCT00129116|728669|P2|COMPLETED|Primary Phase||73
297605|NCT00129116|728670|P1|COMPLETED|Primary Phase||76
297606|NCT00129116|728666|P5|STARTED|Primary Phase||77
297607|NCT00129116|728667|P4|STARTED|Primary Phase||78
297608|NCT00129116|728668|P3|STARTED|Primary Phase||78
297609|NCT00129116|728669|P2|STARTED|Primary Phase||77
297610|NCT00129116|728670|P1|STARTED|Primary Phase||78
297611|NCT00128921|728935|P3|NOT COMPLETED|Overall Study||0
297612|NCT00128921|728936|P2|NOT COMPLETED|Overall Study||5
297613|NCT00128921|728937|P1|NOT COMPLETED|Overall Study||5
297614|NCT00128921|728935|P3|COMPLETED|Overall Study||0
297615|NCT00128921|728936|P2|COMPLETED|Overall Study||3
297616|NCT00128921|728937|P1|COMPLETED|Overall Study||5
297617|NCT00128921|728935|P3|Received Bortezomib|Overall Study||0
297618|NCT00128921|728936|P2|Received Bortezomib|Overall Study||6
297619|NCT00128921|728937|P1|Received Bortezomib|Overall Study||10
297620|NCT00128921|728935|P3|STARTED|Overall Study||0
297621|NCT00128921|728936|P2|STARTED|Overall Study||8
297622|NCT00128921|728937|P1|STARTED|Overall Study||10
297623|NCT00128830|728954|P1|NOT COMPLETED|Overall Study||72
297624|NCT00128830|728954|P1|COMPLETED|Overall Study||139
297625|NCT00128830|728954|P1|STARTED|Overall Study||211
297626|NCT00128713|728972|P3|NOT COMPLETED|Overall Study||0
297627|NCT00128713|728973|P2|NOT COMPLETED|Overall Study||0
297628|NCT00128713|728974|P1|NOT COMPLETED|Overall Study||0
297629|NCT00128713|728972|P3|COMPLETED|Overall Study||449
297630|NCT00128713|728973|P2|COMPLETED|Overall Study||449
297631|NCT00128713|728974|P1|COMPLETED|Overall Study||453
297632|NCT00128713|728972|P3|STARTED|Overall Study||449
297633|NCT00128713|728973|P2|STARTED|Overall Study||449
297634|NCT00128713|728974|P1|STARTED|Overall Study||453
297635|NCT00128661|728996|P2|NOT COMPLETED|Overall Study||258
297636|NCT00128661|728997|P1|NOT COMPLETED|Overall Study||274
297637|NCT00128661|728996|P2|COMPLETED|Overall Study||3481
297638|NCT00128661|728997|P1|COMPLETED|Overall Study||3453
297639|NCT00128661|728996|P2|STARTED|Overall Study||3739
297640|NCT00128661|728997|P1|STARTED|Overall Study||3727
297641|NCT00128492|729043|P2|NOT COMPLETED|Overall Study||59
297642|NCT00128492|729044|P1|NOT COMPLETED|Overall Study||20
297643|NCT00128492|729043|P2|COMPLETED|Overall Study||130
297644|NCT00128492|729044|P1|COMPLETED|Overall Study||65
297645|NCT00128492|729043|P2|STARTED|Overall Study||189
297646|NCT00128492|729044|P1|STARTED|Overall Study||85
297647|NCT00128401|729104|P2|NOT COMPLETED|Overall Study||4
297648|NCT00128401|729105|P1|NOT COMPLETED|Overall Study||6
297649|NCT00128401|729104|P2|COMPLETED|Overall Study||15
297650|NCT00128401|729105|P1|COMPLETED|Overall Study||14
297651|NCT00128401|729104|P2|STARTED|Overall Study||19
297652|NCT00128401|729105|P1|STARTED|Overall Study||20
297653|NCT00128219|729116|P2|NOT COMPLETED|Overall Study||71
297654|NCT00128219|729117|P1|NOT COMPLETED|Overall Study||69
297655|NCT00128219|729116|P2|COMPLETED|Overall Study||263
297656|NCT00128219|729117|P1|COMPLETED|Overall Study||264
297657|NCT00128219|729116|P2|STARTED|Overall Study||334
297658|NCT00128219|729117|P1|STARTED|Overall Study||333
297659|NCT00128206|729201|P2|NOT COMPLETED|Overall Study||120
297660|NCT00128206|729202|P1|NOT COMPLETED|Overall Study||137
297661|NCT00128206|729201|P2|COMPLETED|Overall Study||60
297662|NCT00128206|729202|P1|COMPLETED|Overall Study||47
297663|NCT00128206|729201|P2|STARTED|Overall Study||180
297664|NCT00128206|729202|P1|STARTED|Overall Study||184
297665|NCT00128193|729220|P12|NOT COMPLETED|Overall Study||2
297666|NCT00128193|729221|P11|NOT COMPLETED|Overall Study||3
297667|NCT00128193|729222|P10|NOT COMPLETED|Overall Study||2
297668|NCT00128193|729223|P9|NOT COMPLETED|Overall Study||2
297669|NCT00128193|729224|P8|NOT COMPLETED|Overall Study||0
297670|NCT00128193|729225|P7|NOT COMPLETED|Overall Study||4
297671|NCT00128193|729226|P6|NOT COMPLETED|Overall Study||3
297672|NCT00128193|729227|P5|NOT COMPLETED|Overall Study||2
297673|NCT00128193|729228|P4|NOT COMPLETED|Overall Study||1
297674|NCT00128193|729229|P3|NOT COMPLETED|Overall Study||3
297675|NCT00128193|729230|P2|NOT COMPLETED|Overall Study||0
297676|NCT00128193|729231|P1|NOT COMPLETED|Overall Study||0
297677|NCT00128193|729220|P12|COMPLETED|Overall Study||18
297678|NCT00128193|729221|P11|COMPLETED|Overall Study||17
297679|NCT00128193|729222|P10|COMPLETED|Overall Study||18
297680|NCT00128193|729223|P9|COMPLETED|Overall Study||18
297681|NCT00128193|729224|P8|COMPLETED|Overall Study||20
297682|NCT00128193|729225|P7|COMPLETED|Overall Study||16
297683|NCT00128193|729226|P6|COMPLETED|Overall Study||17
297684|NCT00128193|729227|P5|COMPLETED|Overall Study||18
297685|NCT00128193|729228|P4|COMPLETED|Overall Study||44
297686|NCT00128193|729229|P3|COMPLETED|Overall Study||42
297687|NCT00128193|729230|P2|COMPLETED|Overall Study||5
297688|NCT00128193|729231|P1|COMPLETED|Overall Study||5
297689|NCT00128193|729220|P12|STARTED|Overall Study||20
297690|NCT00128193|729221|P11|STARTED|Overall Study||20
297691|NCT00128193|729222|P10|STARTED|Overall Study||20
297692|NCT00128193|729223|P9|STARTED|Overall Study||20
297693|NCT00128193|729224|P8|STARTED|Overall Study||20
297694|NCT00128193|729225|P7|STARTED|Overall Study||20
297695|NCT00128193|729226|P6|STARTED|Overall Study||20
297696|NCT00128193|729227|P5|STARTED|Overall Study||20
297697|NCT00128193|729228|P4|STARTED|Overall Study||45
297698|NCT00128193|729229|P3|STARTED|Overall Study||45
297699|NCT00128193|729230|P2|STARTED|Overall Study||5
297700|NCT00128193|729231|P1|STARTED|Overall Study||5
297701|NCT00128180|729467|P2|NOT COMPLETED|Overall Study||0
297702|NCT00128180|729468|P1|NOT COMPLETED|Overall Study||0
297703|NCT00128180|729467|P2|COMPLETED|Overall Study||34
297704|NCT00128180|729468|P1|COMPLETED|Overall Study||32
297705|NCT00128180|729467|P2|STARTED|Overall Study||34
297706|NCT00128180|729468|P1|STARTED|Overall Study||32
297707|NCT00127933|729494|P2|NOT COMPLETED|Overall Study||0
297708|NCT00127933|729495|P1|NOT COMPLETED|Overall Study||1
297709|NCT00127933|729494|P2|COMPLETED|Overall Study||34
297710|NCT00127933|729495|P1|COMPLETED|Overall Study||122
297711|NCT00127933|729494|P2|Postoperative|Overall Study||27
297712|NCT00127933|729495|P1|Postoperative|Overall Study||98
297713|NCT00127933|729494|P2|Quality of Life Population|Overall Study||33
297714|NCT00127933|729495|P1|Quality of Life Population|Overall Study||118
297715|NCT00127933|729494|P2|Safety Population|Overall Study||34
297716|NCT00127933|729495|P1|Safety Population|Overall Study||122
297717|NCT00127933|729494|P2|Clinical Response|Overall Study||34
297718|NCT00127933|729495|P1|Clinical Response|Overall Study||122
297719|NCT00127933|729494|P2|Pathological Response|Overall Study||28
297720|NCT00127933|729495|P1|Pathological Response|Overall Study||101
297721|NCT00127933|729494|P2|STARTED|Overall Study||34
297722|NCT00127933|729495|P1|STARTED|Overall Study||123
297723|NCT00127855|729516|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
297724|NCT00127855|729517|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
297725|NCT00127855|729518|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
297726|NCT00127855|729519|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
297727|NCT00127855|729520|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
297728|NCT00127855|729516|P5|COMPLETED|Polysaccharide Challenge Dose||77
297729|NCT00127855|729517|P4|COMPLETED|Polysaccharide Challenge Dose||81
297730|NCT00127855|729518|P3|COMPLETED|Polysaccharide Challenge Dose||77
297731|NCT00127855|729519|P2|COMPLETED|Polysaccharide Challenge Dose||79
297732|NCT00127855|729520|P1|COMPLETED|Polysaccharide Challenge Dose||80
297733|NCT00127855|729516|P5|STARTED|Polysaccharide Challenge Dose||77
297734|NCT00127855|729517|P4|STARTED|Polysaccharide Challenge Dose||81
297735|NCT00127855|729518|P3|STARTED|Polysaccharide Challenge Dose||77
297736|NCT00127855|729519|P2|STARTED|Polysaccharide Challenge Dose||79
297737|NCT00127855|729520|P1|STARTED|Polysaccharide Challenge Dose||80
297738|NCT00127855|729516|P5|NOT COMPLETED|Primary Vaccination Course||4
297739|NCT00127855|729517|P4|NOT COMPLETED|Primary Vaccination Course||0
297740|NCT00127855|729518|P3|NOT COMPLETED|Primary Vaccination Course||2
297741|NCT00127855|729519|P2|NOT COMPLETED|Primary Vaccination Course||1
297742|NCT00127855|729520|P1|NOT COMPLETED|Primary Vaccination Course||2
297743|NCT00127855|729516|P5|COMPLETED|Primary Vaccination Course||78
297744|NCT00127855|729517|P4|COMPLETED|Primary Vaccination Course||81
297745|NCT00127855|729518|P3|COMPLETED|Primary Vaccination Course||78
297746|NCT00127855|729519|P2|COMPLETED|Primary Vaccination Course||81
297747|NCT00127855|729520|P1|COMPLETED|Primary Vaccination Course||80
297748|NCT00127855|729516|P5|STARTED|Primary Vaccination Course||82
297749|NCT00127855|729517|P4|STARTED|Primary Vaccination Course||81
297750|NCT00127855|729518|P3|STARTED|Primary Vaccination Course||80
297751|NCT00127855|729519|P2|STARTED|Primary Vaccination Course||82
297752|NCT00127855|729520|P1|STARTED|Primary Vaccination Course||82
297753|NCT00127842|729702|P1|NOT COMPLETED|Overall Study||39
297754|NCT00127842|729702|P1|COMPLETED|Overall Study||71
297755|NCT00127842|729702|P1|STARTED|Overall Study||110
297756|NCT00127803|729720|P4|NOT COMPLETED|Overall Study||1
297757|NCT00127803|729721|P3|NOT COMPLETED|Overall Study||0
297758|NCT00127803|729722|P2|NOT COMPLETED|Overall Study||0
297759|NCT00127803|729723|P1|NOT COMPLETED|Overall Study||3
297760|NCT00127803|729720|P4|COMPLETED|Overall Study||11
297761|NCT00127803|729721|P3|COMPLETED|Overall Study||12
297762|NCT00127803|729722|P2|COMPLETED|Overall Study||13
297763|NCT00127803|729723|P1|COMPLETED|Overall Study||10
297764|NCT00127803|729720|P4|STARTED|Overall Study||12
297765|NCT00127803|729721|P3|STARTED|Overall Study||12
297766|NCT00127803|729722|P2|STARTED|Overall Study||13
297767|NCT00127803|729723|P1|STARTED|Overall Study||13
297768|NCT00127790|729745|P4|NOT COMPLETED|Post-Treatment||0
297769|NCT00127790|729746|P3|NOT COMPLETED|Post-Treatment||0
297770|NCT00127790|729747|P2|NOT COMPLETED|Post-Treatment||0
297771|NCT00127790|729748|P1|NOT COMPLETED|Post-Treatment||0
297772|NCT00127790|729745|P4|COMPLETED|Post-Treatment||4
297773|NCT00127790|729746|P3|COMPLETED|Post-Treatment||6
297774|NCT00127790|729747|P2|COMPLETED|Post-Treatment||5
297775|NCT00127790|729748|P1|COMPLETED|Post-Treatment||6
297776|NCT00127790|729745|P4|STARTED|Post-Treatment||4
297777|NCT00127790|729746|P3|STARTED|Post-Treatment||6
297778|NCT00127790|729747|P2|STARTED|Post-Treatment||5
297779|NCT00127790|729748|P1|STARTED|Post-Treatment||6
297780|NCT00127790|729745|P4|NOT COMPLETED|Pre-Treatment||0
297781|NCT00127790|729746|P3|NOT COMPLETED|Pre-Treatment||0
297782|NCT00127790|729747|P2|NOT COMPLETED|Pre-Treatment||0
297783|NCT00127790|729748|P1|NOT COMPLETED|Pre-Treatment||0
297784|NCT00127790|729745|P4|COMPLETED|Pre-Treatment||4
297785|NCT00127790|729746|P3|COMPLETED|Pre-Treatment||6
297786|NCT00127790|729747|P2|COMPLETED|Pre-Treatment||5
297787|NCT00127790|729748|P1|COMPLETED|Pre-Treatment||6
297788|NCT00127790|729745|P4|STARTED|Pre-Treatment||4
297789|NCT00127790|729746|P3|STARTED|Pre-Treatment||6
297790|NCT00127790|729747|P2|STARTED|Pre-Treatment||5
297791|NCT00127790|729748|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
297792|NCT00127712|729772|P2|NOT COMPLETED|Overall Study||0
297793|NCT00127712|729773|P1|NOT COMPLETED|Overall Study||5
297794|NCT00127712|729772|P2|COMPLETED|Overall Study||65
297795|NCT00127712|729773|P1|COMPLETED|Overall Study||60
297796|NCT00127712|729772|P2|STARTED|Overall Study||65
297797|NCT00127712|729773|P1|STARTED|Overall Study||65
297798|NCT00127660|729789|P4|NOT COMPLETED|Overall Study||0
297799|NCT00127660|729790|P3|NOT COMPLETED|Overall Study||5
297800|NCT00127660|729791|P2|NOT COMPLETED|Overall Study||3
297801|NCT00127660|729792|P1|NOT COMPLETED|Overall Study||3
297802|NCT00127660|729789|P4|COMPLETED|Overall Study||150
297803|NCT00127660|729790|P3|COMPLETED|Overall Study||143
297804|NCT00127660|729791|P2|COMPLETED|Overall Study||151
297805|NCT00127660|729792|P1|COMPLETED|Overall Study||150
297806|NCT00127660|729789|P4|STARTED|Overall Study||150
297807|NCT00127660|729790|P3|STARTED|Overall Study||148
297808|NCT00127660|729791|P2|STARTED|Overall Study||154
297809|NCT00127660|729792|P1|STARTED|Overall Study||153
297810|NCT00127530|729804|P2|NOT COMPLETED|Overall Study||21
297811|NCT00127530|729805|P1|NOT COMPLETED|Overall Study||1
297812|NCT00127530|729804|P2|COMPLETED|Overall Study||207
297813|NCT00127530|729805|P1|COMPLETED|Overall Study||71
297814|NCT00127530|729804|P2|STARTED|Overall Study||228
297815|NCT00127530|729805|P1|STARTED|Overall Study||72
297816|NCT00127439|729813|P2|NOT COMPLETED|Overall Study||0
297817|NCT00127439|729814|P1|NOT COMPLETED|Overall Study||0
297818|NCT00127439|729813|P2|COMPLETED|Overall Study||10
297819|NCT00127439|729814|P1|COMPLETED|Overall Study||9
297820|NCT00127439|729813|P2|STARTED|Overall Study||10
297821|NCT00127439|729814|P1|STARTED|Overall Study||9
297822|NCT00127413|729840|P4|NOT COMPLETED|Overall Study||2
297823|NCT00127413|729841|P3|NOT COMPLETED|Overall Study||8
297824|NCT00127413|729842|P2|NOT COMPLETED|Overall Study||4
297825|NCT00127413|729843|P1|NOT COMPLETED|Overall Study||6
297826|NCT00127413|729840|P4|COMPLETED|Overall Study||5
297827|NCT00127413|729841|P3|COMPLETED|Overall Study||5
297828|NCT00127413|729842|P2|COMPLETED|Overall Study||6
297829|NCT00127413|729843|P1|COMPLETED|Overall Study||6
297830|NCT00127413|729840|P4|STARTED|Overall Study||7
297831|NCT00127413|729841|P3|STARTED|Overall Study||13
297832|NCT00127413|729842|P2|STARTED|Overall Study||10
297833|NCT00127413|729843|P1|STARTED|Overall Study||12
297834|NCT00127231|729855|P2|NOT COMPLETED|Overall Study||6
297835|NCT00127231|729856|P1|NOT COMPLETED|Overall Study||6
297836|NCT00127231|729855|P2|COMPLETED|Overall Study||68
297837|NCT00127231|729856|P1|COMPLETED|Overall Study||68
297838|NCT00127231|729855|P2|STARTED|Overall Study||74
297839|NCT00127231|729856|P1|STARTED|Overall Study||74
297840|NCT00127218|729872|P2|NOT COMPLETED|Overall Study||15
297841|NCT00127218|729873|P1|NOT COMPLETED|Overall Study||13
297842|NCT00127218|729872|P2|COMPLETED|Overall Study||58
297843|NCT00127218|729873|P1|COMPLETED|Overall Study||59
297844|NCT00127218|729872|P2|STARTED|Overall Study||73
297845|NCT00127218|729873|P1|STARTED|Overall Study||72
297846|NCT00127192|729886|P5|NOT COMPLETED|Overall Study||5
297847|NCT00127192|729887|P4|NOT COMPLETED|Overall Study||1
297848|NCT00127192|729888|P3|NOT COMPLETED|Overall Study||2
297849|NCT00127192|729889|P2|NOT COMPLETED|Overall Study||1
297850|NCT00127192|729890|P1|NOT COMPLETED|Overall Study||3
297851|NCT00127192|729886|P5|COMPLETED|Overall Study||68
297852|NCT00127192|729887|P4|COMPLETED|Overall Study||67
297853|NCT00127192|729888|P3|COMPLETED|Overall Study||68
297854|NCT00127192|729889|P2|COMPLETED|Overall Study||71
297855|NCT00127192|729890|P1|COMPLETED|Overall Study||77
297856|NCT00127192|729886|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
297857|NCT00127192|729887|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
297858|NCT00127192|729888|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
297859|NCT00127192|729889|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
297860|NCT00127192|729890|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
297861|NCT00127166|729914|P2|NOT COMPLETED|Period II||0
297862|NCT00127166|729915|P1|NOT COMPLETED|Period II||3
297863|NCT00127166|729914|P2|COMPLETED|Period II||73
297864|NCT00127166|729915|P1|COMPLETED|Period II||72
297865|NCT00127166|729914|P2|STARTED|Period II||73
297866|NCT00127166|729915|P1|STARTED|Period II||75
297867|NCT00127166|729914|P2|NOT COMPLETED|Washout Period||1
297868|NCT00127166|729915|P1|NOT COMPLETED|Washout Period||0
297869|NCT00127166|729914|P2|COMPLETED|Washout Period||73
297870|NCT00127166|729915|P1|COMPLETED|Washout Period||75
297871|NCT00127166|729914|P2|STARTED|Washout Period||74
297872|NCT00127166|729915|P1|STARTED|Washout Period||75
297873|NCT00127166|729914|P2|NOT COMPLETED|Period I||2
297874|NCT00127166|729915|P1|NOT COMPLETED|Period I||3
297875|NCT00127166|729914|P2|COMPLETED|Period I||74
297876|NCT00127166|729915|P1|COMPLETED|Period I||75
297877|NCT00127166|729914|P2|STARTED|Period I||76
297878|NCT00127166|729915|P1|STARTED|Period I||78
297879|NCT00127101|729935|P6|NOT COMPLETED|Continuation Phase||3
297880|NCT00127101|729936|P5|NOT COMPLETED|Continuation Phase||3
297881|NCT00127101|729937|P4|NOT COMPLETED|Continuation Phase||0
297882|NCT00127101|729938|P3|NOT COMPLETED|Continuation Phase||1
297883|NCT00127101|729939|P2|NOT COMPLETED|Continuation Phase||0
297884|NCT00127101|729940|P1|NOT COMPLETED|Continuation Phase||0
297885|NCT00127101|729935|P6|COMPLETED|Continuation Phase||0
297886|NCT00127101|729936|P5|COMPLETED|Continuation Phase||0
297887|NCT00127101|729937|P4|COMPLETED|Continuation Phase||0
297888|NCT00127101|729938|P3|COMPLETED|Continuation Phase||0
297889|NCT00127101|729939|P2|COMPLETED|Continuation Phase||0
297890|NCT00127101|729940|P1|COMPLETED|Continuation Phase||0
297891|NCT00127101|729935|P6|STARTED|Continuation Phase||3
297892|NCT00127101|729936|P5|STARTED|Continuation Phase||3
297893|NCT00127101|729937|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
297894|NCT00127101|729938|P3|STARTED|Continuation Phase||1
297895|NCT00127101|729939|P2|STARTED|Continuation Phase||0
297896|NCT00127101|729940|P1|STARTED|Continuation Phase||0
297897|NCT00127101|729935|P6|NOT COMPLETED|Base Protocol||1
297898|NCT00127101|729936|P5|NOT COMPLETED|Base Protocol||2
297899|NCT00127101|729937|P4|NOT COMPLETED|Base Protocol||0
297900|NCT00127101|729938|P3|NOT COMPLETED|Base Protocol||2
297901|NCT00127101|729939|P2|NOT COMPLETED|Base Protocol||4
297902|NCT00127101|729940|P1|NOT COMPLETED|Base Protocol||2
297903|NCT00127101|729935|P6|COMPLETED|Base Protocol||3
297904|NCT00127101|729936|P5|COMPLETED|Base Protocol||3
297905|NCT00127101|729937|P4|COMPLETED|Base Protocol||3
297906|NCT00127101|729938|P3|COMPLETED|Base Protocol||1
297907|NCT00127101|729939|P2|COMPLETED|Base Protocol||1
297908|NCT00127101|729940|P1|COMPLETED|Base Protocol||1
297909|NCT00127101|729935|P6|STARTED|Base Protocol||4
297910|NCT00127101|729936|P5|STARTED|Base Protocol||5
297911|NCT00127101|729937|P4|STARTED|Base Protocol||3
297912|NCT00127101|729938|P3|STARTED|Base Protocol||3
297913|NCT00127101|729939|P2|STARTED|Base Protocol||5
297914|NCT00127101|729940|P1|STARTED|Base Protocol||3
297915|NCT00127036|729962|P2|NOT COMPLETED|Overall Study||11
297916|NCT00127036|729963|P1|NOT COMPLETED|Overall Study||8
297917|NCT00127036|729962|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
297918|NCT00127036|729963|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
297919|NCT00127036|729962|P2|STARTED|Overall Study||31
297920|NCT00127036|729963|P1|STARTED|Overall Study||34
297921|NCT00126776|729975|P2|NOT COMPLETED|Overall Study||0
297922|NCT00126776|729976|P1|NOT COMPLETED|Overall Study||0
297923|NCT00126776|729975|P2|COMPLETED|Overall Study||371
297924|NCT00126776|729976|P1|COMPLETED|Overall Study||372
297925|NCT00126776|729975|P2|STARTED|Overall Study||371
297926|NCT00126776|729976|P1|STARTED|Overall Study||372
297927|NCT00126750|729982|P2|NOT COMPLETED|Overall Study||266
297928|NCT00126750|729983|P1|NOT COMPLETED|Overall Study||180
297929|NCT00126750|729982|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
297930|NCT00126750|729983|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
297931|NCT00126750|729982|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
297932|NCT00126750|729983|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
297933|NCT00126737|729993|P4|NOT COMPLETED|Overall Study||7
297934|NCT00126737|729994|P3|NOT COMPLETED|Overall Study||6
297935|NCT00126737|729995|P2|NOT COMPLETED|Overall Study||3
297936|NCT00126737|729996|P1|NOT COMPLETED|Overall Study||6
297937|NCT00126737|729993|P4|COMPLETED|Overall Study||18
297938|NCT00126737|729994|P3|COMPLETED|Overall Study||24
297939|NCT00126737|729995|P2|COMPLETED|Overall Study||24
297940|NCT00126737|729996|P1|COMPLETED|Overall Study||22
297941|NCT00126737|729993|P4|STARTED|Overall Study||25
297942|NCT00126737|729994|P3|STARTED|Overall Study||30
297943|NCT00126737|729995|P2|STARTED|Overall Study||27
297944|NCT00126737|729996|P1|STARTED|Overall Study||28
297945|NCT00126659|730025|P3|NOT COMPLETED|Overall Study||2
297946|NCT00126659|730026|P2|NOT COMPLETED|Overall Study||0
297947|NCT00126659|730027|P1|NOT COMPLETED|Overall Study||0
297948|NCT00126659|730025|P3|COMPLETED|Overall Study||2
297949|NCT00126659|730026|P2|COMPLETED|Overall Study||3
297950|NCT00126659|730027|P1|COMPLETED|Overall Study||3
297951|NCT00126659|730025|P3|STARTED|Overall Study||4
297952|NCT00126659|730026|P2|STARTED|Overall Study||3
297953|NCT00126659|730027|P1|STARTED|Overall Study||3
297954|NCT00126594|730035|P2|NOT COMPLETED|Overall Study||37
297955|NCT00126594|730036|P1|NOT COMPLETED|Overall Study||39
297956|NCT00126594|730035|P2|COMPLETED|Overall Study||3
297957|NCT00126594|730036|P1|COMPLETED|Overall Study||1
297958|NCT00126594|730035|P2|STARTED|Overall Study||40
297959|NCT00126594|730036|P1|STARTED|Overall Study||40
297960|NCT00126581|730053|P2|NOT COMPLETED|Overall Study||20
297961|NCT00126581|730054|P1|NOT COMPLETED|Overall Study||13
297962|NCT00126581|730053|P2|COMPLETED|Overall Study||80
297963|NCT00126581|730054|P1|COMPLETED|Overall Study||68
297964|NCT00126581|730053|P2|STARTED|Overall Study||100
297965|NCT00126581|730054|P1|STARTED|Overall Study||81
297966|NCT00126568|730074|P1|NOT COMPLETED|Overall Study||2
297967|NCT00126568|730074|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
297968|NCT00126568|730074|P1|STARTED|Overall Study||20
297969|NCT00126555|730081|P1|NOT COMPLETED|Overall Study||6
297970|NCT00126555|730081|P1|COMPLETED|Overall Study||17
297971|NCT00126555|730081|P1|STARTED|Overall Study||23
297972|NCT00126503|730097|P2|NOT COMPLETED|Overall Study||21
297973|NCT00126503|730098|P1|NOT COMPLETED|Overall Study||47
297974|NCT00126503|730097|P2|COMPLETED|Overall Study||0
297975|NCT00126503|730098|P1|COMPLETED|Overall Study||1
297976|NCT00126503|730097|P2|STARTED|Overall Study||21
297977|NCT00126503|730098|P1|STARTED|Overall Study||48
297978|NCT00126490|730110|P1|NOT COMPLETED|Overall Study||1
297979|NCT00126490|730110|P1|COMPLETED|Overall Study||18
297980|NCT00126490|730110|P1|STARTED|Overall Study||19
297981|NCT00126438|730120|P2|NOT COMPLETED|Overall Study||10
297982|NCT00126438|730121|P1|NOT COMPLETED|Overall Study||34
297983|NCT00126438|730120|P2|COMPLETED|Overall Study||52
297984|NCT00126438|730121|P1|COMPLETED|Overall Study||419
297985|NCT00126438|730120|P2|STARTED|Overall Study||62
297986|NCT00126438|730121|P1|STARTED|Overall Study||453
297987|NCT00126425|730129|P2|NOT COMPLETED|Overall Study||11
297988|NCT00126425|730130|P1|NOT COMPLETED|Overall Study||41
297989|NCT00126425|730129|P2|COMPLETED|Overall Study||37
297990|NCT00126425|730130|P1|COMPLETED|Overall Study||498
297991|NCT00126425|730129|P2|STARTED|Overall Study||48
297992|NCT00126425|730130|P1|STARTED|Overall Study||539
297993|NCT00126191|730138|P2|NOT COMPLETED|Overall Study||2
297994|NCT00126191|730139|P1|NOT COMPLETED|Overall Study||0
297995|NCT00126191|730138|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
297996|NCT00126191|730139|P1|COMPLETED|Overall Study||2
297997|NCT00126191|730138|P2|STARTED|Overall Study||8
297998|NCT00126191|730139|P1|STARTED|Overall Study||2
297999|NCT00126126|730149|P2|NOT COMPLETED|Overall Study||2
298000|NCT00126126|730150|P1|NOT COMPLETED|Overall Study||0
298001|NCT00126126|730149|P2|COMPLETED|Overall Study||7
298002|NCT00126126|730150|P1|COMPLETED|Overall Study||9
298003|NCT00126126|730149|P2|STARTED|Overall Study||9
298004|NCT00126126|730150|P1|STARTED|Overall Study||9
298005|NCT00126113|730160|P2|NOT COMPLETED|Overall Study||2
298006|NCT00126113|730161|P1|NOT COMPLETED|Overall Study||3
298007|NCT00126113|730160|P2|COMPLETED|Overall Study||35
298008|NCT00126113|730161|P1|COMPLETED|Overall Study||34
298009|NCT00126113|730160|P2|STARTED|Overall Study||37
298010|NCT00126113|730161|P1|STARTED|Overall Study||37
298011|NCT00125957|730175|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
298012|NCT00125957|730176|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
298013|NCT00125957|730175|P2|COMPLETED|Second Intervention (3 Weeks)||17
298014|NCT00125957|730176|P1|COMPLETED|Second Intervention (3 Weeks)||15
298015|NCT00125957|730175|P2|STARTED|Second Intervention (3 Weeks)||17
298016|NCT00125957|730176|P1|STARTED|Second Intervention (3 Weeks)||15
298017|NCT00125957|730175|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
298018|NCT00125957|730176|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
298019|NCT00125957|730175|P2|COMPLETED|First Intervention (3 Weeks)||17
298020|NCT00125957|730176|P1|COMPLETED|First Intervention (3 Weeks)||15
298021|NCT00125957|730175|P2|STARTED|First Intervention (3 Weeks)||17
298022|NCT00125957|730176|P1|STARTED|First Intervention (3 Weeks)||15
298023|NCT00125931|730184|P1|NOT COMPLETED|Overall Study||0
298024|NCT00125931|730184|P1|COMPLETED|Overall Study||10
298025|NCT00125931|730184|P1|STARTED|Overall Study||10
298026|NCT00125762|730189|P1|NOT COMPLETED|Overall Study||159
298027|NCT00125762|730189|P1|COMPLETED|Overall Study||748
298028|NCT00125762|730189|P1|STARTED|Overall Study||907
298029|NCT00125658|730196|P2|NOT COMPLETED|Overall Study||0
298030|NCT00125658|730197|P1|NOT COMPLETED|Overall Study||0
298031|NCT00125658|730196|P2|COMPLETED|Overall Study||6
298032|NCT00125658|730197|P1|COMPLETED|Overall Study||8
298033|NCT00125658|730196|P2|STARTED|Overall Study||6
298034|NCT00125658|730197|P1|STARTED|Overall Study||8
298035|NCT00125619|730217|P2|NOT COMPLETED|Overall Study||0
298036|NCT00125619|730218|P1|NOT COMPLETED|Overall Study||0
298037|NCT00125619|730217|P2|COMPLETED|Overall Study||8
298038|NCT00125619|730218|P1|COMPLETED|Overall Study||8
298039|NCT00125619|730217|P2|STARTED|Overall Study||8
298040|NCT00125619|730218|P1|STARTED|Overall Study||8
298041|NCT00125593|730238|P2|NOT COMPLETED|Overall Study||103
298042|NCT00125593|730239|P1|NOT COMPLETED|Overall Study||101
298043|NCT00125593|730238|P2|COMPLETED|Overall Study||4517
298044|NCT00125593|730239|P1|COMPLETED|Overall Study||4549
298045|NCT00125593|730238|P2|STARTED|Overall Study||4620
298046|NCT00125593|730239|P1|STARTED|Overall Study||4650
298047|NCT00125528|730259|P2|NOT COMPLETED|Overall Study||1
298048|NCT00125528|730260|P1|NOT COMPLETED|Overall Study||2
298049|NCT00125528|730259|P2|COMPLETED|Overall Study||20
298050|NCT00125528|730260|P1|COMPLETED|Overall Study||18
298051|NCT00125528|730259|P2|STARTED|Overall Study||21
298052|NCT00125528|730260|P1|STARTED|Overall Study||20
298053|NCT00125515|730271|P3|NOT COMPLETED|Overall Study||21
298054|NCT00125515|730272|P2|NOT COMPLETED|Overall Study||20
298055|NCT00125515|730273|P1|NOT COMPLETED|Overall Study||20
298056|NCT00125515|730271|P3|COMPLETED|Overall Study||6
298057|NCT00125515|730272|P2|COMPLETED|Overall Study||7
298058|NCT00125515|730273|P1|COMPLETED|Overall Study||7
298059|NCT00125515|730271|P3|STARTED|Overall Study||27
298060|NCT00125515|730272|P2|STARTED|Overall Study||27
298061|NCT00125515|730273|P1|STARTED|Overall Study||27
298062|NCT00125268|730283|P2|NOT COMPLETED|Overall Study||1
298063|NCT00125268|730284|P1|NOT COMPLETED|Overall Study||1
298064|NCT00125268|730283|P2|COMPLETED|Overall Study||13
298065|NCT00125268|730284|P1|COMPLETED|Overall Study||15
298066|NCT00125268|730283|P2|STARTED|Overall Study||14
298067|NCT00125268|730284|P1|STARTED|Overall Study||16
298068|NCT00125242|730296|P2|NOT COMPLETED|Overall Study||2
298069|NCT00125242|730297|P1|NOT COMPLETED|Overall Study||7
298070|NCT00125242|730296|P2|COMPLETED|Overall Study||14
298071|NCT00125242|730297|P1|COMPLETED|Overall Study||87
298072|NCT00125242|730296|P2|STARTED|Overall Study||16
298073|NCT00125242|730297|P1|STARTED|Overall Study||94
298074|NCT00125190|730302|P1|NOT COMPLETED|Overall Study||15
298075|NCT00125190|730302|P1|COMPLETED|Overall Study||30
298076|NCT00125190|730302|P1|STARTED|Overall Study||45
298077|NCT00125164|730320|P4|NOT COMPLETED|Overall Study||6
298078|NCT00125164|730321|P3|NOT COMPLETED|Overall Study||4
298079|NCT00125164|730322|P2|NOT COMPLETED|Overall Study||0
298080|NCT00125164|730323|P1|NOT COMPLETED|Overall Study||2
298081|NCT00125164|730320|P4|COMPLETED|Overall Study||45
298082|NCT00125164|730321|P3|COMPLETED|Overall Study||40
298083|NCT00125164|730322|P2|COMPLETED|Overall Study||16
298084|NCT00125164|730323|P1|COMPLETED|Overall Study||23
298085|NCT00125164|730320|P4|STARTED|Overall Study||51
298086|NCT00125164|730321|P3|STARTED|Overall Study||44
298087|NCT00125164|730322|P2|STARTED|Overall Study||16
298088|NCT00125164|730323|P1|STARTED|Overall Study||25
298089|NCT00125138|730377|P4|NOT COMPLETED|Overall Study||5
298090|NCT00125138|730378|P3|NOT COMPLETED|Overall Study||4
298091|NCT00125138|730379|P2|NOT COMPLETED|Overall Study||3
298092|NCT00125138|730380|P1|NOT COMPLETED|Overall Study||3
298093|NCT00125138|730377|P4|COMPLETED|Overall Study||25
298094|NCT00125138|730378|P3|COMPLETED|Overall Study||21
298095|NCT00125138|730379|P2|COMPLETED|Overall Study||17
298096|NCT00125138|730380|P1|COMPLETED|Overall Study||12
298097|NCT00125138|730377|P4|STARTED|Overall Study||30
298098|NCT00125138|730378|P3|STARTED|Overall Study||25
298099|NCT00125138|730379|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
298100|NCT00125138|730380|P1|STARTED|Overall Study||15
298101|NCT00125034|730396|P2|NOT COMPLETED|Overall Study||0
298102|NCT00125034|730397|P1|NOT COMPLETED|Overall Study||0
298103|NCT00125034|730396|P2|COMPLETED|Overall Study||168
298104|NCT00125034|730397|P1|COMPLETED|Overall Study||170
298105|NCT00125034|730396|P2|STARTED|Overall Study|Randomized & treated|168
298106|NCT00125034|730397|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
298107|NCT00124982|730429|P3|NOT COMPLETED|Long-term Period||89
298108|NCT00124982|730430|P2|NOT COMPLETED|Long-term Period||0
298109|NCT00124982|730431|P1|NOT COMPLETED|Long-term Period||0
298110|NCT00124982|730429|P3|COMPLETED|Long-term Period||441
298111|NCT00124982|730430|P2|COMPLETED|Long-term Period||0
298112|NCT00124982|730431|P1|COMPLETED|Long-term Period||0
298113|NCT00124982|730429|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
298114|NCT00124982|730430|P2|STARTED|Long-term Period||0
298115|NCT00124982|730431|P1|STARTED|Long-term Period||0
298116|NCT00124982|730429|P3|NOT COMPLETED|Short-term Period||0
298117|NCT00124982|730430|P2|NOT COMPLETED|Short-term Period||114
298118|NCT00124982|730431|P1|NOT COMPLETED|Short-term Period||72
298119|NCT00124982|730429|P3|COMPLETED|Short-term Period||0
298120|NCT00124982|730430|P2|COMPLETED|Short-term Period||483
298121|NCT00124982|730431|P1|COMPLETED|Short-term Period||377
298122|NCT00124982|730429|P3|STARTED|Short-term Period||0
298123|NCT00124982|730430|P2|STARTED|Short-term Period||597
298124|NCT00124982|730431|P1|STARTED|Short-term Period||449
298125|NCT00124943|730513|P4|NOT COMPLETED|Phase II||5
298126|NCT00124943|730514|P3|NOT COMPLETED|Phase II||0
298127|NCT00124943|730515|P2|NOT COMPLETED|Phase II||2
298128|NCT00124943|730516|P1|NOT COMPLETED|Phase II||0
298129|NCT00124943|730513|P4|COMPLETED|Phase II||50
298130|NCT00124943|730514|P3|COMPLETED|Phase II||3
298131|NCT00124943|730515|P2|COMPLETED|Phase II||49
298132|NCT00124943|730516|P1|COMPLETED|Phase II||3
298133|NCT00124943|730513|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
298134|NCT00124943|730514|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
298135|NCT00124943|730515|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
298136|NCT00124943|730516|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
298137|NCT00124943|730513|P4|NOT COMPLETED|Phase I||0
298138|NCT00124943|730514|P3|NOT COMPLETED|Phase I||0
298139|NCT00124943|730515|P2|NOT COMPLETED|Phase I||0
298140|NCT00124943|730516|P1|NOT COMPLETED|Phase I||0
298141|NCT00124943|730513|P4|COMPLETED|Phase I||3
298142|NCT00124943|730514|P3|COMPLETED|Phase I||3
298143|NCT00124943|730515|P2|COMPLETED|Phase I||3
298144|NCT00124943|730516|P1|COMPLETED|Phase I||3
298145|NCT00124943|730513|P4|STARTED|Phase I||3
298146|NCT00124943|730514|P3|STARTED|Phase I||3
298147|NCT00124943|730515|P2|STARTED|Phase I||3
298148|NCT00124943|730516|P1|STARTED|Phase I||3
298149|NCT00124748|730556|P2|NOT COMPLETED|Overall Study||284
298150|NCT00124748|730557|P1|NOT COMPLETED|Overall Study||143
298151|NCT00124748|730556|P2|COMPLETED|Overall Study||35
298152|NCT00124748|730557|P1|COMPLETED|Overall Study||14
298153|NCT00124748|730556|P2|Safety Population|Overall Study||316
298154|NCT00124748|730557|P1|Safety Population|Overall Study||157
298155|NCT00124748|730556|P2|STARTED|Overall Study||319
298156|NCT00124748|730557|P1|STARTED|Overall Study||157
298157|NCT00124735|730609|P10|NOT COMPLETED|Overall Study||2
298158|NCT00124735|730610|P9|NOT COMPLETED|Overall Study||3
298159|NCT00124735|730611|P8|NOT COMPLETED|Overall Study||1
298160|NCT00124735|730612|P7|NOT COMPLETED|Overall Study||0
298161|NCT00124735|730613|P6|NOT COMPLETED|Overall Study||2
298162|NCT00124735|730614|P5|NOT COMPLETED|Overall Study||2
298163|NCT00124735|730615|P4|NOT COMPLETED|Overall Study||3
298164|NCT00124735|730616|P3|NOT COMPLETED|Overall Study||0
298165|NCT00124735|730617|P2|NOT COMPLETED|Overall Study||2
298166|NCT00124735|730618|P1|NOT COMPLETED|Overall Study||1
298167|NCT00124735|730609|P10|COMPLETED|Overall Study||18
298168|NCT00124735|730610|P9|COMPLETED|Overall Study||22
298169|NCT00124735|730611|P8|COMPLETED|Overall Study||19
298170|NCT00124735|730612|P7|COMPLETED|Overall Study||6
298171|NCT00124735|730613|P6|COMPLETED|Overall Study||5
298172|NCT00124735|730614|P5|COMPLETED|Overall Study||17
298173|NCT00124735|730615|P4|COMPLETED|Overall Study||18
298174|NCT00124735|730616|P3|COMPLETED|Overall Study||18
298175|NCT00124735|730617|P2|COMPLETED|Overall Study||6
298176|NCT00124735|730618|P1|COMPLETED|Overall Study||4
298177|NCT00124735|730609|P10|STARTED|Overall Study||20
298178|NCT00124735|730610|P9|STARTED|Overall Study||25
298179|NCT00124735|730611|P8|STARTED|Overall Study||20
298180|NCT00124735|730612|P7|STARTED|Overall Study||6
298181|NCT00124735|730613|P6|STARTED|Overall Study||7
298182|NCT00124735|730614|P5|STARTED|Overall Study||19
298183|NCT00124735|730615|P4|STARTED|Overall Study||21
298184|NCT00124735|730616|P3|STARTED|Overall Study||18
298185|NCT00124735|730617|P2|STARTED|Overall Study||8
298186|NCT00124735|730618|P1|STARTED|Overall Study||5
298187|NCT00124709|730664|P2|NOT COMPLETED|Overall Study||272
298188|NCT00124709|730665|P1|NOT COMPLETED|Overall Study||255
298189|NCT00124709|730664|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
298190|NCT00124709|730665|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
298191|NCT00124709|730664|P2|Patients Who Received Study Medication|Overall Study||544
298192|NCT00124709|730665|P1|Patients Who Received Study Medication|Overall Study||543
298193|NCT00124709|730664|P2|STARTED|Overall Study||545
298194|NCT00124709|730665|P1|STARTED|Overall Study||546
298195|NCT00124657|730682|P3|NOT COMPLETED|Overall Study||32
298196|NCT00124657|730683|P2|NOT COMPLETED|Overall Study||5
298197|NCT00124657|730684|P1|NOT COMPLETED|Overall Study||16
298198|NCT00124657|730682|P3|COMPLETED|Overall Study||7
298199|NCT00124657|730683|P2|COMPLETED|Overall Study||0
298200|NCT00124657|730684|P1|COMPLETED|Overall Study||2
298201|NCT00124657|730682|P3|STARTED|Overall Study||39
298202|NCT00124657|730683|P2|STARTED|Overall Study||5
298203|NCT00124657|730684|P1|STARTED|Overall Study||18
298204|NCT00124618|730719|P1|NOT COMPLETED|Overall Study||1
298205|NCT00124618|730719|P1|COMPLETED|Overall Study||57
298206|NCT00124618|730719|P1|STARTED|Overall Study||58
298207|NCT00124579|730726|P1|NOT COMPLETED|Maintenance||2
298208|NCT00124579|730726|P1|COMPLETED|Maintenance||0
298209|NCT00124579|730726|P1|STARTED|Maintenance||2
298210|NCT00124579|730726|P1|NOT COMPLETED|Induction||5
298211|NCT00124579|730726|P1|COMPLETED|Induction||2
298212|NCT00124579|730726|P1|STARTED|Induction||7
298213|NCT00124462|730734|P2|NOT COMPLETED|Overall Study||13
298214|NCT00124462|730735|P1|NOT COMPLETED|Overall Study||11
298215|NCT00124462|730734|P2|COMPLETED|Overall Study||27
298216|NCT00124462|730735|P1|COMPLETED|Overall Study||29
298217|NCT00124462|730734|P2|STARTED|Overall Study||40
298218|NCT00124462|730735|P1|STARTED|Overall Study||40
298219|NCT00124449|730745|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
298220|NCT00124449|730746|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
298221|NCT00124449|730745|P2|COMPLETED|18-Month Untreated Observation Period||4
298222|NCT00124449|730746|P1|COMPLETED|18-Month Untreated Observation Period||7
298223|NCT00124449|730745|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
298224|NCT00124449|730746|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
298225|NCT00124449|730745|P2|STARTED|18-Month Untreated Observation Period||17
298226|NCT00124449|730746|P1|STARTED|18-Month Untreated Observation Period||22
298227|NCT00124449|730745|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
298228|NCT00124449|730746|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
298229|NCT00124449|730745|P2|COMPLETED|6-month Double-Blind Treatment Period||17
298230|NCT00124449|730746|P1|COMPLETED|6-month Double-Blind Treatment Period||22
298231|NCT00124449|730745|P2|STARTED|6-month Double-Blind Treatment Period||28
298232|NCT00124449|730746|P1|STARTED|6-month Double-Blind Treatment Period||28
298233|NCT00124176|730781|P2|NOT COMPLETED|Overall Study||0
298234|NCT00124176|730782|P1|NOT COMPLETED|Overall Study||0
298235|NCT00124176|730781|P2|COMPLETED|Overall Study||41
298236|NCT00124176|730782|P1|COMPLETED|Overall Study||40
298237|NCT00124176|730781|P2|Received Study Drug|Overall Study||41
298238|NCT00124176|730782|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
298239|NCT00124176|730781|P2|STARTED|Overall Study||41
298240|NCT00124176|730782|P1|STARTED|Overall Study||40
298241|NCT00124072|730800|P4|NOT COMPLETED|Overall Study||500
298242|NCT00124072|730801|P3|NOT COMPLETED|Overall Study||492
298243|NCT00124072|730802|P2|NOT COMPLETED|Overall Study||512
298244|NCT00124072|730803|P1|NOT COMPLETED|Overall Study||514
298245|NCT00124072|730800|P4|COMPLETED|Overall Study||2515
298246|NCT00124072|730801|P3|COMPLETED|Overall Study||2524
298247|NCT00124072|730802|P2|COMPLETED|Overall Study||2504
298248|NCT00124072|730803|P1|COMPLETED|Overall Study||2503
298249|NCT00124072|730800|P4|STARTED|Overall Study||3015
298250|NCT00124072|730801|P3|STARTED|Overall Study||3016
298251|NCT00124072|730802|P2|STARTED|Overall Study||3016
298252|NCT00124072|730803|P1|STARTED|Overall Study||3017
298253|NCT00124020|730815|P2|NOT COMPLETED|Overall Study||91
298254|NCT00124020|730816|P1|NOT COMPLETED|Overall Study||88
298255|NCT00124020|730815|P2|COMPLETED|Overall Study||289
298256|NCT00124020|730816|P1|COMPLETED|Overall Study||289
298257|NCT00124020|730815|P2|STARTED|Overall Study||380
298258|NCT00124020|730816|P1|STARTED|Overall Study||377
298259|NCT00123955|730824|P2|NOT COMPLETED|Overall Study||4
298260|NCT00123955|730825|P1|NOT COMPLETED|Overall Study||5
298261|NCT00123955|730824|P2|COMPLETED|Overall Study||34
298262|NCT00123955|730825|P1|COMPLETED|Overall Study||37
298263|NCT00123955|730824|P2|STARTED|Overall Study||38
298264|NCT00123955|730825|P1|STARTED|Overall Study||42
298265|NCT00123734|730837|P1|NOT COMPLETED|Overall Study||8
298266|NCT00123734|730837|P1|COMPLETED|Overall Study||74
298267|NCT00123734|730837|P1|STARTED|Overall Study||82
298268|NCT00123682|730872|P4|NOT COMPLETED|Overall Study||95
298269|NCT00123682|730873|P3|NOT COMPLETED|Overall Study||154
298270|NCT00123682|730874|P2|NOT COMPLETED|Overall Study||203
298271|NCT00123682|730875|P1|NOT COMPLETED|Overall Study||320
298272|NCT00123682|730872|P4|COMPLETED|Overall Study||430
298273|NCT00123682|730873|P3|COMPLETED|Overall Study||438
298274|NCT00123682|730874|P2|COMPLETED|Overall Study||731
298275|NCT00123682|730875|P1|COMPLETED|Overall Study||749
298276|NCT00123682|730872|P4|STARTED|Overall Study||525
298277|NCT00123682|730873|P3|STARTED|Overall Study||592
298278|NCT00123682|730874|P2|STARTED|Overall Study||934
298279|NCT00123682|730875|P1|STARTED|Overall Study||1069
298280|NCT00123643|730895|P2|NOT COMPLETED|Overall Study||0
298281|NCT00123643|730896|P1|NOT COMPLETED|Overall Study||0
298282|NCT00123643|730895|P2|COMPLETED|Overall Study||16
298283|NCT00123643|730896|P1|COMPLETED|Overall Study||20
298284|NCT00123643|730895|P2|STARTED|Overall Study||16
298285|NCT00123643|730896|P1|STARTED|Overall Study||20
298286|NCT00123630|730904|P2|NOT COMPLETED|Overall Study||0
298287|NCT00123630|730905|P1|NOT COMPLETED|Overall Study||0
298288|NCT00123630|730904|P2|COMPLETED|Overall Study||15
298289|NCT00123630|730905|P1|COMPLETED|Overall Study||15
298290|NCT00123630|730904|P2|STARTED|Overall Study||15
298291|NCT00123630|730905|P1|STARTED|Overall Study||15
298292|NCT00123604|730913|P2|NOT COMPLETED|Overall Study||1
298293|NCT00123604|730914|P1|NOT COMPLETED|Overall Study||1
298294|NCT00123604|730913|P2|COMPLETED|Overall Study||16
298295|NCT00123604|730914|P1|COMPLETED|Overall Study||18
298296|NCT00123604|730913|P2|STARTED|Overall Study||17
298297|NCT00123604|730914|P1|STARTED|Overall Study||19
298298|NCT00123487|730922|P2|NOT COMPLETED|Treated With Study Drug||305
298299|NCT00123487|730923|P1|NOT COMPLETED|Treated With Study Drug||304
298300|NCT00123487|730922|P2|COMPLETED|Treated With Study Drug||0
298301|NCT00123487|730923|P1|COMPLETED|Treated With Study Drug||0
298302|NCT00123487|730922|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
298303|NCT00123487|730923|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
298304|NCT00123487|730922|P2|NOT COMPLETED|Randomized||1
298305|NCT00123487|730923|P1|NOT COMPLETED|Randomized||1
298306|NCT00123487|730922|P2|COMPLETED|Randomized||304
298307|NCT00123487|730923|P1|COMPLETED|Randomized||305
298308|NCT00123487|730922|P2|STARTED|Randomized||305
298309|NCT00123487|730923|P1|STARTED|Randomized||306
298310|NCT00123474|730967|P4|NOT COMPLETED|As Treated at Study Closure||167
298311|NCT00123474|730968|P3|NOT COMPLETED|As Treated at Study Closure||167
298312|NCT00123474|730969|P2|NOT COMPLETED|As Treated at Study Closure||163
298313|NCT00123474|730970|P1|NOT COMPLETED|As Treated at Study Closure||165
298314|NCT00123474|730967|P4|COMPLETED|As Treated at Study Closure||0
298315|NCT00123474|730968|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
298316|NCT00123474|730969|P2|COMPLETED|As Treated at Study Closure||0
298317|NCT00123474|730970|P1|COMPLETED|As Treated at Study Closure||0
298318|NCT00123474|730967|P4|STARTED|As Treated at Study Closure||167
298319|NCT00123474|730968|P3|STARTED|As Treated at Study Closure||167
298320|NCT00123474|730969|P2|STARTED|As Treated at Study Closure||163
298321|NCT00123474|730970|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
298322|NCT00123474|730967|P4|NOT COMPLETED|Randomized to Treatment||1
298323|NCT00123474|730968|P3|NOT COMPLETED|Randomized to Treatment||2
298324|NCT00123474|730969|P2|NOT COMPLETED|Randomized to Treatment||4
298325|NCT00123474|730970|P1|NOT COMPLETED|Randomized to Treatment||1
298326|NCT00123474|730967|P4|COMPLETED|Randomized to Treatment||167
298327|NCT00123474|730968|P3|COMPLETED|Randomized to Treatment||166
298328|NCT00123474|730969|P2|COMPLETED|Randomized to Treatment||163
298329|NCT00123474|730970|P1|COMPLETED|Randomized to Treatment||166
298330|NCT00123474|730967|P4|STARTED|Randomized to Treatment||168
298331|NCT00123474|730968|P3|STARTED|Randomized to Treatment||168
298332|NCT00123474|730969|P2|STARTED|Randomized to Treatment||167
298333|NCT00123474|730970|P1|STARTED|Randomized to Treatment||167
298334|NCT00123422|731064|P3|NOT COMPLETED|Overall Study||10
298335|NCT00123422|731065|P2|NOT COMPLETED|Overall Study||6
298336|NCT00123422|731066|P1|NOT COMPLETED|Overall Study||4
298337|NCT00123422|731064|P3|COMPLETED|Overall Study||25
298338|NCT00123422|731065|P2|COMPLETED|Overall Study||27
298339|NCT00123422|731066|P1|COMPLETED|Overall Study||31
298340|NCT00123422|731064|P3|8-week Testing|Overall Study||27
298341|NCT00123422|731065|P2|8-week Testing|Overall Study||30
298342|NCT00123422|731066|P1|8-week Testing|Overall Study||32
298343|NCT00123422|731064|P3|STARTED|Overall Study||35
298344|NCT00123422|731065|P2|STARTED|Overall Study||33
298345|NCT00123422|731066|P1|STARTED|Overall Study||35
298346|NCT00123409|731079|P2|NOT COMPLETED|Overall Study||3
298347|NCT00123409|731080|P1|NOT COMPLETED|Overall Study||4
298348|NCT00123409|731079|P2|COMPLETED|Overall Study||71
298349|NCT00123409|731080|P1|COMPLETED|Overall Study||68
298350|NCT00123409|731079|P2|STARTED|Overall Study||74
298351|NCT00123409|731080|P1|STARTED|Overall Study||72
298352|NCT00123162|731090|P2|NOT COMPLETED|Overall Study||0
298353|NCT00123162|731091|P1|NOT COMPLETED|Overall Study||0
298354|NCT00123162|731090|P2|COMPLETED|Overall Study||12
298355|NCT00123162|731091|P1|COMPLETED|Overall Study||13
298356|NCT00123162|731090|P2|STARTED|Overall Study||12
298357|NCT00123162|731091|P1|STARTED|Overall Study||13
298358|NCT00123123|731102|P3|NOT COMPLETED|Overall Study||0
298359|NCT00123123|731103|P2|NOT COMPLETED|Overall Study||0
298360|NCT00123123|731104|P1|NOT COMPLETED|Overall Study||0
298361|NCT00123123|731102|P3|COMPLETED|Overall Study||58
298362|NCT00123123|731103|P2|COMPLETED|Overall Study||58
298363|NCT00123123|731104|P1|COMPLETED|Overall Study||59
298364|NCT00123123|731102|P3|STARTED|Overall Study||58
298365|NCT00123123|731103|P2|STARTED|Overall Study||58
298366|NCT00123123|731104|P1|STARTED|Overall Study||59
298367|NCT00122980|731117|P2|NOT COMPLETED|Overall Study||40
298368|NCT00122980|731118|P1|NOT COMPLETED|Overall Study||43
298369|NCT00122980|731117|P2|COMPLETED|Overall Study|Study terminated early|26
298370|NCT00122980|731118|P1|COMPLETED|Overall Study|Study terminated early|24
298371|NCT00122980|731117|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
298372|NCT00122980|731118|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
298373|NCT00122954|731142|P2|NOT COMPLETED|Overall Study||3
298374|NCT00122954|731143|P1|NOT COMPLETED|Overall Study||2
298375|NCT00122954|731142|P2|COMPLETED|Overall Study||18
298376|NCT00122954|731143|P1|COMPLETED|Overall Study||16
298377|NCT00122954|731142|P2|STARTED|Overall Study||21
298378|NCT00122954|731143|P1|STARTED|Overall Study||18
298379|NCT00122681|731153|P2|NOT COMPLETED|Overall Study||1521
298380|NCT00122681|731154|P1|NOT COMPLETED|Overall Study||1514
298381|NCT00122681|731153|P2|COMPLETED|Overall Study||7798
298382|NCT00122681|731154|P1|COMPLETED|Overall Study||7811
298383|NCT00122681|731153|P2|STARTED|Overall Study||9319
298384|NCT00122681|731154|P1|STARTED|Overall Study||9325
298385|NCT00122460|731228|P2|NOT COMPLETED|Overall Study||1
298386|NCT00122460|731229|P1|NOT COMPLETED|Overall Study||7
298387|NCT00122460|731228|P2|COMPLETED|Overall Study||219
298388|NCT00122460|731229|P1|COMPLETED|Overall Study||215
298389|NCT00122460|731228|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
298390|NCT00122460|731229|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
298391|NCT00122447|731255|P4|NOT COMPLETED|Overall Study||3
298392|NCT00122447|731256|P3|NOT COMPLETED|Overall Study||1
298393|NCT00122447|731257|P2|NOT COMPLETED|Overall Study||5
298394|NCT00122447|731258|P1|NOT COMPLETED|Overall Study||1
298395|NCT00122447|731255|P4|COMPLETED|Overall Study||14
298396|NCT00122447|731256|P3|COMPLETED|Overall Study||16
298397|NCT00122447|731257|P2|COMPLETED|Overall Study||13
298398|NCT00122447|731258|P1|COMPLETED|Overall Study||17
298399|NCT00122447|731255|P4|STARTED|Overall Study||17
298400|NCT00122447|731256|P3|STARTED|Overall Study||17
298401|NCT00122447|731257|P2|STARTED|Overall Study||18
298402|NCT00122447|731258|P1|STARTED|Overall Study||18
298403|NCT00122382|731278|P3|NOT COMPLETED|Open-Label Study||26
298404|NCT00122382|731279|P2|NOT COMPLETED|Open-Label Study||0
298405|NCT00122382|731280|P1|NOT COMPLETED|Open-Label Study||0
298406|NCT00122382|731278|P3|COMPLETED|Open-Label Study||433
298407|NCT00122382|731279|P2|COMPLETED|Open-Label Study||0
298408|NCT00122382|731280|P1|COMPLETED|Open-Label Study||0
298409|NCT00122382|731278|P3|STARTED|Open-Label Study||459
298410|NCT00122382|731279|P2|STARTED|Open-Label Study||0
298411|NCT00122382|731280|P1|STARTED|Open-Label Study||0
298412|NCT00122382|731278|P3|NOT COMPLETED|Double-Blind Study||0
298413|NCT00122382|731279|P2|NOT COMPLETED|Double-Blind Study||28
298414|NCT00122382|731280|P1|NOT COMPLETED|Double-Blind Study||24
298415|NCT00122382|731278|P3|COMPLETED|Double-Blind Study||0
298416|NCT00122382|731279|P2|COMPLETED|Double-Blind Study||227
298417|NCT00122382|731280|P1|COMPLETED|Double-Blind Study||232
298418|NCT00122382|731278|P3|Treated|Double-Blind Study||0
298419|NCT00122382|731279|P2|Treated|Double-Blind Study||253
298420|NCT00122382|731280|P1|Treated|Double-Blind Study||256
298421|NCT00122382|731278|P3|STARTED|Double-Blind Study||0
298422|NCT00122382|731279|P2|STARTED|Double-Blind Study|participants randomized|255
298423|NCT00122382|731280|P1|STARTED|Double-Blind Study|participants randomized|256
298424|NCT00122369|731333|P3|NOT COMPLETED|Overall Study||0
298425|NCT00122369|731334|P2|NOT COMPLETED|Overall Study||0
298426|NCT00122369|731335|P1|NOT COMPLETED|Overall Study||0
298427|NCT00122369|731333|P3|COMPLETED|Overall Study||78
298428|NCT00122369|731334|P2|COMPLETED|Overall Study||82
298429|NCT00122369|731335|P1|COMPLETED|Overall Study||76
298430|NCT00122369|731333|P3|STARTED|Overall Study||78
298431|NCT00122369|731334|P2|STARTED|Overall Study||82
298432|NCT00122369|731335|P1|STARTED|Overall Study||76
298433|NCT00122317|731424|P1|NOT COMPLETED|Overall Study||11
298434|NCT00122317|731424|P1|COMPLETED|Overall Study||176
298435|NCT00122317|731424|P1|STARTED|Overall Study||187
298436|NCT00122187|731433|P2|NOT COMPLETED|Overall Study||2
298437|NCT00122187|731434|P1|NOT COMPLETED|Overall Study||2
298438|NCT00122187|731433|P2|COMPLETED|Overall Study||2
298439|NCT00122187|731434|P1|COMPLETED|Overall Study||2
298440|NCT00122187|731433|P2|Post-intervention Data Collection|Overall Study||2
298441|NCT00122187|731434|P1|Post-intervention Data Collection|Overall Study||2
298442|NCT00122187|731433|P2|Intervention Implemented|Overall Study||4
298443|NCT00122187|731434|P1|Intervention Implemented|Overall Study||3
298444|NCT00122187|731433|P2|Randomized to Intervention or Usual Care|Overall Study||4
298445|NCT00122187|731434|P1|Randomized to Intervention or Usual Care|Overall Study||4
298446|NCT00122187|731433|P2|Matched by Colonoscopy Volume|Overall Study||4
298447|NCT00122187|731434|P1|Matched by Colonoscopy Volume|Overall Study||4
298448|NCT00122187|731433|P2|STARTED|Overall Study||4
298449|NCT00122187|731434|P1|STARTED|Overall Study||4
298450|NCT00122135|731448|P2|NOT COMPLETED|Overall Study||0
298451|NCT00122135|731449|P1|NOT COMPLETED|Overall Study||3
298452|NCT00122135|731448|P2|COMPLETED|Overall Study||60
298453|NCT00122135|731449|P1|COMPLETED|Overall Study||57
298454|NCT00122135|731448|P2|STARTED|Overall Study||60
298455|NCT00122135|731449|P1|STARTED|Overall Study||60
298456|NCT00122109|731457|P2|NOT COMPLETED|Overall Study||7
298457|NCT00122109|731458|P1|NOT COMPLETED|Overall Study||6
298458|NCT00122109|731457|P2|COMPLETED|Overall Study||57
298459|NCT00122109|731458|P1|COMPLETED|Overall Study||55
298460|NCT00122109|731457|P2|STARTED|Overall Study|ITT|64
298461|NCT00122109|731458|P1|STARTED|Overall Study|ITT|61
298462|NCT00121836|731482|P1|NOT COMPLETED|Overall Study||55
298463|NCT00121836|731482|P1|COMPLETED|Overall Study||54
298464|NCT00121836|731482|P1|STARTED|Overall Study||109
298465|NCT00121810|731493|P2|NOT COMPLETED|Overall Study||39
298466|NCT00121810|731494|P1|NOT COMPLETED|Overall Study||30
298467|NCT00121810|731493|P2|COMPLETED|Overall Study||115
298468|NCT00121810|731494|P1|COMPLETED|Overall Study||121
298469|NCT00121810|731493|P2|Intent-to-Treat (ITT) Population|Overall Study||151
298470|NCT00121810|731494|P1|Intent-to-Treat (ITT) Population|Overall Study||148
298471|NCT00121810|731493|P2|Safety Population|Overall Study||153
298472|NCT00121810|731494|P1|Safety Population|Overall Study||148
298473|NCT00121810|731493|P2|STARTED|Overall Study||154
298474|NCT00121810|731494|P1|STARTED|Overall Study||151
298475|NCT00121719|731522|P14|NOT COMPLETED|Overall Study||7
298476|NCT00121719|731523|P13|NOT COMPLETED|Overall Study||24
298477|NCT00121719|731524|P12|NOT COMPLETED|Overall Study||5
298478|NCT00121719|731525|P11|NOT COMPLETED|Overall Study||6
298479|NCT00121719|731526|P10|NOT COMPLETED|Overall Study||3
298480|NCT00121719|731527|P9|NOT COMPLETED|Overall Study||6
298481|NCT00121719|731528|P8|NOT COMPLETED|Overall Study||9
298482|NCT00121719|731529|P7|NOT COMPLETED|Overall Study||12
298483|NCT00121719|731530|P6|NOT COMPLETED|Overall Study||3
298484|NCT00121719|731531|P5|NOT COMPLETED|Overall Study||3
298485|NCT00121719|731532|P4|NOT COMPLETED|Overall Study||3
298486|NCT00121719|731533|P3|NOT COMPLETED|Overall Study||4
298487|NCT00121719|731534|P2|NOT COMPLETED|Overall Study||4
298488|NCT00121719|731535|P1|NOT COMPLETED|Overall Study||4
298489|NCT00121719|731522|P14|COMPLETED|Overall Study||0
298490|NCT00121719|731523|P13|COMPLETED|Overall Study||0
298491|NCT00121719|731524|P12|COMPLETED|Overall Study||0
298492|NCT00121719|731525|P11|COMPLETED|Overall Study||0
298493|NCT00121719|731526|P10|COMPLETED|Overall Study||0
298494|NCT00121719|731527|P9|COMPLETED|Overall Study||0
298495|NCT00121719|731528|P8|COMPLETED|Overall Study||0
298496|NCT00121719|731529|P7|COMPLETED|Overall Study||0
298497|NCT00121719|731530|P6|COMPLETED|Overall Study||0
298498|NCT00121719|731531|P5|COMPLETED|Overall Study||0
298499|NCT00121719|731532|P4|COMPLETED|Overall Study||0
298500|NCT00121719|731533|P3|COMPLETED|Overall Study||0
298501|NCT00121719|731534|P2|COMPLETED|Overall Study||0
298502|NCT00121719|731535|P1|COMPLETED|Overall Study||0
298503|NCT00121719|731522|P14|STARTED|Overall Study||7
298504|NCT00121719|731523|P13|STARTED|Overall Study||24
298505|NCT00121719|731524|P12|STARTED|Overall Study||5
298506|NCT00121719|731525|P11|STARTED|Overall Study||6
298507|NCT00121719|731526|P10|STARTED|Overall Study||3
298508|NCT00121719|731527|P9|STARTED|Overall Study||6
298509|NCT00121719|731528|P8|STARTED|Overall Study||9
298510|NCT00121719|731529|P7|STARTED|Overall Study||12
298511|NCT00121719|731530|P6|STARTED|Overall Study||3
298512|NCT00121719|731531|P5|STARTED|Overall Study||3
298513|NCT00121719|731532|P4|STARTED|Overall Study||3
298514|NCT00121719|731533|P3|STARTED|Overall Study||4
298515|NCT00121719|731534|P2|STARTED|Overall Study||4
298516|NCT00121719|731535|P1|STARTED|Overall Study||4
298517|NCT00121667|731712|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
298518|NCT00121667|731713|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
298519|NCT00121667|731714|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
298520|NCT00121667|731715|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
298521|NCT00121667|731712|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
298522|NCT00121667|731713|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
298523|NCT00121667|731714|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
298524|NCT00121667|731715|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
298525|NCT00121667|731712|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
298607|NCT00121134|732005|P3|STARTED|Overall Study||41
298526|NCT00121667|731713|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
298527|NCT00121667|731714|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
298528|NCT00121667|731715|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
298529|NCT00121667|731712|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
298530|NCT00121667|731713|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
298531|NCT00121667|731714|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
298532|NCT00121667|731715|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
298533|NCT00121667|731712|P4|NOT COMPLETED|Short Term (ST) Period||67
298534|NCT00121667|731713|P3|NOT COMPLETED|Short Term (ST) Period||41
298535|NCT00121667|731714|P2|NOT COMPLETED|Short Term (ST) Period||48
298536|NCT00121667|731715|P1|NOT COMPLETED|Short Term (ST) Period||44
298537|NCT00121667|731712|P4|COMPLETED|Short Term (ST) Period||112
298538|NCT00121667|731713|P3|COMPLETED|Short Term (ST) Period||140
298539|NCT00121667|731714|P2|COMPLETED|Short Term (ST) Period||143
298540|NCT00121667|731715|P1|COMPLETED|Short Term (ST) Period||148
298541|NCT00121667|731712|P4|STARTED|Short Term (ST) Period||179
298542|NCT00121667|731713|P3|STARTED|Short Term (ST) Period||181
298543|NCT00121667|731714|P2|STARTED|Short Term (ST) Period||191
298544|NCT00121667|731715|P1|STARTED|Short Term (ST) Period||192
298545|NCT00121641|731813|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
298546|NCT00121641|731814|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
298547|NCT00121641|731815|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
298548|NCT00121641|731816|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
298549|NCT00121641|731817|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
298550|NCT00121641|731813|P5|COMPLETED|48-month Short Term + Long Term Period||8
298551|NCT00121641|731814|P4|COMPLETED|48-month Short Term + Long Term Period||24
298552|NCT00121641|731815|P3|COMPLETED|48-month Short Term + Long Term Period||28
298553|NCT00121641|731816|P2|COMPLETED|48-month Short Term + Long Term Period||24
298554|NCT00121641|731817|P1|COMPLETED|48-month Short Term + Long Term Period||23
298555|NCT00121641|731813|P5|STARTED|48-month Short Term + Long Term Period||66
298556|NCT00121641|731814|P4|STARTED|48-month Short Term + Long Term Period||95
298557|NCT00121641|731815|P3|STARTED|48-month Short Term + Long Term Period||98
298558|NCT00121641|731816|P2|STARTED|48-month Short Term + Long Term Period||106
298559|NCT00121641|731817|P1|STARTED|48-month Short Term + Long Term Period||102
298560|NCT00121641|731813|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
298561|NCT00121641|731814|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
298562|NCT00121641|731815|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
298563|NCT00121641|731816|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
298564|NCT00121641|731817|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
298565|NCT00121641|731813|P5|COMPLETED|24-week Short-term Treatment Period||25
298566|NCT00121641|731814|P4|COMPLETED|24-week Short-term Treatment Period||55
298567|NCT00121641|731815|P3|COMPLETED|24-week Short-term Treatment Period||69
298568|NCT00121641|731816|P2|COMPLETED|24-week Short-term Treatment Period||68
298569|NCT00121641|731817|P1|COMPLETED|24-week Short-term Treatment Period||73
298570|NCT00121641|731813|P5|STARTED|24-week Short-term Treatment Period||66
298571|NCT00121641|731814|P4|STARTED|24-week Short-term Treatment Period||95
298572|NCT00121641|731815|P3|STARTED|24-week Short-term Treatment Period||98
298573|NCT00121641|731816|P2|STARTED|24-week Short-term Treatment Period||106
298574|NCT00121641|731817|P1|STARTED|24-week Short-term Treatment Period||102
298575|NCT00121485|731930|P2|NOT COMPLETED|Overall Study||7
298576|NCT00121485|731931|P1|NOT COMPLETED|Overall Study||1
298577|NCT00121485|731930|P2|COMPLETED|Overall Study||59
298578|NCT00121485|731931|P1|COMPLETED|Overall Study||133
298579|NCT00121485|731930|P2|STARTED|Overall Study||66
298580|NCT00121485|731931|P1|STARTED|Overall Study||134
298581|NCT00121472|731965|P1|NOT COMPLETED|Overall Study||0
298582|NCT00121472|731965|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
298583|NCT00121472|731965|P1|STARTED|Overall Study||194
298584|NCT00121238|731976|P1|NOT COMPLETED|Overall Study||3
298585|NCT00121238|731976|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
298586|NCT00121238|731976|P1|STARTED|Overall Study||16
298587|NCT00121225|731984|P1|NOT COMPLETED|Overall Study||0
298588|NCT00121225|731984|P1|COMPLETED|Overall Study||32
298589|NCT00121225|731984|P1|STARTED|Overall Study||32
298590|NCT00121199|731988|P1|NOT COMPLETED|Overall Study||28
298591|NCT00121199|731988|P1|COMPLETED|Overall Study||45
298592|NCT00121199|731988|P1|Eligible and Began Protocol Therapy|Overall Study||64
298593|NCT00121199|731988|P1|Eligible|Overall Study||64
298594|NCT00121199|731988|P1|STARTED|Overall Study||73
298595|NCT00121186|731995|P1|NOT COMPLETED|Overall Study||0
298596|NCT00121186|731995|P1|COMPLETED|Overall Study||1
298597|NCT00121186|731995|P1|STARTED|Overall Study||1
298598|NCT00121134|732004|P4|NOT COMPLETED|Overall Study||9
298599|NCT00121134|732005|P3|NOT COMPLETED|Overall Study||21
298600|NCT00121134|732006|P2|NOT COMPLETED|Overall Study||15
298601|NCT00121134|732007|P1|NOT COMPLETED|Overall Study||16
298602|NCT00121134|732004|P4|COMPLETED|Overall Study||31
298603|NCT00121134|732005|P3|COMPLETED|Overall Study||20
298604|NCT00121134|732006|P2|COMPLETED|Overall Study||26
298605|NCT00121134|732007|P1|COMPLETED|Overall Study||24
298606|NCT00121134|732004|P4|STARTED|Overall Study||40
298608|NCT00121134|732006|P2|STARTED|Overall Study||41
298609|NCT00121134|732007|P1|STARTED|Overall Study||40
298610|NCT00120874|732019|P2|NOT COMPLETED|Overall Study||1
298611|NCT00120874|732020|P1|NOT COMPLETED|Overall Study||0
298612|NCT00120874|732019|P2|COMPLETED|Overall Study||9
298613|NCT00120874|732020|P1|COMPLETED|Overall Study||10
298614|NCT00120874|732019|P2|Completed Study; Started Extension Study|Overall Study||10
298615|NCT00120874|732020|P1|Completed Study; Started Extension Study|Overall Study||10
298616|NCT00120874|732019|P2|STARTED|Overall Study||10
298617|NCT00120874|732020|P1|STARTED|Overall Study||10
298618|NCT00120627|732058|P2|NOT COMPLETED|Overall Study||5
298619|NCT00120627|732059|P1|NOT COMPLETED|Overall Study||5
298620|NCT00120627|732058|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
298621|NCT00120627|732059|P1|COMPLETED|Overall Study||66
298622|NCT00120627|732058|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
298623|NCT00120627|732059|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
298624|NCT00120627|732058|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
298625|NCT00120627|732059|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
298626|NCT00120627|732058|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
298627|NCT00120627|732059|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
298628|NCT00120523|732085|P2|NOT COMPLETED|Follow-Up Period||24
298629|NCT00120523|732086|P1|NOT COMPLETED|Follow-Up Period||30
298630|NCT00120523|732085|P2|COMPLETED|Follow-Up Period||46
298631|NCT00120523|732086|P1|COMPLETED|Follow-Up Period||90
298632|NCT00120523|732085|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
298633|NCT00120523|732086|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
298634|NCT00120523|732085|P2|NOT COMPLETED|Treatment Period||339
298635|NCT00120523|732086|P1|NOT COMPLETED|Treatment Period||369
298636|NCT00120523|732085|P2|COMPLETED|Treatment Period||874
298637|NCT00120523|732086|P1|COMPLETED|Treatment Period||836
298638|NCT00120523|732085|P2|STARTED|Treatment Period||1213
298639|NCT00120523|732086|P1|STARTED|Treatment Period||1205
298640|NCT00120406|732110|P2|NOT COMPLETED|Overall Study||16
298641|NCT00120406|732111|P1|NOT COMPLETED|Overall Study||19
298642|NCT00120406|732110|P2|COMPLETED|Overall Study||222
298643|NCT00120406|732111|P1|COMPLETED|Overall Study||217
298644|NCT00120406|732110|P2|STARTED|Overall Study||238
298645|NCT00120406|732111|P1|STARTED|Overall Study||236
298646|NCT00120289|732121|P2|NOT COMPLETED|Overall Study||109
298647|NCT00120289|732122|P1|NOT COMPLETED|Overall Study||121
298648|NCT00120289|732121|P2|COMPLETED|Overall Study||1587
298649|NCT00120289|732122|P1|COMPLETED|Overall Study||1597
298650|NCT00120289|732121|P2|STARTED|Overall Study||1696
298651|NCT00120289|732122|P1|STARTED|Overall Study||1718
298652|NCT00120250|732134|P2|NOT COMPLETED|Overall Study||2
298653|NCT00120250|732135|P1|NOT COMPLETED|Overall Study||1
298654|NCT00120250|732134|P2|COMPLETED|Overall Study||12
298655|NCT00120250|732135|P1|COMPLETED|Overall Study||12
298656|NCT00120250|732134|P2|STARTED|Overall Study||14
298657|NCT00120250|732135|P1|STARTED|Overall Study||13
298658|NCT00120042|732151|P3|NOT COMPLETED|Overall Study||0
298659|NCT00120042|732152|P2|NOT COMPLETED|Overall Study||0
298660|NCT00120042|732153|P1|NOT COMPLETED|Overall Study||0
298661|NCT00120042|732151|P3|COMPLETED|Overall Study||83
298662|NCT00120042|732152|P2|COMPLETED|Overall Study||83
298663|NCT00120042|732153|P1|COMPLETED|Overall Study||85
298664|NCT00120042|732151|P3|STARTED|Overall Study||83
298665|NCT00120042|732152|P2|STARTED|Overall Study||83
298666|NCT00120042|732153|P1|STARTED|Overall Study||85
298667|NCT00119678|732163|P2|NOT COMPLETED|Open-label Treatment Period||0
298668|NCT00119678|732164|P1|NOT COMPLETED|Open-label Treatment Period||110
298669|NCT00119678|732163|P2|COMPLETED|Open-label Treatment Period||0
298670|NCT00119678|732164|P1|COMPLETED|Open-label Treatment Period||0
298671|NCT00119678|732163|P2|STARTED|Open-label Treatment Period||0
298672|NCT00119678|732164|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
298673|NCT00119678|732163|P2|NOT COMPLETED|Double-blind Treatment Period||26
298674|NCT00119678|732164|P1|NOT COMPLETED|Double-blind Treatment Period||41
298675|NCT00119678|732163|P2|COMPLETED|Double-blind Treatment Period||35
298676|NCT00119678|732164|P1|COMPLETED|Double-blind Treatment Period||81
298677|NCT00119678|732163|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
298678|NCT00119678|732164|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
298679|NCT00119678|732163|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
298680|NCT00119678|732164|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
298681|NCT00119678|732163|P2|STARTED|Double-blind Treatment Period||61
298682|NCT00119678|732164|P1|STARTED|Double-blind Treatment Period||122
298683|NCT00119405|732210|P1|NOT COMPLETED|Overall Study||1
298684|NCT00119405|732210|P1|COMPLETED|Overall Study||17
298685|NCT00119405|732210|P1|STARTED|Overall Study||18
298686|NCT00119392|732214|P1|NOT COMPLETED|Overall Study||5
298687|NCT00119392|732214|P1|COMPLETED|Overall Study||40
298688|NCT00119392|732214|P1|STARTED|Overall Study||45
298689|NCT00119379|732224|P2|NOT COMPLETED|Overall Study||1
298690|NCT00119379|732225|P1|NOT COMPLETED|Overall Study||4
298691|NCT00119379|732224|P2|COMPLETED|Overall Study||23
298692|NCT00119379|732225|P1|COMPLETED|Overall Study||22
298693|NCT00119379|732224|P2|STARTED|Overall Study||24
298694|NCT00119379|732225|P1|STARTED|Overall Study||26
298695|NCT00119262|732243|P2|NOT COMPLETED|Overall Study||58
298696|NCT00119262|732244|P1|NOT COMPLETED|Overall Study||46
298697|NCT00119262|732243|P2|COMPLETED|Overall Study||64
298698|NCT00119262|732244|P1|COMPLETED|Overall Study||58
298699|NCT00119262|732243|P2|Eligible and Treated|Overall Study||119
298700|NCT00119262|732244|P1|Eligible and Treated|Overall Study||102
298701|NCT00119262|732243|P2|Treated|Overall Study||120
298702|NCT00119262|732244|P1|Treated|Overall Study||103
298703|NCT00119262|732243|P2|Eligible|Overall Study||120
298704|NCT00119262|732244|P1|Eligible|Overall Study||103
298705|NCT00119262|732243|P2|STARTED|Overall Study||122
298706|NCT00119262|732244|P1|STARTED|Overall Study||104
298707|NCT00119158|732256|P2|NOT COMPLETED|Placebo Treatment||0
298708|NCT00119158|732257|P1|NOT COMPLETED|Placebo Treatment||0
298709|NCT00119158|732256|P2|COMPLETED|Placebo Treatment||45
298710|NCT00119158|732257|P1|COMPLETED|Placebo Treatment||45
298711|NCT00119158|732256|P2|STARTED|Placebo Treatment||45
298712|NCT00119158|732257|P1|STARTED|Placebo Treatment||45
298713|NCT00119158|732256|P2|NOT COMPLETED|Active Treatment||0
298714|NCT00119158|732257|P1|NOT COMPLETED|Active Treatment||0
298715|NCT00119158|732256|P2|COMPLETED|Active Treatment||45
298716|NCT00119158|732257|P1|COMPLETED|Active Treatment||45
298717|NCT00119158|732256|P2|STARTED|Active Treatment||45
298718|NCT00119158|732257|P1|STARTED|Active Treatment|patients are self controls|45
298719|NCT00119041|732268|P3|NOT COMPLETED|Overall Study||0
298720|NCT00119041|732269|P2|NOT COMPLETED|Overall Study||0
298721|NCT00119041|732270|P1|NOT COMPLETED|Overall Study||0
298722|NCT00119041|732268|P3|COMPLETED|Overall Study||22
298723|NCT00119041|732269|P2|COMPLETED|Overall Study||83
298724|NCT00119041|732270|P1|COMPLETED|Overall Study||199
298725|NCT00119041|732268|P3|STARTED|Overall Study||22
298726|NCT00119041|732269|P2|STARTED|Overall Study||83
298727|NCT00119041|732270|P1|STARTED|Overall Study||199
298728|NCT00119015|732281|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
298729|NCT00119015|732282|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
298730|NCT00119015|732283|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
298731|NCT00119015|732281|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
298732|NCT00119015|732282|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
298733|NCT00119015|732283|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
298734|NCT00119015|732281|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
298735|NCT00119015|732282|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
298736|NCT00119015|732283|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
298737|NCT00119015|732281|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
298738|NCT00119015|732282|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
298739|NCT00119015|732283|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
298740|NCT00119015|732281|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
298741|NCT00119015|732282|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
298742|NCT00119015|732283|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
298743|NCT00119015|732281|P3|STARTED|Open-Label Phase (2 Weeks)||0
298744|NCT00119015|732282|P2|STARTED|Open-Label Phase (2 Weeks)||0
298745|NCT00119015|732283|P1|STARTED|Open-Label Phase (2 Weeks)||102
298746|NCT00118911|732299|P2|NOT COMPLETED|Overall Study||5
298747|NCT00118911|732300|P1|NOT COMPLETED|Overall Study||2
298748|NCT00118911|732299|P2|COMPLETED|Overall Study||38
298749|NCT00118911|732300|P1|COMPLETED|Overall Study||41
298750|NCT00118911|732299|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
298751|NCT00118911|732300|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
298752|NCT00118911|732299|P2|6 Month Follow-up|Overall Study||30
298753|NCT00118911|732300|P1|6 Month Follow-up|Overall Study||37
298754|NCT00118911|732299|P2|Completed Post-Treatment Assessment|Overall Study||37
298755|NCT00118911|732300|P1|Completed Post-Treatment Assessment|Overall Study||41
298756|NCT00118911|732299|P2|Received Intervention as Assigned|Overall Study||38
298757|NCT00118911|732300|P1|Received Intervention as Assigned|Overall Study||41
298758|NCT00118911|732299|P2|STARTED|Overall Study||43
298759|NCT00118911|732300|P1|STARTED|Overall Study||43
298760|NCT00118898|732312|P4|NOT COMPLETED|Overall Study||141
298761|NCT00118898|732313|P3|NOT COMPLETED|Overall Study||123
298762|NCT00118898|732314|P2|NOT COMPLETED|Overall Study||141
298763|NCT00118898|732315|P1|NOT COMPLETED|Overall Study||121
298764|NCT00118898|732312|P4|COMPLETED|Overall Study||322
298765|NCT00118898|732313|P3|COMPLETED|Overall Study||342
298766|NCT00118898|732314|P2|COMPLETED|Overall Study||324
298767|NCT00118898|732315|P1|COMPLETED|Overall Study||343
298768|NCT00118898|732312|P4|Initiated Treatment|Overall Study||462
298769|NCT00118898|732313|P3|Initiated Treatment|Overall Study||464
298770|NCT00118898|732314|P2|Initiated Treatment|Overall Study||461
298771|NCT00118898|732315|P1|Initiated Treatment|Overall Study||461
298772|NCT00118898|732312|P4|STARTED|Overall Study||463
298773|NCT00118898|732313|P3|STARTED|Overall Study||465
298774|NCT00118898|732314|P2|STARTED|Overall Study||465
298775|NCT00118898|732315|P1|STARTED|Overall Study||464
298776|NCT00118755|732411|P2|NOT COMPLETED|Overall Study||215
298777|NCT00118755|732412|P1|NOT COMPLETED|Overall Study||210
298778|NCT00118755|732411|P2|COMPLETED|Overall Study||3
298779|NCT00118755|732412|P1|COMPLETED|Overall Study||7
298780|NCT00118755|732411|P2|Safety Population|Overall Study||211
298781|NCT00118755|732412|P1|Safety Population|Overall Study||208
298782|NCT00118755|732411|P2|STARTED|Overall Study||218
298783|NCT00118755|732412|P1|STARTED|Overall Study||217
298784|NCT00118742|732426|P2|NOT COMPLETED|Overall Study||66
298785|NCT00118742|732427|P1|NOT COMPLETED|Overall Study||49
298786|NCT00118742|732426|P2|COMPLETED|Overall Study||82
298787|NCT00118742|732427|P1|COMPLETED|Overall Study||96
298788|NCT00118742|732426|P2|STARTED|Overall Study||148
298789|NCT00118742|732427|P1|STARTED|Overall Study||145
298790|NCT00118703|732441|P2|NOT COMPLETED|Overall Study||9
298791|NCT00118703|732442|P1|NOT COMPLETED|Overall Study||5
298792|NCT00118703|732441|P2|COMPLETED|Overall Study||165
298793|NCT00118703|732442|P1|COMPLETED|Overall Study||168
298794|NCT00118703|732441|P2|STARTED|Overall Study||174
298795|NCT00118703|732442|P1|STARTED|Overall Study||173
298796|NCT00118534|732454|P2|NOT COMPLETED|Overall Study||0
298797|NCT00118534|732455|P1|NOT COMPLETED|Overall Study||0
298798|NCT00118534|732454|P2|COMPLETED|Overall Study||471
298799|NCT00118534|732455|P1|COMPLETED|Overall Study||472
298800|NCT00118534|732454|P2|STARTED|Overall Study||471
298801|NCT00118534|732455|P1|STARTED|Overall Study||472
298802|NCT00118482|732539|P2|NOT COMPLETED|Overall Study||29
298803|NCT00118482|732540|P1|NOT COMPLETED|Overall Study||30
298804|NCT00118482|732539|P2|COMPLETED|Overall Study||76
298805|NCT00118482|732540|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
298806|NCT00118482|732539|P2|STARTED|Overall Study||105
298807|NCT00118482|732540|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
298808|NCT00118430|732551|P3|NOT COMPLETED|Overall Study||28
298809|NCT00118430|732552|P2|NOT COMPLETED|Overall Study||24
298810|NCT00118430|732553|P1|NOT COMPLETED|Overall Study||21
298811|NCT00118430|732551|P3|COMPLETED|Overall Study||222
298812|NCT00118430|732552|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
298813|NCT00118430|732553|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
298814|NCT00118430|732551|P3|STARTED|Overall Study||250
298815|NCT00118430|732552|P2|STARTED|Overall Study||127
298816|NCT00118430|732553|P1|STARTED|Overall Study||123
298817|NCT00118417|732568|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
298818|NCT00118417|732569|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
298819|NCT00118417|732568|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
298820|NCT00118417|732569|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
298821|NCT00118417|732568|P2|STARTED|Phase III (Weeks 12 to 24)||10
298822|NCT00118417|732569|P1|STARTED|Phase III (Weeks 12 to 24)||9
298823|NCT00118417|732568|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
298824|NCT00118417|732569|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
298825|NCT00118417|732568|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
298826|NCT00118417|732569|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
298827|NCT00118417|732568|P2|STARTED|Phase II (Weeks 6 to 12)||13
298828|NCT00118417|732569|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
298829|NCT00118417|732568|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
298830|NCT00118417|732569|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
298831|NCT00118417|732568|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
298832|NCT00118417|732569|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
298833|NCT00118417|732568|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
298834|NCT00118417|732569|P1|STARTED|Phase I (Weeks 0 to 6)||39
298835|NCT00118404|732582|P3|NOT COMPLETED|Overall Study||20
298836|NCT00118404|732583|P2|NOT COMPLETED|Overall Study||16
298837|NCT00118404|732584|P1|NOT COMPLETED|Overall Study||24
298838|NCT00118404|732582|P3|COMPLETED|Overall Study||49
298839|NCT00118404|732583|P2|COMPLETED|Overall Study||70
298840|NCT00118404|732584|P1|COMPLETED|Overall Study||62
298841|NCT00118404|732582|P3|STARTED|Overall Study||69
298842|NCT00118404|732583|P2|STARTED|Overall Study||86
298843|NCT00118404|732584|P1|STARTED|Overall Study||86
298844|NCT00118378|732600|P2|NOT COMPLETED|Overall Study||8
298845|NCT00118378|732601|P1|NOT COMPLETED|Overall Study||2
298846|NCT00118378|732600|P2|COMPLETED|Overall Study||45
298847|NCT00118378|732601|P1|COMPLETED|Overall Study||60
298848|NCT00118378|732600|P2|STARTED|Overall Study||53
298849|NCT00118378|732601|P1|STARTED|Overall Study||62
298850|NCT00118365|732615|P2|NOT COMPLETED|Overall Study||60
298851|NCT00118365|732616|P1|NOT COMPLETED|Overall Study||59
298852|NCT00118365|732615|P2|COMPLETED|Overall Study||124
298853|NCT00118365|732616|P1|COMPLETED|Overall Study||132
298854|NCT00118365|732615|P2|STARTED|Overall Study||184
298855|NCT00118365|732616|P1|STARTED|Overall Study||191
298856|NCT00118352|732685|P3|NOT COMPLETED|Overall Study||0
298857|NCT00118352|732686|P2|NOT COMPLETED|Overall Study||0
298858|NCT00118352|732687|P1|NOT COMPLETED|Overall Study||0
298859|NCT00118352|732685|P3|COMPLETED|Overall Study||0
298860|NCT00118352|732686|P2|COMPLETED|Overall Study||0
298861|NCT00118352|732687|P1|COMPLETED|Overall Study||12
298862|NCT00118352|732685|P3|STARTED|Overall Study||0
298863|NCT00118352|732686|P2|STARTED|Overall Study||0
298864|NCT00118352|732687|P1|STARTED|Overall Study||12
298865|NCT00118287|732713|P1|NOT COMPLETED|Overall Study||2
298866|NCT00118287|732713|P1|COMPLETED|Overall Study||30
298867|NCT00118287|732713|P1|STARTED|Overall Study||32
298868|NCT00118248|732719|P2|NOT COMPLETED|Overall Study||0
298869|NCT00118248|732720|P1|NOT COMPLETED|Overall Study||0
298870|NCT00118248|732719|P2|COMPLETED|Overall Study||24
298871|NCT00118248|732720|P1|COMPLETED|Overall Study||17
298872|NCT00118248|732719|P2|STARTED|Overall Study||24
298873|NCT00118248|732720|P1|STARTED|Overall Study||17
298874|NCT00118157|732733|P1|NOT COMPLETED|Overall Study||12
298875|NCT00118157|732733|P1|COMPLETED|Overall Study||7
298876|NCT00118157|732733|P1|STARTED|Overall Study||19
298877|NCT00118144|732738|P1|NOT COMPLETED|Overall Study||1
298878|NCT00118144|732738|P1|COMPLETED|Overall Study||41
298879|NCT00118144|732738|P1|STARTED|Overall Study||42
298880|NCT00118131|732744|P1|NOT COMPLETED|Overall Study||0
298881|NCT00118131|732744|P1|COMPLETED|Overall Study||49
298882|NCT00118131|732744|P1|STARTED|Overall Study||49
298883|NCT00118092|732751|P1|NOT COMPLETED|Overall Study||2
298884|NCT00118092|732751|P1|COMPLETED|Overall Study||15
298885|NCT00118092|732751|P1|STARTED|Overall Study||17
298886|NCT00118053|732759|P1|NOT COMPLETED|Overall Study||0
298887|NCT00118053|732759|P1|COMPLETED|Overall Study||5
298888|NCT00118053|732759|P1|STARTED|Overall Study||5
298889|NCT00118040|732769|P3|NOT COMPLETED|Overall Study||6
298890|NCT00118040|732770|P2|NOT COMPLETED|Overall Study||2
298891|NCT00118040|732771|P1|NOT COMPLETED|Overall Study||1
298892|NCT00118040|732769|P3|COMPLETED|Overall Study||14
298893|NCT00118040|732770|P2|COMPLETED|Overall Study||18
298894|NCT00118040|732771|P1|COMPLETED|Overall Study||19
298895|NCT00118040|732769|P3|STARTED|Overall Study||20
298896|NCT00118040|732770|P2|STARTED|Overall Study||20
298897|NCT00118040|732771|P1|STARTED|Overall Study||20
298898|NCT00117988|732832|P1|NOT COMPLETED|Overall Study||4
298899|NCT00117988|732832|P1|COMPLETED|Overall Study||18
298900|NCT00117988|732832|P1|STARTED|Overall Study||22
298901|NCT00117962|732838|P2|NOT COMPLETED|Overall Study||25
298902|NCT00117962|732839|P1|NOT COMPLETED|Overall Study||22
298903|NCT00117962|732838|P2|COMPLETED|Overall Study||28
298904|NCT00117962|732839|P1|COMPLETED|Overall Study||26
298905|NCT00117962|732838|P2|STARTED|Overall Study||53
298906|NCT00117962|732839|P1|STARTED|Overall Study||48
298907|NCT00117949|732855|P4|NOT COMPLETED|Overall Study||24
298908|NCT00117949|732856|P3|NOT COMPLETED|Overall Study||24
298909|NCT00117949|732857|P2|NOT COMPLETED|Overall Study||24
298910|NCT00117949|732858|P1|NOT COMPLETED|Overall Study||10
298911|NCT00117949|732855|P4|COMPLETED|Overall Study||0
298912|NCT00117949|732856|P3|COMPLETED|Overall Study||0
298913|NCT00117949|732857|P2|COMPLETED|Overall Study||0
298914|NCT00117949|732858|P1|COMPLETED|Overall Study||0
298915|NCT00117949|732855|P4|STARTED|Overall Study||24
298916|NCT00117949|732856|P3|STARTED|Overall Study||24
298917|NCT00117949|732857|P2|STARTED|Overall Study||24
298918|NCT00117949|732858|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
298919|NCT00117845|732892|P1|NOT COMPLETED|Overall Study||1
298920|NCT00117845|732892|P1|COMPLETED|Overall Study||16
298921|NCT00117845|732892|P1|STARTED|Overall Study||17
298922|NCT00117806|732899|P2|NOT COMPLETED|Overall Study||16
298923|NCT00117806|732900|P1|NOT COMPLETED|Overall Study||38
298924|NCT00117806|732899|P2|COMPLETED|Overall Study||60
298925|NCT00117806|732900|P1|COMPLETED|Overall Study||43
298926|NCT00117806|732899|P2|STARTED|Overall Study||76
298927|NCT00117806|732900|P1|STARTED|Overall Study||81
298928|NCT00117793|732910|P1|NOT COMPLETED|Overall Study||12
298929|NCT00117793|732910|P1|COMPLETED|Overall Study||5
298930|NCT00117793|732910|P1|STARTED|Overall Study||17
298931|NCT00117715|732925|P1|NOT COMPLETED|Overall Study||72
298932|NCT00117715|732925|P1|COMPLETED|Overall Study||49
298933|NCT00117715|732925|P1|5 Year|Overall Study||49
298934|NCT00117715|732925|P1|4.5 Year|Overall Study||55
298935|NCT00117715|732925|P1|4 Year|Overall Study||58
298936|NCT00117715|732925|P1|3.5 Year|Overall Study||60
298937|NCT00117715|732925|P1|3 Year|Overall Study||61
298938|NCT00117715|732925|P1|2.5 Year|Overall Study||70
298939|NCT00117715|732925|P1|2 Year|Overall Study||76
298940|NCT00117715|732925|P1|1.5 Year|Overall Study||85
298941|NCT00117715|732925|P1|1 Year|Overall Study||88
298942|NCT00117715|732925|P1|STARTED|Overall Study||121
298943|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
298944|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
298945|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
298946|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
298947|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
298948|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 433 - 480||82
298949|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
298950|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
298951|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
298952|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
298953|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
298954|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
298955|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
298956|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
298957|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
298958|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
298959|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 337 - 384||93
298960|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 337 - 384||183
298961|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
298962|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
298963|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
298964|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
298965|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 289 - 336||100
298966|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 289 - 336||192
298967|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
298968|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
298969|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
298970|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
298971|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 241 - 288||103
298972|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 241 - 288||202
298973|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
298974|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
298975|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
298976|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
298977|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 193 - 240||106
298978|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 193 - 240||209
298979|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
298980|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
298981|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
298982|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
298983|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 145 - 192||109
298984|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 145 - 192||219
298985|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
298986|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
298987|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
298988|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
298989|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 97 - 144||110
298990|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 97 - 144||225
298991|NCT00117676|732933|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
298992|NCT00117676|732934|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
298993|NCT00117676|732933|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
298994|NCT00117676|732934|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
298995|NCT00117676|732933|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
298996|NCT00117676|732934|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
298997|NCT00117676|732933|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
298998|NCT00117676|732934|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
298999|NCT00117676|732933|P2|COMPLETED|Double-blind Period Through Week 48||121
299000|NCT00117676|732934|P1|COMPLETED|Double-blind Period Through Week 48||244
299001|NCT00117676|732933|P2|STARTED|Double-blind Period Through Week 48||128
299002|NCT00117676|732934|P1|STARTED|Double-blind Period Through Week 48||254
299003|NCT00117637|733023|P2|NOT COMPLETED|Second Intervention (Period 2)||22
299004|NCT00117637|733024|P1|NOT COMPLETED|Second Intervention (Period 2)||10
299005|NCT00117637|733023|P2|COMPLETED|Second Intervention (Period 2)||39
299006|NCT00117637|733024|P1|COMPLETED|Second Intervention (Period 2)||39
299007|NCT00117637|733023|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
299008|NCT00117637|733024|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
299009|NCT00117637|733023|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
299010|NCT00117637|733024|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
299011|NCT00117637|733023|P2|NOT COMPLETED|First Intervention (Period 1)||25
299012|NCT00117637|733024|P1|NOT COMPLETED|First Intervention (Period 1)||18
299013|NCT00117637|733023|P2|COMPLETED|First Intervention (Period 1)||67
299014|NCT00117637|733024|P1|COMPLETED|First Intervention (Period 1)||79
299015|NCT00117637|733023|P2|Subjects Received Treatment|First Intervention (Period 1)||90
299016|NCT00117637|733024|P1|Subjects Received Treatment|First Intervention (Period 1)||97
299017|NCT00117637|733023|P2|STARTED|First Intervention (Period 1)||92
299018|NCT00117637|733024|P1|STARTED|First Intervention (Period 1)||97
299019|NCT00117598|733099|P5|NOT COMPLETED|After Treament Cross Over||4
299020|NCT00117598|733100|P4|NOT COMPLETED|After Treament Cross Over||3
299021|NCT00117598|733101|P3|NOT COMPLETED|After Treament Cross Over||0
299022|NCT00117598|733102|P2|NOT COMPLETED|After Treament Cross Over||0
299023|NCT00117598|733103|P1|NOT COMPLETED|After Treament Cross Over||0
299024|NCT00117598|733099|P5|COMPLETED|After Treament Cross Over||0
299025|NCT00117598|733100|P4|COMPLETED|After Treament Cross Over||0
299026|NCT00117598|733101|P3|COMPLETED|After Treament Cross Over||0
299027|NCT00117598|733102|P2|COMPLETED|After Treament Cross Over||0
299028|NCT00117598|733103|P1|COMPLETED|After Treament Cross Over||0
299029|NCT00117598|733099|P5|STARTED|After Treament Cross Over||4
299030|NCT00117598|733100|P4|STARTED|After Treament Cross Over||3
299031|NCT00117598|733101|P3|STARTED|After Treament Cross Over||0
299032|NCT00117598|733102|P2|STARTED|After Treament Cross Over||0
299033|NCT00117598|733103|P1|STARTED|After Treament Cross Over||0
299034|NCT00117598|733099|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
299035|NCT00117598|733100|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
299036|NCT00117598|733101|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
299037|NCT00117598|733102|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
299038|NCT00117598|733103|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
299039|NCT00117598|733099|P5|COMPLETED|Prior to Treatment Cross Over||0
299040|NCT00117598|733100|P4|COMPLETED|Prior to Treatment Cross Over||0
299041|NCT00117598|733101|P3|COMPLETED|Prior to Treatment Cross Over||4
299042|NCT00117598|733102|P2|COMPLETED|Prior to Treatment Cross Over||3
299043|NCT00117598|733103|P1|COMPLETED|Prior to Treatment Cross Over||0
299044|NCT00117598|733099|P5|STARTED|Prior to Treatment Cross Over||0
299045|NCT00117598|733100|P4|STARTED|Prior to Treatment Cross Over||0
299046|NCT00117598|733101|P3|STARTED|Prior to Treatment Cross Over||56
299047|NCT00117598|733102|P2|STARTED|Prior to Treatment Cross Over||56
299048|NCT00117598|733103|P1|STARTED|Prior to Treatment Cross Over||57
299049|NCT00117585|733131|P1|NOT COMPLETED|Overall Study||0
299050|NCT00117585|733131|P1|COMPLETED|Overall Study||341
299051|NCT00117585|733131|P1|STARTED|Overall Study||341
299052|NCT00117572|733137|P2|NOT COMPLETED|Overall Study||6
299053|NCT00117572|733138|P1|NOT COMPLETED|Overall Study||6
299054|NCT00117572|733137|P2|COMPLETED|Overall Study||135
299055|NCT00117572|733138|P1|COMPLETED|Overall Study||138
299056|NCT00117572|733137|P2|STARTED|Overall Study||141
299057|NCT00117572|733138|P1|STARTED|Overall Study||144
299058|NCT00117559|733170|P2|NOT COMPLETED|Overall Study||1
299059|NCT00117559|733171|P1|NOT COMPLETED|Overall Study||1
299060|NCT00117559|733170|P2|COMPLETED|Overall Study||9
299061|NCT00117559|733171|P1|COMPLETED|Overall Study||8
299062|NCT00117559|733170|P2|STARTED|Overall Study||10
299063|NCT00117559|733171|P1|STARTED|Overall Study||9
299064|NCT00117338|733179|P2|NOT COMPLETED|Overall Study||4
299065|NCT00117338|733180|P1|NOT COMPLETED|Overall Study||5
299066|NCT00117338|733179|P2|COMPLETED|Overall Study||127
299067|NCT00117338|733180|P1|COMPLETED|Overall Study||140
299068|NCT00117338|733179|P2|STARTED|Overall Study||131
299069|NCT00117338|733180|P1|STARTED|Overall Study||145
299070|NCT00117325|733200|P2|NOT COMPLETED|Overall Study||12
299071|NCT00117325|733201|P1|NOT COMPLETED|Overall Study||13
299072|NCT00117325|733200|P2|COMPLETED|Overall Study||167
299073|NCT00117325|733201|P1|COMPLETED|Overall Study||160
299074|NCT00117325|733200|P2|STARTED|Overall Study||179
299075|NCT00117325|733201|P1|STARTED|Overall Study||173
299076|NCT00117312|733233|P4|NOT COMPLETED|Overall Study||21
299077|NCT00117312|733234|P3|NOT COMPLETED|Overall Study||24
299078|NCT00117312|733235|P2|NOT COMPLETED|Overall Study||20
299079|NCT00117312|733236|P1|NOT COMPLETED|Overall Study||10
299080|NCT00117312|733233|P4|COMPLETED|Overall Study||3
299081|NCT00117312|733234|P3|COMPLETED|Overall Study||0
299082|NCT00117312|733235|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
299083|NCT00117312|733236|P1|COMPLETED|Overall Study||0
299084|NCT00117312|733233|P4|Started FE200486 CS06A|Overall Study||9
299085|NCT00117312|733234|P3|Started FE200486 CS06A|Overall Study||16
299086|NCT00117312|733235|P2|Started FE200486 CS06A|Overall Study||11
299087|NCT00117312|733236|P1|Started FE200486 CS06A|Overall Study||1
299088|NCT00117312|733233|P4|STARTED|Overall Study||24
299089|NCT00117312|733234|P3|STARTED|Overall Study||24
299090|NCT00117312|733235|P2|STARTED|Overall Study||24
299091|NCT00117312|733236|P1|STARTED|Overall Study||10
299092|NCT00117286|733252|P2|NOT COMPLETED|Overall Study||21
299093|NCT00117286|733253|P1|NOT COMPLETED|Overall Study||28
299094|NCT00117286|733252|P2|COMPLETED|Overall Study||6
299095|NCT00117286|733253|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
299096|NCT00117286|733252|P2|Switched to Higher Dose|Overall Study||17
299097|NCT00117286|733253|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
299098|NCT00117286|733252|P2|STARTED|Overall Study||27
299099|NCT00117286|733253|P1|STARTED|Overall Study|Safety analysis set|30
299100|NCT00117156|733261|P1|NOT COMPLETED|Overall Study||11
299101|NCT00117156|733261|P1|COMPLETED|Overall Study||15
299102|NCT00117156|733261|P1|STARTED|Overall Study||26
299103|NCT00116857|733271|P2|NOT COMPLETED|Overall Study||4
299104|NCT00116857|733272|P1|NOT COMPLETED|Overall Study||3
299105|NCT00116857|733271|P2|COMPLETED|Overall Study||56
299106|NCT00116857|733272|P1|COMPLETED|Overall Study||59
299107|NCT00116857|733271|P2|STARTED|Overall Study||60
299108|NCT00116857|733272|P1|STARTED|Overall Study||62
299109|NCT00116844|733280|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
299110|NCT00116844|733281|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
299111|NCT00116844|733280|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
299112|NCT00116844|733281|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
299113|NCT00116844|733280|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
299114|NCT00116844|733281|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
299115|NCT00116844|733280|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
299116|NCT00116844|733281|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
299117|NCT00116844|733280|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
299118|NCT00116844|733281|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
299119|NCT00116844|733280|P2|STARTED|Period 2: Washout Period (7 Days)||33
299120|NCT00116844|733281|P1|STARTED|Period 2: Washout Period (7 Days)||28
299121|NCT00116844|733280|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
299122|NCT00116844|733281|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
299123|NCT00116844|733280|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
299124|NCT00116844|733281|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
299125|NCT00116844|733280|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
299126|NCT00116844|733281|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
299127|NCT00116831|733299|P2|NOT COMPLETED|Overall Study||72
299128|NCT00116831|733300|P1|NOT COMPLETED|Overall Study||73
299129|NCT00116831|733299|P2|COMPLETED|Overall Study||259
299130|NCT00116831|733300|P1|COMPLETED|Overall Study||264
299131|NCT00116831|733299|P2|STARTED|Overall Study||331
299132|NCT00116831|733300|P1|STARTED|Overall Study||337
299133|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
299134|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
299135|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
299136|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
299137|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
299138|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 433 - 480||57
299139|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
299140|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
299141|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
299142|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
299143|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
299144|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
299145|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
299146|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
299147|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
299148|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
299149|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 337 - 384||57
299150|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 337 - 384||98
299151|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
299152|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
299153|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
299154|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
299155|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 289 - 336||64
299156|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 289 - 336||104
299157|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
299158|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
299159|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
299160|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
299161|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 241 - 288||64
299162|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 241 - 288||110
299163|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
299164|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
299165|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
299166|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
299167|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 193 - 240||68
299168|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 193 - 240||123
299169|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
299170|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
299171|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
299172|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
299173|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 145 - 192||74
299174|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 145 - 192||133
299175|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
299176|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
299177|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
299178|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
299179|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 97 - 144||83
299180|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 97 - 144||144
299181|NCT00116805|733378|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
299182|NCT00116805|733379|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
299183|NCT00116805|733378|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
299184|NCT00116805|733379|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
299185|NCT00116805|733378|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
299186|NCT00116805|733379|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
299187|NCT00116805|733378|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
299188|NCT00116805|733379|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
299189|NCT00116805|733378|P2|COMPLETED|Double-blind Period Through Week 48||85
299190|NCT00116805|733379|P1|COMPLETED|Double-blind Period Through Week 48||165
299191|NCT00116805|733378|P2|STARTED|Double-blind Period Through Week 48||90
299192|NCT00116805|733379|P1|STARTED|Double-blind Period Through Week 48||176
299193|NCT00116779|733472|P2|NOT COMPLETED|Overall Study||19
299194|NCT00116779|733473|P1|NOT COMPLETED|Overall Study||21
299195|NCT00116779|733472|P2|COMPLETED|Overall Study||45
299196|NCT00116779|733473|P1|COMPLETED|Overall Study||42
299197|NCT00116779|733472|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
299198|NCT00116779|733473|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
299199|NCT00116753|733506|P3|NOT COMPLETED|Overall Study||24
299200|NCT00116753|733507|P2|NOT COMPLETED|Overall Study||30
299201|NCT00116753|733508|P1|NOT COMPLETED|Overall Study||32
299202|NCT00116753|733506|P3|COMPLETED|Overall Study||128
299203|NCT00116753|733507|P2|COMPLETED|Overall Study||125
299204|NCT00116753|733508|P1|COMPLETED|Overall Study||121
299205|NCT00116753|733506|P3|ITT Population|Overall Study||147
299206|NCT00116753|733507|P2|ITT Population|Overall Study||150
299207|NCT00116753|733508|P1|ITT Population|Overall Study||150
299208|NCT00116753|733506|P3|STARTED|Overall Study||152
299209|NCT00116753|733507|P2|STARTED|Overall Study||155
299210|NCT00116753|733508|P1|STARTED|Overall Study|Randomised.|153
299211|NCT00116688|733530|P2|NOT COMPLETED|Overall Study||4
299212|NCT00116688|733531|P1|NOT COMPLETED|Overall Study||92
299213|NCT00116688|733530|P2|COMPLETED|Overall Study||17
299214|NCT00116688|733531|P1|COMPLETED|Overall Study||200
299215|NCT00116688|733530|P2|Received Study Medication|Overall Study||20
299216|NCT00116688|733531|P1|Received Study Medication|Overall Study||291
299217|NCT00116688|733530|P2|STARTED|Overall Study||21
299218|NCT00116688|733531|P1|STARTED|Overall Study||292
299219|NCT00116649|733546|P1|NOT COMPLETED|Overall Study||155
299220|NCT00116649|733546|P1|COMPLETED|Overall Study||396
299221|NCT00116649|733546|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
299222|NCT00116428|733553|P2|NOT COMPLETED|Overall Study||5
299223|NCT00116428|733554|P1|NOT COMPLETED|Overall Study||3
299224|NCT00116428|733553|P2|COMPLETED|Overall Study||56
299225|NCT00116428|733554|P1|COMPLETED|Overall Study||103
299226|NCT00116428|733553|P2|Underwent Study Ablation Procedure|Overall Study||36
299227|NCT00116428|733554|P1|Underwent Study Ablation Procedure|Overall Study||103
299228|NCT00116428|733553|P2|STARTED|Overall Study||61
299229|NCT00116428|733554|P1|STARTED|Overall Study||106
299230|NCT00116272|733572|P2|NOT COMPLETED|Overall Study||6
299231|NCT00116272|733573|P1|NOT COMPLETED|Overall Study||11
299232|NCT00116272|733572|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
299233|NCT00116272|733573|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
299234|NCT00116272|733572|P2|STARTED|Overall Study||164
299235|NCT00116272|733573|P1|STARTED|Overall Study||370
299236|NCT00116207|733625|P2|NOT COMPLETED|Overall Study||4
299237|NCT00116207|733626|P1|NOT COMPLETED|Overall Study||9
299238|NCT00116207|733625|P2|COMPLETED|Overall Study||18
299239|NCT00116207|733626|P1|COMPLETED|Overall Study||13
299240|NCT00116207|733625|P2|STARTED|Overall Study||22
299241|NCT00116207|733626|P1|STARTED|Overall Study||22
299242|NCT00116168|733642|P4|NOT COMPLETED|Overall Study||0
299243|NCT00116168|733643|P3|NOT COMPLETED|Overall Study||0
299244|NCT00116168|733644|P2|NOT COMPLETED|Overall Study||5
299245|NCT00116168|733645|P1|NOT COMPLETED|Overall Study||6
299246|NCT00116168|733642|P4|COMPLETED|Overall Study||6
299247|NCT00116168|733643|P3|COMPLETED|Overall Study||6
299248|NCT00116168|733644|P2|COMPLETED|Overall Study||6
299249|NCT00116168|733645|P1|COMPLETED|Overall Study||0
299250|NCT00116168|733642|P4|STARTED|Overall Study||6
299251|NCT00116168|733643|P3|STARTED|Overall Study||6
299252|NCT00116168|733644|P2|STARTED|Overall Study||11
299253|NCT00116168|733645|P1|STARTED|Overall Study||6
299254|NCT00115934|733709|P2|NOT COMPLETED|Overall Study||2
299255|NCT00115934|733710|P1|NOT COMPLETED|Overall Study||4
299256|NCT00115934|733709|P2|COMPLETED|Overall Study||274
299257|NCT00115934|733710|P1|COMPLETED|Overall Study||275
299258|NCT00115934|733709|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
299259|NCT00115934|733710|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
299260|NCT00115869|733750|P2|NOT COMPLETED|Overall Study||296
299261|NCT00115869|733751|P1|NOT COMPLETED|Overall Study||317
299262|NCT00115869|733750|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
299263|NCT00115869|733751|P1|COMPLETED|Overall Study||3894
299264|NCT00115869|733750|P2|Completed Data Collection at 12th Grade|Overall Study||3847
299265|NCT00115869|733751|P1|Completed Data Collection at 12th Grade|Overall Study||3876
299266|NCT00115869|733750|P2|STARTED|Overall Study||4177
299267|NCT00115869|733751|P1|STARTED|Overall Study||4211
299268|NCT00115804|733759|P1|NOT COMPLETED|Overall Study||2
299269|NCT00115804|733759|P1|COMPLETED|Overall Study||4
299270|NCT00115804|733759|P1|STARTED|Overall Study||6
299271|NCT00115765|733774|P4|NOT COMPLETED|Overall Study||31
299272|NCT00115765|733775|P3|NOT COMPLETED|Overall Study||121
299273|NCT00115765|733776|P2|NOT COMPLETED|Overall Study||100
299274|NCT00115765|733777|P1|NOT COMPLETED|Overall Study||35
299275|NCT00115765|733774|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
299276|NCT00115765|733775|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
299277|NCT00115765|733776|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
299278|NCT00115765|733777|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
299279|NCT00115765|733774|P4|STARTED|Overall Study||115
299280|NCT00115765|733775|P3|STARTED|Overall Study||410
299281|NCT00115765|733776|P2|STARTED|Overall Study||413
299282|NCT00115765|733777|P1|STARTED|Overall Study||115
299283|NCT00115739|733815|P1|NOT COMPLETED|Overall Study||3
299284|NCT00115739|733815|P1|COMPLETED|Overall Study||8
299285|NCT00115739|733815|P1|STARTED|Overall Study||11
299286|NCT00115349|733824|P2|NOT COMPLETED|Overall Study||9
299287|NCT00115349|733825|P1|NOT COMPLETED|Overall Study||11
299288|NCT00115349|733824|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
299289|NCT00115349|733825|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
299290|NCT00115349|733824|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
299291|NCT00115349|733825|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
299292|NCT00115297|733833|P2|NOT COMPLETED|Overall Study||0
299293|NCT00115297|733834|P1|NOT COMPLETED|Overall Study||0
299294|NCT00115297|733833|P2|COMPLETED|Overall Study||32
299295|NCT00115297|733834|P1|COMPLETED|Overall Study||30
299296|NCT00115297|733833|P2|STARTED|Overall Study||32
299297|NCT00115297|733834|P1|STARTED|Overall Study||30
299298|NCT00115063|733846|P2|NOT COMPLETED|Overall Study||104
299299|NCT00115063|733847|P1|NOT COMPLETED|Overall Study||99
299300|NCT00115063|733846|P2|COMPLETED|Overall Study||86
299301|NCT00115063|733847|P1|COMPLETED|Overall Study||101
299302|NCT00115063|733846|P2|STARTED|Overall Study||190
299303|NCT00115063|733847|P1|STARTED|Overall Study||200
299304|NCT00114972|733865|P2|NOT COMPLETED|Overall Study||12
299305|NCT00114972|733866|P1|NOT COMPLETED|Overall Study||48
299306|NCT00114972|733865|P2|COMPLETED|Overall Study||891
299307|NCT00114972|733866|P1|COMPLETED|Overall Study||849
299308|NCT00114972|733865|P2|STARTED|Overall Study||903
299309|NCT00114972|733866|P1|STARTED|Overall Study||897
299310|NCT00114959|733886|P1|NOT COMPLETED|Overall Study||8
299311|NCT00114959|733886|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
299312|NCT00114959|733886|P1|STARTED|Overall Study||15
299313|NCT00114777|733896|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
299314|NCT00114777|733897|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
299315|NCT00114777|733898|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
299316|NCT00114777|733896|P3|COMPLETED|Long-Term Extension to Month 84||57
299317|NCT00114777|733897|P2|COMPLETED|Long-Term Extension to Month 84||84
299318|NCT00114777|733898|P1|COMPLETED|Long-Term Extension to Month 84||74
299319|NCT00114777|733896|P3|STARTED|Long-Term Extension to Month 84||87
299320|NCT00114777|733897|P2|STARTED|Long-Term Extension to Month 84||113
299321|NCT00114777|733898|P1|STARTED|Long-Term Extension to Month 84||104
299322|NCT00114777|733896|P3|NOT COMPLETED|Randomization to Month 36||84
299323|NCT00114777|733897|P2|NOT COMPLETED|Randomization to Month 36||61
299324|NCT00114777|733898|P1|NOT COMPLETED|Randomization to Month 36||75
299325|NCT00114777|733896|P3|COMPLETED|Randomization to Month 36||100
299326|NCT00114777|733897|P2|COMPLETED|Randomization to Month 36||114
299327|NCT00114777|733898|P1|COMPLETED|Randomization to Month 36||109
299328|NCT00114777|733896|P3|STARTED|Randomization to Month 36||184
299329|NCT00114777|733897|P2|STARTED|Randomization to Month 36||175
299330|NCT00114777|733898|P1|STARTED|Randomization to Month 36||184
299331|NCT00114634|733972|P1|NOT COMPLETED|Overall Study||3
299332|NCT00114634|733972|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
299333|NCT00114634|733972|P1|STARTED|Overall Study||13
299334|NCT00114530|733988|P2|NOT COMPLETED|Overall Study||20
299335|NCT00114530|733989|P1|NOT COMPLETED|Overall Study||9
299336|NCT00114530|733988|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
299337|NCT00114530|733989|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
299338|NCT00114530|733988|P2|STARTED|Overall Study||39
299339|NCT00114530|733989|P1|STARTED|Overall Study||36
299340|NCT00114517|734098|P4|NOT COMPLETED|Overall Study||10
299341|NCT00114517|734099|P3|NOT COMPLETED|Overall Study||14
299342|NCT00114517|734100|P2|NOT COMPLETED|Overall Study||11
299343|NCT00114517|734101|P1|NOT COMPLETED|Overall Study||12
299344|NCT00114517|734098|P4|COMPLETED|Overall Study||176
299345|NCT00114517|734099|P3|COMPLETED|Overall Study||172
299346|NCT00114517|734100|P2|COMPLETED|Overall Study||123
299347|NCT00114517|734101|P1|COMPLETED|Overall Study||125
299348|NCT00114517|734098|P4|STARTED|Overall Study||186
299349|NCT00114517|734099|P3|STARTED|Overall Study||186
299350|NCT00114517|734100|P2|STARTED|Overall Study||134
299351|NCT00114517|734101|P1|STARTED|Overall Study||137
299352|NCT00114504|734113|P2|NOT COMPLETED|Overall Study||0
299353|NCT00114504|734114|P1|NOT COMPLETED|Overall Study||0
299354|NCT00114504|734113|P2|COMPLETED|Overall Study||22
299355|NCT00114504|734114|P1|COMPLETED|Overall Study||21
299356|NCT00114504|734113|P2|STARTED|Overall Study||22
299357|NCT00114504|734114|P1|STARTED|Overall Study||21
299358|NCT00114244|734126|P2|NOT COMPLETED|Overall Study||7
299359|NCT00114244|734127|P1|NOT COMPLETED|Overall Study||2
299360|NCT00114244|734126|P2|COMPLETED|Overall Study||30
299361|NCT00114244|734127|P1|COMPLETED|Overall Study||13
299362|NCT00114244|734126|P2|STARTED|Overall Study||37
299363|NCT00114244|734127|P1|STARTED|Overall Study||15
299364|NCT00114231|734139|P2|NOT COMPLETED|Overall Study||2
299365|NCT00114231|734140|P1|NOT COMPLETED|Overall Study||9
299366|NCT00114231|734139|P2|COMPLETED|Overall Study||26
299367|NCT00114231|734140|P1|COMPLETED|Overall Study||53
299368|NCT00114231|734139|P2|STARTED|Overall Study||28
299369|NCT00114231|734140|P1|STARTED|Overall Study||62
299370|NCT00114166|734149|P1|NOT COMPLETED|Overall Study||1
299371|NCT00114166|734149|P1|COMPLETED|Overall Study|total numbers of eligible and evaluable participants|80
299372|NCT00114166|734149|P1|Registered to Regimen II|Overall Study||65
299373|NCT00114166|734149|P1|Registered to Regimen I|Overall Study||15
299374|NCT00114166|734149|P1|STARTED|Overall Study|total number of participants enrolled|81
299375|NCT00114140|734155|P1|NOT COMPLETED|Overall Study||7
299376|NCT00114140|734155|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
299377|NCT00114140|734155|P1|STARTED|Overall Study||136
299378|NCT00114127|734169|P2|NOT COMPLETED|Overall Study||4
299379|NCT00114127|734170|P1|NOT COMPLETED|Overall Study||4
299380|NCT00114127|734169|P2|COMPLETED|Overall Study||11
299381|NCT00114127|734170|P1|COMPLETED|Overall Study||9
299382|NCT00114127|734169|P2|STARTED|Overall Study||15
299383|NCT00114127|734170|P1|STARTED|Overall Study||13
299384|NCT00114101|734180|P2|NOT COMPLETED|Overall Study||0
299385|NCT00114101|734181|P1|NOT COMPLETED|Overall Study||0
299386|NCT00114101|734180|P2|COMPLETED|Overall Study||229
299387|NCT00114101|734181|P1|COMPLETED|Overall Study||231
299388|NCT00114101|734180|P2|STARTED|Overall Study||229
299389|NCT00114101|734181|P1|STARTED|Overall Study||231
299390|NCT00113919|734193|P1|NOT COMPLETED|Overall Study||14
299391|NCT00113919|734193|P1|COMPLETED|Overall Study||0
299392|NCT00113919|734193|P1|STARTED|Overall Study||14
299393|NCT00113880|734200|P3|NOT COMPLETED|Overall Study||0
299394|NCT00113880|734201|P2|NOT COMPLETED|Overall Study||0
299395|NCT00113880|734202|P1|NOT COMPLETED|Overall Study||0
299396|NCT00113880|734200|P3|COMPLETED|Overall Study||62492
299397|NCT00113880|734201|P2|COMPLETED|Overall Study||71949
299398|NCT00113880|734202|P1|COMPLETED|Overall Study||63061
299399|NCT00113880|734200|P3|STARTED|Overall Study||62492
299400|NCT00113880|734201|P2|STARTED|Overall Study||71949
299401|NCT00113880|734202|P1|STARTED|Overall Study||63061
299402|NCT00113841|734261|P2|NOT COMPLETED|Overall Study||2
299403|NCT00113841|734262|P1|NOT COMPLETED|Overall Study||1
299404|NCT00113841|734261|P2|COMPLETED|Overall Study||15
299405|NCT00113841|734262|P1|COMPLETED|Overall Study||15
299406|NCT00113841|734261|P2|STARTED|Overall Study||17
299407|NCT00113841|734262|P1|STARTED|Overall Study||16
299408|NCT00113763|734270|P2|NOT COMPLETED|Overall Study||26
299409|NCT00113763|734271|P1|NOT COMPLETED|Overall Study||73
299410|NCT00113763|734270|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
299411|NCT00113763|734271|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
299412|NCT00113763|734270|P2|Received Study Drug|Overall Study||0
299413|NCT00113763|734271|P1|Received Study Drug|Overall Study||229
299414|NCT00113763|734270|P2|STARTED|Overall Study||232
299415|NCT00113763|734271|P1|STARTED|Overall Study||231
299416|NCT00113607|734297|P2|NOT COMPLETED|Overall Study||337
299417|NCT00113607|734298|P1|NOT COMPLETED|Overall Study||335
299418|NCT00113607|734297|P2|COMPLETED|Overall Study||0
299419|NCT00113607|734298|P1|COMPLETED|Overall Study||0
299420|NCT00113607|734297|P2|STARTED|Overall Study|Number of randomized participants|337
299421|NCT00113607|734298|P1|STARTED|Overall Study|Number of randomized participants|335
299422|NCT00113568|734312|P1|NOT COMPLETED|Overall Study||545
299423|NCT00113568|734312|P1|COMPLETED|Overall Study||239
299424|NCT00113568|734312|P1|Intent to Treat Population|Overall Study||723
299425|NCT00113568|734312|P1|STARTED|Overall Study||784
299426|NCT00113529|734324|P1|NOT COMPLETED|Overall Study||34
299427|NCT00113529|734324|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
299428|NCT00113529|734324|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
299429|NCT00113516|734357|P2|NOT COMPLETED|Part 2||66
299430|NCT00113516|734358|P1|NOT COMPLETED|Part 2||0
299431|NCT00113516|734357|P2|COMPLETED|Part 2||0
299432|NCT00113516|734358|P1|COMPLETED|Part 2||0
299433|NCT00113516|734357|P2|STARTED|Part 2||66
299434|NCT00113516|734358|P1|STARTED|Part 2||0
299435|NCT00113516|734357|P2|NOT COMPLETED|Part 1||0
299436|NCT00113516|734358|P1|NOT COMPLETED|Part 1||84
299437|NCT00113516|734357|P2|COMPLETED|Part 1||0
299438|NCT00113516|734358|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
299439|NCT00113516|734357|P2|STARTED|Part 1||0
299440|NCT00113516|734358|P1|STARTED|Part 1||84
299441|NCT00113490|734401|P2|NOT COMPLETED|Overall Study||3
299442|NCT00113490|734402|P1|NOT COMPLETED|Overall Study||2
299443|NCT00113490|734401|P2|COMPLETED|Overall Study||67
299444|NCT00113490|734402|P1|COMPLETED|Overall Study||64
299445|NCT00113490|734401|P2|STARTED|Overall Study||70
299446|NCT00113490|734402|P1|STARTED|Overall Study||66
299447|NCT00113425|734415|P1|NOT COMPLETED|Overall Study||15
299448|NCT00113425|734415|P1|COMPLETED|Overall Study||29
299449|NCT00113425|734415|P1|STARTED|Overall Study||44
299450|NCT00113399|734435|P2|NOT COMPLETED|Overall Study||5
299451|NCT00113399|734436|P1|NOT COMPLETED|Overall Study||2
299452|NCT00113399|734435|P2|COMPLETED|Overall Study||3
299453|NCT00113399|734436|P1|COMPLETED|Overall Study||5
299454|NCT00113399|734435|P2|STARTED|Overall Study||8
299455|NCT00113399|734436|P1|STARTED|Overall Study||7
299456|NCT00113386|734444|P2|NOT COMPLETED|Overall Study||4
299457|NCT00113386|734445|P1|NOT COMPLETED|Overall Study||7
299458|NCT00113386|734444|P2|COMPLETED|Overall Study||5
299459|NCT00113386|734445|P1|COMPLETED|Overall Study||3
299460|NCT00113386|734444|P2|STARTED|Overall Study||9
299461|NCT00113386|734445|P1|STARTED|Overall Study||10
299462|NCT00113373|734451|P1|NOT COMPLETED|Overall Study||3
299463|NCT00113373|734451|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
299464|NCT00113373|734451|P1|STARTED|Overall Study||28
299465|NCT00113360|734457|P1|NOT COMPLETED|Overall Study||7
299466|NCT00113360|734457|P1|COMPLETED|Overall Study||60
299467|NCT00113360|734457|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
299468|NCT00113334|734461|P1|NOT COMPLETED|Overall Study||0
299469|NCT00113334|734461|P1|COMPLETED|Overall Study||6
299470|NCT00113334|734461|P1|STARTED|Overall Study||6
299471|NCT00113321|734465|P1|NOT COMPLETED|Overall Study||0
299472|NCT00113321|734465|P1|COMPLETED|Overall Study||16
299473|NCT00113321|734465|P1|STARTED|Overall Study||16
299474|NCT00113295|734471|P2|NOT COMPLETED|Overall Study||1
299475|NCT00113295|734472|P1|NOT COMPLETED|Overall Study||5
299476|NCT00113295|734471|P2|COMPLETED|Overall Study||10
299477|NCT00113295|734472|P1|COMPLETED|Overall Study||6
299478|NCT00113295|734471|P2|STARTED|Overall Study||11
299479|NCT00113295|734472|P1|STARTED|Overall Study||11
299480|NCT00113269|734491|P4|NOT COMPLETED|Overall Study||40
299481|NCT00113269|734492|P3|NOT COMPLETED|Overall Study||41
299482|NCT00113269|734493|P2|NOT COMPLETED|Overall Study||22
299483|NCT00113269|734494|P1|NOT COMPLETED|Overall Study||25
299484|NCT00113269|734491|P4|COMPLETED|Overall Study||140
299485|NCT00113269|734492|P3|COMPLETED|Overall Study||134
299486|NCT00113269|734493|P2|COMPLETED|Overall Study||48
299487|NCT00113269|734494|P1|COMPLETED|Overall Study||51
299488|NCT00113269|734491|P4|Received Treatment|Overall Study||171
299489|NCT00113269|734492|P3|Received Treatment|Overall Study||164
299490|NCT00113269|734493|P2|Received Treatment|Overall Study||69
299491|NCT00113269|734494|P1|Received Treatment|Overall Study||70
299492|NCT00113269|734491|P4|STARTED|Overall Study||180
299493|NCT00113269|734492|P3|STARTED|Overall Study||175
299494|NCT00113269|734493|P2|STARTED|Overall Study||70
299495|NCT00113269|734494|P1|STARTED|Overall Study||76
299496|NCT00113230|734544|P1|NOT COMPLETED|Overall Study||0
299497|NCT00113230|734544|P1|COMPLETED|Overall Study||25
299498|NCT00113230|734544|P1|STARTED|Overall Study||25
299499|NCT00113217|734548|P1|NOT COMPLETED|Overall Study||0
299500|NCT00113217|734548|P1|COMPLETED|Overall Study||50
299501|NCT00113217|734548|P1|STARTED|Overall Study||50
299502|NCT00113087|734554|P2|NOT COMPLETED|Overall Study||21
299503|NCT00113087|734555|P1|NOT COMPLETED|Overall Study||24
299504|NCT00113087|734554|P2|COMPLETED|Overall Study||94
299505|NCT00113087|734555|P1|COMPLETED|Overall Study||91
299506|NCT00113087|734554|P2|STARTED|Overall Study||115
299507|NCT00113087|734555|P1|STARTED|Overall Study||115
299508|NCT00113022|734619|P2|NOT COMPLETED|Overall Study||2
299509|NCT00113022|734620|P1|NOT COMPLETED|Overall Study||3
299510|NCT00113022|734619|P2|COMPLETED|Overall Study||2
299511|NCT00113022|734620|P1|COMPLETED|Overall Study||2
299512|NCT00113022|734619|P2|STARTED|Overall Study||4
299513|NCT00113022|734620|P1|STARTED|Overall Study||5
299514|NCT00112957|734626|P1|NOT COMPLETED|Overall Study||19
299515|NCT00112957|734626|P1|COMPLETED|Overall Study||4
299516|NCT00112957|734626|P1|STARTED|Overall Study||23
299517|NCT00112918|734641|P3|NOT COMPLETED|Overall Study||299
299518|NCT00112918|734642|P2|NOT COMPLETED|Overall Study||345
299519|NCT00112918|734643|P1|NOT COMPLETED|Overall Study||297
299520|NCT00112918|734641|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
299521|NCT00112918|734642|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
299522|NCT00112918|734643|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
299523|NCT00112918|734641|P3|Stage III Disease Population|Overall Study||952
299524|NCT00112918|734642|P2|Stage III Disease Population|Overall Study||960
299525|NCT00112918|734643|P1|Stage III Disease Population|Overall Study||955
299526|NCT00112918|734641|P3|Received Treatment|Overall Study||1135
299527|NCT00112918|734642|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
299528|NCT00112918|734643|P1|Received Treatment|Overall Study||1126
299529|NCT00112918|734641|P3|STARTED|Overall Study||1145
299530|NCT00112918|734642|P2|STARTED|Overall Study||1155
299531|NCT00112918|734643|P1|STARTED|Overall Study||1151
299532|NCT00112905|734666|P1|NOT COMPLETED|Overall Study||12
299533|NCT00112905|734666|P1|COMPLETED|Overall Study||15
299534|NCT00112905|734666|P1|Eligible and Treated|Overall Study||22
299535|NCT00112905|734666|P1|STARTED|Overall Study||27
299536|NCT00112866|734675|P2|NOT COMPLETED|Overall Study||2
299537|NCT00112866|734676|P1|NOT COMPLETED|Overall Study||2
299538|NCT00112866|734675|P2|COMPLETED|Overall Study||13
299539|NCT00112866|734676|P1|COMPLETED|Overall Study||13
299540|NCT00112866|734675|P2|STARTED|Overall Study||15
299541|NCT00112866|734676|P1|STARTED|Overall Study||15
299542|NCT00112840|734698|P3|NOT COMPLETED|Overall Study||6
299543|NCT00112840|734699|P2|NOT COMPLETED|Overall Study||0
299544|NCT00112840|734700|P1|NOT COMPLETED|Overall Study||2
299545|NCT00112840|734698|P3|COMPLETED|Overall Study||40
299546|NCT00112840|734699|P2|COMPLETED|Overall Study||6
299547|NCT00112840|734700|P1|COMPLETED|Overall Study||6
299548|NCT00112840|734698|P3|STARTED|Overall Study||46
299549|NCT00112840|734699|P2|STARTED|Overall Study||6
299550|NCT00112840|734700|P1|STARTED|Overall Study||8
299551|NCT00112736|734719|P2|NOT COMPLETED|Overall Study||0
299552|NCT00112736|734720|P1|NOT COMPLETED|Overall Study||1
299553|NCT00112736|734719|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
299554|NCT00112736|734720|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
299555|NCT00112736|734719|P2|STARTED|Overall Study||47
299556|NCT00112736|734720|P1|STARTED|Overall Study||22
299557|NCT00112723|734733|P3|NOT COMPLETED|Overall Study||2
299558|NCT00112723|734734|P2|NOT COMPLETED|Overall Study||7
299559|NCT00112723|734735|P1|NOT COMPLETED|Overall Study||2
299560|NCT00112723|734733|P3|COMPLETED|Overall Study||12
299561|NCT00112723|734734|P2|COMPLETED|Overall Study||12
299562|NCT00112723|734735|P1|COMPLETED|Overall Study||11
299563|NCT00112723|734733|P3|Patients Evaluable for Toxicity|Overall Study||12
299564|NCT00112723|734734|P2|Patients Evaluable for Toxicity|Overall Study||12
299565|NCT00112723|734735|P1|Patients Evaluable for Toxicity|Overall Study||11
299566|NCT00112723|734733|P3|STARTED|Overall Study||14
299567|NCT00112723|734734|P2|STARTED|Overall Study||19
299568|NCT00112723|734735|P1|STARTED|Overall Study||13
299569|NCT00112671|734760|P1|NOT COMPLETED|Overall Study||0
299570|NCT00112671|734760|P1|COMPLETED|Overall Study||17
299571|NCT00112671|734760|P1|STARTED|Overall Study||17
299572|NCT00112593|734766|P1|NOT COMPLETED|Overall Study||0
299573|NCT00112593|734766|P1|COMPLETED|Overall Study||5
299574|NCT00112593|734766|P1|STARTED|Overall Study||5
299575|NCT00112489|734775|P1|NOT COMPLETED|Overall Study||40
299576|NCT00112489|734775|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
299577|NCT00112489|734775|P1|STARTED|Overall Study|All patients enrolled on study|55
299578|NCT00112463|734779|P1|NOT COMPLETED|Overall Study||39
299579|NCT00112463|734779|P1|COMPLETED|Overall Study||1
299580|NCT00112463|734779|P1|STARTED|Overall Study||40
299581|NCT00112437|734791|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
299582|NCT00112437|734792|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
299583|NCT00112437|734793|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
299584|NCT00112437|734794|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
299585|NCT00112437|734795|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299586|NCT00112437|734796|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299587|NCT00112437|734797|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299588|NCT00112437|734798|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299589|NCT00112437|734799|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299590|NCT00112437|734800|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299591|NCT00112437|734801|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299592|NCT00112437|734802|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299593|NCT00112437|734803|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299594|NCT00112437|734804|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299595|NCT00112437|734805|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299596|NCT00112437|734806|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299597|NCT00112437|734807|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299598|NCT00112437|734808|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299599|NCT00112437|734809|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299600|NCT00112437|734810|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299601|NCT00112437|734811|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299602|NCT00112437|734812|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299603|NCT00112437|734813|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299604|NCT00112437|734814|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299605|NCT00112437|734815|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299606|NCT00112437|734816|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
299607|NCT00112437|734791|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
299608|NCT00112437|734792|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
299609|NCT00112437|734793|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
299610|NCT00112437|734794|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
299611|NCT00112437|734795|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
299612|NCT00112437|734796|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
299613|NCT00112437|734797|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
299614|NCT00112437|734798|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
299615|NCT00112437|734799|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
299616|NCT00112437|734800|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
299617|NCT00112437|734801|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
299618|NCT00112437|734802|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
299619|NCT00112437|734803|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
299620|NCT00112437|734804|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
299621|NCT00112437|734805|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
299622|NCT00112437|734806|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
299623|NCT00112437|734807|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
299624|NCT00112437|734808|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
299625|NCT00112437|734809|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
299626|NCT00112437|734810|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
299627|NCT00112437|734811|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
299628|NCT00112437|734812|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
299629|NCT00112437|734813|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
299630|NCT00112437|734814|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
299631|NCT00112437|734815|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
299632|NCT00112437|734816|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
299633|NCT00112437|734791|P26|STARTED|Years 6-10 (60-Month Extension)||32
299634|NCT00112437|734792|P25|STARTED|Years 6-10 (60-Month Extension)||23
299635|NCT00112437|734793|P24|STARTED|Years 6-10 (60-Month Extension)||34
299636|NCT00112437|734794|P23|STARTED|Years 6-10 (60-Month Extension)||28
299637|NCT00112437|734795|P22|STARTED|Years 6-10 (60-Month Extension)||0
299638|NCT00112437|734796|P21|STARTED|Years 6-10 (60-Month Extension)||0
299639|NCT00112437|734797|P20|STARTED|Years 6-10 (60-Month Extension)||0
299640|NCT00112437|734798|P19|STARTED|Years 6-10 (60-Month Extension)||0
299641|NCT00112437|734799|P18|STARTED|Years 6-10 (60-Month Extension)||0
299642|NCT00112437|734800|P17|STARTED|Years 6-10 (60-Month Extension)||0
299643|NCT00112437|734801|P16|STARTED|Years 6-10 (60-Month Extension)||0
299644|NCT00112437|734802|P15|STARTED|Years 6-10 (60-Month Extension)||0
299645|NCT00112437|734803|P14|STARTED|Years 6-10 (60-Month Extension)||0
299646|NCT00112437|734804|P13|STARTED|Years 6-10 (60-Month Extension)||0
299647|NCT00112437|734805|P12|STARTED|Years 6-10 (60-Month Extension)||0
299648|NCT00112437|734806|P11|STARTED|Years 6-10 (60-Month Extension)||0
299649|NCT00112437|734807|P10|STARTED|Years 6-10 (60-Month Extension)||0
299650|NCT00112437|734808|P9|STARTED|Years 6-10 (60-Month Extension)||0
299651|NCT00112437|734809|P8|STARTED|Years 6-10 (60-Month Extension)||0
299652|NCT00112437|734810|P7|STARTED|Years 6-10 (60-Month Extension)||0
299653|NCT00112437|734811|P6|STARTED|Years 6-10 (60-Month Extension)||0
299654|NCT00112437|734812|P5|STARTED|Years 6-10 (60-Month Extension)||0
299655|NCT00112437|734813|P4|STARTED|Years 6-10 (60-Month Extension)||0
299656|NCT00112437|734814|P3|STARTED|Years 6-10 (60-Month Extension)||0
299657|NCT00112437|734815|P2|STARTED|Years 6-10 (60-Month Extension)||0
299658|NCT00112437|734816|P1|STARTED|Years 6-10 (60-Month Extension)||0
299659|NCT00112437|734791|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299660|NCT00112437|734792|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299661|NCT00112437|734793|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299662|NCT00112437|734794|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299663|NCT00112437|734795|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
299664|NCT00112437|734796|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
299665|NCT00112437|734797|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299666|NCT00112437|734798|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299667|NCT00112437|734799|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299668|NCT00112437|734800|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299669|NCT00112437|734801|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299670|NCT00112437|734802|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299671|NCT00112437|734803|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299672|NCT00112437|734804|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299673|NCT00112437|734805|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299674|NCT00112437|734806|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299675|NCT00112437|734807|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299676|NCT00112437|734808|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299677|NCT00112437|734809|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299678|NCT00112437|734810|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299679|NCT00112437|734811|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299680|NCT00112437|734812|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299681|NCT00112437|734813|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299682|NCT00112437|734814|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299683|NCT00112437|734815|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299684|NCT00112437|734816|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
299685|NCT00112437|734791|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
299686|NCT00112437|734792|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
299687|NCT00112437|734793|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
299688|NCT00112437|734794|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
299689|NCT00112437|734795|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
299690|NCT00112437|734796|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
299691|NCT00112437|734797|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
299692|NCT00112437|734798|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
299693|NCT00112437|734799|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
299694|NCT00112437|734800|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
299695|NCT00112437|734801|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
299696|NCT00112437|734802|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
299697|NCT00112437|734803|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
299698|NCT00112437|734804|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
299699|NCT00112437|734805|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
299700|NCT00112437|734806|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
299701|NCT00112437|734807|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
299702|NCT00112437|734808|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
299703|NCT00112437|734809|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
299704|NCT00112437|734810|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
299705|NCT00112437|734811|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
299706|NCT00112437|734812|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
299707|NCT00112437|734813|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
299708|NCT00112437|734814|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
299709|NCT00112437|734815|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
299710|NCT00112437|734816|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
299711|NCT00112437|734791|P26|STARTED|Years 4-5 (24-Month Extension)||0
299712|NCT00112437|734792|P25|STARTED|Years 4-5 (24-Month Extension)||0
299713|NCT00112437|734793|P24|STARTED|Years 4-5 (24-Month Extension)||0
299714|NCT00112437|734794|P23|STARTED|Years 4-5 (24-Month Extension)||0
299715|NCT00112437|734795|P22|STARTED|Years 4-5 (24-Month Extension)||100
299716|NCT00112437|734796|P21|STARTED|Years 4-5 (24-Month Extension)||41
299717|NCT00112437|734797|P20|STARTED|Years 4-5 (24-Month Extension)||0
299718|NCT00112437|734798|P19|STARTED|Years 4-5 (24-Month Extension)||0
299719|NCT00112437|734799|P18|STARTED|Years 4-5 (24-Month Extension)||0
299720|NCT00112437|734800|P17|STARTED|Years 4-5 (24-Month Extension)||0
299721|NCT00112437|734801|P16|STARTED|Years 4-5 (24-Month Extension)||0
299722|NCT00112437|734802|P15|STARTED|Years 4-5 (24-Month Extension)||0
299723|NCT00112437|734803|P14|STARTED|Years 4-5 (24-Month Extension)||0
299724|NCT00112437|734804|P13|STARTED|Years 4-5 (24-Month Extension)||0
299725|NCT00112437|734805|P12|STARTED|Years 4-5 (24-Month Extension)||0
299726|NCT00112437|734806|P11|STARTED|Years 4-5 (24-Month Extension)||0
299727|NCT00112437|734807|P10|STARTED|Years 4-5 (24-Month Extension)||0
299728|NCT00112437|734808|P9|STARTED|Years 4-5 (24-Month Extension)||0
299729|NCT00112437|734809|P8|STARTED|Years 4-5 (24-Month Extension)||0
299730|NCT00112437|734810|P7|STARTED|Years 4-5 (24-Month Extension)||0
299731|NCT00112437|734811|P6|STARTED|Years 4-5 (24-Month Extension)||0
299732|NCT00112437|734812|P5|STARTED|Years 4-5 (24-Month Extension)||0
299733|NCT00112437|734813|P4|STARTED|Years 4-5 (24-Month Extension)||0
299734|NCT00112437|734814|P3|STARTED|Years 4-5 (24-Month Extension)||0
299735|NCT00112437|734815|P2|STARTED|Years 4-5 (24-Month Extension)||0
299736|NCT00112437|734816|P1|STARTED|Years 4-5 (24-Month Extension)||0
299737|NCT00112437|734791|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
299738|NCT00112437|734792|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
299739|NCT00112437|734793|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
299740|NCT00112437|734794|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
299741|NCT00112437|734795|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
299742|NCT00112437|734796|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
299743|NCT00112437|734797|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
299744|NCT00112437|734798|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
299745|NCT00112437|734799|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
299746|NCT00112437|734800|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
299747|NCT00112437|734801|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
299748|NCT00112437|734802|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
299749|NCT00112437|734803|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
299750|NCT00112437|734804|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
299751|NCT00112437|734805|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
299752|NCT00112437|734806|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
299753|NCT00112437|734807|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
299754|NCT00112437|734808|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
299755|NCT00112437|734809|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
299756|NCT00112437|734810|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
299757|NCT00112437|734811|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
299758|NCT00112437|734812|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
299759|NCT00112437|734813|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
299760|NCT00112437|734814|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
299761|NCT00112437|734815|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
299762|NCT00112437|734816|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
299763|NCT00112437|734791|P26|COMPLETED|Year 3 (12-Month Extension)||0
299764|NCT00112437|734792|P25|COMPLETED|Year 3 (12-Month Extension)||0
299765|NCT00112437|734793|P24|COMPLETED|Year 3 (12-Month Extension)||0
299766|NCT00112437|734794|P23|COMPLETED|Year 3 (12-Month Extension)||0
299767|NCT00112437|734795|P22|COMPLETED|Year 3 (12-Month Extension)||0
299768|NCT00112437|734796|P21|COMPLETED|Year 3 (12-Month Extension)||0
299769|NCT00112437|734797|P20|COMPLETED|Year 3 (12-Month Extension)||19
299770|NCT00112437|734798|P19|COMPLETED|Year 3 (12-Month Extension)||16
299771|NCT00112437|734799|P18|COMPLETED|Year 3 (12-Month Extension)||20
299772|NCT00112437|734800|P17|COMPLETED|Year 3 (12-Month Extension)||16
299773|NCT00112437|734801|P16|COMPLETED|Year 3 (12-Month Extension)||13
299774|NCT00112437|734802|P15|COMPLETED|Year 3 (12-Month Extension)||17
299775|NCT00112437|734803|P14|COMPLETED|Year 3 (12-Month Extension)||16
299776|NCT00112437|734804|P13|COMPLETED|Year 3 (12-Month Extension)||18
299777|NCT00112437|734805|P12|COMPLETED|Year 3 (12-Month Extension)||17
299778|NCT00112437|734806|P11|COMPLETED|Year 3 (12-Month Extension)||17
299779|NCT00112437|734807|P10|COMPLETED|Year 3 (12-Month Extension)||0
299780|NCT00112437|734808|P9|COMPLETED|Year 3 (12-Month Extension)||0
299781|NCT00112437|734809|P8|COMPLETED|Year 3 (12-Month Extension)||0
299782|NCT00112437|734810|P7|COMPLETED|Year 3 (12-Month Extension)||0
299783|NCT00112437|734811|P6|COMPLETED|Year 3 (12-Month Extension)||0
299784|NCT00112437|734812|P5|COMPLETED|Year 3 (12-Month Extension)||0
299785|NCT00112437|734813|P4|COMPLETED|Year 3 (12-Month Extension)||0
299786|NCT00112437|734814|P3|COMPLETED|Year 3 (12-Month Extension)||0
299787|NCT00112437|734815|P2|COMPLETED|Year 3 (12-Month Extension)||0
299788|NCT00112437|734816|P1|COMPLETED|Year 3 (12-Month Extension)||0
299789|NCT00112437|734791|P26|STARTED|Year 3 (12-Month Extension)||0
299790|NCT00112437|734792|P25|STARTED|Year 3 (12-Month Extension)||0
299791|NCT00112437|734793|P24|STARTED|Year 3 (12-Month Extension)||0
299792|NCT00112437|734794|P23|STARTED|Year 3 (12-Month Extension)||0
299793|NCT00112437|734795|P22|STARTED|Year 3 (12-Month Extension)||0
299794|NCT00112437|734796|P21|STARTED|Year 3 (12-Month Extension)||0
299795|NCT00112437|734797|P20|STARTED|Year 3 (12-Month Extension)||20
299796|NCT00112437|734798|P19|STARTED|Year 3 (12-Month Extension)||18
299797|NCT00112437|734799|P18|STARTED|Year 3 (12-Month Extension)||21
299798|NCT00112437|734800|P17|STARTED|Year 3 (12-Month Extension)||19
299799|NCT00112437|734801|P16|STARTED|Year 3 (12-Month Extension)||17
299800|NCT00112437|734802|P15|STARTED|Year 3 (12-Month Extension)||18
299801|NCT00112437|734803|P14|STARTED|Year 3 (12-Month Extension)||17
299802|NCT00112437|734804|P13|STARTED|Year 3 (12-Month Extension)||18
299803|NCT00112437|734805|P12|STARTED|Year 3 (12-Month Extension)||22
299804|NCT00112437|734806|P11|STARTED|Year 3 (12-Month Extension)||19
299805|NCT00112437|734807|P10|STARTED|Year 3 (12-Month Extension)||0
299806|NCT00112437|734808|P9|STARTED|Year 3 (12-Month Extension)||0
299807|NCT00112437|734809|P8|STARTED|Year 3 (12-Month Extension)||0
299808|NCT00112437|734810|P7|STARTED|Year 3 (12-Month Extension)||0
299809|NCT00112437|734811|P6|STARTED|Year 3 (12-Month Extension)||0
299810|NCT00112437|734812|P5|STARTED|Year 3 (12-Month Extension)||0
299811|NCT00112437|734813|P4|STARTED|Year 3 (12-Month Extension)||0
299812|NCT00112437|734814|P3|STARTED|Year 3 (12-Month Extension)||0
299813|NCT00112437|734815|P2|STARTED|Year 3 (12-Month Extension)||0
299814|NCT00112437|734816|P1|STARTED|Year 3 (12-Month Extension)||0
299815|NCT00112437|734791|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
299816|NCT00112437|734792|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
299817|NCT00112437|734793|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
299818|NCT00112437|734794|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
299819|NCT00112437|734795|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
299820|NCT00112437|734796|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
299821|NCT00112437|734797|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
299822|NCT00112437|734798|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
299823|NCT00112437|734799|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
299824|NCT00112437|734800|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
299825|NCT00112437|734801|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
299826|NCT00112437|734802|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
299827|NCT00112437|734803|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
299828|NCT00112437|734804|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
299829|NCT00112437|734805|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
299830|NCT00112437|734806|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
299831|NCT00112437|734807|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
299832|NCT00112437|734808|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
299833|NCT00112437|734809|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
299834|NCT00112437|734810|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
299835|NCT00112437|734811|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
299836|NCT00112437|734812|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
299837|NCT00112437|734813|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
299838|NCT00112437|734814|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
299839|NCT00112437|734815|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
299840|NCT00112437|734816|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
299841|NCT00112437|734791|P26|COMPLETED|Year 2 (12-Month Extension)||0
299842|NCT00112437|734792|P25|COMPLETED|Year 2 (12-Month Extension)||0
299843|NCT00112437|734793|P24|COMPLETED|Year 2 (12-Month Extension)||0
299844|NCT00112437|734794|P23|COMPLETED|Year 2 (12-Month Extension)||0
299845|NCT00112437|734795|P22|COMPLETED|Year 2 (12-Month Extension)||0
299846|NCT00112437|734796|P21|COMPLETED|Year 2 (12-Month Extension)||0
299847|NCT00112437|734797|P20|COMPLETED|Year 2 (12-Month Extension)||0
299848|NCT00112437|734798|P19|COMPLETED|Year 2 (12-Month Extension)||0
299849|NCT00112437|734799|P18|COMPLETED|Year 2 (12-Month Extension)||0
299850|NCT00112437|734800|P17|COMPLETED|Year 2 (12-Month Extension)||0
299851|NCT00112437|734801|P16|COMPLETED|Year 2 (12-Month Extension)||0
299852|NCT00112437|734802|P15|COMPLETED|Year 2 (12-Month Extension)||0
299853|NCT00112437|734803|P14|COMPLETED|Year 2 (12-Month Extension)||0
299854|NCT00112437|734804|P13|COMPLETED|Year 2 (12-Month Extension)||0
299855|NCT00112437|734805|P12|COMPLETED|Year 2 (12-Month Extension)||0
299856|NCT00112437|734806|P11|COMPLETED|Year 2 (12-Month Extension)||0
299857|NCT00112437|734807|P10|COMPLETED|Year 2 (12-Month Extension)||50
299858|NCT00112437|734808|P9|COMPLETED|Year 2 (12-Month Extension)||62
299859|NCT00112437|734809|P8|COMPLETED|Year 2 (12-Month Extension)||55
299860|NCT00112437|734810|P7|COMPLETED|Year 2 (12-Month Extension)||53
299861|NCT00112437|734811|P6|COMPLETED|Year 2 (12-Month Extension)||60
299862|NCT00112437|734812|P5|COMPLETED|Year 2 (12-Month Extension)||0
299863|NCT00112437|734813|P4|COMPLETED|Year 2 (12-Month Extension)||0
299864|NCT00112437|734814|P3|COMPLETED|Year 2 (12-Month Extension)||0
299865|NCT00112437|734815|P2|COMPLETED|Year 2 (12-Month Extension)||0
299866|NCT00112437|734816|P1|COMPLETED|Year 2 (12-Month Extension)||0
299867|NCT00112437|734791|P26|STARTED|Year 2 (12-Month Extension)||0
299868|NCT00112437|734792|P25|STARTED|Year 2 (12-Month Extension)||0
299869|NCT00112437|734793|P24|STARTED|Year 2 (12-Month Extension)||0
299870|NCT00112437|734794|P23|STARTED|Year 2 (12-Month Extension)||0
299871|NCT00112437|734795|P22|STARTED|Year 2 (12-Month Extension)||0
299872|NCT00112437|734796|P21|STARTED|Year 2 (12-Month Extension)||0
299873|NCT00112437|734797|P20|STARTED|Year 2 (12-Month Extension)||0
299874|NCT00112437|734798|P19|STARTED|Year 2 (12-Month Extension)||0
299875|NCT00112437|734799|P18|STARTED|Year 2 (12-Month Extension)||0
299876|NCT00112437|734800|P17|STARTED|Year 2 (12-Month Extension)||0
299877|NCT00112437|734801|P16|STARTED|Year 2 (12-Month Extension)||0
299878|NCT00112437|734802|P15|STARTED|Year 2 (12-Month Extension)||0
299879|NCT00112437|734803|P14|STARTED|Year 2 (12-Month Extension)||0
299880|NCT00112437|734804|P13|STARTED|Year 2 (12-Month Extension)||0
299881|NCT00112437|734805|P12|STARTED|Year 2 (12-Month Extension)||0
299882|NCT00112437|734806|P11|STARTED|Year 2 (12-Month Extension)||0
299883|NCT00112437|734807|P10|STARTED|Year 2 (12-Month Extension)||63
299884|NCT00112437|734808|P9|STARTED|Year 2 (12-Month Extension)||69
299885|NCT00112437|734809|P8|STARTED|Year 2 (12-Month Extension)||63
299886|NCT00112437|734810|P7|STARTED|Year 2 (12-Month Extension)||62
299887|NCT00112437|734811|P6|STARTED|Year 2 (12-Month Extension)||63
299888|NCT00112437|734812|P5|STARTED|Year 2 (12-Month Extension)||0
299889|NCT00112437|734813|P4|STARTED|Year 2 (12-Month Extension)||0
299890|NCT00112437|734814|P3|STARTED|Year 2 (12-Month Extension)||0
299891|NCT00112437|734815|P2|STARTED|Year 2 (12-Month Extension)||0
299892|NCT00112437|734816|P1|STARTED|Year 2 (12-Month Extension)||0
299893|NCT00112437|734791|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299894|NCT00112437|734792|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299895|NCT00112437|734793|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299896|NCT00112437|734794|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299897|NCT00112437|734795|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299898|NCT00112437|734796|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299899|NCT00112437|734797|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299900|NCT00112437|734798|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299901|NCT00112437|734799|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299902|NCT00112437|734800|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299903|NCT00112437|734801|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299904|NCT00112437|734802|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299905|NCT00112437|734803|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299906|NCT00112437|734804|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299907|NCT00112437|734805|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299908|NCT00112437|734806|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299909|NCT00112437|734807|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299910|NCT00112437|734808|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299911|NCT00112437|734809|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299912|NCT00112437|734810|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299913|NCT00112437|734811|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
299914|NCT00112437|734812|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
299915|NCT00112437|734813|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
299916|NCT00112437|734814|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
299917|NCT00112437|734815|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
299918|NCT00112437|734816|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
299919|NCT00112437|734791|P26|COMPLETED|Year 1 (12-Month Base Study)||0
299920|NCT00112437|734792|P25|COMPLETED|Year 1 (12-Month Base Study)||0
299921|NCT00112437|734793|P24|COMPLETED|Year 1 (12-Month Base Study)||0
299922|NCT00112437|734794|P23|COMPLETED|Year 1 (12-Month Base Study)||0
299923|NCT00112437|734795|P22|COMPLETED|Year 1 (12-Month Base Study)||0
299924|NCT00112437|734796|P21|COMPLETED|Year 1 (12-Month Base Study)||0
299925|NCT00112437|734797|P20|COMPLETED|Year 1 (12-Month Base Study)||0
299926|NCT00112437|734798|P19|COMPLETED|Year 1 (12-Month Base Study)||0
299927|NCT00112437|734799|P18|COMPLETED|Year 1 (12-Month Base Study)||0
299928|NCT00112437|734800|P17|COMPLETED|Year 1 (12-Month Base Study)||0
299929|NCT00112437|734801|P16|COMPLETED|Year 1 (12-Month Base Study)||0
299930|NCT00112437|734802|P15|COMPLETED|Year 1 (12-Month Base Study)||0
299931|NCT00112437|734803|P14|COMPLETED|Year 1 (12-Month Base Study)||0
299932|NCT00112437|734804|P13|COMPLETED|Year 1 (12-Month Base Study)||0
299933|NCT00112437|734805|P12|COMPLETED|Year 1 (12-Month Base Study)||0
299934|NCT00112437|734806|P11|COMPLETED|Year 1 (12-Month Base Study)||0
299935|NCT00112437|734807|P10|COMPLETED|Year 1 (12-Month Base Study)||0
299936|NCT00112437|734808|P9|COMPLETED|Year 1 (12-Month Base Study)||0
299937|NCT00112437|734809|P8|COMPLETED|Year 1 (12-Month Base Study)||0
299938|NCT00112437|734810|P7|COMPLETED|Year 1 (12-Month Base Study)||0
299939|NCT00112437|734811|P6|COMPLETED|Year 1 (12-Month Base Study)||0
299940|NCT00112437|734812|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
299941|NCT00112437|734813|P4|COMPLETED|Year 1 (12-Month Base Study)||71
299942|NCT00112437|734814|P3|COMPLETED|Year 1 (12-Month Base Study)||65
299943|NCT00112437|734815|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
299944|NCT00112437|734816|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
299945|NCT00112437|734791|P26|STARTED|Year 1 (12-Month Base Study)||0
299946|NCT00112437|734792|P25|STARTED|Year 1 (12-Month Base Study)||0
299947|NCT00112437|734793|P24|STARTED|Year 1 (12-Month Base Study)||0
299948|NCT00112437|734794|P23|STARTED|Year 1 (12-Month Base Study)||0
299949|NCT00112437|734795|P22|STARTED|Year 1 (12-Month Base Study)||0
299950|NCT00112437|734796|P21|STARTED|Year 1 (12-Month Base Study)||0
299951|NCT00112437|734797|P20|STARTED|Year 1 (12-Month Base Study)||0
299952|NCT00112437|734798|P19|STARTED|Year 1 (12-Month Base Study)||0
299953|NCT00112437|734799|P18|STARTED|Year 1 (12-Month Base Study)||0
299954|NCT00112437|734800|P17|STARTED|Year 1 (12-Month Base Study)||0
299955|NCT00112437|734801|P16|STARTED|Year 1 (12-Month Base Study)||0
299956|NCT00112437|734802|P15|STARTED|Year 1 (12-Month Base Study)||0
299957|NCT00112437|734803|P14|STARTED|Year 1 (12-Month Base Study)||0
299958|NCT00112437|734804|P13|STARTED|Year 1 (12-Month Base Study)||0
299959|NCT00112437|734805|P12|STARTED|Year 1 (12-Month Base Study)||0
299960|NCT00112437|734806|P11|STARTED|Year 1 (12-Month Base Study)||0
299961|NCT00112437|734807|P10|STARTED|Year 1 (12-Month Base Study)||0
299962|NCT00112437|734808|P9|STARTED|Year 1 (12-Month Base Study)||0
299963|NCT00112437|734809|P8|STARTED|Year 1 (12-Month Base Study)||0
299964|NCT00112437|734810|P7|STARTED|Year 1 (12-Month Base Study)||0
299965|NCT00112437|734811|P6|STARTED|Year 1 (12-Month Base Study)||0
299966|NCT00112437|734812|P5|STARTED|Year 1 (12-Month Base Study)||78
299967|NCT00112437|734813|P4|STARTED|Year 1 (12-Month Base Study)||79
299968|NCT00112437|734814|P3|STARTED|Year 1 (12-Month Base Study)||77
299969|NCT00112437|734815|P2|STARTED|Year 1 (12-Month Base Study)||82
299970|NCT00112437|734816|P1|STARTED|Year 1 (12-Month Base Study)||83
299971|NCT00112385|735096|P2|NOT COMPLETED|Overall Study||1
299972|NCT00112385|735097|P1|NOT COMPLETED|Overall Study||1
299973|NCT00112385|735096|P2|COMPLETED|Overall Study||4
299974|NCT00112385|735097|P1|COMPLETED|Overall Study||10
299975|NCT00112385|735096|P2|STARTED|Overall Study||5
299976|NCT00112385|735097|P1|STARTED|Overall Study||11
299977|NCT00112359|735187|P2|NOT COMPLETED|Overall Study||13
299978|NCT00112359|735188|P1|NOT COMPLETED|Overall Study||27
299979|NCT00112359|735187|P2|COMPLETED|Overall Study||67
299980|NCT00112359|735188|P1|COMPLETED|Overall Study||57
299981|NCT00112359|735187|P2|STARTED|Overall Study||80
299982|NCT00112359|735188|P1|STARTED|Overall Study||84
299983|NCT00112294|735214|P2|NOT COMPLETED|Overall Study||0
299984|NCT00112294|735215|P1|NOT COMPLETED|Overall Study||5
299985|NCT00112294|735214|P2|COMPLETED|Overall Study|Off all study therapies.|320
299986|NCT00112294|735215|P1|COMPLETED|Overall Study|Off all study therapies.|320
299987|NCT00112294|735214|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
299988|NCT00112294|735215|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
299989|NCT00112294|735214|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
299990|NCT00112294|735215|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
299991|NCT00112151|735259|P6|NOT COMPLETED|Overall Study||3
299992|NCT00112151|735260|P5|NOT COMPLETED|Overall Study||6
299993|NCT00112151|735261|P4|NOT COMPLETED|Overall Study||3
299994|NCT00112151|735262|P3|NOT COMPLETED|Overall Study||3
299995|NCT00112151|735263|P2|NOT COMPLETED|Overall Study||5
299996|NCT00112151|735264|P1|NOT COMPLETED|Overall Study||4
299997|NCT00112151|735259|P6|COMPLETED|Overall Study||25
299998|NCT00112151|735260|P5|COMPLETED|Overall Study||22
299999|NCT00112151|735261|P4|COMPLETED|Overall Study||24
300000|NCT00112151|735262|P3|COMPLETED|Overall Study||25
300001|NCT00112151|735263|P2|COMPLETED|Overall Study||23
300002|NCT00112151|735264|P1|COMPLETED|Overall Study||24
300003|NCT00112151|735259|P6|STARTED|Overall Study||28
300004|NCT00112151|735260|P5|STARTED|Overall Study||28
300005|NCT00112151|735261|P4|STARTED|Overall Study||27
300006|NCT00112151|735262|P3|STARTED|Overall Study||28
300007|NCT00112151|735263|P2|STARTED|Overall Study||28
300008|NCT00112151|735264|P1|STARTED|Overall Study||28
300009|NCT00112112|735295|P2|NOT COMPLETED|Overall Study||0
300010|NCT00112112|735296|P1|NOT COMPLETED|Overall Study||0
300011|NCT00112112|735295|P2|COMPLETED|Overall Study||10
300012|NCT00112112|735296|P1|COMPLETED|Overall Study||10
300013|NCT00112112|735295|P2|STARTED|Overall Study||10
300014|NCT00112112|735296|P1|STARTED|Overall Study||10
300015|NCT00112047|735438|P2|NOT COMPLETED|Atripla Phase||20
300016|NCT00112047|735439|P1|NOT COMPLETED|Atripla Phase||18
300017|NCT00112047|735438|P2|COMPLETED|Atripla Phase||106
300018|NCT00112047|735439|P1|COMPLETED|Atripla Phase||142
300019|NCT00112047|735438|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
300020|NCT00112047|735439|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
300021|NCT00112047|735438|P2|NOT COMPLETED|Randomized Phase||88
300022|NCT00112047|735439|P1|NOT COMPLETED|Randomized Phase||70
300023|NCT00112047|735438|P2|COMPLETED|Randomized Phase||166
300024|NCT00112047|735439|P1|COMPLETED|Randomized Phase||187
300025|NCT00112047|735438|P2|STARTED|Randomized Phase|ITT analysis population|254
300026|NCT00112047|735439|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
300027|NCT00111917|735539|P2|NOT COMPLETED|Overall Study||1
300028|NCT00111917|735540|P1|NOT COMPLETED|Overall Study||1
300029|NCT00111917|735539|P2|COMPLETED|Overall Study||3
300030|NCT00111917|735540|P1|COMPLETED|Overall Study||8
300031|NCT00111917|735539|P2|STARTED|Overall Study||4
300032|NCT00111917|735540|P1|STARTED|Overall Study||9
300033|NCT00111839|735555|P3|NOT COMPLETED|Overall Study||49
300034|NCT00111839|735556|P2|NOT COMPLETED|Overall Study||46
300035|NCT00111839|735557|P1|NOT COMPLETED|Overall Study||48
300036|NCT00111839|735555|P3|COMPLETED|Overall Study||0
300037|NCT00111839|735556|P2|COMPLETED|Overall Study||5
300038|NCT00111839|735557|P1|COMPLETED|Overall Study||2
300039|NCT00111839|735555|P3|Treated|Overall Study||47
300040|NCT00111839|735556|P2|Treated|Overall Study||51
300041|NCT00111839|735557|P1|Treated|Overall Study||50
300042|NCT00111839|735555|P3|STARTED|Overall Study||49
300043|NCT00111839|735556|P2|STARTED|Overall Study||51
300044|NCT00111839|735557|P1|STARTED|Overall Study||50
300045|NCT00111813|735577|P6|NOT COMPLETED|Overall Study||6
300046|NCT00111813|735578|P5|NOT COMPLETED|Overall Study||6
300047|NCT00111813|735579|P4|NOT COMPLETED|Overall Study||5
300048|NCT00111813|735580|P3|NOT COMPLETED|Overall Study||10
300049|NCT00111813|735581|P2|NOT COMPLETED|Overall Study||3
300050|NCT00111813|735582|P1|NOT COMPLETED|Overall Study||3
300051|NCT00111813|735577|P6|COMPLETED|Overall Study||0
300052|NCT00111813|735578|P5|COMPLETED|Overall Study||0
300053|NCT00111813|735579|P4|COMPLETED|Overall Study||1
300054|NCT00111813|735580|P3|COMPLETED|Overall Study||0
300055|NCT00111813|735581|P2|COMPLETED|Overall Study||0
300056|NCT00111813|735582|P1|COMPLETED|Overall Study||0
300057|NCT00111813|735577|P6|STARTED|Overall Study||6
300058|NCT00111813|735578|P5|STARTED|Overall Study||6
300059|NCT00111813|735579|P4|STARTED|Overall Study||6
300060|NCT00111813|735580|P3|STARTED|Overall Study||10
300061|NCT00111813|735581|P2|STARTED|Overall Study||3
300062|NCT00111813|735582|P1|STARTED|Overall Study||3
300063|NCT00111800|735621|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
300064|NCT00111800|735622|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
300065|NCT00111800|735623|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
300066|NCT00111800|735624|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
300067|NCT00111800|735625|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
300068|NCT00111800|735626|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
300069|NCT00111800|735621|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
300070|NCT00111800|735622|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
300071|NCT00111800|735623|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
300072|NCT00111800|735624|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
300073|NCT00111800|735625|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
300074|NCT00111800|735626|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
300075|NCT00111800|735621|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
300076|NCT00111800|735622|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
300077|NCT00111800|735623|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
300078|NCT00111800|735624|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
300079|NCT00111800|735625|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
300080|NCT00111800|735626|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
300081|NCT00111800|735621|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
300082|NCT00111800|735622|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
300083|NCT00111800|735623|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
300084|NCT00111800|735624|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
300085|NCT00111800|735625|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
300086|NCT00111800|735626|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
300087|NCT00111800|735621|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
300088|NCT00111800|735622|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
300089|NCT00111800|735623|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
300090|NCT00111800|735624|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
300091|NCT00111800|735625|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
300092|NCT00111800|735626|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
300093|NCT00111800|735621|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
300094|NCT00111800|735622|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
300095|NCT00111800|735623|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
300096|NCT00111800|735624|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
300097|NCT00111800|735625|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
300098|NCT00111800|735626|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
300099|NCT00111761|735796|P2|NOT COMPLETED|Part 2||0
300100|NCT00111761|735797|P1|NOT COMPLETED|Part 2||8
300101|NCT00111761|735796|P2|COMPLETED|Part 2||0
300102|NCT00111761|735797|P1|COMPLETED|Part 2||16
300103|NCT00111761|735796|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
300104|NCT00111761|735797|P1|STARTED|Part 2||24
300105|NCT00111761|735796|P2|NOT COMPLETED|Part 1||5
300106|NCT00111761|735797|P1|NOT COMPLETED|Part 1||0
300107|NCT00111761|735796|P2|COMPLETED|Part 1|Completed through safety followup|14
300108|NCT00111761|735797|P1|COMPLETED|Part 1||0
300109|NCT00111761|735796|P2|STARTED|Part 1||19
300110|NCT00111761|735797|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
300111|NCT00111657|735814|P1|NOT COMPLETED|Overall Study||16
300112|NCT00111657|735814|P1|COMPLETED|Overall Study|Completed all intended doses.|21
300113|NCT00111657|735814|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
300114|NCT00111007|735826|P2|NOT COMPLETED|Long Term Follow-up||45
300115|NCT00111007|735827|P1|NOT COMPLETED|Long Term Follow-up||47
300116|NCT00111007|735826|P2|COMPLETED|Long Term Follow-up||62
300117|NCT00111007|735827|P1|COMPLETED|Long Term Follow-up||54
300118|NCT00111007|735826|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
300119|NCT00111007|735827|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
300120|NCT00111007|735826|P2|NOT COMPLETED|Active Follow-up||2
300121|NCT00111007|735827|P1|NOT COMPLETED|Active Follow-up||6
300122|NCT00111007|735826|P2|COMPLETED|Active Follow-up||2
300123|NCT00111007|735827|P1|COMPLETED|Active Follow-up||0
300124|NCT00111007|735826|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
300125|NCT00111007|735827|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
300126|NCT00111007|735826|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
300127|NCT00111007|735827|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
300128|NCT00111007|735826|P2|COMPLETED|Double-blind (DB) Treatment||24
300129|NCT00111007|735827|P1|COMPLETED|Double-blind (DB) Treatment||27
300130|NCT00111007|735826|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
300131|NCT00111007|735827|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
300132|NCT00111007|735826|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
300133|NCT00111007|735827|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
300134|NCT00110994|735843|P2|NOT COMPLETED|Long Term Follow-up||17
300135|NCT00110994|735844|P1|NOT COMPLETED|Long Term Follow-up||19
300136|NCT00110994|735843|P2|COMPLETED|Long Term Follow-up||30
300137|NCT00110994|735844|P1|COMPLETED|Long Term Follow-up||22
300138|NCT00110994|735843|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
300139|NCT00110994|735844|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
300140|NCT00110994|735843|P2|NOT COMPLETED|Active Follow-up||2
300141|NCT00110994|735844|P1|NOT COMPLETED|Active Follow-up||1
300142|NCT00110994|735843|P2|COMPLETED|Active Follow-up||0
300143|NCT00110994|735844|P1|COMPLETED|Active Follow-up||0
300144|NCT00110994|735843|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
300145|NCT00110994|735844|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
300146|NCT00110994|735843|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
300147|NCT00110994|735844|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
300148|NCT00110994|735843|P2|COMPLETED|Double-blind (DB) Treatment||3
300149|NCT00110994|735844|P1|COMPLETED|Double-blind (DB) Treatment||9
300150|NCT00110994|735843|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
300151|NCT00110994|735844|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
300152|NCT00110994|735843|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
300153|NCT00110994|735844|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
300154|NCT00110890|735870|P2|NOT COMPLETED|Overall Study||179
300155|NCT00110890|735871|P1|NOT COMPLETED|Overall Study||361
300156|NCT00110890|735870|P2|COMPLETED|Overall Study|Follow-up Phase|5
300157|NCT00110890|735871|P1|COMPLETED|Overall Study|Follow-up Phase|7
300158|NCT00110890|735870|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
300159|NCT00110890|735871|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
300160|NCT00110890|735870|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
300161|NCT00110890|735871|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
300162|NCT00110890|735870|P2|STARTED|Overall Study||184
300163|NCT00110890|735871|P1|STARTED|Overall Study||368
300164|NCT00110812|735888|P3|NOT COMPLETED|Extended Follow-up||4
300165|NCT00110812|735889|P2|NOT COMPLETED|Extended Follow-up||4
300166|NCT00110812|735890|P1|NOT COMPLETED|Extended Follow-up||2
300167|NCT00110812|735888|P3|COMPLETED|Extended Follow-up||69
300168|NCT00110812|735889|P2|COMPLETED|Extended Follow-up||65
300169|NCT00110812|735890|P1|COMPLETED|Extended Follow-up||78
300170|NCT00110812|735888|P3|STARTED|Extended Follow-up||73
300171|NCT00110812|735889|P2|STARTED|Extended Follow-up||69
300172|NCT00110812|735890|P1|STARTED|Extended Follow-up||80
300173|NCT00110812|735888|P3|NOT COMPLETED|Main Study||13
300174|NCT00110812|735889|P2|NOT COMPLETED|Main Study||11
300175|NCT00110812|735890|P1|NOT COMPLETED|Main Study||8
300176|NCT00110812|735888|P3|COMPLETED|Main Study||74
300177|NCT00110812|735889|P2|COMPLETED|Main Study||78
300178|NCT00110812|735890|P1|COMPLETED|Main Study||83
300179|NCT00110812|735888|P3|STARTED|Main Study||87
300180|NCT00110812|735889|P2|STARTED|Main Study||89
300181|NCT00110812|735890|P1|STARTED|Main Study||91
300182|NCT00110617|735935|P2|NOT COMPLETED|Overall Study||29
300183|NCT00110617|735936|P1|NOT COMPLETED|Overall Study||39
300184|NCT00110617|735935|P2|COMPLETED|Overall Study||39
300185|NCT00110617|735936|P1|COMPLETED|Overall Study||96
300186|NCT00110617|735935|P2|On Going at Week 24|Overall Study||53
300187|NCT00110617|735936|P1|On Going at Week 24|Overall Study||126
300188|NCT00110617|735935|P2|Full Analysis 2; Received ICL670|Overall Study||53
300189|NCT00110617|735936|P1|Full Analysis 2; Received ICL670|Overall Study||135
300190|NCT00110617|735935|P2|Safety Set 1; Received Study Drug|Overall Study||56
300191|NCT00110617|735936|P1|Safety Set 1; Received Study Drug|Overall Study||135
300192|NCT00110617|735935|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
300193|NCT00110617|735936|P1|STARTED|Overall Study||135
300194|NCT00110513|735949|P1|NOT COMPLETED|Overall Study||0
300195|NCT00110513|735949|P1|COMPLETED|Overall Study||18
300196|NCT00110513|735949|P1|STARTED|Overall Study||18
300197|NCT00110461|735956|P3|NOT COMPLETED|Acute Phase||23
300198|NCT00110461|735957|P2|NOT COMPLETED|Acute Phase||22
300199|NCT00110461|735958|P1|NOT COMPLETED|Acute Phase||14
300200|NCT00110461|735956|P3|COMPLETED|Acute Phase||76
300201|NCT00110461|735957|P2|COMPLETED|Acute Phase||77
300202|NCT00110461|735958|P1|COMPLETED|Acute Phase||84
300203|NCT00110461|735956|P3|STARTED|Acute Phase||99
300204|NCT00110461|735957|P2|STARTED|Acute Phase||99
300205|NCT00110461|735958|P1|STARTED|Acute Phase||98
300206|NCT00110461|735956|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
300207|NCT00110461|735957|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
300208|NCT00110461|735958|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
300209|NCT00110461|735956|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
300210|NCT00110461|735957|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
300211|NCT00110461|735958|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
300212|NCT00110461|735956|P3|STARTED|30-Week, Double-blind Treatment Phase||99
300213|NCT00110461|735957|P2|STARTED|30-Week, Double-blind Treatment Phase||99
300214|NCT00110461|735958|P1|STARTED|30-Week, Double-blind Treatment Phase||98
300215|NCT00110396|736053|P1|NOT COMPLETED|Overall Study||36
300216|NCT00110396|736053|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
300217|NCT00110396|736053|P1|STARTED|Overall Study||260
300218|NCT00110357|736061|P2|NOT COMPLETED|Overall Study||19
300219|NCT00110357|736062|P1|NOT COMPLETED|Overall Study||27
300220|NCT00110357|736061|P2|COMPLETED|Overall Study|Number Still on Study|0
300221|NCT00110357|736062|P1|COMPLETED|Overall Study|Number Still on Study|0
300222|NCT00110357|736061|P2|STARTED|Overall Study||19
300223|NCT00110357|736062|P1|STARTED|Overall Study||27
300224|NCT00110305|736150|P2|NOT COMPLETED|Overall Study||32
300225|NCT00110305|736151|P1|NOT COMPLETED|Overall Study||114
300226|NCT00110305|736150|P2|COMPLETED|Overall Study||57
300227|NCT00110305|736151|P1|COMPLETED|Overall Study||165
300228|NCT00110305|736150|P2|STARTED|Overall Study||89
300229|NCT00110305|736151|P1|STARTED|Overall Study||279
300230|NCT00110214|736204|P2|NOT COMPLETED|Overall Study||503
300231|NCT00110214|736205|P1|NOT COMPLETED|Overall Study||509
300232|NCT00110214|736204|P2|COMPLETED|Overall Study||21
300233|NCT00110214|736205|P1|COMPLETED|Overall Study||17
300234|NCT00110214|736204|P2|STARTED|Overall Study||524
300235|NCT00110214|736205|P1|STARTED|Overall Study||526
300236|NCT00110149|736217|P1|NOT COMPLETED|Overall Study||3
300237|NCT00110149|736217|P1|COMPLETED|Overall Study||9
300238|NCT00110149|736217|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
300239|NCT00110149|736217|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
300240|NCT00110136|736222|P1|NOT COMPLETED|Overall Study||0
300241|NCT00110136|736222|P1|COMPLETED|Overall Study||9
300242|NCT00110136|736222|P1|STARTED|Overall Study||9
300243|NCT00110084|736231|P1|NOT COMPLETED|Overall Study||28
300244|NCT00110084|736231|P1|COMPLETED|Overall Study||22
300245|NCT00110084|736231|P1|STARTED|Overall Study||50
300246|NCT00110019|736240|P2|NOT COMPLETED|Overall Study||413
300247|NCT00110019|736241|P1|NOT COMPLETED|Overall Study||406
300248|NCT00110019|736240|P2|COMPLETED|Overall Study||0
300249|NCT00110019|736241|P1|COMPLETED|Overall Study||4
300250|NCT00110019|736240|P2|Treated|Overall Study||397
300251|NCT00110019|736241|P1|Treated|Overall Study||393
300252|NCT00110019|736240|P2|Eligible|Overall Study||398
300253|NCT00110019|736241|P1|Eligible|Overall Study||395
300254|NCT00110019|736240|P2|STARTED|Overall Study||413
300255|NCT00110019|736241|P1|STARTED|Overall Study||410
300256|NCT00109967|736253|P2|NOT COMPLETED|Overall Study||6
300257|NCT00109967|736254|P1|NOT COMPLETED|Overall Study||20
300258|NCT00109967|736253|P2|COMPLETED|Overall Study||15
300259|NCT00109967|736254|P1|COMPLETED|Overall Study||30
300260|NCT00109967|736253|P2|STARTED|Overall Study||21
300261|NCT00109967|736254|P1|STARTED|Overall Study||50
300262|NCT00109928|736268|P1|NOT COMPLETED|Overall Study||13
300263|NCT00109928|736268|P1|COMPLETED|Overall Study||21
300264|NCT00109928|736268|P1|Eligible and Began Protocol Therapy|Overall Study||33
300265|NCT00109928|736268|P1|Eligible|Overall Study||33
300266|NCT00109928|736268|P1|STARTED|Overall Study||34
300267|NCT00109876|736275|P1|NOT COMPLETED|Overall Study||0
300268|NCT00109876|736275|P1|COMPLETED|Overall Study||51
300269|NCT00109876|736275|P1|STARTED|Overall Study||51
300270|NCT00109850|736285|P1|NOT COMPLETED|Overall Study||4
300271|NCT00109850|736285|P1|COMPLETED|Overall Study||18
300272|NCT00109850|736285|P1|Eligible and Began Protocol Therapy|Overall Study||21
300273|NCT00109850|736285|P1|Eligible|Overall Study||21
300274|NCT00109850|736285|P1|STARTED|Overall Study||22
300275|NCT00109837|736292|P1|NOT COMPLETED|Overall Study||23
300276|NCT00109837|736292|P1|COMPLETED|Overall Study||56
300277|NCT00109837|736292|P1|Eligible and Ph- and Treated|Overall Study||60
300278|NCT00109837|736292|P1|Eligible and Ph-|Overall Study||61
300279|NCT00109837|736292|P1|Eligible|Overall Study||78
300280|NCT00109837|736292|P1|STARTED|Overall Study||79
300281|NCT00109772|736302|P2|NOT COMPLETED|Open-label Extension||49
300282|NCT00109772|736303|P1|NOT COMPLETED|Open-label Extension||45
300283|NCT00109772|736302|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
300284|NCT00109772|736303|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
300285|NCT00109772|736302|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
300286|NCT00109772|736303|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
300287|NCT00109772|736302|P2|NOT COMPLETED|Double-blind Treatment||15
300288|NCT00109772|736303|P1|NOT COMPLETED|Double-blind Treatment||22
300289|NCT00109772|736302|P2|COMPLETED|Double-blind Treatment||79
300290|NCT00109772|736303|P1|COMPLETED|Double-blind Treatment||68
300291|NCT00109772|736302|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
300292|NCT00109772|736303|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
300293|NCT00109772|736302|P2|STARTED|Double-blind Treatment||94
300294|NCT00109772|736303|P1|STARTED|Double-blind Treatment||90
300295|NCT00109733|736343|P2|NOT COMPLETED|Overall Study||4
300296|NCT00109733|736344|P1|NOT COMPLETED|Overall Study||2
300297|NCT00109733|736343|P2|COMPLETED|Overall Study||12
300298|NCT00109733|736344|P1|COMPLETED|Overall Study||13
300299|NCT00109733|736343|P2|STARTED|Overall Study||16
300300|NCT00109733|736344|P1|STARTED|Overall Study||15
300301|NCT00109590|736361|P3|NOT COMPLETED|Overall Study||4
300302|NCT00109590|736362|P2|NOT COMPLETED|Overall Study||2
300303|NCT00109590|736363|P1|NOT COMPLETED|Overall Study||2
300304|NCT00109590|736361|P3|COMPLETED|Overall Study||56
300305|NCT00109590|736362|P2|COMPLETED|Overall Study||56
300306|NCT00109590|736363|P1|COMPLETED|Overall Study||55
300307|NCT00109590|736361|P3|RECEIVED TREATMENT|Overall Study||57
300308|NCT00109590|736362|P2|RECEIVED TREATMENT|Overall Study||56
300309|NCT00109590|736363|P1|RECEIVED TREATMENT|Overall Study||56
300310|NCT00109590|736361|P3|STARTED|Overall Study||60
300311|NCT00109590|736362|P2|STARTED|Overall Study||58
300312|NCT00109590|736363|P1|STARTED|Overall Study||57
300313|NCT00109577|736405|P2|NOT COMPLETED|Overall Study||3
300314|NCT00109577|736406|P1|NOT COMPLETED|Overall Study||3
300315|NCT00109577|736405|P2|COMPLETED|Overall Study||17
300316|NCT00109577|736406|P1|COMPLETED|Overall Study||17
300317|NCT00109577|736405|P2|STARTED|Overall Study||20
300318|NCT00109577|736406|P1|STARTED|Overall Study||20
300319|NCT00109473|736414|P2|NOT COMPLETED|52 Week Extension Phase||5
300320|NCT00109473|736415|P1|NOT COMPLETED|52 Week Extension Phase||4
300321|NCT00109473|736414|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
300322|NCT00109473|736415|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
300323|NCT00109473|736414|P2|Analyzed|52 Week Extension Phase||8
300324|NCT00109473|736415|P1|Analyzed|52 Week Extension Phase||9
300325|NCT00109473|736414|P2|STARTED|52 Week Extension Phase||8
300326|NCT00109473|736415|P1|STARTED|52 Week Extension Phase||9
300327|NCT00109473|736414|P2|NOT COMPLETED|Week 12 to Week 24||0
300328|NCT00109473|736415|P1|NOT COMPLETED|Week 12 to Week 24||1
300329|NCT00109473|736414|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
300330|NCT00109473|736415|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
300331|NCT00109473|736414|P2|Analyzed|Week 12 to Week 24||9
300332|NCT00109473|736415|P1|Analyzed|Week 12 to Week 24||9
300333|NCT00109473|736414|P2|STARTED|Week 12 to Week 24||9
300334|NCT00109473|736415|P1|STARTED|Week 12 to Week 24||10
300335|NCT00109473|736414|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
300336|NCT00109473|736415|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
300337|NCT00109473|736414|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
300338|NCT00109473|736415|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
300339|NCT00109473|736414|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
300340|NCT00109473|736415|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
300341|NCT00109473|736414|P2|STARTED|Baseline (0 Through 12 Weeks)||10
300342|NCT00109473|736415|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
300343|NCT00109343|736437|P3|NOT COMPLETED|Overall Study||30
300344|NCT00109343|736438|P2|NOT COMPLETED|Overall Study||37
300345|NCT00109343|736439|P1|NOT COMPLETED|Overall Study||64
300346|NCT00109343|736437|P3|COMPLETED|Overall Study||229
300347|NCT00109343|736438|P2|COMPLETED|Overall Study||221
300348|NCT00109343|736439|P1|COMPLETED|Overall Study||446
300349|NCT00109343|736437|P3|Vaccinated at Visit 4|Overall Study||240
300350|NCT00109343|736438|P2|Vaccinated at Visit 4|Overall Study||235
300351|NCT00109343|736439|P1|Vaccinated at Visit 4|Overall Study||466
300352|NCT00109343|736437|P3|Vaccinated at Visit 2|Overall Study||246
300353|NCT00109343|736438|P2|Vaccinated at Visit 2|Overall Study||246
300354|NCT00109343|736439|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
300355|NCT00109343|736437|P3|Vaccinated at Visit 1|Overall Study||259
300356|NCT00109343|736438|P2|Vaccinated at Visit 1|Overall Study||258
300357|NCT00109343|736439|P1|Vaccinated at Visit 1|Overall Study||510
300358|NCT00109343|736437|P3|STARTED|Overall Study||259
300359|NCT00109343|736438|P2|STARTED|Overall Study||258
300360|NCT00109343|736439|P1|STARTED|Overall Study||510
300361|NCT00109031|736484|P4|NOT COMPLETED|Overall Study||0
300362|NCT00109031|736485|P3|NOT COMPLETED|Overall Study||2
300363|NCT00109031|736486|P2|NOT COMPLETED|Overall Study||2
300364|NCT00109031|736487|P1|NOT COMPLETED|Overall Study||0
300365|NCT00109031|736484|P4|COMPLETED|Overall Study||12
300366|NCT00109031|736485|P3|COMPLETED|Overall Study||12
300367|NCT00109031|736486|P2|COMPLETED|Overall Study||8
300368|NCT00109031|736487|P1|COMPLETED|Overall Study||11
300369|NCT00109031|736484|P4|STARTED|Overall Study||12
300370|NCT00109031|736485|P3|STARTED|Overall Study||14
300371|NCT00109031|736486|P2|STARTED|Overall Study||10
300372|NCT00109031|736487|P1|STARTED|Overall Study||11
300373|NCT00109005|736523|P2|NOT COMPLETED|Overall Study||0
300374|NCT00109005|736524|P1|NOT COMPLETED|Overall Study||0
300375|NCT00109005|736523|P2|COMPLETED|Overall Study||9
300376|NCT00109005|736524|P1|COMPLETED|Overall Study||8
300377|NCT00109005|736523|P2|STARTED|Overall Study||9
300378|NCT00109005|736524|P1|STARTED|Overall Study||8
300379|NCT00108953|736538|P2|NOT COMPLETED|Follow-up||33
300380|NCT00108953|736539|P1|NOT COMPLETED|Follow-up||29
300381|NCT00108953|736538|P2|COMPLETED|Follow-up||12
300382|NCT00108953|736539|P1|COMPLETED|Follow-up||11
300383|NCT00108953|736538|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
300384|NCT00108953|736539|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
300385|NCT00108953|736538|P2|NOT COMPLETED|Treatment Period||0
300386|NCT00108953|736539|P1|NOT COMPLETED|Treatment Period||0
300387|NCT00108953|736538|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
300388|NCT00108953|736539|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
300389|NCT00108953|736538|P2|STARTED|Treatment Period|ITT population|49
300390|NCT00108953|736539|P1|STARTED|Treatment Period|ITT population|47
300391|NCT00108862|736561|P2|NOT COMPLETED|Overall Study||62
300392|NCT00108862|736562|P1|NOT COMPLETED|Overall Study||68
300393|NCT00108862|736561|P2|COMPLETED|Overall Study||339
300394|NCT00108862|736562|P1|COMPLETED|Overall Study||337
300395|NCT00108862|736561|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
300396|NCT00108862|736562|P1|STARTED|Overall Study||405
300397|NCT00108732|736590|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
300398|NCT00108732|736590|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
300399|NCT00108732|736590|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
300400|NCT00108732|736590|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
300401|NCT00108732|736590|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
300402|NCT00108732|736590|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
300403|NCT00108732|736590|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
300404|NCT00108628|736599|P2|NOT COMPLETED|Overall Study||10
300405|NCT00108628|736600|P1|NOT COMPLETED|Overall Study||20
300406|NCT00108628|736599|P2|COMPLETED|Overall Study||53
300407|NCT00108628|736600|P1|COMPLETED|Overall Study||41
300408|NCT00108628|736599|P2|Completed Treatment|Overall Study||57
300409|NCT00108628|736600|P1|Completed Treatment|Overall Study||42
300410|NCT00108628|736599|P2|Received One or More Sessions|Overall Study||58
300411|NCT00108628|736600|P1|Received One or More Sessions|Overall Study||53
300412|NCT00108628|736599|P2|STARTED|Overall Study||63
300413|NCT00108628|736600|P1|STARTED|Overall Study||61
300414|NCT00108550|736626|P2|NOT COMPLETED|Overall Study||16
300415|NCT00108550|736627|P1|NOT COMPLETED|Overall Study||16
300416|NCT00108550|736626|P2|COMPLETED|Overall Study||37
300417|NCT00108550|736627|P1|COMPLETED|Overall Study||39
300418|NCT00108550|736626|P2|STARTED|Overall Study||53
300419|NCT00108550|736627|P1|STARTED|Overall Study||55
300420|NCT00108524|736637|P2|NOT COMPLETED|Overall Study||18
300421|NCT00108524|736638|P1|NOT COMPLETED|Overall Study||29
300422|NCT00108524|736637|P2|COMPLETED|Overall Study||61
300423|NCT00108524|736638|P1|COMPLETED|Overall Study||52
300424|NCT00108524|736637|P2|STARTED|Overall Study||79
300425|NCT00108524|736638|P1|STARTED|Overall Study||81
300426|NCT00108485|736650|P2|NOT COMPLETED|Overall Study||2
300427|NCT00108485|736651|P1|NOT COMPLETED|Overall Study||3
300428|NCT00108485|736650|P2|COMPLETED|Overall Study||2
300429|NCT00108485|736651|P1|COMPLETED|Overall Study||2
300430|NCT00108485|736650|P2|STARTED|Overall Study||4
300431|NCT00108485|736651|P1|STARTED|Overall Study||5
300432|NCT00108433|736659|P2|NOT COMPLETED|Overall Study||17
300433|NCT00108433|736660|P1|NOT COMPLETED|Overall Study||21
300434|NCT00108433|736659|P2|COMPLETED|Overall Study||14
300435|NCT00108433|736660|P1|COMPLETED|Overall Study||9
300436|NCT00108433|736659|P2|STARTED|Overall Study||31
300437|NCT00108433|736660|P1|STARTED|Overall Study||30
300438|NCT00108355|736676|P2|NOT COMPLETED|Overall Study||2
300439|NCT00108355|736677|P1|NOT COMPLETED|Overall Study||2
300440|NCT00108355|736676|P2|COMPLETED|Overall Study||12
300441|NCT00108355|736677|P1|COMPLETED|Overall Study||13
300442|NCT00108355|736676|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
300443|NCT00108355|736677|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
300444|NCT00108342|736687|P2|NOT COMPLETED|Overall Study||0
300445|NCT00108342|736688|P1|NOT COMPLETED|Overall Study||1
300446|NCT00108342|736687|P2|COMPLETED|Overall Study||9
300447|NCT00108342|736688|P1|COMPLETED|Overall Study||7
300448|NCT00108342|736687|P2|STARTED|Overall Study||9
300449|NCT00108342|736688|P1|STARTED|Overall Study||8
300450|NCT00108303|736697|P3|NOT COMPLETED|Overall Study||0
300451|NCT00108303|736698|P2|NOT COMPLETED|Overall Study||0
300452|NCT00108303|736699|P1|NOT COMPLETED|Overall Study||0
300453|NCT00108303|736697|P3|COMPLETED|Overall Study||180
300454|NCT00108303|736698|P2|COMPLETED|Overall Study||179
300455|NCT00108303|736699|P1|COMPLETED|Overall Study||179
300456|NCT00108303|736697|P3|STARTED|Overall Study||180
300457|NCT00108303|736698|P2|STARTED|Overall Study||179
300458|NCT00108303|736699|P1|STARTED|Overall Study||179
300459|NCT00108277|736714|P3|NOT COMPLETED|Overall Study||16
300460|NCT00108277|736715|P2|NOT COMPLETED|Overall Study||12
300461|NCT00108277|736716|P1|NOT COMPLETED|Overall Study||10
300462|NCT00108277|736714|P3|COMPLETED|Overall Study||19
300463|NCT00108277|736715|P2|COMPLETED|Overall Study||16
300464|NCT00108277|736716|P1|COMPLETED|Overall Study||19
300465|NCT00108277|736714|P3|STARTED|Overall Study||35
300466|NCT00108277|736715|P2|STARTED|Overall Study||28
300467|NCT00108277|736716|P1|STARTED|Overall Study||29
300468|NCT00108160|736726|P2|NOT COMPLETED|Overall Study||21
300469|NCT00108160|736727|P1|NOT COMPLETED|Overall Study||39
300470|NCT00108160|736726|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
300471|NCT00108160|736727|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
300472|NCT00108160|736726|P2|Completed Visit 7 (18 mo)|Overall Study||31
300473|NCT00108160|736727|P1|Completed Visit 7 (18 mo)|Overall Study||34
300474|NCT00108160|736726|P2|Completed Visit 6 (15 mo)|Overall Study||33
300475|NCT00108160|736727|P1|Completed Visit 6 (15 mo)|Overall Study||36
300476|NCT00108160|736726|P2|Completed Visit 5 (12 mo)|Overall Study||37
300477|NCT00108160|736727|P1|Completed Visit 5 (12 mo)|Overall Study||37
300478|NCT00108160|736726|P2|Completed Visit 4 (9 mo)|Overall Study||37
300479|NCT00108160|736727|P1|Completed Visit 4 (9 mo)|Overall Study||38
300480|NCT00108160|736726|P2|Completed Visit 3 (6 mo)|Overall Study||38
300481|NCT00108160|736727|P1|Completed Visit 3 (6 mo)|Overall Study||44
300482|NCT00108160|736726|P2|Completed Visit 2 (3 mo)|Overall Study||46
300483|NCT00108160|736727|P1|Completed Visit 2 (3 mo)|Overall Study||54
300484|NCT00108160|736726|P2|Completed Visit 1 (2 Wks)|Overall Study||54
300485|NCT00108160|736727|P1|Completed Visit 1 (2 Wks)|Overall Study||72
300486|NCT00108160|736726|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
300487|NCT00108160|736727|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
300488|NCT00108160|736726|P2|STARTED|Overall Study||63
300489|NCT00108160|736727|P1|STARTED|Overall Study||83
300490|NCT00108082|736740|P3|NOT COMPLETED|Overall Study||43
300491|NCT00108082|736741|P2|NOT COMPLETED|Overall Study||32
300492|NCT00108082|736742|P1|NOT COMPLETED|Overall Study||38
300493|NCT00108082|736740|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
300494|NCT00108082|736741|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
300495|NCT00108082|736742|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
300496|NCT00108082|736740|P3|STARTED|Overall Study||96
300497|NCT00108082|736741|P2|STARTED|Overall Study||100
300498|NCT00108082|736742|P1|STARTED|Overall Study||91
300499|NCT00108069|736791|P2|NOT COMPLETED|Overall Study||13
300500|NCT00108069|736792|P1|NOT COMPLETED|Overall Study||30
300501|NCT00108069|736791|P2|COMPLETED|Overall Study||0
300502|NCT00108069|736792|P1|COMPLETED|Overall Study||0
300503|NCT00108069|736791|P2|STARTED|Overall Study||13
300504|NCT00108069|736792|P1|STARTED|Overall Study||30
300505|NCT00107991|736806|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
300506|NCT00107991|736806|P1|COMPLETED|18-Week Post Treatment Assessment||8
300507|NCT00107991|736806|P1|STARTED|18-Week Post Treatment Assessment||10
300508|NCT00107991|736806|P1|NOT COMPLETED|12 Week Treatment Period||5
300509|NCT00107991|736806|P1|COMPLETED|12 Week Treatment Period||10
300510|NCT00107991|736806|P1|STARTED|12 Week Treatment Period||15
300511|NCT00107991|736806|P1|NOT COMPLETED|Eligibility Assessment||23
300512|NCT00107991|736806|P1|COMPLETED|Eligibility Assessment||15
300513|NCT00107991|736806|P1|STARTED|Eligibility Assessment||38
300514|NCT00107978|736816|P2|NOT COMPLETED|Overall Study||50
300515|NCT00107978|736817|P1|NOT COMPLETED|Overall Study||33
300516|NCT00107978|736816|P2|COMPLETED|Overall Study||431
300517|NCT00107978|736817|P1|COMPLETED|Overall Study||425
300518|NCT00107978|736816|P2|STARTED|Overall Study||481
300519|NCT00107978|736817|P1|STARTED|Overall Study||458
300520|NCT00107952|736825|P2|NOT COMPLETED|Overall Study||81
300521|NCT00107952|736826|P1|NOT COMPLETED|Overall Study||95
300522|NCT00107952|736825|P2|COMPLETED|Overall Study||299
300523|NCT00107952|736826|P1|COMPLETED|Overall Study||286
300524|NCT00107952|736825|P2|STARTED|Overall Study||380
300525|NCT00107952|736826|P1|STARTED|Overall Study||381
300526|NCT00107900|736838|P6|NOT COMPLETED|Overall Study||9
300527|NCT00107900|736839|P5|NOT COMPLETED|Overall Study||21
300528|NCT00107900|736840|P4|NOT COMPLETED|Overall Study||12
300529|NCT00107900|736841|P3|NOT COMPLETED|Overall Study||25
300530|NCT00107900|736842|P2|NOT COMPLETED|Overall Study||3
300531|NCT00107900|736843|P1|NOT COMPLETED|Overall Study||10
300532|NCT00107900|736838|P6|COMPLETED|Overall Study||94
300533|NCT00107900|736839|P5|COMPLETED|Overall Study||94
300534|NCT00107900|736840|P4|COMPLETED|Overall Study||87
300535|NCT00107900|736841|P3|COMPLETED|Overall Study||104
300536|NCT00107900|736842|P2|COMPLETED|Overall Study||72
300537|NCT00107900|736843|P1|COMPLETED|Overall Study||75
300538|NCT00107900|736838|P6|STARTED|Overall Study||103
300539|NCT00107900|736839|P5|STARTED|Overall Study||115
300540|NCT00107900|736840|P4|STARTED|Overall Study||99
300541|NCT00107900|736841|P3|STARTED|Overall Study||129
300542|NCT00107900|736842|P2|STARTED|Overall Study||75
300543|NCT00107900|736843|P1|STARTED|Overall Study||85
300544|NCT00107783|736877|P2|NOT COMPLETED|Overall Study||4
300545|NCT00107783|736878|P1|NOT COMPLETED|Overall Study||3
300546|NCT00107783|736877|P2|COMPLETED|Overall Study||16
300547|NCT00107783|736878|P1|COMPLETED|Overall Study||17
300548|NCT00107783|736877|P2|STARTED|Overall Study||20
300549|NCT00107783|736878|P1|STARTED|Overall Study||20
300550|NCT00107653|736894|P2|NOT COMPLETED|Overall Study||76
300551|NCT00107653|736895|P1|NOT COMPLETED|Overall Study||79
300552|NCT00107653|736894|P2|COMPLETED|Overall Study||224
300553|NCT00107653|736895|P1|COMPLETED|Overall Study||190
300554|NCT00107653|736894|P2|STARTED|Overall Study||300
300555|NCT00107653|736895|P1|STARTED|Overall Study||269
300556|NCT00107614|736941|P1|NOT COMPLETED|Overall Study||12
300557|NCT00107614|736941|P1|COMPLETED|Overall Study||0
300558|NCT00107614|736941|P1|STARTED|Overall Study||12
300559|NCT00107575|736947|P2|NOT COMPLETED|Overall Study||10
300560|NCT00107575|736948|P1|NOT COMPLETED|Overall Study||11
300561|NCT00107575|736947|P2|COMPLETED|Overall Study||107
300562|NCT00107575|736948|P1|COMPLETED|Overall Study||108
300563|NCT00107575|736947|P2|STARTED|Overall Study||117
300564|NCT00107575|736948|P1|STARTED|Overall Study||119
300565|NCT00107536|736962|P1|NOT COMPLETED|Overall Study||0
300566|NCT00107536|736962|P1|COMPLETED|Overall Study||26
300567|NCT00107536|736962|P1|STARTED|Overall Study||26
300568|NCT00107380|736972|P1|NOT COMPLETED|Overall Study||30
300569|NCT00107380|736972|P1|COMPLETED|Overall Study||56
300570|NCT00107380|736972|P1|Eligible|Overall Study||84
300571|NCT00107380|736972|P1|STARTED|Overall Study||86
300572|NCT00107315|736978|P1|NOT COMPLETED|Overall Study||15
300573|NCT00107315|736978|P1|COMPLETED|Overall Study||1
300574|NCT00107315|736978|P1|STARTED|Overall Study||16
300575|NCT00107276|736985|P1|NOT COMPLETED|Overall Study||72
300576|NCT00107276|736985|P1|COMPLETED|Overall Study||40
300577|NCT00107276|736985|P1|Eligible|Overall Study||96
300578|NCT00107276|736985|P1|STARTED|Overall Study||112
300579|NCT00107198|736991|P1|NOT COMPLETED|Overall Study||52
300580|NCT00107198|736991|P1|COMPLETED|Overall Study||136
300581|NCT00107198|736991|P1|STARTED|Overall Study||188
300582|NCT00107172|737001|P2|NOT COMPLETED|Overall Study||5
300583|NCT00107172|737002|P1|NOT COMPLETED|Overall Study||5
300584|NCT00107172|737001|P2|COMPLETED|Overall Study||103
300585|NCT00107172|737002|P1|COMPLETED|Overall Study||109
300586|NCT00107172|737001|P2|STARTED|Overall Study||108
300587|NCT00107172|737002|P1|STARTED|Overall Study||114
300588|NCT00107120|737032|P2|NOT COMPLETED|Overall Study||24
300589|NCT00107120|737033|P1|NOT COMPLETED|Overall Study||29
300590|NCT00107120|737032|P2|COMPLETED|Overall Study||133
300591|NCT00107120|737033|P1|COMPLETED|Overall Study||126
300592|NCT00107120|737032|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
300593|NCT00107120|737033|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
300594|NCT00107042|737045|P2|NOT COMPLETED|Overall Study||16
300595|NCT00107042|737046|P1|NOT COMPLETED|Overall Study||22
300596|NCT00107042|737045|P2|COMPLETED|Overall Study||47
300597|NCT00107042|737046|P1|COMPLETED|Overall Study||38
300598|NCT00107042|737045|P2|STARTED|Overall Study||63
300599|NCT00107042|737046|P1|STARTED|Overall Study||60
300600|NCT00106964|737112|P3|NOT COMPLETED|Overall Study||7
300601|NCT00106964|737113|P2|NOT COMPLETED|Overall Study||15
300602|NCT00106964|737114|P1|NOT COMPLETED|Overall Study||13
300603|NCT00106964|737112|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
300604|NCT00106964|737113|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
300605|NCT00106964|737114|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
300606|NCT00106964|737112|P3|STARTED|Overall Study||127
300607|NCT00106964|737113|P2|STARTED|Overall Study||126
300608|NCT00106964|737114|P1|STARTED|Overall Study||118
300609|NCT00106938|737139|P2|NOT COMPLETED|Overall Study||71
300610|NCT00106938|737140|P1|NOT COMPLETED|Overall Study||176
300611|NCT00106938|737139|P2|COMPLETED|Overall Study||293
300612|NCT00106938|737140|P1|COMPLETED|Overall Study||913
300613|NCT00106938|737139|P2|STARTED|Overall Study||364
300614|NCT00106938|737140|P1|STARTED|Overall Study||1089
300615|NCT00106704|737209|P2|NOT COMPLETED|Overall Study||151
300616|NCT00106704|737210|P1|NOT COMPLETED|Overall Study||131
300617|NCT00106704|737209|P2|COMPLETED|Overall Study||68
300618|NCT00106704|737210|P1|COMPLETED|Overall Study||91
300619|NCT00106704|737209|P2|STARTED|Overall Study||219
300620|NCT00106704|737210|P1|STARTED|Overall Study||222
300621|NCT00106639|737221|P3|NOT COMPLETED|Overall Study||2
300622|NCT00106639|737222|P2|NOT COMPLETED|Overall Study||7
300623|NCT00106639|737223|P1|NOT COMPLETED|Overall Study||3
300624|NCT00106639|737221|P3|COMPLETED|Overall Study||19
300625|NCT00106639|737222|P2|COMPLETED|Overall Study||13
300626|NCT00106639|737223|P1|COMPLETED|Overall Study||17
300627|NCT00106639|737221|P3|STARTED|Overall Study||21
300628|NCT00106639|737222|P2|STARTED|Overall Study||20
300629|NCT00106639|737223|P1|STARTED|Overall Study||20
300630|NCT00106626|737350|P4|NOT COMPLETED|Overall Study||13
300631|NCT00106626|737351|P3|NOT COMPLETED|Overall Study||12
300632|NCT00106626|737352|P2|NOT COMPLETED|Overall Study||6
300633|NCT00106626|737353|P1|NOT COMPLETED|Overall Study||10
300634|NCT00106626|737350|P4|COMPLETED|Overall Study||3
300635|NCT00106626|737351|P3|COMPLETED|Overall Study||2
300636|NCT00106626|737352|P2|COMPLETED|Overall Study||3
300637|NCT00106626|737353|P1|COMPLETED|Overall Study||3
300638|NCT00106626|737350|P4|STARTED|Overall Study||16
300639|NCT00106626|737351|P3|STARTED|Overall Study||14
300640|NCT00106626|737352|P2|STARTED|Overall Study||9
300641|NCT00106626|737353|P1|STARTED|Overall Study||13
300642|NCT00106535|737371|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
300643|NCT00106535|737372|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
300644|NCT00106535|737373|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
300645|NCT00106535|737374|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
300646|NCT00106535|737371|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
300647|NCT00106535|737372|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
300648|NCT00106535|737373|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
300649|NCT00106535|737374|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
300650|NCT00106535|737371|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
300651|NCT00106535|737372|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
300652|NCT00106535|737373|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
300653|NCT00106535|737374|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
300654|NCT00106535|737371|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
300655|NCT00106535|737372|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
300656|NCT00106535|737373|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
300657|NCT00106535|737374|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
300658|NCT00106535|737371|P4|COMPLETED|2-year Placebo Controlled Period||0
300659|NCT00106535|737372|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
300660|NCT00106535|737373|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
300661|NCT00106535|737374|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
300662|NCT00106535|737371|P4|Completed Week 52|2-year Placebo Controlled Period||0
300663|NCT00106535|737372|P3|Completed Week 52|2-year Placebo Controlled Period||338
300664|NCT00106535|737373|P2|Completed Week 52|2-year Placebo Controlled Period||342
300665|NCT00106535|737374|P1|Completed Week 52|2-year Placebo Controlled Period||326
300666|NCT00106535|737371|P4|Completed Week 24|2-year Placebo Controlled Period||0
300667|NCT00106535|737372|P3|Completed Week 24|2-year Placebo Controlled Period||366
300668|NCT00106535|737373|P2|Completed Week 24|2-year Placebo Controlled Period||373
300669|NCT00106535|737374|P1|Completed Week 24|2-year Placebo Controlled Period||356
300670|NCT00106535|737371|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
300671|NCT00106535|737372|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
300672|NCT00106535|737373|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
300673|NCT00106535|737374|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
300674|NCT00106535|737371|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
300675|NCT00106535|737372|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
300676|NCT00106535|737373|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
300677|NCT00106535|737374|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
300678|NCT00106535|737371|P4|STARTED|2-year Placebo Controlled Period||0
300679|NCT00106535|737372|P3|STARTED|2-year Placebo Controlled Period||401
300680|NCT00106535|737373|P2|STARTED|2-year Placebo Controlled Period||401
300681|NCT00106535|737374|P1|STARTED|2-year Placebo Controlled Period||394
300682|NCT00106431|737667|P1|NOT COMPLETED|Overall Study||65
300683|NCT00106431|737667|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
300684|NCT00106431|737667|P1|STARTED|Overall Study||102
300685|NCT00106392|737679|P2|NOT COMPLETED|Overall Study||27
300686|NCT00106392|737680|P1|NOT COMPLETED|Overall Study||26
300687|NCT00106392|737679|P2|COMPLETED|Overall Study||42
300688|NCT00106392|737680|P1|COMPLETED|Overall Study||36
300689|NCT00106392|737679|P2|Full Analysis Set (FAS)|Overall Study||61
300690|NCT00106392|737680|P1|Full Analysis Set (FAS)|Overall Study||53
300691|NCT00106392|737679|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
300692|NCT00106392|737680|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
300693|NCT00106392|737679|P2|STARTED|Overall Study||69
300694|NCT00106392|737680|P1|STARTED|Overall Study||62
300695|NCT00106353|737698|P7|NOT COMPLETED|Part 2||16
300696|NCT00106353|737699|P6|NOT COMPLETED|Part 2||18
300697|NCT00106353|737700|P5|NOT COMPLETED|Part 2||16
300698|NCT00106353|737701|P4|NOT COMPLETED|Part 2||0
300699|NCT00106353|737702|P3|NOT COMPLETED|Part 2||0
300700|NCT00106353|737703|P2|NOT COMPLETED|Part 2||0
300701|NCT00106353|737704|P1|NOT COMPLETED|Part 2||0
300702|NCT00106353|737698|P7|COMPLETED|Part 2||0
300703|NCT00106353|737699|P6|COMPLETED|Part 2||1
300704|NCT00106353|737700|P5|COMPLETED|Part 2||1
300705|NCT00106353|737701|P4|COMPLETED|Part 2||0
300706|NCT00106353|737702|P3|COMPLETED|Part 2||0
300707|NCT00106353|737703|P2|COMPLETED|Part 2||0
300708|NCT00106353|737704|P1|COMPLETED|Part 2||0
300709|NCT00106353|737698|P7|STARTED|Part 2||16
300710|NCT00106353|737699|P6|STARTED|Part 2||19
300711|NCT00106353|737700|P5|STARTED|Part 2||17
300712|NCT00106353|737701|P4|STARTED|Part 2||0
300713|NCT00106353|737702|P3|STARTED|Part 2||0
300714|NCT00106353|737703|P2|STARTED|Part 2||0
300715|NCT00106353|737704|P1|STARTED|Part 2||0
300716|NCT00106353|737698|P7|NOT COMPLETED|Part 1||0
300717|NCT00106353|737699|P6|NOT COMPLETED|Part 1||0
300718|NCT00106353|737700|P5|NOT COMPLETED|Part 1||0
300719|NCT00106353|737701|P4|NOT COMPLETED|Part 1||7
300720|NCT00106353|737702|P3|NOT COMPLETED|Part 1||3
300721|NCT00106353|737703|P2|NOT COMPLETED|Part 1||5
300722|NCT00106353|737704|P1|NOT COMPLETED|Part 1||4
300723|NCT00106353|737698|P7|COMPLETED|Part 1||0
300724|NCT00106353|737699|P6|COMPLETED|Part 1||0
300725|NCT00106353|737700|P5|COMPLETED|Part 1||0
300726|NCT00106353|737701|P4|COMPLETED|Part 1||0
300727|NCT00106353|737702|P3|COMPLETED|Part 1||0
300728|NCT00106353|737703|P2|COMPLETED|Part 1||0
300729|NCT00106353|737704|P1|COMPLETED|Part 1||0
300730|NCT00106353|737698|P7|STARTED|Part 1||0
300731|NCT00106353|737699|P6|STARTED|Part 1||0
300732|NCT00106353|737700|P5|STARTED|Part 1||0
300733|NCT00106353|737701|P4|STARTED|Part 1||7
300734|NCT00106353|737702|P3|STARTED|Part 1||3
300735|NCT00106353|737703|P2|STARTED|Part 1||5
300736|NCT00106353|737704|P1|STARTED|Part 1||4
300737|NCT00106249|737831|P2|NOT COMPLETED|Overall Study||2
300738|NCT00106249|737832|P1|NOT COMPLETED|Overall Study||3
300739|NCT00106249|737831|P2|COMPLETED|Overall Study||11
300740|NCT00106249|737832|P1|COMPLETED|Overall Study||11
300741|NCT00106249|737831|P2|STARTED|Overall Study||13
300742|NCT00106249|737832|P1|STARTED|Overall Study||14
300743|NCT00106184|737844|P2|NOT COMPLETED|Overall Study||2
300744|NCT00106184|737845|P1|NOT COMPLETED|Overall Study||3
300745|NCT00106184|737844|P2|COMPLETED|Overall Study||102
300746|NCT00106184|737845|P1|COMPLETED|Overall Study||93
300747|NCT00106184|737844|P2|Treated|Overall Study|104 subjects were randomized.|102
300748|NCT00106184|737845|P1|Treated|Overall Study|96 subjects were randomized.|93
300749|NCT00106184|737844|P2|STARTED|Overall Study||104
300750|NCT00106184|737845|P1|STARTED|Overall Study||96
300751|NCT00106119|737855|P2|NOT COMPLETED|Second Intervention||0
300752|NCT00106119|737856|P1|NOT COMPLETED|Second Intervention||0
300753|NCT00106119|737855|P2|COMPLETED|Second Intervention||7
300754|NCT00106119|737856|P1|COMPLETED|Second Intervention||7
300755|NCT00106119|737855|P2|STARTED|Second Intervention||7
300756|NCT00106119|737856|P1|STARTED|Second Intervention||7
300757|NCT00106119|737855|P2|NOT COMPLETED|Washout Period of 30 Days||0
300758|NCT00106119|737856|P1|NOT COMPLETED|Washout Period of 30 Days||0
300759|NCT00106119|737855|P2|COMPLETED|Washout Period of 30 Days||7
300760|NCT00106119|737856|P1|COMPLETED|Washout Period of 30 Days||7
300761|NCT00106119|737855|P2|STARTED|Washout Period of 30 Days||7
300762|NCT00106119|737856|P1|STARTED|Washout Period of 30 Days||7
300763|NCT00106119|737855|P2|NOT COMPLETED|First Intervention||0
300764|NCT00106119|737856|P1|NOT COMPLETED|First Intervention||0
300765|NCT00106119|737855|P2|COMPLETED|First Intervention||7
300766|NCT00106119|737856|P1|COMPLETED|First Intervention||7
300767|NCT00106119|737855|P2|STARTED|First Intervention||7
300768|NCT00106119|737856|P1|STARTED|First Intervention||7
300769|NCT00106106|737876|P2|NOT COMPLETED|Overall Study||4
300770|NCT00106106|737877|P1|NOT COMPLETED|Overall Study||4
300771|NCT00106106|737876|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
300772|NCT00106106|737877|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
300773|NCT00106106|737876|P2|Completed Both MRS Scans|Overall Study||15
300774|NCT00106106|737877|P1|Completed Both MRS Scans|Overall Study||18
300775|NCT00106106|737876|P2|STARTED|Overall Study||23
300776|NCT00106106|737877|P1|STARTED|Overall Study||26
300777|NCT00106080|737887|P2|NOT COMPLETED|Overall Study||27
300778|NCT00106080|737888|P1|NOT COMPLETED|Overall Study||43
300779|NCT00106080|737887|P2|COMPLETED|Overall Study||155
300780|NCT00106080|737888|P1|COMPLETED|Overall Study||151
300781|NCT00106080|737887|P2|STARTED|Overall Study||182
300782|NCT00106080|737888|P1|STARTED|Overall Study||194
300783|NCT00106028|737898|P2|NOT COMPLETED|Overall Study||12
300784|NCT00106028|737899|P1|NOT COMPLETED|Overall Study||6
300785|NCT00106028|737898|P2|COMPLETED|Overall Study|Completed Month 36|82
300786|NCT00106028|737899|P1|COMPLETED|Overall Study|Completed Month 36|43
300787|NCT00106028|737898|P2|Month 12 Completed/Started Open Label|Overall Study||87
300788|NCT00106028|737899|P1|Month 12 Completed/Started Open Label|Overall Study||49
300789|NCT00106028|737898|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
300790|NCT00106028|737899|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
300791|NCT00106002|737993|P1|NOT COMPLETED|Overall Study||2
300792|NCT00106002|737993|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
300793|NCT00106002|737993|P1|STARTED|Overall Study||37
300794|NCT00105989|738001|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
300795|NCT00105989|738002|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
300796|NCT00105989|738001|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
300797|NCT00105989|738002|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
300798|NCT00105989|738001|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
300799|NCT00105989|738002|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
300800|NCT00105989|738001|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
300801|NCT00105989|738002|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
300802|NCT00105989|738001|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
300803|NCT00105989|738002|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
300804|NCT00105989|738001|P2|STARTED|Continuation - Open Label:Week 10-34||0
300805|NCT00105989|738002|P1|STARTED|Continuation - Open Label:Week 10-34||413
300806|NCT00105989|738001|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
300807|NCT00105989|738002|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
300808|NCT00105989|738001|P2|COMPLETED|Acute - Open Label: Week 0-10||0
300809|NCT00105989|738002|P1|COMPLETED|Acute - Open Label: Week 0-10||413
300810|NCT00105989|738001|P2|STARTED|Acute - Open Label: Week 0-10||0
300811|NCT00105989|738002|P1|STARTED|Acute - Open Label: Week 0-10||514
300812|NCT00105586|738118|P2|NOT COMPLETED|Overall Study||16
300813|NCT00105586|738119|P1|NOT COMPLETED|Overall Study||17
300814|NCT00105586|738118|P2|COMPLETED|Overall Study||69
300815|NCT00105586|738119|P1|COMPLETED|Overall Study||75
300816|NCT00105586|738118|P2|STARTED|Overall Study||85
300817|NCT00105586|738119|P1|STARTED|Overall Study||92
300818|NCT00105560|738127|P1|NOT COMPLETED|Overall Study||1
300819|NCT00105560|738127|P1|COMPLETED|Overall Study||58
300820|NCT00105560|738127|P1|STARTED|Overall Study||59
300821|NCT00105534|738149|P2|NOT COMPLETED|Overall Study||33
300822|NCT00105534|738150|P1|NOT COMPLETED|Overall Study||22
300823|NCT00105534|738149|P2|COMPLETED|Overall Study||317
300824|NCT00105534|738150|P1|COMPLETED|Overall Study||313
300825|NCT00105534|738149|P2|STARTED|Overall Study||350
300826|NCT00105534|738150|P1|STARTED|Overall Study||335
300827|NCT00105521|738162|P4|NOT COMPLETED|Overall Study||17
300828|NCT00105521|738163|P3|NOT COMPLETED|Overall Study||17
300829|NCT00105521|738164|P2|NOT COMPLETED|Overall Study||11
300830|NCT00105521|738165|P1|NOT COMPLETED|Overall Study||15
300831|NCT00105521|738162|P4|COMPLETED|Overall Study||85
300832|NCT00105521|738163|P3|COMPLETED|Overall Study||80
300833|NCT00105521|738164|P2|COMPLETED|Overall Study||90
300834|NCT00105521|738165|P1|COMPLETED|Overall Study||83
300835|NCT00105521|738162|P4|STARTED|Overall Study||102
300836|NCT00105521|738163|P3|STARTED|Overall Study||97
300837|NCT00105521|738164|P2|STARTED|Overall Study||101
300838|NCT00105521|738165|P1|STARTED|Overall Study||98
300839|NCT00105482|738189|P2|NOT COMPLETED|Overall Study||55
300840|NCT00105482|738190|P1|NOT COMPLETED|Overall Study||59
300841|NCT00105482|738189|P2|COMPLETED|Overall Study||30
300842|NCT00105482|738190|P1|COMPLETED|Overall Study||28
300843|NCT00105482|738189|P2|STARTED|Overall Study||85
300844|NCT00105482|738190|P1|STARTED|Overall Study||87
300845|NCT00105469|738206|P2|NOT COMPLETED|Overall Study||11
300846|NCT00105469|738207|P1|NOT COMPLETED|Overall Study||22
300847|NCT00105469|738206|P2|COMPLETED|Overall Study||367
300848|NCT00105469|738207|P1|COMPLETED|Overall Study||343
300849|NCT00105469|738206|P2|STARTED|Overall Study||378
300850|NCT00105469|738207|P1|STARTED|Overall Study||365
300851|NCT00105443|738217|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
300852|NCT00105443|738218|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
300853|NCT00105443|738219|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
300854|NCT00105443|738220|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
300855|NCT00105443|738217|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
300856|NCT00105443|738218|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
300857|NCT00105443|738219|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
300858|NCT00105443|738220|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
300859|NCT00105443|738217|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
300860|NCT00105443|738218|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
300861|NCT00105443|738219|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
300862|NCT00105443|738220|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
300863|NCT00105443|738217|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
300864|NCT00105443|738218|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
300865|NCT00105443|738219|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
300866|NCT00105443|738220|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
300867|NCT00105443|738217|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
300868|NCT00105443|738218|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
300869|NCT00105443|738219|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
300870|NCT00105443|738220|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
300871|NCT00105443|738217|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
300872|NCT00105443|738218|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
300873|NCT00105443|738219|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
300874|NCT00105443|738220|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
300875|NCT00105443|738217|P4|NOT COMPLETED|Double-Blind Treatment||0
300876|NCT00105443|738218|P3|NOT COMPLETED|Double-Blind Treatment||11
300877|NCT00105443|738219|P2|NOT COMPLETED|Double-Blind Treatment||0
300878|NCT00105443|738220|P1|NOT COMPLETED|Double-Blind Treatment||14
300879|NCT00105443|738217|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
300880|NCT00105443|738218|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
300881|NCT00105443|738219|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
300882|NCT00105443|738220|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
300883|NCT00105443|738217|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
300884|NCT00105443|738218|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
300885|NCT00105443|738219|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
300886|NCT00105443|738220|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
300887|NCT00105443|738217|P4|STARTED|Double-Blind Treatment||47
300888|NCT00105443|738218|P3|STARTED|Double-Blind Treatment||256
300889|NCT00105443|738219|P2|STARTED|Double-Blind Treatment||57
300890|NCT00105443|738220|P1|STARTED|Double-Blind Treatment||242
300891|NCT00105235|738247|P1|NOT COMPLETED|Overall Study||7
300892|NCT00105235|738247|P1|COMPLETED|Overall Study||20
300893|NCT00105235|738247|P1|STARTED|Overall Study||27
300894|NCT00105196|738260|P2|NOT COMPLETED|Overall Study||23
300895|NCT00105196|738261|P1|NOT COMPLETED|Overall Study||30
300896|NCT00105196|738260|P2|COMPLETED|Overall Study||149
300897|NCT00105196|738261|P1|COMPLETED|Overall Study||147
300898|NCT00105196|738260|P2|STARTED|Overall Study||172
300899|NCT00105196|738261|P1|STARTED|Overall Study||177
300900|NCT00105183|738284|P3|NOT COMPLETED|Overall Study||23
300901|NCT00105183|738285|P2|NOT COMPLETED|Overall Study||19
300902|NCT00105183|738286|P1|NOT COMPLETED|Overall Study||22
300903|NCT00105183|738284|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
300904|NCT00105183|738285|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
300905|NCT00105183|738286|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
300906|NCT00105183|738284|P3|STARTED|Overall Study|Randomized|62
300907|NCT00105183|738285|P2|STARTED|Overall Study|Randomized|79
300908|NCT00105183|738286|P1|STARTED|Overall Study|Randomized|82
300909|NCT00105157|738322|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
300910|NCT00105157|738323|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
300911|NCT00105157|738324|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
300912|NCT00105157|738325|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
300913|NCT00105157|738322|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
300914|NCT00105157|738323|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
300915|NCT00105157|738324|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
300916|NCT00105157|738325|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
300917|NCT00105157|738322|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
300918|NCT00105157|738323|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
300919|NCT00105157|738324|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
300920|NCT00105157|738325|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
300921|NCT00105157|738322|P4|NOT COMPLETED|Open-Label Continuation of DB||1
300922|NCT00105157|738323|P3|NOT COMPLETED|Open-Label Continuation of DB||9
300923|NCT00105157|738324|P2|NOT COMPLETED|Open-Label Continuation of DB||10
300924|NCT00105157|738325|P1|NOT COMPLETED|Open-Label Continuation of DB||7
300925|NCT00105157|738322|P4|COMPLETED|Open-Label Continuation of DB||5
300926|NCT00105157|738323|P3|COMPLETED|Open-Label Continuation of DB||24
300927|NCT00105157|738324|P2|COMPLETED|Open-Label Continuation of DB||21
300928|NCT00105157|738325|P1|COMPLETED|Open-Label Continuation of DB||23
300929|NCT00105157|738322|P4|STARTED|Open-Label Continuation of DB||6
300930|NCT00105157|738323|P3|STARTED|Open-Label Continuation of DB||33
300931|NCT00105157|738324|P2|STARTED|Open-Label Continuation of DB||31
300932|NCT00105157|738325|P1|STARTED|Open-Label Continuation of DB||30
300933|NCT00105157|738322|P4|NOT COMPLETED|Double-Blind (DB)||39
300934|NCT00105157|738323|P3|NOT COMPLETED|Double-Blind (DB)||12
300935|NCT00105157|738324|P2|NOT COMPLETED|Double-Blind (DB)||14
300936|NCT00105157|738325|P1|NOT COMPLETED|Double-Blind (DB)||14
300937|NCT00105157|738322|P4|COMPLETED|Double-Blind (DB)||6
300938|NCT00105157|738323|P3|COMPLETED|Double-Blind (DB)||33
300939|NCT00105157|738324|P2|COMPLETED|Double-Blind (DB)||31
300940|NCT00105157|738325|P1|COMPLETED|Double-Blind (DB)||30
300941|NCT00105157|738322|P4|Treated|Double-Blind (DB)||45
300942|NCT00105157|738323|P3|Treated|Double-Blind (DB)||45
300943|NCT00105157|738324|P2|Treated|Double-Blind (DB)||45
300944|NCT00105157|738325|P1|Treated|Double-Blind (DB)||43
300945|NCT00105157|738322|P4|STARTED|Double-Blind (DB)||45
300946|NCT00105157|738323|P3|STARTED|Double-Blind (DB)||45
300947|NCT00105157|738324|P2|STARTED|Double-Blind (DB)||45
300948|NCT00105157|738325|P1|STARTED|Double-Blind (DB)||44
300949|NCT00105079|738519|P2|NOT COMPLETED|Overall Study||35
300950|NCT00105079|738520|P1|NOT COMPLETED|Overall Study||39
300951|NCT00105079|738519|P2|COMPLETED|Overall Study||135
300952|NCT00105079|738520|P1|COMPLETED|Overall Study||128
300953|NCT00105079|738519|P2|Safety Population|Overall Study||168
300954|NCT00105079|738520|P1|Safety Population|Overall Study||163
300955|NCT00105079|738519|P2|STARTED|Overall Study||170
300956|NCT00105079|738520|P1|STARTED|Overall Study||167
300957|NCT00105066|738538|P2|NOT COMPLETED|Overall Study||5
300958|NCT00105066|738539|P1|NOT COMPLETED|Overall Study||2
300959|NCT00105066|738538|P2|COMPLETED|Overall Study||45
300960|NCT00105066|738539|P1|COMPLETED|Overall Study||25
300961|NCT00105066|738538|P2|STARTED|Overall Study||50
300962|NCT00105066|738539|P1|STARTED|Overall Study||27
300963|NCT00105027|738555|P6|NOT COMPLETED|Overall Study||13
300964|NCT00105027|738556|P5|NOT COMPLETED|Overall Study||15
300965|NCT00105027|738557|P4|NOT COMPLETED|Overall Study||16
300966|NCT00105027|738558|P3|NOT COMPLETED|Overall Study||9
300967|NCT00105027|738559|P2|NOT COMPLETED|Overall Study||9
300968|NCT00105027|738560|P1|NOT COMPLETED|Overall Study||15
300969|NCT00105027|738555|P6|COMPLETED|Overall Study||125
300970|NCT00105027|738556|P5|COMPLETED|Overall Study||121
300971|NCT00105027|738557|P4|COMPLETED|Overall Study||121
300972|NCT00105027|738558|P3|COMPLETED|Overall Study||82
300973|NCT00105027|738559|P2|COMPLETED|Overall Study||83
300974|NCT00105027|738560|P1|COMPLETED|Overall Study||73
300975|NCT00105027|738555|P6|STARTED|Overall Study||138
300976|NCT00105027|738556|P5|STARTED|Overall Study||136
300977|NCT00105027|738557|P4|STARTED|Overall Study||137
300978|NCT00105027|738558|P3|STARTED|Overall Study||91
300979|NCT00105027|738559|P2|STARTED|Overall Study||92
300980|NCT00105027|738560|P1|STARTED|Overall Study||88
300981|NCT00105001|738577|P3|NOT COMPLETED|Overall Study||0
300982|NCT00105001|738578|P2|NOT COMPLETED|Overall Study||0
300983|NCT00105001|738579|P1|NOT COMPLETED|Overall Study||0
300984|NCT00105001|738577|P3|COMPLETED|Overall Study||69
300985|NCT00105001|738578|P2|COMPLETED|Overall Study||71
300986|NCT00105001|738579|P1|COMPLETED|Overall Study||70
300987|NCT00105001|738577|P3|STARTED|Overall Study||69
300988|NCT00105001|738578|P2|STARTED|Overall Study||71
300989|NCT00105001|738579|P1|STARTED|Overall Study||70
300990|NCT00104884|738599|P1|NOT COMPLETED|Overall Study||4
300991|NCT00104884|738599|P1|COMPLETED|Overall Study||0
300992|NCT00104884|738599|P1|STARTED|Overall Study||4
300993|NCT00104871|738603|P1|NOT COMPLETED|Overall Study||1
300994|NCT00104871|738603|P1|COMPLETED|Overall Study||21
300995|NCT00104871|738603|P1|STARTED|Overall Study||22
300996|NCT00104728|738608|P1|NOT COMPLETED|Overall Study||19
300997|NCT00104728|738608|P1|COMPLETED|Overall Study||23
300998|NCT00104728|738608|P1|STARTED|Overall Study|42 consented on study|42
300999|NCT00104650|738616|P3|NOT COMPLETED|Follow-up Period||10
301000|NCT00104650|738617|P2|NOT COMPLETED|Follow-up Period||13
301001|NCT00104650|738618|P1|NOT COMPLETED|Follow-up Period||11
301002|NCT00104650|738616|P3|COMPLETED|Follow-up Period||18
301003|NCT00104650|738617|P2|COMPLETED|Follow-up Period||12
301004|NCT00104650|738618|P1|COMPLETED|Follow-up Period||14
301005|NCT00104650|738616|P3|STARTED|Follow-up Period||28
301006|NCT00104650|738617|P2|STARTED|Follow-up Period||25
301007|NCT00104650|738618|P1|STARTED|Follow-up Period||25
301008|NCT00104650|738616|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
301009|NCT00104650|738617|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
301010|NCT00104650|738618|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
301011|NCT00104650|738616|P3|COMPLETED|Treatment Period (25 Weeks)||28
301012|NCT00104650|738617|P2|COMPLETED|Treatment Period (25 Weeks)||25
301013|NCT00104650|738618|P1|COMPLETED|Treatment Period (25 Weeks)||25
301014|NCT00104650|738616|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
301015|NCT00104650|738617|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
301016|NCT00104650|738618|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
301017|NCT00104650|738616|P3|STARTED|Treatment Period (25 Weeks)||38
301018|NCT00104650|738617|P2|STARTED|Treatment Period (25 Weeks)||36
301019|NCT00104650|738618|P1|STARTED|Treatment Period (25 Weeks)||37
301020|NCT00104637|738650|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
301021|NCT00104637|738651|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
301022|NCT00104637|738650|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
301023|NCT00104637|738651|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
301024|NCT00104637|738650|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
301025|NCT00104637|738651|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
301026|NCT00104637|738650|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
301027|NCT00104637|738651|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
301028|NCT00104637|738650|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
301029|NCT00104637|738651|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
301030|NCT00104637|738650|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
301031|NCT00104637|738651|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
301032|NCT00104637|738650|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
301033|NCT00104637|738651|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
301034|NCT00104637|738650|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
301035|NCT00104637|738651|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
301036|NCT00104637|738650|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
301037|NCT00104637|738651|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
301038|NCT00104572|738680|P3|NOT COMPLETED|Overall Study||0
301039|NCT00104572|738681|P2|NOT COMPLETED|Overall Study||3
301040|NCT00104572|738682|P1|NOT COMPLETED|Overall Study||3
301041|NCT00104572|738680|P3|COMPLETED|Overall Study||9
301042|NCT00104572|738681|P2|COMPLETED|Overall Study||10
301043|NCT00104572|738682|P1|COMPLETED|Overall Study||10
301044|NCT00104572|738680|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
301045|NCT00104572|738681|P2|STARTED|Overall Study|These are the analysed subjects|13
301046|NCT00104572|738682|P1|STARTED|Overall Study|These are the analysed subjects|13
301047|NCT00104520|738692|P2|NOT COMPLETED|Overall Study||71
301048|NCT00104520|738693|P1|NOT COMPLETED|Overall Study||50
301049|NCT00104520|738692|P2|COMPLETED|Overall Study||64
301050|NCT00104520|738693|P1|COMPLETED|Overall Study||26
301051|NCT00104520|738692|P2|STARTED|Overall Study||135
301052|NCT00104520|738693|P1|STARTED|Overall Study||76
301053|NCT00104416|738713|P5|NOT COMPLETED|Continuation Phase||5
301054|NCT00104416|738714|P4|NOT COMPLETED|Continuation Phase||2
301055|NCT00104416|738715|P3|NOT COMPLETED|Continuation Phase||6
301056|NCT00104416|738716|P2|NOT COMPLETED|Continuation Phase||0
301057|NCT00104416|738717|P1|NOT COMPLETED|Continuation Phase||0
301058|NCT00104416|738713|P5|COMPLETED|Continuation Phase||27
301059|NCT00104416|738714|P4|COMPLETED|Continuation Phase||65
301060|NCT00104416|738715|P3|COMPLETED|Continuation Phase||63
301061|NCT00104416|738716|P2|COMPLETED|Continuation Phase||0
301062|NCT00104416|738717|P1|COMPLETED|Continuation Phase||0
301063|NCT00104416|738713|P5|STARTED|Continuation Phase||32
301064|NCT00104416|738714|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
301065|NCT00104416|738715|P3|STARTED|Continuation Phase||69
301066|NCT00104416|738716|P2|STARTED|Continuation Phase||0
301067|NCT00104416|738717|P1|STARTED|Continuation Phase||0
301068|NCT00104416|738713|P5|NOT COMPLETED|Double-Blind Phase||0
301069|NCT00104416|738714|P4|NOT COMPLETED|Double-Blind Phase||0
301070|NCT00104416|738715|P3|NOT COMPLETED|Double-Blind Phase||0
301071|NCT00104416|738716|P2|NOT COMPLETED|Double-Blind Phase||10
301072|NCT00104416|738717|P1|NOT COMPLETED|Double-Blind Phase||8
301073|NCT00104416|738713|P5|COMPLETED|Double-Blind Phase||0
301074|NCT00104416|738714|P4|COMPLETED|Double-Blind Phase||0
301075|NCT00104416|738715|P3|COMPLETED|Double-Blind Phase||0
301076|NCT00104416|738716|P2|COMPLETED|Double-Blind Phase||66
301077|NCT00104416|738717|P1|COMPLETED|Double-Blind Phase||69
301078|NCT00104416|738713|P5|STARTED|Double-Blind Phase||0
301079|NCT00104416|738714|P4|STARTED|Double-Blind Phase||0
301080|NCT00104416|738715|P3|STARTED|Double-Blind Phase||0
301081|NCT00104416|738716|P2|STARTED|Double-Blind Phase||76
301082|NCT00104416|738717|P1|STARTED|Double-Blind Phase||77
301083|NCT00104299|738762|P2|NOT COMPLETED|Overall Study||10
301084|NCT00104299|738763|P1|NOT COMPLETED|Overall Study||9
301085|NCT00104299|738762|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
301086|NCT00104299|738763|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
301087|NCT00104299|738762|P2|STARTED|Overall Study||98
301088|NCT00104299|738763|P1|STARTED|Overall Study||99
301089|NCT00104247|738785|P2|NOT COMPLETED|Overall Study||1
301090|NCT00104247|738786|P1|NOT COMPLETED|Overall Study||1
301091|NCT00104247|738785|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
301092|NCT00104247|738786|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
301093|NCT00104247|738785|P2|STARTED|Overall Study||47
301094|NCT00104247|738786|P1|STARTED|Overall Study||42
301095|NCT00104234|738794|P2|NOT COMPLETED|Overall Study||1
301096|NCT00104234|738795|P1|NOT COMPLETED|Overall Study||0
301097|NCT00104234|738794|P2|COMPLETED|Overall Study||19
301098|NCT00104234|738795|P1|COMPLETED|Overall Study||19
301099|NCT00104234|738794|P2|STARTED|Overall Study||20
301100|NCT00104234|738795|P1|STARTED|Overall Study||19
301101|NCT00104104|738805|P2|NOT COMPLETED|Overall Study||72
301102|NCT00104104|738806|P1|NOT COMPLETED|Overall Study||75
301103|NCT00104104|738805|P2|COMPLETED|Overall Study||17
301104|NCT00104104|738806|P1|COMPLETED|Overall Study||15
301105|NCT00104104|738805|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
301106|NCT00104104|738806|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
301107|NCT00104104|738805|P2|Safety Population (Including Site 74)|Overall Study||88
301108|NCT00104104|738806|P1|Safety Population (Including Site 74)|Overall Study||88
301109|NCT00104104|738805|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
301110|NCT00104104|738806|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
301111|NCT00104052|738820|P1|NOT COMPLETED|Overall Study||29
301112|NCT00104052|738820|P1|COMPLETED|Overall Study||78
301113|NCT00104052|738820|P1|STARTED|Overall Study||107
301114|NCT00103857|738831|P7|NOT COMPLETED|50-Week Extension Study||0
301115|NCT00103857|738832|P6|NOT COMPLETED|50-Week Extension Study||20
301116|NCT00103857|738833|P5|NOT COMPLETED|50-Week Extension Study||21
301117|NCT00103857|738834|P4|NOT COMPLETED|50-Week Extension Study||36
301118|NCT00103857|738835|P3|NOT COMPLETED|50-Week Extension Study||26
301119|NCT00103857|738836|P2|NOT COMPLETED|50-Week Extension Study||27
301120|NCT00103857|738837|P1|NOT COMPLETED|50-Week Extension Study||38
301121|NCT00103857|738831|P7|COMPLETED|50-Week Extension Study||0
301122|NCT00103857|738832|P6|COMPLETED|50-Week Extension Study||78
301123|NCT00103857|738833|P5|COMPLETED|50-Week Extension Study||101
301124|NCT00103857|738834|P4|COMPLETED|50-Week Extension Study||98
301125|NCT00103857|738835|P3|COMPLETED|50-Week Extension Study||95
301126|NCT00103857|738836|P2|COMPLETED|50-Week Extension Study||80
301127|NCT00103857|738837|P1|COMPLETED|50-Week Extension Study||65
301128|NCT00103857|738831|P7|STARTED|50-Week Extension Study||0
301129|NCT00103857|738832|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
301130|NCT00103857|738833|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
301131|NCT00103857|738834|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
301132|NCT00103857|738835|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
301133|NCT00103857|738836|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
301134|NCT00103857|738837|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
301135|NCT00103857|738831|P7|NOT COMPLETED|54-Week Base Study||38
301136|NCT00103857|738832|P6|NOT COMPLETED|54-Week Base Study||61
301137|NCT00103857|738833|P5|NOT COMPLETED|54-Week Base Study||41
301138|NCT00103857|738834|P4|NOT COMPLETED|54-Week Base Study||42
301139|NCT00103857|738835|P3|NOT COMPLETED|54-Week Base Study||47
301140|NCT00103857|738836|P2|NOT COMPLETED|54-Week Base Study||56
301141|NCT00103857|738837|P1|NOT COMPLETED|54-Week Base Study||57
301142|NCT00103857|738831|P7|COMPLETED|54-Week Base Study||79
301143|NCT00103857|738832|P6|COMPLETED|54-Week Base Study||115
301144|NCT00103857|738833|P5|COMPLETED|54-Week Base Study||141
301145|NCT00103857|738834|P4|COMPLETED|54-Week Base Study||148
301146|NCT00103857|738835|P3|COMPLETED|54-Week Base Study||135
301147|NCT00103857|738836|P2|COMPLETED|54-Week Base Study||126
301148|NCT00103857|738837|P1|COMPLETED|54-Week Base Study||122
301149|NCT00103857|738831|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
301150|NCT00103857|738832|P6|STARTED|54-Week Base Study||176
301151|NCT00103857|738833|P5|STARTED|54-Week Base Study||182
301152|NCT00103857|738834|P4|STARTED|54-Week Base Study||190
301153|NCT00103857|738835|P3|STARTED|54-Week Base Study||182
301154|NCT00103857|738836|P2|STARTED|54-Week Base Study||182
301155|NCT00103857|738837|P1|STARTED|54-Week Base Study||179
301156|NCT00103844|738902|P2|NOT COMPLETED|Overall Study||0
301157|NCT00103844|738903|P1|NOT COMPLETED|Overall Study||0
301158|NCT00103844|738902|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
301159|NCT00103844|738903|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
301160|NCT00103844|738902|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
301161|NCT00103844|738903|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
301162|NCT00103844|738902|P2|STARTED|Overall Study||49
301163|NCT00103844|738903|P1|STARTED|Overall Study||101
301164|NCT00103740|738936|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
301165|NCT00103740|738937|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
301166|NCT00103740|738936|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
301167|NCT00103740|738937|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
301168|NCT00103740|738936|P2|STARTED|Period 2 - Extended Observation Period||63
301169|NCT00103740|738937|P1|STARTED|Period 2 - Extended Observation Period||78
301170|NCT00103740|738936|P2|NOT COMPLETED|Period 1 - Core||4
301171|NCT00103740|738937|P1|NOT COMPLETED|Period 1 - Core||7
301172|NCT00103740|738936|P2|COMPLETED|Period 1 - Core||89
301173|NCT00103740|738937|P1|COMPLETED|Period 1 - Core||85
301174|NCT00103740|738936|P2|STARTED|Period 1 - Core||93
301175|NCT00103740|738937|P1|STARTED|Period 1 - Core||92
301176|NCT00103662|738965|P2|NOT COMPLETED|Overall Study||33
301177|NCT00103662|738966|P1|NOT COMPLETED|Overall Study||19
301178|NCT00103662|738965|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
301179|NCT00103662|738966|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
301180|NCT00103662|738965|P2|STARTED|Overall Study||154
301181|NCT00103662|738966|P1|STARTED|Overall Study||148
301182|NCT00103610|738992|P2|NOT COMPLETED|Overall Study||80
301183|NCT00103610|738993|P1|NOT COMPLETED|Overall Study||38
301184|NCT00103610|738992|P2|COMPLETED|Overall Study||68
301185|NCT00103610|738993|P1|COMPLETED|Overall Study||112
301186|NCT00103610|738992|P2|STARTED|Overall Study||148
301187|NCT00103610|738993|P1|STARTED|Overall Study||150
301188|NCT00103506|739017|P2|NOT COMPLETED|Overall Study||324
301189|NCT00103506|739018|P1|NOT COMPLETED|Overall Study||322
301190|NCT00103506|739017|P2|COMPLETED|Overall Study||0
301191|NCT00103506|739018|P1|COMPLETED|Overall Study||0
301192|NCT00103506|739017|P2|STARTED|Overall Study||324
301193|NCT00103506|739018|P1|STARTED|Overall Study||322
301194|NCT00103311|739030|P2|NOT COMPLETED|Overall Study||1
301195|NCT00103311|739031|P1|NOT COMPLETED|Overall Study||4
301196|NCT00103311|739030|P2|COMPLETED|Overall Study||30
301197|NCT00103311|739031|P1|COMPLETED|Overall Study||29
301198|NCT00103311|739030|P2|STARTED|Overall Study||31
301199|NCT00103311|739031|P1|STARTED|Overall Study||33
301200|NCT00103259|739043|P2|NOT COMPLETED|Overall Study||12
301201|NCT00103259|739044|P1|NOT COMPLETED|Overall Study||12
301202|NCT00103259|739043|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
301203|NCT00103259|739044|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
301204|NCT00103259|739043|P2|Eligible Patients Who Cross Over|Overall Study||10
301205|NCT00103259|739044|P1|Eligible Patients Who Cross Over|Overall Study||0
301206|NCT00103259|739043|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
301207|NCT00103259|739044|P1|Cross Over to the Other Arm|Overall Study||0
301208|NCT00103259|739043|P2|Eligible and Treated|Overall Study||38
301209|NCT00103259|739044|P1|Eligible and Treated|Overall Study||23
301210|NCT00103259|739043|P2|Treated|Overall Study||41
301211|NCT00103259|739044|P1|Treated|Overall Study||23
301212|NCT00103259|739043|P2|Eligible|Overall Study||41
301213|NCT00103259|739044|P1|Eligible|Overall Study||27
301214|NCT00103259|739043|P2|STARTED|Overall Study||44
301215|NCT00103259|739044|P1|STARTED|Overall Study||27
301216|NCT00103207|739056|P1|NOT COMPLETED|Overall Study||38
301217|NCT00103207|739056|P1|COMPLETED|Overall Study||34
301218|NCT00103207|739056|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
301219|NCT00103207|739056|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
301220|NCT00103207|739056|P1|STARTED|Overall Study||72
301221|NCT00103194|739066|P1|NOT COMPLETED|Overall Study||31
301222|NCT00103194|739066|P1|COMPLETED|Overall Study||18
301223|NCT00103194|739066|P1|Eligible and Treated|Overall Study||35
301224|NCT00103194|739066|P1|Eligible|Overall Study||35
301225|NCT00103194|739066|P1|Treated|Overall Study||49
301226|NCT00103194|739066|P1|STARTED|Overall Study||49
301227|NCT00103142|739075|P2|NOT COMPLETED|Overall Study||1
301228|NCT00103142|739076|P1|NOT COMPLETED|Overall Study||3
301229|NCT00103142|739075|P2|COMPLETED|Overall Study||36
301230|NCT00103142|739076|P1|COMPLETED|Overall Study||33
301231|NCT00103142|739075|P2|STARTED|Overall Study||37
301232|NCT00103142|739076|P1|STARTED|Overall Study||36
301233|NCT00103116|739084|P1|NOT COMPLETED|Overall Study||0
301234|NCT00103116|739084|P1|COMPLETED|Overall Study||32
301235|NCT00103116|739084|P1|STARTED|Overall Study||32
301236|NCT00103012|739092|P3|NOT COMPLETED|Overall Study||4
301237|NCT00103012|739093|P2|NOT COMPLETED|Overall Study||1
301238|NCT00103012|739094|P1|NOT COMPLETED|Overall Study||3
301239|NCT00103012|739092|P3|COMPLETED|Overall Study||12
301240|NCT00103012|739093|P2|COMPLETED|Overall Study||13
301241|NCT00103012|739094|P1|COMPLETED|Overall Study||14
301242|NCT00103012|739092|P3|STARTED|Overall Study||16
301243|NCT00103012|739093|P2|STARTED|Overall Study||14
301244|NCT00103012|739094|P1|STARTED|Overall Study||17
301245|NCT00102804|739104|P2|NOT COMPLETED|Overall Study||222
301246|NCT00102804|739105|P1|NOT COMPLETED|Overall Study||441
301247|NCT00102804|739104|P2|COMPLETED|Overall Study||0
301248|NCT00102804|739105|P1|COMPLETED|Overall Study||0
301249|NCT00102804|739104|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
301250|NCT00102804|739105|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
301251|NCT00102804|739104|P2|STARTED|Overall Study||222
301252|NCT00102804|739105|P1|STARTED|Overall Study||441
301253|NCT00102687|739126|P5|NOT COMPLETED|Maintenance Period||13
301254|NCT00102687|739127|P4|NOT COMPLETED|Maintenance Period||10
301255|NCT00102687|739128|P3|NOT COMPLETED|Maintenance Period||6
301256|NCT00102687|739129|P2|NOT COMPLETED|Maintenance Period||4
301257|NCT00102687|739130|P1|NOT COMPLETED|Maintenance Period||7
301258|NCT00102687|739126|P5|COMPLETED|Maintenance Period||8
301259|NCT00102687|739127|P4|COMPLETED|Maintenance Period||12
301260|NCT00102687|739128|P3|COMPLETED|Maintenance Period||2
301261|NCT00102687|739129|P2|COMPLETED|Maintenance Period||2
301262|NCT00102687|739130|P1|COMPLETED|Maintenance Period||6
301263|NCT00102687|739126|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
301264|NCT00102687|739127|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
301265|NCT00102687|739128|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
301266|NCT00102687|739129|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
301267|NCT00102687|739130|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
301268|NCT00102687|739126|P5|NOT COMPLETED|Initial Period||0
301269|NCT00102687|739127|P4|NOT COMPLETED|Initial Period||0
301270|NCT00102687|739128|P3|NOT COMPLETED|Initial Period||26
301271|NCT00102687|739129|P2|NOT COMPLETED|Initial Period||28
301272|NCT00102687|739130|P1|NOT COMPLETED|Initial Period||18
301273|NCT00102687|739126|P5|COMPLETED|Initial Period||0
301274|NCT00102687|739127|P4|COMPLETED|Initial Period||0
301275|NCT00102687|739128|P3|COMPLETED|Initial Period||25
301276|NCT00102687|739129|P2|COMPLETED|Initial Period||22
301277|NCT00102687|739130|P1|COMPLETED|Initial Period||32
301278|NCT00102687|739126|P5|STARTED|Initial Period||0
301279|NCT00102687|739127|P4|STARTED|Initial Period||0
301280|NCT00102687|739128|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
301281|NCT00102687|739129|P2|STARTED|Initial Period||50
301282|NCT00102687|739130|P1|STARTED|Initial Period||50
301283|NCT00102596|739194|P2|NOT COMPLETED|Part C||0
301284|NCT00102596|739195|P1|NOT COMPLETED|Part C||0
301285|NCT00102596|739194|P2|COMPLETED|Part C||2
301286|NCT00102596|739195|P1|COMPLETED|Part C||0
301287|NCT00102596|739194|P2|STARTED|Part C|Only 2 patients participated in Part C|2
301288|NCT00102596|739195|P1|STARTED|Part C||0
301289|NCT00102596|739194|P2|NOT COMPLETED|Part B||0
301290|NCT00102596|739195|P1|NOT COMPLETED|Part B||0
301291|NCT00102596|739194|P2|COMPLETED|Part B||10
301292|NCT00102596|739195|P1|COMPLETED|Part B||0
301293|NCT00102596|739194|P2|STARTED|Part B||10
301294|NCT00102596|739195|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
301295|NCT00102596|739194|P2|NOT COMPLETED|Part A||0
301296|NCT00102596|739195|P1|NOT COMPLETED|Part A||7
301297|NCT00102596|739194|P2|COMPLETED|Part A||0
301298|NCT00102596|739195|P1|COMPLETED|Part A||4
301299|NCT00102596|739194|P2|Participants Assigned Treatment|Part A||0
301300|NCT00102596|739195|P1|Participants Assigned Treatment|Part A||5
301301|NCT00102596|739194|P2|STARTED|Part A||0
301302|NCT00102596|739195|P1|STARTED|Part A||11
301303|NCT00102531|739206|P2|NOT COMPLETED|Overall Study||11
301304|NCT00102531|739207|P1|NOT COMPLETED|Overall Study||5
301305|NCT00102531|739206|P2|COMPLETED|Overall Study||1
301306|NCT00102531|739207|P1|COMPLETED|Overall Study||2
301307|NCT00102531|739206|P2|STARTED|Overall Study||12
301308|NCT00102531|739207|P1|STARTED|Overall Study||7
301309|NCT00102518|739213|P1|NOT COMPLETED|Overall Study||87
301310|NCT00102518|739213|P1|COMPLETED|Overall Study||238
301311|NCT00102518|739213|P1|STARTED|Overall Study||325
301312|NCT00102440|739222|P3|NOT COMPLETED|Overall Study||66
301313|NCT00102440|739223|P2|NOT COMPLETED|Overall Study||98
301314|NCT00102440|739224|P1|NOT COMPLETED|Overall Study||88
301315|NCT00102440|739222|P3|COMPLETED|Overall Study||187
301316|NCT00102440|739223|P2|COMPLETED|Overall Study||153
301317|NCT00102440|739224|P1|COMPLETED|Overall Study||168
301318|NCT00102440|739222|P3|STARTED|Overall Study||253
301319|NCT00102440|739223|P2|STARTED|Overall Study||251
301320|NCT00102440|739224|P1|STARTED|Overall Study||256
301321|NCT00102063|739274|P3|NOT COMPLETED|Overall Study||10
301322|NCT00102063|739275|P2|NOT COMPLETED|Overall Study||18
301323|NCT00102063|739276|P1|NOT COMPLETED|Overall Study||16
301324|NCT00102063|739274|P3|COMPLETED|Overall Study||90
301325|NCT00102063|739275|P2|COMPLETED|Overall Study||84
301326|NCT00102063|739276|P1|COMPLETED|Overall Study||84
301327|NCT00102063|739274|P3|STARTED|Overall Study||100
301328|NCT00102063|739275|P2|STARTED|Overall Study||102
301329|NCT00102063|739276|P1|STARTED|Overall Study||100
301330|NCT00101933|739307|P2|NOT COMPLETED|Overall Study||0
301331|NCT00101933|739308|P1|NOT COMPLETED|Overall Study||0
301332|NCT00101933|739307|P2|COMPLETED|Overall Study||55
301333|NCT00101933|739308|P1|COMPLETED|Overall Study||54
301334|NCT00101933|739307|P2|STARTED|Overall Study||55
301335|NCT00101933|739308|P1|STARTED|Overall Study||54
301336|NCT00101907|739334|P6|NOT COMPLETED|Overall Study||0
301337|NCT00101907|739335|P5|NOT COMPLETED|Overall Study||5
301338|NCT00101907|739336|P4|NOT COMPLETED|Overall Study||1
301339|NCT00101907|739337|P3|NOT COMPLETED|Overall Study||1
301340|NCT00101907|739338|P2|NOT COMPLETED|Overall Study||1
301341|NCT00101907|739339|P1|NOT COMPLETED|Overall Study||2
301342|NCT00101907|739334|P6|COMPLETED|Overall Study||2
301343|NCT00101907|739335|P5|COMPLETED|Overall Study||6
301344|NCT00101907|739336|P4|COMPLETED|Overall Study||5
301345|NCT00101907|739337|P3|COMPLETED|Overall Study||5
301346|NCT00101907|739338|P2|COMPLETED|Overall Study||7
301347|NCT00101907|739339|P1|COMPLETED|Overall Study||6
301348|NCT00101907|739334|P6|STARTED|Overall Study||2
301349|NCT00101907|739335|P5|STARTED|Overall Study||11
301350|NCT00101907|739336|P4|STARTED|Overall Study||6
301351|NCT00101907|739337|P3|STARTED|Overall Study||6
301352|NCT00101907|739338|P2|STARTED|Overall Study||8
301353|NCT00101907|739339|P1|STARTED|Overall Study||8
301354|NCT00101868|739381|P2|NOT COMPLETED|Overall Study||32
301355|NCT00101868|739382|P1|NOT COMPLETED|Overall Study||29
301356|NCT00101868|739381|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
301357|NCT00101868|739382|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
301358|NCT00101868|739381|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
301359|NCT00101868|739382|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
301360|NCT00101816|739394|P2|NOT COMPLETED|Overall Study||0
301361|NCT00101816|739395|P1|NOT COMPLETED|Overall Study||0
301362|NCT00101816|739394|P2|COMPLETED|Overall Study||99
301363|NCT00101816|739395|P1|COMPLETED|Overall Study||10
301364|NCT00101816|739394|P2|STARTED|Overall Study||99
301365|NCT00101816|739395|P1|STARTED|Overall Study||10
301366|NCT00101686|739452|P10|NOT COMPLETED|Overall Study||30
301367|NCT00101686|739453|P9|NOT COMPLETED|Overall Study||30
301368|NCT00101686|739454|P8|NOT COMPLETED|Overall Study||30
301369|NCT00101686|739455|P7|NOT COMPLETED|Overall Study||27
301370|NCT00101686|739456|P6|NOT COMPLETED|Overall Study||72
301371|NCT00101686|739457|P5|NOT COMPLETED|Overall Study||73
301372|NCT00101686|739458|P4|NOT COMPLETED|Overall Study||72
301373|NCT00101686|739459|P3|NOT COMPLETED|Overall Study||69
301374|NCT00101686|739460|P2|NOT COMPLETED|Overall Study||73
301375|NCT00101686|739461|P1|NOT COMPLETED|Overall Study||71
301376|NCT00101686|739452|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
301377|NCT00101686|739453|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
301464|NCT00101283|739655|P2|COMPLETED|Overall Study||13
301378|NCT00101686|739454|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
301379|NCT00101686|739455|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
301380|NCT00101686|739456|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
301381|NCT00101686|739457|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
301382|NCT00101686|739458|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
301383|NCT00101686|739459|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
301384|NCT00101686|739460|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
301385|NCT00101686|739461|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
301386|NCT00101686|739452|P10|Received Treatment|Overall Study||29
301387|NCT00101686|739453|P9|Received Treatment|Overall Study||30
301388|NCT00101686|739454|P8|Received Treatment|Overall Study||29
301389|NCT00101686|739455|P7|Received Treatment|Overall Study||27
301390|NCT00101686|739456|P6|Received Treatment|Overall Study||70
301391|NCT00101686|739457|P5|Received Treatment|Overall Study||71
301392|NCT00101686|739458|P4|Received Treatment|Overall Study||70
301393|NCT00101686|739459|P3|Received Treatment|Overall Study||67
301394|NCT00101686|739460|P2|Received Treatment|Overall Study||67
301395|NCT00101686|739461|P1|Received Treatment|Overall Study||70
301396|NCT00101686|739452|P10|STARTED|Overall Study||30
301397|NCT00101686|739453|P9|STARTED|Overall Study||30
301398|NCT00101686|739454|P8|STARTED|Overall Study||30
301399|NCT00101686|739455|P7|STARTED|Overall Study||27
301400|NCT00101686|739456|P6|STARTED|Overall Study||72
301401|NCT00101686|739457|P5|STARTED|Overall Study||73
301402|NCT00101686|739458|P4|STARTED|Overall Study||72
301403|NCT00101686|739459|P3|STARTED|Overall Study||69
301404|NCT00101686|739460|P2|STARTED|Overall Study||73
301405|NCT00101686|739461|P1|STARTED|Overall Study||71
301406|NCT00101660|739508|P2|NOT COMPLETED|Overall Study||0
301407|NCT00101660|739509|P1|NOT COMPLETED|Overall Study||0
301408|NCT00101660|739508|P2|COMPLETED|Overall Study||288
301409|NCT00101660|739509|P1|COMPLETED|Overall Study||99
301410|NCT00101660|739508|P2|STARTED|Overall Study||288
301411|NCT00101660|739509|P1|STARTED|Overall Study||99
301412|NCT00101647|739527|P2|NOT COMPLETED|Overall Study||0
301413|NCT00101647|739528|P1|NOT COMPLETED|Overall Study||0
301414|NCT00101647|739527|P2|COMPLETED|Overall Study||161
301415|NCT00101647|739528|P1|COMPLETED|Overall Study||13
301416|NCT00101647|739527|P2|STARTED|Overall Study|Randomized|161
301417|NCT00101647|739528|P1|STARTED|Overall Study|Randomized|13
301418|NCT00101582|739578|P2|NOT COMPLETED|Overall Study||15
301419|NCT00101582|739579|P1|NOT COMPLETED|Overall Study||11
301420|NCT00101582|739578|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
301421|NCT00101582|739579|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
301422|NCT00101582|739578|P2|Received Study Drug|Overall Study||94
301423|NCT00101582|739579|P1|Received Study Drug|Overall Study||91
301424|NCT00101582|739578|P2|STARTED|Overall Study||94
301425|NCT00101582|739579|P1|STARTED|Overall Study||94
301426|NCT00101452|739602|P3|NOT COMPLETED|Overall Study||43
301427|NCT00101452|739603|P2|NOT COMPLETED|Overall Study||43
301428|NCT00101452|739604|P1|NOT COMPLETED|Overall Study||44
301429|NCT00101452|739602|P3|COMPLETED|Overall Study||22
301430|NCT00101452|739603|P2|COMPLETED|Overall Study||26
301431|NCT00101452|739604|P1|COMPLETED|Overall Study||21
301432|NCT00101452|739602|P3|STARTED|Overall Study||65
301433|NCT00101452|739603|P2|STARTED|Overall Study||69
301434|NCT00101452|739604|P1|STARTED|Overall Study||65
301435|NCT00101439|739618|P2|NOT COMPLETED|Period 2||2
301436|NCT00101439|739619|P1|NOT COMPLETED|Period 2||0
301437|NCT00101439|739618|P2|COMPLETED|Period 2||28
301438|NCT00101439|739619|P1|COMPLETED|Period 2||28
301439|NCT00101439|739618|P2|STARTED|Period 2||30
301440|NCT00101439|739619|P1|STARTED|Period 2||28
301441|NCT00101439|739618|P2|NOT COMPLETED|Period 1||0
301442|NCT00101439|739619|P1|NOT COMPLETED|Period 1||0
301443|NCT00101439|739618|P2|COMPLETED|Period 1||30
301444|NCT00101439|739619|P1|COMPLETED|Period 1||28
301445|NCT00101439|739618|P2|STARTED|Period 1||30
301446|NCT00101439|739619|P1|STARTED|Period 1||28
301447|NCT00101413|739627|P1|NOT COMPLETED|Overall Study||0
301448|NCT00101413|739627|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
301449|NCT00101413|739627|P1|STARTED|Overall Study||52
301450|NCT00101400|739635|P1|NOT COMPLETED|Survival Follow-Up||7
301451|NCT00101400|739635|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
301452|NCT00101400|739635|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
301453|NCT00101400|739635|P1|NOT COMPLETED|Treatment||0
301454|NCT00101400|739635|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
301455|NCT00101400|739635|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
301456|NCT00101361|739646|P2|NOT COMPLETED|Overall Study||0
301457|NCT00101361|739647|P1|NOT COMPLETED|Overall Study||0
301458|NCT00101361|739646|P2|COMPLETED|Overall Study||104
301459|NCT00101361|739647|P1|COMPLETED|Overall Study||108
301460|NCT00101361|739646|P2|STARTED|Overall Study||104
301461|NCT00101361|739647|P1|STARTED|Overall Study||108
301462|NCT00101283|739655|P2|NOT COMPLETED|Overall Study||3
301463|NCT00101283|739656|P1|NOT COMPLETED|Overall Study||0
301465|NCT00101283|739656|P1|COMPLETED|Overall Study||16
301466|NCT00101283|739655|P2|Began Treatment|Overall Study||13
301467|NCT00101283|739656|P1|Began Treatment|Overall Study||16
301468|NCT00101283|739655|P2|STARTED|Overall Study||16
301469|NCT00101283|739656|P1|STARTED|Overall Study||16
301470|NCT00101192|739666|P1|NOT COMPLETED|Overall Study||7
301471|NCT00101192|739666|P1|COMPLETED|Overall Study||69
301472|NCT00101192|739666|P1|STARTED|Overall Study||76
301473|NCT00101166|739670|P1|NOT COMPLETED|Overall Study||10
301474|NCT00101166|739670|P1|COMPLETED|Overall Study||18
301475|NCT00101166|739670|P1|STARTED|Overall Study||28
301476|NCT00101101|739678|P1|NOT COMPLETED|Overall Study||20
301477|NCT00101101|739678|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
301478|NCT00101101|739678|P1|STARTED|Overall Study||43
301479|NCT00101036|739686|P2|NOT COMPLETED|Overall Study||0
301480|NCT00101036|739687|P1|NOT COMPLETED|Overall Study||0
301481|NCT00101036|739686|P2|COMPLETED|Overall Study||40
301482|NCT00101036|739687|P1|COMPLETED|Overall Study||17
301483|NCT00101036|739686|P2|STARTED|Overall Study||40
301484|NCT00101036|739687|P1|STARTED|Overall Study||17
301485|NCT00100932|739701|P2|NOT COMPLETED|Overall Study||27
301486|NCT00100932|739702|P1|NOT COMPLETED|Overall Study||73
301487|NCT00100932|739701|P2|COMPLETED|Overall Study||1
301488|NCT00100932|739702|P1|COMPLETED|Overall Study||5
301489|NCT00100932|739701|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
301490|NCT00100932|739702|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
301491|NCT00100841|739712|P1|NOT COMPLETED|Overall Study||0
301492|NCT00100841|739712|P1|COMPLETED|Overall Study||66
301493|NCT00100841|739712|P1|STARTED|Overall Study||66
301494|NCT00100815|739717|P1|NOT COMPLETED|Overall Study||49
301495|NCT00100815|739717|P1|COMPLETED|Overall Study||1
301496|NCT00100815|739717|P1|STARTED|Overall Study||50
301497|NCT00100802|739725|P1|NOT COMPLETED|Overall Study||80
301498|NCT00100802|739725|P1|COMPLETED|Overall Study||38
301499|NCT00100802|739725|P1|STARTED|Overall Study||118
301500|NCT00100789|739730|P1|NOT COMPLETED|Overall Study||64
301501|NCT00100789|739730|P1|COMPLETED|Overall Study||3
301502|NCT00100789|739730|P1|Eligible and Began Protocol Therapy|Overall Study||63
301503|NCT00100789|739730|P1|Eligible|Overall Study||64
301504|NCT00100789|739730|P1|STARTED|Overall Study||67
301505|NCT00100698|739739|P2|NOT COMPLETED|Overall Study||2
301506|NCT00100698|739740|P1|NOT COMPLETED|Overall Study||6
301507|NCT00100698|739739|P2|COMPLETED|Overall Study||27
301508|NCT00100698|739740|P1|COMPLETED|Overall Study||21
301509|NCT00100698|739739|P2|STARTED|Overall Study||29
301510|NCT00100698|739740|P1|STARTED|Overall Study||27
301511|NCT00100659|739782|P2|NOT COMPLETED|Overall Study||2
301512|NCT00100659|739783|P1|NOT COMPLETED|Overall Study||3
301513|NCT00100659|739782|P2|COMPLETED|Overall Study||57
301514|NCT00100659|739783|P1|COMPLETED|Overall Study||52
301515|NCT00100659|739782|P2|STARTED|Overall Study||59
301516|NCT00100659|739783|P1|STARTED|Overall Study||55
301517|NCT00100230|739791|P2|NOT COMPLETED|Overall Study||15
301518|NCT00100230|739792|P1|NOT COMPLETED|Overall Study||12
301519|NCT00100230|739791|P2|COMPLETED|Overall Study||22
301520|NCT00100230|739792|P1|COMPLETED|Overall Study||29
301521|NCT00100230|739791|P2|STARTED|Overall Study||37
301522|NCT00100230|739792|P1|STARTED|Overall Study||41
301523|NCT00100178|739805|P3|NOT COMPLETED|Overall Study||10
301524|NCT00100178|739806|P2|NOT COMPLETED|Overall Study||10
301525|NCT00100178|739807|P1|NOT COMPLETED|Overall Study||9
301526|NCT00100178|739805|P3|COMPLETED|Overall Study||32
301527|NCT00100178|739806|P2|COMPLETED|Overall Study||21
301528|NCT00100178|739807|P1|COMPLETED|Overall Study||32
301529|NCT00100178|739805|P3|STARTED|Overall Study||42
301530|NCT00100178|739806|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
301531|NCT00100178|739807|P1|STARTED|Overall Study||41
301532|NCT00100048|739820|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
301533|NCT00100048|739821|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
301534|NCT00100048|739822|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
301535|NCT00100048|739823|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
301536|NCT00100048|739824|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
301537|NCT00100048|739825|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
301538|NCT00100048|739820|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
301539|NCT00100048|739821|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
301540|NCT00100048|739822|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
301541|NCT00100048|739823|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
301542|NCT00100048|739824|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
301543|NCT00100048|739825|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
301544|NCT00100048|739820|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
301545|NCT00100048|739821|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
301546|NCT00100048|739822|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
301547|NCT00100048|739823|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
301548|NCT00100048|739824|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
301549|NCT00100048|739825|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
301550|NCT00100048|739820|P6|Treated|Cohort I & II-Combination Therapy Phase||38
301551|NCT00100048|739821|P5|Treated|Cohort I & II-Combination Therapy Phase||0
301552|NCT00100048|739822|P4|Treated|Cohort I & II-Combination Therapy Phase||40
301553|NCT00100048|739823|P3|Treated|Cohort I & II-Combination Therapy Phase||41
301554|NCT00100048|739824|P2|Treated|Cohort I & II-Combination Therapy Phase||40
301555|NCT00100048|739825|P1|Treated|Cohort I & II-Combination Therapy Phase||39
301556|NCT00100048|739820|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
301557|NCT00100048|739821|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
301558|NCT00100048|739822|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
301559|NCT00100048|739823|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
301560|NCT00100048|739824|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
301561|NCT00100048|739825|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
301562|NCT00100048|739820|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
301563|NCT00100048|739821|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
301564|NCT00100048|739822|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
301565|NCT00100048|739823|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
301566|NCT00100048|739824|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
301567|NCT00100048|739825|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
301568|NCT00100048|739820|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
301569|NCT00100048|739821|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
301570|NCT00100048|739822|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
301571|NCT00100048|739823|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
301572|NCT00100048|739824|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
301573|NCT00100048|739825|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
301574|NCT00100048|739820|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
301575|NCT00100048|739821|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
301576|NCT00100048|739822|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
301577|NCT00100048|739823|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
301578|NCT00100048|739824|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
301579|NCT00100048|739825|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
301580|NCT00100048|739820|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
301581|NCT00100048|739821|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
301582|NCT00100048|739822|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
301583|NCT00100048|739823|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
301584|NCT00100048|739824|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
301585|NCT00100048|739825|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
301586|NCT00099983|739934|P2|NOT COMPLETED|Overall Study||25
301587|NCT00099983|739935|P1|NOT COMPLETED|Overall Study||24
301588|NCT00099983|739934|P2|COMPLETED|Overall Study||124
301589|NCT00099983|739935|P1|COMPLETED|Overall Study||123
301590|NCT00099983|739934|P2|STARTED|Overall Study||149
301591|NCT00099983|739935|P1|STARTED|Overall Study||147
301592|NCT00099632|739947|P6|NOT COMPLETED|Overall Study||2
301593|NCT00099632|739948|P5|NOT COMPLETED|Overall Study||1
301594|NCT00099632|739949|P4|NOT COMPLETED|Overall Study||1
301595|NCT00099632|739950|P3|NOT COMPLETED|Overall Study||3
301596|NCT00099632|739951|P2|NOT COMPLETED|Overall Study||1
301597|NCT00099632|739952|P1|NOT COMPLETED|Overall Study||1
301598|NCT00099632|739947|P6|COMPLETED|Overall Study||66
301599|NCT00099632|739948|P5|COMPLETED|Overall Study||70
301600|NCT00099632|739949|P4|COMPLETED|Overall Study||66
301601|NCT00099632|739950|P3|COMPLETED|Overall Study||72
301602|NCT00099632|739951|P2|COMPLETED|Overall Study||67
301603|NCT00099632|739952|P1|COMPLETED|Overall Study||72
301604|NCT00099632|739947|P6|STARTED|Overall Study||68
301605|NCT00099632|739948|P5|STARTED|Overall Study||71
301606|NCT00099632|739949|P4|STARTED|Overall Study||67
301607|NCT00099632|739950|P3|STARTED|Overall Study||75
301608|NCT00099632|739951|P2|STARTED|Overall Study||68
301609|NCT00099632|739952|P1|STARTED|Overall Study||73
301610|NCT00099437|739992|P2|NOT COMPLETED|Overall Study||349
301611|NCT00099437|739993|P1|NOT COMPLETED|Overall Study||366
301612|NCT00099437|739992|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
301613|NCT00099437|739993|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
301614|NCT00099437|739992|P2|STARTED|Overall Study|randomised patients|362
301615|NCT00099437|739993|P1|STARTED|Overall Study|randomised patients|374
301616|NCT00099359|740016|P3|NOT COMPLETED|Overall Study||68
301617|NCT00099359|740017|P2|NOT COMPLETED|Overall Study||65
301618|NCT00099359|740018|P1|NOT COMPLETED|Overall Study||54
301619|NCT00099359|740016|P3|COMPLETED|Overall Study||506
301620|NCT00099359|740017|P2|COMPLETED|Overall Study||515
301621|NCT00099359|740018|P1|COMPLETED|Overall Study||527
301622|NCT00099359|740016|P3|STARTED|Overall Study||574
301623|NCT00099359|740017|P2|STARTED|Overall Study||580
301624|NCT00099359|740018|P1|STARTED|Overall Study||581
301625|NCT00099268|740041|P2|NOT COMPLETED|Overall Study||82
301626|NCT00099268|740042|P1|NOT COMPLETED|Overall Study||92
301627|NCT00099268|740041|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
301628|NCT00099268|740042|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
301629|NCT00099268|740041|P2|Intent-to-Treat|Overall Study||372
301630|NCT00099268|740042|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
301631|NCT00099268|740041|P2|STARTED|Overall Study||373
301632|NCT00099268|740042|P1|STARTED|Overall Study||374
301633|NCT00099047|740060|P2|NOT COMPLETED|Overall Study||0
301634|NCT00099047|740061|P1|NOT COMPLETED|Overall Study||0
301635|NCT00099047|740060|P2|COMPLETED|Overall Study||12
301636|NCT00099047|740061|P1|COMPLETED|Overall Study||11
301637|NCT00099047|740060|P2|STARTED|Overall Study||12
301638|NCT00099047|740061|P1|STARTED|Overall Study||11
301639|NCT00099021|740067|P1|NOT COMPLETED|Overall Study||0
301640|NCT00099021|740067|P1|COMPLETED|Overall Study||21
301641|NCT00099021|740067|P1|STARTED|Overall Study||21
301642|NCT00098956|740073|P1|NOT COMPLETED|Overall Study||0
301643|NCT00098956|740073|P1|COMPLETED|Overall Study||19
301644|NCT00098956|740073|P1|STARTED|Overall Study||19
301645|NCT00098865|740078|P1|NOT COMPLETED|Overall Study||9
301646|NCT00098865|740078|P1|COMPLETED|Overall Study||6
301647|NCT00098865|740078|P1|STARTED|Overall Study||15
301648|NCT00098839|740086|P2|NOT COMPLETED|Overall Study||33
301649|NCT00098839|740087|P1|NOT COMPLETED|Overall Study||32
301650|NCT00098839|740086|P2|COMPLETED|Overall Study||27
301651|NCT00098839|740087|P1|COMPLETED|Overall Study||24
301652|NCT00098839|740086|P2|STARTED|Overall Study||60
301653|NCT00098839|740087|P1|STARTED|Overall Study||56
301654|NCT00098813|740098|P1|NOT COMPLETED|Overall Study||19
301655|NCT00098813|740098|P1|COMPLETED|Overall Study||1
301656|NCT00098813|740098|P1|STARTED|Overall Study||20
301657|NCT00098787|740105|P3|NOT COMPLETED|Overall Study||63
301658|NCT00098787|740106|P2|NOT COMPLETED|Overall Study||75
301659|NCT00098787|740107|P1|NOT COMPLETED|Overall Study||73
301660|NCT00098787|740105|P3|COMPLETED|Overall Study||0
301661|NCT00098787|740106|P2|COMPLETED|Overall Study||0
301662|NCT00098787|740107|P1|COMPLETED|Overall Study||0
301663|NCT00098787|740105|P3|Eligible and Treated|Overall Study||59
301664|NCT00098787|740106|P2|Eligible and Treated|Overall Study||66
301665|NCT00098787|740107|P1|Eligible and Treated|Overall Study||61
301666|NCT00098787|740105|P3|Treated|Overall Study||62
301667|NCT00098787|740106|P2|Treated|Overall Study||73
301668|NCT00098787|740107|P1|Treated|Overall Study||70
301669|NCT00098787|740105|P3|STARTED|Overall Study||63
301670|NCT00098787|740106|P2|STARTED|Overall Study||75
301671|NCT00098787|740107|P1|STARTED|Overall Study||73
301672|NCT00098774|740121|P1|NOT COMPLETED|Overall Study||18
301673|NCT00098774|740121|P1|COMPLETED|Overall Study||26
301674|NCT00098774|740121|P1|STARTED|Overall Study||44
301675|NCT00098748|740131|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
301676|NCT00098748|740132|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
301677|NCT00098748|740133|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
301678|NCT00098748|740131|P3|COMPLETED|Continued on Open-Label Treatment||0
301679|NCT00098748|740132|P2|COMPLETED|Continued on Open-Label Treatment||10
301680|NCT00098748|740133|P1|COMPLETED|Continued on Open-Label Treatment||7
301681|NCT00098748|740131|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
301682|NCT00098748|740132|P2|STARTED|Continued on Open-Label Treatment||25
301683|NCT00098748|740133|P1|STARTED|Continued on Open-Label Treatment||15
301684|NCT00098748|740131|P3|NOT COMPLETED|Received Study Treatment||44
301685|NCT00098748|740132|P2|NOT COMPLETED|Received Study Treatment||36
301686|NCT00098748|740133|P1|NOT COMPLETED|Received Study Treatment||48
301687|NCT00098748|740131|P3|COMPLETED|Received Study Treatment||18
301688|NCT00098748|740132|P2|COMPLETED|Received Study Treatment||25
301689|NCT00098748|740133|P1|COMPLETED|Received Study Treatment||15
301690|NCT00098748|740131|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
301691|NCT00098748|740132|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
301692|NCT00098748|740133|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
301693|NCT00098748|740131|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
301694|NCT00098748|740132|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
301695|NCT00098748|740133|P1|STARTED|Received Study Treatment||63
301696|NCT00098748|740131|P3|NOT COMPLETED|Assigned to Study Treatment||2
301697|NCT00098748|740132|P2|NOT COMPLETED|Assigned to Study Treatment||2
301698|NCT00098748|740133|P1|NOT COMPLETED|Assigned to Study Treatment||0
301699|NCT00098748|740131|P3|COMPLETED|Assigned to Study Treatment||62
301700|NCT00098748|740132|P2|COMPLETED|Assigned to Study Treatment||61
301701|NCT00098748|740133|P1|COMPLETED|Assigned to Study Treatment||63
301702|NCT00098748|740131|P3|STARTED|Assigned to Study Treatment||64
301703|NCT00098748|740132|P2|STARTED|Assigned to Study Treatment||63
301704|NCT00098748|740133|P1|STARTED|Assigned to Study Treatment||63
301705|NCT00098722|740189|P7|NOT COMPLETED|Observation Phase||17
301706|NCT00098722|740190|P6|NOT COMPLETED|Observation Phase||45
301707|NCT00098722|740191|P5|NOT COMPLETED|Observation Phase||0
301708|NCT00098722|740192|P4|NOT COMPLETED|Observation Phase||0
301709|NCT00098722|740193|P3|NOT COMPLETED|Observation Phase||0
301710|NCT00098722|740194|P2|NOT COMPLETED|Observation Phase||0
301711|NCT00098722|740195|P1|NOT COMPLETED|Observation Phase||0
301712|NCT00098722|740189|P7|COMPLETED|Observation Phase||48
301713|NCT00098722|740190|P6|COMPLETED|Observation Phase||160
301714|NCT00098722|740191|P5|COMPLETED|Observation Phase||0
301715|NCT00098722|740192|P4|COMPLETED|Observation Phase||0
301716|NCT00098722|740193|P3|COMPLETED|Observation Phase||0
301717|NCT00098722|740194|P2|COMPLETED|Observation Phase||0
301718|NCT00098722|740195|P1|COMPLETED|Observation Phase||0
301719|NCT00098722|740189|P7|STARTED|Observation Phase||65
301720|NCT00098722|740190|P6|STARTED|Observation Phase||205
301721|NCT00098722|740191|P5|STARTED|Observation Phase||0
301722|NCT00098722|740192|P4|STARTED|Observation Phase||0
301723|NCT00098722|740193|P3|STARTED|Observation Phase||0
301724|NCT00098722|740194|P2|STARTED|Observation Phase||0
301725|NCT00098722|740195|P1|STARTED|Observation Phase||0
301726|NCT00098722|740189|P7|NOT COMPLETED|Open Label Phase||0
301727|NCT00098722|740190|P6|NOT COMPLETED|Open Label Phase||0
301728|NCT00098722|740191|P5|NOT COMPLETED|Open Label Phase||50
301729|NCT00098722|740192|P4|NOT COMPLETED|Open Label Phase||272
301730|NCT00098722|740193|P3|NOT COMPLETED|Open Label Phase||0
301731|NCT00098722|740194|P2|NOT COMPLETED|Open Label Phase||0
301732|NCT00098722|740195|P1|NOT COMPLETED|Open Label Phase||0
301733|NCT00098722|740189|P7|COMPLETED|Open Label Phase||0
301734|NCT00098722|740190|P6|COMPLETED|Open Label Phase||0
301735|NCT00098722|740191|P5|COMPLETED|Open Label Phase||0
301736|NCT00098722|740192|P4|COMPLETED|Open Label Phase||0
301737|NCT00098722|740193|P3|COMPLETED|Open Label Phase||0
301738|NCT00098722|740194|P2|COMPLETED|Open Label Phase||0
301739|NCT00098722|740195|P1|COMPLETED|Open Label Phase||0
301740|NCT00098722|740189|P7|STARTED|Open Label Phase||0
301741|NCT00098722|740190|P6|STARTED|Open Label Phase||0
301742|NCT00098722|740191|P5|STARTED|Open Label Phase||50
301743|NCT00098722|740192|P4|STARTED|Open Label Phase||272
301744|NCT00098722|740193|P3|STARTED|Open Label Phase||0
301745|NCT00098722|740194|P2|STARTED|Open Label Phase||0
301746|NCT00098722|740195|P1|STARTED|Open Label Phase||0
301747|NCT00098722|740189|P7|NOT COMPLETED|Double Blind Phase||0
301748|NCT00098722|740190|P6|NOT COMPLETED|Double Blind Phase||0
301749|NCT00098722|740191|P5|NOT COMPLETED|Double Blind Phase||0
301750|NCT00098722|740192|P4|NOT COMPLETED|Double Blind Phase||0
301751|NCT00098722|740193|P3|NOT COMPLETED|Double Blind Phase||94
301752|NCT00098722|740194|P2|NOT COMPLETED|Double Blind Phase||194
301753|NCT00098722|740195|P1|NOT COMPLETED|Double Blind Phase||186
301754|NCT00098722|740189|P7|COMPLETED|Double Blind Phase||0
301755|NCT00098722|740190|P6|COMPLETED|Double Blind Phase||0
301756|NCT00098722|740191|P5|COMPLETED|Double Blind Phase||0
301757|NCT00098722|740192|P4|COMPLETED|Double Blind Phase||0
301758|NCT00098722|740193|P3|COMPLETED|Double Blind Phase||0
301759|NCT00098722|740194|P2|COMPLETED|Double Blind Phase||0
301760|NCT00098722|740195|P1|COMPLETED|Double Blind Phase||0
301761|NCT00098722|740189|P7|Treated|Double Blind Phase||0
301762|NCT00098722|740190|P6|Treated|Double Blind Phase||0
301763|NCT00098722|740191|P5|Treated|Double Blind Phase||0
301764|NCT00098722|740192|P4|Treated|Double Blind Phase||0
301765|NCT00098722|740193|P3|Treated|Double Blind Phase||91
301766|NCT00098722|740194|P2|Treated|Double Blind Phase||191
301767|NCT00098722|740195|P1|Treated|Double Blind Phase||182
301768|NCT00098722|740189|P7|STARTED|Double Blind Phase||0
301769|NCT00098722|740190|P6|STARTED|Double Blind Phase||0
301770|NCT00098722|740191|P5|STARTED|Double Blind Phase||0
301771|NCT00098722|740192|P4|STARTED|Double Blind Phase||0
301772|NCT00098722|740193|P3|STARTED|Double Blind Phase||94
301773|NCT00098722|740194|P2|STARTED|Double Blind Phase||194
301774|NCT00098722|740195|P1|STARTED|Double Blind Phase||186
301775|NCT00098670|740258|P1|NOT COMPLETED|Overall Study||0
301776|NCT00098670|740258|P1|COMPLETED|Overall Study||102
301777|NCT00098670|740258|P1|STARTED|Overall Study||102
301778|NCT00098475|740269|P4|NOT COMPLETED|Step 2||0
301779|NCT00098475|740270|P3|NOT COMPLETED|Step 2||0
301780|NCT00098475|740271|P2|NOT COMPLETED|Step 2||10
301781|NCT00098475|740272|P1|NOT COMPLETED|Step 2||5
301782|NCT00098475|740269|P4|COMPLETED|Step 2||0
301783|NCT00098475|740270|P3|COMPLETED|Step 2||0
301784|NCT00098475|740271|P2|COMPLETED|Step 2||5
301785|NCT00098475|740272|P1|COMPLETED|Step 2||0
301786|NCT00098475|740269|P4|Eligible|Step 2||0
301787|NCT00098475|740270|P3|Eligible|Step 2||0
301788|NCT00098475|740271|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
301789|NCT00098475|740272|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
301790|NCT00098475|740269|P4|Treated|Step 2||0
301791|NCT00098475|740270|P3|Treated|Step 2||0
301792|NCT00098475|740271|P2|Treated|Step 2||14
301793|NCT00098475|740272|P1|Treated|Step 2||4
301794|NCT00098475|740269|P4|STARTED|Step 2||0
301795|NCT00098475|740270|P3|STARTED|Step 2||0
301796|NCT00098475|740271|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
301797|NCT00098475|740272|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
301798|NCT00098475|740269|P4|NOT COMPLETED|Step 1||3
301799|NCT00098475|740270|P3|NOT COMPLETED|Step 1||4
301800|NCT00098475|740271|P2|NOT COMPLETED|Step 1||173
301801|NCT00098475|740272|P1|NOT COMPLETED|Step 1||171
301802|NCT00098475|740269|P4|COMPLETED|Step 1||0
301803|NCT00098475|740270|P3|COMPLETED|Step 1||0
301804|NCT00098475|740271|P2|COMPLETED|Step 1||49
301805|NCT00098475|740272|P1|COMPLETED|Step 1||52
301806|NCT00098475|740269|P4|Eligible|Step 1||3
301807|NCT00098475|740270|P3|Eligible|Step 1||4
301808|NCT00098475|740271|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
301809|NCT00098475|740272|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
301810|NCT00098475|740269|P4|Treated|Step 1||3
301811|NCT00098475|740270|P3|Treated|Step 1||4
301812|NCT00098475|740271|P2|Treated|Step 1||220
301813|NCT00098475|740272|P1|Treated|Step 1||223
301814|NCT00098475|740269|P4|STARTED|Step 1||3
301815|NCT00098475|740270|P3|STARTED|Step 1||4
301816|NCT00098475|740271|P2|STARTED|Step 1||222
301817|NCT00098475|740272|P1|STARTED|Step 1||223
301818|NCT00098371|740284|P1|NOT COMPLETED|Overall Study||0
301819|NCT00098371|740284|P1|COMPLETED|Overall Study||64
301820|NCT00098371|740284|P1|STARTED|Overall Study||64
301821|NCT00098345|740309|P1|NOT COMPLETED|Overall Study||13
301822|NCT00098345|740309|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
301823|NCT00098345|740309|P1|STARTED|Overall Study||30
301824|NCT00098306|740322|P7|NOT COMPLETED|Observational Phase||26
301825|NCT00098306|740323|P6|NOT COMPLETED|Observational Phase||46
301826|NCT00098306|740324|P5|NOT COMPLETED|Observational Phase||0
301827|NCT00098306|740325|P4|NOT COMPLETED|Observational Phase||0
301828|NCT00098306|740326|P3|NOT COMPLETED|Observational Phase||0
301829|NCT00098306|740327|P2|NOT COMPLETED|Observational Phase||0
301830|NCT00098306|740328|P1|NOT COMPLETED|Observational Phase||0
301831|NCT00098306|740322|P7|COMPLETED|Observational Phase||55
301832|NCT00098306|740323|P6|COMPLETED|Observational Phase||204
301833|NCT00098306|740324|P5|COMPLETED|Observational Phase||0
301834|NCT00098306|740325|P4|COMPLETED|Observational Phase||0
301835|NCT00098306|740326|P3|COMPLETED|Observational Phase||0
301836|NCT00098306|740327|P2|COMPLETED|Observational Phase||0
301837|NCT00098306|740328|P1|COMPLETED|Observational Phase||0
301838|NCT00098306|740322|P7|STARTED|Observational Phase||81
301839|NCT00098306|740323|P6|STARTED|Observational Phase||250
301840|NCT00098306|740324|P5|STARTED|Observational Phase||0
301841|NCT00098306|740325|P4|STARTED|Observational Phase||0
301842|NCT00098306|740326|P3|STARTED|Observational Phase||0
301843|NCT00098306|740327|P2|STARTED|Observational Phase||0
301844|NCT00098306|740328|P1|STARTED|Observational Phase||0
301845|NCT00098306|740322|P7|NOT COMPLETED|Open Label||0
301846|NCT00098306|740323|P6|NOT COMPLETED|Open Label||0
301847|NCT00098306|740324|P5|NOT COMPLETED|Open Label||62
301848|NCT00098306|740325|P4|NOT COMPLETED|Open Label||327
301849|NCT00098306|740326|P3|NOT COMPLETED|Open Label||0
301850|NCT00098306|740327|P2|NOT COMPLETED|Open Label||0
301851|NCT00098306|740328|P1|NOT COMPLETED|Open Label||0
301852|NCT00098306|740322|P7|COMPLETED|Open Label||0
301853|NCT00098306|740323|P6|COMPLETED|Open Label||0
301854|NCT00098306|740324|P5|COMPLETED|Open Label||0
301855|NCT00098306|740325|P4|COMPLETED|Open Label||0
301856|NCT00098306|740326|P3|COMPLETED|Open Label||0
301857|NCT00098306|740327|P2|COMPLETED|Open Label||0
301858|NCT00098306|740328|P1|COMPLETED|Open Label||0
301859|NCT00098306|740322|P7|STARTED|Open Label||0
301860|NCT00098306|740323|P6|STARTED|Open Label||0
301861|NCT00098306|740324|P5|STARTED|Open Label||62
301862|NCT00098306|740325|P4|STARTED|Open Label||327
301863|NCT00098306|740326|P3|STARTED|Open Label||0
301864|NCT00098306|740327|P2|STARTED|Open Label||0
301865|NCT00098306|740328|P1|STARTED|Open Label||0
301866|NCT00098306|740322|P7|NOT COMPLETED|Double Blind||0
301867|NCT00098306|740323|P6|NOT COMPLETED|Double Blind||0
301868|NCT00098306|740324|P5|NOT COMPLETED|Double Blind||0
301869|NCT00098306|740325|P4|NOT COMPLETED|Double Blind||0
301870|NCT00098306|740326|P3|NOT COMPLETED|Double Blind||120
301871|NCT00098306|740327|P2|NOT COMPLETED|Double Blind||240
301872|NCT00098306|740328|P1|NOT COMPLETED|Double Blind||241
301873|NCT00098306|740322|P7|COMPLETED|Double Blind||0
301874|NCT00098306|740323|P6|COMPLETED|Double Blind||0
301875|NCT00098306|740324|P5|COMPLETED|Double Blind||0
301876|NCT00098306|740325|P4|COMPLETED|Double Blind||0
301877|NCT00098306|740326|P3|COMPLETED|Double Blind||0
301878|NCT00098306|740327|P2|COMPLETED|Double Blind||0
301879|NCT00098306|740328|P1|COMPLETED|Double Blind||0
301880|NCT00098306|740322|P7|Treated|Double Blind||0
301881|NCT00098306|740323|P6|Treated|Double Blind||0
301882|NCT00098306|740324|P5|Treated|Double Blind||0
301883|NCT00098306|740325|P4|Treated|Double Blind||0
301884|NCT00098306|740326|P3|Treated|Double Blind||118
301885|NCT00098306|740327|P2|Treated|Double Blind||235
301886|NCT00098306|740328|P1|Treated|Double Blind||232
301887|NCT00098306|740322|P7|STARTED|Double Blind||0
301888|NCT00098306|740323|P6|STARTED|Double Blind||0
301889|NCT00098306|740324|P5|STARTED|Double Blind||0
301890|NCT00098306|740325|P4|STARTED|Double Blind||0
301891|NCT00098306|740326|P3|STARTED|Double Blind||120
301892|NCT00098306|740327|P2|STARTED|Double Blind||240
301893|NCT00098306|740328|P1|STARTED|Double Blind||241
301894|NCT00098293|740394|P5|NOT COMPLETED|Supplemental Phase (SP)||33
301895|NCT00098293|740395|P4|NOT COMPLETED|Supplemental Phase (SP)||0
301896|NCT00098293|740396|P3|NOT COMPLETED|Supplemental Phase (SP)||0
301897|NCT00098293|740397|P2|NOT COMPLETED|Supplemental Phase (SP)||0
301898|NCT00098293|740398|P1|NOT COMPLETED|Supplemental Phase (SP)||0
301899|NCT00098293|740394|P5|COMPLETED|Supplemental Phase (SP)||94
301900|NCT00098293|740395|P4|COMPLETED|Supplemental Phase (SP)||0
301901|NCT00098293|740396|P3|COMPLETED|Supplemental Phase (SP)||0
301902|NCT00098293|740397|P2|COMPLETED|Supplemental Phase (SP)||0
301903|NCT00098293|740398|P1|COMPLETED|Supplemental Phase (SP)||0
301904|NCT00098293|740394|P5|STARTED|Supplemental Phase (SP)||127
301905|NCT00098293|740395|P4|STARTED|Supplemental Phase (SP)||0
301906|NCT00098293|740396|P3|STARTED|Supplemental Phase (SP)||0
301907|NCT00098293|740397|P2|STARTED|Supplemental Phase (SP)||0
301908|NCT00098293|740398|P1|STARTED|Supplemental Phase (SP)||0
301909|NCT00098293|740394|P5|NOT COMPLETED|Open-label (OL) Phase||0
301910|NCT00098293|740395|P4|NOT COMPLETED|Open-label (OL) Phase||65
301911|NCT00098293|740396|P3|NOT COMPLETED|Open-label (OL) Phase||41
301912|NCT00098293|740397|P2|NOT COMPLETED|Open-label (OL) Phase||25
301913|NCT00098293|740398|P1|NOT COMPLETED|Open-label (OL) Phase||0
301914|NCT00098293|740394|P5|COMPLETED|Open-label (OL) Phase||0
301915|NCT00098293|740395|P4|COMPLETED|Open-label (OL) Phase||65
301916|NCT00098293|740396|P3|COMPLETED|Open-label (OL) Phase||158
301917|NCT00098293|740397|P2|COMPLETED|Open-label (OL) Phase||177
301918|NCT00098293|740398|P1|COMPLETED|Open-label (OL) Phase||0
301919|NCT00098293|740394|P5|STARTED|Open-label (OL) Phase||0
301920|NCT00098293|740395|P4|STARTED|Open-label (OL) Phase||130
301921|NCT00098293|740396|P3|STARTED|Open-label (OL) Phase||199
301922|NCT00098293|740397|P2|STARTED|Open-label (OL) Phase||202
301923|NCT00098293|740398|P1|STARTED|Open-label (OL) Phase||0
301924|NCT00098293|740394|P5|NOT COMPLETED|Between DB and OL Phase||0
301925|NCT00098293|740395|P4|NOT COMPLETED|Between DB and OL Phase||0
301926|NCT00098293|740396|P3|NOT COMPLETED|Between DB and OL Phase||3
301927|NCT00098293|740397|P2|NOT COMPLETED|Between DB and OL Phase||0
301928|NCT00098293|740398|P1|NOT COMPLETED|Between DB and OL Phase||0
301929|NCT00098293|740394|P5|COMPLETED|Between DB and OL Phase||0
301930|NCT00098293|740395|P4|COMPLETED|Between DB and OL Phase||0
301931|NCT00098293|740396|P3|COMPLETED|Between DB and OL Phase||199
301932|NCT00098293|740397|P2|COMPLETED|Between DB and OL Phase||202
301933|NCT00098293|740398|P1|COMPLETED|Between DB and OL Phase||0
301934|NCT00098293|740394|P5|STARTED|Between DB and OL Phase||0
301935|NCT00098293|740395|P4|STARTED|Between DB and OL Phase||0
301936|NCT00098293|740396|P3|STARTED|Between DB and OL Phase||202
301937|NCT00098293|740397|P2|STARTED|Between DB and OL Phase||202
301938|NCT00098293|740398|P1|STARTED|Between DB and OL Phase||0
301939|NCT00098293|740394|P5|NOT COMPLETED|Double-blind (DB) Phase||0
301940|NCT00098293|740395|P4|NOT COMPLETED|Double-blind (DB) Phase||0
301941|NCT00098293|740396|P3|NOT COMPLETED|Double-blind (DB) Phase||170
301942|NCT00098293|740397|P2|NOT COMPLETED|Double-blind (DB) Phase||166
301943|NCT00098293|740398|P1|NOT COMPLETED|Double-blind (DB) Phase||177
301944|NCT00098293|740394|P5|COMPLETED|Double-blind (DB) Phase||0
301945|NCT00098293|740395|P4|COMPLETED|Double-blind (DB) Phase||0
301946|NCT00098293|740396|P3|COMPLETED|Double-blind (DB) Phase||202
301947|NCT00098293|740397|P2|COMPLETED|Double-blind (DB) Phase||202
301948|NCT00098293|740398|P1|COMPLETED|Double-blind (DB) Phase||0
301949|NCT00098293|740394|P5|Treated|Double-blind (DB) Phase||0
301950|NCT00098293|740395|P4|Treated|Double-blind (DB) Phase||0
301951|NCT00098293|740396|P3|Treated|Double-blind (DB) Phase||361
301952|NCT00098293|740397|P2|Treated|Double-blind (DB) Phase||360
301953|NCT00098293|740398|P1|Treated|Double-blind (DB) Phase||174
301954|NCT00098293|740394|P5|STARTED|Double-blind (DB) Phase||0
301955|NCT00098293|740395|P4|STARTED|Double-blind (DB) Phase||0
301956|NCT00098293|740396|P3|STARTED|Double-blind (DB) Phase||372
301957|NCT00098293|740397|P2|STARTED|Double-blind (DB) Phase||368
301958|NCT00098293|740398|P1|STARTED|Double-blind (DB) Phase||177
301959|NCT00098254|740451|P1|NOT COMPLETED|Overall Study||3
301960|NCT00098254|740451|P1|COMPLETED|Overall Study||34
301961|NCT00098254|740451|P1|STARTED|Overall Study||37
301962|NCT00098059|740472|P2|NOT COMPLETED|Overall Study||1
301963|NCT00098059|740473|P1|NOT COMPLETED|Overall Study||0
301964|NCT00098059|740472|P2|COMPLETED|Overall Study||46
301965|NCT00098059|740473|P1|COMPLETED|Overall Study||27
301966|NCT00098059|740472|P2|STARTED|Overall Study||47
301967|NCT00098059|740473|P1|STARTED|Overall Study||27
301968|NCT00098020|740517|P1|NOT COMPLETED|Overall Study||6
301969|NCT00098020|740517|P1|COMPLETED|Overall Study||6
301970|NCT00098020|740517|P1|Started Isotretinoin|Overall Study||8
301971|NCT00098020|740517|P1|STARTED|Overall Study||12
301972|NCT00097981|740524|P2|NOT COMPLETED|Overall Study||100
301973|NCT00097981|740525|P1|NOT COMPLETED|Overall Study||106
301974|NCT00097981|740524|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
301975|NCT00097981|740525|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
301976|NCT00097981|740524|P2|Received Study Medication|Overall Study||106
301977|NCT00097981|740525|P1|Received Study Medication|Overall Study||110
301978|NCT00097981|740524|P2|STARTED|Overall Study|Enrollment at randomization|112
301979|NCT00097981|740525|P1|STARTED|Overall Study|Enrollment at randomization|113
301980|NCT00097786|740547|P4|NOT COMPLETED|Overall Study||310
301981|NCT00097786|740548|P3|NOT COMPLETED|Overall Study||313
301982|NCT00097786|740549|P2|NOT COMPLETED|Overall Study||292
301983|NCT00097786|740550|P1|NOT COMPLETED|Overall Study||296
301984|NCT00097786|740547|P4|COMPLETED|Overall Study||2036
301985|NCT00097786|740548|P3|COMPLETED|Overall Study||2016
301986|NCT00097786|740549|P2|COMPLETED|Overall Study||2023
301987|NCT00097786|740550|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
301988|NCT00097786|740547|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
301989|NCT00097786|740548|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
301990|NCT00097786|740549|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
301991|NCT00097786|740550|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
301992|NCT00097786|740547|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
301993|NCT00097786|740548|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
301994|NCT00097786|740549|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
301995|NCT00097786|740550|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
301996|NCT00097786|740547|P4|Complete FU for Progression to Diabetes|Overall Study||1762
301997|NCT00097786|740548|P3|Complete FU for Progression to Diabetes|Overall Study||1734
301998|NCT00097786|740549|P2|Complete FU for Progression to Diabetes|Overall Study||1712
301999|NCT00097786|740550|P1|Complete FU for Progression to Diabetes|Overall Study||1709
302000|NCT00097786|740547|P4|STARTED|Overall Study||2346
302001|NCT00097786|740548|P3|STARTED|Overall Study||2329
302002|NCT00097786|740549|P2|STARTED|Overall Study||2315
302003|NCT00097786|740550|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
302004|NCT00097773|740572|P4|NOT COMPLETED|Overall Study||3
302005|NCT00097773|740573|P3|NOT COMPLETED|Overall Study||8
302006|NCT00097773|740574|P2|NOT COMPLETED|Overall Study||8
302007|NCT00097773|740575|P1|NOT COMPLETED|Overall Study||8
302008|NCT00097773|740572|P4|COMPLETED|Overall Study||73
302009|NCT00097773|740573|P3|COMPLETED|Overall Study||68
302010|NCT00097773|740574|P2|COMPLETED|Overall Study||68
302011|NCT00097773|740575|P1|COMPLETED|Overall Study||68
302012|NCT00097773|740572|P4|STARTED|Overall Study||76
302013|NCT00097773|740573|P3|STARTED|Overall Study||76
302014|NCT00097773|740574|P2|STARTED|Overall Study||76
302015|NCT00097773|740575|P1|STARTED|Overall Study||76
302016|NCT00097721|740595|P2|NOT COMPLETED|Overall Study||33
302017|NCT00097721|740596|P1|NOT COMPLETED|Overall Study||71
302018|NCT00097721|740595|P2|COMPLETED|Overall Study||0
302019|NCT00097721|740596|P1|COMPLETED|Overall Study||0
302020|NCT00097721|740595|P2|STARTED|Overall Study||33
302021|NCT00097721|740596|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
302022|NCT00097708|740613|P3|NOT COMPLETED|Overall Study||65
302023|NCT00097708|740614|P2|NOT COMPLETED|Overall Study||56
302024|NCT00097708|740615|P1|NOT COMPLETED|Overall Study||64
302025|NCT00097708|740613|P3|COMPLETED|Overall Study||97
302026|NCT00097708|740614|P2|COMPLETED|Overall Study||120
302027|NCT00097708|740615|P1|COMPLETED|Overall Study||109
302028|NCT00097708|740613|P3|Treated|Overall Study||160
302029|NCT00097708|740614|P2|Treated|Overall Study||176
302030|NCT00097708|740615|P1|Treated|Overall Study||171
302031|NCT00097708|740613|P3|Intent-to-Treat (ITT)|Overall Study||149
302032|NCT00097708|740614|P2|Intent-to-Treat (ITT)|Overall Study||169
302033|NCT00097708|740615|P1|Intent-to-Treat (ITT)|Overall Study||165
302034|NCT00097708|740613|P3|STARTED|Overall Study||162
302035|NCT00097708|740614|P2|STARTED|Overall Study||176
302036|NCT00097708|740615|P1|STARTED|Overall Study||173
302037|NCT00097695|740627|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
302038|NCT00097695|740628|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
302039|NCT00097695|740629|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
302040|NCT00097695|740630|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
302041|NCT00097695|740627|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
302042|NCT00097695|740628|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
302043|NCT00097695|740629|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
302044|NCT00097695|740630|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
302045|NCT00097695|740627|P4|STARTED|The Open Label Extension (OLE) Phase||20
302046|NCT00097695|740628|P3|STARTED|The Open Label Extension (OLE) Phase||3
302047|NCT00097695|740629|P2|STARTED|The Open Label Extension (OLE) Phase||26
302048|NCT00097695|740630|P1|STARTED|The Open Label Extension (OLE) Phase||23
302049|NCT00097695|740627|P4|NOT COMPLETED|The Controlled Phase||20
302050|NCT00097695|740628|P3|NOT COMPLETED|The Controlled Phase||5
302051|NCT00097695|740629|P2|NOT COMPLETED|The Controlled Phase||3
302052|NCT00097695|740630|P1|NOT COMPLETED|The Controlled Phase||4
302053|NCT00097695|740627|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
302054|NCT00097695|740628|P3|COMPLETED|The Controlled Phase||3
302055|NCT00097695|740629|P2|COMPLETED|The Controlled Phase||26
302056|NCT00097695|740630|P1|COMPLETED|The Controlled Phase||23
302057|NCT00097695|740627|P4|STARTED|The Controlled Phase||20
302058|NCT00097695|740628|P3|STARTED|The Controlled Phase||8
302059|NCT00097695|740629|P2|STARTED|The Controlled Phase||29
302060|NCT00097695|740630|P1|STARTED|The Controlled Phase||27
302061|NCT00097591|740646|P2|NOT COMPLETED|Overall Study||394
302062|NCT00097591|740647|P1|NOT COMPLETED|Overall Study||410
302063|NCT00097591|740646|P2|COMPLETED|Overall Study||6401
302064|NCT00097591|740647|P1|COMPLETED|Overall Study||6403
302242|NCT00096122|741032|P1|STARTED|Overall Study||95
302065|NCT00097591|740646|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
302066|NCT00097591|740647|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
302067|NCT00097539|740670|P7|NOT COMPLETED|Overall Study||171
302068|NCT00097539|740671|P6|NOT COMPLETED|Overall Study||5892
302069|NCT00097539|740672|P5|NOT COMPLETED|Overall Study||1758
302070|NCT00097539|740673|P4|NOT COMPLETED|Overall Study||3585
302071|NCT00097539|740674|P3|NOT COMPLETED|Overall Study||9108
302072|NCT00097539|740675|P2|NOT COMPLETED|Overall Study||6531
302073|NCT00097539|740676|P1|NOT COMPLETED|Overall Study||19066
302074|NCT00097539|740670|P7|COMPLETED|Overall Study||68
302075|NCT00097539|740671|P6|COMPLETED|Overall Study||2118
302076|NCT00097539|740672|P5|COMPLETED|Overall Study||386
302077|NCT00097539|740673|P4|COMPLETED|Overall Study||2066
302078|NCT00097539|740674|P3|COMPLETED|Overall Study||3411
302079|NCT00097539|740675|P2|COMPLETED|Overall Study||2825
302080|NCT00097539|740676|P1|COMPLETED|Overall Study||8220
302081|NCT00097539|740670|P7|STARTED|Overall Study||239
302082|NCT00097539|740671|P6|STARTED|Overall Study||8010
302083|NCT00097539|740672|P5|STARTED|Overall Study||2144
302084|NCT00097539|740673|P4|STARTED|Overall Study||5651
302085|NCT00097539|740674|P3|STARTED|Overall Study||12519
302086|NCT00097539|740675|P2|STARTED|Overall Study||9356
302087|NCT00097539|740676|P1|STARTED|Overall Study||27286
302088|NCT00097500|740722|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
302089|NCT00097500|740723|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
302090|NCT00097500|740722|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
302091|NCT00097500|740723|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
302092|NCT00097500|740722|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
302093|NCT00097500|740723|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
302094|NCT00097500|740722|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
302095|NCT00097500|740723|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
302096|NCT00097500|740722|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
302097|NCT00097500|740723|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
302098|NCT00097500|740722|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
302099|NCT00097500|740723|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
302100|NCT00097448|740747|P2|NOT COMPLETED|Overall Study||1
302101|NCT00097448|740748|P1|NOT COMPLETED|Overall Study||4
302102|NCT00097448|740747|P2|COMPLETED|Overall Study||129
302103|NCT00097448|740748|P1|COMPLETED|Overall Study||121
302104|NCT00097448|740747|P2|STARTED|Overall Study||130
302105|NCT00097448|740748|P1|STARTED|Overall Study||125
302106|NCT00097370|740754|P1|NOT COMPLETED|Stage 3||59
302107|NCT00097370|740754|P1|COMPLETED|Stage 3||0
302108|NCT00097370|740754|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
302109|NCT00097370|740754|P1|NOT COMPLETED|Stage 2||13
302110|NCT00097370|740754|P1|COMPLETED|Stage 2||59
302111|NCT00097370|740754|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
302112|NCT00097370|740754|P1|NOT COMPLETED|Stage 1||6
302113|NCT00097370|740754|P1|COMPLETED|Stage 1||31
302114|NCT00097370|740754|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
302115|NCT00097253|740771|P1|NOT COMPLETED|Water (Control)||0
302116|NCT00097253|740771|P1|COMPLETED|Water (Control)||56
302117|NCT00097253|740771|P1|STARTED|Water (Control)||56
302118|NCT00097253|740771|P1|NOT COMPLETED|Lemon||0
302119|NCT00097253|740771|P1|COMPLETED|Lemon||56
302120|NCT00097253|740771|P1|STARTED|Lemon||56
302121|NCT00097253|740771|P1|NOT COMPLETED|Lavender||0
302122|NCT00097253|740771|P1|COMPLETED|Lavender||56
302123|NCT00097253|740771|P1|STARTED|Lavender||56
302124|NCT00096993|740788|P2|NOT COMPLETED|Overall Study||65
302125|NCT00096993|740789|P1|NOT COMPLETED|Overall Study||65
302126|NCT00096993|740788|P2|COMPLETED|Overall Study||0
302127|NCT00096993|740789|P1|COMPLETED|Overall Study||1
302128|NCT00096993|740788|P2|STARTED|Overall Study||65
302129|NCT00096993|740789|P1|STARTED|Overall Study||66
302130|NCT00096954|740805|P2|NOT COMPLETED|Overall Study||20
302131|NCT00096954|740806|P1|NOT COMPLETED|Overall Study||24
302132|NCT00096954|740805|P2|COMPLETED|Overall Study||154
302133|NCT00096954|740806|P1|COMPLETED|Overall Study||135
302134|NCT00096954|740805|P2|Received Study Drug|Overall Study||171
302135|NCT00096954|740806|P1|Received Study Drug|Overall Study||157
302136|NCT00096954|740805|P2|STARTED|Overall Study||174
302137|NCT00096954|740806|P1|STARTED|Overall Study||159
302138|NCT00096941|740818|P1|NOT COMPLETED|Overall Study||3
302139|NCT00096941|740818|P1|COMPLETED|Overall Study||0
302140|NCT00096941|740818|P1|STARTED|Overall Study||3
302141|NCT00096785|740825|P2|NOT COMPLETED|Overall Study||1
302142|NCT00096785|740826|P1|NOT COMPLETED|Overall Study||2
302143|NCT00096785|740825|P2|COMPLETED|Overall Study|As randomized cohort|33
302144|NCT00096785|740826|P1|COMPLETED|Overall Study|As randomized cohort|33
302145|NCT00096785|740825|P2|As-Treated Population|Overall Study||33
302146|NCT00096785|740826|P1|As-Treated Population|Overall Study||36
302147|NCT00096785|740825|P2|As-Randomized Population|Overall Study||34
302148|NCT00096785|740826|P1|As-Randomized Population|Overall Study||35
302149|NCT00096785|740825|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
302150|NCT00096785|740826|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
302151|NCT00096681|740850|P1|NOT COMPLETED|Overall Study||0
302152|NCT00096681|740850|P1|COMPLETED|Overall Study||762
302153|NCT00096681|740850|P1|STARTED|Overall Study||762
302154|NCT00096538|740855|P1|NOT COMPLETED|Overall Study||1
302155|NCT00096538|740855|P1|COMPLETED|Overall Study||5
302156|NCT00096538|740855|P1|STARTED|Overall Study||6
302157|NCT00096486|740863|P4|NOT COMPLETED|Overall Study||2
302158|NCT00096486|740864|P3|NOT COMPLETED|Overall Study||2
302159|NCT00096486|740865|P2|NOT COMPLETED|Overall Study||0
302160|NCT00096486|740866|P1|NOT COMPLETED|Overall Study||0
302161|NCT00096486|740863|P4|COMPLETED|Overall Study||36
302162|NCT00096486|740864|P3|COMPLETED|Overall Study||24
302163|NCT00096486|740865|P2|COMPLETED|Overall Study||6
302164|NCT00096486|740866|P1|COMPLETED|Overall Study||4
302165|NCT00096486|740863|P4|STARTED|Overall Study||38
302166|NCT00096486|740864|P3|STARTED|Overall Study||26
302167|NCT00096486|740865|P2|STARTED|Overall Study||6
302168|NCT00096486|740866|P1|STARTED|Overall Study||4
302169|NCT00096460|740878|P2|NOT COMPLETED|Overall Study||1
302170|NCT00096460|740879|P1|NOT COMPLETED|Overall Study||7
302171|NCT00096460|740878|P2|COMPLETED|Overall Study||7
302172|NCT00096460|740879|P1|COMPLETED|Overall Study||15
302173|NCT00096460|740878|P2|STARTED|Overall Study||8
302174|NCT00096460|740879|P1|STARTED|Overall Study||22
302175|NCT00096447|740885|P1|NOT COMPLETED|Overall Study||1
302176|NCT00096447|740885|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
302177|NCT00096447|740885|P1|STARTED|Overall Study||31
302178|NCT00096382|740901|P2|NOT COMPLETED|Overall Study||0
302179|NCT00096382|740902|P1|NOT COMPLETED|Overall Study||2
302180|NCT00096382|740901|P2|COMPLETED|Overall Study||3
302181|NCT00096382|740902|P1|COMPLETED|Overall Study||21
302182|NCT00096382|740901|P2|STARTED|Overall Study||3
302183|NCT00096382|740902|P1|STARTED|Overall Study||23
302184|NCT00096356|740912|P2|NOT COMPLETED|Overall Study||53
302185|NCT00096356|740913|P1|NOT COMPLETED|Overall Study||44
302186|NCT00096356|740912|P2|COMPLETED|Overall Study||61
302187|NCT00096356|740913|P1|COMPLETED|Overall Study||78
302188|NCT00096356|740912|P2|STARTED|Overall Study||114
302189|NCT00096356|740913|P1|STARTED|Overall Study||122
302190|NCT00096278|740925|P2|NOT COMPLETED|Overall Study||20
302191|NCT00096278|740926|P1|NOT COMPLETED|Overall Study||18
302192|NCT00096278|740925|P2|COMPLETED|Overall Study||1334
302193|NCT00096278|740926|P1|COMPLETED|Overall Study||1338
302194|NCT00096278|740925|P2|STARTED|Overall Study||1354
302195|NCT00096278|740926|P1|STARTED|Overall Study||1356
302196|NCT00096265|740935|P3|NOT COMPLETED|Overall Study||0
302197|NCT00096265|740936|P2|NOT COMPLETED|Overall Study||0
302198|NCT00096265|740937|P1|NOT COMPLETED|Overall Study||1
302199|NCT00096265|740935|P3|COMPLETED|Overall Study||41
302200|NCT00096265|740936|P2|COMPLETED|Overall Study||40
302201|NCT00096265|740937|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
302202|NCT00096265|740935|P3|STARTED|Overall Study||41
302203|NCT00096265|740936|P2|STARTED|Overall Study||40
302204|NCT00096265|740937|P1|STARTED|Overall Study||45
302205|NCT00096226|740963|P1|NOT COMPLETED|Overall Study||17
302206|NCT00096226|740963|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
302207|NCT00096226|740963|P1|STARTED|Overall Study||60
302208|NCT00096200|740970|P3|NOT COMPLETED|Overall Study||0
302209|NCT00096200|740971|P2|NOT COMPLETED|Overall Study||7
302210|NCT00096200|740972|P1|NOT COMPLETED|Overall Study||1
302211|NCT00096200|740970|P3|COMPLETED|Overall Study||5
302212|NCT00096200|740971|P2|COMPLETED|Overall Study||23
302213|NCT00096200|740972|P1|COMPLETED|Overall Study||8
302214|NCT00096200|740970|P3|STARTED|Overall Study||5
302215|NCT00096200|740971|P2|STARTED|Overall Study||30
302216|NCT00096200|740972|P1|STARTED|Overall Study||9
302217|NCT00096174|740980|P1|NOT COMPLETED|Overall Study||62
302218|NCT00096174|740980|P1|COMPLETED|Overall Study||7
302219|NCT00096174|740980|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
302220|NCT00096174|740980|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
302221|NCT00096174|740980|P1|STARTED|Overall Study||69
302222|NCT00096161|740990|P4|NOT COMPLETED|Overall Study||0
302223|NCT00096161|740991|P3|NOT COMPLETED|Overall Study||0
302224|NCT00096161|740992|P2|NOT COMPLETED|Overall Study||0
302225|NCT00096161|740993|P1|NOT COMPLETED|Overall Study||0
302226|NCT00096161|740990|P4|COMPLETED|Overall Study||0
302227|NCT00096161|740991|P3|COMPLETED|Overall Study||6
302228|NCT00096161|740992|P2|COMPLETED|Overall Study||10
302229|NCT00096161|740993|P1|COMPLETED|Overall Study||20
302230|NCT00096161|740990|P4|STARTED|Overall Study||0
302231|NCT00096161|740991|P3|STARTED|Overall Study||6
302232|NCT00096161|740992|P2|STARTED|Overall Study||10
302233|NCT00096161|740993|P1|STARTED|Overall Study||20
302234|NCT00096135|741025|P2|NOT COMPLETED|Overall Study||15
302235|NCT00096135|741026|P1|NOT COMPLETED|Overall Study||63
302236|NCT00096135|741025|P2|COMPLETED|Overall Study||27
302237|NCT00096135|741026|P1|COMPLETED|Overall Study||63
302238|NCT00096135|741025|P2|STARTED|Overall Study||42
302239|NCT00096135|741026|P1|STARTED|Overall Study||126
302240|NCT00096122|741032|P1|NOT COMPLETED|Overall Study||0
302241|NCT00096122|741032|P1|COMPLETED|Overall Study||95
302243|NCT00096109|741036|P1|NOT COMPLETED|Overall Study||0
302244|NCT00096109|741036|P1|COMPLETED|Overall Study||11
302245|NCT00096109|741036|P1|STARTED|Overall Study||11
302246|NCT00096044|741042|P1|NOT COMPLETED|Overall Study||34
302247|NCT00096044|741042|P1|COMPLETED|Overall Study||11
302248|NCT00096044|741042|P1|STARTED|Overall Study||45
302249|NCT00096031|741051|P1|NOT COMPLETED|Overall Study||63
302250|NCT00096031|741051|P1|COMPLETED|Overall Study||0
302251|NCT00096031|741051|P1|Eligible and Began Protocol Therapy|Overall Study||55
302252|NCT00096031|741051|P1|Eligible|Overall Study||57
302253|NCT00096031|741051|P1|STARTED|Overall Study||63
302254|NCT00096018|741059|P2|NOT COMPLETED|Overall Study||14
302255|NCT00096018|741060|P1|NOT COMPLETED|Overall Study||2
302256|NCT00096018|741059|P2|COMPLETED|Overall Study||16
302257|NCT00096018|741060|P1|COMPLETED|Overall Study||11
302258|NCT00096018|741059|P2|Treated With Study Therapy|Overall Study||25
302259|NCT00096018|741060|P1|Treated With Study Therapy|Overall Study||13
302260|NCT00096018|741059|P2|STARTED|Overall Study||30
302261|NCT00096018|741060|P1|STARTED|Overall Study||13
302262|NCT00095979|741068|P1|NOT COMPLETED|Overall Study||2
302263|NCT00095979|741068|P1|COMPLETED|Overall Study||50
302264|NCT00095979|741068|P1|STARTED|Overall Study||52
302265|NCT00095940|741086|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
302266|NCT00095940|741087|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
302267|NCT00095940|741088|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
302268|NCT00095940|741089|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
302269|NCT00095940|741090|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
302270|NCT00095940|741091|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
302271|NCT00095940|741092|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
302272|NCT00095940|741093|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
302273|NCT00095940|741094|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
302274|NCT00095940|741086|P9|COMPLETED|Lapatinib Continuation/Phase II||1
302275|NCT00095940|741087|P8|COMPLETED|Lapatinib Continuation/Phase II||0
302276|NCT00095940|741088|P7|COMPLETED|Lapatinib Continuation/Phase II||0
302277|NCT00095940|741089|P6|COMPLETED|Lapatinib Continuation/Phase II||0
302278|NCT00095940|741090|P5|COMPLETED|Lapatinib Continuation/Phase II||0
302279|NCT00095940|741091|P4|COMPLETED|Lapatinib Continuation/Phase II||0
302280|NCT00095940|741092|P3|COMPLETED|Lapatinib Continuation/Phase II||1
302281|NCT00095940|741093|P2|COMPLETED|Lapatinib Continuation/Phase II||0
302282|NCT00095940|741094|P1|COMPLETED|Lapatinib Continuation/Phase II||0
302283|NCT00095940|741086|P9|STARTED|Lapatinib Continuation/Phase II||14
302284|NCT00095940|741087|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
302285|NCT00095940|741088|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
302286|NCT00095940|741089|P6|STARTED|Lapatinib Continuation/Phase II||13
302287|NCT00095940|741090|P5|STARTED|Lapatinib Continuation/Phase II||0
302288|NCT00095940|741091|P4|STARTED|Lapatinib Continuation/Phase II||0
302289|NCT00095940|741092|P3|STARTED|Lapatinib Continuation/Phase II||17
302290|NCT00095940|741093|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
302291|NCT00095940|741094|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
302292|NCT00095940|741086|P9|NOT COMPLETED|Molecular Biology Phase||0
302293|NCT00095940|741087|P8|NOT COMPLETED|Molecular Biology Phase||0
302294|NCT00095940|741088|P7|NOT COMPLETED|Molecular Biology Phase||0
302295|NCT00095940|741089|P6|NOT COMPLETED|Molecular Biology Phase||0
302296|NCT00095940|741090|P5|NOT COMPLETED|Molecular Biology Phase||0
302297|NCT00095940|741091|P4|NOT COMPLETED|Molecular Biology Phase||0
302298|NCT00095940|741092|P3|NOT COMPLETED|Molecular Biology Phase||0
302299|NCT00095940|741093|P2|NOT COMPLETED|Molecular Biology Phase||0
302300|NCT00095940|741094|P1|NOT COMPLETED|Molecular Biology Phase||0
302301|NCT00095940|741086|P9|COMPLETED|Molecular Biology Phase||0
302302|NCT00095940|741087|P8|COMPLETED|Molecular Biology Phase||2
302303|NCT00095940|741088|P7|COMPLETED|Molecular Biology Phase||2
302304|NCT00095940|741089|P6|COMPLETED|Molecular Biology Phase||0
302305|NCT00095940|741090|P5|COMPLETED|Molecular Biology Phase||0
302306|NCT00095940|741091|P4|COMPLETED|Molecular Biology Phase||0
302307|NCT00095940|741092|P3|COMPLETED|Molecular Biology Phase||0
302308|NCT00095940|741093|P2|COMPLETED|Molecular Biology Phase||2
302309|NCT00095940|741094|P1|COMPLETED|Molecular Biology Phase||2
302310|NCT00095940|741086|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
302311|NCT00095940|741087|P8|STARTED|Molecular Biology Phase||2
302312|NCT00095940|741088|P7|STARTED|Molecular Biology Phase||2
302313|NCT00095940|741089|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
302314|NCT00095940|741090|P5|STARTED|Molecular Biology Phase||0
302315|NCT00095940|741091|P4|STARTED|Molecular Biology Phase||0
302316|NCT00095940|741092|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
302317|NCT00095940|741093|P2|STARTED|Molecular Biology Phase||2
302318|NCT00095940|741094|P1|STARTED|Molecular Biology Phase||2
302319|NCT00095875|741118|P2|NOT COMPLETED|Overall Study||9
302320|NCT00095875|741119|P1|NOT COMPLETED|Overall Study||14
302321|NCT00095875|741118|P2|COMPLETED|Overall Study||66
302322|NCT00095875|741119|P1|COMPLETED|Overall Study||56
302323|NCT00095875|741118|P2|STARTED|Overall Study||75
302324|NCT00095875|741119|P1|STARTED|Overall Study||70
302325|NCT00095836|741127|P1|NOT COMPLETED|Overall Study||4
302326|NCT00095836|741127|P1|COMPLETED|Overall Study||23
302327|NCT00095836|741127|P1|STARTED|Overall Study||27
302328|NCT00095784|741134|P1|NOT COMPLETED|Overall Study||0
302329|NCT00095784|741134|P1|COMPLETED|Overall Study||21
302330|NCT00095784|741134|P1|STARTED|Overall Study||21
302331|NCT00095628|741157|P1|NOT COMPLETED|Overall Study||1
302332|NCT00095628|741157|P1|COMPLETED|Overall Study||20
302333|NCT00095628|741157|P1|STARTED|Overall Study||21
302334|NCT00095576|741168|P2|NOT COMPLETED|Overall Study||1481
302335|NCT00095576|741169|P1|NOT COMPLETED|Overall Study||1475
302336|NCT00095576|741168|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
302337|NCT00095576|741169|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
302338|NCT00095576|741168|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
302339|NCT00095576|741169|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
302340|NCT00095576|741168|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
302341|NCT00095576|741169|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
302342|NCT00095576|741168|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
302343|NCT00095576|741169|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
302344|NCT00095576|741168|P2|STARTED|Overall Study||1495
302345|NCT00095576|741169|P1|STARTED|Overall Study||1484
302346|NCT00095563|741181|P1|NOT COMPLETED|Overall Study||0
302347|NCT00095563|741181|P1|COMPLETED|Overall Study||39
302348|NCT00095563|741181|P1|STARTED|Overall Study||39
302349|NCT00095498|741193|P3|NOT COMPLETED|Overall Study||39
302350|NCT00095498|741194|P2|NOT COMPLETED|Overall Study||35
302351|NCT00095498|741195|P1|NOT COMPLETED|Overall Study||37
302352|NCT00095498|741193|P3|COMPLETED|Overall Study||39
302353|NCT00095498|741194|P2|COMPLETED|Overall Study||38
302354|NCT00095498|741195|P1|COMPLETED|Overall Study||39
302355|NCT00095498|741193|P3|Received Investigational Product|Overall Study||75
302356|NCT00095498|741194|P2|Received Investigational Product|Overall Study||71
302357|NCT00095498|741195|P1|Received Investigational Product|Overall Study||72
302358|NCT00095498|741193|P3|STARTED|Overall Study||78
302359|NCT00095498|741194|P2|STARTED|Overall Study||73
302360|NCT00095498|741195|P1|STARTED|Overall Study||76
302361|NCT00095303|741622|P2|NOT COMPLETED|Follow Up Study||58
302362|NCT00095303|741623|P1|NOT COMPLETED|Follow Up Study||59
302363|NCT00095303|741622|P2|COMPLETED|Follow Up Study||121
302364|NCT00095303|741623|P1|COMPLETED|Follow Up Study||140
302365|NCT00095303|741622|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
302366|NCT00095303|741623|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
302367|NCT00095303|741622|P2|NOT COMPLETED|Main Study||87
302368|NCT00095303|741623|P1|NOT COMPLETED|Main Study||91
302369|NCT00095303|741622|P2|COMPLETED|Main Study||148
302370|NCT00095303|741623|P1|COMPLETED|Main Study||154
302371|NCT00095303|741622|P2|STARTED|Main Study||235
302372|NCT00095303|741623|P1|STARTED|Main Study||245
302373|NCT00095238|741691|P2|NOT COMPLETED|Overall Study||852
302374|NCT00095238|741692|P1|NOT COMPLETED|Overall Study||857
302375|NCT00095238|741691|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
302376|NCT00095238|741692|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
302377|NCT00095238|741691|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
302378|NCT00095238|741692|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
302379|NCT00095238|741691|P2|STARTED|Overall Study|number randomized|2061
302380|NCT00095238|741692|P1|STARTED|Overall Study|number randomized|2067
302381|NCT00095212|741754|P2|NOT COMPLETED|Overall Study||3
302382|NCT00095212|741755|P1|NOT COMPLETED|Overall Study||1
302383|NCT00095212|741754|P2|COMPLETED|Overall Study||9
302384|NCT00095212|741755|P1|COMPLETED|Overall Study||12
302385|NCT00095212|741754|P2|STARTED|Overall Study||12
302386|NCT00095212|741755|P1|STARTED|Overall Study||13
302387|NCT00095199|741785|P4|NOT COMPLETED|Overall Study||143
302388|NCT00095199|741786|P3|NOT COMPLETED|Overall Study||160
302389|NCT00095199|741787|P2|NOT COMPLETED|Overall Study||242
302390|NCT00095199|741788|P1|NOT COMPLETED|Overall Study||296
302391|NCT00095199|741785|P4|COMPLETED|Overall Study||23
302392|NCT00095199|741786|P3|COMPLETED|Overall Study||7
302393|NCT00095199|741787|P2|COMPLETED|Overall Study||62
302394|NCT00095199|741788|P1|COMPLETED|Overall Study||6
302395|NCT00095199|741785|P4|STARTED|Overall Study||166
302396|NCT00095199|741786|P3|STARTED|Overall Study||167
302397|NCT00095199|741787|P2|STARTED|Overall Study||304
302398|NCT00095199|741788|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
302399|NCT00095173|741826|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
302400|NCT00095173|741827|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
302401|NCT00095173|741828|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
302402|NCT00095173|741829|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
302403|NCT00095173|741830|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
302404|NCT00095173|741831|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
302405|NCT00095173|741826|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
302406|NCT00095173|741827|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
302407|NCT00095173|741828|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
302408|NCT00095173|741829|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
302409|NCT00095173|741830|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
302410|NCT00095173|741831|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
302411|NCT00095173|741826|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
302412|NCT00095173|741827|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
302413|NCT00095173|741828|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
302414|NCT00095173|741829|P3|STARTED|Open-Label Extension Phase (Period C)||0
302415|NCT00095173|741830|P2|STARTED|Open-Label Extension Phase (Period C)||0
302416|NCT00095173|741831|P1|STARTED|Open-Label Extension Phase (Period C)||0
302417|NCT00095173|741826|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
302418|NCT00095173|741827|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
302419|NCT00095173|741828|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
302420|NCT00095173|741829|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
302421|NCT00095173|741830|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
302422|NCT00095173|741831|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
302423|NCT00095173|741826|P6|COMPLETED|Double-Blind Phase (Period B)||0
302424|NCT00095173|741827|P5|COMPLETED|Double-Blind Phase (Period B)||0
302425|NCT00095173|741828|P4|COMPLETED|Double-Blind Phase (Period B)||0
302426|NCT00095173|741829|P3|COMPLETED|Double-Blind Phase (Period B)||31
302427|NCT00095173|741830|P2|COMPLETED|Double-Blind Phase (Period B)||49
302428|NCT00095173|741831|P1|COMPLETED|Double-Blind Phase (Period B)||0
302429|NCT00095173|741826|P6|STARTED|Double-Blind Phase (Period B)||0
302430|NCT00095173|741827|P5|STARTED|Double-Blind Phase (Period B)||0
302431|NCT00095173|741828|P4|STARTED|Double-Blind Phase (Period B)||0
302432|NCT00095173|741829|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
302433|NCT00095173|741830|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
302434|NCT00095173|741831|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
302435|NCT00095173|741826|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
302436|NCT00095173|741827|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
302437|NCT00095173|741828|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
302438|NCT00095173|741829|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
302439|NCT00095173|741830|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
302440|NCT00095173|741831|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
302441|NCT00095173|741826|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
302442|NCT00095173|741827|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
302443|NCT00095173|741828|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
302444|NCT00095173|741829|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
302445|NCT00095173|741830|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
302446|NCT00095173|741831|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
302447|NCT00095173|741826|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
302448|NCT00095173|741827|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
302449|NCT00095173|741828|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
302450|NCT00095173|741829|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
302451|NCT00095173|741830|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
302452|NCT00095173|741831|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
302453|NCT00095147|741869|P5|NOT COMPLETED|Long-term Extension Period||45
302454|NCT00095147|741870|P4|NOT COMPLETED|Long-term Extension Period||0
302455|NCT00095147|741871|P3|NOT COMPLETED|Long-term Extension Period||0
302456|NCT00095147|741872|P2|NOT COMPLETED|Long-term Extension Period||0
302457|NCT00095147|741873|P1|NOT COMPLETED|Long-term Extension Period||0
302458|NCT00095147|741869|P5|COMPLETED|Long-term Extension Period||327
302459|NCT00095147|741870|P4|COMPLETED|Long-term Extension Period||0
302460|NCT00095147|741871|P3|COMPLETED|Long-term Extension Period||0
302461|NCT00095147|741872|P2|COMPLETED|Long-term Extension Period||0
302462|NCT00095147|741873|P1|COMPLETED|Long-term Extension Period||0
302463|NCT00095147|741869|P5|STARTED|Long-term Extension Period||372
302464|NCT00095147|741870|P4|STARTED|Long-term Extension Period||0
302465|NCT00095147|741871|P3|STARTED|Long-term Extension Period||0
302466|NCT00095147|741872|P2|STARTED|Long-term Extension Period||0
302467|NCT00095147|741873|P1|STARTED|Long-term Extension Period||0
302468|NCT00095147|741869|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
302469|NCT00095147|741870|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
302470|NCT00095147|741871|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
302471|NCT00095147|741872|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
302472|NCT00095147|741873|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
302473|NCT00095147|741869|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
302474|NCT00095147|741870|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
302475|NCT00095147|741871|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
302476|NCT00095147|741872|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
302477|NCT00095147|741873|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
302478|NCT00095147|741869|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
302479|NCT00095147|741870|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
302480|NCT00095147|741871|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
302481|NCT00095147|741872|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
302482|NCT00095147|741873|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
302483|NCT00095147|741869|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
302484|NCT00095147|741870|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
302485|NCT00095147|741871|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
302486|NCT00095147|741872|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
302487|NCT00095147|741873|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
302488|NCT00095147|741869|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
302489|NCT00095147|741870|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
302490|NCT00095147|741871|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
302491|NCT00095147|741872|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
302492|NCT00095147|741873|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
302493|NCT00095147|741869|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
302494|NCT00095147|741870|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
302495|NCT00095147|741871|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
302496|NCT00095147|741872|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
302497|NCT00095147|741873|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
302498|NCT00095121|742068|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
302499|NCT00095121|742069|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
302500|NCT00095121|742068|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
302501|NCT00095121|742069|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
302502|NCT00095121|742068|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
302503|NCT00095121|742069|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
302504|NCT00095121|742068|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
302505|NCT00095121|742069|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
302506|NCT00095121|742068|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
302507|NCT00095121|742069|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
302508|NCT00095121|742068|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
302509|NCT00095121|742069|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
302510|NCT00095121|742068|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
302511|NCT00095121|742069|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
302512|NCT00095056|742115|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
302513|NCT00095056|742116|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
302514|NCT00095056|742115|P2|COMPLETED|Phase B (Weeks 12-54)||20
302515|NCT00095056|742116|P1|COMPLETED|Phase B (Weeks 12-54)||46
302516|NCT00095056|742115|P2|STARTED|Phase B (Weeks 12-54)||25
302517|NCT00095056|742116|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
302518|NCT00095056|742115|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
302519|NCT00095056|742116|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
302520|NCT00095056|742115|P2|COMPLETED|Phase A (Weeks 0-12)||25
302521|NCT00095056|742116|P1|COMPLETED|Phase A (Weeks 0-12)||58
302522|NCT00095056|742115|P2|STARTED|Phase A (Weeks 0-12)||26
302523|NCT00095056|742116|P1|STARTED|Phase A (Weeks 0-12)||65
302524|NCT00094900|742124|P1|NOT COMPLETED|Overall Study||1
302525|NCT00094900|742124|P1|COMPLETED|Overall Study||10
302526|NCT00094900|742124|P1|STARTED|Overall Study||11
302527|NCT00094887|742226|P2|NOT COMPLETED|Overall Study||6
302528|NCT00094887|742227|P1|NOT COMPLETED|Overall Study||5
302529|NCT00094887|742226|P2|COMPLETED|Overall Study||69
302530|NCT00094887|742227|P1|COMPLETED|Overall Study||70
302531|NCT00094887|742226|P2|STARTED|Overall Study|75|75
302532|NCT00094887|742227|P1|STARTED|Overall Study|75|75
302533|NCT00094861|742235|P2|NOT COMPLETED|Overall Study||9
302534|NCT00094861|742236|P1|NOT COMPLETED|Overall Study||18
302535|NCT00094861|742235|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
302536|NCT00094861|742236|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
302537|NCT00094861|742235|P2|Participants Treated|Overall Study||48
302538|NCT00094861|742236|P1|Participants Treated|Overall Study||46
302539|NCT00094861|742235|P2|STARTED|Overall Study||49
302540|NCT00094861|742236|P1|STARTED|Overall Study||46
302541|NCT00094835|742263|P7|NOT COMPLETED|Overall Study||2
302542|NCT00094835|742264|P6|NOT COMPLETED|Overall Study||3
302543|NCT00094835|742265|P5|NOT COMPLETED|Overall Study||4
302544|NCT00094835|742266|P4|NOT COMPLETED|Overall Study||1
302545|NCT00094835|742267|P3|NOT COMPLETED|Overall Study||3
302546|NCT00094835|742268|P2|NOT COMPLETED|Overall Study||3
302547|NCT00094835|742269|P1|NOT COMPLETED|Overall Study||4
302548|NCT00094835|742263|P7|COMPLETED|Overall Study||4
302549|NCT00094835|742264|P6|COMPLETED|Overall Study||3
302550|NCT00094835|742265|P5|COMPLETED|Overall Study||3
302551|NCT00094835|742266|P4|COMPLETED|Overall Study||4
302552|NCT00094835|742267|P3|COMPLETED|Overall Study||4
302553|NCT00094835|742268|P2|COMPLETED|Overall Study||8
302554|NCT00094835|742269|P1|COMPLETED|Overall Study||5
302555|NCT00094835|742263|P7|Treated With Motesanib|Overall Study||6
302556|NCT00094835|742264|P6|Treated With Motesanib|Overall Study||5
302557|NCT00094835|742265|P5|Treated With Motesanib|Overall Study||7
302558|NCT00094835|742266|P4|Treated With Motesanib|Overall Study||4
302559|NCT00094835|742267|P3|Treated With Motesanib|Overall Study||6
302560|NCT00094835|742268|P2|Treated With Motesanib|Overall Study||11
302561|NCT00094835|742269|P1|Treated With Motesanib|Overall Study||6
302562|NCT00094835|742263|P7|STARTED|Overall Study||6
302563|NCT00094835|742264|P6|STARTED|Overall Study||6
302564|NCT00094835|742265|P5|STARTED|Overall Study||7
302565|NCT00094835|742266|P4|STARTED|Overall Study||5
302566|NCT00094835|742267|P3|STARTED|Overall Study||7
302567|NCT00094835|742268|P2|STARTED|Overall Study||11
302568|NCT00094835|742269|P1|STARTED|Overall Study||9
302569|NCT00094809|742347|P2|NOT COMPLETED|Overall Study||65
302570|NCT00094809|742348|P1|NOT COMPLETED|Overall Study||52
302571|NCT00094809|742347|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
302572|NCT00094809|742348|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
302573|NCT00094809|742347|P2|Completed All 4 Cycles of Treatment|Overall Study||90
302574|NCT00094809|742348|P1|Completed All 4 Cycles of Treatment|Overall Study||98
302575|NCT00094809|742347|P2|Properly Consented; Received Study Drug|Overall Study||118
302576|NCT00094809|742348|P1|Properly Consented; Received Study Drug|Overall Study||123
302577|NCT00094809|742347|P2|Received Study Drug|Overall Study||118
302578|NCT00094809|742348|P1|Received Study Drug|Overall Study||124
302579|NCT00094809|742347|P2|STARTED|Overall Study||126
302580|NCT00094809|742348|P1|STARTED|Overall Study||126
302581|NCT00094770|742374|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
302582|NCT00094770|742375|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
302583|NCT00094770|742374|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
302584|NCT00094770|742375|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
302585|NCT00094770|742374|P2|STARTED|Year 2 (Week 0 to Week 104)||584
302586|NCT00094770|742375|P1|STARTED|Year 2 (Week 0 to Week 104)||588
302587|NCT00094770|742374|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
302588|NCT00094770|742375|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
302589|NCT00094770|742374|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
302590|NCT00094770|742375|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
302591|NCT00094770|742374|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
302592|NCT00094770|742375|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
302593|NCT00094757|742406|P3|NOT COMPLETED|Overall Study||30
302594|NCT00094757|742407|P2|NOT COMPLETED|Overall Study||62
302595|NCT00094757|742408|P1|NOT COMPLETED|Overall Study||53
302596|NCT00094757|742406|P3|COMPLETED|Overall Study||80
302597|NCT00094757|742407|P2|COMPLETED|Overall Study||144
302598|NCT00094757|742408|P1|COMPLETED|Overall Study||152
302599|NCT00094757|742406|P3|STARTED|Overall Study||110
302600|NCT00094757|742407|P2|STARTED|Overall Study||206
302601|NCT00094757|742408|P1|STARTED|Overall Study||205
302602|NCT00094653|742428|P3|NOT COMPLETED|Overall Study||126
302603|NCT00094653|742429|P2|NOT COMPLETED|Overall Study||106
302604|NCT00094653|742430|P1|NOT COMPLETED|Overall Study||321
302605|NCT00094653|742428|P3|COMPLETED|Overall Study||10
302606|NCT00094653|742429|P2|COMPLETED|Overall Study||31
302607|NCT00094653|742430|P1|COMPLETED|Overall Study||82
302608|NCT00094653|742428|P3|Treated|Overall Study||131
302609|NCT00094653|742429|P2|Treated|Overall Study||131
302610|NCT00094653|742430|P1|Treated|Overall Study||381
302611|NCT00094653|742428|P3|STARTED|Overall Study||136
302612|NCT00094653|742429|P2|STARTED|Overall Study||137
302613|NCT00094653|742430|P1|STARTED|Overall Study||403
302614|NCT00094575|742493|P2|NOT COMPLETED|Overall Study||146
302615|NCT00094575|742494|P1|NOT COMPLETED|Overall Study||146
302616|NCT00094575|742493|P2|COMPLETED|Overall Study||291
302617|NCT00094575|742494|P1|COMPLETED|Overall Study||298
302618|NCT00094575|742493|P2|STARTED|Overall Study||437
302619|NCT00094575|742494|P1|STARTED|Overall Study||444
302620|NCT00094536|742514|P1|NOT COMPLETED|Treatment and Follow-up||31
302621|NCT00094536|742514|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
302622|NCT00094536|742514|P1|36 Month Follow-up|Treatment and Follow-up||51
302623|NCT00094536|742514|P1|24 Month Follow-up|Treatment and Follow-up||53
302624|NCT00094536|742514|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
302625|NCT00094536|742514|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
302626|NCT00094536|742514|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
302627|NCT00094536|742514|P1|COMPLETED|Inclusion Exclusion Evaluation||82
302628|NCT00094536|742514|P1|STARTED|Inclusion Exclusion Evaluation||106
302629|NCT00094497|742520|P2|NOT COMPLETED|Overall Study||0
302630|NCT00094497|742521|P1|NOT COMPLETED|Overall Study||0
302631|NCT00094497|742520|P2|COMPLETED|Overall Study||153
302632|NCT00094497|742521|P1|COMPLETED|Overall Study||151
302633|NCT00094497|742520|P2|Received Second Line Therapy|Overall Study||101
302634|NCT00094497|742521|P1|Received Second Line Therapy|Overall Study||84
302635|NCT00094497|742520|P2|Treated|Overall Study||149
302636|NCT00094497|742521|P1|Treated|Overall Study||148
302637|NCT00094497|742520|P2|STARTED|Overall Study||153
302638|NCT00094497|742521|P1|STARTED|Overall Study||151
302639|NCT00094458|742538|P6|NOT COMPLETED|OLE: Open-Label Extension||4
302640|NCT00094458|742539|P5|NOT COMPLETED|OLE: Open-Label Extension||5
302641|NCT00094458|742540|P4|NOT COMPLETED|OLE: Open-Label Extension||1
302642|NCT00094458|742541|P3|NOT COMPLETED|OLE: Open-Label Extension||0
302643|NCT00094458|742542|P2|NOT COMPLETED|OLE: Open-Label Extension||0
302644|NCT00094458|742543|P1|NOT COMPLETED|OLE: Open-Label Extension||0
302645|NCT00094458|742538|P6|COMPLETED|OLE: Open-Label Extension||13
302646|NCT00094458|742539|P5|COMPLETED|OLE: Open-Label Extension||13
302647|NCT00094458|742540|P4|COMPLETED|OLE: Open-Label Extension||7
302648|NCT00094458|742541|P3|COMPLETED|OLE: Open-Label Extension||0
302649|NCT00094458|742542|P2|COMPLETED|OLE: Open-Label Extension||0
302650|NCT00094458|742543|P1|COMPLETED|OLE: Open-Label Extension||0
302651|NCT00094458|742538|P6|STARTED|OLE: Open-Label Extension||17
302652|NCT00094458|742539|P5|STARTED|OLE: Open-Label Extension||18
302653|NCT00094458|742540|P4|STARTED|OLE: Open-Label Extension||8
302654|NCT00094458|742541|P3|STARTED|OLE: Open-Label Extension||0
302655|NCT00094458|742542|P2|STARTED|OLE: Open-Label Extension||0
302656|NCT00094458|742543|P1|STARTED|OLE: Open-Label Extension||0
302657|NCT00094458|742538|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
302658|NCT00094458|742539|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
302659|NCT00094458|742540|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
302660|NCT00094458|742541|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
302661|NCT00094458|742542|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
302662|NCT00094458|742543|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
302663|NCT00094458|742538|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
302664|NCT00094458|742539|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
302665|NCT00094458|742540|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
302666|NCT00094458|742541|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
302667|NCT00094458|742542|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
302668|NCT00094458|742543|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
302669|NCT00094458|742538|P6|STARTED|Study Extension: Week 30 Through Week 50||0
302670|NCT00094458|742539|P5|STARTED|Study Extension: Week 30 Through Week 50||0
302671|NCT00094458|742540|P4|STARTED|Study Extension: Week 30 Through Week 50||0
302672|NCT00094458|742541|P3|STARTED|Study Extension: Week 30 Through Week 50||108
302673|NCT00094458|742542|P2|STARTED|Study Extension: Week 30 Through Week 50||97
302674|NCT00094458|742543|P1|STARTED|Study Extension: Week 30 Through Week 50||75
302675|NCT00094458|742538|P6|NOT COMPLETED|Main Study: Through Week 30||0
302676|NCT00094458|742539|P5|NOT COMPLETED|Main Study: Through Week 30||0
302677|NCT00094458|742540|P4|NOT COMPLETED|Main Study: Through Week 30||0
302678|NCT00094458|742541|P3|NOT COMPLETED|Main Study: Through Week 30||48
302679|NCT00094458|742542|P2|NOT COMPLETED|Main Study: Through Week 30||58
302680|NCT00094458|742543|P1|NOT COMPLETED|Main Study: Through Week 30||84
302681|NCT00094458|742538|P6|COMPLETED|Main Study: Through Week 30||0
302682|NCT00094458|742539|P5|COMPLETED|Main Study: Through Week 30||0
302683|NCT00094458|742540|P4|COMPLETED|Main Study: Through Week 30||0
302684|NCT00094458|742541|P3|COMPLETED|Main Study: Through Week 30||121
302685|NCT00094458|742542|P2|COMPLETED|Main Study: Through Week 30||111
302686|NCT00094458|742543|P1|COMPLETED|Main Study: Through Week 30||86
302687|NCT00094458|742538|P6|STARTED|Main Study: Through Week 30||0
302688|NCT00094458|742539|P5|STARTED|Main Study: Through Week 30||0
302689|NCT00094458|742540|P4|STARTED|Main Study: Through Week 30||0
302690|NCT00094458|742541|P3|STARTED|Main Study: Through Week 30||169
302691|NCT00094458|742542|P2|STARTED|Main Study: Through Week 30||169
302692|NCT00094458|742543|P1|STARTED|Main Study: Through Week 30||170
302693|NCT00094328|742581|P1|NOT COMPLETED|Overall Study||1
302694|NCT00094328|742581|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
302695|NCT00094328|742581|P1|STARTED|Overall Study|Received treatment|14
302696|NCT00094302|742591|P2|NOT COMPLETED|Overall Study||406
302697|NCT00094302|742592|P1|NOT COMPLETED|Overall Study||417
302698|NCT00094302|742591|P2|COMPLETED|Overall Study||1316
302699|NCT00094302|742592|P1|COMPLETED|Overall Study||1306
302700|NCT00094302|742591|P2|STARTED|Overall Study||1722
302701|NCT00094302|742592|P1|STARTED|Overall Study||1723
302702|NCT00094172|742648|P2|NOT COMPLETED|Overall Study||7
302703|NCT00094172|742649|P1|NOT COMPLETED|Overall Study||14
302704|NCT00094172|742648|P2|COMPLETED|Overall Study||25
302705|NCT00094172|742649|P1|COMPLETED|Overall Study||36
302706|NCT00094172|742648|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
302707|NCT00094172|742649|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
302708|NCT00094107|742659|P1|NOT COMPLETED|Overall Study||32
302709|NCT00094107|742659|P1|COMPLETED|Overall Study||0
302710|NCT00094107|742659|P1|STARTED|Overall Study||32
302711|NCT00094094|742668|P1|NOT COMPLETED|Overall Study||32
302712|NCT00094094|742668|P1|COMPLETED|Overall Study||0
302713|NCT00094094|742668|P1|STARTED|Overall Study||32
302714|NCT00094055|742677|P1|NOT COMPLETED|Overall Study||60
302715|NCT00094055|742677|P1|COMPLETED|Overall Study||0
302716|NCT00094055|742677|P1|STARTED|Overall Study||60
302717|NCT00093847|742688|P2|NOT COMPLETED|Overall Study||10
302718|NCT00093847|742689|P1|NOT COMPLETED|Overall Study||8
302719|NCT00093847|742688|P2|COMPLETED|Overall Study||24
302720|NCT00093847|742689|P1|COMPLETED|Overall Study||31
302721|NCT00093847|742688|P2|STARTED|Overall Study||34
302722|NCT00093847|742689|P1|STARTED|Overall Study||39
302723|NCT00093808|742697|P1|NOT COMPLETED|Overall Study||2
302724|NCT00093808|742697|P1|COMPLETED|Overall Study||45
302725|NCT00093808|742697|P1|STARTED|Overall Study||47
302726|NCT00093795|742707|P3|NOT COMPLETED|Overall Study||17
302727|NCT00093795|742708|P2|NOT COMPLETED|Overall Study||16
302728|NCT00093795|742709|P1|NOT COMPLETED|Overall Study||20
302729|NCT00093795|742707|P3|COMPLETED|Overall Study||1613
302730|NCT00093795|742708|P2|COMPLETED|Overall Study||1618
302731|NCT00093795|742709|P1|COMPLETED|Overall Study||1610
302732|NCT00093795|742707|P3|STARTED|Overall Study||1630
302733|NCT00093795|742708|P2|STARTED|Overall Study||1634
302734|NCT00093795|742709|P1|STARTED|Overall Study||1630
302735|NCT00093782|742729|P1|NOT COMPLETED|Overall Study||0
302736|NCT00093782|742729|P1|COMPLETED|Overall Study||36
302737|NCT00093782|742729|P1|STARTED|Overall Study||36
302738|NCT00093756|742741|P2|NOT COMPLETED|Overall Study||0
302739|NCT00093756|742742|P1|NOT COMPLETED|Overall Study||0
302740|NCT00093756|742741|P2|COMPLETED|Overall Study||21
302741|NCT00093756|742742|P1|COMPLETED|Overall Study||27
302742|NCT00093756|742741|P2|STARTED|Overall Study||21
302743|NCT00093756|742742|P1|STARTED|Overall Study||27
302744|NCT00093496|742754|P2|NOT COMPLETED|Overall Study||3
302745|NCT00093496|742755|P1|NOT COMPLETED|Overall Study||1
302746|NCT00093496|742754|P2|COMPLETED|Overall Study||11
302747|NCT00093496|742755|P1|COMPLETED|Overall Study||14
302748|NCT00093496|742754|P2|STARTED|Overall Study||14
302749|NCT00093496|742755|P1|STARTED|Overall Study||15
302750|NCT00093470|742768|P2|NOT COMPLETED|Overall Study||0
302751|NCT00093470|742769|P1|NOT COMPLETED|Overall Study||73
302752|NCT00093470|742768|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
302753|NCT00093470|742769|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
302754|NCT00093470|742768|P2|Patients With Toxicity Assessment|Overall Study||69
302755|NCT00093470|742769|P1|Patients With Toxicity Assessment|Overall Study||72
302756|NCT00093470|742768|P2|Treated|Overall Study||71
302757|NCT00093470|742769|P1|Treated|Overall Study||72
302758|NCT00093470|742768|P2|STARTED|Overall Study||71
302759|NCT00093470|742769|P1|STARTED|Overall Study||73
302760|NCT00093379|742777|P1|NOT COMPLETED|Overall Study||0
302761|NCT00093379|742777|P1|COMPLETED|Overall Study||20
302762|NCT00093379|742777|P1|STARTED|Overall Study||20
302763|NCT00093145|742783|P1|NOT COMPLETED|Overall Study||17
302764|NCT00093145|742783|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
302765|NCT00093145|742783|P1|At Least One Response Assessment|Overall Study||31
302766|NCT00093145|742783|P1|STARTED|Overall Study||32
302767|NCT00093041|742798|P6|NOT COMPLETED|Overall Study||3
302768|NCT00093041|742799|P5|NOT COMPLETED|Overall Study||1
302769|NCT00093041|742800|P4|NOT COMPLETED|Overall Study||1
302770|NCT00093041|742801|P3|NOT COMPLETED|Overall Study||2
302771|NCT00093041|742802|P2|NOT COMPLETED|Overall Study||3
302772|NCT00093041|742803|P1|NOT COMPLETED|Overall Study||2
302773|NCT00093041|742798|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
302774|NCT00093041|742799|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
302775|NCT00093041|742800|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
302776|NCT00093041|742801|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
302777|NCT00093041|742802|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
302778|NCT00093041|742803|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
302779|NCT00093041|742798|P6|STARTED|Overall Study||7
302780|NCT00093041|742799|P5|STARTED|Overall Study||4
302781|NCT00093041|742800|P4|STARTED|Overall Study||4
302782|NCT00093041|742801|P3|STARTED|Overall Study||5
302783|NCT00093041|742802|P2|STARTED|Overall Study||4
302784|NCT00093041|742803|P1|STARTED|Overall Study||4
302785|NCT00093015|742825|P2|NOT COMPLETED|Overall Study||664
302786|NCT00093015|742826|P1|NOT COMPLETED|Overall Study||665
302787|NCT00093015|742825|P2|COMPLETED|Overall Study||1348
302788|NCT00093015|742826|P1|COMPLETED|Overall Study||1361
302789|NCT00093015|742825|P2|Received Study Medication|Overall Study||2004
302790|NCT00093015|742826|P1|Received Study Medication|Overall Study||2019
302791|NCT00093015|742825|P2|STARTED|Overall Study||2012
302792|NCT00093015|742826|P1|STARTED|Overall Study||2026
302793|NCT00092677|742854|P2|NOT COMPLETED|Overall Study||11
302794|NCT00092677|742855|P1|NOT COMPLETED|Overall Study||5
302795|NCT00092677|742854|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
302796|NCT00092677|742855|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
302797|NCT00092677|742854|P2|STARTED|Overall Study||929
302798|NCT00092677|742855|P1|STARTED|Overall Study||944
302799|NCT00092547|742899|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
302800|NCT00092547|742900|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
302801|NCT00092547|742901|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
302802|NCT00092547|742899|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
302803|NCT00092547|742900|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
302804|NCT00092547|742901|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
302805|NCT00092547|742899|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
302806|NCT00092547|742900|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
302807|NCT00092547|742901|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
302808|NCT00092547|742899|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
302809|NCT00092547|742900|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
302810|NCT00092547|742901|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
302811|NCT00092547|742899|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
302812|NCT00092547|742900|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
302813|NCT00092547|742901|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
302814|NCT00092547|742899|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
302815|NCT00092547|742900|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
302816|NCT00092547|742901|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
302817|NCT00092547|742899|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
302818|NCT00092547|742900|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
302819|NCT00092547|742901|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
302820|NCT00092547|742899|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
302821|NCT00092547|742900|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
302822|NCT00092547|742901|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
302823|NCT00092547|742899|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
302824|NCT00092547|742900|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
302825|NCT00092547|742901|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
302826|NCT00092547|742899|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
302827|NCT00092547|742900|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
302828|NCT00092547|742901|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
302829|NCT00092547|742899|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
302830|NCT00092547|742900|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
302831|NCT00092547|742901|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
302832|NCT00092547|742899|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
302833|NCT00092547|742900|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
302834|NCT00092547|742901|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
302835|NCT00092547|742899|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
302836|NCT00092547|742900|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
302837|NCT00092547|742901|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
302838|NCT00092547|742899|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
302839|NCT00092547|742900|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
302840|NCT00092547|742901|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
302841|NCT00092547|742899|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
302842|NCT00092547|742900|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
302843|NCT00092547|742901|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
302844|NCT00092547|742899|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
302845|NCT00092547|742900|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
302846|NCT00092547|742901|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
302847|NCT00092547|742899|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
302848|NCT00092547|742900|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
302849|NCT00092547|742901|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
302850|NCT00092547|742899|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
302851|NCT00092547|742900|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
302852|NCT00092547|742901|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
302853|NCT00092547|742899|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
302854|NCT00092547|742900|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
302855|NCT00092547|742901|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
302856|NCT00092547|742899|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
302857|NCT00092547|742900|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
302858|NCT00092547|742901|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
302859|NCT00092547|742899|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
302860|NCT00092547|742900|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
302861|NCT00092547|742901|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
302862|NCT00092547|742899|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
302863|NCT00092547|742900|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
302864|NCT00092547|742901|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
302865|NCT00092547|742899|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
302866|NCT00092547|742900|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
302867|NCT00092547|742901|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
302868|NCT00092547|742899|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
302869|NCT00092547|742900|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
302870|NCT00092547|742901|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
302871|NCT00092547|742899|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
302872|NCT00092547|742900|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
302873|NCT00092547|742901|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
302874|NCT00092547|742899|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
302875|NCT00092547|742900|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
302876|NCT00092547|742901|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
302877|NCT00092534|742945|P3|NOT COMPLETED|Extension Study||145
302878|NCT00092534|742946|P2|NOT COMPLETED|Extension Study||0
302879|NCT00092534|742947|P1|NOT COMPLETED|Extension Study||0
302880|NCT00092534|742945|P3|COMPLETED|Extension Study||449
302881|NCT00092534|742946|P2|COMPLETED|Extension Study||0
302882|NCT00092534|742947|P1|COMPLETED|Extension Study||0
302883|NCT00092534|742945|P3|STARTED|Extension Study||594
302884|NCT00092534|742946|P2|STARTED|Extension Study||0
302885|NCT00092534|742947|P1|STARTED|Extension Study||0
302886|NCT00092534|742945|P3|NOT COMPLETED|Base Study Follow Up Period||0
302887|NCT00092534|742946|P2|NOT COMPLETED|Base Study Follow Up Period||694
302888|NCT00092534|742947|P1|NOT COMPLETED|Base Study Follow Up Period||316
302889|NCT00092534|742945|P3|COMPLETED|Base Study Follow Up Period||0
302890|NCT00092534|742946|P2|COMPLETED|Base Study Follow Up Period||5277
302891|NCT00092534|742947|P1|COMPLETED|Base Study Follow Up Period||5626
302892|NCT00092534|742945|P3|STARTED|Base Study Follow Up Period||0
302893|NCT00092534|742946|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
302894|NCT00092534|742947|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
302895|NCT00092534|742945|P3|NOT COMPLETED|Base Study Vaccination Period||0
302896|NCT00092534|742946|P2|NOT COMPLETED|Base Study Vaccination Period||126
302897|NCT00092534|742947|P1|NOT COMPLETED|Base Study Vaccination Period||171
302898|NCT00092534|742945|P3|COMPLETED|Base Study Vaccination Period||0
302899|NCT00092534|742946|P2|COMPLETED|Base Study Vaccination Period||5954
302900|NCT00092534|742947|P1|COMPLETED|Base Study Vaccination Period||5916
302901|NCT00092534|742945|P3|STARTED|Base Study Vaccination Period||0
302902|NCT00092534|742946|P2|STARTED|Base Study Vaccination Period||6080
302903|NCT00092534|742947|P1|STARTED|Base Study Vaccination Period||6087
302904|NCT00092521|742965|P4|NOT COMPLETED|Extension Study (Group 4)||209
302905|NCT00092521|742966|P3|NOT COMPLETED|Extension Study (Group 4)||0
302906|NCT00092521|742967|P2|NOT COMPLETED|Extension Study (Group 4)||0
302907|NCT00092521|742968|P1|NOT COMPLETED|Extension Study (Group 4)||0
302908|NCT00092521|742965|P4|COMPLETED|Extension Study (Group 4)||635
302909|NCT00092521|742966|P3|COMPLETED|Extension Study (Group 4)||0
302910|NCT00092521|742967|P2|COMPLETED|Extension Study (Group 4)||0
302911|NCT00092521|742968|P1|COMPLETED|Extension Study (Group 4)||0
302912|NCT00092521|742965|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
302913|NCT00092521|742966|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
302914|NCT00092521|742967|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
302915|NCT00092521|742968|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
302916|NCT00092521|742965|P4|Initiated Extension Study|Extension Study (Group 4)||829
302917|NCT00092521|742966|P3|Initiated Extension Study|Extension Study (Group 4)||0
302918|NCT00092521|742967|P2|Initiated Extension Study|Extension Study (Group 4)||0
302919|NCT00092521|742968|P1|Initiated Extension Study|Extension Study (Group 4)||0
302920|NCT00092521|742965|P4|STARTED|Extension Study (Group 4)||844
302921|NCT00092521|742966|P3|STARTED|Extension Study (Group 4)||0
302922|NCT00092521|742967|P2|STARTED|Extension Study (Group 4)||0
302923|NCT00092521|742968|P1|STARTED|Extension Study (Group 4)||0
302924|NCT00092521|742965|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
302925|NCT00092521|742966|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
302926|NCT00092521|742967|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
302927|NCT00092521|742968|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
302928|NCT00092521|742965|P4|COMPLETED|Follow-Up (After Month 7)||0
302929|NCT00092521|742966|P3|COMPLETED|Follow-Up (After Month 7)||1959
302930|NCT00092521|742967|P2|COMPLETED|Follow-Up (After Month 7)||155
302931|NCT00092521|742968|P1|COMPLETED|Follow-Up (After Month 7)||2353
302932|NCT00092521|742965|P4|STARTED|Follow-Up (After Month 7)||0
302933|NCT00092521|742966|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
302934|NCT00092521|742967|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
302935|NCT00092521|742968|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
302936|NCT00092521|742965|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
302937|NCT00092521|742966|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
302938|NCT00092521|742967|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
302939|NCT00092521|742968|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
302940|NCT00092521|742965|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
302941|NCT00092521|742966|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
302942|NCT00092521|742967|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
302943|NCT00092521|742968|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
302944|NCT00092521|742965|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
302945|NCT00092521|742966|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
302946|NCT00092521|742967|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
302947|NCT00092521|742968|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
302948|NCT00092495|742982|P5|NOT COMPLETED|Extension Study||0
302949|NCT00092495|742983|P4|NOT COMPLETED|Extension Study||0
302950|NCT00092495|742984|P3|NOT COMPLETED|Extension Study||0
302951|NCT00092495|742985|P2|NOT COMPLETED|Extension Study||0
302952|NCT00092495|742986|P1|NOT COMPLETED|Extension Study||0
302953|NCT00092495|742982|P5|COMPLETED|Extension Study||12
302954|NCT00092495|742983|P4|COMPLETED|Extension Study||0
302955|NCT00092495|742984|P3|COMPLETED|Extension Study||0
302956|NCT00092495|742985|P2|COMPLETED|Extension Study||0
302957|NCT00092495|742986|P1|COMPLETED|Extension Study||0
302958|NCT00092495|742982|P5|STARTED|Extension Study||12
302959|NCT00092495|742983|P4|STARTED|Extension Study||0
302960|NCT00092495|742984|P3|STARTED|Extension Study||0
302961|NCT00092495|742985|P2|STARTED|Extension Study||0
302962|NCT00092495|742986|P1|STARTED|Extension Study||0
302963|NCT00092495|742982|P5|NOT COMPLETED|Base Study Follow-up Period||0
302964|NCT00092495|742983|P4|NOT COMPLETED|Base Study Follow-up Period||14
302965|NCT00092495|742984|P3|NOT COMPLETED|Base Study Follow-up Period||4
302966|NCT00092495|742985|P2|NOT COMPLETED|Base Study Follow-up Period||3
302967|NCT00092495|742986|P1|NOT COMPLETED|Base Study Follow-up Period||3
302968|NCT00092495|742982|P5|COMPLETED|Base Study Follow-up Period||0
302969|NCT00092495|742983|P4|COMPLETED|Base Study Follow-up Period||446
302970|NCT00092495|742984|P3|COMPLETED|Base Study Follow-up Period||126
302971|NCT00092495|742985|P2|COMPLETED|Base Study Follow-up Period||122
302972|NCT00092495|742986|P1|COMPLETED|Base Study Follow-up Period||112
302973|NCT00092495|742982|P5|STARTED|Base Study Follow-up Period||0
302974|NCT00092495|742983|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
302975|NCT00092495|742984|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
302976|NCT00092495|742985|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
302977|NCT00092495|742986|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
302978|NCT00092495|742982|P5|NOT COMPLETED|Base Study Vaccination Period||0
302979|NCT00092495|742983|P4|NOT COMPLETED|Base Study Vaccination Period||88
302980|NCT00092495|742984|P3|NOT COMPLETED|Base Study Vaccination Period||34
302981|NCT00092495|742985|P2|NOT COMPLETED|Base Study Vaccination Period||22
302982|NCT00092495|742986|P1|NOT COMPLETED|Base Study Vaccination Period||37
302983|NCT00092495|742982|P5|COMPLETED|Base Study Vaccination Period||0
302984|NCT00092495|742983|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
302985|NCT00092495|742984|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
302986|NCT00092495|742985|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
302987|NCT00092495|742986|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
302988|NCT00092495|742982|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
302989|NCT00092495|742983|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
302990|NCT00092495|742984|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
302991|NCT00092495|742985|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
302992|NCT00092495|742986|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
302993|NCT00092495|742982|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
302994|NCT00092495|742983|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
302995|NCT00092495|742984|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
302996|NCT00092495|742985|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
302997|NCT00092495|742986|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
302998|NCT00092495|742982|P5|STARTED|Base Study Vaccination Period||0
302999|NCT00092495|742983|P4|STARTED|Base Study Vaccination Period||1529
303000|NCT00092495|742984|P3|STARTED|Base Study Vaccination Period||508
303001|NCT00092495|742985|P2|STARTED|Base Study Vaccination Period||514
303002|NCT00092495|742986|P1|STARTED|Base Study Vaccination Period||504
303003|NCT00092456|743052|P4|NOT COMPLETED|Overall Study||16
303004|NCT00092456|743053|P3|NOT COMPLETED|Overall Study||29
303005|NCT00092456|743054|P2|NOT COMPLETED|Overall Study||17
303006|NCT00092456|743055|P1|NOT COMPLETED|Overall Study||25
303007|NCT00092456|743052|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
303008|NCT00092456|743053|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
303009|NCT00092456|743054|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
303010|NCT00092456|743055|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
303011|NCT00092456|743052|P4|Vaccinated at Visit 3|Overall Study||98
303012|NCT00092456|743053|P3|Vaccinated at Visit 3|Overall Study||200
303013|NCT00092456|743054|P2|Vaccinated at Visit 3|Overall Study||210
303014|NCT00092456|743055|P1|Vaccinated at Visit 3|Overall Study||202
303015|NCT00092456|743052|P4|Vaccinated at Visit 2|Overall Study||104
303016|NCT00092456|743053|P3|Vaccinated at Visit 2|Overall Study||210
303017|NCT00092456|743054|P2|Vaccinated at Visit 2|Overall Study||217
303018|NCT00092456|743055|P1|Vaccinated at Visit 2|Overall Study||208
303019|NCT00092456|743052|P4|Vaccinated at Visit 1|Overall Study||113
303020|NCT00092456|743053|P3|Vaccinated at Visit 1|Overall Study||229
303021|NCT00092456|743054|P2|Vaccinated at Visit 1|Overall Study||225
303022|NCT00092456|743055|P1|Vaccinated at Visit 1|Overall Study||226
303023|NCT00092456|743052|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
303024|NCT00092456|743053|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
303025|NCT00092456|743054|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
303026|NCT00092456|743055|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
303027|NCT00092443|743103|P2|NOT COMPLETED|Overall Study||54
303028|NCT00092443|743104|P1|NOT COMPLETED|Overall Study||58
303029|NCT00092443|743103|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
303030|NCT00092443|743104|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
303031|NCT00092443|743103|P2|Vaccinated at Visit 3|Overall Study||608
303032|NCT00092443|743104|P1|Vaccinated at Visit 3|Overall Study||593
303033|NCT00092443|743103|P2|Vaccinated at Visit 2|Overall Study||627
303034|NCT00092443|743104|P1|Vaccinated at Visit 2|Overall Study||618
303035|NCT00092443|743103|P2|Vaccinated at Visit 1|Overall Study||660
303036|NCT00092443|743104|P1|Vaccinated at Visit 1|Overall Study||650
303037|NCT00092443|743103|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
303038|NCT00092443|743104|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
303039|NCT00092417|743122|P2|NOT COMPLETED|Overall Study||1
303040|NCT00092417|743123|P1|NOT COMPLETED|Overall Study||5
303041|NCT00092417|743122|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
303042|NCT00092417|743123|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
303043|NCT00092417|743122|P2|Vaccinated|Overall Study||234
303044|NCT00092417|743123|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
303045|NCT00092417|743122|P2|STARTED|Overall Study|Started Period Group 2|234
303046|NCT00092417|743123|P1|STARTED|Overall Study|Started Period Group 1|464
303047|NCT00092131|743137|P2|NOT COMPLETED|Treatment Period II||1
303048|NCT00092131|743138|P1|NOT COMPLETED|Treatment Period II||0
303049|NCT00092131|743137|P2|COMPLETED|Treatment Period II||25
303050|NCT00092131|743138|P1|COMPLETED|Treatment Period II||24
303051|NCT00092131|743137|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
303052|NCT00092131|743138|P1|STARTED|Treatment Period II||24
303053|NCT00092131|743137|P2|NOT COMPLETED|Treatment Period I||0
303054|NCT00092131|743138|P1|NOT COMPLETED|Treatment Period I||1
303055|NCT00092131|743137|P2|COMPLETED|Treatment Period I||26
303056|NCT00092131|743138|P1|COMPLETED|Treatment Period I||24
303057|NCT00092131|743137|P2|STARTED|Treatment Period I||26
303058|NCT00092131|743138|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
303059|NCT00092118|743168|P2|NOT COMPLETED|Overall Study||89
303060|NCT00092118|743169|P1|NOT COMPLETED|Overall Study||84
303061|NCT00092118|743168|P2|COMPLETED|Overall Study||913
303062|NCT00092118|743169|P1|COMPLETED|Overall Study||906
303063|NCT00092118|743168|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
303064|NCT00092118|743169|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
303065|NCT00091962|743182|P3|NOT COMPLETED|Overall Study||0
303066|NCT00091962|743183|P2|NOT COMPLETED|Overall Study||0
303067|NCT00091962|743184|P1|NOT COMPLETED|Overall Study||0
303068|NCT00091962|743182|P3|COMPLETED|Overall Study||151
303069|NCT00091962|743183|P2|COMPLETED|Overall Study||152
303070|NCT00091962|743184|P1|COMPLETED|Overall Study||150
303071|NCT00091962|743182|P3|STARTED|Overall Study||151
303072|NCT00091962|743183|P2|STARTED|Overall Study||152
303073|NCT00091962|743184|P1|STARTED|Overall Study||150
303074|NCT00091949|743203|P2|NOT COMPLETED|Overall Study||151
303075|NCT00091949|743204|P1|NOT COMPLETED|Overall Study||175
303076|NCT00091949|743203|P2|COMPLETED|Overall Study||1786
303077|NCT00091949|743204|P1|COMPLETED|Overall Study||1764
303078|NCT00091949|743203|P2|STARTED|Overall Study||1937
303079|NCT00091949|743204|P1|STARTED|Overall Study||1939
303080|NCT00091832|743228|P6|NOT COMPLETED|Overall Study||11
303081|NCT00091832|743229|P5|NOT COMPLETED|Overall Study||15
303082|NCT00091832|743230|P4|NOT COMPLETED|Overall Study||14
303083|NCT00091832|743231|P3|NOT COMPLETED|Overall Study||12
303084|NCT00091832|743232|P2|NOT COMPLETED|Overall Study||11
303085|NCT00091832|743233|P1|NOT COMPLETED|Overall Study||14
303086|NCT00091832|743228|P6|COMPLETED|Overall Study||32
303087|NCT00091832|743229|P5|COMPLETED|Overall Study||27
303088|NCT00091832|743230|P4|COMPLETED|Overall Study||29
303089|NCT00091832|743231|P3|COMPLETED|Overall Study||30
303090|NCT00091832|743232|P2|COMPLETED|Overall Study||31
303091|NCT00091832|743233|P1|COMPLETED|Overall Study||29
303092|NCT00091832|743228|P6|Received Study Medication|Overall Study||43
303093|NCT00091832|743229|P5|Received Study Medication|Overall Study||42
303094|NCT00091832|743230|P4|Received Study Medication|Overall Study||43
303095|NCT00091832|743231|P3|Received Study Medication|Overall Study||41
303096|NCT00091832|743232|P2|Received Study Medication|Overall Study||42
303097|NCT00091832|743233|P1|Received Study Medication|Overall Study||43
303098|NCT00091832|743228|P6|STARTED|Overall Study||43
303099|NCT00091832|743229|P5|STARTED|Overall Study||42
303100|NCT00091832|743230|P4|STARTED|Overall Study||43
303101|NCT00091832|743231|P3|STARTED|Overall Study||42
303102|NCT00091832|743232|P2|STARTED|Overall Study||42
303103|NCT00091832|743233|P1|STARTED|Overall Study||43
303104|NCT00091819|743351|P2|NOT COMPLETED|Overall Study||46
303105|NCT00091819|743352|P1|NOT COMPLETED|Overall Study||42
303106|NCT00091819|743351|P2|COMPLETED|Overall Study||387
303107|NCT00091819|743352|P1|COMPLETED|Overall Study||387
303108|NCT00091819|743351|P2|STARTED|Overall Study||433
303109|NCT00091819|743352|P1|STARTED|Overall Study||429
303110|NCT00091793|743360|P2|NOT COMPLETED|Overall Study||22
303111|NCT00091793|743361|P1|NOT COMPLETED|Overall Study||24
303112|NCT00091793|743360|P2|COMPLETED|Overall Study||144
303113|NCT00091793|743361|P1|COMPLETED|Overall Study||142
303114|NCT00091793|743360|P2|STARTED|Overall Study||166
303115|NCT00091793|743361|P1|STARTED|Overall Study||166
303116|NCT00091572|743385|P2|NOT COMPLETED|Overall Study||82
303117|NCT00091572|743386|P1|NOT COMPLETED|Overall Study||95
303118|NCT00091572|743385|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
303119|NCT00091572|743386|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
303120|NCT00091572|743385|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
303121|NCT00091572|743386|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
303122|NCT00091507|743400|P2|NOT COMPLETED|Overall Study||19
303123|NCT00091507|743401|P1|NOT COMPLETED|Overall Study||21
303124|NCT00091507|743400|P2|COMPLETED|Overall Study||460
303125|NCT00091507|743401|P1|COMPLETED|Overall Study||411
303126|NCT00091507|743400|P2|STARTED|Overall Study||479
303127|NCT00091507|743401|P1|STARTED|Overall Study||432
303128|NCT00091442|743417|P2|NOT COMPLETED|Overall Study||373
303129|NCT00091442|743418|P1|NOT COMPLETED|Overall Study||369
303130|NCT00091442|743417|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
303131|NCT00091442|743418|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
303132|NCT00091442|743417|P2|STARTED|Overall Study||378
303133|NCT00091442|743418|P1|STARTED|Overall Study||373
303134|NCT00091390|743428|P1|NOT COMPLETED|Overall Study||4
303135|NCT00091390|743428|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
303136|NCT00091390|743428|P1|STARTED|Overall Study||129
303137|NCT00091273|743432|P1|NOT COMPLETED|Overall Study||0
303138|NCT00091273|743432|P1|COMPLETED|Overall Study||9
303139|NCT00091273|743432|P1|STARTED|Overall Study||9
303140|NCT00091260|743438|P1|NOT COMPLETED|Overall Study||0
303141|NCT00091260|743438|P1|COMPLETED|Overall Study||82
303142|NCT00091260|743438|P1|STARTED|Overall Study||82
303143|NCT00091169|743446|P2|NOT COMPLETED|Overall Study||53
303144|NCT00091169|743447|P1|NOT COMPLETED|Overall Study||57
303145|NCT00091169|743446|P2|COMPLETED|Overall Study||134
303146|NCT00091169|743447|P1|COMPLETED|Overall Study||132
303147|NCT00091169|743446|P2|Treated|Overall Study||170
303148|NCT00091169|743447|P1|Treated|Overall Study||163
303149|NCT00091169|743446|P2|STARTED|Overall Study||187
303150|NCT00091169|743447|P1|STARTED|Overall Study||189
303151|NCT00091026|743465|P2|NOT COMPLETED|Overall Study||3
303152|NCT00091026|743466|P1|NOT COMPLETED|Overall Study||1
303153|NCT00091026|743465|P2|COMPLETED|Overall Study||68
303154|NCT00091026|743466|P1|COMPLETED|Overall Study||71
303155|NCT00091026|743465|P2|STARTED|Overall Study||71
303156|NCT00091026|743466|P1|STARTED|Overall Study||72
303157|NCT00090987|743476|P1|NOT COMPLETED|Overall Study||21
303158|NCT00090987|743476|P1|COMPLETED|Overall Study||9
303159|NCT00090987|743476|P1|STARTED|Overall Study||30
303160|NCT00090857|743482|P2|NOT COMPLETED|Overall Study||3
303161|NCT00090857|743483|P1|NOT COMPLETED|Overall Study||4
303162|NCT00090857|743482|P2|COMPLETED|Overall Study||13
303163|NCT00090857|743483|P1|COMPLETED|Overall Study||29
303164|NCT00090857|743482|P2|STARTED|Overall Study||16
303165|NCT00090857|743483|P1|STARTED|Overall Study||33
303166|NCT00090844|743513|P2|NOT COMPLETED|Overall Study||1
303167|NCT00090844|743514|P1|NOT COMPLETED|Overall Study||1
303168|NCT00090844|743513|P2|COMPLETED|Overall Study||21
303169|NCT00090844|743514|P1|COMPLETED|Overall Study||26
303170|NCT00090844|743513|P2|STARTED|Overall Study||22
303171|NCT00090844|743514|P1|STARTED|Overall Study||27
303172|NCT00090779|743522|P2|NOT COMPLETED|Step 3||5
303173|NCT00090779|743523|P1|NOT COMPLETED|Step 3||7
303174|NCT00090779|743522|P2|COMPLETED|Step 3||0
303175|NCT00090779|743523|P1|COMPLETED|Step 3||0
303176|NCT00090779|743522|P2|STARTED|Step 3||5
303177|NCT00090779|743523|P1|STARTED|Step 3||7
303178|NCT00090779|743522|P2|NOT COMPLETED|Step 2||18
303179|NCT00090779|743523|P1|NOT COMPLETED|Step 2||6
303180|NCT00090779|743522|P2|COMPLETED|Step 2||1
303181|NCT00090779|743523|P1|COMPLETED|Step 2||0
303182|NCT00090779|743522|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
303183|NCT00090779|743523|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
303184|NCT00090779|743522|P2|NOT COMPLETED|Step 1||15
303185|NCT00090779|743523|P1|NOT COMPLETED|Step 1||11
303186|NCT00090779|743522|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
303187|NCT00090779|743523|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
303188|NCT00090779|743522|P2|STARTED|Step 1||64
303189|NCT00090779|743523|P1|STARTED|Step 1||66
303190|NCT00090766|743547|P3|NOT COMPLETED|Overall Study||3
303191|NCT00090766|743548|P2|NOT COMPLETED|Overall Study||2
303192|NCT00090766|743549|P1|NOT COMPLETED|Overall Study||3
303193|NCT00090766|743547|P3|COMPLETED|Overall Study||22
303194|NCT00090766|743548|P2|COMPLETED|Overall Study||19
303195|NCT00090766|743549|P1|COMPLETED|Overall Study||14
303196|NCT00090766|743547|P3|STARTED|Overall Study||25
303197|NCT00090766|743548|P2|STARTED|Overall Study||21
303198|NCT00090766|743549|P1|STARTED|Overall Study||17
303199|NCT00090753|743591|P2|NOT COMPLETED|Extended Treatment Period||191
303200|NCT00090753|743592|P1|NOT COMPLETED|Extended Treatment Period||359
303201|NCT00090753|743591|P2|COMPLETED|Extended Treatment Period||59
303202|NCT00090753|743592|P1|COMPLETED|Extended Treatment Period||94
303203|NCT00090753|743591|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
303204|NCT00090753|743592|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
303205|NCT00090753|743591|P2|NOT COMPLETED|First Treatment Period||178
303206|NCT00090753|743592|P1|NOT COMPLETED|First Treatment Period||256
303207|NCT00090753|743591|P2|COMPLETED|First Treatment Period||302
303208|NCT00090753|743592|P1|COMPLETED|First Treatment Period||492
303209|NCT00090753|743591|P2|STARTED|First Treatment Period||480
303210|NCT00090753|743592|P1|STARTED|First Treatment Period||748
303211|NCT00090610|743602|P2|NOT COMPLETED|Overall Study||1
303212|NCT00090610|743603|P1|NOT COMPLETED|Overall Study||1
303213|NCT00090610|743602|P2|COMPLETED|Overall Study||74
303214|NCT00090610|743603|P1|COMPLETED|Overall Study||74
303215|NCT00090610|743602|P2|STARTED|Overall Study||75
303216|NCT00090610|743603|P1|STARTED|Overall Study||75
303217|NCT00090584|743619|P2|NOT COMPLETED|Baseline to 8 Months||41
303218|NCT00090584|743620|P1|NOT COMPLETED|Baseline to 8 Months||44
303219|NCT00090584|743619|P2|COMPLETED|Baseline to 8 Months||112
303220|NCT00090584|743620|P1|COMPLETED|Baseline to 8 Months||110
303221|NCT00090584|743619|P2|STARTED|Baseline to 8 Months||153
303222|NCT00090584|743620|P1|STARTED|Baseline to 8 Months||154
303223|NCT00090584|743619|P2|NOT COMPLETED|Baseline to 10 Weeks||12
303224|NCT00090584|743620|P1|NOT COMPLETED|Baseline to 10 Weeks||15
303225|NCT00090584|743619|P2|COMPLETED|Baseline to 10 Weeks||141
303226|NCT00090584|743620|P1|COMPLETED|Baseline to 10 Weeks||139
303227|NCT00090584|743619|P2|STARTED|Baseline to 10 Weeks||153
303228|NCT00090584|743620|P1|STARTED|Baseline to 10 Weeks||154
303229|NCT00090519|743652|P2|NOT COMPLETED|Overall Study||75
303230|NCT00090519|743653|P1|NOT COMPLETED|Overall Study||73
303231|NCT00090519|743652|P2|COMPLETED|Overall Study||285
303232|NCT00090519|743653|P1|COMPLETED|Overall Study||298
303233|NCT00090519|743652|P2|STARTED|Overall Study||360
303234|NCT00090519|743653|P1|STARTED|Overall Study||371
303235|NCT00090493|743677|P1|NOT COMPLETED|Overall Study||2
303236|NCT00090493|743677|P1|COMPLETED|Overall Study||2
303237|NCT00090493|743677|P1|STARTED|Overall Study||4
303238|NCT00090363|743684|P3|NOT COMPLETED|Overall Study||96
303239|NCT00090363|743685|P2|NOT COMPLETED|Overall Study||107
303240|NCT00090363|743686|P1|NOT COMPLETED|Overall Study||106
303241|NCT00090363|743684|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
303242|NCT00090363|743685|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
303243|NCT00090363|743686|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
303244|NCT00090363|743684|P3|Received Study Treatment.|Overall Study||98
303245|NCT00090363|743685|P2|Received Study Treatment.|Overall Study||107
303246|NCT00090363|743686|P1|Received Study Treatment.|Overall Study||107
303247|NCT00090363|743684|P3|STARTED|Overall Study||98
303248|NCT00090363|743685|P2|STARTED|Overall Study||107
303249|NCT00090363|743686|P1|STARTED|Overall Study||107
303250|NCT00090545|743708|P2|NOT COMPLETED|Overall Study||24
303251|NCT00090545|743709|P1|NOT COMPLETED|Overall Study||22
303252|NCT00090545|743708|P2|COMPLETED|Overall Study||0
303253|NCT00090545|743709|P1|COMPLETED|Overall Study||0
303254|NCT00090545|743708|P2|STARTED|Overall Study||24
303255|NCT00090545|743709|P1|STARTED|Overall Study||22
303256|NCT00090285|743719|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
303257|NCT00090285|743720|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
303258|NCT00090285|743721|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303259|NCT00090285|743722|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303260|NCT00090285|743723|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303261|NCT00090285|743724|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303262|NCT00090285|743719|P6|COMPLETED|Long-term Follow-up (EXT2)||664
303263|NCT00090285|743720|P5|COMPLETED|Long-term Follow-up (EXT2)||709
303264|NCT00090285|743721|P4|COMPLETED|Long-term Follow-up (EXT2)||0
303265|NCT00090285|743722|P3|COMPLETED|Long-term Follow-up (EXT2)||0
303266|NCT00090285|743723|P2|COMPLETED|Long-term Follow-up (EXT2)||0
303267|NCT00090285|743724|P1|COMPLETED|Long-term Follow-up (EXT2)||0
303268|NCT00090285|743719|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
303269|NCT00090285|743720|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
303270|NCT00090285|743721|P4|STARTED|Long-term Follow-up (EXT2)||0
303271|NCT00090285|743722|P3|STARTED|Long-term Follow-up (EXT2)||0
303272|NCT00090285|743723|P2|STARTED|Long-term Follow-up (EXT2)||0
303273|NCT00090285|743724|P1|STARTED|Long-term Follow-up (EXT2)||0
303274|NCT00090285|743719|P6|NOT COMPLETED|Extension 1||0
303275|NCT00090285|743720|P5|NOT COMPLETED|Extension 1||0
303276|NCT00090285|743721|P4|NOT COMPLETED|Extension 1||1
303277|NCT00090285|743722|P3|NOT COMPLETED|Extension 1||57
303278|NCT00090285|743723|P2|NOT COMPLETED|Extension 1||0
303279|NCT00090285|743724|P1|NOT COMPLETED|Extension 1||0
303280|NCT00090285|743719|P6|COMPLETED|Extension 1||0
303281|NCT00090285|743720|P5|COMPLETED|Extension 1||0
303282|NCT00090285|743721|P4|COMPLETED|Extension 1||15
303283|NCT00090285|743722|P3|COMPLETED|Extension 1||1041
303284|NCT00090285|743723|P2|COMPLETED|Extension 1||0
303285|NCT00090285|743724|P1|COMPLETED|Extension 1||0
303286|NCT00090285|743719|P6|STARTED|Extension 1||0
303287|NCT00090285|743720|P5|STARTED|Extension 1||0
303288|NCT00090285|743721|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
303289|NCT00090285|743722|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
303290|NCT00090285|743723|P2|STARTED|Extension 1||0
303291|NCT00090285|743724|P1|STARTED|Extension 1||0
303292|NCT00090285|743719|P6|NOT COMPLETED|Base Study Follow-up Period||0
303293|NCT00090285|743720|P5|NOT COMPLETED|Base Study Follow-up Period||0
303294|NCT00090285|743721|P4|NOT COMPLETED|Base Study Follow-up Period||0
303295|NCT00090285|743722|P3|NOT COMPLETED|Base Study Follow-up Period||0
303296|NCT00090285|743723|P2|NOT COMPLETED|Base Study Follow-up Period||342
303297|NCT00090285|743724|P1|NOT COMPLETED|Base Study Follow-up Period||335
303298|NCT00090285|743719|P6|COMPLETED|Base Study Follow-up Period||0
303299|NCT00090285|743720|P5|COMPLETED|Base Study Follow-up Period||0
303300|NCT00090285|743721|P4|COMPLETED|Base Study Follow-up Period||0
303301|NCT00090285|743722|P3|COMPLETED|Base Study Follow-up Period||0
303302|NCT00090285|743723|P2|COMPLETED|Base Study Follow-up Period||1479
303303|NCT00090285|743724|P1|COMPLETED|Base Study Follow-up Period||1487
303304|NCT00090285|743719|P6|STARTED|Base Study Follow-up Period||0
303305|NCT00090285|743720|P5|STARTED|Base Study Follow-up Period||0
303306|NCT00090285|743721|P4|STARTED|Base Study Follow-up Period||0
303307|NCT00090285|743722|P3|STARTED|Base Study Follow-up Period||0
303308|NCT00090285|743723|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
303309|NCT00090285|743724|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
303310|NCT00090285|743719|P6|NOT COMPLETED|Base Study Vaccination Period||0
303311|NCT00090285|743720|P5|NOT COMPLETED|Base Study Vaccination Period||0
303312|NCT00090285|743721|P4|NOT COMPLETED|Base Study Vaccination Period||0
303313|NCT00090285|743722|P3|NOT COMPLETED|Base Study Vaccination Period||0
303314|NCT00090285|743723|P2|NOT COMPLETED|Base Study Vaccination Period||219
303315|NCT00090285|743724|P1|NOT COMPLETED|Base Study Vaccination Period||214
303316|NCT00090285|743719|P6|COMPLETED|Base Study Vaccination Period||0
303317|NCT00090285|743720|P5|COMPLETED|Base Study Vaccination Period||0
303318|NCT00090285|743721|P4|COMPLETED|Base Study Vaccination Period||0
303319|NCT00090285|743722|P3|COMPLETED|Base Study Vaccination Period||0
303320|NCT00090285|743723|P2|COMPLETED|Base Study Vaccination Period||1814
303321|NCT00090285|743724|P1|COMPLETED|Base Study Vaccination Period||1818
303322|NCT00090285|743719|P6|Vaccinated|Base Study Vaccination Period||0
303323|NCT00090285|743720|P5|Vaccinated|Base Study Vaccination Period||0
303324|NCT00090285|743721|P4|Vaccinated|Base Study Vaccination Period||0
303325|NCT00090285|743722|P3|Vaccinated|Base Study Vaccination Period||0
303326|NCT00090285|743723|P2|Vaccinated|Base Study Vaccination Period||2030
303327|NCT00090285|743724|P1|Vaccinated|Base Study Vaccination Period||2025
303328|NCT00090285|743719|P6|STARTED|Base Study Vaccination Period||0
303329|NCT00090285|743720|P5|STARTED|Base Study Vaccination Period||0
303330|NCT00090285|743721|P4|STARTED|Base Study Vaccination Period||0
303331|NCT00090285|743722|P3|STARTED|Base Study Vaccination Period||0
303332|NCT00090285|743723|P2|STARTED|Base Study Vaccination Period||2033
303333|NCT00090285|743724|P1|STARTED|Base Study Vaccination Period||2032
303334|NCT00090259|743761|P2|NOT COMPLETED|Overall Study||48
303335|NCT00090259|743762|P1|NOT COMPLETED|Overall Study||62
303336|NCT00090259|743761|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
303337|NCT00090259|743762|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
303338|NCT00090259|743761|P2|STARTED|Overall Study||1921
303339|NCT00090259|743762|P1|STARTED|Overall Study||1913
303340|NCT00090233|743778|P2|NOT COMPLETED|Overall Study||5065
303341|NCT00090233|743779|P1|NOT COMPLETED|Overall Study||4999
303342|NCT00090233|743778|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
303343|NCT00090233|743779|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
303344|NCT00090233|743778|P2|Vaccinated at Visit 3|Overall Study||29598
303345|NCT00090233|743779|P1|Vaccinated at Visit 3|Overall Study||29667
303346|NCT00090233|743778|P2|Vaccinated at Visit 2|Overall Study||31066
303347|NCT00090233|743779|P1|Vaccinated at Visit 2|Overall Study||31052
303348|NCT00090233|743778|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
303349|NCT00090233|743779|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
303350|NCT00090233|743778|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
303351|NCT00090233|743779|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
303352|NCT00090220|743803|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
303353|NCT00090220|743804|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
303354|NCT00090220|743805|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303355|NCT00090220|743806|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303356|NCT00090220|743807|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303357|NCT00090220|743808|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
303358|NCT00090220|743803|P6|COMPLETED|Long-term Follow-up (EXT2)||623
303359|NCT00090220|743804|P5|COMPLETED|Long-term Follow-up (EXT2)||641
303360|NCT00090220|743805|P4|COMPLETED|Long-term Follow-up (EXT2)||0
303361|NCT00090220|743806|P3|COMPLETED|Long-term Follow-up (EXT2)||0
303362|NCT00090220|743807|P2|COMPLETED|Long-term Follow-up (EXT2)||0
303363|NCT00090220|743808|P1|COMPLETED|Long-term Follow-up (EXT2)||0
303364|NCT00090220|743803|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
303365|NCT00090220|743804|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
303366|NCT00090220|743805|P4|STARTED|Long-term Follow-up (EXT2)||0
303367|NCT00090220|743806|P3|STARTED|Long-term Follow-up (EXT2)||0
303368|NCT00090220|743807|P2|STARTED|Long-term Follow-up (EXT2)||0
303369|NCT00090220|743808|P1|STARTED|Long-term Follow-up (EXT2)||0
303370|NCT00090220|743803|P6|NOT COMPLETED|Extension 1 (EXT1)||0
303371|NCT00090220|743804|P5|NOT COMPLETED|Extension 1 (EXT1)||0
303372|NCT00090220|743805|P4|NOT COMPLETED|Extension 1 (EXT1)||2
303373|NCT00090220|743806|P3|NOT COMPLETED|Extension 1 (EXT1)||55
303374|NCT00090220|743807|P2|NOT COMPLETED|Extension 1 (EXT1)||0
303375|NCT00090220|743808|P1|NOT COMPLETED|Extension 1 (EXT1)||0
303376|NCT00090220|743803|P6|COMPLETED|Extension 1 (EXT1)||0
303377|NCT00090220|743804|P5|COMPLETED|Extension 1 (EXT1)||0
303378|NCT00090220|743805|P4|COMPLETED|Extension 1 (EXT1)||5
303379|NCT00090220|743806|P3|COMPLETED|Extension 1 (EXT1)||1267
303380|NCT00090220|743807|P2|COMPLETED|Extension 1 (EXT1)||0
303381|NCT00090220|743808|P1|COMPLETED|Extension 1 (EXT1)||0
303382|NCT00090220|743803|P6|Vaccinated|Extension 1 (EXT1)||0
303383|NCT00090220|743804|P5|Vaccinated|Extension 1 (EXT1)||0
303384|NCT00090220|743805|P4|Vaccinated|Extension 1 (EXT1)||7
303385|NCT00090220|743806|P3|Vaccinated|Extension 1 (EXT1)||1321
303386|NCT00090220|743807|P2|Vaccinated|Extension 1 (EXT1)||0
303387|NCT00090220|743808|P1|Vaccinated|Extension 1 (EXT1)||0
303388|NCT00090220|743803|P6|STARTED|Extension 1 (EXT1)||0
303389|NCT00090220|743804|P5|STARTED|Extension 1 (EXT1)||0
303390|NCT00090220|743805|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
303391|NCT00090220|743806|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
303392|NCT00090220|743807|P2|STARTED|Extension 1 (EXT1)||0
303393|NCT00090220|743808|P1|STARTED|Extension 1 (EXT1)||0
303394|NCT00090220|743803|P6|NOT COMPLETED|Base Study Follow-up Period||0
303395|NCT00090220|743804|P5|NOT COMPLETED|Base Study Follow-up Period||0
303396|NCT00090220|743805|P4|NOT COMPLETED|Base Study Follow-up Period||0
303397|NCT00090220|743806|P3|NOT COMPLETED|Base Study Follow-up Period||0
303398|NCT00090220|743807|P2|NOT COMPLETED|Base Study Follow-up Period||164
303399|NCT00090220|743808|P1|NOT COMPLETED|Base Study Follow-up Period||160
303400|NCT00090220|743803|P6|COMPLETED|Base Study Follow-up Period||0
303401|NCT00090220|743804|P5|COMPLETED|Base Study Follow-up Period||0
303402|NCT00090220|743805|P4|COMPLETED|Base Study Follow-up Period||0
303403|NCT00090220|743806|P3|COMPLETED|Base Study Follow-up Period||0
303404|NCT00090220|743807|P2|COMPLETED|Base Study Follow-up Period||1687
303405|NCT00090220|743808|P1|COMPLETED|Base Study Follow-up Period||1695
303406|NCT00090220|743803|P6|STARTED|Base Study Follow-up Period||0
303407|NCT00090220|743804|P5|STARTED|Base Study Follow-up Period||0
303408|NCT00090220|743805|P4|STARTED|Base Study Follow-up Period||0
303409|NCT00090220|743806|P3|STARTED|Base Study Follow-up Period||0
303410|NCT00090220|743807|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
303411|NCT00090220|743808|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
303412|NCT00090220|743803|P6|NOT COMPLETED|Base Study Vaccination Period||0
303413|NCT00090220|743804|P5|NOT COMPLETED|Base Study Vaccination Period||0
303414|NCT00090220|743805|P4|NOT COMPLETED|Base Study Vaccination Period||0
303415|NCT00090220|743806|P3|NOT COMPLETED|Base Study Vaccination Period||0
303416|NCT00090220|743807|P2|NOT COMPLETED|Base Study Vaccination Period||63
303417|NCT00090220|743808|P1|NOT COMPLETED|Base Study Vaccination Period||64
303418|NCT00090220|743803|P6|COMPLETED|Base Study Vaccination Period||0
303419|NCT00090220|743804|P5|COMPLETED|Base Study Vaccination Period||0
303420|NCT00090220|743805|P4|COMPLETED|Base Study Vaccination Period||0
303421|NCT00090220|743806|P3|COMPLETED|Base Study Vaccination Period||0
303422|NCT00090220|743807|P2|COMPLETED|Base Study Vaccination Period||1845
303423|NCT00090220|743808|P1|COMPLETED|Base Study Vaccination Period||1847
303424|NCT00090220|743803|P6|Vaccinated|Base Study Vaccination Period||0
303425|NCT00090220|743804|P5|Vaccinated|Base Study Vaccination Period||0
303426|NCT00090220|743805|P4|Vaccinated|Base Study Vaccination Period||0
303427|NCT00090220|743806|P3|Vaccinated|Base Study Vaccination Period||0
303428|NCT00090220|743807|P2|Vaccinated|Base Study Vaccination Period||1907
303429|NCT00090220|743808|P1|Vaccinated|Base Study Vaccination Period||1910
303430|NCT00090220|743803|P6|STARTED|Base Study Vaccination Period||0
303431|NCT00090220|743804|P5|STARTED|Base Study Vaccination Period||0
303432|NCT00090220|743805|P4|STARTED|Base Study Vaccination Period||0
303433|NCT00090220|743806|P3|STARTED|Base Study Vaccination Period||0
303434|NCT00090220|743807|P2|STARTED|Base Study Vaccination Period||1908
303435|NCT00090220|743808|P1|STARTED|Base Study Vaccination Period||1911
303436|NCT00090402|743903|P3|NOT COMPLETED|Overall Study||1
303437|NCT00090402|743904|P2|NOT COMPLETED|Overall Study||2
303438|NCT00090402|743905|P1|NOT COMPLETED|Overall Study||2
303439|NCT00090402|743903|P3|COMPLETED|Overall Study||12
303440|NCT00090402|743904|P2|COMPLETED|Overall Study||11
303441|NCT00090402|743905|P1|COMPLETED|Overall Study||11
303442|NCT00090402|743903|P3|STARTED|Overall Study||13
303443|NCT00090402|743904|P2|STARTED|Overall Study||13
303444|NCT00090402|743905|P1|STARTED|Overall Study||13
303445|NCT00090142|743919|P2|NOT COMPLETED|Treatment Period II||0
303446|NCT00090142|743920|P1|NOT COMPLETED|Treatment Period II||1
303447|NCT00090142|743919|P2|COMPLETED|Treatment Period II||28
303448|NCT00090142|743920|P1|COMPLETED|Treatment Period II||25
303449|NCT00090142|743919|P2|STARTED|Treatment Period II||28
303450|NCT00090142|743920|P1|STARTED|Treatment Period II||26
303451|NCT00090142|743919|P2|NOT COMPLETED|Treatment Period I||3
303452|NCT00090142|743920|P1|NOT COMPLETED|Treatment Period I||5
303453|NCT00090142|743919|P2|COMPLETED|Treatment Period I||28
303454|NCT00090142|743920|P1|COMPLETED|Treatment Period I||26
303455|NCT00090142|743919|P2|STARTED|Treatment Period I||31
303456|NCT00090142|743920|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
303457|NCT00090103|743951|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
303458|NCT00090103|743952|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
303459|NCT00090103|743953|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
303460|NCT00090103|743951|P3|COMPLETED|16-Week Safety Follow-up Period||1143
303461|NCT00090103|743952|P2|COMPLETED|16-Week Safety Follow-up Period||1205
303462|NCT00090103|743953|P1|COMPLETED|16-Week Safety Follow-up Period||1224
303463|NCT00090103|743951|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
303464|NCT00090103|743952|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
303465|NCT00090103|743953|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
303466|NCT00090103|743951|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
303467|NCT00090103|743952|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
303468|NCT00090103|743953|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
303469|NCT00090103|743951|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
303470|NCT00090103|743952|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
303471|NCT00090103|743953|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
303472|NCT00090103|743951|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
303473|NCT00090103|743952|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
303474|NCT00090103|743953|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
303475|NCT00090051|744053|P2|NOT COMPLETED|Overall Study||95
303476|NCT00090051|744054|P1|NOT COMPLETED|Overall Study||109
303477|NCT00090051|744053|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
303478|NCT00090051|744054|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
303479|NCT00090051|744053|P2|Safety Population; Received Study Drug|Overall Study||274
303480|NCT00090051|744054|P1|Safety Population; Received Study Drug|Overall Study||272
303481|NCT00090051|744053|P2|STARTED|Overall Study||276
303482|NCT00090051|744054|P1|STARTED|Overall Study||276
303483|NCT00003224|744094|P6|NOT COMPLETED|Overall Study||0
303484|NCT00003224|744095|P5|NOT COMPLETED|Overall Study||0
303485|NCT00003224|744096|P4|NOT COMPLETED|Overall Study||0
303486|NCT00003224|744097|P3|NOT COMPLETED|Overall Study||0
303487|NCT00003224|744098|P2|NOT COMPLETED|Overall Study||0
303488|NCT00003224|744099|P1|NOT COMPLETED|Overall Study||0
303489|NCT00003224|744094|P6|COMPLETED|Overall Study||3
303490|NCT00003224|744095|P5|COMPLETED|Overall Study||4
303491|NCT00003224|744096|P4|COMPLETED|Overall Study||2
303492|NCT00003224|744097|P3|COMPLETED|Overall Study||4
303493|NCT00003224|744098|P2|COMPLETED|Overall Study||5
303494|NCT00003224|744099|P1|COMPLETED|Overall Study||4
303495|NCT00003224|744094|P6|STARTED|Overall Study||3
303496|NCT00003224|744095|P5|STARTED|Overall Study||4
303497|NCT00003224|744096|P4|STARTED|Overall Study||2
303498|NCT00003224|744097|P3|STARTED|Overall Study||4
303499|NCT00003224|744098|P2|STARTED|Overall Study||5
303500|NCT00003224|744099|P1|STARTED|Overall Study||4
303501|NCT00089999|744119|P2|NOT COMPLETED|Overall Study||69
303502|NCT00089999|744120|P1|NOT COMPLETED|Overall Study||69
303503|NCT00089999|744119|P2|COMPLETED|Overall Study||0
303504|NCT00089999|744120|P1|COMPLETED|Overall Study||0
303505|NCT00089999|744119|P2|STARTED|Overall Study||69
303506|NCT00089999|744120|P1|STARTED|Overall Study||69
303507|NCT00089986|744143|P3|NOT COMPLETED|Overall Study||10
303508|NCT00089986|744144|P2|NOT COMPLETED|Overall Study||24
303509|NCT00089986|744145|P1|NOT COMPLETED|Overall Study||15
303510|NCT00089986|744143|P3|COMPLETED|Overall Study||172
303511|NCT00089986|744144|P2|COMPLETED|Overall Study||574
303512|NCT00089986|744145|P1|COMPLETED|Overall Study||584
303513|NCT00089986|744143|P3|STARTED|Overall Study||182
303514|NCT00089986|744144|P2|STARTED|Overall Study||598
303515|NCT00089986|744145|P1|STARTED|Overall Study||599
303516|NCT00089973|744162|P1|NOT COMPLETED|Overall Study||50
303517|NCT00089973|744162|P1|COMPLETED|Overall Study||0
303518|NCT00089973|744162|P1|STARTED|Overall Study||50
303519|NCT00089895|744177|P2|NOT COMPLETED|Overall Study||42
303520|NCT00089895|744178|P1|NOT COMPLETED|Overall Study||35
303521|NCT00089895|744177|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
303522|NCT00089895|744178|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
303523|NCT00089895|744177|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
303524|NCT00089895|744178|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
303525|NCT00089843|744190|P4|NOT COMPLETED|Overall Study||7
303526|NCT00089843|744191|P3|NOT COMPLETED|Overall Study||5
303527|NCT00089843|744192|P2|NOT COMPLETED|Overall Study||4
303528|NCT00089843|744193|P1|NOT COMPLETED|Overall Study||2
303529|NCT00089843|744190|P4|COMPLETED|Overall Study||11
303530|NCT00089843|744191|P3|COMPLETED|Overall Study||15
303531|NCT00089843|744192|P2|COMPLETED|Overall Study||16
303532|NCT00089843|744193|P1|COMPLETED|Overall Study||17
303533|NCT00089843|744190|P4|STARTED|Overall Study||18
303534|NCT00089843|744191|P3|STARTED|Overall Study||20
303535|NCT00089843|744192|P2|STARTED|Overall Study||20
303536|NCT00089843|744193|P1|STARTED|Overall Study||19
303537|NCT00089791|744205|P2|NOT COMPLETED|Overall Study||630
303538|NCT00089791|744206|P1|NOT COMPLETED|Overall Study||700
303539|NCT00089791|744205|P2|COMPLETED|Overall Study||3272
303540|NCT00089791|744206|P1|COMPLETED|Overall Study||3206
303541|NCT00089791|744205|P2|Safety Analysis Set|Overall Study||3886
303542|NCT00089791|744206|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
303543|NCT00089791|744205|P2|Received Study Medication|Overall Study||3879
303544|NCT00089791|744206|P1|Received Study Medication|Overall Study||3883
303545|NCT00089791|744205|P2|STARTED|Overall Study||3902
303546|NCT00089791|744206|P1|STARTED|Overall Study||3906
303547|NCT00089752|744218|P2|NOT COMPLETED|Overall Study||22
303548|NCT00089752|744219|P1|NOT COMPLETED|Overall Study||20
303549|NCT00089752|744218|P2|COMPLETED|Overall Study||118
303550|NCT00089752|744219|P1|COMPLETED|Overall Study||121
303551|NCT00089752|744218|P2|STARTED|Overall Study||140
303552|NCT00089752|744219|P1|STARTED|Overall Study||141
303553|NCT00089778|744240|P3|NOT COMPLETED|Overall Study||1
303554|NCT00089778|744241|P2|NOT COMPLETED|Overall Study||0
303555|NCT00089778|744242|P1|NOT COMPLETED|Overall Study||0
303556|NCT00089778|744240|P3|COMPLETED|Overall Study||7
303557|NCT00089778|744241|P2|COMPLETED|Overall Study||1
303558|NCT00089778|744242|P1|COMPLETED|Overall Study||2
303559|NCT00089778|744240|P3|STARTED|Overall Study||8
303560|NCT00089778|744241|P2|STARTED|Overall Study||1
303561|NCT00089778|744242|P1|STARTED|Overall Study||2
303562|NCT00089674|744255|P2|NOT COMPLETED|Overall Study||267
303563|NCT00089674|744256|P1|NOT COMPLETED|Overall Study||289
303564|NCT00089674|744255|P2|COMPLETED|Overall Study||467
303565|NCT00089674|744256|P1|COMPLETED|Overall Study||445
303566|NCT00089674|744255|P2|Received Study Drug|Overall Study||726
303567|NCT00089674|744256|P1|Received Study Drug|Overall Study||730
303568|NCT00089674|744255|P2|STARTED|Overall Study||734
303569|NCT00089674|744256|P1|STARTED|Overall Study||734
303570|NCT00089661|744282|P2|NOT COMPLETED|Overall Study||26
303571|NCT00089661|744283|P1|NOT COMPLETED|Overall Study||21
303572|NCT00089661|744282|P2|COMPLETED|Overall Study||99
303573|NCT00089661|744283|P1|COMPLETED|Overall Study||106
303574|NCT00089661|744282|P2|STARTED|Overall Study||125
303575|NCT00089661|744283|P1|STARTED|Overall Study||127
303576|NCT00089648|744299|P1|NOT COMPLETED|Overall Study||41
303577|NCT00089648|744299|P1|COMPLETED|Overall Study||20
303578|NCT00089648|744299|P1|STARTED|Overall Study||61
303579|NCT00089635|744315|P1|NOT COMPLETED|Overall Study||43
303580|NCT00089635|744315|P1|COMPLETED|Overall Study||160
303581|NCT00089635|744315|P1|STARTED|Overall Study||203
303582|NCT00089583|744329|P2|NOT COMPLETED|Overall Study||38
303583|NCT00089583|744330|P1|NOT COMPLETED|Overall Study||7
303584|NCT00089583|744329|P2|COMPLETED|Overall Study||51
303585|NCT00089583|744330|P1|COMPLETED|Overall Study||13
303586|NCT00089583|744329|P2|STARTED|Overall Study||89
303587|NCT00089583|744330|P1|STARTED|Overall Study||20
303588|NCT00089609|744424|P2|NOT COMPLETED|Overall Study||1
303589|NCT00089609|744425|P1|NOT COMPLETED|Overall Study||3
303590|NCT00089609|744424|P2|COMPLETED|Overall Study||12
303591|NCT00089609|744425|P1|COMPLETED|Overall Study||57
303592|NCT00089609|744424|P2|STARTED|Overall Study||13
303593|NCT00089609|744425|P1|STARTED|Overall Study||60
303594|NCT00089544|744444|P2|NOT COMPLETED|Overall Study||0
303595|NCT00089544|744445|P1|NOT COMPLETED|Overall Study||1
303596|NCT00089544|744444|P2|COMPLETED|Overall Study||7
303597|NCT00089544|744445|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
303598|NCT00089544|744444|P2|STARTED|Overall Study||7
303599|NCT00089544|744445|P1|STARTED|Overall Study||16
303600|NCT00089505|744459|P4|NOT COMPLETED|Overall Study||21
303601|NCT00089505|744460|P3|NOT COMPLETED|Overall Study||21
303602|NCT00089505|744461|P2|NOT COMPLETED|Overall Study||2
303603|NCT00089505|744462|P1|NOT COMPLETED|Overall Study||9
303604|NCT00089505|744459|P4|COMPLETED|Overall Study||230
303605|NCT00089505|744460|P3|COMPLETED|Overall Study||228
303606|NCT00089505|744461|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
303607|NCT00089505|744462|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
303608|NCT00089505|744459|P4|STARTED|Overall Study||251
303609|NCT00089505|744460|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
303610|NCT00089505|744461|P2|STARTED|Overall Study||120
303611|NCT00089505|744462|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
303612|NCT00089479|744506|P2|NOT COMPLETED|Overall Study||289
303613|NCT00089479|744507|P1|NOT COMPLETED|Overall Study||331
303614|NCT00089479|744506|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
303615|NCT00089479|744507|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
303616|NCT00089479|744506|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
303617|NCT00089479|744507|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
303618|NCT00089479|744506|P2|STARTED|Overall Study||1307
303619|NCT00089479|744507|P1|STARTED|Overall Study||1304
303620|NCT00089414|744534|P3|NOT COMPLETED|Overall Study||0
303621|NCT00089414|744535|P2|NOT COMPLETED|Overall Study||0
303622|NCT00089414|744536|P1|NOT COMPLETED|Overall Study||0
303623|NCT00089414|744534|P3|COMPLETED|Overall Study||2
303624|NCT00089414|744535|P2|COMPLETED|Overall Study||1
303625|NCT00089414|744536|P1|COMPLETED|Overall Study||2
303626|NCT00089414|744534|P3|STARTED|Overall Study||2
303627|NCT00089414|744535|P2|STARTED|Overall Study||1
303628|NCT00089414|744536|P1|STARTED|Overall Study||2
303629|NCT00089297|744550|P1|NOT COMPLETED|Overall Study||38
303630|NCT00089297|744550|P1|COMPLETED|Overall Study||36
303631|NCT00089297|744550|P1|Eligible|Overall Study||63
303632|NCT00089297|744550|P1|Treated|Overall Study||70
303633|NCT00089297|744550|P1|STARTED|Overall Study||74
303634|NCT00089141|744559|P2|NOT COMPLETED|Overall Study||24
303635|NCT00089141|744560|P1|NOT COMPLETED|Overall Study||18
303636|NCT00089141|744559|P2|COMPLETED|Overall Study||53
303637|NCT00089141|744560|P1|COMPLETED|Overall Study||56
303638|NCT00089141|744559|P2|STARTED|Overall Study||77
303639|NCT00089141|744560|P1|STARTED|Overall Study||74
303640|NCT00089076|744582|P1|NOT COMPLETED|Overall Study||10
303641|NCT00089076|744582|P1|COMPLETED|Overall Study||8
303642|NCT00089076|744582|P1|STARTED|Overall Study||18
303643|NCT00089011|744595|P2|NOT COMPLETED|Overall Study||0
303644|NCT00089011|744596|P1|NOT COMPLETED|Overall Study||0
303645|NCT00089011|744595|P2|COMPLETED|Overall Study||50
303646|NCT00089011|744596|P1|COMPLETED|Overall Study||100
303647|NCT00089011|744595|P2|STARTED|Overall Study||50
303648|NCT00089011|744596|P1|STARTED|Overall Study||100
303649|NCT00088985|744616|P1|NOT COMPLETED|Overall Study||3
303650|NCT00088985|744616|P1|COMPLETED|Overall Study||4
303651|NCT00088985|744616|P1|STARTED|Overall Study||7
303652|NCT00088972|744623|P2|NOT COMPLETED|Overall Study||4
303653|NCT00088972|744624|P1|NOT COMPLETED|Overall Study||2
303654|NCT00088972|744623|P2|COMPLETED|Overall Study||1
303655|NCT00088972|744624|P1|COMPLETED|Overall Study||1
303656|NCT00088972|744623|P2|STARTED|Overall Study||5
303657|NCT00088972|744624|P1|STARTED|Overall Study||3
303658|NCT00088907|744634|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
303659|NCT00088907|744635|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
303660|NCT00088907|744634|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
303661|NCT00088907|744635|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
303662|NCT00088907|744634|P2|Treated|Single Gefitinib Treatment (Step 2)||0
303663|NCT00088907|744635|P1|Treated|Single Gefitinib Treatment (Step 2)||19
303664|NCT00088907|744634|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
303665|NCT00088907|744635|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
303666|NCT00088907|744634|P2|NOT COMPLETED|Randomized Study (Step 1)||134
303667|NCT00088907|744635|P1|NOT COMPLETED|Randomized Study (Step 1)||136
303668|NCT00088907|744634|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
303669|NCT00088907|744635|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
303670|NCT00088907|744634|P2|Eligible and Treated|Randomized Study (Step 1)||122
303671|NCT00088907|744635|P1|Eligible and Treated|Randomized Study (Step 1)||117
303672|NCT00088907|744634|P2|Eligible|Randomized Study (Step 1)||122
303673|NCT00088907|744635|P1|Eligible|Randomized Study (Step 1)||117
303674|NCT00088907|744634|P2|Treated|Randomized Study (Step 1)||124
303675|NCT00088907|744635|P1|Treated|Randomized Study (Step 1)||129
303676|NCT00088907|744634|P2|STARTED|Randomized Study (Step 1)||134
303677|NCT00088907|744635|P1|STARTED|Randomized Study (Step 1)||136
303678|NCT00088881|744646|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
303679|NCT00088881|744646|P1|COMPLETED|Step 3 - Radiation Therapy||1
303680|NCT00088881|744646|P1|STARTED|Step 3 - Radiation Therapy||1
303681|NCT00088881|744646|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
303682|NCT00088881|744646|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
303683|NCT00088881|744646|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
303778|NCT00087555|744954|P1|NOT COMPLETED|Overall Study||12
303779|NCT00087555|744952|P3|COMPLETED|Overall Study||46
303684|NCT00088881|744646|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
303685|NCT00088881|744646|P1|NOT COMPLETED|Step 1 - R-CHOP||14
303686|NCT00088881|744646|P1|COMPLETED|Step 1 - R-CHOP||48
303687|NCT00088881|744646|P1|Eligible and Treated|Step 1 - R-CHOP||53
303688|NCT00088881|744646|P1|STARTED|Step 1 - R-CHOP||62
303689|NCT00088634|744657|P2|NOT COMPLETED|Overall Study||43
303690|NCT00088634|744658|P1|NOT COMPLETED|Overall Study||38
303691|NCT00088634|744657|P2|COMPLETED|Overall Study||47
303692|NCT00088634|744658|P1|COMPLETED|Overall Study||52
303693|NCT00088634|744657|P2|STARTED|Overall Study||90
303694|NCT00088634|744658|P1|STARTED|Overall Study||90
303695|NCT00088621|744670|P1|NOT COMPLETED|Overall Study||54
303696|NCT00088621|744670|P1|COMPLETED|Overall Study||7
303697|NCT00088621|744670|P1|STARTED|Overall Study||61
303698|NCT00088595|744674|P1|NOT COMPLETED|Overall Study||28
303699|NCT00088595|744674|P1|COMPLETED|Overall Study||17
303700|NCT00088595|744674|P1|STARTED|Overall Study||45
303701|NCT00088530|744692|P2|NOT COMPLETED|Overall Study||54
303702|NCT00088530|744693|P1|NOT COMPLETED|Overall Study||50
303703|NCT00088530|744692|P2|COMPLETED|Overall Study||16
303704|NCT00088530|744693|P1|COMPLETED|Overall Study||20
303705|NCT00088530|744692|P2|STARTED|Overall Study||70
303706|NCT00088530|744693|P1|STARTED|Overall Study||70
303707|NCT00088465|744705|P1|NOT COMPLETED|Overall Study||561
303708|NCT00088465|744705|P1|COMPLETED|Overall Study||370
303709|NCT00088465|744705|P1|STARTED|Overall Study||931
303710|NCT00088374|744728|P1|NOT COMPLETED|Overall Study||2
303711|NCT00088374|744728|P1|COMPLETED|Overall Study||7
303712|NCT00088374|744728|P1|STARTED|Overall Study||9
303713|NCT00088218|744739|P2|NOT COMPLETED|Overall Study||0
303714|NCT00088218|744740|P1|NOT COMPLETED|Overall Study||0
303715|NCT00088218|744739|P2|COMPLETED|Overall Study||79
303716|NCT00088218|744740|P1|COMPLETED|Overall Study||16
303717|NCT00088218|744739|P2|STARTED|Overall Study||79
303718|NCT00088218|744740|P1|STARTED|Overall Study||16
303719|NCT00088166|744748|P2|NOT COMPLETED|Overall Study||61
303720|NCT00088166|744749|P1|NOT COMPLETED|Overall Study||53
303721|NCT00088166|744748|P2|COMPLETED|Overall Study||39
303722|NCT00088166|744749|P1|COMPLETED|Overall Study||47
303723|NCT00088166|744748|P2|STARTED|Overall Study||100
303724|NCT00088166|744749|P1|STARTED|Overall Study||100
303725|NCT00088153|744773|P2|NOT COMPLETED|Overall Study||25
303726|NCT00088153|744774|P1|NOT COMPLETED|Overall Study||24
303727|NCT00088153|744773|P2|COMPLETED|Overall Study||30
303728|NCT00088153|744774|P1|COMPLETED|Overall Study||31
303729|NCT00088153|744773|P2|STARTED|Overall Study||55
303730|NCT00088153|744774|P1|STARTED|Overall Study||55
303731|NCT00087698|744784|P1|NOT COMPLETED|Overall Study||36
303732|NCT00087698|744784|P1|COMPLETED|Overall Study||41
303733|NCT00087698|744784|P1|STARTED|Overall Study||77
303734|NCT00087685|744793|P1|NOT COMPLETED|Overall Study||14
303735|NCT00087685|744793|P1|COMPLETED|Overall Study||21
303736|NCT00087685|744793|P1|STARTED|Overall Study||35
303737|NCT00087672|744798|P1|NOT COMPLETED|Overall Study||0
303738|NCT00087672|744798|P1|COMPLETED|Overall Study||41
303739|NCT00087672|744798|P1|STARTED|Overall Study||41
303740|NCT00087646|744806|P4|NOT COMPLETED|Overall Study||84
303741|NCT00087646|744807|P3|NOT COMPLETED|Overall Study||65
303742|NCT00087646|744808|P2|NOT COMPLETED|Overall Study||42
303743|NCT00087646|744809|P1|NOT COMPLETED|Overall Study||135
303744|NCT00087646|744806|P4|COMPLETED|Overall Study||229
303745|NCT00087646|744807|P3|COMPLETED|Overall Study||91
303746|NCT00087646|744808|P2|COMPLETED|Overall Study||114
303747|NCT00087646|744809|P1|COMPLETED|Overall Study||182
303748|NCT00087646|744806|P4|STARTED|Overall Study||313
303749|NCT00087646|744807|P3|STARTED|Overall Study||156
303750|NCT00087646|744808|P2|STARTED|Overall Study||156
303751|NCT00087646|744809|P1|STARTED|Overall Study||317
303752|NCT00087633|744837|P2|NOT COMPLETED|Overall Study||17
303753|NCT00087633|744838|P1|NOT COMPLETED|Overall Study||24
303754|NCT00087633|744837|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
303755|NCT00087633|744838|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
303756|NCT00087633|744837|P2|STARTED|Overall Study|Randomized|60
303757|NCT00087633|744838|P1|STARTED|Overall Study|Randomized|55
303758|NCT00087607|744848|P2|NOT COMPLETED|Overall Study||122
303759|NCT00087607|744849|P1|NOT COMPLETED|Overall Study||122
303760|NCT00087607|744848|P2|COMPLETED|Overall Study||71
303761|NCT00087607|744849|P1|COMPLETED|Overall Study||70
303762|NCT00087607|744848|P2|STARTED|Overall Study||193
303763|NCT00087607|744849|P1|STARTED|Overall Study||192
303764|NCT00087594|744889|P2|NOT COMPLETED|Overall Study||12
303765|NCT00087594|744890|P1|NOT COMPLETED|Overall Study||8
303766|NCT00087594|744889|P2|COMPLETED|Overall Study||12
303767|NCT00087594|744890|P1|COMPLETED|Overall Study||16
303768|NCT00087594|744889|P2|STARTED|Overall Study||24
303769|NCT00087594|744890|P1|STARTED|Overall Study||24
303770|NCT00087568|744924|P2|NOT COMPLETED|Overall Study||2
303771|NCT00087568|744925|P1|NOT COMPLETED|Overall Study||30
303772|NCT00087568|744924|P2|COMPLETED|Overall Study||23
303773|NCT00087568|744925|P1|COMPLETED|Overall Study||2
303774|NCT00087568|744924|P2|STARTED|Overall Study||25
303775|NCT00087568|744925|P1|STARTED|Overall Study||32
303776|NCT00087555|744952|P3|NOT COMPLETED|Overall Study||21
303777|NCT00087555|744953|P2|NOT COMPLETED|Overall Study||11
303780|NCT00087555|744953|P2|COMPLETED|Overall Study||51
303781|NCT00087555|744954|P1|COMPLETED|Overall Study||54
303782|NCT00087555|744952|P3|Treated|Overall Study||67
303783|NCT00087555|744953|P2|Treated|Overall Study||60
303784|NCT00087555|744954|P1|Treated|Overall Study||65
303785|NCT00087555|744952|P3|STARTED|Overall Study||67
303786|NCT00087555|744953|P2|STARTED|Overall Study||62
303787|NCT00087555|744954|P1|STARTED|Overall Study||66
303788|NCT00087529|744964|P2|NOT COMPLETED|Overall Study||68
303789|NCT00087529|744965|P1|NOT COMPLETED|Overall Study||31
303790|NCT00087529|744964|P2|COMPLETED|Overall Study||224
303791|NCT00087529|744965|P1|COMPLETED|Overall Study||116
303792|NCT00087529|744964|P2|STARTED|Overall Study||292
303793|NCT00087529|744965|P1|STARTED|Overall Study||147
303794|NCT00087516|744980|P4|NOT COMPLETED|Overall Study||85
303795|NCT00087516|744981|P3|NOT COMPLETED|Overall Study||97
303796|NCT00087516|744982|P2|NOT COMPLETED|Overall Study||169
303797|NCT00087516|744983|P1|NOT COMPLETED|Overall Study||161
303798|NCT00087516|744980|P4|COMPLETED|Overall Study||38
303799|NCT00087516|744981|P3|COMPLETED|Overall Study||33
303800|NCT00087516|744982|P2|COMPLETED|Overall Study||81
303801|NCT00087516|744983|P1|COMPLETED|Overall Study||77
303802|NCT00087516|744980|P4|STARTED|Overall Study||123
303803|NCT00087516|744981|P3|STARTED|Overall Study||130
303804|NCT00087516|744982|P2|STARTED|Overall Study||250
303805|NCT00087516|744983|P1|STARTED|Overall Study||238
303806|NCT00087490|745012|P2|NOT COMPLETED|Overall Study||269
303807|NCT00087490|745013|P1|NOT COMPLETED|Overall Study||258
303808|NCT00087490|745012|P2|COMPLETED|Overall Study||264
303809|NCT00087490|745013|P1|COMPLETED|Overall Study||286
303810|NCT00087490|745012|P2|Treated|Overall Study||515
303811|NCT00087490|745013|P1|Treated|Overall Study||537
303812|NCT00087490|745012|P2|STARTED|Overall Study||533
303813|NCT00087490|745013|P1|STARTED|Overall Study||544
303814|NCT00087438|745047|P1|NOT COMPLETED|Overall Study||4
303815|NCT00087438|745047|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
303816|NCT00087438|745047|P1|STARTED|Overall Study||59
303817|NCT00087152|745051|P1|NOT COMPLETED|Overall Study||6
303818|NCT00087152|745051|P1|COMPLETED|Overall Study||21
303819|NCT00087152|745051|P1|STARTED|Overall Study||27
303820|NCT00087139|745060|P3|NOT COMPLETED|Overall Study||36
303821|NCT00087139|745061|P2|NOT COMPLETED|Overall Study||49
303822|NCT00087139|745062|P1|NOT COMPLETED|Overall Study||39
303823|NCT00087139|745060|P3|COMPLETED|Overall Study||0
303824|NCT00087139|745061|P2|COMPLETED|Overall Study||0
303825|NCT00087139|745062|P1|COMPLETED|Overall Study||0
303826|NCT00087139|745060|P3|Patients w/ Measurable Disease Response|Overall Study||0
303827|NCT00087139|745061|P2|Patients w/ Measurable Disease Response|Overall Study||2
303828|NCT00087139|745062|P1|Patients w/ Measurable Disease Response|Overall Study||5
303829|NCT00087139|745060|P3|Patients With PSA Response|Overall Study||4
303830|NCT00087139|745061|P2|Patients With PSA Response|Overall Study||8
303831|NCT00087139|745062|P1|Patients With PSA Response|Overall Study||10
303832|NCT00087139|745060|P3|Patients With Measurable Disease|Overall Study||24
303833|NCT00087139|745061|P2|Patients With Measurable Disease|Overall Study||25
303834|NCT00087139|745062|P1|Patients With Measurable Disease|Overall Study||22
303835|NCT00087139|745060|P3|Patients for the Analysis of PSA Respons|Overall Study||22
303836|NCT00087139|745061|P2|Patients for the Analysis of PSA Respons|Overall Study||34
303837|NCT00087139|745062|P1|Patients for the Analysis of PSA Respons|Overall Study||30
303838|NCT00087139|745060|P3|Eligible and Treated|Overall Study||32
303839|NCT00087139|745061|P2|Eligible and Treated|Overall Study||42
303840|NCT00087139|745062|P1|Eligible and Treated|Overall Study||35
303841|NCT00087139|745060|P3|Treated|Overall Study||36
303842|NCT00087139|745061|P2|Treated|Overall Study||48
303843|NCT00087139|745062|P1|Treated|Overall Study||39
303844|NCT00087139|745060|P3|STARTED|Overall Study||36
303845|NCT00087139|745061|P2|STARTED|Overall Study||49
303846|NCT00087139|745062|P1|STARTED|Overall Study||39
303847|NCT00086996|745077|P1|NOT COMPLETED|Overall Study||64
303848|NCT00086996|745077|P1|COMPLETED|Overall Study||34
303849|NCT00086996|745077|P1|Eligible and Began Protocol Therapy|Overall Study||93
303850|NCT00086996|745077|P1|Eligible|Overall Study||93
303851|NCT00086996|745077|P1|STARTED|Overall Study||98
303852|NCT00086957|745084|P3|NOT COMPLETED|Overall Study||0
303853|NCT00086957|745085|P2|NOT COMPLETED|Overall Study||0
303854|NCT00086957|745086|P1|NOT COMPLETED|Overall Study||0
303855|NCT00086957|745084|P3|COMPLETED|Overall Study||22
303856|NCT00086957|745085|P2|COMPLETED|Overall Study||7
303857|NCT00086957|745086|P1|COMPLETED|Overall Study||2
303858|NCT00086957|745084|P3|STARTED|Overall Study||22
303859|NCT00086957|745085|P2|STARTED|Overall Study||7
303860|NCT00086957|745086|P1|STARTED|Overall Study||2
303861|NCT00086684|745099|P3|NOT COMPLETED|Overall Study||53
303862|NCT00086684|745100|P2|NOT COMPLETED|Overall Study||55
303863|NCT00086684|745101|P1|NOT COMPLETED|Overall Study||55
303864|NCT00086684|745099|P3|COMPLETED|Overall Study||69
303865|NCT00086684|745100|P2|COMPLETED|Overall Study||74
303866|NCT00086684|745101|P1|COMPLETED|Overall Study||63
303867|NCT00086684|745099|P3|STARTED|Overall Study||122
303868|NCT00086684|745100|P2|STARTED|Overall Study||129
303869|NCT00086684|745101|P1|STARTED|Overall Study||118
303870|NCT00086619|745114|P2|NOT COMPLETED|Overall Study||17
303871|NCT00086619|745115|P1|NOT COMPLETED|Overall Study||15
303872|NCT00086619|745114|P2|COMPLETED|Overall Study||23
303873|NCT00086619|745115|P1|COMPLETED|Overall Study||25
303874|NCT00086619|745114|P2|Completed 12 Month Visit|Overall Study||26
303875|NCT00086619|745115|P1|Completed 12 Month Visit|Overall Study||26
303876|NCT00086619|745114|P2|Completed Baseline Visit|Overall Study||36
303877|NCT00086619|745115|P1|Completed Baseline Visit|Overall Study||34
303878|NCT00086619|745114|P2|STARTED|Overall Study||40
303879|NCT00086619|745115|P1|STARTED|Overall Study||40
303880|NCT00086580|745125|P2|NOT COMPLETED|Observation Period||65
303881|NCT00086580|745126|P1|NOT COMPLETED|Observation Period||46
303882|NCT00086580|745125|P2|COMPLETED|Observation Period||56
303883|NCT00086580|745126|P1|COMPLETED|Observation Period||49
303884|NCT00086580|745125|P2|STARTED|Observation Period||121
303885|NCT00086580|745126|P1|STARTED|Observation Period||95
303886|NCT00086580|745125|P2|NOT COMPLETED|Follow-up Period||119
303887|NCT00086580|745126|P1|NOT COMPLETED|Follow-up Period||104
303888|NCT00086580|745125|P2|COMPLETED|Follow-up Period||18
303889|NCT00086580|745126|P1|COMPLETED|Follow-up Period||37
303890|NCT00086580|745125|P2|STARTED|Follow-up Period||137
303891|NCT00086580|745126|P1|STARTED|Follow-up Period||141
303892|NCT00086580|745125|P2|NOT COMPLETED|Treatment Period||60
303893|NCT00086580|745126|P1|NOT COMPLETED|Treatment Period||65
303894|NCT00086580|745125|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
303895|NCT00086580|745126|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
303896|NCT00086580|745125|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
303897|NCT00086580|745126|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
303898|NCT00086580|745125|P2|STARTED|Treatment Period||167
303899|NCT00086580|745126|P1|STARTED|Treatment Period||168
303900|NCT00086411|745174|P4|NOT COMPLETED|Overall Study||12
303901|NCT00086411|745175|P3|NOT COMPLETED|Overall Study||13
303902|NCT00086411|745176|P2|NOT COMPLETED|Overall Study||11
303903|NCT00086411|745177|P1|NOT COMPLETED|Overall Study||11
303904|NCT00086411|745174|P4|COMPLETED|Overall Study||53
303905|NCT00086411|745175|P3|COMPLETED|Overall Study||49
303906|NCT00086411|745176|P2|COMPLETED|Overall Study||52
303907|NCT00086411|745177|P1|COMPLETED|Overall Study||59
303908|NCT00086411|745174|P4|STARTED|Overall Study||65
303909|NCT00086411|745175|P3|STARTED|Overall Study||62
303910|NCT00086411|745176|P2|STARTED|Overall Study||63
303911|NCT00086411|745177|P1|STARTED|Overall Study||70
303912|NCT00086385|745191|P4|NOT COMPLETED|Overall Study||1
303913|NCT00086385|745192|P3|NOT COMPLETED|Overall Study||1
303914|NCT00086385|745193|P2|NOT COMPLETED|Overall Study||2
303915|NCT00086385|745194|P1|NOT COMPLETED|Overall Study||2
303916|NCT00086385|745191|P4|COMPLETED|Overall Study||98
303917|NCT00086385|745192|P3|COMPLETED|Overall Study||103
303918|NCT00086385|745193|P2|COMPLETED|Overall Study||97
303919|NCT00086385|745194|P1|COMPLETED|Overall Study||98
303920|NCT00086385|745191|P4|STARTED|Overall Study||99
303921|NCT00086385|745192|P3|STARTED|Overall Study||104
303922|NCT00086385|745193|P2|STARTED|Overall Study||99
303923|NCT00086385|745194|P1|STARTED|Overall Study||100
303924|NCT00086515|745206|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
303925|NCT00086515|745207|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
303926|NCT00086515|745206|P2|COMPLETED|Phase B (Weeks 24-104)||109
303927|NCT00086515|745207|P1|COMPLETED|Phase B (Weeks 24-104)||201
303928|NCT00086515|745206|P2|STARTED|Phase B (Weeks 24-104)||164
303929|NCT00086515|745207|P1|STARTED|Phase B (Weeks 24-104)||391
303930|NCT00086515|745206|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
303931|NCT00086515|745207|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
303932|NCT00086515|745206|P2|COMPLETED|Phase A to Phase B Transition Period||164
303933|NCT00086515|745207|P1|COMPLETED|Phase A to Phase B Transition Period||391
303934|NCT00086515|745206|P2|STARTED|Phase A to Phase B Transition Period||192
303935|NCT00086515|745207|P1|STARTED|Phase A to Phase B Transition Period||415
303936|NCT00086515|745206|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
303937|NCT00086515|745207|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
303938|NCT00086515|745206|P2|COMPLETED|Phase A (Weeks 0-24)||192
303939|NCT00086515|745207|P1|COMPLETED|Phase A (Weeks 0-24)||415
303940|NCT00086515|745206|P2|STARTED|Phase A (Weeks 0-24)||237
303941|NCT00086515|745207|P1|STARTED|Phase A (Weeks 0-24)||464
303942|NCT00086502|745219|P2|NOT COMPLETED|Overall Study||20
303943|NCT00086502|745220|P1|NOT COMPLETED|Overall Study||26
303944|NCT00086502|745219|P2|COMPLETED|Overall Study||158
303945|NCT00086502|745220|P1|COMPLETED|Overall Study||149
303946|NCT00086502|745219|P2|STARTED|Overall Study||178
303947|NCT00086502|745220|P1|STARTED|Overall Study||175
303948|NCT00086450|745230|P2|NOT COMPLETED|Overall Study||0
303949|NCT00086450|745231|P1|NOT COMPLETED|Overall Study||0
303950|NCT00086450|745230|P2|COMPLETED|Overall Study||947
303951|NCT00086450|745231|P1|COMPLETED|Overall Study||953
303952|NCT00086450|745230|P2|STARTED|Overall Study||947
303953|NCT00086450|745231|P1|STARTED|Overall Study||953
303954|NCT00086346|745245|P2|NOT COMPLETED|Patients Dosed With Test Article||23
303955|NCT00086346|745246|P1|NOT COMPLETED|Patients Dosed With Test Article||140
303956|NCT00086346|745245|P2|COMPLETED|Patients Dosed With Test Article||187
303957|NCT00086346|745246|P1|COMPLETED|Patients Dosed With Test Article||249
303958|NCT00086346|745245|P2|STARTED|Patients Dosed With Test Article||210
303959|NCT00086346|745246|P1|STARTED|Patients Dosed With Test Article||389
303960|NCT00086346|745245|P2|NOT COMPLETED|Randomization||4
303961|NCT00086346|745246|P1|NOT COMPLETED|Randomization||4
303962|NCT00086346|745245|P2|COMPLETED|Randomization||210
303963|NCT00086346|745246|P1|COMPLETED|Randomization||389
303964|NCT00086346|745245|P2|STARTED|Randomization||214
303965|NCT00086346|745246|P1|STARTED|Randomization||393
303966|NCT00086281|745273|P15|NOT COMPLETED|Phase 2||0
303967|NCT00086281|745274|P14|NOT COMPLETED|Phase 2||1
303968|NCT00086281|745275|P13|NOT COMPLETED|Phase 2||1
303969|NCT00086281|745276|P12|NOT COMPLETED|Phase 2||0
303970|NCT00086281|745277|P11|NOT COMPLETED|Phase 2||0
303971|NCT00086281|745278|P10|NOT COMPLETED|Phase 2||0
303972|NCT00086281|745279|P9|NOT COMPLETED|Phase 2||0
303973|NCT00086281|745280|P8|NOT COMPLETED|Phase 2||0
303974|NCT00086281|745281|P7|NOT COMPLETED|Phase 2||0
303975|NCT00086281|745282|P6|NOT COMPLETED|Phase 2||0
303976|NCT00086281|745283|P5|NOT COMPLETED|Phase 2||0
303977|NCT00086281|745284|P4|NOT COMPLETED|Phase 2||0
303978|NCT00086281|745285|P3|NOT COMPLETED|Phase 2||0
303979|NCT00086281|745286|P2|NOT COMPLETED|Phase 2||0
303980|NCT00086281|745287|P1|NOT COMPLETED|Phase 2||0
303981|NCT00086281|745273|P15|COMPLETED|Phase 2||0
303982|NCT00086281|745274|P14|COMPLETED|Phase 2||26
303983|NCT00086281|745275|P13|COMPLETED|Phase 2||22
303984|NCT00086281|745276|P12|COMPLETED|Phase 2||0
303985|NCT00086281|745277|P11|COMPLETED|Phase 2||0
303986|NCT00086281|745278|P10|COMPLETED|Phase 2||0
303987|NCT00086281|745279|P9|COMPLETED|Phase 2||0
303988|NCT00086281|745280|P8|COMPLETED|Phase 2||0
303989|NCT00086281|745281|P7|COMPLETED|Phase 2||0
303990|NCT00086281|745282|P6|COMPLETED|Phase 2||0
303991|NCT00086281|745283|P5|COMPLETED|Phase 2||0
303992|NCT00086281|745284|P4|COMPLETED|Phase 2||0
303993|NCT00086281|745285|P3|COMPLETED|Phase 2||0
303994|NCT00086281|745286|P2|COMPLETED|Phase 2||0
303995|NCT00086281|745287|P1|COMPLETED|Phase 2||0
303996|NCT00086281|745273|P15|STARTED|Phase 2||0
303997|NCT00086281|745274|P14|STARTED|Phase 2||27
303998|NCT00086281|745275|P13|STARTED|Phase 2||23
303999|NCT00086281|745276|P12|STARTED|Phase 2||0
304000|NCT00086281|745277|P11|STARTED|Phase 2||0
304001|NCT00086281|745278|P10|STARTED|Phase 2||0
304002|NCT00086281|745279|P9|STARTED|Phase 2||0
304003|NCT00086281|745280|P8|STARTED|Phase 2||0
304004|NCT00086281|745281|P7|STARTED|Phase 2||0
304005|NCT00086281|745282|P6|STARTED|Phase 2||0
304006|NCT00086281|745283|P5|STARTED|Phase 2||0
304007|NCT00086281|745284|P4|STARTED|Phase 2||0
304008|NCT00086281|745285|P3|STARTED|Phase 2||0
304009|NCT00086281|745286|P2|STARTED|Phase 2||0
304010|NCT00086281|745287|P1|STARTED|Phase 2||0
304011|NCT00086281|745273|P15|NOT COMPLETED|Phase 1||3
304012|NCT00086281|745274|P14|NOT COMPLETED|Phase 1||1
304013|NCT00086281|745275|P13|NOT COMPLETED|Phase 1||1
304014|NCT00086281|745276|P12|NOT COMPLETED|Phase 1||1
304015|NCT00086281|745277|P11|NOT COMPLETED|Phase 1||3
304016|NCT00086281|745278|P10|NOT COMPLETED|Phase 1||1
304017|NCT00086281|745279|P9|NOT COMPLETED|Phase 1||0
304018|NCT00086281|745280|P8|NOT COMPLETED|Phase 1||0
304019|NCT00086281|745281|P7|NOT COMPLETED|Phase 1||0
304020|NCT00086281|745282|P6|NOT COMPLETED|Phase 1||0
304021|NCT00086281|745283|P5|NOT COMPLETED|Phase 1||0
304022|NCT00086281|745284|P4|NOT COMPLETED|Phase 1||0
304023|NCT00086281|745285|P3|NOT COMPLETED|Phase 1||0
304024|NCT00086281|745286|P2|NOT COMPLETED|Phase 1||0
304025|NCT00086281|745287|P1|NOT COMPLETED|Phase 1||0
304026|NCT00086281|745273|P15|COMPLETED|Phase 1||0
304027|NCT00086281|745274|P14|COMPLETED|Phase 1||0
304028|NCT00086281|745275|P13|COMPLETED|Phase 1||0
304029|NCT00086281|745276|P12|COMPLETED|Phase 1||0
304030|NCT00086281|745277|P11|COMPLETED|Phase 1||0
304031|NCT00086281|745278|P10|COMPLETED|Phase 1||0
304032|NCT00086281|745279|P9|COMPLETED|Phase 1||2
304033|NCT00086281|745280|P8|COMPLETED|Phase 1||1
304034|NCT00086281|745281|P7|COMPLETED|Phase 1||1
304035|NCT00086281|745282|P6|COMPLETED|Phase 1||3
304036|NCT00086281|745283|P5|COMPLETED|Phase 1||1
304037|NCT00086281|745284|P4|COMPLETED|Phase 1||11
304038|NCT00086281|745285|P3|COMPLETED|Phase 1||8
304039|NCT00086281|745286|P2|COMPLETED|Phase 1||12
304040|NCT00086281|745287|P1|COMPLETED|Phase 1||11
304041|NCT00086281|745273|P15|STARTED|Phase 1||3
304042|NCT00086281|745274|P14|STARTED|Phase 1||1
304043|NCT00086281|745275|P13|STARTED|Phase 1||1
304044|NCT00086281|745276|P12|STARTED|Phase 1||1
304045|NCT00086281|745277|P11|STARTED|Phase 1||3
304046|NCT00086281|745278|P10|STARTED|Phase 1||1
304047|NCT00086281|745279|P9|STARTED|Phase 1||2
304048|NCT00086281|745280|P8|STARTED|Phase 1||1
304049|NCT00086281|745281|P7|STARTED|Phase 1||1
304050|NCT00086281|745282|P6|STARTED|Phase 1||3
304051|NCT00086281|745283|P5|STARTED|Phase 1||1
304052|NCT00086281|745284|P4|STARTED|Phase 1||11
304053|NCT00086281|745285|P3|STARTED|Phase 1||8
304054|NCT00086281|745286|P2|STARTED|Phase 1||12
304055|NCT00086281|745287|P1|STARTED|Phase 1||11
304056|NCT00086307|745300|P3|NOT COMPLETED|Overall Study||8
304057|NCT00086307|745301|P2|NOT COMPLETED|Overall Study||1
304058|NCT00086307|745302|P1|NOT COMPLETED|Overall Study||2
304059|NCT00086307|745300|P3|COMPLETED|Overall Study||5
304060|NCT00086307|745301|P2|COMPLETED|Overall Study||12
304061|NCT00086307|745302|P1|COMPLETED|Overall Study||11
304062|NCT00086307|745300|P3|STARTED|Overall Study||13
304063|NCT00086307|745301|P2|STARTED|Overall Study||13
304064|NCT00086307|745302|P1|STARTED|Overall Study||13
304065|NCT00086190|745313|P3|NOT COMPLETED|Overall Study||6
304066|NCT00086190|745314|P2|NOT COMPLETED|Overall Study||4
304067|NCT00086190|745315|P1|NOT COMPLETED|Overall Study||8
304068|NCT00086190|745313|P3|COMPLETED|Overall Study||33
304069|NCT00086190|745314|P2|COMPLETED|Overall Study||30
304070|NCT00086190|745315|P1|COMPLETED|Overall Study||34
304071|NCT00086190|745313|P3|STARTED|Overall Study||39
304072|NCT00086190|745314|P2|STARTED|Overall Study||34
304073|NCT00086190|745315|P1|STARTED|Overall Study||42
304074|NCT00086138|745373|P2|NOT COMPLETED|Overall Study||3
304075|NCT00086138|745374|P1|NOT COMPLETED|Overall Study||4
304076|NCT00086138|745373|P2|COMPLETED|Overall Study||64
304077|NCT00086138|745374|P1|COMPLETED|Overall Study||60
304078|NCT00086138|745373|P2|STARTED|Overall Study||67
304079|NCT00086138|745374|P1|STARTED|Overall Study||64
304080|NCT00086047|745384|P2|NOT COMPLETED|Overall Study||7
304081|NCT00086047|745385|P1|NOT COMPLETED|Overall Study||7
304082|NCT00086047|745384|P2|COMPLETED|Overall Study||50
304083|NCT00086047|745385|P1|COMPLETED|Overall Study||50
304084|NCT00086047|745384|P2|STARTED|Overall Study||57
304085|NCT00086047|745385|P1|STARTED|Overall Study||57
304086|NCT00085917|745393|P2|NOT COMPLETED|Overall Study||3
304087|NCT00085917|745394|P1|NOT COMPLETED|Overall Study||4
304088|NCT00085917|745393|P2|COMPLETED|Overall Study||11
304089|NCT00085917|745394|P1|COMPLETED|Overall Study||11
304090|NCT00085917|745393|P2|STARTED|Overall Study||14
304091|NCT00085917|745394|P1|STARTED|Overall Study||15
304092|NCT00085839|745406|P2|NOT COMPLETED|Overall Study||0
304093|NCT00085839|745407|P1|NOT COMPLETED|Overall Study||0
304094|NCT00085839|745406|P2|COMPLETED|Overall Study||51
304095|NCT00085839|745407|P1|COMPLETED|Overall Study||52
304096|NCT00085839|745406|P2|STARTED|Overall Study||51
304097|NCT00085839|745407|P1|STARTED|Overall Study||52
304098|NCT00085735|745423|P6|NOT COMPLETED|Overall Study||31
304099|NCT00085735|745424|P5|NOT COMPLETED|Overall Study||42
304100|NCT00085735|745425|P4|NOT COMPLETED|Overall Study||19
304101|NCT00085735|745426|P3|NOT COMPLETED|Overall Study||17
304102|NCT00085735|745427|P2|NOT COMPLETED|Overall Study||10
304103|NCT00085735|745428|P1|NOT COMPLETED|Overall Study||12
304104|NCT00085735|745423|P6|COMPLETED|Overall Study||115
304105|NCT00085735|745424|P5|COMPLETED|Overall Study||105
304106|NCT00085735|745425|P4|COMPLETED|Overall Study||46
304107|NCT00085735|745426|P3|COMPLETED|Overall Study||46
304108|NCT00085735|745427|P2|COMPLETED|Overall Study||54
304109|NCT00085735|745428|P1|COMPLETED|Overall Study||52
304110|NCT00085735|745423|P6|STARTED|Overall Study||146
304111|NCT00085735|745424|P5|STARTED|Overall Study||147
304112|NCT00085735|745425|P4|STARTED|Overall Study||65
304113|NCT00085735|745426|P3|STARTED|Overall Study||63
304114|NCT00085735|745427|P2|STARTED|Overall Study||64
304115|NCT00085735|745428|P1|STARTED|Overall Study||64
304116|NCT00085709|745456|P2|NOT COMPLETED|Overall Study||50
304117|NCT00085709|745457|P1|NOT COMPLETED|Overall Study||53
304118|NCT00085709|745456|P2|COMPLETED|Overall Study||270
304119|NCT00085709|745457|P1|COMPLETED|Overall Study||264
304120|NCT00085709|745456|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
304121|NCT00085709|745457|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
304122|NCT00085709|745456|P2|Eligible|Overall Study||301
304123|NCT00085709|745457|P1|Eligible|Overall Study||298
304124|NCT00085709|745456|P2|STARTED|Overall Study||320
304125|NCT00085709|745457|P1|STARTED|Overall Study||317
304126|NCT00085644|745473|P3|NOT COMPLETED|Open-Label Period||109
304127|NCT00085644|745474|P2|NOT COMPLETED|Open-Label Period||0
304128|NCT00085644|745475|P1|NOT COMPLETED|Open-Label Period||0
304129|NCT00085644|745473|P3|COMPLETED|Open-Label Period||202
304130|NCT00085644|745474|P2|COMPLETED|Open-Label Period||0
304131|NCT00085644|745475|P1|COMPLETED|Open-Label Period||0
304132|NCT00085644|745473|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
304133|NCT00085644|745474|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
304134|NCT00085644|745475|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
304135|NCT00085644|745473|P3|NOT COMPLETED|Double-Blind Period||0
304136|NCT00085644|745474|P2|NOT COMPLETED|Double-Blind Period||6
304137|NCT00085644|745475|P1|NOT COMPLETED|Double-Blind Period||13
304138|NCT00085644|745473|P3|COMPLETED|Double-Blind Period||0
304139|NCT00085644|745474|P2|COMPLETED|Double-Blind Period||101
304140|NCT00085644|745475|P1|COMPLETED|Double-Blind Period||195
304141|NCT00085644|745473|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
304142|NCT00085644|745474|P2|STARTED|Double-Blind Period||107
304143|NCT00085644|745475|P1|STARTED|Double-Blind Period||208
304144|NCT00085631|745516|P3|NOT COMPLETED|Overall Study||7
304145|NCT00085631|745517|P2|NOT COMPLETED|Overall Study||11
304146|NCT00085631|745518|P1|NOT COMPLETED|Overall Study||4
304147|NCT00085631|745516|P3|COMPLETED|Overall Study||32
304148|NCT00085631|745517|P2|COMPLETED|Overall Study||38
304149|NCT00085631|745518|P1|COMPLETED|Overall Study||9
304150|NCT00085631|745516|P3|STARTED|Overall Study||39
304151|NCT00085631|745517|P2|STARTED|Overall Study||49
304152|NCT00085631|745518|P1|STARTED|Overall Study||13
304153|NCT00085566|745528|P3|NOT COMPLETED|Overall Study||14
304154|NCT00085566|745529|P2|NOT COMPLETED|Overall Study||0
304155|NCT00085566|745530|P1|NOT COMPLETED|Overall Study||0
304156|NCT00085566|745528|P3|COMPLETED|Overall Study||43
304157|NCT00085566|745529|P2|COMPLETED|Overall Study||3
304158|NCT00085566|745530|P1|COMPLETED|Overall Study||3
304159|NCT00085566|745528|P3|STARTED|Overall Study||57
304160|NCT00085566|745529|P2|STARTED|Overall Study||3
304161|NCT00085566|745530|P1|STARTED|Overall Study||3
304162|NCT00085540|745540|P2|NOT COMPLETED|Overall Study||2
304163|NCT00085540|745541|P1|NOT COMPLETED|Overall Study||0
304164|NCT00085540|745540|P2|COMPLETED|Overall Study||40
304165|NCT00085540|745541|P1|COMPLETED|Overall Study||8
304166|NCT00085540|745540|P2|STARTED|Overall Study||42
304167|NCT00085540|745541|P1|STARTED|Overall Study||8
304168|NCT00085436|745548|P1|NOT COMPLETED|Overall Study||0
304169|NCT00085436|745548|P1|COMPLETED|Overall Study||18
304170|NCT00085436|745548|P1|STARTED|Overall Study||18
304171|NCT00085423|745552|P1|NOT COMPLETED|Overall Study||2
304172|NCT00085423|745552|P1|COMPLETED|Overall Study||18
304173|NCT00085423|745552|P1|STARTED|Overall Study||20
304174|NCT00085410|745558|P1|NOT COMPLETED|Overall Study||0
304175|NCT00085410|745558|P1|COMPLETED|Overall Study||20
304176|NCT00085410|745558|P1|STARTED|Overall Study||20
304177|NCT00085293|745572|P1|NOT COMPLETED|Overall Study||0
304178|NCT00085293|745572|P1|COMPLETED|Overall Study||12
304179|NCT00085293|745572|P1|STARTED|Overall Study||12
304180|NCT00085254|745580|P3|NOT COMPLETED|Overall Study||0
304181|NCT00085254|745581|P2|NOT COMPLETED|Overall Study||0
304182|NCT00085254|745582|P1|NOT COMPLETED|Overall Study||0
304183|NCT00085254|745580|P3|COMPLETED|Overall Study||48
304184|NCT00085254|745581|P2|COMPLETED|Overall Study||46
304185|NCT00085254|745582|P1|COMPLETED|Overall Study||18
304186|NCT00085254|745580|P3|STARTED|Overall Study||48
304187|NCT00085254|745581|P2|STARTED|Overall Study||46
304188|NCT00085254|745582|P1|STARTED|Overall Study||18
304189|NCT00085202|745598|P2|NOT COMPLETED|Overall Study||24
304190|NCT00085202|745599|P1|NOT COMPLETED|Overall Study||18
304191|NCT00085202|745598|P2|COMPLETED|Overall Study||120
304192|NCT00085202|745599|P1|COMPLETED|Overall Study||251
304193|NCT00085202|745598|P2|STARTED|Overall Study||144
304194|NCT00085202|745599|P1|STARTED|Overall Study||269
304195|NCT00085098|745620|P2|NOT COMPLETED|Overall Study||2
304196|NCT00085098|745621|P1|NOT COMPLETED|Overall Study||1
304197|NCT00085098|745620|P2|COMPLETED|Overall Study||11
304198|NCT00085098|745621|P1|COMPLETED|Overall Study||10
304199|NCT00085098|745620|P2|STARTED|Overall Study||13
304200|NCT00085098|745621|P1|STARTED|Overall Study||11
304201|NCT00084864|745631|P4|NOT COMPLETED|Overall Study||0
304202|NCT00084864|745632|P3|NOT COMPLETED|Overall Study||0
304203|NCT00084864|745633|P2|NOT COMPLETED|Overall Study||0
304204|NCT00084864|745634|P1|NOT COMPLETED|Overall Study||1
304205|NCT00084864|745631|P4|COMPLETED|Overall Study||4
304206|NCT00084864|745632|P3|COMPLETED|Overall Study||4
304207|NCT00084864|745633|P2|COMPLETED|Overall Study||7
304208|NCT00084864|745634|P1|COMPLETED|Overall Study||9
304209|NCT00084864|745631|P4|STARTED|Overall Study||4
304210|NCT00084864|745632|P3|STARTED|Overall Study||4
304211|NCT00084864|745633|P2|STARTED|Overall Study||7
304212|NCT00084864|745634|P1|STARTED|Overall Study||10
304213|NCT00084838|745660|P1|NOT COMPLETED|Overall Study||13
304214|NCT00084838|745660|P1|COMPLETED|Overall Study||12
304215|NCT00084838|745660|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
304216|NCT00084838|745660|P1|STARTED|Overall Study||25
304217|NCT00084747|745682|P1|NOT COMPLETED|Overall Study||13
304218|NCT00084747|745682|P1|COMPLETED|Overall Study||17
304219|NCT00084747|745682|P1|STARTED|Overall Study||30
304220|NCT00084682|745687|P1|NOT COMPLETED|Overall Study||1
304221|NCT00084682|745687|P1|COMPLETED|Overall Study||13
304222|NCT00084682|745687|P1|STARTED|Overall Study||14
304223|NCT00084617|745691|P1|NOT COMPLETED|Overall Study||9
304224|NCT00084617|745691|P1|COMPLETED|Overall Study||30
304225|NCT00084617|745691|P1|STARTED|Overall Study||39
304226|NCT00084487|745697|P1|NOT COMPLETED|Overall Study||1
304227|NCT00084487|745697|P1|COMPLETED|Overall Study||20
304228|NCT00084487|745697|P1|STARTED|Overall Study||21
304229|NCT00084409|745707|P2|NOT COMPLETED|Overall Study||12
304230|NCT00084409|745708|P1|NOT COMPLETED|Overall Study||15
304231|NCT00084409|745707|P2|COMPLETED|Overall Study|4 Current, 8 former|65
304232|NCT00084409|745708|P1|COMPLETED|Overall Study|9 current, 6 former|60
304233|NCT00084409|745707|P2|STARTED|Overall Study|41 current, 36 former|77
304234|NCT00084409|745708|P1|STARTED|Overall Study|40 Current, 35 former|75
304235|NCT00084383|745736|P1|NOT COMPLETED|Overall Study||47
304236|NCT00084383|745736|P1|COMPLETED|Overall Study||13
304237|NCT00084383|745736|P1|STARTED|Overall Study||60
304238|NCT00084318|745743|P2|NOT COMPLETED|Overall Study||13
304239|NCT00084318|745744|P1|NOT COMPLETED|Overall Study||22
304240|NCT00084318|745743|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
304241|NCT00084318|745744|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
304242|NCT00084318|745743|P2|STARTED|Overall Study||119
304243|NCT00084318|745744|P1|STARTED|Overall Study||119
304244|NCT00084266|745762|P2|NOT COMPLETED|Overall Study||423
304245|NCT00084266|745763|P1|NOT COMPLETED|Overall Study||441
304246|NCT00084266|745762|P2|COMPLETED|Overall Study||184
304247|NCT00084266|745763|P1|COMPLETED|Overall Study||177
304248|NCT00084266|745762|P2|Treated|Overall Study||587
304249|NCT00084266|745763|P1|Treated|Overall Study||597
304250|NCT00084266|745762|P2|STARTED|Overall Study||607
304251|NCT00084266|745763|P1|STARTED|Overall Study||618
304252|NCT00084136|745800|P3|NOT COMPLETED|NRTI Comparison||82
304253|NCT00084136|745801|P2|NOT COMPLETED|NRTI Comparison||0
304254|NCT00084136|745802|P1|NOT COMPLETED|NRTI Comparison||101
304255|NCT00084136|745800|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
304256|NCT00084136|745801|P2|COMPLETED|NRTI Comparison||0
304257|NCT00084136|745802|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
304258|NCT00084136|745800|P3|STARTED|NRTI Comparison||526
304259|NCT00084136|745801|P2|STARTED|NRTI Comparison||0
304260|NCT00084136|745802|P1|STARTED|NRTI Comparison||519
304261|NCT00084136|745800|P3|NOT COMPLETED|PI Comparison||0
304262|NCT00084136|745801|P2|NOT COMPLETED|PI Comparison||47
304263|NCT00084136|745802|P1|NOT COMPLETED|PI Comparison||55
304264|NCT00084136|745800|P3|COMPLETED|PI Comparison||0
304265|NCT00084136|745801|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
304266|NCT00084136|745802|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
304267|NCT00084136|745800|P3|STARTED|PI Comparison||0
304268|NCT00084136|745801|P2|STARTED|PI Comparison||526
304269|NCT00084136|745802|P1|STARTED|PI Comparison||519
304270|NCT00084084|745861|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
304271|NCT00084084|745861|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
304272|NCT00084084|745861|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
304273|NCT00084084|745861|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
304274|NCT00084084|745861|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
304275|NCT00084084|745861|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
304276|NCT00083915|745871|P2|NOT COMPLETED|Overall Study||37
304277|NCT00083915|745872|P1|NOT COMPLETED|Overall Study||50
304278|NCT00083915|745871|P2|COMPLETED|Overall Study||8
304279|NCT00083915|745872|P1|COMPLETED|Overall Study||2
304280|NCT00083915|745871|P2|STARTED|Overall Study||45
304281|NCT00083915|745872|P1|STARTED|Overall Study||52
304282|NCT00083889|745880|P2|NOT COMPLETED|Overall Study||375
304283|NCT00083889|745881|P1|NOT COMPLETED|Overall Study||375
304284|NCT00083889|745880|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
304285|NCT00083889|745881|P1|COMPLETED|Overall Study||0
304286|NCT00083889|745880|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
304287|NCT00083889|745881|P1|Received Treatment|Overall Study||375
304288|NCT00083889|745880|P2|STARTED|Overall Study||375
304289|NCT00083889|745881|P1|STARTED|Overall Study||375
304290|NCT00004146|745930|P1|NOT COMPLETED|Overall Study||0
304291|NCT00004146|745930|P1|COMPLETED|Overall Study||55
304292|NCT00004146|745930|P1|STARTED|Overall Study||55
304293|NCT00083759|745939|P2|NOT COMPLETED|Overall Study||83
304294|NCT00083759|745940|P1|NOT COMPLETED|Overall Study||84
304295|NCT00083759|745939|P2|COMPLETED|Overall Study||66
304296|NCT00083759|745940|P1|COMPLETED|Overall Study||66
304297|NCT00083759|745939|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
304298|NCT00083759|745940|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
304299|NCT00083720|745948|P1|NOT COMPLETED|Overall Study||0
304300|NCT00083720|745948|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
304301|NCT00083720|745948|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
304302|NCT00083616|745958|P1|NOT COMPLETED|Overall Study||31
304303|NCT00083616|745958|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
304304|NCT00083616|745958|P1|Received Study Medication|Overall Study||182
304305|NCT00083616|745958|P1|STARTED|Overall Study||185
304306|NCT00083551|745972|P2|NOT COMPLETED|Overall Study||0
304307|NCT00083551|745973|P1|NOT COMPLETED|Overall Study||0
304308|NCT00083551|745972|P2|COMPLETED|Overall Study||345
304309|NCT00083551|745973|P1|COMPLETED|Overall Study||323
304310|NCT00083551|745972|P2|STARTED|Overall Study||345
304311|NCT00083551|745973|P1|STARTED|Overall Study||323
304312|NCT00083382|745979|P1|NOT COMPLETED|Overall Study||0
304313|NCT00083382|745979|P1|COMPLETED|Overall Study||83
304314|NCT00083382|745979|P1|STARTED|Overall Study||83
304315|NCT00082888|745983|P1|NOT COMPLETED|Overall Study||22
304316|NCT00082888|745983|P1|COMPLETED|Overall Study||71
304317|NCT00082888|745983|P1|STARTED|Overall Study||93
304318|NCT00082810|745987|P1|NOT COMPLETED|Overall Study||31
304319|NCT00082810|745987|P1|COMPLETED|Overall Study||2
304320|NCT00082810|745987|P1|STARTED|Overall Study||33
304321|NCT00082758|745997|P3|NOT COMPLETED|Overall Study||0
304322|NCT00082758|745998|P2|NOT COMPLETED|Overall Study||17
304323|NCT00082758|745999|P1|NOT COMPLETED|Overall Study||15
304324|NCT00082758|745997|P3|COMPLETED|Overall Study||0
304325|NCT00082758|745998|P2|COMPLETED|Overall Study||7
304326|NCT00082758|745999|P1|COMPLETED|Overall Study||0
304327|NCT00082758|745997|P3|STARTED|Overall Study||0
304328|NCT00082758|745998|P2|STARTED|Overall Study||24
304329|NCT00082758|745999|P1|STARTED|Overall Study||15
304330|NCT00083226|746007|P1|NOT COMPLETED|Overall Study||42
304331|NCT00083226|746007|P1|COMPLETED|Overall Study||0
304332|NCT00083226|746007|P1|STARTED|Overall Study||42
304333|NCT00083174|746015|P3|NOT COMPLETED|Open-label Extension||0
304334|NCT00083174|746016|P2|NOT COMPLETED|Open-label Extension||0
304335|NCT00083174|746017|P1|NOT COMPLETED|Open-label Extension||0
304336|NCT00083174|746015|P3|COMPLETED|Open-label Extension||2831
304337|NCT00083174|746016|P2|COMPLETED|Open-label Extension||0
304338|NCT00083174|746017|P1|COMPLETED|Open-label Extension||0
304339|NCT00083174|746015|P3|STARTED|Open-label Extension||2831
304340|NCT00083174|746016|P2|STARTED|Open-label Extension||0
304341|NCT00083174|746017|P1|STARTED|Open-label Extension||0
304342|NCT00083174|746015|P3|NOT COMPLETED|Randomization Period||0
304343|NCT00083174|746016|P2|NOT COMPLETED|Randomization Period||0
304344|NCT00083174|746017|P1|NOT COMPLETED|Randomization Period||0
304345|NCT00083174|746015|P3|COMPLETED|Randomization Period||0
304346|NCT00083174|746016|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
304347|NCT00083174|746017|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
304348|NCT00083174|746015|P3|STARTED|Randomization Period||0
304349|NCT00083174|746016|P2|STARTED|Randomization Period||2275
304350|NCT00083174|746017|P1|STARTED|Randomization Period||2285
304351|NCT00083122|746039|P2|NOT COMPLETED|Overall Study||0
304352|NCT00083122|746040|P1|NOT COMPLETED|Overall Study||0
304353|NCT00083122|746039|P2|COMPLETED|Overall Study||5
304354|NCT00083122|746040|P1|COMPLETED|Overall Study||40
304355|NCT00083122|746039|P2|STARTED|Overall Study||5
304356|NCT00083122|746040|P1|STARTED|Overall Study||40
304357|NCT00082433|746051|P2|NOT COMPLETED|Overall Study||597
304358|NCT00082433|746052|P1|NOT COMPLETED|Overall Study||594
304359|NCT00082433|746051|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
304360|NCT00082433|746052|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
304361|NCT00082433|746051|P2|STARTED|Overall Study||612
304362|NCT00082433|746052|P1|STARTED|Overall Study||609
304363|NCT00082381|746072|P2|NOT COMPLETED|Overall Study||26
304364|NCT00082381|746073|P1|NOT COMPLETED|Overall Study||55
304365|NCT00082381|746072|P2|COMPLETED|Overall Study||242
304366|NCT00082381|746073|P1|COMPLETED|Overall Study||228
304367|NCT00082381|746072|P2|Received Treatment (Intent to Treat)|Overall Study||267
304368|NCT00082381|746073|P1|Received Treatment (Intent to Treat)|Overall Study||282
304369|NCT00082381|746072|P2|STARTED|Overall Study||268
304370|NCT00082381|746073|P1|STARTED|Overall Study||283
304371|NCT00082407|746093|P2|NOT COMPLETED|Overall Study||27
304372|NCT00082407|746094|P1|NOT COMPLETED|Overall Study||56
304373|NCT00082407|746093|P2|COMPLETED|Overall Study||223
304374|NCT00082407|746094|P1|COMPLETED|Overall Study||199
304375|NCT00082407|746093|P2|Received Treatment (Intent to Treat)|Overall Study||248
304376|NCT00082407|746094|P1|Received Treatment (Intent to Treat)|Overall Study||253
304377|NCT00082407|746093|P2|STARTED|Overall Study||250
304378|NCT00082407|746094|P1|STARTED|Overall Study||255
304379|NCT00082368|746112|P1|NOT COMPLETED|Overall Study||1
304380|NCT00082368|746112|P1|COMPLETED|Overall Study||11
304381|NCT00082368|746112|P1|STARTED|Overall Study||12
304382|NCT00082355|746117|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
304383|NCT00082355|746117|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
304384|NCT00082355|746117|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
304385|NCT00082355|746117|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
304386|NCT00082355|746117|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
304387|NCT00082355|746117|P1|STARTED|Initial Results of Thrombolytic Therapy||30
304388|NCT00082342|746124|P2|NOT COMPLETED|Overall Study||0
304389|NCT00082342|746125|P1|NOT COMPLETED|Overall Study||0
304390|NCT00082342|746124|P2|COMPLETED|Overall Study||12
304391|NCT00082342|746125|P1|COMPLETED|Overall Study||13
304392|NCT00082342|746124|P2|STARTED|Overall Study||12
304393|NCT00082342|746125|P1|STARTED|Overall Study||13
304394|NCT00082329|746145|P1|NOT COMPLETED|Overall Study||0
304395|NCT00082329|746145|P1|COMPLETED|Overall Study||9
304396|NCT00082329|746145|P1|STARTED|Overall Study||9
304397|NCT00082173|746151|P2|NOT COMPLETED|Overall Study||11
304398|NCT00082173|746152|P1|NOT COMPLETED|Overall Study||10
304399|NCT00082173|746151|P2|COMPLETED|Overall Study||61
304400|NCT00082173|746152|P1|COMPLETED|Overall Study||64
304401|NCT00082173|746151|P2|STARTED|Overall Study||72
304402|NCT00082173|746152|P1|STARTED|Overall Study||74
304403|NCT00003726|746160|P1|NOT COMPLETED|Overall Study||1
304404|NCT00003726|746160|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
304405|NCT00003726|746160|P1|STARTED|Overall Study||1
304406|NCT00081939|746164|P1|NOT COMPLETED|Overall Study||0
304407|NCT00081939|746164|P1|COMPLETED|Overall Study||303
304408|NCT00081939|746164|P1|STARTED|Overall Study||303
304409|NCT00082017|746168|P2|NOT COMPLETED|Overall Study||0
304410|NCT00082017|746169|P1|NOT COMPLETED|Overall Study||0
304411|NCT00082017|746168|P2|COMPLETED|Overall Study||9
304412|NCT00082017|746169|P1|COMPLETED|Overall Study||11
304413|NCT00082017|746168|P2|STARTED|Overall Study||9
304414|NCT00082017|746169|P1|STARTED|Overall Study||11
304415|NCT00081861|746185|P1|NOT COMPLETED|Overall Study||0
304416|NCT00081861|746185|P1|COMPLETED|Overall Study||13
304417|NCT00081861|746185|P1|STARTED|Overall Study||13
304418|NCT00081770|746192|P3|NOT COMPLETED|Overall Study||456
304419|NCT00081770|746193|P2|NOT COMPLETED|Overall Study||546
304420|NCT00081770|746194|P1|NOT COMPLETED|Overall Study||502
304421|NCT00081770|746192|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
304422|NCT00081770|746193|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
304423|NCT00081770|746194|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
304424|NCT00081770|746192|P3|STARTED|Overall Study||1035
304425|NCT00081770|746193|P2|STARTED|Overall Study||1016
304426|NCT00081770|746194|P1|STARTED|Overall Study||1019
304427|NCT00081731|746213|P2|NOT COMPLETED|Overall Study||8
304428|NCT00081731|746214|P1|NOT COMPLETED|Overall Study||8
304429|NCT00081731|746213|P2|COMPLETED|Overall Study||459
304430|NCT00081731|746214|P1|COMPLETED|Overall Study||472
304431|NCT00081731|746213|P2|STARTED|Overall Study||467
304432|NCT00081731|746214|P1|STARTED|Overall Study||480
304433|NCT00081653|746234|P2|NOT COMPLETED|Overall Study||37
304434|NCT00081653|746235|P1|NOT COMPLETED|Overall Study||47
304435|NCT00081653|746234|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
304436|NCT00081653|746235|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
304437|NCT00081653|746234|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
304438|NCT00081653|746235|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
304439|NCT00081497|746253|P2|NOT COMPLETED|Overall Study||2
304440|NCT00081497|746254|P1|NOT COMPLETED|Overall Study||3
304441|NCT00081497|746253|P2|COMPLETED|Overall Study||37
304442|NCT00081497|746254|P1|COMPLETED|Overall Study||25
304443|NCT00081497|746253|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
304444|NCT00081497|746254|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
304445|NCT00081458|746272|P3|NOT COMPLETED|Overall Study||4
304446|NCT00081458|746273|P2|NOT COMPLETED|Overall Study||8
304447|NCT00081458|746274|P1|NOT COMPLETED|Overall Study||1
304448|NCT00081458|746272|P3|COMPLETED|Overall Study||29
304449|NCT00081458|746273|P2|COMPLETED|Overall Study||27
304450|NCT00081458|746274|P1|COMPLETED|Overall Study||15
304451|NCT00081458|746272|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
304452|NCT00081458|746273|P2|Received Treatment|Overall Study||35
304453|NCT00081458|746274|P1|Received Treatment|Overall Study||16
304454|NCT00081458|746272|P3|STARTED|Overall Study||33
304455|NCT00081458|746273|P2|STARTED|Overall Study||35
304456|NCT00081458|746274|P1|STARTED|Overall Study||16
304457|NCT00081328|746288|P3|NOT COMPLETED|Overall Study||0
304458|NCT00081328|746289|P2|NOT COMPLETED|Overall Study||0
304459|NCT00081328|746290|P1|NOT COMPLETED|Overall Study||0
304460|NCT00081328|746288|P3|COMPLETED|Overall Study||234
304461|NCT00081328|746289|P2|COMPLETED|Overall Study||233
304462|NCT00081328|746290|P1|COMPLETED|Overall Study||232
304463|NCT00081328|746288|P3|STARTED|Overall Study||234
304464|NCT00081328|746289|P2|STARTED|Overall Study||233
304465|NCT00081328|746290|P1|STARTED|Overall Study||232
304466|NCT00081289|746330|P2|NOT COMPLETED|Overall Study||21
304467|NCT00081289|746331|P1|NOT COMPLETED|Overall Study||21
304468|NCT00081289|746330|P2|COMPLETED|Overall Study||52
304469|NCT00081289|746331|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
304470|NCT00081289|746330|P2|STARTED|Overall Study||73
304471|NCT00081289|746331|P1|STARTED|Overall Study||73
304472|NCT00081263|746339|P2|NOT COMPLETED|Overall Study||22
304473|NCT00081263|746340|P1|NOT COMPLETED|Overall Study||17
304474|NCT00081263|746339|P2|COMPLETED|Overall Study||41
304475|NCT00081263|746340|P1|COMPLETED|Overall Study||50
304476|NCT00081263|746339|P2|STARTED|Overall Study||63
304477|NCT00081263|746340|P1|STARTED|Overall Study||67
304478|NCT00081159|746350|P2|NOT COMPLETED|Overall Study||5
304479|NCT00081159|746351|P1|NOT COMPLETED|Overall Study||2
304480|NCT00081159|746350|P2|COMPLETED|Overall Study||35
304481|NCT00081159|746351|P1|COMPLETED|Overall Study||37
304482|NCT00081159|746350|P2|STARTED|Overall Study||40
304483|NCT00081159|746351|P1|STARTED|Overall Study||39
304484|NCT00080938|746361|P1|NOT COMPLETED|Overall Study||24
304485|NCT00080938|746361|P1|COMPLETED|Overall Study||2
304486|NCT00080938|746361|P1|Eligible and Treated|Overall Study||21
304487|NCT00080938|746361|P1|Began Protocol Therapy|Overall Study||25
304488|NCT00080938|746361|P1|STARTED|Overall Study||26
304489|NCT00080912|746370|P2|NOT COMPLETED|Overall Study||0
304490|NCT00080912|746371|P1|NOT COMPLETED|Overall Study||0
304491|NCT00080912|746370|P2|COMPLETED|Overall Study||425
304492|NCT00080912|746371|P1|COMPLETED|Overall Study||425
304493|NCT00080912|746370|P2|STARTED|Overall Study||425
304494|NCT00080912|746371|P1|STARTED|Overall Study||425
304495|NCT00080899|746377|P1|NOT COMPLETED|Overall Study||1
304496|NCT00080899|746377|P1|COMPLETED|Overall Study||22
304497|NCT00080899|746377|P1|STARTED|Overall Study||23
304498|NCT00080535|746382|P1|NOT COMPLETED|Overall Study||0
304499|NCT00080535|746382|P1|COMPLETED|Overall Study||10
304500|NCT00080535|746382|P1|STARTED|Overall Study||10
304501|NCT00080483|746389|P2|NOT COMPLETED|Overall Study||2
304502|NCT00080483|746390|P1|NOT COMPLETED|Overall Study||2
304503|NCT00080483|746389|P2|COMPLETED|Overall Study||16
304504|NCT00080483|746390|P1|COMPLETED|Overall Study||15
304505|NCT00080483|746389|P2|STARTED|Overall Study||18
304506|NCT00080483|746390|P1|STARTED|Overall Study||17
304507|NCT00002525|746398|P2|NOT COMPLETED|Overall Study||0
304508|NCT00002525|746399|P1|NOT COMPLETED|Overall Study||186
304509|NCT00002525|746398|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
304510|NCT00002525|746399|P1|COMPLETED|Overall Study||241
304511|NCT00002525|746398|P2|Dukes' B2 Stage|Overall Study||139
304512|NCT00002525|746399|P1|Dukes' B2 Stage|Overall Study||150
304513|NCT00002525|746398|P2|Dukes' B3 or C Stage|Overall Study||158
304514|NCT00002525|746399|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
304515|NCT00002525|746398|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
304516|NCT00002525|746399|P1|Treated|Overall Study||419
304517|NCT00002525|746398|P2|STARTED|Overall Study||428
304518|NCT00002525|746399|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
304519|NCT00080470|746415|P2|NOT COMPLETED|Overall Study||28
304520|NCT00080470|746416|P1|NOT COMPLETED|Overall Study||34
304521|NCT00080470|746415|P2|COMPLETED|Overall Study||14
304522|NCT00080470|746416|P1|COMPLETED|Overall Study||11
304523|NCT00080470|746415|P2|STARTED|Overall Study||42
304524|NCT00080470|746416|P1|STARTED|Overall Study||45
304525|NCT00080301|746426|P2|NOT COMPLETED|Overall Study||11
304526|NCT00080301|746427|P1|NOT COMPLETED|Overall Study||5
304527|NCT00080301|746426|P2|COMPLETED|Overall Study|Participants who are off treatment|366
304528|NCT00080301|746427|P1|COMPLETED|Overall Study|Participants who are off treatment|370
304529|NCT00080301|746426|P2|Still on Treatment|Overall Study||1
304530|NCT00080301|746427|P1|Still on Treatment|Overall Study||0
304531|NCT00080301|746426|P2|Never Treated|Overall Study||10
304532|NCT00080301|746427|P1|Never Treated|Overall Study||5
304533|NCT00080301|746426|P2|STARTED|Overall Study||377
304534|NCT00080301|746427|P1|STARTED|Overall Study||375
304535|NCT00080288|746447|P2|NOT COMPLETED|Overall Study||38
304536|NCT00080288|746448|P1|NOT COMPLETED|Overall Study||30
304537|NCT00080288|746447|P2|COMPLETED|Overall Study||89
304538|NCT00080288|746448|P1|COMPLETED|Overall Study||97
304539|NCT00080288|746447|P2|STARTED|Overall Study||127
304540|NCT00080288|746448|P1|STARTED|Overall Study||127
304541|NCT00080223|746456|P1|NOT COMPLETED|Overall Study||76
304542|NCT00080223|746456|P1|COMPLETED|Overall Study||7
304543|NCT00080223|746456|P1|STARTED|Overall Study||83
304544|NCT00002540|746466|P2|NOT COMPLETED|Overall Study||2464
304545|NCT00002540|746467|P1|NOT COMPLETED|Overall Study||801
304546|NCT00002540|746466|P2|COMPLETED|Overall Study||35876
304547|NCT00002540|746467|P1|COMPLETED|Overall Study||37544
304548|NCT00002540|746466|P2|STARTED|Overall Study||38340
304549|NCT00002540|746467|P1|STARTED|Overall Study||38345
304550|NCT00080119|746497|P4|NOT COMPLETED|Overall Study||163
304551|NCT00080119|746498|P3|NOT COMPLETED|Overall Study||165
304552|NCT00080119|746499|P2|NOT COMPLETED|Overall Study||62
304553|NCT00080119|746500|P1|NOT COMPLETED|Overall Study||56
304554|NCT00080119|746497|P4|COMPLETED|Overall Study||111
304555|NCT00080119|746498|P3|COMPLETED|Overall Study||108
304556|NCT00080119|746499|P2|COMPLETED|Overall Study||339
304557|NCT00080119|746500|P1|COMPLETED|Overall Study||347
304558|NCT00080119|746497|P4|STARTED|Overall Study||274
304559|NCT00080119|746498|P3|STARTED|Overall Study||273
304560|NCT00080119|746499|P2|STARTED|Overall Study||401
304561|NCT00080119|746500|P1|STARTED|Overall Study||403
304562|NCT00079937|746534|P2|NOT COMPLETED|Overall Study||32
304563|NCT00079937|746535|P1|NOT COMPLETED|Overall Study||69
304564|NCT00079937|746534|P2|COMPLETED|Overall Study||175
304565|NCT00079937|746535|P1|COMPLETED|Overall Study||352
304566|NCT00079937|746534|P2|STARTED|Overall Study||207
304567|NCT00079937|746535|P1|STARTED|Overall Study||421
304568|NCT00009737|746553|P2|NOT COMPLETED|Overall Study||123
304569|NCT00009737|746554|P1|NOT COMPLETED|Overall Study||170
304570|NCT00009737|746553|P2|COMPLETED|Overall Study||860
304571|NCT00009737|746554|P1|COMPLETED|Overall Study||834
304572|NCT00009737|746553|P2|STARTED|Overall Study||983
304573|NCT00009737|746554|P1|STARTED|Overall Study||1004
304574|NCT00079781|746573|P3|NOT COMPLETED|Follow-up Period||2
304575|NCT00079781|746574|P2|NOT COMPLETED|Follow-up Period||0
304576|NCT00079781|746575|P1|NOT COMPLETED|Follow-up Period||4
304577|NCT00079781|746573|P3|COMPLETED|Follow-up Period||12
304578|NCT00079781|746574|P2|COMPLETED|Follow-up Period||9
304579|NCT00079781|746575|P1|COMPLETED|Follow-up Period||38
304580|NCT00079781|746573|P3|STARTED|Follow-up Period||14
304581|NCT00079781|746574|P2|STARTED|Follow-up Period||9
304582|NCT00079781|746575|P1|STARTED|Follow-up Period||42
304583|NCT00079781|746573|P3|NOT COMPLETED|Evaluation Period||0
304584|NCT00079781|746574|P2|NOT COMPLETED|Evaluation Period||0
304585|NCT00079781|746575|P1|NOT COMPLETED|Evaluation Period||0
304586|NCT00079781|746573|P3|COMPLETED|Evaluation Period||14
304587|NCT00079781|746574|P2|COMPLETED|Evaluation Period||9
304588|NCT00079781|746575|P1|COMPLETED|Evaluation Period||42
304589|NCT00079781|746573|P3|STARTED|Evaluation Period||14
304590|NCT00079781|746574|P2|STARTED|Evaluation Period||9
304591|NCT00079781|746575|P1|STARTED|Evaluation Period||42
304592|NCT00079781|746573|P3|NOT COMPLETED|Pre-implant Period||1
304593|NCT00079781|746574|P2|NOT COMPLETED|Pre-implant Period||1
304594|NCT00079781|746575|P1|NOT COMPLETED|Pre-implant Period||3
304595|NCT00079781|746573|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
304596|NCT00079781|746574|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
304597|NCT00079781|746575|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
304598|NCT00079781|746573|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
304599|NCT00079781|746574|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
304600|NCT00079781|746575|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
304601|NCT00079677|746584|P2|NOT COMPLETED|Overall Study||14
304602|NCT00079677|746585|P1|NOT COMPLETED|Overall Study||20
304603|NCT00079677|746584|P2|COMPLETED|Overall Study||118
304604|NCT00079677|746585|P1|COMPLETED|Overall Study||111
304605|NCT00079677|746584|P2|STARTED|Overall Study||132
304606|NCT00079677|746585|P1|STARTED|Overall Study||131
304607|NCT00002601|746593|P1|NOT COMPLETED|Overall Study||0
304608|NCT00002601|746593|P1|COMPLETED|Overall Study||13
304609|NCT00002601|746593|P1|STARTED|Overall Study||13
304610|NCT00079417|746601|P1|NOT COMPLETED|Overall Study||9
304611|NCT00079417|746601|P1|COMPLETED|Overall Study||19
304612|NCT00079417|746601|P1|STARTED|Overall Study||28
304613|NCT00079391|746605|P1|NOT COMPLETED|Overall Study||1
304614|NCT00079391|746605|P1|COMPLETED|Overall Study||49
304615|NCT00079391|746605|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
304616|NCT00079339|746617|P3|NOT COMPLETED|Overall Study||6
304617|NCT00079339|746618|P2|NOT COMPLETED|Overall Study||39
304618|NCT00079339|746619|P1|NOT COMPLETED|Overall Study||5
304619|NCT00079339|746617|P3|COMPLETED|Overall Study||0
304620|NCT00079339|746618|P2|COMPLETED|Overall Study||1
304621|NCT00079339|746619|P1|COMPLETED|Overall Study||0
304622|NCT00079339|746617|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
304623|NCT00079339|746618|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
304624|NCT00079339|746619|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
304625|NCT00079339|746617|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
304626|NCT00079339|746618|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
304627|NCT00079339|746619|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
304628|NCT00079339|746617|P3|Enrolled in Phase I|Overall Study||6
304629|NCT00079339|746618|P2|Enrolled in Phase I|Overall Study||6
304630|NCT00079339|746619|P1|Enrolled in Phase I|Overall Study||5
304631|NCT00079339|746617|P3|STARTED|Overall Study||6
304632|NCT00079339|746618|P2|STARTED|Overall Study||40
304633|NCT00079339|746619|P1|STARTED|Overall Study||5
304634|NCT00079326|746635|P2|NOT COMPLETED|Overall Study||0
304635|NCT00079326|746636|P1|NOT COMPLETED|Overall Study||0
304636|NCT00079326|746635|P2|COMPLETED|Overall Study||24
304637|NCT00079326|746636|P1|COMPLETED|Overall Study||15
304638|NCT00079326|746635|P2|STARTED|Overall Study||24
304639|NCT00079326|746636|P1|STARTED|Overall Study||15
304640|NCT00079274|746650|P7|NOT COMPLETED|Overall Study||0
304641|NCT00079274|746651|P6|NOT COMPLETED|Overall Study||20
304642|NCT00079274|746652|P5|NOT COMPLETED|Overall Study||15
304643|NCT00079274|746653|P4|NOT COMPLETED|Overall Study||444
304644|NCT00079274|746654|P3|NOT COMPLETED|Overall Study||27
304645|NCT00079274|746655|P2|NOT COMPLETED|Overall Study||27
304646|NCT00079274|746656|P1|NOT COMPLETED|Overall Study||321
304647|NCT00079274|746650|P7|COMPLETED|Overall Study||332
304648|NCT00079274|746651|P6|COMPLETED|Overall Study||26
304649|NCT00079274|746652|P5|COMPLETED|Overall Study||30
304650|NCT00079274|746653|P4|COMPLETED|Overall Study||906
304651|NCT00079274|746654|P3|COMPLETED|Overall Study||84
304652|NCT00079274|746655|P2|COMPLETED|Overall Study||84
304653|NCT00079274|746656|P1|COMPLETED|Overall Study||1081
304654|NCT00079274|746650|P7|STARTED|Overall Study||332
304655|NCT00079274|746651|P6|STARTED|Overall Study||46
304656|NCT00079274|746652|P5|STARTED|Overall Study||45
304657|NCT00079274|746653|P4|STARTED|Overall Study||1350
304658|NCT00079274|746654|P3|STARTED|Overall Study||111
304659|NCT00079274|746655|P2|STARTED|Overall Study||111
304660|NCT00079274|746656|P1|STARTED|Overall Study||1402
304661|NCT00079183|746669|P1|NOT COMPLETED|Overall Study||7
304662|NCT00079183|746669|P1|COMPLETED|Overall Study||37
304663|NCT00079183|746669|P1|Drop Outs|Overall Study||7
304664|NCT00079183|746669|P1|STARTED|Overall Study||44
304665|NCT00079040|746684|P1|NOT COMPLETED|Overall Study||2
304666|NCT00079040|746684|P1|COMPLETED|Overall Study||63
304667|NCT00079040|746684|P1|STARTED|Overall Study||65
304668|NCT00079001|746692|P2|NOT COMPLETED|Overall Study||0
304669|NCT00079001|746693|P1|NOT COMPLETED|Overall Study||0
304670|NCT00079001|746692|P2|COMPLETED|Overall Study||322
304671|NCT00079001|746693|P1|COMPLETED|Overall Study||323
304672|NCT00079001|746692|P2|STARTED|Overall Study||322
304673|NCT00079001|746693|P1|STARTED|Overall Study||323
304674|NCT00078949|746707|P4|NOT COMPLETED|Maintenance||3
304675|NCT00078949|746708|P3|NOT COMPLETED|Maintenance||3
304676|NCT00078949|746709|P2|NOT COMPLETED|Maintenance||0
304677|NCT00078949|746710|P1|NOT COMPLETED|Maintenance||0
304678|NCT00078949|746707|P4|COMPLETED|Maintenance||112
304679|NCT00078949|746708|P3|COMPLETED|Maintenance||112
304680|NCT00078949|746709|P2|COMPLETED|Maintenance||0
304681|NCT00078949|746710|P1|COMPLETED|Maintenance||0
304682|NCT00078949|746707|P4|STARTED|Maintenance||115
304683|NCT00078949|746708|P3|STARTED|Maintenance||115
304684|NCT00078949|746709|P2|STARTED|Maintenance||0
304685|NCT00078949|746710|P1|STARTED|Maintenance||0
304686|NCT00078949|746707|P4|NOT COMPLETED|Salvage||0
304687|NCT00078949|746708|P3|NOT COMPLETED|Salvage||0
304688|NCT00078949|746709|P2|NOT COMPLETED|Salvage||5
304689|NCT00078949|746710|P1|NOT COMPLETED|Salvage||4
304690|NCT00078949|746707|P4|COMPLETED|Salvage||0
304691|NCT00078949|746708|P3|COMPLETED|Salvage||0
304692|NCT00078949|746709|P2|COMPLETED|Salvage||304
304693|NCT00078949|746710|P1|COMPLETED|Salvage||306
304694|NCT00078949|746707|P4|STARTED|Salvage||0
304695|NCT00078949|746708|P3|STARTED|Salvage||0
304696|NCT00078949|746709|P2|STARTED|Salvage||309
304697|NCT00078949|746710|P1|STARTED|Salvage||310
304698|NCT00078767|746724|P2|NOT COMPLETED|Overall Study||1
304699|NCT00078767|746725|P1|NOT COMPLETED|Overall Study||1
304700|NCT00078767|746724|P2|COMPLETED|Overall Study||11
304701|NCT00078767|746725|P1|COMPLETED|Overall Study||11
304702|NCT00078767|746724|P2|STARTED|Overall Study||12
304703|NCT00078767|746725|P1|STARTED|Overall Study||12
304704|NCT00078754|746742|P3|NOT COMPLETED|Overall Study||15
304705|NCT00078754|746743|P2|NOT COMPLETED|Overall Study||19
304706|NCT00078754|746744|P1|NOT COMPLETED|Overall Study||15
304707|NCT00078754|746742|P3|COMPLETED|Overall Study||16
304708|NCT00078754|746743|P2|COMPLETED|Overall Study||11
304709|NCT00078754|746744|P1|COMPLETED|Overall Study||14
304710|NCT00078754|746742|P3|STARTED|Overall Study||31
304711|NCT00078754|746743|P2|STARTED|Overall Study||30
304712|NCT00078754|746744|P1|STARTED|Overall Study||29
304713|NCT00078728|746754|P2|NOT COMPLETED|Overall Study||3
304714|NCT00078728|746755|P1|NOT COMPLETED|Overall Study||4
304715|NCT00078728|746754|P2|COMPLETED|Overall Study||17
304716|NCT00078728|746755|P1|COMPLETED|Overall Study||16
304717|NCT00078728|746754|P2|STARTED|Overall Study||20
304718|NCT00078728|746755|P1|STARTED|Overall Study||20
304719|NCT00078715|746763|P2|NOT COMPLETED|Second Intervention||0
304720|NCT00078715|746764|P1|NOT COMPLETED|Second Intervention||0
304721|NCT00078715|746763|P2|COMPLETED|Second Intervention||4
304722|NCT00078715|746764|P1|COMPLETED|Second Intervention||2
304723|NCT00078715|746763|P2|STARTED|Second Intervention||4
304724|NCT00078715|746764|P1|STARTED|Second Intervention||2
304725|NCT00078715|746763|P2|NOT COMPLETED|First Intervention||0
304726|NCT00078715|746764|P1|NOT COMPLETED|First Intervention||0
304727|NCT00078715|746763|P2|COMPLETED|First Intervention||4
304728|NCT00078715|746764|P1|COMPLETED|First Intervention||2
304729|NCT00078715|746763|P2|STARTED|First Intervention||4
304730|NCT00078715|746764|P1|STARTED|First Intervention||2
304731|NCT00005947|746772|P2|NOT COMPLETED|Overall Study||41
304732|NCT00005947|746773|P1|NOT COMPLETED|Overall Study||57
304733|NCT00005947|746772|P2|COMPLETED|Overall Study||4
304734|NCT00005947|746773|P1|COMPLETED|Overall Study||25
304735|NCT00005947|746772|P2|STARTED|Overall Study||45
304736|NCT00005947|746773|P1|STARTED|Overall Study||82
304737|NCT00078559|746781|P1|NOT COMPLETED|Overall Study||0
304738|NCT00078559|746781|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
304739|NCT00078559|746781|P1|STARTED|Overall Study||10
304740|NCT00002597|746809|P2|NOT COMPLETED|Overall Study||23
304741|NCT00002597|746810|P1|NOT COMPLETED|Overall Study||26
304742|NCT00002597|746809|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
304743|NCT00002597|746810|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
304744|NCT00002597|746809|P2|STARTED|Overall Study||1015
304745|NCT00002597|746810|P1|STARTED|Overall Study||1013
304746|NCT00078377|746835|P3|NOT COMPLETED|Overall Study||9
304747|NCT00078377|746836|P2|NOT COMPLETED|Overall Study||16
304748|NCT00078377|746837|P1|NOT COMPLETED|Overall Study||11
304749|NCT00078377|746835|P3|COMPLETED|Overall Study||55
304750|NCT00078377|746836|P2|COMPLETED|Overall Study||49
304751|NCT00078377|746837|P1|COMPLETED|Overall Study||56
304752|NCT00078377|746835|P3|STARTED|Overall Study||64
304753|NCT00078377|746836|P2|STARTED|Overall Study||65
304754|NCT00078377|746837|P1|STARTED|Overall Study||67
304755|NCT00076687|746853|P3|NOT COMPLETED|Overall Study||4
304756|NCT00076687|746854|P2|NOT COMPLETED|Overall Study||5
304757|NCT00076687|746855|P1|NOT COMPLETED|Overall Study||6
304758|NCT00076687|746853|P3|COMPLETED|Overall Study||51
304759|NCT00076687|746854|P2|COMPLETED|Overall Study||47
304760|NCT00076687|746855|P1|COMPLETED|Overall Study||42
304761|NCT00076687|746853|P3|STARTED|Overall Study||55
304762|NCT00076687|746854|P2|STARTED|Overall Study||52
304763|NCT00076687|746855|P1|STARTED|Overall Study||48
304764|NCT00078403|746875|P3|NOT COMPLETED|Overall Study||28
304765|NCT00078403|746876|P2|NOT COMPLETED|Overall Study||16
304766|NCT00078403|746877|P1|NOT COMPLETED|Overall Study||18
304767|NCT00078403|746875|P3|COMPLETED|Overall Study||141
304768|NCT00078403|746876|P2|COMPLETED|Overall Study||26
304769|NCT00078403|746877|P1|COMPLETED|Overall Study||26
304770|NCT00078403|746875|P3|STARTED|Overall Study||169
304862|NCT00077376|747181|P1|NOT COMPLETED|Overall Study||22
304771|NCT00078403|746876|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
304772|NCT00078403|746877|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
304773|NCT00078325|746937|P3|NOT COMPLETED|Overall Study||11
304774|NCT00078325|746938|P2|NOT COMPLETED|Overall Study||19
304775|NCT00078325|746939|P1|NOT COMPLETED|Overall Study||21
304776|NCT00078325|746937|P3|COMPLETED|Overall Study||120
304777|NCT00078325|746938|P2|COMPLETED|Overall Study||114
304778|NCT00078325|746939|P1|COMPLETED|Overall Study||110
304779|NCT00078325|746937|P3|STARTED|Overall Study||131
304780|NCT00078325|746938|P2|STARTED|Overall Study||133
304781|NCT00078325|746939|P1|STARTED|Overall Study||131
304782|NCT00078312|746950|P1|NOT COMPLETED|Overall Study||177
304783|NCT00078312|746950|P1|COMPLETED|Overall Study||151
304784|NCT00078312|746950|P1|STARTED|Overall Study||328
304785|NCT00078286|746956|P2|NOT COMPLETED|Overall Study||83
304786|NCT00078286|746957|P1|NOT COMPLETED|Overall Study||96
304787|NCT00078286|746956|P2|COMPLETED|Overall Study||152
304788|NCT00078286|746957|P1|COMPLETED|Overall Study||138
304789|NCT00078286|746956|P2|STARTED|Overall Study||235
304790|NCT00078286|746957|P1|STARTED|Overall Study||234
304791|NCT00077974|746965|P1|NOT COMPLETED|Overall Study||104
304792|NCT00077974|746965|P1|COMPLETED|Overall Study||2
304793|NCT00077974|746965|P1|STARTED|Overall Study||106
304794|NCT00077857|746982|P2|NOT COMPLETED|Overall Study||204
304795|NCT00077857|746983|P1|NOT COMPLETED|Overall Study||201
304796|NCT00077857|746982|P2|COMPLETED|Overall Study||31
304797|NCT00077857|746983|P1|COMPLETED|Overall Study||34
304798|NCT00077857|746982|P2|Safety Population: Actual Dose Received|Overall Study||248
304799|NCT00077857|746983|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
304800|NCT00077857|746982|P2|Received Study Drug|Overall Study||234
304801|NCT00077857|746983|P1|Received Study Drug|Overall Study||231
304802|NCT00077857|746982|P2|STARTED|Overall Study||235
304803|NCT00077857|746983|P1|STARTED|Overall Study||235
304804|NCT00077766|747003|P2|NOT COMPLETED|Overall Study||25
304805|NCT00077766|747004|P1|NOT COMPLETED|Overall Study||39
304806|NCT00077766|747003|P2|COMPLETED|Overall Study||131
304807|NCT00077766|747004|P1|COMPLETED|Overall Study||118
304808|NCT00077766|747003|P2|STARTED|Overall Study||156
304809|NCT00077766|747004|P1|STARTED|Overall Study||157
304810|NCT00077922|747022|P1|NOT COMPLETED|Overall Study||0
304811|NCT00077922|747022|P1|COMPLETED|Overall Study||15
304812|NCT00077922|747022|P1|STARTED|Overall Study||15
304813|NCT00077675|747029|P2|NOT COMPLETED|Overall Study||9
304814|NCT00077675|747030|P1|NOT COMPLETED|Overall Study||11
304815|NCT00077675|747029|P2|COMPLETED|Overall Study||89
304816|NCT00077675|747030|P1|COMPLETED|Overall Study||92
304817|NCT00077675|747029|P2|STARTED|Overall Study||98
304818|NCT00077675|747030|P1|STARTED|Overall Study||103
304819|NCT00077649|747040|P4|NOT COMPLETED|Overall Study||17
304820|NCT00077649|747041|P3|NOT COMPLETED|Overall Study||15
304821|NCT00077649|747042|P2|NOT COMPLETED|Overall Study||9
304822|NCT00077649|747043|P1|NOT COMPLETED|Overall Study||14
304823|NCT00077649|747040|P4|COMPLETED|Overall Study||30
304824|NCT00077649|747041|P3|COMPLETED|Overall Study||32
304825|NCT00077649|747042|P2|COMPLETED|Overall Study||38
304826|NCT00077649|747043|P1|COMPLETED|Overall Study||33
304827|NCT00077649|747040|P4|Completed 24 Weeks of Follow-up|Overall Study||31
304828|NCT00077649|747041|P3|Completed 24 Weeks of Follow-up|Overall Study||36
304829|NCT00077649|747042|P2|Completed 24 Weeks of Follow-up|Overall Study||40
304830|NCT00077649|747043|P1|Completed 24 Weeks of Follow-up|Overall Study||36
304831|NCT00077649|747040|P4|STARTED|Overall Study||47
304832|NCT00077649|747041|P3|STARTED|Overall Study||47
304833|NCT00077649|747042|P2|STARTED|Overall Study||47
304834|NCT00077649|747043|P1|STARTED|Overall Study||47
304835|NCT00077636|747091|P2|NOT COMPLETED|Overall Study||92
304836|NCT00077636|747092|P1|NOT COMPLETED|Overall Study||44
304837|NCT00077636|747091|P2|COMPLETED|Overall Study||641
304838|NCT00077636|747092|P1|COMPLETED|Overall Study||692
304839|NCT00077636|747091|P2|STARTED|Overall Study||733
304840|NCT00077636|747092|P1|STARTED|Overall Study||736
304841|NCT00077623|747113|P3|NOT COMPLETED|Overall Study||32
304842|NCT00077623|747114|P2|NOT COMPLETED|Overall Study||43
304843|NCT00077623|747115|P1|NOT COMPLETED|Overall Study||36
304844|NCT00077623|747113|P3|COMPLETED|Overall Study||159
304845|NCT00077623|747114|P2|COMPLETED|Overall Study||148
304846|NCT00077623|747115|P1|COMPLETED|Overall Study||154
304847|NCT00077623|747113|P3|STARTED|Overall Study||191
304848|NCT00077623|747114|P2|STARTED|Overall Study||191
304849|NCT00077623|747115|P1|STARTED|Overall Study||190
304850|NCT00077610|747150|P3|NOT COMPLETED|Overall Study||46
304851|NCT00077610|747151|P2|NOT COMPLETED|Overall Study||56
304852|NCT00077610|747152|P1|NOT COMPLETED|Overall Study||54
304853|NCT00077610|747150|P3|COMPLETED|Overall Study||180
304854|NCT00077610|747151|P2|COMPLETED|Overall Study||168
304855|NCT00077610|747152|P1|COMPLETED|Overall Study||169
304856|NCT00077610|747150|P3|Started Treatment|Overall Study||225
304857|NCT00077610|747151|P2|Started Treatment|Overall Study||220
304858|NCT00077610|747152|P1|Started Treatment|Overall Study||221
304859|NCT00077610|747150|P3|STARTED|Overall Study||226
304860|NCT00077610|747151|P2|STARTED|Overall Study||224
304861|NCT00077610|747152|P1|STARTED|Overall Study||223
304863|NCT00077376|747181|P1|COMPLETED|Overall Study||39
304864|NCT00077376|747181|P1|HER2+ in Central Testing|Overall Study||39
304865|NCT00077376|747181|P1|Treated|Overall Study||59
304866|NCT00077376|747181|P1|STARTED|Overall Study||61
304867|NCT00077207|747192|P1|NOT COMPLETED|Overall Study||30
304868|NCT00077207|747192|P1|COMPLETED|Overall Study||36
304869|NCT00077207|747192|P1|STARTED|Overall Study||66
304870|NCT00077064|747204|P2|NOT COMPLETED|Overall Study||6
304871|NCT00077064|747205|P1|NOT COMPLETED|Overall Study||0
304872|NCT00077064|747204|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
304873|NCT00077064|747205|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
304874|NCT00077064|747204|P2|STARTED|Overall Study||16
304875|NCT00077064|747205|P1|STARTED|Overall Study||17
304876|NCT00076999|747221|P5|NOT COMPLETED|Overall Study||25
304877|NCT00076999|747222|P4|NOT COMPLETED|Overall Study||1
304878|NCT00076999|747223|P3|NOT COMPLETED|Overall Study||17
304879|NCT00076999|747224|P2|NOT COMPLETED|Overall Study||24
304880|NCT00076999|747225|P1|NOT COMPLETED|Overall Study||12
304881|NCT00076999|747221|P5|COMPLETED|Overall Study||9
304882|NCT00076999|747222|P4|COMPLETED|Overall Study||5
304883|NCT00076999|747223|P3|COMPLETED|Overall Study||2
304884|NCT00076999|747224|P2|COMPLETED|Overall Study||7
304885|NCT00076999|747225|P1|COMPLETED|Overall Study||13
304886|NCT00076999|747221|P5|STARTED|Overall Study||34
304887|NCT00076999|747222|P4|STARTED|Overall Study||6
304888|NCT00076999|747223|P3|STARTED|Overall Study||19
304889|NCT00076999|747224|P2|STARTED|Overall Study||31
304890|NCT00076999|747225|P1|STARTED|Overall Study||25
304891|NCT00003222|747344|P2|NOT COMPLETED|Overall Study||1
304892|NCT00003222|747345|P1|NOT COMPLETED|Overall Study||0
304893|NCT00003222|747344|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
304894|NCT00003222|747345|P1|COMPLETED|Overall Study||13
304895|NCT00003222|747344|P2|STARTED|Overall Study||28
304896|NCT00003222|747345|P1|STARTED|Overall Study||13
304897|NCT00076804|747357|P2|NOT COMPLETED|Overall Study||69
304898|NCT00076804|747358|P1|NOT COMPLETED|Overall Study||60
304899|NCT00076804|747357|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
304900|NCT00076804|747358|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
304901|NCT00076804|747357|P2|STARTED|Overall Study||137
304902|NCT00076804|747358|P1|STARTED|Overall Study||137
304903|NCT00076752|747370|P1|NOT COMPLETED|Overall Study||3
304904|NCT00076752|747370|P1|COMPLETED|Overall Study||6
304905|NCT00076752|747370|P1|STARTED|Overall Study||9
304906|NCT00076622|747393|P4|NOT COMPLETED|Overall Study||0
304907|NCT00076622|747394|P3|NOT COMPLETED|Overall Study||0
304908|NCT00076622|747395|P2|NOT COMPLETED|Overall Study||0
304909|NCT00076622|747396|P1|NOT COMPLETED|Overall Study||0
304910|NCT00076622|747393|P4|COMPLETED|Overall Study||18
304911|NCT00076622|747394|P3|COMPLETED|Overall Study||40
304912|NCT00076622|747395|P2|COMPLETED|Overall Study||13
304913|NCT00076622|747396|P1|COMPLETED|Overall Study||23
304914|NCT00076622|747393|P4|STARTED|Overall Study||18
304915|NCT00076622|747394|P3|STARTED|Overall Study||40
304916|NCT00076622|747395|P2|STARTED|Overall Study||13
304917|NCT00076622|747396|P1|STARTED|Overall Study||23
304918|NCT00076570|747416|P2|NOT COMPLETED|Overall Study||8
304919|NCT00076570|747417|P1|NOT COMPLETED|Overall Study||8
304920|NCT00076570|747416|P2|COMPLETED|Overall Study||8
304921|NCT00076570|747417|P1|COMPLETED|Overall Study||7
304922|NCT00076570|747416|P2|STARTED|Overall Study||16
304923|NCT00076570|747417|P1|STARTED|Overall Study||15
304924|NCT00003298|747425|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
304925|NCT00003298|747425|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
304926|NCT00003298|747425|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
304927|NCT00003298|747425|P1|STARTED|Step 2 (Adjuvant Therapy)||10
304928|NCT00003298|747425|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
304929|NCT00003298|747425|P1|COMPLETED|Re-register to Step 2 After Surgery||10
304930|NCT00003298|747425|P1|STARTED|Re-register to Step 2 After Surgery||28
304931|NCT00003298|747425|P1|NOT COMPLETED|Surgery||7
304932|NCT00003298|747425|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
304933|NCT00003298|747425|P1|STARTED|Surgery||35
304934|NCT00003298|747425|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
304935|NCT00003298|747425|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
304936|NCT00003298|747425|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
304937|NCT00003298|747425|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
304938|NCT00003298|747425|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
304939|NCT00076336|747435|P2|NOT COMPLETED|Overall Study||56
304940|NCT00076336|747436|P1|NOT COMPLETED|Overall Study||52
304941|NCT00076336|747435|P2|COMPLETED|Overall Study||60
304942|NCT00076336|747436|P1|COMPLETED|Overall Study||64
304943|NCT00076336|747435|P2|Completed Week 104|Overall Study||62
304944|NCT00076336|747436|P1|Completed Week 104|Overall Study||70
304945|NCT00076336|747435|P2|Completed Week 52|Overall Study||94
304946|NCT00076336|747436|P1|Completed Week 52|Overall Study||97
304947|NCT00076336|747435|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
304948|NCT00076336|747436|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
304949|NCT00076336|747435|P2|Safety Population|Overall Study||116
304950|NCT00076336|747436|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
304951|NCT00076336|747435|P2|STARTED|Overall Study||116
304952|NCT00076336|747436|P1|STARTED|Overall Study||116
304953|NCT00076258|747452|P2|NOT COMPLETED|Overall Study||3
304954|NCT00076258|747453|P1|NOT COMPLETED|Overall Study||1
304955|NCT00076258|747452|P2|COMPLETED|Overall Study||61
304956|NCT00076258|747453|P1|COMPLETED|Overall Study||61
304957|NCT00076258|747452|P2|STARTED|Overall Study||64
304958|NCT00076258|747453|P1|STARTED|Overall Study||62
304959|NCT00076245|747463|P4|NOT COMPLETED|Overall Study||1
304960|NCT00076245|747464|P3|NOT COMPLETED|Overall Study||0
304961|NCT00076245|747465|P2|NOT COMPLETED|Overall Study||0
304962|NCT00076245|747466|P1|NOT COMPLETED|Overall Study||0
304963|NCT00076245|747463|P4|COMPLETED|Overall Study||14
304964|NCT00076245|747464|P3|COMPLETED|Overall Study||15
304965|NCT00076245|747465|P2|COMPLETED|Overall Study||15
304966|NCT00076245|747466|P1|COMPLETED|Overall Study||16
304967|NCT00076245|747463|P4|STARTED|Overall Study||15
304968|NCT00076245|747464|P3|STARTED|Overall Study||15
304969|NCT00076245|747465|P2|STARTED|Overall Study||15
304970|NCT00076245|747466|P1|STARTED|Overall Study||16
304971|NCT00076219|747482|P2|NOT COMPLETED|Overall Study||11
304972|NCT00076219|747483|P1|NOT COMPLETED|Overall Study||18
304973|NCT00076219|747482|P2|COMPLETED|Overall Study||550
304974|NCT00076219|747483|P1|COMPLETED|Overall Study||545
304975|NCT00076219|747482|P2|STARTED|Overall Study||561
304976|NCT00076219|747483|P1|STARTED|Overall Study||563
304977|NCT00076102|747489|P1|NOT COMPLETED|Overall Study||5
304978|NCT00076102|747489|P1|COMPLETED|Overall Study||31
304979|NCT00076102|747489|P1|STARTED|Overall Study||36
304980|NCT00076050|747503|P2|NOT COMPLETED|Overall Study||43
304981|NCT00076050|747504|P1|NOT COMPLETED|Overall Study||23
304982|NCT00076050|747503|P2|COMPLETED|Overall Study||83
304983|NCT00076050|747504|P1|COMPLETED|Overall Study||99
304984|NCT00076050|747503|P2|STARTED|Overall Study||126
304985|NCT00076050|747504|P1|STARTED|Overall Study||122
304986|NCT00076024|747517|P4|NOT COMPLETED|Phase 2, Open-label||16
304987|NCT00076024|747518|P3|NOT COMPLETED|Phase 2, Open-label||0
304988|NCT00076024|747519|P2|NOT COMPLETED|Phase 2, Open-label||0
304989|NCT00076024|747520|P1|NOT COMPLETED|Phase 2, Open-label||0
304990|NCT00076024|747517|P4|COMPLETED|Phase 2, Open-label||0
304991|NCT00076024|747518|P3|COMPLETED|Phase 2, Open-label||0
304992|NCT00076024|747519|P2|COMPLETED|Phase 2, Open-label||0
304993|NCT00076024|747520|P1|COMPLETED|Phase 2, Open-label||0
304994|NCT00076024|747517|P4|STARTED|Phase 2, Open-label||16
304995|NCT00076024|747518|P3|STARTED|Phase 2, Open-label||0
304996|NCT00076024|747519|P2|STARTED|Phase 2, Open-label||0
304997|NCT00076024|747520|P1|STARTED|Phase 2, Open-label||0
304998|NCT00076024|747517|P4|NOT COMPLETED|Phase 2, Double-blind||0
304999|NCT00076024|747518|P3|NOT COMPLETED|Phase 2, Double-blind||56
305000|NCT00076024|747519|P2|NOT COMPLETED|Phase 2, Double-blind||112
305001|NCT00076024|747520|P1|NOT COMPLETED|Phase 2, Double-blind||0
305002|NCT00076024|747517|P4|COMPLETED|Phase 2, Double-blind||0
305003|NCT00076024|747518|P3|COMPLETED|Phase 2, Double-blind||0
305004|NCT00076024|747519|P2|COMPLETED|Phase 2, Double-blind||0
305005|NCT00076024|747520|P1|COMPLETED|Phase 2, Double-blind||0
305006|NCT00076024|747517|P4|Treated|Phase 2, Double-blind||0
305007|NCT00076024|747518|P3|Treated|Phase 2, Double-blind||56
305008|NCT00076024|747519|P2|Treated|Phase 2, Double-blind||111
305009|NCT00076024|747520|P1|Treated|Phase 2, Double-blind||0
305010|NCT00076024|747517|P4|STARTED|Phase 2, Double-blind||0
305011|NCT00076024|747518|P3|STARTED|Phase 2, Double-blind||56
305012|NCT00076024|747519|P2|STARTED|Phase 2, Double-blind||112
305013|NCT00076024|747520|P1|STARTED|Phase 2, Double-blind||0
305014|NCT00076024|747517|P4|NOT COMPLETED|Phase 1, Lead-in||0
305015|NCT00076024|747518|P3|NOT COMPLETED|Phase 1, Lead-in||0
305016|NCT00076024|747519|P2|NOT COMPLETED|Phase 1, Lead-in||0
305017|NCT00076024|747520|P1|NOT COMPLETED|Phase 1, Lead-in||6
305018|NCT00076024|747517|P4|COMPLETED|Phase 1, Lead-in||0
305019|NCT00076024|747518|P3|COMPLETED|Phase 1, Lead-in||0
305020|NCT00076024|747519|P2|COMPLETED|Phase 1, Lead-in||0
305021|NCT00076024|747520|P1|COMPLETED|Phase 1, Lead-in||0
305022|NCT00076024|747517|P4|STARTED|Phase 1, Lead-in||0
305023|NCT00076024|747518|P3|STARTED|Phase 1, Lead-in||0
305024|NCT00076024|747519|P2|STARTED|Phase 1, Lead-in||0
305025|NCT00076024|747520|P1|STARTED|Phase 1, Lead-in||6
305026|NCT00076011|747534|P1|NOT COMPLETED|Overall Study||52
305027|NCT00076011|747534|P1|COMPLETED|Overall Study||0
305028|NCT00076011|747534|P1|STARTED|Overall Study||52
305029|NCT00075946|747546|P5|NOT COMPLETED|Overall Study||188
305030|NCT00075946|747547|P4|NOT COMPLETED|Overall Study||30
305031|NCT00075946|747548|P3|NOT COMPLETED|Overall Study||28
305032|NCT00075946|747549|P2|NOT COMPLETED|Overall Study||151
305033|NCT00075946|747550|P1|NOT COMPLETED|Overall Study||148
305034|NCT00075946|747546|P5|COMPLETED|Overall Study||0
305035|NCT00075946|747547|P4|COMPLETED|Overall Study||0
305036|NCT00075946|747548|P3|COMPLETED|Overall Study||0
305037|NCT00075946|747549|P2|COMPLETED|Overall Study||0
305038|NCT00075946|747550|P1|COMPLETED|Overall Study||0
305039|NCT00075946|747546|P5|Included in Primary Analysis|Overall Study||0
305040|NCT00075946|747547|P4|Included in Primary Analysis|Overall Study||29
305041|NCT00075946|747548|P3|Included in Primary Analysis|Overall Study||23
305042|NCT00075946|747549|P2|Included in Primary Analysis|Overall Study||146
305043|NCT00075946|747550|P1|Included in Primary Analysis|Overall Study||143
305044|NCT00075946|747546|P5|Treated and With Toxicity Data Available|Overall Study||154
305045|NCT00075946|747547|P4|Treated and With Toxicity Data Available|Overall Study||29
305046|NCT00075946|747548|P3|Treated and With Toxicity Data Available|Overall Study||27
305047|NCT00075946|747549|P2|Treated and With Toxicity Data Available|Overall Study||148
305048|NCT00075946|747550|P1|Treated and With Toxicity Data Available|Overall Study||142
305049|NCT00075946|747546|P5|STARTED|Overall Study||188
305050|NCT00075946|747547|P4|STARTED|Overall Study||30
305051|NCT00075946|747548|P3|STARTED|Overall Study||28
305052|NCT00075946|747549|P2|STARTED|Overall Study||151
305053|NCT00075946|747550|P1|STARTED|Overall Study||148
305054|NCT00075881|747565|P1|NOT COMPLETED|Overall Study||43
305055|NCT00075881|747565|P1|COMPLETED|Overall Study||1
305056|NCT00075881|747565|P1|Reinduction Treatment|Overall Study||7
305057|NCT00075881|747565|P1|Maintenance Treatment|Overall Study||15
305058|NCT00075881|747565|P1|Induction Treatment|Overall Study||42
305059|NCT00075881|747565|P1|Treated|Overall Study||42
305060|NCT00075881|747565|P1|Eligible|Overall Study||43
305061|NCT00075881|747565|P1|STARTED|Overall Study||44
305062|NCT00075829|747576|P4|NOT COMPLETED|Overall Study||24
305063|NCT00075829|747577|P3|NOT COMPLETED|Overall Study||34
305064|NCT00075829|747578|P2|NOT COMPLETED|Overall Study||118
305065|NCT00075829|747579|P1|NOT COMPLETED|Overall Study||258
305066|NCT00075829|747576|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
305067|NCT00075829|747577|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
305068|NCT00075829|747578|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
305069|NCT00075829|747579|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
305070|NCT00075829|747576|P4|STARTED|Overall Study||37
305071|NCT00075829|747577|P3|STARTED|Overall Study||48
305072|NCT00075829|747578|P2|STARTED|Overall Study||189
305073|NCT00075829|747579|P1|STARTED|Overall Study||436
305074|NCT00075816|747609|P2|NOT COMPLETED|Overall Study||11
305075|NCT00075816|747610|P1|NOT COMPLETED|Overall Study||14
305076|NCT00075816|747609|P2|COMPLETED|Overall Study||262
305077|NCT00075816|747610|P1|COMPLETED|Overall Study||264
305078|NCT00075816|747609|P2|STARTED|Overall Study||273
305079|NCT00075816|747610|P1|STARTED|Overall Study||278
305080|NCT00075803|747650|P2|NOT COMPLETED|Overall Study||0
305081|NCT00075803|747651|P1|NOT COMPLETED|Overall Study||0
305082|NCT00075803|747650|P2|COMPLETED|Overall Study||305
305083|NCT00075803|747651|P1|COMPLETED|Overall Study||295
305084|NCT00075803|747650|P2|STARTED|Overall Study||305
305085|NCT00075803|747651|P1|STARTED|Overall Study||295
305086|NCT00075764|747679|P2|NOT COMPLETED|Overall Study||349
305087|NCT00075764|747680|P1|NOT COMPLETED|Overall Study||345
305088|NCT00075764|747679|P2|COMPLETED|Overall Study||0
305089|NCT00075764|747680|P1|COMPLETED|Overall Study||0
305090|NCT00075764|747679|P2|STARTED|Overall Study||349
305091|NCT00075764|747680|P1|STARTED|Overall Study||345
305092|NCT00075725|747704|P12|NOT COMPLETED|Overall Study||18
305093|NCT00075725|747705|P11|NOT COMPLETED|Overall Study||9
305094|NCT00075725|747706|P10|NOT COMPLETED|Overall Study||18
305095|NCT00075725|747707|P9|NOT COMPLETED|Overall Study||117
305096|NCT00075725|747708|P8|NOT COMPLETED|Overall Study||295
305097|NCT00075725|747709|P7|NOT COMPLETED|Overall Study||75
305098|NCT00075725|747710|P6|NOT COMPLETED|Overall Study||313
305099|NCT00075725|747711|P5|NOT COMPLETED|Overall Study||66
305100|NCT00075725|747712|P4|NOT COMPLETED|Overall Study||78
305101|NCT00075725|747713|P3|NOT COMPLETED|Overall Study||121
305102|NCT00075725|747714|P2|NOT COMPLETED|Overall Study||49
305103|NCT00075725|747715|P1|NOT COMPLETED|Overall Study||74
305104|NCT00075725|747704|P12|COMPLETED|Overall Study||10
305105|NCT00075725|747705|P11|COMPLETED|Overall Study||3
305106|NCT00075725|747706|P10|COMPLETED|Overall Study||16
305107|NCT00075725|747707|P9|COMPLETED|Overall Study||185
305108|NCT00075725|747708|P8|COMPLETED|Overall Study||401
305109|NCT00075725|747709|P7|COMPLETED|Overall Study||171
305110|NCT00075725|747710|P6|COMPLETED|Overall Study||397
305111|NCT00075725|747711|P5|COMPLETED|Overall Study||166
305112|NCT00075725|747712|P4|COMPLETED|Overall Study||168
305113|NCT00075725|747713|P3|COMPLETED|Overall Study||175
305114|NCT00075725|747714|P2|COMPLETED|Overall Study||57
305115|NCT00075725|747715|P1|COMPLETED|Overall Study||172
305116|NCT00075725|747704|P12|STARTED|Overall Study||28
305117|NCT00075725|747705|P11|STARTED|Overall Study||12
305118|NCT00075725|747706|P10|STARTED|Overall Study||34
305119|NCT00075725|747707|P9|STARTED|Overall Study||302
305120|NCT00075725|747708|P8|STARTED|Overall Study||696
305121|NCT00075725|747709|P7|STARTED|Overall Study||246
305122|NCT00075725|747710|P6|STARTED|Overall Study||710
305123|NCT00075725|747711|P5|STARTED|Overall Study||232
305124|NCT00075725|747712|P4|STARTED|Overall Study||246
305125|NCT00075725|747713|P3|STARTED|Overall Study||296
305126|NCT00075725|747714|P2|STARTED|Overall Study||106
305127|NCT00075725|747715|P1|STARTED|Overall Study||246
305128|NCT00075608|747804|P1|NOT COMPLETED|Overall Study||0
305129|NCT00075608|747804|P1|COMPLETED|Overall Study||12
305130|NCT00075608|747804|P1|STARTED|Overall Study||12
305131|NCT00075582|747812|P2|NOT COMPLETED|Overall Study||35
305132|NCT00075582|747813|P1|NOT COMPLETED|Overall Study||50
305133|NCT00075582|747812|P2|COMPLETED|Overall Study||50
305134|NCT00075582|747813|P1|COMPLETED|Overall Study||255
305135|NCT00075582|747812|P2|STARTED|Overall Study||85
305136|NCT00075582|747813|P1|STARTED|Overall Study||305
305137|NCT00075504|747823|P2|NOT COMPLETED|Overall Study||7
305138|NCT00075504|747824|P1|NOT COMPLETED|Overall Study||9
305139|NCT00075504|747823|P2|COMPLETED|Overall Study||3
305140|NCT00075504|747824|P1|COMPLETED|Overall Study||14
305141|NCT00075504|747823|P2|STARTED|Overall Study||10
305142|NCT00075504|747824|P1|STARTED|Overall Study||23
305143|NCT00075478|747836|P2|NOT COMPLETED|Overall Study||1
305144|NCT00075478|747837|P1|NOT COMPLETED|Overall Study||1
305145|NCT00075478|747836|P2|COMPLETED|Overall Study||44
305146|NCT00075478|747837|P1|COMPLETED|Overall Study||41
305147|NCT00075478|747836|P2|STARTED|Overall Study||45
305148|NCT00075478|747837|P1|STARTED|Overall Study||42
305149|NCT00075400|747857|P1|NOT COMPLETED|Overall Study||3
305150|NCT00075400|747857|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
305151|NCT00075400|747857|P1|STARTED|Overall Study||26
305152|NCT00075335|747871|P1|NOT COMPLETED|Overall Study||0
305153|NCT00075335|747871|P1|COMPLETED|Overall Study||8
305154|NCT00075335|747871|P1|STARTED|Overall Study||8
305155|NCT00075270|747878|P2|NOT COMPLETED|Overall Study||284
305156|NCT00075270|747879|P1|NOT COMPLETED|Overall Study||286
305157|NCT00075270|747878|P2|COMPLETED|Overall Study||4
305158|NCT00075270|747879|P1|COMPLETED|Overall Study||5
305159|NCT00075270|747878|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
305160|NCT00075270|747879|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
305161|NCT00075270|747878|P2|STARTED|Overall Study||288
305162|NCT00075270|747879|P1|STARTED|Overall Study||291
305163|NCT00075218|747925|P3|NOT COMPLETED|Open-Label Treatment||255
305164|NCT00075218|747926|P2|NOT COMPLETED|Open-Label Treatment||0
305165|NCT00075218|747927|P1|NOT COMPLETED|Open-Label Treatment||0
305166|NCT00075218|747925|P3|COMPLETED|Open-Label Treatment||0
305167|NCT00075218|747926|P2|COMPLETED|Open-Label Treatment||0
305168|NCT00075218|747927|P1|COMPLETED|Open-Label Treatment||0
305169|NCT00075218|747925|P3|STARTED|Open-Label Treatment||255
305170|NCT00075218|747926|P2|STARTED|Open-Label Treatment||0
305171|NCT00075218|747927|P1|STARTED|Open-Label Treatment||0
305172|NCT00075218|747925|P3|NOT COMPLETED|Double-Blind Treatment||0
305173|NCT00075218|747926|P2|NOT COMPLETED|Double-Blind Treatment||15
305174|NCT00075218|747927|P1|NOT COMPLETED|Double-Blind Treatment||91
305175|NCT00075218|747925|P3|COMPLETED|Double-Blind Treatment||0
305176|NCT00075218|747926|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
305177|NCT00075218|747927|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
305178|NCT00075218|747925|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
305179|NCT00075218|747926|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
305180|NCT00075218|747927|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
305181|NCT00075218|747925|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
305182|NCT00075218|747926|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
305183|NCT00075218|747927|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
305184|NCT00075218|747925|P3|STARTED|Double-Blind Treatment||0
305185|NCT00075218|747926|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
305186|NCT00075218|747927|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
305187|NCT00075088|747962|P2|NOT COMPLETED|Overall Study||0
305188|NCT00075088|747963|P1|NOT COMPLETED|Overall Study||0
305189|NCT00075088|747962|P2|COMPLETED|Overall Study||391
305190|NCT00075088|747963|P1|COMPLETED|Overall Study||403
305191|NCT00075088|747962|P2|STARTED|Overall Study||391
305192|NCT00075088|747963|P1|STARTED|Overall Study||403
305193|NCT00075023|747976|P2|NOT COMPLETED|Part Two||0
305194|NCT00075023|747977|P1|NOT COMPLETED|Part Two||0
305195|NCT00075023|747976|P2|COMPLETED|Part Two||0
305196|NCT00075023|747977|P1|COMPLETED|Part Two||0
305197|NCT00075023|747976|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
305198|NCT00075023|747977|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
305199|NCT00075023|747976|P2|NOT COMPLETED|Pilot Study||2
305200|NCT00075023|747977|P1|NOT COMPLETED|Pilot Study||2
305201|NCT00075023|747976|P2|COMPLETED|Pilot Study||3
305202|NCT00075023|747977|P1|COMPLETED|Pilot Study||3
305203|NCT00075023|747976|P2|STARTED|Pilot Study||5
305204|NCT00075023|747977|P1|STARTED|Pilot Study||5
305205|NCT00074984|747986|P2|NOT COMPLETED|Overall Study||8
305206|NCT00074984|747987|P1|NOT COMPLETED|Overall Study||3
305207|NCT00074984|747986|P2|COMPLETED|Overall Study||43
305208|NCT00074984|747987|P1|COMPLETED|Overall Study||28
305209|NCT00074984|747986|P2|STARTED|Overall Study||51
305210|NCT00074984|747987|P1|STARTED|Overall Study||31
305211|NCT00074958|748002|P1|NOT COMPLETED|Overall Study||1
305212|NCT00074958|748002|P1|COMPLETED|Overall Study||15
305213|NCT00074958|748002|P1|STARTED|Overall Study||16
305214|NCT00074815|748010|P3|NOT COMPLETED|Overall Study||12
305215|NCT00074815|748011|P2|NOT COMPLETED|Overall Study||6
305216|NCT00074815|748012|P1|NOT COMPLETED|Overall Study||5
305217|NCT00074815|748010|P3|COMPLETED|Overall Study||30
305218|NCT00074815|748011|P2|COMPLETED|Overall Study||34
305219|NCT00074815|748012|P1|COMPLETED|Overall Study||37
305220|NCT00074815|748010|P3|STARTED|Overall Study||42
305221|NCT00074815|748011|P2|STARTED|Overall Study||40
305222|NCT00074815|748012|P1|STARTED|Overall Study||42
305223|NCT00074802|748022|P2|NOT COMPLETED|Overall Study||7
305224|NCT00074802|748023|P1|NOT COMPLETED|Overall Study||9
305225|NCT00074802|748022|P2|COMPLETED|Overall Study||25
305226|NCT00074802|748023|P1|COMPLETED|Overall Study||20
305227|NCT00074802|748022|P2|STARTED|Overall Study||32
305228|NCT00074802|748023|P1|STARTED|Overall Study||29
305229|NCT00074711|748043|P2|NOT COMPLETED|Overall Study||15
305230|NCT00074711|748044|P1|NOT COMPLETED|Overall Study||15
305231|NCT00074711|748043|P2|COMPLETED|Overall Study||106
305232|NCT00074711|748044|P1|COMPLETED|Overall Study||105
305233|NCT00074711|748043|P2|STARTED|Overall Study||121
305234|NCT00074711|748044|P1|STARTED|Overall Study||120
305235|NCT00074581|748062|P2|NOT COMPLETED|Overall Study||226
305236|NCT00074581|748063|P1|NOT COMPLETED|Overall Study||244
305237|NCT00074581|748062|P2|COMPLETED|Overall Study||1541
305238|NCT00074581|748063|P1|COMPLETED|Overall Study||1545
305239|NCT00074581|748062|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
305240|NCT00074581|748063|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
305241|NCT00074412|748073|P2|NOT COMPLETED|Overall Study||84
305242|NCT00074412|748074|P1|NOT COMPLETED|Overall Study||82
305243|NCT00074412|748073|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
305244|NCT00074412|748074|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
305245|NCT00074412|748073|P2|Month 12 Visit|Overall Study||735
305246|NCT00074412|748074|P1|Month 12 Visit|Overall Study||733
305247|NCT00074412|748073|P2|Month 9 Visit|Overall Study||741
305248|NCT00074412|748074|P1|Month 9 Visit|Overall Study||741
305249|NCT00074412|748073|P2|Month 6 Visit|Overall Study||748
305250|NCT00074412|748074|P1|Month 6 Visit|Overall Study||748
305251|NCT00074412|748073|P2|Month 5 Visit|Overall Study||750
305252|NCT00074412|748074|P1|Month 5 Visit|Overall Study||756
305253|NCT00074412|748073|P2|Month 4 Visit|Overall Study||752
305254|NCT00074412|748074|P1|Month 4 Visit|Overall Study||758
305255|NCT00074412|748073|P2|Month 3 Visit|Overall Study||755
305256|NCT00074412|748074|P1|Month 3 Visit|Overall Study||759
305257|NCT00074412|748073|P2|Week 8 Visit|Overall Study||759
305258|NCT00074412|748074|P1|Week 8 Visit|Overall Study||759
305259|NCT00074412|748073|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
305260|NCT00074412|748074|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
305261|NCT00074308|748090|P5|NOT COMPLETED|Overall Study||0
305262|NCT00074308|748091|P4|NOT COMPLETED|Overall Study||0
305263|NCT00074308|748092|P3|NOT COMPLETED|Overall Study||0
305264|NCT00074308|748093|P2|NOT COMPLETED|Overall Study||0
305265|NCT00074308|748094|P1|NOT COMPLETED|Overall Study||0
305266|NCT00074308|748090|P5|COMPLETED|Overall Study||23
305267|NCT00074308|748091|P4|COMPLETED|Overall Study||8
305268|NCT00074308|748092|P3|COMPLETED|Overall Study||3
305269|NCT00074308|748093|P2|COMPLETED|Overall Study||3
305270|NCT00074308|748094|P1|COMPLETED|Overall Study||3
305271|NCT00074308|748090|P5|STARTED|Overall Study||23
305272|NCT00074308|748091|P4|STARTED|Overall Study||8
305273|NCT00074308|748092|P3|STARTED|Overall Study||3
305274|NCT00074308|748093|P2|STARTED|Overall Study||3
305275|NCT00074308|748094|P1|STARTED|Overall Study||3
305276|NCT00074269|748104|P1|NOT COMPLETED|Overall Study||0
305277|NCT00074269|748104|P1|COMPLETED|Overall Study||5
305278|NCT00074269|748104|P1|STARTED|Overall Study||5
305279|NCT00074165|748114|P1|NOT COMPLETED|Overall Study||0
305280|NCT00074165|748114|P1|COMPLETED|Overall Study||17
305281|NCT00074165|748114|P1|STARTED|Overall Study||17
305282|NCT00074152|748121|P2|NOT COMPLETED|Overall Study||33
305283|NCT00074152|748122|P1|NOT COMPLETED|Overall Study||55
305284|NCT00074152|748121|P2|COMPLETED|Overall Study||52
305285|NCT00074152|748122|P1|COMPLETED|Overall Study||22
305286|NCT00074152|748121|P2|STARTED|Overall Study||85
305287|NCT00074152|748122|P1|STARTED|Overall Study||77
305288|NCT00074035|748132|P1|NOT COMPLETED|Overall Study||0
305289|NCT00074035|748132|P1|COMPLETED|Overall Study||38
305290|NCT00074035|748132|P1|STARTED|Overall Study||38
305291|NCT00073983|748139|P1|NOT COMPLETED|Overall Study||1
305292|NCT00073983|748139|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
305293|NCT00073983|748139|P1|STARTED|Overall Study||54
305294|NCT00073957|748154|P1|NOT COMPLETED|Overall Study||0
305295|NCT00073957|748154|P1|COMPLETED|Overall Study||25
305296|NCT00073957|748154|P1|STARTED|Overall Study||25
305297|NCT00073918|748160|P1|NOT COMPLETED|Overall Study||4
305298|NCT00073918|748160|P1|COMPLETED|Overall Study||107
305299|NCT00073918|748160|P1|STARTED|Overall Study||111
305300|NCT00073528|748169|P2|NOT COMPLETED|Overall Study||642
305301|NCT00073528|748170|P1|NOT COMPLETED|Overall Study||644
305302|NCT00073528|748169|P2|COMPLETED|Overall Study||0
305303|NCT00073528|748170|P1|COMPLETED|Overall Study||0
305304|NCT00073528|748169|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
305305|NCT00073528|748170|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
305306|NCT00073528|748169|P2|STARTED|Overall Study||642
305307|NCT00073528|748170|P1|STARTED|Overall Study||644
305308|NCT00073333|748247|P3|NOT COMPLETED|Overall Study||0
305309|NCT00073333|748248|P2|NOT COMPLETED|Overall Study||14
305310|NCT00073333|748249|P1|NOT COMPLETED|Overall Study||14
305311|NCT00073333|748247|P3|COMPLETED|Overall Study||19
305312|NCT00073333|748248|P2|COMPLETED|Overall Study||27
305313|NCT00073333|748249|P1|COMPLETED|Overall Study||32
305314|NCT00073333|748247|P3|STARTED|Overall Study||19
305315|NCT00073333|748248|P2|STARTED|Overall Study||41
305316|NCT00073333|748249|P1|STARTED|Overall Study||46
305317|NCT00073307|748259|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
305318|NCT00073307|748260|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
305319|NCT00073307|748261|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
305320|NCT00073307|748259|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
305321|NCT00073307|748260|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
305322|NCT00073307|748261|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
305323|NCT00073307|748259|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
305324|NCT00073307|748260|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
305325|NCT00073307|748261|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
305326|NCT00073307|748259|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
305327|NCT00073307|748260|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
305328|NCT00073307|748261|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
305329|NCT00073307|748259|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
305330|NCT00073307|748260|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
305331|NCT00073307|748261|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
305332|NCT00073307|748259|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
305333|NCT00073307|748260|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
305334|NCT00073307|748261|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
305335|NCT00073307|748259|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
305336|NCT00073307|748260|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
305337|NCT00073307|748261|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
305338|NCT00073307|748259|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
305339|NCT00073307|748260|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
305340|NCT00073307|748261|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
305341|NCT00073073|748279|P1|NOT COMPLETED|Overall Study||4
305342|NCT00073073|748279|P1|COMPLETED|Overall Study||42
305343|NCT00073073|748279|P1|STARTED|Overall Study||46
305344|NCT00073021|748292|P2|NOT COMPLETED|Overall Study||16
305345|NCT00073021|748293|P1|NOT COMPLETED|Overall Study||26
305346|NCT00073021|748292|P2|COMPLETED|Overall Study||113
305347|NCT00073021|748293|P1|COMPLETED|Overall Study||113
305348|NCT00073021|748292|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
305349|NCT00073021|748293|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
305350|NCT00073008|748323|P2|NOT COMPLETED|Overall Study||63
305351|NCT00073008|748324|P1|NOT COMPLETED|Overall Study||62
305352|NCT00073008|748323|P2|COMPLETED|Overall Study||3
305353|NCT00073008|748324|P1|COMPLETED|Overall Study||3
305354|NCT00073008|748323|P2|STARTED|Overall Study||66
305355|NCT00073008|748324|P1|STARTED|Overall Study||65
305356|NCT00072761|748356|P2|NOT COMPLETED|Overall Study||2
305357|NCT00072761|748357|P1|NOT COMPLETED|Overall Study||9
305358|NCT00072761|748356|P2|COMPLETED|Overall Study||95
305359|NCT00072761|748357|P1|COMPLETED|Overall Study||90
305360|NCT00072761|748356|P2|STARTED|Overall Study||97
305361|NCT00072761|748357|P1|STARTED|Overall Study||99
305362|NCT00072475|748363|P1|NOT COMPLETED|Overall Study||97
305363|NCT00072475|748363|P1|COMPLETED|Overall Study||45
305364|NCT00072475|748363|P1|STARTED|Overall Study||142
305365|NCT00072449|748371|P1|NOT COMPLETED|Overall Study||0
305366|NCT00072449|748371|P1|COMPLETED|Overall Study||12
305367|NCT00072449|748371|P1|STARTED|Overall Study||12
305368|NCT00072293|748380|P2|NOT COMPLETED|Overall Study||2
305369|NCT00072293|748381|P1|NOT COMPLETED|Overall Study||1
305370|NCT00072293|748380|P2|COMPLETED|Overall Study||467
305371|NCT00072293|748381|P1|COMPLETED|Overall Study||464
305372|NCT00072293|748380|P2|STARTED|Overall Study||469
305373|NCT00072293|748381|P1|STARTED|Overall Study||465
305374|NCT00072280|748393|P2|NOT COMPLETED|Follow-up||2
305375|NCT00072280|748394|P1|NOT COMPLETED|Follow-up||2
305376|NCT00072280|748393|P2|COMPLETED|Follow-up||0
305377|NCT00072280|748394|P1|COMPLETED|Follow-up||0
305378|NCT00072280|748393|P2|STARTED|Follow-up||2
305379|NCT00072280|748394|P1|STARTED|Follow-up||2
305380|NCT00072280|748393|P2|NOT COMPLETED|Treatment||2
305381|NCT00072280|748394|P1|NOT COMPLETED|Treatment||1
305382|NCT00072280|748393|P2|COMPLETED|Treatment||2
305383|NCT00072280|748394|P1|COMPLETED|Treatment||2
305384|NCT00072280|748393|P2|STARTED|Treatment||4
305385|NCT00072280|748394|P1|STARTED|Treatment||3
305386|NCT00072189|748399|P1|NOT COMPLETED|Overall Study||1
305387|NCT00072189|748399|P1|COMPLETED|Overall Study||16
305388|NCT00072189|748399|P1|STARTED|Overall Study||17
305389|NCT00072176|748407|P2|NOT COMPLETED|Overall Study||1
305390|NCT00072176|748408|P1|NOT COMPLETED|Overall Study||1
305391|NCT00072176|748407|P2|COMPLETED|Overall Study||27
305392|NCT00072176|748408|P1|COMPLETED|Overall Study||33
305393|NCT00072176|748407|P2|STARTED|Overall Study||28
305394|NCT00072176|748408|P1|STARTED|Overall Study||34
305395|NCT00071981|748420|P4|NOT COMPLETED|Overall Study||45
305396|NCT00071981|748421|P3|NOT COMPLETED|Overall Study||37
305397|NCT00071981|748422|P2|NOT COMPLETED|Overall Study||41
305398|NCT00071981|748423|P1|NOT COMPLETED|Overall Study||46
305399|NCT00071981|748420|P4|COMPLETED|Overall Study||3
305400|NCT00071981|748421|P3|COMPLETED|Overall Study||0
305401|NCT00071981|748422|P2|COMPLETED|Overall Study||2
305402|NCT00071981|748423|P1|COMPLETED|Overall Study||1
305403|NCT00071981|748420|P4|Have Helper T Cell Response Data|Overall Study||39
305404|NCT00071981|748421|P3|Have Helper T Cell Response Data|Overall Study||25
305405|NCT00071981|748422|P2|Have Helper T Cell Response Data|Overall Study||27
305406|NCT00071981|748423|P1|Have Helper T Cell Response Data|Overall Study||37
305407|NCT00071981|748420|P4|Have CTL Response Data|Overall Study||41
305408|NCT00071981|748421|P3|Have CTL Response Data|Overall Study||29
305409|NCT00071981|748422|P2|Have CTL Response Data|Overall Study||30
305410|NCT00071981|748423|P1|Have CTL Response Data|Overall Study||40
305411|NCT00071981|748420|P4|Eligible and Treated|Overall Study||42
305412|NCT00071981|748421|P3|Eligible and Treated|Overall Study||32
305413|NCT00071981|748422|P2|Eligible and Treated|Overall Study||33
305414|NCT00071981|748423|P1|Eligible and Treated|Overall Study||41
305415|NCT00071981|748420|P4|Treated|Overall Study||48
305416|NCT00071981|748421|P3|Treated|Overall Study||36
305417|NCT00071981|748422|P2|Treated|Overall Study||38
305418|NCT00071981|748423|P1|Treated|Overall Study||45
305419|NCT00071981|748420|P4|Eligible|Overall Study||42
305420|NCT00071981|748421|P3|Eligible|Overall Study||33
305421|NCT00071981|748422|P2|Eligible|Overall Study||36
305422|NCT00071981|748423|P1|Eligible|Overall Study||43
305423|NCT00071981|748420|P4|STARTED|Overall Study||48
305424|NCT00071981|748421|P3|STARTED|Overall Study||37
305425|NCT00071981|748422|P2|STARTED|Overall Study||43
305426|NCT00071981|748423|P1|STARTED|Overall Study||47
305427|NCT00072566|748449|P1|NOT COMPLETED|Overall Study||0
305428|NCT00072566|748449|P1|COMPLETED|Overall Study||70
305429|NCT00072566|748449|P1|STARTED|Overall Study||70
305430|NCT00072514|748455|P1|NOT COMPLETED|Overall Study||4
305431|NCT00072514|748455|P1|COMPLETED|Overall Study||51
305432|NCT00072514|748455|P1|STARTED|Overall Study||55
305433|NCT00071812|748466|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
305434|NCT00071812|748467|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
305435|NCT00071812|748468|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
305436|NCT00071812|748469|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
305437|NCT00071812|748466|P4|COMPLETED|24-Week Open-Label Extension Period||178
305438|NCT00071812|748467|P3|COMPLETED|24-Week Open-Label Extension Period||7
305439|NCT00071812|748468|P2|COMPLETED|24-Week Open-Label Extension Period||11
305440|NCT00071812|748469|P1|COMPLETED|24-Week Open-Label Extension Period||0
305441|NCT00071812|748466|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
305442|NCT00071812|748467|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
305443|NCT00071812|748468|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
305444|NCT00071812|748469|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
305445|NCT00071812|748466|P4|NOT COMPLETED|24-Week Double-Blind Period||11
305446|NCT00071812|748467|P3|NOT COMPLETED|24-Week Double-Blind Period||8
305447|NCT00071812|748468|P2|NOT COMPLETED|24-Week Double-Blind Period||6
305448|NCT00071812|748469|P1|NOT COMPLETED|24-Week Double-Blind Period||10
305449|NCT00071812|748466|P4|COMPLETED|24-Week Double-Blind Period||60
305450|NCT00071812|748467|P3|COMPLETED|24-Week Double-Blind Period||63
305451|NCT00071812|748468|P2|COMPLETED|24-Week Double-Blind Period||66
305452|NCT00071812|748469|P1|COMPLETED|24-Week Double-Blind Period||59
305453|NCT00071812|748466|P4|STARTED|24-Week Double-Blind Period||71
305454|NCT00071812|748467|P3|STARTED|24-Week Double-Blind Period||71
305455|NCT00071812|748468|P2|STARTED|24-Week Double-Blind Period||72
305456|NCT00071812|748469|P1|STARTED|24-Week Double-Blind Period||69
305457|NCT00071799|748511|P2|NOT COMPLETED|Overall Study||98
305458|NCT00071799|748512|P1|NOT COMPLETED|Overall Study||70
305459|NCT00071799|748511|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
305460|NCT00071799|748512|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
305461|NCT00071799|748511|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
305462|NCT00071799|748512|P1|STARTED|Overall Study||179
305463|NCT00071890|748554|P2|NOT COMPLETED|Overall Study||0
305464|NCT00071890|748555|P1|NOT COMPLETED|Overall Study||0
305465|NCT00071890|748554|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
305466|NCT00071890|748555|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
305467|NCT00071890|748554|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
305468|NCT00071890|748555|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
305469|NCT00071760|748565|P1|NOT COMPLETED|Overall Study||54
305470|NCT00071760|748565|P1|COMPLETED|Overall Study||0
305471|NCT00071760|748565|P1|Ongoing|Overall Study||25
305472|NCT00071760|748565|P1|STARTED|Overall Study||54
305473|NCT00071721|748626|P2|NOT COMPLETED|Overall Study||91
305474|NCT00071721|748627|P1|NOT COMPLETED|Overall Study||72
305475|NCT00071721|748626|P2|COMPLETED|Overall Study||69
305476|NCT00071721|748627|P1|COMPLETED|Overall Study||81
305477|NCT00071721|748626|P2|STARTED|Overall Study||160
305478|NCT00071721|748627|P1|STARTED|Overall Study||153
305479|NCT00071513|748645|P2|NOT COMPLETED|Follow-up Assessment||6
305480|NCT00071513|748646|P1|NOT COMPLETED|Follow-up Assessment||6
305481|NCT00071513|748645|P2|COMPLETED|Follow-up Assessment||247
305482|NCT00071513|748646|P1|COMPLETED|Follow-up Assessment||233
305483|NCT00071513|748645|P2|STARTED|Follow-up Assessment||253
305484|NCT00071513|748646|P1|STARTED|Follow-up Assessment||239
305485|NCT00071513|748645|P2|NOT COMPLETED|Intervention Component||3
305486|NCT00071513|748646|P1|NOT COMPLETED|Intervention Component||2
305487|NCT00071513|748645|P2|COMPLETED|Intervention Component||253
305488|NCT00071513|748646|P1|COMPLETED|Intervention Component||239
305489|NCT00071513|748645|P2|STARTED|Intervention Component||256
305490|NCT00071513|748646|P1|STARTED|Intervention Component||241
305491|NCT00071487|748658|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
305492|NCT00071487|748659|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
305493|NCT00071487|748660|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
305494|NCT00071487|748661|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
305495|NCT00071487|748658|P4|COMPLETED|24-Week Open-Label Extension Period||279
305496|NCT00071487|748659|P3|COMPLETED|24-Week Open-Label Extension Period||23
305497|NCT00071487|748660|P2|COMPLETED|24-Week Open-Label Extension Period||19
305498|NCT00071487|748661|P1|COMPLETED|24-Week Open-Label Extension Period||0
305499|NCT00071487|748658|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
305500|NCT00071487|748659|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
305501|NCT00071487|748660|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
305502|NCT00071487|748661|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
305503|NCT00071487|748658|P4|NOT COMPLETED|52-Week Double-Blind Period||21
305504|NCT00071487|748659|P3|NOT COMPLETED|52-Week Double-Blind Period||17
305505|NCT00071487|748660|P2|NOT COMPLETED|52-Week Double-Blind Period||27
305506|NCT00071487|748661|P1|NOT COMPLETED|52-Week Double-Blind Period||20
305507|NCT00071487|748658|P4|COMPLETED|52-Week Double-Blind Period||90
305508|NCT00071487|748659|P3|COMPLETED|52-Week Double-Blind Period||94
305509|NCT00071487|748660|P2|COMPLETED|52-Week Double-Blind Period||87
305510|NCT00071487|748661|P1|COMPLETED|52-Week Double-Blind Period||93
305511|NCT00071487|748658|P4|STARTED|52-Week Double-Blind Period||111
305512|NCT00071487|748659|P3|STARTED|52-Week Double-Blind Period||111
305513|NCT00071487|748660|P2|STARTED|52-Week Double-Blind Period||114
305514|NCT00071487|748661|P1|STARTED|52-Week Double-Blind Period||113
305515|NCT00071396|748705|P1|NOT COMPLETED|Overall Study||3
305516|NCT00071396|748705|P1|COMPLETED|Overall Study|Evaluable for response.|41
305517|NCT00071396|748705|P1|STARTED|Overall Study||44
305518|NCT00071110|748711|P2|NOT COMPLETED|Overall Study||4
305519|NCT00071110|748712|P1|NOT COMPLETED|Overall Study||0
305520|NCT00071110|748711|P2|COMPLETED|Overall Study||25
305521|NCT00071110|748712|P1|COMPLETED|Overall Study||28
305522|NCT00071110|748711|P2|STARTED|Overall Study||29
305523|NCT00071110|748712|P1|STARTED|Overall Study||28
305524|NCT00071032|748726|P2|NOT COMPLETED|Overall Study||8
305525|NCT00071032|748727|P1|NOT COMPLETED|Overall Study||9
305526|NCT00071032|748726|P2|COMPLETED|Overall Study||1001
305527|NCT00071032|748727|P1|COMPLETED|Overall Study||998
305528|NCT00071032|748726|P2|STARTED|Overall Study||1009
305529|NCT00071032|748727|P1|STARTED|Overall Study||1007
305530|NCT00071006|748735|P1|NOT COMPLETED|Overall Study||12
305531|NCT00071006|748735|P1|COMPLETED|Overall Study||0
305532|NCT00071006|748735|P1|STARTED|Overall Study||12
305533|NCT00070941|748748|P3|NOT COMPLETED|Overall Study||4
305534|NCT00070941|748749|P2|NOT COMPLETED|Overall Study||8
305535|NCT00070941|748750|P1|NOT COMPLETED|Overall Study||10
305536|NCT00070941|748748|P3|COMPLETED|Overall Study||2
305537|NCT00070941|748749|P2|COMPLETED|Overall Study||3
305538|NCT00070941|748750|P1|COMPLETED|Overall Study||2
305539|NCT00070941|748748|P3|STARTED|Overall Study||6
305540|NCT00070941|748749|P2|STARTED|Overall Study||11
305541|NCT00070941|748750|P1|STARTED|Overall Study||12
305542|NCT00071058|748758|P1|NOT COMPLETED|Overall Study||1
305543|NCT00071058|748758|P1|COMPLETED|Overall Study||49
305544|NCT00071058|748758|P1|STARTED|Overall Study||50
305545|NCT00003907|748765|P2|NOT COMPLETED|Overall Study||23
305546|NCT00003907|748766|P1|NOT COMPLETED|Overall Study||13
305547|NCT00003907|748765|P2|COMPLETED|Overall Study||8
305548|NCT00003907|748766|P1|COMPLETED|Overall Study||6
305549|NCT00003907|748765|P2|Eligible and Treated|Overall Study||29
305550|NCT00003907|748766|P1|Eligible and Treated|Overall Study||17
305551|NCT00003907|748765|P2|Received Protocol Therapy (Treated)|Overall Study||31
305552|NCT00003907|748766|P1|Received Protocol Therapy (Treated)|Overall Study||18
305553|NCT00003907|748765|P2|Eligible|Overall Study||29
305554|NCT00003907|748766|P1|Eligible|Overall Study||18
305555|NCT00003907|748765|P2|STARTED|Overall Study||31
305556|NCT00003907|748766|P1|STARTED|Overall Study||19
305557|NCT00070564|748782|P6|NOT COMPLETED|Overall Study||52
305558|NCT00070564|748783|P5|NOT COMPLETED|Overall Study||79
305559|NCT00070564|748784|P4|NOT COMPLETED|Overall Study||167
305560|NCT00070564|748785|P3|NOT COMPLETED|Overall Study||171
305561|NCT00070564|748786|P2|NOT COMPLETED|Overall Study||203
305562|NCT00070564|748787|P1|NOT COMPLETED|Overall Study||200
305563|NCT00070564|748782|P6|COMPLETED|Overall Study||244
305564|NCT00070564|748783|P5|COMPLETED|Overall Study||203
305565|NCT00070564|748784|P4|COMPLETED|Overall Study||481
305566|NCT00070564|748785|P3|COMPLETED|Overall Study||526
305567|NCT00070564|748786|P2|COMPLETED|Overall Study||490
305568|NCT00070564|748787|P1|COMPLETED|Overall Study||478
305569|NCT00070564|748782|P6|STARTED|Overall Study||296
305570|NCT00070564|748783|P5|STARTED|Overall Study||282
305571|NCT00070564|748784|P4|STARTED|Overall Study||648
305572|NCT00070564|748785|P3|STARTED|Overall Study||697
305573|NCT00070564|748786|P2|STARTED|Overall Study||693
305574|NCT00070564|748787|P1|STARTED|Overall Study||678
305575|NCT00070499|748841|P4|NOT COMPLETED|Overall Study||110
305576|NCT00070499|748842|P3|NOT COMPLETED|Overall Study||120
305577|NCT00070499|748843|P2|NOT COMPLETED|Overall Study||26
305578|NCT00070499|748844|P1|NOT COMPLETED|Overall Study||38
305579|NCT00070499|748841|P4|COMPLETED|Overall Study||17
305580|NCT00070499|748842|P3|COMPLETED|Overall Study||6
305581|NCT00070499|748843|P2|COMPLETED|Overall Study||52
305582|NCT00070499|748844|P1|COMPLETED|Overall Study||37
305583|NCT00070499|748841|P4|Eligible and Treated|Overall Study||123
305584|NCT00070499|748842|P3|Eligible and Treated|Overall Study||123
305585|NCT00070499|748843|P2|Eligible and Treated|Overall Study||73
305586|NCT00070499|748844|P1|Eligible and Treated|Overall Study||72
305587|NCT00070499|748841|P4|Eligible|Overall Study||125
305588|NCT00070499|748842|P3|Eligible|Overall Study||123
305589|NCT00070499|748843|P2|Eligible|Overall Study||73
305590|NCT00070499|748844|P1|Eligible|Overall Study||73
305591|NCT00070499|748841|P4|STARTED|Overall Study||127
305592|NCT00070499|748842|P3|STARTED|Overall Study||126
305593|NCT00070499|748843|P2|STARTED|Overall Study||78
305594|NCT00070499|748844|P1|STARTED|Overall Study||75
305595|NCT00070317|748870|P1|NOT COMPLETED|Overall Study||13
305596|NCT00070317|748870|P1|COMPLETED|Overall Study||89
305597|NCT00070317|748870|P1|STARTED|Overall Study||102
305598|NCT00070291|748875|P1|NOT COMPLETED|Step 2||1
305599|NCT00070291|748875|P1|COMPLETED|Step 2||0
305600|NCT00070291|748875|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
305601|NCT00070291|748875|P1|NOT COMPLETED|Step 1||2
305602|NCT00070291|748875|P1|COMPLETED|Step 1||2
305603|NCT00070291|748875|P1|Treated|Step 1||3
305604|NCT00070291|748875|P1|STARTED|Step 1||4
305605|NCT00070135|748880|P1|NOT COMPLETED|Overall Study||0
305606|NCT00070135|748880|P1|COMPLETED|Overall Study||114
305607|NCT00070135|748880|P1|STARTED|Overall Study||114
305608|NCT00070109|748891|P5|NOT COMPLETED|Overall Study||8
305609|NCT00070109|748892|P4|NOT COMPLETED|Overall Study||20
305610|NCT00070109|748893|P3|NOT COMPLETED|Overall Study||8
305611|NCT00070109|748894|P2|NOT COMPLETED|Overall Study||6
305612|NCT00070109|748895|P1|NOT COMPLETED|Overall Study||8
305613|NCT00070109|748891|P5|COMPLETED|Overall Study||0
305614|NCT00070109|748892|P4|COMPLETED|Overall Study||0
305615|NCT00070109|748893|P3|COMPLETED|Overall Study||0
305616|NCT00070109|748894|P2|COMPLETED|Overall Study||0
305617|NCT00070109|748895|P1|COMPLETED|Overall Study||0
305618|NCT00070109|748891|P5|STARTED|Overall Study||8
305619|NCT00070109|748892|P4|STARTED|Overall Study||20
305620|NCT00070109|748893|P3|STARTED|Overall Study||8
305621|NCT00070109|748894|P2|STARTED|Overall Study||6
305622|NCT00070109|748895|P1|STARTED|Overall Study||8
305623|NCT00070018|748908|P1|NOT COMPLETED|Overall Study||4
305624|NCT00070018|748908|P1|COMPLETED|Overall Study||42
305625|NCT00070018|748908|P1|Eligible and Began Protocol Therapy|Overall Study||46
305626|NCT00070018|748908|P1|Eligible|Overall Study||46
305627|NCT00070018|748908|P1|STARTED|Overall Study||46
305628|NCT00069953|748912|P1|NOT COMPLETED|Overall Study||2
305629|NCT00069953|748912|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
305630|NCT00069953|748912|P1|STARTED|Overall Study||43
305631|NCT00069784|748918|P2|NOT COMPLETED|Overall Study||0
305632|NCT00069784|748919|P1|NOT COMPLETED|Overall Study||1212
305633|NCT00069784|748918|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
305634|NCT00069784|748919|P1|COMPLETED|Overall Study|completed study treatment|5052
305635|NCT00069784|748918|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
305636|NCT00069784|748919|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
305637|NCT00069784|748918|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
305638|NCT00069784|748919|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
305639|NCT00069823|748939|P2|NOT COMPLETED|Overall Study||3
305640|NCT00069823|748940|P1|NOT COMPLETED|Overall Study||6
305641|NCT00069823|748939|P2|COMPLETED|Overall Study||200
305642|NCT00069823|748940|P1|COMPLETED|Overall Study||193
305643|NCT00069823|748939|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
305722|NCT00069095|749108|P6|NOT COMPLETED|Post-study Treatment Phase||29
305644|NCT00069823|748940|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
305645|NCT00069641|748983|P3|NOT COMPLETED|Overall Study||1
305646|NCT00069641|748984|P2|NOT COMPLETED|Overall Study||0
305647|NCT00069641|748985|P1|NOT COMPLETED|Overall Study||1
305648|NCT00069641|748983|P3|COMPLETED|Overall Study||31
305649|NCT00069641|748984|P2|COMPLETED|Overall Study||32
305650|NCT00069641|748985|P1|COMPLETED|Overall Study||31
305651|NCT00069641|748983|P3|STARTED|Overall Study||32
305652|NCT00069641|748984|P2|STARTED|Overall Study||32
305653|NCT00069641|748985|P1|STARTED|Overall Study||32
305654|NCT00069277|749010|P1|NOT COMPLETED|Overall Study||21
305655|NCT00069277|749010|P1|COMPLETED|Overall Study||0
305656|NCT00069277|749010|P1|STARTED|Overall Study||21
305657|NCT00069264|749014|P1|NOT COMPLETED|Overall Study||32
305658|NCT00069264|749014|P1|COMPLETED|Overall Study||0
305659|NCT00069264|749014|P1|STARTED|Overall Study||32
305660|NCT00069329|749018|P1|NOT COMPLETED|Overall Study||2
305661|NCT00069329|749018|P1|COMPLETED|Overall Study||41
305662|NCT00069329|749018|P1|STARTED|Overall Study||43
305663|NCT00069238|749042|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
305664|NCT00069238|749043|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
305665|NCT00069238|749044|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
305666|NCT00069238|749042|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
305667|NCT00069238|749043|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
305668|NCT00069238|749044|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
305669|NCT00069238|749042|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
305670|NCT00069238|749043|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
305671|NCT00069238|749044|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
305672|NCT00069238|749042|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
305673|NCT00069238|749043|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
305674|NCT00069238|749044|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
305675|NCT00069238|749042|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
305676|NCT00069238|749043|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
305677|NCT00069238|749044|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
305678|NCT00069238|749042|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
305679|NCT00069238|749043|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
305680|NCT00069238|749044|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
305681|NCT00069238|749042|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
305682|NCT00069238|749043|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
305683|NCT00069238|749044|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
305684|NCT00069238|749042|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
305685|NCT00069238|749043|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
305686|NCT00069238|749044|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
305687|NCT00069238|749042|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
305688|NCT00069238|749043|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
305689|NCT00069238|749044|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
305690|NCT00069121|749052|P2|NOT COMPLETED|Overall Study||276
305691|NCT00069121|749053|P1|NOT COMPLETED|Overall Study||302
305692|NCT00069121|749052|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
305693|NCT00069121|749053|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
305694|NCT00069121|749052|P2|Received Treatment|Overall Study|Safety Population|938
305695|NCT00069121|749053|P1|Received Treatment|Overall Study|Safety Population|926
305696|NCT00069121|749052|P2|STARTED|Overall Study||944
305697|NCT00069121|749053|P1|STARTED|Overall Study||942
305698|NCT00069108|749075|P2|NOT COMPLETED|Overall Study||219
305699|NCT00069108|749076|P1|NOT COMPLETED|Overall Study||213
305700|NCT00069108|749075|P2|COMPLETED|Overall Study||95
305701|NCT00069108|749076|P1|COMPLETED|Overall Study||100
305702|NCT00069108|749075|P2|STARTED|Overall Study||314
305703|NCT00069108|749076|P1|STARTED|Overall Study||313
305704|NCT00069095|749108|P6|NOT COMPLETED|Follow-up Phase||101
305705|NCT00069095|749109|P5|NOT COMPLETED|Follow-up Phase||92
305706|NCT00069095|749110|P4|NOT COMPLETED|Follow-up Phase||112
305707|NCT00069095|749111|P3|NOT COMPLETED|Follow-up Phase||120
305708|NCT00069095|749112|P2|NOT COMPLETED|Follow-up Phase||206
305709|NCT00069095|749113|P1|NOT COMPLETED|Follow-up Phase||174
305710|NCT00069095|749108|P6|COMPLETED|Follow-up Phase||171
305711|NCT00069095|749109|P5|COMPLETED|Follow-up Phase||186
305712|NCT00069095|749110|P4|COMPLETED|Follow-up Phase||187
305713|NCT00069095|749111|P3|COMPLETED|Follow-up Phase||178
305714|NCT00069095|749112|P2|COMPLETED|Follow-up Phase||93
305715|NCT00069095|749113|P1|COMPLETED|Follow-up Phase||110
305716|NCT00069095|749108|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
305717|NCT00069095|749109|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
305718|NCT00069095|749110|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
305719|NCT00069095|749111|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
305720|NCT00069095|749112|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
305721|NCT00069095|749113|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
305723|NCT00069095|749109|P5|NOT COMPLETED|Post-study Treatment Phase||36
305724|NCT00069095|749110|P4|NOT COMPLETED|Post-study Treatment Phase||17
305725|NCT00069095|749111|P3|NOT COMPLETED|Post-study Treatment Phase||21
305726|NCT00069095|749112|P2|NOT COMPLETED|Post-study Treatment Phase||13
305727|NCT00069095|749113|P1|NOT COMPLETED|Post-study Treatment Phase||8
305728|NCT00069095|749108|P6|COMPLETED|Post-study Treatment Phase||0
305729|NCT00069095|749109|P5|COMPLETED|Post-study Treatment Phase||0
305730|NCT00069095|749110|P4|COMPLETED|Post-study Treatment Phase||0
305731|NCT00069095|749111|P3|COMPLETED|Post-study Treatment Phase||0
305732|NCT00069095|749112|P2|COMPLETED|Post-study Treatment Phase||0
305733|NCT00069095|749113|P1|COMPLETED|Post-study Treatment Phase||0
305734|NCT00069095|749108|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
305735|NCT00069095|749109|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
305736|NCT00069095|749110|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
305737|NCT00069095|749111|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
305738|NCT00069095|749112|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
305739|NCT00069095|749113|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
305740|NCT00069095|749108|P6|NOT COMPLETED|Primary Treatment Phase||301
305741|NCT00069095|749109|P5|NOT COMPLETED|Primary Treatment Phase||302
305742|NCT00069095|749110|P4|NOT COMPLETED|Primary Treatment Phase||320
305743|NCT00069095|749111|P3|NOT COMPLETED|Primary Treatment Phase||314
305744|NCT00069095|749112|P2|NOT COMPLETED|Primary Treatment Phase||302
305745|NCT00069095|749113|P1|NOT COMPLETED|Primary Treatment Phase||295
305746|NCT00069095|749108|P6|COMPLETED|Primary Treatment Phase||48
305747|NCT00069095|749109|P5|COMPLETED|Primary Treatment Phase||48
305748|NCT00069095|749110|P4|COMPLETED|Primary Treatment Phase||31
305749|NCT00069095|749111|P3|COMPLETED|Primary Treatment Phase||36
305750|NCT00069095|749112|P2|COMPLETED|Primary Treatment Phase||15
305751|NCT00069095|749113|P1|COMPLETED|Primary Treatment Phase||22
305752|NCT00069095|749108|P6|STARTED|Primary Treatment Phase||349
305753|NCT00069095|749109|P5|STARTED|Primary Treatment Phase||350
305754|NCT00069095|749110|P4|STARTED|Primary Treatment Phase||351
305755|NCT00069095|749111|P3|STARTED|Primary Treatment Phase||350
305756|NCT00069095|749112|P2|STARTED|Primary Treatment Phase||317
305757|NCT00069095|749113|P1|STARTED|Primary Treatment Phase||317
305758|NCT00069160|749167|P2|NOT COMPLETED|Overall Study||0
305759|NCT00069160|749168|P1|NOT COMPLETED|Overall Study||0
305760|NCT00069160|749167|P2|COMPLETED|Overall Study||25
305761|NCT00069160|749168|P1|COMPLETED|Overall Study||23
305762|NCT00069160|749167|P2|STARTED|Overall Study||25
305763|NCT00069160|749168|P1|STARTED|Overall Study||23
305764|NCT00068822|749183|P2|NOT COMPLETED|Optional Crossover Intervention||0
305765|NCT00068822|749184|P1|NOT COMPLETED|Optional Crossover Intervention||0
305766|NCT00068822|749183|P2|COMPLETED|Optional Crossover Intervention||29
305767|NCT00068822|749184|P1|COMPLETED|Optional Crossover Intervention||9
305768|NCT00068822|749183|P2|Crossover at Month 3|Optional Crossover Intervention||27
305769|NCT00068822|749184|P1|Crossover at Month 3|Optional Crossover Intervention||8
305770|NCT00068822|749183|P2|Crossover at Month 1|Optional Crossover Intervention||2
305771|NCT00068822|749184|P1|Crossover at Month 1|Optional Crossover Intervention||1
305772|NCT00068822|749183|P2|STARTED|Optional Crossover Intervention||29
305773|NCT00068822|749184|P1|STARTED|Optional Crossover Intervention||9
305774|NCT00068822|749183|P2|NOT COMPLETED|First Randomized Intervention||2
305775|NCT00068822|749184|P1|NOT COMPLETED|First Randomized Intervention||1
305776|NCT00068822|749183|P2|COMPLETED|First Randomized Intervention||61
305777|NCT00068822|749184|P1|COMPLETED|First Randomized Intervention||67
305778|NCT00068822|749183|P2|STARTED|First Randomized Intervention||63
305779|NCT00068822|749184|P1|STARTED|First Randomized Intervention||68
305780|NCT00068770|749196|P2|NOT COMPLETED|Overall Study||0
305781|NCT00068770|749197|P1|NOT COMPLETED|Overall Study||0
305782|NCT00068770|749196|P2|COMPLETED|Overall Study||22
305783|NCT00068770|749197|P1|COMPLETED|Overall Study||13
305784|NCT00068770|749196|P2|STARTED|Overall Study||22
305785|NCT00068770|749197|P1|STARTED|Overall Study||13
305786|NCT00068718|749205|P1|NOT COMPLETED|Overall Study||0
305787|NCT00068718|749205|P1|COMPLETED|Overall Study||35
305788|NCT00068718|749205|P1|STARTED|Overall Study||35
305789|NCT00068601|749217|P2|NOT COMPLETED|Overall Study||60
305790|NCT00068601|749218|P1|NOT COMPLETED|Overall Study||62
305791|NCT00068601|749217|P2|COMPLETED|Overall Study||66
305792|NCT00068601|749218|P1|COMPLETED|Overall Study||69
305793|NCT00068601|749217|P2|STARTED|Overall Study||126
305794|NCT00068601|749218|P1|STARTED|Overall Study||131
305795|NCT00068588|749231|P3|NOT COMPLETED|Overall Study||4
305796|NCT00068588|749232|P2|NOT COMPLETED|Overall Study||0
305797|NCT00068588|749233|P1|NOT COMPLETED|Overall Study||0
305798|NCT00068588|749231|P3|COMPLETED|Overall Study||17
305799|NCT00068588|749232|P2|COMPLETED|Overall Study||3
305800|NCT00068588|749233|P1|COMPLETED|Overall Study||0
305801|NCT00068588|749231|P3|STARTED|Overall Study||21
305802|NCT00068588|749232|P2|STARTED|Overall Study||3
305803|NCT00068588|749233|P1|STARTED|Overall Study||0
305804|NCT00068575|749243|P1|NOT COMPLETED|Overall Study||0
305805|NCT00068575|749243|P1|COMPLETED|Overall Study||28
305806|NCT00068575|749243|P1|STARTED|Overall Study||28
305807|NCT00068445|749249|P2|NOT COMPLETED|Treatment||16
305808|NCT00068445|749250|P1|NOT COMPLETED|Treatment||29
305809|NCT00068445|749249|P2|COMPLETED|Treatment||46
305810|NCT00068445|749250|P1|COMPLETED|Treatment||34
305811|NCT00068445|749249|P2|STARTED|Treatment||62
305812|NCT00068445|749250|P1|STARTED|Treatment||63
305813|NCT00068445|749249|P2|NOT COMPLETED|Randomization||4
305814|NCT00068445|749250|P1|NOT COMPLETED|Randomization||2
305815|NCT00068445|749249|P2|COMPLETED|Randomization||62
305816|NCT00068445|749250|P1|COMPLETED|Randomization||63
305817|NCT00068445|749249|P2|STARTED|Randomization||66
305818|NCT00068445|749250|P1|STARTED|Randomization||65
305819|NCT00068419|749274|P1|NOT COMPLETED|Overall Study||60
305820|NCT00068419|749274|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
305821|NCT00068419|749274|P1|STARTED|Overall Study||70
305822|NCT00068406|749278|P1|NOT COMPLETED|Overall Study||3
305823|NCT00068406|749278|P1|COMPLETED|Overall Study||58
305824|NCT00068406|749278|P1|STARTED|Overall Study||61
305825|NCT00068393|749283|P1|NOT COMPLETED|Overall Study||10
305826|NCT00068393|749283|P1|COMPLETED|Overall Study||29
305827|NCT00068393|749283|P1|Eligible and Treated|Overall Study||38
305828|NCT00068393|749283|P1|STARTED|Overall Study||39
305829|NCT00068380|749289|P1|NOT COMPLETED|Overall Study||5
305830|NCT00068380|749289|P1|COMPLETED|Overall Study||12
305831|NCT00068380|749289|P1|STARTED|Overall Study||17
305832|NCT00068367|749298|P1|NOT COMPLETED|Overall Study||0
305833|NCT00068367|749298|P1|COMPLETED|Overall Study||20
305834|NCT00068367|749298|P1|STARTED|Overall Study||20
305835|NCT00068341|749307|P3|NOT COMPLETED|Overall Study||0
305836|NCT00068341|749308|P2|NOT COMPLETED|Overall Study||0
305837|NCT00068341|749309|P1|NOT COMPLETED|Overall Study||0
305838|NCT00068341|749307|P3|COMPLETED|Overall Study||44
305839|NCT00068341|749308|P2|COMPLETED|Overall Study||15
305840|NCT00068341|749309|P1|COMPLETED|Overall Study||15
305841|NCT00068341|749307|P3|STARTED|Overall Study||44
305842|NCT00068341|749308|P2|STARTED|Overall Study||15
305843|NCT00068341|749309|P1|STARTED|Overall Study||15
305844|NCT00068250|749333|P4|NOT COMPLETED|Phase II: Dose Level 2||0
305845|NCT00068250|749334|P3|NOT COMPLETED|Phase II: Dose Level 2||0
305846|NCT00068250|749335|P2|NOT COMPLETED|Phase II: Dose Level 2||0
305847|NCT00068250|749336|P1|NOT COMPLETED|Phase II: Dose Level 2||0
305848|NCT00068250|749333|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
305849|NCT00068250|749334|P3|COMPLETED|Phase II: Dose Level 2||0
305850|NCT00068250|749335|P2|COMPLETED|Phase II: Dose Level 2||0
305851|NCT00068250|749336|P1|COMPLETED|Phase II: Dose Level 2||0
305852|NCT00068250|749333|P4|STARTED|Phase II: Dose Level 2||47
305853|NCT00068250|749334|P3|STARTED|Phase II: Dose Level 2||0
305854|NCT00068250|749335|P2|STARTED|Phase II: Dose Level 2||0
305855|NCT00068250|749336|P1|STARTED|Phase II: Dose Level 2||0
305856|NCT00068250|749333|P4|NOT COMPLETED|Phase I: Dose Level 2||0
305857|NCT00068250|749334|P3|NOT COMPLETED|Phase I: Dose Level 2||0
305858|NCT00068250|749335|P2|NOT COMPLETED|Phase I: Dose Level 2||1
305859|NCT00068250|749336|P1|NOT COMPLETED|Phase I: Dose Level 2||0
305860|NCT00068250|749333|P4|COMPLETED|Phase I: Dose Level 2||0
305861|NCT00068250|749334|P3|COMPLETED|Phase I: Dose Level 2||0
305862|NCT00068250|749335|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
305863|NCT00068250|749336|P1|COMPLETED|Phase I: Dose Level 2||0
305864|NCT00068250|749333|P4|STARTED|Phase I: Dose Level 2||0
305865|NCT00068250|749334|P3|STARTED|Phase I: Dose Level 2||0
305866|NCT00068250|749335|P2|STARTED|Phase I: Dose Level 2||7
305867|NCT00068250|749336|P1|STARTED|Phase I: Dose Level 2||0
305868|NCT00068250|749333|P4|NOT COMPLETED|Phase I: Dose Level 1||0
305869|NCT00068250|749334|P3|NOT COMPLETED|Phase I: Dose Level 1||0
305870|NCT00068250|749335|P2|NOT COMPLETED|Phase I: Dose Level 1||0
305871|NCT00068250|749336|P1|NOT COMPLETED|Phase I: Dose Level 1||0
305872|NCT00068250|749333|P4|COMPLETED|Phase I: Dose Level 1||0
305873|NCT00068250|749334|P3|COMPLETED|Phase I: Dose Level 1||0
305874|NCT00068250|749335|P2|COMPLETED|Phase I: Dose Level 1||0
305875|NCT00068250|749336|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
305876|NCT00068250|749333|P4|STARTED|Phase I: Dose Level 1||0
305877|NCT00068250|749334|P3|STARTED|Phase I: Dose Level 1||0
305878|NCT00068250|749335|P2|STARTED|Phase I: Dose Level 1||0
305879|NCT00068250|749336|P1|STARTED|Phase I: Dose Level 1||6
305880|NCT00068237|749346|P1|NOT COMPLETED|Overall Study||5
305881|NCT00068237|749346|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
305882|NCT00068237|749346|P1|STARTED|Overall Study||49
305883|NCT00068107|749350|P1|NOT COMPLETED|Overall Study||9
305884|NCT00068107|749350|P1|COMPLETED|Overall Study||3
305885|NCT00068107|749350|P1|STARTED|Overall Study||12
305886|NCT00067990|749363|P2|NOT COMPLETED|Overall Study||22
305887|NCT00067990|749364|P1|NOT COMPLETED|Overall Study||10
305888|NCT00067990|749363|P2|COMPLETED|Overall Study||54
305889|NCT00067990|749364|P1|COMPLETED|Overall Study||67
305890|NCT00067990|749363|P2|STARTED|Overall Study||76
305891|NCT00067990|749364|P1|STARTED|Overall Study||77
305892|NCT00067808|749375|P3|NOT COMPLETED|Overall Study||0
305893|NCT00067808|749376|P2|NOT COMPLETED|Overall Study||0
305894|NCT00067808|749377|P1|NOT COMPLETED|Overall Study||0
305895|NCT00067808|749375|P3|COMPLETED|Overall Study||14
305896|NCT00067808|749376|P2|COMPLETED|Overall Study||93
305897|NCT00067808|749377|P1|COMPLETED|Overall Study||17
305898|NCT00067808|749375|P3|STARTED|Overall Study||14
305899|NCT00067808|749376|P2|STARTED|Overall Study||93
305900|NCT00067808|749377|P1|STARTED|Overall Study||17
305901|NCT00067470|749387|P2|NOT COMPLETED|Overall Study||1
305902|NCT00067470|749388|P1|NOT COMPLETED|Overall Study||0
305903|NCT00067470|749387|P2|COMPLETED|Overall Study||19
305904|NCT00067470|749388|P1|COMPLETED|Overall Study||19
305905|NCT00067470|749387|P2|STARTED|Overall Study||20
305906|NCT00067470|749388|P1|STARTED|Overall Study||19
305907|NCT00067236|749400|P2|NOT COMPLETED|Overall Study||26
305908|NCT00067236|749401|P1|NOT COMPLETED|Overall Study||20
305909|NCT00067236|749400|P2|COMPLETED|Overall Study||99
305910|NCT00067236|749401|P1|COMPLETED|Overall Study||108
305911|NCT00067236|749400|P2|STARTED|Overall Study||125
305912|NCT00067236|749401|P1|STARTED|Overall Study||128
305913|NCT00066963|749410|P3|NOT COMPLETED|Overall Study||39
305914|NCT00066963|749411|P2|NOT COMPLETED|Overall Study||31
305915|NCT00066963|749412|P1|NOT COMPLETED|Overall Study||26
305916|NCT00066963|749410|P3|COMPLETED|Overall Study||87
305917|NCT00066963|749411|P2|COMPLETED|Overall Study||93
305918|NCT00066963|749412|P1|COMPLETED|Overall Study|any follow-up|100
305919|NCT00066963|749410|P3|STARTED|Overall Study||126
305920|NCT00066963|749411|P2|STARTED|Overall Study||124
305921|NCT00066963|749412|P1|STARTED|Overall Study||126
305922|NCT00066937|749424|P4|NOT COMPLETED|6 Month Follow-up||1
305923|NCT00066937|749425|P3|NOT COMPLETED|6 Month Follow-up||3
305924|NCT00066937|749426|P2|NOT COMPLETED|6 Month Follow-up||3
305925|NCT00066937|749427|P1|NOT COMPLETED|6 Month Follow-up||7
305926|NCT00066937|749424|P4|COMPLETED|6 Month Follow-up||14
305927|NCT00066937|749425|P3|COMPLETED|6 Month Follow-up||22
305928|NCT00066937|749426|P2|COMPLETED|6 Month Follow-up||29
305929|NCT00066937|749427|P1|COMPLETED|6 Month Follow-up||26
305930|NCT00066937|749424|P4|STARTED|6 Month Follow-up||15
305931|NCT00066937|749425|P3|STARTED|6 Month Follow-up||25
305932|NCT00066937|749426|P2|STARTED|6 Month Follow-up||32
305933|NCT00066937|749427|P1|STARTED|6 Month Follow-up||33
305934|NCT00066937|749424|P4|NOT COMPLETED|3 Month Follow-up||4
305935|NCT00066937|749425|P3|NOT COMPLETED|3 Month Follow-up||1
305936|NCT00066937|749426|P2|NOT COMPLETED|3 Month Follow-up||1
305937|NCT00066937|749427|P1|NOT COMPLETED|3 Month Follow-up||5
305938|NCT00066937|749424|P4|COMPLETED|3 Month Follow-up||15
305939|NCT00066937|749425|P3|COMPLETED|3 Month Follow-up||25
305940|NCT00066937|749426|P2|COMPLETED|3 Month Follow-up||32
305941|NCT00066937|749427|P1|COMPLETED|3 Month Follow-up||33
305942|NCT00066937|749424|P4|STARTED|3 Month Follow-up||19
305943|NCT00066937|749425|P3|STARTED|3 Month Follow-up||26
305944|NCT00066937|749426|P2|STARTED|3 Month Follow-up||33
305945|NCT00066937|749427|P1|STARTED|3 Month Follow-up||38
305946|NCT00066937|749424|P4|NOT COMPLETED|Treatment Phase||5
305947|NCT00066937|749425|P3|NOT COMPLETED|Treatment Phase||11
305948|NCT00066937|749426|P2|NOT COMPLETED|Treatment Phase||5
305949|NCT00066937|749427|P1|NOT COMPLETED|Treatment Phase||3
305950|NCT00066937|749424|P4|COMPLETED|Treatment Phase||19
305951|NCT00066937|749425|P3|COMPLETED|Treatment Phase||26
305952|NCT00066937|749426|P2|COMPLETED|Treatment Phase||33
305953|NCT00066937|749427|P1|COMPLETED|Treatment Phase||38
305954|NCT00066937|749424|P4|STARTED|Treatment Phase||24
305955|NCT00066937|749425|P3|STARTED|Treatment Phase||37
305956|NCT00066937|749426|P2|STARTED|Treatment Phase||38
305957|NCT00066937|749427|P1|STARTED|Treatment Phase||41
305958|NCT00066807|749451|P2|NOT COMPLETED|Overall Study||15
305959|NCT00066807|749452|P1|NOT COMPLETED|Overall Study||14
305960|NCT00066807|749451|P2|COMPLETED|Overall Study||0
305961|NCT00066807|749452|P1|COMPLETED|Overall Study||0
305962|NCT00066807|749451|P2|STARTED|Overall Study||15
305963|NCT00066807|749452|P1|STARTED|Overall Study||14
305964|NCT00066781|749466|P2|NOT COMPLETED|Overall Study||0
305965|NCT00066781|749467|P1|NOT COMPLETED|Overall Study||0
305966|NCT00066781|749466|P2|COMPLETED|Overall Study||17
305967|NCT00066781|749467|P1|COMPLETED|Overall Study||14
305968|NCT00066781|749466|P2|STARTED|Overall Study||17
305969|NCT00066781|749467|P1|STARTED|Overall Study||14
305970|NCT00066742|749477|P1|NOT COMPLETED|Consolidation Chemotherapy||3
305971|NCT00066742|749477|P1|COMPLETED|Consolidation Chemotherapy||39
305972|NCT00066742|749477|P1|Eligible|Consolidation Chemotherapy||40
305973|NCT00066742|749477|P1|STARTED|Consolidation Chemotherapy||42
305974|NCT00066742|749477|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
305975|NCT00066742|749477|P1|COMPLETED|Induction Chemoradiotherapy||43
305976|NCT00066742|749477|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
305977|NCT00066742|749477|P1|Eligible|Induction Chemoradiotherapy||69
305978|NCT00066742|749477|P1|STARTED|Induction Chemoradiotherapy||72
305979|NCT00066703|749486|P2|NOT COMPLETED|Overall Study||582
305980|NCT00066703|749487|P1|NOT COMPLETED|Overall Study||612
305981|NCT00066703|749486|P2|COMPLETED|Overall Study||756
305982|NCT00066703|749487|P1|COMPLETED|Overall Study||722
305983|NCT00066703|749486|P2|STARTED|Overall Study||1338
305984|NCT00066703|749487|P1|STARTED|Overall Study||1334
305985|NCT00066690|749500|P3|NOT COMPLETED|Overall Study||564
305986|NCT00066690|749501|P2|NOT COMPLETED|Overall Study||522
305987|NCT00066690|749502|P1|NOT COMPLETED|Overall Study||598
305988|NCT00066690|749500|P3|COMPLETED|Overall Study||457
305989|NCT00066690|749501|P2|COMPLETED|Overall Study||502
305990|NCT00066690|749502|P1|COMPLETED|Overall Study||423
305991|NCT00066690|749500|P3|STARTED|Overall Study||1021
305992|NCT00066690|749501|P2|STARTED|Overall Study||1024
305993|NCT00066690|749502|P1|STARTED|Overall Study||1021
305994|NCT00066573|749518|P2|NOT COMPLETED|Overall Study||28
305995|NCT00066573|749519|P1|NOT COMPLETED|Overall Study||28
305996|NCT00066573|749518|P2|COMPLETED|Overall Study||3759
305997|NCT00066573|749519|P1|COMPLETED|Overall Study||3761
305998|NCT00066573|749518|P2|STARTED|Overall Study||3787
305999|NCT00066573|749519|P1|STARTED|Overall Study||3789
306000|NCT00066469|749531|P1|NOT COMPLETED|Overall Study||16
306001|NCT00066469|749531|P1|COMPLETED|Overall Study||39
306002|NCT00066469|749531|P1|STARTED|Overall Study||55
306003|NCT00066365|749537|P2|NOT COMPLETED|Overall Study||14
306004|NCT00066365|749538|P1|NOT COMPLETED|Overall Study||23
306005|NCT00066365|749537|P2|COMPLETED|Overall Study||4
306006|NCT00066365|749538|P1|COMPLETED|Overall Study||8
306007|NCT00066365|749537|P2|STARTED|Overall Study||18
306008|NCT00066365|749538|P1|STARTED|Overall Study||31
306009|NCT00066222|749566|P1|NOT COMPLETED|Overall Study||1
306010|NCT00066222|749566|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
306011|NCT00066222|749566|P1|STARTED|Overall Study||72
306012|NCT00066170|749579|P4|NOT COMPLETED|Overall Study||9
306013|NCT00066170|749580|P3|NOT COMPLETED|Overall Study||4
306014|NCT00066170|749581|P2|NOT COMPLETED|Overall Study||10
306015|NCT00066170|749582|P1|NOT COMPLETED|Overall Study||7
306016|NCT00066170|749579|P4|COMPLETED|Overall Study||48
306017|NCT00066170|749580|P3|COMPLETED|Overall Study||59
306018|NCT00066170|749581|P2|COMPLETED|Overall Study||45
306019|NCT00066170|749582|P1|COMPLETED|Overall Study||49
306020|NCT00066170|749579|P4|Intent to Treat|Overall Study||54
306021|NCT00066170|749580|P3|Intent to Treat|Overall Study||63
306022|NCT00066170|749581|P2|Intent to Treat|Overall Study||50
306023|NCT00066170|749582|P1|Intent to Treat|Overall Study||55
306024|NCT00066170|749579|P4|STARTED|Overall Study||57
306025|NCT00066170|749580|P3|STARTED|Overall Study||63
306026|NCT00066170|749581|P2|STARTED|Overall Study||55
306027|NCT00066170|749582|P1|STARTED|Overall Study||56
306028|NCT00066066|749595|P6|NOT COMPLETED|Overall Study||5
306029|NCT00066066|749596|P5|NOT COMPLETED|Overall Study||3
306030|NCT00066066|749597|P4|NOT COMPLETED|Overall Study||4
306031|NCT00066066|749598|P3|NOT COMPLETED|Overall Study||7
306032|NCT00066066|749599|P2|NOT COMPLETED|Overall Study||4
306033|NCT00066066|749600|P1|NOT COMPLETED|Overall Study||6
306034|NCT00066066|749595|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
306035|NCT00066066|749596|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
306036|NCT00066066|749597|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
306037|NCT00066066|749598|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
306038|NCT00066066|749599|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
306039|NCT00066066|749600|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
306040|NCT00066066|749595|P6|12 Month|Overall Study||9
306041|NCT00066066|749596|P5|12 Month|Overall Study||19
306042|NCT00066066|749597|P4|12 Month|Overall Study||11
306043|NCT00066066|749598|P3|12 Month|Overall Study||21
306044|NCT00066066|749599|P2|12 Month|Overall Study||11
306045|NCT00066066|749600|P1|12 Month|Overall Study||18
306046|NCT00066066|749595|P6|6 Month|Overall Study||14
306047|NCT00066066|749596|P5|6 Month|Overall Study||21
306048|NCT00066066|749597|P4|6 Month|Overall Study||13
306049|NCT00066066|749598|P3|6 Month|Overall Study||23
306050|NCT00066066|749599|P2|6 Month|Overall Study||13
306051|NCT00066066|749600|P1|6 Month|Overall Study||19
306052|NCT00066066|749595|P6|3 Month|Overall Study||15
306053|NCT00066066|749596|P5|3 Month|Overall Study||22
306054|NCT00066066|749597|P4|3 Month|Overall Study||16
306055|NCT00066066|749598|P3|3 Month|Overall Study||23
306056|NCT00066066|749599|P2|3 Month|Overall Study||17
306057|NCT00066066|749600|P1|3 Month|Overall Study||21
306058|NCT00066066|749595|P6|Baseline|Overall Study||20
306059|NCT00066066|749596|P5|Baseline|Overall Study||27
306060|NCT00066066|749597|P4|Baseline|Overall Study||20
306061|NCT00066066|749598|P3|Baseline|Overall Study||30
306062|NCT00066066|749599|P2|Baseline|Overall Study||22
306063|NCT00066066|749600|P1|Baseline|Overall Study||27
306064|NCT00066066|749595|P6|STARTED|Overall Study||20
306065|NCT00066066|749596|P5|STARTED|Overall Study||27
306066|NCT00066066|749597|P4|STARTED|Overall Study||20
306067|NCT00066066|749598|P3|STARTED|Overall Study||30
306068|NCT00066066|749599|P2|STARTED|Overall Study||22
306069|NCT00066066|749600|P1|STARTED|Overall Study||27
306070|NCT00065806|749616|P2|NOT COMPLETED|Overall Study||19
306071|NCT00065806|749617|P1|NOT COMPLETED|Overall Study||20
306072|NCT00065806|749616|P2|COMPLETED|Overall Study||89
306073|NCT00065806|749617|P1|COMPLETED|Overall Study||93
306074|NCT00065806|749616|P2|STARTED|Overall Study||108
306075|NCT00065806|749617|P1|STARTED|Overall Study||113
306076|NCT00014560|749659|P1|NOT COMPLETED|Overall Study||3
306077|NCT00014560|749659|P1|COMPLETED|Overall Study||0
306078|NCT00014560|749659|P1|STARTED|Overall Study||3
306079|NCT00065611|749665|P2|NOT COMPLETED|Overall Study||1
306080|NCT00065611|749666|P1|NOT COMPLETED|Overall Study||0
306081|NCT00065611|749665|P2|COMPLETED|Overall Study||3
306082|NCT00065611|749666|P1|COMPLETED|Overall Study||4
306083|NCT00065611|749665|P2|STARTED|Overall Study||4
306084|NCT00065611|749666|P1|STARTED|Overall Study||4
306085|NCT00065507|749678|P2|NOT COMPLETED|Overall Study||29
306086|NCT00065507|749679|P1|NOT COMPLETED|Overall Study||29
306087|NCT00065507|749678|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
306088|NCT00065507|749679|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
306089|NCT00065507|749678|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
306090|NCT00065507|749679|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
306091|NCT00065507|749678|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
306092|NCT00065507|749679|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
306093|NCT00065507|749678|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
306094|NCT00065507|749679|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
306095|NCT00065507|749678|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
306096|NCT00065507|749679|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
306097|NCT00065507|749678|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
306098|NCT00065507|749679|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
306099|NCT00065468|749744|P3|NOT COMPLETED|Overall Study||210
306100|NCT00065468|749745|P2|NOT COMPLETED|Overall Study||209
306101|NCT00065468|749746|P1|NOT COMPLETED|Overall Study||207
306102|NCT00065468|749744|P3|COMPLETED|Overall Study||0
306103|NCT00065468|749745|P2|COMPLETED|Overall Study||0
306104|NCT00065468|749746|P1|COMPLETED|Overall Study||0
306105|NCT00065468|749744|P3|Received Treatment|Overall Study||208
306106|NCT00065468|749745|P2|Received Treatment|Overall Study||208
306107|NCT00065468|749746|P1|Received Treatment|Overall Study||200
306108|NCT00065468|749744|P3|STARTED|Overall Study||210
306109|NCT00065468|749745|P2|STARTED|Overall Study||209
306110|NCT00065468|749746|P1|STARTED|Overall Study||207
306111|NCT00065442|749777|P2|NOT COMPLETED|Overall Study||220
306112|NCT00065442|749778|P1|NOT COMPLETED|Overall Study||125
306113|NCT00065442|749777|P2|COMPLETED|Overall Study||121
306114|NCT00065442|749778|P1|COMPLETED|Overall Study||46
306115|NCT00065442|749777|P2|STARTED|Overall Study||341
306116|NCT00065442|749778|P1|STARTED|Overall Study||171
306117|NCT00065429|749793|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306118|NCT00065429|749794|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306119|NCT00065429|749795|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
306120|NCT00065429|749796|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306121|NCT00065429|749797|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306122|NCT00065429|749798|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306123|NCT00065429|749799|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306124|NCT00065429|749793|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306125|NCT00065429|749794|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306126|NCT00065429|749795|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
306127|NCT00065429|749796|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306128|NCT00065429|749797|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306129|NCT00065429|749798|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306130|NCT00065429|749799|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
306131|NCT00065429|749793|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
306132|NCT00065429|749794|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
306133|NCT00065429|749795|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
306134|NCT00065429|749796|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
306135|NCT00065429|749797|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
306136|NCT00065429|749798|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
306137|NCT00065429|749799|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
306138|NCT00065429|749793|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
306139|NCT00065429|749794|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
306140|NCT00065429|749795|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
306141|NCT00065429|749796|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
306142|NCT00065429|749797|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
306143|NCT00065429|749798|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
306144|NCT00065429|749799|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
306145|NCT00065429|749793|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
306146|NCT00065429|749794|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
306147|NCT00065429|749795|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
306148|NCT00065429|749796|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
306149|NCT00065429|749797|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
306150|NCT00065429|749798|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
306151|NCT00065429|749799|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
306152|NCT00065429|749793|P7|STARTED|Phase I - May 2001 - Oct 2002||4
306153|NCT00065429|749794|P6|STARTED|Phase I - May 2001 - Oct 2002||4
306154|NCT00065429|749795|P5|STARTED|Phase I - May 2001 - Oct 2002||9
306155|NCT00065429|749796|P4|STARTED|Phase I - May 2001 - Oct 2002||4
306156|NCT00065429|749797|P3|STARTED|Phase I - May 2001 - Oct 2002||4
306157|NCT00065429|749798|P2|STARTED|Phase I - May 2001 - Oct 2002||3
306158|NCT00065429|749799|P1|STARTED|Phase I - May 2001 - Oct 2002||4
306159|NCT00065260|749813|P2|NOT COMPLETED|Overall Study||1
306160|NCT00065260|749814|P1|NOT COMPLETED|Overall Study||0
306161|NCT00065260|749813|P2|COMPLETED|Overall Study||26
306162|NCT00065260|749814|P1|COMPLETED|Overall Study||27
306163|NCT00065260|749813|P2|STARTED|Overall Study||27
306164|NCT00065260|749814|P1|STARTED|Overall Study||27
306165|NCT00065156|749820|P1|NOT COMPLETED|Overall Study||124
306166|NCT00065156|749820|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
306167|NCT00065156|749820|P1|Modified Intent to Treat Population|Overall Study||94
306168|NCT00065156|749820|P1|STARTED|Overall Study||148
306169|NCT00065065|749837|P2|NOT COMPLETED|Overall Study||20
306170|NCT00065065|749838|P1|NOT COMPLETED|Overall Study||10
306171|NCT00065065|749837|P2|COMPLETED|Overall Study||33
306172|NCT00065065|749838|P1|COMPLETED|Overall Study||42
306173|NCT00065065|749837|P2|STARTED|Overall Study||53
306174|NCT00065065|749838|P1|STARTED|Overall Study||52
306175|NCT00003895|749850|P2|NOT COMPLETED|Overall Study||4
306176|NCT00003895|749851|P1|NOT COMPLETED|Overall Study||7
306177|NCT00003895|749850|P2|COMPLETED|Overall Study||14
306178|NCT00003895|749851|P1|COMPLETED|Overall Study||11
306179|NCT00003895|749850|P2|STARTED|Overall Study||18
306180|NCT00003895|749851|P1|STARTED|Overall Study||18
306181|NCT00064987|749859|P2|NOT COMPLETED|Overall Study||0
306182|NCT00064987|749860|P1|NOT COMPLETED|Overall Study||3
306183|NCT00064987|749859|P2|COMPLETED|Overall Study||6
306184|NCT00064987|749860|P1|COMPLETED|Overall Study||7
306185|NCT00064987|749859|P2|STARTED|Overall Study||6
306186|NCT00064987|749860|P1|STARTED|Overall Study||10
306187|NCT00064844|749880|P2|NOT COMPLETED|Overall Study||19
306188|NCT00064844|749881|P1|NOT COMPLETED|Overall Study||8
306189|NCT00064844|749880|P2|COMPLETED|Overall Study||32
306190|NCT00064844|749881|P1|COMPLETED|Overall Study||37
306191|NCT00064844|749880|P2|12 Month Follow-up|Overall Study||32
306192|NCT00064844|749881|P1|12 Month Follow-up|Overall Study||37
306193|NCT00064844|749880|P2|6 Month Follow-up|Overall Study||40
306194|NCT00064844|749881|P1|6 Month Follow-up|Overall Study||39
306195|NCT00064844|749880|P2|3 Month Follow-up|Overall Study||47
306196|NCT00064844|749881|P1|3 Month Follow-up|Overall Study||40
306197|NCT00064844|749880|P2|2 Week Follow-up|Overall Study||51
306198|NCT00064844|749881|P1|2 Week Follow-up|Overall Study||45
306199|NCT00064844|749880|P2|STARTED|Overall Study||51
306200|NCT00064844|749881|P1|STARTED|Overall Study||45
306201|NCT00064753|749891|P2|NOT COMPLETED|Overall Study||648
306202|NCT00064753|749892|P1|NOT COMPLETED|Overall Study||674
306203|NCT00064753|749891|P2|COMPLETED|Overall Study||1406
306204|NCT00064753|749892|P1|COMPLETED|Overall Study||1382
306205|NCT00064753|749891|P2|STARTED|Overall Study||2054
306206|NCT00064753|749892|P1|STARTED|Overall Study||2056
306207|NCT00064792|749922|P2|NOT COMPLETED|Overall Study||0
306208|NCT00064792|749923|P1|NOT COMPLETED|Overall Study||5
306209|NCT00064792|749922|P2|COMPLETED|Overall Study||10
306210|NCT00064792|749923|P1|COMPLETED|Overall Study||8
306211|NCT00064792|749922|P2|STARTED|Overall Study||10
306212|NCT00064792|749923|P1|STARTED|Overall Study||13
306213|NCT00064701|749934|P3|NOT COMPLETED|Clinical Continuation Phase||140
306214|NCT00064701|749935|P2|NOT COMPLETED|Clinical Continuation Phase||178
306215|NCT00064701|749936|P1|NOT COMPLETED|Clinical Continuation Phase||170
306216|NCT00064701|749934|P3|COMPLETED|Clinical Continuation Phase||11
306217|NCT00064701|749935|P2|COMPLETED|Clinical Continuation Phase||4
306218|NCT00064701|749936|P1|COMPLETED|Clinical Continuation Phase||9
306219|NCT00064701|749934|P3|STARTED|Clinical Continuation Phase||151
306220|NCT00064701|749935|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
306221|NCT00064701|749936|P1|STARTED|Clinical Continuation Phase||179
306222|NCT00064701|749934|P3|NOT COMPLETED|One Year Post-transplant||72
306223|NCT00064701|749935|P2|NOT COMPLETED|One Year Post-transplant||43
306224|NCT00064701|749936|P1|NOT COMPLETED|One Year Post-transplant||40
306225|NCT00064701|749934|P3|COMPLETED|One Year Post-transplant||151
306226|NCT00064701|749935|P2|COMPLETED|One Year Post-transplant||183
306227|NCT00064701|749936|P1|COMPLETED|One Year Post-transplant||179
306228|NCT00064701|749934|P3|Received Study Drug|One Year Post-transplant||212
306229|NCT00064701|749935|P2|Received Study Drug|One Year Post-transplant||214
306230|NCT00064701|749936|P1|Received Study Drug|One Year Post-transplant||212
306231|NCT00064701|749934|P3|STARTED|One Year Post-transplant||223
306232|NCT00064701|749935|P2|STARTED|One Year Post-transplant||226
306233|NCT00064701|749936|P1|STARTED|One Year Post-transplant||219
306234|NCT00064662|749988|P2|NOT COMPLETED|Overall Study||61
306235|NCT00064662|749989|P1|NOT COMPLETED|Overall Study||74
306236|NCT00064662|749988|P2|COMPLETED|Overall Study||265
306237|NCT00064662|749989|P1|COMPLETED|Overall Study||255
306238|NCT00064662|749988|P2|STARTED|Overall Study||326
306239|NCT00064662|749989|P1|STARTED|Overall Study||329
306240|NCT00064350|750000|P3|NOT COMPLETED|Cross-Over||0
306241|NCT00064350|750001|P2|NOT COMPLETED|Cross-Over||14
306242|NCT00064350|750002|P1|NOT COMPLETED|Cross-Over||6
306243|NCT00064350|750000|P3|COMPLETED|Cross-Over||0
306244|NCT00064350|750001|P2|COMPLETED|Cross-Over||13
306245|NCT00064350|750002|P1|COMPLETED|Cross-Over||4
306246|NCT00064350|750000|P3|Eligible and Treated|Cross-Over||0
306247|NCT00064350|750001|P2|Eligible and Treated|Cross-Over||21
306248|NCT00064350|750002|P1|Eligible and Treated|Cross-Over||7
306249|NCT00064350|750000|P3|Treated|Cross-Over||0
306250|NCT00064350|750001|P2|Treated|Cross-Over||26
306251|NCT00064350|750002|P1|Treated|Cross-Over||9
306252|NCT00064350|750000|P3|STARTED|Cross-Over||0
306253|NCT00064350|750001|P2|STARTED|Cross-Over||27
306254|NCT00064350|750002|P1|STARTED|Cross-Over||10
306255|NCT00064350|750000|P3|NOT COMPLETED|Randomization||0
306256|NCT00064350|750001|P2|NOT COMPLETED|Randomization||18
306257|NCT00064350|750002|P1|NOT COMPLETED|Randomization||26
306258|NCT00064350|750000|P3|COMPLETED|Randomization||0
306259|NCT00064350|750001|P2|COMPLETED|Randomization||28
306260|NCT00064350|750002|P1|COMPLETED|Randomization||33
306261|NCT00064350|750000|P3|Eligible and Treated|Randomization||0
306262|NCT00064350|750001|P2|Eligible and Treated|Randomization||31
306263|NCT00064350|750002|P1|Eligible and Treated|Randomization||50
306264|NCT00064350|750000|P3|Treated|Randomization||0
306265|NCT00064350|750001|P2|Treated|Randomization||40
306266|NCT00064350|750002|P1|Treated|Randomization||55
306267|NCT00064350|750000|P3|STARTED|Randomization||0
306268|NCT00064350|750001|P2|STARTED|Randomization||46
306269|NCT00064350|750002|P1|STARTED|Randomization||59
306270|NCT00064350|750000|P3|NOT COMPLETED|Induction Treatment||236
306271|NCT00064350|750001|P2|NOT COMPLETED|Induction Treatment||9
306272|NCT00064350|750002|P1|NOT COMPLETED|Induction Treatment||8
306273|NCT00064350|750000|P3|COMPLETED|Induction Treatment||1
306274|NCT00064350|750001|P2|COMPLETED|Induction Treatment||37
306275|NCT00064350|750002|P1|COMPLETED|Induction Treatment||51
306276|NCT00064350|750000|P3|Eligible and Treated|Induction Treatment||194
306277|NCT00064350|750001|P2|Eligible and Treated|Induction Treatment||46
306278|NCT00064350|750002|P1|Eligible and Treated|Induction Treatment||59
306279|NCT00064350|750000|P3|Treated|Induction Treatment||228
306280|NCT00064350|750001|P2|Treated|Induction Treatment||46
306281|NCT00064350|750002|P1|Treated|Induction Treatment||59
306282|NCT00064350|750000|P3|STARTED|Induction Treatment||237
306283|NCT00064350|750001|P2|STARTED|Induction Treatment||46
306284|NCT00064350|750002|P1|STARTED|Induction Treatment||59
306285|NCT00064337|750017|P1|NOT COMPLETED|Maintenance||10
306286|NCT00064337|750017|P1|COMPLETED|Maintenance||3
306287|NCT00064337|750017|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
306288|NCT00064337|750017|P1|NOT COMPLETED|Transplant||21
306289|NCT00064337|750017|P1|COMPLETED|Transplant||46
306290|NCT00064337|750017|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
306291|NCT00064337|750017|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
306292|NCT00064337|750017|P1|COMPLETED|PBSCC or Induction/PBSCC||73
306293|NCT00064337|750017|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
306294|NCT00064298|750026|P2|NOT COMPLETED|Overall Study||5
306295|NCT00064298|750027|P1|NOT COMPLETED|Overall Study||6
306296|NCT00064298|750026|P2|COMPLETED|Overall Study||57
306297|NCT00064298|750027|P1|COMPLETED|Overall Study||66
306298|NCT00064298|750026|P2|STARTED|Overall Study||62
306299|NCT00064298|750027|P1|STARTED|Overall Study||72
306300|NCT00064259|750035|P4|NOT COMPLETED|Overall Study||1
306301|NCT00064259|750036|P3|NOT COMPLETED|Overall Study||0
306302|NCT00064259|750037|P2|NOT COMPLETED|Overall Study||0
306303|NCT00064259|750038|P1|NOT COMPLETED|Overall Study||1
306304|NCT00064259|750035|P4|COMPLETED|Overall Study||0
306305|NCT00064259|750036|P3|COMPLETED|Overall Study||6
306306|NCT00064259|750037|P2|COMPLETED|Overall Study||4
306307|NCT00064259|750038|P1|COMPLETED|Overall Study||3
306308|NCT00064259|750035|P4|STARTED|Overall Study||1
306309|NCT00064259|750036|P3|STARTED|Overall Study||6
306310|NCT00064259|750037|P2|STARTED|Overall Study||4
306311|NCT00064259|750038|P1|STARTED|Overall Study||4
306312|NCT00064038|750044|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
306313|NCT00064038|750045|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
306314|NCT00064038|750046|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
306315|NCT00064038|750044|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
306316|NCT00064038|750045|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
306317|NCT00064038|750046|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
306318|NCT00064038|750044|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
306319|NCT00064038|750045|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
306320|NCT00064038|750046|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
306321|NCT00064038|750044|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
306322|NCT00064038|750045|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
306323|NCT00064038|750046|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
306324|NCT00064038|750044|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
306325|NCT00064038|750045|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
306326|NCT00064038|750046|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
306327|NCT00064038|750044|P3|NOT COMPLETED|Initial Randomization||0
306328|NCT00064038|750045|P2|NOT COMPLETED|Initial Randomization||98
306329|NCT00064038|750046|P1|NOT COMPLETED|Initial Randomization||100
306330|NCT00064038|750044|P3|COMPLETED|Initial Randomization||0
306331|NCT00064038|750045|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
306332|NCT00064038|750046|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
306333|NCT00064038|750044|P3|Safety Population|Initial Randomization||0
306334|NCT00064038|750045|P2|Safety Population|Initial Randomization||94
306335|NCT00064038|750046|P1|Safety Population|Initial Randomization||96
306336|NCT00064038|750044|P3|Eligible and Analyzable|Initial Randomization||0
306337|NCT00064038|750045|P2|Eligible and Analyzable|Initial Randomization||95
306338|NCT00064038|750046|P1|Eligible and Analyzable|Initial Randomization||97
306339|NCT00064038|750044|P3|STARTED|Initial Randomization||0
306340|NCT00064038|750045|P2|STARTED|Initial Randomization||98
306341|NCT00064038|750046|P1|STARTED|Initial Randomization||100
306342|NCT00064025|750056|P1|NOT COMPLETED|Overall Study||7
306343|NCT00064025|750056|P1|COMPLETED|Overall Study||68
306344|NCT00064025|750056|P1|STARTED|Overall Study||75
306345|NCT00063999|750065|P2|NOT COMPLETED|Overall Study||24
306346|NCT00063999|750066|P1|NOT COMPLETED|Overall Study||45
306347|NCT00063999|750065|P2|COMPLETED|Overall Study||665
306348|NCT00063999|750066|P1|COMPLETED|Overall Study||647
306349|NCT00063999|750065|P2|STARTED|Overall Study||689
306350|NCT00063999|750066|P1|STARTED|Overall Study||692
306351|NCT00063986|750082|P1|NOT COMPLETED|Overall Study||6
306352|NCT00063986|750082|P1|COMPLETED|Overall Study||104
306353|NCT00063986|750082|P1|Eligible and Treated|Overall Study||104
306354|NCT00063986|750082|P1|Treated|Overall Study||105
306355|NCT00063986|750082|P1|STARTED|Overall Study||110
306356|NCT00063934|750094|P1|NOT COMPLETED|Overall Study||1
306357|NCT00063934|750094|P1|COMPLETED|Overall Study||30
306358|NCT00063934|750094|P1|STARTED|Overall Study||31
306359|NCT00063635|750103|P3|NOT COMPLETED|Overall Study||9
306360|NCT00063635|750104|P2|NOT COMPLETED|Overall Study||8
306361|NCT00063635|750105|P1|NOT COMPLETED|Overall Study||6
306362|NCT00063635|750103|P3|COMPLETED|Overall Study||49
306363|NCT00063635|750104|P2|COMPLETED|Overall Study||50
306364|NCT00063635|750105|P1|COMPLETED|Overall Study||51
306365|NCT00063635|750103|P3|STARTED|Overall Study||58
306366|NCT00063635|750104|P2|STARTED|Overall Study||58
306367|NCT00063635|750105|P1|STARTED|Overall Study||57
306368|NCT00063622|750146|P3|NOT COMPLETED|Overall Study||11
306369|NCT00063622|750147|P2|NOT COMPLETED|Overall Study||4
306370|NCT00063622|750148|P1|NOT COMPLETED|Overall Study||10
306371|NCT00063622|750146|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
306372|NCT00063622|750147|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
306373|NCT00063622|750148|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
306374|NCT00063622|750146|P3|STARTED|Overall Study||83
306375|NCT00063622|750147|P2|STARTED|Overall Study||84
306376|NCT00063622|750148|P1|STARTED|Overall Study||80
306377|NCT00063570|750173|P2|NOT COMPLETED|Overall Study||0
306378|NCT00063570|750174|P1|NOT COMPLETED|Overall Study||0
306379|NCT00063570|750173|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
306380|NCT00063570|750174|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
306381|NCT00063570|750173|P2|STARTED|Overall Study||21
306382|NCT00063570|750174|P1|STARTED|Overall Study||52
306383|NCT00063362|750190|P2|NOT COMPLETED|Overall Study||4
306384|NCT00063362|750191|P1|NOT COMPLETED|Overall Study||4
306385|NCT00063362|750190|P2|COMPLETED|Overall Study||22
306386|NCT00063362|750191|P1|COMPLETED|Overall Study||19
306387|NCT00063362|750190|P2|STARTED|Overall Study||26
306388|NCT00063362|750191|P1|STARTED|Overall Study||23
306389|NCT00063258|750199|P2|NOT COMPLETED|Overall Study||0
306390|NCT00063258|750200|P1|NOT COMPLETED|Overall Study||4
306391|NCT00063258|750199|P2|COMPLETED|Overall Study||0
306392|NCT00063258|750200|P1|COMPLETED|Overall Study||1
306393|NCT00063258|750199|P2|STARTED|Overall Study||0
306394|NCT00063258|750200|P1|STARTED|Overall Study||5
306395|NCT00063154|750206|P1|NOT COMPLETED|Overall Study||51
306396|NCT00063154|750206|P1|COMPLETED|Overall Study||0
306397|NCT00063154|750206|P1|STARTED|Overall Study||51
306398|NCT00063232|750213|P1|NOT COMPLETED|Overall Study||0
306399|NCT00063232|750213|P1|COMPLETED|Overall Study||26
306400|NCT00063232|750213|P1|STARTED|Overall Study||26
306401|NCT00062764|750219|P1|NOT COMPLETED|Overall Study||0
306402|NCT00062764|750219|P1|COMPLETED|Overall Study||18
306403|NCT00062764|750219|P1|STARTED|Overall Study||18
306404|NCT00062751|750232|P5|NOT COMPLETED|Overall Study||6
306405|NCT00062751|750233|P4|NOT COMPLETED|Overall Study||5
306406|NCT00062751|750234|P3|NOT COMPLETED|Overall Study||30
306407|NCT00062751|750235|P2|NOT COMPLETED|Overall Study||30
306408|NCT00062751|750236|P1|NOT COMPLETED|Overall Study||33
306409|NCT00062751|750232|P5|COMPLETED|Overall Study||0
306410|NCT00062751|750233|P4|COMPLETED|Overall Study||1
306411|NCT00062751|750234|P3|COMPLETED|Overall Study||3
306412|NCT00062751|750235|P2|COMPLETED|Overall Study||0
306413|NCT00062751|750236|P1|COMPLETED|Overall Study||0
306414|NCT00062751|750232|P5|STARTED|Overall Study||6
306415|NCT00062751|750233|P4|STARTED|Overall Study||6
306416|NCT00062751|750234|P3|STARTED|Overall Study||33
306417|NCT00062751|750235|P2|STARTED|Overall Study||30
306418|NCT00062751|750236|P1|STARTED|Overall Study||33
306419|NCT00062738|750307|P3|NOT COMPLETED|Overall Study||0
306420|NCT00062738|750308|P2|NOT COMPLETED|Overall Study||0
306421|NCT00062738|750309|P1|NOT COMPLETED|Overall Study||0
306422|NCT00062738|750307|P3|COMPLETED|Overall Study||17
306423|NCT00062738|750308|P2|COMPLETED|Overall Study||18
306424|NCT00062738|750309|P1|COMPLETED|Overall Study||17
306425|NCT00062738|750307|P3|STARTED|Overall Study||17
306426|NCT00062738|750308|P2|STARTED|Overall Study||18
306427|NCT00062738|750309|P1|STARTED|Overall Study||17
306428|NCT00062647|750322|P2|NOT COMPLETED|Overall Study||13
306429|NCT00062647|750323|P1|NOT COMPLETED|Overall Study||16
306430|NCT00062647|750322|P2|COMPLETED|Overall Study||17
306431|NCT00062647|750323|P1|COMPLETED|Overall Study||14
306432|NCT00062647|750322|P2|STARTED|Overall Study||30
306433|NCT00062647|750323|P1|STARTED|Overall Study||30
306434|NCT00062439|750329|P1|NOT COMPLETED|Consolidation Chemotherapy||2
306435|NCT00062439|750329|P1|COMPLETED|Consolidation Chemotherapy||20
306436|NCT00062439|750329|P1|STARTED|Consolidation Chemotherapy||22
306437|NCT00062439|750329|P1|NOT COMPLETED|Surgery||7
306438|NCT00062439|750329|P1|COMPLETED|Surgery||22
306439|NCT00062439|750329|P1|STARTED|Surgery||29
306440|NCT00062439|750329|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
306441|NCT00062439|750329|P1|COMPLETED|Post Chemoradiation Assessment||29
306442|NCT00062439|750329|P1|STARTED|Post Chemoradiation Assessment||38
306443|NCT00062439|750329|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
306444|NCT00062439|750329|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
306445|NCT00062439|750329|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
306446|NCT00062374|750341|P1|NOT COMPLETED|Overall Study||12
306447|NCT00062374|750341|P1|COMPLETED|Overall Study||43
306448|NCT00062374|750341|P1|STARTED|Overall Study||55
306449|NCT00062010|750346|P1|NOT COMPLETED|Overall Study||3
306450|NCT00062010|750346|P1|COMPLETED|Overall Study||34
306451|NCT00062010|750346|P1|Eligible and Treated|Overall Study||34
306452|NCT00062010|750346|P1|STARTED|Overall Study||37
306453|NCT00061945|750354|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
306454|NCT00061945|750355|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
306455|NCT00061945|750354|P2|COMPLETED|Course IV: Alemtuzumab||50
306456|NCT00061945|750355|P1|COMPLETED|Course IV: Alemtuzumab||18
306457|NCT00061945|750354|P2|STARTED|Course IV: Alemtuzumab||66
306458|NCT00061945|750355|P1|STARTED|Course IV: Alemtuzumab||25
306459|NCT00061945|750354|P2|NOT COMPLETED|Registration Through Course 3||115
306460|NCT00061945|750355|P1|NOT COMPLETED|Registration Through Course 3||94
306461|NCT00061945|750354|P2|COMPLETED|Registration Through Course 3||66
306462|NCT00061945|750355|P1|COMPLETED|Registration Through Course 3||25
306463|NCT00061945|750354|P2|STARTED|Registration Through Course 3||181
306464|NCT00061945|750355|P1|STARTED|Registration Through Course 3||119
306465|NCT00061932|750365|P2|NOT COMPLETED|Overall Study||4
306466|NCT00061932|750366|P1|NOT COMPLETED|Overall Study||13
306467|NCT00061932|750365|P2|COMPLETED|Overall Study||8
306468|NCT00061932|750366|P1|COMPLETED|Overall Study||16
306469|NCT00061932|750365|P2|STARTED|Overall Study||12
306470|NCT00061932|750366|P1|STARTED|Overall Study||29
306471|NCT00061893|750372|P1|NOT COMPLETED|Overall Study||18
306472|NCT00061893|750372|P1|COMPLETED|Overall Study||20
306473|NCT00061893|750372|P1|STARTED|Overall Study||38
306474|NCT00061633|750379|P2|NOT COMPLETED|Overall Study||11
306475|NCT00061633|750380|P1|NOT COMPLETED|Overall Study||5
306476|NCT00061633|750379|P2|COMPLETED|Overall Study||74
306477|NCT00061633|750380|P1|COMPLETED|Overall Study||79
306478|NCT00061633|750379|P2|STARTED|Overall Study||85
306479|NCT00061633|750380|P1|STARTED|Overall Study||84
306480|NCT00061373|750388|P2|NOT COMPLETED|Overall Study||0
306481|NCT00061373|750389|P1|NOT COMPLETED|Overall Study||0
306482|NCT00061373|750388|P2|COMPLETED|Overall Study||3
306483|NCT00061373|750389|P1|COMPLETED|Overall Study||15
306484|NCT00061373|750388|P2|Aspirin and Tinzaparin|Overall Study||3
306485|NCT00061373|750389|P1|Aspirin and Tinzaparin|Overall Study||15
306486|NCT00061373|750388|P2|STARTED|Overall Study||3
306487|NCT00061373|750389|P1|STARTED|Overall Study||15
306488|NCT00061048|750405|P1|NOT COMPLETED|Overall Study||22
306489|NCT00061048|750405|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
306490|NCT00061048|750405|P1|STARTED|Overall Study||29
306491|NCT00060944|750415|P2|NOT COMPLETED|Overall Study||134
306492|NCT00060944|750416|P1|NOT COMPLETED|Overall Study||136
306493|NCT00060944|750415|P2|COMPLETED|Overall Study||0
306494|NCT00060944|750416|P1|COMPLETED|Overall Study||0
306495|NCT00060944|750415|P2|Treated|Overall Study||130
306496|NCT00060944|750416|P1|Treated|Overall Study||130
306497|NCT00060944|750415|P2|STARTED|Overall Study||134
306498|NCT00060944|750416|P1|STARTED|Overall Study||136
306499|NCT00060840|750432|P2|NOT COMPLETED|Overall Study||9
306500|NCT00060840|750433|P1|NOT COMPLETED|Overall Study||4
306501|NCT00060840|750432|P2|COMPLETED|Overall Study||68
306502|NCT00060840|750433|P1|COMPLETED|Overall Study||69
306503|NCT00060840|750432|P2|STARTED|Overall Study||77
306504|NCT00060840|750433|P1|STARTED|Overall Study||73
306505|NCT00060528|750439|P4|NOT COMPLETED|Overall Study||0
306506|NCT00060528|750440|P3|NOT COMPLETED|Overall Study||0
306507|NCT00060528|750441|P2|NOT COMPLETED|Overall Study||0
306508|NCT00060528|750442|P1|NOT COMPLETED|Overall Study||0
306509|NCT00060528|750439|P4|COMPLETED|Overall Study||8
306510|NCT00060528|750440|P3|COMPLETED|Overall Study||7
306511|NCT00060528|750441|P2|COMPLETED|Overall Study||9
306512|NCT00060528|750442|P1|COMPLETED|Overall Study||8
306513|NCT00060528|750439|P4|STARTED|Overall Study||8
306514|NCT00060528|750440|P3|STARTED|Overall Study||7
306515|NCT00060528|750441|P2|STARTED|Overall Study||9
306516|NCT00060528|750442|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
306517|NCT00060424|750456|P1|NOT COMPLETED|Overall Study||0
306518|NCT00060424|750456|P1|COMPLETED|Overall Study||21
306519|NCT00060424|750456|P1|STARTED|Overall Study||21
306520|NCT00060346|750464|P1|NOT COMPLETED|Overall Study||0
306521|NCT00060346|750464|P1|COMPLETED|Overall Study||16
306522|NCT00060346|750464|P1|Eligible and Treated|Overall Study||16
306523|NCT00060346|750464|P1|STARTED|Overall Study||16
306524|NCT00060333|750468|P1|NOT COMPLETED|Overall Study||0
306525|NCT00060333|750468|P1|COMPLETED|Overall Study||20
306526|NCT00060333|750468|P1|STARTED|Overall Study||20
306527|NCT00060008|750479|P1|NOT COMPLETED|Overall Study||0
306528|NCT00060008|750479|P1|COMPLETED|Overall Study||18
306529|NCT00060008|750479|P1|STARTED|Overall Study||18
306530|NCT00059839|750486|P2|NOT COMPLETED|Overall Study||17
306531|NCT00059839|750487|P1|NOT COMPLETED|Overall Study||12
306532|NCT00059839|750486|P2|COMPLETED|Overall Study||47
306533|NCT00059839|750487|P1|COMPLETED|Overall Study||53
306534|NCT00059839|750486|P2|STARTED|Overall Study||64
306535|NCT00059839|750487|P1|STARTED|Overall Study||65
306536|NCT00059787|750493|P1|NOT COMPLETED|Overall Study||20
306537|NCT00059787|750493|P1|COMPLETED|Overall Study||36
306538|NCT00059787|750493|P1|STARTED|Overall Study||56
306539|NCT00059475|750509|P8|NOT COMPLETED|Overall Study||0
306540|NCT00059475|750510|P7|NOT COMPLETED|Overall Study||0
306541|NCT00059475|750511|P6|NOT COMPLETED|Overall Study||0
306542|NCT00059475|750512|P5|NOT COMPLETED|Overall Study||0
306543|NCT00059475|750513|P4|NOT COMPLETED|Overall Study||0
306544|NCT00059475|750514|P3|NOT COMPLETED|Overall Study||0
306545|NCT00059475|750515|P2|NOT COMPLETED|Overall Study||0
306546|NCT00059475|750516|P1|NOT COMPLETED|Overall Study||0
306547|NCT00059475|750509|P8|COMPLETED|Overall Study||7
306548|NCT00059475|750510|P7|COMPLETED|Overall Study||34
306549|NCT00059475|750511|P6|COMPLETED|Overall Study||2
306550|NCT00059475|750512|P5|COMPLETED|Overall Study||33
306551|NCT00059475|750513|P4|COMPLETED|Overall Study||3
306552|NCT00059475|750514|P3|COMPLETED|Overall Study||24
306553|NCT00059475|750515|P2|COMPLETED|Overall Study||2
306554|NCT00059475|750516|P1|COMPLETED|Overall Study||33
306555|NCT00059475|750509|P8|STARTED|Overall Study||7
306556|NCT00059475|750510|P7|STARTED|Overall Study||34
306557|NCT00059475|750511|P6|STARTED|Overall Study||2
306558|NCT00059475|750512|P5|STARTED|Overall Study||33
306559|NCT00059475|750513|P4|STARTED|Overall Study||3
306560|NCT00059475|750514|P3|STARTED|Overall Study||24
306561|NCT00059475|750515|P2|STARTED|Overall Study||2
306562|NCT00059475|750516|P1|STARTED|Overall Study||33
306563|NCT00059332|750544|P2|NOT COMPLETED|Overall Study||2
306564|NCT00059332|750545|P1|NOT COMPLETED|Overall Study||3
306565|NCT00059332|750544|P2|COMPLETED|Overall Study||855
306566|NCT00059332|750545|P1|COMPLETED|Overall Study||840
306567|NCT00059332|750544|P2|STARTED|Overall Study||857
306568|NCT00059332|750545|P1|STARTED|Overall Study||843
306569|NCT00059215|750571|P4|NOT COMPLETED|Overall Study||15
306570|NCT00059215|750572|P3|NOT COMPLETED|Overall Study||15
306571|NCT00059215|750573|P2|NOT COMPLETED|Overall Study||14
306572|NCT00059215|750574|P1|NOT COMPLETED|Overall Study||13
306573|NCT00059215|750571|P4|COMPLETED|Overall Study||239
306574|NCT00059215|750572|P3|COMPLETED|Overall Study||236
306575|NCT00059215|750573|P2|COMPLETED|Overall Study||186
306576|NCT00059215|750574|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
306577|NCT00059215|750571|P4|STARTED|Overall Study||254
306578|NCT00059215|750572|P3|STARTED|Overall Study||251
306579|NCT00059215|750573|P2|STARTED|Overall Study||200
306580|NCT00059215|750574|P1|STARTED|Overall Study||200
306581|NCT00058825|750600|P1|NOT COMPLETED|Overall Study||22
306582|NCT00058825|750600|P1|COMPLETED|Overall Study||5
306583|NCT00058825|750600|P1|STARTED|Overall Study||27
306584|NCT00058552|750616|P2|NOT COMPLETED|Overall Study||62
306585|NCT00058552|750617|P1|NOT COMPLETED|Overall Study||65
306586|NCT00058552|750616|P2|COMPLETED|Overall Study||2
306587|NCT00058552|750617|P1|COMPLETED|Overall Study||0
306588|NCT00058552|750616|P2|STARTED|Overall Study||64
306589|NCT00058552|750617|P1|STARTED|Overall Study||65
306590|NCT00058539|750635|P1|NOT COMPLETED|Overall Study||42
306591|NCT00058539|750635|P1|COMPLETED|Overall Study||0
306592|NCT00058539|750635|P1|STARTED|Overall Study||42
306593|NCT00058240|750649|P4|NOT COMPLETED|Second Dose Level||0
306594|NCT00058240|750650|P3|NOT COMPLETED|Second Dose Level||0
306595|NCT00058240|750651|P2|NOT COMPLETED|Second Dose Level||0
306596|NCT00058240|750652|P1|NOT COMPLETED|Second Dose Level||0
306597|NCT00058240|750649|P4|COMPLETED|Second Dose Level||4
306598|NCT00058240|750650|P3|COMPLETED|Second Dose Level||2
306599|NCT00058240|750651|P2|COMPLETED|Second Dose Level||0
306600|NCT00058240|750652|P1|COMPLETED|Second Dose Level||0
306601|NCT00058240|750649|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
306602|NCT00058240|750650|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
306603|NCT00058240|750651|P2|STARTED|Second Dose Level||0
306604|NCT00058240|750652|P1|STARTED|Second Dose Level||0
306605|NCT00058240|750649|P4|NOT COMPLETED|First Dose Level||0
306606|NCT00058240|750650|P3|NOT COMPLETED|First Dose Level||0
306607|NCT00058240|750651|P2|NOT COMPLETED|First Dose Level||0
306608|NCT00058240|750652|P1|NOT COMPLETED|First Dose Level||0
306609|NCT00058240|750649|P4|COMPLETED|First Dose Level||12
306610|NCT00058240|750650|P3|COMPLETED|First Dose Level||17
306611|NCT00058240|750651|P2|COMPLETED|First Dose Level||3
306612|NCT00058240|750652|P1|COMPLETED|First Dose Level||20
306613|NCT00058240|750649|P4|Treated|First Dose Level||12
306614|NCT00058240|750650|P3|Treated|First Dose Level||17
306615|NCT00058240|750651|P2|Treated|First Dose Level||3
306616|NCT00058240|750652|P1|Treated|First Dose Level||20
306617|NCT00058240|750649|P4|STARTED|First Dose Level||12
306618|NCT00058240|750650|P3|STARTED|First Dose Level||17
306619|NCT00058240|750651|P2|STARTED|First Dose Level||3
306620|NCT00058240|750652|P1|STARTED|First Dose Level||20
306621|NCT00058214|750662|P1|NOT COMPLETED|Overall Study||1
306622|NCT00058214|750662|P1|COMPLETED|Overall Study||24
306623|NCT00058214|750662|P1|STARTED|Overall Study||25
306624|NCT00058019|750669|P2|NOT COMPLETED|Overall Study||0
306625|NCT00058019|750670|P1|NOT COMPLETED|Overall Study||0
306626|NCT00058019|750669|P2|COMPLETED|Overall Study||12
306627|NCT00058019|750670|P1|COMPLETED|Overall Study||39
306628|NCT00058019|750669|P2|STARTED|Overall Study||12
306629|NCT00058019|750670|P1|STARTED|Overall Study||39
306630|NCT00057954|750683|P1|NOT COMPLETED|Overall Study||2
306631|NCT00057954|750683|P1|COMPLETED|Overall Study||4
306632|NCT00057954|750683|P1|STARTED|Overall Study||6
306633|NCT00057941|750691|P2|NOT COMPLETED|Overall Study||74
306634|NCT00057941|750692|P1|NOT COMPLETED|Overall Study||74
306635|NCT00057941|750691|P2|COMPLETED|Overall Study||0
306636|NCT00057941|750692|P1|COMPLETED|Overall Study||0
306637|NCT00057941|750691|P2|Eligible|Overall Study||69
306638|NCT00057941|750692|P1|Eligible|Overall Study||72
306639|NCT00057941|750691|P2|Treated|Overall Study||74
306640|NCT00057941|750692|P1|Treated|Overall Study||74
306641|NCT00057941|750691|P2|STARTED|Overall Study||74
306642|NCT00057941|750692|P1|STARTED|Overall Study||74
306643|NCT00057876|750700|P2|NOT COMPLETED|Overall Study||27
306644|NCT00057876|750701|P1|NOT COMPLETED|Overall Study||29
306645|NCT00057876|750700|P2|COMPLETED|Overall Study||9
306646|NCT00057876|750701|P1|COMPLETED|Overall Study||9
306647|NCT00057876|750700|P2|Eligible and Treated|Overall Study||34
306648|NCT00057876|750701|P1|Eligible and Treated|Overall Study||34
306649|NCT00057876|750700|P2|Began Protocol Therapy|Overall Study||34
306650|NCT00057876|750701|P1|Began Protocol Therapy|Overall Study||35
306651|NCT00057876|750700|P2|Eligible|Overall Study||34
306652|NCT00057876|750701|P1|Eligible|Overall Study||37
306653|NCT00057876|750700|P2|STARTED|Overall Study||36
306654|NCT00057876|750701|P1|STARTED|Overall Study||38
306655|NCT00057863|750711|P1|NOT COMPLETED|Overall Study||3
306656|NCT00057863|750711|P1|COMPLETED|Overall Study||32
306657|NCT00057863|750711|P1|STARTED|Overall Study||35
306658|NCT00057837|750720|P2|NOT COMPLETED|Overall Study||39
306659|NCT00057837|750721|P1|NOT COMPLETED|Overall Study||31
306660|NCT00057837|750720|P2|COMPLETED|Overall Study||31
306661|NCT00057837|750721|P1|COMPLETED|Overall Study||39
306662|NCT00057837|750720|P2|Patients With Response|Overall Study||38
306663|NCT00057837|750721|P1|Patients With Response|Overall Study||46
306664|NCT00057837|750720|P2|Eligible and Treated|Overall Study||66
306665|NCT00057837|750721|P1|Eligible and Treated|Overall Study||66
306666|NCT00057837|750720|P2|Treated|Overall Study||68
306667|NCT00057837|750721|P1|Treated|Overall Study||69
306668|NCT00057837|750720|P2|STARTED|Overall Study||70
306669|NCT00057837|750721|P1|STARTED|Overall Study||70
306670|NCT00057811|750733|P2|NOT COMPLETED|Overall Study||12
306671|NCT00057811|750734|P1|NOT COMPLETED|Overall Study||10
306672|NCT00057811|750733|P2|COMPLETED|Overall Study||34
306673|NCT00057811|750734|P1|COMPLETED|Overall Study||41
306674|NCT00057811|750733|P2|STARTED|Overall Study||46
306675|NCT00057811|750734|P1|STARTED|Overall Study||51
306676|NCT00057785|750746|P1|NOT COMPLETED|Overall Study||0
306677|NCT00057785|750746|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
306678|NCT00057785|750746|P1|STARTED|Overall Study||68
306679|NCT00057746|750753|P3|NOT COMPLETED|Overall Study||1
306680|NCT00057746|750754|P2|NOT COMPLETED|Overall Study||0
306681|NCT00057746|750755|P1|NOT COMPLETED|Overall Study||0
306682|NCT00057746|750753|P3|COMPLETED|Overall Study||66
306683|NCT00057746|750754|P2|COMPLETED|Overall Study||67
306684|NCT00057746|750755|P1|COMPLETED|Overall Study||131
306685|NCT00057746|750753|P3|STARTED|Overall Study||67
306686|NCT00057746|750754|P2|STARTED|Overall Study||67
306687|NCT00057746|750755|P1|STARTED|Overall Study||131
306688|NCT00023673|750766|P4|NOT COMPLETED|Overall Study||2
306689|NCT00023673|750767|P3|NOT COMPLETED|Overall Study||0
306690|NCT00023673|750768|P2|NOT COMPLETED|Overall Study||0
306691|NCT00023673|750769|P1|NOT COMPLETED|Overall Study||0
306692|NCT00023673|750766|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
306693|NCT00023673|750767|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
306694|NCT00023673|750768|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
306695|NCT00023673|750769|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
306696|NCT00023673|750766|P4|STARTED|Overall Study||46
306697|NCT00023673|750767|P3|STARTED|Overall Study||0
306698|NCT00023673|750768|P2|STARTED|Overall Study||9
306699|NCT00023673|750769|P1|STARTED|Overall Study||8
306700|NCT00057681|750785|P3|NOT COMPLETED|Overall Study||34
306701|NCT00057681|750786|P2|NOT COMPLETED|Overall Study||72
306702|NCT00057681|750787|P1|NOT COMPLETED|Overall Study||65
306703|NCT00057681|750785|P3|COMPLETED|Overall Study||69
306704|NCT00057681|750786|P2|COMPLETED|Overall Study||67
306705|NCT00057681|750787|P1|COMPLETED|Overall Study||72
306706|NCT00057681|750785|P3|STARTED|Overall Study||103
306707|NCT00057681|750786|P2|STARTED|Overall Study||139
306708|NCT00057681|750787|P1|STARTED|Overall Study||137
306709|NCT00057577|750803|P2|NOT COMPLETED|Overall Study||0
306710|NCT00057577|750804|P1|NOT COMPLETED|Overall Study||0
306711|NCT00057577|750803|P2|COMPLETED|Overall Study||225
306712|NCT00057577|750804|P1|COMPLETED|Overall Study||227
306713|NCT00057577|750803|P2|STARTED|Overall Study||225
306714|NCT00057577|750804|P1|STARTED|Overall Study||227
306715|NCT00057551|750821|P3|NOT COMPLETED|Overall Study||16
306716|NCT00057551|750822|P2|NOT COMPLETED|Overall Study||27
306717|NCT00057551|750823|P1|NOT COMPLETED|Overall Study||25
306718|NCT00057551|750821|P3|COMPLETED|Overall Study||80
306719|NCT00057551|750822|P2|COMPLETED|Overall Study||168
306720|NCT00057551|750823|P1|COMPLETED|Overall Study||175
306721|NCT00057551|750821|P3|STARTED|Overall Study||96
306722|NCT00057551|750822|P2|STARTED|Overall Study||195
306723|NCT00057551|750823|P1|STARTED|Overall Study||200
306724|NCT00057330|750833|P2|NOT COMPLETED|Overall Study||920
306725|NCT00057330|750834|P1|NOT COMPLETED|Overall Study||1132
306726|NCT00057330|750833|P2|COMPLETED|Overall Study||2826
306727|NCT00057330|750834|P1|COMPLETED|Overall Study||3445
306728|NCT00057330|750833|P2|STARTED|Overall Study||3746
306729|NCT00057330|750834|P1|STARTED|Overall Study||4577
306730|NCT00056862|750864|P2|NOT COMPLETED|Overall Study||0
306731|NCT00056862|750865|P1|NOT COMPLETED|Overall Study||1
306732|NCT00056862|750864|P2|COMPLETED|Overall Study||27
306733|NCT00056862|750865|P1|COMPLETED|Overall Study||30
306734|NCT00056862|750864|P2|STARTED|Overall Study||27
306735|NCT00056862|750865|P1|STARTED|Overall Study||31
306736|NCT00056563|750881|P2|NOT COMPLETED|Overall Study||0
306737|NCT00056563|750882|P1|NOT COMPLETED|Overall Study||0
306738|NCT00056563|750881|P2|COMPLETED|Overall Study||134
306739|NCT00056563|750882|P1|COMPLETED|Overall Study||121
306740|NCT00056563|750881|P2|STARTED|Overall Study||134
306741|NCT00056563|750882|P1|STARTED|Overall Study||121
306742|NCT00056550|750890|P1|NOT COMPLETED|Overall Study||0
306743|NCT00056550|750890|P1|COMPLETED|Overall Study||14
306744|NCT00056550|750890|P1|STARTED|Overall Study||14
306745|NCT00056498|750897|P2|NOT COMPLETED|Overall Study||7
306746|NCT00056498|750898|P1|NOT COMPLETED|Overall Study||5
306747|NCT00056498|750897|P2|COMPLETED|Overall Study||28
306748|NCT00056498|750898|P1|COMPLETED|Overall Study||25
306749|NCT00056498|750897|P2|STARTED|Overall Study||35
306750|NCT00056498|750898|P1|STARTED|Overall Study||30
306751|NCT00056472|750910|P2|NOT COMPLETED|Overall Study||69
306752|NCT00056472|750911|P1|NOT COMPLETED|Overall Study||48
306753|NCT00056472|750910|P2|COMPLETED|Overall Study||61
306754|NCT00056472|750911|P1|COMPLETED|Overall Study||81
306755|NCT00056472|750910|P2|STARTED|Overall Study||130
306756|NCT00056472|750911|P1|STARTED|Overall Study||129
306757|NCT00056407|750923|P2|NOT COMPLETED|Overall Study||1193
306758|NCT00056407|750924|P1|NOT COMPLETED|Overall Study||1211
306759|NCT00056407|750923|P2|COMPLETED|Overall Study||2912
306760|NCT00056407|750924|P1|COMPLETED|Overall Study||2915
306761|NCT00056407|750923|P2|STARTED|Overall Study||4105
306762|NCT00056407|750924|P1|STARTED|Overall Study||4126
306763|NCT00056316|750982|P2|NOT COMPLETED|Overall Study||3
306764|NCT00056316|750983|P1|NOT COMPLETED|Overall Study||3
306765|NCT00056316|750982|P2|COMPLETED|Overall Study||38
306766|NCT00056316|750983|P1|COMPLETED|Overall Study||30
306767|NCT00056316|750982|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
306768|NCT00056316|750983|P1|STARTED|Overall Study||33
306769|NCT00056160|750997|P2|NOT COMPLETED|Final Follow-up||0
306770|NCT00056160|750998|P1|NOT COMPLETED|Final Follow-up||6
306771|NCT00056160|750997|P2|COMPLETED|Final Follow-up||0
306772|NCT00056160|750998|P1|COMPLETED|Final Follow-up||0
306773|NCT00056160|750997|P2|STARTED|Final Follow-up||0
306774|NCT00056160|750998|P1|STARTED|Final Follow-up||6
306775|NCT00056160|750997|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
306776|NCT00056160|750998|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
306777|NCT00056160|750997|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
306778|NCT00056160|750998|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
306779|NCT00056160|750997|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
306780|NCT00056160|750998|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
306781|NCT00056160|750997|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
306782|NCT00056160|750998|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
306783|NCT00056160|750997|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
306784|NCT00056160|750998|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
306785|NCT00056160|750997|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
306786|NCT00056160|750998|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
306787|NCT00055692|751010|P1|NOT COMPLETED|Overall Study||0
306788|NCT00055692|751010|P1|COMPLETED|Overall Study||46
306789|NCT00055692|751010|P1|STARTED|Overall Study||46
306790|NCT00055601|751021|P2|NOT COMPLETED|Overall Study||2
306791|NCT00055601|751022|P1|NOT COMPLETED|Overall Study||2
306792|NCT00055601|751021|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
306793|NCT00055601|751022|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
306794|NCT00055601|751021|P2|STARTED|Overall Study||49
306795|NCT00055601|751022|P1|STARTED|Overall Study||48
306796|NCT00055497|751036|P4|NOT COMPLETED|Overall Study||90
306797|NCT00055497|751037|P3|NOT COMPLETED|Overall Study||2
306798|NCT00055497|751038|P2|NOT COMPLETED|Overall Study||3
306799|NCT00055497|751039|P1|NOT COMPLETED|Overall Study||5
306800|NCT00055497|751036|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
306801|NCT00055497|751037|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
306802|NCT00055497|751038|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
306803|NCT00055497|751039|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
306804|NCT00055497|751036|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
306805|NCT00055497|751037|P3|STARTED|Overall Study||18
306806|NCT00055497|751038|P2|STARTED|Overall Study||19
306807|NCT00055497|751039|P1|STARTED|Overall Study||18
306808|NCT00055471|751084|P3|NOT COMPLETED|Period 2: Extension Period||0
306809|NCT00055471|751085|P2|NOT COMPLETED|Period 2: Extension Period||0
306810|NCT00055471|751086|P1|NOT COMPLETED|Period 2: Extension Period||0
306811|NCT00055471|751084|P3|COMPLETED|Period 2: Extension Period||0
306812|NCT00055471|751085|P2|COMPLETED|Period 2: Extension Period||6
306813|NCT00055471|751086|P1|COMPLETED|Period 2: Extension Period||3
306814|NCT00055471|751084|P3|STARTED|Period 2: Extension Period||0
306815|NCT00055471|751085|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
306816|NCT00055471|751086|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
306817|NCT00055471|751084|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
306818|NCT00055471|751085|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
306819|NCT00055471|751086|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
306820|NCT00055471|751084|P3|COMPLETED|Period 1: Dose Escalation Period||0
306821|NCT00055471|751085|P2|COMPLETED|Period 1: Dose Escalation Period||8
306822|NCT00055471|751086|P1|COMPLETED|Period 1: Dose Escalation Period||3
306823|NCT00055471|751084|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
306824|NCT00055471|751085|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
306825|NCT00055471|751086|P1|STARTED|Period 1: Dose Escalation Period||3
306826|NCT00055237|751114|P2|NOT COMPLETED|Overall Study||0
306827|NCT00055237|751115|P1|NOT COMPLETED|Overall Study||0
306828|NCT00055237|751114|P2|COMPLETED|Overall Study||2
306829|NCT00055237|751115|P1|COMPLETED|Overall Study||17
306830|NCT00055237|751114|P2|STARTED|Overall Study||2
306831|NCT00055237|751115|P1|STARTED|Overall Study||17
306832|NCT00054847|751122|P2|NOT COMPLETED|Overall Study||100
306833|NCT00054847|751123|P1|NOT COMPLETED|Overall Study||98
306834|NCT00054847|751122|P2|COMPLETED|Overall Study||266
306835|NCT00054847|751123|P1|COMPLETED|Overall Study||269
306836|NCT00054847|751122|P2|STARTED|Overall Study||366
306837|NCT00054847|751123|P1|STARTED|Overall Study||367
306838|NCT00054717|751137|P2|NOT COMPLETED|Overall Study||299
306839|NCT00054717|751138|P1|NOT COMPLETED|Overall Study||262
306840|NCT00054717|751137|P2|COMPLETED|Overall Study||18
306841|NCT00054717|751138|P1|COMPLETED|Overall Study||51
306842|NCT00054717|751137|P2|STARTED|Overall Study||317
306843|NCT00054717|751138|P1|STARTED|Overall Study||313
306844|NCT00054704|751326|P2|NOT COMPLETED|Overall Study||5
306845|NCT00054704|751327|P1|NOT COMPLETED|Overall Study||5
306846|NCT00054704|751326|P2|COMPLETED|Overall Study||6
306847|NCT00054704|751327|P1|COMPLETED|Overall Study||4
306848|NCT00054704|751326|P2|STARTED|Overall Study||11
306849|NCT00054704|751327|P1|STARTED|Overall Study||9
306850|NCT00054691|751333|P1|NOT COMPLETED|Overall Study||3
306851|NCT00054691|751333|P1|COMPLETED|Overall Study||37
306852|NCT00054691|751333|P1|STARTED|Overall Study||40
306853|NCT00054665|751338|P2|NOT COMPLETED|Part B||0
306854|NCT00054665|751339|P1|NOT COMPLETED|Part B||0
306855|NCT00054665|751338|P2|COMPLETED|Part B||44
306856|NCT00054665|751339|P1|COMPLETED|Part B||0
306857|NCT00054665|751338|P2|STARTED|Part B|26 participants received only Part B|44
306858|NCT00054665|751339|P1|STARTED|Part B||0
306859|NCT00054665|751338|P2|NOT COMPLETED|Part A||0
306860|NCT00054665|751339|P1|NOT COMPLETED|Part A||0
306861|NCT00054665|751338|P2|COMPLETED|Part A||0
306862|NCT00054665|751339|P1|COMPLETED|Part A||23
306863|NCT00054665|751338|P2|STARTED|Part A||0
306864|NCT00054665|751339|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
306865|NCT00054639|751347|P1|NOT COMPLETED|Overall Study||2
306866|NCT00054639|751347|P1|COMPLETED|Overall Study||46
306867|NCT00054639|751347|P1|STARTED|Overall Study||48
306868|NCT00054353|751353|P2|NOT COMPLETED|Overall Study||0
306869|NCT00054353|751354|P1|NOT COMPLETED|Overall Study||0
306870|NCT00054353|751353|P2|COMPLETED|Overall Study||4
306871|NCT00054353|751354|P1|COMPLETED|Overall Study||12
306872|NCT00054353|751353|P2|STARTED|Overall Study||4
306873|NCT00054353|751354|P1|STARTED|Overall Study||12
306874|NCT00054327|751380|P6|NOT COMPLETED|Overall Study||0
306875|NCT00054327|751381|P5|NOT COMPLETED|Overall Study||0
306876|NCT00054327|751382|P4|NOT COMPLETED|Overall Study||0
306877|NCT00054327|751383|P3|NOT COMPLETED|Overall Study||0
306878|NCT00054327|751384|P2|NOT COMPLETED|Overall Study||0
306879|NCT00054327|751385|P1|NOT COMPLETED|Overall Study||1
306880|NCT00054327|751380|P6|COMPLETED|Overall Study||2
306881|NCT00054327|751381|P5|COMPLETED|Overall Study||10
306882|NCT00054327|751382|P4|COMPLETED|Overall Study||4
306883|NCT00054327|751383|P3|COMPLETED|Overall Study||3
306884|NCT00054327|751384|P2|COMPLETED|Overall Study||4
306885|NCT00054327|751385|P1|COMPLETED|Overall Study||10
306886|NCT00054327|751380|P6|STARTED|Overall Study||2
306887|NCT00054327|751381|P5|STARTED|Overall Study||10
306888|NCT00054327|751382|P4|STARTED|Overall Study||4
306889|NCT00054327|751383|P3|STARTED|Overall Study||3
306890|NCT00054327|751384|P2|STARTED|Overall Study||4
306891|NCT00054327|751385|P1|STARTED|Overall Study||11
306892|NCT00054275|751423|P1|NOT COMPLETED|Overall Study||11
306893|NCT00054275|751423|P1|COMPLETED|Overall Study||28
306894|NCT00054275|751423|P1|STARTED|Overall Study||39
306895|NCT00054132|751429|P1|NOT COMPLETED|Overall Study||1
306896|NCT00054132|751429|P1|COMPLETED|Overall Study||37
306897|NCT00054132|751429|P1|STARTED|Overall Study||38
306898|NCT00054028|751440|P1|NOT COMPLETED|Overall Study||0
306899|NCT00054028|751440|P1|COMPLETED|Overall Study||31
306900|NCT00054028|751440|P1|Phase II|Overall Study||22
306901|NCT00054028|751440|P1|Phase I|Overall Study||9
306902|NCT00054028|751440|P1|STARTED|Overall Study||31
306903|NCT00053898|751448|P2|NOT COMPLETED|Overall Study||13
306904|NCT00053898|751449|P1|NOT COMPLETED|Overall Study||14
306905|NCT00053898|751448|P2|COMPLETED|Overall Study||1539
306906|NCT00053898|751449|P1|COMPLETED|Overall Study||1538
306907|NCT00053898|751448|P2|STARTED|Overall Study||1552
306908|NCT00053898|751449|P1|STARTED|Overall Study||1552
306909|NCT00053846|751473|P2|NOT COMPLETED|Overall Study||27
306910|NCT00053846|751474|P1|NOT COMPLETED|Overall Study||26
306911|NCT00053846|751473|P2|COMPLETED|Overall Study||192
306912|NCT00053846|751474|P1|COMPLETED|Overall Study||187
306913|NCT00053846|751473|P2|STARTED|Overall Study||219
306914|NCT00053846|751474|P1|STARTED|Overall Study||213
306915|NCT00053703|751483|P3|NOT COMPLETED|Overall Study||15
306916|NCT00053703|751484|P2|NOT COMPLETED|Overall Study||13
306917|NCT00053703|751485|P1|NOT COMPLETED|Overall Study||18
306918|NCT00053703|751483|P3|COMPLETED|Overall Study||25
306919|NCT00053703|751484|P2|COMPLETED|Overall Study||28
306920|NCT00053703|751485|P1|COMPLETED|Overall Study||17
306921|NCT00053703|751483|P3|STARTED|Overall Study||40
306922|NCT00053703|751484|P2|STARTED|Overall Study||41
306923|NCT00053703|751485|P1|STARTED|Overall Study||35
306924|NCT00053677|751510|P2|NOT COMPLETED|Overall Study||6
306925|NCT00053677|751511|P1|NOT COMPLETED|Overall Study||22
306926|NCT00053677|751510|P2|COMPLETED|Overall Study||13
306927|NCT00053677|751511|P1|COMPLETED|Overall Study||36
306928|NCT00053677|751510|P2|STARTED|Overall Study||19
306929|NCT00053677|751511|P1|STARTED|Overall Study||58
306930|NCT00053495|751522|P5|NOT COMPLETED|Overall Study||0
306931|NCT00053495|751523|P4|NOT COMPLETED|Overall Study||0
306932|NCT00053495|751524|P3|NOT COMPLETED|Overall Study||0
306933|NCT00053495|751525|P2|NOT COMPLETED|Overall Study||0
306934|NCT00053495|751526|P1|NOT COMPLETED|Overall Study||0
306935|NCT00053495|751522|P5|COMPLETED|Overall Study||49
306936|NCT00053495|751523|P4|COMPLETED|Overall Study||51
306937|NCT00053495|751524|P3|COMPLETED|Overall Study||101
306938|NCT00053495|751525|P2|COMPLETED|Overall Study||101
306939|NCT00053495|751526|P1|COMPLETED|Overall Study||51
306940|NCT00053495|751522|P5|STARTED|Overall Study||49
306941|NCT00053495|751523|P4|STARTED|Overall Study||51
306942|NCT00053495|751524|P3|STARTED|Overall Study||101
306943|NCT00053495|751525|P2|STARTED|Overall Study||101
306944|NCT00053495|751526|P1|STARTED|Overall Study||51
306945|NCT00053482|751578|P5|NOT COMPLETED|Overall Study||0
306946|NCT00053482|751579|P4|NOT COMPLETED|Overall Study||0
306947|NCT00053482|751580|P3|NOT COMPLETED|Overall Study||0
306948|NCT00053482|751581|P2|NOT COMPLETED|Overall Study||0
306949|NCT00053482|751582|P1|NOT COMPLETED|Overall Study||0
306950|NCT00053482|751578|P5|COMPLETED|Overall Study||52
306951|NCT00053482|751579|P4|COMPLETED|Overall Study||50
306952|NCT00053482|751580|P3|COMPLETED|Overall Study||102
306953|NCT00053482|751581|P2|COMPLETED|Overall Study||102
306954|NCT00053482|751582|P1|COMPLETED|Overall Study||51
306955|NCT00053482|751578|P5|STARTED|Overall Study||52
306956|NCT00053482|751579|P4|STARTED|Overall Study||50
306957|NCT00053482|751580|P3|STARTED|Overall Study||102
306958|NCT00053482|751581|P2|STARTED|Overall Study||102
306959|NCT00053482|751582|P1|STARTED|Overall Study||51
306960|NCT00053417|751633|P4|NOT COMPLETED|Overall Study||6
306961|NCT00053417|751634|P3|NOT COMPLETED|Overall Study||1
306962|NCT00053417|751635|P2|NOT COMPLETED|Overall Study||2
306963|NCT00053417|751636|P1|NOT COMPLETED|Overall Study||2
306964|NCT00053417|751633|P4|COMPLETED|Overall Study||51
306965|NCT00053417|751634|P3|COMPLETED|Overall Study||49
306966|NCT00053417|751635|P2|COMPLETED|Overall Study||50
306967|NCT00053417|751636|P1|COMPLETED|Overall Study||45
306968|NCT00053417|751633|P4|STARTED|Overall Study||57
306969|NCT00053417|751634|P3|STARTED|Overall Study||50
306970|NCT00053417|751635|P2|STARTED|Overall Study||52
306971|NCT00053417|751636|P1|STARTED|Overall Study||47
306972|NCT00053365|751646|P1|NOT COMPLETED|Overall Study||6
306973|NCT00053365|751646|P1|COMPLETED|Overall Study||55
306974|NCT00053365|751646|P1|STARTED|Overall Study||61
306975|NCT00053352|751656|P2|NOT COMPLETED|Overall Study||10
306976|NCT00053352|751657|P1|NOT COMPLETED|Overall Study||21
306977|NCT00053352|751656|P2|COMPLETED|Overall Study||102
306978|NCT00053352|751657|P1|COMPLETED|Overall Study||169
306979|NCT00053352|751656|P2|STARTED|Overall Study||112
306980|NCT00053352|751657|P1|STARTED|Overall Study||190
306981|NCT00053014|751666|P1|NOT COMPLETED|Overall Study||0
306982|NCT00053014|751666|P1|COMPLETED|Overall Study||5
306983|NCT00053014|751666|P1|STARTED|Overall Study||5
306984|NCT00003830|751673|P2|NOT COMPLETED|Overall Study||793
306985|NCT00003830|751674|P1|NOT COMPLETED|Overall Study||832
306986|NCT00003830|751673|P2|COMPLETED|Overall Study||2011
306987|NCT00003830|751674|P1|COMPLETED|Overall Study||1975
306988|NCT00003830|751673|P2|STARTED|Overall Study||2804
306989|NCT00003830|751674|P1|STARTED|Overall Study||2807
306990|NCT00052962|751700|P2|NOT COMPLETED|Overall Study||2
306991|NCT00052962|751701|P1|NOT COMPLETED|Overall Study||1
306992|NCT00052962|751700|P2|COMPLETED|Overall Study||15
306993|NCT00052962|751701|P1|COMPLETED|Overall Study||12
306994|NCT00052962|751700|P2|STARTED|Overall Study||17
306995|NCT00052962|751701|P1|STARTED|Overall Study||13
306996|NCT00052715|751709|P1|NOT COMPLETED|Overall Study||1
306997|NCT00052715|751709|P1|COMPLETED|Overall Study||30
306998|NCT00052715|751709|P1|STARTED|Overall Study||31
306999|NCT00052429|751716|P1|NOT COMPLETED|Overall Study||0
307000|NCT00052429|751716|P1|COMPLETED|Overall Study||25
307001|NCT00052429|751716|P1|STARTED|Overall Study||25
307002|NCT00049543|751723|P2|NOT COMPLETED|Overall Study||9
307003|NCT00049543|751724|P1|NOT COMPLETED|Overall Study||2
307004|NCT00049543|751723|P2|COMPLETED|Overall Study||243
307005|NCT00049543|751724|P1|COMPLETED|Overall Study||249
307006|NCT00049543|751723|P2|STARTED|Overall Study||252
307007|NCT00049543|751724|P1|STARTED|Overall Study||251
307008|NCT00049530|751734|P1|NOT COMPLETED|Overall Study||32
307009|NCT00049530|751734|P1|COMPLETED|Overall Study||0
307010|NCT00049530|751734|P1|Eligible and Treated|Overall Study||29
307011|NCT00049530|751734|P1|STARTED|Overall Study||32
307012|NCT00049517|751743|P6|NOT COMPLETED|Conditioning/Transplant||6
307013|NCT00049517|751744|P5|NOT COMPLETED|Conditioning/Transplant||6
307014|NCT00049517|751745|P4|NOT COMPLETED|Conditioning/Transplant||43
307015|NCT00049517|751746|P3|NOT COMPLETED|Conditioning/Transplant||38
307016|NCT00049517|751747|P2|NOT COMPLETED|Conditioning/Transplant||50
307017|NCT00049517|751748|P1|NOT COMPLETED|Conditioning/Transplant||52
307018|NCT00049517|751743|P6|COMPLETED|Conditioning/Transplant||18
307019|NCT00049517|751744|P5|COMPLETED|Conditioning/Transplant||15
307020|NCT00049517|751745|P4|COMPLETED|Conditioning/Transplant||32
307021|NCT00049517|751746|P3|COMPLETED|Conditioning/Transplant||25
307022|NCT00049517|751747|P2|COMPLETED|Conditioning/Transplant||40
307023|NCT00049517|751748|P1|COMPLETED|Conditioning/Transplant||27
307024|NCT00049517|751743|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
307025|NCT00049517|751744|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
307026|NCT00049517|751745|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
307027|NCT00049517|751746|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
307028|NCT00049517|751747|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
307029|NCT00049517|751748|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
307030|NCT00049517|751743|P6|STARTED|Conditioning/Transplant||24
307031|NCT00049517|751744|P5|STARTED|Conditioning/Transplant||21
307032|NCT00049517|751745|P4|STARTED|Conditioning/Transplant||75
307033|NCT00049517|751746|P3|STARTED|Conditioning/Transplant||63
307034|NCT00049517|751747|P2|STARTED|Conditioning/Transplant||90
307035|NCT00049517|751748|P1|STARTED|Conditioning/Transplant||79
307036|NCT00049517|751743|P6|NOT COMPLETED|Induction||54
307037|NCT00049517|751744|P5|NOT COMPLETED|Induction||60
307038|NCT00049517|751745|P4|NOT COMPLETED|Induction||0
307039|NCT00049517|751746|P3|NOT COMPLETED|Induction||0
307040|NCT00049517|751747|P2|NOT COMPLETED|Induction||0
307041|NCT00049517|751748|P1|NOT COMPLETED|Induction||0
307042|NCT00049517|751743|P6|COMPLETED|Induction||108
307043|NCT00049517|751744|P5|COMPLETED|Induction||128
307044|NCT00049517|751745|P4|COMPLETED|Induction||75
307045|NCT00049517|751746|P3|COMPLETED|Induction||63
307046|NCT00049517|751747|P2|COMPLETED|Induction||90
307047|NCT00049517|751748|P1|COMPLETED|Induction||79
307048|NCT00049517|751743|P6|Treated|Induction||160
307049|NCT00049517|751744|P5|Treated|Induction||186
307050|NCT00049517|751745|P4|Treated|Induction||75
307051|NCT00049517|751746|P3|Treated|Induction||63
307052|NCT00049517|751747|P2|Treated|Induction||90
307053|NCT00049517|751748|P1|Treated|Induction||79
307054|NCT00049517|751743|P6|STARTED|Induction||162
307055|NCT00049517|751744|P5|STARTED|Induction||188
307056|NCT00049517|751745|P4|STARTED|Induction||75
307057|NCT00049517|751746|P3|STARTED|Induction||63
307058|NCT00049517|751747|P2|STARTED|Induction||90
307059|NCT00049517|751748|P1|STARTED|Induction||79
307060|NCT00049504|751758|P1|NOT COMPLETED|Overall Study||0
307061|NCT00049504|751758|P1|COMPLETED|Overall Study||55
307062|NCT00049504|751758|P1|STARTED|Overall Study||55
307063|NCT00049322|751766|P2|NOT COMPLETED|Overall Study||6
307064|NCT00049322|751767|P1|NOT COMPLETED|Overall Study||1
307065|NCT00049322|751766|P2|COMPLETED|Overall Study||9
307066|NCT00049322|751767|P1|COMPLETED|Overall Study||14
307067|NCT00049322|751766|P2|STARTED|Overall Study||15
307068|NCT00049322|751767|P1|STARTED|Overall Study||15
307069|NCT00049257|751779|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
307070|NCT00049257|751779|P1|COMPLETED|Follow-up Period for Survival Status||41
307071|NCT00049257|751779|P1|STARTED|Follow-up Period for Survival Status||45
307072|NCT00049257|751779|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
307073|NCT00049257|751779|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
307074|NCT00049257|751779|P1|STARTED|Carboplatin, Paclitaxel||58
307075|NCT00049127|751791|P5|NOT COMPLETED|Overall Study||0
307076|NCT00049127|751792|P4|NOT COMPLETED|Overall Study||0
307077|NCT00049127|751793|P3|NOT COMPLETED|Overall Study||1
307078|NCT00049127|751794|P2|NOT COMPLETED|Overall Study||0
307079|NCT00049127|751795|P1|NOT COMPLETED|Overall Study||0
307080|NCT00049127|751791|P5|COMPLETED|Overall Study||12
307081|NCT00049127|751792|P4|COMPLETED|Overall Study||0
307082|NCT00049127|751793|P3|COMPLETED|Overall Study||39
307083|NCT00049127|751794|P2|COMPLETED|Overall Study||0
307084|NCT00049127|751795|P1|COMPLETED|Overall Study||12
307085|NCT00049127|751791|P5|STARTED|Overall Study||12
307086|NCT00049127|751792|P4|STARTED|Overall Study||0
307087|NCT00049127|751793|P3|STARTED|Overall Study||40
307088|NCT00049127|751794|P2|STARTED|Overall Study||0
307089|NCT00049127|751795|P1|STARTED|Overall Study||12
307090|NCT00049036|751824|P2|NOT COMPLETED|Overall Study||0
307091|NCT00049036|751825|P1|NOT COMPLETED|Overall Study||0
307092|NCT00049036|751824|P2|COMPLETED|Overall Study||55
307093|NCT00049036|751825|P1|COMPLETED|Overall Study||51
307094|NCT00049036|751824|P2|STARTED|Overall Study||55
307095|NCT00049036|751825|P1|STARTED|Overall Study||51
307096|NCT00048997|751833|P2|NOT COMPLETED|Overall Study||3
307097|NCT00048997|751834|P1|NOT COMPLETED|Overall Study||13
307098|NCT00048997|751833|P2|COMPLETED|Overall Study||177
307099|NCT00048997|751834|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
307100|NCT00048997|751833|P2|STARTED|Overall Study||180
307101|NCT00048997|751834|P1|STARTED|Overall Study||176
307102|NCT00047385|751841|P2|NOT COMPLETED|Overall Study||500
307103|NCT00047385|751842|P1|NOT COMPLETED|Overall Study||267
307104|NCT00047385|751841|P2|COMPLETED|Overall Study||26232
307105|NCT00047385|751842|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
307106|NCT00047385|751841|P2|STARTED|Overall Study||26732
307107|NCT00047385|751842|P1|STARTED|Overall Study||26722
307108|NCT00047320|751860|P1|NOT COMPLETED|Overall Study||28
307109|NCT00047320|751860|P1|COMPLETED|Overall Study||76
307110|NCT00047320|751860|P1|STARTED|Overall Study||104
307111|NCT00047008|751871|P2|NOT COMPLETED|Overall Study||11
307112|NCT00047008|751872|P1|NOT COMPLETED|Overall Study||11
307113|NCT00047008|751871|P2|COMPLETED|Overall Study||360
307114|NCT00047008|751872|P1|COMPLETED|Overall Study||361
307115|NCT00047008|751871|P2|STARTED|Overall Study||371
307116|NCT00047008|751872|P1|STARTED|Overall Study||372
307117|NCT00046930|751880|P2|NOT COMPLETED|Overall Study||4
307118|NCT00046930|751881|P1|NOT COMPLETED|Overall Study||12
307119|NCT00046930|751880|P2|COMPLETED|Overall Study||221
307120|NCT00046930|751881|P1|COMPLETED|Overall Study||212
307121|NCT00046930|751880|P2|STARTED|Overall Study||225
307122|NCT00046930|751881|P1|STARTED|Overall Study||224
307123|NCT00046891|751896|P2|NOT COMPLETED|Overall Study||30
307124|NCT00046891|751897|P1|NOT COMPLETED|Overall Study||29
307125|NCT00046891|751896|P2|COMPLETED|Overall Study||83
307126|NCT00046891|751897|P1|COMPLETED|Overall Study||84
307127|NCT00046891|751896|P2|STARTED|Overall Study||113
307128|NCT00046891|751897|P1|STARTED|Overall Study||113
307129|NCT00046839|751917|P2|NOT COMPLETED|Overall Study||2
307130|NCT00046839|751918|P1|NOT COMPLETED|Overall Study||1
307131|NCT00046839|751917|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
307132|NCT00046839|751918|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
307133|NCT00046839|751917|P2|STARTED|Overall Study||13
307134|NCT00046839|751918|P1|STARTED|Overall Study||8
307135|NCT00045734|751925|P1|NOT COMPLETED|Overall Study||1
307136|NCT00045734|751925|P1|COMPLETED|Overall Study||22
307137|NCT00045734|751925|P1|STARTED|Overall Study||23
307138|NCT00045708|751940|P3|NOT COMPLETED|Phase 2||0
307139|NCT00045708|751941|P2|NOT COMPLETED|Phase 2||0
307140|NCT00045708|751942|P1|NOT COMPLETED|Phase 2||0
307141|NCT00045708|751940|P3|COMPLETED|Phase 2||19
307142|NCT00045708|751941|P2|COMPLETED|Phase 2||0
307143|NCT00045708|751942|P1|COMPLETED|Phase 2||0
307144|NCT00045708|751940|P3|STARTED|Phase 2||19
307145|NCT00045708|751941|P2|STARTED|Phase 2||0
307146|NCT00045708|751942|P1|STARTED|Phase 2||0
307147|NCT00045708|751940|P3|NOT COMPLETED|Phase 1||0
307148|NCT00045708|751941|P2|NOT COMPLETED|Phase 1||1
307149|NCT00045708|751942|P1|NOT COMPLETED|Phase 1||0
307150|NCT00045708|751940|P3|COMPLETED|Phase 1||0
307151|NCT00045708|751941|P2|COMPLETED|Phase 1||16
307152|NCT00045708|751942|P1|COMPLETED|Phase 1||21
307153|NCT00045708|751940|P3|STARTED|Phase 1||0
307154|NCT00045708|751941|P2|STARTED|Phase 1||17
307155|NCT00045708|751942|P1|STARTED|Phase 1||21
307156|NCT00045630|751967|P1|NOT COMPLETED|Overall Study||6
307157|NCT00045630|751967|P1|COMPLETED|Overall Study||71
307158|NCT00045630|751967|P1|Eligible and Began Protocol Therapy|Overall Study||74
307159|NCT00045630|751967|P1|Eligible|Overall Study||75
307160|NCT00045630|751967|P1|STARTED|Overall Study||77
307161|NCT00045487|751973|P1|NOT COMPLETED|Overall Study||11
307162|NCT00045487|751973|P1|COMPLETED|Overall Study||30
307163|NCT00045487|751973|P1|STARTED|Overall Study||41
307164|NCT00045435|751977|P1|NOT COMPLETED|Overall Study||0
307165|NCT00045435|751977|P1|COMPLETED|Overall Study||17
307166|NCT00045435|751977|P1|STARTED|Overall Study||17
307167|NCT00045305|751986|P1|NOT COMPLETED|Overall Study||14
307168|NCT00045305|751986|P1|COMPLETED|Overall Study||3
307169|NCT00045305|751986|P1|Eligible and Treated|Overall Study||17
307170|NCT00045305|751986|P1|STARTED|Overall Study||17
307171|NCT00045162|751997|P2|NOT COMPLETED|Overall Study||118
307172|NCT00045162|751998|P1|NOT COMPLETED|Overall Study||142
307173|NCT00045162|751997|P2|COMPLETED|Overall Study||217
307174|NCT00045162|751998|P1|COMPLETED|Overall Study||194
307175|NCT00045162|751997|P2|STARTED|Overall Study||335
307176|NCT00045162|751998|P1|STARTED|Overall Study||336
307177|NCT00045110|752013|P3|NOT COMPLETED|775mg Dose Escalation||0
307178|NCT00045110|752014|P2|NOT COMPLETED|775mg Dose Escalation||0
307179|NCT00045110|752015|P1|NOT COMPLETED|775mg Dose Escalation||0
307180|NCT00045110|752013|P3|COMPLETED|775mg Dose Escalation||0
307181|NCT00045110|752014|P2|COMPLETED|775mg Dose Escalation||0
307182|NCT00045110|752015|P1|COMPLETED|775mg Dose Escalation||7
307183|NCT00045110|752013|P3|STARTED|775mg Dose Escalation||0
307184|NCT00045110|752014|P2|STARTED|775mg Dose Escalation||0
307185|NCT00045110|752015|P1|STARTED|775mg Dose Escalation||7
307186|NCT00045110|752013|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
307187|NCT00045110|752014|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
307188|NCT00045110|752015|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
307189|NCT00045110|752013|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
307190|NCT00045110|752014|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
307191|NCT00045110|752015|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
307192|NCT00045110|752013|P3|STARTED|650mg Phase 1 Dose Escalation||0
307193|NCT00045110|752014|P2|STARTED|650mg Phase 1 Dose Escalation||0
307194|NCT00045110|752015|P1|STARTED|650mg Phase 1 Dose Escalation||6
307195|NCT00045110|752013|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
307196|NCT00045110|752014|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
307197|NCT00045110|752015|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
307198|NCT00045110|752013|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
307199|NCT00045110|752014|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
307200|NCT00045110|752015|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
307201|NCT00045110|752013|P3|STARTED|525mg Phase 1 Dose Escalation||0
307202|NCT00045110|752014|P2|STARTED|525mg Phase 1 Dose Escalation||0
307203|NCT00045110|752015|P1|STARTED|525mg Phase 1 Dose Escalation||3
307204|NCT00045110|752013|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
307205|NCT00045110|752014|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
307206|NCT00045110|752015|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
307207|NCT00045110|752013|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
307208|NCT00045110|752014|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
307209|NCT00045110|752015|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
307210|NCT00045110|752013|P3|STARTED|400mg Phase 1 Dose Escalation||0
307211|NCT00045110|752014|P2|STARTED|400mg Phase 1 Dose Escalation||0
307212|NCT00045110|752015|P1|STARTED|400mg Phase 1 Dose Escalation||3
307213|NCT00045110|752013|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
307214|NCT00045110|752014|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
307215|NCT00045110|752015|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
307216|NCT00045110|752013|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
307217|NCT00045110|752014|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
307218|NCT00045110|752015|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
307219|NCT00045110|752013|P3|STARTED|275mg Phase 1 Dose Escalation||0
307220|NCT00045110|752014|P2|STARTED|275mg Phase 1 Dose Escalation||0
307221|NCT00045110|752015|P1|STARTED|275mg Phase 1 Dose Escalation||3
307222|NCT00045110|752013|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
307223|NCT00045110|752014|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
307224|NCT00045110|752015|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
307225|NCT00045110|752013|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
307226|NCT00045110|752014|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
307227|NCT00045110|752015|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
307228|NCT00045110|752013|P3|STARTED|200mg Phase 1 Dose Escalation||0
307229|NCT00045110|752014|P2|STARTED|200mg Phase 1 Dose Escalation||0
307230|NCT00045110|752015|P1|STARTED|200mg Phase 1 Dose Escalation||4
307231|NCT00045110|752013|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
307232|NCT00045110|752014|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
307233|NCT00045110|752015|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
307234|NCT00045110|752013|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
307235|NCT00045110|752014|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
307236|NCT00045110|752015|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
307237|NCT00045110|752013|P3|STARTED|100mg Phase 1 Dose Escalalation||45
307238|NCT00045110|752014|P2|STARTED|100mg Phase 1 Dose Escalalation||59
307239|NCT00045110|752015|P1|STARTED|100mg Phase 1 Dose Escalalation||6
307240|NCT00045032|752064|P3|NOT COMPLETED|Overall Study||726
307241|NCT00045032|752065|P2|NOT COMPLETED|Overall Study||708
307242|NCT00045032|752066|P1|NOT COMPLETED|Overall Study||863
307243|NCT00045032|752064|P3|COMPLETED|Overall Study||974
307244|NCT00045032|752065|P2|COMPLETED|Overall Study||994
307245|NCT00045032|752066|P1|COMPLETED|Overall Study||834
307246|NCT00045032|752064|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
307247|NCT00045032|752065|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
307248|NCT00045032|752066|P1|Crossover to Adjuvant Herceptin|Overall Study||888
307249|NCT00045032|752064|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
307250|NCT00045032|752065|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
307251|NCT00045032|752066|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
307252|NCT00042991|752200|P7|NOT COMPLETED|Overall Study||2
307253|NCT00042991|752201|P6|NOT COMPLETED|Overall Study||5
307254|NCT00042991|752202|P5|NOT COMPLETED|Overall Study||3
307255|NCT00042991|752203|P4|NOT COMPLETED|Overall Study||2
307256|NCT00042991|752204|P3|NOT COMPLETED|Overall Study||6
307257|NCT00042991|752205|P2|NOT COMPLETED|Overall Study||40
307258|NCT00042991|752206|P1|NOT COMPLETED|Overall Study||6
307259|NCT00042991|752200|P7|COMPLETED|Overall Study||1
307260|NCT00042991|752201|P6|COMPLETED|Overall Study||0
307261|NCT00042991|752202|P5|COMPLETED|Overall Study||0
307262|NCT00042991|752203|P4|COMPLETED|Overall Study||0
307263|NCT00042991|752204|P3|COMPLETED|Overall Study||1
307264|NCT00042991|752205|P2|COMPLETED|Overall Study||3
307265|NCT00042991|752206|P1|COMPLETED|Overall Study||0
307266|NCT00042991|752200|P7|Phase-II Trial|Overall Study||0
307267|NCT00042991|752201|P6|Phase-II Trial|Overall Study||0
307268|NCT00042991|752202|P5|Phase-II Trial|Overall Study||0
307269|NCT00042991|752203|P4|Phase-II Trial|Overall Study||0
307270|NCT00042991|752204|P3|Phase-II Trial|Overall Study||0
307271|NCT00042991|752205|P2|Phase-II Trial|Overall Study||36
307272|NCT00042991|752206|P1|Phase-II Trial|Overall Study||0
307273|NCT00042991|752200|P7|Phase-I Trial|Overall Study||3
307274|NCT00042991|752201|P6|Phase-I Trial|Overall Study||5
307275|NCT00042991|752202|P5|Phase-I Trial|Overall Study||3
307276|NCT00042991|752203|P4|Phase-I Trial|Overall Study||2
307277|NCT00042991|752204|P3|Phase-I Trial|Overall Study||7
307278|NCT00042991|752205|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
307279|NCT00042991|752206|P1|Phase-I Trial|Overall Study||6
307280|NCT00042991|752200|P7|STARTED|Overall Study||3
307281|NCT00042991|752201|P6|STARTED|Overall Study||5
307282|NCT00042991|752202|P5|STARTED|Overall Study||3
307283|NCT00042991|752203|P4|STARTED|Overall Study||2
307284|NCT00042991|752204|P3|STARTED|Overall Study||7
307285|NCT00042991|752205|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
307286|NCT00042991|752206|P1|STARTED|Overall Study||6
307287|NCT00042939|752249|P2|NOT COMPLETED|Overall Study||21
307288|NCT00042939|752250|P1|NOT COMPLETED|Overall Study||24
307289|NCT00042939|752249|P2|COMPLETED|Overall Study||25
307290|NCT00042939|752250|P1|COMPLETED|Overall Study||24
307291|NCT00042939|752249|P2|Patients With EGFR Results Available|Overall Study||31
307292|NCT00042939|752250|P1|Patients With EGFR Results Available|Overall Study||30
307293|NCT00042939|752249|P2|Eligible and Began Protocol Therapy|Overall Study||43
307294|NCT00042939|752250|P1|Eligible and Began Protocol Therapy|Overall Study||44
307295|NCT00042939|752249|P2|Treated|Overall Study||45
307296|NCT00042939|752250|P1|Treated|Overall Study||46
307297|NCT00042939|752249|P2|STARTED|Overall Study||46
307298|NCT00042939|752250|P1|STARTED|Overall Study||48
307299|NCT00041132|752264|P1|NOT COMPLETED|Overall Study||30
307300|NCT00041132|752264|P1|COMPLETED|Overall Study||26
307301|NCT00041132|752264|P1|Eligible and Began Protocol Therapy|Overall Study||49
307302|NCT00041132|752264|P1|Eligible|Overall Study||49
307303|NCT00041132|752264|P1|STARTED|Overall Study||56
307304|NCT00041119|752274|P4|NOT COMPLETED|Overall Study||0
307305|NCT00041119|752275|P3|NOT COMPLETED|Overall Study||0
307306|NCT00041119|752276|P2|NOT COMPLETED|Overall Study||0
307307|NCT00041119|752277|P1|NOT COMPLETED|Overall Study||0
307308|NCT00041119|752274|P4|COMPLETED|Overall Study||789
307309|NCT00041119|752275|P3|COMPLETED|Overall Study||1151
307310|NCT00041119|752276|P2|COMPLETED|Overall Study||789
307311|NCT00041119|752277|P1|COMPLETED|Overall Study||1142
307312|NCT00041119|752274|P4|STARTED|Overall Study||789
307313|NCT00041119|752275|P3|STARTED|Overall Study||1151
307314|NCT00041119|752276|P2|STARTED|Overall Study||789
307315|NCT00041119|752277|P1|STARTED|Overall Study||1142
307316|NCT00041080|752299|P2|NOT COMPLETED|Overall Study||10
307317|NCT00041080|752300|P1|NOT COMPLETED|Overall Study||30
307318|NCT00041080|752299|P2|COMPLETED|Overall Study||60
307319|NCT00041080|752300|P1|COMPLETED|Overall Study||39
307320|NCT00041080|752299|P2|STARTED|Overall Study|number patients enrolled on study|70
307321|NCT00041080|752300|P1|STARTED|Overall Study|number patients enrolled on study|69
307322|NCT00041067|752306|P1|NOT COMPLETED|Overall Study||76
307323|NCT00041067|752306|P1|COMPLETED|Overall Study||0
307324|NCT00041067|752306|P1|Eligible|Overall Study||74
307325|NCT00041067|752306|P1|STARTED|Overall Study||76
307326|NCT00040937|752313|P1|NOT COMPLETED|Maintenance||0
307327|NCT00040937|752313|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
307328|NCT00040937|752313|P1|STARTED|Maintenance||76
307329|NCT00040937|752313|P1|NOT COMPLETED|Autologous PBSCT||31
307330|NCT00040937|752313|P1|COMPLETED|Autologous PBSCT||77
307331|NCT00040937|752313|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
307332|NCT00040937|752313|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
307333|NCT00040937|752313|P1|COMPLETED|Induction/PBSC Mobilization||110
307334|NCT00040937|752313|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
307335|NCT00040846|752326|P6|NOT COMPLETED|Overall Study||0
307336|NCT00040846|752327|P5|NOT COMPLETED|Overall Study||0
307337|NCT00040846|752328|P4|NOT COMPLETED|Overall Study||0
307338|NCT00040846|752329|P3|NOT COMPLETED|Overall Study||0
307339|NCT00040846|752330|P2|NOT COMPLETED|Overall Study||0
307340|NCT00040846|752331|P1|NOT COMPLETED|Overall Study||0
307341|NCT00040846|752326|P6|COMPLETED|Overall Study||0
307342|NCT00040846|752327|P5|COMPLETED|Overall Study||0
307343|NCT00040846|752328|P4|COMPLETED|Overall Study||0
307344|NCT00040846|752329|P3|COMPLETED|Overall Study||0
307345|NCT00040846|752330|P2|COMPLETED|Overall Study||0
307346|NCT00040846|752331|P1|COMPLETED|Overall Study||60
307347|NCT00040846|752326|P6|STARTED|Overall Study||0
307348|NCT00040846|752327|P5|STARTED|Overall Study||0
307349|NCT00040846|752328|P4|STARTED|Overall Study||0
307350|NCT00040846|752329|P3|STARTED|Overall Study||0
307351|NCT00040846|752330|P2|STARTED|Overall Study||0
307352|NCT00040846|752331|P1|STARTED|Overall Study||60
307353|NCT00040742|752373|P4|NOT COMPLETED|Overall Study||34
307354|NCT00040742|752374|P3|NOT COMPLETED|Overall Study||46
307355|NCT00040742|752375|P2|NOT COMPLETED|Overall Study||49
307356|NCT00040742|752376|P1|NOT COMPLETED|Overall Study||39
307357|NCT00040742|752373|P4|COMPLETED|Overall Study||152
307358|NCT00040742|752374|P3|COMPLETED|Overall Study||141
307359|NCT00040742|752375|P2|COMPLETED|Overall Study||134
307360|NCT00040742|752376|P1|COMPLETED|Overall Study||149
307361|NCT00040742|752373|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
307362|NCT00040742|752374|P3|STARTED|Overall Study||187
307363|NCT00040742|752375|P2|STARTED|Overall Study||183
307364|NCT00040742|752376|P1|STARTED|Overall Study||188
307365|NCT00039377|752390|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
307366|NCT00039377|752391|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
307367|NCT00039377|752392|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
307368|NCT00039377|752393|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
307369|NCT00039377|752390|P4|COMPLETED|Course 5 (Transplant Assignments)||1
307370|NCT00039377|752391|P3|COMPLETED|Course 5 (Transplant Assignments)||19
307371|NCT00039377|752392|P2|COMPLETED|Course 5 (Transplant Assignments)||15
307372|NCT00039377|752393|P1|COMPLETED|Course 5 (Transplant Assignments)||0
307373|NCT00039377|752390|P4|STARTED|Course 5 (Transplant Assignments)||1
307374|NCT00039377|752391|P3|STARTED|Course 5 (Transplant Assignments)||19
307375|NCT00039377|752392|P2|STARTED|Course 5 (Transplant Assignments)||15
307376|NCT00039377|752393|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
307377|NCT00039377|752390|P4|NOT COMPLETED|Initial Registration||0
307378|NCT00039377|752391|P3|NOT COMPLETED|Initial Registration||0
307379|NCT00039377|752392|P2|NOT COMPLETED|Initial Registration||0
307380|NCT00039377|752393|P1|NOT COMPLETED|Initial Registration||22
307381|NCT00039377|752390|P4|COMPLETED|Initial Registration||0
307382|NCT00039377|752391|P3|COMPLETED|Initial Registration||0
307383|NCT00039377|752392|P2|COMPLETED|Initial Registration||0
307384|NCT00039377|752393|P1|COMPLETED|Initial Registration||35
307385|NCT00039377|752390|P4|STARTED|Initial Registration||0
307386|NCT00039377|752391|P3|STARTED|Initial Registration||0
307387|NCT00039377|752392|P2|STARTED|Initial Registration||0
307388|NCT00039377|752393|P1|STARTED|Initial Registration||57
307389|NCT00039195|752405|P1|NOT COMPLETED|Overall Study||0
307390|NCT00039195|752405|P1|COMPLETED|Overall Study||98
307391|NCT00039195|752405|P1|STARTED|Overall Study||98
307392|NCT00039130|752409|P1|NOT COMPLETED|Overall Study||30
307393|NCT00039130|752409|P1|COMPLETED|Overall Study||75
307394|NCT00039130|752409|P1|STARTED|Overall Study||105
307395|NCT00036738|752415|P1|NOT COMPLETED|Overall Study||0
307396|NCT00036738|752415|P1|COMPLETED|Overall Study||28
307397|NCT00036738|752415|P1|STARTED|Overall Study||28
307398|NCT00033657|752423|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
307399|NCT00033657|752424|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
307400|NCT00033657|752423|P2|COMPLETED|Adjuvant Chemotherapy||16
307401|NCT00033657|752424|P1|COMPLETED|Adjuvant Chemotherapy||18
307402|NCT00033657|752423|P2|STARTED|Adjuvant Chemotherapy||33
307403|NCT00033657|752424|P1|STARTED|Adjuvant Chemotherapy||36
307404|NCT00033657|752423|P2|NOT COMPLETED|Surgical Resection||3
307405|NCT00033657|752424|P1|NOT COMPLETED|Surgical Resection||0
307406|NCT00033657|752423|P2|COMPLETED|Surgical Resection||33
307407|NCT00033657|752424|P1|COMPLETED|Surgical Resection||36
307408|NCT00033657|752423|P2|STARTED|Surgical Resection||36
307409|NCT00033657|752424|P1|STARTED|Surgical Resection||36
307410|NCT00033657|752423|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
307411|NCT00033657|752424|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
307412|NCT00033657|752423|P2|COMPLETED|Neoadjuvant Chemotherapy||36
307413|NCT00033657|752424|P1|COMPLETED|Neoadjuvant Chemotherapy||36
307414|NCT00033657|752423|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
307415|NCT00033657|752424|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
307416|NCT00033657|752423|P2|Eligible|Neoadjuvant Chemotherapy||43
307417|NCT00033657|752424|P1|Eligible|Neoadjuvant Chemotherapy||42
307418|NCT00033657|752423|P2|STARTED|Neoadjuvant Chemotherapy||47
307419|NCT00033657|752424|P1|STARTED|Neoadjuvant Chemotherapy||50
307420|NCT00033631|752438|P2|NOT COMPLETED|Overall Study||15
307421|NCT00033631|752439|P1|NOT COMPLETED|Overall Study||18
307422|NCT00033631|752438|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
307423|NCT00033631|752439|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
307424|NCT00033631|752438|P2|STARTED|Overall Study||763
307425|NCT00033631|752439|P1|STARTED|Overall Study||769
307426|NCT00033540|752457|P1|NOT COMPLETED|Overall Study||57
307427|NCT00033540|752457|P1|COMPLETED|Overall Study||0
307428|NCT00033540|752457|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
307429|NCT00033540|752457|P1|Eligible|Overall Study||54
307430|NCT00033540|752457|P1|STARTED|Overall Study||57
307431|NCT00033514|752467|P2|NOT COMPLETED|Overall Study||4
307432|NCT00033514|752468|P1|NOT COMPLETED|Overall Study||1
307433|NCT00033514|752467|P2|COMPLETED|Overall Study||7
307434|NCT00033514|752468|P1|COMPLETED|Overall Study||15
307435|NCT00033514|752467|P2|STARTED|Overall Study||11
307436|NCT00033514|752468|P1|STARTED|Overall Study||16
307437|NCT00033371|752478|P2|NOT COMPLETED|Overall Study||10
307438|NCT00033371|752479|P1|NOT COMPLETED|Overall Study||6
307439|NCT00033371|752478|P2|COMPLETED|Overall Study||47
307440|NCT00033371|752479|P1|COMPLETED|Overall Study||49
307441|NCT00033371|752478|P2|STARTED|Overall Study||57
307442|NCT00033371|752479|P1|STARTED|Overall Study||55
307443|NCT00033293|752487|P2|NOT COMPLETED|Overall Study||18
307444|NCT00033293|752488|P1|NOT COMPLETED|Overall Study||10
307445|NCT00033293|752487|P2|COMPLETED|Overall Study||9
307446|NCT00033293|752488|P1|COMPLETED|Overall Study||16
307447|NCT00033293|752487|P2|STARTED|Overall Study||27
307448|NCT00033293|752488|P1|STARTED|Overall Study||26
307449|NCT00031694|752506|P1|NOT COMPLETED|Overall Study||19
307450|NCT00031694|752506|P1|COMPLETED|Overall Study||0
307451|NCT00031694|752506|P1|STARTED|Overall Study||19
307452|NCT00030901|752512|P3|NOT COMPLETED|Randomization||88
307453|NCT00030901|752513|P2|NOT COMPLETED|Randomization||101
307454|NCT00030901|752514|P1|NOT COMPLETED|Randomization||0
307455|NCT00030901|752512|P3|COMPLETED|Randomization||137
307456|NCT00030901|752513|P2|COMPLETED|Randomization||126
307457|NCT00030901|752514|P1|COMPLETED|Randomization||0
307458|NCT00030901|752512|P3|Eligible|Randomization||211
307459|NCT00030901|752513|P2|Eligible|Randomization||212
307460|NCT00030901|752514|P1|Eligible|Randomization||0
307461|NCT00030901|752512|P3|STARTED|Randomization||225
307462|NCT00030901|752513|P2|STARTED|Randomization||227
307463|NCT00030901|752514|P1|STARTED|Randomization||0
307464|NCT00030901|752512|P3|NOT COMPLETED|Initial Registration||0
307465|NCT00030901|752513|P2|NOT COMPLETED|Initial Registration||0
307466|NCT00030901|752514|P1|NOT COMPLETED|Initial Registration||167
307467|NCT00030901|752512|P3|COMPLETED|Initial Registration||0
307468|NCT00030901|752513|P2|COMPLETED|Initial Registration||0
307469|NCT00030901|752514|P1|COMPLETED|Initial Registration||452
307470|NCT00030901|752512|P3|STARTED|Initial Registration||0
307471|NCT00030901|752513|P2|STARTED|Initial Registration||0
307472|NCT00030901|752514|P1|STARTED|Initial Registration||619
307473|NCT00030823|752522|P1|NOT COMPLETED|Overall Study||1
307474|NCT00030823|752522|P1|COMPLETED|Overall Study||13
307475|NCT00030823|752522|P1|STARTED|Overall Study||14
307476|NCT00028769|752526|P1|NOT COMPLETED|Overall Study||41
307477|NCT00028769|752526|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
307478|NCT00028769|752526|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
307479|NCT00028769|752526|P1|Eligible|Overall Study||36
307480|NCT00028769|752526|P1|STARTED|Overall Study||41
307481|NCT00028002|752532|P1|NOT COMPLETED|Overall Study||11
307574|NCT00024167|752749|P1|STARTED|Overall Study||65
307575|NCT00024102|752760|P2|NOT COMPLETED|Overall Study||0
307482|NCT00028002|752532|P1|COMPLETED|Overall Study|Subjects comtributing data to the primary analysis are considered to have completed the study.|52
307483|NCT00028002|752532|P1|STARTED|Overall Study||63
307484|NCT00027846|752539|P3|NOT COMPLETED|Overall Study||37
307485|NCT00027846|752540|P2|NOT COMPLETED|Overall Study||68
307486|NCT00027846|752541|P1|NOT COMPLETED|Overall Study||2
307487|NCT00027846|752539|P3|COMPLETED|Overall Study||41
307488|NCT00027846|752540|P2|COMPLETED|Overall Study||219
307489|NCT00027846|752541|P1|COMPLETED|Overall Study||11
307490|NCT00027846|752539|P3|STARTED|Overall Study||78
307491|NCT00027846|752540|P2|STARTED|Overall Study||287
307492|NCT00027846|752541|P1|STARTED|Overall Study||13
307493|NCT00027560|752559|P1|NOT COMPLETED|Overall Study||1
307494|NCT00027560|752559|P1|COMPLETED|Overall Study||50
307495|NCT00027560|752559|P1|STARTED|Overall Study||51
307496|NCT00026494|752572|P4|NOT COMPLETED|Overall Study||0
307497|NCT00026494|752573|P3|NOT COMPLETED|Overall Study||6
307498|NCT00026494|752574|P2|NOT COMPLETED|Overall Study||0
307499|NCT00026494|752575|P1|NOT COMPLETED|Overall Study||2
307500|NCT00026494|752572|P4|COMPLETED|Overall Study||16
307501|NCT00026494|752573|P3|COMPLETED|Overall Study||16
307502|NCT00026494|752574|P2|COMPLETED|Overall Study||4
307503|NCT00026494|752575|P1|COMPLETED|Overall Study||5
307504|NCT00026494|752572|P4|STARTED|Overall Study||16
307505|NCT00026494|752573|P3|STARTED|Overall Study||22
307506|NCT00026494|752574|P2|STARTED|Overall Study||4
307507|NCT00026494|752575|P1|STARTED|Overall Study||7
307508|NCT00026312|752587|P2|NOT COMPLETED|Overall Study||269
307509|NCT00026312|752588|P1|NOT COMPLETED|Overall Study||34
307510|NCT00026312|752587|P2|COMPLETED|Overall Study||1064
307511|NCT00026312|752588|P1|COMPLETED|Overall Study||82
307512|NCT00026312|752587|P2|STARTED|Overall Study||1333
307513|NCT00026312|752588|P1|STARTED|Overall Study||116
307514|NCT00026221|752606|P3|NOT COMPLETED|Overall Study||0
307515|NCT00026221|752607|P2|NOT COMPLETED|Overall Study||0
307516|NCT00026221|752608|P1|NOT COMPLETED|Overall Study||0
307517|NCT00026221|752606|P3|COMPLETED|Overall Study||25
307518|NCT00026221|752607|P2|COMPLETED|Overall Study||16
307519|NCT00026221|752608|P1|COMPLETED|Overall Study||16
307520|NCT00026221|752606|P3|STARTED|Overall Study||25
307521|NCT00026221|752607|P2|STARTED|Overall Study||16
307522|NCT00026221|752608|P1|STARTED|Overall Study||16
307523|NCT00026208|752627|P2|NOT COMPLETED|Overall Study||0
307524|NCT00026208|752628|P1|NOT COMPLETED|Overall Study||2
307525|NCT00026208|752627|P2|COMPLETED|Overall Study||4
307526|NCT00026208|752628|P1|COMPLETED|Overall Study||70
307527|NCT00026208|752627|P2|STARTED|Overall Study||4
307528|NCT00026208|752628|P1|STARTED|Overall Study||72
307529|NCT00025662|752644|P1|NOT COMPLETED|Overall Study||3
307530|NCT00025662|752644|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
307531|NCT00025662|752644|P1|STARTED|Overall Study||25
307532|NCT00025506|752652|P1|NOT COMPLETED|Overall Study||10
307533|NCT00025506|752652|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
307534|NCT00025506|752652|P1|STARTED|Overall Study||55
307535|NCT00025259|752673|P7|NOT COMPLETED|Overall Study||51
307536|NCT00025259|752674|P6|NOT COMPLETED|Overall Study||52
307537|NCT00025259|752675|P5|NOT COMPLETED|Overall Study||36
307538|NCT00025259|752676|P4|NOT COMPLETED|Overall Study||114
307539|NCT00025259|752677|P3|NOT COMPLETED|Overall Study||81
307540|NCT00025259|752678|P2|NOT COMPLETED|Overall Study||89
307541|NCT00025259|752679|P1|NOT COMPLETED|Overall Study||45
307542|NCT00025259|752673|P7|COMPLETED|Overall Study||102
307543|NCT00025259|752674|P6|COMPLETED|Overall Study||101
307544|NCT00025259|752675|P5|COMPLETED|Overall Study||6
307545|NCT00025259|752676|P4|COMPLETED|Overall Study||457
307546|NCT00025259|752677|P3|COMPLETED|Overall Study||301
307547|NCT00025259|752678|P2|COMPLETED|Overall Study||292
307548|NCT00025259|752679|P1|COMPLETED|Overall Study||7
307549|NCT00025259|752673|P7|STARTED|Overall Study||153
307550|NCT00025259|752674|P6|STARTED|Overall Study||153
307551|NCT00025259|752675|P5|STARTED|Overall Study||42
307552|NCT00025259|752676|P4|STARTED|Overall Study||571
307553|NCT00025259|752677|P3|STARTED|Overall Study||382
307554|NCT00025259|752678|P2|STARTED|Overall Study||381
307555|NCT00025259|752679|P1|STARTED|Overall Study||52
307556|NCT00025233|752715|P1|NOT COMPLETED|Overall Study||4
307557|NCT00025233|752715|P1|COMPLETED|Overall Study||46
307558|NCT00025233|752715|P1|STARTED|Overall Study||50
307559|NCT00025155|752730|P1|NOT COMPLETED|Overall Study||2
307560|NCT00025155|752730|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
307561|NCT00025155|752730|P1|STARTED|Overall Study||51
307562|NCT00024258|752741|P1|NOT COMPLETED|Overall Study||9
307563|NCT00024258|752741|P1|COMPLETED|Overall Study||13
307564|NCT00024258|752741|P1|STARTED|Overall Study||22
307565|NCT00024167|752748|P2|NOT COMPLETED|Overall Study||47
307566|NCT00024167|752749|P1|NOT COMPLETED|Overall Study||53
307567|NCT00024167|752748|P2|COMPLETED|Overall Study||15
307568|NCT00024167|752749|P1|COMPLETED|Overall Study||12
307569|NCT00024167|752748|P2|Induction Treatment Option 2 Completed|Overall Study||41
307570|NCT00024167|752749|P1|Induction Treatment Option 2 Completed|Overall Study||43
307571|NCT00024167|752748|P2|Induction Treatment Option 1 Completed|Overall Study||21
307572|NCT00024167|752749|P1|Induction Treatment Option 1 Completed|Overall Study||22
307573|NCT00024167|752748|P2|STARTED|Overall Study||62
307576|NCT00024102|752761|P1|NOT COMPLETED|Overall Study||0
307577|NCT00024102|752760|P2|COMPLETED|Overall Study||307
307578|NCT00024102|752761|P1|COMPLETED|Overall Study||326
307579|NCT00024102|752760|P2|STARTED|Overall Study||307
307580|NCT00024102|752761|P1|STARTED|Overall Study||326
307581|NCT00023764|752773|P1|NOT COMPLETED|Overall Study||14
307582|NCT00023764|752773|P1|COMPLETED|Overall Study||89
307583|NCT00023764|752773|P1|STARTED|Overall Study||103
307584|NCT00023712|752780|P2|NOT COMPLETED|Overall Study||1
307585|NCT00023712|752781|P1|NOT COMPLETED|Overall Study||2
307586|NCT00023712|752780|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
307587|NCT00023712|752781|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
307588|NCT00023712|752780|P2|STARTED|Overall Study|total number of participants enrolled on study|30
307589|NCT00023712|752781|P1|STARTED|Overall Study|total number of participants enrolled on study|28
307590|NCT00022698|752805|P2|NOT COMPLETED|Overall Study||35
307591|NCT00022698|752806|P1|NOT COMPLETED|Overall Study||8
307592|NCT00022698|752805|P2|COMPLETED|Overall Study||17
307593|NCT00022698|752806|P1|COMPLETED|Overall Study||7
307594|NCT00022698|752805|P2|STARTED|Overall Study||52
307595|NCT00022698|752806|P1|STARTED|Overall Study||15
307596|NCT00022672|752831|P2|NOT COMPLETED|Extension Phase||51
307597|NCT00022672|752832|P1|NOT COMPLETED|Extension Phase||3
307598|NCT00022672|752831|P2|COMPLETED|Extension Phase||7
307599|NCT00022672|752832|P1|COMPLETED|Extension Phase||11
307600|NCT00022672|752831|P2|Safety Set: Received Study Drug|Extension Phase||58
307601|NCT00022672|752832|P1|Safety Set: Received Study Drug|Extension Phase||14
307602|NCT00022672|752831|P2|STARTED|Extension Phase||58
307603|NCT00022672|752832|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
307604|NCT00022672|752831|P2|NOT COMPLETED|Main Phase: 24 Months||100
307605|NCT00022672|752832|P1|NOT COMPLETED|Main Phase: 24 Months||87
307606|NCT00022672|752831|P2|COMPLETED|Main Phase: 24 Months||4
307607|NCT00022672|752832|P1|COMPLETED|Main Phase: 24 Months||16
307608|NCT00022672|752831|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
307609|NCT00022672|752832|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
307610|NCT00022672|752831|P2|STARTED|Main Phase: 24 Months||104
307611|NCT00022672|752832|P1|STARTED|Main Phase: 24 Months||103
307612|NCT00022659|752865|P1|NOT COMPLETED|Overall Study||2
307613|NCT00022659|752865|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
307614|NCT00022659|752865|P1|STARTED|Overall Study||64
307615|NCT00022633|752878|P2|NOT COMPLETED|Overall Study||5
307616|NCT00022633|752879|P1|NOT COMPLETED|Overall Study||32
307617|NCT00022633|752878|P2|COMPLETED|Overall Study||5
307618|NCT00022633|752879|P1|COMPLETED|Overall Study||23
307619|NCT00022633|752878|P2|Eligible|Overall Study||10
307620|NCT00022633|752879|P1|Eligible|Overall Study||51
307621|NCT00022633|752878|P2|STARTED|Overall Study||10
307622|NCT00022633|752879|P1|STARTED|Overall Study||55
307623|NCT00022516|752892|P2|NOT COMPLETED|Overall Study||230
307624|NCT00022516|752893|P1|NOT COMPLETED|Overall Study||3
307625|NCT00022516|752892|P2|COMPLETED|Overall Study||314
307626|NCT00022516|752893|P1|COMPLETED|Overall Study||539
307627|NCT00022516|752892|P2|STARTED|Overall Study||544
307628|NCT00022516|752893|P1|STARTED|Overall Study||542
307629|NCT00022490|752905|P1|NOT COMPLETED|Overall Study||0
307630|NCT00022490|752905|P1|COMPLETED|Overall Study||24
307631|NCT00022490|752905|P1|STARTED|Overall Study||24
307632|NCT00021255|752912|P3|NOT COMPLETED|Overall Study||149
307633|NCT00021255|752913|P2|NOT COMPLETED|Overall Study||270
307634|NCT00021255|752914|P1|NOT COMPLETED|Overall Study||121
307635|NCT00021255|752912|P3|COMPLETED|Overall Study||926
307636|NCT00021255|752913|P2|COMPLETED|Overall Study||804
307637|NCT00021255|752914|P1|COMPLETED|Overall Study||952
307638|NCT00021255|752912|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
307639|NCT00021255|752913|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
307640|NCT00021255|752914|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
307641|NCT00021255|752912|P3|Treated|Overall Study||1057
307642|NCT00021255|752913|P2|Treated|Overall Study||1072
307643|NCT00021255|752914|P1|Treated|Overall Study||1045
307644|NCT00021255|752912|P3|STARTED|Overall Study|Randomized|1075
307645|NCT00021255|752913|P2|STARTED|Overall Study|Randomized|1074
307646|NCT00021255|752914|P1|STARTED|Overall Study|Randomized|1073
307647|NCT00021229|752931|P3|NOT COMPLETED|Overall Study||16
307648|NCT00021229|752932|P2|NOT COMPLETED|Overall Study||33
307649|NCT00021229|752933|P1|NOT COMPLETED|Overall Study||35
307650|NCT00021229|752931|P3|COMPLETED|Overall Study||0
307651|NCT00021229|752932|P2|COMPLETED|Overall Study||0
307652|NCT00021229|752933|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
307653|NCT00021229|752931|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
307654|NCT00021229|752932|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
307655|NCT00021229|752933|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
307656|NCT00021229|752931|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
307750|NCT00012012|753080|P1|NOT COMPLETED|Overall Study||1
307751|NCT00012012|753079|P2|COMPLETED|Overall Study||15
307657|NCT00021229|752932|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
307658|NCT00021229|752933|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
307659|NCT00021229|752931|P3|Enrolled in Phase I|Overall Study||16
307660|NCT00021229|752932|P2|Enrolled in Phase I|Overall Study||33
307661|NCT00021229|752933|P1|Enrolled in Phase I|Overall Study||35
307662|NCT00021229|752931|P3|STARTED|Overall Study||16
307663|NCT00021229|752932|P2|STARTED|Overall Study||33
307664|NCT00021229|752933|P1|STARTED|Overall Study||36
307665|NCT00020722|752959|P1|NOT COMPLETED|Overall Study||0
307666|NCT00020722|752959|P1|COMPLETED|Overall Study||7
307667|NCT00020722|752959|P1|STARTED|Overall Study||7
307668|NCT00019747|752966|P2|NOT COMPLETED|Overall Study||0
307669|NCT00019747|752967|P1|NOT COMPLETED|Overall Study||0
307670|NCT00019747|752966|P2|COMPLETED|Overall Study||16
307671|NCT00019747|752967|P1|COMPLETED|Overall Study||23
307672|NCT00019747|752966|P2|STARTED|Overall Study||16
307673|NCT00019747|752967|P1|STARTED|Overall Study||23
307674|NCT00019682|752975|P2|NOT COMPLETED|Overall Study||6
307675|NCT00019682|752976|P1|NOT COMPLETED|Overall Study||1
307676|NCT00019682|752975|P2|COMPLETED|Overall Study||85
307677|NCT00019682|752976|P1|COMPLETED|Overall Study||93
307678|NCT00019682|752975|P2|STARTED|Overall Study||91
307679|NCT00019682|752976|P1|STARTED|Overall Study||94
307680|NCT00019604|752988|P1|NOT COMPLETED|Overall Study||39
307681|NCT00019604|752988|P1|COMPLETED|Overall Study||5
307682|NCT00019604|752988|P1|STARTED|Overall Study||44
307683|NCT00017563|753001|P1|NOT COMPLETED|Overall Study||1
307684|NCT00017563|753001|P1|COMPLETED|Overall Study||56
307685|NCT00017563|753001|P1|STARTED|Overall Study||57
307686|NCT00016913|753005|P1|NOT COMPLETED|Overall Study||0
307687|NCT00016913|753005|P1|COMPLETED|Overall Study||27
307688|NCT00016913|753005|P1|STARTED|Overall Study||27
307689|NCT00016354|753011|P8|NOT COMPLETED|Overall Study||1
307690|NCT00016354|753012|P7|NOT COMPLETED|Overall Study||0
307691|NCT00016354|753013|P6|NOT COMPLETED|Overall Study||0
307692|NCT00016354|753014|P5|NOT COMPLETED|Overall Study||0
307693|NCT00016354|753015|P4|NOT COMPLETED|Overall Study||0
307694|NCT00016354|753016|P3|NOT COMPLETED|Overall Study||0
307695|NCT00016354|753017|P2|NOT COMPLETED|Overall Study||0
307696|NCT00016354|753018|P1|NOT COMPLETED|Overall Study||0
307697|NCT00016354|753011|P8|COMPLETED|Overall Study||6
307698|NCT00016354|753012|P7|COMPLETED|Overall Study||6
307699|NCT00016354|753013|P6|COMPLETED|Overall Study||1
307700|NCT00016354|753014|P5|COMPLETED|Overall Study||1
307701|NCT00016354|753015|P4|COMPLETED|Overall Study||1
307702|NCT00016354|753016|P3|COMPLETED|Overall Study||1
307703|NCT00016354|753017|P2|COMPLETED|Overall Study||1
307704|NCT00016354|753018|P1|COMPLETED|Overall Study||1
307705|NCT00016354|753011|P8|STARTED|Overall Study||7
307706|NCT00016354|753012|P7|STARTED|Overall Study||6
307707|NCT00016354|753013|P6|STARTED|Overall Study||1
307708|NCT00016354|753014|P5|STARTED|Overall Study||1
307709|NCT00016354|753015|P4|STARTED|Overall Study||1
307710|NCT00016354|753016|P3|STARTED|Overall Study||1
307711|NCT00016354|753017|P2|STARTED|Overall Study||1
307712|NCT00016354|753018|P1|STARTED|Overall Study||1
307713|NCT00015847|753022|P1|NOT COMPLETED|Overall Study||0
307714|NCT00015847|753022|P1|COMPLETED|Overall Study||25
307715|NCT00015847|753022|P1|STARTED|Overall Study||25
307716|NCT00014495|753032|P4|NOT COMPLETED|Overall Study||1
307717|NCT00014495|753033|P3|NOT COMPLETED|Overall Study||1
307718|NCT00014495|753034|P2|NOT COMPLETED|Overall Study||0
307719|NCT00014495|753035|P1|NOT COMPLETED|Overall Study||0
307720|NCT00014495|753032|P4|COMPLETED|Overall Study||5
307721|NCT00014495|753033|P3|COMPLETED|Overall Study||19
307722|NCT00014495|753034|P2|COMPLETED|Overall Study||3
307723|NCT00014495|753035|P1|COMPLETED|Overall Study||3
307724|NCT00014495|753032|P4|STARTED|Overall Study||6
307725|NCT00014495|753033|P3|STARTED|Overall Study||20
307726|NCT00014495|753034|P2|STARTED|Overall Study||3
307727|NCT00014495|753035|P1|STARTED|Overall Study||3
307728|NCT00012298|753049|P7|NOT COMPLETED|Overall Study||0
307729|NCT00012298|753050|P6|NOT COMPLETED|Overall Study||0
307730|NCT00012298|753051|P5|NOT COMPLETED|Overall Study||0
307731|NCT00012298|753052|P4|NOT COMPLETED|Overall Study||0
307732|NCT00012298|753053|P3|NOT COMPLETED|Overall Study||0
307733|NCT00012298|753054|P2|NOT COMPLETED|Overall Study||0
307734|NCT00012298|753055|P1|NOT COMPLETED|Overall Study||0
307735|NCT00012298|753049|P7|COMPLETED|Overall Study||39
307736|NCT00012298|753050|P6|COMPLETED|Overall Study||6
307737|NCT00012298|753051|P5|COMPLETED|Overall Study||5
307738|NCT00012298|753052|P4|COMPLETED|Overall Study||4
307739|NCT00012298|753053|P3|COMPLETED|Overall Study||9
307740|NCT00012298|753054|P2|COMPLETED|Overall Study||7
307741|NCT00012298|753055|P1|COMPLETED|Overall Study||11
307742|NCT00012298|753049|P7|STARTED|Overall Study||39
307743|NCT00012298|753050|P6|STARTED|Overall Study||6
307744|NCT00012298|753051|P5|STARTED|Overall Study||5
307745|NCT00012298|753052|P4|STARTED|Overall Study||4
307746|NCT00012298|753053|P3|STARTED|Overall Study||9
307747|NCT00012298|753054|P2|STARTED|Overall Study||7
307748|NCT00012298|753055|P1|STARTED|Overall Study||11
307749|NCT00012012|753079|P2|NOT COMPLETED|Overall Study||3
307752|NCT00012012|753080|P1|COMPLETED|Overall Study||26
307753|NCT00012012|753079|P2|STARTED|Overall Study||18
307754|NCT00012012|753080|P1|STARTED|Overall Study||27
307755|NCT00011986|753091|P5|NOT COMPLETED|Overall Study||0
307756|NCT00011986|753092|P4|NOT COMPLETED|Overall Study||0
307757|NCT00011986|753093|P3|NOT COMPLETED|Overall Study||0
307758|NCT00011986|753094|P2|NOT COMPLETED|Overall Study||0
307759|NCT00011986|753095|P1|NOT COMPLETED|Overall Study||0
307760|NCT00011986|753091|P5|COMPLETED|Overall Study||861
307761|NCT00011986|753092|P4|COMPLETED|Overall Study||861
307762|NCT00011986|753093|P3|COMPLETED|Overall Study||862
307763|NCT00011986|753094|P2|COMPLETED|Overall Study||864
307764|NCT00011986|753095|P1|COMPLETED|Overall Study||864
307765|NCT00011986|753091|P5|Initiated Treatment|Overall Study||851
307766|NCT00011986|753092|P4|Initiated Treatment|Overall Study||846
307767|NCT00011986|753093|P3|Initiated Treatment|Overall Study||854
307768|NCT00011986|753094|P2|Initiated Treatment|Overall Study||860
307769|NCT00011986|753095|P1|Initiated Treatment|Overall Study||862
307770|NCT00011986|753091|P5|STARTED|Overall Study||861
307771|NCT00011986|753092|P4|STARTED|Overall Study||861
307772|NCT00011986|753093|P3|STARTED|Overall Study||862
307773|NCT00011986|753094|P2|STARTED|Overall Study||864
307774|NCT00011986|753095|P1|STARTED|Overall Study||864
307775|NCT00010257|753109|P2|NOT COMPLETED|Overall Study||0
307776|NCT00010257|753110|P1|NOT COMPLETED|Overall Study||1
307777|NCT00010257|753109|P2|COMPLETED|Overall Study||21
307778|NCT00010257|753110|P1|COMPLETED|Overall Study||24
307779|NCT00010257|753109|P2|STARTED|Overall Study||21
307780|NCT00010257|753110|P1|STARTED|Overall Study||25
307781|NCT00009945|753120|P2|NOT COMPLETED|Overall Study||5
307782|NCT00009945|753121|P1|NOT COMPLETED|Overall Study||7
307783|NCT00009945|753120|P2|COMPLETED|Overall Study||1656
307784|NCT00009945|753121|P1|COMPLETED|Overall Study||1655
307785|NCT00009945|753120|P2|STARTED|Overall Study||1661
307786|NCT00009945|753121|P1|STARTED|Overall Study||1662
307787|NCT00008385|753137|P2|NOT COMPLETED|Overall Study||802
307788|NCT00008385|753138|P1|NOT COMPLETED|Overall Study||387
307789|NCT00008385|753137|P2|COMPLETED|Overall Study||238
307790|NCT00008385|753138|P1|COMPLETED|Overall Study||134
307791|NCT00008385|753137|P2|Off Treatment Reasons Reported|Overall Study||795
307792|NCT00008385|753138|P1|Off Treatment Reasons Reported|Overall Study||398
307793|NCT00008385|753137|P2|Treated|Overall Study||865
307794|NCT00008385|753138|P1|Treated|Overall Study||477
307795|NCT00008385|753137|P2|STARTED|Overall Study||1040
307796|NCT00008385|753138|P1|STARTED|Overall Study||521
307797|NCT00008138|753148|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
307798|NCT00008138|753148|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
307799|NCT00008138|753148|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
307800|NCT00008138|753148|P1|NOT COMPLETED|Interval Debulking||2
307801|NCT00008138|753148|P1|COMPLETED|Interval Debulking||36
307802|NCT00008138|753148|P1|Received Protocol Surgery|Interval Debulking||36
307803|NCT00008138|753148|P1|STARTED|Interval Debulking||38
307804|NCT00008138|753148|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
307805|NCT00008138|753148|P1|COMPLETED|Neoadjuvant Chemotherapy||38
307806|NCT00008138|753148|P1|Eligible|Neoadjuvant Chemotherapy||58
307807|NCT00008138|753148|P1|STARTED|Neoadjuvant Chemotherapy||58
307808|NCT00006916|753154|P1|NOT COMPLETED|Overall Study||5
307809|NCT00006916|753154|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
307810|NCT00006916|753154|P1|STARTED|Overall Study||19
307811|NCT00006903|753160|P3|NOT COMPLETED|Overall Study||6
307812|NCT00006903|753161|P2|NOT COMPLETED|Overall Study||4
307813|NCT00006903|753162|P1|NOT COMPLETED|Overall Study||10
307814|NCT00006903|753160|P3|COMPLETED|Overall Study||27
307815|NCT00006903|753161|P2|COMPLETED|Overall Study||20
307816|NCT00006903|753162|P1|COMPLETED|Overall Study||0
307817|NCT00006903|753160|P3|STARTED|Overall Study||33
307818|NCT00006903|753161|P2|STARTED|Overall Study||24
307819|NCT00006903|753162|P1|STARTED|Overall Study||10
307820|NCT00006721|753175|P3|NOT COMPLETED|Overall Study||33
307821|NCT00006721|753176|P2|NOT COMPLETED|Overall Study||25
307822|NCT00006721|753177|P1|NOT COMPLETED|Overall Study||4
307823|NCT00006721|753175|P3|COMPLETED|Overall Study||242
307824|NCT00006721|753176|P2|COMPLETED|Overall Study||254
307825|NCT00006721|753177|P1|COMPLETED|Overall Study||13
307826|NCT00006721|753175|P3|Eligible and Began Protocol Therapy|Overall Study||265
307827|NCT00006721|753176|P2|Eligible and Began Protocol Therapy|Overall Study||267
307828|NCT00006721|753177|P1|Eligible and Began Protocol Therapy|Overall Study||14
307829|NCT00006721|753175|P3|Eligible|Overall Study||265
307830|NCT00006721|753176|P2|Eligible|Overall Study||267
307831|NCT00006721|753177|P1|Eligible|Overall Study||15
307832|NCT00006721|753175|P3|STARTED|Overall Study||275
307833|NCT00006721|753176|P2|STARTED|Overall Study||279
307834|NCT00006721|753177|P1|STARTED|Overall Study||17
307835|NCT00006478|753195|P1|NOT COMPLETED|Overall Study||7
307836|NCT00006478|753195|P1|COMPLETED|Overall Study||12
307837|NCT00006478|753195|P1|STARTED|Overall Study||19
307838|NCT00006392|753203|P4|NOT COMPLETED|Overall Study||160
307839|NCT00006392|753204|P3|NOT COMPLETED|Overall Study||160
307840|NCT00006392|753205|P2|NOT COMPLETED|Overall Study||158
307841|NCT00006392|753206|P1|NOT COMPLETED|Overall Study||167
307842|NCT00006392|753203|P4|COMPLETED|Overall Study||8696
307843|NCT00006392|753204|P3|COMPLETED|Overall Study||8703
307844|NCT00006392|753205|P2|COMPLETED|Overall Study||8752
307845|NCT00006392|753206|P1|COMPLETED|Overall Study||8737
307846|NCT00006392|753203|P4|STARTED|Overall Study||8856
307847|NCT00006392|753204|P3|STARTED|Overall Study||8863
307848|NCT00006392|753205|P2|STARTED|Overall Study||8910
307849|NCT00006392|753206|P1|STARTED|Overall Study||8904
307850|NCT00006389|753236|P1|NOT COMPLETED|Overall Study||1
307851|NCT00006389|753236|P1|COMPLETED|Overall Study||11
307852|NCT00006389|753236|P1|STARTED|Overall Study||12
307853|NCT00006244|753242|P1|NOT COMPLETED|Overall Study||0
307854|NCT00006244|753242|P1|COMPLETED|Overall Study||36
307855|NCT00006244|753242|P1|STARTED|Overall Study||36
307856|NCT00006237|753253|P2|NOT COMPLETED|Overall Study||61
307857|NCT00006237|753254|P1|NOT COMPLETED|Overall Study||125
307858|NCT00006237|753253|P2|COMPLETED|Overall Study||159
307859|NCT00006237|753254|P1|COMPLETED|Overall Study||87
307860|NCT00006237|753253|P2|Eligible and Treated|Overall Study||199
307861|NCT00006237|753254|P1|Eligible and Treated|Overall Study||203
307862|NCT00006237|753253|P2|Eligible|Overall Study||200
307863|NCT00006237|753254|P1|Eligible|Overall Study||203
307864|NCT00006237|753253|P2|STARTED|Overall Study||220
307865|NCT00006237|753254|P1|STARTED|Overall Study||212
307866|NCT00006110|753266|P2|NOT COMPLETED|Overall Study||0
307867|NCT00006110|753267|P1|NOT COMPLETED|Overall Study||0
307868|NCT00006110|753266|P2|COMPLETED|Overall Study||30
307869|NCT00006110|753267|P1|COMPLETED|Overall Study||52
307870|NCT00006110|753266|P2|STARTED|Overall Study||30
307871|NCT00006110|753267|P1|STARTED|Overall Study||52
307872|NCT00006101|753281|P2|NOT COMPLETED|Overall Study||5
307873|NCT00006101|753282|P1|NOT COMPLETED|Overall Study||5
307874|NCT00006101|753281|P2|COMPLETED|Overall Study||33
307875|NCT00006101|753282|P1|COMPLETED|Overall Study||33
307876|NCT00006101|753281|P2|STARTED|Overall Study||38
307877|NCT00006101|753282|P1|STARTED|Overall Study||38
307878|NCT00006011|753291|P3|NOT COMPLETED|Overall Study||73
307879|NCT00006011|753292|P2|NOT COMPLETED|Overall Study||77
307880|NCT00006011|753293|P1|NOT COMPLETED|Overall Study||65
307881|NCT00006011|753291|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
307882|NCT00006011|753292|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
307883|NCT00006011|753293|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
307884|NCT00006011|753291|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
307885|NCT00006011|753292|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
307886|NCT00006011|753293|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
307887|NCT00005957|753301|P2|NOT COMPLETED|Overall Study||28
307888|NCT00005957|753302|P1|NOT COMPLETED|Overall Study||8
307889|NCT00005957|753301|P2|COMPLETED|Overall Study||888
307890|NCT00005957|753302|P1|COMPLETED|Overall Study||908
307891|NCT00005957|753301|P2|STARTED|Overall Study||916
307892|NCT00005957|753302|P1|STARTED|Overall Study||916
307893|NCT00005879|753312|P2|NOT COMPLETED|Overall Study||10
307894|NCT00005879|753313|P1|NOT COMPLETED|Overall Study||8
307895|NCT00005879|753312|P2|COMPLETED|Overall Study||88
307896|NCT00005879|753313|P1|COMPLETED|Overall Study||93
307897|NCT00005879|753312|P2|STARTED|Overall Study||98
307898|NCT00005879|753313|P1|STARTED|Overall Study||101
307899|NCT00005803|753321|P1|NOT COMPLETED|Overall Study||22
307900|NCT00005803|753321|P1|COMPLETED|Overall Study||54
307901|NCT00005803|753321|P1|STARTED|Overall Study||76
307902|NCT00005047|753336|P4|NOT COMPLETED|Overall Study||0
307903|NCT00005047|753337|P3|NOT COMPLETED|Overall Study||0
307904|NCT00005047|753338|P2|NOT COMPLETED|Overall Study||0
307905|NCT00005047|753339|P1|NOT COMPLETED|Overall Study||19
307906|NCT00005047|753336|P4|COMPLETED|Overall Study||158
307907|NCT00005047|753337|P3|COMPLETED|Overall Study||227
307908|NCT00005047|753338|P2|COMPLETED|Overall Study||56
307909|NCT00005047|753339|P1|COMPLETED|Overall Study||39
307910|NCT00005047|753336|P4|STARTED|Overall Study||158
307911|NCT00005047|753337|P3|STARTED|Overall Study||227
307912|NCT00005047|753338|P2|STARTED|Overall Study||56
307913|NCT00005047|753339|P1|STARTED|Overall Study||58
307914|NCT00005044|753355|P2|NOT COMPLETED|Overall Study||52
307915|NCT00005044|753356|P1|NOT COMPLETED|Overall Study||38
307916|NCT00005044|753355|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
307917|NCT00005044|753356|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
307918|NCT00005044|753355|P2|STARTED|Overall Study||789
307919|NCT00005044|753356|P1|STARTED|Overall Study||790
307920|NCT00004888|753376|P2|NOT COMPLETED|Overall Study||24
307921|NCT00004888|753377|P1|NOT COMPLETED|Overall Study||11
307922|NCT00004888|753376|P2|COMPLETED|Overall Study||22
307923|NCT00004888|753377|P1|COMPLETED|Overall Study||27
307924|NCT00004888|753376|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
307925|NCT00004888|753377|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
307926|NCT00004859|753395|P2|NOT COMPLETED|Overall Study||282
307927|NCT00004859|753396|P1|NOT COMPLETED|Overall Study||118
307928|NCT00004859|753395|P2|COMPLETED|Overall Study||12
307929|NCT00004859|753396|P1|COMPLETED|Overall Study||177
308021|NCT00003820|753550|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
307930|NCT00004859|753395|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
307931|NCT00004859|753396|P1|Treated and Having Toxicity Data|Overall Study||289
307932|NCT00004859|753395|P2|Treated|Overall Study||289
307933|NCT00004859|753396|P1|Treated|Overall Study||289
307934|NCT00004859|753395|P2|Eligible|Overall Study||271
307935|NCT00004859|753396|P1|Eligible|Overall Study||275
307936|NCT00004859|753395|P2|STARTED|Overall Study||294
307937|NCT00004859|753396|P1|STARTED|Overall Study||295
307938|NCT00004259|753410|P4|NOT COMPLETED|Overall Study||0
307939|NCT00004259|753411|P3|NOT COMPLETED|Overall Study||0
307940|NCT00004259|753412|P2|NOT COMPLETED|Overall Study||4
307941|NCT00004259|753413|P1|NOT COMPLETED|Overall Study||1
307942|NCT00004259|753410|P4|COMPLETED|Overall Study||14
307943|NCT00004259|753411|P3|COMPLETED|Overall Study||15
307944|NCT00004259|753412|P2|COMPLETED|Overall Study||99
307945|NCT00004259|753413|P1|COMPLETED|Overall Study||97
307946|NCT00004259|753410|P4|STARTED|Overall Study||14
307947|NCT00004259|753411|P3|STARTED|Overall Study||15
307948|NCT00004259|753412|P2|STARTED|Overall Study||103
307949|NCT00004259|753413|P1|STARTED|Overall Study||98
307950|NCT00004228|753434|P7|NOT COMPLETED|Overall Study||12
307951|NCT00004228|753435|P6|NOT COMPLETED|Overall Study||14
307952|NCT00004228|753436|P5|NOT COMPLETED|Overall Study||16
307953|NCT00004228|753437|P4|NOT COMPLETED|Overall Study||7
307954|NCT00004228|753438|P3|NOT COMPLETED|Overall Study||19
307955|NCT00004228|753439|P2|NOT COMPLETED|Overall Study||15
307956|NCT00004228|753440|P1|NOT COMPLETED|Overall Study||9
307957|NCT00004228|753434|P7|COMPLETED|Overall Study||45
307958|NCT00004228|753435|P6|COMPLETED|Overall Study||51
307959|NCT00004228|753436|P5|COMPLETED|Overall Study||51
307960|NCT00004228|753437|P4|COMPLETED|Overall Study||6
307961|NCT00004228|753438|P3|COMPLETED|Overall Study||46
307962|NCT00004228|753439|P2|COMPLETED|Overall Study||51
307963|NCT00004228|753440|P1|COMPLETED|Overall Study||51
307964|NCT00004228|753434|P7|STARTED|Overall Study||57
307965|NCT00004228|753435|P6|STARTED|Overall Study||65
307966|NCT00004228|753436|P5|STARTED|Overall Study||67
307967|NCT00004228|753437|P4|STARTED|Overall Study||13
307968|NCT00004228|753438|P3|STARTED|Overall Study||65
307969|NCT00004228|753439|P2|STARTED|Overall Study||66
307970|NCT00004228|753440|P1|STARTED|Overall Study||60
307971|NCT00004143|753463|P1|NOT COMPLETED|Overall Study||0
307972|NCT00004143|753463|P1|COMPLETED|Overall Study||2
307973|NCT00004143|753463|P1|STARTED|Overall Study||2
307974|NCT00004092|753474|P2|NOT COMPLETED|Overall Study||0
307975|NCT00004092|753475|P1|NOT COMPLETED|Overall Study||0
307976|NCT00004092|753474|P2|COMPLETED|Overall Study||51
307977|NCT00004092|753475|P1|COMPLETED|Overall Study||21
307978|NCT00004092|753474|P2|STARTED|Overall Study||51
307979|NCT00004092|753475|P1|STARTED|Overall Study||21
307980|NCT00004054|753485|P2|NOT COMPLETED|Overall Study||0
307981|NCT00004054|753486|P1|NOT COMPLETED|Overall Study||0
307982|NCT00004054|753485|P2|COMPLETED|Overall Study||200
307983|NCT00004054|753486|P1|COMPLETED|Overall Study||197
307984|NCT00004054|753485|P2|STARTED|Overall Study||200
307985|NCT00004054|753486|P1|STARTED|Overall Study||197
307986|NCT00003910|753500|P2|NOT COMPLETED|Step 2||0
307987|NCT00003910|753501|P1|NOT COMPLETED|Step 2||0
307988|NCT00003910|753500|P2|COMPLETED|Step 2||16
307989|NCT00003910|753501|P1|COMPLETED|Step 2||0
307990|NCT00003910|753500|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
307991|NCT00003910|753501|P1|STARTED|Step 2||0
307992|NCT00003910|753500|P2|NOT COMPLETED|Step 1||0
307993|NCT00003910|753501|P1|NOT COMPLETED|Step 1||0
307994|NCT00003910|753500|P2|COMPLETED|Step 1||0
307995|NCT00003910|753501|P1|COMPLETED|Step 1||55
307996|NCT00003910|753500|P2|STARTED|Step 1||0
307997|NCT00003910|753501|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
307998|NCT00003901|753506|P1|NOT COMPLETED|Overall Study||17
307999|NCT00003901|753506|P1|COMPLETED|Overall Study||1030
308000|NCT00003901|753506|P1|STARTED|Overall Study||1047
308001|NCT00003896|753517|P1|NOT COMPLETED|Overall Study||29
308002|NCT00003896|753517|P1|COMPLETED|Overall Study||39
308003|NCT00003896|753517|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
308004|NCT00003896|753517|P1|STARTED|Overall Study||68
308005|NCT00003875|753523|P1|NOT COMPLETED|Overall Study||1
308006|NCT00003875|753523|P1|COMPLETED|Overall Study||29
308007|NCT00003875|753523|P1|STARTED|Overall Study||30
308008|NCT00003869|753532|P2|NOT COMPLETED|Overall Study||12
308009|NCT00003869|753533|P1|NOT COMPLETED|Overall Study||41
308010|NCT00003869|753532|P2|COMPLETED|Overall Study||80
308011|NCT00003869|753533|P1|COMPLETED|Overall Study||53
308012|NCT00003869|753532|P2|STARTED|Overall Study||92
308013|NCT00003869|753533|P1|STARTED|Overall Study||94
308014|NCT00003820|753549|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
308015|NCT00003820|753550|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
308016|NCT00003820|753549|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
308017|NCT00003820|753550|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
308018|NCT00003820|753549|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
308019|NCT00003820|753550|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
308020|NCT00003820|753549|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
308022|NCT00003820|753549|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
308023|NCT00003820|753550|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
308024|NCT00003820|753549|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
308025|NCT00003820|753550|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
308026|NCT00003820|753549|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
308027|NCT00003820|753550|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
308028|NCT00003820|753549|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
308029|NCT00003820|753550|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
308030|NCT00003820|753549|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
308031|NCT00003820|753550|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
308032|NCT00003820|753549|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
308033|NCT00003820|753550|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
308034|NCT00003820|753549|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
308035|NCT00003820|753550|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
308036|NCT00003820|753549|P2|STARTED|Cycle 1 (Initial Treatment)||16
308037|NCT00003820|753550|P1|STARTED|Cycle 1 (Initial Treatment)||23
308038|NCT00003782|753559|P3|NOT COMPLETED|Overall Study||26
308039|NCT00003782|753560|P2|NOT COMPLETED|Overall Study||31
308040|NCT00003782|753561|P1|NOT COMPLETED|Overall Study||30
308041|NCT00003782|753559|P3|COMPLETED|Overall Study||1758
308042|NCT00003782|753560|P2|COMPLETED|Overall Study||1753
308043|NCT00003782|753561|P1|COMPLETED|Overall Study||1753
308044|NCT00003782|753559|P3|STARTED|Overall Study||1784
308045|NCT00003782|753560|P2|STARTED|Overall Study||1784
308046|NCT00003782|753561|P1|STARTED|Overall Study||1783
308047|NCT00003702|753571|P2|NOT COMPLETED|Overall Study||11
308048|NCT00003702|753572|P1|NOT COMPLETED|Overall Study||13
308049|NCT00003702|753571|P2|COMPLETED|Overall Study||109
308050|NCT00003702|753572|P1|COMPLETED|Overall Study||107
308051|NCT00003702|753571|P2|STARTED|Overall Study||120
308052|NCT00003702|753572|P1|STARTED|Overall Study||120
308053|NCT00003659|753581|P1|NOT COMPLETED|Overall Study||3
308054|NCT00003659|753581|P1|COMPLETED|Overall Study||36
308055|NCT00003659|753581|P1|STARTED|Overall Study||39
308056|NCT00003641|753589|P2|NOT COMPLETED|Overall Study||174
308057|NCT00003641|753590|P1|NOT COMPLETED|Overall Study||569
308058|NCT00003641|753589|P2|COMPLETED|Overall Study||407
308059|NCT00003641|753590|P1|COMPLETED|Overall Study||0
308060|NCT00003641|753589|P2|Toxicity Assessed|Overall Study||568
308061|NCT00003641|753590|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
308062|NCT00003641|753589|P2|Treated|Overall Study||569
308063|NCT00003641|753590|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
308064|NCT00003641|753589|P2|STARTED|Overall Study||581
308065|NCT00003641|753590|P1|STARTED|Overall Study||569
308066|NCT00003631|753601|P3|NOT COMPLETED|Overall Study||9
308067|NCT00003631|753602|P2|NOT COMPLETED|Overall Study||1
308068|NCT00003631|753603|P1|NOT COMPLETED|Overall Study||3
308069|NCT00003631|753601|P3|COMPLETED|Overall Study||15
308070|NCT00003631|753602|P2|COMPLETED|Overall Study||43
308071|NCT00003631|753603|P1|COMPLETED|Overall Study||47
308072|NCT00003631|753601|P3|STARTED|Overall Study||24
308073|NCT00003631|753602|P2|STARTED|Overall Study||44
308074|NCT00003631|753603|P1|STARTED|Overall Study||50
308075|NCT00003590|753611|P1|NOT COMPLETED|Overall Study||22
308076|NCT00003590|753611|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
308077|NCT00003590|753611|P1|Eligible and Began Protocol Therapy|Overall Study||28
308078|NCT00003590|753611|P1|Eligible|Overall Study||28
308079|NCT00003590|753611|P1|STARTED|Overall Study||29
308080|NCT00003537|753616|P1|NOT COMPLETED|Overall Study||1
308081|NCT00003537|753616|P1|COMPLETED|Overall Study||18
308082|NCT00003537|753616|P1|STARTED|Overall Study||19
308083|NCT00003535|753621|P1|NOT COMPLETED|Overall Study||5
308084|NCT00003535|753621|P1|COMPLETED|Overall Study||4
308085|NCT00003535|753621|P1|STARTED|Overall Study||9
308086|NCT00003483|753626|P1|NOT COMPLETED|Overall Study||1
308087|NCT00003483|753626|P1|COMPLETED|Overall Study||2
308088|NCT00003483|753626|P1|STARTED|Overall Study||3
308089|NCT00003479|753631|P1|NOT COMPLETED|Overall Study||3
308090|NCT00003479|753631|P1|COMPLETED|Overall Study||6
308091|NCT00003479|753631|P1|STARTED|Overall Study||9
308092|NCT00003477|753636|P1|NOT COMPLETED|Overall Study||4
308093|NCT00003477|753636|P1|COMPLETED|Overall Study||8
308094|NCT00003477|753636|P1|STARTED|Overall Study||12
308095|NCT00003476|753641|P1|NOT COMPLETED|Overall Study||1
308096|NCT00003476|753641|P1|COMPLETED|Overall Study||7
308097|NCT00003476|753641|P1|STARTED|Overall Study||8
308098|NCT00003475|753646|P1|NOT COMPLETED|Overall Study||13
308099|NCT00003475|753646|P1|COMPLETED|Overall Study||27
308100|NCT00003475|753646|P1|STARTED|Overall Study||40
308101|NCT00003474|753651|P1|NOT COMPLETED|Overall Study||14
308102|NCT00003474|753651|P1|COMPLETED|Overall Study||26
308103|NCT00003474|753651|P1|STARTED|Overall Study||40
308104|NCT00003473|753656|P1|NOT COMPLETED|Overall Study||3
308105|NCT00003473|753656|P1|COMPLETED|Overall Study||17
308106|NCT00003473|753656|P1|STARTED|Overall Study||20
308107|NCT00003472|753661|P1|NOT COMPLETED|Overall Study||3
308108|NCT00003472|753661|P1|COMPLETED|Overall Study||10
308109|NCT00003472|753661|P1|STARTED|Overall Study||13
308110|NCT00003471|753666|P1|NOT COMPLETED|Overall Study||4
308111|NCT00003471|753666|P1|COMPLETED|Overall Study||3
308112|NCT00003471|753666|P1|STARTED|Overall Study||7
308113|NCT00003470|753671|P1|NOT COMPLETED|Overall Study||6
308114|NCT00003470|753671|P1|COMPLETED|Overall Study||21
308115|NCT00003470|753671|P1|STARTED|Overall Study||27
308116|NCT00003469|753676|P1|NOT COMPLETED|Overall Study||0
308117|NCT00003469|753676|P1|COMPLETED|Overall Study||4
308118|NCT00003469|753676|P1|STARTED|Overall Study||4
308119|NCT00003468|753681|P1|NOT COMPLETED|Overall Study||2
308120|NCT00003468|753681|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
308121|NCT00003468|753681|P1|STARTED|Overall Study||11
308122|NCT00003460|753686|P1|NOT COMPLETED|Overall Study||1
308123|NCT00003460|753686|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
308124|NCT00003460|753686|P1|STARTED|Overall Study||13
308125|NCT00003459|753691|P1|NOT COMPLETED|Overall Study||9
308126|NCT00003459|753691|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
308127|NCT00003459|753691|P1|STARTED|Overall Study||40
308128|NCT00003458|753696|P1|NOT COMPLETED|Overall Study||4
308129|NCT00003458|753696|P1|COMPLETED|Overall Study||30
308130|NCT00003458|753696|P1|STARTED|Overall Study||34
308131|NCT00003457|753701|P1|NOT COMPLETED|Overall Study||9
308132|NCT00003457|753701|P1|COMPLETED|Overall Study||31
308133|NCT00003457|753701|P1|STARTED|Overall Study||40
308134|NCT00003456|753706|P1|NOT COMPLETED|Overall Study||8
308135|NCT00003456|753706|P1|COMPLETED|Overall Study||32
308136|NCT00003456|753706|P1|STARTED|Overall Study||40
308137|NCT00003453|753711|P1|NOT COMPLETED|Overall Study||1
308138|NCT00003453|753711|P1|COMPLETED|Overall Study|One patient was not evaluable|5
308139|NCT00003453|753711|P1|STARTED|Overall Study||6
308140|NCT00003389|753718|P2|NOT COMPLETED|Overall Study||60
308141|NCT00003389|753719|P1|NOT COMPLETED|Overall Study||98
308142|NCT00003389|753718|P2|COMPLETED|Overall Study||366
308143|NCT00003389|753719|P1|COMPLETED|Overall Study||330
308144|NCT00003389|753718|P2|Eligible Patients|Overall Study||399
308145|NCT00003389|753719|P1|Eligible Patients|Overall Study||395
308146|NCT00003389|753718|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
308147|NCT00003389|753719|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
308148|NCT00003389|753718|P2|STARTED|Overall Study||426
308149|NCT00003389|753719|P1|STARTED|Overall Study||428
308150|NCT00003377|753734|P5|NOT COMPLETED|Period II||1
308151|NCT00003377|753735|P4|NOT COMPLETED|Period II||0
308152|NCT00003377|753736|P3|NOT COMPLETED|Period II||0
308153|NCT00003377|753737|P2|NOT COMPLETED|Period II||0
308154|NCT00003377|753738|P1|NOT COMPLETED|Period II||0
308155|NCT00003377|753734|P5|COMPLETED|Period II||16
308156|NCT00003377|753735|P4|COMPLETED|Period II||0
308157|NCT00003377|753736|P3|COMPLETED|Period II||0
308158|NCT00003377|753737|P2|COMPLETED|Period II||0
308159|NCT00003377|753738|P1|COMPLETED|Period II||0
308160|NCT00003377|753734|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
308161|NCT00003377|753735|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
308162|NCT00003377|753736|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
308163|NCT00003377|753737|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
308164|NCT00003377|753738|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
308165|NCT00003377|753734|P5|NOT COMPLETED|Period I||0
308166|NCT00003377|753735|P4|NOT COMPLETED|Period I||1
308167|NCT00003377|753736|P3|NOT COMPLETED|Period I||1
308168|NCT00003377|753737|P2|NOT COMPLETED|Period I||0
308169|NCT00003377|753738|P1|NOT COMPLETED|Period I||0
308170|NCT00003377|753734|P5|COMPLETED|Period I||0
308171|NCT00003377|753735|P4|COMPLETED|Period I||2
308172|NCT00003377|753736|P3|COMPLETED|Period I||2
308173|NCT00003377|753737|P2|COMPLETED|Period I||3
308174|NCT00003377|753738|P1|COMPLETED|Period I||3
308175|NCT00003377|753734|P5|STARTED|Period I||0
308176|NCT00003377|753735|P4|STARTED|Period I||3
308177|NCT00003377|753736|P3|STARTED|Period I||3
308178|NCT00003377|753737|P2|STARTED|Period I||3
308179|NCT00003377|753738|P1|STARTED|Period I||3
308180|NCT00003199|753752|P1|NOT COMPLETED|Overall Study||22
308181|NCT00003199|753752|P1|COMPLETED|Overall Study||28
308182|NCT00003199|753752|P1|STARTED|Overall Study||50
308183|NCT00003138|753760|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
308184|NCT00003138|753761|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
308185|NCT00003138|753760|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
308186|NCT00003138|753761|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
308187|NCT00003138|753760|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
308188|NCT00003138|753761|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
308189|NCT00003138|753760|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
308190|NCT00003138|753761|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
308191|NCT00003138|753760|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
308192|NCT00003138|753761|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
308193|NCT00003138|753760|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
308194|NCT00003138|753761|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
308195|NCT00003138|753760|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
308196|NCT00003138|753761|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
308197|NCT00003138|753760|P2|NOT COMPLETED|Step 2 (Cross Over)||0
308198|NCT00003138|753761|P1|NOT COMPLETED|Step 2 (Cross Over)||26
308199|NCT00003138|753760|P2|COMPLETED|Step 2 (Cross Over)||0
308200|NCT00003138|753761|P1|COMPLETED|Step 2 (Cross Over)||0
308201|NCT00003138|753760|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
308202|NCT00003138|753761|P1|STARTED|Step 2 (Cross Over)||26
308203|NCT00003138|753760|P2|NOT COMPLETED|Step 1||57
308204|NCT00003138|753761|P1|NOT COMPLETED|Step 1||61
308205|NCT00003138|753760|P2|COMPLETED|Step 1||0
308206|NCT00003138|753761|P1|COMPLETED|Step 1||0
308207|NCT00003138|753760|P2|Patients With Transfusion Data|Step 1||42
308208|NCT00003138|753761|P1|Patients With Transfusion Data|Step 1||37
308209|NCT00003138|753760|P2|Patients With QOL Data at 4 Months|Step 1||42
308210|NCT00003138|753761|P1|Patients With QOL Data at 4 Months|Step 1||42
308211|NCT00003138|753760|P2|Eligible and Treated|Step 1||50
308212|NCT00003138|753761|P1|Eligible and Treated|Step 1||52
308213|NCT00003138|753760|P2|Treated|Step 1||53
308214|NCT00003138|753761|P1|Treated|Step 1||56
308215|NCT00003138|753760|P2|Patients With Complete Data|Step 1||53
308216|NCT00003138|753761|P1|Patients With Complete Data|Step 1||57
308217|NCT00003138|753760|P2|STARTED|Step 1||57
308218|NCT00003138|753761|P1|STARTED|Step 1||61
308219|NCT00002975|753774|P1|NOT COMPLETED|Overall Study||5
308220|NCT00002975|753774|P1|COMPLETED|Overall Study||175
308221|NCT00002975|753774|P1|Treated With Study Therapy|Overall Study||175
308222|NCT00002975|753774|P1|STARTED|Overall Study||180
308223|NCT00002931|753778|P1|NOT COMPLETED|Overall Study||2
308224|NCT00002931|753778|P1|COMPLETED|Overall Study||46
308225|NCT00002931|753778|P1|STARTED|Overall Study||48
308226|NCT00002874|753786|P2|NOT COMPLETED|Overall Study||35
308227|NCT00002874|753787|P1|NOT COMPLETED|Overall Study||45
308228|NCT00002874|753786|P2|COMPLETED|Overall Study||384
308229|NCT00002874|753787|P1|COMPLETED|Overall Study||376
308230|NCT00002874|753786|P2|STARTED|Overall Study||419
308231|NCT00002874|753787|P1|STARTED|Overall Study||421
308232|NCT00002850|753812|P3|NOT COMPLETED|Overall Study||4
308233|NCT00002850|753813|P2|NOT COMPLETED|Overall Study||2
308234|NCT00002850|753814|P1|NOT COMPLETED|Overall Study||5
308235|NCT00002850|753812|P3|COMPLETED|Overall Study||63
308236|NCT00002850|753813|P2|COMPLETED|Overall Study||74
308237|NCT00002850|753814|P1|COMPLETED|Overall Study||64
308238|NCT00002850|753812|P3|STARTED|Overall Study||67
308239|NCT00002850|753813|P2|STARTED|Overall Study||76
308240|NCT00002850|753814|P1|STARTED|Overall Study||69
308241|NCT00002842|753822|P1|NOT COMPLETED|Overall Study||27
308242|NCT00002842|753822|P1|COMPLETED|Overall Study||22
308243|NCT00002842|753822|P1|STARTED|Overall Study||49
308244|NCT00002766|753828|P2|NOT COMPLETED|Overall Study||4
308245|NCT00002766|753829|P1|NOT COMPLETED|Overall Study||3
308246|NCT00002766|753828|P2|COMPLETED|Overall Study||85
308247|NCT00002766|753829|P1|COMPLETED|Overall Study||78
308248|NCT00002766|753828|P2|STARTED|Overall Study||89
308249|NCT00002766|753829|P1|STARTED|Overall Study||81
308250|NCT00002651|753837|P3|NOT COMPLETED|Consolidation and Randomization||860
308251|NCT00002651|753838|P2|NOT COMPLETED|Consolidation and Randomization||838
308252|NCT00002651|753839|P1|NOT COMPLETED|Consolidation and Randomization||0
308253|NCT00002651|753837|P3|COMPLETED|Consolidation and Randomization||22
308254|NCT00002651|753838|P2|COMPLETED|Consolidation and Randomization||29
308255|NCT00002651|753839|P1|COMPLETED|Consolidation and Randomization||0
308256|NCT00002651|753837|P3|Assessable for Toxicity|Consolidation and Randomization||702
308257|NCT00002651|753838|P2|Assessable for Toxicity|Consolidation and Randomization||732
308258|NCT00002651|753839|P1|Assessable for Toxicity|Consolidation and Randomization||0
308259|NCT00002651|753837|P3|Eligible|Consolidation and Randomization||770
308260|NCT00002651|753838|P2|Eligible|Consolidation and Randomization||765
308261|NCT00002651|753839|P1|Eligible|Consolidation and Randomization||0
308262|NCT00002651|753837|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
308263|NCT00002651|753838|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
308264|NCT00002651|753839|P1|STARTED|Consolidation and Randomization||0
308265|NCT00002651|753837|P3|NOT COMPLETED|Induction||0
308266|NCT00002651|753838|P2|NOT COMPLETED|Induction||0
308267|NCT00002651|753839|P1|NOT COMPLETED|Induction||1343
308268|NCT00002651|753837|P3|COMPLETED|Induction||0
308269|NCT00002651|753838|P2|COMPLETED|Induction||0
308270|NCT00002651|753839|P1|COMPLETED|Induction||1697
308271|NCT00002651|753837|P3|Eligible and Began Protocol Therapy|Induction||0
308272|NCT00002651|753838|P2|Eligible and Began Protocol Therapy|Induction||0
308273|NCT00002651|753839|P1|Eligible and Began Protocol Therapy|Induction||2950
308274|NCT00002651|753837|P3|Eligible|Induction||0
308275|NCT00002651|753838|P2|Eligible|Induction||0
308276|NCT00002651|753839|P1|Eligible|Induction||2950
308277|NCT00002651|753837|P3|STARTED|Induction||0
308278|NCT00002651|753838|P2|STARTED|Induction||0
308279|NCT00002651|753839|P1|STARTED|Induction||3040
308280|NCT00002558|753857|P2|NOT COMPLETED|Overall Study||1
308281|NCT00002558|753858|P1|NOT COMPLETED|Overall Study||0
308282|NCT00002558|753857|P2|COMPLETED|Overall Study||15
308283|NCT00002558|753858|P1|COMPLETED|Overall Study||92
308284|NCT00002558|753857|P2|STARTED|Overall Study||16
308285|NCT00002558|753858|P1|STARTED|Overall Study||92
308286|NCT00052078|753868|P4|NOT COMPLETED|Overall Study||15
308287|NCT00052078|753869|P3|NOT COMPLETED|Overall Study||13
308288|NCT00052078|753870|P2|NOT COMPLETED|Overall Study||6
308289|NCT00052078|753871|P1|NOT COMPLETED|Overall Study||23
308290|NCT00052078|753868|P4|COMPLETED|Overall Study||61
308291|NCT00052078|753869|P3|COMPLETED|Overall Study||127
308292|NCT00052078|753870|P2|COMPLETED|Overall Study||133
308293|NCT00052078|753871|P1|COMPLETED|Overall Study||110
308294|NCT00052078|753868|P4|STARTED|Overall Study||76
308295|NCT00052078|753869|P3|STARTED|Overall Study||140
308296|NCT00052078|753870|P2|STARTED|Overall Study||139
308297|NCT00052078|753871|P1|STARTED|Overall Study||133
308298|NCT00051636|753883|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
308299|NCT00051636|753884|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
308300|NCT00051636|753883|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
308301|NCT00051636|753884|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
308302|NCT00051636|753883|P2|STARTED|Period 2- Extended Observation Period||52
308303|NCT00051636|753884|P1|STARTED|Period 2- Extended Observation Period||75
308304|NCT00051636|753883|P2|NOT COMPLETED|Period 1 - Core||6
308305|NCT00051636|753884|P1|NOT COMPLETED|Period 1 - Core||4
308306|NCT00051636|753883|P2|COMPLETED|Period 1 - Core||76
308307|NCT00051636|753884|P1|COMPLETED|Period 1 - Core||86
308308|NCT00051636|753883|P2|STARTED|Period 1 - Core||82
308309|NCT00051636|753884|P1|STARTED|Period 1 - Core||90
308310|NCT00051558|753912|P2|NOT COMPLETED|Overall Study||96
308311|NCT00051558|753913|P1|NOT COMPLETED|Overall Study||91
308312|NCT00051558|753912|P2|COMPLETED|Overall Study||118
308313|NCT00051558|753913|P1|COMPLETED|Overall Study||123
308314|NCT00051558|753912|P2|STARTED|Overall Study||214
308315|NCT00051558|753913|P1|STARTED|Overall Study||214
308316|NCT00051363|753949|P2|NOT COMPLETED|Overall Study||144
308317|NCT00051363|753950|P1|NOT COMPLETED|Overall Study||115
308318|NCT00051363|753949|P2|COMPLETED|Overall Study||403
308319|NCT00051363|753950|P1|COMPLETED|Overall Study||443
308320|NCT00051363|753949|P2|Completed 6M Vist On-Study|Overall Study||403
308321|NCT00051363|753950|P1|Completed 6M Vist On-Study|Overall Study||443
308322|NCT00051363|753949|P2|Completed 6M Visit On-Treatment|Overall Study||372
308323|NCT00051363|753950|P1|Completed 6M Visit On-Treatment|Overall Study||427
308324|NCT00051363|753949|P2|Completed 2M Visit On-Study|Overall Study||432
308325|NCT00051363|753950|P1|Completed 2M Visit On-Study|Overall Study||468
308326|NCT00051363|753949|P2|Completed 2M Visit On-Treatment|Overall Study||417
308327|NCT00051363|753950|P1|Completed 2M Visit On-Treatment|Overall Study||456
308328|NCT00051363|753949|P2|Randomized & Analyzed|Overall Study||542
308329|NCT00051363|753950|P1|Randomized & Analyzed|Overall Study||556
308330|NCT00051363|753949|P2|STARTED|Overall Study||547
308331|NCT00051363|753950|P1|STARTED|Overall Study||558
308332|NCT00051168|753984|P1|NOT COMPLETED|Overall Study||135
308333|NCT00051168|753984|P1|COMPLETED|Overall Study||367
308334|NCT00051168|753984|P1|STARTED|Overall Study||502
308335|NCT00051025|753990|P2|NOT COMPLETED|Overall Study||4
308336|NCT00051025|753991|P1|NOT COMPLETED|Overall Study||2
308337|NCT00051025|753990|P2|COMPLETED|Overall Study||0
308338|NCT00051025|753991|P1|COMPLETED|Overall Study||3
308339|NCT00051025|753990|P2|STARTED|Overall Study||4
308340|NCT00051025|753991|P1|STARTED|Overall Study||5
308341|NCT00050986|753999|P1|NOT COMPLETED|Overall Study||2
308342|NCT00050986|753999|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
308343|NCT00050986|753999|P1|STARTED|Overall Study||55
308344|NCT00050960|754005|P2|NOT COMPLETED|Overall Study||304
308345|NCT00050960|754006|P1|NOT COMPLETED|Overall Study||302
308346|NCT00050960|754005|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
308347|NCT00050960|754006|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
308348|NCT00050960|754005|P2|STARTED|Overall Study||306
308349|NCT00050960|754006|P1|STARTED|Overall Study||306
308350|NCT00050778|754015|P3|NOT COMPLETED|Overall Study||18
308351|NCT00050778|754016|P2|NOT COMPLETED|Overall Study||21
308352|NCT00050778|754017|P1|NOT COMPLETED|Overall Study||45
308353|NCT00050778|754015|P3|COMPLETED|Overall Study||92
308354|NCT00050778|754016|P2|COMPLETED|Overall Study||92
308355|NCT00050778|754017|P1|COMPLETED|Overall Study||66
308356|NCT00050778|754015|P3|Treated|Overall Study||108
308357|NCT00050778|754016|P2|Treated|Overall Study||108
308358|NCT00050778|754017|P1|Treated|Overall Study||107
308359|NCT00050778|754015|P3|STARTED|Overall Study||110
308360|NCT00050778|754016|P2|STARTED|Overall Study||113
308361|NCT00050778|754017|P1|STARTED|Overall Study|Randomized.|111
308362|NCT00050622|754043|P1|NOT COMPLETED|Overall Study||1
308363|NCT00050622|754043|P1|COMPLETED|Overall Study||153
308364|NCT00050622|754043|P1|STARTED|Overall Study||154
308365|NCT00050167|754081|P2|NOT COMPLETED|Overall Study||1
308366|NCT00050167|754082|P1|NOT COMPLETED|Overall Study||1
308367|NCT00050167|754081|P2|COMPLETED|Overall Study||300
308368|NCT00050167|754082|P1|COMPLETED|Overall Study||301
308369|NCT00050167|754081|P2|STARTED|Overall Study||301
308370|NCT00050167|754082|P1|STARTED|Overall Study||302
308371|NCT00050089|754092|P4|NOT COMPLETED|Overall Study||0
308372|NCT00050089|754093|P3|NOT COMPLETED|Overall Study||0
308373|NCT00050089|754094|P2|NOT COMPLETED|Overall Study||0
308374|NCT00050089|754095|P1|NOT COMPLETED|Overall Study||0
308375|NCT00050089|754092|P4|COMPLETED|Overall Study|For primary outcome assessment|78
308376|NCT00050089|754093|P3|COMPLETED|Overall Study|For primary outcome assessment|86
308377|NCT00050089|754094|P2|COMPLETED|Overall Study|For primary outcome assessment|98
308378|NCT00050089|754095|P1|COMPLETED|Overall Study|For primary outcome assessment|106
308379|NCT00050089|754092|P4|Baseline|Overall Study||78
308380|NCT00050089|754093|P3|Baseline|Overall Study||86
308381|NCT00050089|754094|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
308382|NCT00050089|754095|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
308383|NCT00050089|754092|P4|STARTED|Overall Study||78
308384|NCT00050089|754093|P3|STARTED|Overall Study||86
308385|NCT00050089|754094|P2|STARTED|Overall Study||98
308386|NCT00050089|754095|P1|STARTED|Overall Study||106
308387|NCT00050011|754115|P2|NOT COMPLETED|Overall Study||126
308388|NCT00050011|754116|P1|NOT COMPLETED|Overall Study||121
308389|NCT00050011|754115|P2|COMPLETED|Overall Study||175
308390|NCT00050011|754116|P1|COMPLETED|Overall Study||180
308391|NCT00050011|754115|P2|Intent-to-treat Population|Overall Study||300
308392|NCT00050011|754116|P1|Intent-to-treat Population|Overall Study||300
308393|NCT00050011|754115|P2|STARTED|Overall Study||301
308394|NCT00050011|754116|P1|STARTED|Overall Study||301
308395|NCT00049842|754138|P2|NOT COMPLETED|Follow-up Phase||5
308396|NCT00049842|754139|P1|NOT COMPLETED|Follow-up Phase||7
308397|NCT00049842|754138|P2|COMPLETED|Follow-up Phase||189
308398|NCT00049842|754139|P1|COMPLETED|Follow-up Phase||211
308399|NCT00049842|754138|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
308400|NCT00049842|754139|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
308401|NCT00049842|754138|P2|NOT COMPLETED|Treatment Phase||78
308402|NCT00049842|754139|P1|NOT COMPLETED|Treatment Phase||93
308403|NCT00049842|754138|P2|COMPLETED|Treatment Phase||192
308404|NCT00049842|754139|P1|COMPLETED|Treatment Phase||177
308405|NCT00049842|754138|P2|STARTED|Treatment Phase||270
308406|NCT00049842|754139|P1|STARTED|Treatment Phase||270
308407|NCT00048932|754157|P3|NOT COMPLETED|Open Label Period (OL)||441
308408|NCT00048932|754158|P2|NOT COMPLETED|Open Label Period (OL)||0
308409|NCT00048932|754159|P1|NOT COMPLETED|Open Label Period (OL)||0
308410|NCT00048932|754157|P3|COMPLETED|Open Label Period (OL)||743
308411|NCT00048932|754158|P2|COMPLETED|Open Label Period (OL)||0
308412|NCT00048932|754159|P1|COMPLETED|Open Label Period (OL)||0
308413|NCT00048932|754157|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
308414|NCT00048932|754158|P2|STARTED|Open Label Period (OL)||0
308415|NCT00048932|754159|P1|STARTED|Open Label Period (OL)||0
308416|NCT00048932|754157|P3|NOT COMPLETED|Double Blind Period (DB)||0
308417|NCT00048932|754158|P2|NOT COMPLETED|Double Blind Period (DB)||87
308418|NCT00048932|754159|P1|NOT COMPLETED|Double Blind Period (DB)||123
308419|NCT00048932|754157|P3|COMPLETED|Double Blind Period (DB)||0
308420|NCT00048932|754158|P2|COMPLETED|Double Blind Period (DB)||395
308421|NCT00048932|754159|P1|COMPLETED|Double Blind Period (DB)||836
308422|NCT00048932|754157|P3|STARTED|Double Blind Period (DB)||0
308423|NCT00048932|754158|P2|STARTED|Double Blind Period (DB)|Number Treated|482
308424|NCT00048932|754159|P1|STARTED|Double Blind Period (DB)|Number Treated|959
308425|NCT00048815|754186|P3|NOT COMPLETED|Overall Study||4
308426|NCT00048815|754187|P2|NOT COMPLETED|Overall Study||4
308427|NCT00048815|754188|P1|NOT COMPLETED|Overall Study||6
308428|NCT00048815|754186|P3|COMPLETED|Overall Study||19
308429|NCT00048815|754187|P2|COMPLETED|Overall Study||22
308430|NCT00048815|754188|P1|COMPLETED|Overall Study||18
308431|NCT00048815|754186|P3|STARTED|Overall Study||23
308432|NCT00048815|754187|P2|STARTED|Overall Study||26
308433|NCT00048815|754188|P1|STARTED|Overall Study||24
308434|NCT00048581|754201|P3|NOT COMPLETED|Open-Label Period||167
308435|NCT00048581|754202|P2|NOT COMPLETED|Open-Label Period||0
308436|NCT00048581|754203|P1|NOT COMPLETED|Open-Label Period||0
308437|NCT00048581|754201|P3|COMPLETED|Open-Label Period||150
308438|NCT00048581|754202|P2|COMPLETED|Open-Label Period||0
308439|NCT00048581|754203|P1|COMPLETED|Open-Label Period||0
308440|NCT00048581|754201|P3|STARTED|Open-Label Period||317
308441|NCT00048581|754202|P2|STARTED|Open-Label Period||0
308442|NCT00048581|754203|P1|STARTED|Open-Label Period||0
308443|NCT00048581|754201|P3|NOT COMPLETED|Double-Blind Period||0
308444|NCT00048581|754202|P2|NOT COMPLETED|Double-Blind Period||34
308445|NCT00048581|754203|P1|NOT COMPLETED|Double-Blind Period||35
308446|NCT00048581|754201|P3|COMPLETED|Double-Blind Period||0
308447|NCT00048581|754202|P2|COMPLETED|Double-Blind Period||99
308448|NCT00048581|754203|P1|COMPLETED|Double-Blind Period||223
308449|NCT00048581|754201|P3|STARTED|Double-Blind Period||0
308450|NCT00048581|754202|P2|STARTED|Double-Blind Period||133
308451|NCT00048581|754203|P1|STARTED|Double-Blind Period||258
308452|NCT00048568|754370|P3|NOT COMPLETED|Open-Label Period||160
308453|NCT00048568|754371|P2|NOT COMPLETED|Open-Label Period||0
308454|NCT00048568|754372|P1|NOT COMPLETED|Open-Label Period||0
308455|NCT00048568|754370|P3|COMPLETED|Open-Label Period||379
308456|NCT00048568|754371|P2|COMPLETED|Open-Label Period||0
308457|NCT00048568|754372|P1|COMPLETED|Open-Label Period||0
308458|NCT00048568|754370|P3|STARTED|Open-Label Period||539
308459|NCT00048568|754371|P2|STARTED|Open-Label Period||0
308460|NCT00048568|754372|P1|STARTED|Open-Label Period||0
308461|NCT00048568|754370|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
308462|NCT00048568|754371|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
308463|NCT00048568|754372|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
308464|NCT00048568|754370|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
308465|NCT00048568|754371|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
308466|NCT00048568|754372|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
308467|NCT00048568|754370|P3|STARTED|Double-Blind Period Days 170 to 365||0
308468|NCT00048568|754371|P2|STARTED|Double-Blind Period Days 170 to 365||174
308469|NCT00048568|754372|P1|STARTED|Double-Blind Period Days 170 to 365||401
308470|NCT00048568|754370|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
308471|NCT00048568|754371|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
308472|NCT00048568|754372|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
308473|NCT00048568|754370|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
308474|NCT00048568|754371|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
308475|NCT00048568|754372|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
308476|NCT00048568|754370|P3|STARTED|Double-Blind Period Days 1 to 169||0
308477|NCT00048568|754371|P2|STARTED|Double-Blind Period Days 1 to 169||219
308478|NCT00048568|754372|P1|STARTED|Double-Blind Period Days 1 to 169||433
308479|NCT00048893|754660|P1|NOT COMPLETED|Overall Study||0
308480|NCT00048893|754660|P1|COMPLETED|Overall Study||37
308481|NCT00048893|754660|P1|STARTED|Overall Study||37
308482|NCT00048737|754671|P1|NOT COMPLETED|Overall Study||0
308483|NCT00048737|754671|P1|COMPLETED|Overall Study||70
308484|NCT00048737|754671|P1|STARTED|Overall Study||70
308485|NCT00048724|754677|P2|NOT COMPLETED|Overall Study||118
308486|NCT00048724|754678|P1|NOT COMPLETED|Overall Study||116
308487|NCT00048724|754677|P2|COMPLETED|Overall Study||197
308488|NCT00048724|754678|P1|COMPLETED|Overall Study||195
308489|NCT00048724|754677|P2|STARTED|Overall Study||315
308490|NCT00048724|754678|P1|STARTED|Overall Study||311
308491|NCT00048542|754690|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
308492|NCT00048542|754691|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
308493|NCT00048542|754692|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
308494|NCT00048542|754693|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
308495|NCT00048542|754694|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
308496|NCT00048542|754695|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
308497|NCT00048542|754696|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
308498|NCT00048542|754697|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
308499|NCT00048542|754690|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
308500|NCT00048542|754691|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
308501|NCT00048542|754692|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
308502|NCT00048542|754693|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
308503|NCT00048542|754694|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
308504|NCT00048542|754695|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
308505|NCT00048542|754696|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
308506|NCT00048542|754697|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
308507|NCT00048542|754690|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
308508|NCT00048542|754691|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
308509|NCT00048542|754692|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
308510|NCT00048542|754693|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
308511|NCT00048542|754694|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
308512|NCT00048542|754695|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
308513|NCT00048542|754696|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
308514|NCT00048542|754697|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
308515|NCT00048542|754690|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
308516|NCT00048542|754691|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
308517|NCT00048542|754692|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
308518|NCT00048542|754693|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
308519|NCT00048542|754694|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
308520|NCT00048542|754695|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
308521|NCT00048542|754696|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
308522|NCT00048542|754697|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
308523|NCT00048542|754690|P8|COMPLETED|Open-Label Extension BSA Phase||0
308524|NCT00048542|754691|P7|COMPLETED|Open-Label Extension BSA Phase||0
308525|NCT00048542|754692|P6|COMPLETED|Open-Label Extension BSA Phase||47
308526|NCT00048542|754693|P5|COMPLETED|Open-Label Extension BSA Phase||59
308527|NCT00048542|754694|P4|COMPLETED|Open-Label Extension BSA Phase||0
308528|NCT00048542|754695|P3|COMPLETED|Open-Label Extension BSA Phase||0
308529|NCT00048542|754696|P2|COMPLETED|Open-Label Extension BSA Phase||0
308530|NCT00048542|754697|P1|COMPLETED|Open-Label Extension BSA Phase||0
308531|NCT00048542|754690|P8|STARTED|Open-Label Extension BSA Phase||0
308532|NCT00048542|754691|P7|STARTED|Open-Label Extension BSA Phase||0
308533|NCT00048542|754692|P6|STARTED|Open-Label Extension BSA Phase||57
308534|NCT00048542|754693|P5|STARTED|Open-Label Extension BSA Phase||71
308535|NCT00048542|754694|P4|STARTED|Open-Label Extension BSA Phase||0
308536|NCT00048542|754695|P3|STARTED|Open-Label Extension BSA Phase||0
308537|NCT00048542|754696|P2|STARTED|Open-Label Extension BSA Phase||0
308538|NCT00048542|754697|P1|STARTED|Open-Label Extension BSA Phase||0
308539|NCT00048542|754690|P8|NOT COMPLETED|Double-Blind Phase||0
308540|NCT00048542|754691|P7|NOT COMPLETED|Double-Blind Phase||0
308541|NCT00048542|754692|P6|NOT COMPLETED|Double-Blind Phase||0
308542|NCT00048542|754693|P5|NOT COMPLETED|Double-Blind Phase||0
308543|NCT00048542|754694|P4|NOT COMPLETED|Double-Blind Phase||0
308544|NCT00048542|754695|P3|NOT COMPLETED|Double-Blind Phase||1
308545|NCT00048542|754696|P2|NOT COMPLETED|Double-Blind Phase||1
308546|NCT00048542|754697|P1|NOT COMPLETED|Double-Blind Phase||3
308547|NCT00048542|754690|P8|COMPLETED|Double-Blind Phase||0
308548|NCT00048542|754691|P7|COMPLETED|Double-Blind Phase||0
308549|NCT00048542|754692|P6|COMPLETED|Double-Blind Phase||0
308550|NCT00048542|754693|P5|COMPLETED|Double-Blind Phase||0
308551|NCT00048542|754694|P4|COMPLETED|Double-Blind Phase||28
308552|NCT00048542|754695|P3|COMPLETED|Double-Blind Phase||29
308553|NCT00048542|754696|P2|COMPLETED|Double-Blind Phase||36
308554|NCT00048542|754697|P1|COMPLETED|Double-Blind Phase||35
308555|NCT00048542|754690|P8|STARTED|Double-Blind Phase||0
308556|NCT00048542|754691|P7|STARTED|Double-Blind Phase||0
308557|NCT00048542|754692|P6|STARTED|Double-Blind Phase||0
308558|NCT00048542|754693|P5|STARTED|Double-Blind Phase||0
308559|NCT00048542|754694|P4|STARTED|Double-Blind Phase||28
308560|NCT00048542|754695|P3|STARTED|Double-Blind Phase||30
308561|NCT00048542|754696|P2|STARTED|Double-Blind Phase||37
308562|NCT00048542|754697|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
308563|NCT00048347|754763|P1|NOT COMPLETED|Overall Study||2
308564|NCT00048347|754763|P1|COMPLETED|Overall Study||16
308565|NCT00048347|754763|P1|STARTED|Overall Study||18
308566|NCT00048165|754769|P2|NOT COMPLETED|Completed 12 Months Study||3
308567|NCT00048165|754770|P1|NOT COMPLETED|Completed 12 Months Study||3
308568|NCT00048165|754769|P2|COMPLETED|Completed 12 Months Study||167
308569|NCT00048165|754770|P1|COMPLETED|Completed 12 Months Study||162
308570|NCT00048165|754769|P2|STARTED|Completed 12 Months Study||170
308571|NCT00048165|754770|P1|STARTED|Completed 12 Months Study||165
308572|NCT00048165|754769|P2|NOT COMPLETED|Completed 6 Months Study||48
308573|NCT00048165|754770|P1|NOT COMPLETED|Completed 6 Months Study||51
308574|NCT00048165|754769|P2|COMPLETED|Completed 6 Months Study||170
308575|NCT00048165|754770|P1|COMPLETED|Completed 6 Months Study||165
308576|NCT00048165|754769|P2|STARTED|Completed 6 Months Study||218
308577|NCT00048165|754770|P1|STARTED|Completed 6 Months Study||216
308578|NCT00048074|754805|P3|NOT COMPLETED|Overall Study||97
308579|NCT00048074|754806|P2|NOT COMPLETED|Overall Study||87
308580|NCT00048074|754807|P1|NOT COMPLETED|Overall Study||81
308581|NCT00048074|754805|P3|COMPLETED|Overall Study||372
308582|NCT00048074|754806|P2|COMPLETED|Overall Study||361
308583|NCT00048074|754807|P1|COMPLETED|Overall Study||384
308584|NCT00048074|754805|P3|STARTED|Overall Study||469
308585|NCT00048074|754806|P2|STARTED|Overall Study||448
308586|NCT00048074|754807|P1|STARTED|Overall Study||465
308587|NCT00048061|754864|P4|NOT COMPLETED|Overall Study||79
308588|NCT00048061|754865|P3|NOT COMPLETED|Overall Study||84
308589|NCT00048061|754866|P2|NOT COMPLETED|Overall Study||73
308590|NCT00048061|754867|P1|NOT COMPLETED|Overall Study||75
308591|NCT00048061|754864|P4|COMPLETED|Overall Study||322
308592|NCT00048061|754865|P3|COMPLETED|Overall Study||316
308593|NCT00048061|754866|P2|COMPLETED|Overall Study||328
308594|NCT00048061|754867|P1|COMPLETED|Overall Study||325
308595|NCT00048061|754864|P4|STARTED|Overall Study||401
308596|NCT00048061|754865|P3|STARTED|Overall Study||400
308597|NCT00048061|754866|P2|STARTED|Overall Study||401
308598|NCT00048061|754867|P1|STARTED|Overall Study||400
308599|NCT00048048|754946|P12|NOT COMPLETED|Extension Year 2||2
308600|NCT00048048|754947|P11|NOT COMPLETED|Extension Year 2||4
308601|NCT00048048|754948|P10|NOT COMPLETED|Extension Year 2||0
308602|NCT00048048|754949|P9|NOT COMPLETED|Extension Year 2||0
308603|NCT00048048|754950|P8|NOT COMPLETED|Extension Year 2||0
308604|NCT00048048|754951|P7|NOT COMPLETED|Extension Year 2||0
308605|NCT00048048|754952|P6|NOT COMPLETED|Extension Year 2||0
308606|NCT00048048|754953|P5|NOT COMPLETED|Extension Year 2||0
308607|NCT00048048|754954|P4|NOT COMPLETED|Extension Year 2||0
308608|NCT00048048|754955|P3|NOT COMPLETED|Extension Year 2||0
308609|NCT00048048|754956|P2|NOT COMPLETED|Extension Year 2||0
308610|NCT00048048|754957|P1|NOT COMPLETED|Extension Year 2||0
308611|NCT00048048|754946|P12|COMPLETED|Extension Year 2||13
308612|NCT00048048|754947|P11|COMPLETED|Extension Year 2||19
308613|NCT00048048|754948|P10|COMPLETED|Extension Year 2||2
308614|NCT00048048|754949|P9|COMPLETED|Extension Year 2||0
308615|NCT00048048|754950|P8|COMPLETED|Extension Year 2||0
308616|NCT00048048|754951|P7|COMPLETED|Extension Year 2||0
308617|NCT00048048|754952|P6|COMPLETED|Extension Year 2||0
308618|NCT00048048|754953|P5|COMPLETED|Extension Year 2||0
308619|NCT00048048|754954|P4|COMPLETED|Extension Year 2||0
308620|NCT00048048|754955|P3|COMPLETED|Extension Year 2||0
308621|NCT00048048|754956|P2|COMPLETED|Extension Year 2||0
308622|NCT00048048|754957|P1|COMPLETED|Extension Year 2||0
308623|NCT00048048|754946|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
308624|NCT00048048|754947|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
308625|NCT00048048|754948|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
308626|NCT00048048|754949|P9|STARTED|Extension Year 2||0
308627|NCT00048048|754950|P8|STARTED|Extension Year 2||0
308628|NCT00048048|754951|P7|STARTED|Extension Year 2||0
308629|NCT00048048|754952|P6|STARTED|Extension Year 2||0
308630|NCT00048048|754953|P5|STARTED|Extension Year 2||0
308631|NCT00048048|754954|P4|STARTED|Extension Year 2||0
308632|NCT00048048|754955|P3|STARTED|Extension Year 2||0
308633|NCT00048048|754956|P2|STARTED|Extension Year 2||0
308634|NCT00048048|754957|P1|STARTED|Extension Year 2||0
308635|NCT00048048|754946|P12|NOT COMPLETED|Extension Year 1||4
308636|NCT00048048|754947|P11|NOT COMPLETED|Extension Year 1||2
308637|NCT00048048|754948|P10|NOT COMPLETED|Extension Year 1||2
308638|NCT00048048|754949|P9|NOT COMPLETED|Extension Year 1||0
308639|NCT00048048|754950|P8|NOT COMPLETED|Extension Year 1||0
308640|NCT00048048|754951|P7|NOT COMPLETED|Extension Year 1||0
308641|NCT00048048|754952|P6|NOT COMPLETED|Extension Year 1||0
308642|NCT00048048|754953|P5|NOT COMPLETED|Extension Year 1||0
308643|NCT00048048|754954|P4|NOT COMPLETED|Extension Year 1||0
308644|NCT00048048|754955|P3|NOT COMPLETED|Extension Year 1||0
308645|NCT00048048|754956|P2|NOT COMPLETED|Extension Year 1||0
308646|NCT00048048|754957|P1|NOT COMPLETED|Extension Year 1||0
308647|NCT00048048|754946|P12|COMPLETED|Extension Year 1||15
308648|NCT00048048|754947|P11|COMPLETED|Extension Year 1||14
308649|NCT00048048|754948|P10|COMPLETED|Extension Year 1||14
308650|NCT00048048|754949|P9|COMPLETED|Extension Year 1||0
308651|NCT00048048|754950|P8|COMPLETED|Extension Year 1||0
308652|NCT00048048|754951|P7|COMPLETED|Extension Year 1||0
308653|NCT00048048|754952|P6|COMPLETED|Extension Year 1||0
308654|NCT00048048|754953|P5|COMPLETED|Extension Year 1||0
308655|NCT00048048|754954|P4|COMPLETED|Extension Year 1||0
308656|NCT00048048|754955|P3|COMPLETED|Extension Year 1||0
308657|NCT00048048|754956|P2|COMPLETED|Extension Year 1||0
308658|NCT00048048|754957|P1|COMPLETED|Extension Year 1||0
308659|NCT00048048|754946|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
308660|NCT00048048|754947|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
308661|NCT00048048|754948|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
308662|NCT00048048|754949|P9|STARTED|Extension Year 1||0
308663|NCT00048048|754950|P8|STARTED|Extension Year 1||0
308664|NCT00048048|754951|P7|STARTED|Extension Year 1||0
308665|NCT00048048|754952|P6|STARTED|Extension Year 1||0
308666|NCT00048048|754953|P5|STARTED|Extension Year 1||0
308667|NCT00048048|754954|P4|STARTED|Extension Year 1||0
308668|NCT00048048|754955|P3|STARTED|Extension Year 1||0
308669|NCT00048048|754956|P2|STARTED|Extension Year 1||0
308670|NCT00048048|754957|P1|STARTED|Extension Year 1||0
308671|NCT00048048|754946|P12|NOT COMPLETED|Core Treatment||0
308672|NCT00048048|754947|P11|NOT COMPLETED|Core Treatment||0
308673|NCT00048048|754948|P10|NOT COMPLETED|Core Treatment||0
308674|NCT00048048|754949|P9|NOT COMPLETED|Core Treatment||0
308675|NCT00048048|754950|P8|NOT COMPLETED|Core Treatment||1
308676|NCT00048048|754951|P7|NOT COMPLETED|Core Treatment||0
308677|NCT00048048|754952|P6|NOT COMPLETED|Core Treatment||0
308678|NCT00048048|754953|P5|NOT COMPLETED|Core Treatment||0
308679|NCT00048048|754954|P4|NOT COMPLETED|Core Treatment||0
308680|NCT00048048|754955|P3|NOT COMPLETED|Core Treatment||1
308681|NCT00048048|754956|P2|NOT COMPLETED|Core Treatment||0
308682|NCT00048048|754957|P1|NOT COMPLETED|Core Treatment||0
308683|NCT00048048|754946|P12|COMPLETED|Core Treatment||0
308684|NCT00048048|754947|P11|COMPLETED|Core Treatment||0
308685|NCT00048048|754948|P10|COMPLETED|Core Treatment||0
308686|NCT00048048|754949|P9|COMPLETED|Core Treatment||10
308687|NCT00048048|754950|P8|COMPLETED|Core Treatment||5
308688|NCT00048048|754951|P7|COMPLETED|Core Treatment||6
308689|NCT00048048|754952|P6|COMPLETED|Core Treatment||9
308690|NCT00048048|754953|P5|COMPLETED|Core Treatment||6
308691|NCT00048048|754954|P4|COMPLETED|Core Treatment||6
308692|NCT00048048|754955|P3|COMPLETED|Core Treatment||9
308693|NCT00048048|754956|P2|COMPLETED|Core Treatment||6
308694|NCT00048048|754957|P1|COMPLETED|Core Treatment||6
308695|NCT00048048|754946|P12|STARTED|Core Treatment||0
308696|NCT00048048|754947|P11|STARTED|Core Treatment||0
308697|NCT00048048|754948|P10|STARTED|Core Treatment||0
308698|NCT00048048|754949|P9|STARTED|Core Treatment||10
308699|NCT00048048|754950|P8|STARTED|Core Treatment||6
308700|NCT00048048|754951|P7|STARTED|Core Treatment||6
308701|NCT00048048|754952|P6|STARTED|Core Treatment||9
308702|NCT00048048|754953|P5|STARTED|Core Treatment||6
308703|NCT00048048|754954|P4|STARTED|Core Treatment||6
308704|NCT00048048|754955|P3|STARTED|Core Treatment||10
308705|NCT00048048|754956|P2|STARTED|Core Treatment||6
308706|NCT00048048|754957|P1|STARTED|Core Treatment||6
308707|NCT00048035|755013|P8|NOT COMPLETED|Extension Year 2||3
308708|NCT00048035|755014|P7|NOT COMPLETED|Extension Year 2||3
308709|NCT00048035|755015|P6|NOT COMPLETED|Extension Year 2||0
308710|NCT00048035|755016|P5|NOT COMPLETED|Extension Year 2||0
308711|NCT00048035|755017|P4|NOT COMPLETED|Extension Year 2||0
308712|NCT00048035|755018|P3|NOT COMPLETED|Extension Year 2||0
308713|NCT00048035|755019|P2|NOT COMPLETED|Extension Year 2||0
308714|NCT00048035|755020|P1|NOT COMPLETED|Extension Year 2||0
308715|NCT00048035|755013|P8|COMPLETED|Extension Year 2||10
308716|NCT00048035|755014|P7|COMPLETED|Extension Year 2||11
308717|NCT00048035|755015|P6|COMPLETED|Extension Year 2||0
308718|NCT00048035|755016|P5|COMPLETED|Extension Year 2||0
308719|NCT00048035|755017|P4|COMPLETED|Extension Year 2||0
308720|NCT00048035|755018|P3|COMPLETED|Extension Year 2||0
308721|NCT00048035|755019|P2|COMPLETED|Extension Year 2||0
308722|NCT00048035|755020|P1|COMPLETED|Extension Year 2||0
308723|NCT00048035|755013|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
308724|NCT00048035|755014|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
308725|NCT00048035|755015|P6|STARTED|Extension Year 2||0
308726|NCT00048035|755016|P5|STARTED|Extension Year 2||0
308727|NCT00048035|755017|P4|STARTED|Extension Year 2||0
308728|NCT00048035|755018|P3|STARTED|Extension Year 2||0
308729|NCT00048035|755019|P2|STARTED|Extension Year 2||0
308730|NCT00048035|755020|P1|STARTED|Extension Year 2||0
308731|NCT00048035|755013|P8|NOT COMPLETED|Extension Year 1||11
308732|NCT00048035|755014|P7|NOT COMPLETED|Extension Year 1||11
308733|NCT00048035|755015|P6|NOT COMPLETED|Extension Year 1||0
308734|NCT00048035|755016|P5|NOT COMPLETED|Extension Year 1||0
308735|NCT00048035|755017|P4|NOT COMPLETED|Extension Year 1||0
308736|NCT00048035|755018|P3|NOT COMPLETED|Extension Year 1||0
308737|NCT00048035|755019|P2|NOT COMPLETED|Extension Year 1||0
308738|NCT00048035|755020|P1|NOT COMPLETED|Extension Year 1||0
308739|NCT00048035|755013|P8|COMPLETED|Extension Year 1||15
308740|NCT00048035|755014|P7|COMPLETED|Extension Year 1||16
308741|NCT00048035|755015|P6|COMPLETED|Extension Year 1||0
308742|NCT00048035|755016|P5|COMPLETED|Extension Year 1||0
308743|NCT00048035|755017|P4|COMPLETED|Extension Year 1||0
308744|NCT00048035|755018|P3|COMPLETED|Extension Year 1||0
308745|NCT00048035|755019|P2|COMPLETED|Extension Year 1||0
308746|NCT00048035|755020|P1|COMPLETED|Extension Year 1||0
308747|NCT00048035|755013|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
308748|NCT00048035|755014|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
308749|NCT00048035|755015|P6|STARTED|Extension Year 1||0
308750|NCT00048035|755016|P5|STARTED|Extension Year 1||0
308751|NCT00048035|755017|P4|STARTED|Extension Year 1||0
308752|NCT00048035|755018|P3|STARTED|Extension Year 1||0
308753|NCT00048035|755019|P2|STARTED|Extension Year 1||0
308754|NCT00048035|755020|P1|STARTED|Extension Year 1||0
308755|NCT00048035|755013|P8|NOT COMPLETED|Core Period||0
308756|NCT00048035|755014|P7|NOT COMPLETED|Core Period||0
308757|NCT00048035|755015|P6|NOT COMPLETED|Core Period||1
308758|NCT00048035|755016|P5|NOT COMPLETED|Core Period||1
308759|NCT00048035|755017|P4|NOT COMPLETED|Core Period||1
308760|NCT00048035|755018|P3|NOT COMPLETED|Core Period||1
308761|NCT00048035|755019|P2|NOT COMPLETED|Core Period||2
308762|NCT00048035|755020|P1|NOT COMPLETED|Core Period||4
308763|NCT00048035|755013|P8|COMPLETED|Core Period||0
308764|NCT00048035|755014|P7|COMPLETED|Core Period||0
308765|NCT00048035|755015|P6|COMPLETED|Core Period||14
308766|NCT00048035|755016|P5|COMPLETED|Core Period||15
308767|NCT00048035|755017|P4|COMPLETED|Core Period||14
308768|NCT00048035|755018|P3|COMPLETED|Core Period||14
308769|NCT00048035|755019|P2|COMPLETED|Core Period||13
308770|NCT00048035|755020|P1|COMPLETED|Core Period||11
308771|NCT00048035|755013|P8|STARTED|Core Period||0
308772|NCT00048035|755014|P7|STARTED|Core Period||0
308773|NCT00048035|755015|P6|STARTED|Core Period||15
308774|NCT00048035|755016|P5|STARTED|Core Period||16
308775|NCT00048035|755017|P4|STARTED|Core Period||15
308776|NCT00048035|755018|P3|STARTED|Core Period||15
308777|NCT00048035|755019|P2|STARTED|Core Period||15
308778|NCT00048035|755020|P1|STARTED|Core Period||15
308779|NCT00047879|755058|P2|NOT COMPLETED|Overall Study||3
308780|NCT00047879|755059|P1|NOT COMPLETED|Overall Study||4
308781|NCT00047879|755058|P2|COMPLETED|Overall Study||0
308782|NCT00047879|755059|P1|COMPLETED|Overall Study||0
308783|NCT00047879|755058|P2|STARTED|Overall Study||3
308784|NCT00047879|755059|P1|STARTED|Overall Study||4
308785|NCT00047697|755071|P2|NOT COMPLETED|Overall Study||2
308786|NCT00047697|755072|P1|NOT COMPLETED|Overall Study||0
308787|NCT00047697|755071|P2|COMPLETED|Overall Study||14
308788|NCT00047697|755072|P1|COMPLETED|Overall Study||18
308789|NCT00047697|755071|P2|STARTED|Overall Study||16
308790|NCT00047697|755072|P1|STARTED|Overall Study||18
308791|NCT00047619|755084|P2|NOT COMPLETED|Overall Study||0
308792|NCT00047619|755085|P1|NOT COMPLETED|Overall Study||0
308793|NCT00047619|755084|P2|COMPLETED|Overall Study||14
308794|NCT00047619|755085|P1|COMPLETED|Overall Study||14
308795|NCT00047619|755084|P2|STARTED|Overall Study||14
308796|NCT00047619|755085|P1|STARTED|Overall Study||14
308797|NCT00047463|755095|P2|NOT COMPLETED|Overall Study||3
308798|NCT00047463|755096|P1|NOT COMPLETED|Overall Study||0
308799|NCT00047463|755095|P2|COMPLETED|Overall Study||19
308800|NCT00047463|755096|P1|COMPLETED|Overall Study||13
308801|NCT00047463|755095|P2|STARTED|Overall Study||22
308802|NCT00047463|755096|P1|STARTED|Overall Study||13
308803|NCT00046475|755107|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
308804|NCT00046475|755108|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
308805|NCT00046475|755109|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
308806|NCT00046475|755107|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
308807|NCT00046475|755108|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
308808|NCT00046475|755109|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
308809|NCT00046475|755107|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
308810|NCT00046475|755108|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
308811|NCT00046475|755109|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
308812|NCT00046475|755107|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
308813|NCT00046475|755108|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
308814|NCT00046475|755109|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
308815|NCT00046475|755107|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
308816|NCT00046475|755108|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
308817|NCT00046475|755109|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
308818|NCT00046475|755107|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
308819|NCT00046475|755108|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
308820|NCT00046475|755109|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
308821|NCT00046475|755107|P3|NOT COMPLETED|Titration (1 Week)||0
308822|NCT00046475|755108|P2|NOT COMPLETED|Titration (1 Week)||0
308823|NCT00046475|755109|P1|NOT COMPLETED|Titration (1 Week)||0
308824|NCT00046475|755107|P3|COMPLETED|Titration (1 Week)||0
308825|NCT00046475|755108|P2|COMPLETED|Titration (1 Week)||0
308826|NCT00046475|755109|P1|COMPLETED|Titration (1 Week)||136
308827|NCT00046475|755107|P3|STARTED|Titration (1 Week)||0
308828|NCT00046475|755108|P2|STARTED|Titration (1 Week)||0
308829|NCT00046475|755109|P1|STARTED|Titration (1 Week)||136
308830|NCT00046475|755107|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
308831|NCT00046475|755108|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
308832|NCT00046475|755109|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
308833|NCT00046475|755107|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
308834|NCT00046475|755108|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
308835|NCT00046475|755109|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
308836|NCT00046475|755107|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
308837|NCT00046475|755108|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
308838|NCT00046475|755109|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
308839|NCT00046566|755148|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
308840|NCT00046566|755149|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
308841|NCT00046566|755150|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
308842|NCT00046566|755148|P3|COMPLETED|Intervention 3 (8 Weeks)||88
308843|NCT00046566|755149|P2|COMPLETED|Intervention 3 (8 Weeks)||92
308844|NCT00046566|755150|P1|COMPLETED|Intervention 3 (8 Weeks)||93
308845|NCT00046566|755148|P3|STARTED|Intervention 3 (8 Weeks)||88
308846|NCT00046566|755149|P2|STARTED|Intervention 3 (8 Weeks)||92
308847|NCT00046566|755150|P1|STARTED|Intervention 3 (8 Weeks)||93
308848|NCT00046566|755148|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
308849|NCT00046566|755149|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
308850|NCT00046566|755150|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
308851|NCT00046566|755148|P3|COMPLETED|Intervention 2 (8 Weeks)||88
308852|NCT00046566|755149|P2|COMPLETED|Intervention 2 (8 Weeks)||92
308853|NCT00046566|755150|P1|COMPLETED|Intervention 2 (8 Weeks)||93
308854|NCT00046566|755148|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
308855|NCT00046566|755149|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
308856|NCT00046566|755150|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
308857|NCT00046566|755148|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
308858|NCT00046566|755149|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
308859|NCT00046566|755150|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
308860|NCT00046566|755148|P3|COMPLETED|Intervention 1 (8 Weeks)||101
308861|NCT00046566|755149|P2|COMPLETED|Intervention 1 (8 Weeks)||104
308862|NCT00046566|755150|P1|COMPLETED|Intervention 1 (8 Weeks)||101
308863|NCT00046566|755148|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
308864|NCT00046566|755149|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
308865|NCT00046566|755150|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
308866|NCT00046228|755167|P3|NOT COMPLETED|1 Year||12
308867|NCT00046228|755168|P2|NOT COMPLETED|1 Year||14
308868|NCT00046228|755169|P1|NOT COMPLETED|1 Year||19
308869|NCT00046228|755167|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
308870|NCT00046228|755168|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
308871|NCT00046228|755169|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
308872|NCT00046228|755167|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
308873|NCT00046228|755168|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
308874|NCT00046228|755169|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
308875|NCT00046228|755167|P3|NOT COMPLETED|90 Days||15
308876|NCT00046228|755168|P2|NOT COMPLETED|90 Days||8
308877|NCT00046228|755169|P1|NOT COMPLETED|90 Days||13
308878|NCT00046228|755167|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
308879|NCT00046228|755168|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
308880|NCT00046228|755169|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
308881|NCT00046228|755167|P3|STARTED|90 Days||828
308882|NCT00046228|755168|P2|STARTED|90 Days||818
308883|NCT00046228|755169|P1|STARTED|90 Days||806
308884|NCT00045942|755213|P9|NOT COMPLETED|PKC412A2104E2||6
308885|NCT00045942|755214|P8|NOT COMPLETED|PKC412A2104E2||7
308886|NCT00045942|755215|P7|NOT COMPLETED|PKC412A2104E2||7
308887|NCT00045942|755216|P6|NOT COMPLETED|PKC412A2104E2||9
308888|NCT00045942|755217|P5|NOT COMPLETED|PKC412A2104E2||0
308889|NCT00045942|755218|P4|NOT COMPLETED|PKC412A2104E2||0
308890|NCT00045942|755219|P3|NOT COMPLETED|PKC412A2104E2||0
308891|NCT00045942|755220|P2|NOT COMPLETED|PKC412A2104E2||0
308892|NCT00045942|755221|P1|NOT COMPLETED|PKC412A2104E2||0
308893|NCT00045942|755213|P9|COMPLETED|PKC412A2104E2||0
308894|NCT00045942|755214|P8|COMPLETED|PKC412A2104E2||0
308895|NCT00045942|755215|P7|COMPLETED|PKC412A2104E2||0
308896|NCT00045942|755216|P6|COMPLETED|PKC412A2104E2||0
308897|NCT00045942|755217|P5|COMPLETED|PKC412A2104E2||0
308898|NCT00045942|755218|P4|COMPLETED|PKC412A2104E2||0
308899|NCT00045942|755219|P3|COMPLETED|PKC412A2104E2||0
308900|NCT00045942|755220|P2|COMPLETED|PKC412A2104E2||0
308901|NCT00045942|755221|P1|COMPLETED|PKC412A2104E2||0
308902|NCT00045942|755213|P9|Primary Efficacy|PKC412A2104E2||6
308903|NCT00045942|755214|P8|Primary Efficacy|PKC412A2104E2||7
308904|NCT00045942|755215|P7|Primary Efficacy|PKC412A2104E2||7
308905|NCT00045942|755216|P6|Primary Efficacy|PKC412A2104E2||9
308906|NCT00045942|755217|P5|Primary Efficacy|PKC412A2104E2||0
308907|NCT00045942|755218|P4|Primary Efficacy|PKC412A2104E2||0
308908|NCT00045942|755219|P3|Primary Efficacy|PKC412A2104E2||0
308909|NCT00045942|755220|P2|Primary Efficacy|PKC412A2104E2||0
308910|NCT00045942|755221|P1|Primary Efficacy|PKC412A2104E2||0
308911|NCT00045942|755213|P9|STARTED|PKC412A2104E2||6
308912|NCT00045942|755214|P8|STARTED|PKC412A2104E2||7
308913|NCT00045942|755215|P7|STARTED|PKC412A2104E2||7
308914|NCT00045942|755216|P6|STARTED|PKC412A2104E2||9
308915|NCT00045942|755217|P5|STARTED|PKC412A2104E2||0
308916|NCT00045942|755218|P4|STARTED|PKC412A2104E2||0
308917|NCT00045942|755219|P3|STARTED|PKC412A2104E2||0
308918|NCT00045942|755220|P2|STARTED|PKC412A2104E2||0
308919|NCT00045942|755221|P1|STARTED|PKC412A2104E2||0
308920|NCT00045942|755213|P9|NOT COMPLETED|PKC412A2104E1||0
308921|NCT00045942|755214|P8|NOT COMPLETED|PKC412A2104E1||0
308922|NCT00045942|755215|P7|NOT COMPLETED|PKC412A2104E1||0
308923|NCT00045942|755216|P6|NOT COMPLETED|PKC412A2104E1||0
308924|NCT00045942|755217|P5|NOT COMPLETED|PKC412A2104E1||27
308925|NCT00045942|755218|P4|NOT COMPLETED|PKC412A2104E1||33
308926|NCT00045942|755219|P3|NOT COMPLETED|PKC412A2104E1||17
308927|NCT00045942|755220|P2|NOT COMPLETED|PKC412A2104E1||18
308928|NCT00045942|755221|P1|NOT COMPLETED|PKC412A2104E1||0
308929|NCT00045942|755213|P9|COMPLETED|PKC412A2104E1||0
308930|NCT00045942|755214|P8|COMPLETED|PKC412A2104E1||0
308931|NCT00045942|755215|P7|COMPLETED|PKC412A2104E1||0
308932|NCT00045942|755216|P6|COMPLETED|PKC412A2104E1||0
308933|NCT00045942|755217|P5|COMPLETED|PKC412A2104E1||0
308934|NCT00045942|755218|P4|COMPLETED|PKC412A2104E1||0
308935|NCT00045942|755219|P3|COMPLETED|PKC412A2104E1||0
308936|NCT00045942|755220|P2|COMPLETED|PKC412A2104E1||0
308937|NCT00045942|755221|P1|COMPLETED|PKC412A2104E1||0
308938|NCT00045942|755213|P9|Primary Efficacy|PKC412A2104E1||0
308939|NCT00045942|755214|P8|Primary Efficacy|PKC412A2104E1||0
308940|NCT00045942|755215|P7|Primary Efficacy|PKC412A2104E1||0
308941|NCT00045942|755216|P6|Primary Efficacy|PKC412A2104E1||0
308942|NCT00045942|755217|P5|Primary Efficacy|PKC412A2104E1||25
308943|NCT00045942|755218|P4|Primary Efficacy|PKC412A2104E1||32
308944|NCT00045942|755219|P3|Primary Efficacy|PKC412A2104E1||17
308945|NCT00045942|755220|P2|Primary Efficacy|PKC412A2104E1||18
308946|NCT00045942|755221|P1|Primary Efficacy|PKC412A2104E1||0
308947|NCT00045942|755213|P9|STARTED|PKC412A2104E1||0
308948|NCT00045942|755214|P8|STARTED|PKC412A2104E1||0
308949|NCT00045942|755215|P7|STARTED|PKC412A2104E1||0
308950|NCT00045942|755216|P6|STARTED|PKC412A2104E1||0
308951|NCT00045942|755217|P5|STARTED|PKC412A2104E1||27
308952|NCT00045942|755218|P4|STARTED|PKC412A2104E1||33
308953|NCT00045942|755219|P3|STARTED|PKC412A2104E1||17
308954|NCT00045942|755220|P2|STARTED|PKC412A2104E1||18
308955|NCT00045942|755221|P1|STARTED|PKC412A2104E1||0
308956|NCT00045942|755213|P9|NOT COMPLETED|PKC412A2104 (Core)||0
308957|NCT00045942|755214|P8|NOT COMPLETED|PKC412A2104 (Core)||0
308958|NCT00045942|755215|P7|NOT COMPLETED|PKC412A2104 (Core)||0
308959|NCT00045942|755216|P6|NOT COMPLETED|PKC412A2104 (Core)||0
308960|NCT00045942|755217|P5|NOT COMPLETED|PKC412A2104 (Core)||0
308961|NCT00045942|755218|P4|NOT COMPLETED|PKC412A2104 (Core)||0
308962|NCT00045942|755219|P3|NOT COMPLETED|PKC412A2104 (Core)||0
308963|NCT00045942|755220|P2|NOT COMPLETED|PKC412A2104 (Core)||0
308964|NCT00045942|755221|P1|NOT COMPLETED|PKC412A2104 (Core)||20
308965|NCT00045942|755213|P9|COMPLETED|PKC412A2104 (Core)||0
308966|NCT00045942|755214|P8|COMPLETED|PKC412A2104 (Core)||0
308967|NCT00045942|755215|P7|COMPLETED|PKC412A2104 (Core)||0
308968|NCT00045942|755216|P6|COMPLETED|PKC412A2104 (Core)||0
308969|NCT00045942|755217|P5|COMPLETED|PKC412A2104 (Core)||0
308970|NCT00045942|755218|P4|COMPLETED|PKC412A2104 (Core)||0
308971|NCT00045942|755219|P3|COMPLETED|PKC412A2104 (Core)||0
308972|NCT00045942|755220|P2|COMPLETED|PKC412A2104 (Core)||0
308973|NCT00045942|755221|P1|COMPLETED|PKC412A2104 (Core)||0
308974|NCT00045942|755213|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
308975|NCT00045942|755214|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
308976|NCT00045942|755215|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
308977|NCT00045942|755216|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
308978|NCT00045942|755217|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
308979|NCT00045942|755218|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
308980|NCT00045942|755219|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
308981|NCT00045942|755220|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
308982|NCT00045942|755221|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
308983|NCT00045942|755213|P9|STARTED|PKC412A2104 (Core)||0
308984|NCT00045942|755214|P8|STARTED|PKC412A2104 (Core)||0
308985|NCT00045942|755215|P7|STARTED|PKC412A2104 (Core)||0
308986|NCT00045942|755216|P6|STARTED|PKC412A2104 (Core)||0
308987|NCT00045942|755217|P5|STARTED|PKC412A2104 (Core)||0
308988|NCT00045942|755218|P4|STARTED|PKC412A2104 (Core)||0
308989|NCT00045942|755219|P3|STARTED|PKC412A2104 (Core)||0
308990|NCT00045942|755220|P2|STARTED|PKC412A2104 (Core)||0
308991|NCT00045942|755221|P1|STARTED|PKC412A2104 (Core)||20
308992|NCT00044655|755303|P2|NOT COMPLETED|Overall Study||38
308993|NCT00044655|755304|P1|NOT COMPLETED|Overall Study||20
308994|NCT00044655|755303|P2|COMPLETED|Overall Study||79
308995|NCT00044655|755304|P1|COMPLETED|Overall Study||82
308996|NCT00044655|755303|P2|STARTED|Overall Study||117
308997|NCT00044655|755304|P1|STARTED|Overall Study||102
308998|NCT00044512|755310|P1|NOT COMPLETED|Follow Up||2
308999|NCT00044512|755310|P1|COMPLETED|Follow Up||135
309000|NCT00044512|755310|P1|STARTED|Follow Up||137
309001|NCT00044512|755310|P1|NOT COMPLETED|Treatment||0
309002|NCT00044512|755310|P1|COMPLETED|Treatment||137
309003|NCT00044512|755310|P1|STARTED|Treatment||137
309004|NCT00044213|755325|P4|NOT COMPLETED|Overall Study||136
309005|NCT00044213|755326|P3|NOT COMPLETED|Overall Study||138
309006|NCT00044213|755327|P2|NOT COMPLETED|Overall Study||112
309007|NCT00044213|755328|P1|NOT COMPLETED|Overall Study||100
309008|NCT00044213|755325|P4|COMPLETED|Overall Study||301
309009|NCT00044213|755326|P3|COMPLETED|Overall Study||294
309010|NCT00044213|755327|P2|COMPLETED|Overall Study||306
309011|NCT00044213|755328|P1|COMPLETED|Overall Study||321
309012|NCT00044213|755325|P4|STARTED|Overall Study||437
309013|NCT00044213|755326|P3|STARTED|Overall Study||432
309014|NCT00044213|755327|P2|STARTED|Overall Study||418
309015|NCT00044213|755328|P1|STARTED|Overall Study||421
309016|NCT00044044|755347|P5|NOT COMPLETED|Overall Study||36
309017|NCT00044044|755348|P4|NOT COMPLETED|Overall Study||44
309018|NCT00044044|755349|P3|NOT COMPLETED|Overall Study||40
309019|NCT00044044|755350|P2|NOT COMPLETED|Overall Study||41
309020|NCT00044044|755351|P1|NOT COMPLETED|Overall Study||44
309021|NCT00044044|755347|P5|COMPLETED|Overall Study||36
309022|NCT00044044|755348|P4|COMPLETED|Overall Study||29
309023|NCT00044044|755349|P3|COMPLETED|Overall Study||31
309024|NCT00044044|755350|P2|COMPLETED|Overall Study||28
309025|NCT00044044|755351|P1|COMPLETED|Overall Study||27
309026|NCT00044044|755347|P5|STARTED|Overall Study||72
309027|NCT00044044|755348|P4|STARTED|Overall Study||73
309028|NCT00044044|755349|P3|STARTED|Overall Study||71
309029|NCT00044044|755350|P2|STARTED|Overall Study||69
309030|NCT00044044|755351|P1|STARTED|Overall Study||71
309031|NCT00044005|755381|P3|NOT COMPLETED|Overall Study||22
309032|NCT00044005|755382|P2|NOT COMPLETED|Overall Study||14
309033|NCT00044005|755383|P1|NOT COMPLETED|Overall Study||19
309034|NCT00044005|755381|P3|COMPLETED|Overall Study||11
309035|NCT00044005|755382|P2|COMPLETED|Overall Study||19
309036|NCT00044005|755383|P1|COMPLETED|Overall Study||13
309037|NCT00044005|755381|P3|STARTED|Overall Study||33
309038|NCT00044005|755382|P2|STARTED|Overall Study||33
309039|NCT00044005|755383|P1|STARTED|Overall Study||32
309040|NCT00043979|755393|P3|NOT COMPLETED|Period 2||0
309041|NCT00043979|755394|P2|NOT COMPLETED|Period 2||0
309042|NCT00043979|755395|P1|NOT COMPLETED|Period 2||0
309043|NCT00043979|755393|P3|COMPLETED|Period 2||10
309044|NCT00043979|755394|P2|COMPLETED|Period 2||13
309045|NCT00043979|755395|P1|COMPLETED|Period 2||0
309046|NCT00043979|755393|P3|STARTED|Period 2||10
309047|NCT00043979|755394|P2|STARTED|Period 2||13
309048|NCT00043979|755395|P1|STARTED|Period 2||0
309049|NCT00043979|755393|P3|NOT COMPLETED|Period 1||3
309050|NCT00043979|755394|P2|NOT COMPLETED|Period 1||4
309051|NCT00043979|755395|P1|NOT COMPLETED|Period 1||7
309052|NCT00043979|755393|P3|COMPLETED|Period 1||10
309053|NCT00043979|755394|P2|COMPLETED|Period 1||13
309054|NCT00043979|755395|P1|COMPLETED|Period 1||23
309055|NCT00043979|755393|P3|STARTED|Period 1||13
309056|NCT00043979|755394|P2|STARTED|Period 1||17
309057|NCT00043979|755395|P1|STARTED|Period 1||30
309058|NCT00043550|755416|P3|NOT COMPLETED|Overall Study||20
309059|NCT00043550|755417|P2|NOT COMPLETED|Overall Study||12
309060|NCT00043550|755418|P1|NOT COMPLETED|Overall Study||22
309061|NCT00043550|755416|P3|COMPLETED|Overall Study||30
309062|NCT00043550|755417|P2|COMPLETED|Overall Study||39
309063|NCT00043550|755418|P1|COMPLETED|Overall Study||33
309064|NCT00043550|755416|P3|Week 8 Completed|Overall Study||35
309065|NCT00043550|755417|P2|Week 8 Completed|Overall Study||40
309066|NCT00043550|755418|P1|Week 8 Completed|Overall Study||35
309067|NCT00043550|755416|P3|STARTED|Overall Study||50
309068|NCT00043550|755417|P2|STARTED|Overall Study||51
309069|NCT00043550|755418|P1|STARTED|Overall Study||55
309070|NCT00043186|755435|P9|NOT COMPLETED|Overall Study||17
309071|NCT00043186|755436|P8|NOT COMPLETED|Overall Study||16
309072|NCT00043186|755437|P7|NOT COMPLETED|Overall Study||17
309073|NCT00043186|755438|P6|NOT COMPLETED|Overall Study||8
309074|NCT00043186|755439|P5|NOT COMPLETED|Overall Study||18
309075|NCT00043186|755440|P4|NOT COMPLETED|Overall Study||22
309076|NCT00043186|755441|P3|NOT COMPLETED|Overall Study||20
309077|NCT00043186|755442|P2|NOT COMPLETED|Overall Study||15
309078|NCT00043186|755443|P1|NOT COMPLETED|Overall Study||17
309079|NCT00043186|755435|P9|COMPLETED|Overall Study||30
309080|NCT00043186|755436|P8|COMPLETED|Overall Study||31
309081|NCT00043186|755437|P7|COMPLETED|Overall Study||25
309082|NCT00043186|755438|P6|COMPLETED|Overall Study||39
309083|NCT00043186|755439|P5|COMPLETED|Overall Study||36
309084|NCT00043186|755440|P4|COMPLETED|Overall Study||19
309085|NCT00043186|755441|P3|COMPLETED|Overall Study||24
309086|NCT00043186|755442|P2|COMPLETED|Overall Study||29
309087|NCT00043186|755443|P1|COMPLETED|Overall Study||29
309088|NCT00043186|755435|P9|STARTED|Overall Study||47
309089|NCT00043186|755436|P8|STARTED|Overall Study||47
309090|NCT00043186|755437|P7|STARTED|Overall Study||42
309091|NCT00043186|755438|P6|STARTED|Overall Study||47
309092|NCT00043186|755439|P5|STARTED|Overall Study||54
309093|NCT00043186|755440|P4|STARTED|Overall Study||41
309094|NCT00043186|755441|P3|STARTED|Overall Study||44
309095|NCT00043186|755442|P2|STARTED|Overall Study||44
309096|NCT00043186|755443|P1|STARTED|Overall Study||46
309097|NCT00042432|755771|P2|NOT COMPLETED|Overall Study||7
309098|NCT00042432|755772|P1|NOT COMPLETED|Overall Study||9
309099|NCT00042432|755771|P2|COMPLETED|Overall Study||20
309100|NCT00042432|755772|P1|COMPLETED|Overall Study||18
309101|NCT00042432|755771|P2|STARTED|Overall Study||27
309102|NCT00042432|755772|P1|STARTED|Overall Study||27
309103|NCT00042224|755782|P2|NOT COMPLETED|Overall Study||3
309104|NCT00042224|755783|P1|NOT COMPLETED|Overall Study||3
309105|NCT00042224|755782|P2|COMPLETED|Overall Study||16
309106|NCT00042224|755783|P1|COMPLETED|Overall Study||17
309107|NCT00042224|755782|P2|STARTED|Overall Study||19
309108|NCT00042224|755783|P1|STARTED|Overall Study||20
309109|NCT00041938|755791|P2|NOT COMPLETED|Overall Study||31
309110|NCT00041938|755792|P1|NOT COMPLETED|Overall Study||38
309111|NCT00041938|755791|P2|COMPLETED|Overall Study||1111
309112|NCT00041938|755792|P1|COMPLETED|Overall Study||1125
309113|NCT00041938|755791|P2|Withdrew Consent|Overall Study||14
309114|NCT00041938|755792|P1|Withdrew Consent|Overall Study||20
309115|NCT00041938|755791|P2|Lost to Follow-up|Overall Study||17
309116|NCT00041938|755792|P1|Lost to Follow-up|Overall Study||18
309117|NCT00041938|755791|P2|Only Vital Status Known|Overall Study||46
309118|NCT00041938|755792|P1|Only Vital Status Known|Overall Study||44
309119|NCT00041938|755791|P2|Primary Endpoint|Overall Study||302
309120|NCT00041938|755792|P1|Primary Endpoint|Overall Study||320
309121|NCT00041938|755791|P2|Completed Follow-up|Overall Study||745
309122|NCT00041938|755792|P1|Completed Follow-up|Overall Study||761
309123|NCT00041938|755791|P2|STARTED|Overall Study||1142
309124|NCT00041938|755792|P1|STARTED|Overall Study||1163
309125|NCT00041756|755825|P5|NOT COMPLETED|Overall Study||60
309126|NCT00041756|755826|P4|NOT COMPLETED|Overall Study||16
309127|NCT00041756|755827|P3|NOT COMPLETED|Overall Study||13
309128|NCT00041756|755828|P2|NOT COMPLETED|Overall Study||15
309129|NCT00041756|755829|P1|NOT COMPLETED|Overall Study||8
309130|NCT00041756|755825|P5|COMPLETED|Overall Study||19
309131|NCT00041756|755826|P4|COMPLETED|Overall Study||64
309132|NCT00041756|755827|P3|COMPLETED|Overall Study||66
309133|NCT00041756|755828|P2|COMPLETED|Overall Study||65
309134|NCT00041756|755829|P1|COMPLETED|Overall Study||69
309135|NCT00041756|755825|P5|STARTED|Overall Study||79
309136|NCT00041756|755826|P4|STARTED|Overall Study||80
309137|NCT00041756|755827|P3|STARTED|Overall Study||79
309138|NCT00041756|755828|P2|STARTED|Overall Study||80
309139|NCT00041756|755829|P1|STARTED|Overall Study||77
309140|NCT00041717|755848|P2|NOT COMPLETED|Overall Study||12
309141|NCT00041717|755849|P1|NOT COMPLETED|Overall Study||33
309142|NCT00041717|755848|P2|COMPLETED|Overall Study||86
309143|NCT00041717|755849|P1|COMPLETED|Overall Study||81
309144|NCT00041717|755848|P2|STARTED|Overall Study||98
309145|NCT00041717|755849|P1|STARTED|Overall Study||114
309146|NCT00041470|755857|P1|NOT COMPLETED|Overall Study||38
309147|NCT00041470|755857|P1|COMPLETED|Overall Study||0
309148|NCT00041470|755857|P1|STARTED|Overall Study||38
309149|NCT00040664|755862|P4|NOT COMPLETED|Overall Study||27
309150|NCT00040664|755863|P3|NOT COMPLETED|Overall Study||13
309151|NCT00040664|755864|P2|NOT COMPLETED|Overall Study||13
309152|NCT00040664|755865|P1|NOT COMPLETED|Overall Study||53
309153|NCT00040664|755862|P4|COMPLETED|Overall Study||8
309154|NCT00040664|755863|P3|COMPLETED|Overall Study||4
309155|NCT00040664|755864|P2|COMPLETED|Overall Study||4
309156|NCT00040664|755865|P1|COMPLETED|Overall Study||16
309157|NCT00040664|755862|P4|STARTED|Overall Study||35
309158|NCT00040664|755863|P3|STARTED|Overall Study||17
309159|NCT00040664|755864|P2|STARTED|Overall Study||17
309160|NCT00040664|755865|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
309161|NCT00041392|755915|P2|NOT COMPLETED|Overall Study||0
309162|NCT00041392|755916|P1|NOT COMPLETED|Overall Study||0
309163|NCT00041392|755915|P2|COMPLETED|Overall Study||191
309164|NCT00041392|755916|P1|COMPLETED|Overall Study||198
309165|NCT00041392|755915|P2|STARTED|Overall Study||191
309166|NCT00041392|755916|P1|STARTED|Overall Study||198
309167|NCT00040365|755922|P1|NOT COMPLETED|Overall Study||11
309168|NCT00040365|755922|P1|COMPLETED|Overall Study||19
309169|NCT00040365|755922|P1|Completed Follow Up Phase|Overall Study||19
309170|NCT00040365|755922|P1|STARTED|Overall Study||30
309171|NCT00039871|755931|P1|NOT COMPLETED|Overall Study||1384
309172|NCT00039871|755931|P1|COMPLETED|Overall Study||928
309173|NCT00039871|755931|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
309174|NCT00039741|755941|P4|NOT COMPLETED|Overall Study||14
309175|NCT00039741|755942|P3|NOT COMPLETED|Overall Study||11
309176|NCT00039741|755943|P2|NOT COMPLETED|Overall Study||12
309177|NCT00039741|755944|P1|NOT COMPLETED|Overall Study||15
309178|NCT00039741|755941|P4|COMPLETED|Overall Study||50
309179|NCT00039741|755942|P3|COMPLETED|Overall Study||54
309180|NCT00039741|755943|P2|COMPLETED|Overall Study||56
309181|NCT00039741|755944|P1|COMPLETED|Overall Study||51
309182|NCT00039741|755941|P4|Death|Overall Study||0
309183|NCT00039741|755942|P3|Death|Overall Study||0
309184|NCT00039741|755943|P2|Death|Overall Study||1
309185|NCT00039741|755944|P1|Death|Overall Study||0
309186|NCT00039741|755941|P4|STARTED|Overall Study||64
309187|NCT00039741|755942|P3|STARTED|Overall Study||65
309188|NCT00039741|755943|P2|STARTED|Overall Study||68
309189|NCT00039741|755944|P1|STARTED|Overall Study||66
309190|NCT00038948|755988|P2|NOT COMPLETED|Overall Study||77
309191|NCT00038948|755989|P1|NOT COMPLETED|Overall Study||169
309192|NCT00038948|755988|P2|COMPLETED|Overall Study||198
309193|NCT00038948|755989|P1|COMPLETED|Overall Study||386
309194|NCT00038948|755988|P2|STARTED|Overall Study||275
309195|NCT00038948|755989|P1|STARTED|Overall Study||555
309196|NCT00038857|756001|P1|NOT COMPLETED|Overall Study||1
309197|NCT00038857|756001|P1|COMPLETED|Overall Study||28
309198|NCT00038857|756001|P1|STARTED|Overall Study||29
309199|NCT00038727|756008|P3|NOT COMPLETED|Overall Study||0
309200|NCT00038727|756009|P2|NOT COMPLETED|Overall Study||0
309201|NCT00038727|756010|P1|NOT COMPLETED|Overall Study||0
309202|NCT00038727|756008|P3|COMPLETED|Overall Study||936
309203|NCT00038727|756009|P2|COMPLETED|Overall Study||927
309204|NCT00038727|756010|P1|COMPLETED|Overall Study||916
309205|NCT00038727|756008|P3|DPPOS Phase 3 Enrolled|Overall Study||936
309206|NCT00038727|756009|P2|DPPOS Phase 3 Enrolled|Overall Study||927
309207|NCT00038727|756010|P1|DPPOS Phase 3 Enrolled|Overall Study||916
309208|NCT00038727|756008|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
309209|NCT00038727|756009|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
309210|NCT00038727|756010|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
309211|NCT00038727|756008|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
309212|NCT00038727|756009|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
309213|NCT00038727|756010|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
309214|NCT00038727|756008|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
309215|NCT00038727|756009|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
309216|NCT00038727|756010|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
309217|NCT00038727|756008|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
309218|NCT00038727|756009|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
309219|NCT00038727|756010|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
309220|NCT00038610|756021|P1|NOT COMPLETED|Overall Study||0
309221|NCT00038610|756021|P1|COMPLETED|Overall Study||54
309222|NCT00038610|756021|P1|STARTED|Overall Study||54
309223|NCT00038467|756029|P2|NOT COMPLETED|Overall Study||542
309224|NCT00038467|756030|P1|NOT COMPLETED|Overall Study||542
309225|NCT00038467|756029|P2|COMPLETED|Overall Study||1830
309226|NCT00038467|756030|P1|COMPLETED|Overall Study||1810
309227|NCT00038467|756029|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
309228|NCT00038467|756030|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
309229|NCT00038467|756029|P2|STARTED|Overall Study||2372
309230|NCT00038467|756030|P1|STARTED|Overall Study||2352
309231|NCT00038103|756092|P2|NOT COMPLETED|Overall Study||56
309232|NCT00038103|756093|P1|NOT COMPLETED|Overall Study||55
309233|NCT00038103|756092|P2|COMPLETED|Overall Study||0
309234|NCT00038103|756093|P1|COMPLETED|Overall Study||0
309235|NCT00038103|756092|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
309236|NCT00038103|756093|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
309237|NCT00038103|756092|P2|STARTED|Overall Study||56
309238|NCT00038103|756093|P1|STARTED|Overall Study||55
309239|NCT00037830|756116|P3|NOT COMPLETED|Overall Study||1
309240|NCT00037830|756117|P2|NOT COMPLETED|Overall Study||7
309241|NCT00037830|756118|P1|NOT COMPLETED|Overall Study||10
309242|NCT00037830|756116|P3|COMPLETED|Overall Study||16
309243|NCT00037830|756117|P2|COMPLETED|Overall Study||31
309244|NCT00037830|756118|P1|COMPLETED|Overall Study||29
309245|NCT00037830|756116|P3|STARTED|Overall Study||17
309246|NCT00037830|756117|P2|STARTED|Overall Study||38
309247|NCT00037830|756118|P1|STARTED|Overall Study||39
309248|NCT00036569|756139|P1|NOT COMPLETED|Overall Study||0
309249|NCT00036569|756139|P1|COMPLETED|Overall Study||32
309250|NCT00036569|756139|P1|STARTED|Overall Study||32
309251|NCT00036270|756150|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
309252|NCT00036270|756151|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
309253|NCT00036270|756150|P2|COMPLETED|Study Treatment to 5 Year Report||1380
309254|NCT00036270|756151|P1|COMPLETED|Study Treatment to 5 Year Report||2333
309255|NCT00036270|756150|P2|Treated|Study Treatment to 5 Year Report||4814
309256|NCT00036270|756151|P1|Treated|Study Treatment to 5 Year Report||4852
309257|NCT00036270|756150|P2|STARTED|Study Treatment to 5 Year Report||4868
309258|NCT00036270|756151|P1|STARTED|Study Treatment to 5 Year Report||4898
309259|NCT00036270|756150|P2|NOT COMPLETED|Randomized to Study Treatment||7
309260|NCT00036270|756151|P1|NOT COMPLETED|Randomized to Study Treatment||6
309261|NCT00036270|756150|P2|COMPLETED|Randomized to Study Treatment||4868
309262|NCT00036270|756151|P1|COMPLETED|Randomized to Study Treatment||4898
309263|NCT00036270|756150|P2|STARTED|Randomized to Study Treatment||4875
309264|NCT00036270|756151|P1|STARTED|Randomized to Study Treatment||4904
309265|NCT00035932|756170|P3|NOT COMPLETED|Overall Study||49
309266|NCT00035932|756171|P2|NOT COMPLETED|Overall Study||60
309267|NCT00035932|756172|P1|NOT COMPLETED|Overall Study||56
309268|NCT00035932|756170|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
309269|NCT00035932|756171|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
309270|NCT00035932|756172|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
309271|NCT00035932|756170|P3|Discontinued on or After Week 96|Overall Study||6
309272|NCT00035932|756171|P2|Discontinued on or After Week 96|Overall Study||4
309273|NCT00035932|756172|P1|Discontinued on or After Week 96|Overall Study||4
309274|NCT00035932|756170|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
309275|NCT00035932|756171|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
309276|NCT00035932|756172|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
309277|NCT00035932|756170|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
309278|NCT00035932|756171|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
309279|NCT00035932|756172|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
309280|NCT00035932|756170|P3|STARTED|Overall Study|123 randomized, 118 treated|118
309281|NCT00035932|756171|P2|STARTED|Overall Study|115 randomized, 110 treated|110
309282|NCT00035932|756172|P1|STARTED|Overall Study|120 randomized, 119 treated|119
309283|NCT00035815|756298|P2|NOT COMPLETED|Overall Study||11
309284|NCT00035815|756299|P1|NOT COMPLETED|Overall Study||17
309285|NCT00035815|756298|P2|COMPLETED|Overall Study||152
309286|NCT00035815|756299|P1|COMPLETED|Overall Study||150
309287|NCT00035815|756298|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
309288|NCT00035815|756299|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
309289|NCT00035555|756312|P3|NOT COMPLETED|Overall Study||22
309290|NCT00035555|756313|P2|NOT COMPLETED|Overall Study||16
309291|NCT00035555|756314|P1|NOT COMPLETED|Overall Study||16
309292|NCT00035555|756312|P3|COMPLETED|Overall Study||51
309293|NCT00035555|756313|P2|COMPLETED|Overall Study||55
309294|NCT00035555|756314|P1|COMPLETED|Overall Study||58
309295|NCT00035555|756312|P3|Number Who Received Study Drug|Overall Study||71
309296|NCT00035555|756313|P2|Number Who Received Study Drug|Overall Study||71
309297|NCT00035555|756314|P1|Number Who Received Study Drug|Overall Study||74
309298|NCT00035555|756312|P3|Number Who Had Undergone Transplantation|Overall Study||73
309299|NCT00035555|756313|P2|Number Who Had Undergone Transplantation|Overall Study||71
309300|NCT00035555|756314|P1|Number Who Had Undergone Transplantation|Overall Study||74
309301|NCT00035555|756312|P3|STARTED|Overall Study|Randomized patients|73
309302|NCT00035555|756313|P2|STARTED|Overall Study|Randomized patients|71
309303|NCT00035555|756314|P1|STARTED|Overall Study|Randomized patients|74
309304|NCT00033917|756357|P2|NOT COMPLETED|Overall Study||0
309305|NCT00033917|756358|P1|NOT COMPLETED|Overall Study||0
309306|NCT00033917|756357|P2|COMPLETED|Overall Study||222
309307|NCT00033917|756358|P1|COMPLETED|Overall Study||209
309308|NCT00033917|756357|P2|STARTED|Overall Study||222
309309|NCT00033917|756358|P1|STARTED|Overall Study||209
309310|NCT00032630|756370|P2|NOT COMPLETED|Overall Study||43
309311|NCT00032630|756371|P1|NOT COMPLETED|Overall Study||49
309312|NCT00032630|756370|P2|COMPLETED|Overall Study||1061
309313|NCT00032630|756371|P1|COMPLETED|Overall Study||1050
309314|NCT00032630|756370|P2|STARTED|Overall Study||1104
309315|NCT00032630|756371|P1|STARTED|Overall Study||1099
309316|NCT00032591|756381|P2|NOT COMPLETED|Follow-up||5
309317|NCT00032591|756382|P1|NOT COMPLETED|Follow-up||2
309318|NCT00032591|756381|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
309319|NCT00032591|756382|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
309320|NCT00032591|756381|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
309321|NCT00032591|756382|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
309322|NCT00032591|756381|P2|NOT COMPLETED|Randomization||0
309323|NCT00032591|756382|P1|NOT COMPLETED|Randomization||0
309324|NCT00032591|756381|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
309325|NCT00032591|756382|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
309326|NCT00032591|756381|P2|STARTED|Randomization||1457
309327|NCT00032591|756382|P1|STARTED|Randomization|2922 underwent randomization|1465
309328|NCT00032591|756381|P2|NOT COMPLETED|Screening||415
309329|NCT00032591|756382|P1|NOT COMPLETED|Screening||408
309330|NCT00032591|756381|P2|COMPLETED|Screening||1457
309331|NCT00032591|756382|P1|COMPLETED|Screening|823 were excluded from the study|1465
309332|NCT00032591|756381|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
309333|NCT00032591|756382|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
309334|NCT00032487|756398|P2|NOT COMPLETED|Overall Study||120
309335|NCT00032487|756399|P1|NOT COMPLETED|Overall Study||139
309336|NCT00032487|756398|P2|COMPLETED|Overall Study||772
309337|NCT00032487|756399|P1|COMPLETED|Overall Study||760
309338|NCT00032487|756398|P2|STARTED|Overall Study||892
309339|NCT00032487|756399|P1|STARTED|Overall Study||899
309340|NCT00031551|756409|P2|NOT COMPLETED|Overall Study||0
309341|NCT00031551|756410|P1|NOT COMPLETED|Overall Study||2
309342|NCT00031551|756409|P2|COMPLETED|Overall Study||25
309343|NCT00031551|756410|P1|COMPLETED|Overall Study||0
309344|NCT00031551|756409|P2|STARTED|Overall Study||25
309345|NCT00031551|756410|P1|STARTED|Overall Study||2
309346|NCT00031486|756422|P2|NOT COMPLETED|Overall Study||12
309347|NCT00031486|756423|P1|NOT COMPLETED|Overall Study||7
309348|NCT00031486|756422|P2|COMPLETED|Overall Study||35
309349|NCT00031486|756423|P1|COMPLETED|Overall Study||33
309350|NCT00031486|756422|P2|STARTED|Overall Study||47
309351|NCT00031486|756423|P1|STARTED|Overall Study||40
309352|NCT00031460|756449|P2|NOT COMPLETED|Overall Study||14
309353|NCT00031460|756450|P1|NOT COMPLETED|Overall Study||9
309354|NCT00031460|756449|P2|COMPLETED|Overall Study||8
309355|NCT00031460|756450|P1|COMPLETED|Overall Study||15
309356|NCT00031460|756449|P2|STARTED|Overall Study||22
309357|NCT00031460|756450|P1|STARTED|Overall Study||24
309358|NCT00031447|756464|P2|NOT COMPLETED|Overall Study||7
309359|NCT00031447|756465|P1|NOT COMPLETED|Overall Study||10
309360|NCT00031447|756464|P2|COMPLETED|Overall Study||8
309361|NCT00031447|756465|P1|COMPLETED|Overall Study||4
309362|NCT00031447|756464|P2|STARTED|Overall Study||15
309363|NCT00031447|756465|P1|STARTED|Overall Study||14
309364|NCT00030992|756477|P1|NOT COMPLETED|Overall Study||0
309365|NCT00030992|756477|P1|COMPLETED|Overall Study||102
309366|NCT00030992|756477|P1|STARTED|Overall Study||102
309367|NCT00030147|756486|P4|NOT COMPLETED|Overall Study||0
309368|NCT00030147|756487|P3|NOT COMPLETED|Overall Study||0
309369|NCT00030147|756488|P2|NOT COMPLETED|Overall Study||1
309370|NCT00030147|756489|P1|NOT COMPLETED|Overall Study||0
309371|NCT00030147|756486|P4|COMPLETED|Overall Study||11
309372|NCT00030147|756487|P3|COMPLETED|Overall Study||16
309373|NCT00030147|756488|P2|COMPLETED|Overall Study||18
309374|NCT00030147|756489|P1|COMPLETED|Overall Study||17
309375|NCT00030147|756486|P4|STARTED|Overall Study||11
309376|NCT00030147|756487|P3|STARTED|Overall Study||16
309377|NCT00030147|756488|P2|STARTED|Overall Study||19
309378|NCT00030147|756489|P1|STARTED|Overall Study||17
309379|NCT00029536|756507|P4|NOT COMPLETED|Overall Study||0
309380|NCT00029536|756508|P3|NOT COMPLETED|Overall Study||0
309381|NCT00029536|756509|P2|NOT COMPLETED|Overall Study||0
309382|NCT00029536|756510|P1|NOT COMPLETED|Overall Study||0
309383|NCT00029536|756507|P4|COMPLETED|Overall Study||59
309384|NCT00029536|756508|P3|COMPLETED|Overall Study||105
309385|NCT00029536|756509|P2|COMPLETED|Overall Study||45
309386|NCT00029536|756510|P1|COMPLETED|Overall Study||85
309387|NCT00029536|756507|P4|STARTED|Overall Study||59
309388|NCT00029536|756508|P3|STARTED|Overall Study||105
309389|NCT00029536|756509|P2|STARTED|Overall Study||45
309390|NCT00029536|756510|P1|STARTED|Overall Study||85
309391|NCT00029172|756534|P1|NOT COMPLETED|Overall Study||6
309392|NCT00029172|756534|P1|COMPLETED|Overall Study||182
309393|NCT00029172|756534|P1|STARTED|Overall Study||188
309394|NCT00029146|756540|P2|NOT COMPLETED|Overall Study||1
309395|NCT00029146|756541|P1|NOT COMPLETED|Overall Study||2
309396|NCT00029146|756540|P2|COMPLETED|Overall Study||97
309397|NCT00029146|756541|P1|COMPLETED|Overall Study||95
309398|NCT00029146|756540|P2|STARTED|Overall Study||98
309399|NCT00029146|756541|P1|STARTED|Overall Study||97
309400|NCT00029107|756570|P2|NOT COMPLETED|Overall Study||0
309401|NCT00029107|756571|P1|NOT COMPLETED|Overall Study||0
309402|NCT00029107|756570|P2|COMPLETED|Overall Study||12
309403|NCT00029107|756571|P1|COMPLETED|Overall Study||12
309404|NCT00029107|756570|P2|STARTED|Overall Study||12
309405|NCT00029107|756571|P1|STARTED|Overall Study||12
309406|NCT00028262|756577|P1|NOT COMPLETED|Overall Study||1
309407|NCT00028262|756577|P1|COMPLETED|Overall Study||9
309408|NCT00028262|756577|P1|STARTED|Overall Study||10
309409|NCT00028093|756583|P2|NOT COMPLETED|Overall Study||0
309410|NCT00028093|756584|P1|NOT COMPLETED|Overall Study||0
309411|NCT00028093|756583|P2|COMPLETED|Overall Study||25
309412|NCT00028093|756584|P1|COMPLETED|Overall Study||25
309413|NCT00028093|756583|P2|STARTED|Overall Study||25
309414|NCT00028093|756584|P1|STARTED|Overall Study||25
309415|NCT00027378|756592|P2|NOT COMPLETED|Overall Study||3
309416|NCT00027378|756593|P1|NOT COMPLETED|Overall Study||0
309417|NCT00027378|756592|P2|COMPLETED|Overall Study||23
309418|NCT00027378|756593|P1|COMPLETED|Overall Study||24
309419|NCT00027378|756592|P2|STARTED|Overall Study||26
309420|NCT00027378|756593|P1|STARTED|Overall Study||24
309421|NCT00027027|756606|P5|NOT COMPLETED|Overall Study||8
309422|NCT00027027|756607|P4|NOT COMPLETED|Overall Study||3
309423|NCT00027027|756608|P3|NOT COMPLETED|Overall Study||4
309424|NCT00027027|756609|P2|NOT COMPLETED|Overall Study||3
309425|NCT00027027|756610|P1|NOT COMPLETED|Overall Study||3
309426|NCT00027027|756606|P5|COMPLETED|Overall Study||0
309427|NCT00027027|756607|P4|COMPLETED|Overall Study||0
309428|NCT00027027|756608|P3|COMPLETED|Overall Study||0
309429|NCT00027027|756609|P2|COMPLETED|Overall Study||0
309430|NCT00027027|756610|P1|COMPLETED|Overall Study||0
309431|NCT00027027|756606|P5|Treated Beyond Cycle 2|Overall Study||4
309432|NCT00027027|756607|P4|Treated Beyond Cycle 2|Overall Study||2
309433|NCT00027027|756608|P3|Treated Beyond Cycle 2|Overall Study||2
309434|NCT00027027|756609|P2|Treated Beyond Cycle 2|Overall Study||1
309435|NCT00027027|756610|P1|Treated Beyond Cycle 2|Overall Study||1
309436|NCT00027027|756606|P5|Discontinued at Cycle 2|Overall Study||3
309437|NCT00027027|756607|P4|Discontinued at Cycle 2|Overall Study||1
309438|NCT00027027|756608|P3|Discontinued at Cycle 2|Overall Study||1
309439|NCT00027027|756609|P2|Discontinued at Cycle 2|Overall Study||2
309440|NCT00027027|756610|P1|Discontinued at Cycle 2|Overall Study||2
309441|NCT00027027|756606|P5|Completed 2 Cycles of Treatment|Overall Study||7
309442|NCT00027027|756607|P4|Completed 2 Cycles of Treatment|Overall Study||3
309443|NCT00027027|756608|P3|Completed 2 Cycles of Treatment|Overall Study||3
309444|NCT00027027|756609|P2|Completed 2 Cycles of Treatment|Overall Study||3
309445|NCT00027027|756610|P1|Completed 2 Cycles of Treatment|Overall Study||3
309446|NCT00027027|756606|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
309447|NCT00027027|756607|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
309448|NCT00027027|756608|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
309449|NCT00027027|756609|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
309450|NCT00027027|756610|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
309451|NCT00027027|756606|P5|STARTED|Overall Study||8
309452|NCT00027027|756607|P4|STARTED|Overall Study||3
309453|NCT00027027|756608|P3|STARTED|Overall Study||4
309454|NCT00027027|756609|P2|STARTED|Overall Study||3
309455|NCT00027027|756610|P1|STARTED|Overall Study||3
309456|NCT00025883|756657|P1|NOT COMPLETED|Overall Study||17
309457|NCT00025883|756657|P1|COMPLETED|Overall Study||86
309458|NCT00025883|756657|P1|Partial Lipodystrophy|Overall Study||40
309459|NCT00025883|756657|P1|Generalized Lipodystrophy|Overall Study||63
309460|NCT00025883|756657|P1|STARTED|Overall Study||103
309461|NCT00023595|756669|P5|NOT COMPLETED|10 Year Follow up||0
309462|NCT00023595|756670|P4|NOT COMPLETED|10 Year Follow up||0
309463|NCT00023595|756671|P3|NOT COMPLETED|10 Year Follow up||3
309464|NCT00023595|756672|P2|NOT COMPLETED|10 Year Follow up||10
309465|NCT00023595|756673|P1|NOT COMPLETED|10 Year Follow up||12
309466|NCT00023595|756669|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
309467|NCT00023595|756670|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
309468|NCT00023595|756671|P3|COMPLETED|10 Year Follow up||73
309469|NCT00023595|756672|P2|COMPLETED|10 Year Follow up||524
309470|NCT00023595|756673|P1|COMPLETED|10 Year Follow up||590
309471|NCT00023595|756669|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
309472|NCT00023595|756670|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
309473|NCT00023595|756671|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
309474|NCT00023595|756672|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
309475|NCT00023595|756673|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
309476|NCT00023595|756669|P5|NOT COMPLETED|5 Year Follow up||3
309477|NCT00023595|756670|P4|NOT COMPLETED|5 Year Follow up||7
309478|NCT00023595|756671|P3|NOT COMPLETED|5 Year Follow up||1
309479|NCT00023595|756672|P2|NOT COMPLETED|5 Year Follow up||2
309480|NCT00023595|756673|P1|NOT COMPLETED|5 Year Follow up||2
309481|NCT00023595|756669|P5|COMPLETED|5 Year Follow up||498
309482|NCT00023595|756670|P4|COMPLETED|5 Year Follow up||416
309483|NCT00023595|756671|P3|COMPLETED|5 Year Follow up||75
309484|NCT00023595|756672|P2|COMPLETED|5 Year Follow up||532
309485|NCT00023595|756673|P1|COMPLETED|5 Year Follow up||600
309486|NCT00023595|756669|P5|STARTED|5 Year Follow up||501
309487|NCT00023595|756670|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
309488|NCT00023595|756671|P3|STARTED|5 Year Follow up||76
309489|NCT00023595|756672|P2|STARTED|5 Year Follow up||534
309490|NCT00023595|756673|P1|STARTED|5 Year Follow up||602
309491|NCT00023452|756884|P2|NOT COMPLETED|Overall Study||872
309492|NCT00023452|756885|P1|NOT COMPLETED|Overall Study||1323
309493|NCT00023452|756884|P2|COMPLETED|Overall Study||3273
309494|NCT00023452|756885|P1|COMPLETED|Overall Study||2585
309495|NCT00023452|756884|P2|Completed Study|Overall Study||3475
309496|NCT00023452|756885|P1|Completed Study|Overall Study||3174
309497|NCT00023452|756884|P2|Not Treated|Overall Study||105
309498|NCT00023452|756885|P1|Not Treated|Overall Study||149
309499|NCT00023452|756884|P2|Completed Treatment|Overall Study||3273
309500|NCT00023452|756885|P1|Completed Treatment|Overall Study||2585
309501|NCT00023452|756884|P2|Enrolled as Part of a Cluster|Overall Study||971
309502|NCT00023452|756885|P1|Enrolled as Part of a Cluster|Overall Study||718
309503|NCT00023452|756884|P2|Randomized|Overall Study||3174
309504|NCT00023452|756885|P1|Randomized|Overall Study||3190
309505|NCT00023452|756884|P2|STARTED|Overall Study||4145
309506|NCT00023452|756885|P1|STARTED|Overall Study||3908
309507|NCT00023322|756909|P1|NOT COMPLETED|Overall Study||1
309508|NCT00023322|756909|P1|COMPLETED|Overall Study||12
309509|NCT00023322|756909|P1|STARTED|Overall Study||13
309510|NCT00023309|756916|P2|NOT COMPLETED|Overall Study||0
309511|NCT00023309|756917|P1|NOT COMPLETED|Overall Study||0
309512|NCT00023309|756916|P2|COMPLETED|Overall Study||19
309513|NCT00023309|756917|P1|COMPLETED|Overall Study||22
309514|NCT00023309|756916|P2|STARTED|Overall Study||19
309515|NCT00023309|756917|P1|STARTED|Overall Study||22
309516|NCT00022763|756933|P2|NOT COMPLETED|Overall Study||17
309517|NCT00022763|756934|P1|NOT COMPLETED|Overall Study||9
309518|NCT00022763|756933|P2|COMPLETED|Overall Study||11
309519|NCT00022763|756934|P1|COMPLETED|Overall Study||15
309520|NCT00022763|756933|P2|STARTED|Overall Study||28
309521|NCT00022763|756934|P1|STARTED|Overall Study||24
309522|NCT00016718|756960|P3|NOT COMPLETED|Overall Study||0
309523|NCT00016718|756961|P2|NOT COMPLETED|Overall Study||0
309524|NCT00016718|756962|P1|NOT COMPLETED|Overall Study||0
309525|NCT00016718|756960|P3|COMPLETED|Overall Study||16
309526|NCT00016718|756961|P2|COMPLETED|Overall Study||21
309527|NCT00016718|756962|P1|COMPLETED|Overall Study||6
309528|NCT00016718|756960|P3|STARTED|Overall Study||16
309529|NCT00016718|756961|P2|STARTED|Overall Study||21
309530|NCT00016718|756962|P1|STARTED|Overall Study||6
309531|NCT00014911|756976|P1|NOT COMPLETED|Overall Study||11
309532|NCT00014911|756976|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
309533|NCT00014911|756976|P1|STARTED|Overall Study||36
309534|NCT00006604|756992|P17|NOT COMPLETED|Overall Study||9
309535|NCT00006604|756993|P16|NOT COMPLETED|Overall Study||5
309536|NCT00006604|756994|P15|NOT COMPLETED|Overall Study||10
309537|NCT00006604|756995|P14|NOT COMPLETED|Overall Study||6
309538|NCT00006604|756996|P13|NOT COMPLETED|Overall Study||4
309539|NCT00006604|756997|P12|NOT COMPLETED|Overall Study||6
309540|NCT00006604|756998|P11|NOT COMPLETED|Overall Study||8
309541|NCT00006604|756999|P10|NOT COMPLETED|Overall Study||19
309542|NCT00006604|757000|P9|NOT COMPLETED|Overall Study||1
309543|NCT00006604|757001|P8|NOT COMPLETED|Overall Study||3
309544|NCT00006604|757002|P7|NOT COMPLETED|Overall Study||9
309545|NCT00006604|757003|P6|NOT COMPLETED|Overall Study||3
309546|NCT00006604|757004|P5|NOT COMPLETED|Overall Study||2
309547|NCT00006604|757005|P4|NOT COMPLETED|Overall Study||5
309548|NCT00006604|757006|P3|NOT COMPLETED|Overall Study||4
309549|NCT00006604|757007|P2|NOT COMPLETED|Overall Study||0
309550|NCT00006604|757008|P1|NOT COMPLETED|Overall Study||2
309551|NCT00006604|756992|P17|COMPLETED|Overall Study||6
309552|NCT00006604|756993|P16|COMPLETED|Overall Study||1
309553|NCT00006604|756994|P15|COMPLETED|Overall Study||14
309554|NCT00006604|756995|P14|COMPLETED|Overall Study||0
309555|NCT00006604|756996|P13|COMPLETED|Overall Study||22
309556|NCT00006604|756997|P12|COMPLETED|Overall Study||6
309557|NCT00006604|756998|P11|COMPLETED|Overall Study||13
309558|NCT00006604|756999|P10|COMPLETED|Overall Study||6
309559|NCT00006604|757000|P9|COMPLETED|Overall Study||4
309560|NCT00006604|757001|P8|COMPLETED|Overall Study||2
309561|NCT00006604|757002|P7|COMPLETED|Overall Study||12
309562|NCT00006604|757003|P6|COMPLETED|Overall Study||2
309563|NCT00006604|757004|P5|COMPLETED|Overall Study||3
309564|NCT00006604|757005|P4|COMPLETED|Overall Study||1
309565|NCT00006604|757006|P3|COMPLETED|Overall Study||1
309566|NCT00006604|757007|P2|COMPLETED|Overall Study||2
309567|NCT00006604|757008|P1|COMPLETED|Overall Study||4
309568|NCT00006604|756992|P17|STARTED|Overall Study||15
309569|NCT00006604|756993|P16|STARTED|Overall Study||6
309570|NCT00006604|756994|P15|STARTED|Overall Study||24
309571|NCT00006604|756995|P14|STARTED|Overall Study||6
309572|NCT00006604|756996|P13|STARTED|Overall Study||26
309573|NCT00006604|756997|P12|STARTED|Overall Study||12
309574|NCT00006604|756998|P11|STARTED|Overall Study||21
309575|NCT00006604|756999|P10|STARTED|Overall Study||25
309576|NCT00006604|757000|P9|STARTED|Overall Study||5
309577|NCT00006604|757001|P8|STARTED|Overall Study||5
309578|NCT00006604|757002|P7|STARTED|Overall Study||21
309579|NCT00006604|757003|P6|STARTED|Overall Study||5
309580|NCT00006604|757004|P5|STARTED|Overall Study||5
309581|NCT00006604|757005|P4|STARTED|Overall Study||6
309582|NCT00006604|757006|P3|STARTED|Overall Study||5
309583|NCT00006604|757007|P2|STARTED|Overall Study||2
309584|NCT00006604|757008|P1|STARTED|Overall Study||6
309585|NCT00004978|757124|P2|NOT COMPLETED|Overall Study||270
309586|NCT00004978|757125|P1|NOT COMPLETED|Overall Study||244
309587|NCT00004978|757124|P2|COMPLETED|Overall Study||1790
309588|NCT00004978|757125|P1|COMPLETED|Overall Study||1846
309589|NCT00004978|757124|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
309590|NCT00004978|757125|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
309591|NCT00021541|757151|P2|NOT COMPLETED|Period 2-crossover||11
309592|NCT00021541|757152|P1|NOT COMPLETED|Period 2-crossover||10
309593|NCT00021541|757151|P2|COMPLETED|Period 2-crossover||12
309594|NCT00021541|757152|P1|COMPLETED|Period 2-crossover||10
309595|NCT00021541|757151|P2|STARTED|Period 2-crossover||23
309596|NCT00021541|757152|P1|STARTED|Period 2-crossover||20
309597|NCT00021541|757151|P2|NOT COMPLETED|Period 1-First Treatment||8
309598|NCT00021541|757152|P1|NOT COMPLETED|Period 1-First Treatment||11
309599|NCT00021541|757151|P2|COMPLETED|Period 1-First Treatment||23
309600|NCT00021541|757152|P1|COMPLETED|Period 1-First Treatment||20
309601|NCT00021541|757151|P2|Ineligible Patients|Period 1-First Treatment||2
309602|NCT00021541|757152|P1|Ineligible Patients|Period 1-First Treatment||0
309603|NCT00021541|757151|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
309604|NCT00021541|757152|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
309605|NCT00021541|757151|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
309606|NCT00021541|757152|P1|STARTED|Period 1-First Treatment||31
309607|NCT00018031|757162|P1|NOT COMPLETED|Overall Study||0
309608|NCT00018031|757162|P1|COMPLETED|Overall Study||36
309609|NCT00018031|757162|P1|STARTED|Overall Study||36
309610|NCT00015457|757166|P2|NOT COMPLETED|Second Intervention||0
309611|NCT00015457|757167|P1|NOT COMPLETED|Second Intervention||1
309612|NCT00015457|757166|P2|COMPLETED|Second Intervention||5
309613|NCT00015457|757167|P1|COMPLETED|Second Intervention||7
309614|NCT00015457|757166|P2|STARTED|Second Intervention||5
309615|NCT00015457|757167|P1|STARTED|Second Intervention||8
309616|NCT00015457|757166|P2|NOT COMPLETED|First Intervention||3
309617|NCT00015457|757167|P1|NOT COMPLETED|First Intervention||0
309618|NCT00015457|757166|P2|COMPLETED|First Intervention||5
309619|NCT00015457|757167|P1|COMPLETED|First Intervention||8
309620|NCT00015457|757166|P2|STARTED|First Intervention||8
309621|NCT00015457|757167|P1|STARTED|First Intervention||8
309622|NCT00013611|757177|P2|NOT COMPLETED|Overall Study||100
309623|NCT00013611|757178|P1|NOT COMPLETED|Overall Study||91
309624|NCT00013611|757177|P2|COMPLETED|Overall Study||746
309625|NCT00013611|757178|P1|COMPLETED|Overall Study||758
309626|NCT00013611|757177|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
309627|NCT00013611|757178|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
309628|NCT00010803|757196|P2|NOT COMPLETED|Overall Study||98
309629|NCT00010803|757197|P1|NOT COMPLETED|Overall Study||97
309630|NCT00010803|757196|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
309631|NCT00010803|757197|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
309632|NCT00010803|757196|P2|STARTED|Overall Study|Randomized|1524
309633|NCT00010803|757197|P1|STARTED|Overall Study|Randomized|1545
309634|NCT00010439|757207|P1|NOT COMPLETED|Overall Study||0
309635|NCT00010439|757207|P1|COMPLETED|Overall Study||10
309636|NCT00010439|757207|P1|6 Months|Overall Study||10
309637|NCT00010439|757207|P1|STARTED|Overall Study||10
309638|NCT00007644|757214|P2|NOT COMPLETED|Overall Study||0
309639|NCT00007644|757215|P1|NOT COMPLETED|Overall Study||0
309640|NCT00007644|757214|P2|COMPLETED|Overall Study||367
309641|NCT00007644|757215|P1|COMPLETED|Overall Study||364
309642|NCT00007644|757214|P2|STARTED|Overall Study||367
309643|NCT00007644|757215|P1|STARTED|Overall Study||364
309644|NCT00007475|757224|P4|NOT COMPLETED|Overall Study||0
309645|NCT00007475|757225|P3|NOT COMPLETED|Overall Study||0
309646|NCT00007475|757226|P2|NOT COMPLETED|Overall Study||0
309647|NCT00007475|757227|P1|NOT COMPLETED|Overall Study||4
309648|NCT00007475|757224|P4|COMPLETED|Overall Study||0
309649|NCT00007475|757225|P3|COMPLETED|Overall Study||2
309650|NCT00007475|757226|P2|COMPLETED|Overall Study||1
309651|NCT00007475|757227|P1|COMPLETED|Overall Study||8
309652|NCT00007475|757224|P4|Initiate Cyclophosphamide|Overall Study||0
309653|NCT00007475|757225|P3|Initiate Cyclophosphamide|Overall Study||2
309654|NCT00007475|757226|P2|Initiate Cyclophosphamide|Overall Study||1
309655|NCT00007475|757227|P1|Initiate Cyclophosphamide|Overall Study||12
309656|NCT00007475|757224|P4|Initial Plasma Exchange|Overall Study||0
309657|NCT00007475|757225|P3|Initial Plasma Exchange|Overall Study||2
309658|NCT00007475|757226|P2|Initial Plasma Exchange|Overall Study||1
309659|NCT00007475|757227|P1|Initial Plasma Exchange|Overall Study||12
309660|NCT00007475|757224|P4|Post-initial Transplant Proteinuria|Overall Study||0
309661|NCT00007475|757225|P3|Post-initial Transplant Proteinuria|Overall Study||2
309662|NCT00007475|757226|P2|Post-initial Transplant Proteinuria|Overall Study||1
309663|NCT00007475|757227|P1|Post-initial Transplant Proteinuria|Overall Study||12
309664|NCT00007475|757224|P4|Initial Transplant|Overall Study||0
309665|NCT00007475|757225|P3|Initial Transplant|Overall Study||2
309666|NCT00007475|757226|P2|Initial Transplant|Overall Study||1
309667|NCT00007475|757227|P1|Initial Transplant|Overall Study||12
309668|NCT00007475|757224|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
309669|NCT00007475|757225|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
309670|NCT00007475|757226|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
309671|NCT00007475|757227|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
309672|NCT00007475|757224|P4|STARTED|Overall Study||0
309673|NCT00007475|757225|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
309674|NCT00007475|757226|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
309675|NCT00007475|757227|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
309676|NCT00007345|757249|P2|NOT COMPLETED|Overall Study||11
309677|NCT00007345|757250|P1|NOT COMPLETED|Overall Study||2
309678|NCT00007345|757249|P2|COMPLETED|Overall Study||73
309679|NCT00007345|757250|P1|COMPLETED|Overall Study||45
309680|NCT00007345|757249|P2|STARTED|Overall Study||84
309681|NCT00007345|757250|P1|STARTED|Overall Study||47
309682|NCT00006489|757272|P4|NOT COMPLETED|Overall Study||11
309683|NCT00006489|757273|P3|NOT COMPLETED|Overall Study||15
309684|NCT00006489|757274|P2|NOT COMPLETED|Overall Study||14
309685|NCT00006489|757275|P1|NOT COMPLETED|Overall Study||13
309686|NCT00006489|757272|P4|COMPLETED|Overall Study||32
309687|NCT00006489|757273|P3|COMPLETED|Overall Study||25
309688|NCT00006489|757274|P2|COMPLETED|Overall Study||26
309689|NCT00006489|757275|P1|COMPLETED|Overall Study||29
309690|NCT00006489|757272|P4|STARTED|Overall Study||43
309691|NCT00006489|757273|P3|STARTED|Overall Study||40
309692|NCT00006489|757274|P2|STARTED|Overall Study||40
309693|NCT00006489|757275|P1|STARTED|Overall Study||42
309694|NCT00006409|757299|P6|NOT COMPLETED|Post-3 Year Intervention||62
309695|NCT00006409|757300|P5|NOT COMPLETED|Post-3 Year Intervention||62
309696|NCT00006409|757301|P4|NOT COMPLETED|Post-3 Year Intervention||0
309697|NCT00006409|757302|P3|NOT COMPLETED|Post-3 Year Intervention||0
309698|NCT00006409|757303|P2|NOT COMPLETED|Post-3 Year Intervention||0
309699|NCT00006409|757304|P1|NOT COMPLETED|Post-3 Year Intervention||0
309700|NCT00006409|757299|P6|COMPLETED|Post-3 Year Intervention||1714
309701|NCT00006409|757300|P5|COMPLETED|Post-3 Year Intervention||1664
309702|NCT00006409|757301|P4|COMPLETED|Post-3 Year Intervention||0
309703|NCT00006409|757302|P3|COMPLETED|Post-3 Year Intervention||0
309704|NCT00006409|757303|P2|COMPLETED|Post-3 Year Intervention||0
309705|NCT00006409|757304|P1|COMPLETED|Post-3 Year Intervention||0
309706|NCT00006409|757299|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
309707|NCT00006409|757300|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
309708|NCT00006409|757301|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
309709|NCT00006409|757302|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
309710|NCT00006409|757303|P2|STARTED|Post-3 Year Intervention||0
309711|NCT00006409|757304|P1|STARTED|Post-3 Year Intervention||0
309712|NCT00006409|757299|P6|NOT COMPLETED|Post-2 Year Intervention||0
309713|NCT00006409|757300|P5|NOT COMPLETED|Post-2 Year Intervention||0
309714|NCT00006409|757301|P4|NOT COMPLETED|Post-2 Year Intervention||168
309715|NCT00006409|757302|P3|NOT COMPLETED|Post-2 Year Intervention||251
309716|NCT00006409|757303|P2|NOT COMPLETED|Post-2 Year Intervention||0
309717|NCT00006409|757304|P1|NOT COMPLETED|Post-2 Year Intervention||0
309718|NCT00006409|757299|P6|COMPLETED|Post-2 Year Intervention||0
309719|NCT00006409|757300|P5|COMPLETED|Post-2 Year Intervention||0
309720|NCT00006409|757301|P4|COMPLETED|Post-2 Year Intervention||1545
309721|NCT00006409|757302|P3|COMPLETED|Post-2 Year Intervention||1540
309722|NCT00006409|757303|P2|COMPLETED|Post-2 Year Intervention||0
309723|NCT00006409|757304|P1|COMPLETED|Post-2 Year Intervention||0
309724|NCT00006409|757299|P6|STARTED|Post-2 Year Intervention||0
309725|NCT00006409|757300|P5|STARTED|Post-2 Year Intervention||0
309726|NCT00006409|757301|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
309727|NCT00006409|757302|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
309728|NCT00006409|757303|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
309729|NCT00006409|757304|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
309730|NCT00006409|757299|P6|NOT COMPLETED|Baseline||0
309731|NCT00006409|757300|P5|NOT COMPLETED|Baseline||0
309732|NCT00006409|757301|P4|NOT COMPLETED|Baseline||0
309733|NCT00006409|757302|P3|NOT COMPLETED|Baseline||0
309734|NCT00006409|757303|P2|NOT COMPLETED|Baseline||70
309735|NCT00006409|757304|P1|NOT COMPLETED|Baseline||48
309736|NCT00006409|757299|P6|COMPLETED|Baseline||0
309737|NCT00006409|757300|P5|COMPLETED|Baseline||0
309738|NCT00006409|757301|P4|COMPLETED|Baseline||0
309739|NCT00006409|757302|P3|COMPLETED|Baseline||0
309740|NCT00006409|757303|P2|COMPLETED|Baseline||786
309741|NCT00006409|757304|P1|COMPLETED|Baseline||817
309742|NCT00006409|757299|P6|STARTED|Baseline||0
309743|NCT00006409|757300|P5|STARTED|Baseline||0
309744|NCT00006409|757301|P4|STARTED|Baseline||0
309745|NCT00006409|757302|P3|STARTED|Baseline||0
309746|NCT00006409|757303|P2|STARTED|Baseline||856
309747|NCT00006409|757304|P1|STARTED|Baseline||865
309748|NCT00006305|757328|P4|NOT COMPLETED|Overall Study||14
309749|NCT00006305|757329|P3|NOT COMPLETED|Overall Study||15
309750|NCT00006305|757330|P2|NOT COMPLETED|Overall Study||10
309751|NCT00006305|757331|P1|NOT COMPLETED|Overall Study||17
309752|NCT00006305|757328|P4|COMPLETED|Overall Study||585
309753|NCT00006305|757329|P3|COMPLETED|Overall Study||578
309754|NCT00006305|757330|P2|COMPLETED|Overall Study||574
309755|NCT00006305|757331|P1|COMPLETED|Overall Study||575
309756|NCT00006305|757328|P4|STARTED|Overall Study||599
309757|NCT00006305|757329|P3|STARTED|Overall Study||593
309758|NCT00006305|757330|P2|STARTED|Overall Study||584
309759|NCT00006305|757331|P1|STARTED|Overall Study||592
309760|NCT00006289|757347|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
309761|NCT00006289|757348|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
309762|NCT00006289|757347|P2|COMPLETED|Second Intervention (5 Weeks)||9
309763|NCT00006289|757348|P1|COMPLETED|Second Intervention (5 Weeks)||9
309764|NCT00006289|757347|P2|STARTED|Second Intervention (5 Weeks)||10
309765|NCT00006289|757348|P1|STARTED|Second Intervention (5 Weeks)||10
309766|NCT00006289|757347|P2|NOT COMPLETED|Washout (>= 1 Week)||0
309767|NCT00006289|757348|P1|NOT COMPLETED|Washout (>= 1 Week)||0
309768|NCT00006289|757347|P2|COMPLETED|Washout (>= 1 Week)||10
309769|NCT00006289|757348|P1|COMPLETED|Washout (>= 1 Week)||10
309770|NCT00006289|757347|P2|STARTED|Washout (>= 1 Week)||10
309771|NCT00006289|757348|P1|STARTED|Washout (>= 1 Week)||10
309772|NCT00006289|757347|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
309773|NCT00006289|757348|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
309774|NCT00006289|757347|P2|COMPLETED|First Intervention (5 Weeks)||10
309775|NCT00006289|757348|P1|COMPLETED|First Intervention (5 Weeks)||10
309776|NCT00006289|757347|P2|STARTED|First Intervention (5 Weeks)||10
309777|NCT00006289|757348|P1|STARTED|First Intervention (5 Weeks)||11
309778|NCT00006184|757366|P2|NOT COMPLETED|Overall Study||0
309779|NCT00006184|757367|P1|NOT COMPLETED|Overall Study||1
309780|NCT00006184|757366|P2|COMPLETED|Overall Study||10
309781|NCT00006184|757367|P1|COMPLETED|Overall Study||9
309782|NCT00006184|757366|P2|STARTED|Overall Study||10
309783|NCT00006184|757367|P1|STARTED|Overall Study||10
309784|NCT00006178|757374|P1|NOT COMPLETED|Overall Study||0
309785|NCT00006178|757374|P1|COMPLETED|Overall Study||12
309786|NCT00006178|757374|P1|STARTED|Overall Study||12
309787|NCT00006170|757385|P4|NOT COMPLETED|Overall Study||39
309788|NCT00006170|757386|P3|NOT COMPLETED|Overall Study||43
309789|NCT00006170|757387|P2|NOT COMPLETED|Overall Study||50
309790|NCT00006170|757388|P1|NOT COMPLETED|Overall Study||49
309791|NCT00006170|757385|P4|COMPLETED|Overall Study||28
309792|NCT00006170|757386|P3|COMPLETED|Overall Study||46
309793|NCT00006170|757387|P2|COMPLETED|Overall Study||37
309794|NCT00006170|757388|P1|COMPLETED|Overall Study||57
309795|NCT00006170|757385|P4|STARTED|Overall Study||67
309796|NCT00006170|757386|P3|STARTED|Overall Study||89
309797|NCT00006170|757387|P2|STARTED|Overall Study||87
309798|NCT00006170|757388|P1|STARTED|Overall Study||106
309799|NCT00006156|757408|P2|NOT COMPLETED|Overall Study||0
309800|NCT00006156|757409|P1|NOT COMPLETED|Overall Study||0
309801|NCT00006156|757408|P2|COMPLETED|Overall Study||7
309802|NCT00006156|757409|P1|COMPLETED|Overall Study||42
309803|NCT00006156|757408|P2|STARTED|Overall Study||7
309804|NCT00006156|757409|P1|STARTED|Overall Study||42
309805|NCT00006164|757418|P2|NOT COMPLETED|Overall Study||81
309806|NCT00006164|757419|P1|NOT COMPLETED|Overall Study||70
309807|NCT00006164|757418|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
309808|NCT00006164|757419|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
309809|NCT00006164|757418|P2|STARTED|Overall Study||533
309810|NCT00006164|757419|P1|STARTED|Overall Study||517
309811|NCT00006151|757455|P2|NOT COMPLETED|Overall Study||14
309812|NCT00006151|757456|P1|NOT COMPLETED|Overall Study||13
309813|NCT00006151|757455|P2|COMPLETED|Overall Study||16
309814|NCT00006151|757456|P1|COMPLETED|Overall Study||17
309815|NCT00006151|757455|P2|STARTED|Overall Study||30
309816|NCT00006151|757456|P1|STARTED|Overall Study||30
309817|NCT00005937|757462|P1|NOT COMPLETED|Overall Study||5
309818|NCT00005937|757462|P1|COMPLETED|Overall Study||37
309819|NCT00005937|757462|P1|STARTED|Overall Study||42
309820|NCT00005908|757466|P2|NOT COMPLETED|Overall Study||0
309821|NCT00005908|757467|P1|NOT COMPLETED|Overall Study||1
309822|NCT00005908|757466|P2|COMPLETED|Overall Study||20
309823|NCT00005908|757467|P1|COMPLETED|Overall Study||9
309824|NCT00005908|757466|P2|STARTED|Overall Study||20
309825|NCT00005908|757467|P1|STARTED|Overall Study||10
309826|NCT00005906|757476|P1|NOT COMPLETED|Overall Study||3
309827|NCT00005906|757476|P1|COMPLETED|Overall Study||1
309828|NCT00005906|757476|P1|STARTED|Overall Study||4
309829|NCT00005901|757484|P2|NOT COMPLETED|Overall Study||0
309830|NCT00005901|757485|P1|NOT COMPLETED|Overall Study||0
309831|NCT00005901|757484|P2|COMPLETED|Overall Study||15
309832|NCT00005901|757485|P1|COMPLETED|Overall Study||19
309833|NCT00005901|757484|P2|STARTED|Overall Study||15
309834|NCT00005901|757485|P1|STARTED|Overall Study||19
309835|NCT00005669|757503|P2|NOT COMPLETED|Overall Study||7
309836|NCT00005669|757504|P1|NOT COMPLETED|Overall Study||8
309837|NCT00005669|757503|P2|COMPLETED|Overall Study||40
309838|NCT00005669|757504|P1|COMPLETED|Overall Study||45
309839|NCT00005669|757503|P2|STARTED|Overall Study||47
309840|NCT00005669|757504|P1|STARTED|Overall Study||53
309841|NCT00004980|757520|P2|NOT COMPLETED|Overall Study||2
309842|NCT00004980|757521|P1|NOT COMPLETED|Overall Study||2
309843|NCT00004980|757520|P2|COMPLETED|Overall Study||21
309844|NCT00004980|757521|P1|COMPLETED|Overall Study||25
309845|NCT00004980|757520|P2|STARTED|Overall Study||23
309846|NCT00004980|757521|P1|STARTED|Overall Study||27
309847|NCT00004732|757535|P2|NOT COMPLETED|Overall Study||111
309848|NCT00004732|757536|P1|NOT COMPLETED|Overall Study||69
309849|NCT00004732|757535|P2|COMPLETED|Overall Study||1129
309850|NCT00004732|757536|P1|COMPLETED|Overall Study||1193
309851|NCT00004732|757535|P2|STARTED|Overall Study||1240
309852|NCT00004732|757536|P1|STARTED|Overall Study||1262
309853|NCT00004635|757546|P2|NOT COMPLETED|Period Two||9
309854|NCT00004635|757547|P1|NOT COMPLETED|Period Two||6
309855|NCT00004635|757546|P2|COMPLETED|Period Two||50
309856|NCT00004635|757547|P1|COMPLETED|Period Two||38
309857|NCT00004635|757546|P2|STARTED|Period Two||59
309858|NCT00004635|757547|P1|STARTED|Period Two||44
309859|NCT00004635|757546|P2|NOT COMPLETED|Period One||6
309860|NCT00004635|757547|P1|NOT COMPLETED|Period One||6
309861|NCT00004635|757546|P2|COMPLETED|Period One||74
309862|NCT00004635|757547|P1|COMPLETED|Period One||73
309863|NCT00004635|757546|P2|Received Treatment|Period One||75
309864|NCT00004635|757547|P1|Received Treatment|Period One||73
309865|NCT00004635|757546|P2|STARTED|Period One||80
309866|NCT00004635|757547|P1|STARTED|Period One||79
309867|NCT00004563|757559|P2|NOT COMPLETED|Overall Study||24
309868|NCT00004563|757560|P1|NOT COMPLETED|Overall Study||25
309869|NCT00004563|757559|P2|COMPLETED|Overall Study||55
309870|NCT00004563|757560|P1|COMPLETED|Overall Study||54
309871|NCT00004563|757559|P2|STARTED|Overall Study||79
309872|NCT00004563|757560|P1|STARTED|Overall Study||79
309873|NCT00004562|757572|P2|NOT COMPLETED|Overall Study||91
309874|NCT00004562|757573|P1|NOT COMPLETED|Overall Study||102
309875|NCT00004562|757572|P2|COMPLETED|Overall Study||1009
309876|NCT00004562|757573|P1|COMPLETED|Overall Study||999
309877|NCT00004562|757572|P2|STARTED|Overall Study||1100
309878|NCT00004562|757573|P1|STARTED|Overall Study||1101
309879|NCT00004547|757584|P3|NOT COMPLETED|Overall Study||22
309880|NCT00004547|757585|P2|NOT COMPLETED|Overall Study||9
309881|NCT00004547|757586|P1|NOT COMPLETED|Overall Study||22
309882|NCT00004547|757584|P3|COMPLETED|Overall Study||35
309883|NCT00004547|757585|P2|COMPLETED|Overall Study||39
309884|NCT00004547|757586|P1|COMPLETED|Overall Study||61
309885|NCT00004547|757584|P3|Not Evaluable|Overall Study||23
309886|NCT00004547|757585|P2|Not Evaluable|Overall Study||9
309887|NCT00004547|757586|P1|Not Evaluable|Overall Study||21
309888|NCT00004547|757584|P3|STARTED|Overall Study||57
309889|NCT00004547|757585|P2|STARTED|Overall Study||48
309890|NCT00004547|757586|P1|STARTED|Overall Study||83
309891|NCT00001984|757604|P1|NOT COMPLETED|Overall Study||0
309892|NCT00001984|757604|P1|COMPLETED|Overall Study||5
309893|NCT00001984|757604|P1|STARTED|Overall Study||5
309894|NCT00001962|757614|P1|NOT COMPLETED|Overall Study||28
309895|NCT00001962|757614|P1|COMPLETED|Overall Study||72
309896|NCT00001962|757614|P1|STARTED|Overall Study||100
309897|NCT00001959|757618|P1|NOT COMPLETED|Overall Study||3
309898|NCT00001959|757618|P1|COMPLETED|Overall Study||18
309899|NCT00001959|757618|P1|STARTED|Overall Study||21
309900|NCT00001941|757624|P5|NOT COMPLETED|Overall Study||1
309901|NCT00001941|757625|P4|NOT COMPLETED|Overall Study||0
309902|NCT00001941|757626|P3|NOT COMPLETED|Overall Study||0
309903|NCT00001941|757627|P2|NOT COMPLETED|Overall Study||0
309904|NCT00001941|757628|P1|NOT COMPLETED|Overall Study||0
309905|NCT00001941|757624|P5|COMPLETED|Overall Study||19
309906|NCT00001941|757625|P4|COMPLETED|Overall Study||3
309907|NCT00001941|757626|P3|COMPLETED|Overall Study||3
309908|NCT00001941|757627|P2|COMPLETED|Overall Study||5
309909|NCT00001941|757628|P1|COMPLETED|Overall Study||3
309910|NCT00001941|757624|P5|STARTED|Overall Study||20
309911|NCT00001941|757625|P4|STARTED|Overall Study||3
309912|NCT00001941|757626|P3|STARTED|Overall Study||3
309913|NCT00001941|757627|P2|STARTED|Overall Study||5
309914|NCT00001941|757628|P1|STARTED|Overall Study||3
309915|NCT00000392|757637|P2|NOT COMPLETED|Overall Study||32
309916|NCT00000392|757638|P1|NOT COMPLETED|Overall Study||40
309917|NCT00000392|757637|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
309918|NCT00000392|757638|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
309919|NCT00000392|757637|P2|STARTED|Overall Study||109
309920|NCT00000392|757638|P1|STARTED|Overall Study||106
309921|NCT00001832|757660|P15|NOT COMPLETED|Treatment Period||0
309922|NCT00001832|757661|P14|NOT COMPLETED|Treatment Period||0
309923|NCT00001832|757662|P13|NOT COMPLETED|Treatment Period||0
309924|NCT00001832|757663|P12|NOT COMPLETED|Treatment Period||0
309925|NCT00001832|757664|P11|NOT COMPLETED|Treatment Period||0
309926|NCT00001832|757665|P10|NOT COMPLETED|Treatment Period||0
309927|NCT00001832|757666|P9|NOT COMPLETED|Treatment Period||0
309928|NCT00001832|757667|P8|NOT COMPLETED|Treatment Period||1
309929|NCT00001832|757668|P7|NOT COMPLETED|Treatment Period||0
309930|NCT00001832|757669|P6|NOT COMPLETED|Treatment Period||1
309931|NCT00001832|757670|P5|NOT COMPLETED|Treatment Period||0
309932|NCT00001832|757671|P4|NOT COMPLETED|Treatment Period||0
309933|NCT00001832|757672|P3|NOT COMPLETED|Treatment Period||0
309934|NCT00001832|757673|P2|NOT COMPLETED|Treatment Period||0
309935|NCT00001832|757674|P1|NOT COMPLETED|Treatment Period||0
309936|NCT00001832|757660|P15|COMPLETED|Treatment Period||2
309937|NCT00001832|757661|P14|COMPLETED|Treatment Period||3
309938|NCT00001832|757662|P13|COMPLETED|Treatment Period||6
309939|NCT00001832|757663|P12|COMPLETED|Treatment Period||7
309940|NCT00001832|757664|P11|COMPLETED|Treatment Period||1
309941|NCT00001832|757665|P10|COMPLETED|Treatment Period||6
309942|NCT00001832|757666|P9|COMPLETED|Treatment Period||8
309943|NCT00001832|757667|P8|COMPLETED|Treatment Period||6
309944|NCT00001832|757668|P7|COMPLETED|Treatment Period||4
309945|NCT00001832|757669|P6|COMPLETED|Treatment Period||50
309946|NCT00001832|757670|P5|COMPLETED|Treatment Period||6
309947|NCT00001832|757671|P4|COMPLETED|Treatment Period||3
309948|NCT00001832|757672|P3|COMPLETED|Treatment Period||3
309949|NCT00001832|757673|P2|COMPLETED|Treatment Period||3
309950|NCT00001832|757674|P1|COMPLETED|Treatment Period||0
309951|NCT00001832|757660|P15|STARTED|Treatment Period||2
309952|NCT00001832|757661|P14|STARTED|Treatment Period||3
309953|NCT00001832|757662|P13|STARTED|Treatment Period||6
309954|NCT00001832|757663|P12|STARTED|Treatment Period||7
309955|NCT00001832|757664|P11|STARTED|Treatment Period||1
309956|NCT00001832|757665|P10|STARTED|Treatment Period||6
309957|NCT00001832|757666|P9|STARTED|Treatment Period||8
309958|NCT00001832|757667|P8|STARTED|Treatment Period||7
309959|NCT00001832|757668|P7|STARTED|Treatment Period||4
309960|NCT00001832|757669|P6|STARTED|Treatment Period||51
309961|NCT00001832|757670|P5|STARTED|Treatment Period||6
309962|NCT00001832|757671|P4|STARTED|Treatment Period||3
309963|NCT00001832|757672|P3|STARTED|Treatment Period||3
309964|NCT00001832|757673|P2|STARTED|Treatment Period||3
309965|NCT00001832|757674|P1|STARTED|Treatment Period||0
309966|NCT00001832|757660|P15|NOT COMPLETED|Apheresis Period||0
309967|NCT00001832|757661|P14|NOT COMPLETED|Apheresis Period||0
309968|NCT00001832|757662|P13|NOT COMPLETED|Apheresis Period||0
309969|NCT00001832|757663|P12|NOT COMPLETED|Apheresis Period||0
309970|NCT00001832|757664|P11|NOT COMPLETED|Apheresis Period||0
309971|NCT00001832|757665|P10|NOT COMPLETED|Apheresis Period||0
309972|NCT00001832|757666|P9|NOT COMPLETED|Apheresis Period||0
309973|NCT00001832|757667|P8|NOT COMPLETED|Apheresis Period||0
309974|NCT00001832|757668|P7|NOT COMPLETED|Apheresis Period||0
309975|NCT00001832|757669|P6|NOT COMPLETED|Apheresis Period||0
309976|NCT00001832|757670|P5|NOT COMPLETED|Apheresis Period||0
309977|NCT00001832|757671|P4|NOT COMPLETED|Apheresis Period||0
309978|NCT00001832|757672|P3|NOT COMPLETED|Apheresis Period||0
309979|NCT00001832|757673|P2|NOT COMPLETED|Apheresis Period||0
309980|NCT00001832|757674|P1|NOT COMPLETED|Apheresis Period||60
309981|NCT00001832|757660|P15|COMPLETED|Apheresis Period||0
309982|NCT00001832|757661|P14|COMPLETED|Apheresis Period||0
309983|NCT00001832|757662|P13|COMPLETED|Apheresis Period||0
309984|NCT00001832|757663|P12|COMPLETED|Apheresis Period||0
309985|NCT00001832|757664|P11|COMPLETED|Apheresis Period||0
309986|NCT00001832|757665|P10|COMPLETED|Apheresis Period||0
309987|NCT00001832|757666|P9|COMPLETED|Apheresis Period||0
309988|NCT00001832|757667|P8|COMPLETED|Apheresis Period||0
309989|NCT00001832|757668|P7|COMPLETED|Apheresis Period||0
309990|NCT00001832|757669|P6|COMPLETED|Apheresis Period||0
309991|NCT00001832|757670|P5|COMPLETED|Apheresis Period||0
309992|NCT00001832|757671|P4|COMPLETED|Apheresis Period||0
309993|NCT00001832|757672|P3|COMPLETED|Apheresis Period||0
309994|NCT00001832|757673|P2|COMPLETED|Apheresis Period||0
309995|NCT00001832|757674|P1|COMPLETED|Apheresis Period||110
309996|NCT00001832|757660|P15|STARTED|Apheresis Period||0
309997|NCT00001832|757661|P14|STARTED|Apheresis Period||0
309998|NCT00001832|757662|P13|STARTED|Apheresis Period||0
309999|NCT00001832|757663|P12|STARTED|Apheresis Period||0
310000|NCT00001832|757664|P11|STARTED|Apheresis Period||0
310001|NCT00001832|757665|P10|STARTED|Apheresis Period||0
310002|NCT00001832|757666|P9|STARTED|Apheresis Period||0
310003|NCT00001832|757667|P8|STARTED|Apheresis Period||0
310004|NCT00001832|757668|P7|STARTED|Apheresis Period||0
310005|NCT00001832|757669|P6|STARTED|Apheresis Period||0
310006|NCT00001832|757670|P5|STARTED|Apheresis Period||0
310007|NCT00001832|757671|P4|STARTED|Apheresis Period||0
310008|NCT00001832|757672|P3|STARTED|Apheresis Period||0
310009|NCT00001832|757673|P2|STARTED|Apheresis Period||0
310010|NCT00001832|757674|P1|STARTED|Apheresis Period||170
310011|NCT00001723|757720|P2|NOT COMPLETED|Overall Study||16
310012|NCT00001723|757721|P1|NOT COMPLETED|Overall Study||13
310013|NCT00001723|757720|P2|COMPLETED|Overall Study||84
310014|NCT00001723|757721|P1|COMPLETED|Overall Study||87
310015|NCT00001723|757720|P2|STARTED|Overall Study||100
310016|NCT00001723|757721|P1|STARTED|Overall Study||100
310017|NCT00001703|757737|P1|NOT COMPLETED|Overall Study||5
310018|NCT00001703|757737|P1|COMPLETED|Overall Study||1
310019|NCT00001703|757737|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
310020|NCT00001703|757737|P1|STARTED|Overall Study||6
310021|NCT00001656|757744|P2|NOT COMPLETED|Overall Study||0
310022|NCT00001656|757745|P1|NOT COMPLETED|Overall Study||1
310023|NCT00001656|757744|P2|COMPLETED|Overall Study||12
310024|NCT00001656|757745|P1|COMPLETED|Overall Study||12
310025|NCT00001656|757744|P2|STARTED|Overall Study||12
310026|NCT00001656|757745|P1|STARTED|Overall Study||13
310027|NCT00001596|757775|P2|NOT COMPLETED|Overall Study||10
310028|NCT00001596|757776|P1|NOT COMPLETED|Overall Study||17
310029|NCT00001596|757775|P2|COMPLETED|Overall Study||2
310030|NCT00001596|757776|P1|COMPLETED|Overall Study||6
310031|NCT00001596|757775|P2|STARTED|Overall Study||12
310032|NCT00001596|757776|P1|STARTED|Overall Study||23
310033|NCT00001586|757798|P2|NOT COMPLETED|Overall Study||0
310034|NCT00001586|757799|P1|NOT COMPLETED|Overall Study||0
310035|NCT00001586|757798|P2|COMPLETED|Overall Study||56
310036|NCT00001586|757799|P1|COMPLETED|Overall Study||49
310037|NCT00001586|757798|P2|STARTED|Overall Study||56
310038|NCT00001586|757799|P1|STARTED|Overall Study||49
310039|NCT00001575|757807|P1|NOT COMPLETED|Overall Study||45
310040|NCT00001575|757807|P1|COMPLETED|Overall Study||42
310041|NCT00001575|757807|P1|Treated|Overall Study||65
310042|NCT00001575|757807|P1|STARTED|Overall Study||87
310043|NCT00001566|757813|P1|NOT COMPLETED|Overall Study||19
310044|NCT00001566|757813|P1|COMPLETED|Overall Study||23
310045|NCT00001566|757813|P1|Completed Immunotherapy|Overall Study||23
310046|NCT00001566|757813|P1|STARTED|Overall Study||42
310047|NCT00001304|757827|P2|NOT COMPLETED|Overall Study||0
310048|NCT00001304|757828|P1|NOT COMPLETED|Overall Study||0
310049|NCT00001304|757827|P2|COMPLETED|Overall Study||14
310050|NCT00001304|757828|P1|COMPLETED|Overall Study||13
310051|NCT00001304|757827|P2|STARTED|Overall Study||14
310052|NCT00001304|757828|P1|STARTED|Overall Study||13
310053|NCT00001262|757849|P3|NOT COMPLETED|Overall Study||0
310054|NCT00001262|757850|P2|NOT COMPLETED|Overall Study||14
310055|NCT00001262|757851|P1|NOT COMPLETED|Overall Study||10
310056|NCT00001262|757849|P3|COMPLETED|Overall Study||3
310057|NCT00001262|757850|P2|COMPLETED|Overall Study||8
310058|NCT00001262|757851|P1|COMPLETED|Overall Study||25
310059|NCT00001262|757849|P3|STARTED|Overall Study||3
310060|NCT00001262|757850|P2|STARTED|Overall Study||22
310061|NCT00001262|757851|P1|STARTED|Overall Study||35
310062|NCT00001213|757877|P1|NOT COMPLETED|Overall Study||18
310063|NCT00001213|757877|P1|COMPLETED|Overall Study||310
310064|NCT00001213|757877|P1|STARTED|Overall Study||328
310065|NCT00001151|757882|P1|NOT COMPLETED|Overall Study||5
310066|NCT00001151|757882|P1|COMPLETED|Overall Study||1
310067|NCT00001151|757882|P1|STARTED|Overall Study||6
310068|NCT00000378|757888|P2|NOT COMPLETED|Overall Study||14
310069|NCT00000378|757889|P1|NOT COMPLETED|Overall Study||16
310070|NCT00000378|757888|P2|COMPLETED|Overall Study||38
310071|NCT00000378|757889|P1|COMPLETED|Overall Study||42
310072|NCT00000378|757888|P2|STARTED|Overall Study||52
310073|NCT00000378|757889|P1|STARTED|Overall Study||58
310074|NCT00000371|757897|P2|NOT COMPLETED|Overall Study||16
310075|NCT00000371|757898|P1|NOT COMPLETED|Overall Study||13
310076|NCT00000371|757897|P2|COMPLETED|Overall Study||12
310077|NCT00000371|757898|P1|COMPLETED|Overall Study||14
310078|NCT00000371|757897|P2|STARTED|Overall Study||28
310079|NCT00000371|757898|P1|STARTED|Overall Study||27
310080|NCT00000620|757906|P8|NOT COMPLETED|Overall Study||146
310081|NCT00000620|757907|P7|NOT COMPLETED|Overall Study||149
310082|NCT00000620|757908|P6|NOT COMPLETED|Overall Study||152
310083|NCT00000620|757909|P5|NOT COMPLETED|Overall Study||135
310084|NCT00000620|757910|P4|NOT COMPLETED|Overall Study||178
310085|NCT00000620|757911|P3|NOT COMPLETED|Overall Study||170
310086|NCT00000620|757912|P2|NOT COMPLETED|Overall Study||136
310087|NCT00000620|757913|P1|NOT COMPLETED|Overall Study||162
310088|NCT00000620|757906|P8|COMPLETED|Overall Study||1224
310089|NCT00000620|757907|P7|COMPLETED|Overall Study||1242
310090|NCT00000620|757908|P6|COMPLETED|Overall Study||1026
310091|NCT00000620|757909|P5|COMPLETED|Overall Study||1049
310092|NCT00000620|757910|P4|COMPLETED|Overall Study||1205
310093|NCT00000620|757911|P3|COMPLETED|Overall Study||1204
310094|NCT00000620|757912|P2|COMPLETED|Overall Study||1057
310095|NCT00000620|757913|P1|COMPLETED|Overall Study||1016
310096|NCT00000620|757906|P8|STARTED|Overall Study||1370
310097|NCT00000620|757907|P7|STARTED|Overall Study||1391
310098|NCT00000620|757908|P6|STARTED|Overall Study||1178
310099|NCT00000620|757909|P5|STARTED|Overall Study||1184
310100|NCT00000620|757910|P4|STARTED|Overall Study||1383
310101|NCT00000620|757911|P3|STARTED|Overall Study||1374
310102|NCT00000620|757912|P2|STARTED|Overall Study||1193
310103|NCT00000620|757913|P1|STARTED|Overall Study||1178
310104|NCT00000575|757932|P3|NOT COMPLETED|Overall Study||0
310105|NCT00000575|757933|P2|NOT COMPLETED|Overall Study||0
310106|NCT00000575|757934|P1|NOT COMPLETED|Overall Study||0
310107|NCT00000575|757932|P3|COMPLETED|Overall Study||418
310108|NCT00000575|757933|P2|COMPLETED|Overall Study||312
310109|NCT00000575|757934|P1|COMPLETED|Overall Study||311
310110|NCT00000575|757932|P3|STARTED|Overall Study||418
310111|NCT00000575|757933|P2|STARTED|Overall Study||312
310112|NCT00000575|757934|P1|STARTED|Overall Study||311
310113|NCT00000479|757964|P4|NOT COMPLETED|Overall Study||0
310114|NCT00000479|757965|P3|NOT COMPLETED|Overall Study||0
310115|NCT00000479|757966|P2|NOT COMPLETED|Overall Study||0
310116|NCT00000479|757967|P1|NOT COMPLETED|Overall Study||0
310117|NCT00000479|757964|P4|COMPLETED|Overall Study||9971
310118|NCT00000479|757965|P3|COMPLETED|Overall Study||9966
310119|NCT00000479|757966|P2|COMPLETED|Overall Study||9971
310120|NCT00000479|757967|P1|COMPLETED|Overall Study||9968
310121|NCT00000479|757964|P4|STARTED|Overall Study||9971
310122|NCT00000479|757965|P3|STARTED|Overall Study||9966
310123|NCT00000479|757966|P2|STARTED|Overall Study||9971
310124|NCT00000479|757967|P1|STARTED|Overall Study||9968
310125|NCT00004500|757983|P2|NOT COMPLETED|Overall Study||0
310126|NCT00004500|757984|P1|NOT COMPLETED|Overall Study||0
310127|NCT00004500|757983|P2|COMPLETED|Overall Study||31
310128|NCT00004500|757984|P1|COMPLETED|Overall Study||38
310129|NCT00004500|757983|P2|1 Year Follow-Up|Overall Study||24
310130|NCT00004500|757984|P1|1 Year Follow-Up|Overall Study||24
310131|NCT00004500|757983|P2|STARTED|Overall Study||31
310132|NCT00004500|757984|P1|STARTED|Overall Study||38
310133|NCT00004412|757997|P3|NOT COMPLETED|Crossover Period||0
310134|NCT00004412|757998|P2|NOT COMPLETED|Crossover Period||0
310135|NCT00004412|757999|P1|NOT COMPLETED|Crossover Period||0
310136|NCT00004412|757997|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
310137|NCT00004412|757998|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
310138|NCT00004412|757999|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
310139|NCT00004412|757997|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
310140|NCT00004412|757998|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
310141|NCT00004412|757999|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
310142|NCT00004412|757997|P3|NOT COMPLETED|Randomized Period||0
310143|NCT00004412|757998|P2|NOT COMPLETED|Randomized Period||0
310144|NCT00004412|757999|P1|NOT COMPLETED|Randomized Period||3
310145|NCT00004412|757997|P3|COMPLETED|Randomized Period||0
310146|NCT00004412|757998|P2|COMPLETED|Randomized Period||12
310147|NCT00004412|757999|P1|COMPLETED|Randomized Period||8
310148|NCT00004412|757997|P3|STARTED|Randomized Period||0
310149|NCT00004412|757998|P2|STARTED|Randomized Period||12
310150|NCT00004412|757999|P1|STARTED|Randomized Period||11
310151|NCT00000143|758009|P2|NOT COMPLETED|Overall Study||0
310152|NCT00000143|758010|P1|NOT COMPLETED|Overall Study||0
310153|NCT00000143|758009|P2|COMPLETED|Overall Study||30
310154|NCT00000143|758010|P1|COMPLETED|Overall Study||31
310155|NCT00000143|758009|P2|STARTED|Overall Study||30
310156|NCT00000143|758010|P1|STARTED|Overall Study||31
310157|NCT00000142|758019|P3|NOT COMPLETED|Overall Study||0
310158|NCT00000142|758020|P2|NOT COMPLETED|Overall Study||0
310159|NCT00000142|758021|P1|NOT COMPLETED|Overall Study||0
310160|NCT00000142|758019|P3|COMPLETED|Overall Study||12
310161|NCT00000142|758020|P2|COMPLETED|Overall Study||26
310162|NCT00000142|758021|P1|COMPLETED|Overall Study||26
310163|NCT00000142|758019|P3|STARTED|Overall Study||12
310164|NCT00000142|758020|P2|STARTED|Overall Study||26
310165|NCT00000142|758021|P1|STARTED|Overall Study||26
310166|NCT00000136|758031|P2|NOT COMPLETED|Overall Study||0
310167|NCT00000136|758032|P1|NOT COMPLETED|Overall Study||0
310168|NCT00000136|758031|P2|COMPLETED|Overall Study||127
310169|NCT00000136|758032|P1|COMPLETED|Overall Study||107
310170|NCT00000136|758031|P2|STARTED|Overall Study||127
310171|NCT00000136|758032|P1|STARTED|Overall Study||107
310172|NCT00000135|758040|P2|NOT COMPLETED|Overall Study||14
310173|NCT00000135|758041|P1|NOT COMPLETED|Overall Study||27
310174|NCT00000135|758040|P2|COMPLETED|Overall Study||91
310175|NCT00000135|758041|P1|COMPLETED|Overall Study||77
310176|NCT00000135|758040|P2|STARTED|Overall Study||105
310177|NCT00000135|758041|P1|STARTED|Overall Study||104
310178|NCT00000134|758050|P3|NOT COMPLETED|Overall Study||0
310179|NCT00000134|758051|P2|NOT COMPLETED|Overall Study||0
310180|NCT00000134|758052|P1|NOT COMPLETED|Overall Study||0
310181|NCT00000134|758050|P3|COMPLETED|Overall Study||96
310182|NCT00000134|758051|P2|COMPLETED|Overall Study||94
310183|NCT00000134|758052|P1|COMPLETED|Overall Study||89
310184|NCT00000134|758050|P3|STARTED|Overall Study||96
310185|NCT00000134|758051|P2|STARTED|Overall Study||94
310186|NCT00000134|758052|P1|STARTED|Overall Study||89
310187|NCT00000125|758062|P2|NOT COMPLETED|Overall Study||238
310188|NCT00000125|758063|P1|NOT COMPLETED|Overall Study||239
310189|NCT00000125|758062|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
310190|NCT00000125|758063|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
310191|NCT00000125|758062|P2|Completed OHTS Phase I, June 2002|Overall Study||702
310192|NCT00000125|758063|P1|Completed OHTS Phase I, June 2002|Overall Study||706
310193|NCT00000125|758062|P2|STARTED|Overall Study||817
310194|NCT00000125|758063|P1|STARTED|Overall Study||819
